effect	O
of	O
emo	B-T103
##din	I-T103
on	O
mobility	B-T038
signal	I-T038
transduction	I-T038
system	I-T038
of	O
gallbladder	B-T017
smooth	B-T017
muscle	I-T017
in	O
guinea	B-T204
pig	I-T204
with	O
chol	B-T038
##eli	I-T038
##thi	I-T038
##asis	I-T038
to	O
study	B-T062
the	O
effect	O
of	O
emo	B-T103
##din	I-T103
on	O
protein	B-T038
and	O
gene	B-T038
expressions	I-T038
of	O
the	O
massage	O
##rs	O
in	O
mobility	B-T038
signal	I-T038
transduction	I-T038
system	I-T038
of	O
cholecyst	B-T017
smooth	B-T017
muscle	I-T017
cells	I-T017
in	O
guinea	B-T204
pig	I-T204
with	O
cholesterol	B-T031
calculus	I-T031
.	O
the	O
guinea	B-T204
pigs	I-T204
were	O
randomly	O
divided	O
into	O
4	O
groups	O
,	O
such	O
as	O
control	O
group	O
,	O
gall	O
-	O
stone	O
(	O
gs	O
)	O
group	O
,	O
emo	B-T103
##din	I-T103
group	O
and	O
urs	B-T103
##odeoxycholic	I-T103
acid	I-T103
(	O
ua	B-T103
)	O
group	O
.	O
cholesterol	B-T031
calculus	I-T031
models	O
were	O
induced	O
in	O
guinea	B-T204
pigs	I-T204
of	O
gs	O
,	O
emo	B-T103
##din	I-T103
and	O
ua	B-T103
groups	O
by	O
lith	B-T168
##ogenic	I-T168
diet	I-T168
,	O
while	O
emo	B-T103
##din	I-T103
or	O
ua	B-T103
were	O
given	O
to	O
the	O
corresponding	O
group	O
for	O
7	O
weeks	O
.	O
the	O
histomorph	O
##ological	O
and	O
ultrastructure	O
change	O
of	O
gallbladder	B-T017
were	O
detected	B-T033
by	O
microscope	B-T074
and	O
electron	B-T074
microscope	I-T074
,	O
the	O
content	O
of	O
plasma	B-T031
cholecystokinin	B-T103
(	O
cck	B-T103
)	O
and	O
[	B-T103
ca	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
]	I-T103
i	I-T103
were	O
analyzed	B-T062
successively	O
by	O
radioimmunoassay	B-T058
and	O
flow	B-T058
cytometry	I-T058
.	O
the	O
protein	B-T103
and	O
mrna	B-T103
of	O
gs	B-T103
##α	I-T103
,	O
gi	B-T103
##α	I-T103
and	O
cap	B-T103
in	O
cholecyst	B-T017
cells	B-T017
were	O
determined	O
by	O
western	B-T058
blotting	I-T058
and	O
real	B-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
rt	B-T062
-	I-T062
pcr	I-T062
)	O
.	O
emo	B-T103
##din	I-T103
or	O
ua	B-T103
can	O
relieve	O
pathogenic	B-T033
changes	O
in	O
epithelial	B-T017
cells	I-T017
and	O
muscle	B-T017
cells	I-T017
in	O
gallbladder	B-T017
of	O
guinea	B-T204
pig	I-T204
with	O
cholesterol	B-T031
calculus	I-T031
by	O
microscope	B-T074
and	O
transmission	B-T074
electron	I-T074
microscope	I-T074
.	O
in	O
the	O
cholecyst	B-T017
cells	B-T017
of	O
gs	O
group	O
,	O
cck	B-T103
levels	O
in	O
plasma	B-T031
and	O
[	B-T103
ca	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
]	I-T103
i	I-T103
decreased	O
,	O
the	O
protein	B-T103
and	O
mrna	B-T103
of	O
gs	O
were	O
down	B-T038
-	I-T038
regulated	I-T038
,	O
the	O
protein	B-T103
and	O
mrna	B-T103
of	O
gi	B-T103
and	O
cap	B-T103
were	O
up	B-T038
-	I-T038
regulated	I-T038
.	O
emo	B-T103
##din	I-T103
significantly	O
decreased	O
the	O
format	O
##ive	O
rate	O
of	O
gallstone	O
,	O
improved	O
the	O
pathogenic	B-T033
change	O
in	O
epithelial	B-T017
cells	I-T017
and	O
muscle	B-T017
cells	I-T017
,	O
increased	O
cck	B-T103
levels	O
in	O
plasma	B-T031
and	O
[	B-T103
ca	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
]	I-T103
i	I-T103
in	O
cholecyst	B-T017
cells	B-T017
,	O
enhanced	O
the	O
protein	B-T103
and	O
mrna	B-T103
of	O
gs	B-T103
in	O
cholecyst	B-T017
cells	B-T017
,	O
reduced	O
the	O
protein	B-T103
and	O
mrna	B-T103
of	O
gi	B-T103
and	O
cap	B-T103
in	O
cholecyst	B-T017
cells	B-T017
in	O
guinea	B-T204
pig	I-T204
with	O
cholesterol	B-T031
calculus	I-T031
.	O
the	O
dysfunction	O
of	O
gallbladder	B-T038
contraction	I-T038
gives	O
rise	O
to	O
the	O
disorders	B-T038
of	O
mobility	B-T038
signal	I-T038
transduction	I-T038
system	I-T038
in	O
cholecyst	B-T017
smooth	B-T017
muscle	I-T017
cells	I-T017
,	O
including	O
low	O
content	O
of	O
plasma	B-T031
cck	B-T103
and	O
[	B-T103
ca	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
]	I-T103
i	I-T103
in	O
cholecyst	B-T017
cells	B-T017
,	O
abnormal	B-T103
protein	I-T103
and	O
mrna	B-T103
of	O
gs	B-T103
,	O
gi	B-T103
and	O
cap	B-T103
.	O
emo	B-T103
##din	I-T103
can	O
enhance	O
the	O
contract	B-T038
##ibility	I-T038
of	I-T038
gallbladder	I-T038
and	O
alleviate	O
cholestasis	B-T038
by	O
regulating	B-T038
plasma	B-T031
cck	B-T103
levels	O
,	O
[	B-T103
ca	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
]	I-T103
i	I-T103
in	O
cholecyst	B-T017
cells	B-T017
and	O
the	O
protein	B-T103
and	O
mrna	B-T103
of	O
gs	B-T103
,	O
gi	B-T103
and	O
cap	B-T103
.	O

treating	O
the	O
binge	B-T038
or	O
the	O
(	B-T017
fat	I-T017
)	I-T017
body	I-T017
?	O
representations	O
of	O
fat	B-T033
##ness	I-T033
in	O
a	O
gold	O
standard	O
psychological	O
treatment	O
manual	O
for	O
binge	B-T038
eating	I-T038
disorder	I-T038
this	O
article	O
reports	B-T058
the	O
results	B-T033
of	O
a	O
fo	B-T204
##uc	I-T204
##aul	I-T204
##di	I-T204
##an	I-T204
-	O
informed	O
discourse	O
analysis	O
exploring	O
representations	O
of	O
fat	B-T033
##ness	I-T033
embedded	O
within	O
an	O
empirically	O
based	O
psychological	O
treatment	O
manual	O
for	O
binge	B-T038
eating	I-T038
disorder	I-T038
,	O
a	O
condition	O
characterized	O
by	O
over	O
##val	O
##uation	O
of	O
weight	O
and	O
shape	O
.	O
analyses	B-T062
indicate	B-T033
that	O
the	O
manual	B-T170
priori	O
##ti	O
##zes	O
weight	B-T033
loss	I-T033
with	O
relatively	O
less	O
emphasis	O
placed	O
on	O
treating	O
the	O
diagnostic	O
symptoms	B-T033
and	O
underlying	O
mechanisms	O
of	O
binge	B-T038
eating	I-T038
disorder	I-T038
.	O
we	O
raise	O
critical	O
concerns	O
about	O
these	O
observations	B-T062
and	O
link	O
our	O
findings	B-T033
to	O
mainstream	O
psychology	B-T091
'	I-T091
s	I-T091
adoption	O
of	O
the	O
medical	O
framing	O
of	O
fat	B-T033
##ness	I-T033
as	O
obesity	B-T038
within	O
the	O
[UNK]	O
gold	O
standard	O
[UNK]	O
approach	O
to	O
intervention	B-T058
.	O
we	O
recommend	O
that	O
psychology	B-T091
as	O
a	O
discipline	B-T058
aband	O
##ons	O
the	O
weight	B-T033
loss	I-T033
imperative	O
associated	O
with	O
binge	B-T038
eating	I-T038
disorder	I-T038
and	O
fat	B-T017
bodies	I-T017
.	O
we	O
recommend	O
that	O
practitioners	B-T097
locate	O
the	O
problem	B-T033
of	O
fat	B-T038
sham	I-T038
##e	I-T038
in	O
society	B-T092
as	O
opposed	O
to	O
the	O
individual	B-T098
person	O
'	O
s	O
body	B-T204
and	O
provide	O
individuals	B-T098
with	O
tools	O
to	O
identify	O
and	O
resist	O
fat	B-T033
stigma	I-T033
and	O
opp	O
##ression	O
,	O
rather	O
than	O
provide	O
them	O
with	O
tools	O
to	O
res	O
##hap	O
##e	O
their	O
bodies	B-T204
.	O

secondary	B-T017
ossification	I-T017
center	I-T017
appearance	O
and	O
closure	B-T058
in	I-T058
the	I-T058
pelvis	I-T058
and	O
proximal	B-T082
femur	I-T082
variable	O
ossification	B-T038
patterns	B-T082
of	O
the	O
pelvis	B-T017
in	O
skeletal	B-T022
##ly	I-T022
immature	O
patients	O
can	O
make	O
the	O
interpretation	O
of	O
pelvic	B-T017
radiographs	B-T058
challenging	O
.	O
inconsistencies	O
among	O
prior	O
studies	O
and	O
lack	O
of	O
sex	O
comparisons	O
underscore	O
the	O
need	O
for	O
a	O
more	O
comprehensive	O
characterization	O
of	O
the	O
secondary	B-T017
ossification	I-T017
centers	I-T017
.	O
this	O
study	O
evaluates	B-T058
the	O
chron	B-T170
##ology	I-T170
and	O
sex	O
differences	O
for	O
appearance	O
and	O
closure	B-T058
of	I-T058
pelvic	I-T058
and	O
proximal	B-T082
femoral	I-T082
secondary	B-T017
ossification	I-T017
centers	I-T017
using	O
computed	B-T058
tomography	I-T058
(	O
ct	B-T058
)	O
.	O
patients	O
who	O
underwent	O
abdominal	B-T058
and	O
pelvic	O
ct	O
scans	O
between	O
january	O
2009	O
and	O
december	O
2014	O
at	O
2	O
tertiary	O
level	O
1	O
trauma	B-T092
centers	I-T092
were	O
retrospectively	O
reviewed	O
.	O
patients	O
between	O
the	O
ages	O
of	O
2	O
and	O
32	O
years	O
with	O
adequate	O
imaging	B-T058
of	O
the	O
pelvis	B-T017
and	O
proximal	B-T082
femur	I-T082
##s	I-T082
were	O
included	O
.	O
patients	O
with	O
a	O
history	O
of	O
orthopaedic	B-T091
trauma	I-T091
or	O
pathology	B-T091
affecting	O
ossification	B-T038
were	O
excluded	O
.	O
ct	B-T058
scans	I-T058
were	O
assessed	O
for	O
the	O
appearance	O
and	O
closure	B-T058
of	O
the	O
following	O
secondary	B-T017
ossification	I-T017
centers	I-T017
:	O
anterior	B-T017
inferior	I-T017
iliac	I-T017
spine	I-T017
(	O
aii	B-T017
##s	I-T017
)	O
,	O
anterior	B-T017
superior	I-T017
iliac	I-T017
spine	I-T017
(	O
asi	B-T017
##s	I-T017
)	O
,	O
femoral	B-T017
head	I-T017
(	O
fh	B-T017
)	O
,	O
greater	B-T017
troch	I-T017
##anter	I-T017
(	O
gt	B-T017
)	O
,	O
iliac	B-T017
crest	I-T017
(	O
ic	B-T017
)	O
,	O
isch	B-T017
##ial	I-T017
tuber	I-T017
##osity	I-T017
(	O
it	B-T017
)	O
,	O
lesser	B-T017
troch	I-T017
##anter	I-T017
(	O
lt	B-T017
)	O
,	O
posterior	B-T017
superior	I-T017
iliac	I-T017
spine	I-T017
(	O
psi	B-T017
##s	I-T017
)	O
,	O
symp	B-T082
##hy	I-T082
##sis	I-T082
pub	I-T082
##is	I-T082
(	O
sp	B-T082
)	O
,	O
and	O
tri	B-T017
##radi	I-T017
##ate	I-T017
cartilage	I-T017
(	O
tr	B-T017
##c	I-T017
)	O
.	O
basic	O
descriptive	O
statistics	O
are	O
reported	O
.	O
a	O
total	O
of	O
49	O
##6	O
ct	B-T058
scans	I-T058
met	O
inclusion	O
criteria	O
(	O
240	O
males	O
and	O
256	O
females	O
)	O
.	O
the	O
order	O
of	O
appearance	O
of	O
the	O
secondary	B-T017
ossification	I-T017
centers	I-T017
was	O
:	O
(	O
male	O
)	O
gt	B-T017
,	O
lt	B-T017
,	O
aii	B-T017
##s	I-T017
,	O
it	B-T017
,	O
asi	B-T017
##s	I-T017
,	O
psi	B-T017
##s	I-T017
,	O
ic	B-T017
,	O
and	O
sp	B-T082
;	O
(	O
female	O
)	O
gt	B-T017
,	O
lt	B-T017
,	O
it	B-T017
,	O
aii	B-T017
##s	I-T017
,	O
psi	B-T017
##s	I-T017
,	O
ic	B-T017
,	O
asi	B-T017
##s	I-T017
,	O
and	O
sp	B-T082
.	O
the	O
order	O
of	O
closure	B-T058
was	O
similar	O
:	O
(	O
male	O
)	O
tr	B-T017
##c	I-T017
,	O
lt	B-T017
,	O
fh	B-T017
,	O
aii	B-T017
##s	I-T017
,	O
gt	B-T017
,	O
asi	B-T017
##s	I-T017
,	O
psi	B-T017
##s	I-T017
,	O
it	B-T017
,	O
ic	B-T017
,	O
and	O
sp	B-T082
;	O
(	O
female	O
)	O
lt	B-T017
,	O
tr	B-T017
##c	I-T017
,	O
aii	B-T017
##s	I-T017
,	O
fh	B-T017
,	O
gt	B-T017
,	O
asi	B-T017
##s	I-T017
,	O
psi	B-T017
##s	I-T017
,	O
it	B-T017
,	O
ic	B-T017
,	O
and	O
sp	B-T082
.	O
female	O
ossification	B-T017
centers	I-T017
appeared	O
~	O
1	O
to	O
2	O
years	O
before	O
males	O
in	O
all	O
locations	B-T082
.	O
female	O
ossification	B-T017
centers	I-T017
closed	O
~	O
1	O
to	O
2	O
years	O
before	O
males	O
in	O
all	O
locations	B-T082
except	O
tr	B-T017
##c	I-T017
,	O
ic	B-T017
,	O
and	O
sp	B-T082
.	O
the	O
appearance	O
and	O
closure	B-T058
of	I-T058
the	I-T058
pelvis	I-T058
and	O
proximal	B-T082
femur	I-T082
secondary	B-T017
ossification	I-T017
centers	I-T017
follow	O
a	O
predictable	O
pattern	O
of	O
development	O
,	O
occurring	O
slightly	O
earlier	O
in	O
females	O
than	O
males	O
.	O
knowledge	O
of	O
more	O
precise	O
ages	O
of	O
develop	O
##men	O
t	O
and	O
sex	O
differences	O
better	O
characterize	O
this	O
complex	O
skeletal	B-T038
development	I-T038
.	O
future	O
studies	O
may	O
use	O
secondary	B-T017
ossification	I-T017
centers	I-T017
to	O
further	O
evaluate	B-T058
skeletal	O
maturity	O
,	O
assess	O
pediatric	B-T091
pathology	B-T091
,	O
and	O
aid	O
surgical	B-T058
management	I-T058
.	O
level	O
iii	O
.	O

a	O
comparison	O
of	O
the	O
localization	O
of	O
rectal	B-T038
carcinomas	I-T038
according	O
to	O
the	O
general	B-T082
rules	B-T170
of	O
the	O
japanese	B-T170
classification	I-T170
of	I-T170
colorectal	I-T170
carcinoma	I-T170
(	O
jc	B-T170
##cr	I-T170
##c	I-T170
)	O
and	O
western	B-T082
guidelines	B-T170
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
localization	O
of	O
rectal	B-T038
cancers	I-T038
as	O
classified	B-T170
according	O
to	O
the	O
general	B-T082
rules	B-T170
of	O
the	O
japanese	B-T170
classification	I-T170
of	I-T170
colorectal	I-T170
carcinoma	I-T170
(	O
jc	B-T170
##cr	I-T170
##c	I-T170
)	O
and	O
also	O
according	O
to	O
the	O
european	B-T092
society	I-T092
for	I-T092
medical	I-T092
oncology	I-T092
(	O
es	B-T092
##mo	I-T092
)	O
and	O
the	O
national	B-T092
comprehensive	I-T092
cancer	I-T092
network	I-T092
(	O
ncc	B-T092
##n	I-T092
)	O
guidelines	B-T170
,	O
which	O
are	O
based	O
on	O
rigid	B-T058
endoscopic	I-T058
measurements	O
.	O
the	O
medical	B-T170
records	I-T170
of	O
patients	O
scheduled	O
to	O
receive	O
curative	B-T058
surgery	I-T058
for	O
histologically	O
proven	O
rectal	B-T038
adenocarcinoma	I-T038
during	O
2009	O
-	O
2015	O
were	O
investigated	O
(	O
n	O
=	O
230	O
)	O
.	O
rigid	B-T058
proct	I-T058
##oscopy	I-T058
was	O
performed	O
in	O
patients	O
with	O
rectal	B-T038
cancer	I-T038
located	B-T082
in	I-T082
the	O
upper	B-T082
(	O
ra	B-T082
)	O
or	O
lower	B-T082
(	O
rb	B-T082
)	O
division	B-T058
using	O
double	B-T058
-	I-T058
contrast	I-T058
barium	I-T058
enema	I-T058
.	O
the	O
median	O
values	O
of	O
height	O
from	O
the	O
anal	B-T017
ver	I-T017
##ge	I-T017
were	O
7	O
.	O
5	O
cm	O
(	O
range	O
2	O
-	O
12	O
)	O
and	O
3	O
cm	O
(	O
0	O
-	O
9	O
.	O
5	O
)	O
on	O
rigid	B-T058
proct	I-T058
##oscopy	I-T058
for	O
cancers	B-T038
assigned	O
as	O
ra	B-T082
and	O
rb	B-T082
,	O
respectively	O
.	O
all	O
159	O
cancers	B-T038
at	O
ra	B-T082
or	O
rb	B-T082
were	O
located	B-T082
within	B-T082
12	O
cm	O
from	O
the	O
anal	B-T017
ver	I-T017
##ge	I-T017
by	O
rigid	B-T058
proct	I-T058
##oscopy	I-T058
,	O
while	O
only	O
79	O
.	O
7	O
%	O
of	O
ra	B-T082
or	O
82	O
.	O
1	O
%	O
of	O
rb	B-T082
cancers	B-T038
were	O
located	B-T082
in	I-T082
the	O
mid	B-T082
(	O
5	O
.	O
1	O
-	O
10	O
cm	O
)	O
or	O
low	O
(	O
≤	O
##5	O
cm	O
)	O
rectum	B-T017
,	O
respectively	O
.	O
ra	B-T082
and	O
rb	B-T082
cancers	B-T038
are	O
deemed	O
to	O
be	O
rectal	B-T038
cancers	I-T038
according	O
to	O
ncc	B-T092
##n	I-T092
guidelines	B-T170
,	O
but	O
these	O
classifications	B-T170
are	O
not	O
interchange	O
##able	O
with	O
mid	B-T082
-	I-T082
and	O
low	O
-	O
rectal	B-T038
cancers	I-T038
,	O
respectively	O
,	O
according	O
to	O
the	O
es	B-T092
##mo	I-T092
guidelines	B-T170
.	O

activation	B-T038
of	O
general	B-T103
control	I-T103
nond	I-T103
##ere	I-T103
##pre	I-T103
##ss	I-T103
##ible	I-T103
2	I-T103
kinase	I-T103
protects	O
human	B-T204
glomerular	B-T017
endothelial	I-T017
cells	I-T017
from	O
harmful	O
high	B-T033
-	I-T033
glucose	I-T033
-	O
induced	O
molecular	B-T038
pathways	I-T038
considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	B-T103
restriction	O
on	O
diabetic	B-T038
nephropathy	I-T038
(	O
dn	B-T038
)	O
and	O
the	O
role	O
of	O
renal	B-T017
endothelium	B-T017
in	O
its	O
pathogenesis	B-T038
,	O
we	O
evaluated	B-T058
the	O
effect	O
of	O
general	B-T103
control	I-T103
nond	I-T103
##ere	I-T103
##pre	I-T103
##ss	I-T103
##ible	I-T103
2	I-T103
(	I-T103
gc	I-T103
##n2	I-T103
)	I-T103
kinase	I-T103
activation	B-T038
,	O
a	O
sensor	O
of	O
amino	B-T103
acid	I-T103
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	B-T038
pathways	I-T038
in	O
primary	O
human	B-T204
glomerular	B-T017
endothelial	I-T017
cells	I-T017
(	O
gen	B-T017
##c	I-T017
)	O
.	O
gen	B-T017
##c	I-T017
were	O
cultured	B-T058
under	O
normal	O
or	O
high	B-T038
-	I-T038
glucose	I-T038
conditions	I-T038
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
gc	B-T103
##n2	I-T103
kinase	I-T103
activator	B-T038
,	O
tryptophan	B-T103
##ol	I-T103
.	O
glucose	B-T103
transporter	I-T103
1	I-T103
(	O
glut1	B-T103
)	O
expression	B-T038
was	O
assessed	O
by	O
western	B-T058
blotting	I-T058
and	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
using	O
a	O
fluoro	B-T103
##genic	I-T103
probe	I-T103
.	O
activities	B-T038
of	O
glyceraldehyde	B-T103
3	I-T103
-	I-T103
phosphate	I-T103
dehydrogenase	I-T103
(	O
gapdh	B-T103
)	O
and	O
protein	B-T103
kinase	I-T103
c	I-T103
(	O
pkc	B-T103
)	O
were	O
assessed	O
by	O
commercial	B-T058
activity	I-T058
assays	I-T058
,	O
sorbitol	B-T103
colorimetric	B-T058
##ally	I-T058
,	O
methyl	B-T103
##gly	I-T103
##oxal	I-T103
by	O
elisa	B-T058
and	O
o	B-T103
-	I-T103
linked	I-T103
β	I-T103
-	I-T103
n	I-T103
-	I-T103
acetyl	I-T103
glucosamine	I-T103
(	I-T103
o	I-T103
-	I-T103
glcnac	I-T103
)	I-T103
-	I-T103
modified	I-T103
proteins	I-T103
by	O
western	B-T058
blotting	I-T058
.	O
high	B-T033
glucose	I-T033
induced	O
glut1	B-T103
expression	B-T038
,	O
increased	O
ros	B-T103
and	O
inhibited	O
gapdh	B-T103
.	O
also	O
it	O
increased	O
the	O
poly	B-T103
##ol	I-T103
pathway	B-T038
product	O
sorbitol	B-T103
,	O
pkc	B-T103
activity	B-T038
,	O
the	O
level	O
of	O
the	O
o	B-T103
-	I-T103
glcnac	I-T103
-	I-T103
modified	I-T103
proteins	I-T103
that	O
produced	O
by	O
the	O
hex	B-T103
##osamine	I-T103
pathway	B-T038
and	O
the	O
advanced	B-T103
glycation	I-T103
end	I-T103
##produc	I-T103
##ts	I-T103
'	I-T103
precursor	O
methyl	B-T103
##gly	I-T103
##oxal	I-T103
.	O
co	O
-	O
treatment	O
of	O
gen	B-T017
##c	I-T017
with	O
tryptophan	B-T103
##ol	I-T103
restored	O
the	O
above	O
high	B-T033
-	I-T033
glucose	I-T033
-	O
induced	O
alterations	O
.	O
activation	B-T038
of	O
gc	B-T103
##n2	I-T103
kinase	I-T103
protects	O
gen	B-T017
##c	I-T017
from	O
high	B-T033
-	I-T033
glucose	I-T033
-	O
induced	O
harmful	O
molecular	B-T038
pathways	I-T038
.	O
by	O
inhibiting	O
concurrently	O
many	O
pathways	B-T038
involved	O
in	O
dn	B-T038
pathogenesis	B-T038
,	O
gc	B-T103
##n2	I-T103
kinase	I-T103
may	O
serve	O
as	O
a	O
pharmaceutical	B-T091
target	O
for	O
the	O
treatment	B-T058
of	O
dn	B-T038
.	O

a	O
novel	O
mechanical	B-T074
simulator	I-T074
for	O
cannulation	B-T058
and	O
sphincter	O
##otomy	O
after	O
bill	B-T058
##rot	I-T058
##h	I-T058
ii	I-T058
or	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
reconstruction	I-T058
in	O
patients	O
with	O
bill	B-T058
##rot	I-T058
##h	I-T058
ii	I-T058
(	O
b	B-T058
ii	I-T058
)	O
or	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
anatomy	B-T017
,	O
endoscopic	B-T058
retrograde	I-T058
cholangiopancre	I-T058
##atography	I-T058
(	O
ercp	B-T058
)	O
is	O
demanding	O
.	O
here	O
,	O
we	O
describe	O
a	O
novel	O
simulator	B-T074
with	O
simulated	B-T062
fluoroscopy	B-T058
for	O
cannulation	B-T058
and	O
sphincter	O
##otomy	O
training	O
in	O
such	O
situations	O
.	O
a	O
custom	O
-	O
made	O
simulation	B-T074
system	I-T074
was	O
built	O
based	O
upon	O
a	O
common	O
cha	O
##ss	O
##is	O
of	O
a	O
series	O
of	O
previously	O
described	O
ercp	B-T058
simulator	B-T074
##s	I-T074
.	O
the	O
papilla	B-T017
is	O
made	O
out	O
of	O
organic	O
material	O
and	O
can	O
be	O
cut	O
by	O
high	O
frequency	O
current	O
.	O
the	O
advancement	O
of	O
guide	O
##wire	O
##s	O
and	O
other	O
instruments	B-T074
within	O
transparent	O
mock	O
bile	B-T017
ducts	I-T017
can	O
be	O
viewed	O
in	O
the	O
window	O
of	O
the	O
simulator	B-T074
without	O
the	O
need	O
for	O
fluoroscopy	B-T058
.	O
the	O
ercp	B-T058
b	B-T058
ii	I-T058
/	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
simulation	B-T074
system	I-T074
was	O
first	O
evaluated	B-T058
during	O
an	O
ercp	B-T058
course	O
.	O
there	O
were	O
no	O
technical	O
problems	O
related	O
to	O
the	O
novel	O
simulator	B-T074
during	O
the	O
course	O
.	O
after	O
sphincter	O
##otomy	O
,	O
the	O
organic	O
papillae	B-T017
could	O
easily	O
be	O
exchanged	O
within	O
a	O
few	O
seconds	O
.	O
overall	O
,	O
the	O
novel	O
b	B-T058
ii	I-T058
/	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
simulator	B-T074
achieved	O
favorable	O
results	O
by	O
trainees	B-T097
and	O
expert	B-T097
endoscop	B-T097
##ists	I-T097
in	O
all	O
categories	B-T170
assessed	O
.	O
the	O
new	O
b	B-T058
ii	I-T058
/	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
mechanical	B-T074
simulator	I-T074
is	O
simple	O
and	O
practic	O
##able	O
.	O
a	O
first	O
evaluation	B-T058
during	O
an	O
ercp	B-T058
course	O
showed	O
promising	O
results	O
.	O

atp	B-T103
release	O
from	O
bladder	B-T017
uroth	I-T017
##elium	I-T017
and	O
sero	B-T017
##sa	I-T017
in	O
a	O
rat	O
model	B-T038
of	O
partial	B-T038
bladder	I-T038
outlet	I-T038
obstruction	I-T038
over	B-T038
##active	I-T038
bladder	I-T038
is	O
one	O
of	O
the	O
major	O
health	B-T033
problem	I-T033
especially	O
in	O
elderly	B-T098
people	I-T098
.	O
adenosine	B-T103
triphosphate	I-T103
(	O
atp	B-T103
)	O
is	O
released	O
from	O
urinary	B-T017
bladder	I-T017
cells	I-T017
and	O
acts	O
as	O
a	O
smooth	B-T038
muscle	I-T038
contraction	I-T038
and	O
sensory	O
signal	O
in	O
mict	B-T038
##urition	I-T038
but	O
little	O
is	O
known	O
about	O
the	O
role	O
of	O
atp	B-T103
release	O
in	O
the	O
pathophysiology	B-T038
of	O
over	B-T038
##active	I-T038
bladder	I-T038
.	O
to	O
assess	O
the	O
relationship	O
between	O
atp	B-T103
and	O
over	B-T038
##active	I-T038
bladder	I-T038
,	O
we	O
used	O
a	O
partial	B-T038
bladder	I-T038
outlet	I-T038
obstruction	I-T038
(	O
pb	B-T038
##oo	I-T038
)	O
model	B-T038
in	O
rats	B-T204
.	O
the	O
bladder	B-T017
caused	O
several	O
changes	O
by	O
pb	B-T038
##oo	I-T038
:	O
an	O
increase	O
in	O
bladder	B-T017
weight	O
,	O
hypertrophy	B-T038
of	O
sub	B-T017
-	I-T017
uroth	I-T017
##elium	I-T017
and	O
sub	B-T017
-	I-T017
serosal	I-T017
area	I-T017
,	O
and	O
frequent	O
non	O
-	O
voiding	B-T038
bladder	I-T038
contraction	I-T038
during	O
urine	B-T031
storage	O
.	O
basal	B-T082
atp	B-T103
release	O
from	O
uroth	B-T017
##elium	I-T017
and	O
sero	B-T017
##sa	I-T017
of	O
pb	B-T038
##oo	I-T038
rats	B-T204
was	O
significantly	O
higher	O
than	O
that	O
of	O
normal	O
rats	B-T204
.	O
dist	B-T033
##ention	I-T033
induced	O
atp	B-T103
release	O
from	O
uroth	B-T017
##elium	I-T017
of	O
normal	O
and	O
pb	B-T038
##oo	I-T038
rats	B-T204
had	O
no	O
significant	O
change	O
.	O
however	O
,	O
dist	B-T033
##ention	I-T033
-	O
induced	O
atp	B-T103
release	O
from	O
sero	B-T017
##sa	I-T017
of	O
pb	B-T038
##oo	I-T038
rats	B-T204
was	O
higher	O
than	O
that	O
of	O
normal	O
.	O
these	O
findings	O
may	O
identify	O
atp	B-T103
especially	O
released	O
from	O
sero	B-T017
##sa	I-T017
as	O
one	O
of	O
causes	O
of	O
non	O
-	O
voiding	B-T038
contractions	I-T038
and	O
over	B-T038
##active	I-T038
bladder	I-T038
symptoms	B-T033
.	O

acute	B-T038
ph	I-T038
-	I-T038
negative	I-T038
lymphoblastic	I-T038
leukemias	I-T038
in	O
adults	O
:	O
risk	B-T033
factors	I-T033
in	O
the	O
use	O
of	O
the	O
all	B-T170
-	I-T170
2009	I-T170
protocol	I-T170
to	O
analyze	O
well	O
-	O
known	O
risk	B-T033
factors	I-T033
(	O
rfs	B-T033
)	O
,	O
such	O
as	O
age	O
,	O
immunophen	B-T058
##otype	I-T058
,	O
baseline	O
leuk	B-T038
##ocytosis	I-T038
,	O
enhanced	O
lactate	B-T103
dehydrogenase	I-T103
(	O
ldh	B-T103
)	O
activity	B-T038
,	O
time	O
to	O
achieve	O
complete	O
remission	B-T033
,	O
a	O
risk	O
group	O
,	O
and	O
cytogenetic	B-T038
abnormalities	I-T038
)	O
in	O
patients	O
with	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
(	O
all	B-T038
)	O
in	O
the	O
use	O
of	O
the	O
all	B-T170
-	I-T170
2009	I-T170
protocol	I-T170
.	O
the	O
protocol	B-T170
covered	O
298	O
patients	O
(	O
137	O
women	B-T098
(	O
including	O
13	O
pregnant	B-T098
women	I-T098
)	O
and	O
161	O
men	B-T098
)	O
aged	O
15	O
to	O
55	O
years	O
(	O
median	O
age	O
28	O
years	O
)	O
with	O
ph	B-T038
-	I-T038
negative	I-T038
all	I-T038
.	O
the	O
phenotype	O
was	O
unknown	O
in	O
6	O
patients	O
.	O
three	O
(	O
1	O
%	O
)	O
were	O
ascertained	O
to	O
have	O
a	O
bip	O
##he	O
##no	O
##ty	O
##pic	O
variant	O
.	O
182	O
(	O
62	O
.	O
4	O
%	O
)	O
patients	O
were	O
found	O
to	O
have	O
b	B-T038
-	I-T038
cell	I-T038
all	I-T038
(	O
early	O
pre	B-T038
-	I-T038
b	I-T038
all	I-T038
(	O
n	O
=	O
51	O
)	O
;	O
common	O
all	B-T038
(	O
n	O
=	O
92	O
)	O
,	O
and	O
pre	B-T038
-	I-T038
b	I-T038
all	I-T038
(	O
n	O
=	O
39	O
)	O
;	O
107	O
(	O
36	O
.	O
6	O
%	O
)	O
patients	O
had	O
t	B-T038
-	I-T038
cell	I-T038
all	I-T038
(	O
early	O
t	B-T038
-	I-T038
all	I-T038
(	O
n	O
=	O
56	O
)	O
;	O
thymic	B-T017
t	B-T038
-	I-T038
all	I-T038
(	O
n	O
=	O
41	O
)	O
,	O
and	O
mature	O
t	B-T038
-	I-T038
all	I-T038
(	O
n	O
=	O
10	O
)	O
.	O
according	O
to	O
the	O
baseline	O
clinical	O
and	O
laboratory	B-T092
parameters	B-T033
(	O
leuk	B-T038
##ocytosis	I-T038
of	O
30	O
·	O
109	O
/	O
l	O
and	O
more	O
for	O
b	B-T038
-	I-T038
all	I-T038
;	O
and	O
that	O
of	O
100	O
·	O
109	O
/	O
l	O
and	O
more	O
for	O
t	B-T038
-	I-T038
all	I-T038
;	O
phenotype	O
в	O
-	O
i	O
for	O
b	B-T038
-	I-T038
all	I-T038
,	O
phenotype	O
т	O
-	O
i	O
-	O
ii	O
-	O
iv	O
for	O
t	B-T038
-	I-T038
all	I-T038
;	O
ldh	B-T103
activity	B-T038
was	O
more	O
than	O
twice	O
the	O
normal	O
values	O
;	O
the	O
presence	B-T033
of	O
translocation	B-T038
t	I-T038
(	I-T038
4	I-T038
;	I-T038
11	I-T038
)	I-T038
)	O
,	O
the	O
high	O
-	O
risk	O
group	O
included	O
most	O
patients	O
with	O
b	B-T038
-	I-T038
all	I-T038
(	O
n	O
=	O
110	O
(	O
72	O
.	O
8	O
%	O
)	O
)	O
and	O
t	B-T038
-	I-T038
all	I-T038
(	O
n	O
=	O
76	O
(	O
76	O
%	O
)	O
)	O
.	O
thirty	O
-	O
five	O
patients	O
with	O
t	B-T038
-	I-T038
all	I-T038
underwent	O
autologous	B-T058
bone	I-T058
marrow	I-T058
transplantation	I-T058
(	O
bmt	B-T058
)	O
.	O
allogeneic	B-T058
bmt	I-T058
was	O
performed	O
in	O
18	O
(	O
7	O
%	O
)	O
of	O
the	O
258	O
patients	O
who	O
had	O
undergone	O
an	O
induction	B-T062
phase	I-T062
.	O
five	O
-	O
year	O
overall	O
survival	O
for	O
all	O
the	O
patients	O
included	O
in	O
the	O
investigation	B-T058
was	O
59	O
%	O
;	O
relapse	B-T058
-	I-T058
free	I-T058
survival	O
was	O
65	O
%	O
,	O
which	O
was	O
significantly	O
different	O
in	O
the	O
patients	O
with	O
b	B-T038
-	I-T038
all	I-T038
and	O
in	O
those	O
with	O
t	B-T038
-	I-T038
all	I-T038
:	O
the	O
overall	O
survival	O
rates	O
were	O
53	O
.	O
3	O
and	O
67	O
.	O
5	O
%	O
(	O
p	O
=	O
0	O
.	O
1	O
)	O
;	O
the	O
relapse	O
-	O
free	O
survival	O
was	O
56	O
and	O
79	O
%	O
(	O
p	O
=	O
0	O
.	O
005	O
)	O
,	O
respectively	O
.	O
multivariate	O
analysis	O
including	O
the	O
well	O
-	O
known	O
rfs	B-T033
demonstrated	O
that	O
the	O
latter	O
for	O
t	B-T038
-	I-T038
all	I-T038
were	O
of	O
no	O
independent	O
prognostic	O
value	O
and	O
only	O
the	O
patient	O
'	O
s	O
age	O
was	O
identified	O
for	O
b	B-T038
-	I-T038
all	I-T038
(	O
p	O
=	O
0	O
.	O
013	O
)	O
.	O
a	O
lower	O
chemotherapeutic	B-T103
load	O
and	O
a	O
small	O
number	O
of	O
allogeneic	B-T058
bmt	I-T058
##s	I-T058
did	O
not	O
affect	O
total	O
positive	O
treatment	B-T058
results	B-T033
in	O
adult	O
patients	O
with	O
all	B-T038
,	O
by	O
compl	O
##ying	O
with	O
the	O
principle	O
achieving	O
the	O
continuity	O
of	O
cytostatic	B-T103
effects	O
and	O
by	O
preserving	O
the	O
total	O
cytostatic	B-T103
loading	O
dose	O
.	O
the	O
results	B-T033
of	O
the	O
russian	B-T082
investigation	B-T058
casts	O
some	O
doubt	O
on	O
the	O
necessity	O
of	O
using	O
very	O
intensive	O
consolidation	O
cycles	O
and	O
performing	O
a	O
large	O
number	O
of	O
allogeneic	B-T058
bmt	I-T058
##s	I-T058
in	O
adult	O
patients	O
with	O
all	B-T038
.	O

hospital	B-T097
##ist	I-T097
co	O
-	O
management	O
of	O
pediatric	O
orthopaedic	B-T058
surgical	O
patients	O
at	O
a	O
community	B-T092
hospital	I-T092
the	O
benefits	O
of	O
hospital	B-T097
##ist	I-T097
co	O
-	O
management	O
of	O
pediatric	O
surgical	O
patients	O
include	O
better	O
##ing	O
patient	B-T058
safety	I-T058
,	O
decreasing	B-T033
negative	O
patient	O
outcomes	O
,	O
providing	O
comprehensive	B-T058
medical	I-T058
care	I-T058
,	O
and	O
establishing	O
a	O
dedicated	O
resource	O
to	O
patients	O
for	O
postoperative	B-T058
care	I-T058
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
characterize	O
the	O
nature	O
of	O
patients	O
co	O
-	O
managed	O
by	O
a	O
pediatric	O
hospital	B-T097
##ist	I-T097
.	O
the	O
authors	B-T097
hypothesize	O
that	O
hospital	B-T097
##ist	I-T097
co	O
-	O
management	O
is	O
safe	B-T033
and	O
efficacious	O
in	O
pediatric	O
orthopaedic	B-T058
surgical	O
patients	O
who	O
are	O
admitted	B-T058
to	O
a	O
community	B-T092
hospital	I-T092
.	O
a	O
retrospective	B-T062
review	I-T062
was	O
performed	O
of	O
all	O
pediatric	O
orthopaedic	B-T058
surgical	O
patients	O
admitted	B-T058
to	O
a	O
community	B-T092
hospital	I-T092
who	O
were	O
co	O
-	O
managed	O
by	O
a	O
pediatric	O
hospital	B-T097
##ist	I-T097
.	O
indications	O
for	O
hospitalization	B-T058
included	O
pain	B-T058
control	I-T058
,	O
antibiotic	B-T058
infusion	I-T058
,	O
and	O
need	O
for	O
neurovascular	B-T058
monitoring	I-T058
.	O
parameters	O
of	O
postoperative	B-T058
care	I-T058
and	O
co	O
-	O
management	O
were	O
assessed	O
,	O
including	O
presence	B-T033
of	O
complications	O
,	O
medication	B-T058
introduction	I-T058
or	O
adjustment	O
by	O
the	O
hospital	B-T097
##ist	I-T097
,	O
follow	B-T058
-	I-T058
up	I-T058
adherence	O
,	O
and	O
readmission	B-T058
/	O
complication	O
rates	O
after	O
discharge	B-T058
.	O
thirty	O
-	O
two	O
patients	O
were	O
assessed	O
with	O
an	O
average	O
age	O
of	O
8	O
.	O
8	O
years	O
.	O
twenty	O
-	O
five	O
percent	O
of	O
patients	O
had	O
an	O
associated	O
comorbidity	O
,	O
including	O
asthma	B-T038
,	O
attention	B-T038
deficit	I-T038
disorder	I-T038
,	O
and	O
/	O
or	O
autism	B-T038
.	O
the	O
pediatric	O
hospital	B-T097
##ist	I-T097
added	O
pain	O
medication	O
to	O
the	O
original	O
postoperative	B-T058
orders	I-T058
placed	O
by	O
the	O
orthopaedic	B-T097
##s	I-T097
team	I-T097
in	O
44	O
percent	O
of	O
patients	O
(	O
14	O
of	O
the	O
32	O
)	O
either	O
for	O
breakthrough	B-T033
pain	I-T033
or	O
better	O
long	O
-	O
term	O
coverage	O
.	O
additionally	O
,	O
25	O
percent	O
of	O
patients	O
had	O
pain	O
medication	O
adjusted	O
from	O
the	O
original	O
dosing	O
and	O
schedule	B-T058
.	O
the	O
hospital	B-T097
##ist	I-T097
team	O
contacted	O
the	O
surgeon	B-T097
about	O
the	O
four	O
patients	O
(	O
12	O
.	O
5	O
percent	O
)	O
.	O
in	O
three	O
of	O
the	O
cases	O
,	O
the	O
surgeon	B-T097
was	O
contacted	O
to	O
discuss	O
pain	O
medication	O
,	O
and	O
one	O
patient	O
w	O
##oke	O
up	O
ag	O
##itated	O
from	O
anesthesia	B-T058
,	O
necessitating	O
a	O
visit	O
from	O
the	O
surgeon	B-T097
on	O
the	O
pediatrics	O
floor	O
.	O
the	O
length	O
of	O
stay	O
was	O
one	O
day	O
for	O
all	O
patients	O
.	O
the	O
hospital	B-T097
##ists	I-T097
round	O
##ed	O
on	O
and	O
discharged	B-T058
patients	I-T058
the	O
subsequent	O
morning	O
.	O
all	O
patients	O
were	O
given	O
a	O
follow	O
-	O
up	O
appointment	O
and	O
schedule	O
by	O
the	O
hospital	B-T097
##ist	I-T097
team	O
,	O
and	O
every	O
patient	O
followed	B-T058
up	I-T058
accordingly	O
within	O
ten	O
days	O
of	O
discharge	B-T058
.	O
no	O
complications	O
or	O
hospital	B-T058
readmissions	I-T058
occurred	O
within	O
thirty	O
days	O
of	O
discharge	B-T058
.	O
hospital	B-T097
##ist	I-T097
co	O
-	O
management	O
of	O
pediatric	O
orthopaedic	B-T058
surgical	O
patients	O
in	O
a	O
community	B-T092
hospital	I-T092
allows	O
for	O
better	O
medical	O
comorbidity	O
and	O
medication	B-T058
management	I-T058
.	O
hospital	B-T097
##ist	I-T097
s	O
can	O
provide	O
closer	O
observation	O
during	O
the	O
inpatient	O
stay	O
and	O
help	O
stream	O
##line	O
communication	O
between	O
providers	B-T097
and	O
patients	O
while	O
allowing	O
the	O
surgeon	B-T097
the	O
ability	O
to	O
be	O
more	O
mobile	O
.	O
co	O
-	O
management	O
is	O
safe	B-T033
and	O
efficacious	O
in	O
pediatric	O
orthopaedic	B-T058
surgical	O
patients	O
who	O
are	O
admitted	B-T058
to	O
a	O
community	B-T092
hospital	I-T092
.	O

increased	O
cerebral	O
blood	O
volume	O
pulsatility	O
during	O
head	B-T082
-	I-T082
down	I-T082
tilt	I-T082
with	O
elevated	B-T033
carbon	I-T033
dioxide	I-T033
:	O
the	O
space	B-T062
##co	I-T062
##t	I-T062
study	I-T062
astr	B-T097
##ona	I-T097
##uts	I-T097
abo	O
##ard	O
the	O
international	O
space	O
station	O
(	O
iss	O
)	O
have	O
exhibited	O
hyper	B-T038
##opic	I-T038
shifts	I-T038
,	O
posterior	B-T082
eye	B-T017
globe	I-T017
flatten	O
##ing	O
,	O
dilated	B-T033
optic	B-T017
nerve	I-T017
sheath	I-T017
##s	I-T017
,	O
and	O
even	O
optic	B-T038
disc	I-T038
swelling	I-T038
from	O
space	O
##fl	O
##ight	O
.	O
elevated	B-T038
intracranial	I-T038
pressure	I-T038
(	O
icp	B-T038
)	O
consequent	O
to	O
cephal	B-T082
##ad	I-T082
fluid	B-T038
shifts	I-T038
is	O
commonly	O
hypothesized	O
as	O
contributing	O
to	O
these	O
ocular	B-T033
changes	I-T033
.	O
head	B-T082
-	I-T082
down	I-T082
tilt	I-T082
(	O
hd	B-T082
##t	I-T082
)	O
is	O
frequently	O
utilized	O
as	O
an	O
earth	B-T082
-	O
based	O
analog	O
to	O
study	O
similar	O
fluid	B-T038
shifts	I-T038
.	O
sealed	B-T082
environments	I-T082
like	O
the	O
iss	O
also	O
exhibit	O
elevated	O
carbon	B-T103
dioxide	I-T103
(	O
co2	B-T103
)	O
,	O
a	O
potent	O
arteriolar	B-T103
vasodilator	I-T103
that	O
could	O
further	O
affect	O
cerebral	O
blood	O
volume	O
and	O
flow	B-T033
,	O
intracranial	B-T082
compliance	B-T033
,	O
and	O
icp	B-T038
.	O
a	O
collaborative	B-T062
pilot	I-T062
study	I-T062
between	O
the	O
national	B-T092
space	I-T092
biomedical	I-T092
research	I-T092
institute	I-T092
and	O
the	O
german	B-T092
aeros	I-T092
##pa	I-T092
##ce	I-T092
center	I-T092
tested	O
the	O
hypotheses	O
that	O
:	O
(	O
1	O
)	O
hd	B-T082
##t	I-T082
and	O
elevated	O
co2	B-T103
physiologically	O
interact	O
,	O
and	O
(	O
2	O
)	O
cerebrovascular	O
pulsatility	O
is	O
related	O
to	O
hd	B-T082
##t	I-T082
and	O
/	O
or	O
elevated	O
co2	B-T103
in	O
a	O
double	B-T062
-	I-T062
blind	I-T062
crossover	B-T062
study	I-T062
(	O
n	O
=	O
6	O
)	O
,	O
we	O
measured	O
cerebral	O
blood	O
volume	O
(	O
cb	O
##v	O
)	O
pulsatility	O
via	O
near	B-T058
-	I-T058
infrared	I-T058
spectroscopy	I-T058
,	O
alongside	O
non	O
-	O
invasive	O
icp	B-T038
and	O
intraocular	B-T038
pressure	I-T038
(	O
iop	B-T038
)	O
during	O
28	O
-	O
hr	O
-	O
12	O
##°	O
hd	B-T082
##t	I-T082
at	O
both	O
nominal	O
(	O
0	O
.	O
04	O
%	O
)	O
and	O
elevated	O
(	O
0	O
.	O
5	O
%	O
)	O
ambient	O
co2	B-T103
in	O
our	O
cohort	B-T098
,	O
cb	O
##v	O
pulsatility	O
increased	O
significantly	O
over	O
time	O
at	O
cardiac	B-T082
frequencies	O
(	O
0	O
.	O
031	O
##±0	O
.	O
009	O
μm	O
/	O
hr	O
increase	O
in	O
[	O
hb	O
##t	O
]	O
pulsatility	O
amplitude	B-T082
)	O
and	O
may	O
##er	O
wave	O
frequencies	O
(	O
0	O
.	O
019	O
##±0	O
.	O
005	O
μm	O
/	O
hr	O
increase	O
)	O
.	O
the	O
hd	B-T082
##t	I-T082
-	O
co2	B-T103
interaction	O
on	O
pulsatility	O
was	O
not	O
robust	O
,	O
but	O
rather	O
driven	O
by	O
an	O
individual	B-T098
.	O
significant	O
differences	O
between	O
atmosphere	O
##s	O
were	O
not	B-T033
detected	I-T033
in	O
icp	B-T038
or	O
iop	B-T038
.	O
further	O
work	O
is	O
needed	O
to	O
reproduce	O
these	O
findings	O
in	O
a	O
larger	O
cohort	B-T098
,	O
to	O
determine	O
whether	O
a	O
[UNK]	B-T033
water	I-T033
hamm	I-T033
##er	I-T033
[UNK]	I-T033
effect	I-T033
in	O
cerebral	B-T017
pulsatility	O
is	O
also	O
present	O
during	O
space	O
##fl	O
##ight	O
,	O
and	O
whether	O
it	O
is	O
associated	O
with	O
ocular	B-T033
changes	I-T033
in	O
astr	B-T097
##ona	I-T097
##uts	I-T097
.	O

metalloproteinase	B-T103
mep	B-T103
##rin	I-T103
α	I-T103
regulates	O
migration	B-T038
and	O
invasion	B-T033
of	O
human	B-T204
hepatocarcin	B-T038
##oma	I-T038
cells	B-T017
and	O
is	O
a	O
mediator	O
of	O
the	O
oncoprotein	B-T103
rep	B-T103
##tin	I-T103
hepatocellular	B-T038
carcinoma	I-T038
is	O
associated	O
with	O
a	O
high	O
rate	O
of	O
intra	B-T082
-	I-T082
hepatic	I-T082
invasion	B-T033
that	O
carries	O
a	O
poor	B-T033
prognosis	I-T033
.	O
mep	B-T103
##rin	I-T103
alpha	I-T103
(	O
mep	B-T103
##1a	I-T103
)	O
is	O
a	O
secreted	B-T038
metalloproteinase	B-T103
with	O
many	O
substrates	O
relevant	O
to	O
cancer	B-T033
invasion	I-T033
.	O
we	O
found	O
that	O
mep	B-T103
##1a	I-T103
was	O
a	O
target	O
of	O
rep	B-T103
##tin	I-T103
,	O
a	O
protein	B-T103
that	I-T103
is	I-T103
oncogenic	I-T103
in	O
hcc	B-T038
.	O
we	O
studied	O
mep	B-T103
##1a	I-T103
regulation	B-T038
by	O
rep	B-T103
##tin	I-T103
,	O
its	O
role	O
in	O
hcc	B-T038
,	O
and	O
whether	O
it	O
mediates	O
rep	B-T103
##tin	I-T103
oncogenic	B-T103
effects	O
.	O
mep	B-T103
##a	I-T103
and	O
rep	B-T103
##tin	I-T103
expression	B-T038
was	O
measured	O
in	O
human	B-T204
hcc	B-T038
by	O
qrt	B-T062
-	I-T062
pcr	I-T062
and	O
in	O
cultured	B-T017
cells	I-T017
by	O
pcr	B-T062
,	O
western	B-T058
blot	I-T058
and	O
enzymatic	O
activity	O
measurements	O
.	O
cell	B-T038
growth	I-T038
was	O
assessed	O
by	O
counting	B-T058
and	O
mts	B-T062
assay	I-T062
.	O
cell	B-T038
migration	I-T038
was	O
measured	O
in	O
boy	B-T074
##den	I-T074
chambers	I-T074
and	O
wound	B-T038
healing	I-T038
assays	B-T058
,	O
and	O
cell	B-T033
invasion	I-T033
in	O
boy	B-T074
##den	I-T074
chambers	I-T074
.	O
silencing	B-T038
rep	B-T017
##tin	I-T017
decreased	O
mep	B-T103
##1a	I-T103
expression	B-T038
and	O
activity	O
,	O
without	O
affecting	O
mep	B-T103
##rin	I-T103
β	I-T103
.	O
mep	B-T103
##1a	I-T103
,	O
but	O
not	O
mep	B-T103
##rin	I-T103
β	I-T103
,	O
was	O
overexpressed	B-T038
in	O
a	O
series	O
of	O
242	O
human	B-T204
hcc	B-T038
(	O
2	O
.	O
04	O
fold	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
and	O
a	O
high	O
expression	B-T038
correlated	O
with	O
a	O
poor	B-T033
prognosis	I-T033
.	O
mep	B-T103
##1a	I-T103
and	O
rep	B-T103
##tin	I-T103
expressions	B-T038
were	O
positively	O
correlated	O
(	O
r	O
=	O
0	O
.	O
39	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
silencing	B-T038
mep	B-T017
##1a	I-T017
had	O
little	O
effect	O
on	O
cell	B-T038
proliferation	I-T038
,	O
but	O
decreased	O
cell	B-T038
migration	I-T038
and	O
invasion	B-T033
of	O
hu	B-T017
##h	I-T017
##7	I-T017
and	O
hep	B-T017
##3b	I-T017
cells	I-T017
.	O
conversely	O
,	O
overexpression	B-T038
of	O
mep	B-T103
##1a	I-T103
or	O
addition	O
of	O
recombinant	O
mep	B-T103
##1a	I-T103
increased	O
migration	B-T038
and	O
invasion	B-T033
.	O
finally	O
,	O
overexpression	B-T038
of	O
mep	B-T103
##1a	I-T103
restored	O
a	O
normal	O
cell	B-T038
migration	I-T038
in	O
cells	B-T017
where	O
rep	B-T103
##tin	I-T103
was	O
depleted	O
.	O
mep	B-T103
##1a	I-T103
is	O
overexpressed	B-T038
in	O
most	O
hcc	B-T038
and	O
induces	O
hcc	B-T038
cell	B-T038
migration	I-T038
and	O
invasion	B-T033
.	O
mep	B-T103
##1a	I-T103
expression	B-T038
is	O
regulated	O
by	O
rep	B-T103
##tin	I-T103
,	O
and	O
mep	B-T103
##1a	I-T103
mediates	O
rep	B-T103
##tin	I-T103
-	O
induced	O
migration	B-T038
.	O
overall	O
,	O
we	O
suggest	O
that	O
mep	B-T103
##1a	I-T103
may	O
be	O
a	O
useful	O
target	O
in	O
hcc	B-T038
.	O

pupil	B-T201
sizes	I-T201
scale	B-T170
with	O
attentional	B-T170
load	I-T170
and	O
task	O
experience	B-T038
in	O
a	O
multiple	O
object	O
tracking	B-T082
task	O
previous	O
studies	O
have	O
related	O
changes	O
in	O
attentional	B-T170
load	I-T170
to	O
pupil	B-T201
size	I-T201
modulations	B-T082
.	O
however	O
,	O
studies	O
relating	O
changes	O
in	O
attentional	B-T170
load	I-T170
and	O
task	O
experience	B-T038
on	O
a	O
fine	O
##r	O
scale	B-T170
to	O
pupil	B-T201
size	I-T201
modulations	B-T082
are	O
scarce	O
.	O
here	O
,	O
we	O
investigated	O
how	O
these	O
changes	O
affect	B-T038
pupil	B-T201
sizes	I-T201
.	O
to	O
manipulate	O
attentional	B-T170
load	I-T170
,	O
participants	B-T098
cover	O
##tl	O
##y	O
tracked	B-T082
between	O
zero	O
and	O
five	O
objects	O
among	O
several	O
randomly	O
moving	O
objects	O
on	O
a	O
computer	O
screen	O
.	O
to	O
investigate	O
effects	O
of	O
task	O
experience	B-T038
,	O
the	O
experiment	O
was	O
conducted	O
on	O
three	O
consecutive	O
days	O
.	O
we	O
found	O
that	O
pupil	B-T201
sizes	I-T201
increased	O
with	O
each	O
increment	O
in	O
attentional	B-T170
load	I-T170
.	O
across	O
days	O
,	O
we	O
found	O
systematic	O
pupil	B-T201
size	I-T201
reductions	O
.	O
we	O
compared	O
the	O
model	O
fit	O
for	O
predicting	O
pupil	B-T201
size	I-T201
modulations	B-T082
using	O
attentional	B-T170
load	I-T170
,	O
task	O
experience	B-T038
,	O
and	O
task	B-T058
performance	I-T058
as	O
predictors	O
.	O
we	O
found	O
that	O
a	O
model	B-T170
which	O
included	O
attentional	B-T170
load	I-T170
and	O
task	O
experience	B-T038
as	O
predictors	O
had	O
the	O
best	O
model	O
fit	O
while	O
adding	O
performance	B-T058
as	O
a	O
predictor	O
to	O
this	O
model	B-T170
reduced	O
the	O
overall	O
model	O
fit	O
.	O
overall	O
,	O
results	O
suggest	O
that	O
pupil	B-T058
##lo	I-T058
##metry	I-T058
provides	O
a	O
viable	O
metric	O
for	O
precisely	O
assessing	O
attentional	B-T170
load	I-T170
and	O
task	O
experience	B-T038
in	O
visuospatial	O
tasks	O
.	O

a	O
thermophilic	O
-	O
like	O
ene	B-T103
-	I-T103
reductase	I-T103
originating	O
from	O
an	O
acid	O
##ophilic	O
iron	B-T007
oxid	I-T007
##izer	I-T007
ene	B-T103
-	I-T103
reductase	I-T103
##s	I-T103
originating	O
from	O
extrem	O
##ophiles	O
are	O
gaining	O
importance	O
in	O
the	O
field	O
of	O
bioc	O
##atal	O
##ysis	O
due	O
to	O
higher	O
-	O
stability	O
properties	O
.	O
the	O
genome	B-T017
of	O
the	O
acid	O
##ophilic	O
iron	B-T007
-	I-T007
oxidizing	I-T007
bacterium	I-T007
[UNK]	O
ferro	B-T007
##v	I-T007
##um	I-T007
[UNK]	I-T007
sp	I-T007
.	I-T007
ja	I-T007
##12	I-T007
was	O
found	O
to	O
harbor	O
a	O
thermophilic	O
-	O
like	O
ene	B-T103
-	I-T103
reductase	I-T103
(	O
fo	B-T103
##y	I-T103
##e	I-T103
-	I-T103
1	I-T103
)	O
.	O
the	O
fo	B-T017
##y	I-T017
##e	I-T017
-	I-T017
1	I-T017
gene	I-T017
was	O
ligated	O
into	O
a	O
pet	B-T103
##16	I-T103
##bp	I-T103
expression	B-T038
vector	B-T103
system	I-T103
,	O
and	O
the	O
enzyme	B-T103
was	O
produced	O
in	O
escherichia	B-T007
coli	I-T007
bl	B-T017
##21	I-T017
(	I-T017
de	I-T017
##3	I-T017
;	I-T017
pl	I-T017
##ys	I-T017
##s	I-T017
)	I-T017
cells	I-T017
in	O
yields	O
of	O
10	O
mg	O
l	O
(	O
-	O
1	O
)	O
.	O
fo	B-T103
##y	I-T103
##e	I-T103
-	I-T103
1	I-T103
showed	O
remarkable	O
activity	B-T038
and	O
rates	O
on	O
n	B-T103
-	I-T103
phenyl	I-T103
##maleimide	I-T103
and	O
n	B-T103
-	I-T103
phenyl	I-T103
-	I-T103
2	I-T103
-	I-T103
methyl	I-T103
##maleimide	I-T103
(	O
up	O
to	O
89	O
u	O
mg	O
(	O
-	O
1	O
)	O
,	O
>	O
97	O
%	O
conversion	O
,	O
95	O
%	O
(	O
r	O
)	O
-	O
selective	O
)	O
with	O
both	O
nicotinamide	B-T103
cofactors	I-T103
,	O
nadph	B-T103
and	O
nadh	B-T103
.	O
the	O
catalytic	O
efficiency	O
with	O
nadph	B-T103
was	O
27	O
times	O
higher	O
compared	O
to	O
nadh	B-T103
.	O
at	O
the	O
temperature	O
maximum	O
(	O
50	O
°c	O
)	O
and	O
ph	O
optimum	O
(	O
6	O
.	O
5	O
)	O
,	O
activity	B-T038
was	O
almost	O
doubled	O
to	O
160	O
u	O
mg	O
(	O
-	O
1	O
)	O
.	O
these	O
findings	B-T033
accomplish	O
fo	B-T103
##y	I-T103
##e	I-T103
-	I-T103
1	I-T103
for	O
a	O
valuable	O
bioc	O
##atalyst	O
in	O
the	O
synthesis	O
of	O
succin	B-T103
##imide	I-T103
##s	I-T103
.	O
the	O
appearance	O
of	O
a	O
thermophilic	O
-	O
like	O
ene	B-T103
-	I-T103
reductase	I-T103
in	O
an	O
acidic	B-T082
habitat	I-T082
is	O
discussed	O
with	O
respect	O
to	O
its	O
phylogenetic	O
placement	O
and	O
to	O
the	O
genomic	B-T017
neighborhood	B-T082
of	O
the	O
encoding	O
gene	B-T017
,	O
award	O
##ing	O
fo	B-T103
##y	I-T103
##e	I-T103
-	I-T103
1	I-T103
a	O
putative	O
involvement	O
in	O
a	O
quorum	B-T038
-	I-T038
sensing	I-T038
process	O
.	O

characterization	O
and	O
ectopic	B-T038
expression	I-T038
of	O
cow	B-T017
##ri	I-T017
##1	I-T017
,	O
an	O
ap	B-T017
##2	I-T017
/	I-T017
er	I-T017
##eb	I-T017
##p	I-T017
domain	O
-	O
containing	O
transcription	B-T103
factor	I-T103
from	O
coc	B-T204
##on	I-T204
##ut	I-T204
(	O
coc	B-T204
##os	I-T204
nu	I-T204
##ci	I-T204
##fer	I-T204
##a	I-T204
l	I-T204
.	O
)	O
endosperm	B-T204
,	O
changes	O
the	O
seeds	B-T204
oil	B-T103
content	O
in	O
transgenic	B-T204
arabidopsis	B-T204
thaliana	I-T204
and	O
rice	B-T204
(	O
oryz	B-T204
##a	I-T204
sativa	I-T204
l	I-T204
.	O
)	O
coc	B-T204
##on	I-T204
##ut	I-T204
(	O
coc	B-T204
##os	I-T204
nu	I-T204
##ci	I-T204
##fer	I-T204
##a	I-T204
l	I-T204
.	I-T204
)	O
is	O
a	O
key	O
tropical	O
crop	B-T204
and	O
a	O
member	O
of	O
the	O
monoc	O
##otyl	O
##ed	O
##onous	O
family	O
are	B-T204
##ca	I-T204
##ce	I-T204
##ae	I-T204
(	O
palm	B-T204
##aceae	I-T204
)	O
.	O
few	O
genes	B-T017
and	O
related	O
metabolic	B-T038
processes	I-T038
involved	O
in	O
coc	B-T204
##on	I-T204
##ut	I-T204
endosperm	B-T204
development	O
have	O
been	O
investigated	O
.	O
in	O
this	O
study	B-T062
,	O
a	O
new	O
member	O
of	O
the	O
wr	B-T017
##i1	I-T017
gene	B-T017
family	I-T017
was	O
isolated	O
from	O
coc	B-T204
##on	I-T204
##ut	I-T204
endosperm	B-T204
and	O
was	O
named	O
cow	B-T017
##ri	I-T017
##1	I-T017
.	O
its	O
transcriptional	B-T038
activities	O
and	O
interactions	O
with	O
the	O
acetyl	B-T103
-	I-T103
coa	I-T103
carboxylase	I-T103
(	O
bcc	B-T103
##p2	I-T103
)	O
promoter	B-T103
of	O
cow	B-T017
##ri	I-T017
##1	I-T017
were	O
confirmed	O
by	O
the	O
yeast	B-T062
two	I-T062
-	I-T062
hybrid	I-T062
and	O
yeast	B-T062
one	I-T062
-	I-T062
hybrid	I-T062
approaches	O
,	O
respectively	O
.	O
functional	O
characterization	O
was	O
carried	O
out	O
through	O
seed	B-T204
-	O
specific	O
expression	B-T038
in	O
arabidopsis	B-T204
and	O
endosperm	B-T204
-	O
specific	O
expression	B-T038
in	O
rice	B-T204
.	O
in	O
transgenic	B-T204
arabidopsis	B-T204
,	O
high	O
over	B-T038
-	I-T038
expressions	I-T038
of	O
cow	B-T017
##ri	I-T017
##1	I-T017
in	O
seven	O
independent	O
t2	B-T204
lines	B-T204
were	O
detected	O
by	O
quantitative	B-T062
real	I-T062
-	I-T062
time	I-T062
pcr	I-T062
.	O
the	O
relative	O
mrna	B-T103
accumulation	O
of	O
genes	B-T017
encoding	O
enzymes	B-T103
involved	O
in	O
either	O
fatty	B-T038
acid	I-T038
biosynthesis	I-T038
or	O
triacylglycerol	B-T103
##s	I-T103
assembly	O
(	O
bcc	B-T017
##p2	I-T017
,	O
ka	B-T017
##si	I-T017
,	O
mat	B-T017
,	O
en	B-T017
##r	I-T017
,	O
fat	B-T017
##a	I-T017
,	O
and	O
gp	B-T017
##dh	I-T017
)	O
were	O
also	O
assayed	B-T058
in	O
mature	O
seeds	B-T204
.	O
furthermore	O
,	O
lipid	B-T103
and	O
fatty	B-T103
acids	I-T103
c16	B-T103
:	I-T103
0	I-T103
and	O
c18	B-T103
:	I-T103
0	I-T103
significantly	O
increased	O
.	O
in	O
two	O
homozygous	O
t2	B-T204
transgenic	B-T204
rice	B-T204
lines	I-T204
(	O
g	B-T204
##5	I-T204
and	O
g2	B-T204
)	O
,	O
different	O
cow	B-T017
##ri	I-T017
##1	I-T017
expression	B-T038
levels	O
were	O
detected	O
,	O
but	O
no	O
cow	B-T017
##ri	I-T017
##1	I-T017
transcripts	B-T103
were	O
detected	O
in	O
the	O
wild	B-T017
type	I-T017
.	O
analyses	B-T062
of	O
the	O
seed	B-T204
oil	B-T103
content	O
,	O
starch	B-T103
content	O
,	O
and	O
total	O
protein	B-T103
content	O
indicated	O
that	O
the	O
two	O
t2	B-T204
transgenic	B-T204
lines	I-T204
showed	O
a	O
significant	O
increase	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
seed	B-T204
oil	B-T103
content	O
.	O
the	O
transgenic	B-T204
lines	I-T204
also	O
showed	O
a	O
significant	O
increase	O
in	O
starch	B-T103
content	O
,	O
whereas	O
total	O
protein	B-T103
content	O
decreased	O
significantly	O
.	O
further	O
analysis	B-T062
of	O
the	O
fatty	B-T103
acid	I-T103
composition	O
revealed	O
that	O
palmitic	B-T103
acid	I-T103
(	O
c16	B-T103
:	I-T103
0	I-T103
)	O
and	O
linolenic	B-T103
acid	I-T103
(	O
c18	B-T103
:	I-T103
3	I-T103
)	O
increased	O
significantly	O
in	O
the	O
seeds	B-T204
of	O
the	O
transgenic	B-T204
rice	B-T204
lines	I-T204
,	O
but	O
oleic	B-T103
acid	I-T103
(	O
c18	B-T103
:	I-T103
1	I-T103
)	O
levels	O
significantly	O
declined	O
.	O

conservation	O
of	O
the	O
red	B-T204
kit	I-T204
##e	I-T204
mil	B-T204
##v	I-T204
##us	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
(	O
av	B-T204
##es	I-T204
:	O
acc	O
##ip	O
##itr	O
##iform	O
##es	O
)	O
is	O
not	O
affected	O
by	O
the	O
establishment	O
of	O
a	O
broad	O
hybrid	O
zone	B-T082
with	O
the	O
black	B-T204
kit	I-T204
##e	I-T204
mil	B-T204
##v	I-T204
##us	I-T204
migr	I-T204
##ans	I-T204
migr	I-T204
##ans	I-T204
in	O
central	O
europe	O
among	O
acc	O
##ip	O
##itr	O
##iform	O
##es	O
sens	O
##u	O
strict	O
##o	O
,	O
only	O
a	O
few	O
species	B-T170
have	O
been	O
reported	B-T170
to	O
form	O
hybrid	O
zones	B-T082
;	O
these	O
include	O
the	O
red	B-T204
kit	I-T204
##e	I-T204
mil	B-T204
##v	I-T204
##us	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
and	O
black	B-T204
kit	I-T204
##e	I-T204
mil	B-T204
##v	I-T204
##us	I-T204
migr	I-T204
##ans	I-T204
migr	I-T204
##ans	I-T204
.	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
is	O
endemic	O
to	O
the	O
western	O
pale	O
##arctic	O
and	O
has	O
an	O
estimated	O
total	O
population	O
of	O
20	O
-	O
24	O
,	O
000	O
breeding	B-T038
pairs	O
.	O
the	O
species	B-T170
was	O
in	O
decline	O
until	O
the	O
1970s	O
due	O
to	O
pers	O
##ecu	O
##tion	O
and	O
has	O
declined	O
again	O
since	O
the	O
1990s	O
due	O
to	O
ingestion	B-T038
of	O
rodent	B-T103
##icide	I-T103
-	I-T103
treated	I-T103
ba	I-T103
##its	I-T103
,	O
illegal	O
poisoning	B-T037
and	O
changes	O
in	O
agricultural	O
practices	O
,	O
particularly	O
in	O
its	O
core	B-T082
range	O
.	O
whereas	O
f1	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
×	O
m	B-T204
.	I-T204
migr	I-T204
.	I-T204
migr	I-T204
##ans	I-T204
hybrid	O
offspring	O
have	O
been	O
found	O
,	O
f2	O
and	O
f3	O
hybrids	O
have	O
only	O
rarely	O
been	O
reported	B-T170
,	O
with	O
low	O
nestin	O
##g	O
success	O
rates	O
of	O
f1	O
hybrids	O
and	O
partial	O
hybrid	O
sterility	O
likely	O
playing	O
a	O
role	O
.	O
here	O
,	O
we	O
analyzed	B-T062
the	O
mitochondrial	B-T017
(	O
co	B-T017
##1	I-T017
and	O
cyt	B-T017
##b	I-T017
)	O
and	O
nuclear	B-T017
(	O
myc	B-T017
)	O
dna	B-T103
loci	B-T082
of	O
184	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
,	O
124	O
m	B-T204
.	I-T204
migr	I-T204
.	I-T204
migr	I-T204
##ans	I-T204
and	O
3	O
f1	O
hybrid	O
individuals	O
collected	O
across	O
central	O
europe	O
.	O
in	O
agreement	B-T170
with	O
previous	O
studies	B-T062
,	O
we	O
found	O
low	O
heterozygosity	O
in	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
regardless	O
of	O
locus	B-T082
.	O
we	O
found	O
that	O
populations	O
of	O
both	O
examined	B-T033
species	B-T170
were	O
characterized	O
by	O
a	O
high	O
gene	B-T038
flow	I-T038
within	O
populations	O
,	O
with	O
all	O
of	O
the	O
major	O
haplotypes	O
distributed	O
across	O
the	O
entire	O
examined	B-T033
area	B-T082
.	O
few	O
haplotypes	O
displayed	O
statistically	O
significant	O
aggregation	O
in	O
one	O
region	B-T082
over	O
another	O
.	O
we	O
did	O
not	O
find	O
mitochondrial	B-T103
dna	I-T103
of	O
one	O
species	B-T170
in	O
individuals	O
with	O
the	O
pl	B-T017
##uma	I-T017
##ge	I-T017
of	O
the	O
other	O
species	B-T170
,	O
except	O
in	O
f1	O
hybrids	O
,	O
which	O
agrees	O
with	O
hal	B-T170
##da	I-T170
##ne	I-T170
##´	I-T170
##s	I-T170
rule	I-T170
.	O
it	O
remains	O
to	O
be	O
investigated	O
by	O
genomic	B-T017
methods	O
whether	O
occasional	O
gene	B-T038
flow	I-T038
occurs	O
through	O
the	O
paternal	O
line	O
,	O
as	O
the	O
examined	B-T033
myc	B-T017
gene	I-T017
displayed	O
only	O
marginal	O
divergence	B-T082
between	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
and	O
m	B-T204
.	I-T204
migr	I-T204
.	I-T204
migr	I-T204
##ans	I-T204
.	O
the	O
central	O
europe	O
an	O
population	O
of	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
is	O
clearly	O
subject	O
to	O
free	O
intraspecific	O
gene	B-T038
flow	I-T038
,	O
which	O
has	O
direct	O
implications	O
when	O
considering	O
the	O
origin	O
of	O
individuals	O
in	O
m	B-T204
.	I-T204
mil	I-T204
##v	I-T204
##us	I-T204
re	O
-	O
introduction	O
programs	O
.	O

the	O
add	B-T204
##er	I-T204
(	O
vip	B-T204
##era	I-T204
ber	I-T204
##us	I-T204
)	O
in	O
southern	B-T082
alt	I-T082
##ay	I-T082
mountain	I-T082
##s	I-T082
:	O
population	O
characteristics	O
,	O
distribution	B-T082
,	O
morphology	O
and	O
phylogenetic	O
position	O
as	O
the	O
most	O
widely	O
distributed	B-T082
snake	B-T204
in	O
eur	B-T082
##asia	I-T082
,	O
the	O
add	B-T204
##er	I-T204
(	O
vip	B-T204
##era	I-T204
ber	I-T204
##us	I-T204
)	O
has	O
been	O
extensively	O
investigated	O
in	O
europe	B-T082
but	O
poorly	O
understood	O
in	O
asia	B-T082
.	O
the	O
southern	B-T082
alt	I-T082
##ay	I-T082
mountain	I-T082
##s	I-T082
represent	O
the	O
add	B-T204
##er	I-T204
'	I-T204
s	I-T204
southern	B-T082
distribution	B-T082
limit	O
in	O
central	B-T082
asia	I-T082
,	O
whereas	O
its	O
population	O
status	O
has	O
never	O
been	O
assessed	O
.	O
we	O
conducted	O
,	O
for	O
the	O
first	O
time	O
,	O
field	B-T062
surveys	I-T062
for	O
the	O
add	B-T204
##er	I-T204
at	O
two	O
areas	B-T082
of	O
southern	B-T082
alt	I-T082
##ay	I-T082
mountain	I-T082
##s	I-T082
using	O
a	O
combination	O
of	O
line	B-T062
trans	I-T062
##ects	I-T062
and	O
random	O
searches	O
.	O
we	O
also	O
described	O
the	O
morphological	O
characteristics	O
of	O
the	O
collected	B-T058
specimens	I-T058
and	O
conducted	O
analyses	B-T062
of	O
external	B-T082
morphology	O
and	O
molecular	O
phylogeny	O
.	O
the	O
results	O
showed	O
that	O
the	O
add	B-T204
##er	I-T204
distributed	B-T082
in	O
both	O
survey	B-T062
sites	B-T082
and	O
we	O
recorded	B-T170
a	O
total	O
of	O
34	O
sight	O
##ings	O
.	O
in	O
kan	B-T082
##as	I-T082
river	I-T082
valley	I-T082
,	O
the	O
estimated	O
encounter	O
rate	O
over	O
a	O
total	O
of	O
137	O
km	O
trans	B-T062
##ects	I-T062
was	O
0	O
.	O
15	O
±	O
0	O
.	O
05	O
sight	O
##ings	O
/	O
km	O
.	O
the	O
occurrence	O
of	O
melan	B-T038
##ism	I-T038
was	O
only	O
17	O
%	O
.	O
the	O
small	O
size	O
was	O
typical	O
for	O
the	O
add	B-T204
##ers	I-T204
in	O
southern	B-T082
alt	I-T082
##ay	I-T082
mountain	I-T082
##s	I-T082
in	O
contrast	O
to	O
other	O
geographic	O
populations	O
of	O
the	O
nom	O
##inate	O
subspecies	B-T170
.	O
a	O
phylogenetic	O
tree	O
obtained	O
by	O
bayesian	O
inference	O
based	O
on	O
dna	B-T082
sequences	I-T082
of	O
the	O
mitochondrial	B-T103
cytochrome	I-T103
b	I-T103
(	O
1	O
,	O
023	O
bp	O
)	O
grouped	B-T082
them	O
within	O
the	O
northern	O
clade	O
of	O
the	O
species	B-T170
but	O
failed	O
to	O
separate	O
them	O
from	O
the	O
subspecies	B-T170
v	B-T204
.	I-T204
b	I-T204
.	I-T204
sac	I-T204
##hal	I-T204
##ine	I-T204
##ns	I-T204
##is	I-T204
.	O
our	O
discovery	O
extends	O
the	O
distribution	B-T082
range	O
of	O
v	B-T204
.	I-T204
ber	I-T204
##us	I-T204
and	O
provides	O
a	O
basis	O
for	O
further	O
researches	B-T062
.	O
we	O
discuss	O
the	O
hypothesis	O
that	O
the	O
add	B-T204
##er	I-T204
expands	B-T082
its	O
distribution	B-T082
border	B-T170
to	O
the	O
southwest	B-T082
along	O
the	O
mountain	B-T082
##s	I-T082
'	O
elevation	B-T082
gradient	O
,	O
but	O
the	O
population	B-T098
abundance	O
declines	O
gradually	O
due	O
to	O
a	O
drying	O
climate	O
.	O

effect	O
of	O
alpha	B-T103
lipo	I-T103
##ic	I-T103
acid	I-T103
on	O
in	O
vitro	O
development	B-T038
of	O
bovine	B-T204
secondary	B-T017
pre	I-T017
##ant	I-T017
##ral	I-T017
follicles	I-T017
the	O
present	O
study	B-T062
aimed	O
to	O
evaluate	B-T058
the	O
in	O
vitro	O
effect	O
of	O
alpha	B-T103
lipo	I-T103
##ic	I-T103
acid	I-T103
(	O
ala	B-T103
)	O
addition	O
to	O
the	O
culture	B-T103
medium	I-T103
on	O
the	O
development	B-T038
of	O
the	O
bovine	B-T204
secondary	B-T017
pre	I-T017
##ant	I-T017
##ral	I-T017
follicles	I-T017
.	O
bovine	B-T204
secondary	B-T017
pre	I-T017
##ant	I-T017
##ral	I-T017
follicles	I-T017
were	O
collected	O
and	O
divided	O
into	O
two	O
groups	O
depending	O
on	O
their	O
size	B-T082
(	O
80	O
-	O
100	O
μm	O
and	O
100	O
-	O
110	O
μm	O
)	O
.	O
they	O
were	O
cultured	O
in	O
vitro	O
for	O
15	O
days	O
(	O
d	O
)	O
using	O
different	O
media	B-T103
including	O
at	O
three	O
different	O
doses	O
of	O
ala	B-T103
.	O
the	O
genes	B-T038
expression	I-T038
levels	O
of	O
follicle	B-T017
-	I-T017
stimulating	I-T017
hormone	I-T017
beta	I-T017
-	I-T017
subunit	I-T017
(	O
fsh	B-T017
##r	I-T017
)	O
,	O
insulin	B-T017
-	I-T017
like	I-T017
growth	I-T017
factor	I-T017
(	O
igf	B-T017
-	I-T017
1	I-T017
)	O
,	O
activin	B-T017
,	O
luteinizing	B-T017
hormone	I-T017
/	I-T017
chorio	I-T017
##go	I-T017
##na	I-T017
##d	I-T017
##otropin	I-T017
receptor	I-T017
,	O
bone	B-T017
morphogenetic	I-T017
protein	I-T017
receptor	I-T017
type	I-T017
ia	I-T017
,	O
transforming	B-T017
growth	I-T017
factor	I-T017
beta	I-T017
receptor	I-T017
1	I-T017
,	O
growth	B-T017
differentiation	I-T017
factor	I-T017
9	I-T017
,	O
bcl2	B-T017
-	I-T017
associated	I-T017
x	I-T017
protein	I-T017
(	O
bax	B-T017
)	O
,	O
and	O
c	B-T017
-	I-T017
myc	I-T017
were	O
studied	O
using	O
real	B-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
.	O
the	O
protein	B-T038
expression	I-T038
levels	O
of	O
fsh	B-T103
##r	I-T103
,	O
igf	B-T103
-	I-T103
1	I-T103
,	O
and	O
bax	B-T103
were	O
measured	O
using	O
western	B-T058
blot	I-T058
analysis	I-T058
.	O
the	O
results	O
of	O
the	O
present	O
work	O
revealed	O
that	O
in	O
vitro	O
addition	O
of	O
ala	B-T103
-	O
induced	O
significant	O
increase	B-T038
in	I-T038
the	I-T038
growth	I-T038
and	O
development	B-T038
of	O
secondary	B-T017
pre	I-T017
##ant	I-T017
##ral	I-T017
follicles	I-T017
throughout	O
the	O
culture	B-T058
period	O
as	O
compared	O
to	O
control	O
.	O
the	O
fsh	B-T017
##r	I-T017
,	O
igf	B-T017
-	I-T017
1	I-T017
,	O
luteinizing	B-T017
hormone	I-T017
/	I-T017
chorio	I-T017
##go	I-T017
##na	I-T017
##d	I-T017
##otropin	I-T017
receptor	I-T017
,	O
bone	B-T017
morphogenetic	I-T017
protein	I-T017
receptor	I-T017
type	I-T017
ia	I-T017
,	O
transforming	B-T017
growth	I-T017
factor	I-T017
beta	I-T017
receptor	I-T017
1	I-T017
,	O
growth	B-T017
differentiation	I-T017
factor	I-T017
9	I-T017
,	O
and	O
activin	B-T017
a	I-T017
genes	I-T017
were	O
upregulated	B-T038
in	O
ala	B-T103
-	O
treated	O
follicles	B-T017
as	O
compared	O
to	O
the	O
control	O
.	O
on	O
contrary	O
,	O
pre	B-T017
##apoptotic	I-T017
genes	I-T017
bax	B-T017
and	O
c	B-T017
-	I-T017
myc	I-T017
were	O
downregulated	B-T038
in	O
treated	O
follicles	B-T017
compared	O
to	O
control	O
ones	O
.	O
the	O
protein	B-T033
levels	I-T033
of	O
fsh	B-T103
##r	I-T103
and	O
igf	B-T103
-	I-T103
1	I-T103
were	O
highly	O
expressed	B-T038
in	O
treated	O
follicles	B-T017
compared	O
to	O
control	O
;	O
however	O
,	O
bax	B-T103
protein	I-T103
was	O
downregulated	B-T038
in	O
the	O
treated	O
follicles	B-T017
groups	O
.	O
the	O
addition	O
of	O
ala	B-T103
to	O
the	O
culture	B-T103
medium	I-T103
enhances	O
secondary	B-T017
pre	I-T017
##ant	I-T017
##ral	I-T017
follicles	I-T017
development	B-T038
and	O
growth	B-T038
.	O

how	O
should	O
i	O
study	O
for	O
the	O
exam	O
?	O
self	O
-	O
regulated	O
learning	O
strategies	O
and	O
achievement	B-T170
in	O
introduc	B-T091
##tory	I-T091
biology	I-T091
in	O
college	O
introduc	O
##tory	O
science	O
courses	O
,	O
students	B-T098
are	O
challenged	O
with	O
master	O
##ing	O
large	O
amounts	O
of	O
disciplinary	O
content	O
while	O
developing	O
as	O
autonomous	O
and	O
effective	O
learners	B-T098
.	O
self	O
-	O
regulated	O
learning	O
(	O
sr	O
##l	O
)	O
is	O
the	O
process	O
of	O
setting	O
learning	O
goals	O
,	O
monitoring	O
progress	O
toward	O
them	O
,	O
and	O
applying	O
appropriate	O
study	O
strategies	O
.	O
sr	O
##l	O
characterizes	O
successful	O
,	O
[UNK]	O
expert	O
[UNK]	O
learners	B-T098
,	O
and	O
develops	O
with	O
time	O
and	O
practice	O
.	O
in	O
a	O
large	O
,	O
undergraduate	O
introduc	B-T091
##tory	I-T091
biology	I-T091
course	O
,	O
we	O
investigated	O
:	O
1	O
)	O
what	O
sr	O
##l	O
strategies	O
students	B-T098
reported	O
using	O
the	O
most	O
when	O
studying	O
for	O
exams	O
,	O
2	O
)	O
which	O
strategies	O
were	O
associated	O
with	O
higher	O
achievement	O
and	O
with	O
grade	B-T170
improvement	B-T033
on	O
exams	O
,	O
and	O
3	O
)	O
what	O
study	O
approaches	O
students	B-T098
proposed	O
to	O
use	O
for	O
future	O
exams	O
.	O
higher	O
-	O
achieving	O
students	B-T098
,	O
and	O
students	B-T098
whose	O
exam	O
grades	B-T170
improved	B-T033
in	O
the	O
first	O
half	O
of	O
the	O
sem	O
##ester	O
,	O
reported	O
using	O
specific	O
cognitive	B-T038
and	O
metac	B-T038
##ognitive	I-T038
strategies	I-T038
significantly	O
more	O
frequently	O
than	O
their	O
lower	O
-	O
achieving	O
peers	B-T098
.	O
lower	O
-	O
achieving	O
students	B-T098
more	O
frequently	O
reported	O
that	O
they	O
did	O
not	O
implement	O
their	O
planned	O
strategies	O
or	O
,	O
if	O
they	O
did	O
,	O
still	O
did	O
not	O
improve	O
their	O
outcomes	O
.	O
these	O
results	O
suggest	O
that	O
many	O
students	B-T098
entering	O
introduc	B-T091
##tory	I-T091
biology	I-T091
have	O
limited	O
knowledge	O
of	O
sr	O
##l	O
strategies	O
and	O
/	O
or	O
limited	O
ability	O
to	O
implement	O
them	O
,	O
which	O
can	O
impact	O
their	O
achievement	B-T170
.	O
course	O
-	O
specific	O
interventions	B-T058
that	O
promote	O
sr	O
##l	O
development	O
should	O
be	O
considered	O
as	O
integral	O
ped	O
##agog	O
##ical	O
tools	O
,	O
aimed	O
at	O
foster	O
##ing	O
development	O
of	O
students	B-T098
'	O
lifelong	O
learning	O
skills	O
.	O

the	O
anatomical	B-T204
mum	I-T204
##mi	I-T204
##es	I-T204
of	O
mom	O
##be	O
##ll	O
##o	O
:	O
detection	B-T033
of	O
cocaine	B-T103
,	O
nicotine	B-T103
,	O
and	O
caffeine	B-T103
in	O
the	O
hair	B-T017
of	O
psychiatric	O
patients	O
of	O
the	O
early	O
20th	O
century	O
the	O
mom	B-T092
##be	I-T092
##ll	I-T092
##o	I-T092
psychiatric	I-T092
hospital	I-T092
in	O
limb	O
##iate	O
,	O
near	O
mil	O
##an	O
,	O
replaced	O
the	O
old	O
sen	B-T092
##av	I-T092
##ra	I-T092
hospital	I-T092
as	O
the	O
psychiatric	B-T092
hospital	I-T092
for	O
the	O
province	O
of	O
mil	O
##an	O
in	O
the	O
19th	O
century	O
.	O
during	O
the	O
early	O
20th	O
century	O
,	O
bodies	B-T204
of	O
several	O
mom	O
##be	O
##ll	O
##o	O
patients	O
were	O
dissected	O
and	O
preserved	B-T058
by	O
gi	B-T204
##use	I-T204
##pp	I-T204
##e	I-T204
para	I-T204
##vic	I-T204
##ini	I-T204
,	O
an	O
anatom	B-T097
##ist	I-T097
who	O
operated	O
within	O
the	O
as	O
##yl	O
##um	O
.	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
examine	O
and	O
mem	O
##orial	O
##ize	O
this	O
important	O
assembl	B-T062
##age	I-T062
.	O
to	O
this	O
end	O
,	O
we	O
were	O
allowed	O
to	O
sample	O
the	O
head	B-T017
hair	I-T017
of	O
six	O
such	O
preparations	O
for	O
toxicological	O
analysis	B-T062
.	O
by	O
means	O
of	O
high	B-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
,	O
cocaine	B-T103
and	O
its	O
main	O
metabolite	B-T103
,	O
benzoyl	B-T103
##ec	I-T103
##go	I-T103
##ni	I-T103
##ne	I-T103
,	O
were	O
detected	B-T033
in	O
two	O
out	O
of	O
six	O
hair	O
samples	O
.	O
the	O
concentrations	O
for	O
cocaine	B-T103
were	O
0	O
.	O
151	O
and	O
0	O
.	O
09	O
##ng	O
/	O
mg	O
and	O
for	O
benzoyl	B-T103
##ec	I-T103
##go	I-T103
##ni	I-T103
##ne	I-T103
0	O
.	O
103	O
and	O
0	O
.	O
147	O
##ng	O
/	O
mg	O
,	O
respectively	O
.	O
given	O
that	O
cocaine	B-T103
was	O
a	O
commonly	O
used	O
medicine	B-T103
,	O
beginning	O
in	O
the	O
mid	O
-	O
19th	O
century	O
and	O
persisting	O
into	O
the	O
20th	O
century	O
,	O
it	O
is	O
not	O
surprising	O
that	O
some	O
patients	B-T092
may	O
have	O
ingested	B-T038
this	O
drug	B-T103
.	O
in	O
addition	O
to	O
the	O
detection	B-T033
of	O
cocaine	B-T103
,	O
these	O
analyses	B-T062
also	O
provided	O
evidence	O
of	O
nicotine	B-T103
and	O
caffeine	B-T103
intake	O
.	O

hypoc	B-T103
##retin	I-T103
/	I-T103
orexin	I-T103
peptides	I-T103
excit	O
##e	O
rat	B-T204
neuroendocrine	B-T022
dopamine	B-T017
neurons	I-T017
through	O
orexin	B-T103
2	I-T103
receptor	I-T103
-	O
mediated	O
activation	O
of	O
a	O
mixed	O
cation	B-T103
current	B-T038
hypoc	B-T103
##retin	I-T103
/	I-T103
orexin	I-T103
(	O
h	B-T103
/	I-T103
o	I-T103
)	O
neurons	B-T017
of	O
the	O
lateral	B-T082
hypothalamus	I-T082
are	O
compelling	O
modulator	B-T098
candidates	I-T098
for	O
the	O
chron	B-T091
##obiology	I-T091
of	O
neuroendocrine	B-T022
output	O
and	O
,	O
as	O
a	O
consequence	O
,	O
hormone	O
release	O
from	O
the	O
anterior	B-T017
pituitary	I-T017
.	O
here	O
we	O
investigate	O
the	O
effects	O
of	O
h	B-T103
/	I-T103
o	I-T103
peptides	I-T103
upon	O
tuber	B-T017
##oin	I-T017
##fu	I-T017
##nd	I-T017
##ibular	I-T017
dopamine	I-T017
(	I-T017
ti	I-T017
##da	I-T017
)	I-T017
neurons	I-T017
-	O
cells	B-T017
which	O
control	O
,	O
via	O
inhibition	O
,	O
the	O
pituitary	B-T017
secretion	B-T038
of	I-T038
prolactin	I-T038
.	O
in	O
whole	B-T062
cell	I-T062
recordings	I-T062
performed	O
in	O
male	O
rat	B-T204
hypothalamic	B-T082
slices	I-T082
,	O
application	O
of	O
h	B-T103
/	I-T103
o	I-T103
-	I-T103
a	I-T103
,	O
as	O
well	O
as	O
h	B-T103
/	I-T103
o	I-T103
-	I-T103
b	I-T103
,	O
excited	O
oscill	O
##ating	O
ti	B-T017
##da	I-T017
neurons	I-T017
,	O
inducing	O
a	O
reversible	O
depolar	O
##ising	O
switch	O
from	O
phasic	O
to	O
tonic	O
discharge	O
.	O
the	O
h	B-T103
/	I-T103
o	I-T103
-	O
induced	O
inward	B-T082
current	B-T038
underpinning	O
this	O
effect	O
was	O
post	B-T017
-	I-T017
synaptic	I-T017
(	O
as	O
it	O
end	O
##ured	O
in	O
the	O
presence	B-T033
of	O
tetrodotoxin	B-T103
)	O
,	O
appeared	O
to	O
be	O
carried	O
by	O
a	O
na	B-T103
(	I-T103
+	I-T103
)	I-T103
-	O
dependent	O
transient	B-T103
receptor	I-T103
potential	I-T103
-	I-T103
like	I-T103
channel	I-T103
(	O
as	O
it	O
was	O
blocked	O
by	O
2	B-T103
-	I-T103
ap	I-T103
##b	I-T103
and	O
was	O
diminished	O
by	O
removal	O
of	O
extracellular	B-T017
na	B-T103
(	I-T103
+	I-T103
)	I-T103
)	O
,	O
and	O
was	O
a	O
consequence	O
of	O
ox	B-T103
##2r	I-T103
receptor	I-T103
activation	O
(	O
as	O
it	O
was	O
blocked	O
by	O
the	O
ox	B-T103
##2r	I-T103
receptor	I-T103
antagonist	B-T103
tcs	B-T103
ox	I-T103
##2	I-T103
29	I-T103
,	O
but	O
not	O
the	O
ox	B-T103
##1r	I-T103
receptor	I-T103
antagonist	B-T103
sb	B-T103
334	I-T103
##86	I-T103
##7	I-T103
)	O
.	O
application	B-T058
of	O
the	O
hormone	B-T103
,	O
melatonin	B-T103
,	O
failed	O
to	O
alter	O
ti	B-T017
##da	I-T017
membrane	B-T038
potential	I-T038
or	O
oscillatory	O
activity	O
.	O
this	O
first	O
description	B-T170
of	O
the	O
electrophysiological	O
effects	O
of	O
h	B-T103
/	I-T103
os	I-T103
upon	O
the	O
ti	B-T017
##da	I-T017
network	I-T017
identifies	O
cellular	B-T038
mechanisms	I-T038
that	O
may	O
contribute	O
to	O
the	O
circadian	B-T038
rhythmic	I-T038
##ity	I-T038
of	O
prolactin	B-T038
secretion	I-T038
.	O

simultaneous	O
edi	O
##ted	O
mrs	B-T058
of	O
gaba	B-T103
and	O
glutathione	B-T103
edi	O
##ted	O
mrs	B-T058
allows	O
the	O
detection	B-T058
of	O
low	O
-	O
concentration	O
metabolites	B-T103
,	O
whose	O
signals	O
are	O
not	O
resolved	O
in	O
the	O
mr	B-T058
spectrum	I-T058
.	O
tailored	O
acquisition	O
##s	O
can	O
be	O
designed	O
to	O
detect	B-T058
,	O
for	O
example	O
,	O
the	O
inhibitory	O
neurotransmitter	B-T103
γ	B-T103
-	I-T103
aminobutyric	I-T103
acid	I-T103
(	O
gaba	B-T103
)	O
,	O
or	O
the	O
reduction	B-T038
-	I-T038
oxidation	I-T038
(	O
redox	B-T038
)	O
compound	O
glutathione	B-T103
(	O
gsh	B-T103
)	O
,	O
and	O
single	O
-	O
voxel	O
edi	O
##ted	O
experiments	B-T062
are	O
generally	O
acquired	O
at	O
a	O
rate	O
of	O
one	O
metabolite	B-T103
-	O
per	B-T062
-	I-T062
experiment	I-T062
.	O
we	O
demonstrate	O
that	O
simultaneous	O
detection	B-T058
of	O
the	O
overlapping	O
signals	O
of	O
gaba	B-T103
and	O
gsh	B-T103
is	O
possible	O
using	O
had	B-T058
##ama	I-T058
##rd	I-T058
encoding	I-T058
and	I-T058
reconstruction	I-T058
of	I-T058
meg	I-T058
##a	I-T058
-	I-T058
edi	I-T058
##ted	I-T058
spectroscopy	I-T058
(	O
herm	B-T058
##es	I-T058
)	O
.	O
herm	B-T058
##es	I-T058
applies	O
orthogonal	O
editing	O
encoding	O
(	O
following	O
a	O
had	B-T170
##ama	I-T170
##rd	I-T170
scheme	I-T170
)	O
,	O
such	O
that	O
gsh	B-T103
-	I-T103
and	O
gaba	B-T103
-	O
edi	O
##ted	O
difference	O
spectra	O
can	O
be	O
reconstructed	O
from	O
a	O
single	B-T062
multiplexed	I-T062
experiment	I-T062
.	O
at	O
a	O
te	O
of	O
80	O
##ms	O
,	O
20	O
-	O
ms	O
editing	O
pulses	O
are	O
applied	O
at	O
4	O
.	O
56	O
##pp	O
##m	O
(	O
on	O
gsh	B-T103
)	O
,	O
1	O
.	O
9	O
##pp	O
##m	O
(	O
on	O
gaba	B-T103
)	O
,	O
both	O
offset	O
##s	O
(	O
using	O
a	O
dual	O
-	O
lobe	O
cos	O
##ine	O
-	O
modulated	O
pulse	O
)	O
or	O
neither	O
.	O
had	B-T170
##ama	I-T170
##rd	I-T170
combinations	I-T170
of	O
the	O
four	O
sub	B-T062
-	I-T062
experiments	I-T062
yield	O
gaba	B-T103
and	O
gsh	B-T103
difference	O
spectra	O
.	O
it	O
is	O
shown	O
that	O
herm	B-T058
##es	I-T058
gives	O
excellent	O
separation	O
of	O
the	O
edi	O
##ted	O
gaba	B-T103
and	O
gsh	B-T103
signals	O
in	O
phantoms	O
,	O
and	O
resulting	O
edi	O
##ted	O
lines	O
##hap	O
##es	O
agree	B-T033
well	O
with	O
separate	O
mes	B-T058
##cher	I-T058
-	I-T058
gar	I-T058
##wood	I-T058
point	I-T058
-	I-T058
resolved	I-T058
spectroscopy	I-T058
(	O
meg	B-T058
##a	I-T058
-	I-T058
press	I-T058
)	O
acquisition	O
##s	O
.	O
in	B-T082
vivo	I-T082
,	O
the	O
quality	O
and	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
(	O
snr	O
)	O
of	O
herm	B-T058
##es	I-T058
spectra	O
are	O
similar	O
to	O
those	O
of	O
sequentially	O
acquired	O
meg	B-T058
##a	I-T058
-	I-T058
press	I-T058
spectra	O
,	O
with	O
the	O
benefit	O
of	O
saving	O
half	O
the	O
acquisition	O
time	O
.	O

breast	B-T058
augmentation	I-T058
after	O
conservation	B-T058
surgery	I-T058
and	O
radiation	B-T058
therapy	I-T058
there	O
is	O
a	O
paucity	O
of	O
data	O
regarding	O
outcomes	O
for	O
patients	O
undergoing	O
breast	B-T058
augmentation	I-T058
with	O
implants	B-T074
after	O
breast	B-T058
conservation	I-T058
surgery	I-T058
(	O
bcs	B-T058
)	O
and	O
radiotherapy	B-T058
.	O
this	O
retrospective	B-T062
study	I-T062
examined	O
outcomes	O
for	O
patients	O
with	O
breast	B-T074
implant	I-T074
-	O
only	O
augmentation	B-T058
after	O
bcs	B-T058
and	O
radiotherapy	B-T058
.	O
between	O
june	O
1998	O
and	O
december	O
2010	O
,	O
67	O
##1	O
women	B-T098
underwent	O
prosthetic	B-T074
breast	B-T058
reconstruction	I-T058
.	O
nineteen	O
patients	O
(	O
2	O
.	O
8	O
%	O
)	O
underwent	O
an	O
augmentation	B-T058
after	O
bcs	B-T058
and	O
radiotherapy	B-T058
.	O
the	O
mean	O
age	O
was	O
55	O
.	O
8	O
years	O
(	O
range	O
,	O
40	O
-	O
69	O
years	O
)	O
.	O
sixteen	O
of	O
these	O
patients	O
underwent	O
one	B-T058
-	I-T058
stage	I-T058
implant	I-T058
-	O
only	O
breast	B-T058
augmentation	I-T058
,	O
whereas	O
3	O
patients	O
underwent	O
two	B-T058
-	I-T058
stage	I-T058
expand	I-T058
##er	I-T058
and	O
then	O
implant	B-T058
augmentation	I-T058
.	O
all	O
surgeries	B-T058
were	O
successful	O
.	O
the	O
average	O
size	O
of	O
breast	B-T074
implant	I-T074
used	O
was	O
258	O
.	O
7	O
##€	O
‰	O
g	O
.	O
seven	O
patients	O
also	O
received	O
contralateral	B-T082
augmentation	B-T058
with	O
an	O
average	O
implant	O
size	O
of	O
232	O
.	O
2	O
##€	O
‰	O
g	O
.	O
one	O
patient	O
received	O
oral	O
antibiotics	B-T103
for	O
minor	O
wound	B-T038
infection	I-T038
.	O
patients	O
were	O
judged	O
to	O
have	O
an	O
excellent	O
(	O
14	O
/	O
19	O
;	O
73	O
.	O
7	O
%	O
)	O
,	O
good	O
(	O
3	O
/	O
19	O
;	O
15	O
.	O
8	O
%	O
)	O
,	O
or	O
fair	O
(	O
2	O
/	O
19	O
;	O
10	O
.	O
5	O
%	O
)	O
cosmetic	O
result	O
.	O
the	O
breasts	B-T017
of	O
selected	O
patients	O
with	O
breast	B-T038
cancer	I-T038
after	O
bcs	B-T058
and	O
radiotherapy	B-T058
.	O
with	O
asymmetry	O
can	O
be	O
adequately	O
augmented	O
with	O
breast	B-T074
implants	I-T074
alone	O
.	O

implementing	O
non	O
-	O
invasive	O
prenatal	B-T058
diagnosis	I-T058
(	O
nip	B-T058
##d	I-T058
)	O
in	O
a	O
national	B-T092
health	I-T092
service	I-T092
laboratory	I-T092
;	O
from	O
dominant	O
to	O
recessive	O
disorders	B-T038
our	O
uk	B-T092
national	I-T092
health	I-T092
service	I-T092
regional	I-T092
genetics	I-T092
laboratory	I-T092
offers	O
nip	B-T058
##d	I-T058
for	O
autosomal	B-T038
dominant	I-T038
and	O
de	O
novo	O
conditions	O
(	O
ach	B-T017
##ondr	I-T017
##oplasia	I-T017
,	O
than	B-T017
##ata	I-T017
##ph	I-T017
##oric	I-T017
dysplasia	I-T017
,	O
aper	B-T017
##t	I-T017
syndrome	I-T017
)	O
,	O
paternal	O
mutation	B-T038
exclusion	O
for	O
cystic	B-T038
fibrosis	I-T038
and	O
a	O
range	O
of	O
bes	O
##po	O
##ke	O
tests	O
.	O
nip	B-T058
##d	I-T058
avoids	O
the	O
risks	B-T033
associated	O
with	O
invasive	B-T058
testing	I-T058
,	O
making	O
prenatal	B-T058
diagnosis	I-T058
more	O
accessible	O
to	O
families	O
at	O
high	O
genetic	O
risk	O
.	O
however	O
,	O
the	O
challenge	O
remains	O
in	O
offering	O
definitive	O
diagnosis	B-T033
for	O
autosomal	B-T038
recessive	I-T038
diseases	I-T038
,	O
which	O
is	O
complicated	O
by	O
the	O
predominance	O
of	O
the	O
maternal	O
mutant	B-T038
allele	B-T017
in	O
the	O
cell	B-T103
-	I-T103
free	I-T103
dna	I-T103
sample	O
and	O
thus	O
requires	O
a	O
variety	O
of	O
different	O
approaches	B-T082
.	O
validation	B-T062
and	O
diagnostic	O
implementation	O
for	O
nip	B-T058
##d	I-T058
of	O
congenital	B-T038
adrenal	I-T038
hyperplasia	I-T038
(	O
cah	B-T038
)	O
is	O
further	O
complicated	O
by	O
presence	B-T033
of	O
a	O
pseudo	B-T017
##gene	I-T017
that	O
requires	O
a	O
different	O
approach	B-T082
.	O
we	O
have	O
used	O
an	O
assay	B-T058
targeting	O
approximately	O
67	O
##00	O
heterozygous	O
snps	B-T082
around	O
the	O
cah	B-T017
gene	I-T017
(	O
cyp2	B-T017
##1a2	I-T017
)	O
to	O
construct	O
the	O
high	B-T033
-	I-T033
risk	I-T033
parental	O
haplotypes	O
and	O
tested	O
this	O
approach	B-T082
in	O
five	O
cases	O
,	O
showing	O
that	O
inheritance	O
of	O
the	O
parental	O
alleles	B-T017
can	O
be	O
correctly	O
identified	O
using	O
nip	B-T058
##d	I-T058
.	O
we	O
are	O
evaluating	O
various	O
measures	O
of	O
the	O
fetal	B-T017
fraction	O
to	O
help	O
determine	O
inheritance	O
of	O
parental	O
mutations	B-T038
.	O
we	O
are	O
currently	O
exploring	O
the	O
utility	O
of	O
an	O
nip	B-T058
##d	I-T058
multi	B-T058
-	I-T058
disorder	I-T058
panel	I-T058
for	O
autosomal	B-T038
recessive	I-T038
disease	I-T038
,	O
to	O
make	O
testing	O
more	O
widely	O
applicable	O
to	O
families	O
with	O
a	O
variety	O
of	O
serious	O
genetic	B-T038
conditions	I-T038
.	O

anemia	B-T038
complicating	O
type	B-T038
2	I-T038
diabetes	I-T038
:	O
prevalence	O
,	O
risk	B-T033
factors	I-T033
and	O
prognosis	B-T058
to	O
determine	O
the	O
prevalence	O
,	O
risk	B-T033
factors	I-T033
and	O
prognosis	B-T058
of	O
anemia	B-T038
in	O
representative	B-T097
community	O
-	O
based	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
.	O
data	O
from	O
the	O
fre	B-T062
##man	I-T062
##tle	I-T062
diabetes	I-T062
study	I-T062
phase	I-T062
ii	I-T062
(	O
fd	B-T062
##s2	I-T062
;	O
n	O
=	O
155	O
##1	O
,	O
mean	O
age	O
65	O
.	O
7	O
##years	O
,	O
51	O
.	O
9	O
%	O
males	O
)	O
and	O
bus	B-T062
##se	I-T062
##lt	I-T062
##on	I-T062
diabetes	I-T062
study	I-T062
(	O
bd	B-T062
##s	I-T062
;	O
n	O
=	O
186	O
,	O
mean	O
age	O
70	O
.	O
2	O
##years	O
,	O
50	O
.	O
0	O
%	O
males	O
)	O
cohorts	B-T098
,	O
and	O
from	O
186	O
matched	O
bd	B-T062
##s	I-T062
participants	B-T098
without	O
diabetes	B-T038
,	O
were	O
analyzed	B-T062
.	O
the	O
prevalence	O
of	O
anemia	B-T038
(	O
hemoglobin	B-T103
≤	O
##130	O
##g	O
/	O
l	O
males	O
,	O
≤	O
##120	O
##g	O
/	O
l	O
females	O
)	O
was	O
determined	O
in	O
each	O
sample	B-T031
.	O
in	O
fd	B-T062
##s2	I-T062
,	O
associates	O
of	O
anemia	B-T038
were	O
assessed	O
using	O
multiple	O
logistic	B-T062
regression	I-T062
and	O
cox	B-T170
proportional	I-T170
hazards	I-T170
modeling	I-T170
identified	O
predictors	B-T033
of	O
death	B-T038
during	O
4	O
.	O
3	O
##±1	O
.	O
2	O
##years	O
post	O
-	O
recruitment	O
.	O
the	O
prevalence	O
of	O
anemia	B-T038
at	O
baseline	O
was	O
11	O
.	O
5	O
%	O
in	O
fd	B-T062
##s2	I-T062
participants	B-T098
,	O
17	O
.	O
8	O
%	O
in	O
bd	B-T062
##s	I-T062
type	O
2	O
patients	O
and	O
5	O
.	O
4	O
%	O
in	O
bd	B-T062
##s	I-T062
participants	B-T098
without	O
diabetes	B-T038
.	O
in	O
fd	B-T062
##s2	I-T062
,	O
163	O
of	O
178	O
patients	O
with	O
anemia	B-T038
(	O
91	O
.	O
6	O
%	O
)	O
had	O
at	O
least	O
one	O
other	O
risk	B-T033
factor	I-T033
(	O
serum	B-T058
vitamin	I-T058
b12	I-T058
<	O
140	O
##pm	O
##ol	O
/	O
l	O
,	O
serum	B-T033
ferritin	I-T033
<	O
30	O
##μg	O
/	O
l	O
and	O
/	O
or	O
transferrin	B-T058
saturation	I-T058
<	O
20	O
%	O
,	O
serum	B-T058
testosterone	I-T058
<	O
10	O
##nm	O
##ol	O
/	O
l	O
(	O
males	O
)	O
,	O
gli	B-T103
##ta	I-T103
##zo	I-T103
##ne	I-T103
therapy	B-T058
,	O
estimated	B-T058
glomerular	I-T058
filtration	I-T058
rate	I-T058
(	O
egfr	B-T058
)	O
<	O
60	O
##ml	O
/	O
min	O
1	O
.	O
73	O
##m	O
(	O
2	O
)	O
,	O
malignancy	B-T038
,	O
hemoglobin	B-T038
##opathy	I-T038
)	O
.	O
more	O
ane	B-T033
##mic	I-T033
than	O
non	B-T033
-	I-T033
ane	I-T033
##mic	I-T033
fd	B-T062
##s2	I-T062
patients	O
died	O
(	O
28	O
.	O
7	O
%	O
versus	O
8	O
.	O
0	O
%	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
after	O
adjustment	O
for	O
other	O
independent	O
predictors	B-T033
(	O
age	O
as	O
time	O
-	O
scale	O
,	O
male	O
sex	O
,	O
aboriginal	B-T033
##ity	I-T033
,	O
marital	O
status	O
,	O
smoking	O
,	O
egfr	B-T058
)	O
,	O
anemia	B-T038
was	O
associated	O
with	O
a	O
57	O
%	O
increase	O
in	O
mortality	O
(	O
p	O
=	O
0	O
.	O
015	O
)	O
.	O
type	B-T038
2	I-T038
diabetes	I-T038
at	O
least	O
double	O
##s	O
the	O
risk	O
of	O
anemia	B-T038
but	O
other	O
mostly	O
modifiable	O
risk	B-T033
factors	I-T033
are	O
usually	O
present	B-T033
.	O
anemia	B-T038
is	O
associated	O
with	O
an	O
increased	B-T033
risk	I-T033
of	I-T033
death	I-T033
after	O
adjustment	O
for	O
other	O
predictors	B-T033
.	O

comparison	O
of	O
son	B-T058
##oe	I-T058
##last	I-T058
##ography	I-T058
with	O
son	B-T058
##our	I-T058
##eth	I-T058
##rog	I-T058
##ra	I-T058
##ph	I-T058
##y	I-T058
and	O
retrograde	O
ureth	O
##rog	O
##ra	O
##ph	O
##y	O
in	O
the	O
evaluation	B-T058
of	O
male	O
anterior	B-T017
urethral	I-T017
strictures	I-T017
retrograde	O
ureth	O
##rog	O
##ra	O
##ph	O
##y	O
(	O
rug	O
)	O
is	O
the	O
most	O
common	O
and	O
preferred	O
imaging	O
modality	O
for	O
imaging	B-T058
of	O
the	O
anterior	B-T017
urethral	I-T017
strictures	I-T017
despite	O
its	O
well	O
-	O
known	O
limitations	O
and	O
disadvantages	O
.	O
son	B-T058
##our	I-T058
##eth	I-T058
##rog	I-T058
##ra	I-T058
##ph	I-T058
##y	I-T058
(	O
sug	B-T058
)	O
was	O
introduced	O
in	O
1988	O
to	O
overcome	O
the	O
limitations	O
of	O
rug	O
and	O
to	O
provide	O
more	O
accurate	O
results	O
.	O
as	O
proper	O
selection	O
of	O
imaging	O
modality	O
is	O
very	O
important	O
for	O
planning	B-T170
the	I-T170
treatment	I-T170
,	O
various	O
advances	O
in	O
this	O
area	O
are	O
required	O
.	O
one	O
of	O
the	O
major	O
factors	O
for	O
recurrence	O
of	O
stricture	B-T038
disease	I-T038
is	O
spong	B-T038
##io	I-T038
##fi	I-T038
##br	I-T038
##osis	I-T038
.	O
son	B-T058
##oe	I-T058
##last	I-T058
##ography	I-T058
(	O
se	B-T058
)	O
is	O
a	O
newer	B-T062
technique	I-T062
,	O
tried	O
in	O
various	O
other	O
pathologies	B-T091
.	O
in	O
this	O
study	O
,	O
we	O
have	O
used	O
this	O
technique	O
for	O
the	O
first	O
time	O
to	O
assess	O
its	O
efficacy	O
in	O
the	O
evaluation	O
of	O
anterior	B-T017
urethral	I-T017
stricture	I-T017
disease	I-T017
by	O
comparison	O
with	O
rug	O
and	O
sug	B-T058
.	O
between	O
august	O
2014	O
and	O
may	O
2015	O
,	O
77	O
patients	O
with	O
clinical	O
features	O
of	O
anterior	B-T017
urethral	I-T017
stricture	I-T017
disease	I-T017
were	O
included	O
in	O
the	O
study	O
and	O
evaluated	O
by	O
rug	O
followed	O
by	O
sug	B-T058
and	O
se	B-T058
for	O
stricture	O
location	B-T082
,	O
length	O
,	O
depth	B-T201
of	O
spong	B-T038
##io	I-T038
##fi	I-T038
##br	I-T038
##osis	I-T038
and	O
peri	B-T082
##urethral	I-T082
pathologies	B-T091
.	O
the	O
results	O
were	O
then	O
correlated	O
with	O
operative	O
and	O
histopathological	O
findings	O
.	O
overall	O
diagnostic	O
accuracy	O
of	O
se	B-T058
,	O
sug	B-T058
,	O
and	O
rg	O
##u	O
for	O
the	O
estimation	O
of	O
stricture	O
location	B-T082
,	O
and	O
length	O
were	O
estimated	O
92	O
.	O
68	O
%	O
vs	O
.	O
91	O
.	O
54	O
%	O
,	O
79	O
%	O
vs	O
.	O
78	O
.	O
87	O
%	O
and	O
80	O
.	O
48	O
%	O
vs	O
.	O
43	O
.	O
66	O
%	O
,	O
respectively	O
,	O
while	O
for	O
depth	B-T201
of	O
spong	B-T038
##io	I-T038
##fi	I-T038
##br	I-T038
##osis	I-T038
se	B-T058
,	O
and	O
sug	B-T058
had	O
accuracy	O
rates	O
of	O
87	O
.	O
3	O
%	O
,	O
48	O
%	O
,	O
respectively	O
.	O
the	O
mean	O
length	O
measured	O
on	O
se	B-T058
was	O
nearest	O
to	O
the	O
mean	O
intra	O
-	O
operative	O
stricture	O
length	O
(	O
21	O
.	O
34	O
+	O
11	O
.	O
8	O
mm	O
)	O
.	O
se	B-T058
findings	O
significantly	O
correlated	O
with	O
the	O
colour	B-T033
of	I-T033
bladder	I-T033
mucosa	I-T033
on	O
cyst	B-T058
##oscopic	I-T058
examination	I-T058
(	O
p	O
=	O
0	O
.	O
003	O
)	O
whereas	O
the	O
association	O
was	O
non	O
-	O
significant	O
(	O
p	O
=	O
0	O
.	O
127	O
)	O
for	O
difficulty	O
in	O
incision	B-T058
.	O
while	O
a	O
nonsignificant	O
correlation	O
existed	O
between	O
sug	B-T058
findings	O
related	O
both	O
to	O
the	O
colour	B-T033
of	I-T033
the	I-T033
bladder	I-T033
mucosa	I-T033
and	O
difficulty	O
in	O
incision	B-T058
on	O
cyst	B-T058
##oscopy	I-T058
,	O
se	B-T058
findings	O
had	O
a	O
significant	O
association	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
with	O
histopathology	O
findings	O
for	O
severe	O
degree	B-T058
of	I-T058
fibrosis	I-T058
.	O
son	B-T058
##oe	I-T058
##last	I-T058
##ography	I-T058
estimates	O
stricture	O
site	O
and	O
length	O
better	O
in	O
comparison	O
with	O
rug	O
and	O
sug	B-T058
.	O
it	O
estimates	O
degree	O
of	O
spong	B-T038
##io	I-T038
##fi	I-T038
##br	I-T038
##osis	I-T038
which	O
serves	O
as	O
an	O
important	O
prognostic	B-T201
factor	I-T201
for	O
stricture	O
recurrence	O
more	O
accurately	O
than	O
sug	B-T058
.	O

analysis	B-T058
of	O
til	B-T103
##ian	I-T103
##in	I-T103
and	O
aca	B-T103
##cetin	I-T103
in	O
aga	B-T204
##st	I-T204
##ache	I-T204
rug	I-T204
##osa	I-T204
by	O
high	B-T058
-	I-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
with	O
ionic	B-T103
liquids	I-T103
-	O
ultrasound	O
based	O
extraction	B-T058
ionic	B-T103
liquid	I-T103
1	B-T103
-	I-T103
butyl	I-T103
-	I-T103
3	I-T103
-	I-T103
methyl	I-T103
##imid	I-T103
##azolium	I-T103
bromide	I-T103
-	O
methanol	B-T103
-	O
based	O
ultrasonic	O
-	O
assisted	O
extraction	B-T058
(	O
il	B-T058
##ua	I-T058
##e	I-T058
)	O
was	O
used	O
to	O
extract	B-T058
til	B-T103
##ian	I-T103
##in	I-T103
and	O
aca	B-T103
##cetin	I-T103
from	O
the	O
aerial	B-T204
parts	I-T204
of	O
aga	B-T204
##st	I-T204
##ache	I-T204
rug	I-T204
##ose	I-T204
(	O
a	B-T204
.	I-T204
rug	I-T204
##ose	I-T204
)	O
,	O
and	O
simultaneously	O
determined	O
by	O
reversed	B-T058
phase	I-T058
high	I-T058
performance	I-T058
liquid	I-T058
chromatographic	I-T058
(	O
rp	B-T058
-	I-T058
hplc	I-T058
)	O
method	O
with	O
ultraviolet	B-T170
detection	I-T170
(	O
rp	B-T170
-	I-T170
hplc	I-T170
-	I-T170
uv	I-T170
)	I-T170
.	O
an	O
inert	O
##s	O
##ust	O
##ain	O
rp	O
-	O
c18	O
column	O
was	O
used	O
with	O
the	O
mobile	B-T103
phase	I-T103
consisting	O
of	O
methanol	B-T103
and	O
0	O
.	O
2	O
%	O
acetic	B-T103
acid	I-T103
as	O
gradient	O
elution	O
at	O
the	O
detection	O
wavelength	O
of	O
332	O
nm	O
.	O
the	O
flow	O
rate	O
was	O
0	O
.	O
8	O
ml	O
/	O
min	O
,	O
and	O
the	O
column	O
temperature	O
was	O
30	O
°c	O
.	O
under	O
the	O
optimized	O
conditions	O
,	O
til	B-T103
##ian	I-T103
##in	I-T103
and	O
aca	B-T103
##cetin	I-T103
displayed	O
good	O
linearity	O
in	O
the	O
ranges	O
of	O
0	O
.	O
05	O
##95	O
-	O
4	O
.	O
76	O
and	O
0	O
.	O
05	O
##85	O
-	O
4	O
.	O
68	O
μg	O
/	O
ml	O
,	O
respectively	O
,	O
with	O
the	O
average	O
recoveries	O
being	O
96	O
.	O
93	O
and	O
97	O
.	O
88	O
%	O
,	O
respectively	O
.	O
the	O
method	O
of	O
il	B-T058
##ua	I-T058
##e	I-T058
was	O
compared	O
with	O
the	O
traditional	O
methods	O
,	O
it	O
exhibited	O
higher	O
efficiency	O
,	O
higher	O
reproducibility	O
and	O
environmental	B-T082
friendly	I-T082
in	O
analyzing	O
the	O
active	O
compounds	B-T103
in	O
traditional	B-T091
chinese	I-T091
medicines	I-T091
(	O
tcm	B-T091
##s	I-T091
)	O
.	O

targeting	B-T038
the	O
nrf2	B-T103
/	O
amyloid	B-T038
-	I-T038
beta	I-T038
lia	I-T038
##ison	I-T038
in	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
:	O
a	O
rational	O
approach	O
amyloid	B-T103
is	O
a	O
prominent	O
feature	O
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
.	O
yet	O
,	O
a	O
linear	B-T082
linkage	O
between	O
amyloid	B-T103
-	I-T103
β	I-T103
peptide	I-T103
(	O
aβ	B-T103
)	O
and	O
the	O
disease	O
onset	O
and	O
progression	B-T038
has	O
recently	O
been	O
questioned	O
.	O
in	O
this	O
context	O
,	O
the	O
crucial	O
partnership	O
between	O
aβ	B-T038
and	O
nrf2	B-T038
pathways	I-T038
is	O
acquiring	O
paramount	O
importance	O
,	O
offering	O
prospects	O
for	O
deciph	O
##ering	O
the	O
aβ	B-T103
-	O
centered	O
disease	B-T038
network	O
.	O
here	O
,	O
we	O
report	O
on	O
a	O
new	O
class	O
of	O
anti	B-T103
##aggreg	I-T103
##ating	I-T103
agents	I-T103
rational	O
##ly	O
designed	O
to	O
simultaneously	O
activate	B-T038
transcription	I-T038
-	O
based	O
antioxidant	B-T103
responses	B-T038
,	O
whose	O
lead	B-T103
1	I-T103
showed	O
interesting	O
properties	O
in	O
a	O
preliminary	O
investigation	O
.	O
relying	O
on	O
the	O
requirements	B-T033
of	O
aβ	B-T103
recognition	O
,	O
we	O
identified	O
the	O
catechol	B-T103
derivative	I-T103
12	I-T103
.	O
in	O
sh	O
-	O
sy5y	O
neuroblastoma	O
cells	O
,	O
12	B-T103
combined	O
remarkable	O
free	B-T103
radical	I-T103
scavenger	I-T103
properties	O
to	O
the	O
ability	O
to	O
trigger	O
the	O
nrf2	B-T038
pathway	I-T038
and	O
induce	B-T038
the	O
nrf2	B-T103
-	O
dependent	O
defensive	B-T033
gene	B-T017
nq	I-T017
##o1	I-T017
by	O
means	O
of	O
electrophilic	O
activation	O
of	O
the	O
transcriptional	B-T038
response	I-T038
.	O
moreover	O
,	O
12	O
prevented	O
the	O
formation	O
of	O
cytotoxic	O
stable	O
oligomeric	B-T103
intermediates	I-T103
,	O
being	O
significantly	O
more	O
effective	O
,	O
and	O
per	O
se	O
less	B-T037
toxic	I-T037
,	O
than	O
prototype	B-T103
1	I-T103
.	O
more	O
importantly	O
,	O
as	O
different	O
chemical	O
features	O
were	O
exploited	O
to	O
regulate	B-T038
nrf2	I-T038
and	O
aβ	B-T103
activities	B-T038
,	O
the	O
two	O
pathways	B-T038
could	O
be	O
tuned	O
independently	O
.	O
these	O
findings	O
point	O
to	O
compound	B-T103
12	I-T103
and	O
its	O
derivatives	B-T103
as	O
promising	O
tools	O
for	O
investigating	O
the	O
therapeutic	O
potential	O
of	O
the	O
nrf2	B-T103
/	O
aβ	B-T103
cellular	B-T017
network	O
,	O
laying	O
foundation	O
for	O
generating	O
new	O
drug	B-T103
leads	I-T103
to	O
confron	O
##t	O
ad	B-T038
.	O

early	O
assessment	B-T058
of	O
bilateral	B-T058
inguinal	I-T058
hernia	I-T058
repair	I-T058
:	O
a	O
comparison	O
between	O
the	O
laparoscopic	B-T058
total	I-T058
extrap	I-T058
##eri	I-T058
##ton	I-T058
##eal	I-T058
and	O
stop	B-T058
##pa	I-T058
approaches	I-T058
the	O
present	O
clinical	B-T062
trial	I-T062
was	O
designed	O
to	O
compare	O
the	O
results	O
of	O
bilateral	B-T058
inguinal	I-T058
hernia	I-T058
repair	I-T058
between	O
patients	O
who	O
underwent	O
the	O
conventional	O
stop	B-T058
##pa	I-T058
technique	I-T058
and	O
laparoscopic	B-T058
total	I-T058
extrap	I-T058
##eri	I-T058
##ton	I-T058
##eal	I-T058
repair	I-T058
(	O
lt	B-T058
##e	I-T058
)	O
with	O
a	O
single	O
mesh	B-T074
and	O
without	O
stap	B-T058
##le	I-T058
fixation	I-T058
.	O
this	O
controlled	O
,	O
randomised	B-T062
clinical	B-T062
trial	I-T062
was	O
conducted	O
at	O
general	B-T092
surgery	I-T092
and	I-T092
trauma	I-T092
of	I-T092
the	I-T092
clinics	I-T092
hospital	I-T092
,	O
medical	B-T092
school	I-T092
,	O
the	O
university	B-T092
of	I-T092
s	I-T092
##γ	I-T092
##o	I-T092
paulo	I-T092
between	O
september	O
2010	O
and	O
february	O
2011	O
.	O
totally	O
,	O
50	O
male	O
patients	O
,	O
with	O
a	O
bilateral	B-T017
inguinal	I-T017
hernia	I-T017
,	O
older	O
than	O
25	O
years	O
were	O
considered	O
eligible	O
for	O
the	O
study	B-T062
.	O
the	O
following	O
parameters	O
were	O
analysed	B-T062
during	O
the	O
early	O
post	O
-	O
operative	O
period	O
:	O
(	O
1	O
)	O
the	O
intensity	O
of	O
surgical	O
trauma	O
,	O
operation	O
time	O
,	O
c	B-T103
-	I-T103
reactive	I-T103
protein	I-T103
(	O
crp	B-T103
)	O
levels	O
,	O
white	B-T058
blood	I-T058
cell	I-T058
count	I-T058
,	O
bleeding	B-T038
and	O
pain	B-T201
intensity	I-T201
;	O
(	O
2	O
)	O
quality	O
of	O
life	O
assessment	B-T058
;	O
and	O
(	O
3	O
)	O
post	B-T038
-	I-T038
operative	I-T038
complications	I-T038
.	O
lt	B-T058
##e	I-T058
procedure	I-T058
was	O
longer	O
than	O
the	O
stop	B-T058
##pa	I-T058
procedure	I-T058
(	O
134	O
.	O
6	O
min	O
΁	O
38	O
.	O
3	O
vs	O
.	O
90	O
.	O
6	O
min	O
΁	O
41	O
.	O
3	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
levels	O
of	O
crp	B-T103
were	O
higher	O
in	O
the	O
stop	B-T058
##pa	I-T058
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
but	O
the	O
number	O
of	O
leucocytes	B-T017
,	O
haemat	B-T033
##ocrit	I-T033
,	O
and	O
haemoglobin	B-T103
were	O
similar	O
between	O
the	O
groups	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
there	O
was	O
no	O
difference	O
in	O
pain	B-T033
during	O
the	O
1	O
st	O
and	O
7	O
th	O
post	B-T033
-	I-T033
operative	I-T033
,	O
physical	B-T033
functioning	I-T033
,	O
physical	O
limitation	O
,	O
the	O
impact	O
of	O
pain	B-T033
on	O
daily	O
activities	O
,	O
and	O
the	O
carolina	B-T170
##s	I-T170
comfort	I-T170
scale	I-T170
during	O
the	O
7	O
th	O
and	O
15	O
th	O
post	B-T033
-	I-T033
operative	I-T033
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
complications	B-T038
occurred	O
in	O
88	O
%	O
of	O
stop	B-T058
##pa	I-T058
group	O
(	O
22	O
patients	O
)	O
and	O
64	O
%	O
in	O
lt	B-T058
##e	I-T058
group	O
(	O
16	O
patients	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
comparative	B-T062
study	I-T062
between	O
the	O
stop	B-T058
##pa	I-T058
and	O
lt	B-T058
##e	I-T058
approaches	O
for	O
the	O
bilateral	B-T058
inguinal	I-T058
hernia	I-T058
repair	I-T058
demonstrated	O
that	O
:	O
(	O
1	O
)	O
the	O
lt	B-T058
##e	I-T058
approach	O
showed	O
less	O
surgical	O
trauma	O
despite	O
the	O
longer	O
operation	O
time	O
;	O
(	O
2	O
)	O
quality	O
of	O
life	O
during	O
the	O
early	O
post	O
-	O
operative	O
period	O
were	O
similar	O
;	O
and	O
(	O
3	O
)	O
complication	B-T038
rates	O
were	O
higher	O
in	O
the	O
stop	B-T058
##pa	I-T058
group	O
.	O

in	B-T082
vivo	I-T082
three	B-T082
-	I-T082
dimensional	I-T082
patellar	B-T017
mechanics	O
:	O
normal	O
knees	B-T017
compared	O
with	O
dom	B-T082
##ed	I-T082
and	O
anatomic	O
patellar	B-T017
components	O
patellofemoral	B-T082
complications	O
are	O
a	O
major	O
cause	O
of	O
revision	B-T058
surgery	I-T058
following	O
total	B-T058
knee	I-T058
arthroplasty	I-T058
(	O
tka	B-T058
)	O
.	O
high	O
forces	O
occurring	O
at	O
the	O
patellofemoral	B-T082
articulation	I-T082
coupled	O
with	O
a	O
small	O
patellofemoral	B-T082
contact	B-T082
area	I-T082
pose	O
substantial	O
design	O
challenges	O
.	O
in	O
this	O
study	B-T062
,	O
the	O
three	B-T082
-	I-T082
dimensional	I-T082
(	O
3d	B-T082
)	O
in	B-T082
vivo	I-T082
mechanics	O
of	O
dom	B-T082
##ed	I-T082
and	O
anatomically	O
shaped	B-T082
patellar	B-T017
components	O
were	O
compared	O
with	O
those	O
of	O
native	O
patella	B-T017
##e	I-T017
.	O
ten	O
normal	O
knees	B-T017
,	O
10	O
treated	B-T058
with	I-T058
an	O
lcs	B-T058
-	I-T058
ps	I-T058
(	I-T058
low	I-T058
contact	I-T058
stress	I-T058
-	I-T058
posterior	I-T058
stabilized	I-T058
)	I-T058
tka	I-T058
(	O
anatomically	O
shaped	B-T082
patellar	B-T017
component	O
)	O
,	O
and	O
10	O
treated	B-T058
with	I-T058
a	O
pfc	B-T058
sigma	I-T058
rp	I-T058
-	I-T058
ps	I-T058
(	I-T058
press	I-T058
-	I-T058
fit	I-T058
condylar	I-T058
sigma	I-T058
rotating	I-T058
platform	I-T058
-	I-T058
posterior	I-T058
stabilized	I-T058
)	I-T058
tka	I-T058
(	O
dom	B-T082
##ed	I-T082
patellar	B-T017
component	O
)	O
were	O
analyzed	B-T062
under	O
fluoroscopic	B-T058
surveillance	O
while	O
the	O
patient	O
performed	O
a	O
weight	B-T033
-	I-T033
bearing	I-T033
deep	B-T082
knee	B-T033
bend	I-T033
from	O
full	O
knee	O
extension	O
to	O
maximum	O
knee	B-T033
flexion	I-T033
.	O
relevant	O
bone	O
geometries	O
were	O
segmented	B-T082
out	O
from	O
computed	B-T058
tomography	I-T058
(	O
ct	B-T058
)	O
scans	B-T058
,	O
and	O
computer	O
-	O
assisted	O
-	O
design	O
(	O
cad	O
)	O
models	B-T170
of	O
the	O
implanted	B-T074
components	O
were	O
obtained	O
from	O
the	O
manufacturer	O
.	O
three	B-T082
-	I-T082
dimensional	I-T082
patellofemoral	B-T082
kinematics	B-T091
were	O
obtained	O
using	O
a	O
3d	B-T082
-	O
to	O
-	O
2d	B-T082
registration	O
process	O
.	O
contact	O
mechanics	O
were	O
calculated	O
using	O
a	O
distance	O
map	O
between	O
the	O
artic	B-T017
##ulating	I-T017
patellar	I-T017
and	O
femoral	B-T082
surfaces	I-T082
.	O
both	O
patellar	B-T017
component	O
designs	O
exhibited	O
good	O
rotational	B-T091
kinematics	I-T091
and	O
tracked	O
well	O
within	O
the	O
femoral	B-T017
troch	I-T017
##le	I-T017
##a	I-T017
when	O
compared	O
with	O
the	O
normal	O
patella	B-T017
.	O
the	O
contact	B-T082
areas	I-T082
in	O
the	O
tka	B-T058
groups	O
peaked	O
at	O
60	O
##°	O
of	O
knee	B-T033
flexion	I-T033
(	O
mean	O
and	O
standard	O
deviation	O
,	O
201	O
±	O
63	O
.	O
4	O
mm	O
for	O
the	O
lcs	O
-	O
ps	O
group	O
and	O
218	O
±	O
95	O
.	O
4	O
mm	O
for	O
the	O
sigma	O
rp	O
-	O
ps	O
group	O
)	O
,	O
and	O
the	O
areas	B-T082
were	O
substantially	O
smaller	O
than	O
those	O
previously	O
reported	B-T170
for	O
the	O
normal	O
patella	B-T017
.	O
contact	B-T082
points	I-T082
in	O
the	O
tka	B-T058
groups	O
stay	O
##ed	O
close	O
to	O
the	O
center	B-T082
of	O
the	O
patellar	B-T017
components	O
.	O
both	O
designs	O
performed	O
satisfactorily	O
,	O
although	O
patellofemoral	B-T082
contact	B-T082
areas	I-T082
were	O
reduced	O
in	O
comparison	O
with	O
those	O
in	O
the	O
native	O
patella	B-T017
.	O
therapeutic	O
level	O
iii	O
.	O
see	O
instructions	O
for	O
authors	O
for	O
a	O
complete	O
description	O
of	O
levels	O
of	O
evidence	O
.	O

changes	O
in	O
parenting	O
strategies	O
after	O
a	O
young	O
person	B-T098
'	I-T098
s	I-T098
self	B-T037
-	I-T037
harm	I-T037
:	O
a	O
qualitative	B-T062
study	I-T062
when	O
faced	O
with	O
the	O
discovery	O
of	O
their	O
child	O
'	O
s	O
self	B-T037
-	I-T037
harm	I-T037
,	O
mothers	O
and	O
fathers	O
may	O
re	B-T058
-	I-T058
evaluate	I-T058
their	O
parenting	O
strategies	O
.	O
this	O
can	O
include	O
changes	O
to	O
the	O
amount	O
of	O
support	O
they	O
provide	O
their	O
child	O
and	O
changes	O
to	O
the	O
degree	O
to	O
which	O
they	O
control	O
and	O
monitor	O
their	O
child	O
.	O
we	O
conducted	O
an	O
in	B-T062
-	I-T062
depth	I-T062
qualitative	I-T062
study	I-T062
with	O
37	O
parents	O
of	O
young	O
people	B-T098
who	O
had	O
self	B-T037
-	I-T037
harm	I-T037
##ed	I-T037
in	O
which	O
we	O
explored	O
how	O
and	O
why	O
their	O
parenting	O
changed	O
after	O
the	O
discovery	O
of	O
self	B-T037
-	I-T037
harm	I-T037
.	O
early	O
on	O
,	O
parents	O
often	O
found	O
themselves	O
[UNK]	O
walking	O
on	O
eggs	O
##hel	O
##ls	O
[UNK]	O
so	O
as	O
not	O
to	O
ups	B-T038
##et	I-T038
their	O
child	O
,	O
but	O
later	O
they	O
felt	O
more	O
able	O
to	O
take	O
some	O
control	O
.	O
parents	O
'	O
reactions	O
to	O
the	O
self	B-T037
-	I-T037
harm	I-T037
often	O
depended	O
on	O
how	O
they	O
conceptual	O
##ised	O
it	O
:	O
as	O
part	O
of	O
adolescence	O
,	O
as	O
a	O
mental	O
health	O
issue	O
or	O
as	O
[UNK]	O
na	O
##ught	O
##y	O
behaviour	O
[UNK]	O
.	O
parenting	O
of	O
other	O
children	O
in	O
the	O
family	O
could	O
also	O
be	O
affected	O
,	O
with	O
parents	O
worry	O
##ing	O
about	O
less	O
of	O
their	O
time	O
being	O
available	O
for	O
siblings	O
.	O
many	O
parents	O
developed	O
specific	O
strategies	O
they	O
felt	O
helped	O
them	O
to	O
be	O
more	O
effective	O
parents	O
,	O
such	O
as	O
learning	B-T038
to	O
avoid	O
bla	B-T038
##ming	I-T038
themselves	O
or	O
their	O
child	O
for	O
the	O
self	B-T037
-	I-T037
harm	I-T037
and	O
developing	O
new	O
ways	O
to	O
communicate	B-T033
with	O
their	O
child	O
.	O
parents	O
were	O
generally	O
ea	O
##ger	O
to	O
pass	O
their	O
knowledge	B-T170
on	O
to	O
other	O
people	B-T098
in	O
the	O
same	O
situation	O
.	O
parents	O
reported	O
changes	O
in	O
their	O
parenting	O
behaviours	O
after	O
the	O
discovery	O
of	O
a	O
child	O
'	O
s	O
self	B-T037
-	I-T037
harm	I-T037
.	O
professionals	B-T097
involved	O
in	O
the	O
care	O
of	O
young	O
people	B-T098
who	O
self	B-T037
-	I-T037
harm	I-T037
might	O
use	O
this	O
information	O
in	O
supporting	O
and	O
advis	O
##ing	O
parents	O
.	O

anti	B-T103
-	I-T103
cd45	I-T103
##rb	I-T103
and	O
donor	O
-	O
specific	O
spleen	O
cells	O
transfusion	O
inhibition	O
allograft	B-T038
skin	I-T038
rejection	I-T038
mediated	O
by	O
memory	B-T017
t	I-T017
cells	I-T017
donor	O
-	O
reactive	O
memory	B-T017
t	I-T017
(	I-T017
tm	I-T017
)	I-T017
cells	I-T017
mediate	O
accelerated	O
rejection	B-T038
,	O
which	O
is	O
known	O
as	O
a	O
barrier	O
to	O
the	O
survival	O
of	O
transplanted	B-T017
organs	I-T017
.	O
selective	O
interference	O
with	O
the	O
anti	B-T103
-	I-T103
cd45	I-T103
##rb	I-T103
monoclonal	I-T103
antibody	I-T103
(	I-T103
α	I-T103
-	I-T103
cd45	I-T103
##rb	I-T103
)	I-T103
reliably	O
induces	O
donor	B-T098
-	O
specific	O
tolerance	B-T038
.	O
in	O
this	O
study	B-T062
,	O
pre	O
-	O
sensitization	O
to	O
female	O
c57bl	B-T204
/	I-T204
6	I-T204
mice	I-T204
with	O
the	O
skin	B-T022
of	O
female	O
bla	B-T204
##b	I-T204
/	I-T204
c	I-T204
mice	I-T204
generated	O
a	O
large	O
number	O
of	O
tm	B-T017
cells	I-T017
and	O
resulted	O
in	O
rapid	O
rejection	B-T038
of	O
the	O
secondly	O
transplanted	O
allografts	B-T103
.	O
α	B-T103
-	I-T103
cd45	I-T103
##rb	I-T103
did	O
induce	O
the	O
tolerance	B-T038
to	O
skin	B-T103
allograft	I-T103
primarily	O
transplanted	O
but	O
failed	O
to	O
induce	O
tolerance	B-T038
in	O
the	O
pre	B-T204
-	I-T204
sensitized	I-T204
mice	I-T204
.	O
donor	O
-	O
specific	O
spleen	O
cell	O
transfusion	O
(	O
dst	O
)	O
alone	O
also	O
failed	O
to	O
induce	O
the	O
tolerance	B-T038
in	O
the	O
pre	O
-	O
sensitized	O
recipients	O
.	O
interestingly	O
,	O
combination	O
of	O
α	B-T103
-	I-T103
cd45	I-T103
##rb	I-T103
with	O
dst	O
inhibited	O
the	O
rejection	B-T038
induced	O
by	O
memory	B-T017
t	I-T017
cells	I-T017
in	O
the	O
pre	B-T204
-	I-T204
sensitized	I-T204
mice	I-T204
.	O
cd25	B-T017
+	I-T017
t	I-T017
-	I-T017
cell	I-T017
depletion	B-T058
in	O
α	B-T103
-	I-T103
cd45	I-T103
##rb	I-T103
combined	O
with	O
dst	O
therapy	B-T058
recipients	O
could	O
prevent	O
skin	B-T103
allograft	I-T103
tolerance	B-T038
from	O
establishing	O
.	O
in	O
addition	O
,	O
adoptive	B-T058
transfer	I-T058
of	O
donor	B-T098
-	O
primed	O
memory	B-T017
t	I-T017
cells	I-T017
into	O
the	O
tolerant	B-T038
recipients	O
markedly	O
bro	O
##ke	O
the	O
established	O
tolerance	B-T038
.	O
our	O
findings	B-T033
indicate	O
that	O
α	B-T103
-	I-T103
cd45	I-T103
##rb	I-T103
and	O
dst	O
can	O
synergistically	O
inhibit	O
the	O
accelerated	O
rejection	B-T038
mediated	O
by	O
memory	B-T017
t	I-T017
cells	I-T017
and	O
induce	O
long	O
-	O
term	O
skin	B-T103
allograft	I-T103
acceptance	B-T038
in	O
mice	B-T204
.	O

genome	B-T062
-	I-T062
wide	I-T062
association	I-T062
mapping	I-T062
in	O
winter	B-T204
barley	I-T204
for	O
grain	B-T204
yield	O
and	O
cul	B-T204
##m	I-T204
cell	B-T017
wall	I-T017
polymer	O
content	O
using	O
the	O
high	O
-	O
throughput	O
comp	B-T058
##p	I-T058
technique	I-T058
a	O
collection	O
of	O
112	O
winter	B-T204
barley	I-T204
varieties	I-T204
(	O
hor	B-T204
##de	I-T204
##um	I-T204
vulgar	I-T204
##e	I-T204
l	I-T204
.	I-T204
)	O
was	O
grown	B-T038
in	O
the	O
field	O
for	O
two	O
years	O
(	O
2008	O
/	O
09	O
and	O
2009	O
/	O
10	O
)	O
in	O
northern	B-T082
italy	B-T082
and	O
grain	B-T204
and	O
straw	B-T103
yields	O
recorded	O
.	O
in	O
the	O
first	O
year	O
of	O
the	O
trial	O
,	O
a	O
severe	O
attack	O
of	O
barley	B-T005
yellow	I-T005
mosaic	I-T005
virus	I-T005
(	O
bay	B-T005
##mv	I-T005
)	O
strongly	O
influenced	O
final	O
performances	O
with	O
an	O
average	O
reduction	O
of	O
~	O
50	O
%	O
for	O
grain	B-T204
and	O
straw	B-T103
harvested	O
in	O
comparison	O
to	O
the	O
second	O
year	O
.	O
the	O
genetic	B-T058
determination	I-T058
(	O
gd	B-T058
)	O
for	O
grain	B-T204
yield	O
was	O
0	O
.	O
49	O
and	O
0	O
.	O
70	O
,	O
for	O
the	O
two	O
years	O
respectively	O
,	O
and	O
for	O
straw	B-T103
yield	O
gd	B-T058
was	O
low	O
in	O
2009	O
(	O
0	O
.	O
09	O
)	O
and	O
higher	O
in	O
2010	O
(	O
0	O
.	O
29	O
)	O
.	O
cell	B-T017
wall	I-T017
polymers	O
in	O
cul	B-T204
##ms	I-T204
were	O
quantified	O
by	O
means	O
of	O
the	O
monoclonal	B-T103
antibodies	I-T103
lm	B-T103
##6	I-T103
,	O
lm	B-T103
##11	I-T103
,	O
ji	B-T103
##m1	I-T103
##3	I-T103
and	O
bs	B-T103
-	I-T103
400	I-T103
-	I-T103
3	I-T103
and	O
the	O
carbohydrate	B-T103
-	I-T103
binding	I-T103
module	I-T103
cb	I-T103
##m	I-T103
##3a	I-T103
using	O
the	O
high	O
-	O
throughput	O
comp	B-T058
##p	I-T058
technique	I-T058
.	O
of	O
these	O
,	O
lm	B-T103
##6	I-T103
,	O
which	O
detects	B-T033
arabin	B-T103
##an	I-T103
components	O
,	O
showed	O
a	O
relatively	O
high	O
gd	B-T058
in	O
both	O
years	O
and	O
a	O
significantly	O
negative	B-T033
correlation	O
with	O
grain	B-T204
yield	O
(	O
gy	O
##ld	O
)	O
.	O
overall	O
,	O
heritability	O
(	O
h2	O
)	O
was	O
calculated	O
for	O
gy	O
##ld	O
,	O
lm	B-T103
##6	I-T103
and	O
ji	B-T103
##m	I-T103
and	O
resulted	O
to	O
be	O
0	O
.	O
42	O
,	O
0	O
.	O
32	O
and	O
0	O
.	O
20	O
,	O
respectively	O
.	O
a	O
total	O
of	O
4	O
,	O
97	O
##6	O
snps	B-T082
from	O
the	O
9	O
##k	O
is	O
##elect	O
array	O
were	O
used	O
in	O
the	O
study	B-T062
for	O
the	O
analysis	O
of	O
population	O
structure	O
,	O
linkage	O
disequilibrium	O
(	O
ld	O
)	O
and	O
genome	B-T062
-	I-T062
wide	I-T062
association	I-T062
study	I-T062
(	O
gwas	B-T062
)	O
.	O
marker	O
-	O
trait	O
associations	O
(	O
mta	O
)	O
were	O
analyzed	O
for	O
grain	B-T204
yield	O
and	O
cell	B-T017
wall	I-T017
determination	O
by	O
lm	B-T103
##6	I-T103
and	O
ji	B-T103
##m1	I-T103
##3	I-T103
as	O
these	O
were	O
the	O
traits	O
showing	O
significant	O
correlations	O
between	O
the	O
years	O
.	O
a	O
single	B-T017
qtl	I-T017
for	O
gy	O
##ld	O
containing	O
three	O
mta	O
##s	O
was	O
found	O
on	O
chromosome	B-T017
3h	I-T017
located	O
close	O
to	O
the	O
hv	B-T017
-	I-T017
eif	I-T017
##4	I-T017
##e	I-T017
gene	I-T017
,	O
which	O
is	O
known	O
to	O
regulate	O
resistance	O
to	O
bay	B-T005
##mv	I-T005
.	O
subsequently	O
the	O
qtl	B-T017
was	O
shown	O
to	O
be	O
tightly	O
linked	O
to	O
ry	B-T017
##m	I-T017
##4	I-T017
,	O
a	O
locus	B-T082
for	O
resistance	O
to	O
the	O
virus	B-T005
.	O
gwas	B-T062
on	O
arabin	B-T103
##ans	I-T103
quantified	O
by	O
lm	B-T103
##6	I-T103
resulted	O
in	O
the	O
identification	O
of	O
major	O
qtls	B-T017
closely	O
located	O
on	O
3h	B-T017
and	O
hypotheses	O
regarding	O
putative	B-T017
candidate	I-T017
genes	I-T017
were	O
formulated	O
through	O
the	O
study	B-T062
of	O
gene	B-T038
expression	I-T038
levels	O
based	O
on	O
bioinformatics	B-T091
tools	O
.	O

und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
and	O
art	B-T058
use	O
in	O
the	O
kenya	B-T170
aids	I-T170
indicator	I-T170
survey	I-T170
2012	I-T170
:	O
relevance	O
to	O
targets	O
for	O
hiv	O
diagnosis	O
and	O
treatment	B-T058
in	O
kenya	B-T082
to	O
assess	O
the	O
impact	O
of	O
und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
and	O
antiretroviral	B-T058
(	I-T058
ar	I-T058
##v	I-T058
)	I-T058
therapy	I-T058
(	O
art	B-T058
)	O
on	O
national	O
estimates	O
of	O
diagnosed	O
hiv	O
and	O
art	B-T058
coverage	O
in	O
kenya	B-T082
.	O
hiv	O
-	O
positive	O
dried	B-T031
blood	I-T031
spot	I-T031
samples	I-T031
from	O
kenya	B-T170
'	I-T170
s	I-T170
second	I-T170
aids	I-T170
indicator	I-T170
survey	I-T170
were	O
tested	O
for	O
an	O
ar	O
##v	O
biomarker	B-T201
by	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
.	O
estimates	O
of	O
diagnosed	O
hiv	O
and	O
art	B-T058
use	O
based	O
on	O
self	B-T062
-	I-T062
report	I-T062
were	O
compared	O
with	O
those	O
corrected	O
for	O
und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
and	O
art	B-T058
use	O
based	O
on	O
ar	O
##v	O
testing	O
.	O
multivariate	O
analysis	O
determined	O
factors	O
associated	O
with	O
und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
and	O
art	B-T058
use	O
among	O
persons	B-T098
on	O
art	B-T058
.	O
among	O
55	O
##9	O
hiv	O
-	O
positive	O
samples	B-T031
,	O
the	O
ar	O
##v	O
biomarker	B-T201
was	O
detected	B-T033
in	O
42	O
.	O
5	O
%	O
(	O
ci	O
37	O
.	O
4	O
-	O
47	O
.	O
7	O
)	O
.	O
ar	B-T103
##v	I-T103
drugs	I-T103
were	O
present	O
in	O
90	O
.	O
7	O
%	O
(	O
ci	O
86	O
.	O
1	O
-	O
95	O
.	O
2	O
)	O
reporting	O
hiv	O
-	O
positive	O
status	O
and	O
receiving	O
art	B-T058
,	O
66	O
.	O
7	O
%	O
(	O
ci	O
59	O
.	O
9	O
-	O
73	O
.	O
4	O
)	O
reporting	O
hiv	O
-	O
positive	O
status	O
irrespective	O
of	O
art	B-T058
use	O
,	O
21	O
.	O
0	O
%	O
(	O
ci	O
13	O
.	O
4	O
-	O
28	O
.	O
6	O
)	O
reporting	B-T058
hiv	B-T033
-	I-T033
negative	I-T033
status	I-T033
,	O
and	O
19	O
.	O
3	O
%	O
(	O
ci	O
9	O
.	O
0	O
-	O
29	O
.	O
5	O
)	O
reporting	B-T058
no	B-T033
previous	O
hiv	B-T058
test	I-T058
.	O
after	O
correcting	O
for	O
und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
and	O
art	B-T058
use	O
,	O
diagnosed	O
hiv	O
increased	O
from	O
46	O
.	O
9	O
%	O
to	O
57	O
.	O
2	O
%	O
and	O
art	B-T058
coverage	O
increased	O
from	O
31	O
.	O
8	O
%	O
to	O
42	O
.	O
8	O
%	O
.	O
und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
on	O
art	B-T058
was	O
associated	O
with	O
being	O
aged	B-T098
25	O
-	O
39	O
years	O
and	O
not	O
visiting	O
a	O
health	B-T097
provider	I-T097
in	O
the	O
past	O
year	O
,	O
while	O
younger	O
age	O
and	O
higher	O
wealth	O
was	O
associated	O
with	O
und	O
##isc	O
##lo	O
##se	O
##d	O
art	B-T058
use	O
.	O
substantial	O
levels	O
of	O
und	O
##isc	O
##lo	O
##se	O
##d	O
hiv	B-T038
infection	I-T038
and	O
art	B-T058
use	O
while	O
on	O
art	B-T058
were	O
observed	O
,	O
resulting	O
in	O
diagnosed	O
hiv	O
underestimated	O
by	O
112	O
,	O
000	O
persons	B-T098
and	O
art	B-T058
coverage	O
by	O
131	O
,	O
000	O
persons	B-T098
.	O
supplement	O
##ing	O
self	B-T062
-	I-T062
reported	I-T062
art	B-T058
status	O
with	O
objective	O
measures	O
of	O
art	B-T058
use	O
in	O
national	O
population	B-T098
-	O
based	O
sero	B-T058
-	I-T058
surveys	I-T058
can	O
improve	B-T033
monitoring	B-T058
of	O
treatment	B-T058
targets	O
in	O
countries	B-T082
.	O

perineal	B-T037
injuries	I-T037
and	O
birth	B-T033
positions	I-T033
among	O
299	O
##2	O
women	B-T098
with	O
a	O
low	B-T033
risk	I-T033
pregnancy	I-T033
who	O
opt	O
##ed	O
for	O
a	O
home	B-T033
##birth	I-T033
whether	O
certain	O
birth	B-T033
positions	I-T033
are	O
associated	O
with	O
perineal	B-T037
injuries	I-T037
and	O
severe	O
perineal	O
trauma	O
(	O
spt	O
)	O
is	O
still	O
unclear	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
describe	O
the	O
prevalence	O
of	O
perineal	B-T037
injuries	I-T037
of	O
different	O
severity	O
in	O
a	O
low	O
-	O
risk	O
population	B-T098
of	O
women	B-T098
who	O
planned	O
to	O
give	O
birth	B-T033
at	I-T033
home	I-T033
and	O
to	O
compare	O
the	O
prevalence	O
of	O
perineal	B-T037
injuries	I-T037
,	O
spt	O
and	O
epis	B-T058
##io	I-T058
##to	I-T058
##my	I-T058
in	O
different	O
birth	B-T033
positions	I-T033
in	O
four	O
nord	B-T082
##ic	I-T082
countries	I-T082
.	O
a	O
population	B-T098
-	O
based	O
prospective	B-T062
cohort	I-T062
study	I-T062
of	O
planned	O
home	B-T033
births	I-T033
in	O
four	O
nord	B-T082
##ic	I-T082
countries	I-T082
.	O
to	O
assess	O
medical	O
outcomes	O
a	O
questionnaire	B-T170
completed	O
after	O
birth	B-T038
by	O
the	O
attending	O
midwif	B-T097
##e	I-T097
was	O
used	O
.	O
descriptive	B-T062
statistics	I-T062
,	O
bivariate	O
analysis	O
and	O
logistic	B-T062
regression	I-T062
were	O
used	O
to	O
analyze	O
the	O
data	O
.	O
two	O
thousand	O
nine	O
hundred	O
ninety	O
-	O
two	O
women	B-T098
with	O
planned	O
home	B-T033
births	I-T033
,	O
who	O
birth	O
##ed	O
spontaneously	O
at	O
home	B-T082
or	O
after	O
transfer	B-T058
to	I-T058
hospital	I-T058
,	O
between	O
2008	O
and	O
2013	O
were	O
included	O
.	O
the	O
prevalence	O
of	O
spt	O
was	O
0	O
.	O
7	O
%	O
and	O
the	O
prevalence	O
of	O
epis	B-T058
##io	I-T058
##to	I-T058
##my	I-T058
was	O
1	O
.	O
0	O
%	O
.	O
there	O
were	O
differences	O
between	O
the	O
countries	O
regarding	O
all	O
maternal	B-T033
characteristics	O
.	O
no	O
association	O
between	O
flexible	O
sacr	B-T082
##um	I-T082
positions	B-T082
and	O
sutured	O
perineal	B-T037
injuries	I-T037
was	O
found	O
(	O
or	O
1	O
.	O
02	O
;	O
95	O
%	O
ci	O
0	O
.	O
86	O
-	O
1	O
.	O
21	O
)	O
or	O
spt	O
(	O
or	O
0	O
.	O
68	O
;	O
ci	O
95	O
%	O
0	O
.	O
26	O
-	O
1	O
.	O
79	O
)	O
.	O
flexible	O
sacr	B-T082
##um	I-T082
positions	B-T082
were	O
associated	O
with	O
fewer	O
epis	B-T058
##io	I-T058
##to	I-T058
##mi	I-T058
##es	I-T058
(	O
or	O
0	O
.	O
20	O
;	O
ci	O
95	O
%	O
0	O
.	O
10	O
-	O
0	O
.	O
54	O
)	O
.	O
a	O
low	O
prevalence	O
of	O
spt	O
and	O
epis	B-T058
##io	I-T058
##to	I-T058
##my	I-T058
was	O
found	O
among	O
women	B-T098
opt	O
##ing	O
for	O
a	O
home	B-T033
birth	I-T033
in	O
four	O
nord	B-T082
##ic	I-T082
countries	I-T082
.	O
women	B-T098
used	O
a	O
variety	O
of	O
birth	B-T033
positions	I-T033
and	O
a	O
majority	O
gave	O
birth	B-T038
in	O
flexible	O
sacr	B-T082
##um	I-T082
positions	B-T082
.	O
no	O
associations	O
were	O
found	O
between	O
flexible	O
sacr	B-T082
##um	I-T082
positions	B-T082
and	O
spt	O
.	O
flexible	O
sacr	B-T082
##um	I-T082
positions	B-T082
were	O
associated	O
with	O
fewer	O
epis	B-T058
##io	I-T058
##to	I-T058
##mi	I-T058
##es	I-T058
.	O

mitotic	O
phospho	B-T103
##ty	I-T103
##rosine	I-T103
network	B-T170
analysis	I-T170
reveals	O
that	O
tyrosine	B-T038
phosphorylation	I-T038
regulates	O
pol	B-T103
##o	I-T103
-	I-T103
like	I-T103
kinase	I-T103
1	I-T103
(	O
pl	B-T103
##k1	I-T103
)	O
tyrosine	B-T038
phosphorylation	I-T038
is	O
closely	O
associated	O
with	O
cell	B-T038
proliferation	I-T038
.	O
during	O
the	O
cell	B-T038
cycle	I-T038
,	O
serine	B-T038
and	I-T038
threonine	I-T038
phosphorylation	I-T038
plays	O
the	O
leading	O
role	O
,	O
and	O
such	O
phosphorylation	B-T038
events	O
are	O
most	O
dynamic	O
during	O
the	O
mitotic	B-T038
phase	I-T038
of	O
the	O
cell	B-T038
cycle	I-T038
.	O
however	O
,	O
mitotic	O
phospho	B-T103
##ty	I-T103
##rosine	I-T103
is	O
not	O
well	O
characterized	O
.	O
although	O
a	O
few	O
functionally	O
-	O
relevant	O
mitotic	O
phospho	B-T103
##ty	I-T103
##rosine	I-T103
sites	B-T082
have	O
been	O
characterized	O
,	O
evidence	O
suggests	O
that	O
this	O
modification	O
may	O
be	O
more	O
prevalent	O
than	O
previously	O
appreciated	O
.	O
here	O
,	O
we	O
examined	B-T033
tyrosine	B-T038
phosphorylation	I-T038
in	O
mitotic	B-T017
human	I-T017
cells	I-T017
including	O
those	O
on	O
spindle	B-T103
-	I-T103
associated	I-T103
proteins	I-T103
.	O
?	O
database	O
mining	O
confirmed	O
~	O
2000	O
mitotic	O
phospho	B-T103
##ty	I-T103
##rosine	I-T103
sites	B-T082
,	O
and	O
network	B-T170
analysis	I-T170
revealed	O
a	O
number	O
of	O
subn	O
##et	O
##work	O
##s	O
that	O
were	O
enriched	O
in	O
tyrosine	B-T103
-	I-T103
phosphorylated	I-T103
proteins	I-T103
,	O
including	O
components	O
of	O
the	O
kinet	B-T017
##och	I-T017
##ore	I-T017
or	O
spindle	B-T017
and	O
src	B-T103
family	I-T103
kinases	I-T103
.	O
we	O
identified	O
pol	B-T103
##o	I-T103
-	I-T103
like	I-T103
kinase	I-T103
1	I-T103
(	O
pl	B-T103
##k1	I-T103
)	O
,	O
a	O
major	O
signaling	B-T038
hub	O
in	O
the	O
spindle	B-T017
subn	O
##et	O
##work	O
,	O
as	O
phosphorylated	B-T103
at	O
the	O
conserved	O
tyr	B-T103
(	I-T103
217	I-T103
)	I-T103
in	O
the	O
kinase	B-T082
domain	I-T082
.	O
substitution	B-T038
of	O
tyr	B-T103
(	I-T103
217	I-T103
)	I-T103
with	O
a	O
phospho	O
##mi	O
##met	O
##ic	O
residue	O
eliminated	O
pl	B-T103
##k1	I-T103
activity	O
in	O
vitro	O
and	O
in	O
cells	B-T017
.	O
further	O
analysis	B-T062
showed	O
that	O
tyr	B-T103
(	I-T103
217	I-T103
)	I-T103
phosphorylation	B-T038
reduced	O
the	O
phosphorylation	B-T038
of	I-T038
thr	I-T038
(	I-T038
210	I-T038
)	I-T038
in	O
the	O
activation	B-T082
loop	I-T082
,	O
a	O
phosphorylation	B-T038
event	O
necessary	O
for	O
pl	B-T103
##k1	I-T103
activity	O
.	O
our	O
data	O
indicate	O
that	O
mitotic	O
tyrosine	B-T038
phosphorylation	I-T038
regulated	O
a	O
key	O
serine	B-T103
/	I-T103
threonine	I-T103
kinase	I-T103
hub	O
in	O
mitotic	B-T017
cells	I-T017
and	O
suggested	O
that	O
spatially	O
separating	O
tyrosine	B-T038
phosphorylation	I-T038
events	O
can	O
reveal	O
previously	O
unrecognized	O
regulatory	O
events	O
and	O
complexes	O
associated	O
with	O
specific	O
structures	B-T017
of	O
the	O
cell	B-T038
cycle	I-T038
.	O

dynam	B-T103
##in	I-T103
-	I-T103
related	I-T103
protein	I-T103
1	I-T103
mediates	O
low	B-T103
glucose	I-T103
-	O
induced	O
endothelial	B-T038
dysfunction	I-T038
in	O
human	B-T204
arterioles	B-T017
intensive	O
glycemic	B-T038
regulation	I-T038
has	O
resulted	O
in	O
an	O
increased	O
incidence	O
of	O
hypoglycemia	B-T038
.	O
hypoglycemic	B-T038
burden	O
correlates	O
with	O
adverse	O
cardiovascular	B-T038
complications	I-T038
and	O
contributes	O
acutely	O
and	O
chronically	O
to	O
endothelial	B-T038
dysfunction	I-T038
.	O
prior	O
data	O
indicate	O
that	O
mitochondrial	B-T033
dysfunction	I-T033
contributes	O
to	O
hypoglycemia	B-T038
-	O
induced	O
endothelial	B-T038
dysfunction	I-T038
,	O
but	O
the	O
mechanisms	O
behind	O
this	O
linkage	O
remain	O
unknown	O
.	O
we	O
attempt	O
to	O
determine	O
whether	O
clinically	O
relevant	O
low	B-T103
-	I-T103
glucose	I-T103
(	O
lg	B-T103
)	O
exposures	O
acutely	O
induce	O
endothelial	B-T038
dysfunction	I-T038
through	O
activation	O
of	O
the	O
mitochondrial	B-T038
fission	I-T038
process	I-T038
.	O
characterization	O
of	O
mitochondrial	B-T033
morphology	I-T033
was	O
carried	O
out	O
in	O
cultured	O
endothelial	B-T017
cells	I-T017
by	O
using	O
confocal	B-T058
microscopy	I-T058
.	O
isolated	O
human	B-T204
arterioles	B-T017
were	O
used	O
to	O
explore	O
the	O
effect	O
lg	B-T103
-	O
induced	O
mitochondrial	B-T038
fission	I-T038
has	O
on	O
the	O
formation	O
of	O
detrimental	O
reactive	O
oxygen	O
species	O
(	O
ros	O
)	O
,	O
bioavailability	O
of	O
nitric	B-T103
oxide	I-T103
(	O
no	B-T103
)	O
,	O
and	O
endothelial	B-T038
-	I-T038
dependent	I-T038
vascular	I-T038
relaxation	I-T038
.	O
fluorescence	B-T058
microscopy	I-T058
was	O
employed	O
to	O
visualize	O
changes	O
in	O
mitochondrial	B-T017
ros	O
and	O
no	B-T103
levels	O
and	O
video	B-T058
##mic	I-T058
##roscopy	I-T058
applied	O
to	O
measure	O
vasodilation	B-T038
response	O
.	O
pharmacological	O
disruption	O
of	O
the	O
prof	B-T103
##ission	I-T103
protein	I-T103
dr	B-T103
##p1	I-T103
with	O
mdi	B-T103
##vi	I-T103
-	I-T103
1	I-T103
during	O
lg	B-T103
exposure	O
reduced	O
mitochondrial	B-T038
fragmentation	I-T038
among	O
vascular	B-T017
endothelial	I-T017
cells	I-T017
(	O
lg	B-T103
:	O
0	O
.	O
46	O
##9	O
;	O
lg	B-T103
+	O
mdi	B-T103
##vi	I-T103
-	I-T103
1	I-T103
:	O
0	O
.	O
276	O
;	O
p	O
=	O
0	O
.	O
003	O
)	O
,	O
prevented	O
formation	O
of	O
vascular	B-T017
ros	O
(	O
lg	B-T103
:	O
2	O
.	O
036	O
;	O
lg	B-T103
+	O
mdi	B-T103
##vi	I-T103
-	I-T103
1	I-T103
:	O
1	O
.	O
77	O
##4	O
;	O
p	O
=	O
0	O
.	O
005	O
)	O
,	O
increased	O
the	O
presence	B-T033
of	O
no	B-T103
(	O
lg	B-T103
:	O
1	O
.	O
352	O
;	O
lg	B-T103
+	O
mdi	B-T103
##vi	I-T103
-	I-T103
1	I-T103
:	O
1	O
.	O
50	O
##2	O
;	O
p	O
=	O
0	O
.	O
048	O
)	O
,	O
and	O
improved	B-T033
vascular	B-T038
dilation	I-T038
response	O
to	O
acetylcholine	B-T103
(	O
lg	B-T103
:	O
31	O
.	O
6	O
%	O
;	O
lg	B-T103
+	O
mdi	B-T103
##vi	I-T103
-	I-T103
1	I-T103
;	O
78	O
.	O
5	O
%	O
at	O
maximum	O
dose	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
additionally	O
,	O
decreased	O
expression	B-T038
of	O
dr	B-T103
##p1	I-T103
via	O
sirna	B-T103
knockdown	B-T062
during	O
lg	B-T103
conditions	O
also	O
improved	B-T033
vascular	B-T038
relaxation	I-T038
.	O
exposure	O
to	O
lg	B-T103
impar	O
##ts	O
endothelial	B-T038
dysfunction	I-T038
coupled	O
with	O
altered	O
mitochondrial	B-T017
phenotypes	O
among	O
isolated	O
human	B-T204
arterioles	B-T017
.	O
disruption	O
of	O
dr	B-T103
##p1	I-T103
and	O
subsequent	O
mitochondrial	B-T038
fragmentation	I-T038
events	O
prevents	O
impaired	O
vascular	B-T038
dilation	I-T038
,	O
restores	O
mitochondrial	B-T017
phenotype	O
,	O
and	O
implicate	O
##s	O
mitochondrial	B-T038
fission	I-T038
as	O
a	O
primary	O
mediator	O
of	O
lg	B-T103
-	O
induced	O
endothelial	B-T038
dysfunction	I-T038
.	O
new	O
&	O
noteworthy	O
acute	O
low	B-T103
-	I-T103
glucose	I-T103
exposure	O
induces	O
mitochondrial	B-T038
fragmentation	I-T038
in	O
endothelial	B-T017
cells	I-T017
via	O
dr	B-T103
##p1	I-T103
and	O
is	O
associated	O
with	O
impaired	O
endothelial	B-T017
function	B-T038
in	O
human	B-T204
arterioles	B-T017
.	O
targeting	B-T038
of	O
dr	B-T103
##p1	I-T103
prevents	O
fragmentation	B-T038
,	O
improves	O
vas	O
##of	O
##unction	O
,	O
and	O
may	O
provide	O
a	O
therapeutic	O
target	O
for	O
improving	O
cardiovascular	B-T038
complications	I-T038
among	O
diabetics	B-T033
.	O
listen	O
to	O
this	O
article	O
'	O
s	O
corresponding	O
pod	O
##cast	O
@	O
http	B-T170
:	I-T170
/	I-T170
/	I-T170
aj	I-T170
##ph	I-T170
##ear	I-T170
##t	I-T170
.	I-T170
pod	I-T170
##bean	I-T170
.	I-T170
com	I-T170
/	I-T170
e	I-T170
/	I-T170
mitochondrial	I-T170
-	I-T170
dynamics	I-T170
-	I-T170
impact	I-T170
-	I-T170
endothelial	I-T170
-	I-T170
function	I-T170
/	I-T170
.	O

morphogenetic	B-T038
alterations	O
of	O
altern	B-T204
##aria	I-T204
altern	I-T204
##ata	I-T204
exposed	O
to	O
dic	B-T103
##arbox	I-T103
##imide	I-T103
fungi	I-T103
##ci	I-T103
##de	I-T103
,	O
ipr	B-T103
##odi	I-T103
##one	I-T103
fungi	O
##ci	O
##de	O
-	O
resistant	O
altern	B-T204
##aria	I-T204
altern	I-T204
##ata	I-T204
impede	O
the	O
practical	O
control	O
of	O
the	O
altern	B-T038
##aria	I-T038
diseases	I-T038
in	O
crop	B-T204
fields	O
.	O
this	O
study	O
aimed	O
to	O
investigate	O
cytological	O
fungi	B-T103
##ci	I-T103
##de	I-T103
resistance	B-T038
mechanisms	O
of	O
a	B-T204
.	I-T204
altern	I-T204
##ata	I-T204
against	O
dic	B-T103
##arbox	I-T103
##imide	I-T103
fungi	I-T103
##ci	I-T103
##de	I-T103
ipr	B-T103
##odi	I-T103
##one	I-T103
.	O
a	B-T204
.	I-T204
altern	I-T204
##ata	I-T204
isolated	O
from	O
cac	B-T204
##t	I-T204
##us	I-T204
brown	O
spot	O
was	O
cultured	B-T058
on	O
potato	O
-	O
dextrose	O
agar	O
(	O
pda	O
)	O
with	O
or	O
without	O
ipr	B-T103
##odi	I-T103
##one	I-T103
,	O
and	O
the	O
fungal	B-T058
cultures	I-T058
with	O
different	O
growth	B-T038
characteristics	O
from	O
no	O
,	O
initial	O
and	O
full	O
growth	B-T038
were	O
observed	O
by	O
light	B-T058
and	O
electron	B-T058
microscopy	I-T058
.	O
myc	B-T204
##elia	I-T204
began	O
to	O
grow	B-T038
from	O
one	O
day	O
after	O
incubation	O
(	O
da	O
##i	O
)	O
and	O
continued	O
to	O
be	O
in	O
full	O
growth	B-T038
(	O
control	B-T038
-	I-T038
growth	I-T038
,	O
con	B-T038
-	I-T038
g	I-T038
)	O
on	O
pda	O
without	O
fungi	B-T103
##ci	I-T103
##de	I-T103
,	O
while	O
on	O
pda	O
with	O
ipr	B-T103
##odi	I-T103
##one	I-T103
,	O
no	O
fungal	O
growth	O
(	O
ipr	O
##odi	O
##one	O
-	O
no	O
growth	O
,	O
ipr	O
-	O
n	O
)	O
occurred	O
for	O
the	O
first	O
3	O
da	O
##i	O
,	O
but	O
once	O
the	O
initial	O
growth	B-T038
(	O
ipr	B-T038
##odi	I-T038
##one	I-T038
-	I-T038
initial	I-T038
growth	I-T038
,	O
ipr	B-T038
-	I-T038
i	I-T038
)	O
began	O
at	O
4	O
-	O
5	O
da	O
##i	O
,	O
the	O
colonies	B-T017
grew	O
and	O
expanded	B-T082
continuously	O
to	O
be	O
in	O
full	O
growth	B-T038
(	O
ipr	B-T038
##odi	I-T038
##one	I-T038
-	I-T038
growth	I-T038
,	O
ipr	B-T038
-	I-T038
g	I-T038
)	O
,	O
suggesting	O
ipr	B-T038
-	I-T038
i	I-T038
may	O
be	O
a	O
turning	O
moment	O
of	O
the	O
morphogenetic	B-T038
changes	O
resistin	B-T038
##g	I-T038
fungi	B-T038
##ci	I-T038
##da	I-T038
##l	I-T038
toxicity	O
.	O
con	B-T038
-	I-T038
g	I-T038
formed	O
multicellular	B-T204
conidia	I-T204
with	O
cell	O
walls	O
and	O
sept	B-T017
##a	I-T017
and	O
intact	O
dense	O
cytoplasm	B-T017
.	O
in	O
ipr	O
-	O
n	O
,	O
fungal	B-T204
sporulation	B-T038
was	O
inhibited	O
by	O
forming	O
mostly	O
und	B-T033
##evelop	I-T033
##ed	I-T033
unic	B-T204
##ellular	I-T204
conidia	I-T204
with	O
degraded	B-T033
and	O
necrotic	B-T038
cytoplasm	B-T017
.	O
however	O
,	O
in	O
ipr	B-T038
-	I-T038
i	I-T038
,	O
conspicuous	B-T038
cellular	I-T038
changes	I-T038
occurred	O
during	O
sporulation	B-T038
by	O
forming	O
multicellular	B-T204
conidia	I-T204
with	O
double	B-T033
layered	I-T033
(	O
thickened	B-T033
)	O
cell	O
walls	O
and	O
accumulation	B-T033
of	O
proliferated	O
lipid	B-T017
bodies	I-T017
in	O
the	O
conidia	B-T204
##l	I-T204
cytoplasm	B-T017
,	O
which	O
may	O
inhibit	O
the	O
penetration	O
of	O
the	O
fungi	B-T103
##ci	I-T103
##de	I-T103
into	O
conidia	B-T204
##l	I-T204
cells	B-T017
,	O
reducing	O
fungi	B-T103
##ci	I-T103
##de	I-T103
-	O
associated	O
toxicity	O
,	O
and	O
may	O
be	O
utilized	O
as	O
energy	O
and	O
nutritional	O
sources	B-T033
,	O
respectively	O
,	O
for	O
the	O
further	O
fungal	B-T204
growth	B-T038
to	O
form	O
mature	O
colonies	B-T017
as	O
in	O
ipr	B-T038
-	I-T038
g	I-T038
that	O
formed	O
multicellular	B-T204
conidia	I-T204
with	O
cell	O
walls	O
and	O
intact	O
cytoplasm	B-T017
with	O
lipid	B-T017
bodies	I-T017
as	O
in	O
con	B-T038
-	I-T038
g	I-T038
.	O

triterp	B-T103
##enoids	I-T103
from	O
the	O
stems	B-T204
of	O
trip	B-T204
##ter	I-T204
##yg	I-T204
##ium	I-T204
reg	I-T204
##eli	I-T204
##i	I-T204
three	O
new	O
triterp	B-T103
##enoids	I-T103
,	O
tri	B-T103
##reg	I-T103
##el	I-T103
##olide	I-T103
##s	I-T103
a	O
,	O
b	O
(	O
1	O
,	O
2	O
)	O
,	O
and	O
tri	B-T103
##reg	I-T103
##el	I-T103
##oic	I-T103
acid	I-T103
(	O
3	O
)	O
,	O
were	O
isolated	O
from	O
the	O
stems	B-T204
of	O
trip	B-T204
##ter	I-T204
##yg	I-T204
##ium	I-T204
reg	I-T204
##eli	I-T204
##i	I-T204
along	O
with	O
twenty	O
known	O
triterp	B-T103
##ene	I-T103
analogues	B-T103
(	O
4	O
-	O
23	O
)	O
.	O
the	O
structures	O
of	O
three	O
new	O
compounds	B-T103
were	O
identified	O
by	O
analyzing	O
their	O
nmr	B-T058
spectroscopic	I-T058
and	O
hr	B-T058
##esi	I-T058
##ms	I-T058
data	O
.	O
compounds	B-T103
4	B-T103
,	O
7	B-T103
,	O
8	B-T103
,	O
10	B-T103
,	O
13	B-T103
,	O
14	B-T103
,	O
17	B-T103
,	O
21	B-T103
-	I-T103
23	I-T103
were	O
isolated	O
from	O
t	B-T204
.	I-T204
reg	I-T204
##eli	I-T204
##i	I-T204
for	O
the	O
first	O
time	O
.	O
compounds	B-T103
3	B-T103
,	O
5	B-T103
,	O
6	B-T103
,	O
8	B-T103
,	O
9	B-T103
,	O
10	B-T103
,	O
14	B-T103
and	O
16	B-T103
showed	O
inhibitory	B-T038
effects	I-T038
on	I-T038
the	I-T038
proliferation	I-T038
of	O
human	B-T017
breast	I-T017
cancer	I-T017
cells	I-T017
mcf	B-T017
-	I-T017
7	I-T017
by	O
24	O
.	O
1	O
%	O
,	O
69	O
.	O
6	O
%	O
,	O
72	O
.	O
8	O
%	O
,	O
21	O
.	O
6	O
%	O
,	O
23	O
.	O
1	O
%	O
,	O
43	O
.	O
3	O
%	O
,	O
25	O
.	O
5	O
%	O
and	O
23	O
.	O
5	O
%	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
at	O
a	O
concentration	O
of	O
10	O
##μm	O
,	O
respectively	O
.	O

experiences	O
of	O
support	O
in	O
working	O
toward	O
personal	O
recovery	B-T038
goals	B-T170
:	O
a	O
collaborative	O
,	O
qualitative	B-T062
study	I-T062
recovery	B-T038
can	O
be	O
understood	O
as	O
a	O
subjective	O
process	O
guided	O
by	O
personal	O
expectations	O
,	O
goals	B-T170
and	O
hope	B-T038
##s	I-T038
.	O
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
explore	O
how	O
persons	B-T098
using	O
a	O
community	B-T092
mental	I-T092
health	I-T092
centre	I-T092
(	O
cm	B-T092
##hc	I-T092
)	O
experienced	O
that	O
their	O
expectations	O
for	O
treatment	B-T058
,	O
and	O
goals	B-T170
and	O
hope	B-T038
##s	I-T038
for	O
recovery	B-T038
were	O
supported	O
by	O
the	O
health	B-T097
professionals	I-T097
during	O
treatment	B-T058
.	O
employing	O
a	O
herm	O
##ene	O
##ut	O
##ic	O
-	O
phenomenological	O
approach	O
,	O
eight	O
service	O
users	O
were	O
interviewed	O
about	O
their	O
expectations	O
for	O
treatment	B-T058
and	O
their	O
goals	B-T170
and	O
hope	B-T038
##s	I-T038
for	O
recovery	B-T038
at	O
the	O
start	O
of	O
their	O
contact	O
with	O
health	B-T097
professionals	I-T097
at	O
a	O
cm	B-T092
##hc	I-T092
.	O
two	O
years	O
later	O
,	O
they	O
were	O
re	O
-	O
interviewed	O
about	O
their	O
experiences	O
of	O
treatment	B-T058
and	O
support	O
from	O
the	O
health	B-T097
professionals	I-T097
in	O
their	O
work	O
towards	O
these	O
goals	B-T170
and	O
hope	B-T038
##s	I-T038
.	O
a	O
collaborative	O
approach	O
was	O
adopted	O
.	O
a	O
co	B-T097
-	I-T097
researcher	I-T097
with	O
lived	O
experience	O
took	O
part	O
in	O
all	O
stages	O
of	O
the	O
study	B-T062
.	O
data	O
were	O
analysed	O
by	O
means	O
of	O
a	O
data	O
-	O
driven	O
stepwise	O
approach	O
in	O
line	O
with	O
thematic	B-T062
analysis	I-T062
.	O
five	O
themes	O
reflecting	O
how	O
participants	B-T098
experienced	O
support	O
from	O
health	B-T097
professionals	I-T097
at	O
the	O
cm	B-T092
##hc	I-T092
in	O
their	O
work	O
towards	O
their	O
recovery	B-T038
goals	B-T170
were	O
elicited	O
,	O
as	O
follows	O
:	O
developing	O
an	O
understanding	O
of	O
ones	O
##elf	O
and	O
one	O
'	O
s	O
mental	B-T033
health	I-T033
problems	I-T033
;	O
learning	O
how	O
to	O
change	O
feelings	B-T038
and	O
behaviours	O
;	O
being	B-T033
'	I-T033
push	I-T033
##ed	I-T033
'	I-T033
into	I-T033
social	I-T033
arena	I-T033
##s	I-T033
;	O
finding	B-T033
helpful	I-T033
medication	I-T033
;	O
and	O
counselling	B-T058
in	O
family	B-T033
,	O
practical	B-T033
and	O
financial	B-T033
issues	I-T033
.	O
the	O
participants	B-T098
'	O
expectations	O
about	O
counselling	B-T058
with	O
regard	O
to	O
longer	O
-	O
term	O
family	B-T033
,	O
practical	B-T033
,	O
and	O
financial	B-T033
challenges	I-T033
were	O
insufficient	O
##ly	O
met	O
by	O
the	O
cm	B-T092
##hc	I-T092
.	O
in	O
the	O
experience	O
of	O
the	O
service	O
users	O
,	O
recovery	B-T038
occurred	O
within	O
the	O
context	O
of	O
their	O
everyday	O
life	O
with	O
or	O
without	O
the	O
support	O
of	O
their	O
professional	B-T097
helper	B-T097
##s	I-T097
.	O
to	O
facilitate	O
recovery	B-T038
,	O
health	B-T097
professionals	I-T097
should	O
acknowled	O
##ge	O
the	O
service	O
user	O
'	O
s	O
personal	O
goals	B-T170
and	O
hope	B-T038
##s	I-T038
and	O
take	O
a	O
more	O
comprehensive	O
and	O
longer	O
-	O
term	O
approach	O
to	O
his	O
or	O
her	O
needs	O
and	O
desire	O
##s	O
.	O
acknowled	O
##ging	O
and	O
facilitating	O
recovery	B-T038
goals	B-T170
by	O
offering	O
counselling	B-T058
with	O
regard	O
to	O
family	B-T033
,	O
practical	B-T033
and	O
financial	B-T033
issues	I-T033
seems	O
particularly	O
important	O
.	O

the	O
aortic	B-T082
root	I-T082
:	O
natural	O
history	O
after	O
root	B-T058
-	I-T058
sparing	I-T058
ascending	I-T058
replacement	I-T058
in	O
nonsyn	B-T033
##dro	I-T033
##mic	I-T033
aneurysmal	O
patients	O
leaving	O
native	O
aortic	B-T017
tissue	I-T017
in	B-T082
situ	I-T082
in	O
root	B-T058
-	I-T058
sparing	I-T058
ascending	I-T058
aortic	I-T058
replacement	I-T058
raises	O
concern	O
regarding	O
potential	O
later	O
need	O
for	O
root	B-T082
reoperation	B-T058
or	O
for	O
the	O
potential	O
occurrence	O
of	O
localized	B-T082
dissections	B-T038
or	O
rupture	B-T037
in	O
the	O
residual	O
root	B-T082
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
natural	B-T038
growth	I-T038
of	O
the	O
aortic	B-T082
root	I-T082
after	O
root	B-T058
-	I-T058
sparing	I-T058
aortic	I-T058
replacement	I-T058
.	O
in	O
all	O
,	O
102	O
consecutive	O
patients	O
(	O
mean	O
age	O
61	O
.	O
8	O
±	O
12	O
.	O
5	O
years	O
;	O
60	O
%	O
male	B-T098
)	O
who	O
had	O
undergone	O
root	B-T058
-	I-T058
sparing	I-T058
aortic	I-T058
replacement	I-T058
had	O
sufficient	O
retriev	O
##able	O
information	O
regarding	O
their	O
aortic	B-T082
root	I-T082
diameter	O
at	O
postoperative	O
baseline	O
and	O
follow	B-T058
-	I-T058
up	I-T058
imaging	B-T058
by	O
computed	B-T058
tomography	I-T058
or	O
echocardiography	B-T058
.	O
the	O
annual	O
growth	O
rate	O
was	O
evaluated	O
and	O
also	O
compared	O
according	O
to	O
the	O
influence	O
of	O
valve	O
morphology	O
and	O
concomitant	O
aortic	B-T058
valve	I-T058
replacement	I-T058
.	O
furthermore	O
,	O
the	O
years	O
of	O
natural	O
history	O
that	O
would	O
require	O
for	O
root	B-T082
enlargement	B-T017
to	O
meet	O
a	O
50	O
mm	O
threshold	O
of	O
the	O
root	B-T082
diameter	O
were	O
calculated	O
.	O
the	O
estimated	O
growth	O
rate	O
of	O
the	O
aortic	B-T082
root	I-T082
after	O
root	B-T058
-	I-T058
sparing	I-T058
aortic	I-T058
replacement	I-T058
is	O
between	O
0	O
.	O
27	O
and	O
0	O
.	O
51	O
mm	O
per	O
year	O
(	O
mean	O
0	O
.	O
41	O
mm	O
,	O
varying	O
according	O
to	O
the	O
underlying	O
diameter	O
)	O
and	O
therefore	O
fivefold	O
less	O
than	O
other	O
aortic	B-T082
regions	I-T082
.	O
accordingly	O
,	O
a	O
root	B-T038
aneurysm	I-T038
indicating	O
reoperation	B-T058
would	O
not	O
be	O
expected	B-T170
for	O
29	O
.	O
1	O
years	O
on	O
average	O
.	O
only	O
patients	O
with	O
a	O
diameter	O
of	O
45	O
mm	O
or	O
more	O
are	O
at	O
risk	O
for	O
reoperation	B-T058
,	O
and	O
not	O
until	B-T170
at	O
least	O
after	O
10	O
.	O
4	O
years	O
have	B-T033
passed	I-T033
.	O
neither	O
the	O
valve	O
morphology	O
(	O
p	O
=	O
0	O
.	O
62	O
)	O
nor	O
concomitant	O
aortic	B-T058
valve	I-T058
replacement	I-T058
(	O
p	O
=	O
0	O
.	O
86	O
)	O
influenced	O
rate	O
of	O
root	B-T038
dilation	I-T038
.	O
in	O
nonsyn	B-T033
##dro	I-T033
##mic	I-T033
patients	O
,	O
the	O
aortic	B-T082
root	I-T082
is	O
the	O
slow	O
##est	O
growing	B-T038
portion	B-T082
of	O
the	O
thoracic	B-T017
aorta	I-T017
.	O
leaving	O
the	O
native	O
root	B-T082
,	O
as	O
in	O
root	B-T058
-	I-T058
sparing	I-T058
ascending	I-T058
aortic	I-T058
replacement	I-T058
,	O
is	O
a	O
safe	B-T082
approach	I-T082
regarding	O
secondary	B-T082
root	I-T082
intervention	B-T058
for	O
aortic	B-T082
root	I-T082
diameters	O
of	O
45	O
mm	O
or	O
less	O
.	O

effects	O
of	O
sirna	B-T103
-	O
mediated	O
suppression	B-T038
of	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
expression	B-T038
on	O
the	O
proliferation	B-T038
and	O
apoptosis	B-T038
of	O
vaginal	O
epithelial	O
cells	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
investigate	O
the	O
effects	O
of	O
human	B-T038
papillomavirus	I-T038
(	I-T038
hpv	I-T038
)	I-T038
infection	I-T038
on	O
the	O
gynecological	O
disease	O
of	O
vagin	B-T038
##itis	I-T038
and	O
to	O
demonstrate	O
how	O
the	O
small	B-T103
interfering	I-T103
rna	I-T103
(	O
sirna	B-T103
)	O
method	O
may	O
be	O
used	O
for	O
hpv	B-T005
prevention	B-T058
in	O
the	O
clinic	B-T092
.	O
human	B-T204
vaginal	O
epithelial	O
cells	O
were	O
transfected	B-T062
with	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
expression	O
vector	O
and	O
sirna	B-T103
-	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
vectors	B-T103
and	O
a	O
control	O
group	O
was	O
transfected	B-T062
with	O
scr	O
##amb	O
##led	O
sirna	B-T103
.	O
cell	B-T038
proliferation	I-T038
in	O
each	O
group	O
was	O
analyzed	O
using	O
the	O
mtt	B-T058
assay	I-T058
and	O
the	O
expression	B-T038
of	O
apoptosis	B-T038
-	O
associated	O
proteins	B-T103
was	O
measured	O
by	O
western	B-T058
blot	I-T058
analysis	I-T058
.	O
compared	O
with	O
the	O
control	O
group	O
,	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
mrna	B-T103
and	O
protein	B-T033
levels	I-T033
were	O
significantly	O
increased	O
following	O
transfection	B-T062
with	O
the	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
expression	O
vector	O
in	O
cells	B-T017
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
but	O
this	O
result	O
was	O
significantly	O
reversed	O
by	O
silencing	B-T038
of	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
in	O
addition	O
,	O
cell	B-T038
proliferation	I-T038
in	O
the	O
hpv	O
-	O
11	O
group	O
was	O
lower	O
than	O
that	O
in	O
the	O
control	O
group	O
;	O
however	O
,	O
cell	B-T038
proliferation	I-T038
was	O
significantly	O
increased	O
in	O
cells	B-T017
transfected	B-T062
with	O
silenced	B-T038
l1	B-T017
compared	O
with	O
that	O
in	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
furthermore	O
,	O
silencing	B-T038
of	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
significantly	O
decreased	O
caspase	B-T017
-	I-T017
3	I-T017
and	O
caspase	B-T017
-	I-T017
9	I-T017
expressions	B-T038
in	O
cells	B-T017
,	O
whereas	O
the	O
expression	B-T038
was	O
increased	O
in	O
the	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
present	O
study	B-T062
suggested	O
that	O
sirna	B-T103
-	O
mediated	O
silencing	B-T038
of	O
hpv	B-T017
-	I-T017
11	I-T017
l1	I-T017
may	O
have	O
potential	O
therapeutic	B-T058
applications	I-T058
for	O
treating	O
gynecological	O
diseases	O
associated	O
with	O
hpv	B-T005
-	I-T005
11	I-T005
infection	B-T038
.	O

source	O
app	O
##ortion	O
##ment	O
and	O
heavy	B-T103
metal	I-T103
health	O
risk	O
(	O
hm	O
##hr	O
)	O
quantification	O
from	O
sources	B-T033
in	O
a	O
southern	B-T082
city	B-T082
in	O
china	B-T082
,	O
using	O
an	O
me	B-T170
##2	I-T170
-	O
hm	O
##hr	O
model	O
heavy	B-T103
metals	I-T103
(	O
cr	B-T103
,	O
co	B-T103
,	O
ni	B-T103
,	O
as	B-T103
,	O
cd	B-T103
,	O
and	O
pb	B-T103
)	O
can	O
be	O
bound	O
to	O
pm	O
adversely	B-T038
affecting	I-T038
human	B-T204
health	O
.	O
quantifying	O
the	O
source	B-T033
impacts	O
on	O
heavy	B-T103
metals	I-T103
can	O
provide	O
source	B-T033
-	O
specific	O
estimates	O
of	O
the	O
heavy	B-T103
metal	I-T103
health	O
risk	O
(	O
hm	O
##hr	O
)	O
to	O
guide	O
effective	O
development	O
of	O
strategies	O
to	O
reduce	O
such	O
risks	O
from	O
exposure	O
to	O
heavy	B-T103
metals	I-T103
in	O
pm2	O
.	O
5	O
(	O
particulate	O
matter	O
(	O
pm	O
)	O
with	O
aer	O
##odynamic	O
diameter	O
less	O
than	O
or	O
equal	O
to	O
2	O
.	O
5	O
μm	O
)	O
.	O
in	O
this	O
study	O
,	O
a	O
method	O
combining	O
multil	B-T170
##inea	I-T170
##r	I-T170
engine	I-T170
2	I-T170
(	O
me	B-T170
##2	I-T170
)	O
and	O
a	O
risk	B-T058
assessment	I-T058
model	O
is	O
developed	O
to	O
more	O
effectively	O
quantify	O
source	B-T033
contributions	O
to	O
hm	O
##hr	O
,	O
including	O
heavy	B-T103
metal	I-T103
non	B-T033
-	I-T033
cancer	I-T033
risk	I-T033
(	O
non	B-T033
-	I-T033
hm	I-T033
##cr	I-T033
)	O
and	O
cancer	O
risk	O
(	O
hm	O
##cr	O
)	O
.	O
the	O
combined	O
model	O
(	O
called	O
me	O
##2	O
-	O
hm	O
##hr	O
)	O
has	O
two	O
steps	O
:	O
step	O
##1	O
,	O
source	B-T033
contributions	O
to	O
heavy	B-T103
metals	I-T103
are	O
estimated	O
by	O
employing	O
the	O
me	B-T170
##2	I-T170
model	O
;	O
step	O
##2	O
,	O
the	O
source	B-T033
contributions	O
in	O
step	O
1	O
are	O
introduced	O
into	O
the	O
risk	B-T058
assessment	I-T058
model	O
to	O
calculate	O
the	O
source	B-T033
contributions	O
to	O
hm	O
##hr	O
.	O
the	O
approach	O
was	O
applied	O
to	O
hu	B-T082
##zo	I-T082
##u	I-T082
,	O
china	B-T082
and	O
five	O
significant	O
sources	B-T033
were	O
identified	O
.	O
soil	O
dust	O
is	O
the	O
largest	O
source	B-T033
of	O
non	B-T033
-	I-T033
hm	I-T033
##cr	I-T033
.	O
for	O
hm	O
##cr	O
,	O
the	O
source	B-T033
contributions	O
of	O
soil	O
dust	O
,	O
coal	B-T103
combustion	O
,	O
cement	O
dust	O
,	O
vehicle	B-T103
,	O
and	O
secondary	O
sources	B-T033
are	O
1	O
.	O
0	O
×	O
10	O
(	O
-	O
4	O
)	O
,	O
3	O
.	O
7	O
×	O
10	O
(	O
-	O
5	O
)	O
,	O
2	O
.	O
7	O
×	O
10	O
(	O
-	O
6	O
)	O
,	O
1	O
.	O
6	O
×	O
10	O
(	O
-	O
6	O
)	O
and	O
1	O
.	O
9	O
×	O
10	O
(	O
-	O
9	O
)	O
,	O
respectively	O
.	O
the	O
soil	O
dust	O
is	O
the	O
largest	O
contributor	O
to	O
hm	O
##cr	O
,	O
being	O
driven	O
by	O
the	O
high	O
impact	O
of	O
soil	O
dust	O
on	O
pm2	O
.	O
5	O
and	O
the	O
abundance	O
of	O
heavy	B-T103
metals	I-T103
in	O
soil	O
dust	O
.	O

synthesis	O
of	O
some	O
unique	O
carbam	B-T103
##ate	I-T103
derivatives	B-T103
bearing	O
2	B-T103
-	I-T103
fur	I-T103
##oyl	I-T103
-	I-T103
1	I-T103
-	I-T103
piper	I-T103
##azine	I-T103
as	O
a	O
valuable	O
therapeutic	B-T103
agents	I-T103
the	O
aim	O
of	O
the	O
research	B-T062
work	I-T062
was	O
to	O
synthesize	O
different	O
biologically	B-T103
active	I-T103
carbam	B-T103
##ate	I-T103
derivatives	B-T103
bearing	O
2	B-T103
-	I-T103
fur	I-T103
##oyl	I-T103
-	I-T103
1	I-T103
-	I-T103
piper	I-T103
##azine	I-T103
and	O
having	O
modest	O
toxicity	B-T037
.	O
the	O
synthesis	O
was	O
completed	O
as	O
a	O
multiple	O
sequence	O
.	O
the	O
structural	B-T082
confirmation	B-T033
of	O
all	O
the	O
synthesized	O
compounds	O
was	O
obtained	O
by	O
ei	B-T058
-	I-T058
ms	I-T058
,	O
ir	B-T058
and	O
1h	B-T058
-	I-T058
nmr	I-T058
spectral	O
data	O
.	O
the	O
enzyme	B-T038
inhibition	I-T038
and	O
antibacterial	B-T033
potential	I-T033
of	O
the	O
synthesized	B-T103
compounds	I-T103
was	O
evaluated	B-T058
.	O
to	O
find	O
the	O
utility	O
of	O
the	O
prepared	O
compounds	B-T103
as	O
possible	O
therapeutic	B-T103
agents	I-T103
their	O
cytotoxicity	B-T038
was	O
also	O
checked	O
.	O
all	O
the	O
compounds	B-T103
were	O
active	O
against	O
acetylcholinesterase	B-T103
enzyme	I-T103
,	O
especially	O
12	B-T103
and	O
14	B-T103
showed	O
very	O
good	O
inhibitory	B-T038
potential	I-T038
relative	O
to	O
es	B-T103
##erine	I-T103
,	O
a	O
reference	O
standard	O
.	O
almost	O
all	O
the	O
compounds	B-T103
showed	O
good	O
activities	O
against	O
both	O
gram	B-T007
-	I-T007
positive	I-T007
and	O
gram	B-T007
-	I-T007
negative	I-T007
bacterial	I-T007
strains	I-T007
.	O

gene	B-T038
expression	I-T038
reveals	O
evidence	O
for	O
egfr	B-T103
-	O
dependent	O
proximal	B-T017
-	I-T017
distal	I-T017
limb	I-T017
patterning	B-T038
in	O
a	O
myri	B-T204
##ap	I-T204
##od	I-T204
evolution	B-T038
of	O
segmented	B-T017
limbs	I-T017
is	O
one	O
of	O
the	O
key	O
innovations	O
of	O
arthropod	B-T204
##a	I-T204
,	O
allowing	O
development	O
of	O
functionally	O
specific	O
specialized	O
head	B-T082
and	O
trunk	B-T082
appendage	B-T017
##s	I-T017
,	O
a	O
major	O
factor	O
behind	O
their	O
unm	O
##atch	O
##ed	O
evolutionary	O
success	O
.	O
proxim	B-T017
##odi	I-T017
##st	I-T017
##al	I-T017
limb	I-T017
patterning	B-T038
is	O
controlled	O
by	O
two	O
regulatory	B-T038
networks	I-T038
in	O
the	O
vine	O
##gar	O
fly	O
drosophila	B-T204
melanogaster	I-T204
,	O
and	O
other	O
insects	B-T204
.	O
the	O
first	O
is	O
represented	O
by	O
the	O
function	O
of	O
the	O
morph	B-T103
##ogens	I-T103
wing	B-T103
##less	I-T103
(	O
wg	B-T103
)	O
and	O
dec	B-T103
##apent	I-T103
##apl	I-T103
##eg	I-T103
##ic	I-T103
(	O
dpp	B-T103
)	O
;	O
the	O
second	O
by	O
the	O
egfr	B-T038
-	I-T038
signaling	I-T038
cascade	I-T038
.	O
while	O
the	O
role	O
of	O
wg	B-T103
and	O
dpp	B-T103
has	O
been	O
studied	B-T062
in	O
a	O
wide	O
range	O
of	O
arthropod	B-T204
##s	I-T204
representing	O
all	O
main	O
branches	O
,	O
that	O
is	O
,	O
panc	B-T204
##ru	I-T204
##st	I-T204
##acea	I-T204
(	O
=	O
hexa	B-T204
##po	I-T204
##da	I-T204
+	O
crustace	B-T204
##a	I-T204
)	O
,	O
myri	B-T204
##ap	I-T204
##oda	I-T204
and	O
chel	B-T204
##ice	I-T204
##ra	I-T204
##ta	I-T204
,	O
investigation	O
of	O
the	O
potential	O
role	O
of	O
egfr	B-T038
-	I-T038
signaling	I-T038
is	O
restricted	O
to	O
insects	B-T204
(	O
hexa	B-T204
##po	I-T204
##da	I-T204
)	O
.	O
gene	B-T062
expression	I-T062
analysis	I-T062
of	O
egfr	B-T103
,	O
its	O
potential	O
ligands	B-T103
,	O
and	O
putative	B-T103
downstream	I-T103
factors	I-T103
in	O
the	O
pill	B-T204
mill	I-T204
##ip	I-T204
##ed	I-T204
##e	I-T204
glomer	B-T204
##is	I-T204
margin	I-T204
##ata	I-T204
(	O
myri	B-T204
##ap	I-T204
##oda	I-T204
:	O
dipl	B-T204
##opo	I-T204
##da	I-T204
)	O
,	O
reveals	O
that	O
-	O
in	O
at	O
least	O
mand	B-T204
##ib	I-T204
##ulate	I-T204
arthropod	B-T204
##s	I-T204
-	O
egfr	B-T038
-	I-T038
signaling	I-T038
is	O
likely	O
a	O
conserved	O
regulatory	B-T033
mechanism	I-T033
in	O
proxim	B-T017
##odi	I-T017
##st	I-T017
##al	I-T017
limb	I-T017
patterning	B-T038
.	O

long	O
-	O
term	O
antib	O
##io	O
##fil	O
##m	O
activity	O
of	O
carboxymethyl	B-T103
chitosan	I-T103
on	O
mixed	B-T007
biofilm	I-T007
on	O
silicone	B-T103
silicone	B-T103
voice	B-T074
prostheses	I-T074
are	O
most	O
frequently	O
used	O
in	O
voice	B-T058
rehabilitation	I-T058
of	O
laryng	B-T058
##ectomized	I-T058
patients	O
.	O
however	O
,	O
the	O
functional	O
device	O
lifetimes	O
are	O
limited	O
due	O
to	O
formation	O
of	O
mixed	B-T007
biofilms	I-T007
.	O
existing	O
in	B-T062
vitro	I-T062
models	I-T062
simulating	O
biofilm	B-T038
formation	I-T038
are	O
restricted	O
to	O
only	O
short	O
-	O
term	O
periods	O
.	O
the	O
goal	B-T170
of	O
this	O
study	B-T062
was	O
to	O
determine	O
the	O
effect	O
of	O
carboxymethyl	B-T103
chitosan	I-T103
on	O
mixed	B-T038
biofilm	I-T038
formation	I-T038
of	O
fungi	B-T204
and	O
bacteria	B-T007
on	O
silicone	B-T103
over	O
a	O
long	O
-	O
term	O
period	O
.	O
mixed	O
species	B-T170
biofilms	B-T007
of	O
candida	B-T204
albicans	I-T204
,	O
candida	B-T204
tropical	I-T204
##is	I-T204
,	O
lactobacillus	B-T007
gas	I-T007
##se	I-T007
##ri	I-T007
,	O
streptococcus	B-T007
saliva	I-T007
##ri	I-T007
##us	I-T007
,	O
rot	B-T007
##hi	I-T007
##a	I-T007
dent	I-T007
##ocar	I-T007
##io	I-T007
##sa	I-T007
,	O
and	O
staphylococcus	B-T007
epidermidis	I-T007
were	O
cultivated	O
on	O
the	O
surfaces	B-T082
of	O
medical	B-T103
-	I-T103
grade	I-T103
silicone	I-T103
with	O
and	O
without	O
addition	O
of	O
carboxymethyl	B-T103
chitosan	I-T103
.	O
biofilm	O
kinetics	O
was	O
monitored	O
using	O
specially	O
designed	O
image	O
analysis	O
software	O
to	O
calculate	O
the	O
percent	O
##ual	O
surface	O
covering	O
of	O
each	O
platelet	B-T017
.	O
biofilm	O
architecture	O
was	O
investigated	O
by	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
.	O
a	O
cover	O
of	O
living	O
mixed	B-T007
biofilm	I-T007
could	O
be	O
generated	O
over	O
22	O
days	O
on	O
silicone	B-T103
and	O
the	O
maximum	O
of	O
22	O
%	O
biofilm	B-T007
surface	O
covering	O
at	O
day	O
22	O
.	O
however	O
,	O
less	O
than	O
4	O
%	O
surface	O
coverage	O
was	O
observed	O
on	O
the	O
carboxymethyl	B-T103
chitosan	I-T103
-	O
treated	O
plates	O
in	O
the	O
testing	O
period	O
.	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
confirms	B-T033
that	O
,	O
on	O
surfaces	B-T082
treated	O
by	O
carboxymethyl	B-T103
chitosan	I-T103
,	O
the	O
biofilm	B-T007
was	O
less	O
dense	O
.	O
in	O
addition	O
,	O
there	O
were	O
fewer	O
layers	O
of	O
cells	B-T017
and	O
prof	B-T033
##use	I-T033
cellular	I-T033
debris	I-T033
,	O
together	O
with	O
degrading	O
and	O
morphologically	B-T017
altered	I-T017
yeast	B-T017
cells	I-T017
.	O
carboxymethyl	B-T103
chitosan	I-T103
may	O
serve	O
as	O
a	O
possible	B-T033
antib	O
##io	O
##fil	O
##m	O
agent	O
to	O
limit	O
biofilm	B-T038
formation	I-T038
on	O
voice	B-T074
prostheses	I-T074
.	O
na	O
laryng	B-T074
##oscope	I-T074
,	O
126	O
:	O
e4	O
##0	O
##4	O
-	O
e4	O
##0	O
##8	O
,	O
2016	O
.	O

nucleic	B-T058
acid	I-T058
detection	I-T058
with	O
crispr	B-T103
-	O
cas	O
##13	O
##a	O
/	O
c2	O
##c2	O
rapid	O
,	O
inexpensive	O
,	O
and	O
sensitive	O
nucleic	B-T058
acid	I-T058
detection	I-T058
may	O
aid	O
point	O
-	O
of	O
-	O
care	O
pathogen	O
detection	B-T058
,	O
genotyping	B-T058
,	O
and	O
disease	B-T038
monitoring	B-T058
.	O
the	O
rna	B-T103
-	O
guided	O
,	O
rna	B-T103
-	O
targeting	O
clustered	B-T103
regularly	I-T103
intersp	I-T103
##aced	I-T103
short	I-T103
pal	I-T103
##ind	I-T103
##romic	I-T103
repeats	I-T103
(	O
crispr	B-T103
)	O
effector	O
cas	O
##13	O
##a	O
(	O
previously	O
known	O
as	O
c2	O
##c2	O
)	O
exhibits	O
a	O
[UNK]	O
collateral	B-T082
effect	O
[UNK]	O
of	O
prom	O
##isc	O
##uous	O
ribonuclease	B-T038
activity	I-T038
upon	O
target	O
recognition	O
.	O
we	O
combine	O
the	O
collateral	B-T082
effect	O
of	O
cas	O
##13	O
##a	O
with	O
isothermal	B-T058
amplification	I-T058
to	O
establish	O
a	O
crispr	B-T103
-	O
based	O
diagnostic	O
(	O
crispr	B-T103
-	O
dx	O
)	O
,	O
providing	O
rapid	O
dna	B-T103
or	O
rna	B-T103
detection	B-T058
with	O
att	O
##omol	O
##ar	O
sensitivity	O
and	O
single	B-T103
-	I-T103
base	I-T103
mismatch	O
specificity	O
.	O
we	O
use	O
this	O
cas	O
##13	O
##a	O
-	O
based	O
molecular	O
detection	B-T058
platform	O
,	O
termed	O
specific	O
high	O
-	O
sensitivity	O
enzymatic	O
reporter	O
unl	O
##ocking	O
(	O
she	O
##r	O
##lock	O
)	O
,	O
to	O
detect	B-T033
specific	O
strains	O
of	O
zik	B-T005
##a	I-T005
and	O
dengue	B-T005
virus	I-T005
,	O
distinguish	O
pathogenic	O
bacteria	B-T007
,	O
genotype	O
human	B-T204
dna	B-T103
,	O
and	O
identify	O
mutations	B-T038
in	O
cell	B-T017
-	I-T017
free	I-T017
tumor	B-T103
dna	I-T103
.	O
furthermore	O
,	O
she	O
##r	O
##lock	O
reaction	O
reagents	B-T103
can	O
be	O
lyophilized	B-T058
for	O
cold	O
-	O
chain	O
independence	O
and	O
long	O
-	O
term	O
storage	O
and	O
be	O
readily	O
reconstituted	O
on	O
paper	O
for	O
field	O
applications	O
.	O

evaluation	B-T058
of	O
the	O
condom	B-T170
barriers	I-T170
scale	I-T170
for	O
young	O
black	B-T098
men	I-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
:	O
reliability	O
and	O
validity	O
of	O
3	O
subscales	B-T170
reliable	O
and	O
valid	O
scale	B-T170
measures	O
of	O
barriers	B-T058
to	O
condom	O
use	O
are	O
not	O
available	O
for	O
young	O
black	B-T098
men	I-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
(	O
yb	B-T098
##ms	I-T098
##m	I-T098
)	O
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
condom	B-T170
barriers	I-T170
scales	I-T170
for	O
application	O
with	O
yb	B-T098
##ms	I-T098
##m	I-T098
.	O
a	O
clinic	O
-	O
based	O
sample	O
of	O
600	O
yb	B-T098
##ms	I-T098
##m	I-T098
completed	O
a	O
computer	O
-	O
assisted	O
self	O
-	O
interview	O
.	O
the	O
primary	O
measure	O
was	O
a	O
14	O
-	O
item	O
abbreviated	B-T170
version	I-T170
of	O
the	O
condom	B-T170
barriers	I-T170
scale	I-T170
.	O
reliability	O
and	O
criterion	O
validity	O
were	O
assessed	O
.	O
all	O
3	O
subscales	B-T170
were	O
reliable	O
:	O
partner	B-T098
-	O
related	O
barriers	B-T058
(	O
cronbach	O
α	O
=	O
0	O
.	O
73	O
)	O
,	O
sensation	B-T038
-	O
related	O
barriers	B-T058
(	O
α	O
=	O
0	O
.	O
70	O
)	O
,	O
and	O
motivation	B-T038
-	O
related	O
barriers	B-T058
(	O
α	O
=	O
0	O
.	O
81	O
)	O
.	O
a	O
complete	O
absence	O
of	O
barriers	O
was	O
common	O
:	O
47	O
.	O
0	O
%	O
(	O
partner	B-T098
-	O
related	O
)	O
,	O
30	O
.	O
7	O
%	O
(	O
sensation	B-T038
-	O
related	O
)	O
,	O
and	O
46	O
.	O
5	O
%	O
(	O
motivation	B-T038
-	O
related	O
)	O
.	O
dichotom	O
##ized	O
subscales	B-T170
were	O
significantly	O
associated	O
with	O
reporting	O
any	O
condom	B-T033
##less	I-T033
insert	O
##ive	O
anal	O
sex	O
(	O
all	O
ps	O
<	O
0	O
.	O
001	O
)	O
and	O
any	O
condom	B-T033
##less	I-T033
receptive	O
anal	O
sex	O
(	O
all	O
ps	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
subscales	B-T170
were	O
significantly	O
associated	O
with	O
these	O
measures	O
of	O
condom	B-T033
##less	I-T033
sex	B-T038
preserved	O
at	O
a	O
continuous	O
level	O
(	O
all	O
ps	O
<	O
0	O
.	O
001	O
,	O
except	O
for	O
sensation	B-T038
barriers	B-T058
associated	O
with	O
condom	B-T033
##less	I-T033
receptive	O
anal	O
sex	O
=	O
0	O
.	O
03	O
)	O
.	O
further	O
,	O
the	O
subscales	B-T170
were	O
significantly	O
associated	O
with	O
reporting	O
any	O
condom	O
use	O
problems	O
(	O
all	O
ps	O
<	O
0	O
.	O
001	O
)	O
and	O
a	O
measure	O
of	O
condom	B-T033
##less	I-T033
oral	O
sex	O
(	O
all	O
ps	O
<	O
0	O
.	O
001	O
,	O
except	O
for	O
partner	B-T098
-	O
related	O
barriers	B-T058
=	O
0	O
.	O
31	O
)	O
.	O
finally	O
,	O
the	O
sensation	B-T038
-	O
related	O
barriers	B-T058
subscale	B-T170
was	O
significantly	O
associated	O
with	O
testing	O
positive	B-T033
for	O
chlamydia	B-T007
and	O
/	O
or	O
gonorrh	B-T038
##ea	I-T038
(	O
p	O
=	O
0	O
.	O
049	O
)	O
.	O
the	O
3	O
identified	O
subscales	B-T170
yielded	O
adequate	O
reliability	O
and	O
strong	O
evidence	O
of	O
validity	O
,	O
thereby	O
suggesting	O
the	O
utility	O
of	O
these	O
brief	O
measures	O
for	O
use	O
in	O
observational	B-T062
and	O
experimental	B-T062
research	I-T062
with	O
yb	B-T098
##ms	I-T098
##m	I-T098
.	O

construction	O
of	O
fused	O
poly	O
##he	O
##ter	O
##ocycl	O
##es	O
through	O
sequential	O
[	O
4	O
+	O
2	O
]	O
and	O
[	O
3	O
+	O
2	O
]	O
cycloaddition	O
##s	O
a	O
method	O
for	O
pd	B-T103
-	O
catalyzed	O
aerobic	O
oxidative	B-T038
reaction	I-T038
of	O
quin	B-T103
##azolin	I-T103
##ones	I-T103
and	O
alk	B-T103
##ynes	I-T103
has	O
been	O
developed	O
for	O
sequential	O
[	O
4	O
+	O
2	O
]	O
and	O
[	O
3	O
+	O
2	O
]	O
cycloaddition	O
##s	O
to	O
assemble	O
a	O
novel	O
fused	O
-	O
polycyclic	O
system	O
containing	O
tetrahydro	B-T103
##pyr	I-T103
##idine	I-T103
and	O
dihydro	B-T103
##furan	I-T103
rings	I-T103
.	O
the	O
reaction	O
process	O
involves	O
c	O
-	O
h	O
and	O
n	O
-	O
h	O
bond	O
functionalization	O
for	O
the	O
formation	O
of	O
tetrahydro	B-T103
##pyr	I-T103
##idine	I-T103
and	O
an	O
oxygen	B-T103
radical	I-T103
cyclization	O
for	O
the	O
dihydro	B-T103
##furan	I-T103
ring	I-T103
.	O
this	O
atom	B-T103
-	O
and	O
step	O
-	O
economical	O
synthesis	O
is	O
highly	O
efficient	O
and	O
has	O
good	O
substrate	O
tolerance	O
,	O
which	O
provides	O
a	O
new	O
approach	O
for	O
the	O
construction	O
of	O
polycyclic	O
molecules	O
with	O
potential	O
pharmaceutical	B-T091
interest	I-T091
.	I-T091

advanced	B-T098
age	I-T098
is	O
not	O
a	O
barrier	O
to	O
creating	O
a	O
functional	O
arteriovenous	B-T017
fistula	I-T017
:	O
a	O
retrospective	B-T062
study	I-T062
arteriovenous	B-T017
fistulas	I-T017
(	O
avf	B-T017
##s	I-T017
)	O
are	O
the	O
recommended	O
form	O
of	O
vascular	O
access	O
for	O
hemodialysis	B-T058
.	O
however	O
,	O
controversy	O
exists	O
regarding	O
whether	O
avf	B-T017
##s	I-T017
are	O
suitable	O
for	O
elderly	B-T098
patients	O
.	O
single	B-T062
-	I-T062
center	I-T062
retrospective	I-T062
review	I-T062
to	O
investigate	O
the	O
impact	O
of	O
age	O
on	O
avf	B-T017
outcomes	O
.	O
five	O
hundred	O
and	O
twenty	O
-	O
five	O
patients	O
with	O
avf	B-T017
creation	O
were	O
stratified	O
based	O
on	O
age	O
<	O
65	O
,	O
65	O
-	O
75	O
,	O
and	O
>	O
75	O
years	O
.	O
avf	B-T017
outcomes	O
including	O
primary	O
failure	O
,	O
avf	B-T017
patency	B-T038
(	O
primary	O
,	O
secondary	O
,	O
and	O
functional	O
)	O
,	O
and	O
avf	B-T017
complications	B-T038
were	O
studied	O
for	O
3	O
years	O
following	O
avf	B-T017
creation	O
.	O
the	O
cohort	B-T098
was	O
63	O
%	O
male	B-T098
,	O
44	O
%	O
caucasian	B-T098
,	O
and	O
55	O
%	O
had	O
diabetes	B-T038
or	O
cardiovascular	B-T038
disease	I-T038
.	O
39	O
%	O
were	O
aged	O
<	O
65	O
years	O
,	O
33	O
%	O
65	O
-	O
75	O
years	O
,	O
and	O
28	O
%	O
were	O
aged	O
>	O
75	O
years	O
.	O
no	O
differences	O
in	O
rates	O
of	O
primary	O
failure	O
,	O
loss	O
of	O
primary	O
patency	B-T038
,	O
complications	B-T038
,	O
or	O
need	O
for	O
intervention	B-T058
were	O
observed	O
between	O
age	O
groups	O
.	O
there	O
was	O
a	O
significant	O
association	O
of	O
age	O
with	O
secondary	O
patency	B-T038
and	O
functional	O
patency	B-T038
,	O
with	O
age	O
>	O
75	O
being	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
shortened	O
lifespan	O
of	O
the	O
fistula	O
.	O
for	O
patients	O
aged	O
>	O
75	O
years	O
,	O
secondary	O
patency	B-T038
at	O
3	O
years	O
was	O
64	O
%	O
compared	O
to	O
75	O
%	O
-	O
78	O
%	O
for	O
younger	O
patients	O
.	O
functional	O
patency	B-T038
at	O
2	O
years	O
was	O
69	O
%	O
for	O
those	O
aged	O
>	O
75	O
years	O
compared	O
to	O
78	O
%	O
-	O
81	O
%	O
for	O
younger	O
patients	O
.	O
we	O
found	O
no	O
difference	O
in	O
avf	B-T017
maturation	B-T038
,	O
primary	O
patency	B-T038
,	O
complications	B-T038
,	O
or	O
interventions	B-T058
in	O
those	O
over	O
the	O
age	O
of	O
75	O
compared	O
to	O
younger	O
counterparts	O
.	O
while	O
secondary	O
and	O
functional	O
patency	B-T038
rates	O
were	O
significantly	O
lower	O
in	O
those	O
aged	O
>	O
75	O
years	O
,	O
the	O
magnitude	O
of	O
difference	O
is	O
likely	O
not	O
clinically	O
relevant	O
.	O
therefore	O
,	O
we	O
recommend	O
that	O
advanced	B-T098
age	I-T098
alone	O
should	O
not	O
preclude	O
patients	O
from	O
avf	B-T017
creation	O
.	O

evaluating	O
the	O
relative	O
effectiveness	O
of	O
high	B-T170
-	I-T170
intensity	I-T170
and	O
low	O
-	O
intensity	O
models	O
of	O
behaviour	O
change	O
communication	B-T058
interventions	I-T058
for	O
abortion	B-T033
care	O
-	O
seeking	O
in	O
bi	O
##har	O
and	O
jh	O
##ark	O
##hand	O
,	O
india	B-T082
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
this	O
study	O
aimed	O
to	O
compare	O
the	O
effectiveness	O
of	O
a	O
high	B-T170
-	I-T170
intensity	I-T170
model	I-T170
(	O
him	B-T170
)	O
and	O
a	O
low	O
-	O
intensity	O
model	O
(	O
lim	O
)	O
of	O
behaviour	O
change	O
communication	B-T058
interventions	I-T058
in	O
bi	O
##har	O
and	O
jh	O
##ark	O
##hand	O
states	O
of	O
india	B-T082
designed	O
to	O
improve	O
women	B-T098
'	I-T098
s	I-T098
knowledge	B-T033
and	O
usage	O
of	O
safe	B-T033
abortion	I-T033
services	O
,	O
as	O
well	O
as	O
the	O
dose	O
effect	O
of	O
intervention	B-T058
exposure	O
.	O
we	O
conducted	O
two	O
cross	B-T062
-	I-T062
sectional	I-T062
household	I-T062
surveys	I-T062
among	O
married	B-T033
women	B-T098
aged	O
15	O
-	O
49	O
years	O
in	O
intervention	B-T058
and	O
comparison	O
districts	O
.	O
difference	O
-	O
in	O
-	O
difference	O
models	O
were	O
used	O
to	O
assess	O
the	O
efficacy	O
of	O
the	O
intervention	B-T058
,	O
adjusting	O
for	O
sociodemographic	B-T033
characteristics	I-T033
.	O
although	O
both	O
intervention	B-T058
types	O
improved	O
abortion	B-T033
knowledge	B-T170
,	O
the	O
him	B-T170
intervention	B-T058
was	O
more	O
effective	O
in	O
improving	O
comprehensive	B-T170
knowledge	I-T170
about	O
abortion	B-T033
.	O
in	O
particular	O
,	O
there	O
were	O
improvements	O
in	O
knowledge	B-T170
on	O
legal	B-T058
##ity	I-T058
of	I-T058
abortion	I-T058
(	O
aor	O
=	O
2	O
.	O
2	O
;	O
95	O
%	O
ci	O
1	O
.	O
6	O
to	O
2	O
.	O
9	O
)	O
and	O
nearby	O
sources	O
of	O
safe	B-T058
abortion	I-T058
care	I-T058
(	O
aor	O
=	O
1	O
.	O
7	O
;	O
95	O
%	O
ci	O
1	O
.	O
2	O
to	O
1	O
.	O
3	O
)	O
.	O
higher	O
level	O
of	O
exposure	O
to	O
abortion	O
-	O
related	O
messages	O
was	O
related	O
to	O
more	O
accurate	O
knowledge	B-T170
about	O
abortion	B-T033
within	O
both	O
intervention	B-T058
groups	O
.	O
evidence	O
was	O
mixed	O
on	O
changes	O
in	O
abortion	B-T033
care	O
-	O
seeking	O
behaviour	O
.	O
more	O
work	O
is	O
needed	O
to	O
ensure	O
that	O
women	B-T098
seek	O
safe	B-T033
abortion	I-T033
services	O
in	O
lie	O
##u	O
of	O
informal	O
services	O
that	O
may	O
be	O
more	O
likely	O
to	O
lead	O
to	O
post	B-T038
##ab	I-T038
##ortion	I-T038
complications	I-T038
.	O

the	O
platelet	B-T103
-	I-T103
activating	I-T103
receptor	I-T103
c	B-T103
-	I-T103
type	I-T103
lectin	I-T103
receptor	I-T103
-	I-T103
2	I-T103
plays	O
an	O
essential	O
role	O
in	O
liver	B-T038
regeneration	I-T038
after	O
partial	B-T058
hepatectomy	I-T058
in	O
mice	B-T204
essential	O
##s	O
regeneration	B-T038
role	O
of	O
c	B-T103
-	I-T103
type	I-T103
lectin	I-T103
receptor	I-T103
-	I-T103
2	I-T103
(	O
cle	B-T103
##c	I-T103
-	I-T103
2	I-T103
)	O
after	O
70	B-T058
%	I-T058
hepatectomy	I-T058
(	O
hp	B-T058
##x	I-T058
)	O
was	O
investigated	O
.	O
wild	B-T017
-	I-T017
type	I-T017
or	O
cle	B-T017
##c	I-T017
-	I-T017
2	I-T017
deleted	B-T038
from	O
platelets	B-T017
of	O
chimeric	B-T204
mice	I-T204
(	O
fl	B-T204
##ko	I-T204
)	O
underwent	O
hp	B-T058
##x	I-T058
.	O
the	O
liver	O
/	O
body	O
weight	O
ratio	O
was	O
significantly	O
lower	O
in	O
the	O
fl	B-T204
##ko	I-T204
than	O
in	O
the	O
wild	B-T204
-	I-T204
type	I-T204
.	O
cle	B-T103
##c	I-T103
-	I-T103
2	I-T103
plays	O
an	O
essential	O
role	O
in	O
liver	B-T038
regeneration	I-T038
after	O
hp	B-T058
##x	I-T058
.	O
background	O
and	O
aim	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
c	B-T103
-	I-T103
type	I-T103
lectin	I-T103
receptor	I-T103
(	I-T103
cle	I-T103
##c	I-T103
)	I-T103
-	I-T103
2	I-T103
in	O
liver	B-T038
regeneration	I-T038
following	O
partial	B-T058
liver	I-T058
resection	I-T058
in	O
mice	B-T204
.	O
materials	O
and	O
methods	O
irradiated	O
chimeric	B-T204
mice	I-T204
transplanted	O
with	O
fetal	O
liver	B-T017
cells	I-T017
from	O
wild	B-T204
-	I-T204
type	I-T204
(	I-T204
wt	I-T204
)	I-T204
mice	I-T204
,	O
cle	B-T017
##c	I-T017
-	I-T017
2	I-T017
-	O
deleted	B-T038
(	O
ko	O
)	O
mice	B-T204
or	O
mice	B-T204
with	O
cle	B-T017
##c	I-T017
-	I-T017
2	I-T017
deleted	B-T038
specifically	O
from	O
platelets	B-T017
(	O
fl	O
##ko	O
)	O
were	O
generated	O
.	O
mice	B-T204
underwent	O
70	B-T058
%	I-T058
partial	I-T058
hepatectomy	I-T058
(	O
ph	B-T058
)	O
.	O
immunohistochemical	B-T058
staining	I-T058
was	O
performed	O
to	O
investigate	O
the	O
expression	B-T038
of	O
the	O
endogenous	O
ligand	B-T103
for	O
cle	B-T103
##c	I-T103
-	I-T103
2	I-T103
,	O
pod	B-T103
##oplanin	I-T103
.	O
the	O
accumulation	B-T038
of	O
platelets	B-T017
in	O
the	O
liver	B-T017
was	O
also	O
quantified	O
.	O
the	O
hepatic	B-T082
expression	B-T038
of	O
the	O
il	B-T103
-	I-T103
6	I-T103
/	O
gp	B-T103
##130	I-T103
and	O
stat3	B-T103
,	O
akt	B-T103
and	O
erk1	B-T103
/	I-T103
2	I-T103
was	O
also	O
examined	O
.	O
results	O
the	O
liver	O
/	O
body	O
weight	O
ratio	O
and	O
expression	B-T038
of	O
all	O
cell	B-T038
proliferation	I-T038
markers	B-T058
were	O
significantly	O
lower	O
in	O
the	O
fl	B-T204
##ko	I-T204
group	I-T204
than	O
in	O
the	O
wt	B-T204
group	I-T204
.	O
the	O
expression	B-T038
of	O
phosphorylated	B-T103
(	I-T103
p	I-T103
)	I-T103
akt	I-T103
and	O
per	B-T103
##k1	I-T103
/	O
2	O
was	O
similar	O
in	O
the	O
wt	B-T204
and	O
fl	B-T204
##ko	I-T204
groups	I-T204
.	O
on	O
the	O
other	O
hand	O
,	O
the	O
expression	B-T038
of	O
pst	B-T103
##at	I-T103
##3	I-T103
and	O
il	B-T103
-	I-T103
6	I-T103
was	O
significantly	O
stronger	O
in	O
the	O
wt	B-T204
group	I-T204
than	O
in	O
the	O
fl	B-T204
##ko	I-T204
group	I-T204
.	O
the	O
expression	B-T038
of	O
pod	B-T103
##oplanin	I-T103
was	O
detected	O
in	O
the	O
hepatic	B-T017
sinus	I-T017
##oids	I-T017
of	O
both	O
groups	O
.	O
however	O
,	O
the	O
extent	O
to	O
which	O
platelets	B-T017
accumulated	O
in	O
hepatic	B-T017
sinus	I-T017
##oids	I-T017
was	O
significantly	O
less	O
in	O
the	O
fl	B-T204
##ko	I-T204
group	I-T204
than	O
in	O
the	O
wt	B-T204
group	I-T204
.	O
conclusion	O
cle	B-T103
##c	I-T103
-	I-T103
2	I-T103
was	O
involved	O
in	O
hepatic	B-T038
regeneration	I-T038
after	O
liver	B-T058
resection	I-T058
and	O
cle	B-T103
##c	I-T103
-	I-T103
2	I-T103
-	O
related	O
liver	B-T038
regeneration	I-T038
was	O
attributed	O
to	O
the	O
interaction	O
between	O
platelets	B-T017
and	O
sinusoidal	B-T082
endothelial	B-T017
cells	I-T017
.	O

individual	B-T098
classification	B-T170
of	O
strong	O
risk	O
attitudes	B-T038
:	O
an	O
application	O
across	O
lot	O
##ter	O
##y	O
types	O
and	O
age	O
groups	O
empirical	O
evaluations	O
of	O
risk	O
attitudes	B-T038
often	O
rely	O
on	O
a	O
weak	O
definition	B-T170
of	O
risk	O
that	O
concerns	O
preferences	O
towards	O
risky	O
and	O
risk	O
##less	O
options	O
(	O
e	O
.	O
g	O
.	O
,	O
a	O
lot	O
##ter	O
##y	O
vs	O
.	O
a	O
sure	O
outcome	O
)	O
.	O
a	O
large	O
body	O
of	O
work	O
has	O
shown	O
that	O
individuals	B-T098
tend	O
to	O
be	O
weak	O
risk	O
avers	O
##e	O
in	O
choice	O
contexts	O
involving	O
risky	O
and	O
risk	O
##less	O
gains	O
but	O
weak	O
risk	O
seeking	O
in	O
contexts	O
involving	O
losses	O
,	O
a	O
phenomenon	O
known	O
as	O
the	O
reflection	O
effect	O
.	O
recent	O
attempts	O
to	O
evaluate	O
age	O
differences	O
in	O
risk	O
attitudes	B-T038
have	O
relied	O
on	O
this	O
weak	O
definition	B-T170
,	O
testing	O
whether	O
the	O
reflection	O
effect	O
increases	O
or	O
diminishes	O
as	O
we	O
grow	O
older	O
.	O
the	O
present	O
work	O
argues	O
that	O
weak	O
risk	O
attitudes	B-T038
have	O
limited	O
general	O
##izability	O
and	O
proposes	O
the	O
use	O
of	O
a	O
strong	O
definition	B-T170
of	O
risk	O
that	O
is	O
concerned	O
with	O
preferences	O
towards	O
options	O
with	O
the	O
same	O
expected	O
value	O
but	O
different	O
degrees	O
of	O
risk	O
(	O
i	O
.	O
e	O
.	O
,	O
outcome	O
variance	O
)	O
.	O
a	O
re	B-T062
##analysis	I-T062
of	O
previously	O
-	O
published	O
data	O
and	O
the	O
results	O
from	O
a	O
new	O
study	O
show	O
that	O
only	O
a	O
minority	O
of	O
individuals	B-T098
manifests	O
the	O
reflection	O
effect	O
under	O
a	O
strong	O
definition	B-T170
of	O
risk	O
,	O
and	O
that	O
,	O
when	O
facing	O
certain	O
lot	O
##ter	O
##y	O
-	O
pair	O
types	O
,	O
older	B-T098
adults	I-T098
appear	O
to	O
be	O
more	O
risk	O
seeking	O
than	O
younger	O
adults	O
.	O

examining	O
the	O
contribution	O
of	O
motor	O
movement	O
and	O
language	O
dominance	O
to	O
increased	O
left	B-T082
lateralization	B-T038
during	O
sign	O
generation	O
in	O
native	O
sign	B-T098
##ers	I-T098
the	O
neural	B-T022
systems	I-T022
supporting	O
speech	B-T038
and	O
sign	O
processing	B-T038
are	O
very	O
similar	O
,	O
although	O
not	O
identical	O
.	O
in	O
a	O
previous	O
ft	B-T062
##cd	I-T062
study	I-T062
of	O
hearing	B-T038
native	O
sign	B-T098
##ers	I-T098
(	O
gut	O
##ier	O
##re	O
##z	O
-	O
sig	O
##ut	O
,	O
daw	O
##s	O
,	O
et	O
al	O
.	O
,	O
2015	O
)	O
we	O
found	O
stronger	O
left	B-T082
lateralization	B-T038
for	O
sign	O
than	O
speech	B-T038
.	O
given	O
that	O
this	O
increased	O
lateralization	B-T038
could	O
not	O
be	O
explained	O
by	O
hand	B-T017
movement	B-T038
alone	O
,	O
the	O
contribution	O
of	O
motor	O
movement	O
versus	O
'	O
linguistic	O
'	O
processes	B-T038
to	O
the	O
strength	O
of	O
hemispheric	B-T082
lateralization	B-T038
during	O
sign	O
production	B-T038
remains	O
unclear	O
.	O
here	O
we	O
directly	O
contrast	O
lateralization	B-T038
strength	O
of	O
cover	O
##t	O
versus	O
overt	O
sign	O
##ing	O
during	O
phonological	O
and	O
semantic	O
fluency	O
tasks	O
.	O
to	O
address	O
the	O
possibility	O
that	O
hearing	B-T038
native	O
sign	B-T098
##ers	I-T098
'	O
elevated	O
lateralization	O
indices	O
(	O
lis	O
)	O
were	O
due	O
to	O
performing	O
a	O
task	O
in	O
their	O
less	O
dominant	O
language	O
,	O
here	O
we	O
test	O
deaf	O
native	O
sign	B-T098
##ers	I-T098
,	O
whose	O
dominant	O
language	O
is	O
british	O
sign	O
language	O
(	O
bs	O
##l	O
)	O
.	O
sign	B-T098
##ers	I-T098
were	O
more	O
strongly	O
left	B-T082
lateral	B-T038
##ized	I-T038
for	O
overt	O
than	O
cover	O
##t	O
sign	O
generation	O
.	O
however	O
,	O
the	O
strength	O
of	O
lateralization	B-T038
was	O
not	O
correlated	O
with	O
the	O
amount	O
of	O
time	O
producing	O
movements	B-T038
of	O
the	O
right	B-T017
hand	I-T017
.	O
comparisons	O
with	O
previous	O
data	O
from	O
hearing	B-T038
native	O
english	O
speakers	B-T098
suggest	O
stronger	O
laterality	O
indices	O
for	O
sign	O
than	O
speech	B-T038
in	O
both	O
cover	O
##t	O
and	O
overt	O
tasks	O
.	O
this	O
increased	O
left	B-T082
lateralization	B-T038
may	O
be	O
driven	O
by	O
specific	O
properties	O
of	O
sign	O
production	B-T038
such	O
as	O
the	O
increased	O
use	O
of	O
self	O
-	O
monitoring	O
mechanisms	O
or	O
the	O
nature	O
of	O
phonological	B-T038
encoding	I-T038
of	O
signs	O
.	O

effects	O
of	O
static	B-T058
cold	I-T058
storage	I-T058
and	O
hypothermic	B-T058
machine	I-T058
perfusion	I-T058
on	O
oxidative	B-T058
stress	I-T058
factors	I-T058
,	O
adhesion	B-T103
molecules	I-T103
,	O
and	O
zinc	B-T103
finger	I-T103
transcription	I-T103
factor	I-T103
proteins	I-T103
before	O
and	O
after	O
liver	B-T058
transplantation	I-T058
background	O
this	O
study	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
static	B-T058
cold	I-T058
storage	I-T058
(	O
scs	B-T058
)	O
and	O
hypothermic	B-T058
machine	I-T058
perfusion	I-T058
(	O
hm	B-T058
##p	I-T058
)	O
on	O
the	O
oxidative	B-T058
stress	I-T058
factors	I-T058
(	O
os	B-T058
##f	I-T058
)	O
,	O
adhesion	B-T103
molecules	I-T103
(	O
am	B-T103
)	O
,	O
and	O
zinc	B-T103
finger	I-T103
transcription	I-T103
factor	I-T103
(	O
snail	B-T103
)	O
before	O
and	O
after	O
liver	B-T058
transplantation	I-T058
.	O
material	O
and	O
methods	O
experimental	O
dogs	B-T204
were	O
randomly	O
divided	O
into	O
donor	O
(	O
group	O
a	O
)	O
,	O
scs	B-T058
(	O
group	O
b	O
)	O
,	O
and	O
hm	B-T058
##p	I-T058
(	O
group	O
c	O
)	O
(	O
n	O
=	O
30	O
)	O
groups	O
.	O
livers	B-T058
retrieved	I-T058
from	O
group	O
a	O
were	O
transplanted	B-T058
into	O
group	O
b	O
after	O
scs	B-T058
,	O
and	O
the	O
livers	B-T017
sampled	O
from	O
group	O
b	O
were	O
transplanted	B-T058
into	O
group	O
c	O
after	O
hm	B-T058
##p	I-T058
.	O
the	O
dogs	O
in	O
group	O
a	O
were	O
euthanized	O
and	O
disc	O
##arded	O
,	O
and	O
the	O
livers	B-T017
sampled	O
from	O
group	O
c	O
were	O
used	O
for	O
other	O
experiments	O
.	O
twenty	O
dogs	B-T204
with	O
successful	O
liver	B-T058
transplants	I-T058
were	O
randomly	O
selected	O
from	O
groups	O
b	O
and	O
c	O
for	O
analysis	O
.	O
results	O
during	O
the	O
liver	B-T017
sampling	B-T062
process	I-T062
,	O
the	O
levels	O
of	O
os	B-T058
##f	I-T058
,	O
am	B-T103
,	O
and	O
snail	O
between	O
the	O
2	O
groups	O
showed	O
no	O
significant	O
differences	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
;	O
before	O
the	O
transplantation	B-T058
,	O
the	O
levels	O
of	O
chemokine	B-T103
cxcl	I-T103
##14	I-T103
and	O
snail	B-T103
between	O
the	O
2	O
groups	O
showed	O
no	O
significant	O
differences	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
,	O
and	O
compared	O
with	O
group	O
b	O
,	O
hif	O
-	O
1α	O
and	O
p	B-T103
-	I-T103
selectin	I-T103
in	O
group	O
c	O
were	O
lower	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
;	O
60	O
min	O
after	O
the	O
transplantation	B-T058
,	O
hif	B-T103
-	I-T103
1α	I-T103
,	O
chemokine	B-T103
cxcl	I-T103
##14	I-T103
,	O
p	B-T103
-	I-T103
selectin	I-T103
,	O
and	O
snail	B-T103
in	O
group	O
c	O
were	O
lower	O
than	O
that	O
in	O
group	O
b	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
conclusions	O
hm	B-T058
##p	I-T058
can	O
significantly	O
reduce	O
the	O
levels	O
of	O
os	B-T058
##f	I-T058
and	O
inflammatory	O
factors	O
,	O
which	O
is	O
conduc	B-T033
##ive	I-T033
for	O
liver	B-T058
transplantation	I-T058
.	O

effect	O
of	O
peritoneal	B-T058
lavage	I-T058
solution	O
temperature	O
on	O
body	O
temperature	O
in	O
anaesthe	B-T033
##tised	I-T033
cats	B-T204
and	O
small	O
dogs	B-T204
a	O
prospective	B-T062
,	O
randomised	B-T062
,	O
non	B-T062
-	I-T062
blinded	I-T062
,	O
clinical	B-T062
study	I-T062
to	O
assess	O
the	O
effect	O
of	O
peritoneal	B-T058
lavage	I-T058
using	O
warm	O
##ed	O
fluid	O
on	O
body	O
temperature	O
in	O
anesth	B-T033
##eti	I-T033
##se	I-T033
##d	I-T033
cats	B-T204
and	O
dogs	B-T204
of	O
less	O
than	O
10	O
kg	O
body	O
mass	O
undergoing	O
coel	B-T058
##io	I-T058
##to	I-T058
##my	I-T058
.	O
a	O
standardised	B-T170
anaesthetic	I-T170
protocol	I-T170
was	O
used	O
.	O
oesophageal	B-T058
and	O
rectal	B-T033
temperatures	I-T033
were	O
measured	O
at	O
various	O
time	O
points	O
.	O
at	O
the	O
end	O
of	O
surgery	B-T058
,	O
group	O
1	O
patients	O
(	O
n	O
=	O
10	O
)	O
were	O
lavage	B-T058
##d	I-T058
with	O
200	O
ml	O
/	O
kg	O
sterile	O
isotonic	B-T103
saline	I-T103
at	O
34	O
##±1	O
##°c	O
and	O
group	O
2	O
(	O
n	O
=	O
10	O
)	O
at	O
40	O
##±1	O
##°c	O
.	O
groups	O
were	O
similar	O
with	O
respect	O
to	O
age	O
,	O
mass	O
,	O
body	O
condition	O
and	O
surgical	B-T058
incision	I-T058
length	O
.	O
duration	O
of	O
anaesthesia	B-T058
,	O
surgical	B-T058
procedures	I-T058
and	O
peritoneal	B-T058
lavage	I-T058
was	O
similar	O
between	O
groups	O
.	O
linear	O
regression	O
showed	O
no	B-T033
significant	I-T033
change	I-T033
in	O
oesophageal	B-T058
temperature	I-T058
during	O
the	O
lavage	B-T058
period	O
for	O
group	O
1	O
(	O
p	O
=	O
0	O
.	O
64	O
)	O
,	O
but	O
a	O
significant	O
increase	O
for	O
group	O
2	O
patients	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
with	O
mean	O
temperature	O
changes	O
of	O
-	O
0	O
.	O
5	O
##°c	O
(	O
from	O
(	O
36	O
.	O
3	O
##°c	O
to	O
35	O
.	O
9	O
##°c	O
)	O
and	O
+	O
0	O
.	O
9	O
##°c	O
(	O
from	O
35	O
.	O
4	O
##°c	O
to	O
36	O
.	O
3	O
##°c	O
)	O
,	O
respectively	O
.	O
similar	O
results	B-T033
were	O
found	O
for	O
rectal	B-T033
temperature	I-T033
,	O
with	O
mean	O
changes	O
of	O
-	O
0	O
.	O
5	O
##°c	O
and	O
+	O
0	O
.	O
8	O
##°c	O
(	O
p	O
=	O
0	O
.	O
92	O
##2	O
and	O
0	O
.	O
045	O
)	O
,	O
respectively	O
.	O
the	O
use	O
of	O
isotonic	B-T103
crystall	B-T103
##oid	I-T103
solution	I-T103
for	O
peritoneal	B-T058
lavage	I-T058
at	O
a	O
temperature	O
of	O
40	O
##±1	O
##°c	O
significantly	O
warm	O
##s	O
small	O
animal	O
patients	O
,	O
when	O
applied	O
in	O
a	O
clinical	O
setting	O
,	O
compared	O
with	O
lavage	B-T058
solution	O
at	O
34	O
##±1	O
##°c	O
.	O

who	O
pers	O
##ua	O
##des	O
who	O
?	O
an	O
analysis	B-T062
of	O
pers	O
##ua	O
##si	O
##on	O
choices	O
related	O
to	O
antibiotic	B-T103
-	O
free	O
food	B-T168
personal	O
communication	O
,	O
in	O
which	O
one	O
person	B-T098
pers	O
##ua	O
##des	O
another	O
to	O
engage	O
in	O
a	O
particular	O
behavior	O
,	O
is	O
one	O
means	O
through	O
which	O
behaviors	O
spread	O
.	O
to	O
better	O
understand	B-T038
how	O
personal	O
communication	O
spread	O
##s	O
behavior	O
,	O
we	O
investigated	O
adults	O
'	O
(	O
n	O
=	O
228	O
)	O
likelihood	O
of	O
pers	O
##ua	O
##ding	O
others	O
in	O
a	O
fic	O
##tit	O
##ious	O
social	B-T098
network	I-T098
to	O
bu	O
##y	O
antibiotic	B-T103
-	O
free	O
food	B-T168
,	O
and	O
who	O
they	O
attempted	O
to	O
pers	O
##ua	O
##de	O
,	O
based	O
on	O
behavioral	O
determinants	O
,	O
homo	O
##phi	O
##ly	O
,	O
and	O
super	O
##di	O
##ff	O
##use	O
##r	O
traits	O
.	O
for	O
potential	O
consumers	B-T098
,	O
the	O
findings	B-T033
showed	O
that	O
behavioral	O
determinants	O
,	O
behavioral	O
intentions	B-T038
,	O
and	O
ma	O
##ven	O
##ism	O
predicted	O
intentions	B-T038
to	O
pers	O
##ua	O
##de	O
others	O
.	O
homo	O
##phi	O
##ly	O
,	O
ma	O
##ven	O
##ism	O
,	O
and	O
connectivity	O
predicted	O
patterns	B-T082
of	O
interpersonal	O
pers	O
##ua	O
##si	O
##on	O
.	O
for	O
veget	B-T098
##arians	I-T098
(	O
without	O
homo	O
##phi	O
##ly	O
in	O
action	O
)	O
,	O
behavioral	O
determinants	O
and	O
ma	O
##ven	O
##ism	O
predicted	O
pers	O
##ua	O
##si	O
##on	O
intentions	B-T038
.	O
pers	O
##ua	O
##si	O
##ven	O
##ess	O
was	O
associated	O
with	O
targeting	O
more	O
network	B-T098
members	B-T098
;	O
ma	O
##ven	O
##ism	O
was	O
associated	O
with	O
selecting	O
structurally	B-T082
central	B-T082
members	B-T098
.	O

ct	B-T058
angiography	I-T058
for	O
planning	O
transcatheter	B-T058
aortic	I-T058
valve	I-T058
replacement	I-T058
using	O
automated	O
tube	O
voltage	O
selection	O
:	O
image	O
quality	O
and	O
radiation	O
exposure	O
to	O
assess	O
image	O
quality	O
and	O
accuracy	O
of	O
ct	B-T058
angiography	I-T058
(	O
cta	B-T058
)	O
for	O
transcatheter	B-T058
aortic	I-T058
valve	I-T058
replacement	I-T058
(	O
tav	B-T058
##r	I-T058
)	O
planning	O
performed	O
with	O
3rd	B-T058
generation	I-T058
dual	I-T058
-	I-T058
source	I-T058
ct	I-T058
(	O
dsc	B-T058
##t	I-T058
)	O
.	O
we	O
evaluated	O
125	O
patients	O
who	O
underwent	O
tav	B-T058
##r	I-T058
-	O
planning	O
cta	B-T058
on	O
3rd	B-T058
generation	I-T058
dsc	I-T058
##t	I-T058
.	O
a	O
two	B-T058
-	I-T058
part	I-T058
protocol	I-T058
was	O
performed	O
including	O
retrospectively	O
ecg	B-T058
-	I-T058
gated	I-T058
coronary	I-T058
cta	I-T058
(	O
cct	B-T058
##a	I-T058
)	O
and	O
prospectively	O
ecg	B-T058
-	I-T058
triggered	I-T058
aorto	I-T058
##iliac	I-T058
cta	I-T058
using	O
60	O
##ml	O
of	O
contrast	B-T103
medium	I-T103
.	O
automated	O
tube	O
voltage	O
selection	O
and	O
advanced	B-T058
iterative	I-T058
reconstruction	I-T058
were	O
applied	O
.	O
effective	O
dose	O
(	O
ed	O
)	O
,	O
signal	O
-	O
to	O
-	O
noise	O
(	O
snr	O
)	O
and	O
contrast	O
-	O
to	O
-	O
noise	O
ratios	O
(	O
cn	O
##r	O
)	O
were	O
calculated	O
.	O
five	B-T170
-	I-T170
point	I-T170
scales	I-T170
were	O
used	O
for	O
subjective	O
image	B-T058
quality	I-T058
analysis	I-T058
.	O
in	O
patients	O
who	O
underwent	O
tav	B-T058
##r	I-T058
,	O
si	B-T033
##zing	I-T033
parameters	I-T033
were	O
obtained	O
.	O
image	O
quality	O
was	O
rated	O
good	O
to	O
excellent	O
in	O
97	O
.	O
6	O
%	O
of	O
cct	B-T058
##a	I-T058
and	O
100	O
%	O
of	O
aorto	B-T058
##iliac	I-T058
cta	I-T058
##s	I-T058
.	O
cta	B-T058
studies	B-T062
at	O
>	O
100	O
##k	O
##v	O
showed	O
decreased	O
objective	O
image	O
quality	O
compared	O
to	O
70	O
-	O
100	O
##k	O
##v	O
(	O
snr	O
,	O
all	O
p	O
##≤	O
##0	O
.	O
045	O
##9	O
;	O
cn	O
##r	O
,	O
all	O
p	O
##≤	O
##0	O
.	O
046	O
##2	O
)	O
.	O
mean	O
ed	O
increased	O
continuously	O
from	O
70	O
to	O
>	O
100	O
##k	O
##v	O
(	O
cct	B-T058
##a	I-T058
:	O
4	O
.	O
5	O
##±1	O
.	O
7	O
##ms	O
##v	O
-	O
13	O
.	O
6	O
##±2	O
.	O
9	O
##ms	O
##v	O
,	O
all	O
p	O
##≤	O
##0	O
.	O
023	O
##3	O
;	O
aorto	B-T058
##iliac	I-T058
cta	I-T058
:	O
2	O
.	O
4	O
##±0	O
.	O
9	O
##ms	O
##v	O
-	O
6	O
.	O
8	O
##±2	O
.	O
7	O
##ms	O
##v	O
,	O
all	O
p	O
##≤	O
##0	O
.	O
041	O
##4	O
)	O
.	O
in	O
39	O
patients	O
tav	B-T058
##r	I-T058
was	O
performed	O
and	O
annulus	B-T017
diameter	O
was	O
within	O
the	O
recommended	O
range	O
in	O
all	O
patients	O
.	O
no	B-T033
severe	O
cardiac	B-T038
or	O
vascular	B-T038
complications	I-T038
were	O
noted	O
.	O
3rd	B-T058
generation	I-T058
dsc	I-T058
##t	I-T058
provides	O
diagnostic	O
image	O
quality	O
in	O
tav	B-T058
##r	I-T058
-	O
planning	O
cta	B-T058
and	O
facilitates	O
reliable	O
assessment	B-T058
of	O
tav	B-T058
##r	I-T058
device	B-T074
and	O
delivery	O
option	O
while	O
reducing	O
radiation	O
dose	O
.	O

adverse	B-T038
events	I-T038
risk	O
associated	O
with	O
angiogenesis	B-T103
inhibitors	I-T103
addition	O
to	O
therapy	B-T058
in	O
ovarian	B-T038
cancer	I-T038
:	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
randomized	B-T062
controlled	I-T062
trials	I-T062
inhibition	B-T038
of	I-T038
angiogenesis	I-T038
has	O
been	O
regarded	O
as	O
an	O
attractive	O
treatment	B-T058
strategy	I-T058
for	O
advanced	B-T038
or	O
recurrent	B-T038
ovarian	I-T038
cancer	I-T038
.	O
we	O
conduct	O
this	O
meta	B-T062
-	I-T062
analysis	I-T062
to	O
investigate	O
the	O
risk	O
of	O
adverse	B-T038
events	I-T038
of	O
special	O
interest	O
related	O
to	O
angiogenesis	B-T103
inhibitors	I-T103
(	O
ais	B-T103
)	O
in	O
ovarian	B-T038
cancer	I-T038
.	O
databases	B-T170
from	O
pubmed	B-T170
,	O
web	B-T170
of	I-T170
science	I-T170
and	O
cochrane	B-T092
library	I-T092
up	O
to	O
december	O
2015	O
were	O
searched	O
to	O
identify	O
relevant	O
studies	B-T062
.	O
eligible	O
studies	B-T062
included	O
prospective	B-T062
randomized	I-T062
controlled	I-T062
phase	I-T062
ii	I-T062
/	I-T062
iii	I-T062
clinical	I-T062
trials	I-T062
evaluating	B-T058
therapy	B-T058
with	O
or	O
without	O
ais	B-T103
for	O
ovarian	B-T038
cancer	I-T038
.	O
summary	O
relative	O
risk	O
(	O
rr	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
cis	O
)	O
were	O
calculated	O
using	O
random	O
-	O
effects	O
or	O
fixed	O
-	O
effects	O
according	O
to	O
the	O
heterogeneity	O
among	O
included	O
trials	B-T062
.	O
a	O
total	O
of	O
7	O
,	O
76	O
##1	O
patients	O
from	O
ten	O
clinical	B-T062
trials	I-T062
were	O
included	O
in	O
the	O
meta	B-T062
-	I-T062
analysis	I-T062
.	O
pooled	O
rr	O
showed	O
that	O
the	O
use	O
of	O
ais	B-T103
was	O
associated	O
with	O
a	O
statistically	O
increased	O
risk	O
in	O
four	O
of	O
the	O
adverse	O
outcomes	O
studied	O
:	O
arterial	B-T038
thromboembolic	I-T038
events	O
(	O
rr	O
=	O
2	O
.	O
0	O
)	O
,	O
gastrointestinal	B-T038
(	I-T038
gi	I-T038
)	I-T038
perforation	I-T038
(	O
rr	O
=	O
3	O
.	O
86	O
)	O
,	O
proteinuria	B-T033
(	O
rr	O
=	O
2	O
.	O
44	O
)	O
,	O
and	O
hypertension	B-T038
(	O
rr	O
=	O
5	O
.	O
39	O
)	O
.	O
no	O
statistically	O
significant	O
differences	O
were	O
found	O
for	O
hemorrhagic	B-T038
events	O
(	O
p	O
=	O
0	O
.	O
07	O
)	O
,	O
venous	B-T038
thromboembolic	I-T038
events	O
(	O
p	O
=	O
0	O
.	O
13	O
)	O
,	O
or	O
fatal	O
adverse	B-T038
events	I-T038
(	O
p	O
=	O
0	O
.	O
26	O
)	O
.	O
the	O
addition	O
of	O
ais	B-T103
to	O
therapy	B-T058
in	O
ovarian	B-T038
cancer	I-T038
did	O
significantly	O
increase	O
the	O
risk	O
of	O
arterial	B-T038
thromboembolic	I-T038
events	O
,	O
gi	B-T038
perforation	I-T038
,	O
proteinuria	B-T033
and	O
hypertension	B-T038
,	O
but	O
not	O
for	O
venous	B-T038
thromboembolic	I-T038
events	O
,	O
hemorrhagic	B-T038
events	O
,	O
or	O
fatal	O
adverse	B-T038
events	I-T038
.	O

results	O
for	O
patients	O
with	O
sarcoma	B-T038
not	O
otherwise	O
specified	O
and	O
other	O
diagnoses	B-T033
than	O
ewing	B-T038
sarcoma	I-T038
treated	B-T033
according	O
to	O
the	O
euro	B-T062
-	I-T062
ewing	I-T062
99	I-T062
trial	I-T062
euro	B-T062
-	I-T062
ewing	I-T062
99	I-T062
trial	I-T062
of	O
the	O
european	B-T098
ewing	B-T038
tumor	I-T038
working	O
initiative	B-T033
of	O
national	B-T092
groups	O
(	O
ee	B-T170
##99	I-T170
)	O
was	O
an	O
international	O
phase	B-T062
iii	I-T062
study	I-T062
in	O
patients	O
with	O
ewing	B-T038
sarcoma	I-T038
.	O
the	O
german	B-T092
society	I-T092
of	I-T092
pediatric	I-T092
oncology	I-T092
and	I-T092
hematology	I-T092
(	I-T092
gp	I-T092
##oh	I-T092
)	I-T092
data	I-T092
center	I-T092
registered	B-T058
and	O
followed	O
patients	O
with	O
other	O
diagnoses	B-T033
than	O
ewing	B-T038
sarcoma	I-T038
who	O
were	O
treated	B-T033
according	O
to	O
the	O
ee	B-T170
##99	I-T170
protocol	I-T170
in	O
an	O
additional	O
non	B-T170
-	I-T170
ewing	I-T170
database	I-T170
.	O
data	O
of	O
27	O
patients	O
with	O
other	O
diagnoses	B-T033
than	O
ewing	B-T038
sarcoma	I-T038
treated	B-T033
according	O
to	O
the	O
ee	B-T170
##99	I-T170
protocol	I-T170
were	O
analyzed	B-T062
.	O
patients	O
had	O
misc	O
##ella	O
##ne	O
##ous	O
histologic	O
diagnoses	B-T033
,	O
the	O
majority	O
were	O
diagnosed	B-T033
with	O
sarcoma	B-T038
not	O
otherwise	O
specified	O
(	O
nos	O
)	O
arising	O
in	O
bone	B-T017
and	O
soft	B-T017
tissue	I-T017
(	O
63	O
%	O
)	O
.	O
the	O
median	O
age	O
at	O
diagnosis	B-T033
was	O
16	O
.	O
9	O
years	O
(	O
range	O
4	O
.	O
5	O
-	O
41	O
.	O
4	O
)	O
.	O
localized	B-T038
disease	I-T038
was	O
diagnosed	B-T033
in	O
61	O
.	O
5	O
%	O
of	O
the	O
patients	O
and	O
38	O
.	O
5	O
%	O
had	O
distant	B-T038
metastases	I-T038
at	O
time	O
of	O
primary	O
diagnosis	B-T033
.	O
the	O
median	O
follow	B-T058
-	I-T058
up	I-T058
time	O
was	O
3	O
.	O
7	O
years	O
(	O
range	O
0	O
.	O
5	O
-	O
9	O
.	O
5	O
)	O
.	O
patients	O
with	O
localized	B-T038
disease	I-T038
showed	O
a	O
3	O
-	O
year	O
event	O
-	O
free	O
survival	O
(	O
efs	O
)	O
of	O
68	O
%	O
,	O
compared	O
to	O
3	O
-	O
year	O
efs	O
of	O
20	O
%	O
in	O
patients	O
with	O
metastases	B-T038
(	O
p	O
=	O
0	O
.	O
042	O
)	O
.	O
three	O
-	O
year	O
efs	O
for	O
patients	O
with	O
sarcoma	B-T038
nos	O
was	O
52	O
%	O
,	O
patients	O
with	O
localized	B-T038
and	O
metastatic	B-T038
disease	I-T038
showed	O
3	O
-	O
year	O
efs	O
of	O
66	O
and	O
20	O
%	O
,	O
respectively	O
.	O
efs	O
in	O
patients	O
with	O
other	O
diagnoses	B-T033
than	O
ewing	B-T038
sarcoma	I-T038
treated	B-T033
according	O
to	O
ee	B-T170
##99	I-T170
was	O
significantly	O
higher	O
in	O
patients	O
with	O
localized	B-T038
than	O
metastatic	B-T038
disease	I-T038
.	O
sarcomas	B-T038
of	O
soft	B-T017
tissue	I-T017
and	O
bone	B-T017
that	O
cann	O
##ot	O
be	O
classified	B-T170
to	O
current	O
diagnostic	O
categories	O
constitute	O
a	O
therapeutic	O
challenge	B-T058
.	O

early	O
high	O
school	O
engagement	O
in	O
students	B-T098
with	O
attention	B-T038
/	I-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
students	B-T098
with	O
attention	B-T038
/	I-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
continue	O
to	O
langu	O
##ish	O
behind	O
their	O
peers	B-T098
with	O
regard	O
to	O
academic	O
achievement	O
and	O
education	B-T033
attainment	I-T033
.	O
school	O
engagement	O
is	O
potentially	O
modifiable	O
,	O
and	O
targeting	O
engagement	O
may	O
be	O
a	O
means	O
to	O
improve	O
education	O
outcomes	O
.	O
to	O
investigate	O
school	O
engagement	O
for	O
students	B-T098
with	O
adhd	B-T038
during	O
the	O
crucial	O
high	O
school	O
transition	O
period	O
and	O
to	O
identify	O
factors	O
associated	O
with	O
low	B-T033
school	I-T033
engagement	I-T033
.	O
participants	B-T098
are	O
adolescents	O
(	O
12	O
-	O
15	O
years	O
)	O
in	O
the	O
first	O
and	O
third	O
year	O
of	O
high	B-T092
school	I-T092
with	O
diagnosed	B-T062
adhd	B-T038
(	O
n	O
=	O
130	O
)	O
.	O
participants	B-T098
were	O
recruited	O
from	O
21	O
paediatric	B-T091
practices	O
.	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
assessing	O
school	O
engagement	O
.	O
data	O
were	O
collected	O
through	O
direct	O
assessment	B-T058
and	O
child	O
,	O
parent	O
,	O
and	O
teacher	B-T097
surveys	B-T170
.	O
school	O
engagement	O
is	O
measured	O
as	O
student	O
attitudes	O
to	O
school	B-T092
(	O
cognitive	B-T038
and	O
emotional	B-T038
)	O
and	O
suspension	O
rates	O
(	O
behavioural	O
)	O
.	O
multivariable	B-T170
regression	I-T170
analyses	I-T170
examined	O
student	B-T098
,	O
family	O
,	O
and	O
school	O
factors	O
affecting	O
engagement	O
.	O
in	O
comparison	O
with	O
state	O
data	O
,	O
students	B-T098
with	O
adhd	B-T038
in	O
the	O
first	O
year	O
of	O
high	B-T092
school	I-T092
were	O
less	O
motivated	O
(	O
p	O
<	O
.	O
01	O
)	O
and	O
less	O
connected	O
to	O
peers	B-T098
(	O
p	O
<	O
.	O
01	O
)	O
.	O
overall	O
,	O
there	O
was	O
no	O
discordance	O
in	O
third	O
year	O
attitudes	B-T038
.	O
there	O
were	O
high	B-T033
rates	I-T033
of	I-T033
suspension	I-T033
in	O
both	O
years	O
in	O
comparison	O
to	O
state	O
-	O
wide	O
suspensions	O
(	O
21	O
%	O
vs	O
.	O
6	O
%	O
,	O
p	O
<	O
.	O
01	O
)	O
.	O
explanatory	O
factors	O
for	O
poor	O
attitudes	B-T038
include	O
adolescent	O
depression	B-T038
,	O
poor	O
adolescent	O
supervision	B-T058
,	O
and	O
dev	B-T038
##alu	I-T038
##ing	I-T038
education	O
.	O
conduct	O
problems	O
and	O
increased	O
hyperactivity	B-T038
were	O
related	O
to	O
increased	B-T033
likelihood	I-T033
of	I-T033
being	I-T033
suspended	I-T033
,	O
whilst	O
higher	O
cognitive	B-T038
ability	I-T038
,	O
family	O
socio	O
-	O
economic	O
status	O
,	O
and	O
independent	O
schools	B-T092
reduced	O
risk	O
.	O
potentially	O
modifiable	O
individual	B-T098
and	O
family	O
factors	O
including	O
adolescent	O
depression	B-T038
,	O
behavioural	B-T038
problems	I-T038
,	O
education	O
values	O
,	O
and	O
family	O
supervision	B-T058
could	O
be	O
targeted	O
to	O
better	O
manage	O
the	O
high	O
school	O
transition	O
for	O
students	B-T098
with	O
adhd	B-T038
.	O

safety	O
and	O
immuno	B-T062
##gene	I-T062
##ci	I-T062
##ty	I-T062
of	O
a	O
live	O
attenuated	B-T103
rif	B-T103
##t	I-T103
valley	I-T103
fever	I-T103
vaccine	I-T103
(	O
cl	B-T103
##13	I-T103
##t	I-T103
)	O
in	O
came	B-T204
##ls	I-T204
rif	B-T038
##t	I-T038
valley	I-T038
fever	I-T038
is	O
an	O
emerging	O
zoonotic	O
viral	B-T038
disease	I-T038
,	O
en	B-T038
##zo	I-T038
##otic	I-T038
and	O
endemic	B-T038
in	O
africa	B-T082
and	O
the	O
arabia	B-T082
##n	I-T082
penins	I-T082
##ula	I-T082
,	O
which	O
poses	O
a	O
significant	O
threat	O
to	O
both	O
human	B-T204
and	O
animal	B-T204
health	O
.	O
the	O
disease	B-T038
is	O
most	O
severe	O
in	O
ruminants	B-T204
causing	O
abortions	B-T038
in	O
pregnant	B-T038
animals	B-T204
,	O
especially	O
sheep	B-T204
animals	I-T204
and	O
high	O
mortality	O
in	O
young	O
populations	B-T098
.	O
high	O
mortality	O
rates	O
and	O
severe	O
clinical	O
manifestation	O
have	O
also	O
been	O
reported	B-T170
among	O
came	B-T204
##l	I-T204
populations	B-T098
in	O
africa	B-T082
,	O
to	O
attend	O
however	O
none	O
of	O
the	O
currently	O
available	O
live	B-T103
vaccines	I-T103
against	O
rv	B-T038
##f	I-T038
have	O
been	O
tested	O
for	O
safety	O
and	O
efficacy	O
in	O
this	O
species	B-T170
.	O
in	O
this	O
study	B-T062
,	O
the	O
safety	O
and	O
efficacy	O
(	O
through	O
a	O
neutralizing	B-T103
antibody	I-T103
response	O
)	O
of	O
the	O
thermost	B-T103
##able	I-T103
live	I-T103
attenuated	I-T103
rv	B-T103
##f	I-T103
cl	I-T103
##13	I-T103
##t	I-T103
vaccine	I-T103
were	O
evaluated	B-T058
in	O
came	B-T204
##ls	I-T204
in	O
two	O
different	O
preliminary	O
experiments	B-T062
involving	O
16	O
came	B-T204
##ls	I-T204
,	O
(	O
that	O
12	O
came	B-T204
##ls	I-T204
and	O
4	O
pregnant	B-T038
came	B-T204
##ls	I-T204
)	O
.	O
the	O
study	B-T062
revealed	O
that	O
the	O
cl	B-T103
##13	I-T103
##t	I-T103
vaccine	I-T103
was	O
safe	O
to	O
use	O
in	O
came	B-T204
##ls	I-T204
and	O
no	O
abortions	B-T038
or	O
teratogenic	B-T038
effects	I-T038
were	O
observed	O
.	O
the	O
single	O
dose	O
of	O
the	O
vaccine	B-T103
stimulated	O
a	O
strong	O
and	O
long	O
-	O
lasting	O
neutralizing	B-T103
antibody	I-T103
response	O
for	O
up	O
to	O
12	O
months	O
.	O
the	O
presence	B-T033
of	O
neutralization	B-T103
antibodies	I-T103
is	O
likely	O
to	O
correlate	O
with	O
protection	O
;	O
however	O
protection	O
would	O
need	O
to	O
be	O
confirmed	O
by	O
challenge	O
experiments	B-T062
using	O
the	O
virulent	O
rv	B-T005
##f	I-T005
virus	I-T005
.	O

green	O
and	O
rapid	O
synthesis	O
of	O
silver	B-T103
nanoparticles	O
using	O
bor	B-T204
##ago	I-T204
officinal	I-T204
##is	I-T204
leaf	B-T204
extract	B-T103
:	O
anticancer	B-T033
and	O
antibacterial	B-T033
activities	I-T033
this	O
study	O
highlights	O
the	O
facile	O
,	O
reliable	O
,	O
cost	O
effective	O
,	O
and	O
eco	O
##fr	O
##ie	O
##nd	O
##ly	O
synthesis	O
of	O
silver	B-T103
nanoparticles	O
(	O
agnps	O
)	O
using	O
bor	B-T204
##ago	I-T204
officinal	I-T204
##is	I-T204
leaves	B-T204
extract	B-T103
efficiently	O
.	O
the	O
biosynthesis	O
of	O
agnps	O
was	O
verified	O
by	O
uv	O
-	O
vis	O
spectrum	O
which	O
showed	O
the	O
surface	B-T062
plasmon	I-T062
resonance	I-T062
(	O
spr	B-T062
)	O
band	O
at	O
42	O
##2	O
nm	O
.	O
transmission	B-T058
electron	I-T058
microscope	I-T058
(	I-T058
tem	I-T058
)	I-T058
analysis	I-T058
revealed	O
that	O
the	O
particles	O
were	O
spherical	B-T082
,	O
hexagonal	B-T082
,	O
and	O
irregular	O
in	O
shape	B-T082
and	O
had	O
size	O
ranging	O
from	O
30	O
to	O
80	O
nm	O
.	O
the	O
energy	B-T058
dispersive	I-T058
x	I-T058
-	I-T058
ray	I-T058
spectroscopy	I-T058
(	O
ed	B-T058
##x	I-T058
)	O
and	O
elemental	B-T058
mapping	I-T058
have	O
displayed	O
the	O
purity	O
and	O
maximum	O
distribution	O
of	O
silver	B-T103
in	O
the	O
agnps	B-T103
.	O
the	O
crystalline	B-T103
nature	O
of	O
agnps	B-T103
had	O
been	O
identified	O
using	O
x	B-T058
-	I-T058
ray	I-T058
diffraction	I-T058
(	O
xrd	B-T058
)	O
and	O
selected	B-T058
area	I-T058
diffraction	I-T058
pattern	I-T058
(	O
sa	O
##ed	O
)	O
.	O
the	O
particle	O
size	O
analysis	O
revealed	O
that	O
the	O
z	O
-	O
average	O
diameter	O
of	O
the	O
agnps	B-T103
was	O
50	O
.	O
86	O
nm	O
with	O
polyd	O
##ispers	O
##ity	O
index	O
(	O
pdi	O
)	O
0	O
.	O
136	O
.	O
zeta	O
potential	O
analysis	O
displayed	O
the	O
colloidal	O
stability	O
of	O
agnps	B-T103
.	O
this	O
work	O
also	O
showed	O
the	O
efficacy	O
of	O
agnps	O
against	O
lung	B-T017
cancer	B-T017
cell	I-T017
lines	I-T017
(	O
a549	B-T017
)	O
and	O
cervical	B-T017
cancer	B-T017
cell	I-T017
line	I-T017
(	O
hela	B-T017
)	O
,	O
in	O
vitro	O
.	O
the	O
agnps	O
showed	O
cytotoxicity	B-T038
to	O
the	O
a549	B-T017
and	O
hela	B-T017
cancer	B-T017
cell	I-T017
line	I-T017
at	O
the	O
concentrations	O
5	O
and	O
2	O
μg	O
/	O
ml	O
.	O
the	O
agnps	B-T103
were	O
also	O
explored	O
for	O
the	O
antibacterial	B-T033
activity	I-T033
including	O
biofilm	B-T007
inhibition	O
against	O
pathogenic	B-T033
bacteria	B-T007
.	O
the	O
b	B-T204
.	I-T204
officinal	I-T204
##is	I-T204
leaves	B-T204
extract	B-T103
can	O
be	O
used	O
efficiently	O
for	O
green	O
synthesis	O
agnps	B-T103
.	O
the	O
biosynth	O
##esized	O
agnps	B-T103
demonstrated	O
potentials	O
as	O
anticancer	B-T103
and	O
antibacterial	B-T103
agents	I-T103
.	O
this	O
work	O
provides	O
helpful	O
insight	O
into	O
the	O
development	O
of	O
new	O
anticancer	B-T103
and	O
antimicrobial	B-T103
agents	I-T103
.	O

overcoming	O
structural	B-T082
inequalities	O
in	O
oral	B-T058
health	I-T058
:	O
the	O
role	O
of	O
dental	B-T058
curricula	B-T170
to	O
date	O
the	O
role	O
of	O
health	B-T092
professional	I-T092
schools	I-T092
in	O
addressing	O
oral	B-T058
health	I-T058
inequalities	O
have	O
been	O
minimal	O
,	O
as	O
attempts	O
have	O
focused	O
principally	O
upon	O
systemic	O
reform	O
and	O
broader	O
societal	O
oblig	O
##ations	O
.	O
professional	O
##ism	O
is	O
a	O
broad	O
competency	O
that	O
is	O
taught	O
throughout	O
dental	B-T092
schools	I-T092
and	O
encompasses	O
a	O
range	O
of	O
attributes	O
.	O
professional	O
##ism	O
as	O
a	O
competency	O
draws	O
some	O
debate	O
and	O
appears	O
to	O
be	O
a	O
shifting	O
phenomenon	O
.	O
we	O
may	O
ask	O
if	O
professional	O
##ism	O
in	O
the	O
dental	B-T058
curricula	B-T170
may	O
be	O
better	O
addressed	O
by	O
social	O
accountability	O
?	O
social	O
accountability	O
direct	O
##s	O
oral	B-T058
health	I-T058
professional	B-T170
curricula	I-T170
(	O
education	B-T170
,	O
research	B-T062
,	O
and	O
service	O
activities	O
)	O
towards	O
addressing	O
the	O
priority	O
health	O
concerns	O
of	O
the	O
community	O
,	O
in	O
our	O
case	O
oral	B-T058
health	I-T058
inequalities	O
.	O
although	O
working	O
toward	O
dental	B-T092
schools	I-T092
becoming	O
more	O
socially	O
account	O
##able	O
seems	O
like	O
a	O
sens	O
##ible	O
way	O
to	O
address	B-T170
oral	B-T058
health	I-T058
inequalities	O
,	O
it	O
might	O
have	O
limitations	O
.	O
we	O
will	O
consider	O
some	O
of	O
the	O
challenges	O
in	O
the	O
dental	B-T058
curricula	B-T170
by	O
considering	O
some	O
of	O
the	O
political	O
,	O
structural	B-T082
,	O
social	O
and	O
ethical	O
factors	O
that	O
influence	O
our	O
institutions	B-T092
and	O
our	O
graduates	B-T098
.	O

clinical	B-T170
pear	I-T170
##ls	I-T170
in	O
tremor	B-T033
and	O
other	O
hyper	B-T038
##kinetic	I-T038
movement	I-T038
disorders	B-T038
hyper	B-T038
##kinetic	I-T038
movements	I-T038
,	O
such	O
as	O
tremor	B-T033
,	O
myoclonus	B-T033
,	O
chor	B-T038
##ea	I-T038
,	O
and	O
dystonia	B-T033
,	O
occur	O
in	O
many	O
neurologic	B-T038
and	O
medical	B-T038
conditions	I-T038
.	O
accurate	O
clinical	B-T058
evaluation	I-T058
is	O
the	O
important	O
first	O
step	O
for	O
the	O
proper	O
diagnosis	B-T062
and	O
treatment	B-T058
of	O
patients	O
with	O
abnormal	B-T038
movements	I-T038
.	O

evaluation	B-T170
of	O
an	O
international	O
educational	O
programme	O
for	O
health	B-T097
care	I-T097
professionals	I-T097
on	O
best	O
practice	O
in	O
the	O
management	O
of	O
a	O
perinatal	O
death	B-T038
:	O
improving	O
perinatal	O
mortality	O
review	O
and	O
outcomes	O
via	O
education	O
(	O
improve	O
)	O
stillbirth	B-T033
##s	I-T033
and	O
neonatal	B-T033
deaths	I-T033
are	O
devastating	O
events	O
for	O
both	O
parents	O
and	O
clinicians	O
and	O
are	O
global	B-T091
public	I-T091
health	I-T091
concerns	O
.	O
careful	O
clinical	B-T058
management	I-T058
after	O
these	O
deaths	B-T038
is	O
required	O
,	O
including	O
appropriate	O
investigation	B-T058
and	O
assessment	B-T058
to	O
determine	O
cause	O
(	O
s	O
)	O
to	O
prevent	O
future	O
losses	O
,	O
and	O
to	O
improve	O
ber	B-T058
##eav	I-T058
##ement	I-T058
care	I-T058
for	O
families	O
.	O
an	O
educational	O
programme	O
for	O
health	B-T097
care	I-T097
professionals	I-T097
working	O
in	O
maternal	B-T033
and	O
child	B-T058
health	I-T058
has	O
been	O
designed	O
to	O
address	O
these	O
needs	O
according	O
to	O
the	O
perinatal	B-T170
society	I-T170
of	I-T170
australia	I-T170
and	I-T170
new	I-T170
zealand	I-T170
guideline	I-T170
for	I-T170
perinatal	I-T170
mortality	I-T170
:	O
improving	O
perinatal	O
mortality	O
review	O
and	O
outcomes	O
via	O
education	O
(	O
improve	O
)	O
.	O
the	O
programme	O
has	O
a	O
major	O
focus	O
on	O
stillbirth	B-T033
and	O
is	O
delivered	O
as	O
six	O
interactive	O
skills	O
-	O
based	O
stations	O
.	O
we	O
aimed	O
to	O
determine	O
participants	B-T098
'	O
pre	O
-	O
and	O
post	O
-	O
programme	O
knowledge	B-T170
of	O
and	O
confidence	B-T038
in	O
the	O
management	O
of	O
perinatal	O
deaths	B-T038
,	O
along	O
with	O
satisfaction	B-T038
with	O
the	O
programme	O
.	O
we	O
also	O
aimed	O
to	O
determine	O
suitability	O
for	O
international	O
use	O
.	O
the	O
improve	O
programme	O
was	O
delivered	O
to	O
health	B-T097
professionals	I-T097
in	O
maternity	B-T092
hospitals	I-T092
in	O
all	O
seven	O
australian	B-T082
states	B-T082
and	O
territories	O
and	O
modified	O
for	O
use	O
internationally	O
with	O
pilot	O
##ing	O
in	O
vietnam	B-T082
,	O
fi	B-T082
##ji	I-T082
,	O
and	O
the	O
netherlands	B-T082
(	O
with	O
the	O
assistance	B-T058
of	O
the	O
international	B-T092
stillbirth	I-T092
alliance	I-T092
,	O
is	B-T092
##a	I-T092
)	O
.	O
modifications	O
were	O
made	O
to	O
programme	B-T170
materials	I-T170
in	O
consultation	B-T058
with	O
local	O
teams	O
and	O
included	O
translation	B-T170
for	O
the	O
vietnam	O
programme	O
.	O
participants	B-T098
completed	O
pre	O
-	O
and	O
post	O
-	O
programme	O
evaluation	B-T170
questionnaires	B-T170
on	O
knowledge	B-T170
and	O
confidence	B-T038
on	O
six	O
key	O
components	O
of	O
perinatal	O
death	B-T038
management	O
as	O
well	O
as	O
a	O
satisfaction	B-T170
questionnaire	I-T170
.	O
over	O
the	O
period	O
may	O
2012	O
to	O
may	O
2015	O
,	O
30	O
improve	O
workshops	O
were	O
conducted	O
,	O
including	O
26	O
with	O
75	O
##8	O
participants	B-T098
in	O
australia	B-T082
and	O
four	O
with	O
136	O
participants	B-T098
internationally	O
.	O
evaluations	B-T170
showed	O
a	O
significant	O
improvement	O
between	O
pre	O
-	O
and	O
post	O
-	O
programme	O
knowledge	B-T170
and	O
confidence	B-T038
in	O
all	O
six	O
stations	O
and	O
overall	O
,	O
and	O
a	O
high	O
degree	O
of	O
satisfaction	B-T038
in	O
all	O
settings	B-T082
.	O
the	O
improve	O
programme	O
has	O
been	O
well	O
received	O
in	O
australia	B-T082
and	O
in	O
three	O
different	O
international	O
settings	B-T082
and	O
is	O
now	O
being	O
made	O
available	O
through	O
is	B-T092
##a	I-T092
.	O
future	O
research	B-T062
is	O
required	O
to	O
determine	O
whether	O
the	O
immediate	O
improvements	O
in	O
knowledge	B-T170
are	O
sustained	O
with	O
less	O
causes	O
of	O
death	B-T038
being	O
classified	O
as	O
unknown	O
,	O
changes	O
in	O
clinical	O
practice	O
and	O
improvement	O
in	O
parents	O
'	O
experiences	O
with	O
care	O
.	O
the	O
suitability	O
for	O
this	O
programme	O
in	O
low	B-T033
-	I-T033
income	I-T033
countries	B-T082
also	O
needs	O
to	O
be	O
established	O
.	O

genome	B-T058
-	I-T058
wide	I-T058
snp	I-T058
linkage	I-T058
mapping	I-T058
and	O
qtl	B-T017
analysis	B-T058
for	O
fiber	B-T204
quality	O
and	O
yield	O
traits	O
in	O
the	O
up	B-T204
##land	I-T204
cotton	I-T204
recombinant	B-T204
inbred	I-T204
lines	I-T204
population	O
it	O
is	O
of	O
significance	O
to	O
discover	O
genes	B-T017
related	O
to	O
fiber	B-T204
quality	O
and	O
yield	O
traits	O
and	O
tightly	O
linked	O
markers	B-T038
for	O
marker	B-T062
-	I-T062
assisted	I-T062
selection	I-T062
(	O
mas	B-T062
)	O
in	O
cotton	B-T204
breeding	B-T038
.	O
in	O
this	O
study	O
,	O
188	B-T204
f	I-T204
##8	I-T204
recombinant	B-T204
inbred	I-T204
lines	I-T204
(	O
ril	B-T204
##s	I-T204
)	O
,	O
derived	O
from	O
a	O
intraspecific	O
cross	B-T038
between	O
hs	B-T204
##46	I-T204
and	O
marc	B-T204
##ab	I-T204
##uc	I-T204
##ag	I-T204
##8	I-T204
##us	I-T204
-	I-T204
1	I-T204
-	I-T204
88	I-T204
were	O
genotyped	O
by	O
the	O
cotton	B-T204
63	O
##k	O
single	B-T058
nucleotide	I-T058
polymorphism	I-T058
(	I-T058
snp	I-T058
)	I-T058
assay	I-T058
.	O
field	O
trials	O
were	O
conducted	O
in	O
san	O
##ya	O
,	O
hai	O
##na	O
##n	O
province	O
,	O
during	O
the	O
2014	O
-	O
2015	O
crop	O
##ping	O
seasons	O
under	O
standard	O
conditions	O
.	O
results	O
revealed	O
significant	O
differences	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
among	O
ril	B-T204
##s	I-T204
,	O
environments	B-T082
and	O
replication	O
##s	O
for	O
fiber	B-T204
quality	O
and	O
yield	O
traits	O
.	O
broad	O
-	O
sense	O
her	O
##ita	O
##bil	O
##ities	O
of	O
all	O
traits	O
including	O
fiber	B-T204
length	O
,	O
fiber	B-T204
uniformity	O
,	O
micron	O
##air	O
##e	O
,	O
fiber	B-T204
elongation	B-T038
,	O
fiber	B-T204
strength	O
,	O
bol	B-T204
##l	I-T204
weight	O
,	O
and	O
lin	O
##t	O
percentage	O
ranged	O
from	O
0	O
.	O
26	O
to	O
0	O
.	O
66	O
.	O
a	O
178	O
##4	O
.	O
28	O
cm	O
(	O
centi	O
##mo	O
##r	O
##gans	O
)	O
linkage	B-T058
map	I-T058
,	O
harboring	O
261	O
##8	O
polymorphic	O
snp	B-T082
markers	B-T038
,	O
was	O
constructed	O
,	O
which	O
had	O
0	O
.	O
68	O
cm	O
per	O
marker	B-T038
density	O
.	O
seventy	O
-	O
one	O
quantitative	B-T017
trait	I-T017
locus	I-T017
(	O
qtls	B-T017
)	O
for	O
fiber	B-T204
quality	O
and	O
yield	O
traits	O
were	O
detected	O
on	O
21	O
chromosomes	B-T017
,	O
explaining	O
4	O
.	O
70	O
~	O
32	O
.	O
28	O
%	O
phenotypic	O
variance	O
,	O
in	O
which	O
16	O
were	O
identified	O
as	O
stable	O
qtls	B-T017
across	O
two	O
environments	B-T082
.	O
meanwhile	O
,	O
12	O
certain	O
regions	B-T017
were	O
investigated	O
to	O
be	O
involved	O
in	O
the	O
control	O
of	O
one	O
(	O
hots	B-T082
##pot	I-T082
)	O
or	O
more	O
(	O
cluster	B-T017
)	O
traits	O
,	O
mainly	O
focused	O
on	O
chr	B-T017
##05	I-T017
,	O
chr	B-T017
##09	I-T017
,	O
chr	B-T017
##10	I-T017
,	O
chr	B-T017
##14	I-T017
,	O
chr	B-T017
##19	I-T017
,	O
and	O
chr	B-T017
##20	I-T017
.	O
nineteen	O
pairs	O
of	O
epist	B-T017
##atic	I-T017
qtls	B-T017
(	O
e	B-T017
-	I-T017
qtls	I-T017
)	O
were	O
identified	O
,	O
of	O
which	O
two	O
pairs	O
involved	O
in	O
two	O
additive	O
qtls	B-T017
.	O
these	O
additive	O
qtls	B-T017
,	O
e	B-T017
-	I-T017
qtls	I-T017
,	O
and	O
qtl	B-T017
clusters	B-T017
were	O
tightly	O
linked	O
to	O
snp	B-T082
markers	B-T038
,	O
which	O
may	O
serve	O
as	O
target	O
regions	B-T017
for	O
map	B-T058
-	I-T058
based	I-T058
cloning	I-T058
,	O
gene	B-T062
discovery	I-T062
,	O
and	O
mas	B-T062
in	O
cotton	B-T204
breeding	B-T038
.	O

shared	B-T038
decision	I-T038
making	I-T038
and	O
the	O
promise	O
of	O
a	O
respect	O
##ful	O
and	O
equ	O
##itable	O
healthcare	B-T092
system	I-T092
in	O
peru	B-T082
peru	B-T082
has	O
achieved	O
sustained	O
development	O
in	O
the	O
last	O
two	O
decades	O
.	O
however	O
,	O
despite	O
this	O
achievement	O
,	O
it	O
has	O
not	O
been	O
matched	O
with	O
improvements	O
in	O
the	O
quality	O
of	O
education	O
and	O
health	B-T058
;	O
investment	O
in	O
both	O
sectors	O
is	O
among	O
the	O
lowest	O
in	O
the	O
region	B-T082
.	O
this	O
situation	O
perpet	O
##uates	O
huge	O
gaps	B-T033
in	O
infrastructure	O
and	O
also	O
conditions	O
a	O
poor	O
literacy	O
level	O
of	O
the	O
population	B-T098
specifically	O
in	O
health	O
.	O
currently	O
,	O
there	O
is	O
a	O
fragmented	O
model	B-T170
of	O
patient	B-T058
care	I-T058
,	O
in	O
which	O
the	O
systems	B-T092
are	O
exclusive	O
of	O
each	O
other	O
.	O
they	O
do	O
not	O
cooper	O
##ate	O
or	O
communicate	O
with	O
each	O
other	O
;	O
and	O
if	O
there	O
is	O
no	O
vertical	O
communication	O
within	O
the	O
system	B-T092
,	O
preventing	O
referral	B-T058
of	I-T058
patients	I-T058
directly	O
from	O
the	O
basic	B-T033
level	I-T033
to	O
the	O
complex	B-T033
level	I-T033
of	O
care	B-T058
when	O
needed	O
.	O
in	O
addition	O
,	O
there	O
has	O
been	O
no	O
progress	O
in	O
the	O
development	O
of	O
an	O
emp	O
##ath	O
##etic	O
,	O
respect	O
##ful	O
or	O
person	O
-	O
centered	O
clinical	O
practice	O
;	O
instead	O
,	O
economic	O
,	O
social	O
and	O
educational	O
differences	O
perpet	O
##uate	O
a	O
paternal	O
##istic	O
clinical	O
practice	O
.	O
the	O
task	O
of	O
orienting	O
medical	O
training	O
towards	O
the	O
development	O
of	O
human	O
##ism	O
is	O
pend	O
##ing	O
.	O
the	O
patient	O
is	O
the	O
center	O
of	O
the	O
medical	B-T062
act	I-T062
and	O
the	O
main	O
objective	O
of	O
doctors	B-T097
'	I-T097
actions	O
.	O
a	O
human	O
##istic	O
care	O
approach	O
will	O
not	O
only	O
empower	O
the	O
person	B-T098
in	O
the	O
clinical	O
encounter	O
-	O
to	O
participate	O
and	O
make	O
decisions	O
related	O
to	O
his	O
/	O
her	O
health	B-T058
care	I-T058
-	O
but	O
it	O
will	O
allow	O
us	O
to	O
move	O
towards	O
an	O
emp	O
##ath	O
##etic	O
,	O
caring	O
,	O
respect	O
##ful	O
and	O
kind	O
model	B-T170
of	O
clinical	O
practice	O
.	O

real	O
-	O
world	O
impact	O
of	O
non	B-T033
-	I-T033
breast	I-T033
cancer	I-T033
-	I-T033
specific	I-T033
death	I-T033
on	O
overall	O
survival	O
in	O
resectable	O
breast	B-T038
cancer	I-T038
the	O
real	O
-	O
world	O
occurrence	O
rate	O
of	O
non	B-T033
-	I-T033
breast	I-T033
cancer	I-T033
-	I-T033
specific	I-T033
death	I-T033
(	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
)	O
and	O
its	O
impact	O
on	O
patients	O
with	O
breast	B-T038
cancer	I-T038
are	O
poorly	O
recognized	O
.	O
women	B-T098
with	O
resectable	O
breast	B-T038
cancer	I-T038
from	O
1990	O
to	O
2007	O
in	O
the	O
surveillance	B-T092
,	I-T092
epidemiology	I-T092
,	I-T092
and	I-T092
end	I-T092
results	I-T092
database	I-T092
(	O
n	O
=	O
199	O
,	O
96	O
##3	O
)	O
were	O
analyzed	B-T062
.	O
the	O
outcome	O
events	O
of	O
breast	B-T038
cancer	I-T038
were	O
classified	O
as	O
breast	O
cancer	O
-	O
specific	O
death	O
(	O
bcs	O
##d	O
)	O
,	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
,	O
or	O
survival	O
.	O
binary	B-T062
logistic	I-T062
##s	I-T062
was	O
used	O
to	O
estimate	O
the	O
occurrence	O
rates	O
of	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
and	O
bcs	O
##d	O
with	O
different	O
clinicopathological	O
factors	O
.	O
the	O
gray	B-T170
method	I-T170
was	O
used	O
to	O
measure	O
the	O
cumulative	O
incidence	O
of	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
and	O
bcs	O
##d	O
.	O
the	O
ratio	O
of	O
non	B-T033
-	I-T033
bcs	I-T033
##ds	I-T033
to	O
all	O
causes	B-T033
of	I-T033
death	I-T033
and	O
stacked	B-T082
cumulative	O
incidence	O
function	B-T170
plots	I-T170
were	O
used	O
to	O
present	O
the	O
impact	O
of	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
on	O
overall	O
survival	O
(	O
os	O
)	O
.	O
models	B-T170
of	I-T170
cox	I-T170
proportional	I-T170
hazards	I-T170
regression	I-T170
and	O
competing	B-T170
risk	I-T170
regression	I-T170
were	O
compared	O
to	O
highlight	O
the	O
suitable	B-T170
model	I-T170
.	O
there	O
were	O
12	O
,	O
87	O
##9	O
non	B-T033
-	I-T033
bcs	I-T033
##ds	I-T033
(	O
6	O
.	O
44	O
%	O
)	O
and	O
28	O
,	O
78	O
##4	O
bcs	O
##ds	O
(	O
14	O
.	O
39	O
%	O
)	O
.	O
the	O
oldest	O
age	O
group	O
(	O
>	O
62	O
years	O
)	O
,	O
black	B-T098
race	I-T098
,	O
and	O
a	O
single	O
or	O
divor	O
##ced	O
marital	O
status	O
were	O
associated	O
with	O
more	O
non	B-T033
-	I-T033
bcs	I-T033
##ds	I-T033
.	O
with	O
adjustments	O
for	O
age	O
,	O
a	O
hormone	B-T038
receptor	I-T038
-	I-T038
positive	I-T038
(	I-T038
hor	I-T038
+	I-T038
)	I-T038
status	I-T038
was	O
no	O
longer	O
related	O
to	O
increased	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
s	O
.	O
in	O
patients	O
with	O
grade	B-T038
1	I-T038
,	I-T038
stage	I-T038
i	I-T038
disease	I-T038
and	O
an	O
hor	B-T038
+	I-T038
status	I-T038
as	O
well	O
as	O
the	O
oldest	O
subgroup	O
,	O
a	O
great	O
dilution	O
of	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
on	O
all	O
causes	B-T033
of	I-T033
death	I-T033
could	O
be	O
observed	O
,	O
and	O
this	O
led	O
to	O
incorrect	O
interpretations	O
.	O
the	O
inacc	O
##ura	O
##cy	O
,	O
caused	O
by	O
the	O
commonly	O
used	O
cox	B-T170
proportional	I-T170
hazards	I-T170
model	I-T170
,	O
could	O
be	O
corrected	O
by	O
a	O
competing	B-T170
risk	I-T170
model	I-T170
.	O
os	O
was	O
largely	O
impaired	O
by	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
during	O
early	O
breast	B-T038
cancer	I-T038
.	O
for	O
some	O
future	O
clinical	B-T062
trial	I-T062
planning	O
,	O
especially	O
for	O
the	O
oldest	O
patients	O
and	O
those	O
with	O
hor	B-T038
+	I-T038
breast	B-T038
cancer	I-T038
,	O
non	B-T033
-	I-T033
bcs	I-T033
##d	I-T033
should	O
be	O
considered	O
a	O
competing	O
risk	O
event	O
.	O
cancer	O
2017	O
.	O
©	O
2017	O
american	B-T092
cancer	I-T092
society	I-T092
.	O

differential	O
transcriptome	B-T082
expression	B-T038
in	O
human	B-T204
nucleus	B-T017
accumbens	I-T017
as	O
a	O
function	O
of	O
loneliness	B-T033
loneliness	B-T033
is	O
associated	O
with	O
impaired	B-T038
mental	B-T038
and	O
physical	O
health	O
.	O
studies	O
of	O
lon	B-T098
##ely	I-T098
individuals	I-T098
reported	O
differential	B-T038
expression	I-T038
of	O
inflammatory	O
genes	B-T017
in	O
peripheral	B-T082
leukocytes	B-T017
and	O
diminished	O
activation	B-T038
in	O
brain	B-T017
reward	B-T082
regions	I-T082
such	O
as	O
nucleus	B-T017
accumbens	I-T017
,	O
but	O
could	O
not	O
address	O
gene	B-T038
expression	I-T038
in	O
the	O
human	B-T204
brain	B-T017
.	O
here	O
,	O
we	O
examined	O
genome	B-T038
-	I-T038
wide	I-T038
rna	I-T038
expression	I-T038
in	O
post	B-T058
-	I-T058
mortem	I-T058
nucleus	B-T017
accumbens	I-T017
from	O
donors	B-T098
(	O
n	O
=	O
26	O
)	O
with	O
known	O
loneliness	B-T033
measures	O
.	O
loneliness	B-T033
was	O
associated	O
with	O
171	O
##0	O
differentially	B-T103
expressed	I-T103
transcripts	I-T103
and	O
genes	B-T017
from	O
159	O
##9	O
genes	B-T017
(	O
degs	B-T017
;	O
false	O
discovery	O
rate	O
p	O
<	O
0	O
.	O
05	O
,	O
fold	O
change	O
⩾	O
|	O
2	O
|	O
,	O
controlling	O
for	O
confound	O
##s	O
)	O
previously	O
associated	O
with	O
behavioral	O
processes	O
,	O
neurological	B-T038
disease	I-T038
,	O
psychological	B-T038
disorders	I-T038
,	O
cancer	B-T038
,	O
organism	O
##al	O
injury	B-T037
and	O
skeletal	B-T038
and	O
muscular	B-T038
disorders	I-T038
,	O
as	O
well	O
as	O
networks	O
of	O
upstream	B-T082
rna	B-T017
regulators	I-T017
.	O
furthermore	O
,	O
a	O
number	O
of	O
degs	B-T017
were	O
associated	O
with	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
genes	B-T017
(	O
that	O
was	O
correlated	O
with	O
loneliness	B-T033
in	O
this	O
sample	O
,	O
although	O
gene	B-T062
expression	I-T062
analyses	I-T062
controlled	O
for	O
ad	B-T038
diagnosis	B-T033
)	O
.	O
these	O
results	O
identify	O
novel	O
targets	O
for	O
future	O
mechanistic	B-T062
studies	I-T062
of	O
gene	B-T017
networks	O
in	O
nucleus	B-T017
accumbens	I-T017
and	O
gene	B-T038
regulatory	I-T038
mechanisms	I-T038
across	O
a	O
variety	O
of	O
diseases	B-T038
exacerbated	O
by	O
loneliness	B-T033
.	O
molecular	B-T170
psychiatry	I-T170
advance	I-T170
online	I-T170
publication	I-T170
,	O
1	O
november	O
2016	O
;	O
doi	O
:	O
10	O
.	O
103	O
##8	O
/	O
mp	O
.	O
2016	O
.	O
186	O
.	O

effect	O
of	O
nutritional	B-T033
##ly	I-T033
induced	I-T033
hyperlipid	B-T038
##aemia	I-T038
on	O
in	O
vitro	O
bovine	B-T204
embryo	B-T017
quality	O
depends	O
on	O
the	O
type	O
of	O
major	O
fatty	B-T103
acid	I-T103
in	O
the	O
diet	B-T168
the	O
present	O
study	B-T062
examined	B-T033
whether	O
the	O
effects	O
of	O
dietary	B-T168
-	O
induced	O
hyperlipid	B-T038
##aemia	I-T038
on	O
preimplantation	B-T038
embryo	I-T038
development	I-T038
depend	O
on	O
the	O
predominant	O
fatty	B-T103
acid	I-T103
(	O
fa	B-T103
)	O
type	O
in	O
the	O
diet	B-T168
.	O
in	O
a	O
combined	O
in	B-T082
vivo	I-T082
-	O
in	O
vitro	O
bovine	B-T204
model	B-T204
,	O
two	O
groups	O
of	O
cows	B-T204
(	O
n	O
=	O
3	O
in	O
each	O
group	O
)	O
were	O
fed	O
with	O
three	O
diets	B-T168
consecutively	O
(	O
4	O
weeks	O
feeding	O
for	O
each	O
)	O
:	O
(	O
1	O
)	O
a	O
maintenance	B-T168
control	I-T168
diet	I-T168
(	O
cont	B-T168
)	O
;	O
(	O
2	O
)	O
a	O
high	O
-	O
starch	B-T168
diet	B-T168
rich	O
in	O
saturated	B-T168
fat	I-T168
(	O
sat	B-T168
)	O
;	O
and	O
(	O
3	O
)	O
a	O
high	O
-	O
starch	B-T168
diet	B-T168
rich	O
in	O
omega	B-T103
-	I-T103
3	I-T103
unsaturated	B-T103
fat	I-T103
(	O
uns	B-T103
##at	I-T103
)	O
.	O
two	O
feeding	O
sequences	O
were	O
used	O
to	O
test	O
for	O
carry	O
-	O
over	O
effects	O
:	O
group	O
a	O
was	O
fed	O
cont	B-T168
,	O
sat	B-T168
##1	I-T168
and	O
then	O
uns	B-T103
##at	I-T103
##2	I-T103
,	O
whereas	O
group	O
b	O
was	O
fed	O
cont	B-T168
,	O
uns	B-T103
##at1	I-T103
and	O
then	O
sat	B-T168
##2	I-T168
.	O
serum	B-T031
was	O
collected	O
after	O
each	O
dietary	B-T168
period	O
,	O
analysed	B-T062
and	O
tested	O
in	O
bovine	B-T204
in	O
vitro	O
embryo	B-T058
culture	I-T058
.	O
introducing	O
sat	B-T168
and	O
uns	B-T103
##at	I-T103
diets	B-T168
induced	O
hyperlipid	B-T038
##aemia	I-T038
(	O
specifically	O
hypercholesterol	B-T038
##aemia	I-T038
and	O
elevated	O
free	B-T103
fas	I-T103
)	O
and	O
reduced	O
insulin	B-T038
sensitivity	I-T038
.	O
carry	O
-	O
over	O
effects	O
in	O
serum	B-T031
metabolites	B-T103
and	O
fa	B-T058
profile	I-T058
were	O
dependent	O
on	O
the	O
diet	B-T168
and	O
feeding	O
sequence	O
.	O
sat	B-T168
##1	I-T168
and	O
sat	B-T168
##2	I-T168
serum	B-T031
decreased	O
blastocyst	B-T017
rates	O
and	O
altered	O
blastocyst	B-T017
mrna	B-T038
expression	I-T038
related	O
to	O
apoptosis	B-T038
and	O
oxidative	B-T038
stress	I-T038
.	O
uns	B-T103
##at1	I-T103
and	O
uns	B-T103
##at	I-T103
##2	I-T103
serum	B-T031
resulted	O
in	O
normal	O
embryo	B-T017
development	O
and	O
quality	O
.	O
other	O
in	O
vitro	O
effects	O
depended	O
on	O
the	O
sequence	O
of	O
feeding	O
.	O
in	O
conclusion	O
,	O
substitution	O
of	O
saturated	B-T168
fat	I-T168
with	O
omega	B-T103
-	I-T103
3	I-T103
fat	I-T103
in	O
a	O
high	B-T058
-	I-T058
caloric	I-T058
diet	I-T058
induced	O
hyperlipid	B-T038
##aemia	I-T038
with	O
an	O
fa	B-T058
profile	I-T058
yielding	O
similar	O
rates	O
and	O
quality	O
of	O
blastocysts	B-T017
compared	O
with	O
norm	O
##olipid	O
##aemic	O
controls	O
.	O

pharmacological	B-T058
venous	I-T058
thromboembolism	I-T058
prophylaxis	I-T058
in	O
meningioma	B-T038
patients	O
:	O
should	O
it	O
be	O
earlier	O
than	O
clinical	O
practice	O
?	O
we	O
read	O
the	O
report	B-T170
by	O
cel	O
##ti	O
##kc	O
##i	O
et	O
al	O
in	O
the	O
turkish	B-T092
neurosurgery	I-T092
with	O
great	O
interest	O
.	O
in	O
this	O
single	O
-	O
center	O
retrospective	B-T062
study	I-T062
,	O
they	O
analysed	O
44	O
##9	O
intracranial	B-T038
meningioma	I-T038
patients	O
underwent	O
open	B-T058
surgery	I-T058
.	O
they	O
stated	O
that	O
venous	B-T038
thromboembolism	I-T038
(	O
vte	B-T038
)	O
had	O
been	O
seen	O
in	O
21	O
(	O
4	O
.	O
6	O
%	O
)	O
of	O
their	O
patients	O
.	O
this	O
is	O
an	O
important	O
issue	O
because	O
vte	B-T038
,	O
including	O
deep	B-T038
vein	I-T038
thrombosis	I-T038
(	O
dvt	B-T038
)	O
and	O
pulmonary	B-T038
embolism	I-T038
(	O
pe	B-T038
)	O
,	O
is	O
the	O
most	O
common	O
overall	O
complication	B-T038
in	O
meningioma	B-T058
surgery	I-T058
and	O
is	O
fatal	O
in	O
up	O
to	O
one	O
third	O
of	O
patients	O
(	O
2	O
)	O
.	O
we	O
supp	O
##ose	O
that	O
prophylaxis	B-T058
of	O
vte	B-T038
is	O
most	O
effective	O
when	O
mechanical	O
and	O
pharmacological	B-T058
prophylaxis	I-T058
are	O
combined	O
.	O
we	O
consider	O
that	O
there	O
key	O
some	O
practical	O
questions	O
to	O
be	O
answered	O
for	O
a	O
proper	O
clinical	O
extrapolation	O
.	O

pir	B-T103
##fen	I-T103
##idone	I-T103
normalize	O
##s	O
the	O
tumor	O
microenvironment	O
to	O
improve	O
chemotherapy	B-T058
normalization	B-T058
of	O
the	O
tumor	O
microenvironment	O
by	O
selectively	O
targeting	O
components	B-T017
of	O
the	O
tumor	B-T038
extracellular	B-T017
matrix	I-T017
has	O
been	O
recently	O
proposed	O
to	O
have	O
the	O
potential	O
to	O
decomp	O
##ress	O
tumor	B-T038
blood	B-T017
vessels	I-T017
,	O
increase	O
vessel	B-T017
perfusion	O
and	O
thus	O
,	O
improve	O
drug	B-T058
delivery	I-T058
and	O
the	O
efficacy	O
of	O
cancer	B-T058
therapy	I-T058
.	O
therefore	O
,	O
we	O
now	O
need	O
to	O
identify	O
safe	O
and	O
well	O
tolerated	B-T033
pharmaceutical	B-T103
agents	I-T103
that	O
are	O
able	O
to	O
remod	O
##el	O
the	O
microenvironment	O
of	O
solid	B-T038
tumors	I-T038
and	O
enhance	O
chemotherapy	B-T058
.	O
in	O
this	O
study	B-T062
,	O
we	O
rep	O
##ur	O
##po	O
##se	O
##d	O
pir	B-T103
##fen	I-T103
##idone	I-T103
,	O
a	O
clinically	O
approved	O
anti	O
-	O
fibrotic	O
drug	O
for	O
the	O
treatment	B-T058
of	O
idiopathic	B-T038
pulmonary	I-T038
fibrosis	I-T038
,	O
to	O
investigate	O
its	O
possible	O
role	O
on	O
tumor	O
microenvironment	O
normalization	B-T058
.	O
using	O
two	O
orthotopic	B-T082
mammary	B-T017
tumor	B-T170
models	I-T170
we	O
demonstrate	O
that	O
pir	B-T103
##fen	I-T103
##idone	I-T103
reduces	O
collagen	B-T103
and	O
hyaluronan	B-T103
levels	O
and	O
,	O
as	O
a	O
result	O
,	O
significantly	O
increases	O
blood	B-T017
vessel	I-T017
functionality	O
and	O
perfusion	O
and	O
improves	O
the	O
anti	O
-	O
tumor	O
efficacy	O
of	O
doxorubicin	B-T103
.	O
reduction	O
of	O
extracellular	B-T017
matrix	I-T017
components	I-T017
were	O
mediated	O
via	O
tgfβ	O
signaling	O
pathway	O
inhibition	O
due	O
to	O
downregulation	B-T038
of	O
tgfβ	B-T017
##1	I-T017
,	O
col	B-T017
##1a1	I-T017
,	O
col	B-T017
##3a	I-T017
##1	I-T017
,	O
has	B-T017
##2	I-T017
,	O
has	B-T017
##3	I-T017
expression	B-T038
levels	O
.	O
our	O
findings	B-T033
provide	O
evidence	O
that	O
rep	O
##ur	O
##po	O
##sin	O
##g	O
pir	B-T103
##fen	I-T103
##idone	I-T103
could	O
be	O
used	O
as	O
a	O
promising	O
strategy	B-T062
to	O
enhance	O
drug	B-T058
delivery	I-T058
to	O
solid	B-T038
tumors	I-T038
by	O
normal	B-T058
##izing	I-T058
the	O
tumor	O
microenvironment	O
.	O

when	O
emotion	B-T038
and	O
expression	B-T033
diverg	O
##e	O
:	O
the	O
social	O
costs	O
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
patients	O
with	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
are	O
perceived	B-T038
more	O
negatively	B-T033
than	O
their	O
healthy	O
peers	B-T098
,	O
yet	O
it	O
remains	O
unclear	O
what	O
factors	O
contribute	O
to	O
this	O
negative	B-T033
social	B-T038
perception	I-T038
.	O
based	O
on	O
a	O
cohort	B-T098
of	O
17	O
pd	B-T038
patients	O
and	O
20	O
healthy	O
controls	O
,	O
we	O
assessed	O
how	O
naive	O
raters	O
judge	O
the	O
emotion	B-T038
and	O
emotional	B-T033
intensity	O
displayed	O
in	O
dynamic	O
facial	B-T033
expressions	I-T033
as	O
adults	O
with	O
and	O
without	O
pd	B-T038
wat	O
##ched	O
emotionally	B-T038
ev	O
##oca	O
##tive	O
films	B-T170
(	O
experiment	B-T062
1	O
)	O
,	O
and	O
how	O
age	O
-	O
matched	O
peers	B-T098
naive	O
to	O
patients	O
'	O
disease	B-T038
status	O
judge	O
their	O
social	O
des	O
##ira	O
##bil	O
##ity	O
along	O
various	O
dimensions	O
from	O
audio	B-T170
##vis	I-T170
##ual	I-T170
stimuli	O
(	O
interview	B-T097
exce	I-T097
##rp	I-T097
##ts	I-T097
)	O
recorded	O
after	O
certain	O
films	B-T170
(	O
experiment	B-T062
2	O
)	O
.	O
in	O
experiment	B-T062
1	O
,	O
participants	B-T098
with	O
pd	B-T038
were	O
rated	O
as	O
significantly	O
more	O
facial	B-T033
##ly	I-T033
expressive	I-T033
than	O
healthy	O
controls	O
;	O
moreover	O
,	O
ratings	O
demonstrated	O
that	O
pd	B-T038
patients	O
were	O
routinely	O
mist	O
##aken	O
for	O
experiencing	B-T038
a	O
negative	B-T033
emotion	B-T038
,	O
whereas	O
controls	O
were	O
rated	O
as	O
displaying	O
a	O
more	O
positive	B-T033
emotion	B-T038
than	O
they	O
reported	B-T058
feeling	B-T038
.	O
in	O
experiment	B-T062
2	O
,	O
results	B-T033
showed	O
that	O
age	B-T098
-	I-T098
peers	I-T098
rated	O
pd	B-T038
patients	O
as	O
significantly	O
less	O
socially	O
desirable	O
than	O
control	O
participants	B-T098
.	O
specifically	O
,	O
pd	B-T038
patients	O
were	O
rated	O
as	O
less	O
involved	O
,	O
interested	B-T038
,	O
friendly	O
,	O
intelligent	O
,	O
optim	B-T033
##istic	I-T033
,	O
atten	O
##tive	O
,	O
and	O
physically	O
attractive	O
than	O
healthy	O
controls	O
.	O
taken	O
together	O
,	O
our	O
results	B-T033
point	O
to	O
a	O
disconn	O
##ect	O
between	O
how	O
pd	B-T038
patients	O
report	B-T058
feeling	B-T038
and	O
attribution	B-T038
##s	I-T038
that	O
others	O
make	O
about	O
their	O
emotions	B-T038
and	O
social	O
characteristics	O
,	O
underl	O
##ining	O
significant	O
social	O
challenges	O
of	O
the	O
disease	B-T038
.	O
in	O
particular	O
,	O
changes	O
in	O
the	O
ability	O
to	O
modulate	B-T082
the	O
expression	B-T033
of	O
negative	B-T033
emotions	B-T038
may	O
contribute	O
to	O
the	O
negative	B-T033
social	O
impressions	O
that	O
many	O
pd	B-T038
patients	O
face	O
.	O

silk	O
fibro	O
##in	O
based	O
carrier	B-T103
system	I-T103
for	O
delivery	O
of	O
fibrinogen	B-T103
and	O
thrombin	B-T103
as	O
coagul	B-T103
##ant	I-T103
supplements	O
the	O
control	O
of	O
bleeding	B-T038
is	O
one	O
of	O
the	O
most	O
important	O
interventions	B-T058
after	O
a	O
traumatic	B-T037
injury	I-T037
.	O
hemostatic	B-T103
devices	I-T103
delivering	O
blood	B-T038
clotting	I-T038
accelerating	O
agents	B-T103
such	O
as	O
fibrinogen	B-T103
are	O
increasingly	O
used	O
due	O
to	O
their	O
efficacy	O
and	O
their	O
ease	O
of	O
application	B-T058
.	O
in	O
the	O
present	O
study	O
,	O
we	O
describe	O
a	O
method	B-T170
to	O
incorporate	O
the	O
coagul	B-T103
##ant	I-T103
supplements	O
fibrinogen	B-T103
and	O
thrombin	B-T103
in	O
silk	O
protein	O
sponges	B-T074
by	O
mixing	O
the	O
coagul	B-T103
##ants	I-T103
with	O
an	O
aqueous	B-T103
silk	B-T103
solution	O
,	O
followed	O
by	O
mold	B-T058
##ing	I-T058
,	O
freeze	B-T058
-	I-T058
drying	I-T058
and	O
water	B-T058
annealing	I-T058
.	O
in	O
this	O
combination	O
system	O
we	O
demonstrate	O
the	O
delivery	O
of	O
fibrinogen	B-T103
while	O
maintaining	O
its	O
hemostatic	B-T038
potential	I-T038
.	O
concentration	O
ratios	O
of	O
silk	B-T103
to	O
fibrinogen	B-T103
of	O
1	O
.	O
0	O
%	O
/	O
2	O
.	O
8	O
%	O
,	O
2	O
.	O
3	O
%	O
/	O
1	O
.	O
5	O
%	O
and	O
3	O
.	O
0	O
%	O
/	O
0	O
.	O
8	O
%	O
were	O
used	O
.	O
the	O
thrombin	B-T103
-	O
induced	O
fibrin	B-T103
polymeric	B-T103
network	O
filled	O
the	O
space	O
in	O
and	O
next	O
to	O
the	O
silk	B-T103
spong	B-T082
##y	I-T082
structure	I-T082
but	O
also	O
remained	O
interconnected	O
to	O
the	O
silk	B-T103
,	O
providing	O
an	O
intact	O
network	O
.	O
the	O
mechanical	O
characterization	O
of	O
the	O
fibrinogen	O
-	O
releasing	O
silk	B-T103
sponges	B-T074
before	O
and	O
after	O
the	O
induction	O
of	O
the	O
fibrinogen	B-T103
polymerization	O
demonstrated	O
that	O
the	O
fibrin	B-T103
network	O
resulted	O
in	O
reduced	O
permanent	O
deformation	O
from	O
21	O
.	O
1	O
%	O
to	O
6	O
.	O
5	O
%	O
,	O
19	O
.	O
6	O
%	O
to	O
5	O
.	O
7	O
%	O
and	O
12	O
.	O
7	O
%	O
to	O
9	O
.	O
4	O
%	O
for	O
the	O
2	O
.	O
8	O
%	O
,	O
1	O
.	O
5	O
%	O
and	O
0	O
.	O
8	O
%	O
fibrinogen	B-T103
-	O
containing	O
silk	B-T103
sponges	B-T074
,	O
respectively	O
.	O
moreover	O
,	O
the	O
fibrin	B-T103
formation	O
lead	O
to	O
a	O
more	O
linear	B-T082
elastic	O
behavior	O
over	O
longer	O
strain	O
ranges	O
.	O
in	O
combination	O
,	O
the	O
calc	B-T103
##ein	I-T103
-	I-T103
am	I-T103
/	O
pi	B-T103
staining	B-T103
##s	I-T103
and	O
mtt	B-T062
assay	I-T062
results	O
indicate	O
uniform	O
cell	B-T038
adhesion	I-T038
on	O
the	O
surface	B-T082
and	O
cyto	O
##com	O
##pati	O
##bil	O
##ity	O
of	O
the	O
silk	B-T103
/	O
fibrin	B-T103
sponges	B-T074
,	O
respectively	O
.	O
moreover	O
,	O
the	O
co	O
-	O
delivery	O
of	O
thrombin	B-T103
with	O
fibrinogen	B-T103
via	O
silk	B-T103
as	O
carrier	B-T103
material	I-T103
is	O
described	O
,	O
offering	O
a	O
more	O
mechanically	O
robust	O
and	O
durable	O
system	O
while	O
preserving	O
hemostatic	B-T038
features	I-T038
of	O
the	O
coagul	B-T103
##ant	I-T103
substances	I-T103
for	O
the	O
generation	O
of	O
hemostatic	B-T103
devices	I-T103
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

synthesis	O
,	O
sar	O
and	O
molecular	B-T062
docking	I-T062
study	B-T062
of	O
novel	O
non	B-T103
-	I-T103
β	I-T103
-	I-T103
lactam	I-T103
inhibitors	I-T103
of	O
tem	B-T103
type	I-T103
β	I-T103
-	I-T103
lactamase	I-T103
the	O
novel	O
classes	O
of	O
acyl	B-T103
##ated	I-T103
phenoxy	I-T103
##anil	I-T103
##ide	I-T103
and	O
thio	B-T103
##urea	I-T103
compounds	I-T103
were	O
investigated	O
for	O
their	O
ability	O
to	O
inhibit	B-T038
tem	B-T103
type	I-T103
β	I-T103
-	I-T103
lactamase	I-T103
enzyme	I-T103
.	O
two	O
compounds	B-T103
4	I-T103
##g	I-T103
and	O
5	B-T103
##c	I-T103
reveal	O
the	O
inhibition	B-T038
potency	O
in	O
micromolar	O
range	O
and	O
show	O
their	O
action	O
by	O
non	B-T038
-	I-T038
covalent	I-T038
binding	I-T038
in	O
the	O
vicinity	O
of	O
the	O
tem	B-T103
-	I-T103
171	I-T103
active	O
site	O
.	O
the	O
structure	O
activity	O
relationship	O
around	O
carbon	O
chain	O
length	O
and	O
different	O
substituents	O
in	O
ortho	O
-	O
and	O
para	O
-	O
positions	O
of	O
acyl	B-T103
##ated	I-T103
phenoxy	I-T103
##anil	I-T103
##ide	I-T103
as	O
well	O
as	O
molecular	B-T062
modelling	I-T062
study	B-T062
has	O
been	O
performed	O
.	O

air	O
pollution	O
characteristics	O
and	O
health	O
risks	O
in	O
hen	B-T082
##an	I-T082
province	I-T082
,	O
china	B-T082
events	O
of	O
severe	O
air	O
pollution	O
occurred	O
frequently	O
in	O
china	B-T082
recently	O
,	O
thus	O
understanding	O
of	O
the	O
air	O
pollution	O
characteristics	O
and	O
its	O
health	O
risks	O
is	O
very	O
important	O
.	O
in	O
this	O
work	O
,	O
we	O
analyzed	O
a	O
two	O
-	O
year	O
dataset	B-T170
(	O
march	O
2014	O
-	O
february	O
2016	O
)	O
including	O
daily	O
concentrations	O
of	O
six	O
criteria	O
pollutants	B-T103
(	O
pm2	O
.	O
5	O
,	O
pm10	O
,	O
co	B-T103
,	O
so2	B-T103
,	O
no2	B-T103
,	O
and	O
o3	B-T103
)	O
from	O
18	O
cities	O
in	O
hen	B-T082
##an	I-T082
province	I-T082
.	O
results	O
reveal	O
the	O
serious	O
air	O
pollution	O
status	O
in	O
hen	B-T082
##an	I-T082
province	I-T082
,	O
especially	O
the	O
northern	B-T082
part	I-T082
,	O
and	O
zh	B-T082
##eng	I-T082
##z	I-T082
##hou	I-T082
is	O
the	O
city	B-T082
with	O
the	O
worst	O
air	O
quality	O
.	O
annual	O
average	O
pm2	O
.	O
5	O
concentrations	O
exceed	O
the	O
second	O
grade	O
of	O
chinese	O
ambient	O
air	O
quality	O
standard	O
(	O
75	O
##μg	O
/	O
m	O
(	O
3	O
)	O
)	O
at	O
both	O
2014	O
and	O
2015	O
.	O
pm2	O
.	O
5	O
is	O
typically	O
the	O
major	O
pollutant	B-T103
,	O
but	O
ozone	B-T103
pollution	O
can	O
be	O
significant	O
during	O
summer	O
.	O
furthermore	O
,	O
as	O
the	O
commonly	O
used	O
air	B-T170
quality	I-T170
index	I-T170
(	O
aq	B-T170
##i	I-T170
)	O
neglect	O
##s	O
the	O
mutual	O
health	O
effects	O
from	O
multiple	O
pollutants	B-T103
,	O
we	O
introduced	O
the	O
aggregate	B-T170
air	I-T170
quality	I-T170
index	I-T170
(	O
aa	B-T170
##qi	I-T170
)	O
and	O
health	B-T170
-	I-T170
risk	I-T170
based	I-T170
air	I-T170
quality	I-T170
index	I-T170
(	O
ha	B-T170
##qi	I-T170
)	O
to	O
evaluate	O
the	O
health	O
risks	O
.	O
results	O
show	O
that	O
based	O
on	O
ha	B-T170
##qi	I-T170
,	O
the	O
current	O
aq	B-T170
##i	I-T170
system	O
likely	O
significantly	O
underestimate	O
the	O
health	O
risks	O
of	O
air	O
pollution	O
,	O
highlighting	O
that	O
the	O
general	B-T098
public	I-T098
may	O
need	O
strict	O
##er	O
health	O
protection	O
measures	O
.	O
the	O
population	O
-	O
weighted	O
two	O
-	O
year	O
average	O
ha	B-T170
##qi	I-T170
data	O
further	O
demonstrates	O
that	O
all	O
population	O
in	O
the	O
studied	O
cities	B-T082
in	O
hen	B-T082
##an	I-T082
province	I-T082
live	O
with	O
polluted	O
air	O
-	O
72	O
%	O
of	O
the	O
population	O
is	O
exposed	O
to	O
air	O
that	O
is	O
unhealthy	B-T033
for	O
sensitive	O
people	B-T098
,	O
while	O
28	O
%	O
of	O
people	B-T098
is	O
exposed	O
to	O
air	O
that	O
can	O
be	O
harmful	O
to	O
healthy	O
people	B-T098
;	O
and	O
the	O
health	O
risks	O
are	O
much	O
greater	O
during	O
winter	O
than	O
during	O
other	O
seasons	O
.	O
future	O
works	O
should	O
further	O
improve	O
the	O
ha	B-T170
##qi	I-T170
algorithm	B-T170
,	O
and	O
validate	O
the	O
links	O
between	O
the	O
clinical	B-T170
/	O
epidemiologic	O
data	B-T170
and	O
the	O
ha	B-T170
##qi	I-T170
values	O
.	O

fire	O
##cr	O
##ack	O
##er	O
eye	B-T033
exposure	I-T033
:	O
experimental	B-T062
study	I-T062
and	O
simulation	B-T062
understanding	O
the	O
mechanisms	O
of	O
traumatic	O
ocular	B-T037
injury	I-T037
is	O
helpful	O
to	O
make	O
accurate	O
diagnoses	B-T033
before	O
the	O
symptoms	B-T033
emerge	O
and	O
to	O
develop	O
specific	O
eye	O
protection	O
.	O
the	O
comprehension	B-T038
of	O
the	O
dynamics	O
of	O
primary	O
blast	B-T037
injury	I-T037
mechanisms	O
is	O
a	O
challenging	O
issue	B-T033
.	O
the	O
question	O
is	O
whether	O
the	O
pressure	O
wave	O
propagation	O
and	O
reflection	O
alone	O
could	O
cause	O
ocular	O
damage	O
.	O
to	O
date	O
,	O
there	O
are	O
diss	O
##enting	O
opinions	O
and	O
no	O
conclusive	O
evidence	O
there	O
##up	O
##on	O
.	O
a	O
previous	O
numerical	B-T058
investigation	I-T058
of	O
blast	O
trauma	B-T037
highlighted	O
the	O
dynamic	O
effect	O
of	O
pressure	O
propagation	O
and	O
its	O
amplification	O
by	O
the	O
geometry	O
of	O
the	O
bony	B-T017
orbit	I-T017
,	O
inducing	O
a	O
resonance	O
cavity	B-T082
effect	O
and	O
a	O
standing	O
wave	O
hazardous	O
for	O
eye	B-T017
tissues	B-T017
.	O
the	O
objective	O
of	O
the	O
current	O
work	O
is	O
to	O
find	O
experimental	O
evidence	O
of	O
the	O
numerically	O
identified	O
phenomenon	O
.	O
therefore	O
,	O
tests	B-T170
aimed	O
at	O
evaluating	B-T058
the	O
response	O
of	O
porcine	B-T204
eyes	B-T017
to	O
blast	O
over	O
##pre	O
##ss	O
##ure	O
generated	O
by	O
fire	O
##cr	O
##ack	O
##ers	O
explosion	O
were	O
performed	O
.	O
the	O
orbital	B-T082
cavity	I-T082
effect	O
was	O
considered	O
mounting	O
the	O
enucle	O
##ated	O
eyes	O
inside	O
a	O
dum	O
##my	O
orbit	B-T082
.	O
the	O
experimental	O
measurements	O
obtained	O
during	O
the	O
explosion	O
tests	B-T170
presented	O
in	O
this	O
paper	B-T170
corroborate	O
the	O
numerical	O
evidence	O
of	O
a	O
high	O
-	O
frequency	O
pressure	O
amplification	O
,	O
enhancing	O
the	O
loading	O
on	O
the	O
ocular	B-T017
tissues	B-T017
,	O
attributable	B-T038
to	O
the	O
orbital	B-T082
bony	I-T082
walls	I-T082
surrounding	O
the	O
eye	B-T017
.	O

allevi	O
##ation	O
of	O
hepatic	B-T082
fat	B-T033
accumulation	I-T033
by	O
betaine	B-T103
involves	O
reduction	O
of	O
homocysteine	B-T103
via	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
betaine	B-T103
-	I-T103
homocysteine	I-T103
methyltransferase	I-T103
(	O
bh	B-T103
##mt	I-T103
)	O
we	O
investigated	O
the	O
anti	O
-	O
lipo	O
##genic	O
effect	O
of	O
betaine	B-T103
in	O
rats	B-T204
fed	O
methionine	B-T103
and	O
choline	B-T103
-	O
deficient	O
diet	B-T168
(	O
mcd	B-T168
)	O
.	O
intake	O
of	O
mcd	B-T168
for	O
3	O
wk	O
resulted	O
in	O
a	O
significant	O
accumulation	B-T033
of	O
hepatic	B-T082
lipids	B-T103
,	O
which	O
was	O
prevented	O
by	O
betaine	B-T103
supplementation	B-T058
in	O
drinking	O
water	O
(	O
1	O
%	O
)	O
.	O
phosphorylation	B-T038
of	O
amp	B-T103
-	I-T103
activated	I-T103
protein	I-T103
kinase	I-T103
(	O
ampk	B-T103
)	O
,	O
acetyl	B-T103
-	I-T103
coa	I-T103
carboxylase	I-T103
(	O
acc	B-T103
)	O
,	O
sterol	B-T103
regulatory	I-T103
element	I-T103
-	I-T103
binding	I-T103
protein	I-T103
1c	I-T103
(	O
srebp	B-T103
-	I-T103
1c	I-T103
)	O
,	O
and	O
liver	B-T103
kinase	I-T103
b1	I-T103
(	O
lk	B-T103
##b1	I-T103
)	O
was	O
inhibited	O
by	O
mcd	B-T168
intake	O
,	O
and	O
these	O
changes	O
were	O
all	O
inhibited	O
by	O
betaine	B-T103
feeding	B-T058
.	O
meanwhile	O
,	O
betaine	B-T103
supplementation	B-T058
reversed	O
the	O
reduction	O
of	O
methionine	B-T038
and	I-T038
s	I-T038
-	I-T038
adenosyl	I-T038
##meth	I-T038
##ionine	I-T038
(	O
sam	B-T038
)	O
,	O
and	O
the	O
elevation	O
of	O
homocysteine	B-T058
levels	I-T058
in	O
the	O
liver	B-T017
,	I-T017
which	O
could	O
be	O
attributable	O
to	O
the	O
induction	B-T038
of	O
betaine	B-T103
-	I-T103
homocysteine	I-T103
methyl	I-T103
##trans	I-T103
##fe	I-T103
##ase	I-T103
(	O
bh	B-T103
##mt	I-T103
)	O
and	O
methionine	B-T103
adenosyl	I-T103
##transferase	I-T103
(	O
mat	B-T103
)	O
.	O
different	O
cell	B-T017
lines	I-T017
were	O
used	O
to	O
clarify	O
the	O
role	O
of	O
homocysteine	B-T103
on	O
activation	B-T038
of	O
the	O
ampk	B-T103
pathway	O
.	O
homocysteine	B-T103
treatment	O
decreased	O
pam	B-T103
##p	I-T103
##k	I-T103
,	O
pac	B-T103
##c	I-T103
,	O
ps	B-T103
##re	I-T103
##bp	I-T103
-	I-T103
1c	I-T103
and	O
pl	B-T103
##kb	I-T103
##1	I-T103
in	O
hepg2	B-T017
cells	I-T017
.	O
metformin	B-T103
-	O
induced	O
activation	B-T038
of	O
ampk	B-T103
was	O
also	O
inhibited	O
by	O
homocysteine	B-T103
.	O
treatment	O
with	O
hydroxyl	B-T103
##amine	I-T103
,	O
a	O
cyst	B-T103
##athion	I-T103
##ine	I-T103
β	I-T103
-	I-T103
synthase	I-T103
inhibitor	B-T103
,	O
resulted	O
in	O
a	O
reduction	O
of	O
pam	B-T103
##p	I-T103
##k	I-T103
,	O
pac	B-T103
##c	I-T103
and	O
ps	B-T103
##re	I-T103
##bp	I-T103
-	I-T103
1c	I-T103
,	O
accompanied	O
by	O
an	O
elevation	O
of	O
intracellular	B-T082
homocysteine	B-T103
.	O
betaine	B-T103
treatment	B-T058
prevented	O
the	O
homocysteine	B-T103
-	O
induced	O
reduction	O
of	O
pam	B-T103
##p	I-T103
##k	I-T103
,	O
pac	B-T103
##c	I-T103
,	O
ps	B-T103
##re	I-T103
##bp	I-T103
-	I-T103
1c	I-T103
and	O
pl	B-T103
##kb	I-T103
##1	I-T103
in	O
h4	B-T017
##ii	I-T017
##e	I-T017
cells	I-T017
,	O
but	O
not	O
in	O
hepg2	B-T017
cells	I-T017
.	O
also	O
the	O
elevation	O
of	O
cellular	O
homocysteine	B-T103
and	O
inhibition	O
of	O
protein	B-T038
expression	I-T038
of	O
bh	B-T103
##mt	I-T103
were	O
prevented	O
by	O
betaine	B-T103
only	O
in	O
h4	B-T017
##ii	I-T017
##e	I-T017
cells	I-T017
which	O
express	B-T038
bh	B-T103
##mt	I-T103
.	O
the	O
results	O
suggest	O
that	O
the	O
beneficial	O
effect	O
of	O
betaine	B-T103
against	O
hepatic	B-T082
lipid	B-T103
accumulation	B-T033
may	O
be	O
attributed	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
depletion	O
of	O
homocysteine	B-T103
via	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
bh	B-T103
##mt	I-T103
in	O
hepatocytes	B-T017
.	O

a	O
novel	O
selective	O
inhibitor	B-T103
of	O
delta	B-T103
-	I-T103
5	I-T103
desaturase	I-T103
lowers	O
insulin	B-T038
resistance	I-T038
and	O
reduces	B-T033
body	I-T033
weight	I-T033
in	O
diet	B-T168
-	O
induced	O
obese	B-T038
c57bl	B-T204
/	I-T204
6j	I-T204
mice	I-T204
obesity	B-T038
is	O
now	O
recognized	O
as	O
a	O
state	O
of	O
chronic	O
low	O
-	O
grade	O
inflammation	B-T038
and	O
is	O
called	O
as	O
metabolic	O
inflammation	B-T038
.	O
delta	B-T103
-	I-T103
5	I-T103
desaturase	I-T103
(	O
d5	B-T103
##d	I-T103
)	O
is	O
an	O
enzyme	B-T103
that	O
metabol	O
##izes	O
di	B-T103
##hom	I-T103
##o	I-T103
-	I-T103
γ	I-T103
-	I-T103
linolenic	I-T103
acid	I-T103
(	O
dg	B-T103
##la	I-T103
)	O
to	O
arachidonic	B-T103
acid	I-T103
(	O
aa	B-T103
)	O
.	O
thus	O
,	O
d5	B-T103
##d	I-T103
inhibition	B-T038
increases	O
dg	B-T103
##la	I-T103
(	O
precursor	O
to	O
anti	O
-	O
inflammatory	O
eicosan	B-T103
##oids	I-T103
)	O
while	O
decreasing	O
aa	B-T103
(	O
precursor	O
to	O
pro	O
-	O
inflammatory	O
eicosan	B-T103
##oids	I-T103
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O
here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	B-T038
resistance	I-T038
and	O
the	O
anti	B-T103
-	I-T103
obesity	I-T103
effect	O
of	O
a	O
d5	B-T103
##d	I-T103
selective	O
inhibitor	O
(	O
compound	B-T103
-	I-T103
326	I-T103
)	O
,	O
an	O
orally	B-T082
active	O
small	B-T103
-	I-T103
molecule	I-T103
,	O
in	O
a	O
high	B-T168
-	I-T168
fat	I-T168
diet	I-T168
-	O
induced	O
obese	B-T204
(	I-T204
dio	I-T204
)	I-T204
mouse	I-T204
model	B-T038
.	O
in	O
vivo	O
d5	B-T103
##d	I-T103
inhibition	B-T038
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	B-T031
aa	B-T103
/	O
dg	B-T103
##la	I-T103
profiles	O
.	O
in	O
dio	B-T204
mice	I-T204
,	O
chronic	O
treatment	O
with	O
compound	B-T103
-	I-T103
326	I-T103
lowered	O
insulin	B-T038
resistance	I-T038
and	O
caused	O
body	B-T033
weight	I-T033
loss	I-T033
without	O
significant	O
impact	O
on	O
cumulative	O
calorie	O
intake	O
.	O
decreased	O
macrophage	B-T033
infiltration	I-T033
into	I-T033
adipose	I-T033
tissue	I-T033
was	O
expected	O
from	O
mrna	B-T058
analysis	I-T058
.	O
increased	O
daily	O
energy	B-T038
expenditure	I-T038
was	O
also	O
observed	O
following	O
administration	B-T058
of	O
compound	B-T103
-	I-T103
326	I-T103
,	O
in	O
line	O
with	O
sustained	O
body	B-T033
weight	I-T033
loss	I-T033
.	O
these	O
data	O
indicate	O
that	O
the	O
novel	O
d5	B-T103
##d	I-T103
selective	O
inhibitor	B-T103
,	O
compound	B-T103
-	I-T103
326	I-T103
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	B-T038
and	O
diabetic	B-T038
patients	O
.	O

molecular	O
serum	B-T031
signature	B-T201
of	O
treatment	B-T038
resistant	I-T038
depression	I-T038
a	O
substantial	O
number	O
of	O
patients	O
suffering	O
from	O
major	B-T038
depressive	I-T038
disorder	I-T038
(	O
mdd	B-T038
)	O
do	O
not	O
respond	O
to	O
multiple	O
trials	B-T062
of	O
anti	B-T103
-	I-T103
depress	I-T103
##ants	I-T103
,	O
develop	O
a	O
chronic	O
course	B-T038
of	I-T038
disease	I-T038
and	O
become	O
treatment	B-T058
resistant	B-T038
.	O
most	O
of	O
the	O
studies	O
investigating	O
molecular	O
changes	O
in	O
treatment	B-T038
-	I-T038
resistant	I-T038
depression	I-T038
(	O
tr	B-T038
##d	I-T038
)	O
have	O
only	O
examined	O
a	O
limited	O
number	O
of	O
molecules	O
and	O
genes	B-T017
.	O
consequently	O
,	O
biomarkers	B-T201
associated	O
with	O
tr	B-T038
##d	I-T038
are	O
still	O
lacking	O
.	O
this	O
study	O
aimed	O
to	O
use	O
recently	O
advanced	O
high	B-T091
-	I-T091
throughput	I-T091
proteomic	I-T091
platforms	I-T091
to	O
identify	O
peripheral	B-T082
biomarkers	B-T201
of	O
tr	B-T038
##d	I-T038
defined	O
by	O
two	O
staging	B-T170
models	I-T170
,	O
the	O
tha	B-T170
##se	I-T170
and	I-T170
ru	I-T170
##sh	I-T170
staging	I-T170
model	I-T170
(	O
tr	B-T170
##m	I-T170
)	O
and	O
the	O
ma	B-T170
##ud	I-T170
##s	I-T170
##ley	I-T170
staging	I-T170
model	I-T170
(	O
msm	B-T170
)	O
.	O
serum	B-T031
collected	O
from	O
an	O
inpatient	O
cohort	O
of	O
65	O
individuals	B-T098
suffering	O
from	O
mdd	B-T038
was	O
analysed	O
using	O
two	O
different	O
mass	B-T058
spectrometric	I-T058
-	I-T058
based	I-T058
platforms	I-T058
,	O
label	B-T058
-	I-T058
free	I-T058
liquid	I-T058
chromatography	I-T058
mass	I-T058
spectrometry	I-T058
(	O
lc	B-T058
-	I-T058
ms	I-T058
(	I-T058
e	I-T058
)	I-T058
)	O
and	O
selective	O
reaction	O
monitoring	O
(	O
sr	O
##m	O
)	O
,	O
as	O
well	O
as	O
a	O
multiplex	B-T058
bead	I-T058
based	I-T058
assay	I-T058
.	O
in	O
the	O
lc	B-T058
-	I-T058
ms	I-T058
(	I-T058
e	I-T058
)	I-T058
analysis	I-T058
,	O
proteins	B-T103
involved	O
in	O
the	O
acute	B-T038
phase	I-T038
response	I-T038
and	O
complement	B-T038
activation	I-T038
and	O
coagulation	B-T038
were	O
significantly	O
different	O
between	O
the	O
staging	B-T170
groups	I-T170
in	O
both	O
models	B-T170
.	O
in	O
the	O
multiplex	B-T058
bead	I-T058
-	I-T058
based	I-T058
assay	I-T058
analysis	O
tnf	B-T058
-	I-T058
α	I-T058
levels	I-T058
(	O
log	O
(	O
odds	O
)	O
=	O
-	O
4	O
.	O
95	O
,	O
p	O
=	O
0	O
.	O
045	O
)	O
were	O
significantly	O
different	O
in	O
the	O
tr	B-T170
##m	I-T170
comparison	O
.	O
using	O
sr	O
##m	O
,	O
significant	O
changes	O
of	O
three	O
apolipoprotein	B-T103
##s	I-T103
a	I-T103
-	I-T103
i	I-T103
(	O
β	O
=	O
0	O
.	O
029	O
,	O
p	O
=	O
0	O
.	O
035	O
)	O
,	O
m	B-T103
(	O
β	O
=	O
-	O
0	O
.	O
017	O
,	O
p	O
=	O
0	O
.	O
009	O
)	O
and	O
f	B-T103
(	O
β	O
=	O
-	O
0	O
.	O
031	O
,	O
p	O
=	O
0	O
.	O
024	O
)	O
were	O
associated	O
with	O
the	O
tr	B-T170
##m	I-T170
but	O
not	O
the	O
msm	B-T170
.	O
overall	O
,	O
our	O
findings	B-T033
suggest	O
that	O
proteins	B-T103
,	O
which	O
are	O
involved	O
in	O
immune	B-T038
and	O
complement	B-T038
activation	I-T038
,	O
may	O
represent	O
potential	O
biomarkers	B-T201
that	O
could	O
be	O
used	O
by	O
clinicians	B-T097
to	O
identify	O
high	B-T033
-	I-T033
risk	I-T033
patients	O
.	O
nevertheless	O
,	O
given	O
that	O
the	O
molecular	O
changes	O
between	O
the	O
staging	B-T170
groups	I-T170
were	O
subtle	O
,	O
the	O
results	O
need	O
to	O
be	O
interpreted	O
cautious	O
##ly	O
.	O

reliability	O
and	O
validity	O
of	O
the	O
diabetes	B-T058
eating	I-T058
problem	I-T058
survey	I-T058
-	I-T058
revised	I-T058
on	O
turkish	B-T098
children	O
and	O
adolescents	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
mellitus	I-T038
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
examine	O
the	O
reliability	O
and	O
validity	O
of	O
turkish	B-T098
version	B-T170
of	O
diabetes	B-T058
eating	I-T058
problem	I-T058
survey	I-T058
-	I-T058
revised	I-T058
(	O
dep	B-T058
##s	I-T058
-	I-T058
r	I-T058
)	O
for	O
children	O
and	O
adolescent	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
mellitus	I-T038
.	O
a	O
total	O
of	O
200	O
children	O
and	O
adolescents	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
,	O
ages	O
9	O
-	O
18	O
years	O
,	O
completed	O
the	O
dep	B-T058
##s	I-T058
-	I-T058
r	I-T058
turkish	B-T098
version	B-T170
.	O
in	O
addition	O
to	O
tests	O
of	O
validity	O
,	O
confirmatory	O
factor	O
analysis	O
was	O
conducted	O
to	O
investigate	O
the	O
factor	O
structure	O
of	O
the	O
16	O
-	O
item	O
turkish	B-T098
version	B-T170
of	O
dep	B-T058
##s	I-T058
-	I-T058
r	I-T058
.	O
the	O
turkish	B-T098
version	B-T170
of	O
dep	B-T058
##s	I-T058
-	I-T058
r	I-T058
demonstrated	O
satisfactory	O
cronbach	O
'	O
s	O
∝	O
(	O
0	O
.	O
84	O
##7	O
)	O
and	O
was	O
significantly	O
correlated	O
with	O
ag	O
e	O
(	O
r	O
=	O
0	O
.	O
194	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
hemoglobin	B-T033
a1c	I-T033
levels	I-T033
(	O
r	O
=	O
0	O
.	O
303	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
bmi	B-T201
-	O
sds	O
(	O
r	O
=	O
0	O
.	O
412	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
indicating	O
criterion	O
validity	O
.	O
median	O
dep	B-T058
##s	I-T058
-	I-T058
r	I-T058
scores	O
of	O
turkish	B-T098
version	B-T170
for	O
the	O
total	O
samples	B-T098
,	O
females	O
and	O
males	O
were	O
as	O
follows	O
:	O
11	O
.	O
0	O
,	O
11	O
.	O
5	O
and	O
10	O
.	O
5	O
respectively	O
.	O
disturbed	O
eating	O
behaviors	O
and	O
insulin	B-T103
restriction	O
were	O
associated	O
with	O
poor	O
metabolic	B-T038
control	I-T038
.	O
a	O
short	O
,	O
self	O
-	O
administered	O
diabetes	B-T038
specific	O
screening	B-T058
tool	O
for	O
disordered	O
eating	O
behavior	O
can	O
be	O
used	O
routinely	O
in	O
the	O
clinical	O
care	B-T058
of	O
adolescents	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
.	O
the	O
turkish	B-T098
version	B-T170
of	O
dep	B-T058
##s	I-T058
-	I-T058
r	I-T058
is	O
a	O
valid	O
screening	B-T058
tool	O
for	O
disordered	O
eating	O
behaviors	O
in	O
type	B-T038
1	I-T038
diabetes	I-T038
and	O
it	O
is	O
potentially	O
important	O
to	O
early	O
detect	O
disordered	O
eating	O
behaviors	O
.	O

blastocyst	B-T204
##is	I-T204
subtyp	I-T204
##ing	I-T204
and	O
its	O
association	O
with	O
intestinal	B-T038
parasites	I-T038
in	O
children	O
from	O
different	O
geographical	B-T082
regions	I-T082
of	I-T082
colombia	I-T082
blastocyst	B-T204
##is	I-T204
is	O
a	O
common	O
enteric	B-T033
prot	I-T033
##ist	I-T033
colon	I-T033
##izing	I-T033
probably	O
more	O
than	O
1	O
billion	O
people	B-T098
with	O
a	O
large	O
variety	O
of	O
non	O
-	O
human	O
hosts	O
.	O
remarkable	O
genetic	O
diversity	O
has	O
been	O
observed	O
,	O
leading	O
to	O
the	O
subdiv	B-T170
##ision	I-T170
of	I-T170
the	I-T170
genus	I-T170
into	O
multiple	B-T170
subtypes	I-T170
(	O
st	B-T170
)	O
,	O
some	O
of	O
which	O
are	O
exclusively	O
found	O
in	O
non	O
-	O
human	O
hosts	O
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
distribution	O
of	O
blastocyst	B-T204
##is	I-T204
sts	I-T204
/	O
18s	B-T017
alleles	I-T017
in	O
symptomatic	O
(	O
abdominal	B-T033
pain	I-T033
,	O
anal	B-T033
pruritus	I-T033
,	O
diarrhea	B-T033
,	O
headache	B-T033
,	O
nausea	B-T033
##s	I-T033
and	O
/	O
or	O
vom	B-T033
##it	I-T033
)	O
and	O
asymptomatic	B-T033
children	O
from	O
nine	O
geographical	B-T082
regions	I-T082
of	I-T082
colombia	I-T082
.	O
a	O
total	O
of	O
202	O
##6	O
fecal	B-T058
samples	I-T058
were	O
collected	O
as	O
part	O
of	O
a	O
national	O
survey	O
to	O
estimate	O
the	O
frequency	O
of	O
intestinal	B-T038
parasites	I-T038
in	O
children	O
.	O
a	O
set	O
of	O
256	O
samples	O
that	O
were	O
blastocyst	B-T204
##is	I-T204
positive	I-T204
was	O
finally	O
selected	O
.	O
the	O
samples	O
were	O
submitted	O
to	O
dna	B-T062
extraction	I-T062
,	O
real	B-T062
time	I-T062
pcr	I-T062
and	O
sequencing	B-T058
using	O
blastocyst	O
##is	O
-	O
specific	O
primers	B-T103
targeting	O
the	O
small	B-T017
subunit	I-T017
rrna	B-T017
gene	I-T017
for	O
st	B-T058
identification	I-T058
.	O
dna	B-T103
of	O
asc	B-T204
##aris	I-T204
lum	I-T204
##br	I-T204
##ico	I-T204
##ides	I-T204
(	O
16	O
.	O
4	O
%	O
)	O
,	O
trich	B-T204
##ur	I-T204
##is	I-T204
trich	I-T204
##i	I-T204
##ura	I-T204
(	O
8	O
.	O
2	O
%	O
)	O
,	O
hook	B-T204
##worms	I-T204
(	O
nec	B-T204
##ator	I-T204
american	I-T204
##us	I-T204
/	O
anc	B-T204
##yl	I-T204
##ostom	I-T204
##a	I-T204
duodenal	I-T204
##e	I-T204
)	O
(	O
7	O
.	O
3	O
%	O
)	O
,	O
giardia	B-T204
duodenal	I-T204
##is	I-T204
(	O
23	O
.	O
1	O
%	O
)	O
,	O
ent	B-T204
##amoeba	I-T204
complex	I-T204
(	O
82	O
%	O
)	O
,	O
ent	B-T204
##amoeba	I-T204
coli	I-T204
(	O
55	O
%	O
)	O
,	O
hym	B-T204
##enol	I-T204
##epi	I-T204
##s	I-T204
nan	I-T204
##a	I-T204
(	O
0	O
.	O
8	O
%	O
)	O
,	O
endo	B-T204
##lim	I-T204
##ax	I-T204
nan	I-T204
##a	I-T204
(	O
33	O
.	O
2	O
%	O
)	O
and	O
neo	B-T204
##bal	I-T204
##anti	I-T204
##di	I-T204
##um	I-T204
coli	I-T204
(	O
2	O
.	O
7	O
%	O
)	O
was	O
detected	O
in	O
the	O
blastocyst	B-T204
##is	I-T204
-	O
positive	B-T033
samples	I-T033
.	O
we	O
detected	O
st	B-T204
##1	I-T204
(	O
21	O
.	O
4	O
%	O
)	O
,	O
st	B-T204
##2	I-T204
(	O
19	O
.	O
5	O
%	O
)	O
,	O
st	B-T204
##3	I-T204
(	O
55	O
.	O
5	O
%	O
)	O
,	O
st	B-T204
##4	I-T204
(	O
0	O
.	O
8	O
%	O
)	O
,	O
st	B-T204
##6	I-T204
(	O
2	O
%	O
)	O
and	O
st	B-T204
##7	I-T204
(	O
0	O
.	O
8	O
%	O
)	O
;	O
alleles	B-T017
1	O
,	O
2	O
,	O
4	O
,	O
81	O
,	O
82	O
and	O
83	O
for	O
st	B-T204
##1	I-T204
;	O
alleles	B-T017
9	O
,	O
11	O
,	O
12	O
,	O
15	O
,	O
67	O
,	O
71	O
and	O
73	O
for	O
st	B-T204
##2	I-T204
;	O
alleles	B-T017
34	O
,	O
36	O
,	O
38	O
,	O
45	O
,	O
49	O
,	O
55	O
,	O
134	O
and	O
128	O
for	O
st	B-T204
##3	I-T204
;	O
allele	B-T017
42	O
for	O
st	B-T204
##4	I-T204
;	O
allele	B-T017
122	O
for	O
st	B-T204
##6	I-T204
,	O
and	O
allele	B-T017
142	O
for	O
st	B-T204
##7	I-T204
.	O
further	O
studies	O
implementing	O
high	O
-	O
resolution	O
molecular	B-T201
markers	I-T201
are	O
necessary	O
to	O
understand	O
the	O
dynamics	O
of	O
blastocyst	B-T204
##is	I-T204
transmission	O
and	O
the	O
role	O
of	O
this	O
stra	B-T204
##men	I-T204
##op	I-T204
##ila	I-T204
in	O
health	O
and	O
disease	O
.	O

associations	O
of	O
body	B-T201
mass	I-T201
index	I-T201
and	O
physical	O
activity	O
with	O
sexual	B-T038
dysfunction	I-T038
in	O
breast	B-T038
cancer	I-T038
survivors	O
sexual	B-T038
dysfunction	I-T038
is	O
a	O
common	O
and	O
distress	B-T033
##ing	I-T033
consequence	O
of	O
breast	B-T038
cancer	I-T038
(	O
bc	B-T038
)	O
treatment	B-T058
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
investigated	O
the	O
sexual	B-T038
functioning	I-T038
of	O
bc	B-T038
patients	O
and	O
its	O
association	B-T038
with	O
women	B-T098
'	I-T098
s	I-T098
personal	O
characteristics	O
and	O
cancer	B-T058
treatments	I-T058
.	O
in	O
this	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
,	O
sexual	B-T038
function	I-T038
was	O
assessed	O
using	O
the	O
female	B-T170
sexual	I-T170
function	I-T170
index	I-T170
(	O
fs	B-T170
##fi	I-T170
)	O
.	O
the	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
hrqol	O
)	O
was	O
measured	O
using	O
the	O
european	B-T092
organization	I-T092
for	I-T092
research	I-T092
and	I-T092
treatment	I-T092
of	I-T092
cancer	I-T092
(	O
eo	B-T092
##rt	I-T092
##c	I-T092
)	O
ql	B-T170
##q	I-T170
-	I-T170
c3	I-T170
##0	I-T170
and	O
its	O
breast	B-T170
module	I-T170
br	I-T170
-	I-T170
23	I-T170
.	O
of	O
the	O
235	O
participants	B-T098
approached	O
,	O
216	O
participants	B-T098
were	O
included	O
in	O
the	O
study	O
.	O
of	O
these	O
,	O
63	O
patients	O
reported	O
no	O
sexual	O
activity	O
in	O
the	O
last	O
month	O
and	O
thus	O
were	O
analyzed	O
only	O
in	O
relation	O
to	O
the	O
sexual	B-T038
desire	I-T038
domain	O
of	O
fs	B-T170
##fi	I-T170
.	O
a	O
total	O
of	O
154	O
(	O
71	O
.	O
3	O
%	O
)	O
patients	O
were	O
classified	O
with	O
hypo	B-T038
##active	I-T038
sexual	I-T038
desire	I-T038
disorder	I-T038
(	O
hsd	B-T038
##d	I-T038
)	O
.	O
from	O
those	O
patients	O
reporting	O
sexual	O
activity	O
in	O
the	O
last	O
month	O
,	O
63	O
.	O
3	O
%	O
(	O
97	O
out	O
of	O
153	O
)	O
were	O
classified	O
with	O
sexual	B-T038
dysfunction	I-T038
.	O
using	O
hierarchical	B-T062
logistic	I-T062
regression	I-T062
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
r	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	B-T170
of	O
sexual	B-T038
dysfunction	I-T038
and	O
hsd	B-T038
##d	I-T038
were	O
6	O
.	O
8	O
and	O
7	O
.	O
2	O
%	O
,	O
respectively	O
.	O
age	O
,	O
bmi	B-T201
,	O
and	O
physical	O
activity	O
were	O
independently	O
associated	O
with	O
sexual	B-T038
dysfunction	I-T038
and	O
hsd	B-T038
##d	I-T038
.	O
additionally	O
,	O
bc	B-T038
patients	O
with	O
sexual	B-T038
dysfunction	I-T038
reported	O
lower	O
scores	O
on	O
global	O
hrqol	O
,	O
role	O
functioning	O
,	O
and	O
fatigue	B-T033
.	O
based	O
on	O
our	O
findings	B-T033
,	O
bc	B-T038
survivors	O
should	O
be	O
encouraged	O
to	O
practice	B-T038
regular	O
physical	O
activity	O
and	O
to	O
lose	O
weight	O
in	O
order	O
to	O
avoid	O
sexual	B-T038
dysfunction	I-T038
.	O
however	O
,	O
future	O
clinical	B-T062
trials	I-T062
are	O
needed	O
to	O
confirm	O
these	O
findings	B-T033
.	O

the	O
impact	O
of	O
childhood	B-T038
maltreatment	I-T038
on	O
the	O
differential	O
efficacy	O
of	O
cba	B-T058
##sp	I-T058
versus	O
esc	B-T103
##italopram	I-T103
in	O
patients	O
with	O
chronic	B-T038
depression	I-T038
:	O
a	O
secondary	O
analysis	O
childhood	B-T038
maltreatment	I-T038
(	O
cm	B-T038
)	O
has	O
been	O
indicated	B-T033
as	O
a	O
predictor	O
of	O
a	O
differential	O
response	O
to	O
antidepressant	B-T058
treatment	I-T058
with	O
psychotherapy	B-T058
compared	O
to	O
medication	B-T103
.	O
in	O
this	O
secondary	O
analysis	O
,	O
we	O
investigated	O
whether	O
the	O
presence	O
of	O
cm	B-T038
results	O
in	O
a	O
differential	O
indication	O
for	O
the	O
cognitive	B-T058
behavioral	I-T058
analysis	I-T058
system	I-T058
of	I-T058
psychotherapy	I-T058
(	O
cba	B-T058
##sp	I-T058
)	O
or	O
esc	B-T103
##italopram	I-T103
plus	O
clinical	B-T058
management	I-T058
(	O
esc	B-T103
)	O
.	O
sixty	O
patients	O
with	O
chronic	B-T038
depression	I-T038
were	O
randomized	B-T062
to	O
either	O
22	O
sessions	O
of	O
cba	B-T058
##sp	I-T058
or	O
esc	B-T103
over	O
the	O
course	O
of	O
8	O
weeks	O
of	O
acute	O
and	O
20	O
weeks	O
of	O
extended	O
treatment	B-T058
at	O
2	O
german	B-T082
treatment	B-T082
sites	I-T082
.	O
cm	B-T038
was	O
assessed	O
using	O
the	O
childhood	O
trauma	O
questionnaire	B-T170
and	O
the	O
clinician	B-T097
rated	O
early	B-T170
trauma	I-T170
inventory	I-T170
.	O
intention	B-T062
-	I-T062
to	I-T062
-	I-T062
treat	I-T062
analyses	I-T062
were	O
used	O
to	O
examine	O
the	O
impact	O
of	O
cm	B-T038
on	O
depression	B-T038
,	O
global	O
functioning	O
,	O
and	O
quality	O
of	O
life	O
.	O
the	O
presence	O
of	O
cm	B-T038
did	O
not	O
result	O
in	O
significant	O
differences	O
in	O
treatment	B-T201
response	I-T201
to	O
cba	B-T058
##sp	I-T058
or	O
esc	B-T103
on	O
any	O
outcome	O
measure	O
after	O
28	O
weeks	O
of	O
treatment	B-T058
independent	O
of	O
the	O
type	O
of	O
cm	B-T038
assessment	B-T058
.	O
after	O
8	O
weeks	O
,	O
a	O
significant	O
cm	B-T038
×	O
treatment	B-T058
interaction	O
was	O
found	B-T033
for	O
scores	O
on	O
the	O
mont	B-T170
##go	I-T170
##mer	I-T170
##y	I-T170
-	I-T170
as	I-T170
##berg	I-T170
depression	I-T170
rating	I-T170
scale	I-T170
.	O
patients	O
with	O
a	O
history	B-T033
of	O
cm	B-T038
receiving	O
cba	B-T058
##sp	I-T058
had	O
a	O
significantly	O
lower	O
response	O
rate	O
compared	O
to	O
patients	O
without	O
cm	B-T038
and	O
to	O
those	O
receiving	O
esc	B-T103
after	O
8	O
weeks	O
.	O
conclusively	O
,	O
cba	B-T058
##sp	I-T058
and	O
esc	B-T103
are	O
equally	O
effective	O
treatment	B-T058
options	O
for	O
the	O
difficult	O
to	O
treat	O
subgroup	B-T170
of	O
patients	O
with	O
chronic	B-T038
depression	I-T038
and	O
a	O
history	B-T033
of	O
cm	B-T038
.	O
cm	B-T038
may	O
be	O
a	O
predictor	O
of	O
a	O
longer	O
latency	O
of	O
treatment	B-T201
response	I-T201
in	O
the	O
case	O
of	O
psychotherapy	B-T058
.	O
cba	B-T058
##sp	I-T058
and	O
esc	B-T103
##italopram	I-T103
are	O
equally	O
effective	O
treatment	B-T058
options	O
for	O
chronic	B-T038
depression	I-T038
.	O
both	O
treatments	B-T058
are	O
also	O
equally	O
effective	O
for	O
the	O
difficult	O
to	O
treat	O
subgroup	B-T170
of	O
patients	O
with	O
chronic	B-T038
depression	I-T038
and	O
a	O
history	B-T033
of	O
childhood	B-T038
maltreatment	I-T038
.	O
childhood	B-T038
maltreatment	I-T038
may	O
result	O
in	O
a	O
longer	O
latency	O
of	O
treatment	B-T201
response	I-T201
in	O
the	O
case	O
of	O
psychotherapy	B-T058
.	O

evaluation	B-T058
of	O
spontaneous	O
bone	B-T038
regeneration	I-T038
after	O
enucleation	B-T058
of	O
large	O
cysts	B-T038
of	O
the	O
jaw	B-T017
##s	I-T017
using	O
radiographic	O
computed	B-T058
software	B-T170
spontaneous	O
regeneration	B-T038
of	I-T038
bone	I-T038
is	O
commonly	O
seen	O
in	O
the	O
small	O
surgical	B-T058
defects	O
caused	O
by	O
enucleation	B-T058
of	O
cysts	B-T038
.	O
however	O
,	O
in	O
case	O
of	O
large	O
surgical	B-T058
defects	O
caused	O
by	O
the	O
enucleation	B-T058
,	O
spontaneous	O
regeneration	B-T038
of	I-T038
bone	I-T038
is	O
a	O
rare	O
phenomenon	O
and	O
it	O
depends	O
on	O
factors	O
,	O
such	O
as	O
age	O
of	O
the	O
patient	O
,	O
intact	O
peri	B-T017
##oste	I-T017
##um	I-T017
,	O
and	O
proper	O
stabilization	B-T058
.	O
the	O
study	B-T062
included	O
16	O
patients	O
,	O
who	O
reported	B-T058
to	O
the	O
department	B-T092
of	I-T092
oral	I-T092
and	I-T092
maxillofacial	I-T092
surgery	I-T092
with	O
the	O
complaint	B-T038
of	O
pain	B-T033
and	O
swelling	B-T033
in	O
the	O
jaw	B-T017
##s	I-T017
diagnosed	B-T033
as	O
cyst	B-T038
.	O
the	O
sample	O
included	O
equal	O
numbers	O
of	O
male	O
and	O
female	O
subjects	O
aged	O
between	O
15	O
and	O
40	O
years	O
.	O
panoramic	B-T058
radiographs	I-T058
were	O
taken	O
pre	O
-	O
and	O
postoperatively	O
on	O
day	O
2	O
of	O
the	O
enucleation	B-T058
.	O
the	O
dimensions	O
of	O
the	O
cyst	B-T038
were	O
evaluated	B-T058
on	O
the	O
radiograph	B-T058
according	O
to	O
the	O
prof	O
##orm	O
##a	O
.	O
subsequent	O
radiographs	B-T058
were	O
taken	O
at	O
regular	O
intervals	O
of	O
1	O
.	O
5	O
,	O
3	O
,	O
and	O
6	O
months	O
using	O
standard	O
parameters	O
and	O
were	O
analyzed	B-T062
using	O
mci	O
##d	O
##™	O
analysis	O
software	B-T170
of	O
imaging	B-T058
research	I-T058
.	O
mean	O
reduction	B-T058
was	O
seen	O
in	O
up	O
to	O
39	O
and	O
60	O
%	O
in	O
the	O
cystic	O
cavity	B-T017
size	B-T082
and	O
increase	O
in	O
the	O
mean	O
density	O
up	O
to	O
59	O
and	O
90	O
.	O
2	O
%	O
at	O
3	O
and	O
6	O
months	O
intervals	O
respectively	O
.	O
spontaneous	O
bone	B-T038
regeneration	I-T038
was	O
seen	O
even	O
after	O
primary	O
closure	B-T058
of	O
the	O
large	O
cystic	O
defect	O
without	O
the	O
need	O
for	O
placement	B-T058
of	O
foreign	O
substances	O
or	O
grafts	B-T103
and	O
it	O
also	O
eliminated	O
the	O
complications	B-T038
resulting	O
from	O
placement	B-T058
of	O
foreign	O
substance	O
.	O
further	O
studies	B-T062
are	O
required	O
in	O
a	O
larger	O
sample	O
with	O
longer	O
follow	B-T058
-	I-T058
up	I-T058
durations	O
to	O
confirm	O
the	O
outcome	O
of	O
the	O
present	O
work	O
for	O
the	O
benefit	O
of	O
patients	O
.	O
the	O
present	O
study	B-T062
depicted	O
that	O
spontaneous	O
bone	B-T038
regeneration	I-T038
can	O
occur	O
with	O
accepted	O
results	O
after	O
simple	O
enucleation	B-T058
of	O
jaw	B-T017
cyst	B-T038
without	O
the	O
aid	O
of	O
any	O
graft	B-T103
material	I-T103
.	O
hence	O
,	O
simple	O
enucleation	B-T058
may	O
be	O
considered	O
as	O
a	O
first	B-T058
line	I-T058
of	I-T058
treatment	I-T058
modality	O
for	O
cystic	O
lesion	B-T033
of	O
the	O
jaw	B-T017
##s	I-T017
.	O
this	O
simpl	O
##ifies	O
the	O
surgical	B-T058
procedure	I-T058
,	O
decreases	O
the	O
economic	O
and	O
biologic	O
costs	O
,	O
and	O
reduces	B-T058
the	O
risk	O
of	O
postoperative	B-T038
complications	I-T038
.	O
follow	B-T058
-	I-T058
up	I-T058
is	O
necessary	O
along	O
with	O
patient	O
'	O
s	O
compliance	O
for	O
the	O
success	O
of	O
treatment	O
.	O

combination	B-T103
of	O
tel	B-T103
##mi	I-T103
##sa	I-T103
##rt	I-T103
##an	I-T103
with	O
sildenafil	B-T103
ameliorate	O
progression	B-T038
of	O
diabetic	B-T038
nephropathy	I-T038
in	O
streptozotocin	B-T103
-	O
induced	O
diabetic	B-T033
model	O
diabetic	B-T038
nephropathy	I-T038
(	O
dn	B-T038
)	O
is	O
a	O
leading	O
cause	O
of	O
end	B-T038
-	I-T038
stage	I-T038
renal	I-T038
disease	I-T038
in	O
the	O
world	O
.	O
several	O
signaling	B-T038
pathways	I-T038
are	O
involved	O
in	O
the	O
pathogenesis	B-T038
of	O
dn	B-T038
including	O
elevation	B-T082
in	O
level	O
of	O
angiotensin	B-T103
ii	I-T103
,	O
formation	O
of	O
advanced	B-T103
glycation	I-T103
end	I-T103
products	I-T103
(	O
age	B-T103
)	O
,	O
activation	B-T038
of	O
protein	B-T103
kinase	I-T103
c	I-T103
(	O
pkc	B-T103
)	O
,	O
and	O
lipid	B-T033
accumulation	I-T033
.	O
these	O
pathways	B-T038
activate	O
one	O
another	O
mutually	O
leading	O
to	O
oxidative	B-T038
stress	I-T038
,	O
increasing	O
expression	B-T038
of	O
transforming	B-T103
growth	I-T103
factor	I-T103
beta	I-T103
-	I-T103
1	I-T103
(	O
tgf	B-T103
-	I-T103
β	I-T103
1	I-T103
)	O
and	O
release	O
of	O
interleukin	B-T103
##s	I-T103
and	O
adhesion	B-T103
molecules	I-T103
,	O
so	O
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
interrup	O
##t	O
more	O
than	O
pathogenic	B-T033
pathway	O
to	O
ameliorate	O
the	O
progression	B-T038
of	O
dn	B-T038
.	O
in	O
the	O
present	O
study	B-T062
,	O
white	O
male	O
rats	O
(	O
n	O
=	O
48	O
)	O
were	O
divided	O
into	O
six	O
groups	O
(	O
8	O
rats	O
each	O
)	O
,	O
the	O
first	O
two	O
groups	O
served	O
as	O
normal	O
control	O
and	O
a	O
control	O
vehicle	O
group	O
while	O
the	O
remaining	O
four	O
groups	O
were	O
rendered	O
diabetic	B-T033
by	O
a	O
single	O
intraperitoneal	B-T058
injection	I-T058
of	O
streptozotocin	B-T103
(	O
stz	B-T103
)	O
and	O
being	O
left	O
for	O
4	O
weeks	O
to	O
develop	O
dn	B-T038
.	O
thereafter	O
,	O
the	O
rats	O
were	O
divided	O
into	O
dn	B-T038
group	O
,	O
dn	B-T038
group	O
receiving	O
tel	B-T103
##mi	I-T103
##sa	I-T103
##rt	I-T103
##an	I-T103
or	O
sildenafil	B-T103
or	O
tel	B-T103
##mi	I-T103
##sa	I-T103
##rt	I-T103
##an	I-T103
sildenafil	B-T103
combination	B-T103
.	O
after	O
the	O
specified	O
treatment	O
period	O
,	O
urine	B-T031
samples	I-T031
were	O
collected	O
(	O
using	O
metabolic	O
cages	O
)	O
to	O
measure	O
proteinuria	B-T033
,	O
animals	B-T204
were	O
then	O
euthanized	O
,	O
blood	B-T031
and	O
tissue	B-T017
samples	I-T017
were	O
collected	O
for	O
measurement	B-T058
of	I-T058
blood	I-T058
glucose	I-T058
,	O
bun	B-T058
,	O
s	B-T058
.	I-T058
cr	I-T058
,	O
ldl	B-T058
,	O
no	B-T058
,	O
tgf	B-T058
-	I-T058
β1	I-T058
,	O
il	B-T058
-	I-T058
1β	I-T058
,	O
age	B-T058
##ps	I-T058
,	O
and	O
sod	B-T058
.	O
the	O
combination	B-T058
therapy	I-T058
showed	O
significant	O
decrease	O
in	O
bun	B-T103
,	O
s	B-T103
.	I-T103
cr	I-T103
,	O
ldl	B-T103
,	O
tgf	B-T103
-	I-T103
β1	I-T103
,	O
il	B-T103
-	I-T103
1β	I-T103
,	O
proteinuria	B-T033
and	O
age	B-T103
##ps	I-T103
and	O
significant	O
increase	O
in	O
sod	B-T103
and	O
no	B-T103
.	O
the	O
findings	O
showed	O
that	O
combination	B-T058
therapy	I-T058
was	O
able	O
to	O
ameliorate	O
dn	B-T038
and	O
that	O
the	O
effects	O
were	O
superior	O
to	O
the	O
single	O
drugs	B-T103
alone	O
.	O

homogeneous	O
synthesis	O
of	O
ag	O
nanoparticles	O
-	O
doped	O
water	B-T103
-	I-T103
soluble	I-T103
cellulose	I-T103
acetate	I-T103
for	O
versatile	O
applications	O
we	O
report	B-T170
a	O
facile	O
and	O
efficient	O
approach	B-T082
for	O
synthesis	O
of	O
well	B-T082
-	I-T082
dispersed	I-T082
and	O
stable	O
silver	O
nanoparticles	O
(	O
ag	O
nps	O
)	O
using	O
water	B-T103
-	I-T103
soluble	I-T103
cellulose	I-T103
acetate	I-T103
(	O
ca	B-T103
)	O
as	O
both	O
reduct	B-T103
##ant	I-T103
and	O
stabilize	O
##r	O
.	O
partially	O
substituted	O
ca	B-T103
with	O
highly	O
active	O
hydroxyl	B-T103
groups	I-T103
and	O
excellent	O
water	O
-	O
solubility	O
is	O
able	B-T033
to	O
reduce	O
silver	B-T103
ions	I-T103
in	O
homogeneous	O
aqueous	O
medium	O
effectively	O
.	O
the	O
synthesized	O
ag	O
nps	O
were	O
characterized	O
by	O
uv	B-T058
-	I-T058
vis	I-T058
spectroscopy	I-T058
,	O
x	B-T058
-	I-T058
ray	I-T058
diffraction	I-T058
,	O
x	B-T058
-	I-T058
ray	I-T058
photoelectron	I-T058
spectroscopy	I-T058
,	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
and	O
energy	B-T058
dispersive	I-T058
x	I-T058
-	I-T058
ray	I-T058
spectro	I-T058
##sc	I-T058
##ope	I-T058
analysis	B-T058
.	O
the	O
as	O
-	O
prepared	B-T033
ag	O
nps	O
were	O
well	B-T082
-	I-T082
dispersed	I-T082
,	O
showing	O
a	O
surface	B-T062
plasmon	I-T062
resonance	I-T062
peak	O
at	O
42	O
##6	O
nm	O
.	O
the	O
resulted	O
ag	O
nps	O
@	O
ca	B-T103
nano	O
##hy	O
##brids	O
exhibit	O
high	O
catalytic	O
activity	O
for	O
the	O
reduction	O
of	O
4	B-T103
-	I-T103
nitroph	I-T103
##enol	I-T103
to	O
4	B-T103
-	I-T103
amino	I-T103
##phenol	I-T103
in	O
the	O
presence	O
of	O
nab	B-T103
##h4	I-T103
.	O
meanwhile	O
,	O
the	O
nano	O
##hy	O
##brids	O
are	O
also	O
effective	O
in	O
inhibiting	O
the	O
growth	B-T038
of	O
bacterial	B-T007
.	O
this	O
environmentally	O
friendly	O
method	O
promotes	O
the	O
use	O
of	O
renewable	O
natural	O
resources	O
to	O
prepare	O
a	O
variety	O
of	O
inorganic	O
-	O
organic	O
materials	O
for	O
catalysis	O
,	O
antibacterial	B-T103
,	O
sensors	O
and	O
other	O
applications	O
.	O

the	O
role	O
of	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
bearing	I-T074
##s	I-T074
in	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
and	O
hip	B-T058
resurf	I-T058
##acing	I-T058
:	O
review	B-T170
article	I-T170
the	O
current	O
role	O
of	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
(	I-T074
mom	I-T074
)	I-T074
bearing	I-T074
##s	I-T074
in	O
hip	B-T058
arthroplasty	I-T058
remains	O
controversial	O
.	O
the	O
low	O
wear	O
offered	O
by	O
mom	B-T074
bearing	I-T074
##s	I-T074
compared	O
to	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
polyethylene	I-T074
and	O
the	O
possibility	O
of	O
a	O
lower	O
risk	O
of	O
dislocation	B-T037
with	O
larger	O
head	O
sizes	O
,	O
encouraged	O
a	O
trend	O
towards	O
the	O
re	B-T058
-	I-T058
introduction	I-T058
of	O
the	O
mom	B-T074
bearing	I-T074
couple	O
.	O
however	O
,	O
recent	O
evidence	O
has	O
shown	O
that	O
not	O
all	O
designs	O
of	O
the	O
mom	B-T074
bearing	I-T074
have	O
been	O
successful	O
.	O
the	O
purpose	O
of	O
this	O
paper	O
is	O
to	O
provide	O
an	O
update	O
on	O
the	O
use	O
of	O
mom	B-T074
bearing	I-T074
##s	I-T074
and	O
address	O
the	O
following	O
issues	O
:	O
(	O
1	O
)	O
the	O
reint	B-T058
##roduc	I-T058
##tion	I-T058
of	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
bearing	I-T074
##s	I-T074
in	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
,	O
(	O
2	O
)	O
the	O
failure	O
of	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
bearing	I-T074
##s	I-T074
in	O
stem	B-T058
##med	I-T058
total	I-T058
hip	I-T058
arthroplasty	I-T058
,	O
(	O
3	O
)	O
the	O
role	O
of	O
metal	B-T058
-	I-T058
on	I-T058
-	I-T058
metal	I-T058
hip	I-T058
resurf	I-T058
##acing	I-T058
in	O
modern	O
orthopaedic	B-T091
##s	I-T091
and	O
(	O
4	O
)	O
metal	B-T058
-	I-T058
on	I-T058
-	I-T058
metal	I-T058
hip	I-T058
resurf	I-T058
##acing	I-T058
versus	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
.	O
a	O
literature	B-T170
search	O
strategy	O
was	O
conducted	O
using	O
various	O
search	O
terms	O
in	O
medline	B-T170
and	O
embase	B-T170
.	O
the	O
highest	O
quality	B-T170
articles	I-T170
that	O
met	O
the	O
inclusion	O
criteria	O
and	O
best	O
answered	O
the	O
topics	O
of	O
focus	O
of	O
this	O
review	B-T170
were	O
selected	O
.	O
key	O
search	O
terms	O
included	O
'	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
'	O
,	O
'	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
'	O
and	O
'	O
hip	B-T058
resurf	I-T058
##acing	I-T058
'	O
.	O
the	O
initial	O
search	O
retrieved	O
124	O
##0	O
articles	B-T170
.	O
twenty	O
-	O
two	O
articles	B-T170
were	O
selected	O
and	O
used	O
in	O
the	O
review	B-T170
.	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
hip	I-T074
resurf	I-T074
##acing	I-T074
is	O
still	O
a	O
suitable	O
treatment	B-T058
option	O
in	O
specific	O
patient	O
populations	O
with	O
the	O
appropriate	O
implant	B-T058
design	I-T058
and	O
surgical	O
skill	O
,	O
while	O
stem	O
##med	O
metal	B-T074
-	I-T074
on	I-T074
-	I-T074
metal	I-T074
total	I-T074
hip	I-T074
arthroplasty	I-T074
should	O
be	O
avoided	O
in	O
all	O
patient	O
populations	O
.	O
continued	O
follow	B-T058
-	I-T058
up	I-T058
of	O
patients	O
undergoing	O
metal	B-T058
-	I-T058
on	I-T058
-	I-T058
metal	I-T058
hip	I-T058
resurf	I-T058
##acing	I-T058
is	O
critical	O
in	O
order	O
to	O
further	O
understand	O
the	O
long	O
-	O
term	O
outcomes	O
of	O
these	O
patients	O
and	O
why	O
certain	O
complications	B-T038
tend	O
to	O
occur	O
with	O
this	O
procedure	O
.	O

predicting	O
violence	B-T038
and	O
rec	O
##idi	O
##vis	O
##m	O
in	O
a	O
large	O
sample	O
of	O
males	O
on	O
prob	O
##ation	O
or	O
par	O
##ole	O
this	O
study	B-T062
evaluated	O
the	O
utility	O
of	O
items	O
and	O
scales	O
from	O
the	O
io	B-T082
##wa	I-T082
violence	B-T038
and	O
victimization	O
instrument	B-T170
in	O
a	O
sample	O
of	O
196	O
##1	O
males	O
from	O
the	O
state	O
of	O
io	B-T082
##wa	I-T082
who	O
were	O
on	O
prob	O
##ation	O
or	O
released	B-T033
from	I-T033
prison	I-T033
to	O
par	O
##ole	O
supervision	O
.	O
this	O
is	O
the	O
first	O
study	B-T062
to	O
examine	O
the	O
potential	O
of	O
the	O
io	B-T082
##wa	I-T082
violence	B-T038
and	O
victimization	O
instrument	B-T170
to	O
predict	O
criminal	O
off	O
##enses	O
.	O
the	O
males	O
were	O
followed	O
for	O
30	O
months	O
immediately	O
following	O
their	O
admission	O
to	O
prob	O
##ation	O
or	O
par	O
##ole	O
.	O
auc	O
analyses	B-T062
indicated	O
fair	O
to	O
good	O
predictive	O
power	O
for	O
the	O
io	B-T082
##wa	I-T082
violence	B-T038
and	O
victimization	O
instrument	B-T170
for	O
charges	O
of	O
violence	B-T038
and	O
victimization	O
,	O
but	O
chance	O
predictive	O
power	O
for	O
drug	O
off	O
##enses	O
.	O
notably	O
,	O
both	O
scales	O
of	O
the	O
instrument	B-T170
performed	O
equally	O
well	O
at	O
the	O
30	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
.	O
items	O
on	O
the	O
io	B-T082
##wa	I-T082
violence	B-T038
and	O
victimization	O
instrument	B-T170
not	O
only	O
predicted	O
violence	B-T038
,	O
but	O
are	O
straightforward	O
to	O
score	O
.	O
violence	B-T038
management	O
strategies	O
are	O
discussed	O
as	O
they	O
relate	O
to	O
the	O
current	O
findings	O
,	O
including	O
the	O
potential	O
to	O
expand	B-T082
the	O
measure	O
to	O
other	O
jur	B-T170
##isd	I-T170
##iction	I-T170
##s	I-T170
and	O
populations	B-T098
.	O

the	O
relationship	O
between	O
anthrop	B-T062
##ometry	I-T062
and	O
body	O
composition	O
from	O
computed	B-T058
tomography	I-T058
:	O
the	O
mediators	O
of	O
atherosclerosis	B-T038
in	O
south	B-T098
asians	I-T098
living	O
in	O
america	B-T082
study	O
few	O
studies	O
examine	O
the	O
relationships	O
between	O
anthrop	B-T062
##ometry	I-T062
and	O
the	O
body	O
composition	O
measures	O
they	O
approximate	O
,	O
or	O
whether	O
they	O
differ	O
by	O
sex	O
,	O
and	O
no	O
studies	O
have	O
examined	O
these	O
relationships	O
in	O
south	B-T098
asians	I-T098
living	O
in	O
the	O
us	B-T082
.	O
we	O
conducted	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
of	O
87	O
##1	O
participants	B-T098
in	O
the	O
mediators	O
of	O
atherosclerosis	B-T038
in	O
south	B-T098
asians	I-T098
living	O
in	O
america	B-T082
(	B-T062
mas	I-T062
##ala	I-T062
)	I-T062
study	I-T062
who	O
had	O
bmi	B-T201
<	O
40	O
kg	O
/	O
m	O
(	O
2	O
)	O
and	O
underwent	O
abdominal	B-T058
ct	I-T058
scans	I-T058
for	O
measurement	O
of	O
visceral	B-T017
and	O
subcutaneous	B-T017
fat	I-T017
.	O
linear	O
regression	O
was	O
used	O
to	O
model	B-T170
the	O
associations	O
between	O
anthropometric	B-T170
measures	I-T170
and	O
naturally	O
log	O
-	O
transformed	O
body	O
composition	O
measures	O
.	O
all	O
measures	O
of	O
anthrop	B-T062
##ometry	I-T062
,	O
except	O
height	O
,	O
were	O
significantly	O
associated	O
with	O
visceral	B-T017
fat	I-T017
and	O
had	O
a	O
significant	O
non	O
-	O
linear	O
component	O
(	O
p	O
<	O
.	O
05	O
)	O
.	O
the	O
only	O
associations	O
for	O
visceral	B-T017
fat	I-T017
that	O
exhibited	O
significant	O
heterogeneity	O
by	O
sex	O
were	O
waist	B-T201
circumference	I-T201
(	O
%	O
difference	O
in	O
visceral	B-T017
fat	I-T017
slope	O
:	O
women	B-T098
1	O
.	O
92	O
,	O
men	B-T098
2	O
.	O
74	O
,	O
p	O
=	O
.	O
007	O
for	O
interaction	O
)	O
and	O
waist	O
-	O
to	O
-	O
hip	O
ratio	O
(	O
women	B-T098
25	O
.	O
9	O
,	O
men	B-T098
71	O
##7	O
.	O
4	O
,	O
p	O
<	O
.	O
001	O
)	O
.	O
except	O
for	O
height	O
,	O
all	O
measures	O
of	O
anthrop	B-T062
##ometry	I-T062
were	O
significantly	O
associated	O
with	O
subcutaneous	B-T017
fat	I-T017
,	O
had	O
a	O
significant	O
quadratic	O
component	O
,	O
and	O
significant	O
heterogeneity	O
by	O
sex	O
(	O
weight	O
(	O
kg	O
)	O
:	O
2	O
.	O
74	O
for	O
women	B-T098
,	O
4	O
.	O
08	O
for	O
men	B-T098
;	O
bmi	B-T201
(	O
kg	O
/	O
m	O
(	O
2	O
)	O
)	O
:	O
10	O
.	O
3	O
,	O
14	O
.	O
0	O
;	O
waist	B-T201
circumference	I-T201
(	O
cm	O
)	O
:	O
1	O
.	O
51	O
,	O
3	O
.	O
36	O
;	O
hip	B-T201
circumference	I-T201
(	O
cm	O
)	O
:	O
2	O
.	O
53	O
,	O
4	O
.	O
50	O
)	O
with	O
p	O
<	O
.	O
001	O
for	O
each	O
.	O
in	O
mas	O
##ala	O
participants	B-T098
,	O
the	O
relationships	O
of	O
anthropometric	B-T170
measures	I-T170
with	O
visceral	B-T017
and	O
subcutaneous	B-T017
fat	I-T017
appear	O
similar	O
to	O
other	O
race	B-T098
/	O
ethnic	B-T098
groups	I-T098
,	O
but	O
with	O
weaker	O
non	O
-	O
linearity	O
and	O
heterogeneity	O
by	O
sex	O
.	O
given	O
these	O
results	O
,	O
researchers	B-T097
should	O
consider	O
separate	O
models	O
by	O
sex	O
for	O
us	O
south	B-T098
asians	I-T098
when	O
approxim	O
##ating	O
subcutaneous	B-T017
fat	I-T017
or	O
when	O
using	O
waist	B-T201
circumference	I-T201
to	O
approximate	O
visceral	B-T017
fat	I-T017
.	O

discover	O
##ing	O
key	O
residues	O
of	O
dengue	B-T005
virus	I-T005
ns	B-T103
##2b	I-T103
-	I-T103
ns	I-T103
##3	I-T103
-	I-T103
protease	I-T103
:	O
new	O
binding	B-T103
sites	I-T103
for	O
antiviral	O
inhibitors	O
design	O
the	O
ns	B-T103
##2b	I-T103
-	I-T103
ns	I-T103
##3	I-T103
protease	I-T103
is	O
essential	O
for	O
the	O
dengue	B-T005
virus	I-T005
(	O
denv	B-T005
)	O
replication	B-T038
process	I-T038
.	O
this	O
complex	B-T017
constitutes	O
a	O
target	O
for	O
efficient	O
antiviral	B-T103
discovery	O
because	O
a	O
drug	B-T103
could	O
inhibit	O
the	O
viral	B-T038
polyp	I-T038
##rotein	I-T038
processing	I-T038
.	O
furthermore	O
,	O
since	O
the	O
protease	B-T103
is	O
highly	O
conserved	B-T082
between	O
the	O
four	O
dengue	B-T005
virus	I-T005
serotypes	B-T170
,	O
it	O
is	O
probable	O
that	O
a	O
drug	B-T103
would	O
be	O
equally	O
effective	O
against	O
all	O
of	O
them	O
.	O
in	O
this	O
article	O
,	O
a	O
strategy	O
is	O
reported	O
that	O
allowed	O
us	O
to	O
identify	O
influential	O
residues	O
on	O
the	O
function	O
of	O
the	O
dengue	B-T005
ns	B-T103
##2b	I-T103
-	I-T103
ns	I-T103
##3	I-T103
protease	I-T103
.	O
moreover	O
,	O
this	O
is	O
a	O
strategy	O
that	O
could	O
be	O
applied	O
to	O
virtually	O
any	O
protein	B-T103
for	O
the	O
search	O
of	O
alternative	O
influential	O
residues	O
,	O
and	O
for	O
non	O
-	O
competitive	O
inhibitor	O
development	O
.	O
first	O
,	O
we	O
incorporated	O
several	O
features	O
derived	O
from	O
computational	B-T091
alanine	B-T103
scanning	B-T062
mutagenesis	I-T062
,	O
sequence	B-T082
,	O
structure	B-T082
conservation	I-T082
,	O
and	O
other	O
structure	B-T082
-	O
based	O
characteristics	O
.	O
second	O
,	O
these	O
features	O
were	O
used	O
as	O
variables	O
to	O
obtain	O
a	O
multilayer	B-T170
percept	I-T170
##ron	I-T170
model	I-T170
to	O
identify	O
defined	O
groups	O
(	O
clusters	O
)	O
of	O
key	O
residues	O
as	O
possible	O
candidate	O
pockets	O
for	O
binding	B-T103
sites	I-T103
of	O
new	O
leads	O
on	O
the	O
denv	B-T005
protease	B-T103
.	O
the	O
identified	O
residues	O
included	O
:	O
i	O
)	O
amino	B-T103
acids	I-T103
close	O
to	O
the	O
beta	B-T082
sheet	I-T082
-	O
loop	O
-	O
beta	B-T082
sheet	I-T082
known	O
to	O
be	O
important	O
in	O
its	O
closed	B-T082
conformation	I-T082
for	O
ns	B-T103
##2b	I-T103
ii	O
)	O
residues	O
close	O
to	O
the	O
active	O
site	O
,	O
iii	O
)	O
several	O
residues	O
evenly	O
spread	O
on	O
the	O
ns	B-T103
##2b	I-T103
-	I-T103
ns	I-T103
##3	I-T103
contact	O
surface	O
,	O
and	O
iv	O
)	O
some	O
inner	O
residues	O
most	O
likely	O
related	O
to	O
the	O
overall	O
stability	O
of	O
the	O
protease	B-T103
.	O
in	O
addition	O
,	O
we	O
found	O
concordance	O
on	O
our	O
list	O
of	O
residues	O
with	O
previously	O
identified	O
amino	B-T103
acids	I-T103
part	O
of	O
a	O
highly	O
conserved	O
peptide	B-T103
studied	O
for	O
vaccine	B-T062
development	I-T062
.	O

development	O
of	O
a	O
novel	O
quantitative	O
structure	O
-	O
activity	O
relationship	O
model	B-T170
to	O
accurately	O
predict	O
pulmonary	B-T038
absorption	I-T038
and	O
replace	O
routine	O
use	O
of	O
the	O
isolated	O
perfused	O
resp	B-T038
##iring	I-T038
rat	B-T017
lung	I-T017
model	B-T170
we	O
developed	O
and	O
tested	O
a	O
novel	O
quantitative	O
structure	O
-	O
activity	O
relationship	O
(	O
qsar	O
)	O
model	B-T170
to	O
better	O
understand	O
the	O
physicochemical	O
drivers	O
of	O
pulmonary	B-T038
absorption	I-T038
,	O
and	O
to	O
facilitate	O
compound	O
design	O
through	O
improved	O
prediction	O
of	O
absorption	O
.	O
the	O
model	B-T170
was	O
tested	O
using	O
a	O
large	O
array	O
of	O
both	O
existing	O
and	O
newly	O
designed	O
compounds	B-T103
.	O
pulmonary	B-T038
absorption	I-T038
data	O
was	O
generated	O
using	O
the	O
isolated	O
perfused	O
resp	B-T038
##iring	I-T038
rat	B-T017
lung	I-T017
(	O
ipr	B-T017
##lu	I-T017
)	O
model	B-T170
for	O
82	O
drug	B-T062
discovery	I-T062
compounds	B-T103
and	O
17	O
marketed	B-T103
drugs	I-T103
.	O
this	O
dataset	O
was	O
used	O
to	O
build	O
a	O
novel	O
qsar	O
model	B-T170
based	O
on	O
calculated	O
physicochemical	O
properties	O
.	O
a	O
further	O
9	O
compounds	B-T103
were	O
used	O
to	O
test	O
the	O
model	B-T170
'	I-T170
s	I-T170
predictive	O
capability	O
.	O
the	O
qsar	O
model	B-T170
performed	O
well	O
on	O
the	O
9	O
compounds	B-T103
in	O
the	O
[UNK]	O
test	B-T170
set	I-T170
[UNK]	O
with	O
a	O
predicted	O
versus	O
observed	O
correlation	O
of	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
85	O
,	O
and	O
>	O
65	O
%	O
of	O
compounds	B-T103
correctly	O
categor	O
##ised	O
.	O
calculated	O
descriptors	O
associated	O
with	O
permeability	O
and	O
hydrophobicity	O
positively	O
correlated	O
with	O
pulmonary	B-T038
absorption	I-T038
,	O
whereas	O
those	O
associated	O
with	O
charge	O
,	O
ion	O
##isation	O
and	O
size	B-T082
negatively	O
correlated	O
.	O
the	O
novel	O
qsar	O
model	B-T170
described	O
here	O
can	O
replace	O
routine	O
generation	O
of	O
ipr	B-T017
##lu	I-T017
model	B-T170
data	O
for	O
ranking	B-T170
and	O
classifying	B-T170
compounds	B-T103
prior	O
to	O
synthesis	O
.	O
it	O
will	O
also	O
provide	O
scientists	O
working	O
in	O
the	O
field	O
of	O
inhaled	B-T062
drug	I-T062
discovery	I-T062
with	O
a	O
deeper	O
understanding	O
of	O
the	O
physicochemical	O
drivers	O
of	O
pulmonary	B-T038
absorption	I-T038
based	O
on	O
a	O
relevant	O
respiratory	O
compound	B-T103
dataset	B-T170
.	O

co	B-T058
-	I-T058
chip	I-T058
enables	O
genome	B-T062
-	I-T062
wide	I-T062
mapping	I-T062
of	O
histone	B-T082
mark	I-T082
co	O
-	O
occurrence	O
at	O
single	O
-	O
molecule	O
resolution	O
histone	B-T038
modifications	I-T038
play	O
an	O
important	O
role	O
in	O
chromatin	B-T038
organization	I-T038
and	O
transcriptional	B-T038
regulation	I-T038
,	O
but	O
despite	O
the	O
large	O
amount	O
of	O
genome	B-T017
-	I-T017
wide	I-T017
histone	B-T038
modification	I-T038
data	O
collected	O
in	O
different	O
cells	B-T017
and	O
tissues	B-T017
,	O
little	O
is	O
known	O
about	O
co	O
-	O
occurrence	O
of	O
modifications	B-T038
on	O
the	O
same	O
nucleosome	B-T103
.	O
here	O
we	O
present	O
a	O
genome	O
-	O
wide	O
quantitative	O
method	O
for	O
combinatorial	B-T170
indexed	I-T170
chromatin	B-T058
immunoprecipitation	I-T058
(	O
co	B-T058
-	I-T058
chip	I-T058
)	O
to	O
characterize	O
co	O
-	O
occurrence	O
of	O
histone	B-T038
modifications	I-T038
on	O
nucleosomes	B-T103
.	O
using	O
co	B-T058
-	I-T058
chip	I-T058
,	O
we	O
study	B-T062
the	O
genome	B-T017
-	I-T017
wide	I-T017
co	O
-	O
occurrence	O
of	O
14	O
chromatin	B-T082
marks	I-T082
(	O
70	O
pairwise	O
combinations	O
)	O
,	O
and	O
find	O
previously	O
undes	O
##cribed	O
co	O
-	O
occurrence	O
patterns	B-T082
,	O
including	O
the	O
co	O
-	O
occurrence	O
of	O
h3k	B-T017
##9	I-T017
##me	I-T017
##1	I-T017
and	O
h3k	B-T017
##27	I-T017
##ac	I-T017
in	O
super	B-T082
-	I-T082
enhancers	I-T082
.	O
finally	O
,	O
we	O
apply	O
co	B-T058
-	I-T058
chip	I-T058
to	O
measure	O
the	O
distribution	O
of	O
the	O
bival	O
##ent	O
h3k	B-T017
##4	I-T017
##me3	I-T017
-	O
h3k	B-T017
##27	I-T017
##me3	I-T017
domains	B-T082
in	O
two	O
distinct	O
mouse	B-T017
embryonic	I-T017
stem	I-T017
cell	I-T017
(	O
mes	B-T017
##c	I-T017
)	O
states	O
and	O
in	O
four	O
adult	B-T017
tissues	I-T017
.	O
we	O
observe	O
dynamic	O
changes	O
in	O
5	O
,	O
78	O
##6	O
regions	O
and	O
discover	O
both	O
loss	O
and	O
de	O
novo	O
gain	O
of	O
bival	O
##ency	O
in	O
key	O
tissue	O
-	O
specific	O
regulatory	B-T017
genes	I-T017
,	O
suggesting	O
a	O
functional	O
role	O
for	O
bival	O
##ent	O
domains	B-T082
during	O
different	O
stages	O
of	O
development	O
.	O
these	O
results	O
show	O
that	O
co	B-T058
-	I-T058
chip	I-T058
can	O
reveal	O
the	O
complex	O
interactions	O
between	O
histone	B-T038
modifications	I-T038
.	O

dna	B-T038
annealing	I-T038
by	O
red	B-T103
##β	I-T103
is	O
insufficient	O
for	O
homologous	B-T038
recombination	I-T038
and	O
the	O
additional	O
requirements	O
involve	O
intra	O
-	O
and	O
inter	O
-	O
molecular	O
interactions	O
single	B-T103
strand	I-T103
annealing	I-T103
proteins	I-T103
(	O
ssa	B-T103
##ps	I-T103
)	O
like	O
red	B-T103
##β	I-T103
initiate	O
homologous	B-T038
recombination	I-T038
by	O
annealing	B-T103
complementary	I-T103
dna	I-T103
strands	I-T103
.	O
we	O
show	O
that	O
c	B-T038
-	I-T038
terminally	I-T038
truncated	I-T038
red	B-T103
##β	I-T103
,	O
whilst	O
still	O
able	O
to	O
promote	O
annealing	B-T038
and	O
nucle	B-T038
##oprotein	I-T038
filament	I-T038
formation	I-T038
,	O
is	O
unable	O
to	O
mediate	O
homologous	B-T038
recombination	I-T038
.	O
mutations	B-T038
of	O
the	O
c	B-T082
-	I-T082
terminal	I-T082
domain	I-T082
were	O
evaluated	O
using	O
both	O
single	B-T103
-	O
and	O
double	B-T103
stranded	I-T103
(	O
ss	B-T103
and	O
ds	B-T103
)	O
substrates	O
in	O
recombination	B-T038
assays	B-T058
.	O
mutations	B-T058
of	O
critical	B-T103
amino	I-T103
acids	I-T103
affected	O
either	O
dsdna	B-T103
recombination	B-T038
or	O
both	O
ssdna	B-T103
and	O
dsdna	B-T038
recombination	I-T038
indicating	O
two	O
separ	O
##able	O
functions	O
,	O
one	O
of	O
which	O
is	O
critical	O
for	O
dsdna	B-T038
recombination	I-T038
and	O
the	O
second	O
for	O
recombination	B-T038
per	O
se	O
.	O
as	O
evaluated	O
by	O
co	B-T058
-	I-T058
immunoprecipitation	I-T058
experiments	I-T058
,	O
the	O
dsdna	B-T038
recombination	I-T038
function	I-T038
relates	O
to	O
the	O
red	B-T103
##α	I-T103
-	O
red	B-T103
##β	I-T103
protein	B-T038
-	I-T038
protein	I-T038
interaction	I-T038
,	O
which	O
requires	O
not	O
only	O
contacts	O
in	O
the	O
c	B-T082
-	I-T082
terminal	I-T082
domain	I-T082
but	O
also	O
a	O
region	O
near	O
the	O
n	B-T082
-	I-T082
terminus	I-T082
.	O
because	O
the	O
nucle	B-T038
##oprotein	I-T038
filament	I-T038
formed	I-T038
with	O
c	B-T038
-	I-T038
terminally	I-T038
truncated	I-T038
red	B-T103
##β	I-T103
has	O
altered	O
properties	O
,	O
the	O
second	O
c	B-T038
-	I-T038
terminal	I-T038
function	I-T038
could	O
be	O
due	O
to	O
an	O
interaction	B-T038
required	O
for	O
functional	O
filaments	B-T017
.	O
alternatively	O
the	O
second	O
c	B-T038
-	I-T038
terminal	I-T038
function	I-T038
could	O
indicate	O
a	O
requirement	O
for	O
a	O
red	B-T103
##β	I-T103
-	O
host	B-T038
factor	I-T038
interaction	I-T038
.	O
these	O
data	O
further	O
advance	O
the	O
model	O
for	O
red	B-T038
recombination	I-T038
and	O
the	O
proposition	O
that	O
red	B-T103
##β	I-T103
and	O
rad	B-T103
##52	I-T103
ssa	B-T103
##ps	I-T103
share	O
ancestral	O
and	O
mechanistic	O
roots	O
.	O

high	B-T058
-	I-T058
fructose	I-T058
diet	I-T058
is	O
as	O
detrimental	O
as	O
high	B-T058
-	I-T058
fat	I-T058
diet	I-T058
in	O
the	O
induction	B-T058
of	O
insulin	B-T038
resistance	I-T038
and	O
diabetes	B-T038
mediated	O
by	O
hepatic	B-T082
/	O
pancreatic	B-T017
endoplasmic	B-T038
reticulum	I-T038
(	I-T038
er	I-T038
)	I-T038
stress	I-T038
in	O
the	O
context	O
of	O
high	O
human	B-T204
consumption	O
of	O
fructose	B-T103
diets	B-T168
,	O
there	O
is	O
an	O
imperative	O
need	O
to	O
understand	B-T038
how	O
dietary	O
fructose	B-T033
intake	I-T033
influence	O
cellular	B-T017
and	O
molecular	O
mechanisms	O
and	O
thereby	O
affect	O
β	B-T033
-	I-T033
cell	I-T033
dysfunction	I-T033
and	O
insulin	B-T038
resistance	I-T038
.	O
while	O
evidence	O
exists	O
for	O
a	O
relationship	O
between	O
high	O
-	O
fat	B-T103
-	O
induced	O
insulin	B-T038
resistance	I-T038
and	O
metabolic	B-T038
disorders	I-T038
,	O
there	O
is	O
lack	O
of	O
studies	B-T062
in	O
relation	O
to	O
high	B-T058
-	I-T058
fructose	I-T058
diet	I-T058
.	O
therefore	O
,	O
we	O
attempted	O
to	O
study	B-T062
the	O
effect	O
of	O
different	O
diets	B-T168
viz	O
.	O
,	O
high	B-T058
-	I-T058
fat	I-T058
diet	I-T058
(	O
hfd	B-T058
)	O
,	O
high	B-T058
-	I-T058
fructose	I-T058
diet	I-T058
(	O
hfs	B-T058
)	O
,	O
and	O
a	O
combination	O
(	O
hfs	B-T058
+	O
hfd	B-T058
)	O
diet	B-T168
on	O
glucose	B-T038
homeostasis	I-T038
and	O
insulin	B-T038
sensitivity	I-T038
in	O
male	O
wistar	B-T204
rats	I-T204
compared	O
to	O
control	B-T204
animals	I-T204
fed	O
with	O
normal	O
pellet	O
diet	B-T168
.	O
investigations	O
include	O
oral	B-T058
glucose	I-T058
tolerance	I-T058
test	I-T058
,	O
insulin	B-T058
tolerance	I-T058
test	I-T058
,	O
histopathology	B-T058
by	O
h	B-T058
&	I-T058
e	I-T058
and	O
mass	B-T058
##on	I-T058
'	I-T058
s	I-T058
trich	I-T058
##rome	I-T058
staining	I-T058
,	O
mrna	B-T038
expression	I-T038
by	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
,	O
protein	B-T058
expression	I-T058
by	O
western	B-T058
blot	I-T058
,	O
and	O
caspase	B-T038
-	I-T038
3	I-T038
activity	I-T038
by	O
color	B-T058
##imetry	I-T058
.	O
rats	B-T204
subjected	O
to	O
high	B-T058
-	I-T058
fat	I-T058
/	O
fructose	B-T058
diets	I-T058
became	O
glucose	B-T103
intoler	O
##ant	O
,	O
insulin	B-T038
-	I-T038
resistant	I-T038
,	O
and	O
dyslipid	B-T033
##emic	I-T033
.	O
compared	O
to	O
control	B-T204
animals	I-T204
,	O
rats	B-T204
subjected	O
to	O
different	O
combination	O
of	O
fat	B-T058
/	O
fructose	B-T058
diets	I-T058
showed	O
increased	O
mrna	B-T038
and	O
protein	B-T038
expression	I-T038
of	O
a	O
battery	O
of	O
er	B-T038
stress	I-T038
markers	O
both	O
in	O
pancreas	B-T017
and	O
liver	B-T017
.	O
transcription	B-T103
factors	I-T103
of	O
β	B-T038
-	I-T038
cell	I-T038
function	I-T038
(	O
ins	B-T103
##ig	I-T103
##1	I-T103
,	O
srebp	B-T103
##1c	I-T103
and	O
pd	B-T103
##x1	I-T103
)	O
as	O
well	O
as	O
hepatic	B-T082
gluconeogenesis	B-T038
(	O
fox	B-T103
##o1	I-T103
and	O
pep	B-T103
##ck	I-T103
)	O
were	O
adversely	B-T038
affected	I-T038
in	O
diet	B-T168
-	O
induced	O
insulin	B-T038
-	I-T038
resistant	I-T038
rats	B-T204
.	O
the	O
convergence	O
of	O
chronic	O
er	B-T038
stress	I-T038
towards	O
apoptosis	B-T038
in	O
pancreas	B-T017
/	O
liver	B-T017
was	O
also	O
indicated	B-T033
by	O
increased	O
levels	O
of	O
chop	B-T103
mrna	I-T103
&	O
increased	O
activity	O
of	O
both	O
jnk	B-T038
and	O
caspase	B-T038
-	I-T038
3	I-T038
in	O
rats	B-T204
subjected	O
to	O
high	B-T058
-	I-T058
fat	I-T058
/	O
fructose	B-T058
diets	I-T058
.	O
our	O
study	B-T062
expose	O
##s	O
the	O
experimental	O
support	O
in	O
that	O
high	B-T058
-	I-T058
fructose	I-T058
diet	I-T058
is	O
equally	O
detrimental	O
in	O
causing	O
metabolic	B-T038
disorders	I-T038
.	O

palliative	B-T091
care	I-T091
with	O
attachment	O
hybrid	O
removable	O
prosthesis	O
abutment	B-T017
injury	B-T037
,	O
unsatisfactory	O
aesthetic	O
##s	O
and	O
lesser	O
retention	B-T058
exist	O
with	O
the	O
cast	O
partial	O
denture	O
.	O
though	O
these	O
constraints	O
exist	O
in	O
the	O
removable	B-T074
partial	I-T074
denture	I-T074
(	O
rp	B-T074
##d	I-T074
)	O
it	O
is	O
still	O
widely	O
used	O
because	O
of	O
the	O
simplicity	O
in	O
design	B-T058
,	O
fabrication	O
,	O
economics	O
and	O
patient	B-T058
comfort	I-T058
.	O
this	O
clinical	B-T170
report	I-T170
describes	O
a	O
hybrid	O
rp	B-T074
##d	I-T074
technique	O
which	O
uses	O
extra	O
coronal	B-T082
attachment	O
that	O
reduces	O
the	O
limitations	O
and	O
provides	O
better	O
comfort	B-T038
for	O
the	O
patient	O
.	O

results	O
of	O
an	O
international	B-T062
postm	I-T062
##ark	I-T062
##eting	I-T062
surveillance	I-T062
study	I-T062
of	O
pl	B-T103
-	I-T103
vegf	I-T103
##16	I-T103
##5	I-T103
safety	O
and	O
efficacy	O
in	O
210	O
patients	O
with	O
peripheral	B-T038
arterial	I-T038
disease	I-T038
the	O
effective	O
treatment	B-T058
of	O
chronic	O
lower	B-T017
limb	I-T017
ischemia	B-T038
is	O
one	O
of	O
the	O
most	O
challenging	O
issues	O
confron	O
##ting	O
vascular	B-T097
surgeons	I-T097
.	O
current	O
pharmacological	O
therapies	B-T058
play	O
an	O
auxiliary	O
role	O
and	O
cann	O
##ot	O
prevent	O
disease	B-T038
progression	I-T038
,	O
and	O
new	O
treatment	B-T058
methods	I-T058
are	O
needed	O
.	O
pl	B-T103
-	I-T103
vegf	I-T103
##16	I-T103
##5	I-T103
,	O
a	O
gene	B-T058
therapy	I-T058
drug	B-T103
,	O
was	O
approved	O
in	O
russia	B-T082
for	O
the	O
treatment	B-T058
of	O
atherosclerotic	O
peripheral	B-T038
arterial	I-T038
disease	I-T038
(	O
pad	B-T038
)	O
after	O
clinical	B-T062
studies	I-T062
in	O
2011	O
.	O
the	O
study	B-T062
drug	B-T103
is	O
an	O
original	O
gene	B-T103
construction	I-T103
in	O
which	O
pl	B-T103
-	I-T103
vegf	I-T103
##16	I-T103
##5	I-T103
1	O
.	O
2	O
mg	O
is	O
the	O
active	B-T103
substance	I-T103
.	O
this	O
postm	B-T062
##ark	I-T062
##eting	I-T062
surveillance	I-T062
study	I-T062
was	O
undertaken	O
to	O
evaluate	O
the	O
safety	O
(	O
identification	O
of	O
uncommon	O
side	B-T038
effects	I-T038
)	O
and	O
efficacy	O
of	O
gene	B-T058
therapy	I-T058
in	O
patients	O
in	O
routine	O
clinical	O
practice	O
.	O
in	O
total	O
,	O
210	O
patients	O
with	O
stage	O
ii	O
-	O
iii	O
chronic	O
limb	B-T017
ischemia	B-T038
(	O
according	O
to	O
the	O
fon	B-T170
##tain	I-T170
##e	I-T170
classification	I-T170
modified	O
by	O
av	O
po	O
##k	O
##rov	O
##sk	O
##y	O
)	O
in	O
33	O
healthcare	B-T092
facilities	I-T092
in	O
russia	B-T082
and	O
the	O
uk	B-T082
##ra	I-T082
##ine	I-T082
were	O
enrolled	O
in	O
the	O
study	B-T062
.	O
the	O
control	O
group	O
(	O
n	O
=	O
60	O
)	O
received	O
conservative	B-T058
therapy	I-T058
without	O
prostaglandins	B-T103
and	O
prostacyclin	B-T103
##s	I-T103
,	O
and	O
the	O
treatment	B-T098
group	I-T098
(	O
n	O
=	O
150	O
)	O
received	O
treatment	B-T058
with	O
pl	B-T103
-	I-T103
vegf	I-T103
##16	I-T103
##5	I-T103
as	O
two	O
intramuscular	O
injections	O
for	O
a	O
total	O
dose	O
of	O
2	O
.	O
4	O
mg	O
.	O
pain	B-T033
-	I-T033
free	I-T033
walking	I-T033
distance	I-T033
(	O
pw	B-T033
##d	I-T033
)	O
(	O
the	O
primary	O
efficacy	O
criterion	O
for	O
fon	B-T170
##tain	I-T170
##e	I-T170
stages	O
ii	O
-	O
iii	O
)	O
,	O
blood	B-T033
flow	I-T033
linear	I-T033
velocity	I-T033
(	O
bf	B-T033
##lv	I-T033
)	O
,	O
and	O
ankle	B-T201
-	I-T201
brachial	I-T201
index	I-T201
(	O
abi	B-T201
)	O
were	O
monitored	O
for	O
6	O
months	O
.	O
the	O
safety	O
of	O
pl	B-T103
-	I-T103
vegf	I-T103
##16	I-T103
##5	I-T103
gene	B-T062
transfer	I-T062
in	O
terms	O
of	O
the	O
trial	B-T062
protocol	I-T062
was	O
initially	O
evaluated	O
6	O
months	O
after	O
the	O
start	O
of	O
the	O
study	O
;	O
adverse	B-T038
events	I-T038
(	O
aes	B-T038
)	O
and	O
serious	B-T038
adverse	I-T038
events	I-T038
(	O
sa	B-T038
##es	I-T038
)	O
were	O
recorded	O
during	O
both	O
routine	O
visits	B-T058
and	O
uns	O
##ched	O
##uled	O
requests	O
for	O
medical	O
care	O
.	O
overall	O
,	O
pw	B-T033
##d	I-T033
increased	O
by	O
177	O
%	O
,	O
from	O
100	O
.	O
3	O
±	O
6	O
.	O
9	O
to	O
277	O
.	O
1	O
±	O
16	O
.	O
2	O
m	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
,	O
in	O
the	O
treatment	B-T098
group	I-T098
,	O
whereas	O
the	O
mean	O
value	O
was	O
unchanged	O
in	O
the	O
control	O
group	O
(	O
p	O
=	O
0	O
.	O
218	O
)	O
.	O
both	O
bf	B-T033
##lv	I-T033
and	O
abi	B-T201
values	I-T201
increased	O
by	O
24	O
%	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
in	O
the	O
treatment	B-T098
group	I-T098
but	O
decreased	O
in	O
the	O
control	O
group	O
.	O
the	O
greatest	O
therapeutic	B-T201
effect	I-T201
was	O
observed	O
for	O
stage	O
iii	O
disease	B-T038
:	O
pw	B-T033
##d	I-T033
increased	O
by	O
68	O
##3	O
%	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
.	O
no	B-T033
angiogenic	B-T058
therapy	I-T058
-	O
related	O
aes	B-T038
or	O
side	B-T038
effects	I-T038
were	O
recorded	O
,	O
and	O
target	O
limb	B-T058
salvage	I-T058
was	O
96	O
and	O
97	O
%	O
in	O
the	O
treatment	B-T098
and	O
control	O
groups	O
,	O
respectively	O
.	O
the	O
results	O
obtained	O
in	O
this	O
study	B-T062
are	O
not	O
significantly	O
different	O
from	O
those	O
observed	O
in	O
the	O
phase	B-T062
iib	I-T062
/	O
iii	B-T062
registration	O
clinical	B-T062
study	I-T062
completed	O
in	O
2011	O
.	O
pl	B-T103
-	I-T103
vegf	I-T103
##16	I-T103
##5	I-T103
intramuscular	B-T082
gene	B-T062
transfer	I-T062
is	O
an	O
effective	O
treatment	B-T058
for	O
moderate	O
to	O
severe	O
claudication	B-T038
due	O
to	O
chronic	O
lower	B-T017
limb	I-T017
ischemia	B-T038
in	O
routine	O
clinical	O
practice	O
.	O
clinicaltrials	O
.	O
gov	O
identifier	O
:	O
nct0	O
##23	O
##69	O
##80	O
##9	O
.	O

assessing	O
the	O
learning	B-T038
potential	O
of	O
an	O
interactive	O
digital	O
game	O
versus	O
an	O
interactive	O
-	O
style	O
did	O
##actic	O
lecture	B-T170
:	O
the	O
continued	O
importance	O
of	O
did	O
##actic	O
teaching	O
in	O
medical	B-T097
student	I-T097
education	O
games	O
with	O
educational	O
intent	O
offer	O
a	O
possible	B-T033
advantage	O
of	O
being	O
more	O
interactive	O
and	O
increasing	O
learn	B-T098
##er	I-T098
satisfaction	B-T038
.	O
we	O
conducted	O
a	O
two	B-T062
-	I-T062
armed	I-T062
experiment	I-T062
to	O
evaluate	B-T058
student	B-T098
satisfaction	B-T038
and	O
content	O
master	O
##y	O
for	O
an	O
introduc	O
##tory	O
pediatric	B-T091
radiology	I-T091
topic	B-T170
,	O
taught	O
by	O
either	O
an	O
interactive	O
digital	O
game	O
or	O
with	O
a	O
traditional	O
did	O
##actic	O
lecture	B-T170
.	O
medical	B-T097
students	I-T097
participating	O
in	O
a	O
fourth	O
-	O
year	O
radiology	B-T091
elective	O
were	O
invited	O
to	O
participate	O
.	O
student	B-T098
cohorts	B-T098
were	O
alternatively	O
given	O
a	O
faculty	B-T097
-	O
supervised	O
1h	O
session	O
playing	O
a	O
simple	O
interactive	O
digital	O
tic	O
-	O
tac	O
-	O
toe	O
qu	O
##iz	O
module	O
on	O
pediatric	B-T058
gastrointestinal	I-T058
radiology	I-T058
or	O
a	O
1h	O
did	O
##actic	O
introduc	O
##tory	O
lecture	B-T170
on	O
the	O
same	O
topic	B-T170
.	O
survey	B-T170
questions	B-T170
assessed	O
the	O
learners	B-T098
'	I-T098
perceived	B-T038
ability	O
to	O
recall	O
the	O
material	O
as	O
well	O
as	O
their	O
satisfaction	B-T038
with	O
the	O
educational	O
experience	B-T038
.	O
results	O
of	O
an	O
end	O
-	O
of	O
-	O
rotation	O
exam	O
were	O
reviewed	O
to	O
evaluate	B-T058
a	O
quantitative	O
measure	O
of	O
learning	B-T038
between	O
groups	O
.	O
survey	B-T170
responses	B-T038
were	O
analyzed	B-T062
with	O
a	O
chi	B-T170
-	I-T170
squared	I-T170
test	I-T170
.	O
exam	O
results	O
for	O
both	O
groups	O
were	O
analyzed	B-T062
with	O
a	O
paired	O
student	O
'	O
s	O
t	O
-	O
test	O
.	O
students	B-T098
in	O
the	O
lecture	B-T170
group	O
had	O
higher	O
test	O
scores	O
compared	O
to	O
students	B-T098
in	O
the	O
game	O
group	O
(	O
4	O
.	O
0	O
/	O
5	O
versus	O
3	O
.	O
6	O
/	O
5	O
,	O
p	O
=	O
0	O
.	O
045	O
)	O
.	O
students	B-T098
in	O
the	O
lecture	B-T170
group	O
reported	B-T058
greater	O
understanding	B-T038
and	O
recall	B-T038
of	O
the	O
material	O
than	O
students	B-T098
in	O
the	O
game	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
and	O
p	O
=	O
0	O
.	O
004	O
,	O
respectively	O
)	O
.	O
students	B-T098
in	O
the	O
lecture	B-T170
group	O
perceived	B-T038
the	O
lecture	B-T170
to	O
be	O
more	O
enjoy	O
##able	O
and	O
a	O
better	O
use	O
of	O
their	O
time	O
compared	O
to	O
those	O
in	O
the	O
game	O
group	O
(	O
p	O
=	O
0	O
.	O
04	O
and	O
p	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
.	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
between	O
the	O
lecture	B-T170
and	O
game	O
group	O
in	O
ability	O
to	O
maintain	O
interest	O
(	O
p	O
=	O
0	O
.	O
187	O
)	O
.	O
in	O
comparison	O
to	O
pre	O
-	O
survey	O
results	O
,	O
there	O
was	O
a	O
statistically	O
significant	O
decrease	O
in	O
interest	O
for	O
further	O
digital	O
interactive	O
materials	O
reported	B-T058
by	O
students	B-T098
in	O
the	O
game	O
group	O
(	O
p	O
=	O
0	O
.	O
146	O
)	O
.	O
our	O
experience	B-T038
supported	O
the	O
use	O
of	O
a	O
traditional	O
lecture	B-T170
over	O
a	O
digital	O
game	O
module	O
.	O
while	O
these	O
results	O
might	O
be	O
affected	O
by	O
the	O
specific	O
lecture	B-T170
and	O
digital	O
content	O
in	O
any	O
given	O
comparison	O
,	O
a	O
digital	O
module	O
is	O
not	O
always	O
the	O
superior	O
option	O
.	O

initial	O
clinical	B-T033
results	I-T033
with	O
the	O
thermo	O
##co	O
##ol	O
##®	O
smart	O
##to	O
##uch	O
##®	O
surround	O
flow	O
catheter	O
the	O
biosens	O
##e	O
webs	O
##ter	O
thermo	O
##co	O
##ol	O
(	O
®	O
)	O
smart	O
##to	O
##uch	O
(	O
®	O
)	O
surround	O
flow	O
(	O
sts	O
##f	O
)	O
catheter	O
is	O
a	O
recently	O
developed	O
ablation	B-T058
catheter	B-T074
incorporating	O
surround	B-T038
flow	I-T038
(	O
sf	B-T038
)	O
technology	O
to	O
ensure	O
efficient	O
cooling	O
and	O
force	O
sensing	O
to	O
quantify	O
tissue	B-T017
contact	O
.	O
in	O
our	O
unit	O
,	O
it	O
supers	O
##eded	O
the	O
thermo	O
##co	O
##ol	O
(	O
®	O
)	O
sf	O
catheter	O
from	O
the	O
time	O
of	O
its	O
introduction	O
in	O
may	O
2015	O
.	O
procedure	B-T058
-	O
related	O
data	O
were	O
collected	O
prospectively	O
for	O
the	O
first	O
100	O
ablation	B-T058
procedures	I-T058
performed	O
in	O
our	O
department	O
using	O
the	O
sts	O
##f	O
catheter	O
.	O
from	O
a	O
database	B-T170
of	O
65	O
##4	O
procedures	B-T058
performed	O
in	O
our	O
unit	O
using	O
the	O
sf	O
catheter	O
,	O
we	O
selected	O
one	O
to	O
match	O
each	O
sts	B-T058
##f	I-T058
procedure	I-T058
,	O
matching	O
for	O
procedure	B-T170
type	I-T170
,	O
operator	B-T098
experience	B-T038
,	O
patient	O
age	O
,	O
and	O
gender	O
.	O
the	O
groups	O
were	O
well	O
matched	O
for	O
patient	O
age	O
,	O
gender	O
,	O
and	O
procedure	B-T170
type	I-T170
.	O
procedure	O
duration	O
was	O
similar	O
in	O
both	O
groups	O
(	O
mean	O
225	O
.	O
5	O
vs	O
.	O
221	O
.	O
4	O
min	O
,	O
iqr	O
106	O
.	O
5	O
vs	O
.	O
91	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
55	O
)	O
,	O
but	O
fluoroscopy	O
duration	O
was	O
shorter	O
in	O
the	O
sts	O
##f	O
group	O
(	O
mean	O
25	O
.	O
8	O
vs	O
.	O
30	O
.	O
0	O
,	O
iqr	O
19	O
.	O
6	O
vs	O
.	O
18	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
03	O
)	O
.	O
no	B-T033
complication	I-T033
occurred	O
in	O
the	O
sts	O
##f	O
group	O
.	O
complications	B-T038
occurred	O
in	O
two	O
cases	O
in	O
the	O
sf	O
group	O
(	O
one	O
pericardial	B-T038
effusion	I-T038
requiring	O
drainage	B-T058
and	O
one	O
need	O
for	O
permanent	O
pacing	B-T058
)	O
.	O
complete	B-T033
procedural	I-T033
success	I-T033
was	O
achieved	O
in	O
98	O
cases	O
in	O
the	O
sts	O
##f	O
group	O
and	O
94	O
cases	O
in	O
the	O
sf	O
group	O
(	O
p	O
=	O
0	O
.	O
15	O
)	O
.	O
the	O
composite	O
endpoint	O
of	O
procedure	O
failure	O
or	O
acute	O
complication	B-T038
was	O
less	O
common	O
in	O
the	O
sts	O
##f	O
group	O
(	O
2	O
vs	O
.	O
8	O
,	O
p	O
=	O
0	O
.	O
05	O
)	O
.	O
the	O
sts	O
##f	O
catheter	O
is	O
safe	O
and	O
effective	O
in	O
treating	O
a	O
range	O
of	O
arrhythmias	B-T033
.	O
compared	O
with	O
the	O
sf	O
catheter	O
,	O
it	O
shows	O
a	O
trend	O
towards	O
improved	O
safety	O
-	O
efficacy	O
balance	O
.	O

draft	B-T082
genome	I-T082
sequences	I-T082
of	O
15	O
isolates	B-T103
of	O
listeria	B-T007
monocytogenes	I-T007
serotype	I-T007
1	I-T007
/	I-T007
2a	I-T007
,	O
subgroup	B-T170
st	O
##20	O
##4	O
listeria	B-T007
monocytogenes	I-T007
sequence	O
type	O
204	O
(	O
st	O
##20	O
##4	O
)	O
strains	O
have	O
been	O
isolated	O
from	O
a	O
range	B-T168
of	I-T168
food	I-T168
,	O
environmental	B-T082
,	O
and	O
clinical	O
sources	B-T033
in	O
australia	B-T082
.	O
this	O
study	O
describes	O
the	O
draft	B-T082
genome	I-T082
sequences	I-T082
of	O
15	O
isolates	O
collected	O
from	O
meat	B-T168
and	O
dairy	B-T168
associated	I-T168
sources	I-T168
.	O

limb	B-T017
remote	B-T058
ischaemic	I-T058
postcon	I-T058
##dition	I-T058
##ing	I-T058
-	O
induced	O
elevation	O
of	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
confers	O
neuroprotection	B-T038
to	O
rats	B-T204
with	O
cerebral	B-T038
ischaemia	I-T038
/	O
reperfusion	B-T037
injury	I-T037
:	O
activation	O
of	O
the	O
akt	B-T038
pathway	I-T038
limb	B-T017
remote	B-T058
ischaemic	I-T058
postcon	I-T058
##dition	I-T058
##ing	I-T058
(	O
rip	B-T058
##ost	I-T058
##c	I-T058
)	O
is	O
an	O
effective	O
and	O
well	O
-	O
acknowledged	O
treatment	B-T058
for	O
brain	O
ischaemia	O
injury	O
.	O
the	O
present	O
study	B-T062
aimed	O
to	O
evaluate	O
the	O
role	O
of	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
in	O
the	O
neuroprotection	B-T038
of	O
rip	B-T058
##ost	I-T058
##c	I-T058
against	O
cerebral	B-T038
ischaemia	I-T038
/	O
reperfusion	B-T037
(	I-T037
i	I-T037
/	I-T037
r	I-T037
)	I-T037
injury	I-T037
in	O
rats	B-T204
.	O
the	O
middle	B-T017
cerebral	I-T017
artery	I-T017
occlusion	I-T017
(	O
mcao	B-T017
)	O
model	O
was	O
established	O
in	O
rats	B-T204
and	O
then	O
rip	B-T058
##ost	I-T058
##c	I-T058
was	O
carried	O
out	O
by	O
three	O
cycles	O
of	O
10	O
minutes	O
occlusion	B-T017
/	O
10	O
minutes	O
release	O
of	O
the	O
bilateral	B-T082
femoral	B-T017
artery	I-T017
at	O
the	O
beginning	O
of	O
the	O
reperfusion	B-T058
.	O
to	O
downreg	B-T038
##ulate	I-T038
the	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
level	O
,	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
sirna	I-T103
was	O
injected	B-T058
into	O
the	O
lateral	B-T082
ventricle	I-T082
24	O
hours	O
before	O
mcao	B-T017
.	O
according	O
to	O
our	O
present	O
study	B-T062
,	O
rip	B-T058
##ost	I-T058
##c	I-T058
attenuated	O
cerebral	B-T038
i	I-T038
/	O
r	B-T037
injury	I-T037
by	O
decreasing	B-T033
infarct	B-T038
volume	O
,	O
improving	O
neurobehavioral	O
score	O
and	O
suppressing	O
blood	B-T017
brain	I-T017
barrier	I-T017
(	O
bbb	B-T017
)	O
leakage	B-T038
.	O
moreover	O
,	O
the	O
mrna	B-T103
and	O
protein	B-T033
levels	I-T033
of	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
were	O
upregulated	B-T038
by	O
rip	B-T058
##ost	I-T058
##c	I-T058
at	O
24	O
hours	O
and	O
72	O
hours	O
after	O
reperfusion	B-T058
.	O
downregulation	B-T038
of	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
attenuated	O
the	O
neuroprotection	B-T038
of	O
rip	B-T058
##ost	I-T058
##c	I-T058
.	O
finally	O
,	O
the	O
result	O
showed	O
that	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
was	O
upregulated	B-T038
by	O
rip	B-T058
##ost	I-T058
##c	I-T058
via	O
activation	O
of	O
the	O
pi3k	B-T038
/	I-T038
akt	I-T038
pathway	I-T038
.	O
taken	O
together	O
,	O
these	O
results	O
provide	O
evidence	O
that	O
upregulation	B-T038
of	O
fib	B-T103
##ulin	I-T103
-	I-T103
5	I-T103
is	O
involved	O
in	O
the	O
beneficial	O
effect	O
of	O
rip	B-T058
##ost	I-T058
##c	I-T058
against	O
cerebral	B-T038
i	I-T038
/	O
r	B-T037
injury	I-T037
.	O

associations	O
of	O
gender	O
and	O
a	O
proxy	O
of	O
female	O
menopausal	B-T201
status	I-T201
with	O
histological	O
features	O
of	O
drug	B-T038
-	I-T038
induced	I-T038
liver	I-T038
injury	I-T038
gender	O
and	O
menopause	B-T038
may	O
contribute	O
to	O
type	O
and	O
severity	O
of	O
drug	B-T038
-	I-T038
induced	I-T038
liver	I-T038
injury	I-T038
(	O
dil	B-T038
##i	I-T038
)	O
by	O
influencing	O
host	O
responses	B-T033
to	O
injury	B-T037
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
assess	O
the	O
associations	O
of	O
gender	O
and	O
female	O
age	O
50	O
[	O
a	O
proxy	O
of	O
menopause	B-T038
]	O
with	O
histological	O
features	O
of	O
liver	B-T037
injury	I-T037
in	O
212	O
adults	O
enrolled	O
in	O
the	O
drug	B-T038
-	I-T038
induced	I-T038
liver	I-T038
injury	I-T038
network	O
(	O
dil	O
##in	O
)	O
registry	B-T170
.	O
all	O
participants	B-T098
had	O
a	O
causality	O
score	O
of	O
at	O
least	O
'	O
probable	B-T033
'	O
,	O
a	O
liver	B-T058
biopsy	I-T058
within	O
30	O
days	O
of	O
dil	B-T038
##i	I-T038
onset	O
,	O
and	O
no	O
prior	O
chronic	B-T038
liver	I-T038
disease	I-T038
.	O
biochemical	O
and	O
histological	O
injury	B-T037
types	O
were	O
classified	O
as	O
hepatocellular	B-T038
or	O
cholest	B-T038
##atic	I-T038
/	I-T038
mixed	I-T038
injury	I-T038
.	O
the	O
cohort	B-T098
was	O
divided	O
into	O
three	O
gender	O
/	O
age	O
categories	B-T170
:	O
men	B-T098
(	O
41	O
.	O
0	O
%	O
)	O
,	O
women	B-T098
<	O
50	O
years	O
(	O
27	O
.	O
4	O
%	O
)	O
and	O
women	B-T098
≥50	O
years	O
of	O
age	O
(	O
31	O
.	O
6	O
%	O
)	O
.	O
interaction	O
of	O
gender	O
and	O
age	O
category	B-T170
(	O
≥50	O
or	O
not	O
)	O
was	O
assessed	O
.	O
hepatocellular	B-T038
injury	I-T038
was	O
more	O
prevalent	O
in	O
women	B-T098
<	O
50	O
years	O
vs	O
.	O
others	O
(	O
p	O
=	O
.	O
002	O
)	O
.	O
after	O
adjusting	O
for	O
biochemical	O
injury	B-T037
types	O
,	O
black	B-T098
race	I-T098
and	O
possible	B-T033
ageing	B-T038
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	B-T038
was	O
noted	O
in	O
biopsies	B-T058
of	O
women	B-T098
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	B-T098
and	O
women	B-T098
≥50	O
years	O
(	O
p	O
=	O
.	O
009	O
and	O
p	O
=	O
.	O
05	O
##5	O
respectively	O
)	O
.	O
compared	O
to	O
those	O
of	O
men	B-T098
,	O
biopsies	B-T058
of	O
women	B-T098
showed	O
greater	O
plasma	B-T038
cell	I-T038
infiltration	I-T038
,	O
hepatocyte	B-T038
apoptosis	I-T038
,	O
hepatocyte	B-T017
rosette	B-T033
##s	I-T033
and	O
lobular	O
dis	O
##arr	O
##ay	O
but	O
less	O
iron	B-T103
-	O
positive	B-T033
hepatocytes	B-T017
and	O
histological	O
cholestasis	B-T038
(	O
p	O
<	O
.	O
05	O
)	O
.	O
these	O
associations	O
persisted	O
after	O
excluding	O
cases	O
of	O
amoxicillin	B-T103
/	I-T103
clavul	I-T103
##anic	I-T103
acid	I-T103
,	O
anabolic	B-T103
steroids	I-T103
or	O
nitro	B-T103
##furan	I-T103
##to	I-T103
##in	I-T103
dil	B-T038
##i	I-T038
which	O
showed	O
gender	O
-	O
specific	O
distributions	O
.	O
gender	O
and	O
a	O
proxy	O
of	O
menopause	B-T038
were	O
associated	O
with	O
various	O
features	O
of	O
inflammation	B-T038
and	O
injury	B-T037
in	O
dil	B-T038
##i	I-T038
.	O

haemoglobin	B-T038
##opathies	I-T038
and	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
among	O
the	O
trib	B-T098
##als	I-T098
working	O
in	O
the	O
tea	B-T168
gard	O
##ens	O
of	O
ass	O
##am	O
,	O
india	B-T082
prevalence	O
of	O
haemoglobin	B-T038
##opathies	I-T038
and	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
are	O
very	O
high	O
in	O
india	B-T082
but	O
information	O
about	O
its	O
status	O
among	O
the	O
trib	B-T098
##als	I-T098
working	O
in	O
the	O
tea	B-T168
gard	O
##ens	O
of	O
ass	O
##am	O
is	O
very	O
less	O
.	O
the	O
present	O
study	B-T062
was	O
carried	O
out	O
to	O
determine	O
the	O
prevalence	O
of	O
haemoglobin	B-T038
##opathies	I-T038
and	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
among	O
the	O
trib	B-T098
##als	I-T098
working	O
in	O
the	O
tea	B-T168
gard	O
##ens	O
of	O
ass	O
##am	O
.	O
a	O
total	O
120	O
##4	O
samples	O
from	O
the	O
trib	B-T098
##als	I-T098
working	O
in	O
tea	B-T168
gard	O
##ens	O
of	O
ass	O
##am	O
were	O
analysed	B-T062
for	O
both	O
complete	B-T058
blood	I-T058
count	I-T058
(	O
cb	B-T058
##c	I-T058
)	O
and	O
high	B-T058
pressure	I-T058
liquid	I-T058
chromatography	I-T058
(	O
hplc	B-T058
)	O
for	O
detection	B-T058
of	O
haemoglobin	B-T038
##opathies	I-T038
and	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
.	O
this	O
study	B-T062
showed	O
that	O
the	O
prevalence	O
of	O
sickle	B-T038
cell	I-T038
anaemia	I-T038
and	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
were	O
very	O
high	O
among	O
this	O
population	B-T098
.	O
our	O
results	O
indicated	B-T033
a	O
higher	O
prevalence	O
of	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
(	O
3	O
.	O
07	O
%	O
)	O
among	O
the	O
mun	B-T098
##da	I-T098
ethnic	I-T098
group	I-T098
and	O
higher	O
prevalence	O
of	O
sickle	B-T038
cell	I-T038
anaemia	I-T038
(	O
4	O
.	O
73	O
%	O
)	O
among	O
the	O
loh	B-T098
##ar	I-T098
ethnic	I-T098
group	I-T098
.	O
this	O
was	O
the	O
first	O
study	B-T062
to	O
report	O
the	O
presence	B-T033
of	O
hbe	B-T103
among	O
the	O
trib	B-T098
##als	I-T098
working	O
in	O
the	O
tea	B-T168
gard	O
##ens	O
of	O
ass	O
##am	O
.	O
based	O
on	O
the	O
present	O
findings	B-T033
,	O
sickle	B-T038
cell	I-T038
anaemia	I-T038
and	O
β	B-T038
-	I-T038
thalass	I-T038
##aemia	I-T038
were	O
major	O
health	O
problem	B-T033
for	O
the	O
trib	B-T098
##als	I-T098
working	O
in	O
the	O
tea	B-T168
gard	O
##ens	O
of	O
ass	O
##am	O
.	O
proper	O
diagnostic	B-T058
facilities	I-T058
for	O
haemoglobin	B-T038
##opathy	I-T038
and	O
thalass	B-T038
##aemia	I-T038
should	O
be	O
established	O
in	O
these	O
areas	B-T082
,	O
including	O
establishment	O
of	O
haemoglobin	B-T038
##opathy	I-T038
and	O
thalass	B-T038
##aemia	I-T038
database	B-T170
collection	O
,	O
haematological	B-T092
analysis	I-T092
laboratories	I-T092
,	O
genetic	B-T092
counselling	I-T092
clinics	I-T092
,	O
prenatal	B-T092
diagnosis	I-T092
centres	I-T092
and	O
neonatal	B-T092
screening	I-T092
centres	I-T092
.	O

predictors	O
and	O
moder	O
##ators	O
of	O
spontaneous	O
pret	O
##end	O
play	O
in	O
children	O
with	O
and	O
without	O
autism	B-T038
spectrum	I-T038
disorder	I-T038
although	O
pret	O
##end	O
play	O
has	O
long	O
been	O
linked	O
to	O
children	O
'	O
s	O
normative	O
cognitive	B-T038
development	I-T038
,	O
inconsistent	O
findings	B-T033
call	O
for	O
greater	O
rig	O
##or	O
in	O
examining	O
this	O
relation	O
(	O
lil	O
##la	O
##rd	O
et	O
al	O
.	O
,	O
2013	O
)	O
.	O
spontaneous	O
pret	O
##end	O
play	O
is	O
often	O
impacted	O
in	O
atypical	O
development	B-T038
,	O
notably	O
in	O
autism	B-T038
spectrum	I-T038
disorder	I-T038
(	O
asd	B-T038
)	O
.	O
since	O
asd	B-T038
traits	O
exist	O
along	O
a	O
continuum	B-T082
in	O
the	O
general	B-T098
population	I-T098
,	O
investigating	O
how	O
pret	O
##end	O
play	O
varies	O
across	O
the	O
range	O
of	O
asd	B-T038
symptoms	B-T033
by	O
index	O
##ing	O
variations	O
in	O
asd	B-T038
traits	O
in	O
both	O
typically	O
developing	O
and	O
asd	B-T038
populations	B-T098
may	O
provide	O
insight	O
into	O
how	O
asd	B-T038
symptoms	B-T033
may	O
influence	O
the	O
relation	O
between	O
pret	O
##end	O
play	O
and	O
associated	O
processes	O
in	O
cognitive	B-T038
development	I-T038
.	O
this	O
study	B-T062
used	O
rigorous	O
observational	O
methods	O
to	O
assess	O
spontaneous	O
pret	O
##end	O
play	O
.	O
specifically	O
,	O
5	O
-	O
min	O
free	O
-	O
play	O
sessions	O
with	O
two	O
discrete	O
to	O
##y	O
sets	O
were	O
double	O
-	O
coded	O
by	O
blinded	O
code	O
##rs	O
(	O
code	O
##r	O
assignment	O
counter	O
##balanced	O
)	O
.	O
key	O
facets	O
of	O
pret	B-T038
##ense	I-T038
development	I-T038
[	O
attribution	O
of	O
pret	O
##end	O
properties	O
(	O
app	O
)	O
,	O
object	O
substitution	O
(	O
os	O
)	O
,	O
imag	B-T038
##inary	I-T038
objects	I-T038
]	O
were	O
examined	O
.	O
these	O
facets	O
of	O
pret	O
##end	O
play	O
production	B-T038
were	O
then	O
analyzed	B-T062
in	O
relation	O
to	O
asd	B-T038
symptoms	B-T033
,	O
as	O
well	O
as	O
plausible	O
,	O
long	O
-	O
theor	O
##ized	O
correlates	O
[	O
theory	O
of	O
mind	O
(	O
tom	O
)	O
,	O
verbal	O
ability	O
,	O
familiarity	B-T038
,	O
and	O
interest	B-T038
in	O
specific	O
to	O
##ys	O
]	O
.	O
forty	O
children	O
(	O
mage	O
=	O
6	O
;	O
5	O
,	O
sd	O
##age	O
=	O
1	O
.	O
45	O
;	O
29	O
males	O
)	O
,	O
six	O
of	O
whom	O
met	O
the	O
threshold	O
for	O
asd	B-T038
diagnosis	B-T033
via	O
parent	O
-	O
reported	O
asd	B-T038
symptoms	B-T033
,	O
participated	O
in	O
play	O
sessions	O
and	O
completed	O
measures	O
of	O
verbal	O
iq	O
and	O
tom	O
.	O
besides	O
the	O
measure	O
of	O
child	O
asd	B-T038
symptoms	B-T033
,	O
parents	O
completed	O
a	O
survey	B-T170
of	O
their	O
child	O
'	O
s	O
interest	B-T038
in	O
and	O
familiarity	B-T038
with	O
the	O
play	O
session	O
to	O
##ys	O
.	O
overall	O
,	O
greater	O
tom	O
predicted	O
more	O
app	O
,	O
and	O
more	O
interest	B-T038
in	O
the	O
to	O
##ys	O
presented	O
predicted	O
more	O
os	O
.	O
in	O
terms	O
of	O
overall	O
pret	O
##end	O
play	O
production	B-T038
,	O
two	O
results	O
were	O
counter	O
##int	O
##uit	O
##ive	O
.	O
first	O
,	O
among	O
children	O
with	O
more	O
asd	B-T038
symptoms	B-T033
,	O
verbal	O
ability	O
marginally	O
negatively	O
predicted	O
pret	O
##end	O
play	O
production	B-T038
.	O
second	O
,	O
among	O
children	O
with	O
fewer	O
asd	B-T038
symptoms	B-T033
,	O
tom	O
negatively	O
predicted	O
pret	O
##end	O
play	O
production	B-T038
.	O
further	O
probing	O
revealed	O
that	O
the	O
negative	O
effect	O
of	O
asd	B-T038
symptoms	B-T033
on	O
pret	O
##end	O
play	O
was	O
simultaneously	O
moderated	O
by	O
both	O
variables	O
:	O
low	O
tom	O
and	O
high	O
verbal	O
ability	O
both	O
related	O
to	O
less	O
pret	O
##end	O
play	O
production	O
among	O
children	O
with	O
more	O
asd	B-T038
symptoms	B-T033
.	O
implications	O
for	O
assessment	O
and	O
subsequent	O
treatment	B-T058
for	O
pret	O
##end	O
ability	O
among	O
children	O
with	O
varying	O
degrees	O
of	O
asd	B-T038
symptoms	B-T033
,	O
as	O
well	O
as	O
for	O
future	O
research	O
,	O
are	O
discussed	O
.	O

personal	O
##ly	O
meaningful	O
ritu	O
##als	O
:	O
a	O
way	O
to	O
increase	O
compass	O
##ion	O
and	O
decrease	O
burnout	B-T033
among	O
hospice	B-T058
staff	B-T097
and	O
volunteers	B-T098
ritu	O
##als	O
can	O
increase	O
a	O
sense	O
of	O
connected	O
##ness	O
,	O
meaning	O
,	O
and	O
support	O
,	O
especially	O
after	O
the	O
death	B-T038
of	O
those	O
for	O
whom	O
we	O
care	O
.	O
hospice	B-T058
staff	O
may	O
benefit	O
from	O
the	O
use	O
of	O
personal	O
ritu	O
##als	O
as	O
they	O
cope	O
with	O
the	O
frequent	O
deaths	O
of	O
their	O
patients	O
,	O
ultimately	O
aiming	O
to	O
provide	O
compass	O
##ionate	O
care	O
while	O
minimizing	O
burnout	B-T033
.	O
this	O
study	O
investigated	O
the	O
role	O
of	O
personal	O
##ly	O
meaningful	O
ritu	O
##als	O
in	O
increasing	O
compass	O
##ion	O
and	O
decreasing	O
burnout	B-T033
among	O
hospice	B-T058
staff	O
and	O
volunteers	B-T098
.	O
an	O
online	B-T170
survey	I-T170
was	O
completed	O
by	O
members	O
of	O
the	O
national	O
hospice	B-T058
and	O
palliative	O
care	O
organization	O
(	O
nh	O
##pc	O
##o	O
)	O
which	O
inqu	O
##ired	O
about	O
personal	O
ritu	O
##al	O
practices	O
,	O
and	O
included	O
the	O
professional	B-T170
quality	I-T170
of	I-T170
life	I-T170
(	I-T170
pro	B-T170
##qol	I-T170
)	I-T170
scale	I-T170
to	O
measure	O
current	O
levels	O
of	O
compass	O
##ion	O
satisfaction	B-T038
,	O
burnout	B-T033
,	O
and	O
secondary	B-T038
traumatic	I-T038
stress	I-T038
.	O
three	O
hundred	O
ninety	O
hospice	B-T058
staff	O
and	O
volunteers	B-T098
from	O
across	O
38	O
states	B-T082
completed	O
the	O
online	B-T170
survey	I-T170
.	O
the	O
majority	O
of	O
participants	B-T098
were	O
caucasian	B-T098
and	O
female	O
,	O
with	O
an	O
average	O
of	O
nine	O
years	O
of	O
experience	O
in	O
hospice	B-T058
and	O
palliative	O
care	O
.	O
the	O
majority	O
of	O
hospice	B-T058
staff	O
and	O
volunteers	B-T098
used	O
personal	O
##ly	O
meaningful	O
ritu	O
##als	O
after	O
the	O
death	B-T038
of	O
their	O
patients	O
to	O
help	O
them	O
cope	O
(	O
71	O
%	O
)	O
.	O
those	O
who	O
used	O
ritu	O
##als	O
demonstrated	O
significantly	O
higher	O
compass	O
##ion	O
satisfaction	B-T038
and	O
significantly	O
lower	O
burnout	B-T033
as	O
measured	O
by	O
the	O
pro	B-T170
##qol	I-T170
,	O
with	O
professional	O
support	O
,	O
social	O
support	O
,	O
and	O
age	O
playing	O
significant	B-T033
roles	I-T033
as	O
well	O
.	O
ritu	O
##als	O
may	O
be	O
an	O
important	O
way	O
to	O
increase	O
compass	O
##ion	O
and	O
decrease	O
burnout	B-T033
among	O
hospice	B-T058
staff	O
and	O
volunteers	B-T098
.	O
organizations	O
may	O
benefit	O
from	O
providing	O
training	O
and	O
support	O
for	O
personalized	O
ritu	O
##als	O
among	O
team	O
members	O
,	O
especially	O
new	O
staff	O
who	O
may	O
be	O
at	O
greater	O
risk	O
for	O
burnout	B-T033
.	O

multicentric	B-T038
cast	I-T038
##lem	I-T038
##an	I-T038
disease	I-T038
of	O
hyaline	B-T031
vascular	B-T017
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	B-T170
report	I-T170
cast	B-T038
##lem	I-T038
##an	I-T038
disease	I-T038
is	O
a	O
rare	O
lymphoproliferative	B-T038
disorder	I-T038
presenting	O
with	O
localized	B-T082
or	O
disseminated	B-T082
lymphadenopathy	B-T038
and	O
systemic	O
manifestations	O
.	O
it	O
can	O
be	O
categorized	B-T170
in	O
numerous	O
ways	O
,	O
such	O
as	O
unic	B-T038
##entric	I-T038
versus	O
multicentric	B-T038
,	O
histopathological	O
variants	O
(	O
hyaline	B-T031
-	O
vascular	B-T017
,	O
plasma	B-T017
cell	I-T017
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	B-T033
viral	B-T038
infections	I-T038
(	O
human	B-T005
immunodeficiency	I-T005
virus	I-T005
,	O
human	B-T005
herpesvirus	I-T005
-	I-T005
8	I-T005
,	O
or	O
kaposi	B-T005
sarcoma	I-T005
herpesvirus	I-T005
)	O
.	O
presentation	O
ranges	O
from	O
asymptomatic	B-T033
to	O
symptoms	B-T033
involving	O
multiple	O
organs	B-T017
.	O
even	O
though	O
the	O
exact	O
mechanism	O
of	O
pathogenesis	B-T038
is	O
unknown	O
,	O
treatment	O
is	O
directed	O
toward	O
possible	O
etiologies	O
such	O
as	O
interleukin	B-T103
-	I-T103
6	I-T103
,	O
cluster	B-T103
of	I-T103
differentiation	I-T103
20	I-T103
,	O
and	O
viral	O
agents	O
.	O
a	O
36	O
-	O
year	O
-	O
old	O
sri	B-T098
lan	I-T098
##ka	I-T098
##n	I-T098
woman	B-T098
presented	O
with	O
generalized	O
body	B-T033
swelling	I-T033
and	O
foam	O
##y	O
urine	O
of	O
2	O
weeks	O
'	O
duration	O
.	O
examination	B-T058
revealed	O
pall	B-T033
##or	I-T033
;	O
generalized	B-T033
edema	I-T033
;	O
axillary	B-T082
,	O
cervical	B-T082
,	O
and	O
inguinal	B-T038
lymphadenopathy	I-T038
;	O
hypertension	B-T038
;	O
and	O
hepat	B-T033
##omegaly	I-T033
.	O
investigations	B-T058
showed	O
bic	B-T033
##yt	I-T033
##openia	I-T033
,	O
nephrotic	B-T033
range	I-T033
proteinuria	I-T033
with	O
hypoal	B-T038
##bumin	I-T038
##emia	I-T038
,	O
hypog	B-T038
##amma	I-T038
##globulin	I-T038
##emia	I-T038
,	O
and	O
features	O
of	O
hyaline	B-T031
-	O
vascular	B-T017
type	O
cast	B-T038
##lem	I-T038
##an	I-T038
disease	I-T038
in	O
a	O
lymph	B-T058
node	I-T058
biopsy	I-T058
.	O
she	O
was	O
managed	B-T058
with	O
rituximab	B-T103
and	O
had	O
good	O
clinical	O
improvement	O
.	O
cast	B-T038
##lem	I-T038
##an	I-T038
disease	I-T038
has	O
a	O
broad	B-T082
spectrum	O
of	O
clinical	O
manifestations	O
,	O
disease	B-T038
pathogen	B-T038
##eses	I-T038
,	O
and	O
associations	O
and	O
/	O
or	O
complications	B-T038
.	O
medical	O
professionals	B-T097
need	O
to	O
be	O
familiar	O
with	O
this	O
spectrum	O
because	O
timely	O
diagnosis	B-T033
and	O
aggressive	B-T058
targeted	I-T058
therapy	I-T058
are	O
the	O
cornerstone	O
##s	O
of	O
managing	O
these	O
patients	O
.	O

how	O
do	O
wett	O
##ability	O
,	O
zeta	O
potential	O
and	O
hydroxylation	B-T033
degree	I-T033
affect	O
the	O
biological	B-T033
response	I-T033
of	O
biomaterials	B-T103
?	O
it	O
is	O
well	O
known	O
that	O
composition	O
,	O
electric	O
charge	O
,	O
wett	O
##ability	O
and	O
roughness	O
of	O
implant	B-T074
surfaces	B-T082
have	O
great	O
influence	O
on	O
their	O
interaction	O
with	O
the	O
biological	B-T031
fluids	I-T031
and	O
tissues	B-T017
,	O
but	O
systematic	B-T062
studies	I-T062
of	O
different	O
materials	O
in	O
the	O
same	O
experimental	O
conditions	O
are	O
still	O
lacking	O
in	O
the	O
scientific	B-T170
literature	I-T170
.	O
the	O
aim	O
of	O
this	O
research	B-T062
is	O
to	O
investigate	O
the	O
correlations	O
between	O
some	O
surface	O
characteristics	O
(	O
wett	O
##ability	O
,	O
zeta	O
potential	O
and	O
hydroxylation	B-T033
degree	I-T033
)	O
and	O
the	O
biological	B-T033
response	I-T033
(	O
protein	B-T033
adsorption	I-T033
,	O
blood	B-T031
wett	O
##ability	O
,	O
cell	B-T038
and	O
bacterial	B-T038
adhesion	I-T038
)	O
to	O
some	O
model	O
biomaterials	B-T103
.	O
the	O
resulting	O
knowledge	O
can	O
be	O
applied	O
for	O
the	O
development	O
of	O
future	O
innovative	O
surfaces	B-T082
for	O
implantable	B-T103
biomaterials	I-T103
.	O
roughness	O
was	O
not	O
considered	O
as	O
a	O
variable	O
because	O
it	O
is	O
a	O
widely	O
explored	O
feature	O
:	O
smooth	B-T082
surfaces	I-T082
prepared	O
by	O
a	O
controlled	B-T170
protocol	I-T170
were	O
compared	O
in	O
order	O
to	O
have	O
no	O
roughness	O
effects	O
.	O
three	O
oxides	B-T103
(	O
zr	B-T103
##o2	I-T103
,	O
al2o3	B-T103
,	O
sio2	B-T103
)	O
,	O
three	O
metals	B-T103
(	O
316	B-T103
##ls	I-T103
##s	I-T103
steel	I-T103
,	O
ti	B-T103
,	O
nb	B-T103
)	O
and	O
two	O
polymers	B-T103
(	O
coron	B-T103
##a	I-T103
treated	I-T103
polystyrene	I-T103
for	O
cell	O
culture	O
and	O
untreated	B-T103
polystyrene	I-T103
for	O
bacteria	B-T058
culture	I-T058
)	O
,	O
widely	O
used	O
for	O
biomedical	O
applications	O
,	O
were	O
considered	O
.	O
the	O
surfaces	B-T082
were	O
characterized	O
by	O
contact	B-T062
profil	I-T062
##ometry	I-T062
,	O
sem	B-T058
-	O
eds	B-T058
,	O
xps	B-T058
,	O
ftir	B-T062
,	O
zeta	O
potential	O
and	O
wett	O
##ability	O
with	O
different	O
fluids	O
.	O
protein	B-T033
adsorption	I-T033
,	O
blood	B-T031
wett	O
##ability	O
,	O
bacterial	B-T038
and	O
cell	B-T038
adhesion	I-T038
were	O
evaluated	O
in	O
order	O
to	O
investigate	O
the	O
correlations	O
between	O
the	O
surface	O
physi	O
##ochemical	O
properties	O
and	O
biological	B-T033
responses	I-T033
.	O
from	O
a	O
methodological	O
stand	O
##point	O
,	O
xps	B-T058
and	O
electro	O
##kinetic	O
measurements	O
emerged	O
as	O
the	O
more	O
suitable	O
techniques	O
respectively	O
for	O
the	O
evaluation	O
of	O
hydroxylation	B-T033
degree	I-T033
and	O
surface	O
charge	O
/	O
isoelectric	O
point	O
.	O
moreover	O
,	O
determination	O
of	O
wett	O
##ability	O
by	O
blood	B-T031
appeared	O
a	O
specific	O
and	O
crucial	O
test	B-T170
,	O
the	O
results	O
of	O
which	O
are	O
not	O
easily	O
predictable	O
by	O
using	O
other	O
type	O
of	O
tests	B-T170
.	O
hydroxylation	B-T033
degree	I-T033
resulted	O
correlated	O
to	O
the	O
wett	O
##ability	O
by	O
water	B-T103
,	O
but	O
not	O
directly	O
to	O
surface	O
charge	O
.	O
wetting	B-T062
tests	I-T062
with	O
different	O
media	O
showed	O
the	O
possibility	O
to	O
highlight	O
some	O
differences	O
among	O
look	O
-	O
alike	O
materials	O
.	O
a	O
dependence	O
of	O
protein	B-T033
absorption	I-T033
on	O
hydroxylation	B-T033
degree	I-T033
,	O
charge	O
and	O
wett	O
##ability	O
was	O
evidenced	O
and	O
its	O
maximum	O
was	O
registered	O
for	O
surfaces	B-T082
with	O
low	O
wett	O
##ability	O
in	O
both	O
water	B-T103
based	O
and	O
protein	B-T103
containing	O
media	O
and	O
a	O
moderate	O
surface	O
charge	O
.	O
as	O
far	O
as	O
bacterial	B-T038
adhesion	I-T038
is	O
concerned	O
,	O
no	O
effect	O
of	O
surface	O
charge	O
or	O
protein	B-T033
adsorption	I-T033
was	O
evidenced	O
,	O
while	O
the	O
presence	O
of	O
a	O
high	O
acid	O
component	O
of	O
the	O
surface	O
energy	O
appeared	O
significant	O
.	O
finally	O
,	O
the	O
combination	O
of	O
hydroxylation	B-T033
degree	I-T033
,	O
wett	O
##ability	O
,	O
surface	O
charge	O
and	O
energy	O
(	O
polar	O
component	O
)	O
emerged	O
as	O
a	O
key	O
parameter	O
for	O
cell	B-T038
adhesion	I-T038
and	O
viability	B-T038
.	O

functional	B-T038
adaptation	I-T038
of	O
crustace	B-T204
##an	I-T204
exo	O
##sk	O
##eletal	O
elements	B-T103
through	O
structural	B-T082
and	O
compositional	O
diversity	O
:	O
a	O
combined	O
experimental	B-T062
and	O
theoretical	B-T062
study	I-T062
the	O
crustace	B-T204
##an	I-T204
cuticle	B-T204
is	O
a	O
composite	O
material	O
that	O
covers	O
the	O
whole	O
animal	B-T204
and	O
forms	O
the	O
continuous	O
exo	O
##sk	O
##eleton	O
.	O
nano	O
-	O
fibers	O
composed	O
of	O
chitin	B-T103
and	O
protein	B-T103
molecules	I-T103
form	O
most	O
of	O
the	O
organic	O
matrix	B-T103
of	O
the	O
cuticle	B-T204
that	O
,	O
at	O
the	O
macros	O
##cale	O
,	O
is	O
organized	O
in	O
up	O
to	O
eight	O
hierarchical	O
levels	O
.	O
at	O
least	O
two	O
of	O
them	O
,	O
the	O
exo	B-T204
-	I-T204
and	O
endoc	B-T204
##ut	I-T204
##icle	I-T204
,	O
contain	O
a	O
mineral	B-T103
phase	I-T103
of	O
mainly	O
mg	B-T103
-	O
calcit	B-T103
##e	I-T103
,	O
amorphous	O
calcium	B-T103
carbonate	I-T103
and	O
phosphate	B-T103
.	O
the	O
high	O
number	O
of	O
hierarchical	O
levels	O
and	O
the	O
compositional	O
diversity	O
provide	O
a	O
high	O
degree	O
of	O
freedom	O
for	O
varying	O
the	O
physical	B-T201
,	O
in	O
particular	O
mechanical	O
,	O
properties	O
of	O
the	O
material	O
.	O
this	O
makes	O
the	O
cuticle	B-T204
a	O
versatile	O
material	O
ideally	O
suited	O
to	O
form	O
a	O
variety	O
of	O
skeletal	B-T082
elements	B-T103
that	O
are	O
adapted	B-T038
to	O
different	O
functions	O
and	O
the	O
eco	O
-	O
physiological	O
strains	O
of	O
individual	B-T170
species	I-T170
.	O
this	O
review	B-T170
presents	O
our	O
recent	O
analytical	O
,	O
experimental	B-T062
and	O
theoretical	B-T062
studies	I-T062
on	O
the	O
cuticle	B-T204
,	O
summar	O
##ising	O
at	O
which	O
hierarchical	O
levels	O
structure	B-T082
and	O
composition	O
are	O
modified	O
to	O
achieve	O
the	O
required	O
physical	B-T201
properties	I-T201
.	O
we	O
describe	O
our	O
multi	O
-	O
scale	O
hierarchical	O
modeling	O
approach	O
based	O
on	O
the	O
results	O
from	O
these	O
studies	B-T062
,	O
aiming	O
at	O
systematically	O
predicting	O
the	O
structure	B-T082
-	O
composition	O
-	O
property	O
relations	O
of	O
cuticle	B-T204
composites	O
from	O
the	O
molecular	O
level	O
to	O
the	O
macro	O
-	O
scale	O
.	O
this	O
modeling	O
approach	O
provides	O
a	O
tool	O
to	O
facilitate	O
the	O
development	O
of	O
optimized	O
biomimetic	O
materials	O
within	O
a	O
knowledge	O
-	O
based	O
design	O
approach	O
.	O

safety	B-T062
of	O
transr	O
##adi	O
##al	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	B-T082
anticoagulant	B-T058
therapy	I-T058
cardiac	B-T058
catheterization	I-T058
in	O
anticoagul	O
##ated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	B-T058
has	O
been	O
withdrawn	B-T058
,	O
at	O
least	O
in	O
the	O
previous	O
48	O
##h	O
,	O
and	O
sometimes	O
bridging	B-T058
therapy	I-T058
with	I-T058
heparin	I-T058
is	O
used	O
.	O
a	O
prospective	O
observational	B-T062
study	I-T062
including	O
48	O
##9	O
patients	O
undergoing	O
transr	B-T058
##adi	I-T058
##al	I-T058
catheterization	I-T058
was	O
conducted	O
.	O
a	O
total	O
of	O
140	O
patients	O
were	O
under	O
ace	B-T103
##no	I-T103
##co	I-T103
##uma	I-T103
##rol	I-T103
(	O
group	B-T170
a	I-T170
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	B-T170
b	I-T170
)	O
for	O
complications	B-T038
after	O
the	O
procedure	B-T058
(	O
bleeding	B-T038
and	O
vascular	B-T038
access	I-T038
complications	I-T038
)	O
.	O
patients	O
in	O
group	B-T170
a	I-T170
were	O
older	B-T098
(	O
74	O
##±1	O
##2	O
years	O
vs	O
.	O
68	O
##±1	O
##7	O
years	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
the	O
main	O
indication	O
for	O
anticoagulation	B-T058
was	O
atrial	B-T038
fibrillation	I-T038
(	O
58	O
.	O
6	O
%	O
)	O
.	O
no	B-T033
complications	B-T038
occurred	O
during	O
the	O
procedures	B-T058
.	O
there	O
were	O
no	B-T033
acute	B-T038
bleeding	I-T038
##s	I-T038
just	O
after	O
the	O
band	B-T074
##age	I-T074
removal	O
.	O
during	O
the	O
first	O
24h	O
,	O
only	O
3	O
(	O
2	O
.	O
1	O
%	O
)	O
radial	B-T038
occlusions	I-T038
in	O
group	B-T170
a	I-T170
and	O
2	O
(	O
0	O
.	O
6	O
%	O
)	O
in	O
group	B-T170
b	I-T170
(	O
p	O
=	O
0	O
.	O
14	O
)	O
were	O
recorded	O
.	O
hematomas	B-T038
between	O
5	O
and	O
10	O
##cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	B-T170
a	I-T170
vs	O
.	O
4	O
.	O
6	O
%	O
in	O
group	B-T170
b	I-T170
.	O
during	O
the	O
1	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
period	O
,	O
one	O
more	O
radial	B-T038
occlusion	I-T038
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1	O
.	O
1	O
%	O
)	O
additional	O
mild	O
hematomas	B-T038
in	O
group	B-T170
b	I-T170
and	O
none	O
in	O
group	B-T170
a	I-T170
(	O
p	O
=	O
0	O
.	O
48	O
)	O
.	O
performing	O
a	O
transr	O
##adi	O
##al	O
diagnostic	O
cardiac	O
catheterization	O
without	O
removal	O
of	O
the	O
oral	B-T082
chronic	O
anticoagulation	O
appears	O
safe	B-T033
in	O
patients	O
under	O
ace	B-T103
##no	I-T103
##cu	I-T103
##mar	I-T103
##ol	I-T103
therapy	B-T058
.	O

smooth	O
versus	O
texture	O
##d	O
surfaces	B-T082
:	O
feature	O
-	O
based	O
category	B-T170
selectivity	O
in	O
human	B-T204
visual	B-T017
cortex	I-T017
in	O
fmri	B-T058
studies	I-T058
,	O
human	B-T204
lateral	B-T017
occipital	I-T017
(	I-T017
lo	I-T017
)	I-T017
cortex	I-T017
is	O
thought	O
to	O
respond	O
selectively	O
to	O
images	B-T170
of	O
objects	O
,	O
compared	O
with	O
non	O
##ob	O
##je	O
##ct	O
##s	O
.	O
however	O
,	O
it	O
remains	O
unresolved	O
whether	O
all	O
objects	O
evoke	O
equivalent	O
levels	O
of	O
activity	O
in	O
lo	B-T017
,	O
and	O
,	O
if	O
not	O
,	O
which	O
image	O
features	O
produce	O
stronger	O
activation	O
.	O
here	O
,	O
we	O
used	O
an	O
unbiased	B-T170
parametric	I-T170
texture	I-T170
model	I-T170
to	O
predict	O
preferred	O
versus	O
nonp	O
##ref	O
##err	O
##ed	O
stimuli	O
in	O
lo	B-T017
.	O
observation	B-T062
and	O
psychophysical	O
results	O
showed	O
that	O
predicted	O
preferred	O
stimuli	O
(	O
both	O
objects	O
and	O
non	O
##ob	O
##je	O
##ct	O
##s	O
)	O
had	O
smooth	O
(	O
rather	O
than	O
texture	O
##d	O
)	O
surfaces	B-T082
.	O
these	O
predictions	O
were	O
confirmed	O
using	O
fmri	B-T058
,	O
for	O
objects	O
and	O
non	O
##ob	O
##je	O
##ct	O
##s	O
.	O
similar	O
preferences	O
were	O
also	O
found	O
in	O
the	O
fusiform	B-T022
face	I-T022
area	I-T022
(	O
ffa	B-T022
)	O
.	O
consistent	O
with	O
this	O
:	O
(	O
1	O
)	O
ffa	B-T022
and	O
lo	B-T017
responded	O
more	O
strongly	O
to	O
nonf	O
##rec	O
##kl	O
##ed	O
(	O
smooth	O
)	O
faces	B-T082
,	O
compared	O
with	O
otherwise	O
identical	O
fre	B-T033
##ck	I-T033
##led	I-T033
(	O
texture	O
##d	O
)	O
faces	B-T082
;	O
and	O
(	O
2	O
)	O
strong	O
functional	O
connections	B-T082
were	O
found	O
between	O
lo	B-T017
and	O
ffa	B-T022
.	O
thus	O
,	O
lo	B-T017
and	O
ffa	B-T022
may	O
be	O
part	O
of	O
an	O
information	O
-	O
processing	O
stream	O
distinguished	O
by	O
feature	O
-	O
based	O
category	B-T170
selectivity	O
(	O
smooth	O
>	O
texture	O
##d	O
)	O
.	O

evaluation	O
of	O
dnmt	B-T017
##1	I-T017
gene	O
expression	O
profile	O
and	O
methylation	B-T038
of	O
its	O
promoter	B-T103
region	I-T103
in	O
patients	O
with	O
ankylosing	B-T038
spondylitis	I-T038
ankylosing	B-T038
spondylitis	I-T038
(	O
as	B-T038
)	O
is	O
an	O
autoimmune	B-T038
disease	I-T038
with	O
a	O
chronic	B-T038
inflammatory	I-T038
arthritis	I-T038
.	O
the	O
critical	O
role	O
of	O
methylation	B-T038
in	O
the	O
biology	B-T091
of	O
immunocyt	B-T017
##es	I-T017
has	O
increasingly	O
been	O
surveyed	B-T170
to	O
discover	O
disease	B-T038
etiology	O
.	O
dna	B-T103
methyltransferase	I-T103
1	I-T103
(	O
dnmt	B-T103
##1	I-T103
)	O
is	O
an	O
enzyme	B-T103
,	O
which	O
establishes	O
and	O
regulates	B-T038
patterns	B-T082
of	O
methylated	B-T103
cytosine	I-T103
residues	O
.	O
the	O
aim	O
of	O
the	O
current	O
investigation	B-T058
was	O
to	O
unve	O
##il	O
if	O
methylation	B-T038
circumstances	O
of	O
cpg	B-T103
sites	B-T082
in	O
dnmt	B-T017
##1	I-T017
promoter	B-T103
could	O
affect	O
the	O
mrna	B-T038
expression	I-T038
level	O
of	O
this	O
gene	B-T017
in	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
(	O
pbmcs	B-T017
)	O
from	O
as	B-T038
patients	O
.	O
pbmcs	B-T017
were	O
isolated	O
from	O
whole	B-T031
blood	I-T031
of	O
40	O
as	B-T038
patients	O
and	O
40	O
healthy	O
individuals	B-T098
.	O
total	O
rna	B-T103
and	O
dna	B-T103
contents	O
of	O
leukocytes	B-T017
were	O
extracted	B-T058
.	O
after	O
##ward	O
,	O
quantitative	O
analysis	O
was	O
carried	O
out	O
by	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
using	O
the	O
sy	B-T170
##br	I-T170
green	I-T170
pcr	I-T170
master	I-T170
mix	I-T170
.	O
finally	O
,	O
to	O
determine	O
the	O
methylation	B-T038
level	O
,	O
pcr	B-T062
products	B-T103
of	O
bis	B-T103
##ulf	I-T103
##ite	I-T103
-	I-T103
treated	I-T103
dna	I-T103
from	O
patients	O
and	O
controls	O
were	O
sequenced	B-T058
.	O
compared	O
with	O
healthy	O
controls	O
,	O
expression	B-T038
level	I-T038
of	O
dnmt	B-T017
##1	I-T017
in	O
as	B-T038
patients	O
was	O
significantly	O
downregulated	B-T038
.	O
methylation	B-T038
of	O
dnmt	B-T017
##1	I-T017
promoter	B-T103
was	O
significantly	O
higher	O
in	O
as	B-T038
patients	O
in	O
comparison	O
to	O
controls	O
.	O
while	O
a	O
negative	B-T033
correlation	O
between	O
methylation	B-T038
and	O
expression	B-T038
level	I-T038
of	O
dnmt	B-T017
##1	I-T017
was	O
observed	O
in	O
as	B-T038
patients	O
,	O
both	O
methylation	B-T038
and	O
expression	B-T038
level	I-T038
of	O
dnmt	B-T017
##1	I-T017
did	O
not	O
correlate	O
with	O
clinical	O
manifestations	O
.	O
considering	O
the	O
observation	O
that	O
decreased	O
expression	B-T038
level	I-T038
of	O
dnmt	B-T017
##1	I-T017
was	O
associated	O
with	O
hypermethylation	B-T038
of	O
dnmt	B-T017
##1	I-T017
promoter	B-T103
in	O
pbmcs	B-T017
from	O
as	B-T038
patients	O
,	O
this	O
survey	B-T170
suggests	O
that	O
dysregulation	O
of	O
dnmt	B-T017
##1	I-T017
expression	B-T038
through	O
altered	O
methylation	B-T038
level	O
of	O
other	O
target	O
genes	B-T017
would	O
probably	O
contribute	O
to	O
as	B-T038
development	O
.	O

the	O
relationship	O
between	O
histological	O
prost	B-T038
##atitis	I-T038
and	O
lower	B-T033
urinary	I-T033
tract	I-T033
symptoms	I-T033
and	O
sexual	B-T038
function	I-T038
this	O
prospective	B-T062
analysis	I-T062
assessed	O
the	O
effect	O
of	O
histological	O
prost	B-T038
##atitis	I-T038
on	O
lower	B-T022
urinary	I-T022
tract	I-T022
functions	O
and	O
sexual	B-T038
function	I-T038
.	O
the	O
patients	O
were	O
separated	O
into	O
two	O
groups	O
as	O
histologically	O
observed	O
prost	B-T038
##atitis	I-T038
(	O
group	O
a	O
)	O
and	O
no	B-T033
prost	I-T033
##atitis	I-T033
(	O
group	O
b	O
)	O
according	O
to	O
the	O
biopsy	B-T058
outcomes	O
.	O
international	B-T170
prostate	I-T170
symptom	I-T170
score	I-T170
,	O
international	B-T201
index	I-T201
of	I-T201
erectile	I-T201
function	I-T201
-	I-T201
5	I-T201
scores	I-T201
,	O
maximal	B-T033
and	O
average	B-T033
flow	I-T033
rate	I-T033
,	O
and	O
residual	B-T033
urine	I-T033
volumes	I-T033
were	O
compared	O
statistically	O
between	O
groups	O
.	O
there	O
was	O
no	O
significant	O
difference	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
in	O
baseline	O
age	O
(	O
t	O
=	O
0	O
.	O
64	O
)	O
,	O
body	B-T201
mass	I-T201
index	I-T201
value	I-T201
(	O
t	O
=	O
0	O
.	O
51	O
)	O
,	O
prostate	O
volume	O
(	O
t	O
=	O
0	O
.	O
87	O
)	O
,	O
prostate	B-T058
-	I-T058
specific	I-T058
antigen	I-T058
levels	I-T058
(	O
t	O
=	O
0	O
.	O
43	O
)	O
,	O
maximal	B-T033
(	O
t	O
=	O
0	O
.	O
84	O
)	O
and	O
average	B-T033
flow	I-T033
rate	I-T033
(	O
t	O
=	O
0	O
.	O
59	O
)	O
,	O
and	O
post	O
-	O
void	O
residual	B-T033
urine	I-T033
volume	I-T033
(	O
t	O
=	O
0	O
.	O
71	O
)	O
.	O
mean	O
international	B-T170
prostate	I-T170
symptom	I-T170
score	I-T170
in	O
patients	O
with	O
prost	B-T038
##atitis	I-T038
was	O
numerically	O
but	O
not	O
significantly	O
higher	O
than	O
that	O
in	O
those	O
without	O
prost	B-T038
##atitis	I-T038
(	O
t	O
=	O
0	O
.	O
79	O
##4	O
,	O
p	O
=	O
0	O
.	O
06	O
##6	O
)	O
.	O
mean	O
international	B-T201
index	I-T201
of	I-T201
erectile	I-T201
function	I-T201
-	I-T201
5	I-T201
score	I-T201
in	O
the	O
prost	B-T038
##atitis	I-T038
group	O
was	O
significantly	O
lower	O
than	O
that	O
in	O
those	O
without	O
prost	B-T038
##atitis	I-T038
(	O
t	O
=	O
1	O
.	O
85	O
##4	O
,	O
p	O
=	O
0	O
.	O
013	O
)	O
.	O
histological	O
prost	B-T038
##atitis	I-T038
notably	O
affected	O
sexual	B-T038
function	I-T038
of	O
patients	O
and	O
may	O
serve	O
as	O
a	O
major	O
risk	B-T033
factor	I-T033
for	O
sexual	B-T038
dysfunction	I-T038
while	O
having	O
little	O
effect	O
on	O
lower	B-T033
urinary	I-T033
tract	I-T033
symptoms	I-T033
.	O

binding	O
of	O
pollutants	B-T103
to	O
biomolecules	B-T103
:	O
a	O
simulation	B-T062
study	I-T062
a	O
number	O
of	O
cases	O
around	O
the	O
world	B-T098
have	O
been	O
reported	O
where	O
animals	B-T204
were	O
found	B-T033
dead	I-T033
or	O
dying	B-T038
with	O
symptoms	B-T033
resembling	O
a	O
thiamine	B-T038
(	B-T038
vitamin	I-T038
b	I-T038
)	I-T038
deficiency	I-T038
,	O
and	O
for	O
some	O
of	O
these	O
,	O
a	O
link	O
to	O
pollutants	B-T103
has	O
been	O
suggested	O
.	O
here	O
,	O
we	O
investigate	B-T058
whether	O
biomolecules	B-T103
involved	O
in	O
thi	B-T038
##amin	I-T038
binding	I-T038
and	O
transport	B-T038
could	O
be	O
blocked	O
by	O
a	O
range	O
of	O
different	O
pollutants	B-T103
.	O
we	O
used	O
in	O
silico	O
docking	B-T038
of	O
five	O
compound	B-T103
classes	B-T170
(	O
25	O
compounds	B-T103
in	O
total	O
)	O
to	O
each	O
of	O
five	O
targets	O
(	O
prion	B-T103
protein	I-T103
,	O
ec	B-T017
##f	I-T017
-	I-T017
type	I-T017
abc	I-T017
transporter	I-T017
,	O
thi	B-T103
-	I-T103
box	I-T103
rib	I-T103
##os	I-T103
##wi	I-T103
##tc	I-T103
##h	I-T103
receptor	I-T103
,	O
thi	B-T103
##amin	I-T103
pyrophosph	I-T103
##okinase	I-T103
,	O
and	O
y	B-T103
##ko	I-T103
##f	I-T103
protein	I-T103
)	O
and	O
subsequently	O
performed	O
molecular	O
dynamics	O
(	O
md	O
)	O
simulations	O
to	O
assess	O
the	O
stability	O
of	O
the	O
complexes	B-T103
.	O
the	O
compound	B-T103
classes	B-T170
were	O
thi	B-T103
##amin	I-T103
analogues	B-T103
(	O
control	O
)	O
,	O
pesticides	B-T103
,	O
veterinary	O
medicines	B-T103
,	O
polychlorinated	B-T103
biphenyls	I-T103
,	O
and	O
dioxin	B-T103
##s	I-T103
,	O
all	O
of	O
which	O
are	O
prevalent	O
in	O
the	O
environment	B-T082
to	O
some	O
extent	O
.	O
a	O
few	O
anthropogenic	O
compounds	B-T103
were	O
found	O
to	O
bind	B-T038
the	O
ec	B-T017
##f	I-T017
-	I-T017
type	I-T017
abc	I-T017
transporter	I-T017
,	O
but	O
none	B-T033
binds	I-T033
stably	I-T033
to	O
prion	B-T103
protein	I-T103
.	O
for	O
the	O
rib	B-T103
##os	I-T103
##wi	I-T103
##tc	I-T103
##h	I-T103
,	O
most	O
compounds	B-T103
remained	O
in	O
their	O
binding	O
pockets	O
during	O
50	O
ns	O
of	O
md	O
simulation	O
,	O
indicating	O
that	O
rna	B-T103
provides	O
a	O
prom	O
##isc	O
##uous	O
binding	B-T103
site	I-T103
.	O
in	O
both	O
y	B-T103
##ko	I-T103
##f	I-T103
and	O
thi	B-T103
##amin	I-T103
pyrophosph	I-T103
##okinase	I-T103
(	O
tp	B-T103
##k	I-T103
)	O
,	O
most	O
compounds	B-T103
remain	O
tightly	O
bound	O
.	O
however	O
,	O
tp	B-T103
##k	I-T103
biomolecules	B-T103
undergo	O
pollutant	B-T103
-	O
induced	O
conformational	B-T038
changes	I-T038
.	O
although	O
most	O
compounds	B-T103
are	O
found	O
to	O
bind	O
to	O
some	O
of	O
these	O
targets	O
,	O
a	O
larger	O
data	O
set	O
is	O
needed	O
along	O
with	O
more	O
quantitative	O
methods	O
like	O
free	O
energy	O
perturbation	O
calculations	O
before	O
firm	O
conclusions	O
can	O
be	O
drawn	O
.	O
this	O
study	B-T062
is	O
in	O
part	O
a	O
test	O
bed	O
for	O
large	O
-	O
scale	O
quantitative	O
computational	O
screening	O
of	O
interactions	O
between	O
biological	B-T103
entities	I-T103
and	O
pollutant	B-T103
molecules	I-T103
.	O

il	B-T103
-	I-T103
27	I-T103
is	O
essential	O
for	O
suppression	B-T058
of	O
experimental	O
allergic	B-T038
asthma	I-T038
by	O
the	O
tlr	B-T103
##7	I-T103
/	O
8	B-T103
agonist	B-T103
r	B-T103
##84	I-T103
##8	I-T103
(	O
res	B-T103
##iqu	I-T103
##imod	I-T103
)	O
different	O
models	B-T038
of	I-T038
experimental	I-T038
allergic	B-T038
asthma	I-T038
have	O
shown	O
that	O
the	O
tlr	B-T103
##7	I-T103
/	O
8	B-T103
agonist	B-T103
res	B-T103
##iqu	I-T103
##imod	I-T103
(	O
r	B-T103
##84	I-T103
##8	I-T103
)	O
is	O
a	O
potential	O
inhibitor	O
of	O
type	B-T017
2	I-T017
helper	I-T017
cell	I-T017
-	O
driven	O
inflammatory	B-T038
responses	I-T038
.	O
however	O
,	O
the	O
mechanisms	O
mediating	O
its	O
therapeutic	B-T201
effects	I-T201
are	O
not	O
fully	O
understood	O
.	O
using	O
a	O
model	B-T038
of	I-T038
experimental	I-T038
allergic	B-T038
asthma	I-T038
,	O
we	O
show	O
that	O
induction	B-T058
of	O
il	B-T103
-	I-T103
27	I-T103
by	O
r	B-T103
##84	I-T103
##8	I-T103
is	O
critical	O
for	O
the	O
observed	O
amelior	O
##ative	O
effects	O
.	O
r	B-T103
##84	I-T103
##8	I-T103
significantly	O
inhibited	O
all	O
hallmarks	B-T017
of	O
experimental	O
allergic	B-T038
asthma	I-T038
,	O
including	O
airway	B-T038
hyperre	I-T038
##activity	I-T038
,	O
eosinophilic	O
airway	B-T017
inflammation	B-T038
,	O
mucus	B-T038
hypers	I-T038
##ecretion	I-T038
,	O
and	O
ag	B-T103
-	O
specific	B-T103
ig	I-T103
production	B-T038
.	O
whereas	O
r	B-T103
##84	I-T103
##8	I-T103
significantly	O
reduced	O
il	B-T103
-	I-T103
5	I-T103
,	O
il	B-T103
-	I-T103
13	I-T103
,	O
and	O
il	B-T103
-	I-T103
17	I-T103
,	O
it	O
induced	O
ifn	B-T103
-	I-T103
γ	I-T103
and	O
il	B-T103
-	I-T103
27	I-T103
.	O
neutralization	O
of	O
il	B-T103
-	I-T103
27	I-T103
completely	O
reversed	O
the	O
therapeutic	B-T201
effect	I-T201
of	O
r	B-T103
##84	I-T103
##8	I-T103
in	O
the	O
experimental	O
asthma	B-T038
model	B-T038
,	O
demonstrating	O
dependence	O
of	O
r	B-T103
##84	I-T103
##8	I-T103
-	O
mediated	O
suppression	B-T058
on	O
il	B-T103
-	I-T103
27	I-T103
.	O
in	O
vitro	O
,	O
r	B-T103
##84	I-T103
##8	I-T103
induced	B-T058
production	O
of	O
il	B-T103
-	I-T103
27	I-T103
by	O
murine	B-T204
alveolar	B-T017
macrophages	I-T017
and	O
dendritic	B-T017
cells	I-T017
and	O
enhanced	O
expression	B-T038
of	O
programmed	O
death	O
-	O
ligand	O
1	O
,	O
whose	O
expression	B-T038
on	O
monocytes	B-T017
and	O
dendritic	B-T017
cells	I-T017
has	O
been	O
shown	O
to	O
regulate	B-T038
peripheral	B-T038
tolerance	I-T038
in	O
both	O
murine	B-T204
and	O
human	B-T204
studies	O
.	O
moreover	O
,	O
in	O
vitro	O
il	B-T103
-	I-T103
27	I-T103
enhanced	O
secretion	B-T038
of	O
ifn	B-T103
-	I-T103
γ	I-T103
whereas	O
it	O
inhibited	O
il	B-T103
-	I-T103
5	I-T103
and	O
il	B-T103
-	I-T103
13	I-T103
,	O
demonstrating	O
its	O
direct	O
effect	O
on	O
attenuating	O
th2	B-T017
responses	O
.	O
taken	O
together	O
,	O
our	O
study	O
proves	O
that	O
r	B-T103
##84	I-T103
##8	I-T103
-	O
mediated	O
suppression	B-T058
of	O
experimental	O
asthma	B-T038
is	O
dependent	O
on	O
il	B-T103
-	I-T103
27	I-T103
.	O
these	O
data	O
provide	O
evidence	O
of	O
a	O
central	O
role	O
of	O
il	B-T103
-	I-T103
27	I-T103
for	O
the	O
control	O
of	O
th2	B-T017
-	O
mediated	O
allergic	B-T038
diseases	I-T038
.	O

comparing	O
the	O
bulk	O
##ing	O
effect	O
of	O
calcium	B-T103
hydroxyapatite	I-T103
and	O
defl	B-T103
##ux	I-T103
injection	B-T058
into	O
the	O
bladder	B-T017
neck	I-T017
for	O
improvement	O
of	O
urinary	B-T038
incontinence	I-T038
in	O
bladder	B-T038
ex	I-T038
##st	I-T038
##rophy	I-T038
-	I-T038
epis	I-T038
##pa	I-T038
##di	I-T038
##as	I-T038
complex	I-T038
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	B-T058
injection	I-T058
of	O
calcium	B-T103
hydroxyapatite	I-T103
(	O
cah	B-T103
##a	I-T103
)	O
into	O
the	O
bladder	B-T017
neck	I-T017
(	O
bn	B-T017
)	O
region	O
of	O
patients	O
with	O
urinary	B-T038
incontinence	I-T038
and	O
bladder	B-T038
ex	I-T038
##st	I-T038
##rophy	I-T038
-	I-T038
epis	I-T038
##pa	I-T038
##di	I-T038
##as	I-T038
complex	I-T038
(	O
bee	B-T038
##c	I-T038
)	O
.	O
we	O
designed	O
a	O
retrospective	B-T062
cohort	I-T062
study	I-T062
in	O
which	O
we	O
retrospectively	B-T062
studied	I-T062
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bee	B-T038
##c	I-T038
who	O
had	O
undergone	O
cah	B-T103
##a	I-T103
or	O
defl	B-T103
##ux	I-T103
injection	B-T058
for	O
continence	B-T058
improvement	I-T058
between	O
2009	O
and	O
2014	O
.	O
sixteen	O
incontin	B-T038
##ent	I-T038
patients	O
with	O
a	O
mean	O
±	O
sd	O
age	O
of	O
8	O
.	O
09	O
±	O
3	O
.	O
5	O
years	O
received	O
an	O
endoscopic	B-T058
submucosal	I-T058
injection	I-T058
of	O
5	O
.	O
4	O
ml	O
of	O
pure	O
cah	B-T103
##a	I-T103
powder	O
with	O
autologous	O
plasma	B-T031
(	O
group	O
a	O
)	O
.	O
patients	O
in	O
group	O
b	O
(	O
n	O
=	O
21	O
)	O
,	O
control	O
group	O
,	O
with	O
a	O
mean	O
±	O
sd	O
age	O
of	O
7	O
.	O
51	O
±	O
2	O
.	O
8	O
years	O
received	O
defl	B-T103
##ux	I-T103
injection	B-T058
(	O
5	O
.	O
1	O
ml	O
)	O
.	O
the	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
after	O
injection	B-T058
was	O
38	O
±	O
5	O
.	O
2	O
and	O
33	O
±	O
4	O
.	O
1	O
months	O
in	O
groups	O
a	O
and	O
b	O
,	O
respectively	O
.	O
no	O
post	B-T038
-	I-T038
injection	I-T038
complication	I-T038
was	O
detected	B-T033
in	O
none	O
of	O
the	O
patients	O
during	O
the	O
follow	B-T058
-	I-T058
up	I-T058
.	O
eleven	O
patients	O
(	O
68	O
.	O
75	O
%	O
)	O
in	O
group	O
a	O
became	O
socially	O
dry	O
following	O
1	O
-	O
2	O
injections	B-T058
,	O
the	O
degree	O
of	O
incontinence	B-T038
was	O
improved	O
in	O
4	O
patients	O
(	O
25	O
%	O
)	O
,	O
and	O
there	O
was	O
no	B-T033
change	I-T033
in	O
one	O
patient	O
(	O
6	O
.	O
25	O
%	O
)	O
.	O
however	O
,	O
defl	B-T103
##ux	I-T103
injection	B-T058
resulted	O
in	O
complete	O
dry	O
##ness	O
in	O
14	O
(	O
66	O
.	O
66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	B-T038
in	O
5	O
(	O
23	O
.	O
81	O
%	O
)	O
and	O
no	B-T033
change	I-T033
in	O
2	O
patients	O
(	O
9	O
.	O
52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	B-T058
achievement	I-T058
between	O
cah	B-T103
##a	I-T103
and	O
defl	B-T103
##ux	I-T103
groups	O
(	O
p	O
=	O
0	O
.	O
9	O
)	O
.	O
the	O
statistical	O
analysis	O
was	O
not	O
significantly	O
different	O
in	O
terms	O
of	O
bladder	B-T033
capacity	I-T033
(	O
p	O
=	O
0	O
.	O
7	O
)	O
or	O
q	O
max	O
(	O
p	O
=	O
0	O
.	O
8	O
)	O
.	O
the	O
preliminary	O
results	O
of	O
this	O
study	B-T062
revealed	O
that	O
cah	B-T103
##a	I-T103
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulk	B-T103
##ing	I-T103
agent	I-T103
in	O
treatment	B-T058
of	O
urinary	B-T038
incontinence	I-T038
in	O
bee	B-T038
##c	I-T038
.	O

establishment	O
and	O
application	O
of	O
a	O
flow	B-T058
cytometry	I-T058
-	O
based	O
method	B-T170
for	O
detecting	B-T033
histone	B-T038
acetylation	I-T038
levels	O
histone	B-T103
deacetylase	I-T103
inhibitors	I-T103
,	O
which	O
have	O
also	O
received	O
attention	O
in	O
aids	B-T038
and	O
other	O
diseases	B-T038
,	O
are	O
a	O
new	O
class	O
of	O
anticancer	B-T103
drugs	I-T103
developed	O
in	O
recent	O
years	O
.	O
however	O
,	O
there	O
is	O
still	O
a	O
lack	O
of	O
a	O
unified	O
and	O
reliable	O
method	B-T170
for	O
detecting	B-T033
histone	B-T038
acetylation	I-T038
levels	O
in	O
basic	B-T062
and	O
clinical	B-T062
research	I-T062
.	O
in	O
this	O
study	B-T062
,	O
we	O
developed	O
a	O
flow	B-T058
cytometry	I-T058
-	O
based	O
method	B-T170
to	O
detect	B-T033
histone	B-T038
acetylation	I-T038
levels	O
by	O
comparing	O
different	O
sample	O
processing	O
temperature	O
(	O
on	O
ice	B-T103
vs	O
.	O
room	B-T033
temperature	I-T033
)	O
,	O
permeabil	B-T038
##ization	I-T038
method	B-T170
(	O
intracellular	B-T017
vs	O
.	O
nuclear	B-T017
)	O
,	O
antibody	B-T103
dose	O
(	O
antibody	B-T058
titration	I-T058
)	O
and	O
antibody	B-T103
incubation	O
time	O
(	O
time	O
gradient	O
)	O
using	O
whole	B-T031
blood	I-T031
and	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
.	O
in	O
addition	O
,	O
we	O
applied	O
this	O
optimized	O
method	B-T170
in	O
in	O
vitro	O
experiment	B-T062
and	O
clinical	B-T062
trial	I-T062
of	O
chi	B-T103
##dam	I-T103
##ide	I-T103
(	O
the	O
only	O
china	B-T082
fda	B-T170
approved	I-T170
hdac	I-T170
##i	I-T170
)	O
,	O
the	O
result	O
of	O
which	O
confirmed	B-T033
that	O
the	O
flow	B-T058
cytometry	I-T058
-	O
based	O
method	B-T170
for	O
detecting	B-T033
histone	B-T038
acetylation	I-T038
levels	O
is	O
a	O
reliable	O
,	O
fast	O
and	O
convenient	O
method	B-T170
which	O
can	O
be	O
used	O
in	O
basic	B-T062
and	O
clinical	B-T062
research	I-T062
.	O

heterotopic	B-T038
ossification	I-T038
after	O
the	O
use	O
of	O
recombinant	B-T103
human	I-T103
bone	I-T103
morphogenetic	I-T103
protein	I-T103
-	I-T103
7	I-T103
to	O
present	O
the	O
incidence	O
of	O
heterotopic	B-T038
ossification	I-T038
after	O
the	O
use	O
of	O
recombinant	B-T103
human	I-T103
bone	I-T103
morphogenetic	I-T103
protein	I-T103
-	I-T103
7	I-T103
(	O
rhb	B-T103
##mp	I-T103
-	I-T103
7	I-T103
)	O
for	O
the	O
treatment	B-T058
of	O
nonunion	B-T033
##s	I-T033
.	O
bone	B-T103
morphogenetic	I-T103
proteins	I-T103
(	O
bmp	B-T103
##s	I-T103
)	O
promote	O
bone	B-T038
formation	I-T038
by	O
auto	B-T038
-	I-T038
induction	I-T038
.	O
recombinant	B-T103
human	I-T103
bmp	I-T103
-	I-T103
7	I-T103
in	O
combination	O
with	O
bone	B-T103
grafts	I-T103
was	O
used	O
in	O
84	O
patients	O
for	O
the	O
treatment	B-T058
of	O
long	B-T033
bone	I-T033
nonunion	I-T033
##s	I-T033
.	O
all	O
patients	O
were	O
evaluated	B-T058
radiographic	O
##aly	O
for	O
the	O
development	O
of	O
heterotopic	B-T038
ossification	I-T038
during	O
the	O
standard	O
assessment	B-T058
for	O
the	O
nonunion	B-T033
healing	B-T038
.	O
in	O
all	O
patients	O
(	O
80	O
.	O
9	O
%	O
)	O
with	O
radiographic	O
signs	B-T033
of	O
heterotopic	B-T038
ossification	I-T038
,	O
a	O
ct	B-T058
scan	I-T058
was	O
performed	O
.	O
nonunion	B-T033
site	B-T082
palpation	B-T058
and	O
rom	B-T058
evaluation	I-T058
of	O
the	O
adjacent	B-T082
joints	B-T082
were	O
also	O
carried	O
out	O
.	O
factors	O
related	O
to	O
the	O
patient	O
(	O
age	O
,	O
gender	O
)	O
,	O
the	O
nonunion	B-T033
(	O
location	B-T082
,	O
size	B-T082
,	O
chronic	O
##ity	O
,	O
number	O
of	O
previous	O
procedures	O
,	O
infection	B-T038
,	O
surrounding	B-T082
tissues	B-T017
condition	O
)	O
and	O
the	O
surgical	B-T058
procedure	I-T058
(	O
graft	B-T103
and	O
fixation	B-T058
type	O
,	O
amount	O
of	O
rhb	B-T103
##mp	I-T103
-	I-T103
7	I-T103
)	O
were	O
correlated	O
with	O
the	O
development	O
of	O
heterotopic	B-T038
ossification	I-T038
and	O
statistical	O
analysis	O
with	O
pearson	B-T170
##s	I-T170
χ	I-T170
(	I-T170
2	I-T170
)	I-T170
test	I-T170
was	O
performed	O
.	O
eighty	O
point	O
nine	O
percent	O
of	O
the	O
nonunion	B-T033
##s	I-T033
treated	O
with	O
rhb	B-T103
##mp	I-T103
-	I-T103
7	I-T103
,	O
healed	O
with	O
no	O
need	O
for	O
further	O
procedures	O
.	O
heterotopic	B-T038
bone	I-T038
formation	I-T038
occurred	O
in	O
15	O
of	O
84	O
patients	O
(	O
17	O
.	O
8	O
%	O
)	O
and	O
it	O
was	O
apparent	O
in	O
the	O
routine	O
radiological	B-T058
evaluation	I-T058
of	O
the	O
nonunion	B-T033
site	O
,	O
in	O
a	O
mean	O
time	O
of	O
5	O
.	O
5	O
mo	O
after	O
the	O
rhb	B-T103
##mp	I-T103
-	I-T103
7	I-T103
application	O
(	O
range	O
3	O
-	O
12	O
)	O
.	O
the	O
heterotopic	B-T038
ossification	I-T038
was	O
located	O
at	O
the	O
femur	B-T017
in	O
8	O
cases	O
,	O
at	O
the	O
tibia	B-T017
in	O
6	O
,	O
and	O
at	O
the	O
humerus	B-T017
in	O
ο	O
##ne	O
patient	O
.	O
in	O
4	O
patients	O
a	O
palpable	B-T033
mass	I-T033
was	O
present	O
and	O
only	O
in	O
one	O
patient	O
,	O
with	O
a	O
para	B-T033
-	I-T033
articular	I-T033
knee	I-T033
nonunion	I-T033
treated	O
with	O
rhb	B-T103
##mp	I-T103
-	I-T103
7	I-T103
,	O
the	O
size	B-T082
of	O
heterotopic	B-T038
ossification	I-T038
affected	O
the	O
knee	B-T033
range	I-T033
of	I-T033
motion	I-T033
.	O
all	O
the	O
patients	O
with	O
heterotopic	B-T038
ossification	I-T038
were	O
male	O
.	O
statistical	O
analysis	O
proved	O
that	O
patient	O
'	O
s	O
gender	O
was	O
the	O
only	O
important	O
factor	O
for	O
the	O
development	O
of	O
heterotopic	B-T038
ossification	I-T038
(	O
p	O
=	O
0	O
.	O
007	O
)	O
.	O
heterotopic	B-T038
ossification	I-T038
after	O
the	O
use	O
of	O
rhb	B-T103
##mp	I-T103
-	I-T103
7	I-T103
in	O
nonunion	B-T033
##s	I-T033
was	O
common	O
but	O
it	O
did	O
not	O
compromise	O
the	O
final	O
clinical	O
outcome	O
in	O
most	O
cases	O
,	O
and	O
affected	O
only	O
male	O
patients	O
.	O

modeling	B-T062
the	O
flux	O
of	O
metabolites	B-T103
in	O
the	O
juvenile	B-T103
hormone	I-T103
biosynthesis	B-T038
pathway	B-T038
using	O
generalized	O
additive	O
models	O
and	O
ordinary	B-T170
differential	I-T170
equations	I-T170
juvenile	B-T103
hormone	I-T103
(	O
jh	B-T103
)	O
regulates	O
development	O
and	O
reproductive	B-T038
maturation	I-T038
in	O
insects	B-T204
.	O
the	O
corpora	B-T017
all	I-T017
##ata	I-T017
(	O
ca	B-T017
)	O
from	O
female	O
adult	B-T204
mosquitoes	I-T204
synthesize	O
fluctuating	O
levels	O
of	O
jh	B-T103
,	O
which	O
have	O
been	O
linked	O
to	O
the	O
ovarian	B-T038
development	I-T038
and	O
are	O
influenced	O
by	O
nutritional	O
signals	B-T038
.	O
the	O
rate	O
of	O
jh	B-T103
biosynthesis	B-T038
is	O
controlled	O
by	O
the	O
rate	O
of	O
flux	O
of	O
isopren	B-T103
##oids	I-T103
in	O
the	O
pathway	B-T038
,	O
which	O
is	O
the	O
outcome	O
of	O
a	O
complex	O
interplay	O
of	O
changes	O
in	O
precursor	O
pools	O
and	O
enzyme	B-T103
levels	O
.	O
a	O
comprehensive	O
study	B-T062
of	O
the	O
changes	O
in	O
enzymatic	B-T038
activities	I-T038
and	O
precursor	O
pool	O
sizes	O
have	O
been	O
previously	O
reported	O
for	O
the	O
mosquito	B-T204
aedes	B-T204
aegypti	I-T204
jh	B-T103
biosynthesis	B-T038
pathway	B-T038
.	O
in	O
the	O
present	O
studies	B-T062
,	O
we	O
used	O
two	O
different	O
quantitative	O
approaches	O
to	O
describe	O
and	O
predict	O
how	O
changes	O
in	O
the	O
individual	O
metabolic	O
reactions	O
in	O
the	O
pathway	B-T038
affect	O
jh	B-T103
synthesis	B-T038
.	O
first	O
,	O
we	O
constructed	O
generalized	O
additive	O
models	O
(	O
gam	O
##s	O
)	O
that	O
described	O
the	O
association	O
between	O
changes	O
in	O
specific	O
metabolite	B-T103
concentrations	O
with	O
changes	O
in	O
enzymatic	B-T038
activities	I-T038
and	O
substrate	O
concentrations	O
.	O
changes	O
in	O
substrate	O
concentrations	O
explained	O
50	O
%	O
or	O
more	O
of	O
the	O
model	O
devi	O
##ances	O
in	O
7	O
of	O
the	O
13	O
metabolic	O
steps	O
analyzed	B-T062
.	O
addition	O
of	O
information	O
on	O
enzymatic	B-T038
activities	I-T038
almost	O
always	O
improved	O
the	O
fitness	O
of	O
gam	O
##s	O
built	O
solely	O
based	O
on	O
substrate	O
concentrations	O
.	O
gam	O
##s	O
were	O
validated	O
using	O
experimental	O
data	O
that	O
were	O
not	O
included	O
when	O
the	O
model	O
was	O
built	O
.	O
in	O
addition	O
,	O
a	O
system	O
of	O
ordinary	B-T170
differential	I-T170
equations	I-T170
(	O
od	B-T170
##e	I-T170
)	O
was	O
developed	O
to	O
describe	O
the	O
instantaneous	O
changes	O
in	O
metabolites	B-T103
as	O
a	O
function	O
of	O
the	O
levels	O
of	O
enzymatic	B-T038
catalytic	I-T038
activities	I-T038
.	O
the	O
results	O
demonstrated	O
the	O
ability	O
of	O
the	O
models	O
to	O
predict	O
changes	O
in	O
the	O
flux	O
of	O
metabolites	B-T103
in	O
the	O
jh	B-T103
pathway	B-T038
,	O
and	O
can	O
be	O
used	O
in	O
the	O
future	O
to	O
design	O
and	O
validate	B-T062
experimental	O
manipulations	O
of	O
jh	B-T103
synthesis	B-T038
.	O

simultaneous	O
thrombosis	B-T038
of	O
multiple	B-T017
coronary	I-T017
arteries	I-T017
in	O
a	O
patient	O
with	O
rheumatoid	B-T038
arthritis	I-T038
we	O
present	O
a	O
case	O
of	O
simultaneous	O
coronary	B-T038
thrombosis	I-T038
of	I-T038
the	I-T038
left	I-T038
main	I-T038
,	O
the	O
left	B-T017
anterior	I-T017
descending	I-T017
artery	I-T017
and	O
the	O
right	B-T017
coronary	I-T017
artery	I-T017
in	O
a	O
patient	O
,	O
recently	O
diagnosed	B-T058
with	O
rheumatoid	B-T038
arthritis	I-T038
.	O

engineering	B-T062
the	O
ribosomal	B-T103
dna	I-T103
in	O
a	O
meg	O
##aba	O
##se	O
synthetic	O
chromosome	O
we	O
designed	O
and	O
synthesized	O
a	O
97	O
##6	O
,	O
06	O
##7	O
-	O
base	O
pair	O
linear	O
chromosome	O
,	O
syn	O
##x	O
##ii	O
,	O
based	O
on	O
native	O
chromosome	B-T017
xii	I-T017
in	O
saccharomyces	B-T204
cerevisiae	I-T204
syn	O
##x	O
##ii	O
was	O
assembled	O
using	O
a	O
two	O
-	O
step	O
method	O
,	O
specified	O
by	O
successive	O
meg	B-T062
##ach	I-T062
##unk	I-T062
integration	I-T062
and	O
meiotic	B-T062
recombination	I-T062
-	I-T062
mediated	I-T062
assembly	I-T062
,	O
producing	O
a	O
functional	O
chromosome	B-T017
in	O
s	B-T204
.	I-T204
cerevisiae	I-T204
.	O
minor	O
growth	O
defect	O
[UNK]	O
bug	O
##s	O
[UNK]	O
detected	B-T033
in	O
syn	O
##x	O
##ii	O
,	O
caused	O
by	O
deletion	B-T038
of	O
trna	B-T103
genes	B-T017
,	O
were	O
rescued	O
by	O
introducing	O
an	O
ectopic	B-T017
copy	I-T017
of	O
a	O
single	B-T103
trna	I-T103
gene	B-T017
.	O
the	O
ribosomal	B-T017
gene	I-T017
cluster	I-T017
(	O
rdna	B-T017
)	O
on	O
syn	O
##x	O
##ii	O
was	O
left	O
intact	O
during	O
the	O
assembly	B-T062
process	I-T062
and	O
subsequently	O
replaced	O
by	O
a	O
modified	O
rdna	B-T017
unit	O
used	O
to	O
regenerate	O
rdna	B-T017
at	O
three	O
distinct	O
chromosomal	B-T017
locations	I-T017
.	O
the	O
signature	O
sequences	B-T082
within	O
rdna	B-T017
,	O
which	O
can	O
be	O
used	O
to	O
determine	O
species	B-T170
identity	B-T033
,	O
were	O
sw	O
##apped	O
to	O
generate	O
a	O
saccharomyces	B-T204
syn	O
##x	O
##ii	O
strain	O
that	O
would	O
be	O
identified	O
as	O
saccharomyces	B-T204
bay	I-T204
##anus	I-T204
by	O
standard	O
dna	O
barc	O
##oding	O
procedures	O
.	O

memory	B-T038
consolidation	I-T038
effects	O
on	O
memory	B-T038
stabilization	I-T038
and	O
item	B-T038
integration	I-T038
in	O
older	B-T098
adults	I-T098
this	O
study	B-T062
examined	O
the	O
differential	O
effects	O
of	O
aging	B-T038
on	O
consolidation	B-T038
processes	I-T038
that	O
strengthen	O
newly	O
acquired	O
memory	O
traces	O
in	O
ver	O
##idic	O
##al	O
form	O
(	O
memory	B-T038
stabilization	I-T038
)	O
versus	O
consolidation	B-T038
processes	I-T038
that	O
are	O
responsible	O
for	O
integrating	B-T038
these	O
memory	O
traces	O
into	O
an	O
existing	O
body	O
of	O
knowledge	B-T170
(	O
item	B-T038
integration	I-T038
)	O
.	O
older	B-T098
adults	I-T098
learned	B-T038
13	O
non	B-T170
##word	I-T170
##s	I-T170
and	O
were	O
tested	O
on	O
their	O
memory	B-T038
for	O
the	O
non	B-T170
##word	I-T170
##s	I-T170
,	O
and	O
on	O
whether	O
these	O
non	B-T170
##word	I-T170
##s	I-T170
impacted	O
upon	O
processing	O
of	O
similar	O
-	O
sound	O
##ing	O
english	O
words	B-T170
immediately	O
and	O
24	O
hours	O
later	O
.	O
participants	B-T098
accurately	O
recognized	O
the	O
non	B-T170
##word	I-T170
##s	I-T170
immediately	O
,	O
but	O
showed	O
significant	O
decreases	O
in	O
delayed	O
recognition	B-T038
and	O
recall	B-T038
.	O
in	O
comparison	O
,	O
the	O
non	B-T170
##word	I-T170
##s	I-T170
impacted	O
upon	O
processing	O
of	O
similar	B-T170
-	I-T170
sound	I-T170
##ing	I-T170
words	I-T170
only	O
in	O
the	O
delayed	B-T170
test	I-T170
.	O
together	O
,	O
these	O
findings	O
suggest	O
that	O
memory	B-T038
consolidation	I-T038
processes	I-T038
may	O
be	O
more	O
evident	O
in	O
item	B-T038
integration	I-T038
than	O
memory	B-T038
stabilization	I-T038
processes	I-T038
for	O
new	O
decl	O
##arative	O
memories	B-T038
in	O
older	B-T098
adults	I-T098
.	O

are	O
eyes	B-T017
a	O
mirror	O
of	O
the	O
sou	O
##l	O
?	O
what	O
eye	B-T017
wrink	B-T017
##les	I-T017
reveal	O
about	O
a	O
horse	B-T204
'	I-T204
s	I-T204
emotional	B-T038
state	I-T038
finding	O
valid	O
indicators	O
of	O
emotional	B-T038
states	I-T038
is	O
one	O
of	O
the	O
big	O
##gest	O
challenges	O
in	O
animal	O
welfare	O
science	O
.	O
here	O
,	O
we	O
investigated	O
in	O
horses	B-T204
whether	O
variation	O
in	O
the	O
expression	O
of	O
eye	B-T017
wrink	B-T017
##les	I-T017
caused	O
by	O
contraction	B-T038
of	O
the	O
inner	B-T017
eye	I-T017
##br	I-T017
##ow	I-T017
raise	O
##r	O
reflects	B-T038
emotional	B-T033
valence	I-T033
.	O
by	O
confron	O
##ting	O
horses	B-T204
with	O
positive	B-T033
and	O
negative	B-T033
conditions	O
,	O
we	O
aimed	O
to	O
induce	O
positive	B-T033
and	O
negative	B-T033
emotional	B-T038
states	I-T038
,	O
hypothesis	O
##ing	O
that	O
positive	B-T033
emotions	B-T038
would	O
reduce	O
whereas	O
negative	B-T033
emotions	B-T038
would	O
increase	O
eye	B-T017
wrink	B-T017
##le	I-T017
expression	O
.	O
sixteen	O
horses	B-T204
were	O
individually	O
exposed	O
in	O
a	O
balanced	O
order	O
to	O
two	O
positive	B-T033
(	O
gro	O
##oming	O
,	O
food	O
anticipation	O
)	O
and	O
two	O
negative	B-T033
condition	O
s	O
(	O
food	B-T168
competition	O
,	O
wav	O
##ing	O
a	O
plastic	O
bag	O
)	O
.	O
each	O
condition	O
lasted	O
for	O
60	O
seconds	O
and	O
was	O
preceded	O
by	O
a	O
60	O
second	O
control	O
phase	O
.	O
throughout	O
both	O
phases	O
,	O
pictures	O
of	O
the	O
eyes	B-T017
were	O
taken	O
,	O
and	O
for	O
each	O
horse	B-T204
four	O
pictures	O
per	O
condition	O
and	O
phase	O
were	O
randomly	O
selected	O
.	O
pictures	O
were	O
scored	O
in	O
random	O
order	O
and	O
by	O
two	O
experiment	O
##ers	O
blind	B-T062
to	O
condition	O
and	O
phase	O
for	O
six	O
outcome	O
measures	O
:	O
qualitative	O
impression	O
,	O
eyelid	B-T017
shape	B-T082
,	O
marked	O
##ness	O
of	O
the	O
wrink	B-T017
##les	I-T017
,	O
presence	B-T033
of	O
eye	B-T017
white	I-T017
,	O
number	O
of	O
wrink	B-T017
##les	I-T017
,	O
and	O
the	O
angle	B-T082
between	O
the	O
line	O
through	O
the	O
eye	B-T017
##ball	I-T017
and	O
the	O
highest	O
wrink	B-T017
##le	I-T017
.	O
the	O
angle	B-T082
decreased	O
during	O
gro	O
##oming	O
and	O
increased	O
during	O
food	B-T168
competition	O
compared	O
to	O
control	O
phase	O
s	O
,	O
whereas	O
the	O
two	O
phases	O
did	O
not	O
differ	O
during	O
food	O
anticipation	O
and	O
the	O
plastic	O
bag	O
condition	O
.	O
no	O
effects	O
on	O
the	O
other	O
outcome	O
measures	O
were	O
detected	B-T033
.	O
taken	O
together	O
,	O
we	O
have	O
defined	O
a	O
set	O
of	O
measures	O
to	O
assess	O
eye	B-T017
wrink	B-T017
##le	I-T017
expression	O
reliably	O
,	O
of	O
which	O
one	O
measure	O
was	O
affected	O
by	O
the	O
conditions	O
the	O
horses	B-T204
were	O
exposed	O
to	O
.	O
variation	O
in	O
eye	B-T017
wrink	B-T017
##le	I-T017
expression	O
might	O
provide	B-T168
valuable	O
information	O
on	O
horse	B-T204
welfare	O
but	O
further	O
validation	B-T062
of	O
specific	O
measures	O
across	O
different	O
conditions	O
is	O
needed	O
.	O

net	B-T103
##ars	I-T103
##udi	I-T103
##l	I-T103
increases	O
outflow	B-T058
facility	I-T058
in	O
human	B-T204
eyes	B-T017
through	O
multiple	O
mechanisms	O
net	B-T103
##ars	I-T103
##udi	I-T103
##l	I-T103
is	O
a	O
rho	B-T103
kinase	I-T103
/	I-T103
norepinephrine	I-T103
transporter	I-T103
inhibitor	I-T103
currently	O
in	O
phase	B-T062
3	I-T062
clinical	I-T062
development	I-T062
for	O
glaucoma	B-T038
treatment	B-T058
.	O
we	O
investigated	O
the	O
effects	O
of	O
its	O
active	O
metabolite	B-T103
,	O
net	B-T103
##ars	I-T103
##udi	I-T103
##l	I-T103
-	I-T103
m1	I-T103
,	O
on	O
outflow	B-T058
facility	I-T058
(	O
c	B-T058
)	O
,	O
outflow	O
hydrodynamic	O
##s	O
,	O
and	O
morphology	O
of	O
the	O
conventional	O
outflow	O
pathway	O
in	O
enucle	O
##ated	O
human	O
eyes	O
.	O
paired	O
human	B-T204
eyes	B-T017
(	O
n	O
=	O
5	O
)	O
were	O
perfused	B-T058
with	O
either	O
0	O
.	O
3	O
μm	O
net	B-T103
##ars	I-T103
##udi	I-T103
##l	I-T103
-	I-T103
m1	I-T103
or	O
vehicle	B-T103
solution	I-T103
at	O
constant	O
pressure	O
(	O
15	O
mm	O
hg	O
)	O
.	O
after	O
3	O
hours	O
,	O
fluorescent	B-T074
microspheres	I-T074
were	O
added	O
to	O
perfusion	B-T058
media	B-T103
to	O
trace	O
the	O
outflow	O
patterns	O
before	O
perfusion	B-T058
-	O
fixation	B-T058
.	O
the	O
percentage	O
effective	O
filtration	O
length	O
(	O
pef	O
##l	O
)	O
was	O
calculated	O
from	O
the	O
measured	O
lengths	O
of	O
tracer	B-T103
distribution	O
in	O
the	O
trabecular	B-T017
mesh	I-T017
##work	I-T017
(	O
tm	B-T017
)	O
,	O
epis	B-T017
##cler	I-T017
##al	I-T017
veins	I-T017
(	O
es	B-T017
##vs	I-T017
)	O
,	O
and	O
along	O
the	O
inner	O
wall	O
(	O
i	O
##w	O
)	O
of	O
sch	B-T082
##lem	I-T082
##m	I-T082
'	I-T082
s	I-T082
canal	I-T082
after	O
global	O
and	O
confocal	B-T058
imaging	I-T058
.	O
morphologic	B-T017
changes	I-T017
along	O
the	O
trabecular	B-T017
outflow	O
pathway	O
were	O
investigated	O
by	O
confocal	B-T058
,	O
light	B-T058
,	O
and	O
electron	B-T058
microscopy	I-T058
.	O
perfusion	B-T058
with	O
net	B-T103
##ars	I-T103
##udi	I-T103
##l	I-T103
-	I-T103
m1	I-T103
significantly	O
increased	O
c	B-T058
when	O
compared	O
to	O
baseline	O
(	O
51	O
%	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
to	O
paired	O
controls	O
(	O
102	O
%	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
as	O
well	O
as	O
significantly	O
increased	O
pef	O
##l	O
in	O
both	O
i	O
##w	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
es	B-T017
##vs	I-T017
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
in	O
treated	O
eyes	B-T017
,	O
pef	O
##l	O
was	O
significantly	O
higher	O
in	O
es	B-T017
##vs	I-T017
than	O
in	O
the	O
i	O
##w	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
was	O
associated	O
with	O
increased	O
cross	B-T082
-	I-T082
sectional	I-T082
area	I-T082
of	O
es	B-T017
##vs	I-T017
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
percentage	O
effective	O
filtration	O
length	O
in	O
es	B-T017
##vs	I-T017
positively	O
correlated	O
with	O
the	O
percentage	O
change	O
in	O
c	B-T058
(	O
r2	O
=	O
0	O
.	O
58	O
,	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O
a	O
significant	O
increase	O
in	O
juxt	B-T017
##aca	I-T017
##nal	I-T017
##icular	I-T017
connective	I-T017
tissue	I-T017
(	O
jc	B-T017
##t	I-T017
)	O
thickness	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
was	O
found	O
in	O
treated	O
eyes	B-T017
compared	O
to	O
controls	O
.	O
net	B-T103
##ars	I-T103
##udi	I-T103
##l	I-T103
acutely	O
increased	O
c	B-T058
by	O
expansion	O
of	O
the	O
jc	B-T017
##t	I-T017
and	O
dil	O
##ating	O
the	O
es	B-T017
##vs	I-T017
,	O
which	O
led	O
to	O
redistribution	O
of	O
aqueous	O
outflow	O
through	O
a	O
larger	B-T082
area	I-T082
of	O
the	O
i	O
##w	O
and	O
es	B-T017
##vs	I-T017
.	O

performance	O
and	O
safety	O
of	O
collagen	B-T103
##ated	I-T103
xeno	I-T103
##gene	I-T103
##ic	I-T103
bone	I-T103
block	I-T103
for	O
lateral	B-T058
alveolar	I-T058
ridge	I-T058
augmentation	I-T058
and	O
staged	B-T058
implant	I-T058
placement	I-T058
.	O
a	O
monoc	B-T062
##enter	I-T062
,	I-T062
prospective	I-T062
single	I-T062
-	I-T062
arm	I-T062
clinical	I-T062
study	I-T062
to	O
assess	O
the	O
clinical	O
safety	O
and	O
performance	O
of	O
collagen	B-T103
##ated	I-T103
xeno	I-T103
##gene	I-T103
##ic	I-T103
bone	I-T103
block	I-T103
(	O
cx	B-T103
##bb	I-T103
)	O
for	O
lateral	B-T058
alveolar	I-T058
ridge	I-T058
augmentation	I-T058
and	O
two	O
-	O
stage	O
implant	B-T058
placement	I-T058
.	O
in	O
ten	O
patients	O
exhibiting	O
a	O
single	O
-	O
tooth	B-T017
gap	B-T082
,	O
the	O
surgical	B-T058
procedure	I-T058
included	O
the	O
preparation	O
of	O
muco	B-T017
##peri	I-T017
##osteal	I-T017
flaps	I-T017
,	O
a	O
rigid	B-T058
fixation	I-T058
of	O
cx	B-T103
##bb	I-T103
(	O
ge	B-T170
##ist	I-T170
##lich	I-T170
bio	I-T170
-	I-T170
graft	I-T170
(	I-T170
®	I-T170
)	I-T170
)	O
using	O
an	O
oste	B-T074
##osynthesis	I-T074
screw	I-T074
,	O
and	O
contour	B-T082
augmentation	B-T058
.	O
after	O
24	O
weeks	O
of	O
submerged	B-T038
healing	I-T038
,	O
the	O
primary	B-T103
endpoint	I-T103
was	O
defined	O
as	O
the	O
final	O
ridge	B-T082
width	O
sufficient	O
to	O
place	O
an	O
adequately	O
dimension	O
##ed	O
titanium	O
implant	O
at	O
the	O
respective	O
sites	B-T082
.	O
secondary	O
outcomes	O
included	O
,	O
for	O
example	O
,	O
the	O
gain	O
in	O
ridge	B-T082
width	O
(	O
mm	O
)	O
.	O
clinical	B-T062
parameters	I-T062
(	O
e	O
.	O
g	O
.	O
,	O
bleeding	B-T033
on	I-T033
probing	I-T033
-	O
bo	B-T033
##p	I-T033
,	O
probing	O
depth	O
-	O
pd	O
,	O
mucosal	B-T017
recession	I-T017
-	O
mr	B-T017
)	O
were	O
assessed	O
immediately	O
after	O
the	O
cement	B-T058
##ation	I-T058
of	I-T058
the	I-T058
crown	I-T058
and	O
at	O
the	O
final	B-T058
visit	I-T058
.	O
at	O
24	O
weeks	O
,	O
implant	B-T058
placement	I-T058
could	O
be	O
achieved	O
in	O
8	O
of	O
10	O
patients	O
exhibiting	O
a	O
mean	O
gain	O
in	O
ridge	B-T082
width	O
(	O
mean	O
±	O
sd	O
)	O
of	O
3	O
.	O
88	O
±	O
1	O
.	O
75	O
mm	O
.	O
histological	O
analysis	B-T062
has	O
pointed	O
to	O
a	O
homogeneous	B-T082
osseous	B-T017
organization	O
of	O
cx	B-T103
##bb	I-T103
.	O
the	O
changes	O
of	O
mean	O
bo	B-T033
##p	I-T033
,	O
pd	O
,	O
and	O
mr	B-T017
values	O
at	O
the	O
final	B-T058
visit	I-T058
amounted	O
to	O
16	O
.	O
62	O
±	O
32	O
.	O
02	O
%	O
,	O
0	O
.	O
04	O
±	O
0	O
.	O
21	O
mm	O
,	O
and	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
12	O
mm	O
,	O
respectively	O
.	O
cx	B-T103
##bb	I-T103
may	O
be	O
successfully	O
used	O
to	O
support	O
lateral	B-T058
alveolar	I-T058
ridge	I-T058
augmentation	I-T058
and	O
two	O
-	O
stage	O
implant	B-T058
placement	I-T058
.	O

contextual	B-T038
factors	I-T038
for	O
st	B-T038
##unting	I-T038
among	O
children	O
of	O
age	O
6	O
to	O
24	O
months	O
in	O
an	O
under	O
-	O
privile	O
##ged	O
community	O
of	O
dha	B-T082
##ka	I-T082
,	O
bangladesh	B-T082
to	O
determine	O
factors	O
associated	O
with	O
st	B-T038
##unting	I-T038
among	O
children	O
aged	O
6	O
to	O
24	O
months	O
in	O
a	O
sl	O
##um	O
of	O
dha	B-T082
##ka	I-T082
,	O
bangladesh	B-T082
.	O
we	O
conducted	O
this	O
case	B-T062
control	I-T062
study	I-T062
during	O
november	O
2009	O
to	O
december	O
2012	O
.	O
children	O
were	O
classified	O
as	O
case	O
if	O
length	O
-	O
for	O
-	O
age	O
z	O
-	O
score	O
(	O
la	O
##z	O
)	O
was	O
<	O
-	O
2	O
and	O
as	O
control	O
if	O
la	O
##z	O
was	O
>	O
-	O
1	O
sd	O
.	O
the	O
logistic	O
regression	O
model	O
was	O
used	O
to	O
find	O
the	O
factors	O
associated	O
with	O
st	B-T038
##unting	I-T038
.	O
the	O
significant	O
risk	B-T033
factors	I-T033
for	O
st	B-T038
##unting	I-T038
were	O
:	O
child	O
'	O
s	O
age	O
>	O
12	O
months	O
,	O
maternal	O
undern	B-T038
##utrition	I-T038
,	O
mother	B-T033
'	I-T033
s	I-T033
education	I-T033
<	O
5	O
years	O
,	O
consumption	B-T038
of	O
untreated	O
drinking	O
water	O
and	O
monthly	O
family	O
income	O
<	O
100	O
us	O
##d	O
.	O
the	O
findings	B-T033
of	O
this	O
study	B-T062
re	O
##iter	O
##ated	O
the	O
role	O
of	O
maternal	O
undern	B-T038
##utrition	I-T038
and	O
less	B-T033
education	I-T033
,	O
consumption	B-T038
of	O
untreated	O
drinking	O
water	O
and	O
poor	O
family	O
income	O
as	O
important	O
associated	O
factors	O
of	O
childhood	O
st	B-T038
##unting	I-T038
in	O
resource	O
-	O
poor	O
setting	O
.	O

the	O
effect	O
of	O
l	B-T103
-	I-T103
arginine	I-T103
on	O
dural	B-T038
healing	I-T038
after	O
experimentally	O
induced	O
dural	B-T017
defect	O
in	O
a	O
rat	B-T204
model	O
incomplete	O
repair	B-T038
of	O
the	O
dura	B-T017
mater	I-T017
may	O
result	O
in	O
numerous	O
complications	B-T038
such	O
as	O
cerebrospinal	B-T038
fluid	I-T038
leakage	I-T038
and	O
meningitis	B-T038
.	O
for	O
this	O
reason	O
,	O
accurate	O
repair	B-T038
of	O
the	O
dura	B-T017
mater	I-T017
is	O
essential	O
.	O
in	O
this	O
study	O
,	O
the	O
effect	O
of	O
systemic	O
and	O
local	B-T082
supplementation	O
of	O
l	B-T103
-	I-T103
arginine	I-T103
on	O
dural	B-T038
healing	I-T038
was	O
evaluated	O
.	O
thirty	O
male	O
wistar	B-T204
rats	I-T204
were	O
used	O
and	O
divided	O
into	O
control	O
,	O
local	B-T082
,	O
and	O
systemic	O
l	B-T103
-	I-T103
arginine	I-T103
groups	O
,	O
with	O
10	O
rats	B-T204
in	O
each	O
.	O
in	O
each	O
group	O
,	O
a	O
5	O
-	O
mm	O
experimental	B-T058
incision	I-T058
was	O
made	O
at	O
the	O
lumbar	B-T082
segment	I-T082
of	I-T082
the	I-T082
dura	I-T082
mater	I-T082
and	O
cerebrospinal	B-T038
fluid	I-T038
leakage	I-T038
was	O
induced	O
.	O
each	O
group	O
was	O
divided	O
into	O
2	O
subgroups	B-T170
and	O
at	O
the	O
end	O
of	O
the	O
first	O
and	O
sixth	O
weeks	O
,	O
the	O
rats	B-T204
were	O
killed	B-T058
and	O
the	O
damaged	O
segments	B-T082
of	O
the	O
dura	B-T017
were	O
separated	O
,	O
histologically	O
evaluated	O
and	O
the	O
dural	B-T038
healing	I-T038
indicators	O
including	O
cell	B-T017
types	I-T017
,	O
granulation	B-T017
tissue	I-T017
formation	O
,	O
collagen	B-T103
deposit	O
,	O
and	O
vascularization	O
were	O
compared	O
between	O
groups	O
.	O
the	O
systematic	O
supplementation	O
of	O
l	B-T103
-	I-T103
arginine	I-T103
showed	O
a	O
significant	O
effect	O
in	O
dural	B-T038
healing	I-T038
compared	O
with	O
the	O
control	O
group	O
.	O
after	O
the	O
first	O
week	O
,	O
granulation	B-T017
formation	O
increased	O
considerably	O
(	O
p	O
<	O
0	O
.	O
031	O
)	O
,	O
and	O
after	O
6	O
weeks	O
,	O
collagen	B-T103
deposition	O
and	O
neovascularization	B-T038
were	O
significantly	O
different	O
compared	O
with	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
030	O
;	O
p	O
<	O
0	O
.	O
009	O
)	O
.	O
in	O
comparison	O
between	O
different	O
groups	O
at	O
the	O
end	O
of	O
the	O
first	O
and	O
sixth	O
weeks	O
,	O
maximum	O
changes	O
in	O
healing	B-T038
indicators	O
were	O
observed	O
in	O
the	O
systemic	O
group	O
and	O
the	O
least	O
variations	O
were	O
related	O
to	O
the	O
control	O
group	O
.	O
the	O
systemic	O
supplementation	O
of	O
l	B-T103
-	I-T103
arginine	I-T103
may	O
accelerate	O
dural	B-T038
healing	I-T038
by	O
increasing	O
the	O
level	O
of	O
granulation	B-T017
tissue	I-T017
formation	O
,	O
collagen	B-T103
deposition	O
,	O
and	O
vascularization	O
.	O

discontinued	B-T033
splen	B-T017
##og	I-T017
##onad	I-T017
##al	I-T017
fusion	I-T017
and	O
bilateral	B-T017
empty	I-T017
scr	I-T017
##ot	I-T017
##um	I-T017
in	O
an	O
18	O
-	O
month	O
-	O
old	O
boy	O
splen	B-T017
##og	I-T017
##onad	I-T017
##al	I-T017
fusion	I-T017
is	O
a	O
rare	O
benign	O
congenital	B-T017
anomaly	I-T017
defined	O
as	O
the	O
presence	O
of	O
splenic	B-T017
tissue	I-T017
adherent	O
to	O
gonads	B-T017
.	O
it	O
was	O
first	O
described	O
in	O
188	O
##3	O
by	O
bost	B-T204
##ro	I-T204
##em	I-T204
,	O
a	O
german	B-T098
pathologist	B-T097
.	O
we	O
present	O
a	O
case	O
of	O
an	O
18	O
-	O
month	O
-	O
old	O
boy	O
who	O
was	O
referred	O
as	O
a	O
case	O
of	O
bilateral	B-T017
empty	I-T017
scr	I-T017
##ot	I-T017
##um	I-T017
since	O
birth	O
.	O
during	O
routine	O
laparoscopic	B-T058
exploration	B-T058
,	O
right	B-T017
vas	I-T017
deferens	I-T017
and	O
testicular	O
vessels	O
were	O
entering	O
the	O
right	B-T017
internal	I-T017
inguinal	I-T017
ring	I-T017
so	O
right	B-T082
inguinal	I-T082
exploration	B-T058
was	O
done	O
,	O
which	O
revealed	O
blind	B-T033
ending	I-T033
vas	B-T017
deferens	I-T017
and	O
testicular	O
vessels	O
and	O
the	O
left	B-T017
testis	I-T017
was	O
found	O
intra	B-T082
-	I-T082
abdominal	I-T082
##ly	I-T082
near	O
the	O
left	O
internal	B-T082
ring	I-T082
with	O
a	O
mass	B-T033
on	O
its	O
upper	B-T017
pole	I-T017
.	O
wedge	B-T058
biopsy	I-T058
was	O
taken	O
from	O
the	O
upper	B-T017
pole	I-T017
of	I-T017
the	I-T017
test	I-T017
##icle	I-T017
(	O
site	B-T082
of	O
the	O
mass	B-T033
)	O
for	O
tissue	O
diagnosis	O
followed	O
by	O
orchid	B-T058
##opexy	I-T058
.	O
histology	B-T058
showed	O
splenic	B-T017
tissue	I-T017
.	O
although	O
splen	B-T017
##og	I-T017
##onad	I-T017
##al	I-T017
fusion	I-T017
is	O
a	O
rare	O
condition	B-T038
,	O
surgeons	B-T097
should	O
be	O
aware	O
of	O
this	O
rare	B-T038
disease	I-T038
entity	O
to	O
avoid	O
unnecessary	B-T058
aggressive	O
interventions	B-T058
such	O
as	O
orch	B-T058
##ie	I-T058
##ct	I-T058
##omy	I-T058
.	O

the	O
usefulness	O
of	O
employing	B-T033
an	O
electronic	B-T074
traction	I-T074
table	I-T074
to	O
determine	O
flexibility	O
in	O
adolescent	B-T017
idiopathic	I-T017
scoliosis	I-T017
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
develop	O
new	O
equipment	O
for	O
the	O
assessment	B-T058
of	O
the	O
flexibility	O
of	O
the	O
spine	B-T017
with	O
different	O
forces	O
.	O
this	O
new	O
system	O
should	O
provide	O
a	O
different	O
perspective	O
to	O
adolescent	B-T017
idiopathic	I-T017
scoliosis	I-T017
(	O
ais	B-T017
)	O
for	O
the	O
selection	O
of	O
fusion	O
levels	O
and	O
surgical	B-T058
success	O
.	O
eighteen	O
patients	O
suffering	O
from	O
ais	B-T017
who	O
were	O
scheduled	O
to	O
undergo	O
posterior	B-T082
instrumented	B-T058
spinal	I-T058
fusion	I-T058
in	O
our	O
clinic	B-T092
were	O
recruited	O
in	O
this	O
study	B-T062
.	O
the	O
electronic	B-T074
traction	I-T074
table	I-T074
(	O
et	B-T074
##t	I-T074
)	O
that	O
was	O
designed	O
in	O
our	O
clinic	B-T092
was	O
used	O
to	O
evaluate	O
the	O
radio	O
##gic	O
##al	O
and	O
clinical	O
parameters	O
of	O
the	O
spine	B-T017
.	O
the	O
significant	O
prescrip	O
##tive	O
angle	O
of	O
major	O
cob	B-T033
##b	I-T033
angles	I-T033
between	O
postoperative	O
angles	O
were	O
longitudinal	B-T082
traction	B-T058
and	O
lateral	B-T033
push	I-T033
##ing	I-T033
cob	I-T033
##b	I-T033
angles	I-T033
.	O
longitudinal	B-T082
traction	B-T058
and	O
lateral	B-T033
push	I-T033
##ing	I-T033
angles	I-T033
were	O
more	O
correlated	O
with	O
correction	O
ratios	O
.	O
there	O
was	O
a	O
significant	O
difference	O
between	O
longitudinal	B-T082
traction	B-T058
minor	O
cob	B-T033
##b	I-T033
angle	I-T033
,	O
longitudinal	B-T082
traction	B-T058
lateral	B-T033
push	I-T033
##ing	I-T033
minor	I-T033
cob	I-T033
##b	I-T033
angle	I-T033
and	O
postoperative	B-T033
minor	I-T033
cob	I-T033
##b	I-T033
angles	I-T033
.	O
the	O
deformity	B-T017
is	O
needed	O
to	O
balance	O
both	O
traction	B-T058
##al	I-T058
and	O
rotational	O
forces	O
and	O
useful	O
technique	O
to	O
evaluate	O
curve	O
flexibility	O
before	O
the	O
operation	B-T058
.	O
electronic	B-T074
traction	I-T074
table	I-T074
is	O
a	O
new	O
device	B-T074
for	O
determining	O
preoperative	O
flexibility	O
with	O
longitudinal	B-T082
traction	B-T058
and	O
lateral	B-T058
push	I-T058
##ing	I-T058
radiographs	I-T058
.	O
it	O
can	O
be	O
useful	O
for	O
choosing	O
selective	O
fusion	O
levels	O
at	O
the	O
proximal	B-T082
and	O
distal	B-T082
end	O
of	O
the	O
vertebral	B-T017
column	I-T017
.	O

management	B-T058
of	O
precipitated	B-T038
opiate	I-T038
withdrawal	I-T038
syndrome	I-T038
induced	O
by	O
nal	B-T103
##me	I-T103
##fen	I-T103
##e	I-T103
mist	O
##aken	O
##ly	O
prescribed	O
in	O
opiate	B-T103
-	O
dependent	O
patients	O
:	O
a	O
review	B-T170
for	O
clinicians	B-T097
nal	B-T103
##me	I-T103
##fen	I-T103
##e	I-T103
,	O
a	O
long	B-T103
-	I-T103
acting	I-T103
µ	I-T103
-	I-T103
opioid	I-T103
antagonist	I-T103
approved	O
to	O
treat	O
alcohol	O
use	O
disorder	O
,	O
is	O
occasionally	O
mist	O
##aken	O
##ly	O
prescribed	O
to	O
opiate	B-T103
-	O
dependent	O
or	O
opioid	B-T103
-	O
treated	O
patients	O
.	O
we	O
review	O
recent	O
literature	B-T170
on	O
drug	B-T038
-	I-T038
drug	I-T038
interactions	I-T038
between	O
nal	B-T103
##me	I-T103
##fen	I-T103
##e	I-T103
and	O
opioids	B-T103
that	O
lead	O
to	O
precipitated	B-T038
opioid	I-T038
withdrawal	I-T038
,	O
and	O
focus	O
on	O
its	O
management	B-T058
and	O
planning	O
for	O
care	B-T058
at	O
discharge	B-T058
.	O
areas	O
covered	O
:	O
this	O
article	O
provides	O
a	O
brief	O
and	O
comprehensive	B-T058
review	I-T058
of	O
management	O
of	O
precipitated	B-T038
opioid	I-T038
withdrawal	I-T038
syndrome	I-T038
when	O
nal	B-T103
##me	I-T103
##fen	I-T103
##e	I-T103
is	O
associated	O
with	O
an	O
opioid	B-T103
,	O
whether	O
misuse	B-T033
##d	I-T033
or	O
legal	O
##ly	O
prescribed	O
.	O
expert	O
opinion	O
:	O
when	O
treating	O
an	O
opiate	B-T103
-	O
dependent	O
patient	O
with	O
co	O
-	O
occurring	O
alcohol	O
use	O
disorder	O
,	O
both	O
conditions	O
need	O
to	O
be	O
a	O
focus	O
of	O
clinical	O
attention	O
.	O
new	O
drugs	B-T103
for	O
alcohol	O
use	O
disorder	O
have	O
been	O
approved	O
,	O
but	O
must	O
be	O
given	O
cautious	O
##ly	O
and	O
with	O
a	O
full	O
understanding	O
of	O
their	O
potential	O
drug	B-T038
-	I-T038
drug	I-T038
interactions	I-T038
with	O
opioid	B-T103
medications	B-T170
.	O
opiate	B-T103
-	O
dependent	O
patients	O
should	O
be	O
intensively	O
monitored	O
for	O
risk	B-T033
factors	I-T033
of	O
alcohol	O
use	O
disorder	O
and	O
should	O
be	O
continuously	O
motivated	O
for	O
treatment	O
maintenance	O
.	O
when	O
nal	B-T103
##me	I-T103
##fen	I-T103
##e	I-T103
is	O
administered	B-T058
to	O
opiate	B-T103
-	O
dependent	O
patients	O
,	O
acute	O
opioid	B-T038
withdrawal	I-T038
syndrome	I-T038
may	O
occur	O
.	O
management	B-T058
of	O
precipitated	O
acute	O
opioid	B-T038
withdrawal	I-T038
may	O
include	O
short	O
or	O
long	B-T038
-	I-T038
acting	I-T038
µ	I-T038
-	I-T038
opioid	I-T038
agonists	I-T038
during	O
hospitalization	B-T058
,	O
in	O
addition	O
to	O
supportive	B-T058
treatment	I-T058
.	O
the	O
best	O
management	B-T058
of	O
polyd	B-T033
##rug	I-T033
abusers	I-T033
is	O
based	O
on	O
a	O
multidisciplinary	B-T058
approach	I-T058
,	O
which	O
should	O
be	O
pursued	O
and	O
improved	B-T033
through	O
continuing	O
medical	O
education	O
.	O

modifiable	O
healthy	O
lifestyle	O
behaviors	O
:	O
10	O
-	O
year	O
health	O
outcomes	O
from	O
a	O
health	B-T058
promotion	I-T058
program	I-T058
previous	O
studies	O
have	O
examined	O
the	O
impact	O
of	O
healthy	O
lifestyle	O
choices	O
on	O
health	O
-	O
related	O
outcomes	O
;	O
however	O
,	O
given	O
their	O
fragmented	O
,	O
often	O
cross	B-T062
-	I-T062
sectional	I-T062
nature	I-T062
,	O
assessing	B-T058
the	I-T058
relative	I-T058
impact	I-T058
of	O
daily	O
modifiable	O
behaviors	O
on	O
overall	O
long	O
-	O
term	O
outcomes	O
,	O
particularly	O
for	O
a	O
diverse	O
working	B-T098
adult	I-T098
population	I-T098
,	O
remains	O
challenging	O
.	O
relationships	O
between	O
ten	O
self	B-T062
-	I-T062
reported	I-T062
healthy	O
lifestyle	O
behaviors	O
and	O
health	O
outcomes	O
during	O
the	O
subsequent	O
9	O
years	O
in	O
a	O
cohort	B-T098
of	O
10	O
,	O
248	O
participants	B-T098
enrolled	O
during	O
2003	O
in	O
a	O
voluntary	O
workplace	B-T082
wellness	B-T058
program	I-T058
were	O
assessed	O
.	O
cox	B-T170
proportional	I-T170
-	I-T170
hazards	I-T170
models	I-T170
computed	O
hazard	O
ratios	O
(	O
hrs	O
)	O
for	O
lifestyle	O
characteristics	O
associated	O
with	O
time	O
to	O
one	O
of	O
seven	O
self	B-T062
-	I-T062
reported	I-T062
chronic	B-T038
diseases	I-T038
or	O
death	B-T038
.	O
data	B-T033
were	I-T033
collected	I-T033
between	O
2003	O
and	O
2012	O
and	O
analyzed	O
between	O
2014	O
and	O
2016	O
.	O
behaviors	O
that	O
most	O
significantly	O
affected	O
future	O
outcomes	O
were	O
low	B-T058
-	I-T058
fat	I-T058
diet	I-T058
,	O
aerobic	B-T058
exercise	I-T058
,	O
nonsmok	O
##ing	O
,	O
and	O
adequate	B-T033
sleep	I-T033
.	O
a	O
dose	B-T062
-	I-T062
response	I-T062
effect	I-T062
was	O
seen	O
between	O
dietary	B-T033
fat	I-T033
intake	I-T033
and	O
hypertension	B-T038
,	O
obesity	B-T038
,	O
diabetes	B-T038
,	O
heart	B-T038
disease	I-T038
,	O
and	O
hypercholesterolemia	B-T038
.	O
after	O
dietary	B-T033
fat	I-T033
intake	I-T033
,	O
aerobic	B-T058
exercise	I-T058
was	O
the	O
next	O
most	O
significant	O
behavior	O
associated	O
with	O
development	B-T062
of	I-T062
outcomes	I-T062
.	O
compared	O
with	O
sedentary	O
participants	B-T098
,	O
those	O
who	O
exercised	O
4	O
days	O
per	O
week	O
were	O
less	O
likely	O
to	O
develop	O
new	O
-	O
onset	O
diabetes	O
(	O
hr	O
=	O
0	O
.	O
31	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
20	O
,	O
0	O
.	O
48	O
)	O
;	O
heart	B-T038
disease	I-T038
(	O
hr	O
=	O
0	O
.	O
46	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
27	O
,	O
0	O
.	O
80	O
)	O
;	O
and	O
hypercholesterolemia	B-T038
(	O
hr	O
=	O
0	O
.	O
61	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
50	O
,	O
0	O
.	O
74	O
)	O
.	O
low	B-T058
-	I-T058
fat	I-T058
diet	I-T058
and	O
adequate	B-T033
sleep	I-T033
were	O
more	O
significant	O
than	O
commonly	O
promoted	O
healthy	O
behaviors	O
,	O
such	O
as	O
eating	O
a	O
daily	O
breakfast	O
.	O
modifiable	O
lifestyle	O
behaviors	O
targeted	O
in	O
health	B-T058
promotion	I-T058
programs	I-T058
should	O
be	O
priori	O
##ti	O
##zed	O
in	O
an	O
evidence	O
-	O
based	O
manner	O
.	O
top	O
priorities	O
for	O
workplace	B-T082
health	B-T058
promotion	I-T058
should	O
include	O
low	B-T058
-	I-T058
fat	I-T058
diet	I-T058
,	O
aerobic	B-T058
exercise	I-T058
,	O
nonsmok	O
##ing	O
,	O
and	O
adequate	B-T033
sleep	I-T033
.	O

chitosan	B-T103
-	O
functional	O
##ised	O
poly	B-T103
(	I-T103
2	I-T103
-	I-T103
hydroxyethyl	I-T103
methacrylate	I-T103
)	I-T103
core	B-T103
-	I-T103
shell	I-T103
microg	I-T103
##els	I-T103
as	O
drug	B-T074
delivery	I-T074
carriers	I-T074
:	O
salicylic	B-T103
acid	I-T103
loading	O
and	O
release	O
this	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	B-T103
-	O
functional	O
##ised	O
poly	B-T103
(	I-T103
2	I-T103
-	I-T103
hydroxyethyl	I-T103
methacrylate	I-T103
)	I-T103
(	O
cs	B-T103
/	O
phe	B-T103
##ma	I-T103
)	O
core	B-T103
-	I-T103
shell	I-T103
microg	I-T103
##els	I-T103
as	O
drug	B-T074
delivery	I-T074
carriers	I-T074
.	O
cs	B-T103
/	O
phe	B-T103
##ma	I-T103
microg	B-T103
##els	I-T103
were	O
prepared	O
by	O
emuls	O
##ifier	O
-	O
free	O
emulsion	O
polymer	O
##isation	O
with	O
n	B-T103
,	I-T103
n	I-T103
'	I-T103
-	I-T103
methylene	I-T103
##bi	I-T103
##sa	I-T103
##cr	I-T103
##ylamide	I-T103
(	O
mb	B-T103
##a	I-T103
)	O
as	O
a	O
crosslink	B-T103
##er	I-T103
.	O
the	O
study	B-T062
on	I-T062
drug	I-T062
loading	I-T062
,	O
using	O
salicylic	B-T103
acid	I-T103
(	O
sa	B-T103
)	O
as	O
a	O
model	B-T103
drug	I-T103
,	O
was	O
performed	O
.	O
the	O
results	O
showed	O
that	O
the	O
encapsulation	O
efficiency	O
(	O
ee	O
)	O
increased	O
as	O
drug	B-T103
-	O
to	O
-	O
microg	O
##el	O
ratio	O
was	O
increased	O
.	O
higher	O
ee	O
can	O
be	O
achieved	O
with	O
the	O
increase	O
in	O
degree	O
of	O
crosslinking	O
,	O
by	O
increasing	O
the	O
amount	O
of	O
mb	B-T103
##a	I-T103
from	O
0	O
.	O
01	O
g	O
to	O
0	O
.	O
03	O
g	O
.	O
in	O
addition	O
,	O
the	O
highest	O
ee	O
(	O
61	O
.	O
1	O
%	O
)	O
was	O
observed	O
at	O
ph	O
3	O
.	O
the	O
highest	O
release	O
of	O
sa	O
(	O
60	O
%	O
)	O
was	O
noticed	O
at	O
ph	O
2	O
.	O
4	O
,	O
while	O
the	O
lowest	O
one	O
(	O
49	O
.	O
4	O
%	O
)	O
was	O
obtained	O
at	O
ph	O
7	O
.	O
4	O
.	O
moreover	O
,	O
the	O
highest	O
release	O
of	O
sa	O
was	O
enhanced	O
by	O
the	O
presence	O
of	O
0	O
.	O
2	O
m	O
nacl	B-T103
.	O
the	O
ph	O
-	O
and	O
ionic	O
-	O
sensitivity	O
of	O
cs	B-T103
/	O
phe	B-T103
##ma	I-T103
could	O
be	O
useful	O
as	O
a	O
sustained	B-T103
release	I-T103
delivery	I-T103
device	I-T103
,	O
especially	O
for	O
oral	O
delivery	O
.	O

psychological	B-T038
factors	I-T038
associated	O
with	O
nafld	B-T038
/	O
nash	B-T038
:	O
a	O
systematic	B-T170
review	I-T170
nonalcoholic	B-T038
fatty	I-T038
liver	I-T038
disease	I-T038
(	O
nafld	B-T038
)	O
represents	O
one	O
of	O
the	O
most	O
common	O
chronic	B-T038
liver	I-T038
diseases	I-T038
worldwide	O
.	O
so	O
far	O
,	O
the	O
pathogenesis	B-T038
of	O
nafld	B-T038
and	O
its	O
more	O
severe	O
variant	O
nonalcoholic	B-T038
steatohepatitis	I-T038
(	O
nash	B-T038
)	O
is	O
yet	O
unclear	O
,	O
with	O
many	O
mechanisms	O
being	O
proposed	O
as	O
possible	O
causes	O
.	O
this	O
article	O
aims	O
to	O
review	O
the	O
psychological	B-T038
factors	I-T038
associated	O
with	O
nafld	B-T038
/	O
nash	B-T038
.	O
three	O
main	O
categories	O
of	O
factors	O
have	O
been	O
investigated	O
:	O
emotional	B-T033
,	O
cognitive	O
and	O
behavioral	O
.	O
five	O
electronic	O
databases	O
were	O
searched	O
,	O
limited	O
to	O
studies	O
published	O
in	O
the	O
english	O
language	O
,	O
during	O
the	O
period	O
2005	O
-	O
2015	O
:	O
pubmed	B-T170
,	O
th	B-T170
##oms	I-T170
##on	I-T170
isi	I-T170
-	I-T170
web	I-T170
of	I-T170
science	I-T170
,	O
scopus	B-T170
,	O
pro	B-T170
##ques	I-T170
##t	I-T170
,	O
and	O
science	B-T170
##di	I-T170
##rect	I-T170
.	O
results	O
indicated	O
the	O
most	O
relevant	O
emotional	B-T033
factors	O
to	O
be	O
depression	B-T038
and	O
anxiety	B-T033
.	O
the	O
areas	O
of	O
investigation	O
for	O
cognitive	B-T038
functioning	I-T038
concern	O
those	O
contents	O
and	O
processes	O
related	O
to	O
the	O
ability	O
to	O
initiate	O
and	O
maintain	O
lifestyle	O
changes	O
.	O
the	O
most	O
important	O
behavioral	O
factors	O
identified	O
are	O
physical	O
activity	O
,	O
nutrition	B-T038
/	O
food	B-T038
intake	I-T038
and	O
substance	O
consumption	B-T038
:	O
coffee	B-T168
,	O
alcohol	B-T168
,	O
cigarettes	O
.	O
some	O
of	O
the	O
factors	O
identified	O
act	O
as	O
protective	O
factors	O
,	O
other	O
as	O
vulnerability	B-T033
factors	I-T033
.	O
nafld	B-T038
/	O
nash	B-T038
may	O
be	O
considered	O
a	O
cognitive	B-T038
-	I-T038
behavioral	I-T038
disease	I-T038
,	O
the	O
most	O
effective	O
management	B-T058
being	O
lifestyle	O
changes	O
,	O
with	O
emphasis	O
on	O
diet	B-T168
and	O
exercise	O
.	O

survey	B-T062
of	O
neonatal	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
nurse	B-T097
attitudes	B-T038
toward	O
therapeutic	B-T058
hypothermia	I-T058
treatment	I-T058
the	O
traumatic	O
experiences	O
of	O
parent	O
s	O
of	O
babies	O
treated	B-T058
with	I-T058
therapeutic	B-T058
hypothermia	I-T058
(	O
th	B-T058
)	O
have	O
been	O
described	O
.	O
no	O
research	B-T062
has	O
assessed	O
neonatal	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
(	O
nicu	B-T092
)	O
nurse	B-T097
experience	O
in	O
providing	O
care	O
to	O
hypothermic	B-T033
babies	O
and	O
emotional	O
support	O
to	O
their	O
parents	O
.	O
to	O
assess	O
nicu	B-T092
nurse	B-T097
attitudes	B-T038
to	O
the	O
provision	O
of	O
th	B-T058
with	O
respect	O
to	O
perceptions	B-T038
about	O
baby	O
pain	B-T033
/	O
sedation	B-T058
,	O
need	O
for	O
nurse	B-T097
and	O
parent	O
education	O
,	O
decision	B-T038
making	I-T038
about	O
initiation	O
of	O
th	B-T058
,	O
and	O
barriers	O
to	O
best	O
care	O
.	O
a	O
survey	B-T062
was	O
electronically	O
sent	O
to	O
219	O
nurses	B-T097
at	O
2	O
affiliated	O
academic	O
level	O
iii	O
nicu	B-T092
##s	I-T092
:	O
1	O
rural	O
and	O
1	O
urban	O
location	O
.	O
there	O
were	O
17	O
questions	O
where	O
responses	B-T170
were	O
selected	O
from	O
a	O
pres	O
##et	O
list	O
and	O
7	O
opportunities	O
for	O
nurses	B-T097
to	O
provide	O
free	O
text	O
responses	B-T170
.	O
the	O
response	B-T170
rate	O
was	O
38	O
%	O
(	O
n	O
=	O
83	O
)	O
.	O
overwhelming	O
similarities	O
between	O
the	O
urban	B-T092
and	O
rural	B-T092
institutions	I-T092
were	O
found	O
with	O
nicu	B-T092
nurses	B-T097
expressing	O
understanding	O
of	O
the	O
indications	O
for	O
initiating	O
th	B-T058
,	O
agreement	O
that	O
th	B-T058
improves	O
long	O
-	O
term	O
outcomes	O
and	O
that	O
the	O
benefits	O
of	O
th	B-T058
outweigh	O
the	O
risks	O
.	O
nurses	B-T097
at	O
the	O
urban	B-T092
institution	I-T092
more	O
frequently	O
expressed	O
concerns	O
surrounding	O
inadequate	O
treatment	B-T058
of	O
baby	O
pain	B-T033
/	O
sedation	B-T058
,	O
and	O
nurses	B-T097
at	O
both	O
institutions	O
strongly	O
emphasized	O
the	O
need	O
for	O
more	O
nurse	B-T097
and	O
parent	O
education	O
about	O
th	B-T058
and	O
improved	O
time	O
##line	O
##ss	O
of	O
decision	B-T038
making	I-T038
for	O
initiation	O
of	O
th	B-T058
.	O
nicu	B-T092
nurses	B-T097
specifically	O
want	O
to	O
learn	O
more	O
about	O
outcomes	O
of	O
babies	O
after	O
treatment	B-T058
with	O
th	B-T058
and	O
feel	O
that	O
parents	O
need	O
more	O
education	O
about	O
th	B-T058
.	O
research	B-T062
is	O
urgently	O
needed	O
to	O
better	O
understand	O
the	O
implications	O
of	O
th	B-T058
treatment	I-T058
for	O
parent	O
-	O
baby	O
bonding	O
.	O

the	O
cost	O
-	O
effectiveness	O
of	O
family	O
/	O
family	B-T058
-	I-T058
based	I-T058
therapy	I-T058
for	O
treatment	O
of	O
externalizing	B-T038
disorders	I-T038
,	O
substance	B-T038
use	I-T038
disorders	I-T038
and	O
delinqu	B-T038
##ency	I-T038
:	O
a	O
systematic	O
review	B-T170
family	B-T058
therapy	I-T058
and	O
family	O
-	O
based	O
treatment	O
has	O
been	O
commonly	O
applied	O
in	O
children	O
and	O
adolescents	O
in	O
mental	B-T058
health	I-T058
care	I-T058
and	O
has	O
been	O
proven	O
to	O
be	O
effective	O
.	O
there	O
is	O
an	O
increased	O
interest	O
in	O
economic	O
evaluations	O
of	O
these	O
,	O
often	O
expensive	O
,	O
interventions	B-T058
.	O
the	O
aim	O
of	O
this	O
systematic	O
review	B-T170
is	O
to	O
summarize	O
and	O
evaluate	B-T058
the	O
evidence	O
on	O
cost	O
-	O
effectiveness	O
of	O
family	O
/	O
family	B-T058
-	I-T058
based	I-T058
therapy	I-T058
for	O
externalizing	B-T038
disorders	I-T038
,	O
substance	B-T038
use	I-T038
disorders	I-T038
and	O
delinqu	B-T038
##ency	I-T038
.	O
a	O
systematic	O
literature	O
search	O
was	O
performed	O
in	O
pubmed	B-T170
,	O
education	O
resource	O
information	O
centre	O
(	O
er	O
##ic	O
)	O
,	O
psycinfo	O
and	O
cochrane	B-T170
reviews	B-T170
including	O
studies	B-T058
conducted	O
after	O
1990	O
and	O
before	O
the	O
first	O
of	O
august	O
of	O
2013	O
.	O
full	O
economic	O
evaluations	O
investigating	O
family	O
/	O
family	B-T058
-	I-T058
based	I-T058
interventions	I-T058
for	O
adolescents	O
between	O
10	O
and	O
20	O
years	O
treated	O
for	O
substance	B-T038
use	I-T038
disorders	I-T038
,	O
delinqu	B-T038
##ency	I-T038
or	O
externalizing	B-T038
disorders	I-T038
were	O
included	O
.	O
seven	O
hundred	O
thirty	O
-	O
one	O
articles	B-T170
met	O
the	O
search	O
criteria	O
and	O
51	O
studies	B-T058
were	O
initially	O
selected	O
.	O
the	O
final	O
selection	O
resulted	O
in	O
the	O
inclusion	O
of	O
11	O
studies	B-T058
.	O
the	O
quality	O
of	O
these	O
studies	B-T058
was	O
assessed	O
.	O
within	O
the	O
identified	O
studies	B-T058
,	O
there	O
was	O
great	O
variation	O
in	O
the	O
specific	O
type	O
of	O
family	O
/	O
family	B-T058
-	I-T058
based	I-T058
interventions	I-T058
and	O
disorders	B-T038
.	O
according	O
to	O
the	O
outcomes	O
of	O
the	O
checklist	O
##s	O
,	O
the	O
overall	O
quality	O
of	O
the	O
economic	O
evaluations	O
was	O
low	O
.	O
results	O
varied	O
by	O
study	B-T058
.	O
due	O
to	O
the	O
variations	O
in	O
setting	O
,	O
design	O
and	O
outcome	O
it	O
was	O
not	O
feasible	O
to	O
pool	O
results	O
using	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
.	O
the	O
quality	O
of	O
the	O
identified	O
economic	O
evaluations	O
of	O
family	O
/	O
family	B-T058
-	I-T058
based	I-T058
therapy	I-T058
for	O
treatment	O
of	O
externalizing	B-T038
disorders	I-T038
,	O
adolescent	O
substance	B-T038
use	I-T038
disorders	I-T038
and	O
delinqu	B-T038
##ency	I-T038
was	O
insufficient	O
to	O
determine	O
the	O
cost	O
-	O
effectiveness	O
.	O
although	O
commonly	O
applied	O
,	O
family	O
/	O
family	B-T058
-	I-T058
based	I-T058
therapy	I-T058
is	O
costly	O
and	O
more	O
research	O
of	O
higher	O
quality	O
is	O
needed	O
.	O

straight	B-T017
configuration	I-T017
saphenous	I-T017
vein	I-T017
transposition	B-T058
to	O
popliteal	B-T017
artery	I-T017
for	O
vascular	O
access	O
the	O
saphenous	B-T017
vein	I-T017
is	O
commonly	O
used	O
as	O
a	O
vascular	B-T017
graft	I-T017
in	O
peripheral	O
artery	O
surgery	B-T058
but	O
rarely	O
used	O
for	O
vascular	O
access	O
.	O
the	O
literature	B-T170
on	O
straight	B-T017
configuration	I-T017
saphenous	I-T017
vein	I-T017
transposition	B-T058
to	O
the	O
popliteal	B-T017
artery	I-T017
is	O
scarce	O
.	O
here	O
we	O
present	O
two	O
cases	O
of	O
straight	B-T017
configuration	I-T017
saphenous	I-T017
vein	I-T017
transposition	B-T058
to	O
the	O
popliteal	B-T017
artery	I-T017
for	O
vascular	O
access	O
,	O
the	O
surgical	B-T058
technique	I-T058
and	O
respective	O
follow	B-T058
-	I-T058
up	I-T058
.	O
two	O
young	O
men	B-T098
,	O
aged	O
29	O
and	O
36	O
years	O
,	O
were	O
chosen	O
for	O
lower	B-T058
-	I-T058
limb	I-T058
vascular	I-T058
access	I-T058
for	O
hemodialysis	B-T058
.	O
the	O
first	O
patient	O
was	O
parap	B-T038
##legic	I-T038
since	O
birth	O
.	O
he	O
used	O
his	O
arms	O
to	O
move	O
so	O
upper	O
extremity	O
vascular	O
access	O
was	O
avoided	O
.	O
the	O
second	O
patient	O
presented	O
with	O
an	O
infected	B-T033
upper	O
extremity	O
arteriovenous	O
graft	O
(	O
av	O
##g	O
)	O
and	O
after	O
multiple	O
closed	O
avf	B-T017
##s	I-T017
he	O
had	O
no	O
more	O
available	O
arm	B-T017
veins	I-T017
.	O
both	O
patients	O
received	O
autologous	O
lower	O
extremity	O
straight	B-T017
configuration	I-T017
saphenous	I-T017
vein	I-T017
transposition	B-T058
##s	I-T058
to	O
the	O
popliteal	B-T017
artery	I-T017
under	O
spinal	B-T058
anesthesia	I-T058
in	O
may	O
and	O
october	O
2012	O
,	O
respectively	O
.	O
cannulation	B-T058
of	O
the	O
fistula	B-T017
was	O
allowed	O
after	O
one	O
month	O
.	O
there	O
were	O
no	B-T033
early	I-T033
complications	I-T033
.	O
slight	B-T033
swelling	I-T033
on	O
the	O
leg	B-T017
appeared	O
in	O
one	O
of	O
the	O
patients	O
.	O
both	O
fistulas	B-T017
were	O
still	O
functional	O
after	O
36	O
and	O
32	O
months	O
,	O
respectively	O
.	O
the	O
straight	B-T017
configuration	I-T017
saphenous	I-T017
vein	I-T017
transposition	B-T058
to	O
popliteal	B-T017
artery	I-T017
is	O
simple	O
to	O
perform	O
,	O
offers	O
a	O
long	B-T082
and	I-T082
straight	I-T082
segment	I-T082
for	O
cannulation	B-T058
and	O
may	O
be	O
a	O
suitable	O
autologous	O
vascular	O
access	O
in	O
selected	O
patients	O
.	O

association	O
of	O
physical	O
activity	O
on	O
body	O
composition	O
,	O
cardiometabolic	B-T033
risk	I-T033
factors	I-T033
,	O
and	O
prevalence	O
of	O
cardiovascular	B-T038
disease	I-T038
in	O
the	O
korean	B-T098
population	I-T098
(	O
from	O
the	O
fifth	O
korea	B-T082
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
,	O
2008	O
-	O
2011	O
)	O
data	O
regarding	O
associations	O
among	O
physical	O
activity	O
(	O
pa	O
)	O
level	O
,	O
body	O
composition	O
,	O
and	O
prevalence	O
of	O
cardiovascular	B-T038
diseases	I-T038
in	O
asian	O
populations	O
are	O
rare	O
.	O
the	O
international	B-T170
physical	I-T170
activity	I-T170
questionnaire	I-T170
(	O
ipa	B-T170
##q	I-T170
)	O
was	O
utilized	O
to	O
estimate	O
pa	O
levels	O
and	O
analyze	B-T062
the	O
association	O
of	O
pa	O
level	O
with	O
various	O
body	O
composition	O
parameters	O
and	O
the	O
prevalence	O
of	O
cardiovascular	B-T038
diseases	I-T038
by	O
using	O
data	O
from	O
the	O
korean	B-T082
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
from	O
2008	O
to	O
2011	O
.	O
moderate	O
and	O
high	O
pa	O
levels	O
were	O
associated	O
with	O
lower	O
prevalence	O
of	O
hypertension	B-T038
and	O
diabetes	B-T038
mellitus	I-T038
,	O
and	O
lower	O
concentrations	O
of	O
serum	B-T033
ferritin	I-T033
,	O
parathyroid	B-T033
hormone	I-T033
,	O
and	O
alkaline	B-T033
phosphatase	I-T033
.	O
sarcopenia	B-T038
(	O
low	O
vs	O
.	O
moderate	O
vs	O
.	O
high	O
pa	O
group	O
:	O
14	O
.	O
3	O
%	O
vs	O
.	O
10	O
.	O
5	O
%	O
vs	O
.	O
7	O
.	O
3	O
%	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
underweight	B-T033
(	O
5	O
.	O
7	O
%	O
vs	O
.	O
4	O
.	O
9	O
%	O
vs	O
.	O
3	O
.	O
5	O
%	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
and	O
central	B-T033
obesity	I-T033
(	O
7	O
.	O
8	O
%	O
vs	O
.	O
6	O
.	O
9	O
%	O
vs	O
.	O
6	O
.	O
3	O
%	O
,	O
p	O
=	O
0	O
.	O
002	O
)	O
were	O
more	O
often	O
observed	O
in	O
the	O
low	O
pa	O
group	O
.	O
the	O
prevalence	O
rates	O
of	O
cardiovascular	B-T038
diseases	I-T038
were	O
lower	O
in	O
the	O
moderate	O
(	O
odds	O
ratio	O
[	O
or	O
]	O
,	O
0	O
.	O
82	O
##2	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
,	O
0	O
.	O
73	O
##7	O
-	O
0	O
.	O
91	O
##6	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
high	O
activity	O
groups	O
(	O
or	O
,	O
0	O
.	O
66	O
##3	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
58	O
##9	O
-	O
0	O
.	O
74	O
##8	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
than	O
in	O
the	O
low	O
activity	O
group	O
,	O
even	O
after	O
adjusting	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
,	O
underlying	B-T038
disease	I-T038
,	O
and	O
general	B-T038
or	O
abdominal	B-T033
obesity	I-T033
and	O
muscle	B-T033
mass	I-T033
.	O
regular	O
physical	O
activity	O
was	O
associated	O
with	O
a	O
low	O
prevalence	O
of	O
cardiovascular	B-T038
diseases	I-T038
(	O
stroke	B-T037
,	O
myocardial	B-T038
infarction	I-T038
,	O
stable	B-T038
angina	I-T038
,	O
and	O
chronic	B-T038
renal	I-T038
disease	I-T038
)	O
,	O
which	O
was	O
independent	O
of	O
body	O
composition	O
and	O
conventional	O
risk	B-T033
factors	I-T033
in	O
the	O
korean	B-T098
population	I-T098
,	O
with	O
a	O
positive	B-T033
dose	O
-	O
response	O
relationship	O
.	O

distinct	B-T017
cortical	I-T017
and	I-T017
sub	I-T017
-	I-T017
cortical	I-T017
neurogenic	I-T017
domains	I-T017
for	O
gabaergic	B-T038
interne	B-T017
##uron	I-T017
precursor	O
transcription	B-T103
factors	I-T103
nk	B-T103
##x2	I-T103
.	I-T103
1	I-T103
,	O
olig	B-T103
##2	I-T103
and	O
cou	B-T103
##p	I-T103
-	I-T103
tf	I-T103
##ii	I-T103
in	O
early	O
fetal	O
human	B-T204
tele	B-T017
##nc	I-T017
##ephal	I-T017
##on	I-T017
the	O
extent	O
of	O
similarities	O
and	O
differences	O
between	O
cortical	B-T038
gabaergic	I-T038
interne	I-T038
##uron	I-T038
generation	I-T038
in	O
rodent	B-T204
and	O
primate	B-T204
tele	B-T017
##nc	I-T017
##ephal	I-T017
##on	I-T017
remains	O
content	O
##ious	O
.	O
we	O
examined	O
expression	B-T038
of	O
three	O
interne	B-T017
##uron	I-T017
precursor	O
transcription	B-T103
factors	I-T103
,	O
alongside	O
other	O
markers	B-T201
,	O
using	O
immunohistochemistry	B-T058
on	O
8	O
-	O
12	O
post	O
-	O
conception	O
##al	O
weeks	O
(	O
pc	O
##w	O
)	O
human	B-T204
tele	B-T017
##nc	I-T017
##ephal	I-T017
##on	I-T017
sections	O
.	O
nk	B-T103
##x2	I-T103
.	I-T103
1	I-T103
,	O
olig	B-T103
##2	I-T103
,	O
and	O
cou	B-T103
##p	I-T103
-	I-T103
tf	I-T103
##ii	I-T103
expression	B-T038
occupied	O
distinct	O
(	O
although	O
overlapping	O
)	O
neurogenic	B-T017
domains	I-T017
which	O
extended	O
into	O
the	O
cortex	B-T017
and	O
revealed	O
three	O
cg	B-T017
##e	I-T017
compartments	I-T017
:	O
lateral	B-T082
,	O
medial	B-T082
,	O
and	O
ventral	B-T082
.	O
nk	B-T103
##x2	I-T103
.	I-T103
1	I-T103
expression	B-T038
was	O
very	O
largely	O
confined	O
to	O
the	O
mg	B-T017
##e	I-T017
,	O
medial	B-T082
cg	B-T017
##e	I-T017
,	O
and	O
ventral	B-T082
septum	B-T017
confirming	O
that	O
,	O
at	O
this	O
developmental	O
stage	O
,	O
interne	B-T017
##uron	I-T017
generation	O
from	O
nk	B-T103
##x2	I-T103
.	I-T103
1	I-T103
+	O
precursor	O
s	O
closely	O
resembles	O
the	O
process	O
observed	O
in	O
rodents	B-T204
.	O
olig	B-T103
##2	I-T103
immunoreactivity	O
was	O
observed	O
in	O
gabaergic	B-T017
cells	I-T017
of	O
the	O
proliferative	B-T038
zones	B-T082
of	O
the	O
mg	B-T017
##e	I-T017
and	O
septum	B-T017
,	O
but	O
not	O
necessarily	O
co	O
-	O
expressed	O
with	O
nk	B-T103
##x2	I-T103
.	I-T103
1	I-T103
,	O
and	O
olig	B-T103
##2	I-T103
expression	B-T038
was	O
also	O
extensively	O
seen	O
in	O
the	O
lg	B-T017
##e	I-T017
,	O
cg	B-T017
##e	I-T017
,	O
and	O
cortex	B-T017
.	O
at	O
8	O
pc	O
##w	O
,	O
olig	B-T103
##2	I-T103
+	O
cells	B-T017
were	O
only	O
present	O
in	O
the	O
medial	B-T082
and	O
anterior	B-T082
cortical	B-T017
wall	I-T017
suggesting	O
a	O
migratory	O
pathway	O
for	O
interne	B-T017
##uron	I-T017
precursor	O
s	O
via	O
the	O
septum	B-T017
into	O
the	O
medial	B-T082
cortex	B-T017
.	O
by	O
12	O
pc	O
##w	O
,	O
olig	B-T103
##2	I-T103
+	O
cells	B-T017
were	O
present	O
throughout	O
the	O
cortex	B-T017
and	O
many	O
were	O
actively	O
dividing	O
but	O
without	O
co	O
-	O
expressing	O
cortical	B-T017
progenitor	B-T017
markers	B-T201
.	O
dividing	O
cou	B-T103
##p	I-T103
-	I-T103
tf	I-T103
##ii	I-T103
+	O
progenitor	B-T017
cells	I-T017
were	O
localized	B-T082
to	O
ventral	B-T082
cg	B-T017
##e	I-T017
as	O
previously	O
described	O
but	O
were	O
also	O
numerous	O
in	O
adjacent	O
ventral	B-T082
cortex	B-T017
;	O
in	O
both	O
the	O
cases	O
,	O
cou	B-T103
##p	I-T103
-	I-T103
tf	I-T103
##ii	I-T103
was	O
co	O
-	O
expressed	O
with	O
pax	B-T103
##6	I-T103
in	O
proliferative	B-T038
zones	B-T082
and	O
tb	B-T103
##r1	I-T103
or	O
cal	B-T103
##retin	I-T103
##in	I-T103
in	O
post	O
-	O
mitotic	O
cortical	B-T017
neurons	I-T017
.	O
thus	O
cou	B-T103
##p	I-T103
-	I-T103
tf	I-T103
##ii	I-T103
+	O
progenitors	B-T017
gave	O
rise	O
to	O
pyramidal	B-T017
cells	I-T017
,	O
but	O
also	O
interneurons	B-T017
which	O
not	O
only	O
migrated	O
posterior	O
##ly	O
into	O
the	O
cortex	B-T017
from	O
ventral	B-T082
cg	B-T017
##e	I-T017
but	O
also	O
anterior	B-T082
##ly	I-T082
via	O
the	O
lg	B-T017
##e	I-T017
.	O

gain	B-T038
-	I-T038
of	I-T038
-	I-T038
function	I-T038
mutation	I-T038
in	O
scn	B-T017
##5a	I-T017
causes	O
ventricular	B-T038
arrhythmias	I-T038
and	O
early	B-T033
onset	I-T033
atrial	B-T038
fibrillation	I-T038
mutations	B-T038
in	O
scn	B-T017
##5a	I-T017
,	O
the	O
gene	B-T017
encoding	O
the	O
α	O
-	O
subunit	O
of	O
the	O
cardiac	B-T017
sodium	B-T103
channel	I-T103
(	I-T103
nav	I-T103
##1	I-T103
.	I-T103
5	I-T103
)	I-T103
,	O
are	O
associated	O
with	O
a	O
broad	O
spectrum	O
of	O
inherited	O
cardiac	B-T033
arrhythmia	I-T033
disorders	I-T033
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
identify	O
the	O
genetic	O
and	O
functional	O
determinants	O
underlying	O
a	O
dutch	B-T098
family	O
that	O
presented	O
with	O
a	O
combined	O
phenotype	O
of	O
ventricular	B-T038
arrhythmias	I-T038
with	O
a	O
likely	O
adrenergic	O
component	O
,	O
either	O
in	O
isolation	O
or	O
in	O
combination	O
with	O
a	O
mildly	O
decreased	O
heart	B-T038
function	I-T038
and	O
early	B-T033
onset	I-T033
(	O
<	O
55	O
years	O
)	O
atrial	B-T038
fibrillation	I-T038
.	O
we	O
performed	O
next	O
generation	O
sequencing	B-T082
in	O
the	O
proband	O
of	O
a	O
two	O
-	O
generation	O
dutch	B-T098
family	O
and	O
demonstrated	O
a	O
novel	O
missense	B-T038
mutation	I-T038
in	O
scn	B-T017
##5a	I-T017
-	I-T017
(	I-T017
p	I-T017
.	I-T017
m1	I-T017
##85	I-T017
##1	I-T017
##v	I-T017
)	I-T017
which	O
co	O
-	O
segregated	O
with	O
the	O
clinical	O
phenotype	O
in	O
the	O
family	O
.	O
we	O
functionally	O
evaluated	O
the	O
putative	O
genetic	O
defect	O
by	O
patch	O
clamp	O
electrophysiological	O
studies	O
in	O
human	O
embryonic	O
kidney	B-T017
cells	I-T017
transfected	B-T062
with	O
mutant	B-T038
or	O
wild	B-T017
-	I-T017
type	I-T017
nav	I-T017
##1	I-T017
.	I-T017
5	I-T017
.	O
the	O
current	O
inactivation	O
was	O
slower	O
and	O
recovery	O
from	O
inactivation	O
was	O
faster	O
in	O
scn	B-T103
##5a	I-T103
-	I-T103
m1	I-T103
##85	I-T103
##1	I-T103
##v	I-T103
channels	I-T103
.	O
the	O
voltage	O
dependence	O
of	O
inactivation	O
was	O
shifted	O
towards	O
more	O
positive	B-T033
potentials	O
and	O
consequently	O
,	O
a	O
larger	O
ttx	B-T103
-	O
sensitive	O
window	O
current	O
was	O
observed	O
in	O
scn	B-T103
##5a	I-T103
-	I-T103
m1	I-T103
##85	I-T103
##1	I-T103
##v	I-T103
channels	I-T103
.	O
furthermore	O
,	O
a	O
higher	O
ups	O
##tr	O
##oke	O
velocity	O
was	O
observed	O
for	O
the	O
scn	B-T103
##5a	I-T103
-	I-T103
m1	I-T103
##85	I-T103
##1	I-T103
##v	I-T103
channels	I-T103
,	O
while	O
the	O
depolarization	O
voltage	O
was	O
more	O
negative	B-T033
,	O
both	O
indicating	O
increased	O
excitability	O
.	O
this	O
mutation	B-T038
leads	O
to	O
a	O
gain	O
-	O
of	O
-	O
function	O
mechanism	O
based	O
on	O
increased	O
channel	B-T103
availability	O
and	O
increased	O
window	O
current	O
,	O
fitting	O
the	O
observed	O
clinical	O
phenotype	O
of	O
(	O
likely	O
adrenergic	O
-	O
induced	O
)	O
ventricular	B-T038
arrhythmias	I-T038
and	O
atrial	B-T038
fibrillation	I-T038
.	O
these	O
findings	B-T033
further	O
expand	O
the	O
range	O
of	O
cardiac	B-T033
arrhythmias	I-T033
associated	O
with	O
mutations	B-T038
in	O
scn	B-T017
##5a	I-T017
.	O

fad	O
##ing	O
with	O
time	O
of	O
pd	O
-	O
l1	O
immunoreactivity	O
in	O
non	B-T038
-	I-T038
small	I-T038
cells	I-T038
lung	I-T038
cancer	I-T038
tissues	B-T017
:	O
a	O
methodological	O
study	O
blockade	O
of	O
inhibitory	B-T038
immune	I-T038
checkpoint	I-T038
##s	I-T038
is	O
currently	O
arising	O
as	O
a	O
potential	O
immunologic	O
option	O
for	O
tumor	B-T058
therapy	I-T058
.	O
inhibition	O
of	O
programmed	B-T103
cell	I-T103
death	I-T103
protein	I-T103
1	I-T103
and	O
/	O
or	O
its	O
specific	O
ligand	B-T103
programmed	O
death	O
-	O
ligand	O
1	O
(	O
pd	O
-	O
l1	O
)	O
was	O
effective	O
in	O
clinical	B-T062
trials	I-T062
in	O
advanced	O
melanoma	B-T038
,	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
(	O
nsclc	B-T038
)	O
bladder	B-T038
and	O
kidney	B-T038
cancer	I-T038
.	O
the	O
predictive	O
role	O
of	O
the	O
immunohistochemical	O
(	O
ihc	O
)	O
expression	B-T038
of	O
pd	O
-	O
l1	O
is	O
highly	O
debated	O
.	O
different	O
reagents	B-T103
,	O
clones	B-T017
,	O
cutoff	O
##s	O
of	O
cell	B-T017
expression	B-T038
and	O
subjective	O
interpretation	B-T033
of	O
pd	O
-	O
l1	O
immunoreactivity	O
in	O
epithelial	B-T017
cells	I-T017
and	O
lymphocytes	B-T017
are	O
the	O
main	O
issue	B-T033
.	O
in	O
this	O
study	O
we	O
selected	O
58	O
consecutive	O
nsclc	B-T038
surgical	B-T017
specimens	I-T017
that	O
underwent	O
pathologic	B-T058
examination	I-T058
from	O
january	O
2014	O
to	O
july	O
2015	O
.	O
using	O
a	O
tissue	O
microarray	B-T058
approach	I-T058
we	O
evaluated	O
the	O
ihc	O
expression	O
of	O
pd	O
-	O
l1	O
in	O
tumor	B-T017
-	I-T017
infiltrating	I-T017
lymphocytes	I-T017
and	O
tumor	B-T017
cells	I-T017
(	O
tcs	B-T017
)	O
and	O
compared	O
the	O
ich	O
staining	O
with	O
tumor	B-T091
histology	I-T091
,	O
grade	B-T170
and	O
the	O
age	O
of	O
the	O
tissue	B-T017
blocks	I-T017
.	O
the	O
main	O
new	O
finding	B-T033
was	O
the	O
fad	O
##ing	O
of	O
pd	O
-	O
l1	O
ihc	O
expression	O
in	O
tcs	B-T017
in	O
tissues	B-T017
processed	O
in	O
2014	O
compared	O
with	O
2015	O
.	O
pd	O
-	O
l1	O
expression	B-T038
in	O
tumor	B-T017
-	I-T017
infiltrating	I-T017
lymphocytes	I-T017
in	O
the	O
2	O
years	O
was	O
similar	O
.	O
we	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tcs	B-T017
in	O
high	O
grade	O
nsclc	B-T038
and	O
in	O
the	O
squamous	B-T038
carcinoma	I-T038
hist	B-T201
##otype	I-T201
compared	O
with	O
low	O
grade	O
tumors	B-T091
and	O
the	O
adenocarcinoma	B-T038
histology	B-T091
(	O
p	O
=	O
0	O
.	O
013	O
)	O
.	O
we	O
demonstrated	O
that	O
the	O
ihc	O
evaluation	O
of	O
pd	O
-	O
l1	O
in	O
nsclc	B-T038
archival	B-T017
tissues	I-T017
is	O
feasible	O
and	O
can	O
be	O
implemented	O
in	O
a	O
routine	O
pathology	B-T091
setting	I-T091
,	O
but	O
it	O
should	O
be	O
carefully	O
assessed	O
in	O
tissue	B-T017
blocks	I-T017
older	O
than	O
1	O
year	O
.	O

biliary	B-T017
phospholipids	B-T103
sustain	O
enter	B-T017
##ocyte	I-T017
proliferation	B-T038
and	O
intestinal	B-T038
tumor	I-T038
progression	B-T038
via	O
nuclear	B-T103
receptor	I-T103
lr	B-T103
##h1	I-T103
in	O
mice	B-T204
the	O
proliferative	O
-	O
crypt	O
compartment	O
of	O
the	O
intestinal	B-T017
epithelium	I-T017
is	O
enriched	O
in	O
phospholipids	B-T103
and	O
accumulation	B-T033
of	O
phospholipids	B-T103
has	O
been	O
described	O
in	O
colorectal	B-T038
tumors	I-T038
.	O
here	O
we	O
hypothesize	O
that	O
biliary	B-T017
phospholipid	B-T103
flow	O
could	O
directly	O
contribute	O
to	O
the	O
proliferative	O
power	O
of	O
normal	B-T017
and	O
dysplastic	B-T017
enterocytes	I-T017
.	O
we	O
used	O
abc	B-T017
##b4	I-T017
(	O
-	O
/	O
-	O
)	O
mice	B-T204
which	O
lack	O
biliary	B-T017
phospholipid	B-T103
secretion	B-T038
.	O
we	O
first	O
show	O
that	O
abc	B-T017
##b4	I-T017
(	O
-	O
/	O
-	O
)	O
mice	B-T204
are	O
protected	O
against	O
intestinal	B-T017
tumorigenesis	B-T038
.	O
at	O
the	O
molecular	O
level	O
,	O
the	O
transcriptional	B-T038
activity	I-T038
of	O
the	O
nuclear	B-T103
receptor	I-T103
liver	B-T103
receptor	I-T103
homolog	I-T103
-	I-T103
1	I-T103
(	O
lr	B-T103
##h1	I-T103
)	O
is	O
reduced	O
in	O
abc	B-T017
##b4	I-T017
(	O
-	O
/	O
-	O
)	O
mice	B-T204
and	O
its	O
re	O
-	O
activation	O
re	O
-	O
establishes	O
a	O
tumor	B-T038
burden	O
comparable	O
to	O
control	O
mice	B-T204
.	O
feeding	O
abc	B-T017
##b4	I-T017
(	O
-	O
/	O
-	O
)	O
mice	B-T204
a	O
diet	B-T168
supplemented	I-T168
with	O
phospholipids	B-T103
completely	O
overcome	O
##s	O
the	O
intestinal	B-T038
tumor	I-T038
protective	O
phenotype	O
,	O
thus	O
corrob	O
##orating	O
the	O
hypothesis	O
that	O
the	O
absence	O
of	O
biliary	B-T017
phospholipids	B-T103
and	O
not	O
lack	O
of	O
abc	B-T017
##b4	I-T017
gene	I-T017
per	O
se	O
is	O
responsible	O
for	O
the	O
protection	O
.	O
in	O
turn	O
,	O
phospholipids	B-T103
cann	O
##ot	O
re	O
-	O
establish	O
intestinal	B-T017
tumorigenesis	B-T038
in	O
abc	B-T017
##b4	I-T017
(	O
-	O
/	O
-	O
)	O
mice	B-T204
crossed	O
with	O
mice	B-T204
with	O
intestinal	B-T017
specific	O
ablation	B-T058
of	O
lr	B-T103
##h1	I-T103
,	O
a	O
nuclear	B-T103
hormone	I-T103
receptor	I-T103
that	O
is	O
activates	O
by	O
phospholipids	B-T103
.	O
our	O
data	O
identify	O
the	O
key	O
role	O
of	O
biliary	B-T017
phospholipids	B-T103
in	O
sustaining	O
intestinal	B-T017
mucosa	I-T017
proliferation	O
and	O
tumor	B-T038
progression	I-T038
through	O
the	O
activation	O
of	O
nuclear	B-T103
receptor	I-T103
lr	B-T103
##h1	I-T103
.	O

association	O
between	O
postpartum	B-T038
depression	I-T038
and	O
the	O
practice	B-T038
of	O
exclusive	O
breastfeeding	O
in	O
the	O
first	O
three	O
months	O
of	O
life	O
to	O
investigate	O
the	O
association	O
between	O
postpartum	B-T038
depression	I-T038
and	O
the	O
occurrence	O
of	O
exclusive	O
breastfeeding	O
.	O
this	O
is	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
conducted	O
in	O
the	O
states	B-T082
of	O
the	O
northeast	B-T082
region	I-T082
,	O
during	O
the	O
vaccination	B-T058
campaign	I-T058
in	O
2010	O
.	O
the	O
sample	O
consisted	O
of	O
258	O
##3	O
mother	O
-	O
child	O
pairs	O
,	O
with	O
children	O
aged	O
from	O
15	O
days	O
to	O
3	O
months	O
.	O
the	O
edi	B-T170
##nb	I-T170
##urg	I-T170
##h	I-T170
postnatal	I-T170
depression	I-T170
scale	I-T170
was	O
used	O
to	O
screen	B-T058
for	O
postpartum	B-T038
depression	I-T038
.	O
the	O
outcome	O
was	O
lack	O
of	O
exclusive	O
breastfeeding	O
,	O
defined	O
as	O
the	O
occurrence	O
of	O
this	O
practice	O
in	O
the	O
24h	O
preceding	O
the	O
interview	O
.	O
postpartum	B-T038
depression	I-T038
was	O
the	O
explanatory	O
variable	O
of	O
interest	O
and	O
the	O
covariates	O
were	O
:	O
socioeconomic	O
and	O
demographic	O
conditions	O
;	O
maternal	B-T058
health	I-T058
care	I-T058
;	O
prenatal	B-T058
,	O
delivery	B-T058
,	O
and	O
postnatal	B-T058
care	I-T058
;	O
and	O
the	O
child	O
'	O
s	O
biological	O
factors	O
.	O
multivariate	O
logistic	O
regression	O
analysis	O
was	O
conducted	O
to	O
control	O
for	O
possible	O
confounding	O
factors	O
.	O
exclusive	O
breastfeeding	O
was	O
observed	O
in	O
50	O
.	O
8	O
%	O
of	O
the	O
infants	O
and	O
11	O
.	O
8	O
%	O
of	O
women	B-T098
had	O
symptoms	B-T033
of	O
postpartum	B-T038
depression	I-T038
.	O
in	O
the	O
multivariate	O
logistic	O
regression	O
analysis	O
,	O
a	O
higher	O
chance	O
of	O
exclusive	O
breastfeeding	O
absence	O
was	O
found	O
among	O
mothers	O
with	O
symptoms	B-T033
of	O
postpartum	B-T038
depression	I-T038
(	O
or	O
=	O
1	O
.	O
67	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
among	O
younger	B-T098
subjects	I-T098
(	O
or	O
=	O
1	O
.	O
89	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
those	O
who	O
reported	O
receiving	O
benefits	O
from	O
the	O
bol	O
##sa	O
famil	O
##ia	O
program	O
(	O
or	O
=	O
1	O
.	O
25	O
;	O
p	O
=	O
0	O
.	O
016	O
)	O
,	O
and	O
those	O
started	O
antenatal	B-T058
care	I-T058
later	O
during	O
pregnancy	B-T038
(	O
or	O
=	O
2	O
.	O
14	O
;	O
p	O
=	O
0	O
.	O
032	O
)	O
.	O
postpartum	B-T038
depression	I-T038
contributed	O
to	O
reducing	O
the	O
practice	O
of	O
exclusive	O
breastfeeding	O
.	O
therefore	O
,	O
this	O
disorder	B-T038
should	O
be	O
included	O
in	O
the	O
prenatal	B-T058
and	O
early	O
postpartum	O
support	B-T170
guidelines	I-T170
for	O
breastfeeding	B-T038
,	O
especially	O
in	O
low	O
socioeconomic	O
status	O
women	B-T098
.	O

effects	O
of	O
complex	O
life	O
cycles	O
on	O
genetic	O
diversity	O
:	O
cyclic	B-T038
##al	I-T038
parth	I-T038
##eno	I-T038
##genesis	I-T038
neutral	O
patterns	O
of	O
population	B-T098
genetic	O
diversity	O
in	O
species	B-T170
with	O
complex	O
life	O
cycles	O
are	O
difficult	O
to	O
anticipate	O
.	O
cyclic	B-T038
##al	I-T038
parth	I-T038
##eno	I-T038
##genesis	I-T038
(	O
cp	B-T038
)	O
,	O
in	O
which	O
organisms	O
undergo	O
several	O
rounds	O
of	O
clonal	B-T017
reproduction	B-T038
followed	O
by	O
a	O
sexual	O
event	O
,	O
is	O
one	O
such	O
life	O
cycle	O
.	O
many	O
species	B-T170
,	O
including	O
crop	B-T204
pests	O
(	O
aphid	B-T204
##s	I-T204
)	O
,	O
human	B-T204
parasites	I-T204
(	O
trem	B-T204
##ato	I-T204
##des	I-T204
)	O
or	O
models	B-T170
used	O
in	O
evolutionary	B-T091
science	I-T091
(	O
daph	B-T204
##nia	I-T204
)	O
,	O
are	O
cyclic	O
##al	O
parth	O
##eno	O
##gens	O
.	O
it	O
is	O
therefore	O
crucial	O
to	O
understand	O
the	O
impact	O
of	O
such	O
a	O
life	O
cycle	O
on	O
neutral	O
genetic	O
diversity	O
.	O
in	O
this	O
paper	O
,	O
we	O
describe	O
distributions	O
of	O
genetic	O
diversity	O
under	O
conditions	O
of	O
cp	B-T038
with	O
various	O
clonal	B-T017
phase	O
lengths	O
.	O
using	O
a	O
markov	O
chain	O
model	O
of	O
cp	B-T038
for	O
a	O
single	O
locus	B-T082
and	O
individual	O
-	O
based	O
simulations	B-T062
for	O
two	O
loci	B-T082
,	O
our	O
analysis	O
first	O
demonstrates	O
that	O
strong	O
depart	O
##ures	O
from	O
full	O
sexuality	O
are	O
observed	O
after	O
only	O
a	O
few	O
generations	O
of	O
clonal	O
##ity	O
.	O
the	O
convergence	O
towards	O
predictions	O
made	O
under	O
conditions	O
of	O
full	O
clonal	O
##ity	O
during	O
the	O
clonal	B-T017
phase	O
depends	O
on	O
the	O
balance	O
between	O
mutations	B-T038
and	O
genetic	B-T038
drift	I-T038
.	O
second	O
,	O
the	O
sexual	O
event	O
of	O
cp	B-T038
usually	O
res	O
##ets	O
the	O
genetic	O
diversity	O
at	O
a	O
single	O
locus	B-T082
towards	O
predictions	O
made	O
under	O
full	O
sexuality	O
.	O
however	O
,	O
this	O
single	O
recombination	B-T038
event	O
is	O
insufficient	O
to	O
res	O
##hu	O
##ff	O
##le	O
gamet	B-T038
##ic	I-T038
phases	I-T038
towards	O
full	O
-	O
sexuality	O
predictions	O
.	O
finally	O
,	O
for	O
similar	O
levels	O
of	O
clonal	O
##ity	O
,	O
cp	B-T038
and	O
acycl	O
##ic	O
partial	O
clonal	O
##ity	O
(	O
wherein	O
a	O
fixed	O
proportion	O
of	O
individuals	B-T098
are	O
clonal	O
##ly	O
produced	O
within	O
each	O
generation	O
)	O
differentially	O
affect	O
the	O
distribution	O
of	O
genetic	O
diversity	O
.	O
overall	O
,	O
this	O
work	O
provides	O
solid	O
predictions	O
of	O
neutral	O
genetic	O
diversity	O
that	O
may	O
serve	O
as	O
a	O
null	B-T170
model	I-T170
in	O
detecting	O
the	O
action	O
of	O
common	O
evolutionary	B-T038
or	O
demographic	O
processes	O
in	O
cyclic	O
##al	O
parth	O
##eno	O
##gens	O
(	O
for	O
example	O
,	O
selection	O
or	O
bottleneck	O
##s	O
)	O
.	O

dynamics	O
of	O
bacterial	O
class	B-T007
bacilli	I-T007
in	O
the	O
deep	B-T082
##est	I-T082
valley	I-T082
lake	I-T082
of	O
ka	O
##sh	O
##mi	O
##r	O
-	O
the	O
man	B-T082
##as	I-T082
##bal	I-T082
lake	I-T082
in	O
recognition	O
of	O
the	O
importance	O
of	O
bacteria	B-T007
as	O
ecological	B-T103
indicators	I-T103
of	O
the	O
aquatic	O
systems	O
a	O
comprehensive	B-T062
and	I-T062
systematic	I-T062
analysis	I-T062
was	O
carried	O
out	O
on	O
man	B-T082
##as	I-T082
##bal	I-T082
lake	I-T082
,	O
the	O
deep	B-T082
##est	I-T082
spring	I-T082
fed	I-T082
valley	I-T082
lake	I-T082
of	O
ka	O
##sh	O
##mi	O
##r	O
.	O
the	O
main	O
objective	O
env	O
##isa	O
##ged	O
was	O
to	O
analyze	B-T062
bacterial	O
community	O
composition	O
(	O
bcc	O
)	O
and	O
for	O
this	O
purpose	O
systematic	O
and	O
regular	O
sampling	O
of	O
waters	B-T103
from	O
ten	O
different	O
sampling	B-T082
stations	I-T082
,	O
predetermined	O
in	O
the	O
lake	B-T082
according	O
to	O
differences	O
in	O
degree	O
of	O
human	O
interference	O
and	O
also	O
as	O
zones	B-T082
of	O
special	O
ecological	O
interests	O
were	O
selected	O
.	O
the	O
isolated	O
species	B-T170
were	O
identified	O
according	O
to	O
berg	B-T170
##ey	I-T170
'	I-T170
s	I-T170
manual	I-T170
specification	I-T170
by	O
examining	O
their	O
micro	O
and	O
macro	O
morphological	O
characteristics	O
and	O
biochemical	O
characteristics	O
on	O
different	O
culture	B-T103
media	I-T103
.	O
further	O
confirmation	B-T033
was	O
done	O
by	O
sequencing	O
the	O
16s	B-T017
rrna	I-T017
gene	I-T017
by	O
using	O
universal	B-T103
bacterial	I-T103
primers	I-T103
27	B-T103
##f	I-T103
and	O
142	B-T103
##9	I-T103
##r	I-T103
.	O
from	O
all	O
the	O
sampling	B-T082
stations	I-T082
the	O
class	B-T007
bacilli	I-T007
showed	O
a	O
maximum	O
relative	O
abundance	O
with	O
a	O
contribution	O
of	O
16	O
bacterial	B-T170
species	I-T170
.	O
the	O
whole	O
process	O
resulted	O
in	O
the	O
identification	O
of	O
bacillus	B-T007
aer	I-T007
##ius	I-T007
,	O
bacillus	B-T007
alt	I-T007
##itud	I-T007
##inis	I-T007
,	O
bacillus	B-T007
anthrac	I-T007
##is	I-T007
,	O
bacillus	B-T007
cereus	I-T007
,	O
bacillus	B-T007
ginseng	I-T007
##iso	I-T007
##li	I-T007
,	O
bacillus	B-T007
pu	I-T007
##mi	I-T007
##lu	I-T007
##s	I-T007
,	O
bacillus	B-T007
safe	I-T007
##ns	I-T007
##is	I-T007
,	O
bacillus	B-T007
stra	I-T007
##to	I-T007
##sp	I-T007
##her	I-T007
##icus	I-T007
,	O
bacillus	B-T007
subtilis	I-T007
,	O
bacillus	B-T007
te	I-T007
##qu	I-T007
##ile	I-T007
##ns	I-T007
##is	I-T007
,	O
bacillus	B-T007
thermo	I-T007
##cop	I-T007
##ri	I-T007
##ae	I-T007
,	O
bacillus	B-T007
thuringiensis	I-T007
,	O
brev	B-T007
##ib	I-T007
##acil	I-T007
##lu	I-T007
##s	I-T007
agr	I-T007
##i	I-T007
strain	I-T007
,	O
lys	B-T007
##ini	I-T007
##ba	I-T007
##cil	I-T007
##lu	I-T007
##s	I-T007
boron	I-T007
##itol	I-T007
##era	I-T007
##ns	I-T007
,	O
lys	B-T007
##ini	I-T007
##ba	I-T007
##cil	I-T007
##lu	I-T007
##s	I-T007
pakistan	I-T007
##ensis	I-T007
and	O
lys	B-T007
##ini	I-T007
##ba	I-T007
##cil	I-T007
##lu	I-T007
##s	I-T007
sph	I-T007
##aer	I-T007
##icus	I-T007
.	O

mechanisms	O
of	O
replacement	O
of	O
circulating	O
viruses	B-T005
by	O
seasonal	B-T038
and	O
pandemic	B-T005
influenza	I-T005
a	I-T005
viruses	I-T005
seasonal	B-T038
influenza	I-T038
causes	O
annual	O
epidemics	O
by	O
the	O
accumulation	B-T033
of	O
antigenic	B-T038
changes	I-T038
.	O
pandemic	B-T038
influenza	I-T038
occurs	O
through	O
a	O
major	O
antigenic	B-T038
change	I-T038
of	O
the	O
influenza	B-T005
a	I-T005
virus	I-T005
,	O
which	O
can	O
originate	O
from	O
other	O
hosts	O
.	O
although	O
new	O
antigenic	B-T038
variants	I-T038
of	O
the	O
influenza	B-T005
a	I-T005
virus	I-T005
replace	O
formerly	O
circulating	O
seasonal	B-T005
and	O
pandemic	B-T005
viruses	I-T005
,	O
replacement	O
mechanisms	O
remain	O
poorly	O
understood	O
.	O
a	O
stochastic	B-T170
individual	I-T170
-	I-T170
based	I-T170
se	I-T170
##ir	I-T170
(	I-T170
susceptible	I-T170
-	I-T170
exposed	I-T170
-	I-T170
infectious	I-T170
-	I-T170
recovered	I-T170
)	I-T170
model	I-T170
with	O
two	O
viral	O
strains	O
(	O
formerly	O
circulating	O
old	O
strain	O
and	O
newly	O
emerged	O
strain	O
)	O
was	O
developed	O
for	O
simulations	B-T062
to	O
elucidate	O
the	O
replacement	O
mechanisms	O
.	O
factors	O
and	O
conditions	O
of	O
virus	B-T005
and	O
host	O
populations	O
affecting	O
the	O
replacement	O
were	O
identified	O
.	O
replacement	O
is	O
more	O
likely	O
to	O
occur	O
in	O
tropical	B-T082
regions	I-T082
than	O
temperate	B-T082
regions	I-T082
.	O
the	O
magnitude	O
of	O
the	O
ongoing	O
epidemic	O
by	O
the	O
old	O
strain	O
,	O
herd	B-T038
immunity	I-T038
against	O
the	O
old	O
strain	O
,	O
and	O
timing	O
of	O
appearance	O
of	O
the	O
new	O
strain	O
are	O
not	O
that	O
important	O
for	O
replacement	O
.	O
it	O
is	O
probable	O
that	O
the	O
frequency	O
of	O
replacement	O
by	O
a	O
pandemic	B-T005
virus	I-T005
is	O
higher	O
than	O
a	O
seasonal	B-T005
virus	I-T005
because	O
of	O
the	O
high	O
initial	O
susceptibility	O
and	O
high	O
basic	O
reproductive	B-T038
number	O
of	O
the	O
pandemic	B-T005
virus	I-T005
.	O
the	O
findings	O
of	O
this	O
study	O
on	O
replacement	O
mechanisms	O
could	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
virus	B-T038
transmission	I-T038
dynamics	O
and	O
may	O
possibly	O
be	O
helpful	O
in	O
establishing	O
an	O
effective	O
strategy	O
to	O
mitigate	O
the	O
impact	O
of	O
seasonal	B-T038
and	O
pandemic	B-T038
influenza	I-T038
.	O

fluor	B-T103
##anth	I-T103
##ene	I-T103
degradation	O
and	O
binding	B-T038
mechanism	O
study	B-T062
based	O
on	O
the	O
active	O
-	O
site	O
structure	B-T082
of	O
ring	B-T103
-	I-T103
hydroxyl	I-T103
##ating	I-T103
dioxygenase	I-T103
in	O
microb	B-T007
##acterium	I-T007
para	I-T007
##oxy	I-T007
##da	I-T007
##ns	I-T007
jp	I-T007
##m1	I-T007
in	O
this	O
study	B-T062
,	O
a	O
gram	B-T007
-	I-T007
positive	I-T007
fluor	I-T007
##anth	I-T007
##ene	I-T007
-	I-T007
degrading	I-T007
bacterial	I-T007
strain	O
was	O
isolated	O
from	O
crude	B-T103
oil	I-T103
in	O
dag	O
##ang	O
oil	O
##field	O
and	O
identified	O
as	O
microb	B-T007
##acterium	I-T007
para	I-T007
##oxy	I-T007
##da	I-T007
##ns	I-T007
jp	I-T007
##m1	I-T007
by	O
the	O
analysis	B-T062
of	O
16s	B-T103
rdna	I-T103
sequence	B-T082
.	O
after	O
25	O
days	O
of	O
incubation	B-T058
,	O
the	O
strain	O
jp	B-T007
##m1	I-T007
could	O
degrade	O
91	O
.	O
78	O
%	O
of	O
the	O
initial	O
amount	O
of	O
fluor	B-T103
##anth	I-T103
##ene	I-T103
.	O
moreover	O
,	O
four	O
metabolites	B-T103
9	B-T103
-	I-T103
fluor	I-T103
##enone	I-T103
-	I-T103
1	I-T103
-	I-T103
carboxylic	I-T103
acid	I-T103
,	O
9	B-T103
-	I-T103
fluor	I-T103
##enone	I-T103
,	O
phthal	B-T103
##ic	I-T103
acid	I-T103
,	O
and	O
benzoic	B-T103
acid	I-T103
were	O
detected	O
in	O
the	O
culture	B-T103
solution	I-T103
.	O
the	O
gene	B-T082
sequence	I-T082
encoding	O
the	O
aromatic	B-T103
-	I-T103
ring	I-T103
-	I-T103
hydroxyl	I-T103
##ating	I-T103
dioxygenase	I-T103
was	O
amplified	B-T038
in	O
the	O
strain	O
jp	B-T007
##m1	I-T007
by	O
pcr	B-T062
.	O
based	O
on	O
the	O
translated	O
protein	B-T082
sequence	I-T082
,	O
a	O
homology	B-T062
modeling	I-T062
method	I-T062
was	O
applied	O
to	O
build	O
the	O
crystal	B-T103
structure	I-T103
of	O
dioxygenase	B-T103
.	O
subsequently	O
,	O
the	O
interaction	O
mechanism	O
between	O
fluor	B-T103
##anth	I-T103
##ene	I-T103
and	O
the	O
active	O
site	O
of	O
dioxygenase	B-T103
was	O
simulated	B-T062
and	O
analyzed	B-T062
by	O
molecular	B-T062
docking	I-T062
.	O
consequently	O
,	O
a	O
feasible	O
degrading	O
pathway	B-T038
of	O
fluor	B-T103
##anth	I-T103
##ene	I-T103
in	O
the	O
strain	O
jp	B-T007
##m1	I-T007
was	O
proposed	O
based	O
on	O
the	O
metabolites	B-T103
and	O
the	O
interaction	O
analyses	O
.	O
additionally	O
,	O
the	O
thermodynamic	B-T062
analysis	I-T062
showed	O
that	O
the	O
strain	O
jp	B-T007
##m1	I-T007
had	O
high	O
tolerance	O
for	O
fluor	B-T103
##anth	I-T103
##ene	I-T103
,	O
and	O
the	O
influence	O
of	O
fluor	B-T103
##anth	I-T103
##ene	I-T103
for	O
the	O
bacterial	B-T007
growth	B-T038
activity	O
was	O
negligible	O
under	O
100	O
to	O
400	O
mg	O
l	O
(	O
-	O
1	O
)	O
concentrations	O
.	O
taken	O
together	O
,	O
this	O
study	B-T062
indicates	O
that	O
the	O
strain	O
jp	B-T007
##m1	I-T007
has	O
high	O
potential	O
for	O
further	O
study	B-T062
in	O
bio	O
##rem	O
##ed	O
##iation	O
of	O
polycyclic	B-T103
aromatic	I-T103
hydrocarbon	I-T103
(	O
pah	B-T103
)	O
-	O
contaminated	O
sites	B-T082
.	O

predictive	B-T170
factors	I-T170
for	O
long	O
-	O
term	O
outcome	O
of	O
subth	B-T017
##ala	I-T017
##mic	I-T017
nucleus	I-T017
deep	B-T058
brain	I-T058
stimulation	I-T058
for	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
despite	O
the	O
recognition	O
of	O
the	O
usefulness	O
of	O
subth	B-T017
##ala	I-T017
##mic	I-T017
nucleus	I-T017
deep	B-T058
brain	I-T058
stimulation	I-T058
(	O
stn	B-T017
-	O
dbs	B-T058
)	O
for	O
the	O
treatment	O
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
,	O
preoperative	O
predictive	B-T170
factors	I-T170
for	O
the	O
long	O
-	O
term	O
outcome	O
of	O
stn	B-T017
-	O
dbs	B-T058
are	O
not	O
sufficiently	O
established	O
.	O
we	O
performed	O
this	O
study	B-T062
to	O
determine	O
such	O
predictive	B-T170
factors	I-T170
.	O
the	O
subjects	O
were	O
66	O
patients	O
who	O
were	O
classified	B-T170
into	O
two	O
groups	O
on	O
the	O
basis	O
of	O
their	O
activities	O
of	O
daily	O
living	O
(	O
adl	O
)	O
evaluated	O
five	O
years	O
after	O
the	O
stn	B-T017
-	O
dbs	B-T058
surgery	B-T058
:	O
33	O
patients	O
were	O
assigned	O
to	O
the	O
independent	O
adl	O
group	O
(	O
group	O
i	O
)	O
and	O
the	O
remaining	O
33	O
patients	O
to	O
the	O
dependent	O
adl	O
group	O
(	O
group	O
d	O
)	O
.	O
group	O
i	O
patients	O
showed	O
a	O
schw	O
##ab	O
and	O
england	O
(	O
s	O
&	O
e	O
)	O
scale	O
score	O
of	O
more	O
than	O
70	O
during	O
the	O
off	O
-	O
period	O
,	O
indicating	O
that	O
these	O
patients	O
can	O
maintain	O
their	O
independent	O
adl	O
all	O
the	O
time	O
.	O
group	O
d	O
patients	O
showed	O
a	O
score	O
of	O
70	O
or	O
lower	O
during	O
the	O
off	O
-	O
period	O
,	O
indicating	O
that	O
these	O
patients	O
cann	O
##ot	O
maintain	O
their	O
independent	O
adl	O
for	O
an	O
entire	O
day	O
.	O
we	O
studied	B-T062
the	O
differences	O
in	O
the	O
preoperative	B-T033
state	I-T033
between	O
these	O
two	O
groups	O
.	O
statistically	O
significant	O
differences	O
were	O
noted	O
in	O
pd	B-T038
onset	O
age	O
,	O
age	O
at	O
surgery	B-T058
,	O
preoperative	O
unified	O
parkinson	O
'	O
s	O
disease	O
rating	O
scale	O
(	O
upd	O
##rs	O
)	O
part	B-T082
i	I-T082
score	O
,	O
part	B-T082
ii	I-T082
score	O
,	O
total	O
subs	O
##core	O
for	O
axial	B-T033
symptoms	I-T033
in	O
part	B-T082
iii	I-T082
,	O
mini	B-T033
-	I-T033
mental	I-T033
state	I-T033
examination	I-T033
(	I-T033
mmse	I-T033
)	I-T033
score	I-T033
and	O
s	O
&	O
e	O
score	O
.	O
multiple	O
logistic	O
regression	O
analysis	O
showed	O
that	O
the	O
significant	O
independent	O
variables	O
related	O
to	O
long	O
-	O
term	O
independent	O
adl	O
were	O
the	O
age	O
at	O
surgery	B-T058
,	O
mmse	B-T033
score	I-T033
and	O
preoperative	O
s	O
&	O
e	O
scale	O
score	O
during	O
the	O
off	O
-	O
period	O
.	O
the	O
pd	B-T038
onset	O
age	O
,	O
age	O
at	O
surgery	B-T058
,	O
preoperative	O
high	O
-	O
level	O
adl	O
,	O
cognitive	B-T038
function	I-T038
,	O
and	O
axial	B-T033
symptoms	I-T033
are	O
important	O
predictive	B-T170
factors	I-T170
for	O
the	O
long	O
-	O
term	O
outcome	O
of	O
stn	B-T017
-	O
dbs	B-T058
.	O

the	O
clinico	O
-	O
radiological	B-T091
paradox	B-T033
of	O
cognitive	B-T038
function	I-T038
and	O
mri	B-T058
burden	O
of	O
white	B-T017
matter	I-T017
lesions	B-T033
in	O
people	B-T098
with	O
multiple	B-T038
sclerosis	I-T038
:	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T170
-	I-T170
analysis	I-T170
moderate	O
correlation	O
exists	O
between	O
the	O
imaging	O
quantification	O
of	O
brain	B-T017
white	B-T017
matter	I-T017
lesions	B-T033
and	O
cognitive	O
performance	O
in	O
people	B-T098
with	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
.	O
this	O
may	O
reflect	O
the	O
greater	O
importance	O
of	O
other	O
features	O
,	O
including	O
sub	O
##vis	O
##ible	O
pathology	B-T091
,	O
or	O
methodological	O
limitations	O
of	O
the	O
primary	O
literature	B-T170
.	O
to	O
summar	O
##ise	O
the	O
cognitive	O
clinico	O
-	O
radiological	B-T091
paradox	B-T033
and	O
explore	O
the	O
potential	O
methodological	O
factors	O
that	O
could	O
influence	O
the	O
assessment	O
of	O
this	O
relationship	O
.	O
systematic	B-T170
review	I-T170
and	O
meta	B-T170
-	I-T170
analysis	I-T170
of	O
primary	O
research	B-T062
relating	O
cognitive	B-T038
function	I-T038
to	O
white	B-T017
matter	I-T017
lesion	B-T033
burden	O
.	O
fifty	O
papers	O
met	O
eligibility	O
criteria	O
for	O
review	B-T170
,	O
and	O
meta	B-T170
-	I-T170
analysis	I-T170
of	O
overall	O
results	O
was	O
possible	O
in	O
thirty	O
-	O
two	O
(	O
205	O
##0	O
participants	B-T098
)	O
.	O
aggregate	O
correlation	O
between	O
cognition	B-T038
and	O
t2	B-T033
lesion	B-T033
burden	O
was	O
r	O
=	O
-	O
0	O
.	O
30	O
(	O
95	O
%	O
confidence	O
interval	O
:	O
-	O
0	O
.	O
34	O
,	O
-	O
0	O
.	O
26	O
)	O
.	O
wide	O
methodological	O
variability	O
was	O
seen	O
,	O
particularly	O
related	O
to	O
key	O
factors	O
in	O
the	O
cognitive	O
data	O
capture	O
and	O
image	B-T058
analysis	I-T058
techniques	I-T058
.	O
resolving	O
the	O
persistent	O
clinico	O
-	O
radiological	B-T091
paradox	B-T033
will	O
likely	O
require	O
simultaneous	O
evaluation	B-T058
of	O
multiple	O
components	O
of	O
the	O
complex	O
pathology	B-T091
using	O
optimum	O
measurement	O
techniques	O
for	O
both	O
cognitive	O
and	O
mri	B-T058
feature	O
quantification	O
.	O
we	O
recommend	O
a	O
consensus	O
initiative	O
to	O
support	O
common	O
standards	O
for	O
image	B-T058
analysis	I-T058
in	O
ms	B-T038
,	O
enabling	O
benchmark	O
##ing	O
while	O
also	O
supporting	O
ongoing	O
innovation	B-T170
.	O

the	O
r2	B-T103
##r3	I-T103
##my	I-T103
##b	I-T103
vv	B-T103
##my	I-T103
##bp	I-T103
##a1	I-T103
from	O
grape	B-T204
repro	O
##grams	O
the	O
phenyl	B-T038
##prop	I-T038
##anoid	I-T038
pathway	I-T038
in	O
tobacco	B-T204
flowers	B-T204
this	O
work	O
shows	O
that	O
,	O
in	O
tobacco	B-T204
,	O
the	O
ectopic	B-T038
expression	I-T038
of	O
vv	B-T103
##my	I-T103
##bp	I-T103
##a1	I-T103
,	O
a	O
grape	B-T204
regulator	O
of	O
pro	B-T103
##anth	I-T103
##ocyan	I-T103
##idin	I-T103
biosynthesis	O
,	O
up	B-T038
-	I-T038
or	I-T038
down	I-T038
-	I-T038
regulates	I-T038
different	O
branches	O
of	O
the	O
phenyl	B-T038
##pro	I-T038
##anoid	I-T038
pathway	I-T038
,	O
in	O
a	O
structure	O
-	O
specific	O
fashion	O
.	O
pro	B-T103
##anth	I-T103
##ocyan	I-T103
##idin	I-T103
##s	I-T103
are	O
flavonoids	B-T103
of	O
paramount	O
importance	O
for	O
animal	B-T168
and	O
human	B-T168
diet	I-T168
.	O
research	B-T062
interest	O
increasingly	O
tilt	O
##s	O
towards	O
generating	O
crops	B-T204
enriched	O
with	O
these	O
health	O
-	O
promoting	O
compounds	O
.	O
flavonoids	B-T103
synthesis	O
is	O
regulated	O
by	O
the	O
mb	B-T017
##w	I-T017
transcriptional	B-T017
complex	I-T017
,	O
made	O
of	O
r2	B-T103
##r3	I-T103
##my	I-T103
##b	I-T103
,	O
bh	B-T103
##l	I-T103
##h	I-T103
and	O
wd	B-T103
##40	I-T103
proteins	I-T103
,	O
with	O
the	O
myb	B-T103
components	O
lia	O
##ble	O
for	O
channel	B-T082
##ing	I-T082
the	O
complex	B-T103
towards	O
specific	O
branches	O
of	O
the	O
pathway	B-T038
.	O
hence	O
,	O
using	O
tobacco	B-T204
as	O
a	O
model	O
,	O
here	O
,	O
we	O
tested	O
if	O
the	O
ectopic	B-T038
expression	I-T038
of	O
the	O
pro	B-T103
##anth	I-T103
##ocyan	I-T103
##idin	I-T103
regulator	O
vv	B-T103
##my	I-T103
##bp	I-T103
##a1	I-T103
from	O
grape	B-T204
induces	O
the	O
biosynthesis	O
of	O
these	O
compounds	O
in	O
not	O
-	O
naturally	O
committed	B-T017
cells	I-T017
.	O
here	O
,	O
we	O
show	O
,	O
via	O
targeted	O
transcriptomic	B-T038
and	O
metabolic	O
analyses	B-T062
of	O
primary	O
transgenic	B-T204
lines	I-T204
and	O
their	O
progeny	O
,	O
that	O
vv	B-T103
##my	I-T103
##bp	I-T103
##a1	I-T103
alters	O
the	O
phenyl	B-T038
##prop	I-T038
##anoid	I-T038
pathway	I-T038
in	O
tobacco	B-T204
floral	B-T204
organs	I-T204
,	O
in	O
a	O
structure	O
-	O
specific	O
fashion	O
.	O
we	O
also	O
report	O
that	O
a	O
modest	O
vv	B-T103
##my	I-T103
##bp	I-T103
##a1	I-T103
expression	B-T038
is	O
sufficient	O
to	O
induce	O
the	O
expression	B-T038
of	O
both	O
pro	B-T103
##anth	I-T103
##ocyan	I-T103
##idin	I-T103
-	O
specific	O
and	O
early	B-T017
genes	I-T017
of	O
the	O
phenyl	B-T038
##prop	I-T038
##anoid	I-T038
pathway	I-T038
.	O
consequently	O
,	O
pro	B-T103
##anth	I-T103
##ocyan	I-T103
##idin	I-T103
##s	I-T103
and	O
chloro	B-T103
##genic	I-T103
acids	I-T103
are	O
induced	O
or	O
de	O
novo	O
synthet	O
##ised	O
in	O
floral	B-T204
limbs	I-T204
,	I-T204
tubes	I-T204
and	O
sta	B-T204
##men	I-T204
##s	I-T204
.	O
other	O
phenyl	B-T038
##prop	I-T038
##anoid	I-T038
branches	I-T038
are	O
conversely	O
induced	O
or	O
depleted	O
according	O
to	O
the	O
floral	B-T204
structure	I-T204
.	O
our	O
study	O
documents	O
a	O
novel	O
and	O
distinct	O
function	O
of	O
vv	B-T103
##my	I-T103
##bp	I-T103
##a1	I-T103
with	O
respect	O
to	O
other	O
myb	B-T103
##s	I-T103
regulating	O
pro	B-T103
##anth	I-T103
##ocyan	I-T103
##idin	I-T103
##s	I-T103
.	O
present	O
findings	O
may	O
have	O
major	O
implications	O
in	O
designing	O
strategies	O
for	O
enrich	O
##ing	O
crops	B-T204
with	O
health	O
-	O
promoting	O
compounds	O
.	O

antagonistic	B-T038
self	B-T038
-	I-T038
organizing	I-T038
patterning	I-T038
systems	O
control	O
maintenance	O
and	O
regeneration	B-T038
of	O
the	O
anteroposterior	B-T082
axis	B-T082
in	O
planar	B-T204
##ians	I-T204
planar	B-T204
##ian	I-T204
flat	B-T204
##worms	I-T204
maintain	O
their	O
body	B-T017
plan	O
in	O
the	O
face	O
of	O
constant	O
internal	O
turnover	O
and	O
can	O
regenerate	O
from	O
arbitrary	O
tissue	B-T017
fragments	B-T031
.	O
both	O
phenomena	O
require	O
self	O
-	O
maintaining	O
and	O
self	B-T038
-	I-T038
organizing	I-T038
patterning	I-T038
mechanisms	O
,	O
the	O
molecular	O
mechanisms	O
of	O
which	O
remain	O
poorly	O
understood	O
.	O
we	O
show	O
that	O
a	O
morph	B-T038
##ogenic	I-T038
gradient	O
of	O
canonical	B-T038
wnt	I-T038
signaling	I-T038
patterns	O
gene	B-T038
expression	I-T038
along	O
the	O
planar	B-T204
##ian	I-T204
anteroposterior	B-T082
(	O
a	B-T082
/	I-T082
p	I-T082
)	O
axis	B-T082
.	O
our	O
results	O
demonstrate	O
that	O
gradient	O
formation	O
likely	O
occurs	O
autonomous	O
##ly	O
in	O
the	O
tail	B-T017
and	O
that	O
an	O
autoreg	B-T038
##ulatory	I-T038
module	O
of	O
wnt	B-T103
-	O
mediated	O
wnt	B-T017
expression	B-T038
both	O
shapes	O
the	O
gradient	O
at	O
steady	O
state	O
and	O
govern	O
##s	O
its	O
re	O
-	O
establishment	O
during	O
regeneration	B-T038
.	O
functional	O
antagonism	B-T038
between	O
the	O
tail	B-T017
wnt	B-T103
gradient	O
and	O
an	O
unknown	O
head	B-T082
patterning	B-T038
system	O
further	O
determines	O
the	O
spatial	B-T082
proportions	O
of	O
the	O
planar	B-T204
##ian	I-T204
a	B-T082
/	I-T082
p	I-T082
axis	B-T082
and	O
mediates	O
mutually	O
exclusive	O
molecular	B-T038
fate	I-T038
choices	O
during	O
regeneration	B-T038
.	O
overall	O
,	O
our	O
results	O
suggest	O
that	O
the	O
planar	B-T204
##ian	I-T204
a	B-T082
/	I-T082
p	I-T082
axis	B-T082
is	O
patterned	O
by	O
self	B-T038
-	I-T038
organizing	I-T038
patterning	I-T038
systems	O
deployed	O
from	O
either	O
end	O
that	O
are	O
functionally	O
coupled	O
by	O
mutual	O
antagonism	B-T038
.	O

selective	O
reaching	B-T038
in	O
macaques	B-T204
:	O
evidence	O
for	O
action	O
-	O
centred	O
attention	B-T038
when	O
a	O
monkey	B-T204
select	O
##s	O
a	O
piece	O
of	O
food	B-T168
lying	O
on	O
the	O
ground	O
from	O
among	O
other	O
viable	O
objects	O
in	O
the	O
near	O
vicinity	B-T082
,	O
only	O
the	O
desired	O
item	B-T168
govern	O
##s	O
the	O
particular	O
pattern	B-T082
and	O
direction	B-T082
of	O
the	O
animal	B-T204
'	I-T204
s	I-T204
reaching	B-T038
action	O
.	O
it	O
would	O
seem	O
then	O
that	O
selection	O
is	O
an	O
important	O
component	O
controlling	O
the	O
animal	B-T204
'	I-T204
s	I-T204
action	O
.	O
but	O
,	O
we	O
may	O
ask	O
,	O
is	O
the	O
selection	O
process	O
in	O
such	O
cases	O
imper	O
##vious	O
to	O
the	O
presence	O
of	O
other	O
objects	O
that	O
could	O
constitute	O
potential	O
obstacles	O
to	O
or	O
constraints	O
on	O
movement	B-T038
execution	O
?	O
and	O
if	O
it	O
is	O
,	O
in	O
fact	O
,	O
per	O
##vious	O
to	O
other	O
objects	O
,	O
do	O
they	O
have	O
a	O
direct	O
influence	O
on	O
the	O
organization	B-T038
of	O
the	O
response	O
?	O
the	O
kinematics	B-T091
of	O
macaques	B-T204
'	O
reaching	B-T038
movements	B-T038
were	O
examined	B-T033
by	O
the	O
current	O
study	B-T062
that	O
analysed	B-T062
some	O
exempl	O
##ars	O
as	O
they	O
selectively	O
reached	B-T038
to	O
grasp	B-T038
a	O
food	B-T168
item	I-T168
in	O
the	O
absence	O
as	O
well	O
as	O
in	O
the	O
presence	O
of	O
potential	O
obstacles	O
(	O
i	O
.	O
e	O
.	O
,	O
stones	O
)	O
that	O
could	O
affect	B-T038
the	O
arm	B-T082
trajectory	B-T082
.	O
changes	O
in	O
movement	B-T038
parameter	O
##ization	O
were	O
noted	O
in	O
temporal	O
measures	O
,	O
such	O
as	O
movement	B-T038
time	O
,	O
as	O
well	O
as	O
in	O
spatial	O
ones	O
,	O
such	O
as	O
paths	O
of	O
trajectory	B-T082
.	O
generally	O
speaking	O
,	O
the	O
presence	O
of	O
stones	O
in	O
the	O
vicinity	B-T082
of	O
the	O
acting	O
hand	B-T017
stall	O
##ed	O
the	O
reaching	B-T038
movement	B-T038
and	O
affected	B-T038
the	O
arm	B-T082
trajectory	B-T082
as	O
the	O
hand	B-T017
ve	B-T033
##ered	I-T033
away	I-T033
from	O
the	O
stone	O
even	O
when	O
it	O
was	O
not	O
a	O
physical	O
obstacle	O
.	O
we	O
concluded	O
that	O
nearby	O
objects	O
evoke	O
a	O
motor	B-T201
response	I-T201
in	O
macaques	B-T204
,	O
and	O
the	O
attentional	B-T038
mechanisms	O
that	O
allow	O
for	O
a	O
successful	O
action	O
selection	O
are	O
revealed	O
in	O
the	O
reaching	B-T038
path	B-T082
.	O
the	O
data	O
outlined	O
here	O
conc	O
##ur	O
with	O
human	B-T204
studies	B-T062
indicating	O
that	O
potential	O
obstacles	O
are	O
internally	B-T082
represented	O
,	O
a	O
finding	B-T033
implying	O
basic	O
cognitive	O
operations	O
allowing	O
for	O
action	O
selection	O
in	O
macaques	B-T204
.	O

opto	O
##me	O
##cha	O
##nic	O
##al	O
control	O
of	O
quantum	O
yield	O
in	O
trans	O
-	O
cis	O
ultrafast	O
photo	O
##iso	O
##mer	O
##ization	O
of	O
a	O
retinal	B-T103
chromophore	O
model	O
the	O
quantum	O
yield	O
of	O
a	O
photochemical	O
reaction	O
is	O
one	O
of	O
the	O
most	O
fundamental	O
quantities	O
in	O
photoc	O
##hem	O
##istry	O
,	O
as	O
it	O
measures	O
the	O
efficiency	O
of	O
the	O
transduction	B-T038
of	I-T038
light	I-T038
energy	I-T038
into	I-T038
chemical	I-T038
energy	I-T038
.	O
nature	O
has	O
evolved	O
photoreceptors	B-T017
in	O
which	O
the	O
reactivity	O
of	O
a	O
chromophore	O
is	O
enhanced	O
by	O
its	O
molecular	B-T082
environment	I-T082
to	O
achieve	O
high	O
quantum	O
yields	O
.	O
the	O
retinal	B-T103
chromophore	O
steric	O
##ally	O
constrained	O
inside	O
rhodopsin	B-T103
proteins	I-T103
represents	O
an	O
outstanding	O
example	O
of	O
such	O
a	O
control	O
.	O
in	O
a	O
more	O
general	O
framework	O
,	O
mechanical	O
forces	O
acting	O
on	O
a	O
molecular	O
system	O
can	O
strongly	O
modify	O
its	O
reactivity	O
.	O
herein	O
,	O
we	O
show	O
that	O
the	O
exertion	O
of	O
tensile	O
forces	O
on	O
a	O
simplified	O
retinal	B-T103
chromophore	O
model	O
provoke	O
##s	O
a	O
substantial	O
and	O
regular	O
increase	O
in	O
the	O
trans	O
-	O
to	O
-	O
cis	O
photo	O
##iso	O
##mer	O
##ization	O
quantum	O
yield	O
in	O
a	O
counter	O
##int	O
##uit	O
##ive	O
way	O
,	O
as	O
these	O
extension	O
forces	O
facilitate	O
the	O
formation	O
of	O
the	O
more	O
compressed	O
cis	O
photo	O
##iso	O
##mer	O
.	O
a	O
rationale	O
for	O
the	O
mechan	O
##ochemical	O
effect	O
on	O
this	O
photo	O
##iso	O
##mer	O
##ization	O
mechanism	O
is	O
also	O
proposed	O
.	O

proximal	B-T058
soil	I-T058
sensing	I-T058
-	O
a	O
contribution	O
for	O
species	B-T170
habitat	B-T082
distribution	O
modelling	B-T062
of	O
earth	B-T204
##worms	I-T204
in	O
agricultural	B-T082
soils	O
?	O
earth	B-T204
##worms	I-T204
are	O
important	O
for	O
maintaining	O
soil	O
ecosystem	O
functioning	O
and	O
serve	O
as	O
indicators	B-T103
of	O
soil	O
fertility	O
.	O
however	O
,	O
detection	O
of	O
earth	B-T204
##worms	I-T204
is	O
time	O
-	O
consuming	O
,	O
which	O
hinder	O
##s	O
the	O
assessment	O
of	O
earth	B-T204
##worm	I-T204
abundances	O
with	O
high	O
sampling	O
density	O
over	O
entire	O
fields	B-T082
.	O
recent	O
developments	O
of	O
mobile	O
terrestrial	O
sensor	O
platforms	O
for	O
proximal	B-T058
soil	I-T058
sensing	I-T058
(	O
pss	B-T058
)	O
provided	O
new	O
tools	O
for	O
collecting	O
dense	O
spatial	O
information	O
of	O
soils	O
using	O
various	O
sensing	B-T170
principles	I-T170
.	O
yet	O
,	O
the	O
potential	O
of	O
pss	B-T058
for	O
assessing	O
earth	B-T204
##worm	I-T204
habitats	B-T082
is	O
largely	O
unexplored	O
.	O
this	O
study	B-T062
investigates	O
whether	O
pss	B-T058
data	O
contribute	O
to	O
the	O
spatial	O
prediction	O
of	O
earth	B-T204
##worm	I-T204
abundances	O
in	O
species	B-T170
distribution	O
models	B-T170
of	O
agricultural	B-T082
soils	O
.	O
proximal	B-T058
soil	I-T058
sensing	I-T058
data	O
,	O
e	O
.	O
g	O
.	O
,	O
soil	O
electrical	O
conductivity	O
(	O
ec	O
)	O
,	O
ph	O
,	O
and	O
near	B-T058
infrared	I-T058
absorbance	I-T058
(	O
nir	B-T058
)	O
,	O
were	O
collected	O
in	O
real	O
-	O
time	O
in	O
a	O
field	B-T082
with	O
two	O
management	O
strategies	O
(	O
reduced	O
till	O
##age	O
/	O
conventional	O
till	O
##age	O
)	O
and	O
sand	O
##y	O
to	O
lo	O
##am	O
soils	O
.	O
pss	B-T058
was	O
related	O
to	O
observations	B-T062
from	O
a	O
long	O
-	O
term	O
(	O
11	O
years	O
)	O
earth	B-T204
##worm	I-T204
observation	O
study	O
conducted	O
at	O
42	O
plots	B-T082
.	O
earth	B-T204
##worms	I-T204
were	O
sampled	O
from	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
m	O
##³	O
soil	O
blocks	O
and	O
identified	O
to	O
species	B-T170
level	O
.	O
sensor	O
data	O
were	O
highly	O
correlated	O
with	O
earth	B-T204
##worm	I-T204
abundances	O
observed	O
in	O
reduced	O
till	O
##age	O
but	O
less	O
correlated	O
with	O
earth	B-T204
##worm	I-T204
abundances	O
observed	O
in	O
conventional	O
till	O
##age	O
.	O
this	O
may	O
indicate	O
that	O
management	O
influences	O
the	O
sensor	O
-	O
earth	B-T204
##worm	I-T204
relationship	O
.	O
generalized	O
additive	O
models	B-T170
and	O
state	B-T170
-	I-T170
space	I-T170
models	I-T170
showed	O
that	O
modelling	B-T062
based	O
on	O
data	O
fusion	O
from	O
ec	O
,	O
ph	O
,	O
and	O
nir	B-T058
sensors	O
produced	O
better	O
results	O
than	O
modelling	B-T062
without	O
sensor	O
data	O
or	O
data	O
from	O
just	O
a	O
single	O
sensor	O
.	O
regarding	O
the	O
individual	O
earth	B-T204
##worm	I-T204
species	B-T170
,	O
particular	O
sensor	O
combinations	O
were	O
more	O
appropriate	O
than	O
others	O
due	O
to	O
the	O
different	O
habitat	B-T082
requirements	O
of	O
the	O
earth	B-T204
##worms	I-T204
.	O
earth	B-T204
##worm	I-T204
species	B-T170
with	O
soil	O
-	O
specific	O
habitat	B-T082
preferences	O
were	O
spatially	O
predicted	O
with	O
higher	O
accuracy	O
by	O
pss	B-T058
than	O
more	O
ubiquitous	O
species	B-T170
.	O
our	O
findings	B-T033
suggest	O
that	O
pss	B-T058
contributes	O
to	O
the	O
spatial	O
modelling	B-T062
of	O
earth	B-T204
##worm	I-T204
abundances	O
at	O
field	O
scale	O
and	O
that	O
it	O
will	O
support	O
species	B-T170
distribution	O
modelling	B-T062
in	O
the	O
attempt	O
to	O
understand	O
the	O
soil	O
-	O
earth	B-T204
##worm	I-T204
relationships	O
in	O
agro	O
##ec	O
##osystem	O
##s	O
.	O

differential	O
roles	O
of	O
ax	B-T103
##in	I-T103
##1	I-T103
and	O
ax	B-T103
##in	I-T103
##2	I-T103
in	O
tank	B-T103
##yr	I-T103
##ase	I-T103
inhibitor	B-T103
-	I-T103
induced	I-T103
formation	O
of	O
degrad	B-T103
##asome	I-T103
##s	I-T103
and	O
β	B-T103
-	I-T103
catenin	I-T103
degradation	O
inhibition	B-T038
of	O
the	O
tank	B-T103
##yr	I-T103
##ase	I-T103
enzymes	I-T103
(	O
tn	B-T103
##ks	I-T103
##1	I-T103
and	O
tn	B-T103
##ks	I-T103
##2	I-T103
)	O
has	O
recently	O
been	O
shown	O
to	O
induce	O
highly	O
dynamic	O
assemblies	O
of	O
β	B-T103
-	I-T103
catenin	I-T103
destruction	B-T103
complex	I-T103
components	B-T103
known	O
as	O
degrad	B-T103
##asome	I-T103
##s	I-T103
,	O
which	O
promote	O
degradation	O
of	O
β	B-T103
-	I-T103
catenin	I-T103
and	O
reduced	O
wnt	B-T038
signaling	I-T038
activity	O
in	O
colorectal	B-T038
cancer	I-T038
cells	B-T017
.	O
ax	B-T103
##in	I-T103
##1	I-T103
and	O
ax	B-T103
##in	I-T103
##2	I-T103
/	O
conduct	B-T103
##in	I-T103
,	O
the	O
rate	O
-	O
limiting	O
factors	O
for	O
the	O
stability	O
and	O
function	O
of	O
endogenous	O
destruction	B-T103
complexes	I-T103
,	O
are	O
stabilized	B-T033
upon	O
tn	B-T103
##ks	I-T103
inhibition	B-T038
due	O
to	O
abrogated	O
degradation	O
of	O
ax	B-T103
##in	I-T103
by	O
the	O
proteasome	B-T103
.	O
since	O
the	O
role	O
of	O
ax	B-T103
##in	I-T103
##1	I-T103
versus	O
ax	B-T103
##in	I-T103
##2	I-T103
as	O
scaffold	B-T103
##ing	I-T103
proteins	I-T103
in	O
the	O
wnt	B-T038
signaling	I-T038
pathway	I-T038
still	O
remains	O
incompletely	O
understood	B-T038
,	O
we	O
sought	O
to	O
elucidate	O
their	O
relative	O
contribution	O
in	O
the	O
formation	O
of	O
degrad	B-T103
##asome	I-T103
##s	I-T103
,	O
as	O
these	O
protein	B-T103
assemblies	O
most	O
likely	O
represent	O
the	O
morphological	B-T082
and	O
functional	O
correlates	O
of	O
endogenous	O
β	B-T103
-	I-T103
catenin	I-T103
destruction	B-T103
complexes	I-T103
.	O
in	O
sw	B-T017
##48	I-T017
##0	I-T017
colorectal	B-T038
cancer	I-T038
cells	B-T017
treated	O
with	O
the	O
tank	B-T103
##yr	I-T103
##ase	I-T103
inhibitor	I-T103
(	O
tn	B-T103
##ks	I-T103
##i	I-T103
)	O
g0	B-T103
##0	I-T103
##7	I-T103
-	I-T103
lk	I-T103
we	O
found	B-T033
that	O
ax	B-T103
##in	I-T103
##1	I-T103
was	O
not	O
required	O
for	O
degrad	B-T103
##asome	I-T103
formation	O
.	O
in	O
contrast	O
,	O
the	O
formation	O
of	O
degrad	B-T103
##asome	I-T103
##s	I-T103
as	O
well	O
as	O
their	O
capacity	O
to	O
degrade	O
β	B-T103
-	I-T103
catenin	I-T103
were	O
considerably	O
impaired	O
in	O
g0	B-T103
##0	I-T103
##7	I-T103
-	I-T103
lk	I-T103
-	I-T103
treated	I-T103
cells	B-T017
depleted	O
of	O
ax	B-T103
##in	I-T103
##2	I-T103
.	O
these	O
findings	B-T033
give	O
novel	O
insights	B-T038
into	O
differential	O
functional	O
roles	O
of	O
ax	B-T103
##in	I-T103
##1	I-T103
versus	O
ax	B-T103
##in	I-T103
##2	I-T103
in	O
the	O
β	B-T103
-	I-T103
catenin	I-T103
destruction	B-T103
complex	I-T103
.	O

evaluation	O
of	O
the	O
relationship	O
between	O
the	O
static	O
measurement	O
of	O
transverse	B-T082
arch	I-T082
flexibility	O
of	O
the	O
foref	B-T017
##oo	I-T017
##t	I-T017
and	O
gait	B-T033
parameters	O
in	O
healthy	B-T098
subjects	I-T098
[	O
purpose	O
]	O
to	O
investigate	O
the	O
relationship	O
between	O
the	O
static	O
measurement	O
of	O
the	O
transverse	B-T082
arch	I-T082
of	O
the	O
foref	B-T017
##oo	I-T017
##t	I-T017
,	O
using	O
a	O
3	B-T082
-	I-T082
dimensional	I-T082
(	O
3d	B-T082
)	O
foot	O
scanner	O
,	O
and	O
kinetics	O
and	O
kinematics	B-T091
of	O
gait	B-T033
parameters	O
in	O
the	O
sagittal	B-T082
plane	I-T082
.	O
[	O
subjects	B-T098
and	O
methods	B-T170
]	O
twenty	O
healthy	B-T098
subjects	I-T098
participated	O
in	O
this	O
study	B-T062
.	O
the	O
transverse	B-T082
arch	I-T082
of	O
the	O
foref	B-T017
##oo	I-T017
##t	I-T017
was	O
measured	O
under	O
three	O
conditions	O
as	O
follows	O
:	O
condition	O
1	O
,	O
sitting	B-T033
;	O
condition	O
2	O
,	O
standing	B-T082
;	O
and	O
condition	O
3	O
,	O
foot	B-T017
forward	B-T082
and	O
lower	B-T017
leg	I-T017
tilt	O
##ing	O
anterior	B-T082
##ly	I-T082
to	O
the	O
maximum	O
position	B-T082
with	O
heel	B-T082
contact	O
.	O
gait	B-T033
parameters	O
were	O
recorded	O
using	O
a	O
3d	O
motion	O
analysis	O
system	O
and	O
force	O
plate	O
.	O
correlation	O
coefficients	O
between	O
taf	O
for	O
each	O
comparison	O
of	O
conditions	O
and	O
gait	B-T033
parameters	O
were	O
calculated	O
using	O
the	O
spearman	B-T062
correlation	I-T062
analysis	I-T062
.	O
[	O
results	O
]	O
rates	O
of	O
the	O
transverse	B-T082
arch	I-T082
of	O
the	O
foref	B-T017
##oo	I-T017
##t	I-T017
width	O
and	O
height	O
between	O
condition	O
2	O
and	O
condition	O
3	O
were	O
significantly	O
correlated	O
with	O
the	O
anterior	B-T082
and	O
posterior	B-T082
component	O
of	O
ground	O
reaction	O
forces	O
,	O
the	O
hip	B-T082
joint	I-T082
extension	O
angle	B-T082
,	O
and	O
the	O
ankle	B-T082
plantar	B-T038
flexion	I-T038
moment	I-T038
.	O
[	O
conclusion	O
]	O
our	O
study	B-T062
'	I-T062
s	I-T062
findings	B-T033
indicated	B-T033
that	O
increased	O
stiffness	B-T033
of	O
the	O
transverse	B-T082
arch	I-T082
of	O
the	O
foref	B-T017
##oo	I-T017
##t	I-T017
was	O
related	O
to	O
the	O
increase	O
in	O
ankle	B-T082
plantar	B-T038
moment	I-T038
,	O
and	O
decreased	O
stiffness	B-T033
of	O
the	O
transverse	B-T082
arch	I-T082
of	O
the	O
foref	B-T017
##oo	I-T017
##t	I-T017
was	O
related	O
to	O
the	O
increase	O
in	O
hip	B-T082
joint	I-T082
extension	O
angle	B-T082
during	O
gait	B-T033
.	O

interprofessional	O
primary	B-T058
care	I-T058
team	B-T058
meetings	I-T058
:	O
a	O
qualitative	O
approach	B-T082
comparing	O
observations	B-T062
with	O
personal	O
opinions	O
the	O
number	O
of	O
people	B-T098
with	O
multiple	B-T038
chronic	I-T038
conditions	I-T038
requiring	O
primary	B-T058
care	I-T058
services	I-T058
increases	O
.	O
professionals	B-T097
from	O
different	O
disciplines	O
collab	O
##orate	O
and	O
coordinate	O
care	O
to	O
deal	O
with	O
the	O
complex	O
health	B-T058
care	I-T058
needs	I-T058
.	O
there	O
is	O
lack	O
of	O
information	O
on	O
current	O
practices	O
regarding	O
interprofessional	O
team	B-T058
(	I-T058
ipt	I-T058
)	I-T058
meetings	I-T058
.	O
this	O
study	B-T062
aimed	O
to	O
improve	O
our	O
understanding	O
of	O
the	O
process	O
of	O
interprofessional	O
collaboration	O
in	O
primary	B-T058
care	I-T058
team	B-T058
meetings	I-T058
in	O
the	O
netherlands	B-T082
by	O
observing	O
the	O
current	O
practice	O
and	O
exploring	O
personal	O
opinions	O
.	O
qualitative	B-T062
study	I-T062
involving	O
observations	B-T062
of	O
team	B-T058
meeting	I-T058
s	O
and	O
interviews	O
with	O
participants	B-T098
.	O
eight	O
different	O
ipt	B-T058
meetings	I-T058
(	O
n	O
=	O
8	O
)	O
in	O
different	O
primary	B-T058
care	I-T058
practices	I-T058
were	O
observed	O
by	O
means	O
of	O
video	O
recordings	O
.	O
experiences	B-T038
were	O
explored	O
by	O
conducting	O
individual	O
semi	O
-	O
structured	O
interviews	O
(	O
n	O
=	O
60	O
)	O
with	O
participants	B-T098
(	O
i	O
.	O
e	O
.	O
health	B-T097
care	I-T097
professionals	I-T097
from	O
different	O
disciplines	O
)	O
of	O
the	O
observed	O
team	B-T058
meetings	I-T058
.	O
the	O
data	O
were	O
analysed	B-T062
by	O
means	O
of	O
content	O
analysis	O
.	O
most	O
participants	B-T098
expressed	O
favourable	O
opinions	O
about	O
their	O
team	B-T058
meetings	I-T058
.	O
however	O
,	O
observations	B-T062
showed	O
that	O
team	B-T058
meetings	I-T058
were	O
more	O
or	O
less	O
he	O
##ct	O
##ic	O
,	O
and	O
lacked	O
a	O
clear	O
structure	O
and	O
team	B-T097
coord	I-T097
##inator	I-T097
or	O
leader	B-T097
.	O
there	O
appears	O
to	O
be	O
a	O
discrepancy	B-T033
between	O
findings	B-T033
from	O
observations	B-T062
and	O
interviews	O
.	O
from	O
the	O
interviews	O
,	O
four	O
main	O
themes	O
were	O
extracted	O
:	O
(	O
1	O
)	O
team	B-T098
structure	I-T098
and	I-T098
composition	I-T098
,	O
(	O
2	O
)	O
patient	B-T058
-	I-T058
centred	I-T058
##ness	I-T058
,	O
(	O
3	O
)	O
interaction	O
and	O
(	O
4	O
)	O
attitude	B-T038
and	O
motivation	B-T038
.	O
ipt	B-T058
meetings	I-T058
could	O
benefit	O
from	O
improvements	O
in	O
structure	O
,	O
patient	B-T058
-	I-T058
centred	I-T058
##ness	I-T058
and	O
leadership	O
by	O
the	O
chair	B-T097
##pers	I-T097
##ons	I-T097
.	O
given	O
the	O
discrepancy	B-T033
between	O
observations	B-T062
and	O
interviews	O
,	O
it	O
would	O
appear	O
useful	O
to	O
improve	O
team	O
members	O
'	O
awareness	B-T038
of	O
aspects	O
that	O
could	O
be	O
improved	O
before	O
training	O
them	O
in	O
dealing	O
with	O
specific	O
challenges	B-T058
.	O

validation	B-T062
of	O
the	O
neo	B-T103
##gen	I-T103
##®	I-T103
fentanyl	I-T103
elisa	B-T058
kit	O
for	O
blood	B-T031
and	O
urine	B-T031
the	O
neo	B-T103
##gen	I-T103
##®	I-T103
fentanyl	I-T103
ready	O
-	O
to	O
-	O
use	O
enzyme	B-T058
-	I-T058
linked	I-T058
immunosorbent	I-T058
assay	I-T058
kit	O
was	O
validated	O
following	O
the	O
scientific	B-T098
working	I-T098
group	I-T098
for	O
forensic	O
toxicology	O
standard	B-T091
practices	I-T091
for	O
method	O
validation	B-T062
in	O
forensic	O
toxicology	O
laboratory	B-T170
guidelines	I-T170
.	I-T170
two	O
decision	O
points	O
,	O
0	O
.	O
5	O
and	O
1	O
ng	O
/	O
ml	O
,	O
were	O
successfully	O
validated	O
for	O
whole	B-T031
blood	I-T031
.	O
for	O
urine	B-T031
,	O
two	O
decision	O
points	O
,	O
1	O
and	O
5	O
ng	O
/	O
ml	O
,	O
were	O
also	O
successfully	O
validated	O
.	O
the	O
validation	B-T062
included	O
the	O
evaluation	B-T058
of	O
sensitivity	O
,	O
precision	O
,	O
specificity	O
,	O
carry	O
##over	O
,	O
plate	O
drift	O
,	O
rug	O
##ged	O
##ness	O
/	O
robustness	O
and	O
a	O
case	O
sample	O
evaluation	B-T058
.	O
the	O
empirically	O
determined	O
limit	O
of	O
detection	O
was	O
0	O
.	O
25	O
ng	O
/	O
ml	O
for	O
blood	B-T031
and	O
0	O
.	O
5	O
ng	O
/	O
ml	O
for	O
urine	B-T031
.	O
precision	O
was	O
determined	O
at	O
five	O
different	O
concentrations	O
ranging	O
from	O
0	O
.	O
25	O
to	O
1	O
.	O
5	O
ng	O
/	O
ml	O
with	O
15	O
replicates	O
at	O
each	O
level	O
for	O
whole	B-T031
blood	I-T031
and	O
demonstrated	O
a	O
<	O
2	O
.	O
4	O
%	O
coefficient	O
of	O
variation	O
(	O
cv	O
)	O
.	O
in	O
urine	B-T031
,	O
the	O
cv	O
was	O
<	O
5	O
.	O
6	O
%	O
at	O
six	O
different	O
concentrations	O
from	O
0	O
.	O
5	O
to	O
7	O
.	O
5	O
ng	O
/	O
ml	O
with	O
15	O
replicates	O
at	O
each	O
level	O
.	O
cross	B-T038
-	I-T038
reactivity	I-T038
was	O
evaluated	B-T058
for	O
nor	B-T103
##fen	I-T103
##tan	I-T103
##yl	I-T103
,	O
acetyl	O
fentanyl	O
,	O
4	B-T103
-	I-T103
an	I-T103
##ilin	I-T103
##o	I-T103
-	I-T103
n	I-T103
-	I-T103
phen	I-T103
##ethyl	I-T103
##piper	I-T103
##idine	I-T103
,	O
beta	O
-	O
hydroxy	O
##thio	O
##fen	O
##tan	O
##yl	O
,	O
but	B-T103
##yryl	I-T103
fentanyl	I-T103
and	O
furan	B-T103
##yl	I-T103
fentanyl	I-T103
.	O

blood	B-T074
collection	I-T074
tubes	I-T074
and	O
storage	O
temperature	O
should	O
be	O
evaluated	O
when	O
using	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
for	O
measuring	B-T058
25	I-T058
-	I-T058
hydroxyvitamin	I-T058
d	I-T058
a	O
significant	O
bias	O
was	O
found	O
when	O
using	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
system	O
for	O
measurement	B-T058
of	I-T058
25	I-T058
-	I-T058
hydroxyvitamin	I-T058
d	I-T058
(	O
25	B-T103
##oh	I-T103
##d	I-T103
)	O
with	O
vacu	B-T074
##ette	I-T074
##®	I-T074
tubes	I-T074
with	I-T074
serum	I-T074
clot	I-T074
activator	I-T074
and	I-T074
gel	I-T074
.	O
here	O
,	O
we	O
examined	O
whether	O
other	O
commonly	O
used	O
tubes	B-T074
or	O
temperatures	O
affected	O
25	B-T058
##oh	I-T058
##d	I-T058
results	I-T058
obtained	O
with	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
system	O
.	O
serum	B-T031
was	O
collected	O
into	O
five	O
types	O
of	O
vacuum	B-T074
blood	I-T074
collection	I-T074
tubes	I-T074
from	O
three	O
manufacturers	O
,	O
and	O
25	B-T058
##oh	I-T058
##d	I-T058
was	I-T058
analyzed	I-T058
using	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
system	O
and	O
liquid	B-T058
chromatography	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
(	O
lc	B-T058
-	I-T058
ms	I-T058
/	I-T058
ms	I-T058
)	O
immediately	O
or	O
after	O
storage	O
at	O
4	O
##°c	O
or	O
-	O
80	O
##°c	O
for	O
48	O
h	O
.	O
significantly	O
higher	O
25	B-T058
##oh	I-T058
##d	I-T058
values	I-T058
were	O
found	O
when	O
using	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
system	O
with	O
vacu	B-T074
##ette	I-T074
##®	I-T074
tubes	I-T074
with	I-T074
serum	I-T074
clot	I-T074
activator	I-T074
and	I-T074
gel	I-T074
and	O
vacu	B-T074
##ette	I-T074
##®	I-T074
tubes	I-T074
with	I-T074
clot	I-T074
activator	I-T074
but	O
no	O
gel	O
compared	O
with	O
vacu	B-T074
##ette	I-T074
##®	I-T074
tubes	I-T074
with	O
no	O
additives	O
.	O
the	O
25	B-T058
##oh	I-T058
##d	I-T058
values	I-T058
in	O
all	O
of	O
these	O
tubes	O
were	O
not	O
significantly	O
different	O
from	O
those	O
obtained	O
by	O
lc	B-T058
-	I-T058
ms	I-T058
/	I-T058
ms	I-T058
.	O
moreover	O
,	O
after	O
storage	O
at	O
-	O
80	O
##°c	O
for	O
48	O
h	O
,	O
the	O
values	O
obtained	O
in	O
improve	B-T074
##vac	I-T074
##uter	I-T074
##®	I-T074
tubes	I-T074
with	I-T074
serum	I-T074
clot	I-T074
activator	I-T074
and	I-T074
ge	I-T074
l	O
significantly	O
increased	O
,	O
with	O
a	O
mean	O
bias	O
of	O
74	O
.	O
6	O
%	O
compared	O
with	O
the	O
values	O
before	O
storage	O
,	O
on	O
analysis	O
with	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
system	O
.	O
vacu	B-T074
##ette	I-T074
##®	I-T074
tubes	I-T074
containing	O
additives	O
significantly	O
affect	O
the	O
accuracy	O
of	O
25	B-T058
##oh	I-T058
##d	I-T058
results	I-T058
obtained	O
using	O
the	O
si	O
##eme	O
##ns	O
adv	O
##ia	O
cent	O
##au	O
##r	O
xp	O
system	O
.	O
additionally	O
,	O
the	O
composition	O
of	O
serum	B-T031
collected	O
in	O
improve	B-T074
##vac	I-T074
##uter	I-T074
##®	I-T074
tubes	I-T074
was	O
affected	O
by	O
freezing	O
,	O
resulting	O
in	O
different	O
measurements	O
when	O
using	O
the	O
si	O
##eme	O
##ns	O
25	B-T103
##oh	I-T103
##d	I-T103
assay	O
platform	O
.	O

spectral	B-T058
fingerprints	I-T058
of	O
large	O
-	O
scale	O
cortical	B-T017
dynamics	O
during	O
ambiguous	O
motion	B-T038
perception	I-T038
ambiguous	O
stimuli	O
have	O
been	O
widely	O
used	O
to	O
study	O
the	O
neuronal	B-T017
correlates	O
of	O
consciousness	B-T038
.	O
recently	O
,	O
it	O
has	O
been	O
suggested	O
that	O
conscious	B-T038
perception	B-T038
might	O
arise	O
from	O
the	O
dynamic	O
interplay	O
of	O
functionally	O
specialized	O
but	O
widely	O
distributed	O
cortical	B-T017
areas	I-T017
.	O
while	O
previous	O
research	O
mainly	O
focused	O
on	O
phase	B-T038
coupling	I-T038
as	O
a	O
correlate	O
of	O
cortical	B-T017
communication	O
,	O
more	O
recent	O
findings	O
indicated	O
that	O
additional	O
coupling	B-T038
modes	I-T038
might	O
coexist	O
and	O
possibly	O
subs	O
##erve	O
distinct	O
cortical	B-T038
functions	I-T038
.	O
here	O
,	O
we	O
studied	O
two	O
coupling	B-T038
modes	I-T038
,	O
namely	O
phase	B-T038
and	I-T038
envelope	I-T038
coupling	I-T038
,	O
which	O
might	O
differ	O
in	O
their	O
origins	O
,	O
putative	O
functions	O
and	O
dynamics	O
.	O
therefore	O
,	O
we	O
recorded	O
128	O
-	O
channel	O
eeg	B-T058
while	O
participants	B-T098
performed	O
a	O
bis	B-T058
##ta	I-T058
##ble	I-T058
motion	I-T058
task	I-T058
and	O
utilized	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
source	O
-	O
space	O
connectivity	O
analysis	B-T062
techniques	O
to	O
study	O
the	O
functional	O
relevance	O
of	O
different	O
coupling	B-T038
modes	I-T038
for	O
cortical	B-T017
communication	O
.	O
our	O
results	O
indicate	O
that	O
gamma	B-T038
-	I-T038
band	I-T038
phase	I-T038
coupling	I-T038
in	O
extras	O
##tri	O
##ate	O
visual	B-T017
cortex	I-T017
might	O
mediate	O
the	O
integration	O
of	O
visual	B-T058
to	I-T058
##ken	I-T058
##s	I-T058
into	O
a	O
moving	B-T038
stimulus	O
during	O
ambiguous	O
visual	B-T058
stimulation	I-T058
.	O
furthermore	O
,	O
our	O
results	O
suggest	O
that	O
long	O
-	O
range	O
fronto	O
-	O
occipital	O
gamma	O
-	O
band	O
envelope	B-T038
coupling	I-T038
sustain	O
##s	O
the	O
horizontal	O
percept	O
during	O
ambiguous	O
motion	B-T038
perception	I-T038
.	O
additionally	O
,	O
our	O
results	O
support	O
the	O
idea	O
that	O
local	B-T017
pari	I-T017
##eto	I-T017
-	I-T017
occipital	I-T017
alpha	B-T038
-	I-T038
band	I-T038
phase	I-T038
coupling	I-T038
controls	O
the	O
inter	O
-	O
hemispheric	B-T082
information	O
transfer	O
.	O
these	O
findings	O
provide	O
correl	O
##ative	O
evidence	O
for	O
the	O
notion	O
that	O
synchronized	O
oscillatory	O
brain	B-T038
activity	I-T038
reflects	O
the	O
processing	B-T038
of	I-T038
sensory	I-T038
input	O
as	O
well	O
as	O
the	O
information	B-T038
integration	I-T038
across	O
several	O
spatiotemporal	B-T062
scales	I-T062
.	O
the	O
results	O
indicate	O
that	O
distinct	O
coupling	O
modes	O
are	O
involved	O
in	O
different	O
cortical	B-T017
computations	O
and	O
that	O
the	O
rich	O
spatiotemporal	B-T062
correlation	I-T062
structure	B-T017
of	I-T017
the	I-T017
brain	I-T017
might	O
constitute	O
the	O
functional	O
architecture	O
for	O
cortical	B-T017
processing	O
and	O
specific	O
multi	O
-	O
site	O
communication	O
.	O
hum	O
brain	O
map	O
##p	O
37	O
:	O
40	O
##99	O
-	O
41	O
##11	O
,	O
2016	O
.	O
©	O
2016	O
wiley	O
periodicals	O
,	O
inc	O
.	O

reapp	O
##ra	O
##isal	O
modulates	O
attentional	B-T038
bias	I-T038
to	O
ang	B-T033
##ry	I-T033
faces	I-T033
heightened	O
attentional	B-T038
bias	I-T038
to	O
emotional	B-T033
information	O
is	O
one	O
of	O
the	O
main	O
characteristics	O
of	O
disorders	B-T038
related	O
to	O
emotion	B-T038
dysregulation	B-T038
such	O
as	O
anxiety	B-T038
,	O
depression	B-T038
,	O
and	O
substance	B-T038
abuse	I-T038
.	O
although	O
reapp	O
##ra	O
##isal	O
,	O
an	O
emotion	O
regulation	O
strategy	O
,	O
is	O
known	O
to	O
effectively	O
modulate	O
subjective	B-T038
experience	I-T038
of	O
emotions	B-T038
,	O
it	O
remains	O
unknown	O
whether	O
reapp	O
##ra	O
##isal	O
can	O
alter	O
attentional	B-T038
biases	I-T038
to	O
emotional	B-T033
information	O
.	O
in	O
the	O
current	O
research	B-T062
,	O
we	O
investigated	O
the	O
influence	O
of	O
instruction	O
-	O
induced	O
state	O
reapp	O
##ra	O
##isal	O
(	O
study	B-T062
1	I-T062
)	O
and	O
trait	O
reapp	O
##ra	O
##isal	O
(	O
study	B-T062
2	I-T062
)	O
on	O
attentional	B-T038
biases	I-T038
to	O
happy	B-T033
and	O
ang	B-T033
##ry	I-T033
faces	I-T033
.	O
in	O
study	B-T062
1	I-T062
,	O
healthy	O
young	B-T098
women	I-T098
were	O
recruited	O
and	O
randomly	O
assigned	O
to	O
one	O
of	O
the	O
three	O
groups	O
:	O
up	O
-	O
,	O
down	O
-	O
,	O
and	O
no	O
-	O
regulation	O
.	O
participants	B-T098
were	O
instructed	O
to	O
reapp	O
##ra	O
##ise	O
their	O
emotions	B-T038
to	O
increase	O
and	O
decrease	O
emotional	B-T033
experience	B-T038
while	O
viewing	O
an	O
emotionally	B-T170
negative	I-T170
film	I-T170
clip	I-T170
.	O
attentional	B-T038
bias	I-T038
was	O
assessed	O
with	O
a	O
dot	B-T058
-	I-T058
probe	I-T058
task	I-T058
with	O
pictures	O
of	O
ang	B-T038
##ry	I-T038
and	O
happy	B-T038
facial	B-T033
expressions	I-T033
.	O
in	O
study	B-T062
2	I-T062
,	O
a	O
separate	O
group	O
of	O
healthy	O
young	B-T098
men	I-T098
and	O
women	B-T098
participated	O
.	O
participants	B-T098
'	O
trait	O
reapp	O
##ra	O
##isal	O
and	O
suppression	B-T038
as	O
well	O
as	O
state	B-T038
and	O
trait	B-T033
anxiety	I-T033
were	O
assessed	O
.	O
a	O
dot	B-T058
-	I-T058
probe	I-T058
task	I-T058
was	O
completed	O
by	O
all	O
participants	B-T098
.	O
statistical	B-T170
tests	I-T170
in	O
study	B-T062
1	I-T062
revealed	O
that	O
participants	B-T098
who	O
reapp	O
##ra	O
##ised	O
to	O
decrease	O
negative	B-T038
emotions	I-T038
while	O
viewing	O
an	O
emotionally	B-T170
negative	I-T170
film	I-T170
clip	I-T170
had	O
reduced	O
attentional	B-T038
bias	I-T038
to	O
subsequently	O
presented	O
ang	B-T033
##ry	I-T033
faces	I-T033
compared	O
to	O
participants	B-T098
who	O
reapp	O
##ra	O
##ised	O
to	O
increase	O
negative	B-T038
emotions	I-T038
.	O
multiple	B-T170
regression	I-T170
analyses	I-T170
in	O
study	B-T062
2	I-T062
revealed	O
that	O
trait	O
reapp	O
##ra	O
##isal	O
predicted	O
slower	O
orienting	O
toward	O
ang	B-T033
##ry	I-T033
faces	I-T033
,	O
whereas	O
state	B-T038
anxiety	I-T038
predicted	O
slower	O
dise	O
##ng	O
##agement	O
from	O
ang	B-T033
##ry	I-T033
faces	I-T033
.	O
interestingly	O
,	O
trait	B-T038
suppression	I-T038
predicted	O
slower	O
dise	O
##ng	O
##agement	O
from	O
happy	B-T033
faces	I-T033
.	O
taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
both	O
instruction	O
-	O
induced	O
state	O
reapp	O
##ra	O
##isal	O
and	O
trait	O
reapp	O
##ra	O
##isal	O
are	O
linked	O
to	O
reduced	O
attentional	B-T038
bias	I-T038
to	O
negative	B-T033
information	O
and	O
contribute	O
to	O
better	O
understanding	O
of	O
how	O
everyday	O
emotion	O
regulation	O
styles	O
contribute	O
to	O
attentional	O
processing	O
of	O
emotional	B-T033
information	O
.	O

carbon	B-T103
monoxide	I-T103
improves	B-T033
efficacy	O
of	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
during	O
sepsis	B-T038
by	O
production	O
of	O
specialized	O
pro	B-T033
##res	I-T033
##ol	I-T033
##ving	I-T033
lipid	O
mediators	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
are	O
being	O
investigated	O
as	O
a	O
cell	B-T058
-	I-T058
based	I-T058
therapy	I-T058
for	O
a	O
number	O
of	O
disease	B-T038
processes	I-T038
,	O
with	O
promising	O
results	B-T033
in	O
animal	B-T204
models	I-T204
of	O
systemic	O
inflammation	O
and	O
sepsis	B-T038
.	O
studies	B-T062
are	O
ongoing	O
to	O
determine	O
ways	O
to	O
further	O
improve	B-T033
the	O
therapeutic	O
potential	O
of	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
.	O
a	O
gas	B-T103
molecule	O
that	O
improves	B-T033
outcome	O
in	O
experimental	O
sepsis	B-T038
is	O
carbon	B-T103
monoxide	I-T103
.	O
we	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
with	O
carbon	B-T103
monoxide	I-T103
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	B-T017
are	O
administered	O
in	B-T082
vivo	I-T082
after	O
the	O
onset	O
of	O
polym	B-T038
##ic	I-T038
##rob	I-T038
##ial	I-T038
sepsis	B-T038
in	O
mice	B-T204
.	O
animal	B-T204
study	I-T204
and	O
primary	B-T058
cell	I-T058
culture	I-T058
.	O
laboratory	B-T092
investigation	B-T058
.	O
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
.	O
polym	B-T038
##ic	I-T038
##rob	I-T038
##ial	I-T038
sepsis	B-T038
was	O
induced	O
by	O
cecal	B-T017
ligation	B-T058
and	O
puncture	B-T058
.	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
,	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
-	O
conditioned	O
with	O
carbon	B-T103
monoxide	I-T103
,	O
fibroblasts	B-T017
,	O
or	O
fibroblasts	B-T017
-	O
conditioned	O
with	O
carbon	B-T103
monoxide	I-T103
were	O
delivered	O
by	O
tail	B-T017
vein	I-T017
injections	B-T058
to	O
septic	O
mice	B-T204
.	O
the	O
mice	B-T204
were	O
assessed	O
for	O
survival	O
,	O
bacterial	O
clearance	O
,	O
and	O
the	O
inflammatory	B-T038
response	I-T038
during	O
sepsis	B-T038
in	O
each	O
of	O
the	O
groups	O
.	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	B-T038
by	O
neutrophils	B-T017
,	O
the	O
production	O
of	O
specialized	O
pro	B-T033
##res	I-T033
##ol	I-T033
##ving	I-T033
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
function	B-T038
using	O
gene	B-T038
silencing	I-T038
.	O
ex	O
vivo	O
preconditioning	O
with	O
carbon	B-T103
monoxide	I-T103
allowed	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
to	O
be	O
administered	O
later	O
after	O
the	O
onset	O
of	O
sepsis	B-T038
(	O
6	O
hr	O
)	O
,	O
and	O
yet	O
maintain	O
their	O
therapeutic	B-T201
effect	I-T201
with	O
increased	O
survival	O
.	O
carbon	B-T103
monoxide	I-T103
precondition	O
##ed	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
were	O
also	O
able	O
to	O
alleviate	O
organ	B-T037
injury	I-T037
,	O
improve	B-T033
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	B-T038
of	O
inflammation	B-T038
.	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
exposed	O
to	O
carbon	B-T103
monoxide	I-T103
,	O
with	O
docosahexaenoic	B-T103
acid	I-T103
substrate	O
,	O
produced	O
specialized	O
pro	B-T033
##res	I-T033
##ol	I-T033
##ving	I-T033
lipid	O
mediators	O
,	O
particularly	O
d	O
-	O
series	O
resol	B-T103
##vin	I-T103
##s	I-T103
,	O
which	O
promoted	O
survival	O
.	O
silencing	B-T038
of	O
lipoxygenase	B-T038
pathways	I-T038
(	O
5	B-T038
-	I-T038
lipoxygenase	I-T038
and	O
12	B-T038
/	O
15	B-T038
-	I-T038
lipoxygenase	I-T038
)	O
,	O
which	O
are	O
important	O
enzymes	B-T103
for	O
specialized	O
pro	B-T033
##res	I-T033
##ol	I-T033
##ving	I-T033
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
best	O
##owed	O
on	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
by	O
carbon	B-T103
monoxide	I-T103
.	O
taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
pro	B-T033
##res	I-T033
##ol	I-T033
##ving	I-T033
lipid	O
mediators	O
contribute	O
to	O
improved	B-T033
mesenchymal	B-T017
stromal	I-T017
cell	I-T017
efficacy	O
when	O
exposed	O
to	O
carbon	B-T103
monoxide	I-T103
,	O
resulting	O
in	O
an	O
improved	B-T033
therapeutic	B-T201
response	I-T201
during	O
sepsis	B-T038
.	O

high	O
-	O
throughput	O
genotyping	B-T058
with	O
taqman	B-T058
allelic	I-T058
discrimination	I-T058
and	O
allele	B-T058
-	I-T058
specific	I-T058
genotyping	I-T058
assays	I-T058
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
-	O
based	O
genotyping	B-T058
methods	I-T058
,	O
such	O
as	O
taqman	B-T058
allelic	I-T058
discrimination	I-T058
assays	I-T058
and	O
allele	B-T058
-	I-T058
specific	I-T058
genotyping	I-T058
,	O
are	O
particularly	O
useful	O
when	O
screening	B-T058
a	O
hand	O
##ful	O
of	O
single	B-T082
nucleotide	I-T082
polymorphisms	I-T082
in	O
hundreds	O
of	O
samples	O
;	O
either	O
derived	O
from	O
different	O
individuals	B-T098
,	O
tissues	B-T017
,	O
or	O
pre	O
-	O
amplified	B-T038
dna	I-T038
.	O
although	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
-	O
based	O
methods	B-T170
such	O
as	O
taqman	B-T058
are	O
well	O
-	O
established	O
,	O
alternative	O
methods	B-T170
,	O
like	O
allele	B-T058
-	I-T058
specific	I-T058
genotyping	I-T058
,	O
are	O
powerful	O
alternatives	O
,	O
especially	O
for	O
genotyping	B-T058
short	B-T103
tandem	I-T103
repeat	I-T103
(	B-T103
str	I-T103
)	I-T103
length	O
polymorphisms	B-T038
.	O
here	O
,	O
we	O
describe	O
all	O
relevant	O
aspects	O
when	O
developing	O
an	O
assay	B-T058
for	O
a	O
new	O
snp	B-T082
or	O
str	B-T103
using	O
either	O
taqman	B-T058
or	O
allele	B-T058
-	I-T058
specific	I-T058
genotyping	I-T058
,	O
respectively	O
,	O
such	O
as	O
primer	B-T103
and	O
probe	B-T103
design	O
,	O
optimization	O
of	O
reaction	O
conditions	O
,	O
the	O
experimental	B-T058
procedure	I-T058
for	I-T058
typing	I-T058
hundreds	O
of	O
samples	O
,	O
and	O
finally	O
the	O
data	O
evaluation	B-T058
.	O
our	O
goal	B-T170
is	O
to	O
provide	O
a	O
guideline	B-T170
for	O
developing	O
genotyping	B-T058
assays	I-T058
using	O
these	O
two	O
approaches	O
that	O
render	O
reliable	O
and	O
reproducible	O
genotype	B-T058
calls	I-T058
involving	O
minimal	O
optimization	O
.	O

opportunities	O
for	O
genomic	B-T017
prediction	O
for	O
fertility	B-T038
using	O
endocrine	B-T022
and	O
classical	O
fertility	B-T038
traits	O
in	O
dairy	B-T204
cattle	I-T204
endocrine	B-T022
fertility	B-T038
traits	O
,	O
defined	O
from	O
progesterone	B-T103
concentration	O
levels	O
in	O
milk	B-T031
,	O
have	O
been	O
suggested	O
as	O
alternative	O
indicators	O
for	O
fertility	B-T038
in	O
dairy	B-T204
cows	I-T204
because	O
they	O
are	O
less	O
biased	O
by	O
farm	B-T082
management	O
decisions	B-T038
and	O
more	O
directly	O
reflect	O
a	O
cow	B-T204
'	O
s	O
reproductive	B-T038
physiology	B-T038
than	O
classical	O
traits	O
derived	O
from	O
insemination	B-T038
and	O
calving	O
data	O
.	O
to	O
determine	O
the	O
potential	O
use	O
of	O
endocrine	B-T022
fertility	B-T038
traits	O
in	O
genomic	B-T017
evaluations	B-T062
,	O
the	O
improvement	O
in	O
accuracy	O
from	O
using	O
endocrine	B-T022
fertility	B-T038
traits	O
concurrent	O
with	O
classical	O
traits	O
in	O
the	O
genomic	B-T017
prediction	O
of	O
fertility	B-T038
was	O
quantified	O
.	O
the	O
impact	O
of	O
recording	O
all	O
traits	O
on	O
all	O
training	O
animals	B-T204
was	O
also	O
investigated	O
.	O
endocrine	B-T022
and	O
classical	O
fertility	B-T038
records	O
were	O
available	O
on	O
5	O
,	O
339	O
lactation	B-T038
##s	I-T038
from	O
2	O
,	O
44	O
##7	O
holstein	B-T204
cows	I-T204
in	O
ireland	B-T082
,	O
the	O
netherlands	B-T082
,	O
sweden	B-T082
,	O
and	O
the	O
united	B-T082
kingdom	I-T082
.	O
the	O
endocrine	B-T022
traits	O
were	O
comm	O
##ence	O
##ment	O
of	O
luteal	O
activity	O
(	O
c	O
-	O
la	O
)	O
and	O
proportion	O
of	O
samples	O
with	O
luteal	O
activity	O
(	O
pla	O
)	O
;	O
the	O
classical	O
trait	O
was	O
the	O
interval	O
from	O
calving	O
to	O
first	O
service	O
(	O
cfs	O
)	O
.	O
the	O
interval	O
from	O
c	O
-	O
la	O
to	O
first	O
service	O
(	O
c	O
-	O
la	O
##fs	O
)	O
,	O
which	O
is	O
a	O
combination	O
of	O
an	O
endocrine	B-T022
trait	O
and	O
a	O
classical	O
trait	O
,	O
was	O
also	O
investigated	O
.	O
the	O
target	O
(	O
breeding	O
goal	O
)	O
trait	O
for	O
fertility	B-T038
was	O
cfs	O
or	O
c	O
-	O
la	O
##fs	O
,	O
whereas	O
c	O
-	O
la	O
and	O
pla	O
served	O
as	O
predictor	O
traits	O
.	O
genomic	B-T017
ebv	I-T017
(	O
ge	B-T017
##bv	I-T017
)	O
for	O
fertility	B-T038
were	O
derived	O
using	O
genomic	B-T062
blu	I-T062
##p	I-T062
in	O
bivariate	O
models	O
with	O
85	O
,	O
48	O
##5	O
snp	B-T082
.	O
genomic	O
ebv	O
for	O
the	O
separate	O
fertility	B-T038
traits	O
were	O
also	O
computed	O
,	O
in	O
univariate	O
models	O
.	O
the	O
accuracy	O
of	O
ge	B-T017
##bv	I-T017
was	O
evaluated	O
by	O
5	O
-	O
fold	O
cross	B-T062
-	I-T062
validation	I-T062
.	O
the	O
highest	O
accuracy	O
of	O
ge	B-T017
##bv	I-T017
was	O
achieved	O
using	O
bivariate	O
predictions	O
,	O
where	O
both	O
an	O
endocrine	B-T022
fertility	B-T038
trait	O
and	O
the	O
classical	O
fertility	B-T038
trait	O
were	O
used	O
.	O
accuracy	O
of	O
ge	B-T017
##bv	I-T017
for	O
predicting	O
adjusted	O
phenotypes	O
for	O
cfs	O
in	O
the	O
univariate	O
model	O
was	O
0	O
.	O
04	O
,	O
but	O
when	O
predicting	O
cfs	O
using	O
a	O
bivariate	O
model	O
with	O
c	O
-	O
la	O
,	O
the	O
accuracy	O
increased	O
to	O
0	O
.	O
14	O
when	O
all	O
training	B-T204
animals	I-T204
were	O
phenotype	O
##d	O
for	O
c	O
-	O
la	O
and	O
(	O
or	O
not	O
)	O
for	O
cfs	O
.	O
on	O
phenotyping	O
all	O
training	B-T204
animals	I-T204
for	O
both	O
c	O
-	O
la	O
and	O
cfs	O
,	O
accuracy	O
for	O
cfs	O
increased	O
to	O
0	O
.	O
18	O
;	O
however	O
,	O
when	O
validation	B-T062
animals	B-T204
were	O
also	O
phenotype	O
##d	O
for	O
c	O
-	O
la	O
,	O
there	O
was	O
no	B-T033
substantial	O
increase	O
in	O
accuracy	O
.	O
when	O
predicting	O
cfs	O
in	O
bivariate	O
analysis	O
with	O
pla	O
,	O
accuracy	O
ranged	O
from	O
0	O
.	O
07	O
to	O
0	O
.	O
14	O
.	O
this	O
first	O
study	B-T062
on	O
genomic	B-T017
predictions	O
for	O
fertility	B-T038
using	O
endocrine	B-T022
traits	O
suggests	O
some	O
improvement	O
in	O
the	O
accuracy	O
of	O
prediction	O
over	O
using	O
only	O
the	O
classical	O
traits	O
.	O
further	O
studies	B-T062
with	O
larger	O
training	B-T098
populations	I-T098
may	O
show	O
greater	O
improvements	O
.	O

questionable	O
diagnostic	O
benefit	O
of	O
the	O
commercially	O
available	O
panel	O
of	O
bee	B-T103
venom	I-T103
components	O
for	O
many	O
years	O
,	O
only	O
the	O
major	O
allergen	B-T103
rap	B-T103
##i	I-T103
m	I-T103
1	I-T103
has	O
been	O
available	O
on	O
the	O
immuno	B-T170
##cap	I-T170
system	I-T170
for	O
routine	O
diagnosis	B-T033
of	O
bee	B-T038
venom	I-T038
(	I-T038
bv	I-T038
)	I-T038
allergy	I-T038
.	O
now	O
,	O
there	O
are	O
five	O
components	O
available	O
,	O
and	O
we	O
aimed	O
to	O
detect	O
the	O
sensitivity	O
and	O
specificity	O
of	O
rap	B-T103
##i	I-T103
m	I-T103
1	I-T103
,	O
2	B-T103
,	O
3	B-T103
,	O
5	B-T103
,	O
and	O
10	B-T103
in	O
bv	B-T038
-	I-T038
allergic	I-T038
patients	O
.	O
we	O
further	O
evaluated	O
the	O
sensitivity	O
of	O
rap	B-T103
##i	I-T103
m	I-T103
1	I-T103
and	O
2	B-T103
of	O
an	O
alternative	O
platform	O
and	O
investigated	O
possible	O
differences	O
in	O
the	O
sensitization	B-T038
profile	O
between	O
monos	B-T038
##ens	I-T038
##itization	I-T038
and	O
clinically	O
relevant	O
double	B-T038
sensitization	I-T038
.	O
analysis	B-T062
of	O
the	O
whole	O
panel	O
of	O
bv	B-T103
allergens	B-T103
of	O
the	O
cap	B-T170
system	I-T170
still	O
resulted	O
in	O
a	O
lower	O
sensitivity	O
than	O
analysis	B-T062
of	O
the	O
combination	O
of	O
rap	B-T103
##i	I-T103
m	I-T103
1	I-T103
and	O
2	B-T103
of	O
the	O
imm	O
##uli	O
##te	O
(	O
71	O
.	O
6	O
%	O
vs	O
85	O
.	O
8	O
%	O
)	O
.	O
sensitization	B-T038
rate	O
of	O
rap	B-T103
##i	I-T103
m	I-T103
5	I-T103
was	O
more	O
than	O
doubled	O
in	O
double	B-T038
-	I-T038
sensitized	I-T038
patients	O
,	O
while	O
there	O
was	O
no	O
difference	O
for	O
rap	B-T103
##i	I-T103
m	I-T103
2	I-T103
.	O
the	O
benefit	O
of	O
the	O
commercially	O
available	O
panel	O
of	O
bv	B-T103
components	O
is	O
questionable	O
,	O
due	O
to	O
the	O
insufficient	O
sensitivity	O
and	O
still	O
unavailable	O
important	O
cross	B-T038
-	I-T038
reacting	I-T038
allergens	B-T103
.	O

a	O
trial	B-T062
to	O
determine	O
whether	O
septic	B-T038
shock	I-T038
-	O
reversal	O
is	O
quick	O
##er	O
in	O
pediatric	O
patients	O
randomized	B-T062
to	O
an	O
early	O
goal	B-T058
-	I-T058
directed	I-T058
fluid	I-T058
-	I-T058
sparing	I-T058
strategy	I-T058
versus	O
usual	O
care	O
(	O
squ	B-T062
##ee	I-T062
##ze	I-T062
)	O
:	O
study	B-T170
protocol	I-T170
for	O
a	O
pilot	B-T062
randomized	I-T062
controlled	I-T062
trial	I-T062
current	O
pediatric	O
septic	B-T038
shock	I-T038
resuscitation	B-T058
guidelines	B-T170
from	O
the	O
american	B-T092
college	I-T092
of	I-T092
critical	I-T092
care	I-T092
medicine	I-T092
focus	O
on	O
the	O
early	O
and	O
goal	B-T058
-	I-T058
directed	I-T058
administration	I-T058
of	O
intravascular	B-T082
fluid	B-T031
followed	O
by	O
vasoactive	O
medication	B-T103
infusions	B-T058
for	O
persistent	O
and	O
fluid	B-T038
-	I-T038
refractory	I-T038
shock	I-T038
.	O
however	O
,	O
accumulating	B-T033
adult	O
and	O
pediatric	O
data	O
suggest	O
that	O
excessive	O
fluid	B-T058
administration	I-T058
is	O
associated	O
with	O
worse	B-T033
patient	O
outcomes	O
and	O
even	O
increased	B-T033
risk	I-T033
of	I-T033
death	I-T033
.	O
the	O
optimal	O
amount	O
of	O
intravascular	B-T082
fluid	B-T031
required	O
in	O
early	O
pediatric	O
septic	B-T038
shock	I-T038
resuscitation	B-T058
prior	O
to	O
the	O
initiation	O
of	O
vasoactive	O
support	O
remains	O
un	O
##answ	O
##ered	O
.	O
the	O
squ	B-T062
##ee	I-T062
##ze	I-T062
pilot	I-T062
trial	I-T062
is	O
a	O
pragmatic	O
,	O
two	B-T062
-	I-T062
arm	I-T062
,	O
parallel	B-T062
-	I-T062
group	I-T062
,	O
open	B-T062
-	I-T062
label	I-T062
,	O
prospective	B-T062
pilot	I-T062
randomized	I-T062
controlled	I-T062
trial	I-T062
.	O
participants	B-T098
are	O
children	O
aged	O
29	O
days	O
to	O
under	O
18	O
years	O
with	O
suspected	O
or	O
confirmed	B-T033
septic	B-T038
shock	I-T038
and	O
a	O
need	O
for	O
ongoing	O
resuscitation	B-T058
.	O
eligible	O
participants	B-T098
are	O
enrolled	B-T058
under	O
an	O
exception	O
to	O
consent	O
process	O
and	O
randomly	O
assigned	O
via	O
conceal	O
##ed	O
allocation	O
to	O
either	O
the	O
usual	O
care	O
(	O
control	O
)	O
or	O
fluid	B-T058
sparing	I-T058
(	I-T058
intervention	I-T058
)	I-T058
resuscitation	I-T058
strategy	I-T058
.	O
the	O
primary	O
objective	B-T170
of	O
this	O
pilot	B-T062
trial	I-T062
is	O
to	O
determine	O
feasibility	B-T062
,	O
based	O
on	O
the	O
ability	O
to	O
enroll	B-T058
participants	B-T098
and	O
to	O
adhere	O
to	O
the	O
study	B-T170
protocol	I-T170
.	O
the	O
primary	O
outcome	O
measure	O
by	O
which	O
success	O
will	O
be	O
determined	O
is	O
participant	B-T098
enrollment	B-T058
rate	O
(	O
[UNK]	O
pass	O
[UNK]	O
defined	O
as	O
at	O
least	O
two	O
participants	B-T098
/	O
site	B-T082
/	O
month	O
,	O
recognizing	O
that	O
enrollment	B-T058
may	O
be	O
slower	O
during	O
the	O
run	O
-	O
in	O
phase	O
)	O
.	O
secondary	O
objectives	B-T170
include	O
assessing	O
(	O
1	O
)	O
appropriateness	O
of	O
eligibility	O
criteria	O
,	O
and	O
(	O
2	O
)	O
completeness	O
of	O
clinical	O
outcomes	O
to	O
inform	O
the	O
endpoints	O
for	O
the	O
planned	O
multis	B-T062
##ite	I-T062
trial	I-T062
.	O
to	O
support	O
the	O
nested	B-T062
translational	I-T062
study	I-T062
,	O
squ	B-T062
##ee	I-T062
##ze	I-T062
-	I-T062
d	I-T062
,	O
we	O
will	O
also	O
evaluate	O
the	O
feasibility	B-T062
of	O
describing	O
cell	B-T103
-	I-T103
free	I-T103
dna	I-T103
(	O
a	O
procoagulant	B-T103
molecule	I-T103
with	O
prognostic	B-T170
utility	I-T170
)	O
in	O
blood	B-T031
samples	I-T031
obtained	O
from	O
children	O
enrolled	B-T058
into	O
the	O
squ	B-T062
##ee	I-T062
##ze	I-T062
pilot	I-T062
trial	I-T062
at	O
baseline	O
and	O
at	O
24	O
h	O
.	O
the	O
optimal	O
degree	O
of	O
fluid	B-T031
resuscitation	B-T058
and	O
the	O
timing	O
of	O
initiation	O
of	O
vasoactive	O
support	O
in	O
order	O
to	O
achieve	O
recommended	O
therapeutic	O
targets	O
in	O
children	O
with	O
septic	B-T038
shock	I-T038
remains	O
un	O
##answ	O
##ered	O
.	O
no	O
prospective	B-T062
study	I-T062
to	O
date	O
has	O
examined	O
this	O
important	O
question	B-T170
for	O
children	O
in	O
developed	O
countries	O
including	O
canada	B-T082
.	O
recruitment	O
for	O
the	O
squ	B-T062
##ee	I-T062
##ze	I-T062
pilot	I-T062
trial	I-T062
opened	O
on	O
6	O
january	O
2014	O
.	O
findings	B-T033
will	O
inform	O
the	O
feasibility	B-T062
of	O
the	O
planned	O
multicenter	B-T062
trial	I-T062
to	O
answer	O
our	O
overall	O
research	O
question	O
.	O
clinicaltrials	O
.	O
gov	O
identifier	O
nct0	O
##19	O
##73	O
##90	O
##7	O
,	O
registered	O
on	O
23	O
october	O
2013	O
.	O

multidrug	O
resistance	O
of	O
acinetobacter	B-T007
baumannii	I-T007
in	O
lad	B-T092
##oke	I-T092
aki	I-T092
##nt	I-T092
##ola	I-T092
university	I-T092
teaching	I-T092
hospital	I-T092
,	O
os	B-T082
##og	I-T082
##bo	I-T082
,	I-T082
nigeria	I-T082
acinetobacter	B-T007
baumannii	I-T007
is	O
a	O
ubiquitous	O
pathogen	O
that	O
has	O
emerged	O
as	O
a	O
major	O
cause	O
of	O
healthcare	B-T038
-	I-T038
associated	I-T038
infections	I-T038
at	O
lad	B-T092
##oke	I-T092
aki	I-T092
##nt	I-T092
##ola	I-T092
university	I-T092
teaching	I-T092
hospital	I-T092
.	O
isolates	B-T103
were	O
assayed	B-T058
according	O
to	O
standard	B-T170
protocol	I-T170
.	O
the	O
isolates	B-T103
were	O
subjected	O
to	O
molecular	B-T062
techniques	I-T062
to	O
detect	O
bla	B-T017
##ox	I-T017
##a	I-T017
,	I-T017
bla	I-T017
##te	I-T017
##m	I-T017
,	I-T017
bla	I-T017
##ct	I-T017
##x	I-T017
-	I-T017
m	I-T017
,	I-T017
and	I-T017
bla	I-T017
##sh	I-T017
##v	I-T017
genes	I-T017
in	O
strains	B-T007
of	O
the	O
a	B-T007
.	I-T007
baumannii	I-T007
isolates	B-T103
.	O
the	O
prevalence	O
of	O
a	B-T007
.	I-T007
baumannii	I-T007
was	O
8	O
.	O
5	O
%	O
and	O
was	O
most	O
prevalent	O
among	O
patients	O
in	O
the	O
age	O
group	O
51	O
-	O
60	O
(	O
36	O
%	O
)	O
;	O
the	O
male	O
patients	O
(	O
63	O
.	O
6	O
%	O
)	O
were	O
more	O
infected	B-T033
than	O
their	O
female	O
counterparts	O
.	O
patients	O
(	O
72	O
.	O
7	O
%	O
)	O
in	O
the	O
intensive	B-T092
care	I-T092
unit	I-T092
(	O
icu	B-T092
)	O
were	O
most	O
infected	B-T033
with	O
this	O
organism	O
.	O
the	O
isolates	B-T103
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	B-T103
and	O
ciprofloxacin	B-T103
and	O
90	O
.	O
9	O
%	O
to	O
both	O
ceftriaxone	B-T103
and	O
ceftazidime	B-T103
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	B-T103
used	O
in	O
this	O
study	B-T062
were	O
:	O
piperacillin	B-T103
(	O
81	O
.	O
8	O
%	O
)	O
,	O
imipenem	B-T103
(	O
72	O
.	O
7	O
%	O
)	O
,	O
gent	B-T103
##amycin	I-T103
(	O
72	O
.	O
2	O
%	O
)	O
,	O
and	O
meropenem	B-T103
(	O
63	O
.	O
6	O
%	O
)	O
.	O
none	O
of	O
the	O
isolates	B-T103
was	O
,	O
however	O
,	O
resistant	O
to	O
colistin	B-T103
.	O
pcr	B-T062
results	B-T033
showed	O
that	O
bla	B-T017
##ox	I-T017
##a	I-T017
,	I-T017
bla	I-T017
##te	I-T017
##m	I-T017
,	I-T017
and	I-T017
bla	I-T017
##ct	I-T017
##x	I-T017
-	I-T017
m	I-T017
genes	I-T017
were	O
positive	B-T033
in	O
some	O
isolates	B-T103
,	O
while	O
bla	B-T017
##sh	I-T017
##v	I-T017
was	O
not	B-T033
detected	I-T033
in	O
any	O
of	O
the	O
isolates	B-T103
.	O
this	O
study	B-T062
has	O
revealed	O
that	O
the	O
strains	B-T007
of	O
a	B-T007
.	I-T007
baumannii	I-T007
isolated	O
are	O
multiple	O
drug	O
resistant	O
.	O
regular	O
monitoring	B-T058
,	O
jud	O
##icious	O
prescription	B-T058
,	O
and	O
early	O
detection	B-T058
of	O
resistance	O
to	O
these	O
antibiotics	B-T103
are	O
,	O
therefore	O
,	O
necessary	O
to	O
check	O
further	O
dissemination	O
of	O
the	O
organism	O
.	O

identification	O
of	O
potential	O
predictive	O
markers	O
of	O
dexamethasone	B-T103
resistance	B-T038
in	O
childhood	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
response	B-T038
to	O
dexamethasone	B-T103
(	O
dex	B-T103
##a	I-T103
)	O
,	O
as	O
a	O
hallmark	B-T103
drug	I-T103
in	O
the	O
treatment	O
of	O
childhood	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
(	O
all	B-T038
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	B-T201
factors	I-T201
in	O
the	O
prediction	B-T058
of	I-T058
outcome	I-T058
in	O
all	B-T038
.	O
identification	O
of	O
predictive	O
markers	O
of	O
chemo	B-T038
##res	I-T038
##istan	I-T038
##ce	I-T038
is	O
beneficial	O
to	O
selecting	O
of	O
the	O
best	O
therapeutic	B-T058
protocol	I-T058
with	O
the	O
lowest	O
effect	B-T038
adverse	I-T038
.	O
hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	B-T074
targets	I-T074
using	O
the	O
2d	B-T058
##e	I-T058
/	O
ms	B-T058
proteomics	B-T058
study	I-T058
of	O
a	O
dex	B-T103
##a	I-T103
-	O
resistant	B-T017
cell	I-T017
line	I-T017
(	O
reh	B-T017
)	O
as	O
a	O
model	O
for	O
poor	O
dex	B-T103
##a	I-T103
responding	O
patients	O
before	O
and	O
after	O
drug	B-T058
treatment	I-T058
.	O
using	O
the	O
proteomic	B-T058
methods	I-T058
,	O
three	O
differentially	O
expressed	B-T038
proteins	B-T103
were	O
detected	B-T033
,	O
including	O
voltage	B-T103
dependent	I-T103
anion	I-T103
channel	I-T103
1	I-T103
(	O
vd	B-T103
##ac	I-T103
##1	I-T103
)	O
,	O
sorting	B-T103
ne	I-T103
##xin	I-T103
3	I-T103
(	O
sn	B-T103
##x3	I-T103
)	O
,	O
and	O
pref	B-T103
##old	I-T103
##in	I-T103
subunit	I-T103
6	I-T103
(	O
pf	B-T103
##d	I-T103
##n	I-T103
##6	I-T103
)	O
.	O
we	O
observed	O
low	O
expression	B-T038
of	O
three	O
proteins	B-T103
after	O
dex	B-T103
##a	I-T103
treatment	O
in	O
reh	B-T017
cells	I-T017
.	O
we	O
subsequently	O
verified	O
low	O
expression	B-T038
of	O
resulted	O
proteins	B-T103
at	O
the	O
mrna	B-T103
level	O
using	O
the	O
quantitative	B-T058
pcr	I-T058
method	I-T058
.	O
these	O
proteins	B-T103
are	O
promising	O
proteins	B-T103
because	O
of	O
their	O
important	O
roles	O
in	O
drug	B-T038
resistance	I-T038
and	O
regulation	B-T038
of	I-T038
apoptosis	I-T038
(	O
vd	B-T103
##ac	I-T103
##1	I-T103
)	O
,	O
protein	B-T038
trafficking	I-T038
(	O
sn	B-T103
##x3	I-T103
)	O
,	O
and	O
protein	B-T038
folding	I-T038
(	O
pf	B-T103
##d	I-T103
##n	I-T103
##6	I-T103
)	O
.	O
additionally	O
,	O
mrna	B-T103
expression	O
level	O
of	O
these	O
proteins	B-T103
was	O
assessed	O
in	O
17	O
bone	B-T031
marrow	I-T031
samples	I-T031
from	O
children	O
with	O
newly	O
diagnosed	O
all	B-T038
and	O
7	O
non	O
-	O
cancerous	O
samples	O
as	O
controls	O
.	O
the	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	B-T170
subtypes	I-T170
of	O
leukemia	B-T038
,	O
mrna	B-T103
expression	B-T038
of	O
vd	B-T103
##ac	I-T103
##1	I-T103
,	O
sn	B-T103
##x3	I-T103
,	O
and	O
pf	B-T103
##d	I-T103
##n	I-T103
##6	I-T103
decreased	O
in	O
all	B-T038
samples	O
compared	O
with	O
non	O
-	O
cancerous	O
samples	O
particularly	O
in	O
vd	B-T103
##ac	I-T103
##1	I-T103
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
additionally	O
,	O
mrna	B-T103
expression	B-T038
of	O
three	O
proteins	B-T103
was	O
also	O
declined	O
in	O
high	B-T033
-	I-T033
risk	I-T033
samples	O
compared	O
with	O
standard	O
risk	O
cases	O
.	O
these	O
results	O
demonstrated	O
diagnostic	O
and	O
prognostic	B-T170
value	O
of	O
these	O
proteins	B-T103
in	O
childhood	O
all	B-T038
.	O
furthermore	O
,	O
investigation	B-T058
of	O
protein	B-T038
-	I-T038
protein	I-T038
interaction	I-T038
using	O
string	B-T170
database	B-T170
indicated	O
that	O
these	O
proteins	B-T103
involved	O
in	O
the	O
signaling	B-T038
pathway	I-T038
of	O
nr	B-T103
##3c	I-T103
##1	I-T103
as	O
dexamethasone	B-T103
target	B-T033
.	O
in	O
conclusion	O
,	O
our	O
proteomic	B-T058
study	I-T058
in	O
dex	B-T103
##a	I-T103
resistant	B-T038
leukemic	B-T017
cells	I-T017
revealed	O
vd	B-T103
##ac	I-T103
##1	I-T103
,	O
sn	B-T103
##x3	I-T103
,	O
and	O
pf	B-T103
##d	I-T103
##n	I-T103
##6	I-T103
are	O
promising	O
proteins	B-T103
that	O
might	O
serve	O
as	O
potential	O
biomarkers	B-T201
of	O
prognosis	B-T058
and	O
chemotherapy	B-T058
in	O
childhood	O
all	B-T038
.	O

association	O
between	O
neutrophil	B-T017
-	O
to	O
-	O
lymphocyte	B-T017
ratio	O
and	O
differentiated	B-T038
thyroid	I-T038
cancer	I-T038
:	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
the	O
association	O
between	O
neutrophil	B-T017
-	O
to	O
-	O
lymphocyte	B-T017
ratio	O
(	O
nlr	O
)	O
and	O
differentiated	B-T038
thyroid	I-T038
cancer	I-T038
(	O
dtc	B-T038
)	O
is	O
und	O
##ec	O
##ided	O
.	O
to	O
rectif	O
##y	O
this	O
question	O
,	O
we	O
conducted	O
a	O
systematic	O
meta	B-T062
-	I-T062
analysis	I-T062
based	O
on	O
7	O
prospective	B-T062
cohort	I-T062
studies	I-T062
published	B-T170
between	O
2013	O
and	O
2015	O
,	O
comprising	O
73	O
##49	O
patients	O
.	O
six	O
of	O
these	O
cohorts	B-T098
included	O
pretreatment	O
(	O
baseline	O
)	O
nlr	O
data	O
for	O
patients	O
with	O
thyroid	B-T038
nodules	I-T038
.	O
the	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
these	O
6	O
cohorts	B-T098
showed	O
that	O
the	O
nlr	O
of	O
patients	O
with	O
dtc	B-T038
(	O
46	O
##17	O
cases	O
)	O
was	O
statistically	O
similar	O
to	O
patients	O
with	O
benign	B-T038
nodules	I-T038
only	O
(	O
166	O
##6	O
cases	O
)	O
,	O
with	O
a	O
mean	O
difference	O
(	O
md	O
)	O
of	O
0	O
.	O
19	O
(	O
95	O
%	O
ci	O
:	O
-	O
0	O
.	O
09	O
to	O
0	O
.	O
46	O
;	O
i	O
(	O
2	O
)	O
=	O
93	O
%	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
no	O
significant	O
difference	O
in	O
nlr	O
was	O
found	O
between	O
patients	O
with	O
dtc	B-T038
and	O
patients	O
with	O
benign	B-T038
nodules	I-T038
.	O
two	O
studies	B-T058
addressed	O
an	O
association	O
between	O
nlr	O
and	O
papillary	B-T038
thyroid	I-T038
carcinoma	I-T038
in	O
patients	O
stratified	O
by	O
age	O
<	O
45	O
and	O
≥	O
##45	O
years	O
(	O
49	O
##6	O
and	O
89	O
##1	O
cases	O
,	O
respectively	O
)	O
;	O
the	O
pooled	O
md	O
was	O
0	O
.	O
09	O
(	O
95	O
%	O
ci	O
:	O
-	O
0	O
.	O
37	O
to	O
0	O
.	O
55	O
;	O
i	O
(	O
2	O
)	O
=	O
92	O
.	O
2	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
an	O
elevated	O
nlr	O
seems	O
not	O
a	O
reliable	O
indicator	O
of	O
progressing	O
dtc	B-T038
in	O
patients	O
with	O
goiter	B-T038
##s	I-T038
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
nlr	O
between	O
patients	O
aged	O
<	O
45	O
years	O
and	O
those	O
aged	O
≥	O
##45	O
years	O
.	O
well	O
-	O
designed	O
and	O
large	O
-	O
scale	O
investigations	B-T058
are	O
warranted	O
to	O
understand	O
the	O
value	O
of	O
nlr	O
in	O
the	O
prognosis	B-T033
of	O
dtc	B-T038
.	O

silent	O
strain	O
of	O
caregiving	O
:	O
exploring	O
the	O
best	B-T033
predictors	I-T033
of	O
distress	B-T033
in	O
family	O
carers	O
of	O
geriatric	O
patients	O
the	O
aim	O
of	O
this	O
article	O
was	O
to	O
identify	O
the	O
best	B-T033
predictors	I-T033
of	O
distress	B-T033
suffered	I-T033
by	O
family	O
carers	O
(	O
fcs	O
)	O
of	O
geriatric	O
patients	O
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
of	O
100	O
fc	O
-	O
geriatric	O
patient	O
dyads	O
was	O
conducted	O
.	O
the	O
negative	B-T033
impact	I-T033
of	I-T033
care	I-T033
(	O
ni	B-T033
##oc	I-T033
)	O
subscale	O
of	O
the	O
cope	O
index	O
was	O
dichotom	O
##ized	O
to	O
identify	O
lower	B-T033
stress	I-T033
(	O
score	O
of	O
≤	O
##15	O
on	O
the	O
scale	O
)	O
and	O
higher	B-T033
stress	I-T033
(	O
score	O
of	O
≥1	O
##6	O
on	O
the	O
scale	O
)	O
exerted	O
on	O
fcs	O
by	O
the	O
process	B-T058
of	I-T058
providing	I-T058
care	I-T058
.	O
the	O
set	O
of	O
explanatory	B-T170
variables	B-T033
comprised	O
a	O
wide	O
range	O
of	O
sociodemographic	O
and	O
care	B-T058
-	I-T058
related	I-T058
attributes	I-T058
,	O
including	O
patient	B-T033
-	I-T033
related	I-T033
results	I-T033
from	O
comprehensive	O
geriatric	B-T058
assessments	I-T058
and	O
disease	B-T038
profiles	O
.	O
the	O
best	O
combination	O
of	O
explanatory	B-T170
variables	B-T033
that	O
provided	O
the	O
highest	O
predictive	O
pow	O
##e	O
r	O
for	O
distress	B-T033
among	O
fcs	O
in	O
the	O
multiple	O
logistic	O
regression	O
(	O
lr	O
)	O
model	O
was	O
determined	O
according	O
to	O
statistical	O
information	O
criteria	O
.	O
the	O
statistical	O
robustness	O
of	O
the	O
observed	O
relationships	O
and	O
the	O
discriminative	O
power	O
of	O
the	O
model	O
were	O
verified	O
with	O
the	O
cross	B-T062
-	I-T062
validation	I-T062
method	I-T062
.	O
the	O
mean	O
age	O
of	O
fcs	O
was	O
57	O
.	O
2	O
(	O
±	O
##10	O
.	O
6	O
)	O
years	O
,	O
whereas	O
that	O
of	O
geriatric	O
patients	O
was	O
81	O
.	O
7	O
(	O
±	O
##6	O
.	O
4	O
)	O
years	O
.	O
despite	O
the	O
broad	O
initial	O
set	O
of	O
potential	O
explanatory	B-T170
variables	B-T033
,	O
only	O
five	O
predictors	B-T033
were	O
jointly	O
selected	O
for	O
the	O
best	O
statistical	B-T170
model	I-T170
.	O
a	O
higher	O
level	O
of	O
distress	B-T033
was	O
independently	O
predicted	O
by	O
lower	B-T058
self	I-T058
-	I-T058
evaluation	I-T058
of	I-T058
health	I-T058
;	O
worse	O
self	B-T038
-	I-T038
appraisal	I-T038
of	O
coping	O
well	O
as	O
a	O
caregiver	O
;	O
lower	O
sense	O
of	O
general	B-T058
support	I-T058
;	O
more	O
hours	O
of	O
care	O
per	O
week	O
;	O
and	O
the	O
motor	B-T033
retardation	I-T033
of	O
the	O
care	O
##d	O
-	O
for	O
person	O
measured	O
with	O
the	O
speed	O
of	O
the	O
timed	B-T058
up	I-T058
and	I-T058
go	I-T058
(	I-T058
tu	I-T058
##g	I-T058
)	I-T058
test	I-T058
.	O
worse	O
performance	O
on	O
the	O
tu	B-T058
##g	I-T058
test	I-T058
was	O
only	O
the	O
patient	O
-	O
related	O
predictor	B-T033
of	O
distress	B-T033
among	O
the	O
variables	B-T033
examined	O
as	O
contributors	O
to	O
the	O
higher	O
ni	B-T033
##oc	I-T033
.	O
enhancing	O
the	O
mobility	O
of	O
geriatric	O
patients	O
through	O
su	O
##itably	O
tailored	O
kines	B-T058
##ither	I-T058
##ap	I-T058
##eutic	I-T058
methods	I-T058
during	O
their	O
hospital	O
stay	O
may	O
mitigate	O
the	O
burden	O
end	O
##ured	O
by	O
fcs	O
.	O

prognostic	O
value	O
of	O
glut	B-T103
-	I-T103
1	I-T103
expression	B-T038
in	O
oral	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
:	O
a	O
prism	B-T170
##a	I-T170
-	I-T170
compliant	I-T170
meta	I-T170
-	I-T170
analysis	I-T170
a	O
variety	O
of	O
studies	B-T062
have	O
evaluated	B-T058
the	O
correlation	O
between	O
glucose	B-T103
transporter	I-T103
-	I-T103
1	I-T103
(	O
glut	B-T103
-	I-T103
1	I-T103
)	O
expression	B-T038
and	O
prognosis	B-T058
of	O
oral	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
oscc	B-T038
)	O
;	O
however	O
,	O
the	O
results	O
were	O
inconsistent	O
and	O
inconclusive	O
.	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
was	O
performed	O
to	O
assess	O
the	O
prognostic	B-T170
significance	O
of	O
glut	B-T103
-	I-T103
1	I-T103
in	O
oscc	B-T038
.	O
electronic	O
databases	O
of	O
pubmed	B-T170
,	O
embase	B-T170
,	O
and	O
web	B-T170
of	I-T170
science	I-T170
were	O
searched	O
for	O
relevant	B-T062
studies	I-T062
.	O
the	O
last	O
search	O
was	O
updated	O
on	O
july	O
2016	O
.	O
odds	O
ratio	O
(	O
or	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
were	O
pooled	O
to	O
evaluate	B-T058
the	O
relationship	O
between	O
glut	B-T103
-	I-T103
1	I-T103
and	O
clinical	B-T033
features	I-T033
and	O
hazard	O
ratio	O
(	O
hr	O
)	O
and	O
95	O
%	O
ci	O
were	O
combined	O
to	O
measure	O
the	O
effect	O
of	O
glut	B-T103
-	I-T103
1	I-T103
on	O
overall	O
survival	O
(	O
os	O
)	O
.	O
p	O
value	O
<	O
0	O
.	O
05	O
was	O
considered	O
as	O
statistically	O
significant	O
.	O
a	O
total	O
of	O
13	O
studies	B-T062
with	O
130	O
##1	O
subjects	B-T098
were	O
included	O
for	O
meta	B-T062
-	I-T062
analysis	I-T062
.	O
the	O
pooled	O
data	O
showed	O
that	O
high	O
glut	B-T103
-	I-T103
1	I-T103
expression	B-T038
was	O
associated	O
with	O
advanced	B-T201
tumor	I-T201
stages	I-T201
(	O
n	O
=	O
7	O
,	O
or	O
=	O
2	O
.	O
99	O
,	O
95	O
%	O
ci	O
:	O
2	O
.	O
01	O
-	O
4	O
.	O
46	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
higher	B-T170
tumor	I-T170
grade	I-T170
(	O
n	O
=	O
5	O
,	O
or	O
=	O
3	O
.	O
34	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
12	O
-	O
9	O
.	O
94	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
,	O
tumor	B-T082
size	I-T082
(	O
n	O
=	O
5	O
,	O
or	O
=	O
3	O
.	O
36	O
,	O
95	O
%	O
ci	O
:	O
2	O
.	O
04	O
-	O
5	O
.	O
51	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
lymph	B-T033
node	I-T033
metastasis	I-T033
(	O
n	O
=	O
5	O
,	O
or	O
=	O
3	O
.	O
15	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
89	O
-	O
5	O
.	O
25	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
tobacco	O
use	O
(	O
n	O
=	O
3	O
,	O
or	O
=	O
2	O
.	O
18	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
18	O
-	O
4	O
.	O
01	O
,	O
p	O
=	O
0	O
.	O
013	O
)	O
,	O
and	O
distant	B-T201
metastasis	I-T201
(	O
n	O
=	O
2	O
,	O
or	O
=	O
3	O
.	O
06	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
19	O
-	O
7	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
02	O
)	O
.	O
furthermore	O
,	O
increased	O
glut	B-T103
-	I-T103
1	I-T103
expression	B-T038
was	O
also	O
correlated	O
with	O
shorter	O
os	O
(	O
n	O
=	O
8	O
,	O
hr	O
=	O
1	O
.	O
88	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
51	O
-	O
2	O
.	O
33	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
no	O
significant	O
publication	O
bias	O
was	O
detected	B-T033
in	O
this	O
meta	B-T062
-	I-T062
analysis	I-T062
.	O
glut	B-T103
-	I-T103
1	I-T103
overexpression	B-T038
was	O
in	O
connection	O
with	O
aggressive	B-T033
clinical	I-T033
features	I-T033
and	O
worse	O
os	O
in	O
oscc	B-T038
.	O
however	O
,	O
further	O
studies	B-T062
are	O
still	O
needed	O
to	O
verify	O
whether	O
glut	B-T103
-	I-T103
1	I-T103
could	O
serve	O
as	O
a	O
prognostic	B-T170
biomarker	B-T201
for	O
oscc	B-T038
.	O

neutrophil	B-T017
and	O
monocyte	B-T017
function	B-T038
in	O
patients	O
with	O
chronic	B-T038
hepatitis	I-T038
c	I-T038
undergoing	O
antiviral	B-T058
therapy	I-T058
with	O
regimens	B-T058
containing	O
protease	B-T103
inhibitors	I-T103
with	O
and	O
without	O
interferon	B-T103
real	O
-	O
life	O
data	O
showed	O
an	O
increased	O
incidence	O
of	O
bacterial	B-T038
infections	I-T038
in	O
patients	O
with	O
advanced	O
liver	B-T038
disease	I-T038
receiving	O
a	O
protease	B-T103
inhibitor	I-T103
(	O
pi	B-T103
)	O
-	O
containing	O
antiviral	B-T058
regimen	I-T058
against	O
hepatitis	B-T005
c	I-T005
(	O
hcv	B-T005
)	O
.	O
however	O
,	O
the	O
causes	O
of	O
this	O
event	O
are	O
unknown	O
.	O
we	O
hypothesized	O
that	O
pis	B-T103
might	O
impair	O
innate	O
immune	O
responses	O
through	O
the	O
inhibition	B-T038
of	I-T038
proteases	I-T038
participating	O
in	O
the	O
anti	B-T038
-	I-T038
bacterial	I-T038
functions	I-T038
of	O
neutrophils	B-T017
and	O
monocytes	B-T017
.	O
the	O
aims	O
of	O
the	O
study	O
were	O
to	O
assess	O
phagocytic	B-T038
and	I-T038
oxidative	I-T038
burst	I-T038
capacity	O
in	O
neutrophils	B-T017
and	O
monocytes	B-T017
obtained	O
from	O
patients	O
receiving	O
a	O
pi	B-T103
containing	O
-	O
antiviral	B-T058
regimen	I-T058
,	O
and	O
to	O
determine	O
cytokine	B-T038
secretion	I-T038
after	O
neutrophil	B-T017
stimulation	B-T038
with	O
flag	B-T103
##ellin	I-T103
.	O
forty	O
patients	O
with	O
chronic	B-T038
hcv	I-T038
(	O
80	O
%	O
with	O
cirrhosis	B-T038
)	O
were	O
enrolled	O
in	O
the	O
study	O
,	O
28	O
received	O
triple	B-T058
therapy	I-T058
(	O
group	B-T170
a	I-T170
)	O
with	O
pegylated	B-T103
-	I-T103
interferon	I-T103
and	O
ribavirin	B-T103
for	O
4	O
weeks	O
followed	O
by	O
the	O
addition	O
of	O
a	O
pi	B-T103
(	O
tel	B-T103
##apr	I-T103
##ev	I-T103
##ir	I-T103
,	O
boc	B-T103
##epr	I-T103
##ev	I-T103
##ir	I-T103
or	O
sim	B-T103
##epr	I-T103
##ev	I-T103
##ir	I-T103
)	O
,	O
and	O
12	O
patients	O
received	O
an	O
interferon	B-T058
-	I-T058
free	I-T058
regimen	I-T058
(	O
group	B-T170
b	I-T170
)	O
with	O
sim	B-T103
##epr	I-T103
##ev	I-T103
##ir	I-T103
and	O
sof	B-T103
##os	I-T103
##bu	I-T103
##vir	I-T103
.	O
phagocytosis	B-T038
and	I-T038
oxidative	I-T038
burst	I-T038
capacity	O
were	O
analyzed	O
by	O
flow	B-T058
cytometry	I-T058
at	O
baseline	O
,	O
week	O
4	O
,	O
and	O
week	O
8	O
of	O
therapy	B-T058
.	O
in	O
neutrophils	B-T017
from	O
group	B-T170
a	I-T170
patients	O
,	O
oxidative	B-T038
burst	I-T038
rate	O
and	O
oxidative	O
enzymatic	B-T038
activity	I-T038
per	I-T038
cell	I-T038
significantly	O
decreased	O
throughout	O
the	O
study	O
period	O
(	O
p	O
=	O
0	O
.	O
014	O
and	O
p	O
=	O
0	O
.	O
010	O
,	O
respectively	O
)	O
.	O
pairwise	O
comparisons	O
showed	O
a	O
decrease	O
between	O
baseline	O
and	O
week	O
4	O
and	O
8	O
of	O
therapy	B-T058
.	O
no	O
differences	O
were	O
observed	O
after	O
the	O
introduction	B-T058
of	O
the	O
pi	B-T103
.	O
the	O
oxidative	O
enzymatic	B-T038
activity	I-T038
per	I-T038
cell	I-T038
in	O
monocytes	B-T017
significantly	O
decrease	O
during	O
the	O
study	O
period	O
(	O
p	O
=	O
0	O
.	O
042	O
)	O
due	O
to	O
a	O
decrease	O
from	O
baseline	O
to	O
week	O
8	O
of	O
therapy	B-T058
(	O
p	O
=	O
0	O
.	O
037	O
)	O
in	O
patients	O
from	O
group	B-T170
a	I-T170
.	O
none	O
of	O
these	O
findings	O
were	O
observed	O
in	O
group	B-T170
b	I-T170
patients	O
.	O
cytokine	B-T038
secretion	I-T038
did	O
not	O
significantly	O
change	O
during	O
the	O
study	O
in	O
both	O
groups	O
.	O
in	O
conclusion	O
,	O
our	O
data	O
suggest	O
that	O
the	O
use	O
interferon	B-T103
(	O
rather	O
than	O
the	O
pi	B-T103
)	O
has	O
a	O
deleterious	O
effect	O
on	O
neutrophil	B-T017
and	O
monocyte	B-T017
phagocytic	B-T038
and	I-T038
oxidative	I-T038
burst	I-T038
capacity	O
in	O
this	O
cohort	B-T098
of	O
patients	O
with	O
hcv	B-T005
-	O
related	O
advanced	B-T038
liver	I-T038
fibrosis	I-T038
.	O

appearance	O
differences	O
between	O
lot	B-T170
##s	I-T170
and	O
brands	B-T170
of	O
similar	O
shade	O
design	B-T170
##ations	I-T170
of	O
dental	B-T103
composite	I-T103
resins	I-T103
the	O
purposes	O
of	O
this	O
study	B-T062
were	O
to	O
investigate	O
differences	O
in	O
two	O
inherent	O
appearance	O
characteristics	O
between	O
lot	B-T170
##s	I-T170
of	O
an	O
enamel	B-T103
dental	I-T103
composite	I-T103
resin	I-T103
of	O
the	O
same	O
shade	O
and	O
brand	B-T170
,	O
and	O
to	O
further	O
compare	O
these	O
differences	O
to	O
those	O
of	O
similar	O
shade	O
design	B-T170
##ation	I-T170
of	O
a	O
different	O
brand	B-T170
of	O
dental	B-T103
composite	I-T103
resins	I-T103
.	O
appearance	O
analyses	B-T062
proceeded	O
for	O
three	O
different	O
lot	B-T170
##s	I-T170
of	O
shade	O
##s	O
a1	B-T170
,	O
b2	B-T170
,	O
and	O
d3	B-T170
manufactured	O
by	O
one	O
company	B-T092
and	O
for	O
one	O
lot	B-T170
of	O
shade	O
ea	B-T170
##1	I-T170
manufactured	O
by	O
another	O
.	O
samples	O
were	O
measured	O
on	O
black	O
,	O
white	O
,	O
and	O
gray	O
back	O
##ings	O
using	O
spectro	B-T058
##radi	I-T058
##ometry	I-T058
.	O
ku	O
##be	O
##l	O
##ka	O
-	O
mun	O
##k	O
theory	O
was	O
used	O
to	O
determine	O
reflect	O
##ivity	O
of	O
each	O
lot	B-T170
studied	B-T062
.	O
ci	O
##ela	O
##b	O
values	O
and	O
color	O
differences	O
between	O
shade	O
##s	O
and	O
lot	B-T170
##s	I-T170
were	O
analyzed	B-T062
.	O
transl	O
##uce	O
##nc	O
##y	O
indicators	B-T103
were	O
compared	O
between	O
lot	B-T170
##s	I-T170
over	O
thicknesses	O
from	O
0	O
.	O
5	O
to	O
3	O
.	O
0	O
mm	O
.	O
differences	O
in	O
inherent	O
color	O
between	O
some	O
lot	B-T170
##s	I-T170
of	O
same	O
shade	O
design	B-T170
##ations	I-T170
within	O
a	O
brand	B-T170
were	O
found	O
to	O
be	O
above	O
the	O
acceptability	O
threshold	O
.	O
color	O
difference	O
between	O
an	O
enamel	B-T103
composite	I-T103
resin	I-T103
of	O
shade	O
a1	B-T170
and	O
a	O
composite	B-T103
resin	I-T103
of	O
shade	O
ea	B-T170
##1	I-T170
was	O
also	O
above	O
the	O
acceptability	O
threshold	O
.	O
statistically	O
significant	O
differences	O
in	O
the	O
transl	O
##uce	O
##nc	O
##y	O
were	O
found	O
between	O
some	O
lot	B-T170
##s	I-T170
of	O
one	O
shade	O
over	O
the	O
entire	O
range	O
of	O
thicknesses	O
studied	B-T062
.	O
appearance	O
analyses	B-T062
indicate	O
substantial	O
variation	O
between	O
lot	B-T170
##s	I-T170
of	O
same	O
shade	O
design	B-T170
##ations	I-T170
as	O
well	O
as	O
between	O
brands	B-T170
of	O
similar	O
shade	O
design	B-T170
##ations	I-T170
.	O
optical	O
principles	O
applied	O
to	O
important	O
clinical	O
appearance	O
attributes	O
are	O
described	O
which	O
characterize	O
inherent	O
appearance	O
attributes	O
and	O
provide	O
aid	O
in	O
the	O
appearance	O
matching	O
process	O
for	O
dental	B-T103
composite	I-T103
resins	I-T103
used	O
in	O
restorative	B-T058
and	O
operative	B-T058
dental	I-T058
procedures	I-T058
.	O
(	O
j	O
est	O
##he	O
##t	O
rest	O
##or	O
dent	O
29	O
:	O
e6	O
-	O
e1	O
##4	O
,	O
2017	O
)	O
.	O

beyond	O
[UNK]	O
median	O
waiting	O
time	O
[UNK]	O
:	O
development	O
and	O
validation	B-T062
of	O
a	O
competing	O
risk	O
model	O
to	O
predict	O
outcomes	O
on	O
the	O
kidney	B-T017
transplant	B-T170
waiting	I-T170
list	I-T170
median	O
historical	O
time	O
to	O
kidney	B-T058
transplant	I-T058
is	O
misleading	O
because	O
it	O
does	O
not	O
convey	O
the	O
competing	O
risks	O
of	O
death	B-T038
or	O
removal	B-T033
from	I-T033
the	I-T033
waiting	I-T033
list	I-T033
.	O
we	O
developed	O
and	O
validated	O
a	O
competing	O
risk	O
model	O
to	O
calculate	O
likelihood	O
of	O
outcomes	O
for	O
kidney	B-T058
transplant	I-T058
candidates	B-T098
and	O
demonstrate	O
how	O
this	O
information	O
differs	O
from	O
median	O
time	O
to	O
transplant	B-T058
.	O
data	O
were	O
obtained	O
from	O
the	O
us	B-T170
scientific	I-T170
registry	I-T170
of	O
transplant	O
recipients	O
.	O
the	O
retrospective	B-T062
cohort	I-T062
included	O
163	O
63	O
##6	O
adults	O
listed	O
for	O
kidney	B-T058
transplant	I-T058
before	O
december	O
31	O
,	O
2011	O
.	O
predictors	B-T033
were	O
age	O
,	O
sex	O
,	O
blood	B-T201
type	I-T201
,	O
calculated	B-T058
panel	B-T058
-	I-T058
reactive	I-T058
antibodies	I-T058
,	O
donation	B-T058
service	B-T082
area	I-T082
,	O
dialysis	B-T058
duration	O
,	O
comorbid	B-T033
conditions	I-T033
,	O
and	O
body	B-T201
mass	I-T201
index	I-T201
.	O
outcomes	O
were	O
deceased	O
or	O
living	B-T098
donor	I-T098
transplant	B-T058
,	O
death	B-T038
or	O
removal	B-T033
from	I-T033
the	I-T033
list	I-T033
due	O
to	O
deterior	O
##ating	O
medical	O
condition	O
,	O
or	O
removal	B-T033
due	O
to	O
other	O
reasons	O
.	O
we	O
calculated	O
hazards	O
for	O
the	O
possible	B-T033
outcomes	O
,	O
then	O
the	O
cumulative	O
incidence	O
function	B-T038
for	O
a	O
given	O
candidate	B-T098
using	O
competing	O
risk	O
methodology	O
.	O
discrimination	B-T038
and	O
calibration	O
were	O
assessed	O
through	O
c	O
statistics	O
and	O
calibration	O
plots	O
for	O
each	O
cause	O
-	O
specific	O
cox	B-T170
proportional	I-T170
hazard	I-T170
model	I-T170
.	O
c	O
statistics	O
ranged	O
from	O
0	O
.	O
64	O
to	O
0	O
.	O
73	O
.	O
calibration	O
plots	O
showed	O
good	O
calibration	O
.	O
the	O
competing	O
risk	O
model	O
shows	O
probability	O
of	O
all	O
possible	B-T033
outcomes	O
for	O
up	O
to	O
12	O
years	O
given	O
a	O
candidate	B-T098
'	I-T098
s	I-T098
characteristics	O
,	O
contrasted	O
with	O
the	O
median	O
waiting	O
time	O
for	O
that	O
candidate	B-T098
'	I-T098
s	I-T098
donation	B-T058
service	B-T082
area	I-T082
.	O
a	O
competing	O
risk	O
model	O
convey	O
##s	O
more	O
relevant	O
information	O
than	O
the	O
median	O
waiting	O
time	O
for	O
a	O
given	O
transplant	B-T092
center	I-T092
.	O
this	O
model	O
will	O
be	O
updated	O
to	O
create	O
a	O
calc	O
##ulator	O
reflecting	O
the	O
most	O
recent	O
outcomes	O
and	O
changes	O
in	O
allocation	O
policy	B-T170
.	O
it	O
illustrates	O
the	O
convers	O
##ations	O
that	O
should	O
be	O
initiated	O
with	O
transplant	B-T058
candidates	B-T098
.	O

the	O
burden	O
of	O
mental	B-T038
disorders	I-T038
in	O
the	O
eastern	B-T082
mediterranean	I-T082
region	I-T082
,	O
1990	O
-	O
2013	O
the	O
eastern	B-T082
mediterranean	I-T082
region	I-T082
(	O
emr	B-T082
)	O
is	O
witness	O
##ing	O
an	O
increase	O
in	O
chronic	B-T038
disorders	I-T038
,	O
including	O
mental	B-T038
illness	I-T038
.	O
with	O
ongoing	O
unres	O
##t	O
,	O
this	O
is	O
expected	O
to	O
rise	O
.	O
this	O
is	O
the	O
first	O
study	B-T062
to	O
quantify	O
the	O
burden	O
of	O
mental	B-T038
disorders	I-T038
in	O
the	O
emr	B-T082
.	O
we	O
used	O
data	O
from	O
the	O
global	B-T170
burden	I-T170
of	I-T170
disease	I-T170
study	I-T170
(	O
gb	B-T170
##d	I-T170
)	O
2013	O
.	O
dal	O
##ys	O
(	O
disability	O
-	O
adjusted	O
life	O
years	O
)	O
allow	O
assessment	B-T058
of	O
both	O
premature	B-T033
mortality	I-T033
(	O
years	O
of	O
life	O
lost	O
-	O
yl	O
##ls	O
)	O
and	O
nonfatal	O
outcomes	O
(	O
years	O
lived	O
with	O
disability	O
-	O
yl	O
##ds	O
)	O
.	O
dal	O
##ys	O
are	O
computed	O
by	O
adding	O
yl	O
##ls	O
and	O
yl	O
##ds	O
for	O
each	O
age	O
-	O
sex	O
-	O
country	O
group	O
.	O
in	O
2013	O
,	O
mental	B-T038
disorders	I-T038
contributed	O
to	O
5	O
.	O
6	O
%	O
of	O
the	O
total	O
disease	O
burden	O
in	O
the	O
emr	B-T082
(	O
189	O
##4	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
population	B-T098
)	O
:	O
251	O
##9	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
(	O
259	O
##0	O
/	O
100	O
,	O
000	O
males	O
,	O
242	O
##6	O
/	O
100	O
,	O
000	O
females	O
)	O
in	O
high	B-T082
-	I-T082
income	I-T082
countries	I-T082
,	O
188	O
##4	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
(	O
161	O
##8	O
/	O
100	O
,	O
000	O
males	O
,	O
215	O
##7	O
/	O
100	O
,	O
000	O
females	O
)	O
in	O
middle	O
-	O
income	O
countries	B-T082
,	O
160	O
##7	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
(	O
1500	O
/	O
100	O
,	O
000	O
males	O
,	O
171	O
##7	O
/	O
100	O
,	O
000	O
females	O
)	O
in	O
low	B-T033
-	I-T033
income	I-T033
countries	B-T082
.	O
females	O
had	O
a	O
greater	O
proportion	O
of	O
burden	O
due	O
to	O
mental	B-T038
disorders	I-T038
than	O
did	O
males	O
of	O
equivalent	O
ages	O
,	O
except	O
for	O
those	O
under	O
15	O
years	O
of	O
age	O
.	O
the	O
highest	O
proportion	O
of	O
dal	O
##ys	O
occurred	O
in	O
the	O
25	O
-	O
49	O
age	O
group	O
,	O
with	O
a	O
peak	O
in	O
the	O
35	O
-	O
39	O
years	O
age	O
group	O
(	O
53	O
##44	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
)	O
.	O
the	O
burden	O
of	O
mental	B-T038
disorders	I-T038
in	O
emr	B-T082
increased	O
from	O
172	O
##6	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
in	O
1990	O
to	O
191	O
##2	O
dal	O
##ys	O
/	O
100	O
,	O
000	O
in	O
2013	O
(	O
10	O
.	O
8	O
%	O
increase	O
)	O
.	O
within	O
the	O
mental	B-T098
disorders	I-T098
group	I-T098
in	O
emr	B-T082
,	O
depressive	B-T038
disorders	I-T038
accounted	O
for	O
most	O
dal	O
##ys	O
,	O
followed	O
by	O
anxiety	B-T038
disorders	I-T038
.	O
among	O
emr	B-T082
countries	O
,	O
pale	O
##st	O
##ine	O
had	O
the	O
largest	O
burden	O
of	O
mental	B-T038
disorders	I-T038
.	O
nearly	O
all	O
emr	B-T082
countries	I-T082
had	O
a	O
higher	O
mental	O
disorder	O
burden	O
compared	O
to	O
the	O
global	O
level	O
.	O
our	O
findings	O
call	O
for	O
emr	O
mini	O
##st	O
##ries	O
of	O
health	O
to	O
increase	O
provision	O
of	O
mental	B-T058
health	I-T058
services	I-T058
and	O
to	O
address	O
the	O
stigma	O
of	O
mental	O
illness	O
.	O
moreover	O
,	O
our	O
results	O
showing	O
the	O
accelerating	O
burden	O
of	O
mental	O
health	O
are	O
alarm	O
##ing	O
as	O
the	O
region	O
is	O
seeing	O
an	O
increased	O
level	O
of	O
instability	B-T033
.	O
indeed	O
,	O
mental	B-T033
health	I-T033
problems	I-T033
,	O
if	O
not	O
properly	O
addressed	O
,	O
will	O
lead	O
to	O
an	O
increased	O
burden	O
of	O
diseases	O
in	O
the	O
region	B-T082
.	O

grape	B-T204
##vin	I-T204
##e	I-T204
subtil	B-T103
##ase	I-T103
family	I-T103
:	O
update	O
on	O
new	O
sequences	B-T082
and	O
nomenclature	B-T170
proposal	I-T170
in	O
grape	B-T204
##vin	I-T204
##e	I-T204
,	O
serine	B-T103
peptidase	I-T103
##s	I-T103
from	O
the	O
subtil	B-T103
##ase	I-T103
family	I-T103
were	O
recently	O
associated	O
to	O
plasm	B-T204
##opar	I-T204
##a	I-T204
vit	I-T204
##icola	I-T204
resistance	O
.	O
this	O
family	O
in	O
grape	B-T204
##vin	I-T204
##e	I-T204
,	O
first	O
characterized	O
in	O
2014	O
,	O
was	O
re	B-T062
-	I-T062
analyzed	I-T062
last	O
year	O
and	O
82	O
subtil	B-T103
##ase	I-T103
genes	B-T017
were	O
identified	O
.	O
however	O
,	O
in	O
november	O
of	O
2016	O
,	O
the	O
national	B-T092
center	I-T092
for	I-T092
biotechnology	I-T092
information	I-T092
database	B-T170
(	O
nc	B-T092
##bi	I-T092
)	O
made	O
a	O
new	O
public	O
release	O
of	O
the	O
grape	B-T204
##vin	I-T204
##e	I-T204
genome	B-T062
annotation	I-T062
based	O
on	O
new	O
sequencing	B-T170
data	I-T170
and	O
better	O
prediction	O
algorithms	B-T170
.	O
as	O
a	O
consequence	O
,	O
some	O
gene	B-T062
annotations	I-T062
and	O
lengths	O
changed	O
.	O
here	O
we	O
present	O
an	O
update	O
to	O
the	O
grape	B-T204
##vin	I-T204
##e	I-T204
subtil	B-T103
##ase	I-T103
gene	B-T017
family	I-T017
sequences	B-T082
(	O
sb	B-T103
##t	I-T103
)	O
,	O
namely	O
sequence	B-T170
identifier	I-T170
##s	I-T170
,	O
bioinformatic	B-T091
predictions	O
and	O
recommend	O
a	O
nomenclature	B-T170
for	O
the	O
grape	B-T204
##vin	I-T204
##e	I-T204
sb	B-T103
##t	I-T103
genes	B-T017
.	O
our	O
results	B-T033
show	O
that	O
grape	B-T204
##vin	I-T204
##e	I-T204
subtil	B-T103
##ase	I-T103
gene	B-T017
family	I-T017
is	O
now	O
constituted	O
by	O
87	O
subtil	B-T103
##ase	I-T103
genes	B-T017
encoding	O
for	O
109	O
subtil	B-T103
##ase	I-T103
proteins	I-T103
and	O
,	O
despite	O
the	O
reported	O
alterations	B-T038
,	O
expression	B-T038
data	O
on	O
subtil	B-T103
##ases	I-T103
associated	O
to	O
grape	B-T204
##vin	I-T204
##e	I-T204
resistance	O
to	O
p	B-T204
.	I-T204
vit	I-T204
##icola	I-T204
path	O
##osystem	O
did	O
not	O
suffer	O
any	O
alteration	B-T038
.	O

a	O
single	O
session	O
of	O
exhaustive	O
exercise	O
markedly	O
decreases	O
circulating	O
levels	O
of	O
guan	B-T103
##idin	I-T103
##oacetic	I-T103
acid	I-T103
in	O
healthy	O
men	B-T098
and	O
women	B-T098
we	O
evaluated	B-T058
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guan	B-T103
##idin	I-T103
##oacetic	I-T103
acid	I-T103
(	O
ga	B-T103
##a	I-T103
)	O
and	O
creatine	B-T103
in	O
23	O
healthy	B-T098
volunteers	I-T098
subjected	O
to	O
running	O
to	O
exhaustion	B-T033
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
vol	O
##itional	O
failure	O
.	O
blood	B-T031
was	O
taken	O
before	O
and	O
following	O
each	O
exercise	O
session	O
.	O
running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	B-T031
ga	B-T103
##a	I-T103
by	O
20	O
.	O
1	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
ga	B-T103
##a	I-T103
by	O
11	O
.	O
7	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	B-T031
ga	B-T103
##a	I-T103
as	O
a	O
novel	O
biomarker	B-T201
of	O
exhaustion	B-T033
.	O

clonal	B-T017
and	O
serotype	B-T170
dynamics	O
of	O
serogroup	B-T007
6	I-T007
isolates	B-T103
causing	O
invasive	B-T038
pneumococcal	I-T038
disease	I-T038
in	O
portugal	B-T082
:	O
1999	O
-	O
2012	O
although	O
serogroup	B-T007
6	I-T007
was	O
among	O
the	O
first	O
to	O
be	O
recognized	O
among	O
streptococcus	B-T007
pneumoniae	I-T007
,	O
several	O
new	O
serotypes	B-T170
were	O
identified	O
since	O
the	O
introduction	O
of	O
pneumococcal	B-T103
conjugate	I-T103
vaccines	I-T103
(	O
pcv	B-T103
##s	I-T103
)	O
.	O
a	O
decrease	O
of	O
the	O
6b	O
-	O
2	O
variant	O
among	O
invasive	B-T038
pneumococcal	I-T038
disease	I-T038
(	O
ipd	B-T038
)	O
,	O
but	O
not	O
6b	O
-	O
1	O
,	O
was	O
noted	O
post	O
conjugate	B-T103
vaccine	I-T103
introduction	O
,	O
underpin	O
##ned	O
by	O
a	O
decrease	O
of	O
cc	B-T103
##27	I-T103
##3	I-T103
isolates	I-T103
.	O
serotype	B-T007
6	I-T007
##c	I-T007
was	O
associated	O
with	O
adult	O
ipd	B-T038
and	O
increased	O
in	O
this	O
age	O
group	O
representing	O
two	O
lineages	O
(	O
cc	O
##31	O
##5	O
and	O
cc	O
##39	O
##5	O
)	O
,	O
while	O
the	O
same	O
lineages	O
expressed	B-T038
other	O
serogroup	B-T007
6	I-T007
serotypes	B-T170
in	O
children	O
.	O
taken	O
together	O
,	O
these	O
findings	O
suggest	O
a	O
potential	O
cross	B-T038
-	I-T038
protection	I-T038
of	O
pcv	B-T103
##s	I-T103
against	O
serotype	B-T007
6	I-T007
##c	I-T007
ipd	B-T038
among	O
vaccinated	B-T033
children	O
but	O
not	O
among	O
adults	O
.	O
serotype	B-T007
6a	I-T007
became	O
the	O
most	O
important	O
serogroup	B-T007
6	I-T007
serotype	B-T170
in	O
children	O
but	O
it	O
decreased	O
in	O
adult	O
ipd	B-T038
.	O
no	O
other	O
serogroup	B-T007
6	I-T007
serotypes	B-T170
were	O
detected	B-T033
,	O
so	O
available	O
phenotypic	O
or	O
simple	O
genotypic	O
assays	B-T058
remain	O
adequate	O
for	O
distinguishing	O
serotypes	B-T170
within	O
serogroup	B-T007
6	I-T007
isolates	B-T103
.	O

loss	O
of	O
control	O
over	O
alcohol	O
seeking	O
in	O
rats	B-T204
depends	O
on	O
individual	B-T098
vulnerability	O
and	O
duration	O
of	O
alcohol	O
consumption	O
experience	O
alcohol	O
use	O
disorder	O
(	O
aud	O
)	O
is	O
characterized	O
by	O
excessive	B-T033
alcohol	I-T033
use	I-T033
and	O
persistent	O
alcohol	O
seeking	O
despite	O
knowledge	O
of	O
its	O
negative	O
consequences	O
.	O
importantly	O
,	O
aud	O
typically	O
develops	O
after	O
chronic	O
excessive	B-T033
alcohol	I-T033
use	I-T033
in	O
a	O
subgroup	B-T170
of	O
individuals	B-T098
who	O
drink	O
alcohol	O
,	O
suggesting	O
that	O
aud	O
results	O
from	O
an	O
interaction	O
between	O
individual	B-T098
vulnerability	O
and	O
prolonged	O
alcohol	O
exposure	O
.	O
the	O
present	O
study	B-T062
assessed	O
the	O
contribution	O
of	O
prolonged	O
exposure	O
to	O
alcohol	O
and	O
individual	O
levels	O
of	O
alcohol	O
intake	O
to	O
the	O
development	O
of	O
loss	O
of	O
control	O
over	O
alcohol	O
seeking	O
in	O
a	O
conditioned	B-T170
suppression	I-T170
model	I-T170
.	O
to	O
investigate	O
the	O
impact	O
of	O
prolonged	O
alcohol	O
exposure	O
,	O
conditioned	O
suppression	O
of	O
alcohol	O
seeking	O
was	O
assessed	O
after	O
2	O
and	O
4	O
months	O
of	O
intermittent	O
alcohol	O
access	O
(	O
iaa	O
)	O
in	O
a	O
subgroup	B-T170
of	O
rats	B-T204
drinking	O
moderate	O
amounts	O
of	O
alcohol	O
.	O
we	O
observed	O
that	O
suppression	O
of	O
alcohol	O
seeking	O
was	O
reduced	O
after	O
4	O
months	O
compared	O
with	O
2	O
months	O
of	O
iaa	O
.	O
the	O
influence	O
of	O
individual	O
levels	O
of	O
alcohol	O
intake	O
on	O
loss	O
of	O
control	O
over	O
alcohol	O
seeking	O
was	O
subsequently	O
determined	O
by	O
assessing	O
conditioned	O
suppression	O
in	O
subgroups	B-T170
of	O
low	O
and	O
high	O
alcohol	O
drinking	O
rats	B-T204
.	O
unlike	O
the	O
low	O
alcohol	O
drinking	O
rats	B-T204
,	O
the	O
high	O
alcohol	O
drinking	O
rats	B-T204
showed	O
aversion	O
-	O
resistant	O
alcohol	O
seeking	O
after	O
2	O
months	O
of	O
iaa	O
,	O
although	O
both	O
groups	O
showed	O
comparable	O
levels	O
of	O
conditioned	O
freezing	O
.	O
these	O
findings	O
show	O
that	O
the	O
development	O
of	O
loss	O
of	O
control	O
over	O
alcohol	O
seeking	O
,	O
a	O
key	O
characteristic	O
of	O
aud	O
in	O
humans	B-T204
,	O
is	O
dependent	O
on	O
both	O
the	O
extent	O
of	O
alcohol	O
exposure	O
and	O
the	O
individual	B-T098
'	I-T098
s	I-T098
propensity	O
to	O
consume	O
alcohol	O
.	O

association	O
of	O
toll	B-T103
-	I-T103
like	I-T103
receptor	I-T103
4	I-T103
on	O
human	B-T204
monocyte	B-T017
subsets	B-T170
and	O
vulnerability	O
characteristics	O
of	O
coronary	B-T017
plaque	B-T033
as	O
assessed	O
by	O
64	B-T058
-	I-T058
slice	I-T058
multid	I-T058
##etector	I-T058
computed	I-T058
tomography	I-T058
although	O
toll	B-T103
-	I-T103
like	I-T103
receptor	I-T103
4	I-T103
(	O
tlr	B-T103
-	I-T103
4	I-T103
)	O
is	O
involved	O
in	O
monocyte	B-T038
activation	I-T038
in	O
patients	O
with	O
accelerated	O
forms	O
of	O
atherosclerosis	B-T038
,	O
the	O
relationship	O
between	O
the	O
expression	O
of	O
tlr	B-T103
-	I-T103
4	I-T103
on	O
circulating	O
monocyte	B-T017
s	O
and	O
coronary	B-T017
plaque	B-T033
vulnerability	O
has	O
not	O
previously	O
been	O
evaluated	B-T058
.	O
we	O
investigated	O
this	O
relationship	O
using	O
64	B-T058
-	I-T058
slice	I-T058
multid	I-T058
##etector	I-T058
computed	I-T058
tomography	I-T058
(	O
mdct	B-T058
)	O
in	O
patients	O
with	O
stable	B-T038
angina	I-T038
pectoris	I-T038
(	O
sap	B-T038
)	O
.	O
methods	O
and	O
results	O
:	O
we	O
enrolled	O
65	O
patients	O
with	O
sap	B-T038
who	O
underwent	O
mdct	B-T058
.	O
three	O
monocyte	B-T017
subsets	B-T170
(	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
-	I-T017
)	I-T017
,	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
,	O
and	O
cd14	B-T017
(	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
)	O
and	O
expression	O
of	O
tlr	B-T103
-	I-T103
4	I-T103
were	O
measured	O
by	O
flow	B-T058
cytometry	I-T058
.	O
intracoronary	B-T017
plaques	B-T033
were	O
assessed	O
by	O
64	B-T058
-	I-T058
slice	I-T058
mdct	I-T058
.	O
we	O
defined	O
vulnerability	O
of	O
intracoronary	B-T017
plaques	B-T033
according	O
to	O
the	O
presence	O
of	O
positive	B-T038
remodeling	I-T038
(	O
remodeling	B-T033
index	I-T033
>	O
1	O
.	O
05	O
)	O
and	O
/	O
or	O
low	O
ct	B-T058
attenuation	O
(	O
<	O
35	O
hu	O
)	O
.	O
the	O
circulating	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
monocytes	I-T017
more	O
frequently	O
expressed	O
tlr	B-T103
-	I-T103
4	I-T103
than	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
-	I-T017
)	I-T017
and	O
cd14	B-T017
(	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
monocytes	I-T017
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
relative	O
proportion	O
of	O
the	O
expression	O
of	O
tlr	B-T103
-	I-T103
4	I-T103
on	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
monocytes	I-T017
was	O
significantly	O
greater	O
in	O
patients	O
with	O
vulnerable	B-T033
plaque	I-T033
compared	O
with	O
those	O
without	O
(	O
10	O
.	O
4	O
[	O
4	O
.	O
1	O
-	O
14	O
.	O
5	O
]	O
%	O
vs	O
.	O
4	O
.	O
5	O
[	O
2	O
.	O
8	O
-	O
7	O
.	O
8	O
]	O
%	O
,	O
p	O
=	O
0	O
.	O
012	O
)	O
.	O
in	O
addition	O
,	O
the	O
relative	O
proportion	O
of	O
tlr	B-T103
-	I-T103
4	I-T103
expression	O
on	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
monocytes	I-T017
positively	O
correlated	O
with	O
the	O
remodeling	B-T033
index	I-T033
(	O
r	O
=	O
0	O
.	O
28	O
,	O
p	O
=	O
0	O
.	O
025	O
)	O
and	O
negatively	O
correlated	O
with	O
ct	B-T058
attenuation	O
value	O
(	O
r	O
=	O
-	O
0	O
.	O
31	O
,	O
p	O
=	O
0	O
.	O
013	O
)	O
.	O
upregulation	B-T038
of	O
tlr	B-T103
-	I-T103
4	I-T103
on	O
cd14	B-T017
(	I-T017
+	I-T017
+	I-T017
)	I-T017
cd16	I-T017
(	I-T017
+	I-T017
)	I-T017
monocytes	I-T017
might	O
be	O
associated	O
with	O
coronary	B-T017
plaque	B-T033
vulnerability	O
in	O
patients	O
with	O
sap	B-T038
.	O

effects	O
of	O
application	O
of	O
social	O
marketing	O
theory	O
and	O
the	O
health	B-T058
belief	I-T058
model	I-T058
in	O
promoting	O
cervical	B-T058
cancer	I-T058
screening	I-T058
among	O
targeted	O
women	B-T098
in	O
sis	B-T082
##ake	I-T082
##t	I-T082
province	I-T082
,	O
thailand	B-T082
cervical	B-T038
cancer	I-T038
is	O
a	O
major	O
public	B-T033
health	I-T033
problem	I-T033
in	O
thailand	B-T082
,	O
being	O
ranked	B-T170
second	O
only	O
to	O
breast	B-T038
cancer	I-T038
.	O
thai	B-T098
women	B-T098
have	O
been	O
reported	B-T058
to	O
have	O
a	O
low	O
rate	O
of	O
cervical	B-T058
cancer	I-T058
screening	I-T058
(	O
27	O
.	O
7	O
%	O
of	O
the	O
80	O
%	O
goal	B-T170
of	O
who	B-T092
)	O
.	O
we	O
therefore	O
aimed	O
to	O
apply	O
the	O
social	O
marketing	O
theory	O
and	O
health	B-T058
belief	I-T058
model	I-T058
in	O
promoting	O
cervical	B-T058
cancer	I-T058
screening	I-T058
in	O
kan	B-T082
##th	I-T082
##ara	I-T082
##rom	I-T082
district	I-T082
,	O
sis	B-T082
##ake	I-T082
##t	I-T082
province	I-T082
.	O
a	O
total	O
of	O
92	O
from	O
97	O
##4	O
targeted	O
women	B-T098
aged	O
306	O
##0	O
years	O
were	O
randomly	B-T062
divided	O
into	O
two	O
groups	O
.	O
the	O
experimental	B-T098
group	I-T098
underwent	O
application	O
of	O
social	O
marketing	O
theory	O
and	O
a	O
health	B-T058
belief	I-T058
model	I-T058
program	O
promoting	O
cervical	B-T058
cancer	I-T058
screening	I-T058
while	O
the	O
control	O
group	O
received	O
normal	O
services	O
.	O
two	O
research	B-T170
tools	I-T170
were	O
used	O
:	O
(	O
1	O
)	O
application	O
of	O
social	O
marketing	O
theory	O
and	O
health	B-T058
belief	I-T058
model	I-T058
program	O
and	O
(	O
2	O
)	O
questionnaire	B-T170
used	O
to	O
evaluate	O
perceptions	B-T038
of	O
cervical	B-T038
cancer	I-T038
.	O
descriptive	B-T170
and	O
infer	O
##ential	O
statistics	O
including	O
paired	O
sample	B-T170
tt	I-T170
##est	I-T170
and	O
independent	O
tt	B-T170
##est	I-T170
were	O
used	O
to	O
analyze	O
the	O
data	O
.	O
after	O
the	O
program	O
had	O
been	O
used	O
,	O
the	O
mean	O
score	O
of	O
perception	B-T038
of	O
cervical	B-T038
cancer	I-T038
of	O
experimental	B-T098
group	I-T098
was	O
at	O
a	O
higher	O
level	O
(	O
x	O
=	O
4	O
.	O
09	O
;	O
s	O
.	O
d	O
.	O
=	O
0	O
.	O
30	O
)	O
,	O
than	O
in	O
the	O
control	O
group	O
(	O
x	O
=	O
3	O
.	O
82	O
;	O
s	O
.	O
d	O
.	O
=	O
0	O
.	O
20	O
)	O
with	O
statistical	O
significance	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
this	O
research	B-T062
demonstrated	O
an	O
appropriate	O
communication	O
process	O
in	O
behavioral	O
modification	O
to	O
prevent	O
cervical	B-T038
cancer	I-T038
.	O
it	O
can	O
be	O
recommended	O
that	O
this	O
program	O
featuring	O
social	O
marketing	O
and	O
the	O
health	B-T058
belief	I-T058
model	I-T058
be	O
used	O
to	O
promote	O
cervical	B-T058
cancer	I-T058
screening	I-T058
in	O
targeted	O
women	B-T098
and	O
it	O
can	O
be	O
promoted	O
as	O
a	O
guideline	B-T170
for	O
other	O
health	B-T058
services	I-T058
,	O
especially	O
in	O
health	B-T058
promotion	I-T058
and	O
disease	O
prevention	O
.	O

intravascular	B-T082
inflammation	B-T038
triggers	O
intracerebral	B-T082
activated	O
microglia	B-T017
and	O
contributes	O
to	O
secondary	B-T037
brain	I-T037
injury	I-T037
after	O
experimental	O
subarachnoid	B-T038
hemorrhage	I-T038
(	O
es	B-T038
##ah	I-T038
)	O
activation	O
of	O
innate	O
immunity	O
contributes	O
to	O
secondary	B-T037
brain	I-T037
injury	I-T037
after	O
experimental	O
subarachnoid	B-T038
hemorrhage	I-T038
(	O
es	B-T038
##ah	I-T038
)	O
.	O
microglia	B-T017
accumulation	B-T033
and	O
activation	O
within	O
the	O
brain	B-T017
has	O
recently	O
been	O
shown	O
to	O
induce	O
neuronal	B-T038
cell	I-T038
death	I-T038
after	O
es	B-T038
##ah	I-T038
.	O
in	O
isolated	O
mouse	B-T204
brain	B-T017
capillaries	B-T017
after	O
es	B-T038
##ah	I-T038
,	O
we	O
show	O
a	O
significantly	O
increased	O
gene	B-T038
expression	I-T038
for	O
intercellular	B-T017
adhesion	I-T017
molecule	I-T017
-	I-T017
1	I-T017
(	O
icam	B-T017
-	I-T017
1	I-T017
)	O
and	O
p	B-T017
-	I-T017
selectin	I-T017
.	O
hence	O
,	O
we	O
hypothesized	O
that	O
extrac	O
##ere	O
##bral	O
intravascular	B-T082
inflammatory	B-T038
processes	I-T038
might	O
initiate	O
the	O
previously	O
reported	B-T058
microglia	B-T017
accumulation	B-T033
within	O
the	O
brain	B-T017
tissue	I-T017
.	O
we	O
therefore	O
induced	O
es	B-T038
##ah	I-T038
in	O
knockout	B-T204
mice	I-T204
for	O
icam	B-T017
-	I-T017
1	I-T017
(	O
icam	B-T017
-	I-T017
1	I-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
)	O
and	O
p	B-T017
-	I-T017
selectin	I-T017
glycoprotein	I-T017
ligand	I-T017
-	I-T017
1	I-T017
(	O
psg	B-T017
##l	I-T017
-	I-T017
1	I-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
)	O
to	O
find	O
a	O
significant	O
decrease	O
in	O
neutrophil	B-T017
-	O
endothelial	B-T017
interaction	B-T038
within	O
the	O
first	O
7	O
days	O
after	O
the	O
bleeding	B-T038
in	O
a	O
chronic	O
cranial	B-T082
window	O
model	O
.	O
this	O
inhibition	O
of	O
neutrophil	B-T038
recruitment	I-T038
to	O
the	O
endothelium	B-T017
results	O
in	O
significantly	O
ameliorated	B-T033
microglia	B-T017
accumulation	B-T033
and	O
neuronal	B-T038
cell	I-T038
death	I-T038
in	O
knockout	O
animals	O
in	O
comparison	O
to	O
controls	O
.	O
our	O
results	O
suggest	O
an	O
outside	O
-	O
in	O
activation	O
of	O
the	O
cns	B-T022
innate	I-T022
immune	B-T022
system	I-T022
at	O
the	O
vessel	B-T082
/	O
brain	B-T017
interface	O
following	O
es	B-T038
##ah	I-T038
.	O
microglia	B-T017
cells	B-T017
,	O
as	O
part	O
of	O
the	O
brain	B-T017
'	I-T017
s	I-T017
innate	O
immune	O
system	O
,	O
are	O
triggered	O
by	O
an	O
inflammatory	B-T038
reaction	I-T038
in	O
the	O
microvasculature	B-T038
after	O
es	B-T038
##ah	I-T038
,	O
thus	O
contributing	O
to	O
neuronal	B-T038
cell	I-T038
death	I-T038
.	O
this	O
finding	O
offers	O
a	O
whole	O
range	O
of	O
new	O
research	B-T062
targets	O
,	O
as	O
well	O
as	O
possible	O
therapy	O
options	O
for	O
patients	O
suffering	O
from	O
es	B-T038
##ah	I-T038
.	O

stressful	O
life	O
events	O
and	O
leucocyte	B-T038
telomere	I-T038
length	I-T038
:	O
do	O
lifestyle	B-T201
factors	I-T201
,	O
somatic	O
and	O
mental	B-T038
health	I-T038
,	O
or	O
low	B-T038
grade	I-T038
inflammation	I-T038
mediate	O
this	O
relationship	O
?	O
results	O
from	O
a	O
cohort	B-T098
of	O
danish	B-T098
men	I-T098
born	B-T038
in	O
195	O
##3	O
exposure	O
to	O
psychosocial	O
stress	B-T033
is	O
associated	O
with	O
increased	O
risk	O
of	O
a	O
number	O
of	O
somatic	O
and	O
mental	B-T038
disorders	I-T038
with	O
relation	O
to	O
immune	B-T022
system	I-T022
functioning	O
.	O
we	O
aimed	O
to	O
explore	O
whether	O
stressful	O
events	O
in	O
early	O
and	O
recent	O
life	O
was	O
associated	O
with	O
leucocyte	B-T038
telomere	I-T038
length	I-T038
(	O
tl	B-T038
)	O
,	O
which	O
is	O
assumed	O
to	O
reflect	O
the	O
accumulated	B-T033
burden	O
of	O
inflammation	B-T038
and	O
oxidative	B-T038
stress	I-T038
occurring	O
during	O
the	O
life	O
course	O
.	O
we	O
specifically	O
aimed	O
to	O
address	O
whether	O
childhood	O
constitutes	O
a	O
sensitive	O
period	O
and	O
how	O
much	O
of	O
the	O
relation	O
between	O
stressful	O
life	O
events	O
and	O
tl	B-T038
is	O
mediated	O
through	O
somatic	O
and	O
mental	B-T038
health	I-T038
,	O
lifestyle	O
,	O
and	O
markers	B-T201
of	O
low	B-T038
-	I-T038
grade	I-T038
inflammation	I-T038
.	O
a	O
cohort	B-T098
of	O
danish	B-T098
men	I-T098
born	B-T038
in	O
195	O
##3	O
has	O
been	O
followed	O
since	O
birth	B-T038
in	O
the	O
metropol	B-T098
##it	I-T098
cohort	I-T098
.	O
these	O
men	B-T098
underwent	O
a	O
health	B-T058
examination	I-T058
including	O
blood	B-T058
sampling	I-T058
in	O
2010	O
and	O
a	O
subset	O
of	O
324	O
also	O
had	O
a	O
quantitative	B-T058
pcr	I-T058
-	I-T058
based	I-T058
measurement	I-T058
of	O
tl	B-T038
.	O
the	O
relation	O
between	O
stressful	O
life	O
events	O
and	O
tl	B-T038
was	O
analysed	O
using	O
structural	O
equation	O
modelling	O
,	O
which	O
also	O
provided	O
an	O
estimate	O
of	O
the	O
proportion	O
of	O
the	O
total	O
effect	O
mediated	O
by	O
somatic	O
and	O
mental	B-T038
health	I-T038
(	O
cardiovascular	B-T038
disease	I-T038
,	O
body	O
mass	O
and	O
depressive	B-T033
mood	I-T033
)	O
,	O
lifestyle	B-T201
factors	I-T201
,	O
and	O
low	B-T038
grade	I-T038
inflammation	I-T038
(	O
c	B-T103
-	I-T103
reactive	I-T103
protein	I-T103
(	O
crp	B-T103
)	O
,	O
interleukin	B-T103
(	I-T103
il	I-T103
)	I-T103
-	I-T103
6	I-T103
and	O
il	B-T103
-	I-T103
10	I-T103
)	O
.	O
total	O
number	O
of	O
stressful	O
events	O
experienced	O
during	O
the	O
life	O
course	O
was	O
not	O
associated	O
with	O
tl	B-T038
.	O
in	O
terms	O
of	O
sensitive	O
periods	O
,	O
we	O
found	O
that	O
number	O
of	O
stressful	O
events	O
in	O
childhood	O
was	O
associated	O
with	O
shorter	B-T038
tl	I-T038
(	O
β	O
##per	O
number	O
stressful	O
events	O
in	O
childhood	O
=	O
-	O
0	O
.	O
02	O
(	O
se	O
=	O
-	O
0	O
.	O
02	O
)	O
;	O
p	O
=	O
0	O
.	O
05	O
)	O
.	O
this	O
relation	O
was	O
particularly	O
strong	O
for	O
being	O
placed	O
away	O
from	O
home	B-T082
(	O
β	O
=	O
-	O
0	O
.	O
16	O
;	O
p	O
<	O
0	O
.	O
000	O
)	O
.	O
thirty	O
percent	O
of	O
the	O
total	O
effect	O
of	O
stressful	O
events	O
in	O
childhood	O
on	O
tl	B-T038
was	O
mediated	O
by	O
the	O
included	O
variables	O
,	O
with	O
the	O
largest	O
proportion	O
being	O
mediated	O
through	O
depressive	B-T033
mood	I-T033
(	O
16	O
%	O
)	O
and	O
crp	B-T103
(	O
9	O
%	O
)	O
.	O
this	O
study	O
suggests	O
that	O
stressful	O
events	O
in	O
childhood	O
are	O
associated	O
with	O
shorter	B-T038
tl	I-T038
in	O
middle	O
-	O
aged	O
men	O
and	O
that	O
part	O
of	O
this	O
relation	O
is	O
explained	O
by	O
depressive	B-T038
mood	I-T038
and	O
low	B-T038
grade	I-T038
inflammation	I-T038
.	O

sirt	B-T103
##2	I-T103
deacet	B-T038
##ylate	I-T038
##s	I-T038
and	O
inhibits	B-T038
the	I-T038
peroxidase	I-T038
activity	I-T038
of	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
-	I-T103
1	I-T103
to	O
sensitiz	B-T017
##e	I-T017
breast	I-T017
cancer	I-T017
cells	I-T017
to	O
oxidant	B-T038
stress	I-T038
-	O
inducing	O
agents	O
sirt	B-T103
##2	I-T103
is	O
a	O
protein	B-T038
deacetylase	I-T038
with	O
tumor	B-T038
suppressor	I-T038
activity	I-T038
in	O
breast	B-T038
and	O
liver	B-T038
tumors	I-T038
where	O
it	O
is	O
mutated	B-T038
;	O
however	O
,	O
the	O
critical	O
substrates	O
mediating	O
its	O
antitumor	B-T033
activity	I-T033
are	O
not	O
fully	O
defined	O
.	O
here	O
we	O
demonstrate	O
that	O
sirt	B-T103
##2	I-T103
binds	B-T038
,	O
deacet	B-T038
##ylate	I-T038
##s	I-T038
,	O
and	O
inhibits	B-T038
the	I-T038
peroxidase	I-T038
activity	I-T038
of	O
the	O
antioxidant	B-T103
protein	I-T103
perox	I-T103
##ired	I-T103
##oxin	I-T103
(	O
pr	B-T103
##d	I-T103
##x	I-T103
-	I-T103
1	I-T103
)	O
in	O
breast	B-T017
cancer	I-T017
cells	I-T017
.	O
ectopic	B-T082
overexpression	B-T038
of	O
sirt	B-T103
##2	I-T103
,	O
but	O
not	O
its	O
catalytically	B-T038
dead	I-T038
mutant	I-T038
,	O
increased	O
intracellular	B-T082
levels	I-T082
of	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
induced	B-T103
by	I-T103
hydrogen	I-T103
peroxide	I-T103
,	I-T103
which	O
led	O
to	O
increased	O
levels	O
of	O
an	O
over	B-T103
##oxid	I-T103
##ized	I-T103
and	I-T103
multim	I-T103
##eric	I-T103
form	I-T103
of	I-T103
pr	I-T103
##d	I-T103
##x	I-T103
-	I-T103
1	I-T103
with	O
activity	B-T103
as	I-T103
a	I-T103
molecular	I-T103
chaperone	I-T103
.	O
elevated	O
levels	O
of	O
sirt	B-T017
##2	I-T017
sensitized	B-T017
breast	I-T017
cancer	I-T017
cells	I-T017
to	O
intracellular	B-T038
dna	I-T038
damage	I-T038
and	O
cell	B-T038
death	I-T038
induced	I-T038
by	I-T038
oxidative	I-T038
stress	I-T038
,	O
as	O
associated	O
with	O
increased	O
levels	O
of	O
nuclear	B-T103
fox	I-T103
##o3	I-T103
##a	I-T103
and	O
the	O
proapoptotic	B-T103
bim	I-T103
protein	I-T103
.	O
in	O
addition	O
,	O
elevated	O
levels	O
of	O
sirt	B-T103
##2	I-T103
sensitized	B-T017
breast	I-T017
cancer	I-T017
cells	I-T017
to	O
arsenic	B-T103
tri	I-T103
##oxide	I-T103
,	O
an	O
approved	O
therapeutic	O
agent	O
,	O
along	O
with	O
other	O
intracellular	B-T103
ros	I-T103
-	O
inducing	B-T103
agents	I-T103
.	O
conversely	O
,	O
antisense	B-T103
rna	I-T103
-	O
mediated	O
attenuation	O
of	O
sirt	B-T103
##2	I-T103
reversed	O
ros	B-T103
-	O
induced	B-T037
toxicity	I-T037
as	O
demonstrated	O
in	O
a	O
zebrafish	B-T204
embryo	B-T017
model	I-T017
system	I-T017
.	O
collectively	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
tumor	B-T038
suppressor	I-T038
activity	I-T038
of	O
sirt	B-T103
##2	I-T103
requires	O
its	O
ability	O
to	O
restrict	O
the	O
antioxidant	B-T038
activity	I-T038
of	O
pr	B-T103
##d	I-T103
##x	I-T103
-	I-T103
1	I-T103
,	O
thereby	O
sensitizing	B-T017
breast	I-T017
cancer	I-T017
cells	I-T017
to	O
ros	B-T103
-	O
induced	B-T038
dna	I-T038
damage	I-T038
and	O
cell	B-T038
cytotoxicity	I-T038
.	O
cancer	O
res	O
;	O
76	O
(	O
18	O
)	O
;	O
54	O
##67	O
-	O
78	O
.	O
©	O
##20	O
##16	O
aac	O
##r	O
.	O

role	O
of	O
cysteine	B-T103
residues	O
in	O
regulation	O
of	O
peptid	B-T038
##yl	I-T038
-	I-T038
prolyl	I-T038
cis	I-T038
-	I-T038
trans	I-T038
isomerase	I-T038
activity	I-T038
of	O
wheat	B-T168
cyclo	B-T103
##phi	I-T103
##lin	I-T103
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1	I-T017
oxidative	O
conditions	O
result	O
in	O
inhibition	O
of	O
peptid	B-T038
##yl	I-T038
-	I-T038
prolyl	I-T038
cis	I-T038
-	I-T038
trans	I-T038
isomerase	I-T038
(	I-T038
ppi	I-T038
##ase	I-T038
)	I-T038
activity	I-T038
of	O
several	O
cyclo	B-T103
##phi	I-T103
##lin	I-T103
##s	I-T103
.	O
thiol	B-T103
groups	O
have	O
been	O
implicated	O
in	O
redox	B-T038
regulation	O
of	O
these	O
proteins	B-T103
.	O
in	O
our	O
previous	O
study	O
,	O
we	O
proposed	O
that	O
activity	B-T038
of	O
wheat	B-T168
cyclo	B-T103
##phi	I-T103
##lin	I-T103
,	O
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1	I-T017
,	O
may	O
be	O
modulated	B-T082
through	O
a	O
novel	O
dual	O
mechanism	O
of	O
redox	B-T038
regulation	O
.	O
to	O
further	O
understand	O
the	O
regulation	O
of	O
ppi	B-T038
##ase	I-T038
activity	I-T038
of	O
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1	I-T017
,	O
we	O
generated	O
mutants	B-T038
of	O
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1	I-T017
by	O
substitu	O
##ting	O
cysteine	B-T103
residues	O
at	O
positions	B-T082
-	O
40	O
and	O
-	O
122	O
with	O
serine	B-T103
,	O
and	O
at	O
-	O
126	O
with	O
proline	B-T103
.	O
comparative	O
analysis	O
of	O
their	O
ppi	B-T038
##ase	I-T038
activity	I-T038
revealed	O
that	O
catalytic	O
efficiencies	O
(	O
kcat	O
/	O
km	O
)	O
of	O
tac	B-T103
##yp	I-T103
##a	I-T103
-	I-T103
1c	I-T103
##40	I-T103
##s	I-T103
(	O
0	O
.	O
37	O
x	O
106	O
m	O
-	O
1	O
s	O
-	O
1	O
)	O
and	O
tac	B-T103
##yp	I-T103
##a	I-T103
-	I-T103
1c	I-T103
##12	I-T103
##2s	I-T103
(	O
0	O
.	O
31	O
x	O
106	O
m	O
-	O
1	O
s	O
-	O
1	O
)	O
were	O
significantly	O
lower	O
as	O
compared	O
to	O
the	O
native	O
tac	B-T103
##yp	I-T103
##a	I-T103
-	I-T103
1	I-T103
(	O
1	O
.	O
33	O
x	O
106	O
m	O
-	O
1	O
s	O
-	O
1	O
)	O
,	O
whereas	O
kcat	O
/	O
km	O
of	O
the	O
double	O
mutant	B-T038
tac	B-T103
##yp	I-T103
##a	I-T103
-	I-T103
1c	I-T103
##40	I-T103
##s	I-T103
/	I-T103
c12	I-T103
##2s	I-T103
was	O
significantly	O
higher	O
(	O
2	O
.	O
36	O
x	O
106	O
m	O
-	O
1	O
s	O
-	O
1	O
)	O
.	O
compared	O
to	O
wild	B-T017
-	I-T017
type	I-T017
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1	I-T017
,	O
the	O
different	O
mutants	B-T038
also	O
showed	O
differential	O
sensitivity	O
to	O
cu2	B-T103
+	I-T103
.	O
furthermore	O
,	O
the	O
results	O
of	O
this	O
study	B-T062
also	O
revealed	O
that	O
despite	O
lacking	O
ppi	B-T038
##ase	I-T038
activity	I-T038
,	O
the	O
mutant	B-T038
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1c	I-T017
##126	I-T017
##p	I-T017
was	O
able	O
to	O
confer	O
partial	O
protection	O
against	O
heat	B-T038
stress	I-T038
.	O
these	O
observations	B-T062
suggest	O
that	O
the	O
mechanism	O
of	O
tac	B-T017
##yp	I-T017
##a	I-T017
-	I-T017
1	I-T017
-	O
induced	O
thermo	B-T038
##to	I-T038
##ler	I-T038
##ance	I-T038
may	O
also	O
involve	O
other	O
activities	O
besides	O
cis	O
to	O
trans	O
isomer	O
##isation	O
,	O
which	O
needs	O
to	O
be	O
identified	O
further	O
.	O

the	O
sensitivity	O
and	O
specif	O
##ity	O
of	O
dr	B-T103
-	I-T103
70	I-T103
immunoassay	B-T058
as	O
a	O
tumor	B-T103
marker	I-T103
for	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
lung	B-T038
cancer	I-T038
is	O
the	O
most	O
important	O
causes	O
of	O
the	O
cancer	O
related	O
mortality	O
.	O
patients	O
with	O
lung	B-T038
cancer	I-T038
are	O
usually	O
diagnosed	B-T058
at	O
advanced	B-T082
or	O
locally	B-T082
advanced	I-T082
stage	I-T082
,	O
for	O
this	O
reason	O
early	B-T058
diagnosis	I-T058
of	O
lung	B-T038
cancer	I-T038
is	O
very	O
important	O
.	O
for	O
early	B-T058
detection	I-T058
of	O
lung	B-T038
cancer	I-T038
some	O
methods	O
are	O
emphasized	O
such	O
as	O
low	B-T058
-	I-T058
dose	I-T058
computed	I-T058
tomography	I-T058
or	O
tumor	B-T103
biomarkers	I-T103
.	O
in	O
this	O
study	O
we	O
aimed	O
to	O
evaluate	B-T058
dr	B-T103
-	I-T103
70	I-T103
sensitivity	O
and	O
specificity	O
as	O
a	O
tumor	B-T103
marker	I-T103
in	O
detection	B-T058
of	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancers	I-T038
.	O
between	O
may	O
2013	O
and	O
april	O
2014	O
,	O
the	O
serum	B-T031
samples	I-T031
from	O
88	O
non	B-T038
lung	I-T038
cancer	I-T038
patients	O
,	O
86	O
patients	O
with	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
dise	I-T038
##sa	I-T038
##se	I-T038
were	O
obtained	O
.	O
blood	B-T031
samples	I-T031
from	O
each	O
participant	B-T098
were	O
analyzed	B-T062
for	O
dr	B-T103
-	I-T103
70	I-T103
level	O
.	O
totally	O
174	O
patients	O
were	O
enrolled	O
to	O
the	O
study	B-T062
(	O
152	O
male	B-T098
,	O
22	O
female	B-T098
)	O
.	O
histopathologically	O
47	O
(	O
53	O
.	O
4	O
%	O
)	O
patients	O
were	O
diagnosed	B-T058
with	O
squamous	B-T038
cell	I-T038
lung	I-T038
cancer	I-T038
,	O
34	O
(	O
38	O
.	O
6	O
%	O
)	O
with	O
adenocarcinoma	B-T038
,	O
and	O
7	O
(	O
8	O
%	O
)	O
with	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
.	O
the	O
mean	B-T103
serum	I-T103
dr	I-T103
-	I-T103
70	I-T103
levels	O
in	O
lung	B-T038
cancer	I-T038
patients	O
(	O
2	O
.	O
43	O
±	O
1	O
.	O
82	O
µg	O
/	O
ml	O
)	O
was	O
significantly	B-T033
higher	I-T033
compared	O
to	O
the	O
86	O
non	B-T033
-	I-T033
cancerous	I-T033
subjects	B-T098
(	O
1	O
.	O
15	O
±	O
0	O
.	O
70	O
µg	O
/	O
ml	O
)	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
dr	B-T103
-	I-T103
70	I-T103
exhibited	O
clinical	O
sensitivity	O
and	O
specificity	O
of	O
54	O
.	O
5	O
and	O
83	O
.	O
7	O
%	O
,	O
respectively	O
,	O
at	O
an	O
optimal	O
cut	O
off	O
at	O
1	O
.	O
98	O
µg	O
/	O
ml	O
.	O
it	O
could	O
be	O
said	O
that	O
the	O
risk	O
of	O
the	O
presence	O
of	O
the	O
disease	B-T038
is	O
6	O
.	O
171	O
times	O
higher	O
in	O
the	O
cases	O
where	O
dr	B-T103
-	I-T103
70	I-T103
level	O
is	O
1	O
.	O
98	O
µg	O
/	O
ml	O
and	O
higher	O
.	O
dr	B-T103
-	I-T103
70	I-T103
,	O
a	O
marker	B-T103
used	O
to	O
measure	O
fibrin	B-T103
degradation	I-T103
products	I-T103
,	O
generated	O
by	O
all	O
major	O
cancers	B-T038
,	O
may	O
helps	O
to	O
find	O
high	B-T033
risk	I-T033
lung	B-T038
cancer	I-T038
patients	O
.	O

international	B-T170
liver	I-T170
transplant	I-T170
society	I-T170
practice	I-T170
guidelines	I-T170
:	O
diagnosis	B-T033
and	O
management	B-T058
of	O
hepat	B-T038
##opulmonary	I-T038
syndrome	I-T038
and	O
port	B-T038
##opulmonary	I-T038
hypertension	I-T038
two	O
distinct	O
pulmonary	B-T038
vascular	I-T038
disorders	I-T038
,	O
hepat	B-T038
##opulmonary	I-T038
syndrome	I-T038
(	O
hps	B-T038
)	O
and	O
port	B-T038
##opulmonary	I-T038
hypertension	I-T038
(	O
pop	B-T038
##h	I-T038
)	O
may	O
occur	O
as	O
a	O
consequence	O
of	O
hepatic	B-T017
parenchymal	I-T017
or	O
vascular	B-T033
abnormalities	I-T033
.	O
hps	B-T038
and	O
pop	B-T038
##h	I-T038
have	O
major	O
clinical	O
implications	B-T033
for	O
liver	B-T058
transplantation	I-T058
.	O
a	O
european	O
respiratory	O
society	O
task	O
force	O
on	O
pulmonary	B-T038
-	I-T038
hepatic	I-T038
disorders	I-T038
conven	O
##ed	O
in	O
2002	O
to	O
standardize	O
the	O
diagnosis	B-T033
and	O
guide	B-T170
management	I-T170
of	O
these	O
disorders	B-T038
.	O
these	O
international	B-T170
liver	I-T170
transplant	I-T170
society	I-T170
diagnostic	I-T170
and	I-T170
management	I-T170
guidelines	I-T170
are	O
based	O
on	O
that	O
task	O
force	O
consensus	O
and	O
should	O
continue	O
to	O
evolve	O
as	O
clinical	O
experience	O
dict	O
##ates	O
.	O
based	O
on	O
a	O
review	O
of	O
over	O
1000	O
published	O
hps	B-T038
and	O
pop	B-T038
##h	I-T038
articles	O
identified	O
via	O
a	O
medline	B-T170
search	I-T170
(	O
1985	O
-	O
2015	O
)	O
,	O
clinical	B-T170
guidelines	I-T170
were	O
based	O
on	O
,	O
selected	B-T058
single	I-T058
care	I-T058
reports	I-T058
,	O
small	O
series	O
,	O
registries	B-T170
,	O
databases	B-T170
,	O
and	O
expert	O
opinion	O
.	O
the	O
paucity	O
of	O
randomized	B-T062
,	I-T062
controlled	I-T062
trials	I-T062
in	O
either	O
of	O
these	O
disorders	B-T038
was	O
noted	O
.	O
guidelines	B-T170
are	O
presented	O
in	O
5	O
parts	O
;	O
i	O
.	O
definitions	O
/	O
diagnostic	B-T170
criteria	I-T170
;	O
ii	O
.	O
hepat	B-T038
##opulmonary	I-T038
syndrome	I-T038
;	O
iii	O
.	O
port	B-T038
##opulmonary	I-T038
hypertension	I-T038
;	O
iv	O
.	O
implications	B-T033
for	O
liver	B-T058
transplantation	I-T058
;	O
and	O
v	O
.	O
suggestions	O
for	O
future	O
clinical	B-T062
research	I-T062
.	O

functional	O
1	B-T103
,	I-T103
3a	I-T103
,	I-T103
6a	I-T103
-	I-T103
triaz	I-T103
##apent	I-T103
##ale	I-T103
##ne	I-T103
scaffold	O
:	O
design	O
of	O
fluorescent	B-T103
probes	I-T103
for	O
kines	B-T103
##in	I-T103
spindle	I-T103
protein	I-T103
(	O
ks	B-T103
##p	I-T103
)	O
1	B-T103
,	I-T103
3a	I-T103
,	I-T103
6a	I-T103
-	I-T103
triaz	I-T103
##apent	I-T103
##ale	I-T103
##ne	I-T103
is	O
a	O
compact	O
fluorescent	B-T103
chromophore	O
.	O
in	O
this	O
study	B-T062
,	O
triaz	B-T103
##apent	I-T103
##ale	I-T103
##ne	I-T103
was	O
used	O
to	O
modify	O
a	O
series	O
of	O
biphenyl	B-T103
-	I-T103
type	I-T103
inhibitors	B-T103
of	O
kines	B-T103
##in	I-T103
spindle	I-T103
protein	I-T103
(	O
ks	B-T103
##p	I-T103
)	O
to	O
develop	O
fluorescent	B-T103
probes	I-T103
for	O
the	O
intracellular	B-T082
visualization	O
of	O
this	O
protein	B-T103
.	O
microscopic	O
studies	B-T062
demonstrated	O
that	O
these	O
novel	O
triaz	B-T103
##apent	I-T103
##ale	I-T103
##ne	I-T103
-	O
labeled	O
compounds	B-T103
exhibited	O
inhibitory	O
activity	O
towards	O
ks	B-T103
##p	I-T103
in	O
cultured	B-T017
cells	I-T017
and	O
provided	O
important	O
information	O
concerning	O
the	O
intracellular	B-T082
distribution	O
.	O

microbiology	B-T058
of	O
the	O
upper	B-T082
and	O
lower	B-T038
airways	I-T038
in	O
pediatric	O
cystic	B-T038
fibrosis	I-T038
patients	O
objective	O
to	O
evaluate	O
the	O
microbiology	O
of	O
the	O
upper	O
and	O
lower	O
airways	O
in	O
pediatric	O
cystic	B-T038
fibrosis	I-T038
(	O
cf	B-T038
)	O
patients	O
who	O
underwent	O
sinus	B-T058
surgery	I-T058
.	O
study	O
design	O
retrospective	B-T062
case	O
series	O
with	O
chart	O
review	O
.	O
setting	O
tertiary	B-T092
care	I-T092
children	B-T092
'	I-T092
s	I-T092
hospital	I-T092
.	O
subjects	O
and	O
methods	O
a	O
total	O
of	O
201	O
paired	O
sinus	O
and	O
pulmonary	O
cultures	O
from	O
105	O
cf	B-T038
patients	O
were	O
identified	O
between	O
1996	O
and	O
2014	O
.	O
demographics	B-T062
and	O
culture	B-T058
results	O
were	O
analyzed	O
.	O
results	O
the	O
mean	O
age	O
of	O
patients	O
was	O
11	O
.	O
2	O
±	O
5	O
.	O
4	O
years	O
(	O
range	O
,	O
1	O
-	O
27	O
years	O
)	O
,	O
and	O
approximately	O
one	O
-	O
half	O
were	O
female	B-T098
.	O
methicillin	B-T103
-	O
sensitive	O
staphylococcus	B-T007
aureus	I-T007
was	O
the	O
most	O
common	O
pathogen	O
overall	O
.	O
a	O
significantly	O
higher	O
prevalence	O
of	O
pseudomonas	B-T007
aeruginosa	I-T007
(	O
32	O
%	O
for	O
pulmonary	O
and	O
37	O
%	O
for	O
sinus	O
cultures	O
)	O
was	O
observed	O
in	O
older	B-T098
patients	O
versus	O
younger	O
patients	O
(	O
p	O
<	O
.	O
001	O
)	O
.	O
there	O
was	O
low	O
to	O
moderate	O
agreement	O
between	O
sinus	O
and	O
pulmonary	O
cultures	O
(	O
kappa	B-T170
statistic	O
range	O
,	O
0	O
.	O
03	O
-	O
0	O
.	O
56	O
)	O
.	O
the	O
prevalence	O
of	O
methicillin	B-T007
-	I-T007
resistant	I-T007
s	I-T007
aureus	I-T007
(	O
mrsa	B-T007
)	O
increased	O
significantly	O
for	O
lower	O
respiratory	O
tract	O
culture	O
(	O
from	O
5	O
%	O
to	O
16	O
%	O
)	O
and	O
sinus	O
culture	O
(	O
from	O
5	O
%	O
to	O
27	O
%	O
)	O
between	O
1996	O
-	O
2004	O
and	O
2010	O
-	O
2014	O
(	O
p	O
=	O
.	O
016	O
and	O
p	O
<	O
.	O
001	O
,	O
respectively	O
)	O
.	O
the	O
prevalence	O
of	O
positive	B-T033
sinus	O
cultures	O
increased	O
from	O
40	O
%	O
to	O
85	O
%	O
between	O
1996	O
-	O
2004	O
and	O
2010	O
-	O
2014	O
(	O
p	O
=	O
.	O
018	O
)	O
.	O
patients	O
with	O
pulmonary	O
mrsa	B-T007
were	O
more	O
likely	O
to	O
be	O
coin	B-T038
##fected	I-T038
with	O
pulmonary	O
p	B-T007
aeruginosa	I-T007
(	O
risk	O
ratio	O
,	O
2	O
.	O
4	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
2	O
-	O
4	O
.	O
8	O
;	O
p	O
=	O
.	O
015	O
)	O
or	O
aspergillus	B-T204
fumigatus	I-T204
(	O
risk	O
ratio	O
,	O
2	O
.	O
2	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
2	O
-	O
4	O
.	O
8	O
;	O
p	O
=	O
.	O
035	O
)	O
.	O
conclusions	O
there	O
is	O
low	O
to	O
moderate	O
correlation	O
between	O
pulmonary	O
and	O
sinus	B-T082
pathogens	O
in	O
cf	B-T038
patients	O
.	O
this	O
is	O
important	O
to	O
consider	O
when	O
treating	B-T058
infections	B-T038
.	O
the	O
prevalence	O
of	O
mrsa	B-T007
in	O
sinus	O
cultures	O
has	O
increased	O
over	O
time	O
and	O
warrants	O
further	O
investigation	B-T058
.	O

participation	O
in	O
and	O
adherence	O
to	O
physical	O
exercise	O
after	O
completion	O
of	O
primary	B-T038
cancer	I-T038
treatment	B-T058
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
identify	B-T038
demographic	O
,	O
clinical	O
,	O
psychosocial	O
,	O
physical	O
and	O
environmental	B-T082
factors	O
that	O
are	O
associated	O
with	O
participation	O
in	O
and	O
adherence	O
to	O
a	O
combined	O
resistance	O
and	O
endurance	B-T058
exercise	I-T058
program	O
among	O
cancer	O
survivors	O
,	O
shortly	O
after	O
completion	O
of	O
primary	B-T038
cancer	I-T038
treatment	B-T058
.	O
data	O
from	O
the	O
randomized	B-T033
controlled	O
resistance	B-T170
and	I-T170
endurance	I-T170
exercise	I-T170
after	I-T170
chemotherapy	I-T170
(	O
react	B-T170
)	O
study	B-T062
were	O
used	O
for	O
this	O
study	B-T062
.	O
the	O
participants	B-T098
of	O
the	O
react	B-T170
study	B-T062
were	O
randomly	O
allocated	O
to	O
either	O
a	O
high	B-T170
intensity	I-T170
(	O
hi	B-T170
)	O
or	O
low	O
-	O
to	O
-	O
moderate	B-T170
intensity	I-T170
(	O
lm	O
##i	O
)	O
exercise	O
program	O
.	O
patients	O
'	O
participation	O
rate	O
was	O
defined	O
as	O
the	O
cancer	O
survivors	O
'	O
decision	O
to	O
participate	O
in	O
the	O
react	B-T170
study	B-T062
.	O
exercise	O
adherence	O
reflected	B-T038
participants	B-T098
'	O
attendance	O
to	O
the	O
scheduled	O
exercise	O
sessions	O
and	O
their	O
compliance	O
to	O
the	O
prescribed	O
exercises	O
.	O
high	O
session	O
attendance	O
rates	O
were	O
defined	O
as	O
attending	O
at	O
least	O
80	O
%	O
of	O
the	O
sessions	O
.	O
high	O
compliance	O
rates	O
were	O
defined	O
as	O
performing	O
at	O
least	O
of	O
90	O
%	O
of	O
the	O
prescribed	O
exercise	O
across	O
all	O
sessions	O
.	O
correlates	O
of	O
exercise	O
adherence	O
were	O
studied	B-T062
separately	O
for	O
hi	B-T170
and	O
lm	O
##i	O
exercise	O
.	O
demographic	O
,	O
clinical	O
,	O
and	O
physical	O
factors	O
were	O
assessed	O
using	O
self	B-T062
-	I-T062
reported	I-T062
questionnaires	B-T170
.	O
relevant	O
clinical	B-T170
information	I-T170
was	O
extracted	O
from	O
medical	B-T170
records	I-T170
.	O
multivariable	O
logistic	O
regression	O
analyses	O
were	O
applied	O
to	O
identify	B-T038
correlates	O
that	O
were	O
significantly	O
associated	O
with	O
participation	O
,	O
high	O
session	O
attendance	O
,	O
high	O
compliance	O
with	O
resistance	O
and	O
high	O
compliance	O
with	O
endurance	B-T058
exercises	I-T058
.	O
participants	B-T098
were	O
more	O
likely	O
to	O
have	O
higher	B-T170
education	I-T170
,	O
be	O
non	B-T033
-	I-T033
smokers	I-T033
,	O
have	O
lower	O
psychological	O
distress	O
,	O
higher	O
outcome	O
expectations	O
,	O
and	O
perceive	B-T038
more	O
exercise	O
barriers	O
than	O
non	B-T098
-	I-T098
participants	I-T098
.	O
in	O
hi	B-T170
exercise	O
,	O
higher	O
self	B-T038
-	I-T038
efficacy	I-T038
was	O
significantly	O
associated	O
with	O
high	O
session	O
attendance	O
and	O
high	O
compliance	O
with	O
endurance	B-T058
exercises	I-T058
,	O
and	O
lower	O
psychological	O
distress	O
was	O
significantly	O
associated	O
with	O
high	O
compliance	O
with	O
resistance	O
exercise	O
s	O
.	O
in	O
lm	O
##i	O
exercise	O
,	O
being	O
a	O
non	B-T033
-	I-T033
smoker	I-T033
was	O
significantly	O
associated	O
with	O
high	O
compliance	O
with	O
resistance	O
exercises	O
and	O
higher	O
bmi	B-T201
was	O
significantly	O
associated	O
with	O
high	O
compliance	O
with	O
resistance	O
and	O
endurance	B-T058
exercises	I-T058
.	O
furthermore	O
,	O
breast	O
cancer	O
survivors	O
were	O
less	O
likely	O
to	O
report	B-T058
high	O
compliance	O
with	O
resistance	O
and	O
endurance	B-T058
exercises	I-T058
in	O
lm	O
##i	O
exercise	O
compared	O
to	O
survivors	O
of	O
other	O
types	O
of	O
cancer	B-T038
.	O
the	O
discriminative	B-T038
ability	O
of	O
the	O
multivariable	O
models	B-T170
ranged	O
from	O
0	O
.	O
62	O
to	O
0	O
.	O
75	O
.	O
several	O
demographic	O
,	O
clinical	O
and	O
psychosocial	O
factors	O
were	O
associated	O
with	O
participation	O
in	O
and	O
adherence	O
to	O
exercise	O
among	O
cancer	O
survivors	O
.	O
psychosocial	O
factors	O
were	O
more	O
strongly	O
associated	O
with	O
adherence	O
in	O
hi	B-T170
than	O
lm	O
##i	O
exercise	O
.	O
this	O
study	B-T062
was	O
registered	B-T170
at	O
the	O
netherlands	B-T170
trial	I-T170
register	I-T170
[	O
ntr	B-T170
##21	I-T170
##53	I-T170
]	O
on	O
the	O
5	O
(	O
th	O
)	O
of	O
january	O
2010	O
.	O

3m	O
##o	O
:	O
a	O
model	O
for	O
music	B-T170
-	O
based	O
biofeedback	B-T058
in	O
the	O
domain	O
of	O
sports	O
and	O
motor	B-T038
rehabilitation	O
,	O
it	O
is	O
of	O
major	O
importance	O
to	O
regulate	B-T038
and	O
control	O
physiological	B-T038
processes	I-T038
and	O
physical	O
motion	O
in	O
most	O
optimal	O
ways	O
.	O
for	O
that	O
purpose	O
,	O
real	O
-	O
time	O
auditory	O
feedback	O
of	O
physiological	O
and	O
physical	O
information	O
based	O
on	O
sound	O
signals	O
,	O
often	O
termed	O
[UNK]	O
son	O
##ification	O
,	O
[UNK]	O
has	O
been	O
proven	O
particularly	O
useful	O
.	O
however	O
,	O
the	O
use	O
of	O
music	B-T170
in	O
biofeedback	B-T058
systems	O
has	O
been	O
much	O
less	O
explored	B-T058
.	O
in	O
the	O
current	O
article	B-T170
,	O
we	O
asser	O
##t	O
that	O
the	O
use	O
of	O
music	B-T170
,	O
and	O
musical	B-T170
principles	O
,	O
can	O
have	O
a	O
major	O
added	O
value	B-T170
,	O
on	O
top	O
of	O
mer	O
##e	O
sound	O
signals	O
,	O
to	O
the	O
benefit	O
of	O
psychological	O
and	O
physical	O
optimization	O
of	O
sports	O
and	O
motor	B-T038
rehabilitation	O
tasks	O
.	O
in	O
this	O
article	B-T170
,	O
we	O
present	O
the	O
3m	O
##o	O
model	O
to	O
describe	O
three	O
main	O
functions	O
of	O
music	B-T170
that	O
contribute	O
to	O
these	O
benefits	O
.	O
these	O
functions	O
relate	O
the	O
power	O
of	O
music	B-T170
to	O
motiv	B-T038
##ate	I-T038
,	O
and	O
to	O
monitor	B-T058
and	O
modify	O
physiological	O
and	O
physical	O
processes	O
.	O
the	O
model	O
brings	O
together	O
concepts	O
and	O
theories	O
related	O
to	O
human	B-T204
sensorimotor	O
interaction	O
with	O
music	B-T170
,	O
and	O
specif	O
##ies	O
the	O
underlying	O
psychological	O
and	O
physiological	O
principles	O
.	O
this	O
3m	O
##o	O
model	O
is	O
intended	O
to	O
provide	O
a	O
conceptual	O
framework	O
that	O
guides	B-T170
future	O
research	B-T062
on	O
musical	B-T170
biofeedback	B-T058
systems	O
in	O
the	O
domain	O
of	O
sports	O
and	O
motor	B-T038
rehabilitation	O
.	O
journal	O

alanine	B-T103
to	O
serine	B-T103
variant	O
at	O
position	O
98	O
##6	O
of	O
calcium	B-T103
sensing	I-T103
receptor	I-T103
and	O
colorectal	B-T038
cancer	I-T038
risk	O
with	O
regard	O
to	O
the	O
effect	O
of	O
calcium	B-T103
against	O
colorectal	B-T038
cancer	I-T038
(	O
crc	B-T038
)	O
and	O
considering	O
the	O
key	O
role	O
of	O
calcium	B-T103
sensing	I-T103
receptor	I-T103
(	O
cas	B-T103
##r	I-T103
)	O
in	O
calcium	O
homeostasis	O
,	O
this	O
study	O
investigated	O
whether	O
cas	B-T017
##r	I-T017
gene	I-T017
rs	B-T017
##180	I-T017
##17	I-T017
##25	I-T017
or	O
a	B-T017
##98	I-T017
##6	I-T017
##s	I-T017
variant	I-T017
was	O
associated	O
with	O
susceptibility	O
to	O
crc	B-T038
risk	O
.	O
this	O
study	O
was	O
conducted	O
as	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
and	O
303	O
cases	O
with	O
crc	B-T038
and	O
35	O
##4	O
controls	O
were	O
enrolled	O
.	O
all	O
65	O
##7	O
subjects	O
were	O
genotyped	O
for	O
cas	B-T017
##r	I-T017
gene	I-T017
a	B-T017
##98	I-T017
##6	I-T017
##s	I-T017
variant	I-T017
using	O
pcr	B-T062
-	O
rflp	B-T058
method	I-T058
.	O
no	B-T033
significant	I-T033
difference	O
was	O
observed	O
for	O
the	O
a	B-T017
##98	I-T017
##6	I-T017
##s	I-T017
variant	I-T017
of	O
cas	B-T017
##r	I-T017
gene	I-T017
in	O
either	O
genotype	O
or	O
allele	O
frequencies	O
between	O
the	O
cases	O
and	O
the	O
controls	O
and	O
this	O
lack	O
of	O
difference	O
remained	O
non	O
-	O
significant	O
even	O
after	O
adjustment	O
for	O
age	O
,	O
bmi	B-T201
,	O
sex	O
,	O
smoking	B-T201
status	I-T201
,	O
and	O
family	B-T033
history	I-T033
of	O
crc	B-T038
.	O
no	O
evidence	O
for	O
the	O
effect	O
modification	B-T033
of	O
the	O
association	O
a	B-T017
##98	I-T017
##6	I-T017
##s	I-T017
variant	I-T017
and	O
crc	B-T038
by	O
bmi	B-T201
,	O
sex	O
,	O
or	O
tumor	B-T082
site	I-T082
was	O
also	O
observed	O
.	O
furthermore	O
,	O
the	O
risk	O
of	O
obesity	B-T038
in	O
relation	O
to	O
the	O
a	B-T017
##98	I-T017
##6	I-T017
##s	I-T017
variant	I-T017
in	O
the	O
controls	O
and	O
the	O
cases	O
was	O
separately	O
analyzed	B-T062
and	O
we	O
observed	O
no	O
significant	O
difference	O
between	O
normal	B-T033
weight	I-T033
(	O
bmi	B-T201
<	O
25	O
##kg	O
/	O
m	O
(	O
2	O
)	O
)	O
and	O
overweight	B-T033
/	O
obese	B-T038
(	O
bmi	B-T201
≥	O
25	O
##kg	O
/	O
m	O
(	O
2	O
)	O
)	O
subjects	O
.	O
our	O
findings	B-T033
do	O
not	O
support	O
a	O
role	O
for	O
effect	O
of	O
the	O
cas	B-T017
##r	I-T017
gene	I-T017
a	B-T017
##98	I-T017
##6	I-T017
##s	I-T017
variant	I-T017
on	O
crc	B-T038
risk	O
;	O
nevertheless	O
,	O
this	O
finding	B-T033
requires	O
confirmation	B-T033
and	O
the	O
role	O
of	O
the	O
gene	B-T017
variant	I-T017
in	O
carcinogenesis	B-T038
needs	O
to	O
be	O
further	O
investigated	O
.	O

regulated	B-T038
intron	B-T103
removal	O
integrates	O
motivational	O
state	O
and	O
experience	B-T038
myriad	O
experiences	B-T038
produce	O
transient	B-T038
memory	I-T038
,	O
yet	O
,	O
contingent	O
on	O
the	O
internal	B-T038
state	I-T038
of	O
the	O
organism	O
and	O
the	O
sal	O
##ie	O
##nc	O
##y	O
of	O
the	O
experience	B-T038
,	O
only	O
some	O
memories	B-T038
persist	O
over	O
time	O
.	O
how	O
experience	B-T038
and	O
internal	B-T038
state	I-T038
influence	O
the	O
duration	O
of	O
memory	B-T038
at	O
the	O
molecular	O
level	O
remains	O
unknown	O
.	O
a	O
self	O
-	O
assembled	O
aggregated	O
state	O
of	O
drosophila	B-T103
orb	I-T103
##2a	I-T103
protein	I-T103
is	O
required	O
specifically	O
for	O
long	B-T038
-	I-T038
lasting	I-T038
memory	I-T038
.	O
we	O
report	O
that	O
in	O
the	O
adult	O
fly	O
brain	B-T017
the	O
mrna	B-T103
encoding	O
orb	B-T103
##2a	I-T103
protein	I-T103
exists	O
in	O
an	O
unsp	B-T103
##lic	I-T103
##ed	I-T103
non	I-T103
-	I-T103
protein	I-T103
-	I-T103
coding	I-T103
form	I-T103
.	O
the	O
convergence	O
of	O
experience	B-T038
and	O
internal	B-T038
drive	I-T038
transiently	O
increases	O
the	O
spliced	B-T103
protein	I-T103
-	I-T103
coding	I-T103
orb	I-T103
##2a	I-T103
mrna	I-T103
.	O
a	O
screen	O
identified	O
pas	B-T103
##illa	I-T103
,	O
the	O
fly	O
ortholog	O
of	O
mammalian	B-T204
nov	B-T103
##a	I-T103
-	I-T103
1	I-T103
/	O
2	B-T103
,	O
as	O
a	O
mediator	B-T103
of	O
orb	B-T103
##2a	I-T103
mrna	I-T103
processing	B-T038
.	O
a	O
single	B-T103
-	I-T103
nucleotide	I-T103
substitution	O
in	O
the	O
intron	B-T103
##ic	I-T103
region	O
that	O
reduces	O
pas	B-T103
##illa	I-T103
binding	B-T038
and	O
intron	B-T103
removal	O
selectively	O
impairs	O
long	B-T038
-	I-T038
term	I-T038
memory	I-T038
.	O
we	O
posit	O
that	O
pas	B-T103
##illa	I-T103
-	O
mediated	O
processing	B-T038
of	O
unsp	B-T103
##lic	I-T103
##ed	I-T103
orb	I-T103
##2a	I-T103
mrna	I-T103
integrates	O
experience	B-T038
and	O
internal	B-T038
state	I-T038
to	O
control	O
orb	B-T103
##2a	I-T103
protein	I-T103
abundance	O
and	O
long	B-T038
-	I-T038
term	I-T038
memory	I-T038
formation	O
.	O

oxytocin	B-T103
reduces	O
face	B-T082
processing	O
time	O
but	O
leaves	O
recognition	B-T038
accuracy	O
and	O
eye	B-T017
-	O
gaze	B-T033
unaffected	O
previous	O
studies	B-T062
have	O
found	O
that	O
oxytocin	B-T103
(	O
ox	B-T103
##t	I-T103
)	O
can	O
improve	B-T033
the	O
recognition	B-T038
of	O
emotional	B-T033
facial	B-T033
expressions	I-T033
;	O
it	O
has	O
been	O
proposed	O
that	O
this	O
effect	O
is	O
mediated	O
by	O
an	O
increase	O
in	O
attention	B-T038
to	O
the	O
eye	B-T082
-	I-T082
region	I-T082
of	O
faces	B-T082
.	O
nevertheless	O
,	O
evidence	O
in	O
support	O
of	O
this	O
claim	O
is	O
inconsistent	O
,	O
and	O
few	O
studies	B-T062
have	O
directly	O
tested	O
the	O
effect	O
of	O
oxytocin	B-T103
on	O
emotion	B-T038
recognition	B-T038
via	O
altered	O
eye	B-T017
-	O
gaze	B-T033
methods	B-T170
:	O
in	O
a	O
double	B-T062
-	I-T062
blind	I-T062
,	O
within	B-T082
-	O
subjects	B-T098
,	O
randomized	B-T062
control	I-T062
experiment	I-T062
,	O
40	O
healthy	O
male	B-T098
participants	I-T098
received	O
24	O
iu	O
intranasal	B-T058
ox	B-T103
##t	I-T103
and	O
placebo	B-T103
in	O
two	O
identical	O
experimental	O
sessions	O
separated	O
by	O
a	O
2	O
-	O
week	O
interval	O
.	O
visual	B-T038
attention	I-T038
to	O
the	O
eye	B-T082
-	I-T082
region	I-T082
was	O
assessed	O
on	O
both	O
occasions	O
while	O
participants	B-T098
completed	O
a	O
static	O
facial	B-T082
emotion	B-T038
recognition	B-T038
task	O
using	O
medium	O
intensity	O
facial	B-T033
expressions	I-T033
.	O
although	O
ox	B-T103
##t	I-T103
had	O
no	O
effect	O
on	O
emotion	B-T038
recognition	B-T038
accuracy	O
,	O
recognition	B-T038
performance	O
was	O
improved	B-T033
because	O
face	B-T082
processing	O
was	O
faster	O
across	O
emotions	B-T038
under	O
the	O
influence	O
of	O
ox	B-T103
##t	I-T103
.	O
this	O
effect	O
was	O
marginally	O
significant	O
(	O
p	O
<	O
.	O
06	O
)	O
.	O
consistent	O
with	O
a	O
previous	O
study	B-T062
using	O
dynamic	O
stimuli	O
,	O
ox	B-T103
##t	I-T103
had	O
no	O
effect	O
on	O
eye	B-T017
-	O
gaze	B-T033
patterns	B-T082
when	O
viewing	B-T082
static	O
emotional	B-T033
faces	B-T082
and	O
this	O
was	O
not	O
related	O
to	O
recognition	B-T038
accuracy	O
or	O
face	B-T082
processing	O
time	O
.	O
these	O
findings	B-T033
suggest	O
that	O
ox	B-T103
##t	I-T103
-	O
induced	O
enhanced	O
facial	B-T082
emotion	B-T038
recognition	B-T038
is	O
not	O
necessarily	O
mediated	O
by	O
an	O
increase	O
in	O
attention	B-T038
to	O
the	O
eye	B-T082
-	I-T082
region	I-T082
of	O
faces	B-T082
,	O
as	O
previously	O
assumed	O
.	O
we	O
discuss	O
several	O
methodological	O
issues	B-T033
which	O
may	O
explain	O
discrep	B-T033
##ant	I-T033
findings	I-T033
and	O
suggest	O
the	O
effect	O
of	O
ox	B-T103
##t	I-T103
on	O
visual	B-T038
attention	I-T038
may	O
differ	O
depending	O
on	O
task	O
requirements	O
.	O
(	O
ji	O
##ns	O
,	O
2017	O
,	O
23	O
,	O
23	O
-	O
33	O
)	O
.	O

evolution	O
:	O
enhanced	O
foot	O
##ing	O
for	O
snake	B-T204
limb	B-T038
development	I-T038
two	O
groups	O
have	O
studied	O
the	O
loss	O
of	O
limbs	B-T017
in	O
snake	B-T204
evolution	O
by	O
focusing	O
on	O
a	O
long	B-T033
-	I-T033
distance	I-T033
cis	B-T082
-	I-T082
acting	I-T082
enhancer	I-T082
of	O
sonic	B-T017
hedgehog	I-T017
.	O
they	O
find	O
a	O
progressive	O
degeneration	O
of	O
binding	B-T082
sites	I-T082
for	O
key	O
transcription	B-T103
factors	I-T103
,	O
mirror	O
##ing	O
the	O
progressive	O
limb	O
##lessness	O
occurring	O
in	O
these	O
rep	B-T204
##tiles	I-T204
.	O

multiplex	O
social	O
ecological	B-T082
network	B-T062
analysis	I-T062
reveals	O
how	O
social	O
changes	O
affect	O
community	O
robustness	O
more	O
than	O
resource	O
depletion	O
network	B-T062
analysis	I-T062
provides	O
a	O
powerful	O
tool	O
to	O
analyze	O
complex	O
influences	O
of	O
social	O
and	O
ecological	B-T082
structures	I-T082
on	O
community	O
and	O
household	O
dynamics	O
.	O
most	O
network	B-T062
studies	I-T062
of	O
social	O
-	O
ecological	O
systems	O
use	O
simple	O
,	O
und	O
##irect	O
##ed	O
,	O
unw	O
##eight	O
##ed	O
networks	O
.	O
we	O
analyze	O
multiplex	O
,	O
directed	B-T082
,	O
and	O
weighted	O
networks	O
of	O
subs	O
##ist	O
##ence	O
food	B-T168
flows	O
collected	O
in	O
three	O
small	O
indigenous	O
communities	O
in	O
arctic	B-T082
ala	B-T082
##sk	I-T082
##a	I-T082
potentially	O
facing	O
substantial	O
economic	O
and	O
ecological	B-T082
changes	O
.	O
our	O
analysis	O
of	O
plausible	O
future	O
scenarios	O
suggests	O
that	O
changes	O
to	O
social	O
relations	O
and	O
key	O
households	O
have	O
greater	O
effects	O
on	O
community	O
robustness	O
than	O
changes	O
to	O
specific	O
wild	O
food	O
resources	O
.	O

persistent	O
effects	O
of	O
pre	O
-	O
columbia	O
##n	O
plant	B-T204
domestic	O
##ation	O
on	O
amazon	O
##ian	O
forest	O
composition	B-T201
the	O
extent	O
to	O
which	O
pre	O
-	O
columbia	O
##n	O
societies	B-T092
altered	O
amazon	O
##ian	O
landscapes	B-T082
is	O
hot	O
##ly	O
debated	O
.	O
we	O
performed	O
a	O
basin	B-T062
-	I-T062
wide	I-T062
analysis	I-T062
of	O
pre	O
-	O
columbia	O
##n	O
impacts	O
on	O
amazon	O
##ian	O
forests	O
by	O
overl	O
##ay	O
##ing	O
known	O
archae	B-T082
##ological	I-T082
sites	I-T082
in	O
amazon	O
##ia	O
with	O
the	O
distributions	O
and	O
abundances	O
of	O
85	O
wood	B-T204
##y	I-T204
species	B-T170
domestic	O
##ated	O
by	O
pre	O
-	O
columbia	O
##n	O
people	B-T098
##s	I-T098
.	O
domestic	O
##ated	O
species	B-T170
are	O
five	O
times	O
more	O
likely	O
than	O
nond	B-T170
##omes	I-T170
##tic	I-T170
##ated	I-T170
species	I-T170
to	O
be	O
hyper	O
##dom	O
##inant	O
.	O
across	O
the	O
basin	O
,	O
the	O
relative	O
abundance	O
and	O
richness	O
of	O
domestic	O
##ated	O
species	B-T170
increase	O
in	O
forests	O
on	O
and	O
around	O
archae	B-T082
##ological	I-T082
sites	I-T082
.	O
in	O
southwestern	O
and	O
eastern	O
amazon	O
##ia	O
,	O
distance	O
to	O
archae	B-T082
##ological	I-T082
sites	I-T082
strongly	O
influences	O
the	O
relative	O
abundance	O
and	O
richness	O
of	O
domestic	O
##ated	O
species	B-T170
.	O
our	O
analyses	B-T062
indicate	O
that	O
modern	O
tree	B-T204
communities	O
in	O
amazon	O
##ia	O
are	O
structured	O
to	O
an	O
important	O
extent	O
by	O
a	O
long	O
history	O
of	O
plant	B-T204
domestic	O
##ation	O
by	O
amazon	O
##ian	O
people	B-T098
##s	I-T098
.	O

radiation	O
-	O
induced	O
parotid	B-T038
gland	I-T038
atrophy	I-T038
in	O
patients	O
with	O
head	B-T038
and	I-T038
neck	I-T038
cancer	I-T038
after	O
carbon	B-T058
-	I-T058
ion	I-T058
radiotherapy	I-T058
this	O
study	B-T062
aimed	O
to	O
clarify	O
the	O
relationship	O
between	O
dosimetric	B-T058
factors	O
and	O
parotid	B-T038
gland	I-T038
(	I-T038
pg	I-T038
)	I-T038
atrophy	I-T038
after	O
carbon	B-T058
ion	I-T058
radiotherapy	I-T058
(	O
c	B-T058
-	I-T058
ion	I-T058
rt	I-T058
)	O
.	O
fifty	O
-	O
four	O
patients	O
with	O
head	B-T038
and	I-T038
neck	I-T038
tumours	I-T038
were	O
enrolled	O
and	O
93	O
irradiated	O
pgs	B-T017
were	O
analyzed	O
.	O
thirty	O
and	O
24	O
patients	O
were	O
treated	B-T058
with	I-T058
total	O
doses	O
[	O
relative	O
biological	O
effectiveness	O
(	O
rb	O
##e	O
)	O
]	O
of	O
57	O
.	O
6	O
gy	O
and	O
64	O
.	O
0	O
gy	O
,	O
respectively	O
,	O
in	O
16	O
fractions	O
.	O
pg	B-T017
volumes	O
were	O
measured	B-T058
using	O
computed	O
tomographic	O
images	O
obtained	O
before	O
c	B-T058
-	I-T058
ion	I-T058
rt	I-T058
and	O
every	O
3	O
-	O
6	O
months	O
thereafter	O
.	O
the	O
median	O
follow	B-T058
-	I-T058
up	I-T058
period	O
was	O
46	O
.	O
4	O
months	O
(	O
range	O
=	O
24	O
.	O
0	O
-	O
123	O
.	O
0	O
months	O
)	O
.	O
univariate	O
analysis	O
showed	O
that	O
pg	B-T017
volumes	O
receiving	O
more	O
than	O
5	O
,	O
10	O
,	O
15	O
,	O
and	O
20	O
gy	O
rb	O
##e	O
(	O
v	O
##5	O
,	O
v1	O
##0	O
,	O
v1	O
##5	O
and	O
v2	O
##0	O
,	O
respectively	O
)	O
,	O
mean	O
dose	O
,	O
and	O
maximum	O
dose	O
were	O
significantly	O
associated	O
with	O
pg	B-T038
atrophy	I-T038
.	O
multivariate	O
analysis	O
indicated	O
that	O
only	O
v	O
##5	O
was	O
significantly	O
associated	O
with	O
atrophy	B-T038
.	O
increasing	O
v	O
##5	O
was	O
a	O
significant	O
risk	B-T033
factor	I-T033
for	O
pg	B-T038
atrophy	I-T038
after	O
c	B-T058
-	I-T058
ion	I-T058
rt	I-T058
.	O

the	O
novel	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
suppresses	O
tumor	B-T038
progression	I-T038
and	O
promotes	O
paclitaxel	B-T103
sensitivity	O
in	O
non	B-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
through	O
altering	O
stat3	B-T017
expression	B-T038
micrornas	B-T103
have	O
been	O
identified	O
to	O
be	O
involved	O
in	O
center	B-T201
stage	I-T201
of	O
cancer	B-T091
biology	I-T091
.	O
they	O
accommodate	O
cell	B-T038
proliferation	I-T038
and	O
migration	B-T038
by	O
negatively	B-T033
regulate	B-T038
gene	I-T038
expression	I-T038
either	O
by	O
hamper	O
##ing	O
the	O
translation	O
of	O
targeted	B-T103
mrnas	I-T103
or	O
by	O
promoting	O
their	O
degradation	O
.	O
we	O
characterized	O
and	O
identified	O
the	O
novel	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
and	O
its	O
target	O
in	O
human	B-T204
non	B-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
(	O
nsclc	B-T038
)	O
.	O
our	O
results	O
demonstrated	O
that	O
the	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
were	O
downregulated	B-T038
in	O
nsclc	B-T038
tissues	B-T017
and	O
cells	B-T017
.	O
it	O
is	O
confirmed	O
that	O
signal	B-T017
transducer	I-T017
and	I-T017
activator	I-T017
of	I-T017
transcription	I-T017
3	I-T017
(	O
stat3	B-T017
)	O
,	O
a	O
putative	B-T017
target	I-T017
gene	I-T017
,	O
is	O
directly	O
inhibited	O
by	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
.	O
the	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
markedly	O
suppressed	O
the	O
protein	B-T038
expression	I-T038
of	O
stat3	B-T017
,	O
but	O
with	O
no	O
significant	O
influence	O
in	O
corresponding	O
mrna	B-T103
levels	O
,	O
and	O
the	O
direct	O
combination	O
of	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
and	O
stat3	B-T017
was	O
confirmed	O
by	O
a	O
luciferase	O
reporter	O
assay	O
.	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
inhibited	O
cell	B-T038
growth	I-T038
,	O
hampered	O
expression	B-T038
of	O
cell	B-T038
cycle	I-T038
-	O
related	O
proteins	B-T103
and	O
inhibited	O
cell	B-T038
migration	I-T038
and	O
invasion	B-T038
in	O
human	B-T204
nsclc	B-T038
cell	B-T017
lines	I-T017
.	O
further	O
,	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
significantly	O
suppressed	O
tumor	O
growth	O
in	O
nude	B-T204
mice	I-T204
.	O
similarly	O
,	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
impede	O
##d	O
tumorigenesis	B-T038
and	O
metastasis	B-T038
through	O
directly	O
targeting	B-T038
stat3	B-T017
.	O
furthermore	O
,	O
we	O
identified	O
that	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
augmented	O
paclitaxel	B-T103
and	O
cisplatin	B-T103
sensitivity	O
by	O
downreg	B-T038
##ulating	I-T038
stat3	B-T017
and	O
promoting	O
chemotherapy	B-T058
-	O
induced	O
apoptosis	B-T038
.	O
these	O
data	O
demonstrate	O
that	O
mir	B-T103
-	I-T103
96	I-T103
##00	I-T103
might	O
be	O
a	O
useful	O
and	O
novel	O
therapeutic	O
target	O
for	O
nsclc	B-T038
.	O

sho	O
##ut	O
loud	O
##er	O
about	O
poor	O
pay	O
it	O
seems	O
increasingly	O
clear	O
to	O
me	O
that	O
the	O
nhs	B-T058
pay	O
campaign	O
is	O
not	O
making	O
waves	O
either	O
in	O
the	O
nhs	B-T058
or	O
with	O
the	O
public	B-T098
.	O

opposing	O
roles	O
of	O
acetylation	B-T038
and	O
phosphorylation	B-T038
in	O
lif	B-T103
##r	I-T103
-	O
dependent	O
self	B-T038
-	I-T038
renewal	I-T038
growth	B-T038
signaling	B-T038
in	O
mouse	B-T017
embryonic	I-T017
stem	I-T017
cells	I-T017
lif	B-T103
promotes	O
self	B-T038
-	I-T038
renewal	I-T038
of	O
mouse	B-T017
embryonic	I-T017
stem	I-T017
cells	I-T017
(	O
mes	B-T017
##cs	I-T017
)	O
,	O
and	O
in	O
its	O
absence	O
,	O
the	O
cells	B-T017
differentiate	O
.	O
lif	B-T103
binds	O
to	O
the	O
lif	B-T103
receptor	I-T103
(	O
lif	B-T103
##r	I-T103
)	O
and	O
activates	O
the	O
jak	B-T038
-	I-T038
stat3	I-T038
pathway	I-T038
,	O
but	O
it	O
remains	O
unknown	O
how	O
the	O
receptor	B-T017
complex	I-T017
triggers	O
differentiation	O
or	O
self	B-T038
-	I-T038
renewal	I-T038
.	O
here	O
,	O
we	O
report	O
that	O
the	O
lif	B-T103
##r	I-T103
cytoplasmic	B-T017
domain	I-T017
contains	O
a	O
self	B-T038
-	I-T038
renewal	I-T038
domain	O
within	O
the	O
juxt	B-T017
##ame	I-T017
##mb	I-T017
##rane	I-T017
region	I-T017
and	O
a	O
differentiation	O
domain	O
within	O
the	O
c	B-T082
-	I-T082
terminal	I-T082
region	I-T082
.	O
the	O
differentiation	O
domain	O
contains	O
four	O
sp	B-T103
##x	I-T103
##x	I-T103
repeats	I-T103
that	O
are	O
phosphorylated	B-T038
by	O
mapk	B-T103
to	O
restrict	O
stat3	B-T038
activation	I-T038
;	O
the	O
self	B-T038
-	I-T038
renewal	I-T038
domain	O
is	O
characterized	O
by	O
a	O
3	B-T103
##k	I-T103
motif	I-T103
that	O
is	O
acetylated	B-T038
by	O
p300	O
.	O
in	O
mes	B-T017
##cs	I-T017
,	O
acetyl	O
-	O
lif	B-T103
##r	I-T103
undergoes	O
homod	B-T038
##imer	I-T038
##ization	I-T038
,	O
leading	O
to	O
stat3	B-T103
hypo	O
-	O
or	O
hyper	O
-	O
activation	O
depending	O
on	O
the	O
presence	B-T033
or	O
absence	O
of	O
gp	B-T103
##130	I-T103
.	O
lif	B-T103
##r	I-T103
-	O
activated	O
stat3	B-T103
restrict	O
##s	O
differentiation	O
via	O
cytokine	B-T103
induction	O
.	O
thus	O
,	O
lif	B-T103
##r	I-T103
acetylation	B-T038
and	O
serine	B-T038
phosphorylation	I-T038
differentially	O
promote	O
stem	B-T017
cell	I-T017
self	B-T038
-	I-T038
renewal	I-T038
and	O
differentiation	O
.	O

nutritional	O
aspects	O
of	O
night	O
eating	B-T038
and	O
its	O
association	O
with	O
weight	O
status	O
among	O
korean	B-T098
adolescents	O
a	O
growing	O
body	O
of	O
research	B-T062
has	O
indicated	O
that	O
night	O
eating	B-T038
could	O
be	O
associated	O
with	O
poor	B-T033
diet	I-T033
quality	O
and	O
negative	B-T033
health	O
outcomes	O
.	O
this	O
study	B-T170
examined	O
the	O
nutritional	O
aspects	O
of	O
night	O
eating	B-T038
,	O
its	O
related	O
factors	O
,	O
and	O
the	O
association	O
between	O
night	O
eating	B-T038
and	O
body	O
weight	O
among	O
korean	B-T098
adolescents	O
.	O
this	O
study	B-T170
analysed	O
the	O
data	O
from	O
a	O
one	O
day	O
24	O
-	O
hour	O
dietary	B-T062
recall	I-T062
as	O
well	O
as	O
a	O
demographic	B-T062
survey	I-T062
of	O
1	O
,	O
73	O
##8	O
korean	B-T098
adolescents	O
aged	O
12	O
to	O
18	O
-	O
years	O
-	O
old	O
obtained	O
from	O
the	O
2010	O
-	O
2012	O
korea	B-T082
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
.	O
'	O
night	O
eating	B-T038
'	O
was	O
defined	O
as	O
consuming	O
25	O
%	O
or	O
more	O
of	O
one	O
'	O
s	O
daily	O
energy	O
intake	O
between	O
21	O
:	O
00	O
and	O
06	O
:	O
00	O
.	O
subjects	B-T098
compl	O
##ying	O
with	O
the	O
preceding	O
condition	O
were	O
classified	O
as	O
'	O
night	O
eat	B-T098
##ers	I-T098
'	O
,	O
whereas	O
the	O
rest	O
were	O
considered	O
'	O
non	B-T098
-	I-T098
night	I-T098
eat	I-T098
##ers	I-T098
'	O
.	O
logistic	O
regression	O
analysis	O
examined	O
factors	O
related	O
to	O
night	O
eating	B-T038
.	O
multiple	O
linear	O
regression	O
analyses	O
were	O
used	O
to	O
examine	O
the	O
relationship	O
between	O
night	O
eating	B-T038
and	O
bmi	B-T201
z	O
-	O
scores	O
,	O
whereas	O
multin	O
##omial	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
examine	O
the	O
relationship	O
between	O
night	O
eating	B-T038
and	O
weight	O
status	O
.	O
about	O
21	O
%	O
of	O
korean	B-T098
adolescents	O
appeared	O
to	O
be	O
night	O
eat	B-T098
##ers	I-T098
.	O
night	O
eat	B-T098
##ers	I-T098
showed	O
increased	O
breakfast	O
sk	B-T033
##ipping	I-T033
(	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
higher	O
energy	O
intake	O
from	O
snack	B-T168
##s	I-T168
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
greater	O
proportion	O
of	O
energy	O
intake	O
from	O
fat	O
(	O
p	O
=	O
0	O
.	O
029	O
)	O
,	O
and	O
lower	O
dietary	O
diversity	O
scores	O
(	O
p	O
=	O
0	O
.	O
008	O
)	O
than	O
non	B-T098
-	I-T098
night	I-T098
eat	I-T098
##ers	I-T098
.	O
male	O
adolescents	O
presented	O
1	O
.	O
9	O
times	O
higher	O
odds	O
of	O
being	O
night	O
eat	B-T098
##ers	I-T098
than	O
females	O
.	O
adolescents	O
whose	O
both	O
parents	O
were	O
night	O
eat	B-T098
##ers	I-T098
were	O
4	O
.	O
4	O
times	O
as	O
likely	O
to	O
be	O
night	O
eat	B-T098
##ers	I-T098
as	O
those	O
whose	O
neither	O
parents	O
were	O
.	O
female	O
adolescents	O
showed	O
a	O
significant	O
relationship	O
between	O
night	O
eating	B-T038
and	O
bmi	B-T201
z	O
-	O
scores	O
(	O
β	O
=	O
0	O
.	O
28	O
,	O
p	O
=	O
0	O
.	O
004	O
)	O
.	O
however	O
,	O
night	O
eating	B-T038
did	O
not	O
increase	O
odds	O
of	O
being	O
overweight	B-T033
or	O
obese	B-T038
in	O
adolescents	O
.	O
night	O
eating	B-T038
in	O
korean	B-T098
adolescents	O
was	O
related	O
to	O
undesirable	B-T033
dietary	I-T033
behaviours	I-T033
and	O
low	O
diet	O
quality	O
in	O
general	O
as	O
well	O
as	O
higher	O
bmi	B-T201
z	O
-	O
scores	O
in	O
females	O
.	O
male	O
gender	O
and	O
parental	O
night	O
eating	B-T038
appeared	O
to	O
be	O
the	O
factors	O
that	O
significantly	O
increased	O
odds	O
of	O
night	O
eating	B-T038
.	O
these	O
results	O
suggest	O
that	O
night	O
eating	B-T038
should	O
be	O
considered	O
when	O
designing	O
nutrition	O
education	O
or	O
intervention	O
programs	O
targeting	O
adolescents	O
.	O

truncated	B-T204
bovine	I-T204
integrin	B-T103
alpha	I-T103
-	I-T103
v	I-T103
/	I-T103
beta	I-T103
-	I-T103
6	I-T103
as	O
a	O
universal	B-T038
capture	I-T038
ligand	I-T038
for	O
fmd	B-T038
diagnosis	B-T033
foot	B-T038
-	I-T038
and	I-T038
-	I-T038
mouth	I-T038
disease	I-T038
(	O
fmd	B-T038
)	O
is	O
endemic	B-T038
in	O
many	O
regions	B-T082
of	O
the	O
world	B-T098
and	O
is	O
one	O
of	O
the	O
most	O
prevalent	O
epi	O
##zo	O
##otic	O
animal	B-T038
diseases	I-T038
.	O
fmd	B-T038
affects	O
livestock	B-T204
,	O
such	O
as	O
cattle	B-T204
,	O
sheep	B-T204
,	O
goats	B-T204
and	O
pigs	B-T204
,	O
and	O
causes	O
enormous	O
economic	O
losses	O
due	O
to	O
reduced	O
productivity	O
and	O
trade	O
restrictions	O
.	O
preparedness	B-T033
and	O
early	B-T058
diagnosis	I-T058
are	O
essential	O
for	O
effective	B-T058
control	I-T058
of	O
fmd	B-T038
.	O
many	O
diagnostic	B-T058
assays	I-T058
are	O
dependent	O
on	O
raising	O
high	O
-	O
affinity	O
,	O
anti	B-T005
-	I-T005
fmd	I-T005
virus	I-T005
(	O
fmd	B-T005
##v	I-T005
)	O
serotype	B-T103
-	I-T103
specific	I-T103
antibodies	I-T103
in	O
small	O
animals	B-T204
(	O
rabbits	B-T204
and	O
guinea	B-T204
pigs	I-T204
)	O
that	O
give	O
broad	O
virus	B-T005
coverage	O
.	O
here	O
we	O
show	O
that	O
soluble	O
,	O
truncated	O
forms	O
of	O
bovine	B-T204
α	B-T103
##v	I-T103
##β	I-T103
##6	I-T103
bind	B-T038
fmd	B-T005
##v	I-T005
in	O
an	O
authentic	O
rgd	B-T103
and	O
divalent	B-T038
cation	I-T038
dependent	I-T038
interaction	I-T038
and	O
can	O
be	O
used	O
as	O
the	O
trapping	B-T103
reagent	I-T103
in	O
a	O
fmd	B-T005
##v	I-T005
sandwich	B-T058
elisa	I-T058
.	O
in	O
addition	O
,	O
inclusion	O
of	O
flag	B-T103
or	O
his	B-T103
tags	I-T103
facilitates	O
simple	O
purification	B-T058
without	O
the	O
loss	O
of	O
virus	B-T038
binding	I-T038
.	O
we	O
also	O
provide	O
evidence	O
that	O
when	O
combined	O
with	O
a	O
guinea	B-T204
pig	I-T204
polyclonal	B-T031
serum	I-T031
,	O
or	O
serotype	B-T103
-	I-T103
specific	I-T103
monoclonal	I-T103
antibodies	I-T103
,	O
the	O
integrin	B-T103
can	O
be	O
used	O
to	O
detect	B-T033
viruses	B-T005
representative	O
of	O
all	O
fmd	O
##v	O
serotypes	O
.	O
we	O
also	O
show	O
that	O
recombinant	O
fmd	O
##v	O
empty	B-T017
capsid	I-T017
##s	I-T017
,	O
with	O
stabil	O
##ising	O
disulph	O
##ide	O
bonds	O
,	O
can	O
serve	O
as	O
an	O
antigen	B-T103
in	O
the	O
elisa	B-T058
and	O
can	O
therefore	O
replace	O
inactivated	B-T103
virus	I-T103
antigen	I-T103
as	O
a	O
positive	O
control	O
for	O
the	O
assay	B-T058
.	O
our	O
results	B-T033
demonstrate	O
the	O
potential	O
use	O
of	O
bovine	B-T204
α	B-T103
##v	I-T103
##β	I-T103
##6	I-T103
and	O
fmd	B-T005
##v	I-T005
empty	B-T017
capsid	I-T017
##s	I-T017
in	O
fmd	B-T038
diagnostic	B-T058
assays	I-T058
.	O

a	O
new	O
parametric	B-T170
model	I-T170
to	O
assess	O
delay	O
and	O
compression	O
of	O
mortality	O
a	O
decrease	O
in	O
mortality	O
across	O
all	O
ages	O
causes	O
a	O
shift	O
of	O
the	O
age	O
pattern	B-T082
of	O
mortality	O
,	O
or	O
mortality	O
delay	O
,	O
while	O
differences	O
in	O
the	O
rate	O
of	O
decrease	O
across	O
ages	O
cause	O
a	O
change	O
in	O
the	O
shape	B-T082
of	O
the	O
age	B-T033
-	I-T033
at	I-T033
-	I-T033
death	I-T033
distribution	O
,	O
mortality	O
compression	O
or	O
expansion	O
.	O
evidence	O
exists	O
for	O
both	O
compression	O
and	O
delay	O
of	O
mortality	O
.	O
existing	O
parametric	B-T170
models	I-T170
to	O
describe	O
the	O
full	O
age	O
pattern	B-T082
of	O
mortality	O
are	O
not	O
able	O
to	O
capture	O
mortality	O
delay	O
versus	O
mortality	O
compression	O
.	O
more	O
recent	O
models	B-T170
that	O
assess	O
delay	O
versus	O
compression	O
mostly	O
focused	O
on	O
the	O
adult	O
or	O
old	B-T098
ages	I-T098
alone	O
and	O
did	O
not	O
distinguish	O
mortality	O
compression	O
below	O
and	O
above	O
the	O
modal	O
age	O
at	O
death	B-T033
,	O
although	O
they	O
represent	O
different	O
mechanisms	O
.	O
this	O
paper	B-T170
presents	O
a	O
new	O
parametric	B-T170
model	I-T170
that	O
describes	O
the	O
full	O
age	O
pattern	B-T082
of	O
mortality	O
and	O
assesses	O
compression	O
-	O
at	O
different	O
stages	O
of	O
life	O
-	O
and	O
delay	O
of	O
mortality	O
:	O
the	O
code	B-T170
model	I-T170
.	O
the	O
model	B-T170
includes	O
10	O
parameters	O
,	O
of	O
which	O
five	O
are	O
constant	O
over	O
time	O
.	O
the	O
five	O
time	O
-	O
varying	O
parameters	O
reflect	O
delay	O
of	O
mortality	O
and	O
compression	O
of	O
mortality	O
in	O
infancy	O
,	O
adolescence	O
,	O
young	O
adulthood	O
,	O
late	O
adulthood	O
,	O
and	O
old	B-T098
age	I-T098
.	O
the	O
model	B-T170
describes	O
infant	O
and	O
background	O
mortality	O
by	O
two	O
simple	O
functions	O
,	O
uses	O
a	O
mixed	B-T170
logistic	I-T170
model	I-T170
with	O
different	O
slopes	O
in	O
adult	O
,	O
middle	O
,	O
and	O
old	B-T098
age	I-T098
,	O
and	O
includes	O
the	O
modal	O
age	O
at	O
death	B-T033
as	O
a	O
parameter	O
to	O
account	O
for	O
the	O
delay	O
in	O
mortality	O
.	O
applying	O
the	O
code	B-T170
model	I-T170
to	O
age	O
-	O
specific	O
probabilities	O
of	O
death	B-T033
for	O
japanese	B-T098
,	O
french	B-T098
,	O
american	B-T098
,	O
and	O
danish	B-T098
men	B-T098
and	O
women	B-T098
between	O
1950	O
and	O
2010	O
showed	O
a	O
very	O
good	O
fit	O
of	O
the	O
full	O
age	O
pattern	B-T082
of	O
mortality	O
.	O
delay	O
of	O
mortality	O
explained	O
about	O
two	O
-	O
thirds	O
of	O
the	O
increase	O
in	O
life	O
expectancy	O
at	O
birth	B-T038
,	O
whereas	O
compression	O
of	O
mortality	O
due	O
to	O
mortality	O
declines	O
in	O
young	O
age	O
explained	O
about	O
one	O
-	O
third	O
.	O
no	O
strong	O
compression	O
of	O
mortality	O
in	O
late	O
adulthood	O
age	O
was	O
observed	O
.	O
mortality	O
compression	O
in	O
old	B-T098
age	I-T098
has	O
had	O
a	O
small	O
negative	O
impact	O
on	O
life	O
expectancy	O
.	O
the	O
code	B-T170
model	I-T170
proved	O
a	O
valid	O
instrument	O
for	O
describing	O
the	O
full	O
age	O
pattern	B-T082
of	O
mortality	O
and	O
for	O
dise	O
##nt	O
##angli	O
##ng	O
the	O
effects	O
of	O
mortality	O
delay	O
and	O
compression	O
-	O
at	O
different	O
stages	O
of	O
life	O
-	O
on	O
the	O
increase	O
in	O
life	O
expectancy	O
.	O

zoonotic	O
and	O
non	B-T033
-	I-T033
zoonotic	I-T033
parasites	B-T204
of	O
wild	B-T170
rodents	B-T204
in	O
turk	B-T082
##man	I-T082
sah	I-T082
##ra	I-T082
,	I-T082
northeastern	I-T082
iran	I-T082
this	O
study	B-T062
was	O
conducted	O
to	O
collect	B-T062
informative	I-T062
data	I-T062
on	O
the	O
parasitic	B-T038
infection	I-T038
of	O
wild	B-T170
rodents	B-T204
,	O
emphasizing	O
on	O
finding	B-T033
parasites	B-T204
,	O
which	O
have	O
medical	O
importance	O
to	O
human	B-T204
.	O
during	O
2012	O
-	O
2014	O
,	O
a	O
total	O
number	O
of	O
91	O
wild	B-T170
rodents	B-T204
were	O
captured	O
from	O
rural	O
areas	O
of	O
turk	B-T082
##men	I-T082
sah	I-T082
##ra	I-T082
,	I-T082
gol	I-T082
##est	I-T082
##an	I-T082
province	I-T082
,	O
using	O
hand	O
##ma	O
##de	O
traps	O
.	O
animals	B-T204
were	O
anesthetized	B-T033
,	O
surveyed	B-T170
for	O
any	O
ect	B-T204
##oparas	I-T204
##ite	I-T204
and	O
then	O
their	O
carcasses	B-T017
were	O
carefully	O
dissected	O
for	O
examination	B-T033
of	O
endop	B-T204
##ars	I-T204
##ites	I-T204
.	O
four	O
species	B-T170
of	O
rodents	B-T204
including	O
mus	B-T204
muscul	I-T204
##us	I-T204
(	O
52	O
.	O
75	O
%	O
)	O
,	O
rat	B-T204
##t	I-T204
##us	I-T204
nor	I-T204
##ve	I-T204
##gic	I-T204
##us	I-T204
(	O
38	O
.	O
46	O
%	O
)	O
,	O
rho	B-T204
##mb	I-T204
##omys	I-T204
opi	I-T204
##mus	I-T204
(	O
4	O
.	O
40	O
%	O
)	O
and	O
mer	B-T204
##iones	I-T204
lib	I-T204
##yc	I-T204
##us	I-T204
(	O
4	O
.	O
40	O
%	O
)	O
were	O
captured	O
.	O
parasitic	B-T038
infestation	I-T038
was	O
detected	B-T033
in	O
38	O
.	O
5	O
%	O
of	O
sampled	O
rodents	B-T204
.	O
parasite	B-T038
infestation	I-T038
rates	O
of	O
sampled	O
rodents	B-T204
was	O
hym	B-T204
##enol	I-T204
##epi	I-T204
##s	I-T204
dimin	I-T204
##uta	I-T204
=	O
7	O
.	O
7	O
%	O
,	O
cryptosporidium	B-T204
spp	I-T204
=	O
6	O
.	O
6	O
%	O
,	O
trich	B-T204
##ur	I-T204
##is	I-T204
spp	I-T204
.	O
=	O
5	O
.	O
5	O
%	O
,	O
cystic	B-T204
##erc	I-T204
##us	I-T204
fasci	I-T204
##olar	I-T204
##is	I-T204
=	O
2	O
.	O
20	O
%	O
,	O
angio	B-T204
##st	I-T204
##ron	I-T204
##gy	I-T204
##lu	I-T204
##s	I-T204
spp	I-T204
.	O
=	O
2	O
.	O
20	O
%	O
,	O
capill	B-T204
##aria	I-T204
sp	I-T204
.	O
=	O
1	O
.	O
09	O
%	O
,	O
rh	B-T204
##ip	I-T204
##ice	I-T204
##phal	I-T204
##us	I-T204
spp	I-T204
.	O
=	O
8	O
.	O
70	O
%	O
,	O
nos	B-T204
##ops	I-T204
##yll	I-T204
##us	I-T204
fascia	I-T204
##t	I-T204
##us	I-T204
=	O
1	O
.	O
09	O
%	O
,	O
and	O
la	B-T204
##ela	I-T204
##ps	I-T204
nut	I-T204
##tal	I-T204
##li	I-T204
=	O
3	O
.	O
29	O
%	O
.	O
among	O
10	O
genera	B-T170
/	O
species	B-T170
of	O
identified	O
parasites	B-T204
,	O
at	O
least	O
8	O
of	O
them	O
were	O
zoonotic	O
with	O
public	B-T170
health	I-T170
importance	O
.	O
l	B-T204
.	I-T204
nut	I-T204
##tal	I-T204
##li	I-T204
and	O
n	B-T204
.	I-T204
fascia	I-T204
##t	I-T204
##us	I-T204
were	O
the	O
only	O
two	O
non	B-T033
-	I-T033
zoonotic	I-T033
detected	B-T033
parasites	B-T204
in	O
this	O
survey	B-T170
.	O
harboring	O
a	O
wide	B-T082
variety	O
of	O
zoonotic	O
parasites	B-T204
in	O
sampled	O
wild	B-T170
rodents	B-T204
particularly	O
when	O
they	O
live	O
nearby	O
villages	B-T082
,	O
represents	O
a	O
potential	O
risk	O
to	O
native	B-T098
inhabitants	I-T098
.	O
hence	O
,	O
controlling	O
rodents	B-T204
'	O
population	B-T098
in	O
residential	B-T082
regions	I-T082
and	O
improving	B-T033
awareness	B-T038
of	O
local	B-T082
people	B-T098
about	O
the	O
risk	O
of	O
disease	B-T038
transmission	I-T038
through	O
rodents	B-T204
seems	O
to	O
be	O
entirely	O
necessary	O
.	O

peer	B-T098
exclusion	O
during	O
the	O
pubertal	B-T033
transition	O
:	O
the	O
role	O
of	O
social	O
competence	O
for	O
some	O
youth	O
,	O
early	B-T038
puberty	I-T038
is	O
accompanied	O
by	O
peer	B-T098
exclusion	O
.	O
yet	O
early	O
develop	B-T098
##ers	I-T098
may	O
experience	B-T038
less	O
peer	B-T098
exclusion	O
if	O
they	O
have	O
social	O
competence	O
,	O
which	O
would	O
bol	O
##st	O
##er	O
their	O
ability	O
to	O
develop	O
and	O
maintain	O
positive	B-T033
relationships	O
with	O
their	O
peers	B-T098
.	O
accordingly	O
,	O
the	O
present	B-T033
study	B-T062
tests	O
whether	O
pubertal	B-T033
timing	O
and	O
temp	O
##o	O
predicts	O
decrement	O
##s	O
in	O
children	O
'	O
s	O
social	O
competence	O
and	O
whether	O
decrement	O
##s	O
in	O
social	O
competence	O
account	O
for	O
associations	O
between	O
puberty	B-T038
(	O
timing	O
and	O
temp	O
##o	O
)	O
and	O
peer	B-T098
exclusion	O
over	O
time	O
.	O
longitudinal	B-T062
data	O
were	O
drawn	O
from	O
136	O
##4	O
families	O
(	O
48	O
%	O
female	B-T098
;	O
76	O
%	O
white	B-T098
;	O
m	O
=	O
9	O
.	O
32	O
years	O
,	O
sd	O
=	O
.	O
48	O
,	O
at	O
wave	O
3	O
)	O
who	O
participated	O
in	O
waves	O
3	O
-	O
5	O
(	O
i	O
.	O
e	O
.	O
,	O
grades	O
4	O
-	O
6	O
)	O
of	O
phase	B-T062
iii	I-T062
of	O
the	O
nich	B-T092
##d	I-T092
-	O
sec	B-T062
##cy	I-T062
##d	I-T062
.	O
the	O
results	O
from	O
latent	O
growth	O
curve	O
models	O
indicated	O
that	O
earlier	O
pubertal	B-T033
timing	O
and	O
more	O
rapid	O
pubertal	B-T033
temp	O
##o	O
among	O
girls	O
were	O
associated	O
with	O
high	O
initial	O
levels	O
of	O
peer	B-T098
exclusion	O
.	O
moreover	O
,	O
mediation	O
analyses	O
revealed	O
that	O
early	O
develop	B-T098
##ers	I-T098
'	I-T098
susceptibility	O
to	O
peer	B-T098
exclusion	O
was	O
associated	O
with	O
their	O
initial	O
level	O
of	O
social	O
competence	O
.	O
in	O
boys	O
,	O
pubertal	B-T033
timing	O
and	O
temp	O
##o	O
were	O
not	O
directly	O
associated	O
with	O
peer	B-T098
exclusion	O
;	O
instead	O
,	O
indirect	O
effects	O
of	O
pubertal	B-T033
timing	O
on	O
peer	B-T098
exclusion	O
(	O
intercept	O
,	O
slope	O
)	O
occurred	O
through	O
initial	O
levels	O
of	O
social	O
competence	O
.	O
on	O
average	O
,	O
early	O
develop	B-T098
##ers	I-T098
'	I-T098
who	O
had	O
low	O
levels	O
of	O
social	O
competence	O
also	O
had	O
high	O
initial	O
levels	O
of	O
peer	B-T098
exclusion	O
but	O
experienced	B-T038
decrement	O
##s	O
in	O
peer	B-T098
exclusion	O
over	O
time	O
.	O
the	O
association	O
between	O
the	O
intercept	O
##s	O
for	O
puberty	B-T038
and	O
peer	B-T098
exclusion	O
and	O
the	O
slopes	O
for	O
social	O
competence	O
and	O
peer	B-T098
exclusion	O
were	O
stronger	O
for	O
boys	O
than	O
girls	O
.	O
overall	O
,	O
our	O
findings	B-T033
suggest	O
that	O
early	O
develop	B-T098
##ers	I-T098
'	I-T098
susceptibility	O
to	O
and	O
experiences	B-T038
of	O
peer	B-T098
exclusion	O
are	O
associated	O
with	O
their	O
development	O
of	O
social	O
competence	O
.	O

nutrients	B-T168
influence	O
the	O
thermal	O
eco	O
##phys	O
##iology	O
of	O
an	O
intert	O
##idal	O
macro	B-T204
##alg	I-T204
##a	I-T204
:	O
multiple	O
stressors	O
or	O
multiple	O
drivers	O
?	O
urbanization	O
of	O
coast	O
##line	O
##s	O
is	O
leading	O
to	O
increased	O
introduction	O
of	O
nutrients	B-T168
from	O
the	O
terrestrial	B-T082
environment	I-T082
to	O
near	B-T082
##sh	I-T082
##ore	I-T082
habitats	I-T082
.	O
while	O
such	O
nutrient	B-T168
influx	O
##es	O
can	O
be	O
detrimental	O
to	O
coastal	O
marine	O
organisms	O
due	O
to	O
increased	O
eut	O
##rophic	O
##ation	O
and	O
subsequent	O
reduced	O
oxygen	B-T103
,	O
they	O
could	O
also	O
have	O
positive	O
effects	O
(	O
i	O
.	O
e	O
.	O
,	O
increased	O
food	B-T168
availability	O
)	O
on	O
species	B-T170
that	O
are	O
nitrogen	B-T103
-	I-T103
limited	I-T103
such	O
as	O
macro	B-T204
##alg	I-T204
##ae	I-T204
.	O
nutrient	B-T168
enrichment	O
in	O
this	O
environment	B-T082
thus	O
has	O
the	O
potential	O
to	O
counteract	O
some	O
of	O
the	O
negative	O
impacts	O
of	O
increasing	O
temperatures	O
,	O
at	O
least	O
for	O
some	O
species	B-T170
.	O
characterizing	O
the	O
physiological	O
response	O
of	O
organisms	O
to	O
simultaneous	O
changes	O
in	O
multiple	O
drivers	O
such	O
as	O
these	O
is	O
an	O
important	O
first	O
step	O
in	O
predicting	O
how	O
global	O
climate	O
change	O
may	O
lead	O
to	O
ecological	O
responses	O
at	O
more	O
local	O
levels	O
.	O
we	O
evaluated	O
how	O
nutrient	B-T168
enrichment	O
(	O
i	O
.	O
e	O
.	O
,	O
nitrogen	B-T103
availability	O
)	O
affected	O
the	O
growth	B-T038
of	O
fuc	B-T204
##us	I-T204
ves	I-T204
##icul	I-T204
##osus	I-T204
,	O
a	O
foundation	O
##al	O
macro	B-T204
##alg	I-T204
##al	I-T204
species	B-T204
in	O
the	O
north	B-T082
atlantic	I-T082
rock	I-T082
##y	I-T082
intert	I-T082
##idal	I-T082
zone	I-T082
,	O
and	O
found	O
that	O
nutrient	B-T168
-	O
enriched	O
algal	B-T170
blade	I-T170
##s	I-T170
showed	O
a	O
significant	O
increase	O
in	O
tissue	B-T038
growth	I-T038
compared	O
to	O
individuals	O
grown	O
under	O
ambient	O
conditions	O
.	O
we	O
further	O
quantified	O
net	O
photosynthesis	O
by	O
ambient	O
and	O
nutrient	B-T168
-	O
enriched	O
tissues	B-T017
at	O
satur	O
##ating	O
irradiance	O
over	O
a	O
range	O
of	O
temperature	O
conditions	O
(	O
6	O
-	O
30	O
##°c	O
)	O
.	O
respiration	B-T038
was	O
unaffected	O
by	O
nutrient	B-T168
treatment	O
;	O
however	O
,	O
there	O
was	O
a	O
significant	O
increase	O
in	O
photosynthetic	O
oxygen	B-T103
production	O
for	O
nutrient	B-T168
-	O
enriched	O
tissue	B-T017
compared	O
to	O
ambient	O
,	O
but	O
only	O
at	O
elevated	O
(	O
≥1	O
##8	O
##°c	O
)	O
temperatures	O
.	O
this	O
study	B-T062
contributes	O
to	O
a	O
growing	O
body	O
of	O
literature	B-T170
showing	O
the	O
complexity	O
of	O
responses	O
to	O
changes	O
in	O
multiple	O
drivers	O
,	O
and	O
highlights	O
the	O
importance	O
of	O
studying	B-T062
the	O
impacts	O
of	O
global	O
climate	O
change	O
within	O
the	O
context	O
of	O
more	O
local	O
environmental	B-T082
conditions	O
.	O

the	O
ages	B-T170
-	I-T170
re	I-T170
##y	I-T170
##k	I-T170
##ja	I-T170
##vi	I-T170
##k	I-T170
study	I-T170
atlas	I-T170
##es	I-T170
:	O
non	O
-	O
linear	O
multi	O
-	O
spectral	O
template	O
and	O
atlas	B-T170
##es	I-T170
for	O
studies	B-T062
of	O
the	O
ageing	B-T038
brain	B-T017
quantitative	O
analyses	O
of	O
brain	B-T017
structures	B-T082
from	O
magnetic	B-T058
resonance	I-T058
(	O
mr	B-T058
)	O
image	B-T058
data	O
are	O
often	O
performed	O
using	O
automatic	O
segmentation	O
algorithms	B-T170
.	O
many	O
of	O
these	O
algorithms	B-T170
rely	O
on	O
templates	O
and	O
atlas	B-T170
##es	I-T170
in	O
a	O
common	O
coordinate	B-T170
space	I-T170
.	O
most	O
freely	O
available	O
brain	B-T017
atlas	B-T170
##es	I-T170
are	O
generated	O
from	O
relatively	O
young	O
individuals	B-T098
and	O
not	O
always	O
derived	O
from	O
well	O
-	O
defined	O
cohort	O
studies	O
.	O
in	O
this	O
paper	O
,	O
we	O
introduce	O
a	O
publicly	B-T092
available	O
multi	O
-	O
spectral	O
template	O
with	O
corresponding	O
tissue	B-T017
probability	O
atlas	B-T170
##es	I-T170
and	O
regional	B-T082
atlas	B-T170
##es	I-T170
,	O
optimised	O
to	O
use	O
in	O
studies	B-T062
of	O
ageing	B-T038
cohorts	B-T098
(	O
mean	O
age	O
75	O
±	O
5	O
years	O
)	O
.	O
furthermore	O
,	O
we	O
provide	O
validation	B-T062
data	O
from	O
a	O
regional	B-T082
segmentation	O
pipeline	O
to	O
assure	O
the	O
integrity	O
of	O
the	O
dataset	B-T170
.	O

clinical	B-T033
and	O
radiological	B-T058
outcome	O
following	O
pneumothorax	B-T038
after	O
endoscopic	B-T058
lung	I-T058
volume	I-T058
reduction	I-T058
with	O
valves	B-T074
valve	B-T074
implantation	B-T058
has	O
evolved	O
as	O
a	O
therapy	B-T058
for	O
patients	O
with	O
advanced	O
emphysema	B-T038
.	O
although	O
it	O
is	O
a	O
minimally	B-T058
invasive	I-T058
treat	I-T058
##men	I-T058
t	O
,	O
it	O
is	O
associated	O
with	O
complications	B-T038
,	O
the	O
most	O
common	O
being	O
pneumothorax	B-T038
.	O
pneumothorax	B-T038
occurs	O
due	O
to	O
the	O
rapid	O
target	O
lobe	B-T017
volume	B-T058
reduction	I-T058
and	O
may	O
be	O
a	O
predictor	O
of	O
clinical	O
benefit	O
despite	O
this	O
complication	B-T038
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
conduct	O
an	O
exploratory	O
data	O
analysis	O
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	B-T038
following	O
endoscopic	B-T058
valve	I-T058
therapy	I-T058
for	O
emphysema	B-T038
.	O
this	O
study	B-T062
performed	O
a	O
retrospective	B-T062
evaluation	I-T062
of	O
pneumothorax	B-T038
management	B-T058
and	O
the	O
impact	O
of	O
pneumothorax	B-T038
on	O
clinical	B-T033
outcomes	I-T033
in	O
70	O
patients	O
following	O
valve	B-T058
therapy	I-T058
in	O
38	O
##1	O
consecutive	O
patients	O
.	O
pneumothorax	B-T038
rate	O
following	O
valve	B-T058
therapy	I-T058
was	O
18	O
%	O
.	O
pneumothorax	B-T038
management	B-T058
consisted	O
of	O
chest	B-T058
tube	I-T058
insertion	I-T058
,	O
valve	B-T074
removal	B-T058
,	O
and	O
surgical	B-T033
intervention	I-T033
in	O
87	O
%	O
(	O
61	O
/	O
70	O
)	O
,	O
44	O
%	O
(	O
31	O
/	O
70	O
)	O
,	O
and	O
19	O
%	O
(	O
13	O
/	O
70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O
despite	O
pneumothorax	B-T038
,	O
patients	O
experienced	O
modest	O
but	O
significant	O
improvements	O
in	O
lung	B-T038
function	I-T038
parameters	O
(	O
forced	B-T038
expiratory	I-T038
volume	I-T038
in	O
1	O
second	O
:	O
55	O
##±1	O
##48	O
ml	O
,	O
residual	B-T201
volume	I-T201
:	O
-	O
390	O
##±	O
##96	O
##4	O
ml	O
,	O
total	B-T033
lung	I-T033
capacity	I-T033
:	O
-	O
348	O
##±	O
##87	O
##6	O
;	O
all	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
persistent	O
lobar	B-T038
ate	I-T038
##le	I-T038
##ct	I-T038
##asis	I-T038
3	O
months	O
after	O
recovering	O
from	O
pneumothorax	B-T038
,	O
which	O
was	O
associated	O
with	O
relevant	O
clinical	O
improvement	O
,	O
was	O
observed	O
in	O
only	O
21	O
%	O
(	O
15	O
/	O
70	O
)	O
of	O
the	O
patients	O
.	O
pneumothorax	B-T038
is	O
a	O
frequent	O
severe	O
complication	B-T038
following	O
valve	B-T058
therapy	I-T058
that	O
requires	O
further	O
intervention	B-T058
.	O
nevertheless	O
,	O
the	O
pneumothorax	B-T038
does	O
not	O
impair	O
the	O
clinical	O
status	O
in	O
the	O
majority	O
of	O
patients	O
.	O
patients	O
with	O
lobar	B-T038
ate	I-T038
##le	I-T038
##ct	I-T038
##asis	I-T038
benefit	O
after	O
recovering	O
from	O
pneumothorax	B-T038
in	O
terms	O
of	O
lung	B-T038
function	I-T038
parameters	O
.	O

mimicking	O
the	O
cell	B-T017
membrane	I-T017
:	O
bio	O
-	O
inspired	O
simultaneous	O
functions	O
with	O
monovalent	O
anion	B-T103
selectivity	O
and	O
antif	O
##ou	O
##ling	O
properties	O
of	O
anion	B-T103
exchange	O
membrane	B-T074
a	O
new	O
bio	O
-	O
inspired	O
method	O
was	O
applied	O
in	O
this	O
study	O
to	O
simultaneously	O
improve	O
the	O
monovalent	O
anion	B-T103
selectivity	O
and	O
antif	O
##ou	O
##ling	O
properties	O
of	O
anion	B-T103
exchange	O
membranes	B-T074
(	O
ae	O
##ms	O
)	O
.	O
three	O
-	O
layer	O
architecture	O
was	O
developed	O
by	O
deposition	O
of	O
polyd	B-T103
##opamine	I-T103
(	O
pda	B-T103
)	O
and	O
electro	O
-	O
deposition	O
of	O
n	B-T103
-	I-T103
o	I-T103
-	I-T103
sulfon	I-T103
##ic	I-T103
acid	I-T103
benzyl	I-T103
chitosan	I-T103
(	O
ns	B-T103
##bc	I-T103
)	O
.	O
the	O
inner	B-T082
##most	I-T082
and	O
outer	B-T082
##most	I-T082
layers	O
were	O
pda	B-T103
with	O
different	O
deposition	O
time	O
.	O
the	O
middle	B-T082
layer	O
was	O
prepared	O
by	O
ns	B-T103
##bc	I-T103
.	O
fourier	B-T062
transform	I-T062
infrared	I-T062
spectroscopy	I-T062
and	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
confirmed	O
that	O
pda	B-T103
and	O
ns	B-T103
##bc	I-T103
were	O
successfully	O
modified	O
on	O
the	O
surfaces	O
of	O
ae	O
##ms	O
.	O
the	O
contact	O
angle	O
of	O
the	O
membranes	B-T074
indicated	O
an	O
improved	O
hydrophilic	O
##ity	O
of	O
the	O
modified	O
membranes	B-T074
.	O
a	O
series	O
of	O
electro	O
##di	O
##alys	O
##is	O
experiments	O
in	O
which	O
cl	B-T103
(	I-T103
-	I-T103
)	I-T103
/	O
so4	B-T103
(	I-T103
2	I-T103
-	I-T103
)	I-T103
separation	O
was	O
studied	O
,	O
demonstrating	O
the	O
monovalent	O
anion	B-T103
selectivity	O
of	O
the	O
samples	O
.	O
the	O
cl	B-T103
(	I-T103
-	I-T103
)	I-T103
/	O
so4	B-T103
(	I-T103
2	I-T103
-	I-T103
)	I-T103
perm	O
##se	O
##le	O
##ct	O
##ivity	O
of	O
the	O
modified	O
membranes	B-T074
can	O
reach	O
up	O
to	O
2	O
.	O
20	O
,	O
higher	O
than	O
that	O
of	O
the	O
commercial	B-T074
membrane	I-T074
(	O
only	O
0	O
.	O
78	O
)	O
during	O
90	O
minutes	O
in	O
electro	O
##di	O
##alys	O
##is	O
(	O
ed	O
)	O
.	O
the	O
increase	O
value	O
of	O
the	O
resistance	O
of	O
the	O
membranes	B-T074
was	O
also	O
measured	O
to	O
evaluate	O
the	O
antif	O
##ou	O
##ling	O
properties	O
.	O
sodium	B-T103
dodecyl	I-T103
benzene	I-T103
sulfonate	I-T103
(	O
sdb	B-T103
##s	I-T103
)	O
was	O
used	O
as	O
the	O
fouling	O
material	O
in	O
the	O
ed	O
process	O
and	O
the	O
membrane	B-T074
area	O
resistance	O
of	O
modified	B-T074
membrane	I-T074
increase	O
value	O
of	O
was	O
only	O
0	O
.	O
08	O
ω	O
##cm	O
(	O
2	O
)	O
30	O
minutes	O
later	O
.	O

inhibited	O
temperament	B-T038
and	O
hippocampal	B-T017
volume	O
in	O
offspring	O
of	O
parents	O
with	O
bipolar	B-T038
disorder	I-T038
prior	O
studies	O
have	O
suggested	O
that	O
inhibited	O
temperament	B-T038
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
developing	O
anxiety	B-T038
or	O
mood	B-T038
disorder	I-T038
,	O
including	O
bipolar	B-T038
disorder	I-T038
.	O
however	O
,	O
the	O
neurobiological	O
basis	O
for	O
this	O
increased	O
risk	O
is	O
unknown	O
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	B-T033
temperament	B-T038
in	O
symptomatic	O
and	O
asymptomatic	B-T033
child	O
offspring	O
of	O
parents	O
with	O
bipolar	B-T038
disorder	I-T038
(	O
ob	B-T038
##d	I-T038
)	O
and	O
to	O
investigate	O
whether	O
inhibited	O
temperament	B-T038
is	O
associated	O
with	O
aberrant	O
hippocampal	B-T017
volumes	O
compared	O
with	O
healthy	O
control	O
(	O
hc	O
)	O
youth	O
.	O
the	O
ob	B-T038
##d	I-T038
group	O
consisted	O
of	O
45	O
youth	O
,	O
24	O
of	O
whom	O
had	O
current	O
psychiatric	B-T033
symptoms	I-T033
(	B-T038
ob	I-T038
##d	I-T038
(	I-T038
+	I-T038
)	I-T038
s	I-T038
)	I-T038
and	O
21	O
without	O
any	O
psychiatric	B-T033
symptoms	I-T033
(	O
ob	O
##d	O
(	O
-	O
)	O
s	O
)	O
,	O
and	O
were	O
compared	O
with	O
24	O
hc	O
youth	O
.	O
temperament	B-T038
characteristics	O
were	O
measured	O
by	O
using	O
the	O
revised	B-T058
dimensions	I-T058
of	I-T058
temperament	I-T058
survey	I-T058
.	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
was	O
used	O
to	O
measure	O
hippocampal	B-T017
volumes	O
.	O
the	O
association	O
between	O
temperament	B-T038
and	O
hippocampal	B-T017
volumes	O
was	O
tested	O
by	O
using	O
multiple	O
regression	O
analysis	O
.	O
compared	O
with	O
the	O
ob	O
##d	O
(	O
-	O
)	O
s	O
group	O
,	O
the	O
ob	B-T038
##d	I-T038
(	I-T038
+	I-T038
)	I-T038
s	I-T038
group	O
had	O
significantly	O
more	O
inhibited	O
temperament	B-T038
traits	O
,	O
less	O
flexibility	O
,	O
more	O
negative	B-T033
mood	B-T038
,	O
and	O
less	O
regular	O
rhythm	B-T033
in	O
their	O
daily	O
routine	O
##s	O
.	O
in	O
contrast	O
,	O
the	O
ob	O
##d	O
(	O
-	O
)	O
s	O
group	O
was	O
more	O
likely	O
to	O
approach	O
novel	O
situations	O
compared	O
with	O
ob	B-T038
##d	I-T038
(	I-T038
+	I-T038
)	I-T038
s	I-T038
or	O
hc	O
groups	O
.	O
within	O
the	O
ob	B-T038
##d	I-T038
(	I-T038
+	I-T038
)	I-T038
s	I-T038
group	O
,	O
a	O
more	O
inhibited	O
temperament	B-T038
was	O
associated	O
with	O
smaller	O
right	B-T082
hippocampal	B-T017
volumes	O
.	O
in	O
this	O
study	O
,	O
symptomatic	O
ob	B-T038
##d	I-T038
were	O
characterized	O
by	O
an	O
inhibited	O
temperament	B-T038
that	O
was	O
inversely	O
correlated	O
with	O
hippocampal	B-T017
volume	O
.	O
additional	O
longitudinal	B-T062
studies	I-T062
are	O
needed	O
to	O
determine	O
whether	O
inverse	O
correlations	O
between	O
hippocampal	B-T017
volume	O
and	O
inhibited	O
temperament	B-T038
represent	O
early	O
markers	B-T201
of	O
risk	O
for	O
later	O
developing	O
bipolar	B-T038
disorder	I-T038
.	O

a	O
comparison	O
of	O
two	O
comorbidity	O
indices	O
for	O
predicting	O
inpatient	O
rehabilitation	B-T058
outcomes	O
comorbid	B-T033
conditions	I-T033
are	O
important	O
in	O
health	B-T058
care	I-T058
.	O
the	O
best	O
comorbidity	O
index	O
for	O
predicting	O
the	O
impact	O
of	O
comorbidities	O
on	O
rehabilitation	B-T058
outcomes	O
has	O
not	O
been	O
determined	O
.	O
compare	O
the	O
associations	O
of	O
comorbidity	O
measured	O
using	O
the	O
char	O
##ls	O
##on	O
comorbidity	O
index	O
(	O
cci	O
)	O
and	O
the	O
cumulative	O
index	O
rating	O
scale	O
(	O
cir	O
##s	O
)	O
with	O
key	O
rehabilitation	B-T058
outcomes	O
.	O
aim	O
was	O
to	O
determine	O
whether	O
either	O
of	O
these	O
comorbidity	O
indices	O
helped	O
explain	O
the	O
variation	O
in	O
key	O
rehabilitation	B-T058
outcomes	O
.	O
prospective	B-T062
open	I-T062
-	I-T062
cohort	I-T062
study	I-T062
.	O
inpatient	O
rehabilitation	B-T058
ward	B-T092
,	O
mel	B-T082
##bo	I-T082
##urn	I-T082
##e	I-T082
,	O
australia	B-T082
.	O
adults	O
admitted	B-T058
for	O
inpatient	O
rehabilitation	B-T058
(	O
n	O
=	O
280	O
)	O
.	O
the	O
main	O
outcomes	O
were	O
demographic	O
(	O
e	O
.	O
g	O
.	O
age	O
,	O
gender	O
,	O
discharge	B-T058
destin	B-T082
##ation	I-T082
)	O
and	O
clinical	O
outcomes	O
(	O
reason	B-T033
for	O
rehabilitation	B-T058
,	O
length	O
of	O
stay	O
,	O
functional	B-T170
independence	I-T170
measure	I-T170
,	O
cci	O
and	O
cir	O
##s	O
)	O
.	O
a	O
series	O
of	O
regression	B-T170
analyses	I-T170
were	O
performed	O
to	O
determine	O
the	O
influence	O
of	O
comorbidity	O
on	O
three	O
dependent	O
variables	O
:	O
los	O
in	O
rehabilitation	B-T058
;	O
2	O
)	O
the	O
change	O
in	O
functional	B-T170
independence	I-T170
measure	I-T170
-	I-T170
motor	I-T170
score	O
between	O
rehabilitation	B-T058
discharge	B-T058
and	O
admission	B-T058
;	O
and	O
3	O
)	O
the	O
discharge	B-T058
destin	B-T082
##ation	I-T082
(	O
home	B-T082
vs	O
other	O
)	O
.	O
the	O
mean	O
age	O
was	O
57	O
.	O
7	O
years	O
,	O
there	O
were	O
slightly	O
more	O
females	O
(	O
51	O
%	O
)	O
,	O
most	O
(	O
95	O
%	O
)	O
patients	O
previously	O
lived	B-T033
at	I-T033
home	I-T033
with	O
family	O
or	O
other	O
relatives	O
(	O
63	O
%	O
)	O
.	O
the	O
most	O
common	O
reason	B-T033
for	O
rehabilitation	B-T058
was	O
orthopaedic	B-T058
or	O
other	O
conditions	O
(	O
52	O
%	O
)	O
and	O
most	O
(	O
80	O
%	O
)	O
people	B-T098
were	O
discharged	B-T058
home	B-T082
.	O
the	O
median	O
los	O
was	O
27	O
days	O
.	O
there	O
were	O
100	O
(	O
35	O
.	O
7	O
%	O
)	O
patients	O
who	O
had	O
no	O
comorbidity	O
recorded	B-T170
using	O
the	O
cci	O
,	O
112	O
(	O
40	O
.	O
0	O
%	O
)	O
and	O
26	O
(	O
9	O
.	O
3	O
%	O
)	O
who	O
three	O
or	O
more	O
.	O
all	O
patients	O
had	O
at	O
least	O
one	O
comorbidity	O
recorded	B-T170
with	O
the	O
cir	O
##s	O
,	O
and	O
264	O
(	O
94	O
.	O
3	O
%	O
)	O
had	O
3	O
or	O
more	O
comorbidities	O
.	O
there	O
was	O
little	O
or	O
no	O
difference	O
between	O
the	O
cci	O
or	O
cir	O
##s	O
in	O
terms	O
of	O
their	O
ability	O
to	O
explain	O
the	O
variance	O
in	O
los	O
(	O
adjusted	O
r2	O
=	O
0	O
.	O
38	O
with	O
and	O
without	O
comorbidities	O
)	O
,	O
change	O
in	O
disability	B-T033
during	O
rehabilitation	B-T058
(	O
adjusted	O
r2	O
=	O
0	O
.	O
31	O
-	O
0	O
.	O
33	O
with	O
and	O
without	O
comorbidities	O
)	O
or	O
the	O
discharge	B-T058
destin	B-T082
##ation	I-T082
(	O
auc	O
=	O
0	O
.	O
72	O
without	O
comorbidities	O
;	O
0	O
.	O
73	O
-	O
0	O
.	O
74	O
with	O
comorbidities	O
)	O
beyond	O
that	O
accounted	O
for	O
by	O
demographic	O
and	O
clinical	B-T170
information	I-T170
.	O
neither	O
the	O
cir	O
##s	O
nor	O
the	O
cci	O
in	O
our	O
patient	O
sample	O
provide	O
additional	O
information	O
that	O
explains	O
the	O
impact	O
of	O
comorbidities	O
on	O
key	O
rehabilitation	B-T058
outcomes	O
.	O
further	O
research	B-T062
is	O
needed	O
to	O
determine	O
the	O
most	O
appropriate	O
measure	O
of	O
comorbidity	O
of	O
relevance	O
to	O
inpatient	O
rehabilitation	B-T058
outcomes	O
.	O

cha	B-T204
##etom	I-T204
##ium	I-T204
thermo	I-T204
##phi	I-T204
##lu	I-T204
##m	I-T204
formate	B-T103
dehydrogenase	I-T103
has	O
high	O
activity	O
in	O
the	O
reduction	O
of	O
hydrogen	B-T103
carbonate	I-T103
(	O
hco3	B-T103
-	I-T103
)	O
to	O
formate	B-T103
while	O
formate	B-T103
dehydrogenase	I-T103
##s	I-T103
(	O
fd	B-T103
##hs	I-T103
)	O
have	O
been	O
used	O
for	O
cofactor	B-T103
recycling	O
in	O
chemo	B-T038
##enzymatic	I-T038
synthesis	I-T038
,	O
the	O
ability	O
of	O
fd	B-T103
##h	I-T103
to	O
reduce	O
co2	B-T103
could	O
also	O
be	O
utilized	O
in	O
the	O
conversion	O
of	O
co2	B-T103
to	O
useful	O
products	O
via	O
formate	B-T103
(	O
hco	B-T103
##o	I-T103
(	I-T103
-	I-T103
)	I-T103
)	O
.	O
in	O
this	O
study	O
,	O
we	O
investigated	O
the	O
reduction	O
of	O
co2	B-T103
in	O
the	O
form	O
of	O
hydrogen	B-T103
carbonate	I-T103
(	O
hco3	B-T103
(	I-T103
-	I-T103
)	I-T103
)	O
to	O
formate	B-T103
by	O
fd	B-T103
##hs	I-T103
from	O
candida	B-T204
methyl	I-T204
##ica	I-T204
(	O
cm	B-T103
##fd	I-T103
##h	I-T103
)	O
and	O
cha	B-T204
##etom	I-T204
##ium	I-T204
thermo	I-T204
##phi	I-T204
##lu	I-T204
##m	I-T204
(	O
ct	B-T103
##fd	I-T103
##h	I-T103
)	O
in	O
a	O
nadh	B-T103
-	O
dependent	O
reaction	O
.	O
the	O
catalytic	B-T038
performance	I-T038
with	O
hco3	B-T103
(	I-T103
-	I-T103
)	I-T103
as	O
a	O
substrate	O
was	O
evaluated	O
by	O
measuring	O
the	O
kinetic	O
rates	O
and	O
conducting	O
productivity	B-T058
assays	I-T058
.	O
ct	B-T103
##fd	I-T103
##h	I-T103
showed	O
a	O
higher	O
efficiency	O
in	O
converting	O
hco3	B-T103
(	I-T103
-	I-T103
)	I-T103
to	O
formate	B-T103
than	O
cm	B-T103
##fd	I-T103
##h	I-T103
,	O
whereas	O
cm	B-T103
##fd	I-T103
##h	I-T103
was	O
better	O
in	O
the	O
oxidation	B-T038
of	O
formate	B-T103
.	O
the	O
ph	O
optimum	O
of	O
the	O
reduction	O
was	O
at	O
ph	O
7	O
-	O
8	O
.	O
however	O
,	O
the	O
high	O
concentrations	O
of	O
hco3	B-T103
(	I-T103
-	I-T103
)	I-T103
reduced	O
the	O
reaction	O
rate	O
.	O
ct	B-T103
##fd	I-T103
##h	I-T103
was	O
modeled	O
in	O
the	O
presence	O
of	O
hco3	B-T103
(	I-T103
-	I-T103
)	I-T103
showing	O
that	O
it	O
fits	O
to	O
the	O
active	O
site	O
.	O
the	O
active	O
site	O
setting	O
for	O
hydride	B-T038
transfer	I-T038
in	O
co2	B-T103
reduction	O
was	O
modeled	O
.	O
the	O
hydride	B-T038
don	I-T038
##ated	I-T038
by	O
nadh	B-T103
would	O
form	O
a	O
favorable	O
contact	O
to	O
the	O
carbon	B-T103
atom	I-T103
of	O
hco3	B-T103
(	I-T103
-	I-T103
)	I-T103
,	O
resulting	O
in	O
a	O
sur	O
##plus	O
of	O
electrons	B-T103
within	O
the	O
molecule	O
.	O
this	O
would	O
cause	O
the	O
complex	O
formed	O
by	O
hydrogen	B-T103
carbonate	I-T103
and	O
the	O
hydride	B-T103
to	O
break	O
into	O
formate	B-T103
and	O
hydroxide	B-T103
ions	I-T103
.	O

improved	B-T033
risk	O
stratification	B-T062
for	O
patients	O
with	O
high	O
-	O
grade	O
urothelial	B-T038
carcinoma	I-T038
following	O
application	O
of	O
the	O
paris	B-T082
system	O
for	O
reporting	B-T058
urinary	B-T058
cytology	I-T058
the	O
paris	B-T082
system	O
for	O
reporting	B-T058
urinary	B-T058
cytology	I-T058
(	O
tps	B-T058
)	O
requires	O
4	O
cyto	B-T017
##mo	I-T017
##rp	I-T017
##hol	I-T017
##og	I-T017
##ic	I-T017
criteria	O
for	O
a	O
definitive	O
diagnosis	B-T033
of	O
high	B-T038
-	I-T038
grade	I-T038
urothelial	I-T038
carcinoma	I-T038
(	O
hg	B-T038
##uc	I-T038
)	O
in	O
urinary	B-T058
tract	I-T058
cytology	I-T058
(	O
ut	B-T058
##c	I-T058
)	O
specimens	O
:	O
an	O
elevated	O
nuclear	B-T038
-	I-T038
to	I-T038
-	I-T038
cytoplasmic	I-T038
(	I-T038
n	I-T038
/	I-T038
c	I-T038
)	I-T038
ratio	I-T038
(	O
at	O
or	O
above	O
0	O
.	O
7	O
)	O
,	O
markedly	O
atypical	O
nuclear	B-T017
borders	B-T082
,	O
moderate	O
to	O
severe	O
hyperch	B-T033
##romas	I-T033
##ia	I-T033
,	O
and	O
coarse	B-T033
chromatin	I-T033
.	O
however	O
,	O
malignant	O
ut	B-T058
##c	I-T058
specimens	O
often	O
contain	O
degenerative	O
changes	O
,	O
and	O
this	O
limits	O
the	O
number	O
of	O
malignant	B-T017
cells	I-T017
meeting	O
all	O
4	O
tps	B-T058
cyto	B-T017
##mo	I-T017
##rp	I-T017
##hol	I-T017
##og	I-T017
##ic	I-T017
criteria	O
.	O
one	O
hundred	O
twelve	O
ut	B-T058
##c	I-T058
specimens	O
from	O
patients	O
with	O
a	O
subsequent	O
diagnosis	B-T033
of	O
hg	B-T038
##uc	I-T038
were	O
reviewed	O
and	O
reclass	O
##ified	O
according	O
to	O
tps	B-T058
criteria	O
.	O
the	O
presence	B-T033
of	O
tps	B-T058
cyto	B-T017
##mo	I-T017
##rp	I-T017
##hol	I-T017
##og	I-T017
##ic	I-T017
criteria	O
for	O
hg	B-T038
##uc	I-T038
in	O
each	O
specimen	O
was	O
recorded	O
,	O
as	O
was	O
the	O
proportion	O
of	O
atypical	O
cells	B-T017
meeting	O
all	O
4	O
criteria	O
.	O
the	O
number	O
of	O
specimens	O
definitively	O
diagnosed	B-T033
as	O
hg	B-T038
##uc	I-T038
did	O
not	O
significantly	O
change	O
upon	O
reclass	B-T170
##ification	I-T170
.	O
however	O
,	O
approximately	O
40	O
%	O
of	O
indeterminate	O
specimens	O
(	O
21	O
of	O
51	O
)	O
were	O
reclass	O
##ified	O
into	O
a	O
higher	O
risk	O
category	B-T170
.	O
the	O
most	O
restrictive	O
cyto	B-T017
##mo	I-T017
##rp	I-T017
##hol	I-T017
##og	I-T017
##ic	I-T017
criterion	O
was	O
an	O
n	B-T038
/	I-T038
c	I-T038
ratio	I-T038
of	O
0	O
.	O
7	O
or	O
higher	O
(	O
seen	O
in	O
78	O
%	O
of	O
specimens	O
)	O
,	O
and	O
approximately	O
half	O
of	O
specimens	O
containing	O
all	O
4	O
cyto	B-T017
##mo	I-T017
##rp	I-T017
##hol	I-T017
##og	I-T017
##ic	I-T017
criteria	O
did	O
not	O
meet	O
tps	B-T058
'	O
s	O
numerical	O
criterion	O
for	O
hg	B-T038
##uc	I-T038
(	O
at	O
least	O
5	O
malignant	B-T017
cells	I-T017
)	O
.	O
in	O
the	O
majority	O
of	O
specimens	O
qual	O
##ifying	O
for	O
hg	B-T038
##uc	I-T038
by	O
tps	B-T058
standards	O
,	O
only	O
a	O
small	O
fraction	O
of	O
atypical	O
cells	B-T017
(	O
10	O
%	O
-	O
20	O
%	O
)	O
met	O
all	O
the	O
criteria	O
.	O
when	O
applied	O
to	O
malignant	O
ut	B-T058
##c	I-T058
specimens	O
,	O
tps	B-T058
criteria	O
improved	B-T033
specimen	O
risk	O
stratification	B-T062
by	O
up	O
##grad	O
##ing	O
approximately	O
40	O
%	O
of	O
indeterminate	O
specimens	O
into	O
higher	O
risk	O
categories	B-T170
while	O
not	O
significantly	O
changing	O
the	O
frequency	O
of	O
hg	B-T038
##uc	I-T038
diagnoses	B-T033
.	O
cancer	B-T038
cyto	O
##path	O
##ol	O
2017	O
.	O
©	O
2017	O
american	B-T092
cancer	I-T092
society	I-T092
.	O

staphylococcus	B-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
human	B-T204
infection	B-T038
cases	O
in	O
spain	B-T082
:	O
dog	B-T204
-	O
to	O
-	O
human	B-T204
transmission	B-T038
staphylococcus	B-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
is	O
an	O
opportunistic	O
pathogen	O
that	O
has	O
been	O
identified	O
as	O
infectious	O
agent	O
or	O
colon	B-T033
##izer	I-T033
mainly	O
in	O
dogs	B-T204
.	O
s	B-T007
.	I-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
has	O
been	O
also	O
detected	B-T033
in	O
humans	B-T204
and	O
more	O
specifically	O
in	O
people	B-T098
in	O
contact	O
with	O
dogs	B-T204
.	O
in	O
this	O
study	B-T062
,	O
the	O
possible	B-T033
s	B-T007
.	I-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
pet	B-T204
-	O
to	O
-	O
human	B-T204
transmission	B-T038
was	O
analyzed	B-T062
in	O
four	O
clinical	O
human	B-T204
cases	O
.	O
two	O
patients	O
were	O
dog	B-T204
owners	B-T098
and	O
s	B-T007
.	I-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
was	O
also	O
detected	B-T033
as	O
colon	B-T033
##izer	I-T033
in	O
these	O
healthy	O
animals	B-T204
.	O
s	B-T007
.	I-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
isolates	B-T103
from	O
patients	O
and	O
dogs	B-T204
of	O
the	O
same	O
household	O
showed	O
identical	O
pulsed	B-T058
-	I-T058
field	I-T058
gel	I-T058
electrophoresis	I-T058
patterns	B-T082
,	O
sequence	B-T033
types	I-T033
(	O
sts	B-T033
)	O
,	O
and	O
antimicrobial	B-T201
resistance	I-T201
phenotypes	O
and	O
genotypes	O
,	O
and	O
were	O
methicillin	O
susceptible	O
.	O
resistance	O
to	O
erythromycin	B-T103
,	O
clindamycin	B-T103
,	O
tetracycline	B-T103
,	O
trim	B-T103
##eto	I-T103
##pri	I-T103
##m	I-T103
-	I-T103
sulfamethoxazole	I-T103
,	O
and	O
/	O
or	O
ciprofloxacin	B-T103
was	O
identified	O
among	O
s	B-T007
.	I-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
strains	O
.	O
the	O
lineages	O
st	B-T033
##24	I-T033
##1	I-T033
and	O
the	O
new	O
st	B-T033
##52	I-T033
##1	I-T033
were	O
detected	B-T033
in	O
the	O
strains	O
of	O
the	O
two	O
dog	B-T204
-	O
own	B-T098
##er	I-T098
patients	O
,	O
respectively	O
.	O
the	O
strains	O
from	O
the	O
other	O
two	O
patients	O
presented	O
two	O
new	O
sts	B-T033
,	O
st	B-T033
##71	I-T033
##9	I-T033
and	O
st	B-T033
##72	I-T033
##0	I-T033
.	O
to	O
our	O
knowledge	B-T170
,	O
this	O
is	O
the	O
first	O
description	B-T170
of	O
human	B-T204
infections	B-T038
caused	O
by	O
s	B-T007
.	I-T007
pseud	I-T007
##inter	I-T007
##medi	I-T007
##us	I-T007
in	O
spain	B-T082
.	O

liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
quantification	O
of	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
and	O
thi	B-T103
##aclopr	I-T103
##id	I-T103
residues	O
in	O
butter	B-T204
##bur	I-T204
grown	O
under	O
regulated	B-T082
conditions	I-T082
an	O
analytical	O
method	O
was	O
developed	O
to	O
quantify	O
the	O
residual	O
levels	O
of	O
the	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oid	I-T103
insecticides	I-T103
,	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
and	O
thi	B-T103
##aclopr	I-T103
##id	I-T103
,	O
in	O
field	O
-	O
incurred	O
butter	B-T204
##bur	I-T204
samples	O
using	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
(	O
lc	B-T058
-	I-T058
ms	I-T058
/	I-T058
ms	I-T058
)	O
.	O
samples	O
were	O
extracted	B-T058
with	O
acetonitrile	B-T103
and	O
partition	O
##ed	O
with	O
dichloromethane	B-T103
.	O
after	O
partitioning	O
,	O
purification	O
was	O
conducted	O
using	O
a	O
flor	O
##is	O
##il	O
(	O
®	O
)	O
cartrid	O
##ge	O
.	O
linearity	B-T082
of	O
a	O
matrix	O
-	O
matched	O
calibration	O
curve	O
of	O
the	O
two	O
compounds	O
over	O
a	O
concentration	O
range	O
of	O
0	O
.	O
004	O
-	O
0	O
.	O
4	O
##μg	O
/	O
g	O
was	O
excellent	O
,	O
with	O
determination	O
coefficients	O
(	O
r	O
(	O
2	O
)	O
)	O
≥	O
##0	O
.	O
999	O
##8	O
.	O
the	O
limits	O
of	O
detection	O
(	O
lod	O
)	O
and	O
quantitation	O
(	O
lo	O
##q	O
)	O
for	O
both	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
and	O
thi	B-T103
##aclopr	I-T103
##id	I-T103
were	O
0	O
.	O
000	O
##6	O
and	O
0	O
.	O
002	O
##mg	O
/	O
kg	O
,	O
respectively	O
.	O
the	O
average	O
recoveries	O
for	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
and	O
thi	B-T103
##aclopr	I-T103
##id	I-T103
at	O
two	O
spiking	O
levels	O
(	O
0	O
.	O
02	O
and	O
0	O
.	O
1	O
##mg	O
/	O
kg	O
,	O
i	O
.	O
e	O
.	O
,	O
10	O
##×	O
lo	O
##q	O
and	O
50	O
##×	O
lo	O
##q	O
)	O
were	O
between	O
78	O
.	O
23	O
to	O
82	O
.	O
17	O
%	O
,	O
with	O
relative	O
standard	O
deviations	O
(	O
rsd	O
##s	O
)	O
≤	O
##7	O
.	O
22	O
%	O
.	O
the	O
method	O
was	O
successfully	O
applied	O
to	O
field	O
-	O
incurred	O
samples	O
treated	O
with	O
a	O
commercial	B-T170
pesticide	B-T103
product	I-T103
,	O
either	O
once	O
(	O
zero	O
or	O
7	O
days	O
before	O
harvest	O
)	O
or	O
twice	O
(	O
0	O
and	O
7	O
,	O
7	O
and	O
14	O
,	O
or	O
14	O
and	O
21	O
days	O
before	O
harvest	O
)	O
.	O
the	O
highest	O
and	O
lowest	O
residues	O
were	O
obtained	O
for	O
the	O
7	O
and	O
0	O
days	O
'	O
treatment	O
and	O
the	O
21	O
and	O
14	O
days	O
'	O
treatment	O
,	O
respectively	O
.	O
the	O
developed	O
method	O
is	O
simple	O
and	O
accurate	O
and	O
can	O
be	O
extrapolated	O
to	O
other	O
leaf	B-T168
##y	I-T168
vegetables	I-T168
.	O

anti	B-T033
##adi	I-T033
##po	I-T033
##genic	I-T033
activity	I-T033
of	O
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
and	O
its	O
stability	O
in	O
pigmented	O
rice	B-T168
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
,	O
a	O
prevalent	O
compound	O
in	O
pigmented	O
rice	B-T168
varieties	O
,	O
has	O
been	O
reported	O
to	O
ameliorate	O
obesity	B-T038
-	I-T038
associated	I-T038
metabolic	I-T038
disorders	I-T038
.	O
anti	B-T033
##adi	I-T033
##po	I-T033
##genic	I-T033
activities	I-T033
of	O
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
were	O
determined	O
in	O
human	B-T204
adipose	B-T017
-	O
derived	O
mesenchymal	B-T017
stem	I-T017
cells	I-T017
and	O
mouse	B-T204
-	O
derived	O
3t3	B-T017
-	I-T017
l1	I-T017
cells	I-T017
.	O
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
significantly	O
decreased	O
lipid	B-T033
accumulation	I-T033
and	O
reduced	O
glycerol	B-T038
-	I-T038
3	I-T038
-	I-T038
phosphate	I-T038
dehydrogenase	I-T038
activities	I-T038
in	O
both	O
adipocytes	B-T017
.	O
in	O
addition	O
,	O
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
in	O
four	O
pigmented	O
rice	B-T168
varieties	O
(	O
black	B-T168
with	I-T168
giant	I-T168
embryo	I-T168
,	O
brown	B-T168
,	O
sugar	B-T168
##y	I-T168
brown	I-T168
,	O
and	O
red	B-T168
)	O
was	O
stable	O
when	O
stored	O
at	O
4	O
##°c	O
and	O
also	O
at	O
room	O
temperature	O
for	O
22	O
weeks	O
,	O
whereas	O
other	O
bioactive	O
##s	O
such	O
as	O
lutein	B-T103
and	O
β	B-T103
-	I-T103
carotene	I-T103
were	O
stable	O
only	O
at	O
-	O
80	O
##°c	O
.	O
furthermore	O
,	O
the	O
yield	O
of	O
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
from	O
these	O
rice	B-T168
varieties	O
was	O
significantly	O
increased	O
through	O
steam	O
##ing	O
and	O
ro	O
##asting	O
processes	O
.	O
therefore	O
,	O
γ	B-T103
-	I-T103
oryz	I-T103
##anol	I-T103
exerts	O
anti	B-T033
##adi	I-T033
##po	I-T033
##genic	I-T033
activity	I-T033
by	O
suppressing	O
adipocyte	B-T038
differentiation	I-T038
##s	I-T038
and	O
is	O
stable	O
in	O
pigmented	O
rice	B-T168
for	O
an	O
extended	O
period	O
of	O
time	O
during	O
storage	O
and	O
after	O
cooking	O
.	O
thus	O
,	O
the	O
intake	O
of	O
pigmented	O
rice	B-T168
may	O
be	O
a	O
useful	O
strategy	O
for	O
preventing	O
obesity	B-T038
.	O

long	B-T103
non	I-T103
-	I-T103
coding	I-T103
rna	I-T103
sn	B-T017
##hg	I-T017
##6	I-T017
as	O
a	O
potential	O
biomarker	B-T103
for	O
hepatocellular	B-T038
carcinoma	I-T038
long	B-T103
non	I-T103
-	I-T103
coding	I-T103
rnas	I-T103
(	O
lncrnas	B-T103
)	O
refer	O
to	O
all	O
non	B-T103
-	I-T103
protein	I-T103
coding	I-T103
transcripts	B-T103
longer	O
than	O
200	O
nucleotides	B-T103
.	O
their	O
critical	O
roles	O
in	O
different	O
biological	O
pathways	O
have	O
been	O
already	O
well	O
established	O
.	O
altered	O
expression	B-T038
of	O
lncrnas	B-T103
can	O
be	O
involved	O
in	O
the	O
cancer	B-T038
initiation	I-T038
and	O
/	O
or	O
progression	B-T038
.	O
since	O
patients	O
with	O
hepatocellular	B-T038
carcinoma	I-T038
(	O
hcc	B-T038
)	O
are	O
usually	O
diagnosed	B-T033
in	O
late	O
stages	O
,	O
developing	O
diagnostic	B-T058
methods	I-T058
seems	O
to	O
be	O
essential	O
.	O
in	O
this	O
study	B-T062
,	O
the	O
expression	B-T038
levels	O
of	O
different	O
lncrnas	B-T103
were	O
systematically	O
analysed	B-T062
in	O
different	O
genomic	B-T170
and	O
transcriptome	B-T170
datasets	I-T170
.	O
the	O
analyses	B-T062
showed	O
that	O
sn	B-T017
##hg	I-T017
##6	I-T017
is	O
among	O
the	O
lncrnas	B-T103
with	O
distinctive	O
dysregulation	B-T038
of	O
expression	B-T038
and	O
copy	O
number	O
variation	O
in	O
hcc	B-T038
tumors	I-T038
compared	O
with	O
normal	B-T017
tissues	I-T017
.	O
the	O
results	O
also	O
suggest	O
that	O
the	O
dysregulation	B-T038
of	O
sn	B-T017
##hg	I-T017
##6	I-T017
is	O
highly	O
cancer	B-T038
type	O
specific	O
.	O
through	O
co	O
-	O
occurrence	O
analyses	B-T062
,	O
we	O
found	O
that	O
sn	B-T017
##hg	I-T017
##6	I-T017
and	O
its	O
related	O
co	B-T038
-	I-T038
expressed	I-T038
genes	B-T017
on	O
8	B-T082
##q	I-T082
are	O
involved	O
in	O
the	O
structural	B-T082
integrity	O
of	O
ribosome	B-T017
and	O
translation	B-T038
.	O
this	O
comprehensive	O
in	O
silico	O
analysis	B-T062
,	O
provides	O
a	O
resource	O
for	O
investigating	O
sn	B-T017
##hg	I-T017
##6	I-T017
in	O
hepatocellular	B-T038
carcinoma	I-T038
and	O
lay	O
##s	O
the	O
ground	O
##work	O
for	O
design	O
of	O
next	O
researches	B-T062
.	O

patient	O
preferences	O
in	O
treatment	B-T058
choices	O
for	O
early	O
-	O
stage	O
lung	B-T038
cancer	I-T038
decision	B-T038
-	I-T038
making	I-T038
for	O
lung	B-T038
cancer	I-T038
treatment	B-T058
can	O
be	O
complex	O
because	O
it	O
involves	O
both	O
provider	B-T097
recommendations	O
based	O
on	O
the	O
patient	O
'	O
s	O
clinical	O
condition	O
and	O
patient	O
preferences	O
.	O
this	O
study	B-T062
describes	O
the	O
relative	O
importance	O
of	O
several	O
considerations	B-T033
in	O
lung	B-T038
cancer	I-T038
treatment	B-T058
from	O
the	O
patient	O
'	O
s	O
perspective	O
.	O
a	O
conj	B-T062
##oint	I-T062
preference	I-T062
experiment	I-T062
began	O
by	O
asking	O
respondents	B-T098
to	O
imag	O
##ine	O
that	O
they	O
had	O
just	O
been	O
diagnosed	B-T033
with	O
lung	B-T038
cancer	I-T038
.	O
respondents	B-T098
then	O
chose	O
among	O
procedures	B-T058
that	O
differed	O
regarding	O
treatment	B-T058
modalities	O
,	O
the	O
potential	O
for	O
treatment	B-T058
-	O
related	O
complications	B-T038
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	B-T097
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	B-T058
.	O
conj	B-T062
##oint	I-T062
analysis	I-T062
derived	O
relative	O
weights	O
for	O
these	O
attributes	O
.	O
a	O
total	O
of	O
225	O
responses	B-T170
were	O
analyzed	B-T062
.	O
respondents	B-T098
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	B-T058
operations	I-T058
for	O
treatment	B-T058
of	O
their	O
hypothetical	O
lung	B-T038
cancer	I-T038
,	O
followed	O
by	O
stereotactic	B-T058
body	I-T058
radiation	I-T058
therapy	I-T058
(	O
sb	B-T058
##rt	I-T058
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	B-T058
.	O
treatment	B-T058
type	O
and	O
risk	O
of	O
recurrence	O
were	O
the	O
most	O
important	O
attributes	O
from	O
the	O
conj	B-T062
##oint	I-T062
experiment	I-T062
(	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0	O
.	O
23	O
)	O
,	O
followed	O
by	O
provider	B-T097
volume	O
(	O
relative	O
weight	O
of	O
0	O
.	O
21	O
)	O
,	O
risk	O
of	O
major	O
complications	B-T038
(	O
relative	O
weight	O
of	O
0	O
.	O
18	O
)	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	B-T058
(	O
relative	O
weight	O
of	O
0	O
.	O
15	O
)	O
.	O
procedural	B-T058
and	O
treatment	B-T058
preferences	O
did	O
not	O
vary	O
with	O
demographics	O
,	O
self	B-T062
-	I-T062
reported	I-T062
health	O
status	O
,	O
or	O
familiarity	B-T038
with	O
the	O
procedures	B-T058
.	O
survey	B-T170
respondents	B-T098
preferred	O
minimally	O
invasive	B-T058
operations	I-T058
over	O
sb	B-T058
##rt	I-T058
or	O
thoracotomy	B-T058
for	O
treatment	B-T058
of	O
early	O
-	O
stage	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
.	O
treatment	B-T058
modality	O
and	O
risk	O
of	O
cancer	O
recurrence	O
were	O
the	O
most	O
important	O
factors	O
associated	O
with	O
treatment	B-T058
preferences	O
.	O
provider	B-T097
experience	B-T038
outweigh	O
##ed	O
the	O
potential	O
need	O
to	O
travel	O
for	O
lung	B-T038
cancer	I-T038
treatment	B-T058
.	O

delta	B-T033
-	I-T033
frequency	I-T033
stimulation	O
of	O
cerebellar	B-T017
projections	B-T082
can	O
compensate	O
for	O
schizophrenia	B-T038
-	O
related	O
medial	O
frontal	O
dysfunction	O
schizophrenia	B-T038
involves	O
abnormalities	B-T033
in	O
the	O
medial	B-T017
frontal	I-T017
cortex	I-T017
that	O
lead	O
to	O
cognitive	B-T038
deficits	I-T038
.	O
here	O
we	O
investigate	O
a	O
novel	O
strategy	O
to	O
normalize	B-T062
medial	B-T017
frontal	I-T017
brain	I-T017
activity	B-T038
by	O
stimulating	O
cerebellar	B-T017
projections	B-T082
.	O
we	O
used	O
an	O
interval	O
timing	O
task	O
to	O
study	B-T062
elementary	O
cognitive	B-T038
processing	I-T038
that	O
requires	O
both	O
frontal	B-T017
and	O
cerebellar	B-T017
networks	I-T017
that	O
are	O
disrupted	O
in	O
patients	O
with	O
schizophrenia	B-T038
.	O
we	O
report	O
three	O
novel	O
findings	B-T033
.	O
first	O
,	O
patients	O
with	O
schizophrenia	B-T038
had	O
dysfunctional	O
delta	B-T038
rhythms	I-T038
between	O
1	O
-	O
4	O
hz	O
in	O
the	O
medial	B-T017
frontal	I-T017
cortex	I-T017
.	O
we	O
explored	O
cerebellar	B-T017
-	O
frontal	B-T017
interactions	O
in	O
animal	B-T204
models	I-T204
and	O
found	O
that	O
both	O
frontal	B-T017
and	O
cerebellar	B-T017
neurons	I-T017
were	O
modulated	B-T082
during	O
interval	O
timing	O
and	O
had	O
delta	B-T033
-	I-T033
frequency	I-T033
interactions	O
.	O
finally	O
,	O
delta	B-T033
-	I-T033
frequency	I-T033
opto	B-T062
##gene	I-T062
##tic	I-T062
stimulation	O
of	O
thalamic	B-T017
synaptic	B-T017
terminals	I-T017
of	O
lateral	B-T082
cerebellar	B-T017
projection	B-T082
neurons	B-T017
rescued	O
timing	O
performance	O
as	O
well	O
as	O
medial	B-T017
frontal	I-T017
activity	B-T038
in	O
a	O
rodent	B-T038
model	I-T038
of	O
schizophrenia	B-T038
-	I-T038
related	I-T038
frontal	O
dysfunction	O
.	O
these	O
data	O
provide	O
insight	O
into	O
how	O
the	O
cerebellum	B-T017
influences	O
medial	B-T082
frontal	I-T082
networks	I-T082
and	O
the	O
role	O
of	O
the	O
cerebellum	B-T017
in	O
cognitive	B-T038
processing	I-T038
.	O

metabol	B-T091
##omic	I-T091
analysis	O
of	O
glycero	B-T103
##phosph	I-T103
##olipid	I-T103
signatures	O
of	O
inflammation	B-T038
treated	B-T058
with	I-T058
non	B-T103
-	I-T103
steroidal	I-T103
anti	I-T103
-	I-T103
inflammatory	I-T103
drugs	I-T103
-	O
induced	O
-	O
raw264	B-T017
.	I-T017
7	I-T017
cells	I-T017
using	O
(	B-T058
1	I-T058
)	I-T058
h	I-T058
nmr	I-T058
and	O
u	B-T058
-	I-T058
hplc	I-T058
/	O
q	O
-	O
tof	O
-	O
ms	O
non	B-T058
-	I-T058
destructive	I-T058
proton	I-T058
nuclear	I-T058
magnetic	I-T058
resonance	I-T058
(	I-T058
(	I-T058
1	I-T058
)	I-T058
h	I-T058
nmr	I-T058
)	I-T058
spectroscopy	I-T058
and	O
highly	O
sensitive	O
ultra	B-T058
-	I-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
quadrupole	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
u	B-T058
-	I-T058
hplc	I-T058
/	O
q	O
-	O
tof	O
-	O
ms	O
)	O
coupled	O
to	O
data	O
processing	O
methods	B-T170
were	O
applied	O
to	O
analyze	O
the	O
metabolic	B-T091
profiling	I-T091
changes	O
of	O
glycero	B-T103
##phosph	I-T103
##olipids	I-T103
(	O
gp	B-T103
##ls	I-T103
)	O
in	O
raw264	B-T017
.	I-T017
7	I-T017
cells	I-T017
from	O
inflammation	B-T038
to	O
prognosis	B-T058
.	O
analysis	B-T062
of	O
(	B-T058
1	I-T058
)	I-T058
h	I-T058
nmr	I-T058
was	O
shown	O
that	O
the	O
models	B-T170
were	O
grouped	O
successfully	O
,	O
illustrating	O
that	O
all	O
of	O
them	O
had	O
significant	O
differences	O
.	O
based	O
on	O
the	O
highly	O
simple	O
,	O
accurate	O
,	O
non	O
-	O
targeted	O
and	O
non	O
-	O
destructive	O
##ly	O
advantages	O
of	O
(	B-T058
1	I-T058
)	I-T058
h	I-T058
nmr	I-T058
,	O
it	O
could	O
be	O
used	O
as	O
a	O
new	O
screening	O
tool	O
of	O
anti	B-T103
-	I-T103
inflammatory	I-T103
drugs	I-T103
in	O
the	O
metabolic	B-T091
profiling	I-T091
of	O
gp	B-T103
##ls	I-T103
.	O
58	O
gp	B-T103
##ls	I-T103
were	O
identified	O
by	O
u	B-T058
-	I-T058
hplc	I-T058
/	O
q	O
-	O
tof	O
-	O
ms	O
,	O
and	O
19	O
components	O
were	O
firstly	O
identified	O
in	O
this	O
study	B-T062
compared	O
with	O
our	O
previous	O
results	O
.	O
in	O
addition	O
,	O
ten	O
potential	O
biomarkers	B-T201
were	O
proved	O
,	O
of	O
which	O
phosphatidylcholine	B-T103
(	O
pc	B-T103
)	O
(	O
16	O
:	O
0	O
/	O
18	O
:	O
1	O
)	O
and	O
(	O
18	O
:	O
0	O
/	O
18	O
:	O
1	O
)	O
changed	O
consistently	O
in	O
three	O
drug	O
-	O
induced	O
groups	O
and	O
might	O
be	O
the	O
important	O
biomarkers	B-T201
.	O
compared	O
with	O
(	B-T058
1	I-T058
)	I-T058
h	I-T058
nmr	I-T058
,	O
u	B-T058
-	I-T058
hplc	I-T058
/	O
q	O
-	O
tof	O
-	O
ms	O
showed	O
higher	O
sensitivity	O
and	O
specificity	O
and	O
was	O
more	O
suitable	O
for	O
the	O
determination	B-T058
of	O
biomarkers	B-T201
apart	O
from	O
the	O
deficiency	O
of	O
time	O
-	O
consuming	O
sample	B-T058
preparation	I-T058
steps	I-T058
and	O
unambiguous	O
metabolite	B-T103
identification	O
.	O
therefore	O
,	O
it	O
is	O
feasible	O
to	O
analyze	O
the	O
changes	O
of	O
gp	B-T103
##ls	I-T103
during	O
inflammation	B-T038
by	O
combining	O
(	B-T058
1	I-T058
)	I-T058
h	I-T058
nmr	I-T058
spectroscopy	I-T058
with	O
u	B-T058
-	I-T058
hplc	I-T058
/	O
q	O
-	O
tof	O
-	O
ms	O
.	O
the	O
metabolic	B-T091
profiling	I-T091
of	O
gp	B-T103
##ls	I-T103
provides	O
valuable	O
evidence	O
for	O
inflammation	B-T038
diagnosis	B-T033
and	O
prognosis	B-T058
,	O
and	O
might	O
unravel	O
the	O
mechanisms	O
involved	O
in	O
inflammation	B-T038
progression	B-T038
.	O

differences	O
in	O
pain	B-T033
experience	B-T038
and	O
cooperation	O
between	O
consecutive	B-T058
surgeries	I-T058
in	O
patients	O
undergoing	O
phacoemulsification	B-T058
the	O
purpose	O
of	O
this	O
study	B-T062
is	O
to	O
compare	O
pain	B-T033
experience	B-T038
and	O
cooperation	O
between	O
consecutive	B-T058
surgeries	I-T058
in	O
patients	O
undergoing	O
phacoemulsification	B-T058
in	O
both	O
eyes	B-T017
,	O
using	O
sub	B-T058
-	I-T058
ten	I-T058
##on	I-T058
'	I-T058
s	I-T058
local	I-T058
anesthesia	I-T058
without	O
sedation	B-T058
.	O
in	O
this	O
study	B-T062
,	O
268	O
patients	O
with	O
bilateral	O
senile	O
cataracts	O
were	O
recruited	O
.	O
all	O
operations	B-T058
were	O
performed	O
without	O
sedation	B-T058
,	O
using	O
a	O
clear	O
corneal	B-T017
phacoemulsification	B-T058
technique	I-T058
and	O
sub	B-T058
-	I-T058
ten	I-T058
##on	I-T058
'	I-T058
s	I-T058
local	I-T058
anesthesia	I-T058
,	O
by	O
one	O
of	O
four	O
surgeons	B-T097
.	O
the	O
first	O
surgery	B-T058
was	O
performed	O
on	O
the	O
eye	B-T017
with	O
the	O
higher	O
grade	O
cataract	B-T017
.	O
the	O
other	O
eye	B-T017
was	O
operated	O
on	O
within	O
3	O
months	O
by	O
the	O
same	O
surgeon	B-T097
(	O
mean	O
interval	O
1	O
.	O
9	O
±	O
1	O
.	O
1	O
months	O
)	O
.	O
all	O
patients	O
were	O
asked	O
to	O
grade	O
their	O
pain	B-T033
experience	B-T038
during	O
induction	B-T058
and	O
maintenance	O
of	O
anesthesia	B-T058
and	O
also	O
during	O
the	O
phacoemulsification	B-T058
surgery	I-T058
,	O
using	O
a	O
visual	B-T058
analogue	I-T058
scale	I-T058
(	O
vas	B-T058
)	O
from	O
0	O
(	O
no	B-T033
pain	I-T033
)	O
to	O
10	O
(	O
un	B-T033
##bear	I-T033
##able	I-T033
pain	I-T033
)	O
administered	O
after	O
the	O
surgery	B-T058
.	O
the	O
cooperation	O
of	O
the	O
patient	O
was	O
graded	O
from	O
0	O
(	O
no	O
event	O
)	O
to	O
3	O
(	O
marked	B-T038
##ey	I-T038
##e	I-T038
and	O
head	B-T038
movement	I-T038
and	O
lid	B-T033
squ	I-T033
##ee	I-T033
##zing	I-T033
)	O
by	O
the	O
attending	O
surgeon	B-T097
.	O
the	O
vas	O
scores	O
and	O
cooperation	O
scores	O
of	O
the	O
patients	O
were	O
the	O
outcome	O
measurements	O
.	O
the	O
mean	B-T033
pain	I-T033
score	I-T033
was	O
2	O
.	O
11	O
±	O
0	O
.	O
79	O
in	O
the	O
first	O
eye	B-T017
and	O
3	O
.	O
33	O
±	O
0	O
.	O
80	O
in	O
the	O
second	O
eye	B-T017
during	O
the	O
administration	B-T058
of	O
sub	B-T058
-	I-T058
ten	I-T058
##on	I-T058
'	I-T058
s	I-T058
anesthesia	I-T058
,	O
and	O
1	O
.	O
50	O
±	O
0	O
.	O
60	O
in	O
the	O
first	O
eye	B-T017
and	O
2	O
.	O
10	O
±	O
0	O
.	O
57	O
in	O
the	O
second	O
eye	B-T017
during	O
the	O
phacoemulsification	B-T058
surgery	I-T058
.	O
the	O
patient	O
cooperation	O
score	O
was	O
1	O
.	O
60	O
±	O
0	O
.	O
75	O
in	O
the	O
first	O
surgery	B-T058
and	O
2	O
.	O
08	O
±	O
0	O
.	O
72	O
in	O
the	O
second	O
surgery	B-T058
.	O
the	O
differences	O
between	O
the	O
first	O
and	O
second	O
surgeries	B-T058
were	O
statistically	O
significant	O
for	O
all	O
outcome	O
measures	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
patients	O
who	O
previously	O
underwent	O
phac	B-T058
##o	I-T058
surgery	I-T058
in	O
one	O
eye	B-T017
experienced	O
more	O
pain	B-T033
and	O
showed	O
worse	B-T033
cooperation	O
during	O
the	O
phac	B-T058
##o	I-T058
surgery	I-T058
in	O
the	O
second	O
eye	B-T017
,	O
especially	O
if	O
there	O
was	O
a	O
short	O
time	O
between	O
the	O
surgeries	B-T058
,	O
viz	O
.	O
,	O
less	O
than	O
3	O
months	O
.	O
therefore	O
,	O
if	O
the	O
surgeon	B-T097
has	O
difficulty	O
in	O
the	O
first	O
operation	B-T058
gaining	O
the	O
patient	O
'	O
s	O
cooperation	O
,	O
the	O
surgeon	B-T097
must	O
be	O
careful	O
:	O
if	O
contralateral	B-T058
eye	I-T058
surgery	I-T058
is	O
required	O
,	O
the	O
addition	O
of	O
sedation	B-T058
/	O
analgesia	B-T058
should	O
be	O
considered	O
or	O
the	O
surgery	B-T058
postp	O
##oned	O
for	O
a	O
while	O
to	O
abolish	O
the	O
influence	O
of	O
recent	B-T038
memory	I-T038
on	O
the	O
patient	O
'	O
s	O
subsequent	O
pain	B-T033
experience	B-T038
.	O

psychosocial	O
impact	O
on	O
families	O
with	O
an	O
infant	O
with	O
a	O
hypoplastic	B-T038
left	I-T038
heart	I-T038
syndrome	I-T038
during	O
and	O
after	O
the	O
inters	O
##tage	O
monitoring	O
period	O
-	O
a	O
prospective	B-T062
mixed	I-T062
-	I-T062
method	I-T062
study	I-T062
to	O
investigate	O
parents	B-T038
'	I-T038
experiences	I-T038
,	O
coping	O
ability	O
and	O
quality	O
of	O
life	O
while	O
monitoring	B-T058
their	O
sick	O
child	O
with	O
hypoplastic	B-T038
left	I-T038
heart	I-T038
syndrome	I-T038
at	O
home	B-T082
.	O
inters	B-T058
##tage	I-T058
home	I-T058
monitoring	I-T058
for	O
children	O
with	O
hypoplastic	B-T038
left	I-T038
heart	I-T038
syndrome	I-T038
reduces	O
inters	O
##tage	O
mortality	O
between	O
norw	B-T058
##ood	I-T058
stages	I-T058
i	I-T058
and	I-T058
ii	I-T058
.	O
little	O
is	O
known	O
about	O
the	O
psychosocial	O
impact	O
of	O
inters	B-T058
##tage	I-T058
home	I-T058
monitoring	I-T058
.	O
prospective	B-T062
mixed	I-T062
-	I-T062
method	I-T062
study	I-T062
.	O
this	O
study	O
assessed	O
the	O
psychosocial	O
impact	O
on	O
parents	O
during	O
inters	B-T058
##tage	I-T058
home	I-T058
monitoring	I-T058
.	O
this	O
contains	O
for	O
quantitative	O
assessment	O
the	O
short	B-T170
form	I-T170
health	I-T170
survey	I-T170
questionnaire	I-T170
and	O
the	O
impact	O
of	O
family	B-T033
scale	I-T033
administered	I-T033
one	O
and	O
five	O
weeks	O
following	O
discharge	B-T058
before	O
and	O
after	O
stage	O
ii	O
.	O
for	O
qualitative	O
assessment	O
,	O
semi	O
-	O
structured	O
interviews	O
focuss	O
##ing	O
on	O
the	O
postd	B-T033
##isc	I-T033
##har	I-T033
##ge	I-T033
coping	B-T058
strategies	I-T058
were	O
conducted	O
twice	O
,	O
five	O
weeks	O
after	B-T033
hospital	I-T033
discharge	I-T033
before	O
and	O
after	O
stage	O
ii	O
.	O
ten	O
infants	O
(	O
eight	O
males	O
)	O
with	O
hypoplastic	B-T038
left	I-T038
heart	I-T038
syndrome	I-T038
(	O
n	O
=	O
7	O
)	O
or	O
other	O
types	O
of	O
univ	B-T017
##entricular	I-T017
heart	I-T017
malformations	I-T017
(	O
n	O
=	O
3	O
)	O
,	O
and	O
their	O
parents	O
(	O
nine	O
mother	O
/	O
father	O
two	O
-	O
parent	O
households	O
,	O
one	O
single	O
mother	O
)	O
were	O
included	O
.	O
there	O
were	O
no	B-T033
inters	I-T033
##tage	I-T033
deaths	I-T033
.	O
mental	B-T038
health	I-T038
composite	O
summary	O
scores	O
were	O
low	O
in	O
both	O
parents	O
(	O
mothers	O
:	O
40	O
·	O
45	O
±	O
9	O
·	O
07	O
;	O
fathers	O
:	O
40	O
·	O
58	O
±	O
9	O
·	O
69	O
)	O
and	O
lowest	O
for	O
the	O
item	O
'	O
vitality	B-T033
'	O
(	O
mothers	O
:	O
37	O
·	O
0	O
±	O
19	O
·	O
46	O
;	O
fathers	O
:	O
43	O
·	O
12	O
±	O
25	O
·	O
9	O
)	O
before	O
and	O
after	O
stage	O
ii	O
.	O
impact	O
of	O
family	B-T033
scale	I-T033
values	I-T033
showed	O
higher	O
daily	O
and	O
social	O
burdens	O
for	O
mothers	O
.	O
'	O
becoming	O
a	O
family	O
'	O
was	O
the	O
most	O
important	O
task	O
as	O
coping	B-T058
strategy	I-T058
to	O
equilibr	O
##ate	O
the	O
fragile	B-T038
emotional	I-T038
balance	I-T038
.	O
the	O
parents	O
judged	O
inters	B-T058
##tage	I-T058
home	I-T058
monitoring	I-T058
as	O
a	O
protective	B-T058
intervention	I-T058
.	O
although	O
psychosocial	O
burden	O
before	O
and	O
after	O
stage	O
ii	O
remains	O
high	O
,	O
becoming	O
a	O
family	O
is	O
an	O
essential	O
experience	O
for	O
parents	O
and	O
confirms	O
their	O
parent	O
##hood	O
.	O
healthcare	B-T097
professionals	I-T097
must	O
be	O
aware	O
of	O
parents	O
'	O
needs	O
during	O
this	O
vulnerable	O
inters	O
##tage	O
period	O
and	O
to	O
provide	O
psychosocial	O
and	O
nursing	B-T058
support	I-T058
.	O

comparison	O
of	O
gas	O
##oline	O
direct	O
-	O
injection	O
(	O
gd	O
##i	O
)	O
and	O
port	O
fuel	O
injection	O
(	O
pf	O
##i	O
)	O
vehicle	B-T103
emissions	I-T103
:	O
emission	B-T103
certification	O
standards	B-T170
,	O
cold	B-T033
-	I-T033
start	I-T033
,	O
secondary	O
organic	O
aerosol	O
formation	O
potential	O
,	O
and	O
potential	O
climate	O
impacts	O
recent	O
increases	O
in	O
the	O
corpora	O
##te	O
average	O
fuel	O
economy	O
standards	B-T170
have	O
led	O
to	O
widespread	B-T082
adoption	O
of	O
vehicles	O
equipped	O
with	O
gas	O
##oline	O
direct	O
-	O
injection	O
(	O
gd	O
##i	O
)	O
engine	O
##s	O
.	O
changes	O
in	O
engine	O
technologies	O
can	O
alter	O
emissions	B-T103
.	O
to	O
quantify	O
these	O
effects	O
,	O
we	O
measured	O
gas	B-T103
-	I-T103
and	O
particle	O
-	O
phase	O
emissions	B-T103
from	O
82	O
light	O
-	O
duty	O
gas	O
##oline	O
vehicles	O
recruited	O
from	O
the	O
california	B-T082
in	O
-	O
use	O
fle	O
##et	O
tested	B-T170
on	O
a	O
cha	O
##ss	O
##is	O
dynam	O
##ometer	O
using	O
the	O
cold	B-T033
-	I-T033
start	I-T033
unified	O
cycle	O
.	O
the	O
fle	O
##et	O
included	O
15	O
gd	O
##i	O
vehicles	O
,	O
including	O
8	O
gd	O
##is	O
certified	O
to	O
the	O
most	O
-	O
stringent	O
emissions	B-T103
standard	B-T170
,	O
super	B-T170
##ult	I-T170
##ra	I-T170
-	I-T170
low	I-T170
-	I-T170
emission	I-T170
vehicles	I-T170
(	O
sul	B-T170
##ev	I-T170
)	O
.	O
we	O
quantified	O
the	O
effects	O
of	O
engine	O
technology	O
,	O
emission	B-T103
certification	O
standards	B-T170
,	O
and	O
cold	B-T033
-	I-T033
start	I-T033
on	O
emissions	B-T103
.	O
for	O
vehicles	O
certified	O
to	O
the	O
same	O
emissions	B-T103
standard	B-T170
,	O
there	O
is	O
no	O
statistical	O
difference	O
of	O
regulated	O
gas	O
-	O
phase	O
pollutant	B-T103
emissions	B-T103
between	O
pf	O
##is	O
and	O
gd	O
##is	O
.	O
however	O
,	O
gd	O
##is	O
had	O
,	O
on	O
average	O
,	O
a	O
factor	O
of	O
2	O
higher	O
particulate	O
matter	O
(	O
pm	O
)	O
mass	O
emissions	B-T103
than	O
pf	O
##is	O
due	O
to	O
higher	O
elemental	B-T103
carbon	I-T103
(	O
ec	B-T103
)	O
emissions	B-T103
.	O
sul	B-T170
##ev	I-T170
certified	O
gd	O
##is	O
have	O
a	O
factor	O
of	O
2	O
lower	O
pm	O
mass	O
emissions	B-T103
than	O
gd	O
##is	O
certified	O
as	O
ultra	B-T170
##low	I-T170
-	I-T170
emission	I-T170
vehicles	I-T170
(	O
3	O
.	O
0	O
±	O
1	O
.	O
1	O
versus	O
6	O
.	O
3	O
±	O
1	O
.	O
1	O
mg	O
/	O
mi	O
)	O
,	O
suggesting	O
improvements	O
in	O
engine	O
design	O
and	O
calibration	O
.	O
comprehensive	O
organic	O
speciation	O
revealed	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
composition	O
of	O
the	O
volatile	O
organic	B-T103
compounds	I-T103
emissions	B-T103
between	O
pf	O
##i	O
and	O
gd	O
##is	O
,	O
including	O
benzene	B-T103
,	O
toluene	B-T103
,	O
ethyl	B-T103
##benzene	I-T103
,	O
and	O
xyle	B-T103
##nes	I-T103
(	O
bt	B-T103
##ex	I-T103
)	O
.	O
therefore	O
,	O
the	O
secondary	O
organic	O
aerosol	O
and	O
ozone	B-T103
formation	O
potential	O
of	O
the	O
exhaust	O
does	O
not	O
depend	O
on	O
engine	O
technology	O
.	O
cold	B-T033
-	I-T033
start	I-T033
contributes	O
a	O
larger	O
fraction	O
of	O
the	O
total	O
unified	O
cycle	O
emissions	B-T103
for	O
vehicles	O
meeting	O
more	O
-	O
stringent	O
emission	B-T103
standards	B-T170
.	O
organic	O
gas	B-T103
emissions	B-T103
were	O
the	O
most	O
sensitive	O
to	O
cold	B-T033
-	I-T033
start	I-T033
compared	O
to	O
the	O
other	O
pollutants	B-T103
tested	B-T170
here	O
.	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
effects	O
of	O
cold	B-T033
-	I-T033
start	I-T033
on	O
gd	O
##is	O
and	O
pf	O
##is	O
.	O
for	O
our	O
test	O
fle	O
##et	O
,	O
the	O
measured	O
14	O
.	O
5	O
%	O
decrease	O
in	O
co2	B-T103
emissions	B-T103
from	O
gd	O
##is	O
was	O
much	O
greater	O
than	O
the	O
potential	O
climate	O
for	O
##cing	O
associated	O
with	O
higher	O
black	B-T103
carbon	I-T103
emissions	B-T103
.	O
thus	O
,	O
switching	O
from	O
pf	O
##i	O
to	O
gd	O
##i	O
vehicles	O
will	O
likely	O
lead	O
to	O
a	O
reduction	O
in	O
net	O
global	O
warming	O
.	O

stromal	B-T033
alterations	I-T033
in	O
ovarian	B-T038
cancers	I-T038
via	O
wavelength	O
dependent	O
second	B-T058
harmonic	I-T058
generation	I-T058
microscopy	I-T058
and	O
optical	O
scattering	O
ovarian	B-T038
cancer	I-T038
remains	O
the	O
most	O
dead	O
##ly	O
gynecological	B-T091
cancer	B-T038
with	O
a	O
poor	O
aggregate	O
survival	O
rate	O
;	O
however	O
,	O
the	O
specific	O
rates	O
are	O
highly	O
dependent	O
on	O
the	O
stage	O
of	O
the	O
disease	B-T038
upon	O
diagnosis	B-T033
.	O
current	O
screening	B-T058
and	O
imaging	B-T074
tools	I-T074
are	O
insufficient	O
to	O
detect	O
early	B-T033
lesions	I-T033
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	B-T038
cancer	I-T038
that	O
may	O
benefit	O
from	O
specific	O
treatments	B-T058
.	O
as	O
an	O
alternative	O
to	O
current	O
screening	B-T058
and	O
imaging	B-T074
tools	I-T074
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	B-T103
-	O
specific	O
second	B-T058
harmonic	I-T058
generation	I-T058
(	I-T058
sh	I-T058
##g	I-T058
)	I-T058
imaging	I-T058
microscopy	I-T058
and	O
optical	B-T058
scattering	I-T058
measurements	I-T058
to	O
probe	O
the	O
structural	B-T103
differences	O
in	O
the	O
extracellular	B-T017
matrix	I-T017
(	O
ecm	B-T017
)	O
of	O
normal	O
stroma	B-T017
,	O
benign	B-T038
tumors	I-T038
,	O
endometri	B-T038
##oid	I-T038
tumors	I-T038
,	O
and	O
low	B-T038
and	O
high	B-T038
-	I-T038
grade	I-T038
serous	I-T038
tumors	I-T038
.	O
the	O
sh	B-T058
##g	I-T058
signatures	O
of	O
the	O
emission	O
directional	O
##ity	O
and	O
conversion	O
efficiency	O
as	O
well	O
as	O
the	O
optical	O
scattering	O
are	O
related	O
to	O
the	O
organization	O
of	O
collagen	B-T103
on	O
the	O
sub	O
-	O
micron	O
size	B-T170
scale	I-T170
and	O
encode	O
structural	B-T103
information	O
.	O
the	O
wavelength	O
dependence	O
of	O
these	O
readout	O
##s	O
adds	O
additional	O
characterization	O
of	O
the	O
size	B-T082
and	O
distribution	O
of	O
collagen	B-T017
fibrils	I-T017
/	O
fibers	B-T017
relative	O
to	O
the	O
interrog	O
##ating	O
wavelengths	O
.	O
we	O
found	O
a	O
strong	O
wavelength	O
dependence	O
of	O
these	O
metrics	B-T017
that	O
are	O
related	O
to	O
significant	O
structural	B-T103
differences	O
in	O
the	O
collagen	B-T103
organization	O
and	O
are	O
consistent	O
with	O
the	O
dual	O
##istic	O
classification	B-T170
of	O
type	B-T038
i	I-T038
and	I-T038
ii	I-T038
serous	I-T038
tumors	I-T038
.	O
moreover	O
,	O
type	B-T038
i	I-T038
endometri	I-T038
##oid	I-T038
tumors	I-T038
have	O
strongly	O
differing	O
ecm	B-T017
architecture	O
than	O
the	O
serous	B-T038
malignancies	I-T038
.	O
the	O
sh	B-T058
##g	I-T058
metrics	B-T017
and	O
optical	B-T058
scattering	I-T058
measurements	I-T058
were	O
used	O
to	O
form	O
a	O
linear	B-T170
discriminant	I-T170
model	I-T170
to	O
classify	O
the	O
tissues	B-T017
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>	O
90	O
%	O
)	O
between	O
high	B-T038
-	I-T038
grade	I-T038
serous	I-T038
tumors	I-T038
from	O
the	O
other	O
tissue	B-T017
types	I-T017
.	O
high	B-T038
-	I-T038
grade	I-T038
serous	I-T038
tumors	I-T038
account	O
for	O
~	O
70	O
%	O
of	O
ovarian	B-T038
cancers	I-T038
,	O
and	O
this	O
delineation	O
has	O
potential	O
clinical	O
applications	O
in	O
terms	O
of	O
supplement	O
##ing	O
histological	O
analysis	O
,	O
understanding	O
the	O
etiology	O
,	O
as	O
well	O
as	O
development	O
of	O
an	O
in	O
vivo	O
screening	B-T058
tool	I-T058
.	O
sh	B-T058
##g	I-T058
and	O
optical	B-T058
scattering	I-T058
measurements	I-T058
provide	O
sub	O
-	O
resolution	O
information	O
and	O
when	O
combined	O
provide	O
superior	B-T058
diagnostic	I-T058
power	I-T058
over	O
clinical	B-T058
imaging	I-T058
modalities	O
.	O
additionally	O
the	O
measurements	O
are	O
able	O
to	O
delineate	O
the	O
different	O
subtypes	O
of	O
ovarian	B-T038
cancer	I-T038
and	O
may	O
potentially	O
assist	O
in	O
treatment	B-T058
protocols	I-T058
.	O
understanding	O
the	O
altered	O
collagen	B-T103
assembly	O
can	O
supplement	O
histological	O
analysis	O
and	O
provide	O
new	O
insight	O
into	O
the	O
etiology	O
.	O
these	O
methods	O
could	O
become	O
an	O
in	O
vivo	O
screening	B-T058
tool	I-T058
for	O
earlier	O
detection	O
which	O
is	O
important	O
since	O
ovarian	B-T038
malignancies	I-T038
can	O
metastas	B-T038
##ize	I-T038
while	O
undetectable	O
by	O
current	O
clinical	B-T058
imaging	I-T058
resolution	O
.	O

activation	B-T038
of	I-T038
transcription	I-T038
enfor	O
##ces	O
the	O
formation	O
of	O
distinct	O
nuclear	B-T017
bodies	I-T017
in	O
zebrafish	B-T204
embryos	B-T017
nuclear	B-T017
bodies	I-T017
are	O
cellular	B-T082
compartments	I-T082
that	O
lack	O
lipid	B-T017
bilayers	I-T017
and	O
harbor	O
specific	O
rnas	B-T103
and	O
proteins	B-T103
.	O
recent	O
proposals	O
that	O
nuclear	B-T017
bodies	I-T017
form	O
through	O
liquid	O
-	O
liquid	O
phase	O
separation	O
leave	O
the	O
question	O
of	O
how	O
different	O
nuclear	B-T017
bodies	I-T017
maintain	O
their	O
distinct	O
identities	O
un	O
##answ	O
##ered	O
.	O
here	O
we	O
investigate	O
ca	B-T017
##ja	I-T017
##l	I-T017
bodies	I-T017
(	O
cbs	B-T017
)	O
,	O
histone	B-T017
locus	I-T017
bodies	I-T017
(	O
hl	B-T017
##bs	I-T017
)	O
and	O
nucleoli	B-T017
-	O
involved	O
in	O
assembly	O
of	O
the	O
splicing	B-T038
machinery	I-T038
,	O
histone	B-T038
mrna	I-T038
3	I-T038
'	I-T038
end	I-T038
processing	I-T038
,	O
and	O
rrna	B-T038
processing	I-T038
,	O
respectively	O
-	O
in	O
the	O
embryos	B-T017
of	O
the	O
zebrafish	B-T204
,	O
dan	B-T204
##io	I-T204
rer	I-T204
##io	I-T204
.	O
we	O
take	O
advantage	O
of	O
the	O
transcriptional	O
sil	O
##ence	O
of	O
the	O
1	O
-	O
cell	O
embryo	B-T017
and	O
follow	O
nuclear	B-T017
body	I-T017
appearance	O
as	O
zyg	B-T017
##otic	I-T017
transcription	B-T038
becomes	O
activated	O
.	O
cbs	B-T017
are	O
present	O
from	O
fertilization	B-T038
onwards	O
,	O
while	O
hl	B-T017
##b	I-T017
and	O
nucleolar	B-T017
components	B-T017
formed	O
foci	B-T082
several	O
hours	O
later	O
when	O
histone	B-T103
genes	B-T017
and	O
rdna	B-T103
became	O
active	O
.	O
hl	B-T017
##b	I-T017
formation	O
was	O
blocked	O
by	O
transcription	B-T038
inhibition	I-T038
,	O
suggesting	O
nascent	B-T103
histone	I-T103
transcripts	I-T103
recruit	O
hl	B-T017
##b	I-T017
components	B-T017
like	O
u	B-T103
##7	I-T103
snr	I-T103
##np	I-T103
.	O
surprisingly	O
,	O
we	O
found	O
that	O
u	O
##7	O
base	B-T038
-	I-T038
pairing	I-T038
with	O
nascent	B-T103
histone	I-T103
transcripts	I-T103
was	O
not	O
required	O
for	O
localization	B-T038
to	O
hl	B-T017
##bs	I-T017
.	O
rather	O
,	O
the	O
type	O
of	O
sm	O
ring	O
assembled	O
on	O
u	O
##7	O
determined	O
its	O
targeting	O
to	O
hl	B-T017
##bs	I-T017
or	O
cbs	B-T017
;	O
the	O
splice	O
##osomal	O
sm	O
ring	O
targeted	O
snr	B-T103
##nas	I-T103
to	O
cbs	B-T017
while	O
the	O
specialized	O
u	O
##7	O
sm	O
-	O
ring	O
localized	O
to	O
hl	B-T017
##bs	I-T017
,	O
demonstrating	O
the	O
contribution	O
of	O
protein	B-T103
constituents	O
to	O
the	O
distinction	O
among	O
nuclear	B-T017
bodies	I-T017
.	O
thus	O
,	O
nucleolar	B-T017
,	O
hl	B-T017
##b	I-T017
,	O
and	O
cb	B-T017
components	B-T017
can	O
mix	O
in	O
early	O
embryogenesis	B-T038
when	O
transcription	B-T038
is	O
naturally	O
or	O
artificially	O
silenced	O
.	O
these	O
data	O
support	O
a	O
model	O
in	O
which	O
transcription	B-T038
of	O
specific	O
gene	B-T082
loci	I-T082
nucle	O
##ates	O
nuclear	B-T017
body	I-T017
components	B-T017
with	O
high	O
specificity	O
and	O
fidelity	O
to	O
perform	O
distinct	O
regulatory	O
functions	B-T038
.	O

a	O
numerical	O
study	B-T062
on	O
the	O
application	O
of	O
the	O
functionally	O
graded	O
materials	O
in	O
the	O
stent	B-T074
design	O
undesirable	O
deformation	O
of	O
the	O
stent	B-T074
can	O
induce	O
a	O
significant	B-T037
amount	O
of	O
injur	B-T037
##e	I-T037
not	O
only	O
to	O
the	O
blood	B-T017
vessel	I-T017
but	O
also	O
to	O
the	O
plaque	B-T033
.	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
reduce	B-T033
/	I-T033
minimize	I-T033
these	O
undesirable	O
deformations	O
by	O
the	O
application	O
of	O
functionally	O
graded	O
materials	O
(	O
fg	O
##m	O
)	O
.	O
to	O
do	O
this	O
,	O
finite	O
element	O
(	O
fe	O
)	O
method	O
was	O
employed	B-T033
to	O
simulate	B-T062
the	O
expansion	O
of	O
a	O
stent	B-T074
and	O
the	O
corresponding	O
displacement	O
of	O
the	O
stenosis	B-T038
plaque	B-T033
.	O
three	O
hypere	O
##lastic	O
plaque	B-T033
types	O
as	O
well	O
as	O
five	O
elast	B-T074
##oplastic	I-T074
stents	I-T074
were	O
simulated	O
.	O
dog	O
##bon	O
##ing	O
,	O
fore	B-T033
##sh	I-T033
##ort	I-T033
##ening	I-T033
,	O
maximum	O
stress	B-T033
in	O
the	O
plaque	B-T033
,	O
and	O
the	O
pressure	O
which	O
is	O
needed	O
to	O
fully	O
expand	B-T082
the	O
stent	B-T074
for	O
different	O
stent	B-T074
materials	O
,	O
were	O
acquired	O
.	O
while	O
all	O
fg	O
##ms	O
had	O
lower	O
dog	O
##bon	O
##ing	O
in	O
comparison	O
to	O
the	O
stents	B-T074
made	O
of	O
the	O
uniform	O
materials	O
,	O
the	O
stent	B-T074
with	O
the	O
lowest	O
heterogeneous	B-T170
index	I-T170
displayed	O
the	O
lowest	O
amount	O
of	O
dog	O
##bon	O
##ing	O
.	O
steel	B-T103
stent	B-T074
showed	O
the	O
lowest	O
fore	B-T033
##sh	I-T033
##ort	I-T033
##ening	I-T033
and	O
fully	O
expansion	O
pressure	O
but	O
the	O
difference	O
was	O
much	O
lower	O
than	O
that	O
the	O
one	O
for	O
dog	O
##bon	O
##ing	O
.	O
therefore	O
,	O
the	O
fg	O
##m	O
with	O
the	O
heterogeneous	B-T170
index	I-T170
of	O
0	O
.	O
5	O
is	O
expected	O
to	O
exhibit	O
the	O
most	O
suitable	O
results	O
.	O
in	O
addition	O
,	O
the	O
results	O
revealed	O
that	O
the	O
material	O
parameters	O
has	O
crucial	O
effects	O
on	O
the	O
deformation	O
of	O
the	O
stent	B-T074
and	O
,	O
as	O
a	O
result	O
,	O
as	O
a	O
design	O
point	O
of	O
view	O
the	O
fg	O
##m	O
parameters	O
can	O
be	O
tailored	O
to	O
achieve	O
the	O
goal	O
of	O
the	O
biomechanical	O
optimization	O
.	O

heart	B-T201
rate	I-T201
variability	O
as	O
a	O
biomarker	B-T201
for	O
sedation	B-T033
depth	I-T033
estimation	O
in	O
icu	B-T092
patients	O
an	O
automated	O
patient	O
-	O
specific	O
system	O
to	O
classify	O
the	O
level	O
of	O
sedation	O
in	O
icu	B-T092
patients	O
using	O
heart	B-T201
rate	I-T201
variability	O
signal	O
is	O
presented	O
in	O
this	O
paper	B-T170
.	O
ecg	B-T033
from	O
70	O
mechanically	B-T058
ventilated	I-T058
adult	O
patients	O
with	O
administered	O
sedative	B-T103
##s	I-T103
in	O
an	O
icu	B-T092
setting	I-T092
were	O
used	O
to	O
develop	O
a	O
support	O
vector	O
machine	O
based	O
system	O
for	O
sedation	B-T033
depth	I-T033
monitoring	B-T058
using	O
several	O
heart	B-T201
rate	I-T201
variability	O
measures	O
.	O
a	O
leave	B-T062
-	I-T062
one	I-T062
-	I-T062
subject	I-T062
-	I-T062
out	I-T062
cross	I-T062
validation	I-T062
was	O
used	O
for	O
classifier	O
training	O
and	O
performance	O
evaluations	B-T058
.	O
the	O
proposed	O
patient	O
-	O
specific	O
system	O
provided	O
a	O
sensitivity	O
,	O
specificity	O
and	O
an	O
auc	O
of	O
64	O
%	O
,	O
84	O
.	O
8	O
%	O
and	O
0	O
.	O
72	O
,	O
respectively	O
.	O
it	O
is	O
hoped	O
that	O
with	O
the	O
help	O
of	O
additional	O
physiological	O
signals	O
the	O
proposed	O
patient	O
-	O
specific	O
sedation	O
level	O
prediction	O
system	O
could	O
lead	O
to	O
a	O
fully	O
automated	O
multimodal	O
system	O
to	O
assist	O
clinical	O
staff	B-T097
in	O
icus	B-T092
to	O
interpret	O
the	O
sedation	O
level	O
of	O
the	O
patient	O
.	O

immune	B-T033
dysregulation	I-T033
in	O
offspring	O
of	O
a	O
bipolar	B-T038
parent	O
.	O
altered	O
serum	B-T031
levels	O
of	O
immune	O
growth	B-T103
factors	I-T103
at	O
adolescent	O
age	O
immune	B-T033
dysregulation	I-T033
plays	O
a	O
role	O
in	O
the	O
vulnerability	O
for	O
mood	B-T038
disorders	I-T038
.	O
immune	O
growth	B-T103
factors	I-T103
,	O
such	O
as	O
stem	B-T103
cell	I-T103
factor	I-T103
(	O
scf	B-T103
)	O
,	O
insulin	B-T103
-	I-T103
like	I-T103
growth	I-T103
factor	I-T103
-	I-T103
binding	I-T103
protein	I-T103
-	I-T103
2	I-T103
(	O
igf	B-T103
-	I-T103
bp	I-T103
##2	I-T103
)	O
,	O
epidermal	B-T103
growth	I-T103
factor	I-T103
(	O
egf	B-T103
)	O
,	O
il	B-T103
-	I-T103
7	I-T103
and	O
scd	B-T103
##25	I-T103
have	O
repeatedly	O
been	O
reported	O
altered	O
in	O
patients	O
with	O
mood	B-T038
disorders	I-T038
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
levels	O
of	O
these	O
factors	B-T103
in	O
serum	B-T031
of	O
adolescent	O
bipolar	B-T038
offspring	O
,	O
who	O
have	O
a	O
heightened	O
risk	O
for	O
mood	B-T038
disorder	I-T038
development	O
and	O
to	O
also	O
analyze	B-T062
the	O
data	O
combined	O
with	O
previously	O
published	B-T170
data	I-T170
.	O
growth	B-T103
factors	I-T103
were	O
assessed	O
by	O
cba	B-T058
/	O
elisa	B-T058
in	O
adolescent	O
bipolar	B-T038
offspring	O
(	O
n	O
=	O
96	O
,	O
mean	O
age	O
=	O
16	O
years	O
)	O
and	O
in	O
age	O
-	O
and	O
gender	O
-	O
matched	O
healthy	O
controls	O
(	O
n	O
=	O
50	O
)	O
.	O
egf	B-T103
belonged	O
to	O
a	O
mutually	O
correlating	O
cluster	O
of	O
mainly	O
neurotrophic	B-T103
compounds	I-T103
including	O
s100	B-T103
##b	I-T103
and	O
bdnf	B-T103
,	O
which	O
were	O
in	O
general	O
decreased	O
in	O
serum	B-T031
.	O
il	B-T103
-	I-T103
7	I-T103
,	O
scf	B-T103
,	O
igf	B-T103
-	I-T103
bp	I-T103
##2	I-T103
and	O
scd	B-T103
##25	I-T103
,	O
belonged	O
to	O
a	O
different	O
mutually	O
correlating	O
cluster	O
of	O
immune	O
growth	B-T103
factors	I-T103
,	O
which	O
were	O
in	O
general	O
increased	O
:	O
igf	B-T103
-	I-T103
bp	I-T103
##2	I-T103
significantly	O
in	O
serum	B-T031
of	O
offspring	O
without	O
a	O
mood	B-T038
disorder	I-T038
,	O
il	B-T103
-	I-T103
7	I-T103
and	O
scf	B-T103
in	O
serum	B-T031
of	O
offspring	O
who	O
had	O
exp	B-T038
##ir	I-T038
##ience	I-T038
##d	I-T038
a	O
mood	B-T038
episode	I-T038
.	O
this	O
pattern	B-T082
of	O
de	O
-	O
and	O
increases	O
was	O
not	O
different	O
between	O
bipolar	B-T038
offspring	O
that	O
developed	O
or	O
did	O
not	O
develop	O
a	O
mood	B-T038
disorder	I-T038
over	O
time	O
,	O
apart	O
from	O
the	O
igf	B-T103
-	I-T103
bp	I-T103
##2	I-T103
level	O
,	O
which	O
was	O
near	O
significantly	O
higher	O
in	O
offspring	O
later	O
developing	O
a	O
mood	B-T038
disorder	I-T038
.	O
correlations	O
with	O
the	O
previously	O
published	B-T170
immune	B-T017
-	I-T017
cellular	I-T017
abnormalities	I-T017
were	O
not	O
found	O
.	O
in	O
conclusion	O
non	O
-	O
affected	O
adolescents	O
at	O
familial	O
mood	B-T038
disorder	I-T038
development	O
risk	O
were	O
characterized	O
by	O
a	O
distinct	O
pattern	B-T082
of	O
a	O
series	O
of	O
compounds	B-T103
operating	O
in	O
a	O
network	O
of	O
hematopoiesis	B-T038
,	O
neurogenesis	B-T038
and	O
inflammation	B-T038
.	O

water	B-T103
safety	O
in	O
healthcare	B-T092
facilities	I-T092
.	O
the	O
vi	B-T170
##est	I-T170
##e	I-T170
chart	I-T170
##er	I-T170
the	O
study	B-T097
group	I-T097
on	O
hospital	B-T092
hygiene	B-T091
of	O
the	O
italian	B-T092
society	I-T092
of	I-T092
hygiene	I-T092
,	I-T092
preventive	I-T092
medicine	I-T092
and	I-T092
public	I-T092
health	I-T092
(	O
gis	B-T092
##io	I-T092
-	I-T092
sit	I-T092
##i	I-T092
)	O
and	O
the	O
local	B-T092
health	I-T092
authority	I-T092
of	O
fog	B-T082
##gia	I-T082
,	O
ap	B-T082
##uli	I-T082
##a	I-T082
,	O
italy	B-T082
,	O
after	O
the	O
national	O
convention	O
[UNK]	O
safe	O
water	B-T103
in	O
healthcare	B-T092
facilities	I-T092
[UNK]	O
held	O
in	O
vi	B-T082
##est	I-T082
##e	I-T082
-	I-T082
pu	I-T082
##gn	I-T082
##och	I-T082
##ius	I-T082
##o	I-T082
on	O
27	O
-	O
28	O
may	O
2016	O
,	O
present	O
the	O
[UNK]	O
vi	B-T170
##est	I-T170
##e	I-T170
chart	I-T170
##er	I-T170
[UNK]	O
,	O
drawn	O
up	O
in	O
collaboration	O
with	O
experts	B-T097
from	O
the	O
national	O
institute	O
of	O
health	O
and	O
the	O
ministry	O
of	O
health	O
.	O
this	O
paper	O
considers	O
the	O
risk	B-T033
factors	I-T033
that	O
may	O
affect	B-T058
the	O
water	B-T103
safety	O
in	O
healthcare	B-T092
facilities	I-T092
and	O
reports	O
the	O
current	O
regulatory	B-T170
frameworks	I-T170
governing	O
the	O
management	O
of	O
installation	O
##s	O
and	O
the	O
quality	O
of	O
the	O
water	B-T103
.	O
the	O
authors	O
promote	O
a	O
careful	O
analysis	O
of	O
the	O
risks	O
that	O
characterize	O
the	O
health	B-T092
facilities	I-T092
,	O
for	O
the	O
control	O
of	O
which	O
specific	O
actions	O
are	O
recommended	O
in	O
various	O
areas	O
,	O
including	O
water	O
safety	O
plans	O
;	O
approval	O
of	O
treatments	O
;	O
healthcare	B-T092
facilities	I-T092
responsibility	O
,	O
installation	O
and	O
maintenance	O
of	O
facilities	B-T092
;	O
multidisciplinary	B-T082
approach	I-T082
;	O
education	O
and	O
research	B-T062
;	O
regional	O
and	O
national	O
coordination	O
;	O
communication	O
.	O

the	O
application	O
of	O
heterogeneous	O
cluster	O
grouping	O
to	O
reflective	O
writing	O
for	O
medical	O
human	O
##ities	O
literature	B-T062
study	I-T062
to	O
enhance	O
students	B-T098
'	I-T098
empathy	O
,	O
critical	B-T038
thinking	I-T038
,	O
and	O
reflective	O
writing	O
to	O
facilitate	O
interdisciplinary	O
collaboration	O
and	O
to	O
make	O
connections	B-T082
between	O
patients	O
'	O
diseases	B-T038
and	O
their	O
social	O
/	O
cultural	O
contexts	O
,	O
the	O
study	B-T062
examined	B-T033
whether	O
the	O
use	O
of	O
heterogeneous	O
cluster	O
grouping	O
in	O
reflective	O
writing	O
for	O
medical	O
human	O
##ities	O
literature	O
acquisition	O
could	O
have	O
positive	O
effects	O
on	O
medical	B-T092
university	I-T092
students	B-T098
in	O
terms	O
of	O
empathy	O
,	O
critical	B-T038
thinking	I-T038
,	O
and	O
reflective	O
writing	O
.	O
a	O
15	O
-	O
week	O
quasi	O
-	O
experimental	O
design	O
was	O
conducted	O
to	O
investigate	O
the	O
learning	O
outcomes	O
.	O
after	O
conducting	O
cluster	B-T170
algorithms	I-T170
,	O
heterogeneous	O
learning	O
clusters	O
(	O
experimental	O
group	O
;	O
n	O
=	O
43	O
)	O
and	O
non	O
-	O
heterogeneous	O
learning	O
clusters	O
(	O
control	O
group	O
;	O
n	O
=	O
43	O
)	O
were	O
derived	O
for	O
a	O
medical	O
human	O
##ities	O
literature	B-T062
study	I-T062
.	O
before	O
and	O
after	O
the	O
intervention	B-T058
,	O
an	O
empathy	B-T170
scale	I-T170
in	O
patient	B-T058
care	I-T058
(	O
es	B-T170
-	O
pc	B-T058
)	O
,	O
a	O
critical	B-T058
thinking	I-T058
disposition	I-T058
assessment	I-T058
(	O
ctd	B-T058
##a	I-T058
-	I-T058
r	I-T058
)	O
,	O
and	O
a	O
reflective	O
writing	O
test	O
were	O
administered	O
to	O
both	O
groups	O
.	O
the	O
findings	O
showed	O
that	O
on	O
the	O
empathy	B-T170
scale	I-T170
,	O
significant	O
differences	O
in	O
the	O
[UNK]	O
behavioral	O
empathy	O
,	O
[UNK]	O
[UNK]	O
affective	O
empathy	O
,	O
[UNK]	O
and	O
overall	O
sections	O
existed	O
between	O
the	O
post	O
-	O
test	O
mean	O
scores	O
of	O
the	O
experimental	O
group	O
and	O
those	O
of	O
the	O
control	O
group	O
,	O
but	O
such	O
differences	O
did	O
not	O
exist	O
in	O
[UNK]	O
intelligent	O
empathy	O
.	O
[UNK]	O
regarding	O
critical	B-T038
thinking	I-T038
,	O
there	O
were	O
significant	O
differences	O
in	O
[UNK]	O
systematic	O
##ity	O
and	O
analytic	B-T062
##ity	I-T062
,	O
[UNK]	O
[UNK]	O
sk	O
##eptic	O
##ism	O
and	O
well	O
-	O
informed	O
,	O
[UNK]	O
[UNK]	O
maturity	O
and	O
sk	O
##eptic	O
##ism	O
,	O
[UNK]	O
and	O
overall	O
sections	O
.	O
as	O
for	O
reflective	O
writing	O
,	O
significant	O
differences	O
existed	O
in	O
[UNK]	O
ideas	O
,	O
[UNK]	O
[UNK]	O
voice	B-T038
and	O
point	O
of	O
view	O
,	O
[UNK]	O
[UNK]	O
critical	B-T038
thinking	I-T038
and	O
representation	O
,	O
[UNK]	O
[UNK]	O
depth	B-T038
of	I-T038
reflection	I-T038
on	O
personal	O
growth	O
,	O
[UNK]	O
and	O
overall	O
sections	O
,	O
but	O
not	O
in	O
[UNK]	O
focus	O
and	O
context	O
structure	O
[UNK]	O
and	O
[UNK]	O
language	O
and	O
convention	O
##s	O
.	O
[UNK]	O
this	O
study	B-T062
outlined	O
an	O
alternative	O
for	O
using	O
heterogeneous	O
cluster	O
grouping	O
in	O
reflective	O
writing	O
about	O
medical	O
human	O
##ities	O
literature	O
to	O
facilitate	O
interdisciplinary	O
cooperation	O
to	O
provide	O
more	O
human	O
##izing	O
medical	B-T033
care	I-T033
.	O

high	O
occurrence	O
of	O
non	B-T038
-	I-T038
clear	I-T038
cell	I-T038
renal	I-T038
cell	I-T038
carcinoma	I-T038
in	O
om	B-T082
##an	I-T082
it	O
is	O
conventionally	O
accepted	O
that	O
renal	B-T038
cell	I-T038
carcinoma	I-T038
(	O
rcc	B-T038
)	O
occurs	O
in	O
older	O
patients	O
and	O
the	O
clear	B-T038
cell	I-T038
type	I-T038
is	O
the	O
most	O
common	O
histology	B-T091
.	O
however	O
,	O
ethnic	O
variations	O
exist	O
and	O
this	O
study	B-T062
was	O
carried	O
out	O
to	O
determine	O
the	O
epidemiological	O
pattern	O
of	O
rcc	B-T038
in	O
om	B-T082
##an	I-T082
.	O
ninety	O
rcc	B-T038
patients	O
who	O
presented	O
to	O
a	O
tertiary	B-T092
care	I-T092
center	I-T092
in	O
the	O
sul	B-T082
##tan	I-T082
##ate	I-T082
of	I-T082
om	I-T082
##an	I-T082
from	O
2010	O
to	O
2014	O
were	O
studied	B-T062
.	O
the	O
main	B-T033
findings	I-T033
were	O
that	O
the	O
median	O
age	O
of	O
presentation	O
was	O
low	O
,	O
more	O
patients	O
presented	O
with	O
localized	B-T082
stage	O
,	O
and	O
there	O
was	O
a	O
higher	O
incidence	O
of	O
non	B-T038
-	I-T038
clear	I-T038
(	O
especially	O
papillary	B-T038
)	O
histology	B-T091
.	O
data	O
from	O
other	O
gulf	B-T082
countries	I-T082
and	O
possible	O
reasons	O
for	O
the	O
different	O
profile	O
are	O
discussed	O
.	O

transcriptome	B-T058
sequencing	I-T058
and	O
de	O
novo	O
characterization	O
of	O
korean	B-T082
endemic	O
land	B-T204
snail	I-T204
,	O
korean	B-T204
##oh	I-T204
##ad	I-T204
##ra	I-T204
ku	I-T204
##rod	I-T204
##ana	I-T204
for	O
functional	O
transcripts	B-T103
and	O
ssr	B-T103
markers	B-T038
the	O
korean	B-T082
endemic	O
land	B-T204
snail	I-T204
korean	B-T204
##oh	I-T204
##ad	I-T204
##ra	I-T204
ku	I-T204
##rod	I-T204
##ana	I-T204
(	O
gastrop	B-T204
##oda	I-T204
:	O
brady	B-T204
##ba	I-T204
##en	I-T204
##idae	I-T204
)	O
found	O
in	O
humid	O
areas	O
of	O
broad	O
##le	O
##af	O
forests	O
and	O
shr	B-T204
##ubs	I-T204
have	O
been	O
considered	O
vulnerable	O
as	O
the	O
number	O
of	O
individuals	B-T098
are	O
declining	O
in	O
recent	O
years	O
.	O
the	O
species	B-T204
is	O
poorly	O
characterized	O
at	O
the	O
genomic	B-T017
level	I-T017
that	O
limits	O
the	O
understanding	O
of	O
functions	O
at	O
the	O
molecular	O
and	O
genetics	O
level	O
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
performed	O
de	O
novo	O
transcriptome	B-T058
sequencing	I-T058
to	O
produce	O
a	O
comprehensive	O
transcript	B-T103
dataset	B-T170
of	O
visceral	B-T017
mass	I-T017
tissue	I-T017
of	O
k	B-T204
.	I-T204
ku	I-T204
##rod	I-T204
##ana	I-T204
by	O
the	O
illumina	B-T062
paired	I-T062
-	I-T062
end	I-T062
sequencing	I-T062
technology	I-T062
.	O
over	O
234	O
million	O
quality	O
reads	O
were	O
assembled	O
to	O
a	O
total	O
of	O
315	O
,	O
92	O
##4	O
contig	B-T082
##s	I-T082
and	O
191	O
,	O
07	O
##1	O
uni	B-T170
##gene	I-T170
##s	I-T170
,	O
with	O
an	O
average	O
and	O
n	B-T103
##50	I-T103
length	O
of	O
58	O
##5	O
.	O
6	O
and	O
71	O
##5	O
bp	O
and	O
67	O
##8	O
and	O
92	O
##7	O
bp	O
,	O
respectively	O
.	O
overall	O
,	O
36	O
.	O
32	O
%	O
of	O
the	O
uni	B-T170
##gene	I-T170
##s	I-T170
found	O
matches	O
to	O
known	O
protein	B-T082
/	O
nucleotide	B-T082
sequences	I-T082
in	O
the	O
public	B-T170
databases	I-T170
.	O
the	O
direction	B-T082
of	O
the	O
uni	B-T170
##gene	I-T170
##s	I-T170
to	O
functional	O
categories	O
was	O
determined	O
using	O
cog	B-T170
,	O
go	B-T170
,	O
ke	B-T170
##gg	I-T170
,	O
and	O
interp	B-T170
##ros	I-T170
##can	I-T170
protein	B-T082
domain	I-T082
search	O
.	O
the	O
go	B-T170
analysis	B-T062
search	O
resulted	O
in	O
22	O
,	O
96	O
##7	O
uni	B-T170
##gene	I-T170
##s	I-T170
(	O
12	O
.	O
02	O
%	O
)	O
being	O
categorized	O
into	O
40	O
functional	O
groups	O
.	O
the	O
ke	B-T170
##gg	I-T170
annotation	I-T170
revealed	O
that	O
metabolism	O
pathway	O
genes	B-T017
were	O
enriched	O
.	O
the	O
most	O
prominent	O
protein	B-T082
motifs	I-T082
include	O
the	O
zinc	B-T082
finger	I-T082
,	O
ribonuclease	B-T103
h	I-T103
,	O
reverse	B-T103
transcriptase	I-T103
,	O
and	O
ank	B-T038
##yrin	I-T038
repeat	I-T038
domains	I-T038
.	O
the	O
simple	B-T103
sequence	I-T103
repeats	I-T103
(	O
ssr	B-T103
##s	I-T103
)	O
identified	O
from	O
>	O
1	O
kb	O
length	O
of	O
uni	B-T170
##gene	I-T170
##s	I-T170
show	O
a	O
dom	O
##ina	O
##nc	O
##y	O
of	O
dinucleotide	B-T103
repeat	I-T103
motifs	I-T103
followed	O
with	O
tri	B-T103
-	I-T103
and	O
tetra	B-T103
##nu	I-T103
##cle	I-T103
##otide	I-T103
motifs	I-T103
.	O
a	O
number	O
of	O
uni	B-T170
##gene	I-T170
##s	I-T170
were	O
putative	O
##ly	O
assessed	O
to	O
belong	O
to	O
adaptation	B-T038
and	O
defense	B-T038
mechanisms	I-T038
including	O
heat	B-T103
shock	I-T103
proteins	I-T103
70	I-T103
,	O
toll	B-T103
-	I-T103
like	I-T103
receptor	I-T103
4	I-T103
,	O
amp	B-T103
-	I-T103
activated	I-T103
protein	I-T103
kinase	I-T103
,	O
aquaporin	B-T103
-	I-T103
2	I-T103
,	O
etc	O
.	O
our	O
data	O
provide	O
a	O
rich	O
source	O
for	O
the	O
identification	O
and	O
functional	O
characterization	O
of	O
new	O
genes	B-T017
and	O
candidate	O
polymorphic	O
ssr	B-T103
markers	B-T038
in	O
k	B-T204
.	I-T204
ku	I-T204
##rod	I-T204
##ana	I-T204
.	O
the	O
availability	O
of	O
transcriptome	B-T082
information	O
(	O
http	B-T170
:	I-T170
/	I-T170
/	I-T170
bio	I-T170
##inf	I-T170
##o	I-T170
.	I-T170
sch	I-T170
.	I-T170
ac	I-T170
.	I-T170
kr	I-T170
/	I-T170
subm	I-T170
##ission	I-T170
/	I-T170
)	O
would	O
promote	O
the	O
utilization	O
of	O
the	O
resources	O
for	O
phylogenetic	B-T062
##s	I-T062
study	I-T062
and	O
genetic	O
diversity	O
assessment	O
.	O

effect	O
of	O
successive	B-T058
administration	I-T058
of	O
vancomycin	B-T103
and	O
amikacin	B-T103
on	O
auditory	B-T038
function	I-T038
of	O
immature	O
animals	O
effect	O
of	O
successive	B-T058
administration	I-T058
vancomycin	B-T103
and	O
amikacin	B-T103
in	O
therapeutic	O
doses	O
on	O
immature	O
auditory	B-T022
organ	I-T022
was	O
compared	O
to	O
single	O
administration	B-T058
of	O
the	O
same	O
drugs	B-T103
in	O
chronic	O
experiments	B-T062
on	O
immature	O
rabbits	B-T204
by	O
recording	O
of	O
short	O
-	O
latency	O
auditory	B-T201
brainstem	I-T201
response	I-T201
(	O
abr	B-T201
)	O
and	O
distortion	B-T058
product	I-T058
ot	I-T058
##oac	I-T058
##oustic	I-T058
emission	I-T058
(	O
dp	B-T058
##oa	I-T058
##e	I-T058
)	O
.	O
drug	B-T058
administration	I-T058
always	O
increased	O
significantly	O
the	O
abr	B-T201
peak	O
i	O
threshold	O
.	O
ot	B-T037
##otoxic	I-T037
antibiotics	B-T103
did	O
not	O
change	O
dp	B-T058
##oa	I-T058
##e	I-T058
,	O
but	O
selectively	O
affected	O
activity	B-T033
of	O
outer	B-T017
hair	I-T017
cells	I-T017
.	O
no	B-T033
enhancement	O
of	O
the	O
ot	B-T037
##otoxic	I-T037
effects	I-T037
was	O
observed	O
after	O
successive	B-T058
administration	I-T058
of	O
the	O
two	O
antibiotics	B-T103
.	O

elastin	B-T103
is	O
differentially	B-T038
regulated	I-T038
by	O
pressure	B-T058
therapy	I-T058
in	O
a	O
porcine	B-T204
model	B-T204
of	O
hypertrophic	B-T017
scar	I-T017
beneficial	O
effects	O
of	O
pressure	B-T058
therapy	I-T058
for	O
hypertrophic	B-T017
scars	I-T017
have	O
been	O
reported	O
,	O
but	O
the	O
mechanisms	O
of	O
action	O
are	O
not	O
fully	O
understood	O
.	O
this	O
study	B-T062
evaluated	O
elastin	B-T103
and	O
its	O
contribution	O
to	O
scar	B-T017
pl	O
##iab	O
##ility	O
.	O
the	O
relationship	O
between	O
changes	O
in	O
vanc	B-T170
##ou	I-T170
##ver	I-T170
scar	I-T170
scale	I-T170
(	O
vs	B-T170
##s	I-T170
)	O
scores	O
of	O
pressure	B-T058
-	I-T058
treated	I-T058
scars	B-T017
and	O
differential	O
regulation	O
of	O
elastin	B-T103
was	O
assessed	O
.	O
hypertrophic	B-T017
scars	I-T017
were	O
created	O
and	O
assessed	O
weekly	O
using	O
vs	B-T170
##s	I-T170
and	O
biopsy	B-T058
proc	B-T033
##urement	I-T033
.	O
pressure	B-T058
treatment	I-T058
began	O
on	O
day	O
70	O
postin	O
##jury	O
.	O
treated	B-T058
scars	B-T017
were	O
compared	O
with	O
untreated	O
sham	B-T058
##s	I-T058
.	O
treatment	B-T058
lasted	O
2	O
weeks	O
,	O
through	O
day	O
84	O
,	O
and	O
scars	B-T017
were	O
assessed	O
weekly	O
through	O
day	O
126	O
.	O
transcript	B-T103
and	O
protein	B-T033
levels	I-T033
of	O
elastin	B-T103
were	O
quantified	O
.	O
pressure	B-T058
treatment	I-T058
resulted	O
in	O
lower	O
vs	B-T170
##s	I-T170
scores	O
compared	O
with	O
sham	B-T058
-	I-T058
treated	I-T058
scars	B-T017
.	O
pl	O
##iab	O
##ility	O
(	O
vs	O
##sp	O
)	O
was	O
a	O
key	O
contributor	O
to	O
this	O
difference	O
.	O
at	O
day	O
70	O
pretreatment	O
,	O
vs	O
##sp	O
=	O
2	O
.	O
without	B-T058
treatment	I-T058
,	O
sham	B-T058
-	I-T058
treated	I-T058
scars	B-T017
became	O
less	O
pl	O
##iable	O
,	O
while	O
pressure	B-T058
-	I-T058
treated	I-T058
scars	B-T017
became	O
more	O
pl	O
##iable	O
.	O
the	O
percentage	O
of	O
elastin	B-T103
in	O
scars	B-T017
at	O
day	O
70	O
was	O
higher	O
than	O
in	O
unin	B-T022
##ju	I-T022
##red	I-T022
skin	I-T022
.	O
following	O
treatment	B-T058
,	O
the	O
percentage	O
of	O
elastin	B-T103
increased	O
and	O
continued	O
to	O
increase	O
through	O
day	O
126	O
.	O
untreated	O
sham	B-T058
scars	B-T017
did	O
not	O
show	O
a	O
similar	O
increase	O
.	O
quantification	O
of	O
ver	B-T058
##ho	I-T058
##eff	I-T058
-	I-T058
van	I-T058
gi	I-T058
##es	I-T058
##on	I-T058
staining	I-T058
corroborated	O
the	O
findings	B-T033
and	O
immunofluorescence	B-T058
revealed	O
the	O
alignment	O
of	O
elastin	B-T103
fibers	I-T103
.	O
pressure	B-T058
treatment	I-T058
results	O
in	O
increased	O
protein	B-T038
level	I-T038
expression	I-T038
of	O
elastin	B-T103
compared	O
with	O
sham	B-T058
-	O
untreated	O
scars	B-T017
.	O
these	O
findings	B-T033
further	O
characterize	O
the	O
extracellular	B-T017
matrix	I-T017
'	I-T017
s	I-T017
response	O
to	O
the	O
application	O
of	O
pressure	O
as	O
a	O
scar	B-T017
treatment	B-T058
,	O
which	O
will	O
contribute	O
to	O
the	O
refinement	O
of	O
rehabilitation	O
practices	O
and	O
ultimately	O
improvements	O
in	O
functional	O
and	O
psychosocial	O
outcomes	O
for	O
patients	O
.	O

interaction	O
of	O
multiple	O
gene	B-T017
variants	I-T017
and	O
their	O
effects	O
on	O
schizophrenia	B-T038
phenotypes	O
schizophrenia	B-T038
is	O
a	O
clinically	O
heterogeneous	B-T033
disorder	I-T033
and	O
may	O
be	O
explained	O
by	O
its	O
complex	O
genetic	O
architecture	O
.	O
many	O
schizophrenia	B-T038
susceptibility	B-T201
genes	B-T017
were	O
identified	O
but	O
the	O
picture	O
remains	O
unclear	O
due	O
to	O
inconsistent	O
or	O
contradictory	O
genetic	B-T062
association	I-T062
studies	I-T062
.	O
this	O
confusion	O
may	O
,	O
in	O
part	O
,	O
be	O
because	O
symptoms	B-T033
result	O
from	O
the	O
combined	O
interaction	O
of	O
many	O
genes	B-T017
and	O
these	O
interacting	O
genes	B-T017
are	O
associated	O
with	O
specific	O
sub	O
-	O
phenotypes	O
of	O
schizophrenia	B-T038
rather	O
than	O
schizophrenia	B-T038
as	O
a	O
whole	O
.	O
this	O
study	O
investigates	O
the	O
relationship	O
between	O
schizophrenia	B-T038
susceptibility	B-T201
genes	B-T017
and	O
schizophrenia	B-T038
sub	O
-	O
phenotypes	O
by	O
identifying	O
multiple	O
gene	B-T017
variant	I-T017
interactions	O
.	O
fifty	O
snps	B-T082
from	O
21	O
genes	B-T017
were	O
genotyped	B-T058
in	O
235	O
australian	B-T098
participants	B-T098
with	O
schizophrenia	B-T038
screened	B-T058
for	O
various	O
phenotypes	O
.	O
schizophrenia	B-T038
participants	B-T098
were	O
grouped	O
into	O
relevant	O
phenotype	O
clusters	O
using	O
cluster	B-T062
analysis	I-T062
and	O
normalized	B-T062
phenotype	O
cluster	O
scores	O
were	O
calculated	O
for	O
each	O
patient	O
.	O
the	O
relationship	O
between	O
genotypes	O
and	O
normalized	B-T062
phenotype	O
cluster	O
scores	O
were	O
analyzed	O
by	O
linear	B-T170
regression	I-T170
analysis	I-T170
.	O
three	O
phenotype	O
clusters	O
were	O
identified	O
.	O
there	O
was	O
some	O
overlap	O
in	O
symptoms	B-T033
between	O
phenotype	O
clusters	O
,	O
particularly	O
for	O
depression	B-T038
.	O
however	O
,	O
cluster	O
1	O
appears	O
to	O
be	O
characterized	O
by	O
speech	B-T038
disorder	I-T038
and	O
affective	O
behavior	O
symptoms	O
,	O
cluster	O
2	O
has	O
predominantly	O
halluc	B-T038
##ination	I-T038
symptoms	B-T033
and	O
cluster	O
3	O
has	O
mainly	O
del	B-T038
##usion	I-T038
symptoms	B-T033
.	O
interaction	O
of	O
five	O
snps	B-T082
was	O
found	O
to	O
have	O
an	O
effect	O
on	O
cluster	O
1	O
symptoms	B-T033
;	O
ten	O
snps	B-T082
on	O
cluster	O
2	O
symptoms	B-T033
;	O
and	O
eight	O
snps	B-T082
on	O
cluster	O
3	O
symptoms	B-T033
.	O
the	O
interaction	O
of	O
specific	O
susceptibility	B-T201
genes	B-T017
is	O
likely	O
to	O
lead	O
to	O
specific	O
clinical	O
sub	O
-	O
phenotypes	O
of	O
schizophrenia	B-T038
.	O
larger	O
patient	O
cohorts	B-T098
with	O
more	O
extensive	O
clinical	O
data	O
will	O
improve	O
the	O
detection	B-T033
of	O
gene	O
interactions	O
and	O
the	O
resultant	O
schizophrenia	B-T038
clinical	O
phenotypes	O
.	O

improving	O
care	B-T058
transitions	I-T058
across	O
healthcare	B-T058
settings	O
through	O
a	O
human	O
factors	O
approach	O
after	O
more	O
than	O
two	O
decades	O
of	O
research	B-T062
focused	O
on	O
care	B-T058
transition	I-T058
improvement	O
and	O
intervention	B-T058
development	O
,	O
unfavorable	B-T033
outcome	I-T033
measures	O
associated	O
with	O
care	B-T058
transitions	I-T058
across	O
healthcare	B-T058
settings	O
persist	O
.	O
readmissions	O
rates	O
remain	O
an	O
important	O
outcome	O
to	O
target	O
for	O
intervention	B-T058
,	O
adverse	B-T038
events	I-T038
associated	O
with	O
care	B-T058
transitions	I-T058
continue	O
to	O
be	O
an	O
issue	B-T033
,	O
and	O
patients	O
are	O
often	O
dissatis	B-T038
##fi	I-T038
##ed	I-T038
with	O
the	O
quality	O
of	O
their	O
care	O
.	O
currently	O
,	O
interventions	B-T058
to	O
improve	O
care	B-T058
transitions	I-T058
are	O
disease	B-T038
specific	O
,	O
require	O
substantial	O
financial	O
investment	O
##s	O
in	O
training	O
allied	B-T097
healthcare	I-T097
professionals	I-T097
,	O
or	O
focus	O
primarily	O
on	O
hospital	B-T058
-	I-T058
based	I-T058
discharge	I-T058
planning	I-T058
with	O
mixed	O
results	O
.	O
this	O
complex	O
situation	O
requires	O
a	O
method	B-T062
of	I-T062
evaluation	I-T062
that	O
can	O
provide	O
a	O
comprehensive	O
,	O
in	B-T082
-	I-T082
depth	I-T082
,	O
and	O
context	O
-	O
driven	O
investigation	B-T058
of	O
potential	B-T033
risks	I-T033
to	O
safe	O
care	B-T058
transitions	I-T058
across	O
healthcare	B-T058
settings	O
,	O
which	O
can	O
lead	O
to	O
the	O
creation	O
of	O
effective	O
,	O
usa	O
##ble	O
,	O
and	O
sustainable	O
interventions	B-T058
.	O
a	O
systems	O
'	O
approach	O
known	O
as	O
human	O
factors	O
and	O
ergonomic	O
##s	O
(	O
hf	O
##e	O
)	O
evaluates	O
the	O
factors	O
in	O
a	O
system	O
that	O
affect	O
human	O
performance	O
.	O
this	O
article	B-T170
describes	O
how	O
hf	O
##e	O
can	O
complement	O
and	O
further	O
strengthen	O
efforts	O
to	O
improve	O
care	B-T058
transitions	I-T058
.	O

arthro	B-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
gi	I-T007
##nk	I-T007
##go	I-T007
##nis	I-T007
sp	I-T007
.	I-T007
nov	I-T007
.	I-T007
,	O
an	O
actinomyc	B-T007
##ete	I-T007
isolated	O
from	O
rhizosphere	O
of	O
gi	B-T204
##nk	I-T204
##go	I-T204
bil	I-T204
##oba	I-T204
l	I-T204
a	O
gram	B-T033
-	I-T033
stain	I-T033
-	I-T033
positive	I-T033
,	O
aerobic	O
actin	B-T007
##obacterial	I-T007
strain	I-T007
(	O
designated	O
sy	B-T007
##p	I-T007
-	I-T007
a	I-T007
##72	I-T007
##99	I-T007
##t	I-T007
)	O
,	O
which	O
displayed	O
a	O
rod	B-T007
-	I-T007
cocc	I-T007
##us	I-T007
growth	I-T007
life	I-T007
##cycl	I-T007
##e	I-T007
,	O
was	O
isolated	O
from	O
the	O
rhizosphere	O
of	O
gi	B-T204
##nk	I-T204
##go	I-T204
bil	I-T204
##oba	I-T204
l	I-T204
.	O
phylogenetic	B-T062
analyses	I-T062
based	O
on	O
16s	B-T017
rrna	I-T017
gene	I-T017
sequences	I-T017
indicated	O
that	O
strain	B-T007
sy	I-T007
##p	I-T007
-	I-T007
a	I-T007
##72	I-T007
##99	I-T007
##t	I-T007
belongs	O
to	O
the	O
genus	B-T170
arthro	B-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
and	O
is	O
most	O
closely	O
related	O
to	O
arthro	B-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
halo	I-T007
##du	I-T007
##ran	I-T007
##s	I-T007
js	I-T007
##m	I-T007
07	I-T007
##80	I-T007
##85	I-T007
##t	I-T007
(	O
97	O
.	O
4	O
%	O
16s	B-T017
rrna	I-T017
gene	I-T017
sequence	I-T017
similarity	O
)	O
.	O
the	O
dna	B-T103
-	O
dna	B-T103
relatedness	O
value	O
between	O
strain	B-T007
sy	I-T007
##p	I-T007
-	I-T007
a	I-T007
##72	I-T007
##99	I-T007
##t	I-T007
and	O
a	B-T007
.	I-T007
halo	I-T007
##du	I-T007
##ran	I-T007
##s	I-T007
js	I-T007
##m	I-T007
07	I-T007
##80	I-T007
##85	I-T007
##t	I-T007
was	O
37	O
%	O
±	O
##2	O
.	O
9	O
.	O
the	O
cell	B-T017
-	I-T017
wall	I-T017
peptidoglycan	B-T103
was	O
a4	B-T103
##α	I-T103
,	O
and	O
glucose	B-T103
and	O
galactose	B-T103
were	O
whole	B-T103
-	I-T103
cell	I-T103
sugars	I-T103
.	O
the	O
polar	B-T103
lipids	I-T103
consisted	O
of	O
diphosph	B-T103
##atidyl	I-T103
##glycerol	I-T103
,	O
phosphatidyl	B-T103
##glycerol	I-T103
,	O
phosphatidylinositol	B-T103
,	O
two	O
glycolipid	B-T103
##s	I-T103
and	O
an	O
unknown	O
polar	B-T103
lipid	I-T103
.	O
the	O
major	O
men	B-T103
##a	I-T103
##quinone	I-T103
were	O
mk	B-T103
-	I-T103
8	I-T103
(	I-T103
h2	I-T103
)	I-T103
(	O
72	O
%	O
)	O
and	O
mk	B-T103
-	I-T103
9	I-T103
(	I-T103
h2	I-T103
)	I-T103
(	O
28	O
%	O
)	O
,	O
and	O
the	O
predominant	O
cellular	B-T103
fatty	I-T103
acids	I-T103
were	O
ant	B-T103
##ei	I-T103
##so	I-T103
-	I-T103
c1	I-T103
##5	I-T103
:	I-T103
0	I-T103
,	O
iso	B-T103
-	I-T103
c1	I-T103
##5	I-T103
:	I-T103
0	I-T103
and	O
ant	B-T103
##ei	I-T103
##so	I-T103
-	I-T103
c1	I-T103
##7	I-T103
:	I-T103
0	I-T103
.	O
the	O
dna	B-T103
g	O
+	O
c	O
content	O
was	O
68	O
.	O
9	O
mol	O
%	O
.	O
based	O
on	O
the	O
morphological	B-T082
,	O
physiological	O
,	O
biochemical	O
and	O
chemot	O
##ax	O
##onomic	O
characters	O
presented	O
in	O
this	O
study	O
,	O
strain	B-T007
sy	I-T007
##p	I-T007
-	I-T007
a	I-T007
##72	I-T007
##99	I-T007
##t	I-T007
represents	O
a	O
novel	O
species	B-T170
of	O
the	O
genus	B-T170
arthro	B-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
,	O
for	O
which	O
the	O
name	O
arthro	B-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
gi	I-T007
##nk	I-T007
##go	I-T007
##nis	I-T007
sp	I-T007
.	I-T007
nov	I-T007
.	I-T007
is	O
proposed	O
.	O
the	O
type	O
strain	O
is	O
sy	B-T007
##p	I-T007
-	I-T007
a	I-T007
##72	I-T007
##99	I-T007
##t	I-T007
(	O
=	B-T007
dsm	I-T007
100	I-T007
##49	I-T007
##1	I-T007
##t	I-T007
=	I-T007
kc	I-T007
##tc	I-T007
39	I-T007
59	I-T007
##2	I-T007
##t	I-T007
)	O
.	O

elective	B-T058
nephron	B-T058
sparing	I-T058
surgery	I-T058
decreases	O
other	B-T033
cause	I-T033
mortality	I-T033
relative	O
to	O
radical	B-T058
nephrectomy	I-T058
only	O
in	O
specific	O
subgroups	B-T170
of	O
patients	O
with	O
renal	B-T038
cell	I-T038
carcinoma	I-T038
there	O
is	O
no	O
consensus	O
regarding	O
a	O
protective	O
effect	O
on	O
mortality	O
due	O
to	O
a	O
cause	O
other	O
than	O
cancer	B-T038
in	O
patients	O
treated	B-T058
with	I-T058
elective	B-T058
nephron	B-T058
sparing	I-T058
surgery	I-T058
relative	O
to	O
their	O
radical	B-T058
nephrectomy	I-T058
counterparts	O
.	O
we	O
test	O
whether	O
the	O
protective	O
effect	O
of	O
nephron	B-T058
sparing	I-T058
surgery	I-T058
relative	O
to	O
radical	B-T058
nephrectomy	I-T058
is	O
universal	O
or	O
present	O
in	O
specific	O
subgroups	B-T170
of	O
patients	O
.	O
a	O
collaborative	O
database	B-T170
of	O
5	O
institutions	O
was	O
quer	B-T170
##ied	I-T170
to	O
evaluate	B-T058
1	O
,	O
78	O
##3	O
patients	O
without	O
chronic	B-T038
kidney	I-T038
disease	I-T038
diagnosed	B-T033
with	O
a	O
clinical	O
t1	O
renal	O
mass	O
that	O
was	O
treated	B-T058
with	I-T058
nephron	B-T058
sparing	I-T058
surgery	I-T058
or	O
radical	B-T058
nephrectomy	I-T058
.	O
multivariable	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
was	O
done	O
to	O
assess	O
the	O
impact	O
of	O
surgery	B-T058
type	O
(	O
nephron	B-T058
sparing	I-T058
surgery	I-T058
vs	O
radical	B-T058
nephrectomy	I-T058
)	O
on	O
other	B-T033
cause	I-T033
mortality	I-T033
after	O
adjustment	O
for	O
patient	O
and	O
cancer	B-T038
characteristics	O
.	O
interaction	O
terms	O
were	O
used	O
to	O
test	O
the	O
hypothesis	O
that	O
the	O
impact	O
of	O
surgery	B-T058
type	O
varies	O
according	O
to	O
specific	O
subc	B-T098
##oh	I-T098
##orts	I-T098
of	O
patients	O
.	O
ten	O
-	O
year	O
other	B-T033
cause	I-T033
mortality	I-T033
-	O
free	O
survival	O
rates	O
were	O
90	O
%	O
and	O
88	O
%	O
after	O
nephron	B-T058
sparing	I-T058
surgery	I-T058
and	O
radical	B-T058
nephrectomy	I-T058
,	O
respectively	O
.	O
in	O
the	O
overall	O
population	B-T098
radical	B-T058
nephrectomy	I-T058
was	O
not	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
other	B-T033
cause	I-T033
mortality	I-T033
on	O
multivariable	O
analysis	O
compared	O
to	O
nephron	B-T058
sparing	I-T058
surgery	I-T058
(	O
hr	O
0	O
.	O
91	O
,	O
95	O
%	O
ci	O
0	O
.	O
6	O
-	O
1	O
.	O
38	O
,	O
p	O
=	O
0	O
.	O
6	O
)	O
.	O
however	O
,	O
radical	B-T058
nephrectomy	I-T058
increased	O
the	O
risk	O
of	O
other	B-T033
cause	I-T033
mortality	I-T033
according	O
to	O
the	O
increasing	O
baseline	O
char	B-T170
##ls	I-T170
##on	I-T170
comorbidity	I-T170
index	I-T170
(	O
interaction	O
test	O
p	O
=	O
0	O
.	O
000	O
##8	O
)	O
.	O
for	O
example	O
,	O
in	O
a	O
patient	O
with	O
a	O
char	B-T170
##ls	I-T170
##on	I-T170
comorbidity	I-T170
index	I-T170
of	O
4	O
the	O
probability	O
of	O
10	O
-	O
year	O
other	B-T033
cause	I-T033
mortality	I-T033
-	O
free	O
survival	O
was	O
86	O
%	O
after	O
nephron	B-T058
sparing	I-T058
surgery	I-T058
and	O
60	O
%	O
after	O
radical	B-T058
nephrectomy	I-T058
.	O
elective	B-T058
nephron	B-T058
sparing	I-T058
surgery	I-T058
does	O
not	O
improve	B-T033
other	O
cause	O
survival	O
relative	O
to	O
radical	B-T058
nephrectomy	I-T058
consistently	O
in	O
all	O
patients	O
with	O
kidney	B-T038
cancer	I-T038
.	O
patients	O
who	O
are	O
more	O
ill	B-T033
with	O
relevant	O
comorbidities	O
are	O
those	O
who	O
benefit	O
the	O
most	O
from	O
nephron	B-T058
sparing	I-T058
surgery	I-T058
in	O
terms	O
of	O
other	B-T033
cause	I-T033
mortality	I-T033
.	O

hand	B-T058
-	I-T058
assisted	I-T058
laparoscopic	I-T058
versus	O
standard	B-T058
laparoscopic	I-T058
colectomy	I-T058
:	O
are	O
outcomes	O
and	O
operative	O
time	O
different	O
?	O
hal	B-T058
colectomy	B-T058
is	O
a	O
technique	O
perceived	O
to	O
provide	O
the	O
benefits	O
of	O
laparoscopic	B-T058
surgery	I-T058
while	O
improving	O
tactile	O
feedback	O
and	O
operative	O
time	O
.	O
published	O
data	O
are	O
largely	O
limited	O
to	O
small	O
,	O
single	B-T062
-	I-T062
institution	I-T062
studies	I-T062
.	O
the	O
2012	O
-	O
2013	O
national	B-T170
surgical	I-T170
quality	I-T170
improvement	I-T170
program	I-T170
participant	I-T170
data	I-T170
use	I-T170
file	I-T170
was	O
quer	O
##ied	O
for	O
patients	O
undergoing	O
elective	O
sl	B-T058
or	O
hal	B-T058
colectomy	B-T058
.	O
patients	O
underwent	O
1	O
:	O
1	O
propensity	O
matching	O
and	O
had	O
outcomes	O
compared	O
.	O
an	O
additional	O
subgroup	B-T062
analysis	I-T062
was	O
performed	O
for	O
patients	O
undergoing	O
segmental	B-T082
resections	B-T058
only	O
.	O
13	O
,	O
94	O
##9	O
patients	O
were	O
identified	O
,	O
of	O
whom	O
60	O
##84	O
(	O
43	O
.	O
6	O
%	O
)	O
underwent	O
hal	B-T058
colectomy	B-T058
.	O
patients	O
undergoing	O
hal	B-T058
versus	O
sl	B-T058
colectomy	I-T058
had	O
higher	O
rates	O
of	O
postoperative	B-T038
ileus	I-T038
(	O
8	O
.	O
7	O
vs	O
.	O
6	O
.	O
3	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
wound	B-T037
complication	I-T037
(	O
8	O
.	O
8	O
vs	O
.	O
6	O
.	O
8	O
%	O
,	O
p	O
=	O
0	O
.	O
006	O
)	O
,	O
and	O
30	O
-	O
day	O
readmission	B-T058
(	O
7	O
.	O
5	O
vs	O
.	O
6	O
.	O
0	O
%	O
,	O
p	O
=	O
0	O
.	O
002	O
)	O
,	O
without	O
any	O
differences	O
in	O
operative	O
time	O
(	O
156	O
vs	O
.	O
157	O
min	O
,	O
p	O
=	O
0	O
.	O
71	O
##3	O
)	O
.	O
amongst	O
segmental	B-T082
cole	B-T058
##ct	I-T058
##om	I-T058
##ies	I-T058
,	O
hal	B-T058
remained	O
associated	O
with	O
higher	O
rates	O
of	O
wound	B-T037
complications	I-T037
(	O
8	O
.	O
6	O
vs	O
.	O
6	O
.	O
5	O
%	O
,	O
p	O
=	O
0	O
.	O
016	O
)	O
,	O
postoperative	B-T038
ileus	I-T038
(	O
8	O
.	O
9	O
vs	O
.	O
6	O
.	O
3	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
30	O
-	O
day	O
readmission	B-T058
(	O
7	O
.	O
1	O
vs	O
.	O
5	O
.	O
9	O
%	O
,	O
p	O
=	O
0	O
.	O
041	O
)	O
with	O
no	O
difference	O
in	O
operative	O
time	O
between	O
hal	B-T058
and	O
sl	O
(	O
145	O
vs	O
.	O
145	O
min	O
,	O
p	O
=	O
0	O
.	O
334	O
)	O
.	O
use	O
of	O
hal	B-T058
colectomy	B-T058
is	O
associated	O
with	O
increased	O
risk	B-T058
of	O
wound	B-T037
complications	I-T037
,	O
postoperative	B-T038
ileus	I-T038
,	O
and	O
readmissions	B-T058
.	O
importantly	O
,	O
this	O
technique	O
is	O
not	O
associated	O
with	O
any	O
decrease	O
in	O
operative	O
time	O
.	O

a	O
pilot	B-T062
study	I-T062
exploring	O
the	O
relationship	O
between	O
self	O
-	O
compass	O
##ion	O
,	O
self	O
-	O
judgement	B-T038
,	O
self	O
-	O
kind	B-T038
##ness	I-T038
,	O
compass	O
##ion	O
,	O
professional	O
quality	O
of	O
life	O
and	O
wellbeing	B-T033
among	O
uk	B-T082
community	B-T097
nurses	I-T097
compass	B-T038
##ion	I-T038
fatigue	I-T038
and	O
burnout	B-T038
can	O
impact	O
on	O
performance	O
of	O
nurses	B-T097
.	O
this	O
paper	O
explores	O
the	O
relationship	O
between	O
self	O
-	O
compass	O
##ion	O
,	O
self	O
-	O
judgement	B-T038
,	O
self	O
-	O
kind	B-T038
##ness	I-T038
,	O
compass	O
##ion	O
,	O
professional	O
quality	O
of	O
life	O
,	O
and	O
wellbeing	B-T033
among	O
community	B-T097
nurses	I-T097
.	O
to	O
measure	O
associations	O
between	O
self	O
-	O
compass	O
##ion	O
,	O
compass	B-T038
##ion	I-T038
fatigue	I-T038
,	O
wellbeing	B-T033
,	O
and	O
burnout	B-T038
in	O
community	B-T097
nurses	I-T097
.	O
quantitative	O
data	O
were	O
collected	O
using	O
standardised	O
psychometric	B-T170
questionnaires	I-T170
:	O
(	O
1	O
)	O
professional	B-T170
quality	I-T170
of	I-T170
life	I-T170
scale	I-T170
;	O
(	O
2	O
)	O
self	O
-	O
compass	O
##ion	O
scale	O
;	O
(	O
3	O
)	O
short	B-T170
war	I-T170
##wi	I-T170
##ck	I-T170
edi	I-T170
##nb	I-T170
##urg	I-T170
##h	I-T170
mental	I-T170
wellbeing	I-T170
scale	I-T170
;	O
(	O
4	O
)	O
compass	O
##ion	O
for	O
others	O
scale	O
,	O
used	O
to	O
measure	O
relationships	O
between	O
self	O
-	O
compass	O
##ion	O
,	O
compass	B-T038
##ion	I-T038
fatigue	I-T038
,	O
wellbeing	B-T033
,	O
and	O
burnout	B-T038
.	O
a	O
cross	B-T062
sectional	I-T062
sample	O
of	O
registered	B-T097
community	I-T097
nurses	I-T097
(	O
n	O
=	O
37	O
)	O
studying	O
for	O
a	O
postgraduate	O
dipl	O
##oma	O
at	O
a	O
university	B-T092
in	O
the	O
north	B-T082
of	I-T082
england	I-T082
took	O
part	O
in	O
this	O
study	B-T062
.	O
results	O
show	O
that	O
community	B-T097
nurses	I-T097
who	O
score	O
high	O
on	O
measures	O
of	O
self	O
-	O
compass	O
##ion	O
and	O
wellbeing	B-T033
,	O
also	O
report	O
less	O
burnout	B-T038
.	O
greater	O
compass	O
##ion	O
satisfaction	B-T038
was	O
also	O
positively	B-T033
associated	O
with	O
compass	O
##ion	O
for	O
others	O
,	O
and	O
wellbeing	B-T033
,	O
whilst	O
also	O
being	O
negatively	B-T033
correlated	O
with	O
burnout	B-T038
.	O
high	O
levels	O
of	O
self	O
-	O
compass	O
##ion	O
were	O
linked	O
with	O
lower	O
levels	O
of	O
burnout	B-T038
.	O
furthermore	O
when	O
community	B-T097
nurses	I-T097
have	O
greater	O
compass	O
##ion	O
satisfaction	B-T038
they	O
also	O
report	O
more	O
compass	O
##ion	O
for	O
others	O
,	O
increased	O
wellbeing	B-T033
,	O
and	O
less	O
burnout	B-T038
.	O
the	O
implications	O
of	O
this	O
are	O
discussed	O
alongside	O
suggestions	O
for	O
the	O
promotion	O
of	O
greater	O
compass	O
##ion	O

neuroprotective	O
role	O
of	O
microrna	B-T017
-	I-T017
22	I-T017
in	O
a	O
6	B-T103
-	I-T103
hydroxydopamine	I-T103
-	O
induced	O
cell	B-T017
model	B-T038
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
via	O
regulation	B-T038
of	O
its	O
target	O
gene	B-T017
trp	B-T017
##m	I-T017
##7	I-T017
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
,	O
the	O
second	O
most	O
prevalent	B-T082
neurodegenerative	B-T038
disorder	I-T038
with	O
only	O
symptomatic	O
treatment	B-T058
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	B-T017
neurons	I-T017
in	O
the	O
midbrain	B-T017
.	O
ampl	O
##e	O
evidence	O
indicated	O
that	O
micrornas	B-T103
(	O
mir	B-T103
##s	I-T103
)	O
could	O
regulate	B-T038
post	I-T038
-	I-T038
transcriptional	I-T038
gene	B-T038
expression	I-T038
and	O
neuronal	B-T038
disease	I-T038
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
mir	B-T017
-	I-T017
22	I-T017
in	O
pc12	B-T017
pheochromocytoma	I-T017
cells	I-T017
treated	O
with	O
6	B-T103
-	I-T103
hydroxydopamine	I-T103
(	O
6	B-T103
-	I-T103
ohda	I-T103
)	O
to	O
mimic	O
pd	B-T038
.	O
rt	B-T062
-	I-T062
pcr	I-T062
results	O
showed	O
that	O
the	O
expression	B-T038
of	O
mir	B-T017
-	I-T017
22	I-T017
is	O
downregulated	B-T038
in	O
6	B-T103
-	I-T103
ohda	I-T103
-	O
treated	O
pc12	B-T017
cells	I-T017
,	O
and	O
the	O
overexpression	B-T038
of	O
mir	B-T017
-	I-T017
22	I-T017
significantly	O
promoted	O
the	O
survival	B-T038
and	O
proliferation	B-T038
of	O
6	B-T103
-	I-T103
ohda	I-T103
-	O
induced	O
pc12	B-T017
cells	I-T017
,	O
whereas	O
mir	B-T017
-	I-T017
22	I-T017
inhibitor	O
reversed	O
these	O
effects	O
.	O
in	O
addition	O
,	O
pc12	B-T017
cells	I-T017
were	O
treated	O
with	O
mir	B-T017
-	I-T017
22	I-T017
mimics	I-T017
or	O
inhibitor	O
following	O
6	B-T103
-	I-T103
ohda	I-T103
administration	B-T058
,	O
which	O
medic	O
##ated	O
ros	B-T103
production	B-T038
and	O
upregulation	B-T038
or	O
downregulation	B-T038
of	O
caspase	B-T038
-	I-T038
3	I-T038
activity	I-T038
,	O
respectively	O
.	O
a	O
luciferase	B-T103
reporter	O
assay	B-T058
revealed	O
that	O
transient	B-T017
receptor	I-T017
potential	I-T017
mel	I-T017
##astatin	I-T017
7	I-T017
(	O
trp	B-T017
##m	I-T017
##7	I-T017
)	O
is	O
a	O
direct	O
target	O
gene	B-T017
of	O
mir	B-T017
-	I-T017
22	I-T017
,	O
and	O
mir	B-T017
-	I-T017
22	I-T017
overexpression	B-T038
markedly	O
downregulated	B-T038
the	O
level	O
of	O
trp	B-T017
##m	I-T017
##7	I-T017
.	O
strikingly	O
,	O
further	O
analysis	B-T062
showed	O
that	O
mir	B-T017
-	I-T017
22	I-T017
mediated	O
6	B-T103
-	I-T103
ohda	I-T103
-	O
induced	O
pc12	B-T017
cell	B-T038
survival	I-T038
and	O
proliferation	B-T038
by	O
targeting	O
trp	B-T017
##m	I-T017
##7	I-T017
.	O
taken	O
together	O
,	O
the	O
present	O
study	B-T062
showed	O
that	O
mir	B-T017
-	I-T017
22	I-T017
overexpression	B-T038
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	B-T103
-	I-T103
ohda	I-T103
-	O
induced	O
pc12	B-T017
cell	B-T038
growth	I-T038
and	O
apoptosis	B-T038
by	O
targeting	O
trp	B-T017
##m	I-T017
##7	I-T017
.	O

comprehensive	O
functional	B-T062
analysis	I-T062
of	O
large	O
lists	O
of	O
genes	B-T017
and	O
proteins	B-T103
the	O
interpretation	B-T170
of	O
high	B-T170
dimensional	I-T170
datasets	I-T170
resulting	O
from	O
genomic	B-T062
and	O
proteomic	B-T062
experiments	I-T062
in	O
a	O
timely	O
and	O
efficient	O
manner	O
is	O
challenging	O
.	O
cl	B-T170
##ue	I-T170
##go	I-T170
software	I-T170
is	O
a	O
cytos	B-T170
##cape	I-T170
app	I-T170
that	O
extracts	O
representative	O
functional	O
biological	O
information	O
for	O
large	O
lists	O
of	O
genes	B-T017
or	O
proteins	B-T103
.	O
the	O
functional	B-T062
enrichment	I-T062
analysis	I-T062
is	O
based	O
on	O
the	O
latest	O
publicly	O
available	O
data	O
from	O
multiple	O
annotation	B-T170
and	O
ontology	O
resources	O
that	O
can	O
be	O
automatically	O
accessed	B-T082
through	O
cl	B-T170
##ue	I-T170
##go	I-T170
.	O
predefined	B-T170
settings	I-T170
for	O
the	O
selection	O
of	O
the	O
terms	O
are	O
provided	O
to	O
facilitate	O
the	O
analysis	B-T062
.	O
results	O
are	O
visualized	O
as	O
networks	O
in	O
which	O
gene	B-T170
ontology	I-T170
(	O
go	B-T170
)	O
terms	O
and	O
pathways	O
are	O
grouped	O
based	O
on	O
their	O
biological	O
role	O
.	O
many	O
species	B-T170
are	O
now	O
supported	O
by	O
cl	B-T170
##ue	I-T170
##go	I-T170
and	O
additional	O
organisms	O
are	O
added	O
on	O
demand	O
.	O
cl	B-T170
##ue	I-T170
##go	I-T170
can	O
be	O
used	O
together	O
with	O
the	O
cl	B-T170
##ue	I-T170
##ped	I-T170
##ia	I-T170
app	I-T170
to	O
enable	O
the	O
visualization	O
of	O
protein	B-T038
-	I-T038
protein	I-T038
interactions	I-T038
within	O
or	O
between	O
pathways	O
.	O

dabigatran	B-T103
:	O
a	O
new	O
oral	B-T103
anticoagulant	I-T103
.	O
guidelines	B-T170
to	O
follow	O
in	O
oral	B-T058
surgery	I-T058
procedures	I-T058
.	O
a	O
systematic	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
dabigatran	B-T103
is	O
a	O
newly	O
commercial	O
##ized	O
drug	B-T103
that	O
is	O
replacing	O
other	O
anticoagulants	B-T103
in	O
the	O
prevention	O
of	O
venous	B-T038
thromboembolism	I-T038
,	O
stroke	B-T038
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O
it	O
acts	O
directly	O
on	O
thrombin	B-T103
presenting	O
in	O
a	O
dynamic	O
and	O
predictable	O
way	O
,	O
which	O
does	O
not	O
require	O
monitoring	O
these	O
patients	O
.	O
therefore	O
,	O
we	O
consider	O
the	O
need	O
to	O
assess	O
whether	O
their	O
use	O
increases	O
the	O
risk	O
of	O
bleeding	O
involved	O
before	O
any	O
dental	B-T058
treatment	I-T058
.	O
we	O
performed	O
a	O
systematic	O
review	O
with	O
a	O
bibli	O
##ographic	O
search	O
in	O
pubmed	B-T170
/	O
medline	B-T170
along	O
with	O
the	O
cochrane	B-T092
library	I-T092
.	O
we	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	B-T103
other	O
than	O
dabigatran	B-T103
,	O
and	O
works	O
about	O
surgical	B-T058
treatments	I-T058
in	O
anatomical	B-T082
locations	I-T082
other	O
than	O
the	O
oral	B-T082
cavity	I-T082
.	O
we	O
included	O
a	O
total	O
of	O
13	O
papers	O
of	O
which	O
1	O
was	O
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
,	O
9	O
narrative	O
literature	O
reviews	O
,	O
1	O
case	B-T062
series	I-T062
,	O
2	O
clinical	O
cases	O
and	O
1	O
expert	O
opinion	O
.	O
because	O
we	O
did	O
not	O
obtain	O
any	O
properly	O
designed	O
clinical	B-T062
trials	I-T062
,	O
we	O
were	O
unable	O
to	O
conduct	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
.	O
currently	O
,	O
there	O
is	O
no	O
consensus	O
on	O
the	O
procedure	B-T058
to	O
be	O
followed	O
in	O
patients	O
taking	O
dabigatran	B-T103
.	O
however	O
,	O
all	O
authors	O
agree	O
to	O
treat	O
each	O
case	O
individually	O
in	O
accordance	O
to	O
the	O
risk	O
of	O
embolism	B-T038
,	O
postoperative	B-T038
bleeding	I-T038
and	O
renal	B-T038
function	I-T038
.	O
also	O
,	O
it	O
is	O
necessary	O
to	O
perform	O
minimally	O
invasive	B-T058
interventions	I-T058
,	O
and	O
take	O
the	O
appropriate	O
local	O
anti	B-T058
-	I-T058
hemolytic	I-T058
measures	I-T058
.	O

epidemiology	B-T091
and	O
outcomes	O
of	O
injuries	B-T037
in	O
kenya	B-T082
:	O
a	O
multis	O
##ite	O
surveillance	O
study	O
injury	B-T037
is	O
a	O
leading	O
cause	O
of	O
disability	B-T033
and	O
death	B-T033
worldwide	O
,	O
accounting	O
for	O
over	O
5	O
million	O
deaths	B-T033
each	O
year	O
.	O
the	O
injury	B-T037
burden	O
is	O
higher	O
in	O
low	B-T082
-	I-T082
and	I-T082
middle	I-T082
-	I-T082
income	I-T082
countries	I-T082
where	O
more	O
than	O
90	O
%	O
of	O
injury	B-T033
-	I-T033
related	I-T033
deaths	I-T033
occur	O
.	O
despite	O
this	O
burden	O
,	O
the	O
use	O
of	O
prospective	O
trauma	B-T037
registries	O
to	O
describe	O
injury	B-T037
epidemiology	B-T091
and	O
outcomes	O
is	O
limited	O
in	O
low	B-T082
-	I-T082
and	I-T082
middle	I-T082
-	I-T082
income	I-T082
countries	I-T082
.	O
kenya	B-T082
lacks	O
robust	O
data	O
to	O
describe	O
injury	B-T037
epidemiology	B-T091
and	O
care	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
the	O
epidemiology	B-T091
and	O
outcomes	O
of	O
injuries	B-T037
at	O
4	O
referral	B-T092
hospitals	I-T092
in	O
kenya	B-T082
using	O
hospital	B-T092
-	O
based	O
trauma	B-T037
registries	O
.	O
from	O
january	O
2014	O
to	O
may	O
2015	O
,	O
all	O
injured	O
patients	O
presenting	O
to	O
the	O
casual	B-T092
##ty	I-T092
departments	I-T092
of	O
kenya	B-T092
##tt	I-T092
##a	I-T092
national	I-T092
,	O
thi	B-T092
##ka	I-T092
level	I-T092
5	I-T092
,	O
mach	B-T092
##ak	I-T092
##os	I-T092
level	I-T092
5	I-T092
,	O
and	O
mer	B-T092
##u	I-T092
level	I-T092
5	I-T092
hospitals	I-T092
were	O
enrolled	O
prospectively	O
.	O
data	B-T062
collected	I-T062
included	O
demographic	O
characteristics	O
,	O
type	O
of	O
prehospital	B-T058
care	I-T058
received	O
,	O
prehospital	O
time	O
,	O
injury	B-T037
pattern	I-T037
,	O
and	O
outcomes	O
.	O
a	O
total	O
of	O
14	O
,	O
237	O
patients	O
were	O
enrolled	O
in	O
our	O
study	O
.	O
patients	O
were	O
predominantly	O
male	O
(	O
76	O
.	O
1	O
%	O
)	O
and	O
young	O
(	O
mean	O
age	O
28	O
years	O
)	O
.	O
the	O
most	O
common	O
mechanisms	O
of	O
injury	O
were	O
road	O
traffic	B-T037
injuries	I-T037
(	O
36	O
.	O
8	O
%	O
)	O
,	O
falls	B-T037
(	O
26	O
.	O
4	O
%	O
)	O
,	O
and	O
being	O
str	O
##uck	O
/	O
hit	O
by	O
a	O
person	B-T098
or	O
object	O
(	O
20	O
.	O
1	O
%	O
)	O
.	O
burn	B-T037
was	O
the	O
most	O
common	O
mechanism	O
of	O
injury	O
in	O
the	O
age	O
category	B-T170
under	O
5	O
years	O
.	O
body	B-T082
regions	I-T082
commonly	O
injured	O
were	O
lower	B-T017
extremity	I-T017
(	O
35	O
.	O
1	O
%	O
)	O
,	O
upper	B-T017
extremity	I-T017
(	O
33	O
.	O
4	O
%	O
)	O
,	O
and	O
head	B-T082
(	O
26	O
.	O
0	O
%	O
)	O
.	O
the	O
overall	O
mortality	O
rate	O
was	O
2	O
.	O
4	O
%	O
.	O
significant	O
predictors	O
of	O
mortality	O
from	O
multivariate	O
analysis	O
were	O
glasgow	B-T033
coma	I-T033
scale	I-T033
≤	I-T033
##12	I-T033
,	O
estimated	O
injury	B-T170
severity	I-T170
score	I-T170
≥	O
##9	O
,	O
burns	B-T037
,	O
and	O
gun	B-T037
##sh	I-T037
##ot	I-T037
injuries	I-T037
.	O
hospital	B-T092
-	O
based	O
trauma	B-T037
registries	O
can	O
be	O
important	O
sources	O
of	O
data	O
to	O
study	B-T062
the	I-T062
epidemiology	I-T062
of	O
injuries	B-T037
in	O
low	B-T082
-	I-T082
and	I-T082
middle	I-T082
-	I-T082
income	I-T082
countries	I-T082
.	O
data	O
from	O
such	O
trauma	B-T037
registries	O
can	O
highlight	O
key	O
needs	O
and	O
be	O
used	O
to	O
design	O
public	B-T092
health	O
interventions	B-T058
and	O
quality	O
-	O
of	O
-	O
care	O
improvement	O
programs	O
.	O

minor	B-T017
physical	I-T017
anomalies	I-T017
and	O
dermat	B-T082
##ogly	I-T082
##phi	I-T082
##c	I-T082
signs	O
in	O
affective	B-T038
disorders	I-T038
:	O
a	O
systematic	B-T170
review	I-T170
the	O
increased	O
prevalence	O
of	O
minor	B-T017
physical	I-T017
anomalies	I-T017
(	O
mpa	B-T017
##s	I-T017
)	O
and	O
the	O
abnormalities	B-T017
of	I-T017
dermat	I-T017
##ogly	I-T017
##phi	I-T017
##c	I-T017
patterns	I-T017
may	O
be	O
physical	O
manifestations	O
of	O
neurodevelopmental	O
disruption	O
in	O
affective	B-T038
disorders	I-T038
.	O
this	O
paper	O
aims	O
to	O
review	B-T170
the	O
current	O
state	O
of	O
knowledge	O
on	O
the	O
frequency	O
of	O
mpa	B-T017
##s	I-T017
and	O
dermat	B-T017
##ogly	I-T017
##phi	I-T017
##c	I-T017
abnormalities	I-T017
in	O
mood	B-T038
disorders	I-T038
.	O
a	O
medline	B-T170
,	O
psych	B-T170
##inf	I-T170
##o	I-T170
and	O
web	B-T170
of	I-T170
science	I-T170
search	I-T170
was	O
carried	O
out	O
to	O
collect	O
all	O
publications	B-T170
on	O
the	O
frequency	O
of	O
mpa	B-T017
##s	I-T017
and	O
on	O
dermat	B-T017
##ogly	I-T017
##phi	I-T017
##c	I-T017
traits	I-T017
in	O
bipolar	B-T038
disorder	I-T038
and	O
unipolar	B-T038
depression	I-T038
.	O
24	O
studies	B-T062
on	O
mpa	B-T017
##s	I-T017
,	O
19	O
on	O
dermat	B-T058
##ogly	I-T058
##phi	I-T058
##cs	I-T058
,	O
and	O
5	O
dealing	O
with	O
both	O
were	O
found	O
with	O
discrep	B-T033
##ant	I-T033
findings	O
.	O
the	O
relative	O
contribution	O
of	O
neurodevelopmental	O
retardation	O
to	O
the	O
aetiology	O
of	O
affective	B-T038
disorders	I-T038
remains	O
undetermined	O
,	O
the	O
field	O
is	O
open	O
for	O
further	O
research	B-T062
.	O
increased	O
recognition	B-T038
of	O
neurodevelopmental	O
processes	O
in	O
the	O
origin	O
of	O
affective	B-T038
disorders	I-T038
may	O
allow	O
for	O
earlier	O
and	O
more	O
effective	O
intervention	B-T058
and	O
prevention	B-T058
.	O

pedicle	B-T074
screw	I-T074
combined	O
with	O
lateral	B-T074
mass	I-T074
screw	I-T074
fixation	B-T058
in	O
the	O
treatment	B-T058
of	O
basilar	B-T017
invag	I-T017
##ination	I-T017
and	O
congenital	B-T017
c2	I-T017
-	I-T017
c3	I-T017
fusion	I-T017
clinical	B-T058
evaluation	I-T058
of	O
a	O
surgical	B-T058
fixation	B-T058
technique	O
featuring	O
combined	O
use	O
of	O
pedicle	B-T074
screw	I-T074
and	O
lateral	B-T074
mass	I-T074
screw	I-T074
(	O
lm	B-T074
##s	I-T074
)	O
.	O
introduction	O
of	O
a	O
novel	O
technique	O
for	O
the	O
treatment	B-T058
of	O
congenital	B-T017
c2	I-T017
-	I-T017
c3	I-T017
fusion	I-T017
and	O
basilar	B-T017
invag	I-T017
##ination	I-T017
(	O
bi	B-T017
)	O
.	O
posterior	B-T082
occip	B-T082
##ito	I-T082
##cer	I-T082
##vic	I-T082
##al	I-T082
fixation	B-T058
using	O
c2	B-T074
pedicle	I-T074
screw	I-T074
was	O
widely	O
used	O
for	O
bi	B-T017
.	O
however	O
,	O
in	O
cases	O
where	O
bi	B-T017
is	O
concurrent	O
with	O
congenital	B-T017
c2	I-T017
-	I-T017
c3	I-T017
fusion	I-T017
,	O
the	O
c2	B-T017
pedicle	I-T017
##s	I-T017
tend	O
to	O
be	O
thinner	O
than	O
that	O
in	O
normal	O
population	B-T098
and	O
hence	O
more	O
likely	O
to	O
fail	O
.	O
we	O
prompted	O
to	O
tackle	O
the	O
issue	B-T033
by	O
combining	O
the	O
pedicle	B-T074
screw	I-T074
with	O
the	O
additional	O
use	O
of	O
lm	B-T074
##s	I-T074
in	O
attempt	O
to	O
strengthen	O
the	O
fixation	B-T058
.	O
twenty	O
-	O
five	O
patients	O
who	O
underwent	O
combined	O
pedicle	B-T074
screw	I-T074
with	O
lm	B-T074
##s	I-T074
fixation	B-T058
were	O
retrospectively	B-T062
studied	I-T062
.	O
the	O
instrument	B-T074
position	B-T082
,	O
fusion	O
status	O
,	O
and	O
complications	B-T038
were	O
analyzed	B-T062
.	O
none	O
had	O
spinal	B-T037
cord	I-T037
or	O
vertebral	B-T037
artery	I-T037
injury	I-T037
.	O
the	O
average	O
follow	B-T058
-	I-T058
up	I-T058
time	O
was	O
20	O
months	O
.	O
solid	O
fusion	O
was	O
achieved	O
in	O
23	O
patients	O
(	O
92	O
%	O
)	O
as	O
detected	O
radiologically	B-T058
.	O
two	O
cases	O
suffered	O
from	O
recurred	O
bi	B-T017
and	O
instrument	B-T074
failure	B-T033
but	O
eventually	O
achieved	O
solid	O
fusion	O
between	O
the	O
occip	B-T082
##ut	I-T082
and	O
c2	B-T017
was	O
after	O
revision	B-T058
.	O
among	O
all	O
25	O
patients	O
,	O
4	O
suffered	O
from	O
complications	B-T038
including	O
instrument	B-T074
s	O
failure	B-T033
,	O
cerebrospinal	B-T038
fluid	I-T038
leakage	I-T038
,	O
and	O
intracranial	B-T082
infection	B-T038
.	O
the	O
clinical	O
outcome	O
indicates	O
that	O
the	O
technique	O
is	O
reliable	O
for	O
the	O
treatment	B-T058
of	O
bi	B-T017
with	O
congenital	B-T017
c2	I-T017
-	I-T017
c3	I-T017
fusion	I-T017
.	O

risk	B-T033
factors	I-T033
associated	O
with	O
repeated	O
hiv	B-T058
testing	I-T058
among	O
internet	O
-	O
using	O
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
(	O
msm	B-T098
)	O
represent	O
a	O
disproportionately	O
impacted	O
risk	O
group	O
for	O
hiv	B-T005
incidence	O
among	O
at	O
-	O
risk	O
u	B-T082
.	I-T082
s	I-T082
.	O
few	O
studies	B-T062
have	O
identified	O
risk	B-T033
factors	I-T033
associated	O
with	O
hiv	B-T058
testing	I-T058
frequency	O
both	O
within	B-T082
and	O
outside	B-T082
of	O
traditional	O
health	B-T058
care	I-T058
settings	I-T058
.	O
msm	B-T098
enrolled	O
in	O
a	O
prospective	B-T062
cohort	I-T062
were	O
mailed	O
at	B-T074
-	I-T074
home	I-T074
specimen	I-T074
collection	I-T074
kits	I-T074
and	O
followed	O
for	O
a	O
year	O
.	O
incidence	O
density	O
rate	O
ratios	O
(	O
id	O
##r	O
##r	O
)	O
of	O
testing	O
were	O
calculated	O
,	O
and	O
generalized	B-T082
estimating	O
equations	O
were	O
used	O
to	O
analyze	O
the	O
association	O
between	O
hiv	B-T058
testing	I-T058
and	O
behavioral	O
factors	O
.	O
the	O
incidence	O
rate	O
of	O
testing	O
was	O
higher	O
among	O
black	B-T098
msm	B-T098
than	O
white	B-T098
msm	B-T098
(	O
id	O
##r	O
##r	O
:	O
1	O
.	O
3	O
,	O
95	O
%	O
confidence	O
interval	O
ci	O
[	O
1	O
.	O
1	O
,	O
1	O
.	O
5	O
]	O
)	O
and	O
higher	O
among	O
msm	B-T098
who	O
reported	O
3	O
+	O
condom	B-T098
##less	I-T098
anal	B-T017
intercourse	I-T098
partners	I-T098
(	O
ca	B-T098
##i	I-T098
)	O
than	O
msm	B-T098
who	O
reported	O
no	B-T033
ca	B-T098
##i	I-T098
(	O
id	O
##r	O
##r	O
:	O
1	O
.	O
6	O
,	O
95	O
%	O
ci	O
[	O
1	O
.	O
3	O
,	O
2	O
.	O
0	O
]	O
)	O
.	O
increasing	O
availability	O
of	O
hiv	B-T058
testing	I-T058
outside	B-T082
traditional	O
health	B-T058
care	I-T058
settings	I-T058
,	O
including	O
at	O
-	O
home	O
testing	O
kits	O
,	O
in	O
conjunction	O
with	O
targeted	O
behavioral	O
interventions	O
and	O
biomedical	B-T091
treatment	B-T058
prevention	I-T058
##s	I-T058
is	O
needed	O
.	O

co	O
-	O
occurrence	O
and	O
clustering	O
of	O
health	O
conditions	O
at	O
age	O
11	O
:	O
cross	B-T062
-	I-T062
sectional	I-T062
findings	O
from	O
the	O
mill	O
##enn	O
##ium	O
cohort	O
study	O
to	O
identify	O
patterns	O
of	O
co	O
-	O
occurrence	O
and	O
clustering	O
of	O
6	O
common	O
adverse	B-T038
health	O
conditions	O
in	O
11	O
-	O
year	O
-	O
old	O
children	O
and	O
explore	O
differences	O
by	O
sociodemographic	O
factors	O
.	O
nationally	O
representative	O
prospective	B-T062
cohort	I-T062
study	I-T062
.	O
children	O
born	O
in	O
the	O
uk	B-T082
between	O
2000	O
and	O
2002	O
.	O
11	O
39	O
##9	O
11	O
-	O
year	O
-	O
old	O
singleton	O
children	O
for	O
whom	O
data	O
on	O
all	O
6	O
health	O
conditions	O
and	O
sociodemographic	O
information	O
were	O
available	O
(	O
complete	O
cases	O
)	O
.	O
prevalence	O
,	O
co	O
-	O
occurrence	O
and	O
clustering	O
of	O
6	O
common	O
health	O
conditions	O
:	O
whee	B-T033
##ze	I-T033
;	O
eczema	B-T038
;	O
long	B-T033
-	I-T033
standing	I-T033
illness	I-T033
(	O
excluding	O
whee	B-T033
##ze	I-T033
and	O
eczema	B-T038
)	O
;	O
injury	B-T037
;	O
socio	B-T038
##em	I-T038
##otion	I-T038
##al	I-T038
difficulties	I-T038
(	O
measured	O
using	O
strengths	B-T170
and	I-T170
difficulties	I-T170
questionnaire	I-T170
)	O
and	O
unfavourable	O
weight	O
(	O
thin	B-T033
/	O
overweight	B-T033
/	O
obese	B-T038
vs	O
normal	O
)	O
.	O
42	O
.	O
4	O
%	O
of	O
children	O
had	O
2	O
or	O
more	O
adverse	B-T038
health	O
conditions	O
(	O
co	O
-	O
occurrence	O
)	O
.	O
co	O
-	O
occurrence	O
was	O
more	O
common	O
in	O
boys	O
and	O
children	O
from	O
lower	O
income	O
households	O
.	O
latent	B-T062
class	I-T062
analysis	I-T062
identified	O
6	O
classes	B-T170
:	O
'	O
normative	O
'	O
(	O
57	O
.	O
4	O
%	O
)	O
:	O
'	O
atopic	B-T038
burden	O
##ed	O
'	O
(	O
14	O
.	O
0	O
%	O
)	O
;	O
'	O
socio	B-T038
##em	I-T038
##otion	I-T038
##al	I-T038
burden	I-T038
##ed	I-T038
'	O
(	O
11	O
.	O
0	O
%	O
)	O
;	O
'	O
unfavourable	O
weight	O
/	O
injury	B-T037
'	O
(	O
7	O
.	O
7	O
%	O
)	O
;	O
'	O
eczema	B-T038
/	O
injury	B-T037
'	O
(	O
6	O
.	O
0	O
%	O
)	O
and	O
'	O
eczema	B-T038
/	O
unfavourable	O
weight	O
'	O
(	O
3	O
.	O
9	O
%	O
)	O
.	O
as	O
with	O
co	O
-	O
occurrence	O
,	O
class	B-T170
membership	O
differed	O
by	O
sociodemographic	O
factors	O
:	O
boys	O
,	O
children	O
of	O
mothers	O
with	O
lower	O
educational	B-T033
attainment	I-T033
and	O
children	O
from	O
lower	O
income	O
households	O
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
'	O
socio	B-T038
##em	I-T038
##otion	I-T038
##al	I-T038
burden	I-T038
##ed	I-T038
'	O
class	B-T170
.	O
children	O
of	O
mothers	O
with	O
higher	O
educational	B-T033
attainment	I-T033
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
'	O
normative	O
'	O
and	O
'	O
eczema	B-T038
/	O
unfavourable	O
weight	O
'	O
classes	B-T170
.	O
co	O
-	O
occurrence	O
of	O
adverse	B-T038
health	O
conditions	O
at	O
age	O
11	O
is	O
common	O
and	O
is	O
associated	O
with	O
adverse	B-T038
socioeconomic	O
circumstances	O
.	O
holistic	O
,	O
child	O
focused	O
care	O
,	O
particularly	O
in	O
boys	O
and	O
those	O
in	O
lower	O
income	O
groups	O
,	O
may	O
help	O
to	O
prevent	O
and	O
reduce	O
co	O
-	O
occurrence	O
in	O
later	O
childhood	O
and	O
adolescence	O
.	O

collab	O
##orating	O
for	O
systems	O
change	O
:	O
a	O
social	O
science	O
framework	O
for	O
academic	O
roles	O
in	O
community	O
partnerships	O
environmental	B-T091
health	I-T091
researchers	B-T097
,	O
government	B-T092
agencies	I-T092
,	O
and	O
community	O
groups	O
have	O
endorsed	O
long	O
-	O
term	O
community	O
-	O
academic	O
partnerships	B-T092
as	O
an	O
effective	O
strategy	O
to	O
support	O
science	O
-	O
based	O
improvements	O
in	O
environmental	B-T091
health	I-T091
.	O
social	O
sciences	O
concepts	O
,	O
approaches	O
,	O
and	O
methods	B-T170
are	O
fundamental	O
to	O
these	O
translational	B-T092
partnerships	I-T092
.	O
however	O
,	O
appropriate	O
roles	O
for	O
academic	O
partners	B-T098
vary	O
throughout	O
the	O
process	O
of	O
changing	O
systems	O
(	O
policies	B-T170
,	O
practices	O
,	O
programs	O
,	O
etc	O
.	O
)	O
.	O
this	O
can	O
complicate	O
planning	B-T170
,	O
evaluating	O
,	O
and	O
sustaining	O
such	O
partnerships	B-T092
.	O
we	O
set	O
forth	O
a	O
conceptual	O
framework	O
for	O
academic	O
partners	B-T098
'	O
roles	O
at	O
different	O
stages	O
of	O
systems	O
change	O
.	O
we	O
apply	O
this	O
framework	O
to	O
three	O
long	O
##standing	O
academic	O
-	O
community	O
partnerships	B-T092
involving	O
national	B-T092
institute	I-T092
of	I-T092
environmental	I-T092
health	I-T092
sciences	I-T092
community	B-T097
outreach	I-T097
and	I-T097
engagement	I-T097
cores	I-T097
.	O
we	O
conclude	O
by	O
discussing	O
how	O
the	O
framework	O
can	O
help	O
academic	O
partners	B-T098
tap	O
appropriate	O
expertise	O
,	O
red	O
##ef	O
##ine	O
their	O
roles	O
,	O
and	O
evaluate	O
their	O
contributions	O
to	O
community	O
efforts	O
to	O
improve	B-T033
environmental	B-T091
health	I-T091
.	O

clinical	B-T033
features	I-T033
and	O
complications	B-T038
of	O
the	O
hla	B-T103
-	I-T103
b27	I-T103
-	O
associated	O
acute	B-T038
anterior	I-T038
uveitis	I-T038
:	O
a	O
meta	B-T062
##nal	I-T062
##ysis	I-T062
in	O
this	O
article	B-T170
,	O
we	O
report	O
a	O
literature	B-T170
-	I-T170
based	I-T170
meta	B-T062
##nal	I-T062
##ysis	I-T062
we	O
have	O
conducted	O
to	O
outline	O
the	O
clinical	B-T033
features	I-T033
of	O
the	O
hla	B-T103
-	I-T103
b27	I-T103
acute	B-T038
anterior	I-T038
uveitis	I-T038
(	O
aa	B-T038
##u	I-T038
)	O
.	O
the	O
examined	B-T033
material	O
was	O
based	O
on	O
observational	B-T062
studies	I-T062
in	O
which	O
participants	B-T098
were	O
affected	O
by	O
acute	B-T038
anterior	I-T038
uveitis	I-T038
and	O
divided	O
into	O
hla	O
b27	O
+	O
and	O
hla	B-T033
b27	I-T033
-	I-T033
.	O
we	O
performed	O
a	O
search	O
on	O
articles	B-T170
with	O
the	O
words	O
[UNK]	O
hla	B-T038
b27	I-T038
uveitis	I-T038
[UNK]	O
date	O
##d	O
before	O
may	O
2014	O
.	O
among	O
these	O
,	O
29	O
articles	B-T170
were	O
selected	O
for	O
a	O
second	O
review	O
.	O
after	O
a	O
further	O
evaluation	O
,	O
22	O
articles	B-T170
were	O
analyzed	B-T062
.	O
the	O
clinical	O
characteristics	O
studied	O
in	O
the	O
meta	B-T062
##nal	I-T062
##ysis	I-T062
were	O
:	O
(	O
1	O
)	O
systemic	B-T038
disease	I-T038
;	O
(	O
2	O
)	O
sex	O
distribution	O
;	O
(	O
3	O
)	O
laterality	O
;	O
(	O
4	O
)	O
visual	B-T201
acuity	I-T201
;	O
(	O
5	O
)	O
hypop	B-T038
##ion	I-T038
;	O
(	O
6	O
)	O
anterior	B-T103
chamber	I-T103
'	I-T103
s	I-T103
fibrin	I-T103
;	O
(	O
7	O
)	O
elevated	B-T033
intraocular	I-T033
pressure	I-T033
(	O
iop	B-T038
)	O
during	O
inflammation	B-T038
;	O
(	O
8	O
)	O
glaucoma	B-T038
;	O
(	O
9	O
)	O
posterior	B-T038
synech	I-T038
##iae	I-T038
;	O
(	O
10	O
)	O
cataract	B-T017
;	O
(	O
11	O
)	O
cyst	B-T038
##oid	I-T038
macular	I-T038
edema	I-T038
;	O
(	O
12	O
)	O
papill	B-T038
##itis	I-T038
.	O
we	O
have	O
calculated	O
a	O
relative	O
risk	O
(	O
rr	O
)	O
for	O
each	O
outcome	O
measured	O
.	O
the	O
results	O
obtained	O
remark	O
some	O
of	O
the	O
peculiar	O
features	O
linked	O
to	O
the	O
hla	B-T103
b27	I-T103
acute	B-T038
anterior	I-T038
uveitis	I-T038
,	O
such	O
as	O
strong	O
association	O
with	O
ankylosing	B-T038
spondylitis	I-T038
(	O
rr	O
=	O
6	O
.	O
80	O
)	O
and	O
systemic	B-T038
diseases	I-T038
(	O
rr	O
=	O
9	O
.	O
9	O
)	O
,	O
male	O
prevalence	O
(	O
rr	O
=	O
1	O
.	O
2	O
)	O
,	O
unilateral	B-T082
(	O
rr	O
=	O
1	O
.	O
1	O
)	O
or	O
alternating	O
bilateral	B-T082
(	O
rr	O
=	O
2	O
.	O
2	O
)	O
involvement	O
,	O
hypop	B-T038
##ion	I-T038
(	O
rr	O
=	O
5	O
.	O
5	O
)	O
,	O
fibrin	B-T103
##ous	I-T103
reaction	O
and	O
even	O
papill	B-T038
##itis	I-T038
(	O
r	O
=	O
7	O
.	O
7	O
)	O
.	O
simultaneous	O
bilateral	B-T082
(	O
rr	O
=	O
0	O
.	O
3	O
)	O
aa	B-T038
##u	I-T038
is	O
more	O
frequent	O
in	O
hla	B-T103
-	I-T103
b27	I-T103
negative	B-T033
form	O
.	O
we	O
report	O
higher	O
risk	O
of	O
elevated	B-T033
iop	I-T033
and	O
glaucoma	B-T038
(	O
rr	O
=	O
0	O
.	O
6	O
)	O
in	O
b27	B-T038
-	I-T038
acute	I-T038
anterior	I-T038
uveitis	I-T038
.	O
no	O
significant	O
difference	O
between	O
hla	B-T033
b	I-T033
27	I-T033
positive	I-T033
and	O
negative	B-T033
aa	B-T038
##u	I-T038
was	O
observed	O
according	O
to	O
final	O
visual	B-T201
acuity	I-T201
and	O
complications	B-T038
such	O
as	O
posterior	B-T038
synech	I-T038
##iae	I-T038
,	O
cataract	B-T017
,	O
and	O
macular	B-T038
##e	I-T038
edema	I-T038
.	O
we	O
trust	O
that	O
this	O
will	O
inform	O
on	O
the	O
clinical	B-T058
evaluation	I-T058
and	O
therapeutic	O
decision	B-T038
in	O
addressing	O
a	O
still	O
ill	O
-	O
defined	O
ophthalm	O
##ologic	O
condition	O
.	O

exploring	O
consumer	B-T098
and	O
patient	O
knowledge	B-T170
,	O
behavior	O
,	O
and	O
attitude	B-T038
toward	O
medicinal	B-T103
and	O
lifestyle	O
products	O
purchase	O
##d	O
from	O
the	O
internet	O
:	O
a	O
web	O
-	O
based	O
survey	B-T170
in	O
recent	O
years	O
,	O
lifestyle	O
products	O
have	O
emerged	O
to	O
help	O
improve	B-T033
people	B-T098
'	I-T098
s	I-T098
physical	O
and	O
mental	B-T038
performance	O
.	O
the	O
internet	O
plays	O
a	O
major	O
role	O
in	O
the	O
spread	O
of	O
these	O
products	O
.	O
however	O
,	O
the	O
literature	B-T170
has	O
reported	O
issues	O
regarding	O
the	O
authentic	O
##ity	O
of	O
medicines	B-T103
purchase	O
##d	O
from	O
the	O
internet	O
and	O
the	O
impact	O
of	O
counter	B-T103
##fe	I-T103
##it	I-T103
medicines	I-T103
on	O
public	B-T092
health	O
.	O
little	O
or	O
no	O
data	O
are	O
available	O
on	O
the	O
authentic	O
##ity	O
of	O
lifestyle	O
products	O
and	O
actual	O
toxicity	O
associated	O
with	O
their	O
use	O
and	O
misuse	B-T033
.	O
our	O
aim	O
was	O
to	O
investigate	O
consumer	O
and	O
patient	O
attitudes	O
toward	O
the	O
purchase	O
of	O
lifestyle	O
products	O
from	O
the	O
internet	O
,	O
their	O
knowledge	B-T170
of	O
product	O
authentic	O
##ity	O
and	O
toxicity	O
,	O
and	O
their	O
experiences	B-T038
with	O
counter	O
##fe	O
##it	O
lifestyle	O
products	O
.	O
a	O
web	O
-	O
based	O
study	B-T062
was	O
performed	O
between	O
may	O
2014	O
and	O
may	O
2015	O
.	O
uniform	O
collection	B-T062
of	I-T062
data	I-T062
was	O
performed	O
through	O
an	O
anonymous	O
online	B-T170
questionnaire	B-T170
.	O
participants	B-T098
were	O
invited	O
worldwide	B-T082
via	O
ema	B-T170
##il	I-T170
,	O
social	B-T170
media	I-T170
,	O
or	O
personal	O
communication	O
to	O
complete	O
the	O
online	B-T170
questionnaire	B-T170
.	O
a	O
total	O
of	O
320	O
participants	B-T098
completed	O
the	O
questionnaire	B-T170
.	O
the	O
results	O
of	O
the	O
questionnaire	B-T170
showed	O
that	O
208	O
(	O
65	O
.	O
0	O
%	O
)	O
participants	B-T098
purchase	O
##d	O
lifestyle	O
products	O
from	O
the	O
internet	O
mainly	O
due	O
to	O
convenience	O
and	O
reduced	O
cost	O
.	O
more	O
than	O
half	O
(	O
55	O
.	O
6	O
%	O
,	O
178	O
/	O
320	O
)	O
of	O
participants	B-T098
purchase	O
##d	O
cosmetic	O
products	O
,	O
whereas	O
only	O
a	O
minority	O
purchase	O
##d	O
medicinal	B-T103
products	I-T103
.	O
yet	O
,	O
62	O
.	O
8	O
%	O
(	O
201	O
/	O
320	O
)	O
of	O
participants	B-T098
were	O
aware	B-T038
of	O
the	O
presence	B-T033
of	O
counter	O
##fe	O
##it	O
lifestyle	O
products	O
from	O
the	O
internet	O
,	O
and	O
11	O
.	O
9	O
%	O
(	O
38	O
/	O
320	O
)	O
experienced	B-T038
counter	O
##fe	O
##it	O
products	O
.	O
in	O
only	O
0	O
.	O
9	O
%	O
(	O
3	O
/	O
320	O
)	O
of	O
those	O
cases	O
were	O
counter	O
##fe	O
##it	O
lifestyle	O
products	O
reported	B-T058
to	O
authorities	B-T092
.	O
moreover	O
,	O
7	O
.	O
2	O
%	O
(	O
23	O
/	O
320	O
)	O
of	O
the	O
participants	B-T098
experienced	B-T038
adverse	B-T038
effects	I-T038
due	O
to	O
counter	O
##fe	O
##it	O
lifestyle	O
products	O
.	O
in	O
summary	O
,	O
patients	O
experienced	B-T038
counter	O
##fe	O
##it	O
lifestyle	O
products	O
that	O
resulted	O
in	O
adverse	B-T038
effects	I-T038
on	O
their	O
health	O
.	O
although	O
certain	O
adverse	B-T038
effects	I-T038
were	O
reported	B-T058
in	O
this	O
study	B-T062
,	O
counter	O
##fe	O
##it	O
products	O
were	O
under	B-T058
##reported	I-T058
to	O
authorities	B-T092
.	O
further	O
public	O
awareness	O
campaigns	O
and	O
patient	O
education	O
are	O
needed	O
.	O

design	O
,	O
synthesis	O
,	O
and	O
evaluation	B-T058
of	O
curcumin	B-T103
derivatives	B-T103
as	O
nrf2	B-T103
activators	O
and	O
cyto	B-T038
##pro	I-T038
##te	I-T038
##ct	I-T038
##ors	I-T038
against	O
oxidative	B-T038
death	I-T038
activation	O
of	O
nuclear	B-T103
factor	I-T103
erythroid	I-T103
-	I-T103
2	I-T103
-	I-T103
related	I-T103
factor	I-T103
2	I-T103
(	O
nrf2	B-T103
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	B-T038
,	O
and	O
natural	O
curcumin	B-T103
stands	O
out	O
as	O
a	O
potent	O
nrf2	B-T103
activator	O
and	O
cancer	B-T038
chemopreventive	B-T103
agent	I-T103
.	O
in	O
this	O
study	B-T062
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	B-T103
analogs	B-T103
by	O
introducing	O
the	O
gem	O
##inal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nrf2	B-T103
activators	O
and	O
cyto	B-T038
##pro	I-T038
##te	I-T038
##ct	I-T038
##ors	I-T038
against	O
oxidative	B-T038
death	I-T038
.	O
the	O
gem	O
##inally	O
dimethyl	O
##ated	O
and	O
catechol	B-T103
-	O
type	O
curcumin	B-T103
analog	B-T103
(	O
compound	B-T103
3	I-T103
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	B-T103
molecule	I-T103
in	O
terms	O
of	O
its	O
increased	O
stability	B-T038
and	O
cytoprotective	B-T038
activity	O
against	O
the	O
tert	B-T103
-	I-T103
butyl	I-T103
hydroperoxide	I-T103
(	O
t	B-T103
-	I-T103
bh	I-T103
##p	I-T103
)	O
-	O
induced	O
death	B-T038
of	O
hepg2	B-T017
cells	I-T017
.	O
mechanism	O
studies	B-T062
indicate	O
that	O
its	O
cytoprotective	B-T038
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nrf2	B-T103
signaling	B-T038
pathway	I-T038
in	O
the	O
michael	B-T103
acceptor	I-T103
-	O
and	O
catechol	B-T103
-	O
dependent	O
manner	O
##s	O
.	O
additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	B-T103
and	O
iron	B-T103
ion	B-T103
chelator	B-T103
##s	I-T103
that	O
the	O
two	O
metal	B-T103
ion	B-T103
-	O
mediated	O
oxidation	B-T038
##s	I-T038
of	O
compound	B-T103
3	I-T103
to	O
its	O
corresponding	O
electrophilic	O
o	B-T103
-	I-T103
quinone	I-T103
,	O
contribute	O
significantly	O
to	O
its	O
nrf2	B-T103
-	O
dependent	O
cyto	B-T038
##pro	I-T038
##te	I-T038
##ct	I-T038
##ion	I-T038
.	O
this	O
work	O
provides	O
an	O
example	O
of	O
successfully	O
designing	O
natural	O
curcumin	B-T103
-	O
directed	O
nrf2	B-T103
activators	O
by	O
a	O
stability	B-T038
-	O
increasing	O
and	O
pro	O
##electroph	O
##ilic	O
strategy	O
.	O

limits	O
of	O
the	O
possible	O
:	O
diagnostic	O
image	O
quality	O
in	O
coronary	B-T058
angiography	I-T058
with	O
third	B-T058
-	I-T058
generation	I-T058
dual	I-T058
-	I-T058
source	I-T058
ct	I-T058
the	O
usage	O
of	O
coronary	B-T058
ct	I-T058
angiography	I-T058
(	O
cta	B-T058
)	O
is	O
appropriate	O
in	O
patients	O
with	O
acute	B-T033
or	O
chronic	B-T033
chest	I-T033
pain	I-T033
;	O
however	O
the	O
diagnostic	O
accuracy	O
may	O
be	O
challenged	O
with	O
increased	O
aga	O
##ts	O
##ton	O
score	O
(	O
as	O
)	O
,	O
increased	O
heart	B-T201
rate	I-T201
,	O
arrhythmia	B-T033
and	O
severe	B-T038
obesity	I-T038
.	O
thus	O
,	O
we	O
aim	O
to	O
determine	O
the	O
potential	O
of	O
the	O
recently	O
introduced	O
third	B-T058
-	I-T058
generation	I-T058
dual	I-T058
-	I-T058
source	I-T058
ct	I-T058
(	O
dsc	B-T058
##t	I-T058
)	O
for	O
cta	B-T058
in	O
a	O
'	O
real	O
-	O
life	O
'	O
clinical	O
setting	O
.	O
two	O
hundred	O
and	O
sixty	O
-	O
eight	O
consecutive	O
patients	O
(	O
age	O
:	O
67	O
±	O
10	O
years	O
;	O
bmi	B-T201
:	O
27	O
±	O
5	O
kg	O
/	O
m	O
##²	O
;	O
61	O
%	O
male	B-T098
)	O
undergoing	O
clinically	O
indicated	O
cta	B-T058
with	O
dsc	B-T058
##t	I-T058
were	O
included	O
in	O
the	O
retrospective	B-T062
single	I-T062
-	I-T062
center	I-T062
analysis	I-T062
.	O
a	O
contrast	B-T170
-	I-T170
enhanced	I-T170
volume	I-T170
dataset	I-T170
was	O
acquired	O
in	O
sequential	B-T058
(	O
ss	B-T058
##m	I-T058
)	O
(	O
n	O
=	O
151	O
)	O
or	O
helical	B-T058
scan	I-T058
mode	I-T058
(	O
hs	B-T058
##m	I-T058
)	O
(	O
n	O
=	O
117	O
)	O
.	O
coronary	B-T017
segments	I-T017
were	O
classified	O
in	O
diagnostic	O
or	O
non	O
-	O
diagnostic	O
image	O
quality	O
.	O
a	O
subset	O
underwent	O
invasive	B-T058
angiography	I-T058
to	O
determine	O
the	O
diagnostic	O
accuracy	O
of	O
cta	B-T058
.	O
ss	B-T058
##m	I-T058
(	O
96	O
.	O
8	O
±	O
6	O
%	O
)	O
and	O
hs	B-T058
##m	I-T058
(	O
97	O
.	O
5	O
±	O
8	O
%	O
)	O
provided	O
no	O
significant	O
differences	O
in	O
the	O
overall	O
diagnostic	O
image	O
quality	O
.	O
however	O
,	O
as	O
had	O
significant	O
influence	O
on	O
diagnostic	O
image	O
quality	O
exclusively	O
in	O
ss	B-T058
##m	I-T058
(	O
b	O
=	O
0	O
.	O
003	O
;	O
p	O
=	O
0	O
.	O
0001	O
)	O
,	O
but	O
not	O
in	O
hs	B-T058
##m	I-T058
.	O
diagnostic	O
image	O
quality	O
significantly	O
decreased	O
in	O
ss	B-T058
##m	I-T058
in	O
patients	O
with	O
as	O
≥2	O
,	O
000	O
(	O
p	O
=	O
0	O
.	O
03	O
)	O
.	O
ss	B-T058
##m	I-T058
(	O
sensitivity	O
:	O
93	O
.	O
9	O
%	O
;	O
specificity	O
:	O
96	O
.	O
7	O
%	O
;	O
ppv	O
:	O
88	O
.	O
6	O
%	O
;	O
npv	O
:	O
98	O
.	O
3	O
%	O
)	O
and	O
hs	B-T058
##m	I-T058
(	O
sensitivity	O
:	O
97	O
.	O
4	O
%	O
;	O
specificity	O
:	O
94	O
.	O
3	O
%	O
;	O
ppv	O
:	O
86	O
.	O
0	O
%	O
;	O
npv	O
:	O
99	O
.	O
0	O
%	O
)	O
provided	O
comparable	O
diagnostic	O
accuracy	O
(	O
p	O
=	O
n	O
.	O
s	O
.	O
)	O
.	O
ss	B-T058
##m	I-T058
yielded	O
significantly	O
lower	O
radiation	O
doses	O
as	O
compared	O
to	O
hs	B-T058
##m	I-T058
(	O
2	O
.	O
1	O
±	O
2	O
.	O
0	O
vs	O
.	O
5	O
.	O
1	O
±	O
3	O
.	O
3	O
msv	O
;	O
p	O
=	O
0	O
.	O
0001	O
)	O
in	O
age	B-T098
and	O
bmi	B-T201
-	O
matched	O
cohorts	B-T098
.	O
ss	B-T058
##m	I-T058
in	O
third	B-T058
-	I-T058
generation	I-T058
dsc	I-T058
##t	I-T058
enables	O
significant	O
dose	O
savings	O
and	O
provides	O
robust	O
diagnostic	O
image	O
quality	O
in	O
patients	O
with	O
as	O
≤	O
##200	O
##0	O
independent	O
of	O
heart	B-T201
rate	I-T201
,	O
heart	B-T038
rhythm	I-T038
or	O
obesity	B-T038
.	O

adenosine	B-T103
and	O
the	O
adenosine	B-T103
a2	I-T103
##a	I-T103
receptor	I-T103
agonist	I-T103
,	O
cgs	B-T103
##21	I-T103
##68	I-T103
##0	I-T103
,	O
upreg	B-T038
##ulate	I-T038
cd3	B-T103
##9	I-T103
and	O
cd	B-T103
##73	I-T103
expression	O
through	O
e2f	B-T103
-	I-T103
1	I-T103
and	O
creb	B-T103
in	O
regulatory	B-T017
t	I-T017
cells	I-T017
isolated	O
from	O
septic	O
mice	B-T204
the	O
number	O
of	O
regulatory	B-T017
t	I-T017
cells	I-T017
(	O
treg	B-T017
cells	I-T017
)	O
and	O
the	O
expression	O
of	O
ect	B-T103
##onucle	I-T103
##oside	I-T103
triphosphate	I-T103
diphosph	I-T103
##ohydrolase	I-T103
1	I-T103
(	O
ent	B-T103
##pd	I-T103
##1	I-T103
;	O
also	O
known	O
as	O
cd3	B-T103
##9	I-T103
)	O
and	O
5	B-T103
'	I-T103
-	I-T103
ect	I-T103
##onucle	I-T103
##otid	I-T103
##ase	I-T103
(	O
nt	B-T103
##5	I-T103
##e	I-T103
;	O
also	O
known	O
as	O
cd	B-T103
##73	I-T103
)	O
on	O
the	O
treg	B-T017
cell	I-T017
surface	B-T082
are	O
increased	O
during	O
sepsis	B-T038
.	O
in	O
this	O
study	O
,	O
to	O
determine	O
the	O
factors	B-T103
leading	O
to	O
the	O
high	O
expression	O
of	O
cd3	B-T103
##9	I-T103
and	O
cd	B-T103
##73	I-T103
,	O
and	O
the	O
regulation	B-T038
of	I-T038
the	O
cd3	B-T103
##9	I-T103
/	O
cd	B-T103
##73	I-T103
/	O
adenosine	B-T103
pathway	O
in	O
treg	B-T017
cells	I-T017
under	O
septic	O
conditions	O
,	O
we	O
constructed	O
a	O
mouse	B-T038
model	I-T038
of	O
sepsis	B-T038
and	O
separated	O
the	O
treg	B-T017
cells	I-T017
using	O
a	O
flow	B-T074
cyto	I-T074
##meter	I-T074
.	O
the	O
treg	B-T017
cells	I-T017
isolated	O
from	O
the	O
peritoneal	B-T058
lavage	I-T058
and	O
splenocytes	B-T017
of	O
the	O
mice	B-T204
were	O
treated	B-T058
with	I-T058
adenosine	B-T103
or	O
the	O
specific	O
adenosine	B-T103
a2	I-T103
##a	I-T103
receptor	I-T103
agonist	I-T103
,	O
cgs	B-T103
##21	I-T103
##68	I-T103
##0	I-T103
,	O
and	O
were	O
transfected	B-T062
with	O
specific	O
sirna	B-T103
targeting	O
e2f	B-T103
transcription	I-T103
factor	I-T103
1	I-T103
(	O
e2f	B-T103
-	I-T103
1	I-T103
)	O
or	O
cyclic	B-T103
adenosine	I-T103
monophosphate	I-T103
(	I-T103
camp	I-T103
)	I-T103
response	I-T103
element	I-T103
-	I-T103
binding	I-T103
protein	I-T103
(	O
creb	B-T103
)	O
,	O
which	O
are	O
predicted	O
transcription	B-T103
regulatory	I-T103
factors	I-T103
of	O
cd3	B-T103
##9	I-T103
or	O
cd	B-T103
##73	I-T103
.	O
the	O
regulatory	B-T038
relationships	O
among	O
these	O
factors	B-T103
were	O
then	O
determined	O
by	O
western	B-T058
blot	I-T058
analysis	I-T058
and	O
dual	B-T058
-	I-T058
luciferase	I-T058
reporter	I-T058
assay	I-T058
.	O
in	O
addition	O
,	O
changes	O
in	O
adenosine	B-T038
metabolism	I-T038
were	O
measured	O
in	O
the	O
treated	O
cells	B-T017
.	O
the	O
results	O
revealed	O
that	O
adenosine	B-T103
and	O
cgs	B-T103
##21	I-T103
##68	I-T103
##0	I-T103
significantly	O
upregulated	B-T038
cd3	B-T103
##9	I-T103
and	O
cd	B-T103
##73	I-T103
expression	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
e2f	B-T103
-	I-T103
1	I-T103
and	O
creb	B-T103
induced	O
cd3	B-T103
##9	I-T103
and	O
cd	B-T103
##73	I-T103
expression	O
,	O
and	O
were	O
upregulated	B-T038
by	O
adenosine	B-T103
and	O
cgs	B-T103
##21	I-T103
##68	I-T103
##0	I-T103
.	O
adenosine	B-T038
triphosphate	I-T038
(	I-T038
atp	I-T038
)	I-T038
hydrolysis	I-T038
and	O
adenosine	B-T103
generation	O
were	O
inhibited	O
by	O
the	O
knockdown	O
of	O
e2f	B-T103
-	I-T103
1	I-T103
or	O
creb	B-T103
,	O
and	O
were	O
accelerated	O
in	O
the	O
presence	O
of	O
cgs	B-T103
##21	I-T103
##68	I-T103
##0	I-T103
.	O
based	O
on	O
these	O
results	O
,	O
it	O
can	O
be	O
inferred	O
that	O
adenosine	B-T103
,	O
the	O
adenosine	B-T103
a2	I-T103
##a	I-T103
receptor	I-T103
agonist	I-T103
,	O
e2f	B-T103
-	I-T103
1	I-T103
and	O
creb	B-T103
are	O
the	O
possible	O
factors	B-T103
contributing	O
to	O
the	O
high	O
expression	O
of	O
cd3	B-T103
##9	I-T103
and	O
cd	B-T103
##73	I-T103
on	O
the	O
treg	B-T017
cell	I-T017
surface	B-T082
during	O
sepsis	B-T038
.	O
adenosine	B-T103
and	O
its	O
a2	B-T103
##a	I-T103
receptor	I-T103
agonist	I-T103
served	O
as	O
the	O
signal	B-T038
transducer	I-T038
factors	B-T103
of	O
the	O
cd3	B-T103
##9	I-T103
/	O
cd	B-T103
##73	I-T103
/	O
adenosine	B-T103
pathway	O
,	O
accelerating	O
adenosine	B-T103
generation	O
.	O
our	O
study	O
may	O
benefit	O
further	O
research	B-T062
on	O
adenosine	B-T038
metabolism	I-T038
for	O
the	O
treatment	B-T058
of	O
sepsis	B-T038
.	O

or	B-T103
##ai	I-T103
##1	I-T103
-	O
mediated	O
antimicrobial	B-T103
secretion	B-T031
from	O
pancreatic	B-T017
acin	I-T017
##i	I-T017
shapes	O
the	O
gut	O
microbiome	O
and	O
regulates	B-T038
gut	B-T017
innate	O
immunity	O
the	O
gut	O
microbiome	O
participates	O
in	O
numerous	O
physiologic	O
functions	O
and	O
communicate	B-T033
##s	I-T033
intimately	O
with	O
the	O
host	O
immune	B-T022
system	I-T022
.	O
antimicrobial	B-T103
peptides	I-T103
are	O
critic	O
##a	O
l	O
components	B-T103
of	O
intestinal	B-T017
innate	O
immunity	O
.	O
we	O
report	O
a	O
prominent	O
role	O
for	O
antimicrobials	B-T038
secreted	I-T038
by	O
pancreatic	B-T017
acin	I-T017
##i	I-T017
in	O
shaping	O
the	O
gut	O
microbiome	O
that	O
is	O
essential	O
for	O
intestinal	B-T017
innate	O
immunity	O
,	O
barrier	O
function	O
,	O
and	O
survival	O
.	O
deletion	O
of	O
the	O
ca	B-T017
(	I-T017
2	I-T017
+	I-T017
)	I-T017
channel	I-T017
or	I-T017
##ai	I-T017
##1	I-T017
in	O
pancreatic	B-T017
acin	I-T017
##i	I-T017
of	O
adult	O
mice	B-T204
resulted	O
in	O
60	O
%	O
-	O
70	O
%	O
mortality	O
within	O
3	O
weeks	O
.	O
despite	O
robust	O
activation	B-T038
of	I-T038
the	I-T038
intestinal	I-T038
innate	I-T038
immune	I-T038
response	I-T038
,	O
mice	B-T204
lacking	O
acinar	B-T082
or	B-T017
##ai	I-T017
##1	I-T017
exhibited	O
intestinal	B-T017
bacterial	O
outgrowth	B-T038
and	O
dys	O
##biosis	O
,	O
ultimately	O
causing	O
systemic	O
translocation	B-T038
,	O
inflammation	B-T038
,	O
and	O
death	B-T038
.	O
while	O
digestive	B-T103
enzyme	I-T103
supplementation	B-T058
was	O
ineffective	O
,	O
treatments	B-T058
constr	O
##aining	O
bacterial	O
outgrowth	B-T038
(	O
purified	O
liquid	B-T058
diet	I-T058
,	O
broad	B-T103
-	I-T103
spectrum	I-T103
antibiotics	I-T103
)	O
rescued	O
survival	O
,	O
feeding	O
,	O
and	O
weight	B-T033
gain	I-T033
.	O
pancreatic	B-T033
levels	I-T033
of	O
cath	B-T103
##elic	I-T103
##idin	I-T103
-	O
related	O
antimicrobial	B-T103
peptide	I-T103
(	O
cr	B-T103
##amp	I-T103
)	O
were	O
reduced	O
,	O
and	O
supplement	O
of	O
synthetic	O
cr	B-T103
##amp	I-T103
prevented	O
intestinal	B-T038
disease	I-T038
.	O
these	O
findings	B-T033
reveal	O
a	O
critical	O
role	O
for	O
antimicrobial	B-T103
pancreatic	B-T038
secretion	I-T038
in	O
gut	B-T017
innate	O
immunity	O
.	O

coupling	O
of	O
trp	B-T103
##v6	I-T103
and	O
tm	B-T103
##em	I-T103
##16	I-T103
##a	I-T103
in	O
epithelial	B-T017
principal	I-T017
cells	I-T017
of	O
the	O
rat	B-T017
epididymis	I-T017
the	O
epididymis	B-T017
establishes	O
a	O
congen	O
##ial	O
environment	B-T082
for	O
sperm	B-T038
maturation	I-T038
and	O
protection	O
.	O
its	O
fluid	B-T031
is	O
acidic	O
,	O
and	O
the	O
calcium	B-T103
concentration	O
is	O
low	O
and	O
declines	O
along	O
the	O
length	O
of	O
the	O
epididymal	B-T017
tubule	I-T017
.	O
however	O
,	O
our	O
knowledge	O
of	O
ionic	B-T038
currents	I-T038
and	O
mechanisms	O
of	O
calcium	B-T038
homeostasis	I-T038
in	O
rat	B-T017
epididymal	I-T017
epithelial	B-T017
cells	I-T017
remains	O
en	O
##igm	O
##atic	O
.	O
in	O
this	O
study	B-T062
,	O
to	O
better	O
understand	O
calcium	B-T038
regulation	I-T038
in	O
the	O
epididymis	B-T017
,	O
we	O
use	O
the	O
patch	B-T062
-	I-T062
clamp	I-T062
method	I-T062
to	O
record	O
from	O
single	O
rat	B-T204
cauda	B-T017
epididymal	I-T017
principal	B-T017
cells	I-T017
.	O
we	O
detect	B-T033
a	O
constitutively	O
active	O
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
current	B-T038
with	O
characteristics	O
that	O
match	O
the	O
epithelial	B-T017
calcium	B-T103
channel	I-T103
trp	B-T103
##v6	I-T103
.	O
electrophysiological	O
and	O
pharmacological	B-T058
data	I-T058
also	O
reveal	O
a	O
constitutively	O
active	B-T103
calcium	I-T103
-	I-T103
activated	I-T103
chloride	I-T103
conductance	I-T103
(	O
cac	B-T103
##c	I-T103
)	O
.	O
removal	O
of	O
extracellular	B-T017
calcium	B-T103
attenuates	O
not	O
only	O
the	O
trp	B-T103
##v6	I-T103
-	O
like	O
conductance	O
,	O
but	O
also	O
the	O
cac	B-T103
##c	I-T103
.	O
lanthanide	B-T103
block	O
is	O
time	O
dependent	O
such	O
that	O
the	O
trp	B-T103
##v6	I-T103
-	O
like	O
component	O
is	O
inhibited	B-T038
first	O
,	O
followed	O
by	O
the	O
cac	B-T103
##c	I-T103
.	O
the	O
putative	O
cac	B-T103
##c	I-T103
blocker	O
nif	B-T103
##lu	I-T103
##mic	I-T103
acid	I-T103
partially	O
inhibits	B-T038
whole	B-T017
-	I-T017
cell	I-T017
currents	B-T038
,	O
whereas	O
la	B-T103
(	I-T103
3	I-T103
+	I-T103
)	I-T103
almost	O
abolish	O
##es	O
whole	B-T017
-	I-T017
cell	I-T017
currents	B-T038
in	O
principal	B-T017
cells	I-T017
.	O
membrane	B-T038
potential	I-T038
measurements	O
reveal	O
an	O
interplay	O
between	O
la	B-T103
(	I-T103
3	I-T103
+	I-T103
)	I-T103
-	O
sensitive	B-T103
ion	I-T103
channels	I-T103
and	O
those	O
that	O
are	O
sensitive	O
to	O
the	O
specific	B-T170
tm	B-T103
##em	I-T103
##16	I-T103
##a	I-T103
inhibitor	B-T103
tann	B-T103
##ic	I-T103
acid	I-T103
.	O
in	B-T082
vivo	I-T082
perfusion	B-T058
of	O
the	O
cauda	B-T017
epididymal	I-T017
tubule	I-T017
shows	O
a	O
substantial	O
rate	O
of	O
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
reabsorption	B-T038
from	O
the	O
luminal	B-T082
side	I-T082
,	O
which	O
is	O
dose	O
-	O
dependently	O
suppressed	O
by	O
ruthenium	B-T103
red	I-T103
,	O
a	O
putative	O
blocker	O
of	O
epithelial	B-T017
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
channels	I-T103
and	O
cac	B-T103
##c	I-T103
.	O
finally	O
,	O
we	O
discover	O
messenger	B-T103
rna	I-T103
for	O
both	O
trp	B-T103
##v6	I-T103
and	O
tm	B-T103
##em	I-T103
##16	I-T103
##a	I-T103
in	O
the	O
rat	B-T017
epididymis	I-T017
and	O
show	O
that	O
their	O
proteins	B-T103
colocal	B-T082
##ize	I-T082
in	O
the	O
apical	O
membrane	O
of	O
principal	B-T017
cells	I-T017
.	O
collectively	O
,	O
these	O
data	O
provide	O
evidence	O
for	O
a	O
coupling	O
mechanism	O
between	O
trp	B-T103
##v6	I-T103
and	O
tm	B-T103
##em	I-T103
##16	I-T103
##a	I-T103
in	O
principal	B-T017
cells	I-T017
that	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	B-T038
of	I-T038
calcium	I-T038
homeostasis	I-T038
in	O
the	O
epididymis	B-T017
.	O

biochemical	O
evidence	O
for	O
a	O
mitochondrial	B-T017
genetic	O
modifier	B-T017
in	O
the	O
phenotypic	O
manifestation	O
of	O
le	B-T038
##ber	I-T038
'	I-T038
s	I-T038
hereditary	I-T038
optic	I-T038
neuropathy	I-T038
-	O
associated	O
mitochondrial	B-T017
dna	I-T017
mutation	I-T017
le	B-T038
##ber	I-T038
'	I-T038
s	I-T038
hereditary	I-T038
optic	I-T038
neuropathy	I-T038
(	O
lh	B-T038
##on	I-T038
)	O
is	O
the	O
most	O
common	O
mitochondrial	B-T038
disease	I-T038
.	O
mitochondrial	B-T017
modifiers	B-T017
are	O
proposed	O
to	O
modify	O
the	O
phenotypic	O
expression	O
of	O
primary	O
lh	B-T038
##on	I-T038
-	O
associated	O
mitochondrial	B-T103
dna	I-T103
(	O
mtdna	B-T103
)	O
mutations	B-T017
.	O
in	O
this	O
study	B-T062
,	O
we	O
demonstrated	O
that	O
the	O
lh	B-T038
##on	I-T038
susceptibility	B-T201
allele	B-T017
(	O
m	B-T017
.	I-T017
145	I-T017
##02	I-T017
##t	I-T017
>	I-T017
c	I-T017
,	O
p	B-T017
.	I-T017
58	I-T017
##i	I-T017
>	I-T017
v	I-T017
)	O
in	O
the	O
nd	B-T017
##6	I-T017
gene	I-T017
modulated	B-T082
the	O
phenotypic	O
expression	O
of	O
primary	O
lh	B-T038
##on	I-T038
-	O
associated	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
.	O
twenty	O
-	O
two	O
han	O
chinese	O
pedigrees	B-T170
carrying	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
and	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutations	I-T038
exhibited	O
significantly	O
higher	O
penetrance	O
of	O
optic	B-T038
neuropathy	I-T038
than	O
those	O
carrying	O
only	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
.	O
we	O
performed	O
functional	O
assays	B-T058
using	O
the	O
cy	B-T017
##brid	I-T017
cell	I-T017
models	I-T017
,	O
generated	O
by	O
fus	O
##ing	O
mtdna	B-T017
-	I-T017
less	I-T017
ρ	I-T017
(	I-T017
o	I-T017
)	I-T017
cells	I-T017
with	O
enucle	B-T017
##ated	I-T017
cells	I-T017
from	O
lh	B-T038
##on	I-T038
patients	O
carrying	O
both	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
and	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
mutations	I-T038
,	O
only	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
or	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
and	O
a	O
control	O
belonging	O
to	O
the	O
same	O
mtdna	B-T103
hapl	O
##ogroup	O
.	O
these	O
cy	B-T017
##brids	I-T017
cell	I-T017
lines	I-T017
bearing	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
mutation	I-T038
exhibited	O
mild	O
effects	O
on	O
mitochondrial	B-T017
functions	O
compared	O
with	O
those	O
carrying	O
only	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
.	O
however	O
,	O
more	O
severe	O
mitochondrial	B-T017
dysfunctions	O
were	O
observed	O
in	O
cell	B-T017
lines	I-T017
bearing	O
both	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
and	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutations	I-T038
than	O
those	O
carrying	O
only	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
or	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
mutation	I-T038
.	O
in	O
particular	O
,	O
the	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
mutation	I-T038
altered	O
assemble	O
of	O
complex	B-T103
i	I-T103
,	O
thereby	O
aggrav	O
##ating	O
the	O
respiratory	O
phenotypes	O
associated	O
with	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
,	O
resulted	O
in	O
a	O
more	O
defective	O
complex	B-T103
i	I-T103
.	O
furthermore	O
,	O
more	O
reductions	O
in	O
the	O
levels	O
of	O
mitochondrial	B-T017
atp	B-T103
and	O
increasing	O
production	O
of	O
reactive	B-T103
oxygen	I-T103
species	I-T103
were	O
also	O
observed	O
in	O
mutant	B-T038
cells	B-T017
bearing	O
both	O
m	B-T038
.	I-T038
145	I-T038
##02	I-T038
##t	I-T038
>	I-T038
c	I-T038
and	O
m	B-T038
.	I-T038
117	I-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
than	O
those	O
carrying	O
only	O
117	B-T038
##78	I-T038
##g	I-T038
>	I-T038
a	I-T038
mutation	I-T038
.	O
our	O
findings	O
provided	O
new	O
insights	O
into	O
the	O
pathophysiology	O
of	O
lh	B-T038
##on	I-T038
that	O
were	O
manifested	O
by	O
interaction	O
between	O
primary	O
and	O
secondary	O
mtdna	B-T103
mutations	B-T017
.	O

a	O
ras	O
##ch	O
rating	O
scale	O
analysis	B-T062
of	O
the	O
presence	B-T033
of	O
nursing	B-T091
scale	O
-	O
rn	B-T097
the	O
phenomenon	O
of	O
nursing	B-T091
presence	B-T033
encompasses	O
the	O
emotional	B-T033
connection	B-T082
between	O
nurse	B-T097
and	O
patient	O
,	O
and	O
technical	O
skills	O
performed	O
by	O
the	O
nurse	B-T097
.	O
the	O
presence	B-T033
of	O
nursing	B-T091
scale	O
-	O
rn	B-T097
version	B-T170
(	O
pons	O
-	O
rn	B-T097
)	O
was	O
developed	O
to	O
measure	O
nurses	B-T097
'	I-T097
perceptions	B-T038
of	O
their	O
ability	O
to	O
be	O
present	B-T033
to	O
their	O
patients	O
.	O
this	O
study	B-T062
summarizes	B-T170
the	O
process	O
of	O
re	O
-	O
evaluation	O
of	O
the	O
psychometric	B-T058
properties	I-T058
of	O
the	O
pons	O
-	O
rn	B-T097
instrument	O
.	O
a	O
sample	B-T098
of	O
76	O
registered	B-T097
nurses	I-T097
providing	O
direct	O
patient	B-T058
care	I-T058
responded	B-T038
to	O
the	O
31	O
-	O
item	O
questionnaire	B-T170
.	O
the	O
ras	O
##ch	O
rating	O
scale	O
model	O
was	O
used	O
for	O
assessing	O
construct	O
validity	O
of	O
pons	O
-	O
rn	B-T097
data	O
.	O
a	O
principal	O
component	O
analysis	O
(	O
pca	O
)	O
of	O
residual	O
##s	O
supported	O
appropriateness	O
of	O
the	O
subscales	O
defined	O
by	O
a	O
2	B-T082
-	I-T082
dimensional	I-T082
structure	B-T082
.	O
the	O
results	O
of	O
item	O
and	O
person	B-T098
fit	O
analysis	B-T062
,	O
rating	O
scale	O
functioning	O
analysis	B-T062
and	O
reliability	O
analysis	O
have	O
demonstrated	O
that	O
the	O
thirty	O
-	O
one	O
item	O
presence	B-T033
of	O
nursing	B-T091
scale	O
-	O
rn	B-T097
instrument	O
yielded	O
measures	O
with	O
high	O
validity	O
and	O
reliability	O
as	O
two	O
sub	O
-	O
scales	O
.	O
jo	O
##u	O
rn	B-T097

non	O
-	O
tox	O
##igenic	O
environmental	B-T082
vibrio	B-T007
cholerae	I-T007
o1	I-T007
strain	O
from	O
hai	B-T082
##ti	I-T082
provides	O
evidence	O
of	O
pre	O
-	O
pandemic	O
cholera	B-T038
in	O
hispan	B-T082
##iol	I-T082
##a	I-T082
vibrio	B-T007
cholerae	I-T007
is	O
ubiquitous	O
in	O
aquatic	O
environments	O
,	O
with	O
environmental	B-T082
tox	B-T170
##igenic	I-T170
v	B-T007
.	I-T007
cholerae	I-T007
o1	I-T007
strains	O
serving	O
as	O
a	O
source	B-T033
for	O
recurrent	O
cholera	B-T038
epidemics	I-T038
and	O
pandemic	O
disease	B-T038
.	O
however	O
,	O
a	O
number	O
of	O
questions	O
remain	O
about	O
long	O
-	O
term	O
survival	O
and	O
evolution	O
of	O
v	B-T007
.	I-T007
cholerae	I-T007
strains	O
within	O
these	O
aquatic	O
environmental	O
reservoirs	B-T082
.	O
through	O
monitoring	O
of	O
the	O
hai	B-T082
##tian	I-T082
aquatic	O
environment	O
following	O
the	O
2010	O
cholera	B-T038
epidemic	I-T038
,	O
we	O
isolated	O
two	O
novel	O
non	O
-	O
tox	O
##igenic	O
(	O
ctx	B-T017
##a	I-T017
/	I-T017
b	I-T017
-	O
negative	B-T033
)	O
vibrio	B-T007
cholerae	I-T007
o1	I-T007
.	O
these	O
two	O
isolates	B-T103
underwent	O
whole	B-T062
-	I-T062
genome	I-T062
sequencing	I-T062
and	O
were	O
investigated	O
through	O
comparative	O
genomics	B-T091
and	O
bayesian	O
coales	O
##cent	O
analysis	O
.	O
these	O
isolates	B-T103
cluster	O
in	O
the	O
evolutionary	O
tree	B-T204
with	O
strains	O
responsible	O
for	O
clinical	O
cholera	B-T038
,	O
possessing	O
genomic	B-T017
components	I-T017
of	O
6	O
(	O
th	O
)	O
and	O
7	O
(	O
th	O
)	O
pandemic	O
lineages	O
,	O
and	O
diverg	O
##e	O
from	O
[UNK]	O
modern	O
[UNK]	O
cholera	B-T038
strains	O
around	O
154	O
##8	O
c	O
.	O
e	O
.	O
[	O
95	O
%	O
hp	O
##d	O
:	O
153	O
##2	O
-	O
155	O
##5	O
]	O
.	O
vibrio	B-T017
pathogenicity	I-T017
island	I-T017
(	B-T017
vp	I-T017
##i	I-T017
)	I-T017
-	I-T017
1	I-T017
was	O
present	B-T033
;	O
however	O
,	O
s	B-T017
##xt	I-T017
/	I-T017
r3	I-T017
##91	I-T017
-	I-T017
family	I-T017
ice	I-T017
and	O
vp	B-T017
##i	I-T017
-	I-T017
2	I-T017
were	O
absent	O
.	O
rug	O
##ose	O
phenotype	O
conversion	O
and	O
vibrio	B-T005
##pha	I-T005
##ge	I-T005
resistance	O
evidenced	O
adapt	O
##ion	O
for	O
persistence	B-T038
in	O
aquatic	O
environments	O
.	O
the	O
identification	O
of	O
v	B-T007
.	I-T007
cholerae	I-T007
o1	I-T007
strains	O
in	O
the	O
hai	B-T082
##tian	I-T082
environment	O
,	O
which	O
pred	O
##ate	O
the	O
first	O
reported	B-T062
cholera	B-T038
pandemic	O
in	O
181	O
##7	O
,	O
broad	O
##ens	O
our	O
understanding	B-T038
of	O
the	O
history	O
of	O
pandemic	O
##s	O
.	O
it	O
also	O
raises	O
the	O
possibility	O
that	O
these	O
and	O
similar	O
environmental	O
strains	O
could	O
acquire	O
virulence	O
genes	B-T017
from	O
the	O
2010	O
hai	B-T082
##tian	I-T082
epidemic	O
clone	B-T017
,	O
including	O
the	O
cholera	B-T103
toxin	I-T103
producing	O
ctx	B-T103
##ϕ	I-T103
.	O

body	B-T204
diffusion	B-T058
weighted	I-T058
imaging	I-T058
using	O
non	B-T058
-	I-T058
cpm	I-T058
##g	I-T058
fast	I-T058
spin	I-T058
echo	I-T058
ss	B-T058
-	I-T058
fs	I-T058
##e	I-T058
is	O
a	O
fast	O
technique	B-T058
that	O
does	O
not	O
suffer	O
from	O
off	B-T033
-	I-T033
resonance	I-T033
distortions	O
to	O
the	O
degree	O
that	O
epi	B-T058
does	O
.	O
unlike	O
epi	B-T058
,	O
ss	B-T058
-	I-T058
fs	I-T058
##e	I-T058
is	O
ill	O
-	O
suited	O
to	O
diffusion	B-T058
weighted	I-T058
imaging	I-T058
(	O
dwi	B-T058
)	O
due	O
to	O
the	O
carr	B-T033
-	I-T033
pur	I-T033
##cell	I-T033
-	I-T033
me	I-T033
##ib	I-T033
##oo	I-T033
##m	I-T033
-	I-T033
ge	I-T033
##ill	I-T033
(	I-T033
cpm	I-T033
##g	I-T033
)	I-T033
condition	I-T033
.	O
non	B-T033
-	I-T033
cpm	I-T033
##g	I-T033
phase	O
cycling	O
does	O
accommodate	O
ss	B-T058
-	I-T058
fs	I-T058
##e	I-T058
and	O
dwi	B-T058
but	O
places	B-T082
constraints	O
on	O
reconstruction	O
,	O
which	O
are	O
resolved	B-T033
here	O
through	O
parallel	B-T058
imaging	I-T058
.	O
additionally	O
,	O
improved	B-T033
echo	O
stability	O
can	O
be	O
achieved	O
by	O
using	O
short	O
duration	O
and	O
highly	O
selective	O
diverse	O
radiofrequency	O
pulses	O
.	O
here	O
,	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
(	O
snr	O
)	O
comparisons	O
between	O
epi	B-T058
and	O
nc	B-T033
##pm	I-T033
##g	I-T033
ss	B-T058
-	I-T058
fs	I-T058
##e	I-T058
acquisition	O
##s	O
and	O
reconstruction	O
techniques	O
give	O
similar	O
values	O
.	O
diffusion	B-T058
imaging	I-T058
with	O
nc	B-T033
##pm	I-T033
##g	I-T033
ss	B-T058
-	I-T058
fs	I-T058
##e	I-T058
gives	O
similar	O
snr	O
to	O
an	O
epi	B-T058
acquisition	O
,	O
though	O
apparent	O
diffusion	O
coefficient	O
values	O
are	O
higher	O
than	O
seen	O
with	O
epi	B-T058
.	O
in	B-T082
vivo	I-T082
images	B-T170
have	O
good	O
image	O
quality	O
with	O
little	O
distortion	O
.	O
this	O
method	O
has	O
the	O
ability	O
to	O
capture	O
distortion	O
-	O
free	O
dwi	B-T058
images	B-T170
near	O
areas	B-T082
of	O
significant	O
off	B-T033
-	I-T033
resonance	I-T033
as	O
well	O
as	O
preserve	O
adequate	O
snr	O
.	O
parallel	B-T058
imaging	I-T058
and	O
diverse	O
ref	O
##ocus	O
##ing	O
rf	O
pulses	O
allow	O
shorter	O
et	O
##l	O
compared	O
to	O
previous	O
implementation	O
##s	O
and	O
thus	O
reduces	O
phase	O
encode	O
direction	B-T082
blu	O
##r	O
and	O
sar	B-T038
accumulation	B-T033
.	O

a	O
novel	O
role	O
for	O
poly	B-T103
(	I-T103
c	I-T103
)	I-T103
binding	I-T103
proteins	I-T103
in	O
programmed	B-T038
ribosomal	I-T038
frameshift	I-T038
##ing	I-T038
translational	B-T038
control	O
through	O
programmed	B-T038
ribosomal	I-T038
frameshift	I-T038
##ing	I-T038
(	O
prf	B-T038
)	O
is	O
exploited	O
widely	O
by	O
viruses	B-T005
and	O
increasingly	O
documented	O
in	O
cellular	B-T017
genes	B-T017
.	O
frameshift	B-T038
##ing	I-T038
is	O
induced	O
by	O
mrna	B-T103
secondary	I-T103
structures	I-T103
that	O
compromise	O
ribosome	B-T017
fidelity	B-T038
during	O
decoding	O
of	O
a	O
hept	B-T082
##an	I-T082
##ucleotide	I-T082
'	I-T082
slip	I-T082
##per	I-T082
##y	I-T082
'	I-T082
sequence	I-T082
.	O
the	O
nsp	B-T103
##2	I-T103
prf	B-T038
signal	B-T038
of	O
porcine	B-T005
reproductive	I-T005
and	I-T005
respiratory	I-T005
syndrome	I-T005
virus	I-T005
is	O
distinctive	O
in	O
directing	O
both	O
-	B-T038
2	I-T038
and	O
-	B-T038
1	I-T038
prf	I-T038
and	O
in	O
its	O
requirement	O
for	O
a	O
trans	B-T103
-	I-T103
acting	I-T103
protein	I-T103
factor	I-T103
,	O
the	O
viral	B-T005
replic	B-T103
##ase	I-T103
subunit	I-T103
nsp	I-T103
##1	I-T103
##β	I-T103
.	O
here	O
we	O
show	O
that	O
the	O
the	O
trans	B-T038
-	I-T038
activation	I-T038
of	O
frameshift	B-T038
##ing	I-T038
is	O
carried	O
out	O
by	O
a	O
protein	B-T103
complex	I-T103
composed	O
of	O
nsp	B-T103
##1	I-T103
##β	I-T103
and	O
a	O
cellular	B-T017
poly	B-T103
(	I-T103
c	I-T103
)	I-T103
binding	I-T103
protein	I-T103
(	O
pcb	B-T103
##p	I-T103
)	O
.	O
from	O
the	O
results	O
of	O
in	O
vitro	O
translation	B-T038
and	O
electrophoretic	B-T058
mobility	I-T058
shift	I-T058
assays	I-T058
,	O
we	O
demonstrate	O
that	O
a	O
pcb	B-T103
##p	I-T103
/	O
nsp	B-T103
##1	I-T103
##β	I-T103
complex	B-T103
binds	O
to	O
a	O
c	B-T082
-	I-T082
rich	I-T082
sequence	I-T082
downstream	B-T082
of	O
the	O
slip	B-T082
##per	I-T082
##y	I-T082
sequence	I-T082
and	O
here	O
mimics	O
the	O
activity	O
of	O
a	O
structured	O
mrna	B-T103
stimulator	B-T103
of	O
prf	B-T038
.	O
this	O
is	O
the	O
first	O
description	O
of	O
a	O
role	O
for	O
a	O
trans	B-T103
-	I-T103
acting	I-T103
cellular	I-T103
protein	I-T103
in	O
prf	B-T038
.	O
the	O
discovery	O
broad	O
##ens	O
the	O
repertoire	O
of	O
activities	O
associated	O
with	O
poly	B-T103
(	I-T103
c	I-T103
)	I-T103
binding	I-T103
proteins	I-T103
and	O
prototype	O
##s	O
a	O
new	O
class	O
of	O
virus	B-T005
-	O
host	O
interactions	O
.	O

antigen	O
specificity	O
determines	O
anti	B-T103
-	I-T103
red	I-T103
blood	I-T103
cell	I-T103
igg	I-T103
-	I-T103
fc	I-T103
allo	I-T103
##antib	I-T103
##ody	I-T103
glycosylation	O
and	O
thereby	O
severity	O
of	O
haemolytic	B-T038
disease	I-T038
of	I-T038
the	I-T038
fetus	I-T038
and	I-T038
newborn	I-T038
haemolytic	B-T038
disease	I-T038
of	I-T038
the	I-T038
fetus	I-T038
and	I-T038
newborn	I-T038
(	O
hd	B-T038
##f	I-T038
##n	I-T038
)	O
is	O
a	O
severe	O
disease	B-T038
in	O
which	O
fetal	B-T017
red	B-T017
blood	I-T017
cells	I-T017
(	O
rbc	B-T017
)	O
are	O
destroyed	O
by	O
maternal	B-T103
anti	I-T103
-	I-T103
rbc	I-T103
igg	I-T103
allo	I-T103
##antib	I-T103
##odies	I-T103
.	O
hd	B-T038
##f	I-T038
##n	I-T038
is	O
most	O
often	O
caused	O
by	O
anti	B-T103
-	I-T103
d	I-T103
but	O
may	O
also	O
occur	O
due	O
to	O
anti	B-T103
-	I-T103
k	I-T103
,	O
-	B-T103
c	I-T103
-	O
or	O
-	B-T103
e	I-T103
.	O
we	O
recently	O
found	O
n	B-T038
-	I-T038
linked	I-T038
glycosylation	I-T038
of	O
anti	B-T103
-	I-T103
d	I-T103
to	O
be	O
skewed	O
towards	O
low	O
fuc	B-T038
##osylation	I-T038
,	O
thereby	O
increasing	O
the	O
affinity	B-T038
to	O
igg	B-T103
-	I-T103
fc	I-T103
receptor	I-T103
iiia	I-T103
and	O
iiib	B-T103
,	O
which	O
correlated	O
with	O
hd	B-T038
##f	I-T038
##n	I-T038
disease	B-T038
severity	O
.	O
here	O
,	O
we	O
analysed	O
230	O
pregnant	B-T098
women	I-T098
with	O
anti	B-T103
-	I-T103
c	I-T103
,	O
-	B-T103
e	I-T103
or	O
-	B-T103
k	I-T103
allo	B-T103
##antib	I-T103
##odies	I-T103
from	O
a	O
prospective	O
screening	B-T058
cohort	I-T058
and	O
investigated	O
the	O
type	O
of	O
fc	B-T038
-	I-T038
tail	I-T038
glycosylation	I-T038
of	O
these	O
antibodies	B-T103
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	B-T058
and	O
pregnancy	B-T033
outcome	I-T033
.	O
anti	B-T103
-	I-T103
c	I-T103
,	O
-	B-T103
e	I-T103
and	O
-	B-T103
k	I-T103
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	B-T058
-	O
a	O
different	O
kind	O
of	O
fc	B-T038
-	I-T038
glycosylation	I-T038
compared	O
to	O
that	O
of	O
the	O
total	O
igg	B-T103
fraction	I-T103
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti	B-T103
-	I-T103
d	I-T103
.	O
high	O
fc	B-T038
-	I-T038
galact	I-T038
##osylation	I-T038
and	O
sialyl	B-T038
##ation	I-T038
of	O
anti	B-T103
-	I-T103
c	I-T103
correlated	O
with	O
hd	B-T038
##f	I-T038
##n	I-T038
disease	B-T038
severity	O
,	O
while	O
low	O
anti	B-T103
-	I-T103
k	I-T103
fc	B-T038
-	I-T038
fuc	I-T038
##osylation	I-T038
correlated	O
with	O
severe	O
fetal	B-T038
anaemia	I-T038
.	O
igg	B-T038
-	I-T038
fc	I-T038
glycosylation	I-T038
of	O
anti	B-T103
-	I-T103
rbc	I-T103
antibodies	I-T103
is	O
shaped	O
depending	O
on	O
the	O
antigen	B-T103
.	O
these	O
features	O
influence	O
their	O
clinical	O
potency	O
and	O
may	O
therefore	O
be	O
used	O
to	O
predict	O
severity	O
and	O
identify	O
those	O
needing	O
treatment	O
.	O

birth	O
preparedness	O
and	O
complication	O
readiness	O
practice	O
and	O
associated	O
factors	O
among	O
pregnant	B-T098
women	I-T098
,	O
northwest	B-T082
ethiopia	I-T082
background	O
.	O
little	O
is	O
known	O
about	O
birth	O
preparedness	O
and	O
complication	O
readiness	O
(	O
bp	O
##cr	O
)	O
plan	O
in	O
resource	O
limited	O
settings	O
to	O
decrease	O
maternal	O
mortality	O
.	O
therefore	O
,	O
this	O
study	B-T062
was	O
done	O
to	O
assess	O
the	O
status	O
of	O
bp	O
##cr	O
and	O
associated	O
factors	O
among	O
pregnant	B-T098
women	I-T098
in	O
south	B-T082
wol	I-T082
##lo	I-T082
,	O
northwest	B-T082
ethiopia	I-T082
,	O
by	O
involving	O
81	O
##9	O
pregnant	B-T098
women	I-T098
from	O
march	O
to	O
april	O
,	O
2014	O
.	O
data	O
were	O
collected	O
by	O
using	O
pretest	O
##ed	O
interview	B-T097
##er	I-T097
administered	B-T170
questionnaire	I-T170
and	O
analyzed	B-T062
using	O
a	O
computer	B-T170
program	I-T170
of	O
spss	B-T170
version	I-T170
20	I-T170
.	I-T170
00	I-T170
.	O
results	O
.	O
pregnant	B-T098
women	I-T098
who	O
were	O
prepared	B-T033
for	O
at	O
least	O
three	O
elements	O
of	O
bp	O
##cr	O
were	O
24	O
.	O
1	O
%	O
.	O
pregnant	B-T098
women	I-T098
knowing	O
at	O
least	O
three	O
key	O
danger	B-T033
signs	I-T033
during	O
pregnancy	B-T038
,	O
delivery	B-T038
,	O
and	O
postnatal	O
period	O
were	O
23	O
.	O
2	O
%	O
,	O
22	O
.	O
6	O
%	O
,	O
and	O
9	O
.	O
6	O
%	O
,	O
respectively	O
.	O
women	B-T098
having	O
secondary	O
education	O
and	O
higher	O
were	O
6	O
.	O
20	O
(	O
95	O
%	O
ci	O
=	O
[	O
1	O
.	O
36	O
,	O
28	O
.	O
120	O
]	O
)	O
times	O
more	O
likely	O
to	O
be	O
prepared	B-T033
than	O
ill	B-T033
##iter	I-T033
##ates	I-T033
.	O
women	B-T098
having	O
a	O
lifetime	O
history	O
of	O
stillbirth	B-T033
[	O
5	O
.	O
80	O
(	O
1	O
.	O
13	O
,	O
29	O
.	O
63	O
)	O
]	O
,	O
attending	O
anc	B-T058
for	O
last	O
child	O
pregnancy	B-T038
[	O
5	O
.	O
44	O
(	O
2	O
.	O
07	O
,	O
14	O
.	O
27	O
)	O
]	O
,	O
participating	O
in	O
community	O
bp	O
##cr	O
group	O
discussion	O
[	O
4	O
.	O
36	O
(	O
1	O
.	O
17	O
,	O
16	O
.	O
26	O
)	O
]	O
,	O
and	O
having	O
their	O
male	O
partner	O
involved	O
in	O
bp	O
##cr	O
counseling	B-T058
during	O
anc	B-T058
follow	B-T058
-	I-T058
up	I-T058
[	O
4	O
.	O
45	O
(	O
1	O
.	O
95	O
,	O
10	O
.	O
16	O
)	O
]	O
were	O
more	O
likely	O
to	O
be	O
prepared	B-T033
.	O
conclusions	O
.	O
bp	O
##cr	O
was	O
very	O
low	O
and	O
should	O
be	O
strengthened	O
through	O
health	B-T058
communication	I-T058
by	O
involving	O
partner	O
in	O
bp	O
##cr	O
counseling	B-T058
.	O

adoptive	O
##ly	O
transferred	O
natural	B-T017
killer	I-T017
cells	I-T017
maintain	O
long	O
-	O
term	O
antitumor	B-T033
activity	I-T033
by	O
epigenetic	B-T038
imprinting	I-T038
and	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
help	O
natural	B-T017
killer	I-T017
(	I-T017
nk	I-T017
)	I-T017
cell	I-T017
infusions	B-T058
can	O
induce	O
remissions	O
in	O
subsets	O
of	O
patients	O
with	O
different	O
types	O
of	O
cancer	B-T038
.	O
the	O
optimal	O
strategies	O
for	O
nk	B-T017
cell	I-T017
activation	B-T038
prior	O
to	O
infusion	B-T058
are	O
still	O
under	O
debate	O
.	O
there	O
is	O
recent	O
evidence	O
that	O
nk	B-T017
cells	I-T017
can	O
acquire	O
long	O
-	O
term	O
functional	O
competence	O
by	O
pre	O
##activation	O
with	O
the	O
cytokines	B-T103
il	B-T103
-	I-T103
12	I-T103
/	O
15	B-T103
/	O
18	B-T103
.	O
the	O
mechanisms	O
supporting	O
the	O
maintenance	O
of	O
long	O
-	O
term	O
nk	B-T017
cell	I-T017
antitumor	B-T033
activity	I-T033
are	O
incompletely	O
under	O
-	O
sto	O
##od	O
.	O
here	O
,	O
we	O
show	O
that	O
nk	B-T017
cells	I-T017
pre	O
##activated	O
in	B-T058
vitro	I-T058
with	O
il	B-T103
-	I-T103
12	I-T103
/	O
15	B-T103
/	O
18	B-T103
,	O
but	O
not	O
with	O
il	B-T103
-	I-T103
15	I-T103
alone	O
,	O
maintained	O
high	O
antitumor	B-T033
activity	I-T033
even	O
1	O
mo	O
after	O
transfer	O
into	O
lympho	B-T038
##pe	I-T038
##nic	I-T038
rag	B-T017
-	I-T017
2	I-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
γ	O
##c	O
(	O
-	O
/	O
-	O
)	O
mice	B-T204
.	O
the	O
nk	B-T017
cell	I-T017
intrinsic	O
ability	O
for	O
ifn	B-T103
##γ	I-T103
production	O
coincided	O
with	O
demethylation	O
of	O
the	O
conserved	O
non	B-T103
-	I-T103
coding	I-T103
sequence	I-T103
(	O
cns	B-T103
)	O
1	O
in	O
the	O
ifn	B-T017
##g	I-T017
locus	B-T082
,	O
previously	O
shown	O
to	O
enhance	O
transcription	B-T038
of	O
ifn	B-T017
##g	I-T017
.	O
in	O
a	O
xenograft	B-T038
melanoma	I-T038
mouse	I-T038
model	I-T038
,	O
human	B-T204
il	B-T103
-	I-T103
12	I-T103
/	O
15	B-T103
/	O
18	B-T103
-	O
pre	O
##activated	O
nk	B-T017
cells	I-T017
rejected	O
tumors	B-T038
more	O
efficiently	O
.	O
in	O
rag	B-T017
-	I-T017
2	I-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
γ	O
##c	O
(	O
-	O
/	O
-	O
)	O
mice	B-T204
,	O
co	O
-	O
transfer	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
further	O
improved	O
the	O
long	O
-	O
term	O
competence	O
of	O
nk	B-T017
cells	I-T017
for	O
ifn	B-T103
##γ	I-T103
production	O
that	O
was	O
dependent	O
on	O
il	B-T103
-	I-T103
2	I-T103
.	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
activation	B-T038
during	O
homeostatic	B-T038
proliferation	I-T038
required	O
macrophages	B-T017
and	O
further	O
promoted	O
the	O
long	O
-	O
term	O
nk	B-T017
cell	I-T017
antitumor	B-T033
activity	I-T033
.	O
thus	O
,	O
nk	B-T017
cells	I-T017
can	O
[UNK]	O
remember	O
[UNK]	O
a	O
previous	O
exposure	O
to	O
cytokines	B-T103
by	O
epigenetic	B-T038
imprinting	I-T038
resulting	O
in	O
a	O
remarkable	O
stability	O
of	O
the	O
ifn	B-T103
##γ	I-T103
-	O
producing	O
phenotype	O
after	O
adoptive	O
transfer	O
.	O
in	O
addition	O
,	O
our	O
results	O
support	O
combination	O
of	O
cytokine	B-T103
-	O
pre	O
##activated	O
nk	B-T017
cells	I-T017
with	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
activation	B-T038
upon	O
lympho	B-T038
##pe	I-T038
##nic	I-T038
conditioning	O
to	O
achieve	O
long	O
-	O
term	O
nk	B-T017
cell	I-T017
effector	O
function	O
for	O
cancer	B-T058
immunotherapy	I-T058
.	O

tang	B-T170
##o	I-T170
-	O
a	O
screening	B-T058
tool	I-T058
to	O
identify	O
comorbidities	O
on	O
the	O
causal	B-T170
pathway	I-T170
of	O
noct	B-T038
##uria	I-T038
to	O
develop	O
a	O
robust	B-T058
screening	I-T058
metric	I-T058
for	O
use	O
in	O
identifying	O
non	O
-	O
lower	O
urinary	B-T017
tract	I-T017
comorbidities	O
pertinent	O
to	O
the	O
multidisciplinary	B-T058
assessment	I-T058
of	O
patients	O
with	O
noct	B-T038
##uria	I-T038
.	O
variables	O
having	O
a	O
significant	O
risk	O
association	O
with	O
noct	B-T038
##uria	I-T038
of	O
greater	O
than	O
once	O
per	O
night	O
were	O
identified	O
.	O
discriminating	O
items	O
from	O
validated	O
and	O
reliable	O
tools	B-T058
measuring	O
these	O
comorbidities	O
were	O
identified	O
.	O
a	O
self	O
-	O
completed	O
57	O
-	O
item	O
questionnaire	B-T170
was	O
developed	O
and	O
a	O
medical	O
checklist	B-T170
and	O
pertinent	O
clinical	B-T033
measures	I-T033
added	O
.	O
pre	O
-	O
determined	O
criteria	O
were	O
applied	O
to	O
retain	O
or	O
remove	O
items	O
in	O
the	O
development	O
of	O
the	O
short	O
-	O
form	O
(	O
sf	O
)	O
screening	B-T058
tool	I-T058
.	O
the	O
tool	B-T058
was	O
administered	O
to	O
252	O
individuals	B-T098
with	O
noct	B-T038
##uria	I-T038
who	O
were	O
attending	O
either	O
a	O
tertiary	O
level	O
sleep	B-T038
,	O
continence	B-T058
,	O
falls	B-T033
or	O
rehabilitation	B-T058
service	I-T058
for	O
routine	B-T058
care	I-T058
.	O
data	B-T033
collected	I-T033
were	O
subjected	O
to	O
descriptive	B-T170
analysis	I-T170
;	O
criteria	O
were	O
applied	O
to	O
reduce	O
the	O
number	O
of	O
items	O
.	O
using	O
pre	O
-	O
determined	O
domains	O
,	O
a	O
noct	B-T038
##uria	I-T038
screening	B-T058
metric	I-T058
,	O
entitled	O
tang	B-T170
##o	I-T170
,	O
was	O
generated	O
.	O
the	O
acr	O
##onym	O
tang	B-T170
##o	I-T170
stands	O
for	O
targeting	O
the	O
individual	O
'	O
s	O
aetiology	O
of	O
noct	B-T038
##uria	I-T038
to	O
guide	O
outcomes	O
.	O
the	O
demographic	O
characteristics	O
of	O
the	O
sample	O
are	O
described	O
,	O
along	O
with	O
item	O
endors	O
##ement	O
levels	O
.	O
the	O
statistical	O
and	O
structural	O
framework	O
to	O
justify	O
dele	O
##ting	O
or	O
retaining	O
of	O
items	O
from	O
the	O
tang	B-T170
##o	I-T170
long	O
-	O
form	O
to	O
the	O
sf	O
is	O
presented	O
.	O
the	O
resultant	O
tang	B-T170
##o	I-T170
-	O
sf	O
patient	O
-	O
completed	O
noct	B-T038
##uria	I-T038
screening	B-T058
tool	I-T058
is	O
reported	O
.	O
a	O
novel	O
all	O
-	O
cause	O
diagnostic	O
metric	O
for	O
identifying	O
co	O
-	O
existing	O
morbidities	O
of	O
clinical	O
relevance	O
to	O
noct	B-T038
##uria	I-T038
in	O
patients	O
who	O
present	O
across	O
disciplines	B-T058
and	O
medical	B-T091
specialties	I-T091
has	O
been	O
developed	O
.	O
tang	B-T170
##o	I-T170
has	O
the	O
potential	O
to	O
improve	O
practice	O
and	O
smooth	O
inequalities	O
associated	O
with	O
a	O
sil	O
##oe	O
##d	O
approach	O
to	O
assessment	B-T058
and	O
subsequent	O
care	O
of	O
patients	O
with	O
noct	B-T038
##uria	I-T038
.	O

outl	O
##ining	O
a	O
population	B-T098
[UNK]	I-T098
at	I-T098
risk	I-T098
[UNK]	I-T098
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
:	O
evidence	O
from	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
the	O
multifactorial	B-T038
pathogenesis	I-T038
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
requires	O
a	O
careful	O
identification	O
of	O
populations	B-T098
[UNK]	I-T098
at	I-T098
risk	I-T098
[UNK]	I-T098
of	O
developing	O
the	O
disease	B-T038
.	O
in	O
this	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
we	O
analyzed	B-T062
a	O
large	O
italian	B-T082
population	B-T098
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	B-T098
[UNK]	I-T098
at	I-T098
risk	I-T098
[UNK]	I-T098
of	O
pd	B-T038
.	O
we	O
enrolled	O
300	O
pd	B-T038
patients	O
and	O
300	O
controls	O
,	O
gender	O
and	O
age	O
matched	O
,	O
from	O
the	O
same	O
urban	O
geographical	O
area	O
.	O
all	O
subjects	B-T098
were	O
interviewed	O
on	O
demographics	O
,	O
family	B-T033
history	I-T033
of	O
pd	B-T038
,	O
occupational	O
and	O
environmental	O
toxic	O
##ants	O
exposure	O
,	O
smoking	B-T201
status	I-T201
,	O
and	O
alcohol	O
consumption	O
.	O
a	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	B-T031
dosing	O
of	O
iron	B-T058
,	O
copper	B-T058
,	O
mercury	B-T058
,	O
and	O
manganese	B-T058
by	O
means	O
of	O
inductively	B-T058
coupled	I-T058
-	I-T058
plasma	I-T058
-	I-T058
mass	I-T058
-	I-T058
spectrometry	I-T058
(	O
icp	B-T058
-	I-T058
ms	I-T058
)	O
.	O
positive	B-T033
family	B-T033
history	I-T033
,	O
toxic	B-T033
##ants	I-T033
exposure	I-T033
,	O
non	B-T033
-	I-T033
current	I-T033
-	I-T033
smoker	I-T033
,	O
and	O
alcohol	B-T033
noncon	I-T033
##s	I-T033
##umer	I-T033
status	I-T033
occurred	O
as	O
significant	O
risk	B-T033
factors	I-T033
in	O
our	O
population	B-T098
.	O
the	O
number	O
of	O
concurr	B-T033
##ing	I-T033
risk	I-T033
factors	I-T033
overlapping	O
in	O
the	O
same	B-T098
subject	I-T098
impressive	O
##ly	O
increased	O
the	O
overall	O
risk	O
.	O
no	O
significant	O
differences	O
were	O
measured	O
in	O
the	O
metal	B-T103
serum	B-T031
levels	O
.	O
our	O
findings	B-T033
indicate	O
that	O
combination	O
of	O
three	O
to	O
four	O
concurrent	O
pd	B-T038
-	O
risk	B-T033
factors	I-T033
defines	O
a	O
condition	O
[UNK]	O
at	O
risk	O
[UNK]	O
of	O
pd	B-T038
.	O
a	O
simple	O
stratification	B-T062
,	O
based	O
on	O
these	O
questionnaires	B-T170
,	O
might	O
be	O
of	O
help	O
in	O
identifying	B-T062
subjects	I-T062
suitable	O
for	O
neuroprotective	O
strategies	O
.	O

thermo	O
-	O
reversible	O
capture	O
and	O
release	O
of	O
dna	B-T103
by	O
zwitterionic	B-T103
surfactants	I-T103
the	O
thermo	O
-	O
reversible	O
capture	O
and	O
release	O
of	O
dna	B-T103
were	O
studied	O
by	O
the	O
protonation	O
and	O
deprot	O
##onation	O
of	O
alkyl	B-T103
##di	I-T103
##methyl	I-T103
##amine	I-T103
oxide	I-T103
(	O
cn	B-T103
##dm	I-T103
##ao	I-T103
,	O
n	O
=	O
10	O
,	O
12	O
and	O
14	O
)	O
in	O
tris	O
-	O
hcl	O
buffer	O
solution	O
.	O
dna	B-T103
/	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
in	O
tris	O
-	O
hcl	O
buffer	O
solution	O
with	O
ph	O
=	O
7	O
.	O
2	O
is	O
transparent	O
at	O
25	O
°c	O
,	O
indicating	O
that	O
dna	B-T103
molecules	O
exist	O
mainly	O
in	O
individuals	B-T098
and	O
the	O
binding	B-T038
of	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
is	O
weak	O
.	O
with	O
the	O
increase	O
of	O
temperature	O
,	O
the	O
ph	O
of	O
the	O
buffer	O
solution	O
continuously	O
decreases	O
,	O
which	O
leads	O
to	O
protonation	O
of	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
(	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
+	O
h	B-T103
(	I-T103
+	I-T103
)	I-T103
→	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
)	O
and	O
an	O
obvious	O
increase	B-T033
of	I-T033
the	I-T033
turbidity	I-T033
of	O
the	O
samples	O
.	O
this	O
indicates	O
a	O
stronger	O
binding	B-T038
of	O
the	O
protonated	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
to	O
dna	B-T103
.	O
further	O
investigations	O
demonstrated	O
the	O
formation	O
of	O
dna	B-T103
/	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
complexes	B-T103
,	O
in	O
which	O
the	O
stretched	O
dna	B-T103
molecules	O
are	O
effectively	O
compact	B-T033
##ed	I-T033
as	O
evidenced	O
from	O
uv	B-T058
-	I-T058
vis	I-T058
absorption	I-T058
##s	I-T058
,	O
circular	B-T058
dichroism	I-T058
(	O
cd	B-T058
)	O
measurements	O
,	O
atomic	B-T058
force	I-T058
microscopy	I-T058
(	O
afm	B-T058
)	O
observations	B-T062
,	O
dynamic	B-T058
light	I-T058
scattering	I-T058
(	O
dls	B-T058
)	O
measurements	O
and	O
agarose	B-T058
gel	I-T058
electrophoresis	I-T058
(	O
age	B-T058
)	O
.	O
interestingly	O
,	O
when	O
the	O
temperature	O
is	O
turned	O
back	O
to	O
25	O
°c	O
,	O
the	O
compact	B-T033
##ed	I-T033
dna	B-T103
molecules	O
can	O
fully	O
recover	O
to	O
the	O
stretched	O
conformation	O
.	O
this	O
cycle	O
can	O
be	O
repeated	O
several	O
times	O
without	O
obvious	O
loss	O
of	O
efficiency	O
.	O
the	O
effect	O
of	O
the	O
chain	O
length	O
of	O
cn	B-T103
##dm	I-T103
##ao	I-T103
has	O
also	O
been	O
investigated	O
.	O
when	O
c1	B-T103
##4	I-T103
##dm	I-T103
##ao	I-T103
was	O
replaced	O
by	O
c12	B-T103
##dm	I-T103
##ao	I-T103
,	O
similar	O
phenomena	O
can	O
be	O
observed	O
with	O
a	O
slightly	O
higher	O
critical	O
surfactant	B-T103
concentration	O
for	O
dna	B-T103
compaction	B-T033
and	O
a	O
slightly	O
lower	O
ph	O
of	O
tris	O
-	O
hcl	O
buffer	O
solution	O
with	O
ph	O
=	O
6	O
.	O
8	O
.	O
for	O
the	O
dna	B-T103
/	O
c10	B-T103
##dm	I-T103
##ao	I-T103
system	O
,	O
however	O
,	O
no	O
dna	B-T103
compaction	B-T033
was	O
observed	O
even	O
in	O
tris	O
-	O
hcl	O
buffer	O
solution	O
with	O
a	O
much	O
lower	O
ph	O
and	O
a	O
much	O
higher	O
c10	B-T103
##dm	I-T103
##ao	I-T103
concentration	O
.	O
the	O
negative	O
charges	O
of	O
dna	B-T103
molecules	O
can	O
easily	O
be	O
neutralized	O
by	O
positive	O
charges	O
of	O
cationic	B-T103
cn	I-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
(	O
n	O
=	O
12	O
and	O
14	O
)	O
micelles	B-T103
.	O
dna	B-T103
was	O
compact	B-T033
##ed	I-T033
and	O
then	O
insoluble	O
dna	B-T103
/	O
cn	B-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
complexes	B-T103
were	O
formed	O
.	O
because	O
of	O
the	O
much	O
higher	O
critical	O
micelle	B-T103
concentration	O
(	O
cmc	O
)	O
of	O
the	O
shorter	O
chain	O
length	O
c10	B-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
,	O
cationic	B-T103
c10	I-T103
##dm	I-T103
##ao	I-T103
##h	I-T103
(	I-T103
+	I-T103
)	I-T103
micelles	B-T103
cann	O
##ot	O
form	O
under	O
the	O
studied	O
condition	O
to	O
compact	B-T033
dna	B-T103
.	O
the	O
strategy	O
may	O
provide	O
an	O
efficient	O
and	O
alternative	O
approach	O
for	O
stimuli	B-T058
-	I-T058
responsive	I-T058
gene	I-T058
therapy	I-T058
and	O
drug	O
release	O
.	O

neuroticism	B-T038
and	O
fatigue	B-T033
3	O
months	O
after	O
ischemic	B-T038
stroke	I-T038
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
to	O
examine	B-T033
the	O
relation	O
between	O
neuroticism	B-T038
and	O
fatigue	B-T033
in	O
chinese	B-T082
patients	O
with	O
stroke	B-T038
.	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
.	O
acute	O
stroke	B-T092
unit	I-T092
.	O
survivors	O
of	O
ischemic	B-T038
stroke	I-T038
(	O
n	O
=	O
191	O
)	O
recruited	O
from	O
the	O
acute	O
stroke	B-T092
unit	I-T092
between	O
may	O
1	O
,	O
2010	O
,	O
and	O
september	O
1	O
,	O
2011	O
.	O
not	O
applicable	O
.	O
the	O
personality	B-T033
trait	I-T033
of	O
neuroticism	B-T038
was	O
measured	O
with	O
the	O
neuroticism	B-T038
subscale	O
of	O
the	O
chinese	B-T082
version	B-T170
of	O
the	O
neo	B-T058
five	I-T058
-	I-T058
factor	I-T058
inventory	I-T058
.	O
the	O
level	O
of	O
fatigue	B-T033
was	O
measured	O
with	O
the	O
fatigue	B-T170
assessment	I-T170
scale	I-T170
.	O
the	O
national	B-T170
institutes	I-T170
of	I-T170
health	I-T170
stroke	I-T170
scale	I-T170
,	O
geriatric	B-T170
depression	I-T170
scale	I-T170
,	O
barth	B-T170
##el	I-T170
index	I-T170
,	O
and	O
mini	B-T058
-	I-T058
mental	I-T058
state	I-T058
examination	I-T058
were	O
administered	O
to	O
obtain	O
demographic	O
and	O
clinical	B-T170
information	I-T170
.	O
fatigue	B-T170
severity	I-T170
3	O
months	O
after	O
stroke	B-T038
positively	O
correlated	O
with	O
geriatric	B-T170
depression	I-T170
scale	I-T170
and	O
neo	B-T058
five	I-T058
-	I-T058
factor	I-T058
inventory	I-T058
neuroticism	B-T038
scores	O
and	O
negatively	B-T033
correlated	O
with	O
the	O
barth	O
##el	O
index	O
score	O
.	O
neuroticism	B-T038
,	O
independent	B-T033
of	O
depressive	B-T033
symptoms	I-T033
,	O
is	O
a	O
predictor	O
of	O
fatigue	B-T170
severity	I-T170
3	O
months	O
after	O
stroke	B-T038
.	O
interventions	O
such	O
as	O
psychological	O
screening	O
programs	O
are	O
warranted	O
for	O
early	O
detection	B-T058
of	O
patients	O
at	O
high	B-T033
risk	I-T033
of	I-T033
posts	B-T038
##tr	I-T038
##oke	I-T038
depression	I-T038
.	O

pediatric	O
hypo	B-T038
##vitamin	I-T038
##osis	I-T038
d	I-T038
:	O
molecular	O
perspectives	O
and	O
clinical	O
implications	O
vitamin	B-T103
d	I-T103
,	O
a	O
sec	B-T103
##oster	I-T103
##oid	I-T103
,	O
is	O
essential	O
for	O
the	O
development	B-T038
and	O
maintenance	O
of	O
healthy	O
bone	B-T017
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	B-T098
.	O
low	O
level	O
of	O
25	B-T103
-	I-T103
hydroxy	I-T103
vitamin	I-T103
d	I-T103
(	O
25	B-T103
-	I-T103
(	I-T103
oh	I-T103
)	I-T103
-	I-T103
d	I-T103
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	B-T038
health	O
outcomes	O
including	O
rick	B-T038
##ets	I-T038
,	O
oste	B-T038
##omalacia	I-T038
,	O
oste	B-T038
##omal	I-T038
##aci	I-T038
##c	I-T038
myopathy	I-T038
,	O
sarcopenia	B-T038
,	O
and	O
weakness	B-T033
,	O
growth	B-T038
retardation	I-T038
,	O
hypocalcemia	B-T038
,	O
seizure	B-T033
and	O
tet	B-T038
##an	I-T038
##y	I-T038
,	O
autism	B-T038
,	O
cardiovascular	B-T038
diseases	I-T038
,	O
diabetes	B-T038
mellitus	I-T038
,	O
cancers	B-T038
(	O
prostate	B-T038
,	O
colon	B-T038
,	O
breast	B-T038
)	O
,	O
infectious	B-T038
diseases	I-T038
(	O
viral	B-T038
,	O
tuberculosis	B-T038
)	O
,	O
and	O
autoimmune	B-T038
diseases	I-T038
,	I-T038
such	O
as	O
multiple	B-T038
sclerosis	I-T038
and	O
hash	B-T038
##imoto	I-T038
'	I-T038
s	I-T038
thyroiditis	I-T038
.	O
risk	B-T033
factors	I-T033
for	O
hypo	B-T038
##vitamin	I-T038
##osis	I-T038
d	I-T038
are	O
people	B-T098
with	O
dark	B-T038
##er	I-T038
skin	I-T038
pigmentation	I-T038
,	O
use	O
of	O
sunsc	O
##reen	O
,	O
insufficient	O
ultraviolet	O
b	O
exposure	O
,	O
prematurity	B-T038
,	O
living	B-T082
in	I-T082
northern	I-T082
latitude	I-T082
##s	I-T082
,	O
malnutrition	B-T038
,	O
obesity	B-T038
,	O
exclusive	O
breastfeeding	O
,	O
low	B-T033
maternal	I-T033
vitamin	I-T033
d	I-T033
level	I-T033
,	O
certain	O
medications	B-T103
,	O
drinking	B-T038
unf	B-T168
##ort	I-T168
##ified	I-T168
cow	I-T168
'	I-T168
s	I-T168
milk	I-T168
,	O
liver	B-T038
failure	I-T038
,	O
chronic	B-T038
renal	I-T038
insufficiency	I-T038
,	O
cystic	B-T038
fibrosis	I-T038
,	O
asthma	B-T038
,	O
and	O
sickle	O
cell	O
hemoglobin	O
##opathy	O
.	O
this	O
review	B-T170
highlights	O
and	O
summarizes	O
the	O
molecular	O
perspectives	O
of	O
vitamin	B-T038
d	I-T038
deficiency	I-T038
and	O
its	O
potential	O
adverse	B-T038
health	O
outcomes	O
in	O
pediatric	O
age	O
groups	O
.	O
the	O
recommended	O
treatment	O
regimen	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
review	B-T170
.	O

activation	O
of	O
eph	O
##rin	O
##b	O
-	O
eph	O
##b	O
receptor	O
signalling	O
in	O
rat	B-T017
spinal	I-T017
cord	I-T017
contributes	O
to	O
maintenance	O
of	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
(	O
dnp	B-T033
)	O
is	O
severe	O
and	O
intractable	O
in	O
clinic	B-T092
.	O
the	O
specific	O
cellular	B-T038
and	O
molecular	B-T038
mechanisms	O
underlying	O
dnp	B-T033
remain	O
elusive	O
and	O
its	O
treatment	O
are	O
limited	O
.	O
we	O
investigated	O
roles	O
of	O
eph	B-T103
##b1	I-T103
receptor	I-T103
in	O
the	O
development	O
of	O
dnp	B-T033
.	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
was	O
produced	O
in	O
male	O
,	O
adult	O
,	O
sprague	B-T204
-	I-T204
dawley	I-T204
rats	I-T204
by	O
a	O
single	O
i	O
.	O
p	O
.	O
streptozotocin	B-T103
(	O
stz	B-T103
)	O
or	O
allo	B-T103
##xa	I-T103
##n	I-T103
.	O
western	B-T058
blot	I-T058
analysis	I-T058
and	O
immunohistochemistry	B-T058
were	O
used	O
to	O
analyse	O
expression	B-T038
of	O
eph	B-T103
##b1	I-T103
receptor	I-T103
as	O
well	O
as	O
the	O
activation	O
of	O
the	O
glial	B-T017
cells	I-T017
and	O
the	O
pro	B-T103
-	I-T103
inflammatory	I-T103
cytokines	I-T103
in	O
the	O
spinal	B-T017
cord	I-T017
.	O
dnp	B-T033
manifested	O
as	O
mechanical	B-T033
allodynia	I-T033
,	O
which	O
was	O
determined	O
by	O
measuring	O
incidence	O
of	O
foot	B-T017
withdrawal	O
in	O
response	O
to	O
mechanical	B-T082
ind	I-T082
##entation	I-T082
of	O
the	O
hind	B-T082
paw	B-T017
by	O
an	O
electro	O
von	O
fre	O
##y	O
filament	O
.	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
and	O
high	B-T033
blood	I-T033
glucose	I-T033
were	O
exhibited	O
simultaneously	O
in	O
around	O
70	O
%	O
of	O
animals	B-T204
that	O
received	O
i	O
.	O
p	O
.	O
stz	B-T103
or	O
allo	B-T103
##xa	I-T103
##n	I-T103
.	O
phosphorylation	B-T038
of	O
eph	B-T103
##b1	I-T103
,	O
activation	O
of	O
the	O
astrocytes	B-T017
and	O
microglial	B-T017
cells	I-T017
,	O
and	O
level	O
of	O
tumour	B-T103
necrosis	I-T103
factor	I-T103
(	B-T103
tnf	I-T103
)	I-T103
-	I-T103
α	I-T103
and	O
interleukin	B-T103
(	I-T103
il	I-T103
)	I-T103
-	I-T103
1β	I-T103
in	O
the	O
spinal	B-T017
cord	I-T017
were	O
significantly	O
increased	O
in	O
rats	B-T204
with	O
dnp	B-T033
.	O
spinal	B-T082
blocking	O
eph	B-T103
##b1	I-T103
receptor	I-T103
activation	O
in	O
the	O
late	O
phase	O
after	O
stz	B-T103
injection	B-T058
significantly	O
suppressed	O
the	O
established	O
mechanical	B-T033
allodynia	I-T033
as	O
well	O
as	O
activation	O
of	O
the	O
astrocytes	B-T017
and	O
microglial	B-T017
cells	I-T017
and	O
activity	O
of	O
tnf	B-T103
-	I-T103
α	I-T103
and	O
il	B-T103
-	I-T103
1β	I-T103
.	O
however	O
,	O
spinal	B-T082
treatment	O
of	O
eph	B-T103
##b1	I-T103
-	O
fc	B-T103
in	O
the	O
early	O
phase	O
after	O
stz	B-T103
injection	B-T058
did	O
not	O
prevent	O
the	O
induction	O
of	O
dnp	B-T033
.	O
eph	B-T103
##b1	I-T103
receptor	I-T103
activation	O
in	O
the	O
spinal	B-T017
cord	I-T017
is	O
critical	O
to	O
the	O
maintenance	O
,	O
but	O
not	O
induction	O
of	O
diabetic	B-T033
pain	B-T033
.	O
eph	B-T103
##b1	I-T103
receptor	I-T103
may	O
be	O
a	O
potential	O
target	O
for	O
relieving	B-T058
the	O
established	O
diabetic	B-T033
pain	B-T033
.	O
activation	O
of	O
eph	B-T103
##b1	I-T103
receptor	I-T103
in	O
the	O
spinal	B-T017
cord	I-T017
is	O
critical	O
to	O
maintaining	O
the	O
established	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
,	O
but	O
not	O
to	O
diabetic	B-T033
pain	B-T033
induction	O
.	O
spinal	B-T082
blocking	O
eph	B-T103
##b1	I-T103
receptor	I-T103
activation	O
suppresses	O
ongoing	O
diabetic	B-T033
neuropathic	B-T033
pain	I-T033
.	O

prevalence	O
of	O
psychiatric	O
disorders	O
among	O
female	O
juvenile	B-T098
offenders	I-T098
in	B-T098
##mates	I-T098
of	O
juvenile	B-T092
developmental	I-T092
centers	I-T092
are	O
the	O
special	O
group	B-T098
of	O
youth	O
population	B-T098
who	O
are	O
in	O
conflict	O
with	O
law	B-T170
.	O
they	O
are	O
vulnerable	O
to	O
psychiatric	O
illness	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
see	O
the	O
prevalence	O
and	O
type	O
of	O
psychiatric	O
disorders	O
in	O
institutional	B-T033
##ized	I-T033
female	O
juvenile	B-T098
offenders	I-T098
and	O
non	B-T098
-	I-T098
offenders	I-T098
of	O
same	O
age	O
,	O
sex	O
and	O
socioeconomic	O
group	O
in	O
the	O
community	O
.	O
the	O
association	B-T038
of	O
mental	B-T038
disorders	I-T038
was	O
examined	B-T033
in	O
43	O
female	O
in	B-T098
##mates	I-T098
of	O
juvenile	B-T092
development	I-T092
centers	I-T092
and	O
43	O
randomly	O
selected	O
comparison	O
subjects	O
in	O
community	O
.	O
one	O
stage	O
-	O
structured	O
assessment	O
of	O
psychopathology	B-T091
was	O
carried	O
out	O
by	O
using	O
a	O
structured	O
and	O
valid	O
bangl	O
##a	O
version	B-T170
of	O
the	O
development	O
and	O
well	O
-	O
being	O
assessment	O
(	O
daw	O
##ba	O
)	O
.	O
development	O
and	O
well	O
-	O
being	O
assessment	O
generated	O
psychiatric	O
diagnosis	B-T033
was	O
assigned	O
based	O
on	O
icd	B-T170
-	I-T170
10	I-T170
diagnostic	B-T170
criteria	I-T170
for	O
research	B-T062
.	O
the	O
result	O
revealed	O
that	O
,	O
of	O
those	O
who	O
were	O
in	O
conflict	O
with	O
law	B-T170
,	O
93	O
%	O
had	O
mental	B-T038
disorder	I-T038
,	O
whereas	O
14	O
%	O
of	O
non	B-T098
-	I-T098
offenders	I-T098
had	O
psychiatric	O
disorder	O
.	O
among	O
the	O
offenders	B-T098
with	O
psychiatric	O
disorders	O
,	O
most	O
of	O
them	O
(	O
32	O
.	O
6	O
%	O
)	O
suffered	O
from	O
major	B-T038
depressive	I-T038
disorder	I-T038
(	O
mdd	B-T038
)	O
,	O
followed	O
by	O
combined	O
mdd	B-T038
&	O
post	B-T038
traumatic	I-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
.	O
on	O
the	O
other	O
hand	O
,	O
among	O
the	O
non	B-T098
-	I-T098
offenders	I-T098
with	O
psychiatric	O
disorder	O
9	O
.	O
3	O
%	O
suffered	O
from	O
mdd	B-T038
.	O
it	O
can	O
be	O
concluded	O
that	O
considerable	O
psychiatric	O
disorders	O
are	O
prevalent	O
among	O
the	O
female	O
juvenile	B-T098
offenders	I-T098
with	O
comparison	O
to	O
non	B-T098
-	I-T098
offenders	I-T098
.	O
broad	B-T082
-	O
based	O
replication	O
study	O
could	O
confirm	O
these	O
findings	B-T033
.	O

engineering	B-T062
and	O
in	B-T082
vivo	I-T082
applications	O
of	O
rib	B-T103
##os	I-T103
##wi	I-T103
##tc	I-T103
##he	I-T103
##s	I-T103
rib	B-T103
##os	I-T103
##wi	I-T103
##tc	I-T103
##he	I-T103
##s	I-T103
are	O
common	O
gene	B-T017
regulatory	I-T017
units	I-T017
mostly	O
found	O
in	O
bacteria	B-T007
that	O
are	O
capable	O
of	O
altering	O
gene	B-T038
expression	I-T038
in	O
response	O
to	O
a	O
small	B-T103
molecule	I-T103
.	O
these	O
structured	B-T103
rna	I-T103
elements	I-T103
consist	O
of	O
two	O
modular	O
subunits	O
:	O
an	O
aptamer	B-T103
domain	I-T103
that	O
binds	B-T038
with	O
high	O
specificity	O
and	O
affinity	O
to	O
a	O
target	O
ligand	B-T103
and	O
an	O
expression	B-T038
platform	O
that	O
transduc	B-T038
##es	I-T038
ligand	B-T038
binding	I-T038
to	O
a	O
gene	B-T038
expression	I-T038
output	O
.	O
significant	O
progress	O
has	O
been	O
made	O
in	O
engineering	B-T062
novel	O
aptamer	B-T103
domains	I-T103
for	O
new	O
small	B-T103
molecule	I-T103
inducers	O
of	O
gene	B-T038
expression	I-T038
.	O
modified	O
expression	B-T038
platforms	O
have	O
also	O
been	O
optimized	O
to	O
function	O
when	O
fused	O
with	O
both	O
natural	O
and	O
synthetic	O
aptamer	B-T103
domains	I-T103
.	O
as	O
this	O
field	O
expands	O
,	O
the	O
use	O
of	O
these	O
privile	O
##ged	O
scaffolds	O
has	O
permitted	O
the	O
development	O
of	O
tools	O
such	O
as	O
rna	B-T103
-	O
based	O
fluorescent	O
biosensors	O
.	O
in	O
this	O
review	B-T170
,	O
we	O
summarize	B-T170
the	O
methods	B-T170
that	O
have	O
been	O
developed	O
to	O
engine	O
##er	O
new	O
rib	B-T103
##os	I-T103
##wi	I-T103
##tc	I-T103
##he	I-T103
##s	I-T103
and	O
highlight	O
applications	O
of	O
natural	O
and	O
synthetic	O
rib	B-T103
##os	I-T103
##wi	I-T103
##tc	I-T103
##he	I-T103
##s	I-T103
in	O
enzyme	B-T058
and	O
strain	B-T091
engineering	I-T091
,	O
in	O
controlling	O
gene	B-T038
expression	I-T038
and	O
cellular	B-T038
physiology	I-T038
,	O
and	O
in	O
real	B-T058
-	I-T058
time	I-T058
imaging	I-T058
of	O
cellular	B-T103
metabolites	I-T103
and	O
signals	B-T038
.	O
expected	O
final	O
online	O
publication	O
date	O
for	O
the	O
annual	O
review	O
of	O
biochemistry	O
volume	O
86	O
is	O
june	O
20	O
,	O
2017	O
.	O
ple	O
##ase	O
see	O
http	O
:	O
/	O
/	O
www	O
.	O
annual	O
##re	O
##view	O
##s	O
.	O
org	O
/	O
page	O
/	O
journal	O
/	O
pub	O
##da	O
##tes	O
for	O
revised	O
estimates	O
.	O

natural	B-T058
orifice	I-T058
transluminal	I-T058
endoscopic	I-T058
surgery	I-T058
with	O
a	O
snake	O
-	O
mechanism	O
using	O
a	O
mov	B-T074
##able	I-T074
pull	I-T074
##ey	I-T074
natural	B-T058
orifice	I-T058
transluminal	I-T058
endoscopic	I-T058
surgery	I-T058
is	O
an	O
emerging	O
technique	O
.	O
we	O
aimed	O
to	O
develop	O
an	O
advanced	O
surgical	O
robot	O
mechanism	O
for	O
natural	B-T058
orifice	I-T058
surgery	I-T058
.	O
we	O
propose	O
the	O
active	O
-	O
controlled	O
overt	O
##ub	O
##e	O
-	O
type	O
platform	O
with	O
multiple	O
channels	B-T082
for	O
an	O
endoscopic	B-T074
camera	I-T074
and	O
surgical	B-T058
tools	O
.	O
to	O
make	O
such	O
a	O
platform	O
,	O
we	O
suggest	O
an	O
advanced	O
snake	O
mechanism	O
comprising	O
mov	B-T074
##able	I-T074
pull	I-T074
##ey	I-T074
##s	I-T074
to	O
make	O
a	O
snake	O
mechanism	O
with	O
multiple	O
degrees	O
of	O
freedom	O
and	O
high	O
operating	O
force	O
.	O
the	O
stiffness	O
and	O
maneuver	O
##ability	O
of	O
the	O
active	O
-	O
controlled	O
platform	O
appeared	O
satisfactory	O
.	O
using	O
prototype	B-T170
##s	I-T170
and	O
ex	O
vivo	O
experiments	B-T062
,	O
we	O
confirmed	O
that	O
the	O
mechanism	O
was	O
suitable	O
for	O
a	O
snake	O
-	O
like	O
robotic	O
platform	O
for	O
natural	B-T058
orifice	I-T058
surgery	I-T058
.	O
the	O
suggested	O
snake	O
mechanism	O
using	O
mov	B-T074
##able	I-T074
pull	I-T074
##ey	I-T074
##s	I-T074
has	O
the	O
advantages	O
of	O
stiffness	O
and	O
maneuver	O
##ability	O
.	O
this	O
new	O
mechanism	O
can	O
be	O
an	O
alternative	O
platform	O
for	O
natural	B-T058
orifice	I-T058
surgery	I-T058
.	O

medication	O
intervention	O
for	O
chronic	B-T038
kidney	I-T038
disease	I-T038
patients	O
transition	O
##ing	O
from	O
hospital	B-T092
to	O
home	B-T082
:	O
study	B-T062
design	I-T062
and	O
baseline	O
characteristics	O
the	O
hospital	B-T058
readmission	I-T058
rate	O
in	O
the	O
population	B-T098
with	O
chronic	B-T038
kidney	I-T038
disease	I-T038
(	O
ckd	B-T038
)	O
is	O
high	O
and	O
strategies	O
to	O
reduce	O
this	O
risk	O
are	O
urgently	O
needed	O
.	O
the	O
ckd	B-T038
-	O
medication	O
intervention	O
trial	O
(	O
ckd	B-T038
-	O
mit	O
;	O
www	B-T170
.	I-T170
clinicaltrials	I-T170
.	I-T170
gov	I-T170
;	I-T170
nct	I-T170
##o1	I-T170
##45	I-T170
##97	I-T170
##70	I-T170
)	O
is	O
a	O
single	B-T062
-	I-T062
blind	I-T062
(	O
investigators	B-T097
)	O
,	O
randomized	B-T062
,	O
clinical	B-T062
trial	I-T062
conducted	O
at	O
provide	B-T058
##nc	I-T058
##e	I-T058
health	I-T058
care	I-T058
in	O
spo	B-T082
##ka	I-T082
##ne	I-T082
,	I-T082
washington	I-T082
.	O
study	O
participants	O
are	O
hospitalized	O
patients	O
with	O
ckd	B-T038
stages	O
3	O
-	O
5	O
(	O
not	O
treated	B-T058
with	I-T058
kidney	B-T058
replacement	I-T058
therapy	I-T058
)	O
and	O
acute	O
illness	O
.	O
the	O
study	B-T170
intervention	I-T170
is	O
a	O
pharmacist	B-T097
-	I-T097
led	I-T097
,	O
home	B-T058
-	I-T058
based	I-T058
,	O
medication	B-T058
management	I-T058
intervention	B-T058
delivered	O
within	O
7	O
days	O
after	O
hospital	B-T058
discharge	I-T058
.	O
the	O
primary	O
outcome	O
is	O
a	O
composite	O
of	O
hospital	B-T058
readmissions	I-T058
and	O
visits	O
to	O
emergency	B-T092
departments	I-T092
and	O
urgent	B-T092
care	I-T092
centers	I-T092
for	O
90	O
days	O
following	O
hospital	B-T058
discharge	I-T058
.	O
secondary	O
outcomes	O
are	O
achievements	O
of	O
guideline	B-T170
-	I-T170
based	I-T170
targets	O
for	O
ckd	B-T038
risk	B-T033
factors	I-T033
and	O
complications	B-T038
.	O
enrollment	B-T058
began	O
in	O
february	O
2012	O
and	O
ended	O
in	O
may	O
2015	O
.	O
at	O
baseline	O
,	O
the	O
age	O
of	O
participants	B-T098
was	O
69	O
±	O
11	O
years	O
(	O
mean	O
±	O
sd	O
)	O
,	O
50	O
%	O
(	O
77	O
of	O
155	O
)	O
were	O
women	B-T098
,	O
83	O
%	O
(	O
117	O
of	O
141	O
)	O
had	O
hypertension	B-T038
and	O
56	O
%	O
(	O
79	O
of	O
141	O
)	O
had	O
diabetes	B-T038
.	O
at	O
baseline	O
,	O
the	O
estimated	B-T058
glomerular	I-T058
filtration	I-T058
rate	O
was	O
41	O
±	O
14	O
ml	O
/	O
min	O
/	O
1	O
.	O
73	O
m2	O
and	O
urine	B-T058
albumin	I-T058
-	I-T058
to	I-T058
-	I-T058
creatinine	I-T058
ratio	I-T058
was	O
43	O
mg	O
/	O
g	O
(	O
interquartile	O
range	O
8	O
-	O
52	O
##8	O
mg	O
/	O
g	O
)	O
.	O
the	O
most	O
frequent	O
diagnosis	O
category	O
for	O
the	O
index	O
hospital	B-T058
admission	I-T058
was	O
cardiovascular	B-T038
diseases	I-T038
at	O
34	O
%	O
(	O
53	O
of	O
155	O
)	O
,	O
but	O
the	O
most	O
common	O
single	B-T033
diagnosis	I-T033
for	O
admission	B-T058
was	O
community	O
-	O
acquired	O
acute	B-T038
kidney	I-T038
injury	I-T038
at	O
10	O
%	O
(	O
16	O
of	O
155	O
)	O
.	O
participants	B-T098
in	O
ckd	B-T038
-	O
mit	O
are	O
typical	O
of	O
acutely	O
ill	O
hospitalized	O
patients	O
with	O
ckd	B-T038
.	O
a	O
medication	B-T058
management	I-T058
intervention	B-T058
after	O
hospital	B-T058
discharge	I-T058
is	O
under	O
study	B-T062
to	O
reduce	O
post	O
-	O
hospitalization	B-T058
acute	B-T058
care	I-T058
utilization	O
and	O
to	O
improve	O
ckd	B-T038
management	B-T058
.	O

survey	B-T170
of	O
trich	B-T038
##ine	I-T038
##ll	I-T038
##a	I-T038
infection	I-T038
from	O
domestic	B-T204
pigs	I-T204
in	O
the	O
historical	B-T033
endemic	B-T082
areas	I-T082
of	O
hen	B-T082
##an	I-T082
province	I-T082
,	O
central	B-T082
china	I-T082
the	O
aim	O
of	O
this	O
work	O
was	O
to	O
investigate	O
the	O
current	B-T033
situation	I-T033
of	O
trich	B-T038
##ine	I-T038
##ll	I-T038
##a	I-T038
infection	I-T038
from	O
domestic	B-T204
pigs	I-T204
in	O
the	O
historical	B-T033
endemic	B-T082
areas	I-T082
of	O
hen	B-T082
##an	I-T082
province	I-T082
,	O
central	B-T082
china	I-T082
.	O
a	O
total	O
of	O
82	O
##3	O
diaphragm	O
samples	O
from	O
the	O
indoor	B-T204
-	I-T204
raised	I-T204
pigs	I-T204
were	O
collected	O
in	O
five	O
cities	B-T082
of	O
hen	B-T082
##an	I-T082
during	O
2014	O
-	O
2015	O
and	O
examined	B-T033
by	O
artificial	O
digestion	O
method	O
.	O
the	O
overall	O
prevalence	O
of	O
trich	B-T038
##ine	I-T038
##ll	I-T038
##a	I-T038
infection	I-T038
in	O
pigs	B-T204
was	O
0	O
.	O
61	O
%	O
(	O
5	O
/	O
82	O
##3	O
)	O
.	O
trich	B-T204
##ine	I-T204
##ll	I-T204
##a	I-T204
larvae	I-T204
were	O
detected	B-T033
in	O
0	O
.	O
91	O
%	O
(	O
5	O
/	O
550	O
)	O
of	O
pigs	B-T204
from	O
nan	B-T082
##yan	I-T082
##g	I-T082
city	I-T082
of	O
hen	B-T082
##an	I-T082
.	O
the	O
larval	B-T204
burden	O
in	O
infected	O
animals	O
was	O
0	O
.	O
03	O
larvae	B-T204
per	O
gram	O
(	O
lp	O
##g	O
)	O
of	O
muscles	B-T017
with	O
a	O
range	O
from	O
0	O
.	O
02	O
to	O
0	O
.	O
05	O
lp	O
##g	O
.	O
the	O
larvae	B-T204
were	O
identified	O
as	O
trich	B-T204
##ine	I-T204
##ll	I-T204
##a	I-T204
spiral	I-T204
##is	I-T204
by	O
multiple	B-T062
pcr	I-T062
.	O
our	O
study	B-T062
confirms	O
the	O
existence	O
of	O
swine	B-T204
trich	B-T038
##ine	I-T038
##ll	I-T038
##osis	I-T038
in	O
hen	B-T082
##an	I-T082
,	O
but	O
the	O
infection	B-T038
level	O
was	O
under	O
the	O
minimum	O
level	O
for	O
defining	O
infectious	O
sources	O
for	O
humans	B-T204
.	O
however	O
,	O
the	O
prevalence	O
of	O
swine	B-T204
trich	B-T038
##ine	I-T038
##ll	I-T038
##a	I-T038
infection	I-T038
in	O
hen	B-T082
##an	I-T082
need	O
to	O
be	O
further	O
evaluated	B-T058
with	O
a	O
large	O
scale	O
of	O
pork	O
samples	O
for	O
ensuring	O
meat	B-T168
food	O
safety	O
.	O

using	O
a	O
graphical	O
risk	O
tool	O
to	O
examine	O
willingness	B-T033
to	I-T033
take	I-T033
migraine	B-T038
prophylactic	B-T058
medications	B-T103
many	O
migraine	B-T038
suffer	O
##ers	O
use	O
daily	O
prophylactic	B-T058
therapy	I-T058
to	O
reduce	O
the	O
frequency	O
of	O
their	O
headache	B-T033
attacks	O
.	O
the	O
food	B-T092
and	I-T092
drug	I-T092
administration	I-T092
has	O
approved	O
several	O
different	O
medications	B-T103
for	O
migraine	B-T038
prophylaxis	B-T058
,	O
but	O
it	O
is	O
not	O
clear	O
whether	O
suffer	O
##ers	O
perceive	O
these	O
treatments	B-T058
to	O
provide	O
clinically	O
significant	O
benefits	O
given	O
their	O
side	B-T038
effect	I-T038
profiles	B-T058
.	O
three	O
hundred	O
headache	B-T033
suffer	O
##ers	O
were	O
recruited	O
from	O
the	O
community	O
and	O
local	B-T082
headache	B-T033
clinics	B-T092
using	O
print	O
and	O
television	O
advertising	O
.	O
participants	B-T098
reported	O
experiencing	O
problematic	O
headache	B-T033
attacks	O
with	O
a	O
median	O
(	O
iqr	O
)	O
frequency	O
of	O
7	O
.	O
0	O
(	O
4	O
-	O
13	O
)	O
headache	B-T033
days	O
per	O
month	O
.	O
these	O
suffer	O
##ers	O
participated	O
in	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
,	I-T062
single	I-T062
-	I-T062
site	I-T062
,	I-T062
study	I-T062
that	O
used	O
a	O
specially	O
designed	O
computer	O
assessment	O
task	O
.	O
participants	B-T098
were	O
instructed	O
on	O
the	O
probability	O
of	O
experiencing	O
the	O
3	O
most	O
commonly	O
experienced	O
side	B-T038
effects	I-T038
for	O
several	O
blinded	B-T062
medication	B-T103
profiles	B-T058
:	O
div	B-T103
##alp	I-T103
##ro	I-T103
##ex	I-T103
sodium	I-T103
,	O
ven	B-T103
##laf	I-T103
##axine	I-T103
,	O
gabapentin	B-T103
,	O
propranolol	B-T103
,	O
and	O
top	B-T103
##ira	I-T103
##ma	I-T103
##te	I-T103
.	O
after	O
learning	O
the	O
likelihood	O
of	O
experiencing	O
side	B-T038
effect	I-T038
profiles	B-T058
of	O
each	O
medication	B-T103
,	O
participants	B-T098
were	O
asked	O
whether	O
they	O
would	O
be	O
willing	B-T033
to	I-T033
take	I-T033
the	O
medication	B-T103
for	O
a	O
given	O
headache	B-T033
reduction	O
level	O
,	O
which	O
ranged	O
from	O
0	O
to	O
7	O
days	O
per	O
month	O
.	O
the	O
side	B-T038
effect	I-T038
profile	B-T058
for	O
div	B-T103
##alp	I-T103
##ro	I-T103
##ex	I-T103
sodium	I-T103
was	O
associated	O
with	O
the	O
smallest	B-T033
willingness	I-T033
to	I-T033
take	I-T033
,	O
with	O
gabapentin	B-T103
,	O
propranolol	B-T103
,	O
and	O
top	B-T103
##ira	I-T103
##ma	I-T103
##te	I-T103
perceived	O
to	O
be	O
much	O
more	O
agree	O
##able	O
.	O
however	O
,	O
<	O
60	O
%	O
of	O
participants	B-T098
reported	O
willingness	B-T033
to	I-T033
take	I-T033
any	O
of	O
these	O
medications	B-T103
even	O
if	O
they	O
provided	O
a	O
50	O
%	O
reduction	O
in	O
headache	B-T033
frequency	O
.	O
several	O
general	O
predictors	O
of	O
willingness	B-T033
to	I-T033
take	I-T033
were	O
observed	O
including	O
high	O
headache	B-T033
-	O
related	O
disability	B-T033
,	O
depressive	B-T033
symptoms	I-T033
,	O
and	O
pain	B-T103
medication	I-T103
concerns	O
including	O
fear	B-T038
of	O
tolerance	B-T038
.	O
these	O
findings	B-T033
suggest	O
that	O
if	O
properly	O
informed	O
of	O
the	O
side	B-T038
effect	I-T038
profiles	B-T058
of	O
these	O
medications	B-T103
,	O
many	O
patients	O
might	O
opt	O
for	O
other	O
treatments	B-T058
.	O

efficacy	O
and	O
safety	O
of	O
cisplatin	B-T103
,	O
dexamethasone	B-T103
,	O
gemcitabine	B-T103
and	O
peg	B-T103
##asp	I-T103
##arg	I-T103
##ase	I-T103
(	O
dd	B-T103
##gp	I-T103
)	O
regimen	B-T058
in	O
newly	O
diagnosed	O
,	O
advanced	O
-	O
stage	O
extran	B-T038
##odal	I-T038
natural	I-T038
killer	I-T038
/	I-T038
t	I-T038
-	I-T038
cell	I-T038
lymphoma	I-T038
:	O
interim	O
analysis	B-T062
of	O
a	O
phase	O
4	O
study	B-T062
nct0	O
##15	O
##01	O
##14	O
##9	O
to	O
explore	O
a	O
more	O
effective	O
treatment	O
for	O
newly	O
diagnosed	O
,	O
advanced	O
-	O
stage	O
extran	B-T038
##odal	I-T038
natural	I-T038
killer	I-T038
/	I-T038
t	I-T038
-	I-T038
cell	I-T038
lymphoma	I-T038
,	I-T038
nasal	I-T038
type	I-T038
(	O
enk	B-T038
##tl	I-T038
)	O
,	O
we	O
conducted	O
a	O
phase	O
4	O
study	B-T062
of	O
the	O
cisplatin	B-T103
,	O
dexamethasone	B-T103
,	O
gemcitabine	B-T103
,	O
peg	B-T103
##asp	I-T103
##arg	I-T103
##ase	I-T103
(	O
dd	B-T103
##gp	I-T103
)	O
regimen	B-T058
.	O
the	O
primary	O
end	O
point	O
was	O
the	O
2	O
-	O
year	O
progression	O
-	O
free	O
survival	O
(	O
pfs	O
)	O
after	O
the	O
protocol	B-T058
treatment	I-T058
.	O
secondary	O
endpoints	O
included	O
response	O
rate	O
(	O
rr	O
)	O
,	O
overall	O
survival	O
(	O
os	O
)	O
and	O
median	O
survival	O
time	O
(	O
mst	O
)	O
.	O
the	O
interim	O
analysis	B-T062
included	O
data	O
only	O
from	O
march	O
2011	O
to	O
september	O
2013	O
,	O
who	O
received	O
six	O
cycles	O
of	O
dd	B-T103
##gp	I-T103
chemotherapy	B-T058
.	O
a	O
total	O
of	O
25	O
eligible	O
patients	O
were	O
enrolled	O
.	O
seventeen	O
patients	O
(	O
17	O
/	O
24	O
,	O
70	O
.	O
83	O
%	O
)	O
achieved	O
complete	B-T033
response	I-T033
(	O
cr	B-T033
)	O
and	O
four	O
(	O
4	O
/	O
24	O
,	O
16	O
.	O
67	O
%	O
)	O
achieved	O
partial	B-T033
response	I-T033
(	O
pr	B-T033
)	O
,	O
three	O
(	O
3	O
/	O
24	O
,	O
12	O
.	O
50	O
%	O
)	O
had	O
progressive	B-T038
disease	I-T038
(	O
pd	B-T038
)	O
.	O
the	O
rr	O
after	O
treatment	O
was	O
87	O
.	O
50	O
%	O
.	O
after	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
duration	O
of	O
24	O
.	O
67	O
months	O
(	O
range	O
4	O
-	O
48	O
months	O
)	O
.	O
the	O
2	O
-	O
year	O
pfs	O
and	O
os	O
rate	O
were	O
61	O
.	O
80	O
%	O
(	O
95	O
%	O
ci	O
,	O
42	O
.	O
00	O
%	O
to	O
81	O
.	O
60	O
%	O
)	O
and	O
68	O
.	O
50	O
%	O
(	O
95	O
%	O
ci	O
,	O
48	O
.	O
70	O
%	O
to	O
88	O
.	O
30	O
%	O
)	O
,	O
respectively	O
.	O
the	O
mst	O
was	O
36	O
.	O
55	O
months	O
(	O
95	O
%	O
ci	O
,	O
29	O
.	O
41	O
months	O
to	O
43	O
.	O
70	O
months	O
)	O
.	O
grade	B-T170
3	O
/	O
4	O
leukopenia	B-T038
occurred	O
in	O
fourteen	O
patients	O
(	O
58	O
.	O
33	O
%	O
)	O
and	O
grade	B-T170
3	O
/	O
4	O
thrombocytopenia	B-T038
occurred	O
in	O
eleven	O
patients	O
(	O
45	O
.	O
83	O
%	O
)	O
.	O
twelve	O
patients	O
(	O
50	O
.	O
00	O
%	O
)	O
experienced	O
activated	B-T058
partial	I-T058
phr	I-T058
##omb	I-T058
##oplast	I-T058
##in	I-T058
pt	I-T058
##ime	I-T058
(	O
aptt	B-T058
)	O
elongation	B-T033
and	O
fourteen	O
patients	O
(	O
58	O
.	O
33	O
%	O
)	O
experienced	O
hypo	B-T038
##fi	I-T038
##br	I-T038
##ino	I-T038
##gene	I-T038
##mia	I-T038
.	O
in	O
conclusion	O
,	O
dd	B-T103
##gp	I-T103
regimen	B-T058
is	O
an	O
effective	O
and	O
tolerated	B-T033
treatment	O
for	O
newly	O
diagnosed	O
,	O
advanced	O
-	O
stage	O
enk	B-T038
##tl	I-T038
.	O
this	O
trial	B-T062
was	O
registered	B-T058
at	O
www	B-T170
.	I-T170
clinicaltrials	I-T170
.	I-T170
gov	I-T170
as	O
#	O
nct0	O
##15	O
##01	O
##14	O
##9	O
.	O

farnes	B-T103
##yl	I-T103
##thio	I-T103
##sa	I-T103
##lic	I-T103
##ylic	I-T103
acid	I-T103
-	O
loaded	O
lipid	B-T103
-	I-T103
polyethylene	I-T103
glycol	I-T103
-	I-T103
polymer	I-T103
hybrid	I-T103
nanoparticles	I-T103
for	O
treatment	B-T058
of	O
glioblastoma	B-T038
we	O
aimed	O
to	O
develop	O
lipid	B-T103
-	I-T103
polyethylene	I-T103
glycol	I-T103
(	I-T103
peg	I-T103
)	I-T103
-	I-T103
polymer	I-T103
hybrid	I-T103
nanoparticles	I-T103
,	O
which	O
have	O
high	O
affinity	O
to	O
tumour	B-T017
tissue	I-T017
with	O
active	B-T103
ingredient	I-T103
,	O
a	O
new	O
generation	O
antineoplastic	B-T103
drug	I-T103
,	O
farnes	B-T103
##yl	I-T103
##thio	I-T103
##sa	I-T103
##lic	I-T103
##ylic	I-T103
acid	I-T103
(	O
ft	B-T103
##a	I-T103
)	O
for	O
treatment	B-T058
of	O
glioblastoma	B-T038
.	O
farnes	B-T103
##yl	I-T103
##thio	I-T103
##sa	I-T103
##lic	I-T103
##ylic	I-T103
acid	I-T103
-	O
loaded	O
poly	B-T103
(	I-T103
lactic	I-T103
-	I-T103
co	I-T103
-	I-T103
glycol	I-T103
##ic	I-T103
acid	I-T103
)	I-T103
-	I-T103
1	I-T103
,	I-T103
2	I-T103
dist	I-T103
##ear	I-T103
##oyl	I-T103
-	I-T103
glycerol	I-T103
-	I-T103
3	I-T103
-	I-T103
phospho	I-T103
-	I-T103
ethanol	I-T103
##amine	I-T103
-	I-T103
n	I-T103
[	I-T103
methoxy	I-T103
(	I-T103
peg	I-T103
)	I-T103
-	I-T103
2000	I-T103
]	I-T103
ammonium	I-T103
salt	I-T103
(	O
plga	B-T103
-	I-T103
dsp	I-T103
##e	I-T103
-	I-T103
peg	I-T103
)	O
with	O
or	O
without	O
1	B-T103
,	I-T103
2	I-T103
-	I-T103
diol	I-T103
##e	I-T103
##oyl	I-T103
-	I-T103
3	I-T103
-	I-T103
trimethyl	I-T103
##ammonium	I-T103
-	I-T103
prop	I-T103
##ane	I-T103
(	I-T103
dot	I-T103
##ap	I-T103
)	I-T103
hybrid	I-T103
nanoparticles	I-T103
has	O
been	O
prepared	B-T033
and	O
evaluated	B-T058
for	O
in	O
-	O
vitro	O
characterization	O
.	O
cytotoxicity	B-T038
of	O
ft	B-T103
##a	I-T103
-	I-T103
loaded	I-T103
nanoparticles	I-T103
along	O
with	O
its	O
efficacy	O
on	O
rat	B-T017
glioma	I-T017
-	I-T017
2	I-T017
(	I-T017
rg	I-T017
##2	I-T017
)	I-T017
cells	I-T017
was	O
also	O
evaluated	B-T058
both	O
in	O
vitro	O
(	O
in	O
comparison	O
with	O
non	B-T017
-	I-T017
malignant	I-T017
cell	I-T017
line	I-T017
,	I-T017
l	I-T017
##92	I-T017
##9	I-T017
)	O
and	O
in	O
vivo	O
.	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
studies	I-T058
showed	O
that	O
all	O
formulations	O
prepared	O
had	O
smooth	B-T201
surface	I-T201
and	O
spherical	B-T082
in	I-T082
shape	I-T082
.	O
ft	B-T103
##a	I-T103
and	O
ft	B-T103
##a	I-T103
-	I-T103
loaded	I-T103
nanoparticles	I-T103
have	O
cytotoxic	B-T038
activity	I-T038
against	O
rg	B-T017
##2	I-T017
glioma	I-T017
cell	I-T017
lines	I-T017
in	O
cell	O
culture	O
studies	O
,	O
which	O
further	O
increases	O
with	O
addition	O
of	O
dot	B-T103
##ap	I-T103
.	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
and	O
histopathologic	B-T091
evaluation	B-T058
on	O
rg	B-T017
##2	I-T017
tumour	I-T017
cells	I-T017
in	O
rat	B-T038
glioma	I-T038
model	I-T038
(	O
49	O
female	O
wistar	B-T204
rats	I-T204
,	O
250	O
-	O
300	O
g	O
)	O
comparing	O
intravenous	O
and	O
intratumoral	O
injections	O
of	O
the	O
drug	B-T103
have	O
been	O
performed	O
and	O
ft	B-T103
##a	I-T103
-	I-T103
loaded	I-T103
nanoparticles	I-T103
reduced	O
tumour	B-T082
size	I-T082
significantly	O
in	O
in	O
-	O
vivo	O
studies	O
,	O
with	O
higher	O
efficiency	O
of	O
intratumoral	O
administration	O
than	O
intravenous	O
route	O
.	O
farnes	B-T103
##yl	I-T103
##thio	I-T103
##sa	I-T103
##lic	I-T103
##ylic	I-T103
acid	I-T103
-	O
loaded	O
plga	B-T103
-	I-T103
dsp	I-T103
##e	I-T103
-	I-T103
peg	I-T103
-	I-T103
dot	I-T103
##ap	I-T103
hybrid	I-T103
nanoparticles	I-T103
are	O
proven	O
to	O
be	O
effective	O
against	O
glioblastoma	B-T038
in	O
both	O
in	O
-	O
vitro	O
and	O
in	O
-	O
vivo	O
experiments	O
.	O

engaging	B-T033
adolescent	O
girls	O
in	O
trans	O
##action	O
##al	O
sex	O
through	O
compensated	O
dating	O
trans	O
##action	O
##al	O
sex	O
through	O
so	O
-	O
called	O
compensated	O
dating	O
in	O
adolescent	O
girls	O
is	O
a	O
problem	B-T033
in	O
need	O
of	O
public	B-T092
concern	O
.	O
compensated	O
dating	O
typically	O
involves	O
the	O
use	O
of	O
information	B-T170
communication	I-T170
technology	I-T170
to	O
advertis	O
##e	O
,	O
search	O
,	O
bar	O
##ga	O
##in	O
,	O
and	O
eventually	O
arr	O
##ange	O
for	O
trans	O
##action	O
##al	O
sex	O
.	O
the	O
technology	B-T170
enables	B-T038
the	O
sexual	B-T098
partners	I-T098
to	O
maintain	O
privacy	O
and	O
secre	O
##cy	O
in	O
trans	O
##action	O
##al	O
sex	O
.	O
such	O
secre	O
##cy	O
necessitates	O
the	O
girls	B-T098
'	O
disclosure	O
about	O
their	O
life	O
experiences	O
in	O
order	O
to	O
address	O
the	O
concern	O
.	O
the	O
disclosure	O
is	O
the	O
focus	O
of	O
the	O
present	O
qualitative	B-T062
study	I-T062
of	O
27	O
girls	B-T098
practicing	B-T038
the	O
dating	O
in	O
hong	B-T082
kong	I-T082
,	O
china	B-T082
.	O
based	O
on	O
the	O
disclosure	O
,	O
the	O
study	B-T062
presents	O
a	O
grounded	B-T170
theory	I-T170
that	O
epit	O
##om	O
##izes	O
engagement	B-T033
in	O
compensated	O
dating	O
by	O
refer	O
##ential	O
choice	O
.	O
such	O
a	O
refer	O
##ential	O
choice	O
theory	O
unravel	O
##s	O
that	O
choice	O
with	O
reference	O
to	O
the	O
family	O
push	O
and	O
social	O
norms	O
sustain	O
##s	O
the	O
engagement	B-T033
.	O
meanwhile	O
,	O
the	O
choice	O
rest	O
##s	O
on	O
expectancy	O
and	O
reinforcement	O
from	O
experi	O
##ential	O
learning	O
about	O
compensated	O
dating	O
.	O
the	O
theory	O
thus	O
implies	O
ways	O
to	O
under	O
##cu	O
##t	O
the	O
engagement	B-T033
through	O
diver	O
##ting	O
the	O
refer	O
##ential	O
choice	O
of	O
the	O
dating	O
.	O

multid	B-T058
##etector	I-T058
ct	I-T058
of	O
expected	B-T170
findings	B-T033
and	O
complications	B-T038
after	O
contemporary	O
inguinal	B-T058
hernia	I-T058
repair	I-T058
surgery	B-T058
inguinal	B-T058
hernia	I-T058
repair	I-T058
(	O
ih	B-T058
##r	I-T058
)	O
with	O
prosthetic	B-T074
mesh	B-T074
implantation	B-T058
is	O
the	O
most	O
common	O
procedure	B-T058
in	O
general	B-T058
surgery	I-T058
,	O
and	O
may	O
be	O
performed	O
using	O
either	O
an	O
open	B-T082
or	O
laparoscopic	B-T082
approach	I-T082
.	O
this	O
paper	O
provides	O
an	O
overview	O
of	O
contemporary	O
tension	O
-	O
free	O
ih	B-T058
##r	I-T058
techniques	O
and	O
materials	O
,	O
and	O
illustrates	O
the	O
expected	B-T170
postoperative	B-T033
imaging	B-T033
findings	I-T033
and	O
iatrogenic	B-T037
injuries	I-T037
.	O
emphasis	O
is	O
placed	O
on	O
multid	B-T058
##etector	I-T058
ct	I-T058
,	O
which	O
represents	O
the	O
ideal	O
modality	O
to	O
comprehensively	O
visualize	O
the	O
operated	O
groin	B-T082
region	I-T082
and	O
deeper	B-T082
intra	B-T017
-	I-T017
abdominal	I-T017
structures	I-T017
.	O
ct	B-T058
consistently	O
depic	O
##ts	O
sero	B-T038
##ma	I-T038
,	O
mesh	B-T038
infections	I-T038
,	O
hemorrhages	B-T038
,	O
bowel	B-T017
complications	B-T038
and	O
urinary	B-T017
bladder	I-T017
injuries	B-T037
,	O
and	O
thus	O
generally	O
provides	O
a	O
consistent	O
basis	O
for	O
therapeutic	O
choice	O
.	O
since	O
radiologists	B-T097
are	O
increasingly	O
requested	O
to	O
investigate	O
suspected	O
iatrogenic	O
complications	B-T038
,	O
this	O
paper	O
aims	O
to	O
provide	O
an	O
increased	O
familiarity	B-T038
with	O
early	O
ct	B-T058
studies	B-T058
after	O
ih	B-T058
##r	I-T058
,	O
including	O
complications	B-T038
and	O
normal	O
postoperative	B-T033
appearances	O
such	O
as	O
focal	B-T082
pseudo	B-T038
##les	I-T038
##ions	I-T038
,	O
in	O
order	O
to	O
avoid	O
misinterpre	O
##tation	O
and	O
inappropriate	O
management	B-T058
.	O

new	O
directions	O
for	O
psychiatric	B-T058
rehabilitation	I-T058
in	O
the	O
usa	B-T082
american	B-T098
researchers	B-T097
have	O
led	O
the	O
world	B-T098
in	O
developing	O
,	O
evaluating	B-T058
,	O
and	O
dissem	B-T082
##inating	I-T082
evidence	O
-	O
based	O
psychiatric	B-T058
rehabilitation	I-T058
practices	O
for	O
people	B-T098
with	O
serious	O
mental	B-T038
illness	I-T038
.	O
paradoxically	O
,	O
however	O
,	O
the	O
usa	B-T082
lag	O
##s	O
behind	O
most	O
industrialized	O
nations	O
in	O
providing	O
access	O
to	O
high	B-T058
-	I-T058
quality	I-T058
mental	B-T058
health	I-T058
and	O
psychiatric	B-T058
services	I-T058
.	O
this	O
essay	B-T170
examines	O
several	O
evidence	O
-	O
based	O
practices	O
developed	O
in	O
the	O
usa	B-T082
,	O
the	O
spread	O
of	O
these	O
practices	B-T058
,	O
the	O
barriers	O
to	O
ensuring	O
availability	O
to	O
people	B-T098
who	O
could	O
benefit	O
from	O
these	O
services	B-T058
,	O
and	O
some	O
promising	O
directions	O
for	O
overcoming	O
the	O
barriers	O
.	O
factors	O
influencing	O
the	O
growth	O
and	O
sustain	O
##ment	O
of	O
effective	O
client	O
-	O
centred	O
practices	B-T058
include	O
the	O
availability	O
of	O
adequate	O
and	O
stable	O
funding	O
,	O
committed	O
leadership	O
,	O
and	O
the	O
influence	O
of	O
ves	O
##ted	O
interests	O
.	O
two	O
strategies	O
for	O
promoting	O
the	O
spread	O
and	O
sustain	O
##ment	O
of	O
well	O
-	O
implemented	O
evidence	O
-	O
based	O
practices	O
are	O
the	O
adoption	O
of	O
fidelity	O
scales	O
and	O
learning	B-T038
communities	O
.	O

talk	O
##ing	O
or	O
keeping	O
silent	O
about	O
parental	O
mental	B-T033
health	I-T033
problems	I-T033
-	O
a	O
grounded	B-T170
theory	I-T170
of	O
parents	O
'	O
decision	B-T038
making	I-T038
and	O
experiences	B-T038
with	O
their	O
children	O
this	O
grounded	B-T170
theory	I-T170
study	B-T062
explored	O
parents	O
'	O
experiences	B-T038
of	O
responding	O
to	O
their	O
children	O
'	O
s	O
need	O
for	O
understanding	O
parental	O
mental	B-T038
health	I-T038
concerns	O
.	O
fifteen	O
parents	O
with	O
severe	O
and	O
end	O
##uring	O
mental	B-T033
health	I-T033
difficulties	I-T033
participated	O
in	O
the	O
study	B-T062
.	O
the	O
findings	B-T033
suggest	O
four	O
main	O
social	O
processes	O
that	O
influence	O
parents	O
'	O
talk	O
with	O
their	O
children	O
about	O
parental	O
mental	B-T033
health	I-T033
issues	I-T033
,	O
namely	O
[UNK]	O
protecting	B-T038
and	O
being	B-T038
protected	I-T038
,	O
[UNK]	O
[UNK]	O
responding	O
to	O
children	O
'	O
s	O
search	O
for	O
understanding	B-T038
,	O
[UNK]	O
[UNK]	O
priori	O
##tizing	O
family	O
life	O
,	O
[UNK]	O
and	O
[UNK]	O
relating	O
to	O
others	O
.	O
[UNK]	O
implications	O
of	O
the	O
findings	B-T033
for	O
clinical	O
practice	O
and	O
future	O
research	B-T062
are	O
considered	O
.	O
in	O
particular	O
,	O
the	O
need	O
for	O
more	O
family	O
-	O
orient	O
##ated	O
services	O
where	O
parents	O
experience	B-T038
parental	O
mental	B-T033
health	I-T033
problems	I-T033
is	O
highlighted	O
.	O

impaired	B-T033
mobility	I-T033
,	O
depressed	B-T033
mood	I-T033
,	O
cognitive	B-T038
impairment	I-T038
and	O
polypharm	B-T033
##acy	I-T033
are	O
independently	O
associated	O
with	O
disability	B-T033
in	O
older	O
cancer	B-T038
outpatients	O
:	O
the	O
prospective	O
physical	B-T033
frailty	I-T033
in	O
elderly	B-T098
cancer	O
patients	O
(	O
pf	B-T033
-	O
ec	O
)	O
cohort	O
study	O
to	O
assess	O
the	O
prevalence	O
of	O
disability	B-T033
and	O
the	O
oncologic	O
factors	O
associated	O
with	O
disability	B-T033
in	O
older	O
outpatients	O
with	O
cancer	B-T038
.	O
the	O
physical	B-T033
frailty	I-T033
in	O
elderly	B-T098
cancer	O
patients	O
(	O
pf	B-T033
-	O
ec	O
)	O
study	O
(	O
france	B-T082
)	O
is	O
a	O
prospective	B-T062
bic	I-T062
##entric	I-T062
observational	I-T062
cohort	I-T062
study	I-T062
.	O
two	O
hundred	O
and	O
ninety	O
outpatients	O
with	O
cancer	B-T038
were	O
included	O
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
analysis	I-T062
of	O
oncologic	O
factors	O
and	O
geriatric	O
variables	O
associated	O
with	O
disability	B-T033
that	O
were	O
collected	O
using	O
a	O
comprehensive	O
geriatric	B-T058
assessment	I-T058
(	O
cga	B-T058
)	O
was	O
conducted	O
.	O
disability	B-T033
was	O
defined	O
as	O
impairment	O
in	O
activities	O
of	O
daily	O
living	O
(	O
adl	O
)	O
and	O
/	O
or	O
instrumental	B-T033
activities	I-T033
of	I-T033
daily	I-T033
living	I-T033
(	B-T033
iad	I-T033
##l	I-T033
)	O
,	O
simplified	O
to	O
four	O
items	O
.	O
univariate	O
and	O
multivariate	O
logistic	B-T170
models	I-T170
of	O
disabled	O
patients	O
were	O
performed	O
.	O
the	O
three	O
final	O
multivariate	O
models	B-T170
were	O
compared	O
using	O
the	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
(	O
auc	O
/	O
roc	O
)	O
of	O
the	O
logistic	B-T170
model	I-T170
.	O
the	O
mean	O
age	O
was	O
80	O
.	O
6	O
##years	O
,	O
and	O
51	O
%	O
of	O
the	O
patients	O
were	O
women	B-T098
with	O
various	O
types	O
of	O
cancer	B-T038
.	O
the	O
prevalence	O
of	O
disability	B-T033
was	O
67	O
.	O
6	O
%	O
.	O
no	O
oncologic	O
factors	O
(	O
cancer	O
site	O
,	O
cancer	B-T038
extension	I-T038
)	O
were	O
associated	O
with	O
disability	B-T033
.	O
impaired	B-T033
mobility	I-T033
,	O
poor	B-T033
functional	I-T033
status	I-T033
,	O
depressive	B-T033
mood	I-T033
,	O
cognitive	B-T038
impairment	I-T038
and	O
polypharm	B-T033
##acy	I-T033
were	O
independently	O
associated	O
with	O
disability	B-T033
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
auc	O
/	O
roc	O
of	O
the	O
final	O
models	O
was	O
similar	O
.	O
disability	B-T033
was	O
highly	O
prevalent	O
in	O
older	O
cancer	B-T038
outpatients	O
before	O
cancer	B-T058
treatment	I-T058
but	O
was	O
not	O
associated	O
with	O
oncologic	O
factors	O
.	O
impaired	B-T033
mobility	I-T033
,	O
depressed	B-T033
mood	I-T033
,	O
cognitive	B-T038
impairment	I-T038
and	O
polypharm	B-T033
##acy	I-T033
were	O
the	O
geriatric	O
variables	O
significantly	O
and	O
independently	O
associated	O
with	O
disability	B-T033
.	O
identifying	O
these	O
factors	O
prior	O
to	O
cancer	B-T058
treatment	I-T058
could	O
enable	O
the	O
implementation	O
of	O
corrective	O
actions	O
to	O
improve	O
patient	O
autonomy	O
before	O
treatment	B-T058
and	O
during	O
follow	B-T058
-	I-T058
up	I-T058
.	O

th	B-T103
##sd	I-T103
##7a	I-T103
expression	B-T038
in	O
human	B-T204
cancer	B-T038
we	O
recently	O
described	O
a	O
case	O
of	O
a	O
thromb	B-T103
##osp	I-T103
##ond	I-T103
##in	I-T103
type	I-T103
-	I-T103
1	I-T103
domain	I-T103
containing	I-T103
7a	I-T103
(	O
th	B-T103
##sd	I-T103
##7a	I-T103
)	O
associated	O
membranous	B-T038
nephropathy	I-T038
in	O
a	O
female	O
patient	O
who	O
was	O
synchronous	O
##ly	O
suffering	B-T033
from	O
a	O
th	B-T103
##sd	I-T103
##7a	I-T103
-	O
positive	B-T033
malignancy	O
.	O
we	O
here	O
investigated	O
the	O
role	O
of	O
th	B-T103
##sd	I-T103
##7a	I-T103
as	O
a	O
new	O
potential	O
tumor	B-T103
antigen	I-T103
by	O
evaluating	O
over	O
20	O
000	O
tissue	B-T017
spots	I-T017
in	O
more	O
than	O
70	O
different	O
tumor	B-T033
entities	I-T033
by	O
immunohistochemistry	B-T058
using	O
tissue	O
microarrays	O
.	O
th	B-T103
##sd	I-T103
##7a	I-T103
expression	B-T038
was	O
highly	O
variable	O
in	O
different	B-T038
neoplasia	I-T038
##s	I-T038
with	O
differing	O
staining	B-T082
patterns	I-T082
.	O
both	O
gain	B-T033
and	I-T033
loss	I-T033
of	O
th	B-T103
##sd	I-T103
##7a	I-T103
expression	B-T038
compared	O
to	O
expression	B-T038
status	I-T038
in	O
non	B-T017
-	I-T017
tumor	I-T017
tissue	I-T017
were	O
linked	O
to	O
tumor	B-T103
-	I-T103
specific	I-T103
markers	I-T103
in	O
the	O
different	O
tumor	B-T033
entities	I-T033
and	O
were	O
of	O
prognostic	O
value	O
.	O
the	O
potential	O
role	O
of	O
th	B-T103
##sd	I-T103
##7a	I-T103
in	O
tumor	B-T033
development	I-T033
and	O
therapy	B-T058
needs	O
further	O
investigation	O
.	O

mesenchymal	B-T017
stem	I-T017
cells	I-T017
enhance	O
the	O
onc	O
##olytic	O
effect	O
of	O
new	B-T005
##castle	I-T005
disease	I-T005
virus	I-T005
in	O
glioma	B-T038
cells	B-T017
and	O
glioma	B-T038
stem	B-T017
cells	I-T017
via	O
the	O
secretion	B-T038
of	O
trail	B-T103
new	B-T005
##castle	I-T005
disease	I-T005
virus	I-T005
(	O
nd	B-T005
##v	I-T005
)	O
is	O
an	O
avian	B-T005
param	I-T005
##yx	I-T005
##ovirus	I-T005
,	O
which	O
selectively	O
exerts	B-T038
onc	O
##olytic	O
effects	O
in	O
cancer	B-T017
cells	I-T017
.	O
mesenchymal	B-T017
stem	I-T017
cells	I-T017
(	O
mscs	B-T017
)	O
have	O
been	O
reported	O
to	O
affect	O
tumor	O
growth	O
and	O
deliver	O
anti	B-T103
-	I-T103
tumor	I-T103
agents	I-T103
to	O
experimental	O
glioblastoma	B-T038
(	O
gbm	B-T038
)	O
.	O
here	O
,	O
we	O
explored	O
the	O
effects	O
of	O
nd	B-T005
##v	I-T005
-	O
infected	B-T033
mscs	B-T017
derived	O
from	O
different	O
sources	B-T033
,	O
on	O
glioma	B-T038
cells	B-T017
and	O
glioma	B-T038
stem	B-T017
cells	I-T017
(	O
gs	B-T017
##cs	I-T017
)	O
and	O
the	O
mechanisms	O
involved	O
in	O
their	O
effects	O
.	O
the	O
glioma	B-T038
cell	B-T017
lines	I-T017
(	O
a1	B-T017
##72	I-T017
and	O
u	B-T017
##87	I-T017
)	O
and	O
primary	O
gs	B-T017
##cs	I-T017
that	O
were	O
generated	O
from	O
gbm	B-T038
tumors	B-T038
were	O
used	O
in	O
this	O
study	B-T062
.	O
mscs	B-T017
derived	O
from	O
bone	B-T017
marrow	I-T017
,	O
adipose	B-T017
tissue	I-T017
or	O
umbilical	B-T017
cord	I-T017
were	O
infected	B-T033
with	O
nd	B-T005
##v	I-T005
(	O
mth	B-T058
-	I-T058
68	I-T058
/	I-T058
h	I-T058
)	O
.	O
the	O
ability	O
of	O
these	O
cells	B-T017
to	O
deliver	O
the	O
virus	B-T005
to	O
glioma	B-T038
cell	B-T017
lines	I-T017
and	O
gs	B-T017
##cs	I-T017
and	O
the	O
effects	O
of	O
nd	B-T005
##v	I-T005
-	O
infected	B-T033
mscs	B-T017
on	O
cell	B-T038
death	I-T038
and	O
on	O
the	O
stem	O
##ness	O
and	O
self	B-T038
-	I-T038
renewal	I-T038
of	O
gs	B-T017
##cs	I-T017
were	O
examined	B-T033
.	O
the	O
mechanisms	O
involved	O
in	O
the	O
cytotoxic	O
effects	O
of	O
the	O
nd	B-T005
##v	I-T005
-	O
infected	B-T033
mscs	B-T017
and	O
their	O
influence	O
on	O
the	O
radiation	O
sensitivity	O
of	O
gs	B-T017
##cs	I-T017
were	O
examined	B-T033
as	O
well	O
.	O
nd	B-T005
##v	I-T005
induced	O
a	O
dose	O
-	O
dependent	O
cell	B-T038
death	I-T038
in	O
glioma	B-T038
cells	B-T017
and	O
a	O
low	O
level	O
of	O
apoptosis	B-T038
and	O
inhibition	O
of	O
self	B-T038
-	I-T038
renewal	I-T038
in	O
gs	B-T017
##cs	I-T017
.	O
mscs	B-T017
derived	O
from	O
bone	B-T017
marrow	I-T017
,	O
adipose	B-T017
and	O
umbilical	B-T017
cord	I-T017
that	O
were	O
infected	B-T033
with	O
nd	B-T005
##v	I-T005
delivered	O
the	O
virus	B-T005
to	O
co	B-T058
-	I-T058
cultured	I-T058
glioma	B-T038
cells	B-T017
and	O
gs	B-T017
##cs	I-T017
.	O
conditioned	B-T103
medium	I-T103
of	O
nd	B-T005
##v	I-T005
-	O
infected	B-T033
mscs	B-T017
induced	O
higher	O
level	O
of	O
apoptosis	B-T038
in	O
the	O
tumor	B-T017
cells	I-T017
compared	O
with	O
the	O
apoptosis	B-T038
induced	O
by	O
their	O
direct	B-T038
infection	I-T038
with	O
similar	O
virus	O
titers	O
.	O
these	O
results	O
suggest	O
that	O
factor	O
(	O
s	O
)	O
secreted	B-T038
by	O
the	O
infected	B-T033
mscs	B-T017
sensitized	B-T017
the	O
glioma	B-T038
cells	B-T017
to	O
the	O
cytotoxic	O
effects	O
of	O
nd	B-T005
##v	I-T005
.	O
we	O
identified	O
trail	B-T103
as	O
a	O
mediator	O
of	O
the	O
cytotoxic	O
effects	O
of	O
the	O
infected	B-T033
mscs	B-T017
and	O
demonstrated	O
that	O
trail	B-T103
synerg	O
##ized	O
with	O
nd	B-T005
##v	I-T005
in	O
the	O
induction	O
of	O
cell	B-T038
death	I-T038
in	O
glioma	B-T038
cells	B-T017
and	O
gs	B-T017
##cs	I-T017
.	O
moreover	O
,	O
conditioned	O
medium	O
of	O
infected	B-T033
mscs	B-T017
enhanced	O
the	O
sensitivity	O
of	O
gs	B-T017
##cs	I-T017
to	O
γ	O
-	O
radiation	O
.	O
nd	B-T005
##v	I-T005
-	O
infected	B-T033
umbilical	B-T017
cord	I-T017
-	O
derived	O
mscs	B-T017
may	O
provide	O
a	O
novel	O
effective	O
therapeutic	O
approach	B-T082
for	O
targeting	O
gs	B-T017
##cs	I-T017
and	O
gbm	B-T038
and	O
for	O
sensitizing	O
these	O
tumors	B-T038
to	O
γ	O
-	O
radiation	O
.	O

the	O
prevalence	O
of	O
sleep	B-T038
apnea	I-T038
in	O
type	B-T017
b	I-T017
aortic	I-T017
dissection	I-T017
:	O
implications	O
for	O
false	O
lumen	B-T082
thrombosis	B-T038
obstructive	B-T038
sleep	I-T038
apnea	I-T038
(	O
osa	B-T038
)	O
has	O
been	O
implicated	O
in	O
aortic	B-T038
dissection	I-T038
.	O
thrombosis	B-T038
of	O
the	O
false	O
lumen	B-T082
is	O
associated	O
with	O
a	O
prognosis	B-T058
of	O
type	B-T017
b	I-T017
aortic	I-T017
dissection	I-T017
(	O
ao	B-T017
##d	I-T017
)	O
,	O
and	O
partial	B-T017
thrombosis	I-T017
has	O
been	O
reported	O
to	O
be	O
an	O
independent	O
predictor	B-T170
of	O
mortality	O
.	O
this	O
study	B-T062
sought	O
to	O
explore	O
whether	O
the	O
severity	O
of	O
osa	B-T038
is	O
associated	O
with	O
false	O
lumen	B-T082
thrombosis	B-T038
.	O
in	O
this	O
observational	B-T062
study	I-T062
,	O
151	O
type	B-T017
b	I-T017
ao	I-T017
##d	I-T017
patients	O
were	O
recruited	O
consecutively	O
from	O
2013	O
to	O
2015	O
.	O
the	O
status	O
of	O
the	O
false	O
lumen	B-T082
was	O
classified	O
as	O
patent	O
,	O
partially	O
thromb	B-T038
##osed	I-T038
,	O
or	O
completely	O
thromb	B-T038
##osed	I-T038
based	O
on	O
a	O
computer	B-T058
tomography	I-T058
angiography	I-T058
image	O
.	O
patients	O
were	O
divided	O
into	O
non	O
-	O
osa	O
group	O
(	O
apnea	B-T170
-	I-T170
hypopnea	I-T170
index	I-T170
[	O
ahi	B-T170
]	O
<	O
5	O
)	O
,	O
and	O
mild	O
(	O
5	O
≤	O
ahi	B-T170
≤	O
15	O
)	O
,	O
moderate	O
(	O
15	O
<	O
ahi	B-T170
≤	O
30	O
)	O
,	O
and	O
severe	O
osa	O
groups	O
(	O
ahi	B-T170
>	O
30	O
)	O
using	O
the	O
ahi	B-T170
.	O
the	O
prevalence	O
of	O
osa	B-T038
in	O
type	B-T017
b	I-T017
dissection	I-T017
was	O
66	O
.	O
2	O
%	O
.	O
among	O
151	O
cases	O
,	O
51	O
patients	O
(	O
33	O
.	O
8	O
%	O
)	O
were	O
in	O
the	O
non	O
-	O
osa	O
group	O
,	O
56	O
(	O
37	O
.	O
1	O
%	O
)	O
were	O
in	O
the	O
mild	O
group	O
,	O
21	O
(	O
13	O
.	O
9	O
%	O
)	O
were	O
in	O
the	O
moderate	O
group	O
,	O
and	O
23	O
(	O
15	O
.	O
2	O
%	O
)	O
were	O
in	O
the	O
severe	O
group	O
.	O
additionally	O
,	O
a	O
partially	O
thromb	B-T038
##osed	I-T038
false	O
lumen	B-T082
was	O
observed	O
in	O
88	O
patients	O
(	O
58	O
.	O
3	O
%	O
)	O
.	O
multivariable	O
analysis	O
revealed	O
that	O
osa	B-T038
severity	O
was	O
positively	B-T033
associated	O
with	O
partial	O
thrombosis	B-T038
(	O
odds	O
ratio	O
,	O
1	O
.	O
78	O
##4	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
1	O
.	O
182	O
-	O
2	O
.	O
69	O
##1	O
,	O
p	O
=	O
.	O
006	O
)	O
after	O
adjusting	O
for	O
other	O
confounding	O
factors	O
.	O
osa	B-T038
was	O
present	O
in	O
two	O
-	O
thirds	O
of	O
patients	O
with	O
type	B-T017
b	I-T017
ao	I-T017
##d	I-T017
.	O
the	O
severity	O
of	O
osa	B-T038
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
partial	O
false	O
lumen	B-T082
thrombosis	B-T038
.	O
osa	B-T038
may	O
therefore	O
be	O
implicated	O
in	O
both	O
the	O
etiology	O
and	O
prognosis	B-T058
of	O
ao	B-T017
##d	I-T017
.	O

evolution	B-T038
of	O
fitness	O
cost	B-T033
-	I-T033
neutral	I-T033
mutant	B-T038
pfc	B-T103
##rt	I-T103
conferring	O
p	B-T204
.	I-T204
falciparum	I-T204
4	B-T103
-	I-T103
amino	I-T103
##quinoline	I-T103
drug	B-T038
resistance	I-T038
is	O
accompanied	O
by	O
altered	O
parasite	B-T204
metabolism	B-T038
and	O
digestive	B-T017
vacuole	I-T017
physiology	B-T091
southeast	B-T082
asia	I-T082
is	O
an	O
epic	O
##enter	O
of	O
multidrug	O
-	O
resistant	O
plasmodium	B-T204
falciparum	I-T204
strains	I-T204
.	O
selective	O
pressures	O
on	O
the	O
subc	O
##ontin	O
##ent	O
have	O
recurrent	O
##ly	O
produced	O
several	O
allelic	B-T017
variants	B-T017
of	O
parasite	B-T204
drug	B-T038
resistance	I-T038
genes	B-T017
,	O
including	O
the	O
p	B-T017
.	I-T017
falciparum	I-T017
chloroquine	I-T017
resistance	I-T017
transporter	I-T017
(	O
pfc	B-T017
##rt	I-T017
)	O
.	O
despite	O
significant	O
reductions	B-T058
in	O
the	O
deployment	O
of	O
the	O
4	B-T103
-	I-T103
amino	I-T103
##quinoline	I-T103
drug	B-T103
chloroquine	B-T103
(	O
cq	B-T103
)	O
,	O
which	O
selected	O
for	O
the	O
mutant	B-T017
pfc	B-T017
##rt	I-T017
alleles	B-T017
that	O
hal	O
##ted	O
cq	B-T103
efficacy	O
decades	O
ago	O
,	O
the	O
parasite	B-T204
pfc	B-T017
##rt	I-T017
locus	B-T082
is	O
continuously	O
evolving	O
.	O
this	O
is	O
highlighted	O
by	O
the	O
presence	O
of	O
a	O
highly	O
mutated	B-T038
allele	B-T017
,	O
cam	B-T017
##73	I-T017
##4	I-T017
pfc	I-T017
##rt	I-T017
,	O
which	O
has	O
acquired	O
the	O
singular	O
ability	O
to	O
confer	O
parasite	B-T204
cq	B-T103
resistance	B-T038
without	O
an	O
associated	O
fitness	O
cost	O
.	O
here	O
,	O
we	O
used	O
pfc	B-T017
##rt	I-T017
-	O
specific	O
zinc	B-T103
-	I-T103
finger	I-T103
nuclease	I-T103
##s	I-T103
to	O
genetically	O
dissect	O
this	O
allele	B-T017
in	O
the	O
pathogenic	B-T033
setting	O
of	O
asexual	B-T038
blood	I-T038
-	I-T038
stage	I-T038
infection	I-T038
.	O
comparative	O
analysis	O
of	O
drug	B-T038
resistance	I-T038
and	O
growth	B-T038
profiles	O
of	O
recombinant	B-T204
parasites	I-T204
that	O
express	B-T038
cam	B-T017
##73	I-T017
##4	I-T017
or	O
variants	B-T017
thereof	O
,	O
dd	B-T017
##2	I-T017
(	O
the	O
most	O
common	O
southeast	B-T082
asian	I-T082
variant	B-T017
)	O
,	O
or	O
wild	B-T017
-	I-T017
type	I-T017
pfc	B-T017
##rt	I-T017
,	O
revealed	O
previously	O
unknown	O
roles	O
for	O
pfc	B-T103
##rt	I-T103
mutations	B-T038
in	O
modulating	O
parasite	B-T204
susceptibility	O
to	O
multiple	O
antimalarial	B-T103
agents	I-T103
.	O
these	O
results	O
were	O
generated	O
in	O
the	O
gc	B-T017
##03	I-T017
strain	O
,	O
used	O
in	O
multiple	O
earlier	O
pfc	B-T017
##rt	I-T017
studies	B-T062
,	O
and	O
might	O
differ	O
in	O
natural	O
isolates	O
harboring	O
this	O
allele	B-T017
.	O
results	O
presented	O
herein	O
show	O
that	O
cam	B-T017
##73	I-T017
##4	I-T017
-	O
mediated	O
cq	B-T103
resistance	B-T038
is	O
dependent	O
on	O
the	O
rare	O
a1	B-T038
##44	I-T038
##f	I-T038
mutation	B-T038
that	O
has	O
not	O
been	O
observed	O
beyond	O
southeast	B-T082
asia	I-T082
,	O
and	O
reveal	O
distinct	O
impacts	O
of	O
this	O
and	O
other	O
cam	B-T017
##73	I-T017
##4	I-T017
-	O
specific	O
mutations	B-T038
on	O
cq	B-T103
resistance	B-T038
and	O
parasite	B-T204
growth	O
rates	O
.	O
biochemical	B-T058
assays	I-T058
revealed	O
a	O
broad	O
impact	O
of	O
mutant	B-T038
pfc	B-T103
##rt	I-T103
isoforms	B-T103
on	O
parasite	B-T204
metabolism	B-T038
,	O
including	O
nucleoside	O
triphosphate	O
levels	O
,	O
hemoglobin	B-T038
catabolism	I-T038
and	O
disposition	O
of	O
heme	B-T103
,	O
as	O
well	O
as	O
digestive	B-T017
vacuole	I-T017
volume	O
and	O
ph	O
.	O
results	O
from	O
our	O
study	O
provide	O
new	O
insights	O
into	O
the	O
complex	B-T170
molecular	I-T170
basis	I-T170
and	O
physiological	O
impact	O
of	O
pfc	B-T103
##rt	I-T103
-	O
mediated	O
antimalarial	B-T103
drug	B-T038
resistance	I-T038
,	O
and	O
inform	O
ongoing	O
efforts	O
to	O
characterize	O
novel	O
pfc	B-T017
##rt	I-T017
alleles	B-T017
that	O
can	O
underm	O
##ine	O
the	O
efficacy	O
of	O
first	O
-	O
line	O
antimalarial	B-T103
drug	I-T103
regimens	B-T058
.	O

geographical	O
variations	O
in	O
incidence	O
,	O
management	B-T058
and	O
survival	O
of	O
hepatocellular	B-T038
carcinoma	I-T038
in	O
a	O
western	B-T082
country	I-T082
information	O
on	O
the	O
incidence	O
,	O
management	B-T058
,	O
and	O
prognosis	B-T058
of	O
hepatocellular	B-T038
carcinoma	I-T038
(	O
hcc	B-T038
)	O
is	O
derived	O
from	O
population	B-T098
samples	I-T098
,	O
regional	B-T082
data	O
,	O
or	O
registries	B-T170
.	O
comprehensive	O
national	O
evaluations	B-T058
within	O
a	O
given	O
country	B-T082
are	O
lacking	O
.	O
this	O
study	B-T062
aimed	O
to	O
investigate	O
regional	B-T082
variations	O
in	O
hcc	B-T038
care	O
within	O
france	B-T082
.	O
this	O
observational	B-T062
study	I-T062
analysed	O
data	O
from	O
french	B-T098
administrative	B-T170
databases	I-T170
for	O
more	O
than	O
30	O
,	O
000	O
patients	O
with	O
hcc	B-T038
diagnosed	B-T033
between	O
2009	O
and	O
2012	O
,	O
and	O
followed	O
-	O
up	O
until	O
2013	O
.	O
the	O
incidence	O
of	O
hcc	B-T038
,	O
access	B-T082
to	O
surgery	B-T058
,	O
and	O
survival	O
,	O
at	O
both	O
the	O
national	O
level	O
and	O
two	O
geographical	O
levels	O
(	O
the	O
21	O
french	B-T082
regions	I-T082
and	O
95	O
french	B-T098
departments	B-T092
into	O
which	O
france	B-T082
is	O
divided	B-T092
administrative	I-T092
##ly	I-T092
)	O
,	O
were	O
determined	O
.	O
the	O
influence	O
on	O
outcome	O
of	O
the	O
structure	O
of	O
the	O
hospital	B-T092
where	O
hcc	B-T038
was	O
first	O
managed	O
was	O
assessed	O
.	O
at	O
the	O
national	O
level	O
,	O
the	O
median	O
survival	O
was	O
9	O
.	O
4	O
months	O
and	O
only	O
22	O
.	O
8	O
%	O
of	O
patients	O
had	O
curative	B-T033
treatment	I-T033
.	O
there	O
were	O
marked	O
variations	O
between	O
regions	B-T082
and	O
departments	B-T092
in	O
incidence	O
,	O
access	B-T082
to	O
curative	B-T033
treatment	I-T033
(	O
range	O
1	O
.	O
3	O
-	O
28	O
.	O
8	O
%	O
and	O
8	O
.	O
1	O
-	O
32	O
.	O
3	O
%	O
respectively	O
)	O
,	O
and	O
in	O
median	O
survival	O
(	O
range	O
5	O
.	O
7	O
-	O
12	O
.	O
1	O
and	O
4	O
.	O
3	O
-	O
16	O
.	O
5	O
months	O
respectively	O
)	O
.	O
the	O
administrative	O
type	O
and	O
annual	O
hcc	B-T038
-	O
case	O
##load	O
of	O
the	O
hospital	B-T092
where	O
patients	O
were	O
first	O
admitted	B-T058
also	O
had	O
an	O
independent	O
influence	O
on	O
treatment	B-T058
and	O
survival	O
.	O
despite	O
full	O
insurance	O
coverage	O
for	O
all	O
citizens	B-T098
,	O
national	O
measures	O
to	O
reduce	O
inequ	O
##ities	O
in	O
the	O
management	B-T058
of	O
cancer	O
patients	O
,	O
standardised	O
recommendations	O
for	O
hcc	B-T038
surveillance	B-T058
and	O
management	B-T058
,	O
the	O
percentage	O
of	O
patients	O
undergoing	O
curative	B-T033
treatment	I-T033
and	O
their	O
survival	O
may	O
vary	O
four	O
-	O
fold	O
depending	O
on	O
their	O
postc	B-T033
##ode	I-T033
.	O
the	O
hospital	B-T092
in	O
which	O
patients	O
are	O
first	O
managed	O
has	O
a	O
clear	O
influence	O
on	O
accessibility	O
to	O
both	O
good	O
care	O
and	O
survival	O
.	O
population	B-T062
-	I-T062
based	I-T062
studies	I-T062
have	O
highlighted	O
large	O
and	O
sometimes	O
unexpected	O
differences	O
between	O
countries	B-T082
in	O
the	O
survival	O
of	O
patients	O
with	O
malignancy	B-T038
.	O
as	O
these	O
differences	O
are	O
considered	O
to	O
indicate	O
the	O
overall	O
effectiveness	O
of	O
health	O
systems	O
,	O
in	O
addition	O
to	O
the	O
incidence	O
of	O
the	O
cancer	B-T038
or	O
quality	O
of	O
registration	B-T058
,	O
variations	O
within	O
a	O
given	O
country	B-T082
should	O
be	O
minimal	O
.	O
however	O
,	O
similar	O
to	O
between	O
countries	B-T082
differences	O
,	O
this	O
study	B-T062
shows	O
differences	O
within	O
the	O
same	O
country	B-T082
in	O
the	O
incidence	O
,	O
curative	B-T033
treatment	I-T033
rate	O
,	O
and	O
survival	O
of	O
patients	O
with	O
hcc	B-T038
.	O
evidence	O
that	O
access	O
to	O
care	O
and	O
survival	O
varies	O
within	O
a	O
country	B-T082
can	O
strengthen	O
the	O
imp	O
##etus	O
for	O
government	B-T092
and	O
clinicians	B-T097
to	O
address	O
these	O
disparities	O
.	O

characterisation	O
of	O
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
clinical	O
isolates	B-T103
from	O
animals	B-T204
in	O
new	B-T082
zealand	I-T082
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colon	B-T033
##isation	I-T033
in	O
dogs	B-T204
and	O
cats	B-T204
in	O
auc	O
##kl	O
##and	O
to	O
characterise	O
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
(	O
mrsa	B-T007
)	O
isolates	B-T103
from	O
infection	B-T038
sites	I-T038
in	O
animals	B-T204
in	O
new	B-T082
zealand	I-T082
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
mrsa	B-T033
colon	I-T033
##isation	I-T033
in	O
dogs	B-T204
and	O
cats	B-T204
attending	O
veterinary	B-T092
clinics	I-T092
in	O
auc	O
##kl	O
##and	O
.	O
mrsa	B-T007
isolates	B-T103
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
new	B-T082
zealand	I-T082
veterinary	B-T092
diagnostic	I-T092
laboratories	I-T092
between	O
june	O
2012	O
and	O
june	O
2013	O
,	O
were	O
genotypic	O
##ally	O
characterised	O
by	O
dna	B-T062
microarray	I-T062
hybridisation	I-T062
analysis	I-T062
and	O
spa	B-T103
typing	B-T058
.	O
in	O
addition	O
,	O
nasal	B-T017
or	O
perineal	B-T017
skin	I-T017
swabs	O
collected	O
from	O
a	O
cross	O
-	O
sectional	O
sample	O
of	O
dogs	B-T204
(	O
n	O
=	O
36	O
##1	O
)	O
and	O
cats	B-T204
(	O
n	O
=	O
225	O
)	O
attending	O
29	O
veterinary	B-T092
clinics	I-T092
in	O
auc	O
##kl	O
##and	O
during	O
the	O
same	O
period	O
were	O
analysed	B-T062
for	O
mrsa	B-T007
by	O
culture	B-T058
.	O
eight	O
mrsa	B-T007
clinical	O
isolates	B-T103
were	O
submitted	O
for	O
characterisation	O
by	O
the	O
participating	O
laboratories	B-T092
.	O
the	O
isolates	B-T103
originated	O
from	O
five	O
dogs	B-T204
,	O
including	O
two	O
isolates	B-T103
from	O
the	O
same	O
dog	B-T204
,	O
one	O
fo	O
##al	O
,	O
and	O
one	O
isolate	B-T103
had	O
no	O
identification	O
of	O
the	O
source	B-T033
.	O
the	O
strain	O
-	O
types	O
identified	O
were	O
ak	B-T007
##3	I-T007
(	I-T007
st	I-T007
-	I-T007
5	I-T007
scc	I-T007
##me	I-T007
##ci	I-T007
##v	I-T007
t0	O
##45	O
;	O
n	O
=	O
1	O
)	O
,	O
usa	B-T007
##50	I-T007
##0	I-T007
(	I-T007
st	I-T007
##8	I-T007
scc	I-T007
##me	I-T007
##ci	I-T007
##v	I-T007
t0	O
##64	O
;	O
n	O
=	O
1	O
)	O
,	O
ws	B-T007
##pp	I-T007
(	I-T007
st	I-T007
##30	I-T007
scc	I-T007
##me	I-T007
##ci	I-T007
##v	I-T007
t0	O
##19	O
;	O
n	O
=	O
1	O
)	O
,	O
rhin	B-T007
##e	I-T007
hes	I-T007
##se	I-T007
(	I-T007
st	I-T007
##5	I-T007
scc	I-T007
##me	I-T007
##ci	I-T007
##i	I-T007
t0	O
##02	O
;	O
n	O
=	O
2	O
)	O
,	O
and	O
emr	B-T007
##sa	I-T007
-	I-T007
15	I-T007
(	I-T007
st	I-T007
##22	I-T007
scc	I-T007
##me	I-T007
##ci	I-T007
##v	I-T007
t0	O
##32	O
;	O
n	O
=	O
3	O
)	O
.	O
no	O
mrsa	B-T007
were	O
isolated	O
from	O
58	O
##6	O
cultured	O
swabs	O
.	O
methicillin	B-T007
-	I-T007
susceptible	I-T007
s	I-T007
.	I-T007
aureus	I-T007
were	O
detected	B-T033
in	O
9	O
/	O
257	O
(	O
3	O
.	O
5	O
%	O
)	O
swabs	O
and	O
non	B-T007
-	I-T007
aureus	I-T007
staphylococci	I-T007
in	O
22	O
/	O
257	O
(	O
8	O
.	O
5	O
%	O
)	O
swabs	O
.	O
the	O
estimated	O
true	O
mrsa	B-T007
subclinical	O
colon	B-T033
##isation	I-T033
prevalence	O
was	O
0	O
%	O
,	O
with	O
an	O
upper	O
95	O
%	O
ci	O
boundary	O
of	O
1	O
.	O
9	O
%	O
for	O
cats	B-T204
and	O
1	O
.	O
4	O
%	O
for	O
dogs	B-T204
.	O
the	O
modest	O
number	O
of	O
mrsa	B-T007
isolates	B-T103
submitted	O
for	O
this	O
study	B-T170
by	O
the	O
participating	O
laboratories	B-T092
suggests	O
clinical	O
mrsa	B-T038
infection	I-T038
in	O
animals	B-T204
in	O
new	B-T082
zealand	I-T082
continues	O
to	O
be	O
sporadic	O
.	O
the	O
wide	O
variety	O
of	O
strain	O
-	O
types	O
found	O
mirror	O
##ed	O
the	O
evolving	O
strain	O
-	O
type	O
diversity	O
observed	O
in	O
humans	B-T204
.	O
we	O
cann	O
##ot	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non	B-T062
-	I-T062
random	I-T062
sampling	I-T062
of	O
dogs	B-T204
and	O
cats	B-T204
,	O
but	O
the	O
apparent	O
colon	B-T033
##isation	I-T033
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colon	B-T033
##isation	I-T033
in	O
humans	B-T204
in	O
new	B-T082
zealand	I-T082
.	O
these	O
similarities	O
indicate	O
the	O
epidemiology	B-T091
of	O
animal	B-T204
and	O
human	B-T204
mrsa	B-T038
infections	I-T038
are	O
linked	O
.	O
in	O
the	O
last	O
decade	O
,	O
the	O
prevalence	O
of	O
human	B-T204
mrsa	B-T038
infections	I-T038
in	O
new	B-T082
zealand	I-T082
has	O
steadily	O
increased	O
.	O
this	O
is	O
the	O
second	O
published	O
study	B-T170
of	O
mrsa	B-T007
in	O
animals	B-T204
in	O
new	B-T082
zealand	I-T082
.	O
the	O
results	O
indicate	O
clinical	O
mrsa	B-T038
infection	I-T038
in	O
animals	B-T204
remains	O
sporadic	O
,	O
but	O
the	O
diversification	O
of	O
the	O
strain	O
-	O
types	O
may	O
pose	O
new	O
therapeutic	O
challenges	O
to	O
veterin	B-T097
##arians	I-T097
,	O
due	O
to	O
their	O
diverse	O
resist	O
##ome	O
.	O

mechanisms	O
of	O
global	O
cerebral	B-T038
edema	I-T038
formation	O
in	O
aneurysmal	B-T038
subarachnoid	I-T038
hemorrhage	I-T038
a	O
growing	O
body	O
of	O
clinical	O
literature	B-T170
emphasizes	O
the	O
impact	O
of	O
cerebral	B-T038
edema	I-T038
in	O
early	B-T037
brain	I-T037
injury	I-T037
following	O
aneurysmal	B-T038
subarachnoid	I-T038
hemorrhage	I-T038
(	O
asa	B-T038
##h	I-T038
)	O
.	O
aneurysm	B-T038
rupture	I-T038
itself	O
initiates	O
global	O
cerebral	B-T038
edema	I-T038
in	O
up	O
to	O
two	O
thirds	O
of	O
cases	O
.	O
although	O
cerebral	B-T038
edema	I-T038
is	O
not	O
a	O
universal	O
feature	O
of	O
asa	B-T038
##h	I-T038
,	O
it	O
port	O
##ends	O
a	O
poor	O
clinical	O
course	O
,	O
with	O
quantitative	O
analysis	O
revealing	O
a	O
direct	O
correlation	O
between	O
cerebral	B-T038
edema	I-T038
and	O
poor	B-T033
outcome	I-T033
,	O
including	O
mortality	O
and	O
cognitive	O
deficits	O
.	O
mechanistically	O
,	O
global	O
cerebral	B-T038
edema	I-T038
has	O
been	O
linked	O
to	O
global	O
ischemia	B-T038
at	O
the	O
time	O
of	O
aneurysm	B-T038
rupture	I-T038
,	O
dysfunction	O
of	O
autoregulation	B-T038
,	O
blood	B-T038
breakdown	I-T038
products	O
,	O
neuroinflammation	O
,	O
and	O
hyponatremia	B-T038
/	O
endocrine	B-T017
abnormalities	I-T017
.	O
at	O
a	O
molecular	O
level	O
,	O
several	O
cul	O
##pri	O
##ts	O
have	O
been	O
identified	O
,	O
including	O
aquaporin	B-T103
-	I-T103
4	I-T103
,	O
matrix	B-T103
metalloproteinase	I-T103
-	I-T103
9	I-T103
,	O
sur	B-T103
##1	I-T103
-	O
trp	B-T103
##m	I-T103
##4	I-T103
cation	I-T103
channels	I-T103
,	O
vascular	B-T103
endothelial	I-T103
growth	I-T103
factor	I-T103
,	O
bradykinin	B-T103
,	O
and	O
others	O
.	O
here	O
,	O
we	O
review	O
these	O
cellular	B-T017
and	O
molecular	O
mechanisms	O
of	O
global	O
cerebral	B-T038
edema	I-T038
formation	O
in	O
asa	B-T038
##h	I-T038
.	O
given	O
the	O
importance	O
of	O
edema	B-T033
to	O
the	O
outcome	O
of	O
patients	O
with	O
asa	B-T038
##h	I-T038
and	O
its	O
status	O
as	O
a	O
highly	O
modifiable	O
pathological	B-T038
process	I-T038
,	O
a	O
better	O
understanding	O
of	O
cerebral	B-T038
edema	I-T038
in	O
asa	B-T038
##h	I-T038
promises	O
to	O
has	O
##ten	O
the	O
development	O
of	O
medical	B-T058
therapies	I-T058
to	O
improve	O
outcomes	O
in	O
this	O
frequently	O
devastating	O
disease	B-T038
.	O

genetic	O
diversity	O
in	O
various	O
accessions	B-T170
of	O
pine	B-T204
##app	I-T204
##le	I-T204
[	O
ana	B-T204
##nas	I-T204
com	I-T204
##osus	I-T204
(	I-T204
l	I-T204
.	I-T204
)	I-T204
mer	I-T204
##r	I-T204
.	I-T204
]	O
using	O
iss	B-T103
##r	I-T103
and	O
ssr	B-T103
markers	B-T082
inter	B-T103
simple	I-T103
sequence	I-T103
repeat	I-T103
(	O
iss	B-T103
##r	I-T103
)	O
and	O
simple	B-T103
sequence	I-T103
repeat	I-T103
(	O
ssr	B-T103
)	O
markers	B-T082
were	O
used	O
to	O
assess	O
the	O
genetic	O
diversity	O
of	O
36	O
pine	B-T204
##app	I-T204
##le	I-T204
accessions	B-T170
that	O
were	O
introduced	O
from	O
10	O
countries	B-T082
/	O
regions	B-T082
.	O
thirteen	O
iss	B-T103
##r	I-T103
primers	B-T103
amplified	O
96	O
bands	O
,	O
of	O
which	O
91	O
(	O
93	O
.	O
65	O
%	O
)	O
were	O
polymorphic	O
,	O
whereas	O
20	O
ssr	B-T103
primers	B-T103
amplified	O
73	O
bands	O
,	O
of	O
which	O
70	O
(	O
96	O
.	O
50	O
%	O
)	O
were	O
polymorphic	O
.	O
ne	B-T170
##i	I-T170
'	I-T170
s	I-T170
gene	I-T170
diversity	I-T170
(	O
h	B-T170
=	O
0	O
.	O
28	O
)	O
,	O
sh	B-T170
##ann	I-T170
##on	I-T170
'	I-T170
s	I-T170
information	I-T170
index	I-T170
(	O
i	B-T170
=	O
0	O
.	O
43	O
)	O
,	O
and	O
polymorphism	B-T170
information	I-T170
content	I-T170
(	O
pic	B-T170
=	O
0	O
.	O
29	O
)	O
generated	O
using	O
the	O
ssr	B-T103
primers	B-T103
were	O
higher	O
than	O
that	O
with	O
iss	B-T103
##r	I-T103
primers	B-T103
(	O
h	B-T170
=	O
0	O
.	O
23	O
,	O
i	B-T170
=	O
0	O
.	O
37	O
,	O
pic	B-T170
=	O
0	O
.	O
24	O
)	O
,	O
thereby	O
suggesting	O
that	O
the	O
ssr	B-T103
system	I-T103
is	O
more	O
efficient	O
than	O
the	O
iss	B-T103
##r	I-T103
system	I-T103
in	O
assessing	O
genetic	O
diversity	O
in	O
various	O
pine	B-T204
##app	I-T204
##le	I-T204
accessions	B-T170
.	O
mean	O
genetic	O
similarities	O
were	O
0	O
.	O
74	O
,	O
0	O
.	O
61	O
,	O
and	O
0	O
.	O
69	O
,	O
as	O
determined	O
using	O
iss	B-T103
##r	I-T103
,	O
ssr	B-T103
,	O
and	O
combined	O
iss	B-T103
##r	I-T103
/	O
ssr	B-T103
,	O
respectively	O
.	O
these	O
results	O
suggest	O
that	O
the	O
genetic	O
diversity	O
among	O
pine	B-T204
##app	I-T204
##le	I-T204
accessions	B-T170
is	O
very	O
high	O
.	O
we	O
clustered	B-T062
the	O
36	O
pine	B-T204
##app	I-T204
##le	I-T204
accessions	B-T170
into	O
three	O
or	O
five	O
groups	O
on	O
the	O
basis	O
of	O
the	O
phylogenetic	O
trees	O
constructed	O
based	O
on	O
the	O
results	O
of	O
iss	B-T103
##r	I-T103
,	O
ssr	B-T103
,	O
and	O
combined	O
iss	B-T103
##r	I-T103
/	O
ssr	B-T103
analyses	B-T062
using	O
the	O
unw	B-T170
##eight	I-T170
##ed	I-T170
pair	I-T170
-	I-T170
group	I-T170
with	I-T170
arithmetic	I-T170
averaging	I-T170
(	I-T170
up	I-T170
##gm	I-T170
##a	I-T170
)	I-T170
method	I-T170
.	O
the	O
results	O
of	O
principal	O
components	O
analysis	O
(	O
pca	O
)	O
also	O
supported	O
the	O
up	B-T170
##gm	I-T170
##a	I-T170
clustering	B-T062
.	O
these	O
results	O
will	O
be	O
useful	O
not	O
only	O
for	O
the	O
scientific	O
conservation	O
and	O
management	O
of	O
pine	B-T204
##app	I-T204
##le	I-T204
germ	B-T204
##plasm	I-T204
but	O
also	O
for	O
the	O
improvement	O
of	O
the	O
current	O
pine	B-T204
##app	I-T204
##le	I-T204
breeding	B-T038
strategies	I-T038
.	O

genotyping	B-T058
of	O
staphylococcus	B-T007
aureus	I-T007
in	O
bovine	B-T038
mastitis	I-T038
and	O
correlation	O
to	O
phenotypic	O
characteristics	O
reducing	O
the	O
prevalence	O
of	O
mastitis	B-T038
caused	O
by	O
staphylococcus	B-T007
aureus	I-T007
(	O
s	B-T007
.	I-T007
aureus	I-T007
)	O
is	O
essential	O
to	O
improve	O
animal	B-T204
health	O
and	O
reduce	O
economic	O
losses	O
for	O
farmers	B-T097
.	O
the	O
clinical	O
outcome	O
of	O
acute	B-T038
mastitis	I-T038
and	O
risk	O
of	O
progression	O
to	O
persistent	O
mastitis	B-T038
can	O
,	O
at	O
least	O
to	O
some	O
extent	O
,	O
be	O
related	O
to	O
genetic	B-T017
variants	I-T017
of	O
the	O
strain	O
causing	O
the	O
infection	B-T038
.	O
in	O
the	O
present	O
study	B-T062
we	O
have	O
used	O
microarrays	O
to	O
investigate	O
the	O
presence	O
of	O
virulence	B-T038
genes	B-T017
in	O
s	B-T007
.	I-T007
aureus	I-T007
isolates	O
from	O
dairy	O
cows	O
with	O
acute	B-T038
clinical	I-T038
mastitis	I-T038
(	O
n	O
=	O
70	O
)	O
and	O
correlated	O
the	O
findings	B-T033
to	O
other	O
genotypic	O
and	O
phenotypic	O
characteristics	O
.	O
among	O
the	O
most	O
commonly	O
found	O
virulence	B-T103
factors	I-T103
were	O
genes	B-T017
encoding	O
several	O
hem	B-T103
##olysin	I-T103
types	O
,	O
leuk	B-T103
##oci	I-T103
##din	I-T103
##s	I-T103
d	I-T103
and	O
lu	B-T103
##k	I-T103
##m	I-T103
/	O
lu	B-T103
##k	I-T103
##f	I-T103
-	I-T103
p	I-T103
##83	I-T103
,	O
cl	B-T103
##ump	I-T103
##ing	I-T103
factors	I-T103
a	I-T103
and	O
b	B-T103
,	O
fibrinogen	B-T103
binding	I-T103
protein	I-T103
and	O
fibronectin	B-T103
-	I-T103
binding	I-T103
protein	I-T103
a	I-T103
.	O
some	O
virulence	B-T103
factors	I-T103
e	O
.	O
g	O
.	O
fibronectin	B-T103
-	I-T103
binding	I-T103
protein	I-T103
b	I-T103
and	O
staphylococcus	B-T007
aureus	I-T007
surface	B-T103
protein	I-T103
g	I-T103
were	O
less	O
common	O
.	O
genes	B-T017
coding	O
for	O
several	O
staphylococcal	O
enterotoxin	O
##s	O
and	O
toxic	B-T103
shock	I-T103
syndrome	I-T103
toxin	I-T103
-	I-T103
1	I-T103
(	O
tss	B-T103
##t	I-T103
-	I-T103
1	I-T103
)	O
were	O
commonly	O
found	O
,	O
especially	O
in	O
one	O
major	O
puls	O
##otype	O
.	O
no	B-T033
beta	B-T017
-	I-T017
lactamase	I-T017
genes	I-T017
were	O
found	O
in	O
any	O
common	O
puls	O
##otype	O
,	O
while	O
present	O
in	O
some	O
rare	O
puls	O
##otypes	O
,	O
indicated	O
to	O
be	O
of	O
human	O
origin	O
.	O
production	O
of	O
tss	B-T103
##t	I-T103
-	I-T103
1	I-T103
,	O
enterotoxin	B-T103
##s	I-T103
,	O
hem	B-T103
##olysin	I-T103
##s	I-T103
and	O
beta	B-T103
-	I-T103
lactamase	I-T103
could	O
all	O
be	O
positively	O
correlated	O
to	O
presence	O
of	O
the	O
corresponding	O
genes	B-T017
.	O
this	O
study	B-T062
reveals	O
a	O
number	O
of	O
genotypic	O
differences	O
and	O
similarities	O
among	O
common	O
and	O
rare	O
puls	O
##otypes	O
of	O
s	B-T007
.	I-T007
aureus	I-T007
from	O
cases	O
of	O
mastitis	B-T038
in	O
sweden	B-T082
.	O
the	O
results	O
could	O
help	O
the	O
design	O
of	O
diagnostic	B-T062
tools	I-T062
to	O
guide	O
on	O
-	O
farm	O
interventions	O
according	O
to	O
the	O
expected	O
impact	O
on	O
ud	B-T017
##der	I-T017
health	O
from	O
a	O
specific	O
s	B-T007
.	I-T007
aureus	I-T007
genotype	O
.	O

capsular	B-T103
polysaccharide	I-T103
types	O
and	O
virulence	B-T038
-	I-T038
related	I-T038
traits	O
of	O
epidemic	O
kp	B-T038
##c	I-T038
-	O
producing	O
klebsiella	B-T007
pneumoniae	I-T007
isolates	B-T103
in	O
a	O
chinese	B-T082
university	B-T092
hospital	I-T092
klebsiella	B-T007
pneumoniae	I-T007
is	O
an	O
important	O
human	B-T204
pathogen	O
associated	O
with	O
a	O
variety	O
of	O
diseases	B-T038
and	O
the	O
prevalence	O
of	O
bla	B-T017
##k	I-T017
##pc	I-T017
carrying	O
k	B-T007
.	I-T007
pneumoniae	I-T007
(	O
kp	B-T007
##c	I-T007
-	I-T007
kp	I-T007
)	O
is	O
rapidly	O
increasing	O
.	O
capsule	B-T103
is	O
an	O
important	O
virulence	B-T103
factor	I-T103
in	O
k	B-T007
.	I-T007
pneumoniae	I-T007
.	O
in	O
this	O
study	B-T062
,	O
we	O
determined	O
to	O
first	O
systematically	O
characterize	O
capsular	B-T103
polysaccharide	I-T103
(	O
cps	B-T103
)	O
and	O
virulence	B-T038
traits	O
in	O
kp	B-T007
##c	I-T007
-	I-T007
kp	I-T007
strains	O
.	O
a	O
total	O
of	O
56	O
kp	B-T007
##c	I-T007
-	I-T007
kp	I-T007
isolates	B-T103
were	O
recovered	O
from	O
clinical	O
samples	O
in	O
a	O
chinese	B-T092
hospital	I-T092
,	O
which	O
were	O
assigned	O
to	O
clonal	O
lineages	O
by	O
multilocus	B-T062
sequence	I-T062
typing	I-T062
(	O
ml	B-T062
##st	I-T062
)	O
.	O
capsule	B-T103
typing	B-T058
(	O
w	B-T058
##z	I-T058
##i	I-T058
sequencing	I-T058
and	O
w	B-T062
##z	I-T062
##c	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
[	O
pcr	B-T062
]	O
)	O
and	O
virulence	B-T038
genes	B-T017
were	O
characterized	O
by	O
molecular	B-T058
approaches	I-T058
.	O
the	O
virulence	B-T038
of	O
these	O
strains	O
was	O
determined	O
by	O
biofilm	B-T038
formation	I-T038
,	O
serum	B-T031
killing	B-T038
resistance	O
,	O
phagocytosis	B-T038
,	O
and	O
infection	B-T038
models	B-T170
.	O
six	O
different	O
sts	B-T033
were	O
found	B-T033
among	O
56	O
kp	B-T007
##c	I-T007
-	I-T007
kp	I-T007
isolates	B-T103
:	O
76	O
.	O
8	O
%	O
(	O
43	O
of	O
56	O
isolates	B-T103
)	O
belonged	O
to	O
st	B-T033
##11	I-T033
,	O
6	B-T033
isolates	B-T103
belonged	O
to	O
st	B-T033
##14	I-T033
##7	I-T033
,	O
4	O
isolates	B-T103
belonged	O
to	O
st	B-T033
##15	I-T033
,	O
1	O
isolate	O
belonged	O
to	O
st	B-T033
##145	I-T033
##6	I-T033
,	O
1	O
isolate	O
belonged	O
to	O
st	B-T033
##65	I-T033
,	O
and	O
1	O
isolate	O
was	O
st	B-T033
##23	I-T033
.	O
based	O
on	O
the	O
w	B-T058
##z	I-T058
##i	I-T058
gene	I-T058
dna	I-T058
sequences	I-T058
and	O
w	B-T062
##z	I-T062
##c	I-T062
pcr	I-T062
,	O
these	O
56	O
strains	O
were	O
classified	O
as	O
capsular	B-T103
type	O
w	B-T103
##z	I-T103
##i	I-T103
##47	I-T103
-	I-T103
k	I-T103
##47	I-T103
(	O
n	O
=	O
37	O
)	O
,	O
w	B-T103
##z	I-T103
##i	I-T103
##64	I-T103
-	I-T103
k	I-T103
##64	I-T103
(	O
n	O
=	O
8	O
)	O
,	O
w	B-T103
##z	I-T103
##i	I-T103
##8	I-T103
-	I-T103
k	I-T103
##8	I-T103
(	O
n	O
=	O
4	O
)	O
,	O
w	B-T103
##z	I-T103
##i	I-T103
##37	I-T103
-	I-T103
k	I-T103
##37	I-T103
(	O
n	O
=	O
4	O
)	O
,	O
w	B-T103
##z	I-T103
##i	I-T103
##53	I-T103
-	I-T103
k	I-T103
##53	I-T103
(	O
n	O
=	O
1	O
)	O
,	O
w	B-T103
##z	I-T103
##i1	I-T103
##25	I-T103
-	I-T103
k2	I-T103
(	O
n	O
=	O
1	O
)	O
,	O
and	O
w	B-T103
##z	I-T103
##i1	I-T103
-	I-T103
k1	I-T103
(	O
n	O
=	O
1	O
)	O
.	O
heterogeneity	O
was	O
detected	B-T033
in	O
biofilm	B-T038
formation	I-T038
and	O
phagocytosis	B-T038
among	O
different	O
cps	B-T103
types	O
.	O
st	B-T033
##11	I-T033
strains	O
were	O
less	O
virulent	O
than	O
other	O
st	B-T033
strains	O
.	O
kp	B-T007
##c	I-T007
-	I-T007
kp	I-T007
strains	O
exhibit	O
variability	O
of	O
virulence	B-T038
-	I-T038
associated	I-T038
traits	O
.	O
differences	O
were	O
associated	O
with	O
the	O
st	B-T033
types	O
and	O
cps	B-T103
.	O

oral	B-T058
health	I-T058
in	O
transition	O
:	O
the	O
had	B-T098
##z	I-T098
##a	I-T098
forage	I-T098
##rs	I-T098
of	O
tanzania	B-T082
conventional	O
wi	O
##sd	O
##om	O
holds	O
that	O
a	O
decline	O
in	O
oral	B-T058
health	I-T058
accompan	O
##ies	O
the	O
transition	O
from	O
hunting	O
and	O
gathering	O
to	O
agriculture	O
,	O
given	O
increased	O
consumption	B-T038
of	O
carbohydrates	B-T103
.	O
this	O
widely	O
to	O
##uted	O
example	O
of	O
the	O
mismatch	O
between	O
our	O
biology	B-T091
and	O
modern	O
lifestyle	O
has	O
been	O
intu	O
##ited	O
largely	O
from	O
the	O
bio	B-T170
##arch	I-T170
##ae	I-T170
##ological	I-T170
record	I-T170
of	O
the	O
neo	B-T103
##lit	I-T103
##hi	I-T103
##c	I-T103
revolution	I-T103
in	O
the	O
new	B-T098
world	I-T098
.	O
recent	O
studies	B-T062
of	O
other	O
populations	O
have	O
,	O
however	O
,	O
challenged	O
the	O
universal	O
##ity	O
of	O
this	O
asser	O
##tion	O
.	O
here	O
,	O
we	O
present	O
the	O
first	O
comprehensive	O
study	B-T062
of	O
oral	B-T058
health	I-T058
among	O
a	O
living	B-T098
population	I-T098
in	O
transition	O
from	O
the	O
bus	B-T204
##h	I-T204
to	O
village	O
life	O
,	O
the	O
had	B-T098
##z	I-T098
##a	I-T098
hun	O
##ter	O
-	O
gather	B-T098
##ers	I-T098
of	O
tanzania	B-T082
,	O
to	O
test	O
the	O
hypothesis	O
that	O
the	O
shift	O
from	O
foraging	O
to	O
farming	O
,	O
or	O
agricultural	O
intensification	O
,	O
inev	O
##itably	O
leads	O
to	O
increased	O
periodontal	B-T038
disease	I-T038
,	O
caries	B-T038
,	O
and	O
orthodontic	O
disorders	B-T038
.	O
our	O
results	O
showed	O
that	O
women	B-T098
living	O
in	O
villages	B-T082
consuming	B-T038
a	O
mostly	O
agricultural	B-T204
diet	B-T168
exhibited	O
more	O
caries	B-T038
and	O
periodontal	B-T038
disease	I-T038
than	O
those	O
living	O
in	O
the	O
bus	B-T204
##h	I-T204
consuming	B-T038
a	O
mostly	O
wild	B-T168
-	I-T168
food	I-T168
diet	I-T168
.	O
furthermore	O
,	O
men	B-T098
living	O
in	O
the	O
bus	B-T204
##h	I-T204
consuming	B-T038
mostly	O
a	O
wild	B-T168
-	I-T168
food	I-T168
diet	I-T168
had	O
more	O
than	O
those	O
living	O
in	O
the	O
village	B-T082
consuming	B-T038
a	O
mostly	O
agricultural	B-T204
diet	B-T168
.	O
these	O
findings	B-T033
are	O
explained	O
by	O
the	O
high	O
incidence	O
of	O
maize	B-T168
consumption	B-T038
in	O
village	B-T082
settings	O
,	O
along	O
with	O
previously	O
recognized	O
variation	O
in	O
rate	O
of	O
caries	B-T038
between	O
men	B-T098
and	O
women	B-T098
.	O
the	O
unexpected	O
discovery	O
of	O
high	O
caries	B-T038
incidences	O
for	O
men	B-T098
in	O
the	O
bus	B-T204
##h	I-T204
is	O
likely	O
explained	O
by	O
heavy	O
reliance	O
on	O
honey	B-T168
,	O
and	O
perhaps	O
differential	O
access	O
to	O
tobacco	O
and	O
marijuana	B-T103
.	I-T103
these	O
data	O
support	O
the	O
notion	O
##s	O
that	O
mechanisms	O
of	O
car	B-T038
##io	I-T038
##genesis	I-T038
are	O
multifactorial	B-T033
and	O
that	O
the	O
relationships	O
between	O
oral	B-T058
health	I-T058
and	O
the	O
shift	O
from	O
a	O
predominantly	O
wild	B-T168
-	I-T168
food	I-T168
diet	I-T168
to	O
one	O
dominated	O
by	O
cult	B-T204
##igen	I-T204
##s	I-T204
are	O
nu	O
##anced	O
.	O

a	O
delayed	O
diagnosis	B-T033
of	O
chronic	B-T038
mesenteric	I-T038
ischaemia	I-T038
:	O
the	O
role	O
of	O
clinicians	B-T097
'	O
cognitive	O
errors	O
chronic	O
diarrhoea	B-T038
##l	I-T038
illnesses	I-T038
with	O
nausea	B-T033
and	O
weight	B-T033
loss	I-T033
are	O
a	O
common	O
indication	O
for	O
gastroenter	B-T091
##ology	I-T091
review	O
.	O
while	O
many	O
such	O
cases	O
have	O
intra	B-T082
-	I-T082
luminal	I-T082
aeti	O
##ologies	O
,	O
such	O
as	O
inflammatory	B-T038
bowel	I-T038
disease	I-T038
,	O
coeliac	B-T038
disease	I-T038
or	O
other	O
mal	B-T033
##abs	I-T033
##orptive	I-T033
conditions	I-T033
,	O
with	O
many	O
other	O
cases	O
due	O
to	O
functional	O
gut	B-T017
disorders	B-T038
or	O
systemic	O
malignancy	B-T038
,	O
clinicians	B-T097
must	O
also	O
keep	O
vascular	B-T038
disorders	I-T038
in	O
mind	O
.	O
here	O
we	O
report	O
a	O
patient	O
with	O
a	O
delayed	O
diagnosis	B-T033
of	O
chronic	B-T038
mesenteric	I-T038
ischaemia	I-T038
after	O
6	O
months	O
of	O
gastrointestinal	B-T033
symptoms	I-T033
strongly	O
mimicking	O
an	O
alternative	O
diagnosis	B-T033
such	O
as	O
inflammatory	B-T038
bowel	I-T038
disease	I-T038
due	O
an	O
atypical	O
predominance	O
of	O
nausea	B-T033
and	O
diarrhoea	B-T033
rather	O
than	O
pain	B-T033
.	O
we	O
briefly	O
review	O
the	O
literature	B-T170
on	O
treatment	O
of	O
this	O
condition	B-T038
but	O
also	O
discuss	O
with	O
particular	O
attention	O
the	O
sequence	O
of	O
cognitive	O
errors	O
made	O
by	O
clinicians	B-T097
that	O
led	O
to	O
a	O
diagnostic	B-T033
delay	O
,	O
inv	O
##iting	O
readers	O
to	O
thus	O
reflect	O
on	O
how	O
such	O
errors	O
can	O
be	O
minim	O
##ised	O
in	O
their	O
practice	O
.	O

cxcl	B-T103
##5	I-T103
plays	O
a	O
promoting	O
role	O
in	O
osteosarcoma	B-T038
cell	B-T038
migration	I-T038
and	I-T038
invasion	I-T038
in	O
autocrine	B-T038
-	O
and	O
paracrine	O
-	O
dependent	O
manner	O
##s	O
cxcl	B-T103
##5	I-T103
,	O
a	O
cx	B-T103
##c	I-T103
-	I-T103
type	I-T103
chemokine	I-T103
,	O
is	O
an	O
important	O
attract	O
##ant	O
for	O
granul	B-T017
##ocytic	I-T017
immune	I-T017
cells	I-T017
by	O
binding	B-T038
to	I-T038
its	I-T038
receptor	I-T038
cxcr	I-T038
##2	I-T038
.	O
recently	O
,	O
cxcl	B-T103
##5	I-T103
/	O
cxcr	B-T103
##2	I-T103
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	B-T103
role	O
in	O
many	O
human	B-T204
cancers	B-T038
.	O
however	O
,	O
the	O
exact	O
role	O
of	O
cxcl	B-T103
##5	I-T103
in	O
osteosarcoma	B-T038
cell	B-T038
migration	I-T038
and	I-T038
invasion	I-T038
has	O
not	O
been	O
revealed	O
.	O
here	O
we	O
found	O
that	O
the	O
protein	B-T038
expression	I-T038
of	O
cxcl	B-T103
##5	I-T103
was	O
significantly	O
increased	O
in	O
osteosarcoma	B-T038
tissues	B-T017
compared	O
with	O
that	O
in	O
matched	B-T017
adjacent	I-T017
nont	I-T017
##umor	I-T017
tissues	I-T017
.	O
moreover	O
,	O
the	O
expression	B-T038
of	O
cxcl	B-T103
##5	I-T103
was	O
significantly	O
associated	O
with	O
advanced	O
clinical	O
stage	O
and	O
metastasis	B-T038
.	O
further	O
investigation	O
showed	O
that	O
the	O
cxcl	B-T103
##5	I-T103
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	B-T038
cell	B-T017
lines	I-T017
,	O
including	O
sao	B-T017
##s	I-T017
-	I-T017
2	I-T017
,	O
mg	B-T017
##63	I-T017
,	O
u	B-T017
##2o	I-T017
##s	I-T017
,	O
and	O
sw	B-T017
##13	I-T017
##53	I-T017
,	O
when	O
compared	O
with	O
those	O
in	O
normal	B-T017
osteoblast	I-T017
hf	B-T017
##ob	I-T017
##1	I-T017
.	I-T017
19	I-T017
cells	I-T017
.	O
u	B-T017
##2o	I-T017
##s	I-T017
cells	I-T017
were	O
further	O
transfected	B-T038
with	O
cxcl	B-T017
##5	I-T017
-	O
specific	B-T103
sirna	I-T103
or	O
overexpression	B-T038
plasmid	B-T103
.	O
knockdown	B-T062
of	O
cxcl	B-T017
##5	I-T017
significantly	O
suppressed	O
u	B-T017
##2o	I-T017
##s	I-T017
cell	B-T038
migration	I-T038
and	I-T038
invasion	I-T038
.	O
on	O
the	O
contrary	O
,	O
overexpression	B-T038
of	O
cx	B-T103
##lc	I-T103
##5	I-T103
remarkably	O
promoted	O
the	O
migration	B-T038
and	I-T038
invasion	I-T038
of	O
u	B-T017
##2o	I-T017
##s	I-T017
cells	I-T017
.	O
interestingly	O
,	O
both	O
exogenous	O
cxcl	B-T103
##5	I-T103
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
cxcl	B-T103
##5	I-T103
-	O
overexpressing	B-T038
hf	B-T017
##ob	I-T017
##1	I-T017
.	I-T017
19	I-T017
cells	I-T017
could	O
also	O
enhance	O
the	O
migration	B-T038
and	I-T038
invasion	I-T038
of	O
u	B-T017
##2o	I-T017
##s	I-T017
cells	I-T017
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
cxcl	B-T103
##5	I-T103
in	O
u	B-T017
##2o	I-T017
##s	I-T017
cell	B-T038
migration	I-T038
and	I-T038
invasion	I-T038
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O
according	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
cxcl	B-T103
##5	I-T103
is	O
upregulated	O
in	O
osteosarcoma	B-T038
and	O
may	O
play	O
an	O
oncogenic	B-T103
role	O
in	O
osteosarcoma	B-T038
metastasis	B-T038
.	O
therefore	O
,	O
cxcl	B-T103
##5	I-T103
may	O
become	O
a	O
potential	O
therapeutic	O
target	O
for	O
osteosarcoma	B-T038
treatment	O
.	O

interventions	B-T058
to	O
improve	B-T033
grand	O
##par	O
##ent	O
caregivers	O
'	O
mental	B-T038
and	O
physical	B-T033
health	I-T033
:	O
an	O
integrative	B-T170
review	I-T170
the	O
aim	O
of	O
this	O
integrative	B-T170
review	I-T170
is	O
to	O
appra	O
##ise	O
grand	O
##par	O
##ent	O
caregiver	O
interventions	B-T058
that	O
are	O
designed	O
to	O
improve	B-T033
their	O
physical	B-T033
and	O
mental	B-T038
health	I-T038
.	O
a	O
database	B-T170
search	O
was	O
performed	O
to	O
identify	O
relevant	O
studies	B-T062
published	O
between	O
january	O
1	O
,	O
1980	O
,	O
and	O
december	O
31	O
,	O
2014	O
.	O
thirteen	O
publications	B-T170
,	O
including	O
11	O
studies	B-T062
,	O
met	O
all	O
inclusion	O
and	O
exclusion	O
criteria	O
.	O
all	O
studies	B-T062
included	O
grand	O
##par	O
##ent	O
mental	B-T038
health	I-T038
outcomes	O
with	O
fewer	O
focusing	O
on	O
physical	B-T033
health	I-T033
and	O
social	B-T098
relations	I-T098
.	O
improvements	O
were	O
found	O
in	O
all	O
three	O
areas	B-T082
with	O
fewer	O
improvements	O
seen	O
in	O
physical	B-T033
health	I-T033
.	O
however	O
,	O
small	O
effect	O
sizes	O
were	O
seen	O
with	O
most	O
measures	O
of	O
these	O
outcomes	O
.	O
although	O
the	O
interventions	B-T058
led	O
to	O
positive	O
grand	O
##par	O
##ent	O
caregiver	O
outcomes	O
,	O
the	O
studies	B-T062
were	O
limited	O
by	O
their	O
design	O
,	O
only	O
one	O
of	O
which	O
was	O
a	O
randomized	B-T062
controlled	I-T062
trial	I-T062
.	O
also	O
,	O
interventions	B-T058
did	O
not	O
consider	O
variations	O
in	O
the	O
grand	O
##child	O
'	O
s	O
or	O
parent	O
'	O
s	O
ages	O
or	O
if	O
the	O
grand	O
##par	O
##ent	O
provided	O
primary	O
or	O
shared	O
care	O
.	O
these	O
gaps	O
should	O
be	O
addressed	O
in	O
future	O
research	B-T062
.	O

help	O
end	O
the	O
hiv	B-T005
epidemic	O
after	O
many	O
delays	O
,	O
the	O
public	O
consultation	O
on	O
hiv	O
prevention	O
tool	B-T170
prep	B-T058
(	O
pre	B-T058
-	I-T058
exposure	I-T058
prophylaxis	I-T058
)	O
is	O
finally	O
here	O
.	O
now	O
is	O
the	O
time	O
to	O
mobil	O
##ise	O
-	O
help	O
end	O
the	O
hiv	B-T005
epidemic	O
by	O
responding	O
to	O
this	O
nhs	O
england	O
consultation	O
before	O
23	O
september	O
.	O

inflammatory	O
and	O
oxidative	B-T038
stress	I-T038
markers	B-T201
in	O
experimental	O
allergic	B-T038
asthma	I-T038
ovalbumin	B-T103
-	O
induced	O
allergic	B-T038
lung	I-T038
inflammation	I-T038
(	O
ali	B-T038
)	O
is	O
a	O
condition	O
believed	O
to	O
be	O
mediated	O
by	O
cytokines	B-T103
,	O
extracellular	B-T017
matrix	I-T017
remodeling	B-T038
,	O
and	O
redox	B-T038
imbalance	B-T033
.	O
in	O
this	O
study	B-T062
,	O
we	O
evaluated	B-T058
pulmonary	B-T038
function	I-T038
together	O
with	O
inflammatory	O
markers	B-T201
as	O
interleukin	B-T103
-	I-T103
4	I-T103
(	O
il	B-T103
-	I-T103
4	I-T103
)	O
,	O
myeloperoxidase	B-T103
(	O
mpo	B-T103
)	O
,	O
eosinophil	B-T017
cells	I-T017
,	O
and	O
redox	B-T038
markers	B-T201
in	O
the	O
lungs	B-T017
of	O
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
after	O
ovalbumin	B-T103
(	O
ova	B-T103
)	O
sensitization	B-T038
and	O
challenge	B-T058
.	O
our	O
results	O
showed	O
an	O
increase	O
in	O
bronchial	B-T038
hyperresponsiveness	I-T038
stimulated	O
by	O
methacholine	B-T103
(	O
mch	B-T103
)	O
,	O
inflammatory	O
cell	B-T038
influx	I-T038
,	O
especially	O
eosinophils	B-T017
together	O
with	O
an	O
increase	O
of	O
high	B-T103
mobility	I-T103
group	I-T103
box	I-T103
1	I-T103
(	O
hmgb1	B-T103
)	O
and	O
altered	O
lipid	B-T038
peroxidation	I-T038
(	O
lp	B-T038
)	O
and	O
antioxidant	B-T103
defenses	O
in	O
the	O
ova	B-T103
group	O
compared	O
to	O
the	O
control	O
group	O
(	O
p	O
≤	O
0	O
.	O
5	O
)	O
.	O
thus	O
,	O
we	O
demonstrated	O
that	O
ova	B-T103
-	O
induced	O
ali	B-T038
altered	O
redox	B-T038
status	O
concomitantly	O
with	O
impaired	O
lung	B-T038
function	I-T038
,	O
which	O
was	O
associated	O
with	O
hmgb1	B-T103
expression	B-T038
and	O
proteolytic	B-T038
remodeling	B-T038
.	O
taken	O
together	O
all	O
results	O
found	O
here	O
,	O
we	O
may	O
suggest	O
hmgb1	B-T103
is	O
an	O
important	O
therapeutic	O
target	O
for	O
asthma	B-T038
,	O
once	O
orches	O
##trate	O
##s	O
the	O
redox	B-T038
signaling	B-T038
,	O
inflammation	B-T038
,	O
and	O
remodeling	B-T038
that	O
contribute	O
to	O
the	O
disease	B-T038
development	O
.	O

complete	O
genome	B-T058
sequence	I-T058
analysis	I-T058
of	O
a	O
naturally	O
reass	O
##orted	O
infectious	B-T005
burs	I-T005
##al	I-T005
disease	I-T005
virus	I-T005
from	O
india	B-T082
the	O
novel	O
infectious	B-T005
burs	I-T005
##al	I-T005
disease	I-T005
virus	I-T005
(	O
ibd	B-T005
##v	I-T005
)	O
isolate	B-T103
bg	B-T005
##e1	I-T005
##4	I-T005
/	I-T005
ab	I-T005
##t1	I-T005
/	I-T005
mvc	I-T005
/	I-T005
india	I-T005
is	O
a	O
very	O
virulent	O
ibd	B-T005
##v	I-T005
that	O
was	O
isolated	B-T103
from	O
broiler	B-T204
flocks	I-T204
in	O
southern	O
parts	O
of	O
india	B-T082
during	O
2014	O
.	O
here	O
,	O
we	O
report	O
,	O
for	O
the	O
first	O
time	O
in	O
india	B-T082
,	O
the	O
complete	O
genome	B-T017
sequence	I-T017
of	O
bg	B-T005
##e1	I-T005
##4	I-T005
/	I-T005
ab	I-T005
##t1	I-T005
/	I-T005
mvc	I-T005
/	I-T005
india	I-T005
,	O
a	O
reass	O
##ort	O
##ment	O
strain	O
with	O
segments	B-T017
a	I-T017
and	I-T017
b	I-T017
derived	O
from	O
a	O
very	O
virulent	O
ibd	B-T005
##v	I-T005
strain	O
and	O
an	O
attenuated	O
ibd	B-T005
##v	I-T005
,	O
respectively	O
.	O
the	O
findings	O
from	O
this	O
study	O
provide	O
additional	O
insight	O
into	O
the	O
genetic	B-T038
exchange	I-T038
between	O
attenuated	O
and	O
very	O
virulent	O
strains	O
of	O
ibd	B-T005
##v	I-T005
circulating	O
in	B-T082
the	I-T082
field	I-T082
.	O

starvation	B-T033
-	O
and	O
antibiotics	B-T103
-	O
induced	O
formation	B-T038
of	O
persist	B-T007
##er	I-T007
cells	I-T007
in	O
pseudomonas	B-T007
aeruginosa	I-T007
planktonic	B-T007
stationary	B-T058
and	I-T058
exponential	I-T058
cultures	I-T058
of	O
pseudomonas	B-T007
aeruginosa	I-T007
are	O
highly	O
resistant	O
to	O
killing	B-T033
by	O
bactericidal	B-T103
antimicrobials	I-T103
because	O
of	O
the	O
presence	O
of	O
persist	B-T007
##ers	I-T007
,	O
cells	B-T007
that	O
are	O
multidrug	B-T033
tolerant	I-T033
and	O
play	O
a	O
key	O
role	O
in	O
the	O
recalcitr	O
##ance	O
of	O
biofilm	B-T007
infections	B-T038
.	O
the	O
aim	O
of	O
this	O
study	B-T170
was	O
to	O
investigate	O
the	O
formation	B-T038
of	O
persist	B-T007
##er	I-T007
cells	I-T007
in	O
p	B-T007
.	I-T007
aeruginosa	I-T007
stationary	B-T058
vs	O
.	O
exponential	B-T058
cultures	I-T058
using	O
different	O
class	B-T170
antimicrobials	B-T103
.	O
the	O
susceptib	O
##ilities	O
of	O
p	B-T007
.	I-T007
aeruginosa	I-T007
pao	I-T007
##1	I-T007
wild	I-T007
-	I-T007
type	I-T007
and	O
mutant	O
strains	O
to	O
antimicrobials	B-T103
were	O
determined	O
by	O
standard	B-T058
microti	I-T058
##ter	I-T058
broth	I-T058
dilution	I-T058
method	I-T058
.	O
in	O
order	O
to	O
determine	O
persist	B-T007
##er	I-T007
formation	B-T038
,	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
killing	B-T058
experiments	I-T058
were	O
performed	O
with	O
antibiotics	B-T103
.	O
ceftazidime	B-T103
(	O
cephalosporin	B-T103
)	O
showed	O
little	O
efficacy	O
against	O
either	O
culture	B-T058
.	O
stationary	B-T007
-	I-T007
phase	I-T007
cells	I-T007
were	O
more	O
tolerant	B-T033
to	O
imipenem	B-T103
(	O
carbapenem	B-T103
)	O
than	O
exponential	B-T007
cells	I-T007
,	O
leaving	O
a	O
small	O
fraction	O
of	O
persist	B-T007
##ers	I-T007
at	O
high	O
imipenem	B-T103
concentration	O
in	O
both	O
populations	B-T098
.	O
polym	B-T103
##yxin	I-T103
b	I-T103
(	O
polym	B-T103
##yxin	I-T103
)	O
appeared	O
to	O
be	O
ineffective	O
at	O
low	O
concentrations	O
against	O
both	O
cell	B-T098
populations	I-T098
.	O
very	O
high	O
polym	B-T103
##yxin	I-T103
b	I-T103
concentration	O
completely	O
eradicate	O
##d	O
exponential	B-T007
cells	I-T007
and	O
regrowth	O
was	O
seen	O
in	O
a	O
stationary	B-T098
population	I-T098
.	O
stationary	B-T007
cells	I-T007
were	O
more	O
tolerant	B-T033
to	O
tobramycin	B-T103
(	O
aminoglycoside	B-T103
)	O
than	O
exponential	B-T007
cells	I-T007
but	O
a	O
higher	O
concentration	O
of	O
tobramycin	B-T103
completely	O
eliminated	O
survivors	O
.	O
ciprofloxacin	B-T103
(	O
fluoroquinolone	B-T103
)	O
at	O
a	O
low	O
concentration	O
resulted	O
in	O
killing	B-T033
of	O
both	O
cultures	B-T058
of	O
p	B-T007
.	I-T007
aeruginosa	I-T007
,	O
producing	O
persist	B-T007
##ers	I-T007
that	O
were	O
inv	O
##ul	O
##ner	O
##able	O
to	O
killing	B-T033
.	O
stationary	B-T007
cells	I-T007
appear	O
to	O
be	O
somewhat	O
more	O
tolerant	B-T033
than	O
exponential	B-T007
cells	I-T007
in	O
all	O
of	O
these	O
assays	B-T058
.	O
we	O
also	O
showed	O
that	O
nutrient	B-T168
deprivation	O
(	O
serine	B-T103
starvation	B-T033
)	O
regulated	O
by	O
stringent	B-T038
and	I-T038
general	I-T038
stress	I-T038
response	I-T038
,	O
contribute	O
to	O
the	O
increased	B-T033
tolerance	I-T033
of	O
p	B-T007
.	I-T007
aeruginosa	I-T007
exponential	B-T007
and	I-T007
stationary	I-T007
planktonic	I-T007
cells	I-T007
via	O
production	B-T038
of	O
persist	B-T007
##ers	I-T007
.	O

best	B-T170
:	O
next	O
-	O
generation	O
biomedical	B-T170
entity	I-T170
search	I-T170
tool	I-T170
for	O
knowledge	B-T170
discovery	O
from	O
biomedical	O
literature	O
as	O
the	O
volume	O
of	O
publications	B-T170
rapidly	O
increases	O
,	O
searching	O
for	O
relevant	O
information	O
from	O
the	O
literature	B-T170
becomes	O
more	O
challenging	B-T033
.	O
to	O
complement	O
standard	O
search	B-T170
engine	I-T170
##s	I-T170
such	O
as	O
pubmed	B-T170
,	O
it	O
is	O
desirable	O
to	O
have	O
an	O
advanced	B-T170
search	I-T170
tool	I-T170
that	O
directly	O
returns	O
relevant	O
biomedical	O
entities	O
such	O
as	O
targets	B-T074
,	O
drugs	B-T103
,	O
and	O
mutations	B-T038
rather	O
than	O
a	O
long	O
list	O
of	O
articles	O
.	O
some	O
existing	B-T033
tools	B-T170
subm	O
##it	O
a	O
query	B-T170
to	O
pubmed	B-T170
and	O
process	O
retrieved	O
abstracts	B-T170
to	O
extract	O
information	O
at	O
query	B-T170
time	O
,	O
resulting	O
in	O
a	O
slow	O
response	O
time	O
and	O
limited	O
coverage	O
of	O
only	O
a	O
fraction	O
of	O
the	O
pubmed	B-T170
corpus	I-T170
.	O
other	O
tools	B-T170
prepro	O
##cess	O
the	O
pubmed	B-T170
corpus	I-T170
to	O
speed	O
up	O
the	O
response	O
time	O
;	O
however	O
,	O
they	O
are	O
not	O
constantly	O
updated	O
,	O
and	O
thus	O
produce	O
outd	B-T170
##ated	I-T170
results	O
.	O
further	O
,	O
most	O
existing	O
tools	B-T170
cann	O
##ot	O
process	O
sophisticated	O
quer	B-T170
##ies	I-T170
such	O
as	O
searches	O
for	O
mutations	B-T038
that	O
co	O
-	O
occur	O
with	O
query	B-T170
terms	O
in	O
the	O
literature	B-T170
.	O
to	O
address	O
these	O
problems	B-T033
,	O
we	O
introduce	O
best	B-T170
,	O
a	O
biomedical	B-T170
entity	I-T170
search	I-T170
tool	I-T170
.	O
best	B-T170
returns	O
,	O
as	O
a	O
result	O
,	O
a	O
list	O
of	O
10	O
different	O
types	O
of	O
biomedical	O
entities	O
including	O
genes	B-T017
,	O
diseases	B-T038
,	O
drugs	B-T103
,	O
targets	B-T074
,	O
transcription	B-T103
factors	I-T103
,	O
mirnas	B-T103
,	O
and	O
mutations	B-T038
that	O
are	O
relevant	O
to	O
a	O
user	O
'	O
s	O
query	B-T170
.	O
to	O
the	O
best	O
of	O
our	O
knowledge	B-T170
,	O
best	B-T170
is	O
the	O
only	O
system	O
that	O
processes	O
free	O
text	B-T170
quer	B-T170
##ies	I-T170
and	O
returns	O
up	B-T033
-	I-T033
to	I-T033
-	I-T033
date	I-T033
results	O
in	O
real	O
time	O
including	O
mutation	B-T038
information	O
in	O
the	O
results	O
.	O
best	B-T170
is	O
freely	O
accessible	O
at	O
http	O
:	O
/	O
/	O
best	O
.	O
korea	O
.	O
ac	O
.	O
kr	O
.	O

primary	O
pituitary	B-T017
diffuse	B-T038
large	I-T038
b	I-T038
-	I-T038
cell	I-T038
lymphoma	I-T038
with	O
somat	B-T017
##otroph	I-T017
hyperplasia	I-T017
and	O
acromegaly	B-T038
:	O
case	B-T170
report	I-T170
diffuse	B-T038
large	I-T038
b	I-T038
-	I-T038
cell	I-T038
lymphoma	I-T038
(	O
dlbcl	B-T038
)	O
is	O
the	O
most	O
common	O
type	O
of	O
non	B-T038
-	I-T038
hodgkin	I-T038
lymphoma	I-T038
and	O
comprises	O
approximately	O
30	O
%	O
of	O
all	O
lymphomas	B-T038
.	O
patients	O
typically	O
present	B-T033
with	O
a	O
nonp	O
##ain	O
##ful	O
mass	B-T033
in	O
the	O
neck	B-T082
,	O
groin	B-T082
,	O
or	O
abdomen	B-T082
associated	O
with	O
constitutional	B-T033
symptoms	I-T033
.	O
in	O
this	O
report	B-T170
,	O
however	O
,	O
the	O
authors	B-T097
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	B-T098
with	O
hyperprolactin	B-T038
##emia	I-T038
,	O
hypothyroidism	B-T038
,	O
and	O
acromegaly	B-T038
(	O
elevation	O
of	O
insulin	B-T103
-	I-T103
like	I-T103
growth	I-T103
factor	I-T103
-	I-T103
1	I-T103
[	O
igf	B-T103
-	I-T103
1	I-T103
]	O
)	O
with	O
elevated	O
growth	B-T103
hormone	I-T103
-	I-T103
releasing	I-T103
hormone	I-T103
(	O
ghrh	B-T103
)	O
in	O
whom	O
an	O
mri	B-T058
demonstrated	O
diffuse	B-T033
enlargement	I-T033
of	I-T033
the	I-T033
pituitary	I-T033
gland	I-T033
.	O
despite	O
medical	B-T058
treatment	I-T058
,	O
the	O
patient	O
had	O
persistent	O
elevation	O
of	O
igf	B-T103
-	I-T103
1	I-T103
.	O
she	O
underwent	O
a	O
transs	B-T058
##phen	I-T058
##oidal	I-T058
biopsy	I-T058
,	O
which	O
yielded	O
a	O
diagnosis	B-T033
of	O
dlbcl	B-T038
with	O
an	O
activated	O
b	B-T017
-	I-T017
cell	I-T017
immunophen	B-T058
##otype	I-T058
with	O
somat	B-T017
##otroph	I-T017
hyperplasia	I-T017
.	O
after	O
stereo	B-T058
-	I-T058
tactic	I-T058
radiation	I-T058
therapy	I-T058
in	O
combination	O
with	O
chemotherapy	B-T058
,	O
she	O
is	O
currently	O
in	O
remission	B-T038
from	O
her	O
lymphoma	B-T038
and	O
has	O
normalized	B-T062
igf	B-T103
-	I-T103
1	I-T103
levels	O
without	O
medical	B-T058
therapy	I-T058
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	B-T033
.	O
this	O
is	O
the	O
only	O
reported	B-T170
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	B-T058
diagnosis	I-T058
,	O
multidisciplinary	B-T058
evaluation	I-T058
,	O
and	O
critical	O
intraoperative	O
decision	B-T038
-	I-T038
making	I-T038
when	O
treating	O
atypical	O
sel	B-T017
##la	I-T017
##r	I-T017
lesions	B-T033
.	O

quantitative	O
analysis	O
of	O
cell	B-T038
proliferation	I-T038
by	O
a	O
dye	B-T058
dilution	I-T058
assay	I-T058
:	O
application	O
to	O
cell	B-T017
lines	I-T017
and	O
coculture	B-T058
##s	I-T058
cell	B-T038
proliferation	I-T038
represents	O
one	O
of	O
the	O
most	O
fundamental	O
processes	B-T038
in	I-T038
biological	I-T038
systems	I-T038
,	O
thus	O
the	O
quantitative	O
analysis	O
of	O
cell	B-T038
proliferation	I-T038
is	O
important	O
in	O
many	O
biological	B-T091
applications	O
such	O
as	O
drug	B-T058
screening	I-T058
,	O
production	O
of	O
biologics	B-T103
,	O
and	O
assessment	B-T058
of	O
cytotoxicity	B-T038
.	O
conventional	O
proliferation	B-T062
assays	I-T062
mainly	O
quantify	O
cell	B-T058
number	I-T058
based	O
on	O
a	O
calibration	O
curve	O
of	O
a	O
homogeneous	O
cell	B-T017
population	I-T017
,	O
and	O
therefore	O
are	O
not	O
applicable	O
for	O
the	O
analysis	B-T062
of	O
coculture	B-T017
##d	I-T017
cells	I-T017
.	O
moreover	O
,	O
these	O
assays	B-T058
measure	O
cell	B-T038
proliferation	I-T038
indirectly	O
,	O
based	O
on	O
cellular	B-T038
metabolic	I-T038
activity	I-T038
or	O
dna	O
content	O
.	O
to	O
overcome	O
these	O
shortcomings	O
,	O
a	O
dye	B-T058
dilution	I-T058
assay	I-T058
employing	O
fluorescent	B-T103
cell	I-T103
tracking	I-T103
dyes	I-T103
that	O
are	O
retained	O
within	O
cells	B-T017
was	O
applied	O
and	O
was	O
diluted	O
proportionally	O
by	O
subsequent	O
cell	B-T038
divisions	I-T038
.	O
here	O
,	O
it	O
was	O
demonstrated	O
that	O
this	O
assay	B-T058
could	O
be	O
implemented	O
to	O
quantitatively	O
analyze	O
the	O
cell	B-T038
proliferation	I-T038
of	O
different	O
types	O
of	O
cell	B-T017
lines	I-T017
,	O
and	O
to	O
concurrently	O
analyze	B-T062
the	O
proliferation	O
of	O
two	O
types	O
of	O
cell	B-T017
lines	I-T017
in	O
coculture	B-T058
by	O
utilizing	O
cell	B-T062
tracking	I-T062
dyes	B-T103
with	O
different	O
spectral	O
characteristics	O
.	O
the	O
mean	O
division	O
time	O
estimated	O
by	O
the	O
dye	B-T058
dilution	I-T058
assay	I-T058
is	O
compared	O
with	O
the	O
population	O
doubling	O
time	O
obtained	O
from	O
conventional	O
methods	B-T170
and	O
values	O
from	O
literature	B-T170
.	O
additionally	O
,	O
dye	B-T103
transfer	O
between	O
coculture	B-T017
##d	I-T017
cells	I-T017
was	O
investigated	O
and	O
it	O
was	O
found	O
that	O
it	O
is	O
a	O
characteristic	O
of	O
the	O
cells	B-T017
rather	O
than	O
a	O
characteristic	O
of	O
the	O
dye	B-T103
.	O
it	O
was	O
suggested	O
that	O
this	O
method	O
can	O
be	O
easily	O
combined	O
with	O
other	O
flow	B-T058
cytometric	I-T058
analyses	I-T058
of	O
cellular	B-T017
properties	O
,	O
providing	O
valuable	O
information	O
on	O
cell	O
status	O
under	O
diverse	O
conditions	O
.	O
©	O
2017	O
international	O
society	O
for	O
advancement	O
of	O
cytometry	O
.	O

clinical	O
and	O
angiographic	B-T058
correlation	O
of	O
high	B-T103
-	I-T103
sensitivity	I-T103
c	I-T103
-	I-T103
reactive	I-T103
protein	I-T103
with	O
acute	B-T038
st	I-T038
elevation	I-T038
myocardial	I-T038
infarction	I-T038
vascular	B-T038
inflammation	I-T038
and	O
associated	O
ongoing	O
inflammatory	B-T038
responses	I-T038
are	O
considered	O
as	O
the	O
critical	O
cul	O
##pri	O
##ts	O
in	O
the	O
pathogenesis	B-T038
of	O
acute	O
ather	B-T017
##oth	I-T017
##romb	I-T017
##otic	I-T017
events	O
such	O
as	O
acute	B-T038
coronary	I-T038
syndrome	I-T038
(	O
acs	B-T038
)	O
and	O
myocardial	B-T038
infarction	I-T038
(	O
mi	B-T038
)	O
.	O
st	B-T038
segment	I-T038
elevation	I-T038
myocardial	I-T038
infarction	I-T038
(	O
stemi	B-T038
)	O
is	O
considered	O
as	O
one	O
of	O
the	O
prominent	O
clinical	O
forms	O
of	O
acs	B-T038
.	O
moreover	O
,	O
c	B-T103
-	I-T103
reactive	I-T103
protein	I-T103
(	O
crp	B-T103
)	O
is	O
an	O
important	O
acute	B-T103
phase	I-T103
prs	I-T103
##ote	I-T103
##in	I-T103
,	O
which	O
may	O
be	O
estimated	O
using	O
high	B-T058
-	I-T058
sensitivity	I-T058
methods	I-T058
(	O
hs	B-T058
-	I-T058
crp	I-T058
)	O
,	O
and	O
its	O
elevated	O
level	B-T033
in	O
body	B-T031
fluids	I-T031
reflects	O
chronic	B-T038
inflammatory	I-T038
status	O
.	O
the	O
circulating	O
hs	B-T058
-	I-T058
crp	I-T058
level	B-T033
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	B-T038
marker	B-T201
of	O
coronary	B-T038
artery	I-T038
disease	I-T038
(	O
cad	B-T038
)	O
.	O
the	O
present	O
study	B-T062
investigated	O
the	O
correlation	O
of	O
hs	B-T058
-	I-T058
crp	I-T058
level	B-T033
with	O
clinical	O
and	O
angiographic	B-T058
features	O
of	O
stemi	B-T038
,	O
various	O
other	O
traditional	O
risk	B-T033
factors	I-T033
,	O
complications	B-T038
of	O
myocardial	B-T038
infarction	I-T038
and	O
angiographically	O
significant	O
cad	B-T038
.	O
out	O
of	O
190	O
patients	O
with	O
stemi	B-T038
that	O
were	O
analyzed	B-T062
,	O
the	O
interval	O
between	O
symptom	O
onset	O
and	O
reperfusion	B-T058
therapy	I-T058
(	O
window	O
period	O
)	O
varied	O
from	O
0	O
.	O
5	O
to	O
24	O
h	O
.	O
the	O
hs	B-T058
-	I-T058
crp	I-T058
value	O
was	O
found	O
to	O
be	O
higher	O
in	O
non	O
-	O
diabetic	O
patients	O
(	O
0	O
.	O
61	O
mg	O
/	O
dl	O
)	O
compared	O
with	O
diabetic	B-T038
patients	O
(	O
0	O
.	O
87	O
mg	O
/	O
dl	O
)	O
.	O
moreover	O
,	O
a	O
significant	O
correlation	O
between	O
hs	B-T058
-	I-T058
crp	I-T058
and	O
hs	B-T058
-	I-T058
troponin	I-T058
t	I-T058
was	O
also	O
recorded	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
however	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
mean	O
hs	B-T058
-	I-T058
crp	I-T058
values	O
in	O
patients	O
with	O
or	O
without	O
mortality	O
.	O
it	O
is	O
considered	O
that	O
the	O
present	O
study	B-T062
will	O
increase	O
the	O
understanding	O
of	O
atherosclerosis	B-T038
in	O
general	O
and	O
may	O
also	O
have	O
clinical	O
applications	O
in	O
the	O
targeting	O
of	O
therapy	B-T058
for	O
this	O
harmful	O
disease	B-T038
.	O

hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
in	O
women	B-T098
with	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
:	O
prevalence	O
,	O
characteristics	O
and	O
association	O
with	O
body	B-T201
mass	I-T201
index	I-T201
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
is	O
one	O
of	O
the	O
major	O
diagnostic	O
features	O
for	O
the	O
diagnosis	B-T033
of	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
(	O
pcos	B-T038
)	O
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
estimate	O
the	O
prevalence	O
and	O
the	O
characteristics	O
of	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
in	O
women	B-T098
with	O
pcos	B-T038
and	O
to	O
investigate	O
the	O
association	O
of	O
clinical	O
and	O
biochemical	O
characteristics	O
with	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
according	O
to	O
the	O
presence	B-T033
of	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
.	O
we	O
studied	O
266	O
women	B-T098
diagnosed	B-T033
with	O
pcos	B-T038
.	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
was	O
defined	O
by	O
testosterone	B-T103
(	O
t	B-T103
)	O
and	O
/	O
or	O
free	B-T103
testosterone	I-T103
(	O
ft	B-T103
)	O
and	O
/	O
or	O
∆	B-T103
##4	I-T103
androstenedione	I-T103
(	O
δ	B-T103
##4	I-T103
-	I-T103
a	I-T103
)	O
higher	O
than	O
75	O
%	O
of	O
the	O
upper	O
limits	O
of	O
each	O
hormone	B-T103
.	O
patients	O
were	O
stratified	O
in	O
two	O
groups	B-T098
according	O
to	O
a	O
bmi	B-T201
threshold	O
of	O
25	O
kg	O
/	O
m2	O
.	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
was	O
present	B-T033
in	O
78	O
.	O
2	O
%	O
of	O
the	O
patients	O
.	O
elevated	O
levels	O
of	O
t	B-T103
were	O
found	O
in	O
58	O
.	O
4	O
%	O
,	O
while	O
elevated	O
levels	O
of	O
ft	B-T103
and	O
δ	B-T103
##4	I-T103
-	I-T103
a	I-T103
were	O
found	O
in	O
42	O
.	O
5	O
%	O
and	O
34	O
.	O
1	O
%	O
of	O
patients	O
.	O
in	O
normal	B-T033
weight	I-T033
women	B-T098
(	O
bmi	B-T201
≤	O
##25	O
kg	O
/	O
m2	O
)	O
with	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
lower	O
values	O
of	O
hip	B-T201
circumference	I-T201
and	O
homa	B-T058
-	I-T058
ir	I-T058
and	O
increased	O
levels	O
of	O
t	B-T103
,	O
ft	B-T103
,	O
δ	B-T103
##4	I-T103
-	I-T103
a	I-T103
,	O
17	B-T103
-	I-T103
hydroxyp	I-T103
##rogesterone	I-T103
(	O
17	B-T103
-	I-T103
oh	I-T103
##p	I-T103
)	O
,	O
dehydroepiandrosterone	B-T103
sulfate	I-T103
(	O
dhea	B-T103
##s	I-T103
)	O
,	O
white	B-T017
blood	I-T017
cells	I-T017
(	O
wbc	B-T017
)	O
and	O
neutrophils	B-T017
were	O
observed	O
compared	O
to	O
women	B-T098
without	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
.	O
also	O
,	O
in	O
overweight	B-T033
women	B-T098
higher	O
levels	O
of	O
t	B-T103
,	O
ft	B-T103
,	O
δ	B-T103
##4	I-T103
-	I-T103
a	I-T103
,	O
17	B-T103
-	I-T103
oh	I-T103
##p	I-T103
,	O
dhea	B-T103
##s	I-T103
and	O
cortisol	B-T103
were	O
measured	O
,	O
while	O
lower	O
thyroid	B-T058
-	I-T058
stimulating	I-T058
hormone	I-T058
(	I-T058
tsh	I-T058
)	I-T058
levels	I-T058
were	O
comparable	O
to	O
women	B-T098
without	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
.	O
this	O
study	O
showed	O
high	O
prevalence	O
of	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
in	O
pcos	B-T038
women	B-T098
.	O
women	B-T098
with	O
bmi	B-T201
≤	O
##25	O
kg	O
/	O
m2	O
have	O
significant	O
differences	O
in	O
androgens	B-T103
,	O
wbc	B-T017
,	O
neutrophils	B-T017
and	O
homa	B-T058
-	I-T058
ir	I-T058
and	O
women	B-T098
with	O
bmi	B-T201
≥2	O
##5	O
kg	O
/	O
m2	O
in	O
androgens	B-T103
,	O
tsh	B-T103
and	O
cortisol	B-T103
according	O
to	O
the	O
presence	B-T033
or	O
not	O
of	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
.	O

allelic	B-T017
diversity	O
in	O
an	O
nlr	B-T017
gene	I-T017
bph	B-T017
##9	I-T017
enables	O
rice	B-T204
to	O
combat	O
plant	B-T204
##ho	I-T204
##pp	I-T204
##er	I-T204
variation	O
brown	B-T204
plant	I-T204
##ho	I-T204
##pp	I-T204
##er	I-T204
(	O
bph	B-T204
)	O
,	O
nil	B-T204
##apa	I-T204
##r	I-T204
##va	I-T204
##ta	I-T204
lu	I-T204
##gens	I-T204
sta	I-T204
##l	I-T204
,	O
is	O
one	O
of	O
the	O
most	O
devastating	O
insect	B-T204
pests	O
of	O
rice	B-T204
(	O
oryz	B-T204
##a	I-T204
sativa	I-T204
l	I-T204
.	I-T204
)	O
.	O
currently	O
,	O
30	O
bph	B-T204
-	O
resistance	O
genes	O
have	O
been	O
genetically	O
defined	O
,	O
most	O
of	O
which	O
are	O
clustered	O
on	O
specific	O
chromosome	B-T017
regions	I-T017
.	O
here	O
,	O
we	O
describe	O
molecular	B-T058
cloning	I-T058
and	O
characterization	O
of	O
a	O
bph	B-T204
-	O
resistance	O
gene	O
,	O
bph	B-T017
##9	I-T017
,	O
mapped	O
on	O
the	O
long	B-T017
arm	I-T017
of	I-T017
rice	I-T017
chromosome	I-T017
12	I-T017
(	O
12	O
##l	O
)	O
.	O
bph	B-T017
##9	I-T017
encodes	O
a	O
rare	O
type	O
of	O
nucleotide	B-T038
-	I-T038
binding	I-T038
and	O
leucine	B-T082
-	I-T082
rich	I-T082
repeat	I-T082
(	O
nlr	B-T082
)	O
-	O
containing	O
protein	B-T103
that	O
localizes	O
to	O
the	O
endo	B-T017
##me	I-T017
##mb	I-T017
##rane	I-T017
system	I-T017
and	O
causes	O
a	O
cell	B-T038
death	I-T038
phenotype	O
.	O
bph	B-T017
##9	I-T017
activates	O
salicylic	B-T103
acid	I-T103
-	O
and	O
jas	B-T103
##monic	I-T103
acid	I-T103
-	O
signaling	B-T038
pathways	I-T038
in	O
rice	B-T204
plants	B-T204
and	O
confers	O
both	O
anti	O
##x	O
##eno	O
##sis	O
and	O
antib	O
##iosis	O
to	O
bph	B-T204
.	O
we	O
further	O
demonstrated	O
that	O
the	O
eight	O
bph	B-T204
-	O
resistance	O
genes	O
that	O
are	O
clustered	O
on	O
chromosome	B-T017
12	I-T017
##l	I-T017
,	O
including	O
the	O
widely	O
used	O
bph	B-T017
##1	I-T017
,	O
are	O
allelic	O
with	O
each	O
other	O
.	O
to	O
hon	O
##or	O
the	O
priority	O
in	O
the	O
literature	B-T170
,	O
we	O
thus	O
designated	O
this	O
locus	B-T082
as	O
bph	B-T017
##1	I-T017
/	I-T017
9	I-T017
these	O
eight	O
genes	B-T017
can	O
be	O
classified	O
into	O
four	O
allel	B-T017
##otypes	I-T017
,	O
bph	B-T017
##1	I-T017
/	I-T017
9	I-T017
-	I-T017
1	I-T017
,	O
-	B-T017
2	I-T017
,	O
-	B-T017
7	I-T017
,	O
and	O
-	B-T017
9	I-T017
these	O
allel	B-T017
##otypes	I-T017
confer	O
varying	O
levels	O
of	O
resistance	B-T038
to	O
different	O
bio	B-T170
##type	I-T170
##s	I-T170
of	O
bph	B-T204
.	O
the	O
coding	B-T017
region	I-T017
of	O
bph	B-T017
##1	I-T017
/	I-T017
9	I-T017
shows	O
a	O
high	O
level	O
of	O
diversity	O
in	O
rice	B-T204
germ	I-T204
##plasm	I-T204
.	O
homologous	O
fragments	O
of	O
the	O
nucleotide	B-T038
-	I-T038
binding	I-T038
(	O
nb	B-T038
)	O
and	O
leucine	B-T082
-	I-T082
rich	I-T082
repeat	I-T082
(	O
lrr	B-T082
)	O
domains	B-T082
exist	O
,	O
which	O
might	O
have	O
served	O
as	O
a	O
rep	O
##ository	O
for	O
generating	O
allele	B-T017
diversity	O
.	O
our	O
findings	O
reveal	O
a	O
rice	B-T204
plant	B-T204
strategy	O
for	O
modifying	O
the	O
genetic	O
information	O
to	O
gain	O
the	O
upper	O
hand	O
in	O
the	O
strugg	O
##le	O
against	O
insect	B-T204
herbivores	B-T204
.	O
further	O
exploration	O
of	O
natural	O
allelic	O
variation	O
and	O
artificial	B-T062
sh	I-T062
##uff	I-T062
##ling	I-T062
within	O
this	O
gene	B-T017
may	O
allow	O
breeding	B-T038
to	O
be	O
tailored	O
to	O
control	O
emerging	O
bio	B-T170
##type	I-T170
##s	I-T170
of	O
bph	B-T204
.	O

a	O
ple	O
##a	O
for	O
thoracoscopic	B-T058
resection	B-T058
of	O
solitary	B-T038
pulmonary	I-T038
nodule	I-T038
in	O
cancer	B-T038
patients	O
solitary	B-T038
pulmonary	I-T038
nodules	I-T038
(	O
sp	B-T038
##n	I-T038
)	O
are	O
frequently	O
detected	B-T033
in	O
cancer	B-T038
patients	O
.	O
these	O
lesions	B-T033
are	O
often	O
considered	O
as	O
pulmonary	B-T038
metastases	I-T038
and	O
increasingly	O
treated	O
by	O
non	B-T058
-	I-T058
surgical	I-T058
techniques	I-T058
without	O
histological	O
confirmation	B-T033
.	O
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
histological	O
nature	O
of	O
sp	B-T038
##n	I-T038
resected	O
by	O
thorac	B-T058
##oscopy	I-T058
and	O
to	O
identify	O
risk	B-T033
factors	I-T033
of	O
malignancy	B-T038
.	O
single	B-T062
-	I-T062
institution	I-T062
retrospective	I-T062
analysis	I-T062
of	O
all	O
consecutive	O
patients	O
with	O
previously	O
known	O
malignancies	B-T038
who	O
underwent	O
thoracoscopic	B-T058
resection	B-T058
of	O
sp	B-T038
##n	I-T038
with	O
unknown	O
diagnosis	B-T033
between	O
2001	O
and	O
2014	O
.	O
one	O
hundred	O
and	O
forty	O
cancer	B-T038
patients	O
underwent	O
thoracoscopic	B-T058
resection	B-T058
of	O
a	O
sp	B-T038
##n	I-T038
.	O
the	O
resected	O
sp	B-T038
##n	I-T038
was	O
benign	O
in	O
34	O
patients	O
(	O
24	O
.	O
3	O
%	O
)	O
and	O
malignant	O
in	O
106	O
patients	O
.	O
the	O
latter	O
were	O
metastasis	B-T038
in	O
70	O
patients	O
(	O
50	O
%	O
)	O
and	O
a	O
primary	O
lung	B-T038
cancer	I-T038
in	O
36	O
patients	O
(	O
25	O
.	O
7	O
%	O
)	O
.	O
upon	O
univariate	O
analysis	O
,	O
malignancy	B-T038
was	O
significantly	O
associated	O
with	O
age	O
>	O
60	O
years	O
,	O
disease	B-T038
-	O
free	O
interval	O
≥2	O
##4	O
months	O
,	O
sp	B-T038
##n	I-T038
size	B-T082
>	O
8	O
mm	O
,	O
upper	B-T017
lobe	I-T017
localization	O
and	O
suvmax	O
>	O
2	O
.	O
5	O
on	O
pet	B-T058
-	I-T058
ct	I-T058
.	O
upon	O
multivariate	O
analysis	O
,	O
upper	B-T017
lobe	I-T017
localization	O
and	O
suvmax	O
>	O
2	O
.	O
5	O
were	O
associated	O
with	O
malignancy	B-T038
.	O
smoking	O
was	O
significantly	O
associated	O
with	O
sp	B-T038
##n	I-T038
containing	O
primary	O
lung	B-T038
cancer	I-T038
.	O
in	O
this	O
series	O
,	O
only	O
50	O
%	O
of	O
sp	B-T038
##n	I-T038
in	O
patients	O
with	O
known	O
malignant	B-T038
disease	I-T038
were	O
pulmonary	B-T038
metastases	I-T038
and	O
25	O
%	O
had	O
a	O
newly	O
diagnosed	O
nsclc	B-T038
.	O
smoking	O
was	O
associated	O
with	O
primary	O
lung	B-T038
cancer	I-T038
but	O
no	B-T033
other	O
predictor	O
was	O
found	O
to	O
allow	O
the	O
distinction	O
between	O
pulmonary	B-T038
metastasis	I-T038
and	O
lung	B-T038
cancer	I-T038
.	O
these	O
results	O
endors	O
##e	O
the	O
need	O
of	O
histological	O
confirmation	B-T033
of	O
sp	B-T038
##n	I-T038
in	O
patients	O
with	O
previous	O
malignancies	B-T038
to	O
avoid	O
diagnostic	O
uncertainty	B-T033
and	O
suboptimal	O
treatments	B-T058
.	O

map	B-T038
learning	I-T038
and	O
working	B-T038
memory	I-T038
:	O
multimodal	O
learning	O
strategies	O
the	O
current	O
research	B-T062
investigated	O
whether	O
learning	B-T038
spatial	I-T038
information	O
from	O
a	O
map	O
involves	O
different	O
modalities	O
,	O
which	O
are	O
managed	O
by	O
discrete	O
components	O
in	O
working	B-T038
memory	I-T038
.	O
in	O
four	O
experiments	O
,	O
participants	B-T098
studied	O
a	O
map	O
either	O
while	O
performing	O
a	O
simultaneous	O
interference	B-T038
task	I-T038
(	O
high	O
cognitive	O
load	O
)	O
or	O
without	B-T038
interference	I-T038
(	O
low	O
cognitive	O
load	O
)	O
.	O
the	O
modality	O
of	O
interference	B-T038
varied	O
between	O
experiments	O
.	O
experiment	O
1	O
used	O
a	O
tapping	B-T038
task	I-T038
(	O
visuospatial	O
)	O
,	O
experiment	O
2	O
a	O
backward	B-T038
##s	I-T038
counting	I-T038
task	I-T038
(	O
verbal	O
)	O
,	O
experiment	O
3	O
an	O
artic	B-T038
##ulatory	I-T038
suppression	B-T058
task	I-T058
(	O
verbal	O
)	O
and	O
experiment	O
4	O
an	O
n	B-T038
-	I-T038
back	I-T038
task	I-T038
(	O
central	B-T038
executive	I-T038
)	O
.	O
spatial	B-T033
recall	I-T033
was	O
assessed	O
in	O
two	O
tests	O
,	O
directional	B-T038
judgement	I-T038
##s	I-T038
and	O
map	O
drawing	O
.	O
cognitive	O
load	O
was	O
found	O
to	O
affect	O
spatial	B-T033
recall	I-T033
detrimental	O
##ly	O
regardless	O
of	O
interference	B-T038
modality	O
.	O
the	O
findings	O
suggest	O
that	O
when	O
learning	B-T038
maps	I-T038
people	O
use	O
a	O
multimodal	O
learning	O
strategy	O
,	O
util	O
##ising	O
resources	O
from	O
all	O
components	O
of	O
working	B-T038
memory	I-T038
.	O

a	O
novel	O
rapid	O
analysis	B-T062
using	O
mass	B-T058
spectrometry	I-T058
to	O
evaluate	O
downstream	B-T082
refolding	B-T038
of	O
recombinant	B-T103
human	I-T103
insulin	I-T103
-	I-T103
like	I-T103
growth	I-T103
factor	I-T103
-	I-T103
1	I-T103
(	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
)	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
is	O
used	O
to	O
treat	O
elevated	B-T038
blood	I-T038
sugar	I-T038
as	O
well	O
as	O
growth	B-T103
hormone	I-T103
-	O
resistant	O
lar	B-T038
##on	I-T038
-	I-T038
type	I-T038
dwarf	I-T038
##ism	I-T038
.	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
isolated	O
from	O
inclusion	B-T017
bodies	I-T017
in	O
extracts	O
of	O
e	B-T007
.	I-T007
coli	I-T007
must	O
be	O
ref	O
##olded	O
to	O
acquire	O
sufficient	O
activity	O
.	O
however	O
,	O
there	O
is	O
no	O
rapid	O
analytical	O
method	O
for	O
monitoring	O
refolding	B-T038
during	O
the	O
purification	B-T058
process	O
.	O
we	O
prepared	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
drug	B-T103
product	I-T103
,	O
in	O
-	O
process	O
samples	O
during	O
the	O
oxidation	B-T038
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
,	O
forced	O
-	O
reduced	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
,	O
and	O
aerial	O
##ly	O
oxidized	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
after	O
forced	O
reduction	O
.	O
des	O
##al	O
##ted	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
samples	O
were	O
analyzed	O
using	O
maldi	B-T058
-	I-T058
is	I-T058
##d	I-T058
.	O
the	O
peak	O
intensity	O
ratio	O
of	O
product	O
to	O
precursor	O
ion	O
was	O
determined	O
.	O
the	O
charge	O
state	O
distribution	O
(	O
csd	O
)	O
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
ions	O
was	O
evaluated	O
using	O
esi	B-T058
-	I-T058
ms	I-T058
coupled	O
with	O
sec	O
-	O
mode	O
hplc	B-T058
.	O
the	O
drift	O
time	O
and	O
collision	O
cross	O
-	O
sectional	O
areas	O
(	O
ccs	O
)	O
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
ions	O
were	O
evaluated	O
using	O
esi	B-T058
-	I-T058
ims	I-T058
-	I-T058
ms	I-T058
coupled	O
with	O
sec	O
-	O
mode	O
hplc	B-T058
.	O
maldi	B-T058
-	I-T058
is	I-T058
##d	I-T058
data	O
,	O
csd	O
values	O
determined	O
using	O
esi	B-T058
-	I-T058
ms	I-T058
,	O
and	O
the	O
ccs	O
acquired	O
using	O
esi	B-T058
-	I-T058
ims	I-T058
-	I-T058
ms	I-T058
revealed	O
the	O
relationship	O
between	O
the	O
folded	B-T082
and	O
unfolded	O
prote	B-T103
##of	I-T103
##orm	I-T103
##s	I-T103
of	O
forced	O
-	O
reduced	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
and	O
aerial	O
##ly	O
oxidized	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
with	O
the	O
free	O
-	O
sh	O
:	O
protein	O
ratio	O
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
drug	B-T103
product	I-T103
.	O
the	O
collision	O
cross	O
-	O
sectional	O
area	O
,	O
which	O
is	O
determined	O
using	O
esi	B-T058
-	I-T058
ims	I-T058
-	I-T058
ms	I-T058
,	O
provided	O
prote	B-T103
##of	I-T103
##orm	I-T103
information	O
through	O
rapid	O
monitoring	O
(	O
<	O
2	O
min	O
)	O
of	O
in	O
-	O
process	O
samples	O
during	O
the	O
manufacture	O
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
.	O
esi	B-T058
-	I-T058
ims	I-T058
-	I-T058
ms	I-T058
coupled	O
with	O
sec	O
-	O
mode	O
hplc	B-T058
is	O
a	O
rapid	O
and	O
robust	O
method	O
for	O
analyzing	O
the	O
free	O
-	O
sh	O
:	O
protein	O
ratio	O
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
that	O
allows	O
evaluating	O
and	O
monitoring	O
prote	B-T103
##of	I-T103
##orm	I-T103
changes	O
during	O
the	O
oxidation	B-T038
of	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
.	O
esi	B-T058
-	I-T058
ims	I-T058
-	I-T058
ms	I-T058
is	O
applicable	O
as	O
a	O
process	O
analytical	O
technology	O
tool	O
for	O
identifying	O
the	O
[UNK]	O
critical	O
quality	O
attributes	O
[UNK]	O
and	O
implementing	O
[UNK]	O
quality	O
by	O
design	O
[UNK]	O
for	O
manufacturing	O
mec	B-T103
##ase	I-T103
##r	I-T103
##min	I-T103
.	O

toward	O
optimizing	O
dental	B-T074
implant	I-T074
performance	O
:	O
surface	B-T082
characterization	O
of	O
ti	B-T103
and	O
ti	B-T103
##z	I-T103
##r	I-T103
implant	B-T103
materials	I-T103
targeting	O
understanding	O
enhanced	O
osseoin	B-T038
##tegration	I-T038
kinetics	O
,	O
the	O
goal	B-T170
of	O
this	O
study	B-T062
was	O
to	O
characterize	O
the	O
surface	B-T082
morphology	O
and	O
composition	B-T201
of	O
ti	B-T103
and	O
ti	B-T103
##z	I-T103
##r	I-T103
dental	B-T074
implant	I-T074
substrates	O
subjected	O
to	O
one	O
of	O
two	O
surface	B-T082
treatments	O
developed	O
by	O
stra	O
##umann	O
.	O
these	O
two	O
treatments	O
are	O
typically	O
known	O
as	O
sla	B-T074
and	O
sla	B-T074
##ct	I-T074
##ive	I-T074
,	O
with	O
the	O
latter	O
resulting	O
in	O
more	O
rapid	O
osseoin	B-T038
##tegration	I-T038
.	O
a	O
range	O
of	O
techniques	O
was	O
applied	O
to	O
characterize	O
four	O
different	O
substrate	B-T082
/	O
surface	B-T082
treatment	O
combinations	O
(	O
ti	B-T074
##s	I-T074
##la	I-T074
,	O
ti	B-T074
##s	I-T074
##la	I-T074
##ct	I-T074
##ive	I-T074
,	O
ti	B-T074
##z	I-T074
##rs	I-T074
##la	I-T074
,	O
and	O
ti	B-T074
##z	I-T074
##rs	I-T074
##la	I-T074
##ct	I-T074
##ive	I-T074
)	O
.	O
contact	O
angle	B-T082
measurements	O
establish	O
establish	O
their	O
hydrophilic	O
/	O
hydrophobic	O
nature	O
.	O
surface	B-T082
morphology	O
was	O
probed	O
with	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
.	O
x	B-T058
-	I-T058
ray	I-T058
diffraction	I-T058
,	O
raman	B-T058
μ	I-T058
-	I-T058
spectroscopy	I-T058
,	O
and	O
x	B-T058
-	I-T058
ray	I-T058
photoelectron	I-T058
spectroscopy	I-T058
were	O
used	O
to	O
elucidate	O
the	O
composition	B-T201
of	O
the	O
near	O
-	O
surface	B-T082
region	O
.	O
consistent	O
with	O
previous	O
work	O
,	O
surface	B-T082
morphology	O
was	O
found	O
to	O
differ	O
only	O
at	O
the	O
nanoscale	O
,	O
with	O
both	O
sla	B-T074
##ct	I-T074
##ive	I-T074
substrates	O
displaying	O
nano	O
-	O
protrusion	B-T017
##s	I-T017
.	O
spectroscopic	B-T058
data	O
indicate	O
that	O
all	O
substrates	O
exhibit	O
surface	B-T082
films	O
of	O
titanium	B-T103
oxide	I-T103
displaying	O
near	O
tio2	B-T103
stoichiometry	O
.	O
raman	B-T058
μ	I-T058
-	I-T058
spectroscopy	I-T058
reveals	O
that	O
amorphous	O
tio2	B-T103
is	O
most	O
likely	O
the	O
only	O
phase	O
present	B-T033
on	O
ti	B-T074
##s	I-T074
##la	I-T074
,	O
whilst	O
ru	B-T103
##tile	I-T103
-	O
tio2	B-T103
is	O
also	O
evidenced	O
on	O
ti	B-T074
##s	I-T074
##la	I-T074
##ct	I-T074
##ive	I-T074
,	O
ti	B-T074
##z	I-T074
##rs	I-T074
##la	I-T074
,	O
and	O
ti	B-T074
##z	I-T074
##rs	I-T074
##la	I-T074
##ct	I-T074
##ive	I-T074
.	O
for	O
ti	B-T103
##z	I-T103
##r	I-T103
alloy	B-T103
substrates	O
,	O
there	O
is	O
no	O
evidence	O
of	O
discrete	O
phases	O
of	O
oxidized	B-T038
zr	B-T103
.	O
x	B-T058
-	I-T058
ray	I-T058
photoelectron	I-T058
spectra	I-T058
demonstrate	O
that	O
all	O
samples	O
are	O
terminated	O
by	O
adventi	O
##tious	O
carbon	B-T103
,	O
with	O
it	O
being	O
somewhat	O
thicker	O
(	O
∼	O
##1	O
##nm	O
)	O
on	O
ti	B-T074
##s	I-T074
##la	I-T074
and	O
ti	B-T074
##z	I-T074
##rs	I-T074
##la	I-T074
.	O
given	O
previous	O
in	O
vivo	O
studies	O
,	O
acquired	O
data	O
suggest	O
that	O
both	O
nanoscale	O
protrusion	B-T017
##s	I-T017
,	O
and	O
a	O
thinner	O
layer	O
of	O
adventi	O
##tious	O
carbon	B-T103
contribute	O
to	O
the	O
more	O
rapid	O
osseoin	B-T038
##tegration	I-T038
of	O
sla	B-T074
##ct	I-T074
##ive	I-T074
dental	B-T074
implants	I-T074
.	O
composition	B-T201
of	O
the	O
surface	B-T082
oxide	B-T103
layer	O
is	O
apparently	O
less	O
important	O
in	O
determining	O
osseoin	B-T038
##tegration	I-T038
kinetics	O
.	O

the	O
pre	B-T038
-	I-T038
eclampsia	I-T038
ontology	O
:	O
a	O
disease	O
ontology	O
representing	O
the	O
domain	O
knowledge	O
specific	O
to	O
pre	B-T038
-	I-T038
eclampsia	I-T038
pre	B-T038
-	I-T038
eclampsia	I-T038
(	O
pe	B-T038
)	O
is	O
a	O
clinical	O
syndrome	O
characterized	O
by	O
new	O
-	O
onset	O
hypertension	O
and	O
proteinuria	B-T033
at	O
≥2	B-T033
##0	I-T033
weeks	I-T033
of	I-T033
gestation	I-T033
,	O
and	O
is	O
a	O
leading	O
cause	O
of	O
maternal	O
and	O
perinatal	O
morbidity	O
and	O
mortality	O
.	O
previous	O
studies	O
have	O
gathered	O
abundant	O
data	O
about	O
pe	B-T038
such	O
as	O
risk	B-T033
factors	I-T033
and	O
pathological	O
findings	O
.	O
however	O
,	O
most	O
of	O
these	O
data	O
are	O
not	O
semantic	O
##ally	O
structured	O
.	O
clinical	B-T170
data	I-T170
on	O
pe	B-T038
patients	O
are	O
often	O
generated	O
with	O
semantic	O
heterogeneity	O
such	O
as	O
using	O
disparate	B-T170
terminology	I-T170
to	O
describe	O
the	O
same	O
phenomena	O
.	O
in	O
clinical	B-T062
studies	I-T062
,	O
inter	O
##oper	O
##ability	O
of	O
hetero	O
##genic	O
clinical	B-T170
data	I-T170
is	O
required	O
in	O
various	O
situations	O
.	O
in	O
such	O
a	O
situation	O
,	O
it	O
is	O
necessary	O
to	O
develop	O
an	O
inter	O
##operable	O
and	O
standardized	O
semantic	O
framework	O
to	O
research	B-T062
the	O
pathology	O
of	O
pe	B-T038
more	O
comprehensively	O
and	O
to	O
achieve	O
inter	O
##oper	O
##ability	O
of	O
hetero	O
##genic	O
clinical	B-T170
data	I-T170
of	O
pe	B-T038
patients	O
.	O
in	O
this	O
study	O
,	O
we	O
developed	O
an	O
ontology	O
representing	O
clinical	O
features	O
,	O
treatments	B-T058
,	O
genetic	O
factors	O
,	O
environmental	O
factors	O
,	O
and	O
other	O
aspects	O
of	O
the	O
current	O
knowledge	O
in	O
the	O
domain	O
of	O
pe	B-T038
.	O
we	O
call	O
this	O
pre	B-T038
-	I-T038
eclampsia	I-T038
ontology	O
[UNK]	O
peo	O
[UNK]	O
.	O
to	O
achieve	O
inter	O
##oper	O
##ability	O
with	O
other	O
onto	O
##lo	O
##gi	O
##es	O
,	O
the	O
core	O
structure	O
of	O
peo	O
was	O
compliant	O
with	O
the	O
hierarchy	O
of	O
the	O
basic	O
formal	O
ontology	O
(	O
bf	O
##o	O
)	O
.	O
the	O
peo	O
incorporates	O
a	O
wide	O
range	O
of	O
key	O
concepts	O
and	O
terms	O
of	O
pe	B-T038
from	O
clinical	B-T062
and	O
biomedical	B-T062
research	I-T062
in	O
structuring	O
the	O
knowledge	O
base	O
that	O
is	O
specific	O
to	O
pe	B-T038
;	O
therefore	O
,	O
peo	O
is	O
expected	O
to	O
enhance	O
pe	B-T038
-	O
specific	O
information	O
retrieval	O
and	O
knowledge	O
discovery	O
in	O
both	O
clinical	B-T062
and	O
biomedical	B-T062
research	I-T062
fields	O
.	O

bioge	O
##ography	O
and	O
character	O
evolution	B-T038
of	O
the	O
cilia	B-T204
##te	I-T204
genus	B-T170
eu	B-T204
##plo	I-T204
##tes	I-T204
(	O
spiro	B-T204
##trich	I-T204
##ea	I-T204
,	O
eu	B-T204
##plo	I-T204
##tia	I-T204
)	O
,	O
with	O
description	B-T170
of	O
eu	B-T204
##plo	I-T204
##tes	I-T204
cur	I-T204
##ds	I-T204
##i	I-T204
sp	I-T204
.	I-T204
nov	I-T204
cilia	B-T204
##tes	I-T204
comprise	O
a	O
diverse	O
and	O
ecologically	O
important	O
phylum	B-T170
of	O
unic	O
##ellular	O
prot	O
##ists	O
.	O
one	O
of	O
the	O
most	O
spec	O
##ious	O
and	O
best	O
-	O
defined	O
genera	B-T170
is	O
eu	B-T204
##plo	I-T204
##tes	I-T204
,	O
which	O
constitutes	O
more	O
than	O
70	O
morph	B-T170
##osp	I-T170
##ecies	I-T170
,	O
many	O
of	O
which	O
have	O
never	O
been	O
molecularly	O
tested	O
.	O
the	O
increasing	O
number	O
of	O
described	O
eu	B-T204
##plo	I-T204
##tes	I-T204
taxa	O
emphasizes	O
the	O
importance	O
for	O
detailed	O
characterization	O
##s	O
of	O
new	O
ones	O
,	O
requiring	O
standardized	O
morphological	B-T082
observations	B-T062
,	O
sequencing	O
of	O
molecular	B-T201
markers	I-T201
and	O
careful	O
comparison	O
with	O
previous	O
literature	B-T170
.	O
here	O
we	O
describe	O
eu	B-T204
##plo	I-T204
##tes	I-T204
cur	I-T204
##ds	I-T204
##i	I-T204
sp	I-T204
.	I-T204
nov	I-T204
.	O
,	O
distinguishable	O
by	O
the	O
combination	O
of	O
the	O
following	O
features	O
:	O
45	O
-	O
65	O
μm	O
length	O
,	O
oval	O
or	O
elongated	O
shape	O
with	O
both	O
ends	O
round	O
##ed	O
,	O
narrow	O
perist	O
##ome	O
with	O
25	O
-	O
34	O
ad	O
##oral	O
membrane	O
##ll	O
##es	O
,	O
conspicuous	B-T017
par	I-T017
##oral	I-T017
membrane	I-T017
,	O
double	O
-	O
eur	O
##yst	O
##omus	O
dorsal	O
arg	O
##yro	O
##me	O
type	O
,	O
6	O
-	O
7	O
dorsolateral	O
kinet	O
##ies	O
and	O
10	O
fronto	O
##vent	O
##ral	O
cir	O
##ri	O
.	O
three	O
populations	O
of	O
the	O
novel	O
species	B-T170
have	O
been	O
found	O
in	O
brack	B-T103
##ish	I-T103
and	O
marine	B-T082
samples	I-T082
in	O
the	O
mediterranean	B-T082
and	O
the	O
white	B-T082
sea	I-T082
.	O
we	O
provide	O
the	O
ss	B-T017
##u	I-T017
rrna	I-T017
gene	I-T017
sequences	B-T017
of	O
these	O
populations	O
,	O
and	O
an	O
updated	O
phylogeny	O
of	O
the	O
genus	B-T170
eu	B-T204
##plo	I-T204
##tes	I-T204
.	O
using	O
the	O
molecular	O
phylogenetic	O
tree	O
,	O
we	O
inferred	O
aspects	O
of	O
the	O
bioge	O
##ographical	O
history	O
of	O
the	O
genus	B-T170
and	O
the	O
evolution	B-T038
of	O
its	O
most	O
important	O
taxonomic	O
characters	O
in	O
order	O
to	O
provide	O
a	O
frame	O
for	O
future	O
descriptions	B-T170
.	O
ultimately	O
,	O
these	O
data	O
reveal	O
recurrent	O
trends	O
of	O
freshwater	O
invasion	O
and	O
highlight	O
the	O
dynamic	O
,	O
yet	O
convergent	O
,	O
morphological	B-T082
evolution	B-T038
of	O
eu	B-T204
##plo	I-T204
##tes	I-T204
.	O

insectic	O
##idal	O
effects	O
of	O
delta	B-T103
##meth	I-T103
##rin	I-T103
in	O
laboratory	B-T092
and	O
field	O
populations	O
of	O
cul	B-T204
##ico	I-T204
##ides	I-T204
species	I-T204
:	O
how	O
effective	O
are	O
host	O
-	O
contact	O
reduction	O
methods	B-T062
in	O
india	B-T082
?	O
blue	B-T005
##ton	I-T005
##gu	I-T005
##e	I-T005
virus	I-T005
(	O
bt	B-T005
##v	I-T005
)	O
is	O
transmitted	B-T038
by	O
cul	B-T204
##ico	I-T204
##ides	I-T204
biting	B-T204
mid	I-T204
##ges	I-T204
and	O
causes	O
blue	B-T038
##ton	I-T038
##gu	I-T038
##e	I-T038
(	O
bt	B-T038
)	O
,	O
a	O
clinical	B-T038
disease	I-T038
observed	O
primarily	O
in	O
sheep	B-T204
.	O
bt	B-T038
has	O
a	O
detrimental	B-T038
effect	I-T038
on	O
subs	O
##ist	O
##ence	O
farmers	B-T097
in	O
india	B-T082
,	O
where	O
hypere	B-T038
##nd	I-T038
##emic	I-T038
outbreaks	I-T038
impact	O
on	O
small	O
##holding	O
##s	O
in	O
the	O
southern	B-T082
states	I-T082
of	O
the	O
country	B-T082
.	O
in	O
this	O
study	O
,	O
we	O
establish	O
a	O
reliable	O
method	B-T062
for	O
testing	O
the	O
toxic	B-T037
effects	I-T037
of	O
delta	B-T103
##meth	I-T103
##rin	I-T103
on	O
cul	B-T204
##ico	I-T204
##ides	I-T204
and	O
then	O
compare	O
delta	B-T103
##meth	I-T103
##rin	I-T103
with	O
traditional	O
control	O
methods	O
used	O
by	O
farmers	B-T097
in	O
india	B-T082
.	O
effects	O
of	O
delta	B-T103
##meth	I-T103
##rin	I-T103
were	O
initially	O
tested	O
using	O
a	O
colon	O
##ised	O
strain	O
of	O
cul	B-T204
##ico	I-T204
##ides	I-T204
nu	I-T204
##bec	I-T204
##ulos	I-T204
##us	I-T204
me	I-T204
##igen	I-T204
and	O
a	O
modified	O
world	B-T092
health	I-T092
organisation	I-T092
exposure	B-T058
assay	I-T058
.	O
this	O
method	B-T062
was	O
then	O
applied	O
to	O
field	O
populations	O
of	O
cul	B-T204
##ico	I-T204
##ides	I-T204
spp	I-T204
.	I-T204
in	O
india	B-T082
.	O
the	O
field	O
population	O
of	O
c	B-T204
.	I-T204
oxy	I-T204
##st	I-T204
##oma	I-T204
in	O
india	B-T082
had	O
a	O
greater	O
lc50	O
(	O
0	O
.	O
012	O
±	O
0	O
.	O
009	O
%	O
)	O
for	O
delta	B-T103
##meth	I-T103
##rin	I-T103
than	O
laboratory	B-T058
-	I-T058
reared	I-T058
c	B-T204
.	I-T204
nu	I-T204
##bec	I-T204
##ulos	I-T204
##us	I-T204
(	O
0	O
.	O
001	O
##3	O
±	O
0	O
.	O
0002	O
%	O
)	O
.	O
exposure	O
of	O
c	B-T204
.	I-T204
nu	I-T204
##bec	I-T204
##ulos	I-T204
##us	I-T204
to	O
delta	B-T103
##meth	I-T103
##rin	I-T103
at	O
higher	O
ambient	O
temperatures	O
resulted	O
in	O
greater	O
rates	O
of	O
knockdown	O
but	O
a	O
lower	O
mortality	O
rate	O
at	O
24	O
h	O
post	O
-	O
exposure	O
.	O
behavioural	B-T058
assays	I-T058
with	O
c	B-T204
.	I-T204
nu	I-T204
##bec	I-T204
##ulos	I-T204
##us	I-T204
in	O
who	B-T092
tubes	O
provided	O
evidence	O
for	O
contact	O
irr	O
##itan	O
##cy	O
and	O
spatial	O
repell	O
##ence	O
caused	O
by	O
delta	B-T103
##meth	I-T103
##rin	I-T103
.	O
the	O
field	O
experiments	B-T062
in	O
india	B-T082
,	O
however	O
,	O
provided	O
no	O
evidence	O
for	O
repell	O
##ent	O
or	O
toxic	B-T037
effects	I-T037
of	O
delta	B-T103
##meth	I-T103
##rin	I-T103
.	O
traditional	B-T062
methods	I-T062
such	O
as	O
the	O
application	O
of	O
ne	B-T103
##em	I-T103
oil	I-T103
and	O
burning	O
of	O
ne	B-T204
##em	I-T204
leaves	B-T204
also	O
provided	O
no	B-T033
protection	O
.	O
our	O
study	O
demonstrates	O
that	O
field	O
-	O
collected	O
cul	B-T204
##ico	I-T204
##ides	I-T204
in	O
india	B-T082
are	O
less	O
susceptible	O
to	O
delta	B-T103
##meth	I-T103
##rin	I-T103
exposure	O
than	O
laboratory	B-T058
-	I-T058
bred	I-T058
c	B-T204
.	I-T204
nu	I-T204
##bec	I-T204
##ulos	I-T204
##us	I-T204
and	O
traditional	B-T062
methods	I-T062
of	O
insect	O
control	O
do	O
not	O
provide	O
protection	O
to	O
sheep	B-T204
.	O
these	O
low	O
levels	O
of	O
susceptibility	B-T038
to	O
delta	B-T103
##meth	I-T103
##rin	I-T103
have	O
not	O
been	O
recorded	O
before	O
in	O
field	O
populations	O
of	O
cul	B-T204
##ico	I-T204
##ides	I-T204
and	O
suggest	O
resistance	O
to	O
synthetic	B-T103
pyreth	I-T103
##rio	I-T103
##ids	I-T103
.	O
alternative	O
insect	O
control	O
methods	B-T062
,	O
in	O
addition	O
to	O
vaccination	B-T058
,	O
may	O
be	O
needed	O
to	O
protect	O
indian	B-T082
livestock	B-T204
from	O
bt	B-T005
##v	I-T005
transmission	B-T038
.	O

impact	O
of	O
cofactor	B-T103
-	O
binding	B-T082
loop	I-T082
mutations	B-T038
on	O
thermo	B-T038
##to	I-T038
##ler	I-T038
##ance	I-T038
and	O
activity	B-T038
of	O
e	B-T007
.	I-T007
coli	I-T007
trans	B-T103
##ket	I-T103
##olase	I-T103
improvement	O
of	O
thermost	O
##ability	O
in	O
engineered	B-T103
enzymes	I-T103
can	O
allow	O
bioc	O
##atal	O
##ysis	O
on	O
substrates	O
with	O
poor	O
aqueous	O
solubility	O
.	O
denaturation	B-T038
of	O
the	O
cofactor	B-T103
-	O
binding	B-T082
loops	I-T082
of	O
escherichia	B-T007
coli	I-T007
trans	B-T103
##ket	I-T103
##olase	I-T103
(	O
tk	B-T103
)	O
was	O
previously	O
linked	O
to	O
the	O
loss	O
of	O
enzyme	B-T038
activity	I-T038
under	O
conditions	O
of	O
high	O
ph	O
or	O
urea	B-T103
.	O
incubation	B-T058
at	O
temperatures	O
just	O
below	O
the	O
thermal	O
melting	O
transition	O
,	O
above	O
which	O
the	O
protein	B-T103
aggregates	O
,	O
was	O
also	O
found	O
to	O
anneal	O
the	O
enzyme	B-T103
to	O
give	O
an	O
increased	O
specific	O
activity	B-T038
.	O
the	O
potential	O
role	O
of	O
cofactor	B-T103
-	O
binding	B-T082
loop	I-T082
instability	B-T033
in	O
this	O
process	O
remained	O
unclear	O
.	O
in	O
this	O
work	O
,	O
the	O
two	O
cofactor	B-T103
-	O
binding	B-T082
loops	I-T082
(	O
residues	B-T082
185	I-T082
-	I-T082
192	I-T082
and	O
38	B-T082
##2	I-T082
-	I-T082
39	I-T082
##2	I-T082
)	O
were	O
progressively	O
mutated	O
towards	O
the	O
equivalent	O
sequence	B-T082
from	O
the	O
thermost	O
##able	O
therm	B-T007
##us	I-T007
thermo	I-T007
##phi	I-T007
##lu	I-T007
##s	I-T007
tk	B-T103
and	O
variants	B-T017
assessed	O
for	O
their	O
impact	O
on	O
both	O
thermost	O
##ability	O
and	O
activity	O
.	O
cofactor	B-T082
-	I-T082
binding	I-T082
loop	I-T082
2	I-T082
variants	B-T017
had	O
detrimental	O
effects	O
on	O
specific	O
activity	O
at	O
elevated	O
temperatures	O
,	O
whereas	O
the	O
h1	B-T038
##92	I-T038
##p	I-T038
mutation	I-T038
in	O
cofactor	B-T082
-	I-T082
binding	I-T082
loop	I-T082
1	I-T082
resulted	O
in	O
a	O
two	O
-	O
fold	O
improved	O
stability	O
to	O
inactivation	O
at	O
elevated	O
temperatures	O
,	O
and	O
increased	O
the	O
critical	O
onset	O
temperature	O
for	O
aggregation	O
.	O
the	O
specific	O
activity	O
of	O
h1	B-T038
##92	I-T038
##p	I-T038
was	O
3	O
-	O
fold	O
and	O
19	O
-	O
fold	O
higher	O
than	O
that	O
for	O
wild	B-T017
-	I-T017
type	I-T017
at	O
60	O
##°c	O
and	O
65	O
##°c	O
respectively	O
,	O
and	O
also	O
remained	O
2	O
.	O
7	O
-	O
4	O
fold	O
higher	O
after	O
re	O
-	O
cooling	O
from	O
pre	B-T058
-	I-T058
incubations	I-T058
at	O
either	O
55	O
##°c	O
or	O
60	O
##°c	O
for	O
1h	O
.	O
interestingly	O
,	O
h1	B-T038
##92	I-T038
##p	I-T038
was	O
also	O
2	O
-	O
times	O
more	O
active	O
than	O
wild	B-T017
-	I-T017
type	I-T017
tk	B-T103
at	O
25	O
##°c	O
.	O
optimal	O
activity	O
was	O
achieved	O
at	O
60	O
##°c	O
for	O
h1	B-T038
##92	I-T038
##p	I-T038
compared	O
to	O
55	O
##°c	O
for	O
wild	B-T017
type	I-T017
.	O
these	O
results	O
show	O
that	O
cofactor	B-T082
-	I-T082
binding	I-T082
loop	I-T082
1	I-T082
,	O
plays	O
a	O
pivotal	O
role	O
in	O
partial	O
denaturation	B-T038
and	O
aggregation	O
at	O
elevated	O
temperatures	O
.	O
furthermore	O
,	O
a	O
single	B-T038
rigid	I-T038
##ifying	I-T038
mutation	I-T038
within	O
this	O
loop	B-T082
can	O
significantly	O
improve	O
the	O
enzyme	B-T038
specific	I-T038
activity	I-T038
,	O
as	O
well	O
as	O
the	O
stability	O
to	O
thermal	O
denaturation	B-T038
and	O
aggregation	O
,	O
to	O
give	O
an	O
increased	O
temperature	O
optimum	O
for	O
activity	B-T038
.	O

changes	O
in	O
risk	B-T033
factors	I-T033
for	O
young	O
male	O
suicide	B-T033
in	O
new	B-T082
##castle	I-T082
upon	I-T082
ty	I-T082
##ne	I-T082
,	O
196	O
##1	O
-	O
2009	O
aims	O
and	O
method	B-T170
to	O
ascertain	O
differences	O
in	O
patterns	B-T033
of	I-T033
suicide	I-T033
in	O
young	O
men	B-T098
over	O
three	O
decades	O
(	O
1960s	O
,	O
1990s	O
and	O
2000	O
##s	O
)	O
and	O
discuss	O
implications	O
for	O
suicide	B-T033
prevention	O
.	O
data	O
on	O
suicides	B-T033
and	O
open	O
ver	O
##di	O
##ct	O
##s	O
in	O
men	B-T098
aged	O
15	O
-	O
34	O
were	O
obtained	O
from	O
coron	B-T170
##er	I-T170
'	I-T170
s	I-T170
records	I-T170
in	O
new	B-T082
##castle	I-T082
upon	I-T082
ty	I-T082
##ne	I-T082
and	O
analysed	B-T062
using	O
spss	B-T170
software	I-T170
.	O
results	O
an	O
increase	O
in	O
suicide	O
rates	O
from	O
the	O
first	O
to	O
the	O
second	O
decade	O
was	O
followed	O
by	O
a	O
fall	O
in	O
the	O
third	O
decade	O
.	O
this	O
was	O
associated	O
with	O
an	O
increasing	O
proportion	O
of	O
single	O
men	B-T098
,	O
those	O
living	B-T033
alone	I-T033
,	O
unemployment	B-T033
,	O
consumption	O
of	O
alcohol	O
,	O
use	O
of	O
hang	B-T037
##ing	I-T037
,	O
previous	O
suicide	B-T033
attempt	I-T033
and	O
history	O
of	O
treatment	O
for	O
mental	B-T038
illness	I-T038
.	O
clinical	O
implications	O
this	O
study	B-T062
highlights	O
the	O
need	O
for	O
more	O
interventions	B-T058
and	O
focus	B-T038
to	O
be	O
given	O
to	O
young	O
males	O
in	O
the	O
suicide	B-T033
prevention	O
area	O
and	O
is	O
of	O
high	O
importance	O
in	O
the	O
field	B-T170
of	I-T170
public	I-T170
health	I-T170
.	O
areas	O
that	O
could	O
be	O
tackle	O
##d	O
include	O
reducing	O
access	B-T082
to	O
means	O
of	O
suicide	B-T033
,	O
reducing	O
alcohol	O
use	O
,	O
support	O
for	O
relationship	O
difficulties	O
,	O
engagement	B-T058
with	O
mental	B-T058
health	I-T058
services	I-T058
and	O
management	B-T058
of	O
chronic	B-T038
illness	I-T038
.	O

dominant	B-T033
and	O
non	O
-	O
dominant	B-T033
frequency	O
structure	O
of	O
evoked	O
ventricular	B-T038
fibrillation	I-T038
in	O
dogs	B-T204
with	O
myocardial	B-T038
ischemia	I-T038
the	O
first	O
10	O
min	O
of	O
electrically	B-T058
provoked	I-T058
ventricular	B-T038
fibrillation	I-T038
in	O
dogs	B-T204
with	O
ischemic	B-T038
heart	I-T038
disease	I-T038
were	O
characterized	O
by	O
organized	O
myocardial	O
activity	O
evidenced	O
by	O
the	O
dominant	B-T033
ecg	I-T033
frequency	I-T033
structure	O
.	O
during	O
the	O
first	O
2	O
min	O
of	O
ventricular	B-T038
fibrillation	I-T038
,	O
low	O
-	O
frequency	O
oscillations	O
(	O
4	O
-	O
7	O
hz	O
)	O
dominated	O
,	O
while	O
on	O
min	O
3	O
to	O
10	O
after	O
the	O
onset	O
of	O
fibrillation	B-T038
,	O
the	O
dominant	B-T033
frequencies	I-T033
were	O
low	O
and	O
medium	O
(	O
4	O
-	O
12	O
hz	O
)	O
.	O
after	O
10	O
-	O
min	O
fibrillation	B-T038
,	O
the	O
oscillations	O
became	O
non	O
-	O
dominant	B-T033
.	O
thus	O
,	O
ischemic	B-T033
myocardium	I-T033
maintains	O
the	O
organized	O
structure	O
of	O
ventricular	B-T038
fibrillation	I-T038
for	O
the	O
first	O
10	O
min	O
,	O
which	O
is	O
important	O
for	O
the	O
development	O
of	O
automatic	B-T058
diagnostics	I-T058
of	O
abnormal	O
cardiac	O
activity	O
in	O
humans	B-T204
.	O

ethics	O
hyp	O
##e	O
?	O
there	O
has	O
been	O
growing	O
concern	O
about	O
the	O
phenomenon	O
of	O
science	O
hyp	O
##e	O
,	O
the	O
tendency	O
to	O
exagger	O
##ate	O
the	O
value	O
or	O
near	O
-	O
future	O
application	O
of	O
research	O
results	O
.	O
although	O
this	O
is	O
a	O
problem	B-T033
that	O
touch	O
##es	O
every	O
area	B-T091
of	I-T091
biom	I-T091
##edicine	I-T091
,	O
the	O
topic	B-T170
of	O
genetics	B-T091
seems	O
to	O
be	O
particularly	O
prone	O
to	O
enth	B-T038
##us	I-T038
##ias	I-T038
##tic	I-T038
predictions	O
.	O
the	O
world	B-T098
has	O
been	O
tol	O
##d	O
for	O
over	O
two	O
decades	O
-	O
by	O
the	O
media	B-T170
,	O
researchers	B-T097
,	O
poli	O
##tic	O
##ians	O
,	O
and	O
the	O
bio	B-T091
##te	I-T091
##ch	I-T091
industry	O
-	O
that	O
a	O
genome	B-T017
-	O
driven	O
health	B-T058
care	I-T058
revolution	O
is	O
just	O
around	O
the	O
corne	O
##r	O
.	O
and	O
while	O
the	O
revolution	O
never	O
seems	O
to	O
arr	O
##ive	O
,	O
the	O
hope	O
##ful	O
rhe	O
##tor	O
##ic	O
continues	O
.	O
it	O
has	O
been	O
suggested	O
that	O
this	O
unrel	O
##enting	O
[UNK]	O
gen	O
##ohy	O
##pe	O
[UNK]	O
is	O
having	O
a	O
range	O
of	O
adverse	B-T033
social	O
consequences	O
,	O
including	O
misleading	O
the	O
public	B-T098
and	O
hur	B-T033
##ting	I-T033
the	O
long	O
-	O
term	O
legitim	B-T170
##acy	I-T170
of	O
the	O
field	O
.	O
while	O
we	O
need	O
more	O
good	O
data	O
on	O
the	O
nature	O
and	O
magnitude	O
of	O
these	O
possible	O
harms	O
,	O
few	O
would	O
argue	O
with	O
the	O
proposition	B-T170
that	O
sustained	O
science	O
hyp	O
##e	O
is	O
a	O
bad	O
thin	O
##g	O
.	O
we	O
all	O
benefit	O
from	O
robust	O
science	O
and	O
accurate	O
public	B-T098
representations	O
of	O
biomedical	B-T062
research	I-T062
.	O
but	O
,	O
to	O
date	O
,	O
there	O
has	O
been	O
very	O
little	O
consideration	B-T033
of	O
the	O
degree	O
to	O
which	O
the	O
scholars	O
##hip	O
on	O
the	O
related	O
ethical	O
,	O
legal	B-T170
,	O
and	O
social	O
issues	O
has	O
been	O
hyp	O
##ed	O
.	O
are	O
the	O
conclusions	O
from	O
els	O
##i	O
scholars	O
##hip	O
also	O
exaggerated	O
?	O

dimerization	O
of	O
egfr	B-T103
and	O
her2	B-T103
induces	O
breast	B-T038
cancer	I-T038
cell	B-T038
motility	I-T038
through	O
stat1	B-T103
-	O
dependent	O
act	B-T103
##a2	I-T103
induction	O
the	O
dimerization	O
of	O
egfr	B-T103
and	O
her2	B-T103
is	O
associated	O
with	O
poor	O
prognosis	B-T058
such	O
as	O
induction	O
of	O
tumor	O
growth	O
and	O
cell	B-T038
invasion	I-T038
compared	O
to	O
when	O
egfr	B-T103
remains	O
as	O
a	O
homod	O
##imer	O
.	O
however	O
,	O
the	O
mechanism	O
for	O
events	O
after	O
dimerization	O
in	O
breast	B-T038
cancer	I-T038
models	O
is	O
not	O
clear	O
.	O
we	O
found	O
that	O
expressions	B-T038
of	O
alpha	B-T103
-	I-T103
smooth	I-T103
muscle	I-T103
actin	I-T103
(	O
act	B-T103
##a2	I-T103
)	O
and	O
signal	B-T103
transducer	I-T103
and	I-T103
activator	I-T103
of	I-T103
transcription	I-T103
1	I-T103
(	O
stat1	B-T103
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	B-T038
of	O
her2	B-T103
in	O
egfr	B-T103
-	O
positive	B-T033
breast	B-T038
cancer	I-T038
cells	B-T017
.	O
act	B-T103
##a2	I-T103
and	O
stat1	B-T103
expression	B-T038
was	O
also	O
increased	O
in	O
her2	B-T103
-	O
positive	B-T033
breast	B-T038
cancer	I-T038
patients	O
.	O
in	O
contrast	O
,	O
act	B-T103
##a2	I-T103
expression	B-T038
was	O
decreased	O
by	O
her2	B-T103
sirna	I-T103
.	O
next	O
,	O
we	O
investigated	O
the	O
co	O
-	O
relation	O
between	O
stat1	B-T103
and	O
act	B-T103
##a2	I-T103
expression	B-T038
.	O
basal	O
act	B-T103
##a2	I-T103
expression	B-T038
was	O
significantly	O
decreased	O
by	O
treatment	B-T058
with	O
the	O
stat1	B-T103
inhibitor	I-T103
flu	B-T103
##da	I-T103
##ra	I-T103
##bin	I-T103
##e	I-T103
or	O
the	O
jak2	B-T103
inhibitor	I-T103
ag	B-T103
##49	I-T103
##0	I-T103
.	O
in	O
contrast	O
,	O
act	B-T103
##a2	I-T103
expression	B-T038
was	O
increased	O
by	O
stat1	B-T103
overexpression	B-T038
.	O
levels	O
of	O
act	B-T103
##a2	I-T103
,	O
stat1	B-T103
,	O
and	O
her2	B-T103
were	O
increased	O
and	O
relapse	O
free	O
survival	O
was	O
decreased	O
in	O
high	B-T033
-	I-T033
risk	I-T033
breast	B-T038
cancer	I-T038
patients	O
.	O
we	O
also	O
investigated	O
the	O
effect	O
of	O
act	B-T103
##a2	I-T103
on	O
cell	B-T038
motility	I-T038
,	O
which	O
was	O
suppressed	O
by	O
act	B-T103
##a2	I-T103
shrna	I-T103
overexpression	B-T038
in	O
mda	B-T017
-	I-T017
mb	I-T017
##23	I-T017
##1	I-T017
her2	B-T103
and	O
4	B-T017
##t1	I-T017
mammary	I-T017
carcinoma	I-T017
cells	I-T017
.	O
the	O
number	O
of	O
lung	B-T033
metastatic	I-T033
nodules	I-T033
was	O
significantly	O
decreased	O
in	O
act	B-T103
##a2	I-T103
knockdown	B-T204
mice	I-T204
.	O
taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
act	B-T103
##a2	I-T103
by	O
egfr	B-T103
and	O
her2	B-T103
dimerization	O
was	O
regulated	O
through	O
a	O
jak2	B-T103
/	O
stat1	B-T103
signaling	B-T038
pathway	I-T038
,	O
and	O
aberrant	O
act	B-T103
##a2	I-T103
expression	B-T038
accelerated	O
the	O
invasiveness	B-T038
and	O
metastasis	B-T038
of	O
breast	B-T038
cancer	I-T038
cells	B-T017
.	O

sustained	B-T103
delivery	I-T103
of	O
vincristine	B-T103
inside	O
an	O
orthotopic	B-T082
mouse	B-T038
sarcoma	I-T038
model	O
decreases	O
tumor	O
growth	O
sarcoma	B-T038
accounts	O
for	O
20	O
%	O
of	O
solid	B-T038
tumors	I-T038
in	O
children	O
.	O
surgery	B-T058
has	O
significant	O
morbidity	O
.	O
we	O
hypothesized	O
that	O
delivering	O
chemotherapy	B-T058
directly	O
into	O
tumors	B-T038
through	O
sustained	B-T103
release	I-T103
silk	B-T103
systems	O
could	O
slow	O
tumor	O
growth	O
.	O
human	B-T204
ewing	B-T038
sarcoma	I-T038
cells	B-T017
a	I-T017
##67	I-T017
##3	I-T017
were	O
cultured	B-T058
with	O
vincristine	B-T103
and	O
doxorubicin	B-T103
to	O
determine	O
half	O
maximal	O
inhibitory	O
concentration	O
(	O
ic50	O
)	O
.	O
cells	B-T017
were	O
injected	O
into	O
mouse	B-T204
hind	B-T017
leg	I-T017
to	O
create	O
orthotopic	B-T082
tumors	B-T038
.	O
tumor	O
volumes	O
were	O
measured	O
using	O
ultrasound	B-T058
.	O
when	O
volume	O
reached	O
>	O
250	O
##mm	O
(	O
3	O
,	O
)	O
interventions	B-T058
included	O
:	O
implantation	B-T058
of	O
drug	O
-	O
free	O
silk	B-T103
foam	O
(	O
control	O
-	O
f	O
)	O
,	O
doxorubicin	B-T103
400	O
##μg	O
foam	O
(	B-T103
dox	I-T103
##400	I-T103
-	O
f	O
)	O
,	O
vincristine	B-T103
50	O
##μg	O
foam	O
(	O
vin	B-T103
##50	I-T103
-	O
f	O
)	O
,	O
drug	O
-	O
free	O
silk	B-T103
gel	O
(	O
control	O
-	O
g	O
)	O
,	O
vincristine	B-T103
50	O
##μg	O
gel	O
(	O
vin	B-T103
##50	I-T103
-	O
g	O
)	O
,	O
or	O
single	O
dose	O
intravenous	B-T082
vincristine	B-T103
50	O
##μg	O
(	O
vin	B-T103
##50	I-T103
-	O
iv	O
)	O
.	O
end	O
-	O
point	O
was	O
volume	O
>	O
1000	O
##mm	O
(	O
3	O
)	O
.	O
kaplan	O
meier	O
and	O
anova	O
were	O
used	O
.	O
ic50	O
for	O
vincristine	B-T103
and	O
doxorubicin	B-T103
was	O
0	O
.	O
5	O
##ng	O
/	O
ml	O
and	O
200	O
##ng	O
/	O
ml	O
,	O
respectively	O
.	O
there	O
was	O
no	O
difference	O
between	O
dox	B-T103
##400	I-T103
-	O
f	O
[	O
6	O
##±	O
1d	O
##ays	O
to	O
end	O
point	O
(	O
dt	O
##ep	O
)	O
]	O
and	O
control	O
-	O
f	O
(	O
5	O
##±1	O
.	O
3	O
dt	O
##ep	O
)	O
.	O
vin	B-T103
##50	I-T103
-	O
f	O
(	O
12	O
.	O
4	O
##±3	O
.	O
5	O
dt	O
##ep	O
)	O
had	O
slower	B-T033
growth	I-T033
compared	O
to	O
control	O
-	O
f	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
there	O
was	O
no	O
difference	O
between	O
vin	B-T103
##50	I-T103
-	O
f	O
and	O
vin	B-T103
##50	I-T103
-	O
iv	O
(	O
14	O
##±0	O
dt	O
##ep	O
)	O
.	O
growth	B-T033
was	I-T033
slow	I-T033
##est	I-T033
with	O
vin	B-T103
##50	I-T103
-	O
g	O
,	O
28	O
##±1	O
##0	O
.	O
3	O
dt	O
##ep	O
compared	O
to	O
all	O
other	O
treatment	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
sustained	B-T103
delivery	I-T103
of	O
vincristine	B-T103
inside	O
the	O
sarcoma	B-T038
tumor	B-T038
with	O
silk	B-T103
gel	O
decreased	O
tumor	O
growth	O
.	O
applying	O
this	O
intratumoral	B-T058
treatment	I-T058
strategy	O
may	O
potentially	O
decrease	O
the	O
extent	O
of	O
surgical	B-T058
excision	I-T058
.	O

plasma	B-T031
dna	B-T103
and	O
rna	B-T103
differentially	O
impact	O
coagulation	B-T038
during	O
abdominal	B-T038
sepsis	I-T038
-	O
an	O
explor	B-T062
##ative	I-T062
study	I-T062
cell	B-T103
-	I-T103
free	I-T103
dna	I-T103
(	O
cf	B-T103
##dna	I-T103
)	O
and	O
extracellular	B-T017
rna	B-T103
(	O
ex	B-T103
##rna	I-T103
)	O
are	O
both	O
suspected	O
to	O
activate	O
coagulation	B-T038
cascades	I-T038
in	O
sepsis	B-T038
.	O
therefore	O
,	O
our	O
study	B-T062
investigated	O
the	O
influence	O
of	O
plasma	B-T031
##tic	I-T031
nucleic	B-T103
acids	I-T103
on	O
coagulation	B-T038
in	O
septic	O
patients	O
in	O
comparison	O
to	O
patients	O
after	O
major	O
abdominal	B-T058
surgery	I-T058
.	O
a	O
total	O
of	O
15	O
patients	O
with	O
sepsis	B-T038
,	O
10	O
postoperative	O
patients	O
,	O
and	O
10	O
healthy	B-T098
volunteers	I-T098
were	O
included	O
in	O
this	O
longitudinal	B-T062
study	I-T062
.	O
blood	B-T031
was	O
collected	O
at	O
sepsis	B-T038
onset	O
and	O
after	O
surgery	B-T058
respectively	O
,	O
as	O
well	O
as	O
after	O
24	O
,	O
72	O
and	O
168	O
h	O
.	O
levels	O
of	O
cf	B-T103
##dna	I-T103
and	O
ex	B-T103
##rna	I-T103
were	O
measured	O
by	O
quantitative	O
probe	B-T074
-	I-T074
based	I-T074
polymerase	B-T062
chain	I-T062
reaction	I-T062
.	O
in	O
addition	O
,	O
thromb	B-T058
##oe	I-T058
##last	I-T058
##ography	I-T058
for	O
coagulation	B-T038
as	O
well	O
as	O
thromb	B-T058
##oa	I-T058
##gg	I-T058
##reg	I-T058
##ometry	I-T058
for	O
platelet	B-T038
function	I-T038
was	O
conducted	O
.	O
both	O
cf	B-T103
##dna	I-T103
and	O
ex	B-T103
##rna	I-T103
were	O
elevated	O
in	O
patients	O
with	O
sepsis	B-T038
compared	O
with	O
postoperative	O
patients	O
and	O
healthy	B-T098
volunteers	I-T098
.	O
while	O
higher	O
ex	B-T103
##rna	I-T103
levels	O
correlated	O
with	O
a	O
faster	B-T033
clotting	I-T033
time	I-T033
and	O
more	O
stable	B-T038
clot	I-T038
##s	I-T038
,	O
cf	B-T103
##dna	I-T103
correlated	O
with	O
a	O
shorter	B-T033
clotting	I-T033
time	I-T033
but	O
also	O
less	O
fibrinolysis	B-T038
.	O
in	O
addition	O
,	O
higher	O
cf	B-T103
##dna	I-T103
seems	O
to	O
be	O
associated	O
with	O
kidney	B-T038
dysfunction	I-T038
as	O
well	O
as	O
with	O
general	O
markers	B-T201
of	O
cell	O
damage	O
(	O
lactate	B-T103
dehydrogenase	I-T103
and	O
lactate	B-T103
)	O
.	O
both	O
nucleic	B-T103
acid	I-T103
species	O
might	O
be	O
associated	O
with	O
different	O
effects	O
on	O
coagulation	B-T038
during	O
sepsis	B-T038
,	O
with	O
an	O
overall	O
procoagul	B-T038
##atory	I-T038
influence	O
.	O
for	O
this	O
reason	O
,	O
individualized	O
therapeutic	B-T058
approaches	I-T058
in	O
patients	O
suffering	B-T033
from	O
coagulation	B-T038
-	O
associated	B-T033
organ	B-T038
dysfunction	I-T038
might	O
be	O
feasible	O
.	O

gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
inhibits	O
chicken	B-T204
pre	B-T017
-	I-T017
adipocyte	I-T017
proliferation	B-T038
in	O
part	O
by	O
down	B-T038
-	I-T038
regulating	I-T038
kr	B-T017
##upp	I-T017
##el	I-T017
-	I-T017
like	I-T017
factor	I-T017
5	I-T017
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
is	O
abundantly	O
expressed	B-T038
in	O
chicken	B-T204
pre	B-T017
-	I-T017
adipocytes	I-T017
,	O
but	O
its	O
role	O
is	O
unclear	O
.	O
the	O
present	O
study	O
investigated	O
the	O
role	O
of	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
in	O
chicken	B-T204
pre	B-T017
-	I-T017
adipocyte	I-T017
proliferation	B-T038
.	O
cell	B-T062
proliferation	I-T062
assay	I-T062
and	O
gene	B-T062
expression	I-T062
analysis	I-T062
of	O
proliferating	B-T017
cell	I-T017
nuclear	I-T017
antigen	I-T017
(	O
pcna	B-T017
)	O
showed	O
that	O
the	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
mimic	O
inhibited	O
pre	B-T017
-	I-T017
adipocyte	I-T017
proliferation	B-T038
.	O
in	O
contrast	O
,	O
the	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
inhibitor	O
enhanced	O
pre	B-T017
-	I-T017
adipocyte	I-T017
proliferation	B-T038
.	O
the	O
subsequent	O
investigation	O
identified	O
kr	B-T017
##upp	I-T017
##el	I-T017
-	I-T017
like	I-T017
factor	I-T017
5	I-T017
(	O
kl	B-T017
##f5	I-T017
)	O
mrna	B-T103
as	O
a	O
target	O
of	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
.	O
the	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
mimic	O
inhibited	O
kl	B-T017
##f5	I-T017
3	B-T082
(	I-T082
'	I-T082
)	I-T082
utr	I-T082
reporter	B-T017
activity	O
and	O
decreased	O
endogenous	O
kl	B-T017
##f5	I-T017
expression	B-T038
in	O
primary	O
pre	B-T017
-	I-T017
adipocytes	I-T017
.	O
kl	B-T017
##f5	I-T017
knockdown	B-T062
using	O
rnai	B-T038
had	O
a	O
similar	O
effect	O
to	O
that	O
of	O
the	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
mimic	O
on	O
cell	B-T038
proliferation	I-T038
.	O
the	O
promoting	O
effect	O
of	O
the	O
gg	B-T103
##a	I-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
inhibitor	O
on	O
pre	B-T017
-	I-T017
adipocyte	I-T017
proliferation	B-T038
was	O
partially	O
attenuated	O
by	O
kl	B-T017
##f5	I-T017
knockdown	B-T062
.	O
taken	O
together	O
,	O
our	O
results	O
demonstrated	O
that	O
mir	B-T103
-	I-T103
21	I-T103
inhibits	O
chicken	B-T204
pre	B-T017
-	I-T017
adipocyte	I-T017
proliferation	B-T038
,	O
at	O
least	O
in	O
part	O
,	O
by	O
targeting	B-T062
kl	B-T017
##f5	I-T017
.	O

ter	B-T058
##ah	I-T058
##ertz	I-T058
identification	I-T058
and	O
quantification	O
of	O
neurotransmitter	B-T103
and	O
neurot	B-T103
##rophy	I-T103
mixture	I-T103
ter	B-T058
##ah	I-T058
##ertz	I-T058
spectroscopy	I-T058
has	O
been	O
widely	O
used	O
for	O
investigating	O
the	O
fingerprint	B-T058
spectrum	I-T058
of	O
different	O
substances	O
.	O
for	O
cancerous	B-T038
tissues	B-T017
,	O
the	O
greatest	O
difficulty	O
is	O
the	O
absorption	O
peaks	O
of	O
various	O
substances	O
contained	O
in	O
tissues	B-T017
overlap	O
with	O
each	O
other	O
,	O
which	O
are	O
hard	O
to	O
identify	O
and	O
quantitative	O
analyze	B-T062
.	O
as	O
a	O
result	O
,	O
it	O
is	O
very	O
hard	O
to	O
measure	O
the	O
presence	O
of	O
cancer	B-T017
cell	I-T017
and	O
then	O
to	O
diagnose	B-T033
accurately	O
.	O
in	O
this	O
paper	O
,	O
we	O
select	O
three	O
typical	O
neurotransmitters	B-T103
(	O
γ	B-T103
-	I-T103
aminobutyric	I-T103
acid	I-T103
,	O
l	B-T103
-	I-T103
glutamic	I-T103
acid	I-T103
,	O
dopamine	B-T103
hydrochloride	I-T103
)	O
and	O
two	O
typical	O
metabolites	B-T103
(	O
inositol	B-T103
and	O
creatine	B-T103
)	O
in	O
neurons	B-T017
to	O
measure	O
their	O
ter	B-T058
##ah	I-T058
##ertz	I-T058
spectra	I-T058
with	O
different	O
mixture	O
ratios	O
.	O
by	O
choosing	O
characteristic	O
absorption	O
peaks	O
,	O
removing	O
baseline	O
and	O
using	O
the	O
least	O
square	O
method	O
,	O
we	O
can	O
identify	O
the	O
components	O
and	O
proportions	O
of	O
each	O
mixture	O
,	O
where	O
the	O
good	O
##ness	O
of	O
fit	O
to	O
practical	O
situation	O
is	O
up	O
to	O
94	O
%	O
.	O
these	O
results	O
provide	O
important	O
evidences	O
for	O
identifying	O
nerve	B-T103
substances	I-T103
and	O
obtaining	O
exact	O
quantitative	O
analysis	B-T062
.	O

graded	B-T170
structure	I-T170
in	O
sexual	O
definitions	B-T170
:	O
categorization	B-T170
##s	I-T170
of	O
having	O
[UNK]	O
had	B-T033
sex	I-T033
[UNK]	O
and	O
virgin	O
##ity	O
loss	O
among	O
homosexual	B-T098
and	O
heterosexual	B-T098
men	B-T098
and	O
women	B-T098
definitions	B-T170
of	O
sexual	O
behavior	O
display	O
a	O
robust	O
hierarchy	O
of	O
agreement	O
regarding	O
whether	O
or	O
not	O
acts	O
should	O
be	O
class	O
##ed	O
as	O
,	O
for	O
example	O
,	O
sex	B-T038
or	O
virgin	O
##ity	O
loss	O
.	O
the	O
current	O
research	B-T062
offers	O
a	O
theoretical	O
explanation	B-T170
for	O
this	O
hierarchy	O
,	O
propos	O
##ing	O
that	O
sexual	O
definitions	B-T170
display	O
graded	B-T170
categorical	I-T170
structure	I-T170
,	O
arising	O
from	O
good	O
##ness	O
of	O
membership	O
judgments	B-T038
.	O
moder	O
##ation	O
of	O
this	O
graded	B-T170
structure	I-T170
is	O
also	O
predicted	O
,	O
with	O
the	O
focus	O
here	O
on	O
how	O
sexual	O
orientation	O
identity	B-T038
affects	O
sexual	O
definitions	B-T170
.	O
a	O
total	O
of	O
300	O
18	O
-	O
to	O
30	O
-	O
year	O
-	O
old	O
participants	B-T098
completed	O
an	O
online	B-T170
survey	I-T170
,	O
rating	O
18	O
behaviors	O
for	O
how	O
far	O
each	O
constitutes	O
having	O
[UNK]	O
had	B-T033
sex	I-T033
[UNK]	O
and	O
virgin	O
##ity	O
loss	O
.	O
participants	B-T098
fell	O
into	O
one	O
of	O
four	O
groups	O
:	O
heterosexual	B-T098
male	B-T098
or	O
female	B-T098
,	O
gay	B-T098
male	I-T098
or	O
les	B-T098
##bian	I-T098
.	O
the	O
predicted	O
ratings	O
hierarchy	O
emerged	O
,	O
in	O
which	O
bidirectional	O
genital	O
acts	O
were	O
rated	O
significantly	O
higher	O
than	O
unidirectional	O
or	O
nonp	B-T033
##enet	I-T033
##ra	I-T033
##tive	I-T033
contact	I-T033
,	O
which	O
was	O
in	O
turn	O
rated	O
significantly	O
higher	O
than	O
acts	O
involving	O
no	B-T033
genital	I-T033
contact	I-T033
.	O
moder	O
##ation	O
of	O
graded	B-T170
structure	I-T170
was	O
also	O
in	O
line	O
with	O
predictions	O
.	O
compared	O
to	O
the	O
other	O
groups	O
,	O
the	O
les	O
##bian	O
group	O
significantly	O
up	O
##grade	O
##d	O
ratings	O
of	O
genital	O
contact	O
that	O
was	O
either	O
unidirectional	O
or	O
nonp	B-T033
##enet	I-T033
##ra	I-T033
##tive	I-T033
.	O
there	O
was	O
also	O
evidence	O
of	O
up	O
##grad	O
##ing	O
by	O
the	O
gay	B-T098
male	I-T098
sample	O
of	O
anal	O
intercourse	O
ratings	O
.	O
these	O
effects	O
are	O
theor	O
##ized	O
to	O
reflect	O
group	O
-	O
level	O
variation	O
in	O
experience	B-T038
,	O
contextual	B-T038
perspective	I-T038
,	O
and	O
identity	B-T038
-	O
management	O
.	O
the	O
implications	O
of	O
the	O
findings	B-T033
in	O
relation	O
to	O
previous	O
research	B-T062
are	O
discussed	O
.	O
it	O
is	O
suggested	O
that	O
a	O
graded	B-T170
structure	I-T170
approach	O
can	O
greatly	O
benefit	O
future	O
research	B-T062
into	O
sexual	O
definitions	B-T170
,	O
by	O
permitting	O
variable	O
definitions	B-T170
to	O
be	O
predicted	O
and	O
explained	O
,	O
rather	O
than	O
merely	O
identified	O
.	O

a	O
case	O
of	O
ko	B-T038
##ch	I-T038
'	I-T038
s	I-T038
spine	I-T038
treated	O
with	O
modified	O
transp	B-T058
##edic	I-T058
##ular	I-T058
vertebral	I-T058
curettage	I-T058
and	O
posterior	B-T082
fixation	B-T058
:	O
a	O
novel	O
technique	O
tuberculosis	B-T038
(	O
tb	B-T038
)	O
is	O
a	O
chronic	O
granulomatous	B-T038
infection	I-T038
caused	O
by	O
acid	B-T007
-	I-T007
fast	I-T007
mycobacterium	I-T007
tuberculosis	I-T007
bacilli	I-T007
.	O
spinal	B-T082
involvement	I-T082
occurs	O
in	O
less	O
than	O
one	O
percent	O
of	O
tb	B-T038
.	O
spinal	B-T038
tb	I-T038
(	O
pot	B-T038
##t	I-T038
'	I-T038
s	I-T038
disease	I-T038
)	O
accounts	O
for	O
50	O
%	O
of	O
skeletal	O
tb	O
.	O
though	O
it	O
most	O
commonly	O
affects	O
the	O
thoracolumbar	B-T082
junction	I-T082
,	O
it	O
can	O
occur	O
at	O
any	O
level	O
of	O
the	O
spine	B-T017
.	O
early	O
diagnosis	B-T033
and	O
treatment	B-T058
is	O
mandatory	O
in	O
order	O
to	O
avoid	O
neurological	B-T038
complications	I-T038
and	O
spinal	B-T017
deformity	I-T017
.	O
we	O
report	B-T170
a	O
case	O
of	O
a	O
young	O
female	O
with	O
tuberculosis	B-T038
of	O
d1	B-T082
##2	I-T082
-	I-T082
l1	I-T082
who	O
was	O
treated	O
with	O
posterior	B-T082
decompression	B-T058
using	O
a	O
modified	O
transp	B-T058
##edic	I-T058
##ular	I-T058
approach	I-T058
and	O
posterior	B-T082
instrumentation	B-T058
with	O
a	O
successful	O
outcome	O
.	O

divided	O
and	O
sliding	O
superficial	B-T017
temporal	I-T017
artery	I-T017
flap	B-T017
for	O
primary	O
donor	B-T082
-	I-T082
site	I-T082
closure	B-T058
superficial	B-T017
temporal	I-T017
artery	I-T017
(	O
sta	B-T017
)	O
flaps	B-T017
are	O
often	O
used	O
for	O
reconstruction	B-T058
of	O
hair	B-T082
-	I-T082
bearing	I-T082
areas	I-T082
.	O
however	O
,	O
primary	B-T058
closure	I-T058
of	O
the	O
donor	B-T082
site	I-T082
is	O
not	O
easy	O
when	O
the	O
size	B-T082
of	O
the	O
necessary	O
skin	B-T022
island	I-T022
is	O
relatively	O
large	O
.	O
in	O
such	O
cases	O
,	O
skin	B-T017
grafts	I-T017
are	O
needed	O
at	O
the	O
donor	B-T082
site	I-T082
,	O
resulting	O
in	O
bal	B-T038
##d	I-T038
##ness	I-T038
.	O
we	O
have	O
solved	O
this	O
issue	O
by	O
applying	O
the	O
divided	O
and	O
sliding	O
flap	B-T017
technique	O
,	O
which	O
was	O
first	O
reported	O
for	O
primary	B-T058
donor	I-T058
-	I-T058
site	I-T058
closure	I-T058
of	O
a	O
lati	B-T017
##ss	I-T017
##imus	I-T017
dorsi	I-T017
muscul	I-T017
##ocutaneous	I-T017
flap	B-T017
.	O
we	O
applied	O
this	O
technique	O
to	O
the	O
hair	B-T017
-	I-T017
bearing	I-T017
sta	I-T017
flap	B-T017
,	O
where	O
primary	B-T058
donor	I-T058
-	I-T058
site	I-T058
closure	I-T058
is	O
extremely	O
beneficial	O
for	O
preventing	O
bal	B-T038
##d	I-T038
##ness	I-T038
consequent	O
to	O
skin	B-T058
grafting	I-T058
.	O
the	O
sta	B-T017
flap	B-T017
was	O
divided	O
into	O
3	O
,	O
and	O
creation	O
of	O
large	O
flap	B-T017
was	O
possible	O
.	O
therefore	O
,	O
we	O
concluded	O
that	O
the	O
divided	O
and	O
sliding	O
sta	B-T017
flap	B-T017
could	O
at	O
least	O
partially	O
solve	O
the	O
donor	B-T082
-	I-T082
site	I-T082
problem	B-T033
.	O
although	O
further	O
investigation	B-T058
is	O
necessary	O
to	O
validate	B-T062
the	O
maximum	O
possible	B-T033
flap	B-T017
size	B-T082
,	O
this	O
technique	O
may	O
be	O
applicable	O
to	O
at	O
least	O
small	O
defects	O
that	O
are	O
common	O
after	O
skin	B-T038
cancer	I-T038
ablation	B-T058
or	O
trauma	B-T037
.	O

audio	O
##vis	O
##ual	O
integration	B-T038
supports	O
face	B-T082
-	O
name	B-T170
associative	O
memory	B-T038
formation	I-T038
prior	O
multis	O
##ensory	O
experience	B-T038
influences	O
how	O
we	O
perceive	O
our	O
environment	B-T082
,	O
and	O
hence	O
how	O
memories	B-T038
are	O
encoded	O
for	O
subsequent	O
retrieval	O
.	O
this	O
study	B-T062
investigated	O
if	O
audio	O
##vis	O
##ual	O
(	O
av	O
)	O
integration	B-T038
and	O
associative	O
memory	B-T038
formation	I-T038
rely	O
on	O
overlapping	O
or	O
distinct	O
processes	O
.	O
our	O
functional	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
results	O
demonstrate	O
that	O
the	O
neural	B-T017
mechanisms	O
underlying	O
av	O
integration	B-T038
and	O
associative	O
memory	B-T038
overlap	O
substantially	O
.	O
in	O
particular	O
,	O
activity	O
in	O
anterior	O
superior	O
temporal	O
sulcus	O
(	O
sts	B-T082
)	O
is	O
increased	O
during	O
av	O
integration	B-T038
and	O
also	O
determines	O
the	O
success	O
of	O
novel	O
av	O
face	B-T082
-	O
name	B-T170
association	O
formation	O
.	O
dynamic	O
causal	O
modeling	O
results	O
further	O
demonstrate	O
how	O
the	O
anterior	O
sts	O
interacts	O
with	O
the	O
associative	O
memory	B-T038
system	I-T038
to	O
facilitate	O
successful	O
memory	B-T038
formation	I-T038
for	O
av	O
face	B-T082
-	O
name	B-T170
associations	O
.	O
specifically	O
,	O
the	O
connection	O
of	O
fusiform	B-T017
gyrus	I-T017
to	O
anterior	O
sts	O
is	O
enhanced	O
while	O
the	O
reverse	O
connection	O
is	O
reduced	O
when	O
participants	B-T098
subsequently	O
remember	B-T038
##ed	I-T038
both	O
face	B-T082
and	O
name	B-T170
.	O
collectively	O
,	O
our	O
results	O
demonstrate	O
how	O
multis	O
##ensory	O
associative	O
memories	B-T038
can	O
be	O
formed	O
for	O
subsequent	O
retrieval	O
.	O

benthic	B-T170
injury	I-T170
dose	I-T170
-	I-T170
response	I-T170
models	I-T170
for	O
polychlorinated	B-T103
biphenyl	I-T103
-	O
contaminated	O
sediment	O
using	O
equilibrium	B-T170
partitioning	I-T170
the	O
study	B-T062
goal	O
was	O
to	O
develop	O
a	O
sediment	O
polychlorinated	B-T103
biphenyl	I-T103
(	O
pcb	B-T103
)	O
dose	B-T170
-	I-T170
response	I-T170
model	I-T170
based	O
on	O
benthic	O
invertebrate	O
effects	O
to	O
pcbs	B-T103
.	O
the	O
authors	O
used	O
an	O
equilibrium	B-T170
partitioning	I-T170
(	I-T170
eq	I-T170
##p	I-T170
)	I-T170
approach	I-T170
to	O
generate	O
predicted	O
pcb	B-T103
sediment	O
effect	O
concentrations	O
(	O
largely	O
aro	B-T103
##cl	I-T103
##or	I-T103
125	I-T103
##4	I-T103
)	O
associated	O
with	O
a	O
gradient	O
of	O
toxic	B-T037
effects	I-T037
in	O
benthic	O
organisms	O
from	O
effects	O
observed	O
in	O
aquatic	O
toxicity	B-T037
studies	B-T062
.	O
the	O
present	O
study	B-T062
differs	O
from	O
all	O
other	O
eq	B-T170
##p	I-T170
collective	O
sediment	O
investigations	O
in	O
that	O
the	O
authors	O
examined	O
a	O
common	O
dose	O
-	O
response	O
gradient	O
of	O
effects	O
for	O
pcbs	B-T103
rather	O
than	O
a	O
single	O
,	O
protective	O
value	O
.	O
the	O
authors	O
reviewed	O
the	O
chronic	O
aquatic	O
toxicity	B-T037
literature	B-T170
to	O
identify	O
measured	O
aqueous	O
pcb	B-T103
concentrations	O
and	O
associated	O
benthic	O
invertebrate	O
effects	O
.	O
the	O
authors	O
control	O
-	O
normalized	O
the	O
aquatic	O
toxic	B-T037
effect	I-T037
data	O
and	O
expressed	O
results	O
from	O
various	O
studies	B-T062
as	O
a	O
common	O
metric	O
,	O
percent	O
injury	O
.	O
then	O
,	O
they	O
calculated	O
organic	B-T103
carbon	I-T103
-	O
normalized	O
sediment	O
pcb	B-T103
concentrations	O
(	O
mg	O
/	O
kg	O
organic	B-T103
carbon	I-T103
)	O
from	O
the	O
aqueous	O
pcb	B-T103
toxicity	B-T037
data	B-T170
set	I-T170
using	O
eq	B-T170
##p	I-T170
theory	O
based	O
on	O
the	O
us	B-T092
environmental	I-T092
protection	I-T092
agency	I-T092
'	I-T092
s	I-T092
(	O
epi	B-T170
##we	I-T170
##b	I-T170
4	I-T170
.	I-T170
1	I-T170
)	O
derivation	O
of	O
the	O
water	O
-	O
organic	O
carbon	O
partition	O
coefficient	O
(	O
ko	O
##c	O
)	O
.	O
lastly	O
,	O
the	O
authors	O
constructed	O
a	O
nonlinear	O
dose	B-T170
-	I-T170
response	I-T170
numerical	I-T170
model	I-T170
for	O
these	O
syn	O
##optic	O
sediment	O
pcb	B-T103
concentrations	O
and	O
biological	O
effects	O
:	O
y	O
=	O
100	O
/	O
1	O
+	O
10	O
(	O
(	O
[	O
log	O
##ec	O
##50	O
-	O
log	O
##x	O
]	O
×	O
[	O
hill	O
slope	O
]	O
)	O
)	O
(	O
ec50	O
=	O
median	O
effective	O
concentration	O
)	O
.	O
these	O
models	B-T170
were	O
used	O
to	O
generate	O
[UNK]	O
look	O
-	O
up	O
[UNK]	O
tables	B-T170
reporting	O
percent	O
injury	O
in	O
benthic	O
bio	O
##ta	O
for	O
a	O
range	O
of	O
aro	B-T103
##cl	I-T103
##or	I-T103
-	O
specific	O
sediment	O
concentrations	O
.	O
for	O
example	O
,	O
the	O
model	B-T170
using	O
the	O
epi	B-T170
##we	I-T170
##b	I-T170
ko	O
##c	O
estimate	O
predicts	O
mean	O
benthic	O
injury	O
of	O
23	O
.	O
3	O
%	O
,	O
46	O
.	O
0	O
%	O
,	O
70	O
.	O
6	O
%	O
,	O
87	O
.	O
1	O
%	O
,	O
and	O
95	O
%	O
for	O
hypothetical	O
sediment	O
concentrations	O
of	O
1	O
mg	O
/	O
kg	O
,	O
2	O
mg	O
/	O
kg	O
,	O
4	O
mg	O
/	O
kg	O
,	O
8	O
mg	O
/	O
kg	O
,	O
and	O
16	O
mg	O
/	O
kg	O
dry	O
weight	O
of	O
aro	B-T103
##cl	I-T103
##or	I-T103
125	I-T103
##4	I-T103
,	O
respectively	O
(	O
at	O
1	O
%	O
organic	B-T103
carbon	I-T103
)	O
.	O
the	O
authors	O
recommend	O
the	O
model	B-T170
presented	O
for	O
screening	O
but	O
suggest	O
,	O
when	O
possible	O
,	O
determining	O
a	O
site	B-T082
-	I-T082
specific	I-T082
ko	O
##c	O
that	O
,	O
along	O
with	O
the	O
tables	B-T170
and	O
equations	O
,	O
allows	O
users	O
to	O
create	O
their	O
own	O
protective	O
dose	O
-	O
response	O
sediment	O
concentration	O
.	O
environ	O
toxic	O
##ol	O
chem	O
2017	O
;	O
36	O
:	O
131	O
##1	O
-	O
132	O
##9	O
.	O
©	O
2016	O
set	O
##ac	O
.	O

novel	O
insights	O
into	O
development	O
of	O
diabetic	B-T033
bladder	B-T038
disorder	I-T038
provided	O
by	O
metabol	B-T091
##omic	I-T091
analysis	I-T091
of	O
the	O
rat	B-T204
nondiabetic	O
and	O
diabetic	B-T033
detrusor	B-T017
and	O
urothelial	B-T017
layer	I-T017
there	O
are	O
at	O
present	O
no	O
published	O
studies	O
providing	O
a	O
global	O
overview	O
of	O
changes	O
in	O
bladder	B-T017
metabolism	B-T038
resulting	O
from	O
diabetes	B-T038
.	O
such	O
studies	O
have	O
the	O
potential	O
to	O
provide	O
mechanistic	O
insight	O
into	O
the	O
development	O
of	O
diabetic	B-T033
bladder	B-T038
disorder	I-T038
(	I-T038
db	I-T038
##d	I-T038
)	I-T038
.	O
in	O
the	O
present	O
study	O
,	O
we	O
compared	O
the	O
metabol	O
##ome	O
of	O
detrusor	B-T017
and	O
urothelial	B-T017
layer	I-T017
in	O
a	O
1	O
-	O
mo	O
streptozotocin	B-T103
-	O
induced	O
rat	B-T204
model	B-T038
of	O
type	B-T038
1	I-T038
diabetes	I-T038
with	O
nondiabetic	O
controls	O
.	O
our	O
studies	O
revealed	O
that	O
diabetes	B-T038
caused	O
both	O
common	O
and	O
differential	O
changes	O
in	O
the	O
detrusor	B-T017
and	O
urothelial	B-T017
layer	I-T017
'	I-T017
s	I-T017
metabol	O
##ome	O
.	O
diabetes	B-T038
resulted	O
in	O
similar	O
changes	O
in	O
the	O
levels	O
of	O
previously	O
described	O
diabetic	B-T038
markers	B-T201
in	O
both	O
tissues	B-T017
,	O
such	O
as	O
glucose	B-T103
,	O
lactate	B-T103
,	O
2	B-T103
-	I-T103
hydroxybutyrate	I-T103
,	O
branched	B-T103
-	I-T103
chain	I-T103
amino	I-T103
acid	I-T103
degradation	I-T103
products	I-T103
,	O
bile	B-T103
acids	I-T103
,	O
and	O
1	B-T103
,	I-T103
5	I-T103
-	I-T103
anhydro	I-T103
##gluc	I-T103
##itol	I-T103
,	O
as	O
well	O
as	O
markers	B-T201
of	O
oxidative	B-T038
stress	I-T038
.	O
in	O
the	O
detrusor	B-T017
(	O
but	O
not	O
the	O
urothelial	B-T017
layer	I-T017
)	O
,	O
diabetes	B-T038
caused	O
activation	O
of	O
the	O
pent	B-T103
##ose	I-T103
-	I-T103
phosphate	I-T103
and	O
poly	B-T103
##ol	I-T103
pathways	B-T038
,	O
concomitant	O
with	O
a	O
reduction	O
in	O
the	O
tca	B-T038
cycle	I-T038
and	O
β	B-T038
-	I-T038
oxidation	I-T038
.	O
changes	O
in	O
detrusor	B-T017
energy	B-T038
-	I-T038
generating	I-T038
pathways	I-T038
resulted	O
in	O
an	O
accumulation	O
of	O
sorbitol	B-T103
that	O
,	O
through	O
generation	O
of	O
advanced	B-T103
glycation	I-T103
end	I-T103
products	I-T103
,	O
is	O
likely	O
to	O
play	O
a	O
central	O
role	O
in	O
the	O
development	O
of	O
db	B-T038
##d	I-T038
.	O
in	O
the	O
diabetic	B-T033
urothelial	B-T017
layer	I-T017
there	O
was	O
decreased	O
flux	O
of	O
glucose	B-T103
via	O
glycolysis	B-T038
and	O
changes	O
in	O
lipid	B-T038
metabolism	I-T038
,	O
particularly	O
prostaglandin	B-T103
synthesis	O
,	O
which	O
also	O
potentially	O
contributes	O
to	O
detrusor	B-T017
dysfunction	B-T038
.	O

serum	B-T031
vascular	B-T103
endothelial	I-T103
growth	I-T103
factor	I-T103
receptor	I-T103
-	I-T103
3	I-T103
levels	O
in	O
patients	O
with	O
esophageal	B-T038
squamous	I-T038
cell	I-T038
cancer	I-T038
esophageal	B-T038
cancer	I-T038
is	O
one	O
of	O
the	O
most	O
aggressive	O
tumors	B-T038
of	I-T038
the	I-T038
gastrointestinal	I-T038
tract	I-T038
.	O
in	O
this	O
study	O
,	O
we	O
quantified	O
the	O
serum	B-T031
vascular	B-T103
endothelial	I-T103
growth	I-T103
factor	I-T103
-	I-T103
3	I-T103
(	O
vegfr	B-T103
-	I-T103
3	I-T103
)	O
expression	B-T038
in	O
patients	O
with	O
esophageal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
escc	B-T038
)	O
to	O
evaluate	O
the	O
role	O
of	O
vegfr	B-T103
-	I-T103
3	I-T103
in	O
escc	B-T038
.	O
ninety	O
five	O
patients	O
with	O
escc	B-T038
were	O
studied	O
.	O
pre	O
-	O
therapy	O
and	O
preoperative	O
samples	B-T031
were	O
stored	O
and	O
elisa	B-T058
was	O
used	O
to	O
design	O
##ate	O
the	O
concentrations	O
of	O
vegfr	B-T103
-	I-T103
3	I-T103
.	O
the	O
serum	O
values	O
of	O
vegfr	B-T103
-	I-T103
3	I-T103
were	O
significantly	O
higher	O
in	O
patients	O
with	O
escc	B-T038
than	O
in	O
healthy	O
donors	B-T098
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
the	O
results	O
imply	O
a	O
very	O
good	O
sensitivity	O
of	O
vegfr	B-T103
-	I-T103
3	I-T103
in	O
escc	B-T038
.	O
vegfr	B-T103
-	I-T103
3	I-T103
may	O
be	O
a	O
good	O
diagnostic	O
biomarker	B-T201
for	O
escc	B-T038
.	O
biomarker	B-T201
,	O
escc	B-T038
,	O
vegfr	B-T103
-	I-T103
3	I-T103
.	O

ultrasonic	B-T058
computed	I-T058
tomography	I-T058
imaging	I-T058
of	O
iron	O
oxide	O
nanoparticles	O
iron	O
oxide	O
nanoparticles	O
(	O
ion	O
##ps	O
)	O
are	O
becoming	O
increasingly	O
used	O
and	O
intensively	O
investigated	O
in	O
the	O
field	O
of	O
medical	B-T058
imaging	I-T058
.	O
they	O
are	O
currently	O
fda	B-T092
approved	O
for	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
,	O
and	O
it	O
would	O
be	O
highly	O
desirable	O
to	O
visualize	O
them	O
by	O
ultrasound	O
as	O
well	O
.	O
previous	O
reports	B-T170
using	O
the	O
conventional	O
ultrasound	B-T058
b	I-T058
-	I-T058
scan	I-T058
(	I-T058
pulse	I-T058
-	I-T058
echo	I-T058
)	I-T058
imaging	I-T058
technique	I-T058
have	O
shown	O
very	O
limited	O
detect	B-T201
##ability	I-T201
of	O
these	O
particles	B-T103
.	O
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
explore	O
the	O
feasibility	O
of	O
imaging	B-T058
ion	O
##ps	O
using	O
the	O
through	O
-	O
transmission	O
ultrasound	O
methodology	O
and	O
demonstrate	O
their	O
detect	O
##ability	O
using	O
ultrasonic	B-T058
computed	I-T058
tomography	I-T058
(	O
uc	B-T058
##t	I-T058
)	O
.	O
commercially	O
available	O
ion	O
##ps	O
were	O
acoustic	O
##ally	O
analysed	B-T062
to	O
quantify	O
their	O
effect	O
on	O
the	O
speed	O
of	O
sound	O
(	O
sos	O
)	O
and	O
acoustic	O
attenuation	O
as	O
a	O
function	O
of	O
concentration	O
.	O
next	O
,	O
through	B-T058
-	I-T058
transmission	I-T058
projection	I-T058
and	O
uc	B-T058
##t	I-T058
imaging	I-T058
were	O
performed	O
on	O
a	O
breast	B-T017
mimicking	O
phantom	O
and	O
on	O
an	O
ex	B-T038
vivo	I-T038
tissue	I-T038
model	I-T038
,	O
to	O
which	O
ion	O
##ps	O
were	O
injected	O
.	O
finally	O
,	O
an	O
mri	B-T058
scan	I-T058
was	O
performed	O
to	O
verify	O
that	O
the	O
same	O
particles	B-T103
examined	B-T033
in	O
the	O
ultrasound	O
experiment	B-T062
can	O
be	O
imaged	B-T170
by	O
magnetic	O
resonance	O
,	O
using	O
the	O
same	O
clinically	O
relevant	O
concentrations	O
.	O
the	O
results	O
have	O
shown	O
a	O
consistent	O
concentration	O
dependent	O
speed	O
of	O
sound	O
increase	O
(	O
1	O
.	O
86	O
[	O
formula	O
:	O
see	O
text	O
]	O
rise	O
per	O
100	O
µg	O
·	O
ml	O
(	O
-	O
1	O
)	O
ion	O
##ps	O
)	O
.	O
imaging	B-T058
based	O
on	O
this	O
property	O
has	O
shown	O
a	O
substantial	O
contrast	O
-	O
to	O
-	O
noise	O
ratio	O
improvement	O
(	O
up	O
to	O
5	O
fold	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
the	O
sos	O
-	O
related	O
effect	O
generated	O
a	O
well	O
discern	O
##ible	O
image	B-T170
contrast	O
and	O
allowed	O
the	O
detection	B-T033
of	O
the	O
particles	B-T103
existence	O
and	O
location	B-T082
,	O
in	O
both	O
ras	B-T058
##ter	I-T058
-	I-T058
scan	I-T058
projection	I-T058
and	O
uc	B-T058
##t	I-T058
imaging	I-T058
.	O
conversely	O
,	O
no	O
significant	O
change	O
in	O
the	O
acoustic	O
attenuation	O
coefficient	O
was	O
noted	O
.	O
based	O
on	O
these	O
findings	B-T033
,	O
it	O
is	O
concluded	O
that	O
ion	O
##ps	O
can	O
be	O
used	O
as	O
an	O
effective	O
sos	O
-	O
based	O
contrast	B-T103
agent	I-T103
,	O
potentially	O
useful	O
for	O
ultrasonic	O
breast	B-T017
imaging	B-T058
.	O
furthermore	O
,	O
the	O
particle	B-T103
offers	O
the	O
capacity	O
of	O
significantly	O
enhancing	O
diagnosis	O
accuracy	O
using	O
multimodal	B-T058
mri	B-T058
-	O
ultrasound	B-T058
imaging	I-T058
capabilities	O
.	O

targeting	O
the	O
ecology	O
within	O
:	O
the	O
role	O
of	O
the	O
gut	B-T082
-	I-T082
brain	I-T082
axis	I-T082
and	O
human	B-T204
microbiota	O
in	O
drug	B-T038
addiction	I-T038
despite	O
major	O
advances	O
in	O
our	O
understanding	B-T038
of	O
the	O
brain	B-T017
using	O
traditional	B-T091
neuroscience	I-T091
,	O
reliable	O
and	O
efficacious	O
treatments	B-T058
for	O
drug	B-T038
addiction	I-T038
have	O
remained	B-T033
elusive	I-T033
.	O
hence	O
,	O
the	O
time	O
has	O
come	O
to	O
utilize	O
novel	O
approaches	B-T082
,	O
particularly	O
those	O
drawing	O
upon	O
contemporary	O
advances	O
in	O
fields	O
outside	O
of	O
established	O
neurosci	B-T091
##enc	I-T091
e	O
and	O
psychiatry	B-T091
.	O
put	O
another	O
way	O
,	O
the	O
time	O
has	O
come	O
for	O
a	O
paradigm	O
shift	O
in	O
the	O
addiction	B-T038
sciences	O
.	O
apr	O
##opos	O
,	O
a	O
revolution	O
in	O
the	O
area	B-T082
of	O
human	B-T204
health	O
is	O
underway	O
,	O
which	O
is	O
occurring	O
at	O
the	O
ne	O
##x	O
##us	O
between	O
enteric	B-T082
microbiology	B-T091
and	O
neuroscience	B-T091
.	O
it	O
has	O
become	O
increasingly	O
clear	O
that	O
the	O
human	B-T204
microbiota	O
(	O
the	O
vast	O
ecology	O
of	O
bacteria	B-T007
residing	O
within	O
the	O
human	B-T204
organism	O
)	O
,	O
plays	O
an	O
important	O
role	O
in	O
health	O
and	O
disease	B-T038
.	O
this	O
is	O
not	O
surprising	O
,	O
as	O
it	O
has	O
been	O
estimated	O
that	O
bacteria	B-T007
living	O
in	O
the	O
human	B-T204
body	I-T204
(	O
approximately	O
1	O
##kg	O
of	O
mass	O
,	O
roughly	O
equivalent	O
to	O
that	O
of	O
the	O
human	B-T204
brain	B-T017
)	O
out	O
##nu	O
##mb	O
##er	O
human	B-T033
cells	I-T033
10	O
to	O
1	O
.	O
while	O
advances	O
in	O
the	O
understanding	B-T038
of	O
the	O
role	O
of	O
microbiota	O
in	O
other	O
areas	B-T082
of	O
human	B-T204
health	O
have	O
yielded	O
intriguing	O
results	O
(	O
e	O
.	O
g	O
.	O
,	O
clostridium	B-T038
difficile	I-T038
,	O
irritable	B-T038
bowel	I-T038
syndrome	I-T038
,	O
autism	B-T038
,	O
etc	O
.	O
)	O
,	O
to	O
date	O
,	O
no	O
systematic	O
programs	O
of	O
research	B-T062
have	O
examined	B-T033
the	O
role	O
of	O
microbiota	O
in	O
drug	B-T038
addiction	I-T038
.	O
the	O
current	O
hypothesis	O
,	O
therefore	O
,	O
is	O
that	O
gut	O
dys	O
##biosis	O
plays	O
a	O
key	O
role	O
in	O
addictive	B-T038
disorders	B-T038
.	O
in	O
the	O
context	O
of	O
this	O
hypothesis	O
,	O
this	O
paper	B-T170
provides	O
a	O
rationale	O
for	O
future	O
research	B-T062
to	O
target	O
the	O
[UNK]	O
gut	B-T017
-	O
brain	B-T017
axis	B-T082
[UNK]	O
in	O
addiction	B-T038
.	O
a	O
brief	O
background	O
of	O
the	O
gut	B-T017
-	O
brain	B-T017
axis	B-T082
is	O
provided	O
,	O
along	O
with	O
a	O
series	O
of	O
hypothesis	O
-	O
driven	O
ideas	O
outl	O
##ining	O
potential	O
treatments	B-T058
for	O
addiction	B-T038
via	O
manipulations	B-T033
of	O
the	O
[UNK]	O
ecology	O
within	O
.	O
[UNK]	O

variation	O
in	O
the	O
intensity	O
of	O
selection	B-T038
on	O
codon	B-T082
bias	O
over	O
time	O
causes	O
contrasting	B-T082
patterns	I-T082
of	O
base	O
composition	O
evolution	B-T038
in	O
drosophila	B-T204
four	O
-	O
fold	O
degenerate	O
coding	B-T017
sites	I-T017
form	O
a	O
major	O
component	O
of	O
the	O
genome	B-T017
,	O
and	O
are	O
often	O
used	O
to	O
make	O
inferences	O
about	O
selection	B-T038
and	O
dem	O
##ography	O
,	O
so	O
that	O
understanding	O
their	O
evolution	B-T038
is	O
important	O
.	O
despite	O
previous	O
efforts	O
,	O
many	O
questions	O
regarding	O
the	O
causes	O
of	O
base	O
composition	O
changes	O
at	O
these	O
sites	B-T017
in	O
drosophila	B-T204
remain	O
un	O
##answ	O
##ered	O
.	O
to	O
shed	O
further	O
light	O
on	O
this	O
issue	B-T033
,	O
we	O
obtained	O
a	O
new	O
whole	O
-	O
genome	O
polymorphism	O
data	O
set	O
from	O
d	B-T204
.	I-T204
sim	I-T204
##ulans	I-T204
.	O
we	O
analyzed	B-T062
samples	B-T017
from	O
the	O
putative	O
##ly	O
ancestral	O
range	O
of	O
d	B-T204
.	I-T204
sim	I-T204
##ulans	I-T204
,	O
as	O
well	O
as	O
an	O
existing	O
polymorphism	O
data	O
set	O
from	O
an	O
african	O
population	O
of	O
d	B-T204
.	I-T204
melanogaster	I-T204
.	O
by	O
using	O
d	B-T204
.	I-T204
y	I-T204
##ak	I-T204
##ub	I-T204
##a	I-T204
as	O
an	O
out	O
##group	O
,	O
we	O
found	O
clear	O
evidence	O
for	O
selection	B-T038
on	O
4	O
-	O
fold	O
sites	B-T017
along	O
both	O
lineages	O
over	O
a	O
substantial	O
period	O
,	O
with	O
the	O
intensity	O
of	O
selection	B-T038
increasing	O
with	O
gc	O
content	O
.	O
based	O
on	O
an	O
explicit	O
model	O
of	O
base	O
composition	O
evolution	B-T038
,	O
we	O
suggest	O
that	O
the	O
observed	O
at	O
-	O
biased	O
substitution	B-T082
pattern	I-T082
in	O
both	O
lineages	O
is	O
probably	O
due	O
to	O
an	O
ancestral	O
reduction	O
in	O
selection	B-T038
intensity	O
,	O
and	O
is	O
unlikely	O
to	O
be	O
the	O
result	B-T033
of	O
an	O
increase	O
in	O
mutational	B-T038
bias	O
towards	O
at	O
alone	O
.	O
by	O
using	O
two	O
polymorphism	B-T058
-	I-T058
based	I-T058
methods	I-T058
for	O
estimating	O
selection	B-T038
coefficients	O
over	O
different	O
times	O
##cales	O
,	O
we	O
show	O
that	O
the	O
selection	B-T038
intensity	O
on	O
codon	B-T082
usage	O
has	O
been	O
rather	O
stable	O
in	O
d	B-T204
.	I-T204
sim	I-T204
##ulans	I-T204
in	O
the	O
recent	O
past	O
,	O
but	O
the	O
long	O
-	O
term	O
estimates	O
in	O
d	B-T204
.	I-T204
melanogaster	I-T204
are	O
much	O
higher	O
than	O
the	O
short	O
-	O
term	O
ones	O
,	O
indicating	O
a	O
continuing	O
decline	O
in	O
selection	B-T038
intensity	O
,	O
to	O
such	O
an	O
extent	B-T082
that	O
the	O
short	O
-	O
term	O
estimates	O
suggest	O
that	O
selection	B-T038
is	O
only	O
active	O
in	O
the	O
most	O
gc	O
-	O
rich	O
parts	O
of	O
the	O
genome	B-T017
.	O
finally	O
,	O
we	O
provide	O
evidence	O
for	O
complex	O
evolutionary	B-T082
patterns	I-T082
in	O
the	O
putative	O
##ly	O
neutral	B-T103
short	I-T103
introns	I-T103
,	O
which	O
cann	O
##ot	O
be	O
explained	O
by	O
the	O
standard	O
gc	O
-	O
biased	O
gene	B-T038
conversion	I-T038
model	O
.	O
these	O
results	B-T033
reveal	O
a	O
dynamic	O
picture	O
of	O
base	O
composition	O
evolution	B-T038
.	O

difference	B-T062
-	I-T062
in	I-T062
-	I-T062
differences	I-T062
method	I-T062
in	O
comparative	B-T062
effectiveness	I-T062
research	I-T062
:	O
utility	O
with	O
unbalanced	O
groups	O
comparative	B-T062
effectiveness	I-T062
research	I-T062
(	O
cer	B-T062
)	O
often	O
includes	O
observational	B-T170
studies	I-T170
utilizing	O
administrative	B-T033
data	I-T033
.	O
multiple	O
conditioning	O
methods	O
can	O
be	O
used	O
for	O
cer	B-T062
to	O
adjust	O
for	O
group	O
differences	O
,	O
including	O
difference	B-T062
-	I-T062
in	I-T062
-	I-T062
differences	I-T062
(	I-T062
did	I-T062
)	I-T062
estimation	I-T062
.	O
this	O
study	O
presents	O
did	B-T062
and	O
demonstrates	O
how	O
to	O
apply	O
this	O
conditioning	O
method	B-T170
to	O
estimate	O
treatment	O
outcomes	O
in	O
the	O
cer	B-T062
setting	O
by	O
utilizing	O
the	O
markets	B-T170
##can	I-T170
##®	I-T170
databases	I-T170
for	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
patients	O
receiving	O
different	O
therapies	B-T058
.	O
the	O
sample	O
included	O
67	O
##62	O
patients	O
,	O
with	O
36	O
##3	O
in	O
the	O
test	B-T098
cohort	I-T098
[	O
gla	B-T103
##tir	I-T103
##amer	I-T103
acetate	I-T103
(	O
ga	B-T103
)	O
switched	B-T058
to	O
fing	B-T103
##oli	I-T103
##mod	I-T103
(	O
ft	B-T103
##y	I-T103
)	O
]	O
and	O
63	O
##99	O
in	O
the	O
control	O
cohort	O
(	O
ga	B-T103
only	O
,	O
no	B-T033
switch	I-T033
)	O
from	O
a	O
us	B-T170
administrative	I-T170
claims	I-T170
database	I-T170
.	O
a	O
trend	O
analysis	O
was	O
conducted	O
to	O
rule	O
out	O
concerns	O
regarding	O
regression	B-T170
to	O
the	O
mean	O
and	O
to	O
compare	O
relapse	O
rates	O
among	O
treatment	B-T098
cohorts	I-T098
.	O
did	B-T062
analysis	I-T062
was	O
used	O
to	O
enable	O
comparisons	O
among	O
the	O
test	B-T098
and	O
control	O
cohorts	O
.	O
logistic	B-T062
regression	I-T062
was	O
used	O
to	O
estimate	O
the	O
probability	O
of	O
relapse	O
after	O
switching	B-T058
from	O
ga	B-T103
to	O
ft	B-T103
##y	I-T103
,	O
and	O
to	O
compare	O
group	O
differences	O
in	O
the	O
pre	O
-	O
and	O
post	O
-	O
index	O
periods	O
.	O
crude	O
did	B-T062
analysis	I-T062
showed	O
that	O
in	O
the	O
pre	O
-	O
index	O
period	O
more	O
patients	O
in	O
the	O
test	B-T098
cohort	I-T098
experienced	O
an	O
ms	B-T038
relapse	O
and	O
had	O
a	O
higher	O
mean	O
number	O
of	O
relapses	O
than	O
in	O
the	O
control	O
cohort	O
.	O
during	O
the	O
pre	O
-	O
index	O
period	O
,	O
numeric	O
and	O
relative	O
data	O
for	O
ms	B-T038
relapses	O
in	O
patients	O
in	O
the	O
test	B-T098
cohort	I-T098
were	O
significantly	O
higher	O
than	O
in	O
the	O
control	O
cohort	O
,	O
while	O
no	B-T033
significant	I-T033
between	O
-	O
group	O
differences	O
emerged	O
during	O
the	O
post	O
-	O
index	O
period	O
.	O
generalized	O
linear	O
modeling	O
with	O
did	B-T062
regression	O
estimation	O
showed	O
that	O
the	O
mean	O
number	O
of	O
ms	B-T038
relapses	O
decreased	O
significantly	O
in	O
the	O
post	O
-	O
index	O
period	O
among	O
patients	O
in	O
the	O
test	B-T098
cohort	I-T098
compared	O
with	O
patients	O
in	O
the	O
control	O
cohort	O
.	O
in	O
this	O
study	O
,	O
an	O
ms	B-T038
population	B-T098
was	O
utilized	O
to	O
demonstrate	O
how	O
did	B-T062
can	O
be	O
applied	O
to	O
estimate	O
treatment	B-T033
effects	I-T033
in	O
a	O
heterogeneous	O
population	B-T098
,	O
where	O
the	O
test	B-T098
and	O
control	O
cohorts	O
varied	O
greatly	O
.	O
the	O
results	O
show	O
that	O
did	B-T062
offers	O
a	O
robust	O
method	O
for	O
comparing	O
diverse	O
cohorts	B-T098
when	O
other	O
risk	O
-	O
adjustment	O
methods	O
may	O
not	O
be	O
adequate	O
.	O

inducible	O
expression	B-T038
of	O
both	O
erm	B-T017
##b	I-T017
and	O
erm	B-T017
##t	I-T017
conferred	O
high	O
macrolide	B-T033
resistance	I-T033
in	O
streptococcus	B-T007
gall	I-T007
##olyticus	I-T007
subsp	I-T007
.	I-T007
paste	I-T007
##uria	I-T007
##nu	I-T007
##s	I-T007
isolates	O
in	O
china	B-T082
streptococcus	B-T007
gall	I-T007
##olyticus	I-T007
subsp	I-T007
.	I-T007
paste	I-T007
##uria	I-T007
##nu	I-T007
##s	I-T007
is	O
an	O
under	O
-	O
recognized	O
pathogen	O
and	O
zoonotic	B-T007
agent	I-T007
causing	O
opportunistic	B-T038
infections	I-T038
in	O
humans	B-T204
.	O
despite	O
increasing	O
recognition	O
of	O
this	O
subspecies	B-T007
as	O
a	O
cause	O
for	O
human	B-T204
infectious	B-T038
diseases	I-T038
,	O
limited	O
information	O
is	O
known	O
about	O
its	O
antibiotic	O
resistance	O
mechanism	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
aim	O
to	O
identify	O
the	O
molecular	B-T038
mechanism	I-T038
underlying	O
the	O
high	O
macrolide	B-T033
resistance	I-T033
of	O
six	O
s	B-T007
.	I-T007
gall	I-T007
##olyticus	I-T007
subsp	I-T007
.	I-T007
paste	I-T007
##uria	I-T007
##nu	I-T007
##s	I-T007
isolates	O
from	O
dead	B-T033
duck	B-T204
##lings	I-T204
collected	O
in	O
several	O
natural	O
outbreaks	O
in	O
china	B-T082
during	O
2010	O
-	O
2013	O
.	O
all	O
isolates	O
exhibited	O
multi	O
-	O
drug	O
resistance	O
including	O
high	O
macrolide	B-T033
resistance	I-T033
(	O
mic	B-T033
≥	O
102	O
##4	O
mg	O
/	O
l	O
for	O
erythromycin	B-T103
,	O
and	O
512	O
mg	O
/	O
l	O
for	O
clarithromycin	B-T103
)	O
.	O
efflux	B-T017
-	I-T017
encoding	I-T017
me	I-T017
##fa	I-T017
and	O
me	B-T017
##fe	I-T017
genes	I-T017
were	O
not	O
detectable	O
in	O
these	O
isolates	O
.	O
the	O
presence	O
of	O
23	B-T103
##s	I-T103
rrna	I-T103
mutations	B-T038
in	O
specific	O
isolates	O
did	O
not	O
significantly	O
change	O
macrolide	B-T103
mic	B-T033
s	O
.	O
no	O
nucleotide	B-T103
substitutions	O
were	O
found	O
in	O
genes	B-T017
encoding	O
ribosomal	B-T103
proteins	I-T103
l4	I-T103
or	O
l2	B-T103
##2	I-T103
.	O
the	O
erm	B-T017
##b	I-T017
and	O
erm	B-T017
##t	I-T017
genes	I-T017
were	O
found	O
in	O
the	O
genomes	B-T017
of	O
all	O
isolates	O
.	O
these	O
two	O
genes	B-T017
were	O
acquired	O
independently	O
in	O
one	O
highly	O
virulent	O
isolate	O
al	O
##101	O
##00	O
##2	O
,	O
and	O
clustered	O
with	O
tn	O
##91	O
##6	O
and	O
is	O
##12	O
##16	O
,	O
respectively	O
.	O
the	O
expression	B-T038
of	O
both	O
erm	B-T017
##b	I-T017
and	O
erm	B-T017
##t	I-T017
in	O
all	O
isolates	O
was	O
erythromycin	B-T103
inducible	O
and	O
yielded	O
comparable	O
macrolide	B-T103
mics	B-T033
in	O
all	O
six	O
isolates	O
.	O
taken	O
together	O
,	O
inducible	O
expression	B-T038
of	O
both	O
erm	B-T017
##b	I-T017
and	O
erm	B-T017
##t	I-T017
conferred	O
high	O
macrolide	B-T033
resistance	I-T033
in	O
these	O
s	B-T007
.	I-T007
gall	I-T007
##olyticus	I-T007
subsp	I-T007
.	I-T007
paste	I-T007
##rian	I-T007
##us	I-T007
isolates	O
.	O
our	O
findings	B-T033
reveal	O
new	O
macrolide	B-T033
resistance	I-T033
features	O
in	O
s	B-T007
.	I-T007
gall	I-T007
##olyticus	I-T007
subsp	I-T007
.	I-T007
paste	I-T007
##uria	I-T007
##nu	I-T007
##s	I-T007
by	O
both	O
erm	B-T017
##b	I-T017
and	O
erm	B-T017
##t	I-T017
.	O

the	O
value	O
of	O
bios	O
##amp	O
##les	O
in	O
smoking	O
cessation	O
trials	B-T062
:	O
a	O
review	O
of	O
genetic	B-T033
,	O
metabol	B-T091
##omic	I-T091
,	O
and	O
epigenetic	B-T038
findings	B-T033
evidence	O
is	O
emerging	O
that	O
certain	O
genotypes	O
and	O
biomarkers	B-T201
are	O
associated	O
with	O
smoking	O
cessation	O
success	O
and	O
efficacy	O
of	O
smoking	B-T058
cessation	I-T058
treatments	I-T058
.	O
we	O
review	O
key	O
findings	O
that	O
open	O
potential	O
avenues	O
for	O
personal	O
##izing	O
smoking	B-T058
cessation	I-T058
treatment	I-T058
according	O
to	O
an	O
individual	B-T098
'	I-T098
s	I-T098
genetic	B-T058
or	O
metabolic	B-T038
profile	I-T038
.	O
these	O
results	O
provide	O
important	O
incentive	O
for	O
smoking	O
cessation	O
researchers	O
to	O
collect	O
bios	O
##amp	O
##les	O
and	O
perform	O
genotyping	B-T058
in	O
research	B-T062
studies	I-T062
and	O
clinical	B-T062
trials	I-T062
.	O

how	O
should	O
pro	O
##x	O
##ies	O
of	O
cognitive	B-T038
reserve	I-T038
be	O
evaluated	B-T058
in	O
a	O
population	B-T098
of	O
healthy	O
older	B-T098
adults	I-T098
?	O
while	O
some	O
tools	B-T170
have	O
been	O
developed	O
to	O
estimate	O
an	O
individual	B-T098
'	I-T098
s	I-T098
cognitive	B-T038
reserve	I-T038
(	O
cr	B-T038
)	O
,	O
no	O
study	O
has	O
assessed	O
the	O
adequacy	O
of	O
the	O
method	O
used	O
for	O
assessing	O
these	O
cr	B-T038
proxy	O
indicators	O
.	O
therefore	O
,	O
we	O
aimed	O
to	O
determine	O
the	O
most	O
appropriate	O
method	O
to	O
estimate	O
cr	B-T038
by	O
comparing	O
two	O
approaches	O
:	O
(	O
1	O
)	O
the	O
common	O
assessment	B-T058
of	O
cr	B-T038
pro	O
##x	O
##ies	O
in	O
the	O
literature	B-T170
(	O
e	O
.	O
g	O
.	O
years	O
of	O
education	O
)	O
and	O
(	O
2	O
)	O
the	O
calculation	O
of	O
a	O
comprehensive	O
index	B-T170
based	O
on	O
most	O
significant	O
parameters	B-T033
used	O
in	O
the	O
estimation	B-T038
of	O
cr	B-T038
.	O
data	O
on	O
cr	B-T038
pro	O
##x	O
##ies	O
(	O
i	O
.	O
e	O
.	O
education	O
,	O
occupation	O
,	O
and	O
leisure	O
activities	O
)	O
were	O
obtained	O
in	O
a	O
sample	O
of	O
204	O
older	B-T098
adults	I-T098
.	O
regression	B-T170
analyses	I-T170
were	O
used	O
to	O
develop	O
the	O
two	O
indices	B-T170
of	O
cr	B-T038
(	O
i	O
.	O
e	O
.	O
icr	B-T170
-	I-T170
standard	I-T170
and	O
icr	B-T170
-	I-T170
detailed	I-T170
)	O
and	O
to	O
determine	O
which	O
index	B-T170
best	O
represented	O
the	O
level	O
of	O
one	O
'	O
s	O
cr	B-T038
.	O
the	O
icr	B-T170
-	I-T170
standard	I-T170
was	O
calculated	O
using	O
a	O
combination	O
of	O
the	O
three	O
most	O
common	O
measures	O
of	O
reserve	B-T038
in	O
the	O
literature	B-T170
:	O
number	O
of	O
school	O
##ing	O
years	O
,	O
complexity	O
of	O
the	O
primary	O
occupation	O
,	O
and	O
amount	O
of	O
current	O
participation	O
in	O
stimulating	O
activities	O
.	O
the	O
icr	B-T170
-	I-T170
detailed	I-T170
was	O
calculated	O
using	O
the	O
most	O
significant	O
parameters	B-T033
(	O
established	O
in	O
initial	O
analyses	B-T062
)	O
of	O
cr	B-T038
:	O
highest	O
level	O
of	O
education	O
combined	O
with	O
the	O
number	O
of	O
training	O
courses	O
,	O
last	O
occupation	O
,	O
and	O
amount	O
of	O
current	O
participation	O
in	O
social	O
and	O
intellectual	O
activities	O
.	O
the	O
comparison	O
of	O
both	O
indices	B-T170
showed	O
that	O
higher	O
levels	O
of	O
icr	B-T170
-	I-T170
standard	I-T170
and	O
icr	B-T170
-	I-T170
detailed	I-T170
were	O
associated	O
with	O
a	O
greater	O
minimization	O
of	O
the	O
effects	O
of	O
age	O
on	O
cognition	B-T038
.	O
however	O
,	O
the	O
icr	B-T170
-	I-T170
detailed	I-T170
was	O
more	O
strongly	O
associated	O
to	O
this	O
minimization	O
than	O
the	O
icr	B-T170
-	I-T170
standard	I-T170
,	O
suggesting	O
that	O
the	O
icr	B-T170
-	I-T170
detailed	I-T170
best	O
reflect	O
one	O
'	O
s	O
cr	B-T038
.	O
this	O
study	O
is	O
the	O
first	O
to	O
show	O
that	O
it	O
is	O
of	O
great	O
importance	O
to	O
question	O
methods	O
measuring	O
cr	B-T038
pro	O
##x	O
##ies	O
in	O
order	O
to	O
develop	O
a	O
clinical	B-T170
tool	I-T170
allowing	O
a	O
comprehensive	O
and	O
accurate	O
estimation	B-T038
of	O
cr	B-T038
.	O

assessment	B-T058
the	O
exposure	O
level	O
of	O
rare	B-T103
earth	I-T103
elements	I-T103
in	O
workers	B-T098
producing	O
cer	B-T103
##ium	I-T103
,	O
lanth	B-T103
##anum	I-T103
oxide	I-T103
ultraf	B-T103
##ine	I-T103
and	O
nanoparticles	O
in	O
order	O
to	O
assess	O
occupational	O
exposure	O
level	O
of	O
15	O
rare	B-T103
earth	I-T103
elements	I-T103
(	O
ree	B-T103
##s	I-T103
)	O
and	O
identify	O
the	O
associated	O
influence	O
,	O
we	O
used	O
inductively	B-T058
coupled	I-T058
plasma	I-T058
mass	I-T058
spectrometry	I-T058
(	O
icp	B-T058
-	I-T058
ms	I-T058
)	O
based	O
on	O
closed	O
-	O
vessel	O
microwave	O
-	O
assisted	O
wet	O
digestion	O
procedure	O
to	O
determin	B-T058
##ate	I-T058
the	O
concentration	O
of	O
y	B-T103
,	O
la	B-T103
,	O
ce	B-T103
,	O
pr	B-T103
,	O
nd	B-T103
,	O
sm	B-T103
,	O
eu	B-T103
,	O
gd	B-T103
,	O
tb	B-T103
,	O
dy	B-T103
,	O
ho	B-T103
,	O
er	B-T103
,	O
tm	B-T103
,	O
yb	B-T103
and	O
lu	B-T103
in	O
urinary	B-T031
samples	I-T031
obtained	O
from	O
workers	B-T098
producing	O
ultraf	B-T103
##ine	I-T103
and	O
nanoparticles	O
containing	O
cer	B-T103
##ium	I-T103
and	O
lanth	B-T103
##anum	I-T103
oxide	I-T103
.	O
the	O
results	O
suggest	O
that	O
la	B-T103
and	O
ce	B-T103
were	O
the	O
primary	O
component	O
,	O
together	O
accounting	O
for	O
97	O
%	O
of	O
total	O
ree	B-T103
##s	I-T103
in	O
workers	B-T098
.	O
the	O
urinary	B-T031
levels	O
of	O
la	B-T103
,	O
and	O
ce	B-T103
among	O
the	O
workers	B-T098
(	O
6	O
.	O
36	O
,	O
15	O
.	O
32	O
μg	O
.	O
g	O
(	O
-	O
1	O
)	O
creatinine	B-T103
,	O
respectively	O
)	O
were	O
significantly	O
enriched	O
compared	O
to	O
those	O
levels	O
measured	O
in	O
the	O
control	O
subjects	O
(	O
1	O
.	O
52	O
,	O
4	O
.	O
04	O
μg	O
.	O
g	O
(	O
-	O
1	O
)	O
creatinine	B-T103
,	O
respectively	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
this	O
study	B-T062
simultaneously	O
identified	O
the	O
associated	O
individual	B-T098
factors	O
,	O
the	O
results	O
indicate	O
that	O
the	O
concentrations	O
in	O
over	O
5	O
years	O
group	O
(	O
11	O
.	O
64	O
±	O
10	O
.	O
93	O
for	O
la	B-T103
,	O
27	O
.	O
83	O
±	O
24	O
.	O
38	O
for	O
ce	B-T103
)	O
were	O
significantly	O
elevated	O
compared	O
to	O
1	O
-	O
5	O
years	O
group	O
(	O
2	O
.	O
58	O
±	O
1	O
.	O
51	O
for	O
la	B-T103
,	O
6	O
.	O
87	O
±	O
3	O
.	O
90	O
for	O
ce	B-T103
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
compared	O
the	O
urinary	B-T031
levels	O
of	O
la	B-T103
and	O
ce	B-T103
at	O
the	O
separation	O
and	O
packaging	O
locations	B-T082
(	O
9	O
.	O
10	O
±	O
9	O
.	O
51	O
for	O
la	B-T103
,	O
22	O
.	O
29	O
±	O
21	O
.	O
01	O
for	O
ce	B-T103
)	O
with	O
the	O
other	O
locations	B-T082
(	O
2	O
.	O
85	O
±	O
0	O
.	O
98	O
for	O
la	B-T103
,	O
6	O
.	O
37	O
±	O
2	O
.	O
12	O
for	O
ce	B-T103
)	O
,	O
the	O
results	O
show	O
urinary	B-T031
concentrations	O
were	O
significantly	O
higher	O
in	O
workers	B-T098
at	O
separation	O
and	O
packaging	O
locations	B-T082
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
inter	O
-	O
individual	B-T098
variation	O
in	O
levels	O
of	O
la	B-T103
and	O
ce	B-T103
in	O
urine	B-T031
is	O
the	O
result	O
of	O
multi	O
-	O
factorial	O
comprehensive	O
action	O
.	O
further	O
researches	B-T097
should	O
focus	O
on	O
the	O
multiple	O
factors	O
contributing	O
to	O
the	O
ree	B-T103
##s	I-T103
levels	O
of	O
the	O
occupational	O
##ly	O
exposed	O
workers	B-T098
.	O

disease	O
activity	O
and	O
increased	B-T033
risk	I-T033
of	I-T033
cardiovascular	B-T038
death	I-T038
among	O
patients	O
with	O
psoriatic	B-T038
arthritis	I-T038
recent	O
studies	O
indicate	O
increased	O
cardiovascular	B-T038
(	I-T038
cv	I-T038
)	I-T038
morbidity	I-T038
and	O
mortality	B-T038
in	O
patients	O
with	O
psoriatic	B-T038
arthritis	I-T038
(	O
psa	B-T038
)	O
,	O
but	O
results	O
are	O
inconsistent	O
.	O
this	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	O
rate	O
,	O
cause	B-T033
of	I-T033
death	I-T033
,	O
and	O
incidence	O
of	O
acute	O
cv	B-T033
events	I-T033
in	O
patients	O
from	O
northern	B-T082
sweden	B-T082
with	O
psa	B-T038
.	O
patients	O
with	O
established	O
psa	B-T038
(	O
46	O
##4	O
)	O
were	O
included	O
.	O
to	O
calculate	O
standardized	O
mortality	O
ratio	O
(	O
smr	O
)	O
and	O
standardized	O
incidence	O
ratio	O
(	O
sir	O
)	O
for	O
cv	B-T033
events	I-T033
,	O
data	O
were	O
extracted	O
from	O
the	O
national	B-T170
causes	I-T170
of	I-T170
death	I-T170
register	I-T170
and	O
the	O
national	B-T170
inpatient	I-T170
care	I-T170
register	I-T170
in	O
sweden	B-T082
,	O
and	O
compared	O
with	O
the	O
general	B-T098
population	I-T098
.	O
the	O
study	O
period	O
was	O
1995	O
-	O
2011	O
.	O
to	O
study	O
the	O
effect	O
of	O
inflammatory	O
activity	O
,	O
a	O
composite	O
disease	O
activity	O
index	O
(	O
da	O
##i	O
)	O
was	O
used	O
.	O
the	O
smr	O
(	O
95	O
%	O
ci	O
)	O
for	O
overall	O
mortality	O
and	O
diseases	B-T038
of	I-T038
the	I-T038
circulatory	I-T038
system	I-T038
(	O
international	B-T170
classification	I-T170
of	I-T170
diseases	I-T170
,	O
10th	O
edition	O
;	O
i	O
##00	O
-	O
i	O
##99	O
)	O
was	O
1	O
.	O
22	O
(	O
0	O
.	O
89	O
-	O
1	O
.	O
63	O
)	O
and	O
1	O
.	O
64	O
(	O
1	O
.	O
02	O
-	O
2	O
.	O
52	O
)	O
,	O
respectively	O
.	O
in	O
regression	B-T170
analysis	I-T170
,	O
da	O
##i	O
was	O
significantly	O
associated	O
with	O
death	B-T033
(	O
or	O
1	O
.	O
99	O
,	O
95	O
%	O
ci	O
1	O
.	O
41	O
-	O
2	O
.	O
80	O
)	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
remained	O
significant	O
after	O
stratif	O
##ying	O
patients	O
into	O
the	O
2	O
major	O
causes	B-T033
of	I-T033
death	I-T033
:	O
diseases	B-T038
of	I-T038
the	I-T038
circulatory	I-T038
system	I-T038
and	O
malignant	B-T038
neoplasms	I-T038
.	O
peripheral	B-T038
and	O
axial	B-T033
disease	I-T033
was	O
associated	O
with	O
death	B-T033
(	O
or	O
4	O
.	O
02	O
,	O
95	O
%	O
ci	O
1	O
.	O
84	O
-	O
8	O
.	O
84	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
compared	O
with	O
peripheral	B-T038
disease	I-T038
only	O
.	O
the	O
sir	O
(	O
95	O
%	O
ci	O
)	O
for	O
a	O
cv	B-T033
event	I-T033
(	O
myocardial	B-T038
infarction	I-T038
or	O
stroke	B-T037
)	O
was	O
0	O
.	O
59	O
##7	O
(	O
0	O
.	O
40	O
-	O
0	O
.	O
86	O
)	O
;	O
this	O
association	O
was	O
only	O
significant	O
in	O
men	B-T098
.	O
patients	O
with	O
psa	B-T038
had	O
a	O
small	O
but	O
significant	O
increase	O
in	O
smr	O
for	O
death	B-T033
due	O
to	O
diseases	B-T038
of	I-T038
the	I-T038
circulatory	I-T038
system	I-T038
compared	O
with	O
the	O
general	B-T098
population	I-T098
.	O
among	O
patients	O
,	O
death	B-T033
was	O
associated	O
with	O
da	O
##i	O
,	O
as	O
well	O
as	O
axial	B-T033
involvement	I-T033
in	O
combination	O
with	O
peripheral	B-T038
disease	I-T038
,	O
indicating	O
more	O
aggressive	O
disease	O
phenotypes	O
.	O

tea	B-T017
##d1	I-T017
regulates	O
the	O
expression	B-T038
of	O
peripheral	B-T017
myelin	I-T017
protein	I-T017
22	I-T017
during	O
schwann	B-T038
cell	I-T038
development	I-T038
schwann	B-T017
cells	I-T017
are	O
myelin	B-T017
##ating	I-T017
glia	I-T017
in	O
the	O
peripheral	B-T022
nervous	I-T022
system	I-T022
that	O
form	O
the	O
myelin	B-T017
sheath	I-T017
.	O
a	O
major	O
cause	O
of	O
peripheral	B-T038
neuropathy	I-T038
is	O
a	O
copy	B-T082
number	I-T082
variant	I-T082
involving	O
the	O
peripheral	B-T017
myelin	I-T017
protein	I-T017
22	I-T017
(	I-T017
pmp	I-T017
##22	I-T017
)	I-T017
gene	I-T017
,	O
which	O
is	O
located	O
within	O
a	O
1	O
.	O
4	O
-	O
mb	O
duplication	B-T038
on	O
chromosome	B-T017
17	I-T017
associated	O
with	O
the	O
most	O
common	O
form	O
of	O
charco	B-T038
##t	I-T038
-	I-T038
mari	I-T038
##e	I-T038
-	I-T038
tooth	I-T038
disease	I-T038
(	O
cmt	B-T038
##1a	I-T038
)	O
.	O
rodent	B-T038
models	I-T038
of	O
cmt	B-T038
##1a	I-T038
have	O
been	O
used	O
to	O
show	O
that	O
reducing	O
pmp	B-T017
##22	I-T017
overexpression	B-T038
mitigate	O
##s	O
several	O
aspects	O
of	O
a	O
cmt	B-T038
##1a	I-T038
-	O
related	O
phenotype	O
.	O
mechanistic	O
studies	B-T062
of	O
pmp	B-T017
##22	I-T017
regulation	B-T038
identified	O
enhancers	B-T103
regulated	O
by	O
the	O
sox	B-T103
##10	I-T103
(	O
sr	B-T103
##y	I-T103
sex	I-T103
determining	I-T103
region	I-T103
y	I-T103
-	I-T103
box	I-T103
10	I-T103
)	O
and	O
egr	B-T103
##2	I-T103
/	O
kr	B-T103
##ox	I-T103
##20	I-T103
(	O
early	B-T103
growth	I-T103
response	I-T103
protein	I-T103
2	I-T103
)	O
transcription	B-T103
factors	I-T103
in	O
myelinated	B-T017
nerves	I-T017
.	O
however	O
,	O
relatively	O
little	O
is	O
known	O
regarding	O
how	O
other	O
transcription	B-T103
factors	I-T103
induce	O
pmp	B-T017
##22	I-T017
expression	B-T038
during	O
schwann	B-T038
cell	I-T038
development	I-T038
and	O
myelination	B-T038
.	O
here	O
,	O
we	O
examined	O
pmp	B-T017
##22	I-T017
enhancers	B-T103
as	O
a	O
function	O
of	O
cell	B-T038
type	I-T038
-	I-T038
specificity	I-T038
,	O
nerve	B-T037
injury	I-T037
and	O
development	O
.	O
while	O
pmp	B-T017
##22	I-T017
enhancers	B-T103
marked	O
by	O
active	O
histone	B-T038
modifications	I-T038
were	O
lost	O
or	O
remod	O
##eled	O
after	O
injury	B-T037
,	O
we	O
found	O
that	O
these	O
enhancers	B-T103
were	O
permissive	O
in	O
early	O
development	O
prior	O
to	O
pmp	B-T017
##22	I-T017
upregulation	B-T038
.	O
pmp	B-T017
##22	I-T017
enhancers	B-T103
contain	O
binding	B-T103
motifs	I-T103
for	O
tea	B-T103
domain	I-T103
(	O
tea	B-T103
##d	I-T103
)	O
transcription	B-T103
factors	I-T103
of	O
the	O
hipp	B-T038
##o	I-T038
signaling	I-T038
pathway	I-T038
.	O
we	O
discovered	O
that	O
tea	B-T017
##d1	I-T017
and	O
co	O
-	O
activators	O
y	B-T017
##ap	I-T017
and	O
taz	B-T017
are	O
required	O
for	O
pmp	B-T017
##22	I-T017
expression	B-T038
,	O
as	O
well	O
as	O
for	O
the	O
expression	B-T038
of	O
egr	B-T017
##2	I-T017
tea	B-T017
##d1	I-T017
directly	O
binds	O
pmp	B-T017
##22	I-T017
and	O
egr	B-T017
##2	I-T017
enhancers	B-T103
early	O
in	O
development	O
and	O
tea	B-T017
##d1	I-T017
binding	B-T038
is	O
induced	O
during	O
myelination	B-T038
,	O
correlating	O
with	O
pmp	B-T017
##22	I-T017
expression	B-T038
.	O
the	O
data	O
identify	O
tea	B-T017
##d1	I-T017
as	O
a	O
novel	O
regulator	B-T017
of	O
pmp	B-T017
##22	I-T017
expression	B-T038
during	O
development	O
in	O
concert	O
with	O
sox	B-T017
##10	I-T017
and	O
egr	B-T017
##2	I-T017
.	O

young	O
people	B-T098
,	O
mental	B-T038
health	I-T038
practitioners	B-T097
and	O
researchers	B-T097
co	O
-	O
produce	O
a	O
transition	B-T170
preparation	I-T170
programme	I-T170
to	O
improve	O
outcomes	O
and	O
experience	B-T038
for	O
young	O
people	B-T098
leaving	O
child	B-T058
and	I-T058
adolescent	I-T058
mental	I-T058
health	I-T058
services	I-T058
(	O
cam	B-T058
##hs	I-T058
)	O
in	O
the	O
uk	B-T082
young	O
people	B-T098
attending	O
child	B-T058
and	I-T058
adolescent	I-T058
mental	I-T058
health	I-T058
services	I-T058
(	O
cam	B-T058
##hs	I-T058
)	O
are	O
required	O
to	O
move	O
on	O
,	O
either	O
through	O
discharge	O
or	O
referral	B-T058
to	I-T058
an	O
adult	B-T058
service	I-T058
,	O
at	O
age	O
17	O
/	O
18	O
,	O
a	O
period	O
of	O
increased	O
risk	O
for	O
onset	O
of	O
mental	B-T033
health	I-T033
problems	I-T033
and	O
other	O
complex	O
psychosocial	O
and	O
physical	O
changes	O
.	O
cam	B-T058
##hs	I-T058
transitions	O
are	O
often	O
poorly	O
managed	O
with	O
negative	B-T033
outcomes	O
for	O
young	O
people	B-T098
.	O
better	O
preparation	O
may	O
improve	O
outcomes	O
and	O
experience	B-T038
.	O
this	O
study	B-T062
aimed	O
to	O
co	O
-	O
produce	O
,	O
with	O
young	O
people	B-T098
who	O
had	O
transition	O
##ed	O
or	O
were	O
facing	O
transition	O
from	O
cam	B-T058
##hs	I-T058
,	O
a	O
cam	B-T058
##hs	I-T058
transition	B-T170
preparation	I-T170
programme	I-T170
(	O
tpp	B-T170
)	O
,	O
deliver	O
##able	O
in	O
routine	O
nhs	B-T058
settings	O
.	O
eighteen	O
young	O
people	B-T098
,	O
aged	O
17	O
-	O
22	O
,	O
from	O
three	O
uk	B-T082
national	B-T058
health	I-T058
service	I-T058
(	O
nhs	B-T058
)	O
mental	O
health	O
foundation	O
trust	O
##s	O
participated	O
in	O
creative	O
,	O
participatory	O
research	O
workshops	O
.	O
seven	O
parents	O
completed	O
short	O
questionnaires	B-T170
.	O
thirty	O
clinical	B-T097
staff	I-T097
from	O
two	O
trust	O
##s	O
took	O
part	O
in	O
workshops	O
to	O
ensure	O
deliver	O
##ability	O
of	O
young	O
people	B-T098
'	I-T098
s	I-T098
ideas	O
.	O
young	O
people	B-T098
were	O
offered	O
co	O
-	O
research	O
opportunities	O
.	O
most	O
young	O
people	B-T098
felt	O
anxious	B-T033
,	O
fear	B-T038
##ful	I-T038
and	O
uncertain	O
on	O
leaving	O
cam	B-T058
##hs	I-T058
and	O
perceived	B-T038
mental	B-T058
health	I-T058
services	I-T058
as	O
unc	O
##aring	O
.	O
participants	B-T098
outlined	O
transition	O
procedures	O
and	O
draft	O
##ed	O
a	O
range	O
of	O
preparation	O
activities	O
,	O
centred	O
around	O
dedicated	O
transition	O
peer	O
support	O
and	O
a	O
transition	O
book	B-T170
##let	I-T170
,	O
which	O
should	O
be	O
offered	O
to	O
all	O
cam	B-T058
##hs	I-T058
leave	B-T098
##rs	I-T098
,	O
irrespective	O
of	O
discharge	O
or	O
transfer	O
to	O
an	O
adult	B-T058
service	I-T058
.	O
preparation	O
should	O
aim	O
to	O
build	O
confidence	B-T038
to	O
help	O
young	O
people	B-T098
take	O
responsibility	O
for	O
themselves	O
and	O
flour	O
##ish	O
in	O
the	O
adult	O
world	B-T098
:	O
coping	O
or	O
getting	O
through	O
it	O
was	O
not	O
enough	O
.	O
some	O
clinicians	B-T097
also	O
felt	O
anxious	B-T033
at	O
transition	O
and	O
recognised	O
the	O
potential	O
impact	O
on	O
young	O
people	B-T098
of	O
poor	O
communication	O
and	O
lack	O
of	O
understanding	O
between	O
services	B-T058
.	O
parents	O
would	O
appreci	O
##ate	O
help	O
to	O
support	O
their	O
offspring	O
during	O
the	O
transition	O
period	O
.	O
clinicians	B-T097
cited	O
lack	O
of	O
funding	O
and	O
infl	O
##ex	O
##ible	O
nhs	B-T058
procedures	O
and	O
policies	B-T170
as	O
potential	O
barriers	O
to	O
the	O
implementation	O
of	O
young	O
people	B-T098
'	I-T098
s	I-T098
ideas	O
.	O
nine	O
young	O
people	B-T098
took	O
up	O
co	O
-	O
research	O
opportunities	O
.	O
mental	B-T058
health	I-T058
services	I-T058
underestimate	O
the	O
anxiety	B-T033
of	O
cam	B-T058
##hs	I-T058
leave	B-T098
##rs	I-T098
.	O
young	O
people	B-T098
have	O
clear	O
ideas	O
about	O
the	O
preparation	O
they	O
require	O
to	O
leave	O
cam	B-T058
##hs	I-T058
with	O
the	O
confidence	B-T038
to	O
take	O
responsibility	O
for	O
their	O
own	O
health	B-T058
care	I-T058
.	O
close	O
collaboration	O
of	O
nhs	B-T058
staff	B-T097
and	O
researchers	B-T097
facilitates	O
the	O
implementation	O
of	O
research	B-T062
findings	O
.	O

dexmedetomidine	B-T103
effect	O
on	O
emergence	B-T038
agitation	I-T038
and	O
delirium	B-T038
in	O
children	O
undergoing	O
laparoscopic	B-T058
hernia	I-T058
repair	I-T058
:	O
a	O
preliminary	O
study	B-T062
objective	O
to	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	B-T103
(	O
dex	B-T103
)	O
to	O
prevent	O
emergence	B-T038
agitation	I-T038
(	O
ea	B-T038
)	O
and	O
delirium	B-T038
(	O
ed	B-T038
)	O
in	O
children	O
undergoing	O
laparoscopic	B-T058
hernia	I-T058
repair	I-T058
under	O
general	B-T058
anesthesia	I-T058
.	O
methods	O
100	O
children	O
(	O
1	O
-	O
5	O
years	O
,	O
10	O
-	O
25	O
kg	O
)	O
were	O
randomized	B-T062
into	O
four	O
groups	O
:	O
controls	O
(	O
saline	O
)	O
and	O
intravenous	B-T082
dex	B-T103
at	O
0	O
.	O
25	O
,	O
0	O
.	O
5	O
,	O
and	O
1	O
.	O
0	O
µg	O
/	O
kg	O
(	O
d1	O
,	O
d2	O
,	O
d3	O
,	O
respectively	O
)	O
.	O
dex	B-T103
/	O
saline	O
infusion	B-T058
was	O
started	O
following	O
anesthesia	B-T103
.	O
ea	B-T038
and	O
ed	B-T038
were	O
evaluated	O
on	O
a	O
5	B-T170
-	I-T170
point	I-T170
scale	I-T170
.	O
results	O
for	O
the	O
c	O
,	O
d1	O
,	O
d2	O
,	O
and	O
d3	O
groups	O
,	O
respectively	O
,	O
ea	B-T038
frequencies	O
were	O
45	O
.	O
8	O
%	O
,	O
30	O
.	O
4	O
%	O
,	O
12	O
%	O
,	O
4	O
%	O
;	O
ed	B-T038
frequencies	O
29	O
.	O
1	O
%	O
,	O
13	O
%	O
,	O
4	O
%	O
,	O
4	O
%	O
;	O
chip	B-T170
##ps	I-T170
scores	O
8	O
,	O
6	O
,	O
3	O
,	O
3	O
;	O
sevoflurane	B-T103
doses	O
from	O
13	O
.	O
2	O
±	O
3	O
.	O
4	O
(	O
controls	O
)	O
to	O
9	O
.	O
4	O
±	O
3	O
.	O
5	O
ml	O
(	O
d3	O
)	O
.	O
intervals	O
until	O
mask	B-T074
removal	O
/	O
spontaneous	B-T082
eye	I-T082
opening	I-T082
were	O
significantly	O
longer	O
for	O
d2	O
and	O
d3	O
than	O
controls	O
.	O
pac	B-T092
##u	I-T092
stay	O
was	O
longer	O
for	O
d3	O
.	O
conclusions	O
there	O
was	O
significantly	O
less	O
postoperative	O
ea	B-T038
and	O
pain	B-T033
,	O
with	O
less	O
sevoflurane	B-T103
required	O
,	O
using	O
dex	B-T103
.	O

park	O
##s	O
as	O
social	O
and	O
cultural	O
spaces	B-T082
among	O
u	B-T082
.	I-T082
s	I-T082
.	O
-	O
and	O
foreign	O
-	O
born	B-T038
latin	B-T098
##as	I-T098
park	O
##s	O
provide	O
opportunities	O
for	O
people	B-T098
to	O
engage	O
in	O
activities	O
that	O
can	O
promote	O
physical	O
and	O
emotional	B-T033
well	O
-	O
being	O
.	O
using	O
focus	O
groups	O
and	O
personal	O
interviews	O
conducted	O
in	O
selected	O
neighborhoods	O
of	O
a	O
northeastern	B-T082
city	B-T082
with	O
a	O
high	O
rate	O
of	O
obesity	B-T038
,	O
we	O
examined	B-T033
perceptions	B-T038
of	O
barriers	O
and	O
facilitators	O
regarding	O
the	O
use	O
of	O
park	O
##s	O
and	O
park	O
features	O
that	O
would	O
promote	O
physical	O
activity	O
among	O
latin	B-T098
##a	I-T098
women	B-T098
(	O
n	O
=	O
39	O
)	O
.	O
foreign	O
-	O
born	B-T038
latin	B-T098
##as	I-T098
emphasized	O
the	O
environmental	B-T082
characteristics	O
of	O
park	O
##s	O
and	O
the	O
types	O
of	O
amen	O
##ities	O
that	O
can	O
support	O
preferred	O
cultural	O
and	O
social	O
activities	O
,	O
while	O
u	B-T082
.	I-T082
s	I-T082
.	I-T082
-	O
born	B-T038
latin	B-T098
##as	I-T098
emphasized	O
the	O
use	O
of	O
park	O
##s	O
for	O
physical	O
activity	O
and	O
weight	O
management	O
.	O
most	O
striking	O
were	O
the	O
different	O
ways	O
in	O
which	O
foreign	O
-	O
born	B-T038
participants	B-T098
conceptual	B-T038
##ized	I-T038
park	O
##s	O
as	O
socio	O
##cu	O
##lt	O
##ural	O
family	O
centers	O
,	O
extending	O
more	O
common	O
conceptual	B-T038
##izations	I-T038
centered	O
on	O
exercise	O
or	O
individual	B-T098
health	O
gain	O
.	O
these	O
findings	O
suggest	O
the	O
need	O
for	O
new	O
policies	B-T170
that	O
incorporate	O
culturally	O
specific	O
park	O
programming	O
to	O
promote	O
national	O
goals	B-T170
of	O
increasing	O
levels	O
of	O
physical	O
activity	O
for	O
health	O
.	O

identification	O
of	O
predictive	O
dna	B-T038
methylation	I-T038
biomarkers	B-T103
for	O
chemotherapy	B-T058
response	B-T201
in	O
colorectal	B-T038
cancer	I-T038
resistance	B-T038
to	O
5	B-T103
-	I-T103
fluorouracil	I-T103
(	O
5	B-T103
-	I-T103
fu	I-T103
)	O
is	O
a	O
major	O
obstacle	O
to	O
the	O
successful	O
treatment	O
of	O
colorectal	B-T038
cancer	I-T038
(	O
crc	B-T038
)	O
and	O
posed	O
an	O
increased	O
risk	O
of	O
recurrence	O
.	O
dna	B-T038
methylation	I-T038
has	O
been	O
suggested	O
as	O
one	O
of	O
the	O
underlying	O
mechanisms	O
for	O
recurrent	B-T038
disease	I-T038
and	O
its	O
contribution	O
to	O
the	O
development	O
of	O
drug	B-T038
resistance	I-T038
remains	O
to	O
be	O
clarified	O
.	O
this	O
study	B-T062
aimed	O
to	O
determine	O
the	O
methylation	B-T038
phenotype	O
in	O
crc	B-T038
for	O
identification	O
of	O
predictive	O
markers	B-T103
for	O
chemotherapy	B-T058
response	B-T201
.	O
we	O
performed	O
dna	B-T038
methylation	I-T038
profiling	O
on	O
43	O
non	O
-	O
recurrent	O
and	O
five	O
recurrent	O
crc	B-T038
patients	O
using	O
the	O
illumina	B-T062
infin	I-T062
##ium	I-T062
human	I-T062
##methylation	I-T062
##45	I-T062
##0	I-T062
bead	I-T062
##ch	I-T062
##ip	I-T062
assay	I-T062
.	O
in	O
addition	O
,	O
crc	B-T038
cells	B-T017
with	O
different	O
genetic	O
backgrounds	O
,	O
response	B-T201
to	O
5	B-T103
-	I-T103
fu	I-T103
and	O
global	B-T038
methylation	I-T038
levels	O
(	O
ht2	B-T017
##9	I-T017
and	O
sw	B-T017
##48	I-T017
)	O
were	O
treated	O
with	O
5	B-T103
-	I-T103
fu	I-T103
and	O
dna	B-T038
methylation	I-T038
inhibitor	O
5	B-T103
-	I-T103
aza	I-T103
-	I-T103
2	I-T103
'	I-T103
-	I-T103
deoxy	I-T103
##cytidine	I-T103
(	O
5	B-T103
-	I-T103
aza	I-T103
##dc	I-T103
)	O
.	O
the	O
singular	O
and	O
combined	O
effects	O
of	O
these	O
two	O
drug	B-T103
classes	B-T170
on	O
cell	B-T038
viability	I-T038
and	O
global	B-T038
methylation	I-T038
profiles	B-T058
were	O
investigated	O
.	O
our	O
genome	B-T062
-	I-T062
wide	I-T062
methylation	I-T062
study	I-T062
on	O
the	O
clinical	O
specimens	O
showed	O
that	O
recurrent	O
crc	B-T038
##s	I-T038
exhibited	O
higher	O
methylation	B-T038
levels	O
compared	O
to	O
non	O
-	O
recurrent	O
crc	B-T038
##s	I-T038
.	O
we	O
identified	O
47	O
##87	O
significantly	O
differentially	O
methylated	B-T017
genes	I-T017
(	O
p	O
<	O
0	O
.	O
05	O
)	O
;	O
311	O
##2	O
genes	B-T017
were	O
hyper	B-T033
-	O
while	O
167	O
##5	O
genes	B-T017
were	O
hypo	B-T033
##methyl	I-T033
##ated	I-T033
in	O
the	O
recurrent	O
group	O
compared	O
to	O
the	O
non	O
-	O
recurrent	O
.	O
fifty	O
eight	O
and	O
47	O
of	O
the	O
significantly	O
hyper	B-T017
##methyl	I-T017
##ated	I-T017
and	I-T017
hypo	I-T017
##methyl	I-T017
##ated	I-T017
genes	I-T017
have	O
an	O
absolute	O
recurrent	O
/	O
non	O
-	O
recurrent	O
methylation	B-T038
difference	O
of	O
≥2	O
##0	O
%	O
.	O
most	O
of	O
the	O
hyper	B-T017
##methyl	I-T017
##ated	I-T017
genes	I-T017
were	O
involved	O
in	O
the	O
mapk	B-T038
signaling	I-T038
pathway	I-T038
which	O
is	O
a	O
key	O
regulator	O
for	O
apoptosis	B-T038
while	O
the	O
hypo	B-T017
##methyl	I-T017
##ated	I-T017
genes	I-T017
were	O
involved	O
in	O
the	O
pi3k	B-T038
-	I-T038
akt	I-T038
signaling	I-T038
pathway	I-T038
and	O
proliferation	O
process	O
.	O
we	O
also	O
demonstrate	O
that	O
5	B-T103
-	I-T103
aza	I-T103
##dc	I-T103
treatment	O
enhanced	O
response	B-T201
to	O
5	B-T103
-	I-T103
fu	I-T103
which	O
resulted	O
in	O
significant	O
growth	B-T038
inhibition	I-T038
compared	O
to	O
5	B-T103
-	I-T103
fu	I-T103
alone	O
in	O
hyper	B-T017
##methyl	I-T017
##ated	I-T017
cell	I-T017
lines	I-T017
sw	I-T017
##48	I-T017
.	O
in	O
conclusion	O
,	O
we	O
found	O
the	O
evidence	O
of	O
five	O
potentially	O
biologically	O
important	O
genes	B-T017
in	O
recurrent	O
crc	B-T038
##s	I-T038
that	O
could	O
possibly	O
serve	O
as	O
a	O
new	O
potential	O
therapeutic	B-T058
targets	O
for	O
patients	O
with	O
chemo	B-T038
##res	I-T038
##istan	I-T038
##ce	I-T038
.	O
we	O
postulate	O
that	O
aberrant	O
methylation	B-T038
of	O
cc	B-T017
##ne	I-T017
##i	I-T017
,	O
cc	B-T017
##nd	I-T017
##bp1	I-T017
,	O
pon	B-T017
##3	I-T017
,	O
dd	B-T017
##x	I-T017
##43	I-T017
,	O
and	O
chl	B-T017
##1	I-T017
in	O
crc	B-T038
might	O
be	O
associated	O
with	O
the	O
recurrence	O
of	O
crc	B-T038
and	O
5	B-T103
-	I-T103
aza	I-T103
##dc	I-T103
-	O
mediated	O
restoration	O
of	O
5	B-T103
-	I-T103
fu	I-T103
sensitivity	O
is	O
mediated	O
at	O
least	O
in	O
part	O
by	O
mapk	B-T038
signaling	I-T038
pathway	I-T038
.	O

discordance	O
in	O
pathology	B-T170
report	I-T170
after	O
central	B-T058
pathology	I-T058
review	I-T058
:	O
implications	O
for	O
breast	B-T038
cancer	I-T038
adjuvant	B-T058
treatment	I-T058
pathological	O
predictive	B-T170
factors	I-T170
are	O
the	O
most	O
important	O
markers	B-T201
when	O
selecting	O
early	O
breast	B-T038
cancer	I-T038
adjuvant	B-T058
therapy	I-T058
.	O
in	O
randomized	B-T062
clinical	I-T062
trials	I-T062
the	O
variability	O
in	O
pathology	B-T170
report	I-T170
after	O
central	B-T058
pathology	I-T058
review	I-T058
is	O
noteworthy	O
.	O
we	O
evaluated	O
the	O
discordance	O
rate	O
(	O
dr	O
)	O
and	O
inter	O
-	O
rater	O
agreement	O
between	O
local	B-T082
and	O
central	B-T082
histopathological	B-T170
report	I-T170
and	O
the	O
clinical	O
implication	O
on	O
treatment	O
decision	O
.	O
a	O
retrospective	B-T062
analysis	I-T062
was	O
conducted	O
in	O
a	O
series	O
of	O
consecutive	O
early	O
breast	B-T038
cancer	I-T038
tumors	I-T038
diagnosed	O
by	O
local	B-T097
pathologists	I-T097
and	O
subsequently	O
reviewed	O
at	O
the	O
pathology	B-T092
division	I-T092
of	O
european	B-T092
institute	I-T092
of	I-T092
oncology	I-T092
.	O
the	O
inter	O
-	O
rater	O
agreement	O
(	O
k	O
)	O
between	O
local	O
and	O
central	B-T091
pathology	I-T091
was	O
calculated	O
for	O
ki	B-T103
-	I-T103
67	I-T103
,	O
grading	B-T170
,	O
hormone	B-T103
receptors	I-T103
(	O
er	B-T103
/	O
pgr	B-T103
)	O
and	O
her2	B-T201
/	I-T201
neu	I-T201
.	O
the	O
bland	B-T062
-	I-T062
altman	I-T062
plots	I-T062
were	O
derived	O
to	O
determine	O
discrepancies	O
in	O
ki	B-T103
-	I-T103
67	I-T103
,	O
er	B-T103
and	O
pgr	B-T103
.	O
dr	O
was	O
calculated	O
for	O
er	B-T103
/	O
pgr	B-T103
and	O
her2	B-T103
.	O
from	O
2007	O
to	O
2013	O
,	O
187	O
pathology	B-T031
specimens	I-T031
from	O
10	O
cancer	B-T092
centers	I-T092
were	O
reviewed	O
.	O
substantial	O
agreement	O
was	O
observed	O
for	O
er	B-T103
(	O
k	O
##0	O
.	O
61	O
##2	O
;	O
95	O
%	O
ci	O
,	O
05	O
##38	O
-	O
0	O
.	O
68	O
##6	O
)	O
,	O
pgr	B-T103
(	O
k	O
##0	O
.	O
65	O
##9	O
;	O
95	O
%	O
ci	O
,	O
05	O
##80	O
-	O
0	O
.	O
73	O
##7	O
)	O
,	O
ki	B-T103
-	I-T103
67	I-T103
(	O
k	O
##0	O
.	O
60	O
##9	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
53	O
##4	O
-	O
0	O
.	O
68	O
##4	O
)	O
and	O
grading	B-T170
(	O
k	O
##0	O
.	O
66	O
##9	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
56	O
##9	O
-	O
0	O
.	O
76	O
##9	O
)	O
.	O
moderate	O
agreement	O
was	O
found	O
for	O
her2	B-T103
(	O
k	O
##0	O
.	O
54	O
##6	O
;	O
95	O
%	O
ci	O
,	O
044	O
##4	O
-	O
0	O
.	O
64	O
##9	O
)	O
.	O
dr	O
was	O
9	O
.	O
5	O
%	O
(	O
negativity	O
to	O
positivity	O
)	O
and	O
31	O
.	O
7	O
%	O
(	O
positivity	O
to	O
negativity	O
)	O
for	O
her2	B-T103
and	O
26	O
.	O
2	O
%	O
(	O
negativity	O
to	O
positivity	O
)	O
and	O
12	O
.	O
5	O
%	O
(	O
positivity	O
to	O
negativity	O
)	O
for	O
er	B-T103
/	O
pgr	B-T103
.	O
according	O
to	O
changes	O
in	O
her2	B-T103
and	O
er	B-T103
/	O
pgr	B-T103
status	O
,	O
23	O
(	O
12	O
.	O
2	O
%	O
)	O
and	O
33	O
(	O
17	O
.	O
6	O
%	O
)	O
systemic	O
prescription	B-T058
were	O
respectively	O
modified	O
.	O
in	O
our	O
retrospective	B-T062
analysis	I-T062
,	O
central	B-T058
pathological	I-T058
review	I-T058
has	O
a	O
significant	O
impact	O
in	O
the	O
decision	O
-	O
making	O
process	O
in	O
early	O
breast	B-T038
cancer	I-T038
,	O
as	O
shown	O
in	O
clinical	B-T062
trials	I-T062
.	O
further	O
studies	O
are	O
warranted	O
to	O
confirm	O
these	O
prov	O
##oca	O
##tive	O
results	O
.	O

evaluation	B-T058
of	O
mif	B-T017
-	I-T017
173	I-T017
g	I-T017
/	I-T017
c	I-T017
polymorphism	O
in	O
turkish	B-T098
patients	O
with	O
ankylosing	B-T038
spondylitis	I-T038
ankylosing	B-T038
spondylitis	I-T038
(	O
as	B-T038
)	O
is	O
a	O
chronic	B-T038
inflammatory	I-T038
disease	I-T038
mainly	O
affecting	O
the	O
spine	B-T017
and	O
sacro	B-T082
##iliac	I-T082
joints	I-T082
.	O
macrophage	B-T103
migration	I-T103
inhibitory	I-T103
(	I-T103
mif	I-T103
)	I-T103
factor	I-T103
is	O
a	O
regulatory	O
cytokine	B-T103
that	O
inhibits	O
random	O
immune	B-T038
cell	I-T038
migration	I-T038
.	O
mif	B-T017
gene	I-T017
promoter	B-T017
polymorphisms	O
play	O
a	O
role	O
in	O
the	O
progression	B-T038
of	O
several	O
inflammatory	B-T038
disorders	I-T038
.	O
to	O
investigate	O
the	O
relationship	O
between	O
the	O
mif	B-T017
gene	I-T017
-	I-T017
173	I-T017
g	I-T017
/	I-T017
c	I-T017
single	B-T082
-	I-T082
nucleotide	I-T082
polymorphism	I-T082
(	O
snp	B-T082
)	O
and	O
as	B-T038
.	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
.	O
in	O
this	O
study	B-T062
,	O
a	O
total	O
of	O
161	O
as	B-T038
and	O
194	O
normal	O
controls	O
were	O
recruited	O
.	O
the	O
mif	B-T017
gene	I-T017
-	I-T017
173	I-T017
g	I-T017
/	I-T017
c	I-T017
snp	B-T082
was	O
analyzed	B-T062
by	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
using	O
the	O
restriction	B-T058
fragment	I-T058
length	I-T058
polymorphism	I-T058
method	I-T058
.	O
there	O
was	O
no	O
significant	O
difference	O
between	O
groups	B-T098
in	O
terms	O
of	O
genotype	O
distribution	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
when	O
wild	B-T017
-	I-T017
type	I-T017
g	O
/	O
g	O
and	O
g	O
/	O
c	O
+	O
c	O
/	O
c	O
genotypes	O
are	O
compared	O
in	O
terms	O
of	O
clinical	O
characteristics	O
,	O
there	O
is	O
a	O
significant	O
difference	O
between	O
the	O
average	O
age	O
and	O
the	O
duration	O
of	O
disease	O
in	O
as	B-T038
patients	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
no	O
significant	O
relationship	O
between	O
as	B-T038
disease	B-T038
and	O
mif	B-T017
-	I-T017
173	I-T017
g	I-T017
/	I-T017
c	I-T017
polymorphism	O
was	O
found	O
.	O
mif	B-T017
-	I-T017
173	I-T017
g	I-T017
/	I-T017
c	I-T017
polymorphism	O
(	O
c	B-T017
allele	I-T017
)	O
may	O
affect	O
the	O
time	O
of	O
onset	O
and	O
the	O
duration	O
of	O
disease	O
in	O
as	B-T038
patients	O
.	O

when	O
is	O
a	O
test	O
score	O
fair	O
for	O
the	O
individual	B-T098
who	O
is	O
being	O
tested	B-T170
?	O
effects	O
of	O
different	O
scoring	B-T062
procedures	I-T062
across	O
multiple	O
attempts	O
when	O
testing	O
a	O
motor	B-T038
skill	I-T038
task	O
tests	B-T170
or	O
test	B-T170
batteries	I-T170
used	O
for	O
assessing	O
motor	B-T038
skills	I-T038
,	O
either	O
in	O
research	B-T062
studies	I-T062
or	O
in	O
clinical	B-T062
settings	I-T062
,	O
apply	O
a	O
variety	O
of	O
procedures	O
for	O
scoring	B-T062
performances	O
,	O
including	O
every	O
##thi	O
##ng	O
from	O
one	O
to	O
ten	O
attempts	O
,	O
of	O
which	O
the	O
best	O
is	O
scored	O
or	O
an	O
average	O
is	O
computed	B-T058
.	O
the	O
rationale	O
behind	O
scoring	B-T062
procedures	O
is	O
rarely	O
stated	O
,	O
and	O
it	O
seems	O
that	O
the	O
number	O
of	O
attempts	O
allowed	O
is	O
decided	O
without	O
much	O
qual	O
##ification	O
from	O
research	B-T062
.	O
it	O
is	O
uncertain	O
whether	O
procedures	O
fairly	O
capture	O
an	O
individual	B-T098
'	I-T098
s	I-T098
skill	B-T038
level	O
.	O
thus	O
,	O
the	O
validity	O
of	O
the	O
tests	B-T170
may	O
be	O
compromised	O
.	O
the	O
present	O
study	B-T062
tested	B-T170
24	O
young	O
female	B-T098
soccer	O
players	B-T097
on	O
the	O
jug	O
##gl	O
##ing	O
of	O
a	O
soccer	O
ball	O
.	O
they	O
were	O
given	O
10	O
attempts	O
,	O
and	O
trials	O
were	O
scored	O
according	O
to	O
nine	O
different	O
procedures	O
including	O
the	O
'	O
best	O
of	O
'	O
or	O
'	O
mean	O
of	O
'	O
either	O
one	O
,	O
two	O
,	O
three	O
,	O
five	O
,	O
or	O
ten	O
attempts	O
.	O
individual	B-T098
raw	O
scores	O
differed	O
widely	O
across	O
trials	O
,	O
but	O
no	O
general	O
effect	O
of	O
trials	O
was	O
found	O
.	O
the	O
mean	O
(	O
sd	O
)	O
percentage	O
difference	O
between	O
the	O
lowest	O
and	O
highest	O
scores	O
was	O
27	O
.	O
7	O
(	O
9	O
.	O
9	O
)	O
%	O
,	O
with	O
17	O
players	B-T097
(	O
71	O
%	O
)	O
demonstrating	O
a	O
significant	O
change	O
from	O
lowest	O
to	O
highest	O
score	O
.	O
correlations	O
between	O
raw	O
scores	O
were	O
low	O
across	O
trials	O
,	O
while	O
they	O
were	O
generally	O
higher	O
across	O
scoring	B-T062
procedures	O
.	O
the	O
first	O
trial	O
was	O
significantly	O
different	O
from	O
the	O
remaining	O
both	O
as	O
a	O
raw	O
score	O
and	O
as	O
scoring	B-T062
procedure	O
.	O
the	O
mean	O
percentage	O
difference	O
between	O
best	O
-	O
of	O
-	O
two	O
and	O
best	O
-	O
of	O
-	O
ten	O
scores	O
was	O
95	O
%	O
,	O
with	O
50	O
%	O
of	O
the	O
players	B-T097
demonstrating	O
a	O
significant	O
difference	O
between	O
the	O
two	O
scoring	B-T062
procedures	O
.	O
no	O
significant	O
differences	O
were	O
found	O
across	O
mean	O
-	O
of	O
-	O
rule	O
scoring	O
##s	O
.	O
best	O
-	O
of	O
-	O
rule	O
and	O
mean	O
-	O
of	O
-	O
rule	O
scoring	O
##s	O
were	O
significantly	O
different	O
except	O
for	O
the	O
best	O
-	O
of	O
-	O
two	O
vs	O
.	O
mean	O
-	O
of	O
-	O
two	O
.	O
the	O
mean	O
difference	O
between	O
highest	O
and	O
lowest	O
rank	B-T170
across	O
players	B-T097
was	O
6	O
.	O
7	O
(	O
3	O
.	O
6	O
)	O
,	O
with	O
individual	B-T098
ranking	B-T170
##s	I-T170
within	O
the	O
group	B-T098
varying	O
33	O
%	O
on	O
average	O
across	O
procedures	O
.	O
one	O
player	O
moved	O
from	O
3rd	O
to	O
23	O
##rd	O
place	O
because	O
of	O
procedural	O
differences	O
.	O
therefore	O
,	O
it	O
is	O
concluded	O
that	O
scoring	B-T062
procedures	O
affect	O
results	B-T033
and	O
may	O
have	O
an	O
impact	O
on	O
test	B-T033
outcomes	I-T033
.	O
this	O
may	O
present	O
consequences	O
for	O
decision	O
-	O
making	O
from	O
test	B-T033
results	I-T033
,	O
such	O
as	O
diagnosing	B-T033
and	O
selection	O
of	O
intervention	B-T058
groups	O
.	O
we	O
hope	O
that	O
our	O
results	O
would	O
insp	O
##ire	O
further	O
research	B-T062
into	O
the	O
scoring	B-T062
procedures	O
of	O
the	O
vast	O
amount	O
of	O
tests	B-T170
and	O
tasks	O
in	O
common	O
use	O
.	O

determining	O
putative	B-T204
vectors	I-T204
of	O
the	O
bo	B-T038
##gia	I-T038
coc	I-T038
##on	I-T038
##ut	I-T038
syndrome	I-T038
phyto	B-T007
##plasm	I-T007
##a	I-T007
using	O
loop	B-T058
-	I-T058
mediated	I-T058
isothermal	I-T058
amplification	I-T058
of	O
single	B-T168
-	I-T168
insect	I-T168
feeding	I-T168
media	I-T168
phyto	B-T007
##plasm	I-T007
##as	I-T007
are	O
insect	B-T007
vector	I-T007
##ed	I-T007
moll	I-T007
##ic	I-T007
##utes	I-T007
responsible	O
for	O
disease	B-T038
in	O
many	O
economically	O
important	O
crops	B-T204
.	O
determining	O
which	O
insect	B-T204
species	I-T204
are	O
vectors	B-T204
of	O
a	O
given	O
phyto	B-T007
##plasm	I-T007
##a	I-T007
is	O
important	O
for	O
managing	O
disease	B-T038
but	O
is	O
methodological	O
##ly	O
challenging	O
because	O
disease	B-T204
-	I-T204
free	I-T204
plants	I-T204
need	O
to	O
be	O
exposed	O
to	O
large	O
numbers	O
of	O
insects	B-T204
,	O
often	O
over	O
many	O
months	O
.	O
a	O
relatively	O
new	O
method	O
to	O
detect	O
likely	O
transmission	O
involves	O
molecular	B-T058
testing	I-T058
for	O
phyto	B-T007
##plasm	I-T007
##a	I-T007
dna	B-T103
in	O
sucrose	B-T103
solution	O
that	O
insects	B-T204
have	O
fed	O
upon	O
.	O
in	O
this	O
study	B-T062
we	O
combined	O
this	O
feeding	B-T058
medium	I-T058
method	I-T058
with	O
a	O
loop	B-T058
-	I-T058
mediated	I-T058
isothermal	I-T058
amplification	I-T058
(	I-T058
lamp	I-T058
)	I-T058
assay	I-T058
to	O
study	O
62	O
##7	O
insect	B-T204
specimens	O
of	O
11	O
hemip	B-T204
##tera	I-T204
taxa	I-T204
sampled	O
from	O
sites	O
in	O
pap	B-T082
##ua	I-T082
new	I-T082
guinea	I-T082
affected	O
by	O
bo	B-T038
##gia	I-T038
coc	I-T038
##on	I-T038
##ut	I-T038
syndrome	I-T038
(	O
bcs	B-T038
)	O
.	O
the	O
lamp	B-T058
assay	I-T058
detected	O
phyto	B-T007
##plasm	I-T007
##a	I-T007
dna	B-T103
from	O
the	O
feeding	B-T168
solution	I-T168
and	O
head	B-T082
tissue	B-T017
of	O
insects	B-T204
from	O
six	O
taxa	O
belonging	O
to	O
four	O
families	O
:	O
der	B-T204
##bi	I-T204
##da	I-T204
##e	I-T204
,	O
lo	B-T204
##ph	I-T204
##opid	I-T204
##ae	I-T204
,	O
flat	B-T204
##idae	I-T204
and	O
ri	B-T204
##can	I-T204
##ii	I-T204
##da	I-T204
##e	I-T204
.	O
two	O
other	O
taxa	O
yielded	O
positives	O
only	O
from	O
the	O
heads	B-T082
and	O
the	O
remainder	O
tested	O
negative	O
.	O
these	O
results	O
demonstrate	O
the	O
utility	O
of	O
combining	O
single	B-T058
-	I-T058
insect	I-T058
feeding	I-T058
medium	I-T058
tests	I-T058
with	O
lamp	B-T058
assays	I-T058
to	O
identify	O
putative	B-T204
vectors	I-T204
that	O
can	O
be	O
the	O
subject	O
of	O
transmission	O
tests	O
and	O
to	O
better	O
understand	O
phyto	B-T007
##plasm	I-T007
##a	I-T007
path	B-T091
##osystem	I-T091
##s	I-T091
.	O

variation	O
in	O
the	O
age	O
of	O
first	B-T038
reproduction	I-T038
:	O
different	O
strategies	O
or	O
individual	O
quality	O
?	O
although	O
age	O
at	O
first	B-T038
reproduction	I-T038
is	O
a	O
key	O
demographic	O
parameter	O
that	O
is	O
probably	O
under	O
high	B-T033
selective	I-T033
pressure	I-T033
,	O
it	O
is	O
highly	O
variable	O
and	O
the	O
cause	O
of	O
this	O
variability	O
is	O
not	O
well	O
understood	O
.	O
two	O
non	O
-	O
exclusive	O
hypotheses	O
may	O
explain	O
such	O
variability	O
.	O
it	O
could	O
be	O
the	O
expression	O
of	O
different	O
individual	O
strategies	O
,	O
i	O
.	O
e	O
.	O
,	O
different	O
allocation	O
strategies	O
in	O
fitness	O
components	O
,	O
or	O
the	O
consequences	O
of	O
individual	O
difference	O
in	O
intrinsic	B-T082
quality	I-T082
,	O
i	O
.	O
e	O
.	O
,	O
some	O
individuals	B-T098
always	O
doing	O
better	O
than	O
others	O
in	O
all	O
fitness	O
components	O
.	O
we	O
tested	O
these	O
hypotheses	O
in	O
the	O
wa	B-T204
##nd	I-T204
##ering	I-T204
alb	I-T204
##atr	I-T204
##oss	I-T204
investigating	O
relationships	O
between	O
the	O
age	O
at	O
first	B-T038
reproduction	I-T038
and	O
subsequent	O
adult	O
demographic	O
traits	O
.	O
using	O
finite	B-T062
mixture	I-T062
capture	I-T062
recap	I-T062
##ture	I-T062
modeling	I-T062
,	O
we	O
demonstrate	O
that	O
the	O
age	O
at	O
first	B-T038
reproduction	I-T038
is	O
negatively	B-T033
related	O
to	O
both	O
reproductive	B-T038
performances	O
and	O
adult	O
survival	O
,	O
suggesting	O
that	O
individual	O
quality	O
was	O
an	O
important	O
factor	O
explaining	O
variation	O
in	O
the	O
age	O
at	O
first	B-T038
reproduction	I-T038
.	O
our	O
results	O
suggest	O
that	O
age	O
at	O
first	B-T038
breeding	I-T038
is	O
a	O
good	O
predictor	O
of	O
quality	O
in	O
this	O
long	O
-	O
lived	O
sea	B-T204
##bir	I-T204
##d	I-T204
species	I-T204
.	O

utility	O
and	O
applicability	O
of	O
the	O
[UNK]	B-T170
childhood	I-T170
obesity	I-T170
risk	I-T170
evaluation	I-T170
[UNK]	I-T170
(	I-T170
core	I-T170
)	I-T170
-	I-T170
index	I-T170
in	O
predicting	O
obesity	B-T038
in	O
childhood	O
and	O
adolescence	O
in	O
greece	B-T082
from	O
early	O
life	O
:	O
the	O
[UNK]	O
national	O
action	O
plan	O
for	O
public	O
health	O
[UNK]	O
early	O
identification	B-T058
of	O
infants	O
being	O
at	O
high	B-T033
risk	I-T033
to	O
become	O
obese	B-T038
at	O
their	O
later	O
childhood	O
or	O
adolescence	O
can	O
be	O
of	O
vital	O
importance	O
in	O
any	O
obesity	B-T038
prevention	O
initiative	B-T033
.	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
the	O
utility	O
and	O
applicability	O
of	O
the	O
[UNK]	B-T170
childhood	I-T170
obesity	I-T170
risk	I-T170
evaluation	I-T170
(	I-T170
core	I-T170
)	I-T170
[UNK]	I-T170
index	I-T170
as	O
a	O
screening	B-T058
tool	O
for	O
the	O
early	O
prediction	O
of	O
obesity	B-T038
in	O
childhood	O
and	O
adolescence	O
.	O
anthropometric	O
,	O
socio	O
-	O
demographic	O
data	O
were	O
collected	O
cross	O
-	O
sectional	O
##ly	O
and	O
retrospectively	O
from	O
a	O
representative	O
sample	O
of	O
59	O
##46	O
children	O
,	O
and	O
adolescents	O
and	O
were	O
combined	O
for	O
calculating	O
the	O
core	B-T170
-	I-T170
index	I-T170
score	I-T170
.	O
logistic	O
regression	O
analyses	O
were	O
performed	O
to	O
examine	O
the	O
associations	O
of	O
the	O
core	B-T170
-	I-T170
index	I-T170
score	I-T170
with	O
obesity	B-T038
by	O
gender	O
and	O
age	O
group	O
,	O
and	O
cut	B-T062
-	I-T062
off	I-T062
point	I-T062
analysis	I-T062
was	O
also	O
applied	O
to	O
identify	O
the	O
optimal	O
value	O
of	O
the	O
core	B-T170
-	I-T170
index	I-T170
score	I-T170
that	O
differentiate	O
##s	O
obese	B-T038
from	O
non	O
-	O
obese	O
children	O
.	O
mean	B-T170
core	I-T170
-	I-T170
index	I-T170
score	I-T170
in	O
the	O
total	O
sample	O
was	O
3	O
.	O
06	O
(	O
sd	O
1	O
.	O
92	O
)	O
units	O
(	O
range	O
0	O
-	O
11	O
units	O
)	O
.	O
each	O
unit	O
increase	O
in	O
the	O
core	B-T170
-	I-T170
index	I-T170
score	I-T170
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
30	O
%	O
(	O
95	O
%	O
c	O
.	O
i	O
.	O
1	O
.	O
24	O
-	O
1	O
.	O
36	O
)	O
increased	O
likelihood	O
for	O
obesity	B-T038
in	O
childhood	O
or	O
adolescence	O
,	O
while	O
the	O
optimal	O
cut	O
-	O
off	O
value	O
of	O
the	O
core	B-T170
-	I-T170
index	I-T170
score	I-T170
that	O
predicted	O
obesity	B-T038
with	O
the	O
highest	O
possible	O
sensitivity	O
and	O
specificity	O
was	O
found	O
to	O
be	O
3	O
.	O
5	O
.	O
the	O
present	O
study	O
supports	O
the	O
utility	O
and	O
applicability	O
of	O
the	O
core	B-T170
-	I-T170
index	I-T170
as	O
a	O
screening	B-T058
tool	O
for	O
the	O
early	O
identification	B-T058
of	O
infants	O
that	O
are	O
potentially	O
at	O
a	O
higher	B-T033
risk	I-T033
for	O
becoming	O
obese	B-T038
at	O
their	O
childhood	O
and	O
adolescence	O
.	O
this	O
tool	O
could	O
be	O
routinely	O
used	O
by	O
health	B-T097
professionals	I-T097
to	O
identify	O
infants	O
at	O
high	B-T033
risk	I-T033
and	O
provide	O
appropriate	O
counselling	B-T058
to	O
their	O
parents	O
and	O
caregivers	B-T097
so	O
as	O
to	O
maximize	O
the	O
effectiveness	O
of	O
early	O
obesity	B-T038
prevention	O
initiatives	B-T033
.	O
what	O
is	O
known	O
?	O
•	O
childhood	O
obesity	B-T038
has	O
reached	O
epidemic	O
proportions	O
worldwide	O
.	O
•	O
certain	O
perinatal	B-T033
and	O
socio	B-T033
-	I-T033
demographic	I-T033
indices	I-T033
that	O
were	O
previously	O
identified	O
as	O
correlates	O
of	O
childhood	O
obesity	B-T038
in	O
children	O
were	O
combined	O
to	O
develop	O
the	O
core	B-T170
-	I-T170
index	I-T170
,	O
a	O
screening	B-T058
tool	O
that	O
estimates	O
obesity	B-T038
risk	O
in	O
9	O
-	O
13	O
year	O
-	O
old	O
children	O
.	O
what	O
is	O
new	O
?	O
•	O
the	O
utility	O
and	O
applicability	O
of	O
the	O
core	B-T170
-	I-T170
index	I-T170
as	O
screening	B-T058
tool	O
can	O
be	O
extended	O
to	O
the	O
age	O
range	O
of	O
6	O
-	O
15	O
years	O
.	O
•	O
the	O
core	B-T170
-	I-T170
index	I-T170
is	O
a	O
cost	O
-	O
effective	O
screening	B-T058
tool	O
that	O
can	O
assist	O
health	B-T097
professionals	I-T097
in	O
initiating	O
obesity	B-T038
preventive	B-T170
measures	I-T170
from	O
early	O
life	O
.	O

comparative	B-T062
effectiveness	I-T062
of	O
treatments	B-T058
for	O
chronic	B-T038
low	I-T038
back	I-T038
pain	I-T038
:	O
a	O
multiple	B-T062
treatment	I-T062
comparison	I-T062
analysis	I-T062
a	O
systematic	B-T170
review	I-T170
and	O
network	B-T062
meta	I-T062
-	I-T062
analysis	I-T062
.	O
to	O
determine	O
current	B-T058
treatment	I-T058
options	I-T058
of	O
chronic	B-T038
low	I-T038
back	I-T038
pain	I-T038
(	O
lbp	B-T038
)	O
as	O
defined	O
by	O
randomized	B-T062
controlled	I-T062
trials	I-T062
(	O
rcts	B-T062
)	O
and	O
to	O
compare	O
effectiveness	O
of	O
those	O
treatments	B-T058
using	O
a	O
mixed	B-T062
-	I-T062
treatment	I-T062
comparison	I-T062
(	O
mtc	B-T062
)	O
.	O
it	O
is	O
important	O
to	O
provide	O
an	O
evidence	O
-	O
based	O
assessment	B-T058
of	O
the	O
treatment	B-T058
options	I-T058
that	O
exist	O
for	O
lbp	B-T038
.	O
a	O
systematic	B-T062
search	I-T062
of	O
rcts	B-T062
was	O
conducted	O
in	O
medline	B-T170
and	O
the	O
cochrane	B-T092
collaboration	I-T092
library	I-T092
from	O
1990	O
to	O
2014	O
.	O
from	O
the	O
selected	B-T062
studies	I-T062
,	O
we	O
extracted	O
preoperative	O
and	O
postoperative	O
od	B-T033
##i	I-T033
and	O
vas	O
back	O
pain	O
scores	O
,	O
additional	B-T058
surgeries	I-T058
,	O
and	O
complications	B-T038
.	O
standard	B-T062
and	I-T062
network	I-T062
meta	I-T062
-	I-T062
analytic	I-T062
techniques	I-T062
were	O
used	O
.	O
twelve	O
rcts	B-T062
were	O
included	O
in	O
the	O
analysis	B-T062
:	O
5	O
total	B-T058
disk	I-T058
replacement	I-T058
(	O
tdr	B-T058
)	O
versus	O
fusion	B-T058
;	O
1	O
tdr	B-T058
versus	O
exercise	B-T058
and	O
cognitive	B-T058
behavioral	I-T058
therapy	I-T058
(	O
cbt	B-T058
)	O
;	O
5	O
fusion	B-T058
versus	O
exercise	B-T058
and	O
cbt	B-T058
;	O
and	O
1	O
fusion	B-T058
versus	O
physical	B-T058
therapy	I-T058
(	O
pt	B-T058
)	O
.	O
on	O
the	O
basis	O
of	O
mtc	B-T062
,	O
with	O
respect	O
to	O
od	B-T033
##i	I-T033
change	I-T033
scores	I-T033
,	O
the	O
pooled	O
mean	O
difference	O
favoring	O
fusion	B-T058
over	O
exercise	B-T058
and	O
cbt	B-T058
was	O
2	O
.	O
0	O
points	O
(	O
95	O
%	O
ci	O
,	O
-	O
1	O
.	O
2	O
to	O
4	O
.	O
8	O
)	O
.	O
the	O
pooled	O
mean	O
difference	O
favoring	O
tdr	B-T058
over	O
exercise	B-T058
and	O
cbt	B-T058
was	O
6	O
.	O
4	O
points	O
(	O
95	O
%	O
ci	O
,	O
3	O
.	O
2	O
-	O
9	O
.	O
3	O
)	O
.	O
the	O
pooled	O
mean	O
difference	O
favoring	O
fusion	B-T058
over	O
pt	B-T058
was	O
8	O
.	O
8	O
points	O
(	O
95	O
%	O
ci	O
,	O
4	O
.	O
1	O
-	O
13	O
.	O
6	O
)	O
.	O
the	O
pooled	O
mean	O
differences	O
favoring	O
tdr	B-T058
over	O
fusion	B-T058
was	O
4	O
.	O
4	O
points	O
(	O
95	O
%	O
ci	O
,	O
2	O
.	O
37	O
-	O
6	O
.	O
63	O
)	O
.	O
for	O
pt	B-T058
versus	O
structured	B-T058
exercise	I-T058
with	O
cbt	B-T058
,	O
the	O
pooled	O
mean	O
difference	O
favoring	O
exercise	B-T058
with	O
cbt	B-T058
over	O
pt	B-T058
was	O
6	O
.	O
8	O
points	O
(	O
95	O
%	O
ci	O
,	O
1	O
.	O
5	O
-	O
12	O
.	O
8	O
)	O
.	O
for	O
tdr	B-T058
versus	O
pt	B-T058
,	O
the	O
pooled	O
mean	O
difference	O
favoring	O
tdr	B-T058
over	O
pt	B-T058
was	O
13	O
.	O
2	O
points	O
(	O
95	O
%	O
ci	O
,	O
8	O
.	O
0	O
-	O
18	O
.	O
4	O
)	O
.	O
additional	O
surgery	O
rates	O
were	O
similar	O
between	O
treatment	B-T058
options	I-T058
.	O
all	O
4	O
treatments	B-T058
provided	O
some	O
benefit	O
to	O
patients	O
with	O
chronic	B-T038
lbp	I-T038
.	O
according	O
to	O
the	O
mtc	B-T062
analysis	I-T062
,	O
tdr	B-T058
may	O
be	O
the	O
most	O
effective	O
treatment	B-T058
and	O
pt	B-T058
the	O
least	O
effective	O
treatment	B-T058
for	O
chronic	B-T038
lbp	I-T038
.	O
this	O
review	B-T170
is	O
based	O
on	O
a	O
limited	O
number	O
of	O
rct	B-T062
studies	I-T062
and	O
does	O
not	O
support	O
any	O
1	O
treatment	B-T058
modality	O
for	O
all	O
patients	O
.	O

genetic	O
parameters	B-T033
for	O
tick	O
count	O
and	O
ud	B-T017
##der	I-T017
health	O
in	O
commercial	B-T170
and	O
indigenous	O
ewes	O
in	O
south	B-T082
africa	I-T082
the	O
genetics	O
of	O
tick	B-T038
infestation	I-T038
in	O
sheep	B-T204
need	O
study	O
,	O
as	O
host	O
resistance	O
often	O
forms	O
part	O
of	O
integrated	O
pest	O
control	O
programs	O
.	O
repeated	O
ud	B-T017
##der	I-T017
health	O
scores	O
,	O
site	B-T082
-	I-T082
specific	I-T082
tick	O
count	O
,	O
mating	B-T038
weight	O
and	O
reproduction	B-T038
records	B-T170
(	O
n	O
=	O
87	O
##9	O
-	O
120	O
##4	O
)	O
were	O
recorded	O
annually	O
from	O
2010	O
to	O
2015	O
on	O
ewes	O
of	O
the	O
indigenous	O
nam	B-T204
##a	I-T204
##qu	I-T204
##a	I-T204
af	I-T204
##ri	I-T204
##ka	I-T204
##ner	I-T204
(	O
na	B-T204
)	O
fat	B-T170
-	I-T170
tailed	I-T170
breed	I-T170
,	O
as	O
well	O
as	O
the	O
commercial	B-T170
dor	B-T204
##per	I-T204
and	O
sa	B-T204
mut	I-T204
##ton	I-T204
mer	I-T204
##ino	I-T204
(	I-T204
sam	I-T204
##m	I-T204
)	I-T204
breeds	I-T204
.	O
ud	B-T017
##der	I-T017
s	O
were	O
scored	O
subjectively	O
on	O
a	O
1	O
-	O
5	O
scale	O
(	O
1	O
-	O
ud	B-T017
##der	I-T017
intact	O
and	O
5	O
-	O
ud	B-T017
##der	I-T017
damaged	B-T037
severely	I-T037
)	O
and	O
ticks	B-T038
were	O
counted	O
on	O
three	B-T082
locations	I-T082
.	O
the	O
body	B-T082
sites	I-T082
counted	O
were	O
the	O
head	B-T017
and	I-T017
thoracic	I-T017
limb	I-T017
(	O
ht	B-T017
##lt	I-T017
##c	I-T017
)	O
,	O
ud	B-T017
##der	I-T017
-	I-T017
pelvic	I-T017
limb	I-T017
(	O
up	B-T017
##lt	I-T017
##c	I-T017
)	O
and	O
perine	B-T017
##um	I-T017
-	I-T017
bre	I-T017
##ech	I-T017
-	I-T017
tail	I-T017
(	O
pb	B-T017
##tt	I-T017
##c	I-T017
)	O
.	O
these	O
counts	O
were	O
also	O
total	O
##ed	O
for	O
a	O
total	O
tick	O
count	O
(	O
tt	O
##c	O
)	O
.	O
reproduction	B-T038
traits	O
were	O
number	O
of	O
lambs	B-T204
weaned	B-T033
per	O
ew	B-T033
##e	I-T033
lamb	I-T033
##ed	I-T033
and	O
total	O
weight	O
of	O
lamb	B-T033
weaned	I-T033
per	O
ew	B-T033
##e	I-T033
lamb	I-T033
##ed	I-T033
.	O
ud	B-T017
##der	I-T017
health	O
scores	O
of	O
na	B-T204
ewes	O
were	O
lower	O
than	O
those	O
of	O
dor	B-T204
##pers	I-T204
,	O
which	O
in	O
turn	O
had	O
lower	O
scores	O
than	O
sam	B-T204
##m	I-T204
ewes	O
.	O
na	B-T204
ewes	O
had	O
lower	O
values	O
for	O
ht	B-T017
##lt	I-T017
##c	I-T017
,	O
up	B-T017
##lt	I-T017
##c	I-T017
and	O
tt	O
##c	O
than	O
the	O
commercial	B-T170
breeds	B-T170
,	O
but	O
higher	O
values	O
for	O
pb	B-T017
##tt	I-T017
##c	I-T017
than	O
dor	B-T204
##pers	I-T204
.	O
heritability	O
estimates	O
amounted	O
to	O
0	O
.	O
26	O
##±0	O
.	O
04	O
for	O
ht	B-T017
##lt	I-T017
##c	I-T017
,	O
0	O
.	O
53	O
##±0	O
.	O
04	O
for	O
up	B-T017
##lt	I-T017
##c	I-T017
,	O
0	O
.	O
07	O
##±0	O
.	O
06	O
for	O
pb	B-T017
##tt	I-T017
##c	I-T017
,	O
0	O
.	O
44	O
##±0	O
.	O
06	O
for	O
tt	O
##c	O
and	O
0	O
.	O
61	O
##±0	O
.	O
03	O
for	O
ud	B-T017
##der	I-T017
health	O
score	O
.	O
animal	B-T082
permanent	I-T082
environment	I-T082
also	O
affected	O
pb	B-T017
##tt	I-T017
##c	I-T017
(	O
0	O
.	O
14	O
##±0	O
.	O
07	O
)	O
.	O
significant	O
genetic	O
correlations	O
were	O
found	O
between	O
the	O
ht	B-T017
##lt	I-T017
##c	I-T017
and	O
up	B-T017
##lt	I-T017
##c	I-T017
(	O
0	O
.	O
47	O
##±0	O
.	O
10	O
)	O
,	O
up	B-T017
##lt	I-T017
##c	I-T017
and	O
ud	B-T017
##der	I-T017
health	O
score	O
(	O
0	O
.	O
52	O
##±0	O
.	O
07	O
)	O
,	O
ht	B-T017
##lt	I-T017
##c	I-T017
and	O
up	B-T017
##lt	I-T017
##c	I-T017
(	O
0	O
.	O
24	O
##±0	O
.	O
11	O
)	O
as	O
well	O
as	O
up	B-T017
##lt	I-T017
##c	I-T017
and	O
pb	B-T017
##tt	I-T017
##c	I-T017
(	O
-	O
0	O
.	O
44	O
##±0	O
.	O
11	O
)	O
.	O
heavier	O
ewes	O
had	O
higher	O
up	B-T017
##lt	I-T017
##c	I-T017
(	O
0	O
.	O
38	O
##±0	O
.	O
09	O
)	O
,	O
tt	O
##c	O
(	O
0	O
.	O
33	O
##±0	O
.	O
09	O
)	O
and	O
impaired	O
ud	B-T017
##der	I-T017
health	O
(	O
0	O
.	O
21	O
##±0	O
.	O
08	O
)	O
.	O
ud	B-T017
##der	I-T017
health	O
score	O
s	O
and	O
tick	O
counts	O
at	O
all	O
sites	O
were	O
not	O
related	O
to	O
reproduction	B-T038
traits	O
.	O
the	O
indigenous	O
na	B-T204
breed	B-T170
outperformed	O
the	O
commercial	B-T170
breeds	B-T170
with	O
lower	O
values	O
for	O
ht	B-T017
##lt	I-T017
##c	I-T017
,	O
up	B-T017
##lt	I-T017
##c	I-T017
,	O
tt	O
##c	O
and	O
a	O
better	O
ud	B-T017
##der	I-T017
health	O
score	O
.	O
mechanisms	O
contributing	O
to	O
the	O
better	O
performance	O
of	O
the	O
na	B-T204
breed	B-T170
under	O
past	B-T058
##oral	I-T058
conditions	I-T058
and	O
the	O
scope	O
for	O
selection	O
for	O
tick	B-T038
tolerance	O
within	O
breeds	B-T170
should	O
be	O
studied	O
further	O
.	O

genomic	B-T017
characterization	O
of	O
a	O
wild	B-T204
-	I-T204
bird	I-T204
-	O
origin	B-T033
pige	B-T204
##on	I-T204
param	B-T005
##yx	I-T005
##ovirus	I-T005
type	I-T005
1	I-T005
(	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
)	O
first	O
isolated	O
in	O
the	O
northwest	B-T082
region	I-T082
of	I-T082
china	I-T082
pige	B-T204
##on	I-T204
param	B-T005
##yx	I-T005
##ovirus	I-T005
type	I-T005
-	I-T005
1	I-T005
(	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
)	O
is	O
an	O
en	O
##zo	O
##otic	O
in	O
pige	B-T204
##on	I-T204
flocks	O
and	O
causes	O
severe	O
economic	O
losses	O
in	O
the	O
poultry	B-T204
industry	O
in	O
many	O
countries	B-T082
.	O
a	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
isolate	B-T103
,	O
abbreviated	O
as	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
/	I-T005
ql	I-T005
-	I-T005
01	I-T005
/	I-T005
ch	I-T005
/	I-T005
15	I-T005
,	O
was	O
isolated	O
from	O
a	O
great	O
spotted	O
wood	B-T204
##pec	I-T204
##ker	I-T204
in	O
the	O
northwest	B-T082
region	I-T082
of	I-T082
china	I-T082
in	O
2015	O
.	O
the	O
complete	O
genome	B-T017
was	O
sequenced	B-T058
,	O
and	O
the	O
results	O
showed	O
that	O
the	O
virus	B-T005
genome	B-T017
was	O
15	O
,	O
192	O
nt	O
in	O
length	O
,	O
in	O
the	O
gene	B-T038
arrangement	I-T038
3	I-T038
'	I-T038
-	I-T038
np	I-T038
-	I-T038
p	I-T038
-	I-T038
m	I-T038
-	I-T038
f	I-T038
-	I-T038
hn	I-T038
-	I-T038
l	I-T038
-	I-T038
5	I-T038
'	I-T038
.	O
several	O
amino	B-T103
acid	I-T103
mutations	B-T038
were	O
identified	O
in	O
the	O
functional	B-T082
domains	I-T082
of	O
the	O
f	B-T103
and	O
hn	B-T103
proteins	I-T103
.	O
the	O
pathogenicity	O
index	O
of	O
the	O
isolate	B-T103
was	O
evaluated	B-T058
,	O
and	O
the	O
mean	O
death	O
time	O
(	O
md	O
##t	O
)	O
was	O
72	O
h	O
and	O
the	O
intracerebral	O
pathogenicity	O
index	O
(	O
icp	O
##i	O
)	O
was	O
0	O
.	O
92	O
##5	O
,	O
indicating	O
that	O
this	O
isolate	B-T103
was	O
meso	O
##genic	O
.	O
sequencing	B-T058
results	O
showed	O
that	O
it	O
had	O
a	O
virulent	O
new	B-T005
##castle	I-T005
disease	I-T005
virus	I-T005
cleavage	B-T082
motif	I-T082
(	I-T082
112	I-T082
)	I-T082
r	I-T082
-	I-T082
r	I-T082
-	I-T082
q	I-T082
-	I-T082
k	I-T082
-	I-T082
r	I-T082
-	I-T082
f	I-T082
(	I-T082
117	I-T082
)	I-T082
at	O
the	O
fusion	B-T103
protein	I-T103
cleavage	B-T082
site	I-T082
.	O
morbidity	O
and	O
mortality	O
were	O
70	O
%	O
and	O
50	O
%	O
,	O
after	O
inoculation	B-T058
of	O
pigeons	B-T204
,	O
whereas	O
this	O
virus	B-T005
was	O
nonp	B-T033
##ath	I-T033
##ogenic	I-T033
in	O
chickens	B-T204
.	O
different	O
immune	B-T038
responses	I-T038
of	O
pigeons	B-T204
and	O
chickens	B-T204
were	O
induced	O
in	B-T082
vivo	I-T082
,	O
which	O
led	O
to	O
different	O
hi	O
serum	O
antibody	O
titers	O
.	O
the	O
results	O
of	O
phylogenetic	B-T062
and	O
evolutionary	B-T062
distance	I-T062
analysis	I-T062
showed	O
that	O
this	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
strain	O
belonged	O
to	O
sub	B-T170
-	I-T170
genotype	I-T170
via	I-T170
in	O
class	B-T170
ii	I-T170
.	O
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
identification	B-T058
and	O
analysis	B-T062
of	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
co	B-T033
-	I-T033
circulation	I-T033
among	O
wild	B-T204
birds	I-T204
and	O
domestic	B-T204
pige	I-T204
##on	I-T204
flocks	O
in	O
china	B-T082
.	O
the	O
data	O
from	O
this	O
study	B-T062
highlight	O
the	O
important	O
role	O
of	O
wild	B-T204
birds	I-T204
in	O
the	O
dissemination	B-T082
of	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
and	O
provide	O
useful	O
references	B-T170
for	O
improving	O
our	O
understanding	O
of	O
the	O
distribution	B-T082
and	O
evolution	B-T038
of	O
ppm	B-T005
##v	I-T005
-	I-T005
1	I-T005
in	O
china	B-T082
.	O

the	O
ncam	B-T017
##1	I-T017
gene	I-T017
set	I-T017
is	O
linked	O
to	O
depressive	B-T033
symptoms	I-T033
and	O
their	O
brain	B-T017
structural	I-T017
correlates	O
in	O
healthy	B-T098
individuals	I-T098
depressive	B-T033
symptoms	I-T033
exist	O
on	O
a	O
continuum	O
,	O
the	O
far	O
end	O
of	O
which	O
is	O
found	O
in	O
depressive	B-T038
disorders	I-T038
.	O
utilizing	O
the	O
continuous	B-T058
spectrum	I-T058
of	O
depressive	B-T033
symptoms	I-T033
may	O
therefore	O
contribute	O
to	O
the	O
understanding	O
of	O
the	O
biological	B-T033
underpinning	I-T033
##s	I-T033
of	O
depression	B-T038
.	O
gene	B-T058
set	I-T058
enrichment	I-T058
analysis	I-T058
(	O
gs	B-T058
##ea	I-T058
)	O
is	O
an	O
important	O
tool	O
for	O
the	O
identification	O
of	O
gene	B-T017
groups	I-T017
linked	O
to	O
complex	O
traits	O
,	O
and	O
was	O
applied	O
in	O
the	O
present	O
study	O
on	O
genome	B-T062
-	I-T062
wide	I-T062
association	I-T062
study	I-T062
(	O
gwas	B-T062
)	O
data	O
of	O
depression	O
scores	O
and	O
their	O
brain	B-T017
-	I-T017
level	I-T017
structural	I-T017
correlates	O
in	O
healthy	B-T098
young	I-T098
individuals	I-T098
.	O
on	O
symptom	B-T033
level	I-T033
(	O
i	O
.	O
e	O
.	O
depression	O
scores	O
)	O
,	O
robust	O
enrichment	O
was	O
identified	O
for	O
two	O
gene	B-T017
sets	I-T017
:	O
ncam	B-T017
##1	I-T017
interactions	O
and	O
collagen	B-T038
formation	I-T038
.	O
depression	O
scores	O
were	O
also	O
associated	O
with	O
decreased	O
fractional	O
anisotropy	O
(	O
fa	O
)	O
-	O
a	O
brain	B-T017
white	I-T017
matter	I-T017
property	I-T017
-	O
within	B-T017
the	I-T017
forceps	I-T017
minor	I-T017
and	O
the	O
left	B-T017
superior	I-T017
temporal	I-T017
longitudinal	I-T017
fasci	I-T017
##cu	I-T017
##lu	I-T017
##s	I-T017
.	O
within	O
each	O
of	O
these	O
tracts	O
,	O
mean	O
fa	O
value	O
of	O
depression	O
score	O
-	O
associated	O
voxel	O
##s	O
was	O
used	O
as	O
a	O
phenotype	O
in	O
a	O
subsequent	O
gs	B-T058
##ea	I-T058
.	O
the	O
ncam	B-T017
##1	I-T017
interactions	O
gene	B-T017
set	I-T017
was	O
significantly	O
enriched	O
in	O
these	O
tracts	O
.	O
by	O
linking	O
the	O
ncam	B-T017
##1	I-T017
interactions	O
gene	B-T017
set	I-T017
to	O
depression	O
scores	O
and	O
their	O
structural	B-T017
brain	I-T017
correlates	O
in	O
healthy	B-T098
participants	I-T098
,	O
the	O
current	O
study	O
contributes	O
to	O
the	O
understanding	O
of	O
the	O
molecular	B-T033
underpinning	I-T033
##s	I-T033
of	O
depressive	B-T033
symptomatology	I-T033
.	O

signs	B-T033
of	O
dys	B-T038
##arth	I-T038
##ri	I-T038
##a	I-T038
in	O
adults	O
with	O
22	B-T038
##q11	I-T038
.	I-T038
2	I-T038
deletion	I-T038
syndrome	I-T038
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
investigate	O
how	O
adults	O
with	O
22	B-T038
##q11	I-T038
.	I-T038
2	I-T038
deletion	I-T038
syndrome	I-T038
(	O
22	B-T038
##q11	I-T038
##ds	I-T038
)	O
performed	O
on	O
dys	B-T038
##arth	I-T038
##ri	I-T038
##a	I-T038
and	O
intellig	B-T038
##ibility	I-T038
tests	O
compared	O
with	O
a	O
control	O
group	O
.	O
ten	O
participants	B-T098
with	O
confirmed	O
22	B-T038
##q11	I-T038
.	I-T038
2	I-T038
deletion	I-T038
,	O
five	O
males	O
and	O
five	O
females	O
with	O
a	O
mean	O
age	O
of	O
31	O
years	O
(	O
range	O
:	O
19	O
-	O
49	O
)	O
,	O
were	O
compared	O
with	O
a	O
control	O
group	O
matched	O
for	O
gender	O
and	O
age	O
(	O
five	O
males	O
and	O
five	O
females	O
,	O
mean	O
age	O
:	O
32	O
years	O
,	O
range	O
:	O
19	O
-	O
49	O
)	O
.	O
assessment	O
of	O
non	B-T058
-	I-T058
verbal	I-T058
and	I-T058
verbal	I-T058
tasks	I-T058
reflecting	O
respiration	B-T038
,	O
phon	B-T038
##ation	I-T038
,	O
oral	B-T038
motor	I-T038
function	I-T038
,	O
vel	O
##opharyngeal	O
function	O
,	O
articulation	B-T038
,	O
and	O
pros	B-T033
##ody	I-T033
was	O
performed	O
as	O
well	O
as	O
the	O
swedish	B-T170
test	I-T170
of	I-T170
intellig	I-T170
##ibility	I-T170
(	O
sti	B-T170
)	O
.	O
all	O
assessments	O
were	O
made	O
by	O
two	O
raters	O
;	O
inter	O
-	O
rater	O
and	O
intra	O
-	O
rater	O
reliability	O
was	O
acceptable	O
.	O
the	O
participants	B-T098
with	O
22	B-T038
##q11	I-T038
##ds	I-T038
had	O
significantly	O
more	O
problems	B-T033
than	O
the	O
control	O
group	O
on	O
all	O
investigated	O
dimensions	O
except	O
the	O
sti	B-T170
.	O
overall	O
,	O
the	O
severity	O
of	O
their	O
speech	B-T033
deviation	I-T033
was	O
rated	O
as	O
mild	O
to	O
moderate	O
.	O
the	O
largest	O
difficulties	O
were	O
found	O
regarding	O
speech	B-T038
respiration	B-T038
,	O
phon	B-T038
##ation	I-T038
,	O
oral	B-T038
motor	I-T038
function	I-T038
,	O
and	O
vel	O
##opharyngeal	O
function	O
.	O
the	O
results	O
of	O
the	O
present	O
study	B-T062
suggest	O
that	O
a	O
neurological	O
etiology	O
could	O
be	O
added	O
to	O
the	O
previously	O
described	O
structural	O
etiology	O
explaining	O
the	O
speech	B-T033
difficulties	I-T033
found	O
in	O
22	B-T038
##q11	I-T038
##ds	I-T038
.	O
signs	B-T033
of	O
difficulties	O
in	O
both	O
speech	B-T038
motor	I-T038
planning	I-T038
and	O
speech	B-T038
motor	I-T038
programming	I-T038
were	O
found	O
.	O
further	O
studies	B-T062
are	O
needed	O
to	O
confirm	O
the	O
results	O
,	O
as	O
are	O
studies	B-T062
of	O
the	O
association	O
between	O
structural	B-T033
brain	I-T033
abnormalities	I-T033
and	O
neurological	B-T033
speech	I-T033
symptoms	I-T033
.	O
for	O
clinical	O
purposes	O
,	O
it	O
is	O
important	O
that	O
clinicians	B-T097
have	O
knowledge	O
about	O
the	O
variable	O
speech	B-T033
symptoms	I-T033
that	O
may	O
occur	O
in	O
individuals	B-T098
with	O
22	B-T038
##q11	I-T038
##ds	I-T038
and	O
that	O
they	O
be	O
aware	O
of	O
the	O
complexity	O
of	O
the	O
etiology	O
of	O
such	O
speech	B-T033
symptoms	I-T033
.	O
©	O
2017	O
wiley	O
periodicals	O
,	O
inc	O
.	O

from	O
training	O
to	O
practice	O
:	O
the	O
impact	O
of	O
engage	B-T092
,	O
ireland	B-T082
'	I-T082
s	I-T082
national	O
men	O
'	O
s	O
health	O
training	O
programme	O
ireland	B-T082
'	I-T082
s	I-T082
national	B-T170
men	I-T170
'	I-T170
s	I-T170
health	I-T170
policy	I-T170
recommended	O
developing	O
training	O
programmes	O
tailored	B-T058
to	O
the	O
needs	O
of	O
those	O
working	O
in	O
health	B-T097
and	O
allied	B-T097
health	I-T097
professionals	I-T097
and	O
engage	B-T092
was	O
developed	O
to	O
meet	O
that	O
recommendation	O
.	O
this	O
study	B-T062
evaluated	B-T058
the	O
impact	O
of	O
engage	B-T092
on	O
front	O
##line	O
service	O
providers	O
'	O
self	B-T033
-	I-T033
reported	I-T033
knowledge	I-T033
,	O
skills	O
,	O
capacity	O
and	O
practice	O
up	O
to	O
5	O
-	O
months	O
post	O
training	O
.	O
between	O
2012	O
and	O
2015	O
,	O
engage	B-T092
train	O
##ers	O
(	O
n	O
=	O
57	O
)	O
delivered	O
62	O
1	O
-	O
day	O
training	O
programmes	O
to	O
81	O
##0	O
participants	B-T098
.	O
this	O
study	B-T062
was	O
conducted	O
on	O
a	O
subset	B-T170
of	O
those	O
training	O
days	O
(	O
n	O
=	O
26	O
)	O
and	O
participants	B-T098
.	O
quantitative	O
methodologies	B-T062
were	O
used	O
to	O
collect	O
pre	O
(	O
n	O
=	O
295	O
)	O
,	O
post	O
(	O
n	O
=	O
295	O
)	O
and	O
5	O
-	O
month	O
post	O
(	O
n	O
=	O
128	O
)	O
training	O
questionnaire	B-T170
data	O
.	O
overall	O
,	O
participants	B-T098
were	O
highly	O
satisfied	B-T170
with	O
the	O
training	O
immediately	O
post	O
training	O
(	O
8	O
.	O
60	O
±	O
1	O
.	O
60	O
out	O
of	O
10	O
)	O
and	O
at	O
5	O
-	O
month	O
follow	B-T033
up	I-T033
(	O
8	O
.	O
06	O
±	O
1	O
.	O
43	O
out	O
of	O
10	O
)	O
.	O
participants	B-T098
'	I-T098
self	B-T033
-	I-T033
reported	I-T033
level	I-T033
of	I-T033
knowledge	I-T033
,	O
skill	O
and	O
capacity	O
in	O
identifying	O
priorities	O
,	O
engaging	O
men	B-T098
and	O
influencing	O
practice	O
beyond	O
their	O
own	O
organisation	O
increased	O
immediately	O
following	O
training	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
,	O
with	O
the	O
exception	O
of	O
improving	O
capacity	O
to	O
engage	O
men	B-T098
and	O
influencing	O
practice	O
beyond	O
their	O
organisation	O
,	O
these	O
improvements	O
were	O
sustained	O
at	O
5	O
-	O
month	O
post	O
training	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
vast	O
majority	O
of	O
service	O
providers	O
(	O
93	O
.	O
4	O
%	O
)	O
reported	B-T058
that	O
engage	B-T092
had	O
impacted	O
their	O
work	O
practice	O
up	O
to	O
5	O
-	O
month	O
post	O
training	O
.	O
the	O
findings	B-T033
suggest	O
that	O
engage	B-T092
has	O
succeeded	B-T033
in	O
improving	O
service	O
providers	O
'	O
capacity	O
to	O
engage	O
and	O
work	O
with	O
men	B-T098
;	O
improving	O
gender	O
competency	O
in	O
the	O
delivery	O
of	O
health	O
and	O
health	B-T058
related	I-T058
services	I-T058
may	O
increase	O
the	O
utilisation	B-T058
of	O
such	O
services	B-T058
by	O
men	B-T098
and	O
thereby	O
improve	B-T033
health	O
outcomes	O
for	O
men	B-T098
.	O

ophthalmic	B-T033
manifestations	I-T033
of	O
facial	B-T082
dog	B-T037
bites	I-T037
in	O
children	O
to	O
characterize	O
ophthalmic	B-T033
manifestations	I-T033
and	O
peri	B-T037
##ocular	I-T037
injuries	I-T037
of	O
pediatric	O
facial	B-T082
dog	B-T037
bites	I-T037
.	O
a	O
retrospective	O
review	B-T170
of	O
all	O
children	O
younger	O
than	O
18	O
years	O
who	O
sought	O
medical	O
attention	B-T038
after	O
a	O
dog	B-T037
bite	I-T037
to	O
the	O
face	B-T082
between	O
january	O
1	O
,	O
2003	O
and	O
may	O
22	O
,	O
2014	O
was	O
performed	O
at	O
a	O
large	O
tertiary	O
pediatric	B-T092
hospital	I-T092
.	O
data	O
on	O
type	O
and	O
location	B-T033
of	I-T033
injury	I-T033
,	O
surgical	B-T033
intervention	I-T033
,	O
and	O
complications	B-T038
were	O
collected	O
.	O
a	O
total	O
of	O
1	O
,	O
98	O
##9	O
children	O
aged	O
0	O
.	O
19	O
to	O
17	O
years	O
were	O
identified	O
with	O
dog	B-T037
bite	I-T037
s	I-T037
.	O
dog	B-T037
bite	I-T037
s	I-T037
to	O
the	O
face	B-T082
occurred	O
in	O
most	O
patients	O
(	O
n	O
=	O
1	O
,	O
41	O
##4	O
[	O
71	O
%	O
]	O
)	O
.	O
of	O
those	O
children	O
with	O
facial	B-T082
dog	B-T037
bite	I-T037
injuries	I-T037
,	O
230	O
(	O
16	O
%	O
)	O
suffered	B-T038
ophthalmic	B-T033
manifestations	I-T033
.	O
the	O
average	O
age	O
was	O
4	O
.	O
3	O
years	O
.	O
eyelid	B-T037
injuries	I-T037
occurred	O
in	O
227	O
(	O
99	O
%	O
)	O
of	O
children	O
,	O
47	O
(	O
20	O
%	O
)	O
sustained	O
canal	B-T022
##icular	I-T022
system	I-T022
injuries	B-T037
,	O
3	O
(	O
1	O
.	O
3	O
%	O
)	O
suffered	B-T038
corneal	B-T037
abr	I-T037
##asion	I-T037
##s	I-T037
,	O
and	O
2	O
patients	O
sustained	O
facial	B-T082
nerve	B-T037
injury	I-T037
resulting	O
in	O
lag	B-T038
##ophthalm	I-T038
##os	I-T038
.	O
no	O
patients	O
suffered	B-T038
vision	B-T033
loss	I-T033
.	O
complications	B-T038
occurred	O
in	O
32	O
patients	O
(	O
14	O
%	O
)	O
,	O
with	O
the	O
most	O
common	O
being	O
epiph	B-T204
##ora	I-T204
in	O
9	O
patients	O
(	O
28	O
%	O
)	O
,	O
upper	O
eyelid	O
ptosis	O
in	O
8	O
(	O
25	O
%	O
)	O
,	O
and	O
prominent	O
scar	O
formation	O
in	O
4	O
patients	O
(	O
13	O
%	O
)	O
.	O
thirteen	O
children	O
(	O
5	O
.	O
7	O
%	O
)	O
needed	O
one	O
or	O
more	O
secondary	B-T058
procedure	I-T058
to	O
correct	O
complications	B-T038
.	O
the	O
authors	B-T097
report	B-T170
the	O
clinical	O
features	O
and	O
management	O
on	O
the	O
largest	O
series	O
of	O
ophthalmic	B-T037
and	O
peri	B-T037
##ocular	I-T037
injuries	I-T037
associated	O
with	O
pediatric	O
facial	B-T082
dog	B-T037
bite	I-T037
s	I-T037
.	O
these	O
injuries	B-T037
occur	O
in	O
about	O
1	O
in	O
6	O
dog	B-T037
bite	I-T037
s	I-T037
to	O
the	O
face	B-T082
and	O
primarily	O
involve	O
the	O
ocular	B-T017
adnex	I-T017
##a	I-T017
.	O
despite	O
early	O
and	O
appropriate	O
surgical	B-T058
management	I-T058
,	O
complications	B-T038
and	O
the	O
need	O
for	O
revision	B-T058
surgery	I-T058
are	O
relatively	O
common	O
.	O

effects	O
of	O
soybean	B-T103
isoflav	I-T103
##one	I-T103
on	O
intestinal	B-T017
antioxidant	B-T038
capacity	I-T038
and	O
cytokines	B-T103
in	O
young	O
piglets	B-T204
fed	O
oxidized	B-T038
fish	B-T103
oil	I-T103
to	O
investigate	O
the	O
effect	O
of	O
glyc	B-T103
##ite	I-T103
##in	I-T103
,	O
a	O
synthetic	O
soybean	B-T103
isoflav	I-T103
##one	I-T103
(	O
is	B-T103
##f	I-T103
)	O
,	O
on	O
the	O
intestinal	B-T017
antioxidant	B-T038
capacity	I-T038
,	O
morphology	O
,	O
and	O
cytokine	B-T103
content	O
in	O
young	O
piglets	B-T204
fed	O
oxidized	B-T038
fish	B-T103
oil	I-T103
,	O
72	O
4	O
-	O
d	O
-	O
old	O
male	O
piglets	B-T204
were	O
assigned	O
to	O
three	O
treatments	B-T058
.	O
the	O
control	O
group	O
was	O
fed	O
a	O
basal	B-T168
diet	I-T168
containing	O
fresh	O
fish	B-T103
oil	I-T103
,	O
and	O
the	O
other	O
two	O
groups	O
received	O
the	O
same	O
diet	O
except	O
for	O
the	O
substitution	O
with	O
the	O
same	O
dosage	O
of	O
oxidized	B-T038
fish	B-T103
oil	I-T103
alone	O
or	O
with	O
is	B-T103
##f	I-T103
(	O
oxidized	B-T038
fish	B-T103
oil	I-T103
plus	O
is	B-T103
##f	I-T103
)	O
.	O
after	O
21	O
d	O
of	O
feeding	O
,	O
supplementation	B-T058
of	O
oxidized	B-T038
fish	B-T103
oil	I-T103
increased	O
the	O
levels	O
of	O
malondialdehyde	B-T103
(	O
mda	B-T103
)	O
,	O
oxidized	B-T103
glutathione	I-T103
(	O
gssg	B-T103
)	O
,	O
interleukin	B-T103
-	I-T103
1β	I-T103
(	O
il	B-T103
-	I-T103
1β	I-T103
)	O
,	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
-	I-T103
α	I-T103
(	O
tnf	B-T103
-	I-T103
α	I-T103
)	O
,	O
interleukin	B-T103
-	I-T103
2	I-T103
(	O
il	B-T103
-	I-T103
2	I-T103
)	O
,	O
nuclear	B-T103
factor	I-T103
κ	I-T103
b	I-T103
(	B-T103
nf	I-T103
-	I-T103
κb	I-T103
)	O
,	O
inducible	B-T103
nitric	I-T103
oxide	I-T103
synthase	I-T103
(	O
inos	B-T103
)	O
,	O
no	B-T103
,	O
and	O
caspase	B-T103
-	I-T103
3	I-T103
in	O
jejunal	B-T017
mucosa	I-T017
,	O
and	O
decreased	O
the	O
villous	B-T017
height	O
in	O
duodenum	B-T017
and	O
the	O
levels	O
of	O
secretory	B-T103
immunoglobulin	I-T103
a	I-T103
(	B-T103
sig	I-T103
##a	I-T103
)	O
and	O
il	B-T103
-	I-T103
4	I-T103
in	O
the	O
jejunal	B-T017
mucosa	I-T017
compared	O
with	O
supplementation	B-T058
with	O
fresh	O
oil	B-T103
.	O
the	O
addition	O
of	O
oxidized	B-T038
fish	B-T103
oil	I-T103
plus	O
is	B-T103
##f	I-T103
partially	O
alleviated	O
this	O
negative	O
effect	O
.	O
the	O
addition	O
of	O
oxidized	B-T038
fish	B-T103
oil	I-T103
plus	O
is	B-T103
##f	I-T103
increased	O
the	O
villous	B-T017
height	O
and	O
levels	O
of	O
sig	B-T103
##a	I-T103
and	O
il	B-T103
-	I-T103
4	I-T103
in	O
jejunal	B-T017
mucosa	I-T017
,	O
but	O
decreased	O
the	O
levels	O
of	O
il	B-T103
-	I-T103
1β	I-T103
and	O
il	B-T103
-	I-T103
2	I-T103
in	O
jejunal	B-T017
mucosa	I-T017
(	O
p	O
<	O
0	O
.	O
05	O
)	O
compared	O
with	O
oxidized	B-T038
fish	B-T103
oil	I-T103
.	O
collectively	O
,	O
these	O
results	O
show	O
that	O
dietary	B-T058
supplementation	I-T058
of	O
is	B-T103
##f	I-T103
could	O
partly	O
alleviate	O
the	O
negative	O
effect	O
of	O
oxidized	B-T038
fish	B-T103
oil	I-T103
by	O
improving	O
the	O
intestinal	B-T017
morphology	I-T017
as	O
well	O
as	O
the	O
antioxidant	B-T038
capacity	I-T038
and	O
immune	B-T038
function	I-T038
in	O
young	O
piglets	B-T204
.	O

application	B-T058
of	O
laparoscopic	B-T058
lumbar	B-T058
disc	I-T058
##ectomy	I-T058
and	O
artificial	B-T058
disc	I-T058
replacement	I-T058
:	O
at	O
least	O
two	O
years	O
of	O
follow	B-T058
-	I-T058
up	I-T058
this	O
prospective	B-T062
observational	B-T062
study	I-T062
included	O
22	O
patients	O
who	O
were	O
diagnosed	B-T033
with	O
symptomatic	O
degenerative	B-T038
disc	I-T038
disease	I-T038
treated	O
via	O
artificial	B-T058
disc	I-T058
replacement	I-T058
(	O
adr	B-T058
)	O
with	O
a	O
laparoscopic	B-T058
technique	O
.	O
the	O
current	O
study	B-T062
aimed	O
to	O
assess	O
the	O
safety	O
and	O
efficacy	O
of	O
adr	B-T058
using	O
a	O
laparoscopic	B-T058
technique	O
for	O
lumbar	B-T017
disc	I-T017
herniation	I-T017
.	O
symptomatic	O
degenerative	B-T038
disc	I-T038
disease	I-T038
is	O
the	O
major	O
cause	O
of	O
low	B-T033
back	I-T033
pain	I-T033
with	O
lumbar	B-T082
segmental	B-T082
instability	B-T033
.	O
adr	B-T058
has	O
increased	O
in	O
popularity	O
as	O
an	O
alternative	O
treatment	O
for	O
lumbar	B-T017
disc	I-T017
herniation	I-T017
.	O
however	O
,	O
the	O
traditional	O
approach	B-T082
to	O
spinal	B-T058
surgery	I-T058
carries	O
the	O
risk	O
of	O
catastrophic	B-T038
bleeding	B-T038
from	O
injury	B-T037
to	O
major	O
vessels	B-T017
,	O
as	O
well	O
as	O
iatrogenic	O
injury	B-T037
to	O
the	O
viscer	B-T017
##a	I-T017
and	O
associated	B-T017
structures	I-T017
.	O
therefore	O
,	O
laparoscopic	B-T058
lumbar	B-T058
disc	I-T058
##ectomy	I-T058
and	O
adr	B-T058
may	O
represent	O
a	O
useful	O
alternative	O
.	O
twenty	O
-	O
two	O
patients	O
(	O
8	O
males	O
and	O
14	O
females	O
)	O
who	O
were	O
diagnosed	B-T033
with	O
symptomatic	O
degenerative	B-T038
disc	I-T038
disease	I-T038
were	O
included	O
in	O
this	O
study	B-T062
.	O
seven	O
cases	O
involved	O
the	O
l4	O
/	O
5	O
level	O
,	O
and	O
15	O
cases	O
involved	O
the	O
l5	O
/	O
s1	O
level	O
.	O
all	O
patients	O
were	O
ineffective	O
after	O
at	O
least	O
6	O
months	O
of	O
conservative	B-T058
treatments	I-T058
;	O
all	O
patients	O
were	O
informed	O
of	O
the	O
surgery	B-T058
before	O
the	O
operation	B-T058
and	O
provided	O
consent	O
.	O
three	B-T082
-	I-T082
dimensional	I-T082
computed	B-T058
tomographic	I-T058
angiography	I-T058
(	O
3d	B-T082
-	O
cta	B-T058
)	O
of	O
the	O
iliac	B-T017
great	O
blood	B-T017
vessels	I-T017
was	O
completed	O
before	O
the	O
surgery	B-T058
.	O
all	O
surgical	B-T058
procedures	I-T058
were	O
performed	O
under	O
a	O
lapa	B-T074
##roscope	I-T074
.	O
all	O
patients	O
were	O
followed	B-T058
up	I-T058
.	O
all	O
surgeries	B-T058
were	O
successfully	O
completed	O
.	O
the	O
average	O
operation	B-T058
time	O
was	O
120	O
minutes	O
(	O
range	O
110	O
-	O
150	O
min	O
)	O
,	O
and	O
the	O
average	O
hemorrhage	B-T038
was	O
145	O
ml	O
(	O
range	O
80	O
-	O
360	O
ml	O
)	O
.	O
all	O
cases	O
underwent	O
x	B-T058
-	I-T058
rays	I-T058
at	O
3	O
days	O
,	O
3	O
months	O
,	O
6	O
months	O
,	O
1	O
year	O
,	O
and	O
the	O
final	O
postoperative	B-T058
follow	B-T058
-	I-T058
up	I-T058
.	O
the	O
outcome	O
indicated	O
that	O
there	O
was	O
no	O
mobilization	O
,	O
displacement	O
,	O
or	O
subsid	O
##ence	O
in	O
all	O
patients	O
with	O
the	O
exception	O
of	O
one	O
case	O
with	O
prosthesis	O
migration	O
.	O
the	O
follow	B-T058
-	I-T058
up	I-T058
time	O
was	O
43	O
.	O
8	O
months	O
(	O
range	O
24	O
-	O
64	O
months	O
)	O
.	O
the	O
mean	O
visual	B-T201
analog	I-T201
scale	I-T201
(	O
vas	B-T201
)	O
and	O
os	B-T033
##west	I-T033
##ry	I-T033
scores	I-T033
were	O
decreased	O
postoperatively	O
.	O
the	O
mean	O
improvement	O
rate	O
of	O
the	O
vas	B-T201
score	I-T201
was	O
73	O
.	O
5	O
%	O
.	O
lumbar	B-T082
adr	B-T058
using	O
a	O
lapa	B-T074
##roscope	I-T074
represents	O
a	O
novel	O
,	O
minimally	O
invasive	O
treatment	O
for	O
symptomatic	O
degenerative	B-T038
disc	I-T038
disease	I-T038
and	O
severe	O
lumbar	B-T038
disc	I-T038
##ogenic	I-T038
pain	I-T038
.	O

calibration	O
of	O
self	B-T062
-	I-T062
report	I-T062
measures	O
of	O
physical	O
activity	O
and	O
sedentary	O
behavior	O
calibration	O
equations	O
offer	O
potential	O
to	O
improve	O
the	O
accuracy	O
and	O
utility	O
of	O
self	B-T062
-	I-T062
report	I-T062
measures	O
of	O
physical	O
activity	O
(	O
pa	O
)	O
and	O
sedentary	O
behavior	O
(	O
sb	O
)	O
by	O
re	O
-	O
scaling	O
potentially	O
biased	O
estimates	O
.	O
the	O
present	O
study	O
evaluates	O
calibration	O
models	B-T170
designed	O
to	O
estimate	O
pa	O
and	O
sb	O
in	O
a	O
representative	O
sample	O
of	O
adults	O
from	O
the	O
physical	O
activity	O
measurement	B-T062
survey	I-T062
(	O
pam	B-T062
##s	I-T062
)	O
.	O
participants	B-T098
in	O
the	O
pam	B-T062
##s	I-T062
project	O
completed	O
replicate	O
single	O
day	O
trials	O
that	O
involved	O
wearing	O
a	O
sense	O
##we	O
##ar	O
arm	O
##band	O
(	O
sw	O
##a	O
)	O
monitor	B-T074
for	O
24	O
hours	O
followed	O
by	O
a	O
telephone	B-T062
administered	O
24	O
-	O
hour	O
physical	O
activity	O
recall	O
(	O
par	O
)	O
.	O
comprehensive	O
statistical	B-T170
model	I-T170
selection	O
and	O
validation	O
procedures	O
were	O
used	O
to	O
develop	O
and	O
test	O
separate	O
calibration	O
models	B-T170
designed	O
to	O
predict	O
objectively	O
-	O
measured	O
sb	O
and	O
moderate	O
to	O
vigorous	O
pa	O
(	O
mvpa	O
from	O
self	B-T062
-	I-T062
reported	I-T062
par	O
data	O
.	O
equivalence	O
testing	O
was	O
used	O
to	O
evaluate	O
the	O
equivalence	O
of	O
the	O
model	O
-	O
predicted	O
values	O
with	O
the	O
objective	O
measures	O
in	O
a	O
separate	O
hold	O
##out	O
sample	O
.	O
the	O
final	O
prediction	O
model	O
for	O
both	O
sb	O
and	O
mvpa	O
included	O
reported	O
time	O
spent	O
in	O
sb	O
and	O
mvpa	O
,	O
as	O
well	O
as	O
terms	O
capturing	O
sex	O
,	O
age	O
,	O
education	B-T033
,	O
and	O
bmi	B-T201
.	O
cross	B-T062
-	I-T062
validation	I-T062
analyses	O
on	O
an	O
independent	O
sample	O
exhibited	O
high	O
correlations	O
with	O
observed	O
sb	O
(	O
r	O
=	O
0	O
.	O
72	O
)	O
and	O
mvpa	O
(	O
r	O
=	O
0	O
.	O
75	O
)	O
.	O
equivalence	O
testing	O
demonstrated	O
that	O
the	O
model	O
-	O
predicted	O
values	O
were	O
statistically	O
equivalent	O
to	O
the	O
corresponding	O
objective	O
values	O
for	O
both	O
sb	O
and	O
mvpa	O
.	O
the	O
results	O
demonstrate	O
that	O
simple	O
regression	B-T170
models	B-T170
can	O
be	O
used	O
to	O
statistically	O
adjust	O
for	O
over	O
or	O
underestimation	O
in	O
self	B-T062
-	I-T062
report	I-T062
measures	O
among	O
different	O
segments	O
of	O
the	O
population	B-T098
.	O
the	O
models	B-T170
produced	O
group	O
estimates	O
from	O
the	O
par	O
that	O
were	O
statistically	O
equivalent	O
to	O
the	O
observed	O
time	O
spent	O
in	O
sb	O
and	O
mvpa	O
obtained	O
from	O
the	O
objective	O
sw	O
##a	O
monitor	B-T074
;	O
however	O
additional	O
work	O
is	O
needed	O
to	O
correct	O
for	O
estimates	O
of	O
individual	O
behavior	O
.	O

direct	O
repair	B-T058
of	O
lumbar	B-T017
pars	I-T017
inter	I-T017
##articular	I-T017
##is	I-T017
defects	O
by	O
utilizing	O
intraoperative	O
o	O
-	O
arm	O
-	O
based	O
navigation	O
and	O
micro	B-T058
##end	I-T058
##oscopic	I-T058
techniques	I-T058
a	O
retrospective	B-T062
analysis	I-T062
of	O
the	O
clinical	B-T033
outcomes	I-T033
of	O
eight	O
patients	O
with	O
the	O
lumbar	B-T017
pars	I-T017
inter	I-T017
##articular	I-T017
##s	I-T017
defects	O
treated	B-T033
by	O
direct	O
repair	B-T058
with	O
the	O
aid	O
of	O
intraoperative	O
o	O
-	O
arm	O
based	O
navigation	O
and	O
micro	B-T058
##end	I-T058
##oscopic	I-T058
techniques	I-T058
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
the	O
efficacy	O
and	O
safety	O
of	O
direct	O
screw	B-T074
repair	B-T058
by	O
using	O
minimally	B-T058
invasive	I-T058
surgery	I-T058
for	O
the	O
lumbar	B-T017
pars	I-T017
inter	I-T017
##articular	I-T017
##s	I-T017
defects	O
in	O
a	O
pilot	B-T062
study	I-T062
.	O
direct	O
repair	B-T058
of	O
pars	B-T017
inter	I-T017
##articular	I-T017
##s	I-T017
defects	O
has	O
been	O
used	O
to	O
treat	B-T058
young	O
adult	O
patients	O
.	O
reports	B-T170
concerning	O
direct	O
repair	B-T058
by	O
minimally	B-T058
invasive	I-T058
techniques	I-T058
for	O
pars	B-T017
inter	I-T017
##articular	I-T017
##s	I-T017
defects	O
are	O
quite	O
rare	O
.	O
review	O
of	O
medical	B-T170
records	I-T170
identified	O
eight	O
consecutive	O
patients	O
treated	B-T033
with	O
intraoperative	O
o	O
-	O
arm	O
based	O
navigation	O
and	O
micro	B-T058
##end	I-T058
##oscopic	I-T058
techniques	I-T058
.	O
debridement	B-T058
and	O
autograft	B-T058
of	O
pars	B-T017
inter	I-T017
##articular	I-T017
##is	I-T017
defects	O
was	O
performed	O
under	O
micro	B-T058
##end	I-T058
##oscopic	I-T058
procedure	I-T058
.	O
then	O
,	O
percutaneous	B-T082
bilateral	B-T082
intral	B-T082
##amin	I-T082
##ar	I-T082
screws	B-T074
were	O
inserted	B-T058
by	O
utilizing	O
intraoperative	O
navigation	O
.	O
the	O
clinical	B-T170
and	O
radiological	B-T091
data	O
were	O
collected	O
and	O
analyzed	B-T062
retrospectively	O
.	O
eight	O
patients	O
had	O
a	O
mean	O
age	O
of	O
28	O
.	O
4	O
years	O
,	O
and	O
five	O
were	O
30	O
years	O
or	O
younger	O
at	O
the	O
time	O
of	O
treatment	B-T058
.	O
symptoms	B-T033
included	O
axial	B-T082
back	B-T033
pain	I-T033
in	O
100	O
%	O
of	O
patients	O
without	O
concomitant	O
radi	B-T038
##cu	I-T038
##lo	I-T038
##path	I-T038
##y	I-T038
.	O
autograft	B-T058
was	O
used	O
in	O
all	O
cases	O
.	O
the	O
average	O
follow	B-T058
-	I-T058
up	I-T058
duration	O
was	O
27	O
.	O
4	O
months	O
with	O
a	O
range	O
of	O
20	O
to	O
33	O
months	O
.	O
symptoms	B-T033
resolved	B-T033
completely	O
or	O
partially	O
in	O
all	O
patients	O
.	O
low	B-T033
back	I-T033
pain	I-T033
visual	B-T201
analog	I-T201
scores	I-T201
decrease	O
from	O
preoperative	O
6	O
.	O
8	O
to	O
postoperative	O
1	O
.	O
4	O
of	O
eight	O
cases	O
.	O
of	O
16	O
pars	B-T017
defects	O
,	O
healing	B-T038
was	O
observed	O
in	O
13	O
(	O
81	O
.	O
3	O
%	O
)	O
at	O
last	O
radiological	B-T091
follow	B-T058
-	I-T058
up	I-T058
.	O
one	O
patient	O
with	O
bilateral	B-T017
fusion	I-T017
failure	I-T017
refused	O
revision	B-T058
surgery	I-T058
because	O
of	O
mild	B-T033
complaint	I-T033
.	O
no	B-T033
complications	I-T033
such	O
as	O
dural	B-T037
tear	I-T037
,	O
nerve	B-T037
root	I-T037
injury	I-T037
,	O
and	O
infection	B-T038
occurred	O
.	O
minimally	B-T058
invasive	I-T058
direct	O
repair	B-T058
of	O
the	O
pars	B-T017
inter	I-T017
##articular	I-T017
##is	I-T017
defects	O
with	O
intral	B-T082
##amin	I-T082
##ar	I-T082
screws	B-T074
by	O
using	O
micro	B-T058
##end	I-T058
##oscopic	I-T058
system	I-T058
and	O
navigation	O
procedure	O
can	O
provide	O
safe	O
and	O
effective	O
treatment	B-T058
of	O
spondyl	B-T038
##olysis	I-T038
with	O
satisfactory	O
clinical	O
and	O
radiological	B-T091
outcomes	O
,	O
which	O
need	O
some	O
special	B-T074
tools	I-T074
with	O
steep	O
learning	B-T038
curve	I-T038
.	O
4	O
.	O

it	O
'	O
s	O
not	O
all	O
do	O
##om	O
and	O
gl	O
##oo	O
##m	O
:	O
prun	B-T038
##e	I-T038
bell	I-T038
##y	I-T038
syndrome	I-T038
associated	B-T017
with	I-T017
vac	I-T017
##ter	I-T017
##l	I-T017
prun	B-T038
##e	I-T038
bell	I-T038
##y	I-T038
syndrome	I-T038
is	O
a	O
rare	O
abnormality	B-T033
;	O
its	O
association	B-T017
with	I-T017
vac	I-T017
##ter	I-T017
##l	I-T017
is	O
even	O
rare	O
##r	O
.	O
this	O
association	B-T017
has	O
been	O
reported	B-T058
in	O
literature	B-T170
a	O
few	O
times	O
since	O
first	O
reported	B-T058
in	O
1993	O
and	O
so	O
far	O
the	O
majority	O
have	O
either	O
been	O
stillbirth	B-T033
##s	I-T033
or	I-T033
died	I-T033
shortly	I-T033
after	I-T033
birth	I-T033
.	O
we	O
present	O
a	O
case	O
of	O
prun	B-T038
##e	I-T038
bell	I-T038
##y	I-T038
syndrome	I-T038
associated	B-T017
with	I-T017
vac	I-T017
##ter	I-T017
##l	I-T017
who	O
is	O
now	O
one	O
year	O
old	O
.	O

prognostic	B-T201
significance	I-T201
of	O
non	O
-	O
hpv16	O
genotypes	O
in	O
oropharyngeal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
recent	O
studies	O
have	O
found	O
that	O
cases	O
with	O
oropharyngeal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
ops	B-T038
##cc	I-T038
)	O
positive	B-T033
for	O
hpv16	B-T103
genotype	I-T103
have	O
better	O
overall	O
survival	O
compared	O
with	O
cases	O
positive	O
for	O
other	O
hpv	O
genotypes	O
.	O
we	O
sought	O
to	O
further	O
replicate	O
these	O
studies	O
and	O
determine	O
if	O
this	O
relationship	O
is	O
modified	O
by	O
expression	B-T038
of	O
p16	B-T103
tumor	I-T103
suppressor	I-T103
protein	I-T103
.	O
we	O
identified	O
238	O
ops	B-T038
##cc	I-T038
cases	O
from	O
the	O
carolina	B-T062
head	I-T062
and	I-T062
neck	I-T062
cancer	I-T062
study	I-T062
(	O
chance	B-T062
)	O
study	O
,	O
a	O
population	B-T062
based	I-T062
case	I-T062
-	I-T062
control	I-T062
study	I-T062
.	O
tumors	B-T038
that	O
tested	O
positive	B-T033
solely	I-T033
for	O
hpv16	B-T103
genotype	I-T103
and	O
no	O
other	O
genotypes	O
with	O
pcr	B-T062
were	O
classified	B-T170
as	O
hpv16	B-T033
-	I-T033
positive	I-T033
.	O
tumors	B-T038
positive	B-T033
for	I-T033
any	O
other	O
high	B-T033
-	I-T033
risk	I-T033
hpv	B-T103
genotype	I-T103
were	O
classified	B-T170
as	O
non	B-T033
-	I-T033
hpv16	I-T033
-	I-T033
positive	I-T033
.	O
expression	B-T038
of	O
p16	B-T103
in	O
the	O
tumor	B-T038
was	O
determined	O
with	O
immunohistochemistry	B-T058
.	O
follow	O
-	O
up	O
time	O
was	O
calculated	O
from	O
the	O
date	O
of	O
diagnosis	O
to	O
date	O
of	O
death	O
or	O
december	O
31	O
,	O
2013	O
.	O
overall	O
survival	O
was	O
compared	O
with	O
the	O
kaplan	O
-	O
meier	O
curves	O
and	O
log	O
-	O
rank	O
test	O
.	O
hazard	O
ratios	O
(	O
hr	O
)	O
adjusted	O
for	O
smoking	O
,	O
alcohol	O
use	O
,	O
sex	O
,	O
race	B-T098
,	O
and	O
age	O
was	O
calculated	O
with	O
the	O
cox	B-T170
proportional	I-T170
hazard	I-T170
regression	I-T170
.	O
cases	O
with	O
hpv16	B-T033
-	I-T033
positive	I-T033
ops	B-T038
##cc	I-T038
had	O
better	O
overall	O
survival	O
than	O
cases	O
with	O
non	B-T033
-	I-T033
hpv16	I-T033
-	I-T033
positive	I-T033
ops	B-T038
##cc	I-T038
(	O
log	O
-	O
rank	O
p	O
-	O
value	O
:	O
0	O
.	O
010	O
)	O
.	O
when	O
restricted	O
to	O
ops	B-T038
##cc	I-T038
cases	O
positive	B-T033
for	O
p16	B-T038
expression	I-T038
,	O
the	O
same	O
trend	O
continued	O
(	O
log	O
-	O
rank	O
p	O
-	O
value	O
:	O
0	O
.	O
002	O
)	O
.	O
in	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non	B-T033
-	I-T033
hpv16	I-T033
-	I-T033
positive	I-T033
ops	B-T038
##cc	I-T038
had	O
greater	B-T033
risk	I-T033
of	I-T033
death	B-T033
compared	O
to	O
cases	O
with	O
hpv16	B-T033
-	I-T033
positive	I-T033
tumors	B-T038
(	O
hr	O
:	O
1	O
.	O
92	O
;	O
95	O
%	O
ci	O
:	O
1	O
.	O
03	O
,	O
3	O
.	O
60	O
)	O
.	O
this	O
finding	B-T033
indicates	B-T033
that	O
hpv	B-T005
genotyping	O
carries	O
valuable	B-T201
prognostic	I-T201
significance	I-T201
in	O
addition	O
to	O
p16	B-T103
status	O
and	O
future	O
survival	O
studies	O
of	O
ops	B-T038
##cc	I-T038
should	O
take	O
into	O
account	O
differing	O
hpv	O
genotypes	O
.	O

increased	O
risk	O
of	O
pt	B-T038
##ld	I-T038
in	O
lung	B-T033
transplant	I-T033
recipients	I-T033
with	O
cystic	B-T038
fibrosis	I-T038
post	B-T038
-	I-T038
transplant	I-T038
lymphoproliferative	I-T038
disease	I-T038
(	O
pt	B-T038
##ld	I-T038
)	O
is	O
an	O
important	O
cause	O
of	O
morbidity	O
and	O
mortality	O
following	O
lung	B-T058
transplantation	I-T058
.	O
recipients	O
with	O
cystic	B-T038
fibrosis	I-T038
(	O
cf	B-T038
)	O
may	O
have	O
an	O
increased	O
risk	O
of	O
pt	B-T038
##ld	I-T038
although	O
the	O
literature	B-T170
is	O
limited	O
to	O
single	B-T098
center	I-T098
cohorts	I-T098
.	O
our	O
primary	O
aim	O
is	O
to	O
examine	O
pt	B-T038
##ld	I-T038
in	O
an	O
adult	O
lung	B-T058
transplant	I-T058
population	B-T098
by	O
utilizing	O
the	O
international	B-T170
society	I-T170
for	I-T170
heart	I-T170
and	I-T170
lung	I-T170
transplantation	I-T170
registry	I-T170
.	O
we	O
studied	B-T062
30	O
,	O
59	O
##8	O
adult	O
recipients	B-T098
of	O
lung	B-T058
transplants	I-T058
performed	O
between	O
1999	O
and	O
2011	O
.	O
the	O
primary	O
outcome	O
was	O
development	O
of	O
and	O
time	O
to	O
pt	B-T038
##ld	I-T038
.	O
in	O
addition	O
to	O
indication	O
for	O
transplant	B-T058
,	O
other	O
predictors	O
examined	O
included	O
epstein	B-T005
-	I-T005
barr	I-T005
virus	I-T005
(	O
ebv	B-T005
)	O
and	O
cytomegalovirus	B-T005
(	O
cmv	B-T005
)	O
sero	B-T201
##st	I-T201
##atus	I-T201
,	O
gender	O
,	O
and	O
age	O
.	O
outcomes	O
were	O
assessed	O
with	O
univ	O
##ariable	O
and	O
multivariable	B-T170
cox	I-T170
proportional	I-T170
hazard	I-T170
models	I-T170
to	O
obtain	O
hazard	O
ratios	O
(	O
hr	O
)	O
.	O
17	O
%	O
of	O
the	O
cohort	B-T098
had	O
a	O
diagnosis	B-T033
of	O
cf	B-T038
.	O
pt	B-T038
##ld	I-T038
developed	O
in	O
2	O
%	O
of	O
cf	B-T038
recipients	O
compared	O
to	O
1	O
%	O
for	O
non	B-T033
-	I-T033
cf	I-T033
recipients	I-T033
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
compared	O
to	O
non	B-T033
-	I-T033
cf	I-T033
recipients	I-T033
,	O
cf	B-T038
recipients	O
had	O
higher	O
prevalence	O
of	O
ebv	B-T005
and	O
cmv	B-T033
sero	I-T033
##ne	I-T033
##ga	I-T033
##tivity	I-T033
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
ebv	B-T005
and	O
cmv	B-T005
mismatch	O
(	O
d	O
+	O
/	O
r	O
-	O
)	O
.	O
there	O
is	O
a	O
significant	O
association	O
between	O
cf	B-T038
and	O
the	O
development	O
of	O
pt	B-T038
##ld	I-T038
[	O
hr	O
1	O
.	O
66	O
(	O
95	O
%	O
ci	O
1	O
.	O
30	O
-	O
2	O
.	O
12	O
)	O
]	O
.	O
stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
ebv	B-T005
negative	B-T033
non	B-T033
-	I-T033
cf	I-T033
recipients	I-T033
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
pt	B-T038
##ld	I-T038
,	O
whereas	O
ebv	B-T005
negative	O
cf	B-T038
recipients	O
had	O
an	O
almost	O
6	O
.	O
5	O
fold	O
increased	O
risk	O
.	O
cf	B-T038
recipients	O
have	O
a	O
higher	O
risk	O
for	O
pt	B-T038
##ld	I-T038
compared	O
to	O
non	B-T033
-	I-T033
cf	I-T033
recipients	I-T033
.	O
further	O
studies	B-T062
are	O
needed	O
to	O
account	O
for	O
additional	O
risk	B-T033
factors	I-T033
and	O
management	B-T058
in	O
this	O
population	B-T033
post	I-T033
-	I-T033
transplant	I-T033
.	O

optimizing	O
survival	O
of	O
patients	O
with	O
marginally	O
oper	O
##able	O
stage	B-T038
iiia	I-T038
non	I-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
receiving	O
chemoradiotherapy	B-T058
with	O
or	O
without	O
surgery	O
for	O
marginally	O
oper	O
##able	O
stage	B-T038
iiia	I-T038
non	I-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
(	O
nsclc	B-T038
)	O
,	O
surgery	O
might	O
not	O
be	O
done	O
as	O
planned	O
after	O
neoadjuvant	B-T058
concurrent	B-T058
chemoradiotherapy	I-T058
(	O
ccr	B-T058
##t	I-T058
)	O
for	O
reasons	O
(	O
unresectable	B-T201
or	O
medically	O
inoperable	O
conditions	O
,	O
or	O
patient	O
refusal	O
)	O
.	O
this	O
study	B-T062
aims	O
to	O
investigate	O
the	O
outcomes	O
of	O
a	O
phase	B-T058
##d	I-T058
ccr	I-T058
##t	I-T058
protocol	I-T058
established	O
to	O
maximize	O
the	O
oper	O
##ability	O
of	O
marginally	O
oper	O
##able	O
stage	B-T038
iiia	I-T038
nsclc	I-T038
and	O
to	O
care	O
for	O
reassess	O
##ed	O
inoperable	O
patients	O
,	O
in	O
comparison	O
with	O
continuous	B-T058
-	I-T058
course	I-T058
definitive	I-T058
ccr	I-T058
##t	I-T058
.	O
forty	O
-	O
seven	O
patients	O
with	O
marginally	O
oper	O
##able	O
stage	B-T038
iiia	I-T038
nsclc	I-T038
receiving	O
ccr	B-T058
##t	I-T058
were	O
included	O
.	O
twenty	O
-	O
eight	O
patients	O
were	O
treated	O
with	O
our	O
phase	B-T058
##d	I-T058
ccr	I-T058
##t	I-T058
protocol	I-T058
,	O
including	O
neoadjuvant	B-T058
ccr	B-T058
##t	I-T058
followed	O
by	O
surgery	O
(	O
group	O
a	O
,	O
n	O
=	O
16	O
)	O
or	O
,	O
for	O
reassess	O
##ed	O
inoperable	O
patients	O
,	O
maintenance	B-T033
chemotherapy	I-T033
and	O
split	B-T058
-	I-T058
course	I-T058
ccr	I-T058
##t	I-T058
boost	O
(	O
group	O
b	O
,	O
n	O
=	O
12	O
)	O
.	O
the	O
other	O
19	O
were	O
treated	O
with	O
continuous	B-T058
-	I-T058
course	I-T058
definitive	I-T058
ccr	I-T058
##t	I-T058
(	O
group	O
c	O
)	O
.	O
overall	O
survival	O
(	O
os	O
)	O
and	O
progression	O
-	O
free	O
survival	O
(	O
pfs	O
)	O
were	O
analyzed	B-T062
.	O
among	O
all	O
,	O
median	O
os	O
and	O
pfs	O
were	O
35	O
.	O
6	O
and	O
12	O
.	O
8	O
months	O
,	O
respectively	O
(	O
median	O
follow	B-T058
-	I-T058
up	I-T058
,	O
22	O
.	O
3	O
months	O
)	O
.	O
the	O
median	O
os	O
of	O
group	O
a	O
(	O
not	O
reached	O
)	O
was	O
better	O
than	O
that	O
of	O
group	O
b	O
(	O
34	O
.	O
4	O
months	O
)	O
and	O
group	O
c	O
(	O
15	O
.	O
2	O
months	O
)	O
(	O
p	O
=	O
.	O
009	O
)	O
.	O
on	O
multivariate	O
analysis	O
,	O
performance	B-T201
status	I-T201
0	O
to	O
1	O
(	O
hazard	O
ratio	O
[	O
hr	O
]	O
,	O
0	O
.	O
026	O
;	O
p	O
<	O
.	O
001	O
)	O
,	O
adenocarcinoma	B-T038
(	O
hr	O
,	O
0	O
.	O
156	O
;	O
p	O
=	O
.	O
003	O
)	O
,	O
and	O
group	O
a	O
(	O
hr	O
,	O
0	O
.	O
199	O
;	O
p	O
=	O
.	O
033	O
)	O
were	O
independent	B-T201
prognostic	I-T201
factors	I-T201
.	O
the	O
os	O
of	O
group	O
b	O
(	O
hr	O
,	O
0	O
.	O
450	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
118	O
-	O
1	O
.	O
71	O
##7	O
;	O
p	O
=	O
.	O
243	O
)	O
was	O
not	O
statistically	O
different	O
from	O
that	O
of	O
group	O
c	O
.	O
for	O
marginally	O
oper	O
##able	O
stage	B-T038
iiia	I-T038
nsclc	I-T038
,	O
our	O
phase	B-T058
##d	I-T058
ccr	I-T058
##t	I-T058
strategy	I-T058
may	O
optimize	O
survival	O
by	O
maximizing	O
oper	O
##ability	O
and	O
maintain	O
an	O
acceptable	O
survival	O
for	O
reassess	O
##ed	O
inoperable	O
patients	O
by	O
split	B-T058
-	I-T058
course	I-T058
ccr	I-T058
##t	I-T058
boost	O
following	O
maintenance	B-T033
chemotherapy	I-T033
.	O

simulating	B-T062
the	O
potential	O
role	O
of	O
media	O
coverage	O
and	O
infected	B-T033
bats	B-T204
in	O
the	O
2014	O
ebola	B-T038
outbreak	O
multiple	O
epidemiological	O
models	O
have	O
been	O
developed	O
to	O
model	O
the	O
transmission	O
dynamics	O
of	O
ebola	B-T038
virus	I-T038
(	I-T038
eb	I-T038
##ov	I-T038
)	I-T038
disease	I-T038
in	O
west	B-T082
africa	I-T082
in	O
2014	O
because	O
the	O
severity	O
of	O
the	O
epidemic	O
is	O
commonly	O
overestimated	O
.	O
a	O
compartmental	B-T170
model	I-T170
that	O
incorporates	O
the	O
media	O
impact	O
and	O
the	O
effect	O
of	O
infected	B-T033
bats	B-T204
was	O
constructed	O
and	O
calibrated	O
using	O
data	O
reported	O
until	O
the	O
end	O
of	O
2014	O
.	O
the	O
final	O
cumulative	O
number	O
of	O
deaths	O
and	O
confirmed	B-T033
cases	O
were	O
estimated	O
to	O
be	O
1	O
.	O
09	O
##21	O
##×10	O
(	O
4	O
)	O
(	O
95	O
%	O
ci	O
9	O
.	O
77	O
##06	O
##×10	O
(	O
3	O
)	O
-	O
1	O
.	O
207	O
##2	O
##×10	O
(	O
4	O
)	O
)	O
and	O
1	O
.	O
51	O
##93	O
##×10	O
(	O
4	O
)	O
(	O
95	O
%	O
ci	O
1	O
.	O
35	O
##93	O
##×10	O
(	O
4	O
)	O
-	O
1	O
.	O
67	O
##95	O
##×10	O
(	O
4	O
)	O
)	O
,	O
respectively	O
.	O
the	O
epidemic	O
was	O
estimated	O
to	O
end	O
on	O
june	O
2015	O
,	O
which	O
was	O
similar	O
to	O
the	O
data	O
reported	B-T058
by	O
the	O
world	B-T092
health	I-T092
organization	I-T092
.	O
a	O
sensitivity	B-T062
analysis	I-T062
indicated	B-T033
that	O
an	O
increase	O
of	O
either	O
the	O
media	O
impact	O
or	O
the	O
number	O
of	O
infectious	O
bats	B-T204
that	O
are	O
captured	O
daily	O
can	O
increase	O
the	O
cumulative	O
number	O
of	O
confirmed	B-T033
cases	O
/	O
deaths	O
.	O
of	O
the	O
considered	O
epidemiological	O
parameters	O
,	O
only	O
the	O
media	O
coverage	O
can	O
significantly	O
reduce	O
both	O
the	O
peak	B-T033
time	I-T033
and	O
the	O
value	O
of	O
the	O
cumulative	O
confirmed	B-T033
cases	O
/	O
deaths	O
.	O
thus	O
,	O
we	O
propose	O
'	O
the	O
cumulative	O
confirmed	B-T033
cases	O
and	O
deaths	O
'	O
as	O
another	O
media	B-T170
mechanism	O
.	O
in	O
conclusion	O
,	O
the	O
media	O
impact	O
contributed	O
to	O
the	O
control	O
of	O
the	O
2014	O
ebola	B-T038
outbreak	O
,	O
and	O
infectious	O
bats	B-T204
may	O
be	O
a	O
potential	O
source	B-T033
of	O
the	O
epidemic	O
.	O

influence	O
of	O
ozone	B-T103
and	O
parac	B-T103
##etic	I-T103
acid	I-T103
disinfection	B-T058
on	O
adhesion	O
of	O
resili	B-T103
##ent	I-T103
line	I-T103
##rs	I-T103
to	O
acrylic	B-T103
resin	I-T103
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
parac	B-T103
##etic	I-T103
acid	I-T103
(	O
paa	B-T103
)	O
and	O
ozone	B-T103
disinfection	B-T058
on	O
the	O
tensile	O
bond	O
strength	O
(	O
tbs	O
)	O
of	O
silicone	B-T103
-	I-T103
based	I-T103
resili	B-T103
##ent	I-T103
line	I-T103
##rs	I-T103
to	O
acrylic	B-T103
resins	I-T103
.	O
one	O
hundred	O
and	O
twenty	O
dum	B-T082
##bb	I-T082
##ell	I-T082
shaped	I-T082
heat	O
-	O
polymerized	O
acrylic	B-T103
resins	I-T103
were	O
prepared	O
.	O
from	O
the	O
mid	O
segment	O
of	O
the	O
specimens	O
,	O
3	O
mm	O
of	O
acrylic	B-T103
were	O
gr	O
##ind	O
##ed	O
off	O
and	O
separated	O
parts	O
were	O
re	O
##att	O
##ached	O
by	O
resili	B-T103
##ent	I-T103
line	I-T103
##rs	I-T103
.	O
the	O
specimens	O
were	O
divided	O
into	O
2	O
control	O
(	O
control	O
##1	O
,	O
control	O
##7	O
)	O
and	O
4	O
test	O
groups	O
of	O
paa	B-T103
and	O
ozone	B-T103
disinfection	B-T058
(	O
paa	B-T103
##1	I-T103
,	O
paa	B-T103
##7	I-T103
,	O
ozone	B-T103
##1	I-T103
and	O
ozone	B-T103
##7	I-T103
;	O
n	O
=	O
10	O
)	O
.	O
while	O
control	O
groups	O
were	O
immersed	O
in	O
distilled	B-T103
water	I-T103
for	O
10	O
min	O
(	O
control	O
##1	O
)	O
and	O
7	O
days	O
(	O
control	O
##7	O
)	O
,	O
test	O
groups	O
were	O
subjected	O
to	O
paa	B-T103
(	O
16	O
g	O
/	O
l	O
)	O
or	O
ozone	B-T103
rich	O
water	B-T103
(	O
4	O
mg	O
/	O
l	O
)	O
for	O
1	O
cycle	O
(	O
10	O
min	O
for	O
paa	B-T103
and	O
60	O
min	O
for	O
ozone	B-T103
)	O
per	O
day	O
for	O
7	O
days	O
prior	O
to	O
tensile	O
tests	B-T058
.	O
measurements	O
of	O
the	O
tbs	O
were	O
analyzed	O
using	O
3	O
-	O
way	O
anova	O
and	O
tukey	B-T058
'	I-T058
s	I-T058
hsd	I-T058
test	I-T058
.	O
adhesive	O
strength	O
of	O
moll	B-T103
##osi	I-T103
##l	I-T103
decreased	O
significantly	O
by	O
application	O
of	O
ozone	B-T103
disinfection	B-T058
.	O
paa	B-T103
disinfection	B-T058
had	O
no	O
negative	O
effect	O
on	O
the	O
tbs	O
values	O
of	O
moll	B-T103
##osi	I-T103
##l	I-T103
and	O
moll	B-T103
##oplast	I-T103
b	I-T103
to	O
acrylic	B-T103
resin	I-T103
.	O
single	O
application	O
of	O
ozone	B-T103
disinfection	B-T058
did	O
not	O
have	O
any	O
negative	O
effect	O
on	O
tbs	O
values	O
of	O
moll	B-T103
##oplast	I-T103
b	I-T103
,	O
but	O
prolonged	O
exposure	O
to	O
ozone	O
decreased	O
its	O
adhesive	O
strength	O
.	O
the	O
adhesion	O
of	O
resili	B-T103
##ent	I-T103
line	I-T103
##rs	I-T103
to	O
acrylic	O
was	O
not	O
adversely	O
affected	O
by	O
paa	B-T103
disinfection	B-T058
.	O
immersion	O
in	O
oz	O
##onated	O
water	B-T103
significantly	O
decreased	O
tbs	O
of	O
moll	B-T103
##osi	I-T103
##l	I-T103
.	O
prolonged	O
exposure	O
to	O
ozone	B-T103
negatively	O
affects	O
adhesion	O
of	O
moll	B-T103
##oplast	I-T103
b	I-T103
to	O
denture	O
base	O
materials	O
.	O

low	B-T033
birth	I-T033
weight	I-T033
and	O
features	O
of	O
neuroticism	B-T038
and	O
mood	B-T038
disorder	I-T038
in	O
83	O
54	O
##5	O
participants	B-T098
of	O
the	O
uk	B-T082
biob	B-T092
##ank	I-T092
cohort	B-T098
low	B-T033
birth	I-T033
weight	I-T033
has	O
been	O
inconsistent	O
##ly	O
associated	O
with	O
risk	O
of	O
developing	O
affective	B-T038
disorders	I-T038
,	O
including	O
major	B-T038
depressive	I-T038
disorder	I-T038
(	O
mdd	B-T038
)	O
.	O
to	O
date	O
,	O
studies	B-T062
investigating	O
possible	O
associations	O
between	O
birth	O
weight	O
and	O
bipolar	B-T038
disorder	I-T038
(	O
bd	B-T038
)	O
,	O
or	O
personality	B-T033
traits	I-T033
known	O
to	O
predispose	O
to	O
affective	B-T038
disorders	I-T038
such	O
as	O
neuroticism	B-T038
,	O
have	O
not	O
been	O
conducted	O
in	O
large	O
cohorts	B-T098
.	O
to	O
assess	O
whether	O
very	B-T033
low	I-T033
birth	I-T033
weight	I-T033
(	O
<	O
1500	O
g	O
)	O
and	O
low	B-T033
birth	I-T033
weight	I-T033
(	O
1500	O
-	O
249	O
##0	O
g	O
)	O
were	O
associated	O
with	O
higher	B-T033
neuroticism	I-T033
scores	O
assessed	O
in	O
middle	O
age	O
,	O
and	O
lifetime	O
history	O
of	O
either	O
mdd	B-T038
or	O
bd	B-T038
.	O
we	O
controlled	O
for	O
possible	O
confounding	O
factors	O
.	O
retrospective	O
cohort	O
study	O
using	O
baseline	O
data	O
on	O
the	O
83	O
54	O
##5	O
uk	B-T082
biob	B-T092
##ank	I-T092
participants	B-T098
with	O
detailed	O
mental	B-T038
health	I-T038
and	O
birth	O
weight	O
data	O
.	O
main	O
outcomes	O
were	O
prevalent	O
mdd	B-T038
and	O
bd	B-T038
,	O
and	O
neuroticism	B-T038
assessed	O
using	O
the	O
ey	B-T170
##se	I-T170
##nc	I-T170
##k	I-T170
personality	I-T170
inventory	I-T170
neuroticism	I-T170
scale	I-T170
-	I-T170
revised	I-T170
(	O
epi	B-T170
##n	I-T170
-	I-T170
r	I-T170
)	O
.	O
refer	O
##ent	O
to	O
normal	B-T033
birth	I-T033
weight	I-T033
,	O
very	B-T033
low	I-T033
/	O
low	B-T033
birth	I-T033
weight	I-T033
were	O
associated	O
with	O
higher	B-T033
neuroticism	I-T033
scores	O
,	O
increased	O
mdd	B-T038
and	O
bd	B-T038
.	O
the	O
associations	O
between	O
birth	O
weight	O
category	B-T170
and	O
mdd	B-T038
were	O
partially	O
mediated	O
by	O
higher	B-T033
neuroticism	I-T033
.	O
these	O
findings	O
suggest	O
that	O
intrauterine	B-T082
programming	B-T038
may	O
play	O
a	O
role	O
in	O
lifetime	O
vulnerability	O
to	O
affective	B-T038
disorders	I-T038
.	O
none	O
.	O
©	O
the	O
royal	O
college	O
of	O
psychiatrists	O
2016	O
.	O
this	O
is	O
an	O
open	O
access	O
article	O
distributed	O
under	O
the	O
terms	O
of	O
the	O
creative	O
common	O
##s	O
non	O
-	O
commercial	O
,	O
no	O
derivatives	O
(	O
cc	O
by	O
-	O
nc	O
-	O
nd	O
)	O
lic	O
##ence	O
.	O

laparoscopic	B-T058
radical	B-T058
lymph	I-T058
node	I-T058
dissection	I-T058
for	O
advanced	B-T038
colon	I-T038
cancer	I-T038
close	O
to	O
the	O
hepatic	B-T082
flex	I-T082
##ure	I-T082
complete	B-T058
meso	I-T058
##co	I-T058
##lic	I-T058
excision	I-T058
is	O
currently	O
recognized	O
as	O
a	O
standard	B-T058
procedure	I-T058
for	O
colon	B-T038
cancer	I-T038
.	O
gastro	B-T017
##epi	I-T017
##plo	I-T017
##ic	I-T017
,	O
infra	B-T017
##py	I-T017
##lor	I-T017
##ic	I-T017
,	O
and	O
superficial	B-T017
pancreatic	I-T017
head	I-T017
lymph	I-T017
node	I-T017
metastases	B-T038
in	O
the	O
gastroc	B-T017
##olic	I-T017
ligament	I-T017
have	O
been	O
reported	O
for	O
colon	B-T038
cancer	I-T038
close	O
to	O
the	O
hepatic	B-T082
flex	I-T082
##ure	I-T082
.	O
we	O
sought	O
to	O
investigate	O
metastases	B-T038
in	O
the	O
gastroc	B-T017
##olic	I-T017
ligament	I-T017
in	O
colon	B-T038
cancer	I-T038
close	O
to	O
the	O
hepatic	B-T082
flex	I-T082
##ure	I-T082
.	O
this	O
was	O
a	O
single	B-T062
-	I-T062
center	I-T062
retrospective	I-T062
study	I-T062
.	O
all	O
patients	O
with	O
t2	B-T033
or	O
deeper	O
invasive	O
colon	B-T038
cancer	I-T038
in	O
the	O
relevant	O
tumor	B-T082
location	I-T082
who	O
underwent	O
laparoscopic	B-T058
right	I-T058
hemic	I-T058
##olec	I-T058
##to	I-T058
##my	I-T058
or	O
extended	B-T058
right	I-T058
hemic	I-T058
##olec	I-T058
##to	I-T058
##my	I-T058
at	O
our	O
institution	B-T092
between	O
1	O
april	O
2011	O
and	O
31	O
march	O
2015	O
were	O
included	O
.	O
lymph	B-T058
node	I-T058
dissection	I-T058
in	O
the	O
gastroc	B-T017
##olic	I-T017
ligament	I-T017
was	O
performed	O
in	O
35	O
cases	O
.	O
complications	B-T038
occurred	O
in	O
11	O
patients	O
(	O
31	O
%	O
)	O
and	O
were	O
grades	O
i	O
and	O
ii	O
according	O
to	O
the	O
clav	B-T170
##ie	I-T170
##n	I-T170
-	I-T170
din	I-T170
##d	I-T170
##o	I-T170
classification	I-T170
.	O
lymph	B-T038
node	I-T038
metastases	I-T038
in	O
the	O
gastroc	B-T017
##olic	I-T017
ligament	I-T017
were	O
found	O
in	O
only	O
three	O
patients	O
(	O
9	O
%	O
)	O
.	O
each	O
metastasis	B-T038
was	O
larger	O
than	O
9	O
mm	O
.	O
metastases	B-T038
in	O
the	O
gastroc	B-T017
##olic	I-T017
ligament	I-T017
occurred	O
in	O
9	O
%	O
of	O
patients	O
with	O
t2	B-T033
or	O
deeper	O
invasive	O
colon	B-T038
cancer	I-T038
close	O
to	O
the	O
hepatic	B-T082
flex	I-T082
##ure	I-T082
.	O
laparoscopy	B-T058
was	O
feasible	O
and	O
useful	O
during	O
gastroc	B-T058
##olic	I-T058
ligament	I-T058
resection	I-T058
.	O
this	O
study	B-T062
included	O
a	O
small	O
sample	O
and	O
lacked	O
an	O
extended	B-T082
follow	B-T058
-	I-T058
up	I-T058
.	O
further	O
studies	B-T062
are	O
needed	O
to	O
determine	O
the	O
clinical	O
relevance	O
of	O
this	O
finding	B-T033
,	O
particularly	O
in	O
terms	O
of	O
recurrence	O
and	O
long	O
-	O
term	O
survival	O
.	O

utilization	O
and	O
outcomes	B-T062
of	O
sentinel	B-T058
lymph	I-T058
node	I-T058
biopsy	I-T058
for	O
vulvar	B-T038
cancer	I-T038
to	O
examine	O
the	O
use	O
and	O
predictors	O
of	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
in	O
women	B-T098
with	O
vulvar	B-T038
cancer	I-T038
.	O
the	O
perspective	B-T170
database	I-T170
,	O
an	O
all	B-T170
-	I-T170
pay	I-T170
##er	I-T170
database	I-T170
that	O
collect	B-T062
##s	I-T062
data	I-T062
from	O
more	O
than	O
500	O
hospitals	B-T092
,	O
was	O
used	O
to	O
perform	O
a	O
retrospective	B-T062
cohort	I-T062
study	I-T062
of	O
women	B-T098
with	O
vulvar	B-T038
cancer	I-T038
who	O
underwent	O
vulv	B-T058
##ectomy	I-T058
and	O
lymph	B-T058
node	I-T058
assessment	I-T058
from	O
2006	O
to	O
2015	O
.	O
multivariable	O
models	O
were	O
used	O
to	O
determine	O
factors	O
associated	O
with	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
.	O
length	O
of	O
stay	O
and	O
cost	O
were	O
compared	O
between	O
women	B-T098
who	O
underwent	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
and	O
lymphadenectomy	B-T058
.	O
among	O
2	O
,	O
273	O
women	B-T098
,	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
was	O
utilized	O
in	O
61	O
##8	O
(	O
27	O
.	O
2	O
%	O
)	O
and	O
1	O
,	O
65	O
##5	O
(	O
72	O
.	O
8	O
%	O
)	O
underwent	O
ing	B-T058
##uin	I-T058
##ofemoral	I-T058
lymphadenectomy	I-T058
.	O
performance	O
of	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
increased	O
from	O
17	O
.	O
0	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
12	O
.	O
0	O
-	O
22	O
.	O
0	O
%	O
)	O
in	O
2006	O
to	O
39	O
.	O
1	O
%	O
(	O
95	O
%	O
ci	O
27	O
.	O
1	O
-	O
51	O
.	O
0	O
%	O
)	O
in	O
2015	O
.	O
in	O
a	O
multivariable	O
model	O
,	O
women	B-T098
treated	O
more	O
recently	O
were	O
more	O
likely	O
to	O
have	O
undergone	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
,	O
whereas	O
women	B-T098
with	O
more	O
comorbidities	O
and	O
those	O
treated	O
at	O
rural	B-T092
hospitals	I-T092
were	O
less	O
likely	O
to	O
have	O
undergone	O
the	O
procedure	B-T058
.	O
the	O
median	B-T082
length	O
of	O
stay	O
was	O
shorter	O
for	O
those	O
undergoing	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
(	O
median	B-T082
2	O
days	O
,	O
interquartile	O
range	O
1	O
-	O
3	O
)	O
compared	O
with	O
women	B-T098
who	O
underwent	O
ing	B-T058
##uin	I-T058
##ofemoral	I-T058
lymphadenectomy	I-T058
(	O
median	O
3	O
days	O
,	O
interquartile	O
range	O
2	O
-	O
4	O
)	O
.	O
the	O
cost	O
of	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
was	O
$	O
7	O
,	O
59	O
##9	O
(	O
interquartile	O
range	O
$	O
5	O
,	O
73	O
##9	O
-	O
9	O
,	O
92	O
##2	O
)	O
compared	O
with	O
$	O
8	O
,	O
09	O
##5	O
(	O
interquartile	O
range	O
$	O
5	O
,	O
91	O
##7	O
-	O
11	O
,	O
281	O
)	O
for	O
lymphadenectomy	B-T058
.	O
the	O
use	O
of	O
sentinel	B-T058
node	I-T058
biopsy	I-T058
for	O
vulvar	B-T038
cancer	I-T038
has	O
more	O
than	O
doubled	O
since	O
2006	O
.	O
sentinel	B-T058
lymph	I-T058
node	I-T058
biopsy	I-T058
is	O
associated	O
with	O
a	O
shorter	O
hospital	O
stay	O
and	O
decreased	O
cost	O
compared	O
with	O
ing	B-T058
##uin	I-T058
##ofemoral	I-T058
lymphadenectomy	I-T058
.	O

membrane	B-T017
nanocl	O
##ust	O
##ers	O
of	O
fc	B-T103
##γ	I-T103
##ri	I-T103
segreg	O
##ate	O
from	O
inhibitory	O
sir	B-T103
##p	I-T103
##α	I-T103
upon	O
activation	B-T038
of	I-T038
human	I-T038
macrophages	I-T038
signal	B-T038
integration	I-T038
between	O
activating	O
fc	B-T103
receptors	I-T103
and	O
inhibitory	O
signal	B-T103
regulatory	I-T103
protein	I-T103
α	I-T103
(	O
sir	B-T103
##p	I-T103
##α	I-T103
)	O
controls	O
macrophage	B-T017
phagocytosis	B-T038
.	O
here	O
,	O
using	O
dual	B-T058
-	I-T058
color	I-T058
direct	I-T058
stochastic	I-T058
optical	I-T058
reconstruction	I-T058
microscopy	I-T058
,	O
we	O
report	O
that	O
fc	B-T103
##γ	I-T103
receptor	I-T103
i	I-T103
(	O
fc	B-T103
##γ	I-T103
##ri	I-T103
)	O
,	O
fc	B-T103
##γ	I-T103
##ri	I-T103
##i	I-T103
,	O
and	O
sir	B-T103
##p	I-T103
##α	I-T103
are	O
not	O
homogeneous	O
##ly	O
distributed	O
at	O
macrophage	B-T017
surfaces	B-T017
but	O
are	O
organized	O
in	O
discrete	O
nanocl	O
##ust	O
##ers	O
,	O
with	O
a	O
mean	O
radius	O
of	O
71	O
±	O
11	O
nm	O
,	O
60	O
±	O
6	O
nm	O
,	O
and	O
48	O
±	O
3	O
nm	O
,	O
respectively	O
.	O
nanocl	O
##ust	O
##ers	O
of	O
fc	B-T103
##γ	I-T103
##ri	I-T103
,	O
but	O
not	O
fc	B-T103
##γ	I-T103
##ri	I-T103
##i	I-T103
,	O
are	O
constitutively	O
associated	O
with	O
nanocl	O
##ust	O
##ers	O
of	O
sir	B-T103
##p	I-T103
##α	I-T103
,	O
within	O
62	O
±	O
5	O
nm	O
,	O
mediated	O
by	O
the	O
actin	B-T017
cytoskeleton	I-T017
.	O
upon	O
fc	B-T103
receptor	I-T103
activation	B-T038
,	O
src	B-T103
-	I-T103
family	I-T103
kinase	I-T103
signaling	B-T038
leads	O
to	O
segregation	O
of	O
fc	B-T103
##γ	I-T103
##ri	I-T103
and	O
sir	B-T103
##p	I-T103
##α	I-T103
nanocl	O
##ust	O
##ers	O
to	O
be	O
197	O
±	O
3	O
nm	O
apart	O
.	O
co	B-T038
-	I-T038
ligation	I-T038
of	O
sir	B-T103
##p	I-T103
##α	I-T103
with	O
cd4	B-T103
##7	I-T103
abrog	O
##ates	O
nanocl	O
##ust	O
##er	O
segregation	O
.	O
if	O
the	O
balance	O
of	O
signals	B-T038
favors	O
activation	O
,	O
fc	B-T103
##γ	I-T103
##ri	I-T103
nanocl	O
##ust	O
##ers	O
re	O
##organ	O
##ize	O
into	O
periodically	O
spaced	O
concentric	O
rings	O
.	O
thus	O
,	O
a	O
nanometer	O
-	O
and	O
micron	O
-	O
scale	O
reorganization	O
of	O
activating	O
and	O
inhibitory	O
receptors	B-T103
occurs	O
at	O
the	O
surface	O
of	O
human	B-T017
macrophages	I-T017
concurrent	O
with	O
signal	B-T038
integration	I-T038
.	O

expectations	O
for	O
the	O
methodology	O
and	O
translation	B-T062
of	O
animal	B-T062
research	I-T062
:	O
a	O
survey	B-T170
of	O
the	O
general	B-T098
public	I-T098
,	O
medical	B-T097
students	I-T097
and	O
animal	B-T204
researchers	B-T097
in	O
north	B-T082
america	I-T082
to	O
determine	O
what	O
are	O
considered	O
acceptable	O
standards	B-T170
for	O
animal	B-T062
research	I-T062
(	O
ar	B-T062
)	O
methodology	O
and	O
translation	O
rate	O
to	O
humans	B-T204
,	O
a	O
validated	O
survey	B-T170
was	O
sent	O
to	O
:	O
a	O
)	O
a	O
sample	O
of	O
the	O
general	B-T098
public	I-T098
,	O
via	O
sampling	B-T170
survey	I-T170
international	I-T170
(	O
ssi	B-T170
;	O
canada	B-T082
)	O
,	O
amazon	B-T170
mechanical	I-T170
turk	I-T170
(	O
am	B-T170
##t	I-T170
;	O
usa	B-T082
)	O
,	O
a	O
canadian	B-T082
city	I-T082
fes	O
##tiv	O
##al	O
(	O
cf	O
)	O
and	O
a	O
canadian	B-T082
children	B-T092
'	I-T092
s	I-T092
hospital	I-T092
(	O
ch	B-T092
)	O
;	O
b	O
)	O
a	O
sample	O
of	O
medical	B-T097
students	I-T097
(	O
two	O
first	O
-	O
year	O
classes	O
)	O
;	O
and	O
c	O
)	O
a	O
sample	O
of	O
scientists	B-T097
(	O
corresponding	O
authors	B-T097
and	O
academic	B-T092
paediatric	B-T097
##ians	I-T097
)	O
.	O
there	O
were	O
137	O
##9	O
responses	O
from	O
the	O
general	B-T098
public	I-T098
sample	O
(	O
ssi	B-T170
,	O
n	O
=	O
55	O
##7	O
;	O
am	B-T170
##t	I-T170
,	O
n	O
=	O
59	O
##0	O
;	O
cf	O
,	O
n	O
=	O
195	O
;	O
ch	B-T092
,	O
n	O
=	O
102	O
)	O
,	O
205	O
/	O
330	O
(	O
62	O
%	O
)	O
medical	B-T097
student	I-T097
responses	O
,	O
and	O
23	O
/	O
323	O
(	O
7	O
%	O
,	O
too	O
few	O
to	O
report	O
)	O
sci	B-T097
##entis	I-T097
##t	I-T097
responses	O
.	O
asked	O
about	O
methodological	O
quality	O
,	O
most	O
of	O
the	O
general	B-T098
public	I-T098
and	O
medical	B-T097
student	I-T097
respondents	B-T098
expect	O
that	O
:	O
ar	B-T062
is	O
of	O
high	O
quality	O
(	O
e	O
.	O
g	O
.	O
anaesthesia	B-T058
and	O
analgesia	B-T058
are	O
monitored	O
,	O
even	O
overnight	O
,	O
and	O
'	O
human	O
##e	O
'	O
euthanasia	B-T058
,	O
optimal	O
statistical	O
design	O
,	O
comprehensive	O
literature	B-T170
review	I-T170
,	O
random	B-T062
##isation	I-T062
and	O
blind	B-T062
##ing	I-T062
,	O
are	O
performed	O
)	O
,	O
and	O
costs	O
and	O
difficulty	O
are	O
not	O
acceptable	O
justif	O
##ications	O
for	O
lower	O
quality	O
(	O
e	O
.	O
g	O
.	O
costs	O
of	O
expert	O
consultation	B-T058
,	O
or	O
more	O
laboratory	B-T097
staff	I-T097
)	O
.	O
asked	O
about	O
their	O
expectations	O
of	O
translation	B-T062
to	O
humans	B-T204
(	O
of	O
toxicity	B-T037
,	O
carcinogenicity	B-T038
,	O
teratogenic	B-T038
##ity	I-T038
and	O
treatment	O
findings	O
)	O
,	O
most	O
expect	O
translation	B-T062
more	O
than	O
60	O
%	O
of	O
the	O
time	O
.	O
if	O
translation	B-T062
occurred	O
less	O
than	O
20	O
%	O
of	O
the	O
time	O
,	O
a	O
minority	B-T098
disagre	O
##ed	O
that	O
this	O
would	O
[UNK]	O
significantly	O
reduce	O
your	O
support	O
for	O
ar	B-T062
[UNK]	O
.	O
medical	B-T097
students	I-T097
were	O
more	O
supportive	O
of	O
ar	B-T062
,	O
even	O
if	O
translation	B-T062
occurred	O
less	O
than	O
20	O
%	O
of	O
the	O
time	O
.	O
expectations	O
for	O
ar	B-T062
are	O
much	O
higher	O
than	O
empirical	O
data	O
show	O
to	O
have	O
been	O
achieved	O
.	O

eosinophilic	B-T038
gastroenteritis	I-T038
as	O
a	O
rare	O
cause	O
of	O
recurrent	O
epigastric	O
pain	O
eosinophilic	B-T038
gastroenteritis	I-T038
(	O
eg	B-T038
##e	I-T038
)	O
is	O
a	O
rare	O
inflammatory	B-T038
disorder	I-T038
of	O
gastrointestinal	B-T022
tract	I-T022
characterized	O
by	O
eosinophilic	B-T038
infiltration	I-T038
of	O
the	O
bowel	B-T017
wall	I-T017
.	O
it	O
can	O
mimic	O
many	O
gastrointestinal	B-T038
disorders	I-T038
due	O
to	O
its	O
wide	B-T033
spectrum	I-T033
of	I-T033
presentations	I-T033
.	O
diagnose	B-T033
is	O
mostly	O
based	O
on	O
excluding	O
other	O
disorders	B-T038
and	O
a	O
high	O
suspicion	B-T038
.	O
here	O
we	O
report	B-T170
a	I-T170
case	I-T170
of	O
26	O
year	O
old	O
man	B-T098
with	O
a	O
history	B-T033
of	O
sever	B-T033
epigastric	I-T033
pain	I-T033
followed	O
by	O
nausea	B-T033
,	O
vomiting	B-T033
since	O
a	O
few	O
days	O
before	O
admission	B-T058
with	O
final	O
diagnosis	B-T033
of	O
eg	B-T038
##e	I-T038
.	O

quantitative	B-T058
susceptibility	I-T058
mapping	I-T058
using	O
structural	O
feature	O
based	O
collaborative	O
reconstruction	O
(	O
sf	O
##cr	O
)	O
in	O
the	O
human	B-T204
brain	B-T017
the	O
reconstruction	O
of	O
mr	O
quantitative	B-T058
susceptibility	I-T058
mapping	I-T058
(	O
qs	B-T058
##m	I-T058
)	O
from	O
local	O
phase	O
measurements	O
is	O
an	O
ill	O
posed	O
inverse	O
problem	O
and	O
different	O
regular	O
##ization	O
strategies	O
incorporating	O
a	O
priori	O
information	O
extracted	O
from	O
magnitude	O
and	O
phase	B-T170
images	I-T170
have	O
been	O
proposed	O
.	O
however	O
,	O
the	O
anatomy	B-T017
observed	O
in	O
magnitude	O
and	O
phase	B-T170
images	I-T170
does	O
not	O
always	O
coincide	O
spatially	O
with	O
that	O
in	O
susceptibility	O
maps	O
,	O
which	O
could	O
give	O
erroneous	O
estimation	O
in	O
the	O
reconstructed	O
susceptibility	O
map	O
.	O
in	O
this	O
paper	O
,	O
we	O
develop	O
a	O
structural	O
feature	O
based	O
collaborative	O
reconstruction	O
(	O
sf	O
##cr	O
)	O
method	O
for	O
qs	B-T058
##m	I-T058
including	O
both	O
magnitude	O
and	O
susceptibility	O
based	O
information	O
.	O
the	O
sf	O
##cr	O
algorithm	B-T170
is	O
composed	O
of	O
two	O
consecutive	O
steps	O
corresponding	O
to	O
complementary	O
reconstruction	B-T170
models	I-T170
,	O
each	O
with	O
a	O
structural	B-T082
feature	I-T082
based	O
l1	O
norm	O
constraint	O
and	O
a	O
voxel	O
fidelity	O
based	O
l2	O
norm	O
constraint	O
,	O
which	O
allows	O
both	O
the	O
structure	B-T082
edges	O
and	O
tin	O
##y	O
features	O
to	O
be	O
recovered	O
,	O
whereas	O
the	O
noise	O
and	O
artifacts	O
could	O
be	O
reduced	O
.	O
in	O
the	O
m	O
-	O
step	O
,	O
the	O
initial	O
susceptibility	O
map	O
is	O
reconstructed	O
by	O
employing	O
a	O
k	O
-	O
space	O
based	O
compressed	B-T170
sensing	I-T170
model	I-T170
incorporating	O
magnitude	O
prior	O
.	O
in	O
the	O
s	O
-	O
step	O
,	O
the	O
susceptibility	O
map	O
is	O
fitted	O
in	O
spatial	O
domain	O
using	O
weighted	O
constraints	O
derived	O
from	O
the	O
initial	O
susceptibility	O
map	O
from	O
the	O
m	O
-	O
step	O
.	O
simulations	B-T062
and	O
in	B-T082
vivo	I-T082
human	B-T204
experiments	B-T062
at	O
7	O
##t	O
mri	B-T058
show	O
that	O
the	O
sf	O
##cr	O
method	O
provides	O
high	O
quality	O
susceptibility	O
maps	O
with	O
improved	O
rms	O
##e	O
and	O
ms	O
##si	O
##m	O
.	O
finally	O
,	O
the	O
susceptibility	O
values	O
of	O
deep	O
gray	B-T017
matter	I-T017
are	O
analyzed	O
in	O
multiple	B-T082
head	I-T082
positions	I-T082
,	O
with	O
the	O
supine	B-T082
position	I-T082
most	O
approximate	O
to	O
the	O
gold	O
standard	O
cosm	O
##os	O
result	O
.	O

heat	B-T103
-	I-T103
shock	I-T103
protein	I-T103
60	I-T103
of	O
porphyr	B-T007
##omonas	I-T007
gingivalis	I-T007
may	O
induce	O
dysfunction	O
of	O
human	B-T017
umbilical	I-T017
endothelial	I-T017
cells	I-T017
via	O
regulation	B-T038
of	O
endothelial	B-T103
-	I-T103
nitric	I-T103
oxide	I-T103
synthase	I-T103
and	O
vascular	B-T103
endothelial	I-T103
-	I-T103
cadherin	I-T103
accumulating	O
evidence	O
has	O
established	O
that	O
periodontitis	B-T038
was	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
coronary	B-T038
heart	I-T038
disease	I-T038
(	O
cad	B-T038
)	O
.	O
porphyr	B-T007
##omon	I-T007
##us	I-T007
gingivalis	I-T007
(	O
p	B-T007
.	I-T007
gingivalis	I-T007
)	O
,	O
a	O
major	O
periodontal	O
pathogen	O
,	O
has	O
already	O
been	O
shown	O
to	O
have	O
a	O
significant	O
role	O
in	O
the	O
inflammatory	B-T038
response	I-T038
of	O
cad	B-T038
in	B-T082
vivo	I-T082
.	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
identify	O
whether	O
p	B-T007
.	I-T007
gingivalis	I-T007
heat	B-T103
-	I-T103
shock	I-T103
protein	I-T103
60	I-T103
(	O
hsp	B-T103
##60	I-T103
)	O
induced	O
the	O
dysfunction	O
of	O
human	B-T017
umbilical	I-T017
vein	I-T017
endothelial	I-T017
cells	I-T017
(	O
huvecs	B-T017
)	O
in	O
vitro	O
.	O
huvecs	B-T017
were	O
stimulated	O
with	O
a	O
range	O
of	O
p	B-T007
.	I-T007
gingivalis	I-T007
hsp	B-T103
##60	I-T103
concentrations	O
(	O
1	O
,	O
10	O
and	O
100	O
ng	O
/	O
l	O
)	O
at	O
different	O
time	O
-	O
points	O
.	O
the	O
levels	O
of	O
vascular	B-T103
endothelial	I-T103
(	I-T103
ve	I-T103
)	I-T103
-	I-T103
cadherin	I-T103
,	O
endothelial	B-T103
nitric	I-T103
oxide	I-T103
synthase	I-T103
(	O
enos	B-T103
)	O
and	O
cystein	B-T103
##yl	I-T103
aspartate	I-T103
-	I-T103
specific	I-T103
protease	I-T103
-	I-T103
3	I-T103
(	O
caspase	B-T103
-	I-T103
3	I-T103
)	O
were	O
measured	O
using	O
western	B-T058
blot	I-T058
analysis	B-T062
.	O
the	O
apoptotic	B-T038
rate	O
of	O
huvecs	B-T017
was	O
detected	O
using	O
flow	B-T058
cytometry	I-T058
.	O
p	B-T007
.	I-T007
gingivalis	I-T007
hsp	B-T103
##60	I-T103
at	O
a	O
concentration	O
of	O
10	O
ng	O
/	O
l	O
significantly	O
decreased	O
the	O
expression	B-T038
levels	O
of	O
ve	B-T103
-	I-T103
cadherin	I-T103
and	O
enos	B-T103
protein	I-T103
at	O
24	O
h	O
stimulation	O
,	O
whereas	O
no	O
difference	O
in	O
these	O
proteins	B-T103
was	O
identified	O
following	O
a	O
low	O
dose	O
of	O
p	B-T007
.	I-T007
gingivalis	I-T007
hsp	B-T103
##60	I-T103
(	O
1	O
ng	O
/	O
l	O
)	O
.	O
p	B-T007
.	I-T007
gingivalis	I-T007
hsp	B-T103
##60	I-T103
at	O
100	O
ng	O
/	O
l	O
significantly	O
downregulated	B-T038
the	O
expression	B-T038
levels	O
of	O
ve	B-T103
-	I-T103
cadherin	I-T103
and	O
enos	B-T103
protein	I-T103
at	O
12	O
h	O
in	O
huvecs	B-T017
.	O
however	O
,	O
the	O
cleavage	O
of	O
caspase	B-T103
-	I-T103
3	I-T103
showed	O
an	O
opposing	O
change	O
at	O
different	O
concentrations	O
.	O
consistently	O
,	O
p	B-T007
.	I-T007
gingivalis	I-T007
hsp	B-T103
##60	I-T103
induced	O
apoptosis	B-T038
of	O
huvecs	B-T017
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
.	O
these	O
results	O
indicated	O
that	O
p	B-T007
.	I-T007
gingivalis	I-T007
hsp	B-T103
##60	I-T103
may	O
induce	O
dysfunction	O
and	O
apoptosis	B-T038
in	O
huvecs	B-T017
via	O
downreg	B-T038
##ulating	I-T038
the	O
expression	B-T038
levels	O
of	O
ve	B-T103
-	I-T103
cadherin	I-T103
and	O
enos	B-T103
,	O
and	O
promoting	O
the	O
cleavage	O
of	O
caspase	B-T103
-	I-T103
3	I-T103
.	O

multimodal	B-T058
brain	I-T058
imaging	I-T058
with	O
magnet	B-T058
##oencephal	I-T058
##ography	I-T058
:	O
a	O
method	B-T058
for	O
measuring	O
blood	B-T038
pressure	I-T038
and	O
cardiorespiratory	B-T038
oscillations	I-T038
studies	B-T062
with	O
magnet	B-T058
##oencephal	I-T058
##ography	I-T058
(	O
meg	B-T058
)	O
are	O
still	O
quite	O
rarely	O
combined	O
simultaneously	O
with	O
methods	B-T058
that	O
can	O
provide	O
a	O
metabolic	O
dimension	O
to	O
meg	B-T058
investigation	B-T058
s	O
.	O
in	O
addition	O
,	O
continuous	O
blood	B-T058
pressure	I-T058
measurements	I-T058
which	O
compl	O
##y	O
with	O
meg	B-T058
compatibility	O
requirements	O
are	O
lacking	O
.	O
for	O
instance	O
,	O
by	O
combining	O
methods	B-T058
reflecting	O
neurovascular	B-T058
status	I-T058
one	O
could	O
obtain	O
more	O
information	O
on	O
low	O
frequency	O
fluctuations	B-T033
that	O
have	O
recently	O
gained	O
increasing	O
interest	O
as	O
a	O
mediator	O
of	O
functional	O
connectivity	O
within	O
brain	B-T017
networks	I-T017
.	O
this	O
paper	O
presents	O
a	O
multimodal	B-T058
brain	I-T058
imaging	I-T058
setup	O
,	O
capable	O
to	O
non	O
-	O
invasively	O
and	O
continuously	O
measure	O
cerebral	B-T017
hemodynamic	B-T038
,	O
cardiorespiratory	O
and	O
blood	B-T038
pressure	I-T038
oscillations	B-T038
simultaneously	O
with	O
meg	B-T058
.	O
in	O
the	O
setup	O
,	O
all	O
methods	B-T058
apart	O
from	O
meg	B-T058
rely	O
on	O
the	O
use	O
of	O
fibre	O
optics	O
.	O
in	O
particular	O
,	O
we	O
present	O
a	O
method	B-T058
for	O
measuring	O
of	O
blood	B-T038
pressure	I-T038
and	O
cardiorespiratory	B-T038
oscillations	I-T038
continuously	O
with	O
meg	B-T058
.	O
the	O
potential	O
of	O
this	O
type	O
of	O
multimodal	B-T058
setup	O
for	O
brain	B-T062
research	I-T062
is	O
demonstrated	O
by	O
our	O
preliminary	O
studies	O
on	O
human	B-T204
,	O
showing	O
effects	O
of	O
mild	B-T033
hypercapnia	I-T033
,	O
gathered	O
simultaneously	O
with	O
the	O
presented	O
modalities	O
.	O

human	B-T204
amni	B-T017
##on	I-T017
epithelial	B-T017
cells	I-T017
rescue	O
cell	B-T038
death	I-T038
via	O
immunomod	B-T058
##ulation	I-T058
of	O
microglia	B-T017
in	O
a	O
mouse	B-T038
model	I-T038
of	O
perinatal	B-T037
brain	I-T037
injury	I-T037
human	B-T204
amni	B-T017
##on	I-T017
epithelial	B-T017
cells	I-T017
(	O
ha	B-T017
##ecs	I-T017
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	B-T038
-	O
induced	O
tissue	B-T037
injury	I-T037
.	O
perturbation	O
of	O
the	O
immune	B-T038
response	I-T038
is	O
implicated	O
in	O
the	O
pathogenesis	B-T038
of	O
perinatal	B-T037
brain	I-T037
injury	I-T037
;	O
modulating	B-T082
this	O
response	B-T038
could	O
thus	O
be	O
a	O
novel	O
therapy	B-T058
for	O
treating	O
or	O
preventing	O
such	O
injury	B-T037
.	O
the	O
immunomodulatory	B-T058
properties	O
of	O
ha	B-T017
##ecs	I-T017
have	O
been	O
shown	O
in	O
other	O
animal	B-T204
models	I-T204
,	O
but	O
a	O
detailed	O
investigation	B-T058
of	O
the	O
effects	O
on	O
brain	B-T017
immune	O
cells	B-T017
following	O
injury	B-T037
has	O
not	O
been	O
undertaken	O
.	O
here	O
,	O
we	O
investigate	B-T058
the	O
effects	O
of	O
ha	B-T017
##ecs	I-T017
on	O
microglia	B-T017
,	O
the	O
first	O
immune	B-T038
responders	I-T038
to	O
injury	B-T037
within	O
the	O
brain	B-T017
.	O
we	O
generated	O
a	O
mouse	B-T038
model	I-T038
combining	O
neonatal	O
inflammation	B-T038
and	O
perinatal	O
hyperoxia	B-T033
,	O
both	O
of	O
which	O
are	O
risk	B-T033
factors	I-T033
associated	O
with	O
perinatal	B-T037
brain	I-T037
injury	I-T037
.	O
on	O
embryonic	B-T038
day	O
16	O
we	O
administered	B-T058
lipopolysaccharide	B-T103
(	O
lps	B-T103
)	O
,	O
or	O
saline	O
(	O
control	O
)	O
,	O
intra	O
-	O
amniotic	O
##ally	O
to	O
c57bl	B-T204
/	I-T204
6	I-T204
j	I-T204
mouse	I-T204
pups	I-T204
.	O
on	O
postnatal	O
day	O
(	O
p	O
)	O
0	O
,	O
lps	B-T103
pups	B-T204
were	O
placed	O
in	O
hyperoxia	B-T033
(	O
65	O
%	O
oxygen	B-T103
)	O
and	O
control	O
pups	O
in	O
normoxia	O
for	O
14	O
days	O
.	O
pups	B-T204
were	O
given	O
either	O
ha	B-T017
##ecs	I-T017
or	O
saline	O
intravenously	B-T058
on	O
p4	O
.	O
at	O
p1	O
##4	O
,	O
relative	O
to	O
controls	O
,	O
lps	B-T103
and	O
hyperoxia	B-T033
pups	B-T204
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	B-T017
(	O
tunel	B-T062
)	O
in	O
the	O
cortex	B-T017
,	O
striatum	B-T017
and	O
white	B-T017
matter	I-T017
,	O
astrocytes	B-T017
(	O
gfap	B-T103
)	O
in	O
the	O
white	B-T017
matter	I-T017
and	O
activated	O
microglia	B-T017
(	O
cd68	B-T103
)	O
in	O
the	O
cortex	B-T017
and	O
striatum	B-T017
,	O
but	O
no	O
change	O
in	O
total	O
microglia	B-T017
density	O
(	O
ib	B-T103
##a1	I-T103
)	O
.	O
ha	B-T017
##ec	I-T017
administration	B-T058
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	B-T038
and	O
astrocyte	B-T017
area	O
##l	O
coverage	O
in	O
the	O
white	B-T017
matter	I-T017
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	B-T017
.	O
we	O
then	O
stimulated	O
primary	O
microglia	B-T017
(	O
cd45	B-T103
(	O
low	O
)	O
cd11b	B-T103
(	O
+	O
)	O
)	O
with	O
lps	B-T103
for	O
24	O
h	O
,	O
followed	O
by	O
co	B-T058
-	I-T058
culture	I-T058
with	O
ha	B-T017
##ec	I-T017
conditioned	B-T103
medium	I-T103
for	O
48	O
h	O
.	O
ha	B-T017
##ec	I-T017
conditioned	B-T103
medium	I-T103
increased	O
microglial	B-T017
phagocytic	B-T038
activity	I-T038
,	O
decreased	O
microglia	B-T017
apoptosis	B-T038
and	O
decreased	O
m1	B-T038
activation	I-T038
markers	I-T038
(	O
cd86	B-T103
)	O
.	O
stimulating	O
ha	B-T017
##ecs	I-T017
for	O
24	O
h	O
with	O
lps	B-T103
did	O
not	O
alter	O
release	B-T058
of	O
cytokines	B-T103
known	O
to	O
modulate	B-T082
microglia	B-T017
activity	O
.	O
these	O
data	O
demonstrate	O
that	O
ha	B-T017
##ecs	I-T017
can	O
directly	O
immunomod	B-T058
##ulate	I-T058
brain	B-T017
microglia	B-T017
,	O
probably	O
via	O
release	B-T058
of	O
trophic	B-T103
factors	I-T103
.	O
this	O
observation	B-T062
offers	O
promise	O
that	O
ha	B-T017
##ecs	I-T017
may	O
afford	O
therapeutic	B-T058
utility	I-T058
in	O
the	O
management	B-T058
of	O
perinatal	B-T037
brain	I-T037
injury	I-T037
.	O

effect	O
of	O
pun	B-T204
##ica	I-T204
gran	I-T204
##atum	I-T204
fruit	B-T168
peel	I-T168
on	O
glucose	B-T103
-	I-T103
6	I-T103
-	I-T103
phosphate	I-T103
dehydrogenase	I-T103
and	O
malate	B-T103
dehydrogenase	I-T103
in	O
amph	B-T204
##ist	I-T204
##ome	I-T204
gastro	B-T204
##thy	I-T204
##la	I-T204
##x	I-T204
indic	I-T204
##us	I-T204
increasing	O
anthelmin	B-T103
##tic	I-T103
resistance	B-T038
and	O
the	O
impact	O
of	O
conventional	O
anthelmin	B-T103
##tics	I-T103
on	O
the	O
environment	B-T082
,	O
it	O
is	O
important	O
to	O
look	O
for	O
alternative	O
strategies	O
against	O
helminth	B-T204
parasite	I-T204
in	O
sheep	B-T204
.	O
important	O
lipo	B-T103
##genic	I-T103
enzymes	I-T103
like	O
glucose	B-T103
-	I-T103
6	I-T103
-	I-T103
phosphate	I-T103
dehydrogenase	I-T103
(	O
g	B-T103
-	I-T103
6	I-T103
-	I-T103
pd	I-T103
##h	I-T103
)	O
and	O
malate	B-T103
dehydrogenase	I-T103
(	O
md	B-T103
##h	I-T103
)	O
show	O
subcellular	B-T017
distribution	B-T082
pattern	I-T082
.	O
activity	B-T038
of	O
g	B-T103
-	I-T103
6	I-T103
-	I-T103
pd	I-T103
##h	I-T103
was	O
largely	O
restricted	O
to	O
cytosolic	B-T017
fraction	I-T017
while	O
md	B-T103
##h	I-T103
was	O
found	O
in	O
both	O
cytosolic	B-T017
and	O
mitochondrial	B-T017
fraction	I-T017
in	O
gastro	B-T204
##thy	I-T204
##la	I-T204
##x	I-T204
indic	I-T204
##us	I-T204
.	O
following	O
in	O
vitro	O
treatment	O
with	O
ethanolic	B-T103
and	O
aqueous	O
extracts	O
of	O
pun	B-T204
##ica	I-T204
gran	I-T204
##atum	I-T204
fruit	B-T168
peel	I-T168
and	O
commercial	O
anthelmin	B-T103
##tic	I-T103
,	O
alb	B-T103
##endazole	I-T103
g	B-T103
-	I-T103
6	I-T103
-	I-T103
pd	I-T103
##h	I-T103
activity	B-T038
was	O
decreased	O
by	O
19	O
-	O
32	O
%	O
,	O
whereas	O
md	B-T103
##h	I-T103
was	O
suppressed	O
by	O
24	O
-	O
41	O
%	O
,	O
compared	O
to	O
the	O
respective	O
control	O
.	O
alb	B-T103
##endazole	I-T103
was	O
quite	O
effective	O
when	O
compared	O
with	O
negative	O
control	O
and	O
both	O
the	O
extracts	O
.	O
the	O
results	O
indicate	O
that	O
phytochemical	B-T103
##s	I-T103
of	O
plant	B-T204
may	O
act	O
as	O
potential	O
verm	B-T103
##ifug	I-T103
##e	I-T103
or	O
verm	O
##icide	O
.	O

sars	B-T038
-	O
cov	B-T005
fusion	O
peptides	B-T103
induce	O
membrane	B-T017
surface	B-T082
ordering	O
and	O
curvature	O
viral	B-T038
membrane	I-T038
fusion	I-T038
is	O
an	O
orches	O
##trated	O
process	O
triggered	O
by	O
membrane	B-T017
-	I-T017
anchored	I-T017
viral	B-T103
fusion	I-T103
glycoproteins	I-T103
.	O
the	O
s2	B-T103
subunit	B-T103
of	O
the	O
spike	B-T103
glycoprotein	I-T103
from	O
severe	B-T038
acute	I-T038
respiratory	I-T038
syndrome	I-T038
(	O
sars	B-T038
)	O
coronavirus	B-T005
(	O
cov	B-T005
)	O
contains	O
internal	B-T082
domains	I-T082
called	O
fusion	B-T103
peptides	I-T103
(	O
fp	B-T103
)	O
that	O
play	O
essential	O
roles	O
in	O
virus	B-T038
entry	I-T038
.	O
although	O
membrane	B-T038
fusion	I-T038
has	O
been	O
broadly	O
studied	B-T062
,	O
there	O
are	O
still	O
major	O
gaps	O
in	O
the	O
molecular	O
details	O
of	O
lipid	B-T103
rearrangements	O
in	O
the	O
bilayer	B-T017
during	O
fusion	B-T103
peptide	I-T103
-	O
membrane	B-T017
interactions	O
.	O
here	O
we	O
employed	O
differential	B-T058
scanning	I-T058
calorimetry	I-T058
(	O
dsc	B-T058
)	O
and	O
electron	B-T058
spin	I-T058
resonance	I-T058
(	O
esr	B-T058
)	O
to	O
gather	O
information	O
on	O
the	O
membrane	B-T038
fusion	I-T038
mechanism	O
promoted	O
by	O
two	O
putative	O
sars	B-T038
fps	B-T103
.	O
dsc	B-T058
data	O
showed	O
the	O
peptides	B-T103
strongly	O
perturb	O
the	O
structural	B-T082
integrity	O
of	O
anionic	B-T017
vesicles	I-T017
and	O
support	O
the	O
hypothesis	O
that	O
the	O
peptides	B-T103
generate	O
opposing	O
curvature	O
stresses	O
on	O
phosphatidylethanolamine	B-T103
membranes	B-T017
.	O
esr	B-T058
showed	O
that	O
both	O
fps	B-T103
increase	O
lipid	B-T103
packing	O
and	O
head	O
group	O
ordering	O
as	O
well	O
as	O
reduce	O
the	O
intram	B-T017
##embrane	I-T017
water	O
content	O
for	O
anionic	B-T017
membranes	I-T017
.	O
therefore	O
,	O
bending	O
moment	O
in	O
the	O
bilayer	B-T017
could	O
be	O
generated	O
,	O
promoting	O
negative	O
curvature	O
.	O
the	O
significance	O
of	O
the	O
ordering	O
effect	O
,	O
membrane	B-T017
dehydration	B-T033
,	O
changes	O
in	O
the	O
curvature	O
properties	O
and	O
the	O
possible	O
role	O
of	O
negatively	O
charged	O
phospholipids	B-T103
in	O
helping	O
to	O
overcome	O
the	O
high	O
kinetic	O
barrier	O
involved	O
in	O
the	O
different	O
stages	O
of	O
the	O
sars	B-T038
-	O
cov	B-T005
-	O
mediated	O
membrane	B-T038
fusion	I-T038
are	O
discussed	O
.	O

draft	B-T017
genome	I-T017
sequence	B-T082
of	O
provide	B-T007
##nc	I-T007
##ia	I-T007
st	I-T007
##ua	I-T007
##rt	I-T007
##ii	I-T007
ps	I-T007
##71	I-T007
,	O
a	O
multidrug	O
-	O
resistant	O
strain	O
associated	O
with	O
nosocomial	B-T038
infections	I-T038
in	O
greece	B-T082
provide	B-T007
##nc	I-T007
##ia	I-T007
st	I-T007
##ua	I-T007
##rt	I-T007
##ii	I-T007
is	O
frequently	O
associated	O
with	O
nosocomial	B-T038
outbreaks	I-T038
and	O
displays	O
intrinsic	B-T082
resistance	O
to	O
many	O
commonly	O
used	O
antimicrobials	B-T103
.	O
we	O
report	O
here	O
the	O
draft	B-T017
genome	I-T017
sequence	B-T082
of	O
a	O
p	B-T007
.	I-T007
st	I-T007
##ua	I-T007
##rt	I-T007
##ii	I-T007
strain	I-T007
carrying	O
acquired	O
resistance	O
genes	O
conferring	O
pan	O
##res	O
##istan	O
##ce	O
to	O
cephalosporins	B-T103
(	O
bla	B-T017
##sh	I-T017
##v	I-T017
-	I-T017
5	I-T017
and	O
bla	B-T017
##ve	I-T017
##b	I-T017
-	I-T017
1	I-T017
)	O
,	O
carbapenem	B-T103
##s	I-T103
(	O
bla	B-T017
##vi	I-T017
##m	I-T017
-	I-T017
1	I-T017
)	O
,	O
and	O
aminoglycosides	B-T103
(	O
rm	B-T017
##t	I-T017
##b	I-T017
)	O
involved	O
in	O
an	O
outbreak	O
in	O
greek	B-T082
hospitals	B-T092
.	O

interferon	B-T017
gamma	I-T017
and	O
interleukin	B-T017
10	I-T017
polymorphisms	O
in	O
chinese	B-T098
children	O
with	O
hem	B-T038
##ophag	I-T038
##ocytic	I-T038
lympho	I-T038
##his	I-T038
##ti	I-T038
##ocytosis	I-T038
the	O
aim	O
of	O
the	O
study	B-T062
is	O
to	O
investigate	O
the	O
association	O
of	O
interferon	B-T017
gamma	I-T017
(	O
ifn	B-T017
-	I-T017
γ	I-T017
)	O
and	O
interleukin	B-T017
-	I-T017
10	I-T017
(	O
il	B-T017
-	I-T017
10	I-T017
)	O
gene	B-T017
single	B-T082
nucleotide	I-T082
polymorphisms	I-T082
with	O
the	O
susceptibility	B-T201
of	O
hem	B-T038
##ophag	I-T038
##ocytic	I-T038
lympho	I-T038
##his	I-T038
##ti	I-T038
##ocytosis	I-T038
(	O
hl	B-T038
##h	I-T038
)	O
in	O
chinese	B-T098
children	O
without	B-T033
known	I-T033
family	I-T033
history	I-T033
of	I-T033
hl	B-T038
##h	I-T038
.	O
forty	O
children	O
with	O
hl	B-T038
##h	I-T038
and	O
160	O
age	O
-	O
and	O
gender	O
-	O
matched	O
healthy	O
controls	O
from	O
x	B-T092
##uz	I-T092
##hou	I-T092
children	I-T092
'	I-T092
s	I-T092
hospital	I-T092
were	O
enrolled	O
in	O
the	O
study	B-T062
.	O
serum	B-T031
ifn	B-T103
-	I-T103
γ	I-T103
and	O
il	B-T103
-	I-T103
10	I-T103
levels	O
were	O
measured	O
by	O
enzyme	B-T058
linked	I-T058
-	I-T058
immunosorbent	I-T058
assay	I-T058
.	O
polymorphisms	O
of	O
the	O
ifn	B-T017
-	I-T017
γ	I-T017
gene	I-T017
at	O
position	O
+	O
87	O
##4	O
and	O
+	O
210	O
##9	O
,	O
and	O
il	B-T017
-	I-T017
10	I-T017
at	O
position	O
-	O
108	O
##2	O
were	O
analyzed	B-T033
by	O
allele	B-T017
-	O
specific	O
pcr	B-T062
.	O
median	B-T031
serum	I-T031
concentrations	O
of	O
ifn	B-T103
-	I-T103
γ	I-T103
and	O
il	B-T103
-	I-T103
10	I-T103
were	O
significantly	O
higher	O
in	O
children	O
with	O
hl	B-T038
##h	I-T038
compared	O
to	O
healthy	O
controls	O
.	O
the	O
frequencies	O
of	O
ifn	B-T017
-	I-T017
γ	I-T017
+	O
87	O
##4	O
t	O
/	O
a	O
and	O
t	O
/	O
t	O
genotypes	O
,	O
as	O
well	O
as	O
t	B-T017
allele	I-T017
,	O
were	O
significantly	O
higher	O
in	O
the	O
hl	B-T038
##h	I-T038
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
.	O
the	O
frequencies	O
of	O
il	B-T017
-	I-T017
10	I-T017
-	O
108	O
##2	O
g	O
/	O
a	O
genotype	O
and	O
g	B-T017
allele	I-T017
were	O
significantly	O
increased	O
in	O
hl	B-T038
##h	I-T038
patients	O
compared	O
with	O
healthy	O
controls	O
.	O
no	B-T033
significant	I-T033
difference	O
was	O
found	O
in	O
the	O
distribution	O
of	O
ifn	B-T017
-	I-T017
γ	I-T017
+	O
210	O
##9	O
g	O
/	O
a	O
genotypes	O
between	O
children	O
with	O
hl	B-T038
##h	I-T038
and	O
controls	O
.	O
this	O
study	B-T062
presents	B-T033
preliminary	O
evidence	O
for	O
the	O
association	O
between	O
ifn	B-T017
+	O
87	O
##4	O
t	O
/	O
a	O
,	O
t	O
/	O
t	O
,	O
il	B-T017
-	I-T017
10	I-T017
-	O
108	O
##2	O
a	O
/	O
g	O
genotypes	O
,	O
and	O
hl	B-T038
##h	I-T038
susceptibility	B-T201
in	O
chinese	B-T098
children	O
with	O
hl	B-T038
##h	I-T038
.	O

malignancy	B-T038
is	O
associated	O
with	O
microc	B-T038
##alc	I-T038
##ification	I-T038
and	O
higher	O
ap	O
/	O
t	O
ratio	O
in	O
ultrasonography	B-T058
,	O
but	O
not	O
with	O
hash	B-T038
##imoto	I-T038
'	I-T038
s	I-T038
thyroiditis	I-T038
in	O
histopathology	B-T058
in	O
patients	O
with	O
thyroid	B-T038
nodules	I-T038
evaluated	O
as	O
bet	B-T038
##he	I-T038
##sd	I-T038
##a	I-T038
category	I-T038
iii	I-T038
(	O
aus	B-T038
/	O
flu	B-T033
##s	I-T033
)	O
in	O
cytology	B-T058
the	O
predictors	B-T170
of	O
malignancy	B-T038
are	O
important	O
for	O
the	O
decision	O
of	O
appropriate	O
management	B-T058
in	O
nodules	B-T038
with	O
atypia	B-T038
of	I-T038
undetermined	I-T038
significance	I-T038
/	O
follicular	B-T033
lesion	I-T033
of	I-T033
undetermined	I-T033
significance	I-T033
(	O
aus	B-T038
/	O
flu	B-T033
##s	I-T033
)	O
.	O
our	O
aim	O
was	O
to	O
determine	O
the	O
ultrasonographic	B-T170
##al	I-T170
,	O
clinical	B-T170
,	O
and	O
biochemical	B-T170
predictors	I-T170
of	O
malignancy	B-T038
in	O
these	O
patients	O
.	O
a	O
total	O
of	O
42	O
##7	O
patients	O
with	O
cytological	B-T038
##ly	I-T038
bet	I-T038
##he	I-T038
##sd	I-T038
##a	I-T038
category	I-T038
iii	I-T038
(	O
aus	B-T038
/	O
flu	B-T033
##s	I-T033
)	O
thyroid	B-T038
nodules	I-T038
were	O
included	O
in	O
this	O
retrospective	B-T062
study	I-T062
.	O
we	O
divided	O
the	O
nodules	B-T038
into	O
two	O
subgroups	B-T098
according	O
to	O
the	O
histopathology	B-T058
as	O
benign	O
and	O
malignant	O
,	O
and	O
compared	O
the	O
preoperative	O
ultrasonographic	B-T201
##al	I-T201
,	O
clinical	B-T201
,	O
and	O
biochemical	B-T033
findings	I-T033
.	O
in	O
overall	O
,	O
42	O
##7	O
patients	O
with	O
44	O
##9	O
aus	B-T038
/	O
flu	B-T033
##s	I-T033
nodules	B-T038
who	O
had	O
undergone	O
surgery	B-T058
,	O
the	O
rate	O
of	O
malignancy	B-T038
was	O
23	O
.	O
4	O
%	O
(	O
105	O
/	O
44	O
##9	O
)	O
.	O
when	O
evaluated	O
separately	O
,	O
the	O
rate	O
of	O
malignancy	B-T038
was	O
25	O
.	O
8	O
%	O
in	O
nodules	B-T038
with	O
aus	B-T038
(	O
82	O
/	O
318	O
)	O
and	O
17	O
.	O
6	O
%	O
in	O
nodules	B-T038
with	O
flu	B-T033
##s	I-T033
(	O
23	O
/	O
131	O
)	O
(	O
p	O
=	O
0	O
.	O
06	O
##1	O
)	O
.	O
the	O
vast	O
majority	O
of	O
malignant	O
specimens	O
in	O
histopathology	B-T058
consisted	O
of	O
papillary	B-T038
thyroid	I-T038
carcinoma	I-T038
(	O
ptc	B-T038
)	O
(	O
n	O
=	O
91	O
,	O
86	O
.	O
7	O
%	O
)	O
.	O
preoperative	O
ultrasonographic	B-T201
features	I-T201
of	O
105	O
malignant	B-T038
nodules	I-T038
in	O
histopathology	B-T058
were	O
compared	O
with	O
the	O
344	O
benign	B-T038
nodules	I-T038
in	O
histopathology	B-T058
.	O
anteroposterior	O
/	O
transverse	O
(	O
ap	O
/	O
t	O
)	O
ratio	O
was	O
significantly	O
higher	O
in	O
malignant	B-T098
group	I-T098
compared	O
to	O
benign	B-T098
group	I-T098
(	O
p	O
=	O
0	O
.	O
013	O
)	O
.	O
in	O
multiple	B-T062
logistic	I-T062
analysis	I-T062
,	O
we	O
found	O
that	O
higher	O
ap	O
/	O
t	O
ratio	O
and	O
microc	B-T038
##alc	I-T038
##ification	I-T038
were	O
independently	O
associated	O
with	O
malignancy	B-T038
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
malignancy	B-T038
-	O
associated	O
cut	O
-	O
off	O
value	O
of	O
ap	O
/	O
t	O
ratio	O
at	O
maximum	O
sensitivity	O
and	O
specificity	O
was	O
≥	O
##0	O
.	O
81	O
.	O
we	O
did	O
not	O
find	O
any	O
correlation	O
between	O
malignancy	B-T038
and	O
hash	B-T038
##imoto	I-T038
'	I-T038
s	I-T038
thyroiditis	I-T038
in	O
histopathology	B-T058
in	O
multivariate	O
analysis	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
in	O
bet	B-T038
##he	I-T038
##sd	I-T038
##a	I-T038
category	I-T038
iii	I-T038
nodules	I-T038
with	O
higher	O
ap	O
/	O
t	O
ratio	O
and	O
microc	B-T038
##alc	I-T038
##ification	I-T038
,	O
surgery	B-T058
might	O
be	O
considered	O
as	O
a	O
first	O
therapeutic	O
option	O
instead	O
of	O
repeat	O
fine	B-T058
-	I-T058
needle	I-T058
aspiration	I-T058
biopsy	I-T058
or	O
observation	B-T062
.	O

form	O
and	O
function	O
in	O
gene	B-T038
regulatory	I-T038
networks	I-T038
:	O
the	O
structure	B-T082
of	O
network	O
motifs	O
determines	O
fundamental	O
properties	O
of	O
their	O
dynamical	O
state	O
space	O
network	O
motifs	O
have	O
been	O
studied	O
extensively	O
over	O
the	O
past	O
decade	O
,	O
and	O
certain	O
motifs	O
,	O
such	O
as	O
the	O
feed	O
-	O
forward	O
loop	O
,	O
play	O
an	O
important	O
role	O
in	O
regulatory	B-T038
networks	I-T038
.	O
recent	O
studies	B-T062
have	O
used	O
bo	B-T170
##ole	I-T170
##an	I-T170
network	O
motifs	O
to	O
explore	O
the	O
link	O
between	O
form	O
and	O
function	O
in	O
gene	B-T038
regulatory	I-T038
networks	I-T038
and	O
have	O
found	O
that	O
the	O
structure	B-T082
of	O
a	O
motif	O
does	O
not	O
strongly	O
determine	O
its	O
function	O
,	O
if	O
this	O
is	O
defined	O
in	O
terms	O
of	O
the	O
gene	B-T038
expression	I-T038
patterns	B-T082
the	O
motif	O
can	O
produce	O
.	O
here	O
,	O
we	O
offer	O
a	O
different	O
,	O
higher	O
-	O
level	O
definition	B-T170
of	O
the	O
'	O
function	O
'	O
of	O
a	O
motif	O
,	O
in	O
terms	O
of	O
two	O
fundamental	O
properties	O
of	O
its	O
dynamical	O
state	O
space	O
as	O
a	O
bo	B-T170
##ole	I-T170
##an	I-T170
network	O
.	O
one	O
is	O
the	O
basin	O
entropy	O
,	O
which	O
is	O
a	O
complexity	O
measure	O
of	O
the	O
dynamics	O
of	O
bo	B-T170
##ole	I-T170
##an	I-T170
networks	O
.	O
the	O
other	O
is	O
the	O
diversity	O
of	O
cyclic	O
attract	O
##or	O
lengths	O
that	O
a	O
given	O
motif	O
can	O
produce	O
.	O
using	O
these	O
two	O
measures	O
,	O
we	O
examine	O
all	O
104	O
topological	O
##ly	O
distinct	O
three	O
-	O
node	O
motifs	O
and	O
show	O
that	O
the	O
structural	B-T082
properties	O
of	O
a	O
motif	O
,	O
such	O
as	O
the	O
presence	O
of	O
feedback	O
loops	O
and	O
feed	O
-	O
forward	O
loops	O
,	O
predict	O
fundamental	O
characteristics	O
of	O
its	O
dynamical	O
state	O
space	O
,	O
which	O
in	O
turn	O
determine	O
aspects	O
of	O
its	O
functional	O
versatility	O
.	O
we	O
also	O
show	O
that	O
these	O
higher	O
-	O
level	O
properties	O
have	O
a	O
direct	O
bearing	O
on	O
real	O
regulatory	B-T038
networks	I-T038
,	O
as	O
both	O
basin	O
entropy	O
and	O
cycle	O
length	O
diversity	O
show	O
a	O
close	O
correspondence	O
with	O
the	O
prevalence	O
,	O
in	O
neural	B-T038
and	O
genetic	B-T038
regulatory	I-T038
networks	I-T038
,	O
of	O
the	O
13	O
connected	O
motifs	O
without	O
self	O
-	O
interactions	O
that	O
have	O
been	O
studied	O
extensively	O
in	O
the	O
literature	B-T170
.	O

a	O
novel	O
brca1	B-T103
-	I-T103
associated	I-T103
protein	I-T103
-	I-T103
1	I-T103
isoform	B-T103
affects	O
response	O
of	O
mesothelioma	B-T038
cells	I-T038
to	O
drugs	B-T103
impairing	O
brca1	B-T103
-	O
mediated	O
dna	B-T038
repair	I-T038
brca1	B-T103
associated	I-T103
protein	I-T103
##1	I-T103
(	O
bap	B-T103
##1	I-T103
)	O
is	O
a	O
tumor	B-T103
suppressor	I-T103
involved	O
in	O
multiple	O
cellular	B-T038
processes	I-T038
such	O
as	O
transcriptional	B-T038
regulation	I-T038
,	O
chromatin	B-T038
modification	I-T038
by	O
de	B-T038
##ub	I-T038
##iqu	I-T038
##itin	I-T038
##ating	I-T038
histone	B-T103
2a	I-T103
,	O
and	O
dna	B-T038
repair	I-T038
.	O
bap	B-T103
##1	I-T103
mutations	B-T038
are	O
frequent	O
in	O
malignant	B-T038
pleural	I-T038
mesothelioma	I-T038
(	O
mpm	B-T038
)	O
.	O
our	O
aim	O
was	O
to	O
functionally	O
characterize	O
a	O
newly	O
identified	O
isoform	B-T103
of	B-T103
bap	I-T103
##1	I-T103
and	O
investigate	O
the	O
effects	O
of	O
its	O
expression	B-T038
on	O
drug	O
sensitivity	O
in	O
mpm	B-T038
.	O
expression	B-T038
of	O
bap	B-T103
##1	I-T103
isoforms	O
was	O
detected	B-T033
by	O
quantitative	B-T058
polymerase	I-T058
chain	I-T058
reaction	I-T058
in	O
mpm	B-T038
and	O
normal	O
mesoth	B-T017
##elium	I-T017
cell	B-T017
lines	I-T017
and	O
tumor	B-T017
and	O
nont	B-T017
##umor	I-T017
samples	I-T017
.	O
histone	B-T103
h2	I-T103
##a	I-T103
ubiquitination	B-T038
levels	O
were	O
analyzed	B-T062
by	O
western	B-T058
blot	I-T058
after	O
acidic	B-T058
extraction	I-T058
of	O
core	B-T103
histones	I-T103
.	O
subcellular	B-T017
localization	O
of	O
bap	B-T103
##1	I-T103
isoforms	B-T103
was	O
examined	B-T033
by	O
immunofluorescence	B-T058
.	O
mpm	B-T038
cell	B-T038
survival	I-T038
in	O
response	O
to	O
poly	B-T103
(	I-T103
adenosine	I-T103
diphosphate	I-T103
-	I-T103
ribose	I-T103
)	I-T103
polymerase	I-T103
(	O
parp	B-T103
)	O
and	O
dual	O
phosphoinositide	B-T103
3	I-T103
-	I-T103
kinase	I-T103
(	O
pi3k	B-T103
)	O
-	O
mammalian	B-T103
target	I-T103
of	I-T103
rapamycin	I-T103
(	O
mtor	B-T103
)	O
inhibitors	B-T103
was	O
analyzed	B-T062
by	O
in	B-T062
vitro	I-T062
assays	I-T062
.	O
we	O
have	O
identified	O
a	O
novel	O
alternative	B-T103
splice	I-T103
isoform	I-T103
of	O
bap	B-T103
##1	I-T103
(	O
bap	B-T017
##1	I-T017
##δ	I-T017
)	O
that	O
miss	O
##es	O
part	O
of	O
the	O
catalytic	B-T082
domain	I-T082
.	O
cells	B-T017
transfected	B-T062
with	O
bap	B-T017
##1	I-T017
##δ	I-T017
showed	O
reduced	O
de	B-T038
##ub	I-T038
##iqu	I-T038
##itin	I-T038
##ating	I-T038
activity	I-T038
compared	O
with	O
full	O
-	O
length	O
bap	B-T103
##1	I-T103
.	O
the	O
expression	B-T038
of	O
bap	B-T017
##1	I-T017
##δ	I-T017
transcript	B-T103
is	O
more	O
abundant	O
in	O
nont	B-T017
##umor	I-T017
than	O
in	O
tumor	O
samples	O
.	O
mpm	B-T038
cell	B-T017
lines	I-T017
expressing	B-T038
more	O
than	O
20	O
%	O
of	O
bap	B-T017
##1	I-T017
##δ	I-T017
are	O
more	O
sensitive	O
to	O
ol	B-T103
##apa	I-T103
##ri	I-T103
##b	I-T103
(	O
a	O
parp	B-T103
##1	I-T103
inhibitor	B-T103
)	O
cytotoxicity	B-T038
,	O
and	O
this	O
sensitivity	O
is	O
enhanced	O
when	O
ol	B-T103
##apa	I-T103
##ri	I-T103
##b	I-T103
treatment	B-T058
is	O
combined	O
with	O
gd	B-T103
##c	I-T103
##09	I-T103
##80	I-T103
(	O
a	O
dual	O
pi3k	B-T103
-	O
mtor	B-T103
inhibitor	B-T103
)	O
,	O
which	O
induces	O
downregulation	B-T038
of	O
brca1	B-T103
.	O
these	O
observations	B-T062
suggest	O
that	O
bap	B-T017
##1	I-T017
##δ	I-T017
does	O
regulate	B-T038
dna	I-T038
damage	I-T038
response	I-T038
and	O
influences	O
drug	O
sensitivity	O
.	O
it	O
might	O
therefore	O
be	O
relevant	O
to	O
investigate	O
whether	O
patients	O
with	O
high	O
expression	B-T038
of	O
bap	B-T017
##1	I-T017
##δ	I-T017
may	O
be	O
responsive	B-T201
to	O
parp	B-T103
/	O
pi3k	B-T103
-	O
mtor	B-T103
inhibitors	B-T103
.	O

assessment	B-T058
of	O
residual	B-T038
disease	I-T038
with	O
molecular	B-T058
breast	I-T058
imaging	I-T058
in	O
patients	O
undergoing	O
neoadjuvant	B-T058
therapy	I-T058
:	O
association	O
with	O
molecular	O
subtypes	B-T170
assessment	B-T058
of	O
residual	B-T038
disease	I-T038
after	O
neoadjuvant	B-T058
therapy	I-T058
for	O
breast	B-T038
cancer	I-T038
is	O
an	O
ongoing	O
challenge	O
of	O
breast	B-T017
imaging	B-T058
.	O
this	O
study	B-T062
evaluates	B-T058
the	O
accuracy	O
of	O
a	O
novel	O
dedicated	O
system	O
for	O
molecular	B-T058
breast	I-T058
imaging	I-T058
(	O
mb	B-T058
##i	I-T058
)	O
composed	O
of	O
the	O
new	O
generation	O
of	O
cadmium	B-T103
zinc	I-T103
tell	I-T103
##ur	I-T103
##ide	I-T103
detectors	O
in	O
assessing	O
residual	B-T038
disease	I-T038
after	O
neoadjuvant	B-T058
therapy	I-T058
in	O
patients	O
with	O
breast	B-T038
cancer	I-T038
.	O
clinical	B-T170
data	I-T170
,	O
imaging	B-T058
,	O
surgical	O
,	O
and	O
pathological	O
findings	B-T033
of	O
51	O
women	B-T098
with	O
breast	B-T038
cancer	I-T038
undergoing	O
neoadjuvant	B-T058
therapy	I-T058
were	O
recorded	O
.	O
mb	B-T058
##i	I-T058
findings	B-T033
were	O
correlated	O
with	O
surgical	B-T170
pathology	I-T170
results	I-T170
.	O
accuracy	O
of	O
mb	B-T058
##i	I-T058
in	O
predicting	O
complete	B-T033
pathological	I-T033
response	I-T033
and	O
size	B-T082
of	O
residual	B-T038
disease	I-T038
was	O
assessed	O
according	O
to	O
molecular	O
subtypes	B-T170
.	O
the	O
size	B-T082
of	O
the	O
largest	O
focus	O
of	O
uptake	O
on	O
mb	B-T058
##i	I-T058
correlated	O
with	O
the	O
largest	O
dimension	O
measured	O
on	O
pathology	O
(	O
r	O
=	O
0	O
.	O
55	O
;	O
p	O
<	O
.	O
001	O
)	O
.	O
this	O
correlation	O
was	O
stronger	O
for	O
triple	B-T038
negative	I-T038
and	O
her2	B-T201
/	I-T201
neu	I-T201
positive	I-T201
subtypes	B-T170
(	O
r	O
=	O
0	O
.	O
92	O
and	O
0	O
.	O
62	O
,	O
respectively	O
)	O
.	O
sixteen	O
patients	O
(	O
31	O
%	O
)	O
had	O
complete	B-T033
pathological	I-T033
response	I-T033
.	O
the	O
sensitivity	O
and	O
specificity	O
of	O
mb	B-T058
##i	I-T058
for	O
detecting	O
residual	B-T038
disease	I-T038
were	O
83	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
,	O
66	O
-	O
93	O
)	O
and	O
69	O
%	O
(	O
95	O
%	O
ci	O
,	O
42	O
-	O
88	O
)	O
,	O
respectively	O
.	O
for	O
triple	B-T038
negative	I-T038
or	O
her2	B-T201
/	I-T201
neu	I-T201
positive	I-T201
disease	O
the	O
sensitivity	O
and	O
specificity	O
were	O
88	O
%	O
(	O
95	O
%	O
ci	O
,	O
62	O
-	O
98	O
)	O
and	O
75	O
%	O
(	O
95	O
%	O
ci	O
,	O
43	O
-	O
93	O
)	O
,	O
respectively	O
.	O
the	O
accuracy	O
of	O
mb	B-T058
##i	I-T058
in	O
assessing	O
residual	B-T038
disease	I-T038
after	O
neoadjuvant	B-T058
treatment	I-T058
might	O
be	O
related	O
to	O
the	O
molecular	O
subtype	B-T170
.	O
accuracy	O
is	O
highest	O
in	O
the	O
triple	B-T038
negative	I-T038
and	O
her2	B-T201
/	I-T201
neu	I-T201
positive	I-T201
subtypes	B-T170
.	O

electronic	O
tongue	O
##s	O
to	O
assess	O
wine	B-T168
sensory	O
descriptors	B-T170
this	O
work	O
reports	B-T170
the	O
application	O
of	O
an	O
electronic	O
tongue	O
as	O
a	O
tool	O
towards	O
the	O
analysis	B-T062
of	O
wine	B-T168
in	O
tasks	O
such	O
as	O
its	O
discrimination	O
based	O
on	O
the	O
mat	O
##uring	O
in	O
barrel	O
##s	O
or	O
the	O
prediction	O
of	O
the	O
global	O
scores	O
assigned	O
by	O
a	O
sensory	B-T097
panel	I-T097
.	O
to	O
this	O
aim	O
,	O
red	B-T168
wine	I-T168
samples	O
were	O
first	O
analysed	B-T062
with	O
the	O
voltamm	O
##etric	O
sensor	O
array	O
,	O
without	O
performing	O
any	O
sample	O
pretreatment	O
.	O
afterwards	O
,	O
obtained	O
responses	O
were	O
prepro	O
##cess	O
##ed	O
employing	O
fast	B-T170
fourier	I-T170
transform	I-T170
(	O
ff	B-T170
##t	I-T170
)	O
for	O
the	O
compression	O
and	O
reduction	O
of	O
signal	O
complexity	O
,	O
and	O
obtained	O
coefficients	O
were	O
then	O
used	O
as	O
inputs	O
to	O
build	O
the	O
qualitative	O
and	O
quantitative	O
models	O
employing	O
either	O
linear	B-T062
discriminant	I-T062
analysis	I-T062
(	O
lda	B-T062
)	O
or	O
partial	B-T170
least	I-T170
squares	I-T170
regression	I-T170
(	O
pls	B-T170
)	O
,	O
respectively	O
.	O
satisfactory	O
results	O
were	O
obtained	O
overall	O
,	O
with	O
a	O
classification	B-T170
rate	O
of	O
100	O
%	O
in	O
the	O
discrimination	O
of	O
the	O
type	O
of	O
barrel	O
used	O
during	O
wine	B-T168
mat	O
##uring	O
,	O
a	O
normalized	O
nr	O
##ms	O
##e	O
of	O
0	O
.	O
07	O
##7	O
in	O
the	O
estimation	O
of	O
ageing	B-T038
time	O
(	O
months	O
)	O
or	O
0	O
.	O
11	O
in	O
the	O
prediction	O
of	O
the	O
scores	O
(	O
0	O
-	O
10	O
)	O
from	O
a	O
trained	B-T097
sensory	I-T097
panel	I-T097
(	O
all	O
for	O
the	O
external	O
test	O
subset	B-T170
)	O
.	O

activation	O
of	O
the	O
orphan	B-T103
receptor	I-T103
gpr	I-T103
##55	I-T103
by	O
lysophosph	B-T103
##atidyl	I-T103
##inositol	I-T103
promotes	O
metastasis	B-T038
in	O
triple	B-T038
-	I-T038
negative	I-T038
breast	I-T038
cancer	I-T038
the	O
orphan	B-T103
g	I-T103
protein	I-T103
-	I-T103
coupled	I-T103
receptor	I-T103
gpr	B-T103
##55	I-T103
has	O
been	O
directly	O
or	O
indirectly	O
related	O
to	O
basic	O
alterations	O
that	O
drive	O
malignant	O
growth	B-T038
:	O
uncontrolled	O
cancer	O
cell	B-T038
proliferation	I-T038
,	O
sustained	B-T038
angiogenesis	I-T038
,	O
and	O
cancer	O
cell	B-T038
adhesion	I-T038
and	O
migration	O
.	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
involvement	O
of	O
this	O
receptor	B-T103
in	O
metastasis	B-T038
.	O
here	O
,	O
we	O
show	O
that	O
elevated	O
gpr	O
##55	O
expression	O
in	O
human	B-T204
tumors	B-T038
is	O
associated	O
with	O
the	O
aggressive	B-T038
basal	I-T038
/	O
triple	B-T038
-	I-T038
negative	I-T038
breast	I-T038
cancer	I-T038
population	B-T098
,	O
higher	O
probability	O
to	O
develop	O
metastases	B-T038
,	O
and	O
therefore	O
poor	O
patient	O
prognosis	B-T058
.	O
activation	O
of	O
gpr	B-T103
##55	I-T103
by	O
its	O
proposed	O
endogenous	O
ligand	B-T103
lysophosph	B-T103
##atidyl	I-T103
##inositol	I-T103
confers	O
pro	O
-	O
invasive	O
features	O
on	O
breast	B-T017
cancer	I-T017
cells	I-T017
both	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O
specifically	O
,	O
this	O
effect	O
is	O
elicited	O
by	O
coupling	O
to	O
gq	B-T103
/	I-T103
11	I-T103
hetero	I-T103
##tri	I-T103
##mer	I-T103
##ic	I-T103
proteins	I-T103
and	O
the	O
subsequent	O
activation	O
,	O
through	O
erk	B-T103
,	O
of	O
the	O
transcription	B-T103
factor	I-T103
et	I-T103
##v	I-T103
##4	I-T103
/	O
pea	B-T103
##3	I-T103
.	O
together	O
,	O
these	O
data	O
show	O
that	O
gpr	B-T103
##55	I-T103
promotes	O
breast	B-T038
cancer	I-T038
metastasis	B-T038
,	O
and	O
supports	O
the	O
notion	O
that	O
this	O
orphan	B-T103
receptor	I-T103
may	O
constitute	O
a	O
new	O
therapeutic	O
target	O
and	O
potential	O
biomarker	B-T201
in	O
the	O
highly	O
aggressive	B-T170
triple	I-T170
-	I-T170
negative	I-T170
subtype	I-T170
.	O

quality	O
of	O
nursing	B-T170
intensity	I-T170
data	I-T170
:	O
inter	O
-	O
rater	O
reliability	O
of	O
the	O
patient	O
classification	B-T170
after	O
two	O
decades	O
in	O
clinical	O
use	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
measure	O
the	O
inter	O
-	O
rater	O
reliability	O
of	O
the	O
ou	B-T170
##lu	I-T170
patient	I-T170
classification	I-T170
and	O
to	O
discuss	O
existing	O
methods	O
of	O
reliability	O
testing	O
.	O
the	O
ou	B-T170
##lu	I-T170
patient	I-T170
classification	I-T170
,	O
part	O
of	O
the	O
raf	B-T170
##ael	I-T170
##a	I-T170
(	I-T170
®	I-T170
)	I-T170
system	I-T170
,	O
has	O
been	O
developed	O
to	O
assist	O
nursing	B-T097
managers	I-T097
with	O
the	O
proper	O
allocation	O
of	O
nursing	B-T058
resources	O
.	O
due	O
to	O
the	O
increased	O
intensity	O
of	O
inpatient	B-T058
care	I-T058
during	O
recent	O
years	O
,	O
there	O
is	O
a	O
need	O
for	O
the	O
reliability	O
testing	O
of	O
the	O
classification	B-T170
,	O
which	O
has	O
been	O
in	O
clinical	O
use	O
for	O
20	O
years	O
.	O
retrospective	O
statistical	B-T170
study	I-T170
.	O
to	O
test	O
inter	O
-	O
rater	O
reliability	O
,	O
a	O
pair	O
of	O
nurses	B-T097
classified	B-T170
the	O
same	O
patients	O
,	O
without	O
knowledge	O
of	O
each	O
other	O
'	O
s	O
ratings	O
,	O
as	O
a	O
part	O
of	O
annually	O
conducted	O
standardization	B-T062
.	O
data	O
on	O
the	O
parallel	B-T170
classifications	I-T170
(	O
n	O
=	O
19	O
,	O
99	O
##7	O
)	O
was	O
obtained	O
from	O
inpatient	O
units	O
(	O
n	O
=	O
32	O
)	O
with	O
different	O
specialties	B-T091
at	O
a	O
university	B-T092
hospital	I-T092
in	O
finland	B-T082
during	O
2010	O
-	O
2015	O
.	O
parallel	B-T170
classification	I-T170
practices	O
were	O
also	O
analysed	O
.	O
the	O
reliability	O
of	O
the	O
overall	O
classification	B-T170
and	O
its	O
sub	O
##are	O
##as	O
were	O
calculated	O
using	O
suitable	O
statistical	O
coefficients	O
.	O
inter	O
-	O
rater	O
reliability	O
coefficients	O
were	O
a	O
reliable	O
or	O
almost	O
perfect	O
means	O
of	O
considering	O
the	O
nursing	B-T058
intensity	O
category	B-T170
and	O
various	O
practices	O
,	O
but	O
there	O
were	O
detectable	B-T033
differences	O
between	O
sub	O
##are	O
##as	O
.	O
the	O
lowest	O
agreement	O
levels	O
occurred	O
in	O
the	O
sub	O
##are	O
##as	O
'	O
planning	O
and	O
coordination	O
of	O
nursing	O
care	O
'	O
and	O
'	O
guiding	O
of	O
care	O
/	O
continued	B-T058
care	I-T058
and	O
emotional	B-T058
support	I-T058
'	O
.	O
there	O
is	O
a	O
need	O
to	O
develop	O
the	O
descriptions	B-T170
of	O
sub	O
##are	O
##as	O
and	O
to	O
clarify	O
the	O
related	O
concepts	O
.	O
precise	O
nursing	B-T058
documentation	I-T058
can	O
promote	O
a	O
high	O
level	O
of	O
agreement	O
and	O
reliable	O
results	O
.	O
the	O
traditional	O
overall	O
proportion	O
of	O
agreement	O
does	O
not	O
provide	O
an	O
adequate	O
picture	O
of	O
reliability	O
-	O
weighted	O
kappa	O
coefficients	O
should	O
be	O
used	O
instead	O
.	O

structural	O
and	O
functional	O
characterization	O
of	O
the	O
ty	B-T103
##w	I-T103
##3	I-T103
/	O
ta	B-T103
##w	I-T103
##3	I-T103
class	O
of	O
sam	B-T103
-	I-T103
dependent	I-T103
methyltransferase	I-T103
##s	I-T103
s	B-T103
-	I-T103
adenosyl	I-T103
##meth	I-T103
##ionine	I-T103
(	I-T103
sam	I-T103
)	I-T103
-	I-T103
dependent	I-T103
methyltransferase	I-T103
##s	I-T103
regulate	B-T038
a	O
wide	O
range	O
of	O
biological	B-T038
processes	I-T038
through	O
the	O
modification	B-T038
of	O
proteins	B-T103
,	O
nucleic	B-T103
acids	I-T103
,	O
polysaccharides	B-T103
,	O
as	O
well	O
as	O
various	O
metabolites	B-T103
.	O
ty	B-T103
##w	I-T103
##3	I-T103
/	O
ta	B-T103
##w	I-T103
##3	I-T103
is	O
a	O
sam	B-T103
-	I-T103
dependent	I-T103
methyltransferase	I-T103
responsible	O
for	O
the	O
formation	O
of	O
a	O
trna	B-T038
modification	I-T038
known	O
as	O
w	B-T103
##yb	I-T103
##ut	I-T103
##osine	I-T103
and	O
its	O
derivatives	O
that	O
are	O
required	O
for	O
accurate	O
decoding	B-T038
in	O
protein	B-T038
synthesis	I-T038
.	O
here	O
,	O
we	O
report	O
the	O
crystal	B-T017
structure	I-T017
of	O
ta	B-T103
##w	I-T103
##3	I-T103
,	O
a	O
homolog	O
of	O
ty	B-T103
##w	I-T103
##3	I-T103
from	O
sulfo	O
##lo	O
##bu	O
##s	O
sol	O
##fa	O
##ta	O
##ric	O
##us	O
,	O
which	O
revealed	O
a	O
novel	O
α	B-T038
/	I-T038
β	I-T038
fold	I-T038
.	O
the	O
sequence	O
motif	O
(	O
s	B-T082
/	I-T082
t	I-T082
)	I-T082
x	I-T082
##ss	I-T082
##c	I-T082
##x	I-T082
##gr	I-T082
and	O
invariant	O
aspartate	B-T103
and	O
histidine	B-T103
,	O
conserved	O
in	O
ty	B-T103
##w	I-T103
##3	I-T103
/	O
ta	B-T103
##w	I-T103
##3	I-T103
,	O
cluster	O
to	O
form	O
the	O
catalytic	O
center	O
.	O
these	O
structural	B-T103
and	O
sequence	B-T082
features	O
indicate	O
that	O
ty	B-T103
##w	I-T103
##3	I-T103
/	O
ta	B-T103
##w	I-T103
##3	I-T103
proteins	O
constitute	O
a	O
distinct	O
class	O
of	O
sam	B-T103
-	I-T103
dependent	I-T103
methyltransferase	I-T103
##s	I-T103
.	O
using	O
site	B-T038
-	I-T038
directed	I-T038
mutagenesis	I-T038
along	O
with	O
in	B-T058
vivo	I-T058
complementation	I-T058
assays	I-T058
combined	O
with	O
mass	B-T058
spectrometry	I-T058
as	O
well	O
as	O
ligand	B-T038
docking	I-T038
and	O
cofactor	B-T038
binding	I-T038
assays	B-T058
,	O
we	O
have	O
identified	O
the	O
active	O
site	O
of	O
ty	B-T103
##w	I-T103
##3	I-T103
and	O
residues	O
essential	O
for	O
cofactor	B-T038
binding	I-T038
and	O
methyltransferase	B-T038
activity	I-T038
.	O

role	O
of	O
infrared	B-T058
spectroscopy	I-T058
and	O
imaging	B-T058
in	O
cancer	B-T038
diagnosis	B-T033
ftir	B-T062
imaging	B-T058
has	O
been	O
used	O
to	O
diagnose	B-T033
and	O
differentiate	O
the	O
molecular	O
differences	O
between	O
normal	B-T017
and	O
diseased	B-T038
tissues	B-T017
.	O
the	O
differences	O
correspond	O
to	O
the	O
distribution	O
and	O
structure	B-T082
of	O
lipids	B-T103
,	O
proteins	B-T103
,	O
nucleic	B-T103
acids	I-T103
as	O
well	O
as	O
other	O
metabolites	B-T103
.	O
these	O
differences	O
depended	O
on	O
the	O
type	O
and	O
the	O
grade	O
of	O
cancer	B-T038
.	O
the	O
sensitivity	O
of	O
chemotherapy	B-T058
drugs	B-T103
on	O
individual	B-T098
specific	O
was	O
also	O
discussed	O
.	O
here	O
,	O
we	O
emphasize	O
that	O
ftir	B-T062
spectroscopy	I-T062
and	O
imaging	B-T058
can	O
be	O
considered	O
as	O
a	O
promising	O
technique	O
and	O
will	O
find	O
its	O
place	O
on	O
the	O
detection	B-T058
of	O
this	O
dre	B-T038
##ad	I-T038
##ful	I-T038
disease	I-T038
because	O
of	O
high	O
sensitivity	O
,	O
accuracy	O
and	O
inexpensive	O
technique	O
.	O
now	O
the	O
medical	B-T092
community	I-T092
started	O
using	O
and	O
accepting	O
this	O
technique	O
for	O
early	O
stage	O
cancer	B-T038
detection	B-T058
.	O
but	O
,	O
this	O
technique	O
end	O
##ures	O
several	O
challenges	B-T058
on	O
its	O
application	O
into	O
the	O
diagnosis	B-T033
of	O
cancer	B-T038
in	O
regards	O
of	O
sample	O
preparations	O
,	O
data	B-T058
interpretation	I-T058
,	O
and	O
data	O
analysis	O
.	O
in	O
general	O
,	O
more	O
research	B-T062
is	O
needed	O
in	O
this	O
field	O
and	O
it	O
is	O
necessary	O
to	O
understand	O
the	O
morphology	O
and	O
biology	B-T091
of	O
the	O
sample	O
before	O
using	O
the	O
spectroscopy	B-T062
and	O
imaging	B-T058
because	O
invaluable	O
information	O
to	O
be	O
figure	O
##d	O
out	O
.	O

bio	O
##engine	O
##ered	O
3d	B-T082
models	O
for	O
studying	B-T062
human	B-T204
cell	B-T017
-	O
tuberculosis	B-T007
interactions	O
in	B-T082
vivo	I-T082
animal	B-T204
models	I-T204
have	O
intrinsic	O
limitations	O
for	O
studying	B-T062
relationships	O
between	O
tuberculosis	B-T007
and	O
its	O
host	O
and	O
there	O
is	O
a	O
need	O
for	O
alternative	O
,	O
in	O
vitro	O
cellular	O
models	O
.	O
a	O
microsphere	B-T074
-	O
based	O
3d	B-T082
in	O
vitro	O
culture	B-T062
system	I-T062
of	O
mycobacterium	B-T007
tuberculosis	I-T007
-	O
infected	O
human	B-T204
blood	B-T031
mononuclear	O
cells	O
was	O
reported	O
to	O
address	O
specific	O
aspects	O
of	O
host	O
-	O
pathogen	O
interactions	O
.	O

effect	O
of	O
protein	B-T103
repetitive	O
##ness	O
on	O
protein	B-T038
-	I-T038
protein	I-T038
interaction	I-T038
prediction	O
results	O
using	O
support	O
vector	O
machines	O
there	O
are	O
many	O
computational	B-T062
approaches	I-T062
to	O
predict	O
the	O
protein	B-T038
-	I-T038
protein	I-T038
interactions	I-T038
using	O
support	O
vector	O
machines	O
(	O
svm	O
##s	O
)	O
with	O
high	O
performance	O
.	O
in	O
fact	O
,	O
performance	O
of	O
currently	O
reported	O
methods	B-T170
are	O
significantly	O
over	O
-	O
estimated	O
and	O
affected	O
by	O
the	O
object	O
repetitive	O
##ness	O
in	O
the	O
datasets	B-T170
used	O
.	O
to	O
study	B-T062
the	O
effect	O
of	O
object	O
repetitive	O
##ness	O
of	O
datasets	B-T170
on	O
predicting	O
results	O
.	O
we	O
present	O
novel	O
methods	B-T170
to	O
construct	O
different	O
positive	B-T033
datasets	B-T170
with	O
or	O
without	O
repeating	O
proteins	B-T103
using	O
graph	B-T170
maximum	O
matching	O
in	O
the	O
protein	B-T038
-	I-T038
protein	I-T038
interaction	I-T038
datasets	B-T170
and	O
corresponding	O
series	O
of	O
negative	B-T033
datasets	B-T170
with	O
different	O
proteins	B-T103
repetitive	O
##ness	O
are	O
constructed	O
using	O
graph	B-T170
adj	B-T082
##ace	I-T082
##nc	I-T082
##y	I-T082
matrix	I-T082
.	O
the	O
relationship	O
between	O
the	O
svm	O
prediction	O
results	O
and	O
the	O
repeated	O
proteins	B-T103
(	O
repeat	O
numbers	O
and	O
repeat	O
rates	O
)	O
and	O
the	O
distributions	O
of	O
repeated	O
proteins	B-T103
in	O
the	O
datasets	B-T170
are	O
analyzed	O
.	O
protein	B-T103
repetitive	O
##ness	O
of	O
positive	B-T033
and	O
negative	B-T033
datasets	B-T170
can	O
affect	O
the	O
prediction	O
result	O
:	O
high	O
protein	B-T103
repetitive	O
##ness	O
of	O
positive	B-T033
or	O
negative	B-T033
datasets	B-T170
yield	O
high	O
performance	O
prediction	O
result	O
.	O
this	O
indicate	O
that	O
dealing	O
with	O
object	O
repetitive	O
##ness	O
of	O
datasets	B-T170
is	O
a	O
key	O
issue	O
in	O
protein	B-T038
-	I-T038
protein	I-T038
interactions	I-T038
prediction	O
using	O
svm	O
##s	O
since	O
real	O
world	O
data	O
contain	O
certain	O
degrees	O
of	O
repeat	O
proteins	B-T103
.	O

characterization	O
of	O
electroc	B-T058
##ortic	I-T058
##ogram	I-T058
high	O
-	O
gamma	O
signal	O
in	O
response	O
to	O
varying	O
upper	B-T017
extremity	I-T017
movement	B-T038
velocity	O
the	O
mechanism	O
by	O
which	O
the	O
human	B-T204
primary	B-T082
motor	I-T082
cortex	I-T082
(	O
m1	B-T082
)	O
encodes	O
upper	B-T017
extremity	I-T017
movement	B-T038
kinematics	B-T091
is	O
not	O
fully	O
understood	O
.	O
for	O
example	O
,	O
human	B-T204
electroc	B-T058
##ortic	I-T058
##ogram	I-T058
(	O
ecog	B-T058
)	O
signals	O
have	O
been	O
shown	O
to	O
modulate	B-T082
with	O
upper	B-T017
extremity	I-T017
movement	B-T038
s	O
;	O
however	O
,	O
this	O
relationship	O
has	O
not	O
been	O
explicitly	O
characterized	O
.	O
to	O
address	O
this	O
issue	B-T033
,	O
we	O
recorded	O
high	O
-	O
density	O
ecog	B-T058
signals	O
from	O
patients	O
undergoing	O
epilepsy	B-T038
surgery	B-T058
evaluation	B-T058
as	O
they	O
performed	O
elementary	O
upper	B-T017
extremity	I-T017
movements	B-T038
while	O
systematically	O
varying	O
movement	B-T038
speed	O
and	O
duration	O
.	O
specifically	O
,	O
subjects	O
performed	O
intermittent	O
pin	B-T033
##cer	I-T033
grasp	I-T033
/	O
release	O
,	O
elbow	O
flexion	O
/	O
extension	O
,	O
and	O
shoulder	B-T033
flexion	I-T033
/	O
extension	O
at	O
slow	O
,	O
moderate	O
,	O
and	O
fast	O
speeds	O
.	O
in	O
all	O
movements	B-T038
,	O
bursts	O
of	O
power	O
in	O
the	O
high	O
-	O
[	O
formula	O
:	O
see	O
text	O
]	O
band	O
(	O
80	O
-	O
160	O
hz	O
)	O
were	O
observed	O
in	O
m1	B-T082
.	O
in	O
addition	O
,	O
the	O
amplitude	B-T082
of	O
these	O
power	O
bursts	O
and	O
the	O
area	B-T082
of	O
m1	B-T082
with	O
elevated	O
high	O
-	O
[	O
formula	O
:	O
see	O
text	O
]	O
activity	O
were	O
directly	O
proportional	O
to	O
the	O
movement	B-T038
speed	O
.	O
likewise	O
,	O
the	O
duration	O
of	O
elevated	O
high	O
-	O
[	O
formula	O
:	O
see	O
text	O
]	O
activity	O
increased	O
with	O
movement	B-T038
duration	O
.	O
based	O
on	O
linear	O
regression	O
,	O
m1	B-T082
high	O
-	O
[	O
formula	O
:	O
see	O
text	O
]	O
power	O
amplitude	B-T082
and	O
duration	O
covari	O
##ed	O
with	O
movement	B-T038
speed	O
and	O
duration	O
,	O
respectively	O
,	O
with	O
an	O
average	O
[	O
formula	O
:	O
see	O
text	O
]	O
of	O
[	O
formula	O
:	O
see	O
text	O
]	O
and	O
[	O
formula	O
:	O
see	O
text	O
]	O
.	O
these	O
findings	B-T033
indicate	O
that	O
the	O
encoding	O
of	O
upper	B-T017
extremity	I-T017
movement	B-T038
speed	O
by	O
m1	B-T082
high	O
-	O
[	O
formula	O
:	O
see	O
text	O
]	O
activity	O
is	O
primarily	O
linear	B-T082
.	O
also	O
,	O
the	O
fact	O
that	O
this	O
activity	O
remained	O
elevated	O
throughout	O
a	O
movement	B-T038
suggests	O
that	O
m1	B-T082
does	O
not	O
merely	O
generate	O
transient	O
instructions	B-T170
for	O
a	O
specific	O
movement	B-T038
duration	O
,	O
but	O
instead	O
is	O
responsible	O
for	O
the	O
entire	O
##ty	O
of	O
the	O
movement	B-T038
.	O
finally	O
,	O
the	O
spatial	B-T082
distribution	I-T082
of	O
high	O
-	O
[	O
formula	O
:	O
see	O
text	O
]	O
activity	O
suggests	O
the	O
presence	B-T033
of	O
a	O
recruitment	O
phenomenon	O
in	O
which	O
higher	O
speeds	O
or	O
increased	O
muscle	B-T017
activity	O
involve	O
activation	O
of	O
larger	O
m1	B-T082
area	B-T082
s	O
.	O

morphological	B-T082
characteristics	O
regulating	O
phal	B-T017
##lic	I-T017
gla	I-T017
##ns	I-T017
eng	B-T038
##or	I-T038
##ge	I-T038
##ment	I-T038
in	O
the	O
american	B-T204
all	I-T204
##ig	I-T204
##ator	I-T204
the	O
distal	B-T082
part	I-T082
of	O
the	O
cro	B-T204
##co	I-T204
##di	I-T204
##li	I-T204
##an	I-T204
phal	B-T017
##lu	I-T017
##s	I-T017
consists	O
of	O
a	O
bulb	B-T017
##ous	I-T017
gla	I-T017
##ns	I-T017
containing	O
well	O
-	O
developed	O
vascular	B-T017
tissues	I-T017
that	O
can	O
infl	O
##ate	O
before	O
or	O
during	O
sexual	O
activity	O
,	O
enlarg	O
##ing	O
and	O
elab	O
##orating	O
the	O
gla	O
##ns	O
into	O
a	O
complex	O
,	O
though	O
still	O
functionally	O
undefined	O
,	O
cop	O
##ulatory	O
structure	O
.	O
an	O
enlarged	O
gla	O
##ns	O
putative	O
##ly	O
interacts	O
with	O
the	O
female	O
cloac	B-T017
##a	I-T017
and	O
may	O
change	O
the	O
shape	B-T082
of	O
her	B-T022
reproductive	I-T022
tract	I-T022
to	O
facilitate	O
insemination	B-T038
and	O
increase	O
the	O
probability	O
of	O
fertilization	B-T038
.	O
here	O
,	O
we	O
investigated	O
the	O
cellular	B-T038
-	I-T038
level	I-T038
properties	I-T038
of	O
the	O
gla	O
##ns	O
and	O
other	O
infl	B-T017
##atable	I-T017
phal	I-T017
##lic	I-T017
tissues	I-T017
associated	O
with	O
the	O
sperm	B-T017
-	O
conducting	O
sulcus	B-T082
spermat	B-T017
##icus	I-T017
in	O
the	O
american	B-T204
all	I-T204
##ig	I-T204
##ator	I-T204
(	O
all	B-T204
##ig	I-T204
##ator	I-T204
miss	I-T204
##iss	I-T204
##ipp	I-T204
##iensis	I-T204
)	O
.	O
using	O
histochemical	B-T058
staining	I-T058
,	O
we	O
visualized	O
and	O
defined	O
collagen	B-T103
and	O
elastin	B-T017
fiber	I-T017
densities	O
and	O
orientations	B-T082
in	O
these	O
tissues	B-T017
.	O
extracellular	B-T017
matrix	I-T017
architectures	O
provided	O
insights	O
about	O
phal	B-T017
##lic	I-T017
gla	I-T017
##ns	I-T017
material	O
properties	O
and	O
how	O
they	O
may	O
affect	O
tissue	B-T017
strength	O
and	O
flexibility	O
during	O
inflation	O
and	O
in	O
response	O
to	O
cop	O
##ulatory	O
forces	O
.	O
we	O
also	O
investigated	O
the	O
potential	O
sources	O
of	O
fluids	O
that	O
induce	O
inflation	O
in	O
all	B-T204
##ig	I-T204
##ator	I-T204
phal	B-T017
##li	I-T017
.	O
combining	O
serial	B-T058
sectioning	I-T058
and	O
three	B-T058
-	I-T058
dimensional	I-T058
reconstruction	I-T058
,	O
we	O
identified	O
a	O
pair	O
of	O
supra	B-T017
##cr	I-T017
##uc	I-T017
##al	I-T017
plexus	I-T017
vascular	I-T017
bodies	B-T017
at	O
the	O
proximal	O
end	O
of	O
the	O
all	B-T204
##ig	I-T204
##ator	I-T204
phal	B-T017
##lu	I-T017
##s	I-T017
that	O
extend	O
distally	O
adjacent	O
to	O
ventr	B-T017
##o	I-T017
-	I-T017
medial	I-T017
sulcus	I-T017
tissues	I-T017
.	O
together	O
,	O
our	O
gross	O
and	O
histological	B-T033
examination	I-T033
of	O
the	O
american	B-T204
all	I-T204
##ig	I-T204
##ator	I-T204
phal	B-T017
##lic	I-T017
gla	I-T017
##ns	I-T017
suggests	O
that	O
its	O
tissues	B-T017
are	O
arranged	O
in	O
a	O
manner	O
that	O
would	O
allow	O
vascular	B-T017
inflation	O
to	O
expand	O
the	O
gla	O
##ns	O
to	O
a	O
specific	O
and	O
repeatable	O
shape	B-T082
,	O
and	O
potentially	O
release	O
secretory	B-T017
products	I-T017
into	O
the	O
female	B-T022
reproductive	I-T022
tract	I-T022
.	O
both	O
elements	O
could	O
play	O
roles	O
in	O
postc	O
##op	O
##ulatory	O
sexual	O
selection	O
,	O
by	O
mechanically	O
and	O
/	O
or	O
chemically	O
affecting	B-T038
female	I-T038
reproductive	I-T038
physiology	I-T038
.	O

entropy	O
-	O
driven	O
reactions	O
in	O
living	O
cells	B-T017
for	O
assay	B-T058
let	B-T103
-	I-T103
7a	I-T103
microrna	I-T103
imaging	B-T058
of	O
microrna	B-T103
(	O
mirna	B-T103
)	O
in	O
living	O
cells	B-T017
could	O
facilitate	O
the	O
monitoring	O
of	O
the	O
expression	B-T038
and	O
distribution	O
of	O
mirna	B-T103
and	O
research	B-T062
on	O
mirna	B-T103
-	O
related	O
diseases	B-T038
.	O
given	O
the	O
low	O
expression	O
levels	O
and	O
even	O
down	B-T038
-	I-T038
regulation	I-T038
of	O
cellular	B-T017
mirna	B-T103
that	O
is	O
associated	O
with	O
some	O
diseases	B-T038
,	O
enzyme	B-T103
-	O
free	O
amplification	B-T062
strategies	I-T062
are	O
imperative	O
for	O
intracellular	B-T082
mirna	B-T103
assay	B-T058
.	O
in	O
this	O
work	O
,	O
we	O
report	O
an	O
entropy	O
-	O
driven	O
reaction	O
for	O
amplification	B-T062
assay	B-T058
mirna	B-T103
with	O
a	O
detection	O
limit	O
of	O
0	O
.	O
27	O
pm	O
.	O
the	O
resulting	O
signal	O
amplification	O
provides	O
excellent	O
recognition	O
and	O
signal	O
enhancement	O
of	O
specific	O
mirna	B-T103
s	O
in	O
living	O
cells	B-T017
.	O
this	O
method	O
supplies	O
accurate	O
information	O
regarding	O
cellular	B-T017
mirna	B-T103
-	O
related	O
biological	B-T038
events	I-T038
and	O
provides	O
a	O
new	O
tool	O
for	O
highly	O
sensitive	O
and	O
simultaneous	O
imaging	B-T058
of	O
multiple	O
low	O
-	O
level	O
biomarkers	B-T201
,	O
thereby	O
improving	O
the	O
accuracy	O
of	O
early	B-T058
disease	I-T058
diagnosis	I-T058
.	O

physical	O
exercise	O
for	O
late	O
-	O
life	O
depression	B-T038
:	O
effects	O
on	O
heart	B-T201
rate	I-T201
variability	O
late	O
-	O
life	O
major	B-T038
depression	I-T038
is	O
associated	O
with	O
increased	O
cardiovascular	O
risk	O
and	O
impaired	B-T038
autonomic	I-T038
control	I-T038
of	I-T038
the	I-T038
heart	I-T038
,	O
as	O
evident	O
from	O
reduced	O
heart	B-T201
rate	I-T201
variability	O
(	O
hrv	O
)	O
.	O
moreover	O
,	O
antidepressant	B-T103
drug	I-T103
therapy	B-T058
also	O
might	O
be	O
associated	O
with	O
further	O
reductions	O
of	O
hrv	O
.	O
in	O
the	O
seeds	B-T062
study	I-T062
,	O
we	O
investigated	O
whether	O
sert	B-T103
##ral	I-T103
##ine	I-T103
associated	O
with	O
physical	O
exercise	O
protocols	O
led	O
to	O
improvements	O
of	O
hrv	O
,	O
compared	O
with	O
antidepressant	B-T103
drug	I-T103
therapy	B-T058
alone	O
.	O
single	B-T062
-	I-T062
blind	I-T062
randomized	B-T062
controlled	I-T062
trial	I-T062
.	O
psychiatric	O
consultation	O
-	O
lia	O
##ison	O
program	O
for	O
primary	B-T058
care	I-T058
.	O
patients	O
aged	O
65	O
-	O
85	O
years	O
with	O
major	B-T038
depression	I-T038
,	O
recruited	O
from	O
primary	B-T058
care	I-T058
.	O
sert	B-T103
##ral	I-T103
##ine	I-T103
plus	O
structured	O
,	O
tailored	O
group	O
physical	O
exercise	O
(	O
s	O
+	O
ex	O
)	O
versus	O
sert	B-T103
##ral	I-T103
##ine	I-T103
alone	O
(	O
s	O
)	O
for	O
24	O
weeks	O
.	O
hrv	O
indices	B-T170
(	O
rr	O
,	O
percentage	O
of	O
nn	O
intervals	O
greater	O
than	O
50	O
msec	O
[	O
pn	O
##n	O
##50	O
]	O
,	O
square	O
root	O
of	O
the	O
mean	O
squared	O
differences	O
of	O
successive	O
nn	O
intervals	O
[	O
rms	O
##sd	O
]	O
,	O
standard	O
deviation	O
of	O
heart	B-T201
rate	I-T201
[	O
sdh	O
##r	O
]	O
,	O
standard	O
deviation	O
of	O
the	O
nn	O
interval	O
[	O
sd	O
##nn	O
]	O
,	O
high	O
-	O
frequency	O
band	O
[	O
hf	O
]	O
,	O
low	O
-	O
frequency	O
band	O
[	O
lf	O
]	O
,	O
and	O
their	O
ratio	O
[	O
lf	O
/	O
hf	O
]	O
)	O
were	O
measured	O
at	O
baseline	O
,	O
week	O
12	O
,	O
and	O
week	O
24	O
.	O
psychiatric	B-T058
and	O
medical	B-T058
assessments	I-T058
.	O
participants	B-T098
displayed	O
significant	O
improvements	O
of	O
most	O
hrv	O
indices	B-T170
over	O
time	O
,	O
irrespective	O
of	O
the	O
group	O
assignment	O
(	O
pn	O
##n	O
##50	O
,	O
rms	O
##sd	O
,	O
sdh	O
##r	O
,	O
sd	O
##nn	O
,	O
hf	O
,	O
lf	O
,	O
and	O
lf	O
/	O
hf	O
)	O
.	O
moreover	O
,	O
patients	O
in	O
the	O
s	O
+	O
ex	O
group	O
displayed	O
greater	O
increases	O
of	O
different	O
hrv	O
indices	B-T170
(	O
rr	O
,	O
pn	O
##n	O
##50	O
,	O
rms	O
##sd	O
,	O
sdh	O
##r	O
,	O
sd	O
##nn	O
,	O
hf	O
,	O
and	O
lf	O
)	O
compared	O
with	O
those	O
in	O
the	O
s	O
group	O
.	O
the	O
combination	O
of	O
structured	O
physical	O
exercise	O
and	O
sert	B-T103
##ral	I-T103
##ine	I-T103
might	O
exert	O
positive	B-T033
effects	O
on	O
the	O
autonomic	B-T038
control	I-T038
of	I-T038
the	I-T038
heart	I-T038
among	O
older	O
patients	O
with	O
major	B-T038
depression	I-T038
.	O

anti	B-T033
angiogenic	I-T033
effect	I-T033
of	O
che	B-T103
##bu	I-T103
##la	I-T103
##gic	I-T103
acid	I-T103
involves	O
inhibition	O
of	O
vegfr	B-T038
##2	I-T038
and	O
gsk3	B-T038
##β	I-T038
dependent	I-T038
signaling	I-T038
pathways	I-T038
inhibition	O
of	O
angiogenesis	B-T038
is	O
a	O
useful	O
strategy	O
to	O
prevent	O
cancer	B-T038
growth	I-T038
,	O
which	O
targets	O
new	O
vessels	B-T017
that	O
grow	O
to	O
no	O
##ur	O
##ish	O
actively	O
proliferating	O
tumor	B-T017
cells	I-T017
.	O
endothelial	B-T017
cells	I-T017
can	O
use	O
a	O
number	O
of	O
different	O
pathways	B-T038
to	O
cause	O
angiogenesis	B-T038
and	O
each	O
step	O
in	O
these	O
pathways	B-T038
can	O
be	O
targeted	O
.	O
the	O
use	O
of	O
multi	B-T103
targeted	I-T103
drugs	I-T103
is	O
gaining	O
much	O
importance	O
in	O
this	O
scenario	O
.	O
our	O
previous	O
results	O
have	O
shown	O
the	O
anti	B-T033
angiogenic	I-T033
effect	I-T033
of	O
che	B-T103
##bu	I-T103
##la	I-T103
##gic	I-T103
acid	I-T103
-	O
a	O
benzo	B-T103
##pyr	I-T103
##an	I-T103
tann	B-T103
##in	I-T103
present	O
in	O
the	O
fruits	B-T168
of	O
terminal	B-T204
##ia	I-T204
che	I-T204
##bu	I-T204
##la	I-T204
.	O
the	O
present	O
study	O
was	O
designed	O
to	O
examine	O
the	O
molecular	B-T038
mechanism	I-T038
of	O
the	O
anti	B-T033
angiogenic	I-T033
effect	I-T033
of	O
che	B-T103
##bu	I-T103
##la	I-T103
##gic	I-T103
acid	I-T103
.	O
results	O
of	O
our	O
investigations	O
using	O
molecular	B-T170
docking	I-T170
studies	I-T170
and	O
huvecs	B-T017
in	O
culture	B-T058
suggested	O
that	O
che	B-T103
##bu	I-T103
##la	I-T103
##gic	I-T103
acid	I-T103
inhibited	O
gsk	B-T103
-	I-T103
3β	I-T103
dependent	O
β	B-T103
-	I-T103
catenin	I-T103
phosphorylation	B-T038
,	O
an	O
important	O
mediator	O
of	O
ve	B-T103
-	I-T103
cadherin	I-T103
/	O
β	B-T103
-	I-T103
catenin	I-T103
signaling	B-T038
and	O
vegfr	B-T103
##2	I-T103
phosphorylation	B-T038
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
vegf	B-T038
signaling	I-T038
.	O
che	B-T103
##bu	I-T103
##la	I-T103
##gic	I-T103
acid	I-T103
inhibits	O
angiogenesis	B-T038
by	O
blocking	O
both	O
vegf	B-T103
/	O
vegfr	B-T103
##2	I-T103
and	O
cell	B-T038
-	I-T038
cell	I-T038
contact	I-T038
dependent	I-T038
downstream	I-T038
signaling	I-T038
pathway	I-T038
.	O

catastrophic	O
expenditure	O
and	O
imp	O
##over	O
##ishment	O
of	O
patients	O
affected	O
by	O
7	O
rare	B-T038
diseases	I-T038
in	O
china	B-T082
china	B-T082
is	O
actively	O
promoting	O
regulation	O
of	O
rare	B-T038
diseases	I-T038
,	O
rare	B-T038
disease	I-T038
and	O
orphan	B-T103
drugs	I-T103
have	O
been	O
formally	O
incorporated	O
into	O
the	O
national	O
planning	O
.	O
however	O
,	O
few	O
studies	B-T062
have	O
been	O
done	O
to	O
evaluate	O
the	O
afford	O
##ability	O
of	O
rare	B-T038
disease	I-T038
patients	O
in	O
china	B-T082
.	O
this	O
study	O
aims	O
to	O
provide	O
policy	B-T170
recommendations	O
for	O
the	O
establishment	O
of	O
social	B-T170
security	I-T170
mechanism	I-T170
for	O
rare	B-T038
diseases	I-T038
in	O
china	B-T082
,	O
so	O
as	O
to	O
address	O
the	O
problem	O
of	O
poverty	O
caused	O
by	O
these	O
diseases	B-T038
.	O
a	O
total	O
of	O
7	O
rare	B-T038
diseases	I-T038
were	O
selected	O
by	O
delphi	B-T062
method	I-T062
.	O
afford	O
##ability	O
of	O
treatment	B-T058
for	O
the	O
7	O
rare	B-T038
diseases	I-T038
was	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
catastrophic	O
expenditure	O
and	O
imp	O
##over	O
##ishment	O
expenditure	O
among	O
urban	B-T098
and	O
rural	B-T098
residents	I-T098
in	O
china	B-T082
.	O
assessed	O
through	O
annual	O
per	O
capital	O
income	O
,	O
health	O
expenditure	O
for	O
the	O
7	O
rare	B-T038
diseases	I-T038
are	O
all	O
rather	O
high	O
.	O
the	O
highest	O
health	O
expenditure	O
is	O
equivalent	O
to	O
income	O
of	O
69	O
.	O
34	O
years	O
of	O
one	O
urban	B-T098
resident	I-T098
,	O
and	O
the	O
burden	O
is	O
heavier	O
for	O
rural	B-T098
residents	I-T098
.	O
through	O
catastrophic	O
expenditure	O
assessment	O
,	O
proportions	O
of	O
the	O
population	B-T098
experiencing	O
catastrophic	O
expenditure	O
caused	O
by	O
the	O
7	O
rare	B-T038
diseases	I-T038
are	O
all	O
under	O
0	O
.	O
167	O
‰	O
.	O
however	O
,	O
once	O
one	O
is	O
ill	B-T033
and	O
taking	O
medications	B-T170
,	O
he	O
will	O
suffer	O
from	O
catastrophic	O
health	O
expenditure	O
.	O
through	O
imp	O
##over	O
##ishment	O
expenditure	O
assessment	O
,	O
the	O
proportions	O
of	O
imp	O
##over	O
##ishment	O
payment	O
are	O
low	O
among	O
both	O
urban	B-T098
and	O
rural	B-T098
residents	I-T098
,	O
but	O
the	O
7	O
rare	B-T038
diseases	I-T038
could	O
lead	O
nearly	O
4	O
.	O
6	O
million	O
people	B-T098
into	O
poverty	O
on	O
a	O
national	O
scale	O
.	O
the	O
afford	O
##ability	O
of	O
treatment	B-T058
for	O
rare	B-T038
disease	I-T038
as	O
well	O
as	O
orphan	B-T103
drugs	I-T103
is	O
rather	O
poor	O
.	O
residents	B-T098
of	O
different	O
income	O
levels	O
all	O
have	O
difficulties	O
to	O
afford	O
the	O
treatment	B-T058
for	O
rare	B-T038
diseases	I-T038
,	O
so	O
poverty	O
caused	O
by	O
rare	B-T038
diseases	I-T038
is	O
quite	O
widespread	B-T082
.	O
therefore	O
,	O
social	B-T170
security	I-T170
mechanism	I-T170
for	O
rare	B-T038
disease	I-T038
patients	O
should	O
be	O
established	O
and	O
specific	O
payment	O
pattern	O
for	O
orphan	B-T103
drugs	I-T103
should	O
be	O
set	O
up	O
.	O

antibacterial	B-T103
activity	O
of	O
poly	B-T103
##aniline	I-T103
coated	O
silver	B-T103
nanoparticles	O
synthesized	O
from	O
piper	B-T103
bet	I-T103
##le	I-T103
leaves	I-T103
extract	I-T103
plants	B-T204
or	O
natural	O
resources	O
have	O
been	O
found	O
to	O
be	O
a	O
good	O
alternative	O
method	O
for	O
nanoparticles	O
synthesis	O
.	O
in	O
this	O
study	B-T062
,	O
poly	B-T103
##aniline	I-T103
coated	O
silver	B-T103
nanoparticles	O
(	O
agnps	O
)	O
synthesized	O
from	O
piper	B-T103
bet	I-T103
##le	I-T103
leaves	I-T103
extract	I-T103
were	O
investigated	O
for	O
their	O
antibacterial	B-T103
activity	O
.	O
silver	B-T103
nanoparticles	O
were	O
prepared	O
from	O
the	O
reduction	O
of	O
silver	B-T103
nitrate	I-T103
and	O
nab	B-T103
##h4	I-T103
was	O
used	O
as	O
reducing	B-T103
agent	I-T103
.	O
silver	B-T103
nanoparticles	O
and	O
extracts	B-T103
were	O
mixed	O
thoroughly	O
and	O
then	O
coated	O
by	O
poly	B-T103
##aniline	I-T103
.	O
prepared	O
nanoparticles	O
were	O
characterized	O
by	O
visual	O
inspection	O
,	O
ultraviolet	B-T058
-	I-T058
visible	I-T058
spectroscopy	I-T058
(	O
uv	B-T058
)	O
,	O
fourier	B-T062
transform	I-T062
infrared	I-T062
spectroscopy	I-T062
(	O
ft	B-T062
-	I-T062
ir	I-T062
)	O
,	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
(	I-T058
tem	I-T058
)	I-T058
techniques	I-T058
.	O
antibacterial	B-T103
activities	O
of	O
the	O
synthesized	O
silver	B-T103
nanoparticles	O
were	O
tested	O
against	O
staphylococcus	B-T007
aureus	I-T007
atcc	I-T007
259	I-T007
##23	I-T007
,	O
salmonella	B-T007
typhi	I-T007
atcc	I-T007
140	I-T007
##28	I-T007
,	O
escherichia	B-T007
coli	I-T007
atcc	I-T007
259	I-T007
##22	I-T007
and	O
pseudomonas	B-T007
aeruginosa	I-T007
atcc	I-T007
278	I-T007
##53	I-T007
.	O
uv	B-T058
-	I-T058
vis	I-T058
spectrum	I-T058
of	O
reaction	O
mixture	O
showed	O
strong	O
absorption	O
peak	O
with	O
center	O
##ing	O
at	O
400	O
nm	O
.	O
the	O
ft	B-T062
-	I-T062
ir	I-T062
results	B-T033
imply	O
that	O
ag	O
-	O
nps	O
were	O
successfully	O
synthesized	O
and	O
capped	O
with	O
bio	O
-	O
compounds	O
present	O
in	O
p	B-T103
.	I-T103
bet	I-T103
##le	I-T103
.	O
tem	B-T058
image	O
showed	O
that	O
ag	O
-	O
nps	O
formed	O
were	O
well	O
dispersed	B-T082
with	O
a	O
spherical	B-T082
structures	I-T082
and	O
particle	O
size	O
ranging	O
from	O
10	O
to	O
30	O
nm	O
.	O
the	O
result	O
revealed	O
that	O
ag	O
-	O
extract	O
nps	O
showed	O
32	O
.	O
78	O
##±0	O
.	O
64	O
mm	O
zone	O
of	O
inhibition	O
against	O
s	B-T007
.	I-T007
aureus	I-T007
,	O
whereas	O
nor	B-T103
##floxacin	I-T103
(	O
positive	O
control	O
)	O
showed	O
maximum	O
32	O
.	O
15	O
##±0	O
.	O
40	O
mm	O
zone	O
of	O
inhibition	O
for	O
s	B-T007
.	I-T007
aureus	I-T007
.	O
again	O
,	O
maximum	B-T082
zone	I-T082
of	O
inhibition	O
29	O
.	O
55	O
##±0	O
.	O
45	O
mm	O
was	O
found	O
for	O
s	B-T007
.	I-T007
typhi	I-T007
,	O
27	O
.	O
12	O
##±0	O
.	O
38	O
mm	O
for	O
e	B-T007
.	I-T007
coli	I-T007
and	O
21	O
.	O
95	O
##±0	O
.	O
45	O
mm	O
for	O
p	B-T007
.	I-T007
aeruginosa	I-T007
.	O
the	O
results	O
obtained	O
by	O
this	O
study	B-T062
can	O
'	O
t	O
be	O
directly	O
extrapolated	O
to	O
human	B-T204
;	O
so	O
further	B-T062
studies	I-T062
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	B-T103
activity	O
of	O
ag	O
-	O
extract	O
nps	O
for	O
drug	B-T091
development	I-T091
program	I-T091
.	O

safe	O
with	O
self	B-T037
-	I-T037
injury	I-T037
:	O
a	O
practical	B-T170
guide	I-T170
to	O
understanding	B-T038
,	O
responding	O
and	O
harm	B-T058
-	I-T058
reduction	I-T058
inc	O
##kl	O
##e	O
ka	O
##y	O
safe	O
with	O
self	B-T037
-	I-T037
injury	I-T037
:	O
a	O
practical	B-T170
guide	I-T170
to	O
understanding	B-T038
,	O
responding	O
and	O
harm	B-T058
-	I-T058
reduction	I-T058
274	O
##pp	O
£	O
##23	O
.	O
99	O
pcc	O
##s	O
books	O
97	O
##81	O
##91	O
##09	O
##19	O
##16	O
##3	O
191	O
##09	O
##19	O
##160	O
[	O
formula	O
:	O
see	O
text	O
the	O
author	B-T097
begins	O
her	O
book	B-T170
with	O
a	O
concise	O
exploration	O
of	O
the	O
stereotyp	B-T038
##es	I-T038
and	O
truth	O
##s	O
of	O
self	B-T037
-	I-T037
harm	I-T037
.	O
in	O
the	O
following	O
seven	O
chapter	B-T170
##s	I-T170
,	O
she	O
sets	O
out	O
a	O
grounded	B-T170
and	O
often	O
challenging	B-T082
view	I-T082
of	O
how	O
self	B-T037
-	I-T037
harm	I-T037
is	O
understood	B-T038
from	O
differing	O
perspectives	B-T038
.	O

chord	B-T038
##oma	I-T038
ded	I-T038
##ifferentiation	I-T038
after	O
proton	B-T058
beam	I-T058
therapy	I-T058
:	O
a	O
case	B-T170
report	I-T170
and	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
chord	B-T038
##oma	I-T038
is	O
a	O
rare	O
invasive	O
bone	B-T038
tumor	I-T038
that	O
may	O
occur	O
any	O
##wh	O
##ere	O
along	O
the	O
neur	B-T082
##axis	I-T082
.	O
a	O
total	O
of	O
three	O
primary	O
histological	B-T038
varieties	I-T038
have	O
been	O
identified	O
:	O
conventional	B-T038
,	O
chondro	B-T038
##id	I-T038
,	O
and	O
ded	B-T038
##ifferentiated	I-T038
.	O
we	O
report	B-T170
a	O
case	O
of	O
an	O
8	O
-	O
year	O
-	O
old	O
white	B-T098
girl	O
who	O
presented	O
with	O
conventional	B-T038
chord	I-T038
##oma	I-T038
,	O
was	O
treated	B-T033
with	O
surgical	B-T058
resection	I-T058
and	O
mixed	O
proton	O
and	O
photon	B-T058
beam	I-T058
therapy	I-T058
,	O
and	O
had	O
a	O
recurrence	O
in	O
the	O
resection	B-T017
cavity	I-T017
2	O
.	O
5	O
years	O
later	O
with	O
ded	B-T038
##ifferentiated	I-T038
morphology	I-T038
.	O
the	O
recurrent	B-T038
tumor	I-T038
did	O
not	O
express	B-T038
brachy	B-T103
##ury	I-T103
,	O
a	O
recently	O
identified	O
protein	B-T103
specific	O
to	O
tissue	B-T017
of	O
not	B-T017
##och	I-T017
##ord	I-T017
##al	I-T017
origin	O
.	O
the	O
short	O
time	O
period	O
between	O
radiation	B-T058
therapy	I-T058
and	O
ded	B-T038
##ifferentiation	I-T038
,	O
low	O
dose	O
of	O
photons	O
,	O
and	O
rarity	O
of	O
ded	O
##ifferentiated	O
skull	O
base	O
chord	O
##omas	O
in	O
pediatric	O
patients	O
should	O
alert	O
clinicians	B-T097
to	O
the	O
possibility	B-T033
of	O
chord	B-T038
##oma	I-T038
ded	I-T038
##ifferentiation	I-T038
after	O
proton	B-T058
beam	I-T058
therapy	I-T058
.	O

bilateral	B-T082
c1	B-T074
laminar	I-T074
hook	I-T074
##s	I-T074
combined	O
with	O
c2	B-T074
pedicle	I-T074
screw	I-T074
fixation	B-T058
in	O
the	O
treatment	B-T058
of	O
atlant	B-T037
##oa	I-T037
##x	I-T037
##ial	I-T037
subluxation	I-T037
after	O
gr	B-T038
##ise	I-T038
##l	I-T038
syndrome	I-T038
many	O
etiologies	O
can	O
lead	O
to	O
atlant	B-T037
##oa	I-T037
##x	I-T037
##ial	I-T037
sublux	I-T037
##ai	I-T037
##on	I-T037
.	O
in	O
gr	B-T038
##ise	I-T038
##l	I-T038
syndrome	I-T038
(	O
gs	B-T038
)	O
,	O
this	O
subluxation	B-T037
occurs	O
spontaneously	O
after	O
inflammatory	O
processes	O
of	O
the	O
head	B-T082
and	O
neck	B-T082
.	O
diagnosis	B-T033
is	O
typically	O
based	O
on	O
clinical	B-T033
history	I-T033
and	O
a	O
strong	O
suspicion	B-T038
of	O
this	O
syndrome	B-T038
.	O
nonsurgical	B-T058
treatment	I-T058
most	O
often	O
resolve	O
##s	O
the	O
symptoms	B-T033
;	O
however	O
,	O
in	O
some	O
cases	O
surgical	B-T058
treatment	I-T058
is	O
necessary	O
to	O
repair	B-T058
the	O
subluxation	B-T037
.	O
various	O
surgical	B-T058
techniques	I-T058
and	O
instrumentation	B-T074
systems	I-T074
have	O
been	O
used	O
to	O
treat	B-T058
atlant	B-T037
##oa	I-T037
##x	I-T037
##ial	I-T037
subluxation	I-T037
,	O
although	O
there	O
is	O
no	O
consensus	O
regarding	O
the	O
best	O
treatment	B-T058
method	I-T058
for	O
the	O
pediatric	O
population	B-T098
.	O
to	O
describe	O
a	O
case	O
of	O
atlant	B-T037
##oa	I-T037
##x	I-T037
##ial	I-T037
subluxation	I-T037
in	O
a	O
child	O
with	O
gs	B-T038
treated	B-T033
surgically	B-T058
with	O
an	O
alternative	O
construct	B-T074
.	O
this	O
is	O
a	O
case	B-T170
report	I-T170
and	O
literature	B-T170
review	I-T170
.	O
our	O
case	B-T170
study	I-T170
involves	O
a	O
5	O
-	O
year	O
-	O
old	O
girl	O
with	O
a	O
6	O
-	O
month	O
history	B-T033
of	O
unresolved	O
field	B-T037
##ing	I-T037
type	I-T037
ii	I-T037
atlant	I-T037
##oa	I-T037
##x	I-T037
##ial	I-T037
subluxation	I-T037
caused	O
by	O
gs	B-T038
.	O
despite	O
conservative	B-T058
treatment	I-T058
,	O
the	O
patient	O
'	O
s	O
symptoms	B-T033
continued	O
to	O
progress	O
.	O
after	O
two	O
failed	O
closed	B-T058
reduction	I-T058
attempts	O
,	O
open	B-T058
reduction	I-T058
and	O
c1	B-T058
-	I-T058
c2	I-T058
fusion	I-T058
were	O
performed	O
with	O
atlas	B-T074
laminar	I-T074
hook	I-T074
and	O
axis	B-T074
pedicle	I-T074
poly	I-T074
##axial	I-T074
screws	I-T074
.	O
a	O
literature	B-T170
review	I-T170
of	O
the	O
surgical	B-T058
treatment	I-T058
of	O
gs	B-T038
was	O
also	O
performed	O
.	O
after	O
surgery	O
,	O
the	O
patient	O
exhibited	O
full	O
clinical	O
and	O
functional	B-T033
recovery	I-T033
with	O
complete	O
resolution	O
of	O
symptoms	B-T033
.	O
at	O
the	O
36	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
examination	B-T058
,	O
there	O
was	O
continu	O
##al	O
evidence	O
of	O
satisfactory	B-T033
reduction	B-T058
and	O
fusion	B-T058
.	O
no	O
complications	B-T038
were	O
observed	O
.	O
upon	O
completion	O
of	O
the	O
literature	B-T170
review	I-T170
,	O
eight	O
gs	B-T038
cases	O
were	O
found	O
to	O
have	O
been	O
treated	O
surgically	B-T058
with	O
the	O
minimum	O
patient	O
age	O
being	O
9	O
years	O
.	O
conservative	B-T058
management	I-T058
of	O
gs	B-T038
is	O
the	O
most	O
common	O
and	O
effective	O
treatment	B-T058
;	O
however	O
,	O
a	O
few	O
surgical	O
cases	O
have	O
been	O
reported	B-T058
in	O
the	O
literature	B-T170
with	O
good	O
results	O
.	O
satisfactory	B-T033
clinical	B-T033
results	I-T033
and	O
fusion	B-T058
at	O
36	O
months	O
post	B-T033
surgery	I-T033
were	O
seen	O
in	O
a	O
pediatric	O
patient	O
with	O
atlant	B-T037
##oa	I-T037
##x	I-T037
##ial	I-T037
subluxation	I-T037
and	O
instability	B-T033
using	O
atlas	B-T074
laminar	I-T074
hook	I-T074
and	O
axis	B-T074
pedicle	I-T074
poly	I-T074
##axial	I-T074
screws	I-T074
.	O

role	O
of	O
breast	B-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
in	O
predicting	O
residual	O
lobular	B-T038
carcinoma	I-T038
in	I-T038
situ	I-T038
after	O
initial	O
excision	B-T058
breast	B-T058
magnetic	I-T058
resonance	I-T058
(	I-T058
mr	I-T058
)	I-T058
imaging	I-T058
is	O
a	O
useful	O
screening	B-T058
modality	O
in	O
detecting	B-T058
suspicious	B-T033
lesions	B-T033
in	O
patients	O
with	O
a	O
history	B-T033
of	O
lobular	B-T038
carcinoma	I-T038
in	I-T038
situ	I-T038
(	O
lc	B-T038
##is	I-T038
)	O
.	O
this	O
study	B-T062
aimed	O
to	O
evaluate	B-T058
the	O
effectiveness	O
of	O
breast	B-T058
mr	I-T058
imaging	I-T058
in	O
detecting	B-T058
remnant	B-T017
lc	B-T038
##is	I-T038
lesions	B-T033
after	O
initial	O
excision	B-T058
.	O
between	O
2011	O
and	O
2015	O
,	O
29	O
patients	O
with	O
lc	B-T038
##is	I-T038
who	O
underwent	B-T033
initial	O
excision	B-T058
were	O
enrolled	O
.	O
breast	B-T058
ultrasonography	I-T058
and	O
breast	B-T058
mr	I-T058
imaging	I-T058
was	O
conducted	O
after	O
initial	O
excision	B-T058
.	O
imaging	B-T033
findings	I-T033
were	O
compared	O
with	O
pathologic	B-T038
results	O
.	O
there	O
were	O
nine	O
(	O
31	O
.	O
0	O
%	O
)	O
cases	O
with	O
positive	B-T033
margins	I-T033
after	O
initial	O
excision	B-T058
;	O
they	O
were	O
lc	B-T038
##is	I-T038
(	O
n	O
=	O
8	O
)	O
and	O
atypical	B-T038
lobular	I-T038
hyperplasia	I-T038
(	O
n	O
=	O
1	O
)	O
.	O
residual	O
lesions	B-T033
were	O
identified	O
in	O
12	O
cases	O
;	O
they	O
were	O
invasive	B-T038
lobular	I-T038
carcinoma	I-T038
(	O
n	O
=	O
1	O
;	O
3	O
.	O
4	O
%	O
)	O
,	O
lc	B-T038
##is	I-T038
(	O
n	O
=	O
9	O
;	O
31	O
.	O
0	O
%	O
)	O
,	O
atypical	B-T038
lobular	I-T038
hyperplasia	I-T038
(	O
n	O
=	O
1	O
;	O
3	O
.	O
4	O
%	O
)	O
,	O
and	O
papillary	B-T038
carcinoma	I-T038
in	I-T038
situ	I-T038
(	O
n	O
=	O
1	O
;	O
3	O
.	O
4	O
%	O
)	O
.	O
prior	O
to	O
the	O
second	O
operation	B-T058
,	O
these	O
lesions	B-T033
could	O
be	O
detected	O
in	O
seven	O
cases	O
using	O
ultrasonography	B-T058
(	O
sensitivity	O
,	O
53	O
.	O
3	O
%	O
;	O
specificity	O
,	O
100	O
%	O
)	O
and	O
in	O
10	O
cases	O
using	O
breast	B-T058
mr	I-T058
imaging	I-T058
(	O
sensitivity	O
,	O
83	O
.	O
3	O
%	O
;	O
specificity	O
,	O
100	O
%	O
)	O
.	O
breast	B-T058
mr	I-T058
imaging	I-T058
showed	O
higher	O
sensitivity	O
than	O
breast	B-T058
ultrasonography	I-T058
in	O
detecting	B-T058
remnant	B-T017
lc	B-T038
##is	I-T038
lesions	B-T033
.	O
if	O
a	O
suspicious	B-T033
lesion	B-T033
was	O
found	O
using	O
breast	B-T058
mr	I-T058
imaging	I-T058
,	O
a	O
second	O
operation	B-T058
should	O
be	O
considered	O
because	O
of	O
the	O
possibility	B-T033
of	O
multifocal	B-T033
##ity	I-T033
,	O
even	O
if	O
lc	B-T038
##is	I-T038
was	O
confirmed	B-T033
at	O
the	O
initial	O
operation	B-T058
.	O

zinc	B-T103
and	O
wound	B-T038
healing	I-T038
:	O
a	O
review	O
of	O
zinc	B-T103
physiology	B-T038
and	O
clinical	O
applications	O
our	O
understanding	B-T038
of	O
the	O
role	O
of	O
zinc	B-T103
in	O
normal	O
human	B-T204
physiology	B-T038
is	O
constantly	O
expanding	O
,	O
yet	O
there	O
are	O
major	O
gaps	B-T082
in	O
our	O
knowledge	O
with	O
regard	O
to	O
the	O
function	O
of	O
zinc	B-T103
in	O
wound	B-T038
healing	I-T038
.	O
this	O
review	B-T170
aims	O
to	O
provide	O
the	O
clinician	B-T097
with	O
sufficient	O
understanding	O
of	O
zinc	B-T103
biology	B-T091
and	O
an	O
up	O
-	O
to	O
-	O
date	O
perspective	O
on	O
the	O
role	O
of	O
zinc	B-T103
in	O
wound	B-T038
healing	I-T038
.	O
zinc	B-T103
is	O
an	O
essential	O
ion	B-T103
that	O
is	O
crucial	O
for	O
maintenance	O
of	O
normal	O
physiology	B-T038
,	O
and	O
zinc	B-T038
deficiency	I-T038
has	O
many	O
manifestations	O
ranging	O
from	O
delayed	O
wound	B-T038
healing	I-T038
to	O
immune	B-T038
dysfunction	I-T038
and	O
impairment	O
of	O
multiple	O
sensory	O
systems	O
.	O
while	O
consensus	O
has	O
been	O
reached	O
regarding	O
the	O
detrimental	O
effects	O
of	O
zinc	B-T038
deficiency	I-T038
on	O
wound	B-T038
healing	I-T038
,	O
there	O
is	O
considerable	O
disc	O
##ord	O
in	O
the	O
literature	B-T170
on	O
the	O
optimal	B-T170
methods	I-T170
and	O
true	O
benefits	O
of	O
zinc	B-T103
supplementation	O
.	O

hard	B-T204
ticks	I-T204
(	O
aca	B-T204
##ri	I-T204
:	I-T204
ix	I-T204
##odi	I-T204
##da	I-T204
##e	I-T204
)	O
of	O
livestock	B-T204
in	O
nic	B-T082
##ara	I-T082
##gu	I-T082
##a	I-T082
,	O
with	O
notes	B-T170
about	O
distribution	O
we	O
document	B-T170
the	O
species	B-T170
of	O
ticks	B-T204
that	O
parasit	B-T038
##ize	I-T038
livestock	B-T204
in	O
nic	B-T082
##ara	I-T082
##gu	I-T082
##a	I-T082
.	O
the	O
study	B-T062
was	O
based	O
on	O
tick	B-T204
collection	O
on	O
cattle	B-T204
and	O
horses	B-T204
from	O
43	O
##7	O
farms	B-T082
in	O
nine	O
departments	B-T092
.	O
of	O
48	O
##41	O
animals	B-T204
examined	O
(	O
44	O
##81	O
cows	B-T204
and	O
360	O
horses	B-T204
)	O
,	O
329	O
##9	O
were	O
parasit	B-T038
##ized	I-T038
,	O
which	O
represent	O
68	O
%	O
of	O
the	O
bovine	B-T204
##s	I-T204
and	O
67	O
%	O
of	O
the	O
equine	B-T204
##s	I-T204
in	O
study	B-T062
:	O
59	O
cows	B-T204
and	O
25	O
horses	B-T204
were	O
parasit	B-T038
##ized	I-T038
by	O
more	O
than	O
one	O
species	B-T170
.	O
in	O
addition	O
,	O
280	O
specimens	O
of	O
the	O
entom	O
##ological	O
mus	O
##eu	O
##m	O
in	O
le	B-T082
##on	I-T082
were	O
examined	O
.	O
the	O
ticks	B-T204
found	O
on	O
cattle	B-T204
were	O
rh	B-T204
##ip	I-T204
##ice	I-T204
##phal	I-T204
##us	I-T204
microp	I-T204
##lu	I-T204
##s	I-T204
(	O
75	O
.	O
2	O
%	O
of	O
the	O
ticks	B-T204
collected	O
)	O
,	O
ambly	B-T204
##om	I-T204
##ma	I-T204
mix	I-T204
##t	I-T204
##um	I-T204
(	O
20	O
.	O
8	O
%	O
)	O
,	O
a	B-T204
.	I-T204
parvum	I-T204
(	O
2	O
.	O
6	O
%	O
)	O
,	O
a	B-T204
.	I-T204
ten	I-T204
##ellum	I-T204
(	O
0	O
.	O
7	O
%	O
)	O
,	O
a	B-T204
.	I-T204
macula	I-T204
##t	I-T204
##um	I-T204
(	O
0	O
.	O
7	O
%	O
)	O
.	O
while	O
the	O
ticks	B-T204
collected	O
from	O
the	O
horses	B-T204
were	O
:	O
derm	B-T204
##acent	I-T204
##or	I-T204
nit	I-T204
##ens	I-T204
(	O
41	O
.	O
5	O
%	O
)	O
,	O
a	B-T204
.	I-T204
mix	I-T204
##t	I-T204
##um	I-T204
(	O
31	O
.	O
7	O
%	O
)	O
,	O
r	B-T204
.	I-T204
microp	I-T204
##lu	I-T204
##s	I-T204
(	O
13	O
.	O
8	O
%	O
)	O
,	O
a	B-T204
.	I-T204
parvum	I-T204
(	O
6	O
.	O
5	O
%	O
)	O
,	O
a	B-T204
.	I-T204
ten	I-T204
##ellum	I-T204
(	O
3	O
.	O
3	O
%	O
)	O
,	O
d	B-T204
.	I-T204
diss	I-T204
##imil	I-T204
##is	I-T204
(	O
2	O
.	O
4	O
%	O
)	O
and	O
a	B-T204
.	I-T204
macula	I-T204
##t	I-T204
##um	I-T204
(	O
0	O
.	O
8	O
%	O
)	O
.	O

identification	O
of	O
the	O
anti	B-T103
-	I-T103
mycobacterial	I-T103
functional	O
properties	O
of	O
piper	B-T103
##idin	I-T103
##ol	I-T103
derivatives	I-T103
tuberculosis	B-T038
(	O
tb	B-T038
)	O
remains	O
a	O
major	O
global	O
health	O
threat	O
and	O
is	O
now	O
the	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
from	O
a	O
single	O
infectious	O
agent	O
worldwide	O
.	O
the	O
current	O
tb	B-T038
drug	B-T103
regimen	B-T058
is	O
inadequate	O
,	O
and	O
new	O
anti	B-T103
-	I-T103
tubercul	I-T103
##ar	I-T103
agents	I-T103
are	O
urgently	O
required	O
to	O
be	O
able	O
to	O
successfully	O
combat	O
the	O
increasing	O
prevalence	O
of	O
drug	B-T038
-	I-T038
resistant	I-T038
tb	I-T038
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
a	O
piper	B-T103
##idin	I-T103
##ol	I-T103
compound	I-T103
derivative	I-T103
that	O
is	O
highly	O
active	O
against	O
the	O
mycobacterium	B-T007
tuberculosis	I-T007
bacillus	B-T007
.	O
the	O
antibacterial	B-T103
properties	O
of	O
the	O
piper	B-T103
##idin	I-T103
##ol	I-T103
compound	I-T103
and	O
its	O
corresponding	O
bis	B-T103
-	I-T103
mann	I-T103
##ich	I-T103
base	I-T103
analogue	B-T103
were	O
evaluated	B-T058
against	O
m	B-T007
.	I-T007
sm	I-T007
##egm	I-T007
##atis	I-T007
and	O
gram	B-T007
-	I-T007
negative	I-T007
organisms	I-T007
.	O
cytotoxicity	B-T038
studies	B-T062
were	O
undertaken	O
in	O
order	O
to	O
determine	O
the	O
selectivity	B-T170
index	I-T170
for	O
these	O
compounds	B-T103
.	O
spontaneous	O
resistant	O
mutants	B-T038
of	O
m	B-T007
.	I-T007
sm	I-T007
##egm	I-T007
##atis	I-T007
were	O
generated	O
against	O
the	O
piper	B-T103
##idin	I-T103
##ol	I-T103
and	O
corresponding	O
bis	B-T103
-	I-T103
mann	I-T103
##ich	I-T103
base	I-T103
lead	I-T103
derivatives	I-T103
and	O
whole	O
genome	O
sequencing	O
employed	O
to	O
determine	O
the	O
genetic	B-T062
modifications	I-T062
that	O
lead	O
to	O
selection	O
pressure	O
in	O
the	O
presence	O
of	O
these	O
compounds	B-T103
.	O
the	O
piper	B-T103
##idin	I-T103
##ol	I-T103
and	O
the	O
bis	B-T103
-	I-T103
mann	I-T103
##ich	I-T103
base	I-T103
analogue	I-T103
were	O
found	O
to	O
be	O
selective	O
for	O
mycobacteria	B-T007
and	O
rapidly	O
kill	O
this	O
organism	O
with	O
a	O
cytotoxicity	B-T038
selectivity	B-T170
index	I-T170
for	O
mycobacteria	B-T007
of	O
>	O
30	O
-	O
fold	O
.	O
whole	O
genome	O
sequencing	O
of	O
m	B-T007
.	I-T007
sm	I-T007
##egm	I-T007
##atis	I-T007
strains	O
resistant	O
to	O
the	O
lead	B-T103
compounds	I-T103
led	O
to	O
the	O
identification	O
of	O
a	O
number	O
of	O
single	B-T082
nucleotide	I-T082
polymorphisms	I-T082
indicating	O
multiple	O
targets	O
.	O
our	O
results	O
indicate	O
that	O
the	O
piper	B-T103
##idin	I-T103
##ol	I-T103
moiety	I-T103
represents	O
an	O
attractive	O
compound	B-T103
class	I-T103
in	O
the	O
pursuit	O
of	O
novel	O
anti	B-T103
-	I-T103
tubercul	I-T103
##ar	I-T103
agents	I-T103
.	O

distal	B-T082
posterior	B-T017
cerebral	I-T017
artery	I-T017
revascularization	B-T058
for	O
a	O
fusiform	O
pca	B-T017
aneurysm	B-T038
:	O
a	O
less	O
##on	O
learned	O
the	O
need	O
for	O
revascularization	B-T058
with	O
proximal	B-T082
posterior	B-T017
cerebral	I-T017
artery	I-T017
occlusion	B-T017
in	O
the	O
treatment	O
of	O
giant	B-T038
and	O
fusiform	B-T017
aneurysms	I-T017
is	O
unclear	O
.	O
while	O
early	O
series	O
demonstrated	O
only	O
about	O
a	O
10	O
%	O
chance	O
of	O
infarction	B-T038
following	O
posterior	B-T017
cerebral	I-T017
artery	I-T017
occlusion	B-T017
,	O
recently	O
several	O
authors	B-T097
have	O
advocated	O
a	O
bypass	B-T058
prior	O
to	O
parent	O
vessel	B-T017
sacrifice	O
in	O
all	O
cases	O
.	O
we	O
present	O
the	O
case	O
of	O
an	O
adult	O
man	O
with	O
a	O
fusiform	B-T017
aneurysm	I-T017
of	O
the	O
right	O
posterior	B-T017
cerebral	I-T017
artery	I-T017
at	O
the	O
p2	O
-	O
p3	O
junction	O
.	O
he	O
clinically	B-T033
failed	I-T033
a	O
balloon	B-T058
test	I-T058
occlusion	I-T058
preoperatively	O
and	O
therefore	O
underwent	O
an	O
occipital	B-T017
artery	I-T017
to	O
distal	B-T082
posterior	B-T017
cerebral	I-T017
artery	I-T017
bypass	B-T058
with	O
subsequent	O
endovascular	O
occlusion	O
of	O
the	O
parent	O
vessel	O
and	O
aneurysm	B-T038
.	O
despite	O
the	O
fact	O
that	O
the	O
immediate	O
and	O
6	O
month	O
follow	B-T058
up	I-T058
cerebral	B-T058
angiography	I-T058
confirmed	O
a	O
patent	O
bypass	B-T058
,	O
the	O
patient	O
still	O
developed	O
a	O
posterior	B-T017
cerebral	I-T017
artery	I-T017
territory	B-T038
stroke	I-T038
.	O
we	O
believe	O
this	O
case	O
demonstrates	O
that	O
successful	O
distal	B-T082
revascularization	B-T058
in	O
the	O
setting	O
of	O
proximal	B-T082
posterior	B-T017
cerebral	I-T017
artery	I-T017
occlusion	B-T017
does	O
not	O
guarantee	O
against	O
cerebral	B-T038
ischemia	I-T038
and	O
infarction	B-T038
even	O
in	O
those	O
patients	O
that	O
fail	O
a	O
test	B-T058
occlusion	I-T058
.	O

rub	B-T038
##ins	I-T038
##tein	I-T038
-	I-T038
ta	I-T038
##yb	I-T038
##i	I-T038
syndrome	I-T038
associated	O
with	O
pituitary	B-T038
macro	I-T038
##adenoma	I-T038
:	O
a	O
case	B-T170
report	I-T170
rub	B-T038
##ins	I-T038
##tein	I-T038
-	I-T038
ta	I-T038
##yb	I-T038
##i	I-T038
syndrome	I-T038
(	O
rs	B-T038
##ts	I-T038
)	O
is	O
an	O
autosomal	B-T038
dominant	I-T038
disorder	I-T038
that	O
is	O
classically	O
characterized	O
by	O
prenatal	O
and	O
postnatal	O
growth	B-T038
restriction	I-T038
,	O
microc	B-T017
##ephal	I-T017
##y	I-T017
,	O
dysm	B-T017
##orphic	I-T017
craniofacial	I-T017
features	I-T017
,	O
broad	B-T033
thumb	I-T033
##s	I-T033
and	O
toe	B-T033
##s	I-T033
,	O
and	O
intellectual	B-T038
disability	I-T038
.	O
we	O
describe	O
the	O
first	O
reported	O
case	O
of	O
a	O
pituitary	B-T038
macro	I-T038
##adenoma	I-T038
associated	O
with	O
rs	B-T038
##ts	I-T038
.	O
a	O
39	O
-	O
year	O
-	O
old	O
caucasian	B-T098
female	B-T098
with	O
a	O
past	B-T033
medical	I-T033
history	I-T033
of	O
rs	B-T038
##ts	I-T038
diagnosed	B-T033
at	O
age	O
two	O
was	O
found	O
to	O
have	O
a	O
gadolinium	B-T103
-	O
enhancing	O
pituitary	B-T017
mass	I-T017
on	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
of	O
the	O
brain	B-T017
three	O
years	O
ago	O
during	O
workup	O
for	O
migraine	B-T033
-	I-T033
like	I-T033
headaches	I-T033
.	O
subsequent	O
serial	O
imaging	B-T058
showed	O
radiographic	O
evidence	O
of	O
growth	B-T038
up	O
to	O
11	O
.	O
5	O
x	O
14	O
.	O
0	O
x	O
10	O
.	O
0	O
mm	O
in	O
size	B-T082
.	O
the	O
pituitary	B-T017
sel	B-T033
##la	I-T033
##r	I-T033
lesion	I-T033
was	O
resected	B-T058
through	O
an	O
endoscopic	B-T082
trans	B-T082
##nas	I-T082
##al	I-T082
transs	B-T082
##phen	I-T082
##oidal	I-T082
approach	I-T082
and	O
was	O
found	O
to	O
be	O
a	O
thyrot	B-T038
##roph	I-T038
adenoma	I-T038
.	O
rs	B-T038
##ts	I-T038
is	O
a	O
rare	O
,	O
neurodevelopmental	B-T038
genetic	B-T038
disease	I-T038
where	O
most	O
patients	O
with	O
disabilities	O
survive	O
into	O
adulthood	O
.	O
the	O
disorder	B-T038
is	O
associated	O
with	O
an	O
increased	O
predisposition	O
for	O
development	O
of	O
nervous	B-T038
system	I-T038
tumors	I-T038
,	O
including	O
pituitary	B-T038
adenomas	I-T038
.	O

expression	B-T038
##al	I-T038
divergence	B-T082
of	O
insect	B-T204
go	B-T017
##x	I-T017
genes	I-T017
:	O
from	O
specialist	O
to	O
general	O
##ist	O
glucose	B-T103
oxidase	I-T103
insect	B-T204
herbivores	I-T204
often	O
secrete	B-T038
glucose	B-T103
oxidase	I-T103
(	O
go	B-T103
##x	I-T103
)	O
onto	O
plants	B-T204
to	O
counteract	O
plant	B-T204
defenses	O
and	O
potential	O
pathogens	O
.	O
whether	O
general	O
##ist	O
herbivores	B-T204
always	O
have	O
significantly	O
higher	O
go	B-T103
##x	I-T103
activities	O
than	O
their	O
specialist	O
counterparts	O
at	O
any	O
comparable	O
stage	O
or	O
conditions	O
and	O
how	O
this	O
is	O
realized	O
remain	O
unknown	O
.	O
to	O
address	O
these	O
two	O
general	O
questions	O
,	O
we	O
subjected	O
larvae	B-T204
of	O
a	O
pair	O
of	O
sister	O
species	B-T170
differed	O
mainly	O
in	O
host	O
range	O
,	O
the	O
general	O
##ist	O
helic	B-T204
##over	I-T204
##pa	I-T204
arm	I-T204
##ig	I-T204
##era	I-T204
and	O
its	O
specialist	O
counterpart	O
helic	B-T204
##over	I-T204
##pa	I-T204
ass	I-T204
##ult	I-T204
##a	I-T204
,	O
to	O
the	O
same	O
sets	O
of	O
stage	O
,	O
protein	B-T103
to	O
digestib	B-T038
##le	I-T038
carbohydrate	B-T168
(	O
p	O
:	O
c	O
)	O
ratio	O
,	O
allel	B-T103
##ochemical	I-T103
or	O
host	O
plant	O
treatments	O
for	O
simultaneous	O
analyses	O
of	O
go	B-T017
##x	I-T017
transcripts	B-T103
and	O
activities	O
in	O
their	O
labial	B-T017
glands	I-T017
.	O
go	B-T017
##x	I-T017
activity	O
and	O
transcripts	B-T103
are	O
upregulated	B-T038
concurrently	O
with	O
food	B-T168
ingestion	B-T038
and	O
body	B-T038
growth	I-T038
,	O
downregulated	B-T038
with	O
stopping	O
ingestion	B-T038
and	O
wa	O
##nd	O
##ering	O
for	O
pup	B-T038
##ation	I-T038
in	O
both	O
species	B-T170
.	O
the	O
three	O
tested	O
host	O
plants	O
upregulated	B-T038
go	B-T017
##x	I-T017
transcripts	B-T103
,	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
go	B-T017
##x	I-T017
activity	O
in	O
both	O
species	B-T170
.	O
there	O
were	O
significant	O
differences	O
in	O
both	O
go	B-T017
##x	I-T017
transcripts	B-T103
and	O
activity	O
elicited	O
by	O
allel	B-T103
##ochemical	I-T103
##s	I-T103
,	O
but	O
only	O
in	O
go	B-T017
##x	I-T017
transcripts	B-T103
by	O
p	O
:	O
c	O
ratios	O
in	O
both	O
species	B-T170
.	O
go	B-T103
##x	I-T103
activities	O
were	O
higher	O
in	O
h	B-T204
.	I-T204
arm	I-T204
##ig	I-T204
##era	I-T204
than	O
h	B-T204
.	I-T204
ass	I-T204
##ult	I-T204
##a	I-T204
in	O
all	O
the	O
comparable	O
treatments	O
,	O
but	O
go	B-T017
##x	I-T017
transcripts	B-T103
were	O
significantly	O
higher	O
either	O
in	O
general	O
##ists	O
or	O
in	O
specialists	O
,	O
depending	O
on	O
the	O
developmental	O
stages	O
,	O
host	O
plants	O
,	O
p	O
:	O
c	O
ratio	O
and	O
allel	B-T103
##ochemical	I-T103
##s	I-T103
they	O
encounter	O
.	O
these	O
data	O
indicate	O
that	O
the	O
greater	O
go	B-T103
##x	I-T103
activity	O
in	O
general	O
##ist	O
herbivores	B-T204
is	O
not	O
achieved	O
by	O
greater	O
transcription	B-T038
rate	O
,	O
but	O
by	O
greater	O
transcript	B-T103
stability	O
,	O
greater	O
translation	B-T038
rate	O
,	O
better	B-T038
enzyme	I-T038
stability	I-T038
and	O
/	O
or	O
their	O
combination	O
.	O

gut	O
microbiota	O
-	O
mediated	O
protection	O
against	O
diarrhea	B-T033
##l	I-T033
infections	B-T038
the	O
mammalian	B-T204
gut	O
microbiota	O
is	O
a	O
highly	O
abundant	O
and	O
diverse	O
microbial	O
community	O
that	O
resides	O
in	O
the	O
gastrointestinal	B-T022
tract	I-T022
.	O
one	O
major	O
benefit	O
that	O
the	O
gut	O
microbiota	O
provides	O
to	O
its	O
host	O
is	O
colonization	B-T033
resistance	O
-	O
the	O
ability	O
to	O
prevent	O
colonization	B-T033
by	O
foreign	O
microbes	O
,	O
including	O
diarrhea	B-T033
##l	I-T033
pathogens	O
such	O
as	O
clostridium	B-T007
difficile	I-T007
,	O
salmonella	B-T007
enterica	I-T007
serovar	I-T007
typhimurium	I-T007
and	O
diarrhea	B-T007
##genic	I-T007
escherichia	I-T007
coli	I-T007
.	O
we	O
conducted	O
a	O
literature	B-T170
review	I-T170
of	O
the	O
effects	O
of	O
the	O
gut	O
microbiota	O
on	O
infection	B-T038
by	O
diarrhea	B-T033
##l	I-T033
pathogens	O
.	O
we	O
used	O
pubmed	B-T170
to	O
search	O
for	O
relevant	O
articles	B-T170
published	O
before	O
july	O
2016	O
,	O
as	O
well	O
as	O
incorporated	O
data	O
from	O
our	O
laboratory	B-T092
.	O
the	O
gut	O
microbiota	O
provides	O
protection	O
from	O
diarrhea	B-T033
##l	I-T033
infections	B-T038
both	O
by	O
direct	O
inhibition	O
of	O
pathogens	O
and	O
by	O
indirect	O
effects	O
on	O
host	O
functions	O
.	O
direct	O
effects	O
of	O
the	O
microbiota	O
on	O
diarrhea	B-T033
##l	I-T033
pathogens	O
include	O
competing	O
for	O
nutrients	B-T168
and	O
producing	O
metabolites	B-T103
that	O
inhibit	O
pathogen	O
growth	B-T038
or	O
virulence	B-T038
.	O
indirect	O
effects	O
of	O
the	O
gut	O
microbiota	O
include	O
promoting	O
maintenance	O
of	O
the	O
gut	B-T038
mucosal	I-T038
barrier	I-T038
and	O
stimulating	O
innate	O
and	O
adaptive	B-T038
immunity	I-T038
.	O
human	B-T204
epidemiological	B-T062
studies	I-T062
and	O
experimental	O
infections	B-T038
of	O
laboratory	B-T204
animals	I-T204
both	O
demonstrate	O
that	O
antibiotic	B-T058
treatment	I-T058
can	O
alter	O
the	O
gut	O
microbial	O
community	O
and	O
thereby	O
reduce	O
colonization	B-T033
resistance	O
against	O
diarrhea	B-T033
##l	I-T033
pathogens	O
.	O
further	O
research	B-T062
might	O
lead	O
to	O
the	O
development	O
of	O
next	B-T007
-	I-T007
generation	I-T007
probiotics	I-T007
that	O
could	O
be	O
used	O
to	O
bol	O
##st	O
##er	O
colonization	B-T033
resistance	O
and	O
thus	O
prevent	O
travel	B-T038
##lers	I-T038
'	I-T038
diarrhea	I-T038
##l	I-T038
.	O

neoadjuvant	O
chemotherapy	O
of	O
ovarian	B-T038
cancer	I-T038
results	O
in	O
three	O
patterns	O
of	O
tumor	B-T017
-	I-T017
infiltrating	I-T017
lymphocyte	I-T017
response	B-T038
with	O
distinct	O
implications	O
for	O
immunotherapy	B-T058
purpose	O
:	O
some	O
forms	O
of	O
chemotherapy	B-T058
can	O
enhance	O
antitumor	O
immunity	B-T038
through	O
immunogenic	O
cell	B-T038
death	I-T038
,	O
resulting	O
in	O
increased	O
t	B-T038
-	I-T038
cell	I-T038
activation	I-T038
and	O
tumor	O
infiltration	O
.	O
such	O
effects	O
could	O
potentially	O
sensitiz	O
##e	O
tumors	B-T038
to	O
immuno	B-T058
##therap	I-T058
##ies	I-T058
,	O
including	O
checkpoint	B-T038
blockade	I-T038
.	O
we	O
investigated	O
whether	O
platinum	B-T103
-	O
and	O
taxa	B-T103
##ne	I-T103
-	O
based	O
chemotherapy	B-T058
for	O
ovarian	B-T038
cancer	I-T038
induces	O
immunologic	O
changes	O
consistent	O
with	O
this	O
possibility	O
.	O
experimental	B-T062
design	I-T062
:	O
matched	O
pre	O
-	O
and	O
post	O
-	O
neoadjuvant	O
chemotherapy	O
tumor	B-T017
samples	I-T017
from	O
26	O
high	B-T038
-	I-T038
grade	I-T038
serous	I-T038
carcinoma	I-T038
(	O
hg	B-T038
##sc	I-T038
)	O
patients	O
were	O
analyzed	O
by	O
immunohistochemistry	B-T058
(	O
ihc	B-T058
)	O
for	O
a	O
large	O
panel	O
of	O
immune	B-T017
cells	I-T017
and	O
associated	O
factors	O
.	O
the	O
prognostic	O
significance	O
of	O
post	O
-	O
chemotherapy	B-T058
til	B-T017
patterns	O
was	O
assessed	O
in	O
an	O
expanded	O
cohort	B-T098
(	O
n	O
=	O
90	O
)	O
.	O
results	O
:	O
neoadjuvant	O
chemotherapy	O
was	O
associated	O
with	O
increased	O
densities	O
of	O
cd3	B-T103
(	O
+	O
)	O
,	O
cd8	B-T103
(	O
+	O
)	O
,	O
cd8	B-T103
(	O
+	O
)	O
tia	B-T103
-	I-T103
1	I-T103
(	O
+	O
)	O
,	O
pd	B-T103
-	I-T103
1	I-T103
(	O
+	O
)	O
and	O
cd20	B-T103
(	O
+	O
)	O
til	B-T017
.	O
other	O
immune	O
subsets	O
and	O
factors	O
were	O
unchanged	O
,	O
including	O
cd	B-T103
##79	I-T103
##a	I-T103
(	O
+	O
)	O
cd13	B-T103
##8	I-T103
(	O
+	O
)	O
plasma	B-T017
cells	I-T017
,	O
cd68	B-T103
(	O
+	O
)	O
macrophages	B-T017
,	O
and	O
mhc	B-T103
class	I-T103
i	I-T103
on	O
tumor	B-T017
cells	I-T017
.	O
immunosuppressive	B-T038
cell	B-T017
types	O
were	O
also	O
unchanged	O
,	O
including	O
foxp3	B-T103
(	O
+	O
)	O
pd	B-T103
-	I-T103
1	I-T103
(	O
+	O
)	O
cells	B-T017
(	O
putative	O
regulatory	B-T017
t	I-T017
cells	I-T017
)	O
,	O
ido	B-T103
-	I-T103
1	I-T103
(	O
+	O
)	O
cells	O
,	O
and	O
pd	O
-	O
l1	O
(	O
+	O
)	O
cells	O
(	O
both	O
macrophages	B-T017
and	O
tumor	B-T017
cells	I-T017
)	O
.	O
hierarchical	B-T062
clustering	I-T062
revealed	O
three	O
response	O
patterns	O
:	O
(	O
i	O
)	O
til	B-T017
(	O
high	O
)	O
tumors	B-T038
showed	O
increases	O
in	O
multiple	O
immune	O
markers	O
after	O
chemotherapy	O
;	O
(	O
ii	O
)	O
til	B-T017
(	O
low	O
)	O
tumors	O
underwent	O
similar	O
increases	O
,	O
achieving	O
patterns	O
indistinguishable	O
from	O
the	O
first	O
group	O
;	O
and	O
(	O
iii	O
)	O
til	B-T017
(	O
negative	B-T033
)	O
cases	O
generally	O
remained	O
negative	B-T033
.	O
despite	O
the	O
dramatic	O
increases	O
seen	O
in	O
the	O
first	O
two	O
patterns	O
,	O
post	O
-	O
chemotherapy	B-T058
til	B-T017
showed	O
limited	O
prognostic	O
significance	O
.	O
conclusions	O
:	O
chemotherapy	O
augments	O
pre	O
-	O
existing	O
til	B-T017
responses	B-T038
but	O
fails	O
to	O
relieve	O
major	O
immune	B-T038
-	I-T038
suppressive	I-T038
mechanisms	I-T038
or	O
confer	O
significant	O
prognostic	O
benefit	O
.	O
our	O
findings	O
provide	O
rationale	O
for	O
multip	O
##ron	O
##ged	O
approaches	O
to	O
immunotherapy	B-T058
tailored	O
to	O
the	O
baseline	O
features	O
of	O
the	O
tumor	O
microenvironment	O
.	O
clin	O
cancer	O
res	O
;	O
23	O
(	O
4	O
)	O
;	O
92	O
##5	O
-	O
34	O
.	O
©	O
##20	O
##16	O
aac	O
##r	O
.	O

acute	O
clinical	O
adverse	B-T037
radiation	I-T037
effects	I-T037
after	O
gamma	B-T058
knife	I-T058
surgery	I-T058
for	O
vestibular	B-T038
schwannoma	I-T038
##s	I-T038
objective	O
vestibular	B-T038
schwannoma	I-T038
##s	I-T038
(	O
vs	B-T038
##s	I-T038
)	O
represent	O
a	O
common	O
indication	O
of	O
gamma	B-T058
knife	I-T058
surgery	I-T058
(	O
gk	B-T058
##s	I-T058
)	O
.	O
while	O
most	O
studies	B-T062
focus	O
on	O
the	O
long	O
-	O
term	O
morbidity	O
and	O
adverse	B-T037
radiation	I-T037
effects	I-T037
(	O
are	B-T037
##s	I-T037
)	O
,	O
none	O
describe	O
the	O
acute	O
clinical	O
are	B-T037
##s	I-T037
that	O
might	O
appear	O
on	O
a	O
short	O
-	O
term	O
basis	O
.	O
these	O
types	O
of	O
events	O
are	O
investigated	O
,	O
and	O
their	O
incidence	O
,	O
type	O
,	O
and	O
outcomes	B-T062
are	O
reported	B-T170
in	O
the	O
present	O
paper	O
.	O
methods	O
the	O
included	O
patients	O
were	O
treated	O
between	O
july	O
2010	O
and	O
march	O
2016	O
,	O
underwent	O
at	O
least	O
6	O
months	O
of	O
follow	B-T058
-	I-T058
up	I-T058
,	O
and	O
presented	O
with	O
a	O
disabling	O
symptom	B-T033
during	O
the	O
first	O
6	O
months	O
after	O
gk	B-T058
##s	I-T058
that	O
affected	O
their	O
quality	O
of	O
life	O
.	O
the	O
timing	O
of	O
appearance	O
,	O
as	O
well	O
as	O
the	O
type	O
of	O
main	O
symptom	B-T033
and	O
outcome	B-T062
,	O
were	O
noted	O
.	O
the	O
prescribed	O
dose	O
was	O
12	O
gy	O
at	O
the	O
margin	O
.	O
results	O
thirty	O
-	O
five	O
(	O
22	O
%	O
)	O
of	O
159	O
patients	O
who	O
fulfilled	O
the	O
inclusion	O
criteria	O
had	O
acute	O
clinical	O
are	B-T037
##s	I-T037
.	O
the	O
mean	O
followup	B-T058
period	O
was	O
30	O
months	O
(	O
range	O
6	O
-	O
49	O
.	O
2	O
months	O
)	O
.	O
the	O
mean	O
time	O
of	O
appearance	O
was	O
37	O
.	O
9	O
days	O
(	O
median	O
31	O
days	O
;	O
range	O
3	O
-	O
110	O
days	O
)	O
.	O
in	O
patients	O
with	O
de	O
novo	O
symptoms	B-T033
,	O
the	O
more	O
frequent	O
symptoms	B-T033
were	O
vertigo	B-T033
(	O
n	O
=	O
4	O
;	O
11	O
.	O
4	O
%	O
)	O
and	O
gait	B-T033
disturbance	I-T033
(	O
n	O
=	O
3	O
;	O
8	O
.	O
6	O
%	O
)	O
.	O
the	O
exacerbation	B-T033
of	O
a	O
preexisting	O
symptom	B-T033
was	O
more	O
frequently	O
related	O
to	O
hearing	B-T033
loss	I-T033
(	O
n	O
=	O
10	O
;	O
28	O
.	O
6	O
%	O
)	O
,	O
followed	O
by	O
gait	B-T033
disturbance	I-T033
(	O
n	O
=	O
7	O
;	O
20	O
%	O
)	O
and	O
vertigo	B-T033
(	O
n	O
=	O
3	O
,	O
8	O
.	O
6	O
%	O
)	O
.	O
in	O
the	O
univariate	O
logistic	O
regression	O
analysis	O
,	O
the	O
following	O
factors	O
were	O
statistically	O
significant	O
:	O
age	O
(	O
p	O
=	O
0	O
.	O
002	O
;	O
odds	O
ratio	O
[	O
or	O
]	O
0	O
.	O
96	O
)	O
,	O
hearing	O
at	O
baseline	O
by	O
gard	B-T170
##ner	I-T170
-	I-T170
rob	I-T170
##erts	I-T170
##on	I-T170
(	O
gr	B-T170
)	O
class	O
(	O
p	O
=	O
0	O
.	O
006	O
;	O
or	O
0	O
.	O
21	O
)	O
,	O
pure	O
tone	O
average	O
at	O
baseline	O
(	O
p	O
=	O
0	O
.	O
006	O
;	O
or	O
0	O
.	O
97	O
)	O
,	O
and	O
ko	B-T170
##os	I-T170
grade	I-T170
at	O
baseline	O
(	O
with	O
ko	B-T170
##os	I-T170
grade	I-T170
i	I-T170
used	O
as	O
a	O
reference	O
)	O
(	O
for	O
ko	B-T170
##os	I-T170
grade	I-T170
ii	I-T170
,	O
or	O
0	O
.	O
17	O
and	O
p	O
=	O
0	O
.	O
002	O
;	O
for	O
ko	B-T170
##os	I-T170
grade	I-T170
iii	I-T170
,	O
or	O
0	O
.	O
42	O
and	O
p	O
=	O
0	O
.	O
05	O
)	O
.	O
the	O
following	O
were	O
not	O
statistically	O
significant	O
but	O
showed	O
a	O
tendency	O
toward	O
significance	O
:	O
the	O
number	O
of	O
isoc	B-T082
##enter	I-T082
##s	I-T082
(	O
p	O
=	O
0	O
.	O
06	O
;	O
or	O
0	O
.	O
94	O
)	O
and	O
the	O
maximal	O
dose	O
received	O
by	O
the	O
cochlea	B-T038
(	O
p	O
=	O
0	O
.	O
07	O
;	O
or	O
0	O
.	O
74	O
)	O
.	O
fractional	B-T170
polynomial	I-T170
regression	I-T170
analysis	I-T170
showed	O
a	O
nonlinear	O
relationship	O
between	O
the	O
outcome	B-T062
and	O
the	O
radiation	O
dose	O
rate	O
(	O
minimum	O
reached	O
at	O
a	O
cutoff	O
of	O
2	O
.	O
5	O
gy	O
/	O
minute	O
)	O
and	O
the	O
maximal	O
vestibular	B-T082
dose	O
(	O
maximum	O
reached	O
at	O
a	O
cutoff	O
of	O
8	O
gy	O
)	O
,	O
but	O
the	O
small	O
sample	O
size	O
preclude	O
##s	O
a	O
detailed	O
analysis	B-T062
of	O
the	O
former	O
.	O
the	O
clinical	O
acute	O
are	B-T037
##s	I-T037
disappeared	O
in	O
32	O
(	O
91	O
.	O
4	O
%	O
)	O
patients	O
during	O
the	O
first	O
6	O
months	O
after	O
appearance	O
.	O
permanent	O
and	O
somewhat	O
disabling	O
morbidity	O
was	O
found	O
in	O
3	O
cases	O
(	O
1	O
.	O
9	O
%	O
from	O
the	O
whole	O
series	O
)	O
:	O
1	O
each	O
with	O
complete	B-T033
hearing	I-T033
loss	I-T033
(	O
gr	B-T170
class	I-T170
i	I-T170
before	O
and	O
v	B-T170
after	O
)	O
,	O
hemif	B-T033
##acial	I-T033
spasm	I-T033
(	O
persistent	O
but	O
alleviated	O
)	O
,	O
and	O
dys	B-T033
##ge	I-T033
##us	I-T033
##ia	I-T033
.	O
conclusions	O
acute	O
effects	O
after	O
radiosurgery	B-T058
for	O
vs	B-T038
are	O
not	O
rare	O
.	O
they	O
concern	O
predominantly	O
de	O
novo	O
vertigo	B-T033
and	O
gait	B-T033
disturbance	I-T033
and	O
the	O
exacerbation	B-T033
of	O
preex	O
##ist	O
##ent	O
hearing	B-T033
loss	I-T033
.	O
in	O
de	O
novo	O
vestibular	B-T082
symptom	B-T033
s	O
,	O
a	O
vestibular	B-T082
dose	O
of	O
more	O
than	O
8	O
gy	O
is	O
thought	O
to	O
play	O
a	O
role	O
.	O
in	O
most	O
cases	O
,	O
none	O
of	O
these	O
effects	O
are	O
permanent	O
,	O
and	O
they	O
will	O
ultimately	O
improve	O
or	O
disappear	O
with	O
steroid	B-T058
therapy	I-T058
.	O
permanent	O
are	B-T037
##s	I-T037
remain	O
very	O
rare	O
.	O

self	O
-	O
assembled	O
polymeric	B-T103
vectors	B-T074
mixtures	O
:	O
characterization	O
of	O
the	O
polymorphism	O
and	O
existence	O
of	O
synergistic	O
effects	O
in	O
photodynamic	B-T058
therapy	I-T058
the	O
objective	O
of	O
this	O
work	O
was	O
to	O
assess	O
the	O
relation	O
between	O
the	O
purity	O
of	O
polymeric	B-T103
self	O
-	O
assemblies	O
vectors	B-T074
solution	O
and	O
their	O
photodynamic	B-T058
therapeutic	I-T058
efficiency	O
.	O
for	O
this	O
,	O
several	O
amphiphilic	B-T103
block	B-T103
copolymers	I-T103
of	O
poly	B-T103
(	I-T103
ethylene	I-T103
##oxide	I-T103
-	I-T103
b	I-T103
-	I-T103
ε	I-T103
-	I-T103
cap	I-T103
##rolactone	I-T103
)	I-T103
have	O
been	O
used	O
to	O
form	O
self	O
-	O
assemblies	O
with	O
different	O
morphologies	O
(	O
micelles	B-T103
,	O
worm	B-T103
-	I-T103
like	I-T103
micelles	I-T103
or	O
vesicles	O
)	O
.	O
in	O
a	O
first	O
step	O
,	O
controlled	O
mixtures	O
of	O
preformed	O
micelles	B-T103
and	O
vesicles	O
have	O
been	O
characterized	O
both	O
by	O
dynamic	B-T058
light	I-T058
scattering	I-T058
and	O
asymmetrical	B-T058
flow	I-T058
field	I-T058
flow	I-T058
fractionation	I-T058
(	O
as	B-T058
##fl	I-T058
##ff	I-T058
##f	I-T058
)	O
.	O
for	O
this	O
,	O
a	O
custom	O
-	O
made	O
program	B-T170
,	O
storm	B-T170
##s	I-T170
,	O
was	O
developed	O
to	O
analyze	O
dls	B-T058
data	O
in	O
a	O
thorough	O
manner	O
by	O
providing	O
a	O
large	O
set	O
of	O
fitting	O
parameters	O
.	O
this	O
showed	O
that	O
dls	B-T058
only	O
sense	O
##d	O
the	O
larger	O
vesicles	O
when	O
the	O
micelles	B-T103
/	O
vesicles	O
ratio	O
was	O
80	O
/	O
20	O
w	O
/	O
w	O
.	O
on	O
the	O
other	O
hand	O
,	O
as	B-T058
##fl	I-T058
##ff	I-T058
##f	I-T058
allowed	O
clear	O
detection	B-T033
of	O
the	O
presence	O
of	O
micelles	B-T103
when	O
this	O
same	O
ratio	O
was	O
as	O
low	O
as	O
10	O
/	O
90	O
.	O
subsequently	O
,	O
the	O
photodynamic	B-T058
therapy	I-T058
efficiency	O
of	O
various	O
controlled	O
mixtures	O
was	O
assessed	O
using	O
multicellular	O
spheroids	B-T033
when	O
a	O
photosensitizer	B-T103
,	O
phe	B-T103
##ophor	I-T103
##bi	I-T103
##de	I-T103
a	I-T103
,	O
was	O
encapsulated	O
in	O
the	O
polymer	B-T103
self	O
-	O
assemblies	O
.	O
some	O
mixtures	O
were	O
shown	O
to	O
be	O
as	O
efficient	O
as	O
mono	B-T033
##mo	I-T033
##rp	I-T033
##hou	I-T033
##s	I-T033
systems	I-T033
.	O
in	O
some	O
cases	O
,	O
mixtures	O
were	O
found	O
to	O
exhibit	O
a	O
higher	O
pdt	B-T058
efficiency	O
compared	O
to	O
the	O
individual	O
nano	O
-	O
objects	O
,	O
revealing	O
a	O
synergistic	O
effect	O
for	O
the	O
efficient	O
delivery	O
of	O
the	O
photosensitizer	B-T103
.	O
polymorph	O
##ous	O
vectors	B-T074
can	O
therefore	O
be	O
superior	O
in	O
therapeutic	O
applications	O
.	O

left	B-T017
ventricular	I-T017
rotational	B-T082
mechanics	O
in	O
infants	O
with	O
hypoxic	B-T038
ischemic	I-T038
encephalopathy	I-T038
and	O
preterm	O
infants	O
at	O
36	O
weeks	O
postm	O
##enstrual	O
age	O
:	O
a	O
comparison	O
with	O
healthy	O
term	O
controls	O
there	O
is	O
a	O
paucity	O
of	O
data	O
on	O
left	B-T017
ventricle	I-T017
(	O
lv	B-T017
)	O
rotational	B-T091
physiology	I-T091
in	O
neonates	O
.	O
we	O
aimed	O
to	O
assess	O
rotational	B-T082
mechanics	O
in	O
infants	O
with	O
hypoxic	B-T038
ischemic	I-T038
encephalopathy	I-T038
(	O
hi	B-T038
##e	I-T038
)	O
and	O
premature	O
infants	O
(	O
<	O
32	O
weeks	O
)	O
at	O
36	O
weeks	O
postm	O
##enstrual	O
age	O
(	O
pma	O
)	O
(	O
preterm	B-T098
group	I-T098
)	O
and	O
compare	O
them	O
with	O
healthy	O
term	O
controls	O
(	O
term	O
controls	O
)	O
.	O
we	O
also	O
compared	O
the	O
parameters	O
in	O
preterm	O
infants	O
with	O
and	O
without	O
chronic	B-T038
lung	I-T038
disease	I-T038
(	O
cld	B-T038
)	O
.	O
echocardiography	B-T058
was	O
performed	O
within	O
48	O
hours	O
of	O
birth	B-T038
or	O
at	O
36	O
weeks	O
pma	O
.	O
lv	B-T017
basal	B-T082
and	O
apical	O
rotation	O
,	O
twist	B-T082
(	O
and	O
torsion	O
=	O
twist	B-T082
/	O
lv	O
length	O
)	O
,	O
twist	O
rate	O
(	O
lv	O
##tr	O
)	O
,	O
and	O
unt	O
##wi	O
##st	O
rate	O
(	O
lv	O
##utr	O
)	O
were	O
measured	O
.	O
one	O
-	O
way	O
anova	O
was	O
used	O
to	O
compare	O
values	O
.	O
there	O
was	O
no	O
difference	O
in	O
gestation	B-T038
(	O
40	O
.	O
0	O
[	O
39	O
.	O
1	O
-	O
40	O
.	O
3	O
]	O
vs	O
39	O
.	O
9	O
[	O
39	O
.	O
0	O
-	O
40	O
.	O
9	O
]	O
,	O
p	O
>	O
.	O
05	O
)	O
or	O
birthweight	O
(	O
3	O
.	O
7	O
[	O
3	O
.	O
4	O
-	O
4	O
.	O
1	O
]	O
vs	O
3	O
.	O
5	O
[	O
3	O
.	O
2	O
-	O
3	O
.	O
9	O
]	O
,	O
p	O
>	O
.	O
05	O
)	O
between	O
the	O
hi	B-T038
##e	I-T038
group	B-T098
(	O
n	O
=	O
16	O
)	O
and	O
term	O
controls	O
(	O
n	O
=	O
30	O
)	O
.	O
the	O
preterm	B-T098
group	I-T098
(	O
n	O
=	O
35	O
)	O
had	O
a	O
gestation	B-T038
and	O
weight	O
of	O
36	O
.	O
0	O
[	O
34	O
.	O
6	O
-	O
36	O
.	O
3	O
]	O
weeks	O
and	O
2	O
.	O
3	O
[	O
2	O
.	O
0	O
-	O
2	O
.	O
4	O
]	O
kg	O
.	O
the	O
hi	B-T038
##e	I-T038
group	O
had	O
lower	O
twist	B-T082
,	O
torsion	O
,	O
lv	O
##tr	O
,	O
and	O
lv	O
##utr	O
than	O
the	O
other	O
two	O
groups	O
.	O
the	O
preterm	B-T098
group	I-T098
had	O
a	O
more	O
negative	O
(	O
clock	O
##wise	O
)	O
basal	B-T082
rotation	O
while	O
the	O
term	B-T098
group	I-T098
had	O
a	O
more	O
positive	O
(	O
counter	O
##cl	O
##ock	O
##wise	O
)	O
apical	B-T082
rotation	O
.	O
preterm	O
infants	O
with	O
cld	B-T038
had	O
higher	O
apical	B-T082
rotation	O
,	O
twist	B-T082
,	O
and	O
torsion	O
when	O
compared	O
to	O
infants	O
without	O
cld	B-T038
.	O
infants	O
with	O
hi	B-T038
##e	I-T038
have	O
reduced	O
rotational	B-T082
mechanics	O
.	O
preterm	O
infants	O
at	O
36	O
weeks	O
pma	O
have	O
comparable	O
measurements	O
of	O
twist	B-T082
to	O
term	O
infants	O
.	O
this	O
is	O
achieved	O
by	O
predominant	O
basal	B-T082
rather	O
than	O
apical	B-T082
rotation	O
.	O
infants	O
with	O
cld	B-T038
have	O
increased	O
apical	B-T082
rotation	O
.	O

visualization	B-T058
of	O
the	O
intimal	B-T017
flap	I-T017
in	O
intracranial	B-T017
arterial	I-T017
dissection	I-T017
using	O
high	O
-	O
resolution	O
3t	B-T058
mri	I-T058
presence	B-T033
of	O
an	O
intimal	B-T017
flap	I-T017
is	O
a	O
critical	O
imaging	B-T033
finding	I-T033
in	O
diagnosing	B-T033
intracranial	B-T017
artery	I-T017
dissection	I-T017
(	O
ica	B-T017
##d	I-T017
)	O
.	O
recent	O
reports	B-T170
showed	O
that	O
high	O
-	O
resolution	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
was	O
better	O
at	O
identifying	O
intimal	B-T017
flaps	I-T017
as	O
compared	O
with	O
routine	O
mri	B-T058
techniques	I-T058
used	O
in	O
clinical	O
settings	O
.	O
however	O
,	O
no	O
current	O
standardized	O
sequence	O
for	O
high	O
-	O
resolution	O
mri	B-T058
without	O
gadolinium	B-T103
enhancement	O
produces	O
images	O
of	O
satisfactory	O
quality	O
with	O
clinically	O
tolerable	O
scanning	B-T058
times	O
.	O
this	O
study	O
evaluated	B-T058
a	O
none	B-T058
##nh	I-T058
##anced	I-T058
high	I-T058
-	I-T058
resolution	I-T058
fast	I-T058
spin	I-T058
echo	I-T058
(	I-T058
hr	I-T058
-	I-T058
fs	I-T058
##e	I-T058
)	I-T058
mri	I-T058
sequence	O
for	O
visualizing	O
intimal	B-T017
flaps	I-T017
in	O
patients	O
with	O
ica	B-T017
##d	I-T017
.	O
three	O
patients	O
with	O
ica	B-T017
##d	I-T017
underwent	O
plain	O
mri	B-T058
examination	O
using	O
a	O
2	B-T082
-	I-T082
dimensional	I-T082
t2	B-T058
-	I-T058
weighted	I-T058
fs	I-T058
##e	I-T058
imaging	I-T058
sequence	O
optimized	O
for	O
our	O
3t	O
system	O
(	O
in	O
-	O
plane	O
pixel	O
size	O
,	O
.	O
23	O
mm	O
×	O
.	O
23	O
mm	O
;	O
slice	O
thickness	O
3	O
mm	O
with	O
no	O
inters	O
##lic	O
##e	O
gap	O
)	O
,	O
as	O
well	O
as	O
scanning	B-T058
with	O
conventional	O
modalities	O
,	O
including	O
ct	B-T058
angiography	I-T058
,	O
magnetic	B-T058
resonance	I-T058
angiography	I-T058
,	O
and	O
digital	B-T058
subtraction	I-T058
angiography	I-T058
.	O
we	O
assessed	O
whether	O
these	O
imaging	O
methods	O
could	O
visualize	O
an	O
intimal	B-T017
flap	I-T017
and	O
/	O
or	O
double	B-T033
lumen	I-T033
sign	I-T033
in	O
the	O
participants	B-T098
and	O
compared	O
the	O
results	O
between	O
hr	B-T058
-	I-T058
fs	I-T058
##e	I-T058
and	O
the	O
other	O
modalities	O
.	O
hr	B-T058
-	I-T058
fs	I-T058
##e	I-T058
images	O
clearly	O
showed	O
intimal	B-T017
flaps	I-T017
and	O
double	B-T033
lumen	I-T033
signs	I-T033
in	O
all	O
3	O
patients	O
,	O
whereas	O
the	O
conventional	O
modalities	O
identified	O
a	O
double	B-T033
lumen	I-T033
sign	I-T033
in	O
only	O
2	O
of	O
the	O
3	O
patients	O
.	O
the	O
present	O
method	O
of	O
optimized	O
hr	B-T058
-	I-T058
fs	I-T058
##e	I-T058
imaging	I-T058
with	O
a	O
3t	O
system	O
improved	B-T033
visualization	B-T058
of	O
intimal	B-T017
flaps	I-T017
and	O
should	O
thus	O
be	O
considered	O
for	O
assessing	O
patients	O
with	O
suspected	O
ica	B-T017
##d	I-T017
that	O
cann	O
##ot	O
be	O
definitively	O
diagnosed	B-T033
by	O
conventional	O
imaging	O
modalities	O
.	O

reversible	O
humidity	O
sensitive	O
clothing	O
for	O
personal	B-T058
thermoreg	I-T058
##ulation	I-T058
two	O
kinds	O
of	O
humidity	O
-	O
induced	O
,	O
bend	O
##able	O
smart	O
clothing	O
have	O
been	O
designed	B-T062
to	I-T062
reversibly	I-T062
adapt	I-T062
their	O
thermal	O
insula	O
##tion	O
functionality	O
.	O
the	O
first	O
design	O
mimics	O
the	O
pores	B-T017
in	O
human	B-T022
skin	I-T022
,	O
in	O
which	O
pre	O
-	O
cut	O
flaps	O
open	O
to	O
produce	O
pores	B-T017
in	O
naf	B-T103
##ion	I-T103
sheets	O
when	O
humidity	O
increases	O
,	O
as	O
might	O
occur	O
during	O
human	B-T033
sweating	I-T033
thus	O
permitting	O
air	O
flow	O
and	O
reducing	O
both	O
the	O
humidity	O
level	O
and	O
the	O
apparent	O
temperature	O
.	O
like	O
the	O
smart	O
human	B-T017
sweating	I-T017
pores	I-T017
,	O
the	O
flaps	O
can	O
close	O
automatically	O
after	O
the	O
persp	B-T033
##iration	I-T033
to	O
keep	O
the	O
wear	O
##er	O
warm	O
.	O
the	O
second	O
design	O
involves	O
thickness	O
adjustable	O
clot	O
##he	O
##s	O
by	O
inserting	O
the	O
bent	O
polymer	O
sheets	O
between	O
two	O
fabric	O
##s	O
.	O
as	O
the	O
humidity	O
increases	O
,	O
the	O
sheets	O
become	O
thinner	O
,	O
thus	O
reducing	O
the	O
gap	O
between	O
the	O
two	O
fabric	O
##s	O
to	O
reduce	O
the	O
thermal	O
insula	O
##tion	O
.	O
the	O
insula	O
##tion	O
layer	O
can	O
recover	O
its	O
original	O
thickness	O
upon	O
humidity	O
reduction	O
to	O
restore	O
its	O
warm	B-T038
##th	I-T038
-	I-T038
preservation	I-T038
function	O
.	O
such	O
humidity	O
sensitive	O
smart	O
polymer	O
materials	O
can	O
be	O
utilized	O
to	O
adjust	O
personal	B-T038
comfort	I-T038
,	O
and	O
be	O
effective	O
in	O
reducing	B-T033
energy	I-T033
consumption	I-T033
for	O
building	O
heating	O
or	O
cooling	O
with	O
numerous	O
smart	O
design	O
.	O

can	O
we	O
predict	O
burnout	B-T038
among	O
student	B-T097
nurses	I-T097
?	O
an	O
exploration	O
of	O
the	O
ic	B-T170
##wr	I-T170
-	I-T170
1	I-T170
model	I-T170
of	O
individual	B-T098
psychological	O
resilience	O
the	O
nature	O
of	O
nursing	B-T091
work	I-T091
is	O
demanding	B-T058
and	O
can	O
be	O
stressful	O
.	O
previous	O
studies	O
have	O
shown	O
a	O
high	O
rate	O
of	O
burnout	B-T038
among	O
employed	B-T033
nurses	B-T097
.	O
recently	O
,	O
efforts	O
have	O
been	O
made	O
to	O
understand	O
the	O
role	O
of	O
resilience	O
in	O
determining	O
the	O
psychological	O
adjustment	O
of	O
employed	B-T033
nurses	B-T097
.	O
a	O
theoretical	B-T170
model	I-T170
of	O
resilience	O
was	O
proposed	O
recently	O
that	O
includes	O
several	O
constructs	B-T170
identified	O
in	O
the	O
literature	B-T170
related	O
to	O
resilience	O
and	O
to	O
psychological	B-T038
functioning	I-T038
.	O
as	O
nursing	B-T097
students	I-T097
are	O
the	O
future	O
of	O
the	O
nursing	B-T091
workforce	B-T097
it	O
is	O
important	O
to	O
advance	O
our	O
understanding	O
of	O
the	O
determinants	O
of	O
resilience	O
in	O
this	O
population	B-T098
.	O
student	B-T097
nurses	I-T097
who	O
had	O
completed	O
their	O
final	O
practic	O
##um	O
were	O
invited	O
to	O
participate	O
in	O
an	O
online	B-T170
survey	I-T170
measuring	O
the	O
key	O
constructs	B-T170
of	O
the	O
ic	B-T170
##wr	I-T170
-	I-T170
1	I-T170
model	I-T170
.	O
42	O
##2	O
students	B-T097
from	O
across	O
australia	B-T082
and	O
canada	B-T082
completed	O
the	O
survey	B-T170
between	O
july	O
2014	O
and	O
july	O
2015	O
.	O
as	O
well	O
as	O
several	O
key	O
demographics	O
,	O
trait	B-T033
negative	I-T033
affect	I-T033
,	O
mindfulness	B-T038
,	O
self	B-T038
-	I-T038
efficacy	I-T038
,	O
coping	O
,	O
resilience	O
,	O
and	O
burnout	B-T038
were	O
measured	O
.	O
we	O
used	O
structural	O
equation	O
modeling	O
and	O
found	O
support	O
for	O
the	O
major	O
pathways	O
of	O
the	O
model	B-T170
;	O
namely	O
that	O
resilience	O
had	O
a	O
significant	O
influence	O
on	O
the	O
relationship	O
between	O
mindfulness	B-T038
,	O
self	B-T038
-	I-T038
efficacy	I-T038
and	O
coping	O
,	O
and	O
psychological	O
adjustment	O
(	O
burnout	B-T038
scores	O
)	O
.	O
furthermore	O
,	O
as	O
predicted	O
,	O
neuroticism	B-T038
moderated	O
the	O
relationship	O
between	O
coping	O
and	O
burnout	B-T038
.	O
results	O
are	O
discussed	O
in	O
terms	O
of	O
potential	O
approaches	O
to	O
supporting	O
nursing	B-T097
students	I-T097
who	O
may	O
be	O
at	O
risk	O
of	O
burnout	B-T038
.	O

far	O
-	O
infrared	O
protects	O
vascular	B-T017
endothelial	I-T017
cells	I-T017
from	O
advanced	B-T103
glycation	I-T103
end	I-T103
products	I-T103
-	O
induced	O
injury	B-T037
via	O
pl	B-T103
##z	I-T103
##f	I-T103
-	O
mediated	O
autophagy	B-T038
in	O
diabetic	B-T204
mice	I-T204
the	O
accumulation	O
of	O
advanced	B-T103
glycation	I-T103
end	I-T103
products	I-T103
(	O
ages	B-T103
)	O
in	O
diabetic	B-T038
patients	O
induces	O
vascular	B-T017
endothelial	I-T017
injury	B-T037
.	O
promyelocytic	B-T103
leukemia	I-T103
zinc	I-T103
finger	I-T103
protein	I-T103
(	O
pl	B-T103
##z	I-T103
##f	I-T103
)	O
is	O
a	O
transcription	B-T103
factor	I-T103
that	O
can	O
be	O
activated	B-T038
by	O
low	O
-	O
temperature	O
far	O
-	O
infrared	O
(	O
fir	O
)	O
irradiation	O
to	O
exert	B-T038
beneficial	I-T038
effects	I-T038
on	O
the	O
vascular	B-T017
endothelium	I-T017
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
investigated	O
the	O
influence	O
of	O
fir	O
-	O
induced	O
pl	B-T103
##z	I-T103
##f	I-T103
activation	B-T038
on	O
age	B-T103
-	O
induced	O
endothelial	B-T017
injury	B-T037
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
fir	O
irradiation	O
inhibited	O
age	B-T103
-	O
induced	O
apoptosis	B-T038
in	O
human	B-T017
umbilical	I-T017
vein	I-T017
endothelial	I-T017
cells	I-T017
(	O
huvecs	B-T017
)	O
.	O
pl	B-T103
##z	I-T103
##f	I-T103
activation	B-T038
increased	O
the	O
expression	B-T038
of	O
phosphatidylinositol	B-T103
-	I-T103
3	I-T103
kinases	I-T103
(	O
pi3k	B-T103
)	O
,	O
which	O
are	O
important	O
kinases	B-T103
in	O
the	O
autophagic	B-T038
signaling	B-T038
pathway	I-T038
.	O
fir	O
-	O
induced	O
pl	B-T103
##z	I-T103
##f	I-T103
activation	B-T038
led	O
to	O
autophagy	B-T038
in	O
huvec	B-T017
,	O
which	O
was	O
mediated	O
through	O
the	O
upregulation	B-T038
of	O
pi3k	B-T103
.	O
immunofluorescence	B-T058
staining	B-T058
showed	O
that	O
ages	B-T103
were	O
eng	O
##ulf	O
##ed	O
by	O
huvecs	B-T017
and	O
localized	B-T082
to	O
lysosomes	B-T017
.	O
fir	O
-	O
induced	O
autophagy	B-T038
promoted	O
ages	B-T103
degradation	O
in	O
huvecs	B-T017
.	O
in	O
nicotinamide	B-T103
/	O
streptozotocin	B-T103
-	O
induced	O
diabetic	B-T204
mice	I-T204
,	O
fir	O
therapy	B-T058
reduced	O
serum	B-T103
ages	I-T103
and	O
ages	B-T103
deposition	O
at	O
the	O
vascular	B-T017
endothelium	I-T017
.	O
fir	O
therapy	B-T058
also	O
reduced	O
diabetes	B-T038
-	O
induced	O
inflammatory	B-T033
markers	I-T033
in	O
the	O
vascular	B-T017
endothelium	I-T017
and	O
improved	B-T033
vascular	B-T017
endothelial	I-T017
function	O
.	O
these	O
protective	B-T038
effects	I-T038
of	O
fir	O
therapy	B-T058
were	O
not	B-T033
found	I-T033
in	O
pl	B-T103
##z	I-T103
##f	I-T103
-	O
knockout	B-T204
mice	I-T204
.	O
our	O
data	O
suggest	O
that	O
fir	O
-	O
induced	O
pl	B-T103
##z	I-T103
##f	I-T103
activation	B-T038
in	O
vascular	B-T017
endothelial	I-T017
cells	I-T017
protects	O
the	O
vascular	B-T017
endothelium	I-T017
in	O
diabetic	B-T204
mice	I-T204
from	O
age	B-T103
-	O
induced	O
injury	B-T037
.	O

assessment	O
of	O
the	O
extravas	B-T074
##cu	I-T074
##la	I-T074
##r	I-T074
implantable	I-T074
defibrillator	I-T074
:	O
feasibility	O
of	O
subst	B-T058
##ern	I-T058
##al	I-T058
ventricular	I-T058
pacing	I-T058
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
assess	O
feasibility	O
of	O
ventricular	B-T058
pacing	I-T058
and	O
thresholds	O
from	O
within	B-T082
the	O
subst	B-T082
##ern	I-T082
##al	I-T082
space	I-T082
to	O
examine	O
a	O
new	O
extravas	B-T074
##cu	I-T074
##la	I-T074
##r	I-T074
icd	I-T074
configuration	B-T082
with	O
pacing	B-T058
capabilities	O
.	O
in	O
patients	O
undergoing	O
midline	B-T058
sternotomy	I-T058
,	O
a	O
du	B-T074
##ode	I-T074
##cap	I-T074
##olar	I-T074
diagnostic	I-T074
pacing	I-T074
catheter	I-T074
was	O
positioned	B-T082
in	O
the	O
subst	B-T082
##ern	I-T082
##al	I-T082
space	I-T082
anterior	B-T082
to	O
the	O
pericardium	B-T017
,	O
and	O
a	O
cutaneous	B-T033
patch	I-T033
in	O
left	B-T082
lateral	I-T082
position	I-T082
.	O
different	O
unipolar	B-T082
and	O
bipolar	B-T082
pacing	B-T058
configurations	B-T082
were	O
assessed	O
.	O
strength	B-T058
-	I-T058
duration	I-T058
curves	I-T058
were	O
performed	O
to	O
identify	O
the	O
optimal	O
output	B-T058
,	O
starting	O
at	O
25	O
ma	O
with	O
a	O
pulse	O
width	O
of	O
10	O
millis	O
##econds	O
.	O
eight	O
patients	O
with	O
mean	O
age	O
69	O
±	O
9	O
years	O
were	O
included	O
.	O
in	O
5	O
,	O
ventricular	B-T082
capture	O
was	O
achieved	O
in	O
≥1	O
configuration	B-T082
.	O
the	O
mean	O
bipolar	B-T082
pacing	B-T058
thresholds	O
at	O
pw	O
10	O
,	O
5	O
,	O
3	O
,	O
1	O
millis	O
##econds	O
were	O
12	O
.	O
4	O
±	O
3	O
.	O
7	O
ma	O
(	O
5	O
patients	O
)	O
,	O
13	O
.	O
3	O
±	O
5	O
.	O
8	O
ma	O
(	O
3	O
patients	O
)	O
,	O
18	O
.	O
3	O
±	O
5	O
.	O
7	O
ma	O
(	O
3	O
patients	O
)	O
,	O
and	O
25	O
±	O
0	O
ma	O
(	O
2	O
patients	O
)	O
,	O
respectively	O
.	O
the	O
60	O
-	O
mm	O
electrode	B-T074
spacing	O
was	O
the	O
most	O
successful	O
bipolar	B-T082
configuration	B-T082
.	O
unipolar	B-T082
pacing	B-T058
was	O
successful	O
in	O
3	O
out	O
of	O
4	O
patients	O
with	O
mean	O
thresholds	O
of	O
10	O
±	O
0	O
ma	O
at	O
10	O
millis	O
##econds	O
(	O
3	O
patients	O
)	O
,	O
15	O
±	O
0	O
ma	O
at	O
5	O
millis	O
##econds	O
(	O
3	O
patients	O
)	O
,	O
16	O
.	O
7	O
±	O
2	O
.	O
9	O
ma	O
at	O
3	O
millis	O
##econds	O
(	O
3	O
patients	O
)	O
,	O
and	O
20	O
±	O
7	O
.	O
1	O
ma	O
at	O
1	O
millis	O
##econds	O
(	O
2	O
patients	O
)	O
.	O
ventricular	B-T058
pacing	B-T058
from	O
the	O
subst	B-T082
##ern	I-T082
##al	I-T082
space	I-T082
in	O
patients	O
with	O
midline	B-T058
sternotomy	I-T058
is	O
feasible	O
.	O
closed	O
stern	B-T017
##um	I-T017
studies	B-T062
are	O
needed	O
to	O
determine	O
pacing	B-T058
thresholds	O
more	O
accurately	O
.	O

analysis	B-T062
of	O
low	O
-	O
biomass	O
microbial	O
communities	O
in	O
the	O
deep	O
bios	O
##ph	O
##ere	O
over	O
the	O
past	O
few	O
decades	O
,	O
the	O
subs	O
##ea	O
##fl	O
##oor	O
bios	O
##ph	O
##ere	O
has	O
been	O
explored	O
by	O
scientific	O
ocean	O
drilling	O
to	O
depths	B-T082
of	O
about	O
2	O
.	O
5	O
##k	O
##m	O
below	O
the	O
seaf	O
##lo	O
##or	O
.	O
although	O
organic	B-T082
-	I-T082
rich	I-T082
anaerobic	I-T082
sediment	I-T082
##ary	I-T082
habitats	I-T082
in	O
the	O
ocean	O
margins	O
harbor	O
large	O
numbers	O
of	O
microbial	O
cells	O
,	O
microbial	O
populations	O
in	O
ultra	B-T082
##oli	I-T082
##go	I-T082
##tr	I-T082
##oph	I-T082
##ic	I-T082
aerobic	I-T082
sediment	I-T082
##ary	I-T082
habitats	I-T082
in	O
the	O
open	O
ocean	O
gyr	O
##es	O
are	O
several	O
orders	O
of	O
magnitude	O
less	O
abundant	O
.	O
despite	O
advances	O
in	O
cultivation	O
-	O
independent	O
molecular	O
ecological	O
techniques	O
,	O
exploring	O
the	O
low	O
-	O
biomass	O
environment	B-T082
remains	O
technological	O
##ly	O
challenging	O
,	O
especially	O
in	O
the	O
deep	O
subs	O
##ea	O
##fl	O
##oor	O
bios	O
##ph	O
##ere	O
.	O
reviewing	O
the	O
historical	B-T170
background	I-T170
of	O
deep	O
-	O
bios	O
##ph	O
##ere	O
analytical	O
methods	O
,	O
the	O
importance	O
of	O
obtaining	O
clean	O
samples	O
and	O
tracing	B-T033
contamination	O
,	O
as	O
well	O
as	O
methods	B-T170
for	O
detecting	B-T033
microbial	O
life	O
,	O
technological	O
aspects	O
of	O
molecular	B-T091
microbiology	I-T091
,	O
and	O
detecting	B-T033
subs	O
##ea	O
##fl	O
##oor	O
metabolic	B-T038
activity	I-T038
will	O
be	O
discussed	O
.	O

precise	O
prediction	O
of	O
activators	B-T103
for	O
the	O
human	B-T204
constitutive	B-T103
androst	I-T103
##ane	I-T103
receptor	I-T103
using	O
structure	B-T082
-	O
based	O
three	O
-	O
dimensional	O
quantitative	O
structure	O
-	O
activity	O
relationship	O
methods	B-T170
the	O
constitutive	B-T103
androst	I-T103
##ane	I-T103
receptor	I-T103
(	O
car	B-T103
,	O
nr	B-T103
##1	I-T103
##i	I-T103
##3	I-T103
)	I-T103
regulates	B-T038
the	I-T038
expression	I-T038
of	O
numerous	O
drug	B-T038
-	I-T038
metabolizing	I-T038
enzymes	B-T103
and	O
transporters	B-T103
.	O
the	O
upregulation	B-T038
of	O
various	O
enzymes	B-T103
,	O
including	O
cyp2	B-T103
##b6	I-T103
,	O
by	O
car	B-T103
activators	B-T103
is	O
a	O
critical	O
problem	O
leading	O
to	O
clinically	O
severe	O
drug	B-T038
-	I-T038
drug	I-T038
interactions	I-T038
(	O
dd	B-T038
##is	I-T038
)	O
.	O
to	O
date	O
,	O
however	O
,	O
few	O
effective	O
computational	B-T062
approaches	I-T062
for	O
identifying	O
car	B-T103
activators	O
exist	O
.	O
in	O
this	O
study	O
,	O
we	O
aimed	O
to	O
develop	O
three	O
-	O
dimensional	O
quantitative	O
structure	O
-	O
activity	O
relationship	O
(	O
3d	O
-	O
qsar	O
)	O
models	B-T170
to	O
predict	O
the	O
car	B-T103
activating	B-T038
potency	O
of	O
compounds	B-T103
emerging	O
in	O
the	O
drug	B-T062
-	I-T062
discovery	I-T062
process	O
.	O
models	B-T170
were	O
constructed	O
using	O
comparative	B-T062
molecular	I-T062
field	I-T062
analysis	I-T062
(	O
com	B-T062
##fa	I-T062
)	O
based	O
on	O
the	O
molecular	O
alignments	O
of	O
ligands	B-T038
binding	I-T038
to	O
car	B-T103
,	O
which	O
were	O
obtained	O
from	O
ensemble	O
ligand	B-T038
-	I-T038
docking	I-T038
using	O
28	B-T103
compounds	I-T103
as	O
a	O
training	O
set	O
.	O
the	O
com	B-T062
##fa	I-T062
model	B-T170
,	O
modified	O
by	O
adding	O
a	O
lipophilic	O
parameter	O
with	O
calculated	O
log	O
##d	O
##7	O
.	O
4	O
(	O
s	O
+	O
log	O
##d	O
##7	O
.	O
4	O
)	O
,	O
demonstrated	O
statistically	O
good	O
predictive	O
ability	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
99	O
,	O
q	O
(	O
2	O
)	O
=	O
0	O
.	O
74	O
)	O
.	O
we	O
also	O
confirmed	O
the	O
excellent	O
predictability	O
of	O
the	O
3d	O
-	O
qsar	O
model	B-T170
for	O
car	B-T103
activation	B-T038
(	O
r	O
(	O
2	O
)	O
pred	O
=	O
0	O
.	O
71	O
)	O
using	O
seven	O
compounds	B-T103
as	O
a	O
test	O
set	O
for	O
external	B-T062
validation	I-T062
.	O
collectively	O
,	O
our	O
results	O
indicate	O
that	O
the	O
3d	O
-	O
qsar	O
model	B-T170
developed	O
in	O
this	O
study	O
provides	O
precise	O
prediction	O
of	O
car	B-T103
activating	B-T038
potency	O
and	O
,	O
thus	O
,	O
should	O
be	O
useful	O
for	O
selecting	O
drug	B-T103
candidates	I-T103
with	O
minimized	O
dd	B-T038
##i	I-T038
risk	O
related	O
to	O
enzyme	B-T038
-	I-T038
induction	I-T038
in	O
the	O
early	O
drug	B-T062
-	I-T062
discovery	I-T062
stage	O
.	O

developmental	O
profile	B-T058
and	O
diagnoses	B-T062
in	O
children	O
presenting	O
with	O
motor	B-T033
stereotyp	I-T033
##ies	I-T033
motor	B-T033
stereotyp	I-T033
##ies	I-T033
represent	O
a	O
typical	O
example	O
of	O
the	O
difficulty	O
in	O
distinguishing	O
non	O
-	O
clinical	O
behaviors	O
(	O
physiological	B-T038
and	O
transient	O
)	O
from	O
symptoms	B-T033
or	O
among	O
different	O
disorders	B-T038
[	O
[UNK]	O
primary	B-T038
stereotyp	I-T038
##ies	I-T038
,	O
[UNK]	O
associated	O
with	O
autistic	B-T038
spectrum	I-T038
disorder	I-T038
(	O
asd	B-T038
)	O
,	O
intellectual	B-T038
disabilities	I-T038
,	O
genetic	B-T038
syndromes	I-T038
,	O
and	O
sensory	O
impairment	O
]	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
obtain	O
an	O
accurate	O
assessment	B-T058
on	O
the	O
relationship	O
between	O
stereotyp	B-T038
##ies	I-T038
and	O
neurodevelopmental	B-T038
disorders	I-T038
.	O
we	O
studied	B-T062
23	O
children	O
(	O
3	O
girls	O
)	O
,	O
aged	O
36	O
-	O
95	O
months	O
,	O
who	O
requested	O
a	O
consultation	B-T058
due	O
to	O
the	O
persistence	O
or	O
increased	O
severity	O
of	O
motor	B-T033
stereotyp	I-T033
##ies	I-T033
.	O
none	O
of	O
the	O
patients	O
had	O
a	O
previous	O
diagnosis	B-T062
of	O
asd	B-T038
.	O
the	O
assessment	B-T058
included	O
the	O
motor	B-T170
severity	I-T170
stereotyp	I-T170
##y	I-T170
scale	I-T170
(	O
ms	B-T170
##ss	I-T170
)	O
,	O
the	O
repetitive	B-T170
behavior	I-T170
scale	I-T170
-	I-T170
revised	I-T170
(	O
rb	B-T170
##s	I-T170
-	I-T170
r	I-T170
)	O
,	O
the	O
ra	B-T033
##ven	I-T033
'	I-T033
s	I-T033
colored	I-T033
progressive	I-T033
matrices	I-T033
,	O
the	O
child	O
behavior	O
checklist	O
for	O
ages	O
1	O
##½	O
-	O
5	O
or	O
4	O
-	O
18	O
(	O
cb	O
##cl	O
)	O
,	O
the	O
social	B-T170
responsiveness	I-T170
scale	I-T170
(	B-T170
srs	I-T170
)	I-T170
,	O
and	O
the	O
autism	B-T170
diagnostic	I-T170
observation	I-T170
schedule	I-T170
-	I-T170
second	I-T170
edition	I-T170
(	O
ad	B-T170
##os	I-T170
2	I-T170
)	O
.	O
all	O
patients	O
were	O
showing	O
motor	B-T033
stereotyp	I-T033
##ies	I-T033
for	O
periods	O
of	O
time	O
varying	O
from	O
6	O
to	O
77	O
months	O
.	O
the	O
ms	B-T170
##ss	I-T170
showed	O
that	O
each	O
child	O
had	O
a	O
limited	O
number	O
of	O
stereotyp	B-T038
##ies	I-T038
;	O
their	O
frequency	O
and	O
intensity	O
were	O
mild	O
.	O
the	O
interference	O
of	O
stereotyp	B-T038
##ies	I-T038
was	O
variable	O
;	O
the	O
impairment	O
in	O
daily	O
life	O
was	O
mild	O
.	O
the	O
rb	B-T170
##s	I-T170
-	I-T170
r	I-T170
scores	O
were	O
positive	O
for	O
the	O
subscale	O
of	O
[UNK]	O
stereotyp	B-T038
##ic	I-T038
behaviors	I-T038
[UNK]	O
in	O
all	O
children	O
.	O
moreover	O
,	O
several	O
children	O
presented	O
other	O
repetitive	B-T033
behaviors	I-T033
,	O
mainly	O
[UNK]	O
ritu	B-T033
##alis	I-T033
##tic	I-T033
behavior	I-T033
[UNK]	O
and	O
[UNK]	O
same	B-T033
##ness	I-T033
behavior	I-T033
.	O
[UNK]	O
all	O
patients	O
showed	O
a	O
normal	B-T033
cognitive	I-T033
level	I-T033
.	O
the	O
cb	O
##cl	O
evidenced	O
behavioral	B-T038
problems	I-T038
in	O
22	O
%	O
of	O
the	O
children	O
:	O
internalizing	B-T033
problems	I-T033
,	O
attention	B-T038
,	O
and	O
withdrawn	B-T038
were	O
the	O
main	O
complaints	O
.	O
on	O
the	O
srs	B-T170
,	O
all	O
but	O
one	O
of	O
the	O
tested	O
patients	O
obtained	O
clinical	O
scores	O
in	O
the	O
clinical	O
range	O
for	O
at	O
least	O
one	O
area	O
.	O
on	O
the	O
ad	B-T170
##os	I-T170
2	I-T170
,	O
4	O
patients	O
obtained	O
scores	O
indicating	O
a	O
moderate	O
level	O
of	O
asd	B-T038
symptoms	B-T033
,	O
4	O
had	O
a	O
mild	O
level	O
,	O
and	O
15	O
showed	O
no	O
or	O
minimal	O
signs	B-T033
of	O
asd	B-T038
.	O
motor	B-T033
stereotyp	I-T033
##ies	I-T033
in	O
children	O
with	O
normal	B-T033
cognitive	I-T033
level	I-T033
represent	O
a	O
challenging	O
diagnostic	O
issue	B-T033
for	O
which	O
a	O
fine	O
##ly	O
tailored	O
assessment	B-T058
is	O
mandatory	O
in	O
order	O
to	O
define	O
a	O
precise	O
developmental	O
profile	O
.	O
thus	O
,	O
careful	O
and	O
cautious	O
use	O
of	O
standardized	O
tests	O
is	O
warranted	O
to	O
avoid	O
misdiagnosis	B-T033
.	O
furthermore	O
,	O
it	O
is	O
hard	O
to	O
consider	O
motor	B-T033
stereotyp	I-T033
##ies	I-T033
,	O
even	O
the	O
primary	O
ones	O
,	O
exclusively	O
as	O
a	O
movement	B-T038
disorder	I-T038
.	O

evaluation	O
of	O
three	O
protein	B-T058
-	I-T058
extraction	I-T058
methods	I-T058
for	O
proteome	B-T103
analysis	B-T058
of	O
maize	B-T204
leaf	B-T204
mid	B-T170
##ri	I-T170
##b	I-T170
,	O
a	O
compound	B-T017
tissue	I-T017
rich	O
in	O
scler	B-T017
##enchym	I-T017
##a	I-T017
cells	I-T017
leaf	B-T204
morphology	O
is	O
closely	O
related	O
to	O
the	O
growth	B-T038
and	I-T038
development	I-T038
of	O
maize	B-T204
(	I-T204
zea	I-T204
may	I-T204
##s	I-T204
l	I-T204
.	I-T204
)	I-T204
plants	I-T204
and	O
final	O
kernel	B-T168
production	O
.	O
as	O
an	O
important	O
part	O
of	O
the	O
maize	B-T204
leaf	B-T204
,	O
the	O
mid	B-T170
##ri	I-T170
##b	I-T170
holds	O
leaf	B-T204
blade	O
##s	O
in	O
the	O
aerial	B-T204
position	I-T204
for	O
maximum	O
sunlight	O
capture	O
.	O
leaf	B-T204
mid	B-T170
##ri	I-T170
##b	I-T170
s	O
of	O
adult	O
plants	B-T204
contain	O
substantial	O
scler	B-T017
##enchym	I-T017
##a	I-T017
cells	I-T017
with	O
heavily	O
thickened	O
and	O
lign	B-T103
##ified	I-T103
secondary	B-T017
walls	I-T017
and	O
have	O
a	O
high	O
amount	O
of	O
phenolics	B-T103
,	O
making	O
protein	B-T058
extraction	I-T058
and	O
proteome	B-T103
analysis	B-T058
difficult	O
in	O
leaf	B-T204
mid	B-T170
##ri	I-T170
##b	I-T170
tissue	O
.	O
in	O
the	O
present	O
study	O
,	O
three	O
protein	B-T058
-	I-T058
extraction	I-T058
methods	I-T058
that	O
are	O
commonly	O
used	O
in	O
plant	B-T204
proteomics	B-T091
,	O
i	O
.	O
e	O
.	O
,	O
phenol	B-T103
extraction	B-T058
,	O
tca	B-T103
/	O
acetone	B-T103
extraction	B-T058
,	O
and	O
tca	B-T103
/	O
acetone	B-T103
/	O
phenol	B-T103
extraction	B-T058
,	O
were	O
qualitatively	O
and	O
quantitatively	O
evaluated	O
based	O
on	O
2d	O
##e	O
maps	O
and	O
ms	B-T058
/	I-T058
ms	I-T058
analysis	I-T058
using	O
the	O
mid	B-T170
##ri	I-T170
##bs	I-T170
of	O
the	O
10th	O
newly	O
expanded	O
leaves	B-T204
of	O
maize	B-T204
plants	I-T204
.	O
microscopy	B-T058
revealed	O
the	O
existence	O
of	O
substantial	O
amounts	O
of	O
scler	B-T017
##enchym	I-T017
##a	I-T017
undern	O
##ea	O
##th	O
maize	B-T204
mid	B-T170
##ri	I-T170
##b	I-T170
epidermis	B-T204
##es	I-T204
(	O
particularly	O
aba	O
##x	O
##ial	O
epidermis	B-T204
##es	I-T204
)	O
.	O
the	O
spot	O
-	O
number	O
order	O
obtained	O
via	O
2d	B-T058
##e	I-T058
mapping	I-T058
was	O
as	O
follows	O
:	O
phenol	B-T103
extraction	B-T058
(	O
65	O
##5	O
)	O
>	O
tca	B-T103
/	O
acetone	B-T103
extraction	B-T058
(	O
58	O
##9	O
)	O
>	O
tca	B-T103
/	O
acetone	B-T103
/	O
phenol	B-T103
extraction	B-T058
(	O
54	O
##5	O
)	O
.	O
ms	B-T058
/	I-T058
ms	I-T058
analysis	I-T058
identified	O
a	O
total	O
of	O
17	O
spots	O
that	O
exhibited	O
2	O
-	O
fold	O
changes	O
in	O
abundance	O
among	O
the	O
three	O
methods	O
(	O
using	O
phenol	B-T103
extraction	B-T058
as	O
a	O
control	O
)	O
.	O
sixteen	O
of	O
the	O
proteins	B-T103
identified	O
were	O
hydrophilic	O
,	O
with	O
grav	O
##y	O
values	O
ranging	O
from	O
-	O
0	O
.	O
026	O
to	O
-	O
0	O
.	O
48	O
##7	O
.	O
for	O
all	O
three	O
methods	O
,	O
we	O
were	O
able	O
to	O
obtain	O
high	O
-	O
quality	O
protein	B-T103
samples	O
and	O
good	O
2d	B-T058
##e	I-T058
maps	I-T058
for	O
the	O
maize	B-T204
leaf	B-T204
mid	B-T170
##ri	I-T170
##b	I-T170
.	O
however	O
,	O
phenol	B-T103
extraction	B-T058
produced	O
a	O
better	O
2d	B-T058
##e	I-T058
map	I-T058
with	O
greater	O
resolution	O
between	O
spots	O
,	O
and	O
tca	B-T103
/	O
acetone	B-T103
extraction	B-T058
produced	O
higher	O
protein	B-T103
yields	O
.	O
thus	O
,	O
this	O
paper	O
includes	O
a	O
discussion	O
regarding	O
the	O
possible	O
reasons	O
for	O
differential	O
protein	B-T058
extraction	I-T058
among	O
the	O
three	O
methods	O
.	O
this	O
study	O
provides	O
useful	O
information	O
that	O
can	O
be	O
used	O
to	O
select	O
suitable	O
protein	B-T058
extraction	I-T058
methods	O
for	O
the	O
proteome	B-T103
analysis	B-T058
of	O
recalcitrant	O
plant	B-T017
tissues	I-T017
that	O
are	O
rich	O
in	O
scler	B-T017
##enchym	I-T017
##a	I-T017
cells	I-T017
.	O

percentile	O
categorization	B-T170
of	O
qt	B-T033
interval	I-T033
as	O
an	O
approach	B-T082
for	O
identifying	B-T058
adult	O
patients	O
at	O
risk	O
for	O
cardiovascular	B-T201
death	I-T201
the	O
results	O
from	O
studies	O
of	O
the	O
association	O
of	O
qt	B-T033
prolongation	I-T033
with	O
cardiovascular	B-T201
death	I-T201
(	O
cvd	B-T201
)	O
have	O
been	O
inconsistent	O
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
major	O
correction	O
formulas	O
to	O
percentile	O
values	O
of	O
qt	O
for	O
heart	B-T201
rate	I-T201
ranges	O
as	O
to	O
their	O
ability	O
to	O
remove	O
the	O
relationship	O
of	O
qt	O
to	O
heart	B-T201
rate	I-T201
and	O
to	O
predict	O
cvd	B-T201
.	O
participants	B-T098
were	O
16	O
,	O
53	O
##1	O
veterans	B-T098
who	O
had	O
an	O
initial	O
ecg	B-T033
at	O
the	O
veterans	B-T170
affairs	I-T170
medical	I-T170
center	I-T170
,	O
pal	B-T082
##o	I-T082
alt	I-T082
##o	I-T082
,	O
between	O
march	O
31	O
,	O
1987	O
,	O
and	O
december	O
20	O
,	O
1999	O
,	O
and	O
were	O
followed	O
for	O
cvd	B-T201
.	O
the	O
4	O
major	O
correction	O
formulas	O
(	O
ba	O
##ze	O
##tt	O
,	O
fri	O
##der	O
##ici	O
##a	O
,	O
framingham	O
,	O
and	O
hodg	O
##es	O
)	O
were	O
used	O
to	O
correct	O
qt	B-T033
interval	I-T033
.	O
in	O
addition	O
,	O
the	O
percentiles	O
for	O
heart	B-T201
rate	I-T201
ranges	O
as	O
proposed	O
by	O
schw	B-T204
##art	I-T204
##z	I-T204
were	O
calculated	O
.	O
during	O
median	B-T082
follow	O
-	O
up	O
of	O
17	O
.	O
8	O
years	O
,	O
45	O
##5	O
cvd	B-T201
events	O
occurred	O
.	O
when	O
compared	O
to	O
the	O
other	O
equations	O
,	O
qtc	O
ba	O
##ze	O
##tt	O
had	O
the	O
greatest	O
dependence	O
on	O
heart	B-T201
rate	I-T201
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
18	O
)	O
.	O
the	O
hazard	O
ratio	O
(	O
95	O
%	O
confidence	O
interval	O
)	O
for	O
cvd	B-T201
was	O
2	O
.	O
08	O
(	O
1	O
.	O
28	O
-	O
3	O
.	O
9	O
)	O
for	O
the	O
98	O
##th	O
percentile	O
of	O
qt	B-T033
interval	I-T033
by	O
heart	B-T201
rate	I-T201
ranges	O
,	O
2	O
.	O
05	O
(	O
1	O
.	O
27	O
-	O
3	O
.	O
33	O
)	O
for	O
qtc	O
ba	O
##ze	O
##tt	O
,	O
1	O
.	O
39	O
(	O
0	O
.	O
44	O
-	O
4	O
.	O
34	O
)	O
for	O
qtc	O
fri	O
##der	O
##ici	O
##a	O
,	O
1	O
.	O
05	O
(	O
0	O
.	O
26	O
-	O
4	O
.	O
24	O
)	O
for	O
qtc	O
hodg	O
##es	O
,	O
and	O
1	O
.	O
12	O
(	O
0	O
.	O
28	O
-	O
4	O
.	O
52	O
)	O
for	O
qtc	O
framingham	O
.	O
the	O
hazard	O
ratio	O
of	O
qtc	O
ba	O
##ze	O
##tt	O
was	O
significantly	O
higher	O
than	O
the	O
other	O
formulas	B-T170
except	O
for	O
the	O
98	O
##th	O
percentile	O
method	O
.	O
the	O
framingham	O
,	O
hodg	O
##es	O
,	O
and	O
fri	O
##der	O
##ici	O
##a	O
equations	O
remove	O
the	O
effect	O
of	O
heart	B-T201
rate	I-T201
on	O
qt	B-T033
interval	I-T033
significantly	O
better	O
than	O
the	O
ba	O
##ze	O
##tt	O
equation	O
.	O
using	O
qt	B-T033
-	I-T033
interval	I-T033
percentiles	O
based	O
on	O
heart	B-T201
rate	I-T201
provides	O
a	O
consistent	O
approach	B-T082
both	O
for	O
identifying	O
those	O
whose	O
qt	B-T033
intervals	I-T033
prolong	O
due	O
to	O
drugs	B-T058
or	O
other	O
stressors	O
and	O
for	O
assessing	O
cvd	B-T201
risk	O
.	O

trib	B-T103
##3	I-T103
downregulation	B-T038
enhances	O
doxorubicin	B-T103
-	O
induced	O
cytotoxicity	B-T038
in	O
gastric	B-T038
cancer	I-T038
cells	B-T017
trib	B-T103
##3	I-T103
,	O
which	O
is	O
a	O
pseudo	B-T103
##kinase	I-T103
known	O
to	O
regulate	B-T038
multiple	I-T038
pro	I-T038
-	I-T038
survival	I-T038
pathways	I-T038
,	O
appears	O
to	O
be	O
a	O
potential	O
therapeutic	B-T058
target	O
for	O
the	O
treatment	B-T058
of	O
human	B-T204
tumors	B-T038
.	O
however	O
,	O
its	O
precise	O
role	O
in	O
cancer	B-T038
is	O
controversial	O
,	O
as	O
trib	B-T103
##3	I-T103
protein	B-T033
levels	I-T033
have	O
been	O
associated	O
with	O
both	O
good	B-T033
and	O
poor	B-T033
prognosis	I-T033
in	O
cancer	O
patients	O
.	O
here	O
,	O
we	O
investigated	O
the	O
significance	O
of	O
trib	B-T103
##3	I-T103
expression	B-T038
in	O
the	O
survival	B-T038
of	O
gastric	B-T038
cancer	I-T038
cells	B-T017
exposed	O
to	O
anticancer	B-T103
drugs	I-T103
.	O
we	O
found	O
that	O
the	O
tested	O
anticancer	B-T103
drug	I-T103
,	O
doxorubicin	B-T103
,	O
induced	O
cytotoxicity	B-T038
by	O
decreasing	O
trib	B-T017
##3	I-T017
transcription	B-T038
,	O
which	O
was	O
followed	O
by	O
apoptotic	B-T038
cell	I-T038
death	I-T038
.	O
moreover	O
,	O
trib	B-T103
##3	I-T103
sirna	I-T103
knockdown	B-T062
appeared	O
to	O
enhance	O
doxorubicin	B-T103
-	O
induced	O
apoptosis	B-T038
in	O
gastric	B-T038
cancer	I-T038
cells	B-T017
,	O
concurrently	O
with	O
altering	O
the	O
expression	B-T038
of	O
downstream	B-T082
apoptotic	B-T103
factors	I-T103
.	O
conversely	O
,	O
overexpression	B-T038
of	O
trib	B-T103
##3	I-T103
significantly	O
protected	B-T017
cells	I-T017
against	O
doxorubicin	B-T103
-	O
induced	O
apoptosis	B-T038
.	O
our	O
results	O
indicate	O
that	O
downregulation	B-T038
of	O
trib	B-T103
##3	I-T103
appears	O
to	O
promote	O
cell	B-T038
death	I-T038
and	O
enhance	O
doxorubicin	B-T103
-	O
induced	O
apoptosis	B-T038
,	O
supporting	O
the	O
anti	B-T103
-	I-T103
apoptotic	I-T103
role	O
of	O
trib	B-T103
##3	I-T103
.	O
the	O
induction	B-T038
##s	I-T038
of	O
three	O
classes	O
of	O
mapks	B-T103
failed	O
to	O
affect	O
doxorubicin	B-T103
-	O
mediated	O
trib	B-T103
##3	I-T103
downregulation	B-T038
,	O
while	O
trib	B-T103
##3	I-T103
overexpression	B-T038
did	O
not	O
affect	O
doxorubicin	B-T103
-	O
induced	O
mapk	B-T038
activation	I-T038
.	O
in	O
sum	O
,	O
our	O
findings	B-T033
indicate	O
that	O
trib	B-T103
##3	I-T103
plays	O
an	O
anti	B-T103
-	I-T103
apoptotic	I-T103
role	O
in	O
doxorubicin	B-T103
-	O
treated	O
gastric	B-T038
cancer	I-T038
cell	B-T017
lines	I-T017
,	O
perhaps	O
indicating	O
that	O
the	O
status	O
of	O
trib	B-T103
##3	I-T103
expression	B-T038
in	O
response	O
to	O
anticancer	B-T103
drugs	I-T103
,	O
such	O
as	O
doxorubicin	B-T103
,	O
irinotecan	B-T103
or	O
oxaliplatin	B-T103
,	O
may	O
reflect	O
the	O
efficiency	O
for	O
cancer	B-T058
therapy	I-T058
.	O

estrogen	B-T103
and	O
progesterone	B-T103
hormone	B-T103
receptor	O
expression	O
in	O
oral	B-T038
cavity	I-T038
cancer	I-T038
recent	O
studies	O
have	O
shown	O
an	O
increase	O
in	O
the	O
incidence	O
of	O
oral	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
oscc	B-T038
)	O
in	O
younger	O
patients	O
.	O
the	O
hypothesis	O
that	O
tumors	B-T038
could	O
be	O
hormonal	B-T103
##ly	I-T103
induced	O
during	O
pregnancy	B-T038
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	B-T033
factors	I-T033
alcohol	B-T038
or	O
tobacco	B-T038
abuse	I-T038
seems	O
to	O
be	O
plausible	O
.	O
estrogen	B-T103
receptor	I-T103
alpha	I-T103
(	O
erα	B-T103
)	O
and	O
progesterone	B-T103
receptor	I-T103
(	O
pr	B-T103
)	O
expression	O
were	O
analyzed	B-T062
in	O
normal	O
oral	B-T017
mucosa	I-T017
(	O
n	O
=	O
5	O
)	O
,	O
oral	B-T033
precursor	I-T033
lesions	I-T033
(	O
simple	B-T038
hyperplasia	I-T038
,	O
n	O
=	O
11	O
;	O
squamous	B-T038
intraepithelial	I-T038
neoplasia	I-T038
,	O
sin	B-T038
i	I-T038
-	I-T038
iii	I-T038
,	O
n	O
=	O
35	O
)	O
,	O
and	O
oscc	B-T038
specimen	O
.	O
oscc	B-T038
##s	I-T038
were	O
stratified	O
in	O
a	O
young	O
female	O
(	O
n	O
=	O
7	O
)	O
study	O
cohort	B-T098
and	O
older	O
patients	O
(	O
n	O
=	O
46	O
)	O
.	O
in	O
the	O
young	O
female	O
study	O
cohort	B-T098
three	O
patients	O
(	O
n	O
=	O
3	O
/	O
7	O
)	O
developed	O
oscc	B-T038
during	O
or	O
shortly	O
after	O
pregnancy	B-T038
.	O
breast	B-T038
cancer	I-T038
tissues	B-T017
were	O
used	O
as	O
positive	O
control	O
for	O
erα	B-T103
and	O
pr	B-T103
expression	O
.	O
erα	B-T103
expression	O
was	O
found	O
in	O
four	O
oral	B-T033
precursor	I-T033
lesions	I-T033
(	O
squamous	B-T038
intraepithelial	I-T038
neoplasia	I-T038
,	O
sin	B-T038
i	I-T038
-	I-T038
iii	I-T038
,	O
n	O
=	O
4	O
/	O
35	O
,	O
11	O
%	O
)	O
and	O
in	O
five	O
oscc	B-T038
specimen	O
(	O
n	O
=	O
5	O
/	O
46	O
,	O
11	O
%	O
)	O
.	O
the	O
five	O
erα	B-T103
positive	B-T033
oscc	B-T038
samples	O
were	O
older	O
male	O
patients	O
.	O
all	O
patients	O
within	O
the	O
young	O
female	O
study	O
cohort	B-T098
were	O
negatively	B-T033
stained	O
for	O
both	O
erα	B-T103
and	O
pr	B-T103
.	O
er	B-T103
expression	O
could	O
be	O
regarded	O
as	O
a	O
seldom	O
risk	B-T033
factor	I-T033
for	O
oscc	B-T038
.	O
pr	B-T103
expression	O
seems	O
to	O
be	O
not	O
relevant	O
for	O
the	O
development	O
of	O
oscc	B-T038
.	O

cloud	B-T170
-	I-T170
based	I-T170
motifs	I-T170
##im	I-T170
:	O
detecting	B-T033
similarity	O
in	O
large	O
dna	B-T082
motif	I-T082
data	B-T170
sets	I-T170
we	O
developed	O
the	O
cloud	B-T170
-	I-T170
based	I-T170
motifs	I-T170
##im	I-T170
on	O
amazon	O
web	O
services	O
(	O
aw	O
##s	O
)	O
cloud	O
.	O
the	O
tool	B-T170
is	O
an	O
extended	O
version	B-T170
from	O
our	O
web	B-T170
-	I-T170
based	I-T170
tool	I-T170
version	I-T170
2	I-T170
.	I-T170
0	I-T170
,	O
which	O
was	O
developed	O
based	O
on	O
a	O
novel	O
algorithm	B-T170
for	O
detecting	B-T033
similarity	O
in	O
multiple	O
dna	B-T082
motif	I-T082
data	B-T170
sets	I-T170
.	O
this	O
cloud	O
-	O
based	O
version	B-T170
further	O
allows	O
researchers	B-T097
to	O
exploit	O
the	O
computing	O
resources	O
available	O
from	O
aw	O
##s	O
to	O
detect	B-T033
similarity	O
in	O
multiple	O
large	O
-	O
scale	O
dna	B-T082
motif	I-T082
data	B-T170
sets	I-T170
resulting	O
from	O
the	O
next	B-T062
-	I-T062
generation	I-T062
sequencing	I-T062
technology	I-T062
.	O
the	O
tool	B-T170
is	O
highly	O
scalable	O
with	O
expand	O
##able	O
aw	O
##s	O
.	O

a	O
fast	B-T170
peak	I-T170
-	I-T170
searching	I-T170
algorithm	I-T170
for	O
ultrasonic	B-T058
elastography	I-T058
tissue	B-T058
axial	I-T058
strain	I-T058
estimation	I-T058
with	I-T058
ultrasound	I-T058
elastography	I-T058
has	O
become	O
a	O
hot	O
field	O
in	O
recent	O
years	O
.	O
however	O
,	O
for	O
key	O
##points	O
tracking	B-T170
-	I-T170
based	I-T170
elastography	I-T170
algorithms	I-T170
,	O
loc	B-T033
##ating	I-T033
extrem	O
##a	O
in	O
multimodal	O
ultrasonic	O
radiofrequency	O
signals	O
is	O
still	O
a	O
challenging	O
problem	B-T033
.	O
in	O
this	O
paper	O
,	O
a	O
new	O
method	O
is	O
proposed	O
to	O
locate	B-T033
the	O
local	O
maxima	O
and	O
minim	O
##a	O
of	O
the	O
rf	O
signals	O
directly	O
without	O
derivation	O
operation	O
.	O
this	O
algorithm	B-T170
can	O
accurately	O
locate	B-T033
extrem	O
##a	O
even	O
if	O
disturbed	O
peaks	O
resulting	O
from	O
different	O
noise	O
exist	O
.	O
furthermore	O
,	O
the	O
new	O
algorithm	B-T170
can	O
speed	O
up	O
approximately	O
79	O
%	O
of	O
the	O
implementation	O
process	O
as	O
compared	O
with	O
the	O
standard	B-T062
cross	I-T062
-	I-T062
correlation	I-T062
method	I-T062
on	O
the	O
same	O
computing	O
platform	O
.	O
in	O
addition	O
,	O
the	O
elast	O
##ographic	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
and	O
the	O
contrast	O
-	O
to	O
-	O
noise	O
ratio	O
are	O
also	O
significantly	O
improved	O
with	O
this	O
new	O
method	O
.	O

splicing	B-T038
variants	O
of	O
ada	B-T103
##r2	I-T103
and	O
ada	B-T103
##r2	I-T103
-	O
mediated	O
rna	B-T038
editing	I-T038
in	O
glioma	B-T038
the	O
roles	O
of	O
alternative	B-T038
splicing	I-T038
and	O
rna	B-T038
editing	I-T038
in	O
gene	B-T038
regulation	I-T038
and	O
transcriptome	B-T082
diversity	O
are	O
well	O
documented	O
.	O
adenosine	B-T103
deaminase	I-T103
##s	I-T103
acting	O
on	O
rna	B-T103
(	O
ada	B-T103
##rs	I-T103
)	O
are	O
responsible	O
for	O
adenosine	B-T038
-	I-T038
to	I-T038
-	I-T038
inos	I-T038
##ine	I-T038
(	I-T038
a	I-T038
-	I-T038
to	I-T038
-	I-T038
i	I-T038
)	I-T038
editing	I-T038
and	O
exempl	O
##ify	O
the	O
complex	O
association	O
between	O
rna	B-T038
editing	I-T038
and	O
alternative	B-T038
splicing	I-T038
.	O
the	O
self	B-T038
-	I-T038
editing	I-T038
activity	O
of	O
ada	B-T103
##r2	I-T103
,	O
which	O
acts	O
on	O
its	O
own	O
pre	B-T103
-	I-T103
mrna	I-T103
,	O
leads	O
to	O
its	O
alternative	B-T038
splicing	I-T038
.	O
alternative	B-T038
splicing	I-T038
occurs	O
independently	O
at	O
nine	O
splicing	B-T038
sites	O
on	O
ada	B-T103
##r2	I-T103
pre	B-T103
-	I-T103
mrna	I-T103
,	O
generating	O
numerous	O
alternative	B-T038
splicing	I-T038
variants	O
with	O
various	O
catalytic	B-T038
activities	I-T038
.	O
a	B-T038
-	I-T038
to	I-T038
-	I-T038
i	I-T038
rna	I-T038
editing	I-T038
is	O
important	O
in	O
a	O
range	O
of	O
physiological	B-T038
processes	I-T038
in	O
humans	B-T204
and	O
is	O
associated	O
with	O
several	O
diseases	B-T038
,	O
including	O
amyotrophic	B-T038
lateral	I-T038
sclerosis	I-T038
,	O
mood	B-T038
disorders	I-T038
,	O
epilepsy	B-T038
and	O
glioma	B-T038
.	O
reduced	O
editing	B-T038
at	O
the	O
glutamine	B-T103
/	O
arginine	B-T103
site	O
of	O
the	O
ampa	B-T103
receptor	I-T103
subunit	I-T103
glu	I-T103
##a2	I-T103
in	O
glioma	B-T038
,	O
without	O
any	O
alteration	O
in	O
ada	B-T103
##r2	I-T103
expression	B-T038
,	O
is	O
a	O
notable	O
phenomenon	O
.	O
several	O
studies	O
have	O
tried	O
to	O
explain	O
this	O
alteration	O
in	O
the	O
catalytic	B-T038
activity	I-T038
of	O
ada	B-T103
##r2	I-T103
;	O
however	O
,	O
the	O
underlying	O
mechanism	O
remains	O
unclear	O
.	O
the	O
present	O
review	B-T170
summarizes	O
the	O
relevant	O
literature	B-T170
and	O
shares	O
experimental	B-T033
results	I-T033
concerning	O
ada	B-T103
##r2	I-T103
alternative	B-T038
splicing	I-T038
.	O
in	O
particular	O
,	O
the	O
present	O
review	B-T170
demonstrates	O
that	O
shifts	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
active	O
and	O
inactive	O
splicing	B-T038
variants	O
of	O
ada	B-T103
##r2	I-T103
may	O
reduce	O
the	O
ada	B-T103
##r2	I-T103
editing	B-T038
activity	O
in	O
glioma	B-T038
.	O
dominant	O
expression	B-T038
of	O
ada	B-T103
##r2	I-T103
splicing	B-T038
variant	O
with	O
low	O
enzyme	B-T038
activity	I-T038
causes	O
reduced	O
rna	B-T038
editing	I-T038
of	O
glu	B-T103
##a2	I-T103
subunit	I-T103
at	O
the	O
glutamine	B-T103
/	O
arginine	B-T103
site	O
in	O
glioma	B-T038
.	O

pediatric	O
orthopaedic	B-T022
trauma	B-T037
and	O
associated	B-T037
injuries	I-T037
of	O
snow	O
##mo	O
##bil	O
##e	O
,	O
at	O
##v	O
,	O
and	O
dir	O
##t	O
##bi	O
##ke	O
accidents	O
:	O
a	O
19	O
-	O
year	O
experience	O
at	O
a	O
level	O
1	O
pediatric	O
trauma	B-T092
center	I-T092
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
type	O
and	O
severity	O
of	O
orthopaedic	B-T037
and	O
associated	O
injuries	O
for	O
snow	O
##mo	O
##bil	O
##e	O
,	O
all	O
-	O
terr	O
##ain	O
vehicles	O
(	O
at	O
##v	O
)	O
and	O
motor	O
##ized	O
dir	O
##t	O
##bi	O
##ke	O
accidents	O
in	O
a	O
pediatric	O
patient	O
population	O
.	O
a	O
total	O
of	O
75	O
##8	O
patients	O
who	O
presented	O
following	O
either	O
snow	B-T037
##mo	I-T037
##bil	I-T037
##e	I-T037
(	O
n	O
=	O
87	O
)	O
,	O
at	B-T037
##v	I-T037
-	I-T037
related	I-T037
(	O
n	O
=	O
308	O
)	O
or	O
dir	B-T037
##t	I-T037
##bi	I-T037
##ke	I-T037
(	I-T037
n	I-T037
=	I-T037
36	I-T037
##3	I-T037
)	I-T037
-	I-T037
related	I-T037
trauma	I-T037
at	O
our	O
institution	B-T092
between	O
1996	O
and	O
2015	O
were	O
retrospectively	O
reviewed	O
.	O
a	O
total	O
of	O
44	O
##1	O
axial	B-T037
and	O
appendic	B-T037
##ular	I-T037
fractures	I-T037
occurred	O
requiring	O
53	O
##3	O
procedures	O
.	O
snow	O
##mo	O
##bil	O
##e	O
and	O
dir	O
##t	O
##bi	O
##ke	O
accidents	O
were	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
fractures	B-T037
(	O
63	O
%	O
,	O
64	O
%	O
)	O
than	O
the	O
at	B-T098
##v	I-T098
group	I-T098
(	O
50	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
000	O
##8	O
)	O
.	O
snow	O
##mo	O
##bil	O
##e	O
injuries	O
had	O
the	O
highest	O
rate	O
of	O
spinal	B-T037
(	O
23	O
%	O
)	O
and	O
lower	B-T037
extremity	I-T037
fractures	I-T037
(	O
53	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
0004	O
)	O
.	O
snow	B-T098
##mo	I-T098
##bil	I-T098
##e	I-T098
and	O
dir	B-T098
##t	I-T098
##bi	I-T098
##ke	I-T098
cohorts	I-T098
had	O
higher	O
rate	O
of	O
femur	B-T037
fractures	I-T037
(	O
22	O
%	O
,	O
17	O
%	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
whereas	O
the	O
at	B-T098
##v	I-T098
cohort	I-T098
had	O
higher	O
rates	O
of	O
upper	B-T017
extremity	I-T017
(	O
18	O
%	O
)	O
,	O
hand	B-T017
(	O
11	O
%	O
)	O
,	O
scap	B-T017
##ula	I-T017
(	O
4	O
.	O
6	O
%	O
)	O
,	O
and	O
open	B-T037
fractures	I-T037
(	O
28	O
.	O
6	O
%	O
)	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
head	B-T037
trauma	I-T037
was	O
the	O
most	O
commonly	O
associated	O
injury	O
in	O
275	O
patients	O
with	O
the	O
highest	O
rate	O
in	O
the	O
at	B-T098
##v	I-T098
group	I-T098
(	O
44	O
%	O
)	O
who	O
also	O
had	O
the	O
highest	O
rate	O
of	O
no	O
hel	O
##met	O
use	O
(	O
76	O
%	O
)	O
.	O
snow	O
##mo	O
##bil	O
##e	O
and	O
at	O
##v	O
patients	O
had	O
higher	O
injury	B-T170
severity	I-T170
score	I-T170
(	O
11	O
.	O
3	O
,	O
9	O
.	O
6	O
)	O
than	O
dir	O
##t	O
##bi	O
##ke	O
patients	O
(	O
7	O
.	O
8	O
)	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
at	O
##v	O
patients	O
were	O
found	O
to	O
be	O
younger	O
(	O
11	O
.	O
8	O
y	O
)	O
compared	O
with	O
snow	O
##mo	O
##bil	O
##e	O
(	O
13	O
.	O
2	O
y	O
)	O
and	O
dir	O
##t	O
##bi	O
##ke	O
(	O
13	O
.	O
5	O
y	O
)	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
pediatric	O
snow	O
##mo	O
##bil	O
##e	O
,	O
at	O
##v	O
and	O
dir	O
##t	O
##bi	O
##ke	O
accidents	O
result	O
in	O
severe	O
orthopaedic	B-T037
and	O
associated	O
injuries	O
with	O
each	O
vehicle	O
demonstrating	O
significantly	O
different	O
injury	B-T037
patterns	B-T082
.	O
injury	B-T058
prevention	I-T058
should	O
focus	O
on	O
improved	O
safety	B-T058
mechanisms	I-T058
,	O
protective	O
ge	O
##ar	O
,	O
safe	O
areas	O
for	O
off	O
-	O
road	O
vehicle	O
use	O
and	O
strict	B-T170
laws	I-T170
with	O
minimum	O
age	O
requirements	O
level	O
of	O
evidence	O
:	O
:	O
level	O
iv	O
.	O

impact	O
of	O
clinical	B-T062
trial	I-T062
results	B-T033
on	O
the	O
temporal	O
trends	O
of	O
carotid	B-T058
endarterectomy	I-T058
and	O
stenting	B-T058
from	O
2002	O
to	O
2014	O
randomized	B-T062
trials	I-T062
provide	O
conflicting	O
data	O
for	O
the	O
efficacy	O
of	O
carotid	B-T058
-	I-T058
artery	I-T058
stenting	I-T058
compared	O
with	O
endarterectomy	B-T058
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
impact	O
of	O
conflicting	O
clinical	B-T170
trial	I-T170
publications	I-T170
on	O
the	O
utilization	O
rates	O
of	O
carotid	B-T058
revascularization	I-T058
procedures	I-T058
.	O
we	O
conducted	O
a	O
population	B-T062
-	I-T062
level	I-T062
time	I-T062
-	I-T062
series	I-T062
analysis	I-T062
of	O
all	O
individuals	B-T098
who	O
underwent	O
carotid	B-T058
endarterectomy	I-T058
and	O
stenting	B-T058
in	O
ontario	B-T082
,	O
canada	B-T082
(	O
2002	O
-	O
2014	O
)	O
.	O
the	O
primary	B-T062
analysis	I-T062
examined	O
temporal	O
changes	O
in	O
the	O
rates	O
of	O
carotid	B-T058
revascularization	I-T058
procedures	I-T058
after	O
publications	B-T170
of	O
major	O
randomized	B-T062
trials	I-T062
.	O
secondary	O
analyses	O
examined	O
changes	O
in	O
overall	O
and	O
age	O
,	O
sex	O
,	O
carotid	B-T033
-	I-T033
artery	I-T033
symptom	I-T033
,	O
and	O
operator	O
specialty	O
-	O
specific	O
procedure	O
rates	O
.	O
a	O
total	O
of	O
16	O
77	O
##2	O
patients	O
were	O
studied	O
(	O
14	O
39	O
##4	O
endarterectomy	B-T058
[	O
86	O
%	O
]	O
;	O
237	O
##8	O
stenting	B-T058
[	O
14	O
%	O
]	O
)	O
.	O
the	O
overall	O
rate	O
of	O
carotid	B-T058
revascularization	I-T058
decreased	O
from	O
6	O
.	O
0	O
procedures	B-T058
per	O
100	O
000	O
individuals	B-T098
≥	O
##40	O
years	O
old	O
in	O
april	O
2002	O
to	O
4	O
.	O
3	O
procedures	B-T058
in	O
the	O
first	O
quarter	O
of	O
2014	O
(	O
29	O
%	O
decrease	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
rate	O
of	O
endarterectomy	B-T058
decreased	O
by	O
36	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
whereas	O
the	O
rate	O
of	O
carotid	B-T058
-	I-T058
artery	I-T058
stenting	I-T058
increased	O
by	O
72	O
%	O
(	O
p	O
=	O
0	O
.	O
006	O
)	O
.	O
we	O
observed	O
a	O
marked	O
increase	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
in	O
stenting	B-T058
after	O
publication	B-T170
of	O
the	O
sap	B-T062
##phi	I-T062
##re	I-T062
trial	I-T062
(	O
stenting	B-T062
and	I-T062
angioplasty	I-T062
with	I-T062
protection	I-T062
in	I-T062
patients	I-T062
at	I-T062
high	I-T062
risk	I-T062
for	I-T062
endarterectomy	I-T062
)	O
in	O
2004	O
,	O
whereas	O
stenting	B-T058
remained	O
relatively	O
unchanged	B-T033
after	O
subsequent	O
randomized	B-T062
trials	I-T062
published	O
in	O
2006	O
(	O
p	O
=	O
0	O
.	O
11	O
)	O
and	O
2010	O
(	O
p	O
=	O
0	O
.	O
34	O
)	O
.	O
in	O
contrast	O
,	O
endarterectomy	B-T058
decreased	O
after	O
trials	O
published	O
in	O
2006	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
and	O
2010	O
(	O
p	O
=	O
0	O
.	O
005	O
)	O
.	O
although	O
the	O
overall	O
rates	O
of	O
carotid	B-T058
revascularization	I-T058
and	O
endarterectomy	B-T058
have	O
fall	O
##en	O
since	O
2002	O
,	O
the	O
rate	O
of	O
carotid	B-T058
-	I-T058
artery	I-T058
stenting	I-T058
has	O
rise	O
##n	O
since	O
the	O
publication	B-T170
of	O
stenting	B-T058
-	O
favorable	O
sap	B-T062
##phi	I-T062
##re	I-T062
trial	I-T062
.	O
subsequent	O
conflicting	O
randomized	B-T062
trials	I-T062
were	O
associated	O
with	O
a	O
decreasing	B-T033
rate	I-T033
of	O
carotid	B-T058
endarterectomy	I-T058
.	O

non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
inhibits	O
apoptosis	B-T038
induced	O
in	O
pc12	B-T017
cells	I-T017
non	O
##yl	O
##phenol	O
and	O
short	O
-	O
chain	O
non	O
##yl	O
##phenol	O
ethoxy	O
##la	O
##tes	O
such	O
as	O
np	O
##2	O
eo	O
are	O
present	B-T033
in	O
aquatic	O
environment	O
as	O
wastewater	O
contaminants	O
,	O
and	O
their	O
toxic	B-T037
effects	I-T037
on	O
aquatic	O
species	O
have	O
been	O
reported	O
.	O
apoptosis	B-T038
has	O
been	O
shown	O
to	O
be	O
induced	O
by	O
serum	B-T031
deprivation	O
or	O
copper	B-T103
treatment	O
.	O
to	O
understand	O
the	O
toxicity	O
of	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
np	O
##2	O
eo	O
on	O
apoptosis	B-T038
induced	O
by	O
serum	B-T031
deprivation	O
and	O
copper	B-T103
by	O
using	O
pc12	B-T017
cell	I-T017
system	I-T017
.	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
itself	O
showed	O
no	O
toxicity	O
and	O
recovered	O
cell	B-T038
viability	I-T038
from	O
apoptosis	B-T038
.	O
in	O
addition	O
,	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
decreased	O
dna	B-T038
fragmentation	I-T038
caused	O
by	O
apoptosis	B-T038
in	O
pc12	B-T017
cells	I-T017
.	O
this	O
phenomenon	O
was	O
confirmed	O
after	O
treating	O
apoptotic	O
pc12	B-T017
cells	I-T017
with	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
,	O
whereas	O
the	O
cytochrome	B-T103
c	I-T103
release	O
into	O
the	O
cytosol	B-T017
decreased	O
as	O
compared	O
to	O
that	O
in	O
apoptotic	B-T017
cells	I-T017
not	O
treated	O
with	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
s	O
.	O
furthermore	O
,	O
bax	B-T103
contents	O
in	O
apoptotic	B-T017
cells	I-T017
were	O
reduced	O
after	O
exposure	O
to	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
.	O
thus	O
,	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
has	O
the	O
opposite	O
effect	O
on	O
apoptosis	B-T038
in	O
pc12	B-T017
cells	I-T017
compared	O
to	O
non	O
##yl	O
##phenol	O
,	O
which	O
enhances	O
apoptosis	B-T038
induced	O
by	O
serum	B-T031
deprivation	O
.	O
the	O
difference	O
in	O
structure	B-T082
of	O
the	O
two	O
compounds	B-T103
is	O
hypothesized	O
to	O
be	O
responsible	O
for	O
this	O
phenomenon	O
.	O
these	O
results	B-T033
indicated	O
that	O
non	O
##yl	O
##phenol	O
diet	O
##ho	O
##xy	O
##la	O
##te	O
has	O
capability	O
to	O
affect	O
cell	B-T038
differentiation	I-T038
and	O
development	B-T038
and	O
has	O
potentially	O
harmful	B-T037
effect	I-T037
on	O
organisms	O
because	O
of	O
its	O
unexpected	O
impact	O
on	O
apoptosis	B-T038
.	O
©	O
2015	O
wiley	O
periodicals	O
,	O
inc	O
.	O
environ	O
toxic	O
##ol	O
31	O
:	O
138	O
##9	O
-	O
139	O
##8	O
,	O
2016	O
.	O

the	O
histone	B-T103
acetyltransferase	I-T103
gc	I-T103
##n	I-T103
##5	I-T103
positively	B-T038
regulates	I-T038
t	I-T038
cell	I-T038
activation	I-T038
histone	B-T103
acetyltransferase	I-T103
##s	I-T103
(	O
hat	B-T103
##s	I-T103
)	O
regulate	B-T038
inducible	I-T038
transcription	I-T038
in	O
multiple	O
cellular	B-T038
processes	I-T038
and	O
during	O
inflammatory	B-T038
and	O
immune	B-T038
response	I-T038
.	O
however	O
,	O
the	O
functions	B-T038
of	O
general	B-T103
control	I-T103
nonre	I-T103
##pre	I-T103
##ss	I-T103
##ed	I-T103
-	I-T103
protein	I-T103
5	I-T103
(	O
gc	B-T103
##n	I-T103
##5	I-T103
)	O
,	O
an	O
evolutionarily	O
conserved	O
hat	B-T103
from	O
yeast	B-T204
to	O
human	B-T204
,	O
in	O
immune	B-T038
regulation	I-T038
remain	O
un	O
##app	O
##rec	O
##iated	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
conditional	O
##ly	O
deleted	B-T038
gc	B-T103
##n	I-T103
##5	I-T103
(	O
encoded	O
by	O
the	O
kat	B-T017
##2a	I-T017
gene	I-T017
)	O
specifically	O
in	O
t	B-T017
lymphocytes	I-T017
by	O
crossing	B-T038
flo	B-T017
##x	I-T017
##ed	I-T017
gc	I-T017
##n	I-T017
##5	I-T017
and	O
lc	B-T017
##k	I-T017
-	I-T017
cre	I-T017
mice	B-T204
,	O
and	O
demonstrated	O
that	O
gc	B-T103
##n	I-T103
##5	I-T103
plays	O
important	O
roles	O
in	O
multiple	O
stages	O
of	O
t	B-T038
cell	I-T038
functions	I-T038
including	O
development	B-T038
,	O
clonal	B-T038
expansion	I-T038
,	O
and	O
differentiation	B-T038
.	O
loss	B-T033
of	I-T033
gc	B-T103
##n	I-T103
##5	I-T103
functions	O
impaired	B-T038
t	I-T038
cell	I-T038
proliferation	I-T038
,	O
il	B-T038
-	I-T038
2	I-T038
production	I-T038
,	O
and	O
th1	B-T017
/	O
th17	B-T017
,	O
but	O
not	O
th2	B-T017
and	O
regulatory	B-T038
t	I-T038
cell	I-T038
differentiation	I-T038
.	O
gc	B-T103
##n	I-T103
##5	I-T103
is	O
recruited	O
onto	O
the	O
il	B-T017
-	I-T017
2	I-T017
promoter	B-T103
by	O
interacting	O
with	O
the	O
nfat	B-T103
in	O
t	B-T017
cells	I-T017
upon	O
tcr	B-T038
stimulation	I-T038
.	O
interestingly	O
,	O
instead	O
of	O
directly	O
acetyl	B-T038
##ating	I-T038
nfat	B-T103
,	O
gc	B-T103
##n	I-T103
##5	I-T103
catalyzes	O
histone	B-T038
h3	I-T038
lysine	I-T038
h9	I-T038
acetylation	I-T038
to	O
promote	O
il	B-T038
-	I-T038
2	I-T038
production	I-T038
.	O
t	B-T017
cell	I-T017
-	O
specific	O
suppression	O
of	O
gc	B-T103
##n	I-T103
##5	I-T103
partially	O
protected	O
mice	B-T204
from	O
myelin	B-T103
oligodendrocyte	I-T103
glycoprotein	I-T103
-	O
induced	O
experimental	B-T038
autoimmune	I-T038
encephalomyelitis	I-T038
,	O
an	O
experimental	B-T170
model	I-T170
for	O
human	B-T204
multiple	B-T038
sclerosis	I-T038
.	O
our	O
study	O
reveals	O
previously	O
unknown	O
physiological	O
functions	O
for	O
gc	B-T103
##n	I-T103
##5	I-T103
and	O
a	O
molecular	B-T038
mechanism	I-T038
underlying	O
these	O
functions	B-T038
in	O
regulating	B-T038
t	I-T038
cell	I-T038
immunity	I-T038
.	O
hence	O
gc	B-T103
##n	I-T103
##5	I-T103
may	O
be	O
an	O
important	O
new	O
target	O
for	O
autoimmune	B-T038
disease	I-T038
therapy	B-T058
.	O

the	O
construction	O
of	O
three	B-T082
-	I-T082
dimensional	I-T082
composite	B-T103
fibrous	O
macros	B-T082
##tructures	I-T082
with	O
nano	O
##tex	O
##tures	O
for	O
biomedical	B-T091
applications	O
the	O
development	O
of	O
modern	O
biomedical	B-T091
nanotechnology	O
requires	O
three	B-T082
-	I-T082
dimensional	I-T082
macros	B-T082
##tructures	I-T082
with	O
nano	O
##tex	O
##tures	O
to	O
meet	O
the	O
requirements	O
for	O
practical	O
applications	O
in	O
intricate	O
biological	B-T022
systems	I-T022
.	O
additionally	O
,	O
the	O
restoration	O
and	O
regeneration	B-T038
of	O
some	O
specific	O
body	B-T017
tissues	I-T017
and	O
organs	B-T017
rely	O
on	O
the	O
function	O
of	O
conductive	B-T103
polymers	I-T103
,	O
which	O
can	O
provide	O
electrical	O
cues	O
for	O
cells	B-T017
.	O
in	O
this	O
study	O
,	O
we	O
fabricated	O
three	B-T082
-	I-T082
dimensional	I-T082
composite	B-T103
nanofib	O
##re	O
macros	B-T082
##tructures	I-T082
of	O
polyc	B-T103
##apr	I-T103
##olac	I-T103
##ton	I-T103
##e	I-T103
(	O
pcl	B-T103
)	O
with	O
different	O
concentrations	O
of	O
poly	B-T103
##aniline	I-T103
(	O
pan	B-T103
##i	I-T103
)	O
by	O
employing	O
an	O
improved	O
electrosp	O
##inning	O
technology	O
with	O
a	O
specially	O
designed	O
collect	O
##or	O
.	O
the	O
3d	B-T082
structures	B-T082
possessed	O
cap	B-T082
-	I-T082
like	I-T082
macros	I-T082
##tructures	I-T082
with	O
centi	O
##met	O
##re	O
-	O
scale	O
thickness	O
and	O
interconnected	O
pore	O
nano	O
##tex	O
##tures	O
with	O
nanom	O
##etr	O
##e	O
-	O
scale	O
nanofib	O
##res	O
.	O
to	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3d	B-T082
pcl	B-T103
/	O
pan	B-T103
##i	I-T103
composite	B-T103
nanofib	O
##re	O
macros	B-T082
##tructures	I-T082
,	O
mouse	B-T204
myoblasts	B-T017
(	O
c2	B-T017
##c12	I-T017
cells	I-T017
)	O
were	O
cultured	O
as	O
model	B-T038
cells	B-T017
.	O
the	O
initial	O
responses	O
of	O
c2	B-T017
##c12	I-T017
cells	I-T017
to	O
the	O
3d	B-T082
pcl	B-T103
/	O
pan	B-T103
##i	I-T103
composite	B-T103
macros	B-T082
##tructures	I-T082
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
pcl	B-T103
,	O
that	O
is	O
,	O
the	O
cells	B-T017
exhibited	O
typical	O
myo	O
##blas	O
##t	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudop	B-T017
##odia	I-T017
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2	O
.	O
0	O
wt	O
%	O
)	O
of	O
conductive	O
pan	B-T103
##i	I-T103
facilitated	O
cell	B-T038
proliferation	I-T038
,	O
which	O
indicated	O
that	O
pan	B-T103
##i	I-T103
has	O
appreciable	O
cell	B-T038
affinity	I-T038
.	O
moreover	O
,	O
the	O
addition	O
of	O
conductive	O
pan	B-T103
##i	I-T103
to	O
the	O
3d	B-T082
composite	B-T103
nanofib	O
##re	O
macros	B-T082
##tructures	I-T082
considerably	O
enhanced	O
myo	B-T038
##blas	I-T038
##t	I-T038
differentiation	I-T038
and	O
myotub	B-T038
##e	I-T038
maturation	I-T038
.	O
these	O
results	O
suggest	O
that	O
electrospun	O
3d	B-T082
pcl	B-T103
/	O
pan	B-T103
##i	I-T103
composite	B-T103
nanofib	O
##re	O
macros	B-T082
##tructures	I-T082
would	O
have	O
promising	O
applications	O
in	O
tissue	B-T058
engineering	I-T058
.	O

smartphone	O
-	O
based	O
psycho	B-T058
##therap	I-T058
##eutic	I-T058
micro	B-T058
-	I-T058
interventions	I-T058
to	O
improve	O
mood	B-T038
in	O
a	O
real	O
-	O
world	O
setting	O
using	O
mobile	O
communication	O
technology	O
as	O
new	O
personalized	O
approach	B-T082
to	O
treat	B-T058
mental	B-T038
disorders	I-T038
or	O
to	O
more	O
generally	O
improve	O
quality	O
of	O
life	O
is	O
highly	O
promising	O
.	O
knowledge	B-T170
about	O
intervention	B-T058
components	O
that	O
target	O
key	O
psycho	B-T091
##path	I-T091
##ological	I-T091
processes	O
in	O
terms	O
of	O
transd	O
##ia	O
##gn	O
##ostic	O
psychotherapy	B-T058
approaches	B-T082
is	O
urgently	O
needed	O
.	O
we	O
explored	O
the	O
use	O
of	O
smartphone	O
-	O
based	O
micro	B-T058
-	I-T058
interventions	I-T058
based	O
on	O
psycho	B-T170
##therap	I-T170
##eutic	I-T170
techniques	I-T170
,	O
guided	O
by	O
short	O
video	B-T170
-	I-T170
clips	I-T170
,	O
to	O
elicit	O
mood	B-T038
changes	I-T038
.	O
as	O
part	O
of	O
a	O
larger	O
neurof	B-T058
##eedback	I-T058
study	B-T062
,	O
all	O
subjects	B-T098
-	O
after	O
being	O
randomly	O
assigned	O
to	O
an	O
experimental	O
or	O
control	O
neurof	B-T058
##eedback	I-T058
condition	O
-	O
underwent	O
daily	O
smartphone	O
-	O
based	O
micro	B-T058
-	I-T058
interventions	I-T058
for	O
13	O
consecutive	O
days	O
.	O
they	O
were	O
free	O
to	O
choose	O
out	O
of	O
provided	O
techniques	O
,	O
including	O
viscer	O
##osensory	O
attention	B-T038
,	O
emotional	B-T033
imagery	B-T038
,	O
facial	B-T033
expression	I-T033
,	O
and	O
cont	O
##empl	O
##ative	O
repetition	O
.	O
changes	O
in	O
mood	B-T038
were	O
assessed	O
in	O
real	O
world	O
using	O
the	O
multidimensional	B-T170
mood	I-T170
state	I-T170
questionnaire	I-T170
(	O
scales	O
:	O
good	O
-	O
bad	O
,	O
gb	O
;	O
awake	B-T033
-	O
tir	B-T033
##ed	I-T033
,	O
at	O
;	O
and	O
calm	B-T038
-	O
nervous	B-T033
,	O
cn	O
)	O
.	O
twenty	O
-	O
seven	O
men	B-T098
participated	O
on	O
at	O
least	O
11	O
days	O
and	O
were	O
thus	O
included	O
in	O
the	O
analyses	B-T062
.	O
altogether	O
,	O
they	O
underwent	O
335	O
,	O
generally	O
well	O
-	O
tolerated	O
,	O
micro	O
-	O
intervention	O
sessions	O
,	O
with	O
viscer	O
##osensory	O
attention	B-T038
(	O
178	O
sessions	O
,	O
53	O
.	O
13	O
%	O
)	O
and	O
cont	O
##empl	O
##ative	O
repetition	O
(	O
68	O
sessions	O
,	O
20	O
.	O
30	O
%	O
)	O
being	O
the	O
most	O
frequently	O
applied	O
techniques	O
.	O
mixed	O
models	B-T170
indicated	O
that	O
subjects	B-T098
showed	O
better	O
mood	B-T038
[	O
gb	O
:	O
b	O
=	O
0	O
.	O
46	O
##4	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
[	O
0	O
.	O
06	O
##8	O
,	O
0	O
.	O
86	O
##0	O
]	O
,	O
t	O
(	O
61	O
##3	O
.	O
3	O
)	O
=	O
2	O
.	O
298	O
,	O
p	O
=	O
0	O
.	O
022	O
]	O
and	O
became	O
more	O
awake	B-T033
[	O
at	O
:	O
b	O
=	O
0	O
.	O
51	O
##4	O
,	O
95	O
%	O
ci	O
[	O
0	O
.	O
103	O
,	O
0	O
.	O
92	O
##5	O
]	O
,	O
t	O
(	O
61	O
##2	O
.	O
4	O
)	O
=	O
2	O
.	O
45	O
##6	O
,	O
p	O
=	O
0	O
.	O
014	O
]	O
and	O
calm	B-T038
##er	I-T038
[	O
cn	O
:	O
b	O
=	O
0	O
.	O
68	O
##5	O
,	O
95	O
%	O
ci	O
[	O
0	O
.	O
360	O
,	O
1	O
.	O
010	O
]	O
,	O
t	O
(	O
61	O
##2	O
.	O
3	O
)	O
=	O
4	O
.	O
137	O
,	O
p	O
<	O
0	O
.	O
001	O
]	O
from	O
pre	O
-	O
to	O
post	O
-	O
micro	O
-	O
intervention	O
.	O
these	O
mood	B-T038
improvements	O
from	O
pre	O
-	O
to	O
post	O
-	O
micro	O
-	O
intervention	O
were	O
associated	O
with	O
changes	B-T038
in	I-T038
mood	I-T038
from	O
the	O
1st	O
day	O
until	O
the	O
last	O
day	O
with	O
regard	O
to	O
gb	B-T038
mood	I-T038
(	O
r	O
=	O
0	O
.	O
61	O
##4	O
,	O
95	O
%	O
ci	O
[	O
0	O
.	O
297	O
,	O
0	O
.	O
80	O
##9	O
]	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
not	O
at	B-T038
mood	I-T038
(	O
r	O
=	O
0	O
.	O
279	O
,	O
95	O
%	O
ci	O
[	O
-	O
0	O
.	O
122	O
,	O
0	O
.	O
60	O
##2	O
]	O
,	O
p	O
=	O
0	O
.	O
167	O
)	O
and	O
cn	B-T038
mood	I-T038
(	O
r	O
=	O
0	O
.	O
277	O
,	O
95	O
%	O
ci	O
[	O
0	O
.	O
124	O
,	O
0	O
.	O
60	O
##1	O
]	O
,	O
p	O
=	O
0	O
.	O
170	O
)	O
.	O
our	O
findings	B-T033
provide	O
evidence	O
for	O
the	O
applicability	O
of	O
smartphone	O
-	O
based	O
micro	B-T058
-	I-T058
interventions	I-T058
eliciting	O
short	O
-	O
term	O
mood	B-T038
changes	I-T038
,	O
based	O
on	O
techniques	O
used	O
in	O
psycho	B-T058
##therap	I-T058
##eutic	I-T058
approaches	B-T082
,	O
such	O
as	O
mindfulness	B-T038
-	O
based	O
psychotherapy	B-T058
,	O
transc	B-T038
##endent	I-T038
##al	I-T038
medi	I-T038
##tation	I-T038
,	O
and	O
other	O
cont	O
##empl	O
##ative	O
therapies	B-T058
.	O
the	O
results	O
encourage	O
exploring	O
these	O
techniques	O
'	O
capability	O
to	O
improve	O
mood	B-T038
in	O
randomized	O
controlled	B-T062
studies	I-T062
and	O
patients	O
.	O
smartphone	O
-	O
based	O
micro	B-T058
-	I-T058
interventions	I-T058
are	O
promising	O
to	O
modify	O
mood	B-T038
in	O
real	O
-	O
world	O
settings	O
,	O
complement	O
##ing	O
other	O
psycho	B-T058
##therap	I-T058
##eutic	I-T058
interventions	I-T058
,	O
in	O
line	O
with	O
the	O
precision	O
medicine	O
approach	O
.	O
the	O
here	O
presented	O
data	O
were	O
collected	O
within	O
a	O
randomized	B-T062
trial	I-T062
,	O
registered	O
at	O
clinicaltrials	O
.	O
gov	O
(	O
identifier	O
:	O
nct0	O
##19	O
##21	O
##0	O
##88	O
)	O
https	O
:	O
/	O
/	O
clinicaltrials	O
.	O
gov	O
/	O
ct	O
##2	O
/	O
show	O
/	O
nct0	O
##19	O
##21	O
##0	O
##88	O
.	O

brass	B-T103
##inos	I-T103
##ter	I-T103
##oid	I-T103
-	O
induced	O
changes	O
of	O
lipid	B-T103
composition	O
in	O
leaves	B-T204
of	O
pis	B-T204
##um	I-T204
sativ	I-T204
##um	I-T204
l	I-T204
.	I-T204
during	O
senescence	B-T038
the	O
effect	O
of	O
steroid	B-T103
phyto	B-T103
##ho	I-T103
##r	I-T103
##mon	I-T103
##e	I-T103
24	B-T103
-	I-T103
epi	I-T103
##bra	I-T103
##ss	I-T103
##inol	I-T103
##ide	I-T103
(	O
eb	B-T103
##r	I-T103
)	O
on	O
the	O
composition	O
of	O
some	O
lipid	B-T103
classes	B-T170
(	O
free	B-T103
fatty	I-T103
acids	I-T103
,	O
triacylglycerol	B-T103
##s	I-T103
and	O
galact	B-T103
##olipids	I-T103
)	O
in	O
detached	O
pea	B-T204
leaves	B-T204
was	O
studied	O
for	O
the	O
first	O
time	O
.	O
eb	B-T103
##r	I-T103
(	O
0	O
.	O
1	O
##μm	O
)	O
promoted	O
senescence	B-T038
and	O
increased	O
the	O
content	O
of	O
14	O
:	O
0	O
,	O
16	O
:	O
0	O
and	O
18	O
:	O
1	O
free	B-T103
fatty	I-T103
acids	I-T103
as	O
well	O
as	O
18	O
:	O
2	O
and	O
18	O
:	O
3	O
bound	O
to	O
triacylglycerol	B-T103
##s	I-T103
in	O
the	O
detached	O
leaves	B-T204
in	O
contrast	O
to	O
mock	B-T204
-	I-T204
treated	I-T204
leaves	I-T204
.	O
the	O
content	O
of	O
all	O
identified	O
fatty	B-T103
acids	I-T103
bound	O
to	O
galact	B-T103
##olipids	I-T103
decreased	O
in	O
the	O
detached	O
leaves	B-T204
treated	O
with	O
eb	B-T103
##r	I-T103
compared	O
to	O
that	O
in	O
mock	B-T204
-	I-T204
treated	I-T204
leaves	I-T204
.	O
these	O
findings	O
suggest	O
that	O
free	B-T103
fatty	I-T103
acids	I-T103
are	O
lib	O
##erated	O
from	O
polar	O
lipids	B-T103
and	O
then	O
undergo	O
esterification	B-T038
to	O
neutral	B-T103
lipids	I-T103
in	O
the	O
detached	O
leaves	B-T204
upon	O
eb	B-T103
##r	I-T103
treatment	O
.	O
we	O
propose	O
that	O
steroid	B-T103
phyto	B-T103
##ho	I-T103
##r	I-T103
##mon	I-T103
##es	I-T103
may	O
be	O
involved	O
into	O
regulation	B-T038
of	O
leaf	B-T204
senescence	B-T038
via	O
alteration	O
of	O
cell	B-T017
lipid	B-T103
composition	O
.	O

identification	O
and	O
functional	O
analysis	O
of	O
the	O
gtp	B-T005
##v	I-T005
bidirectional	O
promoter	B-T103
region	I-T103
the	O
goat	B-T005
po	I-T005
##x	I-T005
chick	I-T005
embryo	I-T005
-	I-T005
attenuated	I-T005
virus	I-T005
(	O
gtp	B-T005
##v	I-T005
)	O
has	O
been	O
developed	O
as	O
an	O
effective	O
vaccine	B-T103
that	O
can	O
elicit	O
protective	O
immune	B-T038
responses	I-T038
.	O
it	O
possesses	O
a	O
large	O
genome	B-T017
and	O
a	O
robust	O
ability	O
to	O
express	B-T038
exogenous	O
genes	B-T017
.	O
thus	O
,	O
this	O
virus	B-T005
is	O
an	O
ideal	O
vector	O
for	O
recombinant	B-T103
live	I-T103
vaccines	I-T103
for	O
infectious	B-T038
diseases	I-T038
in	O
rumin	B-T204
##ant	I-T204
animals	I-T204
.	O
in	O
this	O
study	O
,	O
we	O
identified	O
a	O
novel	O
bidirectional	O
promoter	B-T103
region	I-T103
of	O
gtp	B-T005
##v	I-T005
through	O
screening	O
named	O
pb	B-T103
##v	I-T103
##v	I-T103
(	I-T103
±	I-T103
)	I-T103
.	O
pb	B-T103
##v	I-T103
##v	I-T103
(	I-T103
±	I-T103
)	I-T103
is	O
located	O
between	O
et	B-T103
##f	I-T103
-	I-T103
l	I-T103
and	O
vit	B-T103
##f	I-T103
-	I-T103
3	I-T103
,	O
which	O
are	O
transcribed	B-T038
in	O
opposite	B-T082
directions	B-T082
.	O
a	O
new	O
recombinant	B-T005
goat	I-T005
po	I-T005
##x	I-T005
virus	I-T005
(	O
rg	B-T005
##tp	I-T005
##v	I-T005
)	O
was	O
constructed	O
,	O
in	O
which	O
duplicate	O
pb	B-T103
##v	I-T103
##v	I-T103
(	I-T103
+	I-T103
)	I-T103
was	O
used	O
as	O
a	O
promoter	B-T103
element	O
to	O
enhance	O
brucella	B-T103
omp	I-T103
##31	I-T103
expression	B-T038
,	O
and	O
duplicate	O
pb	B-T103
##v	I-T103
##v	I-T103
(	O
-	O
)	O
was	O
used	O
as	O
a	O
promoter	B-T103
element	I-T103
to	O
regulate	O
enhanced	B-T103
green	I-T103
fluorescent	I-T103
protein	I-T103
(	O
egfp	B-T103
)	O
at	O
the	O
same	O
time	O
as	O
the	O
selection	O
marker	O
.	O
pb	B-T103
##v	I-T103
##v	I-T103
(	I-T103
-	I-T103
)	I-T103
promoter	I-T103
activity	O
was	O
compared	O
to	O
that	O
of	O
the	O
p7	B-T103
.	I-T103
5	I-T103
promoter	I-T103
of	O
vaccinia	B-T005
virus	I-T005
,	O
as	O
measured	O
by	O
egfp	B-T103
expression	B-T038
;	O
the	O
fluorescence	B-T058
intensity	I-T058
of	O
egfp	B-T103
expressed	B-T038
in	O
cells	B-T017
was	O
confirmed	O
by	O
fluorescence	B-T058
microscopy	I-T058
and	O
flow	B-T058
cytometry	I-T058
.	O
pb	B-T103
##v	I-T103
##v	I-T103
(	I-T103
+	I-T103
)	I-T103
promoter	I-T103
activity	O
was	O
measured	O
by	O
brucella	B-T103
omp	I-T103
##31	I-T103
expression	B-T038
.	O
interaction	O
with	O
the	O
anti	B-T103
-	I-T103
brucella	I-T103
-	I-T103
omp	I-T103
##31	I-T103
monoclonal	I-T103
antibody	I-T103
was	O
confirmed	O
by	O
western	B-T058
blotting	I-T058
,	O
and	O
omp	B-T103
##31	I-T103
mrna	B-T038
expression	I-T038
was	O
assessed	O
by	O
qrt	B-T062
-	I-T062
pcr	I-T062
.	O
the	O
results	O
of	O
this	O
study	O
will	O
be	O
useful	O
for	O
the	O
further	O
study	O
of	O
effective	O
multiv	B-T103
##alent	I-T103
vaccines	I-T103
based	O
on	O
rg	B-T005
##tp	I-T005
##v	I-T005
.	O
this	O
study	O
also	O
provides	O
a	O
theoretical	O
basis	O
for	O
overcoming	O
the	O
problem	O
of	O
low	O
expression	B-T038
of	O
exogenous	O
genes	B-T017
.	O

the	O
epigenetic	B-T038
landscape	I-T038
of	O
age	O
-	O
related	O
diseases	B-T038
:	O
the	O
ger	O
##osc	O
##ience	O
perspective	O
in	O
this	O
review	B-T170
,	O
we	O
summarize	O
current	O
knowledge	O
regarding	O
the	O
epigenetic	B-T038
##s	I-T038
of	O
age	O
-	O
related	O
diseases	B-T038
,	O
focusing	O
on	O
those	O
studies	B-T062
that	O
have	O
described	O
dna	B-T038
methylation	I-T038
landscape	I-T038
in	O
cardio	B-T038
-	I-T038
vascular	I-T038
diseases	I-T038
,	O
musculoskeletal	B-T038
function	I-T038
and	O
frailty	B-T033
.	O
we	O
stress	O
the	O
importance	O
of	O
adopting	O
the	O
conceptual	O
framework	O
of	O
[UNK]	O
ger	O
##osc	O
##ience	O
[UNK]	O
,	O
which	O
starts	O
from	O
the	O
observation	O
that	O
advanced	B-T098
age	O
is	O
the	O
major	O
risk	B-T033
factor	I-T033
for	O
several	O
of	O
these	O
pathologies	O
and	O
aims	O
at	O
identifying	O
the	O
mechanistic	O
links	O
between	O
aging	B-T038
and	O
age	O
-	O
related	O
diseases	B-T038
.	O
dna	B-T038
methylation	I-T038
undergoes	O
a	O
profound	O
remodeling	O
during	O
aging	B-T038
,	O
which	O
includes	O
global	B-T038
hypo	I-T038
##methylation	I-T038
of	O
the	O
genome	B-T017
,	O
hypermethylation	B-T038
at	O
specific	O
loci	B-T017
and	O
an	O
increase	O
in	O
inter	O
-	O
individual	O
variation	O
and	O
in	O
stochastic	O
changes	O
of	O
dna	B-T038
methylation	I-T038
values	O
.	O
these	O
epigenetic	B-T038
modifications	B-T033
can	O
be	O
an	O
important	O
contributor	O
to	O
the	O
development	O
of	O
age	O
-	O
related	O
diseases	B-T038
,	O
but	O
our	O
understanding	O
on	O
the	O
complex	O
relationship	O
between	O
the	O
epigenetic	B-T038
signatures	I-T038
of	O
aging	B-T038
and	O
age	O
-	O
related	O
disease	B-T038
is	O
still	O
poor	O
.	O
the	O
most	O
relevant	O
results	B-T033
in	O
this	O
field	O
come	O
from	O
the	O
use	O
of	O
the	O
so	O
called	O
[UNK]	O
epigenetic	B-T038
##s	I-T038
clock	I-T038
##s	I-T038
[UNK]	O
in	O
cohorts	B-T098
of	O
subjects	B-T098
affected	O
by	O
age	O
-	O
related	O
diseases	B-T038
.	O
we	O
report	O
these	O
studies	B-T062
in	O
final	O
section	O
of	O
this	O
review	B-T170
.	O

complete	O
genome	B-T017
sequences	B-T082
of	O
three	O
outbreak	O
-	O
associated	O
legionella	B-T007
pneumophila	I-T007
isolates	B-T103
we	O
report	O
here	O
the	O
complete	O
genome	B-T017
sequences	B-T082
of	O
three	O
legionella	B-T007
pneumophila	I-T007
isolates	B-T103
that	O
are	O
associated	O
with	O
a	O
legion	B-T038
##na	I-T038
##ires	I-T038
'	I-T038
disease	I-T038
outbreak	O
in	O
new	B-T082
york	I-T082
in	O
2012	O
.	O
two	O
clinical	O
isolates	B-T103
(	O
d	B-T007
##76	I-T007
##30	I-T007
and	O
d	B-T007
##76	I-T007
##32	I-T007
)	O
and	O
one	O
environmental	B-T082
isolate	B-T103
(	O
d	B-T007
##76	I-T007
##31	I-T007
)	O
were	O
recovered	O
from	O
this	O
outbreak	O
.	O
a	O
single	O
isolate	B-T103
-	I-T103
specific	I-T103
virulence	B-T038
gene	B-T017
was	O
found	O
in	O
d	B-T007
##76	I-T007
##32	I-T007
.	O
these	O
isolates	B-T103
were	O
included	O
in	O
a	O
large	O
study	O
evaluating	B-T058
the	O
genomic	B-T017
resolution	O
of	O
various	O
bioinformatics	B-T091
approaches	O
for	O
l	B-T007
.	I-T007
pneumophila	I-T007
serogroup	B-T170
1	I-T170
isolates	B-T103
.	O

amphetamine	B-T038
withdrawal	I-T038
differentially	O
increases	O
the	O
expression	B-T038
of	O
organic	B-T103
cation	I-T103
transporter	I-T103
3	I-T103
and	O
serotonin	B-T103
transporter	I-T103
in	O
limbic	B-T022
brain	B-T017
regions	I-T017
amphetamine	B-T038
withdrawal	I-T038
increases	O
anxiety	B-T033
and	O
stress	B-T033
sensitivity	O
related	O
to	O
blunted	O
ventral	B-T082
hippocampus	B-T017
(	O
vh	B-T017
##ipp	I-T017
)	O
and	O
enhances	O
the	O
central	B-T017
nucleus	I-T017
of	I-T017
the	I-T017
amygdala	I-T017
(	O
cea	B-T017
)	O
serotonin	B-T103
responses	O
.	O
extracellular	B-T017
serotonin	B-T103
levels	O
are	O
regulated	O
by	O
the	O
serotonin	B-T103
transporter	I-T103
(	O
sert	B-T103
)	O
and	O
organic	B-T103
cation	I-T103
transporter	I-T103
3	I-T103
(	O
oct	B-T103
##3	I-T103
)	O
,	O
and	O
vh	B-T017
##ipp	I-T017
oct	B-T103
##3	I-T103
expression	B-T038
is	O
enhanced	O
during	O
24	O
hours	O
of	O
amphetamine	B-T038
withdrawal	I-T038
,	O
while	O
sert	B-T103
expression	B-T038
is	O
unaltered	O
.	O
here	O
,	O
we	O
tested	O
whether	O
oct	B-T103
##3	I-T103
and	O
sert	B-T103
expression	B-T038
in	O
the	O
cea	B-T017
is	O
also	O
affected	O
during	O
acute	O
withdrawal	B-T038
to	O
explain	O
opposing	O
regional	O
alterations	O
in	O
limbic	B-T022
serotonergic	B-T038
neurotransmission	I-T038
and	O
if	O
respective	O
changes	O
continued	O
with	O
two	O
weeks	O
of	O
withdrawal	B-T038
.	O
we	O
also	O
determined	O
whether	O
changes	O
in	O
transporter	B-T103
expression	B-T038
were	O
confined	O
to	O
these	O
regions	O
.	O
male	O
rats	B-T204
received	O
amphetamine	B-T103
or	O
saline	O
for	O
two	O
weeks	O
followed	O
by	O
24	O
hours	O
or	O
two	O
weeks	O
of	O
withdrawal	B-T038
,	O
with	O
transporter	B-T103
expression	B-T038
measured	O
using	O
western	B-T058
immunoblot	I-T058
.	O
oct	B-T103
##3	I-T103
and	O
sert	B-T103
expression	B-T038
increased	O
in	O
the	O
cea	B-T017
at	O
both	O
withdrawal	B-T038
time	O
##points	O
.	O
in	O
the	O
vh	B-T017
##ipp	I-T017
,	O
oct	B-T103
##3	I-T103
expression	B-T038
increased	O
only	O
at	O
24	O
hours	O
of	O
withdrawal	B-T038
,	O
with	O
an	O
equivalent	O
pattern	O
seen	O
in	O
the	O
dors	B-T017
##omedial	I-T017
hypothalamus	I-T017
.	O
no	B-T033
changes	I-T033
were	O
evident	O
in	O
any	O
other	O
regions	B-T082
sampled	O
.	O
these	O
regional	O
##ly	O
specific	O
changes	O
in	O
limbic	B-T022
oct	B-T103
##3	I-T103
and	O
sert	B-T103
expression	B-T038
may	O
partially	O
contribute	O
to	O
the	O
serotonergic	B-T103
imbalance	B-T033
and	O
negative	B-T033
affect	I-T033
during	O
amphetamine	B-T038
withdrawal	I-T038
.	O

kinematic	B-T091
and	O
emg	B-T058
responses	O
to	O
pelvis	B-T017
and	O
leg	B-T017
assistance	O
force	O
during	O
treadmill	O
walking	O
in	O
children	O
with	O
cerebral	B-T038
palsy	I-T038
treadmill	B-T058
training	I-T058
has	O
been	O
used	O
for	O
improving	O
locomotor	B-T038
function	I-T038
in	O
children	O
with	O
cerebral	B-T038
palsy	I-T038
(	O
cp	B-T038
)	O
,	O
but	O
the	O
functional	O
gains	O
are	O
relatively	O
small	O
,	O
suggesting	O
a	O
need	O
to	O
improve	O
current	O
paradigms	O
.	O
the	O
understanding	O
of	O
the	O
kinematic	B-T091
and	O
emg	B-T058
responses	O
to	O
force	O
s	O
applied	O
to	O
the	O
body	B-T017
of	O
subjects	O
during	O
treadmill	O
walking	O
is	O
crucial	O
for	O
improving	O
current	O
paradigms	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
determine	O
the	O
kinematic	B-T091
s	O
and	O
emg	B-T058
responses	O
to	O
the	O
pelvis	B-T017
and	O
/	O
or	O
leg	B-T017
assistance	O
force	O
.	O
ten	O
children	O
with	O
spastic	B-T017
cp	I-T017
were	O
recruited	O
to	O
participate	B-T058
in	O
this	O
study	B-T062
.	O
a	O
controlled	O
assistance	O
force	O
was	O
applied	O
to	O
the	O
pelvis	B-T017
and	O
/	O
or	O
legs	B-T017
during	O
stance	O
and	O
swing	O
phase	O
of	O
gait	O
through	O
a	O
custom	O
designed	O
robotic	O
system	O
during	O
walking	O
.	O
muscle	B-T017
activities	O
and	O
spatial	O
-	O
temporal	O
gait	B-T033
parameters	I-T033
were	O
measured	O
at	O
different	O
loading	O
conditions	O
during	O
walking	O
.	O
in	O
addition	O
,	O
the	O
spatial	B-T033
-	I-T033
temporal	I-T033
gait	I-T033
parameters	I-T033
during	O
over	O
##ground	O
walking	O
before	O
and	O
after	O
treadmill	B-T058
training	I-T058
were	O
also	O
collected	O
.	O
applying	O
pelvis	B-T017
assistance	O
improved	B-T033
step	B-T033
height	I-T033
and	O
applying	O
leg	B-T017
assistance	O
improved	B-T033
step	B-T033
length	I-T033
during	O
walking	O
,	O
but	O
applying	O
leg	B-T017
assistance	O
also	O
reduced	O
muscle	B-T017
activation	O
of	O
ankle	B-T017
flexor	I-T017
during	O
the	O
swing	O
phase	O
of	O
gait	O
.	O
in	O
addition	O
,	O
step	B-T033
length	I-T033
and	O
self	O
-	O
selected	O
walking	O
speed	O
significantly	O
improved	B-T033
after	O
one	O
session	O
of	O
treadmill	B-T058
training	I-T058
with	O
combined	O
pelvis	B-T017
and	O
leg	B-T017
assistance	O
.	O

recurrent	B-T038
noncoding	I-T038
regulatory	I-T038
mutations	I-T038
in	O
pancreatic	B-T038
ductal	I-T038
adenocarcinoma	I-T038
the	O
contributions	O
of	O
coding	B-T038
mutations	I-T038
to	O
tumorigenesis	B-T038
are	O
relatively	O
well	O
known	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
somatic	B-T038
alterations	I-T038
in	O
noncoding	B-T103
dna	I-T103
.	O
here	O
we	O
describe	O
ge	O
##cc	O
##o	O
(	O
genomic	O
enrichment	O
computational	O
clustering	O
operation	O
)	O
to	O
analyze	O
somatic	B-T038
noncoding	I-T038
alterations	I-T038
in	O
308	O
pancreatic	B-T038
ductal	I-T038
adenocarcinomas	I-T038
(	O
pda	B-T038
##s	I-T038
)	O
and	O
identify	O
commonly	O
mutated	B-T082
regulatory	I-T082
regions	I-T082
.	O
we	O
find	O
recurrent	B-T038
noncoding	I-T038
mutations	I-T038
to	O
be	O
enriched	O
in	O
pda	B-T038
pathways	B-T038
,	O
including	O
axon	B-T038
guidance	I-T038
and	O
cell	B-T038
adhesion	I-T038
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	B-T038
and	O
homeobox	B-T017
genes	I-T017
.	O
we	O
identified	O
mutations	B-T038
in	O
protein	B-T082
binding	I-T082
sites	I-T082
correlating	O
with	O
differential	O
expression	B-T038
of	O
proximal	B-T082
genes	B-T017
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	B-T038
on	O
expression	B-T038
.	O
we	O
developed	O
an	O
expression	O
modulation	O
score	O
that	O
quantif	O
##ies	O
the	O
strength	O
of	O
gene	B-T038
regulation	I-T038
imposed	O
by	O
each	O
class	O
of	O
regulatory	B-T017
elements	I-T017
,	O
and	O
found	O
the	O
strongest	O
elements	B-T017
were	O
most	O
frequently	O
mutated	O
,	O
suggesting	O
a	O
selective	O
advantage	O
.	O
our	O
detailed	O
single	B-T058
-	I-T058
cancer	I-T058
analysis	I-T058
of	O
noncoding	B-T038
alterations	I-T038
identifies	O
regulatory	B-T038
mutations	I-T038
as	O
candidates	O
for	O
diagnostic	B-T201
and	O
prognostic	O
markers	O
,	O
and	O
suggests	O
new	O
mechanisms	O
for	O
tumor	B-T038
evolution	I-T038
.	O

fall	B-T033
risk	B-T033
factors	I-T033
analysis	B-T062
based	O
on	O
sample	O
entropy	O
of	O
plantar	B-T082
kinematic	O
signal	O
during	O
stance	O
phase	O
falls	B-T033
are	O
a	O
multi	O
-	O
causal	O
phenomenon	O
with	O
a	O
complex	O
interaction	O
.	O
the	O
aim	O
of	O
our	O
research	B-T062
is	O
to	O
study	B-T062
the	O
effect	O
of	O
multiple	O
variables	O
for	O
potential	O
risk	B-T033
of	I-T033
falls	I-T033
and	O
construct	B-T170
an	O
elderly	B-T170
fall	I-T170
risk	I-T170
assessment	I-T170
model	I-T170
based	O
on	O
demographics	O
data	O
and	O
gait	O
characteristics	O
.	O
a	O
total	O
of	O
101	O
subjects	B-T098
,	O
whom	O
belong	O
to	O
mal	O
##ian	O
##wa	O
street	O
,	O
aged	O
above	O
50	O
years	O
old	O
and	O
participated	O
in	O
questionnaire	B-T170
survey	B-T170
.	O
participants	B-T098
were	O
classified	O
into	O
three	O
groups	O
(	O
high	O
,	O
medium	B-T098
and	O
low	O
risk	O
group	O
)	O
according	O
to	O
the	O
score	O
of	O
elderly	B-T170
fall	I-T170
risk	I-T170
assessment	I-T170
scale	I-T170
.	O
in	O
addition	O
,	O
the	O
data	O
of	O
ground	O
reaction	O
force	O
(	O
gr	O
##f	O
)	O
and	O
ground	O
reaction	O
moment	O
(	O
gr	O
##m	O
)	O
was	O
record	O
when	O
they	O
performed	O
walking	O
at	O
comfortable	O
state	O
.	O
the	O
demographic	O
variables	O
,	O
sample	O
entropy	O
of	O
gr	O
##f	O
and	O
gr	O
##m	O
,	O
and	O
impulse	O
difference	O
of	O
bilateral	O
foot	O
were	O
considered	O
as	O
potential	O
explanatory	B-T170
variables	O
of	O
risk	B-T058
assessment	I-T058
model	B-T170
.	O
firstly	O
,	O
we	O
investigated	O
whether	O
different	O
groups	O
could	O
present	O
difference	O
in	O
every	O
variable	O
.	O
statistical	O
differences	O
were	O
found	B-T033
for	O
the	O
following	O
variables	O
:	O
age	O
(	O
p	O
=	O
2	O
.	O
28	O
##e	O
-	O
05	O
)	O
;	O
impulse	O
difference	O
(	O
p	O
=	O
0	O
.	O
020	O
##36	O
)	O
;	O
sample	O
entropy	O
of	O
gr	O
##f	O
in	O
vertical	B-T082
direction	B-T082
(	O
p	O
=	O
0	O
.	O
014	O
##4	O
)	O
;	O
sample	O
entropy	O
of	O
gr	O
##m	O
in	O
anterior	B-T082
-	I-T082
posterior	I-T082
direction	B-T082
(	O
p	O
=	O
0	O
.	O
038	O
##7	O
)	O
.	O
finally	O
,	O
the	O
multiple	O
regression	B-T170
analysis	I-T170
results	O
indicated	B-T033
that	O
age	O
,	O
impulse	O
difference	O
and	O
sample	O
entropy	O
of	O
resultant	O
gr	O
##m	O
could	O
identify	O
individuals	B-T098
who	O
had	O
different	O
levels	B-T058
of	I-T058
fall	I-T058
risk	I-T058
.	O
therefore	O
,	O
those	O
results	O
could	O
potentially	O
be	O
useful	O
in	O
the	O
fall	B-T058
risk	I-T058
assessment	I-T058
and	O
monitor	B-T058
the	O
state	O
of	O
physical	B-T033
function	I-T033
in	O
elderly	B-T098
population	I-T098
.	O

real	O
role	O
of	O
β	B-T103
-	I-T103
blockers	I-T103
in	O
regression	O
of	O
left	B-T033
ventricular	I-T033
mass	I-T033
in	O
hypertension	B-T038
patients	O
:	O
bayesian	B-T170
network	I-T170
meta	B-T062
-	I-T062
analysis	I-T062
left	B-T038
ventricular	I-T038
hypertrophy	I-T038
(	O
lvh	B-T038
)	O
is	O
commonly	O
present	O
in	O
patients	O
with	O
hypertension	B-T038
(	O
ht	B-T038
)	O
.	O
according	O
to	O
the	O
expert	B-T170
consensus	I-T170
document	I-T170
from	O
american	B-T098
,	O
angiotensin	B-T103
-	I-T103
converting	I-T103
enzyme	I-T103
inhibitor	I-T103
(	O
ace	B-T103
##i	I-T103
)	O
and	O
angiotensin	B-T103
receptor	I-T103
blockers	I-T103
(	O
arb	B-T103
##s	I-T103
)	O
were	O
recommended	O
as	O
1st	O
-	O
line	O
therapeutic	B-T103
drugs	I-T103
.	O
however	O
,	O
none	O
noticed	O
the	O
different	O
efficacy	O
between	O
fat	B-T103
-	I-T103
soluble	I-T103
and	I-T103
selective	I-T103
β1	I-T103
-	I-T103
receptor	I-T103
blockers	I-T103
(	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
)	O
and	O
other	O
β	B-T103
-	I-T103
blockers	I-T103
on	O
regression	O
of	O
lvh	B-T038
before	O
.	O
the	O
aim	O
of	O
this	O
analysis	B-T062
was	O
to	O
compare	O
the	O
efficacy	O
of	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
with	O
the	O
other	O
4	O
different	O
classes	O
of	O
antihypertensive	B-T103
drugs	I-T103
(	O
ace	B-T103
##i	I-T103
,	O
arb	B-T103
##s	I-T103
,	O
calcium	B-T103
channel	I-T103
blockers	I-T103
[	O
cc	B-T103
##bs	I-T103
]	O
,	O
and	O
diuretics	B-T103
)	O
on	O
regression	O
of	O
lvh	B-T038
.	O
relative	O
trials	B-T062
were	O
identified	O
in	O
the	O
pubmed	B-T170
,	O
web	B-T170
of	I-T170
science	I-T170
,	O
ovid	B-T170
eb	I-T170
##m	I-T170
reviews	I-T170
and	O
cochrane	B-T170
databases	I-T170
,	O
and	O
the	O
relevant	O
papers	B-T170
were	O
examined	O
.	O
we	O
performed	O
both	O
traditional	O
and	O
bayesian	B-T170
meta	B-T062
-	I-T062
analysis	I-T062
of	O
randomized	B-T062
controlled	I-T062
trials	I-T062
(	O
rcts	B-T062
)	O
about	O
the	O
regression	O
of	O
lvh	B-T038
.	O
sensitivity	B-T062
analysis	I-T062
and	O
regression	B-T170
analysis	I-T170
were	O
performed	O
to	O
explore	O
possible	O
sources	O
of	O
heterogeneity	O
.	O
inconsist	B-T062
##ency	I-T062
analysis	I-T062
was	O
performed	O
to	O
check	O
whether	O
the	O
analysis	B-T062
of	O
the	O
trials	B-T062
in	O
the	O
network	B-T170
was	O
indeed	O
consistent	O
.	O
a	O
total	O
of	O
41	O
rcts	B-T062
involving	O
256	O
##6	O
patients	O
with	O
ht	B-T038
and	O
lvh	B-T038
were	O
included	O
in	O
this	O
analysis	B-T062
.	O
bayesian	B-T170
network	I-T170
meta	B-T062
-	I-T062
analysis	I-T062
indicated	O
no	O
statistically	O
significant	O
differences	O
between	O
these	O
groups	O
:	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
and	O
ace	B-T103
##i	I-T103
(	O
md	O
,	O
-	O
7	O
.	O
09	O
;	O
95	O
%	O
ci	O
,	O
-	O
14	O
.	O
99	O
,	O
1	O
.	O
27	O
)	O
;	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
and	O
arb	B-T103
(	O
md	O
,	O
-	O
2	O
.	O
66	O
;	O
95	O
%	O
cl	O
,	O
-	O
12	O
.	O
02	O
,	O
6	O
.	O
31	O
)	O
.	O
although	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
showed	O
greater	O
efficacy	O
when	O
compared	O
with	O
diuretic	B-T103
(	O
md	O
,	O
13	O
.	O
04	O
;	O
95	O
%	O
ci	O
,	O
3	O
.	O
38	O
,	O
22	O
.	O
59	O
)	O
or	O
cc	B-T103
##b	I-T103
(	O
md	O
,	O
10	O
.	O
90	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
98	O
,	O
19	O
.	O
49	O
)	O
.	O
the	O
probabilities	O
of	O
being	O
among	O
the	O
most	O
efficacious	O
treatments	B-T058
were	O
:	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
(	O
72	O
%	O
)	O
,	O
arb	B-T103
(	O
27	O
%	O
)	O
,	O
ace	B-T103
##i	I-T103
(	O
0	O
.	O
01	O
%	O
)	O
,	O
cc	B-T103
##b	I-T103
(	O
0	O
.	O
00	O
%	O
)	O
,	O
and	O
diuretic	B-T103
(	O
0	O
.	O
00	O
%	O
)	O
.	O
evidence	O
from	O
our	O
analysis	B-T062
reveals	O
that	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
have	O
potential	O
to	O
become	O
1st	O
-	O
line	O
therapeutic	B-T103
drugs	I-T103
in	O
ht	B-T038
and	O
lvh	B-T038
patients	O
.	O
however	O
,	O
the	O
real	O
efficacy	O
of	O
fs	B-T103
-	I-T103
β	I-T103
-	I-T103
b	I-T103
on	O
regression	O
of	O
lvh	B-T038
should	O
be	O
confirmed	O
by	O
further	O
large	O
,	O
high	O
quality	O
trials	B-T062
considering	O
the	O
limitation	O
of	O
the	O
study	O
number	O
.	O

evidence	O
of	O
tooth	O
##pic	O
##k	O
groove	B-T082
formation	O
in	O
ne	B-T204
##ander	I-T204
##tal	I-T204
anterior	B-T082
and	O
posterior	B-T082
teeth	B-T017
during	O
the	O
microscopic	B-T058
examination	I-T058
of	O
the	O
ne	B-T204
##ander	I-T204
##tal	I-T204
dentition	B-T017
##s	I-T017
from	O
el	B-T082
sid	I-T082
##ron	I-T082
(	O
spain	B-T082
)	O
and	O
hor	B-T082
##t	I-T082
##us	I-T082
(	O
france	B-T082
)	O
,	O
we	O
found	O
unusual	O
fine	O
parallel	O
micros	O
##tri	O
##ations	O
on	O
the	O
mesial	B-T082
and	O
distal	B-T082
sides	I-T082
of	O
all	O
tooth	B-T017
types	O
,	O
near	O
the	O
cervix	B-T082
.	O
as	O
its	O
appearance	O
was	O
similar	O
to	O
tooth	O
##pic	O
##k	O
groove	B-T082
##s	I-T082
described	O
in	O
other	O
homo	B-T204
species	I-T204
,	O
it	O
could	O
correspond	O
to	O
early	O
stages	O
on	O
its	O
formation	O
.	O
to	O
test	O
this	O
hypothesis	O
we	O
developed	O
an	O
experimental	B-T062
replication	I-T062
of	O
a	O
groove	B-T082
using	O
grass	B-T204
stalk	B-T204
##s	I-T204
.	O
comparisons	O
between	O
204	O
isolated	O
ne	B-T204
##ander	I-T204
##tal	I-T204
teeth	B-T017
and	O
the	O
two	O
experimental	O
dental	O
specimens	O
corroborate	O
that	O
the	O
marks	B-T033
correspond	O
to	O
initial	O
stages	O
of	O
tooth	O
##pic	O
##k	O
groove	B-T082
formation	O
,	O
and	O
we	O
propose	O
a	O
five	B-T170
-	I-T170
grade	I-T170
recording	I-T170
scale	I-T170
that	O
summarized	O
the	O
groove	B-T082
formation	O
process	O
.	O
using	O
this	O
new	O
recording	O
procedure	O
,	O
we	O
found	O
that	O
hor	B-T082
##t	I-T082
##us	I-T082
individuals	B-T098
have	O
higher	O
incidence	O
of	O
this	O
trait	O
(	O
eight	O
individuals	B-T098
out	O
of	O
nine	O
)	O
than	O
the	O
el	B-T082
sid	I-T082
##ron	I-T082
individuals	B-T098
(	O
nine	O
out	O
of	O
11	O
)	O
.	O
tooth	O
##pic	O
##k	O
groove	B-T082
##s	I-T082
from	O
el	B-T082
sid	I-T082
##ron	I-T082
show	O
the	O
earliest	O
stages	O
of	O
development	O
,	O
whereas	O
the	O
groove	B-T082
##s	I-T082
found	O
on	O
hor	B-T082
##t	I-T082
##us	I-T082
ne	B-T204
##ander	I-T204
##tal	I-T204
##s	I-T204
were	O
well	O
-	O
developed	O
.	O
tooth	O
##pic	O
##k	O
groove	B-T082
##s	I-T082
were	O
also	O
found	O
in	O
21	O
incisors	B-T017
and	O
canine	B-T017
##s	I-T017
.	O
these	O
differences	O
could	O
be	O
due	O
to	O
the	O
more	O
advanced	O
occlusal	B-T082
dental	B-T037
wear	I-T037
in	O
hor	B-T082
##t	I-T082
##us	I-T082
individuals	B-T098
,	O
may	O
##be	O
age	O
-	O
related	O
and	O
with	O
a	O
more	O
meat	B-T168
-	O
based	O
diet	B-T168
may	O
##be	O
favoring	O
the	O
inclusion	O
of	O
food	B-T168
debris	O
and	O
thus	O
probing	O
as	O
the	O
cleaning	O
methodology	O
.	O
our	O
results	O
allow	O
the	O
identification	O
and	O
characterization	O
of	O
inc	O
##ip	O
##ient	O
tooth	O
##pic	O
##k	O
groove	B-T082
##s	I-T082
on	O
the	O
human	B-T204
fossil	O
record	B-T170
and	O
contribute	O
to	O
increase	O
our	O
knowledge	B-T170
on	O
ne	B-T204
##ander	I-T204
##tal	I-T204
##s	I-T204
behavioral	O
and	O
oral	B-T033
care	I-T033
habits	I-T033
.	O

draft	B-T082
genome	I-T082
sequence	I-T082
of	O
the	O
soil	O
isolate	B-T103
lys	B-T007
##ini	I-T007
##ba	I-T007
##cil	I-T007
##lu	I-T007
##s	I-T007
fusiform	I-T007
##is	I-T007
m	I-T007
##5	I-T007
,	O
a	O
potential	O
hypoxanthine	B-T103
producer	O
lys	B-T007
##ini	I-T007
##ba	I-T007
##cil	I-T007
##lu	I-T007
##s	I-T007
fusiform	I-T007
##is	I-T007
strain	I-T007
m	I-T007
##5	I-T007
is	O
a	O
potential	O
hypoxanthine	B-T103
producer	O
that	O
was	O
isolated	B-T103
from	O
clay	B-T103
soil	O
.	O
here	O
,	O
we	O
present	O
the	O
draft	B-T082
genome	I-T082
sequence	I-T082
that	O
was	O
annotated	B-T062
in	O
order	O
to	O
facilitate	O
future	O
studies	B-T062
of	O
l	B-T007
.	I-T007
fusiform	I-T007
##is	I-T007
m	I-T007
##5	I-T007
.	I-T007

numerical	B-T062
simulation	I-T062
of	O
emitted	B-T103
particle	I-T103
characteristics	O
and	O
airway	B-T017
deposition	O
distribution	B-T038
of	O
symb	B-T103
##ico	I-T103
##rt	I-T103
(	I-T103
®	I-T103
)	I-T103
turb	I-T103
##u	I-T103
##hal	I-T103
##er	I-T103
(	I-T103
®	I-T103
)	I-T103
dry	B-T103
powder	I-T103
fixed	O
combination	B-T103
aerosol	B-T103
drug	I-T103
one	O
of	O
the	O
most	O
widespread	O
dry	B-T103
powder	I-T103
fixed	O
combinations	B-T103
used	O
in	O
asthma	B-T038
and	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
(	O
copd	B-T038
)	O
management	B-T058
is	O
symb	B-T103
##ico	I-T103
##rt	I-T103
(	I-T103
®	I-T103
)	I-T103
turb	I-T103
##u	I-T103
##hal	I-T103
##er	I-T103
(	I-T103
®	I-T103
)	I-T103
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
simulate	B-T062
the	O
deposition	O
distribution	B-T038
of	O
both	O
components	O
of	O
this	O
drug	B-T103
within	O
the	O
airways	B-T017
based	O
on	O
realistic	O
airflow	O
measurements	O
.	O
breathing	B-T038
parameters	O
of	O
25	O
healthy	B-T033
adults	I-T033
(	O
11	O
females	O
and	O
14	O
males	O
)	O
were	O
acquired	O
while	O
inhal	B-T038
##ing	I-T038
through	O
turb	B-T074
##u	I-T074
##hal	I-T074
##er	I-T074
(	I-T074
®	I-T074
)	I-T074
.	O
individual	B-T098
specific	O
emitted	O
doses	O
and	O
particle	O
size	O
distributions	B-T038
of	O
symb	B-T103
##ico	I-T103
##rt	I-T103
(	I-T103
®	I-T103
)	I-T103
turb	I-T103
##u	I-T103
##hal	I-T103
##er	I-T103
(	I-T103
®	I-T103
)	I-T103
were	O
determined	O
.	O
a	O
self	O
-	O
developed	O
particle	B-T103
deposition	O
model	B-T170
was	O
adapted	O
and	O
validated	O
to	O
simulate	B-T062
the	O
deposition	O
of	O
budesonide	B-T103
(	O
inhaled	B-T103
corticosteroid	I-T103
;	O
ics	B-T103
)	O
and	O
form	B-T103
##oter	I-T103
##ol	I-T103
(	O
long	B-T103
acting	I-T103
β2	I-T103
agonist	I-T103
;	O
lab	B-T103
##a	I-T103
)	O
in	O
the	O
upper	B-T082
airways	I-T082
and	O
lungs	B-T017
of	O
the	O
healthy	B-T098
volunteers	I-T098
.	O
based	O
on	O
current	O
simulations	B-T062
the	O
emitted	O
doses	O
varied	O
between	O
50	O
.	O
4	O
%	O
and	O
92	O
.	O
5	O
%	O
of	O
the	O
meter	O
##ed	O
dose	O
for	O
the	O
ics	B-T103
,	O
and	O
between	O
38	O
%	O
and	O
96	O
.	O
1	O
%	O
in	O
case	O
of	O
lab	B-T103
##a	I-T103
component	O
depending	O
on	O
the	O
individual	B-T098
inhalation	B-T201
flow	I-T201
rate	I-T201
.	O
this	O
variability	O
induced	O
a	O
notable	O
inter	O
-	O
individual	B-T098
spread	O
of	O
the	O
deposited	O
lung	B-T017
doses	O
(	O
mean	O
:	O
33	O
.	O
6	O
%	O
,	O
range	O
:	O
20	O
.	O
4	O
%	O
-	O
48	O
.	O
8	O
%	O
for	O
budesonide	B-T103
and	O
mean	O
:	O
29	O
.	O
8	O
%	O
,	O
range	O
:	O
16	O
.	O
4	O
%	O
-	O
42	O
.	O
9	O
%	O
for	O
form	B-T103
##oter	I-T103
##ol	I-T103
)	O
.	O
significant	O
inter	O
-	O
gender	O
differences	O
were	O
also	O
observed	O
.	O
average	O
lung	B-T017
dose	O
of	O
budesonide	B-T103
was	O
29	O
.	O
2	O
%	O
of	O
the	O
meter	O
##ed	O
dose	O
for	O
females	O
and	O
37	O
%	O
for	O
males	O
,	O
while	O
form	B-T103
##oter	I-T103
##ol	I-T103
deposited	O
with	O
26	O
.	O
4	O
%	O
efficiency	O
for	O
females	O
and	O
32	O
.	O
5	O
%	O
for	O
males	O
.	O
present	O
results	O
also	O
highlighted	O
the	O
importance	O
of	O
breath	B-T033
-	I-T033
holding	I-T033
after	O
inhalation	B-T038
of	O
the	O
drug	B-T103
.	O
about	O
a	O
half	O
of	O
the	O
total	O
lung	B-T017
deposition	O
occurred	O
during	O
breath	B-T033
-	I-T033
hold	I-T033
at	O
9	O
.	O
6	O
##s	O
average	O
breath	B-T033
-	I-T033
hold	I-T033
time	O
.	O
calculated	O
deposition	O
##s	O
confirmed	O
appropriate	O
lung	B-T017
deposition	O
of	O
symb	B-T103
##ico	I-T103
##rt	I-T103
(	I-T103
®	I-T103
)	I-T103
turb	I-T103
##u	I-T103
##hal	I-T103
##er	I-T103
(	I-T103
®	I-T103
)	I-T103
for	O
both	O
genders	O
,	O
however	O
more	O
effort	O
for	O
optimal	B-T058
inhalation	I-T058
technique	I-T058
is	O
advised	O
for	O
persons	B-T098
with	O
low	B-T033
vital	I-T033
capacity	I-T033
.	O
this	O
study	B-T062
demonstrated	O
the	O
possibility	O
of	O
personalized	O
prediction	O
of	O
airway	B-T017
deposition	O
of	O
aerosol	B-T103
drugs	I-T103
by	O
numerical	B-T062
simulations	I-T062
.	O
the	O
methodology	O
developed	O
in	O
this	O
study	B-T062
will	O
be	O
applicable	O
also	O
to	O
other	O
marketed	O
drugs	B-T103
in	O
the	O
future	O
.	O

anti	B-T033
-	I-T033
inflammatory	I-T033
activity	O
of	O
el	B-T204
##aea	I-T204
##gn	I-T204
##us	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
fruit	B-T103
extract	I-T103
on	O
rat	B-T204
paw	B-T017
edema	B-T033
the	O
el	B-T204
##aea	I-T204
##gn	I-T204
##us	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
fruit	B-T168
has	O
been	O
traditionally	O
used	O
in	O
iranian	B-T082
herbal	B-T103
medicine	I-T103
to	O
treat	O
diarrhea	B-T033
and	O
rheumatoid	B-T038
arthritis	I-T038
.	O
in	O
the	O
present	O
study	O
,	O
the	O
effects	O
of	O
e	B-T204
.	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
fruit	B-T103
extract	I-T103
on	O
the	O
acute	O
and	O
chronic	O
phases	O
of	O
formalin	B-T103
-	O
induced	O
rat	B-T204
paw	B-T017
edema	B-T033
were	O
examined	B-T033
.	O
the	O
acute	O
and	O
chronic	O
anti	B-T033
-	I-T033
inflammatory	I-T033
effects	I-T033
of	O
e	B-T204
.	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
fruit	B-T103
extract	I-T103
were	O
investigated	O
through	O
the	O
subcutaneous	O
injection	O
of	O
100	O
μl	O
of	O
formalin	B-T103
(	O
2	O
.	O
5	O
%	O
)	O
into	O
a	O
rat	B-T204
'	I-T204
s	I-T204
hind	O
paw	B-T017
.	O
thirty	O
minutes	O
before	O
the	O
procedure	O
,	O
the	O
experimental	O
groups	O
were	O
treated	O
intraperitoneally	B-T082
with	O
hydro	B-T103
##alcoholic	I-T103
fruit	I-T103
extracts	I-T103
of	O
e	B-T204
.	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
(	O
concentrations	O
of	O
100	O
,	O
300	O
,	O
700	O
,	O
and	O
1000	O
mg	O
/	O
kg	O
)	O
;	O
sodium	B-T103
salicylate	I-T103
(	O
ss	B-T103
,	O
400	O
mg	O
/	O
kg	O
)	O
and	O
distilled	B-T103
water	I-T103
were	O
used	O
as	O
positive	B-T033
and	O
negative	B-T033
control	O
groups	O
,	O
respectively	O
.	O
treatment	O
with	O
ss	B-T103
and	O
the	O
fruit	B-T103
extracts	I-T103
were	O
performed	O
daily	O
for	O
8	O
days	O
,	O
and	O
the	O
degree	O
of	O
edema	B-T033
was	O
measured	O
by	O
using	O
mercury	B-T074
plethysm	I-T074
##ometer	I-T074
and	O
digital	B-T074
cal	I-T074
##iper	I-T074
.	O
in	O
the	O
acute	O
anti	B-T033
-	I-T033
inflammatory	I-T033
study	B-T062
,	O
the	O
extract	O
showed	O
a	O
significant	O
anti	O
-	O
inflammatory	O
effect	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O
the	O
results	O
of	O
1000	O
mg	O
/	O
kg	O
of	O
the	O
extract	O
was	O
significantly	O
different	O
compared	O
with	O
the	O
negative	B-T033
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
was	O
comparable	O
to	O
sodium	B-T103
salicylate	I-T103
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
results	O
from	O
the	O
chronic	O
study	B-T062
suggested	O
that	O
e	B-T204
.	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
extract	O
significantly	O
reduced	O
paw	B-T017
edema	B-T033
and	O
inflammation	B-T038
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O
the	O
results	O
also	O
showed	O
that	O
the	O
measurement	O
by	O
digital	B-T074
cal	I-T074
##iper	I-T074
and	O
mercury	B-T074
plethysm	I-T074
##ometer	I-T074
were	O
both	O
reliable	O
and	O
might	O
be	O
applied	O
interchange	O
##ably	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
phytochemical	B-T058
tests	I-T058
indicated	O
that	O
the	O
hydro	B-T103
##alcoholic	I-T103
fruit	I-T103
extract	I-T103
of	O
e	B-T204
.	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
was	O
positive	B-T033
for	O
cardiac	B-T103
glycosides	I-T103
,	O
flavonoids	B-T103
,	O
terp	B-T103
##enoids	I-T103
,	O
and	O
saponins	B-T103
.	O
based	O
on	O
our	O
findings	B-T033
,	O
the	O
e	B-T204
.	I-T204
ang	I-T204
##ust	I-T204
##ifolia	I-T204
fruit	B-T103
extract	I-T103
probably	O
has	O
acute	O
and	O
chronic	O
anti	B-T033
-	I-T033
inflammatory	I-T033
activities	O
to	O
support	O
its	O
applications	O
in	O
fol	B-T058
##k	I-T058
medicine	I-T058
.	O

ocular	B-T037
toxicity	I-T037
of	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
in	O
pigmented	B-T204
and	O
albino	O
rats	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
,	O
a	O
heat	B-T103
shock	I-T103
protein	I-T103
90	I-T103
inhibitor	O
is	O
associated	O
with	O
ocular	B-T017
adverse	B-T038
events	I-T038
(	O
aes	B-T038
)	O
.	O
to	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	B-T017
aes	B-T038
in	O
patients	O
,	O
4	O
investig	B-T062
##ative	I-T062
studies	I-T062
were	O
performed	O
in	O
a	O
step	B-T082
-	I-T082
wise	I-T082
approach	I-T082
to	O
assess	O
retinal	B-T017
structure	I-T017
and	O
function	O
in	O
pigmented	B-T204
(	O
brown	B-T204
norway	I-T204
)	O
and	O
albino	O
(	O
wistar	B-T204
)	O
rats	O
.	O
in	O
rats	B-T204
administered	O
30	O
##mg	O
/	O
kg	O
of	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
,	O
the	O
auc	O
0	O
-	O
24	O
h	O
and	O
cmax	O
are	O
comparable	O
to	O
that	O
in	O
patients	O
at	O
70	O
##mg	O
/	O
m	O
(	O
2	O
)	O
.	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
at	O
≥3	O
##0	O
##mg	O
/	O
kg	O
was	O
poorly	O
tolerated	O
by	O
rats	B-T204
with	O
morbidity	O
or	O
mortality	O
generally	O
after	O
the	O
third	O
weekly	O
treatment	B-T058
.	O
electroretin	B-T058
##ography	I-T058
(	O
erg	B-T058
)	O
changes	O
were	O
observed	O
at	O
doses	O
≥3	O
##0	O
##mg	O
/	O
kg	O
.	O
the	O
erg	B-T058
changes	O
were	O
dose	O
dependent	O
,	O
consistent	O
with	O
an	O
effect	O
on	O
the	O
photoreceptors	B-T017
,	O
and	O
fully	O
reversible	O
.	O
the	O
erg	B-T058
effects	O
could	O
not	O
be	O
minimized	O
by	O
decreasing	O
the	O
cmax	O
while	O
maintaining	O
auc	O
.	O
histopathological	O
changes	O
were	O
seen	O
mainly	O
when	O
rats	B-T204
were	O
administered	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
at	O
100	O
##mg	O
/	O
kg	O
.	O
the	O
2	O
-	O
hour	O
infusion	B-T058
of	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
at	O
100	O
##mg	O
/	O
kg	O
caused	O
dis	O
##organization	O
of	O
the	O
outer	B-T017
segment	I-T017
photoreceptor	I-T017
morphology	O
in	O
male	O
brown	B-T204
norway	I-T204
rats	I-T204
;	O
the	O
severity	O
of	O
the	O
dis	O
##organization	O
increased	O
with	O
the	O
number	O
of	O
administrations	B-T058
,	O
but	O
was	O
reversible	O
during	O
a	O
4	O
-	O
week	O
posttreatment	O
period	O
.	O
there	O
was	O
no	O
major	O
difference	O
in	O
ocular	B-T017
response	O
between	O
brown	B-T204
norway	I-T204
and	O
wistar	B-T204
rats	I-T204
.	O
no	O
changes	O
in	O
serum	B-T033
iron	I-T033
levels	I-T033
,	O
and	O
no	O
changes	O
in	O
rhodopsin	B-T103
,	O
pde	B-T103
##6	I-T103
##α	I-T103
,	O
β	B-T103
-	I-T103
transduc	I-T103
##in	I-T103
concentrations	O
,	O
or	O
retinal	B-T103
pigment	I-T103
epithelium	I-T103
-	I-T103
specific	I-T103
protein	I-T103
rpe	I-T103
##65	I-T103
expression	B-T038
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	B-T058
of	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
at	O
100	O
##mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O
au	B-T103
##y	I-T103
##92	I-T103
##2	I-T103
retinal	B-T017
toxicity	I-T017
in	O
rats	B-T204
recapit	O
##ulates	O
and	O
further	O
characterizes	O
that	O
reported	O
in	O
patients	O
and	O
is	O
shown	O
to	O
be	O
reversible	O
,	O
while	O
a	O
precise	O
molecular	B-T038
mechanism	I-T038
for	O
the	O
effect	O
was	O
not	O
determined	O
.	O

water	O
pip	O
##e	O
(	O
sh	O
##ish	O
##a	O
,	O
hook	O
##ah	O
,	O
arg	O
##hi	O
##le	O
)	O
smoking	O
and	O
second	B-T037
##hand	I-T037
tobacco	I-T037
smoke	I-T037
effects	O
on	O
cyp1a2	B-T103
and	O
cyp2	B-T103
##a	I-T103
##6	I-T103
phenotypes	O
as	O
measured	O
by	O
caffeine	B-T058
urine	I-T058
test	I-T058
public	B-T097
policies	I-T097
to	O
stop	O
or	O
reduce	O
cigarette	O
smoking	O
and	O
exposure	O
to	O
second	B-T037
##hand	I-T037
smoke	I-T037
and	O
associated	B-T038
diseases	I-T038
have	O
yielded	O
successful	O
results	O
over	O
the	O
past	O
decade	O
.	O
yet	O
,	O
the	O
growing	O
worldwide	O
popularity	O
of	O
another	O
form	O
of	O
tobacco	O
consumption	O
,	O
water	O
pip	O
##e	O
smoking	O
,	O
has	O
received	O
relatively	O
less	O
attention	O
.	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pip	O
##e	O
smoking	O
on	O
cytochrome	B-T038
p450	I-T038
(	I-T038
cyp	I-T038
##45	I-T038
##0	I-T038
)	I-T038
activities	I-T038
and	O
drug	B-T038
interaction	I-T038
potential	O
in	O
humans	B-T204
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
second	B-T037
##hand	I-T037
smoke	I-T037
on	O
drug	B-T038
metabolism	I-T038
.	O
in	O
a	O
sample	O
of	O
99	O
healthy	B-T098
volunteers	I-T098
(	O
28	O
water	O
pip	O
##e	O
smokers	O
,	O
30	O
second	B-T037
##hand	I-T037
tobacco	I-T037
smoke	I-T037
exposed	O
persons	B-T098
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
cyp1a2	B-T103
and	O
cyp2	B-T103
##a	I-T103
##6	I-T103
enzyme	B-T038
activities	I-T038
in	B-T082
vivo	I-T082
using	O
caffeine	B-T058
urine	I-T058
test	I-T058
.	O
the	O
median	O
self	B-T062
-	I-T062
reported	I-T062
duration	O
of	O
water	O
pip	O
##e	O
smoking	O
was	O
7	O
.	O
5	O
h	O
/	O
week	O
and	O
3	O
years	O
of	O
exposure	O
in	O
total	O
.	O
the	O
second	B-T037
##hand	I-T037
smoke	I-T037
group	B-T098
had	O
a	O
median	O
of	O
14	O
h	O
of	O
self	B-T062
-	I-T062
reported	I-T062
weekly	O
exposure	O
to	O
tobacco	B-T103
smoke	I-T103
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	B-T103
/	O
hour	O
for	O
a	O
total	O
of	O
3	O
.	O
5	O
years	O
(	O
median	O
)	O
.	O
analysis	B-T062
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
cyp1a2	B-T103
and	O
cyp2	B-T103
##a	I-T103
##6	I-T103
activities	B-T038
among	O
the	O
three	O
study	B-T062
groups	B-T098
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
nor	O
was	O
there	O
a	O
significant	O
association	O
between	O
the	O
extent	O
of	O
water	O
pip	O
##e	O
or	O
second	B-T037
##hand	I-T037
smoke	I-T037
exposure	O
and	O
the	O
cyp1a2	B-T103
and	O
cyp2	B-T103
##a	I-T103
##6	I-T103
activities	B-T038
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
further	O
analysis	B-T062
in	O
a	O
subsam	O
##ple	O
with	O
smoke	O
exposure	O
more	O
than	O
the	O
median	O
values	O
also	O
did	O
not	O
reveal	O
a	O
significant	O
difference	O
from	O
the	O
controls	O
.	O
although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pip	O
##e	O
smoke	O
and	O
second	B-T037
##hand	I-T037
smoke	I-T037
on	O
in	B-T082
vivo	I-T082
activities	B-T038
of	O
these	O
two	O
drug	B-T038
metabolism	I-T038
pathways	B-T038
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e	O
.	O
g	O
.	O
,	O
water	O
pip	O
##e	O
)	O
might	O
affect	O
drug	B-T038
metabolism	I-T038
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	B-T103
smoke	I-T103
.	O
further	O
studies	B-T062
in	O
larger	O
prospective	O
samples	O
are	O
recommended	O
to	O
evaluate	O
water	O
pip	O
##e	O
and	O
second	B-T037
##hand	I-T037
tobacco	I-T037
smoke	I-T037
effects	O
on	O
cyp	B-T103
##45	I-T103
##0	I-T103
function	O
,	O
particularly	O
at	O
higher	O
smoke	B-T103
exposure	O
conditions	O
.	O

autoantibodies	B-T103
to	O
mog	B-T103
in	O
a	O
distinct	O
subgroup	B-T170
of	O
adult	O
multiple	B-T038
sclerosis	I-T038
to	O
evaluate	B-T058
the	O
presence	O
of	O
antibodies	B-T103
to	O
conformation	B-T082
-	O
intact	O
myelin	B-T103
oligodendrocyte	I-T103
glycoprotein	I-T103
(	O
mog	B-T103
)	O
in	O
a	O
subgroup	B-T170
of	O
adult	O
patients	O
with	O
clinically	O
definite	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
pres	O
##elected	O
for	O
a	O
specific	O
clinical	O
phenotype	O
including	O
severe	O
spinal	B-T017
cord	I-T017
,	O
optic	B-T017
nerve	I-T017
,	O
and	O
brainstem	B-T017
involvement	O
.	O
antibodies	B-T103
to	O
mog	B-T103
were	O
investigated	O
using	O
a	O
cell	B-T058
-	I-T058
based	I-T058
assay	I-T058
in	O
3	O
groups	B-T098
of	O
patients	O
:	O
104	O
pres	O
##elected	O
patients	O
with	O
ms	B-T038
(	O
group	B-T098
1	I-T098
)	O
,	O
55	O
age	O
-	O
and	O
sex	O
-	O
matched	O
,	O
otherwise	O
unselected	O
patients	O
with	O
ms	B-T038
(	O
group	B-T098
2	I-T098
)	O
,	O
and	O
in	O
22	O
brain	B-T058
-	I-T058
biopsied	I-T058
patients	O
with	O
demyelinating	B-T038
diseases	I-T038
of	O
the	O
cns	B-T022
(	O
n	O
=	O
19	O
with	O
ms	B-T038
)	O
,	O
4	O
of	O
whom	O
classified	B-T170
as	O
ms	B-T038
type	I-T038
ii	I-T038
(	O
group	B-T098
3	I-T098
)	O
.	O
recognized	O
epitopes	B-T103
were	O
identified	O
with	O
mutated	B-T038
variants	B-T017
of	O
mog	B-T017
.	O
antibodies	B-T103
to	O
mog	B-T103
were	O
found	O
in	O
about	O
5	O
%	O
(	O
5	O
/	O
104	O
)	O
of	O
pres	O
##elected	O
adult	O
patients	O
with	O
ms	B-T038
.	O
in	O
contrast	O
,	O
in	O
groups	B-T098
2	I-T098
and	O
3	B-T098
,	O
none	O
of	O
the	O
patients	O
tested	O
positive	O
for	O
mog	B-T103
antibodies	B-T103
.	O
patients	O
with	O
ms	B-T038
with	O
antibodies	B-T103
to	O
mog	B-T103
predominantly	O
manifested	O
with	O
concomitant	O
severe	O
brainstem	B-T017
and	O
spinal	B-T017
cord	I-T017
involvement	O
and	O
had	O
a	O
severe	O
disease	B-T038
course	I-T038
with	O
high	O
relapse	O
rates	O
and	O
failure	B-T033
to	O
several	O
disease	B-T058
-	I-T058
modifying	I-T058
therapies	I-T058
.	O
three	O
of	O
them	O
had	O
been	O
treated	B-T058
with	I-T058
plasma	B-T058
exchange	I-T058
with	O
a	O
favorable	O
response	O
.	O
all	O
anti	B-T103
-	I-T103
mog	I-T103
-	O
positive	O
patients	O
with	O
ms	B-T038
showed	O
typical	O
ms	B-T038
lesions	B-T033
on	O
brain	B-T058
mri	I-T058
.	O
longitudinal	O
analysis	O
up	O
to	O
9	O
years	O
revealed	O
fluctuations	B-T033
and	O
reappear	O
##ance	O
of	O
anti	B-T038
-	I-T038
mog	I-T038
reactivity	I-T038
.	O
epitope	B-T058
mapping	I-T058
indicated	O
interindividual	O
heterogeneity	O
,	O
yet	O
intra	O
##individual	O
stability	O
of	O
the	O
antibody	B-T038
response	I-T038
.	O
antibodies	B-T103
to	O
mog	B-T103
can	O
be	O
found	O
in	O
a	O
distinct	O
subgroup	B-T170
of	O
adult	O
ms	B-T038
with	O
a	O
specific	O
clinical	O
phenotype	O
and	O
may	O
indicate	O
disease	B-T038
heterogeneity	O
.	O

evaluating	O
clinical	O
,	O
dietary	B-T168
and	O
psychological	O
risk	B-T033
factors	I-T033
for	O
relapse	O
of	O
ulcerative	B-T038
colitis	I-T038
in	O
clinical	O
,	O
endoscopic	B-T082
and	O
histological	O
remission	O
the	O
literature	O
on	O
possible	O
factors	O
that	O
could	O
trigger	O
a	O
relapse	O
in	O
patients	O
with	O
ulcerative	B-T038
colitis	I-T038
(	O
uc	B-T038
)	O
in	O
clinical	O
,	O
endoscopic	B-T082
and	O
histological	O
remission	O
on	O
long	O
term	O
follow	B-T058
up	I-T058
is	O
scarce	O
.	O
to	O
determine	O
the	O
relapse	O
rate	O
in	O
patients	O
with	O
uc	B-T038
in	O
clinical	O
,	O
endoscopic	B-T082
and	O
histological	O
remission	O
and	O
identify	O
factors	O
that	O
may	O
influence	O
the	O
risk	O
of	O
relapse	O
.	O
patients	O
with	O
uc	B-T038
in	O
clinical	O
,	O
endoscopic	B-T082
and	O
histological	O
remission	O
were	O
enrolled	O
between	O
january	O
-	O
july	O
2010	O
and	O
followed	B-T058
up	I-T058
for	O
1	O
year	O
to	O
determine	O
the	O
effect	O
of	O
clinical	O
,	O
dietary	B-T168
and	O
psychological	O
factors	B-T033
on	O
relapse	O
.	O
information	O
regarding	O
factors	O
that	O
may	O
affect	O
relapse	O
such	O
as	O
infection	B-T038
,	O
antibiotic	B-T103
or	O
nsaids	B-T103
use	O
and	O
any	O
other	O
factor	O
which	O
the	O
patient	O
felt	O
important	O
,	O
and	O
compliance	O
with	O
medications	B-T058
was	O
obtained	O
.	O
97	O
patients	O
(	O
59	O
males	B-T098
,	O
mean	O
age	O
39	O
+	O
11	O
.	O
9	O
years	O
)	O
were	O
followed	B-T058
up	I-T058
for	O
a	O
mean	O
duration	O
of	O
9	O
+	O
2	O
.	O
3	O
months	O
.	O
18	O
(	O
18	O
.	O
6	O
%	O
)	O
relapsed	O
with	O
the	O
median	O
time	O
to	O
relapse	O
being	O
3	O
.	O
5	O
months	O
.	O
on	O
univariate	O
analysis	O
more	O
relapse	O
##rs	O
had	O
significantly	O
higher	O
nsaids	B-T103
use	O
within	O
15	O
days	O
of	O
relapse	O
,	O
respiratory	B-T038
tract	I-T038
infection	I-T038
within	O
4	O
weeks	O
,	O
use	O
of	O
steroids	B-T103
more	O
than	O
once	O
in	O
past	O
,	O
higher	O
consumption	B-T038
of	O
calcium	B-T103
,	O
riboflavin	B-T103
,	O
vitamin	B-T103
a	I-T103
and	O
lower	O
consumption	B-T038
of	O
sugars	B-T103
.	O
on	O
multivariate	O
analysis	O
,	O
nsaids	B-T103
use	O
[	O
hr	O
(	O
95	O
%	O
ci	O
)	O
:	O
6	O
.	O
41	O
(	O
1	O
.	O
88	O
-	O
21	O
.	O
9	O
)	O
]	O
and	O
intake	O
of	O
vitamin	B-T103
a	I-T103
[	O
hr	O
(	O
95	O
%	O
ci	O
)	O
:	O
1	O
.	O
008	O
(	O
1	O
.	O
000	O
-	O
1	O
.	O
016	O
)	O
]	O
were	O
statistically	O
significant	O
predictors	O
of	O
relapse	O
.	O
with	O
a	O
relapse	O
rate	O
of	O
18	O
.	O
6	O
%	O
over	O
a	O
follow	B-T058
up	I-T058
of	O
9	O
months	O
in	O
patients	O
with	O
uc	B-T038
in	O
clinical	O
,	O
endoscopic	B-T082
and	O
histological	O
remission	O
,	O
independent	O
predictors	O
of	O
relapse	O
were	O
history	O
of	O
nsaids	B-T103
use	O
within	O
15	O
days	O
of	O
relapse	O
and	O
higher	O
intake	O
of	O
vitamin	B-T103
a	I-T103
.	O

patient	O
-	O
physician	B-T097
discordance	O
in	O
global	O
assessment	O
in	O
rheumatoid	B-T038
arthritis	I-T038
:	O
a	O
systematic	O
literature	B-T170
review	I-T170
with	O
meta	B-T062
-	I-T062
analysis	I-T062
the	O
integration	O
of	O
the	O
patient	O
in	O
therapeutic	O
decision	B-T038
-	I-T038
making	I-T038
is	O
important	O
in	O
the	O
management	B-T058
of	O
rheumatoid	B-T038
arthritis	I-T038
(	O
ra	B-T038
)	O
,	O
but	O
the	O
patient	O
opinion	O
regarding	O
disease	B-T038
status	O
may	O
differ	O
from	O
the	O
physician	B-T097
'	I-T097
s	I-T097
opinion	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
assess	O
in	O
the	O
published	B-T170
literature	I-T170
the	O
frequency	O
and	O
drivers	O
of	O
patient	O
-	O
physician	B-T097
discordance	O
in	O
global	O
assessment	O
in	O
ra	B-T038
.	O
a	O
systematic	O
literature	B-T170
review	I-T170
of	O
all	O
articles	B-T170
published	O
up	O
to	O
january	O
2015	O
in	O
medline	B-T170
or	O
embase	B-T170
,	O
reporting	O
discordance	O
in	O
ra	B-T038
,	O
was	O
conducted	O
by	O
2	O
investigators	B-T097
.	O
discordance	O
was	O
defined	O
based	O
on	O
the	O
absolute	O
difference	O
of	O
patient	B-T170
global	I-T170
(	O
pga	B-T170
)	O
and	O
physician	O
global	O
assessments	O
(	O
ph	O
##ga	O
)	O
on	O
0	O
-	O
10	O
-	O
cm	O
scales	O
.	O
the	O
frequency	O
of	O
discordance	O
and	O
its	O
predictors	B-T033
were	O
collected	O
in	O
each	O
study	B-T062
.	O
frequencies	O
of	O
discordance	O
were	O
pooled	O
by	O
meta	B-T062
-	I-T062
analysis	I-T062
using	O
random	O
effect	O
.	O
in	O
all	O
,	O
12	O
studies	B-T062
were	O
selected	O
(	O
i	O
.	O
e	O
.	O
,	O
11	O
,	O
87	O
##9	O
patients	O
)	O
:	O
weighted	O
mean	O
±	O
sd	O
age	O
was	O
55	O
.	O
1	O
±	O
13	O
.	O
9	O
years	O
,	O
weighted	O
mean	O
±	O
sd	O
disease	O
duration	O
was	O
10	O
.	O
4	O
±	O
9	O
.	O
3	O
years	O
,	O
and	O
80	O
.	O
7	O
%	O
were	O
women	B-T098
.	O
the	O
value	O
of	O
the	O
difference	O
|	O
pga	B-T170
-	O
ph	O
##ga	O
|	O
defining	O
discordance	O
varied	O
between	O
≥	O
##0	O
.	O
5	O
cm	O
(	O
n	O
=	O
2	O
studies	O
)	O
to	O
≥3	O
cm	O
(	O
n	O
=	O
5	O
studies	O
)	O
;	O
the	O
weighted	O
mean	O
value	O
was	O
2	O
.	O
7	O
cm	O
.	O
the	O
pooled	O
percentage	O
of	O
patients	O
with	O
discordance	O
was	O
43	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
36	O
%	O
-	O
51	O
%	O
;	O
range	O
25	O
%	O
-	O
76	O
%	O
)	O
.	O
pga	B-T170
was	O
usually	O
higher	O
than	O
ph	O
##ga	O
.	O
the	O
drivers	O
of	O
pga	B-T170
were	O
pain	B-T033
and	O
functional	O
incap	O
##aci	O
##ty	O
,	O
whereas	O
drivers	O
of	O
ph	O
##ga	O
were	O
joint	B-T170
counts	I-T170
and	O
acute	B-T103
-	I-T103
phase	I-T103
reactants	I-T103
.	O
discordance	O
in	O
global	O
assessment	O
was	O
most	O
frequently	O
defined	O
as	O
a	O
difference	O
of	O
3	O
points	O
or	O
more	O
;	O
even	O
with	O
such	O
a	O
stringent	O
definition	O
,	O
up	O
to	O
half	O
the	O
patients	O
were	O
found	O
to	O
be	O
discordant	O
.	O
the	O
long	O
-	O
term	O
consequences	O
of	O
this	O
discordance	O
remain	O
to	O
be	O
determined	O
.	O

group	B-T017
iii	I-T017
/	I-T017
iv	I-T017
muscle	I-T017
afferents	B-T017
limit	O
the	O
intramuscular	B-T082
metabolic	O
perturbation	O
during	O
whole	B-T017
body	I-T017
exercise	O
in	O
humans	B-T204
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
determine	B-T058
the	O
role	O
of	O
group	B-T017
iii	I-T017
/	I-T017
iv	I-T017
muscle	I-T017
afferents	B-T017
in	O
limiting	O
the	O
endurance	B-T033
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	B-T058
in	O
muscle	B-T017
biopsy	B-T017
samples	I-T017
taken	O
from	O
locomotor	B-T038
muscle	B-T017
.	O
lumbar	B-T082
intrathecal	B-T082
fentanyl	B-T103
was	O
used	O
to	O
attenuate	O
the	O
central	B-T082
projection	B-T082
of	O
μ	B-T103
-	I-T103
opioid	I-T103
receptor	I-T103
-	O
sensitive	O
locomotor	B-T038
muscle	B-T017
afferents	B-T017
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	B-T062
.	O
the	O
findings	B-T033
suggest	O
that	O
the	O
central	B-T082
projection	B-T082
of	O
group	B-T017
iii	I-T017
/	I-T017
iv	I-T017
muscle	I-T017
afferent	B-T017
feedback	B-T038
constr	O
##ains	O
voluntary	O
neural	O
'	O
drive	B-T038
'	O
to	O
working	O
locomotor	B-T038
muscle	B-T017
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	B-T082
metabolic	O
perturbation	O
.	O
therefore	O
,	O
the	O
cns	B-T022
might	O
regulate	B-T038
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	B-T038
muscle	B-T017
and	O
thereby	O
limit	O
peripheral	B-T082
fatigue	B-T033
.	O
it	O
appears	O
that	O
the	O
group	B-T017
iii	I-T017
/	I-T017
iv	I-T017
muscle	I-T017
afferents	B-T017
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	B-T038
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	B-T038
muscle	B-T017
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	B-T082
metabolic	O
disturbance	O
.	O
to	O
investigate	O
the	O
role	O
of	O
metab	B-T038
##o	I-T038
-	O
and	O
mechan	O
##osens	O
##itive	O
group	B-T017
iii	I-T017
/	I-T017
iv	I-T017
muscle	I-T017
afferents	B-T017
in	O
limiting	O
the	O
intramuscular	B-T082
metabolic	O
perturbation	O
during	O
whole	B-T017
body	I-T017
endurance	B-T033
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	B-T062
under	B-T033
control	I-T033
conditions	I-T033
(	O
ctr	B-T033
##l	I-T033
)	O
and	O
with	O
lumbar	B-T082
intrathecal	B-T082
fentanyl	B-T103
impairing	O
lower	B-T017
limb	I-T017
muscle	B-T017
afferent	B-T017
feedback	B-T038
(	O
fent	B-T038
)	O
.	O
vastus	B-T017
lateralis	I-T017
muscle	B-T017
biopsies	B-T017
were	O
obtained	O
before	O
and	O
immediately	O
after	O
exercise	O
.	O
motone	B-T017
##uronal	I-T017
output	B-T058
was	I-T058
estimated	I-T058
through	O
vastus	B-T017
lateralis	I-T017
surface	I-T017
electromyography	B-T058
(	O
emg	B-T058
)	O
.	O
exercise	O
-	O
induced	O
changes	O
in	O
intramuscular	B-T082
metabolites	B-T103
were	O
determine	B-T058
d	O
using	O
liquid	O
and	O
gas	B-T058
chromatography	I-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
.	O
quadriceps	B-T017
fatigue	B-T033
was	O
quantified	O
by	O
pre	O
-	O
to	O
post	O
-	O
exercise	O
changes	O
in	O
potentiated	O
quadriceps	O
twitch	O
torque	O
(	O
δ	O
##q	O
##ts	O
##ing	O
##le	O
)	O
evoked	O
by	O
electrical	O
femoral	B-T017
nerve	I-T017
stimulation	B-T058
.	O
although	O
motone	B-T017
##uronal	I-T017
output	O
was	O
21	O
±	O
12	O
%	O
higher	O
during	O
fent	B-T038
compared	O
to	O
ctr	B-T033
##l	I-T033
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
time	O
to	O
complete	O
the	O
time	O
trial	B-T062
was	O
similar	O
(	O
∼	O
##8	O
.	O
8	O
min	O
)	O
.	O
compared	O
to	O
ctr	B-T033
##l	I-T033
,	O
power	O
output	O
during	O
fent	B-T038
was	O
10	O
±	O
4	O
%	O
higher	O
in	O
the	O
first	O
half	O
of	O
the	O
time	O
trial	B-T062
,	O
but	O
11	O
±	O
5	O
%	O
lower	O
in	O
the	O
second	O
half	O
(	O
both	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
the	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	B-T082
inorganic	B-T103
phosphate	I-T103
,	O
h	B-T103
(	I-T103
+	I-T103
)	I-T103
,	O
adenosine	B-T103
diphosphate	I-T103
,	O
lactate	B-T103
and	O
phospho	B-T103
##cr	I-T103
##ea	I-T103
##tine	I-T103
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
greater	O
in	O
fent	B-T038
than	O
ctr	B-T033
##l	I-T033
.	O
δ	O
##q	O
##ts	O
##ing	O
##le	O
was	O
greater	O
following	O
fent	B-T038
than	O
ctr	B-T033
##l	I-T033
(	O
-	O
52	O
±	O
2	O
vs	O
-	O
31	O
±	O
1	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
this	O
difference	O
was	O
positively	B-T033
correlated	O
with	O
the	O
difference	O
in	O
inorganic	B-T103
phosphate	I-T103
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
79	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
h	O
(	O
+	O
)	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
92	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
in	O
conclusion	O
,	O
during	O
whole	B-T017
body	I-T017
exercise	O
,	O
group	B-T017
iii	I-T017
/	I-T017
iv	I-T017
muscle	I-T017
afferents	B-T017
provide	O
feedback	B-T038
to	O
the	O
cns	B-T022
which	O
,	O
in	O
turn	O
,	O
constr	O
##ains	O
motone	B-T017
##uronal	I-T017
output	O
to	O
the	O
active	O
skeletal	B-T017
muscle	I-T017
.	O
this	O
regulatory	B-T038
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	B-T082
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	B-T033
homeostatic	I-T033
challenge	B-T058
and	O
excessive	O
peripheral	B-T082
fatigue	B-T033
.	O

cognitive	B-T038
impairment	I-T038
in	O
first	O
-	O
episode	O
drug	O
-	O
naive	O
patients	O
with	O
schizophrenia	B-T038
:	O
relationships	O
with	O
serum	O
concentrations	O
of	O
brain	B-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
and	O
glial	B-T103
cell	I-T103
line	I-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
evidence	O
suggests	O
that	O
brain	B-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
(	O
bdnf	B-T103
)	O
and	O
glial	B-T103
cell	I-T103
line	I-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
(	O
gdnf	B-T103
)	O
are	O
important	O
in	O
the	O
regulation	B-T038
of	I-T038
synaptic	I-T038
plasticity	I-T038
,	O
which	O
plays	O
a	O
key	O
role	O
in	O
the	O
cognitive	O
processes	O
in	O
psychiatric	B-T038
disorders	I-T038
.	O
our	O
work	O
aimed	O
at	O
exploring	O
the	O
associations	O
between	O
serum	B-T031
bdnf	B-T103
and	O
gdnf	B-T103
levels	O
and	O
cognitive	B-T038
functions	I-T038
in	O
first	O
-	O
episode	O
drug	O
-	O
naive	O
(	O
fed	O
##n	O
)	O
patients	O
with	O
schizophrenia	B-T038
.	O
the	O
bdnf	B-T103
and	O
gdnf	B-T103
levels	O
of	O
58	O
fed	O
##n	O
patients	O
and	O
55	O
age	O
-	O
and	O
sex	O
-	O
matched	O
healthy	O
controls	O
were	O
measured	O
and	O
test	O
subjects	O
were	O
examined	O
using	O
several	O
neurocognitive	O
tests	O
including	O
the	O
verbal	B-T058
fluency	I-T058
test	I-T058
(	O
vf	B-T058
##t	I-T058
)	O
,	O
the	O
trail	B-T170
making	I-T170
test	I-T170
(	O
tmt	B-T170
)	O
,	O
the	O
digit	B-T170
span	I-T170
test	I-T170
(	O
dst	B-T170
)	O
,	O
and	O
the	O
stroop	B-T058
test	I-T058
.	O
patients	O
performed	O
significantly	O
worse	O
than	O
controls	O
in	O
nearly	O
all	O
neurocognitive	O
performances	O
except	O
the	O
forward	O
subscale	O
part	O
of	O
the	O
dst	B-T170
.	O
bdnf	B-T103
levels	O
were	O
inversely	O
correlated	O
to	O
tmt	O
-	O
part	O
b	O
scores	O
and	O
positively	O
correlated	O
to	O
vf	B-T058
##t	I-T058
-	I-T058
action	I-T058
in	O
the	O
fed	O
##n	O
group	O
.	O
gdnf	B-T103
levels	O
showed	O
a	O
positive	O
correlation	O
with	O
vf	O
##t	O
-	O
action	O
scores	O
and	O
a	O
negative	O
correlation	O
with	O
tmt	O
-	O
part	O
b	O
scores	O
of	O
these	O
patients	O
.	O
current	O
data	O
suggests	O
that	O
cognitive	B-T038
dysfunction	I-T038
widely	O
exists	O
in	O
the	O
early	O
stages	O
of	O
schizophrenia	B-T038
.	O
bdnf	B-T103
and	O
gdnf	B-T103
may	O
be	O
jointly	O
contributed	O
to	O
the	O
pathological	O
mechanisms	O
involved	O
in	O
cognitive	B-T038
impairment	I-T038
in	O
fed	O
##n	O
patients	O
with	O
schizophrenia	B-T038
.	O

dynamic	O
disorder	O
can	O
explain	O
non	O
-	O
exponential	O
kinetics	O
of	O
fast	O
protein	B-T038
mechanical	I-T038
unfolding	I-T038
protein	B-T038
unfolding	I-T038
often	O
does	O
not	O
ob	O
##ey	O
a	O
simple	O
two	O
-	O
state	O
behavior	O
.	O
previous	O
single	B-T058
molecule	I-T058
force	I-T058
spectroscopy	I-T058
studies	B-T058
demonstrated	O
stretched	O
exponential	O
kinetics	O
of	O
protein	B-T038
unfolding	I-T038
under	O
a	O
constant	O
pull	O
##ing	O
force	O
,	O
the	O
molecular	O
origin	O
of	O
which	O
remains	O
subject	O
to	O
debate	O
.	O
we	O
here	O
set	O
out	O
to	O
extensively	O
sample	O
the	O
mechanical	B-T038
unfolding	I-T038
of	O
ubiquitin	B-T103
and	O
nu	B-T103
##g2	I-T103
by	O
molecular	O
dynamics	O
(	O
md	O
)	O
simulations	O
.	O
both	O
proteins	B-T103
show	O
kinetics	O
best	O
fit	O
by	O
stretched	O
exponential	O
##s	O
,	O
with	O
stretching	O
exponent	O
##s	O
similar	O
to	O
those	O
found	O
in	O
experiments	B-T062
,	O
even	O
though	O
static	O
disorder	O
is	O
absent	O
in	O
our	O
short	O
md	O
simulations	O
.	O
instead	O
,	O
we	O
can	O
asc	O
##ri	O
##be	O
non	O
-	O
exponential	O
kinetics	O
to	O
dynamic	O
disorder	O
,	O
due	O
to	O
conformational	B-T082
fluctuations	O
on	O
the	O
nanos	O
##econd	O
times	O
##cale	O
.	O
our	O
study	B-T062
highlights	O
the	O
general	O
role	O
of	O
dynamic	O
disorder	O
in	O
protein	O
kinetics	O
on	O
a	O
broad	O
range	O
of	O
time	O
scales	O
even	O
including	O
those	O
probed	O
in	O
md	O
simulations	O
.	O

medication	B-T058
,	O
rehabilitation	O
and	O
health	O
care	O
consumption	O
in	O
adults	O
with	O
cerebral	B-T038
palsy	I-T038
:	O
a	O
population	B-T062
based	I-T062
study	I-T062
to	O
evaluate	O
medication	B-T058
,	O
rehabilitation	O
and	O
healthcare	O
consumption	O
in	O
adults	O
with	O
cp	B-T038
as	O
a	O
function	O
of	O
gross	B-T170
motor	I-T170
function	I-T170
classification	I-T170
system	I-T170
(	O
gm	B-T170
##fc	I-T170
##s	I-T170
)	O
level	O
.	O
questionnaire	B-T170
-	O
based	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
.	O
brit	B-T082
##tan	I-T082
##y	I-T082
,	O
a	O
french	B-T082
county	I-T082
.	O
adults	O
with	O
cerebral	B-T038
palsy	I-T038
.	O
questionnaires	B-T170
relating	O
to	O
drugs	B-T103
,	O
ortho	B-T074
##tic	I-T074
devices	I-T074
,	O
mobility	B-T074
aids	I-T074
,	O
rehabilitation	O
and	O
medical	B-T033
input	I-T033
were	O
sent	O
to	O
435	O
members	B-T098
of	O
a	O
unique	O
regional	B-T082
french	I-T082
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	B-T038
palsy	I-T038
.	O
the	O
questionnaire	B-T170
was	O
completed	O
by	O
the	O
participant	B-T098
or	O
a	O
helper	O
if	O
necessary	O
.	O
of	O
the	O
282	O
responders	B-T033
,	O
7	O
.	O
8	O
%	O
had	O
a	O
gm	B-T170
##fc	I-T170
##s	I-T170
level	I-T170
of	O
i	O
,	O
14	O
.	O
2	O
%	O
ii	O
,	O
17	O
.	O
7	O
%	O
iii	O
,	O
29	O
.	O
1	O
%	O
iv	O
and	O
31	O
.	O
2	O
%	O
v	O
.	O
participants	B-T098
consumed	O
a	O
large	O
amount	O
of	O
healthcare	O
.	O
almost	O
three	O
-	O
quarters	O
took	O
orally	B-T103
administered	I-T103
drugs	I-T103
,	O
of	O
which	O
antis	O
##pa	O
##st	O
##ic	O
and	O
antiepileptic	B-T103
drugs	I-T103
were	O
among	O
the	O
most	O
frequent	O
.	O
nearly	O
all	O
patients	O
had	O
at	O
least	O
one	O
type	O
of	O
rehabilitation	O
,	O
87	O
.	O
2	O
%	O
had	O
physiotherapy	B-T058
,	O
78	O
%	O
used	O
at	O
least	O
one	O
mobility	B-T074
aid	I-T074
and	O
69	O
.	O
5	O
%	O
used	O
at	O
least	O
one	O
ortho	B-T074
##tic	I-T074
device	I-T074
.	O
the	O
frequency	O
of	O
numerous	O
inputs	O
increased	O
with	O
gm	B-T170
##fc	I-T170
##s	I-T170
level	I-T170
.	O
specificities	O
were	O
found	B-T033
for	O
each	O
gm	B-T170
##fc	I-T170
##s	I-T170
level	I-T170
,	O
e	O
.	O
g	O
.	O
participants	B-T098
with	O
gm	B-T170
##fc	I-T170
##s	I-T170
level	I-T170
iv	O
and	O
v	O
had	O
a	O
high	O
level	O
of	O
medical	B-T033
input	I-T033
and	O
a	O
greater	O
use	O
of	O
trunk	B-T074
-	I-T074
supporting	I-T074
devices	I-T074
,	O
anti	B-T058
##ref	I-T058
##lux	I-T058
and	O
lax	B-T103
##ative	I-T103
.	O
profiles	O
could	O
be	O
established	O
based	O
on	O
gm	B-T170
##fc	I-T170
##s	I-T170
levels	I-T170
.	O
adults	O
with	O
cerebral	B-T038
palsy	I-T038
use	O
a	O
large	O
amount	O
of	O
drugs	B-T103
,	O
mobility	B-T074
aids	I-T074
,	O
ortho	B-T074
##tic	I-T074
devices	I-T074
,	O
rehabilitation	O
and	O
medical	B-T033
input	I-T033
.	O
healthcare	B-T058
is	O
targeted	O
at	O
cerebral	B-T033
palsy	I-T033
-	I-T033
related	I-T033
issues	I-T033
.	O
gm	B-T170
##fc	I-T170
##s	I-T170
is	O
a	O
determinant	O
of	O
healthcare	O
consumption	O
and	O
thus	O
a	O
useful	O
tool	O
for	O
clinical	O
practice	O
to	O
target	O
care	O
appropriately	O
.	O

mus	O
##eu	O
##m	O
specimen	O
data	O
reveal	O
emergence	O
of	O
a	O
plant	B-T038
disease	I-T038
may	O
be	O
linked	O
to	O
increases	O
in	O
the	O
insect	B-T098
vector	I-T098
population	I-T098
the	O
emergence	O
rate	O
of	O
new	O
plant	B-T038
diseases	I-T038
is	O
increasing	O
due	O
to	O
novel	O
introduction	O
##s	O
,	O
climate	O
change	O
,	O
and	O
changes	O
in	O
vector	B-T098
populations	I-T098
,	O
pos	O
##ing	O
risks	O
to	O
agricultural	O
sustainability	O
.	O
assessing	O
and	O
managing	O
future	O
disease	B-T038
risks	O
depends	O
on	O
understanding	O
the	O
causes	O
of	O
contemporary	O
and	O
historical	O
emergence	O
events	O
.	O
since	O
the	O
mid	O
-	O
1990s	O
,	O
potato	B-T097
grow	I-T097
##ers	I-T097
in	O
the	O
western	B-T082
united	I-T082
states	I-T082
,	O
mexico	B-T082
,	O
and	O
central	B-T082
america	I-T082
have	O
experienced	O
severe	O
yield	O
loss	O
from	O
zebr	B-T038
##a	I-T038
chip	I-T038
disease	I-T038
and	O
have	O
responded	O
by	O
increasing	O
insecticide	B-T103
use	O
to	O
suppress	O
populations	B-T098
of	O
the	O
insect	B-T204
vector	I-T204
,	O
the	O
potato	B-T204
ps	I-T204
##yll	I-T204
##id	I-T204
,	O
bacteri	B-T204
##cer	I-T204
##a	I-T204
cock	I-T204
##ere	I-T204
##ll	I-T204
##i	I-T204
(	O
hemip	B-T204
##tera	I-T204
:	O
tri	B-T204
##oz	I-T204
##idae	I-T204
)	O
.	O
despite	O
the	O
severe	O
nature	O
of	O
zebr	B-T038
##a	I-T038
chip	I-T038
outbreaks	O
,	O
the	O
causes	O
of	O
emergence	O
remain	O
unknown	O
.	O
we	O
tested	O
the	O
hypotheses	O
that	O
1	O
)	O
b	B-T204
.	I-T204
cock	I-T204
##ere	I-T204
##ll	I-T204
##i	I-T204
occupancy	O
has	O
increased	O
over	O
the	O
last	O
century	O
in	O
california	B-T082
and	O
2	O
)	O
such	O
increases	O
are	O
related	O
to	O
climate	O
change	O
,	O
specifically	O
warm	O
##er	O
winter	O
##s	O
.	O
we	O
compiled	O
a	O
dataset	B-T170
of	O
87	O
,	O
000	O
mus	O
##eu	O
##m	O
specimen	O
occurrence	O
records	B-T170
across	O
the	O
order	O
hemip	B-T204
##tera	I-T204
collected	O
between	O
190	O
##0	O
and	O
2014	O
.	O
we	O
then	O
analyzed	B-T062
changes	O
in	O
b	B-T204
.	I-T204
cock	I-T204
##ere	I-T204
##ll	I-T204
##i	I-T204
distribution	O
using	O
a	O
hierarchical	B-T170
occupancy	I-T170
model	I-T170
using	O
changes	O
in	O
background	O
species	B-T170
lists	I-T170
to	O
correct	O
for	O
collecting	O
effort	O
.	O
we	O
found	O
evidence	O
that	O
b	B-T204
.	I-T204
cock	I-T204
##ere	I-T204
##ll	I-T204
##i	I-T204
occupancy	O
has	O
increased	O
over	O
the	O
last	O
century	O
.	O
however	O
,	O
these	O
changes	O
appear	O
to	O
be	O
unrelated	O
to	O
climate	O
changes	O
,	O
at	O
least	O
at	O
the	O
scale	O
of	O
our	O
analysis	B-T062
.	O
to	O
the	O
extent	O
that	O
species	B-T170
occupancy	O
is	O
related	O
to	O
abundance	O
,	O
our	O
analysis	B-T062
provides	O
the	O
first	O
quantitative	O
support	O
for	O
the	O
hypothesis	O
that	O
b	B-T204
.	I-T204
cock	I-T204
##ere	I-T204
##ll	I-T204
##i	I-T204
population	B-T098
abundance	O
has	O
increased	O
,	O
but	O
further	O
work	O
is	O
needed	O
to	O
link	O
b	B-T204
.	I-T204
cock	I-T204
##ere	I-T204
##ll	I-T204
##i	I-T204
population	B-T098
dynamics	O
to	O
zebr	B-T038
##a	I-T038
chip	I-T038
epidemics	I-T038
.	O
finally	O
,	O
we	O
demonstrate	O
how	O
this	O
historical	B-T082
macro	I-T082
-	I-T082
ecological	I-T082
approach	I-T082
provides	O
a	O
general	O
framework	O
for	O
comparative	B-T058
risk	I-T058
assessment	I-T058
of	O
future	O
pest	B-T204
and	O
insect	B-T204
vector	I-T204
outbreaks	O
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

prednisolone	B-T103
is	O
associated	O
with	O
a	O
worse	B-T033
lipid	I-T033
profile	I-T033
than	O
hydrocortisone	B-T103
in	O
patients	O
with	O
adrenal	B-T038
insufficiency	I-T038
prednisolone	B-T103
is	O
used	O
as	O
glucocorticoid	B-T103
replacement	B-T058
therapy	I-T058
for	O
adrenal	B-T038
insufficiency	I-T038
(	O
ai	B-T038
)	O
.	O
recent	O
data	O
indicate	O
that	O
its	O
use	O
in	O
ai	B-T038
is	O
associated	O
with	O
low	O
bone	B-T201
mineral	I-T201
density	I-T201
.	O
data	O
on	O
risk	B-T033
factors	I-T033
for	O
cardiovascular	B-T038
disease	I-T038
in	O
patients	O
with	O
ai	B-T038
treated	O
with	O
prednisolone	B-T103
are	O
scarce	O
,	O
despite	O
this	O
condition	O
being	O
the	O
predominant	O
cause	B-T033
of	O
excess	O
mortality	O
.	O
we	O
aimed	O
to	O
address	O
this	O
question	O
using	O
real	O
-	O
world	O
data	O
from	O
the	O
european	B-T170
adrenal	I-T170
insufficiency	I-T170
registry	I-T170
(	O
eu	B-T170
-	I-T170
air	I-T170
)	O
.	O
eu	B-T170
-	I-T170
air	I-T170
,	O
comprising	O
of	O
19	O
centres	B-T092
across	O
germany	B-T082
,	O
the	O
netherlands	B-T082
,	O
sweden	B-T082
and	O
the	O
uk	B-T082
,	O
commenced	O
enroll	O
##ing	O
patients	O
with	O
ai	B-T038
in	O
august	O
2012	O
.	O
patients	O
receiving	O
prednisolone	B-T103
(	O
3	O
-	O
6	O
mg	O
/	O
day	O
,	O
n	O
=	O
50	O
)	O
or	O
hydrocortisone	B-T103
(	O
15	O
-	O
30	O
mg	O
/	O
day	O
,	O
n	O
=	O
90	O
##9	O
)	O
were	O
identified	O
and	O
grouped	B-T082
at	O
a	O
ratio	O
of	O
1	O
:	O
3	O
(	O
prednisolone	B-T103
:	O
hydrocortisone	B-T103
)	O
by	O
matching	O
for	O
gender	O
,	O
age	O
,	O
duration	O
and	O
type	B-T170
of	I-T170
disease	I-T170
.	O
data	O
from	O
baseline	O
and	O
follow	B-T058
-	I-T058
up	I-T058
visits	B-T058
were	O
analysed	O
.	O
data	O
from	O
patients	O
with	O
congenital	B-T038
adrenal	I-T038
hyperplasia	I-T038
were	O
excluded	O
.	O
significantly	O
higher	O
mean	O
±	O
s	O
.	O
d	O
.	O
total	O
(	O
6	O
.	O
3	O
±	O
1	O
.	O
6	O
vs	O
5	O
.	O
4	O
±	O
1	O
.	O
1	O
mmol	O
/	O
l	O
;	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
low	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
(	I-T103
ldl	B-T103
)	I-T103
cholesterol	I-T103
levels	O
(	O
3	O
.	O
9	O
±	O
1	O
.	O
4	O
vs	O
3	O
.	O
2	O
±	O
1	O
.	O
0	O
mmol	O
/	O
l	O
;	O
p	O
=	O
0	O
.	O
013	O
)	O
were	O
identified	O
in	O
47	O
patients	O
on	O
prednisolone	B-T103
vs	O
141	O
receiving	O
hydrocortisone	B-T103
at	O
baseline	O
and	O
at	O
follow	B-T058
-	I-T058
up	I-T058
(	O
p	O
=	O
0	O
.	O
005	O
and	O
p	O
=	O
0	O
.	O
006	O
,	O
respectively	O
)	O
.	O
hba1c	B-T103
,	O
high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
and	O
triglyceride	B-T033
levels	I-T033
,	O
body	B-T201
mass	I-T201
index	I-T201
,	O
systolic	B-T038
and	O
diastolic	B-T038
blood	I-T038
pressure	I-T038
and	O
waist	B-T201
circumference	I-T201
were	O
not	O
significantly	O
different	O
.	O
this	O
is	O
the	O
first	O
matched	O
analysis	B-T062
of	O
its	O
kind	O
.	O
significantly	O
higher	O
ldl	B-T033
levels	I-T033
in	O
patients	O
receiving	O
prednisolone	B-T103
relative	O
to	O
hydrocortisone	B-T103
could	O
predict	O
a	O
higher	O
relative	O
risk	O
of	O
cardiovascular	B-T038
disease	I-T038
in	O
the	O
former	O
group	O
.	O

the	O
cancer	B-T038
war	B-T038
##burg	I-T038
effect	I-T038
may	O
be	O
a	O
test	O
##able	O
example	O
of	O
the	O
minimum	O
entropy	O
production	O
rate	O
principle	O
cancer	B-T017
cells	I-T017
consume	O
more	O
glucose	B-T103
by	O
glycolytic	B-T038
fermentation	I-T038
to	O
lactate	B-T103
than	O
by	O
respiration	B-T038
,	O
a	O
characteristic	O
known	O
as	O
the	O
war	B-T038
##burg	I-T038
effect	I-T038
.	O
in	O
contrast	O
with	O
the	O
34	O
mole	O
##s	O
of	O
atp	B-T103
produced	O
by	O
respiration	B-T038
,	O
fermentation	B-T038
produces	O
two	O
mole	O
##s	O
of	O
atp	B-T103
per	O
mole	O
of	O
glucose	B-T103
consumed	O
,	O
which	O
poses	O
a	O
puzz	O
##le	O
on	O
the	O
function	O
of	O
the	O
war	B-T038
##burg	I-T038
effect	I-T038
.	O
production	O
##s	O
of	O
free	O
energy	O
(	O
δ	O
##g	O
)	O
,	O
enthalpy	O
(	O
δ	O
##h	O
)	O
and	O
entropy	O
(	O
δ	O
##s	O
)	O
per	O
mole	O
linearly	B-T082
vary	O
with	O
the	O
fraction	O
(	O
x	O
)	O
of	O
glucose	B-T103
consumed	O
by	O
fermentation	B-T038
that	O
is	O
frequently	O
estimated	O
around	O
0	O
.	O
9	O
.	O
hence	O
,	O
calculation	O
shows	O
that	O
,	O
in	O
respect	O
to	O
pure	O
respiration	B-T038
,	O
the	O
predominant	O
ferment	B-T038
##ative	I-T038
metabolism	B-T038
decreases	O
around	O
10	O
%	O
the	O
production	O
of	O
entropy	O
per	O
mole	O
of	O
glucose	B-T103
consumed	O
in	O
cancer	B-T017
cells	I-T017
.	O
we	O
hypothesize	O
that	O
increased	O
fermentation	B-T038
could	O
allow	O
cancer	B-T017
cells	I-T017
to	O
accomplish	O
the	O
pri	B-T170
##go	I-T170
##gin	I-T170
##e	I-T170
theore	I-T170
##m	I-T170
of	O
the	O
trend	O
to	O
minimize	O
the	O
rate	O
of	O
production	O
of	O
entropy	O
.	O
according	O
the	O
theore	B-T170
##m	I-T170
,	O
open	B-T017
cellular	I-T017
systems	I-T017
near	O
the	O
steady	O
state	O
could	O
evolve	O
to	O
minimize	O
the	O
rates	O
of	O
entropy	O
production	O
that	O
may	O
be	O
reached	O
by	O
modified	B-T033
replicating	O
cells	B-T017
producing	O
entropy	O
at	O
low	O
rate	O
.	O
remarkably	O
,	O
at	O
co2	B-T103
concentrations	O
above	O
93	O
##0	O
ppm	O
,	O
glucose	B-T103
respiration	B-T038
produces	O
less	O
entropy	O
than	O
fermentation	B-T038
,	O
which	O
suggests	O
experimental	O
tests	B-T058
to	O
validate	O
the	O
hypothesis	O
of	O
minimization	O
of	O
the	O
rate	O
of	O
entropy	O
production	O
through	O
the	O
war	B-T038
##burg	I-T038
effect	I-T038
.	O

reliability	O
of	O
fear	B-T058
assessment	I-T058
in	O
growing	O
pigs	B-T204
exposed	O
to	O
a	O
novel	O
object	O
test	O
in	O
commercial	B-T170
conditions	O
the	O
objective	B-T170
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
reliability	O
and	O
feasibility	B-T062
of	O
a	O
novel	O
object	O
test	O
assessing	O
fear	O
in	O
pigs	B-T204
in	O
commercial	B-T170
conditions	O
.	O
a	O
total	O
of	O
18	O
commercial	B-T170
farms	B-T082
were	O
visited	O
,	O
and	O
321	O
pen	O
##s	O
housing	O
4	O
,	O
220	O
growing	O
pigs	B-T204
were	O
assessed	O
.	O
three	O
balloon	O
##s	O
were	O
used	O
as	O
a	O
novel	B-T204
stimulus	O
.	O
measures	O
were	O
(	O
a	O
)	O
the	O
time	O
it	O
took	O
for	O
the	O
first	O
pig	B-T204
to	O
contact	O
1	O
of	O
the	O
balloon	O
##s	O
,	O
(	O
b	O
)	O
percentage	O
of	O
nonhuman	B-T204
animals	B-T204
wat	O
##ching	O
the	O
balloon	O
##s	O
each	O
for	O
10	O
s	O
,	O
and	O
(	O
c	O
)	O
percentage	O
of	O
animals	B-T204
touch	O
##ing	O
the	O
balloon	O
##s	O
during	O
periods	O
of	O
5	O
s	O
.	O
the	O
time	O
of	O
the	O
first	O
pig	B-T204
to	O
contact	O
1	O
of	O
the	O
balloon	O
##s	O
ranged	O
from	O
0	O
s	O
to	O
36	O
##2	O
s	O
.	O
an	O
effect	O
of	O
the	O
farm	B-T082
was	O
found	O
(	O
p	O
<	O
.	O
0001	O
)	O
for	O
contact	O
latency	O
,	O
ranging	O
from	O
6	O
.	O
8	O
s	O
to	O
73	O
.	O
3	O
s	O
,	O
but	O
little	O
difference	O
was	O
found	O
in	O
terms	O
of	O
intraf	B-T082
##arm	I-T082
variability	O
.	O
interobserver	O
repeatability	O
was	O
also	O
high	O
in	O
this	O
measure	O
,	O
ranging	O
from	O
r	O
=	O
.	O
74	O
to	O
r	O
=	O
.	O
96	O
.	O
as	O
a	O
result	O
,	O
it	O
is	O
concluded	O
that	O
contact	O
latency	O
could	O
be	O
a	O
good	O
measure	O
to	O
assess	O
fear	B-T038
of	O
a	O
novel	O
stimulus	O
in	O
commercial	B-T170
farms	B-T082
.	O

on	O
the	O
identity	O
of	O
the	O
pale	O
##arctic	O
species	B-T170
of	O
the	O
wol	B-T204
##f	I-T204
spider	I-T204
genus	B-T170
<	O
i	O
>	O
tre	B-T204
##ba	I-T204
##co	I-T204
##sa	I-T204
<	O
/	O
i	O
>	O
(	O
ara	B-T204
##nea	I-T204
##e	I-T204
:	O
ly	B-T204
##co	I-T204
##si	I-T204
##da	I-T204
##e	I-T204
)	O
in	O
this	O
paper	B-T170
we	O
propose	O
tre	B-T204
##ba	I-T204
##co	I-T204
##sa	I-T204
br	I-T204
##un	I-T204
##he	I-T204
##si	I-T204
vill	O
##epo	O
##ux	O
,	O
2007	O
as	O
a	O
junior	O
synonym	O
of	O
tre	B-T204
##ba	I-T204
##co	I-T204
##sa	I-T204
europ	I-T204
##aea	I-T204
sz	O
##ine	O
##ta	O
##r	O
&	O
kan	O
-	O
csa	O
##l	O
,	O
2007	O
based	O
on	O
the	O
examination	O
of	O
specimens	O
from	O
all	O
the	O
localities	B-T082
from	O
where	O
those	O
species	B-T170
are	O
known	O
.	O
illustr	O
##ation	O
of	O
the	O
type	O
species	B-T170
of	O
the	O
genus	B-T170
,	O
tre	B-T204
##ba	I-T204
##co	I-T204
##sa	I-T204
mar	I-T204
##x	I-T204
##i	I-T204
(	O
stone	O
,	O
189	O
##0	O
)	O
and	O
specimens	O
from	O
all	O
known	O
localities	B-T082
of	O
t	B-T204
.	I-T204
europ	I-T204
##aea	I-T204
are	O
given	O
to	O
show	O
both	O
the	O
inter	O
-	O
and	O
the	O
intraspecific	O
differences	O
of	O
the	O
genus	B-T170
.	O
scanning	B-T058
electron	I-T058
micrographs	I-T058
were	O
used	O
to	O
illustrate	O
the	O
detailed	O
structure	B-T082
of	O
the	O
female	B-T017
'	I-T017
s	I-T017
genitalia	I-T017
.	O

prevalence	O
of	O
hypothyroidism	B-T038
in	O
and	B-T082
##alu	I-T082
##si	I-T082
##a	I-T082
,	I-T082
spain	I-T082
,	I-T082
determined	O
by	O
thyroid	B-T103
hormone	I-T103
com	O
##s	O
##ump	O
##tion	O
hypothyroidism	B-T038
is	O
the	O
most	O
common	O
condition	O
linked	O
to	O
a	O
hormone	O
deficiency	O
,	O
nevertheless	O
data	O
on	O
its	O
prevalence	O
are	O
scarce	O
in	O
spain	B-T082
.	O
for	O
that	O
reason	O
,	O
we	O
have	O
estimated	O
its	O
prevalence	O
through	O
the	O
registration	B-T058
of	O
patients	O
who	O
had	O
used	O
thyroid	B-T103
hormones	I-T103
in	O
and	B-T082
##alu	I-T082
##si	I-T082
##a	I-T082
(	I-T082
south	I-T082
spain	I-T082
)	I-T082
.	O
data	O
of	O
patients	O
who	O
had	O
withdrawn	O
levo	B-T103
##thy	I-T103
##rox	I-T103
##ine	I-T103
under	O
the	O
public	O
system	O
during	O
2014	O
from	O
the	O
base	O
of	O
the	O
and	B-T058
##alu	I-T058
##si	I-T058
##an	I-T058
health	I-T058
service	I-T058
were	O
considered	O
.	O
prevalence	O
were	O
calculated	O
with	O
confidence	O
intervals	O
of	O
95	O
%	O
for	O
each	O
management	O
area	O
,	O
stratified	O
by	O
sex	O
and	O
age	O
groups	O
,	O
and	O
differences	O
between	O
them	O
were	O
evaluated	B-T058
.	O
321	O
,	O
36	O
##8	O
people	B-T098
(	O
98	O
%	O
older	O
than	O
18	O
years	O
and	O
83	O
%	O
female	O
)	O
were	O
identified	O
as	O
levo	B-T103
##thy	I-T103
##rox	I-T103
##ine	I-T103
users	O
and	O
a	O
prevalence	O
of	O
hypothyroidism	B-T038
of	O
3	O
.	O
95	O
%	O
(	O
95	O
%	O
ci	O
:	O
3	O
.	O
94	O
-	O
3	O
.	O
96	O
)	O
was	O
estimated	O
for	O
the	O
general	O
population	B-T098
.	O
the	O
condition	O
was	O
more	O
common	O
in	O
females	O
,	O
in	O
the	O
older	O
18	O
years	O
7	O
.	O
81	O
%	O
(	O
95	O
%	O
ci	O
:	O
7	O
.	O
80	O
to	O
7	O
.	O
82	O
)	O
compared	O
to	O
males	O
1	O
.	O
75	O
%	O
(	O
95	O
%	O
ci	O
:	O
1	O
.	O
73	O
-	O
1	O
.	O
77	O
)	O
with	O
a	O
ratio	O
of	O
4	O
.	O
5	O
-	O
fold	O
.	O
it	O
increases	O
in	O
the	O
population	B-T098
of	O
women	B-T098
older	O
than	O
45	O
years	O
,	O
10	O
.	O
32	O
%	O
(	O
95	O
%	O
ci	O
:	O
10	O
.	O
30	O
-	O
0	O
.	O
32	O
)	O
and	O
in	O
the	O
over	O
60	O
years	O
11	O
.	O
37	O
%	O
(	O
95	O
%	O
ci	O
:	O
11	O
.	O
35	O
-	O
11	O
.	O
40	O
)	O
.	O
the	O
prevalence	O
in	O
adult	O
women	B-T098
in	O
the	O
western	B-T082
provinces	I-T082
is	O
7	O
.	O
38	O
%	O
(	O
95	O
%	O
ci	O
:	O
7	O
.	O
36	O
-	O
7	O
.	O
40	O
)	O
,	O
in	O
the	O
eastern	B-T082
provinces	I-T082
8	O
.	O
59	O
%	O
(	O
95	O
%	O
ci	O
:	O
8	O
.	O
57	O
-	O
8	O
.	O
62	O
)	O
and	O
in	O
coastal	B-T082
areas	I-T082
6	O
.	O
70	O
%	O
(	O
95	O
%	O
ci	O
:	O
6	O
.	O
68	O
-	O
6	O
.	O
72	O
)	O
compared	O
to	O
the	O
mountain	B-T098
##ous	I-T098
ones	I-T098
,	O
which	O
is	O
8	O
.	O
91	O
%	O
(	O
95	O
%	O
ci	O
:	O
8	O
.	O
88	O
-	O
8	O
.	O
94	O
)	O
.	O
the	O
results	O
den	O
##ote	O
a	O
high	O
prevalence	O
of	O
hypothyroidism	B-T038
in	O
the	O
adult	O
population	B-T098
of	O
and	B-T082
##alu	I-T082
##si	I-T082
##a	I-T082
compared	O
to	O
the	O
nearby	O
countries	B-T082
,	O
with	O
a	O
clear	O
increased	O
associated	O
with	O
females	O
and	O
age	O
.	O
furthermore	O
,	O
the	O
prevalence	O
of	O
the	O
illness	B-T033
presents	O
also	O
a	O
geographically	O
-	O
related	O
variability	O
.	O

arsenic	O
trig	O
##lu	O
##ta	O
##thio	O
##ne	O
[	O
as	O
(	O
gs	O
)	O
3	O
]	O
transport	B-T038
by	O
multidrug	B-T103
resistance	I-T103
protein	I-T103
1	I-T103
(	O
mrp	B-T103
##1	I-T103
/	O
abc	B-T103
##c1	I-T103
)	O
is	O
selectively	O
modified	O
by	O
phosphorylation	B-T038
of	O
tyr	B-T082
##92	I-T082
##0	I-T082
/	I-T082
ser	I-T082
##92	I-T082
##1	I-T082
and	O
glycosylation	B-T038
of	O
asn	B-T082
##19	I-T082
/	I-T082
asn	I-T082
##23	I-T082
the	O
atp	B-T103
-	I-T103
binding	I-T103
cassette	I-T103
(	I-T103
abc	I-T103
)	I-T103
transporter	I-T103
multidrug	B-T103
resistance	I-T103
protein	I-T103
1	I-T103
(	O
mrp	B-T103
##1	I-T103
/	O
abc	B-T103
##c1	I-T103
)	O
is	O
responsible	O
for	O
the	O
cellular	B-T017
export	O
of	O
a	O
chemically	O
diverse	O
array	B-T082
of	O
xenobiotics	B-T103
and	O
endogenous	O
compounds	O
.	O
arsenic	B-T103
,	O
a	O
human	B-T204
carcinogen	B-T103
,	O
is	O
a	O
high	O
-	O
affinity	O
mrp	B-T103
##1	I-T103
substrate	O
as	O
arsenic	O
trig	O
##lu	O
##ta	O
##thio	O
##ne	O
[	O
as	O
(	O
gs	O
)	O
3	O
]	O
.	O
in	O
this	O
study	O
,	O
marked	O
differences	O
in	O
as	O
(	O
gs	O
)	O
3	O
transport	B-T038
kinetics	O
were	O
observed	O
between	O
mrp	B-T103
##1	I-T103
-	O
enriched	O
membrane	B-T017
vesicles	B-T017
prepared	O
from	O
human	B-T204
embryonic	B-T017
kidney	B-T017
293	B-T017
(	I-T017
hek	I-T017
)	I-T017
(	O
km	O
3	O
.	O
8	O
µm	O
and	O
vmax	O
307	O
pmol	O
/	O
mg	O
per	O
minute	O
)	O
and	O
hela	B-T017
(	O
km	O
0	O
.	O
32	O
µm	O
and	O
vmax	O
42	O
pmol	O
/	O
mg	O
per	O
minute	O
)	O
cells	B-T017
.	O
mutant	B-T103
mrp	B-T103
##1	I-T103
lacking	O
n	O
-	O
linked	O
glycosylation	B-T038
[	O
asn	B-T082
##19	I-T082
/	I-T082
23	I-T082
/	I-T082
100	I-T082
##6	I-T082
##gl	I-T082
##n	I-T082
;	O
sugar	O
-	O
free	O
(	B-T103
sf	I-T103
)	I-T103
-	I-T103
mrp	I-T103
##1	I-T103
]	O
expressed	B-T038
in	O
either	O
hek293	B-T017
or	O
hela	B-T017
cells	I-T017
had	O
low	O
km	O
and	O
vmax	O
values	O
for	O
as	O
(	O
gs	O
)	O
3	O
,	O
similar	O
to	O
hela	B-T017
wild	I-T017
-	I-T017
type	I-T017
(	O
wt	O
)	O
mrp	B-T103
##1	I-T103
.	O
when	O
prepared	O
in	O
the	O
presence	B-T033
of	O
phosphatase	B-T103
inhibitors	I-T103
,	O
both	O
wt	B-T103
-	I-T103
and	O
sf	B-T103
-	I-T103
mrp	I-T103
##1	I-T103
-	O
enriched	O
membrane	B-T017
vesicles	B-T017
had	O
a	O
high	O
km	O
value	O
for	O
as	O
(	O
gs	O
)	O
3	O
(	O
3	O
-	O
6	O
µm	O
)	O
,	O
regardless	O
of	O
the	O
cell	B-T017
line	I-T017
.	O
kinetic	B-T033
parameters	I-T033
of	O
as	O
(	O
gs	O
)	O
3	O
for	O
hek	B-T017
-	O
asn	B-T103
##19	I-T103
/	I-T103
23	I-T103
##gl	I-T103
##n	I-T103
-	I-T103
mrp	I-T103
##1	I-T103
were	O
similar	O
to	O
those	O
of	O
hela	B-T017
/	O
hek	B-T017
-	O
sf	B-T103
-	I-T103
mrp	I-T103
##1	I-T103
and	O
hela	B-T017
-	I-T017
wt	I-T017
-	O
mrp	B-T103
##1	I-T103
,	O
whereas	O
those	O
of	O
single	O
glycosylation	B-T038
mutants	B-T103
were	O
like	O
those	O
of	O
hek	B-T017
-	I-T017
wt	I-T017
-	O
mrp	O
##1	O
.	O
mutation	B-T038
of	O
19	O
potential	O
mrp	O
##1	O
phosphorylation	B-T038
sites	B-T082
revealed	O
that	O
hek	B-T017
-	O
tyr	B-T103
##92	I-T103
##0	I-T103
##ph	I-T103
##e	I-T103
/	I-T103
ser	I-T103
##92	I-T103
##1a	I-T103
##la	I-T103
-	I-T103
mrp	I-T103
##1	I-T103
transported	B-T038
as	O
(	O
gs	O
)	O
3	O
like	O
hela	B-T017
-	I-T017
wt	I-T017
-	O
mrp	B-T103
##1	I-T103
,	O
whereas	O
individual	O
hek	B-T017
-	O
tyr	B-T103
##92	I-T103
##0	I-T103
##ph	I-T103
##e	I-T103
-	I-T103
and	O
-	O
ser	B-T103
##92	I-T103
##1a	I-T103
##la	I-T103
-	I-T103
mrp	I-T103
##1	I-T103
mutants	B-T103
were	O
similar	O
to	O
hek	B-T017
-	I-T017
wt	I-T017
-	O
mrp	B-T103
##1	I-T103
.	O
together	O
,	O
these	O
results	O
suggest	O
that	O
asn	B-T082
##19	I-T082
/	I-T082
asn	I-T082
##23	I-T082
glycosylation	B-T038
and	O
tyr	B-T082
##92	I-T082
##0	I-T082
/	I-T082
ser	I-T082
##92	I-T082
##1	I-T082
phosphorylation	B-T038
are	O
responsible	O
for	O
altering	O
the	O
kinetics	O
of	O
mrp	B-T103
##1	I-T103
-	O
mediated	O
as	O
(	O
gs	O
)	O
3	O
transport	B-T038
.	O
the	O
kinetics	O
of	O
as	O
(	O
gs	O
)	O
3	O
transport	B-T038
by	O
hek	B-T017
-	O
asn	B-T082
##19	I-T082
/	I-T082
23	I-T082
##gl	I-T082
##n	I-T082
/	I-T082
tyr	I-T082
##92	I-T082
##0	I-T082
##gl	I-T082
##u	I-T082
/	I-T082
ser	I-T082
##92	I-T082
##1	I-T082
##gl	I-T082
##u	I-T082
were	O
similar	O
to	O
hek	B-T017
-	I-T017
wt	I-T017
-	O
mrp	B-T103
##1	I-T103
,	O
indicating	O
that	O
the	O
phosphorylation	B-T038
-	O
mimicking	O
substitutions	O
abrogated	O
the	O
influence	O
of	O
asn	B-T082
##19	I-T082
/	I-T082
23	I-T082
##gl	I-T082
##n	I-T082
glycosylation	B-T038
.	O
overall	O
,	O
these	O
data	O
suggest	O
that	O
cross	O
-	O
talk	O
between	O
mrp	B-T103
##1	I-T103
glycosylation	B-T038
and	O
phosphorylation	B-T038
occurs	O
and	O
that	O
phosphorylation	B-T038
of	O
tyr	B-T082
##92	I-T082
##0	I-T082
and	O
ser	B-T082
##92	I-T082
##1	I-T082
can	O
switch	O
mrp	B-T103
##1	I-T103
to	O
a	O
lower	O
-	O
affinity	O
,	O
higher	O
-	O
capacity	O
as	O
(	O
gs	O
)	O
3	O
transporter	B-T103
,	O
allowing	O
arsenic	B-T103
detoxification	B-T038
over	O
a	O
broad	B-T082
concentration	O
range	O
.	O

lack	O
of	O
antimicrobial	B-T033
efficacy	O
of	O
mec	B-T103
##etron	I-T103
##ium	I-T103
eti	I-T103
##ls	I-T103
##ulf	I-T103
##ate	I-T103
in	O
propanol	B-T103
-	O
based	O
hand	B-T103
rub	I-T103
##s	I-T103
for	O
surgical	B-T058
hand	B-T058
disinfection	I-T058
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
if	O
mec	B-T103
##etron	I-T103
##ium	I-T103
eti	I-T103
##ls	I-T103
##ulf	I-T103
##ate	I-T103
(	O
mes	B-T103
)	O
contributes	O
to	O
overall	O
efficacy	O
in	O
surgical	B-T058
hand	B-T058
disinfection	I-T058
.	O
three	O
blinded	O
hand	B-T103
rub	I-T103
##s	I-T103
(	O
45	O
%	O
iso	B-T103
-	I-T103
propanol	I-T103
,	O
30	O
%	O
n	B-T103
-	I-T103
propanol	I-T103
)	O
were	O
applied	O
for	O
1	O
.	O
5	O
min	O
and	O
compared	O
with	O
the	O
en	B-T103
127	I-T103
##91	I-T103
reference	O
procedure	O
(	O
crossover	B-T062
design	I-T062
)	O
.	O
one	O
commercial	B-T170
hand	B-T103
rub	I-T103
contained	O
0	O
.	O
2	O
%	O
mes	B-T103
,	O
and	O
the	O
two	O
other	O
hand	B-T103
rub	I-T103
##s	I-T103
were	O
identical	O
apart	O
from	O
0	O
.	O
2	O
%	O
mes	B-T103
.	O
none	O
of	O
the	O
formulations	O
had	O
a	O
log10	O
reduction	O
after	O
3	O
h	O
that	O
was	O
significantly	O
better	O
compared	O
with	O
the	O
reference	O
procedure	O
[	O
mean	O
1	O
.	O
72	O
(	O
standard	O
deviation	O
1	O
.	O
15	O
)	O
]	O
.	O
the	O
antimicrobial	B-T033
contribution	O
of	O
mes	B-T103
in	O
hand	B-T103
rub	I-T103
##s	I-T103
is	O
questionable	O
.	O

sh	O
##ining	O
the	O
light	O
on	O
the	O
dark	O
side	O
of	O
medical	O
leadership	O
-	O
a	O
qualitative	B-T062
study	I-T062
in	O
australia	B-T082
purpose	O
the	O
paper	O
aims	O
to	O
explore	O
the	O
beliefs	O
of	O
doctors	B-T097
in	O
leadership	O
roles	O
of	O
the	O
concept	O
of	O
[UNK]	O
the	O
dark	O
side	O
[UNK]	O
,	O
using	O
data	O
collected	O
from	O
interviews	O
carried	O
out	O
with	O
45	O
doctors	B-T097
in	O
medical	O
leadership	O
roles	O
across	O
australia	B-T082
.	O
the	O
paper	O
looks	O
at	O
the	O
beliefs	O
from	O
the	O
perspectives	O
of	O
doctors	B-T097
who	O
are	O
already	O
in	O
leadership	O
roles	O
themselves	O
;	O
to	O
identify	O
potential	O
barriers	O
they	O
might	O
have	O
encountered	O
and	O
to	O
arr	O
##ive	O
at	O
better	O
-	O
informed	O
strategies	O
to	O
engage	O
more	O
doctors	B-T097
in	O
the	O
leadership	O
of	O
the	O
australian	B-T098
health	O
system	O
.	O
the	O
research	B-T062
question	O
is	O
:	O
[UNK]	O
what	O
are	O
the	O
beliefs	O
of	O
medical	O
leaders	B-T097
that	O
form	O
the	O
key	O
themes	O
or	O
dimensions	O
of	O
the	O
negative	O
perception	O
of	O
the	O
'	O
dark	O
side	O
'	O
?	O
[UNK]	O
.	O
design	O
/	O
methodology	O
/	O
approach	O
the	O
paper	O
analysed	O
data	O
from	O
two	O
similar	O
qualitative	B-T062
studies	I-T062
examining	O
medical	O
leadership	O
and	O
engagement	O
in	O
australia	B-T082
by	O
the	O
same	O
author	O
,	O
in	O
collaboration	O
with	O
other	O
researchers	B-T097
,	O
which	O
used	O
in	O
-	O
depth	O
semi	O
-	O
structured	O
interviews	O
with	O
45	O
purpos	O
##ively	O
sampled	O
senior	O
medical	O
leaders	B-T097
in	O
leadership	O
roles	O
across	O
australia	B-T082
in	O
health	B-T058
services	I-T058
,	O
private	B-T092
and	O
public	B-T092
hospitals	I-T092
,	O
professional	O
associations	O
and	O
health	B-T092
departments	I-T092
.	O
the	O
data	O
were	O
analysed	O
using	O
ded	O
##uctive	O
and	O
inductive	O
approaches	B-T082
through	O
a	O
coding	O
framework	O
based	O
on	O
the	O
interview	O
data	O
and	O
literature	B-T170
review	I-T170
,	O
with	O
all	O
sections	O
of	O
coded	O
data	O
grouped	O
into	O
themes	O
.	O
findings	O
medical	O
leaders	B-T097
had	O
four	O
key	O
beliefs	O
about	O
the	O
[UNK]	O
dark	O
side	O
[UNK]	O
as	O
perceived	O
through	O
the	O
eyes	B-T017
of	O
their	O
own	O
past	O
clinical	O
experience	O
and	O
/	O
or	O
their	O
clinical	O
colleagues	O
.	O
these	O
four	O
beliefs	O
or	O
dimensions	O
of	O
the	O
negative	O
perception	O
coll	O
##o	O
##qu	O
##ially	O
known	O
as	O
[UNK]	O
the	O
dark	O
side	O
[UNK]	O
are	O
the	O
belief	O
that	O
they	O
lack	O
both	O
manager	O
##ial	O
and	O
clinical	O
cred	O
##ibility	O
,	O
they	O
have	O
confused	O
identities	O
,	O
they	O
may	O
be	O
in	O
conflict	O
with	O
clinicians	B-T097
,	O
their	O
clinical	O
colleagues	O
lack	O
insight	O
into	O
the	O
complexities	O
of	O
medical	O
leadership	O
and	O
,	O
as	O
a	O
result	O
,	O
doctors	B-T097
are	O
actively	O
discour	O
##aged	O
from	O
making	O
the	O
transition	O
from	O
clinical	O
practice	O
to	O
medical	O
leadership	O
roles	O
in	O
the	O
first	O
place	O
.	O
research	O
limitations	O
/	O
implications	O
this	O
research	B-T062
was	O
conducted	O
within	O
the	O
western	B-T082
developed	O
-	O
nation	O
setting	O
of	O
australia	B-T082
and	O
only	O
involved	O
interviews	O
with	O
doctors	B-T097
in	O
medical	O
leadership	O
roles	O
.	O
the	O
findings	O
are	O
therefore	O
limited	O
to	O
the	O
doctors	B-T097
'	O
own	O
perceptions	O
of	O
themselves	O
based	O
on	O
their	O
past	O
experiences	O
and	O
beliefs	O
.	O
future	O
research	B-T062
involving	O
doctors	B-T097
who	O
have	O
not	O
chosen	O
to	O
transition	O
to	O
leadership	O
roles	O
,	O
or	O
other	O
health	B-T097
practitioners	I-T097
in	O
other	O
settings	O
,	O
may	O
provide	O
a	O
broader	O
perspective	O
.	O
also	O
,	O
this	O
research	B-T062
was	O
exploratory	O
and	O
descriptive	B-T033
in	O
nature	O
using	O
qualitative	O
methods	O
,	O
and	O
quantitative	O
research	O
can	O
be	O
carried	O
out	O
in	O
the	O
future	O
to	O
extend	O
this	O
research	B-T062
for	O
statistical	O
general	O
##isation	O
.	O
practical	O
implications	O
the	O
paper	O
includes	O
implications	O
for	O
health	B-T092
organisations	I-T092
,	O
training	O
providers	O
,	O
medical	O
employers	B-T097
and	O
health	B-T092
departments	I-T092
and	O
describes	O
a	O
multi	O
-	O
pron	O
##g	O
strategy	O
to	O
address	O
this	O
important	O
issue	O
.	O
original	O
##ity	O
/	O
value	O
this	O
paper	O
fulf	O
##ils	O
an	O
identified	O
need	O
to	O
study	B-T062
the	O
concept	O
of	O
[UNK]	O
moving	O
to	O
the	O
dark	O
side	O
[UNK]	O
as	O
a	O
negative	O
perception	O
of	O
medical	O
leadership	O
and	O
contributes	O
to	O
the	O
evidence	O
in	O
this	O
under	O
-	O
researched	B-T062
area	O
.	O
this	O
paper	O
has	O
used	O
data	O
from	O
two	O
similar	O
studies	B-T062
,	O
combined	O
together	O
for	O
the	O
first	O
time	O
,	O
with	O
new	O
analysis	B-T062
and	O
coding	O
,	O
looking	O
at	O
the	O
concept	O
of	O
the	O
[UNK]	O
dark	O
side	O
[UNK]	O
to	O
discover	O
new	O
emergent	O
findings	O
.	O

spinal	B-T017
load	O
in	O
nurses	B-T097
during	O
emergency	O
lifting	O
of	O
obese	B-T038
patients	O
:	O
preliminary	O
results	O
nurses	B-T097
are	O
exposed	O
to	O
the	O
risk	O
of	O
injury	B-T037
while	O
handling	B-T033
patients	O
.	O
this	O
is	O
particularly	O
true	O
for	O
obese	B-T038
patients	O
.	O
the	O
goal	B-T170
of	O
this	O
paper	O
is	O
to	O
estimate	O
the	O
spinal	B-T017
loads	O
and	O
the	O
related	O
risk	O
of	O
injury	B-T037
to	O
nurses	B-T097
while	O
lifting	O
obese	B-T038
patients	O
from	O
the	O
floor	O
with	O
a	O
bariatric	B-T074
sheet	I-T074
during	O
a	O
hospital	B-T092
emergency	O
.	O
six	O
male	O
nurses	B-T097
participated	O
in	O
this	O
study	B-T062
.	O
the	O
biomechanical	B-T058
analysis	I-T058
focused	O
on	O
the	O
lifting	O
strategy	O
.	O
thirty	O
obese	B-T038
in	O
-	O
patients	O
were	O
enrolled	O
to	O
take	O
part	O
in	O
the	O
experimental	B-T062
study	I-T062
and	O
divided	O
into	O
three	O
groups	O
according	O
to	O
their	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
.	O
three	B-T058
-	I-T058
dimensional	I-T058
motion	I-T058
analysis	I-T058
was	O
conducted	O
using	O
an	O
optoelectronic	B-T074
system	I-T074
.	O
the	O
trunk	B-T082
kinematics	B-T091
and	O
the	O
loading	O
on	O
the	O
spines	B-T017
of	O
the	O
operating	O
nurses	B-T097
were	O
computed	B-T058
.	O
our	O
data	O
showed	O
that	O
when	O
the	O
nurse	B-T097
was	O
operating	O
from	O
the	O
central	O
handle	O
,	O
his	O
trunk	B-T082
was	O
more	O
flex	B-T038
##ed	I-T038
at	O
the	O
end	O
of	O
the	O
lift	O
with	O
a	O
reduced	O
range	B-T201
of	I-T201
motion	I-T201
.	O
the	O
values	O
were	O
higher	O
when	O
the	O
nurse	B-T097
lift	O
##ed	O
patients	O
with	O
higher	O
bmi	B-T201
##s	I-T201
.	O
all	O
kinetic	O
parameters	O
and	O
tension	B-T038
in	O
the	O
lumbar	B-T017
muscles	I-T017
at	O
the	O
end	O
of	O
the	O
movement	B-T038
were	O
characterised	O
by	O
lower	O
values	O
for	O
the	O
nurse	B-T097
placed	O
beside	O
the	O
patient	O
'	O
s	O
head	B-T082
or	O
feet	B-T017
if	O
compared	O
to	O
the	O
operator	O
positioned	O
beside	O
the	O
central	O
handle	O
in	O
all	O
patient	O
groups	O
.	O
our	O
preliminary	O
data	O
suggest	O
that	O
only	O
the	O
reaction	O
load	O
on	O
the	O
spine	B-T017
of	O
the	O
nurse	B-T097
holding	O
the	O
central	O
handle	O
,	O
closest	O
to	O
the	O
patient	O
'	O
s	O
centre	O
of	O
mass	O
,	O
seems	O
to	O
exceed	O
the	O
recommended	O
safety	O
limits	O
.	O

computational	O
analysis	O
of	O
conserved	B-T082
coil	I-T082
functional	O
residues	O
in	O
the	O
mitochondrial	O
genomic	O
sequences	O
of	O
dermat	B-T204
##ophytes	I-T204
dermat	B-T204
##ophyte	I-T204
is	O
a	O
group	O
of	O
closely	O
related	O
fungi	B-T204
that	O
have	O
the	O
capacity	O
to	O
invade	O
keratin	O
##ized	O
tissue	B-T017
of	O
humans	B-T204
and	O
other	O
animals	B-T204
.	O
the	O
infection	B-T038
known	O
as	O
dermat	B-T038
##ophyt	I-T038
##osis	I-T038
,	O
caused	O
by	O
members	O
of	O
the	O
genera	B-T170
microspor	B-T204
##um	I-T204
,	O
trich	B-T204
##ophyt	I-T204
##on	I-T204
,	O
and	O
epiderm	B-T204
##ophyt	I-T204
##on	I-T204
includes	O
infection	B-T038
to	O
the	O
groin	B-T082
(	O
tin	B-T038
##ea	I-T038
cr	I-T038
##ur	I-T038
##is	I-T038
)	O
,	O
bear	B-T017
##d	I-T017
(	O
tin	B-T038
##ea	I-T038
barb	I-T038
##ae	I-T038
)	O
,	O
scalp	B-T017
(	O
tin	B-T038
##ea	I-T038
cap	I-T038
##itis	I-T038
)	O
,	O
feet	B-T017
(	O
tin	B-T038
##ea	I-T038
ped	I-T038
##is	I-T038
)	O
,	O
glabr	B-T017
##ous	I-T017
skin	I-T017
(	O
tin	B-T038
##ea	I-T038
corpor	I-T038
##is	I-T038
)	O
,	O
nail	B-T017
(	O
tin	B-T038
##ea	I-T038
un	I-T038
##gu	I-T038
##ium	I-T038
)	O
,	O
and	O
hand	B-T017
(	O
tin	B-T038
##ea	I-T038
manu	I-T038
##um	I-T038
)	O
.	O
the	O
identification	O
of	O
evolutionary	B-T038
relationship	O
between	O
these	O
three	B-T170
genera	I-T170
of	O
dermat	B-T204
##ophyte	I-T204
is	O
epidemiological	O
##ly	O
important	O
to	O
understand	O
their	O
pathogenicity	O
.	O
mitochondrial	B-T103
dna	I-T103
evolve	B-T038
##s	I-T038
more	O
rapidly	O
than	O
a	O
nuclear	B-T103
dna	I-T103
due	O
to	O
higher	O
rate	O
of	O
mutation	O
but	O
is	O
very	O
less	O
affected	O
by	O
genetic	B-T038
recombination	I-T038
,	O
making	O
it	O
an	O
important	O
tool	O
for	O
phylogenetic	B-T062
studies	I-T062
.	O
thus	O
,	O
here	O
we	O
present	O
a	O
novel	O
scheme	O
to	O
identify	O
the	O
conserved	B-T082
coil	I-T082
functional	O
residues	O
of	O
trich	B-T204
##ophyt	I-T204
##on	I-T204
rub	I-T204
##rum	I-T204
,	O
trich	B-T204
##ophyt	I-T204
##on	I-T204
ment	I-T204
##agr	I-T204
##ophytes	I-T204
,	O
epiderm	B-T204
##ophyt	I-T204
##on	I-T204
flocc	I-T204
##osum	I-T204
and	O
microspor	B-T204
##um	I-T204
canis	I-T204
.	O
protein	B-T017
coding	I-T017
sequences	I-T017
of	O
the	O
mitochondrial	B-T017
genome	I-T017
were	O
aligned	O
for	O
their	O
similar	B-T082
sequences	I-T082
and	O
homology	B-T062
modelling	I-T062
was	O
performed	O
for	O
structure	B-T103
and	O
pocket	O
identification	B-T062
.	O
the	O
results	O
obtained	O
from	O
comparative	O
analysis	O
of	O
the	O
protein	B-T082
sequences	I-T082
revealed	O
the	O
presence	O
of	O
functionally	O
active	O
sites	O
in	O
all	O
the	O
species	O
of	O
the	O
genera	B-T170
trich	B-T204
##ophyt	I-T204
##on	I-T204
and	O
microspor	B-T204
##um	I-T204
.	O
however	O
in	O
epiderm	B-T204
##ophyt	I-T204
##on	I-T204
flocc	I-T204
##osum	I-T204
it	O
was	O
observed	O
in	O
three	O
protein	B-T082
sequences	I-T082
of	O
the	O
five	O
studied	O
.	O
the	O
absence	O
of	O
these	O
conserved	B-T082
coil	I-T082
functional	O
residues	O
in	O
e	B-T204
.	I-T204
flocc	I-T204
##us	I-T204
##um	I-T204
may	O
be	O
correlated	O
with	O
lesser	O
infectivity	O
of	O
this	O
organism	O
.	O
the	O
functional	O
residues	O
identified	O
in	O
the	O
present	O
study	O
could	O
be	O
responsible	O
for	O
the	O
disease	B-T038
and	O
thus	O
can	O
act	O
as	O
putative	O
target	O
sites	O
for	O
drug	O
designing	O
.	O

receipt	O
of	O
thyroid	B-T038
hormone	I-T038
deficiency	I-T038
treatment	B-T058
and	O
risk	O
of	O
herpes	B-T038
zoster	I-T038
thyroid	B-T103
hormone	I-T103
(	O
th	B-T103
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	B-T005
virus	I-T005
gene	B-T038
expression	I-T038
and	O
replication	B-T038
in	O
neurons	B-T017
via	O
epigenetic	B-T038
##s	I-T038
through	O
its	O
nuclear	B-T103
receptors	I-T103
.	O
it	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	B-T038
are	O
predisposed	O
to	O
herpes	B-T038
zoster	I-T038
(	O
hz	B-T038
)	O
,	O
suggesting	O
that	O
the	O
th	B-T038
deficiency	I-T038
may	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
varicella	B-T005
zoster	I-T005
virus	I-T005
(	O
vzv	B-T005
)	O
reactivation	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
test	O
the	O
hypothesis	O
that	O
th	B-T058
treatment	I-T058
will	O
ameliorate	O
the	O
complication	B-T038
of	O
hz	B-T038
.	O
this	O
study	B-T062
investigated	O
the	O
hypothesis	O
by	O
en	O
##qu	O
##iring	O
into	O
a	O
comprehensive	B-T170
medical	I-T170
database	I-T170
at	O
ka	B-T092
##iser	I-T092
permanent	I-T092
##e	I-T092
southern	I-T092
california	I-T092
(	O
kp	B-T092
##sc	I-T092
)	O
to	O
verify	O
whether	O
patients	O
taking	O
th	B-T103
medication	B-T058
experience	O
a	O
reduction	O
in	O
hz	B-T038
occurrence	O
.	O
it	O
was	O
shown	O
by	O
kaplan	O
-	O
meier	O
analysis	O
that	O
hypothyroidism	B-T038
patients	O
taking	O
th	B-T103
medicines	B-T103
had	O
a	O
lower	O
risk	O
of	O
hz	B-T038
.	O
the	O
fully	O
adjusted	O
analysis	B-T062
indicated	O
that	O
patients	O
receiving	O
medication	B-T058
for	O
the	O
treatment	B-T058
of	O
th	B-T038
deficiency	I-T038
exhibited	O
a	O
reduced	O
risk	O
of	O
hz	B-T038
(	O
hazard	O
ratio	O
0	O
.	O
60	O
,	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
51	O
-	O
0	O
.	O
71	O
)	O
.	O
this	O
lower	O
risk	O
of	O
hz	B-T038
was	O
significant	O
in	O
all	O
age	O
groups	O
except	O
the	O
18	O
-	O
39	O
years	O
cohort	B-T098
.	O
in	O
addition	O
,	O
female	O
patients	O
taking	O
th	B-T058
treatment	I-T058
exhibited	O
a	O
lower	O
risk	O
than	O
their	O
male	O
counterparts	O
.	O
together	O
these	O
findings	B-T033
support	O
the	O
hypothesis	O
that	O
a	O
constant	O
level	O
of	O
th	B-T103
will	O
provide	O
a	O
degree	O
of	O
protection	O
from	O
contracting	O
hz	B-T038
.	O
more	O
studies	B-T062
are	O
underway	O
to	O
evaluate	B-T058
the	I-T058
laboratory	I-T058
data	I-T058
for	O
an	O
analysis	B-T062
of	O
hormonal	O
effects	O
on	O
individuals	B-T098
.	O

heavy	B-T058
resistance	I-T058
training	I-T058
in	O
hypoxia	B-T038
enhances	O
1r	O
##m	O
squ	B-T033
##at	I-T033
performance	O
purpose	O
:	O
to	O
determine	O
if	O
heavy	B-T058
resistance	I-T058
training	I-T058
in	O
hypoxia	B-T038
(	O
ih	B-T058
##rt	I-T058
)	O
is	O
more	O
effective	O
at	O
improving	O
strength	O
,	O
power	B-T033
,	O
and	O
increasing	O
lean	B-T201
mass	I-T201
than	O
the	O
same	O
training	O
in	O
normoxia	O
.	O
methods	O
:	O
a	O
pair	O
-	O
matched	O
,	O
placebo	O
-	O
controlled	O
study	O
design	O
included	O
20	O
resistance	B-T058
-	I-T058
trained	I-T058
participants	B-T098
assigned	O
to	O
ih	B-T058
##rt	I-T058
(	O
fio2	B-T058
0	O
.	O
143	O
)	O
or	O
placebo	O
(	O
fio2	B-T058
0	O
.	O
20	O
)	O
,	O
(	O
n	O
=	O
10	O
per	O
group	O
)	O
.	O
participants	B-T098
were	O
matched	O
for	O
strength	O
and	O
training	B-T058
.	O
both	O
groups	O
performed	O
20	O
sessions	O
over	O
7	O
weeks	O
either	O
with	O
ih	B-T058
##rt	I-T058
or	O
placebo	O
.	O
all	O
participants	B-T098
were	O
tested	O
for	O
1r	O
##m	O
,	O
20	O
-	O
m	O
sprint	B-T058
,	O
body	O
composition	O
,	O
and	O
counter	O
##mo	O
##vement	O
jump	O
pre	O
-	O
,	O
mid	O
-	O
,	O
and	O
post	O
-	O
training	B-T058
and	O
compared	O
via	O
magnitude	O
-	O
based	O
inferences	B-T038
.	O
presentation	O
of	O
results	O
:	O
groups	O
were	O
not	O
clearly	O
different	O
for	O
any	O
test	O
at	O
baseline	O
.	O
training	B-T058
improved	B-T033
both	O
absolute	O
(	O
ih	B-T058
##rt	I-T058
:	O
13	O
.	O
1	O
±	O
3	O
.	O
9	O
%	O
,	O
effect	O
size	O
(	O
es	O
)	O
0	O
.	O
60	O
,	O
placebo	O
9	O
.	O
8	O
±	O
4	O
.	O
7	O
%	O
,	O
es	O
0	O
.	O
31	O
)	O
and	O
relative	O
1r	O
##m	O
(	O
ih	B-T058
##rt	I-T058
:	O
13	O
.	O
4	O
±	O
5	O
.	O
1	O
%	O
,	O
es	O
0	O
.	O
76	O
,	O
placebo	O
9	O
.	O
7	O
±	O
5	O
.	O
3	O
%	O
,	O
es	O
0	O
.	O
48	O
)	O
at	O
mid	O
.	O
similarly	O
,	O
at	O
post	O
both	O
groups	O
increased	O
absolute	O
(	O
ih	B-T058
##rt	I-T058
:	O
20	O
.	O
7	O
±	O
7	O
.	O
6	O
%	O
,	O
es	O
0	O
.	O
74	O
,	O
placebo	O
14	O
.	O
1	O
±	O
6	O
.	O
0	O
%	O
,	O
es	O
0	O
.	O
58	O
)	O
and	O
relative	O
1r	O
##m	O
(	O
ih	B-T058
##rt	I-T058
:	O
21	O
.	O
6	O
±	O
8	O
.	O
5	O
%	O
,	O
es	O
1	O
.	O
08	O
,	O
placebo	O
13	O
.	O
2	O
±	O
6	O
.	O
4	O
%	O
,	O
es	O
0	O
.	O
78	O
)	O
.	O
importantly	O
,	O
the	O
change	O
in	O
ih	B-T058
##rt	I-T058
was	O
greater	O
than	O
placebo	O
at	O
mid	O
for	O
both	O
absolute	O
[	O
4	O
.	O
4	O
%	O
greater	O
change	O
,	O
90	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
1	O
.	O
0	O
:	O
8	O
.	O
0	O
%	O
,	O
es	O
0	O
.	O
21	O
,	O
and	O
relative	O
strength	O
(	O
5	O
.	O
6	O
%	O
greater	O
change	O
,	O
90	O
%	O
ci	O
1	O
.	O
0	O
:	O
9	O
.	O
4	O
%	O
,	O
es	O
0	O
.	O
31	O
(	O
relative	O
)	O
]	O
.	O
there	O
was	O
also	O
a	O
greater	O
change	O
for	O
ih	B-T058
##rt	I-T058
at	O
post	O
for	O
both	O
absolute	O
(	O
7	O
.	O
0	O
%	O
greater	O
change	O
,	O
90	O
%	O
ci	O
1	O
.	O
3	O
:	O
13	O
%	O
,	O
es	O
0	O
.	O
33	O
)	O
,	O
and	O
relative	O
1r	O
##m	O
(	O
9	O
.	O
2	O
%	O
greater	O
change	O
,	O
90	O
%	O
ci	O
1	O
.	O
6	O
:	O
14	O
.	O
9	O
%	O
,	O
es	O
0	O
.	O
49	O
)	O
.	O
only	O
ih	B-T058
##rt	I-T058
increased	O
counter	O
##mo	O
##vement	O
jump	O
peak	O
power	B-T033
at	O
post	O
(	O
4	O
.	O
9	O
%	O
,	O
es	O
0	O
.	O
35	O
)	O
,	O
however	O
the	O
difference	O
between	O
ih	B-T058
##rt	I-T058
and	O
placebo	O
was	O
unclear	O
(	O
2	O
.	O
7	O
,	O
90	O
%	O
ci	O
-	O
2	O
.	O
0	O
:	O
7	O
.	O
6	O
%	O
,	O
es	O
0	O
.	O
20	O
)	O
with	O
no	O
clear	O
differences	O
in	O
speed	O
or	O
body	O
composition	O
throughout	O
.	O
conclusion	O
:	O
heavy	B-T058
resistance	I-T058
training	I-T058
in	O
hypoxia	B-T038
is	O
more	O
effective	O
than	O
placebo	O
for	O
improving	O
absolute	O
and	O
relative	O
strength	O
.	O

extract	B-T103
of	I-T103
cau	B-T204
##li	I-T204
##s	I-T204
spa	I-T204
##th	I-T204
##olo	I-T204
##bi	I-T204
,	O
a	O
novel	O
blocker	B-T103
targeting	O
tumor	B-T038
cell	I-T038
‑	I-T038
induced	I-T038
platelet	I-T038
aggregation	I-T038
,	O
inhibits	O
breast	B-T038
cancer	I-T038
metastasis	B-T038
metastasis	B-T038
of	O
breast	B-T038
cancer	I-T038
is	O
the	O
vital	O
step	O
for	O
malignant	B-T038
progression	I-T038
.	O
during	O
such	O
a	O
process	O
,	O
hemat	B-T038
##ogenous	I-T038
metastasis	I-T038
is	O
an	O
indispensable	O
approach	O
for	O
the	O
dissemination	O
of	O
cancer	B-T017
cells	I-T017
.	O
a	O
platelet	B-T017
,	O
contributes	O
to	O
hyper	B-T038
##coagul	I-T038
##able	I-T038
state	I-T038
,	O
and	O
is	O
also	O
identified	O
the	O
crucial	O
factor	O
in	O
the	O
coagulation	B-T038
system	O
for	O
supporting	O
metastasis	B-T038
.	O
therefore	O
,	O
the	O
relationship	O
of	O
a	O
platelet	B-T017
and	O
a	O
tumor	B-T017
cell	I-T017
plays	O
a	O
critical	O
role	O
in	O
tumor	B-T017
cell	I-T017
metastasis	B-T038
.	O
consequently	O
,	O
inhibiting	O
tumor	B-T038
cell	I-T038
‑	I-T038
induced	I-T038
platelet	I-T038
aggregation	I-T038
(	O
tc	B-T038
##ipa	I-T038
)	O
is	O
recon	O
##gn	O
##ized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	B-T038
of	O
tumor	B-T038
metastasis	I-T038
such	O
as	O
aspirin	B-T103
(	O
asa	B-T103
)	O
.	O
under	O
such	O
circumst	O
##ance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissoci	O
##ating	O
the	O
tumor	B-T017
‑	I-T017
platelet	I-T017
(	I-T017
t	I-T017
‑	I-T017
p	I-T017
)	I-T017
complex	I-T017
,	I-T017
80	O
%	O
ethanol	B-T103
extracts	B-T103
of	I-T103
cau	B-T204
##li	I-T204
##s	I-T204
spa	I-T204
##th	I-T204
##olo	I-T204
##bi	I-T204
(	O
set	B-T103
)	O
successfully	O
alleviated	O
the	O
hyper	B-T038
##coagul	I-T038
##ation	I-T038
state	I-T038
,	O
thereby	O
reducing	O
tumor	B-T038
metastasis	I-T038
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	B-T017
cancer	B-T017
cell	I-T017
model	O
.	O
through	O
mtt	B-T058
and	O
anti	B-T058
‑	I-T058
aggregation	I-T058
assay	I-T058
stimulated	I-T058
by	I-T058
adp	I-T058
,	O
we	O
detected	O
the	O
optimum	O
treatment	O
time	O
and	O
the	O
optimum	O
dose	O
of	O
set	B-T103
.	O
by	O
using	O
confocal	B-T058
microscopy	I-T058
,	O
we	O
observed	O
that	O
set	B-T103
can	O
strongly	O
block	O
the	O
formation	O
of	O
t	B-T017
‑	I-T017
p	I-T017
complex	I-T017
i	O
n	O
vitro	O
.	O
the	O
result	O
was	O
further	O
quantified	O
and	O
confirmed	O
by	O
the	O
facs	B-T058
analysis	I-T058
.	O
the	O
fluorescent	O
value	O
of	O
t	B-T017
‑	I-T017
p	I-T017
complex	I-T017
was	O
obviously	O
decreased	O
in	O
the	O
drug	O
‑	O
treated	O
groups	O
.	O
in	B-T082
vivo	I-T082
,	O
4	B-T017
##t1	I-T017
cells	I-T017
were	O
injected	B-T058
through	O
the	O
mouse	B-T204
tail	B-T017
vein	I-T017
for	O
dynamic	B-T058
visualization	I-T058
by	O
small	O
animal	O
imaging	O
system	O
.	O
the	O
metastatic	O
intensity	O
was	O
quantified	O
and	O
the	O
survival	O
curve	O
was	O
analyzed	B-T062
.	O
additionally	O
,	O
general	O
observation	O
and	O
hematoxylin	B-T058
and	I-T058
eosin	I-T058
(	I-T058
h	I-T058
&	I-T058
e	I-T058
)	I-T058
staining	I-T058
of	O
lung	B-T017
tissue	B-T017
was	O
performed	O
.	O
set	B-T103
exerted	O
an	O
obvious	O
effect	O
on	O
the	O
inhibition	O
of	O
metastasis	B-T038
and	O
increasing	O
the	O
survival	O
rate	O
of	O
mice	B-T204
.	O
for	O
the	O
molecular	B-T038
mechanism	I-T038
study	B-T062
of	O
anti	B-T058
‑	I-T058
tc	I-T058
##ipa	I-T058
,	O
zym	B-T062
##ography	I-T062
and	O
r	O
t	B-T062
‑	I-T062
pcr	I-T062
assay	I-T062
prelim	O
##inarily	O
revealed	O
the	O
molecular	B-T038
mechanism	I-T038
of	O
set	B-T103
in	O
the	O
regulation	O
of	O
p	O
‑	B-T038
t	I-T038
interaction	I-T038
.	O
collectively	O
,	O
through	O
drug	O
efficacy	O
identification	O
and	O
pharmacological	O
revealing	O
,	O
we	O
have	O
obtained	O
a	O
promising	O
candidate	O
for	O
the	O
interference	O
of	O
breast	B-T017
metastasis	B-T038
by	O
suppressing	O
tc	B-T038
##ipa	I-T038
,	O
which	O
will	O
be	O
beneficial	O
for	O
clinical	O
cancer	B-T058
treatment	I-T058
.	O

establishing	O
in	O
-	O
hospital	B-T092
geriatric	B-T092
##s	I-T092
services	I-T092
in	O
africa	B-T082
:	O
insights	O
from	O
the	O
university	B-T092
of	I-T092
ben	I-T092
##in	I-T092
teaching	I-T092
hospital	I-T092
geriatric	B-T091
##s	I-T091
project	O
unaware	O
##ness	O
of	O
the	O
peculiar	O
healthcare	B-T058
needs	O
of	O
the	O
elderly	B-T098
and	O
resource	O
constraints	O
may	O
be	O
some	O
reasons	O
why	O
until	O
recently	O
,	O
nigeria	B-T082
##n	I-T082
hospitals	B-T092
have	O
not	O
been	O
equipped	O
with	O
the	O
human	O
and	O
infras	O
##tructural	O
resources	O
required	O
to	O
meet	O
older	B-T098
adults	I-T098
'	O
special	O
healthcare	B-T058
needs	O
.	O
there	O
is	O
paucity	O
of	O
specialized	O
health	B-T092
services	I-T092
for	O
the	O
elderly	B-T098
in	O
africa	B-T082
.	O
nigeria	B-T082
,	O
with	O
a	O
population	B-T098
of	O
over	O
170	O
million	O
,	O
did	O
not	O
have	O
any	O
healthcare	B-T092
facility	I-T092
with	O
dedicated	O
services	B-T058
for	O
the	O
elderly	B-T098
until	O
2012	O
.	O
the	O
university	B-T092
of	I-T092
ben	I-T092
##in	I-T092
teaching	I-T092
hospital	I-T092
(	O
ub	B-T092
##th	I-T092
)	O
in	O
nigeria	B-T082
was	O
established	O
in	O
1973	O
and	O
created	O
its	O
geriatric	B-T091
##s	I-T091
unit	O
in	O
october	O
2013	O
.	O
a	O
prepared	O
environment	O
and	O
trained	B-T058
interdisciplinary	I-T058
teams	I-T058
are	O
pivotal	O
in	O
providing	O
effective	O
healthcare	B-T092
services	I-T092
for	O
the	O
elderly	B-T098
.	O
the	O
ongoing	O
ub	B-T092
##th	I-T092
geriatric	B-T091
##s	I-T091
project	O
aims	O
to	O
provide	O
specialized	O
interdisciplinary	O
health	B-T058
services	I-T058
to	O
older	B-T098
adults	I-T098
and	O
to	O
provide	O
training	O
and	O
continuing	O
professional	O
development	O
in	O
geriatric	B-T091
##s	I-T091
for	O
healthcare	B-T097
staff	I-T097
.	O
in	O
developing	O
our	O
inpatient	O
services	B-T058
,	O
we	O
adopted	O
the	O
acute	O
care	O
for	O
elders	O
(	O
ace	O
)	O
model	O
and	O
worked	O
in	O
tandem	O
with	O
the	O
[UNK]	O
abc	O
##s	O
[UNK]	O
of	O
implementing	O
ace	O
units	O
.	O
in	O
the	O
face	O
of	O
limited	O
resources	O
,	O
it	O
was	O
possible	O
to	O
establish	O
a	O
functional	O
geriatric	B-T091
##s	I-T091
unit	I-T091
with	O
a	O
trained	O
interdisciplinary	B-T058
team	I-T058
.	O
family	O
participation	O
is	O
central	O
in	O
our	O
practice	B-T091
.	O
since	O
october	O
2013	O
,	O
residents	B-T098
and	O
house	B-T097
officers	I-T097
in	O
internal	B-T103
medicine	I-T103
have	O
been	O
undertaking	O
4	O
-	O
and	O
12	O
-	O
weekly	O
rotations	O
,	O
respectively	O
.	O
there	O
is	O
also	O
a	O
robust	O
academic	O
program	O
,	O
which	O
includes	O
once	O
-	O
weekly	O
geriatric	O
pharmacotherapy	B-T058
semin	O
##ars	O
,	O
once	O
-	O
weekly	O
interdisciplinary	O
semin	O
##ars	O
,	O
and	O
2	O
-	O
weekly	O
journal	O
club	O
meetings	O
alternating	O
with	O
semin	O
##ars	O
on	O
geriatric	B-T170
assessment	I-T170
tools	I-T170
.	O
it	O
is	O
possible	O
to	O
establish	O
geriatric	B-T092
services	I-T092
and	O
achieve	O
best	O
practices	B-T091
in	O
resource	O
-	O
limited	O
settings	O
by	O
invest	O
##ing	O
on	O
improving	O
available	O
human	O
resources	O
and	O
infrastructure	B-T170
.	O
we	O
also	O
make	O
recommendations	O
for	O
setting	O
up	O
similar	O
services	B-T092
in	O
other	O
parts	O
of	O
africa	B-T082
.	O

relationship	O
between	O
lrr	B-T017
##k2	I-T017
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
and	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
in	O
asian	B-T098
populations	I-T098
although	O
the	O
leucine	B-T017
-	I-T017
rich	I-T017
repeat	I-T017
kinase	I-T017
2	I-T017
(	O
lrr	B-T017
##k2	I-T017
)	O
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
in	O
taiwan	B-T082
,	O
china	B-T082
,	O
and	O
singapore	B-T082
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O
thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta	B-T062
-	I-T062
analysis	I-T062
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
lrr	B-T017
##k2	I-T017
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
(	O
rs	B-T082
##33	I-T082
##94	I-T082
##93	I-T082
##90	I-T082
)	O
and	O
pd	B-T038
in	O
asian	B-T098
populations	I-T098
.	O
a	O
search	O
for	O
eligible	O
studies	B-T062
was	O
performed	O
in	O
pubmed	B-T170
,	O
embase	B-T170
,	O
sin	B-T170
##omed	I-T170
,	O
and	O
the	O
china	B-T170
knowledge	I-T170
resource	I-T170
integrated	I-T170
database	I-T170
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
and	O
pd	B-T038
.	O
this	O
meta	B-T062
-	I-T062
analysis	I-T062
assessed	O
19	O
studies	B-T062
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9	O
,	O
92	O
##7	O
pd	B-T038
patients	O
and	O
8	O
,	O
60	O
##2	O
controls	O
and	O
found	O
that	O
the	O
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
pd	B-T038
in	O
asian	B-T098
populations	I-T098
.	O
moreover	O
,	O
stratification	B-T062
analyses	I-T062
indicated	O
that	O
the	O
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
pd	B-T038
among	O
chinese	B-T098
as	O
well	O
as	O
non	B-T098
-	I-T098
chinese	I-T098
asian	I-T098
populations	I-T098
and	O
an	O
increased	O
risk	O
of	O
pd	B-T038
in	O
chinese	O
patients	O
from	O
china	B-T082
,	O
taiwan	B-T082
,	O
and	O
singapore	B-T082
.	O
in	O
a	O
stratified	B-T062
analysis	I-T062
conducted	O
according	O
to	O
age	O
,	O
significant	O
associations	O
were	O
found	O
for	O
both	O
late	O
-	O
onset	O
pd	B-T038
and	O
early	O
-	O
onset	O
pd	B-T038
.	O
the	O
present	O
data	O
indicate	O
that	O
the	O
r1	B-T082
##62	I-T082
##8	I-T082
##p	I-T082
polymorphism	I-T082
of	O
the	O
lrr	B-T017
##k2	I-T017
gene	I-T017
contributes	O
to	O
pd	B-T038
susceptibility	B-T201
in	O
asian	B-T098
,	O
especially	O
chinese	B-T098
,	O
populations	B-T098
.	O

beneficial	O
effects	O
of	O
phyll	B-T204
##anthus	I-T204
am	I-T204
##ar	I-T204
##us	I-T204
against	O
high	B-T168
fructose	I-T168
diet	I-T168
induced	O
insulin	B-T038
resistance	I-T038
and	O
hepatic	B-T038
oxidative	I-T038
stress	I-T038
in	O
male	O
wistar	B-T204
rats	I-T204
insulin	B-T038
resistance	I-T038
(	O
ir	B-T038
)	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	B-T038
,	O
type	B-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
,	O
and	O
cardiovascular	B-T038
diseases	I-T038
.	O
emerging	O
evidence	O
suggests	O
that	O
the	O
high	B-T103
-	I-T103
fructose	I-T103
consumption	B-T038
is	O
a	O
potential	O
and	O
important	O
factor	O
responsible	O
for	O
the	O
rising	O
incidence	O
of	O
ir	B-T038
.	O
the	O
present	O
study	B-T062
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
phyll	B-T204
##anthus	I-T204
am	I-T204
##ar	I-T204
##u	I-T204
s	O
(	O
paa	O
##e	O
)	O
on	O
ir	B-T038
and	O
oxidative	B-T038
stress	I-T038
in	O
high	B-T103
-	I-T103
fructose	I-T103
(	O
hf	B-T103
)	O
fed	O
male	O
wistar	B-T204
rats	I-T204
.	O
hf	B-T168
diet	I-T168
(	O
66	O
%	O
of	O
fructose	O
)	O
and	O
paa	O
##e	O
(	O
200	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
day	O
)	O
were	O
given	O
concurrently	O
to	O
the	O
rats	B-T204
for	O
a	O
period	O
of	O
60	O
days	O
.	O
fructose	O
-	O
fed	O
rats	B-T204
showed	O
weight	B-T033
gain	I-T033
,	O
hyperglycemia	B-T038
,	O
hyperinsulinemia	B-T038
,	O
impaired	B-T038
glucose	I-T038
tolerance	I-T038
,	O
impaired	B-T038
insulin	I-T038
sensitivity	I-T038
,	O
dyslipidemia	B-T038
,	O
hyper	B-T038
##le	I-T038
##pt	I-T038
##ine	I-T038
##mia	I-T038
,	O
and	O
hypo	B-T038
##adi	I-T038
##po	I-T038
##ne	I-T038
##ct	I-T038
##ine	I-T038
##mia	I-T038
(	O
p	O
<	O
0	O
.	O
05	O
)	O
after	O
60	O
days	O
.	O
co	B-T058
-	I-T058
administration	I-T058
of	O
paa	O
##e	O
along	O
with	O
hf	B-T168
diet	I-T168
significantly	O
ameliorated	O
all	O
these	O
alterations	O
.	O
regarding	O
hepatic	B-T082
antioxidant	B-T038
status	I-T038
,	O
higher	O
lipid	B-T038
peroxidation	I-T038
and	O
protein	B-T038
oxidation	I-T038
,	O
lower	O
reduced	B-T033
glutathione	I-T033
levels	O
and	O
lower	B-T038
activities	I-T038
of	O
enzymatic	B-T103
antioxidants	I-T103
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
promin	O
##ence	O
and	O
widening	O
of	O
the	O
liver	B-T017
sinus	I-T017
##oids	I-T017
observed	O
in	O
the	O
hf	B-T168
diet	I-T168
-	O
fed	O
rats	B-T204
were	O
significantly	O
prevented	O
by	O
paa	O
##e	O
treatment	B-T058
.	O
these	O
findings	O
indicate	O
that	O
paa	O
##e	O
is	O
beneficial	O
in	O
improving	O
insulin	B-T038
sensitivity	I-T038
and	O
attenuating	O
metabolic	B-T038
syndrome	I-T038
and	O
hepatic	B-T038
oxidative	I-T038
stress	I-T038
in	O
fructose	O
-	O
fed	O
rats	B-T204
.	O

association	O
of	O
fat	O
mass	O
and	O
obesity	B-T038
-	O
associated	O
gene	B-T017
variant	I-T017
with	O
lifestyle	O
factors	O
and	O
body	B-T201
fat	I-T201
in	O
indian	B-T098
children	O
common	O
intron	B-T017
##ic	I-T017
variants	I-T017
of	O
the	O
fat	O
mass	O
and	O
obesity	B-T038
-	O
associated	O
(	B-T017
ft	I-T017
##o	I-T017
)	I-T017
gene	I-T017
have	O
been	O
associated	O
with	O
obesity	B-T038
-	O
related	O
traits	O
in	O
humans	B-T204
.	O
(	O
1	O
)	O
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
study	B-T062
the	O
distribution	O
of	O
ft	B-T017
##o	I-T017
gene	I-T017
variants	B-T017
across	O
different	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
categories	O
and	O
(	O
2	O
)	O
to	O
explore	O
the	O
association	O
between	O
ft	B-T017
##o	I-T017
gene	I-T017
variants	B-T017
and	O
lifestyle	O
factors	O
in	O
obese	B-T038
and	O
normal	B-T033
weight	I-T033
indian	B-T098
children	O
.	O
fifty	O
-	O
six	O
children	O
(	O
26	O
boys	O
,	O
mean	O
age	O
10	O
.	O
3	O
±	O
2	O
.	O
2	O
years	O
)	O
were	O
studied	B-T062
.	O
height	O
,	O
weight	O
,	O
and	O
waist	B-T201
and	O
hip	B-T201
circumference	I-T201
were	O
measured	O
.	O
physical	O
activity	O
(	O
questionnaire	O
)	O
and	O
food	B-T168
intake	O
(	O
food	B-T170
frequency	I-T170
questionnaire	I-T170
)	O
were	O
assessed	O
.	O
body	O
fat	O
percentage	O
(	O
%	O
bf	O
)	O
was	O
measured	O
by	O
dual	B-T058
-	I-T058
energy	I-T058
x	I-T058
-	I-T058
ray	I-T058
absorptiometry	I-T058
.	O
ft	B-T017
##o	I-T017
allelic	I-T017
variants	I-T017
at	O
rs	B-T082
##99	I-T082
##39	I-T082
##60	I-T082
##9	I-T082
site	I-T082
were	O
detected	O
by	O
sy	B-T062
##br	I-T062
green	I-T062
amplification	I-T062
refractory	I-T062
mutation	I-T062
system	I-T062
real	I-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
using	O
allele	B-T017
-	O
specific	O
primers	B-T103
.	O
generalized	O
linear	O
model	O
was	O
used	O
to	O
investigate	O
the	O
simultaneous	O
influence	O
of	O
genetic	O
and	O
lifestyle	O
factors	O
on	O
%	O
bf	O
.	O
mean	O
height	O
,	O
weight	O
,	O
and	O
bmi	B-T201
of	O
normal	O
and	O
obese	B-T038
children	O
were	O
130	O
.	O
6	O
±	O
7	O
.	O
1	O
versus	O
143	O
.	O
2	O
±	O
15	O
.	O
6	O
,	O
24	O
.	O
0	O
±	O
5	O
.	O
2	O
versus	O
53	O
.	O
1	O
±	O
15	O
.	O
8	O
,	O
and	O
13	O
.	O
9	O
±	O
2	O
.	O
1	O
versus	O
25	O
.	O
3	O
±	O
3	O
.	O
2	O
,	O
respectively	O
.	O
the	O
frequency	O
of	O
aa	B-T017
allele	I-T017
was	O
57	O
%	O
among	O
obese	B-T038
children	O
and	O
35	O
%	O
in	O
normal	B-T033
weight	I-T033
children	O
.	O
children	O
with	O
the	O
aa	B-T017
allele	I-T017
who	O
were	O
obese	B-T038
had	O
least	O
physical	O
activity	O
,	O
whereas	O
children	O
with	O
at	B-T017
allele	I-T017
and	O
obesity	B-T038
had	O
the	O
highest	O
intake	O
of	O
calories	O
when	O
compared	O
to	O
children	O
who	O
had	O
at	B-T017
allele	I-T017
and	O
were	O
normal	O
.	O
%	O
bf	O
was	O
positively	O
associated	O
with	O
aa	B-T017
alleles	I-T017
and	O
jun	O
##k	O
food	O
intake	O
and	O
negatively	O
with	O
healthy	O
food	B-T168
intake	O
and	O
moderate	O
physical	O
activity	O
.	O
healthy	O
lifestyle	O
with	O
high	O
physical	O
activity	O
and	O
diet	B-T168
low	O
in	O
calories	O
and	O
fat	B-T103
may	O
help	O
in	O
modifying	O
the	O
risk	O
imposed	O
by	O
ft	B-T017
##o	I-T017
variants	I-T017
in	O
children	O
.	O

function	B-T038
and	O
clinical	O
meaningful	O
##ness	O
of	O
treatments	B-T058
for	O
mild	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
effectiveness	O
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
treatments	B-T058
is	O
commonly	O
evaluated	O
with	O
cop	O
##rim	O
##ary	O
outcomes	O
;	O
cognition	B-T038
with	O
function	B-T038
to	O
ensure	O
clinical	O
meaningful	O
##ness	O
of	O
a	O
cognitive	B-T038
effect	O
.	O
we	O
reviewed	O
the	O
literature	B-T170
for	O
functional	B-T038
outcomes	O
in	O
mild	O
ad	B-T038
or	O
mild	B-T038
cognitive	I-T038
impairment	I-T038
(	O
mci	B-T038
)	O
patients	O
(	O
distinct	O
from	O
combined	O
mild	O
-	O
moderate	O
/	O
severe	O
ad	B-T038
)	O
treated	B-T058
with	I-T058
approved	O
ad	B-T038
drugs	B-T103
.	O
cognitive	B-T058
and	O
functional	B-T038
treatment	B-T058
differences	O
in	O
mild	O
ad	B-T038
patients	O
in	O
sol	B-T103
##ane	I-T103
##z	I-T103
##umab	I-T103
exped	O
##ition	O
/	O
exped	O
##ition	O
##2	O
studies	B-T062
were	O
compared	O
across	O
time	O
.	O
seven	O
publications	B-T170
provided	O
mci	B-T038
/	O
mild	O
ad	B-T038
functional	B-T038
outcomes	O
,	O
one	O
of	O
which	O
reported	O
a	O
significant	O
functional	B-T038
treatment	B-T033
effect	I-T033
.	O
secondary	O
analyses	O
of	O
exped	O
##ition	O
studies	B-T062
suggested	O
a	O
smaller	O
functional	B-T038
effect	O
of	O
sol	B-T103
##ane	I-T103
##z	I-T103
##umab	I-T103
relative	O
to	O
cognition	B-T038
.	O
an	O
increasing	O
effect	O
of	O
sol	B-T103
##ane	I-T103
##z	I-T103
##umab	I-T103
over	O
18	O
months	O
was	O
shown	O
for	O
cognition	B-T038
and	O
function	B-T038
.	O
function	B-T038
as	O
the	O
sole	O
measure	O
to	O
demonstrate	O
clinical	O
meaningful	O
##ness	O
of	O
cognitive	B-T038
effects	O
in	O
mild	O
ad	B-T038
may	O
have	O
limitations	O
.	O
for	O
disease	B-T038
-	O
modifying	O
treatments	B-T058
,	O
point	O
differences	O
on	O
cognitive	B-T038
and	O
functional	B-T038
scales	B-T170
should	O
be	O
qualified	O
with	O
duration	O
of	O
treatment	O
.	O

a	O
case	O
of	O
retrograde	B-T017
intussusception	I-T017
at	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
anastomosis	I-T058
10	O
years	O
after	O
total	B-T058
gastrectomy	I-T058
:	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
a	O
63	O
-	O
year	O
-	O
old	O
man	O
,	O
who	O
had	O
undergone	O
total	B-T058
gastrectomy	I-T058
and	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
reconstruction	I-T058
for	O
gastric	B-T038
cancer	I-T038
10	O
years	O
previously	O
,	O
was	O
admitted	B-T058
to	O
our	O
hospital	B-T092
with	O
complaints	O
of	O
abdominal	B-T033
pain	I-T033
,	O
palpable	O
abdominal	B-T038
tumor	I-T038
,	O
and	O
hemat	B-T033
##emes	I-T033
##is	I-T033
.	O
on	B-T058
admission	I-T058
,	O
the	O
abdominal	B-T033
tenderness	I-T033
was	O
improving	O
and	O
no	O
abdominal	B-T038
tumor	I-T038
was	O
palpable	O
.	O
mild	B-T038
inflammatory	I-T038
changes	O
and	O
anemia	B-T038
were	O
noted	O
on	O
blood	O
examination	O
.	O
abdominal	B-T082
computed	B-T058
tomography	I-T058
revealed	O
a	O
tumor	B-T038
with	O
a	O
layered	O
structure	O
in	O
the	O
left	B-T082
abdomen	I-T082
.	O
the	O
patient	O
was	O
diagnosed	B-T033
with	O
intestinal	B-T038
obstruction	I-T038
secondary	O
to	O
intussusception	B-T038
,	O
and	O
surgery	B-T058
was	O
performed	O
.	O
retrograde	B-T017
intussusception	I-T017
was	O
found	O
at	O
the	O
site	O
of	O
the	O
y	B-T058
anastomosis	I-T058
.	O
we	O
conducted	O
manual	B-T058
reduction	I-T058
using	O
the	O
hut	B-T058
##ch	I-T058
##inson	I-T058
procedure	I-T058
.	O
the	O
intestinal	B-T017
color	O
after	O
the	O
reduction	B-T058
was	O
good	O
,	O
and	O
no	O
intestinal	B-T058
resection	I-T058
was	O
required	O
.	O
postoperative	B-T033
recovery	I-T033
was	O
uneventful	O
,	O
and	O
the	O
patient	O
was	O
discharged	B-T058
12	O
days	O
after	O
surgery	B-T058
.	O
reports	B-T170
of	O
jejunal	B-T017
intussusception	B-T038
after	O
total	B-T058
gastrectomy	I-T058
with	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
reconstruction	I-T058
are	O
relatively	O
rare	O
.	O
here	O
,	O
we	O
report	O
a	O
case	O
of	O
jejunal	B-T017
intussusception	B-T038
after	O
total	B-T058
gastrectomy	I-T058
with	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
reconstruction	I-T058
.	O

an	O
ultras	O
##ensitive	O
electrochem	B-T058
##ilum	I-T058
##inescence	I-T058
sensor	O
based	O
on	O
reduced	B-T103
graphene	I-T103
oxide	I-T103
-	O
copper	B-T103
sulfide	I-T103
composite	O
coupled	O
with	O
capillary	B-T058
electrophoresis	I-T058
for	O
determination	B-T058
of	O
amlodipine	B-T103
bes	I-T103
##ylate	I-T103
in	O
mice	B-T204
plasma	B-T031
a	O
new	O
electrochem	B-T058
##ilum	I-T058
##inescence	I-T058
(	O
ecl	B-T058
)	O
sensor	O
based	O
on	O
reduced	B-T103
graphene	I-T103
oxide	I-T103
-	O
copper	B-T103
sulfide	I-T103
(	O
rgo	B-T103
-	O
cus	B-T103
)	O
composite	O
coupled	O
with	O
capillary	B-T058
electrophoresis	I-T058
(	O
ce	B-T058
)	O
was	O
constructed	O
for	O
the	O
ultras	O
##ensitive	O
detection	B-T058
of	O
amlodipine	B-T103
bes	I-T103
##ylate	I-T103
(	O
aml	B-T103
)	O
for	O
the	O
first	O
time	O
.	O
in	O
this	O
work	O
,	O
rgo	B-T103
-	O
cus	B-T103
composite	O
was	O
synthesized	O
by	O
one	O
-	O
pot	O
hydrothermal	O
method	O
and	O
used	O
for	O
electrode	B-T074
modification	B-T033
.	O
the	O
electrochemical	B-T058
and	O
ecl	B-T058
behaviors	O
of	O
the	O
sensor	O
were	O
investigated	O
.	O
more	O
than	O
5	O
-	O
fold	O
enhance	O
in	O
ecl	B-T058
intensity	O
was	O
observed	O
after	O
modified	O
with	O
rgo	B-T103
-	O
cus	B-T103
composite	O
.	O
the	O
results	B-T033
can	O
be	O
ascribed	O
to	O
the	O
presence	O
of	O
rgo	B-T103
-	O
cus	B-T103
composite	O
on	O
the	O
electrode	B-T074
surface	B-T082
that	O
facilitates	O
the	O
electron	O
transfer	O
rate	O
between	O
the	O
electro	O
##active	O
center	B-T082
of	O
ru	B-T103
(	I-T103
bpy	I-T103
)	I-T103
3	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
and	O
the	O
electrode	B-T074
.	O
the	O
ecl	B-T058
sensor	O
was	O
coupled	O
with	O
ce	B-T058
to	O
improve	O
the	O
selectivity	O
and	O
the	O
ce	B-T058
-	O
ecl	B-T058
parameters	B-T033
that	O
affect	O
separation	O
and	O
detection	B-T058
were	O
optimized	O
.	O
under	O
the	O
optimum	O
conditions	O
,	O
the	O
linear	O
ranges	O
for	O
aml	B-T103
was	O
0	O
.	O
008	O
-	O
5	O
.	O
0	O
##μg	O
/	O
ml	O
with	O
a	O
detection	O
limit	O
of	O
2	O
.	O
8	O
##ng	O
/	O
ml	O
(	O
s	O
/	O
n	O
=	O
3	O
)	O
.	O
the	O
method	B-T058
displayed	O
the	O
advantages	O
of	O
high	O
sensitivity	O
,	O
good	O
selectivity	O
,	O
wide	O
linear	O
range	O
,	O
low	O
detection	O
limit	O
and	O
fine	O
reproducibility	O
,	O
and	O
was	O
used	O
to	O
analyze	O
aml	B-T103
in	O
mice	B-T204
plasma	B-T031
with	O
a	O
satisfactory	O
result	B-T033
,	O
which	O
holds	O
a	O
great	O
potential	O
in	O
the	O
field	O
of	O
pharmaceutical	B-T062
analysis	I-T062
.	O

tissue	B-T017
reservoirs	O
of	O
antiviral	B-T033
t	B-T038
cell	I-T038
immunity	I-T038
in	O
persistent	O
human	B-T204
cmv	B-T038
infection	I-T038
t	B-T017
cell	I-T017
responses	B-T038
to	O
viruses	B-T005
are	O
initiated	O
and	O
maintained	O
in	O
tissue	B-T017
sites	O
;	O
however	O
,	O
knowledge	O
of	O
human	B-T204
antiviral	B-T033
t	B-T017
cells	I-T017
is	O
largely	O
derived	O
from	O
blood	B-T031
.	O
cytomegalovirus	B-T005
(	O
cmv	B-T005
)	O
persists	O
in	O
most	O
humans	B-T204
,	O
requires	O
t	B-T038
cell	I-T038
immunity	I-T038
to	O
control	O
,	O
yet	O
tissue	B-T017
immune	B-T038
responses	I-T038
remain	O
undefined	O
.	O
here	O
,	O
we	O
investigated	O
human	B-T204
cmv	B-T005
-	O
specific	O
t	B-T017
cells	I-T017
,	O
virus	B-T005
persistence	O
and	O
cmv	B-T005
-	O
associated	O
t	B-T017
cell	I-T017
homeostasis	B-T038
in	O
blood	B-T031
,	O
lymphoid	B-T017
,	O
mucosa	B-T017
l	O
and	O
secretory	B-T017
tissues	I-T017
of	O
44	O
cmv	B-T005
seropositive	O
and	O
28	O
seronegative	B-T033
donors	B-T098
.	O
cmv	B-T005
-	O
specific	O
t	B-T017
cells	I-T017
were	O
maintained	O
in	O
distinct	O
distribution	B-T082
patterns	I-T082
,	O
highest	O
in	O
blood	B-T031
,	O
bone	B-T017
marrow	I-T017
(	O
bm	B-T017
)	O
,	O
or	O
lymph	B-T017
nodes	I-T017
(	O
ln	B-T017
)	O
,	O
with	O
the	O
frequency	O
and	O
function	O
in	O
blood	B-T031
distinct	O
from	O
tissues	B-T017
.	O
cmv	B-T005
genomes	B-T017
were	O
detected	B-T033
predominantly	O
in	O
lung	B-T017
and	O
also	O
in	O
spleen	B-T017
,	O
bm	B-T017
,	O
blood	B-T031
and	O
ln	B-T017
.	O
high	O
frequencies	O
of	O
activated	O
cmv	B-T005
-	O
specific	O
t	B-T017
cells	I-T017
were	O
found	O
in	O
blood	B-T031
and	O
bm	B-T017
samples	O
with	O
low	O
virus	B-T038
detection	I-T038
,	O
whereas	O
in	O
lung	B-T017
,	O
cmv	B-T005
-	O
specific	O
t	B-T017
cells	I-T017
were	O
present	O
along	O
with	O
detectable	O
virus	B-T005
.	O
in	O
lns	B-T017
,	O
cmv	B-T005
-	O
specific	O
t	B-T017
cells	I-T017
exhibited	O
quiescent	O
phenotypes	O
independent	O
of	O
virus	B-T005
.	O
overall	O
,	O
t	B-T017
cell	I-T017
differentiation	B-T038
was	O
enhanced	O
in	O
sites	O
of	O
viral	O
persistence	O
with	O
age	O
.	O
together	O
,	O
our	O
results	O
suggest	O
tissue	B-T017
t	B-T017
cell	I-T017
reservoirs	O
for	O
cmv	B-T005
control	B-T058
shaped	O
by	O
both	O
viral	O
and	O
tissue	B-T017
-	O
intrinsic	B-T103
factors	I-T103
,	O
with	O
global	O
effects	O
on	O
homeostasis	B-T038
of	O
tissue	B-T017
t	B-T017
cells	I-T017
over	O
the	O
lifespan	O
.	O

a	O
novel	O
assay	B-T058
to	O
measure	O
tertiary	O
and	O
quaternary	B-T103
amines	I-T103
in	O
wastewater	O
:	O
an	O
indicator	O
for	O
nd	B-T103
##ma	I-T103
wastewater	O
precursors	O
this	O
study	B-T058
examined	B-T033
the	O
potential	O
of	O
using	O
a	O
novel	O
bulk	B-T058
amine	I-T058
assay	I-T058
as	O
an	O
approximation	O
for	O
the	O
tertiary	O
and	O
quaternary	B-T103
amine	I-T103
load	O
in	O
wastewater	O
##s	O
and	O
surface	B-T082
water	B-T103
samples	I-T103
,	O
and	O
this	O
approximation	O
was	O
compared	O
to	O
n	B-T103
-	I-T103
nitroso	I-T103
##di	I-T103
##methyl	I-T103
##amine	I-T103
(	O
nd	B-T103
##ma	I-T103
)	O
formation	O
potential	O
using	O
chlor	B-T103
##amines	I-T103
.	O
an	O
existing	O
colorimetric	B-T058
method	I-T058
was	O
examined	B-T033
and	O
optimized	O
for	O
the	O
detection	B-T033
of	O
amines	B-T103
in	O
environmental	B-T082
water	B-T103
samples	I-T103
.	O
the	O
method	B-T058
consists	O
of	O
liquid	B-T058
-	I-T058
liquid	I-T058
extraction	I-T058
followed	O
by	O
a	O
catalyzed	O
reaction	O
to	O
form	O
a	O
yet	O
-	O
undefined	O
product	O
that	O
is	O
known	O
to	O
be	O
both	O
a	O
strong	O
chromophore	O
and	O
fluorophore	O
.	O
previous	O
work	O
verified	O
that	O
this	O
reaction	O
was	O
effectively	O
catalyzed	O
by	O
a	O
number	O
of	O
compounds	O
containing	O
tertiary	O
and	O
quaternary	B-T103
amine	I-T103
moieties	O
.	O
many	O
tertiary	O
and	O
quaternary	B-T103
compounds	I-T103
are	O
also	O
efficient	O
producers	O
of	O
nd	B-T103
##ma	I-T103
under	O
chlor	O
##amination	O
conditions	O
,	O
and	O
a	O
linear	O
correlation	O
was	O
consequently	O
derived	O
from	O
the	O
bulk	O
amine	O
signals	O
vs	O
.	O
nd	B-T103
##ma	I-T103
formation	O
potential	O
in	O
various	O
wastewater	O
samples	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
74	O
;	O
n	O
=	O
24	O
;	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
results	O
provide	O
evidence	O
that	O
approximately	O
2	O
%	O
of	O
the	O
tertiary	O
and	O
quaternary	O
amines	O
measured	O
can	O
form	O
nd	B-T103
##ma	I-T103
and	O
an	O
estimated	O
0	O
.	O
01	O
-	O
1	O
.	O
3	O
%	O
of	O
nitrogen	B-T103
in	O
dissolved	B-T103
organic	I-T103
nitrogen	I-T103
originates	I-T103
from	O
these	O
bulk	B-T103
amines	I-T103
.	O
the	O
normalization	B-T062
of	O
nd	B-T103
##ma	I-T103
concentration	O
by	O
the	O
amine	B-T103
measurement	O
revealed	O
that	O
ozone	B-T103
effectively	O
destroyed	O
those	O
tertiary	O
and	O
quaternary	B-T103
amine	I-T103
structures	B-T082
more	O
likely	O
to	O
form	O
nd	B-T103
##ma	I-T103
in	O
treated	O
wastewater	O
samples	O
.	O
this	O
bulk	B-T058
amine	I-T058
assay	I-T058
illustrates	O
that	O
proxy	O
measurements	O
of	O
tertiary	O
and	O
quaternary	B-T103
amines	I-T103
can	O
be	O
linked	O
to	O
the	O
nd	B-T103
##ma	I-T103
formation	O
potential	O
of	O
a	O
given	O
sample	O
,	O
and	O
this	O
approach	O
may	O
prove	O
useful	O
as	O
a	O
characterizing	O
tool	O
for	O
nd	B-T103
##ma	I-T103
precursors	O
in	O
wastewater	O
.	O

benefit	O
and	O
risk	B-T058
in	O
short	O
term	O
after	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
by	O
direct	B-T082
anterior	I-T082
approach	I-T082
combined	O
with	O
dual	B-T074
mobility	I-T074
cup	I-T074
no	O
previous	O
reports	O
have	O
described	O
the	O
benefits	O
and	O
risks	B-T058
associated	O
with	O
the	O
dual	B-T074
mobility	I-T074
cup	I-T074
(	O
dm	B-T074
##c	I-T074
)	O
in	O
primary	O
tha	B-T058
via	O
direct	B-T082
anterior	I-T082
approach	I-T082
(	O
da	B-T082
##a	I-T082
)	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
compare	O
the	O
safety	B-T062
and	O
rate	O
of	O
early	O
postoperative	B-T038
complication	I-T038
of	O
the	O
da	B-T082
##a	I-T082
with	O
the	O
dm	B-T074
##c	I-T074
for	O
tha	B-T058
with	O
those	O
of	O
the	O
da	B-T082
##a	I-T082
with	O
a	O
single	B-T074
standard	I-T074
cup	I-T074
,	O
and	O
to	O
investigate	O
the	O
influence	O
of	O
the	O
learning	O
curve	O
of	O
the	O
use	O
of	O
dm	B-T074
##c	I-T074
on	O
intra	O
-	O
and	O
perioperative	O
outcomes	O
.	O
we	O
retrospectively	O
investigated	O
60	O
hips	B-T017
treated	B-T058
in	O
the	O
single	O
-	O
da	B-T082
##a	I-T082
group	O
and	O
60	O
hips	B-T017
treated	B-T058
in	O
the	O
dual	O
-	O
da	B-T082
##a	I-T082
group	O
.	O
a	O
primary	O
/	O
secondary	O
outcome	O
variable	O
was	O
the	O
presence	O
of	O
any	O
intra	B-T038
-	O
or	O
perioperative	O
complication	B-T038
within	O
the	O
first	O
6	O
months	O
/	O
the	O
operative	O
time	O
and	O
hip	O
function	O
at	O
6	O
months	O
postoperatively	O
.	O
we	O
also	O
analyzed	O
influence	O
of	O
the	O
learning	O
curve	O
of	O
the	O
use	O
of	O
dm	B-T074
##c	I-T074
on	O
intra	O
-	O
and	O
perioperative	O
outcomes	O
.	O
no	B-T033
intraoperative	B-T038
complications	I-T038
were	O
observed	O
in	O
either	O
group	O
.	O
one	O
anterior	B-T037
dislocation	I-T037
and	O
one	O
perip	B-T037
##rosthetic	I-T037
hip	I-T037
fracture	I-T037
were	O
occurred	O
in	O
the	O
single	O
-	O
da	B-T082
##a	I-T082
group	O
.	O
the	O
surgical	O
times	O
in	O
the	O
single	O
-	O
da	B-T082
##a	I-T082
and	O
dual	O
-	O
da	B-T082
##a	I-T082
groups	O
were	O
112	O
.	O
0	O
±	O
20	O
.	O
9	O
and	O
121	O
.	O
0	O
±	O
26	O
.	O
9	O
min	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
6	O
-	O
month	O
postoperative	O
hip	O
function	O
scores	O
between	O
the	O
two	O
groups	O
.	O
there	O
was	O
no	O
influence	O
of	O
the	O
learning	O
curve	O
of	O
the	O
use	O
of	O
dm	B-T074
##c	I-T074
on	O
intra	O
-	O
and	O
perioperative	O
outcomes	O
.	O
we	O
have	O
demonstrated	O
the	O
short	O
-	O
term	O
safety	B-T062
and	O
lack	O
of	O
inferior	O
##ity	O
of	O
using	O
the	O
dm	B-T074
##c	I-T074
in	O
the	O
da	B-T082
##a	I-T082
compared	O
with	O
the	O
standard	B-T074
single	I-T074
mobility	I-T074
cup	I-T074
.	O

a	O
randomized	B-T062
trial	I-T062
of	O
plasma	B-T103
-	I-T103
ly	I-T103
##te	I-T103
a	I-T103
and	O
0	O
.	O
9	O
%	O
sodium	O
chloride	O
in	O
acute	B-T038
pediatric	I-T038
gastroenteritis	I-T038
compare	O
the	O
efficacy	O
and	O
safety	O
of	O
plasma	B-T103
-	I-T103
ly	I-T103
##te	I-T103
a	I-T103
(	O
pla	B-T103
)	O
versus	O
0	O
.	O
9	O
%	O
sodium	O
chloride	O
(	O
nacl	O
)	O
intravenous	B-T058
(	I-T058
iv	I-T058
)	I-T058
fluid	I-T058
replacement	I-T058
in	O
children	O
with	O
moderate	O
to	O
severe	B-T038
dehydration	I-T038
secondary	O
to	O
acute	B-T038
gastroenteritis	I-T038
(	O
age	B-T038
)	O
.	O
prospective	B-T062
,	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
study	I-T062
conducted	O
at	O
eight	O
pediatric	O
emergency	B-T092
departments	I-T092
(	O
eds	B-T092
)	O
in	O
the	O
us	B-T082
and	O
canada	B-T082
(	O
nct	O
#	O
012	O
##34	O
##88	O
##3	O
)	O
.	O
the	O
primary	O
outcome	O
measure	O
was	O
serum	B-T033
bicarbonate	I-T033
level	I-T033
at	O
4	O
h	O
.	O
secondary	O
outcomes	O
included	O
safety	O
and	O
tolerability	B-T062
.	O
the	O
hypothesis	O
was	O
that	O
pla	B-T103
would	O
be	O
superior	O
to	O
0	O
.	O
9	O
%	O
nacl	O
in	O
improvement	B-T058
of	I-T058
4	I-T058
-	I-T058
h	I-T058
bicarbonate	I-T058
.	O
patients	O
(	O
n	O
=	O
100	O
)	O
aged	O
≥	O
##6	O
months	O
to	O
<	O
11	O
years	O
with	O
age	B-T038
-	O
induced	O
moderate	O
-	O
to	O
-	O
severe	B-T038
dehydration	I-T038
were	O
enrolled	O
.	O
patients	O
with	O
a	O
baseline	O
bicarbonate	B-T033
level	I-T033
≤	O
##22	O
meq	O
/	O
l	O
formed	O
the	O
modified	O
intent	O
to	O
treat	O
(	O
mit	O
##t	O
)	O
group	B-T098
.	O
at	O
baseline	O
,	O
the	O
treatment	B-T058
groups	B-T098
were	O
comparable	O
except	O
that	O
the	O
pla	B-T103
group	B-T098
was	O
older	O
.	O
at	O
hour	O
4	O
,	O
the	O
pla	B-T103
group	B-T098
had	O
greater	O
increases	B-T033
in	I-T033
serum	I-T033
bicarbonate	I-T033
from	O
baseline	O
than	O
did	O
the	O
0	O
.	O
9	O
%	O
nacl	O
group	B-T098
(	O
mean	O
±	O
sd	O
at	O
4	O
h	O
:	O
18	O
±	O
3	O
.	O
74	O
vs	O
18	O
.	O
0	O
±	O
3	O
.	O
67	O
;	O
change	O
from	O
baseline	O
of	O
1	O
.	O
6	O
and	O
0	O
.	O
0	O
,	O
respectively	O
;	O
p	O
=	O
.	O
004	O
)	O
.	O
both	O
treatment	B-T058
groups	B-T098
received	O
similar	O
fluid	O
volumes	O
.	O
the	O
pla	B-T103
group	B-T098
had	O
less	O
abdominal	B-T033
pain	I-T033
and	O
better	O
dehydration	B-T038
scores	O
at	O
hour	O
2	O
(	O
both	O
p	O
=	O
.	O
03	O
)	O
but	O
not	O
at	O
hour	O
4	O
(	O
p	O
=	O
0	O
.	O
15	O
and	O
0	O
.	O
08	O
,	O
respectively	O
)	O
.	O
no	O
patient	O
experienced	O
clinically	O
relevant	O
worsening	O
of	O
laboratory	B-T033
findings	I-T033
or	O
physical	B-T058
examination	I-T058
,	O
and	O
hospital	O
admission	O
rates	O
were	O
similar	O
.	O
one	O
patient	O
in	O
each	O
treatment	B-T058
group	B-T098
developed	O
hyponatremia	B-T038
.	O
four	O
patients	O
developed	O
hyperkal	B-T033
##emia	I-T033
(	O
pla	B-T103
:	O
1	O
,	O
0	O
.	O
9	O
%	O
nacl	O
:	O
3	O
)	O
.	O
in	O
comparison	O
with	O
0	O
.	O
9	O
%	O
nacl	O
,	O
pla	B-T103
for	O
rehydration	B-T058
in	O
children	O
with	O
age	B-T038
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	B-T058
in	I-T058
serum	I-T058
bicarbonate	I-T058
and	O
dehydration	B-T038
score	O
.	O
nct	O
#	O
012	O
##34	O
##88	O
##3	O
(	O
registration	O
date	O
:	O
november	O
3	O
,	O
2010	O
)	O
.	O

child	B-T033
death	I-T033
and	O
maternal	B-T033
psychosis	B-T038
-	I-T038
like	I-T038
experiences	I-T038
in	O
44	O
low	B-T098
-	I-T098
and	O
middle	O
-	O
income	O
countries	B-T082
:	O
the	O
role	O
of	O
depression	B-T038
studies	O
on	O
the	O
effect	O
of	O
child	B-T033
death	I-T033
on	O
the	O
mental	B-T038
wellbeing	I-T038
of	O
women	B-T098
in	O
low	B-T098
-	I-T098
and	O
middle	O
-	O
income	O
countries	B-T082
(	O
lm	B-T082
##ics	I-T082
)	O
are	O
scarce	O
despite	O
the	O
high	O
child	O
mortality	O
rates	O
.	O
thus	O
,	O
the	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
assess	O
the	O
association	O
between	O
child	B-T033
death	I-T033
and	O
psychosis	B-T038
-	I-T038
like	I-T038
experiences	I-T038
(	O
ple	B-T038
##s	I-T038
)	O
,	O
as	O
well	O
as	O
the	O
role	O
of	O
depression	B-T038
in	O
this	O
association	O
.	O
data	O
from	O
44	O
lm	B-T082
##ics	I-T082
which	O
participated	O
in	O
the	O
world	B-T062
health	I-T062
survey	I-T062
(	O
wh	B-T062
##s	I-T062
)	O
were	O
analyzed	O
.	O
a	O
total	O
of	O
59	O
,	O
44	O
##4	O
women	B-T098
who	O
ever	O
gave	O
birth	B-T038
,	O
aged	O
18	O
-	O
49	O
years	O
,	O
without	O
a	O
self	B-T062
-	I-T062
reported	I-T062
lifetime	O
psychosis	O
diagnosis	O
,	O
were	O
included	O
in	O
the	O
analysis	O
.	O
the	O
world	O
mental	O
health	O
survey	O
version	O
of	O
the	O
composite	B-T170
international	I-T170
diagnostic	I-T170
interview	I-T170
(	O
cid	B-T170
##i	I-T170
)	O
was	O
used	O
to	O
establish	O
the	O
diagnosis	B-T062
of	O
past	O
12	O
-	O
month	O
dsm	B-T170
-	I-T170
iv	I-T170
depression	B-T038
,	O
and	O
assess	O
four	O
positive	B-T033
psychotic	I-T033
symptoms	I-T033
.	O
depression	B-T038
was	O
defined	O
as	O
self	B-T062
-	I-T062
reported	I-T062
lifetime	O
depression	O
diagnosis	O
and	O
/	O
or	O
past	O
12	O
-	O
month	O
depression	B-T038
.	O
multivariable	O
logistic	O
regression	O
analyses	O
were	O
performed	O
.	O
after	O
adjustment	O
for	O
potential	O
confounders	O
,	O
women	B-T098
who	O
experienced	O
child	B-T033
death	I-T033
had	O
higher	O
odds	O
for	O
all	O
types	O
of	O
ple	B-T038
##s	I-T038
(	O
when	O
unadjusted	O
for	O
depression	B-T038
)	O
(	O
or	O
1	O
.	O
20	O
-	O
1	O
.	O
71	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
depression	B-T038
(	O
or	O
=	O
1	O
.	O
64	O
;	O
95	O
%	O
ci	O
=	O
1	O
.	O
39	O
-	O
1	O
.	O
93	O
)	O
.	O
when	O
adjusted	O
for	O
depression	B-T038
,	O
only	O
del	B-T038
##usion	I-T038
of	I-T038
control	I-T038
was	O
strongly	O
associated	O
with	O
child	B-T033
death	I-T033
(	O
or	O
=	O
1	O
.	O
54	O
;	O
95	O
%	O
ci	O
=	O
1	O
.	O
20	O
-	O
1	O
.	O
97	O
)	O
.	O
child	B-T033
death	I-T033
may	O
be	O
an	O
important	O
determinant	O
of	O
mental	B-T038
wellbeing	I-T038
among	O
women	B-T098
in	O
lm	B-T082
##ics	I-T082
.	O
given	O
the	O
known	O
adverse	O
health	O
outcomes	O
associated	O
with	O
ple	B-T038
##s	I-T038
and	O
depression	B-T038
,	O
as	O
well	O
as	O
the	O
co	O
-	O
occurrence	O
of	O
these	O
symptoms	B-T033
,	O
mental	B-T058
health	I-T058
care	I-T058
may	O
be	O
particularly	O
important	O
for	O
mothers	O
who	O
have	O
experienced	O
child	O
loss	O
in	O
lm	B-T082
##ics	I-T082
.	O

a	O
new	O
angle	B-T082
and	O
its	O
relationship	O
with	O
early	O
fixation	B-T038
failure	I-T038
of	O
femoral	B-T037
neck	I-T037
fractures	I-T037
treated	O
with	O
three	O
cannulated	B-T074
compression	I-T074
screws	I-T074
the	O
pa	O
##u	O
##we	O
##ls	O
angle	O
has	O
been	O
used	O
widely	O
,	O
however	O
an	O
accurate	O
evaluation	O
of	O
this	O
angle	B-T082
is	O
difficult	O
because	O
of	O
deformity	B-T017
of	O
the	O
affected	O
lower	B-T017
extremity	I-T017
.	O
therefore	O
we	O
designed	O
a	O
new	O
measurement	O
of	O
the	O
orientation	B-T082
of	O
femoral	B-T037
neck	I-T037
fracture	I-T037
and	O
applied	O
this	O
in	O
a	O
retrospective	B-T062
study	I-T062
to	O
assess	O
:	O
(	O
1	O
)	O
its	O
reproducibility	O
,	O
(	O
2	O
)	O
its	O
advantages	O
compared	O
with	O
the	O
pa	O
##u	O
##we	O
##ls	O
angle	O
,	O
(	O
3	O
)	O
its	O
relationship	O
with	O
the	O
short	B-T058
-	I-T058
term	I-T058
prognosis	I-T058
treated	O
with	O
three	O
cannulated	B-T074
compression	I-T074
screws	I-T074
.	O
this	O
new	O
measurement	O
is	O
reproducible	O
and	O
has	O
some	O
reference	O
meaning	O
for	O
the	O
treatment	B-T058
of	O
femoral	B-T037
neck	I-T037
fractures	I-T037
.	O
two	O
hundred	O
and	O
twenty	O
-	O
eight	O
patients	O
with	O
femoral	B-T037
neck	I-T037
fractures	I-T037
treated	O
with	O
three	O
cannulated	B-T074
compression	I-T074
screws	I-T074
were	O
retrospectively	B-T062
analyzed	I-T062
.	O
the	O
vn	O
angle	O
,	O
which	O
was	O
the	O
angle	B-T082
between	O
the	O
fracture	O
line	O
and	O
the	O
vertical	B-T082
of	O
the	O
neck	B-T082
axis	I-T082
,	O
and	O
the	O
pa	O
##u	O
##we	O
##ls	O
angle	O
were	O
measured	O
respectively	O
.	O
the	O
method	O
of	O
icc	O
was	O
performed	O
to	O
assess	O
the	O
reproducibility	O
of	O
the	O
two	O
angles	B-T082
,	O
and	O
the	O
absolute	O
value	O
of	O
difference	O
in	O
pre	O
-	O
operative	O
and	O
post	O
-	O
operative	O
radiographs	B-T058
was	O
used	O
to	O
evaluate	O
the	O
uniformity	O
of	O
the	O
two	O
angles	B-T082
.	O
these	O
fractures	B-T037
were	O
divided	O
into	O
four	O
groups	O
according	O
to	O
vn	O
angle	O
(	O
vn	O
<	O
0	O
##°	O
(	O
n	O
=	O
92	O
)	O
,	O
0	O
##°	O
##≤	O
##v	O
##n	O
<	O
10	O
##°	O
(	O
n	O
=	O
82	O
)	O
,	O
10	O
##°	O
##≤	O
##v	O
##n	O
<	O
15	O
##°	O
(	O
n	O
=	O
26	O
)	O
,	O
[UNK]	O
(	O
n	O
=	O
28	O
)	O
)	O
,	O
and	O
the	O
short	O
-	O
term	O
(	O
within	O
6	O
months	O
)	O
fixation	B-T058
results	O
of	O
radiographs	B-T058
in	O
these	O
fractures	B-T037
were	O
evaluated	O
.	O
the	O
icc	O
of	O
the	O
vn	O
angle	O
and	O
the	O
pa	O
##u	O
##we	O
##ls	O
angle	O
in	O
pre	O
-	O
operative	O
radiographs	B-T058
were	O
0	O
.	O
93	O
##7	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
:	O
0	O
.	O
92	O
##2	O
-	O
0	O
.	O
95	O
##0	O
)	O
and	O
0	O
.	O
94	O
##2	O
respectively	O
(	O
95	O
%	O
ci	O
:	O
0	O
.	O
91	O
##4	O
-	O
0	O
.	O
97	O
##0	O
)	O
,	O
indicating	O
both	O
angles	B-T082
had	O
a	O
good	O
inter	O
-	O
rater	O
reproducibility	O
.	O
however	O
,	O
there	O
was	O
a	O
great	O
difference	O
between	O
the	O
pa	O
##u	O
##we	O
##ls	O
angle	O
in	O
pre	O
-	O
operative	O
and	O
post	O
-	O
operative	O
radiographs	B-T058
(	O
p	O
=	O
0	O
.	O
037	O
)	O
,	O
the	O
absolute	O
difference	O
was	O
10	O
.	O
66	O
##±6	O
.	O
47	O
(	O
range	O
:	O
1	O
.	O
72	O
-	O
38	O
.	O
48	O
)	O
,	O
while	O
no	O
statistical	O
difference	O
for	O
the	O
vn	O
angle	O
(	O
p	O
=	O
0	O
.	O
08	O
##4	O
)	O
and	O
the	O
absolute	O
difference	O
was	O
2	O
.	O
20	O
##±1	O
.	O
63	O
(	O
range	O
:	O
0	O
.	O
05	O
-	O
7	O
.	O
56	O
)	O
.	O
the	O
overall	O
fixation	B-T038
failure	I-T038
rate	O
which	O
was	O
defined	O
as	O
screw	B-T038
loosening	I-T038
,	O
varus	O
collapse	O
,	O
obvious	O
fracture	B-T037
displacement	I-T037
or	O
femoral	B-T017
neck	I-T017
shortening	O
was	O
11	O
.	O
84	O
%	O
,	O
and	O
the	O
mean	O
failure	O
rates	O
according	O
to	O
vn	O
angles	O
were	O
respectively	O
0	O
%	O
,	O
3	O
.	O
24	O
%	O
(	O
95	O
%	O
ci	O
:	O
1	O
.	O
64	O
-	O
4	O
.	O
84	O
)	O
,	O
22	O
.	O
69	O
%	O
(	O
95	O
%	O
ci	O
:	O
16	O
.	O
43	O
-	O
28	O
.	O
96	O
)	O
,	O
65	O
.	O
45	O
%	O
(	O
95	O
%	O
ci	O
:	O
59	O
.	O
36	O
-	O
71	O
.	O
53	O
)	O
.	O
the	O
mean	O
failure	O
rates	O
of	O
fractures	B-T037
according	O
to	O
post	O
-	O
operative	O
pa	O
##u	O
##we	O
##ls	O
angle	O
(	O
<	O
30	O
##°	O
,	O
30	O
-	O
50	O
##°	O
,	O
>	O
50	O
##°	O
)	O
were	O
respectively	O
0	O
%	O
,	O
1	O
.	O
46	O
%	O
(	O
95	O
%	O
ci	O
:	O
1	O
.	O
42	O
-	O
1	O
.	O
50	O
)	O
and	O
36	O
.	O
24	O
%	O
(	O
95	O
%	O
ci	O
:	O
34	O
.	O
93	O
-	O
37	O
.	O
54	O
)	O
.	O
the	O
vn	O
angle	O
has	O
a	O
good	O
inter	O
-	O
rater	O
reproducibility	O
,	O
a	O
higher	O
reliability	O
than	O
the	O
pa	O
##u	O
##we	O
##ls	O
angle	O
and	O
is	O
closely	O
related	O
to	O
the	O
short	B-T058
-	I-T058
term	I-T058
prognosis	I-T058
of	O
femoral	B-T037
neck	I-T037
fractures	I-T037
treated	O
with	O
cannulated	B-T074
compression	I-T074
screws	I-T074
.	O
level	O
iv	O
,	O
retrospective	O
diagnostic	O
study	O
.	O

hematological	B-T033
,	O
biochemical	B-T033
,	O
and	O
toxic	B-T033
##opathic	I-T033
effects	I-T033
of	O
subch	O
##ronic	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
toxicity	B-T037
in	O
wistar	B-T204
rats	I-T204
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
is	O
one	O
of	O
the	O
most	O
widely	O
used	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oids	I-T103
.	O
this	O
study	O
investigates	O
toxic	B-T037
effects	I-T037
of	O
repeated	O
oral	O
administration	O
of	O
three	O
doses	O
of	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
(	O
1	O
/	O
20	O
,	O
1	O
/	O
10	O
,	O
and	O
1	O
/	O
5	O
of	O
ld50	O
)	O
during	O
60	O
days	O
.	O
for	O
this	O
,	O
male	O
wistar	B-T204
rats	I-T204
were	O
divided	O
into	O
four	O
different	O
groups	O
.	O
hematological	B-T033
,	O
biochemical	B-T033
,	O
and	O
toxic	B-T033
##opathic	I-T033
effects	I-T033
of	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
were	O
evaluated	B-T058
.	O
according	O
to	O
the	O
results	O
,	O
a	O
significant	O
decrease	O
in	O
the	O
body	B-T033
weight	I-T033
gain	I-T033
at	O
the	O
highest	O
dose	O
1	O
/	O
5	O
of	O
ld50	O
of	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
was	O
noticed	O
.	O
an	O
increase	O
in	O
the	O
relative	O
liver	B-T017
weight	O
was	O
also	O
observed	O
at	O
this	O
dose	O
level	O
.	O
the	O
hematological	O
constituents	O
were	O
affected	O
.	O
a	O
significant	O
decrease	O
in	O
rbc	B-T017
,	O
hg	B-T103
##b	I-T103
,	O
and	O
hct	B-T033
in	O
rats	B-T204
treated	O
with	O
higher	O
doses	O
of	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
(	O
1	O
/	O
10	O
and	O
1	O
/	O
5	O
of	O
ld50	O
)	O
was	O
noted	O
.	O
however	O
,	O
a	O
significant	O
increase	O
in	O
wbc	B-T017
and	O
plt	B-T017
were	O
observed	O
at	O
the	O
same	O
doses	O
.	O
furthermore	O
,	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
induced	B-T038
liver	I-T038
toxicity	I-T038
measured	O
by	O
the	O
increased	O
activities	B-T038
of	O
aspartate	B-T103
aminotransferase	I-T103
(	O
ast	B-T103
)	O
,	O
alanine	B-T103
aminotransferase	I-T103
(	O
alt	B-T103
)	O
,	O
alkaline	B-T103
phosphates	I-T103
(	O
alp	B-T103
##s	I-T103
)	O
,	O
and	O
lactate	B-T103
dehydrogenase	I-T103
(	O
ldh	B-T103
)	O
which	O
may	O
be	O
due	O
to	O
the	O
loss	O
of	O
hepatic	B-T017
membrane	I-T017
architecture	I-T017
and	O
hepatocellular	B-T038
damage	I-T038
.	O
in	O
addition	O
,	O
exposure	O
to	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
resulted	O
in	O
a	O
significant	O
decrease	O
in	O
the	O
levels	O
of	O
superoxide	B-T103
dismutase	I-T103
and	O
catalase	B-T103
activities	B-T038
(	O
p	O
≤	O
0	O
.	O
01	O
)	O
with	O
concomitant	O
increase	O
in	O
lipid	B-T038
peroxidation	I-T038
in	O
rat	B-T204
liver	B-T017
.	O
these	O
findings	B-T033
highlight	O
the	O
subch	O
##ronic	O
hepatotoxicity	B-T037
of	O
acet	B-T103
##ami	I-T103
##pri	I-T103
##d	I-T103
.	O

wd	B-T103
##r2	I-T103
##6	I-T103
promotes	O
mit	B-T038
##ophag	I-T038
##y	I-T038
of	O
cardiomyocytes	B-T017
induced	O
by	O
hypoxia	B-T038
through	O
park	B-T103
##in	I-T103
translocation	B-T038
myocardial	B-T038
ischemia	I-T038
is	O
a	O
heart	B-T017
condition	O
caused	O
by	O
reduction	O
of	O
blood	B-T038
flow	I-T038
to	O
the	O
heart	B-T017
,	O
preventing	O
heart	B-T017
from	O
receiving	O
enough	O
oxygen	B-T103
.	O
myocardial	B-T038
ischemia	I-T038
is	O
the	O
most	O
common	O
cause	B-T033
of	I-T033
death	I-T033
globally	B-T082
.	O
heart	B-T017
ischemic	B-T058
preconditioning	I-T058
(	O
ipc	B-T058
)	O
has	O
a	O
protective	O
effect	O
against	O
myocardial	B-T017
cell	I-T017
death	B-T038
induced	O
by	O
ischemia	B-T038
and	O
ischemia	B-T037
-	I-T037
reperfusion	I-T037
injury	I-T037
.	O
wd	B-T103
##r2	I-T103
##6	I-T103
has	O
recently	O
been	O
identified	O
as	O
a	O
protein	B-T103
that	O
is	O
increased	O
following	O
rat	B-T204
cardiac	B-T017
ipc	B-T058
.	O
wd	B-T103
##r2	I-T103
##6	I-T103
can	O
promote	O
the	O
proliferation	B-T038
of	O
h9	B-T017
##c2	I-T017
cells	I-T017
and	O
protect	O
cardiomyocytes	B-T017
against	O
oxidative	B-T038
stress	I-T038
through	O
inhibiting	O
apoptosis	B-T038
.	O
however	O
,	O
its	O
role	O
in	O
myocardial	B-T038
ischemia	I-T038
is	O
unclear	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
explore	O
the	O
role	O
of	O
wd	B-T103
##r2	I-T103
##6	I-T103
in	O
myocardial	B-T038
ischemia	I-T038
and	O
h9	B-T017
##c2	I-T017
cell	I-T017
hypoxia	B-T038
.	O
our	O
results	O
showed	O
that	O
wd	B-T103
##r2	I-T103
##6	I-T103
is	O
induced	O
by	O
myocardial	B-T038
ischemia	I-T038
and	O
h9	B-T017
##c2	I-T017
cell	I-T017
hypoxia	B-T038
.	O
wd	B-T103
##r2	I-T103
##6	I-T103
protects	O
h9	B-T017
##c2	I-T017
cells	I-T017
against	O
hypoxia	B-T038
injury	B-T037
through	O
inhibiting	O
ldh	B-T103
release	O
and	O
increasing	O
cell	B-T038
viability	I-T038
.	O
wd	B-T103
##r2	I-T103
##6	I-T103
promotes	O
hypoxia	B-T038
-	O
induced	O
autophagy	B-T038
in	O
hypoxia	B-T038
of	O
h9	B-T017
##c2	I-T017
cells	I-T017
.	O
we	O
further	O
demonstrated	O
that	O
in	O
h9	B-T017
##c2	I-T017
cell	I-T017
hypoxia	B-T038
,	O
wd	B-T103
##r2	I-T103
##6	I-T103
increases	O
mitochondrial	B-T038
membrane	I-T038
potential	I-T038
,	O
thereby	O
increases	O
park	B-T103
##in	I-T103
translocation	B-T038
of	O
mitochondria	B-T017
.	O
after	O
park	B-T103
##in	I-T103
is	O
translocated	B-T038
at	O
mitochondria	B-T017
,	O
wd	B-T103
##r2	I-T103
##6	I-T103
can	O
increase	O
mitochondria	B-T017
l	O
protein	B-T038
ubiquitination	I-T038
in	O
hypoxia	B-T038
of	O
h9	B-T017
##c2	I-T017
cells	I-T017
.	O
wd	B-T103
##r2	I-T103
##6	I-T103
is	O
a	O
mediator	O
of	O
response	O
to	O
hypoxia	B-T038
,	O
and	O
wd	B-T103
##r2	I-T103
##6	I-T103
plays	O
an	O
important	O
role	O
in	O
hypoxia	B-T038
-	O
mediated	O
autophagy	B-T038
and	O
mit	B-T038
##ophag	I-T038
##y	I-T038
.	O
this	O
study	B-T062
provides	O
novel	O
insights	O
into	O
the	O
protective	O
role	O
of	O
wd	B-T103
##r2	I-T103
##6	I-T103
in	O
cardiomyocyte	B-T017
injury	B-T037
during	O
hypoxia	B-T038
.	O
wd	B-T103
##r2	I-T103
##6	I-T103
may	O
serve	O
as	O
a	O
potential	O
target	O
for	O
the	O
treatment	B-T058
of	O
myocardial	B-T038
ischemia	I-T038
.	O

macular	O
ganglion	B-T017
cell	I-T017
-	O
inner	B-T017
plexiform	I-T017
layer	I-T017
thickness	O
is	O
associated	O
with	O
clinical	B-T038
progression	I-T038
in	O
mild	B-T038
cognitive	I-T038
impairment	I-T038
and	O
alzheimer	B-T038
##s	I-T038
disease	I-T038
we	O
investigated	O
the	O
association	O
of	O
the	O
macular	O
ganglion	B-T017
cell	I-T017
-	O
inner	B-T017
plexiform	I-T017
layer	I-T017
(	O
gc	B-T017
##ipl	I-T017
)	O
and	O
perip	B-T017
##apillary	I-T017
retinal	I-T017
nerve	I-T017
fiber	I-T017
layer	I-T017
(	O
rnfl	B-T017
)	O
thicknesses	O
with	O
disease	B-T038
progression	I-T038
in	O
mild	B-T038
cognitive	I-T038
impairment	I-T038
(	O
mci	B-T038
)	O
and	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
.	O
we	O
recruited	O
42	O
patients	O
with	O
ad	B-T038
,	O
26	O
with	O
mci	B-T038
,	O
and	O
66	O
normal	O
elderly	O
controls	O
.	O
the	O
thicknesses	O
of	O
the	O
rnfl	B-T017
and	O
gc	B-T017
##ipl	I-T017
were	O
measured	O
via	O
spectral	B-T074
-	I-T074
domain	I-T074
optic	I-T074
coherent	I-T074
tomography	I-T074
in	O
all	O
participants	B-T098
at	O
baseline	O
.	O
the	O
patients	O
with	O
mci	B-T038
or	O
ad	B-T038
underwent	O
clinical	O
and	O
neuropsychological	B-T058
tests	I-T058
at	O
baseline	O
and	O
once	O
every	O
year	O
thereafter	O
for	O
2	O
years	O
.	O
the	O
clinical	B-T170
dementia	I-T170
rating	I-T170
scale	I-T170
-	I-T170
sum	I-T170
of	I-T170
boxes	I-T170
(	O
cdr	B-T170
-	I-T170
sb	I-T170
)	O
score	O
exhibited	O
significant	O
negative	B-T033
relationships	O
with	O
the	O
average	B-T017
gc	I-T017
##ipl	I-T017
thickness	O
(	O
β	O
=	O
-	O
0	O
.	O
15	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
the	O
gc	B-T017
##ipl	I-T017
thickness	O
in	O
the	O
super	B-T082
##otemporal	I-T082
,	O
super	B-T082
##onasal	I-T082
,	O
and	O
infer	B-T082
##onasal	I-T082
sectors	I-T082
.	O
the	O
composite	O
memory	O
score	O
exhibited	O
significant	O
positive	B-T033
associations	O
with	O
the	O
average	B-T017
gc	I-T017
##ipl	I-T017
thickness	O
and	O
the	O
gc	B-T017
##ipl	I-T017
thickness	O
in	O
the	O
super	B-T082
##otemporal	I-T082
,	O
infer	B-T082
##onasal	I-T082
,	O
and	O
infer	B-T082
##otemporal	I-T082
sectors	I-T082
.	O
the	O
temporal	B-T017
rnfl	I-T017
thickness	O
,	O
the	O
average	O
and	O
minimum	O
gc	B-T017
##ipl	I-T017
thicknesses	O
,	O
and	O
the	O
gc	B-T017
##ipl	I-T017
thickness	O
in	O
the	O
infer	B-T082
##onasal	I-T082
,	O
inferior	B-T082
,	O
and	O
infer	B-T082
##otemporal	I-T082
sectors	I-T082
at	O
baseline	O
were	O
significantly	O
reduced	O
in	O
mci	B-T038
patients	O
who	O
were	O
converted	O
to	O
ad	B-T038
compared	O
to	O
stable	O
mci	B-T038
patients	O
.	O
the	O
change	O
of	O
cdr	B-T170
-	I-T170
sb	I-T170
from	O
baseline	O
to	O
2	O
years	O
exhibited	O
significant	O
negative	B-T033
associations	O
with	O
the	O
average	O
(	O
β	O
=	O
-	O
0	O
.	O
150	O
,	O
p	O
=	O
0	O
.	O
006	O
)	O
and	O
minimum	B-T017
gc	I-T017
##ipl	I-T017
thicknesses	O
as	O
well	O
as	O
gc	B-T017
##ipl	I-T017
thickness	O
in	O
the	O
super	B-T082
##otemporal	I-T082
,	O
superior	B-T082
,	O
super	B-T082
##onasal	I-T082
,	O
and	O
infer	B-T082
##onasal	I-T082
sectors	I-T082
at	O
baseline	O
.	O
our	O
data	O
suggest	O
that	O
macular	O
gc	B-T017
##ipl	I-T017
thickness	O
represents	O
a	O
promising	O
biomarker	B-T201
for	O
monitoring	O
the	O
progression	B-T038
of	O
mci	B-T038
and	O
ad	B-T038
.	O

ultrasonography	B-T058
for	O
acute	B-T038
appendicitis	I-T038
-	O
the	O
way	O
it	O
looks	O
today	O
despite	O
sophisticated	O
physical	B-T058
examination	I-T058
and	O
laboratory	B-T058
support	I-T058
,	O
diagnosis	B-T033
of	O
acute	B-T038
appendicitis	I-T038
remained	O
challenging	O
in	O
clinical	O
practice	O
with	O
a	O
negative	B-T058
appendectomy	I-T058
rate	O
of	O
15	O
-	O
30	O
%	O
.	O
as	O
a	O
remarkable	O
cl	O
##ue	O
and	O
as	O
early	O
as	O
1986	O
,	O
ultrasonography	B-T058
(	O
us	B-T058
)	O
has	O
been	O
proven	O
a	O
reliable	O
diagnostic	B-T058
method	I-T058
that	O
is	O
also	O
explicitly	O
helpful	O
in	O
difficult	O
cases	O
with	O
atypical	O
presentation	O
and	O
enables	O
to	O
rule	O
out	O
many	O
differential	B-T058
diagnoses	I-T058
.	O
recent	O
publications	B-T170
emphasized	O
the	O
role	O
of	O
multid	B-T058
##etector	I-T058
computed	I-T058
tomography	I-T058
(	O
ct	B-T058
)	O
resulting	O
in	O
a	O
significant	O
reduction	O
of	O
false	B-T033
negative	I-T033
findings	I-T033
at	O
operation	B-T058
.	O
extensive	O
as	O
well	O
as	O
unc	B-T058
##ritic	I-T058
##al	I-T058
application	I-T058
of	O
this	O
method	O
even	O
in	O
children	O
inev	O
##itably	O
causes	O
substantial	O
radiation	B-T037
exposure	I-T037
,	O
a	O
sequel	O
to	O
either	O
pure	O
ign	O
##ora	O
##nc	O
##e	O
or	O
un	O
##qu	O
##al	O
##ified	O
/	O
inadequate	O
performance	O
of	O
us	B-T058
in	O
this	O
particular	O
situation	O
,	O
which	O
in	O
turn	O
can	O
be	O
considered	O
sequel	O
to	O
either	O
eg	B-T033
##ocent	I-T033
##ric	I-T033
or	O
economic	O
preponder	O
##ance	O
.	O
recent	O
data	O
shed	O
new	O
light	O
on	O
the	O
role	O
of	O
us	B-T058
(	O
and	O
ct	B-T058
)	O
in	O
acute	B-T038
appendicitis	I-T038
.	O
therefore	O
,	O
1	O
generation	O
after	O
us	B-T058
with	I-T058
graded	I-T058
compression	I-T058
was	O
etched	O
in	O
stone	O
as	O
the	O
method	O
of	O
choice	O
for	O
diagnosing	B-T033
acute	B-T038
appendicitis	I-T038
(	O
pu	O
##yl	O
##aer	O
##t	O
)	O
,	O
a	O
visual	O
arousal	B-T038
foster	O
##ing	O
its	O
role	O
and	O
performance	O
in	O
clinical	B-T091
medicine	I-T091
appears	O
justified	O
.	O

treatment	O
of	O
carcinoma	B-T038
in	I-T038
situ	I-T038
of	I-T038
the	I-T038
gla	I-T038
##ns	I-T038
penis	I-T038
with	O
topical	O
im	O
##iqu	O
##imod	O
followed	O
by	O
carbon	B-T074
dioxide	I-T074
laser	I-T074
excision	B-T058
different	O
approaches	O
have	O
been	O
described	O
in	O
published	O
studies	O
for	O
carcinoma	B-T038
in	I-T038
situ	I-T038
(	I-T038
cis	I-T038
)	I-T038
of	I-T038
the	I-T038
gla	I-T038
##ns	I-T038
penis	I-T038
(	O
erythro	B-T038
##plasia	I-T038
of	I-T038
que	I-T038
##yr	I-T038
##at	I-T038
)	O
,	O
including	O
topical	B-T058
chemotherapy	I-T058
or	O
immunotherapy	B-T058
and	O
laser	O
or	O
surgical	B-T058
excision	I-T058
.	O
we	O
evaluated	B-T058
the	O
efficacy	O
of	O
topical	O
im	O
##iqu	O
##imod	O
(	O
iq	O
)	O
followed	O
by	O
carbon	B-T074
dioxide	I-T074
laser	I-T074
ablation	B-T058
of	O
the	O
lesion	B-T033
.	O
from	O
2010	O
to	O
2015	O
,	O
10	O
patients	O
affected	O
by	O
cis	B-T038
of	O
the	O
gla	O
##ns	O
were	O
treated	B-T058
by	O
iq	O
,	O
followed	O
by	O
carbon	B-T074
dioxide	I-T074
laser	I-T074
ablation	B-T058
.	O
for	O
every	O
patient	O
,	O
we	O
performed	O
histologic	B-T058
examination	I-T058
before	O
and	O
after	O
iq	O
.	O
local	O
toxicity	B-T037
and	O
adverse	B-T038
effects	I-T038
were	O
recorded	O
.	O
after	O
treatment	O
,	O
histologic	B-T058
examination	I-T058
showed	O
no	B-T033
residual	I-T033
tumor	I-T033
in	O
6	O
patients	O
(	O
complete	B-T033
response	I-T033
[	O
cr	B-T033
]	O
)	O
,	O
stable	B-T033
disease	I-T033
in	O
2	O
patients	O
,	O
and	O
progressive	B-T038
disease	I-T038
in	O
2	O
patients	O
.	O
those	O
with	O
a	O
cr	B-T033
had	O
human	B-T005
papillomavirus	I-T005
-	O
related	O
lesions	B-T033
,	O
and	O
they	O
had	O
no	B-T033
experienced	O
relapses	O
after	O
a	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
of	O
26	O
months	O
.	O
the	O
2	O
patients	O
with	O
progressive	B-T038
disease	I-T038
underwent	O
total	O
pen	B-T058
##ectomy	I-T058
.	O
all	O
patients	O
were	O
alive	B-T033
at	O
the	O
last	O
follow	B-T033
-	I-T033
up	I-T033
examination	I-T033
.	O
all	O
patients	O
experienced	O
a	O
mild	O
local	O
toxicity	B-T037
(	O
burning	B-T033
erythema	I-T033
)	O
but	O
no	B-T033
major	O
adverse	B-T038
effects	I-T038
.	O
local	O
treatment	O
with	O
iq	O
for	O
gla	O
##ns	O
cis	B-T038
is	O
effective	O
mainly	O
for	O
human	B-T005
papillomavirus	I-T005
-	O
related	O
lesions	B-T033
.	O
the	O
present	O
study	O
is	O
the	O
first	O
to	O
record	O
the	O
histologic	B-T058
examination	I-T058
findings	O
before	O
and	O
after	O
iq	O
treatment	O
.	O
the	O
small	O
number	O
of	O
patients	O
,	O
owing	O
to	O
the	O
rarity	O
of	O
this	O
disease	B-T038
,	O
was	O
the	O
main	O
limitation	O
of	O
the	O
present	O
study	O
.	O
iq	O
must	O
be	O
used	O
carefully	O
,	O
and	O
a	O
close	O
follow	B-T058
-	I-T058
up	I-T058
protocol	B-T170
is	O
mandatory	O
because	O
of	O
the	O
lack	O
of	O
long	O
-	O
term	O
efficacy	O
data	O
.	O

unintentional	B-T037
injuries	I-T037
in	O
children	O
up	O
to	O
six	O
years	O
of	O
age	O
and	O
related	O
parental	O
knowledge	B-T170
,	O
attitudes	B-T038
,	O
and	O
behaviors	O
in	O
italy	B-T082
to	O
describe	O
risk	B-T033
factors	I-T033
associated	O
with	O
unintentional	B-T037
injuries	I-T037
among	O
children	O
aged	O
<	O
6	O
years	O
and	O
to	O
examine	O
parents	O
'	O
level	O
of	O
knowledge	B-T170
,	O
attitudes	B-T038
,	O
and	O
behaviors	O
about	O
pediatric	O
injuries	B-T037
and	O
related	O
preventive	O
measures	O
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
survey	I-T062
was	O
conducted	O
between	O
may	O
and	O
july	O
2015	O
on	O
a	O
random	B-T062
sample	I-T062
of	O
79	O
##4	O
parents	O
of	O
3	O
-	O
to	O
6	O
-	O
year	O
-	O
old	O
children	O
through	O
a	O
self	O
-	O
administered	O
anonymous	B-T170
questionnaire	I-T170
.	O
a	O
total	O
of	O
40	O
##9	O
parents	O
participated	O
.	O
two	O
-	O
thirds	O
of	O
the	O
children	O
had	O
experienced	O
at	O
least	O
1	O
unintentional	B-T037
injury	I-T037
in	O
the	O
previous	O
12	O
months	O
.	O
more	O
than	O
one	O
-	O
half	O
of	O
these	O
children	O
were	O
boys	O
.	O
the	O
leading	B-T033
cause	I-T033
was	O
falls	B-T037
;	O
the	O
injuries	B-T037
occurred	O
mainly	O
at	O
home	B-T082
,	O
and	O
only	O
9	O
.	O
2	O
%	O
were	O
brought	O
for	O
attention	O
to	O
an	O
emergency	B-T092
department	I-T092
.	O
parents	O
who	O
did	O
not	O
believe	O
that	O
it	O
is	O
possible	O
to	O
prevent	O
unintentional	B-T037
injuries	I-T037
were	O
more	O
likely	O
to	O
have	O
had	O
a	O
child	O
injured	O
.	O
approximately	O
70	O
%	O
of	O
respondents	B-T098
were	O
aware	B-T038
of	O
security	B-T170
measures	I-T170
to	O
prevent	O
pediatric	O
injuries	B-T037
,	O
and	O
this	O
knowledge	B-T170
was	O
more	O
prevalent	O
in	O
older	O
parents	O
and	O
in	O
those	O
with	O
at	O
least	O
a	O
college	O
level	O
of	O
education	O
compared	O
with	O
those	O
with	O
a	O
middle	O
school	O
education	O
.	O
the	O
perceived	B-T038
utility	O
of	O
education	O
about	O
preventive	O
measures	O
of	O
pediatric	O
injuries	B-T037
had	O
a	O
mean	O
value	O
of	O
8	O
.	O
9	O
on	O
a	O
likert	B-T170
scale	I-T170
of	O
1	O
-	O
10	O
(	O
1	O
,	O
not	O
useful	O
,	O
to	O
10	O
,	O
very	O
useful	O
)	O
and	O
was	O
significantly	O
higher	O
in	O
mothers	O
.	O
this	O
study	O
highlights	O
a	O
clear	O
need	O
for	O
public	B-T058
health	I-T058
educational	O
programs	O
for	O
parents	O
regarding	O
prevention	O
of	O
unintentional	B-T037
injuries	I-T037
in	O
children	O
as	O
a	O
valuable	O
tool	O
to	O
increase	O
safety	O
and	O
injury	B-T058
prevention	I-T058
and	O
to	O
reduce	O
risks	O
,	O
because	O
the	O
majority	O
of	O
such	O
injuries	B-T037
occur	O
at	O
home	B-T082
.	O

evaluation	B-T058
of	O
choroidal	B-T017
thickness	O
in	O
patients	O
with	O
pseudo	B-T038
##ex	I-T038
##fo	I-T038
##li	I-T038
##ation	I-T038
syndrome	I-T038
and	O
pseudo	B-T038
##ex	I-T038
##fo	I-T038
##li	I-T038
##ation	I-T038
glaucoma	I-T038
purpose	O
.	O
to	O
compare	O
the	O
macular	O
and	O
perip	B-T082
##apillary	I-T082
choroidal	B-T017
thickness	O
in	O
eyes	B-T017
with	O
pseudo	B-T038
##ex	I-T038
##fo	I-T038
##li	I-T038
##ation	I-T038
(	I-T038
pex	I-T038
)	I-T038
syndrome	I-T038
and	O
pex	B-T038
glaucoma	I-T038
with	O
the	O
normal	O
eyes	B-T017
of	O
healthy	O
controls	O
.	O
materials	O
and	O
methods	O
.	O
in	O
this	O
prospective	B-T062
study	I-T062
,	O
30	O
eyes	B-T017
of	O
30	O
patients	O
with	O
pex	B-T038
syndrome	I-T038
,	O
28	O
eyes	B-T017
of	O
28	O
patients	O
with	O
pex	B-T038
glaucoma	I-T038
,	O
and	O
30	O
eyes	B-T017
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O
choroidal	B-T017
thicknesses	O
in	O
the	O
macular	O
and	O
perip	B-T082
##apillary	I-T082
areas	B-T082
were	O
measured	O
by	O
using	O
spectral	B-T074
domain	I-T074
optical	I-T074
coherence	I-T074
tomography	I-T074
.	O
results	O
.	O
gender	O
,	O
age	O
,	O
and	O
axial	O
length	O
did	O
not	B-T033
significantly	I-T033
differ	O
between	O
the	O
groups	O
(	O
all	O
,	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
the	O
mean	O
values	O
of	O
choroidal	B-T017
thickness	O
in	O
the	O
macular	O
and	O
perip	B-T082
##apillary	I-T082
areas	B-T082
(	O
except	O
the	O
superior	B-T082
quadrant	B-T082
)	O
in	O
the	O
patients	O
with	O
pex	B-T038
syndrome	I-T038
and	O
pex	B-T038
glaucoma	I-T038
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
mean	O
values	O
of	O
the	O
macular	O
and	O
perip	B-T082
##apillary	I-T082
choroidal	B-T017
thickness	O
in	O
the	O
pex	B-T038
glaucoma	I-T038
group	O
were	O
lower	O
compared	O
with	O
pex	B-T038
syndrome	I-T038
group	O
;	O
however	O
this	O
difference	O
was	O
not	B-T033
significant	I-T033
.	O
conclusions	O
.	O
the	O
findings	B-T033
of	O
this	O
study	B-T062
revealed	O
that	O
macular	O
and	O
perip	B-T082
##apillary	I-T082
choroidal	B-T017
thicknesses	O
were	O
decreased	O
in	O
pex	B-T038
syndrome	I-T038
and	O
pex	B-T038
glaucoma	I-T038
cases	O
.	O
the	O
role	O
of	O
choroid	B-T017
in	O
the	O
development	O
of	O
glaucomatous	B-T038
damage	O
in	O
patients	O
with	O
pex	B-T038
syndrome	I-T038
remains	O
unclear	O
.	O

methodological	O
considerations	O
for	O
designing	O
a	O
community	O
water	O
fluor	O
##idation	O
cessation	O
study	B-T062
high	O
-	O
quality	O
,	O
up	O
-	O
to	O
-	O
date	O
research	B-T062
on	O
community	O
water	O
fluor	O
##idation	O
(	O
cw	O
##f	O
)	O
,	O
and	O
especially	O
on	O
the	O
implications	O
of	O
cw	O
##f	O
cessation	O
for	O
dental	B-T058
health	I-T058
,	O
is	O
limited	O
.	O
although	O
cw	O
##f	O
cessation	O
studies	B-T062
have	O
been	O
conducted	O
,	O
they	O
are	O
few	O
in	O
number	O
;	O
one	O
of	O
the	O
major	O
reasons	O
is	O
the	O
methodological	O
complexity	O
of	O
conducting	O
such	O
a	O
study	B-T062
.	O
this	O
article	O
draws	O
on	O
a	O
systematic	B-T170
review	I-T170
of	O
existing	O
cessation	O
studies	B-T062
(	O
n	O
=	O
15	O
)	O
to	O
explore	O
methodological	O
considerations	O
of	O
conducting	O
cw	O
##f	O
cessation	O
studies	B-T062
in	O
future	O
.	O
we	O
review	O
nine	O
important	O
methodological	O
aspects	O
(	O
study	B-T062
design	I-T062
,	O
comparison	O
community	O
,	O
target	B-T098
population	I-T098
,	O
time	O
frame	O
,	O
sampling	B-T170
strategy	I-T170
,	O
clinical	O
indicators	O
,	O
assessment	O
criteria	O
,	O
covariates	O
and	O
biomarkers	B-T201
)	O
and	O
provide	O
recommendations	O
for	O
planning	B-T058
future	O
cw	O
##f	O
cessation	O
studies	B-T062
that	O
examine	O
effects	O
on	O
dental	B-T038
caries	I-T038
.	O
there	O
is	O
no	O
one	O
ideal	O
study	B-T062
design	I-T062
to	O
answer	O
a	O
research	O
question	O
.	O
however	O
,	O
recommendations	O
proposed	O
regarding	O
methodological	O
aspects	O
to	O
conduct	O
an	O
epidemiological	B-T062
study	I-T062
to	O
observe	O
the	O
effects	O
of	O
cw	O
##f	O
cessation	O
on	O
dental	B-T038
caries	I-T038
,	O
coupled	O
with	O
our	O
identification	O
of	O
important	O
methodological	O
gaps	O
,	O
will	O
be	O
useful	O
for	O
researchers	B-T097
who	O
are	O
looking	O
to	O
optimize	O
resources	O
to	O
conduct	O
such	O
a	O
study	B-T062
with	O
standards	O
of	O
rig	O
##our	O
.	O

supramolecular	O
recognition	O
of	O
amino	B-T103
acids	I-T103
by	O
twisted	B-T103
cuc	I-T103
##urb	I-T103
##it	I-T103
[	I-T103
14	I-T103
]	I-T103
ur	I-T103
##il	I-T103
binding	B-T038
interactions	O
between	B-T082
twisted	B-T103
cuc	I-T103
##urb	I-T103
##it	I-T103
[	I-T103
14	I-T103
]	I-T103
ur	I-T103
##il	I-T103
(	B-T103
t	I-T103
##q	I-T103
[	I-T103
14	I-T103
]	I-T103
)	I-T103
and	O
twenty	O
standard	O
amino	B-T103
acids	I-T103
(	B-T103
aas	I-T103
)	I-T103
have	O
been	O
investigated	O
by	O
nmr	B-T058
spectroscopy	I-T058
and	O
isothermal	B-T058
titration	I-T058
calorimetry	I-T058
(	B-T058
it	I-T058
##c	I-T058
)	I-T058
in	O
aqueous	B-T103
hcl	B-T103
solutions	I-T103
and	O
in	O
dmso	B-T103
.	O
the	O
results	O
showed	O
that	O
t	B-T103
##q	I-T103
[	I-T103
14	I-T103
]	I-T103
displays	O
clear	O
binding	B-T038
affinity	O
for	O
aas	B-T103
with	O
a	O
positively	O
charged	O
side	O
chain	O
or	O
containing	O
an	O
aromatic	B-T103
ring	I-T103
,	O
but	O
weaker	O
binding	B-T038
affinity	O
for	O
aas	B-T103
with	O
hydrophobic	O
or	O
polar	O
side	O
chains	O
,	O
with	O
the	O
binding	B-T038
mode	O
depending	O
on	O
the	O
type	O
of	O
side	O
chain	O
present	O
in	O
the	O
aas	B-T103
.	O

cage	B-T170
##d	I-T170
-	I-T170
op	I-T170
##oss	I-T170
##um	I-T170
:	O
motif	B-T062
enrichment	I-T062
analysis	I-T062
from	O
cage	B-T170
-	O
derived	O
tss	B-T103
##s	I-T103
with	O
the	O
emergence	O
of	O
large	B-T170
-	I-T170
scale	I-T170
cap	I-T170
analysis	I-T170
of	I-T170
gene	I-T170
expression	I-T170
(	I-T170
cage	I-T170
)	I-T170
datasets	I-T170
from	O
individual	B-T092
lab	I-T092
##s	I-T092
and	O
the	O
fa	O
##nt	O
##om	O
consortium	O
,	O
one	O
can	O
now	O
analyze	O
the	O
cis	B-T103
-	I-T103
regulatory	I-T103
regions	I-T103
associated	O
with	O
gene	B-T038
transcription	I-T038
at	O
an	O
unprecedented	O
level	O
of	O
refinement	O
.	O
by	O
coupling	O
transcription	B-T038
factor	I-T038
binding	I-T038
site	I-T038
(	O
tf	B-T038
##bs	I-T038
)	O
enrichment	B-T062
analysis	I-T062
with	O
cage	B-T170
-	O
derived	O
genomic	O
regions	O
,	O
cage	B-T170
##d	I-T170
-	I-T170
op	I-T170
##oss	I-T170
##um	I-T170
can	O
identify	O
tfs	B-T103
that	O
act	O
as	O
key	O
regulators	O
of	O
genes	B-T017
involved	O
in	O
specific	O
mammalian	B-T017
cell	I-T017
and	O
tissue	B-T017
types	I-T017
.	O
the	O
web	B-T170
##to	I-T170
##ol	I-T170
allows	O
for	O
the	O
analysis	B-T062
of	O
cage	B-T170
-	O
derived	O
transcription	B-T103
start	I-T103
sites	I-T103
(	O
tss	B-T103
##s	I-T103
)	O
either	O
provided	O
by	O
the	O
user	B-T098
or	O
selected	O
from	O
∼	O
##130	O
##0	O
mammalian	B-T204
samples	O
from	O
the	O
fa	O
##nt	O
##om	O
##5	O
project	O
with	O
pre	O
-	O
computed	O
tf	B-T038
##bs	I-T038
predicted	O
with	O
jas	B-T170
##par	I-T170
tf	I-T170
binding	I-T170
profiles	I-T170
.	O
the	O
tool	B-T170
helps	O
power	O
insights	B-T038
into	O
the	O
regulation	B-T038
of	I-T038
genes	I-T038
through	O
the	O
study	B-T062
of	O
the	O
specific	O
usage	O
of	O
tss	B-T103
##s	I-T103
within	O
specific	O
cell	B-T170
types	I-T170
and	O
/	O
or	O
under	O
specific	O
conditions	O
.	O
the	O
cage	B-T170
##d	I-T170
-	I-T170
op	I-T170
##osum	I-T170
web	I-T170
tool	I-T170
is	O
implemented	O
in	O
per	B-T170
##l	I-T170
,	O
my	B-T170
##s	I-T170
##ql	I-T170
and	O
apache	B-T170
and	O
is	O
available	O
at	O
http	B-T170
:	I-T170
/	I-T170
/	I-T170
cage	I-T170
##d	I-T170
##op	I-T170
.	I-T170
cm	I-T170
##mt	I-T170
.	I-T170
ub	I-T170
##c	I-T170
.	I-T170
ca	I-T170
/	I-T170
cage	I-T170
##d	I-T170
_	I-T170
op	I-T170
##oss	I-T170
##um	I-T170
contacts	O
:	O
anth	B-T170
##ony	I-T170
.	I-T170
math	I-T170
##eli	I-T170
##er	I-T170
@	I-T170
nc	I-T170
##mm	I-T170
.	I-T170
ui	I-T170
##o	I-T170
.	I-T170
no	I-T170
or	O
w	B-T170
##y	I-T170
##eth	I-T170
@	I-T170
cm	I-T170
##mt	I-T170
.	I-T170
ub	I-T170
##c	I-T170
.	I-T170
ca	I-T170
supplementary	B-T170
information	I-T170
:	O
supplementary	B-T170
data	I-T170
are	O
available	O
at	O
bioinformatics	B-T170
online	B-T170
.	O

impact	O
of	O
antibiotic	B-T103
de	B-T058
-	I-T058
escalation	I-T058
on	O
clinical	O
outcomes	O
in	O
community	O
-	O
acquired	O
pneumococcal	B-T038
pneumonia	I-T038
although	O
antibiotic	B-T103
de	B-T058
-	I-T058
escalation	I-T058
is	O
regarded	O
as	O
a	O
measure	O
that	O
reduces	O
selection	O
pressure	O
,	O
adverse	B-T038
drug	I-T038
effects	I-T038
and	O
costs	O
,	O
evidence	O
supporting	O
this	O
practice	O
in	O
community	B-T038
-	I-T038
acquired	I-T038
pneumococcal	I-T038
pneumonia	I-T038
(	O
cap	B-T038
##p	I-T038
)	O
is	O
lacking	O
.	O
we	O
carried	O
out	O
a	O
retrospective	O
analysis	B-T062
of	O
prospectively	O
collected	O
data	O
of	O
a	O
cohort	B-T098
of	O
hospitalized	O
adults	O
with	O
cap	B-T038
##p	I-T038
.	O
pneumococcal	B-T038
aetiology	O
was	O
established	O
in	O
patients	O
with	O
one	O
or	O
more	O
positive	B-T033
cultures	I-T033
for	O
streptococcus	B-T007
pneumoniae	I-T007
obtained	O
from	O
blood	B-T031
,	O
sterile	B-T031
fluids	I-T031
or	O
sputum	B-T031
,	O
and	O
/	O
or	O
a	O
positive	B-T033
urinary	B-T058
antigen	I-T058
test	I-T058
.	O
de	B-T058
-	I-T058
escalation	I-T058
therapy	I-T058
was	O
considered	O
when	O
the	O
initial	O
antibiotic	B-T058
therapy	I-T058
was	O
narrow	O
##ed	O
to	O
penicillin	B-T103
,	O
amoxicillin	B-T103
or	O
amoxicillin	B-T103
/	I-T103
clavul	I-T103
##anate	I-T103
within	O
the	O
first	O
72	O
h	O
after	O
admission	B-T058
.	O
the	O
primary	O
outcomes	O
were	O
30	O
day	O
mortality	O
and	O
length	O
of	O
hospital	O
stay	O
(	O
los	O
)	O
.	O
adjustment	O
for	O
confounders	O
was	O
performed	O
with	O
multivariate	O
and	O
propensity	O
score	O
analyses	B-T062
.	O
of	O
141	O
##0	O
episodes	O
of	O
cap	B-T038
##p	I-T038
,	O
antibiotic	B-T103
de	B-T058
-	I-T058
escalation	I-T058
within	O
the	O
first	O
72	O
h	O
after	O
admission	B-T058
was	O
performed	O
in	O
166	O
cases	O
.	O
after	O
adjustment	O
,	O
antibiotic	B-T103
de	B-T058
-	I-T058
escalation	I-T058
was	O
not	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
mortality	O
(	O
or	O
=	O
0	O
.	O
83	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
24	O
-	O
2	O
.	O
81	O
)	O
,	O
but	O
it	O
was	O
found	O
to	O
be	O
a	O
protective	O
factor	O
for	O
prolonged	O
los	O
(	O
above	O
the	O
median	O
)	O
(	O
or	O
=	O
0	O
.	O
46	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
30	O
-	O
0	O
.	O
70	O
)	O
.	O
similar	O
results	O
were	O
found	O
in	O
patients	O
classified	O
into	O
high	B-T033
-	I-T033
risk	I-T033
pneumonia	B-T038
severity	O
index	O
classes	O
(	O
iv	O
-	O
v	O
)	O
,	O
those	O
with	O
clinical	B-T033
instability	I-T033
and	O
those	O
with	O
bacter	B-T038
##aemia	I-T038
.	O
no	O
significant	O
differences	O
were	O
documented	B-T058
in	O
adverse	B-T038
drug	I-T038
reactions	I-T038
or	O
readmission	B-T058
(	O
<	O
30	O
days	O
)	O
.	O
antibiotic	B-T103
de	B-T058
-	I-T058
escalation	I-T058
seems	O
to	O
be	O
safe	O
and	O
effective	O
in	O
reducing	O
the	O
duration	O
of	O
los	O
,	O
and	O
did	O
not	O
adversely	B-T038
affect	I-T038
outcomes	O
of	O
patients	O
with	O
cap	B-T038
##p	I-T038
,	O
even	O
those	O
with	O
bacter	B-T038
##aemia	I-T038
and	O
severe	B-T038
disease	I-T038
,	O
and	O
those	O
who	O
were	O
clinically	B-T033
unstable	I-T033
.	O

long	O
term	O
outcome	O
in	O
patients	O
with	O
esophageal	B-T058
stenting	I-T058
for	O
cancer	B-T038
esophagus	I-T038
-	O
our	O
experience	O
at	O
a	O
rural	B-T092
hospital	I-T092
of	O
pun	O
##ja	O
##b	O
,	O
india	B-T082
cancer	B-T038
of	I-T038
the	I-T038
esophagus	I-T038
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
pun	O
##ja	O
##b	O
,	O
india	B-T082
.	O
patients	O
generally	O
present	B-T033
with	O
dysphagia	B-T038
as	O
their	O
first	O
symptom	B-T033
and	O
more	O
often	O
they	O
have	O
advanced	O
disease	O
at	O
the	O
time	O
of	O
presentation	O
to	O
a	O
tertiary	B-T092
care	I-T092
centre	I-T092
.	O
palliative	B-T058
procedures	I-T058
have	O
important	O
roles	O
in	O
this	O
setting	O
.	O
stenting	B-T058
is	O
the	O
best	O
option	O
to	O
palli	O
##ate	O
the	O
symptoms	B-T033
of	O
dysphagia	B-T038
,	O
from	O
which	O
patient	O
is	O
suffering	B-T033
the	I-T033
most	I-T033
.	O
to	O
know	O
the	O
success	O
rate	O
,	O
early	B-T033
and	O
long	O
term	O
complications	B-T038
and	O
mortality	O
in	O
esophageal	B-T058
stenting	I-T058
,	O
when	O
it	O
was	O
done	O
in	O
malignant	B-T038
esophageal	I-T038
stricture	I-T038
patients	O
.	O
one	O
hundred	O
patients	O
,	O
who	O
had	O
undergone	O
esophageal	B-T058
stenting	I-T058
from	O
january	O
2012	O
to	O
january	O
2015	O
,	O
were	O
included	O
in	O
the	O
study	B-T062
.	O
we	O
retrospectively	B-T062
analysed	I-T062
the	O
data	O
for	O
patient	O
characteristics	O
,	O
causes	O
of	O
non	O
-	O
oper	O
##ability	O
,	O
early	B-T033
and	O
long	O
term	O
complications	B-T038
,	O
re	B-T058
-	I-T058
interventions	I-T058
,	O
efficacy	O
and	O
mortality	O
.	O
out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	B-T058
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	B-T058
(	O
52	O
%	O
)	O
,	O
metastatic	B-T038
disease	I-T038
(	O
35	O
%	O
)	O
,	O
cv	B-T038
##a	I-T038
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	B-T033
problem	I-T033
(	O
8	O
%	O
)	O
,	O
un	O
-	O
willing	O
for	O
surgery	B-T058
in	O
5	O
%	O
of	O
patients	O
.	O
majority	O
of	O
patients	O
(	O
94	O
%	O
)	O
had	O
squamous	B-T038
cell	I-T038
carcinoma	I-T038
,	O
while	O
only	O
6	O
%	O
had	O
adenocarcinoma	B-T038
.	O
84	O
%	O
of	O
patients	O
presented	O
with	O
dysphagia	B-T038
with	O
or	O
without	O
chest	B-T033
pain	I-T033
and	O
recurrent	B-T033
cough	I-T033
while	O
16	O
%	O
had	O
recurrent	B-T033
vomiting	I-T033
.	O
58	O
%	O
had	O
dysphagia	B-T038
to	O
liquids	O
and	O
solids	O
and	O
17	O
%	O
had	O
complete	B-T038
dysphagia	I-T038
.	O
after	O
stenting	B-T058
93	O
%	O
had	O
significant	O
improvement	O
in	O
dysphagia	B-T038
score	O
from	O
median	O
of	O
3	O
to	O
1	O
.	O
post	O
procedure	O
stay	O
was	O
3	O
.	O
61	O
##±1	O
.	O
0	O
days	O
.	O
one	O
patient	O
had	O
procedure	B-T058
related	O
major	O
complication	B-T038
in	O
the	O
form	O
of	O
post	B-T037
procedural	I-T037
ble	I-T037
##ed	I-T037
(	O
after	O
16	O
days	O
of	O
stenting	B-T058
)	O
leading	O
to	O
death	B-T033
of	O
that	O
patient	O
.	O
minor	B-T038
complications	B-T038
were	O
present	B-T033
in	O
52	O
patients	O
treated	O
conservatively	O
not	O
affecting	O
the	O
efficacy	O
of	O
procedure	B-T058
.	O
these	O
include	O
pain	B-T033
after	O
stenting	B-T058
(	O
38	O
%	O
)	O
,	O
stent	B-T038
obstruction	I-T038
(	O
23	O
%	O
)	O
and	O
stent	B-T038
migration	I-T038
(	O
6	O
%	O
)	O
.	O
all	O
the	O
minor	B-T038
complications	B-T038
were	O
treated	O
conservatively	O
except	O
in	O
six	O
patients	O
in	O
whom	O
re	B-T058
-	I-T058
stenting	I-T058
was	O
done	O
.	O
esophageal	B-T058
stenting	I-T058
is	O
relatively	O
safe	O
procedure	B-T058
with	O
short	O
stay	O
of	O
the	O
patient	O
in	O
the	O
hospital	B-T092
.	O
although	O
,	O
it	O
helps	O
in	O
alleviating	O
patients	O
'	O
morbidity	O
very	O
effectively	O
and	O
reliably	O
,	O
there	O
are	O
many	O
technical	O
gli	O
##tc	O
##he	O
##s	O
,	O
which	O
needs	O
to	O
be	O
kept	O
into	O
account	O
and	O
patient	O
should	O
be	O
properly	O
counsel	B-T058
##ed	I-T058
before	O
the	O
procedure	B-T058
to	O
prevent	O
and	O
manage	O
post	O
procedure	O
complications	B-T038
and	O
medic	O
##o	O
legal	O
aspects	O
.	O

assessment	B-T062
of	O
neuroanat	O
##omical	O
and	O
behavioural	O
effects	O
of	O
in	O
ov	O
##o	O
methyl	B-T103
##merc	I-T103
##ury	I-T103
exposure	O
in	O
zebr	B-T204
##a	I-T204
fin	I-T204
##ches	I-T204
(	O
ta	B-T204
##en	I-T204
##iop	I-T204
##yg	I-T204
##ia	I-T204
gut	I-T204
##ta	I-T204
##ta	I-T204
)	O
methyl	B-T103
##merc	I-T103
##ury	I-T103
(	O
mehg	B-T103
)	O
readily	O
crosses	O
the	O
blood	B-T017
brain	I-T017
barrier	I-T017
and	O
is	O
a	O
known	O
neuro	O
-	O
toxic	O
##ant	O
.	O
mehg	B-T103
accumulation	B-T033
in	O
the	O
brain	B-T017
causes	O
histopathological	O
alterations	O
,	O
neurobehavioral	O
changes	O
,	O
and	O
impairments	O
to	O
cognitive	O
motor	B-T038
functions	I-T038
in	O
mammalian	B-T204
models	B-T038
.	O
however	O
,	O
in	O
birds	B-T204
the	O
neurotoxic	B-T037
effects	I-T037
of	O
mehg	B-T103
on	O
the	O
developing	O
pre	O
-	O
hatching	B-T038
brain	B-T017
and	O
consequent	O
behavioral	O
alterations	O
in	O
adult	O
birds	B-T204
have	O
not	O
received	O
much	O
attention	B-T038
.	O
moreover	O
,	O
pass	B-T204
##erine	I-T204
birds	I-T204
are	O
poorly	O
represented	O
in	O
mehg	B-T103
neurotoxic	O
##ology	O
studies	B-T062
in	O
comparison	O
to	O
other	O
avian	B-T204
orders	O
.	O
hence	O
in	O
this	O
study	B-T062
,	O
we	O
used	O
the	O
egg	B-T168
injection	B-T170
method	I-T170
to	O
investigate	O
the	O
long	O
term	O
effects	O
of	O
in	O
ov	O
##o	O
mehg	B-T103
exposure	O
on	O
brain	B-T017
histopathology	O
and	O
courts	O
##hip	O
behavior	O
in	O
a	O
model	B-T038
song	B-T204
##bir	I-T204
##d	I-T204
species	B-T170
,	O
the	O
zebr	B-T204
##a	I-T204
fin	I-T204
##ch	I-T204
(	O
ta	B-T204
##en	I-T204
##iop	I-T204
##yg	I-T204
##ia	I-T204
gut	I-T204
##ta	I-T204
##ta	I-T204
)	O
.	O
egg	B-T168
treatment	O
groups	O
included	O
:	O
a	O
low	O
mehg	B-T103
dose	O
of	O
0	O
.	O
2	O
##μg	O
hg	B-T103
g	O
(	O
-	O
1	O
)	O
egg	B-T168
,	O
a	O
high	O
mehg	B-T103
dose	O
of	O
3	O
.	O
2	O
##μg	O
hg	B-T103
g	O
(	O
-	O
1	O
)	O
egg	B-T168
,	O
and	O
a	O
vehicle	B-T103
control	I-T103
(	O
water	B-T103
)	O
.	O
no	B-T033
adverse	I-T033
effects	I-T033
of	O
in	O
ov	O
##o	O
mehg	B-T103
treatment	O
were	O
detected	B-T033
on	O
courts	O
##hip	O
song	O
quality	O
or	O
on	O
mating	B-T038
behavior	I-T038
in	O
experimental	O
males	O
at	O
sexually	B-T033
maturity	I-T033
which	O
would	O
suggest	O
that	O
observable	B-T201
neurobehavioral	O
effects	O
of	O
mehg	B-T103
exposure	O
may	O
depend	O
on	O
the	O
timing	O
of	O
exposure	O
during	O
offspring	O
development	B-T038
.	O
however	O
,	O
neuroanat	O
##omical	O
analysis	B-T062
indicated	B-T033
an	O
increase	O
in	O
tele	B-T017
##nc	I-T017
##ephal	I-T017
##on	I-T017
volume	O
with	O
increased	O
mehg	B-T103
concentrations	O
which	O
may	O
suggest	O
a	O
prolonged	O
inflammatory	B-T038
response	I-T038
in	O
this	O
region	B-T082
of	I-T082
the	I-T082
brain	I-T082
.	O

suppressed	O
translation	B-T038
and	O
ul	B-T103
##k1	I-T103
degradation	B-T038
as	O
potential	O
mechanisms	O
of	O
autophagy	B-T038
limitation	O
under	O
prolonged	O
starvation	B-T033
macro	B-T038
##aut	I-T038
##ophag	I-T038
##y	I-T038
/	O
autophagy	B-T038
is	O
a	O
well	O
-	O
organized	O
process	O
of	O
intracellular	B-T038
degradation	I-T038
,	O
which	O
is	O
rapidly	O
activated	O
under	O
starvation	B-T033
conditions	O
.	O
recent	O
data	O
demonstrate	O
a	O
transcriptional	B-T038
upregulation	B-T038
of	O
several	O
autophagy	B-T038
genes	B-T017
as	O
a	O
mechanism	O
that	O
controls	O
autophagy	B-T038
in	O
response	O
to	O
starvation	B-T033
.	O
here	O
we	O
report	O
that	O
despite	O
the	O
significant	O
upregulation	B-T038
of	O
mrna	B-T103
of	O
the	O
essential	O
autophagy	B-T038
initiation	B-T017
gene	I-T017
ul	B-T017
##k1	I-T017
,	O
its	O
protein	B-T103
level	O
is	O
rapidly	O
reduced	O
under	O
starvation	B-T033
.	O
although	O
both	O
autophagic	B-T038
and	O
proteas	B-T103
##omal	I-T103
systems	I-T103
contribute	O
to	O
the	O
degradation	B-T038
of	O
ul	B-T103
##k1	I-T103
,	O
under	O
prolonged	O
nitrogen	B-T103
deprivation	O
,	O
its	O
level	O
was	O
still	O
reduced	O
in	O
atg	B-T017
##7	I-T017
knockout	B-T017
cells	I-T017
,	O
and	O
only	O
initially	O
stabilized	O
in	O
cells	B-T017
treated	O
with	O
the	O
lysosomal	B-T017
or	O
proteas	B-T103
##omal	I-T103
inhibitors	I-T103
.	O
we	O
demonstrate	O
that	O
under	O
starvation	B-T033
,	O
protein	B-T038
translation	I-T038
is	O
rapidly	O
diminished	O
and	O
,	O
similar	O
to	O
treatments	B-T058
with	O
the	O
prote	B-T103
##osynthesis	I-T103
inhibitors	I-T103
cycloheximide	B-T103
or	O
anis	B-T103
##omycin	I-T103
,	O
is	O
associated	O
with	O
a	O
significant	O
reduction	O
of	O
ul	B-T103
##k1	I-T103
.	O
furthermore	O
,	O
it	O
was	O
found	O
that	O
inhibition	O
of	O
the	O
mitochondrial	B-T017
respiratory	B-T017
complexes	I-T017
or	O
the	O
mitochondrial	B-T017
atp	B-T038
synthase	I-T038
function	I-T038
that	O
could	O
also	O
take	O
place	O
in	O
the	O
absence	O
of	O
substrates	O
,	O
promote	O
upregulation	B-T038
of	O
ul	B-T103
##k1	I-T103
mrna	I-T103
and	O
protein	B-T038
expression	I-T038
in	O
an	O
ampk	B-T103
-	O
dependent	O
manner	O
in	O
u	B-T017
##18	I-T017
##10	I-T017
lung	I-T017
cancer	I-T017
cells	I-T017
growing	O
in	O
complete	O
culture	B-T103
medium	I-T103
.	O
these	O
inhibitors	O
could	O
also	O
drastically	O
increase	O
the	O
ul	B-T103
##k1	I-T103
protein	I-T103
in	O
u	B-T017
##18	I-T017
##10	I-T017
cells	I-T017
with	O
knockout	O
of	O
atg	B-T017
##13	I-T017
,	O
where	O
the	O
ul	B-T103
##k1	I-T103
expression	B-T038
is	O
significantly	O
diminished	O
.	O
however	O
,	O
such	O
upregulation	B-T038
of	O
ul	B-T103
##k1	I-T103
protein	I-T103
is	O
negligible	O
under	O
starvation	B-T033
conditions	O
,	O
further	O
sign	O
##ifying	O
the	O
contribution	O
of	O
translation	B-T038
and	O
suggesting	O
that	O
transcriptional	B-T038
upregulation	B-T038
of	O
ul	B-T103
##k1	I-T103
protein	I-T103
will	O
be	O
diminished	O
under	O
such	O
conditions	O
.	O
thus	O
,	O
we	O
propose	O
a	O
model	O
where	O
inhibition	O
of	O
protein	B-T038
translation	I-T038
,	O
together	O
with	O
the	O
degradation	B-T038
systems	O
,	O
limit	O
autophagy	B-T038
during	O
starvation	B-T033
.	O

gastrointestinal	B-T038
disorders	I-T038
in	O
curr	B-T038
##y	I-T038
-	I-T038
jones	I-T038
syndrome	I-T038
:	O
clinical	O
and	O
molecular	O
insights	B-T038
from	O
an	O
affected	O
newborn	O
curr	B-T038
##y	I-T038
-	I-T038
jones	I-T038
syndrome	I-T038
(	O
c	B-T038
##j	I-T038
##s	I-T038
)	O
is	O
a	O
pattern	B-T082
of	O
malformation	B-T017
that	O
includes	O
crani	B-T038
##osyn	I-T038
##ostosis	I-T038
,	O
pre	B-T033
-	I-T033
axial	I-T033
polys	I-T033
##yn	I-T033
##da	I-T033
##ct	I-T033
##yly	I-T033
,	O
agenesis	B-T017
of	I-T017
the	I-T017
corpus	I-T017
callosum	I-T017
,	O
cutaneous	B-T033
and	O
gastrointestinal	B-T082
abnormalities	O
.	O
a	O
recurrent	O
,	O
mosaic	B-T038
mutation	I-T038
of	O
smo	B-T038
(	I-T038
c	I-T038
.	I-T038
123	I-T038
##4	I-T038
c	I-T038
>	I-T038
t	I-T038
;	I-T038
p	I-T038
.	I-T038
leu	I-T038
##41	I-T038
##2p	I-T038
##he	I-T038
)	I-T038
causes	O
c	B-T038
##j	I-T038
##s	I-T038
.	O
this	O
report	B-T170
describes	O
the	O
gastrointestinal	B-T082
and	O
surgical	B-T033
findings	I-T033
in	O
a	O
baby	O
with	O
c	B-T038
##j	I-T038
##s	I-T038
who	O
presented	O
with	O
abdominal	O
obstruction	O
and	O
reviews	O
the	O
spectrum	B-T033
of	I-T033
gastrointestinal	B-T082
malformations	I-T033
in	O
this	O
rare	B-T038
disorder	I-T038
.	O
a	O
41	O
-	O
week	O
,	O
4	O
,	O
165	O
g	O
,	O
female	O
presented	O
with	O
crani	B-T038
##osyn	I-T038
##ostosis	I-T038
,	O
pre	B-T033
-	I-T033
axial	I-T033
polys	I-T033
##yn	I-T033
##da	I-T033
##ct	I-T033
##yly	I-T033
,	O
and	O
cutaneous	B-T033
findings	I-T033
consistent	O
with	O
a	O
clinical	B-T058
diagnosis	I-T058
of	O
c	B-T038
##j	I-T038
##s	I-T038
.	O
the	O
infant	O
developed	O
abdominal	B-T033
distension	I-T033
beginning	O
on	O
the	O
second	O
day	O
of	O
life	O
.	O
surgical	B-T058
exploration	I-T058
revealed	O
an	O
intestinal	B-T017
mal	I-T017
##rot	I-T017
##ation	I-T017
for	O
which	O
she	O
underwent	O
a	O
lad	B-T058
##d	I-T058
procedure	I-T058
.	O
multiple	B-T033
small	I-T033
nodules	I-T033
were	O
found	B-T033
on	O
the	O
surface	B-T082
of	I-T082
the	I-T082
small	I-T082
and	I-T082
large	I-T082
bowel	I-T082
in	O
addition	O
to	O
an	O
apparent	O
intestinal	B-T017
duplication	I-T017
that	O
seemed	O
to	O
originate	O
posterior	B-T082
to	O
the	O
pancreas	B-T017
.	O
histopathology	O
of	O
serosal	O
nodules	B-T017
revealed	O
bundles	B-T017
of	I-T017
smooth	I-T017
muscle	I-T017
with	O
associated	O
ganglion	B-T017
cells	I-T017
.	O
molecular	B-T062
analysis	I-T062
demonstrated	O
the	O
smo	B-T038
c	I-T038
.	I-T038
123	I-T038
##4	I-T038
c	I-T038
>	I-T038
t	I-T038
mutation	I-T038
in	O
varying	O
amounts	O
in	O
affected	O
skin	B-T022
(	O
up	O
to	O
35	O
%	O
)	O
and	O
intestinal	B-T038
hamart	I-T038
##oma	I-T038
(	O
26	O
%	O
)	O
.	O
gastrointestinal	B-T082
features	B-T033
including	O
structural	B-T033
malformations	B-T017
,	O
motility	B-T038
disorders	I-T038
,	O
and	O
upper	B-T038
gi	I-T038
bleeding	I-T038
are	O
major	O
causes	O
of	O
morbidity	O
in	O
c	B-T038
##j	I-T038
##s	I-T038
.	O
smooth	B-T038
muscle	I-T038
hamart	I-T038
##omas	I-T038
are	O
a	O
recognized	B-T033
feature	I-T033
of	O
children	O
with	O
c	B-T038
##j	I-T038
##s	I-T038
typically	O
presenting	O
with	O
abdominal	O
obstruction	O
requiring	B-T033
surgical	I-T033
intervention	I-T033
.	O
a	O
somatic	B-T038
mutation	I-T038
in	O
smo	B-T017
likely	O
accounts	O
for	O
the	O
structural	B-T033
malformations	B-T017
and	O
predisposition	O
to	O
form	O
bowel	B-T038
hamart	I-T038
##omas	I-T038
and	O
myofib	B-T038
##romas	I-T038
.	O
the	O
mutation	B-T038
burden	O
in	O
the	O
involved	O
tissues	B-T017
likely	O
accounts	O
for	O
the	O
variable	B-T033
manifestations	I-T033
.	O

impact	O
of	O
chemotherapy	B-T058
on	O
diet	B-T168
and	O
nutritional	B-T033
status	I-T033
of	O
women	B-T098
with	O
breast	B-T038
cancer	I-T038
:	O
a	O
prospective	B-T062
study	I-T062
certain	O
food	B-T168
groups	I-T168
are	O
often	O
rejected	O
during	O
chemotherapy	B-T058
(	O
ct	B-T058
)	O
due	O
to	O
the	O
side	B-T038
effects	I-T038
of	I-T038
treatment	I-T038
,	O
which	O
may	O
interfere	O
with	O
adequate	O
diet	O
and	O
nutritional	B-T033
status	I-T033
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	B-T058
the	O
treatment	O
impact	O
on	O
the	O
diet	B-T168
and	O
nutritional	B-T033
status	I-T033
of	O
women	B-T098
with	O
breast	B-T038
cancer	I-T038
(	O
bc	B-T038
)	O
.	O
in	O
this	O
prospective	B-T062
longitudinal	I-T062
study	I-T062
,	O
conducted	O
in	O
2014	O
-	O
2015	O
,	O
55	O
women	B-T098
diagnosed	O
with	O
bc	B-T038
,	O
with	O
a	O
mean	O
age	O
51	O
.	O
5	O
##±1	O
##0	O
.	O
1	O
years	O
,	O
were	O
followed	O
and	O
data	O
were	O
collected	O
at	O
three	O
different	O
times	O
.	O
anthropometric	O
and	O
dietary	B-T058
assessments	I-T058
were	O
performed	O
,	O
the	O
latter	O
by	O
applying	O
nine	O
24h	O
dietary	B-T058
recall	I-T058
s	O
,	O
by	O
using	O
the	O
brazilian	B-T170
healthy	I-T170
eating	I-T170
index	I-T170
revised	I-T170
(	O
bh	B-T170
##ei	I-T170
-	I-T170
r	I-T170
)	O
,	O
and	O
calculating	O
the	O
prevalence	O
of	O
inadequ	O
##acy	O
by	O
the	O
ear	B-T170
cut	I-T170
-	I-T170
off	I-T170
point	I-T170
method	I-T170
.	O
regarding	O
the	O
bh	B-T170
##ei	I-T170
-	I-T170
r	I-T170
analysis	B-T062
,	O
the	O
majority	O
of	O
women	B-T098
had	O
a	O
[UNK]	O
diet	B-T168
requires	O
modification	B-T033
'	O
,	O
both	O
at	O
the	O
beginning	O
(	O
t0	O
,	O
58	O
.	O
2	O
%	O
,	O
n	O
=	O
32	O
)	O
and	O
during	O
treatment	O
(	O
t1	O
,	O
54	O
.	O
5	O
%	O
,	O
n	O
=	O
30	O
)	O
.	O
however	O
,	O
after	O
the	O
end	O
of	O
the	O
ct	B-T058
,	O
the	O
greater	O
percentage	O
of	O
patients	O
(	O
t2	O
,	O
49	O
.	O
1	O
%	O
,	O
n	O
=	O
27	O
)	O
were	O
classified	O
as	O
having	O
an	O
[UNK]	O
inadequate	B-T033
diet	I-T033
[UNK]	O
,	O
since	O
the	O
total	O
fruit	B-T168
consumption	O
as	O
well	O
as	O
the	O
dark	B-T168
green	I-T168
and	O
orange	B-T168
vegetable	I-T168
and	O
leg	B-T204
##ume	I-T204
consumption	O
decreased	O
significantly	O
during	O
treatment	O
(	O
p	O
=	O
0	O
.	O
043	O
and	O
p	O
=	O
0	O
.	O
026	O
,	O
respectively	O
)	O
.	O
there	O
was	O
a	O
significant	O
reduction	O
in	O
the	O
intake	O
of	O
macro	O
and	O
micronutrient	B-T103
##s	I-T103
,	O
with	O
a	O
high	O
prevalence	O
of	O
inadequ	O
##acy	O
,	O
of	O
up	O
to	O
100	O
%	O
,	O
for	O
calcium	B-T103
,	O
iron	B-T103
,	O
phosphorus	B-T103
,	O
magnesium	B-T103
,	O
ni	B-T103
##acin	I-T103
,	O
riboflavin	B-T103
,	O
thi	B-T103
##amin	I-T103
,	O
vitamin	B-T103
b6	I-T103
,	O
vitamin	B-T103
c	I-T103
and	O
zinc	B-T103
.	O
assessment	B-T058
of	O
the	O
nutritional	B-T033
status	I-T033
indicated	O
that	O
56	O
%	O
(	O
n	O
=	O
31	O
)	O
of	O
patients	O
were	O
overweight	B-T033
at	O
these	O
three	O
different	O
times	O
.	O
weight	O
,	O
bmi	B-T201
and	O
waist	B-T201
circumference	I-T201
increased	O
significantly	O
,	O
indicating	O
a	O
worse	B-T033
nutritional	B-T033
status	I-T033
,	O
and	O
there	O
was	O
a	O
correlation	O
between	O
poor	O
diet	O
quality	O
and	O
higher	O
values	O
for	O
bmi	B-T201
,	O
waist	O
-	O
hip	O
ratio	O
and	O
waist	B-T033
-	I-T033
to	I-T033
-	I-T033
height	I-T033
ratio	I-T033
.	O
chemotherapy	B-T058
interferes	O
in	O
the	O
patients	O
'	O
diet	B-T168
generating	O
a	O
negative	O
impact	O
on	O
the	O
quality	O
and	O
intake	O
of	O
micro	B-T103
and	O
macronutr	O
##ients	O
,	O
as	O
well	O
as	O
an	O
impact	O
on	O
their	O
nutritional	B-T033
status	I-T033
,	O
with	O
an	O
increase	O
in	O
anthropometric	O
measurements	O
.	O

recovery	O
of	O
orthog	O
##ra	O
##phi	O
##c	O
processing	B-T038
after	O
stroke	B-T038
:	O
a	O
longitudinal	B-T062
fmri	B-T058
study	O
an	O
intact	O
orthog	O
##ra	O
##phi	O
##c	O
processing	B-T038
system	O
is	O
critical	O
for	O
normal	O
reading	O
and	O
spe	O
##ll	O
##ing	O
.	O
here	O
we	O
investigate	O
the	O
neural	O
changes	O
associated	O
with	O
impairment	O
and	O
subsequent	O
recovery	O
of	O
the	O
orthog	O
##ra	O
##phi	O
##c	O
lexical	O
processing	O
system	O
in	O
an	O
individual	O
with	O
an	O
ischemic	B-T038
left	O
posterior	O
cerebral	O
artery	O
(	O
pca	O
)	O
stroke	O
.	O
this	O
work	O
describes	O
a	O
longitudinal	B-T062
case	I-T062
study	I-T062
of	O
a	O
patient	O
,	O
whose	O
initial	O
##s	O
are	O
mm	B-T204
##y	I-T204
,	O
with	O
impairments	O
in	O
orthog	O
##ra	O
##phi	O
##c	O
lexical	O
processing	O
for	O
reading	O
and	O
spe	O
##ll	O
##ing	O
at	O
stroke	B-T038
onset	O
,	O
and	O
who	O
recovered	O
these	O
skills	O
within	O
1	O
year	O
post	O
stroke	B-T038
.	O
we	O
tested	O
the	O
hypothesis	O
that	O
this	O
acute	O
impairment	O
to	O
reading	O
and	O
spe	O
##ll	O
##ing	O
would	O
be	O
associated	O
with	O
a	O
selective	O
loss	O
of	O
neural	O
activation	O
in	O
the	O
left	B-T017
fusiform	I-T017
gyrus	I-T017
(	O
fg	B-T017
)	O
,	O
and	O
that	O
subsequent	O
recovery	O
would	O
be	O
associated	O
with	O
a	O
gain	O
of	O
neural	O
activation	O
in	O
this	O
region	O
.	O
mm	B-T204
##y	I-T204
'	I-T204
s	I-T204
case	O
provided	O
a	O
unique	O
opportunity	O
to	O
assess	O
the	O
selectivity	O
of	O
neural	O
changes	O
because	O
she	O
demonstrated	O
a	O
behavioral	O
recovery	B-T038
of	I-T038
naming	I-T038
as	I-T038
well	I-T038
;	O
i	O
.	O
e	O
.	O
,	O
if	O
there	O
is	O
neural	O
recovery	O
for	O
reading	O
and	O
spe	O
##ll	O
##ing	O
,	O
but	O
not	O
naming	O
,	O
then	O
these	O
neural	O
changes	O
are	O
selective	O
to	O
the	O
recovery	O
of	O
orthog	O
##ra	O
##phi	O
##c	O
processing	B-T038
.	O
to	O
test	O
our	O
hypothesis	O
,	O
we	O
examined	O
longitudinal	B-T062
behavioral	I-T062
and	O
functional	B-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	O
fmri	B-T058
)	O
data	O
of	O
reading	B-T038
,	O
spe	O
##ll	O
##ing	O
,	O
and	O
visual	B-T170
object	I-T170
naming	I-T170
acquired	O
acutely	O
,	O
3	O
weeks	O
,	O
5	O
months	O
,	O
and	O
one	O
year	O
post	O
stroke	B-T038
.	O
in	O
confirmation	O
of	O
our	O
hypothesis	O
,	O
the	O
loss	O
and	O
subsequent	O
gain	O
of	O
orthog	O
##ra	O
##phi	O
##c	O
lexical	O
processing	O
was	O
associated	O
with	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
neural	O
activation	O
in	O
areas	O
previously	O
associated	O
with	O
orthog	O
##ra	O
##phi	O
##c	O
lexical	O
processing	O
:	O
i	O
.	O
e	O
.	O
,	O
the	O
left	B-T082
mid	I-T082
-	I-T082
fg	I-T082
and	O
inferior	B-T017
frontal	I-T017
junction	I-T017
(	O
if	B-T017
##j	I-T017
)	O
.	O
furthermore	O
,	O
these	O
neural	O
changes	O
were	O
found	O
to	O
be	O
selective	O
to	O
orthog	O
##ra	O
##phi	O
##c	O
processing	B-T038
,	O
as	O
they	O
were	O
observed	O
for	O
reading	B-T038
and	O
spe	O
##ll	O
##ing	O
,	O
but	O
not	O
for	O
visual	B-T170
object	I-T170
naming	I-T170
within	O
the	O
left	B-T082
mid	I-T082
-	I-T082
fg	I-T082
.	O
this	O
work	O
shows	O
that	O
left	O
pca	O
stroke	O
can	O
temporarily	O
and	O
selectively	O
disrupt	O
the	O
orthog	O
##ra	O
##phi	O
##c	O
lexical	O
processing	O
system	O
,	O
not	O
only	O
in	O
the	O
posterior	O
region	O
adjacent	B-T082
to	O
the	O
stroke	B-T038
,	O
but	O
also	O
in	O
relatively	O
distant	O
frontal	O
orthog	O
##ra	O
##phi	O
##c	O
processing	B-T038
regions	O
.	O

alanine	B-T103
aminotransferase	I-T103
is	O
a	O
marker	B-T201
of	O
lipo	B-T038
##to	I-T038
##x	I-T038
##icity	I-T038
consequences	O
and	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
in	O
women	B-T098
with	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
several	O
studies	B-T062
have	O
reported	O
higher	O
levels	O
of	O
alanine	B-T103
aminotransferase	I-T103
(	O
alt	B-T103
)	O
in	O
women	B-T098
with	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
(	O
pcos	B-T038
)	O
compared	O
with	O
control	O
subjects	O
.	O
plasma	B-T058
alt	I-T058
levels	I-T058
are	O
considered	O
a	O
marker	B-T201
of	O
hepatic	B-T082
lipo	B-T038
##to	I-T038
##x	I-T038
##icity	I-T038
because	O
of	O
their	O
significant	O
associations	O
with	O
different	O
hepatic	B-T082
metabolic	O
dysfunctions	O
,	O
such	O
as	O
hepatic	B-T038
steatosis	I-T038
and	O
hepatic	B-T082
insulin	B-T038
resistance	I-T038
.	O
retrospective	B-T170
chart	I-T170
review	O
aiming	O
to	O
assess	O
,	O
in	O
pcos	B-T038
women	B-T098
,	O
the	O
relationship	O
between	O
alt	B-T058
levels	I-T058
and	O
measures	O
of	O
lipo	B-T038
##to	I-T038
##x	I-T038
##icity	I-T038
consequences	O
that	O
are	O
available	O
clinically	O
,	O
both	O
during	O
fasting	B-T058
and	O
using	O
the	O
oral	B-T058
glucose	I-T058
tolerance	I-T058
test	I-T058
.	O
women	B-T098
(	O
n	O
=	O
132	O
)	O
with	O
pcos	B-T038
,	O
were	O
in	O
average	O
27	O
.	O
9	O
years	O
of	O
age	O
,	O
with	O
a	O
mean	O
body	B-T201
mass	I-T201
index	I-T201
of	O
34	O
.	O
1	O
kg	O
/	O
m	O
(	O
2	O
)	O
and	O
49	O
%	O
had	O
a	O
metabolic	B-T038
syndrome	I-T038
(	O
mets	B-T038
)	O
.	O
alt	B-T058
levels	I-T058
were	O
significantly	O
correlated	O
with	O
homeostatic	B-T058
model	I-T058
assessment	I-T058
for	I-T058
insulin	I-T058
resistance	I-T058
(	O
r	O
=	O
0	O
.	O
42	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
hdl	B-T103
-	I-T103
c	I-T103
(	O
r	O
=	O
-	O
0	O
.	O
31	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
mats	B-T170
##ud	I-T170
##a	I-T170
index	I-T170
(	O
-	O
0	O
.	O
45	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
insulin	B-T058
secretion	I-T058
-	I-T058
sensitivity	I-T058
index	I-T058
-	I-T058
2	I-T058
(	O
-	O
0	O
.	O
26	O
,	O
p	O
=	O
0	O
.	O
043	O
)	O
,	O
and	O
free	B-T103
testosterone	I-T103
(	O
0	O
.	O
38	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
not	O
with	O
fasting	B-T033
glucose	I-T033
and	O
triglyceride	B-T033
levels	I-T033
.	O
alt	B-T103
cutoff	O
≥2	O
##4	O
iu	O
/	O
l	O
was	O
associated	O
with	O
all	O
these	O
parameters	O
,	O
including	O
fasting	B-T033
glucose	I-T033
(	O
p	O
=	O
0	O
.	O
021	O
)	O
and	O
triglyceride	B-T033
levels	I-T033
(	O
p	O
=	O
0	O
.	O
041	O
)	O
,	O
and	O
detected	O
more	O
women	B-T098
with	O
the	O
mets	B-T038
(	O
59	O
.	O
2	O
%	O
vs	O
.	O
36	O
.	O
1	O
%	O
,	O
p	O
=	O
0	O
.	O
008	O
)	O
and	O
whole	B-T038
-	I-T038
body	I-T038
insulin	I-T038
resistance	I-T038
(	O
mats	B-T170
##ud	I-T170
##a	I-T170
index	I-T170
<	O
12	O
.	O
3	O
l	O
(	O
2	O
)	O
·	O
10	O
/	O
mmol	O
(	O
2	O
)	O
,	O
85	O
.	O
3	O
%	O
vs	O
.	O
51	O
.	O
9	O
%	O
,	O
p	O
=	O
0	O
.	O
004	O
)	O
.	O
plasma	B-T058
alt	I-T058
levels	I-T058
seem	O
to	O
be	O
a	O
strong	O
predictor	O
not	O
only	O
of	O
liver	B-T017
lipo	B-T038
##to	I-T038
##x	I-T038
##icity	I-T038
but	O
also	O
of	O
systemic	B-T038
lipo	I-T038
##to	I-T038
##x	I-T038
##ic	I-T038
consequences	O
and	O
hyper	B-T033
##and	I-T033
##rogen	I-T033
##emia	I-T033
in	O
women	B-T098
with	O
pcos	B-T038
.	O
although	O
it	O
requires	O
validation	B-T062
in	O
another	O
study	B-T062
,	O
an	O
alt	B-T103
cutoff	O
of	O
≥2	O
##4	O
iu	O
/	O
l	O
may	O
help	O
clinicians	B-T097
identify	O
women	B-T098
with	O
increased	O
metabolic	O
risks	O
.	O

sel	B-T017
##la	I-T017
tur	I-T017
##ci	I-T017
##ca	I-T017
bridging	I-T017
and	O
dental	B-T033
anomalies	I-T033
:	O
is	O
there	O
an	O
association	O
?	O
sel	B-T017
##la	I-T017
tur	I-T017
##ci	I-T017
##ca	I-T017
bridging	I-T017
(	O
st	B-T017
##b	I-T017
)	O
,	O
or	O
calcification	B-T038
of	O
the	O
interc	B-T017
##lin	I-T017
##oid	I-T017
ligament	I-T017
of	O
sel	B-T017
##la	I-T017
tur	I-T017
##ci	I-T017
##ca	I-T017
,	O
has	O
been	O
reported	O
to	O
be	O
associated	O
with	O
some	O
dental	B-T033
anomalies	I-T033
(	O
palatal	B-T033
canine	I-T033
impact	B-T017
##ion	I-T017
and	O
transposition	B-T017
)	O
.	O
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
find	O
any	O
association	O
between	O
canine	B-T033
impact	B-T017
##ion	I-T017
,	O
hyper	B-T033
##d	I-T033
##ont	I-T033
##ia	I-T033
or	O
hypo	B-T017
##d	I-T017
##ont	I-T017
##ia	I-T017
and	O
sel	B-T017
##la	I-T017
##r	I-T017
dimensions	O
or	O
bridging	B-T017
.	O
lateral	B-T082
cephal	B-T058
##ometric	I-T058
radiographs	B-T058
from	O
78	O
patients	O
with	O
impacted	B-T017
canine	B-T033
##s	I-T033
,	O
68	O
with	O
dental	B-T017
agenesis	I-T017
and	O
17	O
with	O
hyper	B-T033
##d	I-T033
##ont	I-T033
##ia	I-T033
were	O
collected	O
.	O
linear	B-T082
dimensions	O
of	O
sel	B-T017
##la	I-T017
tur	I-T017
##ci	I-T017
##ca	I-T017
were	O
calculated	O
and	O
compared	O
to	O
those	O
of	O
a	O
control	O
group	O
(	O
47	O
individuals	B-T098
)	O
.	O
a	O
standardize	B-T170
scoring	I-T170
scale	I-T170
was	O
used	O
to	O
quantify	O
the	O
extent	O
of	O
st	B-T017
##b	I-T017
from	O
each	O
radiographs	B-T058
.	O
the	O
frequency	O
of	O
partial	O
and	O
complete	O
calcifications	B-T038
of	O
sel	B-T017
##la	I-T017
in	O
patients	O
with	O
dental	B-T033
anomalies	I-T033
is	O
increased	O
when	O
compared	O
to	O
controls	O
.	O
st	B-T017
##b	I-T017
can	O
influence	O
the	O
interc	O
##lin	O
##oid	O
distance	O
but	O
does	O
not	O
affect	O
other	O
linear	B-T082
dimensions	O
of	O
sel	B-T017
##la	I-T017
.	O
no	O
statistically	O
significant	O
difference	O
has	O
been	O
found	O
in	O
sel	B-T017
##la	I-T017
##r	I-T017
dimensions	O
and	O
st	B-T017
##b	I-T017
expression	O
when	O
evaluating	O
radiographs	B-T058
at	O
different	O
ages	O
.	O
st	B-T017
##b	I-T017
is	O
frequently	O
found	O
in	O
patients	O
with	O
dental	B-T033
abnormalities	I-T033
.	O

prevalence	O
of	O
physical	O
activity	O
and	O
sitting	B-T038
time	O
among	O
south	B-T098
korean	I-T098
adolescents	O
:	O
results	O
from	O
the	O
korean	B-T098
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
,	O
2013	O
this	O
study	O
aimed	O
to	O
describe	O
physical	O
activity	O
(	O
pa	O
)	O
and	O
sitting	B-T038
time	O
,	O
and	O
to	O
examine	O
associations	O
between	O
sociodemographic	O
factors	O
,	O
weight	O
status	O
,	O
pa	O
,	O
and	O
sitting	B-T038
time	O
among	O
south	B-T098
korean	I-T098
adolescents	O
(	O
12	O
-	O
18	O
years	O
)	O
.	O
findings	O
are	O
based	O
on	O
self	B-T062
-	I-T062
report	I-T062
data	I-T062
from	O
63	O
##8	O
participants	B-T098
in	O
the	O
2013	O
korea	B-T082
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
.	O
only	O
4	O
.	O
9	O
%	O
of	O
adolescents	O
accumulated	O
60	O
minutes	O
of	O
moderate	O
-	O
to	O
-	O
vigorous	O
pa	O
daily	O
.	O
adolescents	O
spent	O
532	O
.	O
4	O
±	O
9	O
.	O
3	O
min	O
##s	O
/	O
d	O
sitting	B-T038
.	O
after	O
controlling	O
for	O
age	O
and	O
sex	O
,	O
individuals	B-T098
in	O
higher	B-T098
income	I-T098
groups	I-T098
compared	O
with	O
the	O
lowest	B-T098
income	I-T098
group	I-T098
,	O
living	O
in	O
nonm	O
##etr	O
##o	O
se	B-T082
##ou	I-T082
##l	I-T082
compared	O
with	O
met	O
##ro	O
se	B-T082
##ou	I-T082
##l	I-T082
,	O
and	O
who	O
were	O
overweight	B-T033
compared	O
with	O
non	O
##over	O
##weight	O
were	O
more	O
likely	O
to	O
meet	O
pa	O
guidelines	B-T170
.	O
participants	B-T098
in	O
the	O
highest	B-T098
income	I-T098
group	I-T098
compared	O
with	O
lowest	B-T098
income	I-T098
group	I-T098
,	O
and	O
residing	O
in	O
nonm	O
##etr	O
##o	O
se	B-T082
##ou	I-T082
##l	I-T082
compared	O
with	O
met	O
##ro	O
se	B-T082
##ou	I-T082
##l	I-T082
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
high	O
sitting	B-T038
time	O
group	O
(	O
>	O
720	O
min	O
/	O
d	O
)	O
(	O
p	O
<	O
.	O
05	O
)	O
.	O
increasing	O
pa	O
and	O
reducing	O
sitting	B-T038
should	O
be	O
a	O
public	B-T170
health	I-T170
priority	O
in	O
south	B-T082
korea	I-T082
.	O

impact	O
of	O
femoral	B-T017
artery	I-T017
puncture	B-T058
using	O
digital	B-T058
subtraction	I-T058
angiography	I-T058
and	O
road	O
mapping	O
on	O
vascular	O
and	O
bleeding	B-T038
complications	B-T038
after	O
transf	O
##emoral	O
transcatheter	B-T058
aortic	I-T058
valve	I-T058
implantation	I-T058
the	O
use	O
of	O
large	O
-	O
diameter	O
sheath	O
##s	O
carries	O
the	O
risk	O
of	O
significant	O
vascular	O
and	O
bleeding	B-T038
complications	B-T038
after	O
transf	O
##emoral	O
transcatheter	B-T058
aortic	I-T058
valve	I-T058
implantation	I-T058
(	O
tavi	B-T058
)	O
.	O
in	O
this	O
analysis	B-T062
,	O
we	O
sought	O
to	O
assess	O
the	O
impact	O
of	O
a	O
modified	O
femoral	B-T017
artery	I-T017
puncture	B-T058
technique	O
using	O
digital	B-T058
subtraction	I-T058
angiography	I-T058
(	O
dsa	B-T058
)	O
and	O
road	O
mapping	O
during	O
transf	O
##emoral	O
tavi	B-T058
on	O
perip	B-T038
##roc	I-T038
##ed	I-T038
##ural	I-T038
vascular	B-T017
and	O
bleeding	B-T038
events	O
.	O
this	O
is	O
a	O
retrospective	O
analysis	B-T062
of	O
transf	O
##emoral	O
tavi	B-T058
patients	O
included	O
in	O
a	O
prospective	B-T170
institutional	I-T170
database	I-T170
.	O
the	O
modified	O
femoral	B-T017
artery	I-T017
puncture	B-T058
technique	O
using	O
dsa	B-T058
-	O
derived	O
road	O
mapping	O
guidance	O
was	O
introduced	O
in	O
october	O
2012	O
.	O
before	O
the	O
introduction	O
of	O
this	O
technique	O
,	O
vascular	B-T017
puncture	B-T058
was	O
acquired	O
based	O
on	O
an	O
integration	O
of	O
angiographic	B-T058
data	O
,	O
the	O
bony	O
ili	B-T017
##ofemoral	I-T017
landmarks	B-T082
and	O
a	O
radio	O
##pa	O
##que	O
object	O
.	O
consecutive	O
patients	O
who	O
underwent	O
tavi	B-T058
with	O
the	O
road	O
mapping	O
technique	O
(	O
rm	O
group	O
,	O
n	O
=	O
160	O
)	O
were	O
compared	O
with	O
consecutive	O
patients	O
who	O
underwent	O
tavi	B-T058
without	O
road	O
mapping	O
(	O
control	O
group	O
,	O
n	O
=	O
160	O
)	O
prior	O
to	O
its	O
introduction	O
.	O
a	O
standardised	O
strategy	O
of	O
perip	B-T058
##roc	I-T058
##ed	I-T058
##ural	I-T058
anticoagulation	I-T058
was	O
adopted	O
in	O
both	O
groups	O
as	O
well	O
as	O
the	O
use	O
of	O
a	O
single	B-T074
suture	I-T074
-	I-T074
based	I-T074
closure	I-T074
device	I-T074
.	O
all	O
endpoints	O
were	O
defined	O
according	O
to	O
the	O
var	B-T170
##c	I-T170
-	I-T170
2	I-T170
criteria	I-T170
for	O
event	O
definition	O
.	O
the	O
mean	O
age	O
in	O
the	O
rm	O
group	O
was	O
80	O
##±7	O
.	O
7	O
years	O
compared	O
to	O
81	O
##±5	O
.	O
9	O
years	O
in	O
the	O
control	O
group	O
(	O
p	O
=	O
0	O
.	O
19	O
)	O
,	O
and	O
females	O
were	O
equally	O
distributed	O
between	O
both	O
groups	O
(	O
63	O
.	O
1	O
%	O
vs	O
.	O
58	O
.	O
1	O
%	O
,	O
p	O
=	O
0	O
.	O
36	O
)	O
.	O
the	O
baseline	B-T170
logistic	I-T170
euros	I-T170
##core	I-T170
was	O
20	O
.	O
7	O
##±1	O
##4	O
.	O
4	O
%	O
vs	O
.	O
24	O
.	O
9	O
##±1	O
##5	O
.	O
2	O
%	O
in	O
the	O
rm	O
and	O
control	O
group	O
,	O
respectively	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O
notably	O
,	O
sheath	B-T082
size	I-T082
was	O
significantly	O
larger	O
in	O
the	O
rm	O
compared	O
to	O
the	O
control	O
group	O
due	O
to	O
the	O
more	O
frequent	O
use	O
of	O
the	O
20	O
fr	O
sheath	O
(	O
23	O
.	O
8	O
%	O
vs	O
.	O
1	O
.	O
8	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
associated	O
with	O
the	O
more	O
frequent	O
implantation	B-T058
of	O
the	O
29	O
mm	O
ed	O
##wards	O
sap	O
##ie	O
##n	O
x	O
##t	O
valve	O
in	O
the	O
rm	O
group	O
(	O
43	O
.	O
8	O
%	O
vs	O
.	O
7	O
%	O
,	O
respectively	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
despite	O
the	O
latter	O
finding	O
,	O
both	O
major	O
vascular	O
complications	O
and	O
major	O
bleeding	B-T038
at	O
30	O
days	O
were	O
significantly	O
lower	O
in	O
the	O
rm	O
group	O
compared	O
to	O
the	O
control	O
group	O
(	O
4	O
.	O
3	O
%	O
vs	O
.	O
11	O
.	O
8	O
%	O
,	O
p	O
=	O
0	O
.	O
01	O
,	O
and	O
14	O
.	O
4	O
%	O
vs	O
.	O
25	O
.	O
6	O
%	O
,	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O
an	O
analysis	B-T062
limited	O
to	O
access	O
site	O
-	O
related	O
complications	B-T038
also	O
revealed	O
lower	O
events	O
in	O
the	O
road	O
map	O
group	O
but	O
did	O
not	O
reach	O
statistical	O
significance	O
(	O
8	O
.	O
1	O
%	O
vs	O
.	O
13	O
.	O
8	O
%	O
,	O
p	O
=	O
0	O
.	O
1	O
)	O
.	O
other	O
forms	O
of	O
vascular	O
and	O
bleeding	B-T038
complications	B-T038
as	O
well	O
as	O
all	O
-	O
cause	O
mortality	O
were	O
comparable	O
in	O
both	O
groups	O
.	O
a	O
modified	O
femoral	B-T017
artery	I-T017
puncture	B-T058
technique	O
using	O
dsa	B-T058
and	O
road	O
mapping	O
was	O
associated	O
with	O
a	O
reduction	O
in	O
major	O
vascular	O
and	O
bleeding	B-T038
complications	B-T038
after	O
transf	O
##emoral	O
tavi	B-T058
,	O
and	O
provides	O
a	O
simple	O
and	O
effective	O
strategy	O
for	O
potentially	O
improving	O
patient	B-T170
outcomes	I-T170
.	O

treatment	B-T058
for	O
rheumatoid	B-T038
arthritis	I-T038
and	O
risk	B-T033
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
:	O
a	O
nested	B-T062
case	I-T062
-	I-T062
control	I-T062
analysis	I-T062
it	O
is	O
increasingly	O
becoming	O
accepted	O
that	O
inflammation	B-T038
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	B-T038
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
,	O
as	O
several	O
immune	B-T022
-	O
related	O
genes	B-T017
have	O
been	O
associated	O
with	O
ad	B-T038
.	O
among	O
these	O
is	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
(	I-T103
tnf	I-T103
)	I-T103
-	I-T103
α	I-T103
,	O
a	O
proinflammatory	B-T103
cytokine	I-T103
known	O
to	O
play	O
an	O
important	O
role	O
in	O
autoimmune	B-T038
disorders	I-T038
,	O
including	O
rheumatoid	B-T038
arthritis	I-T038
(	O
ra	B-T038
)	O
.	O
although	O
ad	B-T038
and	O
ra	B-T038
appear	O
to	O
involve	O
similar	O
pathological	B-T038
mechanisms	I-T038
through	O
the	O
production	B-T038
of	O
tnf	B-T103
-	I-T103
α	I-T103
,	I-T103
the	O
relationship	O
between	O
ad	B-T038
and	O
ra	B-T038
remains	O
unknown	O
.	O
to	O
determine	O
the	O
relative	O
risk	O
of	O
ad	B-T038
among	O
ra	B-T038
patients	O
and	O
non	O
-	O
ra	B-T038
patients	O
,	O
and	O
whether	O
anti	B-T058
-	I-T058
tnf	I-T058
therapy	I-T058
for	O
ra	B-T038
was	O
associated	O
with	O
a	O
lower	O
risk	B-T033
of	O
ad	B-T038
in	O
ra	B-T038
patients	O
.	O
we	O
performed	O
a	O
nested	B-T062
case	I-T062
-	I-T062
control	I-T062
study	I-T062
of	O
more	O
than	O
8	O
.	O
5	O
million	O
commercially	O
insured	O
adults	O
(	O
aged	O
≥1	O
##8	O
years	O
)	O
in	O
all	O
50	O
us	B-T082
states	I-T082
,	O
puerto	B-T082
ri	I-T082
##co	I-T082
,	O
and	O
us	B-T082
virgin	I-T082
islands	I-T082
in	O
the	O
ver	B-T170
##isk	I-T170
health	I-T170
claims	I-T170
database	I-T170
.	O
we	O
derived	O
a	O
sub	B-T098
-	I-T098
cohort	I-T098
of	O
subjects	O
with	O
a	O
diagnosis	B-T033
of	O
ra	B-T038
(	O
controls	O
)	O
,	O
or	O
ra	B-T038
and	O
ad	B-T038
(	O
cases	O
)	O
,	O
matching	B-T062
cases	O
and	O
controls	O
based	O
on	O
age	O
,	O
sex	O
,	O
exposure	O
assessment	O
period	O
,	O
and	O
methotrexate	O
treatment	O
.	O
we	O
also	O
assessed	B-T058
relative	I-T058
risk	I-T058
of	O
ad	B-T038
following	O
exposure	O
to	O
standard	O
ra	B-T038
therapies	B-T058
,	O
including	O
anti	B-T103
-	I-T103
tnf	I-T103
agents	I-T103
(	O
infliximab	B-T103
,	O
adalimumab	B-T103
,	O
etanercept	B-T103
)	O
,	O
methotrexate	B-T103
,	O
prednisone	B-T103
,	O
sulf	B-T103
##asal	I-T103
##azine	I-T103
,	O
and	O
rituximab	B-T103
.	O
odds	O
ratios	O
were	O
adjusted	O
for	O
comorbidities	O
,	O
including	O
coronary	B-T038
artery	I-T038
disease	I-T038
,	O
diabetes	B-T038
mellitus	I-T038
,	O
and	O
peripheral	B-T038
vascular	I-T038
disease	I-T038
.	O
ad	B-T038
was	O
more	O
prevalent	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
among	O
ra	B-T038
patients	O
(	O
0	O
.	O
79	O
%	O
)	O
than	O
among	O
those	O
without	O
ra	B-T038
(	O
0	O
.	O
11	O
%	O
)	O
.	O
chronic	B-T033
conditions	I-T033
such	O
as	O
coronary	B-T038
artery	I-T038
disease	I-T038
(	O
odds	O
ratio	O
[	O
or	O
]	O
1	O
.	O
48	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
1	O
.	O
04	O
-	O
2	O
.	O
05	O
;	O
p	O
=	O
0	O
.	O
03	O
)	O
,	O
diabetes	B-T038
(	O
or	O
1	O
.	O
86	O
;	O
95	O
%	O
ci	O
1	O
.	O
32	O
-	O
2	O
.	O
62	O
;	O
p	O
=	O
0	O
.	O
0004	O
)	O
,	O
and	O
peripheral	B-T038
vascular	I-T038
disease	I-T038
(	O
or	O
1	O
.	O
61	O
;	O
95	O
%	O
ci	O
1	O
.	O
06	O
-	O
2	O
.	O
43	O
;	O
p	O
=	O
0	O
.	O
02	O
)	O
significantly	O
increased	O
the	O
relative	O
risk	O
of	O
ad	B-T038
among	O
ra	B-T038
patients	O
.	O
exposure	O
to	O
anti	B-T103
-	I-T103
tnf	I-T103
agents	I-T103
as	O
a	O
class	O
,	O
but	O
not	O
other	O
immunosuppressive	B-T103
drugs	I-T103
studied	O
,	O
was	O
associated	O
with	O
lowered	O
risk	B-T033
of	O
ad	B-T038
among	O
ra	B-T038
patients	O
(	O
unadjusted	O
or	O
0	O
.	O
44	O
;	O
95	O
%	O
ci	O
0	O
.	O
22	O
-	O
0	O
.	O
87	O
;	O
p	O
=	O
0	O
.	O
02	O
;	O
adjusted	O
or	O
0	O
.	O
45	O
;	O
95	O
%	O
ci	O
0	O
.	O
23	O
-	O
0	O
.	O
90	O
;	O
p	O
=	O
0	O
.	O
02	O
)	O
.	O
sub	O
-	O
group	O
analysis	O
demonstrated	O
that	O
of	O
the	O
three	O
anti	B-T103
-	I-T103
tnf	I-T103
agents	I-T103
studied	O
,	O
only	O
etanercept	B-T103
(	O
unadjusted	O
or	O
,	O
0	O
.	O
33	O
;	O
95	O
%	O
ci	O
0	O
.	O
08	O
-	O
0	O
.	O
94	O
;	O
p	O
=	O
0	O
.	O
03	O
;	O
adjusted	O
or	O
0	O
.	O
30	O
;	O
95	O
%	O
ci	O
0	O
.	O
08	O
-	O
0	O
.	O
89	O
;	O
p	O
=	O
0	O
.	O
02	O
)	O
was	O
associated	O
with	O
a	O
decreased	O
risk	B-T033
of	O
ad	B-T038
in	O
ra	B-T038
patients	O
.	O
there	O
is	O
an	O
increased	O
risk	B-T033
of	O
ad	B-T038
in	O
the	O
studied	O
ra	B-T038
population	O
.	O
the	O
relative	O
risk	O
of	O
ad	B-T038
among	O
ra	B-T038
subjects	O
was	O
lowered	O
in	O
those	O
exposed	O
to	O
etanercept	B-T103
.	O
anti	B-T058
-	I-T058
tnf	I-T058
therapy	I-T058
with	O
etanercept	B-T103
shows	O
promise	O
as	O
a	O
potential	O
treatment	B-T058
for	O
ad	B-T038
.	O

estimation	O
of	O
the	O
hiv	B-T005
-	I-T005
1	I-T005
backward	B-T082
mutation	O
rate	O
from	O
transmitted	B-T038
drug	I-T038
-	I-T038
resistant	I-T038
strains	O
one	O
of	O
the	O
serious	O
threats	O
facing	O
the	O
administration	O
of	O
antiretroviral	B-T058
therapy	I-T058
to	O
human	B-T005
immunodeficiency	I-T005
virus	I-T005
(	O
hiv	B-T005
-	I-T005
1	I-T005
)	O
infected	B-T038
patients	O
is	O
the	O
reported	O
increasing	O
prevalence	O
of	O
transmitted	B-T038
drug	I-T038
resistance	I-T038
.	O
however	O
,	O
given	O
that	O
hiv	B-T005
-	I-T005
1	I-T005
drug	B-T038
-	I-T038
resistant	I-T038
strains	O
are	O
often	O
less	O
fit	O
than	O
the	O
wild	B-T017
-	I-T017
type	I-T017
strains	O
,	O
it	O
is	O
expected	O
that	O
drug	B-T038
-	I-T038
resistant	I-T038
strains	O
that	O
are	O
present	O
during	O
the	O
primary	O
phase	O
of	O
the	O
hiv	B-T038
-	I-T038
1	I-T038
infection	I-T038
are	O
replaced	O
by	O
the	O
fit	O
##ter	O
wild	B-T017
-	I-T017
type	I-T017
strains	O
.	O
this	O
replacement	O
of	O
hiv	B-T033
-	I-T033
1	I-T033
resistant	I-T033
mutations	B-T038
involves	O
the	O
emergence	O
of	O
wild	B-T017
-	I-T017
type	I-T017
strains	O
by	O
a	O
process	O
of	O
backward	B-T082
mutation	B-T038
.	O
how	O
quickly	O
the	O
replacement	O
happ	O
##ens	O
is	O
dependent	O
on	O
the	O
class	O
of	O
hiv	B-T005
-	I-T005
1	I-T005
mutation	B-T038
group	O
.	O
we	O
estimate	O
the	O
backward	B-T082
mutation	O
rates	O
and	O
relative	O
fitness	O
of	O
various	O
mutational	B-T038
groups	O
known	O
to	O
confer	O
hiv	B-T005
-	I-T005
1	I-T005
drug	B-T038
resistance	I-T038
.	O
we	O
do	O
this	O
by	O
fitting	O
a	O
stochastic	O
model	O
to	O
data	O
for	O
individuals	B-T098
who	O
were	O
originally	O
infected	B-T033
by	O
an	O
hiv	B-T005
-	I-T005
1	I-T005
strain	O
carrying	O
any	O
one	O
of	O
the	O
known	O
drug	B-T038
resistance	I-T038
-	O
conferring	O
mutations	B-T038
and	O
observed	O
over	O
a	O
period	O
of	O
time	O
to	O
see	O
whether	O
the	O
resistant	O
strain	O
is	O
replaced	O
.	O
to	O
do	O
this	O
,	O
we	O
seek	O
a	O
distribution	O
,	O
generated	O
from	O
simulations	B-T062
of	O
the	O
stochastic	O
model	O
,	O
that	O
best	O
describes	O
the	O
observed	O
(	O
clinical	B-T170
data	I-T170
)	O
replacement	O
times	O
of	O
a	O
given	O
mutation	B-T038
.	O
we	O
found	O
that	O
lamivudine	O
/	O
emt	O
##ric	O
##itabine	O
-	O
associated	O
mutations	B-T038
have	O
a	O
distinctly	O
higher	O
,	O
backward	B-T082
mutation	O
rate	O
and	O
low	O
relative	O
fitness	O
compared	O
to	O
the	O
other	O
classes	B-T170
(	O
as	O
has	O
been	O
reported	O
before	O
)	O
while	O
protease	B-T103
inhibitors	I-T103
-	O
associated	O
mutations	B-T038
have	O
a	O
slower	O
backward	B-T082
mutation	O
rate	O
and	O
high	O
relative	O
fitness	O
.	O
for	O
the	O
other	O
mutation	B-T038
classes	B-T170
,	O
we	O
found	O
more	O
uncertainty	O
in	O
their	O
estimates	O
.	O

the	O
demand	O
for	O
cigarettes	O
in	O
tanzania	B-T082
and	O
implications	O
for	O
tobacco	B-T103
taxa	O
##tion	O
policy	O
the	O
study	B-T062
attempts	O
to	O
estimate	O
the	O
demand	O
for	O
cigarettes	O
in	O
tanzania	B-T082
and	O
presents	O
simulation	B-T062
results	O
on	O
the	O
effect	O
of	O
the	O
cigarette	O
exc	O
##ise	O
tax	O
on	O
smoking	O
participation	O
,	O
government	O
reven	O
##ue	O
,	O
and	O
related	O
topics	O
.	O
after	O
briefly	O
summar	O
##izing	O
the	O
magnitude	O
and	O
spread	O
of	O
cigarette	B-T033
consumption	I-T033
in	O
the	O
country	B-T082
,	O
the	O
paper	O
reviews	O
some	O
empirical	O
estimates	O
from	O
african	B-T082
and	O
other	O
countries	B-T082
.	O
the	O
2008	O
tanzania	B-T082
##n	I-T082
household	B-T170
budget	I-T170
survey	B-T170
was	O
used	O
to	O
estimate	O
the	O
demand	O
for	O
cigarettes	O
in	O
tanzania	B-T082
.	O
the	O
descriptive	O
statistics	O
suggest	O
that	O
the	O
smoking	O
prevalence	O
for	O
tanzania	B-T082
is	O
15	O
.	O
35	O
percent	O
with	O
low	O
variability	O
across	O
expenditure	O
(	O
income	O
)	O
groups	O
.	O
smoking	O
intensity	O
and	O
per	O
capita	O
consumption	O
were	O
estimated	O
at	O
7	O
.	O
08	O
cigarettes	O
and	O
1	O
.	O
33	O
cigarettes	O
,	O
respectively	O
,	O
a	O
relatively	O
low	O
value	O
.	O
a	O
two	B-T170
-	I-T170
part	I-T170
demand	I-T170
equation	I-T170
model	I-T170
was	O
used	O
to	O
estimate	O
various	O
elastic	O
##ities	O
.	O
for	O
the	O
overall	O
equation	O
,	O
the	O
price	O
elastic	O
##ities	O
of	O
smoking	O
participation	O
,	O
smoking	O
intensity	O
,	O
and	O
total	O
elasticity	O
were	O
estimated	O
at	O
-	O
0	O
.	O
87	O
##9	O
,	O
-	O
0	O
.	O
85	O
##3	O
,	O
and	O
-	O
1	O
.	O
73	O
##2	O
,	O
respectively	O
.	O
compared	O
to	O
similar	O
results	O
in	O
other	O
developing	O
countries	O
,	O
the	O
estimates	O
appear	O
quite	O
high	O
.	O
when	O
estimated	O
by	O
expenditure	O
(	O
income	O
)	O
groups	O
,	O
the	O
magnitude	O
of	O
the	O
elasticity	O
appears	O
higher	O
among	O
high	O
expenditure	O
groups	O
than	O
among	O
low	O
expenditure	O
groups	O
.	O
two	O
simulation	B-T062
exercises	O
were	O
undertaken	O
.	O
first	O
,	O
the	O
effect	O
of	O
different	O
exc	O
##ise	O
rates	O
on	O
smoking	O
participation	O
rate	O
,	O
cigarette	B-T033
consumption	I-T033
,	O
tax	O
reven	O
##ue	O
,	O
and	O
related	O
responses	O
was	O
estimated	O
and	O
highlighted	O
.	O
second	O
,	O
the	O
same	O
exercise	O
was	O
undertaken	O
to	O
determine	O
the	O
effect	O
of	O
a	O
given	O
increase	O
in	O
the	O
cigarette	O
exc	O
##ise	O
tax	O
on	O
various	O
expenditure	O
groups	O
.	O
the	O
overall	O
results	O
suggest	O
that	O
an	O
increase	O
in	O
the	O
exc	O
##ise	O
tax	O
on	O
cigarettes	O
in	O
tanzania	B-T082
would	O
reduce	O
cigarette	B-T033
consumption	I-T033
and	O
increase	O
government	O
tax	O
reven	O
##ue	O
.	O

causes	B-T033
of	I-T033
death	I-T033
among	O
children	O
aged	O
5	O
to	O
14	O
years	O
old	O
from	O
2008	O
to	O
2013	O
in	O
ker	O
##sa	O
health	O
and	O
demographic	O
surveillance	O
system	O
(	O
ker	O
##sa	O
hd	O
##ss	O
)	O
,	O
ethiopia	B-T082
the	O
global	O
burden	O
of	O
mortality	O
among	O
children	O
is	O
still	O
very	O
huge	O
though	O
its	O
trend	O
has	O
started	O
declining	O
following	O
the	O
improvements	O
in	O
the	O
living	O
standard	O
.	O
it	O
presents	O
serious	O
challenges	B-T058
to	O
the	O
well	O
-	O
being	O
of	O
children	O
in	O
many	O
african	B-T082
countries	I-T082
.	O
today	O
,	O
sub	B-T082
-	I-T082
saharan	I-T082
africa	I-T082
alone	O
accounts	O
for	O
about	O
50	O
%	O
of	O
global	O
child	O
mortality	O
.	O
the	O
overall	O
objective	B-T170
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
magnitude	O
and	O
distribution	O
of	O
causes	B-T033
of	I-T033
death	I-T033
among	O
children	O
aged	O
5	O
to	O
14	O
year	O
olds	O
in	O
the	O
population	B-T098
of	O
ker	O
##sa	O
hd	O
##ss	O
using	O
verbal	O
autopsy	B-T058
method	O
for	O
the	O
period	O
2008	O
to	O
2013	O
.	O
ker	O
##sa	O
health	O
and	O
demographic	O
surveillance	O
system	O
(	O
ker	O
##sa	O
hd	O
##ss	O
)	O
was	O
established	O
in	O
september	O
2007	O
.	O
the	O
center	O
consists	O
of	O
10	O
rural	O
and	O
2	O
urban	O
ke	B-T098
##be	I-T098
##les	I-T098
which	O
were	O
selected	O
randomly	O
from	O
38	O
ke	B-T098
##be	I-T098
##les	I-T098
in	O
the	O
district	B-T082
.	O
thus	O
this	O
study	O
was	O
conducted	O
in	O
ker	O
##sa	O
hd	O
##ss	O
and	O
data	O
was	O
taken	O
from	O
ker	B-T170
##sa	I-T170
hd	I-T170
##ss	I-T170
database	I-T170
.	O
the	O
study	B-T062
population	B-T098
included	O
all	O
children	O
aged	O
5	O
to	O
14	O
years	O
registered	O
during	O
the	O
period	O
of	O
2008	O
to	O
2013	O
in	O
ker	O
##sa	O
hd	O
##ss	O
using	O
age	O
specific	O
va	O
questionnaires	B-T170
.	O
data	O
were	O
extracted	O
from	O
spss	B-T170
database	I-T170
and	O
analyzed	O
using	O
stat	B-T170
##a	I-T170
.	O
a	O
total	O
of	O
229	O
deaths	B-T033
were	O
recorded	O
over	O
the	O
period	O
of	O
six	O
years	O
with	O
a	O
crude	O
death	O
rate	O
of	O
219	O
.	O
6	O
per	O
100	O
,	O
000	O
population	B-T098
of	O
this	O
age	O
group	O
over	O
the	O
study	B-T062
period	O
.	O
this	O
death	O
rate	O
was	O
217	O
.	O
5	O
and	O
221	O
.	O
5	O
per	O
100	O
,	O
000	O
populations	B-T098
for	O
females	O
and	O
males	O
,	O
respectively	O
.	O
75	O
%	O
of	O
deaths	B-T033
took	O
place	O
at	O
home	O
.	O
the	O
study	B-T062
identified	O
severe	O
malnutrition	B-T038
(	O
33	O
.	O
9	O
%	O
)	O
,	O
intestinal	B-T038
infectious	I-T038
diseases	I-T038
(	O
13	O
.	O
8	O
%	O
)	O
and	O
acute	B-T038
lower	I-T038
respiratory	I-T038
infections	I-T038
(	O
9	O
.	O
2	O
%	O
)	O
to	O
be	O
the	O
three	O
most	O
leading	O
causes	B-T033
of	I-T033
death	I-T033
.	O
in	O
broad	O
causes	B-T033
of	I-T033
death	I-T033
classification	B-T170
,	O
injuries	B-T037
have	O
been	O
found	O
to	O
be	O
the	O
second	O
most	O
cause	B-T033
of	I-T033
death	I-T033
next	O
to	O
communicable	B-T038
diseases	I-T038
(	O
56	O
.	O
3	O
%	O
)	O
attrib	O
##uting	O
to	O
13	O
.	O
1	O
%	O
of	O
the	O
total	O
deaths	B-T033
.	O
in	O
specific	O
causes	B-T033
of	I-T033
death	I-T033
classification	B-T170
severe	O
malnutrition	B-T038
,	O
intestinal	B-T038
infectious	I-T038
diseases	I-T038
and	O
acute	B-T038
lower	I-T038
respiratory	I-T038
infections	I-T038
were	O
the	O
three	O
leading	O
causes	B-T033
of	I-T033
death	I-T033
where	O
,	O
in	O
broad	O
causes	B-T033
of	I-T033
death	I-T033
communicable	B-T038
diseases	I-T038
and	O
injuries	B-T037
were	O
among	O
the	O
leading	O
causes	B-T033
of	I-T033
death	I-T033
.	O
hence	O
,	O
concerned	O
bodies	O
should	O
take	O
measures	O
to	O
aver	O
##t	O
the	O
situation	O
of	O
mortality	O
from	O
these	O
causes	B-T033
of	I-T033
death	I-T033
and	O
further	O
infer	B-T062
##ential	I-T062
analysis	I-T062
into	O
the	O
prevention	B-T058
and	O
management	B-T058
of	O
infectious	B-T038
diseases	I-T038
should	O
also	O
be	O
taken	O
.	O

c4	B-T103
##b	I-T103
binding	I-T103
protein	I-T103
negatively	B-T038
regulates	I-T038
tlr	B-T103
##1	I-T103
/	O
2	B-T103
response	O
tlr2	B-T103
associates	O
with	O
tlr	B-T103
##1	I-T103
and	O
recognizes	O
microbial	O
lipoproteins	B-T103
.	O
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
,	O
a	O
tri	B-T103
##acyl	I-T103
##ated	I-T103
lipoprotein	I-T103
,	O
is	O
anchored	B-T038
to	O
the	O
extracellular	B-T082
domain	I-T082
of	O
tlr	B-T103
##1	I-T103
and	O
tlr2	B-T103
and	O
induces	O
pro	B-T038
-	I-T038
inflammatory	I-T038
signals	B-T038
.	O
here	O
we	O
show	O
that	O
c4	B-T103
##b	I-T103
binding	I-T103
protein	I-T103
(	O
c4	B-T103
##bp	I-T103
)	O
,	O
which	O
is	O
a	O
complement	B-T038
pathway	I-T038
inhibitor	O
,	O
is	O
a	O
tlr2	B-T103
-	O
associated	O
molecule	O
.	O
immunoprecipitation	B-T058
assay	I-T058
using	O
anti	B-T103
-	I-T103
tlr2	I-T103
mab	I-T103
shows	O
that	O
c4	B-T103
##bp	I-T103
binds	B-T038
to	I-T038
tlr2	B-T103
.	O
in	O
c4	B-T017
##bp	I-T017
-	I-T017
deficient	I-T017
mice	B-T204
,	O
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
-	O
induced	O
il	B-T103
-	I-T103
6	I-T103
levels	O
were	O
increased	O
compared	O
with	O
wild	B-T204
type	I-T204
mice	I-T204
.	O
in	O
c4	B-T103
##bp	I-T103
-	O
expressing	B-T038
cells	B-T017
,	O
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
-	O
induced	O
il	B-T038
-	I-T038
8	I-T038
production	I-T038
was	O
reduced	O
depending	O
on	O
the	O
c4	B-T103
##bp	I-T103
expression	O
levels	O
.	O
these	O
results	O
reveal	O
the	O
important	O
role	O
of	O
c4	B-T103
##bp	I-T103
in	O
negative	B-T038
regulation	I-T038
of	O
tlr	B-T103
##1	I-T103
/	O
2	B-T103
-	O
dependent	B-T103
pro	B-T038
-	I-T038
inflammatory	I-T038
cytokine	B-T038
production	I-T038
.	O
furthermore	O
,	O
using	O
a	O
fluorescent	B-T103
conjugated	I-T103
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
,	O
we	O
show	O
that	O
c4	B-T103
##bp	I-T103
blocks	O
the	O
binding	B-T038
of	I-T038
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
to	O
tlr	B-T103
##1	I-T103
/	O
2	B-T103
.	O
finally	O
,	O
we	O
show	O
that	O
exogenous	O
c4	B-T103
##bp	I-T103
also	O
inhibits	O
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
-	O
induced	B-T038
signaling	I-T038
leading	O
to	O
il	B-T038
-	I-T038
8	I-T038
production	I-T038
.	O
our	O
results	O
indicate	O
c4	B-T103
##bp	I-T103
binding	B-T038
to	I-T038
tlr2	B-T103
and	O
consequent	O
neutralization	O
of	O
its	O
activity	B-T038
otherwise	O
inducing	O
pro	B-T038
-	I-T038
inflammatory	I-T038
cytokine	B-T038
production	I-T038
.	O
c4	B-T103
##bp	I-T103
is	O
a	O
negative	B-T038
regulator	I-T038
of	O
tlr	B-T103
##1	I-T103
/	O
2	B-T103
activity	B-T038
.	O

synthesis	O
and	O
characterization	O
of	O
acetylated	B-T103
amyl	I-T103
##ose	I-T103
and	O
development	O
of	O
inclusion	O
complexes	O
with	O
rifampicin	B-T103
amyl	B-T103
##ose	I-T103
(	O
am	B-T103
)	O
tends	O
to	O
form	O
single	O
helical	O
inclusion	O
complexes	O
with	O
suitable	O
agents	B-T103
.	O
these	O
complexes	B-T103
are	O
considered	O
promising	O
biomaterial	B-T103
carrier	O
since	O
the	O
guest	O
molecules	O
can	O
be	O
released	O
later	O
,	O
leading	O
to	O
many	O
applications	O
,	O
especially	O
in	O
the	O
pharmaceutical	B-T092
industry	I-T092
.	O
rifampicin	B-T103
(	O
rif	B-T103
)	O
has	O
long	O
been	O
recognized	O
as	O
an	O
active	O
drug	B-T103
against	O
mycobacterium	B-T007
tuberculosis	I-T007
,	O
however	O
,	O
the	O
administration	B-T058
of	O
rif	B-T103
in	O
high	O
dosages	O
can	O
originate	O
unwanted	O
side	O
-	O
effects	O
.	O
due	O
to	O
the	O
fact	O
that	O
the	O
use	O
of	O
native	O
amyl	B-T103
##ose	I-T103
(	O
am	B-T103
)	O
in	O
the	O
formation	O
of	O
complexes	B-T103
is	O
limited	O
by	O
their	O
low	O
water	O
solubility	O
,	O
it	O
was	O
acetylated	O
with	O
a	O
medium	O
degree	O
of	O
substitution	O
(	O
ds	O
)	O
,	O
allowing	O
solubil	O
##izing	O
(	O
0	O
.	O
5	O
##gl	O
(	O
-	O
1	O
)	O
)	O
acetylated	B-T103
amyl	I-T103
##ose	I-T103
(	O
am	B-T103
##a	I-T103
)	O
in	O
water	B-T103
at	O
neutral	O
ph	O
,	O
in	O
opposition	O
to	O
that	O
observed	O
with	O
native	O
amyl	B-T103
##ose	I-T103
(	O
trace	O
solubility	O
)	O
.	O
the	O
resulting	O
acetylated	B-T103
amyl	I-T103
##ose	I-T103
was	O
characterized	O
by	O
means	O
of	O
fourier	B-T062
transform	I-T062
infrared	I-T062
(	I-T062
ft	I-T062
-	I-T062
ir	I-T062
)	I-T062
spectroscopy	I-T062
and	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
(	O
sem	B-T058
)	O
.	O
ft	B-T062
-	I-T062
ir	I-T062
results	O
indicated	B-T033
that	O
the	O
acetylation	B-T038
of	O
anhydro	B-T103
##glucose	I-T103
units	O
of	O
amyl	B-T103
##ose	I-T103
corresponds	O
to	O
a	O
low	O
ds	O
,	O
whereas	O
sem	B-T058
results	O
suggested	O
that	O
the	O
smooth	B-T082
surfaces	I-T082
of	O
amyl	B-T103
##ose	I-T103
granules	O
were	O
changed	O
into	O
rough	O
##er	O
surfaces	B-T082
after	O
acetylation	B-T038
.	O
ultraviolet	O
absorption	O
spectroscopy	O
(	O
uv	O
-	O
vis	O
)	O
analysis	B-T062
confirmed	O
the	O
formation	O
and	O
allowed	O
the	O
quantification	O
of	O
both	O
native	O
(	O
am	B-T103
-	O
rif	B-T103
)	O
and	O
acetylated	O
(	O
am	B-T103
##a	I-T103
-	O
rif	B-T103
)	O
amyl	B-T103
##ose	I-T103
inclusion	O
complexes	O
.	O
their	O
characterization	O
in	O
solution	O
was	O
performed	O
by	O
dynamic	B-T058
light	I-T058
scattering	I-T058
(	O
dls	B-T058
)	O
and	O
zeta	O
potential	O
(	O
z	O
##p	O
)	O
measurements	O
.	O
the	O
average	B-T082
size	I-T082
of	O
inclusion	O
complexes	O
as	O
determined	O
by	O
dls	B-T058
,	O
ranged	O
between	O
70	O
and	O
100	O
##nm	O
.	O
besides	O
,	O
z	O
##p	O
analysis	B-T062
showed	O
that	O
both	O
complexes	B-T103
are	O
more	O
stable	O
in	O
the	O
presence	B-T033
of	O
rif	B-T103
.	O
this	O
study	O
may	O
lead	O
to	O
the	O
development	O
of	O
an	O
effective	O
method	O
for	O
the	O
preparation	O
of	O
amyl	B-T103
##ose	I-T103
inclusion	O
complexes	O
,	O
which	O
is	O
beneficial	O
to	O
their	O
further	B-T082
application	O
in	O
drug	B-T074
delivery	I-T074
systems	I-T074
.	O

a	O
novel	O
potent	O
anticancer	B-T103
compound	I-T103
optimized	O
from	O
a	O
natural	O
ori	B-T103
##d	I-T103
##onin	I-T103
scaffold	O
induces	O
apoptosis	B-T038
and	O
cell	B-T038
cycle	I-T038
arrest	I-T038
through	O
the	O
mitochondrial	B-T038
pathway	I-T038
the	O
cytotoxicity	B-T038
of	O
the	O
natural	O
ent	B-T103
-	I-T103
ka	I-T103
##uren	I-T103
##e	I-T103
diterp	I-T103
##enoid	I-T103
,	O
ori	B-T103
##d	I-T103
##onin	I-T103
,	O
has	O
been	O
extensively	O
studied	O
.	O
however	O
,	O
the	O
application	O
of	O
ori	B-T103
##d	I-T103
##onin	I-T103
for	O
cancer	B-T058
therapy	I-T058
was	O
hampered	O
primarily	O
by	O
its	O
moderate	O
potency	O
.	O
in	O
this	O
study	O
,	O
a	O
series	O
of	O
ori	B-T103
##d	I-T103
##onin	I-T103
a	B-T103
-	I-T103
ring	I-T103
modified	I-T103
analogues	I-T103
,	I-T103
and	I-T103
their	I-T103
derivatives	I-T103
bearing	O
various	O
substituents	O
on	O
14	O
-	O
oh	O
position	O
,	O
were	O
designed	O
,	O
synthesized	O
,	O
and	O
evaluated	B-T058
for	O
anticancer	B-T103
efficacy	O
.	O
some	O
of	O
the	O
derivatives	B-T103
were	O
significantly	O
more	O
potent	O
than	O
ori	B-T103
##d	I-T103
##onin	I-T103
against	O
both	O
drug	B-T103
-	O
sensitive	O
and	O
drug	B-T038
-	I-T038
resistant	I-T038
cancer	B-T017
cells	I-T017
.	O
the	O
most	O
potent	O
compound	B-T103
,	I-T103
13	I-T103
##p	I-T103
,	O
was	O
200	O
-	O
fold	O
more	O
efficacious	O
than	O
ori	B-T103
##d	I-T103
##onin	I-T103
in	O
mcf	B-T017
-	I-T017
7	I-T017
cancer	I-T017
cells	I-T017
.	O
furthermore	O
,	O
13	B-T103
##p	I-T103
induced	O
apoptosis	B-T038
and	O
cell	B-T038
cycle	I-T038
arrest	I-T038
at	O
the	O
g2	B-T038
/	I-T038
m	I-T038
phase	I-T038
.	O
a	O
decrease	O
in	O
mitochondrial	B-T038
membrane	I-T038
potential	I-T038
and	O
an	O
increase	O
in	O
bax	B-T103
/	I-T103
bcl	I-T103
-	I-T103
2	I-T103
ratio	O
,	O
accompanied	O
by	O
activated	B-T103
caspase	I-T103
-	I-T103
3	I-T103
cleavage	B-T038
,	O
were	O
observed	O
in	O
mcf	B-T017
-	I-T017
7	I-T017
cells	I-T017
after	O
treatment	B-T058
with	O
13	B-T103
##p	I-T103
,	O
suggesting	O
that	O
the	O
mitochondrial	B-T038
pathway	I-T038
was	O
involved	O
in	O
the	O
13	B-T103
##p	I-T103
-	O
mediated	O
apoptosis	B-T038
.	O
moreover	O
,	O
13	B-T103
##p	I-T103
significantly	O
inhibited	O
tumor	O
growth	O
in	O
mouse	B-T204
xenograft	B-T038
models	I-T038
and	O
had	O
no	B-T033
observable	I-T033
toxic	I-T033
effect	I-T033
.	O

internet	O
gam	O
##ing	O
disorder	B-T038
explains	O
unique	O
variance	O
in	O
psychological	O
distress	O
and	O
disability	B-T033
after	O
controlling	O
for	O
comorbid	B-T033
depression	B-T038
,	O
ocd	B-T038
,	O
adhd	B-T038
,	O
and	O
anxiety	B-T033
this	O
study	B-T062
extends	O
knowledge	B-T170
about	O
the	O
relationship	O
of	O
internet	B-T038
gam	I-T038
##ing	I-T038
disorder	I-T038
(	O
igd	B-T038
)	O
to	O
other	O
established	O
mental	B-T038
disorders	I-T038
by	O
exploring	O
comorbidities	O
with	O
anxiety	B-T033
,	O
depression	B-T038
,	O
attention	B-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
,	O
and	O
obsessive	B-T038
compulsive	I-T038
disorder	I-T038
(	O
ocd	B-T038
)	O
,	O
and	O
assessing	O
whether	O
igd	B-T038
accounts	O
for	O
unique	O
variance	O
in	O
distress	B-T033
and	O
disability	B-T033
.	O
an	O
online	B-T170
survey	I-T170
was	O
completed	O
by	O
a	O
convenience	B-T062
sample	I-T062
that	O
engage	O
##s	O
in	O
internet	O
gam	O
##ing	O
(	O
n	O
=	O
40	O
##4	O
)	O
.	O
participants	B-T098
meeting	O
criteria	O
for	O
igd	B-T038
based	O
on	O
the	O
personal	B-T062
internet	I-T062
gam	I-T062
##ing	I-T062
disorder	I-T062
evaluation	I-T062
-	I-T062
9	I-T062
(	O
pie	B-T062
-	I-T062
9	I-T062
)	O
reported	O
higher	O
comorbidity	O
with	O
depression	B-T038
,	O
ocd	B-T038
,	O
adhd	B-T038
,	O
and	O
anxiety	B-T033
compared	O
with	O
those	O
who	O
did	O
not	O
meet	O
the	O
igd	B-T038
criteria	O
.	O
igd	B-T038
explained	O
a	O
small	O
proportion	O
of	O
unique	O
variance	O
in	O
distress	B-T033
(	O
1	O
%	O
)	O
and	O
disability	B-T033
(	O
3	O
%	O
)	O
.	O
igd	B-T038
accounted	O
for	O
a	O
larger	O
proportion	O
of	O
unique	O
variance	O
in	O
disability	B-T033
than	O
anxiety	B-T033
and	O
adhd	B-T038
,	O
and	O
a	O
similar	O
proportion	O
to	O
depression	B-T038
.	O
replication	O
##s	O
with	O
clinical	B-T098
samples	I-T098
using	O
longitudinal	O
designs	O
and	O
structured	O
diagnostic	O
interviews	O
are	O
required	O
.	O

high	O
throughput	O
selection	O
of	O
antibiotic	O
-	O
resistant	O
transgenic	B-T204
arabidopsis	B-T204
plants	I-T204
kanamycin	B-T103
resistance	O
is	O
the	O
most	O
frequently	O
used	O
antibiotic	O
-	O
resistance	O
marker	B-T201
for	O
arabidopsis	B-T204
transformations	B-T038
,	O
however	O
,	O
this	O
method	B-T170
frequently	O
causes	O
escape	O
of	O
untrans	B-T204
##formed	I-T204
plants	I-T204
,	O
particularly	O
at	O
the	O
high	O
seedling	B-T204
density	O
during	O
the	O
selection	O
.	O
here	O
we	O
developed	O
a	O
robust	O
high	O
-	O
density	O
selection	O
method	B-T170
using	O
top	B-T082
agar	B-T103
for	O
arabidopsis	B-T204
thaliana	I-T204
.	O
top	B-T082
agar	B-T103
effectively	O
suppressed	O
growth	B-T038
of	O
untrans	B-T204
##formed	I-T204
wild	I-T204
-	I-T204
type	I-T204
plants	I-T204
on	O
selection	O
media	B-T103
at	O
high	O
density	O
.	O
survival	O
of	O
the	O
transformed	B-T038
plants	B-T204
during	O
the	O
selection	O
were	O
confirmed	B-T033
by	O
production	O
of	O
green	O
true	O
leaves	B-T204
and	O
expression	B-T038
of	O
a	O
fire	B-T103
##fly	I-T103
luciferase	I-T103
reporter	B-T017
gene	I-T017
.	O
top	B-T082
agar	B-T103
method	B-T170
allowed	O
selection	O
using	O
a	O
large	O
amount	O
of	O
seeds	B-T204
in	O
arabidopsis	B-T204
transformation	B-T038
.	O

automated	O
basal	B-T038
cell	I-T038
carcinoma	I-T038
detection	O
in	O
high	B-T058
-	I-T058
definition	I-T058
optical	I-T058
coherence	I-T058
tomography	I-T058
basal	B-T038
cell	I-T038
carcinoma	I-T038
(	O
bcc	B-T038
)	O
is	O
the	O
most	O
common	O
non	B-T038
-	I-T038
melanoma	I-T038
skin	I-T038
cancer	I-T038
.	O
conventional	O
diagnosis	O
of	O
bcc	B-T038
requires	O
invasive	O
biopsies	B-T058
.	O
recently	O
,	O
a	O
high	B-T058
-	I-T058
definition	I-T058
optical	I-T058
coherence	I-T058
tomography	I-T058
(	O
hd	B-T058
-	I-T058
oct	I-T058
)	O
technique	O
has	O
been	O
developed	O
,	O
which	O
provides	O
a	O
non	O
-	O
invasive	O
in	B-T058
vivo	I-T058
imaging	I-T058
method	I-T058
of	O
skin	B-T022
.	O
good	O
agreement	O
##s	O
of	O
bcc	B-T038
features	O
between	O
hd	B-T058
-	I-T058
oct	I-T058
images	O
and	O
histopathological	O
architecture	O
have	O
been	O
found	O
.	O
therefore	O
it	O
is	O
possible	O
to	O
automatically	O
detect	O
bcc	B-T038
using	O
hd	B-T058
-	I-T058
oct	I-T058
.	O
this	O
paper	O
presents	O
a	O
novel	O
bcc	B-T038
detection	B-T058
method	I-T058
that	O
consists	O
of	O
four	O
steps	O
:	O
graph	O
based	O
skin	B-T082
surface	I-T082
segmentation	B-T058
,	O
surface	O
flatten	O
##ing	O
,	O
deep	O
feature	O
extraction	O
and	O
the	O
bcc	B-T038
classification	O
.	O
the	O
effectiveness	O
of	O
the	O
proposed	O
method	O
is	O
well	O
demonstrated	O
on	O
a	O
dataset	O
of	O
5	O
,	O
040	O
images	O
.	O
it	O
can	O
therefore	O
serve	O
as	O
an	O
automatic	O
tool	O
for	O
screening	O
bcc	B-T038
.	O

sulfur	B-T103
and	O
zinc	B-T103
availability	O
from	O
co	O
-	O
granul	O
##ated	O
zn	B-T103
-	O
enriched	O
elemental	B-T103
sulfur	I-T103
fertilizer	B-T103
##s	I-T103
acidification	O
by	O
oxidation	B-T038
of	O
elemental	B-T103
sulfur	I-T103
(	O
es	B-T103
)	O
can	O
solubil	O
##ize	O
zno	B-T103
,	O
providing	O
slow	O
release	O
of	O
both	O
sulfur	B-T103
(	O
s	B-T103
)	O
and	O
zinc	B-T103
(	O
zn	B-T103
)	O
in	O
soil	O
.	O
for	O
this	O
study	O
,	O
a	O
new	O
granular	O
fertilizer	B-T103
with	O
es	B-T103
and	O
zno	B-T103
was	O
produced	O
and	O
evaluated	O
.	O
the	O
effect	O
of	O
incorporating	O
microorganisms	O
or	O
a	O
carbon	B-T103
source	B-T033
in	O
the	O
granule	O
was	O
also	O
evaluated	O
.	O
four	O
granul	O
##ated	O
es	O
-	O
zn	O
fertilizer	O
##s	O
with	O
and	O
without	O
s	O
-	O
oxidizing	O
microorganisms	O
,	O
a	O
commercial	O
es	O
past	O
##ille	O
,	O
zns	B-T103
##o4	I-T103
,	O
and	O
zno	B-T103
were	O
applied	O
to	O
the	O
center	B-T082
of	O
pet	B-T074
##ri	I-T074
dishes	I-T074
containing	O
two	O
contrasting	O
ph	O
soils	O
.	O
soil	O
ph	O
,	O
cacl2	B-T103
-	O
extractable	O
s	B-T103
and	O
zn	B-T103
,	O
and	O
remaining	O
es	B-T103
were	O
evaluated	O
at	O
30	O
and	O
60	O
days	O
in	O
two	O
soil	O
sections	O
(	O
0	O
-	O
5	O
and	O
5	O
-	O
9	O
mm	O
from	O
the	O
fertilizer	B-T103
application	B-T082
site	I-T082
)	O
.	O
a	O
visualization	B-T058
test	I-T058
was	O
performed	O
to	O
evaluate	O
zn	B-T103
diffusion	O
over	O
time	O
.	O
a	O
significant	O
ph	B-T033
decrease	I-T033
was	O
observed	O
in	O
the	O
acidic	B-T103
soil	O
for	O
all	O
es	O
-	O
zn	O
fertilizer	O
treatments	O
and	O
in	O
the	O
alkaline	O
soil	O
for	O
the	O
acid	B-T007
##ithi	I-T007
##obacillus	I-T007
thio	I-T007
##oxid	I-T007
##ans	I-T007
-	O
inoculated	B-T033
treatment	I-T033
only	O
.	O
in	O
agreement	O
with	O
zn	B-T103
visualization	B-T058
tests	I-T058
,	O
extractable	O
-	O
zn	B-T103
concentrations	O
were	O
higher	O
from	O
the	O
point	O
of	O
application	O
in	O
the	O
acidic	B-T103
(	O
62	O
.	O
9	O
mg	O
dm	O
(	O
-	O
3	O
)	O
)	O
compared	O
to	O
the	O
alkaline	O
soil	O
(	O
5	O
.	O
5	O
mg	O
dm	O
(	O
-	O
3	O
)	O
)	O
.	O
elemental	B-T038
s	I-T038
oxidation	I-T038
was	O
greater	O
in	O
the	O
acidic	B-T103
soil	O
(	O
20	O
.	O
9	O
%	O
)	O
than	O
slightly	O
alkaline	O
soil	O
(	O
12	O
%	O
)	O
.	O
the	O
es	O
-	O
zn	O
granular	O
fertilizer	O
##s	O
increased	O
s	B-T103
and	O
zn	B-T103
concentrations	O
in	O
soil	O
and	O
can	O
provide	O
a	O
strategic	O
##ally	O
slow	O
release	O
of	O
nutrients	B-T168
to	O
the	O
soil	O
.	O

in	B-T082
situ	I-T082
stabilization	O
of	O
heavy	B-T103
metals	I-T103
in	O
multiple	O
-	O
metal	B-T103
contaminated	O
pad	B-T204
##dy	I-T204
soil	O
using	O
different	O
steel	B-T103
sla	O
##g	O
-	O
based	O
silicon	B-T103
fertilizer	B-T103
steel	B-T103
sla	O
##g	O
has	O
been	O
widely	O
used	O
as	O
amend	O
##ment	O
and	O
silicon	B-T103
fertilizer	B-T103
to	O
alleviate	O
the	O
mobility	B-T033
and	O
bioavailability	O
of	O
heavy	B-T103
metals	I-T103
in	O
soil	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
evaluate	B-T058
the	O
influence	O
of	O
particle	O
size	O
,	O
composition	O
,	O
and	O
application	O
rate	O
of	O
sla	O
##g	O
on	O
metal	B-T103
immobilization	O
in	O
acidic	B-T103
soil	O
,	O
metals	B-T103
uptake	B-T038
by	O
rice	B-T204
and	O
rice	B-T204
growth	B-T038
.	O
the	O
results	O
indicated	O
that	O
application	O
of	O
sla	O
##g	O
increased	O
soil	O
ph	O
,	O
plant	B-T204
-	O
available	O
silicon	B-T103
concentrations	O
in	O
soil	O
,	O
and	O
decreased	O
the	O
bioavailability	O
of	O
metals	B-T103
compared	O
with	O
control	O
treatment	O
,	O
whereas	O
pul	O
##ver	O
##ous	O
sla	O
##g	O
(	O
s1	O
)	O
was	O
more	O
effective	O
than	O
granular	O
sla	O
##g	O
(	O
s2	O
and	O
s3	O
)	O
.	O
the	O
acid	B-T103
-	O
extractable	O
fraction	O
of	O
cd	B-T103
in	O
the	O
spiked	O
soil	O
was	O
significantly	O
decreased	O
with	O
application	O
of	O
s1	O
at	O
rates	O
of	O
1	O
and	O
3	O
%	O
,	O
acid	O
-	O
extractable	O
fractions	O
of	O
cu	B-T103
and	O
zn	B-T103
were	O
decreased	O
when	O
treated	O
at	O
3	O
%	O
.	O
use	O
of	O
s1	O
at	O
both	O
rates	O
resulted	O
in	O
significantly	O
lower	O
cd	B-T103
,	O
cu	B-T103
,	O
and	O
zn	B-T103
concentrations	O
in	O
rice	B-T204
tissues	B-T017
than	O
in	O
controls	O
by	O
82	O
.	O
6	O
-	O
92	O
.	O
9	O
,	O
88	O
.	O
4	O
-	O
95	O
.	O
6	O
,	O
and	O
67	O
.	O
4	O
-	O
81	O
.	O
4	O
%	O
,	O
respectively	O
.	O
however	O
,	O
use	O
of	O
pul	O
##ver	O
##ous	O
sla	O
##g	O
at	O
1	O
%	O
significantly	O
promotes	O
rice	B-T204
growth	B-T038
,	O
restricted	O
rice	B-T204
growth	B-T038
when	O
treated	O
at	O
3	O
%	O
.	O
thus	O
,	O
the	O
results	O
explained	O
that	O
reduced	O
particle	O
size	O
and	O
suitable	O
application	O
rate	O
of	O
sla	O
##g	O
could	O
be	O
beneficial	O
to	O
rice	B-T204
growth	B-T038
and	O
metals	B-T103
stabilization	O
.	O

the	O
role	O
of	O
mir	B-T103
-	I-T103
45	I-T103
##1	I-T103
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	B-T038
in	O
malignant	B-T038
glioma	I-T038
cells	B-T017
:	O
ampk	B-T103
signaling	B-T038
,	O
mtor	B-T103
modulation	B-T082
and	O
rac1	B-T103
activation	O
required	O
glioblastoma	B-T038
multiforme	I-T038
(	O
gbm	B-T038
)	O
,	O
who	B-T038
grade	I-T038
iv	I-T038
astrocytoma	I-T038
,	O
is	O
the	O
most	O
common	O
primary	B-T038
neoplasm	I-T038
of	O
the	O
central	B-T022
nervous	I-T022
system	I-T022
(	O
cns	B-T022
)	O
and	O
has	O
the	O
highest	O
malignancy	B-T038
and	O
mortality	O
rates	O
.	O
the	O
invasive	O
nature	O
of	O
gbm	B-T038
complicate	O
##s	O
surgical	B-T058
resection	I-T058
and	O
restrict	O
##s	O
chemotherapeutic	O
access	O
,	O
contributing	O
to	O
poor	O
patient	O
prognosis	B-T058
.	O
the	O
migration	B-T038
of	O
tumor	B-T017
cells	I-T017
is	O
closely	O
related	O
to	O
the	O
tumor	B-T017
cell	I-T017
proliferation	O
.	O
the	O
acquisition	O
of	O
migratory	O
capability	O
,	O
in	O
addition	O
to	O
intracellular	B-T082
factors	O
,	O
is	O
proposed	O
to	O
be	O
a	O
crucial	O
mechanism	O
during	O
the	O
progression	O
of	O
invasion	B-T033
.	O
using	O
qrt	B-T062
-	I-T062
pcr	I-T062
analysis	B-T062
,	O
we	O
determined	O
that	O
the	O
expression	B-T038
of	O
mir	B-T017
-	I-T017
45	I-T017
##1	I-T017
in	O
glioma	B-T038
tissue	B-T017
was	O
lower	O
than	O
in	O
control	B-T017
brain	I-T017
tissue	I-T017
,	O
especially	O
in	O
the	O
central	B-T082
portions	B-T082
of	O
the	O
tumor	B-T038
.	O
in	O
glioma	B-T038
cell	B-T017
lines	I-T017
,	O
we	O
found	O
that	O
decreased	O
mir	B-T017
-	I-T017
45	I-T017
##1	I-T017
expression	B-T038
suppressed	O
tumor	B-T017
cell	I-T017
proliferation	O
but	O
enhanced	O
migration	B-T038
with	O
a	O
concomitant	O
low	O
level	O
of	O
cab	B-T103
##39	I-T103
/	O
ampk	B-T103
/	O
mtor	B-T103
pathway	O
activation	O
and	O
high	O
level	O
of	O
rac1	B-T103
/	O
co	O
##fil	O
##in	O
pathway	O
activation	O
,	O
respectively	O
.	O
notably	O
,	O
the	O
effect	O
of	O
mir	B-T103
-	I-T103
45	I-T103
##1	I-T103
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mtor	B-T103
and	O
rac1	B-T103
was	O
limited	O
when	O
ampk	B-T103
##α	I-T103
##1	I-T103
expression	B-T038
was	O
knock	O
##ed	O
-	O
down	O
with	O
a	O
synthetic	O
shrna	B-T103
.	O
we	O
suggest	O
that	O
the	O
glioma	B-T038
microenvironment	O
results	O
in	O
heterogeneity	O
of	O
mir	B-T017
-	I-T017
45	I-T017
##1	I-T017
expression	B-T038
.	O
our	O
data	O
indicated	O
that	O
mir	B-T103
-	I-T103
45	I-T103
##1	I-T103
relay	O
##s	O
environmental	O
signals	O
by	O
upreg	B-T038
##ulating	I-T038
the	O
activity	O
of	O
ampk	B-T103
signaling	B-T038
,	O
thereby	O
modulating	B-T082
the	O
activation	O
of	O
mtor	B-T103
and	O
rac1	B-T103
/	O
co	O
##fil	O
##in	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	B-T038
cell	O
proliferation	O
and	O
migration	B-T038
,	O
respectively	O
.	O
our	O
results	O
highlight	O
the	O
need	O
to	O
consider	O
opposing	O
roles	O
of	O
a	O
therapeutic	O
target	O
which	O
,	O
while	O
suppressing	O
tumor	B-T017
cell	I-T017
proliferation	O
,	O
could	O
also	O
promote	O
cell	B-T017
infiltration	B-T038
.	O

a	O
randomized	B-T062
controlled	I-T062
nonin	I-T062
##ferior	I-T062
##ity	I-T062
trial	I-T062
of	O
single	O
dose	O
of	O
oral	O
dexamethasone	O
versus	O
5	O
days	O
of	O
oral	O
prednisone	O
in	O
acute	O
adult	O
asthma	B-T038
oral	O
dexamethasone	O
demonstrates	O
bioavailability	O
similar	O
to	O
that	O
of	O
oral	O
prednisone	O
but	O
has	O
a	O
longer	O
half	O
-	O
life	O
.	O
we	O
evaluate	O
whether	O
a	O
single	O
dose	O
of	O
oral	O
dexamethasone	O
plus	O
4	O
days	O
of	O
placebo	B-T103
is	O
not	O
inferior	B-T082
to	O
5	O
days	O
of	O
oral	O
prednisone	O
in	O
treatment	O
of	O
adults	O
with	O
mild	B-T033
to	O
moderate	B-T033
asthma	B-T033
exacerbations	I-T033
to	O
prevent	O
relapse	O
defined	O
as	O
an	O
uns	O
##ched	O
##uled	O
return	O
visit	O
for	O
additional	B-T033
treatment	I-T033
for	O
persistent	B-T038
or	O
worsening	O
asthma	B-T038
within	O
14	O
days	O
.	O
adult	O
emergency	O
department	O
patients	O
(	O
aged	O
18	O
to	O
55	O
years	O
)	O
were	O
randomized	B-T062
to	O
receive	O
either	O
a	O
single	O
dose	O
of	O
12	O
mg	O
of	O
oral	O
dexamethasone	O
with	O
4	O
days	O
of	O
placebo	B-T103
or	O
a	O
5	O
-	O
day	O
course	O
of	O
oral	O
prednisone	O
60	O
mg	O
a	O
day	O
.	O
outcomes	O
including	O
relapse	O
were	O
assessed	O
by	O
a	O
follow	B-T058
-	I-T058
up	I-T058
telephone	I-T058
interview	I-T058
at	O
2	O
weeks	O
.	O
one	O
hundred	O
seventy	O
-	O
three	O
dexamethasone	B-T103
and	O
203	O
prednisone	B-T103
subjects	O
completed	O
the	O
study	O
regimen	O
and	O
telephone	B-T058
follow	I-T058
-	I-T058
up	I-T058
.	O
the	O
dexamethasone	B-T103
group	O
by	O
a	O
small	O
margin	O
surpass	O
##ed	O
the	O
pres	O
##et	O
8	O
%	O
difference	O
between	O
groups	O
for	O
nonin	O
##ferior	O
##ity	O
in	O
relapse	O
rates	O
within	O
14	O
days	O
(	O
12	O
.	O
1	O
%	O
versus	O
9	O
.	O
8	O
%	O
;	O
difference	O
2	O
.	O
3	O
%	O
;	O
95	O
%	O
confidence	O
interval	O
-	O
4	O
.	O
1	O
%	O
to	O
8	O
.	O
6	O
%	O
)	O
.	O
subjects	O
in	O
the	O
2	O
groups	O
had	O
similar	O
rates	O
of	O
hospitalization	B-T058
for	O
their	O
relapse	O
visit	B-T058
(	O
dexamethasone	B-T103
3	O
.	O
4	O
%	O
versus	O
prednisone	B-T103
2	O
.	O
9	O
%	O
;	O
difference	O
0	O
.	O
5	O
%	O
;	O
95	O
%	O
confidence	O
interval	O
-	O
4	O
.	O
1	O
%	O
to	O
3	O
.	O
1	O
%	O
)	O
.	O
adverse	O
effect	O
rates	O
were	O
generally	O
the	O
same	O
in	O
the	O
2	O
groups	O
.	O
a	O
single	O
dose	O
of	O
oral	O
dexamethasone	O
did	O
not	O
demonstrate	O
nonin	O
##ferior	O
##ity	O
to	O
prednisone	B-T103
for	O
5	O
days	O
by	O
a	O
very	O
small	O
margin	O
for	O
treatment	O
of	O
adults	O
with	O
mild	B-T033
to	O
moderate	B-T033
asthma	B-T033
exacerbations	I-T033
.	O
enhanced	O
compliance	B-T033
and	O
convenience	O
may	O
support	O
the	O
use	O
of	O
dexamethasone	B-T103
regardless	O
.	O

comparing	O
the	O
effects	O
of	O
different	O
dynamic	B-T058
sitting	I-T058
strategies	I-T058
in	O
wheelchair	B-T074
seat	I-T074
##ing	I-T074
on	O
lumbar	B-T082
-	I-T082
pelvic	I-T082
angle	I-T082
prolonged	O
static	B-T033
sitting	I-T033
in	O
a	O
wheelchair	B-T074
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
lower	B-T033
back	I-T033
pain	I-T033
.	O
the	O
wheelchair	B-T074
seat	I-T074
##ing	I-T074
system	I-T074
is	O
a	O
key	O
factor	O
of	O
this	O
risk	O
because	O
it	O
affects	O
spinal	B-T082
loading	O
in	O
the	O
sitting	B-T033
position	I-T033
.	O
in	O
this	O
study	B-T062
,	O
7	O
dynamic	B-T058
sitting	I-T058
strategies	I-T058
(	O
dss	B-T058
##s	I-T058
)	O
are	O
examined	B-T033
:	O
lumbar	B-T058
prominent	I-T058
dynamic	I-T058
sitting	I-T058
(	O
lp	B-T058
##ds	I-T058
)	O
,	O
back	B-T058
rec	I-T058
##line	I-T058
##d	I-T058
dynamic	I-T058
sitting	I-T058
(	O
br	B-T058
##ds	I-T058
)	O
,	O
femur	B-T058
upward	I-T058
dynamic	I-T058
sitting	I-T058
(	O
fu	B-T058
##ds	I-T058
)	O
,	O
lumbar	B-T058
prominent	I-T058
with	I-T058
back	I-T058
rec	I-T058
##line	I-T058
##d	I-T058
dynamic	I-T058
sitting	I-T058
(	O
lb	B-T058
##ds	I-T058
)	O
,	O
lumbar	B-T058
prominent	I-T058
with	I-T058
femur	I-T058
upward	I-T058
dynamic	I-T058
sitting	I-T058
(	O
lf	B-T058
##ds	I-T058
)	O
,	O
back	B-T058
rec	I-T058
##line	I-T058
##d	I-T058
with	I-T058
femur	I-T058
upward	I-T058
dynamic	I-T058
sitting	I-T058
(	O
bf	B-T058
##ds	I-T058
)	O
,	O
and	O
lumbar	B-T058
prominent	I-T058
with	I-T058
back	I-T058
rec	I-T058
##line	I-T058
##d	I-T058
with	I-T058
femur	I-T058
upward	I-T058
dynamic	I-T058
sitting	I-T058
(	O
lb	B-T058
##fd	I-T058
##s	I-T058
)	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
analyze	B-T062
the	O
biomechanical	O
effects	O
of	O
these	O
sitting	B-T058
strategies	I-T058
on	O
lumbar	B-T082
-	I-T082
pelvic	I-T082
angles	I-T082
.	O
twenty	O
able	B-T033
-	I-T033
bod	I-T033
##ied	I-T033
participants	B-T098
were	O
recruited	O
for	O
the	O
study	B-T062
.	O
all	O
participants	B-T098
performed	O
lp	B-T058
##ds	I-T058
,	O
br	B-T058
##ds	I-T058
,	O
fu	B-T058
##ds	I-T058
,	O
lb	B-T058
##ds	I-T058
,	O
lf	B-T058
##ds	I-T058
,	O
bf	B-T058
##ds	I-T058
,	O
and	O
lb	B-T058
##fd	I-T058
##s	I-T058
in	O
a	O
random	O
order	O
.	O
all	O
lumbar	B-T082
-	I-T082
pelvic	I-T082
angle	I-T082
parameters	O
,	O
including	O
the	O
static	O
lumbar	B-T082
angle	I-T082
,	O
static	O
pelvic	B-T017
angle	I-T017
,	O
lumbar	B-T033
range	I-T033
of	I-T033
motion	I-T033
,	O
and	O
pelvic	B-T033
range	I-T033
of	I-T033
motion	I-T033
were	O
measured	O
and	O
compared	O
.	O
results	O
show	O
that	O
lb	B-T058
##ds	I-T058
and	O
lb	B-T058
##fd	I-T058
##s	I-T058
enabled	B-T038
the	O
most	O
beneficial	O
lumbar	B-T201
movements	I-T201
,	O
although	O
the	O
difference	O
between	O
the	O
2	O
strategies	O
was	O
nonsignificant	B-T033
.	O
br	B-T058
##ds	I-T058
and	O
bf	B-T058
##ds	I-T058
enabled	B-T038
the	O
most	O
beneficial	O
pelvic	B-T058
movements	I-T058
,	O
although	O
the	O
difference	O
between	O
the	O
2	O
strategies	O
was	O
nonsignificant	B-T033
.	O
among	O
all	O
the	O
upright	O
dss	B-T058
##s	I-T058
,	O
lp	B-T058
##ds	I-T058
and	O
lf	B-T058
##ds	I-T058
enabled	B-T038
the	O
most	O
beneficial	O
lumbar	B-T201
and	O
pelvic	B-T058
movements	I-T058
,	O
although	O
no	B-T033
significant	I-T033
difference	O
was	O
observed	O
between	O
these	O
2	O
strategies	O
.	O
we	O
identified	O
the	O
effects	O
and	O
differences	O
among	O
7	O
dss	B-T058
##s	I-T058
on	O
lumbar	B-T082
-	I-T082
pelvic	I-T082
angles	I-T082
.	O
wheelchair	O
users	O
can	O
choose	O
the	O
most	O
suitable	O
dss	B-T058
that	O
meet	O
##s	O
their	O
needs	O
.	O
these	O
findings	B-T033
may	O
serve	O
as	O
a	O
reference	O
for	O
practicing	B-T097
physicians	I-T097
or	O
wheelchair	O
users	O
to	O
choose	O
an	O
appropriate	O
dynamic	O
wheelchair	B-T074
seat	I-T074
##ing	I-T074
system	O
.	O
isr	O
##ct	O
##n1	O
##23	O
##89	O
##80	O
##8	O
,	O
18	O
##th	O
november	O
2016	O
,	O
retrospectively	O
registered	O
.	O

in	O
vitro	O
differentiation	B-T038
of	O
human	B-T204
pluripotent	B-T017
stem	I-T017
cells	I-T017
into	O
trophoblastic	B-T017
cells	I-T017
the	O
placenta	B-T017
is	O
the	O
first	O
organ	B-T017
to	O
develop	O
during	O
embryogenesis	B-T038
and	O
is	O
required	O
for	O
the	O
survival	O
of	O
the	O
developing	O
embryo	B-T017
.	O
the	O
placenta	B-T017
is	O
comprised	O
of	O
various	O
trophoblastic	B-T017
cells	I-T017
that	O
differentiate	B-T038
from	O
the	O
extra	B-T038
-	I-T038
embryonic	I-T038
troph	I-T038
##ect	I-T038
##oderm	I-T038
cells	I-T038
of	O
the	O
preimplantation	B-T038
blastocyst	B-T017
.	O
as	O
such	O
,	O
our	O
understanding	O
of	O
the	O
early	O
differentiation	B-T038
events	I-T038
of	O
the	O
human	B-T204
placenta	B-T017
is	O
limited	O
because	O
of	O
ethical	O
and	O
legal	O
restrictions	O
on	O
the	O
isolation	B-T058
and	O
manipulation	B-T058
of	O
human	B-T204
embryogenesis	B-T038
.	O
human	B-T017
pluripotent	I-T017
stem	I-T017
cells	I-T017
(	O
hps	B-T017
##cs	I-T017
)	O
are	O
a	O
robust	O
model	B-T170
system	I-T170
for	O
investigating	O
human	B-T038
development	I-T038
and	O
can	O
also	O
be	O
differentiated	B-T038
in	O
vitro	O
into	O
trophoblastic	B-T017
cells	I-T017
that	O
express	O
markers	O
of	O
the	O
various	O
trophoblast	B-T017
cell	B-T017
types	I-T017
.	O
here	O
,	O
we	O
present	O
a	O
detailed	O
protocol	O
for	O
differentiating	B-T038
hps	B-T017
##cs	I-T017
into	O
trophoblastic	B-T017
cells	I-T017
using	O
bone	B-T103
morph	I-T103
##ogenic	I-T103
protein	I-T103
4	I-T103
and	O
inhibitors	O
of	O
the	O
activin	B-T103
/	O
nodal	B-T038
signaling	I-T038
pathways	I-T038
.	O
this	O
protocol	O
generates	O
various	O
trophoblast	B-T017
cell	B-T017
types	I-T017
that	O
can	O
be	O
transfected	B-T062
with	O
sirnas	B-T103
for	O
investigating	O
loss	O
-	O
of	O
-	O
function	O
phenotypes	O
or	O
can	O
be	O
infected	B-T033
with	O
pathogens	O
.	O
additionally	O
,	O
hps	B-T017
##cs	I-T017
can	O
be	O
genetically	O
modified	O
and	O
then	O
differentiated	B-T038
into	O
trophoblast	B-T017
progenitors	B-T017
for	O
gain	O
-	O
of	O
-	O
function	O
analyses	O
.	O
this	O
in	O
vitro	O
differentiation	B-T038
method	I-T038
for	O
generating	O
human	B-T204
trophoblast	B-T017
##s	I-T017
starting	O
from	O
hps	B-T017
##cs	I-T017
overcome	O
##s	O
the	O
ethical	O
and	O
legal	O
restrictions	O
of	O
working	O
with	O
early	O
human	B-T204
embryos	B-T017
,	O
and	O
this	O
system	O
can	O
be	O
used	O
for	O
a	O
variety	O
of	O
applications	O
,	O
including	O
drug	B-T062
discovery	I-T062
and	O
stem	B-T062
cell	I-T062
research	I-T062
.	O

clinical	O
experience	O
with	O
the	O
subcutaneous	O
implantable	O
cardioverter	O
-	O
defibrillator	O
in	O
adults	O
with	O
congenital	B-T017
heart	I-T017
disease	I-T017
sudden	B-T038
cardiac	I-T038
death	I-T038
is	O
a	O
major	O
contributor	O
to	O
mortality	O
for	O
adults	O
with	O
congenital	B-T017
heart	I-T017
disease	I-T017
.	O
the	O
subcutaneous	B-T082
implantable	B-T074
cardioverter	I-T074
-	I-T074
defibrillator	I-T074
(	O
icd	B-T074
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	B-T038
cardiac	I-T038
death	I-T038
,	O
but	O
clinical	B-T033
performance	I-T033
data	O
for	O
adults	O
with	O
congenital	B-T017
heart	I-T017
disease	I-T017
are	O
limited	O
.	O
a	O
retrospective	B-T062
study	I-T062
involving	O
7	O
centers	O
over	O
a	O
5	O
-	O
year	O
period	O
beginning	O
in	O
2011	O
was	O
performed	O
.	O
twenty	O
-	O
one	O
patients	O
(	O
median	O
33	O
.	O
9	O
years	O
)	O
were	O
identified	O
.	O
the	O
most	O
common	O
diagnosis	B-T033
was	O
single	B-T017
ventricle	I-T017
physiology	B-T038
(	O
52	O
%	O
)	O
,	O
9	O
palli	B-T058
##ated	I-T058
by	O
fontan	B-T058
operation	I-T058
and	O
2	O
by	O
aorto	B-T058
##p	I-T058
##ulmonary	I-T058
shunts	I-T058
:	O
d	B-T017
-	I-T017
transposition	I-T017
of	I-T017
the	I-T017
great	I-T017
arteries	I-T017
after	O
mustard	B-T058
/	O
sen	B-T058
##ning	I-T058
(	O
n	O
=	O
2	O
)	O
,	O
tetra	B-T017
##lo	I-T017
##gy	I-T017
of	I-T017
fall	I-T017
##ot	I-T017
(	O
n	O
=	O
2	O
)	O
,	O
aortic	B-T038
valve	I-T038
disease	I-T038
(	O
n	O
=	O
2	O
)	O
,	O
and	O
other	O
biv	O
##entricular	O
surgery	B-T058
(	O
n	O
=	O
4	O
)	O
.	O
a	O
prior	O
cardiac	B-T074
device	I-T074
had	O
been	O
implanted	B-T058
in	O
7	O
(	O
33	O
%	O
)	O
.	O
the	O
icd	B-T074
indication	O
was	O
primary	B-T058
prevention	I-T058
in	O
67	O
%	O
and	O
secondary	B-T058
in	O
33	O
%	O
patient	O
s	O
.	O
the	O
most	O
common	O
reason	O
for	O
subcutaneous	B-T082
icd	B-T074
placement	B-T058
was	O
limited	O
transv	B-T082
##eno	I-T082
##us	I-T082
access	I-T082
for	O
ventricular	B-T074
lead	I-T074
placement	B-T058
(	O
n	O
=	O
10	O
)	O
followed	O
by	O
intracardiac	B-T033
right	I-T033
-	I-T033
to	I-T033
-	I-T033
left	I-T033
shunt	I-T033
(	O
n	O
=	O
5	O
)	O
.	O
ventricular	B-T038
arrhythmia	I-T038
was	O
induced	O
in	O
17	O
(	O
81	O
%	O
)	O
and	O
was	O
converted	O
with	O
≤	O
##80	O
jo	O
##ules	O
in	O
all	O
.	O
there	O
was	O
one	O
implant	B-T038
complication	I-T038
related	I-T038
to	I-T038
infection	I-T038
,	O
not	O
requiring	O
device	B-T058
removal	I-T058
.	O
over	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
of	O
14	O
months	O
,	O
4	O
patients	O
(	O
21	O
%	O
)	O
received	O
inappropriate	B-T038
and	O
1	O
(	O
5	O
%	O
)	O
patient	O
received	O
appropriate	B-T038
shocks	I-T038
.	O
there	O
was	O
one	O
arrhythmic	O
death	O
related	O
to	O
as	B-T038
##yst	I-T038
##ole	I-T038
in	O
a	O
single	B-T017
ventricle	I-T017
patient	O
.	O
subcutaneous	B-T082
icd	B-T074
implantation	B-T058
is	O
feasible	O
for	O
adults	O
with	O
congenital	B-T017
heart	I-T017
disease	I-T017
patients	O
.	O
most	O
candidates	O
have	O
single	B-T017
ventricle	I-T017
heart	B-T038
disease	I-T038
and	O
limited	O
transv	B-T082
##eno	I-T082
##us	I-T082
options	I-T082
for	O
icd	B-T074
placement	B-T058
.	O
despite	O
variable	O
anatomy	O
,	O
this	O
study	B-T062
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	B-T038
arrhythmia	I-T038
and	O
reasonable	B-T033
rhythm	B-T038
discrimination	B-T038
during	O
follow	B-T058
-	I-T058
up	I-T058
.	O

effect	O
of	O
ultrasound	O
and	O
enzymatic	B-T103
pre	O
-	O
treatment	O
on	O
yield	O
and	O
properties	O
of	O
ban	B-T168
##ana	I-T168
juice	B-T168
effect	O
of	O
ultrasound	O
and	O
enzymatic	B-T103
pre	O
-	O
treatments	O
with	O
cellulase	B-T103
and	O
pectin	B-T103
##ase	I-T103
on	O
yield	O
and	O
properties	O
of	O
ban	B-T168
##ana	I-T168
juice	B-T168
were	O
investigated	O
.	O
a	O
two	O
-	O
level	O
full	O
factorial	O
design	O
was	O
employed	O
.	O
the	O
factors	O
selected	O
were	O
ultrasonic	O
##ation	O
time	O
(	O
0	O
and	O
30	O
min	O
)	O
,	O
cellulase	B-T103
concentration	O
(	O
0	O
and	O
0	O
.	O
2	O
%	O
)	O
and	O
pectin	B-T103
##ase	I-T103
concentration	O
(	O
0	O
and	O
0	O
.	O
2	O
%	O
)	O
.	O
the	O
responses	O
studied	O
were	O
yield	O
,	O
viscosity	O
,	O
clarity	B-T058
,	O
total	O
soluble	O
solids	O
(	O
tss	O
)	O
and	O
ph	O
.	O
it	O
was	O
observed	O
that	O
pectin	B-T103
##ase	I-T103
was	O
more	O
effective	O
in	O
increasing	O
the	O
yield	O
of	O
juice	B-T168
compared	O
to	O
cellulase	B-T103
.	O
ultrasonic	O
pre	O
-	O
treatment	O
alone	O
did	O
not	B-T033
significantly	O
increase	O
the	O
yield	O
of	O
juice	B-T168
.	O
when	O
ultrasound	O
was	O
combined	O
with	O
pre	O
-	O
treatment	O
with	O
both	O
the	O
enzymes	B-T103
maximum	O
yield	O
of	O
89	O
.	O
40	O
%	O
was	O
obtained	O
compared	O
to	O
47	O
.	O
30	O
%	O
in	O
the	O
control	O
.	O
the	O
viscosity	O
of	O
the	O
juice	B-T168
decreased	O
with	O
addition	O
of	O
enzymes	B-T103
and	O
with	O
application	O
of	O
ultrasound	O
.	O
the	O
clarity	O
of	O
the	O
juice	B-T168
was	O
not	O
affected	O
by	O
cellulase	B-T103
treatment	O
,	O
but	O
improved	B-T033
with	O
pectin	B-T103
##ase	I-T103
treatment	O
.	O
ultrasonic	O
##ation	O
alone	O
was	O
found	O
to	O
be	O
more	O
effective	O
than	O
pectin	B-T103
##ase	I-T103
or	O
cellulase	B-T103
treatment	O
in	O
improving	O
the	O
clarity	B-T201
of	O
the	O
juice	B-T168
.	O
the	O
tss	O
increased	O
with	O
enzymatic	B-T103
treatment	O
,	O
ultrasonic	O
##ation	O
and	O
their	O
combination	O
.	O
ph	O
was	O
not	O
affected	O
by	O
treatment	O
type	O
,	O
but	O
was	O
found	O
to	O
be	O
lower	O
for	O
the	O
treated	O
juice	B-T168
##s	I-T168
.	O
significant	O
correlations	O
were	O
observed	O
between	O
the	O
various	O
responses	O
.	O

a	O
tan	B-T103
##sh	I-T103
##inone	I-T103
i	I-T103
derivative	O
enhances	O
the	O
activities	B-T038
of	O
antibiotics	B-T103
against	O
staphylococcus	B-T007
aureus	I-T007
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
infections	B-T038
caused	O
by	O
staphylococcus	B-T007
aureus	I-T007
are	O
prevalent	O
.	O
the	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	B-T103
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	B-T007
bacteria	I-T007
,	O
represents	O
a	O
major	O
health	O
problem	B-T033
in	O
both	O
hospital	B-T092
and	O
community	B-T092
settings	I-T092
.	O
using	O
antibiotic	B-T103
enhancers	O
to	O
rescue	O
existing	O
classes	O
of	O
antibiotics	B-T103
is	O
an	O
attractive	O
strategy	O
.	O
in	O
this	O
study	B-T062
,	O
16	B-T103
-	I-T103
aldehyde	I-T103
tan	I-T103
##sh	I-T103
##inone	I-T103
i	I-T103
(	O
alt	B-T103
)	O
was	O
synthesized	O
and	O
bacteri	B-T038
##ostatic	I-T038
activity	I-T038
was	O
explored	O
.	O
in	O
addition	O
,	O
synergistic	O
or	O
additive	O
activity	B-T038
between	O
alt	B-T103
and	O
aminoglycoside	B-T103
antibiotics	I-T103
or	O
β	B-T103
-	I-T103
lactam	I-T103
antibiotics	I-T103
in	O
vitro	O
was	O
identified	O
.	O
moreover	O
,	O
alt	B-T103
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	B-T103
(	O
str	B-T103
)	O
and	O
ampicillin	B-T103
(	O
amp	B-T103
)	O
against	O
s	B-T007
.	I-T007
aureus	I-T007
in	O
a	O
murine	B-T038
infection	I-T038
model	I-T038
.	O
primary	O
mechanistic	O
insight	O
indicated	O
that	O
alt	B-T103
could	O
damage	O
the	O
bacterial	B-T007
cell	B-T017
membrane	I-T017
,	O
leading	O
to	O
accumulation	B-T033
of	O
antibiotics	B-T103
inside	O
bacterial	B-T007
cells	I-T007
.	O
this	O
finding	O
might	O
be	O
useful	O
for	O
treating	O
infections	B-T038
caused	O
by	O
s	B-T007
.	I-T007
aureus	I-T007
and	O
expand	O
the	O
scope	O
of	O
application	O
of	O
tan	B-T103
##sh	I-T103
##inone	I-T103
##s	I-T103
.	O

hip	B-T017
segmentation	O
from	O
mri	B-T058
volumes	O
in	O
infants	O
for	O
dd	B-T017
##h	I-T017
diagnosis	B-T033
and	O
treatment	B-T170
planning	I-T170
diagnosis	B-T033
and	O
surgical	B-T058
management	I-T058
of	O
developmental	B-T017
dysplasia	I-T017
of	I-T017
the	I-T017
hip	I-T017
(	O
dd	B-T017
##h	I-T017
)	O
relies	O
on	O
physical	B-T058
examination	I-T058
and	O
2d	O
ultrasound	B-T058
scanning	I-T058
.	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
can	O
be	O
used	O
to	O
complement	O
existing	O
techniques	O
and	O
could	O
be	O
advantageous	O
in	O
treatment	B-T170
planning	I-T170
due	O
to	O
its	O
larger	O
field	O
of	O
view	O
.	O
in	O
this	O
paper	O
we	O
propose	O
a	O
semi	O
-	O
automatic	O
method	B-T170
to	O
segment	B-T170
surface	I-T170
models	I-T170
of	O
the	O
acet	B-T017
##ab	I-T017
##ulum	I-T017
from	O
mri	B-T058
images	O
.	O
the	O
method	B-T170
incorporates	O
clinical	O
knowledge	B-T170
in	O
the	O
form	O
of	O
intensity	B-T170
prior	I-T170
##s	I-T170
which	O
are	O
integrated	O
into	O
a	O
random	B-T170
walker	I-T170
(	I-T170
rw	I-T170
)	I-T170
formulation	I-T170
.	O
we	O
use	O
a	O
modified	O
rw	B-T170
framework	O
which	O
compensate	O
##s	O
for	O
incomplete	O
or	O
blu	O
##r	O
##red	O
boundaries	B-T170
in	O
the	O
image	O
by	O
using	O
information	O
from	O
neighboring	O
slices	O
in	O
the	O
sequence	O
incorporated	O
as	O
node	O
weights	O
.	O
we	O
conducted	O
a	O
pilot	B-T062
study	I-T062
to	O
evaluate	B-T058
the	O
segmentation	O
on	O
a	O
set	O
of	O
10	O
infant	O
hip	B-T017
mri	B-T058
sequences	O
using	O
a	O
1	O
.	O
5	O
tesla	O
mr	B-T074
scanner	I-T074
.	O
contours	B-T082
obtained	O
from	O
the	O
semi	O
-	O
automated	O
segmentation	O
were	O
compared	O
against	O
manually	O
segmented	O
hip	B-T017
contours	B-T082
using	O
dic	O
##e	O
ratio	O
(	O
dr	O
)	O
,	O
ha	O
##us	O
##d	O
##or	O
##ff	O
distance	O
(	O
hd	O
)	O
and	O
root	O
mean	O
square	O
(	O
rms	O
)	O
distance	O
.	O
the	O
proposed	O
method	B-T170
gave	O
values	O
of	O
(	O
dr	O
=	O
0	O
.	O
84	O
±	O
0	O
.	O
5	O
,	O
hd	O
=	O
3	O
.	O
0	O
±	O
0	O
.	O
7	O
,	O
rms	O
=	O
1	O
.	O
9	O
±	O
0	O
.	O
3	O
)	O
and	O
(	O
dr	O
=	O
0	O
.	O
86	O
±	O
0	O
.	O
2	O
,	O
hd	O
=	O
3	O
.	O
0	O
±	O
0	O
.	O
1	O
,	O
rms	O
=	O
2	O
.	O
0	O
±	O
0	O
.	O
6	O
)	O
for	O
right	B-T082
and	O
left	B-T082
acetabular	I-T082
contours	I-T082
respectively	O
which	O
was	O
higher	O
than	O
the	O
corresponding	O
values	O
obtained	O
from	O
conventional	O
rw	B-T170
segmentation	O
.	O
the	O
execution	O
time	O
of	O
the	O
segmentation	O
algorithm	B-T170
was	O
less	O
than	O
~	O
4	O
seconds	O
on	O
a	O
3	O
.	O
5	O
ghz	O
cp	O
##u	O
.	O

normal	O
levels	O
of	O
urinary	B-T031
cc	B-T103
##16	I-T103
protein	I-T103
.	O
comments	B-T170
on	I-T170
beam	I-T170
##er	I-T170
et	I-T170
al	I-T170
.	I-T170
association	I-T170
of	O
children	O
'	O
s	O
urinary	B-T031
cc	B-T103
##16	I-T103
levels	B-T058
with	O
arsenic	B-T058
concentrations	I-T058
in	O
multiple	O
environmental	O
media	O
.	O
int	O
.	O
j	O
.	O
environ	O
.	O
res	O
.	O
public	O
health	O
2016	O
,	O
13	O
,	O
52	O
##1	O
in	O
193	O
##7	O
,	O
max	B-T204
clar	I-T204
##a	I-T204
described	O
a	O
new	O
type	O
of	O
cell	B-T017
in	O
the	O
human	B-T204
lung	B-T017
,	O
which	O
was	O
later	O
determined	O
to	O
be	O
an	O
exocrine	B-T017
secretory	I-T017
cell	I-T017
type	I-T017
containing	I-T017
granules	I-T017
composed	O
of	O
proteins	B-T103
[	O
1	O
]	O
.	O
[	O
.	O
.	O
.	O
]	O
.	O

management	B-T058
and	O
case	B-T062
outcome	I-T062
of	O
gastric	O
impact	O
##ion	O
in	O
four	O
rap	B-T204
##tors	I-T204
:	O
a	O
case	B-T062
series	I-T062
four	O
captive	O
rap	B-T204
##tors	I-T204
,	O
an	O
american	B-T204
ke	I-T204
##st	I-T204
##rel	I-T204
(	O
falc	B-T204
##o	I-T204
spar	I-T204
##ver	I-T204
##ius	I-T204
)	O
,	O
per	B-T204
##eg	I-T204
##rine	I-T204
falc	I-T204
##on	I-T204
(	O
falc	B-T204
##o	I-T204
per	I-T204
##eg	I-T204
##rin	I-T204
##us	I-T204
)	O
,	O
golden	B-T204
ea	I-T204
##gl	I-T204
##e	I-T204
(	O
aqu	B-T204
##ila	I-T204
chrys	I-T204
##ae	I-T204
##to	I-T204
##s	I-T204
)	O
,	O
and	O
bar	B-T204
##n	I-T204
ow	I-T204
##l	I-T204
(	O
ty	B-T204
##to	I-T204
alb	I-T204
##a	I-T204
)	O
,	O
were	O
diagnosed	B-T033
with	O
ventricular	B-T017
and	O
/	O
or	O
proven	B-T017
##tric	I-T017
##ular	I-T017
foreign	B-T037
material	I-T037
impact	B-T038
##ions	I-T038
consisting	O
of	O
artificial	O
tur	O
##f	O
substrate	O
,	O
paper	O
and	O
plastic	O
substrate	O
,	O
grass	B-T204
,	O
and	O
news	B-T170
##pa	I-T170
##per	I-T170
.	O
partial	B-T038
or	I-T038
total	I-T038
anorexia	I-T038
was	O
reported	O
in	O
all	O
birds	B-T204
and	O
decreased	O
casting	B-T058
in	O
2	O
birds	B-T204
.	O
survey	B-T170
radiographs	B-T058
confirmed	O
presence	O
of	O
gastric	B-T017
enlargement	B-T058
in	O
all	O
4	O
birds	B-T204
.	O
the	O
ke	B-T204
##st	I-T204
##rel	I-T204
and	O
ea	B-T204
##gl	I-T204
##e	I-T204
were	O
treated	O
unsuccessful	O
##ly	O
with	O
gastro	B-T058
##sc	I-T058
##opy	I-T058
and	O
gastric	B-T058
lavage	I-T058
,	O
respectively	O
,	O
followed	O
by	O
surgical	B-T033
intervention	I-T033
to	O
remove	O
the	O
ventricular	B-T017
impact	B-T038
##ions	I-T038
.	O
both	O
birds	B-T204
died	B-T033
of	I-T033
undetermined	I-T033
causes	I-T033
after	O
surgery	O
.	O
the	O
per	B-T204
##eg	I-T204
##rine	I-T204
falc	I-T204
##on	I-T204
died	B-T033
before	B-T058
medical	I-T058
or	O
surgical	B-T033
intervention	I-T033
was	O
started	O
,	O
and	O
the	O
ow	B-T204
##l	I-T204
was	O
managed	O
successfully	O
with	O
oral	O
mineral	O
oil	O
and	O
liquid	B-T058
diet	I-T058
to	O
facilitate	B-T037
eg	I-T037
##estion	I-T037
of	I-T037
the	I-T037
foreign	I-T037
material	I-T037
as	O
a	O
pellet	O
.	O
lead	B-T037
poisoning	I-T037
was	O
suspected	O
as	O
the	O
predisposing	O
cause	O
for	O
foreign	B-T037
body	I-T037
ingestion	I-T037
in	O
the	O
ea	B-T204
##gl	I-T204
##e	I-T204
,	O
but	O
underlying	O
causes	O
for	O
pic	B-T038
##a	I-T038
in	O
the	O
other	O
birds	B-T204
were	O
not	O
determined	O
.	O
radiographs	B-T058
can	O
provide	O
useful	O
diagnostic	O
information	O
in	O
sick	B-T033
rap	B-T204
##tors	I-T204
that	O
exhibit	B-T033
vomiting	I-T033
or	O
changes	B-T033
in	I-T033
appetite	I-T033
or	O
casting	B-T058
frequency	I-T058
,	O
and	O
may	O
help	O
guide	O
treatment	B-T058
decisions	I-T058
of	O
impacted	O
birds	B-T204
.	O
careful	O
consideration	B-T033
of	O
substrate	O
,	O
enrichment	O
items	O
,	O
and	O
access	O
to	O
potential	O
foreign	B-T037
material	I-T037
that	I-T037
could	I-T037
be	I-T037
ingested	I-T037
may	O
be	O
the	O
best	O
pre	O
-	O
empt	O
##ive	O
management	B-T058
strategy	I-T058
in	O
captive	O
rap	B-T204
##tors	I-T204
.	O

identification	B-T038
and	O
sar	O
evaluation	B-T058
of	O
hem	B-T103
##ozo	I-T103
##in	I-T103
-	O
inhibiting	O
benz	B-T103
##amides	I-T103
active	O
against	O
plasmodium	B-T204
falciparum	I-T204
quinoline	B-T103
antimalarial	B-T103
##s	I-T103
target	O
hem	B-T103
##ozo	I-T103
##in	I-T103
formation	O
causing	O
a	O
cytotoxic	O
accumulation	B-T033
of	O
fer	B-T103
##ri	I-T103
##pro	I-T103
##to	I-T103
##por	I-T103
##ph	I-T103
##yrin	I-T103
ix	I-T103
(	O
fe	B-T103
(	I-T103
iii	I-T103
)	I-T103
ppi	I-T103
##x	I-T103
)	O
.	O
well	O
-	O
developed	O
sar	O
models	B-T170
exist	O
for	O
β	B-T103
-	I-T103
hemat	I-T103
##in	I-T103
inhibition	O
,	O
parasite	B-T204
activity	O
,	O
and	O
cellular	B-T038
mechanisms	I-T038
for	O
this	O
compound	B-T170
class	I-T170
,	O
but	O
no	O
compar	O
##ably	O
detailed	O
investigations	B-T033
exist	O
for	O
other	O
hem	B-T103
##ozo	I-T103
##in	I-T103
inhibiting	O
chemot	B-T103
##ype	I-T103
##s	I-T103
.	O
here	O
,	O
benz	B-T103
##amide	I-T103
analogues	B-T103
based	O
on	O
previous	O
hts	B-T058
hits	O
have	O
been	O
purchase	O
##d	O
or	O
synthesized	O
.	O
only	O
derivatives	B-T103
containing	I-T103
an	I-T103
electron	I-T103
deficient	I-T103
aromatic	I-T103
ring	I-T103
and	O
capable	O
of	O
adopting	O
flat	B-T082
conformations	I-T082
,	O
optimal	O
for	O
π	O
-	O
π	O
interactions	O
with	O
fe	B-T103
(	I-T103
iii	I-T103
)	I-T103
ppi	I-T103
##x	I-T103
,	O
inhibited	O
β	B-T103
-	I-T103
hemat	I-T103
##in	I-T103
formation	O
.	O
the	O
two	O
most	O
potent	O
analogues	B-T103
showed	O
nanomolar	O
parasite	B-T204
activity	O
,	O
with	O
little	O
cq	B-T103
cross	B-T038
-	I-T038
resistance	I-T038
,	O
low	O
cytotoxicity	B-T038
,	O
and	O
high	O
in	O
vitro	O
microsomal	O
stability	O
.	O
selected	O
analogues	B-T103
inhibited	O
hem	B-T103
##ozo	I-T103
##in	I-T103
formation	O
in	O
plasmodium	B-T204
falciparum	I-T204
causing	O
high	O
levels	O
of	O
free	O
heme	B-T103
.	O
in	O
contrast	O
to	O
quinoline	B-T103
##s	I-T103
,	O
introduction	O
of	O
amine	O
side	O
chains	O
did	O
not	O
lead	O
to	O
benz	B-T103
##amide	I-T103
accumulation	B-T033
in	O
the	O
parasite	B-T204
.	O
these	O
data	O
reveal	O
complex	O
relationships	O
between	O
heme	B-T038
binding	I-T038
,	O
free	O
heme	B-T103
levels	O
,	O
cellular	B-T038
accumulation	I-T038
,	O
and	O
in	O
vitro	O
activity	O
of	O
potential	O
novel	O
antimalarial	B-T103
##s	I-T103
.	O

nursing	B-T170
##stand	I-T170
##ard	I-T170
.	I-T170
com	I-T170
1	O
nurse	B-T097
don	O
##na	O
wood	O
has	O
been	O
suspended	O
for	O
2	O
months	O
by	O
the	O
nursing	B-T092
and	I-T092
midwifery	I-T092
council	I-T092
(	O
nm	B-T092
##c	I-T092
)	O
for	O
conceal	O
##ing	O
the	O
high	B-T033
temperature	I-T033
of	O
colle	B-T097
##ague	I-T097
pa	O
##ulin	O
##e	O
caffe	O
##r	O
##key	O
,	O
who	O
later	O
developed	O
ebola	B-T038
.	O
read	O
more	O
:	O
rc	B-T170
##ni	I-T170
.	I-T170
com	I-T170
/	I-T170
don	I-T170
##na	I-T170
-	I-T170
wood	I-T170
.	O

experimental	B-T062
study	I-T062
in	O
pulmonary	B-T017
artery	I-T017
sealing	B-T058
with	O
a	O
vessel	B-T074
-	I-T074
sealing	I-T074
device	I-T074
the	O
development	O
of	O
vessel	B-T074
-	I-T074
sealing	I-T074
devices	I-T074
will	O
facilitate	O
safety	O
in	O
video	B-T058
-	I-T058
assisted	I-T058
thoracoscopic	I-T058
surgery	I-T058
.	O
our	O
objective	O
was	O
to	O
evaluate	O
the	O
feasibility	O
and	O
safety	O
of	O
sealing	B-T058
pulmonary	B-T017
arteries	I-T017
with	O
the	O
ens	B-T074
##eal	I-T074
tissue	I-T074
-	I-T074
sealing	I-T074
device	I-T074
.	O
pulmonary	B-T017
arteries	I-T017
from	O
be	B-T204
##agle	I-T204
dogs	I-T204
(	O
mean	O
body	O
weight	O
13	O
.	O
1	O
kg	O
,	O
range	O
10	O
.	O
5	O
-	O
15	O
.	O
4	O
kg	O
)	O
were	O
divided	O
into	O
3	O
groups	O
according	O
to	O
the	O
in	B-T082
-	I-T082
vivo	I-T082
sealing	B-T170
method	I-T170
used	O
(	O
ens	B-T074
##eal	I-T074
,	O
ligation	B-T058
,	O
and	O
proximal	B-T082
ligation	B-T058
plus	O
distal	B-T082
ens	B-T074
##eal	I-T074
)	O
and	O
extracted	O
to	O
evaluate	O
the	O
pressure	O
tolerance	O
up	O
to	O
75	O
mm	O
hg	O
at	O
the	O
sealed	O
end	B-T082
.	O
a	O
left	O
lower	O
lobectomy	B-T058
was	O
performed	O
to	O
evaluate	O
chronic	O
-	O
phase	O
durability	O
of	O
the	O
sealed	B-T074
stump	I-T074
##s	I-T074
in	O
a	O
survival	B-T204
model	I-T204
.	O
two	O
or	O
three	O
branches	O
of	O
the	O
pulmonary	B-T017
arteries	I-T017
in	O
each	O
dog	B-T204
were	O
allocated	O
to	O
each	O
of	O
the	O
3	O
groups	O
.	O
after	O
the	O
scheduled	O
survival	O
period	O
,	O
the	O
pulmonary	B-T017
arteries	I-T017
were	O
sampled	O
.	O
pressure	O
tolerance	O
at	O
the	O
sealed	O
end	B-T082
was	O
evaluated	O
in	O
91	O
pulmonary	B-T017
artery	I-T017
sections	O
.	O
all	O
sealed	O
ends	B-T082
showed	O
pressure	O
tolerance	O
>	O
75	O
mm	O
hg	O
.	O
a	O
left	O
lower	O
lobectomy	B-T058
was	O
performed	O
in	O
13	O
dogs	B-T204
in	O
which	O
35	O
pulmonary	B-T017
artery	I-T017
sections	O
had	O
been	O
allocated	O
into	O
the	O
3	O
groups	O
.	O
no	B-T033
sealing	B-T058
failure	O
was	O
found	O
,	O
and	O
pathological	O
findings	B-T033
showed	O
healing	B-T038
and	O
persistent	O
hemostasis	B-T038
at	O
all	O
sealed	O
ends	B-T082
of	O
the	O
pulmonary	B-T017
arteries	I-T017
after	O
2	O
and	O
4	O
weeks	O
of	O
the	O
survival	O
period	O
.	O
pulmonary	B-T017
arteries	I-T017
sealed	O
in	B-T082
vivo	I-T082
with	O
the	O
ens	B-T074
##eal	I-T074
device	I-T074
showed	O
pressure	O
tolerance	O
>	O
75	O
mm	O
hg	O
in	O
the	O
acute	O
phase	O
,	O
and	O
persistent	O
hemostasis	B-T038
after	O
2	O
or	O
4	O
weeks	O
.	O
pulmonary	B-T017
artery	I-T017
sealing	B-T058
with	O
the	O
ens	B-T074
##eal	I-T074
device	I-T074
is	O
feasible	O
and	O
safe	O
in	O
thoracic	B-T058
surgery	I-T058
settings	O
.	O

effect	O
of	O
primary	B-T058
health	I-T058
care	I-T058
reforms	O
in	O
turkey	B-T082
on	O
health	B-T058
service	I-T058
utilization	I-T058
and	O
user	O
satisfaction	O
strengthening	O
primary	B-T058
health	I-T058
care	I-T058
(	O
phc	B-T058
)	O
is	O
considered	O
a	O
priority	O
for	O
efficient	O
and	O
responsive	O
health	B-T092
systems	I-T092
,	O
but	O
empirical	O
evidence	O
from	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	B-T082
is	O
limited	O
.	O
the	O
stepwise	B-T058
introduction	I-T058
of	O
family	B-T091
medicine	I-T091
across	O
all	O
81	O
provinces	B-T082
of	O
turkey	B-T082
(	O
a	O
middle	O
-	O
income	O
country	B-T082
)	O
between	O
2005	O
and	O
2010	O
,	O
aimed	O
at	O
phc	B-T058
strengthening	O
,	O
presents	O
a	O
natural	B-T062
experiment	I-T062
for	O
assessing	O
the	O
effect	O
of	O
family	B-T091
medicine	I-T091
on	O
health	B-T058
service	I-T058
utilization	I-T058
and	O
user	O
satisfaction	O
.	O
the	O
effect	O
of	O
health	B-T092
system	I-T092
reforms	O
,	O
that	O
introduced	O
family	B-T091
medicine	I-T091
,	O
on	O
utilization	O
was	O
assessed	O
using	O
longitudinal	B-T062
,	O
province	B-T062
-	I-T062
level	I-T062
data	I-T062
for	O
12	O
years	O
and	O
multivariate	O
regression	O
models	O
adjusting	O
for	O
supply	O
-	O
side	O
variables	O
,	O
demographics	O
,	O
socio	O
-	O
economic	O
development	O
and	O
underlying	O
yearly	O
trends	O
.	O
user	O
satisfaction	O
with	O
primary	B-T058
and	O
secondary	B-T058
care	I-T058
services	B-T058
was	O
explored	O
using	O
data	O
from	O
annual	B-T170
life	I-T170
satisfaction	I-T170
surveys	I-T170
.	O
trends	O
in	O
preferred	O
first	O
point	O
of	O
contact	O
(	O
primary	B-T058
vs	O
secondary	B-T058
,	O
public	B-T092
vs	O
.	O
private	B-T092
)	O
,	O
reason	O
for	O
choice	O
and	O
health	B-T058
services	I-T058
issues	O
,	O
were	O
described	O
and	O
stratified	O
by	O
patient	O
characteristics	O
,	O
provider	O
type	O
,	O
and	O
rural	B-T082
/	I-T082
urban	I-T082
settings	I-T082
.	O
between	O
2002	O
and	O
2013	O
,	O
the	O
average	O
number	O
of	O
phc	B-T058
consultations	B-T058
increased	O
from	O
1	O
.	O
75	O
to	O
2	O
.	O
83	O
per	O
person	B-T098
per	O
year	O
.	O
in	O
multivariate	O
models	O
,	O
family	B-T091
medicine	I-T091
introduction	B-T058
was	O
associated	O
with	O
an	O
increase	O
of	O
0	O
.	O
37	O
phc	B-T058
consultations	B-T058
per	O
person	B-T098
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
slower	O
annual	O
growth	O
in	O
phc	B-T058
and	O
secondary	B-T058
care	I-T058
consultations	B-T058
.	O
following	O
family	B-T091
medicine	I-T091
introduction	B-T058
,	O
the	O
growth	O
of	O
phc	B-T058
and	O
secondary	B-T058
care	I-T058
consultations	B-T058
per	O
person	B-T098
was	O
0	O
.	O
08	O
and	O
0	O
.	O
30	O
,	O
respectively	O
,	O
a	O
year	O
.	O
phc	B-T058
increased	O
as	O
preferred	O
provider	O
by	O
9	O
.	O
5	O
%	O
over	O
7	O
years	O
with	O
the	O
reasons	O
of	O
proximity	B-T082
and	O
service	O
satisfaction	O
,	O
which	O
increased	O
by	O
14	O
.	O
9	O
%	O
and	O
11	O
.	O
8	O
%	O
,	O
respectively	O
.	O
reporting	B-T058
of	O
poor	O
facility	O
hygiene	O
,	O
difficulty	O
getting	O
an	O
appointment	O
,	O
poor	O
physician	B-T097
behaviour	O
and	O
high	O
costs	O
of	O
health	O
care	O
all	O
declined	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
phc	B-T058
settings	B-T082
,	O
but	O
remained	O
higher	O
among	O
urban	O
,	O
low	B-T033
-	I-T033
income	I-T033
and	O
working	O
-	O
age	O
populations	B-T098
.	O

metabolic	B-T033
responses	I-T033
of	O
the	O
growing	O
daph	B-T204
##nia	I-T204
simil	I-T204
##is	I-T204
to	O
chronic	O
agnps	O
exposure	O
as	O
revealed	O
by	O
gc	O
-	O
q	O
-	O
tof	O
/	O
ms	O
and	O
lc	O
-	O
q	O
-	O
tof	O
/	O
ms	O
silver	B-T103
nanoparticles	O
(	O
agnps	O
)	O
are	O
one	O
of	O
the	O
most	O
widely	O
used	O
nanomaterials	O
.	O
their	O
fast	B-T033
-	I-T033
growing	I-T033
utilization	O
has	O
increased	O
the	O
occurrence	O
of	O
agnps	O
in	O
the	O
environment	B-T082
,	O
pos	O
##ing	O
potential	O
health	O
and	O
ecological	O
risks	O
.	O
in	O
this	O
study	O
,	O
we	O
conducted	O
chronic	B-T058
toxicity	I-T058
tests	I-T058
and	O
investigated	O
the	O
metabolic	B-T103
changes	O
of	O
the	O
growing	O
daph	B-T204
##na	I-T204
simil	I-T204
##is	I-T204
with	O
exposure	O
to	O
0	O
,	O
0	O
.	O
02	O
,	O
and	O
1	O
ppb	O
agnps	O
,	O
using	O
non	B-T058
-	I-T058
targeted	I-T058
mass	I-T058
spectrometry	I-T058
-	O
based	O
metabolomics	B-T091
.	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
study	O
is	O
the	O
first	O
to	O
report	O
the	O
baseline	O
metabolite	B-T103
change	O
of	O
a	O
common	O
aquatic	O
organism	O
daph	B-T204
##nia	I-T204
crustace	I-T204
##an	I-T204
through	O
its	O
life	O
-	O
cycle	O
.	O
the	O
results	O
show	O
a	O
dynamic	B-T033
kinetic	I-T033
pattern	I-T033
of	O
the	O
growing	O
daph	B-T204
##nia	I-T204
'	I-T204
s	I-T204
metabol	O
##ome	O
underwent	O
a	O
cycle	O
from	O
day	O
0	O
to	O
day	O
21	O
,	O
with	O
the	O
level	O
of	O
metabolites	B-T103
gradually	O
increasing	O
from	O
day	O
0	O
to	O
day	O
13	O
,	O
before	O
falling	O
back	O
to	O
the	O
baseline	O
level	O
of	O
day	O
0	O
on	O
day	O
21	O
.	O
as	O
for	O
the	O
samples	O
exposed	O
to	O
environmental	O
concentrations	O
of	O
agnps	O
,	O
although	O
without	O
morphological	B-T033
or	I-T033
structural	I-T033
changes	I-T033
,	O
numerous	O
metabolite	B-T103
changes	O
occurred	O
abrupt	O
##ly	O
during	O
the	O
first	O
10	O
days	O
,	O
and	O
these	O
changes	O
reached	O
steady	O
state	O
by	O
day	O
13	O
.	O
the	O
significant	O
changes	O
in	O
certain	O
metabolites	B-T103
,	O
such	O
as	O
amino	B-T103
acids	I-T103
(	O
serine	B-T103
,	O
threonine	B-T103
and	O
tyrosine	B-T103
)	O
,	O
sugars	B-T103
(	O
d	B-T103
-	I-T103
allo	I-T103
##se	I-T103
)	O
and	O
fatty	B-T103
acids	I-T103
(	O
arachidonic	B-T103
acid	I-T103
)	O
revealed	O
new	O
insights	O
into	O
how	O
these	O
metabolites	B-T103
in	O
daph	B-T204
##nia	I-T204
respond	O
to	O
chronic	O
agnps	O
stress	O
.	O
these	O
findings	O
highlight	O
the	O
capability	O
of	O
metabolomics	B-T091
to	O
discover	O
early	O
metabolic	B-T033
responses	I-T033
to	O
environmental	B-T082
silver	B-T103
nanoparticles	O
.	O

a	O
case	O
based	O
reflection	B-T033
on	O
communicating	O
end	O
of	O
life	O
information	O
in	O
non	O
-	O
english	O
speaking	O
patients	O
mr	O
x	O
was	O
a	O
56	O
year	O
old	O
chinese	B-T098
man	B-T098
(	O
non	O
-	O
english	O
speaking	O
)	O
,	O
who	O
presented	O
to	O
the	O
emergency	B-T092
department	I-T092
with	O
a	O
range	O
of	O
non	O
-	O
specific	O
symptoms	B-T033
.	O
on	O
full	O
workup	O
,	O
he	O
was	O
diagnosed	B-T033
with	O
an	O
advanced	B-T038
cancer	I-T038
of	I-T038
the	I-T038
pancreas	I-T038
.	O
it	O
was	O
an	O
aggressive	O
,	O
highly	O
treatment	O
resistant	O
cancer	O
,	O
with	O
an	O
alarm	O
##ingly	O
poor	B-T033
prognosis	I-T033
.	O
before	O
the	O
diagnosis	B-T033
had	O
been	O
made	O
,	O
the	O
family	O
had	O
informed	O
our	O
team	B-T058
that	O
we	O
were	O
not	O
to	O
discuss	O
medical	O
issues	B-T033
with	O
mr	O
x	O
directly	O
,	O
and	O
that	O
upon	O
arr	O
##iving	O
on	O
a	O
diagnosis	B-T033
we	O
were	O
to	O
come	O
to	O
them	O
first	O
and	O
they	O
would	O
subsequently	O
inform	O
him	O
.	O
they	O
reported	O
that	O
mr	O
x	O
was	O
in	O
support	O
of	O
this	O
arrangement	O
.	O
eventually	O
we	O
tol	O
##d	O
the	O
family	O
about	O
mr	O
x	O
'	O
s	O
diagnosis	B-T033
,	O
and	O
they	O
asser	O
##ted	O
their	O
collective	O
will	O
to	O
keep	O
this	O
information	O
from	O
him	O
,	O
re	O
##aff	O
##irm	O
##ing	O
that	O
all	O
medical	O
discussion	B-T058
go	O
through	O
them	O
.	O
however	O
,	O
the	O
doctor	B-T097
in	I-T097
charge	I-T097
explained	O
the	O
diagnosis	B-T033
to	O
mr	O
x	O
using	O
an	O
interpret	B-T097
##er	I-T097
while	O
his	O
family	O
were	O
away	O
from	O
his	O
bed	O
.	O
in	O
this	O
discussion	O
,	O
i	O
consider	O
this	O
case	O
from	O
the	O
perspective	O
of	O
respect	B-T058
##ing	I-T058
patients	I-T058
'	I-T058
and	I-T058
families	I-T058
'	I-T058
preferences	I-T058
around	O
medical	B-T058
treatment	I-T058
and	I-T058
care	I-T058
.	O

neural	O
correlates	O
of	O
experimental	O
trauma	B-T037
memory	O
retrieval	O
traumatic	O
memories	B-T038
such	O
as	O
intr	B-T170
##usions	I-T170
and	O
flash	O
##back	O
##s	O
play	O
a	O
major	O
role	O
in	O
the	O
development	O
and	O
maintenance	O
of	O
post	B-T038
-	I-T038
traumatic	I-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
.	O
a	O
thorough	O
understanding	O
of	O
the	O
neural	O
mechanisms	O
underlying	O
traumatic	O
memories	B-T038
is	O
indispensable	O
for	O
precise	O
diagnosis	B-T033
,	O
for	O
personalized	O
treatment	B-T058
and	O
prevention	B-T058
.	O
in	O
particular	O
,	O
the	O
identification	O
of	O
early	O
neural	O
predictor	B-T170
variables	I-T170
for	O
intr	B-T170
##usion	I-T170
development	O
shortly	O
after	O
trauma	B-T037
exposure	O
requires	O
detailed	O
investigation	B-T058
.	O
here	O
,	O
we	O
examined	B-T033
the	O
neural	O
correlates	O
of	O
early	O
experimental	O
trauma	B-T037
memory	O
retrieval	O
in	O
a	O
traumatic	O
film	O
paradigm	O
in	O
42	O
young	O
healthy	O
females	O
,	O
using	O
both	O
implicit	B-T033
and	O
explicit	B-T038
retrieval	O
tasks	O
.	O
we	O
show	O
that	O
implicit	B-T033
experimental	O
trauma	B-T037
retrieval	O
specifically	O
involved	O
the	O
retrosp	B-T017
##len	I-T017
##ial	I-T017
cortex	I-T017
and	O
the	O
anterior	B-T017
cingulate	I-T017
cortex	I-T017
(	O
acc	B-T017
)	O
,	O
while	O
both	O
retrieval	O
tasks	O
resulted	O
in	O
trauma	B-T033
-	I-T033
related	I-T033
activity	O
in	O
the	O
posterior	B-T017
cingulate	I-T017
cortex	I-T017
(	O
pcc	B-T017
)	O
and	O
the	O
prec	B-T017
##une	I-T017
##us	I-T017
.	O
importantly	O
,	O
neural	O
activity	O
early	O
after	O
experimental	O
trauma	B-T037
exposure	O
predicted	O
later	O
intr	B-T170
##usion	I-T170
development	O
,	O
with	O
independent	O
contributions	O
from	O
activity	O
in	O
the	O
retrosp	B-T017
##len	I-T017
##ial	I-T017
cortex	I-T017
(	O
implicit	B-T033
retrieval	O
)	O
and	O
the	O
pcc	B-T017
(	O
explicit	B-T038
retrieval	O
)	O
.	O
additional	O
analyses	B-T062
revealed	O
a	O
stronger	O
connectivity	O
between	O
the	O
bilateral	B-T017
amygdala	I-T017
and	O
the	O
supplementary	B-T082
motor	I-T082
area	I-T082
,	O
prec	B-T017
##entral	I-T017
and	O
parac	B-T017
##entral	I-T017
lob	I-T017
##ule	I-T017
for	O
the	O
control	O
group	O
compared	O
to	O
the	O
experimental	O
trauma	B-T037
group	O
.	O
our	O
study	B-T062
gives	O
new	O
insights	O
in	O
the	O
neural	O
correlates	O
of	O
experimental	O
trauma	B-T037
memory	O
retrieval	O
and	O
their	O
predictive	O
value	O
for	O
subsequent	O
symptom	B-T033
development	O
.	O
our	O
results	O
could	O
provide	O
the	O
basis	O
for	O
personalized	O
early	O
treatment	O
and	O
prevention	O
of	O
ptsd	B-T038
.	O
hum	O
brain	O
map	O
##p	O
,	O
2017	O
.	O
©	O
2017	O
wiley	O
periodicals	O
,	O
inc	O
.	O

size	O
matters	O
to	O
function	O
:	O
brain	O
volume	O
correlates	O
with	O
intrinsic	B-T082
brain	B-T038
activity	I-T038
across	O
healthy	O
individuals	B-T098
a	O
fundamental	O
issue	O
in	O
neuroscience	B-T091
is	O
to	O
understand	O
the	O
structural	B-T082
substrates	O
of	O
neural	O
activities	O
.	O
intrinsic	B-T082
brain	B-T038
activity	I-T038
has	O
been	O
increasingly	O
recognized	O
as	O
an	O
important	O
functional	O
activity	O
mode	O
and	O
is	O
tightly	O
linked	O
with	O
various	O
cognitive	B-T038
functions	I-T038
.	O
structurally	O
,	O
cognitive	B-T038
functions	I-T038
have	O
also	O
shown	O
a	O
relation	O
with	O
brain	O
volume	O
/	O
size	O
.	O
therefore	O
,	O
an	O
association	O
between	O
intrinsic	B-T082
brain	B-T038
activities	I-T038
and	O
brain	O
volume	O
/	O
size	O
can	O
be	O
hypothesized	O
,	O
and	O
brain	O
volume	O
/	O
size	O
may	O
impact	O
intrinsic	B-T082
brain	B-T038
activity	I-T038
in	O
human	B-T204
brains	B-T017
.	O
the	O
present	O
study	B-T062
aimed	O
to	O
explicitly	O
investigate	O
this	O
brain	B-T017
structure	I-T017
-	O
function	B-T038
relationship	O
using	O
two	O
large	O
independent	O
cohorts	B-T098
of	O
176	O
and	O
236	O
young	O
adults	O
.	O
structural	B-T082
-	O
mri	B-T058
was	O
performed	O
to	O
estimate	O
the	O
brain	O
volume	O
,	O
and	O
resting	B-T058
-	I-T058
state	I-T058
functional	I-T058
-	I-T058
mri	I-T058
was	O
applied	O
to	O
extract	O
the	O
amplitude	O
of	O
low	O
-	O
frequency	O
fluctuations	O
(	O
alf	O
##f	O
)	O
,	O
an	O
imaging	O
measure	O
of	O
intrinsic	B-T082
brain	B-T038
activity	I-T038
.	O
intriguing	O
##ly	O
,	O
our	O
results	O
revealed	O
a	O
robust	O
linear	B-T082
correlation	O
between	O
whole	O
-	O
brain	O
size	O
and	O
alf	O
##f	O
.	O
moreover	O
,	O
specific	O
brain	B-T017
lobes	I-T017
/	O
regions	B-T082
,	O
including	O
the	O
frontal	B-T017
lobe	I-T017
,	O
the	O
left	B-T017
middle	I-T017
frontal	I-T017
gyrus	I-T017
,	O
anterior	B-T017
cingulate	I-T017
gyrus	I-T017
,	O
ro	B-T017
##land	I-T017
##ic	I-T017
oper	I-T017
##cu	I-T017
##lu	I-T017
##m	I-T017
,	O
and	O
insula	B-T017
,	O
also	O
showed	O
a	O
reliable	O
,	O
positive	B-T033
volume	O
-	O
alf	O
##f	O
correlation	O
in	O
the	O
two	O
cohorts	B-T098
.	O
these	O
findings	O
offer	O
direct	O
,	O
empirical	O
evidence	O
of	O
a	O
strong	O
association	O
between	O
brain	O
size	O
/	O
volume	O
and	O
intrinsic	B-T082
brain	B-T038
activity	I-T038
,	O
as	O
well	O
as	O
provide	O
novel	O
insight	O
into	O
the	O
structural	B-T082
substrates	O
of	O
the	O
intrinsic	B-T082
brain	B-T038
activity	I-T038
of	O
the	O
human	B-T204
brain	B-T017
.	O

effects	O
of	O
a	O
specific	O
blend	O
of	O
essential	B-T103
oils	I-T103
on	O
apparent	O
nutrient	B-T168
digestion	B-T038
,	O
rumen	B-T017
fermentation	B-T038
and	O
rumen	B-T017
microbial	O
populations	O
in	O
sheep	B-T204
fed	O
a	O
50	O
:	O
50	O
alfalfa	B-T204
hay	I-T204
:	O
concentrate	B-T168
diet	I-T168
an	O
experiment	B-T062
was	O
conducted	O
to	O
investigate	O
the	O
effects	O
of	O
a	O
specific	O
mixture	O
of	O
essential	B-T103
oils	I-T103
(	O
me	B-T103
##o	I-T103
)	O
,	O
containing	O
thym	B-T103
##e	I-T103
,	O
clo	B-T103
##ve	I-T103
and	O
cinnam	B-T103
##on	I-T103
eo	I-T103
,	O
on	O
rumen	B-T017
microbial	B-T038
fermentation	I-T038
,	O
nutrient	B-T168
apparent	O
digestibility	B-T033
and	O
blood	B-T031
metabolites	B-T103
in	O
fistula	B-T204
##ted	I-T204
sheep	I-T204
.	O
six	O
sheep	B-T204
fitted	O
with	O
ruminal	B-T017
fistulas	I-T017
were	O
used	O
in	O
a	O
repeated	B-T170
measurement	I-T170
design	I-T170
with	O
two	O
24	O
-	O
d	O
periods	O
to	O
investigate	O
the	O
effect	O
of	O
adding	O
me	B-T103
##o	I-T103
at	O
0	O
(	O
control	O
)	O
,	O
0	O
.	O
8	O
,	O
and	O
1	O
.	O
6	O
ml	O
/	O
d	O
on	O
apparent	O
nutrient	B-T168
digestibility	B-T033
,	O
rumen	B-T017
fermentation	B-T038
characteristics	O
,	O
rumen	B-T017
microbial	O
population	O
and	O
blood	B-T031
chemical	B-T103
metabolites	I-T103
.	O
animals	B-T204
were	O
fed	O
with	O
a	O
50	O
:	O
50	O
alfalfa	B-T204
hay	I-T204
:	O
concentrate	B-T168
diet	I-T168
.	O
ruminal	O
ph	O
,	O
total	O
volatile	B-T103
fatty	I-T103
acids	I-T103
(	O
vf	B-T103
##a	I-T103
)	O
concentration	O
,	O
molar	O
proportion	O
of	O
individual	O
vf	B-T103
##a	I-T103
,	O
acetate	O
:	O
propionate	O
ratio	O
and	O
methane	B-T038
production	I-T038
were	O
not	O
affected	O
with	O
me	B-T103
##o	I-T103
.	O
relative	O
to	O
the	O
control	O
,	O
small	B-T103
peptides	I-T103
plus	O
amino	O
acid	O
nitrogen	O
and	O
large	B-T103
peptides	I-T103
nitrogen	O
concentration	O
in	O
rumen	B-T031
fluid	I-T031
were	O
not	O
affected	O
with	O
me	B-T103
##o	I-T103
supplementation	B-T058
;	O
while	O
,	O
rumen	B-T031
fluid	I-T031
ammonia	B-T103
nitrogen	O
concentration	O
at	O
0	O
and	O
6	O
h	O
after	O
morning	O
feeding	O
in	O
sheep	B-T204
fed	O
with	O
1	O
.	O
6	O
ml	O
/	O
d	O
of	O
me	B-T103
##o	I-T103
was	O
lower	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
compared	O
to	O
the	O
control	O
and	O
0	O
.	O
8	O
ml	O
/	O
d	O
of	O
me	B-T103
##o	I-T103
.	O
at	O
0	O
h	O
after	O
morning	O
feeding	O
,	O
ammonia	B-T103
nitrogen	O
concentration	O
was	O
higher	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
sheep	B-T204
fed	O
0	O
.	O
8	O
ml	O
/	O
d	O
of	O
me	B-T103
##o	I-T103
relative	O
to	O
1	O
.	O
6	O
ml	O
/	O
d	O
and	O
control	O
diet	B-T168
.	O
ruminal	B-T204
protozoa	I-T204
and	O
hyper	B-T007
ammonia	I-T007
producing	I-T007
(	I-T007
hap	I-T007
)	I-T007
bacteria	I-T007
counts	B-T058
were	O
not	O
affected	O
by	O
addition	O
of	O
me	B-T103
##o	I-T103
in	O
the	O
diet	B-T168
.	O
relative	O
to	O
the	O
control	O
,	O
no	O
changes	O
were	O
observed	O
in	O
the	O
red	B-T058
and	O
white	B-T033
blood	I-T033
cells	I-T033
,	O
hemoglobin	B-T058
,	O
hematocrit	B-T033
,	O
glucose	B-T058
,	O
beta	B-T103
-	I-T103
hydroxybut	I-T103
##yric	I-T103
acid	I-T103
,	O
cholesterol	B-T058
,	O
total	B-T058
protein	I-T058
,	O
albumin	B-T058
,	O
blood	B-T058
urea	I-T058
nitrogen	I-T058
and	O
aspartate	B-T058
aminotransferase	I-T058
and	O
alanine	B-T058
aminotransferase	I-T058
concentration	O
.	O
apparent	O
total	B-T033
tract	I-T033
digestibility	I-T033
of	O
dry	O
matter	O
,	O
crude	B-T103
prote	I-T103
##n	I-T103
,	O
organic	O
matter	O
,	O
and	O
neutral	O
detergent	O
fiber	O
were	O
not	O
influenced	O
by	O
me	B-T103
##o	I-T103
supplementation	B-T058
.	O
the	O
results	O
of	O
the	O
present	O
study	O
suggested	O
that	O
supplementation	B-T058
of	O
me	B-T103
##o	I-T103
may	O
have	O
limited	O
effects	O
on	O
apparent	O
nutrient	B-T168
digestibility	B-T033
,	O
ruminal	B-T038
fermentation	I-T038
and	O
protozoa	B-T204
and	O
hap	B-T007
bacteria	I-T007
count	B-T058
,	O
blood	B-T017
cells	I-T017
and	O
metabolites	B-T103
.	O

membrane	B-T038
protein	I-T038
solubilization	I-T038
and	O
composition	O
of	O
protein	B-T103
detergent	B-T103
complexes	B-T103
membrane	B-T103
proteins	I-T103
are	O
typically	B-T038
expressed	I-T038
in	O
heterologous	O
systems	O
with	O
a	O
view	O
to	O
in	O
vitro	O
characterization	O
.	O
a	O
critical	O
step	O
in	O
the	O
preparation	O
of	O
membrane	B-T103
proteins	I-T103
after	O
expression	B-T038
in	O
any	O
system	O
is	O
the	O
solubilization	B-T038
of	I-T038
the	I-T038
protein	I-T038
in	O
aqueous	O
solution	O
,	O
typically	O
using	O
detergents	B-T103
and	O
lipids	B-T103
,	O
to	O
obtain	O
the	O
protein	B-T103
in	O
a	O
form	O
suitable	O
for	O
purification	O
,	O
structural	B-T058
or	O
functional	O
analysis	B-T062
.	O
this	O
process	O
is	O
particularly	O
difficult	O
as	O
the	O
objective	O
is	O
to	O
prepare	O
the	O
protein	B-T103
in	O
an	O
unn	O
##atur	O
##al	O
environment	B-T082
,	O
a	O
protein	B-T103
detergent	B-T103
complex	B-T103
,	O
separating	O
it	O
from	O
its	O
natural	O
lipid	B-T103
partners	O
while	O
causing	O
the	O
minimum	O
destabilization	B-T038
or	O
modification	B-T033
of	O
the	O
structure	B-T082
.	O
although	O
the	O
process	O
is	O
difficult	O
,	O
and	O
relatively	O
hard	O
to	O
master	O
,	O
an	O
increasing	O
number	O
of	O
membrane	B-T103
proteins	I-T103
have	O
been	O
successfully	O
isolated	O
after	O
expression	B-T038
in	O
a	O
wide	O
variety	O
of	O
systems	O
.	O
in	O
this	O
chapter	O
we	O
give	O
a	O
general	B-T170
protocol	I-T170
for	O
preparing	O
protein	B-T103
detergent	B-T103
complexes	B-T103
that	O
is	O
aimed	O
at	O
guiding	O
the	O
reader	O
through	O
the	O
different	O
critical	O
steps	O
.	O
in	O
the	O
second	O
part	O
of	O
the	O
chapter	O
we	O
illustrate	O
how	O
to	O
analyze	B-T062
the	O
composition	O
of	O
protein	B-T103
detergent	B-T103
complexes	B-T103
;	O
this	O
analysis	B-T062
is	O
important	O
as	O
it	O
has	O
been	O
found	O
that	O
compositional	O
variation	O
often	O
causes	O
irre	O
##produc	O
##ible	O
results	O
.	O

modified	O
anastomotic	B-T058
technique	I-T058
for	O
thorac	B-T058
##ola	I-T058
##par	I-T058
##oscopic	I-T058
iv	I-T058
##or	I-T058
-	I-T058
lewis	I-T058
esophagectomy	I-T058
:	O
early	O
outcomes	O
and	O
technical	O
details	O
thoracoscopic	B-T058
intrathoracic	I-T058
esophag	I-T058
##ogas	I-T058
##tr	I-T058
##ostomy	I-T058
is	O
a	O
technically	O
demanding	O
operation	O
;	O
these	O
technical	O
requirements	O
restrict	O
the	O
extensive	O
application	O
of	O
minimally	O
invasive	O
iv	B-T058
##or	I-T058
-	I-T058
lewis	I-T058
esophagectomy	I-T058
.	O
in	O
an	O
attempt	O
to	O
reduce	O
the	O
difficulty	O
of	O
this	O
surgical	B-T058
procedure	I-T058
,	O
this	O
study	O
developed	O
a	O
modified	O
anastomotic	B-T058
technique	I-T058
for	O
thorac	B-T058
##ola	I-T058
##par	I-T058
##oscopic	I-T058
iv	I-T058
##or	I-T058
-	I-T058
lewis	I-T058
esophagectomy	I-T058
.	O
during	O
the	O
entire	O
##ty	O
of	O
this	O
modified	O
approach	O
,	O
neither	O
technically	O
challenging	O
operations	B-T058
such	O
as	O
intrathoracic	B-T058
suturing	I-T058
or	O
knot	B-T058
##ting	I-T058
,	O
nor	O
special	O
instruments	B-T074
such	O
as	O
an	O
or	B-T074
##vi	I-T074
##l	I-T074
system	I-T074
or	O
a	O
reverse	B-T074
-	I-T074
puncture	I-T074
head	I-T074
are	O
required	O
.	O
between	O
october	O
2015	O
and	O
january	O
2016	O
,	O
15	O
consecutive	O
patients	O
with	O
cancer	B-T038
in	O
the	O
distal	B-T082
third	I-T082
of	I-T082
the	I-T082
esophagus	I-T082
or	O
the	O
gastric	B-T082
cardi	I-T082
##a	I-T082
underwent	O
this	O
modified	O
surgical	B-T058
procedure	I-T058
.	O
the	O
good	O
short	O
-	O
term	O
outcomes	O
that	O
were	O
achieved	O
suggest	O
that	O
the	O
modified	O
anastomotic	B-T058
technique	I-T058
is	O
safe	O
and	O
feasible	O
for	O
thorac	B-T058
##ola	I-T058
##par	I-T058
##oscopic	I-T058
iv	I-T058
##or	I-T058
-	I-T058
lewis	I-T058
esophagectomy	I-T058
.	O

salv	B-T103
##ian	I-T103
##olic	I-T103
acids	I-T103
for	O
injection	B-T103
(	O
saf	B-T103
##i	I-T103
)	O
suppresses	O
inflammatory	B-T038
responses	I-T038
in	O
activated	O
microglia	B-T017
to	O
attenuate	O
brain	B-T037
damage	I-T037
in	O
focal	B-T038
cerebral	I-T038
ischemia	I-T038
inflammatory	B-T038
reactions	I-T038
induced	O
by	O
microglia	B-T017
in	O
the	O
brain	B-T017
play	O
crucial	O
roles	O
in	O
ischemia	B-T038
/	O
reperfusion	B-T037
(	I-T037
i	I-T037
/	I-T037
r	I-T037
)	I-T037
cerebral	I-T037
injuries	I-T037
.	O
microglia	B-T017
activation	O
has	O
been	O
shown	O
to	O
be	O
closely	O
related	O
to	O
tlr4	B-T038
/	O
nf	B-T038
-	I-T038
κb	I-T038
signal	I-T038
pathways	I-T038
.	O
salv	B-T103
##ian	I-T103
##olic	I-T103
acids	I-T103
for	O
injection	B-T103
(	O
saf	B-T103
##i	I-T103
)	O
have	O
been	O
used	O
in	O
clinical	O
practice	O
to	O
treat	O
ischemic	B-T038
stroke	I-T038
with	O
reported	B-T058
neuroprotective	O
effects	O
;	O
however	O
,	O
the	O
underlying	O
mechanisms	O
are	O
still	O
uncertain	O
.	O
first	O
,	O
we	O
studied	B-T062
the	O
effect	O
of	O
saf	B-T103
##i	I-T103
on	O
inflammatory	B-T038
responses	I-T038
in	O
lps	B-T103
-	O
stimulated	O
bv	B-T007
-	I-T007
2	I-T007
microglia	B-T017
.	O
then	O
,	O
to	O
discover	O
whether	O
the	O
beneficial	O
in	O
vitro	O
effects	O
of	O
saf	B-T103
##i	I-T103
lead	O
to	O
in	O
vivo	O
therapeutic	B-T201
effect	I-T201
s	O
,	O
an	O
mcao	B-T017
(	O
middle	B-T017
cerebral	I-T017
artery	I-T017
occlusion	I-T017
)	O
rat	B-T204
model	B-T038
was	O
further	O
employed	B-T033
to	O
elucidate	O
the	O
probable	O
mechanism	O
of	O
saf	B-T103
##i	I-T103
in	O
treating	O
ischemic	B-T038
stroke	I-T038
.	O
rats	B-T204
in	O
the	O
saf	B-T103
##i	I-T103
group	O
were	O
given	O
saf	B-T103
##i	I-T103
(	O
23	O
or	O
46	O
##mg	O
/	O
kg	O
)	O
before	O
i	B-T038
/	O
r	B-T037
injury	I-T037
.	O
the	O
results	O
showed	O
that	O
saf	B-T103
##i	I-T103
treatment	O
significantly	O
decreased	O
neuroinflammation	B-T038
and	O
the	O
infarction	B-T038
volume	O
compared	O
with	O
the	O
vehicle	B-T103
group	O
.	O
activation	O
of	O
microglia	B-T017
cells	I-T017
was	O
reduced	O
,	O
and	O
tlr4	B-T038
/	O
nf	B-T038
-	I-T038
κb	I-T038
signals	I-T038
,	O
which	O
were	O
markedly	O
inhibited	O
by	O
saf	B-T103
##i	I-T103
treatment	O
in	O
ischemic	O
hemisphere	B-T017
,	O
were	O
accompanied	O
by	O
reduced	O
expression	B-T038
and	O
release	B-T058
of	O
cytokines	B-T103
il	B-T103
-	I-T103
1β	I-T103
and	O
il	B-T103
-	I-T103
6	I-T103
.	O
this	O
study	B-T062
provides	O
evidence	O
that	O
saf	B-T103
##i	I-T103
effectively	O
protects	O
the	O
brain	B-T017
after	O
cerebral	B-T038
ischemia	I-T038
,	O
which	O
may	O
be	O
caused	O
by	O
attenuating	O
inflammation	B-T038
in	O
microglia	B-T017
.	O

stepwise	O
cyclo	B-T038
##prop	I-T038
##anat	I-T038
##ion	I-T038
on	O
the	O
polyc	B-T103
##yclo	I-T103
##prop	I-T103
##anate	I-T103
##d	I-T103
poly	I-T103
##ket	I-T103
##ide	I-T103
formation	O
in	O
jaw	B-T103
##sa	I-T103
##my	I-T103
##cin	I-T103
biosynthesis	O
jaw	B-T103
##sa	I-T103
##my	I-T103
##cin	I-T103
is	O
a	O
poly	B-T103
##ket	I-T103
##ide	I-T103
-	O
nucleoside	B-T103
hybrid	O
with	O
a	O
unique	O
polyc	B-T103
##yclo	I-T103
##prop	I-T103
##ane	I-T103
moiety	O
on	O
a	O
single	O
poly	B-T103
##ket	I-T103
##ide	I-T103
chain	I-T103
.	O
the	O
unexpected	O
isolation	O
of	O
cyclo	B-T103
##prop	I-T103
##ane	I-T103
deficient	O
jaw	B-T103
##sa	I-T103
##my	I-T103
##cin	I-T103
analogs	O
allowed	O
us	O
to	O
propose	O
a	O
stepwise	O
cyclo	B-T038
##prop	I-T038
##anat	I-T038
##ion	I-T038
mechanism	O
for	O
the	O
enzymatic	B-T103
synthesis	O
of	O
this	O
poly	B-T103
##ket	I-T103
##ide	I-T103
.	O
the	O
concise	O
timing	O
of	O
the	O
cyclo	B-T038
##prop	I-T038
##anat	I-T038
##ion	I-T038
could	O
be	O
regulated	O
by	O
a	O
del	O
##icate	O
balance	O
between	O
reaction	O
rates	O
of	O
the	O
condensation	O
and	O
cyclo	B-T038
##prop	I-T038
##anat	I-T038
##ion	I-T038
reactions	I-T038
.	O

condition	O
-	O
dependent	O
co	B-T038
-	I-T038
regulation	I-T038
of	O
genomic	B-T017
clusters	I-T017
of	O
virulence	B-T103
factors	I-T103
in	O
the	O
grape	B-T038
##vin	I-T038
##e	I-T038
trunk	I-T038
pathogen	O
neo	B-T204
##fu	I-T204
##si	I-T204
##co	I-T204
##cc	I-T204
##um	I-T204
parvum	I-T204
the	O
asc	B-T204
##omyc	I-T204
##ete	I-T204
neo	B-T204
##fu	I-T204
##si	I-T204
##co	I-T204
##cc	I-T204
##um	I-T204
parvum	I-T204
,	O
one	O
of	O
the	O
causal	B-T033
agents	I-T033
of	O
bot	B-T204
##ry	I-T204
##osph	I-T204
##aer	I-T204
##ia	I-T204
die	I-T204
##back	I-T204
,	O
is	O
a	O
destructive	O
wood	O
-	O
infecting	B-T033
fungus	B-T204
and	O
a	O
serious	O
threat	O
to	O
grape	B-T168
production	O
worldwide	B-T098
.	O
the	O
capability	O
of	O
colon	B-T033
##izing	I-T033
wood	B-T017
##y	I-T017
tissue	I-T017
combined	O
with	O
the	O
secretion	B-T038
of	O
phyto	O
##to	O
##x	O
##ic	O
compounds	B-T103
is	O
thought	O
to	O
underlie	O
its	O
pathogenicity	O
and	O
virulence	B-T038
.	O
here	O
,	O
we	O
describe	O
the	O
repertoire	O
of	O
virulence	B-T103
factors	I-T103
and	O
their	O
transcriptional	B-T038
dynamics	O
as	O
the	O
fungus	B-T204
feeds	B-T168
on	O
different	O
substrates	O
and	O
colon	B-T033
##izes	I-T033
the	O
wood	B-T204
##y	I-T204
stem	I-T204
.	O
we	O
assembled	O
and	O
annotated	O
a	O
highly	O
contiguous	B-T082
genome	B-T017
using	O
single	O
molecule	O
real	O
-	O
time	O
dna	O
sequencing	O
.	O
transcriptome	B-T058
profiling	I-T058
by	O
rna	B-T058
-	I-T058
sequencing	I-T058
determined	O
the	O
genome	B-T017
-	O
wide	O
patterns	B-T082
of	O
expression	B-T038
of	O
virulence	B-T103
factors	I-T103
both	O
in	O
vitro	O
(	O
potato	B-T168
dextrose	B-T103
agar	I-T103
or	O
medium	B-T103
amended	O
with	O
grape	B-T168
wood	O
as	O
substrate	O
)	O
and	O
in	O
plant	B-T204
##a	I-T204
.	O
pairwise	B-T170
statistical	I-T170
testing	I-T170
of	O
differential	O
expression	B-T038
followed	O
by	O
co	B-T062
-	I-T062
expression	I-T062
network	I-T062
analysis	I-T062
revealed	O
that	O
physically	O
clustered	B-T017
genes	I-T017
coding	B-T082
for	O
putative	O
virulence	B-T038
functions	O
were	O
induced	O
depending	O
on	O
substrate	O
or	O
stage	O
of	O
plant	B-T204
infection	B-T038
.	O
co	B-T038
-	I-T038
expressed	I-T038
gene	B-T017
clusters	I-T017
were	O
significantly	O
enriched	O
not	O
only	O
in	O
genes	B-T017
associated	O
with	O
secondary	B-T038
metabolism	I-T038
,	O
but	O
also	O
with	O
cell	B-T038
wall	I-T038
degradation	I-T038
,	O
suggesting	O
that	O
dynamic	O
co	B-T038
-	I-T038
regulation	I-T038
of	O
transcriptional	B-T038
networks	I-T038
contribute	O
to	O
multiple	O
aspects	O
of	O
n	B-T204
.	I-T204
parvum	I-T204
virulence	B-T038
.	O
in	O
most	O
of	O
the	O
co	B-T038
-	I-T038
expressed	I-T038
clusters	B-T017
,	O
all	O
genes	B-T017
shared	O
at	O
least	O
a	O
common	O
motif	O
in	O
their	O
promoter	B-T103
region	I-T103
indicative	O
of	O
co	B-T038
-	I-T038
regulation	I-T038
by	O
the	O
same	O
transcription	B-T103
factor	I-T103
.	O
co	B-T062
-	I-T062
expression	I-T062
analysis	I-T062
also	O
identified	O
chromatin	B-T103
regulators	O
with	O
correlated	O
expression	B-T038
with	O
inducible	O
clusters	B-T017
of	O
virulence	B-T103
factors	I-T103
,	O
suggesting	O
a	O
complex	O
,	O
multi	O
-	O
layered	O
regulation	B-T038
of	O
the	O
virulence	B-T038
repertoire	O
of	O
n	B-T204
.	I-T204
parvum	I-T204
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

two	O
known	O
and	O
one	O
new	O
species	B-T170
of	O
dr	B-T204
##aco	I-T204
##nem	I-T204
##atid	I-T204
##ae	I-T204
and	O
epsilon	B-T204
##emat	I-T204
##ida	I-T204
(	O
nemat	B-T204
##oda	I-T204
,	O
desm	B-T204
##od	I-T204
##ori	I-T204
##da	I-T204
)	O
from	O
the	O
white	B-T082
sea	I-T082
,	O
north	B-T082
russia	I-T082
morphological	B-T082
descriptions	B-T170
of	O
three	O
[UNK]	O
walking	B-T204
nematode	I-T204
[UNK]	O
species	B-T170
found	O
for	O
the	O
first	O
time	O
in	O
the	O
white	B-T082
sea	I-T082
are	O
presented	O
.	O
dr	B-T204
##aco	I-T204
##nem	I-T204
##a	I-T204
op	I-T204
##hi	I-T204
##cephal	I-T204
##um	I-T204
(	O
cla	O
##par	O
##ed	O
##e	O
,	O
186	O
##3	O
)	O
(	O
dr	B-T204
##aco	I-T204
##nem	I-T204
##atid	I-T204
##ae	I-T204
)	O
and	O
epsilon	B-T204
##ema	I-T204
ste	I-T204
##ine	I-T204
##ri	I-T204
chit	O
##wood	O
,	O
193	O
##5	O
(	O
epsilon	B-T204
##emat	I-T204
##idae	I-T204
)	O
,	O
both	O
known	O
from	O
insufficient	O
material	O
and	O
females	O
only	O
,	O
are	O
re	O
-	O
described	O
and	O
problems	B-T033
of	O
their	O
taxonomic	O
identification	O
as	O
well	O
as	O
species	B-T170
compositions	B-T201
of	O
respective	O
genera	B-T170
are	O
discussed	O
.	O
the	O
new	O
species	B-T170
proc	B-T204
##ha	I-T204
##eto	I-T204
##so	I-T204
##ma	I-T204
mari	I-T204
##sa	I-T204
##l	I-T204
##bi	I-T204
sp	I-T204
.	O
n	O
.	O
(	O
dr	B-T204
##aco	I-T204
##nem	I-T204
##atid	I-T204
##ae	I-T204
)	O
differs	O
from	O
other	O
proc	B-T204
##ha	I-T204
##eto	I-T204
##so	I-T204
##ma	I-T204
species	I-T204
except	O
p	B-T204
.	I-T204
long	I-T204
##ica	I-T204
##pi	I-T204
##ta	I-T204
##t	I-T204
##um	I-T204
(	O
all	O
##gen	O
,	O
193	O
##5	O
)	O
in	O
that	O
the	O
pharyngeal	B-T017
bulb	B-T017
lumen	B-T082
is	O
not	B-T033
cut	I-T033
##icularis	I-T033
##ed	I-T033
,	O
from	O
p	B-T204
.	I-T204
long	I-T204
##ica	I-T204
##pi	I-T204
##ta	I-T204
##t	I-T204
##um	I-T204
by	O
shape	B-T017
of	I-T017
body	I-T017
and	O
ros	B-T017
##trum	I-T017
,	O
greater	O
number	O
of	O
cephalic	B-T082
adhesive	B-T017
tubes	I-T017
,	O
and	O
from	O
p	B-T204
.	I-T204
ma	I-T204
##ert	I-T204
##ens	I-T204
##i	I-T204
dec	O
##ra	O
##eme	O
##r	O
,	O
1989	O
by	O
having	O
a	O
relatively	O
longer	O
tail	B-T017
,	O
fewer	O
anterior	B-T082
adhesive	B-T017
tubes	I-T017
and	O
longer	O
spi	O
##cu	O
##les	O
,	O
besides	O
lacking	O
cut	B-T038
##icular	I-T038
thickening	I-T038
in	O
the	O
pharyngeal	B-T017
bulb	B-T017
.	O
dr	B-T204
##aco	I-T204
##nem	I-T204
##a	I-T204
ho	I-T204
##ons	I-T204
##oo	I-T204
##i	I-T204
,	O
d	B-T204
.	I-T204
young	I-T204
##e	I-T204
##oun	I-T204
##i	I-T204
,	O
p	B-T204
.	I-T204
roch	I-T204
##ae	I-T204
##to	I-T204
##so	I-T204
##ma	I-T204
be	I-T204
##oms	I-T204
##e	I-T204
##omen	I-T204
##se	I-T204
,	O
p	B-T204
.	I-T204
brev	I-T204
##ica	I-T204
##ud	I-T204
##atum	I-T204
,	O
p	B-T204
.	I-T204
by	I-T204
##ung	I-T204
##illi	I-T204
,	O
p	B-T204
.	I-T204
cr	I-T204
##ace	I-T204
##ns	I-T204
##e	I-T204
,	O
p	B-T204
.	I-T204
sah	I-T204
##eu	I-T204
##ng	I-T204
##i	I-T204
,	O
p	B-T204
.	I-T204
su	I-T204
##jun	I-T204
##gi	I-T204
,	O
p	B-T204
.	I-T204
sup	I-T204
##se	I-T204
##omen	I-T204
##se	I-T204
er	O
##ected	O
by	O
rho	O
&	O
min	O
(	O
2011	O
)	O
are	O
considered	O
as	O
inval	O
##id	O
species	B-T170
while	O
proc	B-T204
##ha	I-T204
##eto	I-T204
##so	I-T204
##ma	I-T204
arctic	I-T204
##um	I-T204
,	O
p	B-T204
.	I-T204
lu	I-T204
##gu	I-T204
##bre	I-T204
and	O
epsilon	B-T204
##ema	I-T204
cy	I-T204
##gn	I-T204
##oides	I-T204
are	O
assumed	O
as	O
species	B-T170
inqu	I-T170
##ire	I-T170
##nd	I-T170
##a	I-T170
.	O
from	O
a	O
phylogenetic	B-T062
tree	I-T062
based	O
on	O
the	O
18s	B-T017
rrna	I-T017
gene	I-T017
,	O
all	O
three	O
white	B-T082
sea	I-T082
species	B-T170
adj	B-T082
##oin	I-T082
to	O
unidentified	O
species	B-T170
of	O
their	O
respective	O
genera	B-T170
.	O

grade	B-T170
group	I-T170
underestimation	B-T033
in	O
prostate	B-T058
biopsy	I-T058
:	O
predictive	B-T170
factors	I-T170
and	O
outcomes	B-T033
in	O
candidates	B-T098
for	O
active	B-T058
surveillance	I-T058
we	O
intended	O
to	O
analyze	O
the	O
outcomes	B-T033
and	O
predictive	B-T170
factors	I-T170
for	O
underestim	O
##ating	O
the	O
prostate	B-T038
cancer	I-T038
(	O
pca	B-T038
)	O
grade	B-T170
group	I-T170
(	O
gg	B-T170
)	O
from	O
prostate	B-T058
biopsies	I-T058
in	O
a	O
large	O
monoc	B-T098
##entric	I-T098
cohort	I-T098
of	O
patients	O
treated	O
by	O
minimally	B-T058
invasive	I-T058
radical	I-T058
prostatectomy	I-T058
(	O
rp	B-T058
)	O
.	O
using	O
a	O
monoc	B-T170
##entric	I-T170
prospectively	I-T170
maintained	I-T170
database	I-T170
,	O
we	O
included	O
306	O
##2	O
patients	O
who	O
underwent	O
minimally	B-T058
invasive	I-T058
rp	I-T058
between	O
2006	O
and	O
2013	O
.	O
we	O
explored	O
clinicopathologic	O
features	O
and	O
outcomes	B-T033
associated	O
with	O
a	O
gg	B-T170
up	O
##grade	O
from	O
biopsy	B-T058
to	O
rp	B-T058
.	O
multivariate	B-T062
logistic	I-T062
regression	I-T062
was	O
used	O
to	O
develop	O
and	O
validate	O
a	O
nomogram	B-T170
to	O
predict	O
up	O
##grad	O
##ing	O
for	O
gg	B-T170
##1	I-T170
.	O
biopsy	B-T058
gg	B-T170
was	O
up	O
##grade	O
##d	O
after	O
rp	B-T058
in	O
51	O
.	O
5	O
%	O
of	O
cases	O
.	O
patients	O
up	O
##grade	O
##d	O
from	O
gg	B-T170
##1	I-T170
to	O
gg	B-T170
##2	I-T170
or	O
gg	B-T170
##3	I-T170
after	O
rp	B-T058
had	O
a	O
longer	O
time	O
to	O
biochemical	B-T033
recurrence	I-T033
than	O
those	O
with	O
gg	B-T170
##2	I-T170
or	O
gg	B-T170
##3	I-T170
respectively	O
,	O
on	O
both	O
biopsy	B-T058
and	O
rp	B-T058
,	O
but	O
a	O
shorter	O
time	O
to	O
biochemical	B-T033
recurrence	I-T033
than	O
those	O
who	O
remained	O
gg	B-T170
##1	I-T170
after	O
rp	O
(	O
p	O
<	O
.	O
0001	O
)	O
.	O
in	O
multivariate	O
analyses	O
,	O
variables	O
predicting	O
up	O
##grad	O
##ing	O
for	O
gg	B-T170
##1	I-T170
pca	B-T038
were	O
age	O
(	O
p	O
=	O
.	O
001	O
##4	O
)	O
,	O
abnormal	B-T058
digital	I-T058
rectal	I-T058
examination	I-T058
(	O
p	O
<	O
.	O
0001	O
)	O
,	O
prostate	B-T033
-	I-T033
specific	I-T033
antigen	I-T033
density	I-T033
(	O
p	O
<	O
.	O
0001	O
)	O
,	O
percentage	B-T033
of	I-T033
positive	I-T033
cores	I-T033
(	O
p	O
<	O
.	O
0001	O
)	O
,	O
and	O
body	B-T170
mass	I-T170
index	I-T170
(	O
p	O
=	O
.	O
037	O
)	O
.	O
a	O
nomogram	B-T170
was	O
generated	O
and	O
validated	O
internally	O
.	O
biopsy	B-T058
grading	B-T058
system	I-T058
is	O
misleading	O
in	O
approximately	O
50	O
%	O
of	O
cases	O
.	O
up	O
##grad	O
##ing	O
gg	B-T170
from	O
biopsy	B-T058
to	O
rp	B-T058
may	O
have	O
consequences	O
on	O
clinical	B-T033
outcomes	I-T033
.	O
a	O
nomogram	B-T170
using	O
clinicopathologic	O
features	O
could	O
aid	O
the	O
probability	O
of	O
needing	O
to	O
up	O
##grade	O
gg	B-T170
##1	I-T170
patients	O
at	O
their	O
initial	O
evaluation	B-T058
.	O

bj	O
##n	O
award	O
##s	O
2016	O
:	O
iv	B-T058
therapy	I-T058
cla	O
##ire	O
rick	O
##ard	O
profess	B-T097
##or	I-T097
of	O
nursing	B-T097
,	O
national	O
health	O
and	O
medical	O
research	O
council	O
(	O
nh	O
##mr	O
##c	O
)	O
centre	B-T097
of	I-T097
research	I-T097
excellence	I-T097
in	O
nursing	B-T097
,	O
gr	O
##iff	O
##ith	O
university	O
,	O
was	O
award	O
##ed	O
second	O
place	O
in	O
the	O
bj	O
##n	O
award	O
##s	O
2016	O
for	O
iv	B-T058
therapy	I-T058
nurse	B-T097
of	O
the	O
year	O
.	O
here	O
she	O
talk	O
##s	O
about	O
the	O
she	O
has	O
done	O
to	O
be	O
recognised	O
in	O
this	O
field	O
.	O

significance	O
of	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
in	O
early	B-T170
-	I-T170
stage	I-T170
cervical	B-T038
cancer	I-T038
to	O
examine	O
characteristics	O
and	O
survival	O
outcomes	O
of	O
women	B-T098
with	O
surgically	B-T058
-	I-T058
treated	I-T058
cervical	B-T038
cancer	I-T038
exhibiting	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
.	O
we	O
utilized	O
the	O
surveillance	B-T092
,	I-T092
epidemiology	I-T092
,	I-T092
and	I-T092
end	I-T092
results	I-T092
program	I-T092
to	O
identify	O
cervical	B-T038
cancer	I-T038
patients	O
who	O
underwent	O
hysterectomy	B-T058
between	O
1973	O
and	O
2003	O
.	O
logistic	O
regression	O
models	O
were	O
used	O
to	O
identify	O
risk	B-T033
factors	I-T033
for	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
on	O
multivariable	O
analysis	O
.	O
association	O
of	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
and	O
cause	O
-	O
specific	O
survival	O
(	O
css	O
)	O
from	O
cervical	B-T038
cancer	I-T038
was	O
examined	O
with	O
cox	B-T170
proportional	I-T170
hazard	I-T170
regression	I-T170
models	I-T170
on	O
multivariable	O
analysis	O
.	O
we	O
identified	O
83	O
##7	O
(	O
4	O
.	O
9	O
%	O
)	O
cases	O
of	O
uterine	B-T038
corpus	I-T038
invasion	B-T033
and	O
16	O
,	O
237	O
(	O
95	O
.	O
1	O
%	O
)	O
cases	O
of	O
non	O
-	O
invasion	O
.	O
median	O
follow	B-T058
-	I-T058
up	I-T058
time	O
was	O
14	O
.	O
0	O
years	O
.	O
there	O
were	O
164	O
##2	O
deaths	B-T038
due	O
to	O
cervical	B-T038
cancer	I-T038
.	O
uterine	B-T038
corpus	I-T038
invasion	B-T033
was	O
independently	O
associated	O
with	O
older	O
age	O
,	O
non	O
-	O
squamous	O
histology	O
,	O
high	B-T038
-	I-T038
grade	I-T038
tumors	I-T038
,	O
large	B-T082
tumor	I-T082
size	I-T082
,	O
and	O
nodal	B-T082
metastasis	B-T038
on	O
multivariable	O
analysis	O
(	O
all	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
on	O
univ	O
##ariable	O
analysis	O
,	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
was	O
significantly	O
associated	O
with	O
decreased	O
css	O
compared	O
to	O
the	O
non	O
-	O
invasion	O
(	O
5	O
-	O
year	O
rates	O
,	O
79	O
.	O
0	O
%	O
versus	O
94	O
.	O
5	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
after	O
controlling	O
for	O
other	O
significant	O
prognostic	B-T201
factors	I-T201
,	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
remained	O
an	O
independent	O
prognostic	B-T201
factor	I-T201
for	O
decreased	O
css	O
(	O
adjusted	O
-	O
hazard	O
ratio	O
1	O
.	O
45	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
21	O
-	O
1	O
.	O
74	O
)	O
.	O
among	O
stage	B-T170
t1	I-T170
##b	I-T170
cases	O
(	O
n	O
=	O
67	O
##30	O
)	O
,	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
remained	O
an	O
independent	O
prognostic	B-T201
factor	I-T201
for	O
decreased	O
css	O
(	O
adjusted	O
-	O
hazard	O
ratio	O
1	O
.	O
95	O
,	O
95	O
%	O
ci	O
1	O
.	O
47	O
-	O
2	O
.	O
60	O
)	O
.	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
was	O
significantly	O
associated	O
with	O
decreased	O
css	O
in	O
stage	B-T170
t1	I-T170
##b1	I-T170
disease	B-T038
(	O
74	O
.	O
5	O
%	O
versus	O
90	O
.	O
7	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
in	O
stage	B-T170
t1	I-T170
##b2	I-T170
disease	B-T038
(	O
67	O
.	O
0	O
%	O
versus	O
79	O
.	O
5	O
%	O
,	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O
uterine	B-T038
corpus	I-T038
tumor	I-T038
invasion	B-T033
is	O
an	O
independent	O
prognostic	B-T201
factor	I-T201
for	O
decreased	O
survival	O
of	O
women	B-T098
with	O
early	B-T170
-	I-T170
stage	I-T170
cervical	B-T038
cancer	I-T038
.	O

of	O
kind	B-T103
##lin	I-T103
##s	I-T103
and	O
cancer	B-T038
kind	B-T103
##lin	I-T103
##s	I-T103
are	O
4	B-T082
.	I-T082
1	I-T082
-	I-T082
ez	I-T082
##rin	I-T082
-	I-T082
rid	I-T082
##ix	I-T082
##in	I-T082
-	I-T082
mo	I-T082
##esin	I-T082
(	I-T082
ferm	I-T082
)	I-T082
domain	I-T082
containing	O
proteins	B-T103
.	O
there	O
are	O
three	O
kind	B-T103
##lin	I-T103
##s	I-T103
in	O
mammals	B-T204
,	O
which	O
share	O
high	O
sequence	B-T082
identity	O
.	O
kind	B-T103
##lin	I-T103
-	I-T103
1	I-T103
is	O
expressed	B-T038
primarily	O
in	O
epithelial	B-T017
cells	I-T017
,	O
kind	B-T103
##lin	I-T103
-	I-T103
2	I-T103
is	O
widely	O
distributed	O
and	O
is	O
particularly	O
abundant	O
in	O
adherent	B-T017
cells	I-T017
,	O
and	O
kind	B-T103
##lin	I-T103
-	I-T103
3	I-T103
is	O
expressed	B-T038
primarily	O
in	O
hematopoietic	B-T017
cells	I-T017
.	O
these	O
distributions	O
are	O
not	O
exclusive	O
;	O
some	O
cells	B-T017
express	B-T038
multiple	O
kind	B-T103
##lin	I-T103
##s	I-T103
,	O
and	O
transformed	B-T017
cells	I-T017
often	O
exhibit	O
aberrant	O
expression	B-T038
,	O
both	O
in	O
the	O
isoforms	B-T103
and	O
the	O
levels	O
of	O
kind	B-T103
##lin	I-T103
##s	I-T103
.	O
great	O
interest	O
in	O
the	O
kind	B-T103
##lin	I-T103
##s	I-T103
has	O
emerged	O
from	O
the	O
recognition	O
that	O
they	O
play	O
major	O
roles	O
in	O
controlling	O
integrin	B-T103
function	B-T038
.	O
in	O
vitro	O
studies	O
,	O
in	O
vivo	O
studies	O
of	O
mice	B-T204
deficient	O
in	O
kind	B-T103
##lin	I-T103
##s	I-T103
,	O
and	O
studies	B-T062
of	O
patients	O
with	O
genetic	O
deficiencies	O
of	O
kind	B-T103
##lin	I-T103
##s	I-T103
have	O
clearly	O
established	O
that	O
they	O
regulate	O
the	O
capacity	O
of	O
integrins	B-T103
to	O
mediate	O
their	O
functions	O
.	O
kind	B-T103
##lin	I-T103
##s	I-T103
are	O
adaptor	B-T103
proteins	I-T103
;	O
their	O
function	O
ema	O
##nat	O
##e	O
from	O
their	O
interaction	O
with	O
binding	B-T038
partners	O
,	O
including	O
the	O
cytoplasmic	B-T017
tails	I-T017
of	O
integrins	B-T103
and	O
components	O
of	O
the	O
actin	B-T017
cytoskeleton	I-T017
.	O
the	O
purpose	O
of	O
this	O
review	B-T170
is	O
to	O
provide	O
a	O
brief	O
overview	O
of	O
kind	B-T103
##lin	I-T103
structure	B-T103
and	O
function	B-T038
,	O
a	O
consideration	B-T033
of	O
their	O
binding	B-T038
partners	O
,	O
and	O
then	O
to	O
focus	O
on	O
the	O
relationship	O
of	O
each	O
kind	B-T103
##lin	I-T103
family	B-T103
member	O
with	O
cancer	B-T038
.	O
in	O
view	B-T082
of	O
many	O
correlations	O
of	O
kind	B-T103
##lin	I-T103
expression	B-T038
levels	O
and	O
neoplasia	B-T038
and	O
the	O
known	O
association	O
of	O
integrins	B-T103
with	O
tumor	B-T038
progression	I-T038
and	O
metastasis	B-T038
,	O
we	O
consider	O
whether	O
regulation	O
of	O
kind	B-T103
##lin	I-T103
##s	I-T103
or	O
their	O
function	O
would	O
be	O
attractive	O
targets	O
for	O
treatment	B-T058
of	I-T058
cancer	I-T058
.	O

how	O
integrated	B-T058
management	I-T058
strategies	I-T058
promote	O
protein	B-T103
quality	O
of	O
cotton	B-T204
embryos	I-T204
:	O
high	O
levels	O
of	O
soil	O
available	O
n	B-T103
,	O
n	B-T103
assimilation	O
and	O
protein	B-T103
accumulation	B-T033
rate	O
cotton	B-T204
##se	I-T204
##ed	I-T204
is	O
widely	O
used	O
as	O
a	O
source	B-T033
of	O
rumin	B-T204
##ant	I-T204
feed	B-T168
and	O
for	O
industrial	O
purposes	O
.	O
therefore	O
,	O
there	O
is	O
a	O
tremendous	O
need	O
to	O
improve	B-T033
the	O
nutritional	O
value	O
of	O
cotton	B-T204
embryos	I-T204
.	O
in	O
this	O
study	B-T062
,	O
a	O
conventional	B-T058
management	I-T058
(	O
cm	B-T058
)	O
and	O
two	O
integrated	O
cotton	B-T204
management	B-T058
strategies	I-T058
(	O
ims	B-T058
##1	I-T058
,	O
ims	B-T058
##2	I-T058
)	O
were	O
performed	O
at	O
two	O
soil	O
fertility	B-T033
levels	O
to	O
study	B-T062
the	O
relationships	O
among	O
soil	O
n	B-T103
,	O
n	B-T103
assimilation	O
,	O
embryonic	B-T204
protein	B-T103
accumulation	B-T033
and	O
protein	B-T103
quality	O
.	O
the	O
levels	B-T058
of	I-T058
proteins	I-T058
,	O
essential	B-T058
amino	I-T058
acids	I-T058
,	O
and	O
semi	B-T058
-	I-T058
essential	I-T058
amino	I-T058
acids	I-T058
,	O
especially	O
those	O
of	O
glutamate	B-T058
,	O
lysine	B-T058
,	O
and	O
methionine	B-T058
,	O
were	O
higher	O
in	O
ims	B-T058
##1	I-T058
and	O
ims	B-T058
##2	I-T058
embryos	B-T204
than	O
in	O
cm	B-T058
embryos	B-T204
.	O
these	O
changes	O
were	O
significantly	O
positively	B-T033
correlated	O
with	O
the	O
soil	O
-	O
available	O
n	B-T058
content	I-T058
,	O
glutamine	B-T038
synthetase	I-T038
activity	I-T038
and	O
peak	O
value	O
of	O
protein	B-T103
accumulation	B-T033
rate	O
and	O
were	O
negatively	B-T033
correlated	O
with	O
the	O
free	O
amino	B-T058
acid	I-T058
level	I-T058
.	O
these	O
results	O
illustrated	O
that	O
integrated	B-T058
management	I-T058
strategies	I-T058
,	O
especially	O
the	O
rates	O
and	O
timing	O
of	O
n	B-T103
application	O
,	O
raise	O
the	O
level	O
of	O
soil	O
available	O
n	B-T103
,	O
which	O
is	O
beneficial	O
for	O
n	B-T103
assimilation	O
in	O
developing	O
cotton	B-T204
embryos	I-T204
.	O
the	O
protein	B-T058
content	I-T058
was	O
limited	O
by	O
the	O
rate	O
of	O
protein	B-T103
accumulation	B-T033
rather	O
than	O
by	O
the	O
free	O
amino	B-T058
acid	I-T058
content	I-T058
.	O
the	O
combination	O
of	O
target	O
yield	O
fertilization	O
,	O
a	O
growth	B-T038
-	O
driven	O
n	B-T103
application	O
schedule	O
,	O
a	O
high	O
plant	B-T204
density	O
and	O
the	O
seedling	B-T204
raising	O
with	O
bio	O
-	O
organic	O
fertilizer	O
can	O
substantially	O
improve	B-T033
protein	B-T103
quality	O
in	O
cotton	B-T204
embryos	I-T204
,	O
especially	O
at	O
a	O
soil	O
with	O
low	O
soil	O
organic	B-T103
matter	I-T103
and	O
total	O
nitrogen	B-T103
.	O

recombinant	B-T103
protein	B-T082
transduction	I-T082
domain	I-T082
-	O
cu	B-T103
/	I-T103
zn	I-T103
superoxide	I-T103
dismutase	I-T103
alleviate	O
##s	O
bone	B-T038
cancer	I-T038
pain	B-T033
via	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
4	I-T103
modulation	B-T038
and	O
antioxid	B-T038
##ation	I-T038
bone	B-T038
cancer	I-T038
pain	B-T033
(	O
bcp	B-T033
)	O
is	O
a	O
serious	O
chronic	O
clinical	O
condition	O
and	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
were	O
considered	O
to	O
be	O
involved	O
in	O
its	O
development	O
and	O
persist	O
##ency	O
.	O
normally	O
,	O
superoxide	B-T103
dismutase	I-T103
(	O
sod	B-T103
)	O
converts	O
superoxide	B-T103
anions	I-T103
to	O
hydrogen	B-T103
peroxide	I-T103
(	O
h2o2	B-T103
)	O
and	O
h2o2	B-T103
is	O
then	O
natural	O
##ized	O
to	O
be	O
water	B-T103
by	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
4	I-T103
.	O
we	O
reported	B-T170
previously	O
that	O
recombinant	B-T103
protein	B-T082
transduction	I-T082
domain	I-T082
(	O
ptd	B-T082
)	O
-	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
effectively	O
scaven	B-T038
##ged	I-T038
excessive	O
ros	B-T103
and	O
prevented	O
cardiomyocytes	B-T017
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O
however	O
,	O
whether	O
ptd	B-T082
-	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
would	O
prevent	O
bcp	B-T033
development	O
is	O
unknown	O
.	O
in	O
the	O
current	O
study	B-T062
,	O
we	O
found	B-T033
that	O
an	O
implanted	B-T074
carcinoma	B-T038
in	O
the	O
rat	B-T204
tibia	B-T017
induced	O
remarkable	O
hyperalgesia	B-T033
,	O
increased	O
h2o2	B-T103
levels	O
and	O
decreased	O
sod	B-T103
and	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
4	I-T103
levels	O
.	O
after	O
administration	O
of	O
recombinant	B-T103
ptd	B-T082
-	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
to	O
these	O
tumor	O
-	O
burden	O
rats	B-T204
,	O
their	O
hyperalgesia	B-T033
was	O
significantly	O
attenuated	O
and	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
4	I-T103
expression	B-T038
was	O
significantly	O
increased	O
.	O
in	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
n	B-T103
-	I-T103
methyl	I-T103
-	I-T103
d	I-T103
-	I-T103
aspartic	I-T103
acid	I-T103
(	I-T103
nmda	I-T103
)	I-T103
receptors	I-T103
and	O
a	O
decreased	O
expression	O
of	O
γ	B-T103
-	I-T103
aminobutyric	I-T103
acid	I-T103
(	I-T103
gaba	I-T103
)	I-T103
receptors	I-T103
in	O
this	O
cancer	B-T033
pain	I-T033
were	O
prevented	O
by	O
ptd	B-T082
-	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
administration	O
or	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
4	I-T103
overexpression	B-T038
.	O
our	O
data	O
suggested	O
that	O
reactive	B-T103
oxygen	I-T103
species	I-T103
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	B-T038
metastatic	I-T038
pain	B-T033
development	O
and	O
persist	O
##ency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
admin	O
##st	O
##ra	O
##tion	O
of	O
recombinant	B-T103
ptd	I-T103
-	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
via	O
the	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
4	I-T103
modulation	B-T038
from	O
oxidative	B-T038
stress	I-T038
.	O

the	O
role	O
of	O
p2x	B-T103
##7	I-T103
receptors	I-T103
in	O
a	O
rodent	B-T204
pcp	B-T103
-	O
induced	O
schizophrenia	B-T038
model	B-T038
p2x	B-T103
##7	I-T103
receptors	I-T103
(	O
p2x	B-T103
##7	I-T103
##rs	I-T103
)	O
are	O
ligand	B-T103
-	I-T103
gated	I-T103
ion	I-T103
channels	I-T103
sensitive	O
to	O
extracellular	B-T017
atp	B-T103
.	O
here	O
we	O
examined	B-T033
for	O
the	O
first	O
time	O
the	O
role	O
of	O
p2x	B-T103
##7	I-T103
##r	I-T103
in	O
an	O
animal	B-T204
model	I-T204
of	O
schizophrenia	B-T038
.	O
using	O
the	O
pcp	B-T103
induced	O
schizophrenia	B-T038
model	B-T038
we	O
show	O
that	O
both	O
genetic	B-T038
deletion	I-T038
and	O
pharmacological	O
inhibition	O
of	O
p2x	B-T103
##7	I-T103
##rs	I-T103
alleviate	O
schizophrenia	B-T033
-	I-T033
like	I-T033
behavioral	O
alterations	O
.	O
in	O
p2	B-T017
##r	I-T017
##x	I-T017
##7	I-T017
+	I-T017
/	I-T017
+	I-T017
mice	B-T204
,	O
pcp	B-T103
induced	O
hyper	B-T033
##lo	I-T033
##com	I-T033
##otion	I-T033
,	O
stereotyp	B-T038
##e	I-T038
behavior	I-T038
,	O
ataxia	B-T033
and	O
social	B-T033
withdrawal	I-T033
.	O
in	O
p2x	B-T017
##7	I-T017
receptor	I-T017
deficient	O
mice	B-T204
(	O
p2	B-T017
##r	I-T017
##x	I-T017
##7	I-T017
-	I-T017
/	I-T017
-	I-T017
)	O
,	O
the	O
social	B-T033
interactions	I-T033
were	O
increased	O
,	O
whereas	O
the	O
pcp	B-T103
induced	O
hyper	B-T033
##lo	I-T033
##com	I-T033
##otion	I-T033
and	O
stereotyp	B-T038
##e	I-T038
behavior	I-T038
were	O
alleviated	O
.	O
the	O
selective	O
p2x	B-T103
##7	I-T103
receptor	I-T103
antagonist	I-T103
jn	B-T103
##j	I-T103
-	I-T103
47	I-T103
##96	I-T103
##55	I-T103
##67	I-T103
partly	O
replicated	O
the	O
effect	O
of	O
gene	B-T038
deficiency	I-T038
on	O
pcp	B-T103
-	O
induced	O
behavioral	O
changes	O
and	O
counteracted	O
pcp	B-T103
-	O
induced	O
social	B-T033
withdrawal	I-T033
.	O
we	O
also	O
show	O
that	O
pcp	B-T103
treatment	O
upreg	B-T038
##ulates	I-T038
and	O
increases	O
the	O
functional	O
responsiveness	O
of	O
p2x	B-T103
##7	I-T103
##rs	I-T103
in	O
the	O
prefrontal	B-T017
cortex	I-T017
of	O
young	O
adult	O
animals	B-T204
.	O
the	O
amplitude	O
of	O
nmda	B-T103
evoked	O
currents	O
recorded	O
from	O
layer	B-T017
v	I-T017
pyramidal	I-T017
neurons	I-T017
of	O
cortical	B-T017
slices	O
were	O
slightly	O
decreased	O
by	O
both	O
genetic	B-T038
deletion	I-T038
of	O
p2	B-T017
##r	I-T017
##x	I-T017
##7	I-T017
and	O
by	O
jn	B-T103
##j	I-T103
-	I-T103
47	I-T103
##96	I-T103
##55	I-T103
##67	I-T103
.	O
pcp	B-T103
induced	O
alterations	O
in	O
mrna	B-T038
expression	I-T038
encoding	O
schizophrenia	B-T038
-	I-T038
related	I-T038
genes	B-T017
,	O
such	O
as	O
nr	B-T017
##2a	I-T017
,	O
nr	B-T017
##2b	I-T017
,	O
neur	B-T103
##eg	I-T103
##ulin	I-T103
1	I-T103
,	O
nr	B-T103
##1	I-T103
and	O
gaba	B-T103
α1	I-T103
subunit	O
were	O
absent	O
in	O
the	O
pfc	O
of	O
young	O
adult	O
p2	B-T017
##r	I-T017
##x	I-T017
##7	I-T017
-	I-T017
/	I-T017
-	I-T017
animals	B-T038
.	O
our	O
findings	B-T033
point	O
to	O
p2x	B-T103
##7	I-T103
##r	I-T103
as	O
a	O
potential	O
therapeutic	O
target	O
in	O
schizophrenia	B-T038
.	O

variables	O
associated	O
with	O
unplanned	O
general	O
adult	O
icu	B-T058
admission	I-T058
in	O
hospitalised	O
patients	O
:	O
protocol	B-T170
for	O
a	O
systematic	O
review	O
failure	O
to	O
promptly	O
identify	O
deterioration	O
in	O
hospitalised	O
patients	O
is	O
associated	O
with	O
delayed	O
admission	B-T058
to	I-T058
intensive	I-T058
care	I-T058
units	I-T058
(	O
icus	B-T092
)	O
and	O
poor	O
outcomes	O
.	O
existing	O
vital	B-T201
sign	I-T201
-	O
based	O
early	O
warning	O
score	O
(	O
ew	O
##s	O
)	O
algorithms	B-T170
do	O
not	O
have	O
a	O
sufficiently	O
high	O
positive	O
predictive	O
value	O
to	O
be	O
used	O
for	O
automated	O
activation	O
of	O
an	O
icu	B-T092
outreach	B-T097
team	I-T097
.	O
incorporating	O
additional	O
patient	O
data	O
might	O
improve	B-T033
the	O
predictive	O
power	O
of	O
ew	O
##s	O
algorithms	B-T170
;	O
however	O
,	O
it	O
is	O
currently	O
not	O
known	O
which	O
patient	O
data	O
(	O
or	O
variables	O
)	O
are	O
most	O
predictive	O
of	O
icu	B-T058
admission	I-T058
.	O
we	O
describe	O
the	O
protocol	B-T170
for	O
a	O
systematic	O
review	O
of	O
variables	O
associated	O
with	O
icu	B-T058
admission	I-T058
.	O
medline	B-T170
,	O
embase	B-T170
,	O
cinahl	B-T170
and	O
the	O
cochrane	B-T170
library	I-T170
,	O
including	O
cochrane	B-T170
database	I-T170
of	I-T170
systematic	I-T170
reviews	I-T170
and	O
the	O
cochrane	B-T170
central	I-T170
register	I-T170
of	I-T170
controlled	I-T170
trials	I-T170
(	B-T170
central	I-T170
)	I-T170
will	O
be	O
searched	O
for	O
studies	B-T062
that	O
assess	O
the	O
association	O
of	O
routinely	O
recorded	B-T170
variables	O
associated	O
with	O
subsequent	O
unplanned	O
icu	B-T058
admission	I-T058
.	O
only	O
studies	B-T062
involving	O
adult	O
patients	O
admitted	B-T058
to	I-T058
general	B-T082
icus	B-T092
will	O
be	O
included	O
.	O
we	O
will	O
extract	O
data	O
relating	O
to	O
the	O
statistical	B-T062
association	I-T062
between	O
icu	B-T058
admission	I-T058
and	O
predictor	O
variables	O
,	O
the	O
quality	O
of	O
the	O
studies	B-T062
and	O
the	O
general	B-T082
##isa	I-T082
##bil	I-T082
##ity	I-T082
of	O
the	O
findings	B-T033
.	O
the	O
results	O
of	O
this	O
review	O
will	O
aid	O
the	O
development	O
of	O
future	O
models	B-T170
which	O
predict	O
the	O
risk	O
of	O
unplanned	O
icu	B-T058
admission	I-T058
.	O
prosp	O
##ero	O
:	O
cr	O
##d4	O
##20	O
##15	O
##02	O
##96	O
##17	O
.	O

extracellular	B-T017
potassium	B-T103
and	O
seizures	B-T033
:	O
excitation	O
,	O
inhibition	O
and	O
the	O
role	O
of	O
ih	B-T103
seizure	B-T033
activity	I-T033
leads	O
to	O
increases	O
in	O
extracellular	B-T017
potassium	B-T103
concentration	O
(	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
)	O
,	O
which	O
can	O
result	O
in	O
changes	O
in	O
neuronal	B-T017
passive	O
and	O
active	O
membrane	B-T017
properties	O
as	O
well	O
as	O
in	O
population	B-T098
activities	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
examined	O
how	O
extracellular	B-T017
potassium	B-T103
modulates	O
seizure	B-T033
activities	I-T033
using	O
an	O
acute	O
4	B-T103
-	I-T103
ap	I-T103
induced	O
seizure	B-T033
model	B-T170
in	O
the	O
neocortex	B-T017
,	O
both	O
in	B-T082
vivo	I-T082
and	O
in	O
vitro	O
.	O
moderately	O
elevated	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
up	O
to	O
9	O
[	O
formula	O
:	O
see	O
text	O
]	O
mm	O
prolonged	O
seizure	B-T033
durations	O
and	O
shortened	O
interictal	O
intervals	O
as	O
well	O
as	O
depolarized	O
the	O
neuronal	B-T017
resting	B-T038
membrane	I-T038
potential	I-T038
(	O
rm	B-T038
##p	I-T038
)	O
.	O
however	O
,	O
when	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
reached	O
higher	O
than	O
9	O
[	O
formula	O
:	O
see	O
text	O
]	O
mm	O
,	O
seizure	B-T033
like	I-T033
events	I-T033
(	O
sle	B-T033
##s	I-T033
)	O
were	O
blocked	O
and	O
neurons	B-T017
went	O
into	O
a	O
depolarization	O
-	O
blocked	O
state	O
.	O
spreading	O
depression	B-T038
was	O
never	O
observed	O
as	O
the	O
blockade	O
of	O
ictal	B-T033
events	I-T033
could	O
be	O
reversed	O
within	O
1	O
-	O
2	O
[	O
formula	O
:	O
see	O
text	O
]	O
min	O
after	O
the	O
raised	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
was	O
changed	O
back	O
to	O
control	O
levels	O
.	O
this	O
concentration	O
-	O
dependent	O
dual	O
effect	O
of	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
was	O
observed	O
using	O
in	B-T082
vivo	I-T082
and	O
in	O
vitro	O
mouse	B-T017
brain	I-T017
preparations	I-T017
as	O
well	O
as	O
in	O
human	B-T204
neocortical	B-T017
tissue	B-T017
resected	O
during	O
epilepsy	B-T038
surgery	B-T058
.	O
blocking	O
the	O
ih	O
current	O
,	O
mediated	O
by	O
hyperpolarization	B-T103
-	I-T103
activated	I-T103
cyclic	I-T103
nucleotide	I-T103
-	I-T103
gated	I-T103
(	I-T103
hc	I-T103
##n	I-T103
)	I-T103
channels	I-T103
,	O
modulated	O
the	O
elevated	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
influence	O
on	O
sle	B-T033
##s	I-T033
by	O
promoting	O
the	O
high	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
inhibitory	O
actions	O
.	O
these	O
results	O
demonstrate	O
biphasic	O
actions	O
of	O
raised	O
[	O
k	B-T103
[	O
formula	O
:	O
see	O
text	O
]	O
]	O
o	O
on	O
neuronal	B-T017
excitability	B-T033
and	O
seizure	B-T033
activity	I-T033
.	O

an	O
evaluation	B-T058
of	O
neuroendocrine	B-T022
dysfunction	O
following	O
acute	O
aneurysmal	B-T038
subarachnoid	I-T038
hemorrhage	I-T038
:	O
a	O
prospective	B-T062
study	I-T062
the	O
aim	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
pattern	B-T082
of	O
neuroendocrine	B-T022
changes	O
in	O
cases	O
of	O
acute	O
aneurysmal	B-T038
subarachnoid	I-T038
hemorrhage	I-T038
(	O
sah	B-T038
)	O
.	O
endocrine	B-T022
assessment	B-T058
was	O
performed	O
in	O
100	O
consecutive	O
cases	O
of	O
acute	O
aneurysmal	B-T038
sah	I-T038
presenting	O
within	O
7	O
days	O
of	O
ict	B-T038
##us	I-T038
.	O
the	O
gonadotrop	B-T103
##ic	I-T103
,	O
somat	B-T103
##otrophic	I-T103
,	O
thyrot	B-T103
##ropic	I-T103
,	O
and	O
cortic	B-T103
##otrophic	I-T103
axes	O
were	O
evaluated	B-T058
for	O
their	O
possible	O
dysfunction	O
.	O
a	O
total	O
of	O
100	O
cases	O
(	O
38	O
males	O
,	O
62	O
females	O
;	O
age	O
range	O
-	O
17	O
-	O
76	O
years	O
;	O
mean	O
age	O
-	O
43	O
.	O
6	O
years	O
)	O
of	O
acute	O
sah	B-T038
were	O
studied	B-T062
.	O
the	O
aneurysms	B-T038
were	O
located	O
in	O
the	O
anterior	B-T038
circulation	I-T038
(	O
n	O
=	O
95	O
)	O
and	O
posterior	B-T038
circulation	I-T038
(	O
n	O
=	O
5	O
)	O
.	O
the	O
most	O
common	O
hormone	O
deficiency	O
was	O
of	O
growth	B-T103
hormone	I-T103
(	O
n	O
=	O
67	O
)	O
,	O
followed	O
by	O
gonadotrophin	B-T103
(	O
n	O
=	O
50	O
)	O
,	O
cortic	B-T103
##otroph	I-T103
##in	I-T103
(	O
n	O
=	O
49	O
)	O
and	O
thyrot	B-T103
##rophin	I-T103
(	O
n	O
=	O
35	O
)	O
.	O
hyperprolactin	B-T038
##emia	I-T038
was	O
noted	O
in	O
10	O
cases	O
.	O
one	B-T033
-	I-T033
pituitary	I-T033
hormone	I-T033
axis	I-T033
deficiency	I-T033
was	O
noted	O
in	O
26	O
cases	O
while	O
67	O
cases	O
had	O
two	O
or	O
more	O
pituitary	B-T103
hormone	I-T103
axes	O
dysfunction	O
.	O
a	O
total	O
of	O
93	O
cases	O
had	O
hormonal	B-T103
dysfunction	O
in	O
one	O
or	O
more	O
pituitary	B-T103
hormone	I-T103
axes	I-T103
,	O
and	O
seven	O
cases	O
had	O
no	O
hormonal	B-T103
dysfunction	O
.	O
endocrine	O
dysfunction	O
occurs	O
in	O
93	O
%	O
cases	O
of	O
acute	O
sah	B-T038
and	O
multiple	O
pituitary	B-T103
hormone	I-T103
axes	I-T103
dysfunction	O
occurs	O
in	O
67	O
%	O
cases	O
.	O
it	O
is	O
suggested	O
that	O
hormonal	B-T103
evaluation	B-T058
should	O
be	O
considered	O
as	O
part	O
of	O
management	O
of	O
acute	O
sah	B-T038
.	O

the	O
use	O
of	O
inform	O
##ativity	O
in	O
the	O
development	O
of	O
robust	B-T017
vir	I-T017
##omics	I-T017
-	O
based	O
examinations	B-T062
metagen	O
##omics	O
-	O
based	O
studies	O
have	O
provided	O
insight	O
into	O
many	O
of	O
the	O
complex	O
microbial	O
communities	O
responsible	O
for	O
maintaining	B-T058
life	I-T058
on	I-T058
this	I-T058
plane	I-T058
##t	I-T058
.	O
sequencing	B-T062
efforts	O
often	O
uncover	O
novel	O
genetic	B-T017
content	I-T017
;	O
this	O
is	O
most	O
evident	O
for	O
phage	B-T005
communities	I-T005
,	O
in	O
which	O
upward	O
##s	O
of	O
90	O
%	O
of	O
all	O
sequences	B-T058
exhibit	O
no	O
similarity	O
to	O
any	O
sequence	B-T058
in	O
current	O
data	O
rep	O
##osi	O
##tor	O
##ies	O
.	O
for	O
the	O
small	O
fraction	O
that	O
can	O
be	O
identified	O
,	O
the	O
top	O
blast	B-T170
hit	O
is	O
generally	O
posit	O
##ed	O
as	O
being	O
representative	O
of	O
a	O
viral	O
taxon	O
present	O
in	O
the	O
sample	O
of	O
origin	O
.	O
homology	O
-	O
based	O
classification	B-T170
,	O
however	O
,	O
can	O
be	O
misleading	O
as	O
sequence	B-T170
rep	I-T170
##osi	I-T170
##tor	I-T170
##ies	I-T170
capture	O
but	O
a	O
small	O
fraction	O
of	O
phage	B-T005
diversity	I-T005
.	O
furthermore	O
,	O
lateral	B-T082
gene	B-T062
transfer	I-T062
is	O
pervasive	B-T082
within	O
phage	B-T005
communities	I-T005
.	O
as	O
such	O
,	O
the	O
presence	O
of	O
a	O
particular	B-T017
gene	I-T017
may	O
not	O
be	O
indicative	O
of	O
the	O
presence	O
of	O
a	O
particular	B-T005
viral	I-T005
species	I-T005
.	O
rather	O
,	O
it	O
is	O
just	O
that	O
:	O
an	O
indication	O
of	O
the	O
presence	O
of	O
a	O
specific	B-T017
gene	I-T017
.	O
to	O
circumvent	O
this	O
limitation	O
,	O
we	O
have	O
developed	O
a	O
new	O
method	O
for	O
the	O
analysis	B-T058
of	I-T058
viral	I-T058
metagen	I-T058
##omic	I-T058
datasets	I-T058
.	O
blast	B-T170
hits	O
are	O
weighted	O
,	O
integrating	O
the	O
sequence	O
identity	O
and	O
length	B-T062
of	I-T062
alignments	I-T062
as	O
well	O
as	O
a	O
taxonomic	O
signal	O
,	O
such	O
that	O
each	B-T017
gene	I-T017
is	O
evaluated	O
with	O
respect	O
to	O
its	O
information	O
content	O
.	O
through	O
this	O
quantif	O
##iable	O
metric	O
,	O
predictions	O
of	O
viral	O
community	O
structure	O
can	O
be	O
made	O
with	O
confidence	O
.	O
as	O
a	O
proof	O
-	O
of	O
-	O
concept	O
,	O
the	O
approach	O
presented	O
here	O
was	O
implemented	O
and	O
applied	O
to	O
seven	O
freshwater	B-T017
viral	I-T017
metagen	I-T017
##omes	I-T017
.	O
while	O
providing	O
a	O
robust	O
method	O
for	O
evaluating	O
viral	O
metagen	O
##omic	O
data	O
,	O
the	O
tool	B-T170
is	O
versatile	O
and	O
can	O
easily	O
be	O
customized	O
to	O
investigations	B-T058
of	O
any	O
environment	B-T082
or	O
biom	O
##e	O
.	O

penile	B-T017
erosion	I-T017
in	O
a	O
parap	B-T038
##legic	I-T038
man	B-T098
with	O
indwelling	B-T074
urinary	I-T074
catheter	I-T074
and	O
scrotal	B-T033
edema	I-T033
the	O
chronic	O
use	O
of	O
urinary	B-T074
indwelling	I-T074
catheters	I-T074
is	O
a	O
common	O
practice	O
in	O
the	O
setting	O
of	O
long	O
-	O
term	O
patient	B-T058
care	I-T058
and	O
is	O
associated	O
with	O
numerous	O
complications	B-T038
.	O
more	O
awareness	B-T038
about	O
urogenital	B-T022
trauma	B-T037
from	O
urinary	B-T058
catheterization	I-T058
is	O
needed	O
,	O
as	O
it	O
is	O
as	O
common	O
as	O
symptomatic	O
urinary	B-T038
tract	I-T038
infections	I-T038
.	O
there	O
are	O
a	O
number	O
of	O
preventable	O
measures	O
that	O
can	O
be	O
taken	O
to	O
decrease	O
the	O
risk	O
of	O
mechanical	B-T037
trauma	I-T037
to	O
the	O
urethra	B-T017
and	O
gla	B-T017
##ns	I-T017
penis	I-T017
caused	O
by	O
chronic	O
catheterization	B-T058
.	O
we	O
present	O
a	O
case	O
of	O
a	O
27	O
-	O
year	O
old	O
parap	B-T038
##legic	I-T038
male	O
needing	O
a	O
chronic	O
indwelling	B-T074
catheter	I-T074
that	O
acquired	O
ventral	B-T082
penile	B-T017
erosion	I-T017
while	O
being	O
care	O
##d	O
for	O
in	O
the	O
icu	B-T092
setting	I-T092
.	O

high	O
transfer	O
##ability	O
of	O
homo	B-T038
##e	I-T038
##olog	I-T038
-	I-T038
specific	I-T038
markers	I-T038
between	O
bread	B-T168
wheat	B-T168
and	O
newly	O
synthesized	O
hexa	B-T168
##ploid	I-T168
wheat	I-T168
lines	I-T168
bread	B-T168
wheat	B-T168
(	O
tritic	B-T204
##um	I-T204
aes	I-T204
##tiv	I-T204
##um	I-T204
,	O
2n	O
=	O
6	O
##x	O
=	O
42	O
,	O
aa	O
##bb	O
##dd	O
)	O
has	O
a	O
complex	O
allo	B-T017
##hex	I-T017
##aploid	I-T017
genome	I-T017
,	O
which	O
makes	O
it	O
difficult	O
to	O
differentiate	O
between	O
the	O
homo	B-T082
##e	I-T082
##ologous	I-T082
sequences	I-T082
and	O
assign	O
them	O
to	O
the	O
chromosome	B-T017
a	I-T017
,	O
b	B-T017
,	O
or	O
d	B-T017
subgen	B-T017
##omes	I-T017
.	O
the	O
chromosome	B-T017
-	O
based	O
draft	O
genome	B-T017
sequence	B-T082
of	O
the	O
'	O
chinese	B-T168
spring	I-T168
'	O
common	O
wheat	B-T168
cultivar	I-T168
enables	O
the	O
large	O
-	O
scale	O
development	O
of	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
(	O
pcr	B-T062
)	O
-	O
based	O
markers	B-T038
specific	O
for	O
homo	O
##e	O
##olog	O
##s	O
.	O
based	O
on	O
high	O
-	O
confidence	O
'	O
chinese	B-T168
spring	I-T168
'	O
genes	B-T017
with	O
known	O
functions	O
,	O
we	O
developed	O
183	O
putative	O
homo	B-T038
##e	I-T038
##olog	I-T038
-	I-T038
specific	I-T038
markers	I-T038
for	O
chromosomes	B-T017
4b	I-T017
and	O
7	B-T017
##b	I-T017
.	O
these	O
markers	B-T038
were	O
used	O
in	O
pcr	B-T062
assays	I-T062
for	O
the	O
4b	B-T017
and	O
7	B-T017
##b	I-T017
null	O
##iso	O
##me	O
##s	O
and	O
their	O
eu	O
##ploid	O
synthetic	B-T168
hexa	I-T168
##ploid	I-T168
wheat	I-T168
(	I-T168
sh	I-T168
##w	I-T168
)	I-T168
line	I-T168
that	O
was	O
newly	O
generated	O
from	O
a	O
hybridization	O
between	O
tritic	B-T204
##um	I-T204
tur	I-T204
##gi	I-T204
##du	I-T204
##m	I-T204
(	O
aa	O
##bb	O
)	O
and	O
the	O
wild	O
diploid	B-T017
species	I-T017
aeg	B-T204
##il	I-T204
##ops	I-T204
tau	I-T204
##sc	I-T204
##hi	I-T204
##i	I-T204
(	O
dd	O
)	O
.	O
up	O
to	O
64	O
%	O
of	O
the	O
markers	B-T038
for	O
chromosomes	B-T017
4b	I-T017
or	O
7	B-T017
##b	I-T017
in	O
the	O
sh	B-T168
##w	I-T168
background	O
were	O
confirmed	O
to	O
be	O
homo	O
##e	O
##olog	O
-	O
specific	O
.	O
thus	O
,	O
these	O
markers	B-T038
were	O
highly	O
transfer	O
##able	O
between	O
the	O
'	O
chinese	B-T168
spring	I-T168
'	O
bread	B-T168
wheat	B-T168
and	O
sh	B-T168
##w	I-T168
lines	I-T168
.	O
homo	B-T038
##e	I-T038
##olog	I-T038
-	I-T038
specific	I-T038
markers	I-T038
designed	O
using	O
genes	B-T017
with	O
known	O
functions	O
may	O
be	O
useful	O
for	O
genetic	B-T058
investigations	I-T058
involving	O
homo	O
##e	O
##ologous	O
chromosome	B-T017
tracking	O
and	O
homo	O
##e	O
##olog	O
expression	B-T038
and	O
interaction	O
analyses	O
.	O

estrogen	B-T103
deficiency	O
accelerates	O
lumbar	B-T082
facet	I-T082
joints	I-T082
arthritis	B-T038
dramatic	O
increase	O
in	O
the	O
prevalence	O
of	O
lumbar	B-T082
facet	I-T082
joint	I-T082
(	O
lf	B-T082
##j	I-T082
)	O
arthritis	B-T038
in	O
women	B-T098
around	O
the	O
age	O
of	O
menopause	B-T038
indicates	O
a	O
protective	O
role	O
for	O
estrogen	B-T103
in	O
lf	B-T082
##j	I-T082
arthritis	B-T038
.	O
to	O
date	O
,	O
there	O
is	O
no	O
evidence	O
for	O
this	O
indication	O
and	O
the	O
mechanism	O
of	O
such	O
an	O
effect	O
remains	O
poorly	O
understood	O
.	O
in	O
this	O
study	B-T062
,	O
ovariectomized	B-T204
(	I-T204
ovx	I-T204
)	I-T204
mice	I-T204
were	O
used	O
to	O
mimic	O
the	O
estrogen	B-T103
-	O
deficient	O
status	O
of	O
post	B-T038
-	I-T038
menopausal	I-T038
women	B-T098
.	O
micro	B-T058
-	I-T058
ct	I-T058
and	O
immunohistochemistry	B-T058
was	O
employed	O
to	O
assess	O
the	O
morphological	B-T082
and	O
molecular	O
changes	O
in	O
ovariectomy	B-T058
-	O
induced	O
lf	B-T082
##j	I-T082
arthritis	B-T038
.	O
the	O
results	O
show	O
that	O
the	O
lf	B-T082
##j	I-T082
subchondral	B-T201
bone	I-T201
mass	I-T201
was	O
significantly	O
decreased	O
in	O
ovx	B-T204
mice	I-T204
,	O
with	O
increased	O
cavities	B-T082
on	O
the	O
interface	O
of	O
the	O
subchondral	B-T017
bone	I-T017
.	O
severe	O
cartilage	B-T017
degradation	O
was	O
observed	O
in	O
ovariectomy	B-T058
-	O
induced	O
lf	B-T082
##j	I-T082
arthritis	B-T038
.	O
increased	O
blood	B-T017
vessels	I-T017
and	O
innervation	O
##s	O
were	O
also	O
found	O
in	O
degenerated	B-T038
lf	B-T082
##j	I-T082
,	O
particularly	O
in	O
the	O
subchondral	B-T017
bone	I-T017
area	B-T082
.	O
17β	B-T103
-	I-T103
estradiol	I-T103
treatment	B-T058
efficiently	O
suppressed	O
lf	B-T082
##j	I-T082
subchondral	B-T033
bone	I-T033
turnover	I-T033
,	O
markedly	O
inhibited	O
cartilage	B-T017
degradation	O
,	O
and	O
increased	O
blood	B-T017
vessel	I-T017
and	O
nerve	B-T017
ending	I-T017
growth	B-T038
in	O
degenerated	B-T038
lf	B-T082
##j	I-T082
in	O
ovx	B-T204
mice	I-T204
.	O
our	O
study	B-T062
reveals	O
that	O
estrogen	B-T103
is	O
a	O
key	O
factor	O
in	O
regulating	O
lf	O
##j	O
metabolism	O
.	O
severe	O
lf	B-T082
##j	I-T082
degeneration	B-T038
occurs	O
when	O
estrogen	B-T103
is	O
absent	O
in	B-T082
vivo	I-T082
.	O
collapsed	O
subchondral	B-T017
bone	I-T017
may	O
be	O
the	O
initiation	O
of	O
this	O
process	O
,	O
and	O
estrogen	B-T058
replacement	I-T058
therapy	I-T058
can	O
effectively	O
prevent	O
degeneration	B-T038
of	O
lf	B-T082
##j	I-T082
under	O
estrogen	B-T103
-	O
deficient	O
conditions	O
.	O

blu	O
##r	O
perception	B-T038
throughout	O
the	O
visual	B-T082
field	I-T082
in	O
myopia	B-T038
and	O
em	B-T033
##met	I-T033
##rop	I-T033
##ia	I-T033
we	O
evaluated	B-T058
the	O
ability	O
of	O
em	B-T033
##met	I-T033
##ropic	I-T033
and	O
myopic	B-T038
observers	O
to	O
detect	B-T033
and	O
discriminate	O
blu	O
##r	O
across	O
the	O
retina	B-T017
under	O
monocular	B-T038
or	O
binocular	B-T038
viewing	I-T038
conditions	O
.	O
we	O
recruited	O
39	O
young	O
(	O
23	O
-	O
30	O
years	O
)	O
healthy	B-T033
adults	I-T033
(	O
n	O
=	O
19	O
myo	B-T038
##pes	I-T038
)	O
with	O
best	O
-	O
corrected	O
visual	B-T201
acuity	I-T201
0	O
.	O
0	O
logmar	B-T074
(	I-T074
20	I-T074
/	I-T074
20	I-T074
)	I-T074
or	O
better	O
in	O
each	O
eye	B-T017
and	O
no	B-T033
binocular	I-T033
or	O
accommod	B-T033
##ative	I-T033
dysfunction	I-T033
.	O
monocular	B-T038
and	O
binocular	B-T038
blu	O
##r	O
discrimination	O
thresholds	O
were	O
measured	O
as	O
a	O
function	B-T170
of	O
ped	O
##est	O
##al	O
blu	O
##r	O
using	O
naturalistic	O
stimuli	O
with	O
an	O
adaptive	B-T058
4a	I-T058
##fc	I-T058
procedure	I-T058
.	O
stimuli	O
were	O
presented	O
in	O
a	O
46	O
##°	O
diameter	O
window	O
at	O
40	O
cm	O
.	O
gaussian	O
blu	O
##r	O
ped	O
##est	O
##als	O
were	O
confined	O
to	O
an	O
annulus	O
at	O
either	O
0	O
##°	O
,	O
4	O
##°	O
,	O
8	O
##°	O
,	O
or	O
12	O
##°	O
eccentric	O
##ity	O
,	O
with	O
a	O
blu	O
##r	O
increment	O
applied	O
to	O
only	O
one	B-T082
quadrant	I-T082
of	O
the	O
image	B-T170
.	O
the	O
adaptive	B-T058
procedure	I-T058
efficiently	O
estimated	O
a	O
dip	B-T033
##per	I-T033
shaped	I-T033
blu	O
##r	O
discrimination	O
threshold	O
function	B-T170
with	O
two	O
parameters	O
:	O
intrinsic	B-T082
blu	O
##r	O
and	O
blu	O
##r	O
sensitivity	O
.	O
the	O
amount	O
of	O
intrinsic	B-T082
blu	O
##r	O
increased	O
for	O
retinal	O
eccentric	O
##ities	O
beyond	O
4	O
##°	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
was	O
lower	O
in	O
binocular	B-T038
than	O
monocular	B-T038
conditions	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
was	O
similar	O
across	O
refractive	O
groups	O
(	O
p	O
=	O
0	O
.	O
47	O
)	O
.	O
blu	O
##r	O
sensitivity	O
decreased	O
with	O
retinal	O
eccentric	O
##ity	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
was	O
highest	O
for	O
binocular	B-T038
viewing	O
,	O
but	O
only	O
for	O
central	O
vision	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
myo	B-T038
##pes	I-T038
showed	O
worse	B-T033
blu	O
##r	O
sensitivity	O
than	O
em	B-T033
##met	I-T033
##rop	I-T033
##es	I-T033
monocular	B-T038
##ly	I-T038
(	O
p	O
<	O
0	O
.	O
05	O
)	O
but	O
not	O
binocular	B-T038
##ly	I-T038
(	O
p	O
=	O
0	O
.	O
66	O
)	O
.	O
as	O
expected	O
,	O
blu	O
##r	O
perception	B-T038
worsen	B-T033
##s	I-T033
in	O
the	O
visual	B-T038
periphery	I-T038
and	O
binocular	B-T038
summation	B-T038
is	O
most	O
evident	O
in	O
central	O
vision	O
.	O
furthermore	O
,	O
myo	B-T038
##pes	I-T038
exhibit	O
a	O
monocular	B-T038
impairment	O
in	O
blu	O
##r	O
sensitivity	O
that	O
improves	B-T033
under	O
binocular	B-T038
conditions	O
.	O
implications	B-T038
for	O
the	O
development	O
of	O
myopia	B-T038
are	O
discussed	O
.	O

physiology	B-T038
of	O
respiratory	B-T033
disturbances	I-T033
in	O
muscular	B-T038
dyst	I-T038
##roph	I-T038
##ies	I-T038
muscular	B-T038
dystrophy	I-T038
is	O
a	O
group	O
of	O
inherited	O
myo	B-T038
##path	I-T038
##ies	I-T038
characterised	O
by	O
progressive	O
skeletal	B-T038
muscle	I-T038
wasting	I-T038
,	O
including	O
of	O
the	O
respiratory	B-T017
muscles	I-T017
.	O
respiratory	B-T038
failure	I-T038
,	O
i	O
.	O
e	O
.	O
when	O
the	O
respiratory	B-T022
system	I-T022
fails	O
in	O
its	O
gas	O
exchange	O
functions	O
,	O
is	O
a	O
common	O
feature	O
in	O
muscular	B-T038
dystrophy	I-T038
,	O
being	O
the	O
main	O
cause	O
of	O
death	B-T033
,	O
and	O
it	O
is	O
a	O
consequence	O
of	O
lung	B-T017
failure	B-T038
,	O
pump	B-T038
failure	I-T038
or	O
a	O
combination	O
of	O
the	O
two	O
.	O
the	O
former	O
is	O
due	O
to	O
recurrent	O
aspiration	B-T038
,	O
the	O
latter	O
to	O
progressive	O
weakness	B-T033
of	I-T033
respiratory	I-T033
muscles	I-T033
and	O
an	O
increase	O
in	O
the	O
load	O
against	O
which	O
they	O
must	O
contract	O
.	O
in	O
fact	O
,	O
both	O
the	O
resistive	O
and	O
elastic	O
components	O
of	O
the	O
work	O
of	O
breathing	B-T038
increase	O
due	O
to	O
airway	B-T038
obstruction	I-T038
and	O
chest	B-T017
wall	I-T017
and	O
lung	B-T017
stiff	B-T033
##ening	I-T033
,	O
respectively	O
.	O
the	O
respiratory	B-T033
disturbances	I-T033
in	O
muscular	B-T038
dystrophy	I-T038
are	O
restrictive	B-T033
pulmonary	I-T033
function	I-T033
,	O
hypo	B-T038
##vent	I-T038
##ilation	I-T038
,	O
altered	O
thorac	B-T082
##oa	I-T082
##bd	I-T082
##om	I-T082
##inal	I-T082
pattern	O
,	O
hypercapnia	B-T033
,	O
dyspnoea	B-T033
,	O
impaired	O
regulation	O
of	O
breathing	O
,	O
inefficient	B-T033
cough	I-T033
and	O
sleep	B-T038
disordered	I-T038
breathing	I-T038
.	O
they	O
can	O
be	O
present	O
at	O
different	O
rates	O
according	O
to	O
the	O
type	O
of	O
muscular	B-T038
dystrophy	I-T038
and	O
its	O
progression	B-T038
,	O
leading	O
to	O
different	O
onset	O
of	O
each	O
symptom	B-T033
,	O
prognosis	B-T058
and	O
degree	B-T033
of	I-T033
respiratory	I-T033
involvement	I-T033
.	O
a	O
common	O
feature	O
of	O
muscular	B-T038
dystrophy	I-T038
is	O
respiratory	B-T038
failure	I-T038
,	O
i	O
.	O
e	O
.	O
the	O
inability	O
of	O
the	O
respiratory	B-T022
system	I-T022
to	O
provide	O
proper	O
oxygenation	O
and	O
carbon	B-T038
dioxide	I-T038
elimination	I-T038
.	O
in	O
the	O
lung	B-T017
,	O
respiratory	B-T038
failure	I-T038
is	O
caused	O
by	O
recurrent	O
aspiration	B-T038
,	O
and	O
leads	O
to	O
hypox	B-T033
##aemia	I-T033
and	O
hyper	B-T033
##carb	I-T033
##ia	I-T033
.	O
ventilatory	B-T038
failure	I-T038
in	O
muscular	B-T038
dystrophy	I-T038
is	O
caused	O
by	O
increased	O
respiratory	B-T033
load	I-T033
and	O
respiratory	B-T033
muscles	I-T033
weakness	I-T033
.	O
respiratory	B-T033
load	I-T033
increases	O
in	O
muscular	B-T038
dystrophy	I-T038
because	O
scoliosis	B-T017
makes	O
chest	B-T033
wall	I-T033
compliance	I-T033
decrease	O
,	O
ate	B-T038
##le	I-T038
##ct	I-T038
##asis	I-T038
and	O
fibrosis	B-T038
make	O
lung	B-T038
compliance	I-T038
decrease	O
,	O
and	O
airway	B-T038
obstruction	I-T038
makes	O
airway	B-T038
resistance	I-T038
increase	O
.	O
the	O
consequences	O
of	O
respiratory	B-T038
pump	I-T038
failure	I-T038
are	O
restrictive	B-T033
pulmonary	I-T033
function	I-T033
,	O
hypo	B-T038
##vent	I-T038
##ilation	I-T038
,	O
altered	O
thorac	B-T082
##oa	I-T082
##bd	I-T082
##om	I-T082
##inal	I-T082
pattern	O
,	O
hypercapnia	B-T033
,	O
dyspnoea	B-T033
,	O
impaired	O
regulation	O
of	O
breathing	O
,	O
inefficient	B-T033
cough	I-T033
and	O
sleep	B-T038
disordered	I-T038
breathing	I-T038
.	O
to	O
understand	O
the	O
mechanisms	B-T033
leading	O
to	O
respiratory	B-T033
disturbances	I-T033
in	O
patients	O
with	O
muscular	B-T038
dystrophy	I-T038
.	O
to	O
understand	O
the	O
impact	O
of	O
respiratory	B-T033
disturbances	I-T033
in	O
patients	O
with	O
muscular	B-T038
dystrophy	I-T038
.	O
to	O
provide	O
a	O
brief	O
description	O
of	O
the	O
main	O
forms	O
of	O
muscular	B-T038
dystrophy	I-T038
with	O
their	O
respiratory	B-T033
implications	I-T033
.	O

risk	O
and	O
protective	O
factors	O
associated	O
with	O
adolescent	O
girls	O
'	O
substance	B-T038
use	I-T038
:	O
data	O
from	O
a	O
nationwide	O
face	B-T170
##book	I-T170
sample	O
despite	O
overall	O
reductions	O
in	O
teen	O
##age	O
substance	B-T038
use	I-T038
,	O
adolescent	O
girls	O
'	O
rates	O
of	O
substance	B-T038
use	I-T038
remain	O
unaccept	O
##ably	O
high	O
.	O
this	O
article	B-T170
examines	O
whether	O
girls	B-T098
'	O
substance	B-T038
use	I-T038
is	O
associated	O
with	O
general	O
risk	O
and	O
protective	O
factors	O
(	O
goal	B-T038
setting	I-T038
,	O
problem	B-T038
solving	I-T038
,	O
refusal	O
skills	O
,	O
peer	O
use	O
,	O
and	O
self	B-T038
-	I-T038
efficacy	I-T038
)	O
and	O
gender	O
-	O
specific	O
risk	O
and	O
protective	O
factors	O
(	O
communication	O
style	O
,	O
coping	O
skills	O
,	O
self	B-T038
-	I-T038
esteem	I-T038
,	O
body	B-T038
image	I-T038
,	O
perceived	B-T038
stress	I-T038
,	O
anxiety	B-T038
,	O
and	O
depression	B-T038
)	O
.	O
cross	B-T062
-	I-T062
sectional	I-T062
data	I-T062
were	O
collected	O
in	O
2013	O
via	O
online	O
surveys	O
from	O
a	O
nationwide	O
sample	O
of	O
adolescent	O
girls	O
(	O
n	O
=	O
78	O
##8	O
)	O
,	O
aged	O
13	O
and	O
14	O
years	O
,	O
who	O
were	O
recruited	O
through	O
face	B-T170
##book	I-T170
.	O
in	O
multivariate	O
analyses	O
,	O
controlling	O
for	O
correlates	O
of	O
adolescent	O
substance	B-T038
use	I-T038
,	O
11	O
of	O
the	O
13	O
general	O
and	O
gender	O
-	O
specific	O
risk	O
and	O
protective	O
factors	O
were	O
consistently	O
associated	O
with	O
past	O
-	O
month	O
alcohol	O
,	O
cigarette	O
,	O
and	O
other	O
drug	B-T038
use	I-T038
in	O
the	O
expected	O
direction	O
;	O
past	O
-	O
month	O
marijuana	O
use	O
was	O
associated	O
with	O
8	O
of	O
the	O
13	O
factors	O
.	O
refusal	O
skill	O
s	O
,	O
peer	O
use	O
,	O
coping	O
,	O
and	O
depressive	B-T033
mood	I-T033
were	O
most	O
consistently	O
and	O
strongly	O
associated	O
with	O
substance	B-T038
use	I-T038
.	O
substance	B-T058
abuse	I-T058
prevention	I-T058
programs	B-T058
targeting	O
adolescent	O
girls	O
should	O
focus	O
on	O
such	O
general	O
risk	O
and	O
protective	O
factors	O
as	O
problem	B-T038
solving	I-T038
,	O
refusal	O
skill	O
s	O
,	O
peer	O
influences	O
,	O
and	O
self	B-T038
-	I-T038
efficacy	I-T038
,	O
as	O
well	O
as	O
such	O
gender	O
-	O
specific	O
risk	O
and	O
protective	O
factors	O
as	O
communication	O
style	O
,	O
coping	O
,	O
self	B-T038
-	I-T038
esteem	I-T038
,	O
body	B-T038
image	I-T038
,	O
perceived	B-T038
stress	I-T038
,	O
and	O
mood	B-T058
management	I-T058
.	O

from	O
'	O
sense	O
of	O
number	O
'	O
to	O
'	O
sense	B-T038
of	I-T038
magnitude	O
'	O
-	O
the	O
role	O
of	O
continuous	O
magnitudes	O
in	O
numerical	O
cognition	B-T038
in	O
this	O
review	O
,	O
we	O
are	O
pit	O
##ting	O
two	O
theories	O
against	O
each	O
other	O
:	O
the	O
more	O
accepted	O
theory	O
-	O
the	O
'	O
number	O
sense	O
'	O
theory	O
-	O
suggesting	O
that	O
a	O
sense	O
of	O
number	O
is	O
innate	O
and	O
non	O
-	O
symbolic	O
numer	O
##osity	O
is	O
being	O
processed	O
independently	O
of	O
continuous	O
magnitudes	O
(	O
e	O
.	O
g	O
.	O
,	O
size	B-T082
,	O
area	B-T082
,	O
density	O
)	O
;	O
and	O
the	O
newly	O
emerging	O
theory	O
suggesting	O
that	O
(	O
1	O
)	O
both	O
numer	O
##osities	O
and	O
continuous	O
magnitudes	O
are	O
processed	O
holistic	O
##ally	O
when	O
comparing	O
numer	O
##osities	O
,	O
and	O
(	O
2	O
)	O
a	O
sense	O
of	O
number	O
might	O
not	O
be	O
innate	O
.	O
in	O
the	O
first	O
part	O
of	O
this	O
review	O
,	O
we	O
discuss	O
the	O
'	O
number	O
sense	O
'	O
theory	O
.	O
against	O
this	O
background	O
,	O
we	O
demonstrate	O
how	O
the	O
natural	O
correlation	O
between	O
numer	O
##osities	O
and	O
continuous	O
magnitudes	O
makes	O
it	O
nearly	O
impossible	O
to	O
study	O
non	O
-	O
symbolic	O
numer	O
##osity	O
processing	O
in	O
isolation	O
from	O
continuous	O
magnitudes	O
,	O
and	O
therefore	O
the	O
results	O
of	O
behavioral	B-T062
and	O
imaging	B-T058
studies	I-T058
with	O
infants	O
,	O
adults	O
and	O
animals	B-T204
can	O
be	O
explained	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
relying	O
on	O
continuous	O
magnitudes	O
.	O
in	O
the	O
second	O
part	O
,	O
we	O
explain	O
the	O
'	O
sense	B-T038
of	I-T038
magnitude	O
'	O
theory	O
and	O
review	O
studies	O
that	O
directly	O
demonstrate	O
that	O
continuous	O
magnitudes	O
are	O
more	O
automatic	O
and	O
basic	O
than	O
numer	O
##osities	O
.	O
finally	O
,	O
we	O
present	O
outstanding	O
questions	O
.	O
our	O
conclusion	O
is	O
that	O
there	O
is	O
not	O
enough	O
convincing	O
evidence	O
to	O
support	O
the	O
number	O
sense	O
theory	O
any	O
##mo	O
##re	O
.	O
therefore	O
,	O
we	O
encourage	O
researchers	O
not	O
to	O
assume	O
that	O
number	O
sense	O
is	O
simply	O
innate	O
,	O
but	O
to	O
put	O
this	O
hypothesis	O
to	O
the	O
test	O
,	O
and	O
to	O
consider	O
if	O
such	O
an	O
assumption	O
is	O
even	O
test	O
##able	O
in	O
light	O
of	O
the	O
correlation	O
of	O
numer	O
##osity	O
and	O
continuous	O
magnitudes	O
.	O

determinants	O
of	O
on	O
-	O
road	O
driving	O
in	O
multiple	B-T038
sclerosis	I-T038
to	O
investigate	O
the	O
cognitive	O
,	O
visual	O
,	O
and	O
motor	B-T033
deficits	I-T033
underlying	O
poor	O
performance	O
on	O
different	O
dimensions	B-T033
of	O
on	O
-	O
road	O
driving	O
in	O
individuals	B-T098
with	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
.	O
prospective	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
.	O
ms	B-T092
clinic	I-T092
and	O
driving	O
simulator	B-T062
lab	B-T092
.	O
active	B-T098
drivers	I-T098
(	O
n	O
=	O
102	O
)	O
with	O
various	O
types	O
of	O
ms	B-T038
.	O
not	O
applicable	O
.	O
off	O
-	O
road	O
cognitive	O
,	O
visual	O
,	O
and	O
motor	B-T038
functions	I-T038
,	O
as	O
well	O
as	O
13	O
specific	O
driving	O
skills	O
.	O
these	O
skills	O
were	O
categorized	O
into	O
hierarch	B-T062
##ic	I-T062
clusters	I-T062
of	O
operational	O
,	O
tactic	O
##al	O
,	O
visu	O
##o	O
-	O
integrative	O
,	O
and	O
mixed	O
driving	O
.	O
stepwise	B-T170
regression	I-T170
analysis	I-T170
was	O
used	O
to	O
determine	O
the	O
off	O
-	O
road	O
functions	O
influencing	O
performance	O
on	O
the	O
on	O
-	O
road	O
test	O
and	O
each	O
cluster	O
.	O
visuospatial	O
function	O
(	O
p	O
=	O
.	O
002	O
)	O
,	O
inhibition	B-T038
(	O
p	O
=	O
.	O
008	O
)	O
,	O
binocular	B-T033
acuity	I-T033
(	O
p	O
=	O
.	O
04	O
)	O
,	O
vertical	B-T058
visual	I-T058
field	I-T058
(	O
p	O
=	O
.	O
02	O
)	O
,	O
and	O
stereo	B-T038
##ps	I-T038
##is	I-T038
(	O
p	O
=	O
.	O
03	O
)	O
best	O
determined	O
variance	O
in	O
total	O
on	O
-	O
road	O
score	O
(	O
unadjusted	O
r	O
(	O
2	O
)	O
=	O
.	O
37	O
)	O
.	O
attentional	B-T033
shift	I-T033
(	O
p	O
=	O
.	O
0004	O
)	O
,	O
stereo	B-T038
##ps	I-T038
##is	I-T038
(	O
p	O
=	O
.	O
007	O
)	O
,	O
gla	B-T058
##re	I-T058
recovery	I-T058
(	O
p	O
=	O
.	O
047	O
)	O
,	O
and	O
use	O
of	O
assist	B-T074
##ive	I-T074
devices	I-T074
(	O
p	O
=	O
.	O
03	O
)	O
best	O
predicted	O
the	O
operational	B-T062
cluster	I-T062
(	O
unadjusted	O
r	O
(	O
2	O
)	O
=	O
.	O
28	O
)	O
.	O
visuospatial	O
function	O
(	O
p	O
=	O
.	O
002	O
)	O
,	O
inhibition	B-T038
(	O
p	O
=	O
.	O
002	O
)	O
,	O
reasoning	B-T038
(	O
p	O
=	O
.	O
003	O
)	O
,	O
binocular	B-T033
acuity	I-T033
(	O
p	O
=	O
.	O
04	O
)	O
,	O
and	O
stereo	B-T038
##ps	I-T038
##is	I-T038
(	O
p	O
=	O
.	O
005	O
)	O
best	O
determined	O
the	O
tactic	B-T062
##al	I-T062
cluster	I-T062
(	O
unadjusted	O
r	O
(	O
2	O
)	O
=	O
.	O
41	O
)	O
.	O
the	O
visu	B-T170
##o	I-T170
-	I-T170
integrative	I-T170
mode	I-T170
l	O
(	O
unadjusted	O
r	O
(	O
2	O
)	O
=	O
.	O
12	O
)	O
comprised	O
binocular	B-T033
acuity	I-T033
(	O
p	O
=	O
.	O
007	O
)	O
and	O
stereo	B-T038
##ps	I-T038
##is	I-T038
(	O
p	O
=	O
.	O
045	O
)	O
.	O
inhibition	B-T038
(	O
p	O
=	O
.	O
0001	O
)	O
and	O
binocular	B-T033
acuity	I-T033
(	O
p	O
=	O
.	O
001	O
)	O
provided	O
the	O
best	O
model	B-T170
of	O
the	O
mixed	B-T062
cluster	I-T062
(	O
unadjusted	O
r	O
(	O
2	O
)	O
=	O
.	O
25	O
)	O
.	O
our	O
results	O
provide	O
more	O
insights	O
into	O
the	O
specific	O
impairments	O
that	O
influence	O
different	O
dimensions	O
of	O
on	O
-	O
road	O
driving	O
and	O
may	O
be	O
used	O
as	O
a	O
framework	O
for	O
targeted	O
driving	O
intervention	O
programs	O
in	O
ms	B-T038
.	O

the	O
relationship	O
between	O
thiamine	B-T103
and	O
two	O
symb	O
##io	O
##se	O
##s	O
:	O
root	B-T204
nodule	I-T204
symbiosis	O
and	O
arb	B-T204
##uscular	I-T204
myc	I-T204
##orrhiz	I-T204
##a	I-T204
lot	B-T204
##us	I-T204
japonic	I-T204
##us	I-T204
thi	B-T017
##c	I-T017
is	O
expressed	B-T038
in	O
all	O
organs	B-T204
,	O
and	O
the	O
encoded	B-T103
protein	I-T103
catalyzes	O
thiamine	B-T038
biosynthesis	I-T038
.	O
loss	B-T033
of	I-T033
function	I-T033
produces	O
chloro	B-T038
##sis	I-T038
,	O
a	O
typical	O
thiamine	B-T103
-	O
deficiency	O
phenotype	O
,	O
and	O
mortality	O
.	O
to	O
investigate	O
thiamine	B-T103
'	I-T103
s	I-T103
role	O
in	O
symbiosis	O
,	O
we	O
focused	O
on	O
thi	B-T017
##1	I-T017
,	O
a	O
thiamine	B-T017
-	I-T017
biosynthesis	I-T017
gene	I-T017
expressed	B-T038
in	O
roots	B-T204
,	O
nodules	B-T204
,	O
and	O
seeds	B-T204
.	O
the	O
thi	B-T017
##1	I-T017
mutant	I-T017
had	O
green	B-T204
leaves	I-T204
,	O
but	O
formed	O
small	O
nodules	B-T204
and	O
immature	O
seeds	B-T204
.	O
these	O
phenotypes	O
were	O
rescued	O
by	O
thi	B-T017
##1	I-T017
complementation	O
and	O
by	O
exogenous	O
thiamine	B-T103
.	O
thus	O
,	O
thi	B-T017
##1	I-T017
is	O
required	O
for	O
nodule	B-T204
enlargement	O
and	O
seed	B-T038
maturation	I-T038
.	O
on	O
the	O
other	O
hand	O
,	O
colonization	B-T033
by	O
arb	B-T204
##uscular	I-T204
myc	I-T204
##orrhiz	I-T204
##a	I-T204
(	O
am	B-T204
)	O
fungus	B-T204
rhiz	B-T204
##ophag	I-T204
##us	I-T204
irregular	I-T204
##is	I-T204
was	O
not	O
affected	O
in	O
the	O
thi	B-T017
##1	I-T017
mutant	I-T017
or	O
by	O
exogenous	O
thiamine	B-T103
.	O
however	O
,	O
spores	B-T204
of	O
r	B-T204
.	I-T204
irregular	I-T204
##is	I-T204
stored	O
more	O
thiamine	B-T103
than	O
the	O
source	O
(	O
host	O
plants	O
)	O
,	O
despite	O
lacking	O
thiamine	B-T017
biosynthesis	I-T017
genes	I-T017
.	O
therefore	O
,	O
disturbance	O
of	O
the	O
thiamine	B-T103
supply	O
would	O
affect	O
progeny	O
phenotypes	O
such	O
as	O
spore	B-T038
formation	I-T038
and	O
hyp	B-T038
##hal	I-T038
growth	I-T038
.	O
further	O
investigation	O
will	O
be	O
required	O
to	O
elucidate	O
thiamine	B-T103
'	I-T103
s	I-T103
effect	O
on	O
am	B-T204
.	O

the	O
evidence	O
behind	O
integrating	O
palliative	B-T091
care	I-T091
into	O
oncology	B-T038
practice	O
palliative	B-T092
care	I-T092
services	I-T092
provided	O
alongside	O
traditional	O
oncology	O
care	O
have	O
been	O
shown	O
to	O
be	O
beneficial	O
to	O
patients	O
and	O
families	O
.	O
this	O
article	B-T170
provides	O
a	O
brief	O
history	O
of	O
palliative	B-T091
care	I-T091
,	O
a	O
pathway	O
to	O
implementing	O
these	O
services	O
into	O
currently	O
established	O
oncology	B-T058
programs	I-T058
,	O
and	O
a	O
brief	O
discussion	O
of	O
common	O
barriers	O
.	O

studying	B-T062
neuroprotective	O
effect	O
of	O
atorvastatin	B-T103
as	O
a	O
small	B-T103
molecule	I-T103
drug	B-T103
on	O
high	B-T033
glucose	I-T033
-	O
induced	O
neurotoxicity	B-T037
in	O
undifferentiated	O
pc12	B-T017
cells	I-T017
:	O
role	O
of	O
nadph	B-T103
oxidase	I-T103
overproduction	O
of	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
by	O
nadph	B-T103
oxidase	I-T103
(	O
nox	B-T103
)	O
activation	B-T038
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	B-T038
in	O
various	O
tissues	B-T017
.	O
however	O
,	O
there	O
is	O
no	O
comprehensive	O
study	B-T062
on	O
the	O
role	O
of	O
nox	B-T103
##s	I-T103
in	O
high	B-T033
glucose	I-T033
(	O
hg	B-T033
)	O
-	O
induced	O
toxic	B-T037
effect	I-T037
in	O
neural	B-T017
tissues	I-T017
.	O
recently	O
,	O
a	O
therapeutic	O
strategy	O
in	O
oxidative	O
related	O
pathologies	B-T091
has	O
been	O
introduced	O
by	O
blocking	O
the	O
undesirable	O
actions	O
of	O
nox	B-T103
enzymes	I-T103
by	O
small	B-T103
molecules	I-T103
.	O
the	O
protective	O
roles	O
of	O
statins	B-T103
in	O
ameliorating	O
oxidative	B-T038
stress	I-T038
by	O
nox	B-T103
inhibition	B-T038
have	O
been	O
shown	O
in	O
some	O
tissues	B-T017
except	O
neural	B-T017
.	O
we	O
hypothesized	O
then	O
,	O
that	O
different	O
nox	B-T103
##s	I-T103
may	O
have	O
role	O
in	O
hg	B-T033
-	O
induced	O
neural	O
cell	O
injury	O
.	O
furthermore	O
,	O
we	O
postulate	O
that	O
atorvastatin	B-T103
as	O
a	O
small	B-T103
molecule	I-T103
may	O
modulate	B-T082
this	O
nox	B-T038
##s	I-T038
activity	I-T038
to	O
protect	O
neural	B-T017
cells	I-T017
.	O
undifferentiated	O
pc12	B-T017
cells	I-T017
were	O
treated	B-T058
with	I-T058
hg	B-T033
(	O
140	O
mm	O
/	O
24	O
h	O
)	O
in	O
the	O
presence	B-T033
and	O
absence	O
of	O
atorvastatin	B-T103
(	O
1	O
μm	O
/	O
96	O
h	O
)	O
.	O
the	O
cell	B-T038
viability	I-T038
was	O
measured	O
by	O
mtt	B-T062
assay	I-T062
and	O
the	O
gene	O
and	O
protein	B-T033
expressions	I-T033
profile	I-T033
of	O
nox	B-T103
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
rt	B-T062
-	I-T062
pcr	I-T062
and	O
western	B-T058
blotting	I-T058
,	O
respectively	O
.	O
levels	O
of	O
ros	B-T103
and	O
malondialdehyde	B-T103
(	O
mda	B-T103
)	O
were	O
also	O
evaluated	O
.	O
gene	B-T038
and	O
protein	B-T038
expression	I-T038
levels	O
of	O
nox	B-T103
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
ros	B-T103
and	O
mda	B-T103
levels	O
were	O
elevated	O
in	O
hg	B-T033
-	O
treated	O
pc12	B-T017
cells	I-T017
.	O
atorvastatin	B-T103
could	O
significantly	O
decrease	O
hg	B-T033
-	O
induced	O
nox	B-T103
##s	I-T103
,	O
ros	B-T103
and	O
mda	B-T103
elevation	B-T082
and	O
improve	B-T033
impaired	O
cell	B-T038
viability	I-T038
.	O
it	O
can	O
be	O
concluded	O
that	O
hg	B-T033
could	O
elevate	O
nox	B-T038
##s	I-T038
activity	I-T038
,	O
ros	B-T103
and	O
mda	B-T103
levels	O
in	O
neural	B-T017
tissues	I-T017
and	O
atorvastatin	B-T103
as	O
a	O
small	B-T103
molecule	I-T103
nox	B-T103
inhibitor	I-T103
drug	I-T103
may	O
prevent	O
and	O
delay	O
diabetic	B-T038
complications	I-T038
,	O
particularly	O
neuropathy	B-T038
.	O

association	O
among	O
prematurity	B-T038
(	O
<	O
30	O
weeks	O
'	O
gestational	O
age	O
)	O
,	O
blood	B-T038
pressure	I-T038
,	O
urinary	O
albumin	B-T103
,	O
calcium	B-T103
,	O
and	O
phosphate	B-T103
in	O
early	O
childhood	O
there	O
is	O
a	O
paucity	O
of	O
data	O
on	O
blood	B-T038
pressures	I-T038
(	O
bp	B-T038
)	O
,	O
urinary	O
albumin	B-T103
,	O
and	O
mineral	B-T103
excretion	B-T038
in	O
early	O
childhood	O
in	O
contemporary	O
cohorts	B-T098
of	O
extremely	O
low	O
gestational	O
age	O
(	O
ga	O
)	O
neonates	O
.	O
our	O
aim	O
was	O
to	O
compare	O
bps	B-T038
and	O
the	O
urinary	O
excretion	B-T038
of	O
albumin	B-T103
,	O
calcium	B-T103
,	O
and	O
phosphate	B-T103
in	O
preterm	O
and	O
term	B-T038
-	I-T038
born	I-T038
cohorts	B-T098
in	O
early	O
childhood	O
.	O
this	O
was	O
a	O
prospective	B-T062
observational	I-T062
study	I-T062
conducted	O
at	O
a	O
single	O
center	B-T092
,	O
involving	O
children	O
<	O
5	O
years	O
age	O
,	O
born	B-T033
preterm	I-T033
(	O
ga	B-T033
<	I-T033
30	I-T033
weeks	I-T033
)	O
or	O
at	B-T038
term	I-T038
(	O
≥3	B-T033
##7	I-T033
weeks	I-T033
'	I-T033
ga	I-T033
)	O
.	O
urinary	B-T033
albumin	I-T033
(	O
mg	O
/	O
l	O
)	O
,	O
calcium	B-T033
and	O
phosphate	B-T033
levels	I-T033
indexed	B-T170
to	O
creatinine	B-T103
(	O
mg	O
/	O
dl	O
)	O
,	O
and	O
bp	B-T038
were	O
measured	O
.	O
the	O
median	B-T082
(	O
iqr	O
)	O
follow	B-T058
-	I-T058
up	I-T058
age	O
of	O
our	O
cohort	B-T098
(	O
n	O
=	O
106	O
)	O
was	O
30	O
(	O
16	O
-	O
48	O
)	O
months	O
.	O
preterm	O
-	O
born	O
children	O
(	O
n	O
=	O
55	O
)	O
had	O
a	O
significantly	O
lower	O
mean	O
ga	O
and	O
birth	O
weight	O
and	O
higher	O
mean	O
systolic	B-T201
,	O
diastolic	B-T201
,	O
and	O
mean	B-T033
bps	I-T033
,	O
compared	O
with	O
term	B-T038
(	O
n	O
=	O
51	O
)	O
controls	O
.	O
a	O
significantly	O
higher	O
proportion	O
of	O
preterm	O
-	O
born	O
children	O
weighed	O
<	B-T033
10th	I-T033
centi	I-T033
##le	I-T033
and	O
had	O
systolic	B-T201
bp	I-T201
>	B-T033
95	I-T033
##th	I-T033
centi	I-T033
##le	I-T033
at	O
follow	B-T058
-	I-T058
up	I-T058
.	O
albumin	B-T103
and	O
calcium	B-T103
excretion	B-T038
did	O
not	O
differ	O
between	O
the	O
groups	O
;	O
median	O
urine	O
-	O
phosphate	O
creatinine	O
ratios	O
were	O
higher	O
in	O
the	O
preterm	O
group	O
.	O
on	O
logistic	B-T062
regression	I-T062
,	O
lower	O
ga	O
and	O
younger	O
age	O
at	O
follow	B-T058
-	I-T058
up	I-T058
were	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
systolic	B-T201
and	O
diastolic	B-T201
bp	I-T201
above	O
the	O
95	B-T033
##th	I-T033
centi	I-T033
##le	I-T033
;	O
male	O
gender	O
was	O
associated	O
with	O
decreased	O
risk	O
of	O
diastolic	B-T038
hypertension	I-T038
.	O
even	O
in	O
early	O
childhood	O
,	O
children	O
born	O
preterm	O
had	O
significantly	O
elevated	O
bp	B-T038
,	O
compared	O
with	O
their	O
term	B-T038
-	I-T038
born	I-T038
counterparts	O
.	O
closer	O
monitoring	B-T058
of	O
bps	B-T038
in	O
this	O
population	B-T098
may	O
be	O
warranted	O
.	O

plasmodium	B-T204
falciparum	I-T204
choline	B-T103
kinase	I-T103
inhibition	O
leads	O
to	O
a	O
major	O
decrease	O
in	O
phosphatidylethanolamine	B-T103
causing	O
parasite	B-T204
death	B-T038
malaria	B-T038
is	O
a	O
life	B-T033
-	I-T033
threatening	I-T033
disease	B-T038
caused	O
by	O
different	O
species	B-T170
of	O
the	O
protozoan	B-T204
parasite	I-T204
plasmodium	B-T204
,	O
with	O
p	B-T204
.	I-T204
falciparum	I-T204
being	O
the	O
dead	O
##li	O
##est	O
.	O
increasing	O
parasitic	O
resistance	O
to	O
existing	O
antimalarial	B-T103
##s	I-T103
makes	O
the	O
necessity	O
of	O
novel	O
avenues	O
to	O
treat	B-T058
this	O
disease	B-T038
an	O
urgent	O
priority	O
.	O
the	O
enzymes	B-T103
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	B-T103
and	O
phosphatidylethanolamine	B-T103
are	O
attractive	O
drug	O
targets	O
to	O
treat	B-T058
malaria	B-T038
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	B-T204
'	I-T204
s	I-T204
growth	B-T038
and	O
cure	O
##s	O
malaria	B-T038
in	O
a	O
mouse	B-T038
model	I-T038
.	O
we	O
present	O
here	O
a	O
detailed	O
study	B-T062
that	O
reveals	O
a	O
mode	O
of	O
action	O
for	O
two	O
p	B-T204
.	I-T204
falciparum	I-T204
choline	B-T103
kinase	I-T103
inhibitors	B-T103
both	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O
the	O
compounds	O
present	O
distinct	O
binding	B-T038
modes	O
to	O
the	O
choline	B-T103
/	O
ethanol	B-T103
##amine	I-T103
-	O
binding	B-T103
site	I-T103
of	O
p	B-T204
.	I-T204
falciparum	I-T204
choline	B-T103
kinase	I-T103
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O
strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanol	B-T038
##amine	I-T038
kinase	I-T038
activity	I-T038
of	O
the	O
p	B-T204
.	I-T204
falciparum	I-T204
choline	B-T103
kinase	I-T103
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	B-T103
levels	O
within	O
p	B-T204
.	I-T204
falciparum	I-T204
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	B-T204
death	B-T038
.	O
these	O
studies	O
provide	O
an	O
understanding	O
of	O
the	O
mode	O
of	O
action	O
,	O
and	O
act	O
as	O
a	O
spring	O
##board	O
for	O
continued	O
antimalarial	B-T038
development	I-T038
efforts	O
selectively	O
targeting	O
p	B-T204
.	I-T204
falciparum	I-T204
choline	B-T103
kinase	I-T103
.	O

case	B-T170
report	I-T170
of	O
necrotizing	B-T038
fasci	I-T038
##itis	I-T038
associated	O
with	O
streptococcus	B-T007
pneumoniae	I-T007
necrotizing	B-T038
fasci	I-T038
##itis	I-T038
,	O
caused	O
by	O
streptococcus	B-T007
pneumoniae	I-T007
,	O
is	O
an	O
extremely	O
rare	O
and	O
life	B-T033
-	I-T033
threatening	I-T033
bacterial	B-T007
soft	B-T038
tissue	I-T038
infection	I-T038
.	O
we	O
report	B-T058
a	O
case	O
of	O
early	O
necrotizing	B-T038
fasci	I-T038
##itis	I-T038
associated	O
with	O
streptococcus	B-T007
pneumoniae	I-T007
infection	B-T038
in	O
a	O
26	O
-	O
year	O
-	O
old	O
man	B-T098
who	O
was	O
immunocompromised	B-T033
with	O
mixed	B-T038
connective	I-T038
tissue	I-T038
disease	I-T038
.	O
the	O
patient	O
presented	O
with	O
acute	O
,	O
painful	B-T033
,	O
erythemat	O
##ous	O
,	O
and	O
edema	B-T038
##to	I-T038
##us	I-T038
skin	I-T038
lesions	B-T033
of	O
his	O
right	B-T082
lower	I-T082
back	I-T082
,	O
which	O
rapidly	O
progressed	O
to	O
the	O
right	B-T017
knee	I-T017
.	O
the	O
patient	O
underwent	O
surgical	B-T058
exploration	I-T058
,	O
and	O
a	O
diagnosis	B-T033
of	O
necrotizing	B-T038
fasci	I-T038
##itis	I-T038
was	O
confirmed	O
by	O
pathological	O
evidence	O
of	O
necrosis	B-T038
of	O
the	O
fascia	B-T017
and	O
neutrophil	B-T038
infiltration	I-T038
in	O
tissue	O
biopsies	O
.	O
cultures	O
of	O
fascia	B-T082
##l	I-T082
tissue	O
biopsies	O
and	O
blood	B-T031
samples	I-T031
were	O
positive	B-T033
for	O
streptococcus	B-T007
pneumoniae	I-T007
.	O
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	B-T058
of	O
necrotizing	B-T038
fasci	I-T038
##itis	I-T038
resulting	O
from	O
streptococcus	B-T007
pneumoniae	I-T007
diagnosed	B-T033
at	O
early	O
phase	O
;	O
the	O
patient	O
recovered	O
well	O
without	O
surgical	B-T058
debridement	I-T058
.	O

a	O
comparative	B-T062
study	I-T062
of	O
the	O
efficacy	O
of	O
iv	B-T082
dex	B-T103
##ket	I-T103
##oprofen	I-T103
,	O
lor	B-T103
##no	I-T103
##x	I-T103
##ica	I-T103
##m	I-T103
,	O
and	O
dic	B-T103
##lo	I-T103
##phen	I-T103
##ac	I-T103
sodium	I-T103
on	O
postoperative	B-T058
analgesia	I-T058
and	O
tramadol	B-T103
consumption	O
in	O
patients	O
receiving	O
patient	B-T058
-	I-T058
controlled	I-T058
tramadol	B-T103
this	O
study	B-T062
was	O
designed	O
to	O
compare	O
the	O
effects	O
of	O
dex	B-T103
##ket	I-T103
##oprofen	I-T103
,	O
lor	B-T103
##no	I-T103
##x	I-T103
##ica	I-T103
##m	I-T103
,	O
and	O
dic	B-T103
##lo	I-T103
##phen	I-T103
##ac	I-T103
sodium	I-T103
on	O
postoperative	B-T058
analgesia	I-T058
and	O
tramadol	B-T103
consumption	O
in	O
patients	O
receiving	O
postoperative	O
patient	B-T058
-	I-T058
controlled	I-T058
tramadol	B-T103
after	O
a	O
major	O
abdominal	B-T058
surgery	I-T058
.	O
eighty	O
patients	O
were	O
randomized	B-T033
to	O
receive	O
one	O
of	O
the	O
four	O
study	B-T062
drugs	B-T103
.	O
patients	O
in	O
group	O
dex	B-T103
##ket	I-T103
##oprofen	I-T103
(	O
dt	B-T103
)	O
received	O
iv	B-T082
50	O
mg	O
dex	B-T103
##ket	I-T103
##oprofen	I-T103
,	O
group	O
lor	B-T103
##no	I-T103
##x	I-T103
##ica	I-T103
##m	I-T103
(	O
lr	B-T103
)	O
received	O
iv	B-T082
8	O
mg	O
lor	B-T103
##no	I-T103
##x	I-T103
##ica	I-T103
##m	I-T103
,	O
group	O
dic	B-T103
##lo	I-T103
##phen	I-T103
##ac	I-T103
sodium	I-T103
(	O
ds	B-T103
)	O
received	O
75	O
mg	O
iv	B-T082
dic	B-T103
##lo	I-T103
##phen	I-T103
##ac	I-T103
sodium	I-T103
and	O
group	O
saline	O
(	O
s	O
)	O
received	O
0	O
.	O
9	O
%	O
saline	O
in	O
2	O
ml	O
syringe	B-T074
##s	I-T074
,	O
20	O
min	O
before	O
the	O
end	O
of	O
anaesthesia	B-T058
.	O
a	O
standardized	O
(	O
1	O
mg	O
kg	O
(	O
-	O
1	O
)	O
)	O
dose	O
of	O
tramadol	B-T103
was	O
routinely	O
administered	O
to	O
all	O
patients	O
as	O
the	O
loading	O
dose	O
at	O
the	O
end	O
of	O
surgery	B-T058
.	O
postoperatively	O
,	O
whenever	O
patients	O
requested	O
,	O
they	O
were	O
allowed	O
to	O
use	O
a	O
tramadol	B-T103
patient	B-T033
-	I-T033
controlled	I-T033
analgesia	I-T033
device	I-T033
giving	O
a	O
bolus	B-T058
dose	I-T058
(	O
0	O
.	O
2	O
mg	O
kg	O
(	O
-	O
1	O
)	O
)	O
of	O
tramadol	B-T103
.	O
pain	B-T033
,	O
discomfort	B-T033
,	O
and	O
sedation	B-T033
scores	O
,	O
cumulative	O
tramadol	B-T103
consumption	O
,	O
supplemental	O
mep	B-T103
##eri	I-T103
##dine	I-T103
requirement	O
,	O
and	O
side	B-T038
effects	I-T038
were	O
recorded	O
.	O
visual	O
rating	O
scale	O
and	O
patient	O
discomfort	B-T033
scores	O
were	O
significantly	O
lower	O
in	O
dt	B-T103
,	O
lr	B-T103
and	O
ds	B-T103
groups	O
compared	O
to	O
those	O
in	O
in	O
group	O
s	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
cumulative	O
tramadol	B-T103
consumption	O
was	O
significantly	O
lower	O
in	O
non	B-T103
-	I-T103
steroidal	I-T103
anti	I-T103
-	I-T103
inflammatory	I-T103
drug	I-T103
(	O
nsaid	B-T103
)	O
-	O
treated	O
groups	O
at	O
each	O
study	B-T062
period	I-T062
after	O
the	O
second	O
postoperative	O
hour	O
than	O
in	O
group	O
s	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
supplemental	O
mep	B-T103
##eri	I-T103
##dine	I-T103
requirement	O
was	O
significantly	O
higher	O
in	O
group	O
s	O
at	O
each	O
study	B-T062
period	I-T062
after	O
postoperative	O
30	O
min	O
than	O
in	O
nsaid	B-T103
-	O
treated	O
groups	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
after	O
major	O
abdominal	B-T058
surgery	I-T058
,	O
adding	O
iv	B-T082
dic	B-T103
##lo	I-T103
##phen	I-T103
##ac	I-T103
,	O
lor	B-T103
##no	I-T103
##x	I-T103
##ica	I-T103
##m	I-T103
or	O
dex	B-T103
##ket	I-T103
##oprofen	I-T103
to	O
patient	B-T058
-	I-T058
controlled	I-T058
tramadol	B-T103
resulted	O
in	O
lower	O
pain	B-T033
scores	O
,	O
smaller	O
tramadol	B-T103
consumption	O
,	O
less	O
rescue	O
supplemental	O
analgesic	B-T103
requirement	O
,	O
and	O
fewer	O
side	B-T038
effects	I-T038
compared	O
with	O
the	O
tramadol	B-T103
alone	O
group	O
.	O

a	O
child	O
with	O
phenyl	B-T038
##ket	I-T038
##on	I-T038
##uria	I-T038
and	O
focal	B-T038
segmental	I-T038
glomerulosclerosis	I-T038
,	O
the	O
bright	O
side	O
of	O
proteinuria	B-T033
phenyl	B-T038
##ket	I-T038
##on	I-T038
##uria	I-T038
(	O
pk	B-T038
##u	I-T038
)	O
is	O
the	O
most	O
common	O
in	B-T038
##born	I-T038
error	I-T038
of	I-T038
amino	I-T038
acid	I-T038
metabolism	I-T038
.	O
phenylalanine	B-T103
hydroxylase	I-T103
is	O
the	O
underlying	O
deficient	O
enzyme	B-T103
.	O
if	O
left	O
untreated	B-T033
,	O
growth	B-T038
failure	I-T038
,	O
microc	B-T017
##ephal	I-T017
##y	I-T017
,	O
global	B-T038
developmental	I-T038
delay	I-T038
,	O
seizures	B-T033
and	O
severe	O
intellectual	O
impairment	O
would	O
characterize	O
the	O
clinical	O
picture	O
of	O
pk	B-T038
##u	I-T038
.	O
on	O
the	O
other	O
side	O
of	O
protein	B-T103
homeostasis	B-T038
lies	O
nephrotic	B-T038
syndrome	I-T038
.	O
it	O
is	O
a	O
well	O
-	O
known	O
quantitative	O
defect	O
due	O
to	O
significant	O
proteinuria	B-T033
.	O
focal	B-T038
segmental	I-T038
glomerulosclerosis	I-T038
(	O
fs	B-T038
##gs	I-T038
)	O
is	O
a	O
special	O
congenital	O
variant	O
affecting	O
children	O
and	O
adults	O
.	O
here	O
##by	O
,	O
we	O
describe	O
a	O
three	O
-	O
year	O
old	O
male	O
child	O
who	O
presented	B-T033
with	O
generalized	B-T033
edema	I-T033
and	O
global	B-T038
developmental	I-T038
delay	I-T038
.	O
investigations	B-T058
revealed	O
pk	B-T038
##u	I-T038
along	O
with	O
fs	B-T038
##gs	I-T038
.	O
we	O
assume	O
that	O
congenital	B-T038
nephr	I-T038
##osis	I-T038
ameliorated	B-T033
the	O
picture	O
of	O
pk	B-T038
##u	I-T038
,	O
and	O
had	O
a	O
sal	O
##uta	O
##ry	O
effect	O
on	O
the	O
growth	B-T038
and	I-T038
development	I-T038
.	O
such	O
coexistence	O
between	O
pk	B-T038
##u	I-T038
and	O
fs	B-T038
##gs	I-T038
has	O
##n	O
'	O
t	O
been	O
described	O
before	O
.	O

proliferation	B-T038
-	O
related	O
activity	O
in	O
endothelial	B-T017
cells	I-T017
is	O
enhanced	O
by	O
microp	O
##ower	O
plasma	B-T103
nont	B-T058
##her	I-T058
##mal	I-T058
plasma	I-T058
has	O
received	O
a	O
lot	O
of	O
attention	O
as	O
a	O
medical	O
treatment	O
technique	O
in	O
recent	O
years	O
.	O
it	O
can	O
easily	O
create	O
various	O
reactive	B-T103
chemical	I-T103
species	I-T103
(	O
ros	B-T103
)	O
and	O
is	O
harm	O
##less	O
to	O
living	B-T204
body	I-T204
.	O
although	O
plasma	B-T103
at	O
gas	B-T103
-	O
liquid	O
interface	O
has	O
a	O
potential	O
for	O
a	O
biomedical	B-T058
application	I-T058
,	O
the	O
interactions	O
between	O
the	O
gas	B-T103
-	O
liquid	O
plasma	B-T103
and	O
living	B-T017
cells	I-T017
remain	O
unclear	O
.	O
here	O
,	O
we	O
show	O
characteristics	O
of	O
a	O
microp	O
##ower	O
plasma	B-T103
with	O
0	O
.	O
018	O
w	O
of	O
the	O
power	O
input	O
,	O
generated	O
at	O
gas	B-T103
-	O
liquid	O
interface	O
.	O
we	O
also	O
provide	O
the	O
evidence	O
of	O
plasma	B-T103
-	O
induced	O
enhancement	O
in	O
proliferation	B-T038
activity	O
of	O
endothelial	B-T017
cells	I-T017
.	O
the	O
plasma	B-T103
produced	O
h2o2	B-T103
,	O
hn	B-T103
##o2	I-T103
,	O
and	O
hn	B-T103
##o3	I-T103
in	O
phosphate	B-T103
buffered	I-T103
saline	O
containing	O
mg	B-T103
(	I-T103
+	I-T103
+	I-T103
)	I-T103
and	O
ca	B-T103
(	I-T103
+	I-T103
+	I-T103
)	I-T103
(	O
pbs	B-T103
(	O
+	O
)	O
)	O
,	O
and	O
their	O
concentration	O
increased	O
linearly	O
during	O
600	O
-	O
second	O
discharge	O
.	O
the	O
value	O
of	O
ph	O
in	O
pbs	B-T103
(	O
+	O
)	O
against	O
the	O
plasma	B-T103
discharge	O
time	O
was	O
stable	O
at	O
about	O
7	O
.	O
0	O
.	O
temperature	O
in	O
pbs	B-T103
(	O
+	O
)	O
rose	O
mono	O
##tonic	O
##ally	O
,	O
and	O
its	O
rise	O
was	O
up	O
to	O
0	O
.	O
8	O
##°c	O
at	O
the	O
bottom	O
of	O
a	O
cell	B-T017
-	I-T017
cultured	I-T017
dish	O
by	O
the	O
plasma	B-T103
discharge	O
for	O
600	O
s	O
.	O
short	O
-	O
time	O
treatment	O
of	O
the	O
plasma	B-T103
enhanced	O
proliferation	B-T038
activity	O
of	O
endothelial	B-T017
cells	I-T017
.	O
in	O
contrast	O
,	O
the	O
treatment	O
of	O
h2o2	B-T103
does	O
not	O
enhance	O
the	O
cell	B-T038
proliferation	I-T038
.	O
thus	O
,	O
the	O
ros	B-T103
production	O
and	O
the	O
nuclear	O
factor	O
-	O
kappa	O
b	O
(	O
nf	O
-	O
κb	O
)	O
activation	O
due	O
to	O
the	O
plasma	B-T103
treatment	O
might	O
be	O
related	O
to	O
enhancement	O
of	O
the	O
cell	B-T038
proliferation	I-T038
.	O
our	O
results	O
may	O
potentially	O
provide	O
the	O
basis	O
for	O
developing	O
the	O
biomedical	B-T058
applications	I-T058
using	O
the	O
gas	B-T103
-	O
liquid	O
plasma	B-T103
.	O

recent	O
advances	O
in	O
chitosan	B-T103
-	O
based	O
nanopartic	O
##ulate	O
pulmonary	B-T017
drug	B-T074
delivery	I-T074
the	O
advent	O
of	O
biodegradable	O
polymer	O
-	O
encapsulated	O
drug	B-T103
nanoparticles	O
has	O
made	O
the	O
pulmonary	B-T017
route	O
of	O
administration	O
an	O
exciting	O
area	O
of	O
drug	B-T074
delivery	I-T074
research	B-T062
.	O
chitosan	B-T103
,	O
a	O
natural	O
biodegradable	O
and	O
biocompatible	B-T103
polysaccharide	B-T103
has	O
received	O
enormous	O
attention	O
as	O
a	O
carrier	B-T103
for	O
drug	B-T074
delivery	I-T074
.	O
recently	O
,	O
nanoparticles	O
of	O
chitosan	B-T103
(	O
cs	B-T103
)	O
and	O
its	O
synthetic	B-T103
derivatives	I-T103
have	O
been	O
investigated	O
for	O
the	O
encapsulation	O
and	O
delivery	O
of	O
many	O
drugs	B-T103
with	O
improved	B-T033
targeting	O
and	O
controlled	O
release	O
.	O
herein	O
,	O
recent	O
advances	O
in	O
the	O
preparation	O
and	O
use	O
of	O
micro	B-T017
-	I-T017
/	O
nanoparticles	O
of	O
chitosan	B-T103
and	O
its	O
derivatives	B-T103
for	O
pulmonary	B-T017
delivery	O
of	O
various	O
therapeutic	O
agents	O
(	O
drugs	B-T103
,	O
genes	B-T017
,	O
vaccines	B-T103
)	O
are	O
reviewed	O
.	O
although	O
chitosan	B-T103
has	O
wide	O
applications	O
in	O
terms	O
of	O
formulations	B-T062
and	O
routes	O
of	O
drug	O
delivery	O
,	O
this	O
review	B-T170
is	O
focused	O
on	O
pulmonary	B-T017
delivery	B-T058
of	I-T058
drug	I-T058
-	I-T058
encapsulated	I-T058
nanoparticles	I-T058
of	O
chitosan	B-T103
and	O
its	O
derivatives	B-T103
.	O
in	O
addition	O
,	O
the	O
controversial	O
toxicological	B-T037
effects	I-T037
of	O
chitosan	B-T103
nanoparticles	O
for	O
lung	B-T017
delivery	O
will	O
also	O
be	O
discussed	O
.	O

is	O
modern	O
medical	B-T058
management	I-T058
changing	O
ultimate	O
patient	O
outcomes	O
in	O
inflammatory	B-T038
bowel	I-T038
disease	I-T038
?	O
the	O
impact	O
of	O
modern	O
medical	B-T058
management	I-T058
of	O
inflammatory	B-T038
bowel	I-T038
disease	I-T038
(	O
ibd	B-T038
)	O
on	O
surgical	B-T058
necessity	I-T058
and	O
outcomes	O
remains	O
unclear	O
.	O
we	O
hypothesized	O
that	O
surgery	B-T058
rates	O
have	O
decreased	O
while	O
outcomes	O
have	O
worsened	B-T033
due	O
to	O
operating	B-T058
on	O
[UNK]	O
sick	B-T033
##er	I-T033
[UNK]	O
patients	O
since	O
the	O
introduction	O
of	O
biologic	B-T058
medications	I-T058
.	O
the	O
nationwide	O
inpatient	O
sample	O
and	O
icd	B-T170
-	I-T170
9	I-T170
-	I-T170
cm	I-T170
codes	I-T170
were	O
used	O
to	O
identify	O
inpatient	O
admissions	B-T058
for	O
crohn	B-T038
'	I-T038
s	I-T038
disease	I-T038
and	O
ulcerative	B-T038
colitis	I-T038
.	O
trends	O
in	O
ibd	B-T038
nutrition	B-T033
,	O
surgeries	B-T058
,	O
and	O
postoperative	B-T038
complications	I-T038
were	O
determined	O
.	O
there	O
were	O
191	O
,	O
74	O
##3	O
admissions	B-T058
for	O
ibd	B-T038
during	O
the	O
study	B-T062
period	O
.	O
surgery	B-T058
rates	O
were	O
largely	O
unchanged	B-T033
over	O
the	O
study	B-T062
period	O
,	O
ranging	O
from	O
9	O
to	O
12	O
%	O
of	O
admissions	B-T058
in	O
both	O
crohn	B-T038
'	I-T038
s	I-T038
disease	I-T038
and	O
ulcerative	B-T038
colitis	I-T038
.	O
the	O
rate	O
of	O
poor	B-T038
nutrition	I-T038
increased	O
by	O
67	O
%	O
in	O
ulcerative	B-T038
colitis	I-T038
and	O
by	O
83	O
%	O
in	O
crohn	B-T038
'	I-T038
s	I-T038
disease	I-T038
.	O
rates	O
of	O
postoperative	O
anastomotic	B-T038
leak	I-T038
(	O
10	O
.	O
2	O
-	O
13	O
.	O
9	O
%	O
)	O
were	O
unchanged	B-T033
over	O
the	O
years	O
.	O
postoperative	B-T038
infection	I-T038
rates	O
decreased	O
by	O
17	O
%	O
in	O
crohn	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
18	O
%	O
in	O
2003	O
to	O
15	O
%	O
in	O
2012	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
but	O
did	O
not	O
show	O
a	O
trend	O
in	O
any	O
direction	O
in	O
ulcerative	B-T038
colitis	I-T038
.	O
rates	O
of	O
ibd	B-T038
surgery	B-T091
have	O
remained	O
stable	O
while	O
postoperative	B-T038
infectious	I-T038
complications	I-T038
have	O
remained	O
stable	O
or	O
decreased	O
since	O
the	O
implementation	B-T058
of	O
biologic	B-T058
therapies	I-T058
.	O
we	O
identified	O
an	O
increase	O
in	O
poor	B-T038
nutrition	I-T038
in	O
surgical	O
patients	O
.	O

a	O
microfluidic	O
platform	O
to	O
design	O
crosslinked	O
hyaluronic	O
acid	O
nanoparticles	O
(	O
cha	O
##nps	O
)	O
for	O
enhanced	B-T058
mri	I-T058
recent	O
advancements	O
in	O
imaging	B-T058
diagnostics	I-T058
have	O
focused	O
on	O
the	O
use	O
of	O
nanostructures	O
that	O
entrap	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
contrast	B-T103
agents	I-T103
(	O
cas	B-T103
)	O
,	O
without	O
the	O
need	O
to	O
chemically	B-T103
modify	O
the	O
clinically	O
approved	O
compounds	B-T103
.	O
nevertheless	O
,	O
the	O
exploitation	O
of	O
microfluidic	O
platforms	O
for	O
their	O
controlled	O
and	O
continuous	O
production	O
is	O
still	O
missing	O
.	O
here	O
,	O
a	O
microfluidic	O
platform	O
is	O
used	O
to	O
synthesize	O
crosslinked	O
hyaluronic	O
acid	O
nanoparticles	O
(	O
cha	O
##nps	O
)	O
in	O
which	O
a	O
clinically	O
relevant	O
mri	B-T058
-	O
cas	B-T103
,	O
gadolinium	B-T103
diethyl	I-T103
##enet	I-T103
##ri	I-T103
##amine	I-T103
penta	I-T103
-	I-T103
acetic	I-T103
acid	I-T103
(	O
gd	B-T103
-	I-T103
dtpa	I-T103
)	O
,	O
is	O
entrapped	O
.	O
this	O
microfluidic	O
process	O
facilitates	O
a	O
high	O
degree	O
of	O
control	O
over	O
particle	O
synthesis	O
,	O
enabling	O
the	O
production	O
of	O
monod	O
##isperse	O
particles	O
as	O
small	O
as	O
35	O
nm	O
.	O
furthermore	O
,	O
the	O
interference	O
of	O
gd	B-T103
-	I-T103
dtpa	I-T103
during	O
polymer	B-T103
precipitation	O
is	O
overcome	O
by	O
fine	O
##ly	O
tuning	O
process	O
parameters	O
and	O
lever	O
##aging	O
the	O
use	O
of	O
hydrophilic	O
-	O
lipophilic	O
balance	O
(	O
hl	O
##b	O
)	O
of	O
surfactants	B-T103
and	O
ph	O
conditions	O
.	O
for	O
both	O
production	O
strategies	O
proposed	O
to	O
design	O
gd	B-T103
-	O
loaded	O
cha	O
##nps	O
,	O
a	O
boost	O
##ing	O
of	O
the	O
relaxation	O
rate	O
t1	O
is	O
observed	O
since	O
a	O
t1	O
of	O
156	O
##2	O
is	O
achieved	O
with	O
a	O
10	O
μm	O
of	O
gd	B-T103
-	O
loaded	O
cha	O
##nps	O
while	O
a	O
similar	O
value	O
is	O
reached	O
with	O
100	O
μm	O
of	O
the	O
relevant	O
clinical	O
gd	B-T103
-	I-T103
dtpa	I-T103
in	O
solution	O
.	O
the	O
advanced	O
microfluidic	O
platform	O
to	O
synthesize	O
intravascular	B-T082
##ly	I-T082
-	O
injectable	B-T103
and	O
completely	O
biocompatible	B-T103
hydrogel	I-T103
nanoparticles	O
entrap	O
##ping	O
clinically	O
approved	O
cas	B-T103
enables	O
the	O
implementation	O
of	O
straightforward	O
and	O
scalable	O
strategies	O
in	O
diagnostics	O
and	O
therapy	B-T058
applications	O
.	O

metabolomics	B-T103
analysis	B-T062
of	O
anaphyl	B-T038
##act	I-T038
##oid	I-T038
reaction	I-T038
reveals	O
its	O
mechanism	O
in	O
a	O
rat	B-T204
model	B-T204
anaphyl	B-T038
##act	I-T038
##oid	I-T038
reactions	I-T038
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	B-T038
-	I-T038
mediated	I-T038
immediate	I-T038
hypersensitivity	I-T038
reactions	I-T038
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	B-T058
health	I-T058
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	B-T058
tests	I-T058
are	O
limited	O
.	O
comprehensive	O
metabolite	B-T103
analysis	B-T062
may	O
reveal	O
the	O
anaphyl	O
##act	O
##oid	O
effect	O
mechanism	O
systematically	O
and	O
provide	O
reference	O
for	O
future	O
diagnostic	O
purposes	O
.	O
plasma	B-T031
from	O
brown	B-T204
norway	I-T204
rats	I-T204
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	B-T103
48	I-T103
/	I-T103
80	I-T103
(	O
2	O
.	O
5	O
ml	O
/	O
kg	O
)	O
or	O
ovalbumin	B-T103
(	O
20	O
ml	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	B-T062
the	O
effect	O
mechanism	O
of	O
anaphyl	B-T038
##act	I-T038
##oid	I-T038
reactions	I-T038
through	O
metabolomics	B-T103
(	O
uplc	B-T062
-	I-T062
qt	I-T062
##of	I-T062
-	I-T062
ms	I-T062
/	I-T062
ms	I-T062
)	O
.	O
metabolomics	B-T103
integrated	O
with	O
proteomics	B-T170
data	I-T170
were	O
used	O
to	O
analyze	B-T062
the	O
anaphyl	O
##act	O
##oid	O
pathways	B-T038
by	O
metab	B-T170
##oa	I-T170
##nal	I-T170
##yst	I-T170
followed	O
by	O
integrated	O
pathway	B-T170
analysis	I-T170
.	O
thirty	O
metabolites	B-T103
were	O
identified	O
through	O
the	O
met	B-T170
##lin	I-T170
database	I-T170
by	O
ms	B-T062
/	I-T062
ms	I-T062
and	O
18	O
of	O
them	O
were	O
confirmed	O
by	O
authentic	O
standards	O
.	O
the	O
results	O
showed	O
that	O
adenosine	B-T103
,	O
histamine	B-T103
,	O
n	B-T103
-	I-T103
acetyl	I-T103
##his	I-T103
##ta	I-T103
##min	I-T103
##e	I-T103
,	O
n	B-T103
(	I-T103
α	I-T103
)	I-T103
-	I-T103
γ	I-T103
-	I-T103
glutamyl	I-T103
##his	I-T103
##ta	I-T103
##min	I-T103
##e	I-T103
,	O
malate	B-T103
and	O
xanthine	B-T103
are	O
important	O
indices	O
for	O
anaphyl	B-T038
##act	I-T038
##oid	I-T038
reactions	I-T038
.	O
it	O
could	O
be	O
concluded	O
that	O
the	O
effect	O
mechanism	O
is	O
mainly	O
composed	O
of	O
histidine	B-T038
metabolism	I-T038
,	O
arachidonic	B-T038
acid	I-T038
metabolism	I-T038
,	O
energy	B-T038
metabolism	I-T038
,	O
purine	O
metabolism	O
and	O
other	O
small	O
molecules	O
through	O
30	O
metabolites	B-T103
.	O
multiple	O
linear	O
regression	O
analysis	O
indicated	B-T033
that	O
not	O
only	O
histamine	B-T103
but	O
also	O
n	B-T103
(	I-T103
α	I-T103
)	I-T103
-	I-T103
γ	I-T103
-	I-T103
glutamyl	I-T103
##his	I-T103
##ta	I-T103
##min	I-T103
##e	I-T103
and	O
arachidonic	B-T103
acid	I-T103
could	O
be	O
used	O
to	O
evaluate	O
anaphyl	O
##act	O
##oid	O
symptoms	B-T033
of	O
animals	B-T204
.	O
furthermore	O
,	O
the	O
citrate	B-T038
cycle	I-T038
,	O
histidine	B-T038
metabolism	I-T038
and	O
arachidonic	B-T038
acid	I-T038
metabolism	I-T038
could	O
be	O
the	O
main	O
pathways	B-T038
of	O
anaphyl	B-T038
##act	I-T038
##oid	I-T038
reactions	I-T038
as	O
determined	O
by	O
metab	B-T170
##oa	I-T170
##nal	I-T170
##yst	I-T170
.	O
the	O
results	O
may	O
provide	O
a	O
reference	B-T170
to	O
improve	B-T033
diagnostic	O
accuracy	O
and	O
predict	O
and	O
monitor	O
treatment	O
efficacy	O
in	O
anaphyl	B-T038
##act	I-T038
##oid	I-T038
reactions	I-T038
in	O
the	O
clinical	O
setting	O
.	O

effect	O
of	O
new	O
-	O
onset	O
left	B-T038
bundle	I-T038
branch	I-T038
block	I-T038
after	O
transcatheter	B-T058
aortic	I-T058
valve	I-T058
implantation	I-T058
(	O
core	B-T074
##val	I-T074
##ve	I-T074
)	O
on	O
mortality	O
,	O
frequency	O
of	O
re	B-T058
-	I-T058
hospitalization	I-T058
,	O
and	O
need	O
for	O
pacemaker	B-T074
new	O
-	O
onset	O
conduction	B-T038
disturbances	I-T038
are	O
common	O
after	O
transcatheter	B-T058
aortic	I-T058
valve	I-T058
implantation	I-T058
(	O
tavi	B-T058
)	O
.	O
the	O
most	O
common	O
complication	B-T038
is	O
left	B-T038
bundle	I-T038
branch	I-T038
block	I-T038
(	O
lb	B-T038
##bb	I-T038
)	O
.	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
lb	B-T038
##bb	I-T038
after	O
tavi	B-T058
remains	O
controversial	O
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
lb	B-T038
##bb	I-T038
in	O
terms	O
of	O
mortality	O
and	O
morbidity	O
(	O
need	O
for	O
pacemaker	B-T074
##s	I-T074
and	O
admissions	B-T058
for	O
heart	B-T038
failure	I-T038
)	O
at	O
long	B-T058
-	I-T058
term	I-T058
follow	I-T058
-	I-T058
up	I-T058
.	O
from	O
april	O
2008	O
to	O
december	O
2014	O
,	O
220	O
patients	O
who	O
had	O
severe	O
aortic	B-T038
stenosis	I-T038
were	O
treated	B-T058
with	I-T058
the	O
implantation	B-T058
of	O
a	O
core	B-T074
##val	I-T074
##ve	I-T074
prosthesis	I-T074
.	O
sixty	O
-	O
seven	O
of	O
these	O
patients	O
were	O
excluded	O
from	O
the	O
analysis	B-T062
,	O
including	O
22	O
patients	O
with	O
pre	O
-	O
existing	O
lb	B-T038
##bb	I-T038
and	O
45	O
with	O
a	O
permanent	O
pacemaker	O
,	O
implanted	B-T074
previously	O
or	O
within	O
72	O
hours	O
of	O
implantation	B-T058
.	O
the	O
remaining	O
153	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
1	O
(	O
n	O
=	O
80	O
)	O
,	O
those	O
with	O
persistent	O
new	O
-	O
onset	O
lb	B-T038
##bb	I-T038
,	O
and	O
group	O
2	O
(	O
n	O
=	O
73	O
)	O
,	O
those	O
without	O
conduction	B-T038
disturbances	I-T038
after	O
treatment	B-T058
.	O
both	O
groups	O
were	O
followed	B-T058
up	I-T058
at	O
1	O
month	O
,	O
6	O
months	O
,	O
12	O
months	O
,	O
and	O
yearly	O
thereafter	O
.	O
persistent	O
new	O
-	O
onset	O
lb	B-T038
##bb	I-T038
occurred	O
in	O
80	O
patients	O
(	O
36	O
%	O
)	O
immediately	O
after	O
tavi	B-T058
;	O
73	O
patients	O
(	O
33	O
%	O
)	O
did	O
not	O
develop	O
conduction	B-T038
disturbances	I-T038
.	O
the	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
time	O
of	O
both	O
groups	O
was	O
32	O
±	O
22	O
months	O
(	O
range	O
3	O
to	O
82	O
months	O
)	O
,	O
and	O
there	O
were	O
no	O
differences	O
in	O
time	O
between	O
the	O
groups	O
.	O
there	O
were	O
no	O
differences	O
in	O
mortality	O
between	O
the	O
groups	O
(	O
39	O
%	O
vs	O
48	O
%	O
,	O
p	O
=	O
0	O
.	O
58	O
)	O
.	O
no	O
differences	O
were	O
observed	O
between	O
the	O
groups	O
in	O
re	B-T058
-	I-T058
hospitalizations	I-T058
for	O
heart	B-T038
failure	I-T038
(	O
11	O
%	O
vs	O
16	O
%	O
,	O
p	O
=	O
0	O
.	O
55	O
)	O
.	O
group	O
1	O
did	O
not	O
require	O
pacemaker	B-T058
implantation	I-T058
more	O
often	O
at	O
follow	B-T058
-	I-T058
up	I-T058
(	O
10	O
%	O
vs	O
13	O
%	O
,	O
p	O
=	O
0	O
.	O
38	O
)	O
than	O
group	O
2	O
.	O
in	O
conclusion	O
,	O
new	O
-	O
onset	O
lb	B-T038
##bb	I-T038
was	O
not	O
associated	O
with	O
a	O
higher	O
incidence	O
of	O
late	O
need	O
for	O
a	O
permanent	O
pacemaker	O
after	O
core	B-T074
##val	I-T074
##ve	I-T074
implantation	B-T058
.	O
in	O
addition	O
,	O
it	O
was	O
not	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
late	O
mortality	O
or	O
re	B-T058
-	I-T058
hospitalization	I-T058
.	O

pathogenesis	B-T038
of	O
copd	B-T038
and	O
asthma	B-T038
asthma	B-T038
and	O
copd	B-T038
remain	O
two	O
diseases	B-T038
of	I-T038
the	I-T038
respiratory	I-T038
tract	I-T038
with	O
unmet	O
medical	O
needs	O
.	O
this	O
review	B-T170
considers	O
the	O
current	O
state	O
of	O
play	O
with	O
respect	O
to	O
what	O
is	O
known	O
about	O
the	O
underlying	O
pathogenesis	B-T038
of	O
these	O
two	O
chronic	B-T038
inflammatory	I-T038
diseases	I-T038
of	O
the	O
lung	B-T017
.	O
the	O
review	B-T170
highlights	O
why	O
they	O
are	O
different	O
conditions	O
requiring	O
different	O
approaches	O
to	O
treatment	B-T058
and	O
provides	O
a	O
back	O
##dro	O
##p	O
for	O
the	O
subsequent	O
chapter	O
##s	O
in	O
this	O
volume	O
discussing	O
recent	O
advances	O
in	O
the	O
pharmacology	B-T091
and	O
treatment	B-T058
of	O
asthma	B-T038
and	O
copd	B-T038
.	O

study	B-T058
of	O
the	O
microf	B-T082
##ocus	I-T082
x	B-T074
-	I-T074
ray	I-T074
tube	I-T074
based	O
on	O
a	O
point	O
-	O
like	O
target	O
used	O
for	O
micro	B-T058
-	I-T058
computed	I-T058
tomography	I-T058
for	O
a	O
micro	B-T058
-	I-T058
computed	I-T058
tomography	I-T058
(	I-T058
micro	I-T058
-	I-T058
ct	I-T058
)	I-T058
system	I-T058
,	O
the	O
microf	B-T082
##ocus	I-T082
x	B-T074
-	I-T074
ray	I-T074
tube	I-T074
is	O
an	O
essential	O
component	O
because	O
the	O
spatial	O
resolution	O
of	O
ct	B-T058
images	B-T170
,	O
in	O
theory	O
,	O
is	O
mainly	O
determined	O
by	O
the	O
size	B-T082
and	O
stability	O
of	O
the	O
x	B-T058
-	I-T058
ray	I-T058
focal	B-T082
spot	I-T082
of	O
the	O
microf	B-T082
##ocus	I-T082
x	B-T074
-	I-T074
ray	I-T074
tube	I-T074
.	O
however	O
,	O
many	O
factors	O
,	O
including	O
voltage	O
fluctuations	O
,	O
mechanical	O
vibrations	O
,	O
and	O
temperature	O
changes	O
,	O
can	O
cause	O
the	O
size	B-T082
and	O
the	O
stability	O
of	O
the	O
x	B-T058
-	I-T058
ray	I-T058
focal	B-T082
spot	I-T082
to	O
degrade	O
.	O
a	O
new	O
microf	B-T082
##ocus	I-T082
x	B-T074
-	I-T074
ray	I-T074
tube	I-T074
based	O
on	O
a	O
point	O
-	O
like	O
micro	O
-	O
target	O
in	O
which	O
the	O
x	B-T058
-	I-T058
ray	I-T058
target	O
is	O
irradiated	O
with	O
an	O
unf	O
##ocus	O
##ed	O
electron	O
beam	O
was	O
investigated	O
.	O
eg	O
##s	O
##4	O
monte	O
carlo	O
simulation	O
code	O
was	O
employed	O
for	O
the	O
calculation	O
of	O
the	O
x	B-T058
-	I-T058
ray	I-T058
intensity	O
produced	O
from	O
the	O
point	O
-	O
like	O
micro	O
-	O
target	O
and	O
the	O
substrate	O
.	O
the	O
effects	O
of	O
several	O
arrangements	O
of	O
the	O
target	O
material	O
,	O
target	O
and	O
beam	O
size	B-T082
were	O
studied	B-T058
.	O
the	O
simulation	B-T062
results	O
demonstrated	O
that	O
if	O
the	O
intensity	O
of	O
x	B-T058
-	I-T058
rays	I-T058
generated	O
at	O
the	O
point	O
-	O
like	O
target	O
is	O
greater	O
than	O
half	O
of	O
the	O
x	B-T058
-	I-T058
ray	I-T058
intensity	O
produced	O
on	O
the	O
substrate	O
,	O
the	O
x	B-T058
-	I-T058
ray	I-T058
focal	B-T082
spot	I-T082
is	O
determined	O
in	O
part	O
by	O
the	O
point	O
-	O
like	O
target	O
rather	O
than	O
by	O
the	O
electron	O
beam	O
in	O
the	O
conventional	O
x	B-T074
-	I-T074
ray	I-T074
tube	I-T074
.	O
in	O
theory	O
,	O
since	O
it	O
is	O
able	O
to	O
reduce	O
those	O
unfavorable	O
effects	O
such	O
as	O
the	O
electron	B-T033
beam	I-T033
trajectory	I-T033
swing	I-T033
##ing	I-T033
and	O
the	O
beam	O
size	B-T082
changing	O
for	O
the	O
microf	B-T082
##ocus	I-T082
x	B-T074
-	I-T074
ray	I-T074
tube	I-T074
,	O
it	O
could	O
alleviate	O
ct	B-T058
image	B-T170
artifacts	O
caused	O
by	O
the	O
x	B-T058
-	I-T058
ray	I-T058
focal	B-T082
spot	I-T082
shift	O
and	O
size	O
change	O
.	O

digital	B-T017
myo	B-T038
##peri	I-T038
##cyt	I-T038
##oma	I-T038
:	O
a	O
case	B-T170
report	I-T170
and	O
systematic	B-T170
literature	I-T170
review	I-T170
a	O
myo	B-T038
##peri	I-T038
##cyt	I-T038
##oma	I-T038
(	O
mp	B-T038
)	O
is	O
an	O
exceeding	O
##ly	O
rare	O
perivascular	B-T038
tumor	I-T038
of	O
unknown	O
etiology	O
.	O
given	O
their	O
potential	O
for	O
mimic	B-T038
##ry	I-T038
and	O
malignancy	B-T038
,	O
mp	B-T038
tumors	I-T038
pose	O
a	O
unique	O
challenge	O
for	O
surgeons	B-T097
and	O
may	O
be	O
overlooked	O
on	O
differential	B-T058
diagnosis	I-T058
.	O
we	O
present	O
a	O
case	B-T170
report	I-T170
of	O
an	O
otherwise	O
healthy	O
33	O
-	O
year	O
-	O
old	O
right	O
-	O
hand	O
dominant	O
male	B-T098
who	O
presented	O
to	O
our	O
outpatient	B-T092
clinic	I-T092
with	O
a	O
2	O
-	O
month	O
history	O
of	O
painless	O
swelling	B-T033
and	O
erythema	O
of	O
the	O
pulp	O
of	O
his	O
left	O
index	O
finger	O
.	O
subsequent	O
plain	B-T058
film	I-T058
x	I-T058
-	I-T058
ray	I-T058
showed	O
near	O
-	O
complete	O
bony	B-T033
destruction	I-T033
of	O
his	O
distal	B-T017
phal	I-T017
##anx	I-T017
.	O
pathological	B-T038
evaluation	B-T058
of	O
an	O
incisional	B-T058
biopsy	I-T058
showed	O
a	O
benign	B-T038
variant	I-T038
of	O
mp	B-T038
.	O
the	O
lesion	B-T033
was	O
treated	O
by	O
excision	B-T058
with	O
tumor	B-T038
shell	B-T058
##ing	I-T058
,	O
and	O
there	O
was	O
no	O
evidence	O
of	O
recurrence	O
81	O
days	O
postoperatively	O
.	O
a	O
systematic	O
literature	O
review	O
of	O
the	O
management	B-T058
and	O
outcome	O
of	O
all	O
known	O
cases	B-T170
of	O
hand	O
and	O
wrist	O
mp	B-T038
is	O
presented	O
.	O

human	B-T204
brucellosis	B-T038
in	O
south	B-T082
africa	I-T082
:	O
public	B-T170
health	I-T170
and	O
diagnostic	O
pitfalls	O
human	B-T204
brucellosis	B-T038
in	O
south	B-T082
africa	I-T082
(	O
sa	B-T082
)	O
is	O
under	O
-	O
diagnosed	O
and	O
under	B-T033
-	I-T033
reported	I-T033
.	O
this	O
is	O
because	O
many	O
clinicians	B-T097
have	O
little	O
or	O
no	O
experience	O
in	O
managing	O
affected	O
patients	O
,	O
and	O
in	O
part	O
because	O
of	O
the	O
nonspecific	O
and	O
ins	O
##idi	O
##ous	O
nature	O
of	O
the	O
disease	O
.	O
a	O
case	O
of	O
human	B-T204
brucellosis	B-T038
caused	O
by	O
brucella	B-T007
melit	I-T007
##ensis	I-T007
in	O
a	O
patient	O
from	O
the	O
western	O
cape	O
province	O
of	O
sa	B-T082
is	O
described	O
,	O
and	O
the	O
resulting	O
exposure	O
of	O
staff	O
members	O
at	O
two	O
medical	B-T092
microbiology	I-T092
laboratories	I-T092
,	O
as	O
well	O
as	O
the	O
public	B-T058
health	I-T058
investigation	I-T058
that	O
was	O
conducted	O
,	O
are	O
discussed	O
.	O
this	O
article	B-T170
aims	O
to	O
highlight	O
the	O
need	O
for	O
strengthening	O
integration	O
between	O
public	B-T170
health	I-T170
,	O
medical	B-T058
and	O
veterinary	B-T091
services	O
and	O
exposing	O
deficiencies	O
in	O
public	B-T170
health	I-T170
,	O
veterinary	B-T091
and	O
laboratory	B-T092
practices	O
.	O

the	O
prevalence	O
and	O
clinical	O
relevance	O
of	O
asa	B-T103
nonresp	B-T033
##ons	I-T033
##e	I-T033
after	O
cardiac	B-T058
surgery	I-T058
we	O
aimed	O
to	O
identify	O
the	O
prevalence	O
of	O
acetyls	B-T103
##alic	I-T103
##ylic	I-T103
acid	I-T103
(	O
asa	B-T103
)	O
nonresp	B-T033
##ons	I-T033
##e	I-T033
in	O
patients	O
after	O
coronary	B-T058
artery	I-T058
bypass	I-T058
graft	I-T058
(	I-T058
cabg	I-T058
)	I-T058
surgery	I-T058
and	O
the	O
possible	O
consequences	O
for	O
the	O
rate	O
of	O
major	O
cardiovascular	B-T033
events	I-T033
.	O
this	O
prospective	B-T062
,	O
observational	B-T062
,	O
bic	O
##entric	O
cohort	O
study	O
was	O
conducted	O
in	O
two	O
german	B-T092
university	I-T092
hospitals	I-T092
.	O
a	O
total	O
of	O
400	O
patients	O
(	O
200	O
in	O
each	O
study	O
center	O
)	O
undergoing	O
elective	B-T058
cabg	B-T058
surgery	I-T058
were	O
enrolled	O
after	O
written	O
informed	O
consent	O
.	O
platelet	B-T038
function	I-T038
was	O
analyzed	O
on	O
day	O
3	O
(	O
d3	O
)	O
and	O
day	O
5	O
(	O
d5	O
)	O
postoperatively	O
following	O
stimulation	O
with	O
arachidonic	B-T103
acid	I-T103
(	O
asp	B-T058
##ites	I-T058
##t	I-T058
)	O
and	O
with	O
thrombin	B-T103
receptor	I-T103
-	I-T103
activating	I-T103
peptide	I-T103
6	I-T103
(	O
trap	B-T058
##test	I-T058
)	O
using	O
multiple	B-T058
electrode	I-T058
aggreg	I-T058
##ometry	I-T058
(	O
multipl	B-T058
##ate	I-T058
)	O
.	O
individuals	O
with	O
an	O
asp	B-T058
##ites	I-T058
##t	I-T058
≥	O
##40	O
au	O
·	O
min	O
were	O
categorized	O
as	O
asa	B-T103
nonresponders	B-T033
.	O
a	O
1	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
recorded	O
the	O
combined	O
end	O
point	O
of	O
cardiovascular	B-T033
events	I-T033
,	O
hospital	B-T058
admissions	I-T058
,	O
or	O
deaths	B-T033
related	O
to	O
cardiovascular	B-T038
disease	I-T038
.	O
the	O
prevalence	O
of	O
asa	B-T103
nonresp	B-T033
##ons	I-T033
##e	I-T033
was	O
51	O
.	O
5	O
%	O
on	O
d3	O
,	O
and	O
it	O
significantly	O
increased	O
to	O
71	O
.	O
3	O
%	O
on	O
d5	O
(	O
p	O
=	O
.	O
004	O
##9	O
)	O
.	O
the	O
area	O
under	O
the	O
aggregation	B-T058
curve	I-T058
in	O
the	O
trap	B-T058
##test	I-T058
(	O
p	O
<	O
.	O
0001	O
)	O
,	O
the	O
platelet	B-T058
count	I-T058
on	O
d5	O
(	O
p	O
=	O
.	O
009	O
)	O
,	O
and	O
the	O
cardiopulmonary	B-T033
bypass	I-T033
time	I-T033
(	O
p	O
=	O
.	O
01	O
)	O
were	O
identified	O
as	O
independent	O
predictors	O
of	O
an	O
asa	B-T103
nonresp	B-T033
##ons	I-T033
##e	I-T033
.	O
a	O
1	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
recorded	O
54	O
events	O
fulfilling	O
criteria	O
for	O
the	O
combined	O
end	O
point	O
with	O
no	O
difference	O
between	O
asa	B-T103
responders	B-T033
and	O
nonresponders	B-T033
.	O
this	O
study	B-T062
indicates	O
a	O
high	O
incidence	O
of	O
perioperative	O
asa	B-T103
nonresp	B-T033
##ons	I-T033
##e	I-T033
in	O
patients	O
following	O
cabg	B-T058
.	O
no	O
effect	O
on	O
the	O
incidence	O
of	O
cardiovascular	B-T033
events	I-T033
was	O
recorded	O
in	O
the	O
1	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
.	O
therefore	O
,	O
a	O
randomized	B-T062
dosage	I-T062
adjustment	I-T062
trial	I-T062
should	O
elucidate	O
whether	O
a	O
tailored	O
asa	B-T103
treatment	B-T058
after	O
cabg	B-T058
surgery	I-T058
represents	O
a	O
useful	O
concept	O
.	O

'	O
y	B-T058
##ar	I-T058
##n	I-T058
with	O
me	O
'	O
:	O
applying	O
clinical	B-T058
y	I-T058
##ar	I-T058
##ning	I-T058
to	O
improve	O
clinician	B-T097
-	O
patient	O
communication	O
in	O
aboriginal	O
health	B-T058
care	I-T058
although	O
successful	O
communication	O
is	O
at	O
the	O
heart	O
of	O
the	O
clinical	B-T058
consultation	I-T058
,	O
communication	O
between	O
aboriginal	O
patients	O
and	O
practitioners	B-T097
such	O
as	O
doctors	B-T097
,	O
nurses	B-T097
and	O
allied	B-T097
health	I-T097
professionals	I-T097
,	O
continues	O
to	O
be	O
problematic	B-T033
and	O
is	O
arg	O
##ua	O
##bl	O
##y	O
the	O
big	O
##gest	O
barrier	O
to	O
the	O
delivery	O
of	O
successful	O
health	B-T058
care	I-T058
to	O
aboriginal	O
people	O
.	O
this	O
paper	O
presents	O
an	O
over	B-T170
##arch	I-T170
##ing	I-T170
framework	I-T170
for	O
practitioners	B-T097
to	O
help	O
them	O
re	O
##orient	O
##ate	O
their	O
communication	O
with	O
aboriginal	O
patients	O
using	O
'	O
clinical	B-T058
y	I-T058
##ar	I-T058
##ning	I-T058
'	O
.	O
clinical	B-T058
y	I-T058
##ar	I-T058
##ning	I-T058
is	O
a	O
patient	O
-	O
centred	O
approach	O
that	O
mar	O
##ries	O
aboriginal	O
cultural	O
communication	O
preferences	O
with	O
biomedical	B-T091
understanding	O
##s	O
of	O
health	O
and	O
disease	O
.	O
clinical	B-T058
y	I-T058
##ar	I-T058
##ning	I-T058
consists	O
of	O
three	O
interrelated	O
areas	O
:	O
the	O
social	O
y	B-T058
##ar	I-T058
##n	I-T058
,	O
in	O
which	O
the	O
practitioner	B-T097
aims	O
to	O
find	O
common	O
ground	O
and	O
develop	O
the	O
interpersonal	O
relationship	O
;	O
the	O
diagnostic	O
y	B-T058
##ar	I-T058
##n	I-T058
,	O
in	O
which	O
the	O
practitioner	B-T097
facilitates	O
the	O
patient	O
'	O
s	O
health	O
story	O
while	O
interpreting	O
it	O
through	O
a	O
biomedical	B-T091
or	O
scientific	B-T058
lens	I-T058
;	O
and	O
the	O
management	O
y	B-T058
##ar	I-T058
##n	I-T058
,	O
that	O
employs	O
stories	O
and	O
metaph	O
##ors	O
as	O
tools	O
for	O
patients	O
to	O
help	O
them	O
understand	O
a	O
health	B-T033
issue	I-T033
so	O
a	O
collaborative	O
management	O
approach	O
can	O
be	O
adopted	O
.	O
there	O
is	O
cultural	O
and	O
research	B-T062
evidence	O
that	O
supports	O
this	O
approach	O
.	O
clinical	B-T058
y	I-T058
##ar	I-T058
##ning	I-T058
has	O
the	O
potential	O
to	O
improve	O
outcomes	O
for	O
patients	O
and	O
practitioners	B-T097
.	O

prediction	O
of	O
estrogenic	B-T103
bioactivity	O
of	O
environmental	B-T103
chemical	I-T103
metabolites	B-T103
the	O
us	B-T092
environmental	I-T092
protection	I-T092
agency	I-T092
'	I-T092
s	I-T092
(	O
epa	B-T092
)	O
endocrine	O
disrupt	O
##or	O
screening	O
program	O
(	O
eds	O
##p	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
tox	B-T170
##cast	I-T170
/	O
tox	B-T170
##21	I-T170
high	B-T058
-	I-T058
throughput	I-T058
screening	I-T058
assays	I-T058
to	O
assess	O
the	O
endocrine	B-T022
activity	O
of	O
environmental	B-T103
chemicals	I-T103
.	O
considering	O
that	O
in	B-T058
vitro	I-T058
assays	I-T058
may	O
have	O
limited	O
metabolic	O
capacity	O
,	O
inactive	B-T103
chemicals	I-T103
that	O
are	O
biotrans	B-T038
##formed	I-T038
into	O
metabolites	B-T103
with	O
endocrine	B-T022
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	O
and	O
testing	O
.	O
therefore	O
,	O
there	O
is	O
a	O
value	O
in	O
developing	O
novel	O
approaches	O
to	O
account	O
for	O
metabolism	B-T038
and	O
endocrine	B-T022
activity	O
of	O
both	O
parent	B-T103
chemicals	I-T103
and	O
their	O
associated	O
metabolites	B-T103
.	O
we	O
used	O
commercially	O
available	O
software	B-T170
to	O
predict	O
metabolites	B-T103
of	O
50	O
parent	B-T103
compounds	I-T103
,	O
out	O
of	O
which	O
38	O
chemicals	B-T103
are	O
known	O
to	O
have	O
estrogenic	B-T103
metabolites	B-T103
,	O
and	O
12	O
compounds	B-T103
and	O
their	O
metabolites	B-T103
are	O
negative	O
for	O
estrogenic	B-T103
activity	O
.	O
three	O
er	B-T103
qsar	O
models	B-T170
were	O
used	O
to	O
determine	O
potential	O
estrogen	B-T103
bioactivity	O
of	O
the	O
parent	B-T103
compounds	I-T103
and	O
predicted	O
metabolites	B-T103
,	O
the	O
outputs	O
of	O
the	O
models	B-T170
were	O
averaged	O
,	O
and	O
the	O
chemicals	B-T103
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenic	O
##ity	O
of	O
the	O
parent	B-T103
chemical	I-T103
and	O
metabolites	B-T103
.	O
the	O
metabolite	B-T170
prediction	I-T170
software	I-T170
correctly	O
identified	O
known	O
estrogenic	B-T103
metabolites	B-T103
for	O
26	O
out	O
of	O
27	O
parent	B-T103
chemicals	I-T103
with	O
associated	O
metabolite	B-T103
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	B-T103
metabolites	B-T103
were	O
predicted	O
as	O
potential	O
biotransformation	B-T038
products	B-T103
derived	O
from	O
the	O
parent	B-T103
chemical	I-T103
.	O
the	O
qsar	O
models	B-T170
estimated	O
stronger	O
estrogenic	B-T103
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	B-T103
metabolites	B-T103
compared	O
to	O
their	O
parent	B-T103
chemicals	I-T103
.	O
finally	O
,	O
the	O
three	O
models	B-T170
identified	O
a	O
similar	O
set	O
of	O
parent	B-T103
compounds	I-T103
as	O
top	O
ranked	O
chemicals	B-T103
based	O
on	O
the	O
estrogenic	O
##ity	O
of	O
putative	O
metabolites	B-T103
.	O
this	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	B-T033
of	O
chemicals	B-T103
with	O
estrogenic	B-T103
metabolites	B-T103
and	O
may	O
reduce	O
potential	O
false	B-T033
negative	I-T033
results	O
from	O
in	B-T058
vitro	I-T058
assays	I-T058
.	O

differential	O
control	O
and	O
function	O
of	O
arabidopsis	B-T204
prod	B-T017
##h1	I-T017
and	O
prod	B-T017
##h2	I-T017
genes	I-T017
on	O
infection	B-T038
with	O
bio	B-T033
##tr	I-T033
##oph	I-T033
##ic	I-T033
and	O
necro	B-T033
##tr	I-T033
##oph	I-T033
##ic	I-T033
pathogens	O
arabidopsis	B-T204
contains	O
two	O
proline	B-T017
dehydrogenase	I-T017
(	I-T017
prod	I-T017
##h	I-T017
)	I-T017
genes	I-T017
,	O
prod	B-T017
##h1	I-T017
and	O
prod	B-T017
##h2	I-T017
,	O
encoding	O
for	O
homologous	B-T103
and	O
functional	O
isoenzymes	B-T103
.	O
although	O
prod	B-T017
##h1	I-T017
has	O
been	O
studied	O
extensively	O
,	O
especially	O
under	O
abiotic	B-T038
stress	I-T038
,	O
prod	B-T017
##h2	I-T017
has	O
only	O
started	O
to	O
be	O
analysed	O
in	O
recent	O
years	O
.	O
these	O
genes	B-T017
display	O
distinctive	O
expression	B-T038
patterns	B-T082
and	O
show	O
weak	O
transcriptional	B-T038
co	I-T038
-	I-T038
regulation	I-T038
,	O
but	O
are	O
both	O
activated	O
in	O
pathogen	O
-	O
infected	B-T033
tissues	B-T017
.	O
we	O
have	O
demonstrated	O
previously	O
that	O
arabidopsis	B-T204
plants	I-T204
with	O
silenced	B-T038
prod	B-T017
##h1	I-T017
/	O
2	B-T017
expression	B-T038
fail	O
to	O
trigger	O
defence	B-T038
##s	I-T038
against	O
the	O
hemi	B-T033
##bi	I-T033
##otrophic	I-T033
bacterial	B-T007
pathogen	O
pseudomonas	B-T007
syring	I-T007
##ae	I-T007
pv	I-T007
.	I-T007
tomato	I-T007
avr	I-T007
##rp	I-T007
##m1	I-T007
(	O
pst	B-T007
-	I-T007
avr	I-T007
##rp	I-T007
##m1	I-T007
)	O
,	O
and	O
that	O
prod	B-T017
##h1	I-T017
and	O
prod	B-T017
##h2	I-T017
are	O
differentially	O
regulated	O
by	O
salicylic	B-T103
acid	I-T103
(	O
sa	B-T103
)	O
.	O
in	O
the	O
current	O
work	O
,	O
we	O
used	O
prod	B-T204
##h1	I-T204
and	O
prod	B-T204
##h2	I-T204
single	O
-	O
mutant	B-T038
plants	B-T204
to	O
assess	O
the	O
particular	O
contribution	O
of	O
each	O
gene	B-T017
to	O
resistance	O
against	O
pst	B-T007
-	I-T007
avr	I-T007
##rp	I-T007
##m1	I-T007
and	O
the	O
necro	B-T033
##tr	I-T033
##oph	I-T033
##ic	I-T033
fungal	O
pathogen	O
bot	B-T204
##ry	I-T204
##tis	I-T204
cine	I-T204
##re	I-T204
##a	I-T204
.	O
in	O
addition	O
,	O
we	O
studied	O
the	O
sensitivity	O
of	O
prod	B-T017
##h1	I-T017
and	O
prod	B-T017
##h2	I-T017
to	O
the	O
jas	B-T103
##monic	I-T103
acid	I-T103
(	O
ja	B-T103
)	O
defence	B-T038
pathway	B-T038
.	O
we	O
found	O
that	O
prod	B-T103
##h1	I-T103
and	O
prod	B-T103
##h2	I-T103
are	O
both	O
necessary	O
to	O
achieve	O
maximum	O
resistance	O
against	O
pst	B-T007
-	I-T007
avr	I-T007
##rp	I-T007
##m1	I-T007
and	O
b	B-T204
.	I-T204
cine	I-T204
##re	I-T204
##a	I-T204
.	O
however	O
,	O
prod	B-T103
##h2	I-T103
has	O
a	O
major	O
effect	O
on	O
early	O
restriction	O
of	O
b	B-T204
.	I-T204
cine	I-T204
##re	I-T204
##a	I-T204
growth	B-T038
.	O
interestingly	O
,	O
prod	B-T017
##h1	I-T017
is	O
up	B-T038
-	I-T038
regulated	I-T038
by	O
sa	B-T103
and	O
ja	B-T103
,	O
whereas	O
prod	B-T017
##h2	I-T017
is	O
only	O
activated	O
by	O
ja	B-T103
,	O
and	O
both	O
genes	B-T017
display	O
transcriptional	B-T038
inter	I-T038
-	I-T038
regulation	I-T038
at	O
basal	B-T082
and	O
infection	B-T038
conditions	O
.	O
these	O
studies	O
provide	O
the	O
first	O
evidence	O
of	O
the	O
contribution	O
of	O
prod	B-T017
##h2	I-T017
to	O
disease	B-T038
resistance	I-T038
,	O
and	O
describe	O
the	O
differential	O
regulation	O
and	O
non	O
-	O
redundant	O
but	O
complementary	O
function	O
of	O
both	O
enzyme	B-T103
isoforms	I-T103
in	O
infected	B-T033
tissues	B-T017
,	O
providing	O
support	O
for	O
a	O
fundamental	O
role	O
of	O
prod	B-T017
##h	I-T017
in	O
the	O
control	O
of	O
bio	B-T033
##tr	I-T033
##oph	I-T033
##ic	I-T033
and	O
necro	B-T033
##tr	I-T033
##oph	I-T033
##ic	I-T033
pathogens	O
.	O

the	O
burden	O
of	O
hpv	B-T005
-	O
related	O
diseases	B-T038
in	O
italy	B-T082
,	O
2001	O
-	O
12	O
human	B-T038
papillomavirus	I-T038
(	I-T038
hpv	I-T038
)	I-T038
infection	I-T038
is	O
the	O
main	O
cause	O
of	O
cervical	B-T038
cancer	I-T038
and	O
plays	O
a	O
relevant	O
role	O
in	O
the	O
development	O
of	O
genital	O
warts	O
and	O
of	O
the	O
cancer	B-T038
of	O
penis	B-T017
and	O
an	B-T017
##us	I-T017
,	O
head	B-T082
/	O
neck	B-T082
,	O
oroph	B-T082
##arynx	I-T082
and	O
genitourinary	B-T022
system	I-T022
.	O
the	O
aim	O
of	O
this	O
study	B-T062
is	O
the	O
evaluation	O
of	O
hospitalizations	B-T058
due	O
to	O
hpv	B-T038
-	I-T038
related	I-T038
pathologies	I-T038
in	O
2001	O
-	O
12	O
in	O
italy	B-T082
.	O
the	O
national	B-T058
hospital	I-T058
discharge	I-T058
forms	O
were	O
provided	O
by	O
the	O
ministry	B-T092
of	I-T092
health	I-T092
.	O
the	O
hpv	B-T005
-	O
related	O
hospitalizations	B-T058
were	O
identified	O
using	O
specific	O
diagnostic	O
codes	B-T170
,	O
accordingly	O
to	O
the	O
icd	B-T170
-	I-T170
9	I-T170
-	I-T170
cm	I-T170
coding	B-T170
system	I-T170
.	O
the	O
proportion	O
of	O
hospitalizations	B-T058
of	O
potentially	O
hpv	B-T038
-	I-T038
related	I-T038
pathologies	I-T038
,	O
obtained	O
from	O
the	O
literature	B-T170
,	O
was	O
evaluated	O
as	O
well	O
as	O
the	O
hospitalization	O
rates	O
(	O
hr	O
)	O
and	O
their	O
trend	O
over	O
time	O
.	O
uterine	B-T038
cervical	I-T038
cancer	I-T038
and	O
cin	B-T038
iii	I-T038
accounted	O
for	O
40	O
%	O
of	O
hospitalizations	B-T058
(	O
hr	O
:	O
15	O
.	O
6	O
/	O
100	O
000	O
and	O
17	O
.	O
6	O
/	O
100	O
000	O
,	O
respectively	O
)	O
.	O
head	B-T082
/	O
neck	B-T082
and	O
oroph	B-T082
##arynx	I-T082
pathologies	O
accounted	O
for	O
24	O
.	O
5	O
%	O
of	O
cases	O
(	O
hr	O
:	O
16	O
/	O
100	O
000	O
and	O
3	O
.	O
9	O
/	O
100	O
000	O
,	O
in	O
males	O
and	O
females	O
,	O
respectively	O
)	O
,	O
followed	O
by	O
genital	O
warts	O
(	O
17	O
.	O
3	O
%	O
of	O
hospitalizations	B-T058
;	O
hr	O
:	O
7	O
.	O
5	O
/	O
100	O
000	O
in	O
males	O
and	O
8	O
.	O
52	O
/	O
100	O
000	O
in	O
females	O
)	O
,	O
anal	B-T038
(	O
8	O
.	O
1	O
%	O
of	O
hospitalizations	B-T058
)	O
,	O
genitourinary	B-T038
(	O
7	O
.	O
7	O
%	O
)	O
and	O
penis	B-T038
cancers	I-T038
(	O
2	O
.	O
2	O
%	O
)	O
.	O
the	O
study	B-T062
,	O
even	O
if	O
limited	O
to	O
the	O
evaluation	O
of	O
hospitalizations	B-T058
,	O
points	O
out	O
how	O
hpv	B-T038
-	I-T038
related	I-T038
pathologies	I-T038
continue	O
to	O
be	O
a	O
relevant	O
public	O
health	O
issue	B-T033
in	O
italy	B-T082
with	O
a	O
high	O
impact	O
on	O
population	B-T098
.	O

integrating	O
molecular	O
qtl	B-T017
data	O
into	O
genome	B-T062
-	I-T062
wide	I-T062
genetic	I-T062
association	I-T062
analysis	I-T062
:	O
probabilistic	O
assessment	O
of	O
enrichment	O
and	O
colocalization	O
we	O
propose	O
a	O
novel	O
statistical	B-T170
framework	I-T170
for	O
integrating	O
the	O
result	O
from	O
molecular	O
quantitative	B-T017
trait	I-T017
loci	I-T017
(	O
qtl	B-T017
)	O
mapping	O
into	O
genome	B-T062
-	I-T062
wide	I-T062
genetic	I-T062
association	I-T062
analysis	I-T062
of	O
complex	O
traits	O
,	O
with	O
the	O
primary	O
objectives	O
of	O
quantitatively	O
assessing	O
the	O
enrichment	O
of	O
the	O
molecular	O
qtls	B-T017
in	O
complex	O
trait	O
-	O
associated	O
genetic	B-T017
variants	I-T017
and	O
the	O
colocalization	O
##s	O
of	O
the	O
two	O
types	O
of	O
association	O
signals	O
.	O
we	O
introduce	O
a	O
natural	O
bayesian	O
hierarchical	O
model	O
that	O
treat	O
##s	O
the	O
latent	O
association	O
status	O
of	O
molecular	O
qtls	B-T017
as	O
snp	B-T082
-	O
level	O
annotations	O
for	O
candidate	O
snps	B-T082
of	O
complex	O
traits	O
.	O
we	O
detail	O
a	O
computational	O
procedure	O
to	O
sea	O
##ml	O
##ess	O
##ly	O
perform	O
enrichment	O
,	O
fine	O
-	O
mapping	O
and	O
colocalization	O
analyses	B-T062
,	O
which	O
is	O
a	O
distinct	O
feature	O
compared	O
to	O
the	O
existing	O
colocalization	O
analysis	B-T062
procedures	O
in	O
the	O
literature	B-T170
.	O
the	O
proposed	O
approach	B-T082
is	O
computationally	O
efficient	O
and	O
requires	O
only	O
summary	B-T170
-	O
level	O
statistics	O
.	O
we	O
evaluate	O
and	O
demonstrate	O
the	O
proposed	O
computational	O
approach	B-T082
through	O
extensive	O
simulation	O
studies	B-T062
and	O
analyses	B-T062
of	O
blood	O
lipid	O
data	O
and	O
the	O
whole	B-T031
blood	I-T031
eq	B-T017
##tl	I-T017
data	O
from	O
the	O
gt	B-T062
##ex	I-T062
project	I-T062
.	O
in	O
addition	O
,	O
a	O
useful	O
utility	B-T170
from	O
our	O
proposed	O
method	B-T170
enables	O
the	O
computation	O
of	O
expected	O
colocalization	O
signals	O
using	O
simple	O
characteristics	O
of	O
the	O
association	O
data	O
.	O
using	O
this	O
utility	B-T170
,	O
we	O
further	O
illustrate	O
the	O
importance	O
of	O
enrichment	O
analysis	B-T062
on	O
the	O
ability	O
to	O
discover	O
colocalized	O
signals	O
and	O
the	O
potential	O
limitations	O
of	O
currently	O
available	O
molecular	O
qtl	B-T017
data	O
.	O
the	O
software	B-T170
pipeline	O
that	O
implement	O
##s	O
the	O
proposed	O
computation	O
procedures	O
,	O
enl	B-T170
##oc	I-T170
,	O
is	O
freely	O
available	O
at	O
https	B-T170
:	I-T170
/	I-T170
/	I-T170
gi	I-T170
##th	I-T170
##ub	I-T170
.	I-T170
com	I-T170
/	I-T170
x	I-T170
##q	I-T170
##we	I-T170
##n	I-T170
/	I-T170
integrative	I-T170
.	O

the	O
flash	B-T170
##e	I-T170
study	I-T170
:	O
survey	B-T170
development	O
,	O
dy	O
##adic	O
perspectives	O
,	O
and	O
participant	B-T098
characteristics	O
the	O
national	B-T092
cancer	I-T092
institute	I-T092
developed	O
the	O
family	O
life	O
,	O
activity	O
,	O
sun	O
,	O
health	O
,	O
and	O
eating	B-T038
(	O
flash	B-T170
##e	I-T170
)	O
study	B-T170
to	O
examine	O
multiple	O
cancer	B-T058
preventive	I-T058
behaviors	O
within	O
parent	O
-	O
adolescent	O
dyads	O
.	O
the	O
purpose	O
of	O
creating	O
flash	B-T170
##e	I-T170
was	O
to	O
enable	O
the	O
examination	O
of	O
physical	O
activity	O
,	O
diet	B-T168
,	O
and	O
other	O
cancer	B-T058
preventive	I-T058
behaviors	I-T058
and	O
potential	O
correlates	O
among	O
parent	O
-	O
adolescent	O
dyads	O
.	O
flash	B-T170
##e	I-T170
surveys	I-T170
were	O
developed	O
from	O
a	O
process	O
involving	O
literature	B-T170
reviews	I-T170
,	O
scientific	O
input	O
from	O
experts	B-T097
in	O
the	O
field	O
,	O
cognitive	B-T058
testing	I-T058
,	O
and	O
usability	O
testing	O
.	O
this	O
cross	B-T062
-	I-T062
sectional	I-T062
,	O
web	B-T062
-	I-T062
based	I-T062
study	I-T062
of	O
parents	O
and	O
their	O
adolescent	O
children	O
(	O
aged	O
12	O
-	O
17	O
years	O
)	O
was	O
administered	O
between	O
april	O
and	O
october	O
2014	O
.	O
the	O
nationwide	O
sample	O
consisted	O
of	O
1	O
,	O
57	O
##3	O
parent	O
-	O
adolescent	O
dyads	O
(	O
1	O
,	O
69	O
##9	O
parents	O
and	O
1	O
,	O
58	O
##1	O
adolescents	O
)	O
who	O
returned	O
all	O
flash	B-T170
##e	I-T170
surveys	I-T170
.	O
flash	B-T170
##e	I-T170
assessed	O
parent	O
and	O
adolescent	O
reports	O
of	O
several	O
intraper	O
##son	O
##al	O
and	O
interpersonal	O
domains	O
(	O
including	O
psychosocial	O
variables	O
,	O
parenting	O
,	O
and	O
the	O
community	O
and	O
home	B-T082
environments	I-T082
)	O
.	O
on	O
a	O
subset	O
of	O
example	O
flash	B-T170
##e	I-T170
items	O
across	O
these	O
domains	O
,	O
responses	O
of	O
parents	O
and	O
adolescents	O
within	O
the	O
same	O
dyads	O
were	O
positively	O
and	O
significantly	O
correlated	O
(	O
r	O
=	O
0	O
.	O
32	O
-	O
0	O
.	O
63	O
)	O
.	O
analyses	O
were	O
run	O
in	O
2015	O
-	O
2016	O
.	O
flash	B-T170
##e	I-T170
data	O
present	O
multiple	O
opportunities	O
for	O
studying	O
research	O
questions	O
among	O
individuals	B-T098
or	O
dyads	O
,	O
including	O
the	O
ability	O
to	O
examine	O
similarity	O
between	O
parents	O
and	O
adolescents	O
on	O
many	O
constructs	O
relevant	O
to	O
cancer	B-T058
preventive	I-T058
behaviors	I-T058
.	O
flash	B-T170
##e	I-T170
data	O
are	O
publicly	O
available	O
for	O
researchers	B-T097
and	O
practitioners	B-T097
to	O
help	O
advance	O
research	B-T062
on	O
cancer	B-T058
preventive	I-T058
health	O
behaviors	O
.	O

physicians	B-T097
'	I-T097
knowledge	O
on	O
the	O
work	O
-	O
related	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
(	O
copd	B-T038
)	O
may	O
be	O
induced	O
by	O
the	O
work	B-T082
environment	I-T082
conditions	O
.	O
according	O
to	O
the	O
estimates	O
,	O
10	O
-	O
20	O
%	O
of	O
all	O
copd	B-T038
cases	O
are	O
associated	O
with	O
occupational	B-T037
exposure	I-T037
to	O
dust	O
##s	O
and	O
irr	B-T103
##itant	I-T103
gases	B-T103
.	O
however	O
,	O
in	O
2014	O
,	O
only	O
11	O
cases	O
of	O
work	O
-	O
related	O
copd	B-T038
were	O
recognized	O
in	O
poland	B-T082
.	O
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
analyze	B-T062
the	O
reasons	O
for	O
the	O
low	O
incidence	O
of	O
work	O
-	O
related	O
copd	B-T038
in	O
the	O
context	O
of	O
pulmon	B-T097
##ologists	I-T097
'	O
knowledge	O
about	O
occupational	O
risk	B-T033
factors	I-T033
and	O
procedures	O
on	O
reporting	B-T058
suspected	B-T038
occupational	B-T038
diseases	I-T038
.	O
a	O
survey	B-T170
included	O
94	O
pulmon	B-T097
##ologists	I-T097
randomly	O
selected	O
out	O
of	O
225	O
specialists	O
registered	O
at	O
the	O
local	B-T092
physicians	I-T092
chamber	I-T092
in	O
ł	O
##od	O
##z	O
.	O
the	O
study	B-T062
was	O
performed	O
anonymous	O
##ly	O
with	O
the	O
use	O
of	O
original	O
questionnaire	B-T170
.	O
more	O
than	O
a	O
half	O
of	O
the	O
surveyed	B-T170
pulmon	B-T097
##ologists	I-T097
identified	O
environmental	B-T082
risk	B-T033
factors	I-T033
for	O
copd	B-T038
correctly	O
,	O
while	O
only	O
23	O
.	O
4	O
%	O
properly	O
identified	O
the	O
main	O
occupational	O
risk	B-T033
factors	I-T033
as	O
the	O
cause	O
of	O
copd	B-T038
.	O
only	O
58	O
.	O
5	O
%	O
of	O
the	O
pulmon	B-T097
##ologists	I-T097
always	O
asked	O
their	O
patients	O
suffering	B-T033
from	O
copd	B-T038
about	O
their	O
job	O
/	O
profession	O
and	O
60	O
.	O
6	O
%	O
of	O
them	O
did	O
not	O
have	O
any	O
knowledge	O
about	O
procedures	O
on	O
reporting	B-T058
suspected	B-T038
occupational	B-T038
diseases	I-T038
.	O
the	O
physicians	B-T097
rarely	O
ask	O
patients	O
suffering	B-T033
from	O
copd	B-T038
about	O
their	O
job	O
/	O
profession	O
and	O
the	O
relationship	O
between	O
their	O
ail	B-T033
##ments	I-T033
and	O
occupational	B-T037
exposure	I-T037
.	O
what	O
is	O
more	O
,	O
they	O
do	O
not	O
know	O
legal	O
regulations	O
on	O
proper	O
referral	B-T058
of	I-T058
a	I-T058
patient	I-T058
with	O
a	O
suspected	B-T038
case	O
of	O
occupational	B-T038
disease	I-T038
.	O
the	O
results	O
of	O
the	O
study	B-T062
clearly	O
indicate	O
that	O
there	O
is	O
an	O
urgent	O
need	O
for	O
increasing	O
pulmon	B-T097
##ologists	I-T097
'	O
knowledge	O
on	O
work	O
-	O
related	O
copd	B-T038
.	O
med	O
pr	O
2016	O
;	O
67	O
(	O
3	O
)	O
:	O
375	O
-	O
384	O
.	O

electrocardiographic	B-T033
appearance	I-T033
of	O
aortic	B-T038
stenosis	I-T038
before	O
and	O
after	O
aortic	B-T058
valve	I-T058
replacement	I-T058
so	O
far	O
,	O
the	O
specific	O
appearance	O
of	O
qrs	B-T033
complex	I-T033
,	O
st	B-T033
-	I-T033
segment	I-T033
,	O
and	O
t	B-T033
wave	I-T033
was	O
observed	O
in	O
aortic	B-T038
stenosis	I-T038
(	O
as	B-T038
)	O
.	O
s	B-T033
-	I-T033
wave	I-T033
dynamic	O
change	O
in	O
leads	B-T082
v1	I-T082
-	O
v3	B-T082
was	O
not	O
reported	O
in	O
as	B-T038
.	O
in	O
a	O
single	O
-	O
center	O
,	O
prospective	B-T062
study	I-T062
,	O
we	O
included	O
a	O
total	O
number	O
of	O
1	O
.	O
175	O
patients	O
who	O
underwent	O
surgical	B-T058
aortic	B-T058
valve	I-T058
replacement	I-T058
(	O
avr	B-T058
)	O
.	O
we	O
conducted	O
3	O
-	O
year	O
gathering	O
of	O
patients	O
with	O
symptomatic	O
and	O
asymptomatic	B-T033
severe	O
as	B-T038
,	O
and	O
separated	O
them	O
by	O
hemodynamic	O
stability	O
into	O
groups	O
a	O
and	O
b	O
,	O
through	O
ef	B-T201
##lv	I-T201
(	O
of	O
more	O
or	O
less	O
than	O
50	O
%	O
)	O
,	O
av	O
##a	O
(	O
of	O
more	O
or	O
less	O
than	O
0	O
.	O
9	O
cm	O
(	O
2	O
)	O
)	O
,	O
pg	B-T201
(	O
between	O
55	O
and	O
75	O
mm	O
hg	O
or	O
over	O
75	O
mm	O
hg	O
)	O
,	O
and	O
end	O
-	O
diastolic	O
lv	O
dimension	O
(	O
of	O
more	O
or	O
less	O
than	O
56	O
mm	O
)	O
.	O
we	O
evaluated	B-T058
the	O
impact	O
of	O
s	B-T033
-	I-T033
wave	I-T033
magnitude	O
in	O
right	O
prec	O
##ord	O
##ial	O
leads	O
before	O
and	O
after	O
avr	B-T058
in	O
all	O
patients	O
.	O
we	O
followed	O
s	B-T033
-	I-T033
wave	I-T033
changes	O
in	O
electrocardiogram	B-T033
altogether	O
with	O
hemodynamic	B-T058
measurements	I-T058
derived	O
from	O
echocardiography	B-T058
.	O
analysis	B-T062
of	O
echocardiographic	B-T058
parameters	B-T033
,	O
measured	O
in	O
patients	O
before	O
surgery	B-T058
,	O
did	O
not	O
show	O
statistical	O
significance	O
between	O
asymptomatic	B-T033
and	O
symptomatic	O
group	O
.	O
the	O
statistical	O
significance	O
was	O
observed	O
in	O
the	O
change	O
in	O
s	B-T033
-	I-T033
wave	I-T033
magnitude	O
in	O
the	O
right	O
prec	O
##ord	O
##ial	O
leads	O
in	O
both	O
subsets	O
of	O
patients	O
before	O
avr	B-T058
.	O
we	O
found	O
statistically	O
significant	O
predictive	O
value	O
of	O
s	B-T033
-	I-T033
wave	I-T033
magnitude	O
in	O
leads	B-T082
v2	I-T082
-	O
v3	B-T082
for	O
dependent	O
variables	O
pg	B-T201
and	O
end	O
-	O
diastolic	O
lv	O
dimension	O
.	O
s	B-T033
-	I-T033
wave	I-T033
changes	O
in	O
right	O
prec	O
##ord	O
##ial	O
leads	O
can	O
predict	O
increase	O
in	O
pg	B-T201
and	O
critical	O
narrowing	O
of	O
av	O
##a	O
,	O
suggestive	O
of	O
timely	O
referral	B-T058
for	I-T058
avr	B-T058
.	O

benchmark	O
study	B-T062
on	O
fine	O
-	O
mode	O
aerosol	O
in	O
a	O
big	O
urban	O
area	O
and	O
relevant	O
doses	O
deposited	O
in	O
the	O
human	B-T204
respiratory	B-T017
tract	I-T017
it	O
is	O
well	O
-	O
known	O
that	O
the	O
health	O
effects	O
of	O
pm	B-T103
increase	O
as	O
particle	O
size	O
decreases	O
:	O
particularly	O
,	O
great	O
concern	O
has	O
rise	O
##n	O
on	O
the	O
role	O
of	O
ultraf	B-T103
##ine	I-T103
particles	I-T103
(	O
uf	B-T103
##ps	I-T103
)	O
.	O
starting	O
from	O
the	O
knowledge	O
that	O
the	O
main	O
fraction	O
of	O
atmospheric	O
aerosol	O
in	O
rom	B-T082
##e	I-T082
is	O
characterized	O
by	O
significant	O
levels	O
of	O
pm2	B-T103
.	I-T103
5	I-T103
(	O
almost	O
75	O
%	O
of	O
pm10	B-T103
fraction	O
is	O
pm2	B-T103
.	I-T103
5	I-T103
)	O
,	O
the	O
paper	O
is	O
focused	O
on	O
submic	B-T103
##ron	I-T103
particles	I-T103
in	O
such	O
great	O
urban	O
area	O
.	O
the	O
daytime	O
/	O
nighttime	O
,	O
work	O
-	O
/	O
week	O
##days	O
and	O
cold	O
/	O
hot	O
seasonal	O
trends	O
of	O
submic	B-T103
##ron	I-T103
particles	I-T103
will	O
be	O
investigated	O
and	O
discussed	O
along	O
with	O
nox	B-T103
and	O
total	O
pah	B-T103
drift	O
##s	O
demonstrating	O
the	O
primary	O
origin	O
of	O
uf	B-T103
##ps	I-T103
from	O
combustion	O
processes	O
.	O
furthermore	O
,	O
moving	O
from	O
these	O
data	O
,	O
the	O
total	O
dose	O
of	O
submic	B-T103
##ron	I-T103
particles	I-T103
deposited	O
in	O
the	O
respiratory	B-T022
system	I-T022
(	O
i	O
.	O
e	O
.	O
,	O
head	B-T082
,	O
trache	B-T017
##obronchial	I-T017
and	O
alveolar	B-T017
regions	I-T017
in	O
different	O
lung	B-T017
lobes	I-T017
)	O
has	O
been	O
estimated	O
.	O
dos	B-T074
##imeter	I-T074
estimates	O
were	O
performed	O
with	O
the	O
multiple	B-T170
-	I-T170
path	I-T170
particle	I-T170
dosimetry	I-T170
model	I-T170
(	O
mpp	B-T170
##d	I-T170
v	I-T170
.	I-T170
2	I-T170
.	I-T170
1	I-T170
)	O
.	O
the	O
paper	O
discusses	O
the	O
aerosol	O
doses	O
deposited	O
in	O
the	O
respiratory	B-T022
system	I-T022
of	O
individuals	B-T098
exposed	O
in	O
proximity	O
of	O
traffic	O
.	O
during	O
traffic	O
peak	O
hours	O
,	O
about	O
6	O
.	O
6	O
×	O
10	O
(	O
10	O
)	O
particles	B-T103
are	O
deposited	O
into	O
the	O
respiratory	B-T022
system	I-T022
.	O
such	O
dose	O
is	O
almost	O
entirely	O
made	O
of	O
uf	B-T103
##ps	I-T103
.	O
according	O
to	O
the	O
greater	O
dose	O
estimated	O
,	O
right	B-T017
lung	I-T017
lobes	I-T017
are	O
expected	O
to	O
be	O
more	O
susceptible	O
to	O
respiratory	O
pathologies	B-T038
than	O
left	B-T017
lobes	I-T017
.	O

lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
accelerates	O
intestinal	B-T038
transit	I-T038
and	O
alleviate	O
##s	O
small	B-T038
intestinal	I-T038
bacterial	I-T038
overgrowth	I-T038
in	O
patients	O
with	O
chronic	B-T033
constipation	I-T033
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
is	O
an	O
effective	O
treatment	O
for	O
chronic	B-T033
constipation	I-T033
(	O
cc	B-T033
)	O
.	O
the	O
mechanism	O
of	O
action	O
of	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
is	O
through	O
increasing	O
fluid	B-T038
secretion	I-T038
and	O
lubric	O
##ation	O
of	O
the	O
intestinal	B-T082
lumen	I-T082
.	O
the	O
effects	O
of	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
on	O
gastrointestinal	B-T038
transit	I-T038
and	O
small	B-T038
intestinal	I-T038
bacterial	I-T038
overgrowth	I-T038
(	O
sib	B-T038
##o	I-T038
)	O
have	O
not	O
been	O
adequately	O
explored	O
.	O
the	O
current	O
study	B-T062
was	O
designed	O
to	O
investigate	O
whether	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
(	O
1	O
)	O
alters	O
gastrointestinal	B-T038
transit	I-T038
and	O
(	O
2	O
)	O
affects	O
sib	B-T038
##o	I-T038
in	O
patients	O
with	O
constipation	B-T033
.	O
a	O
total	O
of	O
29	O
female	O
patients	O
(	O
mean	O
age	O
=	O
39	O
years	O
;	O
range	O
:	O
19	O
-	O
64	O
)	O
with	O
cc	B-T033
received	O
2	O
weeks	O
of	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
(	O
24	O
##mc	O
##g	O
b	O
.	O
i	O
.	O
d	O
.	O
,	O
p	O
.	O
o	O
.	O
)	O
.	O
stool	B-T033
consistency	I-T033
based	O
on	O
br	B-T170
##ist	I-T170
##ol	I-T170
stool	I-T170
scale	I-T170
and	O
the	O
frequency	B-T033
of	I-T033
bowel	I-T033
movements	I-T033
(	O
bms	B-T038
)	O
were	O
recorded	O
.	O
gastric	O
emptying	O
time	O
,	O
small	O
bowel	O
transit	O
time	O
,	O
colon	B-T017
transit	O
time	O
(	O
ct	O
##t	O
)	O
,	O
combined	O
small	B-T038
and	I-T038
large	I-T038
bowel	I-T038
transit	I-T038
time	I-T038
(	O
sl	B-T038
##bt	I-T038
##t	I-T038
)	O
and	O
whole	O
gut	B-T017
transit	O
time	O
were	O
measured	O
using	O
wireless	B-T058
motility	I-T058
capsule	I-T058
.	O
the	O
sib	B-T038
##o	I-T038
status	O
was	O
assessed	O
by	O
the	O
lact	B-T058
##ulose	I-T058
breath	I-T058
test	I-T058
.	O
data	O
were	O
analyzed	B-T062
using	O
wilcoxon	O
rank	O
,	O
mann	O
-	O
whitney	O
u	O
,	O
spearman	O
׳	O
s	O
rank	O
correlation	O
and	O
chi	B-T170
-	I-T170
square	I-T170
tests	I-T170
.	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
significantly	O
soft	O
##ened	O
the	O
stool	B-T031
and	O
increased	O
the	O
frequency	B-T033
of	I-T033
bm	I-T033
from	O
median	O
of	O
2	O
to	O
4	O
times	O
per	O
week	O
.	O
the	O
ct	O
##t	O
and	O
sl	B-T038
##bt	I-T038
##t	I-T038
were	O
significantly	O
shorter	O
in	O
responders	B-T098
to	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
(	O
i	O
.	O
e	O
.	O
,	O
those	O
with	O
≥	O
2	O
times	O
increase	O
in	O
the	O
number	O
of	O
their	O
weekly	O
bm	B-T038
)	O
compared	O
with	O
nonresponders	B-T098
.	O
the	O
higher	O
frequency	B-T033
of	I-T033
bm	I-T033
after	O
treatment	O
was	O
significantly	O
correlated	O
with	O
the	O
acceleration	O
of	O
ct	O
##t	O
,	O
sl	B-T038
##bt	I-T038
##t	I-T038
and	O
whole	O
gut	B-T017
transit	O
time	O
.	O
in	O
all	O
,	O
17	O
out	O
of	O
25	O
(	O
68	O
%	O
)	O
patients	O
,	O
who	O
were	O
tested	O
for	O
sib	B-T038
##o	I-T038
at	O
baseline	O
,	O
were	O
positive	B-T033
.	O
in	O
addition	O
,	O
7	O
out	O
of	O
17	O
(	O
41	O
%	O
)	O
sib	B-T038
##o	I-T038
-	O
positive	B-T033
patients	O
became	O
sib	B-T038
##o	I-T038
-	O
negative	B-T033
after	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
treatment	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
in	O
cc	B-T033
,	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
improves	O
the	O
frequency	B-T033
of	I-T033
bms	I-T033
,	O
soft	O
##ens	O
the	O
stool	B-T031
,	O
accelerates	O
intestinal	B-T038
transit	I-T038
and	O
decreases	O
accompanying	O
sib	B-T038
##o	I-T038
.	O
the	O
improvement	O
of	O
sib	B-T038
##o	I-T038
could	O
be	O
explained	O
by	O
the	O
clean	O
##sin	O
##g	O
effect	O
of	O
increased	O
intestinal	B-T038
fluid	I-T038
and	O
mucus	B-T031
combined	O
with	O
enhanced	O
intestinal	B-T038
motility	I-T038
with	O
lub	B-T103
##ipr	I-T103
##ost	I-T103
##one	I-T103
.	O

improving	O
exchange	O
with	O
consumers	B-T098
within	O
mental	O
health	O
organizations	O
:	O
recognizing	O
mental	B-T038
ill	I-T038
health	I-T038
experience	O
as	O
a	O
'	O
sn	O
##ea	O
##ky	O
,	O
special	O
degree	O
'	O
stigma	B-T033
##tizing	I-T033
views	O
towards	O
consumers	B-T098
may	O
be	O
held	O
even	O
by	O
those	O
working	O
within	O
mental	O
health	O
organizations	O
.	O
contemporary	O
mental	O
health	O
policies	O
require	O
organizations	O
to	O
work	O
collaborative	O
##ly	O
with	O
consumers	B-T098
in	O
producing	O
and	O
delivering	B-T058
services	O
.	O
using	O
social	O
exchange	O
theory	O
,	O
which	O
emphasis	O
##es	O
mutual	O
exchange	O
to	O
maxim	O
##ise	O
benefits	O
in	O
partnership	O
,	O
the	O
current	O
study	B-T062
explores	O
the	O
perspectives	O
of	O
those	O
working	O
within	O
organizations	O
that	O
have	O
some	O
level	O
of	O
consumer	B-T098
leadership	O
.	O
interviews	O
were	O
conducted	O
with	O
14	O
participants	B-T098
from	O
a	O
range	O
of	O
mental	O
health	O
organizations	O
.	O
data	O
were	O
transcribed	O
,	O
and	O
analyzed	B-T062
using	O
thematic	B-T062
analytic	I-T062
and	O
disc	O
##urs	O
##ive	O
psychological	B-T058
techniques	I-T058
.	O
findings	B-T033
suggest	O
stigma	B-T033
is	O
still	O
prevalent	O
even	O
in	O
organizations	O
that	O
have	O
consumers	B-T098
in	O
leadership	O
positions	O
,	O
and	O
consumers	B-T098
are	O
often	O
perceived	B-T038
as	O
less	O
able	O
to	O
work	O
in	O
mental	O
health	O
organizations	O
than	O
non	O
-	O
consumers	O
.	O
several	O
discourse	O
##s	O
challenged	O
such	O
a	O
view	O
-	O
showing	O
how	O
consumers	B-T098
bring	O
value	O
to	O
mental	O
health	O
organizations	O
through	O
their	O
expertise	O
in	O
the	O
mental	O
health	O
system	O
,	O
and	O
their	O
ability	O
to	O
provide	O
safety	B-T058
and	O
support	O
to	O
other	O
consumers	B-T098
.	O
through	O
a	O
social	O
exchange	O
theory	O
lens	O
,	O
the	O
authors	B-T097
call	O
for	O
organizations	O
to	O
challenge	O
stigma	B-T033
and	O
promote	O
the	O
value	O
that	O
consumers	B-T098
can	O
bring	O
to	O
maximize	O
mutual	O
benefits	O
.	O

pre	O
-	O
hospital	O
policies	B-T170
for	O
the	O
care	B-T058
of	I-T058
patients	I-T058
with	O
acute	B-T038
coronary	I-T038
syndromes	I-T038
in	O
india	B-T082
:	O
a	O
policy	B-T170
document	B-T170
analysis	B-T062
ischemic	B-T033
heart	I-T033
disease	I-T033
is	O
the	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
in	O
india	B-T082
.	O
in	O
high	B-T033
-	I-T033
income	I-T033
countries	B-T082
,	O
pre	B-T058
-	I-T058
hospital	I-T058
systems	I-T058
of	I-T058
care	I-T058
have	O
been	O
developed	O
to	O
manage	O
acute	O
manifestations	O
of	O
ischemic	B-T033
heart	I-T033
disease	I-T033
,	O
such	O
as	O
acute	B-T038
coronary	I-T038
syndrome	I-T038
(	O
acs	B-T038
)	O
.	O
however	O
,	O
it	O
is	O
unknown	O
whether	O
guidelines	B-T170
,	O
policies	B-T170
,	O
regulations	O
,	O
or	O
laws	B-T170
exist	O
to	O
guide	O
pre	O
-	O
hospital	O
acs	B-T038
care	B-T058
in	O
india	B-T082
.	O
we	O
undertook	O
a	O
nation	O
-	O
wide	O
document	B-T170
analysis	B-T062
to	O
address	O
this	O
gap	O
in	O
knowledge	B-T170
.	O
from	O
november	O
2014	O
to	O
may	O
2016	O
,	O
we	O
searched	O
for	O
publicly	O
available	O
emergency	B-T058
care	I-T058
guidelines	B-T170
and	O
legislation	B-T170
addressing	O
pre	O
-	O
hospital	O
acs	B-T038
care	B-T058
in	O
all	O
29	O
indian	B-T082
states	B-T082
and	O
7	O
union	B-T082
territories	I-T082
via	O
internet	O
search	O
and	O
direct	O
correspondence	B-T170
.	O
we	O
found	B-T033
two	O
documents	B-T170
addressing	O
pre	O
-	O
hospital	O
acs	B-T038
care	B-T058
.	O
though	O
india	B-T082
has	O
legislation	O
mand	O
##ating	O
acute	B-T058
care	I-T058
for	O
emergencies	O
such	O
as	O
trauma	B-T037
,	O
regulations	O
or	O
laws	B-T170
to	O
guide	O
pre	O
-	O
hospital	O
acs	B-T038
care	B-T058
are	O
largely	O
absent	O
.	O
policy	B-T097
makers	I-T097
urgently	O
need	O
to	O
develop	O
comprehensive	O
,	O
multi	O
-	O
stakeholder	O
policies	B-T170
for	O
pre	O
-	O
hospital	O
emergency	O
cardiovascular	B-T058
care	I-T058
in	O
india	B-T082
.	O

shear	O
modulus	O
of	O
structured	B-T082
electro	O
##rh	O
##e	O
##ological	O
fluid	O
mixtures	O
some	O
imm	O
##isc	O
##ible	O
blends	O
under	O
a	O
strong	O
electric	O
field	O
often	O
exhibit	O
periodic	O
structures	B-T082
,	O
bridging	O
the	O
gap	O
between	O
two	O
electrodes	B-T074
.	O
upon	O
shear	O
,	O
the	O
structures	B-T082
tilt	O
,	O
and	O
exhibit	O
an	O
elastic	O
response	O
which	O
is	O
mostly	O
governed	O
by	O
the	O
electric	O
energy	O
.	O
assuming	O
a	O
two	O
-	O
dimensional	O
strip	B-T082
##e	I-T082
structure	I-T082
,	O
we	O
calculate	O
the	O
max	O
##well	O
stress	O
,	O
and	O
derive	O
an	O
expression	O
for	O
the	O
shear	O
modulus	O
,	O
demonstrating	O
how	O
it	O
depends	O
on	O
the	O
external	O
electric	O
field	O
,	O
the	O
composition	O
,	O
and	O
the	O
dielectric	O
properties	O
of	O
the	O
blend	O
.	O
we	O
also	O
suggest	O
the	O
notion	O
of	O
effective	O
interfacial	O
tension	O
,	O
which	O
ren	O
##ormal	O
##izes	O
the	O
effect	O
of	O
the	O
electric	O
field	O
.	O
this	O
leads	O
to	O
a	O
simple	O
derivation	O
of	O
the	O
scaling	B-T170
law	I-T170
for	O
the	O
selection	O
of	O
the	O
wavelength	O
of	O
the	O
structure	B-T082
formed	O
under	O
an	O
electric	O
field	O
.	O

evidence	O
-	O
based	O
review	B-T170
and	O
survey	B-T170
of	O
expert	O
opinion	O
of	O
reconstruction	B-T058
of	O
metastatic	B-T038
spine	I-T038
tumors	I-T038
systematic	O
review	B-T170
and	O
consensus	O
expert	O
opinion	O
.	O
to	O
provide	O
surgeons	B-T097
and	O
other	O
health	B-T097
care	I-T097
professionals	I-T097
with	O
guidelines	B-T170
for	O
surgical	B-T058
reconstruction	I-T058
of	O
metastatic	B-T038
spine	B-T038
disease	I-T038
based	O
on	O
evidence	O
and	O
expert	O
opinion	O
.	O
the	O
surgical	B-T058
treatment	I-T058
of	O
spinal	B-T038
metastases	I-T038
is	O
controversial	O
.	O
specifically	O
two	O
aspects	O
of	O
surgical	B-T058
reconstruction	I-T058
are	O
addressed	O
in	O
this	O
study	O
:	O
(	O
i	O
)	O
choice	O
of	O
bone	B-T058
graft	I-T058
used	O
during	O
surgery	B-T058
for	O
metastatic	B-T038
spine	I-T038
tumors	I-T038
and	O
(	O
ii	O
)	O
the	O
design	O
of	O
reconstruction	B-T058
or	O
construct	B-T103
to	O
stabilize	B-T033
.	O
a	O
systematic	O
review	B-T170
of	O
the	O
available	O
medical	O
literature	B-T170
from	O
1980	O
to	O
2015	O
was	O
conducted	O
,	O
and	O
combined	O
with	O
consensus	O
expert	O
opinion	O
from	O
a	O
recent	O
survey	B-T170
of	O
spine	B-T017
surgeons	B-T097
who	O
treat	B-T058
metastatic	B-T038
spine	I-T038
tumors	I-T038
.	O
there	O
is	O
very	O
little	O
evidence	O
in	O
the	O
literature	B-T170
to	O
provide	O
guidance	B-T058
on	O
the	O
use	O
of	O
bone	B-T058
graft	I-T058
in	O
metastatic	B-T038
tumor	I-T038
reconstruction	B-T058
.	O
there	O
is	O
little	O
evidence	O
in	O
the	O
literature	B-T170
to	O
support	O
the	O
preferential	O
use	O
of	O
one	O
graft	B-T170
type	I-T170
over	O
the	O
other	O
.	O
approximately	O
,	O
41	O
%	O
of	O
respondents	B-T098
said	O
they	O
used	O
bone	B-T058
graft	I-T058
or	O
bone	B-T058
graft	I-T058
substitutes	B-T103
to	O
accomplish	O
fusion	B-T058
.	O
there	O
were	O
17	O
studies	B-T062
that	O
described	O
the	O
use	O
of	O
a	O
pref	B-T074
##abric	I-T074
##ated	I-T074
prosthetic	I-T074
,	O
10	O
studies	B-T062
describing	O
the	O
use	O
of	O
polym	B-T103
##ethyl	I-T103
methacrylate	I-T103
(	O
pmma	B-T103
)	O
bone	B-T103
cement	I-T103
,	O
and	O
only	O
three	O
studies	B-T062
describing	O
the	O
use	O
of	O
bone	B-T058
graft	I-T058
for	O
anterior	B-T082
column	B-T017
reconstruction	B-T058
.	O
the	O
use	O
of	O
structural	O
allograft	O
was	O
most	O
popular	O
among	O
the	O
experts	B-T097
for	O
anterior	B-T082
reconstruction	B-T058
,	O
followed	O
by	O
cage	B-T074
reconstruction	B-T058
,	O
and	O
pmma	B-T103
bone	B-T103
cement	I-T103
.	O
achieving	O
bony	B-T082
union	I-T082
may	O
be	O
of	O
importance	O
for	O
the	O
maintenance	O
of	O
spinal	B-T017
stability	O
in	O
the	O
long	O
term	O
after	O
reconstruction	B-T058
.	O
whether	O
bony	B-T082
union	I-T082
is	O
required	O
for	O
patients	O
with	O
shorter	O
life	O
expect	O
##ancies	O
is	O
deb	O
##atable	O
.	O
the	O
literature	B-T170
supports	O
the	O
use	O
of	O
anterior	B-T082
reconstruction	B-T058
with	O
either	O
a	O
pref	B-T074
##abric	I-T074
##ated	I-T074
prosthetic	I-T074
or	O
pmma	B-T103
bone	B-T103
cement	I-T103
.	O
it	O
also	O
supports	O
the	O
use	O
of	O
an	O
anterior	B-T082
construct	B-T103
reinforced	O
with	O
bilateral	B-T082
posterior	B-T082
instrumentation	O
when	O
performing	B-T058
a	O
three	B-T058
-	I-T058
column	I-T058
reconstruction	I-T058
.	O
n	O
/	O
a	O
.	O

phyl	O
##oge	O
##ography	O
of	O
the	O
spanish	B-T098
mo	B-T204
##on	I-T204
moth	I-T204
gr	B-T204
##ael	I-T204
##ls	I-T204
##ia	I-T204
is	I-T204
##ab	I-T204
##ellae	I-T204
(	O
lepid	B-T204
##optera	I-T204
,	O
satur	B-T204
##ni	I-T204
##idae	I-T204
)	O
geographic	O
and	O
demographic	O
factors	O
as	O
well	O
as	O
special	O
##isation	O
to	O
a	O
new	O
host	O
-	O
plant	O
may	O
lead	O
to	O
host	O
-	O
associated	O
differentiation	O
in	O
plant	B-T204
-	O
feeding	O
insects	B-T204
.	O
we	O
explored	O
the	O
phyl	O
##oge	O
##ography	O
of	O
a	O
protected	O
moth	B-T204
,	O
gr	B-T204
##ael	I-T204
##ls	I-T204
##ia	I-T204
is	I-T204
##ab	I-T204
##ellae	I-T204
,	O
and	O
its	O
two	O
recognised	O
host	O
-	O
plant	O
species	B-T170
(	O
pin	B-T204
##us	I-T204
sy	I-T204
##lv	I-T204
##estr	I-T204
##is	I-T204
and	O
p	B-T204
.	I-T204
nigra	I-T204
)	O
in	O
order	O
to	O
seek	O
for	O
any	O
concordance	O
useful	O
to	O
dise	O
##nt	O
##angl	O
##e	O
the	O
evolutionary	O
history	O
of	O
this	O
ic	O
##onic	O
lepid	B-T204
##optera	I-T204
##n	I-T204
.	O
dna	B-T103
variation	O
in	O
one	O
mitochondrial	B-T017
marker	B-T082
and	O
nine	O
nuclear	B-T017
microsatellite	B-T017
loci	I-T017
revealed	O
a	O
strong	O
phyl	B-T033
##oge	I-T033
##ographic	I-T033
pattern	I-T033
across	O
28	O
populations	O
of	O
g	B-T204
.	I-T204
is	I-T204
##ab	I-T204
##ellae	I-T204
studied	O
in	O
spain	B-T082
and	O
france	B-T082
comprising	O
six	O
groups	O
mostly	O
distributed	O
along	O
different	O
mountain	B-T082
ranges	I-T082
.	O
re	B-T062
##analysis	I-T062
of	O
a	O
previously	O
published	O
chloroplast	B-T017
microsatellite	B-T170
dataset	I-T170
revealed	O
a	O
three	O
and	O
two	O
-	O
group	O
structure	O
for	O
spanish	B-T098
p	B-T204
.	I-T204
sy	I-T204
##lv	I-T204
##estr	I-T204
##is	I-T204
and	O
p	B-T204
.	I-T204
nigra	I-T204
,	O
respectively	O
.	O
overall	O
,	O
the	O
population	O
grouping	O
##s	O
of	O
this	O
protected	O
moth	B-T204
did	O
not	O
match	O
the	O
ones	O
of	O
p	B-T204
.	I-T204
sy	I-T204
##lv	I-T204
##estr	I-T204
##is	I-T204
and	O
p	B-T204
.	I-T204
nigra	I-T204
.	O
there	O
was	O
no	O
evidence	O
of	O
host	O
-	O
associated	O
differentiation	O
between	O
populations	O
using	O
p	B-T204
.	I-T204
sy	I-T204
##lv	I-T204
##estr	I-T204
##is	I-T204
and	O
the	O
ones	O
inhab	O
##iting	O
p	B-T204
.	I-T204
nigra	I-T204
.	O
the	O
two	O
major	O
mitochondrial	B-T017
clades	O
of	O
g	B-T204
.	I-T204
is	I-T204
##ab	I-T204
##ellae	I-T204
likely	O
diverged	O
before	O
the	O
last	O
gla	O
##ci	O
##al	O
maximum	O
and	O
geographically	B-T082
separated	O
the	O
species	B-T170
into	O
a	O
[UNK]	O
southern	B-T082
[UNK]	O
(	O
central	O
and	O
southern	O
ib	O
##erian	O
clusters	O
)	O
and	O
a	O
[UNK]	O
northern	B-T082
[UNK]	O
lineage	O
(	O
eastern	O
ib	O
##erian	O
,	O
pyrene	O
##an	O
and	O
french	O
alp	O
##ine	O
clusters	O
)	O
.	O
the	O
eastern	O
ib	O
##erian	O
system	O
,	O
where	O
this	O
insect	B-T204
uses	O
both	O
host	O
-	O
plants	O
,	O
harbour	O
##ed	O
the	O
highest	O
level	O
of	O
genetic	O
diversity	O
.	O
such	O
a	O
group	O
independently	O
colon	B-T033
##ised	I-T033
the	O
west	B-T082
and	O
east	B-T082
parts	I-T082
of	O
the	O
pyrene	O
##es	O
.	O
our	O
results	O
point	O
to	O
a	O
native	O
origin	O
for	O
the	O
french	O
populations	O
occurring	O
in	O
the	O
alp	B-T082
##s	I-T082
,	O
genetically	O
related	O
to	O
the	O
eastern	O
ib	O
##erian	O
and	O
pyrene	O
##an	O
sites	O
.	O
the	O
central	O
ib	O
##erian	O
group	O
derived	O
from	O
southern	O
ib	O
##erian	O
ancestor	O
##s	O
.	O
secondary	O
contacts	O
were	O
inferred	O
between	O
the	O
southern	O
/	O
central	O
ib	O
##erian	O
populations	O
and	O
eastern	O
ib	O
##erian	O
cluster	O
as	O
well	O
as	O
between	O
the	O
two	O
pyrene	O
##an	O
ones	O
.	O
the	O
mit	O
##o	O
-	O
nuclear	O
discordance	O
observed	O
with	O
regard	O
to	O
the	O
eastern	O
ib	O
##erian	O
cluster	O
is	O
congruent	O
with	O
a	O
secondary	O
contact	O
after	O
the	O
evolution	B-T038
of	O
mit	O
##o	O
-	O
nuclear	O
incomp	O
##atib	O
##ilities	O
in	O
geographically	O
isolated	O
areas	O
.	O

estradiol	B-T103
prodrug	B-T103
##s	I-T103
(	O
ep	B-T103
)	O
for	O
efficient	O
oral	B-T058
estrogen	O
treatment	O
and	O
abolished	O
effects	O
on	O
estrogen	B-T103
modulated	O
liver	B-T038
functions	I-T038
oral	B-T058
compared	O
to	O
parenteral	O
estrogen	O
administration	O
is	O
characterized	O
by	O
reduced	O
systemic	O
but	O
prominent	O
hepatic	B-T082
estrogenic	B-T033
effects	I-T033
on	O
lipids	B-T103
,	O
hemostatic	B-T038
factors	I-T038
,	O
gh	B-T103
-	O
/	O
igf	B-T103
i	I-T103
axis	O
,	O
angiotensin	B-T103
##ogen	I-T103
.	O
in	O
order	O
to	O
avoid	O
such	O
adverse	O
metabolic	O
effects	O
of	O
oral	B-T058
treatment	I-T058
,	O
estradiol	B-T103
(	O
e2	B-T103
)	O
prodrug	B-T103
##s	I-T103
(	O
ep	B-T103
)	O
were	O
designed	O
which	O
bypass	O
the	O
liver	B-T017
tissue	I-T017
as	O
inactive	O
molecules	O
.	O
carbon	O
##e1	O
##7	O
-	O
oh	O
sulfon	O
##amide	O
[	O
-	O
o2	O
-	O
nh2	O
]	O
substituted	O
esters	O
of	O
e2	B-T103
(	O
ec50	B-T103
##8	I-T103
,	O
others	O
)	O
were	O
synthesized	O
and	O
tested	O
for	O
carbonic	B-T103
anhydrase	I-T103
ii	I-T103
(	O
ca	B-T103
-	I-T103
ii	I-T103
)	O
binding	B-T038
.	O
ca	B-T103
ii	I-T103
in	O
erythrocytes	B-T017
is	O
thought	O
to	O
opp	O
##ose	O
extraction	O
of	O
ep	B-T103
from	O
portal	B-T017
vein	I-T017
blood	I-T017
during	O
liver	B-T017
passage	B-T082
.	O
ovariectomized	O
(	O
ovx	O
,	O
day	O
minus	O
14	O
)	O
rats	B-T204
were	O
orally	B-T058
treated	I-T058
once	O
daily	O
from	O
day	O
1	O
-	O
3	O
.	O
sacrifice	O
day	O
4	O
.	O
uteri	B-T017
were	O
dissected	O
and	O
weighed	B-T058
.	O
cholesterol	B-T058
fractions	I-T058
and	O
angiotensin	B-T058
##ogen	I-T058
were	O
determined	O
in	O
plasma	B-T031
.	O
oral	O
e2	O
and	O
ethi	B-T103
##n	I-T103
##yl	I-T103
estradiol	I-T103
(	O
ee	B-T103
)	O
generated	O
dose	O
related	O
uterine	B-T017
growth	B-T038
and	O
important	O
hepatic	B-T082
estrogenic	B-T033
effects	I-T033
.	O
ep	B-T103
induced	O
uterine	B-T038
growth	I-T038
at	O
about	O
hundred	O
-	O
fold	O
lower	O
doses	O
.	O
this	O
was	O
possible	O
with	O
almost	O
absent	O
effects	O
on	O
plasma	B-T031
cholesterol	B-T103
or	O
angiotensin	B-T103
##ogen	I-T103
.	O
preliminary	O
pharmacokinetic	B-T062
studies	I-T062
with	O
ec50	B-T103
##8	I-T103
used	O
intravenous	B-T082
and	O
oral	B-T058
administration	I-T058
in	O
male	O
rats	B-T204
.	O
resulting	O
blood	O
levels	O
revealed	O
complete	O
oral	B-T058
bioavailability	O
.	O
further	O
high	O
blood	B-T031
-	O
but	O
low	O
plasma	B-T031
concentrations	O
indicated	O
erythrocyte	B-T017
binding	O
of	O
ec50	B-T103
##8	I-T103
in	B-T082
vivo	I-T082
as	O
potential	O
mechanism	O
of	O
low	O
extraction	O
at	O
liver	B-T017
passage	B-T082
.	O
very	O
high	O
systemic	O
estrogenic	B-T103
##ity	I-T103
combined	O
with	O
markedly	O
lower	O
or	O
absent	O
adverse	O
hepatic	B-T082
estrogenic	B-T033
effects	I-T033
is	O
evidence	O
for	O
a	O
systemic	O
release	O
of	O
e2	B-T103
from	O
sulfon	B-T103
##amide	I-T103
ep	I-T103
.	O
in	O
conclusion	O
,	O
tested	O
oral	B-T058
ep	B-T103
bypass	O
the	O
liver	B-T017
in	O
erythrocytes	B-T017
furn	O
##ishing	O
systemic	O
estradiol	B-T103
at	O
hydrolysis	O
.	O
this	O
mechanism	O
avoids	O
the	O
hepatic	B-T082
estrogenic	O
impact	O
of	O
conventional	O
oral	B-T058
estrogen	B-T058
therapy	I-T058
.	O

tissue	B-T017
microrna	B-T103
profiles	O
as	O
diagnostic	B-T201
and	O
prognostic	O
biomarkers	O
in	O
patients	O
with	O
resectable	B-T058
pancreatic	B-T038
ductal	I-T038
adenocarcinoma	I-T038
and	O
peri	B-T038
##amp	I-T038
##ullary	I-T038
cancers	I-T038
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
validate	O
previously	O
described	O
diagnostic	O
and	O
prognostic	B-T170
microrna	B-T103
expression	O
profiles	O
in	O
tissue	B-T017
samples	O
from	O
patients	O
with	O
pancreatic	B-T038
cancer	I-T038
and	O
other	O
peri	B-T038
##amp	I-T038
##ullary	I-T038
cancers	I-T038
.	O
expression	B-T038
of	O
46	O
selected	O
micrornas	B-T103
was	O
studied	O
in	O
formalin	B-T103
-	O
fixed	O
paraffin	B-T017
-	I-T017
embedded	I-T017
tissue	I-T017
from	O
patients	O
with	O
resected	B-T058
pancreatic	B-T038
ductal	I-T038
adenocarcinoma	I-T038
(	O
n	O
=	O
165	O
)	O
,	O
amp	B-T038
##ullary	I-T038
cancer	I-T038
(	O
n	O
=	O
59	O
)	O
,	O
duodenal	B-T038
cancer	I-T038
(	O
n	O
=	O
6	O
)	O
,	O
distal	B-T082
common	B-T038
bile	I-T038
duct	I-T038
cancer	I-T038
(	O
n	O
=	O
21	O
)	O
,	O
and	O
gastric	B-T038
cancer	I-T038
(	O
n	O
=	O
20	O
)	O
;	O
chronic	B-T038
pancreatitis	I-T038
(	O
n	O
=	O
39	O
)	O
;	O
and	O
normal	B-T033
pancreas	I-T033
(	O
n	O
=	O
35	O
)	O
.	O
the	O
micrornas	B-T103
were	O
analyzed	O
by	O
pcr	B-T062
using	O
the	O
fluid	B-T170
##igm	I-T170
platform	I-T170
.	O
twenty	O
-	O
two	O
micrornas	B-T103
were	O
significantly	O
differently	O
expressed	B-T038
in	O
patients	O
with	O
pancreatic	B-T038
cancer	I-T038
when	O
compared	O
to	O
healthy	O
controls	O
and	O
chronic	B-T038
pancreatitis	I-T038
patients	O
;	O
17	O
mirnas	B-T103
were	O
upregulated	B-T038
(	O
mir	B-T017
-	I-T017
21	I-T017
-	I-T017
5p	I-T017
,	O
-	O
23	B-T017
##a	I-T017
-	I-T017
3p	I-T017
,	O
-	O
31	B-T017
-	I-T017
5p	I-T017
,	O
-	O
34	B-T017
##c	I-T017
-	I-T017
5p	I-T017
,	O
-	O
93	B-T017
-	I-T017
3p	I-T017
,	O
-	O
135	B-T017
##b	I-T017
-	I-T017
3p	I-T017
,	O
-	O
155	B-T017
-	I-T017
5p	I-T017
,	O
-	O
186	B-T017
-	I-T017
5p	I-T017
,	O
-	O
196	B-T017
##b	I-T017
-	I-T017
5p	I-T017
,	I-T017
-	O
203	B-T017
,	O
-	O
205	B-T103
-	I-T103
5p	I-T103
,	O
-	O
210	B-T017
,	O
-	O
222	B-T017
-	I-T017
3p	I-T017
,	O
-	O
45	B-T017
##1	I-T017
,	O
-	O
49	B-T017
##2	I-T017
,	O
-	O
61	B-T017
##4	I-T017
,	O
and	O
mir	B-T017
-	I-T017
62	I-T017
##2	I-T017
)	O
and	O
5	O
were	O
downregulated	B-T038
(	O
mir	B-T017
-	I-T017
122	I-T017
-	I-T017
5p	I-T017
,	O
-	O
130	B-T017
##b	I-T017
-	I-T017
3p	I-T017
,	O
-	O
216	B-T017
##b	I-T017
,	O
-	O
217	B-T017
,	O
and	O
mir	B-T017
-	I-T017
375	I-T017
)	O
.	O
micrornas	B-T103
were	O
grouped	O
into	O
diagnostic	O
indices	O
of	O
varying	O
complexity	O
.	O
ten	O
micrornas	B-T103
associated	O
with	O
prognosis	B-T058
were	O
identified	O
(	O
let	B-T103
-	I-T103
7	I-T103
g	I-T103
,	O
mir	B-T017
-	I-T017
29	I-T017
##a	I-T017
-	I-T017
5p	I-T017
,	O
-	O
34	B-T017
##a	I-T017
-	I-T017
5p	I-T017
,	O
-	O
125	B-T017
##a	I-T017
-	I-T017
3p	I-T017
,	O
-	O
146	B-T017
##a	I-T017
-	I-T017
5p	I-T017
,	O
-	O
187	B-T017
,	O
-	O
205	B-T103
-	I-T103
5p	I-T103
,	O
-	O
212	B-T017
-	I-T017
3p	I-T017
,	O
-	O
222	B-T017
-	I-T017
5p	I-T017
,	O
and	O
mir	B-T017
-	I-T017
450	I-T017
##b	I-T017
-	I-T017
5p	I-T017
)	O
.	O
prognostic	O
indices	O
based	O
on	O
differences	O
in	O
expression	B-T038
of	O
2	O
different	O
micrornas	B-T103
were	O
constructed	O
for	O
pancreatic	B-T038
and	O
amp	B-T038
##ullary	I-T038
cancer	I-T038
combined	O
and	O
separately	O
(	O
30	O
,	O
5	O
,	O
and	O
21	O
indices	O
)	O
.	O
the	O
study	B-T062
confirms	O
that	O
pancreatic	B-T038
cancer	I-T038
tissue	B-T017
has	O
a	O
microrna	B-T103
expression	O
profile	O
that	O
is	O
different	O
from	O
that	O
of	O
other	O
peri	B-T038
##amp	I-T038
##ullary	I-T038
cancers	I-T038
,	O
chronic	B-T038
pancreatitis	I-T038
,	O
and	O
normal	B-T033
pancreas	I-T033
.	O
we	O
identified	O
prognostic	B-T170
micrornas	B-T103
and	O
microrna	B-T103
indices	O
that	O
were	O
associated	O
with	O
shorter	O
overall	O
survival	O
in	O
patients	O
with	O
radical	O
##ly	O
resected	B-T058
pancreatic	B-T038
cancer	I-T038
.	O

low	O
literacy	O
and	O
written	B-T170
drug	I-T170
information	I-T170
:	O
information	O
-	O
seeking	O
,	O
leaflet	B-T170
evaluation	O
and	O
preferences	O
,	O
and	O
roles	O
for	O
images	B-T170
background	O
low	B-T098
-	I-T098
liter	I-T098
##ate	I-T098
patients	O
are	O
at	O
risk	O
to	O
misinterpre	O
##t	O
written	B-T170
drug	I-T170
information	I-T170
.	O
for	O
the	O
(	O
co	O
-	O
)	O
design	O
of	O
targeted	O
patient	B-T170
information	I-T170
,	O
it	O
is	O
key	O
to	O
involve	O
this	O
group	B-T098
in	O
determining	O
their	O
communication	O
barriers	O
and	O
information	O
needs	O
.	O
objective	O
to	O
gain	O
insight	O
into	O
how	O
people	B-T098
with	O
low	O
literacy	O
use	O
and	O
evaluate	O
written	B-T170
drug	I-T170
information	I-T170
,	O
and	O
to	O
identify	O
ways	O
in	O
which	O
they	O
feel	O
the	O
patient	O
leaflet	B-T170
can	O
be	O
improved	O
,	O
and	O
in	O
particular	O
how	O
images	B-T170
could	O
be	O
used	O
.	O
setting	O
food	B-T092
banks	I-T092
and	O
an	O
education	B-T092
institution	I-T092
for	O
dutch	O
language	O
training	O
in	O
the	O
netherlands	B-T082
.	O
method	O
semi	O
-	O
structured	O
focus	O
groups	O
and	O
individual	B-T098
interviews	O
were	O
held	O
with	O
low	B-T098
-	I-T098
liter	I-T098
##ate	I-T098
participants	I-T098
(	O
n	O
=	O
45	O
)	O
.	O
the	O
thematic	O
framework	O
approach	O
was	O
used	O
for	O
analysis	O
to	O
identify	O
themes	O
in	O
the	O
data	O
.	O
main	O
outcome	O
measure	O
low	B-T098
-	I-T098
liter	I-T098
##ate	I-T098
people	I-T098
'	I-T098
s	I-T098
experience	O
with	O
patient	B-T170
information	I-T170
leaflets	B-T170
,	O
ideas	O
for	O
improvements	O
,	O
and	O
perceptions	B-T038
on	O
possible	O
uses	O
for	O
visual	O
##s	O
.	O
results	O
patient	B-T170
information	I-T170
leaflets	B-T170
were	O
considered	O
discour	O
##aging	O
to	O
use	O
,	O
and	O
information	O
difficult	O
to	O
find	O
and	O
understand	B-T038
.	O
many	O
rely	O
on	O
alternative	O
information	B-T033
sources	I-T033
.	O
the	O
leaflet	B-T170
should	O
be	O
shorter	O
,	O
and	O
improved	O
in	O
terms	O
of	O
organisation	O
,	O
leg	O
##ibility	O
and	O
read	O
##ability	O
.	O
participants	B-T098
thought	O
images	B-T170
could	O
increase	O
the	O
leaflet	B-T170
'	I-T170
s	I-T170
appeal	O
,	O
help	O
ask	O
questions	B-T170
,	O
provide	O
an	O
overview	O
,	O
help	O
understand	O
text	B-T170
##ual	I-T170
information	O
,	O
aid	O
recall	B-T038
,	O
reass	O
##ure	O
,	O
and	O
even	O
lead	O
to	O
increased	O
confidence	B-T038
,	O
empowerment	O
and	O
feeling	O
of	O
safety	O
.	O
conclusion	O
already	O
at	O
the	O
stages	O
of	O
pay	O
##ing	O
attention	O
to	O
the	O
leaflet	B-T170
and	O
maintaining	O
interest	O
in	O
the	O
message	O
,	O
low	B-T098
-	I-T098
liter	I-T098
##ate	I-T098
patients	I-T098
experience	B-T038
barriers	O
in	O
the	O
communication	O
process	O
through	O
written	B-T170
drug	I-T170
information	I-T170
.	O
short	O
,	O
structured	O
,	O
visual	O
/	O
text	B-T170
##ual	I-T170
explanations	B-T170
can	O
lower	O
the	O
motivational	O
threshold	O
to	O
use	O
the	O
leaflet	B-T170
,	O
improve	B-T033
understanding	B-T038
,	O
and	O
empower	O
the	O
low	B-T098
-	I-T098
liter	I-T098
##ate	I-T098
target	I-T098
group	I-T098
.	O

social	O
cognition	O
in	O
schizophrenia	B-T038
:	O
factor	O
structure	O
of	O
emotion	B-T038
processing	B-T038
and	O
theory	O
of	O
mind	O
factor	O
analytic	O
studies	O
examining	O
social	O
cognition	O
in	O
schizophrenia	B-T038
have	O
yielded	O
inconsistent	O
results	O
most	O
likely	O
due	O
to	O
the	O
varying	O
number	O
and	O
quality	O
of	O
measures	O
.	O
with	O
the	O
recent	O
conclusion	O
of	O
phase	O
3	O
of	O
the	O
social	O
cognition	O
psychometric	B-T058
evaluation	I-T058
(	I-T058
scope	I-T058
)	I-T058
study	I-T058
,	O
the	O
most	O
psychometric	B-T058
##ally	I-T058
sound	B-T058
measures	I-T058
of	O
social	O
cognition	O
have	O
been	O
identified	O
.	O
therefore	O
,	O
the	O
aims	O
of	O
the	O
present	O
study	B-T062
were	O
to	O
:	O
1	O
)	O
examine	B-T033
the	O
factor	O
structure	O
of	O
social	O
cognition	O
in	O
schizophrenia	B-T038
through	O
the	O
utilization	O
of	O
psychometric	B-T058
##ally	I-T058
sound	B-T058
measures	I-T058
,	O
2	O
)	O
examine	B-T033
the	O
stability	O
of	O
the	O
factor	O
structure	O
across	O
two	O
study	B-T062
visits	O
,	O
3	O
)	O
compare	O
the	O
factor	O
structure	O
of	O
social	O
cognition	O
in	O
schizophrenia	B-T038
to	O
that	O
in	O
healthy	O
controls	O
,	O
and	O
4	O
)	O
examine	B-T033
the	O
relationship	O
between	O
the	O
factors	O
and	O
relevant	O
outcome	O
measures	O
including	O
social	O
functioning	O
and	O
symptoms	B-T033
.	O
results	O
supported	O
a	O
one	B-T170
-	I-T170
factor	I-T170
model	I-T170
for	O
the	O
patient	O
and	O
healthy	O
control	O
samples	O
at	O
both	O
visits	B-T058
.	O
this	O
single	O
factor	O
was	O
significantly	O
associated	O
with	O
negative	B-T033
symptoms	I-T033
in	O
the	O
schizophrenia	B-T038
sample	O
and	O
with	O
social	O
functioning	O
in	O
both	O
groups	B-T098
at	O
both	O
study	B-T062
visits	B-T058
.	O

uveitis	B-T038
in	O
spondyl	B-T038
##oar	I-T038
##thritis	I-T038
patients	O
and	O
its	O
association	O
with	O
hla	B-T103
-	I-T103
b27	I-T103
histocompatibility	I-T103
antigen	I-T103
:	O
prospective	B-T062
study	I-T062
t	O
o	O
perform	O
a	O
prospective	B-T062
study	I-T062
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	B-T038
in	O
spondyl	B-T038
##oar	I-T038
##thritis	I-T038
(	O
spa	B-T038
)	O
patients	O
as	O
well	O
as	O
its	O
association	O
with	O
the	O
hla	B-T103
-	I-T103
b27	I-T103
histocompatibility	I-T103
antigen	I-T103
.	O
the	O
study	B-T062
included	O
219	O
patients	O
with	O
uveitis	B-T038
,	O
all	O
tested	O
for	O
hla	B-T103
-	I-T103
b27	I-T103
antigen	I-T103
and	O
various	O
infections	B-T038
(	O
viral	B-T038
,	O
bacterial	B-T038
,	O
and	O
parasitic	B-T038
)	O
as	O
well	O
as	O
examined	B-T033
for	O
loc	B-T022
##om	I-T022
##oti	I-T022
##ve	I-T022
system	I-T022
involvement	O
.	O
the	O
presence	B-T033
of	O
the	O
hla	B-T103
-	I-T103
b27	I-T103
antigen	I-T103
was	O
determined	O
in	O
142	O
(	O
64	O
.	O
8	O
%	O
)	O
out	O
of	O
219	O
patients	O
,	O
of	O
them	O
87	O
were	O
diagnosed	B-T033
with	O
an	O
entity	O
of	O
the	O
spa	B-T038
group	O
.	O
the	O
remaining	O
77	O
(	O
35	O
.	O
2	O
%	O
)	O
patients	O
appeared	O
to	O
be	O
hla	B-T103
-	I-T103
b27	I-T103
-	O
negative	B-T033
,	O
but	O
13	O
were	O
still	O
diagnosed	B-T033
with	O
an	O
entity	O
of	O
the	O
spa	B-T038
group	O
.	O
there	O
were	O
10	O
(	O
4	O
.	O
6	O
%	O
)	O
patients	O
with	O
2	O
or	O
more	O
diseases	B-T038
from	O
the	O
spa	B-T038
group	O
(	O
«	O
clinical	O
dec	O
##uss	O
##ation	O
»	O
)	O
.	O
when	O
comparing	O
the	O
two	O
groups	O
of	O
hla	O
-	O
b27	O
-	O
positive	O
and	O
negative	B-T033
patients	O
having	O
both	O
spa	B-T038
and	O
uveitis	B-T038
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	B-T082
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	B-T082
-	O
or	O
bilateral	B-T082
involvement	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
we	O
also	O
performed	O
a	O
comparison	O
of	O
hla	O
-	O
b27	O
-	O
positive	O
and	O
negative	B-T033
patients	O
with	O
no	O
account	O
to	O
their	O
spa	B-T038
status	O
and	O
revealed	O
a	O
higher	O
complication	B-T038
rate	O
in	O
those	O
that	O
were	O
«	O
negative	B-T033
»	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
hla	B-T103
-	I-T103
b27	I-T103
-	O
negative	B-T033
patients	O
often	O
have	O
autoimmune	B-T038
or	O
infectious	B-T038
uveitis	I-T038
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	B-T033
.	O
assessing	O
the	O
site	B-T082
and	O
course	O
of	O
uveitis	B-T038
as	O
well	O
as	O
hla	B-T103
-	I-T103
b27	I-T103
testing	O
of	O
uveitis	B-T038
patients	O
has	O
proved	O
important	O
for	O
etiological	O
diagnosis	B-T033
.	O
diseases	B-T038
of	O
the	O
spa	B-T038
group	O
have	O
been	O
shown	O
to	O
be	O
6	O
.	O
7	O
times	O
more	O
common	O
in	O
hla	O
-	O
b27	O
-	O
positive	O
patients	O
as	O
compared	O
to	O
hla	B-T103
-	I-T103
b27	I-T103
-	O
negative	B-T033
ones	O
.	O
clinical	O
presentation	O
of	O
uveitis	B-T038
in	O
the	O
presence	B-T033
of	O
spa	B-T038
in	O
both	O
hla	O
-	O
b27	O
-	O
positive	O
and	O
negative	B-T033
patients	O
resembles	O
that	O
of	O
idiopathic	B-T038
uveitis	I-T038
-	O
an	O
independent	O
hla	B-T103
-	I-T103
b27	I-T103
-	O
associated	O
syndrome	B-T038
(	O
р	O
>	O
0	O
.	O
05	O
)	O
.	O
cases	O
of	O
«	O
dec	O
##uss	O
##ation	O
»	O
between	O
entities	O
of	O
the	O
spa	B-T038
group	O
are	O
usually	O
more	O
severe	O
in	O
terms	O
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	B-T038
and	O
are	O
associated	O
with	O
a	O
worse	B-T033
prognosis	I-T033
.	O
complications	B-T038
of	O
uveitis	B-T038
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non	B-T033
-	I-T033
spa	I-T033
hla	B-T103
-	I-T103
b27	I-T103
-	O
negative	B-T033
patients	O
(	O
р	O
<	O
0	O
.	O
0001	O
)	O
.	O

iterative	B-T033
development	O
and	O
evaluation	B-T058
of	O
a	O
pharmac	B-T091
##ogen	I-T091
##omic	I-T091
-	O
guided	O
clinical	B-T170
decision	I-T170
support	I-T170
system	I-T170
for	O
warfarin	O
dosing	O
pharmac	B-T091
##ogen	I-T091
##omic	I-T091
-	O
guided	O
dosing	O
has	O
the	O
potential	O
to	O
improve	O
patient	O
outcomes	O
but	O
its	O
implementation	O
has	O
been	O
met	O
with	O
clinical	O
challenges	B-T058
.	O
our	O
objective	O
was	O
to	O
develop	O
and	O
evaluate	B-T058
a	O
clinical	B-T170
decision	I-T170
support	I-T170
system	I-T170
(	O
cds	B-T170
##s	I-T170
)	O
for	O
pharmac	B-T091
##ogen	I-T091
##omic	I-T091
-	O
guided	O
warfarin	O
dosing	O
designed	O
for	O
physicians	B-T097
and	O
pharmacists	B-T097
.	O
twelve	O
physicians	B-T097
and	O
pharmacists	B-T097
completed	O
6	O
prescribing	O
tasks	O
using	O
simulated	O
patient	O
scenarios	O
in	O
two	O
iter	B-T033
##ations	I-T033
(	O
development	O
and	O
validation	B-T062
phases	O
)	O
of	O
a	O
newly	O
developed	O
pharmac	B-T091
##ogen	I-T091
##omic	I-T091
-	O
driven	O
cds	B-T170
##s	I-T170
prototype	O
.	O
for	O
each	O
scenario	O
,	O
usability	O
was	O
measured	O
via	O
efficiency	O
,	O
recorded	B-T170
as	O
time	O
to	O
task	O
completion	O
,	O
and	O
participants	B-T098
'	O
perceived	B-T038
satisfaction	B-T038
which	O
were	O
compared	O
using	O
kruskal	B-T170
-	I-T170
wallis	I-T170
and	I-T170
mann	I-T170
whitney	I-T170
u	I-T170
tests	I-T170
,	O
respectively	O
.	O
debr	O
##ief	O
interviews	O
were	O
conducted	O
and	O
qualitatively	B-T058
analyzed	I-T058
.	O
usability	O
findings	O
from	O
the	O
first	O
(	O
i	O
.	O
e	O
.	O
development	O
)	O
iter	B-T033
##ation	I-T033
were	O
incorporated	O
into	O
the	O
cds	B-T170
##s	I-T170
design	O
for	O
the	O
second	O
(	O
i	O
.	O
e	O
.	O
validation	B-T062
)	O
iter	B-T033
##ation	I-T033
.	O
during	O
the	O
cds	B-T170
##s	I-T170
validation	B-T062
iter	B-T033
##ation	I-T033
,	O
participants	B-T098
took	O
more	O
time	O
to	O
complete	O
tasks	O
with	O
a	O
median	B-T082
(	O
iqr	O
)	O
of	O
183	O
(	O
124	O
-	O
247	O
)	O
seconds	O
versus	O
101	O
(	O
73	O
.	O
5	O
-	O
197	O
)	O
seconds	O
in	O
the	O
development	O
iter	B-T033
##ation	I-T033
(	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O
this	O
increase	O
in	O
time	O
on	O
task	O
was	O
due	O
to	O
the	O
increase	O
in	O
time	O
spent	O
in	O
the	O
cds	B-T170
##s	I-T170
corresponding	O
to	O
several	O
design	O
changes	O
.	O
efficiency	O
differences	O
that	O
were	O
observed	O
between	O
pharmacists	B-T097
and	O
physicians	B-T097
in	O
the	O
development	O
iter	B-T033
##ation	I-T033
were	O
eliminated	O
in	O
the	O
validation	B-T062
iter	B-T033
##ation	I-T033
.	O
the	O
increased	O
use	O
of	O
the	O
cds	B-T170
##s	I-T170
corresponded	O
to	O
a	O
greater	O
acceptance	O
of	O
cds	B-T170
##s	I-T170
recommended	O
doses	O
in	O
the	O
validation	B-T062
iter	B-T033
##ation	I-T033
(	O
4	O
%	O
in	O
the	O
first	O
iter	B-T033
##ation	I-T033
vs	O
.	O
37	O
.	O
5	O
%	O
in	O
the	O
second	O
iter	B-T033
##ation	I-T033
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
overall	O
satisfaction	B-T038
did	O
not	O
change	O
statistically	O
between	O
the	O
iter	B-T033
##ations	I-T033
but	O
the	O
qualitative	B-T058
analysis	I-T058
revealed	O
greater	O
trust	O
in	O
the	O
second	O
prototype	O
.	O
a	O
pharmac	B-T091
##ogen	I-T091
##omic	I-T091
-	O
guided	O
cds	B-T170
##s	I-T170
has	O
been	O
developed	O
using	O
warfarin	B-T103
as	O
the	O
test	O
drug	B-T103
.	O
the	O
final	O
cds	B-T170
##s	I-T170
prototype	O
was	O
trust	O
##ed	O
by	O
prescribe	O
##rs	O
and	O
significantly	O
increased	O
the	O
time	O
using	O
the	O
tool	O
and	O
acceptance	O
of	O
the	O
recommended	O
doses	O
.	O
this	O
study	O
is	O
an	O
important	O
step	O
toward	O
incorporating	O
pharmac	B-T091
##ogen	I-T091
##omics	I-T091
into	O
cds	B-T170
##s	I-T170
design	O
for	O
clinical	B-T062
testing	I-T062
.	O

interaction	O
-	O
driven	O
distinctive	O
electronic	B-T082
states	I-T082
of	O
artificial	B-T103
atoms	I-T103
at	O
the	O
zno	B-T103
interface	O
we	O
have	O
investigated	O
the	O
electronic	B-T082
states	I-T082
of	O
planar	O
quantum	O
dots	O
at	O
the	O
zno	B-T103
interface	O
containing	O
a	O
few	O
interacting	O
electrons	B-T103
in	O
an	O
externally	O
applied	O
magnetic	O
field	O
.	O
the	O
electron	B-T103
-	I-T103
electron	I-T103
interaction	O
effects	O
are	O
expected	O
to	O
be	O
much	O
stronger	O
in	O
this	O
case	O
than	O
in	O
traditional	O
semiconductor	O
quantum	O
systems	O
,	O
such	O
as	O
in	O
ga	B-T103
##as	I-T103
or	O
in	B-T103
##as	I-T103
quantum	O
dots	O
.	O
in	O
order	O
to	O
highlight	O
that	O
stronger	O
coul	O
##omb	O
effects	O
in	O
the	O
zno	B-T103
quantum	O
dots	O
,	O
we	O
have	O
compared	O
the	O
energy	O
spectra	O
and	O
the	O
magnetization	O
in	O
this	O
system	O
to	O
those	O
of	O
the	O
in	B-T103
##as	I-T103
quantum	O
dots	O
.	O
we	O
have	O
found	O
that	O
in	O
the	O
zno	B-T103
quantum	O
dots	O
the	O
signatures	O
of	O
stronger	O
coul	O
##omb	O
interaction	O
manifests	O
in	O
an	O
unique	O
ground	B-T082
state	I-T082
that	O
has	O
very	O
different	O
properties	O
than	O
the	O
corresponding	O
ones	O
in	O
the	O
in	B-T103
##as	I-T103
dot	O
.	O
our	O
results	O
for	O
the	O
magnetization	O
also	O
exhibits	O
behaviors	O
never	O
before	O
observed	O
in	O
a	O
quantum	O
dot	O
for	O
a	O
realistic	O
set	O
of	O
parameters	O
.	O
we	O
have	O
found	O
a	O
stronger	O
temperature	O
dependence	O
and	O
other	O
unexpected	O
features	O
,	O
such	O
as	O
paramagnetic	O
-	O
like	O
behavior	O
at	O
high	O
temperatures	O
for	O
a	O
quantum	O
-	O
dot	O
helium	B-T103
.	O

did	O
fid	B-T170
##eli	I-T170
##s	I-T170
projects	O
contribute	O
to	O
the	O
detection	B-T033
of	O
new	O
smear	O
-	O
positive	B-T033
pulmonary	B-T038
tuberculosis	I-T038
cases	O
in	O
china	B-T082
?	O
setting	O
:	O
the	O
first	B-T170
phase	I-T170
of	I-T170
the	I-T170
fund	I-T170
for	I-T170
innovative	I-T170
dots	I-T170
expansion	I-T170
through	I-T170
local	I-T170
initiatives	I-T170
to	I-T170
stop	I-T170
tb	I-T170
(	O
fid	B-T170
##eli	I-T170
##s	I-T170
)	O
projects	O
in	O
china	B-T082
started	O
in	O
2003	O
.	O
objective	O
:	O
to	O
determine	O
whether	O
the	O
fid	B-T170
##eli	I-T170
##s	I-T170
projects	O
contribute	O
d	O
to	O
the	O
increased	O
case	O
detection	B-T033
rate	O
for	O
new	O
smear	O
-	O
positive	B-T033
pulmonary	B-T038
tuberculosis	I-T038
(	O
ptb	B-T038
)	O
in	O
china	B-T082
.	O
methods	O
:	O
we	O
compared	O
the	O
case	O
notification	O
rates	O
(	O
cn	O
##rs	O
)	O
in	O
the	O
intervention	O
year	O
with	O
those	O
of	O
the	O
previous	O
year	O
in	O
the	O
fid	B-T170
##eli	I-T170
##s	I-T170
areas	B-T082
,	O
then	O
compared	O
the	O
difference	O
between	O
the	O
cn	O
##rs	O
of	O
the	O
intervention	O
year	O
and	O
the	O
previous	O
year	O
in	O
the	O
fid	B-T170
##eli	I-T170
##s	I-T170
areas	B-T082
with	O
those	O
in	O
the	O
non	B-T033
-	I-T033
fi	I-T033
-	I-T033
del	I-T033
##is	I-T033
areas	B-T082
within	O
the	O
province	B-T082
.	O
results	O
:	O
there	O
was	O
an	O
increase	O
in	O
the	O
cn	O
##r	O
in	O
the	O
intervention	O
year	O
compared	O
with	O
the	O
previous	O
year	O
for	O
all	O
the	O
project	O
sites	O
.	O
the	O
differences	O
between	O
the	O
cn	O
##r	O
in	O
the	O
intervention	O
year	O
and	O
the	O
previous	O
year	O
ranged	O
from	O
6	O
.	O
4	O
to	O
31	O
.	O
1	O
per	O
100	O
000	O
population	B-T098
in	O
the	O
fid	B-T170
##eli	I-T170
##s	I-T170
areas	B-T082
and	O
from	O
2	O
.	O
9	O
to	O
20	O
.	O
4	O
/	O
100	O
000	O
in	O
the	O
non	B-T033
-	I-T033
fid	I-T033
##eli	I-T033
##s	I-T033
areas	B-T082
.	O
differences	O
-	O
in	O
-	O
differences	O
analysis	B-T062
shows	O
that	O
the	O
differences	O
in	O
the	O
cn	O
##rs	O
in	O
the	O
fid	B-T170
##eli	I-T170
##s	I-T170
areas	B-T082
were	O
not	O
statistically	O
significantly	O
different	O
from	O
those	O
in	O
the	O
non	O
-	O
fid	B-T170
##eli	I-T170
##s	I-T170
areas	B-T082
(	O
p	O
=	O
0	O
.	O
39	O
##3	O
)	O
.	O
conclusion	O
:	O
the	O
fid	B-T170
##eli	I-T170
##s	I-T170
projects	O
may	O
have	O
contributed	O
to	O
the	O
increase	O
in	O
case	O
detection	B-T033
of	O
new	O
smear	O
-	O
positive	B-T033
ptb	B-T038
in	O
china	B-T082
,	O
but	O
the	O
level	O
of	O
evidence	O
is	O
low	O
.	O

generalized	B-T038
epilepsy	I-T038
and	O
myocl	B-T038
##onic	I-T038
seizures	I-T038
in	O
22	B-T038
##q11	I-T038
.	I-T038
2	I-T038
deletion	I-T038
syndrome	I-T038
prompted	O
by	O
the	O
observations	O
of	O
juvenile	B-T038
myocl	I-T038
##onic	I-T038
epilepsy	I-T038
(	O
jm	B-T038
##e	I-T038
)	O
in	O
22	B-T038
##q11	I-T038
.	I-T038
2	I-T038
deletion	I-T038
syndrome	I-T038
(	O
22	B-T038
##q11	I-T038
##ds	I-T038
)	O
and	O
recurrent	B-T082
copy	I-T082
number	I-T082
variants	I-T082
in	O
genetic	O
generalized	B-T038
epilepsy	I-T038
(	O
gg	B-T038
##e	I-T038
)	O
,	O
we	O
searched	O
for	O
further	O
evidence	O
supporting	O
a	O
possible	O
correlation	O
of	O
22	B-T038
##q11	I-T038
##ds	I-T038
with	O
gg	B-T038
##e	I-T038
and	O
with	O
myocl	B-T038
##onic	I-T038
seizures	I-T038
.	O
through	O
routine	B-T058
diagnostics	I-T058
,	O
we	O
identified	O
3	O
novel	O
individuals	B-T098
with	O
the	O
seemingly	O
uncommon	O
combination	O
of	O
22	B-T038
##q11	I-T038
##ds	I-T038
and	O
jm	B-T038
##e	I-T038
.	O
we	O
subsequently	O
screened	B-T058
the	O
literature	B-T170
for	O
reports	B-T170
focuss	O
##ing	O
on	O
the	O
epilepsy	O
phenotype	O
in	O
22	B-T038
##q11	I-T038
##ds	I-T038
.	O
we	O
additionally	O
screened	B-T058
a	O
database	B-T170
of	O
173	O
22	B-T038
##q11	I-T038
##ds	I-T038
patients	O
and	O
identified	O
a	O
fourth	O
individual	B-T098
with	O
jm	B-T038
##e	I-T038
as	O
well	O
as	O
2	O
additional	O
cases	O
with	O
gg	B-T038
##e	I-T038
.	O
we	O
describe	O
6	O
novel	O
and	O
22	O
published	O
cases	O
with	O
co	B-T033
-	I-T033
occurrence	I-T033
of	O
22	B-T038
##q11	I-T038
##ds	I-T038
and	O
gg	B-T038
##e	I-T038
.	O
in	O
many	O
patients	O
,	O
gg	B-T038
##e	I-T038
was	O
associated	O
with	O
myocl	B-T038
##onic	I-T038
seizures	I-T038
allowing	O
for	O
a	O
diagnosis	B-T033
of	O
jm	B-T038
##e	I-T038
in	O
at	O
least	O
6	O
individuals	B-T098
.	O
seventeen	O
of	O
the	O
173	O
22	B-T038
##q11	I-T038
##ds	I-T038
cases	O
(	O
10	O
%	O
)	O
had	O
a	O
diagnosis	B-T033
of	O
either	O
focal	B-T038
or	O
generalized	B-T038
epilepsy	I-T038
.	O
in	O
these	O
cases	O
,	O
focal	B-T038
epilepsy	I-T038
could	O
often	O
be	O
attributed	O
to	O
syndrome	B-T038
-	I-T038
associated	I-T038
hypocalc	I-T038
##aemia	I-T038
,	O
cerebral	B-T033
ble	I-T033
##eds	I-T033
,	O
or	O
structural	B-T033
brain	I-T033
anomalies	I-T033
.	O
however	O
,	O
the	O
cause	O
of	O
gg	B-T038
##e	I-T038
remained	O
unclear	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
describe	O
and	O
review	O
28	O
individuals	B-T098
with	O
22	B-T038
##q11	I-T038
##ds	I-T038
and	O
gg	B-T038
##e	I-T038
(	O
especially	O
jm	B-T038
##e	I-T038
)	O
,	O
showing	O
that	O
both	O
disorders	B-T038
frequently	B-T033
co	I-T033
-	I-T033
occur	I-T033
.	O
compared	O
to	O
the	O
reported	O
prevalence	O
of	O
15	O
-	O
21	O
%	O
,	O
in	O
our	O
case	B-T062
series	I-T062
only	O
10	O
%	O
of	O
22	B-T038
##q11	I-T038
##ds	I-T038
individuals	B-T098
were	O
found	O
to	O
have	O
epilepsy	B-T038
,	O
often	O
gg	B-T038
##e	I-T038
.	O
since	O
22	B-T017
##q11	I-T017
.	I-T017
2	I-T017
does	O
not	O
contain	O
convincing	O
gg	B-T038
##e	I-T038
candidate	B-T017
genes	I-T017
,	O
we	O
discuss	O
the	O
possibility	O
of	O
an	O
aetiological	O
correlation	O
through	O
a	O
possibly	O
disturbed	O
interaction	O
with	O
the	O
gaba	B-T103
##b	I-T103
receptor	I-T103
.	O

the	O
discovery	O
of	O
potent	O
and	O
selective	O
kyn	B-T103
##uren	I-T103
##ine	I-T103
3	I-T103
-	I-T103
monooxygenase	I-T103
inhibitors	B-T103
for	O
the	O
treatment	B-T058
of	O
acute	B-T038
pancreatitis	I-T038
a	O
series	O
of	O
potent	O
,	O
competitive	O
and	O
highly	O
selective	O
kyn	B-T103
##uren	I-T103
##ine	I-T103
monooxygenase	I-T103
inhibitors	B-T103
have	O
been	O
discovered	O
via	O
a	O
substrate	O
-	O
based	O
approach	B-T082
for	O
the	O
treatment	B-T058
of	O
acute	B-T038
pancreatitis	I-T038
.	O
the	O
lead	O
compound	B-T103
demonstrated	O
good	O
cellular	B-T017
potency	O
and	O
clear	O
pharmacodynamic	B-T038
activity	O
in	B-T082
vivo	I-T082
.	O

primary	B-T038
neuroendocrine	I-T038
carcinoma	I-T038
of	O
the	O
breast	B-T017
a	O
single	B-T038
center	I-T038
experience	I-T038
and	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
neuroendocrine	B-T038
carcinoma	I-T038
of	O
the	O
breast	B-T017
is	O
an	O
extremely	O
rare	O
tumor	B-T038
.	O
a	O
standard	O
treatment	B-T058
has	O
yet	O
to	O
be	O
established	O
because	O
only	O
a	O
few	O
cases	O
have	O
been	O
reported	O
in	O
literature	B-T170
.	O
the	O
authors	B-T097
report	O
five	O
cases	O
observed	O
from	O
january	O
2007	O
to	O
december	O
2014	O
and	O
a	O
review	B-T170
of	I-T170
literature	I-T170
.	O
four	O
patients	O
underwent	O
quadrant	B-T058
##ectomy	I-T058
and	O
in	O
two	O
cases	O
axillary	B-T058
nodal	I-T058
dissection	I-T058
and	O
only	O
one	O
to	O
mastectomy	B-T058
with	O
axillary	B-T058
nodal	I-T058
dissection	I-T058
.	O
tumor	B-T082
size	I-T082
was	O
from	O
t1	B-T033
to	O
t2	B-T033
with	O
n0	B-T033
to	O
n1	B-T033
,	O
according	O
tnm	B-T170
classification	I-T170
.	O
pathological	B-T031
specimens	I-T031
were	O
stained	O
with	O
hematoxylin	B-T103
and	O
eosin	B-T103
and	O
an	O
immunohistochemical	O
panel	O
of	O
antibodies	B-T103
(	O
neuron	B-T103
-	I-T103
specific	I-T103
enolase	I-T103
,	O
chrom	B-T103
##ogranin	I-T103
,	O
synapt	B-T103
##ophys	I-T103
##in	I-T103
,	O
estrogen	O
and	O
progesterone	O
receptors	O
,	O
c	B-T103
-	I-T103
erb	I-T103
and	O
ki	B-T103
-	I-T103
67	I-T103
)	O
.	O
all	O
cases	O
showed	O
markers	O
positivity	O
to	O
neuron	B-T103
-	I-T103
specific	I-T103
enolase	I-T103
,	O
chrom	B-T103
##ogranin	I-T103
,	O
synapt	B-T103
##ophys	I-T103
##in	I-T103
and	O
estrogen	O
and	O
progesterone	O
receptors	O
were	O
found	O
.	O
ki	B-T103
-	I-T103
67	I-T103
was	O
higher	O
than	O
40	O
%	O
in	O
four	O
patients	O
.	O
adjuvant	B-T058
chemotherapy	I-T058
was	O
administrated	B-T058
in	O
patients	O
with	O
ki	B-T103
-	I-T103
67	I-T103
>	O
10	O
%	O
;	O
every	O
patients	O
were	O
treated	O
with	O
radiotherapy	B-T058
and	O
with	O
hormonal	B-T058
therapy	I-T058
too	O
.	O
although	O
neuroendocrine	B-T038
breast	I-T038
tumor	I-T038
is	O
considered	O
a	O
distinct	O
entity	O
,	O
the	O
best	O
treatment	B-T058
seems	O
to	O
be	O
correlate	O
to	O
the	O
size	B-T082
of	I-T082
tumor	I-T082
and	O
to	O
the	O
lymph	B-T017
node	I-T017
status	O
and	O
to	O
ki	B-T103
-	I-T103
67	I-T103
index	B-T170
like	O
the	O
common	O
breast	B-T038
cancer	I-T038
.	O
diagnosis	B-T033
,	O
neuroendocrine	B-T038
breast	I-T038
carcinoma	I-T038
.	O

a	O
role	O
for	O
the	O
locus	B-T017
co	I-T017
##eruleus	I-T017
in	O
the	O
analgesic	B-T033
efficacy	I-T033
of	O
n	B-T103
-	I-T103
acetyl	I-T103
##asp	I-T103
##art	I-T103
##yl	I-T103
##glut	I-T103
##amate	I-T103
peptidase	I-T103
(	O
gc	B-T103
##pi	I-T103
##i	I-T103
)	O
inhibitors	B-T103
z	B-T103
##j	I-T103
##43	I-T103
and	O
2	B-T103
-	I-T103
pmp	I-T103
##a	I-T103
n	B-T103
-	I-T103
acetyl	I-T103
##asp	I-T103
##art	I-T103
##yl	I-T103
##glut	I-T103
##amate	I-T103
(	O
naa	B-T103
##g	I-T103
)	O
is	O
the	O
third	O
most	O
prevalent	O
and	O
widely	O
distributed	O
neurotransmitter	B-T103
in	O
the	O
mammalian	B-T204
nervous	B-T022
system	I-T022
.	O
naa	B-T103
##g	I-T103
activates	O
a	O
group	B-T103
ii	I-T103
metabotropic	I-T103
glutamate	I-T103
receptor	I-T103
(	O
mglur	B-T103
##3	I-T103
)	O
and	O
is	O
inactivated	O
by	O
an	O
extracellular	B-T103
enzyme	I-T103
,	I-T103
glutamate	I-T103
carboxyp	I-T103
##eptidase	I-T103
ii	I-T103
(	O
gc	B-T103
##pi	I-T103
##i	I-T103
)	O
in	B-T082
vivo	I-T082
.	O
inhibitors	B-T103
of	I-T103
this	I-T103
enzyme	I-T103
are	O
analgesic	B-T103
in	O
animal	B-T204
models	I-T204
of	O
inflammatory	B-T033
,	O
neuropathic	B-T033
and	O
bone	B-T038
cancer	I-T038
pain	B-T033
.	O
naa	B-T103
##g	I-T103
and	O
gc	B-T103
##pi	I-T103
##i	I-T103
are	O
present	O
in	O
the	O
locus	B-T017
co	I-T017
##eruleus	I-T017
,	O
a	O
center	O
for	O
the	O
descending	O
noradrenergic	O
inhibitory	O
pain	O
system	O
.	O
in	O
the	O
formalin	B-T103
foot	B-T017
##pa	I-T017
##d	I-T017
model	B-T038
,	O
systemic	O
treatment	O
with	O
gc	B-T103
##pi	I-T103
##i	I-T103
inhibitors	I-T103
reduces	O
both	O
phases	O
of	O
the	O
inflammatory	B-T033
pain	I-T033
response	O
and	O
increases	O
release	O
of	O
spinal	B-T082
noradrenaline	B-T103
.	O
this	O
analgesic	B-T033
efficacy	I-T033
is	O
blocked	O
by	O
systemic	O
injection	B-T058
of	O
a	O
group	B-T103
ii	I-T103
mglur	I-T103
antagonist	B-T103
,	O
by	O
intrathecal	B-T058
(	I-T058
spinal	I-T058
)	I-T058
injection	I-T058
of	O
an	O
alpha	B-T103
2	I-T103
adrenergic	I-T103
receptor	I-T103
antagonist	I-T103
and	O
by	O
microinjection	B-T058
of	O
an	O
α	B-T103
-	I-T103
amino	I-T103
-	I-T103
3	I-T103
-	I-T103
hydroxy	I-T103
-	I-T103
5	I-T103
-	I-T103
methyl	I-T103
##iso	I-T103
##xa	I-T103
##zo	I-T103
##le	I-T103
-	I-T103
4	I-T103
-	I-T103
propionic	I-T103
acid	I-T103
(	I-T103
ampa	I-T103
)	I-T103
receptor	I-T103
antagonist	I-T103
directly	O
into	O
the	O
contralateral	B-T082
locus	B-T017
co	I-T017
##eruleus	I-T017
.	O
foot	B-T017
##pa	I-T017
##d	I-T017
inflammation	B-T038
increases	O
release	O
of	O
glutamate	B-T103
in	O
the	O
contralateral	B-T082
locus	B-T017
co	I-T017
##erule	I-T017
##u	I-T017
s	O
and	O
systemic	O
treatment	O
with	O
a	O
gc	B-T103
##pi	I-T103
##i	I-T103
inhibitor	I-T103
blocks	O
this	O
increase	O
.	O
direct	O
injection	B-T058
of	O
gc	B-T103
##pi	I-T103
##i	I-T103
inhibitors	I-T103
into	O
the	O
contralateral	B-T082
or	O
ips	B-T082
##ila	I-T082
##tera	I-T082
l	O
locus	B-T017
co	I-T017
##eruleus	I-T017
reduces	O
both	O
phases	O
of	O
the	O
inflammatory	B-T033
pain	I-T033
response	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
and	O
the	O
contralateral	B-T082
effect	O
also	O
is	O
blocked	O
by	O
intrathecal	B-T058
injection	I-T058
of	O
an	O
alpha	B-T103
2	I-T103
adrenergic	I-T103
receptor	I-T103
antagonist	I-T103
.	O
these	O
data	O
support	O
the	O
hypothesis	O
that	O
the	O
analgesic	B-T033
efficacy	I-T033
of	O
systemically	O
administered	O
gc	B-T103
##pi	I-T103
##i	I-T103
inhibitors	I-T103
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
the	O
contral	B-T082
##ater	I-T082
##a	I-T082
l	O
locus	B-T017
co	I-T017
##eruleus	I-T017
via	O
group	B-T103
ii	I-T103
mglur	I-T103
,	O
ampa	B-T103
and	O
alpha	B-T103
2	I-T103
adrenergic	I-T103
receptors	I-T103
.	O

perspectives	O
on	O
cardiovascular	B-T022
effects	O
of	O
incre	B-T103
##tin	I-T103
-	O
based	O
drugs	B-T103
:	O
from	O
bedside	O
to	O
bench	O
,	O
return	O
trip	O
recently	O
,	O
cardiovascular	B-T022
outcome	O
trials	B-T062
with	O
glucose	B-T103
-	O
lowering	O
drugs	B-T103
used	O
in	O
type	B-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
,	O
namely	O
glucagon	B-T103
-	I-T103
like	I-T103
peptide	I-T103
-	I-T103
1	I-T103
receptor	I-T103
agonists	B-T103
(	O
glp	B-T103
-	I-T103
1ra	I-T103
)	O
,	O
lir	B-T103
##aglu	I-T103
##tide	I-T103
and	O
sem	B-T103
##aglu	I-T103
##tide	I-T103
,	O
showed	O
a	O
reduction	O
in	O
cardiovascular	B-T033
events	I-T033
,	O
which	O
had	O
not	O
been	O
observed	O
in	O
trials	B-T062
with	O
other	O
incre	B-T103
##tin	I-T103
-	O
based	O
drugs	B-T103
,	O
such	O
as	O
li	B-T103
##x	I-T103
##isen	I-T103
##atide	I-T103
or	O
with	O
dip	B-T103
##eptidyl	I-T103
peptidase	I-T103
-	I-T103
4	I-T103
inhibitors	I-T103
(	O
dpp	B-T103
##4	I-T103
##i	I-T103
)	O
.	O
mechanisms	O
underlying	O
the	O
observed	O
cardiovascular	B-T022
differences	O
between	O
dpp	B-T103
##4	I-T103
##i	I-T103
and	O
glp	B-T103
##1	I-T103
-	I-T103
ra	I-T103
,	O
and	O
across	O
individual	O
glp	B-T103
##1	I-T103
-	I-T103
ra	I-T103
are	O
poorly	O
understood	O
.	O
this	O
review	B-T170
is	O
aimed	O
at	O
collecting	O
and	O
summar	O
##izing	O
available	O
evidence	O
from	O
experimental	B-T062
and	O
mechanistic	B-T062
studies	I-T062
on	O
the	O
action	O
of	O
glp	B-T103
##1	I-T103
-	I-T103
ra	I-T103
and	O
dpp	B-T103
##4	I-T103
##i	I-T103
on	O
the	O
cardiovascular	B-T022
system	I-T022
,	O
both	O
deriving	O
from	O
clinical	O
and	O
pre	O
-	O
clinical	O
sources	O
.	O
the	O
results	O
of	O
cardiovascular	B-T022
outcome	O
trials	B-T062
are	O
interpreted	O
on	O
the	O
basis	O
of	O
the	O
experimental	B-T062
preclinical	B-T170
data	I-T170
available	O
,	O
pay	O
##ing	O
particular	O
attention	O
to	O
the	O
heart	B-T038
failure	I-T038
results	O
,	O
and	O
suggesting	O
some	O
novel	O
intriguing	O
hypotheses	O
to	O
explain	O
some	O
of	O
the	O
unexpected	O
findings	O
of	O
cardio	O
##pro	O
##te	O
##ct	O
##ion	O
of	O
incre	B-T103
##tin	I-T103
-	O
based	O
drugs	B-T103
.	O
in	O
particular	O
,	O
we	O
discuss	O
the	O
possible	O
contribution	O
to	O
the	O
incre	B-T103
##tin	I-T103
cardiovascular	B-T022
effects	O
of	O
a	O
direct	O
cardiac	B-T017
action	O
of	O
glp	B-T103
-	I-T103
1	I-T103
metabolites	B-T103
through	O
glp	B-T103
-	I-T103
1	I-T103
receptor	I-T103
-	O
independent	O
pathways	B-T038
,	O
and	O
of	O
dpp	B-T103
##4	I-T103
substrates	O
other	O
than	O
glp	B-T103
-	I-T103
1	I-T103
.	O

photosensitizer	B-T103
decorated	O
red	B-T017
blood	I-T017
cells	I-T017
as	O
an	O
ultra	B-T074
-	I-T074
sensitive	I-T074
light	I-T074
-	I-T074
responsive	I-T074
drug	I-T074
delivery	I-T074
system	I-T074
red	B-T017
blood	I-T017
cells	I-T017
(	O
rbcs	B-T017
)	O
,	O
the	O
most	O
abundant	O
type	O
of	O
cells	B-T017
in	O
our	O
blood	B-T031
,	O
have	O
shown	O
promises	O
as	O
a	O
natural	O
drug	O
delivery	O
system	O
(	O
dd	O
##s	O
)	O
with	O
inherent	O
biocompatibility	O
.	O
herein	O
,	O
we	O
uncover	O
that	O
a	O
photosensitizer	B-T103
,	O
chlor	B-T103
##in	I-T103
e6	I-T103
(	O
ce	B-T103
##6	I-T103
)	O
,	O
could	O
be	O
decorated	O
into	O
the	O
membrane	B-T017
of	O
rbcs	B-T017
upon	O
simple	O
mixing	O
,	O
without	O
affecting	O
the	O
membrane	B-T017
integrity	O
and	O
stability	O
in	O
dark	O
.	O
upon	O
light	O
irradiation	O
with	O
a	O
rather	O
low	O
power	O
density	O
,	O
the	O
generated	O
singlet	B-T103
oxygen	I-T103
by	O
ce	B-T103
##6	I-T103
as	O
the	O
result	O
of	O
photodynamic	O
effect	O
would	O
lead	O
to	O
rather	O
efficient	O
disruption	O
of	O
rbc	B-T017
membrane	B-T017
.	O
with	O
doxorubicin	B-T103
(	O
dox	B-T103
)	O
,	O
a	O
typical	O
chemotherapy	B-T058
drug	B-T103
,	O
as	O
the	O
model	B-T170
,	O
we	O
engine	O
##er	O
a	O
unique	O
type	O
of	O
light	B-T074
-	I-T074
responsive	I-T074
rbc	I-T074
-	I-T074
based	I-T074
dd	I-T074
##s	I-T074
by	O
dec	O
##orating	O
ce	B-T103
##6	I-T103
on	O
the	O
cell	B-T017
membrane	I-T017
and	O
loading	O
dox	B-T103
inside	O
cells	B-T017
.	O
the	O
light	O
triggered	O
cell	B-T017
membrane	I-T017
break	O
down	O
would	O
thus	O
trigger	O
instant	O
release	O
of	O
dox	B-T103
,	O
enabling	O
light	B-T058
-	I-T058
controlled	I-T058
chemotherapy	I-T058
with	O
great	O
specificity	O
.	O
beyond	O
that	O
,	O
our	O
rbc	B-T017
system	O
could	O
also	O
be	O
utilized	O
for	O
loading	O
of	O
larger	O
biomolecules	O
such	O
as	O
enzymes	B-T103
,	O
whose	O
release	O
as	O
well	O
as	O
catalytic	O
function	O
is	O
also	O
controlled	O
by	O
light	O
.	O
our	O
work	O
thus	O
presents	O
a	O
unique	O
type	O
of	O
biocompatible	B-T074
cell	I-T074
-	I-T074
based	I-T074
dd	I-T074
##s	I-T074
that	O
can	O
be	O
precisely	O
controlled	O
by	O
mild	O
external	O
stimuli	O
,	O
promising	O
not	O
only	O
for	O
cancer	B-T058
therapy	I-T058
but	O
also	O
for	O
other	O
potential	O
applications	O
in	O
biotechn	B-T091
##ologies	I-T091
.	O

tracking	O
children	O
with	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
who	O
abandoned	O
therapy	B-T058
:	O
experience	B-T038
,	O
challenges	B-T058
,	O
parental	O
perspectives	B-T082
,	O
and	O
impact	O
of	O
treatment	B-T058
subsid	B-T058
##ies	I-T058
and	O
intensified	B-T058
counseling	I-T058
refusal	O
for	O
treatment	O
and	O
therapy	B-T058
aband	B-T033
##on	I-T033
##ment	I-T033
are	O
important	O
reasons	O
for	O
unfavorable	O
outcome	O
of	O
childhood	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
(	O
all	B-T038
)	O
in	O
resource	O
-	O
poor	O
countries	B-T082
.	O
the	O
present	O
study	B-T062
,	O
conducted	O
on	O
children	O
with	O
all	B-T038
whose	O
treatment	B-T058
was	O
abandoned	O
,	O
attempted	O
to	O
track	O
all	O
these	O
children	O
to	O
ascertain	O
the	O
causes	O
and	O
outcome	O
of	O
therapy	B-T058
aband	B-T033
##on	I-T033
##ment	I-T033
/	O
refusal	O
.	O
in	O
order	O
to	O
improve	O
outcome	O
of	O
all	B-T038
,	O
measures	O
to	O
prevent	O
aband	B-T033
##on	I-T033
##ment	I-T033
were	O
introduced	O
in	O
the	O
form	O
of	O
treatment	B-T058
subsid	B-T058
##ies	I-T058
and	O
intensified	B-T058
multistage	I-T058
counseling	I-T058
.	O
of	O
the	O
77	O
(	O
of	O
41	O
##8	O
)	O
children	O
aband	O
##oning	O
therapy	B-T058
,	O
17	O
(	O
22	O
%	O
)	O
refused	O
up	O
##front	O
,	O
whereas	O
the	O
rest	O
abandoned	O
during	O
various	O
phases	O
of	O
chemotherapy	B-T058
.	O
only	O
39	O
(	O
50	O
.	O
6	O
%	O
)	O
of	O
these	O
77	O
families	O
could	O
be	O
subsequently	O
contacted	O
.	O
financial	B-T033
problems	I-T033
,	O
too	O
many	O
dependent	B-T098
##s	I-T098
at	O
home	B-T082
,	O
and	O
wrong	O
perceptions	B-T038
about	O
cancer	B-T038
led	O
to	O
aband	B-T033
##on	I-T033
##ment	I-T033
in	O
majority	O
.	O
children	B-T033
aband	I-T033
##oning	I-T033
treatment	I-T033
before	O
completion	O
of	O
induction	B-T058
had	O
a	O
significantly	O
shorter	O
survival	O
than	O
who	O
abandoned	O
post	O
induction	O
(	O
p	O
<	O
.	O
0001	O
)	O
.	O
intensified	B-T058
pre	I-T058
##aban	I-T058
##d	I-T058
##on	I-T058
##ment	I-T058
counseling	I-T058
and	O
subsid	O
##ized	O
treatment	B-T058
led	O
to	O
significant	O
reduction	O
in	O
aband	O
##on	O
##ment	O
rates	O
(	O
p	O
<	O
.	O
0001	O
)	O
.	O

the	O
link	O
between	O
self	B-T038
-	I-T038
perceptions	I-T038
of	O
aging	B-T038
,	O
cancer	B-T038
view	O
and	O
physical	O
and	O
mental	B-T038
health	I-T038
of	O
older	O
people	O
with	O
cancer	B-T038
:	O
a	B-T062
cross	I-T062
-	I-T062
sectional	I-T062
study	I-T062
older	O
people	O
may	O
suffer	O
from	O
stigma	B-T038
##s	I-T038
linked	O
to	O
cancer	B-T038
and	O
aging	B-T038
.	O
although	O
some	O
studies	B-T062
suggested	O
that	O
a	O
negative	B-T033
view	B-T082
of	O
cancer	B-T038
may	O
increase	O
the	O
level	B-T033
of	I-T033
depression	I-T033
,	O
such	O
an	O
association	O
has	O
never	O
been	O
studied	B-T062
in	O
the	O
elderly	B-T098
population	I-T098
.	O
similarly	O
,	O
even	O
though	O
it	O
is	O
established	O
that	O
a	O
negative	B-T033
self	B-T038
-	I-T038
perception	I-T038
of	O
aging	B-T038
has	O
deleterious	O
consequences	O
on	O
mental	B-T038
and	O
physical	O
health	O
in	O
normal	O
aging	B-T038
,	O
the	O
influence	O
in	O
pathological	O
contexts	O
,	O
such	O
as	O
oncology	B-T038
,	O
has	O
not	O
been	O
studied	O
.	O
the	O
main	O
aim	O
of	O
this	O
study	O
is	O
thus	O
to	O
analyze	B-T062
the	O
effect	O
of	O
these	O
two	O
stigma	B-T038
##s	I-T038
on	O
the	O
health	O
of	O
elderly	B-T098
oncology	B-T038
patients	O
.	O
101	O
patients	O
suffering	O
from	O
a	O
cancer	B-T038
(	O
breast	B-T038
,	O
gynecological	B-T038
,	O
lung	B-T038
or	O
hematological	B-T038
)	O
were	O
seen	O
as	O
soon	O
as	O
possible	O
after	O
their	O
diagnosis	B-T033
.	O
their	O
self	B-T038
-	I-T038
perception	I-T038
of	O
age	O
,	O
cancer	B-T038
view	O
and	O
health	O
(	O
physical	O
and	O
mental	B-T038
)	O
was	O
assessed	O
.	O
multiple	O
regressions	B-T038
showed	O
that	O
patients	O
with	O
a	O
more	O
negative	B-T033
self	B-T038
-	I-T038
perception	I-T038
of	O
aging	B-T038
and	O
/	O
or	O
more	O
negative	B-T033
cancer	B-T038
view	O
reported	O
poorer	O
global	B-T091
health	I-T091
.	O
we	O
also	O
observed	O
that	O
negative	B-T033
self	B-T038
-	I-T038
perception	I-T038
of	O
aging	B-T038
was	O
associated	O
with	O
worse	O
physical	O
and	O
mental	B-T038
health	I-T038
,	O
whereas	O
negative	B-T033
cancer	B-T038
views	O
were	O
only	O
linked	O
to	O
worse	O
mental	B-T038
health	I-T038
.	O
no	O
interaction	O
was	O
observed	O
between	O
these	O
two	O
stigma	B-T038
##s	I-T038
,	O
suggesting	O
that	O
their	O
action	O
is	O
independent	O
.	O
older	O
patients	O
with	O
cancer	B-T038
face	O
double	O
stigma	O
##ti	O
##zation	O
,	O
due	O
to	O
negative	B-T033
self	B-T038
-	I-T038
perception	I-T038
of	O
aging	B-T038
and	O
cancer	B-T038
,	O
and	O
these	O
stigma	B-T038
##s	I-T038
have	O
impacts	O
on	O
global	O
and	O
mental	B-T038
health	I-T038
.	O
self	B-T038
-	I-T038
perception	I-T038
of	O
aging	B-T038
is	O
also	O
linked	O
to	O
physical	O
health	O
.	O
longitudinal	B-T062
studies	I-T062
will	O
be	O
necessary	O
to	O
analyze	B-T062
the	O
direction	O
of	O
the	O
association	O
between	O
this	O
double	O
stigma	O
##ti	O
##zation	O
and	O
health	O
.	O

pathophysiology	O
,	O
treatment	B-T058
and	O
prevention	B-T058
of	O
ovarian	B-T038
hypers	I-T038
##timulation	I-T038
syndrome	I-T038
severe	O
ovarian	B-T038
hypers	I-T038
##timulation	I-T038
syndrome	I-T038
(	O
oh	B-T038
##ss	I-T038
)	O
is	O
an	O
iatrogenic	O
condition	O
that	O
affects	O
1	O
%	O
of	O
women	B-T098
that	O
undergo	O
treatment	B-T058
with	O
assisted	B-T058
reproductive	I-T058
technology	I-T058
.	O
the	O
review	B-T170
aims	O
to	O
summarize	B-T170
recent	O
evidence	O
on	O
pathophysiology	O
,	O
treatment	B-T058
,	O
and	O
prevention	B-T058
of	O
oh	B-T038
##ss	I-T038
.	O
the	O
pathophysiology	O
is	O
still	O
not	O
completely	O
understood	B-T038
;	O
however	O
,	O
vascular	B-T103
endothelial	I-T103
growth	I-T103
factor	I-T103
is	O
likely	O
to	O
be	O
an	O
important	O
mediator	O
.	O
human	B-T103
chorionic	I-T103
gonadotropin	I-T103
was	O
previously	O
thought	B-T038
to	O
be	O
necessary	O
for	O
oh	B-T038
##ss	I-T038
to	O
occur	O
;	O
however	O
,	O
recent	B-T170
case	I-T170
reports	I-T170
have	O
proven	O
otherwise	O
.	O
the	O
contribution	O
of	O
an	O
attenuated	O
anti	B-T103
-	I-T103
mullerian	I-T103
hormone	I-T103
signalling	B-T038
pathway	I-T038
and	O
cd11c	B-T103
+	O
hla	B-T103
-	I-T103
dr	I-T103
+	O
dendritic	B-T017
cells	I-T017
and	O
associated	O
interleukin	B-T103
##s	I-T103
has	O
been	O
explored	O
recently	O
as	O
contributors	O
to	O
pathogenesis	B-T038
.	O
treatment	B-T058
is	O
largely	O
supportive	B-T058
and	O
is	O
based	O
mainly	O
on	O
consensus	O
statements	O
rather	O
than	O
evidence	O
.	O
therefore	O
,	O
it	O
is	O
important	O
to	O
prevent	O
this	O
condition	O
by	O
identifying	B-T058
women	B-T098
at	O
risk	O
,	O
allowing	O
the	O
clinician	B-T097
to	O
implement	O
preventive	O
strategies	O
,	O
including	O
the	O
use	O
of	O
gnrh	B-T103
antagonist	I-T103
cycles	O
with	O
agonist	B-T103
triggers	O
.	O
more	O
research	B-T062
is	O
required	O
to	O
elucidate	O
the	O
pathophysiology	O
behind	O
the	O
condition	O
.	O
clinicians	B-T097
should	O
employ	O
strategies	O
to	O
prevent	O
oh	B-T038
##ss	I-T038
.	O

risk	B-T033
factors	I-T033
of	O
neurological	B-T033
deterioration	I-T033
in	O
patients	O
with	O
cerebral	B-T038
infarction	I-T038
due	O
to	O
large	B-T038
-	I-T038
artery	I-T038
atherosclerosis	I-T038
in	O
some	O
patients	O
with	O
acute	O
ischemic	B-T038
stroke	I-T038
,	O
neurological	B-T033
deterioration	I-T033
(	O
nd	B-T033
)	O
is	O
observed	O
,	O
and	O
it	O
is	O
difficult	O
to	O
predict	O
at	O
the	O
time	O
of	O
admission	O
.	O
especially	O
in	O
some	O
patients	O
with	O
large	B-T038
-	I-T038
artery	I-T038
atherosclerosis	I-T038
(	O
laa	B-T038
)	O
,	O
aggressive	O
medical	B-T058
treatments	I-T058
and	O
surgical	O
interventions	O
might	O
be	O
helpful	O
to	O
prevent	O
nd	B-T033
.	O
therefore	O
,	O
we	O
investigated	O
factors	O
associated	O
with	O
nd	B-T033
in	O
patients	O
with	O
laa	B-T038
.	O
we	O
studied	B-T062
patients	O
with	O
laa	B-T038
who	O
were	O
admitted	B-T058
to	I-T058
our	I-T058
hospital	I-T058
.	O
we	O
divided	O
them	O
into	O
2	O
groups	O
with	O
(	O
group	O
1	O
)	O
and	O
without	O
deterioration	B-T038
(	O
group	O
2	O
)	O
,	O
and	O
evaluated	B-T058
their	O
medical	B-T170
records	I-T170
,	O
risk	B-T033
factors	I-T033
,	O
and	O
radiological	O
findings	B-T033
,	O
such	O
as	O
number	O
of	O
diffusion	O
-	O
positive	B-T033
lesion	B-T033
and	O
degree	O
of	O
stenosis	O
.	O
our	O
study	B-T098
population	I-T098
consisted	O
of	O
171	O
patients	O
;	O
71	O
(	O
41	O
.	O
5	O
%	O
)	O
did	O
and	O
100	O
(	O
58	O
.	O
5	O
%	O
)	O
did	O
not	O
suffer	B-T038
deterioration	B-T038
.	O
by	O
univariate	O
analysis	O
,	O
blood	B-T038
pressure	I-T038
(	O
bp	B-T038
)	O
,	O
heart	B-T201
rate	I-T201
,	O
national	B-T033
institutes	I-T033
of	I-T033
health	I-T033
stroke	I-T033
scale	I-T033
(	I-T033
nih	I-T033
##ss	I-T033
)	I-T033
score	I-T033
,	O
number	O
of	O
diffusion	O
-	O
positive	B-T033
lesion	B-T033
,	O
count	B-T058
of	I-T058
red	I-T058
blood	I-T058
cell	I-T058
,	O
high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
,	O
and	O
degree	O
of	O
stenosis	O
differed	O
significantly	O
between	O
the	O
2	O
groups	O
.	O
by	O
multivariate	O
analysis	O
,	O
systolic	B-T201
bp	I-T201
(	O
≥1	O
##70	O
mm	O
hg	O
,	O
odds	O
ratio	O
:	O
7	O
.	O
20	O
,	O
p	O
<	O
.	O
001	O
)	O
was	O
associated	O
with	O
nd	B-T033
.	O
furthermore	O
,	O
number	O
of	O
diffusion	B-T058
-	I-T058
weighted	I-T058
image	I-T058
(	O
dwi	B-T058
)	O
-	O
positive	B-T033
lesion	B-T033
(	O
≥	O
##8	O
)	O
,	O
degree	O
of	O
stenosis	O
(	O
>	O
80	O
.	O
0	O
%	O
)	O
,	O
and	O
nih	B-T033
##ss	I-T033
score	I-T033
(	O
≥	O
##4	O
)	O
were	O
also	O
independent	O
factors	O
associated	O
with	O
nd	B-T033
.	O
high	B-T038
bp	I-T038
,	O
severity	O
of	O
neurological	B-T033
deficit	I-T033
at	O
the	O
time	O
of	O
admission	O
,	O
and	O
radiological	O
findings	B-T033
,	O
such	O
as	O
degree	O
of	O
stenosis	O
and	O
number	O
of	O
dwi	B-T058
-	O
positive	B-T033
lesion	B-T033
,	O
are	O
independently	B-T033
associated	O
with	O
nd	B-T033
in	O
patients	O
with	O
laa	B-T038
.	O

er	B-T103
##lot	I-T103
##ini	I-T103
##b	I-T103
plus	O
gemcitabine	B-T103
versus	O
gemcitabine	B-T103
for	O
pancreatic	B-T038
cancer	I-T038
:	O
real	O
-	O
world	B-T098
analysis	B-T062
of	O
korean	B-T082
national	B-T092
database	B-T170
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
has	O
found	O
that	O
the	O
addition	O
of	O
er	B-T103
##lot	I-T103
##ini	I-T103
##b	I-T103
to	O
gemcitabine	B-T103
(	O
gem	B-T103
-	O
e	B-T103
)	O
for	O
pancreatic	B-T038
cancer	I-T038
led	O
to	O
a	O
modest	O
increase	O
in	O
survival	O
.	O
the	O
aim	O
of	O
this	O
national	O
population	B-T098
-	O
based	O
retrospective	B-T062
study	I-T062
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
gem	B-T103
-	O
e	B-T103
to	O
gem	B-T103
alone	O
for	O
pancreatic	B-T038
cancer	I-T038
patients	O
in	O
real	O
clinical	O
practice	O
.	O
patients	O
with	O
pancreatic	B-T038
cancer	I-T038
(	B-T170
icd	I-T170
-	I-T170
10	I-T170
:	O
c2	O
##5	O
)	O
with	O
prescription	B-T170
claims	O
of	O
gemcitabine	B-T103
or	O
er	B-T103
##lot	I-T103
##ini	I-T103
##b	I-T103
between	O
jan	O
1	O
,	O
2007	O
and	O
dec	O
31	O
,	O
2012	O
were	O
retrospectively	O
identified	O
from	O
the	O
korean	B-T082
health	B-T058
insurance	I-T058
claims	O
database	B-T170
.	O
to	O
be	O
included	O
in	O
the	O
study	B-T062
population	B-T098
,	O
patients	O
were	O
required	O
to	O
have	O
had	O
a	O
histological	O
or	O
cytological	B-T033
diagnosis	I-T033
within	O
one	O
year	O
before	O
chemotherapy	B-T058
.	O
patients	O
treated	B-T033
with	I-T033
prior	O
radiotherapy	B-T058
,	O
surgery	B-T058
,	O
or	O
chemotherapy	B-T058
were	O
excluded	O
to	O
reduce	B-T058
heterogeneity	O
.	O
overall	O
survival	O
from	O
the	O
initiation	O
of	O
therapy	B-T058
and	O
the	O
medical	O
costs	O
of	O
gem	B-T103
-	O
e	B-T103
and	O
gem	B-T103
were	O
compared	O
.	O
a	O
total	O
of	O
4	O
,	O
267	O
patients	O
were	O
included	O
in	O
the	O
analysis	B-T062
.	O
overall	O
survival	O
was	O
not	O
significantly	O
longer	O
in	O
patients	O
treated	B-T033
with	O
gem	B-T103
-	O
e	B-T103
(	O
median	O
6	O
.	O
77	O
months	O
for	O
gem	B-T103
-	O
e	B-T103
vs	O
.	O
6	O
.	O
68	O
months	O
for	O
gem	B-T103
,	O
p	O
=	O
0	O
.	O
09	O
##77	O
)	O
.	O
there	O
was	O
also	O
no	O
significant	O
difference	O
in	O
the	O
respective	O
one	O
-	O
year	O
survival	O
rates	O
(	O
27	O
.	O
0	O
%	O
vs	O
.	O
27	O
.	O
3	O
%	O
;	O
p	O
=	O
0	O
.	O
59	O
##88	O
)	O
.	O
multivariate	O
analysis	O
using	O
age	O
,	O
gender	O
,	O
and	O
comorbidities	O
as	O
covariates	O
did	O
not	O
reveal	O
any	O
significant	O
differences	O
in	O
survival	O
.	O
based	O
on	O
this	O
relative	O
effectiveness	O
,	O
the	O
incremental	O
cost	O
per	O
life	O
year	O
gained	O
over	O
gem	B-T103
was	O
estimated	O
at	O
us	O
##d	O
70	O
,	O
84	O
##3	O
.	O
64	O
for	O
gem	B-T103
-	O
e	B-T103
.	O
gem	B-T103
-	O
e	B-T103
for	O
pancreatic	B-T038
cancer	I-T038
is	O
not	O
more	O
effective	O
than	O
gem	B-T103
in	O
a	O
real	O
-	O
world	B-T098
setting	O
,	O
and	O
it	O
does	O
not	O
provide	O
reasonable	B-T033
cost	O
-	O
effectiveness	O
over	O
gem	B-T103
.	O

'	O
you	O
can	O
'	O
t	O
be	O
a	O
person	B-T098
and	O
a	O
doc	B-T097
##to	I-T097
r	O
'	O
:	O
the	O
work	O
-	O
life	O
balance	O
of	O
doctors	B-T097
in	O
training	O
-	O
a	O
qualitative	B-T062
study	I-T062
investigate	O
the	O
work	O
-	O
life	O
balance	O
of	O
doctors	B-T097
in	O
training	O
in	O
the	O
uk	B-T082
from	O
the	O
perspectives	O
of	O
train	O
##ers	O
and	O
trainees	O
.	O
qualitative	O
semistructured	O
focus	O
groups	O
and	O
interviews	O
with	O
trainees	O
and	O
train	O
##ers	O
.	O
postgraduate	O
medical	O
training	O
in	O
london	B-T082
,	O
york	B-T082
##sh	I-T082
##ire	I-T082
and	O
hum	B-T082
##ber	I-T082
,	O
ken	B-T082
##t	I-T082
,	O
sur	B-T082
##rey	I-T082
and	O
sus	B-T082
##se	I-T082
##x	I-T082
,	O
and	O
wales	B-T082
during	O
the	O
junior	B-T097
doctor	I-T097
contract	B-T170
disp	O
##ute	O
at	O
the	O
end	O
of	O
2015	O
.	O
part	O
of	O
a	O
larger	O
general	B-T092
medical	I-T092
council	I-T092
study	B-T062
about	O
the	O
fair	O
##ness	O
of	O
postgraduate	O
medical	O
training	O
.	O
96	O
trainees	O
and	O
41	O
train	O
##ers	O
.	O
trainees	O
comprised	O
uk	B-T082
graduates	B-T098
and	O
international	B-T097
medical	I-T097
graduates	I-T097
,	O
across	O
all	O
stages	O
of	O
training	O
in	O
6	O
specialties	B-T091
(	O
general	B-T091
practice	I-T091
,	O
medicine	B-T091
,	O
obstetrics	B-T091
and	I-T091
gynaec	I-T091
##ology	I-T091
,	O
psychiatry	B-T091
,	O
radiology	B-T091
,	O
surgery	B-T091
)	O
and	O
foundation	B-T092
.	O
postgraduate	O
training	O
was	O
characterised	O
by	O
work	O
-	O
life	O
imbalance	O
.	O
long	O
hours	O
at	O
work	O
were	O
typically	O
supplemented	O
with	O
revision	O
and	O
completion	O
of	O
the	O
e	O
-	O
port	O
##fo	O
##li	O
##o	O
.	O
trainees	O
regularly	O
moved	O
workplace	B-T082
##s	I-T082
which	O
could	O
disrupt	O
their	O
personal	O
lives	O
and	O
sometimes	O
led	O
to	O
separation	O
from	O
friends	B-T098
and	O
family	O
.	O
this	O
made	O
it	O
challenging	O
to	O
cope	O
with	O
personal	O
pressures	O
,	O
the	O
stresses	B-T038
of	O
which	O
could	O
then	O
imping	O
##e	O
on	O
learning	B-T038
and	O
training	O
,	O
while	O
also	O
leaving	O
trainees	O
with	O
a	O
lack	O
of	O
social	O
support	O
outside	O
work	O
to	O
buffer	O
against	O
the	O
considerable	O
stresses	B-T038
of	O
training	O
.	O
low	O
moral	B-T033
##e	I-T033
and	O
harm	B-T033
to	O
well	O
-	O
being	O
resulted	O
in	O
some	O
trainees	O
feeling	B-T038
de	O
##hu	O
##man	O
##ised	O
.	O
work	O
-	O
life	O
imbalance	O
was	O
particularly	O
severe	O
for	O
those	O
with	O
children	O
and	O
especially	O
women	B-T098
who	O
faced	O
a	O
lack	O
of	O
less	O
-	O
than	O
-	O
full	O
-	O
time	O
positions	O
and	O
discriminatory	B-T038
attitudes	B-T038
.	O
female	O
trainees	O
frequently	O
talk	O
##ed	O
about	O
having	O
to	O
choose	O
a	O
specialty	B-T091
they	O
felt	O
was	O
more	O
conduc	O
##ive	O
to	O
a	O
work	O
-	O
life	O
balance	O
such	O
as	O
general	B-T091
practice	I-T091
.	O
the	O
proposed	O
junior	B-T097
doctor	I-T097
contract	B-T170
was	O
felt	O
to	O
exacerbate	B-T033
existing	O
problems	B-T033
.	O
a	O
lack	O
of	O
work	O
-	O
life	O
balance	O
in	O
postgraduate	O
medical	O
training	O
negatively	O
impacted	O
on	O
trainees	O
'	O
learning	B-T038
and	O
well	O
-	O
being	O
.	O
women	B-T098
with	O
children	O
were	O
particularly	O
affected	O
,	O
suggesting	O
this	O
group	O
would	O
benefit	O
the	O
greatest	O
from	O
changes	O
to	O
improve	B-T033
the	O
work	O
-	O
life	O
balance	O
of	O
trainees	O
.	O

the	O
value	O
of	O
transesophageal	B-T058
echocardiography	I-T058
for	O
embolic	B-T038
strokes	I-T038
of	I-T038
undetermined	I-T038
source	I-T038
our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	B-T058
yield	I-T058
of	O
transesophageal	B-T058
echocardiography	I-T058
(	O
tee	B-T058
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	B-T038
stroke	I-T038
(	O
is	B-T038
)	O
fulfilling	O
the	O
diagnostic	B-T170
criteria	I-T170
of	O
embolic	B-T038
strokes	I-T038
of	I-T038
undetermined	I-T038
source	I-T038
(	O
es	B-T038
##us	I-T038
)	O
.	O
we	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
is	B-T038
satisfying	O
es	B-T038
##us	I-T038
criteria	O
who	O
underwent	O
in	O
-	O
hospital	B-T092
tee	B-T058
examination	I-T058
in	O
3	O
tertiary	B-T092
care	I-T092
stroke	I-T092
centers	I-T092
during	O
a	O
12	O
-	O
month	O
period	O
.	O
we	O
also	O
performed	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T062
-	I-T062
analysis	I-T062
estimating	I-T062
the	O
cumulative	O
effect	O
of	O
tee	B-T058
findings	B-T033
on	O
therapeutic	O
management	O
for	O
secondary	B-T058
stroke	I-T058
prevention	I-T058
among	O
different	O
is	B-T038
subgroups	O
.	O
we	O
identified	O
61	O
patients	O
with	O
es	B-T038
##us	I-T038
who	O
underwent	B-T058
investigation	I-T058
with	O
tee	B-T058
(	O
mean	O
age	O
44	O
±	O
12	O
years	O
,	O
49	O
%	O
men	B-T098
,	O
median	O
nih	O
stroke	O
scale	O
score	O
=	O
5	O
points	O
[	O
interquartile	O
range	O
:	O
3	O
-	O
8	O
]	O
)	O
.	O
tee	B-T058
revealed	O
additional	O
findings	B-T033
in	O
52	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
:	O
40	O
%	O
-	O
65	O
%	O
)	O
of	O
the	O
study	B-T098
population	I-T098
.	O
tee	B-T058
findings	B-T033
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	B-T058
therapy	I-T058
,	O
administration	B-T058
of	O
iv	B-T058
antibiotic	I-T058
therapy	I-T058
,	O
and	O
patent	B-T058
foramen	I-T058
oval	I-T058
##e	I-T058
closure	I-T058
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
ci	O
:	O
9	O
%	O
-	O
28	O
%	O
]	O
)	O
patients	O
.	O
the	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	B-T058
therapy	I-T058
attributed	O
to	O
abnormal	B-T033
tee	B-T058
findings	B-T033
among	O
3	O
,	O
56	O
##2	O
acute	O
is	B-T038
patients	O
included	O
in	O
the	O
meta	B-T062
-	I-T062
analysis	I-T062
(	O
12	O
studies	O
)	O
was	O
8	O
.	O
7	O
%	O
(	O
95	O
%	O
ci	O
:	O
7	O
.	O
3	O
%	O
-	O
10	O
.	O
4	O
%	O
)	O
.	O
in	O
subgroup	B-T062
analysis	I-T062
,	O
the	O
rates	O
of	O
initiation	O
of	O
anticoagulation	B-T058
therapy	I-T058
on	O
the	O
basis	O
of	O
tee	B-T058
investigation	O
did	O
not	O
differ	O
(	O
p	O
=	O
0	O
.	O
315	O
)	O
among	O
patients	O
with	O
crypt	O
##ogenic	O
stroke	O
(	O
6	O
.	O
9	O
%	O
[	O
95	O
%	O
ci	O
:	O
4	O
.	O
9	O
%	O
-	O
9	O
.	O
6	O
%	O
]	O
)	O
,	O
es	B-T038
##us	I-T038
(	O
8	O
.	O
1	O
%	O
[	O
95	O
%	O
ci	O
:	O
3	O
.	O
4	O
%	O
-	O
18	O
.	O
1	O
%	O
]	O
)	O
,	O
and	O
is	B-T038
(	O
9	O
.	O
4	O
%	O
[	O
95	O
%	O
ci	O
:	O
7	O
.	O
5	O
%	O
-	O
11	O
.	O
8	O
%	O
]	O
)	O
.	O
abnormal	O
tee	B-T058
findings	B-T033
may	O
decisive	O
##ly	O
affect	O
the	O
selection	O
of	O
appropriate	O
therapeutic	B-T058
strategy	I-T058
in	O
approximately	O
1	O
of	O
7	O
patients	O
with	O
es	B-T038
##us	I-T038
.	O

active	O
packaging	O
of	O
chicken	B-T168
meat	I-T168
##s	I-T168
with	O
modified	O
atmosphere	O
including	O
oxygen	B-T103
scavengers	O
the	O
effects	O
of	O
modified	O
atmosphere	O
packaging	O
(	O
map	O
-	O
70	O
%	O
co2	B-T103
/	O
30	O
%	O
n2	B-T103
)	O
and	O
iron	B-T103
-	O
based	O
oxygen	B-T103
scavengers	O
(	O
os	O
)	O
with	O
various	O
absorption	O
capacities	O
(	O
age	O
##less	O
(	O
®	O
)	O
ss	O
##100	O
,	O
ss	O
##30	O
##0	O
,	O
and	O
ss	O
##50	O
##0	O
)	O
as	O
an	O
active	O
packaging	O
system	O
on	O
microbiological	B-T170
and	O
oxidative	O
changes	O
in	O
chicken	B-T168
thigh	I-T168
meat	I-T168
##s	I-T168
were	O
evaluated	O
during	O
refrig	O
##erated	O
storage	O
(	O
4	O
##°c	O
)	O
for	O
19	O
d	O
at	O
3	O
-	O
day	O
intervals	O
.	O
total	O
aerobic	O
mesop	O
##hi	O
##lic	O
bacteria	O
counts	O
exceeded	O
the	O
acceptability	O
limit	O
at	O
d	O
7	O
in	O
the	O
control	O
group	O
without	O
map	O
(	O
air	O
)	O
,	O
and	O
at	O
d	O
19	O
in	O
map	O
and	O
os	O
containing	O
samples	O
.	O
os	O
utilization	O
resulted	O
in	O
around	O
1	O
.	O
5	O
and	O
1	O
.	O
0	O
log	O
unit	O
reductions	O
in	O
pseudomonas	B-T007
spp	I-T007
.	I-T007
counts	O
at	O
d	O
7	O
and	O
d	O
10	O
of	O
storage	O
,	O
respectively	O
,	O
as	O
compared	O
with	O
air	O
and	O
map	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
map	O
and	O
os	O
groups	O
had	O
fewer	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
coliform	O
counts	O
than	O
did	O
the	O
air	O
group	O
,	O
with	O
an	O
approximately	O
1	O
.	O
0	O
log	O
reduction	O
observed	O
at	O
d	O
10	O
.	O
although	O
in	O
some	O
cases	O
os	O
utilization	O
resulted	O
in	O
lower	O
tbars	B-T103
values	O
and	O
carbonyl	O
and	O
sulph	O
##yd	O
##ryl	O
contents	O
,	O
particularly	O
during	O
later	O
stages	O
of	O
refrig	O
##erated	O
storage	O
as	O
compared	O
to	O
air	O
and	O
map	O
groups	O
,	O
in	O
general	O
,	O
these	O
effects	O
were	O
not	O
always	O
apparent	O
.	O
the	O
results	O
of	O
this	O
study	O
suggested	O
that	O
map	O
suppressed	O
microbiological	O
growth	O
and	O
retarded	O
lipid	B-T038
and	O
protein	B-T038
oxidation	I-T038
in	O
chicken	B-T168
thigh	I-T168
meat	I-T168
##s	I-T168
,	O
with	O
a	O
9	O
-	O
day	O
shelf	O
-	O
life	O
extent	O
##ion	O
with	O
insignificant	O
effects	O
of	O
os	O
.	O

differential	O
effects	O
of	O
crude	B-T103
oil	I-T103
on	O
denitrification	O
and	O
ana	B-T038
##mm	I-T038
##ox	I-T038
,	O
and	O
the	O
impact	O
on	O
n2o	B-T103
production	O
denitrification	O
and	O
ana	B-T038
##mm	I-T038
##ox	I-T038
are	O
key	O
processes	O
for	O
reducing	O
the	O
external	B-T082
nitrogen	B-T103
loads	O
delivered	O
to	O
coastal	B-T082
ecosystems	O
,	O
and	O
these	O
processes	O
can	O
be	O
affected	O
by	O
pollutants	B-T103
.	O
in	O
this	O
study	B-T062
,	O
we	O
investigated	O
the	O
effect	O
of	O
crude	B-T103
oil	I-T103
on	O
denitrification	O
and	O
ana	B-T038
##mm	I-T038
##ox	I-T038
.	O
controlled	B-T062
laboratory	I-T062
experiments	I-T062
were	O
performed	O
using	O
sediment	O
slurr	O
##ies	O
from	O
the	O
lim	B-T082
##a	I-T082
estu	O
##ary	O
(	O
nw	O
portugal	B-T082
)	O
.	O
ana	B-T038
##mm	I-T038
##ox	I-T038
and	O
denitrification	O
rates	O
were	O
measured	O
using	O
(	B-T103
15	I-T103
)	I-T103
n	I-T103
-	I-T103
labeled	I-T103
no3	B-T103
(	I-T103
-	I-T103
)	I-T103
,	O
and	O
the	O
production	O
of	O
(	B-T103
29	I-T103
)	I-T103
n2	I-T103
and	O
(	B-T103
30	I-T103
)	I-T103
n2	I-T103
quantified	O
by	O
membrane	B-T058
inlet	I-T058
mass	I-T058
spectrometry	I-T058
.	O
results	O
revealed	O
that	O
while	O
denitrification	O
rates	O
were	O
stimulated	O
between	O
10	O
and	O
25	O
000	O
times	O
after	O
crude	B-T103
oil	I-T103
amend	B-T170
##ment	I-T170
,	O
ana	B-T038
##mm	I-T038
##ox	I-T038
activity	O
was	O
partially	O
(	O
between	O
2	O
and	O
5	O
times	O
)	O
or	O
completely	O
inhibited	O
by	O
the	O
addition	O
of	O
crude	B-T103
oil	I-T103
when	O
comparing	O
to	O
rates	O
in	O
un	O
##amen	O
##ded	O
controls	O
.	O
similar	O
results	O
were	O
observed	O
across	O
four	O
estu	O
##arine	O
sediment	O
types	O
,	O
despite	O
their	O
different	O
physical	O
-	O
chemical	O
characteristics	O
.	O
moreover	O
,	O
n2o	B-T103
production	O
was	O
reduced	O
by	O
2	O
-	O
36	O
times	O
following	O
crude	B-T103
oil	I-T103
addition	O
.	O
further	O
work	O
is	O
required	O
to	O
fully	O
understand	O
the	O
mechanism	O
(	O
s	O
)	O
of	O
the	O
observed	O
reduction	O
in	O
n2o	B-T103
production	O
.	O
this	O
study	B-T062
represents	O
one	O
of	O
the	O
first	O
contributions	O
to	O
the	O
understanding	O
of	O
the	O
impact	O
of	O
crude	B-T103
oil	I-T103
pollution	O
on	O
denitrification	O
and	O
ana	B-T038
##mm	I-T038
##ox	I-T038
,	O
with	O
profound	O
implications	O
for	O
the	O
management	O
of	O
aquatic	O
ecosystems	O
regarding	O
eut	O
##rophic	O
##ation	O
(	O
n	O
-	O
removal	O
)	O
.	O

effectiveness	O
of	O
workers	B-T098
'	O
general	B-T058
health	I-T058
examination	I-T058
in	O
korea	B-T082
by	O
health	O
examination	O
period	O
and	O
compliance	B-T033
:	O
retrospective	B-T062
cohort	I-T062
study	I-T062
using	O
nationwide	O
data	O
our	O
study	O
evaluated	B-T058
the	O
effectiveness	O
of	O
the	O
workers	B-T098
'	O
general	B-T058
health	I-T058
examination	I-T058
by	O
health	O
examination	O
period	O
and	O
compliance	B-T033
.	O
a	O
retrospective	B-T062
cohort	I-T062
of	O
the	O
health	O
examination	O
participants	B-T098
in	O
2006	O
(	O
baseline	O
year	O
:	O
n	O
##€	O
‰	O
=	O
€	O
‰	O
6	O
,	O
52	O
##7	O
,	O
045	O
)	O
was	O
used	O
.	O
we	O
identified	O
newly	O
occurring	O
cardio	B-T038
-	O
cerebrovascular	B-T038
disease	I-T038
over	O
7	O
years	O
(	O
from	O
2007	O
to	O
2013	O
)	O
.	O
after	O
stratification	B-T062
by	O
age	O
,	O
sex	O
,	O
and	O
national	B-T058
health	I-T058
insurance	I-T058
type	I-T058
,	O
we	O
identified	O
7	O
years	O
'	O
cumulative	O
incidence	O
of	O
cardio	B-T038
-	O
cerebrovascular	B-T038
disease	I-T038
by	O
health	O
examination	O
compliance	B-T033
and	O
estimated	O
its	O
relative	O
risk	O
by	O
health	O
examination	O
period	O
and	O
compliance	B-T033
.	O
the	O
compliant	B-T098
group	I-T098
presented	O
a	O
lower	O
cumulative	O
incidence	O
of	O
cardio	B-T038
-	O
cerebrovascular	B-T038
disease	I-T038
than	O
the	O
non	B-T098
-	I-T098
compliant	I-T098
group	I-T098
;	O
this	O
result	O
was	O
consistent	O
across	O
sex	O
,	O
working	O
age	O
(	O
40	O
##s	O
and	O
50	O
##s	O
)	O
,	O
and	O
workplace	B-T082
policy	O
##holder	O
.	O
relative	O
risk	O
of	O
cardio	B-T038
-	O
cerebrovascular	B-T038
disease	I-T038
by	O
health	O
examination	O
period	O
(	O
1	O
and	O
2	O
years	O
)	O
showed	O
statistically	O
significant	O
results	O
in	O
ischemic	B-T038
heart	I-T038
disease	I-T038
for	O
male	O
participants	B-T098
.	O
of	O
men	B-T098
in	O
their	O
40	O
##s	O
,	O
office	O
workers	O
(	O
over	O
a	O
2	O
-	O
year	O
period	O
)	O
presented	O
statistically	O
higher	B-T033
relative	I-T033
risk	I-T033
of	I-T033
ischemic	B-T038
heart	I-T038
disease	I-T038
than	O
non	B-T098
-	I-T098
office	I-T098
workers	I-T098
(	O
over	O
a	O
1	O
-	O
year	O
period	O
:	O
1	O
.	O
03	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
02	O
-	O
1	O
.	O
03	O
)	O
.	O
however	O
,	O
there	O
were	O
no	O
consistent	O
results	O
in	O
ischemic	O
cerebrovascular	B-T038
disease	I-T038
and	O
hemorrhagic	O
cerebrovascular	B-T038
disease	I-T038
for	O
men	B-T098
or	O
cardio	B-T038
-	O
cerebrovascular	B-T038
disease	I-T038
for	O
women	B-T098
.	O
a	O
1	O
-	O
year	O
period	O
of	O
workers	B-T098
'	O
general	B-T058
health	I-T058
examinations	I-T058
in	O
non	B-T098
-	I-T098
office	I-T098
workers	I-T098
had	O
a	O
more	O
significant	O
prevention	B-T058
effect	O
on	O
ischemic	B-T038
heart	I-T038
disease	I-T038
than	O
a	O
2	O
-	O
year	O
period	O
in	O
office	O
workers	O
among	O
working	O
age	O
(	O
40	O
##s	O
-	O
50	O
##s	O
)	O
men	B-T098
.	O
it	O
is	O
,	O
however	O
,	O
necessary	O
to	O
consider	O
that	O
prevention	B-T058
of	O
cardio	B-T038
-	O
cerebrovascular	B-T038
disease	I-T038
can	O
be	O
partially	O
explained	O
by	O
their	O
occupational	O
characteristics	O
rather	O
than	O
by	O
health	O
examination	O
period	O
.	O

extra	O
carbohydrate	B-T103
binding	I-T103
module	I-T103
contributes	O
to	O
the	O
process	O
##ivity	O
and	O
catalytic	B-T038
activity	I-T038
of	O
a	O
non	B-T103
-	I-T103
modular	I-T103
hydrolase	I-T103
family	O
5	B-T103
endo	I-T103
##gluc	I-T103
##ana	I-T103
##se	I-T103
from	O
fo	B-T204
##mit	I-T204
##ip	I-T204
##oria	I-T204
mediter	I-T204
##rane	I-T204
##a	I-T204
mf	I-T204
##3	I-T204
/	I-T204
22	I-T204
fm	B-T103
##eg	I-T103
from	O
fo	B-T204
##mit	I-T204
##ip	I-T204
##oria	I-T204
mediter	I-T204
##rane	I-T204
##a	I-T204
is	O
a	O
non	B-T103
-	I-T103
modular	I-T103
endo	I-T103
##gluc	I-T103
##ana	I-T103
##se	I-T103
composed	O
of	O
a	O
24	B-T103
-	I-T103
amino	I-T103
acids	I-T103
extension	O
and	O
13	B-T103
-	I-T103
amino	I-T103
acids	I-T103
linker	B-T103
-	I-T103
like	I-T103
peptide	I-T103
at	O
the	O
n	B-T082
-	I-T082
terminus	I-T082
and	O
a	O
312	B-T103
-	I-T103
amino	I-T103
acids	I-T103
gh	B-T082
##5	I-T082
catalytic	I-T082
domain	I-T082
(	O
cd	B-T082
)	O
at	O
the	O
c	B-T082
-	I-T082
terminus	I-T082
.	O
in	O
this	O
study	O
,	O
six	O
fm	B-T103
##eg	I-T103
derivatives	O
with	O
deletion	O
of	O
n	B-T103
-	I-T103
terminal	I-T103
fragments	I-T103
or	O
fusion	B-T103
with	O
an	O
extra	O
family	B-T103
1	I-T103
carbohydrate	I-T103
-	I-T103
binding	I-T103
module	I-T103
(	O
cb	B-T103
##m1	I-T103
)	O
was	O
constructed	O
in	O
order	O
to	O
evaluate	O
the	O
contribution	O
of	O
cb	B-T103
##m1	I-T103
to	O
fm	B-T103
##eg	I-T103
process	O
##ivity	O
and	O
catalytic	B-T038
activity	I-T038
.	O
fm	B-T103
##eg	I-T103
showed	O
a	O
weak	O
process	O
##ivity	O
and	O
released	O
cell	B-T103
##obi	I-T103
##ose	I-T103
(	O
g2	B-T103
)	O
and	O
cell	B-T103
##otri	I-T103
##ose	I-T103
(	O
g3	B-T103
)	O
as	O
main	O
end	O
products	O
,	O
and	O
cell	B-T103
##otri	I-T103
##ose	I-T103
(	O
g4	B-T103
)	O
as	O
minor	O
end	O
product	O
from	O
filter	O
paper	O
(	O
fp	O
)	O
,	O
but	O
more	O
amount	O
of	O
g4	B-T103
was	O
released	O
from	O
regenerated	B-T103
amorphous	I-T103
cellulose	I-T103
(	O
rac	B-T103
)	O
.	O
all	O
derivatives	B-T103
had	O
similar	O
activity	O
on	O
carboxymethyl	B-T103
##cellulose	I-T103
(	O
cmc	B-T103
)	O
with	O
the	O
same	O
optimal	O
ph	O
(	O
7	O
.	O
0	O
)	O
and	O
temperature	O
(	O
50	O
##°c	O
)	O
.	O
however	O
,	O
fus	O
##ing	O
an	O
extra	O
cb	B-T103
##m1	I-T103
to	O
fm	B-T103
##eg	I-T103
##△	I-T103
##24	I-T103
or	O
fm	B-T103
##eg	I-T103
##△	I-T103
##37	I-T103
with	O
flexible	B-T103
peptide	I-T103
significantly	O
improved	O
its	O
process	O
##ivity	O
and	O
catalytic	O
activity	O
to	O
fp	O
and	O
rac	B-T103
.	O
overall	O
,	O
1	O
.	O
79	O
-	O
and	O
1	O
.	O
84	O
-	O
fold	O
increases	O
in	O
the	O
soluble	O
/	O
insoluble	O
product	O
ratio	O
on	O
fp	O
,	O
and	O
1	O
.	O
38	O
-	O
and	O
1	O
.	O
39	O
-	O
fold	O
increases	O
on	O
rac	B-T103
,	O
compared	O
to	O
fm	B-T103
##eg	I-T103
##△	I-T103
##24	I-T103
,	O
were	O
recorded	O
for	O
cb	B-T103
##m1	I-T103
-	O
fm	B-T103
##eg	I-T103
##△	I-T103
##24	I-T103
and	O
cb	B-T103
##m1	I-T103
-	O
linker	O
-	O
fm	B-T103
##eg	I-T103
##△	I-T103
##24	I-T103
,	O
respectively	O
.	O
meanwhile	O
,	O
they	O
displayed	O
2	O
.	O
64	O
-	O
and	O
2	B-T033
.	I-T033
67	I-T033
-	I-T033
fold	I-T033
more	I-T033
activity	I-T033
on	O
rac	B-T103
,	O
and	O
1	O
.	O
68	O
-	O
and	O
1	O
.	O
77	O
-	O
fold	O
on	O
fp	O
,	O
respectively	O
.	O
similar	O
improvement	O
was	O
also	O
obtained	O
for	O
cb	B-T103
##m1	I-T103
-	O
linker	O
-	O
fm	B-T103
##eg	I-T103
##△	I-T103
##37	I-T103
as	O
compared	O
with	O
fm	B-T103
##eg	I-T103
##△	I-T103
##37	I-T103
.	O
interestingly	O
,	O
fusion	O
of	O
an	O
extra	O
cb	B-T103
##m1	I-T103
with	O
fm	B-T103
##eg	I-T103
also	O
caused	O
an	O
alteration	O
of	O
cleavage	O
pattern	O
on	O
insoluble	B-T103
cellulose	I-T103
##s	I-T103
.	O
our	O
results	O
suggest	O
that	O
such	O
improvements	O
in	O
process	O
##ivity	O
and	O
catalytic	O
activity	O
may	O
arise	O
from	O
cb	B-T103
##m1	I-T103
binding	B-T038
affinity	I-T038
.	O
the	O
n	B-T103
-	I-T103
terminal	I-T103
24	I-T103
-	I-T103
or	I-T103
37	I-T103
-	I-T103
amino	I-T103
acids	I-T103
may	O
serve	O
as	O
linker	O
for	O
sufficient	O
spatial	O
separation	O
of	O
the	O
two	B-T082
domains	I-T082
required	O
for	O
process	O
##ivity	O
and	O
catalytic	O
activity	O
.	O
in	O
addition	O
,	O
deletion	O
of	O
the	O
n	B-T103
-	I-T103
terminal	I-T103
24	I-T103
-	I-T103
or	I-T103
37	I-T103
-	I-T103
amino	I-T103
acids	I-T103
led	O
to	O
significant	O
reduction	O
in	O
thermost	O
##ability	O
but	O
not	O
the	O
enzymatic	B-T038
activity	I-T038
.	O

patient	O
satisfaction	O
with	O
postpartum	O
teaching	O
methods	B-T170
postpartum	O
discharge	B-T170
instructions	I-T170
are	O
a	O
crucial	O
part	O
of	O
a	O
mother	O
'	O
s	O
birth	B-T038
experience	B-T038
.	O
finding	B-T033
the	O
method	B-T170
to	O
provide	O
those	O
discharge	B-T170
instructions	I-T170
in	O
a	O
manner	O
that	O
increases	O
the	O
mother	O
'	O
s	O
satisfaction	B-T038
with	O
her	O
hospital	B-T092
experience	B-T038
is	O
important	O
.	O
this	O
quasi	B-T062
-	I-T062
experimental	I-T062
study	I-T062
examined	B-T033
the	O
relationship	O
between	O
new	O
mothers	O
'	O
interaction	B-T033
with	O
nurses	B-T097
providing	O
postpartum	O
instructions	B-T170
by	O
the	O
traditional	O
and	O
class	O
methods	B-T170
and	O
their	O
satisfaction	B-T038
with	O
discharge	O
teaching	O
.	O
the	O
results	O
indicated	O
new	O
mothers	O
were	O
satisfied	B-T038
with	O
both	O
methods	B-T170
of	O
discharge	O
teaching	O
;	O
however	O
,	O
they	O
were	O
more	O
likely	O
to	O
report	O
stronger	O
agreement	O
with	O
overall	O
satisfaction	B-T038
with	O
the	O
traditional	O
method	B-T170
of	O
discharge	O
teaching	O
than	O
with	O
attending	O
the	O
discharge	O
class	O
.	O

retirement	B-T033
crisis	B-T033
warning	O
##s	O
becoming	O
a	O
reality	O
the	O
figures	O
are	O
start	B-T033
##ling	I-T033
:	O
the	O
number	O
of	O
nhs	O
staff	B-T097
applying	O
to	O
retire	B-T033
has	O
surge	O
##d	O
by	O
a	O
quarter	O
since	O
2012	O
.	O
the	O
potential	O
consequences	O
are	O
alarm	O
##ing	O
;	O
a	O
serious	O
shortage	O
of	O
nurses	B-T097
and	O
other	O
healthcare	B-T097
professionals	I-T097
now	O
seems	O
inevitable	O
.	O

geographical	O
factors	O
associated	O
with	O
health	B-T033
disparities	I-T033
in	O
prostate	B-T038
cancer	I-T038
treatment	B-T058
variation	O
in	O
prostate	B-T038
cancer	I-T038
is	O
common	O
,	O
and	O
it	O
is	O
driven	O
by	O
clinical	O
and	O
clinician	B-T097
factors	O
,	O
patient	O
preferences	O
,	O
availability	O
of	O
resources	O
,	O
and	O
access	B-T082
to	O
physicians	B-T097
and	O
treating	B-T092
facilities	I-T092
.	O
most	O
research	B-T062
on	O
treatment	B-T058
disparities	O
in	O
men	B-T098
with	O
prostate	B-T038
cancer	I-T038
has	O
focused	O
on	O
race	B-T098
and	O
socioeconomic	O
factors	O
.	O
however	O
,	O
the	O
ge	O
##ography	O
of	O
disparities	O
-	O
capturing	O
racial	O
and	O
socioeconomic	O
differences	O
based	O
on	O
where	O
patients	O
live	O
-	O
can	O
provide	O
insight	O
into	O
barriers	O
to	O
care	B-T058
and	O
help	O
identify	O
outl	O
##ier	O
areas	O
in	O
which	O
access	B-T082
to	O
care	B-T058
,	O
health	O
resources	O
,	O
or	O
both	O
are	O
more	O
pronounced	O
.	O
research	B-T062
regarding	O
treatment	B-T058
patterns	B-T082
and	O
disparities	O
in	O
prostate	B-T038
cancer	I-T038
using	O
the	O
geographical	B-T170
information	I-T170
system	I-T170
(	O
gis	B-T170
)	O
was	O
searched	O
.	O
studies	B-T062
were	O
limited	O
to	O
english	O
-	O
language	O
articles	B-T170
and	O
research	B-T062
focused	O
on	O
us	B-T082
populations	B-T098
.	O
a	O
total	O
of	O
43	O
articles	B-T170
were	O
found	O
;	O
of	O
those	O
,	O
30	O
provided	O
information	O
about	O
or	O
used	O
spatial	B-T082
or	O
geographical	O
analyses	B-T062
to	O
assess	O
and	O
describe	O
differences	O
or	O
disparities	O
in	O
prostate	B-T038
cancer	I-T038
and	O
its	O
treatment	B-T058
.	O
two	O
additional	O
gis	B-T170
resources	O
were	O
included	O
.	O
the	O
research	B-T062
on	O
geographical	O
and	O
spatial	O
determinants	O
of	O
prostate	B-T038
cancer	I-T038
disparities	O
was	O
reviewed	O
.	O
we	O
also	O
examined	O
geographical	O
analyses	B-T062
at	O
the	O
state	O
level	O
,	O
focusing	O
on	O
florida	B-T082
.	O
overall	O
,	O
we	O
described	O
a	O
geographical	O
framework	O
to	O
disparities	O
that	O
affect	O
men	B-T098
with	O
prostate	B-T038
cancer	I-T038
and	O
reviewed	O
existing	O
published	O
evidence	O
supporting	O
the	O
interplay	O
of	O
geographical	O
factors	O
and	O
disparities	O
in	O
prostate	B-T038
cancer	I-T038
.	O
disparities	O
in	O
prostate	B-T038
cancer	I-T038
are	O
common	O
and	O
persistent	O
,	O
and	O
notable	O
differences	O
in	O
treatment	B-T058
are	O
observable	O
across	O
racial	O
and	O
socioeconomic	O
strata	O
.	O
geographical	O
analysis	B-T062
provides	O
additional	O
information	O
about	O
where	O
disparate	O
groups	B-T098
live	O
and	O
also	O
helps	O
to	O
map	O
access	B-T082
to	O
care	B-T058
.	O
this	O
information	O
can	O
be	O
used	O
by	O
public	B-T097
health	I-T097
official	I-T097
##s	I-T097
,	O
health	B-T097
-	I-T097
systems	I-T097
administrators	I-T097
,	O
clinicians	B-T097
,	O
and	O
policym	B-T097
##akers	I-T097
to	O
better	O
understand	O
and	O
respond	O
to	O
geographical	O
barriers	O
that	O
contribute	O
to	O
disparities	O
in	O
care	O
.	O

attributable	O
risk	O
of	O
ambient	O
pm10	O
on	O
daily	O
mortality	O
and	O
years	O
of	O
life	O
lost	O
in	O
chen	O
##gd	O
##u	O
,	O
china	B-T082
attributable	O
risk	O
is	O
an	O
important	O
indicator	O
for	O
planning	B-T058
and	O
evaluating	B-T058
public	I-T058
health	I-T058
interventions	I-T058
.	O
however	O
,	O
most	O
current	O
measures	O
of	O
the	O
attributable	O
risk	O
of	O
air	B-T103
pollutants	I-T103
have	O
not	O
considered	O
temporal	O
relationships	O
between	O
exposure	O
and	O
risk	O
.	O
more	O
importantly	O
,	O
limited	O
information	O
is	O
available	O
regarding	O
the	O
attributable	O
risk	O
due	O
to	O
ambient	O
air	B-T103
pollutants	I-T103
in	O
basin	O
regions	O
like	O
the	O
sic	O
##hu	O
##an	O
basin	O
,	O
china	B-T082
.	O
to	O
quantify	O
the	O
association	O
between	O
pm10	O
and	O
deaths	B-T033
in	O
the	O
basin	O
region	O
,	O
we	O
used	O
a	O
measure	O
proposed	O
recently	O
within	O
the	O
framework	O
of	O
the	O
distributed	O
lag	O
non	O
-	O
linear	O
model	O
to	O
estimate	O
the	O
attributable	O
risk	O
in	O
chen	O
##gd	O
##u	O
,	O
china	B-T082
.	O
meanwhile	O
,	O
we	O
examined	O
the	O
association	O
between	O
pm10	O
and	O
years	O
of	O
life	O
lost	O
(	O
yl	O
##l	O
)	O
.	O
our	O
analysis	B-T062
showed	O
that	O
population	O
-	O
attributable	O
fractions	O
for	O
non	O
-	O
accidental	O
,	O
respiratory	O
,	O
and	O
cardiovascular	O
mortality	O
were	O
0	O
.	O
56	O
##9	O
%	O
(	O
95	O
%	O
ci	O
:	O
-	O
3	O
.	O
47	O
##4	O
%	O
,	O
4	O
.	O
37	O
##4	O
%	O
)	O
,	O
0	O
.	O
69	O
##5	O
%	O
(	O
95	O
%	O
ci	O
:	O
-	O
5	O
.	O
260	O
%	O
,	O
6	O
.	O
45	O
##7	O
%	O
)	O
,	O
and	O
0	O
.	O
63	O
##1	O
%	O
(	O
95	O
%	O
ci	O
:	O
-	O
6	O
.	O
97	O
##3	O
%	O
,	O
7	O
.	O
390	O
%	O
)	O
,	O
respectively	O
.	O
on	O
average	O
,	O
a	O
1	O
##μg	O
/	O
m	O
(	O
3	O
)	O
increase	O
in	O
pm10	O
was	O
associated	O
with	O
cumulative	O
increases	O
of	O
0	O
.	O
268	O
##93	O
,	O
0	O
.	O
304	O
##37	O
,	O
and	O
0	O
.	O
219	O
##24	O
yl	O
##l	O
for	O
non	O
-	O
accidental	O
,	O
respiratory	O
,	O
and	O
cardiovascular	O
mortality	O
,	O
respectively	O
,	O
referring	O
to	O
20	O
##μg	O
/	O
m	O
(	O
3	O
)	O
.	O
in	O
addition	O
,	O
we	O
found	O
an	O
inverse	B-T082
u	I-T082
-	I-T082
shaped	I-T082
pattern	I-T082
for	O
the	O
cumulative	O
risk	O
with	O
350	O
##μg	O
/	O
m	O
(	O
3	O
)	O
as	O
the	O
reverse	O
point	O
.	O
with	O
a	O
1	O
##μg	O
/	O
m	O
(	O
3	O
)	O
increase	O
in	O
pm10	O
,	O
yl	O
##l	O
changed	O
more	O
significantly	O
than	O
mortality	O
.	O
moreover	O
,	O
pm10	O
demonstrated	O
remarkable	O
effects	O
on	O
yl	O
##l	O
among	O
men	B-T098
and	O
the	O
elderly	B-T098
.	O

identification	O
of	O
protective	O
b	B-T103
-	I-T103
cell	I-T103
epitopes	I-T103
within	O
the	O
novel	O
malaria	B-T103
vaccine	I-T103
candidate	O
p	B-T103
.	I-T103
falciparum	I-T103
schiz	I-T103
##ont	I-T103
egr	I-T103
##ess	I-T103
antigen	I-T103
-	I-T103
1	I-T103
naturally	O
-	O
acquired	O
antibodies	B-T103
to	O
pfs	B-T103
##ea	I-T103
-	I-T103
1a	I-T103
are	O
associated	O
with	O
protection	O
against	O
severe	O
malaria	B-T038
in	O
children	O
.	O
vaccination	B-T058
of	O
mice	B-T204
with	O
pbs	B-T103
##ea	I-T103
-	I-T103
1a	I-T103
decreases	O
parasite	B-T038
##mia	I-T038
and	O
prolong	O
##s	O
survival	O
following	O
plasmodium	B-T204
berg	I-T204
##he	I-T204
##i	I-T204
ank	I-T204
##a	I-T204
challenge	O
.	O
to	O
enhance	O
the	O
immunogenicity	B-T038
of	O
pfs	B-T103
##ea	I-T103
-	I-T103
1a	I-T103
,	O
we	O
identified	O
five	O
linear	O
,	O
b	B-T103
-	I-T103
cell	I-T103
epitopes	I-T103
using	O
peptide	B-T103
microarrays	O
probed	O
with	O
anti	B-T103
-	I-T103
sera	I-T103
from	O
rp	B-T103
##fs	I-T103
##ea	I-T103
-	I-T103
1a	I-T103
-	O
vaccinated	B-T033
non	O
-	O
human	O
primates	B-T204
.	O
we	O
evaluated	B-T058
the	O
relationship	O
between	O
epitope	B-T103
-	O
specific	O
antibody	B-T103
levels	O
and	O
protection	O
from	O
parasite	B-T038
##mia	I-T038
in	O
a	O
longitudinal	O
treatment	B-T058
-	O
rein	O
##fection	O
cohort	B-T098
in	O
western	B-T082
kenya	I-T082
.	O
antibodies	B-T103
to	O
three	O
epitopes	B-T103
were	O
associated	O
with	O
16	O
-	O
17	O
%	O
decreased	O
parasite	B-T038
##mia	I-T038
over	O
an	O
18	O
-	O
week	O
high	O
transmission	O
season	O
.	O
we	O
are	O
currently	O
designing	O
immuno	B-T103
##gens	I-T103
to	O
enhance	O
antibody	B-T038
responses	I-T038
to	O
these	O
three	O
epitopes	B-T103
.	O

the	O
genetic	O
basis	O
for	O
variation	O
in	O
resistance	B-T038
to	O
infection	B-T038
in	O
the	O
drosophila	B-T204
melanogaster	I-T204
genetic	I-T204
reference	I-T204
panel	I-T204
individuals	B-T098
vary	O
extensively	O
in	O
the	O
way	O
they	O
respond	O
to	O
disease	B-T038
but	O
the	O
genetic	O
basis	O
of	O
this	O
variation	O
is	O
not	O
fully	O
understood	O
.	O
we	O
found	O
substantial	O
individual	B-T098
variation	O
in	O
resistance	B-T038
and	O
tolerance	O
to	O
the	O
fungal	B-T204
pathogen	I-T204
meta	I-T204
##rh	I-T204
##iz	I-T204
##ium	I-T204
anis	I-T204
##opl	I-T204
##iae	I-T204
ma	I-T204
##54	I-T204
##9	I-T204
using	O
the	O
drosophila	B-T204
melanogaster	I-T204
genetic	I-T204
reference	I-T204
panel	I-T204
(	O
dg	B-T204
##rp	I-T204
)	O
.	O
in	O
addition	O
,	O
we	O
found	O
that	O
host	B-T038
defense	I-T038
to	O
ma	B-T204
##54	I-T204
##9	I-T204
was	O
correlated	O
with	O
defense	O
to	O
the	O
bacterium	B-T007
pseudomonas	B-T007
aeruginosa	I-T007
pa	I-T007
##14	I-T007
,	O
and	O
several	O
previously	O
published	O
dg	B-T204
##rp	I-T204
phenotypes	O
including	O
oxidative	B-T038
stress	I-T038
sensitivity	O
,	O
starvation	B-T033
stress	O
resistance	O
,	O
hemolymph	B-T031
glucose	B-T058
levels	I-T058
,	O
and	O
sleep	B-T038
indices	B-T170
.	O
we	O
identified	O
polymorphisms	B-T038
associated	O
with	O
differences	O
between	O
lines	O
in	O
both	O
their	O
mean	O
survival	O
times	O
and	O
microenvironment	O
##al	O
plasticity	O
,	O
suggesting	O
that	O
lines	O
differ	O
in	O
their	O
ability	O
to	O
adapt	B-T038
to	O
variable	O
pathogen	O
exposures	O
.	O
the	O
majority	O
of	O
polymorphisms	B-T038
increasing	O
resistance	B-T038
to	O
ma	B-T204
##54	I-T204
##9	I-T204
were	O
sex	O
biased	O
,	O
located	O
in	O
non	B-T103
-	I-T103
coding	I-T103
regions	I-T103
,	O
had	O
moderately	O
large	O
effect	O
and	O
were	O
rare	O
,	O
suggesting	O
that	O
there	O
is	O
a	O
general	O
cost	O
to	O
defense	O
.	O
nevertheless	O
,	O
host	B-T038
defense	I-T038
was	O
not	O
negatively	O
correlated	O
with	O
overall	O
longevity	O
and	O
fecundity	B-T038
.	O
in	O
contrast	O
to	O
ma	B-T204
##54	I-T204
##9	I-T204
,	O
minor	B-T017
alleles	I-T017
were	O
concentrated	O
in	O
the	O
most	O
pa	B-T007
##14	I-T007
-	O
susceptible	O
as	O
well	O
as	O
the	O
most	O
pa	B-T007
##14	I-T007
-	O
resistant	B-T038
lines	O
.	O
a	O
pathway	O
based	O
analysis	B-T062
revealed	O
a	O
network	O
of	O
pa	B-T007
##14	I-T007
and	O
ma	B-T204
##54	I-T204
##9	I-T204
-	O
resistance	B-T038
genes	B-T017
that	O
are	O
functionally	O
connected	O
through	O
processes	O
that	O
encompass	O
phagocytosis	B-T038
and	O
eng	B-T038
##ulf	I-T038
##ment	I-T038
,	O
cell	B-T038
mobility	I-T038
,	O
intermedi	B-T038
##ary	I-T038
metabolism	I-T038
,	O
protein	B-T038
phosphorylation	I-T038
,	O
axon	B-T038
guidance	I-T038
,	O
response	B-T038
to	I-T038
dna	I-T038
damage	I-T038
,	O
and	O
drug	B-T038
metabolism	I-T038
.	O
functional	O
testing	O
with	O
insertion	B-T038
##al	I-T038
mutagenesis	I-T038
lines	O
indicates	O
that	O
12	O
/	O
13	O
candidate	B-T017
genes	I-T017
tested	O
influence	O
susceptibility	O
to	O
ma	B-T204
##54	I-T204
##9	I-T204
.	O
many	O
candidate	B-T017
genes	I-T017
have	O
homologs	B-T082
identified	O
in	O
studies	B-T062
of	O
human	B-T204
disease	B-T038
,	O
suggesting	O
that	O
genes	B-T017
affecting	O
variation	O
in	O
susceptibility	O
are	O
conserved	O
across	O
species	B-T170
.	O

a	O
novel	O
method	B-T170
for	O
interactive	O
multi	O
-	O
objective	O
dose	B-T058
-	I-T058
guided	I-T058
patient	I-T058
positioning	I-T058
in	O
intensity	B-T058
-	I-T058
modulated	I-T058
radiation	I-T058
therapy	I-T058
(	O
imrt	B-T058
)	O
,	O
3d	O
in	O
-	O
room	O
imaging	B-T058
data	O
is	O
typically	O
utilized	O
for	O
accurate	O
patient	O
alignment	O
on	O
the	O
basis	O
of	O
anatomical	B-T082
landmarks	I-T082
.	O
in	O
the	O
presence	O
of	O
non	O
-	O
rigid	O
anatomical	O
changes	O
,	O
it	O
is	O
often	O
not	O
obvious	O
which	O
patient	B-T033
position	I-T033
is	O
most	O
suitable	O
.	O
thus	O
,	O
dose	O
-	O
guided	O
patient	O
alignment	O
is	O
an	O
interesting	O
approach	O
to	O
use	O
available	O
in	O
-	O
room	O
imaging	B-T058
data	O
for	O
up	O
-	O
to	O
-	O
date	O
dose	O
calculation	O
,	O
aimed	O
at	O
finding	B-T033
the	O
position	O
that	O
yields	O
the	O
optimal	O
dose	O
distribution	O
.	O
this	O
contribution	O
presents	O
the	O
first	O
implementation	O
of	O
dose	O
-	O
guided	O
patient	O
alignment	O
as	O
multi	O
-	O
criteria	O
optimization	O
problem	O
.	O
user	O
-	O
defined	O
clinical	O
objectives	B-T170
are	O
employed	O
for	O
setting	O
up	O
a	O
multi	O
-	O
objective	O
problem	O
.	O
using	O
pre	O
-	O
calculated	O
dose	O
distributions	O
at	O
a	O
limited	O
number	O
of	O
patient	B-T058
shifts	I-T058
and	O
dose	O
interpolation	B-T062
,	O
a	O
continuous	O
space	O
of	O
par	B-T058
##eto	I-T058
-	I-T058
efficient	I-T058
patient	I-T058
shifts	I-T058
becomes	O
accessible	O
.	O
par	O
##eto	O
slide	O
##rs	O
facilitate	O
interactive	O
brow	O
##sin	O
##g	O
of	O
the	O
possible	O
shifts	O
with	O
real	O
-	O
time	O
dose	O
display	O
to	O
the	O
user	O
.	O
dose	O
interpolation	B-T062
accuracy	O
is	O
validated	O
and	O
the	O
potential	O
of	O
multi	O
-	O
objective	O
dose	B-T058
-	I-T058
guided	I-T058
positioning	I-T058
demonstrated	O
for	O
three	O
head	B-T038
and	I-T038
neck	I-T038
(	O
h	B-T038
&	I-T038
n	I-T038
)	O
and	O
three	O
prostate	B-T038
cancer	I-T038
patients	O
.	O
dose	B-T058
-	I-T058
guided	I-T058
positioning	I-T058
is	O
compared	O
to	O
repl	O
##anning	O
for	O
all	O
cases	O
.	O
a	O
delineated	O
repl	O
##anning	O
ct	B-T058
served	O
as	O
surrogate	O
for	O
in	O
-	O
room	O
imaging	B-T058
data	O
.	O
dose	O
interpolation	B-T062
accuracy	O
was	O
high	O
.	O
using	O
a	O
[	O
formula	O
:	O
see	O
text	O
]	O
dose	O
difference	O
criterion	O
,	O
a	O
median	O
pass	O
-	O
rate	O
of	O
95	O
.	O
7	O
%	O
for	O
h	B-T038
&	I-T038
n	I-T038
and	O
99	O
.	O
6	O
%	O
for	O
prostate	B-T038
cases	I-T038
was	O
determined	O
in	O
a	O
comparison	O
to	O
exact	O
dose	O
calculations	O
.	O
for	O
all	O
patients	O
,	O
dose	B-T058
-	I-T058
guided	I-T058
positioning	I-T058
allowed	O
to	O
find	O
a	O
clinically	O
preferable	O
dose	O
distribution	O
compared	O
to	O
bony	O
anatomy	O
based	O
alignment	O
.	O
for	O
all	O
h	B-T038
&	I-T038
n	I-T038
cases	O
,	O
mean	O
dose	O
to	O
the	O
spared	O
parotid	B-T017
glands	I-T017
was	O
below	O
[	O
formula	O
:	O
see	O
text	O
]	O
(	O
up	O
to	O
[	O
formula	O
:	O
see	O
text	O
]	O
with	O
bony	O
alignment	O
)	O
and	O
clinical	O
target	O
volume	O
(	O
ct	O
##v	O
)	O
[	O
formula	O
:	O
see	O
text	O
]	O
above	O
99	O
.	O
1	O
%	O
(	O
compared	O
to	O
95	O
.	O
1	O
%	O
)	O
.	O
for	O
all	O
prostate	B-T038
patients	O
,	O
ct	O
##v	O
[	O
formula	O
:	O
see	O
text	O
]	O
was	O
above	O
98	O
.	O
9	O
%	O
(	O
compared	O
to	O
88	O
.	O
5	O
%	O
)	O
and	O
[	O
formula	O
:	O
see	O
text	O
]	O
to	O
the	O
rectum	O
below	O
[	O
formula	O
:	O
see	O
text	O
]	O
(	O
compared	O
to	O
56	O
.	O
1	O
%	O
)	O
.	O
repl	O
##anning	O
yielded	O
improved	O
results	O
for	O
the	O
h	B-T038
&	I-T038
n	I-T038
cases	O
.	O
for	O
the	O
prostate	B-T038
cases	I-T038
,	O
differences	O
to	O
dose	B-T058
-	I-T058
guided	I-T058
positioning	I-T058
were	O
minor	O
.	O

potential	O
drug	B-T038
-	I-T038
drug	I-T038
interactions	I-T038
among	O
prescriptions	B-T058
for	O
elderly	B-T098
patients	O
in	O
primary	B-T058
health	I-T058
care	I-T058
elderly	B-T098
patients	O
are	O
at	O
high	B-T033
risk	I-T033
from	O
drug	B-T038
-	I-T038
drug	I-T038
interactions	I-T038
(	O
dd	B-T038
##is	I-T038
)	O
.	O
this	O
study	B-T062
evaluates	B-T058
the	O
potential	O
dd	B-T038
##is	I-T038
in	O
turkish	O
elderly	B-T098
patients	O
at	O
a	O
primary	B-T058
health	I-T058
care	I-T058
outpatient	B-T092
clinic	I-T092
.	O
online	B-T170
database	I-T170
systems	I-T170
were	O
used	O
to	O
examine	O
dd	B-T038
##is	I-T038
on	O
the	O
prescriptions	B-T058
of	O
patients	O
(	O
n	O
=	O
120	O
##6	O
)	O
.	O
the	O
clinical	B-T033
severity	I-T033
of	O
dd	B-T038
##is	I-T038
was	O
classified	O
by	O
the	O
lex	B-T170
##i	I-T170
-	I-T170
interact	I-T170
online	I-T170
database	I-T170
.	O
of	O
the	O
50	O
##59	O
prescriptions	B-T058
,	O
33	O
%	O
were	O
found	O
to	O
have	O
dd	B-T038
##is	I-T038
.	O
we	O
detected	B-T033
29	O
(	O
0	O
.	O
9	O
%	O
)	O
a	O
,	O
380	O
(	O
11	O
.	O
8	O
%	O
)	O
b	O
,	O
249	O
##4	O
(	O
77	O
.	O
7	O
%	O
)	O
c	O
,	O
289	O
(	O
9	O
%	O
)	O
d	O
,	O
and	O
18	O
(	O
0	O
.	O
6	O
%	O
)	O
x	O
risk	O
rating	O
category	O
dd	B-T038
##is	I-T038
among	O
the	O
prescriptions	B-T058
.	O
prescriptions	B-T058
of	O
female	O
patients	O
and	O
patients	O
aged	O
between	O
65	O
and	O
72	O
years	O
showed	O
significantly	O
higher	O
number	O
of	O
dd	B-T038
##is	I-T038
.	O
the	O
frequency	O
of	O
dd	B-T038
##is	I-T038
increased	O
both	O
with	O
the	O
number	O
of	O
drugs	B-T103
and	O
combined	O
preparations	O
per	O
prescription	B-T058
.	O
acetyls	B-T103
##alic	I-T103
##ylic	I-T103
acid	I-T103
and	O
salbutamol	B-T103
were	O
the	O
most	O
frequently	O
prescribed	O
drugs	B-T103
contributing	O
to	O
clinically	B-T033
important	I-T033
dd	B-T038
##is	I-T038
.	O
additionally	O
,	O
acetyls	B-T103
##alic	I-T103
##ylic	I-T103
acid	I-T103
and	O
esc	B-T103
##italopram	I-T103
,	O
which	O
interact	O
with	O
each	O
other	O
,	O
were	O
found	O
on	O
the	O
list	O
of	O
beer	O
##s	O
criteria	O
.	O
the	O
most	O
predicted	B-T033
clinical	I-T033
outcomes	I-T033
of	O
dd	B-T038
##is	I-T038
were	O
increase	O
in	O
therapeutic	O
efficacy	O
and	O
adverse	B-T038
/	O
toxic	B-T033
reactions	I-T033
.	O
conclusions	O
:	O
prediction	O
of	O
dd	B-T038
##is	I-T038
in	O
elderly	B-T098
patients	O
will	O
provide	O
better	O
prescribing	B-T058
and	O
drug	O
safety	O
.	O
use	O
of	O
nonsteroidal	B-T103
anti	I-T103
-	I-T103
inflammatory	I-T103
agents	I-T103
,	O
selective	B-T103
serotonin	I-T103
reuptake	I-T103
inhibitors	I-T103
,	O
and	O
beta	B-T103
-	I-T103
2	I-T103
adrenergic	I-T103
receptor	I-T103
agonists	I-T103
should	O
be	O
closely	O
monitored	O
.	O

long	B-T103
-	I-T103
chain	I-T103
n	I-T103
-	I-T103
3	I-T103
pufa	I-T103
supplied	O
by	O
the	O
usual	O
diet	B-T168
decrease	O
plasma	B-T103
stear	I-T103
##oyl	I-T103
-	I-T103
coa	I-T103
desaturase	I-T103
index	B-T170
in	O
non	B-T033
-	I-T033
hypertriglycerid	I-T033
##emic	I-T033
older	B-T098
adults	I-T098
at	O
high	O
vascular	B-T017
risk	O
the	O
activity	B-T038
of	O
stear	B-T103
##oyl	I-T103
-	I-T103
coa	I-T103
desaturase	I-T103
-	I-T103
1	I-T103
(	O
scd	B-T103
##1	I-T103
)	O
,	O
the	O
central	B-T103
enzyme	I-T103
in	O
the	O
synthesis	O
of	O
mono	B-T103
##uns	I-T103
##aturated	I-T103
fatty	I-T103
acids	I-T103
(	O
mu	B-T103
##fa	I-T103
)	O
,	O
has	O
been	O
associated	O
with	O
de	O
novo	O
lipogenesis	B-T038
.	O
in	O
experimental	B-T170
models	I-T170
scd	B-T103
##1	I-T103
is	O
down	B-T038
-	I-T038
regulated	I-T038
by	O
polyunsaturated	B-T103
fatty	I-T103
acids	I-T103
(	O
pufa	B-T103
)	O
,	O
but	O
clinical	B-T062
studies	I-T062
are	O
scarce	O
.	O
the	O
effect	O
of	O
long	B-T103
-	I-T103
chain	I-T103
n	I-T103
-	I-T103
3	I-T103
pufa	I-T103
(	O
lc	B-T103
##n	I-T103
-	I-T103
3p	I-T103
##u	I-T103
##fa	I-T103
)	O
supplied	O
by	O
the	O
regular	B-T168
diet	I-T168
,	O
in	O
the	O
absence	O
of	O
fatty	B-T168
fish	I-T168
or	O
fish	B-T168
oil	I-T168
supplementation	B-T168
,	I-T168
remains	O
to	O
be	O
explored	O
.	O
we	O
related	O
1	O
-	O
y	O
changes	O
in	O
plasma	B-T103
scd	I-T103
##1	I-T103
index	B-T170
,	O
as	O
assessed	O
by	O
the	O
c16	B-T103
:	I-T103
1	I-T103
##n	I-T103
-	I-T103
7	I-T103
/	O
c16	B-T103
:	I-T103
0	I-T103
ratio	O
,	O
to	O
both	O
adiposity	O
traits	O
and	O
nutrient	B-T033
intake	I-T033
changes	O
in	O
a	O
sub	B-T098
-	I-T098
cohort	I-T098
(	O
n	O
=	O
243	O
)	O
of	O
non	B-T033
-	I-T033
hypertriglycerid	I-T033
##emic	I-T033
subjects	B-T098
of	O
the	O
pred	B-T062
##imed	I-T062
(	I-T062
preven	I-T062
##ci	I-T062
##on	I-T062
con	I-T062
diet	I-T062
##a	I-T062
mediter	I-T062
##rane	I-T062
##a	I-T062
)	I-T062
trial	I-T062
.	O
after	O
adjustment	O
for	O
confounders	O
,	O
including	O
changes	O
in	O
fasting	B-T033
triglycerides	B-T103
,	O
plasma	B-T103
scd	I-T103
##1	I-T103
index	B-T170
increased	O
in	O
parallel	O
with	O
body	O
weight	O
(	O
0	O
.	O
221	O
[	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
021	O
to	O
0	O
.	O
42	O
##2	O
]	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
and	O
bmi	B-T201
(	O
0	O
.	O
115	O
[	O
0	O
.	O
027	O
to	O
0	O
.	O
202	O
]	O
,	O
p	O
=	O
0	O
.	O
011	O
)	O
.	O
additionally	O
,	O
dietary	B-T168
lc	B-T103
##n	I-T103
-	I-T103
3p	I-T103
##u	I-T103
##fa	I-T103
(	O
but	O
not	O
mu	B-T103
##fa	I-T103
or	O
plant	B-T103
-	I-T103
derived	I-T103
pufa	I-T103
)	O
were	O
associated	O
with	O
decreased	O
plasma	B-T103
scd	I-T103
##1	I-T103
index	B-T170
(	O
-	O
0	O
.	O
54	O
##4	O
[	O
-	O
1	O
.	O
044	O
to	O
-	O
0	O
.	O
043	O
]	O
,	O
p	O
=	O
0	O
.	O
033	O
,	O
for	O
each	O
1	O
g	O
/	O
d	O
-	O
increase	O
in	O
lc	B-T103
##n	I-T103
-	I-T103
3p	I-T103
##u	I-T103
##fa	I-T103
)	O
.	O
no	O
associations	O
were	O
found	O
for	O
other	O
food	B-T168
groups	O
,	O
but	O
there	O
was	O
a	O
trend	O
for	O
fatty	B-T168
fish	I-T168
intake	O
(	O
-	O
0	O
.	O
08	O
##3	O
[	O
-	O
0	O
.	O
177	O
to	O
0	O
.	O
012	O
]	O
,	O
p	O
=	O
0	O
.	O
08	O
##5	O
,	O
for	O
each	O
10	O
g	O
/	O
d	O
-	O
increase	O
)	O
.	O
our	O
data	O
add	O
clinical	O
evidence	O
on	O
the	O
down	B-T038
-	I-T038
regulation	I-T038
of	O
plasma	B-T103
scd	I-T103
##1	I-T103
index	B-T170
by	O
lc	B-T103
##n	I-T103
-	I-T103
3p	I-T103
##u	I-T103
##fa	I-T103
in	O
the	O
context	O
of	O
realistic	O
changes	O
in	O
fish	B-T204
consumption	O
in	O
the	O
custom	O
##ary	O
,	O
non	B-T033
-	I-T033
supplemented	I-T033
diet	B-T168
.	O
http	O
:	O
/	O
/	O
www	O
.	O
controlled	O
-	O
trials	O
.	O
com	O
/	O
isr	O
##ct	O
##n3	O
##57	O
##39	O
##63	O
##9	O
.	O

naphth	B-T103
##ohydro	I-T103
##quinone	I-T103
##s	I-T103
,	O
naphth	B-T103
##o	I-T103
##quinone	I-T103
##s	I-T103
,	O
anthr	B-T103
##a	I-T103
##quinone	I-T103
##s	I-T103
,	O
and	O
a	O
naphth	B-T103
##ohydro	I-T103
##quinone	I-T103
dimer	O
isolated	O
from	O
the	O
aerial	B-T204
parts	I-T204
of	O
mor	B-T204
##ind	I-T204
##a	I-T204
parv	I-T204
##ifolia	I-T204
and	O
their	O
cytotoxic	B-T038
effects	I-T038
through	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
p53	B-T017
five	O
unknown	O
compounds	B-T103
,	O
mor	B-T103
##ind	I-T103
##apa	I-T103
##r	I-T103
##vin	I-T103
##s	I-T103
c	I-T103
-	I-T103
g	I-T103
,	O
consisting	O
of	O
naphth	B-T103
##ohydro	I-T103
##quinone	I-T103
##s	I-T103
,	O
a	O
naphth	B-T103
##o	I-T103
##quinone	I-T103
,	O
an	O
anthr	B-T103
##a	I-T103
##quinone	I-T103
,	O
and	O
a	O
naphth	B-T103
##ohydro	I-T103
##quinone	I-T103
dimer	O
,	O
together	O
with	O
three	O
known	O
quinone	B-T103
##s	I-T103
and	O
seven	O
other	O
known	O
compounds	B-T103
,	O
were	O
isolated	O
from	O
the	O
aerial	B-T204
parts	I-T204
of	O
mor	B-T204
##ind	I-T204
##a	I-T204
parv	I-T204
##ifolia	I-T204
.	O
the	O
structures	O
of	O
mor	B-T103
##ind	I-T103
##apa	I-T103
##r	I-T103
##vin	I-T103
##s	I-T103
c	I-T103
,	O
d	B-T103
,	O
e	B-T103
,	O
f	B-T103
,	O
and	O
g	B-T103
were	O
elucidated	O
on	O
the	O
basis	O
of	O
spectroscopic	B-T058
or	O
x	O
-	O
ray	O
diffraction	O
analysis	O
as	O
methyl	B-T103
4	I-T103
-	I-T103
hydroxy	I-T103
-	I-T103
1	I-T103
,	I-T103
6	I-T103
-	I-T103
dimethoxy	I-T103
-	I-T103
naphthalene	I-T103
-	I-T103
2	I-T103
-	I-T103
carboxylate	I-T103
,	O
methyl	B-T103
4	I-T103
,	I-T103
8	I-T103
-	I-T103
dihydroxy	I-T103
-	I-T103
1	I-T103
-	I-T103
methoxy	I-T103
-	I-T103
naphthalene	I-T103
-	I-T103
2	I-T103
-	I-T103
carboxylate	I-T103
,	O
3	B-T103
-	I-T103
amino	I-T103
-	I-T103
6	I-T103
-	I-T103
methoxy	I-T103
-	I-T103
2	I-T103
-	I-T103
methoxy	I-T103
##carbonyl	I-T103
-	I-T103
1	I-T103
,	I-T103
4	I-T103
-	I-T103
naphth	I-T103
##o	I-T103
##quinone	I-T103
,	O
1	B-T103
,	I-T103
4	I-T103
-	I-T103
dihydroxy	I-T103
-	I-T103
7	I-T103
-	I-T103
hydroxymethyl	I-T103
-	I-T103
anthr	I-T103
##a	I-T103
##quinone	I-T103
,	O
and	O
dimethyl	B-T103
1	I-T103
,	I-T103
1	I-T103
'	I-T103
-	I-T103
dihydroxy	I-T103
-	I-T103
4	I-T103
,	I-T103
4	I-T103
'	I-T103
,	I-T103
7	I-T103
,	I-T103
7	I-T103
'	I-T103
-	I-T103
tetram	I-T103
##ethoxy	I-T103
-	I-T103
2	I-T103
,	I-T103
2	I-T103
'	I-T103
-	I-T103
bin	I-T103
##aph	I-T103
##thal	I-T103
##ene	I-T103
-	I-T103
3	I-T103
,	I-T103
3	I-T103
'	I-T103
-	I-T103
dic	I-T103
##arboxyl	I-T103
##ate	I-T103
,	O
respectively	O
.	O
naphth	B-T103
##o	I-T103
##quinone	I-T103
##s	I-T103
and	O
naphth	B-T103
##ohydro	I-T103
##quinone	I-T103
dimers	O
were	O
previously	O
unknown	O
in	O
the	O
genus	B-T170
mor	B-T204
##ind	I-T204
##a	I-T204
.	O
in	O
addition	O
,	O
the	O
compounds	B-T103
were	O
tested	O
for	O
cytotoxicity	B-T038
against	O
four	O
human	B-T204
cancer	B-T017
cell	I-T017
lines	I-T017
hela	B-T017
,	O
a2	B-T017
##78	I-T017
##0	I-T017
,	O
ket	B-T017
##r3	I-T017
and	O
mcf	B-T017
-	I-T017
7	I-T017
and	O
their	O
effects	O
on	O
p53	B-T017
-	O
activated	O
transcription	B-T038
.	O
three	O
naphth	B-T103
##o	I-T103
##quinone	I-T103
##s	I-T103
had	O
moderate	O
cytotoxic	B-T038
effects	I-T038
with	O
ic50	O
values	O
ranging	O
from	O
1	O
.	O
51	O
to	O
9	O
.	O
56	O
μm	O
,	O
through	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
p53	B-T017
transcriptional	B-T038
activity	I-T038
.	O

viral	B-T103
vector	I-T103
bios	B-T170
##afe	I-T170
##ty	I-T170
in	O
laboratory	B-T062
animal	I-T062
research	I-T062
viral	B-T103
vector	I-T103
research	B-T062
presents	O
unique	O
occupational	B-T091
health	I-T091
and	O
safety	O
challenges	B-T058
to	O
institutions	B-T092
due	O
to	O
the	O
rapid	O
development	O
of	O
##bo	O
##th	O
in	B-T082
vivo	I-T082
and	O
in	O
vitro	O
gene	B-T062
-	I-T062
editing	I-T062
technologies	I-T062
.	O
risks	O
to	O
human	B-T204
and	O
animal	B-T204
health	O
make	O
it	O
inc	O
##umb	O
##ent	O
on	O
institutions	B-T092
to	O
appropriately	O
evaluate	B-T058
viral	B-T103
vector	I-T103
usage	O
in	O
research	B-T062
on	O
the	O
basis	O
of	O
available	O
information	O
and	O
governmental	O
regulations	O
and	O
guidelines	B-T170
.	O
here	O
we	O
review	O
the	O
factors	O
related	O
to	O
risk	B-T058
assessment	I-T058
regarding	O
viral	B-T103
vector	I-T103
usage	O
in	O
animals	B-T204
and	O
the	O
relevant	O
regulatory	B-T170
documents	I-T170
associated	O
with	O
this	O
research	B-T062
,	O
and	O
we	O
highlight	O
the	O
most	O
commonly	O
used	O
viral	B-T103
vectors	I-T103
in	O
research	B-T062
today	O
.	O
this	O
review	O
is	O
particularly	O
focused	O
on	O
the	O
background	O
,	O
use	O
in	O
research	B-T062
and	O
associated	O
health	O
and	O
environmental	O
risks	O
related	O
to	O
adenoviral	B-T005
,	O
adeno	B-T005
-	I-T005
associated	I-T005
viral	I-T005
,	O
lentiviral	B-T005
,	O
and	O
herpes	B-T005
##viral	I-T005
vectors	B-T103
.	O

posterior	B-T037
dislocation	I-T037
of	O
the	O
stern	B-T082
##ocl	I-T082
##avicular	I-T082
joint	I-T082
:	O
report	B-T170
of	O
two	O
cases	O
the	O
authors	O
report	B-T170
the	O
cases	O
of	O
two	O
young	O
patients	O
who	O
had	O
suffered	O
a	O
sport	B-T037
##ing	I-T037
accident	I-T037
with	O
posterior	B-T037
traumatic	I-T037
dislocation	I-T037
of	O
stern	B-T082
##ocl	I-T082
##avicular	I-T082
joint	I-T082
.	O
in	O
one	O
of	O
the	O
patients	O
closed	B-T058
reduction	I-T058
was	O
accomplished	O
by	O
keeping	O
the	O
limb	B-T017
in	O
a	O
sling	B-T074
.	O
the	O
second	O
patient	O
,	O
after	O
reduction	B-T058
was	O
done	O
,	O
presented	O
recurrence	O
of	O
the	O
dislocation	B-T037
,	O
thus	O
requiring	O
surgical	B-T058
treatment	I-T058
.	O
it	O
is	O
important	O
to	O
observe	O
the	O
relevance	O
of	O
computed	B-T058
tomography	I-T058
to	O
help	O
diagnosing	B-T062
,	O
as	O
well	O
as	O
monitoring	O
the	O
reduction	B-T058
procedure	I-T058
.	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
demonstrate	O
two	O
different	O
types	O
of	O
treatment	B-T058
in	O
a	O
rare	O
injury	B-T037
such	O
as	O
the	O
posterior	B-T037
dislocation	I-T037
of	O
stern	B-T082
##ocl	I-T082
##avicular	I-T082
joint	I-T082
.	O

an	O
approach	O
to	O
functionally	O
relevant	O
clustering	O
of	O
the	O
protein	B-T103
univers	I-T103
##e	I-T103
:	O
active	O
site	O
profile	O
-	O
based	O
clustering	O
of	O
protein	B-T103
structures	I-T103
and	O
sequences	B-T082
protein	B-T038
function	I-T038
identification	O
remains	O
a	O
significant	O
problem	O
.	O
solving	O
this	O
problem	O
at	O
the	O
molecular	O
functional	O
level	O
would	O
allow	O
mechanistic	O
determinant	O
identification	O
-	O
amino	B-T103
acids	I-T103
that	O
distinguish	O
details	O
between	O
functional	O
families	O
within	O
a	O
superfamily	O
.	O
active	B-T062
site	I-T062
profiling	I-T062
was	O
developed	O
to	O
identify	O
mechanistic	O
determinants	O
.	O
das	B-T170
##p	I-T170
and	O
das	B-T170
##p2	I-T170
were	O
developed	O
as	O
tools	O
to	O
search	O
sequence	B-T170
databases	I-T170
using	O
active	B-T062
site	I-T062
profiling	I-T062
.	O
here	O
,	O
tu	B-T170
##lip	I-T170
(	O
two	B-T170
-	I-T170
level	I-T170
iterative	I-T170
clustering	I-T170
process	I-T170
)	O
is	O
introduced	O
as	O
an	O
iterative	O
,	O
div	O
##is	O
##ive	O
clustering	O
process	O
that	O
utilizes	O
active	B-T062
site	I-T062
profiling	I-T062
to	O
separate	O
structurally	O
characterized	O
superfamily	O
members	O
into	O
functionally	O
relevant	O
clusters	O
.	O
underlying	O
tu	B-T170
##lip	I-T170
is	O
the	O
observation	O
that	O
functionally	O
relevant	O
families	O
(	O
cur	O
##ated	O
by	O
structure	B-T170
-	I-T170
function	I-T170
linkage	I-T170
database	I-T170
,	O
sf	B-T170
##ld	I-T170
)	O
self	O
-	O
identify	O
in	O
das	B-T170
##p2	I-T170
searches	O
;	O
clusters	O
containing	O
multiple	O
functional	O
families	O
do	O
not	O
.	O
each	O
tu	B-T170
##lip	I-T170
iter	O
##ation	O
produces	O
candidate	O
clusters	O
,	O
each	O
evaluated	O
to	O
determine	O
if	O
it	O
self	O
-	O
identifies	O
using	O
das	B-T170
##p2	I-T170
.	O
if	O
so	O
,	O
it	O
is	O
deemed	O
a	O
functionally	O
relevant	O
group	O
.	O
div	O
##is	O
##ive	O
clustering	O
continues	O
until	O
each	O
structure	O
is	O
either	O
a	O
functionally	O
relevant	O
group	O
member	O
or	O
a	O
singlet	O
.	O
tu	B-T170
##lip	I-T170
is	O
validated	O
on	O
enolase	B-T103
and	O
glutathione	B-T103
transferase	I-T103
structures	O
,	O
superf	O
##amilies	O
well	O
-	O
cur	O
##ated	O
by	O
sf	B-T170
##ld	I-T170
.	O
correlation	O
is	O
strong	O
;	O
small	O
numbers	O
of	O
structures	B-T082
prevent	O
statistically	O
significant	O
analysis	O
.	O
tu	B-T170
##lip	I-T170
-	O
identified	O
enolase	B-T103
clusters	O
are	O
used	O
in	O
das	B-T170
##p2	I-T170
genbank	I-T170
searches	O
to	O
identify	O
sequences	B-T082
sharing	O
functional	O
site	O
features	O
.	O
analysis	O
shows	O
a	O
true	O
positive	O
rate	O
of	O
96	O
%	O
,	O
false	O
negative	O
rate	O
of	O
4	O
%	O
,	O
and	O
maximum	O
false	O
positive	O
rate	O
of	O
4	O
%	O
.	O
f	O
-	O
measure	O
and	O
performance	B-T062
analysis	I-T062
on	O
the	O
enolase	B-T103
search	O
results	O
and	O
comparison	O
to	O
gem	B-T170
##ma	I-T170
and	O
sci	B-T170
-	I-T170
ph	I-T170
##y	I-T170
demonstrate	O
that	O
tu	B-T170
##lip	I-T170
avoids	O
the	O
over	O
-	O
division	O
problem	O
of	O
these	O
methods	O
.	O
mechanistic	O
determinants	O
for	O
enolase	B-T103
families	I-T103
are	O
evaluated	O
and	O
shown	O
to	O
correlate	O
well	O
with	O
literature	B-T170
results	O
.	O

back	O
to	O
the	O
roots	O
:	O
deep	O
view	O
into	O
the	O
evolutionary	B-T038
history	O
of	O
adp	O
-	O
rib	O
##osylation	O
opened	O
by	O
the	O
dna	B-T103
-	O
targeting	O
toxin	B-T103
-	O
antit	B-T103
##oxin	I-T103
module	O
dar	O
##t	O
##g	O
in	O
this	O
issue	O
of	O
molecular	B-T091
cell	I-T091
,	O
jan	O
##ke	O
##vic	O
##ius	O
et	O
al	O
.	O
(	O
2016	O
)	O
characterize	O
the	O
dar	O
##t	O
##g	O
toxin	B-T103
-	O
antit	B-T103
##oxin	I-T103
module	O
in	O
which	O
the	O
dar	B-T103
##t	I-T103
toxin	B-T103
adp	O
-	O
rib	O
##osyl	O
##ates	O
single	B-T103
-	I-T103
stranded	I-T103
dna	I-T103
and	O
the	O
dar	B-T103
##g	I-T103
antit	B-T103
##oxin	I-T103
counteract	O
##s	O
dar	B-T103
##t	I-T103
by	O
direct	O
binding	B-T038
and	O
by	O
enzymatic	B-T103
remov	O
##a	O
l	O
of	O
the	O
adp	O
-	O
rib	O
##osylation	O
.	O

anti	B-T103
-	I-T103
helminth	I-T103
##ic	I-T103
activity	O
of	O
mom	B-T204
##ord	I-T204
##ica	I-T204
char	I-T204
##anti	I-T204
##a	I-T204
l	I-T204
.	O
against	O
fasci	B-T204
##ola	I-T204
hepatic	I-T204
##a	I-T204
eggs	I-T204
after	O
twelve	O
days	O
of	O
incubation	B-T058
in	O
vitro	O
fasci	B-T038
##olo	I-T038
##sis	I-T038
,	O
a	O
parasitic	B-T038
disease	I-T038
caused	O
by	O
the	O
trem	B-T204
##ato	I-T204
##de	I-T204
fasci	B-T204
##ola	I-T204
hepatic	I-T204
##a	I-T204
under	O
##reported	O
is	O
expanding	O
both	O
in	O
human	B-T204
and	O
animal	B-T204
population	I-T204
,	O
throughout	O
the	O
world	B-T098
.	O
the	O
constant	O
use	O
of	O
synthetic	B-T103
drugs	I-T103
to	O
treat	B-T058
this	O
condition	B-T038
has	O
led	O
to	O
the	O
natural	O
selection	O
of	O
resistant	O
strains	O
of	O
the	O
parasite	B-T204
.	O
hence	O
,	O
there	O
is	O
a	O
growing	O
focus	O
on	O
the	O
potential	O
anti	B-T103
-	I-T103
helminth	I-T103
##ic	I-T103
properties	O
of	O
medicinal	B-T204
plants	I-T204
and	O
phyto	B-T103
##pharm	I-T103
##aceu	I-T103
##ticals	I-T103
.	O
the	O
current	O
study	B-T062
assessed	O
the	O
potential	O
anti	O
-	O
fasci	O
##olic	O
##ide	O
action	O
of	O
mom	B-T204
##ord	I-T204
##ica	I-T204
char	I-T204
##anti	I-T204
##a	I-T204
leaf	B-T204
extracts	B-T103
and	O
fractions	O
on	O
the	O
eggs	B-T204
of	I-T204
f	I-T204
.	I-T204
hepatic	I-T204
##a	I-T204
parasites	I-T204
.	O
the	O
lyophilized	O
crude	B-T103
extract	I-T103
(	O
ce	B-T103
)	O
of	O
m	B-T204
.	I-T204
char	I-T204
##anti	I-T204
##a	I-T204
leaves	I-T204
and	O
its	O
sub	O
-	O
fractions	O
,	O
obtained	O
from	O
liquid	B-T058
-	I-T058
liquid	I-T058
partitioning	I-T058
with	O
organic	B-T103
solvents	I-T103
,	O
were	O
analysed	B-T062
by	O
high	B-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
(	O
hplc	B-T058
)	O
,	O
suspended	O
in	O
1	O
%	O
dmso	B-T103
and	O
used	O
in	O
in	O
vitro	O
tests	B-T058
.	O
quadrup	O
##lic	O
##ates	O
of	O
50	O
f	B-T204
.	I-T204
hepatic	I-T204
##a	I-T204
eggs	I-T204
were	O
incubated	B-T058
at	O
23	O
##°c	O
with	O
m	B-T204
.	I-T204
char	I-T204
##anti	I-T204
##a	I-T204
leaf	B-T204
ce	B-T103
in	O
different	O
concentrations	O
.	O
after	O
12	O
days	O
no	O
larvae	B-T204
were	O
formed	O
in	O
eggs	B-T204
incubated	B-T058
with	O
ce	B-T103
concentrations	O
above	O
12	O
.	O
5mg	O
/	O
ml	O
.	O
eggs	B-T204
incubated	B-T058
with	O
ce	B-T103
sub	O
-	O
fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0	O
.	O
1	O
,	O
0	O
.	O
01	O
##μg	O
/	O
ml	O
affected	O
embryonic	B-T038
development	I-T038
,	O
with	O
n	B-T103
-	I-T103
butanol	I-T103
presenting	O
the	O
strongest	O
inhibition	O
of	O
mir	B-T204
##acid	I-T204
##ia	I-T204
formation	O
.	O
in	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
mir	B-T204
##acid	I-T204
##ia	I-T204
hatch	B-T038
##ed	I-T038
in	O
the	O
control	O
experiments	O
using	O
0	O
.	O
03	O
%	O
dmso	B-T103
whereas	O
embryogenesis	B-T038
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
alb	B-T103
##endazole	I-T103
sulph	I-T103
##oxide	I-T103
ab	B-T103
##z	I-T103
(	I-T103
so	I-T103
)	I-T103
.	O
chemical	B-T058
analysis	I-T058
of	O
the	O
ce	B-T103
and	O
sub	O
-	O
fractions	O
revealed	O
a	O
prominent	O
presence	O
of	O
flavonoids	B-T103
.	O
hplc	B-T058
-	I-T058
ms	I-T058
confirmed	O
quercetin	B-T103
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	B-T103
present	O
in	O
the	O
ce	B-T103
and	O
the	O
n	B-T103
-	I-T103
butanol	I-T103
subfraction	O
.	O
this	O
is	O
the	O
first	O
study	B-T062
to	O
analyse	B-T062
the	O
potential	O
anti	O
-	O
fasci	O
##olic	O
##ide	O
action	O
of	O
m	B-T204
.	I-T204
char	I-T204
##anti	I-T204
##a	I-T204
leaf	B-T204
ce	B-T103
and	O
subfraction	O
##s	O
.	O

beneficial	O
effects	O
of	O
vo	B-T103
##gl	I-T103
##ib	I-T103
##ose	I-T103
administration	B-T058
on	O
body	O
weight	O
and	O
lipid	B-T038
metabolism	I-T038
via	O
gastrointestinal	B-T022
bile	B-T103
acid	I-T103
modification	O
this	O
study	B-T062
was	O
designed	O
with	O
the	O
goal	B-T170
of	O
examining	O
the	O
effects	O
of	O
vo	B-T103
##gl	I-T103
##ib	I-T103
##ose	I-T103
administration	B-T058
on	O
body	O
weight	O
and	O
lipid	B-T038
metabolism	I-T038
and	O
underlying	O
mechanism	O
high	B-T058
fat	I-T058
diet	I-T058
-	O
induced	O
obese	B-T204
mice	I-T204
.	O
male	O
c57bl	B-T204
/	I-T204
6	I-T204
mice	I-T204
were	O
randomly	O
assigned	O
to	O
one	O
of	O
four	O
groups	O
:	O
a	O
control	O
diet	O
(	O
ctl	O
)	O
,	O
high	O
-	O
fat	O
diet	O
(	O
hf	O
)	O
,	O
high	O
-	O
fat	O
diet	O
supplemented	O
with	O
vo	O
##gl	O
##ib	O
##ose	O
(	O
vo	O
)	O
,	O
and	O
high	O
fat	O
diet	O
pair	O
-	O
fed	O
group	O
(	O
pf	O
)	O
.	O
after	O
12	O
weeks	O
,	O
the	O
following	O
characteristics	O
were	O
investigated	O
:	O
serum	B-T058
lipid	I-T058
and	O
glucose	B-T033
levels	I-T033
,	O
serum	O
polar	O
metabolite	O
profiles	O
,	O
and	O
expression	O
levels	O
of	O
genes	B-T017
involved	O
in	O
lipid	B-T038
and	O
bile	B-T038
acid	I-T038
metabolism	I-T038
.	O
in	O
addition	O
,	O
pyrosequencing	B-T058
was	O
used	O
to	O
analyze	O
the	O
composition	B-T201
of	O
gut	O
microbiota	O
found	O
in	O
feces	B-T031
.	O
total	B-T033
body	I-T033
weight	I-T033
gain	I-T033
was	O
significantly	O
lower	O
in	O
the	O
vo	O
group	O
than	O
in	O
the	O
ctl	O
,	O
hf	O
,	O
and	O
pf	O
groups	O
.	O
the	O
vo	O
group	O
exhibited	O
improved	O
metabolic	B-T038
profiles	I-T038
including	O
those	O
of	O
blood	B-T058
glucose	I-T058
,	O
triglyceride	B-T033
,	O
and	O
total	B-T033
cholesterol	I-T033
levels	I-T033
.	O
the	O
12	O
-	O
week	O
vo	B-T103
##gl	I-T103
##ib	I-T103
##ose	I-T103
administration	B-T058
decreased	O
the	O
ratio	O
of	O
firm	B-T007
##ic	I-T007
##utes	I-T007
to	O
bacter	B-T007
##oide	I-T007
##tes	I-T007
found	O
in	O
feces	B-T031
.	O
circulating	O
levels	O
of	O
tau	B-T103
##roch	I-T103
##olic	I-T103
and	O
chol	B-T103
##ic	I-T103
acid	I-T103
were	O
significantly	O
higher	O
in	O
the	O
vo	O
group	O
than	O
in	O
the	O
hf	O
and	O
ctl	O
groups	O
.	O
deoxy	B-T103
##chol	I-T103
##ic	I-T103
acid	I-T103
levels	O
tended	O
to	O
be	O
higher	O
in	O
the	O
vo	O
group	O
than	O
in	O
the	O
hf	O
group	O
.	O
vo	B-T103
##gl	I-T103
##ib	I-T103
##ose	I-T103
administration	B-T058
downregulated	B-T038
expression	O
levels	O
of	O
cyp	B-T017
##8	I-T017
##b1	I-T017
and	O
hnf	B-T017
##4	I-T017
##α	I-T017
genes	I-T017
and	O
upregulated	B-T038
those	O
of	O
pgc	B-T017
##1	I-T017
##α	I-T017
,	O
whereas	O
fx	B-T017
##r	I-T017
##α	I-T017
was	O
not	O
affected	O
.	O
vo	B-T103
##gl	I-T103
##ib	I-T103
##ose	I-T103
administration	B-T058
elicits	O
changes	O
in	O
the	O
composition	B-T201
of	O
the	O
intestinal	O
microbiota	O
and	O
circulating	B-T103
metabolites	I-T103
,	O
which	O
ultimately	O
has	O
systemic	O
effects	O
on	O
body	O
weight	O
and	O
lipid	B-T038
metabolism	I-T038
in	O
mice	B-T204
.	O

parallel	O
-	O
processing	O
continuous	O
-	O
flow	O
device	O
for	O
optimization	O
-	O
free	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
a	O
parallel	O
-	O
processing	O
four	B-T062
-	I-T062
station	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
pcr	B-T062
)	O
device	O
has	O
been	O
developed	O
,	O
which	O
performs	O
continuous	O
-	O
flow	O
pcr	B-T062
without	O
optimization	O
of	O
the	O
annealing	B-T038
temperature	O
.	O
since	O
the	O
annealing	B-T038
temperature	O
of	O
each	O
station	O
can	O
be	O
controlled	O
independently	O
,	O
the	O
device	O
covers	O
an	O
annealing	B-T038
temperature	O
range	O
of	O
50	O
-	O
68	O
°c	O
,	O
which	O
is	O
wide	B-T082
enough	O
to	O
perform	O
pcr	B-T062
for	O
any	O
dna	O
fragment	O
regardless	O
of	O
its	O
optimum	O
annealing	B-T038
condition	O
.	O
this	O
arrangement	O
let	O
##s	O
us	O
continuously	O
obtain	O
an	O
amplified	O
amount	O
of	O
a	O
dna	O
fragment	O
at	O
least	O
from	O
one	O
of	O
the	O
stations	O
.	O
the	O
device	O
consists	O
of	O
four	O
identical	O
cylindrical	B-T082
stations	O
(	O
diameter	O
20	O
mm	O
,	O
height	O
55	O
mm	O
)	O
.	O
a	O
polyt	B-T103
##etra	I-T103
##fluor	I-T103
##oethylene	I-T103
capillary	B-T074
reactor	I-T074
(	O
length	O
2	O
m	O
,	O
i	O
.	O
d	O
.	O
100	O
μm	O
,	O
o	O
.	O
d	O
.	O
400	O
μm	O
)	O
is	O
wound	B-T082
helical	I-T082
##ly	I-T082
up	B-T082
around	O
each	O
station	O
.	O
the	O
whole	O
assembly	O
is	O
designed	O
to	O
minimize	O
the	O
number	O
of	O
heating	O
blocks	O
(	O
for	O
providing	O
temperatures	O
of	O
denaturation	B-T038
,	O
annealing	B-T038
,	O
and	O
extension	O
)	O
to	O
be	O
seven	O
and	O
to	O
shape	B-T082
a	O
compact	B-T033
cub	B-T082
##e	I-T082
(	O
height	O
55	O
mm	O
,	O
base	O
60	O
mm	O
×	O
60	O
mm	O
)	O
.	O
the	O
reproducibility	O
for	O
continuous	O
-	O
flow	O
pcr	B-T062
is	O
reasonably	O
high	O
(	O
run	O
-	O
to	O
-	O
run	O
and	O
station	O
-	O
to	O
-	O
station	O
relative	O
standard	O
deviation	O
of	O
their	O
amplification	B-T038
is	O
lower	O
than	O
6	O
%	O
and	O
about	O
4	O
%	O
,	O
respectively	O
)	O
.	O
performance	O
on	O
the	O
optimization	O
-	O
free	O
dna	B-T038
amplification	I-T038
has	O
been	O
evaluated	B-T058
with	O
four	O
dna	B-T017
samples	I-T017
with	O
different	O
annealing	B-T038
conditions	O
and	O
product	O
sizes	B-T082
(	O
323	O
,	O
60	O
##8	O
,	O
82	O
##8	O
,	O
and	O
110	O
##1	O
bp	O
)	O
,	O
which	O
has	O
demonstrated	O
that	O
in	O
all	O
cases	O
,	O
pcr	B-T062
is	O
successful	O
at	O
least	O
on	O
one	O
station	O
.	O
in	O
addition	O
,	O
three	O
dna	O
fragment	O
s	O
with	O
different	O
lengths	O
(	O
323	O
,	O
110	O
##1	O
,	O
and	O
283	O
##6	O
bp	O
)	O
have	O
been	O
successfully	O
amplified	O
in	O
a	O
segmented	B-T082
-	O
flow	O
mode	O
without	O
the	O
carry	O
-	O
over	O
contamination	O
between	O
segments	B-T082
.	O
this	O
result	O
suggests	O
that	O
this	O
device	O
could	O
serve	O
as	O
the	O
pcr	B-T062
module	O
of	O
a	O
continuous	O
-	O
flow	O
high	O
-	O
throughput	O
on	O
-	O
line	O
total	O
dna	O
analysis	O
system	O
integrating	O
all	O
necessary	O
modules	O
from	O
cell	B-T017
lysis	B-T038
/	O
dna	B-T062
extraction	I-T062
to	O
pcr	B-T062
product	O
analysis	B-T062
.	O

volumetric	B-T058
absorpti	I-T058
##ve	I-T058
micros	I-T058
##amp	I-T058
##ling	I-T058
at	O
home	B-T082
as	O
an	O
alternative	O
tool	O
for	O
the	O
monitoring	B-T058
of	O
hba1c	B-T103
in	O
diabetes	B-T038
patients	O
micros	O
##amp	O
##ling	O
techniques	O
have	O
several	O
advantages	O
over	O
traditional	O
blood	B-T058
collection	I-T058
.	O
dried	B-T058
blood	I-T058
spot	I-T058
(	I-T058
dbs	I-T058
)	I-T058
sampling	I-T058
and	O
blood	B-T058
collection	I-T058
with	O
heparin	O
##ized	O
capillaries	O
are	O
the	O
standard	O
techniques	B-T058
.	O
volumetric	B-T058
absorpti	I-T058
##ve	I-T058
micros	I-T058
##amp	I-T058
##ling	I-T058
(	O
va	B-T058
##ms	I-T058
)	O
is	O
a	O
novel	O
technique	B-T058
that	O
collect	O
##s	O
a	O
fixed	O
volume	O
of	O
blood	B-T031
by	O
applying	O
an	O
absorb	O
##ent	O
tip	O
to	O
a	O
blood	B-T031
drop	I-T031
.	O
in	O
the	O
present	O
study	B-T062
we	O
explored	O
the	O
feasibility	O
of	O
hba1c	B-T103
monitoring	B-T058
with	O
va	B-T058
##ms	I-T058
sampling	I-T058
at	O
home	B-T082
and	O
analysis	B-T062
in	O
the	O
laboratory	B-T092
.	O
diabetic	B-T038
patients	O
were	O
enrolled	O
in	O
this	O
study	B-T062
during	O
consultation	B-T058
with	O
the	O
endocrin	B-T097
##ologist	I-T097
.	O
a	O
venous	B-T031
(	O
adults	O
)	O
or	O
capillary	B-T031
(	I-T031
children	I-T031
)	I-T031
sample	I-T031
was	O
taken	O
for	O
immediate	O
hba1c	B-T103
analysis	B-T062
.	O
dbs	B-T058
(	O
n	O
=	O
1	O
)	O
and	O
dried	B-T058
va	I-T058
##ms	I-T058
(	O
n	O
=	O
2	O
)	O
were	O
collected	O
at	O
home	B-T082
and	O
sent	O
to	O
the	O
laboratory	B-T092
.	O
for	O
25	O
pediatric	O
patients	O
one	O
va	B-T058
##ms	I-T058
was	O
collected	O
during	O
consultation	B-T058
for	O
immediate	O
analysis	B-T062
(	O
without	O
drying	O
)	O
,	O
referred	O
to	O
as	O
[UNK]	O
wet	B-T058
va	I-T058
##ms	I-T058
[UNK]	O
.	O
hba1c	B-T103
analyses	B-T062
were	O
performed	O
on	O
a	O
tos	B-T074
##oh	I-T074
hl	I-T074
##c	I-T074
-	I-T074
72	I-T074
##3	I-T074
g	I-T074
##8	I-T074
high	I-T074
-	I-T074
performance	I-T074
liquid	I-T074
chromatography	I-T074
(	I-T074
hplc	I-T074
)	I-T074
analyzer	I-T074
.	O
the	O
median	O
time	O
between	O
sampling	B-T058
at	O
home	B-T082
and	O
analysis	B-T062
was	O
3	O
days	O
.	O
results	O
of	O
hba1c	B-T103
in	O
dried	O
va	B-T058
##ms	I-T058
showed	O
a	O
poor	O
agreement	O
with	O
venous	B-T031
/	O
capillary	B-T031
blood	I-T031
collected	O
in	O
hospital	B-T092
(	O
concordance	O
correlation	O
coefficient	O
ccc	O
=	O
0	O
.	O
72	O
)	O
.	O
similar	O
observations	O
were	O
found	O
with	O
standard	O
dbs	B-T058
.	O
an	O
excellent	O
agreement	O
was	O
obtained	O
between	O
hba1c	B-T103
results	O
on	O
wet	B-T058
va	I-T058
##ms	I-T058
(	O
ccc	O
=	O
0	O
.	O
99	O
##6	O
)	O
and	O
standard	O
blood	B-T031
samples	I-T031
.	O
patients	O
experienced	O
va	B-T058
##ms	I-T058
and	O
dbs	B-T058
as	O
easy	B-T033
and	O
convenient	O
to	O
use	O
.	O
utilizing	O
equipment	O
standard	O
available	O
in	O
the	O
clinical	O
laboratory	B-T092
,	O
the	O
use	O
of	O
home	B-T082
-	O
sampled	O
dried	B-T058
va	I-T058
##ms	I-T058
and	O
dbs	B-T058
is	O
not	O
a	O
reliable	O
tool	O
for	O
the	O
monitoring	B-T058
of	O
hba1c	B-T103
.	O
however	O
,	O
perfect	O
agreement	O
between	O
hba1c	B-T103
measured	O
on	O
wet	B-T058
va	I-T058
##ms	I-T058
and	O
capillary	B-T031
micros	I-T031
##amp	I-T031
##les	I-T031
was	O
obtained	O
.	O

halogen	B-T103
##ated	I-T103
phenolic	I-T103
compounds	I-T103
in	O
wild	B-T204
fish	I-T204
from	O
canadian	B-T082
areas	I-T082
of	O
concern	O
concentrations	O
of	O
halogen	B-T103
##ated	I-T103
phenolic	I-T103
compounds	I-T103
were	O
measured	O
in	O
the	O
plasma	B-T031
of	O
brown	B-T204
bull	I-T204
##head	I-T204
(	O
am	B-T204
##ei	I-T204
##urus	I-T204
nebul	I-T204
##osus	I-T204
)	O
from	O
4	O
canadian	B-T082
areas	I-T082
of	O
concern	O
(	O
ao	B-T082
##cs	I-T082
)	O
,	O
to	O
assess	O
exposure	O
to	O
suspected	O
thyroid	B-T017
-	O
disrupting	B-T103
chemicals	I-T103
.	O
hydroxylated	B-T103
polychlorinated	I-T103
biphenyls	I-T103
(	O
oh	B-T103
-	I-T103
pcbs	I-T103
)	O
were	O
detected	O
in	O
every	O
sample	O
collected	O
in	O
3	O
of	O
the	O
ao	B-T082
##cs	I-T082
;	O
the	O
detection	B-T058
frequency	O
was	O
lower	O
in	O
samples	O
from	O
the	O
detr	O
##oi	O
##t	O
river	O
ao	B-T082
##c	I-T082
.	O
the	O
oh	B-T103
-	I-T103
pcbs	I-T103
most	O
frequently	O
detected	O
were	O
penta	O
##chlor	O
##o	O
,	O
hexa	O
##chlor	O
##o	O
,	O
and	O
hept	O
##achlor	O
##o	O
congeners	O
,	O
which	O
are	O
structurally	O
similar	O
to	O
thyroid	B-T103
hormones	I-T103
.	O
penta	B-T103
##chlor	I-T103
##ophenol	I-T103
(	O
pcp	B-T103
)	O
was	O
detected	O
at	O
highest	O
concentrations	O
(	O
1	O
.	O
8	O
ng	O
/	O
g	O
)	O
in	O
fish	B-T204
from	O
princ	B-T082
##e	I-T082
ed	I-T082
##ward	I-T082
bay	I-T082
,	O
the	O
bay	B-T082
of	I-T082
quin	I-T082
##te	I-T082
lake	I-T082
reference	I-T082
site	I-T082
,	O
and	O
hill	O
##man	O
marsh	O
(	O
the	O
wheat	O
##ley	O
harbour	O
reference	O
site	O
)	O
,	O
suggesting	O
local	O
sources	O
of	O
contamination	O
.	O
elevated	B-T058
pcp	I-T058
concentrations	I-T058
were	O
also	O
detected	O
in	O
the	O
plasma	B-T031
of	O
brown	B-T204
bull	I-T204
##head	I-T204
from	O
exposed	O
sites	O
in	O
the	O
toronto	B-T082
and	I-T082
region	I-T082
ao	I-T082
##c	I-T082
(	O
0	O
.	O
4	O
-	O
0	O
.	O
6	O
ng	O
/	O
g	O
)	O
.	O
tric	B-T103
##lo	I-T103
##sa	I-T103
##n	I-T103
was	O
consistently	O
detected	O
in	O
the	O
toronto	B-T082
and	I-T082
region	I-T082
ao	I-T082
##c	I-T082
(	O
0	O
.	O
05	O
-	O
0	O
.	O
9	O
ng	O
/	O
g	O
)	O
,	O
consistent	O
with	O
wastewater	B-T082
emission	O
.	O
greater	O
concentrations	O
were	O
occasionally	O
detected	O
in	O
the	O
plasma	B-T031
of	O
brown	B-T204
bull	I-T204
##head	I-T204
from	O
the	O
bay	B-T082
of	I-T082
quin	I-T082
##te	I-T082
ao	B-T082
##c	I-T082
.	O
concentrations	O
of	O
poly	B-T103
##brom	I-T103
##inated	I-T103
diphenyl	I-T103
ethers	I-T103
were	O
highest	O
in	O
the	O
toronto	B-T082
and	I-T082
region	I-T082
ao	I-T082
##c	I-T082
,	O
and	O
at	O
2	O
of	O
the	O
bay	B-T082
of	I-T082
quin	I-T082
##te	I-T082
ao	B-T082
##c	I-T082
exposed	O
sites	O
near	O
tre	B-T082
##nt	I-T082
##on	I-T082
and	I-T082
bell	I-T082
##ev	I-T082
##ille	I-T082
.	O
distribution	B-T082
patterns	I-T082
reflected	O
the	O
properties	O
and	O
usage	O
of	O
the	O
compounds	O
under	O
investigation	O
and	O
the	O
characteristics	O
of	O
each	O
ao	B-T082
##c	I-T082
.	O
environ	O
toxic	O
##ol	O
chem	O
2017	O
;	O
999	O
##9	O
:	O
1	O
-	O
8	O
.	O
©	O
2017	O
set	O
##ac	O
.	O

the	O
mess	O
##aging	O
for	O
diabetes	O
intervention	B-T058
reduced	O
barriers	O
to	O
medication	B-T033
adherence	I-T033
among	O
low	B-T033
-	I-T033
income	I-T033
,	O
diverse	O
adults	O
with	O
type	B-T038
2	I-T038
nonadh	B-T033
##erence	I-T033
to	O
diabetes	B-T038
medication	B-T058
is	O
prevalent	O
and	O
costly	O
.	O
mess	O
##aging	O
for	O
diabetes	O
(	O
med	O
)	O
,	O
a	O
mobile	B-T058
health	I-T058
(	O
mh	B-T058
##ealth	I-T058
)	O
intervention	B-T058
,	O
identified	O
and	O
addressed	O
user	B-T098
-	O
specific	O
barriers	O
to	O
medication	B-T033
adherence	I-T033
.	O
we	O
assessed	O
whether	O
med	O
reduced	O
users	B-T098
'	O
targeted	O
barriers	O
and	O
if	O
barrier	O
reductions	O
were	O
associated	O
with	O
within	B-T098
-	I-T098
participant	I-T098
improvements	O
in	O
adherence	O
or	O
glycemic	O
control	O
(	O
hba1c	B-T103
)	O
.	O
adults	O
(	O
n	O
=	O
80	O
)	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
completed	O
self	O
-	O
report	O
measures	O
identifying	O
barriers	O
to	O
adherence	O
at	O
baseline	O
and	O
monthly	O
for	O
3	O
months	O
.	O
at	O
each	O
assessment	B-T058
,	O
17	O
barriers	O
were	O
assessed	O
and	O
ranked	O
for	O
each	O
user	B-T098
.	O
each	O
subsequent	O
month	O
,	O
users	B-T098
received	O
daily	O
text	B-T170
messages	I-T170
addressing	O
their	O
3	O
highest	O
ranked	O
barriers	O
.	O
targeted	O
barriers	O
were	O
different	O
for	O
each	O
participant	B-T098
and	O
could	O
change	O
monthly	O
.	O
paired	O
t	B-T170
-	I-T170
tests	I-T170
assessed	O
within	B-T098
-	I-T098
participant	I-T098
improvement	O
in	O
targeted	O
barriers	O
each	O
month	O
,	O
and	O
nested	O
regression	B-T170
models	I-T170
assessed	O
if	O
changes	O
in	O
a	O
participant	B-T098
'	I-T098
s	I-T098
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	O
and	O
hba1c	B-T103
.	O
participants	B-T098
were	O
69	O
%	O
non	O
-	O
white	O
and	O
82	O
%	O
had	O
income	O
##s	O
<	O
$	O
25	O
##k	O
.	O
average	O
hba1c	B-T103
was	O
8	O
.	O
2	O
±	O
2	O
.	O
0	O
%	O
.	O
assessment	O
completion	O
rates	O
were	O
100	O
%	O
at	O
baseline	O
,	O
59	O
%	O
at	O
1	O
month	O
,	O
30	O
%	O
at	O
2	O
months	O
,	O
and	O
65	O
%	O
at	O
3	O
months	O
.	O
the	O
most	O
commonly	O
reported	O
barriers	O
were	O
the	O
cost	O
of	O
medications	B-T058
(	O
76	O
%	O
)	O
,	O
bel	O
##ieving	O
medications	B-T058
are	O
harmful	O
(	O
58	O
%	O
)	O
,	O
and	O
lacking	O
information	O
about	O
medications	B-T058
(	O
53	O
%	O
)	O
.	O
participants	B-T098
'	O
barrier	O
scores	O
improved	O
each	O
month	O
and	O
barrier	O
improvement	O
predicted	O
adherence	O
assessed	O
via	O
night	O
##ly	O
adherence	O
assessment	O
text	B-T170
messages	I-T170
(	O
p	O
<	O
.	O
001	O
)	O
.	O
among	O
participants	B-T098
who	O
completed	O
assessments	O
each	O
month	O
,	O
barrier	O
improvement	O
in	O
months	O
2	O
and	O
3	O
(	O
p	O
<	O
.	O
05	O
)	O
predicted	O
hba1c	B-T103
improvement	O
.	O
iterative	O
,	O
individual	O
tailoring	O
may	O
overcome	O
users	B-T098
'	O
barriers	O
to	O
adherence	O
.	O
attrition	O
is	O
a	O
challenge	O
for	O
mh	B-T058
##ealth	I-T058
interventions	B-T058
among	O
low	B-T033
-	I-T033
income	I-T033
patients	O
.	O

congenital	B-T017
anomalies	I-T017
following	O
use	O
of	O
isot	B-T103
##retin	I-T103
##oin	I-T103
:	O
emphasis	O
on	O
its	O
legal	O
aspects	O
we	O
described	O
a	O
neonate	O
with	O
severe	O
and	O
multiple	B-T017
abnormalities	I-T017
following	O
use	O
of	O
isot	B-T103
##retin	I-T103
##oin	I-T103
,	O
in	O
spite	O
of	O
the	O
mother	O
'	O
s	O
previous	O
knowledge	B-T170
of	O
drug	O
complications	O
.	O
initial	O
physical	B-T058
examination	I-T058
after	O
delivery	B-T058
showed	O
congenital	B-T017
absence	I-T017
of	O
both	B-T017
eyes	I-T017
and	O
both	O
aur	B-T017
##icles	I-T017
as	O
well	O
as	O
anal	B-T017
atresia	I-T017
and	O
a	O
cleft	B-T017
palate	I-T017
.	O
due	O
to	O
severe	O
respiratory	B-T033
distress	I-T033
and	O
atresia	B-T017
of	O
the	O
an	B-T017
##us	I-T017
,	O
the	O
neonate	O
was	O
admitted	O
to	O
a	O
neonatal	O
intensive	B-T092
care	I-T092
unit	I-T092
and	O
underwent	O
reconstructive	B-T058
surgery	I-T058
.	O
the	O
drug	B-T103
should	O
not	O
have	O
been	O
used	O
during	O
pregnancy	B-T038
.	O
using	O
this	O
drug	B-T103
within	O
pregnancy	B-T038
with	O
awareness	O
of	O
its	O
side	B-T038
effects	I-T038
may	O
have	O
legal	O
consequences	O
.	O

unintentional	O
insecticide	B-T037
poisoning	I-T037
by	O
age	O
:	O
an	O
analysis	B-T062
of	O
queens	O
##land	O
poison	O
##s	O
information	O
centre	O
calls	O
data	O
from	O
the	O
queens	O
##land	O
poison	O
##s	O
information	O
centre	O
(	O
qp	O
##ic	O
)	O
was	O
assessed	O
to	O
determine	O
mechanisms	O
of	O
acute	O
insecticide	B-T037
poisoning	I-T037
in	O
young	O
children	O
(	O
<	O
5	O
years	O
)	O
and	O
whether	O
age	O
affects	B-T038
insecticide	B-T037
-	I-T037
poisoning	I-T037
patterns	B-T082
.	O
records	B-T170
of	O
all	O
insecticide	O
-	O
related	O
calls	O
placed	O
to	O
qp	O
##ic	O
in	O
2014	O
were	O
obtained	O
.	O
a	O
stratified	O
analysis	B-T062
of	O
call	O
patterns	B-T082
by	O
age	O
was	O
conducted	O
.	O
of	O
74	O
##3	O
insecticide	O
-	O
related	O
calls	O
received	O
by	O
qp	O
##ic	O
364	O
(	O
49	O
.	O
0	O
%	O
)	O
were	O
for	O
young	O
children	O
.	O
the	O
number	O
of	O
calls	O
peaked	O
in	O
children	O
aged	O
one	O
.	O
ant	B-T204
and	O
cock	B-T204
##ro	I-T204
##ach	I-T204
ba	O
##its	O
accounted	O
for	O
39	O
.	O
0	O
%	O
of	O
calls	O
.	O
spray	B-T103
##s	I-T103
,	O
which	O
were	O
found	B-T033
to	O
contain	O
not	O
only	O
pyreth	B-T103
##roid	I-T103
##s	I-T103
,	O
pyreth	B-T103
##rin	I-T103
##s	I-T103
and	O
/	O
or	O
piper	B-T103
##on	I-T103
##ly	I-T103
but	I-T103
##oxide	I-T103
but	O
also	O
the	O
organophosph	B-T103
##ate	I-T103
diaz	I-T103
##ino	I-T103
##n	I-T103
,	O
accounted	O
for	O
25	O
.	O
8	O
%	O
of	O
calls	O
.	O
mouth	B-T038
##ing	I-T038
or	O
ing	B-T038
##esting	I-T038
a	O
pest	B-T103
-	I-T103
control	I-T103
product	I-T103
and	O
consuming	O
an	O
item	O
/	O
insect	O
after	O
treatment	O
were	O
common	O
mechanisms	O
for	O
children	O
under	O
the	O
age	O
of	O
two	O
.	O
topical	B-T082
exposure	O
to	O
spray	B-T103
##s	I-T103
,	O
via	O
direct	O
application	O
,	O
typically	O
by	O
the	O
child	O
or	O
an	O
older	O
sibling	O
,	O
peaked	O
in	O
children	O
aged	O
two	O
.	O
in	O
12	O
.	O
3	O
%	O
of	O
calls	O
medical	B-T058
attention	I-T058
for	O
the	O
child	O
was	O
already	O
sought	O
or	O
advised	B-T058
by	I-T058
qp	O
##ic	O
.	O
normal	O
behaviours	O
associated	O
with	O
child	B-T038
development	I-T038
,	O
particularly	O
mouth	B-T038
##ing	I-T038
behaviours	O
,	O
explained	O
the	O
peak	O
of	O
exposure	O
in	O
one	O
-	O
year	O
-	O
olds	O
.	O
this	O
finding	B-T033
should	O
guide	O
strategies	O
to	O
minim	O
##ise	O
poisoning	B-T037
##s	I-T037
in	O
this	O
vulnerable	B-T098
population	I-T098
.	O

effect	O
of	O
single	B-T201
-	I-T201
dose	I-T201
carbapenem	B-T103
exposure	B-T033
on	O
transcriptional	B-T038
expression	I-T038
of	O
bland	O
##m	O
-	O
1	O
and	O
mex	B-T017
##a	I-T017
in	O
pseudomonas	B-T007
aeruginosa	I-T007
the	O
therapeutic	O
option	O
of	O
a	O
carbapenem	B-T103
antibiotic	I-T103
is	O
compromised	O
in	O
pseudomonas	B-T007
aeruginosa	I-T007
owing	O
both	O
to	O
acquired	B-T038
and	O
intrinsic	O
resistance	O
mechanisms	O
.	O
in	O
recent	O
years	O
,	O
new	B-T103
del	I-T103
##hi	I-T103
metallo	I-T103
-	I-T103
β	I-T103
-	I-T103
lactamase	I-T103
has	O
been	O
the	O
focus	O
as	O
a	O
predominant	O
carbapenem	O
resistance	O
determinant	O
.	O
however	O
,	O
it	O
is	O
unclear	O
which	O
of	O
the	O
mechanisms	O
might	O
be	O
adopted	O
by	O
a	O
p	B-T007
.	I-T007
aeruginosa	I-T007
strain	O
possessing	O
both	O
bland	O
##m	O
-	O
1	O
and	O
an	O
overexpressed	B-T038
mex	B-T017
##ab	I-T017
-	I-T017
op	I-T017
##r	I-T017
##m	I-T017
system	O
during	O
carbapenem	B-T103
therapy	B-T058
.	O
this	O
study	O
investigated	O
the	O
interplay	O
of	O
both	O
mechanisms	O
in	O
clinical	B-T103
isolates	I-T103
of	O
p	B-T007
.	I-T007
aeruginosa	I-T007
when	O
exposed	O
to	O
meropenem	B-T103
.	O
five	O
strains	O
were	O
used	O
:	O
(	O
i	O
)	O
strain	B-T038
overexpressing	I-T038
mex	B-T017
##ab	I-T017
-	I-T017
op	I-T017
##r	I-T017
##m	I-T017
but	O
with	O
no	O
bland	O
##m	O
-	O
1	O
;	O
(	O
ii	O
)	O
strain	O
harbour	O
##ing	O
bland	O
##m	O
-	O
1	O
but	O
expressing	B-T038
mex	B-T017
##ab	I-T017
-	I-T017
op	I-T017
##r	I-T017
##m	I-T017
at	O
basal	O
level	O
;	O
(	O
iii	O
)	O
strain	O
possessing	O
bland	O
##m	O
-	O
1	O
and	O
overexpressing	B-T038
mex	B-T017
##ab	I-T017
-	I-T017
op	I-T017
##r	I-T017
##m	I-T017
;	O
(	O
iv	O
)	O
p	B-T007
.	I-T007
aeruginosa	I-T007
pao	I-T007
##1	I-T007
;	O
and	O
(	O
v	O
)	O
p	B-T007
.	I-T007
aeruginosa	I-T007
k2	I-T007
##73	I-T007
##3	I-T007
-	I-T007
pao	I-T007
##1	I-T007
(	O
δ	B-T017
##me	I-T017
##xa	I-T017
##b	I-T017
-	I-T017
op	I-T017
##r	I-T017
##m	I-T017
δ	B-T017
##me	I-T017
##x	I-T017
##cd	I-T017
-	I-T017
op	I-T017
##r	I-T017
##j	I-T017
δ	B-T017
##me	I-T017
##x	I-T017
##ef	I-T017
-	I-T017
op	I-T017
##r	I-T017
##n	I-T017
δ	B-T017
##me	I-T017
##x	I-T017
##xy	I-T017
-	I-T017
op	I-T017
##r	I-T017
##m	I-T017
)	O
into	O
which	O
bland	O
##m	O
-	O
1	O
was	O
cloned	B-T058
.	O
strains	O
were	O
incubated	O
in	O
lu	B-T103
##ri	I-T103
##a	I-T103
-	I-T103
ber	I-T103
##tan	I-T103
##i	I-T103
broth	I-T103
with	O
and	O
without	O
1	O
##μg	O
/	O
ml	O
meropenem	B-T103
.	O
total	B-T058
rna	I-T058
was	O
isolated	O
at	O
45	O
-	O
min	O
intervals	O
and	O
was	O
immediately	O
reverse	B-T038
transcribed	I-T038
to	O
cdna	B-T103
.	O
this	O
was	O
repeated	O
for	O
6h	O
.	O
quantitative	B-T062
real	I-T062
-	I-T062
time	I-T062
pcr	I-T062
was	O
performed	O
for	O
both	O
resistance	B-T062
mechanisms	I-T062
.	O
meropenem	B-T103
exposure	B-T033
did	O
not	O
significantly	O
elevate	B-T038
transcription	I-T038
of	O
either	O
the	O
bland	O
##m	O
-	O
1	O
or	O
mex	B-T017
##a	I-T017
gene	I-T017
.	O
however	O
,	O
an	O
interesting	O
finding	O
was	O
that	O
upon	O
single	B-T201
-	I-T201
dose	I-T201
exposure	B-T033
to	I-T033
carbapenem	I-T033
,	O
the	O
efflux	B-T017
pump	I-T017
system	I-T017
played	O
a	O
major	O
role	O
in	O
bacterial	O
survival	O
compared	O
with	O
nd	B-T103
##m	I-T103
-	I-T103
1	I-T103
.	O
this	O
study	O
gives	O
an	O
insight	O
into	O
the	O
bacterial	B-T038
response	I-T038
to	I-T038
carbapenem	I-T038
antibiotic	I-T038
when	O
two	O
different	O
resistance	B-T062
mechanisms	I-T062
coexist	O
.	O
this	O
type	O
of	O
study	O
would	O
be	O
helpful	O
in	O
designing	O
future	O
antimicrobials	B-T103
.	O

professional	B-T170
rein	I-T170
##vention	I-T170
##s	I-T170
:	O
swedish	B-T098
psychologists	B-T097
,	O
1990	O
-	O
2010	O
since	O
the	O
early	O
20th	O
century	O
,	O
the	O
swedish	B-T098
psychology	B-T091
profession	I-T091
has	O
undergone	O
several	O
changes	O
in	O
its	O
essential	O
tasks	O
,	O
epist	B-T170
##em	I-T170
##ological	I-T170
foundation	I-T170
##s	I-T170
,	O
and	O
social	O
roles	O
.	O
these	O
changes	O
occurred	O
through	O
an	O
ongoing	O
[UNK]	O
tuning	O
[UNK]	O
with	O
swedish	B-T098
society	B-T092
,	O
in	O
which	O
the	O
profession	O
stro	O
##ve	O
to	O
appear	O
relevant	O
to	O
society	B-T092
'	I-T092
s	I-T092
concerns	O
and	O
problems	B-T033
as	O
well	O
as	O
enroll	O
others	O
to	O
share	O
the	O
profession	O
'	O
s	O
goals	B-T170
and	O
aims	O
.	O
studying	O
the	O
history	O
of	O
the	O
profession	O
can	O
thus	O
shed	O
light	O
on	O
the	O
changing	O
definitions	B-T170
and	O
contours	B-T082
of	O
the	O
psychology	B-T091
profession	I-T091
itself	O
as	O
well	O
as	O
on	O
the	O
organization	O
of	O
the	O
society	B-T092
in	O
which	O
it	O
acts	O
.	O
this	O
article	B-T170
examines	O
the	O
history	O
of	O
the	O
swedish	B-T098
psychology	B-T091
profession	I-T091
from	O
1990	O
to	O
2010	O
,	O
through	O
an	O
analysis	B-T062
of	O
the	O
discussions	O
and	O
debate	O
##s	O
taking	O
place	O
in	O
the	O
swedish	B-T098
psychological	B-T170
association	I-T170
'	I-T170
s	I-T170
journal	I-T170
.	O
the	O
analytical	O
framework	O
used	O
draws	O
on	O
work	O
done	O
within	O
act	B-T170
##or	I-T170
-	I-T170
network	I-T170
theory	I-T170
and	O
science	B-T062
studies	I-T062
.	O
we	O
argue	O
that	O
the	O
profession	O
'	O
s	O
institutional	O
connections	O
,	O
defining	O
tasks	O
,	O
epist	B-T170
##em	I-T170
##ological	I-T170
underpinning	O
##s	O
,	O
and	O
social	O
position	O
have	O
changed	O
in	O
major	O
ways	O
during	O
these	O
2	O
decades	O
.	O
overall	O
,	O
as	O
a	O
result	O
of	O
an	O
increasingly	O
felt	O
insecurity	B-T038
,	O
the	O
profession	O
has	O
turned	O
outward	O
and	O
tried	O
to	O
find	O
new	O
ways	O
to	O
legitim	O
##ize	O
itself	O
to	O
poli	O
##tic	O
##ians	O
,	O
the	O
media	B-T170
,	O
patients	O
,	O
and	O
custom	O
##ers	O
through	O
means	O
such	O
as	O
a	O
more	O
eco	O
##no	O
##mi	O
##zed	O
vocabulary	B-T170
and	O
novel	O
forms	O
of	O
empirical	B-T062
research	I-T062
.	O
these	O
changes	O
have	O
led	O
to	O
a	O
more	O
social	O
##ized	O
profession	O
,	O
now	O
more	O
closely	O
tuned	O
to	O
other	O
actors	B-T097
in	O
swedish	B-T098
society	B-T092
,	O
leading	O
to	O
conflicts	O
within	O
the	O
profession	O
over	O
whether	O
this	O
is	O
an	O
opportunity	O
to	O
better	O
control	O
their	O
own	O
destin	O
##y	O
or	O
if	O
it	O
will	O
lead	O
to	O
a	O
loss	O
of	O
autonomy	O
.	O
(	O
psycinfo	B-T170
database	I-T170
record	I-T170

stress	B-T038
and	O
binge	O
drinking	O
:	O
a	O
toxic	B-T037
combination	O
for	O
the	O
teen	O
##age	O
brain	B-T017
young	O
adult	O
university	O
students	O
frequently	O
binge	O
on	O
alcohol	O
and	O
have	O
high	O
stress	B-T033
levels	I-T033
.	O
based	O
on	O
findings	O
in	O
rodents	B-T204
,	O
we	O
predicted	O
that	O
heavy	O
current	O
alcohol	O
use	O
and	O
elevated	O
stress	B-T038
and	O
depression	O
scores	O
would	O
be	O
associated	O
with	O
deficits	O
on	O
high	O
interference	O
memory	B-T038
tasks	O
,	O
while	O
early	B-T033
onset	I-T033
,	O
prolonged	O
binge	O
patterns	O
would	O
lead	O
to	O
broader	O
cognitive	B-T038
deficits	I-T038
on	O
tests	O
of	O
associative	B-T038
encoding	I-T038
and	O
executive	B-T038
functions	I-T038
.	O
we	O
developed	O
the	O
concentration	B-T038
memory	B-T038
task	O
,	O
a	O
novel	O
computerized	O
version	O
of	O
the	O
concentration	B-T038
card	O
game	O
with	O
a	O
high	O
degree	O
of	O
interference	O
.	O
we	O
found	O
that	O
young	O
adults	O
with	O
elevated	O
stress	O
,	O
depression	O
,	O
and	O
alcohol	O
consumption	O
scores	O
were	O
impaired	O
in	O
the	O
concentration	B-T038
memory	B-T038
task	O
.	O
we	O
also	O
analyzed	O
data	O
from	O
a	O
previous	O
study	O
,	O
and	O
found	O
that	O
higher	O
alcohol	O
consumption	O
scores	O
were	O
associated	O
with	O
impaired	O
performance	O
on	O
another	O
high	O
interference	O
memory	B-T038
task	O
,	O
based	O
on	O
kir	B-T170
##wan	I-T170
and	I-T170
star	I-T170
##k	I-T170
'	I-T170
s	I-T170
mn	I-T170
##em	I-T170
##onic	I-T170
similarity	I-T170
test	I-T170
.	O
on	O
the	O
other	O
hand	O
,	O
adolescent	O
onset	O
of	O
binge	O
drinking	O
predicted	O
poorer	O
performance	O
on	O
broader	O
range	O
of	O
memory	B-T038
tests	B-T170
,	O
including	O
a	O
more	O
systematic	B-T170
test	I-T170
of	I-T170
spatial	I-T170
recognition	I-T170
memory	I-T170
,	O
and	O
an	O
associative	B-T038
learning	I-T038
task	O
.	O
our	O
results	O
are	O
broadly	O
consistent	O
with	O
findings	O
in	O
rodents	B-T204
that	O
acute	O
alcohol	O
and	O
stress	B-T038
exposure	O
suppress	O
neurogenesis	B-T038
in	O
the	O
adult	O
hippocampus	B-T017
,	O
which	O
in	O
turn	O
impairs	O
performance	O
in	O
high	O
interference	O
memory	B-T038
tasks	O
,	O
while	O
adolescent	O
onset	O
binge	O
drinking	O
causes	O
more	O
extensive	O
brain	B-T037
damage	I-T037
and	O
cognitive	B-T038
deficits	I-T038
.	O

identification	O
of	O
mir	B-T103
-	I-T103
21	I-T103
-	I-T103
5p	I-T103
as	O
a	O
functional	B-T017
regulator	I-T017
of	O
mesoth	B-T017
##elin	I-T017
expression	B-T038
using	O
microrna	B-T103
capture	O
affinity	O
coupled	O
with	O
next	B-T062
generation	I-T062
sequencing	I-T062
micrornas	B-T103
(	O
mirnas	B-T103
)	O
are	O
small	B-T103
non	I-T103
-	I-T103
coding	I-T103
rnas	I-T103
that	O
regulate	B-T038
mrna	B-T038
expression	I-T038
mainly	O
by	O
silencing	B-T038
target	O
transcripts	B-T103
via	O
binding	B-T038
to	O
mirna	B-T082
recognition	I-T082
elements	I-T082
(	I-T082
mre	I-T082
##s	I-T082
)	I-T082
in	O
the	O
3	B-T082
'	I-T082
untranslated	I-T082
region	I-T082
(	O
3	B-T082
'	I-T082
utr	I-T082
)	O
.	O
the	O
identification	O
of	O
bon	B-T082
##a	I-T082
fid	I-T082
##e	I-T082
targets	O
is	O
challenging	O
for	O
researchers	B-T033
working	I-T033
on	O
the	O
functional	O
aspect	O
of	O
mirnas	B-T103
.	O
recently	O
,	O
we	O
developed	O
a	O
method	O
(	O
mir	O
-	O
catch	O
)	O
based	O
on	O
biotinylated	B-T038
dna	B-T103
antisense	B-T103
oligonucleotides	I-T103
that	O
capture	O
the	O
mrna	B-T103
of	O
interest	O
and	O
facilitates	O
the	O
characterisation	O
of	O
mirnas	B-T038
:	I-T038
:	I-T038
mrna	I-T038
interactions	I-T038
in	O
a	O
physiological	B-T038
cellular	I-T038
context	O
.	O
here	O
,	O
the	O
mir	O
-	O
catch	O
technique	O
was	O
applied	O
to	O
the	O
mesoth	B-T017
##elin	I-T017
(	I-T017
ms	I-T017
##l	I-T017
##n	I-T017
)	I-T017
gene	I-T017
and	O
coupled	O
with	O
next	B-T062
generation	I-T062
sequencing	I-T062
(	O
ngs	B-T062
)	O
,	O
to	O
identify	O
mirnas	B-T103
that	O
regulate	B-T038
ms	B-T017
##l	I-T017
##n	I-T017
mrna	I-T017
and	O
that	O
may	O
be	O
responsible	O
for	O
its	O
increased	O
protein	B-T033
levels	I-T033
found	O
in	O
malignant	B-T038
pleural	I-T038
mesothelioma	I-T038
(	O
mpm	B-T038
)	O
.	O
biotinylated	B-T038
ms	B-T017
##l	I-T017
##n	I-T017
oligos	I-T017
were	O
employed	O
to	O
isolate	O
mirna	B-T103
:	I-T103
:	I-T103
ms	I-T103
##l	I-T103
##n	I-T103
mrna	I-T103
complexes	I-T103
from	O
a	O
normal	O
cell	B-T017
line	I-T017
(	I-T017
met	I-T017
-	I-T017
5a	I-T017
)	I-T017
which	O
expresses	B-T038
low	O
levels	O
of	O
ms	B-T103
##l	I-T103
##n	I-T103
.	O
mirnas	B-T103
targeting	O
the	O
ms	B-T017
##l	I-T017
##n	I-T017
mrna	I-T017
were	O
identified	O
by	O
ngs	B-T062
and	O
mir	B-T103
-	I-T103
21	I-T103
-	I-T103
5p	I-T103
and	O
mir	B-T103
-	I-T103
100	I-T103
-	I-T103
5p	I-T103
were	O
selected	O
for	O
further	O
validation	B-T062
analyses	I-T062
.	O
mir	B-T103
-	I-T103
21	I-T103
-	I-T103
5p	I-T103
was	O
shown	O
to	O
be	O
able	O
to	O
modulate	B-T082
ms	B-T017
##l	I-T017
##n	I-T017
expression	B-T038
in	O
mirna	B-T103
mimic	B-T058
experiments	B-T062
in	O
a	O
panel	O
of	O
malignant	B-T017
and	O
non	O
-	O
malignant	O
cell	B-T017
lines	I-T017
.	O
further	O
mirna	B-T103
inhibitor	O
experiments	B-T062
and	O
luciferase	B-T103
assays	B-T058
in	O
mer	B-T017
##o	I-T017
-	I-T017
14	I-T017
cells	I-T017
validated	O
mir	B-T103
-	I-T103
21	I-T103
-	I-T103
5p	I-T103
as	O
a	O
true	O
regulator	B-T017
of	O
ms	B-T017
##l	I-T017
##n	I-T017
.	O
moreover	O
,	O
in	O
vitro	O
experiments	O
showed	O
that	O
treatment	B-T058
with	O
mir	B-T103
-	I-T103
21	I-T103
-	I-T103
5p	I-T103
mimic	B-T058
reduced	O
proliferation	O
of	O
mpm	B-T038
cell	B-T017
lines	I-T017
.	O
altogether	O
,	O
this	O
work	O
shows	O
that	O
the	O
mir	O
-	O
catch	O
technique	O
,	O
coupled	O
with	O
ngs	B-T062
and	O
in	O
vitro	O
validation	B-T062
,	O
represents	O
a	O
reliable	O
method	O
to	O
identify	O
native	O
mirna	B-T038
:	I-T038
:	I-T038
mrna	I-T038
interactions	I-T038
.	O
mir	B-T103
-	I-T103
21	I-T103
-	I-T103
5p	I-T103
is	O
suggested	O
as	O
novel	O
regulator	B-T017
of	O
ms	B-T017
##l	I-T017
##n	I-T017
with	O
a	O
possible	O
functional	O
role	O
in	O
cellular	B-T038
growth	I-T038
.	O

patient	O
mobility	O
for	O
elective	O
secondary	B-T058
health	I-T058
care	I-T058
services	I-T058
in	O
response	B-T038
to	O
patient	B-T170
choice	I-T170
policies	I-T170
:	O
a	O
systematic	B-T170
review	I-T170
our	O
review	O
establishes	O
the	O
empirical	O
evidence	O
for	O
patient	O
mobility	O
for	O
elective	B-T058
secondary	I-T058
care	I-T058
services	I-T058
in	O
countries	B-T082
that	O
allow	O
patients	O
to	O
choose	O
their	O
health	O
care	O
provider	O
.	O
pubmed	B-T170
and	O
embase	B-T170
were	O
searched	O
for	O
relevant	O
articles	B-T170
between	O
1990	O
and	O
2015	O
.	O
of	O
5	O
,	O
99	O
##4	O
title	B-T170
##s	I-T170
/	O
abstracts	B-T170
reviewed	O
,	O
26	O
studies	B-T062
were	O
included	O
.	O
the	O
studies	B-T062
used	O
three	O
main	O
methodological	O
models	B-T170
to	O
establish	O
mobility	B-T033
.	O
variation	O
in	O
the	O
extent	O
of	O
patient	O
mobility	O
was	O
observed	O
across	O
the	O
studies	O
.	O
mobility	B-T033
was	O
positively	O
associated	O
with	O
lower	O
waiting	O
times	O
,	O
indicators	O
of	O
better	B-T058
service	I-T058
quality	I-T058
,	O
and	O
access	O
to	O
advanced	B-T092
technology	I-T092
.	O
it	O
was	O
negatively	O
associated	O
with	O
advanced	B-T098
age	I-T098
or	O
lower	O
socioeconomic	O
backgrounds	O
.	O
from	O
a	O
policy	B-T170
perspective	B-T170
we	O
demonstrate	O
that	O
a	O
significant	O
proportion	O
of	O
patients	O
are	O
prepared	O
to	O
travel	O
beyond	O
their	O
nearest	O
provider	O
for	O
elective	O
services	O
.	O
as	O
a	O
consequence	O
,	O
some	O
providers	O
are	O
likely	O
to	O
be	O
[UNK]	O
win	O
##ners	O
[UNK]	O
and	O
others	O
[UNK]	O
lose	B-T033
##rs	I-T033
,	O
[UNK]	O
which	O
could	O
result	O
in	O
overall	O
decreased	O
provider	O
capacity	O
or	O
inefficient	O
utilization	O
of	O
existing	O
services	B-T058
.	O
equity	O
also	O
remains	O
a	O
key	O
concern	O
.	O

clinical	O
correlates	O
of	O
faecal	B-T038
incontinence	I-T038
in	O
systemic	B-T038
sclerosis	I-T038
:	O
identifying	O
therapeutic	O
avenues	O
the	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	O
and	O
severity	O
of	O
faecal	B-T038
incontinence	I-T038
(	O
fi	B-T038
)	O
in	O
ssc	B-T038
,	O
its	O
association	O
with	O
other	O
intestinal	B-T017
manifestations	O
and	O
potential	O
predictors	O
of	O
fi	B-T038
,	O
and	O
its	O
impact	O
on	O
quality	O
of	O
life	O
.	O
a	O
multicentre	O
,	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
of	O
298	O
ssc	B-T038
subjects	O
followed	O
in	O
the	O
canadian	B-T092
scleroderma	I-T092
research	I-T092
group	I-T092
cohort	B-T098
was	O
performed	O
using	O
validated	O
questionnaires	B-T170
:	O
jo	B-T170
##r	I-T170
##ge	I-T170
-	I-T170
we	I-T170
##x	I-T170
##ner	I-T170
score	I-T170
(	O
an	O
fi	B-T038
severity	B-T170
scale	I-T170
)	O
,	O
br	B-T170
##ist	I-T170
##ol	I-T170
stool	I-T170
scale	I-T170
(	O
a	O
visual	O
scale	O
of	O
stool	B-T033
consistency	I-T033
)	O
and	O
fi	B-T038
quality	B-T170
-	I-T170
of	I-T170
-	I-T170
life	I-T170
scale	I-T170
.	O
constipation	B-T033
was	O
defined	O
by	O
the	O
rom	B-T170
##e	I-T170
iii	I-T170
criteria	I-T170
.	O
associations	O
between	O
the	O
jo	B-T170
##r	I-T170
##ge	I-T170
-	I-T170
we	I-T170
##x	I-T170
##ner	I-T170
score	I-T170
and	O
other	O
clinical	B-T033
variables	I-T033
were	O
determined	O
using	O
multivariate	B-T170
regression	I-T170
analyses	I-T170
.	O
eighty	O
-	O
one	O
(	O
27	O
.	O
2	O
%	O
)	O
subjects	O
had	O
fi	B-T038
,	O
which	O
was	O
mild	O
in	O
37	O
(	O
12	O
.	O
4	O
%	O
)	O
and	O
moderate	O
to	O
severe	O
in	O
44	O
(	O
14	O
.	O
8	O
%	O
)	O
.	O
most	O
patients	O
had	O
well	O
-	O
formed	O
stools	B-T031
,	O
111	O
(	O
38	O
.	O
8	O
%	O
)	O
reported	O
constipation	B-T033
and	O
38	O
(	O
13	O
.	O
4	O
%	O
)	O
had	O
been	O
previously	O
treated	O
for	O
small	B-T038
intestinal	I-T038
bacterial	I-T038
overgrowth	I-T038
(	O
sib	B-T038
##o	I-T038
)	O
.	O
variables	O
independently	O
associated	O
with	O
fi	B-T038
were	O
:	O
loose	B-T033
vs	O
well	O
-	O
formed	O
stools	B-T031
[	O
odds	O
ratio	O
(	O
or	O
)	O
=	O
7	O
.	O
01	O
,	O
95	O
%	O
ci	O
:	O
2	O
.	O
09	O
,	O
23	O
.	O
51	O
)	O
]	O
,	O
constipation	B-T033
(	O
or	O
=	O
3	O
.	O
64	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
61	O
,	O
8	O
.	O
27	O
,	O
p	O
=	O
0	O
.	O
002	O
)	O
,	O
history	O
of	O
sib	B-T038
##o	I-T038
(	O
or	O
=	O
2	O
.	O
97	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
06	O
,	O
8	O
.	O
27	O
)	O
and	O
urinary	B-T038
incontinence	I-T038
(	O
or	O
=	O
2	O
.	O
45	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
14	O
,	O
5	O
.	O
27	O
)	O
.	O
quality	O
of	O
life	O
measured	O
with	O
the	O
fi	B-T038
quality	B-T170
-	I-T170
of	I-T170
-	I-T170
life	I-T170
scale	I-T170
was	O
inversely	O
correlated	O
with	O
fi	B-T038
severity	O
(	O
correlation	O
coefficients	O
between	O
-	O
0	O
.	O
60	O
##2	O
and	O
-	O
0	O
.	O
70	O
##2	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
fi	B-T038
was	O
common	O
and	O
often	O
severe	O
in	O
ssc	B-T038
.	O
loose	B-T033
stools	I-T033
,	O
sib	B-T038
##o	I-T038
,	O
constipation	B-T033
and	O
urinary	B-T038
incontinence	I-T038
were	O
strongly	O
associated	O
with	O
fi	B-T038
.	O
other	O
than	O
targeting	O
anorectal	O
dysfunction	B-T038
,	O
concomitant	O
treatment	B-T058
of	O
clinical	O
correlates	O
could	O
lead	O
to	O
improvement	O
in	O
fi	B-T038
and	O
quality	O
of	O
life	O
in	O
ssc	B-T038
.	O

mucosa	B-T031
-	O
associated	O
bio	O
##hydro	O
##gen	O
##ating	O
microbes	O
protect	O
the	O
simulated	O
colon	B-T204
microbiome	O
from	O
stress	B-T033
associated	O
with	O
high	O
concentrations	O
of	O
poly	B-T103
-	I-T103
unsaturated	I-T103
fat	I-T103
polyunsaturated	B-T103
fatty	I-T103
acids	I-T103
(	O
pufas	B-T103
)	O
may	O
affect	O
colon	B-T204
microbiome	O
homeostasis	B-T038
by	O
exert	B-T038
##ing	I-T038
(	O
specific	O
)	O
antimicrobial	B-T103
effects	O
and	O
/	O
or	O
interfering	O
with	O
mucosal	B-T031
biofilm	O
formation	O
at	O
the	O
gut	B-T017
mucosal	I-T017
interface	I-T017
.	O
we	O
used	O
standardized	B-T058
batch	I-T058
incubations	I-T058
and	O
the	O
mucosal	B-T170
-	I-T170
simulator	I-T170
of	I-T170
the	I-T170
human	I-T170
microbial	I-T170
intestinal	I-T170
ecosystem	I-T170
(	O
m	B-T170
-	I-T170
sh	I-T170
##ime	I-T170
)	O
to	O
show	O
the	O
in	O
vitro	O
luminal	B-T082
and	O
mucosal	B-T031
effects	O
of	O
the	O
main	O
pufa	B-T103
in	O
the	O
western	B-T058
diet	I-T058
,	O
linoleic	B-T103
acid	I-T103
(	O
la	B-T103
)	O
.	O
high	O
concentrations	O
of	O
la	B-T103
were	O
found	O
to	O
decrease	O
butyrate	B-T103
production	O
and	O
faecal	B-T007
##ib	I-T007
##acterium	I-T007
pra	I-T007
##us	I-T007
##nit	I-T007
##z	I-T007
##ii	I-T007
numbers	O
dependent	O
on	O
la	B-T103
bio	O
##hydro	O
##gen	O
##ation	O
to	O
vacc	B-T103
##enic	I-T103
acid	I-T103
(	O
va	B-T103
)	O
and	O
stear	B-T103
##ic	I-T103
acid	I-T103
(	O
sa	B-T103
)	O
.	O
in	O
faecal	B-T031
batch	B-T058
incubations	I-T058
,	O
la	B-T103
bio	O
##hydro	O
##gen	O
##ation	O
and	O
butyrate	B-T103
production	O
were	O
positively	O
correlated	O
and	O
sa	B-T103
did	O
not	O
inhibit	O
butyrate	B-T103
production	O
.	O
in	O
the	O
m	B-T170
-	I-T170
sh	I-T170
##ime	I-T170
,	O
addition	O
of	O
a	O
mucosal	B-T031
environment	B-T082
stimulated	O
bio	O
##hydro	O
##gen	O
##ation	O
to	O
sa	B-T103
and	O
protected	O
f	B-T007
.	I-T007
pra	I-T007
##us	I-T007
##nit	I-T007
##z	I-T007
##ii	I-T007
from	O
inhibition	O
by	O
la	B-T103
.	O
this	O
was	O
probably	O
due	O
to	O
the	O
preference	O
of	O
two	O
bio	O
##hydro	O
##gen	O
##ating	O
genera	B-T170
rose	B-T007
##bur	I-T007
##ia	I-T007
and	O
pseudo	B-T007
##but	I-T007
##yr	I-T007
##iv	I-T007
##ibr	I-T007
##io	I-T007
for	O
the	O
mucosal	B-T031
niche	O
.	O
co	B-T058
-	I-T058
culture	I-T058
batch	B-T058
incubations	I-T058
using	O
rose	B-T007
##bur	I-T007
##ia	I-T007
hom	I-T007
##inis	I-T007
and	O
f	B-T007
.	I-T007
pra	I-T007
##us	I-T007
##nit	I-T007
##z	I-T007
##ii	I-T007
validated	B-T062
these	O
observations	B-T062
.	O
correlations	O
networks	O
further	O
uncovered	O
the	O
central	O
role	O
of	O
rose	B-T007
##bur	I-T007
##ia	I-T007
and	O
pseudo	B-T007
##but	I-T007
##yr	I-T007
##iv	I-T007
##ibr	I-T007
##io	I-T007
in	O
protecting	O
luminal	B-T082
and	O
mucosal	B-T058
sh	I-T058
##ime	I-T058
microbiota	I-T058
from	O
la	B-T103
-	O
induced	B-T033
stress	I-T033
.	O
our	O
results	O
confirm	O
how	O
cross	O
-	O
shielding	O
interactions	O
provide	O
resilience	O
to	O
the	O
microbiome	O
and	O
demonstrate	O
the	O
importance	O
of	O
bio	O
##hydro	O
##gen	O
##ating	O
,	O
mucosal	B-T031
bacteria	B-T007
for	O
recovery	O
from	O
la	B-T103
stress	B-T033
.	O

new	O
breast	B-T033
pain	I-T033
chart	B-T074
for	O
objective	B-T170
record	I-T170
of	O
mast	B-T033
##algia	I-T033
mast	B-T033
##algia	I-T033
is	O
the	O
commonest	O
afflic	B-T038
##tion	I-T038
of	O
mammary	B-T017
gland	I-T017
among	O
lad	B-T098
##ies	I-T098
of	O
the	O
reproductive	O
age	O
group	O
.	O
since	O
eti	O
##opathogenesis	O
and	O
therapy	B-T058
are	O
different	O
for	O
cyclic	B-T033
##al	I-T033
and	O
nonc	B-T033
##yclic	I-T033
##al	I-T033
pain	I-T033
,	O
it	O
is	O
imperative	O
to	O
ascertain	O
the	O
exact	O
type	O
correctly	O
.	O
this	O
is	O
usually	O
done	O
in	O
the	O
breast	B-T092
clinics	I-T092
by	O
advis	O
##ing	O
the	O
patient	O
to	O
fill	O
a	O
pain	B-T170
diary	I-T170
over	O
a	O
period	O
of	O
2	O
months	O
over	O
two	O
menstrual	B-T038
cycles	I-T038
.	O
the	O
cardi	B-T074
##ff	I-T074
pain	I-T074
chart	I-T074
records	I-T074
the	O
severity	O
of	O
pain	B-T033
in	O
the	O
form	O
of	O
a	O
triangle	O
for	O
mild	O
to	O
moderate	B-T033
pain	I-T033
and	O
a	O
square	B-T082
for	O
severe	B-T033
pain	I-T033
.	O
moreover	O
,	O
cardi	B-T074
##ff	I-T074
pain	I-T074
chart	I-T074
does	O
not	O
allow	O
a	O
patient	O
to	O
record	O
the	O
severity	O
of	O
pain	B-T033
on	O
days	O
of	O
men	B-T038
##se	I-T038
##s	I-T038
,	O
as	O
she	O
has	O
to	O
put	O
the	O
letter	O
[UNK]	O
p	O
[UNK]	O
in	O
the	O
box	O
.	O
these	O
problems	B-T033
have	O
been	O
resolved	O
in	O
the	O
new	O
breast	B-T033
pain	I-T033
chart	B-T074
.	O
in	O
the	O
new	O
pain	B-T074
chart	I-T074
,	O
the	O
lad	B-T098
##y	I-T098
records	O
pain	B-T033
severity	O
in	O
the	O
form	O
of	O
visual	B-T201
linear	I-T201
analogue	I-T201
scale	I-T201
score	I-T201
on	O
every	O
day	O
of	O
menstrual	B-T038
cycle	I-T038
.	O
she	O
enters	O
her	O
menstrual	B-T038
experience	B-T038
on	O
a	O
separate	O
part	O
of	O
chart	B-T074
,	O
which	O
allows	O
us	O
to	O
visualize	B-T082
the	O
full	O
month	O
'	O
s	O
pain	B-T033
severity	O
in	O
an	O
unc	O
##lu	O
##tt	O
##ered	O
way	O
.	O

diagnosis	B-T033
of	O
retinal	B-T017
health	O
in	O
digital	B-T058
fundus	I-T058
images	I-T058
using	O
continuous	B-T062
wavelet	I-T062
transform	I-T062
(	O
cw	B-T062
##t	I-T062
)	O
and	O
entrop	O
##ies	O
vision	B-T038
is	O
paramount	O
to	O
humans	B-T204
to	O
lead	O
an	O
active	O
personal	O
and	O
professional	O
life	O
.	O
the	O
prevalence	O
of	O
ocular	B-T038
diseases	I-T038
is	O
rising	O
,	O
and	O
diseases	B-T038
such	O
as	O
glaucoma	B-T038
,	O
diabetic	B-T038
retinopathy	I-T038
(	O
dr	B-T038
)	O
and	O
age	B-T038
-	I-T038
related	I-T038
macular	I-T038
degeneration	I-T038
(	O
amd	B-T038
)	O
are	O
the	O
leading	O
causes	O
of	O
blindness	B-T033
in	O
developed	O
countries	O
.	O
identifying	O
these	O
diseases	B-T038
in	O
mass	B-T058
screening	I-T058
programmes	I-T058
is	O
time	O
-	O
consuming	O
,	O
labor	O
-	O
intensive	O
and	O
the	O
diagnosis	B-T033
can	O
be	O
subjective	O
.	O
the	O
use	O
of	O
an	O
automated	B-T058
computer	I-T058
aided	I-T058
diagnosis	I-T058
system	I-T058
will	O
reduce	O
the	O
time	O
taken	O
for	O
analysis	B-T062
and	O
will	O
also	O
reduce	O
the	O
inter	O
-	O
observer	O
subjective	O
vari	O
##abilities	O
in	O
image	B-T058
interpretation	I-T058
.	O
in	O
this	O
work	O
,	O
we	O
propose	O
one	O
such	O
system	O
for	O
the	O
automatic	O
classification	B-T170
of	O
normal	O
from	O
abnormal	B-T033
(	O
dr	B-T038
,	O
amd	B-T038
,	O
glaucoma	B-T038
)	O
images	O
.	O
we	O
had	O
a	O
total	O
of	O
40	O
##4	O
normal	O
and	O
108	O
##2	O
abnormal	B-T033
fundus	B-T058
images	I-T058
in	O
our	O
database	B-T170
.	O
as	O
the	O
first	O
step	O
,	O
2d	B-T062
-	I-T062
continuous	I-T062
wavelet	I-T062
transform	I-T062
(	O
cw	B-T062
##t	I-T062
)	O
decomposition	O
on	O
the	O
fundus	B-T058
images	I-T058
of	O
two	O
classes	O
was	O
performed	O
.	O
subsequently	O
,	O
energy	O
features	O
and	O
various	O
entrop	O
##ies	O
namely	O
yag	O
##er	O
,	O
ren	O
##yi	O
,	O
kap	O
##oor	O
,	O
sh	O
##ann	O
##on	O
,	O
and	O
fuzzy	O
were	O
extracted	O
from	O
the	O
decomposed	O
images	O
.	O
then	O
,	O
adaptive	O
synthetic	O
sampling	B-T170
approach	I-T170
was	O
applied	O
to	O
balance	O
the	O
normal	O
and	O
abnormal	B-T033
datasets	B-T170
.	O
next	O
,	O
the	O
extracted	O
features	O
were	O
ranked	O
according	O
to	O
the	O
significance	O
##s	O
using	O
particle	B-T170
sw	I-T170
##arm	I-T170
optimization	I-T170
(	O
pso	B-T170
)	O
.	O
there	O
##up	O
##on	O
,	O
the	O
ranked	O
and	O
selected	O
features	O
were	O
used	O
to	O
train	O
the	O
random	O
forest	O
classifier	O
using	O
stratified	O
10	O
-	O
fold	O
cross	B-T062
validation	I-T062
.	O
overall	O
,	O
the	O
proposed	O
system	O
presented	O
a	O
performance	O
rate	O
of	O
92	O
.	O
48	O
%	O
,	O
and	O
a	O
sensitivity	O
and	O
specificity	O
of	O
89	O
.	O
37	O
%	O
and	O
95	O
.	O
58	O
%	O
respectively	O
using	O
15	O
features	O
.	O
this	O
novel	O
system	O
shows	O
promise	O
in	O
detecting	O
abnormal	B-T033
fundus	B-T058
images	I-T058
,	O
and	O
hence	O
,	O
could	O
be	O
a	O
valuable	O
adjunct	O
eye	B-T017
health	O
screening	B-T058
tool	I-T058
that	O
could	O
be	O
employed	O
in	O
polycl	B-T092
##inic	I-T092
##s	I-T092
,	O
and	O
thereby	O
reduce	O
the	O
workload	O
of	O
specialists	B-T097
at	O
hospitals	B-T092
.	O

graphene	B-T103
/	O
naf	B-T103
##ion	I-T103
composite	O
film	O
modified	O
glassy	O
carbon	B-T074
electrode	I-T074
for	O
simultaneous	O
determination	B-T058
of	O
paracetamol	B-T103
,	O
aspirin	B-T103
and	O
caffeine	B-T103
in	O
pharmaceutical	O
formulations	O
a	O
graphene	B-T103
-	O
naf	B-T103
##ion	I-T103
composite	O
film	O
was	O
fabricated	O
on	O
the	O
glassy	O
carbon	B-T074
electrode	I-T074
(	O
gr	B-T074
-	I-T074
nf	I-T074
/	I-T074
gc	I-T074
##e	I-T074
)	O
,	O
and	O
used	O
for	O
simultaneous	O
determination	B-T058
of	O
paracetamol	B-T103
(	O
par	B-T103
)	O
,	O
aspirin	B-T103
(	O
asa	B-T103
)	O
and	O
caffeine	B-T103
(	O
caf	B-T103
)	O
.	O
the	O
electrochemical	O
behaviors	O
of	O
par	B-T103
,	O
asa	B-T103
and	O
caf	B-T103
were	O
investigated	O
by	O
cyclic	O
voltammetry	O
and	O
square	B-T058
-	I-T058
wave	I-T058
ads	I-T058
##orptive	I-T058
anodic	I-T058
stripping	I-T058
voltammetry	I-T058
.	O
by	O
using	O
stripping	B-T058
one	O
for	O
simultaneous	O
determination	B-T058
of	O
par	B-T103
,	O
asa	B-T103
and	O
caf	B-T103
,	O
their	O
electrochemical	O
oxidation	O
peaks	O
appeared	O
at	O
+	O
0	O
.	O
64	O
,	O
1	O
.	O
04	O
and	O
1	O
.	O
44	O
##v	O
,	O
and	O
good	O
linear	O
current	O
responses	O
were	O
obtained	O
with	O
the	O
detection	O
limits	O
of	O
18	O
##ng	O
##ml	O
(	O
-	O
1	O
)	O
(	O
1	O
.	O
2	O
##×10	O
(	O
-	O
9	O
)	O
m	O
)	O
,	O
11	O
.	O
7	O
##ng	O
##ml	O
(	O
-	O
1	O
)	O
(	O
6	O
.	O
5	O
##×10	O
(	O
-	O
8	O
)	O
m	O
)	O
and	O
7	O
.	O
3	O
##ng	O
##ml	O
(	O
-	O
1	O
)	O
(	O
3	O
.	O
8	O
##×10	O
(	O
-	O
8	O
)	O
m	O
)	O
,	O
respectively	O
.	O
finally	O
,	O
the	O
proposed	O
electrochemical	O
sensor	O
was	O
successfully	O
applied	O
for	O
quantifying	O
par	B-T103
,	O
asa	B-T103
and	O
caf	B-T103
in	O
commercial	B-T170
tablet	O
formulations	O
.	O

effect	O
of	O
halo	B-T007
##to	I-T007
##ler	I-T007
##ant	I-T007
rhiz	I-T007
##obacteria	I-T007
isolated	O
from	O
halo	B-T204
##ph	I-T204
##ytes	I-T204
on	O
the	O
growth	B-T038
of	O
sugar	B-T204
beet	I-T204
(	O
beta	B-T204
vulgaris	I-T204
l	I-T204
.	O
)	O
under	O
salt	B-T038
stress	I-T038
utilization	O
of	O
rhiz	B-T007
##obacteria	I-T007
that	O
have	O
associated	O
with	O
plant	B-T204
roots	I-T204
in	O
harsh	O
environments	B-T082
could	O
be	O
a	O
feasible	B-T062
strategy	I-T062
to	O
deal	O
with	O
limits	O
to	O
agricultural	O
production	O
caused	O
by	O
soil	O
salinity	B-T033
.	O
halo	B-T204
##ph	I-T204
##ytes	I-T204
occur	O
naturally	O
in	O
high	O
-	O
salt	O
environments	O
,	O
and	O
their	O
roots	B-T204
may	O
be	O
associated	O
with	O
promising	O
microbial	O
candidates	O
for	O
promoting	O
growth	B-T038
and	O
salt	B-T038
tolerance	I-T038
in	O
crops	B-T204
.	O
this	O
study	B-T062
aimed	O
to	O
isolate	O
efficient	O
halo	B-T204
##to	I-T204
##ler	I-T204
##ant	I-T204
plant	I-T204
-	O
growth	B-T038
-	O
promoting	O
rhiz	O
##obacterial	O
strains	O
from	O
halo	B-T204
##ph	I-T204
##ytes	I-T204
and	O
evaluate	O
their	O
activity	O
and	O
effects	O
on	O
sugar	B-T204
beet	I-T204
(	O
beta	B-T204
vulgaris	I-T204
l	I-T204
.	O
)	O
growth	B-T038
under	O
salinity	B-T038
stress	I-T038
.	O
a	O
total	O
of	O
23	O
isolates	B-T103
were	O
initially	O
screened	O
for	O
their	O
ability	O
to	O
secrete	O
1	B-T103
-	I-T103
amino	I-T103
##cycl	I-T103
##opropane	I-T103
-	I-T103
1	I-T103
-	I-T103
carboxylate	I-T103
deaminase	I-T103
(	O
acd	B-T103
)	O
as	O
well	O
as	O
other	O
plant	B-T038
-	I-T038
growth	I-T038
-	O
promoting	O
characteristics	O
and	O
subsequently	O
identified	O
by	O
sequencing	O
the	O
16s	B-T103
rrna	I-T103
gene	B-T017
.	O
three	O
isolates	B-T103
,	O
identified	O
as	O
microc	B-T007
##occus	I-T007
y	I-T007
##unn	I-T007
##ane	I-T007
##ns	I-T007
##is	I-T007
,	O
plan	B-T007
##ococcus	I-T007
rif	I-T007
##iet	I-T007
##oe	I-T007
##ns	I-T007
##is	I-T007
and	O
vari	B-T007
##ov	I-T007
##orax	I-T007
paradox	I-T007
##us	I-T007
,	O
enhanced	O
salt	B-T038
stress	I-T038
tolerance	O
remarkably	O
in	O
sugar	B-T204
beet	I-T204
,	O
resulting	O
in	O
greater	O
seed	B-T038
germination	I-T038
and	O
plant	B-T204
biomass	O
,	O
higher	O
photosynthetic	O
capacity	O
and	O
lower	O
stress	B-T033
-	O
induced	O
ethylene	B-T103
production	O
at	O
different	O
nacl	B-T103
concentrations	O
(	O
50	O
-	O
125	O
mm	O
)	O
.	O
these	O
results	O
demonstrate	O
that	O
salinity	B-T033
-	O
adapted	B-T038
,	O
acd	B-T103
-	O
producing	O
bacteria	B-T007
isolated	O
from	O
halo	B-T204
##ph	I-T204
##ytes	I-T204
could	O
promote	O
sugar	B-T204
beet	I-T204
growth	B-T038
under	O
saline	B-T038
stress	I-T038
conditions	I-T038
.	O

description	B-T170
of	O
anc	B-T007
##yl	I-T007
##oma	I-T007
##rin	I-T007
##a	I-T007
subtilis	I-T007
gen	I-T007
.	I-T007
nov	I-T007
.	I-T007
,	I-T007
sp	I-T007
.	I-T007
nov	I-T007
.	I-T007
,	O
isolated	O
from	O
coastal	B-T082
sediment	I-T082
,	O
proposal	O
of	O
mari	B-T007
##ni	I-T007
##lab	I-T007
##ilia	I-T007
##les	I-T007
ord	I-T007
.	I-T007
nov	I-T007
.	I-T007
and	O
transfer	O
of	O
mari	B-T007
##ni	I-T007
##lab	I-T007
##iliac	I-T007
##ea	I-T007
##e	I-T007
,	O
prol	B-T007
##ix	I-T007
##ib	I-T007
##acter	I-T007
##aceae	I-T007
and	O
mari	B-T007
##ni	I-T007
##fil	I-T007
##aceae	I-T007
to	O
the	O
order	B-T170
mari	B-T007
##ni	I-T007
##lab	I-T007
##ilia	I-T007
##les	I-T007
a	O
gram	B-T007
-	I-T007
stain	I-T007
-	I-T007
negative	I-T007
,	O
facultative	B-T007
##ly	I-T007
anaerobic	I-T007
,	O
moderately	O
halo	O
##phi	O
##lic	O
,	O
filamentous	O
,	O
non	B-T007
-	I-T007
motile	I-T007
bacterium	I-T007
,	O
designated	O
fa	B-T007
##10	I-T007
##2	I-T007
##t	I-T007
,	O
was	O
isolated	O
from	O
marine	O
sediment	O
of	O
the	O
coast	B-T082
of	O
we	B-T082
##ih	I-T082
##ai	I-T082
,	I-T082
china	I-T082
.	O
phylogenetic	B-T062
analysis	I-T062
based	O
on	O
16s	B-T103
rrna	I-T103
gene	I-T103
sequences	I-T103
showed	O
that	O
strain	O
fa	B-T007
##10	I-T007
##2	I-T007
##t	I-T007
formed	O
a	O
distinct	O
evolutionary	B-T038
lineage	O
within	O
the	O
family	O
mari	B-T007
##ni	I-T007
##fil	I-T007
##aceae	I-T007
and	O
its	O
closest	B-T033
relative	I-T033
was	O
mari	B-T007
##ni	I-T007
##fil	I-T007
##um	I-T007
fragile	I-T007
jc	I-T007
##m	I-T007
155	I-T007
##79	I-T007
##t	I-T007
(	O
93	O
.	O
2	O
%	O
sequence	O
similarity	O
)	O
.	O
the	O
dna	B-T103
g	O
+	O
c	O
content	O
of	O
the	O
novel	O
strain	O
was	O
36	O
.	O
5	O
mol	O
%	O
.	O
the	O
predominant	O
cellular	B-T017
fatty	B-T103
acids	I-T103
and	O
respiratory	O
quinone	B-T103
were	O
iso	B-T103
-	I-T103
c1	I-T103
##5	I-T103
:	I-T103
0	I-T103
and	O
iso	B-T103
-	I-T103
c1	I-T103
##5	I-T103
:	I-T103
0	I-T103
3	I-T103
-	I-T103
oh	I-T103
,	O
and	O
mk	B-T103
-	I-T103
7	I-T103
,	O
respectively	O
.	O
on	O
the	O
basis	O
of	O
the	O
phylogenetic	O
,	O
phenotypic	O
and	O
physiological	O
data	O
,	O
strain	O
fa	B-T007
##10	I-T007
##2	I-T007
##t	I-T007
represents	O
a	O
novel	O
genus	B-T170
and	O
species	B-T170
,	O
for	O
which	O
the	O
name	O
anc	B-T007
##yl	I-T007
##oma	I-T007
##rin	I-T007
##a	I-T007
subtilis	I-T007
gen	I-T007
.	I-T007
nov	I-T007
.	I-T007
,	I-T007
sp	I-T007
.	I-T007
nov	I-T007
.	I-T007
is	O
proposed	O
.	O
the	O
type	O
strain	O
of	O
anc	B-T007
##yl	I-T007
##oma	I-T007
##rin	I-T007
##a	I-T007
subtilis	I-T007
is	O
fa	B-T007
##10	I-T007
##2	I-T007
##t	I-T007
(	O
=	O
kc	B-T007
##tc	I-T007
42	I-T007
##25	I-T007
##7t	I-T007
=	O
dsm	B-T007
288	I-T007
##25	I-T007
##t	I-T007
=	O
cic	B-T007
##c	I-T007
109	I-T007
##02	I-T007
##t	I-T007
)	O
.	O
furthermore	O
,	O
a	O
new	O
order	B-T170
named	O
mari	B-T007
##ni	I-T007
##lab	I-T007
##ilia	I-T007
##les	I-T007
is	O
proposed	O
to	O
accommodate	B-T033
three	O
families	O
previously	O
classified	B-T170
in	O
the	O
order	B-T170
bacter	B-T007
##oidal	I-T007
##es	I-T007
.	O
mari	B-T007
##ni	I-T007
##lab	I-T007
##ilia	I-T007
##les	I-T007
ord	I-T007
.	I-T007
nov	I-T007
.	I-T007
encompasses	O
the	O
families	O
mari	B-T007
##ni	I-T007
##lab	I-T007
##iliac	I-T007
##ea	I-T007
##e	I-T007
,	O
prol	B-T007
##ix	I-T007
##ib	I-T007
##acter	I-T007
##aceae	I-T007
and	O
mari	B-T007
##ni	I-T007
##fil	I-T007
##aceae	I-T007
.	O

succin	B-T103
##ic	I-T103
acid	I-T103
production	O
by	O
immobilized	B-T017
cultures	B-T058
using	O
spent	O
sulph	O
##ite	O
liqu	O
##or	O
as	O
fermentation	B-T038
medium	O
spent	B-T103
sulph	I-T103
##ite	I-T103
liqu	I-T103
##or	I-T103
(	O
ss	B-T103
##l	I-T103
)	O
was	O
used	O
as	O
carbon	B-T103
source	B-T033
for	O
the	O
production	O
of	O
succin	B-T103
##ic	I-T103
acid	I-T103
using	O
immobilized	B-T017
cultures	B-T058
of	O
actin	B-T007
##obacillus	I-T007
succin	I-T007
##ogenes	I-T007
and	O
bas	B-T007
##fi	I-T007
##a	I-T007
succin	I-T007
##icip	I-T007
##roduc	I-T007
##ens	I-T007
on	O
two	O
different	O
supports	O
,	O
del	O
##ign	O
##ified	O
cellul	O
##osi	O
##c	O
material	O
(	O
dcm	O
)	O
and	O
alginate	B-T103
beads	O
.	O
fed	B-T058
-	I-T058
batch	I-T058
immobilized	I-T058
cultures	I-T058
with	O
a	B-T007
.	I-T007
succin	I-T007
##ogenes	I-T007
in	O
alginate	B-T103
##s	I-T103
resulted	O
in	O
higher	O
sugar	B-T103
to	O
succin	B-T103
##ic	I-T103
acid	I-T103
conversion	O
yield	O
(	O
0	O
.	O
81	O
##g	O
/	O
g	O
)	O
than	O
the	O
respective	O
yield	O
achieved	O
(	O
0	O
.	O
65	O
##g	O
/	O
g	O
)	O
when	O
dcm	O
immobilized	B-T017
cultures	B-T058
were	O
used	O
.	O
the	O
final	O
succin	B-T103
##ic	I-T103
acid	I-T103
concentration	O
and	O
yield	O
achieved	O
in	O
fed	B-T058
-	I-T058
batch	I-T058
with	O
immobilized	B-T017
cultures	B-T058
of	O
b	B-T007
.	I-T007
succin	I-T007
##icip	I-T007
##roduc	I-T007
##ens	I-T007
in	O
alginate	B-T103
##s	I-T103
(	O
45	O
##g	O
/	O
l	O
and	O
0	O
.	O
66	O
##g	O
/	O
g	O
)	O
were	O
higher	O
than	O
a	B-T007
.	I-T007
succin	I-T007
##ogenes	I-T007
immobilized	B-T017
cultures	B-T058
(	O
35	O
.	O
4	O
##g	O
/	O
l	O
and	O
0	O
.	O
61	O
##g	O
/	O
g	O
)	O
using	O
nano	O
-	O
fil	O
##trated	O
ss	O
##l	O
as	O
fermentation	B-T038
medium	O
.	O
immobilized	B-T017
cultures	B-T058
of	O
b	B-T007
.	I-T007
succin	I-T007
##icip	I-T007
##roduc	I-T007
##ens	I-T007
in	O
alginate	B-T103
beads	O
were	O
reuse	O
##d	O
in	O
four	O
sequential	B-T058
fed	I-T058
-	I-T058
batch	I-T058
fermentation	B-T038
##s	I-T038
of	O
nano	O
-	O
fil	B-T103
##trated	I-T103
ss	I-T103
##l	I-T103
leading	O
to	O
the	O
production	O
of	O
64	O
.	O
7	O
##g	O
of	O
succin	B-T103
##ic	I-T103
acid	I-T103
with	O
a	O
yield	O
range	O
of	O
0	O
.	O
42	O
-	O
0	O
.	O
67	O
##g	O
/	O
g	O
and	O
productivity	O
range	O
of	O
0	O
.	O
29	O
-	O
0	O
.	O
65	O
##g	O
/	O
l	O
/	O
h	O
.	O
the	O
immobilized	B-T017
cultures	B-T058
improved	O
the	O
efficiency	O
of	O
succin	B-T103
##ic	I-T103
acid	I-T103
production	O
as	O
compared	O
to	O
free	B-T058
cell	I-T058
cultures	I-T058
.	O

decoding	O
the	O
interactions	B-T038
regulating	O
the	O
active	O
state	O
mechanics	O
of	O
eukaryotic	B-T204
protein	B-T103
kinases	I-T103
eukaryotic	B-T204
protein	B-T103
kinases	I-T103
regulate	O
most	O
cellular	B-T038
functions	I-T038
by	O
phosphoryl	B-T038
##ating	I-T038
targeted	O
protein	B-T103
substrates	O
through	O
a	O
highly	O
conserved	O
catalytic	B-T017
core	I-T017
.	O
in	O
the	O
active	O
state	O
,	O
the	O
catalytic	B-T017
core	I-T017
oscill	O
##ates	O
between	O
open	B-T082
,	O
intermediate	B-T082
,	O
and	O
closed	B-T082
conformations	B-T082
.	O
currently	O
,	O
the	O
intramolecular	B-T038
interactions	I-T038
that	O
regulate	O
the	O
active	O
state	O
mechanics	O
are	O
not	O
well	O
understood	O
.	O
here	O
,	O
using	O
camp	B-T103
-	I-T103
dependent	I-T103
protein	I-T103
kinase	I-T103
as	O
a	O
representative	O
model	O
coupled	O
with	O
biochemical	O
,	O
biophysical	B-T038
,	O
and	O
computational	B-T062
techniques	I-T062
,	O
we	O
define	O
a	O
set	O
of	O
highly	O
conserved	O
electrostatic	O
and	O
hydrophobic	B-T038
interactions	I-T038
working	O
harmon	O
##ious	O
##ly	O
to	O
regulate	O
these	O
mechanics	O
.	O
these	O
include	O
the	O
previously	O
identified	O
salt	B-T038
bridge	I-T038
between	O
a	O
lysine	B-T103
from	O
the	O
β	B-T082
##3	I-T082
-	I-T082
strand	I-T082
and	O
a	O
glutamate	B-T103
from	O
the	O
α	B-T082
##c	I-T082
-	I-T082
helix	I-T082
as	O
well	O
as	O
an	O
electrostatic	O
interaction	O
between	O
the	O
phosphorylated	B-T038
activation	O
loop	B-T082
and	O
α	B-T082
##c	I-T082
-	I-T082
helix	I-T082
and	O
an	O
ensemble	O
of	O
hydrophobic	O
residues	O
of	O
the	O
regulatory	O
spine	O
and	O
shell	O
.	O
moreover	O
,	O
for	O
over	O
three	O
decades	O
it	O
was	O
thought	O
that	O
the	O
highly	O
conserved	O
β	B-T103
##3	I-T103
-	I-T103
lysine	I-T103
was	O
essential	O
for	O
phosphoryl	B-T038
transfer	I-T038
,	O
but	O
our	O
findings	O
show	O
that	O
the	O
β	B-T103
##3	I-T103
-	I-T103
lysine	I-T103
is	O
not	O
required	O
for	O
phosphoryl	B-T038
transfer	I-T038
but	O
is	O
essential	O
for	O
the	O
active	O
state	O
mechanics	O
.	O

mitochondrial	B-T017
ultrastructure	O
and	O
glucose	B-T038
signaling	I-T038
pathways	I-T038
attributed	O
to	O
the	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
ion	I-T103
channel	I-T103
gene	B-T062
-	I-T062
targeted	I-T062
deletion	B-T038
of	O
the	O
potassium	B-T103
channel	I-T103
kv	I-T103
##1	I-T103
.	I-T103
3	I-T103
(	O
kv	B-T033
##1	I-T033
.	I-T033
3	I-T033
(	I-T033
-	I-T033
∕	I-T033
-	I-T033
)	I-T033
)	I-T033
results	I-T033
i	I-T033
n	O
[UNK]	O
s	O
up	B-T204
##er	I-T204
-	I-T204
sm	I-T204
##eller	I-T204
[UNK]	I-T204
mice	I-T204
with	O
a	O
se	O
ns	O
##ory	O
p	O
h	O
en	O
##otype	O
t	O
hat	O
includes	O
an	O
increased	O
olfactory	B-T038
ability	O
linked	O
to	O
changes	O
in	O
olfactory	B-T038
circuitry	O
,	O
increased	O
abundance	O
of	O
olfactory	B-T017
cilia	I-T017
,	O
and	O
increased	O
expression	O
of	O
odor	B-T103
##ant	I-T103
receptors	I-T103
and	O
the	O
g	B-T103
-	I-T103
protein	I-T103
,	I-T103
gol	I-T103
##f	I-T103
.	O
kv	B-T204
##1	I-T204
.	I-T204
3	I-T204
(	I-T204
-	I-T204
∕	I-T204
-	I-T204
)	I-T204
mice	I-T204
a	I-T204
ls	O
##o	O
have	O
a	O
metabolic	O
p	O
h	O
en	O
##otype	O
i	O
nc	O
##lu	O
##ding	O
lo	O
we	O
##r	O
b	O
o	O
dy	O
weight	O
a	O
nd	O
de	O
cre	O
##ased	O
a	O
d	O
ip	O
##osity	O
,	O
in	O
cre	B-T033
##ased	I-T033
total	I-T033
energy	I-T033
expenditure	I-T033
(	O
tee	B-T033
)	O
,	O
increased	O
locomotor	B-T038
activity	I-T038
,	O
and	O
resistance	B-T038
to	O
both	O
diet	B-T168
-	O
and	O
genetic	B-T038
-	I-T038
induced	I-T038
obesity	B-T038
.	O
we	O
explored	O
two	O
cellular	O
aspects	O
to	O
elucidate	O
the	O
mechanism	O
by	O
which	O
loss	O
of	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
channel	I-T103
in	O
the	O
olfactory	B-T017
bulb	I-T017
(	O
ob	B-T017
)	O
may	O
enhance	O
glucose	B-T038
utilization	I-T038
and	O
metabolic	O
rate	O
.	O
first	O
,	O
using	O
in	B-T062
situ	I-T062
hybridization	I-T062
we	O
find	O
that	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
and	O
the	O
insulin	B-T103
-	O
dependent	O
glucose	B-T103
transporter	I-T103
type	I-T103
4	I-T103
(	O
glut4	B-T103
)	O
are	O
co	O
-	O
localized	O
to	O
the	O
mitral	B-T017
cell	B-T017
layer	I-T017
of	O
the	O
ob	B-T017
.	O
disruption	O
of	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
conduction	O
via	O
construction	O
of	O
a	O
pore	B-T038
mutation	I-T038
(	O
w	B-T038
##38	I-T038
##6	I-T038
##f	I-T038
kv	I-T038
##1	I-T038
.	I-T038
3	I-T038
)	O
was	O
sufficient	O
to	O
independently	O
transloc	B-T038
##ate	I-T038
glut4	B-T103
to	O
the	O
plasma	B-T017
membrane	I-T017
in	O
hek	B-T017
293	I-T017
cells	I-T017
.	O
because	O
olfactory	B-T038
sensory	I-T038
perception	I-T038
and	O
the	O
maintenance	O
of	O
action	B-T038
potential	I-T038
(	I-T038
ap	I-T038
)	I-T038
firing	O
frequency	O
by	O
mitral	B-T017
cells	B-T017
of	O
the	O
ob	B-T017
is	O
highly	O
energy	O
demanding	O
and	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
is	O
also	O
expressed	O
in	O
mitochondria	B-T017
,	O
we	O
next	O
explored	O
the	O
structure	O
of	O
this	O
organelle	B-T017
in	O
mitral	B-T017
cells	B-T017
.	O
we	O
challenged	O
wild	B-T204
##type	I-T204
(	O
wt	B-T204
)	O
and	O
kv	B-T204
##1	I-T204
.	I-T204
3	I-T204
(	I-T204
-	I-T204
∕	I-T204
-	I-T204
)	I-T204
male	I-T204
mice	I-T204
with	O
a	O
m	O
od	B-T058
##erate	I-T058
##ly	I-T058
high	I-T058
-	I-T058
fat	I-T058
diet	I-T058
(	I-T058
m	O
hf	B-T058
,	I-T058
31	O
.	O
8	O
%	O
kcal	O
fat	O
)	O
for	O
4	O
months	O
and	O
then	O
examined	O
ob	B-T017
ultrastructure	O
using	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
.	O
in	O
wt	B-T204
mice	I-T204
,	O
mitochondria	B-T017
were	O
significantly	O
enlarged	O
following	O
diet	B-T038
-	I-T038
induced	I-T038
obesity	I-T038
(	O
dio	B-T038
)	O
and	O
there	O
were	O
fewer	O
mitochondria	B-T017
,	O
likely	O
due	O
to	O
mit	B-T038
##ophag	I-T038
##y	I-T038
.	O
interestingly	O
,	O
mitochondria	B-T017
were	O
significantly	O
smaller	O
in	O
kv	B-T204
##1	I-T204
.	I-T204
3	I-T204
(	I-T204
-	I-T204
∕	I-T204
-	I-T204
)	I-T204
mice	I-T204
c	I-T204
omp	O
##ared	O
with	O
that	O
of	O
w	O
t	B-T204
mice	I-T204
.	I-T204
similar	O
to	O
their	O
m	O
eta	O
##bo	O
##lic	O
r	O
esi	O
##st	O
##ance	O
to	O
d	O
io	B-T038
,	I-T038
the	O
k	O
v1	B-T204
.	I-T204
3	I-T204
(	I-T204
-	I-T204
∕	I-T204
-	I-T204
)	I-T204
mice	I-T204
ha	I-T204
d	O
unchanged	O
mit	O
och	B-T017
##ondr	I-T017
##ia	I-T017
in	I-T017
terms	O
of	O
cros	O
s	B-T082
sectional	I-T082
area	B-T082
and	O
abundance	O
following	O
a	O
challenge	O
with	O
modified	B-T058
diet	I-T058
.	O
we	O
are	O
very	O
interested	O
to	O
understand	O
how	O
targeted	O
disruption	O
of	O
the	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
channel	I-T103
in	O
the	O
ob	B-T017
can	O
modify	O
tee	B-T033
.	O
our	O
study	O
demonstrates	O
that	O
kv	B-T103
##1	I-T103
.	I-T103
3	I-T103
regulates	O
mitochondrial	B-T017
structure	I-T017
and	O
alters	O
glucose	B-T038
utilization	I-T038
;	O
two	O
important	O
metabolic	O
changes	O
that	O
could	O
drive	O
whole	O
system	O
changes	O
in	O
metabolism	B-T038
initiated	O
at	O
the	O
ob	B-T017
.	O

on	O
the	O
control	O
of	O
social	O
approach	B-T033
-	I-T033
avoidance	I-T033
behavior	I-T033
:	O
neural	O
and	O
endocrine	O
mechanisms	O
the	O
ability	O
to	O
control	O
our	O
automatic	O
action	O
tendencies	O
is	O
crucial	O
for	O
adequate	O
social	B-T033
interactions	I-T033
.	O
emotional	B-T033
events	O
trigger	O
automatic	O
approach	B-T033
and	I-T033
avoidance	I-T033
tendencies	O
.	O
although	O
these	O
actions	O
may	O
be	O
generally	O
adaptive	O
,	O
the	O
capacity	O
to	O
overr	O
##ide	O
these	O
emotional	B-T033
reactions	I-T033
may	O
be	O
key	O
to	O
flexible	O
behavior	O
during	O
social	B-T033
interaction	I-T033
.	O
the	O
present	O
chapter	O
provides	O
a	O
review	O
of	O
the	O
neuroendocrine	B-T022
mechanisms	O
underlying	O
this	O
ability	O
and	O
their	O
relation	O
to	O
social	O
psycho	B-T091
##path	I-T091
##ologies	I-T091
.	O
aberrant	O
social	O
behavior	O
,	O
such	O
as	O
observed	O
in	O
social	O
anxiety	O
or	O
psycho	B-T038
##path	I-T038
##y	I-T038
,	O
is	O
marked	O
by	O
abnormalities	B-T033
in	O
approach	B-T033
-	I-T033
avoidance	I-T033
tendencies	O
and	O
the	O
ability	O
to	O
control	O
them	O
.	O
key	O
neural	O
regions	B-T082
involved	O
in	O
the	O
regulation	B-T038
of	O
approach	B-T033
-	I-T033
avoidance	I-T033
behavior	I-T033
are	O
the	O
amygdala	B-T017
,	O
widely	O
implicated	O
in	O
automatic	O
emotional	B-T033
processing	B-T038
,	O
and	O
the	O
anterior	B-T082
prefrontal	B-T017
cortex	I-T017
,	O
which	O
exerts	B-T038
control	O
over	O
the	O
amygdala	B-T017
.	O
hormones	B-T103
,	O
especially	O
testosterone	B-T103
and	O
cortisol	B-T103
,	O
have	O
been	O
shown	O
to	O
affect	B-T038
approach	B-T033
-	I-T033
avoidance	I-T033
behavior	I-T033
and	O
the	O
associated	O
neural	O
mechanisms	O
.	O
the	O
present	O
chapter	O
also	O
discusses	O
ways	O
to	O
directly	O
influence	O
social	O
approach	B-T033
and	I-T033
avoidance	I-T033
behavior	I-T033
and	O
will	O
end	O
with	O
a	O
research	B-T062
agenda	O
to	O
further	O
advance	O
this	O
important	O
research	B-T062
field	I-T062
.	O
control	O
over	O
approach	B-T033
-	I-T033
avoidance	I-T033
tendencies	O
may	O
serve	O
as	O
an	O
exempl	B-T170
##ar	I-T170
of	O
emotional	B-T033
action	O
regulation	B-T038
and	O
might	O
have	O
a	O
great	O
value	O
in	O
understanding	B-T038
the	O
underlying	O
mechanisms	O
of	O
the	O
development	O
of	O
affective	B-T038
disorders	I-T038
.	O

acr	B-T092
appropriateness	O
criteria	O
(	O
®	O
)	O
radiologic	O
management	B-T058
of	O
mesenteric	B-T038
ischemia	I-T038
mesenteric	B-T038
vascular	I-T038
insufficiency	I-T038
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	B-T038
infarction	I-T038
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	B-T082
50	O
%	O
.	O
recommended	O
therapy	B-T058
for	O
acute	B-T038
mesenteric	I-T038
ischemia	I-T038
includes	O
aspiration	B-T058
embol	B-T058
##ectomy	I-T058
,	O
transcatheter	B-T058
thrombolysis	B-T058
,	O
and	O
angioplasty	B-T058
with	O
or	O
without	O
stenting	B-T058
for	O
the	O
treatment	B-T058
of	O
underlying	O
arterial	B-T017
stenosis	I-T017
.	O
non	B-T038
##occl	I-T038
##usive	I-T038
mesenteric	I-T038
ischemia	I-T038
may	O
respond	O
to	O
trans	B-T058
##arterial	I-T058
infusion	I-T058
of	O
vasodilator	B-T103
##s	I-T103
such	O
as	O
nitroglycerin	B-T103
,	O
pap	B-T103
##aver	I-T103
##ine	I-T103
,	O
glucagon	B-T103
,	O
and	O
prostaglandin	B-T103
e1	I-T103
.	O
recommended	O
therapy	B-T058
for	O
chronic	B-T038
mesenteric	I-T038
ischemia	I-T038
includes	O
angioplasty	B-T058
with	O
or	O
without	O
stent	B-T058
placement	I-T058
and	O
,	O
if	O
an	O
endovascular	B-T058
approach	I-T058
is	O
not	O
possible	O
,	O
surgical	B-T058
bypass	I-T058
or	O
endarterectomy	B-T058
.	O
the	O
diagnosis	B-T033
of	O
median	B-T038
arcuate	I-T038
ligament	I-T038
syndrome	I-T038
is	O
controversial	O
,	O
but	O
surgical	B-T058
release	O
may	O
be	O
appropriate	O
depending	O
on	O
the	O
clinical	O
situation	O
.	O
venous	B-T082
mesenteric	B-T038
ischemia	I-T038
may	O
respond	O
to	O
systemic	O
anticoagulation	B-T058
alone	O
.	O
trans	B-T082
##hepatic	I-T082
or	O
trans	O
##jug	O
##ular	O
superior	B-T017
mesenteric	I-T017
vein	I-T017
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	B-T033
,	O
condition	B-T033
of	I-T033
the	I-T033
patient	I-T033
,	O
and	O
response	O
to	O
systemic	O
anticoagulation	B-T058
.	O
adjunct	O
trans	B-T058
##jug	I-T058
##ular	I-T058
intrahepatic	I-T058
port	I-T058
##osystem	I-T058
##ic	I-T058
shunt	I-T058
creation	I-T058
can	O
be	O
considered	O
for	O
outflow	O
improvement	O
.	O
the	O
american	B-T092
college	I-T092
of	I-T092
radiology	I-T092
appropriateness	O
criteria	O
are	O
evidence	O
-	O
based	O
guidelines	B-T170
for	O
specific	O
clinical	B-T033
conditions	I-T033
that	O
are	O
reviewed	O
annually	O
by	O
a	O
multidisciplinary	B-T097
expert	I-T097
panel	I-T097
.	O
the	O
guideline	B-T170
development	O
and	O
revision	O
include	O
an	O
extensive	B-T062
analysis	I-T062
of	O
current	O
medical	O
literature	O
from	O
peer	B-T170
-	I-T170
reviewed	I-T170
journals	I-T170
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	B-T062
(	O
ran	B-T170
##d	I-T170
/	O
ucl	O
##a	O
appropriateness	O
method	O
and	O
grading	B-T170
of	I-T170
recommendations	I-T170
assessment	I-T170
,	I-T170
development	I-T170
,	I-T170
and	I-T170
evaluation	I-T170
or	O
grade	B-T170
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	B-T058
and	O
treatment	B-T058
procedures	I-T058
for	O
specific	O
clinical	O
scenarios	O
.	O
in	O
those	O
instances	O
where	O
evidence	O
is	O
lacking	O
or	O
equivocal	O
,	O
expert	O
opinion	O
may	O
supplement	O
the	O
available	O
evidence	O
to	O
recommend	O
imaging	B-T058
or	O
treatment	B-T058
.	O

fine	O
mapping	O
of	O
carbon	B-T017
assimilation	I-T017
rate	I-T017
8	I-T017
,	O
a	O
quantitative	B-T017
trait	I-T017
locus	I-T017
for	O
flag	B-T204
leaf	I-T204
nitrogen	B-T103
content	O
,	O
stomatal	B-T204
conductance	O
and	O
photosynthesis	O
in	O
rice	B-T204
increasing	O
the	O
rate	O
of	O
leaf	O
photosynthesis	O
is	O
one	O
important	O
approach	O
for	O
increasing	O
grain	O
yield	O
in	O
rice	B-T204
(	O
oryz	B-T204
##a	I-T204
sativa	I-T204
)	O
.	O
exploiting	O
the	O
natural	O
variation	O
in	O
co2	O
assimilation	O
rate	O
(	O
a	O
)	O
between	O
rice	B-T204
cultivars	I-T204
using	O
quantitative	O
genetics	O
is	O
one	O
promising	O
means	O
to	O
identify	O
genes	B-T017
contributing	O
to	O
higher	O
photosynthesis	O
.	O
in	O
this	O
study	O
,	O
we	O
determined	O
precise	O
location	B-T082
of	O
carbon	B-T017
assimilation	I-T017
rate	I-T017
8	I-T017
(	O
car	B-T017
##8	I-T017
)	O
by	O
crossing	B-T038
a	O
high	O
-	O
yielding	O
indica	B-T204
cultivar	I-T204
with	O
a	O
japanese	B-T082
commercial	B-T170
cultivar	B-T204
.	O
fine	O
mapping	O
suggested	O
that	O
car	B-T017
##8	I-T017
encodes	O
a	O
putative	B-T103
heme	I-T103
activator	I-T103
protein	I-T103
3	I-T103
(	O
os	B-T103
##hap	I-T103
##3	I-T103
)	O
subunit	O
of	O
a	O
cca	B-T103
##at	I-T103
-	I-T103
box	I-T103
-	I-T103
binding	I-T103
transcription	I-T103
factor	I-T103
called	O
os	B-T017
##hap	I-T017
##3	I-T017
##h	I-T017
.	O
sequencing	O
analysis	O
revealed	O
that	O
the	O
indica	B-T204
allele	B-T017
of	O
car	B-T017
##8	I-T017
has	O
a	O
1	B-T038
-	I-T038
bp	I-T038
deletion	I-T038
at	O
322	O
bp	B-T038
from	O
the	O
start	B-T082
codon	I-T082
,	O
resulting	O
in	O
a	O
truncated	B-T103
protein	I-T103
of	O
125	O
amino	B-T103
acids	I-T103
.	O
in	O
addition	O
,	O
car	B-T017
##8	I-T017
is	O
identical	O
to	O
dth	B-T017
##8	I-T017
/	O
gh	B-T017
##d	I-T017
##8	I-T017
/	O
lh	B-T017
##d1	I-T017
,	O
which	O
was	O
reported	O
to	O
control	O
rice	B-T204
flowering	B-T038
date	O
.	O
the	O
increase	O
of	O
a	O
is	O
largely	O
due	O
to	O
an	O
increase	O
of	O
rub	O
##p	O
regeneration	O
rate	O
via	O
increased	O
leaf	B-T204
nitrogen	B-T103
content	O
,	O
and	O
partially	O
explained	O
by	O
reduced	O
stomatal	B-T204
limitation	O
via	O
increased	O
stomatal	B-T204
conductance	O
relative	O
to	O
a	O
.	O
this	O
allele	B-T017
also	O
increases	O
hydraulic	O
conductivity	O
,	O
which	O
would	O
promote	O
higher	O
stomatal	B-T204
conductance	O
.	O
this	O
indicates	O
that	O
car	B-T017
##8	I-T017
affects	O
multiple	O
physiological	B-T038
aspects	I-T038
relating	O
to	O
photosynthesis	O
.	O
the	O
detailed	O
analysis	B-T062
of	O
molecular	B-T038
functions	I-T038
of	O
car	B-T017
##8	I-T017
would	O
help	O
to	O
understand	O
the	O
association	O
between	O
photosynthesis	O
and	O
flowering	B-T038
and	O
demonstrate	O
specific	O
genetic	O
mechanisms	O
that	O
can	O
be	O
exploited	O
to	O
improve	B-T033
photosynthesis	O
in	O
rice	B-T204
and	O
potentially	O
other	O
crops	O
.	O

novel	B-T062
strategy	I-T062
to	O
expand	O
super	B-T017
-	I-T017
charged	I-T017
nk	I-T017
cells	I-T017
with	O
significant	O
potential	O
to	O
lys	B-T038
##e	I-T038
and	O
differentiate	O
cancer	B-T017
stem	I-T017
cells	I-T017
:	O
differences	O
in	O
nk	B-T038
expansion	I-T038
and	O
function	O
between	O
healthy	B-T098
and	O
cancer	O
patients	O
natural	B-T017
killer	I-T017
(	I-T017
nk	I-T017
)	I-T017
cells	I-T017
are	O
known	O
to	O
target	O
cancer	B-T017
stem	I-T017
cells	I-T017
and	O
undifferentiated	B-T038
tumors	I-T038
.	O
in	O
this	O
paper	O
,	O
we	O
provide	O
a	O
novel	B-T062
strategy	I-T062
for	O
expanding	O
large	O
numbers	O
of	O
super	B-T017
-	I-T017
charged	I-T017
nk	I-T017
cells	I-T017
with	O
significant	O
potential	O
to	O
lys	B-T038
##e	I-T038
and	O
differentiate	O
cancer	B-T017
stem	I-T017
cells	I-T017
and	O
demonstrate	O
the	O
differences	O
in	O
the	O
dynamics	O
of	O
nk	B-T017
cell	I-T017
expansion	B-T038
between	O
healthy	B-T098
donors	I-T098
and	O
cancer	O
patients	O
.	O
decline	B-T033
in	I-T033
cytotoxicity	I-T033
and	O
lower	B-T082
interferon	B-T038
(	I-T038
ifn	I-T038
)	I-T038
-	I-T038
γ	I-T038
secretion	I-T038
by	O
osteoclast	B-T017
(	O
oc	B-T017
)	O
-	O
expanded	O
nk	B-T017
cells	I-T017
from	O
cancer	O
patients	O
correlates	O
with	O
faster	O
expansion	B-T038
of	O
residual	O
contamin	O
##ating	O
t	B-T017
cells	I-T017
within	O
purified	O
nk	B-T017
cells	I-T017
,	O
whereas	O
healthy	B-T098
donors	I-T098
'	O
ocs	B-T017
continue	O
expanding	O
super	B-T017
-	I-T017
charged	I-T017
nk	I-T017
cells	I-T017
while	O
limiting	O
t	B-T017
cell	I-T017
expansion	B-T038
for	O
up	O
to	O
60	O
days	O
.	O
similar	O
to	O
patient	O
nk	B-T017
cells	I-T017
,	O
nk	B-T017
cells	I-T017
from	O
tumor	B-T038
-	O
bearing	O
bl	B-T038
##t	I-T038
-	I-T038
humanized	I-T038
mice	I-T038
promote	O
faster	O
expansion	B-T038
of	O
residual	O
t	B-T033
cells	I-T033
resulting	I-T033
in	I-T033
decreased	I-T033
numbers	I-T033
and	O
function	O
of	O
nk	B-T017
cells	I-T017
,	O
whereas	O
nk	B-T017
cells	I-T017
from	O
mice	B-T204
with	O
no	B-T033
tumor	B-T038
continue	O
expanding	B-T038
nk	B-T017
cells	I-T017
and	O
retain	O
their	O
cytotoxicity	B-T038
.	O
in	O
addition	O
,	O
dendritic	B-T017
cells	I-T017
(	O
dcs	B-T017
)	O
in	O
contrast	O
to	O
ocs	B-T017
are	O
found	O
to	O
promote	O
faster	O
expansion	B-T038
of	O
residual	O
t	B-T017
cells	I-T017
within	O
purified	O
nk	B-T017
cells	I-T017
resulting	O
in	O
the	O
decline	B-T033
in	I-T033
nk	I-T033
cell	I-T033
numbers	I-T033
from	O
healthy	B-T098
individuals	I-T098
.	O
addition	O
of	O
anti	B-T103
-	I-T103
cd3	I-T103
mab	I-T103
inhibits	O
t	B-T038
cell	I-T038
proliferation	I-T038
while	O
enhancing	O
nk	B-T017
cell	I-T017
expansion	B-T038
;	O
however	O
,	O
expanding	B-T038
nk	B-T017
cells	I-T017
have	O
lower	B-T082
cytotoxicity	B-T038
but	O
higher	O
secretion	B-T038
of	I-T038
ifn	I-T038
-	I-T038
γ	I-T038
.	O
expansion	B-T038
and	O
functional	O
activation	O
of	O
super	B-T017
-	I-T017
charged	I-T017
nk	I-T017
cells	I-T017
by	O
ocs	B-T017
is	O
dependent	O
on	O
interleukin	B-T103
(	I-T103
il	I-T103
)	I-T103
-	I-T103
12	I-T103
and	O
il	B-T103
-	I-T103
15	I-T103
.	O
thus	O
,	O
in	O
this	O
report	O
,	O
we	O
not	O
only	O
provide	O
a	O
novel	B-T062
strategy	I-T062
to	O
expand	B-T038
super	B-T017
-	I-T017
charged	I-T017
nk	I-T017
cells	I-T017
,	O
but	O
also	O
demonstrate	O
that	O
rapid	B-T038
and	I-T038
sustained	I-T038
expansion	I-T038
of	O
residual	O
t	B-T017
cells	I-T017
within	O
the	O
purified	O
nk	B-T017
cells	I-T017
during	O
expansion	B-T038
with	O
dcs	B-T017
or	O
ocs	B-T017
could	O
be	O
a	O
potential	O
mechanism	O
by	O
which	O
the	O
numbers	O
and	O
function	O
of	O
nk	B-T033
cells	I-T033
decline	I-T033
in	O
cancer	O
patients	O
and	O
in	O
bl	B-T038
##t	I-T038
-	I-T038
humanized	I-T038
mice	I-T038
.	O

prop	O
##ulsion	O
strategy	O
in	O
the	O
gait	B-T033
of	O
primary	B-T092
school	I-T092
children	O
;	O
the	O
effect	O
of	O
age	O
and	O
speed	O
the	O
strategy	O
used	O
to	O
generate	O
power	O
for	O
forward	O
prop	B-T038
##ulsion	I-T038
in	O
walking	O
and	O
running	O
has	O
recently	O
been	O
highlighted	O
as	O
a	O
marker	B-T201
of	O
gait	B-T033
maturation	B-T038
and	O
elastic	O
energy	O
recycling	O
.	O
this	O
study	B-T062
investigated	B-T058
ankle	B-T082
and	O
hip	B-T017
power	O
generation	O
as	O
a	O
prop	O
##ulsion	O
strategy	O
(	O
ps	O
)	O
during	O
the	O
late	O
stance	O
/	O
early	O
swing	O
phases	O
of	O
walking	O
and	O
running	O
in	O
typically	O
developing	O
(	O
td	O
)	O
children	O
(	O
15	O
:	O
six	O
to	O
nine	O
years	O
;	O
17	O
:	O
nine	O
to	O
13	O
years	O
)	O
using	O
three	B-T082
-	I-T082
dimensional	I-T082
gait	B-T058
analysis	I-T058
.	O
peak	O
ankle	B-T082
power	O
generation	O
at	O
push	O
-	O
off	O
(	O
peak	O
##a2	O
)	O
,	O
peak	O
hip	B-T017
power	O
generation	O
in	O
early	O
swing	O
(	O
peak	O
##h3	O
)	O
and	O
prop	O
##ulsion	O
strategy	O
(	O
ps	O
)	O
[	O
peak	O
##a2	O
/	O
(	O
peak	O
##a2	O
+	O
peak	O
##h3	O
)	O
]	O
were	O
calculated	O
to	O
provide	O
the	O
relative	O
contribution	O
of	O
ankle	B-T082
power	O
to	O
total	O
prop	B-T038
##ulsion	I-T038
.	O
mean	O
ps	O
values	O
decreased	O
as	O
speed	O
increased	O
for	O
comfortable	O
walking	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
fast	O
walking	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
fast	O
running	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
less	O
consistently	O
during	O
jo	O
##gg	O
##ing	O
(	O
p	O
=	O
0	O
.	O
05	O
##4	O
)	O
.	O
ps	O
varied	O
with	O
age	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
only	O
during	O
fast	O
walking	O
.	O
at	O
any	O
speed	O
of	O
fast	O
walking	O
,	O
older	O
children	O
generated	O
more	O
peak	O
##a2	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
less	O
peak	O
##h3	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
than	O
younger	O
children	O
.	O
while	O
the	O
kinetics	O
of	O
running	O
prop	B-T038
##ulsion	I-T038
appear	O
to	O
be	O
developed	O
by	O
age	O
six	O
years	O
,	O
the	O
skills	O
of	O
fast	O
walking	O
appeared	O
to	O
require	O
additional	O
neuromuscular	O
maturity	O
.	O
these	O
findings	B-T033
support	O
the	O
concept	O
that	O
running	O
is	O
a	O
skill	O
that	O
mature	B-T038
##s	I-T038
early	O
for	O
td	O
children	O
.	O

multi	O
-	O
drug	O
-	O
resistant	O
acinetobacter	B-T007
calc	I-T007
##oacetic	I-T007
##us	I-T007
-	I-T007
acinetobacter	I-T007
baumannii	I-T007
complex	I-T007
infection	B-T038
outbreak	O
in	O
dogs	B-T204
and	O
cats	B-T204
in	O
a	O
veterinary	B-T092
hospital	I-T092
members	O
of	O
the	O
acinetobacter	B-T007
calc	I-T007
##oacetic	I-T007
##us	I-T007
-	I-T007
acinetobacter	I-T007
baumannii	I-T007
complex	I-T007
cause	O
severe	O
outbreaks	O
in	O
humans	B-T204
,	O
and	O
are	O
increasingly	O
reported	B-T058
in	O
animals	B-T204
.	O
a	O
retrospective	B-T062
study	I-T062
,	O
describing	O
a	O
severe	O
outbreak	O
in	O
dogs	B-T204
and	O
cats	B-T204
caused	O
by	O
a	O
multidrug	B-T007
resistant	I-T007
member	I-T007
of	O
the	O
acinetobacter	B-T007
calc	I-T007
##oacetic	I-T007
##us	I-T007
-	I-T007
acinetobacter	I-T007
baumannii	I-T007
complex	I-T007
in	O
a	O
veterinary	B-T092
hospital	I-T092
,	O
between	O
july	O
2010	O
and	O
november	O
2012	O
.	O
the	O
study	B-T062
included	O
19	O
dogs	B-T204
and	O
4	O
cats	B-T204
.	O
acinetobacter	B-T007
calc	I-T007
##oacetic	I-T007
##us	I-T007
-	I-T007
acinetobacter	I-T007
baumannii	I-T007
complex	I-T007
bacteria	I-T007
were	O
isolated	O
from	O
urine	B-T031
(	O
9	O
animals	B-T204
)	O
,	O
respiratory	B-T022
tract	I-T022
(	O
11	O
)	O
,	O
tissues	B-T017
(	O
3	O
)	O
and	O
blood	B-T031
(	O
1	O
)	O
.	O
the	O
most	O
common	O
infection	B-T038
-	O
associated	B-T033
findings	I-T033
included	O
fever	B-T033
,	O
purulent	B-T033
discharge	I-T033
from	O
endotracheal	B-T074
tubes	I-T074
,	O
hypotension	B-T033
,	O
and	O
neutrop	B-T038
##ae	I-T038
##nia	I-T038
.	O
infection	B-T038
s	O
led	O
to	O
pneumonia	B-T038
,	O
urinary	B-T038
tract	I-T038
infection	I-T038
,	O
cellulitis	B-T038
and	O
sepsis	B-T038
.	O
infection	B-T038
was	O
transmitted	B-T038
in	O
the	O
intensive	B-T092
care	I-T092
unit	I-T092
,	O
where	O
22	O
of	O
23	O
animals	B-T204
were	O
initially	O
hospitalised	B-T058
.	O
the	O
mortality	O
rate	O
was	O
70	O
%	O
(	O
16	O
of	O
23	O
animals	B-T204
)	O
,	O
and	O
was	O
higher	O
in	O
cases	O
of	O
respiratory	B-T038
infection	I-T038
compared	O
to	O
other	O
infections	B-T038
.	O
aggressive	O
environmental	B-T082
cleaning	O
and	O
disinfection	B-T058
,	O
with	O
staff	O
education	O
for	O
personal	O
hygiene	O
and	O
antis	B-T058
##eps	I-T058
##is	I-T058
,	O
sharply	O
decreased	O
the	O
infection	B-T038
incidence	O
.	O
health	O
care	O
-	O
associated	O
outbreaks	O
with	O
multidrug	O
resistant	O
acinetobacter	B-T007
calc	I-T007
##oacetic	I-T007
##us	I-T007
-	I-T007
acinetobacter	I-T007
baumannii	I-T007
complex	I-T007
in	O
dogs	B-T204
and	O
cats	B-T204
are	O
potentially	O
highly	O
fatal	O
and	O
difficult	O
to	O
eradicate	O
,	O
warrant	O
##ing	O
monitoring	B-T058
,	O
antis	B-T103
##eptic	I-T103
techniques	O
and	O
jud	O
##icious	O
antibiotic	B-T103
use	O
.	O

sex	O
differences	O
in	O
the	O
effect	O
of	O
chronic	O
mild	O
stress	O
on	O
mouse	B-T204
prefrontal	B-T017
cortical	I-T017
bdnf	B-T103
levels	O
:	O
a	O
role	O
of	O
major	O
ovarian	B-T103
hormones	I-T103
depression	B-T038
induced	O
by	O
stress	B-T033
is	O
affected	O
by	O
sex	O
,	O
age	O
and	O
hormonal	O
status	O
of	O
the	O
animal	B-T204
and	O
also	O
by	O
duration	O
and	O
type	O
of	O
the	O
stressors	O
.	O
moreover	O
,	O
higher	O
prevalence	O
of	O
depression	B-T038
and	O
comorbidities	O
in	O
women	B-T098
than	O
men	B-T098
implies	O
the	O
need	O
to	O
include	O
the	O
sex	O
variable	O
in	O
studies	O
on	O
animal	B-T204
models	I-T204
of	O
depression	B-T038
.	O
the	O
present	O
study	O
was	O
therefore	O
initiated	O
to	O
evaluate	O
the	O
effect	O
of	O
sex	O
and	O
ovarian	B-T103
hormones	I-T103
on	O
depression	B-T038
-	O
like	O
phenotypes	O
in	O
mice	B-T204
exposed	O
to	O
a	O
21	O
-	O
day	O
chronic	O
variable	O
mild	O
stress	O
(	O
cv	O
##ms	O
)	O
paradigm	B-T062
.	O
adult	O
male	O
,	O
intact	O
female	O
and	O
,	O
ovariectomized	O
(	O
ovx	O
)	O
female	O
mice	B-T204
exposed	O
to	O
cv	O
##ms	O
displayed	O
desp	O
##air	O
behavior	O
,	O
a	O
depression	B-T038
-	O
like	O
phenotype	O
,	O
in	O
all	O
the	O
groups	O
.	O
however	O
,	O
intact	O
females	O
alone	O
,	O
but	O
not	O
males	O
and	O
ovx	O
females	O
,	O
showed	O
an	B-T038
##hed	I-T038
##onia	I-T038
,	O
another	O
depression	B-T038
-	O
like	O
phenotype	O
.	O
at	O
the	O
molecular	O
level	O
,	O
the	O
expression	B-T038
of	O
brain	B-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
(	O
bdnf	B-T103
)	O
,	O
a	O
neuropeptide	B-T103
associated	O
with	O
depression	B-T038
,	O
and	O
few	O
other	O
stress	B-T033
-	O
specific	O
genes	B-T017
crh	B-T017
,	O
nr	B-T017
##3c	I-T017
##1	I-T017
,	O
cart	B-T017
,	O
and	O
npy	B-T017
were	O
measured	O
in	O
the	O
prefrontal	B-T017
cortex	I-T017
(	O
pfc	B-T017
)	O
region	O
of	O
the	O
reward	O
circuitry	O
.	O
there	O
was	O
a	O
significant	O
decrease	O
in	O
the	O
bdnf	B-T103
protein	B-T038
expression	I-T038
along	O
with	O
an	O
increase	O
in	O
the	O
mrna	B-T038
expression	I-T038
of	O
crh	B-T017
,	O
nr	B-T017
##3c	I-T017
##1	I-T017
,	O
cart	B-T017
,	O
and	O
npy	B-T017
in	O
intact	O
females	O
,	O
but	O
not	O
in	O
the	O
other	O
two	O
groups	O
of	O
mice	B-T204
.	O
ovx	O
females	O
resembled	O
males	O
in	O
behavioral	B-T033
and	O
molecular	B-T033
responses	I-T033
to	O
cv	O
##ms	O
.	O
17β	B-T103
-	I-T103
estradiol	I-T103
(	O
e2	B-T103
)	O
administration	B-T058
,	O
not	O
progesterone	B-T103
(	O
p4	B-T103
)	O
,	O
to	O
ovx	O
female	O
stress	B-T033
mice	B-T204
,	O
mitigated	O
desp	O
##air	O
and	O
enhanced	O
hed	O
##onic	O
capacity	O
with	O
an	O
increased	O
expression	B-T038
of	O
bdnf	B-T103
in	O
pfc	B-T017
.	O
this	O
study	O
strengthen	O
##s	O
the	O
evidence	O
for	O
the	O
beneficial	O
effects	O
of	O
e2	B-T103
administration	B-T058
in	O
stress	B-T033
condition	O
.	O

diverse	O
colle	B-T204
##to	I-T204
##trich	I-T204
##um	I-T204
species	I-T204
cause	O
anthrac	B-T038
##no	I-T038
##se	I-T038
of	O
tea	B-T204
plants	I-T204
(	O
came	B-T204
##ll	I-T204
##ia	I-T204
sinensis	I-T204
(	I-T204
l	I-T204
.	I-T204
)	I-T204
o	I-T204
.	I-T204
ku	I-T204
##nt	I-T204
##ze	I-T204
)	O
in	O
china	B-T082
anthrac	B-T038
##no	I-T038
##se	I-T038
caused	O
by	O
colle	B-T204
##to	I-T204
##trich	I-T204
##um	I-T204
is	O
one	O
of	O
the	O
most	O
severe	O
diseases	B-T038
that	O
can	O
afflic	O
##t	O
came	B-T204
##ll	I-T204
##ia	I-T204
sinensis	I-T204
.	O
however	O
,	O
research	B-T062
on	O
the	O
diversity	O
and	O
geographical	O
distribution	O
of	O
colle	B-T204
##to	I-T204
##trich	I-T204
##um	I-T204
in	O
china	B-T082
remain	O
limited	O
.	O
in	O
this	O
study	B-T062
,	O
106	O
colle	B-T204
##to	I-T204
##trich	I-T204
##um	I-T204
isolates	B-T103
were	O
collected	O
from	O
diseased	B-T038
leaves	B-T204
of	O
ca	B-T204
.	I-T204
sinensis	I-T204
cultivated	O
in	O
the	O
15	O
main	O
tea	O
production	O
provinces	B-T082
in	O
china	B-T082
.	O
multi	B-T062
-	I-T062
locus	I-T062
phylogenetic	I-T062
analysis	I-T062
coupled	O
with	O
morphological	B-T058
identification	I-T058
showed	O
that	O
the	O
collected	O
isolates	B-T103
belonged	O
to	O
11	O
species	B-T170
,	O
including	O
6	O
known	O
species	B-T170
(	O
c	B-T204
.	I-T204
came	I-T204
##ll	I-T204
##iae	I-T204
,	O
c	B-T204
.	I-T204
cl	I-T204
##iv	I-T204
##iae	I-T204
,	O
c	B-T204
.	I-T204
fi	I-T204
##orin	I-T204
##iae	I-T204
,	O
c	B-T204
.	I-T204
fruct	I-T204
##icola	I-T204
,	O
c	B-T204
.	I-T204
kar	I-T204
##st	I-T204
##ii	I-T204
,	O
and	O
c	B-T204
.	I-T204
si	I-T204
##amen	I-T204
##se	I-T204
)	O
,	O
3	O
new	O
record	B-T170
species	I-T170
(	O
c	B-T204
.	I-T204
ae	I-T204
##ni	I-T204
##gm	I-T204
##a	I-T204
,	O
c	B-T204
.	I-T204
endop	I-T204
##hy	I-T204
##tic	I-T204
##a	I-T204
,	O
and	O
c	B-T204
.	I-T204
trunc	I-T204
##atum	I-T204
)	O
,	O
1	O
novel	O
species	B-T170
(	O
c	B-T204
.	I-T204
w	I-T204
##ux	I-T204
##iens	I-T204
##e	I-T204
)	O
,	O
and	O
1	O
indistinguishable	O
strain	O
,	O
herein	O
described	O
as	O
colle	B-T204
##to	I-T204
##trich	I-T204
##um	I-T204
sp	I-T204
.	I-T204
of	O
these	O
species	B-T170
,	O
c	B-T204
.	I-T204
came	I-T204
##ll	I-T204
##iae	I-T204
and	O
c	B-T204
.	I-T204
fruct	I-T204
##icola	I-T204
were	O
the	O
dominant	O
species	B-T170
causing	O
anthrac	B-T038
##no	I-T038
##se	I-T038
in	O
ca	B-T204
.	I-T204
sinensis	I-T204
.	O
in	O
addition	O
,	O
our	O
study	B-T062
provided	O
further	O
evidence	O
that	O
phylogenetic	B-T062
analysis	I-T062
using	O
a	O
combination	O
of	O
ap	B-T082
##ma	I-T082
##t	I-T082
and	I-T082
gs	I-T082
sequences	I-T082
can	O
be	O
used	O
to	O
effectively	O
resolve	O
the	O
taxonomic	O
relationships	O
within	O
the	O
c	B-T204
.	I-T204
gl	I-T204
##oe	I-T204
##ospor	I-T204
##io	I-T204
##ides	I-T204
species	B-T170
complex	I-T170
.	O
finally	O
,	O
pathogenicity	O
tests	B-T058
suggested	O
that	O
c	B-T204
.	I-T204
came	I-T204
##ll	I-T204
##iae	I-T204
,	O
c	B-T204
.	I-T204
ae	I-T204
##ni	I-T204
##gm	I-T204
##a	I-T204
,	O
and	O
c	B-T204
.	I-T204
endop	I-T204
##hy	I-T204
##tic	I-T204
##a	I-T204
are	O
more	O
invasive	O
than	O
other	O
species	B-T170
after	O
the	O
inoculation	B-T058
of	O
the	O
leaves	B-T204
of	O
ca	B-T204
.	I-T204
sinensis	I-T204
.	O

relationship	O
between	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
and	O
in	O
-	O
hospital	O
mortality	O
in	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
patients	O
with	O
low	O
-	O
risk	O
pulmonary	B-T038
embolism	I-T038
pulmonary	B-T038
embolism	I-T038
(	O
pe	B-T038
)	O
is	O
frequent	O
in	O
subjects	B-T098
with	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
(	O
copd	B-T038
)	O
and	O
associated	O
with	O
high	O
mortality	O
.	O
this	O
multi	B-T062
-	I-T062
center	I-T062
retrospective	I-T062
study	I-T062
was	O
performed	O
to	O
investigate	O
if	O
secondary	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
is	O
associated	O
with	O
in	O
-	O
hospital	O
mortality	O
in	O
copd	B-T038
patients	O
with	O
low	O
-	O
risk	O
pe	B-T038
.	O
we	O
identified	O
copd	B-T038
patients	O
with	O
proven	O
pe	B-T038
between	O
october	O
,	O
2005	O
and	O
october	O
,	O
2015	O
.	O
patients	O
in	O
risk	O
classes	O
iii	O
-	O
v	O
on	O
the	O
basis	O
of	O
the	O
pes	B-T033
##i	I-T033
score	I-T033
were	O
excluded	O
.	O
we	O
extracted	O
demographic	O
,	O
clinical	O
and	O
laboratory	O
information	O
at	O
the	O
time	O
of	O
admission	O
from	O
medical	B-T170
records	I-T170
.	O
all	O
subjects	B-T098
were	O
followed	O
until	O
hospital	B-T058
discharge	I-T058
to	O
identify	O
all	O
-	O
cause	O
mortality	O
.	O
we	O
enrolled	O
62	O
##9	O
consecutive	O
patients	O
with	O
copd	B-T038
and	O
pe	B-T038
at	O
low	O
risk	O
:	O
132	O
of	O
them	O
(	O
21	O
.	O
0	O
%	O
)	O
with	O
and	O
49	O
##7	O
(	O
79	O
.	O
0	O
%	O
)	O
without	O
secondary	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
.	O
compared	O
with	O
those	O
without	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
,	O
the	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
group	O
had	O
significantly	O
lower	O
forced	B-T058
expiratory	I-T058
volume	I-T058
in	I-T058
one	I-T058
second	I-T058
(	I-T058
fev1	I-T058
)	I-T058
level	I-T058
(	O
0	O
.	O
9	O
##±0	O
.	O
3	O
vs	O
.	O
1	O
.	O
4	O
##±0	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
000	O
)	O
,	O
lower	B-T033
pao2	I-T033
and	O
spo	B-T038
##2	I-T038
as	O
well	O
as	O
higher	B-T033
paco2	I-T033
(	O
p	O
=	O
0	O
.	O
03	O
,	O
p	O
=	O
0	O
.	O
03	O
and	O
p	O
=	O
0	O
.	O
000	O
,	O
respectively	O
)	O
.	O
copd	B-T038
patients	O
with	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
had	O
a	O
higher	O
proportion	O
of	O
arrhythmia	B-T033
in	O
electrocardiogram	B-T033
(	O
ecg	B-T033
)	O
(	O
49	O
.	O
5	O
%	O
vs	O
.	O
35	O
.	O
7	O
%	O
,	O
p	O
=	O
0	O
.	O
02	O
)	O
,	O
a	O
longer	O
hospital	O
duration	O
time	O
(	O
15	O
.	O
3	O
##±1	O
##0	O
.	O
1	O
vs	O
.	O
9	O
.	O
7	O
##±	O
##9	O
.	O
1	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
a	O
higher	O
mechanical	O
ventilation	O
rate	O
(	O
noninvasive	B-T170
and	O
invasive	O
,	O
51	O
.	O
7	O
%	O
vs	O
.	O
30	O
.	O
3	O
%	O
,	O
p	O
=	O
0	O
.	O
04	O
and	O
31	O
.	O
0	O
%	O
vs	O
.	O
7	O
.	O
9	O
%	O
,	O
p	O
=	O
0	O
.	O
04	O
,	O
respectively	O
)	O
,	O
and	O
a	O
higher	O
in	O
-	O
hospital	O
mortality	O
(	O
12	O
.	O
1	O
%	O
vs	O
.	O
6	O
.	O
6	O
%	O
,	O
p	O
=	O
0	O
.	O
04	O
)	O
.	O
multivariate	O
logistic	O
regression	O
analysis	O
revealed	O
that	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
was	O
associated	O
with	O
mortality	O
in	O
copd	B-T038
patients	O
with	O
low	O
-	O
risk	O
pe	B-T038
(	O
adjusted	O
or	O
1	O
.	O
11	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
04	O
-	O
1	O
.	O
66	O
)	O
.	O
polyc	B-T038
##yth	I-T038
##emia	I-T038
is	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
all	O
-	O
cause	O
in	O
-	O
hospital	O
mortality	O
in	O
copd	B-T038
patients	O
with	O
pe	B-T038
at	O
low	O
risk	O
.	O

bio	B-T058
##electro	I-T058
##chemical	I-T058
anaerobic	O
sewage	O
treatment	O
technology	O
for	O
arctic	B-T082
communities	O
this	O
study	B-T062
describes	O
a	O
novel	O
wastewater	B-T082
treatment	O
technology	O
suitable	O
for	O
small	O
remote	B-T082
northern	B-T082
communities	O
.	O
the	O
technology	O
is	O
based	O
on	O
an	O
enhanced	O
biodegradation	O
of	O
organic	B-T103
carbon	I-T103
through	O
a	O
combination	O
of	O
anaerobic	O
methan	O
##ogenic	O
and	O
microbial	O
electrochemical	B-T058
(	O
bio	B-T058
##electro	I-T058
##chemical	I-T058
)	O
degradation	O
processes	O
leading	O
to	O
biom	B-T103
##ethane	I-T103
production	O
.	O
the	O
microbial	O
electrochemical	B-T058
degradation	O
is	O
achieved	O
in	O
a	O
membrane	B-T033
##less	I-T033
flow	I-T033
-	O
through	O
bio	O
##ano	O
##de	O
-	O
bioc	O
##ath	O
##ode	O
setup	O
operating	O
at	O
an	O
applied	O
voltage	O
below	O
the	O
water	B-T103
electroly	B-T058
##sis	I-T058
threshold	O
.	O
laboratory	B-T092
wastewater	B-T082
treatment	O
tests	B-T170
conducted	O
through	O
a	O
broad	B-T082
range	I-T082
of	O
mesop	O
##hi	O
##lic	O
and	O
psych	O
##roph	O
##ilic	O
temperatures	O
(	O
5	O
-	O
23	O
°c	O
)	O
using	O
synthetic	O
wastewater	B-T082
showed	O
a	O
biochemical	O
oxygen	O
demand	O
(	O
bod	O
##5	O
)	O
removal	O
efficiency	O
of	O
90	O
-	O
97	O
%	O
and	O
an	O
effluent	O
bod	O
##5	O
concentration	O
as	O
low	O
as	O
7	O
mg	O
l	O
(	O
-	O
1	O
)	O
.	O
an	O
electricity	O
consumption	O
of	O
0	O
.	O
6	O
kw	O
##h	O
kg	O
(	O
-	O
1	O
)	O
of	O
chemical	B-T038
oxygen	I-T038
demand	I-T038
(	O
cod	B-T038
)	O
removed	O
was	O
observed	O
.	O
low	O
energy	O
consumption	O
coupled	O
with	O
enhanced	O
methane	B-T103
production	O
led	O
to	O
a	O
net	O
positive	B-T033
energy	O
balance	O
in	O
the	O
bio	B-T058
##electro	I-T058
##chemical	I-T058
treatment	O
system	O
.	O

psychometric	B-T058
analysis	I-T058
of	O
the	O
patient	B-T170
health	I-T170
questionnaire	I-T170
in	O
danish	B-T082
patients	O
with	O
an	O
implantable	B-T074
cardioverter	I-T074
defibrillator	I-T074
(	O
the	O
def	B-T062
##ib	I-T062
-	I-T062
women	I-T062
study	I-T062
)	O
to	O
assess	O
the	O
psychometric	B-T058
properties	I-T058
of	O
the	O
patient	B-T170
health	I-T170
questionnaire	I-T170
(	O
ph	B-T170
##q	I-T170
-	I-T170
9	I-T170
)	O
,	O
a	O
measure	O
of	O
depressive	B-T033
symptoms	I-T033
,	O
in	O
a	O
large	O
danish	B-T082
national	B-T098
cohort	I-T098
of	O
patients	O
with	O
heart	B-T038
disease	I-T038
,	O
implanted	B-T058
with	O
an	O
implantable	B-T074
cardioverter	I-T074
defibrillator	I-T074
(	O
icd	B-T074
)	O
,	O
using	O
item	O
response	O
theory	O
.	O
a	O
prospective	B-T098
cohort	I-T098
of	O
patients	O
implanted	B-T058
with	O
an	O
icd	B-T074
(	O
n	O
=	O
153	O
##1	O
;	O
80	O
.	O
4	O
%	O
men	B-T098
)	O
completed	O
the	O
ph	B-T170
##q	I-T170
-	I-T170
9	I-T170
at	O
the	O
time	O
of	O
implant	B-T058
.	O
data	O
were	O
analyzed	B-T062
using	O
two	O
item	O
response	O
theory	O
models	O
,	O
the	O
partial	B-T170
cred	I-T170
##it	I-T170
model	I-T170
and	O
the	O
generalized	B-T170
partial	I-T170
cred	I-T170
##it	I-T170
model	I-T170
.	O
the	O
analysis	B-T062
showed	O
disordered	B-T170
response	I-T170
thresholds	O
in	O
eight	O
of	O
nine	O
items	O
for	O
the	O
partial	B-T170
cred	I-T170
##it	I-T170
model	I-T170
and	O
five	O
of	O
nine	O
items	O
for	O
the	O
generalized	B-T170
partial	I-T170
cred	I-T170
##it	I-T170
model	I-T170
,	O
indicating	O
that	O
respondents	B-T098
have	O
difficulty	O
discriminating	B-T038
between	O
response	B-T170
options	O
.	O
when	O
coll	O
##aps	O
##ing	O
response	B-T170
options	O
2	O
and	O
3	O
,	O
the	O
resc	O
##ored	O
ph	B-T170
##q	I-T170
-	I-T170
9	I-T170
had	O
a	O
better	O
fit	O
to	O
both	O
models	B-T170
.	O
the	O
unid	O
##imensional	O
##ity	O
and	O
the	O
precision	O
of	O
the	O
resc	O
##ored	O
ph	B-T170
##q	I-T170
-	I-T170
9	I-T170
were	O
confirmed	O
.	O
items	O
did	O
not	O
have	O
any	O
differential	O
functioning	O
(	O
dif	O
)	O
across	O
educational	B-T033
level	I-T033
,	O
age	O
,	O
indication	O
for	O
icd	B-T074
implantation	B-T058
,	O
and	O
severity	O
of	O
heart	B-T038
failure	I-T038
that	O
influence	O
depression	B-T038
outcomes	O
in	O
patients	O
with	O
an	O
icd	B-T074
.	O
one	O
item	O
exhibited	O
dif	O
by	O
gender	O
.	O
three	O
items	O
did	O
not	O
fit	O
the	O
partial	B-T170
cred	I-T170
##it	I-T170
model	I-T170
,	O
but	O
the	O
generalized	B-T170
partial	I-T170
cred	I-T170
##it	I-T170
model	I-T170
could	O
be	O
fitted	O
to	O
the	O
full	O
item	O
set	O
.	O
the	O
unid	O
##imensional	O
##ity	O
and	O
reliability	O
of	O
the	O
danish	O
version	O
of	O
the	O
ph	B-T170
##q	I-T170
-	I-T170
9	I-T170
were	O
confirmed	B-T033
.	O
however	O
,	O
the	O
associated	O
consequences	O
of	O
the	O
number	O
of	O
response	B-T170
options	O
(	O
3	O
-	O
point	O
versus	O
4	O
-	O
point	O
likert	B-T170
scale	I-T170
)	O
need	O
to	O
be	O
further	O
examined	B-T033
for	O
the	O
ph	B-T170
##q	I-T170
-	I-T170
9	I-T170
both	O
as	O
a	O
screening	B-T058
tool	B-T170
and	O
outcome	O
measure	O
.	O

visual	O
confidence	B-T038
visual	O
confidence	B-T038
refers	O
to	O
an	O
observer	O
'	O
s	O
ability	O
to	O
judge	B-T038
the	O
accuracy	O
of	O
her	O
perceptual	B-T038
decisions	I-T038
.	O
even	O
though	O
confidence	B-T038
judgments	B-T038
have	O
been	O
recorded	O
since	O
the	O
early	O
days	O
of	O
psychophys	B-T091
##ics	I-T091
,	O
only	O
recently	O
have	O
they	O
been	O
recognized	O
as	O
essential	O
for	O
a	O
deeper	O
understanding	O
of	O
visual	B-T038
perception	I-T038
.	O
the	O
reluct	O
##ance	O
to	O
study	O
visual	O
confidence	B-T038
may	O
have	O
come	O
in	O
part	O
from	O
obtaining	O
convincing	O
experimental	O
evidence	O
in	O
favor	O
of	O
metac	B-T038
##ognitive	I-T038
abilities	I-T038
rather	O
than	O
just	O
perceptual	B-T038
sensitivity	I-T038
.	O
some	O
effort	O
has	O
thus	O
been	O
dedicated	O
to	O
offer	O
different	O
experimental	O
paradigms	O
to	O
study	B-T062
visual	O
confidence	B-T038
in	O
humans	B-T204
and	O
nonhuman	B-T204
animals	I-T204
.	O
to	O
understand	O
the	O
origins	O
of	O
confidence	B-T038
judgments	B-T038
,	O
investigators	B-T097
have	O
developed	O
two	O
competing	O
frameworks	O
.	O
the	O
approach	O
based	O
on	O
signal	B-T170
decision	I-T170
theory	I-T170
is	O
popular	O
but	O
fails	O
to	O
account	O
for	O
response	O
times	O
.	O
in	O
contrast	O
,	O
the	O
approach	O
based	O
on	O
accumulation	O
of	O
evidence	O
models	B-T170
naturally	O
includes	O
the	O
dynamics	O
of	O
perceptual	B-T038
decisions	I-T038
.	O
these	O
models	B-T170
can	O
explain	O
a	O
range	O
of	O
results	O
,	O
including	O
the	O
apparently	O
paradoxical	O
dissociation	B-T038
between	O
performance	O
and	O
confidence	B-T038
that	O
is	O
sometimes	O
observed	O
.	O

double	B-T038
strand	I-T038
break	I-T038
induction	O
and	O
kinetics	O
indicate	O
preserved	O
hypersensitivity	B-T038
in	O
keratinocytes	B-T017
to	O
subth	O
##erap	O
##eutic	O
doses	O
for	O
7	O
weeks	O
of	O
radiotherapy	B-T058
previously	O
we	O
reported	O
that	O
hyper	O
-	O
radiosensitivity	O
(	O
hrs	O
)	O
was	O
evidenced	O
by	O
quantifying	O
dna	B-T017
double	I-T017
strand	I-T017
break	I-T017
(	I-T017
dsb	I-T017
)	I-T017
foci	I-T017
in	O
epidermis	B-T017
biopsies	B-T058
collected	O
after	O
delivering	O
radio	B-T170
##therap	I-T170
##eutic	I-T170
one	O
and	O
five	O
dose	O
fractions	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
whether	O
hrs	O
was	O
preserved	O
throughout	O
a	O
7	O
-	O
week	O
radiotherapy	B-T058
treatment	B-T058
,	O
and	O
also	O
to	O
examine	O
the	O
rate	O
of	O
foci	B-T017
decline	O
and	O
foci	B-T017
persistence	O
between	O
dose	O
fractions	O
.	O
42	O
patients	O
with	O
prostate	B-T038
cancer	I-T038
received	O
7	O
-	O
week	O
fractionated	O
radiotherapy	B-T058
treatment	I-T058
(	O
rt	B-T058
)	O
with	O
daily	O
dose	O
fractions	O
of	O
0	O
.	O
05	O
-	O
1	O
.	O
10	O
##gy	O
to	O
the	O
skin	B-T022
.	O
before	O
rt	B-T058
,	O
and	O
at	O
several	O
times	O
throughout	O
treatment	B-T058
,	O
skin	B-T058
biopsies	I-T058
(	O
n	O
=	O
45	O
##2	O
)	O
were	O
collected	O
at	O
30	O
##min	O
,	O
and	O
2	O
,	O
3	O
,	O
24	O
,	O
and	O
72	O
##h	O
after	O
dose	O
fractions	O
.	O
dsb	B-T017
-	I-T017
foci	I-T017
markers	B-T082
,	O
γ	B-T017
##h2	I-T017
##ax	I-T017
and	O
53	B-T017
##bp1	I-T017
,	O
were	O
labelled	O
in	O
epidermal	B-T017
keratinocytes	B-T017
with	O
immunofluorescence	B-T058
and	O
immunohistochemical	O
staining	O
.	O
foci	O
were	O
counted	O
both	O
with	O
digital	B-T058
image	I-T058
analysis	I-T058
and	O
manually	O
.	O
hrs	O
in	O
keratinocytes	B-T017
was	O
evidenced	O
by	O
the	O
dose	O
-	O
response	O
relationships	O
of	O
dsb	B-T017
foci	I-T017
,	O
observed	O
throughout	O
the	O
treatment	O
course	O
,	O
independent	O
of	O
sampling	B-T058
time	O
and	O
quantification	O
method	B-T170
.	O
foci	B-T017
observed	O
at	O
24h	O
after	O
dose	O
fractions	O
indicated	O
considerable	O
dsb	B-T038
persistence	O
.	O
accordingly	O
,	O
foci	B-T017
significantly	O
accumulated	O
after	O
5	O
consecutive	O
dose	O
fractions	O
.	O
for	O
doses	O
below	O
0	O
.	O
3	O
##gy	O
,	O
persistent	O
foci	B-T017
could	O
be	O
observed	O
even	O
at	O
72	O
##h	O
after	O
damage	B-T038
induction	O
.	O
a	O
comparison	O
of	O
γ	B-T017
##h2	I-T017
##ax	I-T017
and	O
53	B-T017
##bp1	I-T017
quantification	O
##s	O
in	O
double	O
-	O
stain	O
##e	O
d	O
biopsies	B-T058
showed	O
similar	O
hrs	O
dose	O
-	O
response	O
relationships	O
.	O
these	O
results	O
represented	O
the	O
first	O
evidence	O
of	O
preserved	O
hrs	O
,	O
assessed	O
by	O
γ	B-T017
##h2	I-T017
##ax	I-T017
-	O
and	O
53	B-T017
##bp1	I-T017
-	O
labelled	O
dsb	B-T017
foci	I-T017
,	O
throughout	O
a	O
7	O
-	O
week	O
treatment	O
course	O
with	O
daily	O
repeated	O
subth	O
##erap	O
##eutic	O
dose	O
fractions	O
.	O

importance	O
of	O
ecological	O
factors	O
and	O
colony	O
handling	B-T033
for	O
optimizing	O
health	O
status	O
of	O
api	O
##aries	O
in	O
mediterranean	B-T098
ecosystems	O
we	O
analyzed	B-T062
six	O
api	O
##aries	O
in	O
several	O
natural	B-T082
environments	I-T082
with	O
a	O
mediterranean	B-T098
ecosystem	O
in	O
mad	B-T082
##ri	I-T082
##d	I-T082
,	O
central	B-T082
spain	I-T082
,	O
in	O
order	O
to	O
understand	B-T038
how	O
landscape	B-T082
and	O
management	O
characteristics	O
may	O
influence	O
api	O
##ary	O
health	O
and	O
bee	B-T204
production	O
in	O
the	O
long	O
term	O
.	O
we	O
focused	O
on	O
five	O
criteria	O
(	O
habitat	B-T082
quality	O
,	O
landscape	B-T082
heterogeneity	O
,	O
climate	O
,	O
management	O
and	O
health	O
)	O
,	O
as	O
well	O
as	O
30	O
subc	O
##ri	O
##ter	O
##ia	O
,	O
and	O
we	O
used	O
the	O
analytic	B-T062
hierarchy	I-T062
process	I-T062
(	O
ah	B-T062
##p	I-T062
)	O
to	O
rank	B-T170
them	O
according	O
to	O
relevance	O
.	O
habitat	B-T082
quality	O
proved	O
to	O
have	O
the	O
highest	O
relevance	O
,	O
followed	O
by	O
bee	O
##hi	O
##ve	O
management	O
.	O
within	O
habitat	B-T082
quality	O
,	O
the	O
following	O
subc	O
##ri	O
##ter	O
##ia	O
proved	O
to	O
be	O
most	O
relevant	O
:	O
or	O
##ographic	O
diversity	O
,	O
elevation	B-T082
range	O
and	O
important	O
plant	B-T204
species	B-T170
located	B-T082
1	O
.	O
5	O
km	O
from	O
the	O
api	O
##ary	O
.	O
the	O
most	O
important	O
subc	O
##ri	O
##ter	O
##ia	O
under	O
bee	O
##hi	O
##ve	O
management	O
were	O
honey	B-T168
production	O
,	O
movement	O
of	O
the	O
api	O
##ary	O
to	O
a	O
location	B-T082
with	O
a	O
higher	O
altitude	O
and	O
wax	B-T103
renewal	O
.	O
temperature	O
was	O
the	O
most	O
important	O
subc	O
##ri	O
##ter	O
##ion	O
under	O
climate	O
,	O
while	O
pathogen	O
and	O
var	B-T204
##ro	I-T204
##a	I-T204
loads	B-T033
were	O
the	O
most	O
significant	O
under	O
health	O
.	O
two	O
of	O
the	O
six	O
api	O
##aries	O
showed	O
the	O
best	O
values	O
in	O
the	O
ah	B-T062
##p	I-T062
analysis	B-T062
and	O
showed	O
annual	O
honey	B-T168
production	O
of	O
70	O
and	O
28	O
kg	O
/	O
colony	O
.	O
this	O
high	O
productivity	O
was	O
due	O
primarily	O
to	O
high	O
elevation	B-T082
range	O
and	O
high	O
or	O
##ographic	O
diversity	O
,	O
which	O
favored	O
high	O
habitat	B-T082
quality	O
.	O
in	O
addition	O
,	O
one	O
of	O
these	O
api	O
##aries	O
showed	O
the	O
best	O
value	O
for	O
bee	O
##hi	O
##ve	O
management	O
,	O
while	O
the	O
other	O
showed	O
the	O
best	O
value	O
for	O
health	O
,	O
reflected	O
in	O
the	O
low	O
pathogen	O
load	B-T033
and	O
low	O
average	O
number	O
of	O
viruses	B-T005
.	O
these	O
results	O
highlight	O
the	O
importance	O
of	O
environmental	O
factors	O
and	O
good	O
san	O
##itary	O
practices	O
to	O
maximize	O
api	O
##ary	O
health	O
and	O
honey	B-T168
productivity	O
.	O

a	O
new	O
light	O
on	O
alk	B-T038
##apto	I-T038
##nu	I-T038
##ri	I-T038
##a	I-T038
:	O
a	O
fourier	O
-	O
transform	O
infrared	O
microscopy	O
(	O
ftir	O
##m	O
)	O
and	O
low	B-T058
energy	I-T058
x	I-T058
-	I-T058
ray	I-T058
fluorescence	I-T058
microscopy	I-T058
(	O
lex	B-T058
##r	I-T058
##f	I-T058
)	O
correl	B-T062
##ative	I-T062
study	I-T062
on	O
a	O
rare	B-T038
disease	I-T038
alk	B-T038
##apto	I-T038
##nu	I-T038
##ri	I-T038
##a	I-T038
(	O
ak	B-T038
##u	I-T038
)	O
is	O
an	O
ultra	B-T038
-	I-T038
rare	I-T038
disease	I-T038
associated	O
to	O
the	O
lack	O
of	O
an	O
enzyme	B-T103
involved	O
in	O
tyrosine	B-T038
catabolism	I-T038
.	O
this	O
deficiency	O
results	O
in	O
the	O
accumulation	B-T033
of	O
homogen	B-T103
##tis	I-T103
##ic	I-T103
acid	I-T103
(	O
hg	B-T103
##a	I-T103
)	O
in	O
the	O
form	O
of	O
och	O
##ron	O
##otic	O
pigment	O
in	O
joint	B-T082
cartilage	B-T017
,	O
leading	O
to	O
a	O
severe	O
arthrop	B-T038
##athy	I-T038
.	O
secondary	B-T038
amyloidosis	I-T038
has	O
been	O
also	O
unequivocally	O
assessed	O
as	O
a	O
comorbidity	O
of	O
ak	B-T038
##u	I-T038
arthrop	B-T038
##athy	I-T038
.	O
composition	O
of	O
och	O
##ron	O
##otic	O
pigment	O
and	O
how	O
it	O
is	O
structurally	B-T082
related	O
to	O
amyloid	B-T103
is	O
still	O
unknown	O
.	O
we	O
exploited	O
synchrotron	O
radiation	O
infrared	O
and	O
x	B-T058
-	I-T058
ray	I-T058
fluorescence	I-T058
microscop	I-T058
##ies	I-T058
in	O
combination	O
with	O
conventional	O
bio	B-T058
-	I-T058
assays	I-T058
and	O
analytical	B-T062
tools	O
to	O
characterize	O
chemical	O
composition	O
and	O
morphology	O
of	O
ak	B-T038
##u	I-T038
cartilage	B-T017
.	O
we	O
ev	O
##ince	O
##d	O
that	O
ak	B-T038
##u	I-T038
cartilage	B-T017
is	O
characterized	O
by	O
proteoglycans	B-T103
depletion	O
,	O
increased	B-T033
sodium	I-T033
levels	I-T033
,	O
accumulation	B-T033
of	O
lipids	B-T103
in	O
the	O
peri	B-T082
-	I-T082
lacun	I-T082
##ar	I-T082
regions	I-T082
and	O
amyloid	B-T103
formation	O
.	O
we	O
also	O
highlighted	O
an	O
increase	O
of	O
aromatic	B-T103
compounds	I-T103
and	O
oxygen	B-T103
-	I-T103
containing	I-T103
species	I-T103
,	O
depletion	O
in	O
overall	O
magnesium	B-T103
content	O
(	O
although	O
localized	B-T082
in	O
the	O
peri	B-T082
-	I-T082
lacun	I-T082
##ar	I-T082
region	I-T082
)	O
and	O
the	O
presence	B-T033
of	O
calcium	B-T103
carbonate	I-T103
fragments	O
in	O
proximity	B-T082
of	O
cartilage	B-T082
lacun	I-T082
##ae	I-T082
.	O
we	O
highlighted	O
common	O
features	O
between	O
ak	B-T038
##u	I-T038
and	O
arthrop	B-T038
##athy	I-T038
,	O
but	O
also	O
specific	O
signatures	O
of	O
the	O
disease	B-T038
,	O
like	O
presence	B-T033
of	O
amyloid	B-T103
##s	I-T103
and	O
peculiar	B-T033
calcifications	B-T038
.	O
our	O
analyses	B-T062
provide	O
a	O
unified	O
picture	O
of	O
ak	B-T038
##u	I-T038
cartilage	B-T017
,	O
shedding	O
a	O
new	O
light	O
on	O
the	O
disease	B-T038
and	O
opening	O
new	O
perspectives	O
.	O
och	O
##ron	O
##otic	O
pigment	O
is	O
a	O
hallmark	O
of	O
ak	B-T038
##u	I-T038
and	O
responsible	O
of	O
tissue	B-T038
degeneration	I-T038
.	O
conventional	O
bio	B-T058
-	I-T058
assays	I-T058
have	O
not	O
yet	O
clarified	O
its	O
composition	O
and	O
its	O
structural	B-T082
relationship	O
with	O
amyloid	B-T103
##s	I-T103
.	O
the	O
present	O
work	B-T062
proposes	O
new	O
strategies	O
for	O
filling	O
the	O
aforementioned	O
gap	O
that	O
encompass	O
the	O
integration	O
of	O
new	O
analytical	B-T062
approaches	O
with	O
standardized	O
analyses	B-T062
.	O

albumin	B-T103
-	O
bio	O
##ins	O
##pir	O
##ed	O
gd	B-T103
:	O
cus	B-T103
nano	O
##ther	O
##ano	O
##st	O
##ic	O
agent	O
for	O
in	B-T082
vivo	I-T082
photo	B-T058
##acoustic	I-T058
/	I-T058
magnetic	B-T058
resonance	I-T058
imaging	I-T058
-	I-T058
guided	I-T058
tumor	B-T038
-	I-T058
targeted	I-T058
photothermal	I-T058
therapy	I-T058
photothermal	B-T058
therapy	I-T058
(	O
ptt	B-T058
)	O
is	O
attract	O
##ing	O
increasing	O
interest	O
and	O
becoming	O
more	O
widely	O
used	O
for	O
skin	B-T058
cancer	I-T058
therapy	I-T058
in	O
the	O
clinic	B-T092
,	O
as	O
a	O
result	O
of	O
its	O
noninvasive	O
##ness	O
and	O
low	B-T038
systemic	I-T038
adverse	I-T038
effects	I-T038
.	O
however	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
biocompatible	O
ptt	O
agents	O
,	O
which	O
enable	O
accurate	O
imaging	B-T058
,	O
monitoring	B-T058
,	O
and	O
diagnosis	B-T033
.	O
herein	O
,	O
a	O
biocompatible	O
gd	B-T103
-	O
integrated	O
cus	B-T103
nano	O
##ther	O
##ano	O
##st	O
##ic	O
agent	O
(	O
gd	B-T103
:	O
cus	B-T103
@	O
bsa	B-T103
)	O
was	O
synthesized	O
via	O
a	O
facile	O
and	O
environmentally	O
friendly	O
biomimetic	O
strategy	O
,	O
using	O
bovine	B-T103
serum	I-T103
albumin	I-T103
(	O
bsa	B-T103
)	O
as	O
a	O
bio	O
##te	O
##mp	O
##la	O
##te	O
at	O
physiological	O
temperature	O
.	O
the	O
as	O
-	O
prepared	O
gd	B-T103
:	O
cus	B-T103
@	O
bsa	B-T103
nanoparticles	O
(	O
nps	O
)	O
with	O
ultras	O
##mal	O
##l	O
sizes	O
(	O
ca	O
.	O
9	O
nm	O
)	O
exhibited	O
high	O
photothermal	B-T033
conversion	I-T033
efficiency	I-T033
and	O
good	O
photos	B-T033
##ta	I-T033
##bil	I-T033
##ity	I-T033
under	O
near	O
-	O
infrared	O
(	O
nir	O
)	O
laser	O
irradiation	O
.	O
with	O
doped	B-T103
gd	I-T103
species	I-T103
and	O
strong	O
tunable	O
nir	O
absorbance	O
,	O
gd	B-T103
:	O
cus	B-T103
@	O
bsa	B-T103
nps	O
demonstrate	O
prominent	O
tumor	B-T058
-	I-T058
contrasted	I-T058
imaging	I-T058
performance	O
both	O
on	O
the	O
photo	B-T058
##acoustic	I-T058
and	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
modalities	O
.	O
the	O
subsequent	O
gd	B-T058
:	I-T058
cus	B-T103
@	I-T058
bsa	B-T103
-	I-T058
mediated	I-T058
ptt	I-T058
result	O
shows	O
high	O
therapy	B-T033
efficacy	I-T033
as	O
a	O
result	O
of	O
their	O
potent	O
nir	B-T033
absorption	I-T033
and	O
high	O
photothermal	B-T033
conversion	I-T033
efficiency	I-T033
.	O
the	O
immune	B-T038
response	I-T038
triggered	O
by	O
gd	B-T058
:	I-T058
cus	B-T103
@	I-T058
bsa	B-T103
-	I-T058
mediated	I-T058
ptt	I-T058
is	O
prelim	O
##inarily	O
explored	O
.	O
in	O
addition	O
,	O
toxicity	B-T058
studies	I-T058
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
verify	O
that	O
gd	B-T103
:	O
cus	B-T103
@	O
bsa	B-T103
nps	O
qual	O
##ify	O
as	O
biocompatible	O
agents	O
.	O
a	O
biodistribution	B-T062
study	I-T062
demonstrated	O
that	O
the	O
nps	O
can	O
undergo	O
hepatic	O
clearance	O
from	O
the	O
body	B-T204
.	O
this	O
study	O
highlights	O
the	O
practical	O
##ity	O
and	O
versatility	O
of	O
albumin	B-T103
-	O
mediated	O
biomimetic	O
mineralization	O
of	O
a	O
nano	O
##ther	O
##ano	O
##st	O
##ic	O
agent	O
and	O
also	O
suggests	O
that	O
bio	O
##ins	O
##pir	O
##ed	O
gd	B-T103
:	O
cus	B-T103
@	O
bsa	B-T103
nps	O
possess	O
promising	O
imaging	B-T058
guidance	I-T058
and	O
effective	O
tumor	B-T058
ablation	I-T058
properties	I-T058
,	O
with	O
high	O
spatial	O
resolution	O
and	O
deep	O
tissue	B-T017
penetration	O
.	O

is	B-T103
##x	I-T103
-	I-T103
9	I-T103
can	O
potentiate	O
cell	B-T038
proliferation	I-T038
and	O
neuronal	B-T017
commitment	B-T038
in	O
the	O
rat	B-T204
dentate	B-T017
gyrus	I-T017
adult	O
hippocampal	B-T017
neurogenesis	B-T038
can	O
be	O
modulated	B-T082
by	O
various	O
physiological	O
and	O
pathological	B-T038
conditions	I-T038
,	O
including	O
stress	B-T033
,	O
affective	B-T038
disorders	I-T038
,	O
and	O
several	O
neurological	O
conditions	O
.	O
given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	B-T038
of	O
the	O
hippocampus	B-T017
(	O
namely	O
learning	B-T038
and	O
memory	B-T038
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	B-T017
neurogenesis	B-T038
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O
thus	O
,	O
the	O
search	O
for	O
compounds	B-T103
that	O
can	O
reverse	O
these	O
deficits	O
with	O
minimal	O
side	B-T038
effects	I-T038
has	O
become	O
a	O
recognized	O
priority	O
.	O
in	O
the	O
present	O
study	B-T062
we	O
tested	O
the	O
pro	O
-	O
neurogenic	O
effects	O
of	O
iso	B-T103
##xa	I-T103
##zo	I-T103
##le	I-T103
9	I-T103
(	O
is	B-T103
##x	I-T103
-	I-T103
9	I-T103
)	O
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	O
through	O
the	O
screening	B-T058
of	I-T058
chemical	I-T058
libraries	I-T058
in	O
stem	B-T058
cell	I-T058
-	I-T058
based	I-T058
assays	I-T058
.	O
we	O
found	O
that	O
administration	B-T058
of	O
is	B-T103
##x	I-T103
-	I-T103
9	I-T103
for	O
14	O
##days	O
was	O
able	O
to	O
potentiate	O
cell	B-T038
proliferation	I-T038
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	B-T017
in	O
the	O
hippocampal	B-T017
dg	B-T017
of	O
adult	O
rats	B-T204
.	O
in	O
addition	O
,	O
is	B-T103
##x	I-T103
-	I-T103
9	I-T103
treatment	B-T058
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	B-T038
process	I-T038
observed	O
in	O
vehicle	B-T103
-	O
treated	O
animals	B-T204
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	B-T058
and	O
exposure	O
to	O
daily	O
intraperitoneal	B-T058
injections	I-T058
)	O
.	O
based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	B-T038
studies	B-T062
that	O
require	O
repeated	O
handling	B-T058
and	O
manipulation	B-T058
of	O
animals	B-T204
should	O
include	O
a	O
naive	O
(	O
non	O
-	O
manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	B-T017
cell	B-T038
proliferation	I-T038
and	O
neuronal	B-T017
differentiation	B-T038
.	O
overall	O
,	O
these	O
findings	B-T033
demonstrate	O
that	O
is	B-T103
##x	I-T103
-	I-T103
9	I-T103
is	O
a	O
promising	O
synthetic	O
compound	B-T103
for	O
the	O
mitigation	O
of	O
stress	B-T033
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	B-T017
neurogenesis	B-T038
.	O
future	O
studies	B-T062
are	O
thus	O
warranted	O
to	O
evaluate	B-T058
the	O
pro	O
-	O
neurogenic	O
properties	O
of	O
is	B-T103
##x	I-T103
-	I-T103
9	I-T103
in	O
animal	B-T204
models	I-T204
of	O
affective	B-T038
and	O
neurological	B-T038
disorders	I-T038
associated	O
with	O
impaired	O
hippocampal	B-T017
structural	O
plasticity	O
.	O

does	O
infrared	O
visualization	O
improve	O
selection	O
of	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
sites	B-T082
for	O
indwelling	O
needle	B-T074
at	O
the	O
forearm	B-T017
in	O
second	O
-	O
year	O
nursing	B-T097
students	I-T097
?	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
a	O
vein	B-T074
visualization	I-T074
display	I-T074
system	I-T074
using	O
near	O
-	O
infrared	O
light	O
(	O
[UNK]	O
vein	B-T074
display	I-T074
[UNK]	O
)	O
for	O
the	O
safe	O
and	O
proper	O
selection	O
of	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
sites	B-T082
for	O
indwelling	O
needle	B-T074
placement	O
in	O
the	O
forearm	B-T017
.	O
ten	O
second	O
year	O
nursing	B-T097
students	I-T097
were	O
recruited	O
to	O
apply	O
an	O
indwelling	O
needle	B-T074
line	O
with	O
and	O
without	O
vein	B-T017
display	O
.	O
another	O
ten	O
participants	B-T098
were	O
recruited	O
from	O
various	O
faculty	B-T097
to	O
serve	O
as	O
patients	O
.	O
the	O
quality	O
of	O
the	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
procedure	I-T058
at	O
various	O
selected	O
sites	B-T082
was	O
evaluated	O
according	O
to	O
a	O
scale	B-T170
developed	O
by	O
the	O
authors	B-T097
.	O
time	O
,	O
scores	O
and	O
patterns	O
of	O
puncture	B-T058
-	O
site	B-T082
selection	O
were	O
compared	O
with	O
respect	O
to	O
three	O
different	O
methods	O
:	O
[	O
1	O
]	O
attempt	O
1	O
(	O
tourniquet	B-T074
only	O
)	O
,	O
[	O
2	O
]	O
attempt	O
2	O
(	O
vein	B-T074
display	I-T074
only	O
)	O
and	O
[	O
3	O
]	O
attempt	O
3	O
(	O
both	O
)	O
.	O
to	O
validate	O
the	O
effectiveness	O
of	O
vein	B-T017
display	O
,	O
52	O
trials	O
were	O
conducted	O
in	O
total	O
.	O
we	O
found	O
that	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
site	B-T082
selection	O
time	O
was	O
significantly	O
improved	O
with	O
the	O
vein	B-T074
display	I-T074
,	O
particularly	O
in	O
the	O
case	O
of	O
difficult	O
to	O
administer	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
sites	B-T082
.	O
overall	O
,	O
we	O
found	O
no	O
significant	O
difference	O
with	O
respect	O
to	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
quality	O
,	O
as	O
determined	O
by	O
our	O
scale	B-T170
.	O
these	O
results	O
suggest	O
that	O
equipment	O
such	O
as	O
the	O
vein	B-T074
display	I-T074
can	O
contribute	O
imm	O
##ense	O
##ly	O
to	O
the	O
improvement	O
of	O
practical	O
skills	O
,	O
such	O
as	O
ven	B-T058
##ip	I-T058
##uncture	I-T058
,	O
especially	O
in	O
the	O
context	O
of	O
elderly	B-T098
patients	O
.	O

overall	O
quality	O
properties	O
of	O
ki	B-T168
##wi	I-T168
##fr	I-T168
##uit	I-T168
treated	B-T058
by	I-T058
cinnam	B-T103
##aldehyde	I-T103
and	O
citr	B-T103
##al	I-T103
:	O
microbial	O
,	O
antioxidant	B-T038
capacity	I-T038
during	O
cold	B-T058
storage	I-T058
this	O
work	O
was	O
undertaken	O
to	O
evaluate	B-T058
the	O
microbiological	B-T170
characteristics	O
and	O
antioxidant	B-T038
and	O
physiological	B-T038
activities	I-T038
in	O
ki	B-T168
##wi	I-T168
##fr	I-T168
##uits	I-T168
(	O
actin	B-T204
##ida	I-T204
del	I-T204
##ici	I-T204
##osa	I-T204
var	O
.	O
qi	O
##nm	O
##ei	O
)	O
with	O
/	O
without	O
cinnam	B-T103
##aldehyde	I-T103
(	O
c1	O
)	O
and	O
citr	B-T103
##al	I-T103
(	O
c2	O
)	O
fumig	O
##ation	O
treatments	O
(	O
5	O
μl	O
/	O
l	O
)	O
during	O
0	O
,	O
3	O
,	O
6	O
,	O
9	O
,	O
and	O
12	O
d	O
of	O
storage	O
at	O
4	O
°c	O
.	O
essential	B-T103
oils	I-T103
(	O
eos	B-T103
)	O
treatment	O
lowered	O
the	O
total	O
viable	O
counts	O
,	O
yeast	B-T204
,	O
and	O
mold	B-T204
to	O
1	O
.	O
54	O
,	O
2	O
.	O
36	O
,	O
and	O
2	O
.	O
05	O
log	O
cfu	O
/	O
g	O
,	O
respectively	O
.	O
moreover	O
,	O
eos	B-T103
improved	O
the	O
antioxidant	B-T038
activities	I-T038
of	O
ki	B-T168
##wi	I-T168
##fr	I-T168
##uit	I-T168
.	O
they	O
enhanced	O
phenolics	B-T103
and	O
flavonoids	B-T103
content	O
in	O
fruit	B-T168
tissue	B-T017
by	O
49	O
.	O
48	O
%	O
at	O
day	O
3	O
and	O
56	O
.	O
93	O
%	O
at	O
day	O
6	O
,	O
respectively	O
.	O
in	O
addition	O
,	O
ascorbic	B-T103
acid	I-T103
in	O
treated	O
groups	O
had	O
the	O
lower	O
losing	O
rate	O
.	O
similarly	O
,	O
mda	B-T103
(	O
malondialdehyde	B-T103
)	O
,	O
h2	B-T103
o2	I-T103
(	O
hydrogen	B-T103
peroxide	I-T103
)	O
,	O
and	O
(	O
•	O
)	O
o2	B-T103
(	I-T103
-	I-T103
)	I-T103
(	O
superoxide	B-T103
anion	I-T103
)	O
production	O
were	O
effectively	O
decreased	O
in	O
the	O
range	O
of	O
27	O
.	O
27	O
%	O
to	O
54	O
.	O
38	O
%	O
.	O
physicochemical	O
characteristics	O
showed	O
that	O
ki	B-T168
##wi	I-T168
##fr	I-T168
##uits	I-T168
from	O
treated	O
group	O
maintained	O
higher	O
levels	O
of	O
fle	O
##sh	O
lumin	O
##osity	O
and	O
firm	O
##ness	O
.	O
eos	B-T103
also	O
decreased	O
the	O
levels	O
of	O
reducing	B-T103
sugar	I-T103
by	O
45	O
.	O
97	O
%	O
at	O
day	O
3	O
,	O
and	O
increased	O
the	O
content	O
of	O
soluble	B-T103
protein	I-T103
and	O
hydrolyzed	O
amino	B-T103
acid	I-T103
.	O
therefore	O
,	O
posth	O
##ar	O
##ves	O
##t	O
eos	B-T103
treatment	O
has	O
positive	O
effects	O
on	O
delaying	O
senescence	B-T038
and	O
enhancing	O
antioxidant	B-T038
capacities	I-T038
in	O
ki	B-T168
##wi	I-T168
##fr	I-T168
##uit	I-T168
.	O

impact	O
of	O
alcohol	O
use	O
on	O
eeg	B-T058
dynamics	I-T058
of	O
response	B-T038
inhibition	I-T038
:	O
a	O
cot	B-T062
##win	I-T062
control	I-T062
analysis	I-T062
research	O
indicates	O
that	O
alcohol	O
misuse	O
is	O
associated	O
with	O
behavioral	B-T038
disin	I-T038
##hibition	I-T038
,	O
but	O
the	O
neurophysiological	B-T038
mechanisms	I-T038
governing	O
this	O
relationship	O
remain	O
largely	O
unknown	O
.	O
recent	O
work	O
suggests	O
that	O
successful	O
inhibition	B-T038
and	O
cognitive	B-T038
control	I-T038
involve	O
electrophysiological	O
theta	O
-	O
band	O
dynamics	O
,	O
including	O
medial	B-T017
frontal	I-T017
cortex	I-T017
(	O
mf	B-T017
##c	I-T017
)	O
power	O
enhancement	O
and	O
functional	O
connectivity	O
between	O
the	O
mf	B-T017
##c	I-T017
and	O
dorsal	B-T017
prefrontal	I-T017
cortex	I-T017
(	O
dp	B-T017
##fc	I-T017
)	O
regions	O
,	O
which	O
may	O
be	O
disrupted	O
by	O
alcohol	O
misuse	O
.	O
in	O
addition	O
,	O
research	O
suggests	O
that	O
,	O
compared	O
to	O
men	B-T098
,	O
women	B-T098
are	O
at	O
heightened	O
risk	O
of	O
experiencing	O
the	O
negative	O
physical	O
and	O
neurocognitive	O
correlates	O
of	O
drinking	O
.	O
the	O
present	O
study	B-T062
tested	O
the	O
hypothesis	O
that	O
alcohol	O
misuse	O
has	O
a	O
deleterious	B-T038
effect	I-T038
on	O
theta	B-T058
-	I-T058
band	I-T058
response	B-T038
inhibition	I-T038
eeg	B-T058
dynamics	I-T058
in	O
a	O
sample	B-T098
of	O
300	O
24	O
-	O
year	O
-	O
old	O
same	O
-	O
sex	O
twins	O
.	O
a	O
cot	B-T062
##win	I-T062
control	I-T062
(	I-T062
ctc	I-T062
)	I-T062
design	I-T062
was	O
used	O
to	O
dise	O
##nt	O
##angl	O
##e	O
prem	O
##orbid	O
risk	O
for	O
alcohol	O
use	O
from	O
the	O
causal	O
effects	O
of	O
alcohol	O
exposure	O
.	O
drinking	O
was	O
negatively	O
associated	O
with	O
theta	B-T058
-	I-T058
band	I-T058
mf	O
##c	O
power	O
and	O
mf	B-T017
##c	I-T017
-	O
dp	B-T017
##fc	I-T017
connectivity	B-T082
during	O
response	B-T038
inhibition	I-T038
,	O
and	O
this	O
effect	O
was	O
stronger	O
among	O
women	B-T098
.	O
the	O
ctc	B-T062
analysis	I-T062
suggested	O
that	O
,	O
for	O
women	B-T098
,	O
reduced	O
nog	O
##o	O
-	O
related	O
theta	B-T058
-	I-T058
band	I-T058
mf	O
##c	O
power	O
and	O
mf	B-T017
##c	I-T017
-	O
dp	B-T017
##fc	I-T017
connectivity	B-T082
were	O
both	O
consistent	O
with	O
the	O
potential	O
deleterious	B-T038
causal	I-T038
effects	I-T038
of	O
alcohol	O
exposure	O
.	O
these	O
findings	O
suggest	O
that	O
diminished	O
theta	B-T058
-	I-T058
band	I-T058
mf	O
##c	O
power	O
and	O
mf	B-T017
##c	I-T017
-	O
dp	B-T017
##fc	I-T017
connectivity	B-T082
may	O
be	O
neurophysiological	B-T038
mechanisms	I-T038
underlying	O
alcohol	B-T038
-	I-T038
related	I-T038
disin	I-T038
##hibition	I-T038
.	O
although	O
preliminary	O
,	O
these	O
results	O
suggest	O
that	O
normative	B-T033
levels	I-T033
of	O
alcohol	O
use	O
during	O
emerging	O
adulthood	O
have	O
potential	O
sex	O
-	O
specific	O
causal	O
effects	O
on	O
response	B-T038
inhibition	I-T038
eeg	B-T058
dynamics	I-T058
,	O
and	O
thus	O
have	O
potentially	O
significant	O
public	O
health	O
implications	O
.	O

a	O
comparison	O
of	O
functional	O
outcomes	O
in	O
patients	O
undergoing	O
revision	B-T058
arthroscopic	I-T058
repair	I-T058
of	O
massive	O
rotator	B-T038
cuff	I-T038
tears	I-T038
with	O
and	O
without	O
arthroscopic	B-T082
supras	B-T058
##cap	I-T058
##ular	I-T058
nerve	I-T058
release	I-T058
this	O
study	O
was	O
designed	O
to	O
compare	O
functional	O
outcomes	O
in	O
patients	O
undergoing	O
revision	B-T058
repair	I-T058
of	O
massive	O
rotator	B-T038
cuff	I-T038
tears	I-T038
(	O
retr	O
##acted	O
medial	O
to	O
the	O
glenoid	B-T082
)	O
with	O
gout	B-T038
##all	I-T038
##ier	I-T038
grade	I-T038
4	I-T038
atrophy	I-T038
and	O
concomitant	O
release	B-T058
of	I-T058
the	I-T058
supras	I-T058
##cap	I-T058
##ular	I-T058
nerve	I-T058
to	O
a	O
similar	O
group	O
of	O
patients	O
with	O
grade	B-T038
3	I-T038
atrophy	I-T038
undergoing	O
revision	B-T058
rotator	I-T058
cuff	I-T058
repair	I-T058
(	O
rt	B-T058
##cr	I-T058
)	O
without	O
nerve	B-T058
release	I-T058
.	O
we	O
hypothesized	O
that	O
patients	O
undergoing	O
nerve	B-T058
release	I-T058
would	O
have	O
more	O
favorable	O
functional	O
outcomes	O
as	O
measured	O
by	O
the	O
modified	O
university	B-T092
of	I-T092
california	I-T092
at	O
los	B-T082
angeles	I-T082
shoulder	O
rating	O
scale	O
(	O
ucl	O
##a	O
)	O
.	O
twenty	O
-	O
two	O
patients	O
underwent	O
revision	B-T058
repair	I-T058
of	O
massive	O
rotator	B-T038
cuff	I-T038
tears	I-T038
with	O
release	B-T058
of	I-T058
the	I-T058
supras	I-T058
##cap	I-T058
##ular	I-T058
nerve	I-T058
at	O
the	O
supras	B-T082
##cap	I-T082
##ular	I-T082
notch	I-T082
.	O
we	O
compared	O
total	O
preoperative	O
,	O
postoperative	O
,	O
and	O
change	O
in	O
ucl	O
##a	O
score	O
in	O
these	O
patients	O
to	O
a	O
similar	O
group	B-T098
of	O
22	O
patients	O
undergoing	O
revision	B-T058
rt	I-T058
##cr	I-T058
without	O
supras	B-T058
##cap	I-T058
##ular	I-T058
nerve	I-T058
release	I-T058
.	O
additionally	O
,	O
ucl	O
##a	O
subs	O
##core	O
##s	O
between	O
the	O
two	O
groups	B-T098
were	O
compared	O
preoperatively	O
and	O
at	O
final	O
follow	B-T058
-	I-T058
up	I-T058
.	O
the	O
average	O
preoperative	O
ucl	O
##a	O
score	O
in	O
the	O
nerve	B-T098
-	I-T098
release	I-T098
group	I-T098
was	O
7	O
.	O
91	O
,	O
and	O
final	O
follow	B-T058
-	I-T058
up	I-T058
average	O
was	O
27	O
.	O
86	O
;	O
average	O
3	O
.	O
05	O
grades	O
of	O
strength	O
were	O
recovered	O
.	O
in	O
the	O
comparison	O
group	B-T098
,	O
average	O
preoperative	O
ucl	O
##a	O
score	O
was	O
11	O
.	O
77	O
,	O
and	O
final	O
follow	B-T058
-	I-T058
up	I-T058
average	O
was	O
29	O
.	O
09	O
;	O
average	O
1	O
.	O
32	O
grades	O
of	O
strength	O
were	O
recovered	O
.	O
the	O
average	O
preoperative	O
ucl	O
##a	O
score	O
was	O
significantly	O
worse	O
in	O
the	O
nerve	B-T098
-	I-T098
release	I-T098
group	I-T098
(	O
p	O
=	O
0	O
.	O
007	O
)	O
.	O
the	O
average	O
postoperative	O
ucl	O
##a	O
score	O
was	O
not	O
significantly	O
different	O
(	O
p	O
=	O
0	O
.	O
59	O
##0	O
)	O
between	O
the	O
groups	B-T098
,	O
indicating	O
a	O
better	O
improvement	O
in	O
the	O
nerve	B-T098
-	I-T098
release	I-T098
group	I-T098
with	O
significantly	O
greater	O
improvement	O
in	O
active	O
forward	O
flexion	B-T038
,	O
strength	B-T038
,	O
and	O
pain	B-T058
relief	I-T058
.	O
patients	O
who	O
underwent	O
concomitant	O
release	B-T058
of	I-T058
the	I-T058
supras	I-T058
##cap	I-T058
##ular	I-T058
nerve	I-T058
during	O
revision	B-T058
rt	I-T058
##cr	I-T058
had	O
greater	O
overall	O
improvement	O
as	O
noted	O
in	O
pain	B-T058
relief	I-T058
,	O
active	B-T038
forward	I-T038
flexion	I-T038
,	O
and	O
strength	B-T038
,	O
than	O
a	O
comparable	O
group	B-T098
without	O
nerve	B-T058
release	I-T058
.	O

shift	O
work	O
is	O
associated	O
with	O
metabolic	B-T038
syndrome	I-T038
in	O
young	O
female	O
korean	B-T098
workers	O
shift	O
work	O
is	O
associated	O
with	O
health	O
problems	O
,	O
including	O
metabolic	B-T038
syndrome	I-T038
.	O
this	O
study	B-T062
investigated	O
the	O
association	O
between	O
shift	O
work	O
and	O
metabolic	B-T038
syndrome	I-T038
in	O
young	O
workers	O
.	O
a	O
total	O
of	O
3	O
,	O
317	O
subjects	B-T098
aged	O
20	O
-	O
40	O
years	O
enrolled	O
in	O
the	O
2011	O
-	O
2012	O
korean	B-T098
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
were	O
divided	O
into	O
shift	B-T033
and	O
day	B-T033
workers	I-T033
.	O
we	O
conducted	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
and	O
calculated	O
odds	O
ratios	O
using	O
multivariate	O
logistic	O
regression	O
analysis	O
in	O
order	O
to	O
examine	B-T033
the	O
association	O
between	O
shift	O
work	O
and	O
metabolic	B-T038
syndrome	I-T038
.	O
the	O
prevalence	O
of	O
metabolic	B-T038
syndrome	I-T038
was	O
14	O
.	O
3	O
%	O
and	O
7	O
.	O
1	O
%	O
among	O
male	O
and	O
female	O
shift	B-T033
workers	I-T033
,	O
respectively	O
.	O
after	O
adjusting	O
for	O
confounding	O
factors	O
,	O
shift	O
work	O
was	O
associated	O
with	O
metabolic	B-T038
syndrome	I-T038
in	O
female	O
workers	O
(	O
odds	O
ratio	O
,	O
2	O
.	O
53	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
12	O
to	O
5	O
.	O
70	O
)	O
.	O
shift	O
work	O
was	O
associated	O
with	O
metabolic	B-T038
syndrome	I-T038
in	O
young	O
women	B-T098
.	O
timely	O
efforts	O
are	O
necessary	O
to	O
manage	O
metabolic	B-T038
syndrome	I-T038
in	O
the	O
workplace	B-T082
.	O

utility	O
of	O
a	O
mh	B-T170
##ealth	I-T170
app	I-T170
for	O
self	B-T058
-	I-T058
management	I-T058
and	O
education	O
of	O
cardiac	B-T038
diseases	I-T038
in	O
spanish	B-T082
urban	B-T082
and	I-T082
rural	I-T082
areas	I-T082
analyze	B-T062
the	O
utility	O
of	O
a	O
mobile	B-T170
health	I-T170
app	I-T170
named	O
heart	B-T170
##ke	I-T170
##ep	I-T170
##er	I-T170
in	O
several	B-T098
groups	I-T098
of	I-T098
population	I-T098
and	O
obtain	O
conclusions	O
to	O
be	O
applied	O
to	O
other	B-T170
similar	I-T170
apps	I-T170
.	O
a	O
questionnaire	B-T170
has	O
been	O
designed	O
to	O
evaluate	O
the	O
usage	O
and	O
utility	O
of	O
the	O
heart	B-T170
##ke	I-T170
##ep	I-T170
##er	I-T170
app	I-T170
.	O
the	O
questionnaire	B-T170
information	O
was	O
collected	O
by	O
collab	O
##orating	O
cardiologists	B-T097
from	O
32	O
patients	O
before	O
and	O
after	O
they	O
used	O
the	O
app	B-T170
.	O
patients	O
were	O
randomly	B-T062
selected	I-T062
with	O
established	O
qu	B-T062
##ota	I-T062
##s	I-T062
within	O
interest	B-T098
groups	I-T098
,	O
so	O
that	O
men	B-T098
and	O
women	B-T098
,	O
patients	O
older	B-T098
or	O
younger	O
than	O
60	O
years	O
old	O
and	O
patients	O
living	O
in	O
urban	B-T082
or	I-T082
rural	I-T082
areas	I-T082
were	O
equally	O
represented	O
.	O
using	O
the	O
appropriate	O
statistical	B-T062
techniques	I-T062
we	O
see	O
that	O
the	O
heart	B-T170
##ke	I-T170
##ep	I-T170
##er	I-T170
app	I-T170
was	O
useful	O
for	O
patients	O
as	O
they	O
qual	O
##ify	O
with	O
70	O
points	O
(	O
out	O
of	O
100	O
)	O
the	O
overall	B-T033
opinion	I-T033
of	O
the	O
app	B-T170
,	O
it	O
helps	O
them	O
remember	B-T038
more	O
easily	O
taking	O
their	O
pill	B-T103
##s	I-T103
with	O
a	O
mean	O
improvement	O
of	O
20	O
.	O
94	O
points	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
they	O
perceive	O
a	O
global	O
improvement	O
of	O
their	O
health	O
(	O
8	O
.	O
28	O
points	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
we	O
also	O
observe	O
that	O
these	O
improvements	O
do	O
not	O
depend	O
,	O
in	O
general	O
,	O
on	O
the	O
area	B-T082
(	I-T082
urban	I-T082
or	I-T082
rural	I-T082
)	I-T082
where	O
the	O
patient	O
comes	O
from	O
or	O
on	O
their	O
sex	O
.	O
although	O
older	B-T098
patients	I-T098
needed	O
more	O
help	O
to	O
use	O
the	O
app	B-T170
and	O
used	O
it	O
slightly	O
less	O
frequently	O
,	O
the	O
improvements	O
on	O
several	O
measures	O
considered	O
,	O
such	O
as	O
remember	B-T038
##ing	I-T038
taking	O
pill	B-T103
##s	I-T103
,	O
breathing	O
problems	O
or	O
trou	B-T033
##ble	I-T033
developing	I-T033
activities	I-T033
,	O
depend	O
significantly	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
on	O
age	O
with	O
older	B-T098
patients	I-T098
reporting	O
higher	O
improvements	O
than	O
younger	O
ones	O
.	O
the	O
results	O
obtained	O
with	O
the	O
sample	O
of	O
patients	O
considered	O
in	O
this	O
research	B-T062
prove	O
the	O
utility	O
of	O
the	O
heart	B-T170
##ke	I-T170
##ep	I-T170
##er	I-T170
app	I-T170
.	O
this	O
utility	O
is	O
similar	O
in	O
urban	B-T082
and	I-T082
rural	I-T082
areas	I-T082
and	O
for	O
patients	O
of	O
both	O
sexes	O
and	O
,	O
to	O
some	O
extent	O
,	O
depends	O
on	O
the	O
age	O
of	O
the	O
patient	O
with	O
older	B-T098
patients	I-T098
reporting	O
slightly	O
lower	O
frequency	O
of	O
use	O
but	O
higher	O
health	O
improvements	O
than	O
younger	O
ones	O
.	O

association	O
of	O
leukemia	B-T017
inhibitory	I-T017
factor	I-T017
gene	I-T017
polymorphism	O
and	O
in	O
vitro	O
fertilization	B-T038
outcome	O
in	O
a	O
population	B-T098
in	O
northern	B-T082
iran	I-T082
several	O
studies	B-T062
have	O
been	O
demonstrated	O
that	O
endometrial	B-T082
leukemia	B-T103
inhibitory	I-T103
factor	I-T103
(	O
lif	B-T103
)	O
is	O
important	O
in	O
embryo	B-T038
implantation	I-T038
.	O
lif	B-T103
is	O
a	O
secreted	O
glycoprotein	B-T103
with	O
a	O
variety	O
of	O
biological	B-T038
functions	I-T038
including	O
stimulation	O
of	O
cell	B-T038
proliferation	I-T038
,	O
differentiation	B-T038
and	O
survival	B-T038
that	O
are	O
all	O
essential	O
for	O
blast	B-T017
##ocy	I-T017
##ete	I-T017
development	O
and	O
implantation	B-T038
.	O
the	O
lif	B-T103
receptor	I-T103
activates	O
several	O
signaling	B-T038
pathways	I-T038
in	O
diverse	B-T170
cell	I-T170
types	I-T170
,	O
including	O
jak	O
/	O
stat	O
,	O
mapk	B-T103
and	O
pi3	B-T103
-	I-T103
kinase	I-T103
pathways	B-T038
in	O
the	O
endometrium	B-T017
of	O
fertile	B-T038
woman	B-T098
.	O
it	O
has	O
been	O
suggested	O
that	O
the	O
initial	O
lower	O
expression	B-T038
of	O
lif	B-T103
in	O
proliferative	B-T038
phase	O
may	O
be	O
one	O
of	O
the	O
causes	O
for	O
multiple	O
failure	O
of	O
implantation	B-T058
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
association	O
between	O
maternal	B-T033
genotype	O
of	O
snp	B-T082
39	I-T082
##51	I-T082
##c	I-T082
/	I-T082
t	I-T082
lif	B-T103
and	O
in	B-T058
vitro	I-T058
fertilization	I-T058
and	O
embryo	B-T058
transfer	I-T058
(	O
ivf	B-T058
-	O
et	B-T058
)	O
outcome	O
in	O
infertile	B-T038
women	B-T098
.	O
this	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
was	O
comprised	O
of	O
infertile	B-T038
patients	O
(	O
n	O
=	O
70	O
)	O
and	O
women	B-T098
having	O
one	O
healthy	B-T033
child	I-T033
as	O
controls	O
(	O
n	O
=	O
73	O
)	O
.	O
genotyping	B-T058
for	O
snp	B-T082
-	I-T082
39	I-T082
##51	I-T082
##c	I-T082
/	I-T082
t	I-T082
was	O
performed	O
by	O
pcr	B-T058
/	I-T058
rflp	I-T058
.	O
allele	B-T017
and	O
genotype	O
distribution	O
did	O
not	O
differ	O
significantly	O
between	O
patients	O
and	O
controls	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
the	O
lif	B-T103
genotype	O
frequencies	O
amongst	O
the	O
70	O
cases	O
were	O
c	B-T082
/	I-T082
c	I-T082
=	O
40	O
%	O
,	O
c	B-T082
/	I-T082
t	I-T082
=	O
52	O
.	O
8	O
%	O
and	O
t	B-T082
/	I-T082
t	I-T082
=	O
7	O
.	O
2	O
%	O
;	O
the	O
c	O
and	O
t	O
allele	B-T017
frequencies	O
were	O
66	O
%	O
and	O
34	O
%	O
,	O
respectively	O
.	O
the	O
lif	B-T103
genotype	O
frequencies	O
amongst	O
the	O
73	O
controls	O
were	O
c	B-T082
/	I-T082
c	I-T082
=	O
45	O
.	O
20	O
%	O
,	O
c	B-T082
/	I-T082
t	I-T082
=	O
50	O
.	O
70	O
%	O
and	O
t	B-T082
/	I-T082
t	I-T082
=	O
4	O
.	O
1	O
%	O
;	O
the	O
c	O
and	O
t	O
allele	B-T017
frequencies	O
were	O
70	O
%	O
and	O
30	O
%	O
,	O
respectively	O
.	O
in	O
conclusion	O
,	O
the	O
results	O
of	O
this	O
study	O
indicate	O
that	O
snp	B-T082
39	I-T082
##51	I-T082
##c	I-T082
/	I-T082
t	I-T082
of	O
lif	B-T103
may	O
not	O
be	O
associated	O
with	O
ivf	B-T058
-	O
et	B-T058
outcome	O
in	O
this	O
population	B-T098
.	O
although	O
more	O
studies	B-T062
should	O
be	O
considered	O
with	O
larger	O
number	O
of	O
patients	O
and	O
control	O
subjects	O
to	O
confirm	O
our	O
results	O
.	O

a	O
course	O
-	O
based	O
approach	B-T082
to	O
the	O
doctor	B-T097
of	O
nursing	B-T062
practice	I-T062
project	I-T062
:	O
supporting	O
student	B-T098
growth	O
from	O
concept	O
to	O
completion	O
we	O
describe	O
a	O
course	O
-	O
based	O
approach	B-T082
to	O
the	O
doctor	B-T097
of	O
nursing	B-T062
practice	I-T062
project	I-T062
in	O
which	O
students	B-T098
work	O
in	O
groups	O
of	O
8	O
to	O
12	O
with	O
a	O
faculty	B-T097
member	I-T097
to	O
complete	O
individual	O
final	O
projects	O
that	O
require	O
a	O
minimum	O
of	O
360	O
practic	O
##um	O
hours	O
in	O
3	O
-	O
sem	O
##ester	O
-	O
long	O
courses	O
.	O
project	O
teams	O
include	O
agency	B-T092
or	O
community	O
-	O
based	O
mentors	B-T098
.	O
project	B-T033
findings	I-T033
are	O
disseminated	B-T082
through	O
written	B-T170
and	O
oral	B-T170
reports	I-T170
.	O
this	O
approach	B-T082
preserves	O
faculty	B-T097
resources	O
and	O
provides	O
students	B-T098
with	O
ment	O
##oring	O
,	O
opportunities	O
for	O
reflection	O
,	O
and	O
time	O
for	O
project	O
development	O
.	O

on	O
the	O
development	O
of	O
conjunctival	B-T038
hyperemia	I-T038
computer	B-T058
-	I-T058
assisted	I-T058
diagnosis	I-T058
tools	I-T058
:	O
influence	O
of	O
feature	O
selection	O
and	O
class	B-T170
imbalance	I-T170
in	O
automatic	O
grading	O
##s	O
the	O
sudden	O
increase	O
of	O
blood	B-T038
flow	I-T038
in	O
the	O
bulbar	B-T017
conjunctiva	I-T017
,	O
known	O
as	O
hyperemia	B-T038
,	O
is	O
associated	O
to	O
a	O
red	O
hu	O
##e	O
of	O
variable	O
intensity	O
.	O
experts	O
measure	O
hyperemia	B-T038
using	O
levels	O
in	O
a	O
grading	B-T170
scale	I-T170
,	O
a	O
procedure	O
that	O
is	O
subjective	O
,	O
non	O
-	O
repeatable	O
and	O
time	O
consuming	O
,	O
thus	O
creating	O
a	O
need	O
for	O
its	O
autom	O
##atis	O
##ation	O
.	O
however	O
,	O
the	O
task	O
is	O
far	O
from	O
straightforward	O
due	O
to	O
data	O
issues	O
such	O
as	O
class	B-T170
imbalance	I-T170
or	O
correlated	O
features	O
.	O
in	O
this	O
paper	O
,	O
we	O
study	O
the	O
specific	O
features	O
of	O
hyperemia	B-T038
and	O
propose	O
various	O
approaches	O
to	O
address	O
these	O
problems	O
in	O
the	O
context	O
of	O
an	O
automatic	B-T170
framework	I-T170
for	O
hyperemia	B-T038
grading	B-T033
.	O
overs	B-T170
##amp	I-T170
##ling	I-T170
,	O
unders	B-T170
##amp	I-T170
##ling	I-T170
and	O
smo	B-T170
##te	I-T170
approaches	I-T170
were	O
applied	O
in	O
order	O
to	O
tackle	O
the	O
problem	O
of	O
class	B-T170
imbalance	I-T170
.	O
25	O
features	O
were	O
computed	O
for	O
each	O
image	O
and	O
regression	B-T170
methods	I-T170
were	O
then	O
used	O
to	O
transform	O
them	O
into	O
a	O
value	O
on	O
the	O
grading	B-T170
scale	I-T170
.	O
the	O
values	O
and	O
relationships	O
among	O
features	O
and	O
experts	B-T033
'	I-T033
values	I-T033
were	O
analysed	O
,	O
and	O
five	O
feature	O
selection	O
techniques	O
were	O
subsequently	O
studied	O
.	O
the	O
lowest	O
mean	O
square	O
error	O
(	O
ms	O
##e	O
)	O
for	O
the	O
regression	B-T170
systems	I-T170
trained	O
with	O
individual	O
features	O
is	O
below	O
0	O
.	O
1	O
for	O
both	O
scales	O
.	O
multi	B-T170
-	I-T170
layer	I-T170
percept	I-T170
##ron	I-T170
(	O
ml	B-T170
##p	I-T170
)	O
obtain	O
##s	O
the	O
best	O
values	O
,	O
but	O
is	O
less	O
consistent	O
than	O
the	O
random	B-T170
forest	I-T170
(	I-T170
rf	I-T170
)	I-T170
method	I-T170
.	O
when	O
all	O
features	O
are	O
combined	O
,	O
the	O
best	O
results	O
for	O
both	O
scales	O
are	O
achieved	O
with	O
ml	B-T170
##p	I-T170
.	O
correlation	B-T170
based	I-T170
feature	I-T170
selection	I-T170
(	O
cfs	B-T170
)	O
and	O
m	O
##5	O
provide	O
the	O
best	O
results	O
,	O
ms	O
##e	O
=	O
0	O
.	O
108	O
and	O
ms	O
##e	O
=	O
0	O
.	O
06	O
##1	O
respectively	O
.	O
finally	O
,	O
the	O
class	B-T170
imbalance	I-T170
problem	I-T170
is	O
minim	O
##ised	O
with	O
the	O
smo	B-T170
##te	I-T170
approach	I-T170
for	O
both	O
scales	O
(	O
ms	O
##e	O
<	O
0	O
.	O
006	O
)	O
.	O
machine	O
learning	O
methods	O
are	O
able	O
to	O
perform	O
an	O
objective	O
assessment	O
of	O
hyperemia	B-T038
grading	B-T033
,	O
removing	O
both	O
intra	O
-	O
and	O
inter	O
-	O
expert	O
subject	O
##ivity	O
while	O
providing	O
a	O
gain	O
in	O
computation	O
time	O
.	O
smo	B-T170
##te	I-T170
and	O
overs	B-T170
##amp	I-T170
##ling	I-T170
approaches	I-T170
minim	O
##ise	O
the	O
class	B-T170
imbalance	I-T170
problem	I-T170
,	O
while	O
feature	O
selection	O
reduces	O
the	O
number	O
of	O
features	O
from	O
25	O
to	O
3	O
-	O
5	O
without	O
worsening	O
the	O
ms	O
##e	O
.	O
as	O
the	O
differences	O
between	O
the	O
system	B-T170
and	O
a	O
human	B-T097
expert	I-T097
are	O
similar	O
to	O
the	O
differences	O
between	O
experts	B-T097
,	O
we	O
can	O
therefore	O
conclude	O
that	O
the	O
system	B-T170
behaves	O
like	O
an	O
expert	B-T097
.	O

characterization	O
of	O
novel	O
de	B-T103
##or	I-T103
-	I-T103
family	I-T103
member	O
from	O
the	O
streptomyces	B-T007
ah	I-T007
##yg	I-T007
##roscopic	I-T007
##us	I-T007
strain	O
ck	O
-	O
15	O
that	O
acts	O
as	O
a	O
repressor	B-T103
of	O
morphological	B-T082
development	O
w	B-T103
##uy	I-T103
##ie	I-T103
##nc	I-T103
##in	I-T103
is	O
produced	O
by	O
streptomyces	B-T007
ah	I-T007
##yg	I-T007
##roscopic	I-T007
##us	I-T007
var	I-T007
.	I-T007
w	I-T007
##uy	I-T007
##iensis	I-T007
,	O
which	O
has	O
been	O
widely	O
used	O
in	O
china	B-T082
as	O
an	O
industrial	B-T092
##ly	I-T092
produced	O
biop	B-T103
##est	I-T103
##icide	I-T103
to	O
control	O
various	O
fungal	B-T038
diseases	I-T038
.	O
although	O
its	O
mechanism	O
of	O
action	O
,	O
breeding	B-T038
,	O
and	O
fermentation	B-T038
had	O
been	O
extensively	O
characterized	O
,	O
less	O
is	O
known	O
about	O
the	O
regulatory	B-T038
functions	I-T038
that	O
affect	O
its	O
biosynthesis	O
or	O
morphological	B-T082
development	O
.	O
the	O
w	B-T017
##ys	I-T017
##r3	I-T017
gene	I-T017
of	O
s	B-T007
.	I-T007
ah	I-T007
##yg	I-T007
##roscopic	I-T007
##us	I-T007
strain	O
ck	O
-	O
15	O
,	O
a	O
novel	O
member	O
of	O
the	O
de	B-T103
##or	I-T103
family	I-T103
of	O
regulatory	B-T017
genes	I-T017
,	O
was	O
assessed	O
to	O
determine	O
its	O
function	O
by	O
gene	B-T062
knockdown	I-T062
.	O
herein	O
,	O
we	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
de	B-T103
##or	I-T103
family	I-T103
proteins	I-T103
derived	O
from	O
the	O
same	O
source	B-T033
are	O
likely	O
to	O
be	O
a	O
single	O
branch	B-T082
in	O
a	O
phylogenetic	O
tree	O
and	O
show	O
that	O
w	B-T017
##ys	I-T017
##r3	I-T017
acts	O
as	O
a	O
repressor	B-T103
for	O
its	O
morphological	B-T082
development	O
without	O
effect	O
##ing	O
w	B-T103
##uy	I-T103
##ie	I-T103
##nc	I-T103
##in	I-T103
production	O
.	O
we	O
found	O
that	O
the	O
δ	B-T017
##w	I-T017
##ys	I-T017
##r3	I-T017
strain	O
can	O
grow	O
quickly	O
to	O
reach	O
a	O
plateau	O
stage	O
of	O
maximum	O
biomass	O
at	O
60	O
h	O
,	O
which	O
is	O
~	O
12	O
h	O
faster	O
than	O
the	O
wild	B-T017
-	I-T017
type	I-T017
strain	O
.	O
in	O
the	O
industrial	B-T092
fermentation	B-T038
production	O
process	O
,	O
the	O
δ	B-T017
##w	I-T017
##ys	I-T017
##r3	I-T017
strain	O
can	O
reduce	O
consumption	O
and	O
save	O
both	O
time	O
and	O
money	O
.	O

anatomical	O
subgroup	B-T170
analysis	B-T062
of	O
the	O
mer	O
##idian	O
cohort	B-T098
:	O
posterior	B-T033
fossa	I-T033
abnormalities	I-T033
to	O
assess	O
the	O
diagnostic	O
and	O
clinical	O
contribution	O
of	O
in	B-T058
utero	I-T058
magnetic	I-T058
resonance	I-T058
(	I-T058
iu	I-T058
##mr	I-T058
)	I-T058
imaging	I-T058
in	O
fetuses	B-T017
diagnosed	B-T033
with	O
abnormalities	B-T033
of	I-T033
the	I-T033
posterior	I-T033
fossa	I-T033
as	O
the	O
only	O
intracranial	B-T033
abnormality	I-T033
recognised	O
on	O
antenatal	B-T058
ultrasonography	I-T058
(	O
us	B-T058
##s	I-T058
)	O
.	O
we	O
report	B-T170
a	O
sub	B-T170
-	I-T170
group	I-T170
analysis	B-T062
of	O
fetuses	B-T017
with	O
abnormalities	B-T033
of	I-T033
the	I-T033
posterior	I-T033
fossa	I-T033
diagnosed	B-T033
on	O
antenatal	B-T058
us	I-T058
##s	I-T058
(	O
with	O
or	O
without	O
ventricul	O
##omegaly	O
)	O
from	O
the	O
mer	O
##idian	O
cohort	B-T098
who	O
had	O
iu	B-T058
##mr	I-T058
imaging	I-T058
within	O
2	O
weeks	O
of	O
us	B-T058
##s	I-T058
and	O
outcome	O
reference	O
data	O
were	O
available	O
.	O
the	O
diagnostic	O
accuracy	O
of	O
us	B-T058
##s	I-T058
and	O
iu	B-T058
##mr	I-T058
are	O
reported	B-T170
as	O
well	O
as	O
indicators	B-T103
of	O
diagnostic	O
confidence	O
and	O
effects	O
on	O
prognosis	B-T058
and	O
clinical	B-T058
management	I-T058
.	O
abnormalities	B-T033
confined	I-T033
to	I-T033
the	I-T033
posterior	I-T033
fossa	I-T033
according	O
to	O
us	B-T058
##s	I-T058
were	O
found	O
in	O
81	O
fetuses	B-T017
(	O
67	O
with	O
parenchymal	B-T017
and	O
14	O
with	O
csf	B-T031
-	O
containing	O
lesions	B-T033
)	O
.	O
the	O
overall	O
diagnostic	O
accuracy	O
for	O
detecting	B-T033
an	O
isolated	O
posterior	B-T033
fossa	I-T033
abnormality	I-T033
was	O
65	O
%	O
for	O
us	B-T058
##s	I-T058
and	O
88	O
%	O
for	O
iu	B-T058
##mr	I-T058
(	O
difference	O
=	O
22	O
%	O
,	O
95	O
%	O
ci	O
:	O
14	O
.	O
0	O
to	O
30	O
.	O
5	O
%	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
there	O
was	O
an	O
improvement	O
in	O
'	O
appropriate	O
'	O
diagnostic	O
confidence	O
as	O
assessed	O
by	O
a	O
score	O
-	O
based	O
weighted	O
average	O
'	O
method	B-T170
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
a	O
three	O
-	O
fold	O
reduction	B-T058
in	O
'	O
high	O
confidence	O
but	O
incorrect	O
diagnoses	B-T033
'	O
was	O
achieved	O
by	O
using	O
iu	B-T058
##mr	I-T058
imaging	I-T058
.	O
the	O
prognostic	B-T058
information	I-T058
given	O
to	O
the	O
women	B-T098
after	O
iu	B-T058
##mr	I-T058
imaging	I-T058
changed	O
in	O
44	O
%	O
of	O
cases	O
and	O
the	O
overall	O
effect	O
of	O
iu	B-T058
##mr	I-T058
on	O
clinical	B-T058
management	I-T058
was	O
considered	O
to	O
be	O
'	O
significant	O
'	O
,	O
'	O
major	O
'	O
or	O
'	O
decisive	B-T033
'	O
in	O
35	O
%	O
of	O
cases	O
.	O
our	O
data	O
suggests	O
that	O
any	O
woman	B-T098
whose	O
fetus	B-T017
has	O
a	O
posterior	B-T033
fossa	I-T033
abnormality	I-T033
as	O
the	O
only	O
intracranial	B-T033
finding	I-T033
on	O
us	B-T058
##s	I-T058
should	O
have	O
iu	B-T058
##mr	I-T058
imaging	I-T058
for	O
further	O
evaluation	B-T058
.	O
this	O
is	O
on	O
the	O
basis	O
of	O
improved	B-T033
diagnostic	O
accuracy	O
and	O
confidence	O
which	O
has	O
substantial	O
effects	O
on	O
the	O
prognostic	B-T058
information	I-T058
given	O
to	O
women	B-T098
and	O
changes	O
in	O
clinical	B-T058
management	I-T058
.	O

propranolol	B-T103
effects	O
on	O
decompression	B-T038
sickness	I-T038
in	O
a	O
simulated	O
diss	O
##ub	O
rescue	O
in	O
swine	B-T204
disabled	O
subma	O
##rine	O
(	O
diss	O
##ub	O
)	O
survivors	O
may	O
face	O
elevated	B-T033
co2	I-T033
levels	I-T033
and	O
inert	O
gas	O
saturation	O
,	O
put	O
##ting	O
them	O
at	O
risk	O
for	O
co2	B-T103
toxicity	O
and	O
decompression	B-T038
sickness	I-T038
(	O
dcs	B-T038
)	O
.	O
propranolol	B-T103
was	O
shown	O
to	O
reduce	B-T058
co2	I-T058
production	I-T058
in	O
an	O
experimental	O
diss	O
##ub	O
model	O
in	O
humans	B-T204
but	O
its	O
effects	O
on	O
dcs	B-T038
in	O
a	O
diss	O
##ub	O
rescue	O
scenario	O
are	O
unknown	O
.	O
a	O
100	O
%	O
oxygen	B-T038
pre	I-T038
##bre	I-T038
##ath	I-T038
##e	I-T038
(	O
op	B-T038
##b	I-T038
)	O
reduces	O
dcs	B-T038
incidence	O
and	O
severity	O
and	O
is	O
incorporated	O
into	O
some	O
diss	O
##ub	O
rescue	O
protocols	O
.	O
we	O
used	O
a	O
swine	B-T204
model	I-T204
of	O
diss	O
##ub	O
rescue	O
to	O
study	O
the	O
effect	O
of	O
propranolol	B-T103
on	O
dcs	B-T038
incidence	O
and	O
mortality	O
with	O
and	O
without	O
an	O
op	B-T038
##b	I-T038
.	O
in	O
experiment	O
1	O
,	O
male	O
york	B-T204
##sh	I-T204
##ire	I-T204
swine	I-T204
(	O
70	O
kg	O
)	O
were	O
press	O
##urized	O
to	O
2	O
.	O
8	O
ata	O
for	O
22	O
h	O
.	O
propranolol	B-T103
1	O
.	O
0	O
mg	O
·	O
kg	O
-	O
1	O
(	O
iv	O
)	O
was	O
administered	O
at	O
21	O
.	O
25	O
h	O
.	O
at	O
22	O
h	O
,	O
the	O
animal	B-T204
was	O
rapidly	O
decomp	O
##ressed	O
and	O
observed	O
for	O
dcs	B-T038
type	O
,	O
onset	O
time	O
,	O
and	O
mortality	O
.	O
experimental	O
animals	B-T204
(	O
n	O
=	O
21	O
;	O
69	O
±	O
4	O
.	O
1	O
kg	O
)	O
,	O
prop	B-T103
##1	I-T103
.	I-T103
0	I-T103
,	O
were	O
compared	O
to	O
prop	B-T103
##1	I-T103
.	I-T103
0	I-T103
-	O
op	B-T038
##b4	I-T038
##5	I-T038
(	O
n	O
=	O
8	O
;	O
69	O
±	O
2	O
.	O
8	O
kg	O
)	O
with	O
the	O
same	O
div	O
##e	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
op	B-T038
##b	I-T038
prior	O
to	O
decompression	O
.	O
in	O
experiment	O
2	O
,	O
the	O
same	O
methodology	O
was	O
used	O
with	O
the	O
following	O
changes	O
:	O
swine	B-T204
press	O
##urized	O
to	O
2	O
.	O
8	O
ata	O
for	O
28	O
h	O
;	O
experimental	O
group	O
(	O
n	O
=	O
25	O
;	O
67	O
±	O
3	O
.	O
3	O
kg	O
)	O
,	O
prop	B-T103
##0	I-T103
.	I-T103
5	I-T103
bis	O
,	O
propranolol	B-T103
0	O
.	O
5	O
mg	O
·	O
kg	O
-	O
1	O
bis	O
(	O
twice	O
)	O
(	O
iv	O
)	O
was	O
administered	O
at	O
22	O
h	O
and	O
26	O
h	O
.	O
control	B-T204
animals	I-T204
(	O
n	O
=	O
25	O
;	O
67	O
±	O
3	O
.	O
9	O
kg	O
)	O
received	O
normal	B-T103
saline	I-T103
.	O
op	B-T038
##b	I-T038
reduced	O
mortality	O
in	O
prop	B-T103
##1	I-T103
.	I-T103
0	I-T103
-	O
ob	B-T038
##p4	I-T038
##5	I-T038
compared	O
to	O
prop	B-T103
##1	I-T103
.	I-T103
0	I-T103
(	O
0	O
%	O
vs	O
.	O
71	O
%	O
)	O
.	O
prop	B-T103
##0	I-T103
.	I-T103
5	I-T103
bis	O
had	O
increased	O
mortality	O
compared	O
to	O
control	O
(	O
60	O
-	O
%	O
vs	O
.	O
4	O
%	O
)	O
.	O
administration	O
of	O
beta	B-T103
blockers	I-T103
prior	O
to	O
saturation	O
decompression	O
appears	O
to	O
increase	O
dcs	B-T038
and	O
worsen	O
mortality	O
in	O
a	O
swine	B-T204
model	O
;	O
however	O
,	O
their	O
effects	O
in	O
bo	O
##unc	O
##e	O
diving	O
remain	O
unknown	O
.	O
for	O
##be	O
##s	O
as	O
,	O
regi	O
##s	O
dp	O
,	O
hall	O
##aa	O
,	O
mah	O
##on	O
rt	O
,	O
cron	O
##in	O
wa	O
.	O
propranolol	O
effects	O
on	O
decompression	O
sickness	O
in	O
a	O
simulated	O
diss	O
##ub	O
rescue	O
in	O
swine	O
.	O
aeros	O
##p	O
med	O
hum	O
perform	O
.	O
2017	O
;	O
88	O
(	O
4	O
)	O
:	O
38	O
##5	O
-	O
39	O
##1	O
.	O

the	O
loop	B-T082
2	I-T082
region	I-T082
of	O
ribosomal	B-T103
protein	I-T103
us	I-T103
##5	I-T103
influences	O
spect	B-T103
##ino	I-T103
##my	I-T103
##cin	I-T103
sensitivity	B-T033
,	O
translational	B-T038
fidelity	I-T038
,	O
and	O
ribosome	B-T038
biogenesis	I-T038
ribosomal	B-T103
protein	I-T103
us	I-T103
##5	I-T103
is	O
an	O
essential	O
component	O
of	O
the	O
small	B-T017
ribosomal	I-T017
subunit	I-T017
that	O
is	O
involved	O
in	O
subunit	B-T038
assembly	I-T038
,	O
maintenance	B-T038
of	I-T038
translational	I-T038
fidelity	I-T038
,	O
and	O
the	O
ribosome	B-T017
'	I-T017
s	I-T017
response	O
to	O
the	O
antibiotic	B-T103
spect	I-T103
##ino	I-T103
##my	I-T103
##cin	I-T103
.	O
while	O
many	O
of	O
the	O
characterized	O
us	B-T038
##5	I-T038
mutations	I-T038
that	O
affect	O
decoding	B-T038
map	O
to	O
its	O
interface	B-T038
with	O
us	B-T103
##4	I-T103
,	O
more	O
recent	O
work	O
has	O
shown	O
that	O
residues	O
distant	O
from	O
the	O
us	B-T038
##4	I-T038
-	I-T038
us	I-T038
##5	I-T038
interface	I-T038
can	O
also	O
affect	O
the	O
decoding	O
process	O
.	O
we	O
targeted	O
one	O
such	O
interface	O
-	O
remote	O
area	O
,	O
the	O
loop	B-T082
2	I-T082
region	I-T082
(	O
residues	O
20	O
to	O
31	O
)	O
,	O
for	O
mutagenesis	B-T038
in	O
escherichia	B-T007
.	I-T007
coli	I-T007
and	O
generated	O
21	O
unique	B-T038
mutants	I-T038
.	O
a	O
majority	O
of	O
the	O
loop	B-T082
2	I-T082
alterations	O
confer	O
resistance	O
to	O
spect	B-T103
##ino	I-T103
##my	I-T103
##cin	I-T103
and	O
affect	O
the	O
fidelity	B-T038
of	I-T038
translation	I-T038
.	O
however	O
,	O
only	O
a	O
minority	O
show	O
altered	O
rrna	B-T103
processing	O
or	O
ribosome	B-T038
biogenesis	I-T038
defects	O
.	O

in	O
search	O
of	O
the	O
e	B-T007
.	I-T007
coli	I-T007
compounds	B-T103
that	O
change	O
the	O
antibiotic	B-T103
production	O
pattern	O
of	O
streptomyces	B-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
during	O
inter	O
-	O
species	O
interaction	O
the	O
aim	O
of	O
this	O
work	O
was	O
to	O
investigate	O
the	O
interaction	O
between	O
e	B-T007
.	I-T007
coli	I-T007
and	O
streptomyces	B-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
a3	I-T007
(	I-T007
2	I-T007
)	I-T007
for	O
the	O
increased	O
production	O
of	O
und	B-T103
##ecyl	I-T103
##pro	I-T103
##di	I-T103
##gi	I-T103
##osin	I-T103
and	O
identify	O
the	O
e	B-T007
.	I-T007
coli	I-T007
active	O
##s	O
mediating	O
this	O
inter	O
-	O
species	O
interaction	O
.	O
the	O
antibiotics	B-T103
of	O
interest	O
were	O
the	O
red	B-T103
-	I-T103
pigmented	I-T103
und	I-T103
##ecyl	I-T103
##pro	I-T103
##di	I-T103
##gi	I-T103
##osin	I-T103
and	O
blue	O
-	O
pigmented	O
actin	B-T103
##orh	I-T103
##odin	I-T103
.	O
pure	O
cultures	B-T058
of	O
s	B-T007
.	I-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
in	O
a	O
defined	O
medium	B-T103
produced	O
higher	O
concentrations	O
of	O
actin	B-T103
##orh	I-T103
##odin	I-T103
compared	O
to	O
those	O
of	O
und	B-T103
##ecyl	I-T103
##pro	I-T103
##di	I-T103
##gi	I-T103
##osin	I-T103
.	O
the	O
latter	O
however	O
,	O
is	O
more	O
important	O
due	O
to	O
its	O
immunosuppressive	B-T038
and	O
antitumor	B-T038
properties	I-T038
.	O
as	O
a	O
strategy	O
to	O
increase	O
und	B-T103
##ecyl	I-T103
##pro	I-T103
##di	I-T103
##gi	I-T103
##osin	I-T103
production	O
,	O
we	O
added	O
separately	O
,	O
live	O
cells	O
and	O
heat	O
-	O
killed	O
cells	B-T017
of	O
e	B-T007
.	I-T007
coli	I-T007
c60	I-T007
##0	I-T007
,	O
and	O
the	O
cell	B-T031
-	I-T031
free	I-T031
supernatant	I-T031
of	O
e	B-T007
.	I-T007
coli	I-T007
culture	B-T058
to	O
s	B-T007
.	I-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
cultures	B-T058
in	I-T058
sh	I-T058
##ake	I-T058
flask	I-T058
##s	I-T058
.	O
the	O
interaction	O
with	O
live	O
cells	O
of	O
e	B-T007
.	I-T007
coli	I-T007
altered	O
the	O
antibiotic	B-T103
production	O
pattern	O
and	O
und	B-T103
##ecyl	I-T103
##pro	I-T103
##di	I-T103
##gi	I-T103
##osin	I-T103
production	O
was	O
enhanced	O
by	O
3	O
.	O
5	O
-	O
fold	O
compared	O
to	O
the	O
pure	B-T058
cultures	I-T058
of	O
s	B-T007
.	I-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
and	O
actin	B-T103
##orh	I-T103
##odin	I-T103
decreased	O
by	O
15	O
-	O
fold	O
.	O
the	O
heat	O
-	O
killed	O
cells	B-T017
of	O
e	B-T007
.	I-T007
coli	I-T007
however	O
,	O
had	O
no	O
effect	O
on	O
antibiotic	B-T103
production	O
.	O
in	O
all	O
cases	O
,	O
growth	O
and	O
glucose	B-T033
consumption	I-T033
of	O
s	B-T007
.	I-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
remained	O
almost	O
the	O
same	O
as	O
those	O
observed	O
in	O
the	O
pure	B-T058
culture	I-T058
indicating	O
that	O
the	O
changes	O
in	O
antibiotic	B-T103
production	O
were	O
not	O
due	O
to	O
nutritional	B-T038
stress	B-T033
.	O
results	O
with	O
cell	B-T031
-	I-T031
free	I-T031
supernatant	I-T031
of	O
e	B-T007
.	I-T007
coli	I-T007
culture	B-T058
indicated	O
that	O
the	O
interaction	O
between	O
s	B-T007
.	I-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
and	O
e	B-T007
.	I-T007
coli	I-T007
was	O
mediated	O
via	O
diffus	B-T103
##ible	I-T103
molecule	I-T103
(	I-T103
s	I-T103
)	I-T103
.	O
using	O
a	O
set	O
of	O
extraction	B-T058
procedures	I-T058
and	O
agar	B-T058
-	I-T058
well	I-T058
diffusion	I-T058
bioassays	I-T058
,	O
we	O
isolated	O
and	O
prelim	O
##inarily	O
identified	O
a	O
class	B-T103
of	I-T103
compounds	I-T103
.	O
for	O
the	O
preliminary	O
verification	O
,	O
we	O
added	O
the	O
compound	B-T103
which	O
was	O
the	O
common	O
chemical	O
structural	O
moiety	O
in	O
this	O
class	B-T103
of	I-T103
compounds	I-T103
to	O
the	O
pure	O
s	B-T007
.	I-T007
coel	I-T007
##ico	I-T007
##lor	I-T007
cultures	O
.	O
we	O
observed	O
similar	O
effects	O
on	O
antibiotic	B-T103
production	O
as	O
with	O
the	O
live	O
e	B-T007
.	I-T007
coli	I-T007
cells	B-T017
and	O
their	O
supernatant	B-T031
indicating	O
that	O
this	O
class	B-T103
of	I-T103
compounds	I-T103
secreted	B-T038
by	O
e	B-T007
.	I-T007
coli	I-T007
indeed	O
could	O
act	O
as	O
active	O
##s	O
during	O
intersp	O
##ecies	O
interaction	O
and	O
increase	O
the	O
production	O
of	O
und	B-T103
##ecyl	I-T103
##pro	I-T103
##di	I-T103
##gi	I-T103
##osin	I-T103
.	O

prospective	O
study	O
of	O
dietary	B-T168
non	B-T058
enzymatic	I-T058
antioxidant	I-T058
capacity	I-T058
on	O
the	O
risk	O
of	O
hip	B-T037
fracture	I-T037
in	O
the	O
elderly	B-T098
dietary	B-T168
antioxidants	I-T168
may	O
play	O
an	O
important	O
role	O
in	O
the	O
prevention	O
of	O
bone	B-T038
loss	I-T038
and	O
associated	O
fractures	B-T037
by	O
reducing	O
levels	O
of	O
oxidative	B-T038
stress	I-T038
.	O
we	O
prospectively	O
investigated	O
the	O
association	O
between	O
dietary	B-T168
non	B-T058
enzymatic	I-T058
antioxidant	I-T058
capacity	I-T058
(	O
ne	B-T058
##ac	I-T058
)	O
and	O
the	O
risk	O
of	O
hip	B-T037
fracture	I-T037
and	O
whether	O
this	O
effect	O
was	O
modified	O
by	O
smoking	O
.	O
in	O
the	O
swedish	B-T098
national	I-T098
march	I-T098
cohort	I-T098
13	O
,	O
40	O
##9	O
men	B-T098
and	O
women	B-T098
over	O
the	O
age	O
of	O
55	O
who	O
had	O
not	O
experienced	O
cancer	B-T038
,	O
cardiovascular	B-T038
disease	I-T038
or	O
hip	B-T037
fracture	I-T037
,	O
were	O
followed	O
through	O
record	B-T062
-	I-T062
linkages	I-T062
from	O
1997	O
through	O
2010	O
.	O
ne	B-T058
##ac	I-T058
was	O
assessed	O
by	O
a	O
validated	O
food	B-T170
frequency	I-T170
questionnaire	I-T170
collected	O
at	O
baseline	O
.	O
we	O
categorized	O
the	O
distribution	O
of	O
ne	B-T058
##ac	I-T058
into	O
sex	O
-	O
specific	O
quartiles	O
and	O
used	O
multivariable	B-T170
adjusted	I-T170
cox	I-T170
proportional	I-T170
hazards	I-T170
regression	I-T170
models	I-T170
to	O
estimate	O
hazard	O
ratios	O
(	O
hrs	O
)	O
with	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
ci	O
)	O
.	O
during	O
a	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
time	O
of	O
12	O
.	O
4	O
##years	O
,	O
we	O
identified	O
49	O
##1	O
incident	O
cases	O
of	O
first	O
hip	B-T037
fracture	I-T037
.	O
subjects	O
in	O
the	O
highest	O
quartile	O
of	O
dietary	B-T168
ne	B-T058
##ac	I-T058
had	O
a	O
39	O
%	O
lower	O
risk	O
of	O
incident	O
hip	B-T037
fracture	I-T037
compared	O
to	O
those	O
in	O
the	O
lowest	O
quartile	O
(	O
hr	O
:	O
0	O
.	O
61	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
44	O
-	O
0	O
.	O
85	O
)	O
.	O
the	O
association	O
was	O
non	O
-	O
linear	O
(	O
p	O
for	O
non	O
-	O
linearity	O
:	O
0	O
.	O
004	O
)	O
with	O
a	O
potential	O
threshold	O
between	O
the	O
first	O
and	O
the	O
second	O
quartile	O
and	O
no	O
further	O
risk	O
reduction	O
at	O
higher	O
levels	O
of	O
dietary	B-T168
ne	B-T058
##ac	I-T058
.	O
due	O
to	O
a	O
low	O
smoking	O
prevalence	O
in	O
our	O
study	O
population	O
,	O
we	O
had	O
limited	O
power	O
to	O
detect	O
effect	O
modification	O
between	O
dietary	B-T168
ne	B-T058
##ac	I-T058
and	O
smoking	O
on	O
a	O
multipl	O
##ica	O
##tive	O
or	O
additive	O
scale	O
.	O
higher	O
dietary	O
ne	B-T058
##ac	I-T058
intake	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
hip	B-T037
fracture	I-T037
in	O
the	O
elderly	O
.	O

jak	B-T103
##1	I-T103
-	O
stat3	B-T103
signals	B-T038
are	O
essential	O
effectors	O
of	O
the	O
usp	B-T103
##6	I-T103
/	O
tre	B-T103
##17	I-T103
oncogene	I-T103
in	O
tumorigenesis	B-T038
bone	B-T038
and	O
soft	B-T038
tissue	I-T038
tumors	I-T038
(	O
bs	B-T038
##tt	I-T038
)	O
are	O
relatively	O
poorly	O
understood	O
,	O
hamper	O
##ing	O
the	O
development	O
of	O
effective	O
therapies	B-T058
.	O
here	O
we	O
report	B-T170
a	O
role	O
for	O
the	O
ubiquitin	B-T103
-	I-T103
specific	I-T103
protease	I-T103
6	I-T103
(	O
usp	B-T103
##6	I-T103
)	O
/	O
tre	B-T103
##17	I-T103
oncogene	I-T103
,	O
which	O
is	O
overexpressed	B-T038
upon	O
chromosome	B-T038
translocation	I-T038
in	O
various	O
human	B-T204
tumors	B-T038
,	O
including	O
aneurysmal	B-T038
bone	I-T038
cyst	I-T038
(	O
abc	B-T038
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	B-T033
nodular	B-T038
fasci	I-T038
##itis	I-T038
.	O
ectopic	B-T038
expression	I-T038
of	O
usp	B-T103
##6	I-T103
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	B-T038
,	O
which	O
recapit	O
##ulate	O
key	O
features	O
of	O
abc	B-T038
and	O
nodular	B-T038
fasci	I-T038
##itis	I-T038
;	O
however	O
,	O
the	O
identity	O
of	O
usp	B-T103
##6	I-T103
'	I-T103
s	I-T103
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O
here	O
we	O
report	B-T170
that	O
the	O
jak	B-T103
##1	I-T103
-	O
stat3	B-T103
signaling	B-T038
pathway	I-T038
serves	O
as	O
an	O
essential	O
effector	O
of	O
usp	B-T103
##6	I-T103
in	O
bs	B-T038
##tt	I-T038
formation	O
.	O
we	O
found	O
that	O
usp	B-T103
##6	I-T103
directly	O
de	B-T038
##ub	I-T038
##iqu	I-T038
##itin	I-T038
##ated	I-T038
jak	B-T103
##1	I-T103
,	O
leading	O
to	O
its	O
stabilization	B-T033
and	O
activation	O
of	O
stat3	B-T103
.	O
the	O
tumorigenic	B-T038
potential	O
of	O
usp	B-T103
##6	I-T103
was	O
attenuated	O
significantly	O
by	O
crispr	B-T103
-	O
mediated	O
deletion	B-T038
of	O
jak	B-T017
##1	I-T017
or	O
stat3	B-T017
,	O
or	O
by	O
administration	O
of	O
a	O
jak	B-T103
family	I-T103
inhibitor	O
.	O
analysis	B-T062
of	O
primary	O
clinical	O
samples	O
of	O
nodular	B-T038
fasci	I-T038
##itis	I-T038
confirmed	B-T033
the	O
activation	O
of	O
a	O
jak	B-T103
##1	I-T103
-	O
stat3	B-T103
gene	O
signature	O
in	O
vivo	O
together	O
,	O
our	O
studies	B-T058
highlight	O
jak	B-T103
##1	I-T103
as	O
the	O
first	O
identified	O
substrate	O
for	O
usp	B-T103
##6	I-T103
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	B-T058
investigation	I-T058
of	O
jak	B-T103
and	O
stat3	B-T103
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	B-T058
of	O
bone	B-T038
and	O
soft	B-T038
tissue	I-T038
tumors	I-T038
along	O
with	O
other	O
neoplasms	B-T038
driven	O
by	O
usp	B-T103
##6	I-T103
overexpression	B-T038
.	O
cancer	O
res	O
;	O
76	O
(	O
18	O
)	O
;	O
53	O
##37	O
-	O
47	O
.	O
©	O
##20	O
##16	O
aac	O
##r	O
.	O

presence	B-T033
of	I-T033
citr	B-T103
##inin	I-T103
in	O
grains	B-T168
and	O
its	O
possible	B-T033
health	O
effects	O
citr	B-T103
##inin	I-T103
is	O
a	O
myc	B-T103
##otoxin	I-T103
produced	O
by	O
several	O
species	B-T170
of	O
the	O
genera	B-T204
aspergillus	I-T204
,	O
penicillium	B-T204
and	O
mon	B-T204
##asc	I-T204
##us	I-T204
and	O
it	O
occurs	O
mainly	O
in	O
stored	B-T168
grain	I-T168
.	O
citr	B-T103
##inin	I-T103
is	O
generally	O
formed	O
after	O
harvest	O
and	O
occurs	O
mainly	O
in	O
stored	B-T168
grains	I-T168
,	O
it	O
also	O
occurs	O
in	O
other	O
plant	O
products	O
.	O
often	O
,	O
the	O
co	O
-	O
occurrence	O
with	O
other	O
mycotoxins	B-T103
is	O
observed	O
,	O
especially	O
och	B-T103
##ra	I-T103
##to	I-T103
##xin	I-T103
a	I-T103
,	O
which	O
is	O
usually	O
associated	O
with	O
endemic	B-T038
nephropathy	I-T038
.	O
at	O
the	O
european	B-T092
union	I-T092
level	O
,	O
systematic	O
monitoring	B-T058
of	O
citr	B-T103
##inin	I-T103
in	O
grains	B-T168
began	O
with	O
the	O
aim	O
of	O
determining	O
its	O
highest	O
perm	O
##issible	O
amount	O
in	O
food	B-T168
.	O
thus	O
,	O
far	O
the	O
systematic	O
monitoring	B-T058
of	O
the	O
above	B-T103
mentioned	I-T103
myc	I-T103
##otoxin	I-T103
in	O
cro	B-T082
##atia	I-T082
is	O
yet	O
to	O
begin	O
.	O
the	O
main	B-T170
goal	I-T170
of	O
this	O
study	B-T062
was	O
to	O
determine	O
the	O
presence	B-T033
of	I-T033
citr	B-T103
##inin	I-T103
in	O
grains	B-T168
sampled	O
in	O
the	O
area	B-T082
of	O
me	B-T082
##đ	I-T082
##im	I-T082
##ur	I-T082
##je	I-T082
,	O
os	B-T082
##ij	I-T082
##ek	I-T082
-	I-T082
bar	I-T082
##an	I-T082
##ja	I-T082
,	O
v	B-T082
##uk	I-T082
##ova	I-T082
##r	I-T082
-	I-T082
sri	I-T082
##je	I-T082
##m	I-T082
and	O
bro	B-T082
##d	I-T082
-	I-T082
pos	I-T082
##avi	I-T082
##na	I-T082
county	I-T082
.	O
for	O
the	O
purpose	O
of	O
identification	O
and	O
quantification	O
of	O
citr	B-T103
##inin	I-T103
,	O
high	B-T058
performance	I-T058
liquid	I-T058
chromat	I-T058
##ograph	I-T058
(	I-T058
hplc	I-T058
)	I-T058
with	I-T058
fluorescence	I-T058
was	O
used	B-T033
(	O
calibration	O
curve	O
k	O
>	O
0	O
.	O
999	O
;	O
intra	O
assay	O
cv	O
=	O
2	O
.	O
1	O
%	O
;	O
inter	O
assay	O
cv	O
=	O
4	O
.	O
3	O
%	O
;	O
lo	O
##q	O
<	O
1	O
μg	O
/	O
kg	O
)	O
.	O
from	O
the	O
area	B-T082
of	O
me	B-T082
##đ	I-T082
##im	I-T082
##ur	I-T082
##je	I-T082
county	I-T082
,	O
10	O
samples	O
of	O
corn	B-T168
and	O
10	O
samples	O
of	O
wheat	B-T168
were	O
analyzed	B-T062
.	O
none	O
of	O
the	O
samples	O
contained	O
citr	B-T103
##inin	I-T103
(	O
<	O
1	O
μg	O
/	O
kg	O
)	O
.	O
from	O
the	O
area	B-T082
of	O
os	B-T082
##ij	I-T082
##ek	I-T082
-	I-T082
bar	I-T082
##an	I-T082
##ja	I-T082
and	O
v	B-T082
##uk	I-T082
##ova	I-T082
##r	I-T082
-	I-T082
sri	I-T082
##je	I-T082
##m	I-T082
county	I-T082
,	O
15	O
samples	O
from	O
each	O
county	B-T082
were	O
analyzed	B-T062
.	O
the	O
mean	O
value	O
for	O
the	O
samples	O
of	O
os	B-T082
##ij	I-T082
##ek	I-T082
-	I-T082
bar	I-T082
##an	I-T082
##ja	I-T082
county	I-T082
was	O
19	O
.	O
63	O
μg	O
/	O
kg	O
(	O
median	O
=	O
15	O
.	O
8	O
μg	O
/	O
kg	O
)	O
,	O
while	O
for	O
v	B-T082
##uk	I-T082
##ova	I-T082
##r	I-T082
-	I-T082
sri	I-T082
##je	I-T082
##m	I-T082
county	I-T082
the	O
mean	O
value	O
of	O
citr	B-T103
##inin	I-T103
was	O
14	O
,	O
6	O
μg	O
/	O
kg	O
(	O
median	O
=	O
1	O
.	O
23	O
μg	O
/	O
kg	O
)	O
.	O
from	O
5	O
analyzed	B-T062
samples	O
from	O
bro	B-T082
##d	I-T082
-	I-T082
pos	I-T082
##avi	I-T082
##na	I-T082
county	I-T082
,	O
one	O
of	O
the	O
samples	O
contained	O
citr	B-T103
##inin	I-T103
in	O
the	O
amount	O
of	O
23	O
.	O
8	O
μg	O
/	O
kg	O
,	O
while	O
the	O
registered	B-T058
amount	O
s	O
in	O
the	O
other	O
samples	O
were	O
<	O
1	O
μg	O
/	O
kg	O
.	O
the	O
results	O
show	O
that	O
grains	B-T168
from	O
several	O
counties	B-T082
contain	O
certain	O
amounts	O
of	O
citr	B-T103
##inin	I-T103
possibly	O
indicating	B-T033
a	O
significant	O
intake	O
of	O
citr	B-T103
##inin	I-T103
in	O
humans	B-T204
.	O
it	O
must	O
be	O
stated	O
that	O
grains	B-T168
and	O
grain	B-T168
-	I-T168
based	I-T168
products	I-T168
are	O
the	O
basis	O
of	O
everyday	O
diet	B-T168
of	O
all	O
age	O
groups	O
,	O
especially	O
small	O
children	O
,	O
where	O
higher	O
intake	O
of	O
citr	B-T103
##inin	I-T103
can	O
occur	O
.	O
consequently	O
,	O
we	O
emphasize	O
the	O
need	O
for	O
systematic	O
analysis	B-T062
of	O
larger	O
amount	O
of	O
samples	O
,	O
from	O
both	O
large	B-T168
grains	I-T168
and	O
small	B-T168
grains	I-T168
,	O
especially	O
in	O
the	O
area	B-T082
of	O
bro	B-T082
##d	I-T082
-	I-T082
pos	I-T082
##avi	I-T082
##na	I-T082
county	I-T082
,	O
in	O
order	O
to	O
obtain	O
more	O
realistic	O
notion	O
of	O
citr	B-T103
##inin	I-T103
contamination	O
of	O
grains	B-T168
and	O
to	O
ass	O
##es	O
the	O
health	O
risk	O
in	O
humans	B-T204
.	O

diffuse	B-T037
traumatic	I-T037
brain	I-T037
injury	I-T037
affects	O
chronic	O
corticosterone	B-T103
function	O
in	O
the	O
rat	B-T204
as	O
many	O
as	O
20	O
-	O
55	O
%	O
of	O
patients	O
with	O
a	O
history	B-T033
of	O
traumatic	B-T037
brain	I-T037
injury	I-T037
(	O
tbi	B-T037
)	O
experience	O
chronic	O
endocrine	O
dysfunction	O
,	O
leading	O
to	O
impaired	O
quality	O
of	O
life	O
,	O
impaired	O
rehabilitation	O
efforts	O
and	O
lowered	B-T033
life	I-T033
expectancy	I-T033
.	O
endocrine	O
dysfunction	O
after	O
tbi	B-T037
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	B-T017
within	O
the	O
skull	B-T017
,	O
creating	O
end	O
##uring	O
hypothalamic	B-T017
and	O
pituitary	B-T017
neuropath	B-T038
##ology	I-T038
,	O
and	O
subsequent	O
hypothalamic	B-T022
-	I-T022
pituitary	I-T022
endocrine	I-T022
(	O
hp	B-T022
##e	I-T022
)	O
dysfunction	B-T038
.	O
these	O
experiments	B-T062
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	B-T037
tbi	I-T037
results	O
in	O
chronic	O
dysfunction	B-T038
of	O
corticosterone	B-T103
(	O
cort	B-T103
)	O
,	O
a	O
glucocorticoid	B-T103
released	O
in	O
response	O
to	O
stress	B-T038
and	O
testosterone	B-T103
.	O
we	O
used	O
a	O
rodent	B-T038
model	I-T038
of	O
diffuse	B-T037
tbi	I-T037
induced	O
by	O
midline	B-T037
fluid	I-T037
perc	I-T037
##ussion	I-T037
injury	I-T037
(	O
mf	B-T037
##pi	I-T037
)	O
.	O
at	O
2	O
months	O
postin	O
##jury	O
compared	O
with	O
unin	B-T204
##ju	I-T204
##red	I-T204
control	I-T204
animals	I-T204
,	O
circulating	O
levels	O
of	O
cort	B-T103
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	B-T038
stress	I-T038
and	O
in	O
response	O
to	O
dexamethasone	B-T103
,	O
a	O
synthetic	B-T103
glucocorticoid	I-T103
commonly	O
used	O
to	O
test	O
hp	B-T022
##e	I-T022
axis	B-T082
regulation	B-T038
.	O
testosterone	B-T103
was	O
evaluated	O
at	O
rest	O
.	O
further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	B-T037
-	O
induced	O
neuron	B-T017
morphology	O
(	O
golgi	B-T058
stain	I-T058
)	O
,	O
neuropath	B-T038
##ology	I-T038
(	O
silver	B-T058
stain	I-T058
)	O
and	O
activated	B-T038
astrocytes	B-T017
(	O
gfap	B-T058
)	O
in	O
the	O
paraventricular	B-T017
nucleus	I-T017
(	O
pvn	B-T017
)	O
of	O
the	O
hypothalamus	B-T017
.	O
resting	O
plasma	B-T031
cort	B-T103
levels	O
were	O
decreased	O
at	O
2	O
months	O
postin	O
##jury	O
and	O
there	O
was	O
a	O
blunted	O
cort	B-T103
increase	O
in	O
response	O
to	O
restraint	B-T038
induced	I-T038
stress	I-T038
.	O
no	B-T033
changes	I-T033
in	O
testosterone	B-T103
were	O
measured	O
.	O
these	O
changes	O
in	O
cort	B-T103
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	B-T017
processes	B-T038
in	O
the	O
pvn	B-T017
over	O
time	O
,	O
devoid	O
of	O
neuropath	B-T038
##ology	I-T038
or	O
astrocyt	B-T038
##osis	I-T038
.	O
results	O
provide	O
evidence	O
that	O
a	O
single	O
moderate	O
diffuse	B-T037
tbi	I-T037
leads	O
to	O
changes	O
in	O
cort	B-T103
function	O
,	O
which	O
can	O
contribute	O
to	O
the	O
persistence	O
of	O
symptoms	O
related	O
to	O
endocrine	O
dysfunction	O
.	O
future	O
experiments	B-T062
aim	O
to	O
evaluate	O
additional	O
hp	B-T103
-	I-T103
related	I-T103
hormones	I-T103
and	O
endocrine	B-T022
circuit	O
pathology	O
following	O
diffuse	B-T037
tbi	I-T037
.	O

an	O
hiv	B-T005
-	O
tailored	B-T058
quit	O
-	O
smoking	O
counselling	B-T058
pilot	B-T062
intervention	B-T058
targeting	O
depressive	B-T033
symptoms	I-T033
plus	O
nicotine	B-T058
replacement	I-T058
therapy	I-T058
cardiovascular	B-T038
disease	I-T038
(	O
cvd	B-T038
)	O
rates	O
among	O
people	B-T098
living	O
with	O
hiv	O
/	O
aids	O
(	O
pha	O
##s	O
)	O
are	O
high	O
.	O
rates	O
of	O
cigarette	O
smoking	O
,	O
a	O
leading	O
contributor	O
to	O
cvd	B-T038
among	O
pha	O
##s	O
,	O
are	O
40	O
-	O
70	O
%	O
(	O
2	O
-	O
3	O
times	O
higher	O
than	O
the	O
general	B-T098
population	I-T098
)	O
.	O
furthermore	O
,	O
pha	O
##s	O
have	O
high	O
rates	O
of	O
depression	B-T038
(	O
40	O
-	O
60	O
%	O
)	O
,	O
a	O
risk	B-T033
factor	I-T033
for	O
smoking	O
cessation	O
relapse	O
.	O
the	O
current	O
pilot	B-T062
study	I-T062
examined	B-T033
the	O
effectiveness	O
of	O
a	O
specifically	O
tailored	B-T058
5	O
-	O
session	O
smoking	O
cessation	O
counselling	B-T058
programme	I-T058
for	O
pha	O
##s	O
,	O
which	O
addressed	O
depression	B-T038
,	O
in	O
combination	O
with	O
nicotine	B-T058
replacement	I-T058
therapy	I-T058
(	O
nr	B-T058
##t	I-T058
)	O
in	O
a	O
cohort	B-T098
of	O
pha	O
smokers	B-T033
(	O
n	O
=	O
50	O
)	O
.	O
at	O
6	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
,	O
28	O
%	O
of	O
participants	B-T098
demonstrated	O
biochemically	O
verified	O
abstinence	O
from	O
smoking	O
.	O
this	O
result	B-T033
compares	O
favour	O
##ably	O
to	O
other	O
quit	O
-	O
smoking	O
intervention	B-T058
studies	B-T062
,	O
particularly	O
given	O
the	O
high	O
percentage	O
of	O
hiv	B-T033
+	I-T033
smokers	B-T033
with	O
depression	B-T038
.	O
at	O
study	B-T062
baseline	O
,	O
52	O
%	O
of	O
hiv	B-T033
+	I-T033
smokers	B-T033
scored	O
above	O
the	O
clinical	O
cut	O
-	O
off	O
for	O
depression	B-T038
on	O
the	O
centre	B-T170
for	I-T170
epidemiological	I-T170
studies	I-T170
-	I-T170
depression	I-T170
(	I-T170
ces	I-T170
-	I-T170
d	I-T170
)	I-T170
scale	I-T170
.	O
hiv	B-T033
+	I-T033
smokers	B-T033
with	O
depression	B-T038
at	O
study	B-T062
baseline	O
demonstrated	O
quantitatively	O
lower	O
depression	B-T038
at	O
6	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
with	O
a	O
large	O
effect	O
size	O
(	O
d	O
=	O
1	O
)	O
,	O
though	O
it	O
did	O
not	O
reach	O
statistical	O
significance	O
(	O
p	O
=	O
.	O
05	O
##8	O
)	O
.	O
furthermore	O
,	O
those	O
with	O
depression	B-T038
were	O
no	O
more	O
likely	O
to	O
relapse	O
than	O
those	O
without	O
depression	B-T038
(	O
p	O
=	O
.	O
33	O
)	O
,	O
suggesting	O
that	O
our	O
counselling	B-T058
programme	I-T058
adequately	O
addressed	O
this	O
significant	O
barrier	O
to	O
smoking	O
cessation	O
among	O
pha	O
##s	O
.	O
our	O
pilot	B-T062
study	I-T062
indicates	O
the	O
importance	O
of	O
tailored	B-T058
programmes	I-T058
to	O
help	O
pha	O
##s	O
quit	O
smoking	O
,	O
the	O
significance	O
of	O
addressing	O
depressive	B-T033
symptoms	I-T033
,	O
and	O
the	O
need	O
for	O
tailored	B-T058
counselling	I-T058
programmes	I-T058
to	O
enhance	O
quit	O
rates	O
among	O
pha	O
##s	O
.	O

juice	B-T170
##r	I-T170
provides	O
a	O
one	O
-	O
click	O
system	O
for	O
analyzing	B-T062
loop	B-T058
-	I-T058
resolution	I-T058
hi	I-T058
-	I-T058
c	I-T058
experiments	I-T058
hi	B-T058
-	I-T058
c	I-T058
experiments	I-T058
explore	O
the	O
3d	B-T082
structure	I-T082
of	O
the	O
genome	B-T017
,	O
generating	O
ter	B-T170
##aba	I-T170
##se	I-T170
##s	I-T170
of	I-T170
data	I-T170
to	O
create	O
high	O
-	O
resolution	O
contact	O
maps	O
.	O
here	O
,	O
we	O
introduce	O
juice	B-T170
##r	I-T170
,	O
an	O
open	B-T170
-	I-T170
source	I-T170
tool	I-T170
for	O
analyzing	O
ter	O
##aba	O
##se	O
-	O
scale	O
hi	B-T170
-	I-T170
c	I-T170
datasets	I-T170
.	O
juice	B-T170
##r	I-T170
allows	O
users	B-T098
without	O
a	O
computational	O
background	O
to	O
transform	B-T062
raw	B-T170
sequence	I-T170
data	I-T170
into	O
normalized	O
contact	O
maps	O
with	O
one	O
click	O
.	O
juice	B-T170
##r	I-T170
produces	O
a	O
hi	B-T170
##c	I-T170
file	I-T170
containing	O
compressed	O
contact	B-T082
matrices	I-T082
at	O
many	O
resolution	O
##s	O
,	O
facilitating	O
visualization	B-T038
and	O
analysis	B-T062
at	O
multiple	O
scales	O
.	O
structural	B-T082
features	I-T082
,	O
such	O
as	O
loops	B-T017
and	O
domains	O
,	O
are	O
automatically	O
annotated	O
.	O
juice	B-T170
##r	I-T170
is	O
available	O
as	O
open	O
source	O
software	B-T170
at	O
http	O
:	O
/	O
/	O
aid	O
##en	O
##lab	O
.	O
org	O
/	O
juice	O
##r	O
/	O
.	O

anger	B-T038
and	O
aggression	O
in	O
borderline	B-T038
personality	I-T038
disorder	I-T038
and	O
attention	B-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
-	O
does	O
stress	B-T033
matter	O
?	O
the	O
impact	O
of	O
stress	B-T033
on	O
anger	B-T038
and	O
aggression	O
in	O
borderline	B-T038
personality	I-T038
disorder	I-T038
(	O
bpd	B-T038
)	O
and	O
attention	B-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
has	O
not	O
been	O
thoroughly	O
investigated	O
.	O
the	O
goal	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
different	O
aspects	O
of	O
anger	B-T038
and	O
aggression	O
in	O
patients	O
with	O
these	O
disorders	B-T038
.	O
twenty	O
-	O
nine	O
unm	B-T033
##edic	I-T033
##ated	I-T033
female	O
bpd	B-T038
patients	O
,	O
28	O
adhd	B-T038
patients	O
and	O
30	O
healthy	O
controls	O
(	O
hc	O
)	O
completed	O
self	B-T062
-	I-T062
reports	I-T062
measuring	O
trait	O
anger	B-T038
,	O
aggression	O
and	O
emotion	O
regulation	O
capacities	O
.	O
a	O
modified	O
version	O
of	O
the	O
point	O
subtraction	O
aggression	O
paradigm	O
and	O
a	O
state	B-T062
anger	I-T062
measurement	I-T062
were	O
applied	O
under	O
resting	O
and	O
stress	O
conditions	O
.	O
stress	B-T033
was	O
induced	O
by	O
the	O
mann	B-T058
##he	I-T058
##im	I-T058
multicomponent	I-T058
stress	I-T058
test	I-T058
(	O
mms	B-T058
##t	I-T058
)	O
.	O
both	O
patient	O
groups	O
scored	O
significantly	O
higher	O
on	O
all	O
self	B-T062
-	I-T062
report	I-T062
measures	O
compared	O
to	O
hcs	O
.	O
compared	O
to	O
adhd	B-T038
patients	O
,	O
bpd	B-T038
patients	O
reported	O
higher	O
trait	O
aggression	O
and	O
hostility	B-T038
,	O
a	O
stronger	O
tendency	O
to	O
express	O
anger	B-T038
when	O
provoked	O
and	O
to	O
direct	O
anger	B-T038
inward	O
##ly	O
.	O
furthermore	O
,	O
bpd	B-T038
patients	O
exhibited	O
higher	O
state	O
anger	B-T038
than	O
hcs	O
and	O
adhd	B-T038
patients	O
under	O
both	O
conditions	O
and	O
showed	O
a	O
stress	O
-	O
dependent	O
anger	B-T038
increase	O
.	O
at	O
the	O
behavioral	O
level	O
,	O
no	O
significant	O
effects	O
were	O
found	O
.	O
in	O
bpd	B-T038
patients	O
,	O
aggression	O
and	O
anger	B-T038
were	O
positively	O
correlated	O
with	O
emotion	O
regulation	O
deficits	O
.	O
our	O
findings	B-T033
suggest	O
a	O
significant	O
impact	O
of	O
stress	B-T033
on	O
self	O
-	O
perceived	O
state	O
anger	B-T038
in	O
bpd	B-T038
patients	O
but	O
not	O
on	O
aggressive	O
behavior	O
towards	O
others	O
in	O
females	O
with	O
bpd	B-T038
or	O
adhd	B-T038
.	O
however	O
,	O
it	O
appears	O
to	O
be	O
pronounced	O
inward	O
##ly	O
directed	O
anger	B-T038
which	O
is	O
of	O
clinical	O
importance	O
in	O
bpd	B-T038
patients	O
.	O

overnight	O
switching	B-T058
from	O
ox	B-T103
##carb	I-T103
##azepine	I-T103
to	O
es	B-T103
##lic	I-T103
##arb	I-T103
##azepine	I-T103
acetate	I-T103
:	O
an	O
observational	B-T062
study	I-T062
there	O
are	O
clinical	O
situations	O
where	O
it	O
might	O
be	O
appropriate	O
to	O
switch	B-T058
patients	O
from	O
immediate	B-T103
-	I-T103
release	I-T103
ox	B-T103
##carb	I-T103
##azepine	I-T103
(	O
ox	B-T103
##c	I-T103
)	O
to	O
es	B-T103
##lic	I-T103
##arb	I-T103
##azepine	I-T103
acetate	I-T103
(	O
es	B-T103
##l	I-T103
)	O
.	O
we	O
investigated	O
the	O
effects	O
of	O
transition	O
##ing	O
patients	O
overnight	O
from	O
ox	B-T103
##c	I-T103
to	O
es	B-T103
##l	I-T103
.	O
a	O
retrospective	B-T062
,	O
single	B-T062
-	I-T062
center	I-T062
study	I-T062
was	O
conducted	O
in	O
which	O
patients	O
with	O
drug	B-T038
-	I-T038
resistant	I-T038
focal	B-T038
epilepsy	I-T038
on	O
a	O
stable	O
dose	O
of	O
immediate	B-T103
-	I-T103
release	I-T103
ox	B-T103
##c	I-T103
for	O
at	O
least	O
4	O
weeks	O
were	O
switched	B-T058
overnight	O
to	O
es	B-T103
##l	I-T103
.	O
patients	O
were	O
switched	B-T058
because	O
they	O
experienced	O
persistent	O
seizures	B-T033
with	O
ox	B-T103
##c	I-T103
but	O
were	O
unable	B-T033
to	O
tolerate	O
increased	O
ox	B-T103
##c	I-T103
dosing	O
due	O
to	O
adverse	B-T038
events	I-T038
.	O
tolerability	O
was	O
assessed	O
using	O
the	O
adverse	B-T170
events	I-T170
profile	I-T170
(	O
ae	B-T170
##p	I-T170
)	O
,	O
quality	O
of	O
life	O
was	O
assessed	O
using	O
the	O
quality	B-T170
of	I-T170
life	I-T170
in	I-T170
epilepsy	I-T170
inventory	I-T170
10	I-T170
(	O
qol	B-T170
##ie	I-T170
-	I-T170
10	I-T170
)	O
,	O
and	O
alert	B-T038
##ness	I-T038
was	O
assessed	O
as	O
reaction	O
time	O
using	O
a	O
subt	O
##est	O
of	O
the	O
test	B-T170
battery	I-T170
for	I-T170
attention	I-T170
performance	I-T170
version	I-T170
2	I-T170
.	I-T170
3	I-T170
.	O
assessments	B-T058
were	O
performed	O
immediately	O
prior	O
to	O
and	O
5	O
days	O
after	O
switching	B-T058
from	O
ox	B-T103
##c	I-T103
to	O
es	B-T103
##l	I-T103
(	O
days	O
0	O
and	O
5	O
,	O
respectively	O
)	O
.	O
the	O
analysis	B-T062
included	O
21	O
patients	O
(	O
12	O
women	B-T098
,	O
9	O
men	B-T098
;	O
mean	B-T033
age	I-T033
36	I-T033
years	I-T033
)	O
.	O
after	O
switching	B-T058
from	O
ox	B-T103
##c	I-T103
to	O
es	B-T103
##l	I-T103
,	O
there	O
were	O
significant	O
improvements	O
in	O
mean	O
scores	O
for	O
ae	B-T170
##p	I-T170
(	O
p	O
<	O
.	O
001	O
)	O
,	O
qol	B-T170
##ie	I-T170
-	I-T170
10	I-T170
(	O
p	O
=	O
.	O
001	O
)	O
,	O
and	O
alert	B-T038
##ness	I-T038
(	O
p	O
<	O
.	O
05	O
)	O
.	O
adverse	B-T170
events	I-T170
profile	I-T170
total	O
scores	O
improved	B-T033
for	O
21	O
/	O
21	O
(	O
100	O
.	O
0	O
%	O
)	O
patients	O
,	O
qol	B-T170
##ie	I-T170
-	I-T170
10	I-T170
total	O
scores	O
improved	B-T033
for	O
17	O
/	O
21	O
(	O
81	O
.	O
0	O
%	O
)	O
patients	O
,	O
and	O
alert	B-T038
##ness	I-T038
scores	O
improved	B-T033
for	O
16	O
/	O
21	O
(	O
76	O
.	O
2	O
%	O
)	O
patients	O
.	O
in	O
this	O
short	O
-	O
term	O
,	O
single	B-T062
-	I-T062
center	I-T062
study	I-T062
,	O
an	O
overnight	O
switch	B-T058
from	O
twice	O
-	O
daily	O
ox	B-T103
##c	I-T103
to	O
once	O
-	O
daily	O
es	B-T103
##l	I-T103
in	O
patients	O
with	O
drug	B-T038
-	I-T038
resistant	I-T038
focal	B-T038
epileps	I-T038
##ies	I-T038
resulted	B-T033
in	O
improvements	O
in	O
side	B-T038
effects	I-T038
,	O
quality	O
of	O
life	O
,	O
and	O
alert	B-T038
##ness	I-T038
.	O

the	O
epiderm	B-T170
##™	I-T170
3d	B-T058
human	I-T058
reconstructed	I-T058
skin	I-T058
micronucleus	I-T058
(	I-T058
rs	I-T058
##mn	I-T058
)	I-T058
assay	I-T058
:	O
historical	B-T062
control	I-T062
data	O
and	O
proof	B-T033
of	O
principle	B-T062
studies	I-T062
for	O
mechanistic	B-T058
assay	I-T058
adaptations	O
the	O
in	B-T058
vitro	I-T058
human	I-T058
reconstructed	I-T058
skin	I-T058
micronucleus	I-T058
(	I-T058
rs	I-T058
##mn	I-T058
)	I-T058
assay	I-T058
in	O
epiderm	B-T170
##™	I-T170
is	O
a	O
promising	O
novel	O
animal	B-T062
alternative	I-T062
for	O
evaluating	O
genotoxicity	O
of	O
topically	O
applied	O
chemicals	B-T103
.	O
it	O
is	O
particularly	O
useful	O
for	O
assessing	O
cosmetic	B-T103
ingredients	I-T103
that	O
can	O
no	O
longer	O
be	O
tested	O
using	O
in	B-T082
vivo	I-T082
assays	B-T058
.	O
to	O
advance	O
the	O
use	O
of	O
this	O
test	B-T170
especially	O
for	O
regulatory	B-T170
decision	B-T038
-	I-T038
making	I-T038
,	O
we	O
have	O
established	O
the	O
rs	B-T058
##mn	I-T058
assay	I-T058
in	O
our	O
laboratory	B-T092
according	O
to	O
good	B-T170
laboratory	I-T170
practice	I-T170
and	O
following	O
the	O
principles	O
of	O
the	O
oe	B-T092
##cd	I-T092
test	B-T170
guideline	I-T170
48	I-T170
##7	I-T170
in	O
vitro	O
mammalian	B-T017
cell	I-T017
micronucleus	B-T058
test	I-T058
.	O
proficiency	O
with	O
the	O
assay	B-T058
was	O
established	O
by	O
correctly	O
identifying	O
direct	B-T103
-	I-T103
acting	I-T103
gen	I-T103
##otoxins	I-T103
and	O
gen	B-T103
##otoxins	I-T103
requiring	O
metabolism	B-T038
,	O
as	O
well	O
as	O
non	B-T033
-	I-T033
genotoxic	I-T033
/	O
non	B-T033
-	I-T033
carcinogenic	I-T033
chemicals	B-T103
.	O
we	O
also	O
report	B-T170
the	O
analysis	B-T062
of	O
our	O
historical	B-T062
control	I-T062
data	O
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	O
for	O
%	O
micronuclei	B-T017
in	O
bin	B-T038
##ucle	I-T038
##ated	I-T038
cells	I-T038
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O
technical	O
issues	O
including	O
evaluating	O
various	O
solvents	B-T103
with	O
both	O
48	O
##h	O
and	O
72	O
##h	O
treatment	B-T058
regimens	I-T058
were	O
investigated	O
.	O
for	O
the	O
first	O
time	O
,	O
mechanistic	B-T170
studies	I-T170
using	O
crest	B-T062
analysis	I-T062
revealed	O
that	O
the	O
rs	B-T058
##mn	I-T058
assay	I-T058
is	O
suitable	O
for	O
distinguishing	O
aneu	B-T103
##gens	I-T103
and	O
cla	B-T103
##st	I-T103
##ogens	I-T103
.	O
moreover	O
,	O
the	O
assay	B-T058
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	B-T103
as	O
markers	O
for	O
proliferative	B-T038
and	O
toxic	B-T037
effects	I-T037
of	O
chemicals	B-T103
.	O

theory	O
of	O
mind	O
in	O
adolescents	O
with	O
bipolar	B-T038
disorder	I-T038
in	O
euth	B-T038
##ymic	I-T038
phase	I-T038
:	O
using	O
the	O
stra	B-T170
##ng	I-T170
##e	I-T170
stories	I-T170
test	I-T170
objective	O
:	O
this	O
study	O
evaluated	B-T058
the	O
theory	O
of	O
mind	O
(	O
tom	O
)	O
in	O
adolescents	O
diagnosed	B-T033
with	O
bipolar	B-T038
disorder	I-T038
(	O
bd	B-T038
)	O
during	O
their	O
euth	B-T038
##ymic	I-T038
period	I-T038
compared	O
to	O
a	O
typically	O
developing	O
(	O
td	O
)	O
group	O
.	O
method	O
:	O
the	O
bd	B-T038
group	O
consisted	O
of	O
thirty	O
11	O
-	O
18	O
year	O
old	O
inpatients	O
in	O
euth	B-T038
##ymic	I-T038
phase	I-T038
.	O
the	O
td	O
group	O
included	O
30	O
age	O
,	O
gender	O
,	O
and	O
iq	O
matched	O
volunteer	O
students	B-T098
.	O
to	O
assess	O
the	O
diagnosis	B-T033
and	O
comorbid	I-T038
disorders	I-T038
,	O
we	O
performed	O
the	O
semi	O
-	O
structured	O
interview	O
of	O
the	O
kid	O
##di	O
##e	O
schedule	O
for	O
affective	O
disorders	O
and	O
schizophrenia	O
-	O
present	O
and	O
lifetime	O
version	O
(	O
k	O
-	O
sad	O
##s	O
-	O
pl	O
)	O
for	O
the	O
bd	B-T038
adolescents	O
.	O
to	O
evaluate	I-T058
the	O
severity	O
of	O
attention	B-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
and	O
mania	B-T038
,	O
conn	O
##er	O
'	O
s	O
parent	O
rating	O
scale	O
-	O
revised	O
version	O
(	O
cpr	O
##s	O
-	O
r	O
)	O
,	O
and	O
young	B-T170
mania	I-T170
rating	I-T170
scale	I-T170
(	O
ym	B-T170
##rs	I-T170
)	O
were	O
used	O
,	O
respectively	O
.	O
ra	B-T170
##ven	I-T170
##s	I-T170
progressive	I-T170
matrices	I-T170
was	O
conducted	O
to	O
evaluate	B-T058
intellectual	B-T033
ability	I-T033
in	O
the	O
both	O
groups	O
.	O
happ	B-T170
##e	I-T170
stra	I-T170
##ng	I-T170
##e	I-T170
stories	I-T170
test	I-T170
was	O
performed	O
to	O
assess	O
tom	O
in	O
the	O
participants	B-T098
.	O
data	O
were	O
analyzed	O
using	O
the	O
independent	O
t	B-T170
-	I-T170
test	I-T170
,	O
analysis	O
of	O
covariance	O
,	O
and	O
pearson	B-T062
correlation	I-T062
analysis	I-T062
.	O
results	O
:	O
the	O
two	O
groups	O
did	O
not	O
show	O
any	O
differences	O
in	O
compreh	O
##ending	O
the	O
stories	O
;	O
however	O
,	O
the	O
bd	B-T038
group	O
'	O
s	O
mental	O
##izing	O
scores	O
were	O
significantly	O
weaker	O
than	O
the	O
td	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
conclusion	O
:	O
the	O
tom	O
impairments	O
in	O
adolescents	O
with	O
bd	B-T038
may	O
be	O
explained	O
as	O
a	O
trait	B-T038
marker	I-T038
which	O
may	O
lead	O
to	O
continuation	O
of	O
social	B-T033
problems	I-T033
even	O
during	O
remission	O
.	O
.	O

request	O
and	O
fulfill	O
##ment	O
of	O
postpartum	O
tubal	B-T058
ligation	I-T058
in	O
patients	O
after	O
high	B-T038
-	I-T038
risk	I-T038
pregnancy	I-T038
female	B-T058
sterilization	I-T058
is	O
one	O
of	O
the	O
most	O
prevalent	O
methods	B-T170
of	O
contraception	B-T058
in	O
the	O
united	B-T082
states	I-T082
.	O
prior	O
studies	B-T062
have	O
shown	O
that	O
nearly	O
half	O
of	O
postpartum	O
tubal	B-T058
ligation	I-T058
(	O
ppt	B-T058
##l	I-T058
)	O
requests	O
go	O
unf	O
##ulf	O
##illed	O
.	O
this	O
study	B-T062
seeks	O
to	O
establish	O
whether	O
obstetric	O
or	O
medical	O
risk	O
status	O
influences	O
patients	O
'	O
request	O
for	O
or	O
subsequent	O
completion	O
of	O
ppt	B-T058
##l	I-T058
.	O
this	O
study	B-T062
was	O
a	O
retrospective	B-T062
cohort	I-T062
study	I-T062
of	O
women	B-T098
delivering	B-T038
at	O
a	O
university	B-T092
hospital	I-T092
in	O
2009	O
-	O
2010	O
who	O
received	O
prenatal	B-T058
care	I-T058
in	O
the	O
faculty	B-T097
and	O
resident	B-T092
clinics	I-T092
.	O
high	B-T033
-	I-T033
risk	I-T033
status	O
was	O
defined	O
by	O
society	B-T170
for	I-T170
maternal	I-T170
-	I-T170
fetal	I-T170
medicine	I-T170
guidelines	I-T170
.	O
documentation	B-T170
of	O
contraceptive	B-T170
plan	I-T170
and	O
administration	B-T058
of	O
contraceptive	B-T058
methods	I-T058
was	O
abstracted	O
from	O
patient	B-T170
records	I-T170
.	O
subsequent	O
pregnancies	B-T038
through	O
march	O
1	O
,	O
2013	O
,	O
were	O
abstracted	O
.	O
of	O
306	O
##3	O
participants	B-T098
(	O
204	O
##8	O
low	O
risk	O
and	O
101	O
##5	O
high	B-T033
risk	I-T033
)	O
,	O
231	O
requested	O
ppt	B-T058
##l	I-T058
(	O
7	O
.	O
5	O
%	O
)	O
.	O
this	O
was	O
more	O
likely	O
among	O
high	B-T033
-	I-T033
risk	I-T033
patients	O
than	O
low	O
-	O
risk	O
patients	O
(	O
10	O
.	O
0	O
%	O
vs	O
.	O
6	O
.	O
3	O
%	O
,	O
p	O
<	O
.	O
001	O
)	O
,	O
those	O
with	O
public	O
insurance	O
(	O
13	O
.	O
8	O
%	O
vs	O
.	O
3	O
.	O
2	O
%	O
,	O
p	O
<	O
.	O
001	O
)	O
and	O
those	O
with	O
an	O
unintended	B-T033
index	I-T033
pregnancy	I-T033
(	O
13	O
.	O
8	O
%	O
vs	O
.	O
4	O
.	O
1	O
%	O
,	O
p	O
<	O
.	O
001	O
)	O
.	O
of	O
the	O
patients	O
request	O
##ing	O
ppt	B-T058
##l	I-T058
,	O
118	O
(	O
51	O
.	O
1	O
%	O
)	O
underwent	O
the	O
procedure	B-T058
immediately	O
postpartum	O
.	O
completion	O
was	O
not	O
associated	O
with	O
high	B-T033
-	I-T033
risk	I-T033
status	O
(	O
54	O
.	O
0	O
%	O
)	O
,	O
or	O
with	O
race	B-T098
,	O
insurance	O
status	O
or	O
parity	B-T033
.	O
among	O
113	O
women	B-T098
with	O
an	O
unf	O
##ulf	O
##illed	O
ppt	B-T058
##l	I-T058
request	O
,	O
there	O
were	O
17	O
subsequent	O
pregnancies	B-T038
(	O
15	O
.	O
0	O
%	O
)	O
during	O
the	O
27	O
months	O
of	O
follow	B-T058
-	I-T058
up	I-T058
.	O
though	O
women	B-T098
with	O
high	B-T038
-	I-T038
risk	I-T038
pregnancies	I-T038
were	O
more	O
likely	O
to	O
request	O
ppt	B-T058
##l	I-T058
,	O
they	O
were	O
not	O
more	O
likely	O
to	O
complete	O
the	O
procedure	B-T058
.	O
over	O
one	O
third	O
of	O
high	B-T033
-	I-T033
risk	I-T033
patients	O
'	O
requests	O
were	O
unf	O
##ulf	O
##illed	O
,	O
indicating	O
that	O
significant	O
barriers	O
may	O
remain	O
.	O
though	O
women	B-T098
with	O
high	B-T038
-	I-T038
risk	I-T038
pregnancies	I-T038
were	O
more	O
likely	O
to	O
request	O
ppt	B-T058
##l	I-T058
,	O
they	O
were	O
not	O
more	O
likely	O
to	O
complete	O
the	O
procedure	B-T058
.	O
providers	O
should	O
consider	O
these	O
procedures	B-T058
urgent	O
,	O
especially	O
in	O
high	B-T033
-	I-T033
risk	I-T033
women	B-T098
,	O
and	O
advocate	O
for	O
their	O
patients	O
'	O
access	O
to	O
this	O
procedure	B-T058
.	O

investigating	O
synthetic	O
oligonucleotide	B-T103
targeting	O
of	O
mir	B-T103
##31	I-T103
in	O
duchenne	B-T038
muscular	I-T038
dystrophy	I-T038
exon	B-T038
-	I-T038
sk	I-T038
##ipping	I-T038
via	O
synthetic	O
antisense	B-T103
oligonucleotides	I-T103
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	B-T058
for	O
duchenne	B-T038
muscular	I-T038
dystrophy	I-T038
(	O
dmd	B-T038
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	B-T038
-	I-T038
specific	I-T038
and	O
thus	O
each	O
oligonucleotide	B-T103
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O
the	O
discovery	O
that	O
dystrophin	B-T103
mrna	B-T103
is	O
subject	O
to	O
translational	B-T038
suppression	I-T038
by	O
the	O
microrna	B-T103
mir	B-T103
##31	I-T103
,	O
and	O
that	O
mir	B-T103
##31	I-T103
is	O
elevated	O
in	O
the	O
muscle	B-T017
of	O
dmd	B-T038
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	B-T103
chem	O
##istr	O
##ies	O
employed	O
for	O
exon	B-T038
sk	I-T038
##ipping	I-T038
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	B-T038
block	I-T038
.	O
this	O
approach	O
would	O
act	O
synergistically	O
with	O
exon	B-T038
sk	I-T038
##ipping	I-T038
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3	B-T082
'	I-T082
utr	I-T082
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
dmd	B-T038
patients	O
who	O
express	O
low	O
levels	O
of	O
in	B-T082
-	I-T082
frame	I-T082
transcript	B-T103
.	O
we	O
here	O
present	O
investigations	B-T058
into	O
the	O
feasibility	O
of	O
combining	O
exon	B-T038
sk	I-T038
##ipping	I-T038
with	O
several	O
different	O
strategies	O
for	O
mir	B-T103
##31	I-T103
-	O
modulation	O
,	O
using	O
both	O
in	B-T058
vitro	I-T058
models	O
and	O
the	O
md	B-T204
##x	I-T204
mouse	I-T204
(	O
the	O
classical	O
animal	B-T204
model	I-T204
of	O
dmd	B-T038
)	O
,	O
and	O
monitoring	B-T058
effects	O
on	O
dystrophin	B-T103
at	O
the	O
transcriptional	B-T038
and	O
translational	B-T038
level	O
.	O
we	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	B-T058
culture	I-T058
model	O
,	O
our	O
in	B-T082
vivo	I-T082
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	B-T103
translation	B-T038
,	O
suggesting	O
that	O
mir	B-T103
##31	I-T103
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	B-T103
approaches	O
.	O
possible	O
explanations	O
for	O
this	O
disappointing	O
outcome	O
are	O
discussed	O
,	O
along	O
with	O
suggestions	O
for	O
future	O
investigations	B-T058
.	O

genome	B-T062
-	I-T062
wide	I-T062
detection	I-T062
of	O
selective	B-T038
signatures	I-T038
in	O
chicken	B-T204
through	O
high	B-T082
density	I-T082
snps	I-T082
chicken	B-T204
is	O
recognized	O
as	O
an	O
excellent	O
model	O
for	O
studies	O
of	O
genetic	O
mechanism	O
of	O
phenotypic	O
and	O
genomic	B-T017
evolution	B-T038
,	O
with	O
large	O
effective	O
population	O
size	O
and	O
strong	O
human	B-T204
-	O
driven	O
selection	O
.	O
in	O
the	O
present	O
study	O
,	O
we	O
performed	O
extended	O
haplotype	O
homozyg	O
##osity	O
(	O
eh	O
##h	O
)	O
tests	O
to	O
identify	O
significant	O
core	B-T082
regions	I-T082
employing	O
600	O
##k	O
snp	B-T082
chicken	B-T204
chip	B-T062
in	O
an	O
f2	O
population	O
of	O
1	O
,	O
53	O
##4	O
hens	B-T204
,	O
which	O
was	O
derived	O
from	O
reciprocal	B-T058
crosses	I-T058
between	O
white	B-T204
leg	I-T204
##ho	I-T204
##r	I-T204
##n	I-T204
and	O
don	B-T204
##g	I-T204
##x	I-T204
##ian	I-T204
##g	I-T204
chicken	I-T204
.	O
results	O
indicated	O
that	O
a	O
total	O
of	O
49	O
,	O
151	O
core	B-T082
regions	I-T082
with	O
an	O
average	O
length	O
of	O
9	O
.	O
79	O
kb	O
were	O
identified	O
,	O
which	O
occupied	O
approximately	O
52	O
.	O
15	O
%	O
of	O
genome	B-T017
across	O
all	O
auto	B-T017
##so	I-T017
##me	I-T017
##s	I-T017
,	O
and	O
80	O
##6	O
significant	O
core	B-T082
regions	I-T082
attracted	O
us	O
mostly	O
.	O
genes	B-T017
in	O
candidate	B-T082
regions	I-T082
may	O
experience	O
positive	B-T058
selection	I-T058
and	O
were	O
considered	O
to	O
have	O
possible	O
influence	O
on	O
beneficial	O
economic	O
traits	O
.	O
a	O
panel	O
of	O
genes	B-T017
including	O
aas	B-T017
##dh	I-T017
##pp	I-T017
##t	I-T017
,	O
gdp	B-T017
##d	I-T017
##5	I-T017
,	O
par	B-T017
##3	I-T017
,	O
sox	B-T017
##6	I-T017
,	O
gpc	B-T017
##1	I-T017
and	O
a	O
signal	B-T038
pathway	I-T038
of	O
akt	B-T017
##1	I-T017
were	O
detected	B-T033
with	O
the	O
most	O
extreme	O
p	O
-	O
values	O
.	O
further	O
enrichment	B-T062
analyses	I-T062
indicated	O
that	O
these	O
genes	B-T017
were	O
associated	O
with	O
immune	B-T038
function	I-T038
,	O
sensory	B-T038
organ	I-T038
development	I-T038
and	O
neurogenesis	B-T038
,	O
and	O
may	O
have	O
experienced	O
positive	B-T058
selection	I-T058
in	O
chicken	B-T204
.	O
moreover	O
,	O
some	O
of	O
core	B-T082
regions	I-T082
exactly	O
overlapped	O
with	O
genes	B-T017
exc	O
##ava	O
##ted	O
in	O
our	O
previous	O
gwas	B-T062
,	O
suggesting	O
that	O
these	O
genes	B-T017
have	O
undergone	O
positive	B-T058
selection	I-T058
may	O
affect	O
egg	B-T168
production	O
.	O
findings	O
in	O
our	O
study	O
could	O
draw	O
a	O
comparatively	O
integrate	O
genome	B-T062
-	I-T062
wide	I-T062
map	I-T062
of	O
selection	B-T038
signature	I-T038
in	O
the	O
chicken	B-T204
genome	B-T017
,	O
and	O
would	O
be	O
worth	O
##y	O
for	O
expl	O
##ica	O
##ting	O
the	O
genetic	O
mechanisms	O
of	O
phenotypic	O
diversity	O
in	O
poultry	B-T204
breeding	B-T038
.	O

work	O
process	O
,	O
performance	B-T033
and	O
professional	B-T097
profile	I-T097
of	O
a	O
hearing	B-T058
health	I-T058
network	I-T058
:	O
reference	B-T170
for	O
satisfaction	B-T038
to	O
analyze	B-T062
the	O
correlation	O
between	O
the	O
satisfaction	B-T038
of	O
professionals	B-T097
from	O
the	O
hearing	B-T058
health	I-T058
care	I-T058
network	I-T058
in	O
two	O
micro	O
-	O
regions	B-T082
of	O
min	O
##as	O
ger	O
##ai	O
##s	O
state	O
and	O
the	O
sociodemographic	O
profile	O
,	O
work	O
process	O
,	O
and	O
work	B-T033
performance	I-T033
in	O
the	O
health	B-T058
service	I-T058
.	O
this	O
is	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
,	O
observational	B-T062
,	O
analytic	O
study	O
with	O
a	O
non	B-T062
-	I-T062
probabilistic	I-T062
sample	I-T062
including	O
34	O
professionals	B-T097
from	O
the	O
hearing	B-T058
health	I-T058
care	I-T058
services	I-T058
.	O
data	B-T062
collection	I-T062
occurred	O
through	O
individual	B-T098
interviews	O
in	O
the	O
municipal	B-T082
##ity	I-T082
of	O
professional	O
practice	O
.	O
associations	O
between	O
the	O
professional	B-T038
satisfaction	I-T038
variable	O
and	O
the	O
explanatory	B-T170
variables	O
sociodemographic	O
data	O
,	O
work	O
routine	O
,	O
and	O
developed	O
actions	O
were	O
conducted	O
.	O
professionals	B-T097
with	O
graduate	O
studies	O
were	O
more	O
satisfied	B-T170
with	O
the	O
human	B-T170
resources	I-T170
policy	I-T170
and	O
the	O
activities	O
developed	O
,	O
whereas	O
health	B-T058
civil	B-T097
serv	I-T097
##ants	I-T097
showed	O
more	O
satisfaction	B-T038
with	O
the	O
wa	O
##ge	O
policy	B-T170
and	O
the	O
work	O
schedule	O
.	O
the	O
correlation	B-T062
analysis	I-T062
between	O
work	O
process	O
and	O
satisfaction	B-T038
revealed	O
a	O
moderate	O
positive	B-T033
correlation	O
between	O
items	O
such	O
as	O
health	B-T058
promotion	I-T058
actions	O
,	O
satisfaction	B-T038
with	O
diagnostic	B-T074
equipment	I-T074
,	O
and	O
satisfaction	B-T038
with	O
maintenance	O
equipment	O
.	O
the	O
present	O
study	B-T062
revealed	O
a	O
higher	O
level	O
of	O
satisfaction	B-T038
among	O
professionals	O
with	O
graduate	O
studies	O
(	O
human	B-T170
resources	I-T170
policy	I-T170
and	O
activities	O
developed	O
)	O
and	O
civil	B-T097
serv	I-T097
##ants	I-T097
(	O
wa	O
##ge	O
policy	B-T170
and	O
work	O
schedule	O
)	O
.	O
the	O
relevance	O
of	O
this	O
study	B-T062
lies	O
on	O
the	O
important	O
role	O
that	O
health	B-T097
professionals	I-T097
play	O
on	O
the	O
health	B-T058
care	I-T058
network	I-T058
.	O
additionally	O
,	O
the	O
study	B-T062
of	O
satisfaction	B-T038
level	O
can	O
provide	O
a	O
search	O
for	O
improvements	O
,	O
considering	O
that	O
satisfied	B-T170
professionals	O
not	O
only	O
improve	B-T033
service	O
quality	O
,	O
but	O
also	O
show	O
greater	O
cre	O
##ativity	O
,	O
commitment	O
,	O
and	O
performance	B-T033
.	O

manipulation	O
of	O
an	O
existing	O
crystal	B-T103
form	I-T103
unexpectedly	B-T033
results	I-T033
in	O
inter	B-T103
##w	I-T103
##oven	I-T103
packing	I-T103
networks	I-T103
with	O
pseudo	O
-	O
translational	O
symmetry	O
nonr	B-T103
##ib	I-T103
##osomal	I-T103
peptide	I-T103
synthetase	I-T103
##s	I-T103
(	O
nr	B-T103
##ps	I-T103
##s	I-T103
)	O
are	O
multim	B-T103
##odular	I-T103
enzymes	I-T103
that	O
synthesize	O
a	O
myriad	O
of	O
diverse	O
molecules	O
.	O
tailoring	B-T082
domains	I-T082
have	O
been	O
co	O
-	O
opt	O
##ed	O
into	O
nr	B-T103
##ps	I-T103
##s	I-T103
to	O
introduce	O
further	O
variety	O
into	O
nonr	B-T103
##ib	I-T103
##osomal	I-T103
peptide	I-T103
products	I-T103
.	O
linear	B-T103
gram	I-T103
##ici	I-T103
##din	I-T103
synthetase	I-T103
contains	O
a	O
unique	O
formyl	B-T038
##ation	I-T038
-	O
tailoring	B-T082
domain	I-T082
in	O
its	O
initiation	O
module	O
(	O
f	B-T038
-	I-T038
a	I-T038
-	O
pcp	B-T082
)	O
.	O
the	O
structure	O
of	O
the	O
f	B-T038
-	I-T038
a	I-T038
di	B-T082
-	I-T082
domain	I-T082
has	O
previously	O
been	O
determined	O
in	O
a	O
crystal	B-T103
form	I-T103
which	O
had	O
large	O
solvent	B-T103
channels	B-T082
and	O
no	O
density	O
for	O
the	O
minor	O
as	B-T082
##ub	I-T082
subd	I-T082
##oma	I-T082
##in	I-T082
.	O
an	O
attempt	O
was	O
made	O
to	O
take	O
advantage	O
of	O
this	O
packing	O
by	O
removing	O
the	O
as	B-T082
##ub	I-T082
subd	I-T082
##oma	I-T082
##in	I-T082
from	O
the	O
construct	O
(	O
f	B-T038
-	I-T038
a	I-T038
δ	O
sub	B-T082
)	O
in	O
order	O
to	O
produce	O
a	O
crystal	B-T103
that	O
could	O
accommodate	O
the	O
pcp	B-T082
domain	I-T082
.	O
in	O
the	O
resulting	O
crystal	B-T103
the	O
original	B-T103
packing	I-T103
network	I-T103
was	O
still	O
present	O
,	O
but	O
a	O
second	B-T103
network	I-T103
with	O
the	O
same	O
packing	O
and	O
almost	O
no	O
contact	O
with	O
the	O
original	B-T103
network	I-T103
took	O
the	O
place	O
of	O
the	O
solvent	B-T103
channels	B-T082
and	O
changed	O
the	O
space	B-T103
group	I-T103
of	I-T103
the	I-T103
crystal	I-T103
.	O

gleason	B-T170
grade	I-T170
grouping	I-T170
of	O
prostate	B-T038
cancer	I-T038
is	O
of	O
prognostic	B-T201
value	I-T201
in	O
asian	B-T098
men	B-T098
the	O
international	B-T092
society	I-T092
of	I-T092
urological	I-T092
pathology	I-T092
made	O
recommendations	O
for	O
the	O
use	O
of	O
grade	B-T170
groups	I-T170
(	O
gg	B-T170
)	O
originally	O
described	O
by	O
epstein	B-T170
and	O
colleagues	O
over	O
gleason	B-T033
score	I-T033
(	O
gs	B-T033
)	O
alone	O
in	O
2014	O
,	O
which	O
was	O
subsequently	O
adopted	B-T033
by	O
the	O
who	O
classification	O
in	O
2016	O
.	O
the	O
majority	O
of	O
studies	B-T062
validating	O
this	O
revision	O
have	O
been	O
in	O
caucasian	B-T098
populations	I-T098
.	O
we	O
therefore	O
asked	O
whether	O
the	O
new	O
gg	B-T170
system	I-T170
was	O
retrospectively	O
associated	O
with	O
biochemical	O
disease	O
-	O
free	O
survival	O
in	O
a	O
mixed	B-T098
-	I-T098
ethnicity	I-T098
cohort	B-T098
of	O
asian	B-T098
men	B-T098
.	O
a	O
total	O
of	O
68	O
##0	O
radical	B-T058
prostate	I-T058
##ct	I-T058
##om	I-T058
##ies	I-T058
(	O
rps	B-T058
)	O
from	O
2005	O
to	O
2014	O
were	O
included	O
.	O
gs	B-T033
from	O
initial	O
biopsy	B-T058
and	O
rp	B-T058
were	O
compared	O
and	O
used	O
to	O
alloc	O
##ate	O
cases	O
to	O
gg	B-T170
,	O
defined	O
as	O
:	O
1	O
(	O
gs	B-T033
≤	O
##6	O
)	O
;	O
2	O
(	O
gs	B-T033
3	O
+	O
4	O
=	O
7	O
)	O
;	O
3	O
(	O
gs	B-T033
4	O
+	O
3	O
=	O
7	O
)	O
;	O
4	O
(	O
gs	B-T033
4	O
+	O
4	O
=	O
8	O
/	O
5	O
+	O
3	O
=	O
8	O
/	O
3	O
+	O
5	O
=	O
8	O
)	O
and	O
5	O
(	O
gs	B-T033
9	O
-	O
10	O
)	O
.	O
biochemical	B-T033
recurrence	I-T033
was	O
defined	O
as	O
two	O
consecutive	O
post	O
-	O
rp	B-T058
prostate	B-T103
-	I-T103
specific	I-T103
antigen	I-T103
(	O
psa	B-T103
)	O
levels	O
of	O
>	O
0	O
.	O
2	O
ng	O
/	O
ml	O
after	O
post	O
-	O
rp	B-T058
psa	B-T103
reaching	O
the	O
nadir	O
of	O
<	O
0	O
.	O
1	O
ng	O
/	O
ml	O
.	O
our	O
data	O
showed	O
that	O
kaplan	O
-	O
meier	O
analysis	O
revealed	O
significant	O
differences	O
in	O
biochemical	B-T033
recurrence	I-T033
within	O
gleason	B-T170
gg	I-T170
based	O
on	O
either	O
biopsy	B-T058
or	O
prostatectomy	B-T058
scoring	O
.	O
multivariate	O
analysis	O
further	O
confirmed	O
that	O
a	O
higher	O
gg	B-T170
was	O
significantly	O
associated	O
with	O
risk	O
of	O
biochemical	B-T033
recurrence	I-T033
.	O
this	O
gg	B-T170
system	I-T170
had	O
a	O
higher	O
prognostic	O
discrimination	O
for	O
both	O
initial	O
biopsy	B-T058
and	O
rp	B-T058
than	O
gs	B-T033
.	O
our	O
study	B-T062
validate	B-T062
##s	I-T062
the	O
use	O
of	O
the	O
revised	O
and	O
updated	O
gg	B-T170
system	I-T170
in	O
a	O
mixed	B-T098
-	I-T098
ethnicity	I-T098
population	I-T098
of	O
asian	B-T098
men	B-T098
.	O
higher	O
gg	B-T170
was	O
significantly	O
associated	O
with	O
increased	O
risk	O
of	O
biochemical	B-T033
recurrence	I-T033
.	O
we	O
therefore	O
recommend	O
its	O
use	O
to	O
inform	O
clinical	B-T058
management	I-T058
for	O
patients	O
with	O
prostate	B-T038
cancer	I-T038
.	O

beneficial	O
effects	O
of	O
natural	B-T103
eggs	I-T103
##hel	I-T103
##l	I-T103
membrane	I-T103
(	O
nem	B-T103
)	O
on	O
multiple	O
indices	O
of	O
arthritis	B-T038
in	O
collagen	B-T038
-	I-T038
induced	I-T038
arthritic	I-T038
rats	B-T204
this	O
study	B-T062
was	O
performed	O
to	O
evaluate	B-T058
the	O
potential	O
efficacy	O
of	O
natural	B-T103
eggs	I-T103
##hel	I-T103
##l	I-T103
membrane	I-T103
(	O
nem	B-T103
)	O
in	O
collagen	B-T038
-	I-T038
induced	I-T038
arthritic	I-T038
rats	B-T204
,	O
a	O
well	O
-	O
established	O
rodent	B-T038
model	I-T038
of	I-T038
inflammation	I-T038
and	O
rheumatoid	B-T038
arthritis	I-T038
.	O
rats	B-T204
with	O
developing	O
type	B-T038
ii	I-T038
collagen	I-T038
-	I-T038
induced	I-T038
arthritis	I-T038
(	O
cia	B-T038
)	O
were	O
treated	O
once	O
daily	O
by	O
oral	O
gavage	O
on	O
study	O
days	O
-	O
14	O
to	O
17	O
with	O
vehicle	B-T103
or	O
nem	B-T103
(	O
52	O
mg	O
/	O
kg	O
body	O
weight	O
)	O
.	O
rats	B-T204
were	O
euthanized	B-T062
on	O
study	O
day	O
17	O
.	O
efficacy	O
was	O
assessed	O
by	O
daily	O
ankle	B-T082
cal	B-T074
##iper	I-T074
measurements	O
,	O
ankle	B-T082
diameter	O
expressed	O
as	O
area	O
under	O
the	O
curve	O
(	O
auc	O
##d	O
##0	O
-	O
17	O
)	O
,	O
and	O
histopathologic	B-T091
evaluation	I-T091
of	O
ankle	B-T082
##s	I-T082
and	O
knees	B-T017
.	O
serum	B-T031
biomarkers	B-T201
of	O
cartilage	B-T038
function	I-T038
and	O
inflammation	B-T038
[	O
collagen	B-T058
type	I-T058
ii	I-T058
c	I-T058
-	I-T058
tel	I-T058
##opeptide	I-T058
(	O
ctx	B-T058
##ii	I-T058
)	O
,	O
cartilage	B-T058
oligomeric	I-T058
matrix	I-T058
protein	I-T058
(	O
comp	B-T058
)	O
,	O
and	O
alpha	B-T058
-	I-T058
2	I-T058
-	I-T058
macroglobulin	I-T058
(	O
a2	B-T058
##m	I-T058
)	O
]	O
were	O
measured	O
by	O
elisa	B-T058
.	O
treatment	O
with	O
nem	B-T103
resulted	O
in	O
significant	O
beneficial	O
effects	O
on	O
the	O
daily	O
ankle	B-T082
diameter	O
measurements	O
and	O
ankle	B-T082
diameter	O
auc	O
.	O
ankle	B-T082
and	O
knee	B-T017
histopathology	B-T033
scores	I-T033
were	O
significantly	O
reduced	O
(	O
36	O
%	O
and	O
43	O
%	O
reduction	O
of	O
summed	O
individual	O
histopathology	B-T033
scores	I-T033
for	O
ankle	B-T082
and	O
knee	B-T017
,	O
respectively	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
toward	O
normal	O
for	O
rats	B-T204
given	O
nem	B-T103
compared	O
to	O
vehicle	O
controls	O
.	O
the	O
percent	O
reduction	O
of	O
serum	B-T031
ctx	B-T058
##ii	I-T058
,	O
comp	B-T058
,	O
and	O
a2	B-T058
##m	I-T058
in	O
nem	B-T103
-	O
treated	O
rats	B-T204
ranged	O
from	O
30	O
%	O
to	O
72	O
%	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
nem	B-T103
significantly	O
improved	O
multiple	O
aspects	O
of	O
inflammatory	B-T038
arthritis	I-T038
including	O
inflammation	B-T038
,	O
pann	B-T038
##us	I-T038
,	O
cartilage	B-T037
damage	I-T037
,	O
bone	B-T038
resorption	I-T038
,	O
and	O
periosteal	B-T038
bone	I-T038
formation	I-T038
.	O
this	O
study	B-T062
provides	O
further	O
support	O
for	O
the	O
use	O
of	O
ctx	B-T103
##ii	I-T103
,	O
comp	B-T103
,	O
and	O
a2	B-T103
##m	I-T103
as	O
relevant	O
biomarkers	B-T201
that	O
were	O
responsive	O
to	O
nem	B-T103
.	O

tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
(	I-T103
k2	I-T103
##p2	I-T103
.	I-T103
1	I-T103
)	I-T103
k	I-T103
(	I-T103
+	I-T103
)	I-T103
channels	I-T103
are	O
suppressed	O
in	O
patients	O
with	O
atrial	B-T038
fibrillation	I-T038
and	O
heart	B-T038
failure	I-T038
and	O
provide	O
therapeutic	O
targets	O
for	O
rhythm	O
control	O
atrial	B-T038
fibrillation	I-T038
(	O
af	B-T038
)	O
is	O
the	O
most	O
common	O
cardiac	B-T033
arrhythmia	I-T033
.	O
concomitant	B-T038
heart	I-T038
failure	I-T038
(	O
hf	B-T038
)	O
poses	O
a	O
particular	O
therapeutic	O
challenge	B-T058
and	O
is	O
associated	O
with	O
prolonged	O
atrial	B-T038
electrical	I-T038
refract	I-T038
##orin	I-T038
##ess	I-T038
compared	O
with	O
non	B-T017
-	I-T017
failing	I-T017
hearts	I-T017
.	O
we	O
hypothesized	O
that	O
downregulation	B-T038
of	O
atrial	B-T038
rep	I-T038
##olar	I-T038
##izing	I-T038
tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
(	I-T103
k2	I-T103
##p2	I-T103
.	I-T103
1	I-T103
)	I-T103
k	I-T103
(	I-T103
+	I-T103
)	I-T103
channels	I-T103
contributes	O
to	O
electrical	B-T038
remodeling	I-T038
during	O
af	B-T038
with	O
hf	B-T038
,	O
and	O
that	O
tre	B-T062
##k	I-T062
-	I-T062
1	I-T062
gene	I-T062
transfer	I-T062
would	O
provide	O
rhythm	O
control	O
via	O
normalization	B-T062
of	O
atrial	B-T033
effective	I-T033
refractory	I-T033
periods	I-T033
in	O
this	O
af	B-T038
subset	B-T062
.	O
in	O
patients	O
with	O
chronic	B-T038
af	I-T038
and	O
hf	B-T038
,	O
atrial	B-T103
tre	I-T103
##k	I-T103
-	I-T103
1	I-T103
mrna	B-T103
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	B-T017
atrium	I-T017
)	O
and	O
81	O
%	O
(	O
right	B-T017
atrium	I-T017
)	O
compared	O
with	O
sinus	B-T033
rhythm	I-T033
(	O
sr	B-T033
)	O
subjects	B-T098
.	O
human	B-T204
findings	B-T033
were	O
recapit	O
##ulated	O
in	O
a	O
porcine	O
model	O
of	O
atrial	B-T038
tachy	I-T038
##pa	I-T038
##cing	I-T038
-	I-T038
induced	I-T038
af	I-T038
and	O
reduced	O
left	B-T038
ventricular	I-T038
function	I-T038
.	O
tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
mrna	B-T103
(	O
-	O
66	O
%	O
)	O
and	O
protein	B-T103
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
af	B-T038
animals	B-T204
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sr	B-T033
controls	O
.	O
downregulation	B-T038
of	O
rep	B-T038
##olar	I-T038
##izing	I-T038
tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
channels	I-T103
was	O
associated	O
with	O
prolongation	O
of	O
atrial	B-T033
effective	I-T033
refractory	I-T033
periods	I-T033
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	B-T062
in	O
humans	B-T204
with	O
hf	B-T038
.	O
in	O
a	O
preclinical	O
therapeutic	O
approach	O
,	O
pigs	B-T204
were	O
randomized	B-T062
to	O
either	O
atrial	B-T058
ad	I-T058
-	I-T058
tre	I-T058
##k	I-T058
-	I-T058
1	I-T058
gene	I-T058
therapy	I-T058
or	O
sham	B-T058
treatment	I-T058
.	O
gene	B-T062
transfer	I-T062
effectively	O
increased	O
tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
protein	I-T103
levels	O
and	O
attenuated	O
atrial	B-T033
effective	I-T033
refractory	I-T033
period	I-T033
prolongation	O
in	O
the	O
porcine	O
af	O
model	O
.	O
ad	B-T103
-	I-T103
tre	I-T103
##k	I-T103
-	I-T103
1	I-T103
increased	O
the	O
sr	B-T033
prevalence	O
to	O
62	O
%	O
during	O
follow	O
-	O
up	O
in	O
af	B-T038
animals	B-T204
,	O
compared	O
to	O
35	O
%	O
in	O
the	O
untreated	O
af	B-T038
group	O
.	O
in	O
conclusion	O
,	O
tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
downregulation	B-T038
and	O
rhythm	O
control	O
by	O
ad	B-T062
-	I-T062
tre	I-T062
##k	I-T062
-	I-T062
1	I-T062
transfer	I-T062
suggest	O
mechanistic	B-T058
and	I-T058
potential	I-T058
therapeutic	I-T058
significance	O
of	O
tre	B-T103
##k	I-T103
-	I-T103
1	I-T103
channels	I-T103
in	O
a	O
subgroup	B-T170
of	O
af	B-T038
patients	O
with	O
hf	B-T038
and	O
prolonged	O
atrial	B-T033
effective	I-T033
refractory	I-T033
periods	I-T033
.	O
functional	O
correction	O
of	O
ionic	O
remodeling	O
through	O
tre	B-T058
##k	I-T058
-	I-T058
1	I-T058
gene	I-T058
therapy	I-T058
represents	O
a	O
novel	O
paradigm	O
to	O
optimize	O
and	O
specify	O
af	B-T038
management	O
.	O

genetically	O
encoded	O
calcium	O
indicators	O
for	O
studying	O
long	O
-	O
term	O
calcium	B-T103
dynamics	B-T038
during	O
apoptosis	B-T038
intracellular	B-T038
calcium	I-T038
release	I-T038
is	O
essential	O
for	O
regulating	B-T038
almost	O
all	O
cellular	B-T038
functions	I-T038
.	O
specific	O
spatio	B-T062
-	I-T062
temporal	I-T062
patterns	B-T082
of	O
cytosolic	B-T017
calcium	B-T103
elevations	O
are	O
critical	O
determinants	O
of	O
cell	O
fate	O
in	O
response	O
to	O
pro	O
-	O
apoptotic	O
cellular	B-T017
stressors	O
.	O
as	O
the	O
apoptotic	B-T038
program	I-T038
can	O
take	O
hours	O
or	O
days	O
,	O
measurement	O
of	O
long	O
-	O
term	O
calcium	B-T103
dynamics	B-T038
are	O
essential	O
for	O
understanding	B-T038
the	O
mechanistic	O
role	O
of	O
calcium	B-T103
in	O
apoptotic	B-T038
cell	I-T038
death	I-T038
.	O
due	O
to	O
the	O
technical	O
limitations	O
of	O
using	O
calcium	B-T103
-	O
sensitive	O
dyes	B-T103
to	O
measure	O
cytosolic	B-T017
calcium	B-T103
little	O
is	O
known	O
about	O
long	O
-	O
term	O
calcium	B-T103
dynamics	B-T038
in	O
living	B-T017
cells	I-T017
after	O
treatment	B-T058
with	O
apoptosis	B-T038
-	O
inducing	O
drugs	B-T103
.	O
genetically	O
encoded	O
calcium	O
indicators	O
could	O
potentially	O
overcome	O
some	O
of	O
the	O
limitations	O
of	O
calcium	B-T103
-	O
sensitive	O
dyes	B-T103
.	O
here	O
,	O
we	O
compared	O
the	O
performance	O
of	O
the	O
genetically	O
encoded	O
calcium	B-T103
indicators	B-T103
gca	O
##mp	O
##6	O
##s	O
and	O
gca	O
##mp	O
##6	O
##f	O
with	O
the	O
ratio	B-T103
##met	I-T103
##ric	I-T103
dye	I-T103
fura	B-T103
-	I-T103
2	I-T103
.	O
gca	O
##mp	O
##6	O
##s	O
performed	O
as	O
well	O
or	O
better	O
than	O
fura	B-T103
-	I-T103
2	I-T103
in	O
detecting	O
agonist	B-T103
-	O
induced	O
calcium	B-T103
transients	O
.	O
we	O
then	O
examined	O
the	O
utility	O
of	O
gca	O
##mp	O
##6	O
##s	O
for	O
continuously	O
measuring	O
apoptotic	O
calcium	B-T058
release	I-T058
over	O
the	O
course	O
of	O
ten	O
hours	O
after	O
treatment	B-T058
with	O
staurosporine	B-T103
.	O
we	O
found	O
that	O
gca	O
##mp	O
##6	O
##s	O
was	O
suitable	O
for	O
measuring	O
apoptotic	O
calcium	B-T058
release	I-T058
over	O
long	O
time	O
courses	O
and	O
revealed	O
significant	O
heterogeneity	O
in	O
calcium	B-T058
release	I-T058
dynamics	B-T038
in	O
individual	O
cells	B-T017
challenged	O
with	O
staurosporine	B-T103
.	O
our	O
results	O
suggest	O
gca	O
##mp	O
##6	O
##s	O
is	O
an	O
excellent	O
indicator	B-T103
for	O
monitoring	B-T058
long	O
-	O
term	O
changes	O
cytosolic	B-T017
calcium	B-T103
during	O
apoptosis	B-T038
.	O

civil	O
society	O
-	O
driven	O
drug	O
policy	O
reform	O
for	O
health	O
and	O
human	B-T092
welfare	I-T092
-	O
india	B-T082
the	O
lack	O
of	O
adequate	O
access	O
to	O
opioids	B-T103
in	O
india	B-T082
as	O
analgesics	B-T103
and	O
for	O
agonist	B-T103
therapies	B-T058
,	O
forces	O
millions	O
to	O
live	O
with	O
severe	O
unal	B-T033
##le	I-T033
##vi	I-T033
##ated	I-T033
pain	I-T033
,	O
or	O
langu	O
##ish	O
with	O
suffering	B-T038
associated	O
with	O
drug	B-T038
dependence	I-T038
.	O
although	O
india	B-T082
is	O
a	O
major	O
opi	B-T103
##um	I-T103
export	B-T097
##er	I-T097
,	O
the	O
excessive	O
##ly	O
prohib	O
##itive	O
1985	O
narcotic	B-T170
##s	I-T170
law	I-T170
formulated	O
to	O
control	O
harmful	B-T038
use	I-T038
of	I-T038
drugs	I-T038
,	O
impede	O
##d	O
the	O
availability	O
and	O
access	B-T082
to	O
opioids	B-T103
for	O
medical	O
and	O
scientific	O
purposes	O
.	O
amend	B-T170
##ment	I-T170
of	O
this	O
law	B-T170
in	O
2014	O
established	O
a	O
new	O
national	B-T170
regulatory	I-T170
framework	I-T170
for	O
improved	O
access	B-T082
to	O
essential	O
opioid	B-T103
analgesics	I-T103
.	O
this	O
article	O
reflects	O
on	O
key	O
elements	O
and	O
processes	O
that	O
led	O
to	O
this	O
landmark	O
achievement	O
.	O
unlike	O
quick	O
time	O
##line	O
##s	O
associated	O
with	O
effect	O
##ing	O
policy	O
reforms	O
for	O
law	O
enforcement	O
,	O
real	O
##izing	O
the	O
2014	O
drug	O
policy	O
change	O
primarily	O
to	O
mitigate	O
human	B-T038
suffering	I-T038
,	I-T038
was	O
a	O
22	O
-	O
year	O
-	O
long	O
process	O
.	O
the	O
most	O
exact	O
##ing	O
challenges	O
included	O
recognizing	O
the	O
multilayer	B-T033
##ed	I-T033
complexities	I-T033
of	O
the	O
prior	O
policy	B-T170
framework	I-T170
and	O
understanding	O
their	O
adverse	O
impact	O
on	O
field	O
practices	O
to	O
chart	O
an	O
appropriate	O
and	O
viable	O
path	O
for	O
reform	O
.	O
the	O
evolution	O
of	O
an	O
informal	O
civil	O
society	O
movement	O
involving	O
health	B-T097
care	I-T097
professionals	I-T097
,	O
law	B-T097
##yer	I-T097
##s	I-T097
,	O
media	B-T097
,	O
policy	O
analys	O
##ts	O
,	O
government	B-T097
official	I-T097
##s	I-T097
,	O
and	O
the	O
public	B-T098
was	O
pivotal	O
in	O
addressing	O
these	O
challenges	B-T058
and	O
gar	O
##ner	O
##ing	O
momentum	O
for	O
reform	O
.	O
the	O
success	O
of	O
the	O
effort	O
for	O
improving	O
access	O
to	O
opioid	B-T103
medications	B-T058
was	O
underpin	O
##ned	O
by	O
a	O
three	O
-	O
pron	O
##ged	O
strategy	O
of	O
1	O
)	O
pers	O
##ua	O
##ding	O
the	O
executive	B-T097
arm	I-T097
of	I-T097
the	I-T097
government	I-T097
to	O
take	O
interim	O
enabling	O
measures	B-T170
;	O
2	O
)	O
lever	O
##aging	O
jud	O
##icial	O
intervention	O
through	O
public	B-T098
interest	B-T098
lit	O
##igation	O
;	O
and	O
3	O
)	O
cr	O
##aft	O
##ing	O
a	O
viable	O
policy	O
document	O
for	O
legisl	O
##ative	O
approval	O
and	O
implementation	O
.	O
we	O
hope	O
our	O
findings	O
are	O
useful	O
for	O
real	O
##izing	O
drug	O
policy	O
reforms	O
,	O
given	O
the	O
current	O
transformed	O
global	O
policy	B-T170
mand	O
##ates	O
emphasizing	O
human	B-T092
##itarian	I-T092
,	O
healthcare	B-T058
,	O
and	O
quality	O
-	O
of	O
-	O
life	O
considerations	B-T033
.	O

modeling	B-T062
nurse	O
-	O
patient	O
assignments	O
considering	O
patient	O
acuity	O
and	O
travel	O
distance	O
metrics	O
balancing	O
workload	O
among	O
nurses	B-T097
on	O
a	O
hospital	B-T092
unit	I-T092
is	O
important	O
for	O
the	O
satisfaction	B-T038
and	O
safety	O
of	O
nurses	B-T097
and	O
patients	O
.	O
to	O
balance	O
nurse	B-T097
workload	O
##s	O
,	O
direct	O
patient	B-T058
care	I-T058
activities	I-T058
,	O
indirect	O
patient	B-T058
care	I-T058
activities	I-T058
,	O
and	O
non	O
-	O
patient	O
care	O
activities	O
that	O
occur	O
throughout	O
a	O
shift	O
must	O
be	O
considered	O
.	O
the	O
lay	O
##out	O
of	O
a	O
hospital	B-T092
unit	I-T092
and	O
the	O
location	B-T082
of	O
a	O
nurse	B-T097
'	I-T097
s	I-T097
assigned	O
patients	O
relative	O
to	O
other	O
resources	O
on	O
the	O
unit	B-T092
are	O
also	O
important	O
factors	O
in	O
achieving	B-T033
workload	O
balance	O
.	O
in	O
most	O
hospitals	B-T092
,	O
a	O
unit	O
charge	O
nurse	B-T097
is	O
responsible	B-T033
for	O
the	O
shift	O
assignment	O
of	O
patients	O
to	O
nurses	B-T097
based	O
on	O
experience	B-T038
and	O
past	B-T038
practices	I-T038
.	O
the	O
nurse	O
-	O
patient	O
assignment	O
process	O
is	O
also	O
often	O
a	O
manual	O
process	O
in	O
which	O
the	O
charge	O
nurse	B-T097
must	O
sort	O
through	O
multiple	O
decision	O
criteria	O
in	O
a	O
limited	O
amount	O
of	O
time	O
.	O
in	O
this	O
paper	O
,	O
a	O
methodology	O
for	O
the	O
construction	O
of	O
balanced	O
nurse	O
-	O
patient	O
workload	O
assignments	O
is	O
proposed	O
.	O
through	O
the	O
illustr	O
##ation	O
of	O
this	O
methodology	O
new	O
scoring	O
metrics	O
are	O
developed	O
using	O
measures	O
currently	O
available	O
on	O
,	O
or	O
from	O
,	O
the	O
hospital	B-T092
unit	I-T092
.	O
it	O
was	O
demonstrated	O
that	O
the	O
complex	O
sched	O
##uling	O
problem	B-T033
can	O
be	O
captured	O
.	O
while	O
the	O
methodology	O
was	O
illustrated	O
for	O
a	O
sched	O
##uling	O
problem	B-T033
commonly	O
encountered	O
on	O
a	O
hospital	B-T092
unit	I-T092
,	O
the	O
approach	B-T082
can	O
be	O
adapted	O
to	O
other	O
workforce	O
sched	O
##uling	O
problems	B-T033
in	O
which	O
measures	O
of	O
workload	O
are	O
required	O
and	O
composed	O
of	O
elements	O
imposed	O
by	O
the	O
work	B-T082
environment	I-T082
,	O
variability	O
within	O
the	O
required	O
tasks	O
,	O
and	O
a	O
measurable	O
perception	B-T038
of	O
the	O
relative	O
intensity	O
of	O
the	O
work	O
elements	O
.	O

the	O
flavor	B-T168
and	O
nutritional	O
characteristic	O
of	O
four	O
straw	B-T168
##berry	I-T168
varieties	O
cultured	O
in	O
soil	O
##less	O
system	O
straw	B-T168
##berry	I-T168
fruits	I-T168
(	O
cv	B-T168
.	I-T168
ben	I-T168
##ih	I-T168
##op	I-T168
##pe	I-T168
,	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
,	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
,	O
and	O
gu	B-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
)	O
were	O
harvested	O
and	O
evaluated	O
the	O
flavor	B-T168
and	O
nutritional	O
parameters	O
.	O
by	O
principal	O
component	O
analysis	O
and	O
hierarchical	B-T062
clustering	I-T062
analysis	I-T062
,	O
differences	O
were	O
observed	O
based	O
on	O
the	O
volatile	B-T103
compounds	I-T103
composition	O
,	O
sugar	B-T103
and	O
acid	B-T103
concentration	O
,	O
sweet	O
##ness	O
,	O
and	O
total	B-T103
soluble	I-T103
sugars	I-T103
/	O
total	B-T103
organic	I-T103
acids	I-T103
of	O
the	O
four	O
varieties	O
.	O
a	O
total	O
of	O
37	O
,	O
48	O
,	O
65	O
,	O
and	O
74	O
volatile	B-T103
compounds	I-T103
were	O
identified	O
and	O
determined	O
in	O
cv	B-T168
.	I-T168
ben	I-T168
##ih	I-T168
##op	I-T168
##pe	I-T168
,	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
,	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
,	O
and	O
gu	B-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
straw	I-T168
##berry	I-T168
fruits	I-T168
extracted	B-T058
by	O
head	B-T058
-	I-T058
space	I-T058
solid	I-T058
-	I-T058
phase	I-T058
microextraction	I-T058
(	O
hs	B-T058
-	I-T058
spme	I-T058
)	O
,	O
respectively	O
.	O
esters	B-T103
significantly	O
dominated	O
the	O
chemical	O
composition	O
of	O
the	O
four	O
varieties	O
.	O
furan	B-T103
##e	I-T103
##ol	I-T103
was	O
detected	O
in	O
cultivars	B-T204
of	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
and	O
gu	B-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
,	O
but	O
mes	B-T168
##if	I-T168
##uran	I-T168
was	O
only	O
found	O
in	O
cv	B-T168
.	I-T168
toc	I-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
.	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
and	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
showed	O
higher	O
content	O
of	O
lin	B-T103
##alo	I-T103
##ol	I-T103
and	O
(	B-T103
e	I-T103
)	I-T103
-	I-T103
ner	I-T103
##olid	I-T103
##ol	I-T103
.	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
showed	O
the	O
highest	O
content	O
of	O
total	B-T103
sugars	I-T103
and	O
total	B-T103
acids	I-T103
.	O
gu	B-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
showed	O
higher	O
sweet	O
##ness	O
index	B-T170
than	O
the	O
other	O
three	O
cultivars	B-T204
.	O
firm	O
##ness	O
of	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
was	O
highest	O
among	O
all	O
the	O
varieties	O
.	O
the	O
highest	O
total	O
soluble	O
solids	O
tss	O
value	O
was	O
found	O
in	O
cv	B-T168
.	I-T168
sac	I-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
,	O
followed	O
by	O
the	O
gu	B-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
and	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
varieties	O
.	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
had	O
the	O
highest	O
titr	B-T033
##atable	I-T033
acidity	I-T033
ta	I-T033
value	I-T033
.	O
the	O
content	O
of	O
ascorbic	B-T103
acid	I-T103
(	O
asa	B-T103
)	O
of	O
cv	B-T168
.	I-T168
toc	I-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
was	O
higher	O
than	O
the	O
others	O
,	O
but	O
there	O
was	O
no	B-T033
significant	I-T033
difference	O
in	O
cultivars	B-T204
of	O
ben	B-T168
##ih	I-T168
##op	I-T168
##pe	I-T168
,	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
,	O
and	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
.	O
fructose	B-T103
and	O
glucose	B-T103
were	O
the	O
major	O
sugars	B-T103
in	O
all	O
cultivars	B-T204
.	O
citric	B-T103
acid	I-T103
was	O
the	O
major	O
organic	B-T103
acid	I-T103
in	O
cv	B-T168
.	I-T168
toc	I-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
,	O
cv	B-T168
.	I-T168
sac	I-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
,	O
and	O
cv	B-T168
.	I-T168
gu	I-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
.	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
had	O
higher	O
ratios	O
of	O
tss	O
/	O
ta	B-T033
and	O
total	B-T103
sugars	I-T103
/	O
total	B-T103
organic	I-T103
acids	I-T103
than	O
others	O
,	O
arising	O
from	O
its	O
lower	O
acid	B-T103
content	O
.	O
the	O
order	O
of	O
the	O
comprehensive	O
evaluation	O
score	O
was	O
sac	B-T168
##hi	I-T168
##no	I-T168
##ka	I-T168
>	O
gu	B-T168
##ime	I-T168
##ire	I-T168
##n	I-T168
>	O
toc	B-T168
##hi	I-T168
##otom	I-T168
##e	I-T168
>	O
ben	B-T168
##ih	I-T168
##op	I-T168
##pe	I-T168
.	O

the	O
cla	B-T103
##sp	I-T103
##2	I-T103
protein	O
interaction	O
network	O
in	O
adipocytes	B-T017
links	O
clip	B-T103
##2	I-T103
to	O
aga	B-T103
##p3	I-T103
,	O
cla	B-T103
##sp	I-T103
##2	I-T103
to	O
g2	B-T103
##l1	I-T103
,	O
mark	B-T103
##2	I-T103
,	O
and	O
so	B-T103
##ga	I-T103
##1	I-T103
,	O
and	O
identifies	O
so	B-T103
##ga	I-T103
##1	I-T103
as	O
a	O
microtubule	B-T103
-	I-T103
associated	I-T103
protein	I-T103
cla	B-T103
##sp	I-T103
##2	I-T103
is	O
a	O
microtubule	B-T103
-	I-T103
associated	I-T103
protein	I-T103
that	O
undergoes	O
insulin	B-T103
-	O
stimulated	O
phosphorylation	B-T038
and	O
co	O
-	O
localization	O
with	O
re	O
##organized	O
actin	B-T103
and	O
glut4	B-T103
at	O
the	O
plasma	B-T017
membrane	I-T017
.	O
to	O
gain	O
insight	B-T038
to	O
the	O
role	O
of	O
cla	B-T103
##sp	I-T103
##2	I-T103
in	O
this	O
system	O
,	O
we	O
developed	O
and	O
successfully	O
executed	O
a	O
stream	O
##line	O
##d	O
interact	B-T038
##ome	I-T038
approach	B-T082
and	O
built	O
a	O
cla	B-T103
##sp	I-T103
##2	I-T103
protein	O
network	O
in	O
3t3	B-T017
-	I-T017
l1	I-T017
adipocytes	I-T017
.	O
using	O
two	O
different	O
commercially	B-T170
available	O
antibodies	B-T103
for	O
cla	B-T103
##sp	I-T103
##2	I-T103
and	O
an	O
antibody	B-T103
for	O
epitope	B-T103
-	O
tagged	O
,	O
overexpressed	B-T038
cla	B-T103
##sp	I-T103
##2	I-T103
,	O
we	O
performed	O
multiple	O
affinity	B-T058
purification	I-T058
coupled	O
with	O
mass	B-T058
spectrometry	I-T058
(	O
ap	B-T058
-	O
ms	B-T058
)	O
experiments	B-T062
in	O
combination	O
with	O
label	B-T033
-	I-T033
free	I-T033
quantitative	O
proteomics	B-T091
and	O
analyzed	B-T062
the	O
data	O
with	O
the	O
bioinformatics	B-T091
tool	B-T170
significance	O
analysis	O
of	O
interact	O
##ome	O
(	O
sa	O
##int	O
)	O
.	O
we	O
discovered	O
that	O
cla	B-T103
##sp	I-T103
##2	I-T103
co	B-T103
-	I-T103
immunoprecip	I-T103
##itates	I-T103
(	O
co	B-T103
-	I-T103
ips	I-T103
)	O
the	O
novel	O
protein	B-T103
so	B-T103
##ga	I-T103
##1	I-T103
,	O
the	O
microtubule	B-T103
-	I-T103
associated	I-T103
protein	I-T103
kinase	I-T103
mark	B-T103
##2	I-T103
,	O
and	O
the	O
microtubule	B-T017
/	O
actin	B-T103
-	O
regulating	B-T038
protein	B-T103
g2	B-T103
##l1	I-T103
.	O
the	O
gtpase	B-T103
-	I-T103
activating	I-T103
proteins	I-T103
aga	B-T103
##p1	I-T103
and	O
aga	B-T103
##p3	I-T103
were	O
also	O
enriched	O
in	O
the	O
cla	B-T103
##sp	I-T103
##2	I-T103
interact	B-T038
##ome	I-T038
,	O
although	O
subsequent	O
aga	B-T103
##p3	I-T103
and	O
clip	B-T103
##2	I-T103
interact	B-T038
##ome	I-T038
analysis	B-T062
suggests	O
a	O
preference	O
of	O
aga	B-T103
##p3	I-T103
for	O
clip	B-T103
##2	I-T103
.	O
follow	O
-	O
up	O
mark	B-T103
##2	I-T103
interact	B-T038
##ome	I-T038
analysis	B-T062
confirmed	B-T033
reciprocal	O
co	B-T103
-	I-T103
ip	I-T103
of	O
cla	B-T103
##sp	I-T103
##2	I-T103
and	O
also	O
revealed	O
mark	B-T103
##2	I-T103
can	O
co	B-T103
-	I-T103
ip	I-T103
so	B-T103
##ga	I-T103
##1	I-T103
,	O
glycogen	B-T103
synthase	I-T103
,	O
and	O
glycogen	B-T103
##in	I-T103
.	O
investigating	O
the	O
so	B-T103
##ga	I-T103
##1	I-T103
interact	B-T038
##ome	I-T038
confirmed	B-T033
so	B-T103
##ga	I-T103
##1	I-T103
can	O
reciprocal	O
co	B-T103
-	I-T103
ip	I-T103
both	O
cla	B-T103
##sp	I-T103
##2	I-T103
and	O
mark	B-T103
##2	I-T103
as	O
well	O
as	O
glycogen	B-T103
synthase	I-T103
and	O
glycogen	B-T103
##in	I-T103
.	O
so	B-T103
##ga	I-T103
##1	I-T103
was	O
confirmed	B-T033
to	O
colocal	B-T082
##ize	I-T082
with	O
cla	B-T103
##sp	I-T103
##2	I-T103
and	O
also	O
with	O
tubulin	B-T103
,	O
which	O
identifies	O
so	B-T103
##ga	I-T103
##1	I-T103
as	O
a	O
new	O
microtubule	B-T103
-	I-T103
associated	I-T103
protein	I-T103
.	O
these	O
results	O
introduce	O
the	O
metabolic	B-T038
function	I-T038
of	O
these	O
proposed	O
novel	O
protein	O
networks	O
and	O
their	O
relationship	O
with	O
microtubules	B-T017
as	O
new	O
fields	O
of	O
cytoskeleton	B-T017
-	O
associated	O
protein	B-T091
biology	I-T091
.	O

associations	O
between	O
human	O
breast	O
milk	O
hormones	B-T103
and	O
adip	B-T103
##ocyt	I-T103
##okines	I-T103
and	O
infant	B-T038
growth	I-T038
and	O
body	O
composition	O
in	O
the	O
first	B-T033
6	I-T033
months	I-T033
of	I-T033
life	I-T033
much	O
is	O
to	O
be	O
learn	O
##t	O
about	O
human	O
breast	O
milk	O
(	O
hb	O
##m	O
)	O
.	O
the	O
purpose	O
of	O
this	O
study	O
is	O
to	O
extend	O
our	O
knowledge	O
of	O
hb	O
##m	O
by	O
investigating	O
the	O
role	O
of	O
maternal	B-T033
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
,	O
sex	O
and	O
stage	B-T038
of	I-T038
lactation	I-T038
(	O
month	O
1	O
vs	O
.	O
6	O
)	O
on	O
hb	O
##m	O
insulin	B-T103
,	O
glucose	B-T103
,	O
leptin	B-T103
,	O
il	B-T103
-	I-T103
6	I-T103
and	O
tnf	B-T103
-	I-T103
α	I-T103
and	O
their	O
associations	O
with	O
infant	O
body	O
composition	O
.	O
thirty	O
-	O
seven	O
exclusively	O
breastfeeding	B-T033
infants	I-T033
(	O
n	O
=	O
37	O
;	O
16	O
##♀	O
,	O
21	O
##♂	O
)	O
,	O
and	O
their	O
mothers	B-T033
(	O
19	O
-	O
47	O
kg	O
m	O
(	O
-	O
2	O
)	O
)	O
were	O
studied	O
at	O
1	O
and	O
6	O
months	O
of	O
lactation	B-T038
.	O
infants	O
had	O
body	B-T201
composition	I-T201
measured	I-T201
(	O
using	O
dual	B-T058
-	I-T058
energy	I-T058
x	I-T058
-	I-T058
ray	I-T058
absorptiometry	I-T058
)	O
and	O
hb	O
##m	O
collected	O
.	O
a	O
significant	O
interaction	O
between	O
maternal	B-T033
bmi	B-T201
and	O
infant	O
sex	O
on	O
insulin	B-T058
levels	I-T058
(	O
p	O
=	O
0	O
.	O
032	O
##2	O
)	O
was	O
observed	O
such	O
that	O
insulin	B-T033
was	I-T033
229	I-T033
%	I-T033
higher	I-T033
in	O
obese	B-T038
mothers	O
nursing	O
female	O
infants	O
than	O
in	O
normal	B-T033
weight	I-T033
mothers	O
nursing	B-T038
female	O
infants	O
and	O
179	O
%	O
higher	O
than	O
obese	B-T038
mothers	O
nursing	O
male	O
infants	O
.	O
for	O
leptin	B-T103
,	O
a	O
significant	O
association	O
with	O
bmi	B-T201
category	O
was	O
observed	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
such	O
that	O
overweight	B-T033
and	O
obese	B-T038
mothers	O
had	O
96	O
.	O
5	O
%	O
and	O
315	O
.	O
1	O
%	O
higher	B-T033
leptin	I-T033
levels	I-T033
than	O
normal	B-T033
weight	I-T033
mothers	O
,	O
respectively	O
.	O
leptin	B-T103
was	O
also	O
found	O
to	O
have	O
a	O
significant	O
(	O
p	O
=	O
0	O
.	O
0004	O
)	O
33	O
.	O
7	O
%	O
decrease	O
from	O
months	O
1	O
to	O
6	O
,	O
controlling	O
for	O
bmi	B-T201
category	O
and	O
sex	O
.	O
a	O
significant	O
inverse	O
relationship	O
between	O
month	O
1	O
leptin	B-T103
levels	O
and	O
infant	B-T033
length	I-T033
(	O
p	O
=	O
0	O
.	O
025	O
##7	O
)	O
,	O
percent	B-T033
fat	I-T033
(	O
p	O
=	O
0	O
.	O
022	O
##3	O
)	O
,	O
total	O
fat	O
mass	O
(	O
p	O
=	O
0	O
.	O
022	O
##6	O
)	O
and	O
trunk	O
fat	O
mass	O
(	O
p	O
=	O
0	O
.	O
011	O
##1	O
)	O
at	O
month	O
6	O
was	O
also	O
found	O
.	O
no	O
associations	O
or	O
interactions	O
were	O
observed	O
for	O
glucose	B-T103
,	O
tnf	B-T103
-	I-T103
α	I-T103
or	O
il	B-T103
-	I-T103
6	I-T103
.	O
these	O
data	O
demonstrate	O
that	O
maternal	B-T033
bmi	B-T201
,	O
infant	O
sex	O
and	O
stage	B-T038
of	I-T038
lactation	I-T038
affect	O
the	O
compositional	O
make	O
-	O
up	O
of	O
insulin	B-T103
and	O
leptin	B-T103
.	O

aryl	B-T017
hydrocarbon	I-T017
receptor	I-T017
(	I-T017
ahr	I-T017
)	I-T017
rs	I-T017
##20	I-T017
##66	I-T017
##85	I-T017
##3	I-T017
gene	O
polymorphism	O
association	O
with	O
infertile	B-T038
oligo	B-T038
##asth	I-T038
##eno	I-T038
##tera	I-T038
##to	I-T038
##zo	I-T038
##osperm	I-T038
##ic	I-T038
men	B-T098
and	O
seminal	B-T201
oxidative	B-T038
stress	I-T038
this	O
study	O
aimed	O
to	O
assess	O
the	O
association	O
between	O
aryl	B-T017
hydrocarbon	I-T017
receptor	I-T017
(	I-T017
ahr	I-T017
)	I-T017
rs	I-T017
##20	I-T017
##66	I-T017
##85	I-T017
##3	I-T017
gene	O
polymorphism	O
with	O
infertile	B-T038
oligo	B-T038
##asth	I-T038
##eno	I-T038
##tera	I-T038
##to	I-T038
##zo	I-T038
##osperm	I-T038
##ic	I-T038
(	O
oat	B-T038
)	O
men	B-T098
and	O
seminal	B-T201
oxidative	B-T038
stress	I-T038
(	O
os	B-T038
)	O
.	O
a	O
total	O
of	O
170	O
egypt	B-T098
##ian	I-T098
men	I-T098
were	O
allocated	O
according	O
to	O
their	O
semen	B-T058
analysis	I-T058
into	O
fertile	B-T038
norm	B-T033
##ozo	I-T033
##osperm	I-T033
##ic	I-T033
controls	I-T033
(	O
n	O
=	O
50	O
)	O
and	O
infertile	B-T038
oat	B-T038
men	B-T098
(	O
n	O
=	O
120	O
)	O
.	O
they	O
were	O
subjected	O
to	O
history	B-T058
taking	I-T058
,	O
clinical	B-T201
examination	I-T201
,	O
semen	B-T058
analysis	I-T058
,	O
estimation	O
of	O
seminal	B-T201
glutathione	B-T103
peroxidase	I-T103
(	O
gpx	B-T103
)	O
,	O
and	O
malondialdehyde	B-T103
(	O
mda	B-T103
)	O
.	O
ahr	B-T017
rs	I-T017
##20	I-T017
##66	I-T017
##85	I-T017
##3	I-T017
gene	O
polymorphism	O
was	O
identified	O
in	O
the	O
blood	B-T031
by	O
pcr	B-T062
-	O
rflp	B-T038
.	O
comparing	O
infertile	B-T038
oat	B-T038
men	B-T098
with	O
fertile	B-T038
controls	O
,	O
ahr	B-T017
rs	I-T017
##20	I-T017
##66	I-T017
##85	I-T017
##3	I-T017
genotypes	O
showed	O
decreased	O
prevalence	O
for	O
wild	B-T017
homozygous	O
genotype	O
gg	O
(	O
35	O
.	O
8	O
vs	O
56	O
%	O
)	O
and	O
for	O
heterozygous	O
genotype	O
ga	O
(	O
17	O
.	O
5	O
vs	O
30	O
%	O
)	O
and	O
an	O
increased	O
prevalence	O
for	O
homozygous	O
genotype	O
aa	O
(	O
46	O
.	O
7	O
vs	O
14	O
%	O
)	O
.	O
distribution	O
of	O
alleles	B-T017
of	O
ahr	B-T017
rs	I-T017
##20	I-T017
##66	I-T017
##85	I-T017
##3	I-T017
among	O
oat	B-T038
men	B-T098
compared	O
with	O
fertile	B-T038
men	B-T098
showed	O
decreased	O
prevalence	O
of	O
g	B-T017
allele	I-T017
(	O
44	O
.	O
6	O
vs	O
71	O
%	O
)	O
and	O
an	O
increased	O
prevalence	O
of	O
a	B-T017
allele	I-T017
(	O
55	O
.	O
4	O
vs	O
29	O
%	O
)	O
.	O
seminal	B-T201
mda	B-T103
demonstrated	O
significant	O
increase	O
whereas	O
seminal	B-T201
gpx	B-T103
demonstrated	O
significant	O
decrease	O
in	O
cases	O
with	O
aa	O
and	O
ga	O
/	O
aa	O
genotypes	O
compared	O
to	O
cases	O
with	O
gg	O
genotype	O
.	O
it	O
is	O
concluded	O
that	O
there	O
is	O
a	O
significant	O
association	O
between	O
ahr	B-T017
rs	I-T017
##20	I-T017
##66	I-T017
##85	I-T017
##3	I-T017
genotype	O
polymorphism	O
with	O
decreased	O
sperm	B-T017
parameters	O
as	O
well	O
as	O
increased	O
seminal	B-T201
oxidative	B-T038
stress	I-T038
in	O
infertile	B-T038
oat	B-T038
men	B-T098
.	O

production	O
of	O
bioactive	O
conjugated	B-T103
linoleic	I-T103
acid	I-T103
by	O
the	O
multifunctional	B-T103
enolase	B-T103
from	O
lactobacillus	B-T007
plantarum	I-T007
lactobacillus	B-T007
plantarum	I-T007
α	B-T103
-	I-T103
enolase	I-T103
,	O
a	O
multifunctional	B-T103
-	O
anchor	O
##less	O
-	O
surface	B-T103
protein	I-T103
belonging	O
to	O
the	O
conserved	O
family	O
of	O
enolase	B-T103
##s	I-T103
with	O
a	O
central	O
role	O
in	O
glycolytic	B-T038
metabolism	B-T038
,	O
was	O
characterized	O
to	O
have	O
a	O
side	O
role	O
in	O
the	O
intricate	B-T038
metabolism	I-T038
of	O
bio	O
##hydro	O
##gen	O
##ation	O
of	O
linoleic	B-T103
acid	I-T103
,	O
catalyzing	O
the	O
formation	O
of	O
bioactive	O
9	B-T103
-	I-T103
cis	I-T103
-	I-T103
11	I-T103
-	I-T103
trans	I-T103
-	I-T103
cla	I-T103
through	O
dehydration	O
and	O
isomerization	O
of	O
10	B-T103
-	I-T103
hydroxy	I-T103
-	I-T103
12	I-T103
-	I-T103
cis	I-T103
-	I-T103
octa	I-T103
##de	I-T103
##ce	I-T103
##no	I-T103
##ic	I-T103
acid	I-T103
.	O
the	O
identity	O
of	O
the	O
enolase	B-T103
was	O
confirmed	O
through	O
mass	B-T058
spectrometric	I-T058
analysis	I-T058
that	O
showed	O
the	O
characteristic	O
44	O
##2	O
amino	B-T082
acid	I-T082
sequence	I-T082
with	O
a	O
molecular	O
mass	O
of	O
48	O
.	O
03	O
kda	O
.	O
the	O
enolase	B-T103
was	O
not	O
capable	O
of	O
using	O
linoleic	B-T103
acid	I-T103
directly	O
as	O
a	O
substrate	O
but	O
instead	O
uses	O
its	O
hydroxyl	B-T103
derivative	O
10	B-T103
-	I-T103
hydrox	I-T103
##i	I-T103
-	I-T103
12	I-T103
-	I-T103
cis	I-T103
-	I-T103
octa	I-T103
##de	I-T103
##ce	I-T103
##no	I-T103
##ic	I-T103
acid	I-T103
to	O
finally	O
form	O
bioactive	O
conjugated	B-T103
linoleic	I-T103
acid	I-T103
.	O
biochemical	O
optimization	O
studies	B-T062
were	O
carried	O
out	O
to	O
elucidate	O
the	O
conditions	O
for	O
maximum	O
production	O
of	O
9	B-T103
-	I-T103
cis	I-T103
-	I-T103
11	I-T103
-	I-T103
trans	I-T103
-	I-T103
cla	I-T103
and	O
maximum	O
stability	B-T038
of	O
α	B-T103
-	I-T103
enolase	I-T103
when	O
catalyzing	O
this	O
reaction	O
.	O
furthermore	O
,	O
through	O
structural	B-T058
analysis	I-T058
of	O
the	O
protein	B-T103
,	O
we	O
propose	O
the	O
binding	B-T103
sites	I-T103
of	O
substrate	O
and	O
product	O
molecules	O
that	O
were	O
characterized	O
as	O
two	O
hydrophobic	O
superficial	O
pockets	O
located	O
at	O
opposite	O
ends	O
of	O
the	O
enolase	B-T103
connected	O
through	O
a	O
channel	B-T103
where	O
the	O
catalysis	O
of	O
dehydration	O
and	O
isomerization	O
might	O
occur	O
.	O
these	O
results	O
prove	O
that	O
multifunctional	B-T103
α	B-T103
-	I-T103
enolase	I-T103
also	O
plays	O
a	O
role	O
in	O
cell	B-T038
detoxification	I-T038
from	O
polyunsaturated	B-T103
fatty	I-T103
acids	I-T103
such	O
as	O
linoleic	B-T103
acid	I-T103
,	O
along	O
with	O
the	O
linole	B-T103
##ate	I-T103
isomerase	I-T103
complex	B-T103
.	O

environmental	O
factors	O
and	O
hypertension	B-T038
environmental	O
factors	O
are	O
a	O
major	O
cause	O
of	O
poor	O
health	O
worldwide	B-T098
.	O
the	O
most	O
solid	O
evidence	O
is	O
for	O
air	O
pollution	O
,	O
leading	O
to	O
increased	O
disability	O
-	O
adjusted	O
life	O
years	O
.	O
outdoor	O
temperature	O
and	O
other	O
seasonal	O
climate	O
changes	O
may	O
also	O
influence	O
cardiovascular	B-T082
health	O
,	O
according	O
to	O
their	O
direct	O
modulation	O
of	O
air	O
pollution	O
.	O
moreover	O
,	O
an	O
increasing	O
body	O
of	O
evidence	O
associates	O
environmental	B-T037
exposure	I-T037
to	O
noise	O
with	O
poor	B-T033
cardiovascular	I-T033
outcome	I-T033
,	O
and	O
in	O
particular	O
with	O
hypertension	B-T038
.	O
this	O
review	O
is	O
aimed	O
at	O
reviewing	O
current	O
evidence	O
about	O
the	O
role	O
of	O
these	O
environmental	O
factors	O
in	O
cardiovascular	B-T038
disease	I-T038
and	O
specifically	O
hypertension	B-T038
.	O
in	O
particular	O
,	O
the	O
impact	O
of	O
air	O
pollution	O
,	O
with	O
its	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
effects	O
,	O
the	O
outdoor	O
temperature	O
and	O
noise	O
pollution	O
will	O
be	O
investigated	O
.	O
people	B-T098
belonging	O
to	O
low	O
social	O
classes	O
,	O
as	O
well	O
as	O
children	O
,	O
women	B-T098
,	O
older	O
people	O
and	O
those	O
with	O
established	O
cardiovascular	B-T038
diseases	I-T038
,	O
seem	O
to	O
have	O
a	O
greater	O
susceptibility	O
to	O
the	O
effects	O
of	O
environmental	O
stressors	O
,	O
recall	O
##ing	O
the	O
concept	O
of	O
[UNK]	O
environmental	O
justice	O
[UNK]	O
.	O
the	O
accumulating	O
strong	O
scientific	O
evidence	O
may	O
thus	O
support	O
public	O
health	O
policies	O
aimed	O
at	O
reducing	O
social	O
inequalities	O
in	O
cardiovascular	B-T082
health	O
.	O

bioavailability	B-T062
and	O
health	O
risk	O
assessment	O
of	O
potentially	O
toxic	B-T103
elements	I-T103
in	O
thr	B-T082
##ias	I-T082
##io	I-T082
plain	I-T082
,	I-T082
near	I-T082
ath	I-T082
##ens	I-T082
,	O
greece	B-T082
elevated	O
concentrations	O
of	O
potentially	O
toxic	B-T103
elements	I-T103
(	O
pt	B-T103
##es	I-T103
)	O
are	O
usually	O
found	O
in	O
areas	O
of	O
intense	O
industrial	O
activity	O
.	O
thr	B-T082
##ias	I-T082
##io	I-T082
plain	I-T082
is	O
a	O
plain	B-T082
near	I-T082
ath	I-T082
##ens	I-T082
,	O
greece	B-T082
,	O
where	O
most	O
of	O
the	O
heavy	O
industry	O
of	O
the	O
country	O
has	O
been	O
situated	O
for	O
decades	O
,	O
but	O
it	O
also	O
is	O
a	O
residential	B-T082
and	O
hor	O
##tic	O
##ultural	O
area	B-T082
.	O
we	O
aimed	O
at	O
measuring	O
the	O
levels	O
of	O
pt	B-T103
##es	I-T103
in	O
soils	O
and	O
indigenous	O
plant	B-T204
species	I-T204
and	O
assessing	O
the	O
health	O
risk	O
associated	O
with	O
direct	O
soil	O
ingestion	B-T038
.	O
samples	O
of	O
soils	O
at	O
road	O
##side	O
##s	O
and	O
growing	O
plants	B-T204
were	O
collected	O
from	O
31	O
sites	O
of	O
that	O
area	B-T082
.	O
concentrations	O
of	O
al	B-T103
,	O
as	B-T103
,	O
cd	B-T103
,	O
co	B-T103
,	O
cr	B-T103
,	O
cu	B-T103
,	O
fe	B-T103
,	O
mn	B-T103
,	O
mo	B-T103
,	O
ni	B-T103
,	O
pb	B-T103
,	O
v	B-T103
and	O
zn	B-T103
were	O
measured	O
in	O
both	O
soils	O
(	O
as	O
pseudo	O
-	O
total	O
)	O
and	O
aerial	O
plant	B-T017
tissues	I-T017
.	O
we	O
found	O
that	O
as	B-T103
,	O
cd	B-T103
,	O
cr	B-T103
,	O
cu	B-T103
,	O
ni	B-T103
,	O
pb	B-T103
and	O
zn	B-T103
were	O
higher	O
than	O
maximum	O
regulatory	B-T170
limits	O
.	O
element	B-T103
concentrations	O
in	O
plants	B-T204
were	O
rather	O
lower	O
than	O
expected	O
,	O
probably	O
because	O
indigenous	O
plants	B-T204
have	O
developed	O
exclude	O
##r	O
behaviour	O
over	O
time	O
.	O
copper	B-T103
and	O
zn	B-T103
soil	O
-	O
to	O
-	O
plant	B-T204
coefficients	O
were	O
highest	O
among	O
the	O
other	O
elements	B-T103
;	O
for	O
cu	B-T103
this	O
was	O
unexpected	O
,	O
and	O
probably	O
associated	O
with	O
recent	O
cu	B-T103
-	O
releasing	O
industrial	O
activity	O
.	O
risk	B-T058
assessment	I-T058
analysis	I-T058
indicated	O
that	O
as	B-T103
was	O
the	O
element	B-T103
contributing	O
more	O
than	O
50	O
%	O
of	O
the	O
health	O
risk	O
related	O
to	O
direct	O
soil	O
ingestion	B-T038
,	O
followed	O
by	O
cr	B-T103
,	O
pb	B-T103
,	O
and	O
,	O
surprisingly	O
,	O
mn	B-T103
.	O
we	O
concluded	O
that	O
in	O
a	O
multi	O
-	O
element	B-T103
contamination	O
situation	O
,	O
elevated	O
risk	O
of	O
pt	B-T103
##es	I-T103
(	O
such	O
as	O
as	B-T103
,	O
cr	B-T103
and	O
pb	B-T103
)	O
may	O
reduce	O
the	O
tolerance	O
limits	O
of	O
exposure	O
to	O
less	O
-	O
toxic	B-T103
elements	I-T103
(	O
here	O
,	O
mn	B-T103
)	O
.	O

identification	O
of	O
markers	B-T201
for	O
quiescent	O
pancreatic	B-T017
stellate	I-T017
cells	I-T017
in	O
the	O
normal	O
human	B-T204
pancreas	B-T017
pancreatic	B-T017
stellate	I-T017
cells	I-T017
(	O
psc	B-T017
##s	I-T017
)	O
play	O
a	O
central	O
role	O
as	O
source	O
of	O
fibro	B-T017
##genic	I-T017
cells	I-T017
in	O
pancreatic	B-T038
cancer	I-T038
and	O
chronic	B-T038
pancreatitis	I-T038
.	O
in	O
contrast	O
to	O
quiescent	O
hepatic	B-T017
stellate	I-T017
cells	I-T017
(	O
q	B-T017
##hs	I-T017
##cs	I-T017
)	O
,	O
a	O
specific	O
marker	B-T201
for	O
quiescent	O
psc	B-T017
##s	I-T017
(	O
qp	B-T017
##sc	I-T017
##s	I-T017
)	O
that	O
can	O
be	O
used	O
in	O
formalin	B-T017
-	I-T017
fixed	I-T017
and	I-T017
paraffin	I-T017
embedded	I-T017
(	I-T017
ffp	I-T017
##e	I-T017
)	I-T017
normal	I-T017
human	I-T017
pancreatic	I-T017
tissue	I-T017
has	O
not	O
been	O
identified	O
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
a	O
marker	O
enabling	O
the	O
identification	O
of	O
qp	B-T017
##sc	I-T017
##s	I-T017
in	O
normal	O
human	B-T204
ffp	B-T017
##e	I-T017
pancreatic	I-T017
tissue	I-T017
.	O
immunohistochemical	O
(	O
ihc	O
)	O
,	O
double	O
-	O
ihc	O
,	O
immunofluorescence	B-T058
(	O
if	B-T058
)	O
and	O
double	B-T058
-	I-T058
if	I-T058
analyses	I-T058
were	O
carried	O
out	O
using	O
a	O
tissue	O
microarray	O
consisting	O
of	O
cores	O
with	O
normal	O
human	B-T204
pancreatic	B-T017
tissue	I-T017
.	O
cores	O
with	O
normal	O
human	B-T204
liver	B-T017
served	O
as	O
control	O
.	O
antibodies	B-T103
directed	O
against	O
adip	B-T103
##ophil	I-T103
##in	I-T103
,	O
α	B-T103
-	I-T103
sma	I-T103
,	O
cd14	B-T103
##6	I-T103
,	O
cr	B-T103
##bp	I-T103
-	I-T103
1	I-T103
,	O
cyto	B-T103
##gl	I-T103
##obi	I-T103
##n	I-T103
,	O
desmin	B-T103
,	O
gfap	B-T103
,	O
nestin	B-T103
,	O
s100a	B-T103
##4	I-T103
and	O
vinc	B-T103
##ulin	I-T103
were	O
examined	O
,	O
with	O
special	O
emphasis	O
on	O
their	O
expression	O
in	O
peri	B-T082
##acin	I-T082
##ar	I-T082
cells	B-T017
in	O
the	O
normal	O
human	B-T204
pancreas	B-T017
and	O
peri	B-T017
##sin	I-T017
##us	I-T017
##oidal	I-T017
cells	I-T017
in	O
the	O
normal	O
human	B-T204
liver	B-T017
.	O
the	O
immunolab	B-T058
##elling	I-T058
capacity	O
was	O
evaluated	O
according	O
to	O
a	O
semiquantitative	O
scoring	O
system	O
.	O
double	B-T058
-	I-T058
if	I-T058
of	O
the	O
markers	B-T201
of	O
interest	O
together	O
with	O
markers	B-T201
for	O
other	O
peri	B-T082
##acin	I-T082
##ar	I-T082
cells	B-T017
was	O
performed	O
.	O
moreover	O
,	O
the	O
utility	O
of	O
histochemical	O
stains	O
for	O
the	O
identification	O
of	O
human	B-T204
qp	B-T017
##sc	I-T017
##s	I-T017
was	O
examined	O
,	O
and	O
their	O
ultrastructure	O
was	O
revis	O
##ited	O
by	O
electron	B-T058
microscopy	I-T058
.	O
adip	B-T103
##ophil	I-T103
##in	I-T103
,	O
cr	B-T103
##bp	I-T103
-	I-T103
1	I-T103
,	O
cyto	B-T103
##gl	I-T103
##obi	I-T103
##n	I-T103
and	O
vinc	B-T103
##ulin	I-T103
were	O
expressed	O
in	O
q	B-T017
##hs	I-T017
##cs	I-T017
in	O
the	O
liver	B-T017
,	O
whereas	O
cyto	B-T103
##gl	I-T103
##obi	I-T103
##n	I-T103
and	O
adip	B-T103
##ophil	I-T103
##in	I-T103
were	O
expressed	O
in	O
qp	B-T017
##sc	I-T017
##s	I-T017
in	O
the	O
pancreas	B-T017
.	O
adip	B-T103
##ophil	I-T103
##in	I-T103
immunohistochemistry	B-T058
was	O
highly	O
dependent	O
on	O
the	O
pre	O
##analy	O
##tical	O
time	O
interval	O
(	O
pati	O
)	O
from	O
removal	O
of	O
the	O
tissue	B-T017
to	O
formalin	B-T058
fixation	I-T058
.	O
cyto	B-T103
##gl	I-T103
##obi	I-T103
##n	I-T103
,	O
s100a	B-T103
##4	I-T103
and	O
vinc	B-T103
##ulin	I-T103
were	O
expressed	O
in	O
peri	B-T082
##acin	I-T082
##ar	I-T082
fibroblasts	B-T017
(	O
fbs	B-T017
)	O
.	O
the	O
other	O
examined	O
markers	B-T201
were	O
negative	O
in	O
human	B-T204
qp	B-T017
##sc	I-T017
##s	I-T017
.	O
our	O
data	O
indicate	O
that	O
cyto	B-T103
##gl	I-T103
##obi	I-T103
##n	I-T103
and	O
adip	B-T103
##ophil	I-T103
##in	I-T103
are	O
markers	B-T201
of	O
qp	B-T017
##sc	I-T017
##s	I-T017
in	O
the	O
normal	O
human	B-T204
pancreas	B-T017
.	O
however	O
,	O
the	O
use	O
of	O
adip	B-T103
##ophil	I-T103
##in	I-T103
as	O
a	O
qp	B-T017
##sc	I-T017
marker	O
may	O
be	O
limited	O
due	O
to	O
its	O
high	O
dependence	O
on	O
optimal	O
pati	O
.	O
cyto	B-T103
##gl	I-T103
##obi	I-T103
##n	I-T103
,	O
on	O
the	O
other	O
hand	O
,	O
is	O
a	O
sensitive	O
marker	B-T201
for	O
qp	B-T017
##sc	I-T017
##s	I-T017
but	O
is	O
expressed	O
in	O
fbs	B-T017
as	O
well	O
.	O

proteomics	B-T103
analysis	B-T058
of	O
the	O
endogenous	O
,	O
constitutive	O
,	O
leaf	B-T204
sumo	B-T038
##yl	I-T038
##ome	I-T038
sumo	B-T038
##ylation	I-T038
is	O
a	O
post	B-T038
-	I-T038
translational	I-T038
modification	I-T038
which	O
regulates	B-T038
a	O
number	O
of	O
critical	O
biological	B-T038
processes	I-T038
in	O
,	O
for	O
example	O
mammals	B-T204
,	O
yeast	B-T204
and	O
plants	B-T204
.	O
in	O
order	O
to	O
fully	O
understand	B-T038
the	O
functional	O
effects	O
of	O
sumo	B-T038
##ylation	I-T038
an	O
essential	O
first	O
step	O
is	O
the	O
identification	B-T038
of	O
endogenous	O
targets	O
for	O
sumo	B-T038
##ylation	I-T038
.	O
here	O
we	O
report	B-T170
the	O
results	O
of	O
using	O
a	O
recently	O
developed	O
proteomic	B-T091
approach	I-T091
based	O
on	O
the	O
use	O
of	O
3d	B-T082
gels	B-T103
to	O
identify	O
the	O
endogenous	O
sumo	B-T103
targets	O
in	O
leaves	B-T204
of	O
sol	B-T204
##anum	I-T204
tuber	I-T204
##osum	I-T204
.	O
by	O
using	O
3d	B-T082
gels	B-T103
we	O
avoid	O
the	O
problem	O
of	O
co	O
-	O
migration	O
of	O
proteins	B-T103
,	O
which	O
is	O
a	O
major	O
limitation	O
of	O
2d	B-T082
gels	B-T103
,	O
and	O
we	O
enable	O
the	O
use	O
of	O
the	O
highly	O
sensitive	O
cy	B-T103
##dy	I-T103
##e	I-T103
dig	I-T103
##e	I-T103
fluor	I-T103
saturation	I-T103
dyes	I-T103
.	O
using	O
this	O
new	O
method	O
we	O
have	O
identified	O
39	O
individual	B-T103
proteins	I-T103
as	O
probable	O
sumo	B-T103
targets	O
in	O
leaves	B-T204
of	O
sol	B-T204
##anum	I-T204
tuber	I-T204
##osum	I-T204
.	O
the	O
advantages	O
of	O
this	O
method	B-T058
compared	O
with	O
other	O
approaches	O
are	O
discussed	O
,	O
and	O
possible	B-T033
future	O
developments	O
are	O
outlined	O
.	O
the	O
authors	B-T097
have	O
no	O
conflicts	O
of	O
interest	O
to	O
decl	O
##are	O
.	O
all	O
authors	B-T097
have	O
approved	O
the	O
manuscript	B-T170
and	O
agree	B-T033
with	O
subm	O
##ission	O
to	O
journal	B-T170
of	I-T170
proteomics	I-T170
.	O

initial	O
experience	O
with	O
laparoscopic	B-T058
radical	I-T058
antegrade	I-T058
modular	I-T058
pancre	I-T058
##ato	I-T058
##sp	I-T058
##len	I-T058
##ectomy	I-T058
for	O
left	B-T038
-	I-T038
sided	I-T038
pancreatic	I-T038
cancer	I-T038
in	O
a	O
single	O
institution	B-T092
:	O
technical	O
aspects	O
and	O
oncological	B-T033
outcomes	I-T033
laparoscopic	B-T058
surgery	I-T058
has	O
been	O
performed	O
less	O
frequently	O
in	O
the	O
era	O
of	O
pancreatic	B-T038
cancer	I-T038
due	O
to	O
technical	O
difficulties	O
and	O
concerns	O
about	O
oncological	B-T038
safety	O
.	O
radical	O
antegrade	O
modular	O
pancre	O
##ato	O
##sp	O
##len	O
##ectomy	O
(	O
ramp	O
##s	O
)	O
is	O
expected	O
to	O
be	O
helpful	O
to	O
obtain	O
a	O
negative	B-T033
margin	I-T033
during	O
radical	B-T058
lymph	I-T058
node	I-T058
dissection	I-T058
.	O
we	O
hypothesized	O
that	O
it	O
would	O
also	O
be	O
favorable	O
as	O
a	O
laparoscopic	B-T082
application	I-T082
due	O
to	O
unique	O
features	O
.	O
fifteen	O
laparoscopic	B-T058
ramp	O
##s	O
for	O
well	O
-	O
selected	O
patients	O
with	O
left	B-T038
-	I-T038
sided	I-T038
pancreatic	I-T038
cancer	I-T038
were	O
performed	O
from	O
july	O
2011	O
to	O
april	O
2016	O
.	O
five	O
tro	B-T074
##car	I-T074
##s	I-T074
were	O
usually	O
used	O
,	O
and	O
the	O
operative	B-T058
procedures	I-T058
and	O
range	B-T058
of	I-T058
dissection	I-T058
were	O
similar	O
to	O
or	O
the	O
same	O
as	O
those	O
of	O
open	O
ramp	O
##s	O
described	O
by	O
stra	O
##s	O
##berg	O
.	O
all	O
medical	O
records	O
and	O
follow	B-T170
-	I-T170
up	I-T170
data	I-T170
were	O
reviewed	O
and	O
analyzed	O
.	O
all	O
patients	O
had	O
pancreatic	B-T038
ductal	I-T038
adenocarcinoma	I-T038
.	O
mean	O
operative	O
time	O
was	O
219	O
.	O
3	O
±	O
53	O
.	O
8	O
min	O
,	O
and	O
estimated	B-T033
blood	I-T033
loss	I-T033
was	O
250	O
±	O
70	O
ml	O
.	O
the	O
length	O
of	O
postoperative	O
hospital	O
stay	O
was	O
6	O
.	O
1	O
±	O
1	O
.	O
2	O
days	O
,	O
and	O
postoperative	B-T038
morbidities	O
developed	O
in	O
two	O
patients	O
(	O
13	O
.	O
3	O
%	O
)	O
with	O
urinary	B-T033
retention	I-T033
.	O
the	O
median	O
number	O
of	O
retrieved	O
lymph	B-T017
nodes	I-T017
was	O
18	O
.	O
1	O
±	O
6	O
.	O
2	O
and	O
all	O
had	O
negative	B-T033
margins	I-T033
.	O
median	O
follow	B-T058
-	I-T058
up	I-T058
time	O
was	O
46	O
.	O
0	O
months	O
,	O
and	O
the	O
3	O
-	O
year	O
disease	O
free	O
survival	O
and	O
overall	O
survival	O
rates	O
were	O
56	O
.	O
3	O
%	O
and	O
74	O
.	O
1	O
%	O
,	O
respectively	O
.	O
our	O
early	O
experience	O
with	O
laparoscopic	B-T058
ramp	O
##s	O
achieved	O
feasible	O
perioperative	O
results	O
accompanied	O
by	O
acceptable	O
survival	O
outcomes	O
.	O
laparoscopic	B-T058
ramp	O
##s	O
could	O
be	O
a	O
safe	O
and	O
oncological	B-T038
##ly	I-T038
feasible	O
procedure	O
in	O
well	O
-	O
selected	O
patients	O
with	O
left	B-T038
-	I-T038
sided	I-T038
pancreatic	I-T038
cancer	I-T038
.	O

effective	O
mercury	B-T103
(	I-T103
ii	I-T103
)	I-T103
bio	O
##rem	O
##ova	O
##l	O
from	O
aqueous	O
solution	O
,	O
and	O
its	O
electrochemical	O
determination	O
this	O
work	O
proposed	O
mercury	B-T103
elimination	O
using	O
agricultural	O
waste	O
(	O
all	B-T204
##ium	I-T204
cep	I-T204
##a	I-T204
l	I-T204
.	O
)	O
.	O
the	O
biomass	O
removed	O
99	O
.	O
4	O
%	O
of	O
mercury	B-T103
,	O
following	O
a	O
pseudo	O
-	O
second	O
order	O
kinetics	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
999	O
##9	O
)	O
.	O
the	O
langmuir	B-T170
model	I-T170
was	O
adequately	O
fitted	O
to	O
the	O
adsorption	O
isotherm	O
,	O
thereby	O
obtaining	O
the	O
maximum	O
mercury	B-T103
adsorption	B-T058
capacity	O
of	O
111	O
.	O
1	O
±	O
0	O
.	O
3	O
mg	O
g	O
(	O
-	O
1	O
)	O
.	O
the	O
biomass	O
showed	O
high	O
density	O
of	O
strong	O
mercury	B-T103
chelating	B-T103
groups	I-T103
,	O
thus	O
making	O
it	O
economically	O
attractive	O
.	O
also	O
,	O
the	O
implementation	O
of	O
a	O
mercury	B-T103
-	O
selective	B-T058
electrode	I-T058
for	O
continuous	O
determination	B-T058
in	O
real	O
time	O
is	O
proposed	O
;	O
this	O
electrode	O
replace	O
##s	O
techniques	O
like	O
atomic	B-T058
absorption	I-T058
spectroscopy	I-T058
,	O
thus	O
it	O
can	O
be	O
applied	O
to	O
real	O
time	O
studies	B-T062
.	O
this	O
work	O
therefore	O
presents	O
a	O
new	O
perspective	O
for	O
removing	O
mercury	B-T103
(	I-T103
ii	I-T103
)	I-T103
from	O
contaminated	O
water	O
for	O
environmental	O
remediation	O
.	O

probabilistic	O
acute	O
risk	B-T058
assessment	I-T058
of	O
cumulative	O
exposure	O
to	O
organophosph	B-T103
##orus	I-T103
and	O
carbam	B-T103
##ate	I-T103
pesticides	I-T103
from	O
dietary	B-T168
vegetables	I-T168
and	O
fruits	B-T168
in	O
shanghai	O
populations	B-T098
organophosph	B-T103
##orus	I-T103
pesticides	I-T103
(	O
ops	B-T103
)	O
and	O
carbam	B-T103
##ate	I-T103
pesticides	I-T103
(	O
cps	B-T103
)	O
are	O
among	O
the	O
most	O
widely	O
used	O
pesticides	B-T103
in	O
china	B-T082
,	O
playing	O
a	O
major	O
role	O
in	O
protecting	O
agricultural	B-T204
comm	I-T204
##odi	I-T204
##ties	I-T204
.	O
in	O
this	O
study	O
,	O
we	O
determined	O
the	O
cumulative	O
acute	O
exposure	O
to	O
ops	B-T103
and	O
cps	B-T103
of	O
shanghai	O
residents	B-T098
from	O
vegetables	B-T168
and	O
fruits	B-T168
(	O
vf	B-T168
##s	I-T168
)	O
.	O
the	O
food	O
consumption	O
data	O
were	O
obtained	O
from	O
the	O
shanghai	B-T170
food	I-T170
consumption	I-T170
survey	I-T170
(	O
sh	B-T170
##fc	I-T170
##s	I-T170
)	O
of	O
2012	O
-	O
14	O
including	O
a	O
total	O
of	O
1973	O
participants	B-T098
aged	O
2	O
-	O
90	O
years	O
.	O
the	O
pesticide	B-T103
residue	I-T103
data	O
were	O
obtained	O
from	O
the	O
shanghai	O
monitoring	B-T058
programme	O
during	O
2008	O
-	O
11	O
with	O
34	O
organophosph	B-T103
##ates	I-T103
and	O
11	O
carbam	B-T103
##ates	I-T103
analysed	O
in	O
a	O
total	O
of	O
53	O
##35	O
samples	O
of	O
vf	B-T168
##s	I-T168
.	O
a	O
probabilistic	O
approach	O
was	O
performed	O
as	O
recommended	O
by	O
the	O
efs	B-T170
##a	I-T170
,	O
using	O
the	O
optim	B-T170
##istic	I-T170
model	I-T170
with	O
non	O
-	O
detects	O
set	O
as	O
zero	O
and	O
with	O
processing	O
factors	O
(	O
pfs	O
)	O
being	O
used	O
and	O
the	O
pes	B-T170
##si	I-T170
##mi	I-T170
##st	I-T170
##ic	I-T170
model	I-T170
with	O
non	O
-	O
detects	O
replaced	O
by	O
limit	O
of	O
detection	O
(	O
lod	O
)	O
and	O
without	O
pfs	O
.	O
we	O
used	O
the	O
relative	B-T170
potency	I-T170
factor	I-T170
(	I-T170
rp	I-T170
##f	I-T170
)	I-T170
method	I-T170
to	O
normal	O
##ise	O
the	O
various	O
pesticides	B-T103
to	O
the	O
index	B-T103
compound	I-T103
(	O
ic	B-T103
)	O
of	O
meth	B-T103
##amido	I-T103
##phos	I-T103
and	O
chlorpyr	B-T103
##ifos	I-T103
separately	O
.	O
only	O
in	O
the	O
pes	B-T170
##si	I-T170
##mi	I-T170
##st	I-T170
##ic	I-T170
model	I-T170
using	O
meth	B-T103
##amido	I-T103
##phos	I-T103
as	O
the	O
ic	B-T103
was	O
there	O
was	O
small	O
risk	O
of	O
exposure	O
exceeding	O
the	O
arf	O
##d	O
(	O
3	O
µg	O
kg	O
(	O
-	O
)	O
(	O
1	O
)	O
bw	O
day	O
(	O
-	O
)	O
(	O
1	O
)	O
)	O
in	O
the	O
populations	B-T098
of	O
preschool	O
children	O
(	O
0	O
.	O
029	O
%	O
)	O
,	O
school	O
-	O
age	O
children	O
(	O
0	O
.	O
022	O
%	O
)	O
and	O
adults	O
(	O
0	O
.	O
002	O
%	O
)	O
.	O
there	O
were	O
no	O
risk	O
of	O
exposure	O
exceeding	O
the	O
arf	O
##d	O
of	O
meth	B-T103
##amido	I-T103
##phos	I-T103
in	O
the	O
optim	B-T170
##istic	I-T170
model	I-T170
and	O
of	O
chlorpyr	B-T103
##ifos	I-T103
(	O
100	O
µg	O
kg	O
(	O
-	O
)	O
(	O
1	O
)	O
bw	O
day	O
(	O
-	O
)	O
(	O
1	O
)	O
)	O
in	O
both	O
optim	B-T033
##istic	I-T033
and	O
pes	B-T170
##si	I-T170
##mi	I-T170
##st	I-T170
##ic	I-T170
models	I-T170
in	O
all	O
three	O
populations	B-T098
.	O
considering	O
the	O
chinese	B-T033
habits	I-T033
of	O
overwhelming	O
##ly	O
eating	B-T038
processed	B-T168
food	I-T168
(	O
vegetables	B-T168
being	O
cooked	O
,	O
and	O
fruits	B-T168
being	O
washed	O
or	O
peel	O
##ed	O
)	O
,	O
we	O
conclude	O
that	O
little	O
acute	O
risk	O
was	O
found	O
for	O
the	O
exposure	O
to	O
vf	B-T168
-	O
source	B-T033
##d	I-T033
ops	B-T103
and	O
cps	B-T103
in	O
shanghai	O
.	O

intensive	O
social	O
cognitive	B-T058
treatment	I-T058
(	O
can	O
do	O
treatment	O
)	O
with	O
participation	O
of	O
support	O
partners	B-T098
in	O
persons	B-T098
with	O
relapsing	B-T038
remitting	I-T038
multiple	I-T038
sclerosis	I-T038
:	O
observation	B-T058
of	O
improved	B-T033
self	B-T038
-	I-T038
efficacy	I-T038
,	O
quality	O
of	O
life	O
,	O
anxiety	B-T033
and	O
depression	B-T038
1	O
year	O
later	O
in	O
persons	B-T098
with	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
self	B-T038
-	I-T038
efficacy	I-T038
positively	B-T033
affects	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
hrqol	O
)	O
and	O
physical	O
activity	O
.	O
in	O
a	O
previous	O
study	O
we	O
observed	O
that	O
6	O
months	O
after	O
an	O
intensive	O
3	O
-	O
day	O
social	O
cognitive	B-T058
treatment	I-T058
(	O
can	O
do	O
treatment	O
)	O
with	O
the	O
participation	O
of	O
support	O
partners	B-T098
,	O
self	B-T038
-	I-T038
efficacy	I-T038
and	O
hrqol	O
had	O
improved	B-T033
in	O
persons	B-T098
with	O
relapsing	B-T038
remitting	I-T038
ms	I-T038
(	O
rr	B-T038
##ms	I-T038
)	O
.	O
given	O
the	O
chronic	O
nature	O
of	O
the	O
disease	O
,	O
it	O
is	O
important	O
to	O
know	O
whether	O
these	O
beneficial	O
changes	O
may	O
last	O
.	O
can	O
do	O
treatment	O
was	O
given	O
to	O
60	O
persons	B-T098
with	O
ms	B-T038
and	O
their	O
support	O
partners	B-T098
.	O
at	O
baseline	O
and	O
12	O
months	O
after	O
treatment	B-T058
self	B-T038
-	I-T038
efficacy	I-T038
control	O
,	O
self	B-T038
-	I-T038
efficacy	I-T038
function	O
,	O
physical	O
and	O
mental	B-T038
hrqol	O
,	O
anxiety	B-T033
,	O
depression	B-T038
and	O
fatigue	B-T033
were	O
assessed	O
via	O
self	B-T062
-	I-T062
report	I-T062
questionnaires	B-T170
.	O
differences	O
were	O
tested	O
via	O
a	O
paired	B-T170
t	I-T170
test	I-T170
.	O
of	O
the	O
57	O
persons	B-T098
with	O
ms	B-T038
that	O
completed	O
the	O
baseline	O
assessment	O
and	O
the	O
3	O
-	O
day	O
treatment	O
,	O
38	O
filled	O
in	O
the	O
12th	O
month	O
questionnaires	B-T170
(	O
response	B-T033
rate	O
66	O
.	O
7	O
%	O
)	O
,	O
22	O
with	O
rr	B-T038
##ms	I-T038
and	O
14	O
with	O
progressive	O
ms	B-T038
.	O
in	O
the	O
rr	B-T038
group	O
self	B-T038
-	I-T038
efficacy	I-T038
control	O
had	O
increased	O
by	O
20	O
.	O
2	O
%	O
and	O
physical	O
hrqol	O
by	O
15	O
.	O
0	O
%	O
,	O
and	O
depression	B-T038
and	O
anxiety	B-T033
had	O
decreased	O
by	O
29	O
.	O
8	O
and	O
25	O
.	O
9	O
%	O
,	O
respectively	O
(	O
all	O
p	O
<	O
0	O
.	O
05	O
)	O
;	O
the	O
changes	O
in	O
mental	B-T038
hrqol	O
(	O
+	O
17	O
%	O
)	O
and	O
fatigue	B-T033
(	O
-	O
20	O
%	O
)	O
failed	O
to	O
be	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
08	O
##7	O
,	O
p	O
=	O
0	O
.	O
08	O
##0	O
,	O
respectively	O
)	O
.	O
in	O
the	O
progressive	O
group	O
no	O
changes	O
suggestive	O
of	O
improvement	O
were	O
seen	O
.	O
the	O
findings	O
suggest	O
that	O
a	O
3	O
-	O
day	O
intensive	O
social	O
cognitive	B-T058
treatment	I-T058
(	O
can	O
do	O
treatment	O
)	O
with	O
the	O
participation	O
of	O
support	O
partners	B-T098
may	O
have	O
long	O
lasting	O
beneficial	O
effects	O
on	O
the	O
self	B-T038
-	I-T038
efficacy	I-T038
and	O
hrqol	O
in	O
persons	B-T098
with	O
rr	B-T038
##ms	I-T038
;	O
and	O
that	O
improvements	O
in	O
anxiety	B-T033
and	O
depression	B-T038
,	O
not	O
seen	O
in	O
the	O
6	O
-	O
month	O
study	O
,	O
may	O
yet	O
develop	O
at	O
12	O
months	O
.	O

efficient	O
gene	B-T062
targeting	I-T062
in	O
non	O
-	O
homologous	O
end	O
-	O
joining	O
-	O
deficient	O
lipo	B-T204
##my	I-T204
##ces	I-T204
star	I-T204
##key	I-T204
##i	I-T204
strains	O
microbial	O
lipids	B-T103
are	O
sustainable	O
feedst	O
##ock	O
for	O
the	O
production	O
of	O
ole	B-T103
##ochemical	I-T103
##s	I-T103
and	O
biod	B-T103
##ies	I-T103
##el	I-T103
.	O
ole	B-T204
##aginous	I-T204
yeasts	I-T204
have	O
recently	O
been	O
proposed	O
as	O
alternative	O
lipid	B-T103
producers	B-T204
to	O
plants	B-T204
and	O
animals	B-T204
to	O
promote	O
sustainability	O
in	O
the	O
chemical	B-T092
and	O
fuel	O
industries	O
.	O
the	O
ole	B-T204
##aginous	I-T204
yeast	I-T204
lipo	B-T204
##my	I-T204
##ces	I-T204
star	I-T204
##key	I-T204
##i	I-T204
has	O
great	O
industrial	O
potential	O
as	O
an	O
excellent	O
lipid	B-T103
producer	B-T204
.	O
however	O
,	O
improvement	O
of	O
its	O
lipid	B-T103
productivity	O
is	O
essential	O
for	O
the	O
cost	O
-	O
effective	O
production	O
of	O
ole	B-T103
##ochemical	I-T103
##s	I-T103
and	O
fuels	O
.	O
genetic	B-T062
and	O
metabolic	B-T062
engineering	I-T062
of	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
via	O
gene	O
manipulation	O
techniques	O
may	O
result	O
in	O
improvements	O
in	O
lipid	B-T103
production	O
and	O
our	O
understanding	O
of	O
the	O
mechanisms	O
behind	O
lipid	B-T103
biosynthesis	O
pathways	O
.	O
we	O
previously	O
described	O
an	O
integrative	O
transformation	O
system	O
using	O
a	O
drug	B-T103
-	O
resistant	O
marker	B-T038
for	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
.	O
however	O
,	O
gene	B-T062
-	I-T062
targeting	I-T062
frequencies	O
were	O
very	O
low	O
because	O
non	B-T038
-	I-T038
homologous	I-T038
recombination	I-T038
is	O
probably	O
predominant	O
in	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
.	O
genetic	B-T062
engineering	I-T062
tools	I-T062
for	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
have	O
not	O
been	O
sufficiently	O
developed	O
.	O
in	O
this	O
study	O
,	O
we	O
describe	O
a	O
new	O
genetic	B-T062
tool	I-T062
and	O
its	O
application	O
in	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
.	O
to	O
develop	O
a	O
highly	O
efficient	O
gene	B-T062
-	I-T062
targeting	I-T062
system	I-T062
for	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
,	O
we	O
constructed	O
a	O
series	O
of	O
mutants	B-T017
by	O
disrupting	O
genes	B-T017
for	O
ls	B-T103
##k	I-T103
##u	I-T103
##70	I-T103
##p	I-T103
,	O
ls	B-T103
##k	I-T103
##u	I-T103
##80	I-T103
##p	I-T103
,	O
and	O
/	O
or	O
ls	B-T103
##li	I-T103
##g	I-T103
##4	I-T103
##p	I-T103
,	O
which	O
share	O
homology	O
with	O
other	O
yeasts	B-T204
ku	B-T103
##70	I-T103
##p	I-T103
,	O
ku	B-T103
##80	I-T103
##p	I-T103
,	O
and	O
lig	B-T103
##4	I-T103
##p	I-T103
,	O
respectively	O
,	O
being	O
involved	O
in	O
non	O
-	O
homologous	O
end	O
-	O
joining	O
pathway	O
.	O
deletion	B-T038
of	O
the	O
ls	B-T017
##li	I-T017
##g	I-T017
##4	I-T017
gene	I-T017
dramatically	O
improved	O
the	O
homologous	B-T038
recombination	I-T038
efficiency	O
(	O
80	O
.	O
0	O
%	O
)	O
at	O
the	O
ls	B-T017
##ura	I-T017
##3	I-T017
locus	B-T082
compared	O
with	O
that	O
in	O
the	O
wild	B-T017
-	I-T017
type	I-T017
strain	O
(	O
1	O
.	O
4	O
%	O
)	O
,	O
when	O
2000	B-T082
-	I-T082
bp	I-T082
homologous	I-T082
flanking	I-T082
regions	I-T082
were	O
used	O
.	O
the	O
homologous	B-T038
recombination	I-T038
efficiencies	O
of	O
the	O
double	O
mutant	B-T017
∆	B-T017
##l	I-T017
sk	I-T017
##u	I-T017
##70	I-T017
##∆	I-T017
##ls	I-T017
##li	I-T017
##g	I-T017
##4	I-T017
and	O
the	O
triple	O
mutant	B-T017
∆	B-T017
##ls	I-T017
##k	I-T017
##u	I-T017
##70	I-T017
##∆	I-T017
##ls	I-T017
##k	I-T017
##u	I-T017
##80	I-T017
##∆	I-T017
##ls	I-T017
##li	I-T017
##g	I-T017
##4	I-T017
were	O
also	O
markedly	O
enhanced	O
.	O
therefore	O
,	O
the	O
l	B-T204
.	I-T204
star	I-T204
##key	I-T204
##i	I-T204
∆	B-T017
##ls	I-T017
##li	I-T017
##g	I-T017
##4	I-T017
background	O
strains	O
have	O
promise	O
as	O
efficient	O
recipient	O
strains	O
for	O
genetic	B-T062
and	O
metabolic	B-T062
engineering	I-T062
approaches	O
in	O
this	O
yeast	B-T204
.	O

ur	B-T038
##ach	I-T038
##al	I-T038
carcinoma	I-T038
:	O
report	B-T170
of	O
two	O
cases	O
and	O
review	O
of	O
the	O
literature	B-T170
ur	B-T038
##ach	I-T038
##al	I-T038
carcinoma	I-T038
is	O
a	O
rare	O
tumor	B-T038
that	O
most	O
commonly	O
occurs	O
in	O
ovaries	B-T017
and	O
less	O
often	O
in	O
the	O
adnexal	B-T017
region	B-T082
and	O
urinary	B-T022
system	I-T022
.	O
we	O
herein	O
present	O
two	O
cases	O
of	O
ur	B-T038
##ach	I-T038
##al	I-T038
carcinoma	I-T038
:	O
one	O
case	O
was	O
a	O
32	O
-	O
year	O
-	O
old	O
male	B-T098
patient	O
who	O
presented	O
with	O
painless	B-T033
hematuria	I-T033
with	O
blood	B-T038
clot	I-T038
##s	I-T038
for	O
1	O
month	O
,	O
whereas	O
the	O
other	O
case	O
was	O
a	O
50	O
-	O
year	O
-	O
old	O
woman	B-T098
who	O
presented	O
with	O
gross	B-T033
hematuria	I-T033
with	O
mild	O
dys	B-T033
##uria	I-T033
,	O
urgency	B-T038
and	I-T038
frequent	I-T038
ur	I-T038
##ination	I-T038
for	O
1	O
year	O
.	O
following	O
surgical	B-T058
resection	I-T058
,	O
the	O
two	O
patients	O
were	O
diagnosed	B-T033
with	O
ur	B-T038
##ach	I-T038
##al	I-T038
adenocarcinoma	I-T038
(	O
mixed	O
type	O
)	O
and	O
ur	B-T038
##ach	I-T038
##al	I-T038
mucinous	I-T038
adenocarcinoma	I-T038
,	O
respectively	O
,	O
based	O
on	O
the	O
histopathological	O
examination	B-T058
.	O
a	O
review	O
of	O
previously	O
published	O
cases	O
and	O
relevant	O
literature	B-T170
is	O
also	O
presented	O
.	O
the	O
aim	O
of	O
the	O
present	B-T033
study	B-T062
was	O
to	O
help	O
understand	B-T038
this	O
disease	B-T038
better	O
,	O
in	O
order	O
to	O
reduce	O
the	O
rate	O
of	O
clinical	O
and	O
pathological	O
misdiagnosis	B-T033
.	O

a	O
method	O
of	O
providing	O
engaging	O
format	O
##ive	O
feedback	O
to	O
large	O
cohort	B-T098
first	O
-	O
year	O
physiology	B-T091
and	O
anatomy	B-T091
students	B-T098
a	O
growing	O
body	O
of	O
evidence	O
demonstrates	O
a	O
critical	O
role	O
for	O
effective	O
,	O
meaningful	O
feedback	B-T038
to	O
enhance	O
student	B-T098
learning	B-T038
.	O
effective	O
feedback	B-T038
can	O
become	O
part	B-T082
of	I-T082
the	O
learning	B-T038
cycle	O
that	O
is	O
not	O
only	O
a	O
learning	B-T038
opportunity	O
for	O
the	O
student	B-T098
but	O
can	O
also	O
be	O
used	O
to	O
inform	O
the	O
teacher	B-T097
and	O
ongoing	O
curriculum	O
development	O
.	O
feedback	B-T038
is	O
considered	O
particularly	O
important	O
during	O
the	O
first	O
year	O
of	O
university	B-T092
and	O
can	O
even	O
be	O
viewed	O
as	O
a	O
retention	O
strategy	O
that	O
can	O
help	O
attenuate	O
student	B-T098
performance	B-T038
anxi	I-T038
##eties	I-T038
and	O
solid	O
##ify	O
perceptions	B-T038
of	O
academic	O
support	O
.	O
unfortunately	O
,	O
the	O
provision	O
of	O
individualized	O
,	O
timely	O
feedback	B-T038
can	O
be	O
particularly	O
challenging	O
in	O
first	O
-	O
year	O
courses	O
as	O
they	O
tend	O
to	O
be	O
large	O
and	O
diverse	O
cohort	B-T098
classes	B-T170
that	O
pose	O
challenges	O
of	O
time	O
and	O
logistic	O
##s	O
.	O
various	O
forms	O
of	O
generic	O
feedback	B-T038
can	O
provide	O
rapid	O
and	O
cost	O
-	O
effect	O
feedback	B-T038
to	O
large	O
cohorts	B-T098
but	O
may	O
be	O
of	O
limited	O
benefit	O
to	O
students	B-T098
other	O
than	O
signaling	O
weaknesses	B-T033
in	O
knowledge	B-T170
.	O
the	O
present	B-T033
study	B-T062
describes	O
a	O
method	O
that	O
was	O
used	O
to	O
provide	O
format	O
##ive	O
task	O
-	O
related	O
feedback	O
to	O
a	O
large	O
cohort	B-T098
of	O
first	O
-	O
year	O
physiology	B-T091
and	O
anatomy	B-T091
students	B-T098
.	O
based	O
on	O
student	B-T098
evaluations	B-T058
presented	O
in	O
this	O
study	B-T062
,	O
this	O
method	O
provided	O
feedback	B-T038
in	O
a	O
manner	O
that	O
engaged	O
students	B-T098
,	O
uncovered	O
underlying	B-T033
misc	I-T033
##onception	I-T033
##s	I-T033
,	O
facilitated	O
peer	B-T098
discussion	O
,	O
and	O
provided	O
opportunity	O
for	O
new	O
instruction	O
while	O
allowing	O
the	O
lecture	O
##r	O
to	O
recognize	B-T038
common	O
gaps	B-T082
in	O
knowledge	B-T170
and	O
inform	O
ongoing	O
curriculum	O
development	O
.	O

gut	O
microbiota	O
after	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
gastric	I-T058
bypass	I-T058
and	O
sleeve	B-T058
gastrectomy	I-T058
in	O
a	O
diabetic	B-T038
rat	B-T204
model	B-T038
:	O
increased	O
diversity	O
and	O
associations	O
of	O
discriminant	O
genera	B-T170
with	O
metabolic	B-T038
changes	O
recent	O
work	O
with	O
gut	O
microbiota	O
after	O
bariatric	B-T058
surgery	I-T058
is	O
limited	O
,	O
and	O
the	O
results	O
have	O
not	O
been	O
in	O
agreement	O
.	O
given	O
the	O
role	O
of	O
the	O
gut	O
microbiota	O
in	O
regulating	O
host	O
metabolism	B-T038
,	O
we	O
explored	O
the	O
effect	O
of	O
roux	B-T058
-	I-T058
en	I-T058
-	I-T058
y	I-T058
gastric	I-T058
bypass	I-T058
(	O
ry	B-T058
##g	I-T058
##b	I-T058
)	O
and	O
sleeve	B-T058
gastrectomy	I-T058
(	O
sg	B-T058
)	O
on	O
the	O
modifications	O
of	O
gut	O
microbiota	O
with	O
regard	O
to	O
the	O
potential	O
influence	O
of	O
food	B-T168
intake	O
and	O
/	O
or	O
weight	O
loss	O
and	O
examined	O
their	O
links	O
with	O
host	O
metabolism	B-T038
.	O
z	O
##ucker	O
diabetic	B-T038
fatty	B-T204
rats	I-T204
were	O
divided	O
into	O
the	O
following	O
groups	O
:	O
ry	B-T058
##g	I-T058
##b	I-T058
;	O
sham	B-T058
-	I-T058
operated	I-T058
with	O
pair	O
-	O
fed	O
as	O
ry	B-T058
##g	I-T058
##b	I-T058
;	O
sham	B-T058
-	I-T058
operated	I-T058
fed	O
ad	O
libitum	O
;	O
and	O
sg	B-T058
.	O
the	O
metabolic	O
effects	O
and	O
gut	O
microbiota	O
profile	O
were	O
analyzed	B-T062
10	O
weeks	O
postoperatively	O
.	O
associations	O
between	O
discriminating	O
genera	B-T170
and	O
metabolic	B-T103
markers	I-T103
after	O
ry	B-T058
##g	I-T058
##b	I-T058
were	O
explored	O
.	O
the	O
2	O
procedures	B-T058
induced	O
similar	O
glucose	B-T103
improvement	O
and	O
increased	O
flora	O
diversity	O
after	O
10	O
weeks	O
compared	O
with	O
sham	B-T058
-	I-T058
operated	I-T058
groups	O
.	O
ry	B-T058
##g	I-T058
##b	I-T058
induced	O
a	O
marked	O
higher	O
relative	O
abundance	O
of	O
proteobacteria	B-T007
/	O
gamma	B-T007
##pro	I-T007
##te	I-T007
##obacteria	I-T007
and	O
beta	B-T007
##pro	I-T007
##te	I-T007
##obacteria	I-T007
and	O
increased	O
emergence	O
of	O
fus	B-T007
##obacteria	I-T007
and	O
clostridium	B-T007
,	O
whereas	O
sg	B-T058
resulted	O
in	O
more	O
abundant	O
actin	B-T007
##obacteria	I-T007
compared	O
with	O
other	O
groups	O
.	O
most	O
of	O
the	O
12	O
discriminant	O
genera	B-T170
correlated	O
with	O
changes	O
in	O
metabolic	B-T038
phenotype	O
,	O
but	O
only	O
28	O
.	O
6	O
%	O
of	O
these	O
correlations	O
were	O
independent	O
of	O
weight	O
,	O
and	O
4	O
discriminant	O
genera	B-T170
still	O
negatively	O
correlated	O
with	O
serum	B-T033
insulin	I-T033
level	I-T033
independent	O
of	O
food	B-T168
intake	O
and	O
weight	O
loss	O
after	O
ry	B-T058
##g	I-T058
##b	I-T058
.	O
these	O
data	O
demonstrate	O
that	O
ry	B-T058
##g	I-T058
##b	I-T058
and	O
sg	B-T058
surgery	O
produced	O
similar	O
diversity	O
but	O
different	O
microbiota	O
compositions	O
changes	O
in	O
z	O
##ucker	O
diabetic	B-T038
fatty	B-T204
rats	I-T204
.	O
these	O
findings	O
stimulate	O
deeper	O
exploration	O
##s	O
of	O
functions	B-T038
of	O
the	O
discriminate	O
microbiota	O
and	O
the	O
mechanisms	O
linking	O
postsurgical	O
modulation	B-T082
of	O
gut	O
microbiota	O
and	O
improvements	O
in	O
insulin	B-T038
resistance	I-T038
.	O

remitting	B-T038
seronegative	I-T038
symmetrical	I-T038
synovitis	I-T038
with	I-T038
pit	I-T038
##ting	I-T038
edema	I-T038
:	O
appearance	O
on	O
fdg	O
pet	O
/	O
ct	O
remitting	B-T038
seronegative	I-T038
symmetrical	I-T038
synovitis	I-T038
with	I-T038
pit	I-T038
##ting	I-T038
edema	I-T038
(	O
rs	B-T038
##3	I-T038
##pe	I-T038
)	O
is	O
a	O
rare	B-T038
condition	I-T038
in	O
the	O
elderly	B-T098
and	O
can	O
appear	O
as	O
a	O
first	O
presentation	O
of	O
various	O
types	O
of	O
rheumatic	B-T038
and	O
malignant	B-T038
diseases	I-T038
.	O
we	O
presented	O
a	O
62	O
-	O
year	O
-	O
old	O
man	B-T098
with	O
the	O
diagnosis	B-T033
of	O
rs	B-T038
##3	I-T038
##pe	I-T038
based	O
on	O
the	O
clinical	B-T033
sign	I-T033
and	O
laboratory	O
data	O
.	O
because	O
of	O
the	O
possibility	O
of	O
associated	O
malignancies	B-T038
in	O
rs	B-T038
##3	I-T038
##pe	I-T038
,	O
fdg	O
pet	O
/	O
ct	O
was	O
performed	O
to	O
exclude	O
occult	B-T038
tumors	I-T038
.	O
the	O
images	B-T170
showed	O
multiple	O
,	O
symmetrical	B-T033
##ly	I-T033
,	O
diffusely	B-T082
increased	O
f	B-T103
-	I-T103
fdg	I-T103
uptake	B-T038
in	O
the	O
soft	B-T017
tissue	I-T017
around	O
joints	B-T082
and	O
bones	B-T017
in	O
the	O
shoulders	B-T082
,	O
hips	B-T017
,	O
knees	B-T017
,	O
and	O
ankle	B-T082
##s	I-T082
.	O

dataset	B-T170
of	O
the	O
molecular	O
dynamics	O
simulations	O
of	O
bilayers	O
consisting	O
of	O
short	O
amyloid	B-T103
##ogenic	I-T103
peptide	I-T103
vd	B-T082
##s	I-T082
##w	I-T082
##nv	I-T082
##lv	I-T082
##ag	I-T082
from	O
bg	B-T103
##l2	I-T103
##p	I-T103
-	I-T103
glucan	I-T103
##transferase	I-T103
of	O
s	B-T204
.	I-T204
cerevisiae	I-T204
cell	B-T017
wall	I-T017
the	O
amyloid	B-T103
##ogenic	I-T103
peptide	I-T103
vd	B-T082
##s	I-T082
##w	I-T082
##nv	I-T082
##lv	I-T082
##ag	I-T082
from	O
bg	B-T103
##l2	I-T103
##p	I-T103
-	I-T103
glucan	I-T103
##transferase	I-T103
of	O
saccharomyces	B-T204
cerevisiae	I-T204
cell	B-T017
wall	I-T017
and	O
its	O
modifying	O
analog	B-T103
ves	B-T082
##w	I-T082
##nv	I-T082
##lv	I-T082
##ag	I-T082
were	O
taken	O
for	O
the	O
construction	O
of	O
four	O
types	O
of	O
bilayers	O
which	O
differ	O
by	O
orientation	B-T082
of	O
the	O
peptides	B-T103
in	O
the	O
layers	O
and	O
of	O
the	O
layers	O
relative	O
to	O
each	O
other	O
.	O
these	O
bilayers	O
were	O
used	O
as	O
starting	O
models	B-T170
for	O
the	O
molecular	B-T038
dynamics	I-T038
(	O
md	B-T038
)	O
at	O
three	O
charge	O
states	O
(	O
neutral	O
,	O
ph	O
##3	O
,	O
and	O
ph	O
##5	O
)	O
.	O
the	O
changes	O
of	O
the	O
fraction	O
of	O
secondary	B-T082
structure	I-T082
during	O
1	O
ns	O
simulations	B-T062
were	O
received	O
for	O
96	O
md	O
trajectories	O
.	O
the	O
data	O
article	B-T170
contains	O
the	O
necessary	O
information	O
for	O
the	O
construction	O
of	O
models	B-T170
of	O
β	B-T082
-	I-T082
strands	I-T082
organization	O
in	O
the	O
oligomer	O
structure	B-T082
.	O
these	O
results	O
were	O
used	O
in	O
the	O
associated	O
research	B-T170
article	I-T170
[UNK]	O
structural	O
model	O
of	O
amyloid	B-T103
fibrils	I-T103
for	O
amyloid	B-T103
##ogenic	I-T103
peptide	I-T103
from	O
bg	B-T103
##l2	I-T103
##p	I-T103
-	I-T103
glucan	I-T103
##transferase	I-T103
of	O
s	B-T204
.	I-T204
cerevisiae	I-T204
cell	B-T017
wall	I-T017
and	O
its	O
modifying	O
analog	B-T103
.	O
new	O
morphology	O
of	O
amyloid	B-T103
fibrils	I-T103
[UNK]	O
(	O
sel	O
##iva	O
##no	O
##va	O
et	O
al	O
.	O
,	O
2016	O
)	O
[	O
1	O
]	O
.	O

generation	O
of	O
high	O
-	O
quality	O
sw	B-T170
##ath	I-T170
(	I-T170
®	I-T170
)	I-T170
acquisition	O
data	O
for	O
label	B-T033
-	I-T033
free	I-T033
quantitative	O
proteomics	B-T091
studies	I-T091
using	O
triplet	B-T074
##of	I-T074
(	I-T074
®	I-T074
)	I-T074
mass	I-T074
spectrometer	I-T074
##s	I-T074
data	O
-	O
independent	O
acquisition	O
is	O
a	O
powerful	O
mass	B-T058
spectrometry	I-T058
technique	I-T058
that	O
enables	O
comprehensive	O
ms	B-T058
and	O
ms	B-T062
/	I-T062
ms	I-T062
analysis	B-T062
of	O
all	O
detectable	B-T201
species	O
,	O
providing	O
an	O
information	O
rich	O
data	O
file	O
that	O
can	O
be	O
mine	O
##d	O
deeply	O
.	O
here	O
,	O
we	O
describe	O
how	O
to	O
acquire	O
high	O
-	O
quality	O
sw	B-T170
##ath	I-T170
(	I-T170
®	I-T170
)	I-T170
acquisition	O
data	O
to	O
be	O
used	O
for	O
large	O
quantitative	O
proteomic	B-T091
studies	I-T091
.	O
we	O
specifically	O
focus	O
on	O
using	O
variable	O
sized	B-T082
q	B-T170
##1	I-T170
windows	I-T170
for	O
acquisition	O
of	O
ms	B-T062
/	I-T062
ms	I-T062
data	O
for	O
generating	O
higher	O
specificity	O
quantitative	O
data	O
.	O

self	B-T062
-	I-T062
reported	I-T062
occupational	B-T037
injuries	I-T037
among	O
industrial	O
beef	B-T204
slaughter	O
##house	O
workers	B-T098
in	O
the	O
midw	B-T082
##estern	I-T082
united	I-T082
states	I-T082
although	O
workers	B-T098
in	O
meat	B-T092
##pa	I-T092
##ck	I-T092
##ing	I-T092
facilities	I-T092
in	O
the	O
united	B-T082
states	I-T082
experience	O
high	O
rates	O
of	O
occupational	B-T037
injury	I-T037
,	O
their	O
injury	B-T037
experiences	O
have	O
received	O
limited	O
research	B-T062
attention	O
.	O
prior	O
research	B-T062
indicates	I-T062
under	B-T058
##rep	I-T058
##orting	I-T058
in	O
injury	O
rates	O
in	O
this	O
industry	O
as	O
well	O
significant	O
variation	O
in	O
injury	O
rates	O
among	O
facilities	O
.	O
to	O
add	O
detail	O
to	O
the	O
rates	O
and	O
circumstances	O
surrounding	O
occupational	B-T037
injury	I-T037
among	O
meat	B-T092
##pa	I-T092
##ck	I-T092
##ing	I-T092
workers	B-T098
,	O
we	O
conducted	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
of	O
workers	B-T098
employed	O
at	O
an	O
industrial	B-T092
beef	I-T092
##pa	I-T092
##ck	I-T092
##ing	I-T092
plant	I-T092
in	O
neb	B-T082
##ra	I-T082
##sk	I-T082
##a	I-T082
,	O
united	B-T082
states	I-T082
(	O
n	O
=	O
137	O
)	O
and	O
interviewed	O
workers	B-T098
about	O
recent	O
injury	B-T037
experiences	O
.	O
we	O
assessed	O
frequency	O
,	O
cause	O
and	O
nature	O
of	O
self	B-T062
-	I-T062
reported	I-T062
injury	B-T037
.	O
we	O
estimated	O
annual	O
incidence	O
rates	O
of	O
self	B-T062
-	I-T062
reported	I-T062
injuries	B-T037
using	O
the	O
os	B-T092
##ha	I-T092
formula	B-T170
and	O
compared	O
these	O
rates	O
to	O
industry	O
-	O
wide	O
data	O
.	O
we	O
also	O
evaluated	O
psychological	O
distress	O
in	O
this	O
workforce	O
as	O
measured	O
by	O
the	O
ke	O
##ss	O
##ler	O
-	O
6	O
scale	O
to	O
assess	O
whether	O
distress	B-T033
was	O
associated	O
with	O
recent	O
occupational	B-T037
injury	B-T037
.	O
in	O
this	O
study	O
,	O
15	O
.	O
1	O
%	O
of	O
workers	B-T098
experienced	O
occupational	B-T037
injuries	I-T037
that	O
required	O
time	O
off	O
work	O
,	O
job	O
transfer	O
,	O
or	O
restriction	O
during	O
the	O
past	O
three	O
months	O
.	O
the	O
estimated	O
annual	O
incidence	O
rate	O
was	O
15	O
.	O
2	O
injuries	B-T037
per	O
100	O
full	O
-	O
time	O
workers	B-T098
for	O
these	O
injuries	B-T037
at	O
this	O
plant	O
.	O
ru	O
##sh	O
##ing	O
was	O
identified	O
as	O
the	O
cause	O
of	O
nearly	O
50	O
%	O
of	O
injuries	B-T037
,	O
and	O
repetitive	O
work	O
as	O
the	O
cause	O
of	O
an	O
additional	O
20	O
%	O
of	O
injuries	B-T037
.	O
use	O
of	O
metal	B-T074
mesh	I-T074
sleeve	B-T074
##s	I-T074
(	O
por	O
:	O
0	O
.	O
10	O
(	O
p	O
=	O
0	O
.	O
008	O
)	O
)	O
and	O
metal	B-T074
mesh	I-T074
gloves	O
(	O
por	O
:	O
0	O
.	O
41	O
(	O
p	O
=	O
0	O
.	O
05	O
)	O
were	O
associated	O
with	O
reduced	O
risk	O
of	O
injury	B-T037
.	O
use	O
of	O
a	O
carbon	B-T103
steel	B-T103
for	O
knife	O
sharp	O
##ening	O
(	O
por	O
:	O
5	O
.	O
2	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
)	O
was	O
associated	O
with	O
elevated	O
risk	O
of	O
moderate	O
and	O
severe	O
injury	B-T037
.	O
there	O
were	O
no	O
associations	O
between	O
self	B-T062
-	I-T062
reported	I-T062
occupational	B-T037
injury	I-T037
and	O
overall	O
measures	O
of	O
psychological	O
distress	O
.	O
self	B-T062
-	I-T062
reported	I-T062
incidence	O
rate	O
of	O
severe	O
injury	B-T037
in	O
this	O
plant	O
was	O
more	O
than	O
twice	O
official	O
industry	O
estimates	O
.	O
worker	O
self	B-T062
-	I-T062
reports	I-T062
may	O
illustrate	O
key	O
areas	O
for	O
injury	B-T058
prevention	I-T058
.	O

biom	O
##agnetic	O
monitoring	O
of	O
atmospheric	O
pollution	O
:	O
a	O
review	O
of	O
magnetic	O
signatures	O
from	O
biological	O
sensors	O
biom	O
##agnetic	O
monitoring	O
of	O
atmospheric	O
pollution	O
is	O
a	O
growing	O
application	O
in	O
the	O
field	O
of	O
environmental	B-T082
magnet	O
##ism	O
.	O
particulate	O
matter	O
(	O
pm	O
)	O
in	O
atmospheric	O
pollution	O
contains	O
readily	O
-	O
measurable	O
concentrations	O
of	O
magnetic	B-T103
minerals	I-T103
.	O
biological	O
surfaces	B-T082
,	O
exposed	O
to	O
atmospheric	O
pollution	O
,	O
accumulate	O
magnetic	O
particles	B-T103
over	O
time	O
,	O
providing	O
a	O
record	O
of	O
location	B-T082
-	O
specific	O
,	O
time	B-T033
-	I-T033
integrated	I-T033
air	O
quality	O
information	O
.	O
this	O
review	B-T170
summarizes	O
current	O
knowledge	O
of	O
biological	O
material	O
(	O
'	O
sensors	O
'	O
)	O
used	O
for	O
biom	O
##agnetic	O
monitoring	O
purposes	O
.	O
our	O
work	O
addresses	O
:	O
the	O
range	O
of	O
magnetic	O
properties	O
reported	O
for	O
lichen	B-T204
##s	I-T204
,	O
moss	B-T204
##es	I-T204
,	O
leaves	B-T204
,	O
bark	B-T204
,	O
trunk	B-T204
wood	I-T204
,	O
insects	B-T204
,	O
crustace	B-T204
##ans	I-T204
,	O
mammal	B-T204
and	O
human	B-T017
tissues	I-T017
;	O
their	O
associations	O
with	O
atmospheric	B-T103
pollutant	I-T103
species	I-T103
(	O
pm	O
,	O
nox	B-T103
,	O
trace	B-T103
elements	I-T103
,	O
pahs	B-T103
)	O
;	O
the	O
pros	B-T033
and	I-T033
cons	I-T033
of	O
biom	O
##agnetic	O
monitoring	O
of	O
atmospheric	O
pollution	O
;	O
current	O
challenges	O
for	O
large	O
-	O
scale	O
implementation	O
of	O
biom	O
##agnetic	O
monitoring	O
;	O
and	O
future	O
perspectives	O
.	O
a	O
summary	O
table	O
is	O
presented	O
,	O
with	O
the	O
aim	O
of	O
aid	O
##ing	O
researchers	B-T097
and	O
policy	B-T097
makers	I-T097
in	O
selecting	O
the	O
most	O
suitable	O
biological	O
sensor	O
for	O
their	O
intended	O
biom	O
##agnetic	O
monitoring	O
purpose	O
.	O

neutrophil	B-T103
gelatinase	I-T103
-	I-T103
associated	I-T103
lipo	I-T103
##cal	I-T103
##in	I-T103
in	O
a	O
trip	O
##ha	O
##si	O
##c	O
rat	B-T204
model	I-T204
of	O
adenine	B-T103
-	O
induced	O
kidney	B-T037
injury	I-T037
the	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
whether	O
ng	B-T103
##al	I-T103
,	O
given	O
its	O
advantages	O
over	O
traditional	O
biomarkers	B-T201
,	O
can	O
be	O
used	O
to	O
describe	O
the	O
dynamic	O
characteristics	O
of	O
the	O
renal	B-T038
tubul	I-T038
##oint	I-T038
##ers	I-T038
##tit	I-T038
##ial	I-T038
insult	I-T038
caused	O
by	O
adenine	B-T103
.	O
subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
ng	B-T103
##al	I-T103
as	O
a	O
biomarker	B-T201
of	O
any	O
acute	B-T037
kidney	I-T037
injury	I-T037
,	O
on	O
top	O
of	O
chronic	B-T038
interstitial	I-T038
disease	I-T038
,	O
if	O
ng	B-T103
##al	I-T103
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	B-T204
model	I-T204
.	O
study	B-T098
group	I-T098
rats	B-T204
were	O
fed	O
an	O
adenine	B-T103
diet	B-T168
,	O
and	O
control	O
group	O
rats	B-T204
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O
blood	B-T031
and	O
urine	B-T031
samples	I-T031
for	O
urea	B-T103
,	O
creatinine	B-T103
and	O
ng	B-T103
##al	I-T103
were	O
drawn	O
from	O
each	O
rat	B-T204
at	O
the	O
beginning	O
of	O
the	O
study	B-T062
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O
kidney	B-T017
slices	O
from	O
these	O
rats	B-T204
were	O
stained	B-T058
with	O
hematoxylin	B-T058
-	I-T058
eosin	I-T058
(	O
he	B-T058
)	O
and	O
β	B-T103
-	I-T103
actin	I-T103
staining	B-T058
##s	I-T058
.	O
serum	B-T033
urea	I-T033
,	O
creatinine	B-T058
and	O
ng	B-T103
##al	I-T103
levels	O
and	O
urinary	O
ng	O
##al	O
/	O
creatinine	O
ratio	O
in	O
the	O
study	O
group	O
were	O
higher	O
than	O
baseline	O
and	O
than	O
in	O
the	O
control	O
group	O
;	O
these	O
differences	O
were	O
statistically	O
significant	O
in	O
some	O
of	O
the	O
intervals	O
.	O
tubul	B-T038
##oint	I-T038
##ers	I-T038
##tit	I-T038
##ial	I-T038
changes	O
and	O
adenine	B-T103
crystals	O
were	O
evident	O
in	O
the	O
study	O
group	O
rats	B-T204
.	O
in	O
the	O
rats	B-T204
fed	O
adenine	B-T103
,	O
serum	B-T033
urea	I-T033
,	O
creatinine	B-T058
and	O
ng	B-T103
##al	I-T103
levels	O
and	O
urinary	O
ng	O
##al	O
/	O
creatinine	O
ratio	O
followed	O
a	O
trip	B-T033
##ha	I-T033
##si	I-T033
##c	I-T033
pattern	I-T033
of	O
kidney	B-T037
injury	I-T037
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	B-T103
diet	B-T168
,	O
a	O
partial	O
recovery	B-T038
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	B-T038
kidney	I-T038
disease	I-T038
phase	O
after	O
stabilization	O
of	O
renal	B-T038
function	I-T038
.	O
ng	B-T103
##al	I-T103
can	O
serve	O
a	O
biomarker	B-T201
for	O
acute	B-T037
kidney	I-T037
injury	I-T037
and	O
possibly	O
for	O
chronic	B-T038
kidney	I-T038
disease	I-T038
in	O
the	O
tubul	B-T038
##oint	I-T038
##ers	I-T038
##tit	I-T038
##ial	I-T038
rat	B-T204
model	I-T204
.	O

everolimus	B-T103
for	O
treatment	B-T058
of	O
pseudo	B-T038
##my	I-T038
##ogenic	I-T038
hemangi	I-T038
##oe	I-T038
##nd	I-T038
##oth	I-T038
##elioma	I-T038
pseudo	B-T038
##my	I-T038
##ogenic	I-T038
hemangi	I-T038
##oe	I-T038
##nd	I-T038
##oth	I-T038
##elioma	I-T038
(	O
pm	B-T038
##h	I-T038
)	O
is	O
a	O
recently	O
described	O
vascular	B-T038
neoplasm	I-T038
that	O
occurs	O
most	O
commonly	O
in	O
the	O
soft	B-T017
tissue	I-T017
of	O
the	O
distal	O
extremities	O
of	O
young	O
adults	O
.	O
metastatic	O
pm	B-T038
##h	I-T038
can	O
be	O
fatal	O
and	O
there	O
are	O
no	O
effective	O
medications	B-T103
.	O
we	O
describe	O
a	O
case	O
of	O
a	O
15	O
-	O
year	O
-	O
old	O
boy	O
with	O
metastatic	O
pm	B-T038
##h	I-T038
,	O
who	O
responded	B-T201
to	I-T201
treatment	I-T201
with	O
everolimus	B-T103
,	O
a	O
mammalian	B-T103
target	I-T103
of	I-T103
rapamycin	I-T103
inhibitor	I-T103
.	O
immunohistochemistry	B-T058
showed	O
that	O
mammalian	B-T103
target	I-T103
of	I-T103
rapamycin	I-T103
was	O
expressed	B-T038
in	O
pm	B-T038
##h	I-T038
biopsy	B-T017
specimens	I-T017
,	O
which	O
may	O
explain	O
the	O
reduction	O
in	O
pm	B-T038
##h	I-T038
tumor	B-T082
size	I-T082
following	O
treatment	B-T058
.	O

extremely	O
giant	B-T038
liver	I-T038
hemangioma	I-T038
(	O
50	O
cm	O
)	O
with	O
ka	B-T038
##sa	I-T038
##bach	I-T038
-	I-T038
mer	I-T038
##ri	I-T038
##tt	I-T038
syndrome	I-T038
a	O
33	O
-	O
year	O
-	O
old	O
male	O
has	O
been	O
found	B-T033
with	O
a	O
giant	B-T038
liver	I-T038
hemangioma	I-T038
of	O
initial	O
size	B-T082
29	O
cm	O
for	O
5	O
years	O
.	O
he	O
received	O
arterial	B-T058
embolization	I-T058
twice	O
in	O
order	O
to	O
shrink	B-T082
the	O
tumor	B-T038
;	O
however	O
,	O
no	O
effect	O
was	O
obtained	O
.	O
the	O
tumor	B-T038
had	O
rapidly	O
grown	O
to	O
50	O
cm	O
and	O
caused	O
abnormalities	B-T033
in	O
the	O
hematological	B-T022
and	O
coagul	B-T038
##ative	I-T038
systems	O
.	O
preoperative	O
computed	B-T058
tomography	I-T058
revealed	O
that	O
the	O
right	B-T082
hepatic	B-T017
vein	I-T017
,	O
right	B-T082
hepatic	B-T017
artery	I-T017
,	O
and	O
right	B-T082
portal	B-T017
vein	I-T017
were	O
not	O
involved	O
by	O
the	O
hemangioma	B-T038
.	O
resection	B-T058
of	O
the	O
giant	B-T038
liver	I-T038
hemangioma	I-T038
was	O
successfully	O
performed	O
after	O
intraoperative	O
intentional	O
blood	B-T058
##let	I-T058
##ting	I-T058
with	O
concurrent	O
blood	B-T058
salvage	I-T058
.	O
all	O
hematological	B-T022
and	O
coagul	B-T038
##ative	I-T038
abnormalities	B-T033
had	O
returned	O
to	O
normal	O
after	O
the	O
procedure	B-T058
.	O

construction	O
of	O
an	O
acetylcholinesterase	B-T103
sensor	O
based	O
on	O
synthesized	B-T103
paramagnetic	I-T103
nanoparticles	I-T103
,	O
a	O
simple	O
tool	O
for	O
neurotoxic	O
compounds	O
assay	B-T058
magnetic	B-T103
particles	I-T103
(	O
mps	B-T103
)	O
have	O
been	O
widely	O
used	O
in	O
biological	O
applications	O
in	O
recent	O
years	O
as	O
a	O
carrier	O
for	O
various	O
molecules	O
.	O
their	O
big	O
advantage	O
is	O
in	O
repeated	O
use	O
of	O
immobilized	O
molecules	O
including	O
enzymes	B-T103
.	O
acetylcholinesterase	B-T103
(	O
ache	B-T103
)	O
is	O
an	O
enzyme	B-T103
playing	O
crucial	O
role	O
in	O
neurotransmission	B-T038
and	O
the	O
enzyme	B-T103
is	O
targeted	O
by	O
various	O
molecules	O
like	O
alzheimer	B-T038
'	I-T038
s	I-T038
drugs	B-T103
,	O
pesticides	B-T103
and	O
warf	B-T103
##are	I-T103
agents	I-T103
.	O
in	O
this	O
work	O
,	O
an	O
electrochemical	O
biosensor	O
having	O
ache	B-T103
immobilized	B-T103
onto	O
mps	B-T103
and	O
stabilized	B-T033
through	O
glutaraldehyde	B-T103
(	I-T103
ga	I-T103
)	I-T103
molecule	I-T103
was	O
proposed	O
for	O
assay	B-T058
of	O
the	O
neurotoxic	O
compounds	O
.	O
the	O
prepared	O
nanoparticles	O
were	O
modified	O
by	O
pure	B-T103
ache	I-T103
and	O
they	O
were	O
used	O
for	O
the	O
measurement	O
anti	B-T033
-	I-T033
alzheimer	I-T033
'	I-T033
s	I-T033
drug	B-T103
gal	B-T103
##ant	I-T103
##amine	I-T103
and	O
carbam	B-T103
##ate	I-T103
pesticide	I-T103
carb	B-T103
##ofuran	I-T103
with	O
limit	O
of	O
detection	B-T033
1	O
.	O
5	O
µm	O
and	O
20	O
nm	O
,	O
respectively	O
.	O
all	O
measurements	O
were	O
carried	O
out	O
using	O
screen	O
-	O
printed	O
sensor	O
with	O
carbon	B-T103
working	B-T074
,	O
silver	B-T103
reference	O
,	O
and	O
carbon	B-T103
auxiliary	B-T074
electrode	I-T074
.	O
standard	B-T058
ell	I-T058
##man	I-T058
'	I-T058
s	I-T058
assay	I-T058
was	O
used	O
for	O
validation	B-T062
measurement	O
of	O
both	O
inhibitors	B-T103
.	O
part	O
of	O
this	O
work	O
was	O
the	O
elimination	O
of	O
reversible	O
inhibitors	B-T103
represented	O
by	O
gal	B-T103
##ant	I-T103
##amine	I-T103
from	O
the	O
active	O
site	O
of	O
ache	B-T103
.	O
for	O
this	O
purpose	O
,	O
we	O
used	O
a	O
lower	O
ph	O
to	O
get	O
the	O
original	O
activity	O
of	O
ache	B-T103
after	O
inhibition	O
by	O
gal	B-T103
##ant	I-T103
##amine	I-T103
.	O
we	O
also	O
observed	O
dec	O
##arb	O
##amyl	O
##ation	O
of	O
the	O
ache	B-T103
-	O
carb	B-T103
##ofuran	I-T103
adduct	O
.	O
influence	O
of	O
organic	B-T103
solvents	I-T103
to	O
ache	B-T103
as	O
well	O
as	O
repeatability	O
of	O
measurement	O
with	O
mps	B-T103
with	O
ache	B-T103
was	O
also	O
established	O
.	O

progressive	O
subcortical	O
calcifications	B-T038
secondary	O
to	O
venous	B-T038
hypertension	I-T038
in	O
an	O
intracranial	B-T082
dural	B-T017
arteriovenous	I-T017
fistula	I-T017
intracranial	B-T082
dural	B-T017
arteriovenous	I-T017
fistulas	I-T017
(	O
dav	B-T017
##f	I-T017
)	O
are	O
acquired	B-T033
lesions	I-T033
,	O
with	O
the	O
most	O
commonly	O
reported	B-T058
findings	B-T033
on	O
ct	B-T058
haemorrhage	B-T038
or	O
focal	B-T038
oedema	I-T038
.	O
we	O
describe	O
a	O
case	O
of	O
progressive	O
subcortical	O
calcification	B-T038
on	O
ct	B-T058
secondary	O
to	O
venous	B-T038
hypertension	I-T038
from	O
a	O
high	O
grade	O
dav	B-T017
##f	I-T017
.	O

allogeneic	B-T058
stem	I-T058
cell	I-T058
transplantation	I-T058
for	O
adult	O
patients	O
with	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
who	O
had	O
central	B-T033
nervous	I-T033
system	I-T033
involvement	I-T033
:	O
a	O
study	B-T062
from	O
the	O
adult	O
all	B-T038
working	B-T098
group	I-T098
of	O
the	O
japan	B-T082
society	B-T092
for	O
hematopoietic	B-T058
cell	I-T058
transplantation	I-T058
the	O
prognosis	B-T058
for	O
adult	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
(	O
all	B-T038
)	O
patients	O
with	O
central	B-T033
nervous	I-T033
system	I-T033
(	I-T033
cns	I-T033
)	I-T033
involvement	I-T033
(	O
cns	B-T033
+	I-T033
)	O
who	O
received	O
allogeneic	B-T058
hematopoietic	I-T058
stem	I-T058
cell	I-T058
transplantation	I-T058
(	O
allo	B-T058
-	I-T058
sct	I-T058
)	O
remains	O
unclear	O
.	O
we	O
retrospectively	O
compared	O
the	O
outcomes	O
of	O
allo	B-T058
-	I-T058
sct	I-T058
for	O
patients	O
with	O
cns	B-T033
involvement	I-T033
and	O
for	O
patients	O
without	O
cns	B-T033
involvement	I-T033
(	O
cns	B-T033
-	I-T033
)	O
using	O
a	O
database	B-T170
in	O
japan	B-T082
.	O
the	O
eligibility	O
criteria	O
for	O
this	O
study	B-T062
were	O
as	O
follows	O
:	O
diagnosis	B-T062
of	O
all	B-T038
,	O
aged	O
more	O
than	O
16	O
years	O
,	O
allo	B-T058
-	I-T058
sct	I-T058
between	O
2005	O
and	O
2012	O
,	O
and	O
first	O
sct	B-T058
.	O
data	O
for	O
258	O
##2	O
patients	O
including	O
136	O
cns	O
+	O
patients	O
and	O
244	O
##6	O
cns	O
-	O
patients	O
were	O
used	O
for	O
analyses	B-T062
.	O
as	O
compared	O
with	O
cns	O
-	O
patients	O
,	O
cns	O
+	O
patients	O
were	O
younger	O
,	O
had	O
worse	B-T033
disease	B-T038
status	O
at	O
sct	B-T058
and	O
had	O
poorer	O
performance	B-T201
status	I-T201
(	O
ps	B-T201
)	O
at	O
sct	B-T058
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
incidence	O
of	O
relapse	O
was	O
higher	O
in	O
cns	O
+	O
patients	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
,	O
and	O
incidence	O
of	O
cns	B-T022
relapse	O
was	O
also	O
higher	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
the	O
probability	O
of	O
3	O
-	O
year	O
overall	O
survival	O
(	O
os	O
)	O
was	O
better	O
in	O
cns	O
-	O
patients	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
by	O
univariate	O
analysis	O
.	O
however	O
,	O
in	O
patients	O
who	O
received	O
sct	B-T058
in	O
cr	B-T033
,	O
there	O
was	O
no	O
difference	O
in	O
the	O
probability	O
of	O
os	O
between	O
cns	B-T033
+	I-T033
and	O
cns	B-T033
-	I-T033
patients	O
(	O
p	O
=	O
0	O
.	O
38	O
)	O
and	O
cns	B-T033
involvement	I-T033
did	O
not	O
have	O
an	O
unfavorable	O
effect	O
on	O
os	O
by	O
multivariate	O
analysis	O
.	O
cns	O
+	O
patients	O
who	O
achieved	O
cr	B-T033
showed	O
os	O
comparable	O
to	O
that	O
of	O
cns	O
-	O
patients	O
.	O

potential	O
sunitinib	B-T103
-	O
induced	O
coronary	B-T017
artery	I-T017
and	O
aortic	B-T038
dissections	I-T038
small	B-T058
-	I-T058
molecule	I-T058
multi	I-T058
##ta	I-T058
##r	I-T058
##get	I-T058
##ed	I-T058
tyrosine	I-T058
kinase	I-T058
inhibitor	I-T058
(	I-T058
tk	I-T058
##i	I-T058
)	I-T058
therapy	I-T058
is	O
used	O
in	O
different	O
types	O
of	O
cancer	B-T038
.	O
these	O
drugs	B-T103
have	O
been	O
associated	O
with	O
cardiovascular	B-T037
toxicity	I-T037
,	O
including	O
aortic	B-T038
dissection	I-T038
.	O
to	O
our	O
knowledge	B-T170
,	O
this	O
is	O
the	O
first	O
time	O
that	O
a	O
coronary	B-T038
dissection	I-T038
potentially	O
associated	O
with	O
a	O
tk	B-T058
##i	I-T058
treatment	I-T058
has	O
been	O
described	O
.	O

4	B-T103
-	I-T103
an	I-T103
##ilin	I-T103
##o	I-T103
-	I-T103
2	I-T103
-	I-T103
pyridyl	I-T103
##quin	I-T103
##azoline	I-T103
##s	I-T103
and	O
-	O
pyrimidine	B-T103
##s	I-T103
as	O
highly	O
potent	O
and	O
nontoxic	O
inhibitors	B-T103
of	O
breast	B-T103
cancer	I-T103
resistance	I-T103
protein	I-T103
(	O
abc	B-T103
##g2	I-T103
)	O
multidrug	O
resistance	O
(	O
mdr	O
)	O
mediated	O
by	O
atp	B-T103
-	I-T103
binding	I-T103
cassette	I-T103
(	I-T103
abc	I-T103
)	I-T103
transport	I-T103
proteins	I-T103
remains	O
a	O
major	O
problem	O
in	O
the	O
chemotherapeutic	B-T058
treatment	I-T058
of	O
cancer	B-T038
and	O
might	O
be	O
overcome	O
by	O
inhibition	O
of	O
the	O
transporter	B-T103
.	O
because	O
of	O
the	O
lack	O
of	O
understanding	O
,	O
the	O
complex	O
mechanisms	O
involved	O
in	O
the	O
transport	B-T038
process	I-T038
,	O
in	O
particular	O
for	O
breast	B-T103
cancer	I-T103
resistance	I-T103
protein	I-T103
(	O
bcr	B-T103
##p	I-T103
/	O
abc	B-T103
##g2	I-T103
)	O
,	O
there	O
is	O
a	O
persistent	O
need	O
for	O
studies	O
of	O
inhibitors	B-T103
of	O
abc	B-T103
##g2	I-T103
.	O
in	O
this	O
study	O
,	O
we	O
investigated	O
a	O
systematic	O
series	O
of	O
4	B-T103
-	I-T103
substituted	I-T103
-	I-T103
2	I-T103
-	I-T103
pyridyl	I-T103
##quin	I-T103
##azoline	I-T103
##s	I-T103
in	O
terms	O
of	O
their	O
inhibitory	O
potency	O
as	O
well	O
as	O
selectivity	O
toward	O
abc	B-T103
##g2	I-T103
.	O
for	O
comparison	O
,	O
the	O
quin	B-T103
##azoline	I-T103
scaffold	I-T103
was	O
reduced	O
to	O
the	O
significantly	O
smaller	O
4	B-T103
-	I-T103
methylp	I-T103
##yr	I-T103
##imidine	I-T103
basic	O
structure	O
.	O
furthermore	O
,	O
the	O
cytotoxicity	B-T038
and	O
the	O
ability	O
to	O
reverse	O
mdr	O
was	O
tested	O
with	O
the	O
chemotherapeutic	B-T103
agents	I-T103
sn	B-T103
-	I-T103
38	I-T103
and	O
mit	B-T103
##oxan	I-T103
##tron	I-T103
##e	I-T103
(	O
mx	B-T103
)	O
.	O
interaction	O
of	O
the	O
compounds	B-T103
with	O
abc	B-T103
##g2	I-T103
was	O
investigated	O
by	O
a	O
colorimetric	B-T058
atpase	B-T103
assay	B-T058
.	O
enzyme	O
kinetic	O
studies	O
were	O
carried	O
out	O
with	O
hoechst	B-T103
333	I-T103
##42	I-T103
as	O
fluorescent	B-T103
dye	I-T103
and	O
substrate	O
of	O
abc	B-T103
##g2	I-T103
to	O
elucidate	O
the	O
compounds	B-T103
binding	O
modes	O
.	O

surrogate	O
inacc	O
##ura	O
##cy	O
in	O
predicting	O
older	B-T098
adults	I-T098
'	I-T098
desire	O
for	O
life	O
-	O
sustaining	O
interventions	O
in	O
the	O
event	O
of	O
decision	B-T038
##al	I-T038
incap	O
##aci	O
##ty	O
:	O
is	O
it	O
due	O
in	O
part	O
to	O
erroneous	O
quality	B-T058
-	I-T058
of	I-T058
-	I-T058
life	I-T058
assessments	I-T058
?	O
family	O
members	O
are	O
often	O
called	O
upon	O
to	O
make	O
decisions	B-T038
for	O
an	O
incap	O
##aci	O
##ta	O
##ted	O
relative	O
.	O
yet	O
they	O
have	O
difficulty	O
predicting	O
a	O
lov	O
##ed	O
one	O
'	O
s	O
desire	O
to	O
receive	O
treatments	B-T058
in	O
hypothetical	O
situations	O
.	O
we	O
tested	O
the	O
hypothesis	O
that	O
this	O
difficulty	O
could	O
in	O
part	O
be	O
explained	O
by	O
discrep	O
##ant	O
quality	B-T058
-	I-T058
of	I-T058
-	I-T058
life	I-T058
assessments	I-T058
.	O
the	O
data	O
come	O
from	O
235	O
community	O
-	O
dwelling	O
adults	O
aged	O
70	O
years	O
and	O
over	O
who	O
rated	O
their	O
quality	O
of	O
life	O
and	O
desire	O
for	O
specified	O
interventions	B-T058
in	O
four	O
health	O
states	O
(	O
current	O
state	O
,	O
mild	O
to	O
moderate	O
stroke	B-T038
,	O
inc	O
##urable	O
brain	B-T038
cancer	I-T038
,	O
and	O
severe	O
dementia	B-T038
)	O
.	O
all	O
ratings	O
were	O
made	O
on	O
likert	B-T170
-	I-T170
type	I-T170
scales	I-T170
.	O
using	O
identical	O
rating	O
scales	O
,	O
a	O
surrogate	O
chosen	O
by	O
the	O
older	B-T098
adult	I-T098
was	O
asked	O
to	O
predict	O
the	O
latter	O
'	O
s	O
responses	O
.	O
linear	O
mixed	O
models	O
were	O
fitted	O
to	O
determine	O
whether	O
differences	O
in	O
quality	O
-	O
of	O
-	O
life	O
ratings	O
between	O
the	O
older	B-T098
adult	I-T098
and	O
surrogate	O
were	O
associated	O
with	O
surrogate	O
##s	O
'	O
inacc	O
##ura	O
##cy	O
in	O
predicting	O
desire	O
for	O
treatment	B-T058
.	O
the	O
difference	O
in	O
quality	O
-	O
of	O
-	O
life	O
ratings	O
was	O
a	O
significant	O
predictor	O
of	O
prediction	O
inacc	O
##ura	O
##cy	O
for	O
the	O
three	O
hypothetical	O
health	O
states	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
nearly	O
significant	O
for	O
the	O
current	O
health	O
state	O
(	O
p	O
=	O
0	O
.	O
07	O
##7	O
)	O
.	O
all	O
regression	O
coefficients	O
were	O
negative	B-T033
,	O
implying	O
that	O
the	O
more	O
the	O
surrogate	O
overestimated	O
quality	O
of	O
life	O
compared	O
to	O
the	O
older	B-T098
adult	I-T098
,	O
the	O
more	O
he	O
or	O
she	O
overestimated	O
the	O
older	B-T098
adult	I-T098
'	O
s	O
desire	O
to	O
be	O
treated	O
.	O
discrep	O
##ant	O
quality	O
-	O
of	O
-	O
life	O
ratings	O
are	O
associated	O
with	O
surrogate	O
##s	O
'	O
difficulty	O
in	O
predicting	O
desire	O
for	O
life	O
-	O
sustaining	O
interventions	O
in	O
hypothetical	O
situations	O
.	O
this	O
finding	O
underscores	O
the	O
importance	O
of	O
discussing	O
anticipated	O
quality	O
of	O
life	O
in	O
states	O
of	O
cognitive	B-T038
decline	I-T038
,	O
to	O
better	O
prepare	O
family	O
members	O
for	O
making	O
difficult	O
decisions	B-T038
for	O
their	O
lov	O
##ed	O
ones	O
.	O
isr	O
##ct	O
##n	O
##89	O
##99	O
##33	O
##91	O
.	O

del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
induces	O
autophagic	B-T038
cell	I-T038
death	I-T038
in	O
lung	B-T038
cancer	I-T038
via	O
akt	B-T038
/	O
mtor	B-T038
/	O
p70	B-T103
##s	I-T103
##6	I-T103
##k	I-T103
signaling	B-T038
pathway	I-T038
searching	O
for	O
potential	O
anticancer	B-T103
agents	I-T103
from	O
natural	B-T033
sources	I-T033
is	O
an	O
effective	O
strategy	O
for	O
developing	O
novel	O
chemotherapeutic	B-T103
agents	I-T103
.	O
in	O
this	O
study	B-T062
,	O
data	O
supporting	O
the	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
anticancer	B-T033
effects	I-T033
of	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
,	O
a	O
rarely	O
occurring	O
bif	B-T103
##la	I-T103
##vo	I-T103
##noid	I-T103
from	O
sel	B-T204
##agin	I-T204
##ella	I-T204
do	I-T204
##ed	I-T204
##er	I-T204
##le	I-T204
##ini	I-T204
##i	I-T204
,	O
were	O
reported	O
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
exhibited	O
favorable	O
anticancer	B-T033
properties	O
,	O
as	O
shown	O
by	O
the	O
mtt	B-T062
assay	I-T062
and	O
xenograft	B-T038
model	I-T038
of	O
human	B-T204
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
in	O
male	O
balb	B-T204
/	I-T204
c	I-T204
nude	I-T204
mice	I-T204
without	O
observable	O
adverse	B-T038
effect	I-T038
.	O
by	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
with	O
acridine	B-T103
orange	I-T103
and	O
cyto	B-T038
-	I-T038
id	I-T038
##®	I-T038
##aut	I-T038
##ophag	I-T038
##y	I-T038
detection	O
dyes	B-T103
,	O
western	B-T058
blot	I-T058
analysis	B-T062
,	O
and	O
rt	B-T062
-	I-T062
pcr	I-T062
assay	I-T062
,	O
we	O
confirmed	O
that	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
induces	O
autophagic	B-T038
cell	I-T038
death	I-T038
by	O
increasing	O
the	O
ratio	O
of	O
lc3	B-T103
-	I-T103
ii	I-T103
to	O
lc3	B-T103
-	I-T103
i	I-T103
,	O
which	O
are	O
autophagy	B-T103
-	I-T103
related	I-T103
proteins	I-T103
,	O
and	O
promoting	O
the	O
generation	O
of	O
acidic	B-T017
vesicular	I-T017
organelles	I-T017
and	O
auto	B-T017
##lys	I-T017
##osomes	I-T017
in	O
the	O
cytoplasm	B-T017
of	O
human	O
lung	B-T038
cancer	I-T038
a549	B-T017
and	O
pc	B-T017
-	I-T017
9	I-T017
cells	I-T017
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
downregulated	B-T038
the	O
expression	B-T033
of	I-T033
phospho	I-T033
-	I-T033
akt	I-T033
,	O
phospho	B-T103
-	I-T103
mtor	I-T103
,	O
and	O
phospho	B-T103
-	I-T103
p70	I-T103
##s	I-T103
##6	I-T103
##k	I-T103
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
,	O
suggesting	O
that	O
it	O
induced	O
autophagy	B-T038
by	O
inhibiting	O
the	O
akt	B-T038
/	O
mtor	B-T038
/	O
p70	B-T103
##s	I-T103
##6	I-T103
##k	I-T103
pathway	B-T038
in	O
a549	B-T017
and	O
pc	B-T017
-	I-T017
9	I-T017
cells	I-T017
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
is	O
a	O
potential	O
anticancer	B-T103
agent	I-T103
that	O
can	O
induce	O
autophagic	B-T038
cell	I-T038
death	I-T038
in	O
human	B-T204
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
via	O
the	O
akt	B-T038
/	O
mtor	B-T038
/	O
p70	B-T103
##s	I-T103
##6	I-T103
##k	I-T103
signaling	B-T038
pathway	I-T038
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
showed	O
anti	B-T033
-	I-T033
lung	I-T033
cancer	I-T033
effects	I-T033
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
induced	O
autophagic	B-T038
cell	I-T038
death	I-T038
via	O
akt	B-T038
/	O
mtor	B-T038
/	O
p70	B-T103
##s	I-T103
##6	I-T103
##k	I-T103
signaling	B-T038
pathway	I-T038
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
did	O
not	O
show	O
observable	O
side	B-T038
effects	I-T038
in	O
a	O
xenograft	B-T038
mouse	I-T038
model	I-T038
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
may	O
represent	O
a	O
potential	O
therapeutic	O
agent	O
for	O
lung	B-T038
cancer	I-T038
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
showed	O
anti	B-T033
-	I-T033
lung	I-T033
cancer	I-T033
effects	I-T033
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
induced	O
autophagic	B-T038
cell	I-T038
death	I-T038
via	O
akt	B-T038
/	O
mtor	B-T038
/	O
p70	B-T103
##s	I-T103
##6	I-T103
##k	I-T103
signaling	B-T038
pathway	I-T038
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
did	O
not	O
show	O
observable	O
side	B-T038
effects	I-T038
in	O
a	O
xenograft	B-T038
mouse	I-T038
model	I-T038
.	O
del	B-T103
##ica	I-T103
##flav	I-T103
##one	I-T103
may	O
represent	O
a	O
potential	O
therapeutic	O
agent	O
for	O
lung	B-T038
cancer	I-T038
.	O

unbiased	B-T062
estimates	I-T062
of	O
cerebrospinal	B-T031
fluid	I-T031
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
cutoff	O
##s	O
in	O
a	O
large	O
memory	B-T092
clinic	I-T092
population	B-T098
we	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
in	O
cerebrospinal	B-T031
fluid	I-T031
(	O
csf	B-T031
)	O
,	O
a	O
key	O
marker	B-T201
for	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
,	O
with	O
data	O
-	O
driven	O
gaussian	B-T170
mixture	I-T170
modeling	I-T170
in	O
a	O
memory	B-T092
clinic	I-T092
population	B-T098
.	O
we	O
performed	O
a	O
combined	O
cross	B-T062
-	I-T062
sectional	I-T062
and	O
prospective	B-T062
cohort	I-T062
study	I-T062
.	O
we	O
selected	O
246	O
##2	O
subjects	B-T098
with	O
subjective	B-T038
cognitive	I-T038
decline	I-T038
,	O
mild	B-T038
cognitive	I-T038
impairment	I-T038
,	O
ad	B-T038
-	O
type	O
dementia	B-T038
,	O
and	O
dementia	B-T038
other	O
than	O
ad	B-T038
from	O
the	O
ams	O
##terdam	O
dementia	B-T038
cohort	B-T098
.	O
we	O
defined	O
csf	B-T031
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
cutoff	O
##s	O
by	O
data	O
-	O
driven	O
gaussian	B-T170
mixture	I-T170
modeling	I-T170
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	B-T170
based	O
on	O
clinical	B-T058
diagnosis	I-T058
,	O
age	O
,	O
and	O
apolipoprotein	B-T058
e	I-T058
(	I-T058
apoe	I-T058
)	I-T058
genotype	I-T058
.	O
we	O
investigated	O
whether	O
abnormal	B-T033
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
ad	B-T038
-	O
type	O
dementia	B-T038
than	O
abnormal	B-T033
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
defined	O
by	O
a	O
clinical	B-T058
diagnosis	I-T058
-	O
based	O
cutoff	O
using	O
cox	B-T170
proportional	I-T170
hazards	I-T170
regression	I-T170
.	O
in	O
the	O
total	O
group	O
of	O
patients	O
,	O
we	O
found	O
a	O
cutoff	O
for	O
abnormal	B-T033
csf	B-T031
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
of	O
68	O
##0	O
pg	O
/	O
ml	O
(	O
95	O
%	O
ci	O
660	O
-	O
70	O
##5	O
pg	O
/	O
ml	O
)	O
.	O
similar	O
cutoff	O
##s	O
were	O
found	O
within	O
diagnostic	B-T033
and	O
apoe	B-T058
genotype	I-T058
subgroups	B-T170
.	O
the	O
cutoff	O
was	O
higher	O
in	O
elderly	B-T098
subjects	B-T098
than	O
in	O
younger	O
subjects	B-T098
.	O
the	O
data	O
-	O
driven	O
cutoff	O
was	O
higher	O
than	O
our	O
clinical	B-T058
diagnosis	I-T058
-	O
based	O
cutoff	O
and	O
had	O
a	O
better	O
predictive	O
accuracy	O
for	O
progression	O
to	O
ad	B-T038
-	O
type	O
dementia	B-T038
in	O
nond	O
##ement	O
##ed	O
subjects	B-T098
(	O
hr	O
7	O
.	O
6	O
versus	O
5	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
mixture	B-T170
modeling	I-T170
is	O
a	O
robust	O
method	B-T170
to	O
determine	O
cutoff	O
##s	O
for	O
csf	B-T031
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
.	O
it	O
might	O
better	O
capture	O
biological	O
changes	O
that	O
are	O
related	O
to	O
ad	B-T038
than	O
cutoff	O
##s	O
based	O
on	O
clinical	B-T058
diagnosis	I-T058
.	O

minimally	B-T058
invasive	I-T058
treatment	I-T058
of	O
difficult	O
bleeding	B-T038
lesions	B-T033
of	O
the	O
small	B-T017
bowel	I-T017
bleeding	B-T038
lesions	B-T033
of	O
the	O
small	B-T017
bowel	I-T017
are	O
often	O
difficult	O
to	O
identify	O
due	O
to	O
the	O
obscure	O
symptomatology	B-T033
.	O
localizing	B-T082
these	O
lesions	B-T033
requires	O
specific	O
techniques	O
.	O
the	O
double	B-T058
-	I-T058
balloon	I-T058
enter	I-T058
##oscopy	I-T058
(	O
db	B-T058
##e	I-T058
)	O
could	O
be	O
used	O
to	O
precisely	O
localize	B-T082
and	O
mark	O
lesions	B-T033
,	O
so	O
that	O
a	O
minimally	B-T058
invasive	I-T058
surgical	I-T058
treatment	I-T058
could	O
be	O
performed	O
.	O
twenty	O
robot	O
-	O
assisted	O
small	B-T058
bowel	I-T058
procedures	I-T058
are	O
presented	O
using	O
a	O
combination	O
of	O
db	B-T058
##e	I-T058
for	O
localization	B-T082
and	O
robotic	B-T058
resection	I-T058
.	O
there	O
were	O
10	O
jejunal	O
resections	O
and	O
10	O
ileal	O
resections	O
.	O
mean	O
age	O
was	O
58	O
.	O
7	O
years	O
.	O
mean	O
operative	O
time	O
was	O
153	O
.	O
4	O
minutes	O
,	O
mean	O
blood	B-T033
loss	I-T033
of	O
46	O
ml	O
.	O
no	O
conversion	B-T058
-	I-T058
to	I-T058
-	I-T058
open	I-T058
and	O
there	O
were	O
4	O
post	O
-	O
operative	O
complications	B-T038
.	O
the	O
90	O
-	O
day	O
mortality	O
was	O
nil	O
and	O
the	O
median	O
length	O
of	O
stay	O
was	O
4	O
.	O
1	O
days	O
.	O
final	O
pathology	B-T170
was	O
consistent	O
with	O
malignancy	B-T038
in	O
10	O
cases	O
.	O
the	O
combination	O
of	O
double	B-T058
-	I-T058
balloon	I-T058
enter	I-T058
##oscopy	I-T058
and	O
robotic	B-T058
technology	I-T058
allows	O
accurate	O
identification	O
and	O
selective	O
treatment	O
of	O
lesions	B-T033
that	O
could	O
be	O
otherwise	O
difficult	O
to	O
treat	O
in	O
a	O
minimally	B-T058
invasive	I-T058
fashion	I-T058
.	O

bor	B-T017
##a	I-T017
-	O
dependent	O
pl	B-T103
##k1	I-T103
regulation	B-T038
:	O
a	O
new	O
weap	O
##on	O
for	O
cancer	B-T058
therapy	I-T058
?	O
the	O
mitotic	B-T103
kinase	I-T103
pol	I-T103
##o	I-T103
like	I-T103
kinase	I-T103
1	I-T103
(	O
pl	B-T103
##k1	I-T103
)	O
is	O
overexpressed	B-T038
in	O
many	O
cancers	B-T038
and	I-T038
its	I-T038
inhibition	I-T038
slow	B-T038
##s	I-T038
down	I-T038
proliferation	I-T038
and	O
increases	B-T038
apoptosis	I-T038
in	O
cancer	B-T017
cell	I-T017
lines	I-T017
.	O
understanding	O
how	O
pl	B-T038
##k1	I-T038
is	I-T038
activated	I-T038
is	O
therefore	O
crucial	O
for	O
the	O
development	O
of	O
novel	O
pl	B-T103
##k1	I-T103
inhibitors	I-T103
with	O
anticancer	B-T103
properties	I-T103
.	O
we	O
recently	O
identified	O
a	O
conserved	O
regulatory	O
loop	O
leading	O
to	O
pl	B-T038
##k1	I-T038
activation	I-T038
that	O
involves	O
cyclin	B-T103
-	I-T103
dependent	I-T103
kinase	I-T103
1	I-T103
(	O
cdk	B-T103
##1	I-T103
)	O
.	O

fatty	B-T103
acids	I-T103
have	O
different	O
adipogenic	B-T038
differentiation	I-T038
potentials	O
in	O
stromal	B-T017
vascular	I-T017
cells	I-T017
isolated	O
from	O
abdominal	B-T017
fat	I-T017
in	O
laying	B-T038
hens	B-T204
this	O
study	B-T062
was	O
conducted	O
to	O
examine	O
the	O
effects	O
of	O
fatty	B-T103
acids	I-T103
(	O
fa	B-T103
)	O
with	O
/	O
without	O
chicken	O
serum	O
(	O
cs	O
)	O
on	O
the	O
expression	B-T038
of	O
adipogenic	B-T038
transcripts	B-T103
and	O
adipogenesis	B-T038
in	O
chicken	B-T204
stromal	B-T017
vascular	I-T017
cells	I-T017
(	O
sv	B-T017
##c	I-T017
)	O
.	O
in	O
experiment	O
1	O
,	O
sv	B-T017
##c	I-T017
were	O
grown	O
in	O
dme	B-T103
##m	I-T103
containing	O
10	O
%	O
fbs	B-T103
(	O
control	O
)	O
and	O
treated	O
with	O
300	O
µm	O
oleic	B-T103
acid	I-T103
(	O
ol	B-T103
##a	I-T103
)	O
+	O
fbs	B-T103
,	O
linoleic	B-T103
acid	I-T103
(	O
ln	B-T103
##a	I-T103
)	O
+	O
fbs	B-T103
,	O
palmitic	B-T103
acid	I-T103
(	O
pam	B-T103
)	O
+	O
fbs	B-T103
,	O
or	O
stear	B-T103
##ic	I-T103
acid	I-T103
(	O
sta	B-T103
)	O
+	O
fbs	B-T103
for	O
48	O
h	O
.	O
in	O
experiment	O
2	O
,	O
cells	B-T017
were	O
grown	O
in	O
dme	B-T103
##m	I-T103
containing	O
5	O
%	O
cs	O
and	O
treated	O
with	O
300	O
µm	O
ol	B-T103
##a	I-T103
(	O
cs	O
+	O
ol	B-T103
##a	I-T103
)	O
,	O
pam	B-T103
(	O
cs	O
+	O
pam	B-T103
)	O
,	O
sta	B-T103
(	O
cs	O
+	O
sta	B-T103
)	O
or	O
200	O
µm	O
ln	B-T103
##a	I-T103
(	O
cs	O
+	O
ln	B-T103
##a	I-T103
)	O
for	O
48	O
h	O
.	O
adipogenesis	B-T038
was	O
determined	O
using	O
oil	B-T058
red	I-T058
o	I-T058
staining	I-T058
and	O
glycerol	B-T038
-	I-T038
3	I-T038
-	I-T038
phosphate	I-T038
dehydrogenase	I-T038
(	I-T038
gp	I-T038
##dh	I-T038
)	I-T038
activity	I-T038
.	O
the	O
proportion	O
of	O
ol	B-T103
##a	I-T103
,	O
pam	B-T103
,	O
or	O
sta	B-T103
was	O
increased	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
sv	B-T017
##c	I-T017
grown	O
in	O
either	O
fbs	B-T103
or	O
cs	O
with	O
ol	B-T103
##a	I-T103
,	O
pam	B-T103
or	O
sta	B-T103
.	O
adipogenesis	B-T038
was	O
induced	O
in	O
fbs	B-T103
+	O
ol	B-T103
##a	I-T103
,	O
fbs	B-T103
+	O
ln	B-T103
##a	I-T103
,	O
fbs	B-T103
+	O
pam	B-T103
,	O
fbs	B-T103
+	O
sta	B-T103
,	O
cs	O
+	O
ol	B-T103
##a	I-T103
,	O
cs	O
+	O
ln	B-T103
##a	I-T103
,	O
cs	O
+	O
pam	B-T103
,	O
or	O
cs	O
+	O
sta	B-T103
compared	O
to	O
fbs	B-T103
.	O
gp	B-T038
##dh	I-T038
activity	I-T038
was	O
significantly	O
higher	O
in	O
fbs	B-T103
+	O
ol	B-T103
##a	I-T103
and	O
fbs	B-T103
+	O
ln	B-T103
##a	I-T103
than	O
one	O
in	O
fbs	B-T103
.	O
compared	O
to	O
fbs	B-T103
,	O
the	O
expression	B-T038
of	O
fabp	B-T017
##4	I-T017
mrna	B-T103
increased	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
fbs	B-T103
+	O
ol	B-T103
##a	I-T103
,	O
fbs	B-T103
+	O
ln	B-T103
##a	I-T103
,	O
or	O
fbs	B-T103
+	O
pam	B-T103
,	O
whereas	O
that	O
of	O
c	B-T017
/	I-T017
ebp	I-T017
##α	I-T017
,	O
c	B-T017
/	I-T017
ebp	I-T017
##β	I-T017
,	O
and	O
atg	B-T017
##l	I-T017
increased	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
fbs	B-T103
+	O
ol	B-T103
##a	I-T103
or	O
fbs	B-T103
+	O
ln	B-T103
##a	I-T103
cells	B-T017
.	O
expression	B-T038
of	O
fabp	B-T017
##4	I-T017
and	O
c	B-T017
/	I-T017
ebp	I-T017
##β	I-T017
mrna	B-T103
was	O
higher	O
in	O
cs	O
,	O
cs	O
+	O
ol	B-T103
##a	I-T103
,	O
cs	O
+	O
ln	B-T103
##a	I-T103
,	O
cs	O
+	O
pam	B-T103
,	O
or	O
cs	O
+	O
sta	B-T103
compared	O
with	O
(	O
fbs	B-T103
,	O
whereas	O
the	O
expression	B-T038
of	O
atg	B-T017
##l	I-T017
and	O
c	B-T017
/	I-T017
ebp	I-T017
##α	I-T017
was	O
higher	O
in	O
cs	O
,	O
cs	O
+	O
ol	B-T103
##a	I-T103
,	O
or	O
cs	O
+	O
ln	B-T103
##a	I-T103
than	O
fbs	B-T103
cells	B-T017
.	O
in	O
conclusion	O
,	O
these	O
results	B-T033
showed	O
that	O
fa	B-T103
have	O
different	O
potentials	O
to	O
induce	O
adipogenesis	B-T038
,	O
ln	B-T103
##a	I-T103
is	O
the	O
most	O
potent	O
among	O
the	O
tested	O
fa	B-T103
,	O
and	O
these	O
potentials	O
can	O
be	O
improved	O
in	O
the	O
presence	B-T033
of	O
cs	O
.	O

mitochondrial	B-T017
pyruvate	I-T017
dehydrogenase	I-T017
phosphatase	I-T017
1	I-T017
regulates	O
the	O
early	O
differentiation	B-T038
of	I-T038
cardiomyocytes	I-T038
from	O
mouse	B-T017
embryonic	I-T017
stem	I-T017
cells	I-T017
mitochondria	B-T017
are	O
crucial	O
for	O
maintaining	O
the	O
properties	O
of	O
embryonic	B-T017
stem	I-T017
cells	I-T017
(	O
escs	B-T017
)	O
and	O
for	O
regulating	O
their	O
subsequent	O
differentiation	B-T038
into	O
diverse	O
cell	O
lineages	O
,	O
including	O
cardiomyocytes	B-T017
.	O
however	O
,	O
mitochondrial	B-T103
regulators	I-T103
that	O
manage	O
the	O
rate	O
of	O
differentiation	O
or	O
cell	O
fate	O
have	O
been	O
rarely	O
identified	O
.	O
this	O
study	O
aimed	O
to	O
determine	O
the	O
potential	O
mitochondrial	B-T103
factor	I-T103
that	O
controls	O
the	O
differentiation	B-T038
of	I-T038
escs	I-T038
into	O
cardiac	B-T017
myocytes	I-T017
.	O
we	O
induced	O
cardiomyocyte	B-T038
differentiation	I-T038
from	O
mouse	B-T017
escs	I-T017
(	O
mes	B-T017
##cs	I-T017
)	O
and	O
performed	O
microarray	B-T058
assays	I-T058
to	O
assess	O
messenger	B-T103
rna	I-T103
(	O
mrna	B-T103
)	O
expression	B-T038
changes	O
at	O
differentiation	B-T033
day	I-T033
8	I-T033
(	O
d	B-T033
##8	I-T033
)	O
compared	O
with	O
undifferentiated	O
mes	B-T017
##cs	I-T017
(	O
d	O
##0	O
)	O
.	O
among	O
the	O
differentially	O
expressed	B-T017
genes	I-T017
,	O
pd	B-T017
##p1	I-T017
expression	B-T038
was	O
significantly	O
decreased	O
(	O
27	O
-	O
fold	O
)	O
on	O
d	B-T033
##8	I-T033
compared	O
to	O
d	O
##0	O
,	O
which	O
was	O
accompanied	O
by	O
suppressed	O
mitochondrial	B-T017
indices	B-T170
,	O
including	O
atp	B-T103
levels	O
,	O
membrane	B-T038
potential	I-T038
,	O
ros	B-T038
and	O
mitochondrial	B-T038
ca	I-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
.	O
notably	O
,	O
pd	B-T017
##p1	I-T017
overexpression	B-T038
significantly	O
enhanced	O
the	O
mitochondrial	B-T017
indices	B-T170
and	O
pyruvate	B-T038
dehydrogenase	I-T038
activity	I-T038
and	O
reduced	O
the	O
expression	B-T038
of	O
cardiac	B-T038
differentiation	I-T038
marker	O
mrna	O
and	O
the	O
cardiac	B-T038
differentiation	I-T038
rate	O
compared	O
to	O
a	O
mock	O
control	O
.	O
in	O
confirmation	O
of	O
this	O
,	O
a	O
knockdown	B-T062
of	O
the	O
pd	B-T017
##p1	I-T017
gene	I-T017
promoted	O
the	O
expression	B-T038
of	O
cardiac	B-T038
differentiation	I-T038
marker	O
mrna	O
and	O
the	O
cardiac	B-T038
differentiation	I-T038
rate	O
.	O
in	O
conclusion	O
,	O
our	O
results	O
suggest	O
that	O
mitochondrial	B-T017
pd	I-T017
##p1	I-T017
is	O
a	O
potential	O
regulator	O
that	O
controls	O
cardiac	B-T038
differentiation	I-T038
at	O
an	O
early	O
differentiation	O
stage	O
in	O
escs	B-T017
.	O

quantification	O
of	O
intact	O
plasma	B-T031
ag	B-T103
##t	I-T103
consisting	O
of	O
oxidized	O
and	O
reduced	B-T082
conformations	I-T082
using	O
a	O
modified	O
elisa	B-T058
the	O
pleiotropic	O
actions	O
of	O
the	O
renin	B-T022
-	I-T022
angiotensin	I-T022
system	I-T022
(	O
ras	B-T022
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensin	B-T103
##ogen	I-T103
(	O
ag	B-T103
##t	I-T103
)	O
which	O
generates	O
angiotensin	B-T103
i	I-T103
(	O
ang	B-T103
i	I-T103
)	O
when	O
cleaved	B-T082
by	O
renin	B-T103
.	O
thus	O
,	O
quantification	O
of	O
the	O
intact	O
ag	B-T103
##t	I-T103
(	O
ia	B-T103
##gt	I-T103
)	O
concentrations	O
is	O
important	O
to	O
evaluate	O
the	O
actual	O
renin	B-T103
substrate	I-T103
available	O
.	O
the	O
ia	B-T103
##gt	I-T103
conformation	B-T082
exists	O
as	O
oxidized	B-T103
ag	I-T103
##t	I-T103
(	O
ox	B-T103
##i	I-T103
-	I-T103
ag	I-T103
##t	I-T103
)	O
and	O
reduced	B-T103
ag	I-T103
##t	I-T103
(	O
red	B-T103
-	I-T103
ag	I-T103
##t	I-T103
)	O
in	O
a	O
disulfide	B-T082
bond	I-T082
,	O
and	O
ox	B-T103
##i	I-T103
-	I-T103
ag	I-T103
##t	I-T103
has	O
a	O
higher	O
affinity	O
for	O
renin	B-T103
,	O
which	O
may	O
exacerbate	O
ras	B-T022
-	O
associated	B-T038
diseases	I-T038
.	O
accordingly	O
,	O
we	O
determined	O
ia	B-T103
##gt	I-T103
,	O
ox	B-T103
##i	I-T103
-	I-T103
ag	I-T103
##t	I-T103
,	O
and	O
red	B-T103
-	I-T103
ag	I-T103
##t	I-T103
levels	O
in	O
plasma	B-T031
from	O
rats	B-T204
and	O
mice	B-T204
.	O
blood	B-T031
samples	I-T031
were	O
obtained	O
by	O
cardiac	B-T058
puncture	I-T058
and	O
then	O
immediately	O
mixed	O
with	O
an	O
inhibitor	B-T103
solution	O
containing	O
a	O
renin	B-T103
inhibitor	I-T103
.	O
total	O
ag	B-T103
##t	I-T103
(	O
tag	B-T103
##t	I-T103
)	O
levels	O
were	O
measured	O
by	O
tag	B-T103
##t	I-T103
elisa	B-T058
which	O
detects	B-T033
both	O
cleaved	B-T082
and	O
ia	B-T103
##gt	I-T103
.	O
ia	B-T103
##gt	I-T103
levels	O
were	O
determined	O
by	O
ia	B-T103
##gt	I-T103
elisa	B-T058
which	O
was	O
found	O
to	O
only	O
detect	B-T033
red	B-T103
-	I-T103
ag	I-T103
##t	I-T103
.	O
thus	O
,	O
it	O
was	O
necessary	O
to	O
treat	O
samples	B-T031
with	O
dithiothreitol	B-T103
,	O
a	O
reducing	B-T103
agent	I-T103
,	O
to	O
quantify	O
total	O
ia	B-T103
##gt	I-T103
concentration	O
.	O
tag	B-T103
##t	I-T103
levels	O
in	O
rat	B-T204
and	O
mouse	B-T204
plasma	B-T031
were	O
1	O
,	O
83	O
##9	O
±	O
139	O
and	O
1	O
,	O
08	O
##2	O
±	O
77	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O
ia	B-T103
##gt	I-T103
levels	O
were	O
53	O
%	O
of	O
tag	B-T103
##t	I-T103
in	O
rat	B-T204
plasma	B-T031
but	O
only	O
22	O
%	O
in	O
mouse	B-T204
plasma	B-T031
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	B-T031
renin	B-T103
activity	B-T038
in	O
mice	B-T204
.	O
the	O
ratios	O
of	O
ox	B-T103
##i	I-T103
-	I-T103
ag	I-T103
##t	I-T103
and	O
red	B-T103
-	I-T103
ag	I-T103
##t	I-T103
were	O
∼	O
##4	O
:	O
1	O
(	O
rat	B-T204
)	O
and	O
16	O
:	O
1	O
(	O
mouse	B-T204
)	O
.	O
plasma	B-T031
ia	B-T103
##gt	I-T103
consists	O
of	O
ox	B-T103
##i	I-T103
-	I-T103
ag	I-T103
##t	I-T103
and	O
red	B-T103
-	I-T103
ag	I-T103
##t	I-T103
,	O
suggesting	O
that	O
oxidative	B-T038
stress	I-T038
can	O
influence	O
ang	B-T103
i	I-T103
generation	O
by	O
the	O
ag	B-T103
##t	I-T103
conformation	B-T082
switch	O
.	O
furthermore	O
,	O
the	O
lower	O
availability	O
of	O
plasma	B-T031
ia	B-T103
##gt	I-T103
in	O
mice	B-T204
suggests	O
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	O
factor	O
in	O
ang	B-T103
i	I-T103
formation	O
in	O
this	O
species	B-T170
.	O

voice	O
##s	O
:	O
a	O
convers	O
##ation	O
with	O
alle	B-T204
##n	I-T204
j	I-T204
.	I-T204
wilc	I-T204
##ox	I-T204
alle	B-T204
##n	I-T204
jam	I-T204
##es	I-T204
wilc	I-T204
##ox	I-T204
was	O
born	O
on	O
30	O
september	O
194	O
##6	O
in	O
colum	B-T082
##bu	I-T082
##s	I-T082
,	I-T082
oh	I-T082
.	O
he	O
studied	O
medicine	B-T091
at	O
the	O
university	B-T092
of	I-T092
michigan	I-T092
,	O
graduate	O
##d	O
in	O
1973	O
,	O
and	O
after	O
a	O
rotating	O
intern	O
##sh	O
##ip	O
,	O
he	O
completed	O
a	O
master	O
'	O
s	O
degree	O
in	O
maternal	O
and	O
child	O
health	O
(	O
1976	O
)	O
and	O
a	O
ph	B-T170
##d	I-T170
in	O
epidemiology	B-T091
(	O
1979	O
)	O
at	O
the	O
university	B-T092
of	I-T092
north	I-T092
carolina	I-T092
in	O
chap	B-T082
##el	I-T082
hill	I-T082
.	O
after	O
grad	O
##uation	O
,	O
he	O
went	O
to	O
work	O
at	O
the	O
national	B-T092
institute	I-T092
of	I-T092
environmental	I-T092
health	I-T092
sciences	I-T092
(	O
ni	B-T092
##e	I-T092
##hs	I-T092
,	O
one	O
of	O
the	O
us	B-T092
national	I-T092
institutes	I-T092
of	I-T092
health	I-T092
)	O
in	O
dur	B-T082
##ham	I-T082
,	I-T082
nc	I-T082
,	O
where	O
he	O
has	O
spent	O
his	O
career	O
.	O
he	O
developed	O
a	O
research	O
program	O
in	O
reproductive	O
and	O
perinatal	B-T091
epidemiology	I-T091
,	O
a	O
relatively	O
unexplored	O
area	O
at	O
the	O
time	O
.	O
his	O
studies	O
include	O
the	O
early	O
pregnancy	O
study	O
,	O
which	O
documented	B-T058
the	O
extent	O
of	O
subclinical	O
pregnancy	B-T038
loss	I-T038
in	O
humans	B-T204
and	O
established	O
the	O
fertile	O
days	O
of	O
a	O
woman	B-T098
'	I-T098
s	I-T098
menstrual	B-T038
cycle	I-T038
.	O
he	O
served	O
as	O
the	O
chief	B-T097
of	I-T097
the	O
epidemiology	B-T091
branch	B-T097
from	O
1991	O
to	O
2001	O
,	O
and	O
as	O
editor	B-T097
-	I-T097
in	I-T097
-	I-T097
chief	I-T097
of	O
the	O
journal	B-T170
epidemiology	B-T091
from	O
2001	O
to	O
2014	O
.	O
his	O
text	B-T170
##book	I-T170
,	O
fertility	B-T170
and	I-T170
pregnancy	I-T170
-	I-T170
an	I-T170
epidemiologic	I-T170
perspective	I-T170
,	O
was	O
published	O
by	O
oxford	B-T170
university	I-T170
press	I-T170
in	O
2010	O
.	O
he	O
was	O
elect	O
##ed	O
to	O
the	O
american	B-T092
epidemiological	I-T092
society	I-T092
in	O
1989	O
,	O
and	O
served	O
as	O
its	O
pres	O
##ident	O
in	O
2003	O
.	O
he	O
also	O
served	O
as	O
pres	O
##ident	O
of	O
the	O
society	B-T092
of	I-T092
pediatric	I-T092
and	I-T092
perinatal	I-T092
epidemiological	I-T092
research	I-T092
(	O
1996	O
)	O
and	O
the	O
pres	O
##ident	O
of	O
the	O
society	B-T092
of	I-T092
epidemiological	I-T092
research	I-T092
(	O
1998	O
)	O
.	O
he	O
holds	O
adjunct	O
teaching	O
appointments	O
at	O
the	O
university	B-T092
of	I-T092
north	I-T092
carolina	I-T092
,	O
harv	B-T092
##ard	I-T092
university	I-T092
,	O
and	O
the	O
university	B-T092
of	I-T092
berg	I-T092
##en	I-T092
(	O
norway	B-T082
)	O
,	O
which	O
award	O
##ed	O
him	O
an	O
hon	O
##ora	O
##ry	O
doctor	B-T170
##al	I-T170
degree	I-T170
in	O
2008	O
.	O

systematic	O
identification	B-T038
of	O
pharmacological	B-T038
targets	O
from	O
small	B-T103
-	I-T103
molecule	I-T103
phenotypic	B-T058
screens	I-T058
phenotypic	O
drug	B-T062
discovery	I-T062
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	B-T170
,	O
mainly	O
because	O
it	O
allows	O
drug	B-T103
leads	I-T103
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	B-T033
model	O
distinct	O
disease	B-T033
states	I-T033
.	O
however	O
,	O
a	O
potential	O
disadvantage	O
is	O
the	O
difficulty	O
of	O
linking	O
the	O
observed	O
phenotype	O
to	O
a	O
specific	O
cellular	B-T017
target	O
.	O
to	O
address	O
this	O
problem	B-T033
,	O
we	O
developed	O
depic	B-T170
##k	I-T170
,	O
a	O
computational	O
target	O
de	O
-	O
convolution	O
tool	O
to	O
determine	B-T058
targets	O
specifically	O
linked	O
to	O
small	B-T103
-	I-T103
molecule	I-T103
phenotypic	B-T058
screens	I-T058
.	O
we	O
applied	O
depic	B-T170
##k	I-T170
to	O
eight	O
publicly	B-T092
available	O
screens	O
and	O
predicted	O
59	O
drug	B-T103
target	O
-	O
phenotype	O
associations	O
.	O
in	O
addition	O
to	O
literature	B-T170
-	O
based	O
evidence	O
for	O
our	O
predictions	O
,	O
we	O
provide	O
experimental	O
support	O
for	O
seven	O
predicted	O
associations	O
.	O
interestingly	B-T038
,	O
our	O
analysis	B-T062
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	B-T082
between	O
the	O
wnt	B-T038
signaling	I-T038
pathway	I-T038
and	O
an	O
aromatase	B-T103
,	O
cyp	B-T103
##19	I-T103
##a1	I-T103
.	O
these	O
results	O
demonstrate	O
that	O
the	O
depic	B-T170
##k	I-T170
approach	O
can	O
not	O
only	O
accelerate	O
target	O
de	O
-	O
convolution	O
but	O
also	O
aid	O
in	O
discovery	O
of	O
new	O
functionally	O
relevant	O
biological	O
relationships	O
.	O

n	B-T082
-	I-T082
terminal	I-T082
hypothesis	O
for	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
although	O
the	O
amyloid	B-T103
(	O
abeta	B-T103
peptide	I-T103
,	O
aβ	B-T103
)	O
hypothesis	O
is	O
25	O
years	O
old	O
,	O
is	O
the	O
dominant	O
model	B-T170
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
pathogenesis	B-T038
,	O
and	O
guides	O
the	O
development	O
of	O
potential	O
treatments	B-T058
,	O
it	O
is	O
still	O
controversial	O
.	O
one	O
possible	O
reason	O
is	O
a	O
lack	O
of	O
a	O
mechanistic	O
path	O
from	O
the	O
cleavage	O
products	O
of	O
the	O
amyloid	B-T103
precursor	I-T103
protein	I-T103
(	O
app	B-T103
)	O
such	O
as	O
soluble	O
aβ	O
monomer	O
and	O
soluble	O
molecular	O
fragments	O
to	O
the	O
deleterious	O
effects	O
on	O
synaptic	B-T038
form	I-T038
and	O
function	O
.	O
from	O
a	O
review	O
of	O
the	O
recent	O
literature	B-T170
and	O
our	O
own	O
published	B-T170
work	I-T170
including	O
aggregation	O
kinetics	O
and	O
structural	B-T082
morphology	O
,	O
aβ	B-T103
clearance	O
,	O
molecular	O
simulations	B-T062
,	O
long	B-T038
-	I-T038
term	I-T038
potentiation	I-T038
measurements	O
with	O
inhibition	B-T038
binding	I-T038
,	O
and	O
the	O
binding	B-T038
of	O
a	O
commercial	O
monoclonal	B-T103
antibody	I-T103
,	O
ad	B-T103
##uc	I-T103
##anum	I-T103
##ab	I-T103
,	O
we	O
hypothesize	O
that	O
the	O
n	B-T082
-	I-T082
terminal	I-T082
domains	I-T082
of	O
neurotoxic	O
aβ	B-T103
oligomers	I-T103
are	O
implicated	O
in	O
causing	O
the	O
disease	B-T038
.	O

downregulation	B-T038
of	O
endothelial	B-T103
transient	I-T103
receptor	I-T103
potential	I-T103
van	I-T103
##ill	I-T103
##oid	I-T103
type	I-T103
4	I-T103
channel	I-T103
and	O
small	B-T103
-	I-T103
conductance	I-T103
of	I-T103
ca2	I-T103
+	I-T103
-	I-T103
activated	I-T103
k	I-T103
+	I-T103
channels	I-T103
underpin	O
##s	O
impaired	O
endothelium	B-T103
-	I-T103
dependent	I-T103
hyperpolarization	I-T103
in	O
hypertension	B-T038
endothelium	B-T103
-	I-T103
dependent	I-T103
hyperpolarization	I-T103
(	O
ed	B-T103
##h	I-T103
)	O
-	O
mediated	O
responses	B-T033
are	O
impaired	O
in	O
hypertension	B-T038
,	O
but	O
the	O
underlying	O
mechanisms	O
have	O
not	O
yet	O
been	O
determined	O
.	O
the	O
activation	O
of	O
small	B-T103
-	I-T103
and	O
intermediate	B-T103
-	I-T103
conductance	I-T103
of	I-T103
ca	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	I-T103
activated	I-T103
k	I-T103
(	I-T103
+	I-T103
)	I-T103
channels	I-T103
(	O
sk	B-T103
##ca	I-T103
and	O
ik	B-T103
##ca	I-T103
)	O
underpin	O
##s	O
ed	B-T103
##h	I-T103
-	O
mediated	O
responses	B-T033
.	O
it	O
was	O
recently	O
reported	B-T170
that	O
ca	B-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
influx	I-T038
through	O
endothelial	B-T103
transient	I-T103
receptor	I-T103
potential	I-T103
van	I-T103
##ill	I-T103
##oid	I-T103
type	I-T103
4	I-T103
channel	I-T103
(	O
trp	B-T103
##v	I-T103
##4	I-T103
)	O
is	O
a	O
prerequisite	O
for	O
the	O
activation	O
of	O
sk	B-T103
##ca	I-T103
/	O
ik	B-T103
##ca	I-T103
in	O
endothelial	B-T017
cells	I-T017
in	O
specific	O
beds	O
.	O
here	O
,	O
we	O
attempted	O
to	O
determine	O
whether	O
the	O
impairment	O
of	O
ed	B-T103
##h	I-T103
in	O
hypertension	B-T038
is	O
attributable	O
to	O
the	O
dysfunction	O
of	O
trp	B-T103
##v	I-T103
##4	I-T103
and	O
s	B-T103
/	O
ik	B-T103
##ca	I-T103
,	O
using	O
isolated	O
superior	B-T017
mesenteric	I-T017
arteries	I-T017
of	O
20	O
-	O
week	O
-	O
old	O
stroke	B-T204
-	I-T204
prone	I-T204
spontaneously	I-T204
hypertensive	I-T204
rats	I-T204
(	O
shr	B-T204
##sp	I-T204
)	O
and	O
age	O
-	O
matched	O
wistar	B-T204
-	I-T204
kyoto	I-T204
(	I-T204
wky	I-T204
)	I-T204
rats	I-T204
.	O
in	O
the	O
wky	B-T204
arteries	B-T017
,	O
ed	B-T103
##h	I-T103
-	O
mediated	O
responses	B-T033
were	O
reduced	O
by	O
a	O
combination	O
of	O
sk	B-T103
##ca	I-T103
/	O
ik	B-T103
##ca	I-T103
blockers	O
(	O
apa	B-T103
##min	I-T103
plus	O
tram	B-T103
-	I-T103
34	I-T103
;	O
1	B-T103
-	I-T103
[	I-T103
(	I-T103
2	I-T103
-	I-T103
chlorophenyl	I-T103
)	I-T103
diphenyl	I-T103
##meth	I-T103
##l	I-T103
]	I-T103
-	I-T103
1h	I-T103
-	I-T103
pyrazol	I-T103
##e	I-T103
)	O
and	O
by	O
the	O
blockade	O
of	O
trp	B-T103
##v	I-T103
##4	I-T103
with	O
the	O
selective	O
antagonist	B-T103
rn	B-T103
-	I-T103
173	I-T103
##4	I-T103
or	O
hc	B-T103
-	I-T103
06	I-T103
##70	I-T103
##47	I-T103
.	O
in	O
the	O
shr	B-T204
##sp	I-T204
arteries	B-T017
,	O
ed	B-T103
##h	I-T103
-	I-T103
mediated	I-T103
hyperpolarization	I-T103
and	O
relaxation	O
were	O
significantly	O
impaired	O
when	O
compared	O
with	O
wky	B-T204
.	O
gsk	B-T103
##101	I-T103
##67	I-T103
##90	I-T103
##a	I-T103
,	O
a	O
selective	O
trp	B-T103
##v	I-T103
##4	I-T103
activator	B-T103
,	O
evoked	O
robust	O
hyperpolarization	B-T038
and	O
relaxation	O
in	O
wky	B-T204
arteries	B-T017
.	O
in	O
contrast	O
,	O
in	O
shr	B-T204
##sp	I-T204
arteries	B-T017
,	O
the	O
gsk	B-T103
##101	I-T103
##67	I-T103
##90	I-T103
##a	I-T103
-	O
evoked	O
hyperpolarization	B-T038
was	O
small	O
and	O
relaxation	O
was	O
absent	O
.	O
hyperpolarization	B-T038
and	O
relaxation	O
to	O
cyclohex	B-T103
##yl	I-T103
-	I-T103
[	I-T103
2	I-T103
-	I-T103
(	I-T103
3	I-T103
,	I-T103
5	I-T103
-	I-T103
dimethyl	I-T103
-	I-T103
pyrazol	I-T103
-	I-T103
1	I-T103
-	I-T103
yl	I-T103
)	I-T103
-	I-T103
6	I-T103
-	I-T103
methyl	I-T103
-	I-T103
pyrim	I-T103
##idin	I-T103
-	I-T103
4	I-T103
-	I-T103
yl	I-T103
]	I-T103
-	I-T103
amine	I-T103
,	O
a	O
selective	O
sk	B-T103
##ca	I-T103
activator	B-T103
,	O
were	O
marginally	O
decreased	O
in	O
shr	B-T204
##sp	I-T204
arteries	B-T017
compared	O
with	O
wky	B-T204
arteries	B-T017
.	O
the	O
expression	B-T038
of	O
endothelial	B-T103
trp	I-T103
##v	I-T103
##4	I-T103
and	O
sk	B-T103
##ca	I-T103
protein	O
was	O
significantly	O
decreased	O
in	O
the	O
shr	B-T204
##sp	I-T204
mesenteric	B-T017
arteries	I-T017
compared	O
with	O
those	O
of	O
wky	B-T204
,	O
whereas	O
function	O
and	O
expression	B-T038
of	O
ik	B-T103
##ca	I-T103
were	O
preserved	O
in	O
shr	B-T204
##sp	I-T204
arteries	B-T017
.	O
these	O
findings	B-T033
suggest	O
that	O
ed	B-T103
##h	I-T103
-	O
mediated	O
responses	B-T033
are	O
impaired	O
in	O
superior	B-T017
mesenteric	I-T017
arteries	I-T017
of	O
shr	B-T204
##sp	I-T204
because	O
of	O
a	O
reduction	B-T058
in	O
both	O
trp	B-T103
##v	I-T103
##4	I-T103
and	O
sk	B-T103
##ca	I-T103
input	O
to	O
ed	B-T103
##h	I-T103
.	O

like	O
father	O
,	O
like	O
daughter	O
-	O
inherited	O
cut	B-T017
##is	I-T017
apl	I-T017
##asia	I-T017
occurring	O
in	O
a	O
family	O
with	O
mar	B-T038
##fa	I-T038
##n	I-T038
syndrome	I-T038
:	O
a	O
case	B-T170
report	I-T170
we	O
present	O
the	O
case	O
of	O
a	O
newborn	O
with	O
co	O
-	O
occurrence	O
of	O
mar	B-T038
##fa	I-T038
##n	I-T038
syndrome	I-T038
and	O
apl	B-T017
##asia	I-T017
cut	I-T017
##is	I-T017
congen	I-T017
##ita	I-T017
(	O
acc	B-T017
)	O
and	O
a	O
family	B-T033
history	I-T033
significant	O
for	O
mar	B-T038
##fa	I-T038
##n	I-T038
syndrome	I-T038
and	O
acc	B-T017
in	O
the	O
father	O
.	O
this	O
case	O
details	O
a	O
previously	O
unreported	O
mutation	B-T038
in	O
mar	B-T038
##fa	I-T038
##n	I-T038
syndrome	I-T038
and	O
describes	O
a	O
novel	O
coin	O
##her	O
##itance	O
of	O
mar	B-T038
##fa	I-T038
##n	I-T038
syndrome	I-T038
and	O
acc	B-T017
.	O

what	O
is	O
the	O
real	O
impact	O
of	O
urinary	B-T038
incontinence	I-T038
on	O
female	B-T038
sexual	I-T038
dysfunction	I-T038
?	O
a	O
case	B-T062
control	I-T062
study	I-T062
urinary	B-T038
incontinence	I-T038
(	O
ui	B-T038
)	O
has	O
been	O
associated	O
with	O
negative	B-T033
effects	O
on	O
women	B-T098
'	I-T098
s	I-T098
sexuality	O
.	O
women	B-T098
'	I-T098
s	I-T098
sexuality	O
and	O
sexual	B-T038
function	I-T038
are	O
a	O
complex	O
issue	B-T033
,	O
and	O
the	O
role	O
of	O
ui	B-T038
is	O
not	O
completely	O
clear	O
.	O
to	O
assess	O
the	O
impact	O
of	O
ui	B-T038
on	O
female	B-T038
sexual	I-T038
function	I-T038
by	O
comparing	O
this	O
population	B-T098
with	O
a	O
control	O
group	O
of	O
continent	O
women	B-T098
.	O
we	O
performed	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
from	O
august	O
2012	O
to	O
september	O
2013	O
.	O
we	O
evaluated	B-T058
continent	O
and	O
incontin	O
##ent	O
women	B-T098
(	O
age	O
range	O
=	O
30	O
-	O
70	O
years	O
)	O
for	O
their	O
sexuality	O
.	O
all	O
patients	O
were	O
evaluated	B-T058
by	O
ana	B-T038
##mn	I-T038
##esis	I-T038
,	O
physical	B-T058
examination	I-T058
,	O
and	O
self	B-T062
-	I-T062
report	I-T062
quality	B-T170
-	I-T170
of	I-T170
-	I-T170
life	I-T170
questionnaires	I-T170
.	O
in	O
addition	O
,	O
incontin	O
##ent	O
women	B-T098
underwent	O
a	O
1	O
-	O
hour	O
pad	B-T058
test	I-T058
.	O
patients	O
without	O
sexual	O
activity	O
were	O
evaluated	B-T058
for	O
the	O
role	O
of	O
ui	B-T038
in	O
their	O
sexual	O
abstinence	O
.	O
sexual	O
abstinence	O
was	O
defined	O
as	O
the	O
absence	O
of	O
sexual	O
activity	O
for	O
more	O
than	O
6	O
months	O
.	O
all	O
sexually	B-T033
active	I-T033
women	B-T098
completed	O
the	O
self	B-T062
-	I-T062
report	I-T062
sexuality	O
quotient	O
-	O
female	O
version	B-T170
(	O
sq	O
-	O
f	O
)	O
questionnaire	B-T170
.	O
a	O
total	O
of	O
356	O
women	B-T098
were	O
included	O
in	O
the	O
study	B-T062
(	O
incontin	O
##ent	O
,	O
n	O
=	O
243	O
;	O
continent	O
,	O
n	O
=	O
113	O
)	O
.	O
sexual	O
abstinence	O
was	O
found	O
in	O
162	O
women	B-T098
(	O
45	O
%	O
)	O
.	O
incontin	O
##ent	O
women	B-T098
presented	O
a	O
higher	O
prevalence	O
(	O
p	O
<	O
.	O
001	O
)	O
of	O
sexual	O
abstinence	O
than	O
their	O
counterparts	O
(	O
129	O
[	O
53	O
%	O
]	O
and	O
33	O
[	O
29	O
.	O
2	O
%	O
]	O
,	O
respectively	O
)	O
.	O
age	O
,	O
marital	O
status	O
,	O
and	O
ui	B-T038
were	O
found	O
to	O
be	O
isolated	O
predictive	B-T170
factors	I-T170
for	O
more	O
sexual	O
abstinence	O
in	O
incontin	O
##ent	O
women	B-T098
.	O
sexually	B-T033
active	I-T033
women	B-T098
(	O
incontin	O
##ent	O
,	O
n	O
=	O
114	O
;	O
continent	O
,	O
n	O
=	O
80	O
)	O
presented	O
similar	O
demographic	O
data	O
.	O
despite	O
a	O
similar	O
frequency	O
of	O
sexual	O
activity	O
,	O
incontin	O
##ent	O
women	B-T098
had	O
less	O
sexual	O
desire	O
,	O
fore	B-T033
##pl	I-T033
##ay	I-T033
,	O
harmon	O
##y	O
with	O
a	O
partner	B-T098
,	O
sexual	B-T038
comfort	I-T038
,	O
and	O
sexual	B-T038
satisfaction	I-T038
than	O
their	O
counterparts	O
.	O
women	B-T098
with	O
greater	O
urinary	B-T033
leakage	I-T033
during	O
the	O
1	O
-	O
hour	O
pad	B-T058
test	I-T058
(	O
weight	O
>	O
11	O
g	O
)	O
had	O
the	O
worst	O
sexual	B-T038
function	I-T038
(	O
sq	O
-	O
f	O
)	O
score	O
.	O
women	B-T098
with	O
ui	B-T038
were	O
more	O
likely	O
to	O
be	O
sexual	O
abstin	O
##ent	O
than	O
continent	O
women	B-T098
.	O
furthermore	O
,	O
women	B-T098
with	O
ui	B-T038
showed	O
less	O
sexual	O
desire	O
,	O
sexual	B-T038
comfort	I-T038
,	O
and	O
sexual	B-T038
satisfaction	I-T038
than	O
their	O
counterparts	O
despite	O
having	O
a	O
similar	O
frequency	O
of	O
sexual	O
activity	O
.	O

effect	O
of	O
ultrasonic	O
processing	O
on	O
the	O
changes	O
in	O
activity	O
,	O
aggregation	O
and	O
the	O
secondary	B-T082
and	O
tertiary	B-T082
structure	I-T082
of	O
polyphenol	B-T103
oxidase	I-T103
in	O
oriental	B-T082
sweet	B-T168
mel	I-T168
##on	I-T168
(	O
cuc	B-T204
##um	I-T204
##is	I-T204
mel	I-T204
##o	I-T204
var	I-T204
.	I-T204
mak	I-T204
##u	I-T204
##wa	I-T204
mak	I-T204
##ino	I-T204
)	O
polyphenol	B-T103
oxidase	I-T103
(	O
pp	B-T103
##o	I-T103
)	O
mainly	O
contributes	O
to	O
the	O
brown	O
##ing	O
reaction	O
of	O
fruits	B-T168
and	O
vegetables	B-T168
and	O
causes	O
serious	O
damage	O
to	O
the	O
quality	O
of	O
sweet	B-T168
mel	I-T168
##on	I-T168
products	O
.	O
however	O
,	O
traditional	O
methods	O
to	O
inactivate	O
brown	O
##ing	O
may	O
induce	O
more	O
unexpected	B-T170
risks	O
than	O
ultrasonic	O
processing	O
.	O
meanwhile	O
,	O
there	O
are	O
no	O
reports	B-T170
on	O
the	O
effect	O
of	O
ultrasound	O
on	O
pp	B-T103
##o	I-T103
directly	O
purified	O
from	O
sweet	B-T168
mel	I-T168
##on	I-T168
.	O
the	O
pp	B-T103
##o	I-T103
in	O
the	O
original	O
juice	B-T168
was	O
less	O
inactivated	O
than	O
the	O
purified	O
form	O
when	O
treated	B-T058
with	I-T058
ultrasound	O
.	O
as	O
for	O
purified	O
pp	B-T103
##o	I-T103
,	O
superior	O
to	O
thermal	B-T058
treatment	I-T058
,	O
less	O
heat	O
was	O
needed	O
to	O
inactivate	O
the	O
pp	B-T103
##o	I-T103
with	O
ultrasonic	O
treatment	B-T058
.	O
at	O
intensity	O
lower	O
than	O
200	O
w	O
,	O
ultrasound	O
did	O
not	O
significantly	O
affect	O
the	O
structure	B-T082
and	O
activity	O
of	O
pp	B-T103
##o	I-T103
(	O
p	O
>	O
0	O
.	O
05	O
)	O
,	O
and	O
latent	O
pp	B-T103
##o	I-T103
was	O
activated	O
.	O
at	O
intensity	O
higher	O
than	O
200	O
w	O
,	O
ultrasound	O
inactivated	O
pp	B-T103
##o	I-T103
,	O
induced	O
aggregation	O
and	O
dissociation	B-T038
of	O
pp	B-T103
##o	I-T103
particles	B-T103
and	O
significantly	O
decreased	O
the	O
α	B-T082
-	I-T082
helix	I-T082
structure	I-T082
content	O
.	O
low	O
-	O
frequency	O
high	B-T170
-	I-T170
intensity	I-T170
ultrasound	O
caused	O
an	O
inactivation	O
effect	O
and	O
conformational	B-T038
changes	I-T038
of	O
purified	O
pp	B-T103
##o	I-T103
from	O
oriental	B-T082
sweet	B-T168
mel	I-T168
##ons	I-T168
.	O
changes	O
in	O
the	O
pp	B-T103
##o	I-T103
structure	B-T082
induced	O
by	O
ultrasound	O
eventually	O
inactivated	O
the	O
enzyme	B-T103
.	O
ultrasound	O
may	O
be	O
a	O
potential	O
method	O
to	O
inactivate	O
pp	B-T103
##o	I-T103
in	O
oriental	B-T082
sweet	B-T168
mel	I-T168
##ons	I-T168
.	O
©	O
2016	O
society	O
of	O
chemical	O
industry	O
.	O

bilateral	B-T082
sternal	B-T017
infusion	B-T058
of	O
ropivacaine	B-T103
and	O
length	O
of	O
stay	O
in	O
icu	B-T092
after	O
cardiac	B-T058
surgery	I-T058
with	O
increased	O
respiratory	O
risk	O
:	O
a	O
randomised	B-T062
controlled	I-T062
trial	I-T062
the	O
continuous	O
bilateral	B-T082
infusion	B-T058
of	O
a	O
local	B-T103
anaesthetic	I-T103
solution	B-T103
around	O
the	O
sternotomy	B-T058
wound	B-T037
(	O
bilateral	B-T082
sternal	B-T017
)	O
is	O
an	O
innovative	O
technique	O
for	O
reducing	O
pain	B-T033
after	O
sternotomy	B-T058
.	O
to	O
assess	O
the	O
effects	O
of	O
the	O
technique	O
on	O
the	O
need	O
for	O
intensive	B-T058
care	I-T058
in	O
cardiac	O
patients	O
at	O
increased	O
risk	O
of	O
respiratory	B-T038
complications	I-T038
.	O
randomised	B-T062
,	I-T062
observer	I-T062
-	I-T062
blind	I-T062
controlled	I-T062
trial	I-T062
.	O
single	O
centre	O
,	O
french	B-T092
university	I-T092
hospital	I-T092
.	O
in	O
total	O
,	O
120	O
adults	O
scheduled	O
for	O
open	B-T058
-	I-T058
heart	I-T058
surgery	I-T058
,	O
with	O
one	O
of	O
the	O
following	O
conditions	O
:	O
age	O
more	O
than	O
75	O
years	O
,	O
bmi	B-T201
>	O
30	O
kg	O
m	O
,	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
,	O
active	O
smoking	O
habit	O
.	O
either	O
a	O
bilateral	B-T082
sternal	B-T017
infusion	B-T058
of	O
0	O
.	O
2	O
%	O
ropivacaine	B-T103
(	O
3	O
ml	O
h	O
through	O
each	O
catheter	B-T074
;	O
'	B-T098
intervention	I-T098
'	I-T098
group	I-T098
)	O
,	O
or	O
standardised	O
care	O
only	O
(	O
'	O
control	O
'	O
group	O
)	O
.	O
analgesia	B-T058
was	O
provided	O
with	O
paracetamol	B-T103
and	O
self	O
-	O
administered	O
intravenous	O
morphine	B-T103
.	O
the	O
length	O
of	O
time	O
to	O
readiness	B-T033
for	O
discharge	B-T058
from	O
icu	B-T092
,	O
blind	O
##ly	O
assessed	O
by	O
a	O
committee	O
of	O
experts	B-T097
.	O
no	O
effect	O
was	O
found	O
between	O
groups	O
for	O
the	O
primary	O
outcome	O
(	O
p	O
=	O
0	O
.	O
68	O
##0	O
,	O
intention	B-T062
to	I-T062
treat	I-T062
)	O
;	O
the	O
median	O
values	O
were	O
42	O
.	O
4	O
and	O
37	O
.	O
7	O
h	O
,	O
respectively	O
for	O
the	O
control	O
and	O
intervention	B-T098
groups	I-T098
(	O
p	O
=	O
0	O
.	O
87	O
##3	O
)	O
.	O
similar	O
nonsignificant	O
trends	O
were	O
noted	O
for	O
other	O
postoperative	B-T033
delays	O
.	O
significant	O
effects	O
favour	O
##ing	O
the	O
intervention	B-T058
were	O
noted	O
for	O
dynamic	B-T033
pain	I-T033
,	O
patient	O
satisfaction	O
,	O
occurrence	O
of	O
nausea	O
and	O
vomiting	B-T033
,	O
occurrence	O
of	O
delirium	B-T038
or	O
mental	B-T038
confusion	I-T038
and	O
occurrence	O
of	O
pulmonary	B-T038
complications	I-T038
.	O
in	O
12	O
patients	O
,	O
although	O
no	O
symptoms	B-T033
actually	O
occurred	O
,	O
the	O
total	O
ropivacaine	O
plasma	O
level	O
exceeded	O
the	O
lowest	O
value	O
for	O
which	O
neurological	B-T033
symptoms	I-T033
have	O
been	O
observed	O
in	O
healthy	B-T098
volunteers	I-T098
.	O
because	O
of	O
a	O
small	O
size	O
effect	O
,	O
and	O
despite	O
significant	O
analgesic	B-T033
effects	I-T033
,	O
this	O
strategy	O
failed	O
to	O
reduce	O
the	O
time	O
spent	O
in	O
icu	B-T092
.	O
eud	O
##ra	O
##ct	O
(	O
n	O
##°	O
:	O
2012	O
-	O
005	O
##22	O
##5	O
-	O
69	O
)	O
;	O
clinicaltrials	B-T170
.	I-T170
gov	I-T170
(	O
nct0	O
##18	O
##28	O
##78	O
##8	O
)	O
.	O

modeling	B-T062
the	O
hospital	B-T092
safety	O
partnership	O
preferences	O
of	O
patients	O
and	O
their	O
families	O
:	O
a	O
discrete	O
choice	O
conj	B-T062
##oint	I-T062
experiment	I-T062
patients	O
and	O
their	O
families	O
play	O
an	O
important	O
role	O
in	O
efforts	O
to	O
improve	O
health	B-T058
service	I-T058
safety	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
is	O
to	O
understand	O
the	O
safety	O
partnership	O
preferences	O
of	O
patients	O
and	O
their	O
families	O
.	O
we	O
used	O
a	O
discrete	O
choice	O
conj	B-T062
##oint	I-T062
experiment	I-T062
to	O
model	O
the	O
safety	O
partnership	O
preferences	O
of	O
1	O
,	O
08	O
##4	O
patients	O
or	O
those	O
such	O
as	O
parents	O
acting	O
on	O
their	O
beha	O
##l	O
##f	O
.	O
participants	B-T098
made	O
choices	O
between	O
hypothetical	O
safety	O
partnerships	O
composed	O
by	O
experimentally	O
varying	O
15	O
four	O
-	O
level	O
partnership	O
design	O
attributes	O
.	O
participants	B-T098
preferred	O
an	O
approach	B-T082
to	O
safety	O
based	O
on	O
partnerships	O
between	O
patients	O
and	O
staff	B-T097
rather	O
than	O
a	O
model	O
dele	O
##ga	O
##ting	O
responsibility	O
for	O
safety	O
to	O
hospital	B-T097
staff	I-T097
.	O
they	O
valued	O
the	O
opportunity	O
to	O
participate	O
in	O
point	O
of	O
service	O
safety	O
partnerships	O
,	O
such	O
as	O
identity	O
and	O
medication	O
double	O
check	O
##s	O
,	O
that	O
might	O
afford	O
an	O
immediate	O
risk	O
reduction	O
.	O
latent	O
class	O
analysis	B-T062
yielded	O
two	O
segments	O
.	O
actively	B-T098
engaged	I-T098
participants	I-T098
(	O
73	O
.	O
3	O
%	O
)	O
comprised	O
outpatients	O
with	O
higher	O
education	O
,	O
who	O
anticipated	O
more	O
benefits	O
to	O
safety	O
partnerships	O
,	O
were	O
more	O
confident	O
in	O
their	O
ability	O
to	O
contribute	O
,	O
and	O
were	O
more	O
intent	O
on	O
participating	O
.	O
they	O
were	O
more	O
likely	O
to	O
prefer	O
a	O
personal	O
engagement	B-T058
strategy	O
,	O
valued	O
scientific	O
evidence	O
,	O
preferred	O
a	O
more	O
active	O
approach	B-T082
to	O
safety	O
education	O
,	O
and	O
advocated	O
disclosure	O
of	O
errors	O
.	O
the	O
passively	O
engaged	O
segment	O
(	O
26	O
.	O
7	O
%	O
)	O
anticipated	O
fewer	O
benefits	O
,	O
were	O
less	O
confident	O
in	O
their	O
ability	O
to	O
contribute	O
,	O
and	O
were	O
less	O
intent	O
on	O
participating	O
.	O
they	O
were	O
more	O
likely	O
to	O
prefer	O
an	O
engagement	B-T058
strategy	O
based	O
on	O
sign	O
##age	O
.	O
they	O
preferred	O
that	O
staff	B-T097
explain	O
why	O
they	O
thought	O
patients	O
should	O
help	O
make	O
care	B-T058
safer	O
and	O
decide	O
whether	O
errors	O
were	O
disclosed	O
.	O
inpatients	O
,	O
those	O
with	O
immigrant	B-T033
backgrounds	I-T033
,	O
and	O
those	O
with	O
less	B-T033
education	I-T033
were	O
more	O
likely	O
to	O
be	O
in	O
this	O
segment	O
.	O
health	B-T058
services	I-T058
need	O
to	O
communicate	O
information	O
regarding	O
risks	O
,	O
ask	O
about	O
partnership	O
preferences	O
,	O
create	O
opportunities	O
respect	O
##ing	O
individual	O
differences	O
,	O
and	O
ensure	O
a	O
positive	B-T033
response	I-T033
when	O
patients	O
raise	O
safety	O
concerns	O
.	O

effects	O
of	O
an	O
early	O
intervention	B-T058
using	O
human	B-T204
amniotic	B-T017
epithelial	B-T017
cells	I-T017
in	O
a	O
copd	B-T038
rat	B-T204
model	O
the	O
study	B-T062
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
an	O
early	O
intervention	B-T058
using	O
human	B-T204
amniotic	B-T017
epithelial	B-T017
cell	I-T017
(	O
ha	B-T017
##ec	I-T017
)	O
in	O
a	O
rat	B-T204
model	O
of	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
(	O
copd	B-T038
)	O
.	O
twenty	O
-	O
four	O
specific	O
pathogen	O
-	O
free	O
wistar	B-T204
rats	I-T204
were	O
randomized	B-T062
to	O
the	O
control	O
,	O
copd	B-T038
,	O
and	O
copd	B-T038
+	O
ha	B-T017
##ec	I-T017
groups	O
.	O
copd	B-T038
was	O
established	O
by	O
intratracheal	O
lps	B-T103
injection	O
combined	O
with	O
smoke	B-T103
fumig	O
##ation	O
over	O
30	O
days	O
.	O
on	O
the	O
first	O
day	O
of	O
model	O
establishment	O
rats	B-T204
in	O
the	O
aec	B-T017
group	O
also	O
received	O
intratracheal	O
instillation	O
of	O
500	O
,	O
000	O
ha	B-T017
##ecs	I-T017
isolated	O
from	O
the	O
placenta	B-T017
of	O
healthy	O
donors	B-T098
.	O
the	O
mean	O
linear	O
intercept	O
(	O
ml	O
##i	O
)	O
and	O
mean	O
alveolar	O
number	O
(	O
man	O
)	O
were	O
used	O
to	O
assess	O
the	O
degree	O
of	O
lung	B-T038
emphysema	I-T038
.	O
il	B-T103
-	I-T103
8	I-T103
was	O
measured	O
using	O
a	O
radioimmunoassay	B-T058
,	O
surfactant	B-T103
protein	I-T103
d	I-T103
(	O
sp	B-T103
-	I-T103
d	I-T103
)	O
was	O
measured	O
by	O
elisa	B-T058
,	O
and	O
matrix	B-T103
metalloproteinase	I-T103
(	I-T103
mmp	I-T103
)	I-T103
2	I-T103
and	O
mmp	B-T103
##8	I-T103
expression	B-T038
was	O
assessed	O
by	O
pcr	B-T062
.	O
smoke	B-T103
fumig	O
##ation	O
combined	O
to	O
lps	B-T103
injection	O
successfully	O
established	O
a	O
copd	B-T038
rat	B-T204
model	O
with	O
significant	O
emphysema	B-T038
and	O
airway	B-T038
inflammation	I-T038
,	O
elevated	O
ml	O
##i	O
and	O
man	O
,	O
elevated	O
systemic	O
and	O
lung	B-T017
tissue	B-T017
levels	O
of	O
il	B-T103
-	I-T103
8	I-T103
and	O
sp	B-T103
-	I-T103
d	I-T103
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
high	O
expression	B-T038
of	O
mmp	B-T103
##2	I-T103
and	O
mmp	B-T103
##8	I-T103
.	O
rats	B-T204
in	O
the	O
copd	B-T038
+	O
ha	B-T017
##ec	I-T017
group	O
exhibited	O
alleviated	O
lung	B-T017
damage	B-T037
,	O
ml	O
##i	O
and	O
man	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
reduced	O
systemic	O
and	O
lung	B-T017
tissue	B-T017
levels	O
of	O
il	B-T103
-	I-T103
8	I-T103
and	O
sp	B-T103
-	I-T103
d	I-T103
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
mmp	B-T103
##2	I-T103
and	O
mmp	B-T103
##8	I-T103
expression	B-T038
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
early	O
intervention	B-T058
using	O
ha	B-T017
##ecs	I-T017
could	O
delay	O
disease	B-T038
progression	I-T038
in	O
rats	B-T204
with	O
copd	B-T038
.	O

modification	O
of	O
mechanical	O
properties	O
,	O
polymerization	O
temperature	O
,	O
and	O
handling	O
time	O
of	O
polym	B-T103
##ethyl	I-T103
##meth	I-T103
##acrylate	I-T103
cement	B-T103
for	O
enhancing	O
applicability	O
in	O
vertebr	B-T058
##oplasty	I-T058
polym	B-T103
##ethyl	I-T103
##meth	I-T103
##acrylate	I-T103
(	O
pmma	B-T103
)	O
bone	B-T103
cement	I-T103
is	O
a	O
popular	O
bone	B-T017
void	B-T082
filler	B-T103
for	O
vertebr	B-T058
##oplasty	I-T058
.	O
however	O
,	O
the	O
use	O
of	O
pmma	B-T103
has	O
some	O
drawbacks	O
,	O
including	O
the	O
material	B-T103
'	I-T103
s	I-T103
excessive	O
stiffness	O
,	O
exo	O
##therm	O
##ic	O
polymerization	O
,	O
and	O
short	O
handling	O
time	O
.	O
this	O
study	B-T062
aimed	O
to	O
create	O
an	O
ideal	O
modified	O
bone	B-T103
cement	I-T103
to	O
solve	O
the	O
above	O
-	O
mentioned	O
problems	B-T033
.	O
modified	O
bone	B-T103
cements	I-T103
were	O
prepared	O
by	O
combining	O
pmma	B-T103
with	O
three	O
different	O
volume	O
fractions	O
of	O
cast	B-T103
##or	I-T103
oil	I-T103
(	O
5	O
%	O
,	O
10	O
%	O
,	O
and	O
15	O
%	O
)	O
.	O
the	O
peak	O
polymerization	O
temperatures	O
,	O
times	O
to	O
achieve	O
the	O
peak	O
polymerization	O
temperature	O
,	O
por	O
##osities	O
,	O
densities	O
,	O
modulus	O
and	O
maximum	O
compression	O
strengths	O
of	O
standard	O
(	O
without	O
cast	B-T103
##or	I-T103
oil	I-T103
)	O
,	O
and	O
modified	O
cements	B-T103
were	O
investigated	O
following	O
storage	O
at	O
ambient	O
temperature	O
(	O
22	O
##°c	O
)	O
or	O
under	O
prec	O
##ool	O
##ing	O
conditions	O
(	O
3	O
##°c	O
)	O
.	O
six	O
specimens	O
were	O
tested	O
in	O
each	O
group	O
of	O
the	O
aforementioned	O
parameters	O
.	O
increasing	O
cast	B-T103
##or	I-T103
oil	I-T103
content	O
and	O
prec	O
##ool	O
##ing	O
treatment	O
effectively	O
decreased	O
the	O
peak	O
polymerization	O
temperatures	O
and	O
increased	O
the	O
duration	O
to	O
achieve	O
the	O
peak	O
polymerization	O
temperature	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
furthermore	O
,	O
the	O
mechanical	O
properties	O
of	O
the	O
material	B-T103
,	O
including	O
density	O
,	O
modulus	O
,	O
and	O
maximum	O
compression	O
strength	O
,	O
decreased	O
with	O
increasing	O
cast	B-T103
##or	I-T103
oil	I-T103
content	O
.	O
however	O
,	O
preparation	O
temperature	O
(	O
room	O
temperature	O
versus	O
prec	O
##ool	O
##ing	O
)	O
had	O
no	O
significant	O
effect	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
on	O
these	O
mechanical	O
properties	O
.	O
in	O
conclusion	O
,	O
the	O
addition	O
of	O
cast	B-T103
##or	I-T103
oil	I-T103
to	O
pmma	B-T103
followed	O
by	O
prec	O
##ool	O
##ing	O
created	O
an	O
ideal	O
modified	O
bone	B-T103
cement	I-T103
with	O
a	O
low	O
modulus	O
,	O
low	O
polymerization	O
temperature	O
,	O
and	O
long	O
handling	O
time	O
,	O
enhancing	O
its	O
applicability	O
and	O
safety	O
for	O
vertebr	B-T058
##oplasty	I-T058
.	O

methamphetamine	B-T103
,	O
3	B-T103
,	I-T103
4	I-T103
-	I-T103
methylene	I-T103
##di	I-T103
##oxy	I-T103
##meth	I-T103
##amphetamine	I-T103
(	O
mdma	B-T103
)	O
and	O
3	B-T103
,	I-T103
4	I-T103
-	I-T103
methylene	I-T103
##di	I-T103
##oxy	I-T103
##pyr	I-T103
##ova	I-T103
##ler	I-T103
##one	I-T103
(	O
mdp	B-T103
##v	I-T103
)	O
induce	O
differential	O
cytotoxic	B-T038
effects	I-T038
in	O
bovine	B-T204
brain	B-T017
microvessel	B-T017
endothelial	B-T017
cells	I-T017
design	B-T103
##er	I-T103
drugs	I-T103
such	O
as	O
synthetic	B-T103
psychos	I-T103
##tim	I-T103
##ulant	I-T103
##s	I-T103
are	O
indicative	O
of	O
a	O
worldwide	O
problem	B-T033
of	O
drug	B-T038
abuse	I-T038
and	O
addiction	B-T038
.	O
in	O
addition	O
to	O
methamphetamine	B-T103
(	O
meth	B-T103
)	O
,	O
these	O
drugs	B-T103
include	O
3	B-T103
,	I-T103
4	I-T103
-	I-T103
methylene	I-T103
##di	I-T103
##oxy	I-T103
-	I-T103
methamphetamine	I-T103
(	O
mdma	B-T103
)	O
and	O
commercial	B-T170
preparations	O
of	O
synthetic	B-T103
cath	I-T103
##inone	I-T103
##s	I-T103
including	O
3	B-T103
,	I-T103
4	I-T103
-	I-T103
methylene	I-T103
##di	I-T103
##oxy	I-T103
##pyr	I-T103
##ova	I-T103
##ler	I-T103
##one	I-T103
(	O
mdp	B-T103
##v	I-T103
)	O
,	O
typically	O
referred	O
to	O
as	O
[UNK]	O
bath	B-T103
salts	I-T103
.	O
[UNK]	O
these	O
psychos	B-T103
##tim	I-T103
##ulant	I-T103
##s	I-T103
exert	O
neurotoxic	B-T037
effects	I-T037
by	O
altering	O
monoamine	O
systems	O
in	O
the	O
brain	B-T017
.	O
additionally	O
,	O
meth	B-T103
and	O
mdma	B-T103
adversely	B-T038
affect	I-T038
the	O
integrity	O
of	O
the	O
blood	B-T017
-	I-T017
brain	I-T017
barrier	I-T017
(	O
bbb	B-T017
)	O
:	O
there	O
are	O
no	O
current	O
reports	B-T170
on	O
the	O
effects	O
of	O
mdp	B-T103
##v	I-T103
on	O
the	O
bbb	B-T017
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
compare	O
the	O
effects	O
of	O
meth	B-T103
,	O
mdma	B-T103
and	O
mdp	B-T103
##v	I-T103
on	O
bovine	B-T204
brain	B-T017
microvessel	B-T017
endothelial	B-T017
cells	I-T017
(	O
bb	B-T017
##mv	I-T017
##ecs	I-T017
)	O
,	O
an	O
accepted	O
in	B-T062
vitro	I-T062
model	I-T062
of	O
the	O
bbb	B-T017
.	O
confluent	O
bb	B-T017
##mv	I-T017
##ec	I-T017
monolayers	B-T017
were	O
treated	O
with	O
meth	B-T103
,	O
mdma	B-T103
and	O
mdp	B-T103
##v	I-T103
(	O
0	O
.	O
5	O
##mm	O
-	O
2	O
.	O
5	O
##mm	O
)	O
for	O
24h	O
.	O
meth	B-T103
and	O
mdma	B-T103
increased	O
lactate	B-T103
dehydrogenase	I-T103
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2	O
.	O
5	O
##mm	O
)	O
,	O
whereas	O
mdp	B-T103
##v	I-T103
induced	O
cytotoxicity	B-T038
at	O
all	O
concentration	O
s	O
.	O
mdma	B-T103
and	O
meth	B-T103
decreased	O
cellular	B-T038
proliferation	I-T038
only	O
at	O
2	O
.	O
5	O
##mm	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
mdp	B-T103
##v	I-T103
exposures	O
starting	O
at	O
1	O
##mm	O
.	O
only	O
mdp	B-T103
##v	I-T103
increased	O
reactive	B-T103
oxygen	I-T103
species	I-T103
production	O
at	O
all	O
concentrations	O
tested	O
whereas	O
all	O
3	O
drugs	B-T103
increased	O
nitric	B-T103
oxide	I-T103
production	O
.	O
morphological	B-T062
analysis	I-T062
revealed	O
different	O
patterns	O
of	O
compound	B-T103
-	O
induced	O
cell	O
damage	O
.	O
meth	B-T103
induced	O
vacuole	B-T017
format	O
##io	O
n	O
at	O
1	O
##mm	O
and	O
disruption	O
of	O
the	O
monolayer	B-T017
at	O
2	O
.	O
5	O
##mm	O
.	O
mdma	B-T103
induced	O
disruption	O
of	O
the	O
endothelial	B-T017
monolayer	B-T017
from	O
1	O
##mm	O
without	O
vacu	B-T033
##olization	I-T033
.	O
on	O
the	O
other	O
hand	O
,	O
mdp	B-T103
##v	I-T103
induced	O
monolayer	B-T017
disruption	O
at	O
doses	O
≥	O
##0	O
.	O
5	O
##mm	O
without	O
vacuole	B-T017
formation	O
;	O
at	O
2	O
.	O
5	O
##mm	O
,	O
the	O
few	O
remaining	O
cells	B-T017
lacked	O
endothelial	O
morphology	O
.	O
these	O
data	O
suggest	O
that	O
even	O
though	O
these	O
synthetic	B-T103
psychos	I-T103
##tim	I-T103
##ulant	I-T103
##s	I-T103
alter	O
monoamine	O
##r	O
##gic	O
systems	O
,	O
they	O
each	O
induce	O
bbb	B-T017
toxicity	B-T037
by	O
different	O
mechanisms	O
with	O
mdp	B-T103
##v	I-T103
being	O
the	O
most	O
toxic	O
.	O

development	O
and	O
validation	B-T062
of	O
an	O
easy	O
-	O
to	O
-	O
use	O
risk	B-T058
assessment	I-T058
tool	I-T058
for	O
cumulative	O
low	B-T017
back	I-T017
loading	O
:	O
the	O
lifting	B-T103
fatigue	I-T103
failure	I-T103
tool	I-T103
(	O
lif	B-T103
##ft	I-T103
)	O
recent	O
evidence	O
suggests	O
that	O
musculoskeletal	B-T038
disorders	I-T038
(	O
ms	B-T038
##ds	I-T038
)	O
may	O
be	O
the	O
result	O
of	O
a	O
fatigue	B-T033
failure	O
process	O
in	O
affected	O
tissues	B-T017
.	O
this	O
paper	O
describes	O
a	O
new	O
low	O
back	O
exposure	O
assessment	B-T103
tool	I-T103
(	O
the	O
lifting	B-T103
fatigue	I-T103
failure	I-T103
tool	I-T103
[	O
lif	B-T103
##ft	I-T103
]	O
)	O
,	O
which	O
estimates	O
a	O
[UNK]	O
daily	O
dose	O
[UNK]	O
of	O
cumulative	O
loading	O
on	O
the	O
low	B-T017
back	I-T017
using	O
fatigue	B-T033
failure	O
principles	O
.	O
only	O
three	O
variables	O
are	O
necessary	O
to	O
derive	O
the	O
cumulative	O
load	O
associated	O
with	O
a	O
lifting	O
task	O
:	O
the	O
weight	O
of	O
the	O
load	O
,	O
the	O
maximum	O
horizontal	O
distance	O
from	O
the	O
spine	B-T017
to	O
the	O
load	O
,	O
and	O
the	O
number	O
of	O
repetitions	O
for	O
tasks	B-T058
performed	I-T058
during	O
the	O
work	O
##day	O
.	O
the	O
new	B-T103
tool	I-T103
was	O
validated	B-T062
using	O
two	O
existing	O
epidemiological	O
databases	B-T170
:	O
the	O
lumbar	B-T033
motion	I-T033
monitor	I-T033
(	O
lm	B-T033
##m	I-T033
)	O
database	B-T170
,	O
and	O
a	O
database	B-T170
from	O
a	O
u	B-T082
.	I-T082
s	I-T082
.	O
autom	O
##oti	O
##ve	O
manufacturer	O
.	O
the	O
lif	B-T103
##ft	I-T103
cumulative	B-T058
damage	I-T058
metric	I-T058
explained	O
92	O
%	O
of	O
the	O
devi	O
##ance	O
in	O
low	B-T033
back	I-T033
disorders	I-T033
(	O
lb	B-T033
##ds	I-T033
)	O
in	O
the	O
lm	O
##m	O
database	O
and	O
72	O
-	O
95	O
%	O
of	O
the	O
devi	O
##ance	O
in	O
low	O
back	O
outcomes	O
in	O
the	O
autom	O
##oti	O
##ve	O
database	O
(	O
depending	O
on	O
the	O
outcome	O
measure	O
)	O
.	O
thus	O
,	O
lif	B-T103
##ft	I-T103
is	O
practitioner	O
friendly	O
and	O
its	O
cumulative	O
damage	B-T058
metric	I-T058
highly	O
related	O
to	O
low	O
back	O
outcomes	O
.	O

nutrient	B-T058
intake	I-T058
of	O
infants	O
and	O
tod	O
##dlers	O
in	O
the	O
united	B-T082
arab	I-T082
em	I-T082
##ira	I-T082
##tes	I-T082
:	O
the	O
feeding	O
infants	O
and	O
tod	O
##dlers	O
study	O
this	O
descriptive	O
study	O
evaluated	O
the	O
nutrient	O
adequacy	O
of	O
the	O
diet	B-T168
of	O
infants	O
(	O
aged	O
6	O
-	O
11	O
.	O
9	O
months	O
)	O
and	O
tod	O
##dlers	O
(	O
aged	O
12	O
-	O
24	O
months	O
)	O
in	O
the	O
united	B-T082
arab	I-T082
em	I-T082
##ira	I-T082
##tes	I-T082
.	O
a	O
random	O
sample	O
of	O
1000	O
infants	O
and	O
tod	O
##dlers	O
was	O
recruited	O
from	O
2	O
cities	O
(	O
al	B-T082
ai	I-T082
##n	I-T082
and	O
dub	B-T082
##ai	I-T082
)	O
from	O
march	O
2011	O
to	O
february	O
2012	O
and	O
their	O
usual	O
nutrient	B-T058
intake	I-T058
was	O
determined	O
using	O
24	O
-	O
hour	O
recall	O
.	O
in	O
all	O
,	O
54	O
.	O
2	O
%	O
of	O
infants	O
and	O
25	O
.	O
2	O
%	O
of	O
tod	O
##dlers	O
were	O
breastfeeding	B-T038
.	O
mean	O
energy	O
intake	O
of	O
infant	O
girls	O
in	O
al	B-T082
ai	I-T082
##n	I-T082
and	O
dub	B-T082
##ai	I-T082
was	O
74	O
##7	O
(	O
sd	O
189	O
)	O
kcal	O
and	O
77	O
##3	O
(	O
sd	O
215	O
)	O
kcal	O
respectively	O
and	O
81	O
##0	O
.	O
5	O
(	O
sd	O
232	O
.	O
2	O
)	O
kcal	O
and	O
82	O
##1	O
.	O
9	O
(	O
sd	O
262	O
)	O
kcal	O
for	O
boys	O
.	O
in	O
tod	O
##dlers	O
,	O
mean	O
energy	O
intake	O
for	O
girls	O
in	O
al	O
ai	O
##n	O
and	O
dub	O
##ai	O
was	O
103	O
##2	O
.	O
8	O
(	O
sd	O
252	O
)	O
kcal	O
and	O
101	O
##3	O
(	O
sd	O
339	O
.	O
1	O
)	O
kcal	O
respectively	O
and	O
105	O
##7	O
.	O
2	O
(	O
sd	O
201	O
.	O
8	O
)	O
kcal	O
and	O
103	O
##0	O
.	O
3	O
(	O
sd	O
341	O
.	O
7	O
)	O
kcal	O
for	O
boys	O
.	O
iron	B-T033
intake	I-T033
was	O
low	O
in	O
both	O
groups	O
.	O
mean	O
body	B-T201
mass	I-T201
index	I-T201
and	O
body	O
weight	O
and	O
height	O
were	O
similar	O
to	O
world	B-T092
health	I-T092
organization	I-T092
figures	O
but	O
significant	O
numbers	O
of	O
infants	O
and	O
tod	O
##dlers	O
of	O
both	O
sexes	O
were	O
over	B-T033
-	O
or	O
underweight	B-T033
.	O
although	O
mean	O
energy	O
and	O
macronutr	O
##ient	O
intakes	B-T058
were	O
comparable	O
to	O
the	O
rd	B-T170
##a	I-T170
,	O
significant	O
numbers	O
were	O
over	B-T038
-	O
or	O
under	B-T038
##fed	I-T038
.	O

development	B-T038
of	O
an	O
autom	O
##ato	O
##n	O
model	O
of	O
rotational	O
activity	O
driving	O
atrial	B-T038
fibrillation	I-T038
atrial	B-T038
fibrillation	I-T038
(	O
af	B-T038
)	O
is	O
difficult	O
to	O
treat	B-T058
effectively	O
,	O
owing	O
to	O
uncertainty	B-T033
in	O
where	O
to	O
best	O
abl	B-T058
##ate	I-T058
to	O
eliminate	O
arrhythm	B-T038
##ogenic	I-T038
substrate	O
.	O
a	O
model	O
providing	O
insight	O
into	O
the	O
electrical	O
activation	O
events	O
would	O
be	O
useful	O
to	O
guide	O
catheter	B-T058
ablation	I-T058
strategy	I-T058
.	O
method	O
a	O
two	B-T082
-	I-T082
dimensional	I-T082
,	O
57	O
##6	O
##×	O
##57	O
##6	O
node	O
autom	O
##ato	O
##n	O
was	O
developed	O
to	O
simulate	O
atrial	B-T017
electrical	O
activity	O
.	O
the	O
substrate	O
field	O
was	O
altered	O
by	O
the	O
presence	O
of	O
differing	O
refractory	O
period	O
at	O
varying	O
locations	B-T082
.	O
fibrosis	B-T038
was	O
added	O
in	O
the	O
form	O
of	O
short	O
,	O
randomly	O
positioned	O
lines	O
of	O
conduction	B-T038
block	B-T038
.	O
larger	O
areas	B-T082
of	O
block	B-T038
were	O
used	O
to	O
simulate	O
ablation	B-T033
lesions	I-T033
.	O
anisotropy	O
was	O
imposed	O
in	O
a	O
2	O
:	O
1	O
ratio	O
.	O
a	O
premature	O
electrical	B-T038
impulse	I-T038
from	O
one	O
of	O
four	O
grid	O
corners	O
was	O
utilized	O
to	O
initiate	O
activation	O
.	O
rotational	O
activity	O
was	O
unin	O
##duc	O
##ible	O
when	O
refractory	O
patch	O
dimensions	O
were	O
less	O
than	O
20	O
##×	O
##20	O
##mm	O
.	O
for	O
larger	O
refractory	O
regions	O
,	O
a	O
single	O
premature	O
stimulus	O
was	O
capable	O
of	O
inducing	O
an	O
average	O
of	O
1	O
.	O
19	O
##±1	O
.	O
10	O
rot	B-T074
##ors	I-T074
,	O
which	O
often	O
formed	O
near	O
the	O
patch	O
edges	O
.	O
a	O
maximum	O
of	O
5	O
rot	B-T074
##ors	I-T074
formed	O
when	O
refractory	O
patch	O
dimensions	O
approached	O
the	O
size	B-T082
of	O
the	O
entire	O
left	B-T017
atrial	I-T017
virtual	O
field	O
.	O
rot	B-T074
##ors	I-T074
formed	O
along	O
a	O
refractory	O
patch	O
edge	O
,	O
after	O
wave	B-T033
##front	I-T033
arrival	I-T033
was	I-T033
delayed	I-T033
at	O
turning	O
points	O
or	O
due	O
to	O
the	O
presence	O
of	O
a	O
fiber	B-T017
cluster	O
of	O
sufficient	O
size	B-T082
.	O
however	O
,	O
rotational	O
activity	O
could	O
also	O
occur	O
around	O
a	O
large	O
fiber	B-T017
cluster	O
without	O
the	O
need	O
of	O
spatially	O
variable	O
refract	O
##orin	O
##ess	O
.	O
when	O
obstacles	O
to	O
conduction	B-T038
were	O
lacking	O
in	O
size	B-T082
,	O
nascent	B-T074
rot	I-T074
##ors	I-T074
drift	O
##ed	O
and	O
either	O
extin	O
##gu	O
##ished	O
,	O
or	O
stabilized	B-T033
upon	O
anchoring	B-T038
at	O
a	O
sufficiently	O
large	O
fiber	B-T017
cluster	O
elsewhere	O
in	O
the	O
field	O
.	O
transient	O
rot	B-T074
##ors	I-T074
terminated	O
when	O
travers	O
##ing	O
a	O
region	B-T082
with	O
differing	O
refractory	O
periods	O
,	O
if	O
no	O
obstacle	O
to	O
conduction	B-T038
was	O
present	O
to	O
sufficiently	O
delay	B-T033
wave	I-T033
##front	I-T033
arrival	I-T033
beyond	O
the	O
longest	O
refractory	O
period	O
.	O
other	O
rot	B-T074
##ors	I-T074
were	O
ann	O
##ih	O
##ila	O
##ted	O
when	O
a	O
nearby	O
rot	B-T074
##or	I-T074
with	O
faster	O
spin	O
rate	O
gradually	O
interrupted	O
the	O
activation	B-T038
pathway	I-T038
.	O
elimination	O
of	O
anchor	B-T058
##s	I-T058
by	O
removal	B-T058
,	O
or	O
by	O
simulated	O
ablation	B-T058
over	O
a	O
sufficient	O
region	B-T082
,	O
prevented	O
rot	B-T074
##or	I-T074
onset	O
at	O
a	O
particular	O
location	B-T082
where	O
it	O
would	O
otherwise	O
form	O
.	O
the	O
presence	O
of	O
obstacles	O
to	O
conduction	B-T038
and	O
spatial	B-T033
differences	I-T033
in	O
refractory	O
period	O
are	O
important	O
parameters	O
for	O
initiating	O
and	O
maintaining	O
rotational	O
activity	O
in	O
this	O
simulation	B-T062
of	O
an	O
atrial	B-T017
substrate	O
.	O

influence	O
of	O
surface	O
properties	O
on	O
adhesion	O
forces	O
and	O
attachment	O
of	O
streptococcus	B-T007
mutans	I-T007
to	O
zirconia	B-T103
in	O
vitro	O
zirconia	B-T103
is	O
becoming	O
a	O
prevalent	O
material	O
in	O
dentistry	B-T091
.	O
however	O
,	O
any	O
foreign	B-T037
bodies	I-T037
inserted	B-T058
may	O
provide	O
new	O
niches	O
for	O
the	O
bacteria	B-T007
in	O
oral	B-T082
cavity	I-T082
.	O
the	O
object	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
effect	O
of	O
surface	O
properties	O
including	O
surface	B-T033
roughness	I-T033
and	O
hydrophobicity	O
on	O
the	O
adhesion	O
and	O
biofilm	B-T038
formation	I-T038
of	O
streptococcus	B-T007
mutans	I-T007
(	O
s	B-T007
.	I-T007
mutans	I-T007
)	O
to	O
zirconia	B-T103
.	O
atomic	B-T058
force	I-T058
microscopy	I-T058
was	O
employed	O
to	O
determine	O
the	O
zirconia	B-T103
surface	B-T082
morphology	O
and	O
the	O
adhesion	O
forces	O
between	O
the	O
s	B-T007
.	I-T007
mutans	I-T007
and	O
zirconia	B-T103
.	O
the	O
results	O
showed	O
that	O
the	O
surface	B-T033
roughness	I-T033
was	O
nanoscale	O
and	O
significantly	O
different	O
among	O
tested	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
:	O
coarse	O
(	O
23	O
.	O
94	O
±	O
2	O
.	O
52	O
nm	O
)	O
>	O
medium	O
(	O
17	O
.	O
00	O
±	O
3	O
.	O
81	O
nm	O
)	O
>	O
fine	O
(	O
11	O
.	O
89	O
±	O
1	O
.	O
68	O
nm	O
)	O
.	O
the	O
contact	B-T082
angles	I-T082
of	O
the	O
coarse	O
group	O
were	O
the	O
highest	O
,	O
followed	O
by	O
the	O
medium	O
and	O
the	O
fine	O
groups	O
.	O
increasing	O
the	O
surface	B-T033
roughness	I-T033
and	O
hydrophobicity	O
resulted	O
in	O
an	O
increase	O
of	O
adhesion	O
forces	O
and	O
early	O
attachment	O
(	O
2	O
h	O
and	O
4	O
h	O
)	O
of	O
s	B-T007
.	I-T007
mutans	I-T007
on	O
the	O
zirconia	B-T103
but	O
no	O
influence	O
on	O
the	O
further	O
development	O
of	O
biofilm	B-T007
(	O
6	O
h	O
~	O
24	O
h	O
)	O
.	O
our	O
findings	O
suggest	O
that	O
the	O
surface	B-T033
roughness	I-T033
in	O
nanoscale	O
and	O
hydrophobicity	O
of	O
zirconia	B-T103
had	O
influence	O
on	O
the	O
s	B-T007
.	I-T007
mutans	I-T007
initial	O
adhesion	O
force	O
and	O
early	O
attachment	O
instead	O
of	O
whole	O
stages	O
of	O
biofilm	B-T038
formation	I-T038
.	O

a	O
case	O
of	O
bilateral	B-T082
pneum	B-T038
##oth	I-T038
##orac	I-T038
##es	I-T038
resulting	O
from	O
tracheostomy	B-T058
for	O
advanced	O
laryngeal	B-T038
cancer	I-T038
pneumothorax	B-T038
is	O
a	O
possible	O
complication	B-T038
of	O
tracheostomy	B-T058
.	O
we	O
report	B-T058
a	O
rare	O
case	O
of	O
bilateral	B-T082
pneum	B-T038
##oth	I-T038
##orac	I-T038
##es	I-T038
resulting	O
from	O
tracheostomy	B-T058
in	O
an	O
advanced	O
laryngeal	B-T038
cancer	I-T038
patient	O
.	O
a	O
59	O
-	O
year	O
-	O
old	O
man	O
was	O
referred	O
to	O
our	O
clinic	B-T092
for	O
evaluation	B-T058
and	O
treatment	B-T058
of	O
laryngeal	B-T038
tumor	I-T038
.	O
laryngeal	B-T058
endoscopy	I-T058
showed	O
limited	B-T033
movement	I-T033
of	O
bilateral	B-T017
vocal	I-T017
cords	I-T017
,	O
and	O
computed	B-T058
tomography	I-T058
revealed	O
a	O
tumor	B-T038
lesion	B-T033
extending	O
from	O
the	O
vocal	B-T017
cords	I-T017
to	O
the	O
sub	B-T017
##gl	I-T017
##ott	I-T017
##ic	I-T017
area	I-T017
.	O
three	O
days	O
after	O
the	O
first	B-T033
visit	I-T033
,	O
the	O
patient	O
developed	O
respiratory	B-T033
difficulty	I-T033
,	O
and	O
we	O
elect	O
##ed	O
to	O
perform	O
emergency	B-T058
tracheostomy	I-T058
for	O
airway	B-T058
management	I-T058
.	O
immediately	O
after	O
the	O
start	O
of	O
the	O
procedure	B-T058
,	O
he	O
began	O
hyperv	B-T033
##enti	I-T033
##la	I-T033
##ting	I-T033
,	O
and	O
complained	O
of	O
respiratory	O
discomfort	O
and	O
chest	B-T033
pain	I-T033
.	O
we	O
then	O
recognized	O
a	O
mediastinal	B-T082
air	B-T038
leak	I-T038
,	O
and	O
we	O
suspected	O
pneumothorax	B-T038
resulting	O
from	O
the	O
tracheostomy	B-T058
.	O
chest	B-T058
x	I-T058
-	I-T058
ray	I-T058
showed	O
bilateral	B-T082
pneum	B-T038
##oth	I-T038
##orac	I-T038
##es	I-T038
;	O
therefore	O
,	O
we	O
inserted	B-T058
bilateral	B-T082
chest	B-T082
drainage	B-T074
tubes	I-T074
,	O
which	O
stabilized	B-T033
his	O
respiratory	O
condition	O
.	O
we	O
speculated	O
that	O
the	O
pathogenesis	B-T038
of	O
the	O
bilateral	B-T082
pneum	B-T038
##oth	I-T038
##orac	I-T038
##es	I-T038
was	O
weakened	O
alveolar	B-T017
walls	I-T017
secondary	O
to	O
long	O
-	O
term	O
smoking	O
,	O
and	O
a	O
significant	O
rise	O
in	O
airway	B-T201
pressure	I-T201
because	O
of	O
airway	B-T033
constriction	I-T033
by	O
the	O
neck	B-T082
-	I-T082
extended	I-T082
position	I-T082
and	O
hyperventilation	B-T033
,	O
during	O
tracheostomy	B-T058
.	O

correlation	O
of	O
the	O
lipid	B-T103
profile	B-T058
,	O
bmi	B-T201
and	O
bone	B-T201
mineral	I-T201
density	I-T201
in	O
postmenopausal	B-T038
women	B-T098
to	O
the	O
reduction	O
of	O
bone	B-T201
density	I-T201
and	O
osteoporosis	B-T038
in	O
postmenopausal	B-T038
women	B-T098
contribute	O
elevated	O
lipid	B-T103
parameters	B-T033
and	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
.	O
the	O
goal	O
of	O
our	O
study	B-T062
was	O
to	O
determine	O
the	O
correlation	O
between	O
lipid	B-T103
parameters	B-T033
,	O
bmi	B-T201
and	O
osteoporosis	B-T038
in	O
postmenopausal	B-T038
women	B-T098
.	O
the	O
study	B-T062
was	O
carried	O
out	O
by	O
matched	O
type	O
between	O
experimental	O
group	O
and	O
controls	O
.	O
the	O
experimental	O
group	O
consisted	O
of	O
100	O
females	B-T098
at	O
postmenopausal	B-T038
age	O
,	O
in	O
which	O
by	O
the	O
dex	B-T058
##a	I-T058
method	I-T058
was	O
diagnosed	B-T033
osteoporosis	B-T038
at	O
the	O
department	O
of	O
endocrin	O
##ology	O
,	O
diabetes	O
and	O
metabolic	O
diseases	O
,	O
university	B-T092
medical	I-T092
center	I-T092
of	I-T092
rs	I-T092
during	O
2015	O
-	O
2016	O
,	O
while	O
the	O
control	O
group	O
consisted	O
of	O
100	O
females	B-T098
in	O
a	O
postmenopausal	B-T038
age	O
but	O
without	O
diagnosed	B-T033
osteoporosis	B-T038
.	O
the	O
groups	O
were	O
matched	O
by	O
age	O
(	O
±	O
2	O
years	O
)	O
.	O
to	O
all	O
participants	B-T098
of	O
the	O
study	B-T062
were	O
carried	O
out	O
biochemical	B-T058
analysis	I-T058
of	I-T058
blood	I-T058
,	O
or	O
the	O
analysis	B-T062
of	O
the	O
lipid	B-T103
profile	B-T058
that	O
included	O
total	B-T103
cholesterol	I-T103
,	O
ldl	B-T103
cholesterol	I-T103
,	O
triglycerides	B-T103
(	O
tg	B-T103
)	O
and	O
hdl	B-T103
cholesterol	I-T103
,	O
and	O
was	O
determined	O
the	O
values	O
of	O
bmi	B-T201
and	O
waist	B-T201
circumference	I-T201
(	O
wc	B-T201
)	O
.	O
analysis	B-T062
of	O
the	O
data	O
of	O
our	O
research	B-T062
shows	O
that	O
by	O
the	O
univariate	B-T062
logistic	I-T062
regression	I-T062
the	O
values	O
of	O
lipid	B-T103
parameters	B-T033
total	B-T103
cholesterol	I-T103
(	O
p	O
=	O
0	O
.	O
000	O
)	O
,	O
ldl	B-T103
(	O
p	O
=	O
0	O
.	O
005	O
)	O
and	O
tg	B-T103
(	O
p	O
=	O
0	O
.	O
033	O
)	O
were	O
significantly	O
associated	O
with	O
osteoporosis	B-T038
,	O
while	O
in	O
multivariate	B-T170
logistic	I-T170
model	I-T170
only	O
total	B-T103
cholesterol	I-T103
(	O
p	O
=	O
0	O
.	O
018	O
)	O
was	O
found	O
as	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
osteoporosis	B-T038
in	O
postmenopausal	B-T038
women	B-T098
.	O
bmi	B-T201
values	O
were	O
not	B-T033
statistically	O
significantly	O
associated	O
with	O
osteoporosis	B-T038
(	O
p	O
=	O
0	O
.	O
72	O
##7	O
)	O
.	O
on	O
the	O
decrease	O
in	O
bone	B-T201
mineral	I-T201
density	I-T201
and	O
osteoporosis	B-T038
in	O
postmenopausal	B-T038
women	B-T098
influence	O
many	O
risk	B-T033
factors	I-T033
whose	O
identification	O
has	O
the	O
aim	O
to	O
develop	O
more	O
effective	O
prevention	O
of	O
this	O
disease	B-T038
in	O
the	O
elderly	B-T098
.	O

opioid	B-T103
use	O
in	O
chronic	B-T033
pain	I-T033
patients	O
with	O
chronic	B-T038
kidney	I-T038
disease	I-T038
:	O
a	O
systematic	B-T170
review	I-T170
to	O
investigate	O
the	O
prevalence	O
of	O
chronic	B-T033
pain	I-T033
and	O
opioid	B-T103
management	B-T058
among	O
patients	O
with	O
chronic	B-T038
kidney	I-T038
disease	I-T038
(	O
ckd	B-T038
)	O
.	O
systematic	B-T170
review	I-T170
.	O
a	O
systematic	O
search	O
was	O
performed	O
,	O
including	O
citations	O
from	O
1960	O
to	O
may	O
2015	O
.	O
the	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	B-T170
;	O
prevalence	O
of	O
pain	B-T033
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	B-T103
use	O
;	O
effectiveness	O
of	O
pain	B-T058
control	I-T058
and	O
associated	O
adverse	B-T038
effects	I-T038
of	O
opioids	B-T103
in	O
ckd	B-T038
patients	O
.	O
twelve	O
of	O
131	O
articles	O
met	O
inclusion	O
criteria	O
.	O
there	O
were	O
no	O
randomized	B-T062
controlled	I-T062
trials	I-T062
(	O
rct	B-T062
)	O
evaluable	O
,	O
and	O
12	O
were	O
observational	B-T170
studies	I-T170
.	O
out	O
of	O
12	O
studies	B-T170
,	O
four	O
were	O
of	O
high	O
quality	O
,	O
six	O
were	O
of	O
moderate	O
quality	O
,	O
and	O
the	O
remaining	O
two	O
were	O
low	O
-	O
quality	O
studies	B-T170
.	O
the	O
studies	B-T170
were	O
from	O
different	O
countries	B-T082
with	O
sample	O
size	O
ranging	O
from	O
10	O
to	O
12	O
,	O
78	O
##2	O
.	O
several	O
studies	B-T170
showed	O
a	O
high	O
prevalence	O
of	O
chronic	O
uncontrolled	B-T033
pain	I-T033
.	O
the	O
effectiveness	O
of	O
different	O
categories	O
of	O
opioids	B-T103
,	O
dose	O
,	O
duration	O
,	O
and	O
commonly	O
prescribed	O
opioids	B-T103
varied	O
across	O
studies	B-T170
.	O
based	O
on	O
a	O
systematic	B-T170
review	I-T170
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	B-T033
pain	I-T033
among	O
patients	O
with	O
ckd	B-T038
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underp	O
##res	O
##cription	O
of	O
analgesics	B-T103
or	O
opioids	B-T103
in	O
the	O
ckd	B-T038
population	O
.	O
clinicians	B-T097
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	B-T062
control	I-T062
trials	I-T062
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	B-T103
therapy	B-T058
,	O
appropriate	O
opioid	B-T103
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	B-T058
control	I-T058
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	B-T038
side	I-T038
effects	I-T038
.	O

antenatal	O
consultation	B-T058
following	O
limb	B-T017
malformation	I-T017
discovery	O
using	O
ultrasound	B-T058
scan	I-T058
our	O
unit	B-T092
has	O
been	O
providing	O
antenatal	O
consultations	B-T058
for	O
30	O
years	O
following	O
the	O
discovery	O
of	O
limb	B-T017
malformation	I-T017
with	O
the	O
fetus	B-T017
.	O
each	O
of	O
these	O
consultations	B-T058
is	O
specific	O
and	O
carried	B-T058
out	I-T058
by	O
a	O
multi	B-T058
-	I-T058
professional	I-T058
team	I-T058
.	O
it	O
requires	O
a	O
physical	O
and	O
rehabilitation	B-T091
doctor	B-T097
,	O
an	O
orthopedic	B-T097
surgeon	I-T097
,	O
an	O
occupational	B-T097
therapist	I-T097
for	O
upper	O
limb	O
malformation	O
,	O
a	O
physiotherap	B-T097
##ist	I-T097
for	O
lower	O
malformation	O
and	O
a	O
psycho	B-T097
##lo	I-T097
##gi	I-T097
##st	I-T097
.	O
this	O
multidisciplinary	O
consultation	B-T058
is	O
unique	O
because	O
of	O
each	O
pregnancy	B-T038
story	O
,	O
because	O
of	O
each	O
patient	O
life	O
story	O
but	O
also	O
because	O
of	O
the	O
words	O
used	O
by	O
the	O
son	B-T097
##ologist	I-T097
when	O
ann	O
##oun	O
##cing	O
the	O
diagnosis	B-T033
.	O
we	O
deal	O
with	O
couples	O
shock	B-T033
##ed	I-T033
by	O
the	O
prenatal	B-T058
diagnosis	I-T058
.	O
we	O
help	O
them	O
get	O
acceptance	O
of	O
the	O
child	O
to	O
be	O
born	O
and	O
to	O
forget	O
about	O
their	O
imag	B-T038
##inary	I-T038
child	O
.	O
medical	O
information	O
is	O
often	O
perceived	B-T038
as	O
being	O
[UNK]	O
a	O
surf	O
##eit	O
of	O
information	O
[UNK]	O
difficult	O
to	O
handle	O
by	O
the	O
couple	O
st	O
##unn	O
##ed	O
by	O
the	O
overwhelming	O
diagnosis	B-T033
.	O
we	O
must	O
stress	O
that	O
it	O
is	O
critical	O
to	O
not	O
only	O
have	O
a	O
good	O
medical	O
description	O
of	O
the	O
malformations	B-T017
and	O
potential	B-T058
treatments	I-T058
but	O
also	O
a	O
good	O
psychological	B-T058
support	I-T058
(	O
parents	O
personal	O
life	O
story	O
,	O
self	B-T038
-	I-T038
defense	I-T038
mechanism	I-T038
,	O
guil	B-T038
##t	I-T038
feeling	I-T038
)	O
.	O
the	O
ethical	O
aspect	O
of	O
this	O
consultation	B-T058
is	O
also	O
important	O
.	O
team	B-T058
members	B-T098
must	O
be	O
as	O
neutral	B-T170
as	O
possible	B-T033
in	O
their	O
assessments	B-T058
in	O
order	O
to	O
let	O
the	O
couple	O
take	O
the	O
final	O
decision	B-T038
:	O
the	O
continuation	O
of	O
the	O
pregnancy	B-T038
or	O
a	O
request	O
of	O
voluntary	O
termination	B-T058
of	I-T058
pregnancy	I-T058
.	O
these	O
prenatal	O
consultations	B-T058
highlight	O
the	O
importance	O
of	O
the	O
multidisciplinary	O
global	O
care	B-T058
.	O

the	O
association	O
between	O
maternal	B-T033
hydronephrosis	B-T038
and	O
acute	O
flank	B-T033
pain	I-T033
during	O
pregnancy	B-T038
:	O
a	O
prospective	B-T062
pilot	B-T062
-	I-T062
study	I-T062
maternal	B-T033
hydronephrosis	B-T038
may	O
cause	O
flank	B-T033
pain	I-T033
during	O
pregnancy	B-T038
.	O
we	O
aimed	O
to	O
investigate	O
the	O
association	O
between	O
maternal	B-T033
hydronephrosis	B-T038
and	O
flank	B-T033
pain	I-T033
intensity	B-T201
.	O
from	O
2014	O
to	O
2015	O
,	O
all	O
consecutive	O
women	B-T098
with	O
singleton	B-T038
pregnancies	I-T038
,	O
who	O
presented	O
at	O
our	O
tertiary	O
center	O
due	O
to	O
acute	O
flank	B-T033
pain	I-T033
,	O
were	O
prospectively	B-T062
evaluated	B-T058
by	O
renal	B-T017
ultrasonography	B-T058
and	O
pain	B-T033
questionnaires	B-T170
.	O
a	O
visual	B-T058
analogue	I-T058
scale	I-T058
was	O
used	O
to	O
assess	O
pain	B-T201
intensity	I-T201
.	O
the	O
study	B-T062
had	O
90	O
%	O
power	O
to	O
detect	O
a	O
significant	O
correlation	O
between	O
hydronephrosis	B-T038
and	O
flank	B-T033
pain	I-T033
(	O
spearman	B-T170
'	I-T170
s	I-T170
test	I-T170
)	O
.	O
a	O
total	O
of	O
51	O
consecutive	O
women	B-T098
with	O
left	B-T082
-	I-T082
sided	I-T082
(	O
13	O
.	O
7	O
%	O
)	O
,	O
right	B-T082
-	I-T082
sided	I-T082
(	O
64	O
.	O
7	O
%	O
)	O
or	O
bilateral	B-T082
(	O
21	O
.	O
6	O
%	O
)	O
pain	B-T033
were	O
enrolled	O
.	O
the	O
mean	O
gestational	O
age	O
of	O
these	O
women	B-T098
,	O
who	O
presented	O
due	O
to	O
their	O
pain	B-T033
,	O
was	O
27	O
.	O
5	O
±	O
6	O
.	O
8	O
weeks	O
at	O
the	O
time	O
of	O
consultation	B-T058
.	O
the	O
mean	O
vas	O
score	O
was	O
7	O
.	O
6	O
±	O
2	O
.	O
2	O
.	O
in	O
43	O
/	O
51	O
(	O
84	O
.	O
3	O
%	O
)	O
women	B-T098
,	O
hydronephrosis	B-T038
was	O
found	O
on	O
renal	B-T017
son	O
##ograms	O
.	O
no	O
correlation	O
was	O
found	O
between	O
the	O
grade	O
of	O
hydronephrosis	B-T038
and	O
pain	B-T201
intensity	I-T201
(	O
p	O
=	O
0	O
.	O
46	O
##6	O
;	O
r	O
=	O
-	O
0	O
.	O
28	O
)	O
.	O
women	B-T098
delivered	O
at	O
a	O
mean	O
gestational	O
age	O
of	O
38	O
.	O
1	O
±	O
2	O
.	O
4	O
weeks	O
and	O
their	O
infants	O
had	O
a	O
mean	O
birthweight	O
of	O
313	O
##8	O
±	O
67	O
##7	O
g	O
.	O
hydronephrosis	B-T038
is	O
a	O
common	O
finding	B-T033
among	O
pregnant	B-T098
women	I-T098
with	O
acute	O
flank	B-T033
pain	I-T033
.	O
the	O
grade	O
of	O
hydronephrosis	B-T038
does	O
not	O
affect	O
pain	B-T201
intensity	I-T201
.	O
this	O
study	B-T062
suggests	O
normal	B-T033
pregnancy	I-T033
outcomes	B-T033
in	O
these	O
women	B-T098
.	O

data	O
-	O
driven	O
implementation	O
of	O
alarm	B-T074
reduction	O
interventions	B-T058
in	O
a	O
cardiovascular	B-T092
surgical	I-T092
icu	I-T092
alarm	O
fatigue	O
in	O
the	O
icu	B-T092
setting	O
has	O
been	O
well	O
documented	B-T058
in	O
the	O
literature	B-T170
.	O
the	O
icu	B-T092
'	I-T092
s	I-T092
high	B-T170
-	I-T170
intensity	I-T170
environment	B-T082
requires	O
staff	B-T097
'	I-T097
s	I-T097
vig	B-T038
##ila	I-T038
##nt	I-T038
attention	B-T038
,	O
and	O
distraction	O
from	O
false	O
and	O
non	O
-	O
action	O
##able	O
alarm	B-T074
##s	I-T074
pull	O
##s	O
staff	B-T097
away	O
from	O
important	O
tasks	O
,	O
creates	O
dissatisfaction	B-T038
,	O
and	O
is	O
a	O
potential	O
patient	B-T058
safety	I-T058
risk	O
if	O
alarm	B-T074
##s	I-T074
are	O
missed	O
or	O
ignored	O
.	O
this	O
project	O
was	O
intended	O
to	O
improve	O
patient	B-T058
safety	I-T058
by	O
optimizing	O
alarm	B-T074
systems	O
in	O
a	O
cardiovascular	B-T092
surgical	I-T092
intensive	I-T092
care	I-T092
unit	I-T092
(	O
cvs	B-T092
##ic	I-T092
##u	I-T092
)	O
.	O
specific	O
aims	O
were	O
to	O
examine	B-T033
nurses	B-T097
'	O
attitudes	B-T038
toward	O
clinical	O
alarm	B-T074
signals	O
,	O
assess	O
nurses	B-T097
'	O
ability	O
to	O
discriminate	O
audi	O
##ble	O
alarm	O
signals	O
,	O
and	O
implement	O
a	O
bundle	O
##d	O
set	O
of	O
best	O
practices	O
for	O
monitor	O
alarm	O
reduction	O
without	O
underm	O
##ining	O
patient	B-T058
safety	I-T058
.	O
cvs	B-T092
##ic	I-T092
##u	I-T092
nurses	B-T097
completed	O
an	O
alarm	B-T074
perception	B-T170
survey	I-T170
and	O
participated	O
in	O
alarm	B-T074
discrimin	O
##ability	O
testing	O
.	O
nurse	B-T170
survey	I-T170
data	I-T170
and	O
baseline	O
monitor	O
alarm	B-T074
data	O
were	O
used	O
to	O
select	O
targeted	O
alarm	B-T074
reduction	O
interventions	B-T058
,	O
which	O
were	O
progressively	O
phase	O
##d	O
in	O
.	O
monitor	O
alarm	B-T074
data	O
and	O
cardiorespiratory	B-T033
event	I-T033
data	O
were	O
trend	O
##ed	O
over	O
one	O
year	O
.	O
five	O
of	O
the	O
most	O
frequent	O
cvs	B-T092
##ic	I-T092
##u	I-T092
monitor	O
alarm	O
types	O
-	O
pulse	B-T058
oximetry	I-T058
,	O
heart	B-T201
rate	I-T201
,	O
systolic	B-T033
and	O
diastolic	B-T038
blood	I-T038
pressure	I-T038
,	O
pulse	B-T058
oximetry	I-T058
sensor	O
,	O
and	O
ventricular	B-T038
tachycardia	I-T038
>	O
2	O
-	O
were	O
targeted	O
.	O
after	O
implementation	O
,	O
there	O
was	O
a	O
61	O
%	O
reduction	O
in	O
average	O
alarm	B-T074
##s	I-T074
per	O
monitored	O
bed	O
and	O
a	O
downward	O
trend	O
in	O
cardiorespiratory	B-T033
events	I-T033
.	O
to	O
reduce	O
alarm	O
fatigue	O
it	O
is	O
important	O
to	O
decrease	O
alarm	B-T074
burden	O
through	O
targeted	O
interventions	B-T058
.	O
methods	O
to	O
reduce	O
non	O
-	O
action	O
##able	O
alarm	B-T074
##s	I-T074
include	O
adding	O
short	O
delays	O
to	O
allow	O
alarm	B-T074
self	O
-	O
correction	O
,	O
adjusting	O
default	O
alarm	B-T074
threshold	O
limits	O
,	O
providing	O
alarm	B-T074
notification	B-T058
through	O
a	O
secondary	B-T074
device	I-T074
,	O
and	O
teaching	O
staff	B-T097
to	O
optimize	O
alarm	B-T074
settings	O
for	O
individual	B-T098
patients	O
.	O

regulation	B-T038
of	O
abca1	B-T017
and	O
abc	B-T017
##g1	I-T017
gene	B-T038
expression	I-T038
in	O
the	O
intra	B-T017
##abdominal	I-T017
adipose	I-T017
tissue	I-T017
tissue	B-T038
specific	I-T038
expression	I-T038
of	I-T038
genes	I-T038
encoding	O
cholesterol	B-T103
transporters	B-T103
abca1	B-T103
and	O
abc	B-T103
##g1	I-T103
as	O
well	O
as	O
genes	B-T017
encoding	O
the	O
most	O
important	O
transcriptional	B-T038
regulators	B-T103
of	O
adipogenesis	B-T038
-	O
lx	B-T103
##ra	I-T103
,	O
lx	B-T103
##rb	I-T103
,	O
pparg	B-T103
and	O
ror	B-T103
##a	I-T103
has	O
been	O
investigated	O
in	O
intra	B-T017
##abdominal	I-T017
adipose	I-T017
tissue	I-T017
(	O
iat	B-T017
)	O
samples	O
.	O
a	O
direct	O
correlation	O
between	O
the	O
content	O
of	O
abca1	B-T103
and	O
abc	B-T103
##g1	I-T103
proteins	I-T103
with	O
ror	B-T103
##a	I-T103
protein	I-T103
level	O
(	O
r	O
=	O
0	O
.	O
480	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
r	O
=	O
0	O
.	O
435	O
,	O
p	O
<	O
0	O
.	O
05	O
,	O
respectively	O
)	O
suggests	O
the	O
role	O
of	O
the	O
transcription	B-T103
factor	I-T103
ror	B-T103
##a	I-T103
in	O
the	O
regulation	B-T038
of	O
iat	B-T017
abca1	B-T103
and	O
abc	B-T103
##g1	I-T103
protein	I-T103
levels	O
.	O
abca1	B-T017
and	O
abc	B-T017
##g1	I-T017
gene	B-T038
expression	I-T038
positively	O
correlated	O
with	O
obesity	B-T038
indicators	B-T103
such	O
as	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
(	O
r	O
=	O
0	O
.	O
52	O
##2	O
,	O
p	O
=	O
0	O
.	O
004	O
;	O
r	O
=	O
0	O
.	O
59	O
##4	O
,	O
p	O
=	O
0	O
.	O
001	O
,	O
respectively	O
)	O
and	O
waist	B-T201
circumference	I-T201
(	O
r	O
=	O
0	O
.	O
40	O
##3	O
,	O
p	O
=	O
0	O
.	O
033	O
;	O
r	O
=	O
0	O
.	O
47	O
##4	O
,	O
p	O
=	O
0	O
.	O
013	O
,	O
respectively	O
)	O
.	O
the	O
development	O
of	O
obesity	B-T038
is	O
associated	O
with	O
decreased	O
iat	B-T017
levels	O
of	O
ror	B-T017
##a	I-T017
and	O
lx	B-T017
##rb	I-T017
mrna	B-T103
(	O
p	O
=	O
0	O
.	O
016	O
and	O
p	O
=	O
0	O
.	O
002	O
,	O
respectively	O
)	O
.	O
these	O
data	O
suggest	O
that	O
the	O
nuclear	B-T103
factor	I-T103
ror	I-T103
##a	I-T103
can	O
play	O
a	O
significant	O
role	O
in	O
the	O
regulation	B-T038
of	O
cholesterol	B-T038
metabolism	I-T038
and	O
control	O
iat	B-T017
expression	B-T038
of	O
abca1	B-T103
and	O
abc	B-T103
##g1	I-T103
,	O
while	O
the	O
level	O
of	O
iat	B-T017
lx	B-T017
##rb	I-T017
gene	B-T038
expression	I-T038
may	O
be	O
an	O
important	O
factor	O
associated	O
with	O
the	O
development	O
of	O
obesity	B-T038
.	O

temporal	O
stability	O
of	O
heavy	B-T033
drinking	I-T033
days	O
and	O
drinking	O
reductions	B-T058
among	O
heavy	O
drinkers	O
in	O
the	O
combine	B-T062
study	I-T062
recently	O
,	O
the	O
food	B-T092
and	I-T092
drug	I-T092
administration	I-T092
(	O
fda	B-T092
)	O
proposed	O
to	O
expand	B-T082
the	O
options	O
for	O
primary	O
end	O
points	O
in	O
the	O
development	O
of	O
medications	B-T058
for	O
alcohol	O
use	O
disorder	O
to	O
include	O
either	O
abstinence	O
from	O
alcohol	B-T168
or	O
a	O
non	B-T033
##abs	I-T033
##tine	I-T033
##nt	I-T033
outcome	O
:	O
no	O
heavy	B-T033
drinking	I-T033
days	O
(	O
with	O
a	O
heavy	B-T033
drinking	I-T033
day	O
defined	B-T170
as	O
more	O
than	O
3	O
drinks	B-T168
per	O
day	O
for	O
women	B-T098
and	O
more	O
than	O
4	O
drinks	B-T168
per	O
day	O
for	O
men	B-T098
[	O
>	O
3	O
/	O
>	O
4	O
cutoff	O
]	O
)	O
.	O
the	O
fda	B-T092
also	O
suggested	O
that	O
6	O
months	O
would	O
be	O
the	O
most	O
appropriate	O
length	B-T062
for	I-T062
a	I-T062
clinical	I-T062
trial	I-T062
to	O
demonstrate	O
the	O
stability	O
of	O
this	O
non	B-T033
##abs	I-T033
##tine	I-T033
##nt	I-T033
drinking	O
outcome	O
.	O
however	O
,	O
few	O
alcohol	O
clinical	B-T062
trials	I-T062
have	O
examined	B-T033
the	O
stability	O
of	O
nonh	B-T033
##eav	I-T033
##y	I-T033
drinking	I-T033
during	O
and	O
after	B-T058
treatment	I-T058
.	O
in	O
a	O
secondary	O
analysis	O
of	O
the	O
combine	B-T062
study	I-T062
data	O
(	O
n	O
=	O
1	O
,	O
38	O
##3	O
)	O
,	O
we	O
examined	B-T033
transitions	O
in	O
heavy	B-T033
drinking	I-T033
days	O
during	O
the	O
course	O
of	O
treatment	O
(	O
months	O
1	O
through	O
4	O
)	O
,	O
during	O
the	O
transition	O
out	O
of	O
treatment	B-T058
(	O
months	O
4	O
through	O
7	O
)	O
,	O
and	O
up	O
to	O
12	O
months	O
after	O
##ward	O
(	O
months	O
13	O
through	O
16	O
)	O
using	O
latent	O
variable	O
mixture	O
models	O
.	O
heavy	B-T033
drinking	I-T033
and	O
nonh	B-T033
##eav	I-T033
##y	I-T033
drinking	I-T033
were	O
relatively	O
stable	O
in	O
consecutive	O
months	O
(	O
minimum	O
agreement	O
[	O
kappa	O
]	O
=	O
0	O
.	O
64	O
for	O
months	O
1	O
to	O
2	O
)	O
.	O
most	O
individuals	B-T098
were	O
stable	O
low	O
-	O
risk	O
drinkers	B-T033
/	O
abs	O
##tain	O
##ers	O
or	O
heavy	O
drinkers	O
by	O
the	O
end	O
of	O
treatment	B-T058
,	O
as	O
characterized	O
by	O
a	O
10	O
%	O
probability	O
(	O
or	O
less	O
)	O
of	O
transition	O
##ing	O
out	O
of	O
either	O
a	O
no	O
heavy	B-T033
drinking	I-T033
state	O
or	O
a	O
heavy	B-T033
drinking	I-T033
state	O
.	O
more	O
than	O
two	O
-	O
thirds	O
of	O
the	O
heavy	O
drinkers	O
who	O
exceeded	O
the	O
heavy	B-T033
drinking	I-T033
threshold	O
during	O
treatment	O
reported	B-T058
,	O
on	O
average	O
,	O
a	O
64	O
%	O
reduction	B-T058
in	O
drinking	B-T033
frequency	I-T033
and	O
a	O
38	O
%	O
reduction	B-T058
in	O
drinking	O
intensity	O
from	O
pretreatment	O
drinking	O
levels	O
.	O
the	O
results	B-T033
show	O
stability	O
of	O
no	O
heavy	B-T033
drinking	I-T033
as	O
an	O
outcome	O
within	O
the	O
first	O
4	O
months	O
of	O
treatment	B-T058
and	O
that	O
the	O
>	O
3	O
/	O
>	O
4	O
drink	B-T168
cutoff	O
may	O
mask	O
substantial	O
reductions	B-T058
in	O
alcohol	O
consumption	O
among	O
some	O
patients	O
.	O
future	O
studies	B-T062
should	O
explore	O
the	O
clinical	O
utility	O
of	O
reduction	B-T058
end	O
points	O
.	O

lipid	B-T058
levels	I-T058
and	O
risk	O
of	O
recurrent	B-T038
venous	I-T038
thrombosis	I-T038
:	O
results	O
from	O
the	O
meg	B-T062
##a	I-T062
follow	I-T062
-	I-T062
up	I-T062
study	I-T062
essential	O
##s	O
the	O
role	O
of	O
lipid	B-T058
levels	I-T058
in	O
the	O
risk	O
of	O
recurrent	B-T038
venous	I-T038
thrombosis	I-T038
is	O
unclear	O
.	O
lipids	B-T103
were	O
assessed	O
in	O
patients	O
with	O
a	O
first	O
venous	B-T038
thrombosis	I-T038
(	O
n	O
=	O
210	O
##6	O
)	O
followed	O
for	O
6	O
.	O
9	O
years	O
.	O
lipids	B-T103
were	O
not	O
associated	O
with	O
recurrence	O
,	O
overall	O
or	O
in	O
patients	O
with	O
unpro	O
##vo	O
##ke	O
##d	O
first	O
events	O
.	O
testing	B-T058
lipid	I-T058
levels	I-T058
is	O
not	O
useful	O
to	O
identify	O
patients	O
at	O
an	O
increased	O
risk	O
of	O
recurrence	O
.	O
background	O
knowledge	O
of	O
risk	B-T033
factors	I-T033
for	O
recurrent	B-T038
venous	I-T038
thrombosis	I-T038
may	O
guide	O
decisions	O
on	O
duration	O
of	O
anticoagulation	B-T058
.	O
the	O
association	O
between	O
lipid	B-T058
levels	I-T058
and	O
first	O
venous	B-T038
thrombosis	I-T038
has	O
been	O
studied	O
extensively	O
.	O
however	O
,	O
data	O
on	O
the	O
role	O
of	O
lipids	B-T103
in	O
the	O
risk	O
of	O
recurrence	O
are	O
scarce	O
.	O
objective	O
to	O
assess	O
the	O
association	O
between	O
lipid	B-T058
levels	I-T058
and	O
recurrent	B-T038
venous	I-T038
thrombosis	I-T038
.	O
patients	O
/	O
methods	O
patients	O
with	O
a	O
first	O
venous	B-T038
thrombosis	I-T038
from	O
the	O
meg	B-T062
##a	I-T062
study	I-T062
were	O
included	O
.	O
follow	B-T058
-	I-T058
up	I-T058
started	O
at	O
the	O
date	O
of	O
end	B-T082
of	O
anticoagulant	B-T058
treatment	I-T058
.	O
percentile	O
categories	B-T170
of	O
total	B-T103
/	O
low	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
/	O
high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
cholesterol	I-T103
,	O
triglycerides	B-T103
and	O
apolipoprotein	B-T103
##s	I-T103
b	I-T103
and	O
a1	B-T103
were	O
established	O
(	O
<	O
10th	O
,	O
10th	O
-	O
25	O
##th	O
,	O
25	O
##th	O
-	O
75	O
##th	O
[	O
reference	O
]	O
,	O
75	O
##th	O
-	O
90	O
##th	O
,	O
>	O
90	O
##th	O
percentile	O
)	O
.	O
lipids	B-T103
were	O
measured	O
at	O
least	O
3	O
months	O
after	O
discontin	B-T033
##uing	I-T033
anticoagulation	B-T058
.	O
results	O
of	O
210	O
##6	O
patients	O
followed	O
for	O
a	O
median	O
of	O
6	O
.	O
9	O
years	O
,	O
326	O
developed	O
recurrence	O
(	O
incidence	O
rate	O
,	O
2	O
.	O
7	O
/	O
100	O
patient	O
-	O
years	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
,	O
2	O
.	O
5	O
-	O
3	O
.	O
1	O
)	O
.	O
with	O
hazard	O
ratios	O
ranging	O
from	O
0	O
.	O
88	O
(	O
95	O
%	O
ci	O
,	O
0	O
.	O
55	O
-	O
1	O
.	O
42	O
)	O
to	O
1	O
.	O
33	O
(	O
95	O
%	O
ci	O
,	O
0	O
.	O
86	O
-	O
2	O
.	O
04	O
)	O
in	O
the	O
highest	O
percentile	O
category	B-T170
vs	O
.	O
the	O
reference	O
,	O
we	O
found	O
no	O
association	O
across	O
percentile	O
categories	B-T170
between	O
recurrence	O
and	O
lipid	B-T058
levels	I-T058
in	O
age	O
-	O
and	O
sex	O
-	O
adjusted	O
models	O
,	O
nor	O
after	O
further	B-T082
adjustments	O
for	O
body	B-T201
mass	I-T201
index	I-T201
,	O
diabetes	B-T038
,	O
estrogen	B-T103
and	O
statin	B-T103
use	O
,	O
and	O
duration	O
of	O
anticoagulation	B-T058
.	O
subgroup	B-T170
analyses	B-T062
stratified	O
by	O
unpro	O
##vo	O
##ke	O
##d	O
or	O
provoked	O
first	O
events	O
,	O
location	B-T082
(	O
deep	B-T038
vein	I-T038
thrombosis	I-T038
or	O
pulmonary	B-T038
embolism	I-T038
)	O
and	O
sex	O
also	O
did	O
not	O
reveal	O
an	O
association	O
with	O
any	O
of	O
the	O
lipid	B-T058
levels	I-T058
studied	O
.	O
conclusions	O
testing	B-T058
lipid	I-T058
levels	I-T058
did	O
not	O
identify	O
patients	O
at	O
an	O
increased	O
risk	O
of	O
recurrent	B-T038
venous	I-T038
thrombosis	I-T038
in	O
this	O
study	B-T062
,	O
including	O
those	O
with	O
unpro	O
##vo	O
##ke	O
##d	O
first	O
events	O
,	O
and	O
these	O
should	O
not	O
influence	O
decisions	O
on	O
duration	O
of	O
anticoagulation	B-T058
.	O

obstacle	O
course	O
runs	O
:	O
review	B-T170
of	O
acquired	O
injuries	B-T037
and	O
illnesses	B-T033
at	O
a	O
series	O
of	O
canadian	O
events	O
(	O
race	O
)	O
the	O
growing	O
popularity	O
of	O
obstacle	O
course	O
runs	O
(	O
oc	O
##rs	O
)	O
has	O
led	O
to	O
significant	O
concerns	O
regarding	O
their	O
safety	O
.	O
the	O
influx	O
of	O
injuries	B-T037
and	O
illnesses	B-T033
in	O
rural	O
areas	O
where	O
oc	O
##rs	O
are	O
often	O
held	O
can	O
imp	O
##ose	O
a	O
large	O
burden	O
on	O
emergency	B-T058
medical	I-T058
services	I-T058
(	O
ems	B-T058
)	O
and	O
local	O
eds	O
.	O
literature	B-T170
concerning	O
the	O
safety	O
of	O
these	O
events	O
is	O
minimal	O
and	O
mostly	O
consists	O
of	O
media	B-T170
reports	B-T170
.	O
we	O
sought	O
to	O
characterise	O
the	O
injury	B-T037
and	O
illness	B-T033
profile	O
of	O
oc	O
##rs	O
and	O
the	O
level	O
of	O
medical	B-T058
care	I-T058
required	O
.	O
this	O
study	B-T062
analysed	B-T062
oc	O
##r	O
events	O
occurring	O
in	O
eight	O
locations	O
across	O
canada	B-T082
from	O
may	O
to	O
august	O
2015	O
(	O
total	O
45	O
285	O
participants	B-T098
)	O
.	O
data	O
were	O
extracted	O
from	O
event	O
medical	B-T074
charts	I-T074
of	O
patients	O
presenting	O
to	O
the	O
on	B-T082
##si	I-T082
##te	I-T082
medical	B-T058
team	I-T058
,	O
including	O
injury	B-T037
or	O
illness	B-T033
type	O
,	O
on	O
##si	O
##te	O
treatment	B-T058
and	O
disposition	O
.	O
there	O
were	O
55	O
##7	O
race	B-T098
participants	I-T098
treated	O
at	O
eight	O
oc	O
##r	O
events	O
(	O
1	O
.	O
2	O
%	O
of	O
all	O
participants	B-T098
)	O
.	O
there	O
were	O
60	O
##9	O
medical	B-T170
complaints	I-T170
in	O
total	O
.	O
three	O
quarters	O
of	O
injuries	B-T037
were	O
musculoskeletal	O
in	O
nature	O
.	O
eighty	O
-	O
nine	O
per	O
cent	O
returned	O
to	O
the	O
event	O
with	O
no	O
need	O
for	O
further	O
medical	B-T058
care	I-T058
.	O
the	O
majority	O
of	O
treatments	B-T058
were	O
completed	O
with	O
first	B-T058
aid	I-T058
and	O
basic	O
medical	B-T074
equipment	I-T074
.	O
eleven	O
patients	O
(	O
2	O
%	O
of	O
patients	O
)	O
required	O
transfer	O
to	O
hospital	B-T092
by	O
ems	B-T058
for	O
presentations	O
including	O
fracture	B-T037
,	O
dislocation	B-T037
,	O
head	B-T037
injury	I-T037
,	O
chest	B-T033
pain	I-T033
,	O
fall	O
from	O
height	O
,	O
and	O
abdominal	B-T033
pain	I-T033
.	O
we	O
found	O
that	O
1	O
.	O
2	O
%	O
of	O
race	B-T098
participants	I-T098
presented	O
to	O
on	O
##si	O
##te	O
medical	B-T058
services	I-T058
.	O
the	O
majority	O
of	O
complaints	O
were	O
minor	B-T037
and	O
musculoskeletal	B-T037
in	O
nature	O
.	O
only	O
2	O
%	O
of	O
those	O
treated	O
were	O
transferred	O
to	O
hospital	B-T092
through	O
ems	B-T058
.	O
this	O
is	O
consistent	O
with	O
other	O
types	O
of	O
mass	O
gathering	O
events	O
.	O

most	O
americans	B-T098
have	O
good	O
health	O
,	O
little	O
unmet	O
need	O
,	O
and	O
few	O
health	O
care	O
expenses	O
the	O
distribution	O
of	O
health	O
care	O
expenditures	O
remains	O
highly	O
concentrated	O
,	O
but	O
most	O
americans	B-T098
use	O
few	O
health	O
care	O
resources	O
and	O
have	O
low	O
out	O
-	O
of	O
-	O
pocket	O
spending	O
.	O
more	O
than	O
93	O
percent	O
of	O
[UNK]	O
low	B-T098
spend	I-T098
##ers	I-T098
[UNK]	O
(	O
those	O
in	O
the	O
bottom	O
half	O
of	O
the	O
population	B-T098
)	O
believe	O
they	O
have	O
received	O
all	O
needed	O
care	B-T058
in	O
a	O
timely	O
manner	O
.	O
the	O
low	O
spending	O
by	O
the	O
majority	O
of	O
the	O
population	B-T098
has	O
remained	O
almost	O
unchanged	O
during	O
the	O
thirty	O
-	O
seven	O
-	O
year	O
period	O
examined	B-T033
.	O

a	O
modified	O
esbl	B-T058
nord	I-T058
##mann	I-T058
/	I-T058
dor	I-T058
##te	I-T058
##t	I-T058
/	I-T058
po	I-T058
##ire	I-T058
##l	I-T058
-	I-T058
based	I-T058
protocol	I-T058
to	O
optimize	O
early	O
sepsis	B-T038
management	B-T058
we	O
evaluated	O
a	O
modification	O
of	O
a	O
colorimetric	B-T058
test	I-T058
recently	O
described	O
by	O
dor	O
##te	O
##t	O
et	O
al	O
.	O
(	O
2015	O
)	O
for	O
the	O
rapid	O
detection	B-T058
of	O
esbl	B-T103
-	O
producing	O
enterobacteriaceae	B-T007
directly	O
from	O
positive	B-T033
blood	B-T058
cultures	I-T058
that	O
requires	O
less	O
manipulation	B-T058
,	O
materials	O
and	O
hands	O
-	O
on	O
time	O
.	O
the	O
simplified	O
protocol	B-T058
showed	O
a	O
sensitivity	O
and	O
specificity	O
of	O
100	O
%	O
and	O
95	O
.	O
7	O
%	O
respectively	O
.	O

ez	B-T017
##h2	I-T017
and	O
z	B-T017
##f	I-T017
##x	I-T017
oncogenes	B-T017
in	O
malignant	O
behaviour	O
of	O
parathyroid	B-T038
neoplasms	I-T038
several	O
studies	B-T062
reported	O
somatic	B-T038
mutations	I-T038
of	O
many	O
genes	B-T017
(	O
men	B-T017
##1	I-T017
,	O
ct	B-T017
##nn	I-T017
##b1	I-T017
,	O
cdk	B-T017
##is	I-T017
and	O
others	O
)	O
in	O
parathyroid	B-T038
adenoma	I-T038
,	O
although	O
with	O
different	O
prevalence	O
.	O
recently	O
,	O
activating	O
mutations	B-T038
of	O
the	O
ez	B-T017
##h2	I-T017
and	O
z	B-T017
##f	I-T017
##x	I-T017
oncogenes	B-T017
were	O
identified	O
in	O
benign	O
parathyroid	B-T038
adenoma	I-T038
by	O
whole	B-T062
exome	I-T062
sequencing	I-T062
.	O
the	O
same	O
mutations	B-T038
had	O
been	O
found	O
in	O
blood	B-T031
and	O
ovary	B-T017
malignant	B-T038
tumours	I-T038
.	O
on	O
one	O
hand	O
,	O
this	O
result	O
raised	O
the	O
hypothesis	O
that	O
these	O
oncogenes	B-T017
may	O
play	O
a	O
role	O
in	O
the	O
onset	O
of	O
parathyroid	B-T038
tumour	I-T038
,	O
but	O
it	O
would	O
also	O
suggest	O
they	O
may	O
be	O
involved	O
in	O
malignant	O
,	O
rather	O
benign	O
,	O
parathyroid	B-T038
neoplasm	I-T038
.	O
our	O
aim	O
was	O
to	O
verify	O
the	O
occurrence	O
of	O
selected	O
mutations	B-T038
of	O
the	O
ez	B-T017
##h2	I-T017
and	O
z	B-T017
##f	I-T017
##x	I-T017
genes	I-T017
in	O
an	O
italian	B-T098
cohort	B-T098
of	O
23	O
sporadic	O
parathyroid	B-T038
carcinomas	I-T038
,	O
12	O
atypical	O
and	O
45	O
typical	O
adenomas	B-T038
.	O
dna	B-T103
was	O
extracted	B-T058
from	O
paraffin	B-T017
-	I-T017
embedded	I-T017
tissues	I-T017
,	O
pcr	B-T062
amplified	O
and	O
directly	O
sequenced	O
.	O
no	B-T033
mutations	B-T038
were	O
detected	B-T033
in	O
the	O
coding	B-T103
sequence	I-T103
and	O
boundaries	B-T103
of	O
both	O
genes	B-T017
in	O
any	O
of	O
the	O
samples	O
.	O
two	O
polymorphisms	O
of	O
the	O
ez	B-T017
##h2	I-T017
gene	I-T017
were	O
identified	O
with	O
different	O
prevalence	O
:	O
the	O
rs	B-T017
##20	I-T017
##72	I-T017
##40	I-T017
##7	I-T017
variant	I-T017
was	O
present	B-T033
in	O
the	O
30	O
%	O
of	O
the	O
samples	O
,	O
in	O
keeping	O
with	O
the	O
overall	O
frequency	O
in	O
larger	O
populations	O
,	O
while	O
the	O
rs	B-T017
##78	I-T017
##58	I-T017
##90	I-T017
##34	I-T017
variant	I-T017
,	O
located	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
exon	B-T103
16	I-T103
,	O
was	O
detected	B-T033
in	O
only	O
one	O
proband	O
with	O
familial	O
isolated	O
hyperparathyroidism	B-T038
;	O
we	O
investigated	O
the	O
possible	O
outcome	O
on	O
the	O
splicing	B-T038
process	I-T038
.	O
ez	B-T017
##h2	I-T017
and	O
z	B-T017
##f	I-T017
##x	I-T017
genes	I-T017
do	O
not	O
seem	O
to	O
have	O
an	O
impact	O
on	O
the	O
onset	O
of	O
most	O
parathyroid	B-T038
tumours	I-T038
,	O
both	O
benign	O
and	O
malignant	O
,	O
though	O
further	O
studies	O
on	O
larger	O
cohorts	B-T098
of	O
different	O
ethnicity	O
are	O
needed	O
.	O

sequence	B-T038
-	I-T038
specific	I-T038
dna	I-T038
binding	I-T038
by	O
long	O
hairpin	O
pyrrole	B-T103
-	I-T103
imidazole	I-T103
poly	I-T103
##amides	I-T103
containing	O
an	O
8	B-T103
-	I-T103
amino	I-T103
-	I-T103
3	I-T103
,	I-T103
6	I-T103
-	I-T103
diox	I-T103
##ao	I-T103
##ct	I-T103
##anoic	I-T103
acid	I-T103
unit	O
with	O
the	O
aim	O
of	O
improving	O
aqueous	O
solubility	O
,	O
we	O
designed	O
and	O
synthesized	O
five	O
n	B-T103
-	I-T103
methylp	I-T103
##yr	I-T103
##role	I-T103
(	I-T103
py	I-T103
)	I-T103
-	I-T103
n	I-T103
-	I-T103
methyl	I-T103
##imidazole	I-T103
(	I-T103
im	I-T103
)	I-T103
poly	I-T103
##amides	I-T103
capable	O
of	O
recognizing	O
9	B-T082
-	I-T082
bp	I-T082
sequences	I-T082
.	O
their	O
dna	B-T038
-	I-T038
binding	I-T038
affinities	O
and	O
sequence	B-T082
specificities	O
were	O
evaluated	O
by	O
spr	B-T062
and	O
bind	B-T062
-	I-T062
n	I-T062
-	I-T062
seq	I-T062
analyses	I-T062
.	O
the	O
design	O
of	O
poly	B-T103
##amide	I-T103
1	I-T103
was	O
based	O
on	O
a	O
conventional	O
model	B-T170
,	O
with	O
three	O
consecutive	O
py	B-T103
or	O
im	B-T103
rings	O
separated	O
by	O
a	O
β	B-T103
-	I-T103
alanine	I-T103
to	O
match	O
the	O
curvature	O
and	O
twist	B-T082
of	O
long	O
dna	B-T103
helices	O
.	O
poly	B-T103
##amides	I-T103
2	I-T103
and	I-T103
3	I-T103
contained	O
an	O
8	B-T103
-	I-T103
amino	I-T103
-	I-T103
3	I-T103
,	I-T103
6	I-T103
-	I-T103
diox	I-T103
##ao	I-T103
##ct	I-T103
##anoic	I-T103
acid	I-T103
(	O
ao	B-T103
)	O
unit	O
,	O
which	O
has	O
previously	O
only	O
been	O
used	O
as	O
a	O
linker	B-T103
within	O
linear	O
py	B-T103
-	I-T103
im	I-T103
poly	I-T103
##amides	I-T103
or	O
between	O
py	B-T103
-	O
im	B-T103
hairpin	O
motifs	O
for	O
tandem	O
hairpin	O
.	O
it	O
is	O
demonstrated	O
herein	O
that	O
ao	B-T103
also	O
functions	O
as	O
a	O
linker	B-T103
element	I-T103
that	O
can	O
extend	O
to	O
2	B-T082
-	I-T082
bp	I-T082
in	O
hairpin	O
motifs	O
.	O
notably	O
,	O
although	O
the	O
ao	B-T103
-	O
containing	O
unit	O
can	O
fail	O
to	O
bind	O
the	O
expected	O
sequence	B-T082
,	O
poly	B-T103
##amide	I-T103
4	I-T103
,	O
which	O
has	O
two	O
ao	B-T103
units	O
facing	O
each	O
other	O
in	O
a	O
hairpin	O
form	O
,	O
successfully	O
showed	O
the	O
expected	O
motif	O
and	O
a	O
kd	O
value	O
of	O
16	O
##nm	O
was	O
recorded	O
.	O
poly	B-T103
##amide	I-T103
5	I-T103
,	O
containing	O
a	O
β	B-T103
-	I-T103
alanine	I-T103
-	I-T103
β	I-T103
-	I-T103
alanine	I-T103
unit	O
instead	O
of	O
the	O
ao	B-T103
of	O
poly	B-T103
##amide	I-T103
2	I-T103
,	O
was	O
synthesized	O
for	O
comparison	O
.	O
the	O
aqueous	O
solubil	O
##ities	O
and	O
nuclear	B-T038
localization	I-T038
of	O
three	O
of	O
the	O
poly	B-T103
##amides	I-T103
were	O
also	O
examined	O
.	O
the	O
results	O
suggest	O
the	O
possibility	O
of	O
applying	O
the	O
ao	B-T103
unit	O
in	O
the	O
core	B-T082
of	O
py	B-T103
-	I-T103
im	I-T103
poly	I-T103
##amide	I-T103
compounds	I-T103
.	O

a	O
16	O
y	B-T017
##in	I-T017
yang	I-T017
gene	B-T038
expression	I-T038
ratio	O
signature	O
for	O
er	B-T038
+	I-T038
/	O
node	B-T038
-	I-T038
breast	I-T038
cancer	I-T038
breast	B-T038
cancer	I-T038
is	O
one	O
of	O
the	O
leading	O
causes	O
of	O
cancer	B-T038
death	B-T038
in	O
women	B-T098
.	O
it	O
is	O
a	O
complex	O
and	O
heterogeneous	O
disease	B-T038
with	O
different	O
clinical	O
outcomes	O
.	O
stratif	O
##ying	O
patients	O
into	O
subgroups	B-T170
with	O
different	O
outcomes	O
could	O
help	O
guide	O
clinical	B-T058
decision	I-T058
making	I-T058
.	O
in	O
this	O
study	B-T062
,	O
we	O
used	O
two	O
opposing	O
groups	O
of	O
genes	B-T017
,	O
y	B-T017
##in	I-T017
and	I-T017
yang	I-T017
,	O
to	O
develop	O
a	O
prognostic	B-T201
expression	B-T038
ratio	O
signature	O
.	O
using	O
the	O
metab	B-T170
##ric	I-T170
cohort	B-T062
we	O
identified	O
a1	O
##6	O
-	O
gene	O
signature	O
capable	O
of	O
stratif	O
##ying	O
breast	B-T038
cancer	I-T038
patients	O
into	O
four	O
risk	O
levels	O
with	O
intention	O
that	O
low	O
-	O
risk	O
patients	O
would	O
not	O
undergo	O
adjuvant	O
systemic	B-T058
therapy	I-T058
,	O
intermediate	B-T082
-	O
low	O
-	O
risk	O
patients	O
will	O
be	O
treated	B-T058
with	I-T058
hormonal	B-T058
therapy	I-T058
only	O
,	O
and	O
intermediate	B-T082
-	O
high	O
-	O
and	O
high	O
-	O
risk	O
groups	O
will	O
be	O
treated	B-T058
by	O
chemotherapy	B-T058
in	O
addition	O
to	O
the	O
hormonal	B-T058
therapy	I-T058
.	O
the	O
16	O
-	O
gene	O
signature	O
for	O
four	O
risk	O
level	O
stratification	B-T170
##s	I-T170
of	O
breast	B-T038
cancer	I-T038
patients	O
has	O
been	O
validated	B-T062
using	O
14	O
independent	O
datasets	B-T170
.	O
notably	O
,	O
the	O
low	O
-	O
risk	O
group	B-T098
(	O
n	O
=	O
51	O
)	O
of	O
205	O
estrogen	B-T038
receptor	I-T038
-	I-T038
positive	I-T038
and	O
node	B-T038
negative	I-T038
(	O
er	B-T038
+	I-T038
/	O
node	B-T038
-	I-T038
)	O
patients	O
from	O
three	O
different	O
datasets	B-T170
who	O
had	O
not	O
had	O
any	O
systemic	O
adjuvant	B-T058
therapy	I-T058
had	O
100	O
%	O
15	O
-	O
year	O
disease	O
-	O
specific	O
survival	O
rate	O
.	O
the	O
concordance	B-T170
index	I-T170
of	O
ym	B-T058
##r	I-T058
for	O
er	B-T038
+	I-T038
/	O
node	B-T038
negative	I-T038
patients	O
is	O
close	O
to	O
the	O
commercially	B-T170
available	O
signatures	O
.	O
however	O
,	O
ym	B-T058
##r	I-T058
showed	O
more	O
significance	O
(	O
hr	O
=	O
3	O
.	O
7	O
,	O
p	O
=	O
8	O
.	O
7	O
##e	O
-	O
12	O
)	O
in	O
stratif	O
##ying	O
er	B-T038
+	I-T038
/	O
node	B-T038
-	I-T038
subgroup	B-T170
than	O
onc	B-T058
##otype	I-T058
##d	I-T058
##x	I-T058
(	O
hr	O
=	O
2	O
.	O
7	O
,	O
p	O
=	O
1	O
.	O
3	O
##e	O
-	O
7	O
)	O
,	O
mamm	B-T058
##apr	I-T058
##int	I-T058
(	O
hr	O
=	O
2	O
.	O
5	O
,	O
p	O
=	O
5	O
.	O
8	O
##e	O
-	O
7	O
)	O
,	O
ror	B-T058
##s	I-T058
(	O
hr	O
=	O
2	O
.	O
4	O
,	O
p	O
=	O
1	O
.	O
4e	O
-	O
6	O
)	O
,	O
and	O
np	B-T058
##i	I-T058
(	O
hr	O
=	O
2	O
.	O
6	O
,	O
p	O
=	O
1	O
.	O
2	O
##e	O
-	O
6	O
)	O
.	O
ym	B-T058
##r	I-T058
signature	O
may	O
be	O
developed	O
as	O
a	O
clinical	O
tool	B-T170
to	O
select	O
a	O
subgroup	B-T170
of	O
low	O
-	O
risk	O
er	B-T038
+	I-T038
/	O
node	B-T038
-	I-T038
patients	O
who	O
do	O
not	O
require	O
any	O
adjuvant	O
hormonal	B-T058
therapy	I-T058
(	O
ah	B-T058
##t	I-T058
)	O
.	O

a	O
case	O
presenting	O
with	O
splenic	B-T038
infarct	I-T038
diagnosed	B-T033
as	O
primary	B-T017
bone	I-T017
marrow	I-T017
cd5	B-T017
positive	I-T017
dlbcl	B-T038
:	O
a	O
clinicopathological	O
correlation	O
de	O
novo	O
cd5	B-T017
+	I-T017
diffuse	B-T033
large	I-T033
b	I-T033
cell	I-T033
lymphoma	I-T033
(	O
dlbcl	B-T038
)	O
is	O
a	O
rare	O
and	O
aggressive	B-T033
subtype	I-T033
of	O
dlbcl	B-T038
.	O
it	O
is	O
a	O
distinct	O
clinicopathologic	B-T033
entity	O
with	O
complex	O
molecular	O
profile	O
and	O
poor	B-T033
prognosis	I-T033
.	O
a	O
59	O
year	O
old	O
female	O
presented	B-T033
with	I-T033
pyre	B-T033
##x	I-T033
##ia	I-T033
of	I-T033
unknown	I-T033
origin	I-T033
since	O
1	O
month	O
.	O
on	O
examination	B-T058
,	O
there	O
was	O
severe	B-T033
pall	I-T033
##or	I-T033
,	O
hepat	B-T033
##osp	I-T033
##len	I-T033
##omegaly	I-T033
and	O
no	O
palpable	O
lymphadenopathy	B-T038
.	O
complete	B-T058
blood	I-T058
count	I-T058
revealed	O
bic	B-T033
##yt	I-T033
##openia	I-T033
with	O
normal	B-T033
total	I-T033
leucocyte	I-T033
count	I-T033
.	O
liver	B-T058
and	O
renal	B-T058
function	I-T058
tests	I-T058
were	O
normal	O
.	O
ultrasonography	B-T058
abdomen	I-T058
revealed	O
splenic	B-T033
enlargement	I-T033
with	O
two	B-T033
focal	I-T033
lesions	I-T033
attributed	O
to	O
either	O
splenic	B-T038
abscess	I-T038
or	O
infarcts	B-T038
.	O
patient	O
was	O
being	O
managed	O
as	O
splenic	B-T038
infarct	I-T038
but	O
continued	O
to	O
have	O
bic	B-T033
##yt	I-T033
##openia	I-T033
.	O
further	O
investigation	B-T058
showed	O
elevated	B-T033
serum	I-T033
ferritin	I-T033
,	O
triglycerides	B-T033
and	O
ldh	B-T033
.	O
with	O
a	O
clinical	O
suspicion	B-T038
of	O
infection	B-T038
and	O
haem	B-T038
##ophag	I-T038
##ocytic	I-T038
lympho	I-T038
##his	I-T038
##ti	I-T038
##ocytosis	I-T038
bone	B-T058
marrow	I-T058
aspiration	I-T058
(	I-T058
bm	B-T058
##a	I-T058
)	I-T058
and	I-T058
biopsy	B-T058
(	I-T058
bm	I-T058
##b	I-T058
##x	I-T058
)	I-T058
was	O
done	O
.	O
bm	O
##a	O
showed	O
extensive	O
haem	B-T038
##ophag	I-T038
##ocytosis	I-T038
and	O
~	O
7	O
.	O
4	O
%	O
large	B-T038
lymphoma	I-T038
-	I-T038
like	I-T038
cells	I-T038
.	O
on	O
this	O
basis	O
pet	B-T058
-	I-T058
ct	I-T058
was	O
suggested	O
which	O
showed	O
enlarged	B-T033
spleen	I-T033
with	O
diffuse	B-T033
uptake	I-T033
.	O
bm	B-T058
##b	I-T058
##x	I-T058
showed	O
nodular	B-T017
and	O
intras	B-T082
##inus	I-T082
##oidal	I-T082
collection	O
of	O
abnormal	B-T017
lymphoid	I-T017
cells	I-T017
.	O
on	O
immunohistochemistry	B-T058
,	O
these	O
cells	B-T017
were	O
positive	B-T033
for	I-T033
cd20	I-T033
,	O
cd5	B-T103
,	O
mum	B-T103
##1	I-T103
,	O
bcl	O
-	O
2	O
,	O
bcl	O
-	O
6	O
and	O
negative	B-T033
for	O
cd3	B-T103
,	O
cd10	B-T103
and	O
cd2	B-T103
##3	I-T103
.	O
cd34	B-T103
highlighted	O
focal	B-T082
intras	B-T082
##inus	I-T082
##oidal	I-T082
pattern	B-T082
.	O
the	O
complete	O
clinicopathological	O
profile	O
suggested	O
the	O
diagnosis	B-T033
of	O
de	O
novo	O
cd5	B-T017
+	I-T017
dlbcl	B-T038
,	O
with	O
primary	B-T038
hepat	I-T038
##osp	I-T038
##len	I-T038
##ic	I-T038
pattern	B-T082
of	O
involvement	O
.	O
cd5	B-T017
+	I-T017
dlbcl	B-T038
presenting	O
as	O
splenic	B-T038
infarct	I-T038
is	O
very	B-T033
rare	I-T033
.	O
this	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	B-T033
of	O
a	O
primary	B-T038
aggressive	I-T038
lymphoma	I-T038
with	O
haem	B-T038
##ophag	I-T038
##ocytosis	I-T038
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	B-T033
and	O
splenic	B-T038
infarct	I-T038
without	O
lymphadenopathy	B-T038
.	O
this	O
indicates	O
the	O
importance	O
of	O
good	O
morphological	B-T082
assessment	O
of	O
a	O
bone	B-T031
marrow	I-T031
aspirate	I-T031
and	O
biopsy	B-T058
to	O
make	O
a	O
correct	B-T033
diagnosis	I-T033
.	O

methods	B-T170
,	O
tools	O
and	O
current	O
perspectives	O
in	O
prote	B-T091
##ogen	I-T091
##omics	I-T091
with	O
combined	O
technological	O
advancements	O
in	O
high	B-T062
-	I-T062
throughput	I-T062
next	I-T062
-	I-T062
generation	I-T062
sequencing	I-T062
and	O
deep	B-T058
mass	I-T058
spectrometry	I-T058
-	O
based	O
proteomics	B-T091
,	O
prote	B-T091
##ogen	I-T091
##omics	I-T091
,	O
i	O
.	O
e	O
.	O
,	O
the	O
integrative	B-T062
analysis	I-T062
of	O
proteomic	O
and	O
genomic	O
data	O
,	O
has	O
emerged	O
as	O
a	O
new	O
research	O
field	O
.	O
early	O
efforts	O
in	O
the	O
field	O
were	O
focused	O
on	O
improving	O
protein	B-T103
identification	O
using	O
sample	B-T170
-	I-T170
specific	I-T170
genomic	I-T170
and	O
transcriptomic	B-T170
sequencing	I-T170
data	I-T170
.	O
more	O
recently	O
,	O
integrative	B-T062
analysis	I-T062
of	O
quantitative	O
measurements	O
from	O
genomic	B-T062
and	I-T062
proteomic	I-T062
studies	I-T062
have	O
identified	O
novel	O
insights	O
into	O
gene	B-T038
expression	I-T038
regulation	I-T038
,	O
cell	B-T038
signaling	I-T038
,	O
and	O
disease	B-T038
.	O
many	O
methods	B-T170
and	O
tools	O
have	O
been	O
developed	O
or	O
adapted	O
to	O
enable	O
an	O
array	B-T082
of	O
integrative	O
prote	O
##ogen	O
##omic	O
approaches	O
and	O
in	O
this	O
article	B-T170
,	O
we	O
systematically	O
classify	B-T170
published	O
methods	B-T170
and	O
tools	O
into	O
four	O
major	O
categories	O
,	O
(	O
1	O
)	O
sequence	B-T091
-	I-T091
centr	I-T091
##ic	I-T091
prote	I-T091
##ogen	I-T091
##omics	I-T091
;	O
(	O
2	O
)	O
analysis	B-T062
of	O
prote	O
##ogen	O
##omic	O
relationships	O
;	O
(	O
3	O
)	O
integrative	B-T062
modeling	I-T062
of	O
prote	O
##ogen	O
##omic	O
data	O
;	O
and	O
(	O
4	O
)	O
data	O
sharing	O
and	O
visualization	B-T038
.	O
we	O
provide	O
a	O
comprehensive	O
review	O
of	O
methods	B-T170
and	O
available	O
tools	O
in	O
each	O
category	B-T170
and	O
highlight	O
their	O
typical	O
applications	O
.	O

tooth	B-T033
discol	I-T033
##oration	I-T033
resulting	O
from	O
a	O
nano	O
zinc	B-T103
oxide	I-T103
-	I-T103
eug	I-T103
##enol	I-T103
seal	B-T103
##er	I-T103
a	O
desirable	O
quality	O
of	O
any	O
endodontic	B-T103
seal	I-T103
##er	I-T103
is	O
its	O
ability	O
to	O
be	O
tooth	B-T033
color	I-T033
friendly	O
.	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
evaluate	O
the	O
tooth	B-T033
discol	I-T033
##oration	I-T033
potential	O
of	O
a	O
nano	O
zinc	B-T103
oxide	I-T103
-	I-T103
eug	I-T103
##enol	I-T103
(	O
nz	B-T103
##oe	I-T103
)	O
seal	B-T103
##er	I-T103
.	O
in	O
order	O
to	O
evaluate	O
tooth	B-T033
discol	I-T033
##oration	I-T033
,	O
the	O
pulp	B-T082
chamber	I-T082
of	O
60	O
human	B-T204
maxillary	B-T017
central	I-T017
and	O
lateral	B-T017
incisors	I-T017
were	O
filled	O
with	O
one	O
of	O
the	O
seal	B-T103
##ers	I-T103
,	O
naming	O
ah	B-T103
-	I-T103
26	I-T103
(	O
resin	B-T103
-	I-T103
based	I-T103
seal	I-T103
##er	I-T103
)	O
,	O
pulp	B-T103
##den	I-T103
##t	I-T103
seal	B-T103
##er	I-T103
(	O
zo	B-T103
##e	I-T103
-	O
based	O
)	O
and	O
a	O
nz	B-T103
##oe	I-T103
experimental	O
seal	B-T103
##er	I-T103
.	O
color	O
measurements	O
was	O
assessed	O
at	O
the	O
baseline	O
(	O
before	O
placement	O
of	O
seal	B-T103
##ers	I-T103
)	O
(	O
t0	O
)	O
,	O
24	O
h	O
(	O
t1	O
)	O
and	O
72	O
h	O
(	O
t2	O
)	O
h	O
,	O
1	O
-	O
week	O
(	O
t3	O
)	O
,	O
and	O
1	O
-	O
month	O
(	O
t4	O
)	O
after	O
the	O
placement	O
of	O
seal	B-T103
##ers	I-T103
using	O
the	O
easy	B-T074
shade	I-T074
spectrophot	I-T074
##ometer	I-T074
.	O
data	O
were	O
analyzed	B-T062
in	O
spss	B-T170
software	I-T170
using	O
one	O
-	O
way	O
anova	O
,	O
and	O
repeated	O
measured	O
anova	O
.	O
no	O
significant	O
differences	O
were	O
observed	O
when	O
the	O
paired	B-T170
comparison	I-T170
test	I-T170
was	O
performed	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
the	O
tested	O
nz	B-T103
##oe	I-T103
seal	B-T103
##er	I-T103
had	O
similar	O
tooth	B-T033
discol	I-T033
##oration	I-T033
potential	O
in	O
comparison	O
with	O
ah	B-T103
-	I-T103
26	I-T103
and	O
zo	B-T103
##e	I-T103
seal	B-T103
##er	I-T103
.	O

folate	B-T103
-	O
based	O
single	B-T058
cell	I-T058
screening	I-T058
using	O
surface	B-T058
enhanced	I-T058
raman	I-T058
micro	I-T058
##imaging	I-T058
recent	O
progress	O
in	O
nanotechnology	O
and	O
its	O
application	O
to	O
biomedical	B-T062
settings	I-T062
have	O
generated	O
great	O
advantages	O
in	O
dealing	O
with	O
early	B-T058
cancer	I-T058
diagnosis	I-T058
.	O
the	O
identification	O
of	O
the	O
specific	O
properties	O
of	O
cancer	B-T017
cells	I-T017
,	O
such	O
as	O
the	O
expression	O
of	O
particular	O
plasma	B-T017
membrane	I-T017
molecular	B-T091
receptors	I-T091
,	O
has	O
become	O
crucial	O
in	O
revealing	O
the	O
presence	O
and	O
in	O
assessing	O
the	O
stage	O
of	O
development	O
of	O
the	O
disease	O
.	O
here	O
we	O
report	O
a	O
single	B-T058
cell	I-T058
screening	I-T058
approach	O
based	O
on	O
surface	B-T058
enhanced	I-T058
raman	I-T058
scattering	I-T058
(	I-T058
sers	B-T058
)	I-T058
micro	I-T058
##imaging	I-T058
.	O
we	O
fabricated	O
a	O
sers	B-T058
-	I-T058
labelled	I-T058
nano	O
##ve	O
##ct	O
##or	O
based	O
on	O
the	O
biof	O
##unctional	O
##ization	O
of	O
gold	O
nanoparticles	O
with	O
folic	B-T103
acid	I-T103
.	O
after	O
treating	B-T017
the	I-T017
cells	I-T017
with	O
the	O
nano	O
##ve	O
##ct	O
##or	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	B-T017
cell	I-T017
lines	I-T017
(	O
cancer	B-T017
hela	I-T017
and	O
pc	B-T038
-	I-T038
3	I-T038
,	O
and	O
normal	B-T017
hac	I-T017
##at	I-T017
lines	I-T017
)	O
,	O
su	O
##itably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	B-T103
binding	I-T103
proteins	I-T103
.	O
the	O
nano	O
##ve	O
##ct	O
##or	O
,	O
indeed	O
,	O
binds	O
much	O
more	O
efficiently	O
on	O
cancer	B-T017
cell	I-T017
lines	I-T017
than	O
on	O
normal	O
ones	O
,	O
resulting	O
in	O
a	O
higher	O
sers	B-T058
signal	O
measured	O
on	O
cancer	B-T017
cells	I-T017
.	O
these	O
results	O
pav	O
##e	O
the	O
way	O
for	O
applications	O
in	O
single	B-T058
cell	I-T058
diagnostics	I-T058
and	O
,	O
potentially	O
,	O
in	O
ther	B-T091
##ano	I-T091
##st	I-T091
##ics	I-T091
.	O

preclinical	O
fibrinolysis	B-T038
in	O
patients	O
with	O
st	B-T038
-	I-T038
segment	I-T038
elevation	I-T038
myocardial	I-T038
infarction	I-T038
in	O
a	O
rural	O
region	O
in	O
the	O
current	B-T170
guidelines	I-T170
for	O
the	O
treatment	B-T058
of	O
patients	O
with	O
st	B-T038
-	I-T038
segment	I-T038
elevation	I-T038
myocardial	I-T038
infarction	I-T038
(	O
stemi	B-T038
)	O
,	O
the	O
european	O
society	O
of	O
cardiology	O
(	O
esc	O
)	O
recommends	O
preclinical	O
fibrinolysis	B-T038
as	O
a	O
reperfusion	B-T058
therapy	I-T058
if	O
,	O
due	O
to	O
long	O
transportation	O
times	O
,	O
no	O
cardiac	B-T058
catheter	I-T058
##isation	I-T058
is	O
available	O
within	O
90	O
-	O
120	O
min	O
.	O
however	O
,	O
there	O
is	O
little	O
remaining	O
in	O
-	O
depth	O
expertise	O
in	O
this	O
method	O
because	O
fibrinolysis	B-T038
is	O
presently	O
only	O
rarely	O
indicated	B-T033
.	O
in	O
a	O
rural	O
area	O
in	O
southwestern	B-T082
germany	B-T082
,	O
where	O
an	O
emergency	B-T058
primary	I-T058
percutaneous	I-T058
coronary	I-T058
intervention	I-T058
was	O
not	O
routinely	O
available	O
within	O
90	O
-	O
120	O
min	O
,	O
156	O
stemi	B-T038
patients	O
underwent	O
fibrinolysis	B-T038
with	O
the	O
plasminogen	B-T103
activator	I-T103
ret	I-T103
##ep	I-T103
##las	I-T103
##e	I-T103
,	O
performed	O
by	O
trained	O
emergency	O
physicians	B-T097
.	O
the	O
practical	O
##ity	O
of	O
the	O
treatment	B-T058
,	O
as	O
well	O
as	O
complications	B-T038
and	O
the	O
mortality	O
of	O
the	O
patients	O
in	O
the	O
preclinical	O
phase	O
until	O
arrival	O
at	O
the	O
hospital	B-T092
,	O
were	O
retrospectively	B-T062
studied	I-T062
.	O
the	O
mean	O
time	O
from	O
onset	O
of	O
the	O
symptoms	B-T033
to	O
first	O
medical	B-T058
contact	I-T058
was	O
114	O
±	O
116	O
min	O
.	O
the	O
mean	O
interval	O
to	O
the	O
start	O
of	O
fibrinolysis	B-T038
of	O
13	O
.	O
5	O
±	O
6	O
.	O
4	O
min	O
was	O
within	O
the	O
30	O
min	O
mand	B-T170
##ated	I-T170
by	O
the	O
esc	O
.	O
patients	O
with	O
inferior	B-T038
stemi	I-T038
represented	O
the	O
largest	O
subgroup	B-T170
.	O
occurring	O
in	O
39	O
cases	O
(	O
25	O
%	O
)	O
,	O
complications	B-T038
due	O
to	O
infarction	B-T038
were	O
relatively	O
common	O
during	O
the	O
prehospital	B-T058
phase	O
,	O
including	O
15	O
cases	O
(	O
9	O
.	O
6	O
%	O
)	O
of	O
cardiogenic	B-T038
shock	I-T038
,	O
but	O
in	O
all	O
cases	O
the	O
complications	B-T038
were	O
manage	B-T033
##able	I-T033
.	O
no	O
patient	O
died	B-T033
before	O
arrival	O
at	O
the	O
hospital	B-T092
.	O
as	O
lysis	B-T038
-	O
associated	O
adverse	B-T038
effects	I-T038
,	O
merely	O
two	O
uncomplicated	O
mucosal	B-T033
haemorrhage	I-T033
##s	I-T033
and	O
one	O
case	O
of	O
mild	B-T038
allergic	I-T038
skin	I-T038
reactions	I-T038
were	O
seen	O
.	O
in	O
emergency	O
situations	O
with	O
long	O
transportation	O
times	O
to	O
the	O
nearest	O
suitable	O
cardiac	B-T058
catheter	I-T058
##isation	I-T058
laboratory	B-T092
,	O
preclinical	O
fibrinolysis	B-T038
in	O
stemi	B-T038
still	O
represents	O
a	O
work	O
##able	O
method	O
.	O
success	O
of	O
this	O
strategy	O
requires	O
particularly	O
strong	O
training	O
of	O
the	O
emergency	O
physicians	B-T097
in	O
ecg	B-T058
and	O
lysis	B-T038
therapy	B-T058
,	O
and	O
co	O
-	O
operation	O
with	O
nearby	O
cardiac	B-T092
centres	I-T092
.	O

validity	O
and	O
reliability	O
of	O
fluoroscopy	B-T058
for	O
digital	B-T058
radiography	I-T058
:	O
a	O
new	O
way	O
to	O
evaluate	B-T058
diaphragmatic	B-T017
mobility	O
fluoroscopy	B-T058
is	O
considered	O
the	O
most	O
accurate	O
method	B-T062
to	O
evaluate	B-T058
the	O
diaphragm	B-T017
,	O
yet	O
most	O
existing	O
methods	B-T062
for	O
measuring	O
diaphragmatic	B-T017
mobility	O
using	O
fluoroscopy	B-T058
are	O
complex	O
.	O
to	O
assess	O
the	O
validity	O
and	O
reliability	O
of	O
a	O
new	O
evaluation	B-T062
method	I-T062
of	O
diaphragmatic	B-T017
motion	O
using	O
fluoroscopy	B-T058
by	O
digital	B-T058
radiography	I-T058
of	O
healthy	O
adults	O
.	O
twenty	O
-	O
six	O
adults	O
were	O
evaluated	B-T058
,	O
according	O
to	O
the	O
parameters	O
:	O
anthrop	B-T062
##ometry	I-T062
and	O
pulmonary	B-T058
function	I-T058
test	I-T058
.	O
the	O
evaluation	B-T058
of	O
diaphragm	B-T017
mobility	O
by	O
means	O
of	O
fluoroscopy	B-T058
by	O
digital	B-T058
radiography	I-T058
method	B-T062
was	O
randomly	O
conducted	O
by	O
two	O
raters	O
(	O
a	O
and	O
b	O
)	O
.	O
the	O
pearson	O
correlation	O
coefficient	O
and	O
the	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
were	O
used	O
to	O
assess	O
the	O
concurrent	O
validity	O
.	O
the	O
inter	O
-	O
rater	O
and	O
intra	O
-	O
rater	O
reliability	O
of	O
the	O
measurement	O
of	O
diaphragmatic	B-T017
motion	O
was	O
determined	O
using	O
icc	O
and	O
a	O
confidence	O
interval	O
of	O
95	O
%	O
.	O
there	O
was	O
a	O
relationship	O
in	O
the	O
assessment	B-T058
of	O
the	O
concurrent	O
validity	O
.	O
there	O
was	O
good	O
inter	O
-	O
rater	O
reliability	O
for	O
right	O
hemi	B-T017
##di	I-T017
##aph	I-T017
##rag	I-T017
##m	I-T017
mobility	O
and	O
moderate	O
reliability	O
for	O
left	B-T017
hemi	I-T017
##di	I-T017
##aph	I-T017
##rag	I-T017
##m	I-T017
in	O
the	O
first	O
assessment	B-T058
.	O
in	O
the	O
second	O
assessment	B-T058
,	O
there	O
was	O
good	O
reliability	O
for	O
the	O
mobility	O
of	O
both	O
hemi	B-T017
##di	I-T017
##aph	I-T017
##rag	I-T017
##ms	I-T017
.	O
there	O
was	O
good	O
intra	O
-	O
rater	O
reliability	O
in	O
the	O
mobility	O
of	O
both	O
hemi	B-T017
##di	I-T017
##aph	I-T017
##rag	I-T017
##ms	I-T017
for	O
raters	O
a	O
and	O
b	O
.	O
the	O
evaluation	B-T058
of	O
diaphragmatic	B-T017
motion	O
using	O
fluoroscopy	B-T058
by	O
digital	B-T058
radiography	I-T058
proved	O
to	O
be	O
a	O
valid	O
and	O
reliable	O
method	B-T062
of	O
healthy	O
adults	O
.	O

heterogeneity	O
of	O
colorectal	B-T038
cancer	I-T038
risk	O
by	O
tumour	B-T038
characteristics	O
:	O
large	O
prospective	B-T062
study	I-T062
of	O
uk	B-T082
women	B-T098
associations	O
between	O
behavioural	O
and	O
other	O
personal	O
factors	O
and	O
colorectal	B-T038
cancer	I-T038
risk	O
have	O
been	O
reported	O
to	O
vary	O
by	O
tumour	B-T038
characteristics	O
,	O
but	O
evidence	O
is	O
inconsistent	O
.	O
in	O
a	O
large	O
uk	B-T082
-	O
based	O
prospective	B-T062
study	I-T062
we	O
examined	O
associations	O
of	O
14	O
postulated	O
risk	B-T033
factors	I-T033
with	O
colorectal	B-T038
cancer	I-T038
risk	O
overall	O
,	O
and	O
across	O
three	O
anatomical	B-T082
sites	I-T082
and	O
four	O
morphological	B-T082
subtypes	B-T170
.	O
among	O
1	O
.	O
3	O
million	O
women	B-T098
,	O
18	O
,	O
51	O
##8	O
incident	O
colorectal	B-T038
cancers	I-T038
were	O
identified	O
during	O
13	O
.	O
8	O
(	O
sd	O
3	O
.	O
4	O
)	O
years	O
follow	B-T058
-	I-T058
up	I-T058
via	O
record	O
linkage	O
to	O
national	B-T170
cancer	I-T170
registry	I-T170
data	O
.	O
cox	B-T170
regression	I-T170
yielded	O
adjusted	O
relative	O
risks	O
.	O
statistical	O
significance	O
was	O
assessed	O
using	O
correction	O
for	O
multiple	O
testing	O
.	O
overall	O
,	O
colorectal	B-T038
cancer	I-T038
risk	O
was	O
significantly	O
associated	O
with	O
height	O
,	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
,	O
smoking	O
,	O
alcohol	O
intake	O
,	O
physical	O
activity	O
,	O
parity	B-T033
and	O
menopausal	B-T058
hormone	I-T058
therapy	I-T058
use	O
.	O
for	O
smoking	O
there	O
was	O
substantial	O
heterogeneity	O
across	O
morphological	B-T082
types	O
;	O
relative	O
risks	O
around	O
two	O
or	O
greater	O
were	O
seen	O
in	O
current	O
smokers	B-T033
both	O
for	O
sign	B-T017
##et	I-T017
ring	I-T017
cell	I-T017
and	O
for	O
neuroendocrine	B-T038
tumours	I-T038
.	O
obese	B-T038
women	B-T098
were	O
also	O
at	O
higher	O
risk	O
for	O
sign	B-T017
##et	I-T017
ring	I-T017
cell	I-T017
tumours	B-T038
.	O
for	O
adenocarcinomas	B-T038
,	O
the	O
large	O
majority	O
of	O
colorectal	B-T038
cancers	I-T038
in	O
the	O
cohort	B-T098
,	O
all	O
risk	B-T033
factor	I-T033
associations	O
were	O
weak	O
.	O
there	O
was	O
little	O
or	O
no	O
heterogeneity	O
in	O
risk	O
between	O
tumours	B-T038
of	O
the	O
right	B-T017
colon	I-T017
,	O
left	B-T017
colon	I-T017
and	O
rectum	B-T017
for	O
any	O
of	O
the	O
14	O
factors	B-T033
examined	O
.	O
these	O
epidemiological	B-T091
findings	B-T033
complement	O
an	O
emerging	O
picture	O
from	O
molecular	O
studies	O
of	O
possible	O
different	O
developmental	O
pathways	O
for	O
different	O
tumour	B-T038
types	O
.	O

changes	O
in	O
cardiovascular	B-T082
health	O
status	O
and	O
the	O
risk	O
of	O
new	O
-	O
onset	O
hypertension	O
in	O
ka	B-T098
##il	I-T098
##uan	I-T098
cohort	O
study	O
american	B-T092
heart	I-T092
association	I-T092
cardiovascular	B-T082
health	B-T170
metrics	I-T170
are	O
intimately	O
related	O
to	O
cardiovascular	B-T038
diseases	I-T038
.	O
acting	O
as	O
a	O
key	O
independent	O
risk	B-T033
factor	I-T033
for	O
high	O
morbidity	O
and	O
mortality	O
of	O
cardiovascular	B-T038
diseases	I-T038
,	O
hypertension	B-T038
and	O
its	O
relationship	O
between	O
health	O
status	O
get	O
urgent	O
attention	B-T038
.	O
while	O
the	O
influence	O
of	O
individual	B-T098
health	O
status	O
changes	O
and	O
the	O
future	O
risk	O
of	O
new	O
-	O
onset	O
hypertension	O
is	O
rarely	O
understood	O
,	O
the	O
present	O
study	O
applied	O
this	O
construct	O
to	O
assess	O
the	O
changes	O
of	O
cardiovascular	B-T082
health	O
status	O
and	O
the	O
morbidity	O
of	O
hypertension	B-T038
in	O
ka	B-T098
##il	I-T098
##uan	I-T098
cohort	O
study	O
in	O
north	B-T082
china	B-T082
.	O
the	O
cardiovascular	B-T082
health	O
score	O
(	O
chs	O
)	O
was	O
evaluated	B-T058
by	O
the	O
follow	B-T058
-	I-T058
ups	I-T058
of	O
2006	O
-	O
2007	O
,	O
2008	O
-	O
2009	O
,	O
2010	O
-	O
2011	O
and	O
2012	O
-	O
2013	O
.	O
the	O
study	B-T098
population	I-T098
(	O
n	O
=	O
193	O
##81	O
)	O
was	O
divided	O
into	O
5	O
groups	O
based	O
on	O
the	O
changes	O
in	O
their	O
chs	O
score	O
between	O
the	O
first	O
two	O
follow	B-T058
-	I-T058
ups	I-T058
(	O
△	O
##ch	O
##s	O
)	O
of	O
2006	O
-	O
2007	O
and	O
2008	O
-	O
2009	O
(	O
≤	O
-	O
2	O
,	O
-	O
1	O
,	O
0	O
,	O
1	O
,	O
≥2	O
)	O
.	O
the	O
morbidity	O
of	O
hypertension	B-T038
was	O
collected	O
during	O
2010	O
-	O
2011	O
and	O
2012	O
-	O
2013	O
follow	B-T058
-	I-T058
ups	I-T058
.	O
data	O
analysis	O
showed	O
that	O
during	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
of	O
3	O
.	O
79	O
##±0	O
.	O
96	O
years	O
,	O
morbidity	O
of	O
hypertension	B-T038
had	O
a	O
graded	O
relationship	O
with	O
△	O
##ch	O
##s	O
.	O
as	O
△	O
##ch	O
##s	O
scored	O
from	O
low	O
to	O
high	O
,	O
the	O
standardized	O
morbidity	O
of	O
hypertension	B-T038
for	O
all	O
participants	B-T098
were	O
81	O
.	O
40	O
,	O
75	O
.	O
47	O
,	O
68	O
.	O
37	O
,	O
71	O
.	O
43	O
and	O
83	O
.	O
13	O
per	O
1000	O
person	O
-	O
year	O
,	O
respectively	O
.	O
an	O
increased	O
△	O
##ch	O
##s	O
score	O
of	O
1	O
was	O
associated	O
with	O
a	O
10	O
%	O
decrease	O
in	O
the	O
future	O
risk	O
of	O
new	O
-	O
onset	O
hypertension	O
(	O
hr	O
:	O
0	O
.	O
90	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
88	O
-	O
0	O
.	O
92	O
)	O
.	O
in	O
conclusion	O
,	O
there	O
was	O
a	O
strong	O
inverse	O
relationship	O
between	O
the	O
incidence	O
of	O
new	O
-	O
onset	O
hypertension	O
and	O
elevation	O
of	O
cardiovascular	B-T082
health	B-T170
metrics	I-T170
.	O
population	B-T098
-	O
wide	O
prevention	O
,	O
especially	O
the	O
promotion	B-T058
of	O
lifestyle	O
improvements	O
,	O
is	O
critical	O
to	O
reducing	O
the	O
morbidity	O
of	O
new	O
-	O
onset	O
hypertension	O
.	O

assessment	B-T058
of	O
cerebral	B-T017
blood	O
perfusion	O
reserve	O
with	O
acet	B-T103
##azolamide	I-T103
using	O
3d	B-T058
spiral	I-T058
asl	I-T058
mri	I-T058
:	O
preliminary	O
experience	O
in	O
pediatric	O
patients	O
to	O
demonstrate	O
the	O
clinical	B-T062
feasibility	I-T062
of	O
a	O
new	O
non	B-T058
-	I-T058
cart	I-T058
##esia	I-T058
##n	I-T058
cylindrical	I-T058
##ly	I-T058
-	I-T058
distributed	I-T058
spiral	I-T058
3d	I-T058
pseudo	I-T058
-	I-T058
continuous	I-T058
arterial	I-T058
spin	I-T058
labeling	I-T058
(	I-T058
pca	I-T058
##s	I-T058
##l	I-T058
)	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	I-T058
mri	I-T058
)	I-T058
pulse	B-T082
sequence	I-T082
in	O
pediatric	O
patients	O
in	O
quantifying	O
cerebral	B-T033
blood	I-T033
flow	I-T033
(	O
cbf	B-T033
)	O
response	O
to	O
an	O
acet	B-T103
##azolamide	I-T103
(	I-T103
ac	I-T103
##z	I-T103
)	I-T103
vasodilator	I-T103
challenge	O
.	O
mri	B-T058
exams	I-T058
were	O
performed	O
on	O
two	O
3	O
tesla	O
phil	O
##ips	O
ing	O
##enia	O
systems	O
using	O
32	O
channel	O
head	O
coil	O
arrays	O
.	O
after	O
local	O
institutional	B-T170
review	I-T170
board	I-T170
approval	I-T170
,	O
the	O
3d	B-T058
spiral	I-T058
-	I-T058
based	I-T058
pca	I-T058
##s	I-T058
##l	I-T058
technique	I-T058
was	O
added	O
to	O
a	O
standard	O
brain	B-T058
mri	I-T058
exam	I-T058
and	O
evaluated	O
in	O
13	O
pediatric	O
patients	O
(	O
average	O
age	O
:	O
11	O
.	O
7	O
##±6	O
.	O
4	O
##years	O
,	O
range	O
:	O
1	O
.	O
4	O
-	O
22	O
.	O
2	O
##years	O
)	O
.	O
all	O
patients	O
were	O
administered	B-T058
ac	B-T103
##z	I-T103
for	O
clinically	B-T033
indicated	I-T033
reasons	O
.	O
quantitative	O
whole	B-T058
-	I-T058
brain	I-T058
cbf	I-T058
measurements	I-T058
were	O
computed	O
pre	O
-	O
and	O
post	O
-	O
ac	B-T103
##z	I-T103
to	O
assess	O
cerebrovascular	B-T038
reserve	I-T038
.	O
3d	B-T058
spiral	I-T058
pca	I-T058
##s	I-T058
##l	I-T058
data	O
were	O
successfully	O
reconstructed	O
in	O
all	O
13	O
cases	B-T062
.	O
in	O
11	O
patients	O
,	O
cbf	B-T033
increased	O
2	O
.	O
8	O
%	O
to	O
93	O
.	O
2	O
%	O
after	O
administration	B-T058
of	I-T058
ac	B-T103
##z	I-T103
.	O
in	O
the	O
two	O
remaining	O
patients	O
,	O
cbf	B-T033
decreased	O
by	O
2	O
.	O
4	O
to	O
6	O
.	O
0	O
%	O
after	O
ac	B-T103
##z	I-T103
.	O
the	O
group	O
average	O
change	O
in	O
cbf	B-T033
due	O
to	O
ac	B-T103
##z	I-T103
was	O
approximately	O
25	O
.	O
0	O
%	O
and	O
individual	O
changes	O
were	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
all	O
patients	O
using	O
a	O
paired	O
t	B-T170
-	I-T170
test	I-T170
analysis	I-T170
.	O
cbf	B-T033
perfusion	O
data	O
were	O
diagnostic	O
##ally	O
useful	O
in	O
supporting	O
conventional	O
mr	B-T058
angiography	I-T058
and	O
clinical	B-T170
findings	I-T170
.	O
3d	B-T058
cylindrical	I-T058
##ly	I-T058
-	I-T058
distributed	I-T058
spiral	I-T058
pca	I-T058
##s	I-T058
##l	I-T058
mri	I-T058
provides	O
a	O
robust	O
approach	O
to	O
assess	O
cerebral	B-T033
blood	I-T033
flow	I-T033
and	O
reserve	O
in	O
pediatric	O
patients	O
.	O

development	O
and	O
evaluation	B-T062
of	O
the	O
adhd	B-T170
cognition	I-T170
##s	I-T170
scale	I-T170
for	O
adults	O
the	O
clinical	B-T170
literature	I-T170
on	O
adhd	B-T038
in	O
adults	O
suggests	O
that	O
[UNK]	O
overl	B-T038
##y	I-T038
positive	I-T038
[UNK]	O
or	O
optim	B-T038
##istic	I-T038
cognition	I-T038
##s	I-T038
may	O
contribute	O
to	O
impairment	O
and	O
failure	O
to	O
use	O
self	O
-	O
regulation	O
skills	O
in	O
this	O
population	B-T098
,	O
yet	O
the	O
research	B-T062
literature	B-T170
on	O
this	O
topic	O
is	O
limited	O
.	O
we	O
developed	O
the	O
adhd	B-T170
cognition	I-T170
##s	I-T170
scale	I-T170
(	O
acs	B-T170
)	O
,	O
a	O
brief	O
self	B-T062
-	I-T062
report	I-T062
measure	O
of	O
adhd	B-T038
-	O
related	O
thoughts	B-T038
,	O
and	O
evaluated	O
its	O
psychometric	O
properties	O
.	O
we	O
collected	O
self	B-T062
-	I-T062
report	I-T062
measures	O
,	O
inc	O
##uld	O
##ing	O
the	O
acs	B-T170
,	O
from	O
two	O
large	O
community	O
samples	O
(	O
ns	O
=	O
262	O
,	O
304	O
)	O
.	O
the	O
measure	O
demonstrated	O
a	O
one	O
-	O
factor	O
solution	O
that	O
replicated	O
in	O
the	O
second	O
sample	O
.	O
evidence	O
of	O
good	O
internal	O
consistency	O
and	O
also	O
convergent	O
and	O
divergent	O
validity	O
was	O
obtained	O
for	O
both	O
samples	O
.	O
scores	O
on	O
the	O
acs	B-T170
correlated	O
with	O
functional	O
impairment	O
,	O
time	B-T033
management	I-T033
problems	I-T033
,	O
and	O
avoid	B-T033
##ant	I-T033
coping	I-T033
strategies	O
.	O
with	O
additional	O
study	B-T062
,	O
the	O
acs	B-T170
may	O
be	O
useful	O
to	O
identify	O
and	O
track	O
maladaptive	B-T033
adhd	B-T038
-	O
related	O
cognition	B-T038
##s	I-T038
during	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
treatment	I-T058
,	O
and	O
to	O
further	O
study	B-T062
the	O
role	O
of	O
these	O
thoughts	B-T038
in	O
adhd	B-T038
-	O
related	O
impairment	O
.	O

elucidating	O
a	O
chemical	O
defense	B-T038
mechanism	I-T038
of	O
antarctic	B-T082
sponges	B-T204
:	O
a	O
computational	O
study	O
in	O
2000	O
,	O
a	O
novel	O
secondary	B-T103
metabolite	I-T103
(	O
er	B-T103
##eb	I-T103
##us	I-T103
##inone	I-T103
,	O
er	B-T103
##eb	I-T103
)	O
was	O
isolated	O
from	O
the	O
antarctic	B-T082
sea	B-T204
sponge	I-T204
,	O
iso	B-T204
##di	I-T204
##ct	I-T204
##ya	I-T204
er	I-T204
##ina	I-T204
##ce	I-T204
##a	I-T204
.	O
the	O
bioactivity	O
of	O
er	B-T103
##eb	I-T103
was	O
investigated	O
,	O
and	O
it	O
was	O
found	O
to	O
inhibit	O
mol	B-T038
##ting	I-T038
when	O
fed	O
to	O
the	O
arthropod	B-T204
species	I-T204
orch	B-T204
##omen	I-T204
##e	I-T204
ple	I-T204
##bs	I-T204
.	O
xanth	B-T103
##uren	I-T103
##ic	I-T103
acid	I-T103
(	O
xa	B-T103
)	O
is	O
a	O
known	O
endogenous	O
mol	O
##t	O
regulator	O
present	O
in	O
arthropod	B-T204
##s	I-T204
.	O
experimental	O
studies	O
have	O
confirmed	O
that	O
xa	B-T103
inhibits	O
mol	B-T038
##ting	I-T038
by	O
binding	B-T038
to	O
either	O
(	O
or	O
both	O
)	O
of	O
two	O
p450	B-T103
enzymes	I-T103
(	O
cyp	B-T103
##31	I-T103
##5a	I-T103
##1	I-T103
or	O
cyp	B-T103
##31	I-T103
##4a	I-T103
##1	I-T103
)	O
that	O
are	O
responsible	O
for	O
the	O
final	O
two	O
hydroxylation	O
##s	O
in	O
the	O
production	O
of	O
the	O
mol	B-T103
##t	I-T103
-	I-T103
inducing	I-T103
hormone	I-T103
,	O
20	B-T103
-	I-T103
hydroxy	I-T103
##ecd	I-T103
##ys	I-T103
##one	I-T103
(	O
20	B-T103
##e	I-T103
)	O
.	O
the	O
lack	O
of	O
crystal	B-T103
structures	I-T103
and	O
biochemical	B-T058
assays	I-T058
for	O
cyp	B-T103
##31	I-T103
##5a	I-T103
##1	I-T103
or	O
cyp	B-T103
##31	I-T103
##4a	I-T103
##1	I-T103
,	O
has	O
prevented	O
further	O
experimental	O
exploration	B-T062
of	O
xa	B-T103
and	O
er	B-T103
##eb	I-T103
'	I-T103
s	I-T103
mol	B-T038
##t	I-T038
inhibition	O
mechanisms	O
.	O
herein	O
,	O
a	O
wide	O
array	O
of	O
computational	B-T062
techniques	I-T062
-	O
homology	B-T062
modeling	I-T062
,	O
molecular	O
dynamics	O
simulations	O
,	O
binding	B-T038
site	I-T038
bioinformatics	B-T091
,	O
flexible	B-T038
receptor	I-T038
-	I-T038
flexible	I-T038
ligand	I-T038
docking	I-T038
,	O
and	O
molecular	O
mechanics	O
-	O
generalized	O
born	B-T170
surface	I-T170
area	I-T170
calculations	I-T170
-	O
have	O
been	O
employed	O
to	O
elucidate	O
the	O
structure	O
-	O
function	O
relationships	O
between	O
the	O
aforementioned	O
p450	B-T103
##s	I-T103
and	O
the	O
two	O
described	O
small	O
molecule	O
inhibitors	B-T103
(	O
er	B-T103
##eb	I-T103
and	O
xa	B-T103
)	O
.	O
results	O
indicate	O
that	O
er	B-T103
##eb	I-T103
likely	O
targets	O
cyp	B-T103
##31	I-T103
##5a	I-T103
##1	I-T103
by	O
interacting	O
with	O
a	O
network	O
of	O
aromatic	O
residues	O
in	O
the	O
binding	B-T038
site	I-T038
,	O
while	O
xa	B-T103
may	O
inhibit	O
both	O
cyp	B-T103
##31	I-T103
##5a	I-T103
##1	I-T103
and	O
cyp	B-T103
##31	I-T103
##4a	I-T103
##1	I-T103
because	O
of	O
its	O
aromatic	O
,	O
as	O
well	O
as	O
charged	B-T103
nature	I-T103
.	O

naive	B-T017
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
derived	O
tumor	B-T038
-	O
specific	O
cytotoxic	B-T017
effectors	I-T017
as	O
a	O
potential	O
remed	O
##y	O
for	O
overcoming	O
tgf	B-T103
-	I-T103
β	I-T103
immunosuppression	B-T038
in	O
the	O
tumor	O
microenvironment	O
despite	O
of	O
the	O
potential	O
implications	O
for	O
cancer	B-T058
immunotherapy	I-T058
,	O
conventional	O
approaches	O
using	O
in	O
vitro	O
expanded	B-T082
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
have	O
suboptimal	O
outcomes	O
,	O
mostly	O
due	O
to	O
loss	O
of	O
functionality	O
from	O
cellular	B-T017
exhaustion	O
.	O
we	O
therefore	O
investigated	O
the	O
phenotypic	O
and	O
functional	O
differences	O
among	O
in	O
vitro	O
activated	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
of	O
three	O
different	O
sources	B-T033
,	O
namely	O
naive	B-T017
(	O
nt	B-T017
##eff	I-T017
)	O
,	O
memory	B-T017
(	O
mt	B-T017
##eff	I-T017
)	O
and	O
tumor	B-T017
-	I-T017
infiltrating	I-T017
lymphocytes	I-T017
(	O
til	B-T017
##eff	I-T017
)	O
from	O
human	B-T204
and	O
mice	B-T204
,	O
to	O
better	O
understand	O
mechanisms	O
behind	O
potent	O
effector	B-T017
functions	O
and	O
potential	O
for	O
overcoming	O
current	O
limitations	O
.	O
in	O
line	O
with	O
the	O
greater	O
proliferation	B-T038
activity	O
and	O
longer	O
telomere	B-T017
lengths	O
of	O
nt	B-T017
##eff	I-T017
populations	I-T017
,	O
cells	B-T017
of	O
naive	O
origin	O
exhibited	O
significantly	O
less	O
amounts	O
of	O
t	B-T017
cell	I-T017
exhaustion	O
markers	B-T201
than	O
those	O
of	O
mt	B-T017
##eff	I-T017
and	O
til	B-T017
##eff	I-T017
,	O
and	O
moreover	O
,	O
acquired	O
distinct	O
expression	B-T038
patterns	I-T038
of	O
memory	B-T103
-	I-T103
promoting	I-T103
transcription	I-T103
factors	I-T103
,	O
t	B-T103
-	I-T103
bet	I-T103
and	O
eo	B-T103
##me	I-T103
##s	I-T103
,	O
induced	O
in	O
a	O
rapid	O
and	O
sustainable	O
manner	O
.	O
nt	B-T017
##eff	I-T017
cells	I-T017
appeared	O
to	O
have	O
lower	O
expression	B-T038
of	O
fox	B-T103
##p1	I-T103
and	O
were	O
refractory	O
to	O
apoptosis	B-T038
upon	O
tgf	B-T103
-	I-T103
β	I-T103
conditioning	O
,	O
implying	O
better	O
survival	B-T038
potential	O
and	O
resistance	O
to	O
tumor	B-T038
-	O
induced	O
immune	B-T038
suppression	I-T038
.	O
of	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
pools	O
activated	O
to	O
tumor	B-T038
-	O
specific	O
ctls	B-T017
,	O
naive	B-T017
cell	I-T017
generated	O
effectors	B-T017
possessed	O
the	O
most	O
potent	O
cytotoxic	B-T033
activity	I-T033
,	O
validating	O
implications	O
for	O
use	O
in	O
rational	O
design	O
of	O
adoptive	B-T058
immunotherapy	I-T058
.	O

quantification	O
of	O
urinary	O
mono	B-T103
-	I-T103
hydroxylated	I-T103
metabolites	I-T103
of	O
polycyclic	B-T103
aromatic	I-T103
hydrocarbons	I-T103
by	O
on	B-T058
-	I-T058
line	I-T058
solid	I-T058
phase	I-T058
extraction	I-T058
-	O
high	B-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
human	B-T204
exposure	O
to	O
polycyclic	B-T103
aromatic	I-T103
hydrocarbons	I-T103
(	O
pahs	B-T103
)	O
can	O
be	O
assessed	O
through	O
monitoring	B-T058
of	O
urinary	O
mono	B-T103
-	I-T103
hydroxylated	I-T103
pahs	I-T103
(	O
oh	B-T103
-	I-T103
pahs	I-T103
)	O
.	O
gas	B-T058
chromatography	I-T058
(	O
gc	B-T058
)	O
has	O
been	O
widely	O
used	O
to	O
separate	O
oh	B-T103
-	I-T103
pahs	I-T103
before	O
quantification	O
by	O
mass	B-T058
spectrometry	I-T058
in	O
biom	O
##onitoring	O
studies	B-T062
.	O
however	O
,	O
because	O
gc	B-T058
requires	O
derivatization	O
,	O
it	O
can	O
be	O
time	O
consuming	O
.	O
we	O
developed	O
an	O
on	B-T058
-	I-T058
line	I-T058
solid	I-T058
phase	I-T058
extraction	I-T058
coupled	O
to	O
isotope	B-T103
dilution	O
-	O
high	B-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
(	O
on	B-T058
-	I-T058
line	I-T058
-	I-T058
spe	I-T058
-	O
hplc	B-T058
-	I-T058
ms	I-T058
/	O
ms	B-T058
)	O
method	B-T170
for	O
the	O
quantification	O
in	O
urine	B-T031
of	O
1	B-T103
-	I-T103
oh	I-T103
-	I-T103
naphthalene	I-T103
,	O
2	B-T103
-	I-T103
oh	I-T103
-	I-T103
naphthalene	I-T103
,	O
2	B-T103
-	I-T103
oh	I-T103
-	I-T103
fluor	I-T103
##ene	I-T103
,	O
3	B-T103
-	I-T103
oh	I-T103
-	I-T103
fluor	I-T103
##ene	I-T103
,	O
1	B-T103
-	I-T103
oh	I-T103
-	I-T103
phenanthrene	I-T103
,	O
the	O
sum	O
of	O
2	B-T103
-	I-T103
oh	I-T103
and	O
3	B-T103
-	I-T103
oh	I-T103
-	I-T103
phenanthrene	I-T103
,	O
4	B-T103
-	I-T103
oh	I-T103
-	I-T103
phenanthrene	I-T103
,	O
and	O
1	B-T103
-	I-T103
oh	I-T103
-	I-T103
pyrene	I-T103
.	O
the	O
method	B-T170
,	O
which	O
employed	B-T033
a	O
96	O
-	O
well	B-T082
plate	I-T082
platform	I-T082
and	O
on	B-T058
-	I-T058
line	I-T058
spe	I-T058
,	O
showed	O
good	O
sensitivity	O
(	O
i	O
.	O
e	O
.	O
,	O
limits	O
of	O
detection	B-T058
ranged	O
from	O
0	O
.	O
007	O
to	O
0	O
.	O
09	O
ng	O
/	O
ml	O
)	O
and	O
used	O
only	O
100	O
μl	O
of	O
urine	B-T031
.	O
accuracy	O
,	O
calculated	B-T058
from	O
the	O
recovery	O
percentage	O
at	O
three	O
spiking	B-T082
levels	O
,	O
varied	O
from	O
94	O
to	O
113	O
%	O
,	O
depending	O
on	O
the	O
analyte	O
.	O
the	O
inter	O
-	O
and	O
intra	O
-	O
day	O
precision	O
,	O
calculated	B-T058
from	O
20	O
repeated	O
measurements	O
of	O
two	O
quality	O
control	O
materials	O
,	O
varied	O
from	O
5	O
.	O
2	O
to	O
16	O
.	O
7	O
%	O
.	O
adequate	O
method	B-T170
performance	O
was	O
also	O
confirmed	O
by	O
acceptable	O
recovery	O
(	O
83	O
-	O
102	O
%	O
)	O
of	O
two	O
nis	B-T092
##t	I-T092
standard	O
reference	O
materials	O
(	O
36	O
##72	O
and	O
36	O
##73	O
)	O
.	O
this	O
high	O
-	O
throughput	O
on	B-T058
-	I-T058
line	I-T058
-	I-T058
spe	I-T058
-	O
hplc	B-T058
-	I-T058
ms	I-T058
/	O
ms	B-T058
method	B-T170
can	O
be	O
applied	O
in	O
large	O
-	O
scale	O
epidemiological	B-T062
studies	I-T062
.	O
graphical	O
abstract	O
example	O
lc	O
-	O
ms	O
chromat	O
##ogram	O
of	O
urinary	O
mono	B-T103
-	I-T103
hydroxylated	I-T103
pah	I-T103
metabolites	B-T103
.	O

recruitment	O
of	O
minority	B-T098
adolescents	O
and	O
young	O
adults	O
into	O
randomised	B-T062
clinical	I-T062
trials	I-T062
:	O
testing	O
the	O
design	O
of	O
the	O
technology	B-T058
enhanced	I-T058
community	I-T058
health	I-T058
nursing	I-T058
(	O
tec	B-T058
##h	I-T058
-	I-T058
n	I-T058
)	O
pelvic	B-T038
inflammatory	I-T038
disease	I-T038
trial	O
pelvic	B-T038
inflammatory	I-T038
disease	I-T038
(	O
pid	B-T038
)	O
disproportionately	O
affects	O
adolescent	O
and	O
young	O
adult	O
(	O
ay	O
##a	O
)	O
women	B-T098
and	O
can	O
negatively	O
influence	O
reproductive	B-T091
health	I-T091
trajectories	O
.	O
few	O
randomized	B-T062
controlled	I-T062
trials	I-T062
(	O
rcts	B-T062
)	O
have	O
focused	O
on	O
strategies	O
to	O
improve	B-T033
outpatient	O
adherence	O
or	O
to	O
reduce	O
reproductive	B-T038
morbidity	O
in	O
this	O
population	B-T098
.	O
this	O
paper	O
describes	O
the	O
research	B-T062
methods	I-T062
and	O
preliminary	O
effectiveness	O
of	O
recruitment	O
,	O
retention	O
,	O
and	O
intervention	B-T058
strategies	O
employed	O
in	O
a	O
novel	O
rct	B-T062
designed	O
to	O
test	O
a	O
technology	B-T058
-	I-T058
enhanced	I-T058
community	I-T058
-	I-T058
health	I-T058
nursing	I-T058
(	O
tec	B-T058
##h	I-T058
-	I-T058
n	I-T058
)	O
intervention	B-T058
among	O
urban	O
ay	O
##a	O
with	O
pid	B-T038
.	O
ay	O
##a	O
women	B-T098
aged	O
13	O
-	O
25	O
years	O
were	O
recruited	O
during	O
acute	B-T038
pid	I-T038
visits	B-T058
in	O
outpatient	B-T092
clinics	I-T092
and	O
emergency	B-T092
departments	I-T092
(	O
ed	B-T092
)	O
to	O
participate	B-T058
in	O
this	O
irb	B-T170
-	I-T170
approved	I-T170
trial	O
.	O
participants	B-T098
completed	O
an	O
audio	O
-	O
computerized	O
self	O
-	O
interview	O
(	O
aca	O
##si	O
)	O
,	O
provided	O
vaginal	B-T017
specimens	I-T017
,	O
and	O
were	O
randomized	B-T062
to	O
standard	O
treatment	B-T058
or	O
the	O
intervention	B-T058
.	O
intervention	B-T058
participants	B-T098
received	O
text	O
-	O
mess	O
##aging	O
support	O
for	O
30	O
days	O
and	O
a	O
community	B-T097
health	I-T097
nurse	I-T097
(	I-T097
ch	I-T097
##n	I-T097
)	I-T097
intervention	I-T097
##ist	I-T097
performed	O
a	O
home	O
visit	O
with	O
clinical	O
assessment	O
within	O
5	O
days	O
after	O
enrollment	B-T058
.	O
all	O
patients	O
received	O
a	O
full	O
course	O
of	O
medications	O
and	O
completed	O
research	O
visits	O
at	O
14	O
-	O
days	O
(	O
adherence	O
)	O
,	O
30	O
days	O
and	O
90	O
days	O
with	O
by	O
an	O
outreach	B-T097
worker	I-T097
.	O
sti	B-T038
testing	O
performed	O
at	O
the	O
30	O
-	O
and	O
90	O
-	O
day	O
visits	B-T058
.	O
exploratory	B-T062
analyses	I-T062
using	O
descriptive	B-T062
statistics	I-T062
were	O
conducted	O
to	O
examine	O
recruitment	O
,	O
retention	O
,	O
and	O
follow	B-T058
-	I-T058
up	I-T058
data	O
to	O
test	O
the	O
overall	O
design	O
of	O
the	O
intervention	B-T058
.	O
in	O
the	O
first	O
48	O
months	O
,	O
64	O
%	O
of	O
46	O
##3	O
patients	O
were	O
eligible	O
for	O
the	O
study	O
and	O
81	O
.	O
2	O
%	O
of	O
293	O
eligible	O
patients	O
were	O
recruited	O
for	O
the	O
study	O
(	O
63	O
.	O
3	O
%	O
)	O
;	O
238	O
(	O
81	O
.	O
2	O
%	O
)	O
of	O
eligible	O
patients	O
were	O
enrolled	B-T058
.	O
most	O
participants	B-T098
were	O
african	B-T098
american	I-T098
(	O
95	O
.	O
6	O
%	O
)	O
with	O
a	O
mean	O
age	O
of	O
18	O
.	O
6	O
(	O
2	O
.	O
3	O
)	O
.	O
ninety	O
-	O
four	O
percent	O
of	O
individuals	B-T098
assigned	O
to	O
the	O
tec	B-T058
##h	I-T058
-	I-T058
n	I-T058
intervention	I-T058
completed	O
the	O
nursing	O
visits	O
.	O
all	O
completed	O
visits	O
have	O
been	O
within	O
the	O
5	O
-	O
day	O
window	O
and	O
over	O
90	O
%	O
of	O
patients	O
in	O
both	O
arms	O
have	O
been	O
retained	O
over	O
the	O
3	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
period	O
.	O
biological	O
data	O
suggests	O
a	O
shift	O
in	O
the	O
biological	O
milieu	O
with	O
the	O
predominance	O
of	O
chlamydia	B-T038
trachomatis	I-T038
,	O
mycoplasma	B-T038
genital	I-T038
##ium	I-T038
,	O
and	O
trich	B-T038
##omonas	I-T038
vaginalis	I-T038
infections	I-T038
.	O
preliminary	O
data	O
from	O
the	O
tec	B-T058
##h	I-T058
-	I-T058
n	I-T058
study	O
demonstrated	O
that	O
urban	B-T082
,	O
low	B-T033
-	I-T033
income	I-T033
,	O
minority	B-T098
ay	O
##a	O
with	O
pid	B-T038
can	O
effectively	O
be	O
recruited	O
and	O
retained	O
to	O
participate	B-T058
in	O
sexual	O
and	O
reproductive	B-T091
health	I-T091
rcts	B-T062
with	O
sufficient	O
investment	O
in	O
the	O
design	O
and	O
infrastructure	B-T170
of	I-T170
the	I-T170
study	I-T170
.	O
community	O
-	O
based	O
sexual	O
health	O
interventions	B-T058
appear	O
to	O
be	O
both	O
feasible	O
and	O
acceptable	O
in	O
this	O
population	B-T098
.	O

randomized	B-T062
trials	I-T062
of	O
the	O
teen	O
outreach	O
program	O
in	O
louis	B-T082
##iana	I-T082
and	O
roch	B-T082
##ester	I-T082
,	O
new	B-T082
york	I-T082
to	O
evaluate	B-T058
the	O
teen	O
outreach	O
program	O
,	O
a	O
pregnancy	O
prevention	O
program	O
,	O
in	O
2	O
community	O
-	O
based	O
settings	O
.	O
we	O
evaluated	B-T058
the	O
teen	O
outreach	O
program	O
,	O
a	O
9	O
-	O
month	O
positive	O
youth	O
development	O
program	O
,	O
in	O
3	O
cohorts	B-T098
of	O
youths	O
from	O
2012	O
to	O
2015	O
in	O
2	O
states	B-T082
.	O
in	O
louis	B-T082
##iana	I-T082
,	O
7	O
agencies	B-T092
participated	O
in	O
an	O
individualized	O
randomized	B-T062
controlled	I-T062
trial	I-T062
,	O
with	O
youths	O
randomly	O
assigned	O
to	O
a	O
treatment	B-T058
or	O
control	O
condition	O
.	O
fourteen	O
agencies	B-T092
in	O
roch	B-T082
##ester	I-T082
,	O
new	B-T082
york	I-T082
,	O
participated	O
in	O
a	O
cluster	O
randomized	B-T062
controlled	I-T062
trial	I-T062
.	O
we	O
found	O
no	O
differences	O
between	O
the	O
intervention	B-T058
and	O
control	O
youths	O
on	O
delay	O
of	O
sexual	O
onset	O
in	O
louis	B-T082
##iana	I-T082
(	O
adjusted	O
odds	O
ratio	O
[	O
aor	O
]	O
=	O
0	O
.	O
80	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
=	O
0	O
.	O
62	O
,	O
1	O
.	O
03	O
)	O
or	O
in	O
roch	B-T082
##ester	I-T082
,	O
new	B-T082
york	I-T082
(	O
aor	O
=	O
0	O
.	O
89	O
;	O
95	O
%	O
ci	O
=	O
0	O
.	O
45	O
,	O
1	O
.	O
77	O
)	O
,	O
or	O
for	O
sex	B-T038
with	O
no	O
effective	O
means	O
of	O
birth	B-T103
control	I-T103
(	O
louis	B-T082
##iana	I-T082
,	O
aor	O
=	O
1	O
.	O
18	O
;	O
95	O
%	O
ci	O
=	O
0	O
.	O
78	O
,	O
1	O
.	O
78	O
;	O
roch	B-T082
##ester	I-T082
,	O
aor	O
=	O
0	O
.	O
41	O
;	O
95	O
%	O
ci	O
=	O
0	O
.	O
13	O
,	O
1	O
.	O
27	O
)	O
after	O
controlling	O
for	O
relevant	O
covariates	O
.	O
we	O
found	O
no	B-T033
short	O
-	O
term	O
effects	O
for	O
the	O
offer	O
of	O
the	O
intervention	B-T058
.	O
research	B-T062
might	O
be	O
needed	O
for	O
the	O
long	O
-	O
term	O
and	O
intermediate	O
impacts	O
of	O
youth	O
development	O
programs	O
on	O
these	O
and	O
other	O
adolescent	O
risk	O
behaviors	O
.	O

mas	B-T103
##itinib	I-T103
for	O
treatment	B-T058
of	O
severely	O
symptomatic	O
indolent	B-T038
systemic	I-T038
mast	I-T038
##ocytosis	I-T038
:	O
a	O
randomised	B-T062
,	O
placebo	B-T062
-	I-T062
controlled	I-T062
,	O
phase	B-T062
3	I-T062
study	I-T062
indolent	B-T038
systemic	I-T038
mast	I-T038
##ocytosis	I-T038
,	O
including	O
the	O
sub	O
##va	O
##rian	O
##t	O
of	O
smo	B-T038
##ulder	I-T038
##ing	I-T038
systemic	I-T038
mast	I-T038
##ocytosis	I-T038
,	O
is	O
a	O
lifelong	O
condition	O
associated	O
with	O
reduced	B-T033
quality	I-T033
of	I-T033
life	I-T033
.	O
mas	B-T103
##itinib	I-T103
inhibits	O
kit	B-T103
and	O
ly	B-T103
##n	I-T103
kinases	I-T103
that	O
are	O
involved	O
in	O
indolent	B-T038
systemic	I-T038
mast	I-T038
##ocytosis	I-T038
pathogenesis	B-T038
.	O
we	O
aimed	O
to	O
assess	O
safety	B-T062
and	O
efficacy	B-T062
of	O
mas	B-T103
##itinib	I-T103
versus	O
placebo	B-T103
in	O
severely	B-T033
symptomatic	I-T033
patients	O
who	O
were	O
unresponsive	O
to	O
optimal	O
symptomatic	O
treatments	B-T058
.	O
in	O
this	O
randomised	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	B-T062
-	I-T062
controlled	I-T062
,	O
phase	B-T062
3	I-T062
study	I-T062
,	O
we	O
enrolled	O
adults	O
(	O
aged	O
18	O
-	O
75	O
years	O
)	O
with	O
indolent	B-T038
or	O
smo	B-T038
##ulder	I-T038
##ing	I-T038
systemic	I-T038
mast	I-T038
##ocytosis	I-T038
,	O
according	O
to	O
who	B-T092
classification	B-T170
or	O
documented	B-T170
mast	B-T038
##ocytosis	I-T038
based	O
on	O
histological	B-T201
criteria	I-T201
,	O
at	O
50	O
centres	O
in	O
15	O
countries	B-T082
.	O
we	O
excluded	O
patients	O
with	O
cutaneous	B-T082
or	O
non	O
-	O
severe	O
systemic	B-T038
mast	I-T038
##ocytosis	I-T038
after	O
a	O
protocol	B-T170
amend	I-T170
##ment	I-T170
.	O
patients	O
were	O
centrally	O
randomised	B-T062
(	O
1	O
:	O
1	O
)	O
to	O
receive	O
either	O
oral	O
mas	B-T103
##itinib	I-T103
(	O
6	O
mg	O
/	O
kg	O
per	O
day	O
over	O
24	O
weeks	O
with	O
possible	O
extension	O
)	O
or	O
matched	O
placebo	B-T103
with	O
minim	O
##isation	O
according	O
to	O
severe	B-T033
symptoms	I-T033
.	O
the	O
primary	B-T103
endpoint	I-T103
was	O
cumulative	O
response	B-T201
(	O
≥	O
##75	O
%	O
improvement	O
from	O
baseline	O
within	O
weeks	O
8	O
-	O
24	O
)	O
in	O
at	O
least	O
one	O
severe	B-T033
baseline	I-T033
symptom	I-T033
from	O
the	O
following	O
:	O
pruritus	B-T033
score	O
of	O
9	O
or	O
more	O
,	O
eight	O
or	O
more	O
flush	O
##es	O
per	O
week	O
,	O
hamilton	B-T170
rating	I-T170
scale	I-T170
for	I-T170
depression	I-T170
of	O
19	O
or	O
more	O
,	O
or	O
fatigue	B-T170
impact	I-T170
scale	I-T170
of	O
75	O
or	O
more	O
.	O
we	O
assessed	O
treatment	O
effect	O
using	O
repeated	O
measures	O
methodology	B-T062
for	O
rare	B-T038
diseases	I-T038
via	O
the	O
generalised	B-T170
estimating	I-T170
equation	I-T170
model	I-T170
in	O
a	O
modified	O
intention	B-T062
-	I-T062
to	I-T062
-	I-T062
treat	I-T062
population	B-T098
,	O
including	O
all	O
participants	B-T098
assigned	O
to	O
treatment	B-T058
minus	O
those	O
who	O
with	O
##dr	O
##ew	O
due	O
to	O
a	O
non	B-T033
-	I-T033
treatment	I-T033
-	I-T033
related	I-T033
cause	I-T033
.	O
we	O
assessed	O
safety	B-T062
in	O
all	O
patients	O
who	O
received	O
at	O
least	O
one	O
dose	O
of	O
study	B-T062
drug	I-T062
.	O
this	O
trial	B-T062
is	O
registered	O
with	O
clinicaltrials	B-T062
.	I-T062
gov	I-T062
,	I-T062
number	I-T062
nct00	I-T062
##81	I-T062
##40	I-T062
##73	I-T062
.	O
between	O
feb	O
19	O
,	O
2009	O
,	O
and	O
july	O
15	O
,	O
2015	O
,	O
135	O
patients	O
were	O
randomly	O
assigned	O
to	O
mas	B-T103
##itinib	I-T103
(	O
n	O
=	O
71	O
)	O
or	O
placebo	B-T103
(	O
n	O
=	O
64	O
)	O
.	O
by	O
24	O
weeks	O
,	O
mas	B-T103
##itinib	I-T103
was	O
associated	O
with	O
a	O
cumulative	O
response	B-T201
of	O
18	O
·	O
7	O
%	O
in	O
the	O
primary	B-T103
endpoint	I-T103
(	O
122	O
·	O
6	O
responses	B-T201
of	O
65	O
##6	O
·	O
5	O
possible	O
responses	B-T201
[	O
weighted	O
generalised	O
estimating	O
equation	O
]	O
)	O
compared	O
with	O
7	O
·	O
4	O
%	O
for	O
placebo	B-T103
(	O
48	O
·	O
9	O
of	O
65	O
##6	O
·	O
5	O
;	O
difference	O
11	O
·	O
3	O
%	O
;	O
odds	O
ratio	O
3	O
·	O
6	O
;	O
95	O
%	O
ci	O
1	O
·	O
2	O
-	O
10	O
·	O
8	O
;	O
p	O
=	O
0	O
·	O
007	O
##6	O
)	O
.	O
frequent	O
severe	B-T033
adverse	I-T033
events	I-T033
(	O
>	O
4	O
%	O
difference	O
from	O
placebo	B-T103
)	O
were	O
diarrhoea	B-T033
(	O
eight	O
[	O
11	O
%	O
]	O
of	O
70	O
in	O
the	O
mas	B-T103
##itinib	I-T103
group	O
vs	O
one	O
[	O
2	O
%	O
]	O
of	O
63	O
in	O
the	O
placebo	B-T103
group	O
)	O
,	O
rash	O
(	O
four	O
[	O
6	O
%	O
]	O
vs	O
none	O
)	O
,	O
and	O
asth	B-T033
##enia	I-T033
(	O
four	O
[	O
6	O
%	O
]	O
vs	O
one	O
[	O
2	O
%	O
]	O
)	O
.	O
the	O
most	O
frequent	O
serious	B-T033
adverse	I-T033
events	I-T033
were	O
diarrhoea	B-T033
(	O
three	O
patients	O
[	O
4	O
%	O
]	O
vs	O
one	O
[	O
2	O
%	O
]	O
)	O
and	O
urticaria	B-T038
(	O
two	O
[	O
3	O
%	O
]	O
vs	O
none	O
)	O
,	O
and	O
no	O
life	B-T033
-	I-T033
threatening	I-T033
toxicities	B-T037
occurred	O
.	O
one	O
patient	O
in	O
the	O
placebo	B-T103
group	O
died	B-T033
(	O
unrelated	O
to	O
study	B-T062
treatment	I-T062
)	O
.	O
these	O
study	O
findings	O
indicate	O
that	O
mas	B-T103
##itinib	I-T103
is	O
an	O
effective	O
and	O
well	O
tolerated	B-T103
agent	I-T103
for	O
the	O
treatment	B-T058
of	O
severely	B-T033
symptomatic	I-T033
indolent	B-T038
or	O
smo	B-T038
##ulder	I-T038
##ing	I-T038
systemic	I-T038
mast	I-T038
##ocytosis	I-T038
.	O
ab	O
science	O
(	O
paris	O
,	O
france	O
)	O
.	O

immature	O
stages	O
and	O
larval	B-T204
cha	O
##eto	O
##ta	O
##xy	O
of	O
not	B-T204
##of	I-T204
##air	I-T204
##child	I-T204
##ia	I-T204
sten	I-T204
##yg	I-T204
##ros	I-T204
(	O
qu	O
##ate	O
&	O
alex	O
##ander	O
)	O
(	O
dip	B-T204
##tera	I-T204
:	O
psycho	B-T204
##di	I-T204
##da	I-T204
##e	I-T204
:	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
)	O
some	O
authors	O
have	O
hypothesized	O
that	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
is	O
[UNK]	O
the	O
most	O
ple	B-T170
##si	I-T170
##omorphic	I-T170
subfamily	I-T170
of	O
psycho	B-T204
##di	I-T204
##da	I-T204
##e	I-T204
[UNK]	O
and	O
its	O
members	O
[UNK]	O
are	O
among	O
the	O
most	O
primitive	O
living	O
dip	B-T204
##tera	I-T204
[UNK]	O
.	O
although	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
is	O
of	O
no	B-T033
medical	O
importance	O
,	O
it	O
is	O
of	O
great	O
evolutionary	B-T038
significance	O
,	O
having	O
long	O
been	O
placed	O
as	O
the	O
sister	O
group	O
of	O
phleb	B-T204
##otom	I-T204
##inae	I-T204
.	O
in	O
general	O
,	O
species	B-T170
of	O
this	O
subfamily	B-T170
are	O
rarely	O
collected	O
in	O
their	O
natural	B-T082
environment	I-T082
;	O
therefore	O
,	O
adults	B-T204
and	O
,	O
even	O
more	O
so	O
,	O
the	O
immature	O
stages	O
of	O
these	O
flies	B-T204
are	O
poorly	O
known	O
.	O
we	O
describe	O
the	O
egg	B-T204
,	O
larvae	B-T204
and	O
pup	B-T204
##ae	I-T204
of	O
not	B-T204
##of	I-T204
##air	I-T204
##child	I-T204
##ia	I-T204
sten	I-T204
##yg	I-T204
##ros	I-T204
and	O
provide	O
nomencl	B-T170
##atur	I-T170
##al	I-T170
notes	I-T170
on	O
larval	B-T204
cha	O
##eto	O
##ta	O
##xy	O
based	O
on	O
analyses	O
using	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
(	O
sem	B-T058
)	O
and	O
optic	O
microscopy	O
.	O
the	O
morphology	O
of	O
immature	O
nt	B-T204
.	I-T204
sten	I-T204
##yg	I-T204
##ros	I-T204
is	O
compared	O
with	O
other	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
and	O
psycho	B-T204
##di	I-T204
##da	I-T204
##e	I-T204
species	B-T170
,	O
especially	O
with	O
species	B-T170
of	O
phleb	B-T204
##otom	I-T204
##inae	I-T204
that	O
are	O
superficial	O
##ly	O
similar	O
to	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
.	O
results	O
of	O
this	O
study	B-T062
revealed	O
striking	O
morphological	B-T082
differences	O
between	O
the	O
immature	O
stages	O
of	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
and	O
phleb	B-T204
##otom	I-T204
##inae	I-T204
;	O
the	O
former	O
are	O
lacking	O
abdominal	B-T082
pseudop	B-T017
##ods	I-T017
and	O
microt	B-T017
##rich	I-T017
##ia	I-T017
on	O
the	O
cephalic	B-T082
inte	B-T022
##gu	I-T022
##ment	I-T022
,	O
both	O
of	O
which	O
are	O
present	O
in	O
the	O
larvae	B-T204
of	O
phleb	B-T204
##otom	I-T204
##inae	I-T204
.	O
these	O
morphological	B-T082
differences	O
observed	O
in	O
the	O
immature	O
stages	O
between	O
members	O
of	O
the	O
two	O
subfamilies	B-T170
support	O
the	O
findings	B-T033
of	O
recent	O
molecular	O
studies	O
indicating	O
that	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
and	O
phleb	B-T204
##to	I-T204
##min	I-T204
##ae	I-T204
are	O
evolutionarily	B-T038
not	O
closely	O
related	O
.	O
not	B-T204
##of	I-T204
##air	I-T204
##child	I-T204
##ia	I-T204
sten	I-T204
##yg	I-T204
##ros	I-T204
is	O
now	O
the	O
fourth	O
species	B-T170
of	O
bruc	B-T204
##hom	I-T204
##yi	I-T204
##inae	I-T204
for	O
which	O
the	O
immature	O
stages	O
are	O
described	O
.	O

function	O
analysis	B-T062
of	O
me	B-T017
##f2	I-T017
##c	I-T017
promoter	B-T103
in	O
muscle	B-T038
differentiation	I-T038
regeneration	B-T038
of	I-T038
adult	I-T038
skeletal	I-T038
muscle	I-T038
following	O
injury	B-T037
occurs	O
through	O
the	O
activation	B-T038
of	O
satellite	B-T017
cells	I-T017
,	O
that	O
proliferate	B-T038
##s	I-T038
,	O
differentiate	B-T038
##s	I-T038
,	O
and	O
fus	B-T038
##es	I-T038
with	O
injured	O
myofib	B-T017
##ers	I-T017
.	O
myocyte	B-T103
enhancer	I-T103
factor	I-T103
2	I-T103
(	I-T103
me	I-T103
##f2	I-T103
)	I-T103
proteins	I-T103
are	O
reported	O
that	O
they	O
have	O
the	O
potential	O
contributions	O
to	O
adult	O
muscle	B-T033
regeneration	I-T033
.	O
in	O
order	O
to	O
further	O
understand	O
me	B-T017
##f2	I-T017
##c	I-T017
gene	I-T017
,	O
the	O
promoter	B-T103
of	O
pig	B-T204
me	B-T017
##f2	I-T017
##c	I-T017
gene	I-T017
was	O
analyzed	O
in	O
this	O
paper	O
.	O
quantitative	B-T062
real	I-T062
-	I-T062
time	I-T062
pcr	I-T062
(	O
qrt	B-T062
-	I-T062
pcr	I-T062
)	O
revealed	O
the	O
expression	B-T038
pattern	O
of	O
me	B-T017
##f2	I-T017
##c	I-T017
gene	I-T017
in	O
muscle	B-T017
of	O
eight	O
tissues	B-T017
.	O
the	O
me	B-T017
##f2	I-T017
##c	I-T017
promoter	B-T103
had	O
the	O
higher	O
transcriptional	B-T038
activity	I-T038
in	O
differentiated	B-T038
c2	B-T017
##c12	I-T017
cells	I-T017
than	O
that	O
in	O
proliferating	B-T038
c2	B-T017
##c12	I-T017
cells	I-T017
,	O
which	O
was	O
accompanied	O
by	O
the	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
mrna	B-T038
expression	I-T038
of	O
me	B-T017
##f2	I-T017
##c	I-T017
gene	I-T017
.	O
function	O
deletion	B-T038
and	O
mutation	B-T038
analyses	B-T062
showed	O
that	O
myo	B-T103
##d	I-T103
and	O
me	B-T103
##f2	I-T103
binding	B-T082
sites	I-T082
within	O
the	O
me	B-T017
##f2	I-T017
##c	I-T017
promoter	B-T103
were	O
responsible	O
for	O
the	O
regulation	B-T038
of	O
me	B-T017
##f2	I-T017
##c	I-T017
transcription	B-T038
.	O
me	B-T017
##f2	I-T017
##c	I-T017
could	O
up	B-T038
-	I-T038
regulate	I-T038
the	I-T038
transcriptional	I-T038
activities	I-T038
of	O
me	B-T017
##f2	I-T017
##c	I-T017
promoter	B-T103
constructs	I-T103
which	O
contained	O
a	O
3	B-T082
'	I-T082
-	I-T082
end	I-T082
nucleotide	I-T082
sequence	I-T082
with	O
p300	B-T103
binding	B-T082
site	I-T082
.	O
the	O
electrophoretic	B-T058
mobility	I-T058
shift	I-T058
assays	I-T058
(	O
ems	B-T058
##a	I-T058
)	O
and	O
chromatin	B-T058
immunoprecipitation	I-T058
(	I-T058
chip	I-T058
)	I-T058
assays	I-T058
determined	O
the	O
myo	B-T103
##d	I-T103
binding	B-T082
site	I-T082
in	O
me	B-T017
##f2	I-T017
##c	I-T017
promoter	B-T103
.	O
these	O
results	O
advanced	O
our	O
knowledge	O
of	O
the	O
promoter	B-T103
of	O
the	O
pig	B-T204
me	B-T017
##f2	I-T017
##c	I-T017
gene	I-T017
.	O
and	O
the	O
study	O
of	O
me	B-T017
##f2	I-T017
##c	I-T017
promoter	B-T103
regulator	O
elements	O
helped	O
to	O
elucidating	O
the	O
regulation	B-T038
mechanisms	I-T038
of	O
me	B-T017
##f2	I-T017
##c	I-T017
in	O
muscle	B-T038
differentiation	I-T038
or	O
muscle	B-T058
repair	I-T058
and	O
regeneration	B-T033
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

aspirin	B-T103
suppresses	O
growth	B-T038
in	O
pi3k	B-T017
-	O
mutant	B-T017
breast	B-T038
cancer	I-T038
by	O
activating	O
ampk	B-T103
and	O
inhibiting	O
mtor	B-T103
##c1	I-T103
signaling	O
despite	O
the	O
high	O
incidence	O
of	O
oncogenic	B-T017
mutations	B-T038
in	O
pik	B-T017
##3c	I-T017
##a	I-T017
,	O
the	O
gene	B-T017
encoding	I-T017
the	O
catalytic	B-T082
subunit	I-T082
of	O
pi3k	B-T103
,	O
pi3k	B-T103
inhibitors	B-T103
have	O
yielded	O
little	O
clinical	B-T033
benefit	I-T033
for	O
breast	B-T038
cancer	I-T038
patients	O
.	O
recent	O
epidemiologic	B-T062
studies	I-T062
have	O
suggested	O
a	O
therapeutic	O
benefit	O
from	O
aspirin	B-T103
intake	O
in	O
cancers	B-T038
harboring	O
oncogenic	B-T103
pik	I-T103
##3c	I-T103
##a	I-T103
here	O
,	O
we	O
show	O
that	O
mutant	B-T017
pik	B-T103
##3c	I-T103
##a	I-T103
-	O
expressing	B-T038
breast	B-T017
cancer	I-T017
cells	I-T017
have	O
greater	O
sensitivity	O
to	O
aspirin	B-T103
-	O
mediated	O
growth	B-T038
suppression	B-T038
than	O
their	O
wild	B-T017
-	I-T017
type	I-T017
counterparts	O
.	O
aspirin	B-T103
decreased	O
viability	B-T038
and	O
anchorage	B-T058
-	I-T058
independent	I-T058
growth	I-T058
of	O
mutant	B-T017
pik	B-T103
##3c	I-T103
##a	I-T103
breast	B-T017
cancer	I-T017
cells	I-T017
independently	B-T033
of	O
its	O
effects	O
on	O
cox	B-T103
-	I-T103
2	I-T103
and	O
nf	B-T103
-	I-T103
κb	I-T103
.	O
we	O
ascribed	O
the	O
effects	O
of	O
aspirin	B-T103
to	O
amp	B-T103
-	I-T103
activated	I-T103
protein	I-T103
kinase	I-T103
(	O
ampk	B-T103
)	O
activation	O
,	O
mtor	B-T103
##c1	I-T103
inhibition	B-T038
,	O
and	O
autophagy	B-T038
induction	O
.	O
in	O
vivo	O
,	O
oncogenic	B-T017
pik	B-T103
##3c	I-T103
##a	I-T103
-	O
driven	O
mouse	B-T204
mammary	B-T038
tumors	I-T038
treated	O
daily	O
with	O
aspirin	B-T103
resulted	O
in	O
decreased	O
tumor	O
growth	O
kinetics	O
,	O
whereas	O
combination	O
therapy	B-T058
of	O
aspirin	B-T103
and	O
a	O
pi3k	B-T103
inhibitor	O
further	O
attenuated	O
tumor	O
growth	O
.	O
our	O
study	O
supports	O
the	O
evaluation	B-T058
of	O
aspirin	B-T103
and	O
pi3k	B-T103
pathway	O
inhibitors	B-T103
as	O
a	O
combination	O
therapy	B-T058
for	O
targeting	O
breast	B-T038
cancer	I-T038
.	O
cancer	O
res	O
;	O
77	O
(	O
3	O
)	O
;	O
79	O
##0	O
-	O
801	O
.	O
©	O
##20	O
##16	O
aac	O
##r	O
.	O

biological	O
basis	B-T103
of	O
radiation	B-T058
protection	I-T058
needs	O
rej	B-T058
##uv	I-T058
##ena	I-T058
##tion	I-T058
human	B-T204
beings	I-T204
encounter	O
radiation	O
in	O
many	O
different	O
situations	O
-	O
from	O
proximity	B-T082
to	O
radioactive	B-T103
waste	I-T103
sites	B-T082
to	O
participation	O
in	O
medical	B-T058
procedures	I-T058
using	O
x	O
-	O
rays	O
etc	O
.	O
limits	O
for	O
radiation	B-T037
exposures	I-T037
are	O
legal	O
##ly	O
regulated	O
;	O
however	O
,	O
current	O
radiation	B-T058
protection	I-T058
policy	B-T170
does	O
not	O
explicitly	O
acknowled	O
##ge	O
that	O
biological	O
,	O
cellular	B-T058
and	O
molecular	O
effects	O
of	O
low	O
doses	O
and	O
low	O
dose	O
rates	O
of	O
radiation	O
differ	O
from	O
effects	O
induced	O
by	O
medium	O
and	O
high	O
dose	O
radiation	B-T037
exposures	I-T037
.	O
recent	O
technical	O
developments	O
in	O
biology	B-T091
and	O
medicine	B-T091
,	O
from	O
single	B-T058
cell	I-T058
techniques	I-T058
to	O
big	O
data	O
computational	O
research	O
,	O
have	O
enabled	O
new	O
approaches	O
for	O
study	B-T062
of	O
biology	B-T091
of	O
low	O
doses	O
of	O
radiation	O
.	O
results	O
of	O
the	O
work	O
done	O
so	O
far	O
support	O
the	O
idea	O
that	O
low	O
doses	O
of	O
radiation	O
have	O
effects	O
that	O
differ	O
from	O
those	O
associated	O
with	O
high	O
dose	O
exposures	B-T037
;	O
this	O
work	O
,	O
however	O
,	O
is	O
far	O
from	O
sufficient	O
for	O
the	O
development	O
of	O
a	O
new	O
theoretical	B-T170
framework	I-T170
needed	O
for	O
the	O
understanding	O
of	O
low	O
dose	O
radiation	B-T037
exposures	I-T037
.	O
mechanistic	O
understanding	O
of	O
radiation	O
effects	O
at	O
low	O
doses	O
is	O
necessary	O
in	O
order	O
to	O
develop	O
better	O
radiation	B-T058
protection	I-T058
policy	B-T170
.	O

enos	B-T103
s	B-T038
-	I-T038
nitros	I-T038
##ylate	I-T038
##s	I-T038
β	B-T103
-	I-T103
actin	I-T103
on	O
cys	B-T103
##37	I-T103
##4	I-T103
and	O
regulates	B-T038
pkc	B-T103
-	I-T103
θ	I-T103
at	O
the	O
immune	B-T017
synapse	I-T017
by	O
impairing	O
actin	B-T038
binding	I-T038
to	O
profil	B-T103
##in	I-T103
-	I-T103
1	I-T103
the	O
actin	B-T038
cytoskeleton	I-T038
coordinates	I-T038
the	I-T038
organization	I-T038
of	O
signaling	B-T103
microc	I-T103
##lu	I-T103
##st	I-T103
##ers	I-T103
at	O
the	O
immune	B-T017
synapse	I-T017
(	O
is	B-T017
)	O
;	O
however	O
,	O
the	O
mechanisms	B-T038
involved	O
remain	O
poorly	O
understood	O
.	O
we	O
show	O
here	O
that	O
nitric	B-T103
oxide	I-T103
(	O
no	B-T103
)	O
generated	O
by	O
endothelial	B-T103
nitric	I-T103
oxide	I-T103
synthase	I-T103
(	O
enos	B-T103
)	O
controls	O
the	O
coales	O
##cence	O
of	O
protein	B-T103
kinase	I-T103
c	I-T103
-	I-T103
θ	I-T103
(	O
pkc	B-T103
-	I-T103
θ	I-T103
)	O
at	O
the	O
central	B-T017
supramolecular	I-T017
activation	I-T017
cluster	I-T017
(	O
c	B-T017
-	I-T017
sma	I-T017
##c	I-T017
)	O
of	O
the	O
is	B-T017
.	O
enos	B-T103
translocated	B-T038
with	O
the	O
golgi	B-T017
to	O
the	O
is	B-T017
and	O
partially	O
colocalized	B-T082
with	O
f	B-T103
-	I-T103
actin	I-T103
around	O
the	O
c	B-T017
-	I-T017
sma	I-T017
##c	I-T017
.	O
this	O
resulted	O
in	O
reduced	O
actin	B-T038
polymerization	I-T038
and	O
centr	O
##ip	O
##etal	O
retrograde	O
flow	O
of	O
β	B-T103
-	I-T103
actin	I-T103
and	O
pkc	B-T103
-	I-T103
θ	I-T103
from	O
the	O
lam	B-T017
##ell	I-T017
##ip	I-T017
##odium	I-T017
-	I-T017
like	I-T017
distal	B-T082
(	B-T017
d	I-T017
)	I-T017
-	I-T017
sma	I-T017
##c	I-T017
,	O
promoting	O
pkc	B-T103
-	I-T103
θ	I-T103
activation	B-T038
.	O
furthermore	O
,	O
enos	B-T103
-	O
derived	O
no	B-T103
s	B-T038
-	I-T038
nitros	I-T038
##ylated	I-T038
β	B-T103
-	I-T103
actin	I-T103
on	O
cys	B-T103
##37	I-T103
##4	I-T103
and	O
impaired	O
actin	B-T038
binding	I-T038
to	O
profil	B-T103
##in	I-T103
-	I-T103
1	I-T103
(	O
pf	B-T103
##n1	I-T103
)	O
,	O
as	O
confirmed	O
with	O
the	O
trans	B-T038
##nitros	I-T038
##yl	I-T038
##ating	I-T038
agent	O
s	B-T103
-	I-T103
nitroso	I-T103
-	I-T103
l	I-T103
-	I-T103
cysteine	I-T103
(	O
cys	B-T103
-	I-T103
no	I-T103
)	O
.	O
the	O
importance	O
of	O
no	B-T103
and	O
the	O
formation	O
of	O
pf	B-T103
##n1	I-T103
-	I-T103
actin	I-T103
complexes	I-T103
on	O
the	O
regulation	B-T038
of	O
pkc	B-T103
-	I-T103
θ	I-T103
was	O
corroborated	O
by	O
overexpression	B-T038
of	O
pf	B-T017
##n1	I-T017
-	O
and	O
actin	B-T038
-	I-T038
binding	I-T038
defective	O
mutants	B-T038
of	O
β	B-T017
-	I-T017
actin	I-T017
(	I-T017
c3	I-T017
##74	I-T017
##s	I-T017
)	I-T017
and	O
pf	B-T017
##n1	I-T017
(	I-T017
h1	I-T017
##19	I-T017
##e	I-T017
)	I-T017
,	O
respectively	O
,	O
which	O
reduced	O
the	O
coales	O
##cence	O
of	O
pkc	B-T103
-	I-T103
θ	I-T103
at	O
the	O
c	B-T017
-	I-T017
sma	I-T017
##c	I-T017
.	O
these	O
findings	O
unve	O
##il	O
a	O
novel	O
no	B-T103
-	O
dependent	O
mechanism	B-T038
by	O
which	O
the	O
actin	B-T038
cytoskeleton	I-T038
controls	I-T038
the	I-T038
organization	I-T038
and	O
activation	O
of	O
signaling	B-T103
microc	I-T103
##lu	I-T103
##st	I-T103
##ers	I-T103
at	O
the	O
is	B-T017
.	O

high	O
hba1c	B-T103
at	O
onset	O
cann	O
##ot	O
be	O
used	O
as	O
a	O
predictor	O
for	O
future	O
metabolic	B-T038
control	I-T038
for	O
the	O
individual	B-T098
child	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
mellitus	I-T038
to	O
study	O
how	O
metabolic	B-T038
control	I-T038
at	O
onset	O
of	O
type	B-T038
1	I-T038
diabetes	I-T038
correlates	O
to	O
metabolic	B-T038
control	I-T038
and	O
clinical	O
parameters	B-T033
during	O
childhood	O
until	O
transition	O
from	O
pediatric	B-T058
care	I-T058
to	O
adult	O
diabetes	B-T058
care	I-T058
.	O
data	O
at	O
onset	O
,	O
three	O
months	O
,	O
one	O
,	O
three	O
,	O
and	O
five	O
years	O
after	O
diagnosis	B-T033
and	O
at	O
transition	O
,	O
on	O
hba1c	B-T103
and	O
clinical	O
parameters	B-T033
,	O
on	O
80	O
##84	O
patients	O
in	O
the	O
swedish	B-T170
pediatric	I-T170
quality	I-T170
registry	I-T170
,	I-T170
swed	I-T170
##iab	I-T170
##ki	I-T170
##ds	I-T170
,	O
were	O
used	O
.	O
of	O
these	O
patients	O
,	O
26	O
%	O
had	O
been	O
referred	O
to	O
adult	O
diabetes	B-T058
care	I-T058
by	O
2014	O
.	O
children	O
with	O
hba1c	B-T103
<	O
72	O
mmol	O
/	O
mol	O
(	O
8	O
.	O
7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	B-T098
)	O
at	O
diagnosis	B-T033
continued	O
to	O
have	O
good	O
metabolic	B-T038
control	I-T038
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
hba1c	B-T103
>	O
114	O
mmol	O
/	O
mol	O
(	O
12	O
.	O
6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	B-T098
)	O
at	O
diagnosis	B-T033
,	O
who	O
continued	O
to	O
have	O
high	O
hba1c	B-T103
at	O
follow	B-T058
-	I-T058
up	I-T058
.	O
for	O
the	O
individual	B-T098
,	O
there	O
was	O
no	B-T033
significant	I-T033
correlation	O
between	O
high	O
hba1c	B-T103
at	O
onset	O
and	O
during	O
follow	B-T058
-	I-T058
up	I-T058
.	O
during	O
follow	B-T058
-	I-T058
up	I-T058
,	O
children	O
in	O
the	O
high	O
group	B-T098
were	O
more	O
often	O
smokers	B-T033
,	O
less	O
physically	B-T033
active	I-T033
,	O
and	O
more	O
often	O
had	O
retinopathy	B-T038
than	O
children	O
in	O
the	O
low	O
group	B-T098
(	O
p	O
<	O
.	O
01	O
,	O
.	O
01	O
,	O
.	O
03	O
respectively	O
)	O
.	O
high	O
hba1c	B-T103
at	O
onset	O
was	O
associated	O
with	O
high	O
hba1c	B-T103
during	O
follow	B-T058
-	I-T058
up	I-T058
on	O
a	O
group	B-T098
level	O
,	O
but	O
it	O
cann	O
##ot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	B-T038
control	I-T038
on	O
an	O
individual	B-T098
level	O
.	O
these	O
results	O
emphasize	O
the	O
important	O
work	O
done	O
by	O
the	O
diabetes	B-T038
team	O
in	O
the	O
first	O
years	O
after	O
diagnosis	B-T033
.	O
it	O
is	O
important	O
to	O
continuously	O
set	O
high	O
goals	B-T170
for	O
the	O
achievement	O
of	O
tight	O
metabolic	B-T038
control	I-T038
,	O
in	O
order	O
to	O
decrease	O
the	O
risk	O
of	O
microvascular	O
complications	O
.	O

did	O
municipal	O
solid	O
waste	O
landfill	B-T082
have	O
obvious	O
influence	O
on	O
polychlorinated	B-T103
dibenz	I-T103
##o	I-T103
-	I-T103
p	I-T103
-	I-T103
dioxin	I-T103
##s	I-T103
and	O
polychlorinated	B-T103
dibenz	I-T103
##ofuran	I-T103
##s	I-T103
(	O
pcdd	B-T103
/	O
fs	B-T103
)	O
in	O
ambient	O
air	O
:	O
a	O
case	B-T170
study	I-T170
in	O
east	B-T082
china	I-T082
municipal	O
solid	O
waste	O
(	O
ms	O
##w	O
)	O
landfill	B-T082
was	O
a	O
main	O
way	O
to	O
disposal	O
of	O
ms	O
##w	O
and	O
almost	O
95	O
%	O
of	O
ms	O
##w	O
was	O
disp	O
##osed	O
by	O
landfill	B-T082
##s	I-T082
in	O
the	O
world	B-T098
.	O
in	O
order	O
to	O
understand	O
the	O
influence	O
of	O
ms	O
##w	O
landfill	B-T082
on	O
polychlorinated	B-T103
dibenz	I-T103
##o	I-T103
-	I-T103
p	I-T103
-	I-T103
dioxin	I-T103
##s	I-T103
and	O
polychlorinated	B-T103
dibenz	I-T103
##ofuran	I-T103
##s	I-T103
(	O
pcdd	B-T103
/	O
fs	B-T103
)	O
in	O
surrounding	O
atmosphere	O
,	O
42	O
ambient	O
air	O
samples	O
were	O
collected	O
and	O
analyzed	B-T062
from	O
surrounding	B-T082
sites	I-T082
,	O
background	B-T082
site	I-T082
,	O
up	B-T082
##win	I-T082
##d	I-T082
site	I-T082
and	O
down	B-T082
##win	I-T082
##d	I-T082
site	I-T082
of	O
a	O
ms	O
##w	O
landfill	B-T082
in	O
east	B-T082
china	I-T082
.	O
the	O
results	O
of	O
present	O
study	B-T062
were	O
summarized	O
as	O
follows	O
.	O
(	O
1	O
)	O
the	O
total	O
concentrations	O
of	O
pcdd	B-T103
/	O
fs	B-T103
(	O
∑	O
pcdd	B-T103
/	O
fs	B-T103
)	O
in	O
ambient	O
air	O
from	O
surrounding	B-T082
sites	I-T082
,	O
background	B-T082
site	I-T082
,	O
up	B-T082
##win	I-T082
##d	I-T082
site	I-T082
and	O
down	B-T082
##win	I-T082
##d	I-T082
site	I-T082
were	O
2	O
.	O
215	O
##±1	O
.	O
004	O
,	O
2	O
.	O
05	O
##8	O
##±0	O
.	O
45	O
##8	O
,	O
2	O
.	O
61	O
##7	O
##±1	O
.	O
09	O
##2	O
and	O
1	O
.	O
82	O
##2	O
##±0	O
.	O
56	O
##6	O
##pg	O
##nm	O
(	O
-	O
3	O
)	O
,	O
respectively	O
.	O
(	O
2	O
)	O
the	O
toxic	O
equivalent	O
concentrations	O
(	O
te	O
##q	O
)	O
of	O
pcdd	B-T103
/	O
fs	B-T103
in	O
ambient	O
air	O
from	O
surrounding	B-T082
sites	I-T082
,	O
background	B-T082
site	I-T082
,	O
up	B-T082
##win	I-T082
##d	I-T082
site	I-T082
and	O
down	B-T082
##win	I-T082
##d	I-T082
site	I-T082
were	O
0	O
.	O
103	O
##±0	O
.	O
017	O
,	O
0	O
.	O
09	O
##6	O
##±0	O
.	O
015	O
,	O
0	O
.	O
120	O
##±0	O
.	O
024	O
and	O
0	O
.	O
108	O
##±0	O
.	O
014	O
##pg	O
i	O
-	O
te	O
##q	O
##nm	O
(	O
-	O
3	O
)	O
,	O
respectively	O
.	O
(	O
3	O
)	O
the	O
congen	B-T058
##er	I-T058
profiles	I-T058
,	O
∑	O
pcdd	B-T103
/	O
fs	B-T103
and	O
te	O
##q	O
between	O
background	O
atmosphere	O
and	O
surrounding	O
atmosphere	O
of	O
landfill	B-T082
did	O
not	O
show	O
statistically	O
significant	O
difference	O
.	O
(	O
4	O
)	O
the	O
∑	O
pcdd	B-T103
/	O
fs	B-T103
and	O
te	O
##q	O
in	O
ambient	O
air	O
of	O
down	B-T082
##win	I-T082
##d	I-T082
site	I-T082
were	O
not	O
higher	O
than	O
that	O
of	O
up	B-T082
##win	I-T082
##d	I-T082
site	I-T082
,	O
suggesting	O
that	O
studied	O
landfill	B-T082
did	O
not	O
have	O
obvious	O
influence	O
on	O
pcdd	B-T103
/	O
fs	B-T103
in	O
ambient	O
air	O
from	O
down	B-T082
##win	I-T082
##d	I-T082
site	I-T082
.	O
(	O
5	O
)	O
the	O
95	O
##th	O
percentile	O
carcinogenic	O
risk	O
(	O
cr	O
)	O
of	O
pcdd	B-T103
/	O
fs	B-T103
in	O
ambient	O
air	O
from	O
s	O
ur	B-T082
##rounding	I-T082
sites	I-T082
,	O
background	B-T082
site	I-T082
,	O
up	B-T082
##win	I-T082
##d	I-T082
site	I-T082
and	O
down	B-T082
##win	I-T082
##d	I-T082
site	I-T082
were	O
8	O
.	O
03	O
##×10	O
(	O
-	O
9	O
)	O
,	O
7	O
.	O
57	O
##×10	O
(	O
-	O
9	O
)	O
,	O
9	O
.	O
69	O
##×10	O
(	O
-	O
9	O
)	O
and	O
8	O
.	O
15	O
##×10	O
(	O
-	O
9	O
)	O
,	O
respectively	O
,	O
which	O
were	O
much	O
lower	O
than	O
the	O
threshold	O
value	O
of	O
cr	O
(	O
10	O
(	O
-	O
6	O
)	O
)	O
,	O
suggesting	O
that	O
studied	O
landfill	B-T082
did	O
not	O
influence	O
the	O
cr	O
of	O
pcdd	B-T103
/	O
fs	B-T103
in	O
surrounding	O
atmosphere	O
and	O
negligible	O
cancer	O
risk	O
occurred	O
.	O
(	O
6	O
)	O
the	O
non	O
-	O
carcinogenic	O
risk	O
(	O
non	O
-	O
cr	O
)	O
analysis	B-T062
indicated	O
that	O
landfill	B-T082
did	O
not	O
have	O
influence	O
on	O
the	O
non	O
-	O
cr	O
of	O
pcdd	B-T103
/	O
fs	B-T103
in	O
surrounding	O
atmosphere	O
and	O
no	O
obvious	O
non	O
-	O
carcinogenic	O
effects	O
developed	O
.	O

osseoin	B-T038
##tegration	I-T038
behavior	O
of	O
novel	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
for	O
dental	B-T074
implants	I-T074
:	O
an	O
in	B-T082
vivo	I-T082
study	B-T062
this	O
study	O
aimed	O
to	O
evaluate	B-T058
the	O
effects	O
of	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
implants	B-T074
on	O
mineral	O
apposition	O
rate	O
and	O
new	O
bic	O
contact	O
in	O
rabbits	B-T204
.	O
twelve	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
implants	B-T074
were	O
fabricated	O
and	O
placed	B-T058
into	O
the	O
right	B-T082
femur	B-T017
sites	B-T082
in	O
six	O
rabbits	B-T204
,	O
and	O
commercially	O
pure	O
titanium	B-T103
implants	B-T074
were	O
used	O
as	O
controls	O
in	O
the	O
left	B-T082
femur	B-T017
.	O
tetracycline	B-T103
and	O
ali	B-T103
##z	I-T103
##arin	I-T103
red	I-T103
were	O
administered	O
3	O
weeks	O
and	O
1	O
week	O
before	O
euthan	B-T058
##ization	I-T058
,	O
respectively	O
.	O
at	O
4	O
weeks	O
and	O
8	O
weeks	O
after	O
implantation	B-T058
,	O
animals	B-T204
were	O
euthanized	O
,	O
respectively	O
.	O
surface	B-T082
characterization	O
and	O
implant	O
-	O
bone	O
contact	O
surface	B-T082
analysis	B-T062
were	O
performed	O
by	O
using	O
a	O
scanning	B-T074
electron	I-T074
microscope	I-T074
and	O
an	O
energy	B-T074
dispersive	I-T074
x	I-T074
-	I-T074
ray	I-T074
detector	I-T074
.	O
mineral	O
apposition	O
rate	O
was	O
evaluated	B-T058
using	O
a	O
confocal	B-T058
laser	I-T058
scanning	I-T058
microscope	I-T058
.	O
tolu	B-T058
##idine	I-T058
blue	I-T058
staining	I-T058
was	O
performed	O
on	O
und	B-T033
##ecal	I-T033
##ci	I-T033
##fi	I-T033
##ed	I-T033
sections	O
for	O
histology	B-T091
and	O
histomorph	O
##ology	O
evaluation	O
.	O
scanning	B-T074
electron	I-T074
microscope	I-T074
and	O
histomorph	O
##ology	O
observation	O
revealed	O
a	O
direct	O
contact	O
between	O
implants	B-T074
and	O
bone	B-T017
of	O
all	O
groups	O
.	O
after	O
a	O
healing	B-T038
period	O
of	O
4	O
weeks	O
,	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
implants	B-T074
showed	O
significantly	O
higher	O
mineral	O
apposition	O
rate	O
compared	O
to	O
commercially	O
pure	O
titanium	B-T103
implants	B-T074
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
whereas	O
there	O
was	O
no	B-T033
significant	I-T033
difference	O
between	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
implants	B-T074
and	O
commercially	O
pure	O
titanium	B-T103
implants	B-T074
(	O
p	O
>	O
0	O
.	O
05	O
)	O
at	O
8	O
weeks	O
.	O
no	B-T033
significant	I-T033
difference	O
of	O
bone	O
-	O
to	O
-	O
implant	O
contact	O
was	O
observed	O
between	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
implants	B-T074
and	O
commercially	O
pure	O
titanium	B-T103
implants	B-T074
implants	B-T074
after	O
a	O
healing	B-T038
period	O
of	O
4	O
weeks	O
and	O
8	O
weeks	O
.	O
this	O
study	O
showed	O
that	O
ti	B-T103
-	I-T103
nb	I-T103
-	I-T103
zr	I-T103
-	I-T103
ta	I-T103
-	I-T103
si	I-T103
alloy	I-T103
implants	B-T074
could	O
establish	O
a	O
close	O
direct	O
contact	O
compared	O
##to	O
commercially	O
pure	O
titanium	B-T103
implants	B-T074
implants	B-T074
,	O
improved	B-T033
mineral	O
matrix	O
apposition	O
rate	O
,	O
and	O
may	O
some	O
##day	O
be	O
an	O
alternative	O
as	O
a	O
material	O
for	O
dental	B-T074
implants	I-T074
.	O

skin	O
conductance	O
responses	O
and	O
neural	O
activations	O
during	O
fear	B-T038
conditioning	B-T038
and	O
extinction	B-T038
recall	B-T038
across	O
anxiety	B-T038
disorders	I-T038
the	O
fear	B-T038
conditioning	B-T038
and	O
extinction	B-T038
neuroc	O
##irc	O
##uitry	O
has	O
been	O
extensively	O
studied	B-T062
in	O
healthy	O
and	O
clinical	O
populations	B-T098
,	O
with	O
a	O
particular	B-T082
focus	I-T082
on	O
posttraumatic	B-T038
stress	I-T038
disorder	I-T038
.	O
despite	O
significant	O
overlap	O
of	O
symptoms	B-T033
between	O
posttraumatic	B-T038
stress	I-T038
disorder	I-T038
and	O
anxiety	B-T038
disorders	I-T038
,	O
the	O
latter	O
has	O
received	O
less	O
attention	B-T038
.	O
given	O
that	O
dysregulated	O
fear	B-T038
levels	O
characterize	O
anxiety	B-T038
disorders	I-T038
,	O
examining	B-T058
the	O
neural	O
correlates	O
of	O
fear	B-T038
and	O
extinction	B-T038
learning	B-T038
may	O
shed	O
light	O
on	O
the	O
pathogenesis	B-T038
of	O
underlying	O
anxiety	B-T038
disorders	I-T038
.	O
to	O
investigate	O
the	O
psychophys	B-T038
##iological	I-T038
and	O
neural	O
correlates	O
of	O
fear	B-T038
conditioning	B-T038
and	O
extinction	B-T038
recall	B-T038
in	O
anxiety	B-T038
disorders	I-T038
and	O
to	O
document	B-T170
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	B-T033
or	O
anxiety	B-T033
severity	O
.	O
this	O
investigation	B-T058
was	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
,	O
case	B-T058
-	I-T058
control	I-T058
,	O
functional	B-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
study	B-T062
at	O
an	O
academic	B-T092
medical	I-T092
center	I-T092
.	O
participants	B-T098
were	O
healthy	O
controls	O
and	O
individuals	B-T098
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	B-T038
disorders	I-T038
:	O
generalized	B-T038
anxiety	I-T038
disorder	I-T038
,	O
social	O
anxiety	O
disorder	O
,	O
specific	B-T038
phobia	I-T038
,	O
and	O
panic	B-T038
disorder	I-T038
.	O
the	O
study	B-T062
dates	O
were	O
between	O
march	O
2013	O
and	O
may	O
2015	O
.	O
two	O
-	O
day	O
fear	B-T038
conditioning	B-T038
and	O
extinction	B-T038
paradigm	O
.	O
skin	O
conductance	O
responses	O
,	O
blood	B-T038
oxygenation	I-T038
level	I-T038
-	I-T038
dependent	I-T038
responses	O
,	O
trait	O
anxiety	O
scores	O
from	O
the	O
state	B-T058
trait	I-T058
anxiety	I-T058
inventory	I-T058
-	O
trait	O
form	O
,	O
and	O
function	O
##a	O
l	O
connectivity	O
.	O
this	O
study	B-T062
included	O
21	O
healthy	O
controls	O
(	O
10	O
women	B-T098
)	O
and	O
61	O
individuals	B-T098
with	O
anxiety	B-T038
disorders	I-T038
(	O
36	O
women	B-T098
)	O
.	O
p	O
values	O
reported	B-T058
for	O
the	O
neuroimaging	B-T058
results	B-T033
are	O
all	O
family	O
##wise	O
error	O
corrected	O
.	O
skin	O
conductance	O
responses	O
during	O
extinction	B-T038
recall	B-T038
did	O
not	O
differ	O
between	O
individuals	B-T098
with	O
anxiety	B-T038
disorders	I-T038
and	O
healthy	O
controls	O
(	O
η	O
##p2	O
=	O
0	O
.	O
001	O
,	O
p	O
=	O
.	O
79	O
)	O
,	O
where	O
η	O
##p2	O
is	O
partial	O
eta	O
squared	O
.	O
the	O
anxiety	B-T033
group	B-T098
had	O
lower	O
activation	O
of	O
the	O
ventromedial	B-T017
prefrontal	I-T017
cortex	I-T017
(	O
vm	B-T017
##p	I-T017
##fc	I-T017
)	O
during	O
extinction	B-T038
recall	B-T038
(	O
η	O
##p2	O
=	O
0	O
.	O
178	O
,	O
p	O
=	O
.	O
02	O
)	O
.	O
a	O
similar	O
hypo	B-T033
##active	I-T033
pattern	B-T082
was	O
found	O
during	O
early	O
conditioning	B-T038
(	O
η	O
##p2	O
=	O
0	O
.	O
106	O
,	O
p	O
=	O
.	O
009	O
)	O
.	O
the	O
vm	B-T017
##p	I-T017
##fc	I-T017
hypo	O
##activation	O
was	O
associated	O
with	O
anxiety	B-T033
symptom	I-T033
severity	O
(	O
r	O
=	O
-	O
0	O
.	O
420	O
,	O
p	O
=	O
.	O
01	O
for	O
conditioning	B-T038
and	O
r	O
=	O
-	O
0	O
.	O
46	O
##4	O
,	O
p	O
=	O
.	O
004	O
for	O
extinction	B-T038
recall	B-T038
)	O
and	O
the	O
number	O
of	O
co	O
-	O
occur	O
##ing	O
anxiety	B-T038
disorders	I-T038
diagnosed	B-T033
(	O
η	O
##p2	O
=	O
0	O
.	O
137	O
,	O
p	O
=	O
.	O
009	O
for	O
conditioning	B-T038
and	O
η	O
##p2	O
=	O
0	O
.	O
227	O
,	O
p	O
=	O
.	O
004	O
for	O
extinction	B-T038
recall	B-T038
)	O
.	O
psychophys	B-T038
##iological	I-T038
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	B-T038
network	B-T038
connectivity	I-T038
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	B-T033
group	B-T098
during	O
fear	B-T038
learning	B-T038
(	O
η	O
##p2	O
range	O
between	O
0	O
.	O
08	O
##8	O
and	O
0	O
.	O
176	O
and	O
p	O
range	O
between	O
0	O
.	O
02	O
and	O
0	O
.	O
003	O
)	O
and	O
extinction	B-T038
recall	B-T038
(	O
η	O
##p2	O
range	O
between	O
0	O
.	O
111	O
and	O
0	O
.	O
235	O
and	O
p	O
range	O
between	O
0	O
.	O
02	O
and	O
0	O
.	O
002	O
)	O
.	O
despite	O
no	O
skin	O
conductance	O
response	O
group	B-T098
differences	O
during	O
extinction	B-T038
recall	B-T038
,	O
brain	B-T017
activation	O
patterns	B-T082
between	O
anxious	O
and	O
healthy	O
individuals	B-T098
differed	O
.	O
these	O
findings	B-T033
encourage	O
future	O
studies	B-T062
to	O
examine	B-T058
the	O
conditions	O
longitudinally	B-T062
and	O
in	O
the	O
context	O
of	O
treatment	B-T062
trials	I-T062
to	O
improve	B-T033
and	O
guide	B-T058
therapeutics	I-T058
via	O
advanced	O
neurobiological	B-T091
understanding	B-T038
of	O
each	O
disorder	B-T038
.	O

central	B-T038
myx	I-T038
##oma	I-T038
/	O
myx	B-T038
##ofib	I-T038
##roma	I-T038
of	O
the	O
jaw	B-T017
##s	I-T017
:	O
a	O
clinico	B-T092
-	O
epidemiologic	O
review	B-T170
myx	B-T038
##omas	I-T038
are	O
a	O
group	O
of	O
benign	O
rare	B-T038
tumors	I-T038
of	O
connective	B-T017
-	I-T017
tissue	I-T017
origin	O
that	O
occur	O
in	O
both	O
hard	B-T017
(	I-T017
central	I-T017
)	I-T017
and	O
soft	B-T017
tissues	I-T017
of	O
the	O
body	B-T204
.	O
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
highlight	O
our	O
experience	O
in	O
the	O
management	O
of	O
central	O
myx	O
##oma	O
of	O
the	O
jaw	O
,	O
with	O
emphasis	O
on	O
its	O
clinic	B-T092
-	O
epidemiologic	O
features	O
as	O
seen	O
in	O
our	O
environment	B-T082
.	O
all	O
patients	O
who	O
were	O
managed	O
for	O
central	O
myx	O
##oma	O
of	O
the	O
jaw	O
at	O
the	O
oral	B-T092
and	I-T092
maxillofacial	I-T092
surgery	I-T092
department	I-T092
of	O
a	O
regional	B-T092
university	I-T092
teaching	I-T092
hospital	I-T092
between	O
september	O
1997	O
and	O
october	O
2015	O
were	O
retrospectively	B-T062
studied	I-T062
.	O
details	O
source	O
##d	O
included	O
age	O
,	O
sex	O
,	O
site	B-T082
of	I-T082
tumor	I-T082
,	O
duration	O
,	O
signs	B-T033
/	I-T033
symptoms	I-T033
,	O
treatment	B-T033
given	I-T033
,	O
and	O
complications	B-T038
.	O
data	O
were	O
analyzed	B-T062
using	O
statistical	B-T170
package	I-T170
for	I-T170
social	I-T170
sciences	I-T170
(	I-T170
spss	I-T170
)	I-T170
version	I-T170
16	I-T170
(	O
spss	B-T092
inc	I-T092
.	O
,	O
chicago	B-T082
,	O
il	B-T082
,	O
usa	B-T082
)	O
and	O
micros	B-T170
##of	I-T170
##t	I-T170
exce	I-T170
##l	I-T170
2007	I-T170
(	O
micros	B-T092
##of	I-T092
##t	I-T092
,	O
red	B-T082
##mon	I-T082
##d	I-T082
,	O
wa	B-T082
,	O
usa	B-T082
)	O
.	O
results	O
from	O
descriptive	O
statistics	O
were	O
represented	O
in	O
the	O
form	O
of	O
tables	B-T170
and	O
charts	B-T170
,	O
with	O
a	O
test	B-T170
for	I-T170
significance	I-T170
(	O
ρ	O
)	O
using	O
pearson	B-T170
chi	I-T170
-	I-T170
square	I-T170
(	O
χ	O
(	O
2	O
)	O
)	O
set	O
at	O
0	O
.	O
05	O
.	O
a	O
total	O
of	O
16	O
patients	O
were	O
managed	O
within	O
the	O
period	O
reviewed	O
,	O
consisting	O
of	O
10	O
(	O
62	O
.	O
5	O
%	O
)	O
females	O
and	O
six	O
(	O
37	O
.	O
5	O
%	O
)	O
males	O
,	O
giving	O
a	O
male	O
-	O
to	O
-	O
female	O
ratio	O
of	O
1	O
:	O
1	O
.	O
7	O
.	O
the	O
ages	O
of	O
patients	O
ranged	O
from	O
5	O
to	O
70	O
years	O
,	O
with	O
a	O
mean	O
of	O
27	O
.	O
06	O
##±1	O
##5	O
.	O
45	O
years	O
.	O
the	O
mandible	B-T017
accounted	O
for	O
nine	O
(	O
56	O
.	O
3	O
%	O
)	O
cases	O
and	O
the	O
maxilla	B-T017
for	O
six	O
(	O
37	O
.	O
5	O
%	O
)	O
cases	O
,	O
while	O
a	O
combination	O
of	O
the	O
maxilla	B-T017
and	O
the	O
zyg	B-T017
##oma	I-T017
were	O
involved	O
in	O
one	O
(	O
6	O
.	O
3	O
%	O
)	O
case	O
.	O
buc	B-T017
##co	I-T017
-	I-T017
lingual	I-T017
or	O
buc	B-T017
##co	I-T017
-	I-T017
palatal	I-T017
expansion	B-T082
were	O
the	O
most	O
common	O
presentation	O
(	O
six	O
[	O
46	O
.	O
2	O
%	O
]	O
cases	O
each	O
)	O
.	O
histological	O
assessment	B-T058
of	O
tissue	B-T017
specimens	I-T017
showed	O
that	O
fibromy	B-T038
##x	I-T038
##oma	I-T038
accounted	O
for	O
seven	O
(	O
43	O
.	O
8	O
%	O
)	O
cases	O
,	O
while	O
the	O
remaining	O
nine	O
(	O
56	O
.	O
3	O
%	O
)	O
cases	O
were	O
diagnosed	B-T033
as	O
myx	B-T038
##oma	I-T038
.	O
all	O
patients	O
had	O
jaw	O
resections	O
,	O
and	O
these	O
consisted	O
of	O
mand	B-T058
##ib	I-T058
##ule	I-T058
##ct	I-T058
##om	I-T058
##ies	I-T058
in	O
nine	O
(	O
60	O
.	O
0	O
%	O
)	O
patients	O
and	O
maxill	B-T058
##ectomies	I-T058
in	O
six	O
(	O
40	O
.	O
0	O
%	O
)	O
patients	O
.	O
the	O
duration	O
of	O
hospital	O
stay	O
ranged	O
from	O
5	O
to	O
29	O
days	O
,	O
with	O
a	O
mean	O
of	O
17	O
.	O
86	O
##±7	O
.	O
68	O
days	O
.	O
complications	B-T038
were	O
noted	O
in	O
three	O
patients	O
,	O
and	O
all	O
were	O
surgical	B-T038
wound	I-T038
infections	I-T038
.	O
most	O
patients	O
in	O
our	O
environment	B-T082
present	O
late	O
with	O
large	O
tumors	O
and	O
are	O
usually	O
not	O
compliant	O
with	O
follow	B-T058
-	I-T058
up	I-T058
review	O
.	O
thus	O
,	O
a	O
radical	O
approach	O
is	O
favored	O
in	O
most	O
patients	O
.	O

caries	B-T038
with	O
dental	B-T038
fluoro	I-T038
##sis	I-T038
and	O
oral	O
health	O
behaviour	O
among	O
12	O
-	O
year	O
school	O
children	O
in	O
moderate	O
-	O
fluoride	O
drinking	O
water	O
community	O
in	O
que	B-T082
##tt	I-T082
##a	I-T082
,	O
pakistan	B-T082
to	O
determine	O
the	O
prevalence	O
of	O
dental	B-T038
caries	I-T038
and	O
its	O
relationship	O
with	O
dental	B-T038
fluoro	I-T038
##sis	I-T038
,	O
oral	O
health	O
behaviour	O
and	O
dietary	B-T033
behaviour	I-T033
among	O
12	O
-	O
year	O
school	O
children	O
in	O
moderate	O
-	O
fluoride	O
drinking	O
water	O
community	O
in	O
que	B-T082
##tt	I-T082
##a	I-T082
,	O
pakistan	B-T082
.	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
.	O
government	B-T092
and	O
private	B-T092
schools	I-T092
of	O
que	B-T082
##tt	I-T082
##a	I-T082
,	O
from	O
november	O
2012	O
to	O
february	O
2013	O
.	O
at	O
##otal	O
of	O
34	O
##9	O
children	O
aged	O
12	O
-	O
year	O
from	O
14	O
randomly	O
selected	O
schools	B-T092
were	O
included	O
.	O
the	O
data	B-T062
collection	I-T062
was	O
done	O
on	O
questionnaire	B-T170
designed	O
for	O
children	O
.	O
dental	B-T038
caries	I-T038
status	O
was	O
examined	B-T033
by	O
using	O
who	B-T092
criteria	O
.	O
dental	B-T038
caries	I-T038
was	O
found	O
in	O
81	O
children	O
(	O
23	O
.	O
2	O
%	O
)	O
with	O
mean	O
dmf	O
##t	O
0	O
.	O
61	O
.	O
boys	O
had	O
1	O
.	O
6	O
times	O
more	O
chance	O
to	O
have	O
dental	B-T038
caries	I-T038
than	O
girls	O
.	O
dental	B-T038
fluoro	I-T038
##sis	I-T038
was	O
found	O
in	O
63	O
.	O
6	O
%	O
of	O
children	O
with	O
majority	O
of	O
moderate	O
degree	O
(	O
50	O
.	O
5	O
%	O
)	O
.	O
dental	B-T038
fluoro	I-T038
##sis	I-T038
status	O
was	O
found	O
significantly	O
associated	O
with	O
dental	B-T038
caries	I-T038
status	O
in	O
children	O
.	O
the	O
children	O
who	O
had	O
mild	O
,	O
moderate	O
and	O
severe	O
fluoro	B-T038
##sis	I-T038
,	O
had	O
4	O
times	O
more	O
chances	O
to	O
develop	O
caries	B-T038
than	O
those	O
who	O
did	O
not	O
have	O
fluoro	B-T038
##sis	I-T038
.	O
there	O
was	O
no	O
significant	O
association	O
between	O
children	O
'	O
s	O
caries	B-T038
status	O
and	O
use	O
of	O
paste	B-T103
,	O
brushing	B-T058
habit	I-T058
,	O
mis	B-T103
##wa	I-T103
##k	I-T103
,	O
and	O
visit	O
to	O
the	O
dentist	B-T097
.	O
the	O
use	O
of	O
past	B-T168
##ries	I-T168
and	O
juice	B-T168
##s	I-T168
had	O
a	O
direct	O
relation	O
with	O
the	O
children	O
'	O
s	O
dental	B-T038
caries	I-T038
status	O
.	O
dental	B-T038
caries	I-T038
in	O
children	O
of	O
que	B-T082
##tt	I-T082
##a	I-T082
is	O
not	O
so	O
much	O
frequent	O
as	O
compared	O
to	O
the	O
fluoride	B-T103
deficient	O
countries	B-T082
.	O
however	O
,	O
the	O
high	O
prevalence	O
of	O
moderate	O
dental	B-T038
fluoro	I-T038
##sis	I-T038
and	O
consumption	O
of	O
past	B-T168
##ries	I-T168
and	O
juice	B-T168
##s	I-T168
resulted	O
in	O
dental	B-T038
caries	I-T038
.	O

treatment	B-T058
of	O
erythemat	B-T038
##ote	I-T038
##la	I-T038
##ng	I-T038
##ie	I-T038
##ct	I-T038
##atic	I-T038
ros	I-T038
##acea	I-T038
with	O
the	O
fractionation	B-T058
of	O
high	O
-	O
fluence	O
,	O
long	O
-	O
pulsed	O
59	O
##5	O
-	O
nm	O
pulsed	B-T074
dye	I-T074
laser	I-T074
various	O
lasers	O
have	O
been	O
used	O
for	O
the	O
treatment	B-T058
of	O
erythemat	B-T038
##ote	I-T038
##la	I-T038
##ng	I-T038
##ie	I-T038
##ct	I-T038
##atic	I-T038
ros	I-T038
##acea	I-T038
(	O
et	B-T038
##r	I-T038
)	O
that	O
does	O
not	O
respond	O
to	O
systemic	B-T058
or	O
topical	B-T058
therapy	I-T058
.	O
the	O
pulsed	B-T074
dye	I-T074
lasers	I-T074
(	O
pdl	B-T074
##s	I-T074
)	O
are	O
an	O
effective	O
option	O
for	O
et	B-T038
##r	I-T038
,	O
and	O
the	O
purpura	B-T038
##genic	I-T038
fluence	O
proved	O
to	O
be	O
superior	O
until	O
now	O
.	O
given	O
that	O
purpura	B-T038
and	O
subsequent	O
possible	O
postin	B-T038
##fl	I-T038
##amma	I-T038
##tory	I-T038
hyperp	I-T038
##igmentation	I-T038
(	O
pi	B-T038
##h	I-T038
)	O
are	O
occasionally	O
un	O
##bear	O
##able	O
in	O
some	O
patients	O
,	O
and	O
several	O
studies	O
using	O
the	O
low	O
nonp	B-T033
##ur	I-T033
##p	I-T033
##ura	I-T033
##genic	I-T033
fluence	O
were	O
reported	O
.	O
to	O
deliver	O
the	O
sufficient	O
high	O
fluence	O
of	O
a	O
pdl	B-T074
without	O
generating	O
purpura	B-T038
,	O
we	O
designed	O
the	O
fractionation	B-T058
of	O
high	O
fluence	O
using	O
five	O
passes	O
and	O
longer	O
pulse	O
duration	O
(	O
6	O
millis	O
##econds	O
)	O
of	O
a	O
pdl	B-T074
in	O
succession	O
.	O
a	O
total	O
of	O
eight	O
patients	O
with	O
et	B-T038
##r	I-T038
were	O
enrolled	O
in	O
this	O
study	O
;	O
all	O
patients	O
were	O
treated	O
with	O
pdl	B-T074
10	O
times	O
at	O
2	O
-	O
week	O
intervals	O
.	O
erythema	B-T038
and	O
telangiectasia	B-T038
scores	O
,	O
as	O
well	O
as	O
improvement	O
,	O
were	O
assessed	O
by	O
two	O
physicians	B-T097
using	O
the	O
digital	B-T170
photographs	I-T170
.	O
moderate	O
-	O
to	O
-	O
marked	O
improvement	O
was	O
achieved	O
in	O
most	O
of	O
the	O
patients	O
,	O
and	O
erythema	B-T038
and	O
telangiectasia	B-T038
scores	O
were	O
significantly	O
decreased	O
.	O
purpura	B-T038
and	O
pi	B-T038
##h	I-T038
were	O
not	O
reported	O
in	O
all	O
patients	O
.	O
the	O
fractionation	B-T058
of	O
high	O
-	O
fluence	O
,	O
long	O
-	O
pulsed	O
59	O
##5	O
nm	O
pdl	B-T074
is	O
a	O
very	O
safe	O
and	O
effective	O
treatment	B-T058
for	O
et	B-T038
##r	I-T038
.	O

does	O
sex	O
really	O
matter	O
?	O
explaining	O
intras	B-T170
##pec	I-T170
##ies	I-T170
variation	O
in	O
ocean	B-T082
acidification	O
responses	O
ocean	B-T082
acidification	O
(	O
oa	O
)	O
poses	O
a	O
major	O
threat	O
to	O
marine	O
ecosystems	O
globally	O
,	O
having	O
significant	O
ecological	O
and	O
economic	O
importance	O
.	O
the	O
number	O
and	O
complexity	O
of	O
experiments	B-T062
examining	B-T033
the	O
effects	O
of	O
oa	O
has	O
substantially	O
increased	O
over	O
the	O
past	O
decade	O
,	O
in	O
an	O
attempt	O
to	O
address	O
multi	O
-	O
stressor	O
interactions	O
and	O
long	O
-	O
term	O
responses	O
in	O
an	O
increasing	O
range	O
of	O
aquatic	O
organisms	O
.	O
however	O
,	O
differences	O
in	O
the	O
response	O
of	O
males	O
and	O
females	O
to	O
elevated	B-T033
pco2	I-T033
have	O
been	O
investigated	O
in	O
fewer	O
than	O
4	O
%	O
of	O
studies	O
to	O
date	O
,	O
often	O
being	O
preclude	O
##d	O
by	O
the	O
difficulty	O
of	O
determining	O
sex	O
non	O
-	O
destructive	O
##ly	O
,	O
particularly	O
in	O
early	O
life	O
stages	O
.	O
here	O
we	O
highlight	O
that	O
sex	O
can	O
significantly	O
impact	O
organism	O
responses	O
to	O
oa	O
,	O
differentially	O
affecting	O
physiology	B-T038
,	O
reproduction	B-T038
,	O
biochemistry	O
and	O
ultimately	O
survival	O
.	O
what	O
is	O
more	O
,	O
these	O
impacts	O
do	O
not	O
always	O
conform	O
to	O
ecological	O
theory	O
based	O
on	O
differential	O
resource	O
allocation	O
towards	O
reproduction	B-T038
,	O
which	O
would	O
predict	O
females	O
to	O
be	O
more	O
sensitive	O
to	O
oa	O
owing	O
to	O
the	O
higher	O
production	O
cost	O
of	O
eggs	B-T017
compared	O
with	O
sperm	B-T017
.	O
therefore	O
,	O
non	O
-	O
sex	O
-	O
specific	B-T062
studies	I-T062
may	O
overlo	O
##ok	O
subtle	O
but	O
ecologically	O
significant	O
differences	O
in	O
the	O
responses	O
of	O
males	O
and	O
females	O
to	O
oa	O
,	O
with	O
consequences	O
for	O
forec	O
##asting	O
the	O
fate	O
of	O
natural	O
populations	B-T098
in	O
a	O
near	O
-	O
future	O
ocean	B-T082
.	O

eco	B-T037
##to	I-T037
##x	I-T037
##icity	I-T037
testing	O
and	O
environmental	B-T058
risk	I-T058
assessment	I-T058
of	O
iron	B-T103
nanomaterials	O
for	O
sub	O
-	O
surface	O
remediation	O
-	O
recommendations	O
from	O
the	O
fp	O
##7	O
project	O
nanor	O
##em	O
nanor	O
##emed	O
##iation	O
with	O
iron	B-T103
(	O
fe	B-T103
)	O
nanomaterials	O
opens	O
new	O
door	O
##s	O
for	O
treating	O
contaminated	O
soil	O
and	O
groundwater	B-T103
,	O
but	O
is	O
also	O
accompanied	O
by	O
new	O
potential	O
risks	O
as	O
large	O
quantities	O
of	O
engineered	O
nanomaterials	O
are	O
introduced	O
into	O
the	O
environment	B-T082
.	O
in	O
this	O
study	B-T062
,	O
we	O
have	O
assessed	O
the	O
eco	B-T037
##to	I-T037
##x	I-T037
##icity	I-T037
of	O
four	O
engineered	O
fe	B-T103
nanomaterials	O
,	O
specifically	O
,	O
nano	B-T103
-	I-T103
go	I-T103
##eth	I-T103
##ite	I-T103
,	O
trap	B-T103
-	I-T103
ox	I-T103
fe	I-T103
-	I-T103
zeolite	I-T103
##s	I-T103
,	O
carb	B-T103
##o	I-T103
-	I-T103
iron	I-T103
(	O
®	O
)	O
and	O
ferm	B-T103
##eg	I-T103
##12	I-T103
,	O
developed	O
within	O
the	O
european	O
fp	O
##7	O
project	O
nanor	O
##em	O
for	O
sub	O
-	O
surface	O
remediation	O
towards	O
a	O
test	B-T058
battery	I-T058
consisting	O
of	O
eight	O
eco	B-T037
##to	I-T037
##x	I-T037
##icity	I-T037
tests	B-T058
on	O
bacteria	B-T007
(	O
v	B-T007
.	I-T007
fisher	I-T007
##i	I-T007
,	O
e	B-T007
.	I-T007
coli	I-T007
)	O
,	O
algae	B-T204
(	O
p	B-T204
.	I-T204
subc	I-T204
##ap	I-T204
##ita	I-T204
##ta	I-T204
,	O
chlamyd	B-T204
##omonas	I-T204
sp	I-T204
.	I-T204
)	O
,	O
crustace	B-T204
##ans	I-T204
(	O
d	B-T204
.	I-T204
magna	I-T204
)	O
,	O
worms	B-T204
(	O
e	B-T204
.	I-T204
fet	I-T204
##ida	I-T204
,	O
l	B-T204
.	I-T204
vari	I-T204
##eg	I-T204
##atus	I-T204
)	O
and	O
plants	B-T204
(	O
r	B-T204
.	I-T204
sativ	I-T204
##us	I-T204
,	O
l	B-T204
.	I-T204
multif	I-T204
##lor	I-T204
##um	I-T204
)	O
.	O
the	O
tested	O
materials	O
are	O
commercially	O
available	O
and	O
include	O
fe	B-T103
oxide	I-T103
and	O
nanoscale	B-T103
zero	I-T103
valent	I-T103
iron	I-T103
(	O
nz	B-T103
##vi	I-T103
)	O
,	O
but	O
also	O
hybrid	O
products	O
with	O
fe	B-T103
loaded	O
into	O
a	O
matrix	B-T082
.	O
all	O
but	O
one	O
material	O
,	O
a	O
ball	B-T103
mill	I-T103
##ed	I-T103
nz	I-T103
##vi	I-T103
(	O
ferm	B-T103
##eg	I-T103
##12	I-T103
)	O
,	O
showed	O
no	B-T033
toxicity	I-T033
in	O
the	O
test	B-T058
battery	I-T058
when	O
tested	O
in	O
concentrations	O
up	O
to	O
100	O
mg	O
/	O
l	O
,	O
which	O
is	O
the	O
cutoff	O
for	O
hazard	O
labeling	O
in	O
chemicals	O
regulation	O
in	O
europe	B-T082
.	O
however	O
it	O
should	O
be	O
noted	O
that	O
fe	B-T103
nanomaterials	O
proved	O
challenging	O
to	O
test	O
adequately	O
due	O
to	O
their	O
turbidity	O
,	O
aggregation	O
and	O
sedimentation	O
behavior	O
in	O
aqueous	O
media	O
.	O
this	O
paper	O
provides	O
a	O
number	O
of	O
recommendations	O
concerning	O
future	O
testing	O
of	O
fe	B-T103
nanomaterials	O
and	O
discusses	O
environmental	B-T058
risk	I-T058
assessment	I-T058
considerations	O
related	O
to	O
these	O
.	O

rates	O
and	O
predictors	O
of	O
injury	B-T037
in	O
a	O
population	O
-	O
based	O
cohort	B-T098
of	O
people	B-T098
living	O
with	O
hiv	B-T038
injuries	B-T037
are	O
responsible	O
for	O
10	O
%	O
of	O
the	O
global	O
burden	O
of	O
disease	B-T038
;	O
however	O
,	O
the	O
epidemiology	O
of	O
injury	B-T037
among	O
people	B-T038
living	I-T038
with	I-T038
hiv	I-T038
(	O
pl	B-T038
##hi	I-T038
##v	I-T038
)	O
has	O
not	O
been	O
well	O
elucidated	O
.	O
this	O
study	B-T062
seeks	O
to	O
characterize	O
rates	O
and	O
predictors	O
of	O
injury	B-T037
among	O
pl	B-T038
##hi	I-T038
##v	I-T038
compared	O
to	O
the	O
general	B-T098
population	I-T098
in	O
british	B-T082
columbia	I-T082
(	O
bc	B-T082
)	O
,	O
canada	B-T082
.	O
a	O
population	O
-	O
based	O
dataset	B-T170
was	O
created	O
via	O
linkage	B-T062
between	B-T082
the	O
bc	B-T092
centre	I-T092
for	I-T092
excellence	I-T092
in	I-T092
hiv	I-T092
/	I-T092
aids	I-T092
and	O
population	O
##da	O
##ta	O
##bc	O
.	O
pl	B-T038
##hi	I-T038
##v	I-T038
aged	O
20	O
years	O
and	O
older	O
were	O
compared	O
to	O
a	O
random	O
10	O
%	O
sample	O
of	O
the	O
adult	O
general	B-T098
population	I-T098
.	O
the	O
international	O
classification	B-T170
of	O
diseases	B-T038
9	O
and	O
10	O
codes	O
were	O
used	O
to	O
classify	B-T170
unintentional	B-T037
and	O
intentional	B-T037
injuries	I-T037
based	O
on	O
the	O
external	O
cause	O
of	O
the	O
injury	B-T037
from	O
1996	O
to	O
2013	O
.	O
generalized	B-T170
estimating	I-T170
equation	I-T170
(	O
ge	B-T170
##e	I-T170
)	O
poisson	O
regression	O
models	O
were	O
fit	O
to	O
estimate	O
the	O
effect	O
of	O
hiv	B-T038
status	O
on	O
rates	O
of	O
unintentional	B-T037
and	O
intentional	B-T037
injury	I-T037
,	O
and	O
to	O
identify	O
correlates	O
of	O
injury	B-T037
among	O
pl	B-T038
##hi	I-T038
##v	I-T038
.	O
the	O
crude	O
incidence	O
rate	O
of	O
unintentional	B-T037
injury	I-T037
was	O
18	O
.	O
56	O
/	O
1000	O
person	B-T098
-	O
years	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
17	O
.	O
77	O
-	O
19	O
.	O
39	O
]	O
among	O
pl	B-T038
##hi	I-T038
##v	I-T038
and	O
8	O
.	O
51	O
/	O
1000	O
person	B-T098
-	O
years	O
(	O
95	O
%	O
ci	O
8	O
.	O
42	O
-	O
8	O
.	O
59	O
)	O
in	O
the	O
general	B-T098
population	I-T098
.	O
among	O
pl	B-T038
##hi	I-T038
##v	I-T038
,	O
13	O
.	O
45	O
%	O
of	O
deaths	B-T033
were	O
due	O
to	O
injury	B-T037
,	O
compared	O
to	O
5	O
.	O
52	O
%	O
of	O
deaths	B-T033
in	O
the	O
general	B-T098
population	I-T098
.	O
in	O
adjusted	O
models	B-T170
,	O
pl	B-T038
##hi	I-T038
##v	I-T038
were	O
more	O
likely	O
to	O
report	B-T058
unintentional	B-T037
(	O
incidence	O
rate	O
ratio	O
1	O
.	O
42	O
,	O
95	O
%	O
ci	O
1	O
.	O
32	O
-	O
1	O
.	O
52	O
)	O
and	O
intentional	B-T037
injury	I-T037
(	O
incidence	O
rate	O
ratio	O
1	O
.	O
93	O
,	O
95	O
%	O
ci	O
1	O
.	O
70	O
-	O
2	O
.	O
18	O
)	O
compared	O
to	O
the	O
general	B-T098
population	I-T098
.	O
we	O
identified	O
elevated	O
rates	O
of	O
intentional	B-T037
and	O
unintentional	B-T037
injury	I-T037
among	O
pl	B-T038
##hi	I-T038
##v	I-T038
.	O
injuries	B-T037
are	O
largely	O
preventable	O
;	O
as	O
such	O
,	O
targeted	O
efforts	O
are	O
needed	O
to	O
decrease	O
the	O
burden	O
of	O
injury	B-T037
-	O
related	O
disability	B-T033
and	O
death	B-T033
among	O
pl	B-T038
##hi	I-T038
##v	I-T038
.	O

predictors	O
of	O
30	O
-	O
day	O
mortality	O
in	O
patients	O
with	O
spontaneous	O
primary	O
intracerebral	B-T033
hemorrhage	I-T033
intracerebral	B-T033
hemorrhage	I-T033
(	O
ich	B-T033
)	O
is	O
a	O
life	B-T033
threatening	I-T033
entity	O
,	O
and	O
an	O
early	B-T058
outcome	I-T058
assessment	I-T058
is	O
mandatory	O
for	O
optimizing	O
therapeutic	B-T058
efforts	I-T058
.	O
we	O
retrospectively	O
analyzed	B-T062
data	O
from	O
342	O
patients	O
with	O
spontaneous	O
primary	O
ich	B-T033
to	O
evaluate	O
possible	O
predictors	O
of	O
30	O
-	O
day	O
mortality	O
considering	O
clinical	O
,	O
radiological	O
,	O
and	O
therapeutical	O
parameters	O
.	O
we	O
also	O
applied	O
three	O
widely	O
accepted	O
outcome	B-T170
grading	I-T170
scoring	I-T170
systems	I-T170
[	O
(	O
ich	O
score	O
,	O
fun	O
##c	O
score	O
and	O
intracerebral	B-T170
hemorrhage	I-T170
grading	I-T170
scale	I-T170
(	O
ich	B-T170
-	I-T170
gs	I-T170
)	O
]	O
on	O
our	O
population	B-T098
to	O
evaluate	O
the	O
correlation	O
of	O
these	O
scores	O
with	O
the	O
30	O
-	O
day	O
mortality	O
in	O
our	O
study	B-T062
.	O
we	O
also	O
applied	O
three	O
widely	O
accepted	O
outcome	B-T170
grading	I-T170
scoring	I-T170
systems	I-T170
[	O
(	O
ich	O
score	O
,	O
fun	O
##c	O
score	O
and	O
intracerebral	B-T170
hemorrhage	I-T170
grading	I-T170
scale	I-T170
(	O
ich	B-T170
-	I-T170
gs	I-T170
)	O
]	O
on	O
our	O
population	B-T098
to	O
evaluate	O
the	O
correlation	O
of	O
these	O
scores	O
with	O
the	O
30	O
-	O
day	O
mortality	O
in	O
our	O
study	B-T062
.	O
from	O
342	O
patients	O
(	O
mean	O
age	O
:	O
67	O
years	O
,	O
mean	O
glasgow	B-T170
coma	I-T170
scale	I-T170
[	O
gcs	B-T170
]	O
on	O
admission	B-T058
:	O
9	O
,	O
mean	O
ich	B-T033
volume	O
:	O
62	O
.	O
19	O
ml	O
,	O
most	O
common	O
hematoma	B-T038
location	B-T082
:	O
basal	B-T017
ganglia	I-T017
[	O
43	O
.	O
9	O
%	O
]	O
)	O
,	O
102	O
received	O
surgical	B-T058
and	O
240	O
conservative	B-T058
treatment	I-T058
.	O
the	O
30	O
-	O
day	O
mortality	O
was	O
25	O
.	O
15	O
%	O
.	O
in	O
a	O
multivariate	O
analysis	O
,	O
gcs	B-T170
(	O
odds	O
ratio	O
[	O
or	O
]	O
=	O
0	O
.	O
72	O
##6	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
=	O
0	O
.	O
66	O
##1	O
-	O
0	O
.	O
79	O
##6	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
bleeding	B-T038
volume	O
(	O
or	O
=	O
1	O
.	O
012	O
per	O
ml	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
007	O
-	O
1	O
.	O
017	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
infra	B-T082
##ten	I-T082
##tor	I-T082
##ial	I-T082
hematoma	B-T038
location	B-T082
(	O
or	O
=	O
5	O
.	O
38	O
##1	O
,	O
95	O
%	O
ci	O
=	O
2	O
.	O
166	O
-	O
13	O
.	O
356	O
,	O
p	O
=	O
0	O
.	O
009	O
)	O
were	O
significant	O
predictors	O
for	O
the	O
30	O
-	O
day	O
mortality	O
.	O
after	O
receiver	O
operating	O
characteristics	O
analysis	B-T062
,	O
we	O
defined	O
a	O
[UNK]	O
high	O
-	O
risk	O
group	O
[UNK]	O
for	O
an	O
unfavorable	O
short	O
-	O
term	O
outcome	O
with	O
gcs	B-T170
<	O
11	O
and	O
ich	B-T033
volume	O
>	O
32	O
ml	O
supra	B-T082
##ten	I-T082
##tor	I-T082
##ially	I-T082
or	O
21	O
ml	O
infra	B-T082
##ten	I-T082
##tor	I-T082
##ially	I-T082
.	O
using	O
pearson	B-T170
correlation	I-T170
,	O
we	O
found	O
a	O
correlation	O
of	O
0	O
.	O
98	O
##6	O
between	O
ich	O
score	O
and	O
30	O
-	O
day	O
mortality	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
0	O
.	O
85	O
##3	O
between	O
fun	O
##c	O
score	O
and	O
30	O
-	O
day	O
mortality	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
and	O
0	O
.	O
92	O
##4	O
between	O
ich	B-T170
-	I-T170
gs	I-T170
and	O
30	O
-	O
day	O
mortality	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
gcs	B-T170
score	O
on	O
admission	B-T058
together	O
with	O
the	O
baseline	O
volume	O
and	O
localization	O
of	O
the	O
hemorrhage	B-T038
are	O
strong	O
predictors	O
for	O
30	O
-	O
day	O
mortality	O
in	O
patients	O
with	O
spontaneous	O
primary	O
intracerebral	B-T033
hemorrhage	I-T033
,	O
and	O
by	O
relying	O
on	O
them	O
it	O
is	O
possible	O
to	O
identify	O
high	B-T033
-	I-T033
risk	I-T033
patients	O
with	O
poor	O
short	O
-	O
term	O
outcome	O
.	O
the	O
ich	O
score	O
and	O
the	O
ich	B-T170
-	I-T170
gs	I-T170
accurately	O
predict	O
the	O
30	O
-	O
day	O
mortality	O
.	O

high	O
performance	O
reduction	O
of	O
h2o2	B-T103
with	O
an	O
electron	B-T038
transport	I-T038
dec	B-T103
##ah	I-T103
##eme	I-T103
cytochrome	I-T103
on	O
a	O
porous	O
ito	B-T103
electrode	O
the	O
dec	B-T103
##ah	I-T103
##eme	I-T103
cytochrome	I-T103
mtr	I-T103
##c	I-T103
from	O
she	B-T007
##wan	I-T007
##ella	I-T007
one	I-T007
##iden	I-T007
##sis	I-T007
mr	I-T007
-	I-T007
1	I-T007
immobilized	B-T103
on	O
an	O
ito	B-T103
electrode	O
displays	O
unprecedented	O
h2o2	B-T103
reduction	O
activity	O
.	O
although	O
mtr	B-T103
##c	I-T103
showed	O
lower	O
peroxidase	B-T038
activity	I-T038
in	O
solution	O
compared	O
to	O
horseradish	B-T103
peroxidase	I-T103
,	O
the	O
ten	O
heme	B-T103
cofactors	B-T103
enable	O
excellent	O
electronic	O
communication	O
and	O
a	O
superior	O
activity	O
on	O
the	O
electrode	O
surface	O
.	O
a	O
hierarchical	O
ito	B-T103
electrode	O
enabled	O
optimal	O
immobilization	O
of	O
mtr	B-T103
##c	I-T103
and	O
a	O
high	O
current	O
density	O
of	O
1	O
ma	O
cm	O
(	O
-	O
2	O
)	O
at	O
0	O
.	O
4	O
v	O
vs	O
she	O
could	O
be	O
obtained	O
at	O
ph	O
6	O
.	O
5	O
(	O
eo	O
##ns	O
##et	O
=	O
0	O
.	O
72	O
v	O
)	O
.	O
uv	O
-	O
visible	O
and	O
resonance	B-T058
raman	I-T058
spectro	I-T058
##electro	I-T058
##chemical	I-T058
studies	I-T058
suggest	O
the	O
formation	O
of	O
a	O
high	O
valent	O
iron	O
-	O
oxo	O
species	O
as	O
the	O
catalytic	O
intermediate	O
.	O
our	O
findings	O
demonstrate	O
the	O
potential	O
of	O
multi	B-T103
##hem	I-T103
##e	I-T103
cytochromes	I-T103
to	O
catalyze	O
technological	O
##ly	O
relevant	O
reactions	O
and	O
establish	O
mtr	B-T103
##c	I-T103
as	O
a	O
new	O
benchmark	O
in	O
biotechnological	B-T091
h2o2	B-T103
reduction	O
with	O
scope	O
for	O
applications	O
in	O
fuel	O
cells	O
and	O
biosensors	O
.	O

liver	B-T103
fatty	I-T103
acid	I-T103
binding	I-T103
protein	I-T103
deficiency	O
provoke	O
##s	O
oxidative	B-T038
stress	I-T038
,	O
inflammation	B-T038
,	O
and	O
apoptosis	B-T038
-	O
mediated	O
hepatotoxicity	B-T037
induced	O
by	O
pyr	B-T103
##azin	I-T103
##amide	I-T103
in	O
zebrafish	B-T204
larvae	B-T204
pyr	B-T103
##azin	I-T103
##amide	I-T103
(	O
pz	B-T103
##a	I-T103
)	O
is	O
an	O
essential	O
antit	B-T103
##ubercul	I-T103
##ar	I-T103
drug	I-T103
,	O
but	O
little	O
is	O
still	O
known	O
about	O
its	O
hepatotoxicity	B-T037
potential	O
.	O
this	O
study	O
examined	O
the	O
effects	O
of	O
pz	B-T103
##a	I-T103
exposure	O
on	O
zebrafish	B-T204
(	O
dan	B-T204
##io	I-T204
rer	I-T204
##io	I-T204
)	O
larvae	B-T204
and	O
the	O
mechanisms	O
underlying	O
its	O
hepatotoxicity	B-T037
.	O
a	O
transgenic	B-T017
line	I-T017
of	O
zebrafish	B-T204
larvae	B-T204
that	O
expressed	B-T038
enhanced	B-T103
green	I-T103
fluorescent	I-T103
protein	I-T103
(	O
egfp	B-T103
)	O
in	O
the	O
liver	B-T017
was	O
incubated	B-T058
with	O
1	O
,	O
2	O
.	O
5	O
,	O
and	O
5	O
mm	O
pz	B-T103
##a	I-T103
from	O
72	O
h	O
post	B-T038
##fer	I-T038
##til	I-T038
##ization	I-T038
(	O
hp	O
##f	O
)	O
.	O
different	O
endpoints	O
such	O
as	O
mortality	O
,	O
morphology	B-T033
changes	O
in	O
the	O
size	O
and	O
shape	B-T082
of	O
the	O
liver	B-T017
,	O
histological	B-T091
changes	O
,	O
transaminase	B-T058
analysis	I-T058
and	O
apoptosis	B-T038
,	O
markers	B-T201
of	O
oxidative	B-T038
and	O
genetic	B-T038
damage	I-T038
,	O
as	O
well	O
as	O
the	O
expression	B-T038
of	O
certain	O
genes	B-T017
were	O
selected	O
to	O
evaluate	B-T058
pz	B-T103
##a	I-T103
-	O
induced	O
hepatotoxicity	B-T037
.	O
our	O
results	O
confirm	B-T033
the	O
manner	O
of	O
pz	B-T103
##a	I-T103
dose	O
-	O
dependent	O
hepatotoxicity	B-T037
.	O
pz	B-T103
##a	I-T103
was	O
found	O
to	O
induce	O
marked	O
injury	B-T037
in	O
zebrafish	B-T204
larvae	B-T204
,	O
such	O
as	O
liver	B-T038
atrophy	I-T038
,	O
elevations	B-T033
of	I-T033
transaminase	I-T033
levels	I-T033
,	O
oxidative	B-T038
stress	I-T038
,	O
and	O
hepatocyte	B-T038
apoptosis	I-T038
.	O
to	O
further	O
understand	O
the	O
mechanism	O
behind	O
pz	B-T103
##a	I-T103
-	O
induced	O
hepatotoxicity	B-T037
,	O
changes	O
in	O
gene	O
expression	O
levels	O
in	O
zebrafish	B-T204
larvae	B-T204
exposed	O
to	O
pz	B-T103
##a	I-T103
for	O
72	O
h	O
postex	O
##po	O
##s	O
##ure	O
(	O
hp	O
##e	O
)	O
were	O
determined	O
.	O
the	O
results	O
of	O
this	O
study	O
demonstrated	O
that	O
pz	B-T103
##a	I-T103
decreased	O
the	O
expression	O
levels	O
of	O
liver	B-T103
fatty	I-T103
acid	I-T103
binding	I-T103
protein	I-T103
(	O
l	B-T103
-	I-T103
fabp	I-T103
)	O
and	O
its	O
target	B-T017
gene	I-T017
,	O
peroxisome	B-T103
proliferator	I-T103
-	I-T103
activated	I-T103
receptor	I-T103
α	I-T103
(	O
ppar	B-T103
-	I-T103
α	I-T103
)	O
,	O
and	O
provoked	O
more	O
severe	O
oxidative	B-T038
stress	I-T038
and	O
hepatitis	B-T038
via	O
the	O
upregulation	B-T038
of	O
inflammatory	B-T038
cytokines	I-T038
such	O
as	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
alpha	I-T103
(	O
tnf	B-T103
-	I-T103
α	I-T103
)	O
and	O
transforming	B-T103
growth	I-T103
factor	I-T103
β	I-T103
(	O
tgf	B-T103
-	I-T103
β	I-T103
)	O
.	O
these	O
findings	O
suggest	O
that	O
l	B-T103
-	I-T103
fabp	I-T103
-	O
mediated	O
ppar	B-T103
-	I-T103
α	I-T103
downregulation	B-T038
appears	O
to	O
be	O
a	O
hepat	B-T038
##otoxic	I-T038
response	I-T038
resulting	O
from	O
zebrafish	B-T204
larva	B-T204
liver	B-T017
cell	I-T017
apoptosis	B-T038
,	O
and	O
l	B-T103
-	I-T103
fabp	I-T103
can	O
be	O
used	O
as	O
a	O
biomarker	B-T201
for	O
the	O
early	B-T058
detection	I-T058
of	O
pz	B-T103
##a	I-T103
-	O
induced	O
liver	B-T038
damage	I-T038
in	O
zebrafish	B-T204
larvae	B-T204
.	O

uveitis	B-T038
in	O
children	O
the	O
review	O
provides	O
updates	O
on	O
novel	O
risk	O
markers	O
for	O
the	O
development	O
of	O
pediatric	O
inflammatory	B-T038
uveitis	I-T038
and	O
a	O
severe	B-T038
disease	I-T038
course	I-T038
,	O
on	O
treatment	B-T058
of	O
refractory	B-T033
disease	I-T033
,	O
and	O
on	O
the	O
measurement	O
of	O
visual	O
outcomes	O
.	O
there	O
are	O
several	O
new	O
genetic	B-T038
markers	I-T038
,	O
biomarkers	B-T201
,	O
and	O
clinical	O
factors	O
that	O
may	O
influence	O
a	O
child	O
'	O
s	O
uveitis	B-T038
disease	B-T038
course	I-T038
.	O
it	O
is	O
important	O
to	O
identify	O
children	O
at	O
risk	O
for	O
poor	O
visual	O
outcomes	O
and	O
who	O
are	O
refractory	O
to	O
traditional	B-T058
therapy	I-T058
.	O
racial	B-T033
disparities	I-T033
have	O
recently	O
been	O
reported	B-T170
.	O
we	O
describe	O
agents	B-T103
of	O
potential	O
benefit	O
.	O
in	O
addition	O
,	O
we	O
discuss	O
the	O
importance	O
of	O
patient	B-T170
reported	I-T170
outcomes	I-T170
in	O
this	O
population	O
.	O
uveitis	B-T038
can	O
lead	O
to	O
vision	B-T038
-	I-T038
threatening	I-T038
complications	I-T038
.	O
timely	B-T058
and	I-T058
aggressive	I-T058
treatment	I-T058
of	O
children	O
identified	O
to	O
be	O
at	O
risk	O
for	O
a	O
severe	B-T038
uveitis	I-T038
course	I-T038
may	O
lead	O
to	O
improved	O
outcomes	O
.	O

genome	B-T082
sequences	I-T082
of	O
mycobacter	B-T005
##iop	I-T005
##ha	I-T005
##ges	I-T005
jan	I-T005
##e	I-T005
and	I-T005
sn	I-T005
##ee	I-T005
##ze	I-T005
,	O
new	O
members	O
of	O
cluster	O
g	O
jan	O
##e	O
and	O
sn	O
##ee	O
##ze	O
are	O
newly	O
isolated	O
phages	B-T005
of	O
mycobacterium	B-T007
sm	I-T007
##egm	I-T007
##atis	I-T007
mc	I-T007
(	I-T007
2	I-T007
)	I-T007
155	I-T007
from	O
hill	B-T082
##s	I-T082
##bor	I-T082
##ough	I-T082
,	O
nj	B-T082
,	O
and	O
pal	B-T082
##o	I-T082
ver	I-T082
##de	I-T082
,	O
cost	B-T082
##a	I-T082
ri	I-T082
##ca	I-T082
,	O
respectively	O
.	O
both	O
are	O
cluster	O
g	O
,	O
subcl	O
##ust	O
##er	O
g1	O
mycobacter	B-T005
##iop	I-T005
##ha	I-T005
##ges	I-T005
.	O
notable	O
nucleotide	B-T103
differences	O
exist	O
between	O
genomes	B-T017
in	O
the	O
right	O
half	O
,	O
including	O
the	O
presence	O
of	O
mycobacter	B-T005
##iop	I-T005
##ha	I-T005
##ge	I-T005
mobile	B-T103
element	I-T103
1	I-T103
(	O
mpm	O
##e1	O
)	O
in	O
jan	O
##e	O
.	O

the	O
effects	O
of	O
probiotic	B-T007
and	O
syn	B-T168
##biotic	I-T168
supplementation	B-T058
on	O
metabolic	B-T038
syndrome	I-T038
indices	O
in	O
adults	O
at	O
risk	O
of	O
type	B-T038
2	I-T038
diabetes	I-T038
:	O
study	B-T170
protocol	I-T170
for	O
a	O
randomized	B-T062
controlled	I-T062
trial	I-T062
the	O
incidence	O
of	O
type	B-T038
2	I-T038
diabetes	I-T038
,	O
cardiovascular	B-T038
diseases	I-T038
,	O
and	O
obesity	B-T038
has	O
been	O
rising	O
dramatically	O
;	O
however	O
,	O
their	O
pathogenesis	B-T038
is	O
particularly	O
intriguing	B-T038
.	O
recently	O
,	O
dys	B-T038
##biosis	I-T038
of	O
the	O
intestinal	O
microbiota	O
has	O
emerged	O
as	O
a	O
new	O
candidate	O
that	O
may	O
be	O
linked	O
to	O
metabolic	B-T038
diseases	I-T038
.	O
we	O
hypothesize	O
that	O
selective	O
modulation	O
of	O
the	O
intestinal	O
microbiota	O
by	O
probiotic	B-T007
or	O
syn	B-T168
##biotic	I-T168
supplementation	B-T058
may	O
improve	O
metabolic	B-T038
dysfunction	I-T038
and	O
prevent	O
diabetes	B-T038
in	O
pred	B-T038
##iabetic	I-T038
##s	I-T038
.	O
in	O
this	O
study	B-T062
,	O
a	O
synthesis	O
and	O
study	B-T062
of	O
syn	B-T168
##biotic	I-T168
##s	I-T168
will	O
be	O
carried	O
out	O
for	O
the	O
first	O
time	O
in	O
iran	B-T082
.	O
in	O
a	O
randomized	B-T062
triple	I-T062
-	I-T062
blind	I-T062
controlled	I-T062
clinical	I-T062
trial	I-T062
,	O
120	O
adults	O
with	O
impaired	B-T038
glucose	I-T038
tolerance	I-T038
based	O
on	O
the	O
inclusion	O
criteria	O
will	O
be	O
selected	O
by	O
a	O
simple	O
random	O
sampling	B-T170
method	I-T170
and	O
will	O
be	O
randomly	O
allocated	O
to	O
6	O
months	O
of	O
6	O
g	O
/	O
d	O
probiotic	B-T007
,	O
syn	B-T168
##biotic	I-T168
or	O
placebo	B-T103
.	O
the	O
fecal	B-T031
abundance	O
of	O
bacteria	B-T007
,	O
blood	B-T038
pressure	I-T038
,	O
height	O
,	O
weight	O
,	O
and	O
waist	B-T201
and	O
hip	B-T201
circumference	I-T201
##s	I-T201
will	O
be	O
measured	O
at	O
baseline	O
and	O
following	O
treatment	B-T058
.	O
also	O
,	O
plasma	O
lipid	O
profiles	O
,	O
hba1c	B-T103
,	O
fasting	B-T058
plasma	I-T058
glucose	I-T058
,	O
and	O
insulin	B-T103
levels	O
,	O
will	O
be	O
measured	O
and	O
insulin	B-T058
resistance	I-T058
(	O
homa	B-T058
-	I-T058
ir	I-T058
)	O
and	O
beta	B-T058
-	I-T058
cell	I-T058
function	I-T058
(	O
homa	B-T058
-	I-T058
b	I-T058
)	O
will	O
be	O
calculated	O
at	O
baseline	O
and	O
will	O
be	O
repeated	O
at	O
months	O
3	O
,	O
6	O
,	O
12	O
,	O
and	O
18	O
.	O
the	O
data	O
will	O
be	O
compared	O
within	O
and	O
between	O
groups	O
using	O
statistical	B-T062
methods	I-T062
.	O
the	O
results	O
of	O
this	O
trial	B-T062
could	O
contribute	O
to	O
the	O
evidence	B-T170
-	I-T170
based	I-T170
clinical	I-T170
guidelines	I-T170
that	O
address	O
gut	O
microbiota	O
manipulation	B-T058
to	O
maximize	O
health	O
benefits	O
in	O
prevention	B-T058
and	O
management	B-T058
of	O
metabolic	B-T038
syndrome	I-T038
in	O
pred	B-T038
##iab	I-T038
##etes	I-T038
.	O
iranian	B-T170
registry	I-T170
of	O
clinical	B-T062
trials	I-T062
:	O
ir	B-T170
##ct	I-T170
##20	I-T170
##15	I-T170
##11	I-T170
##03	I-T170
##23	I-T170
##21	I-T170
##n2	I-T170
.	O
registered	O
on	O
27	O
february	O
2016	O
.	O

a	O
holistic	O
approach	O
to	O
age	O
estimation	B-T038
in	O
refuge	B-T098
##e	I-T098
children	O
many	O
refuge	B-T098
##e	I-T098
children	O
arr	O
##iving	O
in	O
australia	B-T082
have	O
an	O
inaccurate	O
##ly	O
documented	B-T058
date	B-T170
of	I-T170
birth	I-T170
(	O
do	B-T170
##b	I-T170
)	O
.	O
a	O
medical	B-T058
assessment	I-T058
of	O
a	O
child	O
'	O
s	O
age	O
is	O
often	O
requested	O
when	O
there	O
is	O
a	O
concern	O
that	O
their	O
documented	B-T058
do	B-T170
##b	I-T170
is	O
incorrect	O
.	O
this	O
study	O
'	O
s	O
aim	O
was	O
to	O
assess	O
the	O
accuracy	O
a	O
holistic	B-T170
age	I-T170
assessment	I-T170
tool	I-T170
(	O
aat	B-T170
)	O
in	O
estimating	B-T038
the	O
age	O
of	O
refuge	B-T098
##e	I-T098
children	O
newly	O
sett	O
##led	O
in	O
australia	B-T082
.	O
a	O
holistic	B-T170
aat	I-T170
that	O
combines	O
medical	O
and	O
non	O
-	O
medical	O
approaches	O
was	O
used	O
to	O
estimate	B-T038
the	O
ages	O
of	O
60	O
refuge	B-T098
##e	I-T098
children	O
with	O
a	O
known	O
do	B-T170
##b	I-T170
.	O
the	O
tool	B-T170
used	O
four	O
components	O
to	O
assess	O
age	O
:	O
an	O
oral	B-T082
narrative	O
,	O
developmental	O
assessment	B-T058
,	O
anthropometric	B-T170
measures	I-T170
and	O
pubertal	B-T033
assessment	B-T058
.	O
assess	B-T097
##ors	I-T097
were	O
blinded	B-T062
to	O
the	O
true	O
age	O
of	O
the	O
child	O
.	O
correlation	O
coefficients	O
for	O
the	O
actual	O
and	O
estimated	B-T038
age	O
were	O
calculated	O
for	O
the	O
tool	B-T170
overall	O
and	O
individual	O
components	O
.	O
the	O
correlation	O
coefficient	O
between	O
the	O
actual	O
and	O
estimated	B-T038
age	O
from	O
the	O
aat	B-T170
was	O
very	O
strong	O
at	O
0	O
.	O
98	O
##02	O
(	O
boys	O
0	O
.	O
97	O
##48	O
,	O
girls	O
0	O
.	O
98	O
##76	O
)	O
.	O
the	O
oral	B-T082
narrative	O
component	O
of	O
the	O
tool	B-T170
performed	O
best	O
(	O
r	O
=	O
0	O
.	O
96	O
##03	O
)	O
.	O
overall	O
,	O
86	O
.	O
7	O
%	O
of	O
age	O
estimates	B-T038
were	O
within	O
1	O
year	O
of	O
the	O
true	O
age	O
.	O
the	O
range	O
of	O
differences	O
was	O
-	O
1	O
.	O
43	O
to	O
3	O
.	O
92	O
years	O
with	O
a	O
standard	O
deviation	O
of	O
0	O
.	O
77	O
years	O
(	O
9	O
.	O
24	O
months	O
)	O
.	O
the	O
aat	B-T170
is	O
a	O
holistic	O
,	O
simple	O
and	O
safe	O
instrument	O
that	O
can	O
be	O
used	O
to	O
estimate	B-T038
age	O
in	O
refuge	B-T098
##e	I-T098
children	O
with	O
results	O
comparable	O
with	O
radiological	B-T091
methods	I-T091
currently	O
used	O
.	O

fu	B-T103
##z	I-T103
##he	I-T103
##ng	I-T103
qi	I-T103
##ng	I-T103
##ji	I-T103
##e	I-T103
granules	I-T103
inhibit	O
growth	B-T038
of	O
hepatoma	O
cells	O
via	O
inducing	O
mitochondria	B-T017
-	O
mediated	O
apoptosis	B-T038
and	O
enhancing	O
immune	B-T038
function	I-T038
fu	B-T103
##z	I-T103
##he	I-T103
##ng	I-T103
qi	I-T103
##ng	I-T103
##ji	I-T103
##e	I-T103
(	B-T103
fz	I-T103
##q	I-T103
##j	I-T103
)	I-T103
granules	I-T103
,	O
a	O
compound	B-T103
chinese	O
medicine	O
,	O
have	O
been	O
used	O
as	O
an	O
adjuvant	B-T058
therapy	I-T058
for	O
ali	B-T022
##ment	I-T022
##ary	I-T022
tract	I-T022
cancers	B-T038
.	O
however	O
,	O
the	O
underlying	O
anticancer	B-T033
mechanisms	O
are	O
still	O
not	O
well	O
understood	O
.	O
in	O
the	O
present	O
study	B-T062
,	O
hepg2	B-T017
cells	I-T017
were	O
treated	O
with	O
fz	B-T103
##q	I-T103
##j	I-T103
-	O
containing	O
serum	B-T031
.	O
cell	B-T038
proliferation	I-T038
was	O
evaluated	B-T058
using	O
mtt	B-T062
assay	I-T062
.	O
apoptosis	B-T038
was	O
analyzed	B-T062
using	O
a	O
flow	B-T074
cyto	I-T074
##meter	I-T074
.	O
cell	O
ultrastructure	O
was	O
observed	O
under	O
a	O
transmission	B-T074
electron	I-T074
microscope	I-T074
.	O
the	O
mitochondrial	B-T038
membrane	I-T038
potential	I-T038
(	O
δ	B-T038
##ψ	I-T038
)	O
was	O
examined	B-T033
with	O
jc	B-T103
-	I-T103
1	I-T103
dye	I-T103
.	O
in	O
h2	B-T038
##2	I-T038
tumor	I-T038
-	I-T038
bearing	I-T038
mice	I-T038
,	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
,	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
,	O
cd3	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
,	O
and	O
natural	B-T017
killer	I-T017
cells	I-T017
(	O
nk	B-T017
)	O
in	O
peripheral	B-T031
blood	I-T031
were	O
evaluated	O
cytometric	B-T074
##ally	I-T074
.	O
interleukin	B-T103
(	I-T103
il	I-T103
)	I-T103
-	I-T103
2	I-T103
and	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
(	B-T103
tnf	I-T103
)	I-T103
-	I-T103
α	I-T103
levels	O
were	O
measured	O
using	O
radioimmunoassay	B-T058
.	O
the	O
mrna	B-T103
levels	O
of	O
bax	B-T017
and	O
bcl	B-T017
-	I-T017
2	I-T017
were	O
examined	B-T033
by	O
reverse	B-T062
transcription	I-T062
-	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
.	O
the	O
protein	B-T103
levels	O
of	O
bax	B-T103
,	O
bcl	B-T103
-	I-T103
2	I-T103
,	O
cytochrome	B-T103
c	I-T103
,	O
caspase	B-T103
3	I-T103
and	O
9	B-T103
,	O
parp	B-T103
,	O
and	O
cd	B-T103
##69	I-T103
were	O
examined	B-T033
by	O
western	B-T058
blotting	I-T058
.	O
the	O
apoptotic	O
cells	B-T017
in	O
tissues	B-T017
were	O
observed	O
using	O
tunel	O
method	O
.	O
alanine	B-T103
transaminase	I-T103
(	O
alt	B-T103
)	O
,	O
aspartate	B-T103
transaminase	I-T103
(	O
ast	B-T103
)	O
,	O
blood	B-T103
urea	I-T103
nitrogen	I-T103
(	O
bun	B-T103
)	O
,	O
and	O
creatinine	B-T103
(	O
cre	B-T103
)	O
were	O
detected	B-T033
by	O
an	O
automatic	O
biochemical	O
analyzer	B-T074
.	O
the	O
results	O
showed	O
that	O
fz	B-T103
##q	I-T103
##j	I-T103
-	O
containing	O
serum	B-T031
remarkably	O
inhibited	O
proliferation	B-T038
of	O
hepg2	B-T017
cells	I-T017
in	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
##s	O
,	O
induced	O
hepg2	B-T017
cell	I-T017
apoptosis	B-T038
and	O
caused	O
a	O
decrease	O
of	O
δ	B-T038
##ψ	I-T038
.	O
analysis	B-T062
of	O
tumor	B-T017
tissue	I-T017
showed	O
that	O
fz	B-T103
##q	I-T103
##j	I-T103
-	O
induced	O
apoptosis	B-T038
was	O
accompanied	O
by	O
downregulation	B-T038
of	O
bcl	B-T103
-	I-T103
2	I-T103
and	O
upregulation	B-T038
of	O
bax	B-T103
,	O
release	O
of	O
cytochrome	B-T103
c	I-T103
,	O
activation	B-T038
of	O
caspase	B-T103
3	I-T103
and	O
9	B-T103
,	O
and	O
cleavage	B-T038
of	O
parp	B-T103
.	O
in	O
addition	O
,	O
fz	B-T103
##q	I-T103
##j	I-T103
increased	O
the	O
percentages	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
and	O
nk	B-T017
cells	I-T017
,	O
the	O
ratio	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
/	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
as	O
well	O
as	O
the	O
levels	O
of	O
serum	B-T031
tnf	B-T103
-	I-T103
α	I-T103
.	O
fz	B-T103
##q	I-T103
##j	I-T103
also	O
increased	O
cd	B-T103
##69	I-T103
expression	B-T038
in	O
tumor	B-T017
tissue	I-T017
.	O
no	B-T033
hepat	I-T033
##ore	I-T033
##nal	I-T033
toxicity	I-T033
was	O
observed	O
in	O
h2	B-T038
##2	I-T038
tumor	I-T038
-	I-T038
bearing	I-T038
mice	I-T038
.	O
these	O
results	O
indicated	B-T033
that	O
fz	B-T103
##q	I-T103
##j	I-T103
could	O
inhibit	O
the	O
growth	B-T038
of	O
hepatoma	O
cells	O
via	O
regulating	O
immune	B-T038
function	I-T038
and	O
inducing	O
mitochondria	B-T017
mediated	O
apoptosis	B-T038
.	O

ph	O
-	O
dependent	O
transmembrane	B-T038
activity	I-T038
of	O
peptide	B-T103
-	O
functionalized	O
gold	B-T103
nanos	I-T103
##ta	I-T103
##rs	I-T103
for	O
computed	B-T058
tomography	I-T058
/	O
photo	B-T058
##acoustic	I-T058
imaging	I-T058
and	O
photothermal	B-T058
therapy	I-T058
progress	O
in	O
multifunctional	O
nanomaterials	O
for	O
tumor	B-T058
therapy	I-T058
mostly	O
depends	O
on	O
the	O
development	O
of	O
tumor	B-T038
-	O
targeting	O
delivery	B-T058
strategies	I-T058
.	O
one	O
approach	O
is	O
to	O
explore	O
a	O
ph	O
-	O
responsive	O
strategy	O
to	O
target	O
the	O
slightly	O
acidic	O
solid	O
tumor	O
microenvironment	O
.	O
a	O
novel	O
class	O
of	O
ph	B-T103
(	I-T103
low	I-T103
)	I-T103
insertion	I-T103
peptides	I-T103
(	O
phl	B-T103
##ips	I-T103
)	O
with	O
ph	O
-	O
dependent	O
transmembrane	B-T038
activity	I-T038
can	O
fold	B-T082
and	O
rapidly	O
insert	O
into	O
the	O
lipid	B-T017
bilayer	I-T017
of	O
tumor	B-T017
cells	I-T017
triggered	O
by	O
acidity	O
,	O
facilitating	O
the	O
cellular	O
internalization	O
of	O
nanomaterials	O
synchronous	O
##ly	O
.	O
here	O
,	O
we	O
innovative	O
##ly	O
decorated	O
gold	B-T103
nanos	I-T103
##ta	I-T103
##rs	I-T103
(	O
gn	B-T103
##ss	I-T103
)	O
with	O
phl	B-T103
##ips	I-T103
(	O
gn	B-T103
##s	I-T103
-	O
phl	B-T103
##ip	I-T103
)	O
to	O
improve	O
their	O
targeting	O
ability	O
and	O
photothermal	B-T058
therapeutic	I-T058
(	O
ptt	B-T058
)	O
efficiency	O
.	O
the	O
obtained	O
gn	B-T103
##s	I-T103
-	O
phl	B-T103
##ip	I-T103
exhibited	O
the	O
excellent	O
characteristics	O
of	O
uniform	O
size	B-T082
and	O
good	O
biocompatibility	O
.	O
as	O
compared	O
to	O
gn	B-T103
##s	I-T103
-	O
mp	B-T103
##eg	I-T103
,	O
the	O
cellular	O
internalization	O
of	O
gn	B-T103
##s	I-T103
-	O
phl	B-T103
##ip	I-T103
was	O
1	O
-	O
fold	O
higher	O
after	O
a	O
2	O
h	O
incubation	O
with	O
cells	B-T017
in	O
media	O
at	O
ph	O
6	O
.	O
4	O
than	O
at	O
ph	O
7	O
.	O
4	O
.	O
moreover	O
,	O
the	O
tumor	B-T038
accumulation	B-T033
of	O
the	O
gn	B-T103
##s	I-T103
-	O
phl	B-T103
##ip	I-T103
was	O
3	O
-	O
fold	O
higher	O
than	O
that	O
of	O
gn	B-T103
##s	I-T103
-	O
mp	B-T103
##eg	I-T103
after	O
intravenous	O
injection	O
into	O
mcf	B-T017
-	I-T017
7	I-T017
breast	B-T038
tumor	I-T038
animal	B-T038
models	I-T038
for	O
24	O
h	O
.	O
furthermore	O
,	O
gn	B-T103
##s	I-T103
-	O
phl	B-T103
##ip	I-T103
exhibited	O
stronger	O
signals	O
than	O
the	O
gn	B-T103
##s	I-T103
-	O
mp	B-T103
##eg	I-T103
through	O
computed	B-T058
tomography	I-T058
(	O
ct	B-T058
)	O
and	O
photo	B-T058
##acoustic	I-T058
(	I-T058
pa	I-T058
)	I-T058
imaging	I-T058
.	O
simultaneously	O
,	O
the	O
desirable	O
targeting	O
efficiency	O
significantly	O
improved	O
the	O
ptt	B-T058
efficacy	O
to	O
tumors	B-T038
,	O
with	O
low	O
side	B-T038
effects	I-T038
on	O
normal	O
tissues	B-T017
.	O
the	O
results	O
clearly	O
demonstrate	O
that	O
the	O
gn	B-T103
##s	I-T103
-	O
phl	B-T103
##ip	I-T103
successfully	O
took	O
advantage	O
of	O
the	O
tumor	B-T038
-	O
targeting	O
ability	O
of	O
phl	B-T103
##ips	I-T103
and	O
the	O
good	O
characteristics	O
of	O
gn	B-T103
##s	I-T103
s	I-T103
,	O
which	O
may	O
contribute	O
to	O
the	O
study	O
of	O
tumor	B-T038
imaging	B-T058
and	O
therapy	B-T058
.	O

nontoxic	O
formulations	O
of	O
scinti	O
##ll	O
##ation	O
nanocrystals	O
for	O
use	O
as	O
x	B-T058
-	I-T058
ray	I-T058
computed	I-T058
tomography	I-T058
contrast	B-T103
agents	I-T103
x	B-T058
-	I-T058
ray	I-T058
computed	I-T058
tomography	I-T058
(	O
ct	B-T058
)	O
is	O
currently	O
one	O
of	O
the	O
most	O
powerful	O
,	O
noninvasive	B-T170
,	O
clinical	O
in	B-T082
vivo	I-T082
imaging	B-T058
techniques	I-T058
,	O
which	O
has	O
resulted	O
from	O
advances	O
in	O
both	O
x	B-T074
-	I-T074
ray	I-T074
device	I-T074
and	O
contrast	O
enhancement	B-T058
technologies	I-T058
.	O
the	O
present	O
study	B-T062
demonstrates	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
metal	B-T103
tungst	I-T103
##ates	I-T103
(	O
such	O
as	O
ca	B-T103
##w	I-T103
##o4	I-T103
)	O
are	O
promising	O
contrast	B-T103
agents	I-T103
for	O
x	B-T058
-	I-T058
ray	I-T058
,	O
radiation	O
,	O
and	O
ct	B-T058
imaging	I-T058
,	O
because	O
of	O
the	O
high	O
x	B-T058
-	I-T058
ray	I-T058
mass	O
attenuation	O
of	O
tungsten	B-T103
(	O
w	B-T103
)	O
.	O
we	O
have	O
developed	O
a	O
method	O
of	O
formulation	O
,	O
in	O
which	O
ca	B-T103
##w	I-T103
##o4	I-T103
(	O
cw	B-T103
##o	I-T103
)	O
nanoparticles	O
(	O
nps	O
)	O
are	O
encapsulated	O
within	O
a	O
biocompatible	O
poly	B-T103
(	I-T103
ethylene	I-T103
glycol	I-T103
-	I-T103
b	I-T103
-	I-T103
d	I-T103
,	I-T103
l	I-T103
-	I-T103
lactic	I-T103
acid	I-T103
)	I-T103
(	I-T103
peg	I-T103
-	I-T103
pla	I-T103
)	I-T103
block	I-T103
copolymer	I-T103
(	I-T103
bcp	I-T103
)	I-T103
capsule	I-T103
.	O
we	O
show	O
that	O
these	O
peg	B-T103
-	I-T103
pla	I-T103
-	O
encapsulated	O
cw	O
##o	O
nps	O
(	O
170	O
±	O
10	O
nm	O
hydrodynamic	O
diameter	O
)	O
produce	O
a	O
higher	O
ct	B-T058
contrast	O
(	O
by	O
a	O
factor	O
of	O
about	O
2	O
)	O
than	O
commercial	O
iodine	B-T103
-	O
based	O
radio	B-T103
##con	I-T103
##trast	I-T103
agents	I-T103
(	O
e	O
.	O
g	O
.	O
,	O
io	B-T103
##hex	I-T103
##ol	I-T103
)	O
at	O
identical	O
molar	O
concentrations	O
of	O
w	B-T103
or	O
i	B-T103
atoms	B-T103
.	O
peg	B-T103
-	I-T103
pla	I-T103
-	O
coated	O
cw	O
##o	O
nps	O
are	O
chemically	O
stable	O
and	O
completely	O
nontoxic	O
.	O
it	O
was	O
confirmed	O
that	O
the	O
maximum	O
tolerated	O
dose	O
(	O
mtd	O
)	O
of	O
this	O
material	O
in	O
mice	B-T204
is	O
significantly	O
higher	O
(	O
250	O
±	O
50	O
mg	O
per	O
kg	O
body	O
weight	O
following	O
a	O
single	O
intravenous	B-T082
(	I-T082
iv	I-T082
)	I-T082
administration	I-T082
)	O
than	O
,	O
for	O
instance	O
,	O
commercially	O
available	O
dextran	B-T103
-	O
coated	O
iron	B-T103
oxide	I-T103
nanoparticles	O
that	O
are	O
currently	O
used	O
clinically	O
as	O
mri	B-T058
contrast	B-T103
agents	I-T103
(	O
mtd	O
in	O
mice	B-T204
≈	O
168	O
mg	O
/	O
kg	O
per	O
dose	O
iv	O
)	O
.	O
iv	O
-	O
injected	O
peg	B-T103
-	I-T103
pla	I-T103
/	O
cw	O
##o	O
nps	O
caused	O
no	B-T033
histopathologic	B-T091
damage	O
in	O
major	O
excretory	B-T017
organs	I-T017
(	O
heart	B-T017
,	O
liver	B-T017
,	O
lungs	B-T017
,	O
spleen	B-T017
,	O
and	O
kidney	B-T017
)	O
.	O
when	O
an	O
iv	O
dose	O
of	O
100	O
mg	O
/	O
kg	O
was	O
given	O
to	O
mice	B-T204
,	O
the	O
blood	B-T038
circulation	I-T038
half	O
-	O
life	O
was	O
measured	O
to	O
be	O
about	O
4	O
h	O
,	O
and	O
more	O
than	O
90	O
%	O
of	O
the	O
nps	O
were	O
cleared	O
from	O
the	O
mice	B-T204
within	O
24	O
h	O
via	O
the	O
renal	B-T017
and	O
hepatobiliary	B-T022
systems	I-T022
.	O
when	O
intratumoral	O
##ly	O
administered	O
,	O
peg	B-T103
-	I-T103
pla	I-T103
-	O
coated	O
cw	O
##o	O
nps	O
showed	O
complete	O
retention	O
in	O
a	O
tumor	B-T038
-	I-T038
bearing	I-T038
mouse	I-T038
model	I-T038
(	O
measurements	O
were	O
made	O
up	O
to	O
1	O
week	O
)	O
.	O
these	O
results	O
suggest	O
that	O
peg	B-T103
-	I-T103
pla	I-T103
-	O
coated	O
cw	O
##o	O
nps	O
are	O
promising	O
materials	O
for	O
use	O
in	O
ct	B-T058
contrast	O
.	O

chlamydia	B-T007
pneumoniae	I-T007
infection	B-T038
promotes	O
vascular	B-T017
endothelial	I-T017
cell	I-T017
angiogenesis	B-T038
through	O
an	O
iq	B-T103
##gap	I-T103
##1	I-T103
-	O
related	O
signaling	B-T038
pathway	I-T038
chlamydia	B-T007
pneumoniae	I-T007
(	O
c	B-T007
.	I-T007
pneumoniae	I-T007
)	O
infection	B-T038
plays	O
a	O
potential	O
role	O
in	O
angiogenesis	B-T038
.	O
however	O
,	O
it	O
is	O
still	O
an	O
en	O
##igm	O
##a	O
how	O
c	B-T007
.	I-T007
pneumoniae	I-T007
is	O
involved	O
in	O
this	O
process	O
.	O
therefore	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
on	O
angiogenesis	B-T038
,	O
and	O
then	O
explored	O
the	O
roles	O
of	O
iq	B-T103
##gap	I-T103
##1	I-T103
-	O
related	O
signaling	B-T038
in	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
-	O
induced	O
angiogenesis	B-T038
.	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
significantly	O
enhanced	O
angiogenesis	B-T038
as	O
assessed	O
by	O
the	O
tube	B-T058
formation	I-T058
assay	I-T058
possibly	B-T033
by	O
inducing	O
vascular	B-T017
endothelial	I-T017
cell	I-T017
(	O
vec	B-T017
)	O
migration	O
in	O
the	O
wound	B-T038
healing	I-T038
and	O
transwell	B-T058
migration	I-T058
assays	I-T058
.	O
subsequently	O
,	O
immunoprecipitation	B-T058
,	O
western	B-T058
blot	I-T058
and	O
tube	B-T058
formation	I-T058
assay	I-T058
results	O
showed	O
that	O
the	O
phosphorylation	B-T038
of	O
both	O
iq	B-T103
##gap	I-T103
##1	I-T103
and	O
n	B-T103
-	I-T103
wasp	I-T103
was	O
required	O
for	O
the	O
angiogenesis	B-T038
induced	O
by	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
.	O
our	O
co	B-T058
-	I-T058
immunoprecipitation	I-T058
study	B-T058
revealed	O
that	O
iq	B-T103
##gap	I-T103
##1	I-T103
physically	O
associated	O
with	O
n	B-T103
-	I-T103
wasp	I-T103
after	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
of	O
vec	B-T017
##s	I-T017
.	O
actin	B-T038
polymerization	I-T038
assay	B-T058
further	O
showed	O
that	O
in	O
c	B-T007
.	I-T007
pneumoniae	I-T007
-	O
infected	B-T033
vec	B-T017
##s	I-T017
,	O
both	O
iq	B-T103
##gap	I-T103
##1	I-T103
and	O
n	B-T103
-	I-T103
wasp	I-T103
were	O
recruited	O
to	O
filamentous	B-T103
actin	I-T103
,	O
and	O
shared	O
some	O
common	O
compartments	O
localized	B-T082
at	O
the	O
leading	B-T017
edge	I-T017
of	O
lam	B-T017
##ell	I-T017
##ip	I-T017
##odia	I-T017
,	O
which	O
was	O
impaired	O
after	O
the	O
depletion	O
of	O
iq	B-T103
##gap	I-T103
##1	I-T103
by	O
using	O
the	O
small	B-T103
interference	I-T103
rna	I-T103
.	O
moreover	O
,	O
the	O
knockdown	B-T062
of	O
iq	B-T017
##gap	I-T017
##1	I-T017
also	O
significantly	O
decreased	O
n	B-T103
-	I-T103
wasp	I-T103
phosphorylation	B-T038
at	O
tyr	B-T103
##25	I-T103
##6	I-T103
induced	O
by	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
.	O
we	O
conclude	O
that	O
c	B-T007
.	I-T007
pneumoniae	I-T007
infection	B-T038
promotes	O
vec	B-T017
migration	O
and	O
angiogenesis	B-T038
presumably	O
through	O
the	O
iq	B-T103
##gap	I-T103
##1	I-T103
-	O
related	O
signaling	B-T038
pathway	I-T038
.	O

epigen	B-T062
##ome	I-T062
-	I-T062
wide	I-T062
analysis	I-T062
links	O
smad3	B-T017
methylation	B-T038
at	O
birth	B-T038
to	O
asthma	B-T038
in	I-T038
children	I-T038
of	O
asthmatic	B-T038
mothers	O
the	O
timing	O
and	O
mechanisms	O
of	O
asthma	B-T038
inception	O
remain	O
imprec	O
##isely	O
defined	O
.	O
although	O
epigenetic	B-T038
mechanisms	O
likely	O
contribute	O
to	O
asthma	B-T038
pathogenesis	B-T038
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
asthma	B-T038
inception	O
.	O
we	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	B-T038
begins	O
already	O
at	O
birth	B-T038
and	O
whether	O
epigenetic	B-T038
mechanisms	O
,	O
specifically	O
dna	B-T038
methylation	I-T038
,	O
contribute	O
to	O
asthma	B-T038
inception	O
.	O
we	O
used	O
the	O
methylated	B-T058
cpg	I-T058
island	I-T058
recovery	I-T058
assay	I-T058
chip	I-T058
to	O
survey	B-T170
dna	B-T038
methylation	I-T038
in	O
cord	B-T031
blood	I-T031
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
non	B-T098
##asth	I-T098
##matic	I-T098
and	O
18	O
asthmatic	B-T038
subjects	B-T098
by	O
age	O
9	O
years	O
)	O
from	O
the	O
infant	O
immune	O
study	B-T062
(	O
ii	B-T062
##s	I-T062
)	O
,	O
an	O
unselected	O
birth	B-T038
cohort	B-T098
closely	O
monitored	O
for	O
asthma	B-T038
for	O
a	O
decade	O
.	O
smad3	B-T017
methylation	B-T038
in	O
ii	B-T062
##s	I-T062
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	B-T038
cohorts	B-T098
(	O
the	O
man	O
##ches	O
##ter	O
asthma	B-T038
and	O
allergy	O
study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
childhood	B-T038
origins	I-T038
of	I-T038
asthma	I-T038
study	B-T062
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	B-T062
by	O
using	O
bis	B-T062
##ulf	I-T062
##ite	I-T062
sequencing	I-T062
or	O
illumina	B-T058
450	I-T058
##k	I-T058
arrays	I-T058
.	O
cord	B-T031
blood	I-T031
mononuclear	O
cell	O
-	O
derived	O
il	B-T103
-	I-T103
1β	I-T103
levels	O
were	O
measured	O
by	O
means	O
of	O
elisa	B-T058
.	O
neonatal	O
immune	O
cells	B-T017
harbored	O
58	O
##9	O
differentially	O
methylated	B-T082
regions	I-T082
that	O
distinguished	O
ii	B-T062
##s	I-T062
children	B-T098
who	O
did	O
and	O
did	O
not	O
have	O
asthma	B-T038
by	O
age	O
9	O
years	O
.	O
in	O
all	O
3	O
cohorts	B-T098
methylation	B-T038
in	O
smad3	B-T017
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	B-T038
-	O
associated	O
,	O
differentially	O
methylated	B-T082
regions	I-T082
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	B-T038
children	O
of	O
asthmatic	B-T038
mothers	O
and	O
was	O
associated	O
with	O
childhood	B-T038
asthma	I-T038
risk	O
.	O
moreover	O
,	O
smad3	B-T017
methylation	B-T038
in	O
ii	B-T062
##s	I-T062
neonates	O
with	O
maternal	O
asthma	B-T038
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
il	B-T103
-	I-T103
1β	I-T103
,	O
an	O
innate	B-T103
inflammatory	I-T103
mediator	I-T103
.	O
the	O
trajectory	O
to	O
childhood	B-T038
asthma	I-T038
begins	O
at	O
birth	B-T038
and	O
involves	O
epigenetic	B-T038
modifications	O
in	O
immunoregulatory	B-T038
and	O
proinflammatory	O
pathways	B-T038
.	O
maternal	O
asthma	B-T038
influences	O
epigenetic	B-T038
mechanisms	O
that	O
contribute	O
to	O
the	O
inception	O
of	O
this	O
trajectory	O
.	O

the	O
effects	O
of	O
paternal	O
high	B-T168
-	I-T168
fat	I-T168
diet	I-T168
exposure	O
on	O
offspring	O
metabolism	B-T038
with	O
epigenetic	B-T038
changes	I-T038
in	O
the	O
mouse	O
adiponectin	B-T017
and	O
leptin	B-T017
gene	B-T017
promoters	I-T017
recent	O
studies	B-T062
have	O
demonstrated	O
that	O
epigenetic	B-T038
changes	I-T038
resulting	O
from	O
malnutrition	B-T038
might	O
play	O
important	O
roles	O
in	O
transgene	O
##ra	O
##tion	O
##al	O
links	O
with	O
metabolic	B-T038
diseases	I-T038
.	O
previously	O
,	O
we	O
observed	O
that	O
exposure	O
to	O
a	O
high	B-T168
-	I-T168
fat	I-T168
diet	I-T168
(	O
hfd	B-T168
)	O
in	O
utero	O
caused	O
a	O
metabolic	O
syndrome	B-T038
-	O
like	O
phenomenon	O
through	O
epigenetic	B-T038
modifications	I-T038
of	O
the	O
adiponectin	B-T017
and	O
leptin	B-T017
genes	I-T017
that	O
persisted	O
for	O
multiple	O
generations	O
.	O
recent	O
etiological	O
studies	B-T062
indicated	B-T033
that	O
paternal	O
bmi	B-T201
had	O
effects	O
on	O
offspring	O
bmi	B-T201
that	O
were	O
independent	O
of	O
but	O
additive	O
to	O
maternal	B-T033
bmi	B-T201
effects	O
.	O
thus	O
,	O
we	O
examined	O
whether	O
paternal	O
hfd	B-T168
-	O
induced	O
obesity	B-T038
affected	O
the	O
metabolic	O
status	O
of	O
offspring	O
through	O
epigenetic	B-T038
changes	I-T038
in	O
the	O
adiponectin	B-T017
and	O
leptin	B-T017
genes	I-T017
.	O
additionally	O
,	O
we	O
investigated	O
whether	O
a	O
normal	O
diet	O
during	O
subsequent	O
generations	O
abolished	O
the	O
epigenetic	B-T038
changes	I-T038
associated	O
with	O
paternal	O
hfd	B-T168
exposure	O
before	O
conception	B-T038
.	O
we	O
observed	O
the	O
effects	O
of	O
paternal	O
hfd	B-T168
exposure	O
before	O
conception	B-T038
over	O
multiple	O
generations	O
on	O
offspring	O
metabolic	O
traits	O
,	O
including	O
weight	B-T033
and	O
fat	B-T103
gain	O
,	O
glucose	B-T038
intolerance	I-T038
,	O
hypertriglyceridemia	B-T038
,	O
abnormal	B-T103
adip	I-T103
##ocyt	I-T103
##okine	I-T103
levels	O
,	O
hypertension	B-T038
,	O
and	O
adiponectin	B-T017
and	O
leptin	B-T017
gene	I-T017
expression	B-T038
and	O
epigenetic	B-T038
changes	I-T038
.	O
normal	O
diet	O
consumption	O
by	O
male	O
offspring	O
during	O
the	O
subsequent	O
generation	O
following	O
paternal	O
hfd	B-T168
exposure	O
diminished	O
whereas	O
consumption	O
for	O
two	O
generations	O
completely	O
abolished	O
the	O
effect	O
of	O
paternal	O
hfd	B-T168
exposure	O
on	O
metabolic	O
traits	O
and	O
adip	B-T103
##ocyt	I-T103
##okine	I-T103
promoter	O
epigenetic	B-T038
changes	I-T038
in	O
the	O
offspring	O
.	O
the	O
effects	O
of	O
paternal	O
hfd	B-T168
exposure	O
on	O
offspring	O
were	O
relatively	O
weaker	O
than	O
those	O
following	O
hfd	B-T168
exposure	O
in	O
utero	O
.	O
however	O
,	O
paternal	O
hfd	B-T168
exposure	O
had	O
an	O
additive	O
metabolic	O
effect	O
for	O
two	O
generations	O
,	O
suggesting	O
that	O
both	O
paternal	O
and	O
maternal	B-T033
nutrition	B-T038
might	O
affect	O
offspring	O
metabolism	B-T038
through	O
epigenetic	B-T038
modifications	I-T038
of	O
adip	B-T017
##ocyt	I-T017
##okine	I-T017
genes	I-T017
for	O
multiple	O
generations	O
.	O

growth	B-T103
differentiation	I-T103
factor	I-T103
15	I-T103
is	O
a	O
myo	B-T103
##mit	I-T103
##okine	I-T103
governing	B-T038
systemic	I-T038
energy	I-T038
homeostasis	I-T038
reduced	O
mitochondrial	B-T017
electron	I-T017
transport	I-T017
chain	I-T017
activity	O
promotes	O
longevity	O
and	O
improves	B-T033
energy	B-T038
homeostasis	I-T038
via	O
cell	B-T038
-	I-T038
autonomous	I-T038
and	O
-	O
non	B-T038
-	I-T038
autonomous	I-T038
factors	I-T038
in	O
multiple	O
model	O
systems	O
.	O
this	O
mit	B-T038
##oh	I-T038
##orm	I-T038
##etic	I-T038
effect	O
is	O
thought	O
to	O
involve	O
the	O
mitochondrial	B-T038
unfolded	I-T038
protein	I-T038
response	I-T038
(	O
upr	B-T038
(	I-T038
mt	I-T038
)	I-T038
)	O
,	O
an	O
adaptive	B-T038
stress	I-T038
-	I-T038
response	I-T038
pathway	O
activated	O
by	O
mitochondrial	B-T017
prote	B-T038
##otoxic	I-T038
stress	I-T038
.	O
using	O
mice	B-T204
with	O
skeletal	B-T017
muscle	I-T017
-	I-T017
specific	I-T017
deficiency	O
of	O
cri	B-T103
##f1	I-T103
(	O
muscle	B-T017
-	I-T017
specific	I-T017
knockout	B-T204
[	O
mk	B-T204
##o	I-T204
]	O
)	O
,	O
an	O
integral	B-T103
protein	I-T103
of	O
the	O
large	B-T017
mit	I-T017
##ori	I-T017
##bos	I-T017
##omal	I-T017
subunit	I-T017
(	O
39	B-T017
##s	I-T017
)	O
,	O
we	O
identified	O
growth	B-T103
differentiation	I-T103
factor	I-T103
15	I-T103
(	O
gdf	B-T103
##15	I-T103
)	O
as	O
a	O
upr	B-T038
(	I-T038
mt	I-T038
)	I-T038
-	O
associated	O
cell	B-T038
-	I-T038
non	I-T038
-	I-T038
autonomous	I-T038
myo	B-T103
##mit	I-T103
##okine	I-T103
that	O
regulates	B-T038
systemic	I-T038
energy	I-T038
homeostasis	I-T038
.	O
mk	B-T204
##o	I-T204
mice	I-T204
were	O
protected	O
against	O
obesity	B-T038
and	O
sensitized	B-T038
to	O
insulin	B-T103
,	O
an	O
effect	O
associated	O
with	O
elevated	O
gdf	B-T103
##15	I-T103
secretion	B-T038
after	O
upr	B-T038
(	I-T038
mt	I-T038
)	I-T038
activation	O
.	O
in	O
ob	B-T204
/	I-T204
ob	I-T204
mice	I-T204
,	O
administration	O
of	O
recombinant	B-T103
gdf	B-T103
##15	I-T103
decreased	O
body	O
weight	O
and	O
improved	B-T033
insulin	B-T038
sensitivity	I-T038
,	O
which	O
was	O
attributed	O
to	O
elevated	O
oxidative	B-T038
metabolism	I-T038
and	O
lipid	B-T038
mobilization	I-T038
in	O
the	O
liver	B-T017
,	O
muscle	B-T017
,	O
and	O
adipose	B-T017
tissue	I-T017
.	O
thus	O
,	O
gdf	B-T103
##15	I-T103
is	O
a	O
potent	O
mit	B-T038
##oh	I-T038
##orm	I-T038
##etic	I-T038
signal	B-T038
that	O
safe	O
##gu	O
##ards	O
against	O
the	O
onset	B-T033
of	I-T033
obesity	I-T033
and	O
insulin	B-T038
resistance	I-T038
.	O

perioperative	B-T058
management	I-T058
of	O
severe	B-T033
hypertension	I-T033
during	O
laparoscopic	B-T058
surgery	I-T058
for	O
pheochromocytoma	B-T038
pha	B-T038
##e	I-T038
##ochrom	I-T038
##ocytoma	I-T038
is	O
a	O
catecholamine	B-T038
-	I-T038
secreting	I-T038
vascular	B-T038
tumour	I-T038
that	O
is	O
derived	O
from	O
chromaffin	B-T017
cell	I-T017
.	O
lethal	B-T033
cardiovascular	B-T038
complications	I-T038
,	O
such	O
as	O
serious	O
hypertension	B-T038
,	O
myocardial	B-T038
infarction	I-T038
and	O
aortic	B-T038
dissection	I-T038
,	O
may	O
occur	O
because	O
of	O
uncontrolled	B-T038
catecholamine	I-T038
release	I-T038
.	O
each	O
stage	O
of	O
anaesthesia	B-T058
management	I-T058
has	O
vital	O
importance	O
because	O
of	O
this	O
destructive	B-T038
catecholamine	I-T038
secretion	I-T038
that	O
may	O
occur	O
during	O
induction	B-T058
,	O
perioperative	O
stage	O
and	O
surgical	B-T058
manipulation	I-T058
.	O
in	O
this	O
study	O
,	O
we	O
report	O
regarding	O
the	O
preoperative	B-T058
preparation	I-T058
and	O
severe	O
,	O
persistent	O
hypertension	O
attack	O
management	O
with	O
a	O
combination	O
of	O
α	B-T103
-	I-T103
adrenergic	I-T103
blockade	I-T103
,	O
β	B-T103
-	I-T103
adrenergic	I-T103
blockade	I-T103
,	O
sodium	B-T103
nitroprusside	I-T103
and	O
remifentanil	B-T103
in	O
a	O
patient	O
who	O
underwent	O
laparoscopic	B-T058
surgery	I-T058
for	O
pha	B-T038
##e	I-T038
##ochrom	I-T038
##ocytoma	I-T038
.	O

cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
protects	O
against	O
pressure	O
overload	O
induced	O
cardiac	B-T038
hypertrophy	I-T038
lack	O
of	O
effective	O
anti	B-T103
-	I-T103
cardiac	I-T103
hypertrophy	I-T103
drugs	I-T103
creates	O
a	O
major	O
cause	O
for	O
the	O
increasing	O
prevalence	O
of	O
heart	B-T038
failure	I-T038
.	O
in	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
anti	B-T033
-	I-T033
hypertrophy	I-T033
and	O
anti	B-T033
-	I-T033
fibrosis	I-T033
potential	O
of	O
a	O
natural	B-T204
plant	I-T204
triterp	B-T103
##enoid	I-T103
,	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
aortic	B-T058
banding	I-T058
(	O
ab	B-T058
)	O
was	O
performed	O
to	O
induce	O
cardiac	B-T038
hypertrophy	I-T038
.	O
after	O
1	O
week	O
of	O
surgery	B-T058
,	O
mice	B-T204
were	O
receive	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
treatment	B-T058
(	O
gavage	O
,	O
0	O
.	O
2	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
2	O
day	O
)	O
.	O
after	O
4	O
weeks	O
of	O
ab	B-T058
,	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
demonstrated	O
a	O
strong	O
anti	B-T033
-	I-T033
hypertrophy	I-T033
and	O
-	B-T033
fibrosis	I-T033
ability	O
as	O
evidenced	O
by	O
decreased	O
of	O
heart	B-T017
weight	O
,	O
myocardial	B-T017
cell	I-T017
cross	O
-	O
sectional	O
area	O
and	O
interstitial	B-T038
fibrosis	I-T038
,	O
ameliorated	O
of	O
systolic	O
and	O
diastolic	B-T201
abnormalities	B-T033
,	O
normalized	O
in	O
gene	B-T038
expression	I-T038
of	O
hypertrophic	B-T038
and	O
fibrotic	O
markers	B-T201
,	O
reserved	O
microvascular	O
density	O
in	O
pressure	O
overload	O
induced	O
hypertrophic	B-T038
mice	B-T204
.	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
also	O
showed	O
significant	O
hypertrophy	B-T038
inhibitory	B-T033
effect	I-T033
in	O
phenylephrine	B-T103
stimulated	O
cardiomyocytes	B-T017
.	O
the	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
-	O
mediated	O
mitigated	O
cardiac	B-T038
hypertrophy	I-T038
was	O
attributable	O
to	O
the	O
increasing	O
level	O
of	O
autophagy	B-T038
,	O
which	O
was	O
associated	O
with	O
the	O
blockade	O
of	O
akt	B-T103
/	O
mtor	B-T103
/	O
fox	B-T103
##o3	I-T103
##a	I-T103
signal	B-T038
pathway	I-T038
,	O
validated	O
by	O
sc	B-T103
##79	I-T103
,	O
mk	B-T103
##22	I-T103
##06	I-T103
,	O
and	O
3	B-T103
-	I-T103
ma	I-T103
,	O
the	O
akt	B-T103
agonist	B-T103
,	O
inhibitor	B-T103
and	O
autophagy	B-T038
inhibitor	B-T103
in	O
vitro	O
.	O
the	O
overexpression	B-T038
of	O
constitutively	O
active	O
akt	B-T103
completely	O
abolished	O
the	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
-	O
mediated	O
protection	O
of	O
cardiac	B-T038
hypertrophy	I-T038
in	O
human	B-T204
cardiomyocytes	B-T017
ac	I-T017
##16	I-T017
.	O
collectively	O
,	O
our	O
findings	O
suggest	O
that	O
cuc	B-T103
##urb	I-T103
##ita	I-T103
##cin	I-T103
b	I-T103
protects	O
against	O
cardiac	B-T038
hypertrophy	I-T038
through	O
increasing	O
the	O
autophagy	B-T038
level	O
in	O
cardiomyocytes	B-T017
,	O
which	O
is	O
associated	O
with	O
the	O
inhibition	B-T038
of	O
akt	B-T103
/	O
mtor	B-T103
/	O
fox	B-T103
##o3	I-T103
##a	I-T103
signal	B-T038
axis	I-T038
.	O
j	O
.	O
cell	O
.	O
biochem	O
.	O
999	O
##9	O
:	O
1	O
-	O
12	O
,	O
2017	O
.	O
©	O
2017	O
wiley	O
periodicals	O
,	O
inc	O
.	O

extracellular	B-T017
vesicles	I-T017
from	O
bone	B-T017
marrow	I-T017
derived	O
mesenchymal	B-T017
stem	I-T017
cells	I-T017
protect	O
against	O
murine	B-T204
hepatic	B-T037
ischemia	I-T037
-	I-T037
reperfusion	B-T037
injury	I-T037
hepatic	B-T037
ischemia	I-T037
-	I-T037
reperfusion	I-T037
injury	I-T037
(	O
iri	B-T037
)	O
and	O
associated	B-T038
inflammation	I-T038
contributes	O
to	O
liver	B-T038
dysfunction	I-T038
and	O
complications	B-T038
after	O
liver	B-T058
surgery	I-T058
and	O
transplantation	B-T058
.	O
mesenchymal	B-T017
stem	I-T017
cells	I-T017
(	O
msc	B-T017
)	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	B-T037
iri	I-T037
because	O
of	O
their	O
rep	O
##arative	O
immunomodulatory	B-T103
effects	O
in	O
injured	O
tissues	B-T017
.	O
recent	O
studies	O
have	O
highlighted	O
beneficial	O
effects	O
of	O
extracellular	B-T017
vesicles	I-T017
from	O
mscs	B-T017
(	O
msc	B-T017
-	O
ev	B-T017
)	O
on	O
tissue	O
injury	O
.	O
the	O
effects	O
of	O
systemically	O
administered	O
mouse	B-T017
bone	I-T017
marrow	I-T017
derived	O
msc	B-T017
-	O
ev	B-T017
were	O
evaluated	O
in	O
an	O
experimental	B-T204
murine	I-T204
model	I-T204
of	O
hepatic	B-T037
iri	I-T037
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	B-T017
artery	I-T017
and	O
portal	B-T017
vein	I-T017
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	B-T058
for	O
periods	O
of	O
up	O
##to	O
6	O
hours	O
.	O
compared	O
with	O
controls	B-T082
,	I-T082
intravenous	I-T082
administration	I-T082
of	O
msc	B-T017
-	O
ev	B-T017
30	O
minutes	O
prior	O
to	O
iri	B-T037
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	B-T038
necrosis	I-T038
,	O
decreased	O
caspase	B-T103
-	I-T103
3	I-T103
positive	I-T103
and	O
apoptotic	B-T017
cells	I-T017
,	O
and	O
reduced	O
serum	O
aminotransferase	B-T103
levels	O
.	O
msc	B-T017
-	O
ev	B-T017
increased	O
hepatic	B-T082
mrna	B-T038
expression	I-T038
of	O
nach	B-T017
##t	I-T017
,	I-T017
lrr	I-T017
and	I-T017
py	I-T017
##d	I-T017
domains	I-T017
-	I-T017
containing	I-T017
protein	I-T017
12	I-T017
(	O
nlr	B-T017
##p1	I-T017
##2	I-T017
)	O
,	O
and	O
the	O
chemokine	B-T017
(	I-T017
c	I-T017
-	I-T017
x	I-T017
-	I-T017
c	I-T017
motif	I-T017
)	I-T017
ligand	I-T017
1	I-T017
(	O
cxcl	B-T017
##1	I-T017
)	O
,	O
and	O
reduced	O
mrna	B-T038
expression	I-T038
of	O
several	O
inflammatory	O
cytokines	B-T103
such	O
as	O
il	B-T103
-	I-T103
6	I-T103
during	O
iri	B-T037
.	O
msc	B-T017
-	O
ev	B-T017
increased	O
cell	B-T038
viability	I-T038
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
nf	B-T103
-	I-T103
κb	I-T103
activity	O
in	O
aml	B-T017
##12	I-T017
murine	I-T017
hepatocytes	I-T017
in	O
vitro	O
.	O
in	O
conclusion	O
,	O
the	O
administration	B-T058
of	O
ev	B-T017
derived	O
from	O
bone	B-T017
marrow	I-T017
derived	O
mscs	B-T017
may	O
ameliorate	B-T033
hepatic	B-T037
iri	I-T037
by	O
reducing	O
hepatic	B-T037
injury	I-T037
through	O
modulation	B-T082
of	O
the	O
inflammatory	B-T038
response	I-T038
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

investigation	O
of	O
arg	B-T017
##yro	I-T017
##phi	I-T017
##lic	I-T017
nucleolar	B-T017
organizing	I-T017
region	I-T017
ischemia	B-T037
/	I-T037
reperfusion	I-T037
(	I-T037
i	I-T037
/	I-T037
r	I-T037
)	I-T037
injury	I-T037
is	O
a	O
complex	O
event	O
frequently	O
observed	O
in	O
vascular	B-T058
surgery	I-T058
and	O
can	O
cause	O
functional	B-T038
and	O
structural	B-T017
cell	O
damage	O
.	O
nucleolar	B-T017
-	I-T017
organizing	I-T017
regions	I-T017
(	O
nor	B-T017
##s	I-T017
)	O
are	O
sites	B-T082
of	O
the	O
ribosomal	B-T017
genes	I-T017
located	O
on	O
chromosomes	B-T017
and	O
can	O
be	O
stained	B-T058
with	O
silver	B-T103
when	O
they	O
are	O
active	O
.	O
thus	O
these	O
proteins	B-T103
are	O
named	O
as	O
arg	B-T103
##yro	I-T103
##phi	I-T103
##lic	I-T103
-	I-T103
nor	I-T103
(	I-T103
agn	I-T103
##or	I-T103
)	I-T103
-	I-T103
associated	I-T103
proteins	I-T103
.	O
we	O
aimed	O
to	O
investigate	O
any	O
possible	O
effects	O
of	O
renal	B-T017
i	B-T037
/	I-T037
r	I-T037
injury	I-T037
on	O
the	O
nor	B-T103
protein	I-T103
synthesis	B-T038
and	O
association	O
between	O
the	O
agn	B-T103
##or	I-T103
proteins	I-T103
amount	O
and	O
histopathological	B-T033
injur	I-T033
##ing	I-T033
score	I-T033
.	O
nine	O
female	O
wistar	B-T204
-	I-T204
albino	I-T204
rats	I-T204
with	O
weight	O
of	O
200	O
-	O
250	O
##g	O
were	O
included	O
into	O
the	O
study	O
.	O
the	O
animals	B-T204
were	O
randomly	O
divided	O
in	O
two	O
groups	O
,	O
a	O
control	O
group	O
and	O
an	O
i	B-T037
/	I-T037
r	I-T037
group	O
.	O
in	O
i	B-T037
/	I-T037
r	I-T037
group	O
,	O
rats	B-T204
were	O
subjected	O
to	O
45	O
minutes	O
of	O
renal	B-T017
pedicle	I-T017
occlusion	B-T038
followed	O
by	O
24	O
hours	O
of	O
reperfusion	B-T038
.	O
in	O
the	O
control	O
group	O
no	O
drug	B-T058
injections	I-T058
or	O
ischemia	B-T037
reperfusion	I-T037
were	O
performed	O
in	O
animals	B-T204
.	O
then	O
histopathological	B-T033
injury	I-T033
score	I-T033
,	O
mean	B-T033
agn	I-T033
##or	I-T033
number	I-T033
and	O
total	B-T033
agn	I-T033
##or	I-T033
area	I-T033
/	O
nuclear	B-T033
area	I-T033
(	O
taa	B-T033
/	O
na	B-T033
)	O
were	O
detected	B-T033
for	O
each	O
rat	B-T204
.	O
the	O
differences	O
between	O
control	O
and	O
i	B-T037
/	I-T037
r	I-T037
groups	O
were	O
significant	O
for	O
histopathological	B-T033
injury	I-T033
scores	I-T033
(	O
p	O
=	O
0	O
.	O
016	O
)	O
.	O
also	O
the	O
differences	O
between	O
control	O
group	O
and	O
i	B-T037
/	I-T037
r	I-T037
group	O
were	O
significant	O
for	O
mean	B-T033
agn	I-T033
##or	I-T033
number	I-T033
(	O
p	O
=	O
0	O
.	O
000	O
)	O
and	O
taa	O
/	O
na	O
ratio	O
(	O
p	O
=	O
0	O
.	O
000	O
)	O
.	O
additionally	O
,	O
there	O
was	O
a	O
positive	O
correlation	O
between	O
taa	O
/	O
na	O
ratio	O
and	O
histopathological	B-T033
injury	I-T033
score	I-T033
(	O
r	O
=	O
0	O
.	O
72	O
##8	O
;	O
p	O
=	O
0	O
.	O
026	O
)	O
and	O
between	O
mean	B-T033
agn	I-T033
##or	I-T033
number	I-T033
and	O
histopathological	B-T033
injury	I-T033
score	I-T033
(	O
r	O
=	O
0	O
.	O
67	O
##0	O
;	O
p	O
=	O
0	O
.	O
048	O
)	O
.	O
the	O
detection	B-T058
of	O
agn	B-T103
##or	I-T103
proteins	I-T103
amount	O
may	O
be	O
used	O
as	O
an	O
indicator	O
to	O
obtain	O
information	O
about	O
the	O
cellular	B-T038
behaviour	I-T038
(	O
self	B-T038
-	I-T038
protective	I-T038
mechanism	O
of	O
tubular	B-T017
epithelial	I-T017
cells	I-T017
)	O
against	O
i	B-T037
/	I-T037
r	I-T037
injury	I-T037
and	O
cellular	O
damage	O
levels	O
(	O
tab	O
.	O
2	O
,	O
fig	O
.	O
4	O
,	O
ref	O
.	O
24	O
)	O
.	O

non	B-T058
-	I-T058
intubated	I-T058
sub	B-T082
##x	I-T082
##iph	I-T082
##oid	I-T082
unip	B-T058
##ortal	I-T058
video	I-T058
-	I-T058
assisted	I-T058
thoracoscopic	I-T058
thym	B-T058
##ectomy	I-T058
using	O
glasses	B-T033
-	I-T033
free	I-T033
3d	B-T082
vision	B-T038
trans	B-T058
-	I-T058
sternal	I-T058
thym	I-T058
##ectomy	I-T058
has	O
long	O
been	O
accepted	O
as	O
the	O
standard	O
surgical	B-T058
procedure	I-T058
for	O
thymic	B-T017
masses	I-T017
.	O
recently	O
,	O
minimally	O
invasive	O
methods	B-T170
,	O
such	O
as	O
video	B-T058
-	I-T058
assisted	I-T058
thoracoscopic	I-T058
surgery	I-T058
(	B-T058
vats	I-T058
)	I-T058
and	O
,	O
even	O
more	O
recently	O
,	O
non	B-T058
-	I-T058
intubated	I-T058
anesthesia	B-T058
,	O
have	O
emerged	O
.	O
these	O
methods	B-T170
provide	O
advantages	O
including	O
reductions	O
in	O
surgical	O
trauma	O
,	O
postoperative	B-T033
associated	I-T033
pain	I-T033
,	O
and	O
in	O
regards	O
to	O
vats	B-T058
,	O
provide	O
certain	O
cosmetic	B-T058
benefits	O
.	O
considering	O
these	O
advantages	O
,	O
we	O
herein	O
present	O
a	O
case	O
of	O
sub	B-T082
##x	I-T082
##iph	I-T082
##oid	I-T082
unip	B-T058
##ortal	I-T058
vats	I-T058
for	O
thymic	B-T017
mass	I-T017
using	O
a	O
glasses	B-T033
-	I-T033
free	I-T033
3d	B-T082
thoracoscopic	B-T082
display	O
system	O
.	O

treated	B-T058
prevalence	O
of	O
attention	B-T038
-	I-T038
deficit	I-T038
/	I-T038
hyperactivity	I-T038
disorder	I-T038
increased	O
from	O
2009	O
to	O
2015	O
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
in	O
the	O
united	B-T082
states	I-T082
the	O
purpose	O
of	O
this	O
brief	O
is	O
to	O
describe	O
changes	O
in	O
the	O
treated	B-T058
prevalence	O
of	O
medically	O
managed	O
attention	B-T038
-	I-T038
deficit	I-T038
/	I-T038
hyperactivity	I-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
among	O
insured	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
in	O
the	O
united	B-T082
states	I-T082
from	O
2009	O
to	O
2015	O
.	O
we	O
examine	B-T033
the	O
differences	O
between	O
those	O
with	O
employ	O
##er	O
-	O
sponsored	O
insurance	O
(	O
esi	O
)	O
and	O
with	O
medicaid	B-T058
insurance	I-T058
.	O
we	O
utilized	O
two	O
large	O
longitudinal	B-T082
administrative	B-T170
datasets	I-T170
containing	O
medical	O
and	O
drug	B-T103
claims	O
data	O
on	O
individuals	B-T098
with	O
esi	O
and	O
medicaid	B-T058
insurance	I-T058
from	O
tr	B-T170
##uv	I-T170
##en	I-T170
health	I-T170
markets	I-T170
##can	I-T170
(	I-T170
®	I-T170
)	I-T170
administrative	I-T170
claims	I-T170
databases	I-T170
.	O
treated	B-T058
prevalence	O
was	O
measured	O
as	O
the	O
percentage	O
of	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
enrolled	O
in	O
a	O
calendar	O
year	O
who	O
met	O
the	O
criteria	O
for	O
medically	O
managed	O
adhd	B-T038
in	O
the	O
same	O
calendar	O
year	O
.	O
subjects	B-T098
were	O
eligible	O
for	O
inclusion	O
if	O
they	O
were	O
aged	O
6	O
-	O
17	O
years	O
and	O
were	O
continuously	O
enrolled	O
during	O
a	O
calendar	O
year	O
.	O
the	O
annual	O
prevalence	O
of	O
treated	B-T058
adhd	B-T038
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
esi	O
increased	O
from	O
4	O
.	O
5	O
%	O
in	O
2009	O
to	O
6	O
.	O
7	O
%	O
in	O
2015	O
.	O
among	O
those	O
with	O
medicaid	B-T058
it	O
increased	O
from	O
11	O
.	O
3	O
%	O
in	O
2009	O
to	O
13	O
.	O
3	O
%	O
in	O
2012	O
,	O
and	O
fell	O
after	O
2012	O
,	O
remaining	O
steady	O
from	O
2013	O
through	O
2015	O
.	O
treated	B-T058
prevalence	O
of	O
adhd	B-T038
increased	O
continuously	O
over	O
time	O
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
esi	O
,	O
but	O
declined	O
slightly	O
after	O
2012	O
among	O
those	O
in	O
the	O
medicaid	B-T058
sample	I-T058
.	O

causes	O
of	O
ecological	B-T082
gradients	O
in	O
leaf	B-T204
margin	B-T082
entire	O
##ty	O
:	O
evaluating	B-T170
the	O
roles	O
of	O
biomechanics	B-T091
,	O
hydraulic	O
##s	O
,	O
vein	O
geometry	O
,	O
and	O
bud	B-T204
packing	O
a	O
recent	O
commentary	B-T170
by	O
ed	O
##wards	O
et	O
al	O
.	O
(	O
am	O
.	O
j	O
.	O
bot	O
.	O
103	O
:	O
97	O
##5	O
-	O
97	O
##8	O
)	O
proposed	O
that	O
constraints	O
imposed	O
by	O
the	O
packing	O
of	O
young	O
leaves	B-T204
in	O
buds	B-T204
could	O
explain	O
the	O
positive	B-T033
association	O
between	O
non	O
-	O
entire	O
leaf	B-T204
margins	B-T082
and	O
latitude	O
but	O
did	O
not	O
thoroughly	O
consider	O
alternative	O
explanations	B-T170
.	O
we	O
review	O
the	O
logic	O
and	O
evidence	O
underlying	O
six	O
major	O
hypotheses	O
for	O
the	O
functional	O
significance	O
of	O
marginal	B-T082
teeth	B-T204
,	O
involving	O
putative	O
effects	O
on	O
(	O
1	O
)	O
leaf	B-T204
cooling	O
,	O
(	O
2	O
)	O
optimal	O
support	O
and	O
supply	O
of	O
the	O
areas	B-T082
served	O
by	O
major	O
veins	B-T017
,	O
(	O
3	O
)	O
enhanced	O
leaf	B-T204
-	O
margin	B-T082
photosynthesis	O
,	O
(	O
4	O
)	O
hyd	B-T038
##ath	I-T038
##odal	I-T038
function	I-T038
,	O
(	O
5	O
)	O
defense	O
against	O
herbivores	B-T204
,	O
and	O
(	O
6	O
)	O
bud	B-T204
packing	O
.	O
theoretical	O
and	O
empirical	O
problems	B-T033
underm	O
##ine	O
all	O
hypotheses	O
except	O
the	O
support	O
-	O
supply	O
hypothesis	O
,	O
which	O
implies	O
that	O
thinner	O
leaves	B-T204
should	O
have	O
non	O
-	O
entire	O
margins	B-T082
.	O
phylogenetically	O
structured	B-T062
analyses	I-T062
across	O
angio	B-T204
##sp	I-T204
##erm	I-T204
##s	I-T204
,	O
the	O
el	O
y	O
##un	O
##que	O
flora	B-T033
,	O
and	O
the	O
genus	B-T170
vib	B-T204
##urn	I-T204
##um	I-T204
all	O
demonstrate	O
that	O
non	O
-	O
entire	O
margins	B-T082
are	O
indeed	O
more	O
common	O
in	O
thinner	O
leaves	B-T204
.	O
across	O
angio	B-T204
##sp	I-T204
##erm	I-T204
##s	I-T204
,	O
the	O
association	O
of	O
leaf	B-T204
thickness	O
with	O
non	O
-	O
entire	O
leaf	B-T204
margins	B-T082
is	O
stronger	O
than	O
that	O
of	O
latitude	O
.	O
we	O
outline	B-T170
a	O
synthetic	B-T170
model	I-T170
showing	O
how	O
biomechanics	B-T091
,	O
hydraulic	O
##s	O
,	O
vein	B-T017
geometry	O
,	O
rates	O
of	O
leaf	B-T204
expansion	B-T038
,	O
and	O
length	O
of	O
development	O
within	O
resting	B-T033
buds	B-T204
,	O
all	O
tie	O
##d	O
to	O
leaf	B-T204
thickness	O
,	O
drive	B-T033
patterns	B-T082
in	O
the	O
distribution	B-T082
of	O
entire	O
vs	O
.	O
non	O
-	O
entire	O
leaf	B-T204
margins	B-T082
.	O
our	O
model	B-T170
accounts	O
for	O
dominance	O
of	O
entire	O
margins	B-T082
in	O
the	O
trop	O
##ics	O
,	O
mediterranean	B-T082
scru	I-T082
##b	I-T082
,	O
and	O
tun	B-T082
##dr	I-T082
##a	I-T082
,	O
non	O
-	O
entire	O
margins	B-T082
in	O
cold	O
temperate	O
deciduous	O
forests	O
and	O
tropical	O
vine	B-T204
##s	I-T204
and	O
early	B-T204
-	I-T204
succession	I-T204
##al	I-T204
trees	I-T204
,	O
and	O
entire	O
leaf	B-T204
margins	B-T082
in	O
monoc	B-T204
##ots	I-T204
.	O
spin	B-T204
##ose	I-T204
-	I-T204
tooth	I-T204
##ed	I-T204
leaves	I-T204
should	O
be	O
favored	O
in	O
short	B-T033
-	I-T033
stature	I-T033
##d	I-T033
ever	B-T204
##gr	I-T204
##een	I-T204
trees	I-T204
and	O
shr	B-T204
##ubs	I-T204
,	O
primarily	O
in	O
mediterranean	B-T082
scru	I-T082
##b	I-T082
and	O
related	O
semi	B-T082
##ari	I-T082
##d	I-T082
habitats	I-T082
.	O

family	O
and	O
healthcare	B-T097
professionals	I-T097
'	O
perceptions	B-T038
of	O
a	O
pilot	O
hospice	B-T058
at	O
home	B-T082
programme	O
for	O
children	O
:	O
a	O
qualitative	O
study	B-T062
parents	O
commonly	O
report	O
a	O
significant	O
improvement	O
in	O
quality	O
of	O
life	O
following	O
the	O
provision	B-T058
of	O
hospice	B-T058
and	O
supportive	B-T058
care	I-T058
and	O
have	O
identified	O
a	O
need	O
for	O
such	O
a	O
service	B-T058
in	O
the	O
home	B-T082
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
understand	O
the	O
experiences	O
of	O
families	O
receiving	O
a	O
nurse	B-T097
led	O
pilot	O
hospice	B-T058
at	O
home	B-T082
programme	O
and	O
the	O
experiences	B-T038
of	O
healthcare	B-T097
professionals	I-T097
delivering	O
and	O
engaging	O
with	O
the	O
programme	O
.	O
an	O
exploratory	O
,	O
qualitative	O
study	B-T062
was	O
conducted	O
,	O
including	O
telephone	B-T062
interviews	I-T062
with	O
parents	O
and	O
focus	O
groups	O
and	O
individual	B-T098
interviews	O
with	O
healthcare	B-T097
professionals	I-T097
.	O
all	O
parents	O
of	O
families	O
who	O
received	O
the	O
programme	O
of	O
care	B-T058
between	O
june	O
2014	O
and	O
september	O
2015	O
and	O
healthcare	B-T097
professionals	I-T097
delivering	O
and	O
engaging	O
with	O
the	O
programme	O
were	O
invited	O
to	O
participate	O
.	O
seven	O
parents	O
participated	O
in	O
telephone	B-T062
interviews	I-T062
.	O
four	O
focus	O
groups	O
took	O
place	O
,	O
two	O
with	O
external	B-T098
stakeholders	I-T098
(	O
18	O
participants	B-T098
in	O
total	O
)	O
,	O
one	O
with	O
in	O
-	O
patient	O
hospice	B-T097
staff	I-T097
(	O
13	O
participants	B-T098
)	O
and	O
one	O
with	O
the	O
hospice	B-T058
at	O
home	O
team	O
(	O
8	O
participants	B-T098
)	O
.	O
two	O
additional	O
interviews	O
took	O
place	O
with	O
individual	B-T098
stakeholders	B-T098
who	O
were	O
unable	O
to	O
attend	O
a	O
scheduled	O
focus	O
group	O
.	O
themes	O
from	O
interviews	O
with	O
parents	O
focused	O
on	O
the	O
value	O
of	O
having	O
consistent	O
and	O
expert	O
care	B-T058
.	O
the	O
findings	O
from	O
healthcare	B-T097
professionals	I-T097
centred	O
on	O
communication	O
within	O
and	O
across	O
services	B-T058
,	O
education	O
and	O
training	O
and	O
lon	O
##e	O
working	O
.	O
the	O
pilot	O
hospice	B-T058
at	O
home	B-T082
programme	O
was	O
wel	O
##com	O
##ed	O
by	O
all	O
those	O
who	O
took	O
part	O
in	O
the	O
study	B-T062
.	O
the	O
programme	O
may	O
be	O
improved	O
by	O
enhanced	O
clarification	O
of	O
roles	O
,	O
enhanced	O
access	O
to	O
multi	O
-	O
disciplinary	O
services	B-T058
,	O
greater	O
communication	O
across	O
services	B-T058
and	O
improved	O
information	O
provision	O
to	O
families	O
.	O

methodology	O
development	O
on	O
aquatic	O
environmental	O
assessment	B-T058
the	O
water	B-T170
framework	I-T170
directive	I-T170
aims	O
at	O
reaching	O
the	O
good	O
ecological	O
status	O
of	O
the	O
surface	B-T082
and	O
ground	B-T082
water	I-T082
bodies	I-T082
(	O
las	O
##z	O
##lo	O
et	O
al	O
.	O
microch	O
##em	O
j	O
85	O
(	O
1	O
)	O
:	O
65	O
-	O
71	O
,	O
2007	O
)	O
.	O
the	O
paper	O
deals	O
with	O
quality	O
evaluation	B-T058
of	O
waters	B-T103
with	O
special	O
focus	O
on	O
the	O
water	B-T103
chemistry	O
parameters	O
as	O
defined	O
in	O
the	O
water	B-T170
framework	I-T170
directive	I-T170
and	O
pertaining	O
legal	O
regulations	O
.	O
the	O
purpose	O
of	O
this	O
paper	O
is	O
to	O
devi	O
##se	O
a	O
quantitative	O
type	O
of	O
water	B-T103
quality	O
assessment	B-T058
method	B-T170
which	O
could	O
provide	O
rapid	O
,	O
accurate	O
,	O
and	O
reliable	O
information	O
on	O
the	O
quality	O
of	O
the	O
surface	B-T082
waters	B-T103
by	O
using	O
water	B-T103
chemistry	O
parameters	O
.	O
quality	O
classes	B-T170
have	O
been	O
defined	O
for	O
every	O
water	B-T103
chemistry	O
parameter	O
in	O
light	O
of	O
the	O
legal	B-T170
limit	I-T170
values	I-T170
of	O
the	O
water	B-T103
parameters	O
.	O
in	O
addition	O
to	O
this	O
,	O
weight	O
indices	O
were	O
calculated	B-T058
on	O
the	O
basis	O
of	O
the	O
outcome	O
of	O
the	O
paired	O
comparison	O
of	O
water	B-T103
chemistry	O
parameters	O
and	O
normalized	B-T062
matrix	B-T082
.	O
this	O
was	O
followed	O
by	O
the	O
parametric	O
level	O
analysis	O
of	O
the	O
water	B-T103
chemistry	O
parameters	O
,	O
and	O
finally	O
,	O
the	O
aquatic	B-T170
environment	I-T170
index	I-T170
(	O
ae	B-T170
##i	I-T170
)	O
was	O
calculated	B-T058
,	O
which	O
provided	O
general	B-T170
information	I-T170
on	O
the	O
quality	O
of	O
water	B-T103
regarding	O
the	O
water	B-T103
chemistry	O
parameters	O
.	O
the	O
method	B-T170
was	O
illustrated	O
on	O
lake	B-T082
bal	B-T082
##ato	I-T082
##n	I-T082
,	O
hung	B-T082
##ary	I-T082
in	O
which	O
case	O
water	B-T103
samples	O
taken	O
from	O
bal	B-T082
##ato	I-T082
##nf	I-T082
##ured	I-T082
city	I-T082
lake	B-T082
area	B-T082
were	O
analyzed	B-T062
and	O
evaluated	B-T058
with	O
the	O
method	B-T170
devised	O
.	O

transcriptomic	B-T082
insights	O
into	O
the	O
allel	O
##opathic	O
effects	O
of	O
the	O
garlic	B-T168
allel	B-T103
##ochemical	I-T103
dial	B-T103
##lyl	I-T103
disulfide	I-T103
on	O
tomato	B-T168
roots	B-T204
garlic	B-T168
is	O
an	O
allel	O
##opathic	O
crop	B-T204
that	O
can	O
alleviate	O
the	O
obstacles	O
to	O
continuous	O
crop	O
##ping	O
of	O
vegetable	B-T204
crops	I-T204
.	O
dial	B-T103
##lyl	I-T103
disulfide	I-T103
(	O
dad	B-T103
##s	I-T103
)	O
,	O
one	O
of	O
the	O
most	O
important	O
allel	B-T103
##ochemical	I-T103
##s	I-T103
in	O
garlic	B-T168
,	O
promotes	O
tomato	B-T168
root	B-T038
growth	I-T038
.	O
therefore	O
,	O
the	O
global	O
transcriptome	B-T082
profiles	O
of	O
dad	B-T103
##s	I-T103
-	O
treated	O
tomato	B-T168
roots	B-T204
over	O
time	O
were	O
investigated	O
to	O
reveal	O
the	O
potential	O
growth	O
-	O
promoting	O
mechanisms	O
.	O
we	O
detected	B-T033
182	O
##8	O
,	O
129	O
##6	O
and	O
119	O
##0	O
differentially	B-T038
expressed	I-T038
genes	B-T017
(	O
degs	B-T017
)	O
in	O
the	O
4	O
,	O
24	O
and	O
48	O
h	O
samples	O
,	O
respectively	O
.	O
most	O
degs	B-T017
involved	O
in	O
assimil	B-T038
##atory	I-T038
sulfate	I-T038
reduction	I-T038
and	O
glutathione	B-T038
metabolism	I-T038
were	O
up	B-T038
-	I-T038
regulated	I-T038
after	O
short	O
-	O
term	O
(	O
4	O
h	O
)	O
dad	B-T103
##s	I-T103
treatment	O
.	O
in	O
addition	O
,	O
increased	B-T033
activity	I-T033
of	I-T033
defensive	I-T033
enzymes	I-T033
and	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
six	O
peroxidase	B-T017
genes	I-T017
were	O
observed	O
,	O
suggesting	O
that	O
dad	B-T103
##s	I-T103
could	O
induce	O
tomato	B-T168
resistance	O
.	O
in	O
plant	B-T038
-	I-T038
pathogen	I-T038
interactions	I-T038
,	O
degs	B-T017
related	O
to	O
calcium	B-T038
signaling	I-T038
were	O
primarily	O
inhibited	O
,	O
while	O
those	O
encoding	O
pathogenesis	B-T103
-	I-T103
related	I-T103
proteins	I-T103
were	O
primarily	O
up	B-T038
-	I-T038
regulated	I-T038
.	O
although	O
plant	B-T204
hormone	B-T038
synthesis	I-T038
and	O
signal	B-T038
transduction	I-T038
were	O
both	O
significantly	O
affected	O
by	O
dad	B-T103
##s	I-T103
,	O
the	O
expression	B-T038
trends	O
of	O
the	O
genes	B-T017
in	O
these	O
two	O
pathways	B-T038
were	O
conflicting	O
.	O
this	O
research	B-T062
provides	O
comprehensive	O
information	O
concerning	O
the	O
changes	O
in	O
the	O
tomato	B-T168
root	B-T204
transcriptome	B-T082
affected	O
by	O
dad	B-T103
##s	I-T103
and	O
may	O
help	O
direct	O
further	O
studies	B-T062
on	O
dad	B-T103
##s	I-T103
-	O
responsive	O
genes	B-T017
to	O
enhance	O
the	O
current	O
understanding	O
of	O
the	O
mechanisms	O
by	O
which	O
dad	B-T103
##s	I-T103
alleviate	O
##s	O
the	O
obstacles	O
to	O
continuous	O
crop	O
##ping	O
.	O

the	O
relationships	O
between	O
symptoms	B-T033
and	O
quality	O
of	O
life	O
over	O
the	O
course	O
of	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
therapy	I-T058
for	O
panic	B-T038
disorder	I-T038
in	O
japan	B-T082
this	O
study	B-T062
examined	B-T033
the	O
relationships	O
between	O
changes	O
in	O
symptoms	B-T033
and	O
changes	O
in	O
quality	O
of	O
life	O
(	O
qol	O
)	O
during	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
therapy	I-T058
(	O
cbt	B-T058
)	O
for	O
panic	B-T038
disorder	I-T038
(	O
pd	B-T038
)	O
.	O
we	O
treated	O
198	O
pd	B-T038
patients	O
with	O
group	O
cbt	B-T058
in	O
japan	B-T082
.	O
using	O
multiple	B-T170
regression	I-T170
analysis	I-T170
,	O
we	O
examined	B-T033
the	O
associations	O
between	O
changes	O
in	O
qol	O
and	O
changes	O
in	O
pd	B-T038
symptoms	B-T033
or	O
comorbid	B-T033
psychological	I-T033
symptoms	I-T033
during	O
cbt	B-T058
.	O
changes	O
in	O
anticipatory	B-T033
anxiety	I-T033
,	O
ago	B-T038
##ra	I-T038
##ph	I-T038
##obic	I-T038
fear	I-T038
/	O
avoidance	B-T038
,	O
and	O
somat	B-T038
##ization	I-T038
were	O
significant	O
predictors	O
of	O
changes	O
in	O
some	O
aspects	O
of	O
qol	O
.	O
it	O
might	O
be	O
useful	O
to	O
decrease	O
somat	B-T038
##ization	I-T038
,	O
anticipatory	B-T033
anxiety	I-T033
,	O
and	O
ago	B-T038
##ra	I-T038
##ph	I-T038
##obic	I-T038
fear	I-T038
to	O
improve	O
qol	O
in	O
cbt	B-T058
for	O
pd	B-T038
.	O

cd16	B-T103
##9	I-T103
identifies	B-T033
an	O
activated	B-T017
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
subset	B-T170
in	O
regional	B-T017
lymph	I-T017
nodes	I-T017
that	O
predicts	O
favorable	O
prognosis	B-T058
in	O
colorectal	B-T038
cancer	I-T038
patients	O
cd16	B-T103
##9	I-T103
was	O
first	O
identified	O
on	O
macrophages	B-T017
(	O
m	B-T017
##ϕ	I-T017
)	O
and	O
linked	O
to	O
antigen	B-T038
presentation	I-T038
.	O
here	O
,	O
we	O
showed	O
cd16	B-T038
##9	I-T038
expression	I-T038
on	O
some	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
lymphocytes	I-T017
in	O
regional	B-T017
lymph	I-T017
nodes	I-T017
(	O
lns	B-T017
)	O
and	O
investigated	O
the	O
function	B-T038
and	O
clinical	B-T033
relevance	I-T033
of	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
in	O
tumor	B-T017
-	I-T017
draining	I-T017
lns	I-T017
of	O
colorectal	B-T038
cancer	I-T038
(	O
crc	B-T038
)	O
patients	O
.	O
fresh	B-T017
tumor	I-T017
-	I-T017
draining	I-T017
ln	I-T017
tissues	I-T017
from	O
39	O
randomly	O
enrolled	O
patients	O
were	O
assessed	O
by	O
flow	B-T058
cytometry	I-T058
for	O
activation	O
and	O
differentiation	B-T038
of	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
and	O
t	B-T038
cell	I-T038
-	I-T038
mediated	I-T038
killing	I-T038
of	I-T038
tumor	I-T038
cells	I-T038
.	O
in	O
total	O
,	O
114	O
tumor	B-T017
-	I-T017
draining	I-T017
ln	I-T017
paraffin	O
sections	O
from	O
crc	B-T038
patients	O
were	O
analyzed	O
by	O
multiple	B-T058
-	I-T058
color	I-T058
immunofluorescence	I-T058
for	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
distribution	O
and	O
clinical	O
values	O
.	O
the	O
prognostic	B-T170
significance	O
of	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
was	O
evaluated	B-T058
by	O
kaplan	O
-	O
meier	O
analysis	O
.	O
a	O
fraction	O
of	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
in	O
regional	B-T017
lns	I-T017
,	O
but	O
not	O
peripheral	B-T031
blood	I-T031
,	O
tons	B-T017
##ils	I-T017
,	O
or	O
tumors	B-T038
,	O
expressed	B-T103
surface	I-T103
cd16	I-T103
##9	I-T103
.	O
in	B-T082
situ	I-T082
detection	B-T058
of	O
draining	B-T017
lns	I-T017
revealed	O
preferential	O
localization	O
of	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
to	O
subc	B-T017
##apsular	I-T017
sinus	I-T017
and	O
interf	B-T082
##oll	I-T082
##icular	I-T082
regions	I-T082
,	O
closely	O
associated	O
with	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
m	I-T017
##ϕ	I-T017
.	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cell	I-T017
ratios	O
were	O
significantly	O
lower	O
in	O
peri	O
-	O
tumor	O
lns	B-T017
than	O
distant	O
-	O
tumor	O
lns	B-T017
.	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
predominantly	O
expressed	O
activation	B-T201
markers	I-T201
(	O
cd	B-T103
##69	I-T103
,	O
hla	B-T103
-	I-T103
dr	I-T103
,	O
pd	B-T103
-	I-T103
1	I-T103
)	O
with	O
slightly	O
lower	O
cd45	B-T103
##ra	I-T103
and	O
cd	B-T103
##62	I-T103
##l	I-T103
levels	O
.	O
they	O
produced	O
high	O
gran	B-T103
##zyme	I-T103
b	I-T103
,	O
perforin	B-T103
,	O
tnf	B-T103
-	I-T103
α	I-T103
,	O
and	O
ifn	B-T103
##γ	I-T103
levels	O
,	O
and	O
promoted	O
tumor	B-T058
-	I-T058
killing	I-T058
efficiency	I-T058
ex	O
vitro	O
.	O
moreover	O
,	O
cd16	B-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
infiltrating	B-T038
tumor	B-T017
-	I-T017
draining	I-T017
lns	I-T017
decreased	O
with	O
disease	B-T038
progression	I-T038
and	O
were	O
strongly	O
associated	O
with	O
crc	B-T038
patient	O
survival	O
.	O
we	O
identified	O
novel	O
activated	O
/	O
cytolytic	B-T017
cd16	I-T017
##9	I-T017
(	I-T017
+	I-T017
)	I-T017
cd8	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
selectively	O
present	O
in	O
regional	B-T017
lns	I-T017
,	O
potentially	O
serving	O
as	O
a	O
powerful	O
prognostic	B-T201
factor	I-T201
and	O
indicator	O
for	O
selecting	O
patients	O
for	O
immunotherapy	B-T058
.	O

efficacy	O
of	O
syn	B-T168
##biotic	I-T168
##s	I-T168
for	O
treatment	B-T058
of	O
bac	B-T038
##illary	I-T038
dys	I-T038
##entery	I-T038
in	O
children	O
:	O
a	O
double	B-T062
-	I-T062
blind	I-T062
,	O
randomized	B-T062
,	O
placebo	O
-	O
controlled	O
study	O
bac	B-T038
##illary	I-T038
dys	I-T038
##entery	I-T038
is	O
a	O
major	O
cause	O
of	O
children	O
'	O
s	O
admission	B-T058
to	I-T058
hospitals	I-T058
.	O
to	O
assess	O
the	O
probiotic	B-T007
and	O
prebiotic	B-T103
(	O
syn	B-T168
##biotic	I-T168
##s	I-T168
)	O
effects	O
in	O
children	O
with	O
dys	B-T038
##entery	I-T038
in	O
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
,	O
200	O
children	O
with	O
dys	B-T038
##entery	I-T038
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
syn	B-T168
##biotic	I-T168
group	O
received	O
1	O
tablet	B-T103
/	O
day	O
of	O
syn	B-T168
##biotic	I-T168
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	B-T103
group	O
received	O
placebo	B-T103
tablets	B-T103
(	O
identical	O
tablet	B-T103
form	O
like	O
probiotics	B-T007
)	O
.	O
the	O
standard	O
treatment	B-T058
was	O
administered	O
for	O
all	O
patients	O
.	O
duration	O
of	O
hospitalization	B-T058
,	O
dys	B-T038
##entery	I-T038
,	O
fever	B-T033
,	O
and	O
the	O
weight	B-T033
loss	I-T033
were	O
assessed	O
in	O
each	O
group	O
.	O
it	O
was	O
concluded	O
that	O
there	O
was	O
no	O
significant	O
difference	O
in	O
both	O
groups	O
in	O
the	O
baseline	O
characteristics	O
.	O
the	O
mean	O
duration	O
of	O
dys	B-T038
##entery	I-T038
reduced	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
mean	O
duration	O
of	O
fever	B-T033
has	O
been	O
significantly	O
reduced	O
in	O
the	O
syn	B-T168
##biotic	I-T168
group	O
(	O
1	O
.	O
64	O
±	O
0	O
.	O
87	O
days	O
)	O
in	O
comparison	O
to	O
the	O
placebo	B-T103
group	O
(	O
2	O
.	O
13	O
±	O
0	O
.	O
94	O
days	O
)	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
average	O
amount	O
of	O
weight	B-T033
loss	I-T033
was	O
significantly	O
lower	O
in	O
the	O
syn	B-T168
##biotic	I-T168
group	O
in	O
comparison	O
to	O
that	O
in	O
the	O
placebo	B-T103
group	O
(	O
129	O
.	O
5	O
±	O
23	O
.	O
38	O
##8	O
gram	O
##s	O
and	O
278	O
±	O
28	O
.	O
38	O
##5	O
gram	O
##s	O
,	O
resp	O
.	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
mean	O
duration	O
of	O
hospitalization	B-T058
in	O
both	O
groups	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
the	O
use	O
of	O
syn	B-T168
##biotic	I-T168
##s	I-T168
as	O
an	O
adjuvant	B-T058
therapy	I-T058
to	O
the	O
standard	O
treatment	B-T058
of	O
dys	B-T038
##entery	I-T038
significantly	O
reduces	O
the	O
duration	O
of	O
dys	B-T038
##entery	I-T038
,	O
fever	B-T033
,	O
and	O
rate	B-T033
of	I-T033
weight	I-T033
losses	I-T033
.	O
the	O
trial	B-T062
is	O
registered	B-T058
with	O
ir	O
##ct	O
##20	O
##11	O
##09	O
##26	O
##76	O
##47	O
##n1	O
.	O

wnt	B-T103
-	I-T103
5a	I-T103
/	O
fri	B-T103
##zz	I-T103
##led	I-T103
##9	I-T103
receptor	B-T038
signaling	I-T038
through	O
the	O
g	B-T103
##α	I-T103
##o	I-T103
/	O
g	B-T103
##β	I-T103
##γ	I-T103
complex	I-T103
regulates	B-T038
dendritic	B-T017
spine	I-T017
formation	B-T038
wnt	B-T103
ligands	I-T103
play	O
crucial	O
roles	O
in	O
the	O
development	O
and	O
regulation	B-T038
of	I-T038
synapse	I-T038
structure	I-T038
and	I-T038
function	I-T038
.	O
specifically	O
,	O
wnt	B-T103
-	I-T103
5a	I-T103
acts	O
as	O
a	O
secreted	B-T103
growth	I-T103
factor	I-T103
that	O
regulates	B-T038
dendritic	B-T017
spine	I-T017
formation	B-T038
in	O
rodent	B-T204
hippocampal	B-T017
neurons	B-T017
,	O
resulting	O
in	O
postsynaptic	B-T017
development	O
that	O
promotes	O
the	O
clustering	B-T038
of	I-T038
the	I-T038
postsynaptic	I-T038
density	I-T038
protein	I-T038
-	I-T038
95	I-T038
(	I-T038
psd	I-T038
-	I-T038
95	I-T038
)	I-T038
.	O
here	O
,	O
we	O
focused	O
on	O
the	O
early	O
events	O
occurring	O
after	O
the	O
interaction	B-T038
between	O
wnt	B-T103
-	I-T103
5a	I-T103
and	O
its	O
fri	B-T103
##zz	I-T103
##led	I-T103
receptor	I-T103
at	O
the	O
neuronal	B-T017
cell	B-T017
surface	I-T017
.	O
additionally	O
,	O
we	O
studied	O
the	O
role	O
of	O
hetero	B-T103
##tri	I-T103
##mer	I-T103
##ic	I-T103
g	I-T103
proteins	I-T103
in	O
wnt	B-T103
-	I-T103
5a	I-T103
-	O
dependent	O
synaptic	B-T017
development	O
.	O
we	O
report	O
that	O
fri	B-T103
##zz	I-T103
##led	I-T103
##9	I-T103
(	O
fz	B-T103
##d	I-T103
##9	I-T103
)	O
,	O
a	O
wnt	B-T103
receptor	B-T103
related	O
to	O
willi	B-T038
##ams	I-T038
'	I-T038
syndrome	I-T038
,	O
is	O
localized	O
in	O
the	O
postsynaptic	O
region	O
,	O
where	O
it	O
interacts	B-T038
with	O
wnt	B-T103
-	I-T103
5a	I-T103
.	O
functionally	O
,	O
fz	B-T103
##d	I-T103
##9	I-T103
is	O
required	O
for	O
the	O
wnt	B-T103
-	I-T103
5a	I-T103
-	O
mediated	O
increase	O
in	O
dendritic	B-T017
spine	I-T017
density	I-T017
.	O
fz	B-T103
##d	I-T103
##9	I-T103
forms	O
a	O
pre	B-T017
-	I-T017
coupled	I-T017
complex	I-T017
with	O
g	B-T103
##α	I-T103
##o	I-T103
under	O
basal	O
conditions	O
that	O
dissoci	B-T038
##ates	I-T038
after	O
wnt	B-T103
-	I-T103
5a	I-T103
stimulation	B-T038
.	O
accordingly	O
,	O
we	O
found	O
that	O
g	B-T038
-	I-T038
protein	I-T038
inhibition	I-T038
abrog	I-T038
##ates	I-T038
wnt	B-T103
-	I-T103
5a	I-T103
-	O
dependent	O
pathway	B-T038
in	O
hippocampal	B-T017
neurons	B-T017
.	O
in	O
particular	O
,	O
the	O
activation	O
of	O
g	B-T103
##α	I-T103
##o	I-T103
appears	O
to	O
be	O
a	O
key	O
factor	O
controlling	O
the	O
wnt	B-T103
-	I-T103
5a	I-T103
-	O
induced	O
dendritic	B-T017
spine	I-T017
density	I-T017
.	O
in	O
addition	O
,	O
we	O
found	O
that	O
g	B-T103
##β	I-T103
##γ	I-T103
is	O
required	O
for	O
the	O
wnt	B-T103
-	I-T103
5a	I-T103
-	O
mediated	O
increase	O
in	O
cytosolic	B-T017
calcium	B-T103
levels	O
and	O
spin	B-T038
##ogenesis	I-T038
.	O
our	O
findings	O
reveal	O
that	O
fz	B-T103
##d	I-T103
##9	I-T103
and	O
hetero	B-T103
##tri	I-T103
##mer	I-T103
##ic	I-T103
g	I-T103
proteins	I-T103
regulate	B-T038
wnt	B-T103
-	I-T103
5a	I-T103
signaling	B-T038
and	O
dendritic	B-T017
spines	I-T017
in	O
cultured	B-T017
hippocampal	B-T017
neurons	B-T017
.	O

diaz	B-T103
##oxide	I-T103
prevents	O
reactive	B-T103
oxygen	I-T103
species	I-T103
and	O
mitochondrial	B-T038
damage	I-T038
,	O
leading	O
to	O
anti	B-T033
-	I-T033
hypertrophic	I-T033
effects	I-T033
pathological	O
cardiac	B-T038
hypertrophy	I-T038
is	O
characterized	O
by	O
wall	B-T017
thickening	B-T033
or	O
chamber	B-T017
enlargement	B-T038
of	O
the	O
heart	B-T017
in	O
response	O
to	O
pressure	O
or	O
volume	O
overload	O
,	O
respectively	O
.	O
this	O
condition	O
will	O
,	O
initially	O
,	O
improve	B-T033
the	O
organ	B-T017
contractile	B-T038
function	I-T038
,	O
but	O
if	O
sustained	O
will	O
render	O
dysfunctional	O
mitochondria	B-T017
and	O
oxidative	B-T038
stress	I-T038
.	O
mitochondrial	B-T103
atp	I-T103
-	I-T103
sensitive	I-T103
k	I-T103
(	I-T103
+	I-T103
)	I-T103
channels	I-T103
(	O
mit	B-T103
##ok	I-T103
##atp	I-T103
)	O
modulate	B-T082
the	O
redox	B-T038
status	I-T038
of	O
the	O
cell	B-T017
and	O
protect	O
against	O
several	O
cardiac	B-T017
insults	O
.	O
here	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
mit	B-T103
##ok	I-T103
##atp	I-T103
opening	B-T082
(	O
using	O
diaz	B-T103
##oxide	I-T103
)	O
will	O
avoid	O
isoproterenol	B-T103
-	O
induced	O
cardiac	B-T038
hypertrophy	I-T038
in	B-T082
vivo	I-T082
by	O
decreasing	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	B-T103
ros	I-T103
)	O
production	O
and	O
mitochondrial	B-T017
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
induced	O
swelling	B-T033
.	O
to	O
induce	O
cardiac	B-T038
hypertrophy	I-T038
,	O
swiss	B-T204
mice	I-T204
were	O
treated	O
intraperitoneally	B-T082
with	O
isoproterenol	B-T103
(	O
30	O
mg	O
/	O
kg	O
/	O
day	O
)	O
for	O
8	O
days	O
.	O
diaz	B-T103
##oxide	I-T103
(	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
was	O
used	O
to	O
open	O
mit	B-T103
##ok	I-T103
##atp	I-T103
and	O
5	B-T103
-	I-T103
hydroxyd	I-T103
##ecan	I-T103
##oate	I-T103
(	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
was	O
administrated	O
as	O
a	O
mit	B-T103
##ok	I-T103
##atp	I-T103
blocker	O
.	O
isoproterenol	B-T103
-	O
treated	O
mice	B-T204
had	O
elevated	O
heart	B-T017
weight	O
/	O
tibia	B-T017
length	O
ratios	O
and	O
increased	O
myocyte	B-T017
cross	B-T033
-	I-T033
sectional	I-T033
areas	I-T033
.	O
additionally	O
,	O
hypertrophic	O
hearts	B-T017
produced	O
higher	O
levels	O
of	O
h2o2	B-T103
and	O
had	O
lower	O
glutathione	B-T038
peroxidase	I-T038
activity	I-T038
.	O
in	O
contrast	O
,	O
mit	B-T103
##ok	I-T103
##atp	I-T103
opening	B-T082
with	O
diaz	B-T103
##oxide	I-T103
blocked	O
all	O
isoproterenol	B-T103
effects	O
in	O
a	O
manner	O
reversed	O
by	O
5	B-T103
-	I-T103
hydroxyd	I-T103
##ecan	I-T103
##oate	I-T103
.	O
isolated	O
mitochondria	B-T017
from	O
isoproterenol	B-T103
-	O
induced	O
hypertrophic	O
hearts	B-T017
had	O
increased	O
susceptibility	O
to	O
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
induced	O
swelling	B-T033
secondary	O
to	O
mitochondrial	B-T103
permeability	I-T103
transition	I-T103
pore	I-T103
opening	B-T082
.	O
mit	B-T103
##ok	I-T103
##atp	I-T103
opening	B-T082
was	O
accompanied	O
by	O
lower	O
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
induced	O
mitochondrial	B-T038
swelling	I-T038
,	O
an	O
effect	O
blocked	O
by	O
5	B-T103
-	I-T103
hydroxyd	I-T103
##ecan	I-T103
##oate	I-T103
.	O
our	O
results	O
suggest	O
that	O
mit	B-T103
##ok	I-T103
##atp	I-T103
opening	B-T082
negatively	B-T033
regulates	B-T038
cardiac	B-T038
hypertrophy	I-T038
by	O
avoiding	O
oxidative	O
impairment	O
and	O
mitochondrial	B-T038
damage	I-T038
.	O

mri	B-T058
-	O
based	O
prostate	B-T038
cancer	I-T038
detection	B-T033
with	O
high	O
-	O
level	O
representation	O
and	O
hierarchical	O
classification	B-T170
extracting	O
the	O
high	O
-	O
level	O
feature	O
representation	O
by	O
using	O
deep	B-T170
neural	I-T170
networks	I-T170
for	O
detection	B-T033
of	O
prostate	B-T038
cancer	I-T038
,	O
and	O
then	O
based	O
on	O
high	O
-	O
level	O
feature	O
representation	O
constructing	O
hierarchical	O
classification	B-T170
to	O
refine	O
the	O
detection	B-T033
results	O
.	O
high	O
-	O
level	O
feature	O
representation	O
is	O
first	O
learned	O
by	O
a	O
deep	B-T170
learning	I-T170
network	I-T170
,	O
where	O
multip	B-T058
##ara	I-T058
##met	I-T058
##ric	I-T058
mr	I-T058
images	B-T170
are	O
used	O
as	O
the	O
input	O
data	O
.	O
then	O
,	O
based	O
on	O
the	O
learned	O
high	O
-	O
level	O
features	O
,	O
a	O
hierarchical	O
classification	B-T170
method	B-T170
is	O
developed	O
,	O
where	O
multiple	B-T170
random	I-T170
forest	I-T170
classifiers	I-T170
are	O
iterative	O
##ly	O
constructed	O
to	O
refine	O
the	O
detection	B-T033
results	O
of	O
prostate	B-T038
cancer	I-T038
.	O
the	O
experiments	B-T062
were	O
carried	O
on	O
21	O
real	O
patient	O
subjects	O
,	O
and	O
the	O
proposed	O
method	B-T170
achieves	O
an	O
averaged	O
section	B-T058
-	I-T058
based	I-T058
evaluation	I-T058
(	O
sb	B-T058
##e	I-T058
)	O
of	O
89	O
.	O
90	O
%	O
,	O
an	O
averaged	O
sensitivity	O
of	O
91	O
.	O
51	O
%	O
,	O
and	O
an	O
averaged	O
specificity	O
of	O
88	O
.	O
47	O
%	O
.	O
the	O
high	O
-	O
level	O
features	O
learned	O
from	O
our	O
proposed	O
method	B-T170
can	O
achieve	O
better	O
performance	O
than	O
the	O
conventional	O
hand	O
##craft	O
##ed	O
features	O
(	O
e	O
.	O
g	O
.	O
,	O
lbp	O
and	O
ha	O
##ar	O
-	O
like	O
features	O
)	O
in	O
detecting	B-T033
prostate	B-T038
cancer	I-T038
regions	B-T082
,	O
also	O
the	O
context	O
features	O
obtained	O
from	O
the	O
proposed	O
hierarchical	O
classification	B-T170
approach	O
are	O
effective	O
in	O
ref	O
##ining	O
cancer	B-T038
detection	B-T033
result	O
.	O

doctor	B-T097
competence	O
and	O
the	O
demand	B-T058
for	O
healthcare	B-T058
:	O
evidence	O
from	O
rural	B-T082
china	I-T082
the	O
agency	B-T092
problem	B-T033
between	O
patients	O
and	O
doctors	B-T097
has	O
long	O
been	O
emphasis	O
##ed	O
in	O
the	O
health	B-T170
economics	I-T170
literature	I-T170
,	O
but	O
the	O
empirical	O
evidence	O
on	O
whether	O
patients	O
can	O
evaluate	O
and	O
respond	O
to	O
better	O
quality	B-T058
care	I-T058
remains	O
mixed	O
and	O
inconclusive	O
.	O
using	O
household	O
data	O
linked	O
to	O
an	O
assessment	O
of	O
village	B-T082
doctors	B-T097
'	I-T097
clinical	O
competence	O
in	O
rural	B-T082
china	I-T082
,	O
we	O
show	O
that	O
there	O
is	O
no	O
correlation	O
between	O
doctor	B-T097
competence	O
and	O
patients	O
'	O
healthcare	B-T058
utilisation	O
,	O
with	O
confidence	O
intervals	O
reasonably	O
tight	O
around	O
zero	O
.	O
household	O
perceptions	B-T038
of	O
quality	O
are	O
an	O
important	O
determinant	O
of	O
care	O
-	O
seeking	O
behaviour	O
,	O
yet	O
patients	O
appear	O
unable	B-T033
to	O
recogn	O
##ise	O
more	O
competent	O
doctors	B-T097
-	O
there	O
is	O
no	O
relationship	O
between	O
doctor	B-T097
competence	O
and	O
perceptions	B-T038
of	O
quality	O
.	O
copyright	O
©	O
2016	O
john	O
wiley	O
&	O
sons	O
,	O
ltd	O
.	O
journal	O
article	O

the	O
relationship	O
between	O
polymorphisms	B-T038
of	O
bdnf	B-T017
##os	I-T017
and	O
bdnf	B-T017
genes	I-T017
and	O
heroin	B-T038
addiction	I-T038
in	O
the	O
han	O
chinese	O
population	O
the	O
number	O
of	O
heroin	B-T103
addicts	O
is	O
increasing	O
in	O
the	O
world	B-T098
.	O
both	O
environmental	O
and	O
genetic	O
factors	O
both	O
play	O
critical	O
roles	O
in	O
the	O
process	O
of	O
heroin	B-T038
addiction	I-T038
.	O
we	O
aimed	O
to	O
investigate	O
the	O
associations	O
between	O
single	B-T082
nucleotide	I-T082
polymorphisms	I-T082
(	O
snps	B-T082
)	O
in	O
lin	B-T017
##7	I-T017
##c	I-T017
,	O
bdnf	B-T017
##os	I-T017
and	O
bdnf	B-T017
genes	I-T017
and	O
drug	B-T038
addiction	I-T038
in	O
the	O
han	O
chinese	O
population	O
.	O
we	O
conducted	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
among	O
69	O
##2	O
cases	O
and	O
700	O
healthy	O
controls	O
from	O
xi	O
'	O
an	O
,	O
china	B-T082
.	O
eight	O
snps	B-T082
were	O
selected	O
and	O
genotyped	B-T058
using	O
mass	B-T170
##arr	I-T170
##ay	I-T170
technology	I-T170
(	O
sequ	B-T092
##eno	I-T092
##m	I-T092
,	O
san	B-T082
die	I-T082
##go	I-T082
,	I-T082
ca	I-T082
,	O
usa	B-T082
)	O
.	O
odds	O
ratios	O
(	O
or	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
cis	O
)	O
were	O
calculated	O
by	O
uncondition	B-T062
##al	I-T062
logistic	I-T062
regression	I-T062
adjusting	O
for	O
age	O
and	O
sex	O
.	O
using	O
the	O
chi	B-T170
-	I-T170
squared	I-T170
test	I-T170
,	O
we	O
found	O
that	O
rs	B-T017
##74	I-T017
##81	I-T017
##31	I-T017
##1	I-T017
(	O
or	O
=	O
1	O
.	O
275	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
08	O
##7	O
-	O
1	O
.	O
49	O
##7	O
,	O
p	O
=	O
0	O
.	O
009	O
)	O
and	O
rs	B-T017
##11	I-T017
##03	I-T017
##00	I-T017
##96	I-T017
(	O
or	O
=	O
1	O
.	O
227	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
049	O
-	O
1	O
.	O
43	O
##6	O
,	O
p	O
=	O
0	O
.	O
011	O
)	O
in	O
the	O
bn	B-T017
##df	I-T017
##os	I-T017
were	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
heroin	B-T038
addiction	I-T038
.	O
by	O
contrast	O
,	O
rs	B-T017
##98	I-T017
##87	I-T017
##12	I-T017
located	O
in	O
bdnf	B-T017
##os	I-T017
showed	O
a	O
decreased	O
risk	O
of	O
heroin	B-T038
addiction	I-T038
(	O
or	O
=	O
0	O
.	O
73	O
##4	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
58	O
##2	O
-	O
0	O
.	O
92	O
##5	O
,	O
p	O
=	O
0	O
.	O
003	O
)	O
.	O
by	O
genetic	B-T170
model	I-T170
analysis	B-T062
,	O
we	O
found	O
that	O
the	O
'	B-T017
t	I-T017
'	I-T017
allele	I-T017
of	O
rs	B-T017
##98	I-T017
##87	I-T017
##12	I-T017
in	O
bdnf	B-T017
##os	I-T017
had	O
a	O
protective	O
role	O
for	O
heroin	B-T038
addiction	I-T038
in	O
the	O
additive	B-T170
model	I-T170
and	O
dominant	B-T170
model	I-T170
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
by	O
contrast	O
,	O
the	O
allele	B-T017
'	I-T017
t	I-T017
'	I-T017
of	O
rs	B-T017
##74	I-T017
##81	I-T017
##31	I-T017
##1	I-T017
in	O
bdnf	B-T017
##os	I-T017
significantly	O
elevated	O
the	O
risk	O
of	O
heroin	B-T038
addiction	I-T038
in	O
the	O
additive	B-T170
model	I-T170
,	O
recessive	B-T170
model	I-T170
and	O
dominant	B-T170
model	I-T170
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
we	O
also	O
found	O
that	O
allele	B-T017
'	I-T017
c	I-T017
'	O
of	O
rs	B-T017
##11	I-T017
##03	I-T017
##00	I-T017
##96	I-T017
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
addiction	B-T038
in	O
the	O
dominant	B-T170
model	I-T170
and	O
additive	B-T170
model	I-T170
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
additionally	O
,	O
we	O
found	O
that	O
rs	B-T017
##62	I-T017
##65	I-T017
,	O
rs	B-T017
##11	I-T017
##03	I-T017
##01	I-T017
##0	I-T017
##4	I-T017
and	O
rs10	B-T017
##76	I-T017
##76	I-T017
##64	I-T017
in	O
bdnf	B-T017
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
heroin	B-T038
addiction	I-T038
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
however	O
,	O
only	O
rs	B-T017
##74	I-T017
##81	I-T017
##31	I-T017
##1	I-T017
in	O
bdnf	B-T017
##os	I-T017
remained	O
significant	O
after	O
bonferroni	O
correction	O
(	O
p	O
<	O
0	O
.	O
006	O
##25	O
)	O
.	O
these	O
results	B-T033
suggest	O
that	O
polymorphisms	B-T038
of	O
bdnf	B-T017
##os	I-T017
play	O
an	O
important	O
role	O
in	O
heroin	B-T038
addiction	I-T038
susceptibility	O
in	O
the	O
chinese	O
han	O
population	O
.	O

cocaine	B-T103
use	O
reverse	O
##s	O
striatal	B-T038
plasticity	I-T038
produced	O
during	O
cocaine	B-T103
seeking	O
relapse	O
is	O
a	O
two	O
-	O
component	O
process	O
consisting	O
of	O
a	O
highly	O
motivated	B-T038
drug	O
-	O
seeking	O
phase	O
that	O
,	O
if	O
successful	O
,	O
is	O
followed	O
by	O
a	O
drug	B-T038
-	I-T038
using	I-T038
phase	O
resulting	O
in	O
temporary	O
sati	B-T038
##ation	I-T038
.	O
in	O
rodents	B-T204
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	B-T038
synaptic	I-T038
potentiation	I-T038
(	O
t	B-T038
-	I-T038
sp	I-T038
)	O
of	O
cortical	B-T082
glutamatergic	I-T082
synapses	I-T082
on	O
nucleus	B-T017
accumbens	I-T017
core	B-T082
medium	B-T017
spin	I-T017
##y	I-T017
neurons	I-T017
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	B-T038
use	I-T038
affects	B-T038
this	O
plasticity	B-T038
.	O
we	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	B-T038
from	O
cocaine	B-T103
self	B-T058
-	I-T058
administration	I-T058
to	O
assess	O
how	O
cocaine	B-T103
use	O
affects	B-T038
t	B-T038
-	I-T038
sp	I-T038
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O
rats	B-T204
were	O
trained	O
to	O
self	B-T058
-	I-T058
administer	I-T058
cocaine	B-T103
(	O
n	O
=	O
96	O
)	O
or	O
were	O
used	O
as	O
yo	O
##ke	O
##d	O
-	O
saline	O
control	B-T204
animals	I-T204
(	O
n	O
=	O
21	O
)	O
.	O
after	O
extinction	B-T038
,	O
reinst	O
##atement	O
was	O
initiated	O
by	O
10	O
minutes	O
of	O
cue	O
-	O
induced	O
drug	O
seeking	O
,	O
followed	O
by	O
45	O
minutes	O
with	O
contingent	O
cocaine	B-T103
access	O
,	O
after	O
which	O
cocaine	B-T103
was	O
discontinued	B-T033
and	O
unre	B-T033
##inf	I-T033
##or	I-T033
##ced	I-T033
lever	I-T033
pressing	I-T033
ens	I-T033
##ued	I-T033
.	O
three	O
measures	O
of	O
t	B-T038
-	I-T038
sp	I-T038
were	O
assayed	B-T058
during	O
reinst	O
##atement	O
:	O
dendritic	B-T017
spine	I-T017
morphology	O
,	O
alpha	B-T103
-	I-T103
amino	I-T103
-	I-T103
3	I-T103
-	I-T103
hydroxy	I-T103
-	I-T103
5	I-T103
-	I-T103
methyl	I-T103
-	I-T103
4	I-T103
-	I-T103
iso	I-T103
##xa	I-T103
##zo	I-T103
##le	I-T103
propionic	I-T103
acid	I-T103
(	O
ampa	B-T103
)	O
to	O
n	B-T103
-	I-T103
methyl	I-T103
-	I-T103
d	I-T103
-	I-T103
aspartate	I-T103
(	O
nmda	B-T103
)	O
ratios	O
,	O
and	O
matrix	B-T103
metalloproteinase	I-T103
activity	B-T038
.	O
we	O
found	B-T033
that	O
cocaine	B-T103
use	O
for	O
10	O
minutes	O
collapsed	O
all	O
three	O
measures	O
of	O
cue	O
-	O
potentiated	O
t	B-T038
-	I-T038
sp	I-T038
back	O
to	O
baseline	O
.	O
moreover	O
,	O
when	O
cocaine	B-T103
use	O
was	O
discontinued	B-T033
45	O
minutes	O
later	O
,	O
dendritic	B-T017
spine	I-T017
morphology	O
and	O
ampa	B-T103
to	O
nmda	B-T103
ratios	O
were	O
restored	O
as	O
animals	B-T204
became	O
motivated	B-T038
to	O
engage	O
unre	O
##ward	O
##ed	O
lever	B-T033
pressing	I-T033
.	O
nonre	O
##inf	O
##or	O
##ced	O
drug	O
seeking	O
was	O
positively	B-T033
correlated	O
with	O
changes	O
in	O
spine	B-T017
morphology	O
,	O
and	O
cocaine	B-T103
access	O
reversed	O
this	O
relationship	O
.	O
using	O
a	O
novel	O
modification	O
of	O
the	O
reinst	O
##atement	O
paradigm	O
,	O
we	O
show	O
that	O
achieving	O
cocaine	B-T103
use	O
reversed	O
the	O
synaptic	O
plasticity	O
underpinning	O
the	O
motivation	B-T038
to	O
seek	O
the	O
drug	B-T103
.	O

dual	B-T058
-	I-T058
color	I-T058
ste	I-T058
##d	I-T058
microscopy	I-T058
reveals	O
a	O
sandwich	B-T082
structure	I-T082
of	O
bass	B-T103
##oon	I-T103
and	O
pic	B-T103
##co	I-T103
##lo	I-T103
in	O
active	B-T017
zones	I-T017
of	O
adult	O
and	O
aged	O
mice	B-T204
presynaptic	B-T017
active	I-T017
zones	I-T017
play	O
a	O
pivotal	O
role	O
as	O
synaptic	B-T017
vesicle	I-T017
release	B-T082
sites	I-T082
for	O
synaptic	B-T038
transmission	I-T038
,	O
but	O
the	O
molecular	O
architecture	O
of	O
active	B-T017
zones	I-T017
in	O
mammalian	B-T204
neuromuscular	B-T017
junctions	I-T017
(	O
nm	B-T017
##j	I-T017
##s	I-T017
)	O
at	O
sub	O
-	O
diffraction	O
limited	O
resolution	O
remains	O
unknown	O
.	O
bass	B-T103
##oon	I-T103
and	O
pic	B-T103
##co	I-T103
##lo	I-T103
are	O
active	B-T017
zone	I-T017
specific	O
cytosolic	B-T017
proteins	B-T103
essential	O
for	O
active	B-T038
zone	I-T038
assembly	I-T038
in	O
nm	B-T017
##j	I-T017
##s	I-T017
,	O
rib	B-T082
##bon	I-T082
synapses	I-T082
,	O
and	O
brain	B-T017
synapses	B-T082
.	O
these	O
proteins	B-T103
are	O
thought	O
to	O
colocal	B-T082
##ize	I-T082
and	O
share	O
some	O
functions	O
at	O
active	B-T017
zones	I-T017
.	O
here	O
,	O
we	O
report	O
an	O
unexpected	O
finding	O
of	O
non	B-T038
-	I-T038
overlapping	I-T038
localization	I-T038
of	O
these	O
two	O
proteins	B-T103
in	O
mouse	B-T204
nm	B-T017
##j	I-T017
##s	I-T017
revealed	O
using	O
dual	O
-	O
color	O
stimulated	O
emission	O
depletion	O
(	O
ste	O
##d	O
)	O
super	B-T058
resolution	I-T058
microscopy	I-T058
.	O
pic	B-T103
##co	I-T103
##lo	I-T103
punct	B-T033
##a	I-T033
sandwich	O
##ed	O
bass	B-T103
##oon	I-T103
punct	B-T033
##a	I-T033
and	O
aligned	O
in	O
a	O
pic	B-T103
##co	I-T103
##lo	I-T103
-	O
bass	B-T103
##oon	I-T103
-	O
pic	B-T103
##co	I-T103
##lo	I-T103
structure	B-T082
in	O
adult	O
nm	B-T017
##j	I-T017
##s	I-T017
.	O
p	O
/	O
q	O
-	O
type	O
voltage	O
-	O
gated	O
calcium	O
channel	O
(	O
vg	O
##cc	O
)	O
punct	B-T033
##a	I-T033
colocalized	B-T082
with	O
bass	B-T103
##oon	I-T103
punct	B-T033
##a	I-T033
.	O
the	O
p	O
/	O
q	O
-	O
type	O
vg	O
##cc	O
and	O
bass	B-T103
##oon	I-T103
protein	B-T033
levels	I-T033
decreased	O
significantly	O
in	O
nm	B-T017
##j	I-T017
##s	I-T017
from	O
aged	O
mouse	B-T204
.	O
in	O
contrast	O
,	O
the	O
pic	B-T103
##co	I-T103
##lo	I-T103
levels	B-T033
in	O
nm	B-T017
##j	I-T017
##s	I-T017
from	O
aged	O
mice	B-T204
were	O
comparable	O
to	O
levels	B-T033
in	O
adult	O
mice	B-T204
.	O
this	O
study	O
revealed	O
the	O
molecular	O
architecture	O
of	O
active	B-T017
zones	I-T017
in	O
mouse	B-T204
nm	B-T017
##j	I-T017
##s	I-T017
at	O
sub	O
-	O
diffraction	O
limited	O
resolution	O
,	O
and	O
described	O
the	O
selective	B-T038
degeneration	I-T038
mechanism	I-T038
of	O
active	B-T017
zone	I-T017
proteins	B-T103
in	O
nm	B-T017
##j	I-T017
##s	I-T017
from	O
aged	O
mice	B-T204
.	O
interestingly	O
,	O
the	O
localization	B-T038
pattern	I-T038
of	O
active	B-T017
zone	I-T017
proteins	B-T103
described	O
herein	O
is	O
similar	O
to	O
active	B-T017
zone	I-T017
structures	B-T082
described	O
using	O
electron	B-T058
microscope	I-T058
tomography	I-T058
.	O

extended	O
use	O
of	O
prostate	B-T058
health	I-T058
index	I-T058
and	O
percentage	O
of	O
[	B-T103
-	I-T103
2	I-T103
]	I-T103
pro	I-T103
-	I-T103
prostate	I-T103
-	I-T103
specific	I-T103
antigen	I-T103
in	O
chinese	B-T098
men	B-T098
with	O
prostate	B-T103
specific	I-T103
antigen	I-T103
10	O
-	O
20	O
ng	O
/	O
ml	O
and	O
normal	O
digital	B-T058
rectal	I-T058
examination	I-T058
we	O
investigated	O
the	O
extended	O
use	O
of	O
prostate	B-T058
health	I-T058
index	I-T058
(	O
phi	B-T058
)	O
and	O
percentage	O
of	O
[	B-T103
-	I-T103
2	I-T103
]	I-T103
pro	I-T103
-	I-T103
prostate	I-T103
-	I-T103
specific	I-T103
antigen	I-T103
(	O
%	B-T103
p2	I-T103
##ps	I-T103
##a	I-T103
)	O
in	O
chinese	B-T098
men	B-T098
with	O
prostate	B-T103
-	I-T103
specific	I-T103
antigen	I-T103
(	O
psa	B-T103
)	O
10	O
-	O
20	O
ng	O
/	O
ml	O
and	O
normal	O
digital	B-T058
rectal	I-T058
examination	I-T058
(	O
dre	B-T058
)	O
.	O
all	O
consecutive	O
chinese	B-T098
men	B-T098
with	O
psa	B-T103
10	O
-	O
20	O
ng	O
/	O
ml	O
and	O
normal	O
dre	B-T058
who	O
agreed	O
for	O
transrectal	B-T058
ultrasound	I-T058
(	O
trus	B-T058
)	O
-	O
guided	O
10	O
-	O
core	O
prostate	B-T058
biopsy	I-T058
were	O
recruited	O
.	O
blood	B-T031
samples	I-T031
were	O
taken	O
immediately	O
before	O
trus	B-T058
-	O
guided	O
prostate	B-T058
biopsy	I-T058
.	O
the	O
performances	O
of	O
total	B-T058
psa	I-T058
(	O
tps	B-T058
##a	I-T058
)	O
,	O
%	O
free	O
-	O
to	O
-	O
total	O
psa	O
(	O
%	O
fps	O
##a	O
)	O
,	O
%	B-T103
p2	I-T103
##ps	I-T103
##a	I-T103
,	O
and	O
phi	B-T058
were	O
compared	O
using	O
logistic	B-T062
regression	I-T062
,	O
receiver	O
operating	O
characteristic	O
,	O
and	O
decision	B-T062
curve	I-T062
analyses	I-T062
(	O
dca	B-T062
)	O
.	O
from	O
2008	O
to	O
2015	O
,	O
312	O
consecutive	O
chinese	B-T098
men	B-T098
were	O
included	O
.	O
among	O
them	O
,	O
53	O
out	O
of	O
312	O
(	O
17	O
.	O
0	O
%	O
)	O
men	B-T098
were	O
diagnosed	B-T033
to	O
have	O
prostate	B-T038
cancer	I-T038
on	O
biopsy	B-T058
.	O
the	O
proportions	O
of	O
men	B-T098
with	O
positive	B-T033
biopsies	B-T058
were	O
6	O
.	O
7	O
%	O
in	O
phi	B-T058
<	O
35	O
,	O
22	O
.	O
8	O
%	O
in	O
phi	B-T058
35	O
-	O
55	O
,	O
and	O
54	O
.	O
5	O
%	O
in	O
phi	B-T058
>	O
55	O
(	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
area	O
under	O
curves	O
(	O
auc	O
)	O
of	O
the	O
base	B-T170
model	I-T170
including	O
age	O
,	O
tps	B-T058
##a	I-T058
and	O
status	O
of	O
initial	O
/	O
repeated	O
biopsy	B-T058
was	O
0	O
.	O
64	O
.	O
adding	O
%	B-T103
p2	I-T103
##ps	I-T103
##a	I-T103
and	O
phi	B-T058
to	O
the	O
base	B-T170
model	I-T170
improved	B-T033
the	O
auc	O
to	O
0	O
.	O
79	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
0	O
.	O
78	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
respectively	O
,	O
and	O
provided	O
net	O
clinical	O
benefit	O
in	O
dca	B-T062
.	O
the	O
positive	B-T033
biopsy	B-T058
rates	O
of	O
gleason	B-T170
7	I-T170
or	I-T170
above	I-T170
prostate	B-T038
cancers	I-T038
were	O
2	O
.	O
2	O
%	O
for	O
phi	B-T058
<	O
35	O
,	O
7	O
.	O
9	O
%	O
for	O
phi	B-T058
35	O
-	O
55	O
,	O
and	O
36	O
.	O
4	O
%	O
for	O
phi	B-T058
>	O
55	O
(	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
by	O
utilizing	O
the	O
phi	B-T058
cutoff	O
of	O
35	O
to	O
men	B-T098
with	O
psa	B-T103
10	O
-	O
20	O
ng	O
/	O
ml	O
and	O
normal	O
dre	B-T058
,	O
57	O
.	O
1	O
%	O
(	O
178	O
of	O
312	O
)	O
biopsies	B-T058
could	O
be	O
avoided	O
.	O
both	O
phi	B-T058
and	O
%	B-T103
p2	I-T103
##ps	I-T103
##a	I-T103
performed	O
well	O
in	O
predicting	O
prostate	B-T038
cancer	I-T038
and	O
high	B-T038
grade	I-T038
prostate	I-T038
cancer	I-T038
.	O
the	O
use	O
of	O
phi	B-T058
and	O
%	B-T103
p2	I-T103
##ps	I-T103
##a	I-T103
should	O
be	O
extended	O
to	O
chinese	B-T098
men	B-T098
with	O
psa	O
10	O
-	O
20	O
ng	O
/	O
ml	O
and	O
normal	O
dre	B-T058
.	O

assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	B-T058
on	O
immunogenicity	B-T038
,	O
react	B-T033
##ogenicity	I-T033
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	B-T170
protocol	I-T170
for	O
an	O
individual	B-T098
participant	B-T098
data	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
randomised	B-T062
controlled	I-T062
trials	I-T062
disease	B-T038
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	B-T038
or	O
inflammatory	B-T038
diseases	I-T038
.	O
sex	O
-	O
differences	O
in	O
immune	B-T038
responses	I-T038
to	O
some	O
vaccines	B-T103
have	O
also	O
been	O
observed	O
,	O
mostly	O
to	O
viral	B-T103
vaccines	I-T103
in	O
adults	O
.	O
little	O
evidence	O
is	O
available	O
on	O
whether	O
sex	O
-	O
differences	O
occur	O
in	O
response	B-T033
to	O
immunisation	B-T058
in	O
infancy	O
even	O
though	O
this	O
is	O
the	O
age	O
group	O
in	O
which	O
most	O
vaccines	B-T103
are	O
administered	O
.	O
factors	O
other	O
than	O
sex	O
,	O
such	O
as	O
timing	O
or	O
coadministration	B-T058
of	O
other	O
vaccines	B-T103
,	O
can	O
also	O
influence	O
the	O
immune	B-T038
response	I-T038
to	O
vaccination	B-T058
.	O
individual	B-T098
participant	B-T098
data	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
randomised	B-T062
controlled	I-T062
trials	I-T062
of	O
vaccines	B-T103
in	O
healthy	O
infants	O
and	O
young	O
children	O
will	O
be	O
conducted	O
.	O
fully	O
an	O
##onym	O
##ised	O
data	O
from	O
∼	O
##170	O
randomised	B-T062
controlled	I-T062
trials	I-T062
of	O
v	O
acc	B-T103
##ines	I-T103
for	O
diphtheria	B-T038
,	O
tetanus	B-T038
,	O
bor	B-T007
##de	I-T007
##te	I-T007
##ll	I-T007
##a	I-T007
pertussis	I-T007
,	O
polio	B-T038
,	O
haemophilus	B-T007
influenzae	I-T007
type	I-T007
b	I-T007
,	O
hepatitis	B-T038
b	I-T038
,	O
streptococcus	B-T007
pneumoniae	I-T007
,	O
neisseria	B-T007
meningitidis	I-T007
,	O
measles	B-T038
,	O
mumps	B-T038
,	O
rubella	B-T038
,	O
varicella	B-T038
and	O
rotavirus	B-T005
will	O
be	O
combined	O
for	O
analysis	B-T062
.	O
outcomes	O
include	O
measures	O
of	O
immunogenicity	B-T038
(	O
immunoglobulins	B-T103
)	O
,	O
react	B-T033
##ogenicity	I-T033
,	O
safety	O
and	O
disease	B-T038
-	O
specific	O
clinical	O
efficacy	O
.	O
data	O
from	O
trials	B-T062
of	O
vaccines	B-T103
containing	O
similar	O
components	O
will	O
be	O
combined	O
in	O
hierarchical	O
models	B-T170
and	O
the	O
effect	O
of	O
sex	O
and	O
timing	O
of	O
vaccinations	B-T058
estimated	O
for	O
each	O
outcome	O
separately	O
.	O
systematic	B-T170
reviews	I-T170
of	O
published	O
estimates	O
of	O
sex	O
-	O
differences	O
cann	O
##ot	O
adequately	O
answer	O
questions	O
in	O
this	O
field	O
since	O
such	O
comparisons	O
are	O
never	O
the	O
main	O
purpose	O
of	O
a	O
clinical	B-T062
trial	I-T062
,	O
thus	O
a	O
large	O
degree	O
of	O
reporting	B-T058
bias	O
exists	O
in	O
the	O
published	O
literature	B-T170
.	O
recent	O
improvements	O
in	O
the	O
widespread	B-T082
availability	O
of	O
individual	B-T098
participant	B-T098
data	O
from	O
randomised	B-T062
controlled	I-T062
trials	I-T062
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	B-T098
participant	B-T098
data	O
meta	B-T062
-	I-T062
analyses	I-T062
which	O
were	O
previously	O
impossible	B-T033
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	B-T170
or	O
reporting	B-T058
bias	O
on	O
the	O
understanding	B-T038
of	O
the	O
infant	O
immune	B-T038
response	I-T038
.	O
preliminary	O
results	O
will	O
be	O
available	O
in	O
2016	O
with	O
final	O
results	O
available	O
in	O
2019	O
.	O
no	O
ethics	O
review	B-T170
is	O
required	O
for	O
secondary	O
analyses	O
of	O
an	O
##onym	O
##ised	O
data	O
.	O

acute	O
macular	B-T038
edema	I-T038
and	O
perip	B-T082
##apillary	I-T082
soft	O
exudate	B-T031
after	O
pancreas	B-T058
transplantation	I-T058
with	O
accelerated	O
progression	B-T038
of	O
diabetic	B-T038
retinopathy	I-T038
the	O
effect	O
of	O
pancreas	B-T058
transplantation	I-T058
on	O
diabetic	B-T038
retinopathy	I-T038
remains	O
inconclusive	O
.	O
herein	O
,	O
we	O
report	O
six	O
patients	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
mellitus	I-T038
(	O
dm	B-T038
)	O
who	O
underwent	O
pancreas	B-T058
transplantation	I-T058
and	O
developed	O
acute	O
macular	B-T038
edema	I-T038
and	O
perip	B-T082
##apillary	I-T082
soft	O
exudate	B-T031
with	O
rapid	O
progression	B-T038
to	O
proliferative	B-T038
diabetic	I-T038
retinopathy	I-T038
.	O
in	O
this	O
retrospective	B-T062
observational	I-T062
study	I-T062
,	O
diabetic	B-T038
patients	O
who	O
underwent	O
pancreas	B-T058
transplantation	I-T058
in	O
a	O
single	O
medical	B-T092
center	I-T092
and	O
developed	O
symptomatic	O
acute	O
macular	B-T038
edema	I-T038
and	O
perip	B-T082
##apillary	I-T082
soft	O
exudate	B-T031
within	B-T082
3	O
months	O
after	O
the	O
operation	B-T058
were	O
enrolled	O
.	O
the	O
complete	O
ophthalmic	O
course	O
and	O
medical	B-T170
records	I-T170
of	O
the	O
patients	O
were	O
retrospectively	O
reviewed	O
.	O
diabetic	B-T038
retinopathy	I-T038
and	O
progression	B-T038
following	O
treatment	B-T058
after	O
pancreas	B-T058
transplantation	I-T058
were	O
measured	O
.	O
six	O
chinese	B-T098
women	B-T098
with	O
type	B-T038
1	I-T038
dm	I-T038
were	O
enrolled	O
in	O
this	O
study	B-T062
.	O
mean	O
hemoglobin	B-T103
(	I-T103
hb	I-T103
)	I-T103
a1c	I-T103
was	O
13	O
.	O
4	O
%	O
prior	O
to	O
transplantation	B-T058
and	O
decreased	O
rapidly	O
to	O
6	O
.	O
5	O
%	O
within	B-T082
2	O
months	O
posts	O
##urgery	O
.	O
the	O
patients	O
had	O
no	O
or	O
mild	O
pret	O
##ran	O
##sp	O
##la	O
##nt	O
diabetic	B-T038
retinopathy	I-T038
and	O
developed	O
acute	O
symptomatic	O
macular	B-T038
edema	I-T038
and	O
perip	B-T082
##apillary	I-T082
soft	O
exudate	B-T031
in	O
both	B-T017
eyes	I-T017
after	O
pancreas	B-T058
transplantation	I-T058
.	O
all	O
macular	B-T038
edema	I-T038
resolved	B-T033
either	O
with	O
or	O
without	O
treatment	B-T058
.	O
five	O
cases	O
progressed	B-T038
to	O
proliferative	B-T038
diabetic	I-T038
retinopathy	I-T038
and	O
received	O
pan	B-T058
##retinal	I-T058
photocoagulation	I-T058
.	O
diabetic	B-T038
retinopathy	I-T038
remained	O
stable	O
in	O
all	O
eyes	B-T017
after	O
treatment	B-T058
,	O
and	O
the	O
visual	O
prognosis	B-T033
was	I-T033
good	I-T033
,	O
except	O
in	O
one	O
eye	B-T017
that	O
had	O
macular	O
branch	B-T038
retinal	I-T038
artery	I-T038
occlusion	I-T038
with	O
foveal	B-T017
involvement	O
.	O
acute	O
macular	B-T038
edema	I-T038
after	O
pancreas	B-T058
transplantation	I-T058
has	O
a	O
favorable	O
treatment	O
outcome	O
despite	O
rapid	O
progression	B-T038
to	O
proliferative	B-T038
diabetic	I-T038
retinopathy	I-T038
.	O
high	O
pret	O
##ran	O
##sp	O
##la	O
##nt	O
hba1c	B-T103
and	O
abrupt	O
blood	B-T103
sugar	I-T103
normalization	O
may	O
be	O
related	O
to	O
the	O
disease	B-T038
course	I-T038
.	O

nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
in	O
thoracic	B-T038
esophageal	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
:	O
a	O
cohort	O
study	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
is	O
a	O
prognostic	B-T201
factor	I-T201
in	O
some	O
sites	O
of	O
malignancies	B-T038
,	O
but	O
its	O
role	O
in	O
esophageal	B-T038
cancer	I-T038
is	O
still	O
unclear	O
.	O
the	O
present	O
study	O
aimed	O
to	O
investigate	O
occurrence	O
and	O
effect	O
of	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastases	O
in	O
thoracic	B-T038
esophageal	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
.	O
all	O
57	O
##8	O
patients	O
undergoing	O
esophagectomy	B-T058
for	O
thoracic	B-T038
esophageal	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
at	O
the	O
center	B-T092
for	I-T092
esophageal	I-T092
diseases	I-T092
located	O
in	O
pad	O
##ova	O
between	O
january	O
1992	O
and	O
december	O
2010	O
were	O
retrospectively	B-T062
evaluated	I-T062
.	O
selection	O
criteria	O
were	O
r0	B-T033
resection	I-T033
,	O
pathological	O
m	B-T033
##0	I-T033
stage	I-T033
and	O
pathological	O
lymph	B-T033
node	I-T033
involvement	I-T033
.	O
patients	O
receiving	O
neoadjuvant	B-T058
therapy	I-T058
were	O
excluded	O
.	O
the	O
selection	O
identified	O
88	O
patients	O
with	O
lymph	B-T033
node	I-T033
involvement	I-T033
confirmed	O
by	O
pathological	O
evaluation	B-T058
.	O
sixteen	O
patients	O
(	O
18	O
.	O
2	O
%	O
)	O
had	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
.	O
adjusting	O
for	O
the	O
number	O
of	O
lymph	B-T038
node	I-T038
metastases	I-T038
,	O
patient	O
with	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
had	O
similar	O
5	O
-	O
year	O
overall	O
survival	O
(	O
14	O
%	O
vs	O
.	O
13	O
%	O
,	O
p	O
=	O
0	O
.	O
93	O
)	O
and	O
5	O
-	O
year	O
disease	O
free	O
survival	O
(	O
14	O
%	O
vs	O
.	O
9	O
%	O
,	O
p	O
=	O
0	O
.	O
48	O
)	O
compared	O
to	O
patients	O
with	O
both	O
perit	B-T082
##umor	I-T082
##al	I-T082
and	O
distant	B-T082
lymph	B-T038
node	I-T038
metastases	I-T038
.	O
the	O
risk	O
difference	O
of	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
was	O
:	O
-	O
24	O
.	O
1	O
%	O
(	O
95	O
%	O
c	O
.	O
i	O
.	O
-	O
43	O
.	O
1	O
%	O
to	O
-	O
5	O
.	O
2	O
%	O
)	O
in	O
patients	O
with	O
more	O
than	O
one	O
lymph	B-T038
node	I-T038
metastasis	I-T038
compared	O
to	O
those	O
with	O
one	O
lymph	B-T038
node	I-T038
metastasis	I-T038
;	O
-	O
2	O
.	O
3	O
%	O
(	O
95	O
%	O
c	O
.	O
i	O
.	O
-	O
29	O
.	O
8	O
%	O
to	O
25	O
.	O
2	O
%	O
)	O
in	O
middle	B-T082
thoracic	B-T017
esophagus	I-T017
and	O
-	O
23	O
.	O
0	O
%	O
(	O
95	O
%	O
c	O
.	O
i	O
.	O
-	O
47	O
.	O
8	O
%	O
to	O
1	O
.	O
8	O
%	O
)	O
in	O
lower	B-T082
thoracic	B-T017
esophagus	I-T017
compared	O
to	O
upper	B-T082
thoracic	B-T017
esophagus	I-T017
;	O
18	O
.	O
1	O
%	O
(	O
95	O
%	O
c	O
.	O
i	O
.	O
3	O
.	O
2	O
%	O
to	O
33	O
.	O
0	O
%	O
)	O
in	O
clinical	O
n0	B-T033
stage	I-T033
vs	O
.	O
clinical	O
n	B-T033
+	I-T033
stage	I-T033
.	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
is	O
a	O
common	O
pattern	O
of	O
metastatic	B-T033
lymph	I-T033
involvement	I-T033
in	O
thoracic	B-T038
esophageal	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
.	O
however	O
,	O
neither	O
overall	O
survival	O
nor	O
disease	O
free	O
survival	O
are	O
associated	O
with	O
nodal	B-T082
sk	B-T033
##ip	I-T033
metastasis	B-T038
occurrence	O
.	O

endurance	B-T033
based	O
personalized	B-T170
fitness	I-T170
plan	I-T170
##ner	I-T170
endurance	B-T033
is	O
an	O
important	O
factor	O
of	O
cardiovascular	B-T038
fitness	I-T038
indicating	O
the	O
capacity	O
of	O
an	O
individual	B-T098
to	O
perform	O
exercise	O
for	O
a	O
longer	O
duration	O
with	O
increased	O
intensity	O
.	O
various	O
subject	O
specific	O
and	O
exercise	O
related	O
parameters	O
affect	O
endurance	B-T033
of	O
an	O
individual	B-T098
.	O
in	O
this	O
work	O
,	O
we	O
propose	O
a	O
statistical	B-T062
technique	I-T062
to	O
model	B-T170
endurance	B-T033
as	O
a	O
function	O
of	O
these	O
factors	O
incorporating	O
the	O
serial	O
dependence	O
of	O
observations	B-T062
generated	O
by	O
individuals	B-T098
over	O
time	O
.	O
the	O
proposed	O
model	B-T170
provides	O
a	O
device	B-T074
to	O
predict	O
future	O
endurance	B-T033
of	O
a	O
test	O
subject	O
following	O
particular	O
exercise	B-T058
regime	I-T058
.	O
this	O
facilitates	O
a	O
test	O
user	O
with	O
a	O
fitness	B-T170
plan	I-T170
##ner	I-T170
with	O
the	O
provision	O
to	O
fix	O
exercise	B-T058
regimes	I-T058
to	O
reach	O
a	O
set	O
fitness	O
goal	B-T170
.	O

mode	O
##m	O
:	O
a	O
comprehensive	O
approach	B-T082
to	O
modelling	B-T062
outcome	O
and	O
costs	O
impacts	O
of	O
interventions	B-T058
for	O
dementia	B-T038
.	O
protocol	B-T170
paper	O
the	O
mode	O
##m	O
project	O
(	O
a	O
comprehensive	O
approach	B-T082
to	O
modelling	B-T062
outcome	O
and	O
costs	O
impacts	O
of	O
interventions	B-T058
for	O
dementia	B-T038
)	O
explores	O
how	O
changes	O
in	O
arrangements	O
for	O
the	O
future	O
treatment	B-T058
and	O
care	O
of	O
people	B-T098
living	O
with	O
dementia	B-T038
,	O
and	O
support	B-T058
for	O
family	O
and	O
other	O
unp	B-T033
##aid	I-T033
carers	B-T097
,	O
could	O
result	O
in	O
better	O
outcomes	O
and	O
more	O
efficient	O
use	O
of	O
resources	O
.	O
mode	O
##m	O
starts	O
with	O
a	O
systematic	O
mapping	O
of	O
the	O
literature	B-T170
on	O
effective	O
and	O
(	O
potentially	O
)	O
cost	O
-	O
effective	O
interventions	B-T058
in	O
dementia	B-T038
care	O
.	O
those	O
findings	O
,	O
as	O
well	O
as	O
data	O
from	O
a	O
cohort	B-T098
,	O
will	O
then	O
be	O
used	O
to	O
model	B-T170
the	O
quality	O
of	O
life	O
and	O
cost	O
impacts	O
of	O
making	O
these	O
evidence	O
-	O
based	O
interventions	B-T058
more	O
widely	O
available	O
in	O
england	B-T082
over	O
the	O
period	O
from	O
now	O
to	O
204	O
##0	O
.	O
modelling	B-T062
will	O
use	O
a	O
suite	O
of	O
models	B-T170
,	O
combining	O
micros	O
##im	O
##ulation	O
and	O
macros	O
##im	O
##ulation	O
methods	O
,	O
modelling	B-T062
the	O
costs	O
and	O
outcomes	O
of	O
care	O
,	O
both	O
for	O
an	O
individual	B-T098
over	O
the	O
life	O
-	O
course	O
from	O
the	O
point	O
of	O
dementia	B-T038
diagnosis	I-T038
,	O
and	O
for	O
individuals	B-T098
and	O
england	B-T082
as	O
a	O
whole	O
in	O
a	O
particular	O
year	O
.	O
project	O
outputs	O
will	O
include	O
an	O
online	O
dementia	B-T170
evidence	I-T170
tool	I-T170
##ki	I-T170
##t	I-T170
,	O
making	O
evidence	O
summar	B-T170
##ies	I-T170
and	O
a	O
literature	B-T170
database	B-T170
available	O
free	O
to	O
any	O
##one	O
,	O
papers	O
in	O
academic	B-T170
journals	I-T170
and	O
other	O
written	O
outputs	O
,	O
and	O
a	O
mode	B-T170
##m	I-T170
leg	I-T170
##acy	I-T170
model	I-T170
,	O
which	O
will	O
enable	O
local	B-T097
commission	I-T097
##ers	I-T097
of	O
services	O
to	O
apply	O
the	O
model	B-T170
to	O
their	O
own	O
populations	B-T098
.	O
modelling	B-T062
the	O
effects	O
of	O
evidence	O
-	O
based	O
cost	O
-	O
effective	O
interventions	B-T058
and	O
making	O
this	O
information	O
widely	O
available	O
has	O
the	O
potential	O
to	O
improve	B-T033
the	O
health	O
and	O
quality	O
of	O
life	O
both	O
of	O
people	B-T098
with	O
dementia	B-T038
and	O
their	O
carers	B-T097
,	O
while	O
ensuring	O
that	O
resources	O
are	O
used	O
efficiently	O
.	O

comparative	O
and	O
evolutionary	B-T062
analysis	I-T062
of	O
an	O
adapt	B-T017
##er	I-T017
molecule	I-T017
myd88	I-T017
in	O
invertebrate	B-T204
metazo	B-T204
##ans	I-T204
the	O
myeloid	B-T017
differentiation	I-T017
factor	I-T017
88	I-T017
(	O
myd88	B-T017
)	O
is	O
an	O
essential	O
adapt	O
##er	O
in	O
toll	B-T103
-	I-T103
like	I-T103
receptor	I-T103
(	O
tlr	B-T103
)	O
signalling	B-T038
pathways	I-T038
,	O
with	O
tlr	B-T103
the	O
first	O
pattern	B-T103
-	I-T103
recognition	I-T103
receptor	I-T103
(	O
pr	B-T103
##r	I-T103
)	O
that	O
was	O
discovered	O
in	O
drosophila	B-T204
.	O
in	O
the	O
present	O
study	B-T062
,	O
a	O
myd88	B-T017
gene	I-T017
was	O
identified	O
and	O
characterized	O
from	O
a	O
commercially	O
important	O
shell	B-T204
##fish	I-T204
,	O
scaph	B-T204
##arc	I-T204
##a	I-T204
subc	I-T204
##ren	I-T204
##ata	I-T204
,	O
including	O
a	O
death	B-T082
domain	I-T082
and	O
tir	B-T082
domain	I-T082
conserved	O
within	O
other	O
moll	B-T204
##usc	I-T204
##s	I-T204
.	O
furthermore	O
,	O
comparative	B-T062
genomic	I-T062
evidence	I-T062
revealed	O
that	O
myd88	B-T017
was	O
of	O
different	O
lengths	O
and	O
contained	O
quantitative	O
exon	B-T103
and	O
intron	B-T103
regions	I-T103
,	O
which	O
might	O
be	O
involved	O
in	O
specific	O
mechanisms	O
.	O
to	O
further	O
explore	O
the	O
phylogenetic	B-T062
relationships	I-T062
of	O
invertebrate	B-T204
metazo	B-T204
##an	I-T204
myd88	B-T017
,	O
we	O
applied	O
mr	B-T170
##ba	I-T170
##y	I-T170
##es	I-T170
and	I-T170
ph	I-T170
##ym	I-T170
##l	I-T170
software	I-T170
to	O
construct	B-T170
phylogenetic	O
trees	O
using	O
bayesian	O
and	O
maximum	B-T170
likelihood	I-T170
approaches	I-T170
,	O
respectively	O
,	O
which	O
suggested	O
that	O
the	O
myd88	B-T017
of	O
arthropod	B-T204
##a	I-T204
was	O
closely	O
related	O
to	O
lower	O
invertebrates	B-T204
,	O
in	O
contrast	O
to	O
morphological	B-T082
taxonomy	O
.	O
finally	O
,	O
we	O
investigated	O
the	O
evolutionary	B-T038
patterns	I-T038
and	O
location	O
of	O
positive	B-T017
selection	I-T017
sites	I-T017
(	O
pss	B-T017
##s	I-T017
)	O
in	O
the	O
myd88	B-T017
gene	I-T017
from	O
arthropod	B-T204
##a	I-T204
,	O
moll	B-T204
##usc	I-T204
##a	I-T204
and	O
insect	B-T204
##a	I-T204
using	O
pam	B-T170
##l	I-T170
software	I-T170
with	O
the	O
maximum	B-T170
likelihood	I-T170
method	I-T170
.	O
the	O
data	O
showed	O
that	O
positive	B-T017
selection	I-T017
sites	I-T017
were	O
detected	B-T033
in	O
these	O
groups	B-T098
,	O
and	O
partial	B-T082
sites	I-T082
were	O
located	O
in	O
the	O
tir	B-T082
domain	I-T082
but	O
were	O
not	B-T033
found	I-T033
in	O
the	O
death	B-T082
domain	I-T082
.	O
to	O
summarize	O
,	O
in	O
this	O
study	B-T062
,	O
we	O
report	O
on	O
the	O
diversification	O
of	O
myd88	B-T017
in	O
invertebrate	B-T204
metazo	B-T204
##ans	I-T204
,	O
the	O
specific	O
evolutionary	B-T038
position	I-T038
of	O
arthropod	B-T204
##a	I-T204
myd88	B-T017
,	O
and	O
the	O
positive	B-T033
selection	B-T038
pressures	I-T038
on	O
myd88	B-T017
of	O
arthropod	B-T204
##a	I-T204
,	O
moll	B-T204
##usc	I-T204
##a	I-T204
and	O
insect	B-T204
##a	I-T204
.	O
these	O
results	O
are	O
a	O
valuable	O
contribution	O
to	O
understand	O
and	O
clarify	O
the	O
evolutionary	B-T038
pattern	I-T038
of	O
tlr	B-T103
/	O
myd88	B-T017
signalling	B-T038
pathways	I-T038
in	O
invertebrate	B-T204
and	O
vertebrate	B-T204
taxa	I-T204
.	O

creative	O
approach	O
for	O
successful	O
aging	B-T038
:	O
a	O
pilot	B-T062
study	I-T062
of	O
an	O
inter	O
##gener	O
##ational	O
health	B-T058
promotion	I-T058
program	I-T058
to	O
develop	O
and	O
evaluate	B-T058
the	O
effectiveness	O
of	O
an	O
inter	O
##gener	O
##ational	O
health	B-T058
promotion	I-T058
program	I-T058
.	O
this	O
was	O
an	O
action	O
research	O
project	O
.	O
a	O
total	O
of	O
34	O
participants	B-T098
attended	O
the	O
12	O
-	O
week	O
program	B-T058
and	O
completed	O
the	O
pre	B-T170
-	I-T170
test	I-T170
and	I-T170
post	I-T170
-	I-T170
test	I-T170
.	O
there	O
were	O
16	O
middle	O
-	O
aged	O
and	O
nine	O
older	B-T098
adults	I-T098
recruited	O
from	O
a	O
district	O
of	O
tai	B-T082
##pe	I-T082
##i	I-T082
,	O
and	O
nine	O
young	O
adults	O
recruited	O
from	O
the	O
principal	B-T097
investigator	I-T097
'	I-T097
s	I-T097
university	B-T092
.	O
the	O
[UNK]	O
attitudes	B-T170
toward	I-T170
aging	I-T170
scale	I-T170
[UNK]	O
and	O
the	O
[UNK]	O
spiritual	B-T170
health	I-T170
scale	I-T170
[UNK]	O
were	O
two	O
assessment	B-T058
instruments	B-T170
used	O
in	O
the	O
study	B-T062
.	O
the	O
results	O
showed	O
that	O
there	O
were	O
significant	O
improvements	O
in	O
the	O
attitudes	B-T170
toward	I-T170
aging	I-T170
scale	I-T170
for	O
the	O
young	O
adult	O
group	O
(	O
aged	O
18	O
-	O
29	O
years	O
)	O
and	O
in	O
the	O
spiritual	B-T170
health	I-T170
scale	I-T170
for	O
the	O
older	B-T098
adult	I-T098
group	O
(	O
aged	O
65	O
-	O
80	O
years	O
)	O
.	O
the	O
evaluation	B-T058
showed	O
that	O
participants	B-T098
were	O
satisfied	B-T038
with	O
the	O
program	B-T058
.	O
the	O
results	O
of	O
the	O
present	O
study	O
provide	O
future	O
directions	O
for	O
successful	O
aging	B-T038
and	O
inter	O
##gener	O
##ational	O
learning	O
.	O
ger	O
##iatr	O
ger	O
##onto	O
##l	O
int	O
2017	O
;	O
•	O
•	O
:	O
•	O
•	O
-	O
•	O
•	O
.	O

women	B-T098
'	I-T098
s	I-T098
perspectives	O
on	O
human	B-T005
papillomavirus	I-T005
self	B-T058
-	I-T058
sampling	I-T058
in	O
the	O
context	O
of	O
the	O
uk	B-T082
cervical	B-T017
screening	O
programme	O
testing	O
for	O
human	B-T005
papillomavirus	I-T005
(	O
hpv	B-T005
)	O
is	O
being	O
incorporated	O
into	O
the	O
cervical	B-T017
screening	O
programme	O
,	O
with	O
the	O
probable	O
future	O
introduction	O
of	O
hpv	B-T005
as	O
a	O
primary	O
test	O
and	O
a	O
possibility	O
of	O
hpv	B-T005
self	B-T058
-	I-T058
sampling	I-T058
.	O
in	O
anticipation	O
of	O
this	O
development	O
,	O
we	O
sought	O
to	O
inform	O
future	O
policy	B-T170
and	O
practice	B-T038
by	O
identifying	O
potential	O
barriers	O
to	O
hpv	B-T005
self	B-T058
-	I-T058
sampling	I-T058
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
survey	I-T062
of	O
194	O
women	B-T098
aged	O
20	O
-	O
64	O
years	O
was	O
conducted	O
.	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
identify	O
determinants	O
of	O
self	B-T058
-	I-T058
sampling	I-T058
intentions	O
.	O
a	O
purpos	O
##ive	O
subsam	O
##ple	O
of	O
19	O
women	B-T098
who	O
reported	O
low	O
self	B-T058
-	I-T058
sampling	I-T058
intentions	O
were	O
interviewed	O
.	O
interviews	O
were	O
framework	O
-	O
analysed	O
.	O
most	O
survey	B-T170
participants	B-T098
(	O
n	O
=	O
133	O
,	O
69	O
.	O
3	O
%	O
)	O
intended	O
to	O
hpv	B-T005
self	O
-	O
sample	O
.	O
lower	O
intention	B-T038
was	O
associated	O
with	O
lower	O
self	O
-	O
efficacy	O
(	O
or	O
=	O
24	O
.	O
96	O
,	O
p	O
##≤	O
.	O
001	O
)	O
,	O
lower	O
education	O
(	O
or	O
=	O
6	O
.	O
06	O
,	O
p	O
##≤	O
.	O
05	O
)	O
and	O
lower	O
perceived	B-T038
importance	O
of	O
hpv	B-T005
as	O
a	O
cause	O
of	O
cervical	B-T038
cancer	I-T038
(	O
or	O
=	O
2	O
.	O
33	O
,	O
p	O
##≤	O
.	O
05	O
)	O
.	O
interviews	O
revealed	O
personal	O
and	O
system	O
-	O
related	O
barriers	O
.	O
personal	O
barriers	O
included	O
a	O
lack	O
of	O
knowledge	B-T170
about	O
hpv	B-T005
self	B-T058
-	I-T058
sampling	I-T058
,	O
women	B-T098
'	I-T098
s	I-T098
low	B-T033
confidence	I-T033
in	O
their	O
ability	O
to	O
self	O
-	O
sample	O
correctly	O
and	O
low	B-T033
confidence	I-T033
in	O
the	O
subsequent	O
results	O
.	O
system	O
-	O
related	O
factors	O
included	O
a	O
lack	B-T033
of	I-T033
confidence	I-T033
in	O
the	O
rationale	O
for	O
modifying	O
the	O
current	O
cervical	B-T017
screening	O
programme	O
,	O
and	O
concerns	O
about	O
sample	O
contamination	O
and	O
identity	O
the	O
##ft	O
.	O
insights	O
gained	O
from	O
this	O
research	B-T062
can	O
be	O
used	O
to	O
guide	O
further	O
en	O
##qu	O
##iry	O
into	O
the	O
possibility	O
of	O
hpv	B-T005
self	B-T058
-	I-T058
sampling	I-T058
and	O
to	O
help	O
inform	O
future	O
policy	B-T170
and	O
practice	B-T038
.	O
personal	O
and	O
system	B-T033
-	I-T033
related	I-T033
barriers	I-T033
including	O
low	B-T033
confidence	I-T033
in	O
the	O
reasons	O
for	O
changing	O
current	O
cervical	B-T017
screening	B-T058
provision	O
need	O
to	O
be	O
addressed	O
,	O
should	O
hpv	B-T005
self	B-T058
-	I-T058
sampling	I-T058
be	O
incorporated	O
into	O
the	O
cervical	B-T017
screening	O
programme	O
.	O

the	O
transcription	B-T103
factors	I-T103
ms	B-T103
##18	I-T103
##8	I-T103
and	O
ams	B-T103
form	O
a	O
complex	O
to	O
activate	O
the	O
expression	B-T038
of	O
cyp	B-T103
##70	I-T103
##3a	I-T103
##2	I-T103
for	O
spor	B-T038
##opol	I-T038
##len	I-T038
##in	I-T038
biosynthesis	I-T038
in	O
arabidopsis	B-T204
thaliana	I-T204
the	O
sex	B-T017
##ine	I-T017
layer	I-T017
of	O
pollen	B-T204
grain	I-T204
is	O
mainly	O
composed	O
of	O
spor	B-T103
##opol	I-T103
##len	I-T103
##ins	I-T103
.	O
the	O
spor	B-T017
##ophytic	I-T017
secretory	I-T017
tape	I-T017
##t	I-T017
##um	I-T017
is	O
required	O
for	O
the	O
biosynthesis	B-T038
of	I-T038
spor	I-T038
##opol	I-T038
##len	I-T038
##in	I-T038
.	O
although	O
several	O
enzymes	B-T103
involved	O
in	O
spor	B-T038
##opol	I-T038
##len	I-T038
##in	I-T038
biosynthesis	I-T038
have	O
been	O
reported	O
,	O
the	O
regulatory	B-T038
mechanism	I-T038
of	O
these	O
enzymes	B-T103
in	O
tape	B-T017
##tal	I-T017
layer	I-T017
remains	O
elusive	O
.	O
abor	B-T103
##ted	I-T103
microspor	I-T103
##es	I-T103
(	O
ams	B-T103
)	O
and	O
male	B-T103
sterile	I-T103
188	I-T103
/	O
myb	B-T103
##10	I-T103
##3	I-T103
/	O
myb	B-T103
##80	I-T103
(	O
ms	B-T103
##18	I-T103
##8	I-T103
/	O
myb	B-T103
##10	I-T103
##3	I-T103
/	O
myb	B-T103
##80	I-T103
)	O
are	O
two	O
tape	B-T017
##tal	I-T017
cell	I-T017
-	O
specific	O
transcription	B-T103
factors	I-T103
required	O
for	O
pollen	B-T038
wall	I-T038
formation	I-T038
.	O
ams	B-T103
functions	O
upstream	B-T082
of	O
ms	B-T103
##18	I-T103
##8	I-T103
.	O
here	O
we	O
report	O
that	O
ams	B-T103
and	O
ms	B-T103
##18	I-T103
##8	I-T103
target	O
the	O
cyp	B-T017
##70	I-T017
##3a	I-T017
##2	I-T017
gene	I-T017
,	O
which	O
is	O
involved	O
in	O
spor	B-T038
##opol	I-T038
##len	I-T038
##in	I-T038
biosynthesis	I-T038
.	O
we	O
found	O
that	O
ams	B-T103
and	O
ms	B-T103
##18	I-T103
##8	I-T103
were	O
localized	B-T082
in	O
tape	B-T017
##t	I-T017
##um	I-T017
while	O
cyp	B-T103
##70	I-T103
##3a	I-T103
##2	I-T103
was	O
localized	B-T082
in	O
both	O
tape	B-T017
##t	I-T017
##um	I-T017
and	O
loc	B-T204
##ule	I-T204
.	O
chromatin	B-T058
immunoprecipitation	I-T058
(	O
chip	B-T058
)	O
showed	O
that	O
ms	B-T103
##18	I-T103
##8	I-T103
directly	O
bound	O
to	O
the	O
promoter	B-T103
of	O
cyp	B-T017
##70	I-T017
##3a	I-T017
##2	I-T017
and	O
luciferase	B-T103
-	I-T103
inducible	I-T103
assay	B-T058
showed	O
that	O
ms	B-T103
##18	I-T103
##8	I-T103
activated	O
the	O
expression	B-T038
of	O
cyp	B-T103
##70	I-T103
##3a	I-T103
##2	I-T103
.	O
yeast	B-T062
two	I-T062
-	I-T062
hybrid	I-T062
and	O
electrophoretic	B-T058
mobility	I-T058
shift	I-T058
assays	I-T058
(	O
ems	B-T058
##as	I-T058
)	O
further	O
demonstrated	O
that	O
ms	B-T103
##18	I-T103
##8	I-T103
complexed	O
with	O
ams	B-T103
.	O
the	O
expression	B-T038
of	O
cyp	B-T017
##70	I-T017
##3a	I-T017
##2	I-T017
could	O
be	O
partially	O
restored	O
by	O
the	O
elevated	O
levels	O
of	O
ms	B-T103
##18	I-T103
##8	I-T103
in	O
the	O
ams	B-T103
mutant	B-T038
.	O
therefore	O
,	O
our	O
data	O
reveal	O
that	O
ms	B-T103
##18	I-T103
##8	I-T103
coordinates	O
with	O
ams	B-T103
to	O
activate	O
cyp	B-T103
##70	I-T103
##3a	I-T103
##2	I-T103
in	O
spor	B-T038
##opol	I-T038
##len	I-T038
##in	I-T038
biosynthesis	I-T038
of	O
plant	B-T204
tape	B-T017
##t	I-T017
##um	I-T017
.	O

effect	O
of	O
hepatitis	B-T038
c	I-T038
virus	I-T038
coinfection	I-T038
on	O
the	O
content	O
of	O
cd4	O
(	O
+	O
)	O
and	O
cd8	O
(	O
+	O
)	O
t	B-T017
cell	I-T017
subpopulations	B-T170
in	O
hiv	B-T005
-	O
infected	B-T033
patients	O
receiving	O
antiretroviral	B-T058
therapy	I-T058
we	O
studied	O
the	O
effect	O
of	O
hepatitis	B-T038
c	I-T038
virus	I-T038
coinfection	I-T038
on	O
t	B-T017
cell	I-T017
subpopulations	B-T170
in	O
hiv	B-T005
-	O
infected	B-T033
patients	O
receiving	O
antiretroviral	B-T058
therapy	I-T058
.	O
coinfection	B-T038
with	O
hepatitis	B-T005
c	I-T005
virus	I-T005
was	O
followed	O
by	O
a	O
decrease	O
in	O
the	O
number	O
of	O
naive	B-T017
cd4	I-T017
(	I-T017
+	I-T017
)	I-T017
t	I-T017
cells	I-T017
and	O
an	O
increase	O
in	O
the	O
count	O
of	O
central	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
memory	I-T017
t	I-T017
cells	I-T017
in	O
these	O
patients	O
.	O
hepatitis	B-T005
c	I-T005
virus	I-T005
had	O
no	O
effect	O
on	O
the	O
number	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
memory	I-T017
t	I-T017
cells	I-T017
(	O
main	O
target	O
for	O
hiv	B-T005
)	O
.	O
this	O
can	O
explain	O
the	O
absence	O
of	O
strong	O
negative	B-T033
effect	O
of	O
hepatitis	B-T005
c	I-T005
virus	I-T005
on	O
the	O
course	O
of	O
hiv	B-T005
infection	B-T038
.	O

trends	O
in	O
dietary	B-T038
intake	I-T038
among	O
adults	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
:	O
nh	B-T062
##anes	I-T062
1988	O
-	O
2012	O
dietary	B-T168
recommendations	O
for	O
adults	O
with	O
diabetes	B-T038
are	O
to	O
follow	O
a	O
healthy	B-T058
diet	I-T058
in	O
appropriate	O
portion	O
sizes	O
.	O
we	O
determined	O
recent	O
trends	O
in	O
energy	O
and	O
nutrient	O
intakes	O
among	O
a	O
nationally	O
representative	O
sample	O
of	O
us	B-T082
adults	O
with	O
and	O
without	O
type	B-T038
2	I-T038
diabetes	I-T038
.	O
participants	B-T098
were	O
adults	O
aged	O
≥2	O
##0	O
years	O
from	O
the	O
cross	B-T062
-	I-T062
sectional	I-T062
national	I-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
surveys	I-T062
,	O
1988	O
-	O
2012	O
(	O
n	O
=	O
49	O
77	O
##0	O
)	O
.	O
diabetes	B-T038
was	O
determined	O
by	O
self	B-T062
-	I-T062
report	I-T062
of	O
a	O
physician	B-T097
'	I-T097
s	I-T097
diagnosis	B-T033
(	O
n	O
=	O
488	O
##5	O
)	O
.	O
intake	O
of	O
energy	O
and	O
nutrients	B-T168
were	O
determined	O
from	O
a	O
24	O
-	O
h	O
recall	O
by	O
participants	B-T098
of	O
all	O
food	B-T168
consumed	O
.	O
linear	O
regression	O
was	O
used	O
to	O
test	O
for	O
trends	O
in	O
mean	O
intake	B-T038
over	O
time	O
for	O
all	O
participants	B-T098
and	O
by	O
demographic	O
characteristics	O
.	O
among	O
adults	O
with	O
diabetes	B-T038
,	O
overall	O
total	O
energy	O
intake	O
increased	O
between	O
1988	O
-	O
1994	O
and	O
2011	O
-	O
2012	O
(	O
168	O
##9	O
kcal	O
versus	O
189	O
##5	O
kcal	O
;	O
ptr	O
##end	O
<	O
0	O
.	O
001	O
)	O
with	O
evidence	O
of	O
a	O
plateau	O
between	O
2003	O
-	O
2006	O
and	O
2011	O
-	O
2012	O
.	O
in	O
2007	O
-	O
2012	O
,	O
energy	O
intake	O
was	O
greater	O
for	O
younger	O
than	O
older	B-T098
adults	I-T098
,	O
for	O
men	B-T098
than	O
women	B-T098
,	O
and	O
for	O
non	O
-	O
hispanic	O
whites	O
versus	O
non	B-T098
-	I-T098
hispanic	I-T098
blacks	I-T098
.	O
there	O
was	O
no	O
change	O
in	O
the	O
percentage	O
of	O
calories	O
from	O
carbohydrate	B-T168
,	O
total	B-T103
fat	I-T103
or	O
protein	B-T168
.	O
percentage	O
of	O
calories	O
from	O
saturated	O
fat	O
was	O
similar	O
across	O
study	B-T062
periods	O
but	O
remained	O
above	O
recommendations	O
(	O
11	O
.	O
2	O
%	O
in	O
2011	O
-	O
2012	O
)	O
.	O
fibre	B-T033
intake	I-T033
significantly	O
decreased	O
and	O
remained	O
below	O
recommendations	O
(	O
ptr	O
##end	O
=	O
0	O
.	O
002	O
)	O
.	O
sodium	B-T168
,	O
cholesterol	B-T103
and	O
calcium	B-T103
intakes	B-T038
increased	O
.	O
there	O
was	O
no	O
change	O
in	O
energy	O
intake	O
among	O
adults	O
without	O
diabetes	B-T038
and	O
dietary	B-T168
trends	O
were	O
similar	O
to	O
those	O
with	O
diabetes	B-T038
.	O
future	O
data	O
are	O
needed	O
to	O
confirm	O
a	O
plateau	O
in	O
energy	O
intake	O
among	O
adults	O
with	O
diabetes	B-T038
,	O
although	O
the	O
opportunity	O
exists	O
to	O
increase	O
fibre	B-T168
and	O
reduce	O
saturated	O
fat	O
.	O

histomorph	B-T058
##ometric	I-T058
and	O
transcriptome	B-T082
evaluation	B-T058
of	O
early	O
healing	B-T033
bone	I-T033
treated	B-T058
with	I-T058
a	O
novel	O
human	B-T031
particulate	I-T031
dentin	I-T031
powder	B-T103
human	B-T031
particulate	I-T031
dentin	I-T031
(	O
hp	B-T031
##d	I-T031
)	O
shows	O
potential	O
as	O
an	O
alternative	O
bone	B-T058
grafting	I-T058
material	B-T103
.	O
however	O
,	O
the	O
mechanism	O
of	O
bone	B-T033
healing	I-T033
at	O
the	O
molecular	O
level	O
after	O
grafting	B-T058
with	O
hp	B-T031
##d	I-T031
is	O
unclear	O
.	O
this	O
study	B-T062
assessed	O
the	O
histological	O
and	O
global	O
gene	B-T038
expression	I-T038
of	O
bone	B-T017
tissues	I-T017
grafted	O
with	O
hp	B-T031
##d	I-T031
.	O
the	O
hp	B-T031
##d	I-T031
was	O
prepared	B-T033
to	O
250	O
-	O
500	O
µm	O
in	O
size	O
.	O
x	B-T058
-	I-T058
ray	I-T058
diffraction	I-T058
(	O
xrd	B-T058
)	O
and	O
energy	B-T058
dispersive	I-T058
x	I-T058
-	I-T058
ray	I-T058
spectroscopy	I-T058
(	O
ed	B-T058
##x	I-T058
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	B-T103
structure	I-T103
,	O
organic	B-T103
compound	I-T103
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O
bony	O
defects	O
were	O
created	O
on	O
the	O
heads	B-T082
of	O
24	O
new	B-T204
zealand	I-T204
white	I-T204
rabbits	I-T204
.	O
sterilized	O
hp	B-T031
##d	I-T031
was	O
used	O
as	O
the	O
grafting	B-T103
material	I-T103
.	O
the	O
quality	O
and	O
quantity	O
of	O
new	B-T038
bone	I-T038
formation	I-T038
was	O
evaluated	B-T058
using	O
micro	B-T058
-	I-T058
ct	I-T058
and	O
histologic	O
analyses	B-T062
during	O
the	O
8	O
week	O
experimental	O
periods	O
.	O
for	O
microarray	B-T058
assay	I-T058
,	O
bone	B-T017
tissue	I-T017
and	O
blood	B-T031
samples	I-T031
were	O
taken	O
at	O
3	O
,	O
5	O
and	O
7	O
d	O
post	O
-	O
implantation	O
.	O
the	O
results	B-T033
of	O
xrd	B-T058
and	O
ed	B-T058
##x	I-T058
showed	O
that	O
hp	B-T031
##d	I-T031
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	O
to	O
natural	O
hydroxyapatite	B-T103
.	O
new	B-T038
bone	I-T038
formation	I-T038
was	O
observed	O
after	O
hp	B-T031
##d	I-T031
implantation	B-T058
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	B-T058
and	I-T058
eosin	I-T058
staining	I-T058
and	O
micro	B-T058
-	I-T058
ct	I-T058
.	O
the	O
bone	O
volume	O
of	O
hp	B-T031
##d	I-T031
treated	O
animals	B-T204
was	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
at	O
all	O
observation	B-T062
times	O
.	O
microarray	B-T058
analysis	I-T058
showed	O
that	O
vascular	B-T038
development	I-T038
coupled	O
with	O
immune	O
and	O
inflammatory	O
related	O
genes	B-T017
were	O
expressed	B-T038
in	O
the	O
early	O
healing	B-T038
stage	O
.	O
the	O
gene	B-T017
coding	I-T017
for	O
the	O
il	B-T103
-	I-T103
1	I-T103
antagonist	I-T103
,	O
il	B-T017
##1r	I-T017
##n	I-T017
,	O
was	O
expressed	B-T038
to	O
inhibit	B-T038
the	O
inflammatory	B-T038
response	I-T038
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
ccl2	B-T017
gene	I-T017
was	O
activated	O
to	O
2	O
.	O
3	O
times	O
the	O
normal	O
level	O
.	O
bmp	B-T017
##2	I-T017
,	O
runx2	B-T017
,	O
col	B-T017
##1a	I-T017
,	O
and	O
opn	B-T017
expression	B-T038
were	O
also	O
up	B-T038
-	I-T038
regulated	I-T038
.	O
ccl2	B-T017
predominated	O
in	O
osteoblast	B-T038
##ogenesis	I-T038
of	O
the	O
hp	B-T031
##d	I-T031
-	O
treated	O
bony	O
defect	O
in	O
the	O
early	O
stage	O
of	O
healing	B-T038
.	O
hp	B-T031
##d	I-T031
accelerated	O
bone	B-T038
regeneration	I-T038
and	O
augmentation	B-T033
.	O
these	O
results	B-T033
suggested	O
that	O
hp	B-T031
##d	I-T031
provided	O
potential	O
as	O
a	O
bone	B-T058
graft	I-T058
resource	O
during	O
the	O
bone	B-T017
healing	B-T038
process	I-T038
.	O

impact	O
of	O
blood	B-T058
transfusions	I-T058
on	O
survival	O
of	O
locally	B-T082
advanced	O
cervical	B-T038
cancer	I-T038
patients	O
undergoing	O
neoadjuvant	O
chemotherapy	O
plus	O
radical	B-T058
surgery	I-T058
transfusions	B-T058
represent	O
one	O
of	O
the	O
main	O
progresses	O
of	O
modern	O
medicine	O
.	O
however	O
,	O
accumulating	O
evidence	O
supports	O
that	O
transfusions	B-T058
correlate	O
with	O
worse	O
survival	O
outcomes	O
in	O
patients	O
affected	O
by	O
solid	B-T038
cancers	I-T038
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
perioperative	O
blood	B-T058
transfusion	I-T058
in	O
locally	B-T082
advanced	O
cervical	B-T038
cancer	I-T038
.	O
data	O
of	O
consecutive	O
patients	O
affected	O
by	O
locally	B-T082
advanced	O
cervical	B-T038
cancer	I-T038
scheduled	O
to	O
undergo	O
neoadjuvant	O
chemotherapy	O
plus	O
radical	B-T058
surgery	I-T058
were	O
retrospectively	B-T062
searched	O
to	O
test	O
the	O
impact	O
of	O
perioperative	O
transfusions	B-T058
on	O
survival	O
outcomes	O
.	O
five	O
-	O
year	O
survival	O
outcomes	O
were	O
evaluated	O
using	O
kaplan	B-T062
-	I-T062
meier	I-T062
and	O
cox	B-T170
models	I-T170
.	O
the	O
study	B-T062
included	O
275	O
patients	O
.	O
overall	O
,	O
170	O
(	O
62	O
%	O
)	O
patients	O
had	O
blood	B-T058
transfusion	I-T058
.	O
via	O
univariate	O
analysis	O
,	O
we	O
observed	O
that	O
transfusion	B-T058
correlated	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
recurrence	B-T038
(	O
hazard	O
ratio	O
[	O
hr	O
]	O
,	O
2	O
.	O
2	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
,	O
1	O
.	O
09	O
-	O
4	O
.	O
40	O
;	O
p	O
=	O
0	O
.	O
02	O
)	O
.	O
other	O
factors	O
associated	O
with	O
5	O
-	O
year	O
disease	O
-	O
free	O
survival	O
were	O
noncompl	B-T033
##ete	I-T033
clinical	B-T033
response	I-T033
after	O
neoadjuvant	O
chemotherapy	O
(	O
hr	O
,	O
2	O
.	O
99	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
92	O
-	O
9	O
.	O
63	O
;	O
p	O
=	O
0	O
.	O
06	O
)	O
and	O
pathological	B-T033
(	O
p	O
=	O
0	O
.	O
03	O
)	O
response	B-T033
at	O
neoadjuvant	O
chemotherapy	O
as	O
well	O
as	O
param	B-T082
##etr	I-T082
##ial	I-T082
(	O
p	O
=	O
0	O
.	O
004	O
)	O
,	O
vaginal	B-T017
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
lymph	B-T017
node	I-T017
(	O
p	O
=	O
0	O
.	O
002	O
)	O
involvement	O
##s	O
.	O
however	O
,	O
via	O
multivariate	O
analysis	O
,	O
only	O
vaginal	B-T017
(	O
hr	O
,	O
3	O
.	O
07	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
20	O
-	O
7	O
.	O
85	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
lymph	B-T017
node	I-T017
involvement	O
##s	O
(	O
hr	O
,	O
2	O
.	O
4	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
00	O
-	O
6	O
.	O
06	O
;	O
p	O
=	O
0	O
.	O
05	O
)	O
correlate	O
with	O
worse	O
disease	O
-	O
free	O
survival	O
.	O
no	O
association	O
with	O
worse	O
outcomes	O
was	O
observed	O
for	O
patients	O
undergoing	O
blood	B-T058
transfusion	I-T058
(	O
hr	O
,	O
2	O
.	O
71	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
91	O
-	O
8	O
.	O
03	O
;	O
p	O
=	O
0	O
.	O
07	O
)	O
.	O
looking	O
at	O
factors	O
influencing	O
overall	O
survival	O
,	O
we	O
observed	O
that	O
lymph	B-T017
node	I-T017
status	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
vaginal	B-T017
involvement	O
(	O
p	O
=	O
0	O
.	O
06	O
)	O
were	O
independently	O
associated	O
with	O
survival	O
.	O
the	O
role	O
of	O
blood	B-T058
transfusions	I-T058
in	O
increasing	O
the	O
risk	O
of	O
developing	O
recurrence	B-T038
in	O
laa	B-T038
##c	I-T038
patients	O
treated	B-T058
by	O
neoadjuvant	O
chemotherapy	O
plus	O
radical	B-T058
surgery	I-T058
remains	O
unclear	O
;	O
further	O
prospective	B-T062
studies	I-T062
are	O
warranted	O
.	O

microbiological	B-T170
and	O
clinical	O
characteristics	O
of	O
hyper	B-T007
##mu	I-T007
##co	I-T007
##vis	I-T007
##co	I-T007
##us	I-T007
klebsiella	I-T007
pneumoniae	I-T007
isolates	B-T103
associated	O
with	O
invasive	B-T038
infections	I-T038
in	O
china	B-T082
a	O
distinctive	B-T038
syndrome	I-T038
caused	O
by	O
hyper	B-T007
##mu	I-T007
##co	I-T007
##vis	I-T007
##co	I-T007
##us	I-T007
klebsiella	I-T007
pneumoniae	I-T007
(	O
hm	B-T007
##k	I-T007
##p	I-T007
)	O
including	O
py	B-T038
##ogenic	I-T038
liver	I-T038
abscess	I-T038
(	O
pla	B-T038
)	O
is	O
now	O
becoming	O
a	O
globally	B-T038
emerging	I-T038
disease	I-T038
.	O
in	O
the	O
present	O
study	B-T062
,	O
22	O
.	O
8	O
%	O
(	O
84	O
/	O
36	O
##9	O
)	O
of	O
k	B-T007
.	I-T007
pneumoniae	I-T007
clinical	O
isolates	B-T103
associated	O
with	O
various	O
types	O
of	O
invasive	B-T038
infections	I-T038
were	O
identified	O
as	O
hm	B-T007
##k	I-T007
##p	I-T007
,	O
with	O
45	O
.	O
2	O
%	O
associated	O
with	O
pla	B-T038
.	O
multivariate	O
regression	O
analysis	O
showed	O
that	O
male	O
patients	O
with	O
41	O
-	O
50	O
years	O
,	O
pla	B-T038
,	O
diabetes	B-T038
mellitus	I-T038
,	O
and	O
hypertension	B-T038
were	O
independent	O
risk	B-T033
factors	I-T033
for	O
hm	B-T038
##k	I-T038
##p	I-T038
infections	I-T038
.	O
k2	B-T170
(	O
42	O
.	O
9	O
%	O
,	O
36	O
/	O
84	O
)	O
was	O
the	O
most	O
common	O
capsular	B-T082
serotype	B-T170
among	O
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
,	O
followed	O
by	O
k1	B-T170
(	O
23	O
.	O
8	O
%	O
,	O
20	O
/	O
84	O
)	O
.	O
seventy	O
-	O
five	O
percentage	O
of	O
k1	B-T170
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
were	O
associated	O
with	O
pla	B-T038
,	O
while	O
k2	B-T170
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
accounted	O
for	O
more	O
types	O
of	O
invasive	B-T038
infections	I-T038
.	O
the	O
positive	B-T033
rates	O
of	O
iu	B-T017
##ta	I-T017
,	O
mr	B-T017
##kd	I-T017
,	O
aer	B-T017
##obac	I-T017
##tin	I-T017
,	O
iron	B-T017
,	O
and	O
rm	B-T017
##pa	I-T017
among	O
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
were	O
significantly	O
higher	O
than	O
those	O
among	O
non	B-T007
-	I-T007
hm	I-T007
##k	I-T007
##p	I-T007
isolates	B-T103
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
there	O
was	O
a	O
correlation	O
between	O
mag	B-T017
##a	I-T017
,	O
yb	B-T017
##ts	I-T017
,	O
all	B-T017
##s	I-T017
,	O
and	O
wc	B-T017
##ag	I-T017
and	O
k1	B-T170
isolates	B-T103
.	O
interestingly	O
,	O
mr	B-T017
##kd	I-T017
was	O
exclusively	B-T033
detected	I-T033
among	O
hm	B-T007
##k	I-T007
##p	I-T007
(	O
32	O
.	O
1	O
%	O
,	O
27	O
/	O
84	O
)	O
and	O
k2	B-T170
isolates	B-T103
(	O
65	O
.	O
9	O
%	O
,	O
27	O
/	O
41	O
)	O
.	O
all	O
k1	B-T170
and	O
k2	B-T170
hm	B-T007
##k	I-T007
##p	I-T007
and	O
non	B-T007
-	I-T007
hm	I-T007
##k	I-T007
##p	I-T007
isolates	B-T103
were	O
positive	B-T033
for	O
rm	B-T017
##pa	I-T017
.	O
aer	B-T017
##obac	I-T017
##tin	I-T017
was	O
found	B-T033
among	O
95	O
.	O
0	O
and	O
97	O
.	O
5	O
%	O
of	O
k1	B-T170
and	O
k2	B-T170
isolates	B-T103
.	O
st	B-T170
##23	I-T170
was	O
found	B-T033
to	O
be	O
the	O
most	O
prevalent	O
st	B-T170
among	O
69	O
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
with	O
k1	B-T170
,	O
k2	B-T170
,	O
k	B-T170
##5	I-T170
,	O
k2	B-T170
##0	I-T170
,	O
and	O
k	B-T170
##57	I-T170
(	O
27	O
.	O
5	O
%	O
,	O
19	O
/	O
69	O
)	O
and	O
was	O
only	O
found	B-T033
among	O
k1	B-T170
isolates	B-T103
.	O
st	B-T170
##65	I-T170
was	O
the	O
second	O
most	O
prevalent	O
st	B-T170
(	O
26	O
.	O
1	O
%	O
,	O
18	O
/	O
69	O
)	O
and	O
was	O
also	O
only	O
found	B-T033
among	O
k2	B-T170
isolates	B-T103
.	O
st	B-T170
##23	I-T170
-	I-T170
k1	I-T170
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
(	O
84	O
.	O
2	O
%	O
,	O
16	O
/	O
19	O
)	O
were	O
associated	O
with	O
pla	B-T038
,	O
while	O
st	B-T170
##65	I-T170
-	I-T170
k2	I-T170
isolates	B-T103
were	O
correlated	O
with	O
more	O
types	B-T170
of	I-T170
infections	I-T170
relative	O
to	O
st	B-T170
##23	I-T170
-	I-T170
k1	I-T170
isolates	B-T103
.	O
pfge	B-T058
results	O
showed	O
that	O
the	O
homology	O
of	O
84	O
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
was	O
diverse	O
.	O
only	O
five	O
pfge	B-T058
clusters	O
with	O
more	O
than	O
75	O
%	O
similarity	O
accounted	O
for	O
more	O
than	O
three	O
isolates	B-T103
.	O
these	O
five	O
pfge	B-T058
clusters	O
only	O
accounted	O
for	O
35	O
(	O
41	O
.	O
7	O
%	O
,	O
35	O
/	O
84	O
)	O
isolates	B-T103
.	O
in	O
conclusion	O
,	O
our	O
study	B-T062
first	O
found	B-T033
that	O
hypertension	B-T038
and	O
male	O
patients	O
with	O
41	O
-	O
50	O
years	O
old	O
were	O
independent	O
risk	B-T033
factors	I-T033
.	O
the	O
composition	B-T201
of	O
st	B-T170
types	I-T170
and	O
pfge	B-T058
clusters	O
among	O
k	B-T007
.	I-T007
pneumoniae	I-T007
k2	B-T170
isolates	B-T103
was	O
more	O
diverse	O
than	O
k1	B-T170
isolates	B-T103
.	O
k1	B-T170
and	O
k2	B-T170
hm	B-T007
##k	I-T007
##p	I-T007
isolates	B-T103
had	O
respective	O
specific	O
profiles	O
of	O
virulence	B-T038
-	O
associated	O
genes	B-T017
.	O

four	B-T082
-	I-T082
dimensional	I-T082
graded	B-T170
consciousness	B-T038
both	O
the	O
multidimensional	B-T082
phenomenon	O
and	O
the	O
polys	O
##em	O
##ous	O
notion	O
of	O
consciousness	B-T038
continue	O
to	O
prove	O
resistant	O
to	O
consistent	O
measurement	O
and	O
unambiguous	B-T170
definition	I-T170
.	O
this	O
is	O
hardly	O
surprising	O
,	O
given	O
that	O
there	O
is	O
no	B-T033
agreement	I-T033
even	O
as	O
regards	O
the	O
most	O
fundamental	O
issues	B-T033
they	O
involve	O
.	O
one	O
of	O
the	O
basic	O
disagreement	O
##s	O
present	O
in	O
the	O
continuing	O
debate	O
about	O
consciousness	B-T038
pert	O
##ains	O
to	O
its	O
grad	B-T170
##ational	I-T170
nature	O
.	O
the	O
general	O
aim	O
of	O
this	O
article	B-T170
is	O
to	O
show	O
how	O
consciousness	B-T038
might	O
be	O
graded	B-T170
and	O
multidimensional	B-T082
at	O
the	O
same	O
time	O
.	O
we	O
therefore	O
focus	O
on	O
the	O
question	B-T170
of	O
what	O
it	O
is	O
,	O
exactly	O
,	O
that	O
is	O
or	O
could	O
be	O
graded	B-T170
in	O
cases	O
of	O
consciousness	B-T038
,	O
and	O
how	O
we	O
can	O
measure	O
it	O
.	O
ultimately	O
,	O
four	O
different	O
grad	B-T170
##able	I-T170
aspects	O
of	O
consciousness	B-T038
will	O
be	O
described	O
:	O
quality	O
,	O
abstract	O
##ness	O
,	O
complexity	B-T038
and	O
usefulness	O
,	O
which	O
belong	O
to	O
four	O
different	O
dimensions	O
,	O
these	O
being	O
understood	O
,	O
respectively	O
,	O
as	O
phenomena	O
##l	O
,	O
semantic	O
,	O
physiological	O
,	O
and	O
functional	O
.	O
consequently	O
,	O
consciousness	B-T038
may	O
be	O
said	O
to	O
vary	O
with	O
respect	O
to	O
phenomena	O
##l	O
quality	O
,	O
semantic	O
abstraction	O
,	O
physiological	O
complexity	B-T038
,	O
and	O
functional	O
usefulness	O
.	O
it	O
is	O
hoped	O
that	O
such	O
a	O
four	B-T082
-	I-T082
dimensional	I-T082
approach	O
will	O
help	O
to	O
clarify	O
and	O
justify	O
claims	O
about	O
the	O
hierarchical	O
nature	O
of	O
consciousness	B-T038
.	O
the	O
approach	B-T082
also	O
proves	O
explan	O
##ator	O
##ily	O
advantageous	O
,	O
as	O
it	O
enables	O
us	O
not	O
only	O
to	O
draw	O
attention	B-T038
to	O
certain	O
new	O
and	O
important	O
differences	O
in	O
respect	O
of	O
subjective	O
measures	O
of	O
awareness	B-T038
and	O
to	O
justify	O
how	O
a	O
given	O
cre	B-T204
##ature	I-T204
may	O
be	O
ranked	B-T170
higher	O
in	O
one	O
dimension	O
of	O
consciousness	B-T038
and	O
lower	O
in	O
terms	O
of	O
another	O
,	O
but	O
also	O
allows	O
for	O
innovative	B-T170
explanations	I-T170
of	O
a	O
variety	O
of	O
well	O
-	O
known	O
phenomena	O
(	O
amongst	O
these	O
,	O
the	O
interpretations	B-T170
of	O
blind	O
##si	O
##gh	O
##t	O
and	O
locked	B-T038
-	I-T038
in	I-T038
syndrome	I-T038
will	O
be	O
briefly	O
outlined	O
here	O
)	O
.	O
moreover	O
,	O
a	O
4d	B-T082
framework	O
makes	O
possible	O
many	O
predictions	O
and	O
hypotheses	O
that	O
may	O
be	O
experimentally	B-T062
tested	O
(	O
we	O
point	O
out	O
a	O
few	O
such	O
possibilities	O
pertaining	O
to	O
interd	O
##imensional	O
dependencies	O
)	O
.	O

anticholinergic	B-T103
premed	B-T058
##ication	I-T058
to	O
prevent	O
bradycardia	B-T038
in	O
combined	O
spinal	B-T058
anesthesia	I-T058
and	O
dexmedetomidine	B-T103
sedation	B-T058
:	O
a	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	O
-	O
controlled	O
study	O
when	O
dexmedetomidine	B-T103
is	O
used	O
in	O
patients	O
undergoing	O
spinal	B-T058
anesthesia	I-T058
,	O
high	O
incidence	O
of	O
bradycardia	B-T038
in	O
response	O
to	O
parasympathetic	B-T022
activation	O
is	O
reported	O
.	O
therefore	O
,	O
we	O
aimed	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
atropine	B-T103
premed	B-T058
##ication	I-T058
for	O
preventing	O
the	O
incidence	O
of	O
bradycardia	B-T038
and	O
the	O
hemodynamic	B-T038
effect	I-T038
on	O
patients	O
undergoing	O
spinal	B-T058
anesthesia	I-T058
with	O
sedation	B-T058
by	O
dexmedetomidine	B-T103
.	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	O
-	O
controlled	O
study	O
.	O
operating	B-T092
room	I-T092
.	O
one	O
hundred	O
fourteen	O
patients	B-T103
(	O
age	O
range	O
,	O
2	O
-	O
65	O
years	O
;	O
american	B-T092
society	I-T092
of	I-T092
anesthesi	I-T092
##ology	I-T092
class	I-T092
i	I-T092
-	I-T092
ii	I-T092
)	O
participated	O
in	O
this	O
study	B-T062
,	O
willing	O
to	O
be	O
sed	O
##ated	O
and	O
to	O
undergo	O
spinal	B-T058
anesthesia	I-T058
.	O
the	O
patients	B-T103
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
a	O
and	O
group	O
c	O
.	O
after	O
performing	O
spinal	B-T058
anesthesia	I-T058
,	O
dexmedetomidine	B-T103
was	O
infused	B-T058
at	O
a	O
loading	O
dose	O
of	O
0	O
.	O
6	O
μg	O
/	O
kg	O
for	O
10	O
minutes	O
,	O
followed	O
by	O
an	O
infusion	B-T058
at	O
0	O
.	O
25	O
μg	O
/	O
(	O
kg	O
h	O
)	O
.	O
simultaneously	O
with	O
the	O
loading	O
dose	O
of	O
dexmedetomidine	B-T103
,	O
patients	B-T103
in	O
group	O
a	O
received	O
an	O
intravenous	O
bolus	O
of	O
0	O
.	O
5	O
mg	O
atropine	B-T103
,	O
whereas	O
patients	B-T103
in	O
group	O
c	O
received	O
an	O
intravenous	O
normal	O
saline	O
bolus	B-T058
.	O
data	O
on	O
administration	B-T058
of	O
atropine	B-T103
and	O
eph	B-T103
##edrine	I-T103
were	O
collected	O
.	O
hemodynamic	B-T058
data	O
including	O
heart	B-T201
rate	I-T201
,	O
systolic	B-T201
blood	I-T201
pressure	I-T201
,	O
diastolic	B-T201
blood	I-T201
pressure	I-T201
(	O
dbp	B-T201
)	O
,	O
and	O
mean	B-T033
blood	I-T033
pressure	I-T033
(	O
mbp	B-T033
)	O
were	O
also	O
recorded	O
.	O
the	O
incidence	O
of	O
bradycardia	B-T038
requiring	O
atropine	B-T103
treatment	B-T058
was	O
significantly	O
higher	O
in	O
group	O
c	O
than	O
group	O
a	O
(	O
p	O
=	O
.	O
035	O
)	O
.	O
however	O
,	O
the	O
incidence	O
of	O
hypotension	B-T033
needing	O
eph	B-T103
##edrine	I-T103
treatment	B-T058
showed	O
no	O
significant	O
difference	O
between	O
the	O
2	O
groups	O
(	O
p	O
=	O
.	O
7	O
)	O
.	O
systolic	B-T201
blood	I-T201
pressure	I-T201
and	O
heart	B-T201
rate	I-T201
showed	O
no	O
significant	O
differences	O
between	O
the	O
2	O
groups	O
(	O
p	O
=	O
.	O
138	O
and	O
.	O
46	O
##4	O
,	O
respectively	O
)	O
.	O
however	O
,	O
group	O
a	O
showed	O
significant	O
increases	O
in	O
dbp	B-T201
and	O
mbp	B-T033
,	O
and	O
group	O
c	O
did	O
not	O
(	O
p	O
=	O
.	O
014	O
and	O
.	O
008	O
,	O
respectively	O
)	O
.	O
prophylactic	B-T058
atropine	B-T103
reduces	O
the	O
incidence	O
of	O
bradycardia	B-T038
in	O
patients	B-T103
undergoing	O
spinal	B-T058
anesthesia	I-T058
with	O
dexmedetomidine	B-T103
sedation	B-T058
.	O
however	O
,	O
dbp	B-T201
and	O
mbp	B-T033
showed	O
significant	O
increases	O
in	O
patients	B-T103
when	O
prophylactic	B-T058
atropine	B-T103
was	O
administrated	B-T058
.	O
therefore	O
,	O
atropine	B-T103
premed	B-T058
##ication	I-T058
should	O
be	O
administered	B-T058
cautious	O
##ly	O
.	O

comparison	O
of	O
alkaline	B-T038
phosphatase	I-T038
activity	I-T038
of	O
mc	B-T017
##3t3	I-T017
-	I-T017
e1	I-T017
cells	I-T017
cultured	O
on	O
different	O
ti	B-T103
surfaces	B-T082
:	O
modified	O
sand	O
##blas	O
##ted	O
with	O
large	O
gr	B-T103
##it	I-T103
and	O
acid	O
-	O
etched	O
(	O
ms	B-T103
##la	I-T103
)	O
,	O
laser	O
-	O
treated	O
,	O
and	O
laser	O
and	O
acid	O
-	O
treated	O
ti	B-T103
surfaces	B-T082
in	O
this	O
study	B-T062
,	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	B-T058
the	O
effect	O
of	O
implant	O
surface	B-T082
treatment	O
on	O
cell	B-T038
differentiation	I-T038
of	O
osteoblast	B-T017
cells	I-T017
.	O
for	O
this	O
purpose	O
,	O
three	O
surfaces	B-T082
were	O
compared	O
:	O
(	O
1	O
)	O
a	O
modified	O
sla	O
(	O
ms	O
##la	O
:	O
sand	O
-	O
blast	O
##ed	O
with	O
large	O
gr	B-T103
##it	I-T103
,	O
acid	O
-	O
etched	O
,	O
and	O
immersed	O
in	O
0	O
.	O
9	O
%	O
nacl	B-T103
)	O
,	O
(	O
2	O
)	O
a	O
laser	O
treatment	O
(	O
lt	O
:	O
laser	O
treatment	O
)	O
titanium	B-T103
surface	B-T082
and	O
(	O
3	O
)	O
a	O
laser	O
and	O
acid	O
-	O
treated	O
(	O
lat	O
:	O
laser	O
treatment	O
,	O
acid	O
-	O
etched	O
)	O
titanium	B-T103
surface	B-T082
.	O
the	O
ms	B-T103
##la	I-T103
surfaces	B-T082
were	O
considered	O
as	O
the	O
control	O
group	O
,	O
and	O
lt	B-T103
and	O
lat	B-T103
surfaces	B-T082
as	O
test	O
groups	O
.	O
alkaline	B-T103
phosphatase	I-T103
expression	B-T038
(	O
alp	B-T103
)	O
was	O
used	O
to	O
quantify	O
osteoblastic	B-T038
differentiation	I-T038
of	O
mc	B-T017
##3t3	I-T017
-	I-T017
e1	I-T017
cell	I-T017
.	O
surface	B-T082
roughness	O
was	O
evaluated	B-T058
by	O
a	O
contact	B-T074
profil	I-T074
##ometer	I-T074
(	O
ur	O
##fp	O
##ak	O
-	O
sv	O
;	O
mit	O
##ut	O
##oy	O
##o	O
,	O
kaw	O
##as	O
##aki	O
,	O
japan	B-T082
)	O
and	O
characterized	O
by	O
two	O
parameters	O
:	O
mean	O
roughness	O
(	O
ra	O
)	O
and	O
maximum	O
peak	O
-	O
to	O
-	O
valley	O
height	O
(	O
rt	O
)	O
.	O
scanning	B-T074
electron	I-T074
microscope	I-T074
revealed	O
that	O
ms	O
##la	O
(	O
control	O
group	O
)	O
surface	B-T082
was	O
not	O
as	O
rough	O
as	O
lt	B-T103
,	O
lat	B-T103
surface	B-T082
(	O
test	O
groups	O
)	O
.	O
alkaline	B-T103
phosphatase	I-T103
expression	B-T038
,	O
the	O
measure	O
of	O
osteoblastic	B-T038
differentiation	I-T038
,	O
and	O
total	O
alp	B-T103
expression	B-T038
by	O
surface	B-T017
-	I-T017
adherent	I-T017
cells	I-T017
were	O
found	O
to	O
be	O
highest	O
at	O
21	O
days	O
for	O
all	O
three	O
surfaces	B-T082
tested	O
(	O
p	O
<	O
.	O
05	O
)	O
.	O
furthermore	O
,	O
alp	B-T103
expression	B-T038
levels	O
of	O
ms	B-T103
##la	I-T103
and	O
lat	B-T103
surfaces	B-T082
were	O
significantly	O
higher	O
than	O
expression	B-T038
levels	O
of	O
lt	B-T103
surface	B-T017
-	I-T017
adherent	I-T017
cells	I-T017
at	O
7	O
,	O
14	O
,	O
and	O
21	O
days	O
,	O
respectively	O
(	O
p	O
<	O
.	O
05	O
)	O
.	O
however	O
,	O
alp	B-T103
expression	B-T038
levels	O
between	O
ms	B-T103
##la	I-T103
and	O
lat	B-T103
surface	B-T082
were	O
equal	O
at	O
7	O
,	O
14	O
,	O
and	O
21	O
days	O
(	O
p	O
>	O
.	O
05	O
)	O
.	O
this	O
study	B-T062
suggested	O
that	O
ms	B-T103
##la	I-T103
and	O
lat	B-T103
surfaces	B-T082
exhibited	O
more	O
favorable	O
environment	B-T082
for	O
osteoblast	B-T038
differentiation	I-T038
when	O
compared	O
with	O
lt	B-T103
surface	B-T082
,	O
the	O
results	O
that	O
are	O
important	O
for	O
implant	B-T074
surface	B-T082
modification	O
studies	B-T062
.	O

evaluation	B-T058
of	O
tobacco	O
control	O
policies	O
in	O
san	B-T082
franc	I-T082
##isco	I-T082
homeless	B-T098
housing	O
programs	O
the	O
2014	O
surgeon	B-T170
general	I-T170
'	I-T170
s	I-T170
report	I-T170
noted	O
that	O
high	O
smoking	O
rates	O
in	O
vulnerable	B-T098
populations	I-T098
such	O
as	O
the	O
homeless	B-T098
have	O
been	O
a	O
persistent	O
public	B-T092
health	O
problem	O
;	O
smoking	O
prevalence	O
among	O
individuals	B-T098
experiencing	O
homeless	B-T033
##ness	I-T033
exceeds	O
70	O
%	O
.	O
historically	O
,	O
service	O
providers	O
for	O
the	O
homeless	B-T098
have	O
not	O
en	O
##acted	O
comprehensive	O
tobacco	O
control	O
policies	O
.	O
we	O
conducted	O
a	O
qualitative	B-T062
study	I-T062
of	O
homeless	B-T098
housing	O
programs	O
in	O
san	B-T082
franc	I-T082
##isco	I-T082
.	O
administrators	B-T097
representing	O
9	O
of	O
the	O
city	O
'	O
s	O
11	O
homeless	B-T092
service	I-T092
agencies	I-T092
were	O
interviewed	O
to	O
assess	O
institutional	O
smoking	O
-	O
related	O
policies	B-T170
and	O
cessation	O
programs	O
and	O
perceived	B-T038
barriers	O
and	O
recept	O
##ivity	O
to	O
instit	O
##uting	O
tobacco	B-T103
control	O
interventions	B-T058
.	O
respondents	B-T098
indicated	B-T033
that	O
although	O
most	O
programs	O
had	O
adopted	O
smoke	B-T103
-	O
free	O
grounds	O
and	O
some	O
had	O
eliminated	O
evidence	O
of	O
staff	B-T097
smoking	O
,	O
the	O
smoking	O
status	O
of	O
clients	O
was	O
assessed	O
only	O
when	O
required	O
by	O
fund	O
##ers	O
.	O
none	O
of	O
the	O
programs	O
offered	B-T033
smoking	O
cessation	O
interventions	B-T058
.	O
most	O
administrators	B-T097
were	O
receptive	O
to	O
adopting	O
policies	B-T170
that	O
would	O
promote	O
a	O
tobacco	B-T103
-	O
free	O
culture	B-T092
;	O
however	O
,	O
they	O
noted	O
that	O
their	O
clients	O
had	O
unique	O
challenges	B-T058
that	O
made	O
traditional	O
smoking	O
cessation	O
programs	O
unf	O
##eas	O
##ible	O
.	O
homeless	B-T098
housing	O
programs	O
in	O
san	B-T082
franc	I-T082
##isco	I-T082
have	O
not	O
yet	O
adopted	O
a	O
tobacco	B-T103
-	O
free	O
culture	B-T092
.	O
existing	O
policies	B-T170
were	O
created	O
in	O
response	O
to	O
external	B-T082
mand	B-T170
##ates	I-T170
,	O
and	O
smoking	O
cessation	O
programs	O
may	O
need	O
to	O
be	O
modified	O
in	O
order	O
to	O
effectively	O
reach	O
clients	O
.	O

bending	B-T170
rules	I-T170
:	O
the	O
shape	B-T082
of	O
the	O
perceptual	B-T038
general	B-T038
##isation	I-T038
gradient	O
is	O
sensitive	O
to	O
inference	B-T170
rules	I-T170
general	B-T038
##ising	I-T038
what	O
is	O
learned	B-T038
about	O
one	O
stimulus	O
to	O
other	O
but	O
perceptual	B-T038
##ly	I-T038
related	O
stimuli	O
is	O
a	O
basic	O
behavioural	O
phenomenon	O
.	O
we	O
evaluated	B-T058
whether	O
a	O
rule	B-T170
learning	B-T038
mechanism	O
may	O
serve	O
to	O
explain	O
such	O
general	B-T038
##isation	I-T038
.	O
to	O
this	O
end	O
,	O
we	O
assessed	O
whether	O
inference	B-T170
rules	I-T170
communicate	B-T033
##d	I-T033
through	O
verbal	O
instructions	O
affect	O
general	B-T038
##isation	I-T038
.	O
expectancy	O
ratings	O
,	O
but	O
not	O
valence	O
ratings	O
,	O
proved	O
sensitive	O
to	O
this	O
manipulation	O
.	O
in	O
addition	O
to	O
revealing	O
a	O
role	B-T170
for	O
inference	B-T170
rules	I-T170
in	O
general	B-T038
##isation	I-T038
,	O
our	O
study	B-T062
has	O
clinical	O
implications	O
as	O
well	O
.	O
more	O
specifically	O
,	O
we	O
argue	O
that	O
targeting	O
inference	B-T170
rules	I-T170
might	O
prove	O
to	O
be	O
an	O
effective	O
strategy	O
to	O
affect	O
the	O
excessive	O
general	B-T038
##isation	I-T038
that	O
is	O
often	O
observed	O
in	O
psychopathology	B-T091
.	O

a	O
giant	B-T017
aneurysmal	B-T038
bone	I-T038
cyst	I-T038
in	O
the	O
mandibular	B-T017
condyle	I-T017
aneurysmal	B-T038
bone	I-T038
cyst	I-T038
(	O
abc	B-T038
)	O
is	O
a	O
rare	O
,	O
rapidly	O
expanding	B-T082
,	O
locally	B-T082
destructive	O
,	O
and	O
easily	B-T033
misdiagnosed	B-T033
lesion	B-T033
.	O
an	O
abc	B-T038
of	O
the	O
condyle	B-T017
is	O
rare	O
.	O
this	O
report	O
presents	O
a	O
25	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
giant	B-T017
abc	B-T038
in	O
the	O
left	B-T082
mandibular	B-T017
condyle	I-T017
.	O
this	O
patient	O
was	O
treated	B-T058
with	I-T058
surgical	B-T058
resection	I-T058
of	O
the	O
affected	O
bone	B-T017
and	O
immediate	O
mandibular	B-T058
reconstruction	I-T058
using	O
autologous	O
bone	B-T017
.	O
follow	O
-	O
up	O
to	O
date	O
showed	O
no	O
signs	B-T033
of	O
recurrence	O
.	O
the	O
clinical	O
feature	O
,	O
imaging	B-T033
finding	I-T033
,	O
pathogenesis	B-T038
,	O
and	O
treatment	B-T058
methods	I-T058
of	O
abc	B-T038
##s	I-T038
are	O
discussed	O
.	O

a	O
recombinant	B-T062
human	B-T204
anti	B-T103
-	I-T103
platelet	I-T103
scfv	B-T103
antibody	I-T103
produced	O
in	O
pic	B-T204
##hi	I-T204
##a	I-T204
pastoris	I-T204
for	O
ather	B-T038
##oma	I-T038
targeting	O
cells	B-T017
of	O
the	O
innate	O
and	O
adaptive	O
immune	B-T022
system	I-T022
are	O
key	O
factors	O
in	O
the	O
progression	B-T038
of	O
atherosclerotic	B-T031
plaque	I-T031
,	O
leading	O
to	O
plaque	B-T033
instability	B-T033
and	O
rupture	B-T037
,	O
potentially	O
resulting	O
in	O
acute	O
ather	B-T017
##oth	I-T017
##romb	I-T017
##otic	I-T017
events	O
such	O
as	O
coronary	B-T038
artery	I-T038
disease	I-T038
,	O
cerebrovascular	B-T038
disease	I-T038
and	O
peripheral	B-T038
arterial	I-T038
disease	I-T038
.	O
here	O
,	O
we	O
describe	O
the	O
cloning	B-T062
,	O
expression	B-T038
,	O
purification	O
,	O
and	O
immunoreactivity	O
assessment	B-T058
of	O
a	O
recombinant	O
single	B-T103
-	I-T103
chain	I-T103
variable	I-T103
fragment	I-T103
(	O
scfv	B-T103
)	O
derived	O
from	O
a	O
human	B-T204
anti	B-T103
-	I-T103
α	I-T103
##ii	I-T103
##b	I-T103
##β	I-T103
##3	I-T103
antibody	I-T103
(	O
hu	B-T103
##ab	I-T103
)	O
selected	O
to	O
target	O
ather	B-T038
##omatous	I-T038
lesions	B-T033
for	O
the	O
presence	B-T033
of	O
platelets	B-T017
.	O
indeed	O
,	O
platelets	B-T017
within	O
ather	B-T031
##oma	I-T031
plaques	I-T031
have	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
inflammation	B-T038
,	O
in	O
platelet	B-T017
-	O
leucocyte	B-T017
aggregates	O
and	O
in	O
thrombi	B-T038
formation	O
and	O
might	O
thus	O
be	O
considered	O
relevant	O
biomarkers	B-T201
of	O
atherosclerotic	O
progression	B-T038
.	O
the	O
dna	B-T082
sequence	I-T082
that	O
encodes	O
the	O
anti	B-T103
-	I-T103
α	I-T103
##ii	I-T103
##b	I-T103
##β	I-T103
##3	I-T103
teg	I-T103
##4	I-T103
scfv	I-T103
previously	O
obtained	O
from	O
a	O
phage	B-T062
-	I-T062
display	I-T062
selection	I-T062
on	O
activated	O
platelets	B-T017
,	O
was	O
inserted	B-T038
into	O
the	O
eukary	B-T204
##ote	I-T204
vector	B-T103
(	O
ppi	B-T103
##c	I-T103
##z	I-T103
##α	I-T103
##a	I-T103
)	O
in	O
fusion	O
with	O
a	O
tag	B-T082
sequence	I-T082
encoding	O
2	O
cysteine	B-T103
##s	I-T103
use	O
##able	O
for	O
specific	O
probes	O
grafting	B-T058
experiments	I-T058
.	O
the	O
recombinant	B-T103
protein	I-T103
was	O
expressed	B-T038
at	O
high	O
yields	O
in	O
pic	B-T204
##hi	I-T204
##a	I-T204
pastoris	I-T204
(	O
30	O
mg	O
/	O
l	O
culture	B-T103
)	O
.	O
the	O
advantage	O
of	O
p	B-T204
.	I-T204
pastoris	I-T204
as	O
an	O
expression	B-T038
system	O
is	O
the	O
production	O
and	O
secretion	B-T038
of	O
recombinant	B-T103
proteins	I-T103
in	O
the	O
supernatant	B-T031
,	O
ru	O
##ling	O
out	O
the	O
difficulties	O
encountered	O
when	O
scfv	B-T103
are	O
produced	O
in	O
the	O
cytoplasm	B-T017
of	O
bacteria	B-T007
(	O
low	O
yield	O
,	O
low	O
solubility	O
and	O
reduced	O
affinity	B-T038
)	O
.	O
the	O
improved	B-T033
conditions	O
allowed	O
for	O
the	O
recovery	O
of	O
highly	O
purified	O
and	O
biologically	B-T103
active	I-T103
scfv	B-T103
fragments	I-T103
ready	O
to	O
be	O
grafted	O
in	O
a	O
site	B-T082
-	O
directed	O
way	O
to	O
nanoparticles	O
for	O
the	O
imaging	B-T058
of	O
atherosclerotic	B-T031
plaques	I-T031
involving	O
inflammatory	O
processes	O
and	O
thus	O
at	O
high	B-T033
risk	I-T033
of	I-T033
instability	B-T033
.	O

cox	B-T007
##iella	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
isolates	B-T103
originating	O
from	O
infected	B-T204
cattle	I-T204
induce	O
a	O
more	O
pronounced	O
proinflammatory	B-T038
cytokine	I-T038
response	I-T038
compared	O
to	O
isolates	B-T103
from	O
infected	B-T204
goats	I-T204
and	O
sheep	B-T204
cox	B-T007
##iella	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
is	O
the	O
causative	B-T033
agent	I-T033
of	O
q	B-T038
fever	I-T038
.	O
although	O
the	O
prevalence	O
of	O
c	B-T007
.	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
in	O
cattle	B-T204
is	O
much	O
higher	O
than	O
in	O
goats	B-T204
and	O
sheep	B-T204
,	O
infected	B-T204
cattle	I-T204
are	O
rarely	O
associated	O
with	O
human	B-T204
outbreaks	O
.	O
we	O
investigated	O
whether	O
the	O
immune	B-T038
response	I-T038
of	O
humans	B-T204
differs	O
after	O
contact	O
with	O
c	B-T007
.	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
isolates	B-T103
from	O
different	O
host	O
origins	O
or	O
with	O
different	O
multilocus	B-T058
variable	I-T058
number	I-T058
of	I-T058
tandem	I-T058
repeat	I-T058
analysis	I-T058
(	O
ml	B-T058
##va	I-T058
)	O
genotypes	O
.	O
cytokine	B-T038
responses	I-T038
were	O
measured	O
in	O
human	B-T204
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
(	O
pbmcs	B-T017
)	O
stimulated	O
with	O
16	O
c	B-T007
.	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
isolates	B-T103
with	O
known	O
ml	B-T058
##va	I-T058
genotype	O
from	O
goats	B-T204
,	O
sheep	B-T204
,	O
cattle	B-T204
,	O
acute	B-T038
and	O
chronic	B-T038
q	I-T038
fever	I-T038
patients	O
.	O
cox	B-T007
##iella	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
isolates	B-T103
originating	O
from	O
cattle	B-T204
induce	O
significantly	O
more	O
il	B-T103
-	I-T103
1β	I-T103
,	O
tnf	B-T103
-	I-T103
α	I-T103
and	O
il	B-T103
-	I-T103
22	I-T103
than	O
the	O
isolates	B-T103
from	O
goats	B-T204
,	O
sheep	B-T204
or	O
chronic	B-T038
q	I-T038
fever	I-T038
patients	O
.	O
comparing	O
the	O
cytokine	B-T103
induction	O
of	O
the	O
isolates	B-T103
based	O
on	O
their	O
mv	B-T058
##la	I-T058
genotype	O
did	O
not	O
reveal	O
differences	O
in	O
response	B-T038
between	O
the	O
ml	B-T058
##va	I-T058
genotypes	O
.	O
the	O
proinflammatory	B-T038
cytokine	I-T038
response	I-T038
induced	O
in	O
human	B-T204
pbmcs	B-T017
by	O
c	B-T007
.	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
isolates	B-T103
from	O
cattle	B-T204
may	O
explain	O
the	O
low	O
incidence	O
of	O
human	B-T204
q	B-T038
fever	I-T038
outbreaks	O
caused	O
by	O
cattle	B-T204
.	O
the	O
cytokine	B-T103
profile	O
of	O
pbmcs	B-T017
stimulated	O
with	O
c	B-T007
.	I-T007
burn	I-T007
##eti	I-T007
##i	I-T007
isolates	B-T103
from	O
chronic	B-T038
q	I-T038
fever	I-T038
patients	O
resembles	O
isolates	B-T103
from	O
goats	B-T204
.	O
furthermore	O
,	O
cytokine	B-T038
responses	I-T038
seem	O
to	O
be	O
depending	O
on	O
host	O
origin	O
than	O
on	O
ml	B-T058
##va	I-T058
genotype	O
.	O

character	O
##ising	O
bias	O
in	O
regulatory	O
risk	O
and	O
decision	O
analysis	O
:	O
an	O
analysis	B-T062
of	O
heuristic	B-T170
##s	I-T170
applied	O
in	O
health	B-T058
technology	I-T058
appraisal	O
,	O
chemicals	B-T103
regulation	O
,	O
and	O
climate	O
change	O
governance	O
in	O
many	O
environmental	O
and	O
public	B-T170
health	I-T170
domains	I-T170
,	O
heuristic	B-T170
methods	I-T170
of	O
risk	O
and	O
decision	O
analysis	O
must	O
be	O
relied	O
upon	O
,	O
either	O
because	O
problem	B-T033
structures	I-T033
are	O
ambiguous	O
,	O
reliable	O
data	O
is	O
lacking	O
,	O
or	O
decisions	B-T038
are	O
urgent	O
.	O
this	O
introduces	O
an	O
additional	O
source	B-T033
of	O
uncertainty	B-T033
beyond	O
model	B-T170
and	O
measurement	O
error	O
-	O
uncertainty	B-T033
stem	O
##ming	O
from	O
relying	O
on	O
inex	O
##act	O
inference	B-T170
rules	I-T170
.	O
here	O
we	O
identify	O
and	O
analyse	O
heuristic	B-T170
##s	I-T170
used	O
to	O
priori	O
##tise	O
risk	O
objects	O
,	O
to	O
discriminate	O
between	O
signal	O
and	O
noise	O
,	O
to	O
weight	O
evidence	O
,	O
to	O
construct	O
models	B-T170
,	O
to	O
extrap	O
##olate	O
beyond	O
datasets	B-T170
,	O
and	O
to	O
make	O
policy	B-T170
.	O
some	O
of	O
these	O
heuristic	B-T170
##s	I-T170
are	O
based	O
on	O
causal	O
general	O
##isations	O
,	O
yet	O
can	O
mis	O
##fi	O
##re	O
when	O
these	O
relationships	O
are	O
presumed	O
rather	O
than	O
tested	O
(	O
e	O
.	O
g	O
.	O
surrogate	O
##s	O
in	O
clinical	B-T062
trials	I-T062
)	O
.	O
others	O
are	O
convention	O
##s	O
designed	O
to	O
confer	O
stability	O
to	O
decision	O
analysis	O
,	O
yet	O
which	O
may	O
introduce	O
serious	O
error	O
when	O
applied	O
ritu	O
##alis	O
##tically	O
(	O
e	O
.	O
g	O
.	O
significance	O
testing	O
)	O
.	O
some	O
heuristic	B-T170
##s	I-T170
can	O
be	O
traced	O
back	O
to	O
formal	O
justif	O
##ications	O
,	O
but	O
only	O
subject	O
to	O
strong	O
assumptions	O
that	O
are	O
often	O
viol	O
##ated	O
in	O
practical	O
applications	O
.	O
heuristic	B-T170
decision	B-T170
rules	I-T170
(	O
e	O
.	O
g	O
.	O
feasibility	B-T170
rules	I-T170
)	O
in	O
principle	O
act	O
as	O
surrogate	O
##s	O
for	O
utility	O
maxim	O
##isation	O
or	O
distribution	O
##al	O
concerns	O
,	O
yet	O
in	O
practice	O
may	O
neglect	O
costs	O
and	O
benefits	O
,	O
be	O
based	O
on	O
arbitrary	O
thresholds	O
,	O
and	O
be	O
prone	O
to	O
gam	O
##ing	O
.	O
we	O
highlight	O
the	O
problem	B-T033
of	O
rule	O
-	O
entr	O
##ench	O
##ment	O
,	O
where	O
analytical	O
choices	O
that	O
are	O
in	O
principle	O
cont	O
##est	O
##able	O
are	O
arbitr	O
##arily	O
fixed	O
in	O
practice	O
,	O
masking	O
uncertainty	B-T033
and	O
potentially	O
introducing	O
bias	O
.	O
strategies	O
for	O
making	O
risk	O
and	O
decision	O
analysis	O
more	O
rigorous	O
include	O
:	O
formal	O
##ising	O
the	O
assumptions	O
and	O
scope	O
conditions	O
under	O
which	O
heuristic	B-T170
##s	I-T170
should	O
be	O
applied	O
;	O
testing	O
rather	O
than	O
presum	O
##ing	O
their	O
underlying	O
empirical	O
or	O
theoretical	O
justif	O
##ications	O
;	O
using	O
sensitivity	O
analysis	B-T062
,	O
simulations	B-T062
,	O
multiple	B-T062
bias	I-T062
analysis	I-T062
,	O
and	O
ded	B-T170
##uctive	I-T170
systems	I-T170
of	I-T170
inference	I-T170
(	O
e	O
.	O
g	O
.	O
directed	B-T170
acycl	I-T170
##ic	I-T170
graphs	I-T170
)	O
to	O
characterise	O
rule	B-T170
uncertainty	B-T033
and	O
refine	O
heuristic	B-T170
##s	I-T170
;	O
adopting	O
[UNK]	O
recovery	B-T170
schemes	I-T170
[UNK]	O
to	O
correct	O
for	O
known	O
biases	O
;	O
and	O
basin	O
##g	O
decision	B-T170
rules	I-T170
on	O
clearly	O
artic	O
##ulated	O
values	O
and	O
evidence	O
,	O
rather	O
than	O
convention	O
.	O

association	O
of	O
exclusive	O
breastfeeding	O
duration	O
with	O
systemic	O
inflammation	O
markers	B-T201
in	O
adolescents	O
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
breastfeeding	O
duration	O
has	O
been	O
associated	O
with	O
less	O
low	O
-	O
grade	O
inflammation	B-T038
in	O
healthy	O
adolescents	O
,	O
but	O
there	O
is	O
scarce	O
information	O
regarding	O
obese	B-T038
subjects	O
.	O
this	O
study	O
aimed	O
to	O
evaluate	O
whether	O
exclusive	O
breastfeeding	O
is	O
related	O
to	O
serum	O
concentrations	O
of	O
inflammatory	O
markers	B-T201
in	O
a	O
population	B-T098
of	O
spanish	B-T098
adolescents	O
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
was	O
performed	O
on	O
1	O
,	O
001	O
adolescents	O
(	O
13	O
.	O
2	O
±	O
1	O
.	O
2	O
years	O
)	O
randomly	O
recruited	O
from	O
schools	B-T092
in	O
southeast	B-T082
spain	B-T082
.	O
data	O
on	O
breastfeeding	O
duration	O
were	O
collected	O
via	O
a	O
parental	B-T170
questionnaire	I-T170
.	O
interleukin	B-T103
-	I-T103
6	I-T103
(	O
il	B-T103
-	I-T103
6	I-T103
)	O
and	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
-	I-T103
alpha	I-T103
(	O
tnf	B-T103
-	I-T103
α	I-T103
)	O
were	O
determined	O
by	O
enzyme	B-T058
-	I-T058
linked	I-T058
immunosorbent	I-T058
assay	I-T058
.	O
c	B-T103
-	I-T103
reactive	I-T103
protein	I-T103
(	O
crp	B-T103
)	O
was	O
determined	O
by	O
solid	B-T058
-	I-T058
phase	I-T058
chemilum	I-T058
##inescent	I-T058
immuno	I-T058
##met	I-T058
##ric	I-T058
assay	I-T058
.	O
non	O
##adjusted	O
and	O
adjusted	O
multivariate	O
correlation	B-T062
analyses	I-T062
confirmed	O
a	O
strong	O
association	O
(	O
p	O
<	O
.	O
001	O
,	O
95	O
%	O
confidence	O
interval	O
)	O
between	O
the	O
three	O
markers	B-T201
of	O
inflammation	B-T038
and	O
exclusive	O
breastfeeding	O
duration	O
.	O
no	B-T033
significant	I-T033
differences	O
were	O
observed	O
for	O
il	B-T103
-	I-T103
6	I-T103
,	O
tnf	B-T103
-	I-T103
α	I-T103
,	O
and	O
crp	B-T103
serum	O
concentrations	O
among	O
normal	B-T201
weight	I-T201
,	O
overweight	B-T033
,	O
and	O
obese	B-T038
adolescents	O
,	O
except	O
for	O
il	B-T103
-	I-T103
6	I-T103
between	O
normal	B-T201
weight	I-T201
and	O
obese	B-T038
subjects	O
.	O
likewise	O
,	O
no	B-T033
significant	I-T033
association	O
was	O
found	B-T033
between	O
these	O
markers	B-T201
of	O
inflammation	B-T038
and	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
z	O
-	O
score	O
.	O
we	O
found	B-T033
a	O
possible	B-T033
association	O
between	O
inflammatory	O
markers	B-T201
and	O
exclusive	O
breastfeeding	O
duration	O
in	O
adolescents	O
,	O
regardless	O
of	O
their	O
bmi	B-T201
.	O
this	O
finding	B-T033
suggests	O
that	O
increased	O
body	O
weight	O
or	O
obesity	B-T038
might	O
not	O
mediate	O
the	O
association	O
between	O
breastfeeding	B-T038
and	O
inflammation	B-T038
.	O
these	O
results	O
contribute	O
to	O
the	O
understanding	B-T038
of	O
the	O
relationship	O
between	O
breastfeeding	B-T038
and	O
inflammatory	O
markers	B-T201
in	O
adolescents	O
.	O

meta	B-T058
##trans	I-T058
##crip	I-T058
##to	I-T058
##mics	I-T058
reveals	O
the	O
active	O
bacterial	B-T007
and	O
eukaryotic	B-T007
fibro	I-T007
##ly	I-T007
##tic	I-T007
communities	I-T007
in	O
the	O
rumen	B-T017
of	O
dairy	O
cow	O
fed	O
a	O
mixed	O
diet	B-T168
ruminants	B-T204
have	O
a	O
unique	O
ability	O
to	O
derive	O
energy	O
from	O
the	O
degradation	O
of	O
plant	B-T204
polysaccharides	B-T103
through	O
the	O
activity	O
of	O
the	O
rumen	B-T017
microbiota	B-T204
.	O
although	O
this	O
process	O
is	O
well	O
studied	O
in	O
vitro	O
,	O
knowledge	O
gaps	O
remain	O
regarding	O
the	O
relative	O
contribution	O
of	O
the	O
microbiota	B-T204
members	I-T204
and	O
enzymes	B-T103
in	B-T082
vivo	I-T082
.	O
the	O
present	O
study	O
used	O
rna	B-T058
-	I-T058
sequencing	I-T058
to	O
reveal	O
both	O
the	O
expression	B-T038
of	O
genes	B-T017
encoding	O
carbohydrate	B-T103
-	I-T103
active	I-T103
enzymes	I-T103
(	O
ca	B-T103
##zymes	I-T103
)	O
by	O
the	O
rumen	B-T017
microbiota	B-T204
of	O
a	O
lactating	O
dairy	O
cow	O
and	O
the	O
microorganisms	O
forming	O
the	O
fiber	B-T204
-	O
degrading	O
community	O
.	O
functional	B-T062
analysis	I-T062
identified	O
12	O
,	O
237	O
ca	B-T103
##zymes	I-T103
,	O
accounting	O
for	O
1	O
%	O
of	O
the	O
transcripts	B-T103
.	O
the	O
ca	B-T103
##zyme	I-T103
profile	O
was	O
dominated	O
by	O
families	O
gh	B-T103
##94	I-T103
(	O
cell	B-T103
##obi	I-T103
##ose	I-T103
-	I-T103
phosphorylase	I-T103
)	O
,	O
gh	B-T103
##13	I-T103
(	O
amylase	B-T103
)	O
,	O
gh	B-T103
##43	I-T103
and	O
gh	B-T103
##10	I-T103
(	O
hemic	B-T103
##ell	I-T103
##ulas	I-T103
##es	I-T103
)	O
,	O
gh	B-T103
##9	I-T103
and	O
gh	B-T103
##48	I-T103
(	O
cellulase	B-T103
##s	I-T103
)	O
,	O
pl	B-T103
##11	I-T103
(	O
pectin	B-T103
##ase	I-T103
)	O
as	O
well	O
as	O
gh	B-T103
##2	I-T103
and	O
gh	B-T103
##3	I-T103
(	O
oligos	B-T103
##acchar	I-T103
##idases	I-T103
)	O
.	O
our	O
data	O
support	O
the	O
pivotal	O
role	O
of	O
the	O
most	O
characterized	O
fibro	B-T007
##ly	I-T007
##tic	I-T007
bacteria	I-T007
(	O
prev	B-T007
##ote	I-T007
##ll	I-T007
##a	I-T007
,	O
rumin	B-T007
##occ	I-T007
##cus	I-T007
and	O
fibrob	B-T007
##acter	I-T007
)	O
,	O
and	O
highlight	O
a	O
substantial	O
,	O
although	O
most	O
probably	O
underestimated	O
,	O
contribution	O
of	O
fungi	B-T204
and	O
cilia	B-T204
##te	I-T204
protozoa	I-T204
to	O
polysaccharide	B-T103
degradation	O
.	O
particularly	O
these	O
results	O
may	O
motiv	O
##ate	O
further	O
exploration	O
of	O
the	O
role	O
and	O
the	O
functions	O
of	O
protozoa	B-T204
in	O
the	O
rumen	B-T017
.	O
moreover	O
,	O
an	O
important	O
part	O
of	O
the	O
fibro	B-T007
##ly	I-T007
##tic	I-T007
bacterial	I-T007
community	I-T007
remains	O
to	O
be	O
characterized	O
since	O
one	O
third	O
of	O
the	O
ca	B-T103
##zyme	I-T103
transcripts	B-T103
originated	O
from	O
distant	O
##ly	O
related	O
strains	B-T007
.	O
these	O
findings	O
are	O
used	O
to	O
highlight	O
limitations	O
of	O
current	O
meta	B-T058
##trans	I-T058
##crip	I-T058
##to	I-T058
##mics	I-T058
approaches	O
to	O
understand	O
the	O
functional	O
rumen	B-T017
microbial	O
community	O
and	O
opportunities	O
to	O
circumvent	O
them	O
.	O

effect	O
of	O
type	B-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
on	O
the	O
pharmacokinetics	O
and	O
transpl	O
##acental	O
transfer	O
of	O
nifedipine	B-T103
in	O
hypertensive	B-T038
pregnant	B-T098
women	I-T098
diabetes	B-T038
mellitus	I-T038
can	O
inhibit	O
cytochrome	B-T103
p450	I-T103
3a	I-T103
##4	I-T103
,	O
an	O
enzyme	B-T103
responsible	O
for	O
the	O
metabolism	B-T038
of	O
nifedipine	B-T103
,	O
used	O
for	O
the	O
treatment	B-T058
of	O
hypertension	B-T038
in	O
pregnant	B-T098
women	I-T098
.	O
we	O
aimed	O
to	O
assess	O
the	O
effect	O
of	O
type	B-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
(	O
t2dm	B-T038
)	O
on	O
the	O
pharmacokinetics	O
,	O
placental	O
transfer	O
and	O
distribution	O
of	O
nifedipine	B-T103
in	O
amniotic	B-T031
fluid	I-T031
in	O
hypertensive	B-T038
pregnant	B-T098
women	I-T098
.	O
the	O
study	B-T062
was	O
conducted	O
in	O
12	O
hypertensive	B-T038
pregnant	B-T098
women	I-T098
[	O
control	O
group	O
(	O
cg	O
)	O
]	O
and	O
10	O
hypertensive	B-T038
pregnant	B-T098
women	I-T098
with	O
t2dm	B-T038
taking	O
slow	O
-	O
release	O
nifedipine	B-T103
(	O
20	O
mg	O
,	O
12	O
/	O
12	O
h	O
)	O
.	O
on	O
the	O
34	O
##th	O
week	O
of	O
gestation	B-T038
,	O
serial	O
blood	B-T031
samples	I-T031
were	O
collected	O
(	O
0	O
-	O
12	O
h	O
)	O
after	O
administration	B-T058
of	O
the	O
medication	B-T103
.	O
at	O
delivery	O
,	O
samples	B-T031
of	O
maternal	O
and	O
fetal	B-T031
blood	I-T031
and	O
amniotic	B-T031
fluid	I-T031
were	O
collected	O
for	O
determination	B-T058
of	O
nifedipine	B-T103
distribution	O
in	O
these	O
compartments	O
.	O
the	O
median	O
pharmacokinetic	O
parameters	O
of	O
cg	O
were	O
:	O
peak	O
plasma	O
concentration	O
(	O
cmax	O
)	O
26	O
.	O
41	O
ng	O
ml	O
(	O
-	O
1	O
)	O
,	O
time	O
to	O
reach	O
cmax	O
(	O
tma	O
##x	O
)	O
1	O
.	O
79	O
h	O
,	O
area	O
under	O
the	O
plasma	O
concentration	O
vs	O
.	O
time	O
curve	O
from	O
0	O
-	O
12	O
h	O
(	O
auc	O
0	O
-	O
12	O
)	O
235	O
.	O
99	O
ng	O
.	O
h	O
ml	O
(	O
-	O
1	O
)	O
,	O
half	O
-	O
life	O
(	O
t	O
##½	O
)	O
4	O
.	O
34	O
h	O
,	O
volume	O
of	O
distribution	O
divided	O
by	O
bioavailability	O
(	O
vd	O
/	O
f	O
)	O
560	O
.	O
96	O
l	O
,	O
and	O
cl	O
##t	O
/	O
f	O
84	O
.	O
77	O
l	O
h	O
(	O
-	O
1	O
)	O
.	O
the	O
parameters	O
for	O
t2dm	B-T038
group	B-T098
were	O
:	O
cmax	O
23	O
.	O
52	O
ng	O
ml	O
(	O
-	O
1	O
)	O
,	O
tma	O
##x	O
1	O
.	O
48	O
h	O
,	O
auc	O
0	O
-	O
12	O
202	O
.	O
23	O
ng	O
.	O
h	O
ml	O
(	O
-	O
1	O
)	O
,	O
t	O
##½	O
5	O
.	O
00	O
h	O
,	O
vd	O
/	O
f	O
60	O
##9	O
.	O
40	O
l	O
,	O
and	O
apparent	O
total	O
clearance	O
(	O
cl	O
##t	O
/	O
f	O
)	O
98	O
.	O
94	O
l	O
h	O
(	O
-	O
1	O
)	O
.	O
the	O
ratios	O
of	O
plasma	O
concentrations	O
of	O
nifedipine	B-T103
in	O
the	O
umbilical	B-T017
vein	I-T017
,	O
interv	B-T082
##ill	I-T082
##ous	I-T082
space	I-T082
and	O
amniotic	B-T031
fluid	I-T031
to	O
those	O
in	O
the	O
maternal	O
vein	O
for	O
cg	O
and	O
t2dm	B-T038
were	O
0	O
.	O
53	O
and	O
0	O
.	O
44	O
,	O
0	O
.	O
78	O
and	O
0	O
.	O
87	O
,	O
respectively	O
,	O
with	O
an	O
amniotic	B-T031
fluid	I-T031
/	O
maternal	O
plasma	B-T031
ratio	O
of	O
0	O
.	O
05	O
for	O
both	O
groups	B-T098
.	O
the	O
ratios	O
of	O
plasma	O
concentrations	O
in	O
the	O
umbilical	B-T017
artery	I-T017
to	O
those	O
in	O
the	O
umbilical	B-T017
vein	I-T017
were	O
0	O
.	O
82	O
for	O
cg	O
and	O
0	O
.	O
88	O
for	O
t2dm	B-T038
.	O
there	O
was	O
no	O
influence	O
of	O
t2dm	B-T038
on	O
the	O
pharmacokinetics	O
or	O
placental	O
transfer	O
of	O
nifedipine	B-T103
in	O
hypertensive	B-T038
women	B-T098
with	O
controlled	B-T033
diabetes	B-T038
.	O

dobutamine	B-T058
stress	I-T058
echocardiography	I-T058
:	O
impact	O
of	O
abnormal	B-T033
blood	B-T033
potassium	I-T033
levels	I-T033
on	O
cardiac	B-T033
arrhythmias	I-T033
guidelines	B-T170
suggest	O
that	O
an	O
abnormal	B-T033
blood	B-T033
potassium	I-T033
level	I-T033
is	O
a	O
relative	O
contraindication	O
to	O
performing	O
dobutamine	B-T058
stress	I-T058
echocardiography	I-T058
(	O
ds	B-T058
##e	I-T058
)	O
.	O
however	O
,	O
this	O
has	O
not	O
been	O
previously	O
studied	O
.	O
we	O
reviewed	O
a	O
consecutive	B-T062
series	I-T062
of	I-T062
patients	I-T062
who	O
had	O
potassium	B-T103
testing	O
within	O
48	O
hours	O
of	O
undergoing	O
ds	B-T058
##e	I-T058
for	O
the	O
evaluation	B-T058
of	O
myocardial	B-T038
ischemia	I-T038
over	O
a	O
10	O
-	O
year	O
period	O
(	O
n	O
=	O
13	O
,	O
198	O
)	O
.	O
normal	O
potassium	B-T103
range	O
in	O
our	O
laboratory	B-T092
is	O
3	O
.	O
6	O
-	O
5	O
.	O
2	O
mmol	O
/	O
l	O
.	O
hem	B-T033
##oly	I-T033
##zed	I-T033
samples	I-T033
were	O
not	O
included	O
.	O
the	O
association	O
of	O
potassium	B-T033
levels	I-T033
with	O
the	O
development	O
of	O
supraventricular	B-T038
and	O
ventricular	B-T038
arrhythmias	I-T038
was	O
assessed	O
.	O
the	O
incidence	O
of	O
clinically	O
significant	O
arrhythmias	B-T033
was	O
very	O
low	O
(	O
supraventricular	B-T038
tachycardia	I-T038
/	O
atrial	B-T038
fibrillation	I-T038
,	O
4	O
.	O
9	O
%	O
;	O
nons	B-T038
##ust	I-T038
##ained	I-T038
ventricular	I-T038
tachycardia	I-T038
,	O
2	O
.	O
9	O
%	O
;	O
sustained	B-T038
ventricular	I-T038
tachycardia	I-T038
or	O
ventricular	B-T038
fibrillation	I-T038
,	O
0	O
.	O
1	O
%	O
)	O
,	O
confirming	O
the	O
overall	O
safety	O
of	O
ds	B-T058
##e	I-T058
.	O
most	O
arrhythmias	B-T033
(	O
88	O
%	O
)	O
occurred	O
in	O
patients	O
with	O
normal	O
potassium	B-T033
levels	I-T033
,	O
and	O
arrhythmia	B-T033
rates	O
remained	O
low	O
in	O
patients	O
with	O
potassium	B-T103
abnormalities	B-T033
.	O
patients	O
with	O
hyperkal	B-T033
##emia	I-T033
had	O
a	O
lower	O
risk	O
of	O
developing	O
mild	O
(	O
odds	O
ratio	O
[	O
or	O
]	O
,	O
0	O
.	O
39	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
22	O
-	O
0	O
.	O
71	O
)	O
and	O
severe	O
(	O
or	O
,	O
0	O
.	O
13	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
01	O
-	O
0	O
.	O
68	O
)	O
supraventricular	B-T038
arrhythmias	I-T038
as	O
well	O
as	O
mild	O
ventricular	B-T038
arrhythmias	I-T038
(	O
or	O
,	O
0	O
.	O
58	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
40	O
-	O
0	O
.	O
83	O
)	O
.	O
even	O
though	O
events	O
were	O
rare	O
,	O
patients	O
with	O
severe	O
hypokal	B-T033
##emia	I-T033
(	O
potassium	B-T033
levels	I-T033
≤	O
3	O
.	O
1	O
mmol	O
/	O
l	O
)	O
had	O
an	O
increased	O
risk	O
of	O
supraventricular	B-T038
arrhythmia	I-T038
and	O
ventricular	B-T038
ect	I-T038
##opy	I-T038
.	O
ds	B-T058
##e	I-T058
is	O
safe	O
even	O
in	O
the	O
setting	O
of	O
abnormalities	B-T033
in	O
blood	B-T033
potassium	I-T033
concentrations	I-T033
,	O
and	O
hence	O
cancell	O
##ation	O
of	O
ds	B-T058
##e	I-T058
in	O
patients	O
with	O
potassium	B-T103
abnormalities	B-T033
does	O
not	O
appear	O
warranted	O
.	O
elevated	O
potassium	B-T033
levels	I-T033
are	O
associated	O
with	O
lower	O
rates	O
of	O
clinically	O
significant	O
supraventricular	B-T038
and	O
ventricular	B-T038
arrhythmias	I-T038
.	O
while	O
remaining	O
at	O
relatively	O
low	O
risk	O
,	O
patients	O
with	O
very	O
low	O
potassium	B-T033
levels	I-T033
(	O
≤	O
##3	O
.	O
1	O
mmol	O
/	O
l	O
)	O
at	O
the	O
time	O
of	O
ds	B-T058
##e	I-T058
have	O
a	O
modestly	O
increased	O
risk	O
of	O
arrhythmia	B-T033
.	O
consideration	O
could	O
be	O
given	O
to	O
correcting	O
severe	O
hypokal	B-T033
##emia	I-T033
prior	O
to	O
ds	B-T058
##e	I-T058
.	O

anti	O
-	O
inflammatory	O
effect	O
of	O
y	B-T103
##u	I-T103
-	I-T103
pin	I-T103
##g	I-T103
-	I-T103
fen	I-T103
##g	I-T103
-	I-T103
san	I-T103
via	O
tgf	B-T103
-	I-T103
β1	I-T103
signaling	B-T038
suppression	I-T038
in	O
rat	B-T204
model	B-T038
of	O
copd	B-T038
y	B-T103
##u	I-T103
-	I-T103
pin	I-T103
##g	I-T103
-	I-T103
fen	I-T103
##g	I-T103
-	I-T103
san	I-T103
(	O
y	B-T103
##p	I-T103
##fs	I-T103
)	O
is	O
a	O
classical	O
traditional	O
chinese	B-T103
medicine	I-T103
that	O
is	O
widely	O
used	O
for	O
treatment	O
of	O
the	O
diseases	B-T038
in	O
respiratory	B-T022
systems	I-T022
,	O
including	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
(	O
copd	B-T038
)	O
recognized	O
as	O
chronic	B-T038
inflammatory	I-T038
disease	I-T038
.	O
however	O
,	O
the	O
molecular	B-T038
mechanism	I-T038
remains	O
unclear	O
.	O
here	O
we	O
detected	O
the	O
factors	O
involved	O
in	O
transforming	B-T103
growth	I-T103
factor	I-T103
beta	I-T103
1	I-T103
(	O
tgf	B-T103
-	I-T103
β1	I-T103
)	O
/	O
smad	B-T103
##2	I-T103
signaling	B-T038
pathway	I-T038
and	O
inflammatory	B-T103
cytokines	I-T103
,	O
to	O
clarify	O
whether	O
y	B-T103
##p	I-T103
##fs	I-T103
could	O
attenuate	O
inflammatory	B-T038
response	I-T038
dependent	O
on	O
tgf	B-T103
-	I-T103
β1	I-T103
/	O
smad	B-T103
##2	I-T103
signaling	B-T038
in	O
copd	B-T038
rats	B-T204
or	O
cigarette	B-T103
smoke	I-T103
extract	I-T103
(	O
cse	B-T103
)	O
-	O
treated	O
human	B-T204
bronchial	B-T017
epithelial	I-T017
(	I-T017
be	I-T017
##as	I-T017
-	I-T017
2b	I-T017
)	I-T017
cells	I-T017
.	O
the	O
copd	B-T038
rat	B-T204
model	B-T038
was	O
established	O
by	O
exposure	O
to	O
cigarette	B-T103
smoke	I-T103
and	O
intratracheal	O
instillation	O
of	O
lipopolysaccharide	B-T103
,	O
y	B-T103
##p	I-T103
##fs	I-T103
was	O
administered	O
to	O
the	O
animals	B-T204
.	O
the	O
efficacy	O
of	O
y	B-T103
##p	I-T103
##fs	I-T103
was	O
evaluated	O
by	O
comparing	O
the	O
severity	O
of	O
pulmonary	B-T038
pathological	I-T038
damage	I-T038
,	O
pro	B-T103
-	I-T103
inflammation	I-T103
cytokines	I-T103
,	O
collagen	B-T017
related	I-T017
genes	I-T017
and	O
the	O
activation	O
of	O
tgf	B-T103
-	I-T103
β1	I-T103
/	O
smad	B-T103
##2	I-T103
signaling	B-T038
pathway	I-T038
.	O
furthermore	O
,	O
cse	B-T103
-	O
treated	O
cells	B-T017
were	O
employed	O
to	O
confirm	O
whether	O
the	O
effect	O
of	O
y	B-T103
##p	I-T103
##fs	I-T103
was	O
dependent	O
on	O
the	O
tgf	B-T103
-	I-T103
β1	I-T103
/	O
smad	B-T103
##2	I-T103
signaling	B-T038
via	O
knockdown	B-T062
smad	B-T017
##2	I-T017
(	O
si	B-T103
-	I-T103
rna	I-T103
)	O
,	O
or	O
pretreatment	O
with	O
the	O
inhibitor	O
of	O
tgf	B-T103
-	I-T103
β1	I-T103
.	O
administration	O
of	O
y	B-T103
##p	I-T103
##fs	I-T103
effectively	O
alleviated	O
injury	B-T037
of	I-T037
lung	I-T037
,	O
suppressed	O
releasing	O
of	O
pro	B-T103
-	I-T103
inflammatory	I-T103
cytokines	I-T103
and	O
collagen	B-T038
deposition	I-T038
in	O
copd	B-T038
animals	B-T204
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
whereas	O
exogenous	B-T103
tgf	I-T103
-	I-T103
β1	I-T103
promoted	O
releasing	O
of	O
il	B-T103
-	I-T103
1β	I-T103
,	O
il	B-T103
-	I-T103
6	I-T103
,	O
tnfα	B-T103
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
administration	O
y	B-T103
##p	I-T103
##fs	I-T103
reduced	O
inflammatory	B-T038
response	I-T038
significantly	O
,	O
also	O
down	B-T038
-	I-T038
regulated	I-T038
tgf	B-T103
-	I-T103
β1	I-T103
/	O
smad	B-T103
##2	I-T103
signaling	B-T038
in	B-T082
vivo	I-T082
and	O
in	O
vitro	O
.	O
unexpectedly	O
,	O
knockdown	B-T062
smad	B-T017
##2	I-T017
or	O
inhibition	O
of	O
tgf	B-T103
-	I-T103
β1	I-T103
abolished	O
anti	O
-	O
inflammatory	O
effect	O
of	O
y	B-T103
##p	I-T103
##fs	I-T103
in	O
cse	B-T103
-	O
treated	O
cells	B-T017
.	O
y	B-T103
##p	I-T103
##fs	I-T103
accomplished	O
anti	O
-	O
inflammatory	O
effects	O
mainly	O
by	O
suppressing	O
phosphorylation	B-T038
of	O
smad	B-T103
##2	I-T103
,	O
tgf	B-T103
-	I-T103
β1	I-T103
/	O
smad	B-T103
##2	I-T103
signaling	B-T038
pathway	I-T038
was	O
required	O
for	O
y	B-T103
##p	I-T103
##fs	I-T103
-	O
mediated	O
anti	O
-	O
inflammation	O
in	O
copd	B-T038
rats	B-T204
or	O
cse	B-T103
-	O
treated	O
be	B-T017
##as	I-T017
-	I-T017
2b	I-T017
cells	I-T017
.	O

an	O
attenuated	O
mycobacterium	B-T007
tuberculosis	I-T007
clinical	O
strain	O
with	O
a	O
defect	O
in	O
es	B-T103
##x	I-T103
-	I-T103
1	I-T103
secretion	B-T038
induces	O
minimal	O
host	O
immune	B-T038
responses	I-T038
and	O
pathology	B-T091
although	O
mycobacterium	B-T007
tuberculosis	I-T007
(	I-T007
m	I-T007
.	I-T007
tb	I-T007
)	I-T007
dk	I-T007
##98	I-T007
##97	I-T007
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	O
from	O
a	O
patient	O
with	O
extrap	B-T038
##ulmonary	I-T038
tuberculosis	I-T038
and	O
vaccination	B-T058
with	O
a	O
subunit	B-T103
vaccine	I-T103
(	O
h5	B-T103
##6	I-T103
)	O
induced	O
poor	O
protection	O
against	O
it	O
.	O
both	O
attenuation	O
and	O
lack	O
of	O
protection	O
are	O
because	O
m	B-T007
.	I-T007
tb	I-T007
dk	I-T007
##98	I-T007
##97	I-T007
cann	O
##ot	O
secrete	B-T038
the	O
es	B-T103
##xa	I-T103
virulence	B-T103
factor	I-T103
nor	O
induce	O
a	O
host	B-T038
response	I-T038
against	O
it	O
.	O
genome	O
sequencing	O
identified	O
a	O
frameshift	B-T038
mutation	I-T038
in	O
the	O
ecc	B-T017
##ca1	I-T017
gene	I-T017
.	O
since	O
the	O
encoded	O
ecc	B-T103
##ca1	I-T103
protein	I-T103
provides	O
energy	O
for	O
es	B-T103
##x	I-T103
-	I-T103
1	I-T103
secretion	B-T038
,	O
it	O
suggested	O
a	O
defect	O
in	O
the	O
es	B-T103
##x	I-T103
-	I-T103
1	I-T103
type	B-T038
vii	I-T038
secretion	I-T038
system	I-T038
.	O
genetic	O
complementation	O
with	O
a	O
plasmid	B-T103
carrying	O
the	O
m	B-T007
.	I-T007
tb	I-T007
h3	I-T007
##7	I-T007
##r	I-T007
##v	I-T007
sequence	O
of	O
ecc	B-T103
##ca1	I-T103
-	I-T103
ecc	I-T103
##cb	I-T103
##1	I-T103
-	I-T103
pe	I-T103
##35	I-T103
re	O
-	O
established	O
es	B-T103
##xa	I-T103
secretion	B-T038
,	O
host	O
specific	O
es	B-T103
##xa	I-T103
t	B-T017
-	I-T017
cell	I-T017
responses	B-T038
,	O
and	O
increased	O
strain	O
virulence	B-T038
.	O
the	O
es	B-T103
##x	I-T103
-	I-T103
1	I-T103
secretion	B-T038
defect	O
prevents	O
several	O
virulence	B-T103
factors	I-T103
from	O
being	O
functional	O
during	O
infection	B-T038
and	O
therefore	O
attenuates	O
m	B-T007
.	I-T007
tb	I-T007
.	O
it	O
preclude	O
##s	O
specific	O
t	B-T017
-	I-T017
cell	I-T017
responses	B-T038
against	O
strong	O
antigens	B-T103
and	O
we	O
found	O
very	O
little	O
in	B-T082
vivo	I-T082
cytokine	B-T038
production	I-T038
,	O
gross	B-T033
pathology	I-T033
or	O
granuloma	B-T038
formation	I-T038
in	O
lungs	B-T017
from	O
m	B-T007
.	I-T007
tb	I-T007
dk	I-T007
##98	I-T007
##97	I-T007
infected	O
animals	O
.	O
this	O
coincides	O
with	O
m	B-T007
.	I-T007
tb	I-T007
dk	I-T007
##98	I-T007
##97	I-T007
being	O
unable	O
to	O
disrupt	O
the	O
phag	B-T017
##osome	I-T017
membrane	I-T017
and	O
make	O
contact	O
to	O
the	O
cytosol	B-T017
.	O

identification	O
of	O
low	O
micromolar	O
dual	O
inhibitors	B-T103
for	O
ald	B-T103
##ose	I-T103
reductase	I-T103
(	O
al	B-T103
##r2	I-T103
)	O
and	O
poly	B-T103
(	I-T103
adp	I-T103
-	I-T103
ribose	I-T103
)	I-T103
polymerase	I-T103
(	O
parp	B-T103
-	I-T103
1	I-T103
)	O
using	O
structure	B-T082
based	O
design	O
approach	O
clinical	B-T062
studies	I-T062
have	O
revealed	O
that	O
diabetic	B-T038
retinopathy	I-T038
is	O
a	O
multifactorial	O
disorder	B-T038
.	O
moreover	O
,	O
studies	O
also	O
suggest	O
that	O
al	B-T103
##r2	I-T103
and	O
parp	B-T103
-	I-T103
1	I-T103
co	O
-	O
occur	O
in	O
retinal	B-T017
cells	B-T017
,	O
making	O
them	O
appropriate	O
targets	O
for	O
the	O
treatment	B-T058
of	O
diabetic	B-T038
retinopathy	I-T038
.	O
to	O
find	O
the	O
dual	O
inhibitors	B-T103
of	O
al	B-T103
##r2	I-T103
and	O
parp	B-T103
-	I-T103
1	I-T103
,	O
the	O
structure	B-T082
based	O
design	O
was	O
carried	O
out	O
in	O
parallel	O
for	O
both	O
the	O
target	O
proteins	B-T103
.	O
a	O
series	O
of	O
novel	O
thiaz	B-T103
##olid	I-T103
##ine	I-T103
-	I-T103
2	I-T103
,	I-T103
4	I-T103
-	I-T103
dione	I-T103
(	O
tz	B-T103
##d	I-T103
)	O
derivatives	O
were	O
therefore	O
rational	O
##ly	O
designed	O
,	O
synthesized	O
and	O
their	O
in	O
vitro	O
inhibitory	B-T038
activities	I-T038
against	O
al	B-T103
##r2	I-T103
and	O
parp	B-T103
-	I-T103
1	I-T103
were	O
evaluated	O
.	O
the	O
experimental	B-T033
results	I-T033
showed	O
that	O
compounds	B-T103
5	I-T103
##b	I-T103
and	O
5	B-T103
##f	I-T103
,	O
with	O
2	O
-	O
chloro	O
and	O
4	O
-	O
fluoro	O
substitutions	O
,	O
showed	O
biochemical	O
activities	O
in	O
micromolar	O
and	O
submic	O
##rom	O
##olar	O
range	O
(	O
ic50	O
1	O
.	O
34	O
-	O
5	O
.	O
03	O
##μm	O
)	O
against	O
both	O
the	O
targeted	O
enzymes	B-T103
.	O
the	O
structure	O
-	O
activity	O
relationship	O
elucidated	O
for	O
these	O
novel	O
inhibitors	B-T103
against	O
both	O
the	O
enzymes	B-T103
provide	O
new	O
insight	O
into	O
the	O
binding	B-T038
mode	O
of	O
the	O
inhibitors	B-T103
to	O
the	O
active	O
sites	O
of	O
enzymes	B-T103
.	O
the	O
positive	B-T033
results	O
of	O
the	O
biochemical	O
assay	B-T058
suggest	O
that	O
these	O
compounds	B-T103
may	O
be	O
further	O
optimized	O
and	O
utilized	O
for	O
the	O
treatment	B-T058
of	O
diabetic	B-T038
retinopathy	I-T038
.	O

voriconazole	B-T103
metabolism	B-T038
is	O
influenced	O
by	O
severe	O
inflammation	B-T038
:	O
a	O
prospective	B-T062
study	I-T062
during	O
an	O
infection	B-T038
or	O
inflammation	B-T038
,	O
several	O
drug	B-T103
-	O
metabolizing	B-T038
enzymes	B-T103
in	O
the	O
liver	B-T017
are	O
down	B-T038
-	I-T038
regulated	I-T038
,	O
including	O
cytochrome	B-T103
p450	I-T103
iso	I-T103
-	I-T103
enzymes	I-T103
.	O
since	O
voriconazole	B-T103
is	O
extensively	O
metabolized	B-T038
by	O
cytochrome	B-T103
p450	I-T103
iso	I-T103
-	I-T103
enzymes	I-T103
,	O
the	O
metabolism	B-T038
of	O
voriconazole	B-T103
can	O
be	O
influenced	O
during	O
inflammation	B-T038
via	O
reduced	O
clearance	B-T038
of	I-T038
the	I-T038
drug	I-T038
,	O
resulting	O
in	O
higher	O
voriconazole	B-T103
trough	O
concentrations	O
.	O
to	O
investigate	O
prospectively	O
the	O
influence	O
of	O
inflammation	B-T038
on	O
voriconazole	B-T103
metabolism	B-T038
and	O
voriconazole	B-T103
trough	O
conce	O
##nt	O
ratio	O
ns	O
.	O
a	O
prospective	B-T062
observational	I-T062
study	I-T062
was	O
performed	O
at	O
the	O
university	B-T092
medical	I-T092
center	I-T092
gro	B-T082
##ning	I-T082
##en	I-T082
.	O
patients	O
were	O
eligible	O
for	O
inclusion	O
if	O
they	O
were	O
≥1	O
##8	O
years	O
old	O
and	O
treated	B-T058
with	I-T058
voriconazole	B-T103
.	O
voriconazole	B-T103
and	O
voriconazole	O
-	O
n	O
-	O
oxide	O
concentrations	O
were	O
determined	O
in	O
disc	O
##arded	O
blood	B-T031
samples	I-T031
.	O
to	O
determine	O
the	O
degree	O
of	O
inflammation	B-T038
,	O
c	B-T058
-	I-T058
reactive	I-T058
protein	I-T058
(	I-T058
crp	I-T058
)	I-T058
concentrations	I-T058
were	O
used	O
.	O
subsequently	O
,	O
a	O
longitudinal	B-T062
data	I-T062
analysis	I-T062
was	O
performed	O
to	O
assess	O
the	O
effect	O
of	O
inflammation	B-T038
on	O
the	O
metabolic	B-T038
ratio	O
and	O
voriconazole	B-T103
trough	O
concentration	O
.	O
thirty	O
-	O
four	O
patients	O
were	O
included	O
.	O
in	O
total	O
48	O
##9	O
voriconazole	B-T103
trough	O
concentrations	O
were	O
included	O
in	O
the	O
longitudinal	B-T062
data	I-T062
analysis	I-T062
.	O
this	O
analysis	B-T062
showed	O
that	O
inflammation	B-T038
,	O
reflected	O
by	O
crp	B-T058
concentrations	I-T058
,	O
significantly	O
influence	O
d	O
the	O
metabolic	B-T038
ratio	O
,	O
voriconazole	B-T103
trough	O
concentration	O
and	O
voriconazole	O
-	O
n	O
-	O
oxide	O
concentration	O
(	O
all	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	B-T103
metabolism	B-T038
.	O
the	O
metabolic	B-T038
ratio	O
was	O
decreased	O
by	O
0	O
.	O
99	O
##22	O
##9	O
(	O
n	O
)	O
and	O
the	O
voriconazole	O
-	O
n	O
-	O
oxide	O
concentration	O
by	O
0	O
.	O
99	O
##77	O
##5	O
(	O
n	O
)	O
,	O
while	O
the	O
voriconazole	B-T103
trough	O
concentration	O
was	O
increased	O
by	O
1	O
.	O
005	O
##32	O
##1	O
(	O
n	O
)	O
,	O
where	O
n	O
is	O
the	O
difference	O
in	O
crp	B-T103
units	O
(	O
in	O
mg	O
/	O
l	O
)	O
.	O
this	O
study	O
shows	O
that	O
voriconazole	B-T103
metabolism	B-T038
is	O
decreased	O
during	O
inflammation	B-T038
,	O
resulting	O
in	O
higher	O
voriconazole	B-T103
trough	O
concentration	O
s	O
.	O
therefore	O
,	O
frequent	O
monitoring	B-T058
of	O
voriconazole	B-T103
serum	O
concentrations	O
is	O
recommended	O
during	O
and	O
following	O
severe	O
inflammation	B-T038
.	O

liver	B-T038
inflammation	I-T038
relates	O
to	O
decreased	O
canal	B-T017
##icular	I-T017
bile	B-T103
transporter	I-T103
expression	B-T038
in	O
pediatric	O
onset	O
intestinal	B-T038
failure	I-T038
although	O
liver	B-T038
disease	I-T038
is	O
a	O
major	O
complication	B-T038
of	O
parenteral	B-T058
nutrition	I-T058
(	O
pn	B-T058
)	O
for	O
intestinal	B-T038
failure	I-T038
(	O
if	B-T038
)	O
,	O
its	O
pathogenesis	B-T038
remains	O
unclear	O
.	O
we	O
investigated	O
potential	O
molecular	O
mechanisms	O
of	O
liver	B-T037
injury	I-T037
in	O
pediatric	O
onset	O
if	B-T038
.	O
liver	B-T017
expression	B-T038
of	O
canal	B-T017
##icular	I-T017
phospholipid	B-T103
(	O
abc	B-T103
##b4	I-T103
)	O
,	O
bile	B-T103
acid	I-T103
(	O
abc	B-T103
##b1	I-T103
##1	I-T103
)	O
,	O
and	O
sterol	B-T103
(	O
abc	B-T103
##g	I-T103
##5	I-T103
/	I-T103
8	I-T103
)	O
transporters	B-T103
,	O
their	O
upstream	B-T103
regulators	I-T103
lx	B-T103
##r	I-T103
and	O
fx	B-T103
##r	I-T103
as	O
well	O
as	O
pro	B-T103
-	I-T103
inflammatory	I-T103
cytokines	I-T103
interleukin	B-T103
-	I-T103
6	I-T103
(	O
il6	B-T103
)	O
and	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
(	O
tnf	B-T103
)	O
were	O
investigated	O
among	O
patients	O
with	O
if	B-T038
[	O
age	O
median	O
3	O
.	O
8	O
(	O
iqr	O
1	O
.	O
2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	B-T037
injury	I-T037
,	O
pn	B-T058
,	O
serum	B-T031
plant	B-T103
sterols	I-T103
,	O
fibroblast	B-T103
growth	I-T103
factor	I-T103
19	I-T103
,	O
and	O
α	B-T103
-	I-T103
tocopherol	I-T103
.	O
patients	O
receiving	O
pn	B-T058
currently	O
(	O
n	O
=	O
18	O
)	O
showed	O
more	O
advanced	O
liver	B-T037
injury	I-T037
than	O
patients	O
after	O
weaning	B-T033
off	O
pn	B-T058
(	O
n	O
=	O
30	O
)	O
.	O
histologic	O
portal	B-T033
inflammation	I-T033
strongly	O
segregated	O
pn	B-T058
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	B-T033
off	O
patients	O
(	O
3	O
%	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
coupled	O
with	O
progression	B-T038
of	O
cholestasis	B-T038
and	O
liver	B-T038
fibrosis	I-T038
.	O
patients	O
with	O
portal	B-T033
inflammation	I-T033
demonstrated	O
markedly	O
induced	O
liver	B-T017
rna	B-T038
expression	I-T038
of	O
il6	B-T017
and	O
tnf	B-T017
,	O
repression	B-T038
of	O
fx	B-T103
##r	I-T103
and	O
its	O
canal	B-T017
##icular	I-T017
bile	B-T103
transporter	I-T103
target	O
gene	B-T017
rna	B-T038
expression	I-T038
,	O
including	O
abc	B-T017
##b4	I-T017
and	O
abc	B-T017
##b1	I-T017
##1	I-T017
as	O
well	O
as	O
decreased	O
protein	B-T038
expression	I-T038
of	O
abc	B-T103
##b1	I-T103
##1	I-T103
and	O
abc	B-T103
##b4	I-T103
.	O
furthermore	O
,	O
upregulation	B-T038
of	O
lx	B-T103
##r	I-T103
and	O
abc	B-T017
##g	I-T017
##5	I-T017
/	I-T017
8	I-T017
rna	B-T038
expression	I-T038
was	O
suppressed	O
in	O
patients	O
with	O
portal	B-T033
inflammation	I-T033
.	O
current	O
pn	B-T058
,	O
increased	O
serum	B-T031
levels	O
of	O
plant	B-T103
sterols	I-T103
stigma	B-T103
##st	I-T103
##ero	I-T103
##l	I-T103
,	O
aven	B-T103
##aster	I-T103
##ol	I-T103
,	O
and	O
sit	B-T103
##osterol	I-T103
along	O
with	O
serum	B-T031
citrulline	B-T103
,	O
a	O
marker	B-T201
of	O
enter	B-T017
##ocyte	I-T017
mass	I-T017
,	O
predicted	O
portal	B-T033
inflammation	I-T033
.	O
in	O
pediatric	O
onset	O
if	B-T038
,	O
current	O
pn	B-T058
delivery	O
synergistically	O
with	O
intestinal	B-T017
compromise	O
promote	O
liver	B-T038
inflammation	I-T038
,	O
which	O
associates	O
with	O
progression	B-T038
of	O
biochemical	O
and	O
histologic	O
liver	B-T037
injury	I-T037
,	O
while	O
reducing	O
expression	B-T038
of	O
canal	B-T017
##icular	I-T017
bile	B-T103
transporters	I-T103
.	O

minimally	O
invasive	O
percutaneous	B-T058
nephr	I-T058
##olith	I-T058
##otomy	I-T058
improves	O
stone	O
-	O
free	O
rates	O
for	O
impacted	O
proximal	B-T082
ureteral	B-T038
stones	I-T038
:	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T062
-	I-T062
analysis	I-T062
urinary	B-T038
stones	I-T038
are	O
common	O
medical	O
disorders	B-T038
and	O
the	O
treatment	O
of	O
impacted	B-T038
proximal	B-T082
ureteral	I-T038
stones	I-T038
(	O
ip	B-T038
##us	I-T038
)	O
is	O
still	O
a	O
challenge	O
for	O
urolog	B-T097
##ists	I-T097
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
compare	B-T062
the	I-T062
efficacy	I-T062
and	O
safety	B-T062
of	O
minimally	O
invasive	O
percutaneous	B-T058
nephr	I-T058
##olith	I-T058
##otomy	I-T058
(	O
mi	O
-	O
pc	B-T058
##nl	I-T058
)	O
and	O
ureter	B-T058
##oscopic	I-T058
lithotripsy	I-T058
(	O
ur	B-T058
##l	I-T058
)	O
in	O
the	O
treatment	O
of	O
ip	B-T038
##us	I-T038
via	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
.	O
we	O
collected	O
studies	B-T062
using	O
pubmed	B-T170
,	O
embase	B-T170
,	O
and	O
cochrane	B-T170
library	I-T170
from	O
1978	O
to	O
november	O
2016	O
and	O
analyzed	B-T062
them	O
using	O
stat	B-T170
##a	I-T170
12	I-T170
.	I-T170
0	I-T170
and	O
rev	B-T170
##man	I-T170
5	I-T170
.	I-T170
3	I-T170
.	O
odds	O
ratios	O
(	O
or	O
s	O
)	O
and	O
standard	O
mean	O
difference	O
(	O
smd	O
)	O
were	O
calculated	O
for	O
binary	O
and	O
continuous	O
variables	O
respectively	O
,	O
accompanied	O
with	O
95	O
%	O
confidence	O
intervals	O
(	O
cis	O
)	O
.	O
all	O
study	B-T062
procedures	O
followed	O
the	O
prism	B-T170
##a	I-T170
guidelines	I-T170
.	O
five	O
prospective	B-T062
studies	I-T062
were	O
included	O
in	O
our	O
meta	B-T062
-	I-T062
analysis	I-T062
,	O
with	O
242	O
mi	O
-	O
pc	B-T058
##nl	I-T058
and	O
256	O
ur	B-T058
##l	I-T058
cases	O
.	O
mi	O
-	O
pc	B-T058
##nl	I-T058
was	O
associated	O
with	O
a	O
longer	O
postoperative	O
hospital	O
stay	O
than	O
ur	B-T058
##l	I-T058
(	O
smd	O
,	O
3	O
.	O
14	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
27	O
to	O
5	O
.	O
55	O
)	O
.	O
however	O
,	O
no	O
significant	O
difference	O
was	O
observed	O
in	O
operative	O
time	O
(	O
smd	O
,	O
-	O
0	O
.	O
38	O
;	O
95	O
%	O
ci	O
,	O
-	O
3	O
.	O
15	O
to	O
2	O
.	O
38	O
)	O
.	O
in	O
addition	O
,	O
mi	O
-	O
pc	B-T058
##nl	I-T058
had	O
higher	O
initial	O
(	O
or	O
,	O
11	O
.	O
12	O
;	O
95	O
%	O
ci	O
,	O
5	O
.	O
56	O
to	O
22	O
.	O
24	O
)	O
and	O
overall	O
stone	O
-	O
free	O
rates	O
(	O
or	O
,	O
8	O
.	O
70	O
;	O
95	O
%	O
ci	O
,	O
3	O
.	O
23	O
to	O
23	O
.	O
45	O
)	O
than	O
ur	B-T058
##l	I-T058
,	O
along	O
with	O
lower	O
possibilities	O
of	O
surgical	B-T058
conversion	I-T058
(	O
or	O
,	O
0	O
.	O
11	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
03	O
to	O
0	O
.	O
49	O
)	O
and	O
postoperative	O
shock	B-T058
wave	I-T058
lithotripsy	I-T058
(	O
or	O
,	O
0	O
.	O
06	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
02	O
to	O
0	O
.	O
18	O
)	O
.	O
regarding	O
complications	B-T038
,	O
no	O
significant	O
differences	O
were	O
observed	O
between	B-T082
mi	O
-	O
pc	B-T058
##nl	I-T058
and	O
ur	B-T058
##l	I-T058
(	O
or	O
,	O
1	O
.	O
39	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
93	O
to	O
2	O
.	O
10	O
)	O
,	O
except	O
for	O
hematuria	B-T038
(	O
or	O
,	O
4	O
.	O
80	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
45	O
to	O
15	O
.	O
94	O
)	O
.	O
mi	O
-	O
pc	B-T058
##nl	I-T058
is	O
optimal	O
and	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
treatment	B-T058
method	I-T058
for	O
ip	B-T038
##us	I-T038
,	O
as	O
it	O
has	O
better	O
efficacy	O
and	O
a	O
safety	B-T062
profile	O
similar	O
to	O
that	O
of	O
ur	B-T058
##l	I-T058
.	O
however	O
,	O
further	O
high	O
quality	O
studies	O
with	O
larger	O
sample	O
size	O
are	O
required	O
in	O
future	O
.	O

ultrasonography	B-T058
and	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
evaluation	B-T058
of	O
pediatric	O
spinal	B-T017
anomalies	I-T017
spinal	B-T017
dys	I-T017
##ra	I-T017
##phi	I-T017
##sm	I-T017
##s	I-T017
are	O
congenital	B-T017
abnormalities	I-T017
of	O
the	O
spine	B-T017
due	O
to	O
imperfect	O
fusion	O
of	O
midline	B-T082
mesenchymal	O
,	O
bony	O
and	O
neural	O
structures	B-T082
.	O
imaging	B-T058
plays	O
a	O
vital	O
role	O
in	O
their	O
evaluation	B-T058
as	O
significant	O
portion	O
of	O
patients	O
may	O
present	O
with	O
concurrent	O
anomalies	B-T017
that	O
need	O
to	O
be	O
corrected	O
simultaneously	O
to	O
avoid	O
repeat	B-T058
surgeries	I-T058
.	O
the	O
aims	O
of	O
the	O
study	B-T062
were	O
to	O
evaluate	B-T058
spinal	B-T017
dys	I-T017
##ra	I-T017
##phi	I-T017
##sm	I-T017
##s	I-T017
using	O
us	B-T058
##g	I-T058
and	O
mri	B-T058
and	O
to	O
correlate	O
imaging	B-T058
findings	O
with	O
operative	O
findings	O
in	O
patients	O
undergoing	O
surgery	B-T058
.	O
hospital	B-T092
based	O
observational	B-T062
study	I-T062
conducted	O
over	O
a	O
period	O
of	O
year	O
.	O
38	O
cases	O
of	O
both	O
sexes	O
and	O
below	O
12	O
years	O
of	O
age	O
with	O
spinal	B-T017
dys	I-T017
##ra	I-T017
##phi	I-T017
##sm	I-T017
were	O
studied	O
.	O
us	B-T058
##g	I-T058
was	O
performed	O
in	O
29	O
cases	O
where	O
acoustic	O
window	O
was	O
available	O
for	O
proper	O
evaluation	B-T058
.	O
mri	B-T058
was	O
performed	O
in	O
all	O
cases	O
.	O
us	B-T058
##g	I-T058
findings	O
were	O
compared	O
with	O
mri	B-T058
findings	O
and	O
operative	O
follow	B-T058
up	I-T058
was	O
taken	O
in	O
23	O
cases	O
who	O
underwent	O
operative	B-T058
management	I-T058
.	O
results	O
were	O
analysed	B-T062
using	O
percentage	O
and	O
arithmetic	O
mean	O
.	O
39	O
.	O
47	O
%	O
cases	O
were	O
male	O
and	O
60	O
.	O
53	O
%	O
cases	O
were	O
female	O
.	O
neonatal	O
period	O
was	O
the	O
most	O
common	O
presenting	O
age	O
group	O
.	O
closed	O
spinal	B-T017
dys	I-T017
##ra	I-T017
##phi	I-T017
##sm	I-T017
(	O
63	O
.	O
16	O
%	O
)	O
was	O
more	O
common	O
than	O
open	B-T082
(	O
36	O
.	O
84	O
%	O
)	O
.	O
79	O
.	O
31	O
%	O
cases	O
showed	O
full	O
agreement	O
between	O
spinal	B-T082
us	B-T058
##g	I-T058
and	O
mri	B-T058
examinations	B-T058
and	O
6	O
out	O
of	O
20	O
.	O
69	O
%	O
showed	O
partial	O
agreement	O
.	O
on	O
operative	O
correlation	O
,	O
us	B-T058
##g	I-T058
findings	O
were	O
confirmatory	B-T033
in	O
91	O
.	O
30	O
%	O
cases	O
and	O
mri	B-T058
findings	O
were	O
confirmatory	B-T033
in	O
100	O
%	O
cases	O
.	O
us	B-T058
##g	I-T058
can	O
be	O
used	O
as	O
the	O
initial	O
modality	O
for	O
evaluation	B-T058
of	O
spinal	B-T017
dys	I-T017
##ra	I-T017
##phi	I-T017
##sm	I-T017
as	O
well	O
as	O
for	O
screening	B-T058
of	O
suspected	O
cases	O
.	O
mri	B-T058
is	O
indicated	O
to	O
confirm	O
abnormal	B-T033
us	B-T058
##g	I-T058
findings	O
,	O
which	O
shows	O
all	O
concurrent	O
abnormalities	B-T017
and	O
also	O
provides	O
additional	O
anatomical	O
details	O
relevant	O
to	O
surgical	B-T170
planning	I-T170
.	O

impact	O
of	O
diabetic	B-T038
ketoac	I-T038
##idosis	I-T038
management	B-T058
in	O
the	O
medical	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
after	O
order	B-T170
set	I-T170
implementation	O
to	O
determine	O
the	O
rate	O
of	O
compliance	B-T058
to	O
the	O
2006	O
and	O
2009	O
ada	B-T170
dk	I-T170
##a	I-T170
guidelines	I-T170
in	O
the	O
medical	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
(	O
mic	B-T092
##u	I-T092
)	O
at	O
a	O
large	O
academic	B-T092
medical	I-T092
centre	I-T092
after	O
the	O
implementation	O
of	O
a	O
computer	B-T170
##ised	I-T170
dk	I-T170
##a	I-T170
order	I-T170
set	I-T170
and	O
protocol	B-T058
.	O
retrospective	O
chart	B-T170
review	I-T170
of	O
adult	O
patients	O
with	O
dk	B-T038
##a	I-T038
admitted	B-T058
to	O
the	O
mic	B-T092
##u	I-T092
.	O
results	O
of	O
pre	B-T170
-	I-T170
order	I-T170
set	I-T170
(	O
pre	B-T170
)	O
were	O
compared	O
to	O
those	O
of	O
data	O
post	B-T170
-	I-T170
order	I-T170
set	I-T170
(	O
post	B-T170
)	O
.	O
the	O
primary	O
outcome	O
was	O
a	O
composite	O
administration	B-T058
of	O
intravenous	B-T058
fluid	I-T058
resuscitation	I-T058
in	O
the	O
first	O
24	O
h	O
,	O
insulin	B-T103
bolus	B-T058
and	O
initial	O
insulin	B-T103
infusion	O
rate	O
.	O
twelve	O
of	O
60	O
patients	O
(	O
20	O
%	O
)	O
in	O
the	O
pre	O
group	O
received	O
treatment	B-T058
compliant	O
with	O
the	O
2006	O
guidelines	B-T170
versus	O
14	O
of	O
55	O
patients	O
(	O
25	O
.	O
5	O
%	O
)	O
in	O
the	O
post	O
group	O
(	O
or	O
1	O
.	O
22	O
95	O
%	O
ci	O
0	O
.	O
44	O
to	O
3	O
.	O
4	O
,	O
p	O
=	O
0	O
.	O
51	O
)	O
.	O
compliance	B-T058
to	O
the	O
2009	O
guidelines	B-T170
was	O
significantly	O
higher	O
in	O
the	O
post	O
group	O
(	O
31	O
.	O
7	O
%	O
versus	O
65	O
.	O
5	O
%	O
,	O
or	O
4	O
.	O
44	O
95	O
%	O
ci	O
1	O
.	O
8	O
to	O
10	O
.	O
92	O
,	O
p	O
=	O
0	O
.	O
0004	O
)	O
.	O
compliance	B-T058
for	O
individual	O
components	O
was	O
26	O
.	O
7	O
%	O
versus	O
70	O
.	O
9	O
%	O
for	O
fluid	B-T058
resuscitation	I-T058
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
,	O
55	O
%	O
versus	O
49	O
.	O
1	O
%	O
for	O
insulin	B-T103
bolus	B-T058
(	O
p	O
=	O
0	O
.	O
58	O
)	O
and	O
60	O
%	O
versus	O
81	O
.	O
3	O
%	O
for	O
initial	O
insulin	B-T103
infusion	O
rate	O
(	O
p	O
=	O
0	O
.	O
014	O
)	O
,	O
respectively	O
.	O
time	O
to	O
dk	B-T038
##a	I-T038
resolution	O
was	O
decreased	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
,	O
and	O
hypoglycaemia	B-T038
was	O
increased	O
(	O
p	O
=	O
0	O
.	O
002	O
##2	O
)	O
.	O
implementation	O
of	O
a	O
computer	B-T170
##ised	I-T170
dk	I-T170
##a	I-T170
order	I-T170
set	I-T170
and	O
protocol	B-T058
was	O
associated	O
with	O
improved	B-T033
compliance	B-T058
to	O
the	O
2009	O
ada	B-T170
dk	I-T170
##a	I-T170
guidelines	I-T170
,	O
24	O
-	O
h	O
fluid	B-T058
resuscitation	I-T058
,	O
initial	O
insulin	B-T103
infusion	O
rate	O
,	O
time	O
to	O
dk	B-T038
##a	I-T038
resolution	O
and	O
appropriate	O
transition	O
to	O
subcutaneous	B-T082
insulin	B-T103
.	O
however	O
,	O
patients	O
in	O
the	O
post	O
implementation	O
group	O
were	O
more	O
likely	O
to	O
exhibit	O
hypoglycaemia	B-T038
.	O
future	O
assessment	O
is	O
warranted	O
.	O

high	O
diversity	O
of	O
plan	B-T007
##ct	I-T007
##omycetes	I-T007
in	O
soils	O
of	O
two	O
lichen	B-T204
-	O
dominated	O
sub	B-T082
-	I-T082
arctic	I-T082
ecosystems	O
of	O
northwest	B-T082
##ern	I-T082
sib	B-T082
##eria	I-T082
a	O
wide	O
variety	O
of	O
terrestrial	B-T082
ecosystems	O
in	O
tun	B-T082
##dr	I-T082
##a	I-T082
have	O
a	O
ground	O
vegetation	O
cover	O
composed	O
of	O
rein	O
##de	O
##er	O
lichen	B-T204
##s	I-T204
(	O
genera	B-T170
clad	B-T204
##onia	I-T204
and	O
cet	B-T204
##ra	I-T204
##ri	I-T204
##a	I-T204
)	O
.	O
the	O
microbial	O
communities	O
of	O
two	O
lichen	B-T204
-	O
dominated	O
ecosystems	O
typical	O
of	O
the	O
sub	B-T082
-	I-T082
arctic	I-T082
zone	I-T082
of	O
northwest	B-T082
##ern	I-T082
sib	B-T082
##eria	I-T082
,	O
that	O
is	O
a	O
forest	O
##ed	O
tun	B-T082
##dr	I-T082
##a	I-T082
soil	O
and	O
a	O
shallow	B-T082
acidic	I-T082
pea	I-T082
##tl	I-T082
##and	I-T082
,	O
were	O
examined	O
in	O
our	O
study	B-T062
.	O
as	O
revealed	O
by	O
molecular	O
analyses	O
,	O
soil	O
and	O
pea	O
##t	O
layers	O
just	O
beneath	O
the	O
lichen	B-T204
cover	O
were	O
abundantly	O
colonized	B-T033
by	O
bacteria	B-T007
from	O
the	O
phylum	B-T170
plan	B-T007
##ct	I-T007
##omycetes	I-T007
.	O
highest	O
abundance	O
of	O
plan	B-T007
##ct	I-T007
##omycetes	I-T007
detected	O
by	O
fluorescence	O
in	B-T062
situ	I-T062
hybridization	I-T062
was	O
in	O
the	O
range	O
2	O
.	O
2	O
-	O
2	O
.	O
7	O
×	O
10	O
(	O
7	O
)	O
cells	O
per	O
gram	O
of	O
wet	O
weight	O
.	O
16s	B-T103
rrna	I-T103
gene	B-T017
fragments	I-T017
from	O
the	O
plan	B-T007
##ct	I-T007
##omycetes	I-T007
comprised	O
8	O
-	O
13	O
%	O
of	O
total	O
16s	B-T103
rrna	I-T103
gene	B-T017
reads	O
retrieved	O
using	O
illumina	B-T170
pair	I-T170
-	I-T170
end	I-T170
sequencing	I-T170
from	O
the	O
soil	O
and	O
pea	O
##t	O
samples	O
.	O
lichen	B-T204
-	O
associated	O
assemblages	O
of	O
plan	B-T007
##ct	I-T007
##omycetes	I-T007
displayed	O
unexpectedly	O
high	O
diversity	O
,	O
with	O
a	O
total	O
of	O
89	O
,	O
66	O
##2	O
reads	O
representing	O
172	O
##3	O
operational	O
taxonomic	O
units	O
determined	O
at	O
97	O
%	O
sequence	O
identity	O
.	O
the	O
soil	O
of	O
forest	O
##ed	O
tun	B-T082
##dr	I-T082
##a	I-T082
was	O
dominated	O
by	O
unc	O
##ult	O
##iva	O
##ted	O
members	O
of	O
the	O
family	O
plan	B-T007
##ct	I-T007
##omyc	I-T007
##eta	I-T007
##ce	I-T007
##ae	I-T007
(	O
53	O
-	O
71	O
%	O
of	O
total	O
plan	B-T007
##ct	I-T007
##omycetes	I-T007
-	O
like	O
reads	O
)	O
,	O
while	O
sequences	B-T082
affiliated	O
with	O
the	O
ph	B-T007
##yc	I-T007
##isph	I-T007
##aer	I-T007
##a	I-T007
-	I-T007
related	I-T007
group	I-T007
wd	I-T007
##21	I-T007
##01	I-T007
(	O
recently	O
assigned	O
to	O
the	O
order	B-T170
tep	B-T007
##idis	I-T007
##phae	I-T007
##ral	I-T007
##es	I-T007
)	O
were	O
most	O
abundant	O
in	O
pea	O
##t	O
(	O
28	O
-	O
51	O
%	O
of	O
total	O
reads	O
)	O
.	O
representatives	O
of	O
the	O
isos	B-T007
##phae	I-T007
##ra	I-T007
-	O
sing	B-T007
##uli	I-T007
##sp	I-T007
##ha	I-T007
##era	I-T007
group	I-T007
(	O
14	O
-	O
28	O
%	O
of	O
total	O
reads	O
)	O
and	O
the	O
lineages	O
defined	O
by	O
the	O
genera	B-T170
gem	B-T007
##ma	I-T007
##ta	I-T007
(	O
1	O
-	O
4	O
%	O
)	O
and	O
plan	B-T007
##ct	I-T007
##op	I-T007
##irus	I-T007
-	O
rub	B-T007
##inis	I-T007
##phae	I-T007
##ra	I-T007
(	O
1	O
-	O
3	O
%	O
)	O
were	O
present	O
in	O
both	O
habitats	B-T082
.	O
two	O
strains	O
of	O
sing	B-T007
##uli	I-T007
##sp	I-T007
##ha	I-T007
##era	I-T007
-	I-T007
like	I-T007
bacteria	I-T007
were	O
isolated	O
from	O
studied	O
soil	O
and	O
pea	O
##t	O
samples	O
.	O
these	O
plan	B-T007
##ct	I-T007
##omycetes	I-T007
displayed	O
good	O
tolerance	O
of	O
low	O
temperatures	O
(	O
4	O
-	O
15	O
##°c	O
)	O
and	O
were	O
capable	O
of	O
growth	B-T038
on	O
a	O
number	O
of	O
polysaccharides	B-T103
,	O
including	O
lichen	B-T103
##an	I-T103
,	O
a	O
characteristic	O
component	O
of	O
lichen	B-T204
-	O
derived	O
phyto	O
##mas	O
##s	O
.	O

